Citrus Sinensis ID: 015374

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------41
Protein Sequence
MKDAPRKHKHKHKHPAVLAAQVQVLPLRFLLACAVLALRAPIAHHPILRTPCRSSTYNLNIITDTIAATTVVYEGAIIDKIEERNLAEIPLPAMSKARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAESSRTRA
Secondary Structure (PSIPRED)
cccccccccccccccccHHHHHccccHHHHHHHHHHHHcccccccccccccccccccccccccccccccccccccccccHHHHHcccccccccccccccccccccccccccEEccccEEEcccccccEEEEEEEEccccEEEEEEEcccccEEEEEEcccccHHHHHHHHHHHHcccccccEEEEccEEEcccccccEEEEEccccccHHHHcccccHHHHHHHHHHHHHHHHHHHHccccccccccccEEEccccccEEEEEcccccccccccccEEEEEccccccHHHHcccccccccccHHHHHHHHHHHHHcccccccccccHHHHHHHHHHccccccccccccccccccccccccccccccHHHHHHHHHccccccccccHHHHHcccccccccccccccccc
Secondary Structure Prediction (SSPRO)
ccccccccccccccHHHHHHHHHHHHHHHHHHHHHHHHccccccccccccccccccEEcEEccccEEEEEEEccccccccccccccccccccccccccccccHHHHccHHHHcHHHcccccccHHHEEEEEEEEEcccEEEEEEEEcccccEEEEEEEccccHHHHHHHHHHHHHccccccEccEEEEEEccccccEEEEEEccccccHHHHcccccHHHHHHHHHHHHHHHHHHHHccEEcccccHHHEEEEccccEEEEccccccEEcccccccccccccHHHccHHHHccccccccHHHHHHHHHHHHHHHHccccccccccHHHHHHHHHHHHccccHHHHcccccccccccccccHHHccHHHHHHHHHHccccccccccHHHHHccHHHcccHHHHcccccc
Coil and Loop (DISEMBL)
mkdaprkhkhkhkhpAVLAAQVQVLPLRFLLACAVLALRapiahhpilrtpcrsstynlNIITDTIAATTVVYEGAIIDKIeernlaeiplpamskarvytdvnvlrpkeywdyesltvqwgdqddyEVVRKVGRGKYSEVFEGinvntnerCIIKILKPVKKKKIKREIKILQNlcggpnvvKLLDIVRdqhsktpsLIFEYVNstdfkvlyptltdyDIRYYIYELLKALDYchsqgimhrdvkphnvmiDHELRKLRLIDwglaefyhpgkeyNVRVASryfkgpellvDLQDYDYSLDMWSLGCMFAgmifrkepffyghdnHDQLVKIAKDCCliiwcnsrhsrkpwskfinadnqhlvspeAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAESSRTRA
Flexible Loop (DISEMBL)
mkdaprkhkhkhkhpavlAAQVQVLPLRFLLACAVLALRAPIahhpilrtpcrssTYNLNIITDTIAATTVVYEGAIIDKIEernlaeiplpamskarvyTDVNVLRPKEYWdyesltvqwgdqddYEVVRKVGRGKYSevfeginvntnerciikilkpvkkkkiKREIKIlqnlcggpnvVKLLDIVRDQHSKTPSLifeyvnstdfkvLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQvraaessrtra
Low Complexity Region (SEG)
MKDAPRkhkhkhkhPAVLAAQVQVLPLRFLLACAVLALRAPIAHHPILRTPCRSSTYNLNiitdtiaattVVYEGAIIDKIEERNLAEIPLPAMSKARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCiikilkpvkkkkikreikiLQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAESSRTRA
Disordered region (IsUnstruct)
***************AVLAAQVQVLPLRFLLACAVLALRAPIAHHPILRTPCRSSTYNLNIITDTIAATTVVYEGAIIDKIEERNLAEIPLPAMSKARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFA************
Disordered Region (DISOPRED)
****************VLAAQVQVLPLRFLLACAVL*************************************************************RVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQV**********
Disordered Region (DISEMBL)
***************AVLAAQVQVLPLRFLLACAVLALRAPIAHHPILRTPCRSSTYNLNIITDTIAATTVVYEGAIIDKIEERNLAEIPLPAMSKARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQ***********
Disordered Region (DISPRO)
*************HPAVLAAQVQVLPLRFLLACAVLALRAPIAHHPILRTPCRSSTYNLNIITDTIAATTVVYEGA**********************VYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRA********
Transmembrane Helix (TMHMM)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
iiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (MEMSAT_SVM)
SSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (Phobius)
SSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MKDAPRKHKHKHKHPAVLAAQVQVLPLRFLLACAVLALRAPIAHHPILRTPCRSSTYNLNIITDTIAATTVVYEGAIIDKIEERNLAEIPLPAMSKARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAESSRTRA
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	408	2.2.26 [Sep-21-2011]
Q08467	409	Casein kinase II subunit	yes	no	0.870	0.867	0.784	1e-162
Q08466	403	Casein kinase II subunit	no	no	0.879	0.890	0.784	1e-161
P28523	332	Casein kinase II subunit	N/A	no	0.772	0.948	0.882	1e-159
O64817	333	Probable casein kinase II	no	no	0.762	0.933	0.851	1e-155
O64816	432	Casein kinase II subunit	no	no	0.769	0.726	0.806	1e-146
Q60737	391	Casein kinase II subunit	yes	no	0.752	0.785	0.731	1e-128
P19139	391	Casein kinase II subunit	yes	no	0.776	0.810	0.712	1e-128
P68400	391	Casein kinase II subunit	yes	no	0.767	0.800	0.716	1e-127
P68399	391	Casein kinase II subunit	yes	no	0.767	0.800	0.716	1e-127
P21868	391	Casein kinase II subunit	yes	no	0.745	0.777	0.735	1e-127

>sp|Q08467|CSK21_ARATH Casein kinase II subunit alpha-1 OS=Arabidopsis thaliana GN=CKA1 PE=1 SV=3

 Score =  572 bits (1473), Expect = e-162,   Method: Compositional matrix adjust.
 Identities = 306/390 (78%), Positives = 326/390 (83%), Gaps = 35/390 (8%)

Query: 41  PIAHHPILRTPCRSSTYNLNIITDTIAATTVVYEGAIID-----KIEERNLAEIPLPAMS 95
           P AH PILR+         +I+T T  A + V     ID     +I + N       AMS
Sbjct: 32  PTAHSPILRS---------SIVTPTARAVSEVSGCTTIDPDFLVEISDSNQTR----AMS 78

Query: 96  KARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCII 155
           KARVYT+VNV+RPK+YWDYESL VQWG+QDDYEVVRKVGRGKYSEVFEGINVN+ E+CII
Sbjct: 79  KARVYTEVNVIRPKDYWDYESLIVQWGEQDDYEVVRKVGRGKYSEVFEGINVNSKEKCII 138

Query: 156 KILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPT 215
           KILKPVKKKKI+REIKILQNLCGGPN+VKLLD+VRDQHSKTPSLIFEYVNSTDFKVLYPT
Sbjct: 139 KILKPVKKKKIRREIKILQNLCGGPNIVKLLDVVRDQHSKTPSLIFEYVNSTDFKVLYPT 198

Query: 216 LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE 275
           LTDYDIRYYIYELLKALD+CHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE
Sbjct: 199 LTDYDIRYYIYELLKALDFCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE 258

Query: 276 YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK 335
           YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDN DQLVKIAK
Sbjct: 259 YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNQDQLVKIAK 318

Query: 336 DCC---LIIWCN--------------SRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRY 378
                 L  + N               RHSRKPWSKFINADNQHLVSPEAIDFLDKLLRY
Sbjct: 319 VLGTDELNAYLNKYQLELDPQLEALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRY 378

Query: 379 DHQDRLTAREAMAHPYFAQVRAAESSRTRA 408
           DHQDRLTA+EAMAH YFAQVRAAE+SR R+
Sbjct: 379 DHQDRLTAKEAMAHAYFAQVRAAETSRMRS 408

Casein kinases are operationally defined by their preferential utilization of acidic proteins such as caseins as substrates. The alpha chain contains the catalytic site. May act as an ectokinase that phosphorylates several extracellular proteins.
Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|Q08466|CSK22_ARATH Casein kinase II subunit alpha-2 OS=Arabidopsis thaliana GN=CKA2 PE=2 SV=3

 Score =  568 bits (1464), Expect = e-161,   Method: Compositional matrix adjust.
 Identities = 305/389 (78%), Positives = 327/389 (84%), Gaps = 30/389 (7%)

Query: 39  RAPIAHHPILRTPCRSSTYNLNIITDTIAATTVVYEGAIIDK-IEERNLAEIPLPA-MSK 96
           RAP+AH  I    C        + T T+ +      G   D+ ++  +LA+I L   MSK
Sbjct: 25  RAPLAHSLIPPLTC--------VNTGTVESDVT---GIRFDRCLDTDSLAKISLSTVMSK 73

Query: 97  ARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIK 156
           ARVYTDVNV+RPK+YWDYESL VQWG+QDDYEVVRKVGRGKYSEVFEGIN+N NE+CIIK
Sbjct: 74  ARVYTDVNVIRPKDYWDYESLNVQWGEQDDYEVVRKVGRGKYSEVFEGINMNNNEKCIIK 133

Query: 157 ILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTL 216
           ILKPVKKKKI+REIKILQNLCGGPN+VKLLD+VRDQHSKTPSLIFEYVNSTDFKVLYPTL
Sbjct: 134 ILKPVKKKKIRREIKILQNLCGGPNIVKLLDVVRDQHSKTPSLIFEYVNSTDFKVLYPTL 193

Query: 217 TDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY 276
           TDYDIRYYIYELLKALD+CHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY
Sbjct: 194 TDYDIRYYIYELLKALDFCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY 253

Query: 277 NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKD 336
           NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDN DQLVKIAK 
Sbjct: 254 NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNQDQLVKIAKV 313

Query: 337 CC---LIIWCN--------------SRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYD 379
                L  + N               RHSRKPWSKFINADN+HLVSPEAID+LDKLLRYD
Sbjct: 314 LGTDELNAYLNKYQLELDTQLEALVGRHSRKPWSKFINADNRHLVSPEAIDYLDKLLRYD 373

Query: 380 HQDRLTAREAMAHPYFAQVRAAESSRTRA 408
           HQDRLTA+EAMAHPYFAQVRAAESSR R 
Sbjct: 374 HQDRLTAKEAMAHPYFAQVRAAESSRMRT 402

Casein kinases are operationally defined by their preferential utilization of acidic proteins such as caseins as substrates. The alpha chain contains the catalytic site. May act as an ectokinase that phosphorylates several extracellular proteins.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P28523|CSK2A_MAIZE Casein kinase II subunit alpha OS=Zea mays GN=ACK2 PE=1 SV=1

 Score =  561 bits (1447), Expect = e-159,   Method: Compositional matrix adjust.
 Identities = 293/332 (88%), Positives = 303/332 (91%), Gaps = 17/332 (5%)

Query: 94  MSKARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERC 153
           MSKARVY DVNVLRPKEYWDYE+LTVQWG+QDDYEVVRKVGRGKYSEVFEGINVN NE+C
Sbjct: 1   MSKARVYADVNVLRPKEYWDYEALTVQWGEQDDYEVVRKVGRGKYSEVFEGINVNNNEKC 60

Query: 154 IIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY 213
           IIKILKPVKKKKIKREIKILQNLCGGPN+VKLLDIVRDQHSKTPSLIFEYVN+TDFKVLY
Sbjct: 61  IIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVLY 120

Query: 214 PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG 273
           PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG
Sbjct: 121 PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG 180

Query: 274 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI 333
           KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI
Sbjct: 181 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI 240

Query: 334 AK---DCCLIIWCN--------------SRHSRKPWSKFINADNQHLVSPEAIDFLDKLL 376
           AK      L ++ N               RHSRKPW KF+NADNQHLVSPEAIDFLDKLL
Sbjct: 241 AKVLGTDGLNVYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLL 300

Query: 377 RYDHQDRLTAREAMAHPYFAQVRAAESSRTRA 408
           RYDHQ+RLTA EAM HPYF QVRAAE+SRTRA
Sbjct: 301 RYDHQERLTALEAMTHPYFQQVRAAENSRTRA 332

Casein kinases are operationally defined by their preferential utilization of acidic proteins such as caseins as substrates. The alpha chain contains the catalytic site.

Zea mays (taxid: 4577)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O64817|CSK23_ARATH Probable casein kinase II subunit alpha OS=Arabidopsis thaliana GN=At2g23080 PE=1 SV=1

 Score =  550 bits (1416), Expect = e-155,   Method: Compositional matrix adjust.
 Identities = 286/336 (85%), Positives = 298/336 (88%), Gaps = 25/336 (7%)

Query: 94  MSKARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERC 153
           MSKARVYTDVNV+RPKEYWDYESL VQWG QDDYEVVRKVGRGKYSEVFEG NVNTNERC
Sbjct: 1   MSKARVYTDVNVVRPKEYWDYESLVVQWGHQDDYEVVRKVGRGKYSEVFEGKNVNTNERC 60

Query: 154 IIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY 213
           +IKILKPVKKKKIKREIKILQNLCGGPN+VKL DIVRD+HSKTPSL+FE+VNS DFKVLY
Sbjct: 61  VIKILKPVKKKKIKREIKILQNLCGGPNIVKLYDIVRDEHSKTPSLVFEFVNSVDFKVLY 120

Query: 214 PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG 273
           PTLTDYDIRYYIYELLKALD+CHSQGIMHRDVKPHNVMIDH+LRKLRLIDWGLAEFYHPG
Sbjct: 121 PTLTDYDIRYYIYELLKALDFCHSQGIMHRDVKPHNVMIDHQLRKLRLIDWGLAEFYHPG 180

Query: 274 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI 333
           KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI
Sbjct: 181 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI 240

Query: 334 AKDCCLIIWCN---------------------SRHSRKPWSKFINADNQHLVSPEAIDFL 372
           AK    ++  N                      RH  KPWSKFINADNQHLVSPEAIDFL
Sbjct: 241 AK----VLGTNELDHYLNKYQLDLDPQLEALVGRHVPKPWSKFINADNQHLVSPEAIDFL 296

Query: 373 DKLLRYDHQDRLTAREAMAHPYFAQVRAAESSRTRA 408
           DKLL+YDHQDRLTAREAM HPYFAQV+AAESSR R 
Sbjct: 297 DKLLQYDHQDRLTAREAMDHPYFAQVKAAESSRLRT 332

Casein kinases are operationally defined by their preferential utilization of acidic proteins such as caseins as substrates. The alpha chain contains the catalytic site. May act as an ectokinase that phosphorylates several extracellular proteins.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O64816|CSK2P_ARATH Casein kinase II subunit alpha, chloroplastic OS=Arabidopsis thaliana GN=At2g23070 PE=2 SV=1

 Score =  519 bits (1337), Expect = e-146,   Method: Compositional matrix adjust.
 Identities = 267/331 (80%), Positives = 291/331 (87%), Gaps = 17/331 (5%)

Query: 93  AMSKARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNER 152
           A SKARVY DVNV+RPK+YWDYESL VQWG QDDYEVVRKVGRGKYSEVFEGI+   NE+
Sbjct: 98  APSKARVYADVNVVRPKDYWDYESLAVQWGVQDDYEVVRKVGRGKYSEVFEGIHATDNEK 157

Query: 153 CIIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL 212
           C+IKILKPVKKKKIKREIKILQNLCGGPN+VKLLDIVRDQ SKTPSLIFE+VN+ DFKVL
Sbjct: 158 CVIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNKDFKVL 217

Query: 213 YPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP 272
           YPTL+DYD+RYYI+ELLKALD+CHS+GIMHRDVKPHNVMIDHE RKLRLIDWGLAEFYHP
Sbjct: 218 YPTLSDYDVRYYIFELLKALDFCHSRGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP 277

Query: 273 GKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVK 332
           GKEYNVRVASRYFKGPELLVDLQDYDYSLD+WSLGCMFAGMIFRKEPFFYGHDN+DQLVK
Sbjct: 278 GKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVK 337

Query: 333 IAKDCC---LIIWCN--------------SRHSRKPWSKFINADNQHLVSPEAIDFLDKL 375
           IAK      L  + N               RHSRKPW+KFIN++NQHL  PEA+DF+DKL
Sbjct: 338 IAKVLGTDELNAYLNKYRIELDPNLTSLVGRHSRKPWTKFINSENQHLAVPEAVDFVDKL 397

Query: 376 LRYDHQDRLTAREAMAHPYFAQVRAAESSRT 406
           LRYDHQ+R TA+EAMAHPYF  +R AESSRT
Sbjct: 398 LRYDHQERPTAKEAMAHPYFYPIRNAESSRT 428

Casein kinases are operationally defined by their preferential utilization of acidic proteins such as caseins as substrates. The alpha chain contains the catalytic site. May act as an ectokinase that phosphorylates several extracellular proteins.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q60737|CSK21_MOUSE Casein kinase II subunit alpha OS=Mus musculus GN=Csnk2a1 PE=1 SV=2

 Score =  457 bits (1175), Expect = e-128,   Method: Compositional matrix adjust.
 Identities = 237/324 (73%), Positives = 271/324 (83%), Gaps = 17/324 (5%)

Query: 92  PAMSKARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNE 151
           P  S+ARVYTDVN  RP+EYWDYES  V+WG+QDDY++VRK+GRGKYSEVFE IN+  NE
Sbjct: 4   PVPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNE 63

Query: 152 RCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKV 211
           + ++KILKPVKKKKIKREIKIL+NL GGPN++ L DIV+D  S+TP+L+FE+VN+TDFK 
Sbjct: 64  KVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQ 123

Query: 212 LYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 271
           LY TLTDYDIR+Y+YE+LKALDYCHS GIMHRDVKPHNVMIDHE RKLRLIDWGLAEFYH
Sbjct: 124 LYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 183

Query: 272 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV 331
           PG+EYNVRVASRYFKGPELLVD Q YDYSLDMWSLGCM A MIFRKEPFF+GHDN+DQLV
Sbjct: 184 PGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLV 243

Query: 332 KIAK--------------DCCLIIWCN---SRHSRKPWSKFINADNQHLVSPEAIDFLDK 374
           +IAK              +  L    N    RHSRK W +F++++NQHLVSPEA+DFLDK
Sbjct: 244 RIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDK 303

Query: 375 LLRYDHQDRLTAREAMAHPYFAQV 398
           LLRYDHQ RLTAREAM HPYF  V
Sbjct: 304 LLRYDHQSRLTAREAMEHPYFYTV 327

Catalytic subunit of a constitutively active serine/threonine-protein kinase complex that phosphorylates a large number of substrates containing acidic residues C-terminal to the phosphorylated serine or threonine. Regulates numerous cellular processes, such as cell cycle progression, apoptosis and transcription, as well as viral infection. May act as a regulatory node which integrates and coordinates numerous signals leading to an appropriate cellular response. During mitosis, functions as a component of the p53/TP53-dependent spindle assembly checkpoint (SAC) that maintains cyclin-B-CDK1 activity and G2 arrest in response to spindle damage. Also required for p53/TP53-mediated apoptosis, phosphorylating 'Ser-392' of p53/TP53 following UV irradiation. Can also negatively regulate apoptosis. Phosphorylates the caspases CASP9 and CASP2 and the apoptotic regulator NOL3. Phosphorylation protects CASP9 from cleavage and activation by CASP8, and inhibits the dimerization of CASP2 and activation of CASP8. Regulates transcription by direct phosphorylation of RNA polymerases I, II, III and IV. Also phosphorylates and regulates numerous transcription factors including NF-kappa-B, STAT1, CREB1, IRF1, IRF2, ATF1, SRF, MAX, JUN, FOS, MYC and MYB. Phosphorylates Hsp90 and its co-chaperones FKBP4 and CDC37, which is essential for chaperone function. Regulates Wnt signaling by phosphorylating CTNNB1 and the transcription factor LEF1. Acts as an ectokinase that phosphorylates several extracellular proteins.

Mus musculus (taxid: 10090)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P19139|CSK21_RAT Casein kinase II subunit alpha OS=Rattus norvegicus GN=Csnk2a1 PE=1 SV=2

 Score =  457 bits (1175), Expect = e-128,   Method: Compositional matrix adjust.
 Identities = 238/334 (71%), Positives = 275/334 (82%), Gaps = 17/334 (5%)

Query: 92  PAMSKARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNE 151
           P  S+ARVYTDVN  RP+EYWDYES  V+WG+QDDY++VRK+GRGKYSEVFE IN+  NE
Sbjct: 4   PVPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNE 63

Query: 152 RCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKV 211
           + ++KILKPVKKKKIKREIKIL+NL GGPN++ L DIV+D  S+TP+L+FE+VN+TDFK 
Sbjct: 64  KVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQ 123

Query: 212 LYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 271
           LY TLTDYDIR+Y+YE+LKALDYCHS GIMHRDVKPHNVMIDHE RKLRLIDWGLAEFYH
Sbjct: 124 LYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 183

Query: 272 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV 331
           PG+EYNVRVASRYFKGPELLVD Q YDYSLDMWSLGCM A MIFRKEPFF+GHDN+DQLV
Sbjct: 184 PGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLV 243

Query: 332 KIAK--------------DCCLIIWCN---SRHSRKPWSKFINADNQHLVSPEAIDFLDK 374
           +IAK              +  L    N    RHSRK W +F++++NQHLVSPEA+DFLDK
Sbjct: 244 RIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDK 303

Query: 375 LLRYDHQDRLTAREAMAHPYFAQVRAAESSRTRA 408
           LLRYDHQ RLTAREAM HPYF  V   ++  + A
Sbjct: 304 LLRYDHQSRLTAREAMEHPYFYTVVKDQARMSSA 337

Catalytic subunit of a constitutively active serine/threonine-protein kinase complex that phosphorylates a large number of substrates containing acidic residues C-terminal to the phosphorylated serine or threonine. Regulates numerous cellular processes, such as cell cycle progression, apoptosis and transcription, as well as viral infection. May act as a regulatory node which integrates and coordinates numerous signals leading to an appropriate cellular response. During mitosis, functions as a component of the p53/TP53-dependent spindle assembly checkpoint (SAC) that maintains cyclin-B-CDK1 activity and G2 arrest in response to spindle damage. Also required for p53/TP53-mediated apoptosis, phosphorylating 'Ser-392' of p53/TP53 following UV irradiation. Can also negatively regulate apoptosis. Phosphorylates the caspases CASP9 and CASP2 and the apoptotic regulator NOL3. Phosphorylation protects CASP9 from cleavage and activation by CASP8, and inhibits the dimerization of CASP2 and activation of CASP8. Regulates transcription by direct phosphorylation of RNA polymerases I, II, III and IV. Also phosphorylates and regulates numerous transcription factors including NF-kappa-B, STAT1, CREB1, IRF1, IRF2, ATF1, SRF, MAX, JUN, FOS, MYC and MYB. Phosphorylates Hsp90 and its co-chaperones FKBP4 and CDC37, which is essential for chaperone function. Regulates Wnt signaling by phosphorylating CTNNB1 and the transcription factor LEF1. Acts as an ectokinase that phosphorylates several extracellular proteins.

Rattus norvegicus (taxid: 10116)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P68400|CSK21_HUMAN Casein kinase II subunit alpha OS=Homo sapiens GN=CSNK2A1 PE=1 SV=1

 Score =  456 bits (1174), Expect = e-127,   Method: Compositional matrix adjust.
 Identities = 240/335 (71%), Positives = 274/335 (81%), Gaps = 22/335 (6%)

Query: 92  PAMSKARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNE 151
           P  S+ARVYTDVN  RP+EYWDYES  V+WG+QDDY++VRK+GRGKYSEVFE IN+  NE
Sbjct: 4   PVPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNE 63

Query: 152 RCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKV 211
           + ++KILKPVKKKKIKREIKIL+NL GGPN++ L DIV+D  S+TP+L+FE+VN+TDFK 
Sbjct: 64  KVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQ 123

Query: 212 LYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 271
           LY TLTDYDIR+Y+YE+LKALDYCHS GIMHRDVKPHNVMIDHE RKLRLIDWGLAEFYH
Sbjct: 124 LYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 183

Query: 272 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV 331
           PG+EYNVRVASRYFKGPELLVD Q YDYSLDMWSLGCM A MIFRKEPFF+GHDN+DQLV
Sbjct: 184 PGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLV 243

Query: 332 KIAK--------------DCCLIIWCN---SRHSRKPWSKFINADNQHLVSPEAIDFLDK 374
           +IAK              +  L    N    RHSRK W +F++++NQHLVSPEA+DFLDK
Sbjct: 244 RIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDK 303

Query: 375 LLRYDHQDRLTAREAMAHPYF-----AQVRAAESS 404
           LLRYDHQ RLTAREAM HPYF      Q R   SS
Sbjct: 304 LLRYDHQSRLTAREAMEHPYFYTVVKDQARMGSSS 338

Catalytic subunit of a constitutively active serine/threonine-protein kinase complex that phosphorylates a large number of substrates containing acidic residues C-terminal to the phosphorylated serine or threonine. Regulates numerous cellular processes, such as cell cycle progression, apoptosis and transcription, as well as viral infection. May act as a regulatory node which integrates and coordinates numerous signals leading to an appropriate cellular response. During mitosis, functions as a component of the p53/TP53-dependent spindle assembly checkpoint (SAC) that maintains cyclin-B-CDK1 activity and G2 arrest in response to spindle damage. Also required for p53/TP53-mediated apoptosis, phosphorylating 'Ser-392' of p53/TP53 following UV irradiation. Can also negatively regulate apoptosis. Phosphorylates the caspases CASP9 and CASP2 and the apoptotic regulator NOL3. Phosphorylation protects CASP9 from cleavage and activation by CASP8, and inhibits the dimerization of CASP2 and activation of CASP8. Regulates transcription by direct phosphorylation of RNA polymerases I, II, III and IV. Also phosphorylates and regulates numerous transcription factors including NF-kappa-B, STAT1, CREB1, IRF1, IRF2, ATF1, SRF, MAX, JUN, FOS, MYC and MYB. Phosphorylates Hsp90 and its co-chaperones FKBP4 and CDC37, which is essential for chaperone function. Regulates Wnt signaling by phosphorylating CTNNB1 and the transcription factor LEF1. Acts as an ectokinase that phosphorylates several extracellular proteins. During viral infection, phosphorylates various proteins involved in the viral life cycles of EBV, HSV, HBV, HCV, HIV, CMV and HPV.

Homo sapiens (taxid: 9606)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P68399|CSK21_BOVIN Casein kinase II subunit alpha OS=Bos taurus GN=CSNK2A1 PE=1 SV=1

 Score =  456 bits (1174), Expect = e-127,   Method: Compositional matrix adjust.
 Identities = 240/335 (71%), Positives = 274/335 (81%), Gaps = 22/335 (6%)

Query: 92  PAMSKARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNE 151
           P  S+ARVYTDVN  RP+EYWDYES  V+WG+QDDY++VRK+GRGKYSEVFE IN+  NE
Sbjct: 4   PVPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNE 63

Query: 152 RCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKV 211
           + ++KILKPVKKKKIKREIKIL+NL GGPN++ L DIV+D  S+TP+L+FE+VN+TDFK 
Sbjct: 64  KVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQ 123

Query: 212 LYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 271
           LY TLTDYDIR+Y+YE+LKALDYCHS GIMHRDVKPHNVMIDHE RKLRLIDWGLAEFYH
Sbjct: 124 LYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 183

Query: 272 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV 331
           PG+EYNVRVASRYFKGPELLVD Q YDYSLDMWSLGCM A MIFRKEPFF+GHDN+DQLV
Sbjct: 184 PGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLV 243

Query: 332 KIAK--------------DCCLIIWCN---SRHSRKPWSKFINADNQHLVSPEAIDFLDK 374
           +IAK              +  L    N    RHSRK W +F++++NQHLVSPEA+DFLDK
Sbjct: 244 RIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDK 303

Query: 375 LLRYDHQDRLTAREAMAHPYF-----AQVRAAESS 404
           LLRYDHQ RLTAREAM HPYF      Q R   SS
Sbjct: 304 LLRYDHQSRLTAREAMEHPYFYTVVKDQARMGSSS 338

Catalytic subunit of a constitutively active serine/threonine-protein kinase complex that phosphorylates a large number of substrates containing acidic residues C-terminal to the phosphorylated serine or threonine. Regulates numerous cellular processes, such as cell cycle progression, apoptosis and transcription, as well as viral infection. May act as a regulatory node which integrates and coordinates numerous signals leading to an appropriate cellular response. During mitosis, functions as a component of the p53/TP53-dependent spindle assembly checkpoint (SAC) that maintains cyclin-B-CDK1 activity and G2 arrest in response to spindle damage. Also required for p53/TP53-mediated apoptosis, phosphorylating 'Ser-392' of p53/TP53 following UV irradiation. Can also negatively regulate apoptosis. Phosphorylates the caspases CASP9 and CASP2 and the apoptotic regulator NOL3. Phosphorylation protects CASP9 from cleavage and activation by CASP8, and inhibits the dimerization of CASP2 and activation of CASP8. Regulates transcription by direct phosphorylation of RNA polymerases I, II, III and IV. Also phosphorylates and regulates numerous transcription factors including NF-kappa-B, STAT1, CREB1, IRF1, IRF2, ATF1, SRF, MAX, JUN, FOS, MYC and MYB. Phosphorylates Hsp90 and its co-chaperones FKBP4 and CDC37, which is essential for chaperone function. Regulates Wnt signaling by phosphorylating CTNNB1 and the transcription factor LEF1. Acts as an ectokinase that phosphorylates several extracellular proteins.

Bos taurus (taxid: 9913)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P21868|CSK21_CHICK Casein kinase II subunit alpha OS=Gallus gallus GN=CSNK2A1 PE=2 SV=1

 Score =  456 bits (1172), Expect = e-127,   Method: Compositional matrix adjust.
 Identities = 236/321 (73%), Positives = 270/321 (84%), Gaps = 17/321 (5%)

Query: 92  PAMSKARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNE 151
           P  S+ARVYTDVN  RP+EYWDYES  V+WG+QDDY++VRK+GRGKYSEVFE IN+  NE
Sbjct: 4   PVPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNE 63

Query: 152 RCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKV 211
           + ++KILKPVKKKKIKREIKIL+NL GGPN++ L DIV+D  S+TP+L+FE+VN+TDFK 
Sbjct: 64  KVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQ 123

Query: 212 LYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 271
           LY TLTDYDIR+Y+YE+LKALDYCHS GIMHRDVKPHNVMIDHE RKLRLIDWGLAEFYH
Sbjct: 124 LYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 183

Query: 272 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV 331
           PG+EYNVRVASRYFKGPELLVD Q YDYSLDMWSLGCM A MIFRKEPFF+GHDN+DQLV
Sbjct: 184 PGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLV 243

Query: 332 KIAK--------------DCCLIIWCN---SRHSRKPWSKFINADNQHLVSPEAIDFLDK 374
           +IAK              +  L    N    RHSRK W +F++++NQHLVSPEA+DFLDK
Sbjct: 244 RIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDK 303

Query: 375 LLRYDHQDRLTAREAMAHPYF 395
           LLRYDHQ RLTAREAM HPYF
Sbjct: 304 LLRYDHQSRLTAREAMEHPYF 324

Casein kinases are operationally defined by their preferential utilization of acidic proteins such as caseins as substrates. The alpha and alpha' chains contain the catalytic site. Participates in Wnt signaling.

Gallus gallus (taxid: 9031)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	408
356511951	411	PREDICTED: casein kinase II subunit alph	0.914	0.907	0.810	1e-171
363814459	398	uncharacterized protein LOC100820471 pre	0.921	0.944	0.785	1e-170
357476359	388	Casein kinase 2 alpha subunit [Medicago	0.892	0.938	0.789	1e-169
391605	333	casein kinase II catalytic subunit [Arab	0.772	0.945	0.867	1e-168
297816254	405	hypothetical protein ARALYDRAFT_485358 [	0.906	0.913	0.781	1e-166
449448246	397	PREDICTED: casein kinase II subunit alph	0.916	0.942	0.789	1e-163
388510076	333	unknown [Medicago truncatula]	0.772	0.945	0.891	1e-163
225438950	405	PREDICTED: casein kinase II subunit alph	0.892	0.898	0.813	1e-162
23397331	386	putative casein kinase II, alpha chain 2	0.894	0.945	0.782	1e-162
224074233	333	predicted protein [Populus trichocarpa]	0.772	0.945	0.903	1e-162

>gi|356511951|ref|XP_003524685.1| PREDICTED: casein kinase II subunit alpha-2-like [Glycine max]

 Score =  608 bits (1567), Expect = e-171,   Method: Compositional matrix adjust.
 Identities = 326/402 (81%), Positives = 342/402 (85%), Gaps = 29/402 (7%)

Query: 24  VLPLRFLLACAVLALRAPIAHHPILRTPCRSSTYNLNIITDTIAATTVVYEGAIIDKIEE 83
            L LRFLL C ++ALRAP+A  PI+R P        N +T+T    TV+    I+ +   
Sbjct: 21  ALLLRFLLVCTLVALRAPVAQPPIVRIPP-------NHLTET--TNTVI---TIVHQRHR 68

Query: 84  RNLAEIPLPAMSKARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFE 143
             ++    PAMSKARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFE
Sbjct: 69  TQISGSTRPAMSKARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFE 128

Query: 144 GINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEY 203
           GINVN+NERCIIKILKPVKKKKIKREIKILQNLCGGPN+VKLLDIVRDQHSKTPSLIFEY
Sbjct: 129 GINVNSNERCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLIFEY 188

Query: 204 VNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLID 263
           VNSTDFKVLYPTLTDYDIRYYIYELLKA+DYCHSQGIMHRDVKPHNVMIDHELRKLRLID
Sbjct: 189 VNSTDFKVLYPTLTDYDIRYYIYELLKAIDYCHSQGIMHRDVKPHNVMIDHELRKLRLID 248

Query: 264 WGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYG 323
           WGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYG
Sbjct: 249 WGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYG 308

Query: 324 HDNHDQLVKIAKDCC---LIIWCN--------------SRHSRKPWSKFINADNQHLVSP 366
           HDNHDQLVKIAK      L  + N               RHSRKPWSKFINADNQHLVSP
Sbjct: 309 HDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSP 368

Query: 367 EAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAESSRTRA 408
           EAIDFLDKLLRYDHQDRLTAREAMAHPYF+QVRAAESSR R 
Sbjct: 369 EAIDFLDKLLRYDHQDRLTAREAMAHPYFSQVRAAESSRMRT 410

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|363814459|ref|NP_001242864.1| uncharacterized protein LOC100820471 precursor [Glycine max] gi|255638871|gb|ACU19738.1| unknown [Glycine max]

 Score =  605 bits (1559), Expect = e-170,   Method: Compositional matrix adjust.
 Identities = 325/414 (78%), Positives = 341/414 (82%), Gaps = 38/414 (9%)

Query: 12  HKHPAVLAAQVQVLPLRFLLACAVLALRAPIAHHPILRTPCRSSTYNLNIITDTIAATTV 71
           H+ PA L        LRFLL C ++ALRAP+A  PILR P        N + +T    T+
Sbjct: 5   HEAPAALL-------LRFLLVCTIVALRAPVAQPPILRIP--------NHLIETTNTFTI 49

Query: 72  VYEGAIIDKIEERNLAEIPLPAMSKARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVR 131
           V++           ++     AMSKARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVR
Sbjct: 50  VHQRY------RTQISGSNRRAMSKARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVR 103

Query: 132 KVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRD 191
           KVGRGKYSEVFEGINVN+NERC+IKILKPVKKKKIKREIKILQNLCGGPN+VKLLDIVRD
Sbjct: 104 KVGRGKYSEVFEGINVNSNERCVIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRD 163

Query: 192 QHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVM 251
           QHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQ IMHRDVKPHNVM
Sbjct: 164 QHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQSIMHRDVKPHNVM 223

Query: 252 IDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFA 311
           IDHELRKLRLIDWGLAEFYHPGKEYNVRVASRY KGPELLVDLQDYDYSLDMWSLGCMFA
Sbjct: 224 IDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYIKGPELLVDLQDYDYSLDMWSLGCMFA 283

Query: 312 GMIFRKEPFFYGHDNHDQLVKIAKDCC---LIIWCN--------------SRHSRKPWSK 354
           GMIFRKEPFFYGHDNHDQLVKIAK      L  + N               RHSRKPWSK
Sbjct: 284 GMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSK 343

Query: 355 FINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAESSRTRA 408
           FINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF+QVRAAESSR R 
Sbjct: 344 FINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFSQVRAAESSRMRT 397

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|357476359|ref|XP_003608465.1| Casein kinase 2 alpha subunit [Medicago truncatula] gi|355509520|gb|AES90662.1| Casein kinase 2 alpha subunit [Medicago truncatula]

 Score =  599 bits (1545), Expect = e-169,   Method: Compositional matrix adjust.
 Identities = 318/403 (78%), Positives = 336/403 (83%), Gaps = 39/403 (9%)

Query: 23  QVLPLRFLLACAVLALRAPIAHHPILRTPCRSSTYNLNIITDTIAATTVVYEGAIIDKIE 82
           Q   LR LL C +++LRAP+A  P +R P +S+  N          TT+     I+ +I 
Sbjct: 7   QAPQLRLLLVCTLISLRAPVAQPPNVRIPTQSNESN--------TTTTI-----IVSQIS 53

Query: 83  ERNLAEIPLPAMSKARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVF 142
                      MSKARVYTDVNV+RPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVF
Sbjct: 54  S---------TMSKARVYTDVNVIRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVF 104

Query: 143 EGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFE 202
           EGINVN++ERC+IKILKPVKKKKIKREIKILQNLCGGPN+VKLLDIVRDQHSKTPSLIFE
Sbjct: 105 EGINVNSSERCVIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLIFE 164

Query: 203 YVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLI 262
           YVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLI
Sbjct: 165 YVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLI 224

Query: 263 DWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFY 322
           DWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFY
Sbjct: 225 DWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFY 284

Query: 323 GHDNHDQLVKIAKDCC---LIIWCN--------------SRHSRKPWSKFINADNQHLVS 365
           GHDNHDQLVKIAK      L  + N               RHSRKPWSKFINADNQHLVS
Sbjct: 285 GHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVS 344

Query: 366 PEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAESSRTRA 408
           PEAID+LDKLLRYDHQDRLTAREAMAHPYF+QVRAAESSR R 
Sbjct: 345 PEAIDYLDKLLRYDHQDRLTAREAMAHPYFSQVRAAESSRMRT 387

Source: Medicago truncatula

Species: Medicago truncatula

Genus: Medicago

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|391605|dbj|BAA01091.1| casein kinase II catalytic subunit [Arabidopsis thaliana]

 Score =  597 bits (1540), Expect = e-168,   Method: Compositional matrix adjust.
 Identities = 288/332 (86%), Positives = 302/332 (90%), Gaps = 17/332 (5%)

Query: 94  MSKARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERC 153
           MSKARVYTDVNV+RPK+YWDYESL VQWG+QDDYEVVRKVGRGKYSEVFEGIN+N NE+C
Sbjct: 1   MSKARVYTDVNVIRPKDYWDYESLNVQWGEQDDYEVVRKVGRGKYSEVFEGINMNNNEKC 60

Query: 154 IIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY 213
           IIKILKPVKKK+I+REIKILQNLCGGPN+VKLLD+VRDQHSKTPSLIFEYVNSTDFKVLY
Sbjct: 61  IIKILKPVKKKEIRREIKILQNLCGGPNIVKLLDVVRDQHSKTPSLIFEYVNSTDFKVLY 120

Query: 214 PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG 273
           PTLTDYDIRYYIYELLKALD+CHSQGIMHRDVKPHNVMIDH LRKLRLIDWGLAEFYHPG
Sbjct: 121 PTLTDYDIRYYIYELLKALDFCHSQGIMHRDVKPHNVMIDHGLRKLRLIDWGLAEFYHPG 180

Query: 274 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI 333
           KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDN DQLVKI
Sbjct: 181 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNQDQLVKI 240

Query: 334 AKDCC---LIIWCN--------------SRHSRKPWSKFINADNQHLVSPEAIDFLDKLL 376
           AK      L  + N               RHSRKPWSKFINADN+HLVSPEAID+LDKLL
Sbjct: 241 AKVLGTDELNAYLNKYQLELDTQLEALVGRHSRKPWSKFINADNRHLVSPEAIDYLDKLL 300

Query: 377 RYDHQDRLTAREAMAHPYFAQVRAAESSRTRA 408
           RYDHQDRLTA+EAMAHPYFAQVRAAESSR R 
Sbjct: 301 RYDHQDRLTAKEAMAHPYFAQVRAAESSRMRT 332

Source: Arabidopsis thaliana

Species: Arabidopsis thaliana

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|297816254|ref|XP_002876010.1| hypothetical protein ARALYDRAFT_485358 [Arabidopsis lyrata subsp. lyrata] gi|297321848|gb|EFH52269.1| hypothetical protein ARALYDRAFT_485358 [Arabidopsis lyrata subsp. lyrata]

 Score =  590 bits (1522), Expect = e-166,   Method: Compositional matrix adjust.
 Identities = 315/403 (78%), Positives = 338/403 (83%), Gaps = 33/403 (8%)

Query: 28  RFLLACAVLALRAPIAHHPILRTPCRSSTYNLNIITDTIAATTVVYEGAIIDK-IEERNL 86
           RFLL CA+L LRAP AH PI    C        + T T+ +      G   ++ ++  +L
Sbjct: 13  RFLLLCAILILRAPTAHSPIPPLTC--------VATGTVESDV---SGISFNRCLDSDSL 61

Query: 87  AEIPLP----AMSKARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVF 142
           AEI L     AMSKARVYTDVNV+RPK+YWDYESL VQWG+QDDYEVVRKVGRGKYSEVF
Sbjct: 62  AEISLSSVTGAMSKARVYTDVNVIRPKDYWDYESLNVQWGEQDDYEVVRKVGRGKYSEVF 121

Query: 143 EGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFE 202
           EGIN+N+NE+CIIKILKPVKKKKI+REIKILQNLCGGPN+VKLLD+VRDQHSKTPSLIFE
Sbjct: 122 EGINMNSNEKCIIKILKPVKKKKIRREIKILQNLCGGPNIVKLLDVVRDQHSKTPSLIFE 181

Query: 203 YVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLI 262
           YVNSTDFKVLYPTLTDYDIRYYIYELLKALD+CHSQGIMHRDVKPHNVMIDHELRKLRLI
Sbjct: 182 YVNSTDFKVLYPTLTDYDIRYYIYELLKALDFCHSQGIMHRDVKPHNVMIDHELRKLRLI 241

Query: 263 DWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFY 322
           DWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFY
Sbjct: 242 DWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFY 301

Query: 323 GHDNHDQLVKIAKDCC---LIIWCN--------------SRHSRKPWSKFINADNQHLVS 365
           GHDN DQLVKIAK      L  + N               RHSRKPWSKFINADN+HLVS
Sbjct: 302 GHDNQDQLVKIAKVLGTDELNAYLNKYQLELDAQLEALVGRHSRKPWSKFINADNRHLVS 361

Query: 366 PEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAESSRTRA 408
           PEAID+LDKLLRYDHQDRLTA+EAMAHPYFAQVRAAESSR R 
Sbjct: 362 PEAIDYLDKLLRYDHQDRLTAKEAMAHPYFAQVRAAESSRMRT 404

Source: Arabidopsis lyrata subsp. lyrata

Species: Arabidopsis lyrata

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449448246|ref|XP_004141877.1| PREDICTED: casein kinase II subunit alpha-1-like [Cucumis sativus] gi|449510998|ref|XP_004163833.1| PREDICTED: casein kinase II subunit alpha-1-like [Cucumis sativus]

 Score =  582 bits (1500), Expect = e-163,   Method: Compositional matrix adjust.
 Identities = 315/399 (78%), Positives = 328/399 (82%), Gaps = 25/399 (6%)

Query: 27  LRFLLACAVLALRAPIAHHPILRTPCRSSTYNLNIITDTIAATTVVYEGAIIDKIEERNL 86
           LR LL   V  L  P++H P LR+P    + + +  +  + A          DKI    L
Sbjct: 6   LRLLLVFTVFFL-LPVSHPPTLRSPPLPPSSDASFFSSAVGAVHG-------DKITPIGL 57

Query: 87  AEIPLPAMSKARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGIN 146
                P MSKARVY DVNVLRPK+YWDYESL VQWGDQDDYEVVRKVGRGKYSEVFEGIN
Sbjct: 58  LGSSYPLMSKARVYADVNVLRPKDYWDYESLAVQWGDQDDYEVVRKVGRGKYSEVFEGIN 117

Query: 147 VNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNS 206
           VN NERCIIKILKPVKKKKIKREIKILQNLCGGPN+VKL DIVRDQHSKTPSLIFEYVNS
Sbjct: 118 VNNNERCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLFDIVRDQHSKTPSLIFEYVNS 177

Query: 207 TDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGL 266
           TDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGL
Sbjct: 178 TDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGL 237

Query: 267 AEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDN 326
           AEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDN
Sbjct: 238 AEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDN 297

Query: 327 HDQLVKIAKDCC---LIIWCN--------------SRHSRKPWSKFINADNQHLVSPEAI 369
           HDQLVKIAK      L  + N               RHSRKPWSKFINADNQHLVSPEAI
Sbjct: 298 HDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAI 357

Query: 370 DFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAESSRTRA 408
           DFLDKLLRYDHQDRLTAREAMAHPYF+QVRAAE+SR R 
Sbjct: 358 DFLDKLLRYDHQDRLTAREAMAHPYFSQVRAAENSRMRT 396

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|388510076|gb|AFK43104.1| unknown [Medicago truncatula]

 Score =  579 bits (1493), Expect = e-163,   Method: Compositional matrix adjust.
 Identities = 296/332 (89%), Positives = 305/332 (91%), Gaps = 17/332 (5%)

Query: 94  MSKARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERC 153
           MSKARVYTDVNV+RPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVN++ERC
Sbjct: 1   MSKARVYTDVNVIRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNSSERC 60

Query: 154 IIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY 213
           +IKILKPVKKKKIKRE+KILQNLCGGPN+VKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY
Sbjct: 61  VIKILKPVKKKKIKREMKILQNLCGGPNIVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY 120

Query: 214 PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG 273
           PTLTDYDIRY IYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG
Sbjct: 121 PTLTDYDIRYCIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG 180

Query: 274 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI 333
           KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI
Sbjct: 181 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI 240

Query: 334 AKDCC---LIIWCN--------------SRHSRKPWSKFINADNQHLVSPEAIDFLDKLL 376
           AK      L  + N               RHSRKPWSKFINADNQHLVSPEAID+LDKLL
Sbjct: 241 AKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDYLDKLL 300

Query: 377 RYDHQDRLTAREAMAHPYFAQVRAAESSRTRA 408
           RYDHQDRLTAREAMAHPYF+QVRAAESSR R 
Sbjct: 301 RYDHQDRLTAREAMAHPYFSQVRAAESSRMRT 332

Source: Medicago truncatula

Species: Medicago truncatula

Genus: Medicago

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|225438950|ref|XP_002284196.1| PREDICTED: casein kinase II subunit alpha-2 isoform 1 [Vitis vinifera]

 Score =  577 bits (1488), Expect = e-162,   Method: Compositional matrix adjust.
 Identities = 315/387 (81%), Positives = 325/387 (83%), Gaps = 23/387 (5%)

Query: 39  RAPIAHHPILRTPCRSSTYNLNIITDTIAATTVVYEGAIIDKIEERNLAEIPLPAMSKAR 98
           RAP+A  P LR P  S     N I   I  T+       + +I   ++A      MSKAR
Sbjct: 24  RAPLALPPNLR-PHSSPPIPDNKIITPIVDTSKARLKLQLSEISSSDVA-----PMSKAR 77

Query: 99  VYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKIL 158
           VY DVNVLRPK+YWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVN+NERCIIKIL
Sbjct: 78  VYADVNVLRPKDYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNSNERCIIKIL 137

Query: 159 KPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTD 218
           KPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTD
Sbjct: 138 KPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTD 197

Query: 219 YDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNV 278
           YDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNV
Sbjct: 198 YDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNV 257

Query: 279 RVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCC 338
           RVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK   
Sbjct: 258 RVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLG 317

Query: 339 ---LIIWCN--------------SRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQ 381
              L  + N               RHSRKPWSKFI+ADNQHLVSPEAIDFLDKLLRYDHQ
Sbjct: 318 TDELNAYLNKYRLELDPQLDALVGRHSRKPWSKFIHADNQHLVSPEAIDFLDKLLRYDHQ 377

Query: 382 DRLTAREAMAHPYFAQVRAAESSRTRA 408
           DRLTAREAMAHPYF QVRAAESSR R 
Sbjct: 378 DRLTAREAMAHPYFFQVRAAESSRMRT 404

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|23397331|gb|AAK44123.2|AF370308_1 putative casein kinase II, alpha chain 2 CK II [Arabidopsis thaliana]

 Score =  577 bits (1487), Expect = e-162,   Method: Compositional matrix adjust.
 Identities = 309/395 (78%), Positives = 332/395 (84%), Gaps = 30/395 (7%)

Query: 33  CAVLALRAPIAHHPILRTPCRSSTYNLNIITDTIAATTVVYEGAIIDK-IEERNLAEIPL 91
           CA+L LRAP+AH  I    C        + T T+ +      G   D+ ++  +LA+I L
Sbjct: 2   CAILILRAPLAHSLIPPLTC--------VNTGTVESDVT---GIRFDRCLDTDSLAKISL 50

Query: 92  PA-MSKARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTN 150
              MSKARVYTDVNV+RPK+YWDYESL VQWG+QDDYEVVRKVGRGKYSEVFEGIN+N N
Sbjct: 51  STVMSKARVYTDVNVIRPKDYWDYESLNVQWGEQDDYEVVRKVGRGKYSEVFEGINMNNN 110

Query: 151 ERCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFK 210
           E+CIIKILKPVKKKKI+REIKILQNLCGGPN+VKLLD+VRDQHSKTPSLIFEYVNSTDFK
Sbjct: 111 EKCIIKILKPVKKKKIRREIKILQNLCGGPNIVKLLDVVRDQHSKTPSLIFEYVNSTDFK 170

Query: 211 VLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY 270
           VLYPTLTDYDIRYYIYELLKALD+CHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY
Sbjct: 171 VLYPTLTDYDIRYYIYELLKALDFCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY 230

Query: 271 HPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQL 330
           HPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDN DQL
Sbjct: 231 HPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNQDQL 290

Query: 331 VKIAKDCC---LIIWCN--------------SRHSRKPWSKFINADNQHLVSPEAIDFLD 373
           VKIAK      L  + N               RHSRKPWSKFINADN+HLVSPEAID+LD
Sbjct: 291 VKIAKVLGTDELNAYLNKYQLELDTQLEALVGRHSRKPWSKFINADNRHLVSPEAIDYLD 350

Query: 374 KLLRYDHQDRLTAREAMAHPYFAQVRAAESSRTRA 408
           KLLRYDHQDRLTA+EAMAHPYFAQVRAAESSR R 
Sbjct: 351 KLLRYDHQDRLTAKEAMAHPYFAQVRAAESSRMRT 385

Source: Arabidopsis thaliana

Species: Arabidopsis thaliana

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224074233|ref|XP_002304312.1| predicted protein [Populus trichocarpa] gi|222841744|gb|EEE79291.1| predicted protein [Populus trichocarpa]

 Score =  577 bits (1486), Expect = e-162,   Method: Compositional matrix adjust.
 Identities = 300/332 (90%), Positives = 306/332 (92%), Gaps = 17/332 (5%)

Query: 94  MSKARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERC 153
           MSKARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVN+NERC
Sbjct: 1   MSKARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNSNERC 60

Query: 154 IIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY 213
           +IKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY
Sbjct: 61  VIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY 120

Query: 214 PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG 273
           PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG
Sbjct: 121 PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG 180

Query: 274 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI 333
           KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI
Sbjct: 181 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI 240

Query: 334 AKDCC---LIIWCN--------------SRHSRKPWSKFINADNQHLVSPEAIDFLDKLL 376
           AK      L  + N               RHSRKPWSKFIN+DNQHLVSPEA+DFLDKLL
Sbjct: 241 AKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINSDNQHLVSPEALDFLDKLL 300

Query: 377 RYDHQDRLTAREAMAHPYFAQVRAAESSRTRA 408
           RYDHQDRLTAREAMAHPYF+QVRAAESSR R 
Sbjct: 301 RYDHQDRLTAREAMAHPYFSQVRAAESSRMRT 332

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	408
UNIPROTKB|Q9AR27	333	OSCKA2 "Casein kinase II alpha	0.593	0.726	0.892	9.5e-150
TAIR|locus:2045349	333	CKA3 "casein kinase II, alpha	0.593	0.726	0.871	2.6e-145
TAIR|locus:2045339	432	AT2G23070 [Arabidopsis thalian	0.595	0.562	0.823	6.6e-136
UNIPROTKB|P68399	391	CSNK2A1 "Casein kinase II subu	0.598	0.624	0.725	1.4e-120
UNIPROTKB|E2RHZ1	391	CSNK2A1 "Uncharacterized prote	0.598	0.624	0.725	1.4e-120
UNIPROTKB|E7EU96	385	CSNK2A1 "Casein kinase II subu	0.598	0.633	0.725	1.4e-120
UNIPROTKB|P68400	391	CSNK2A1 "Casein kinase II subu	0.598	0.624	0.725	1.4e-120
UNIPROTKB|F2Z5I5	391	CSNK2A1 "Uncharacterized prote	0.598	0.624	0.725	1.4e-120
MGI|MGI:88543	391	Csnk2a1 "casein kinase 2, alph	0.598	0.624	0.725	1.4e-120
RGD|621663	391	Csnk2a1 "casein kinase 2, alph	0.598	0.624	0.725	1.4e-120

UNIPROTKB|Q9AR27 OSCKA2 "Casein kinase II alpha subunit" [Oryza sativa Indica Group (taxid:39946)]

 Score = 1171 (417.3 bits), Expect = 9.5e-150, Sum P(2) = 9.5e-150
 Identities = 216/242 (89%), Positives = 221/242 (91%)

Query:    94 MSKARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERC 153
             MSKARVY DVNVLRPKEYWDYE+LTVQWG+QDDYEVVRKVGRGKYSEVFEGINVN NE+C
Sbjct:     1 MSKARVYADVNVLRPKEYWDYEALTVQWGEQDDYEVVRKVGRGKYSEVFEGINVNNNEKC 60

Query:   154 XXXXXXXXXXXXXXXXXXXLQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY 213
                                LQNLCGGPN+VKLLDIVRDQHSKTPSLIFEYVN+TDFKVLY
Sbjct:    61 IIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVLY 120

Query:   214 PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG 273
             PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG
Sbjct:   121 PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG 180

Query:   274 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI 333
             KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI
Sbjct:   181 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI 240

Query:   334 AK 335
             AK
Sbjct:   241 AK 242

GO:0009648 "photoperiodism" evidence=IGI

GO:0010229 "inflorescence development" evidence=IMP

TAIR|locus:2045349 CKA3 "casein kinase II, alpha chain 3" [Arabidopsis thaliana (taxid:3702)]

 Score = 1147 (408.8 bits), Expect = 2.6e-145, Sum P(2) = 2.6e-145
 Identities = 211/242 (87%), Positives = 218/242 (90%)

Query:    94 MSKARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERC 153
             MSKARVYTDVNV+RPKEYWDYESL VQWG QDDYEVVRKVGRGKYSEVFEG NVNTNERC
Sbjct:     1 MSKARVYTDVNVVRPKEYWDYESLVVQWGHQDDYEVVRKVGRGKYSEVFEGKNVNTNERC 60

Query:   154 XXXXXXXXXXXXXXXXXXXLQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY 213
                                LQNLCGGPN+VKL DIVRD+HSKTPSL+FE+VNS DFKVLY
Sbjct:    61 VIKILKPVKKKKIKREIKILQNLCGGPNIVKLYDIVRDEHSKTPSLVFEFVNSVDFKVLY 120

Query:   214 PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG 273
             PTLTDYDIRYYIYELLKALD+CHSQGIMHRDVKPHNVMIDH+LRKLRLIDWGLAEFYHPG
Sbjct:   121 PTLTDYDIRYYIYELLKALDFCHSQGIMHRDVKPHNVMIDHQLRKLRLIDWGLAEFYHPG 180

Query:   274 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI 333
             KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI
Sbjct:   181 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI 240

Query:   334 AK 335
             AK
Sbjct:   241 AK 242

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0007623 "circadian rhythm" evidence=IGI

GO:0006281 "DNA repair" evidence=IDA

GO:0006325 "chromatin organization" evidence=IEP;IDA

GO:0010225 "response to UV-C" evidence=IMP

GO:0010332 "response to gamma radiation" evidence=IMP

GO:0051726 "regulation of cell cycle" evidence=IEP

GO:2001020 "regulation of response to DNA damage stimulus" evidence=IEP

GO:0009612 "response to mechanical stimulus" evidence=RCA

GO:0019722 "calcium-mediated signaling" evidence=RCA

TAIR|locus:2045339 AT2G23070 [Arabidopsis thaliana (taxid:3702)]

 Score = 1088 (388.1 bits), Expect = 6.6e-136, Sum P(2) = 6.6e-136
 Identities = 200/243 (82%), Positives = 214/243 (88%)

Query:    93 AMSKARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNER 152
             A SKARVY DVNV+RPK+YWDYESL VQWG QDDYEVVRKVGRGKYSEVFEGI+   NE+
Sbjct:    98 APSKARVYADVNVVRPKDYWDYESLAVQWGVQDDYEVVRKVGRGKYSEVFEGIHATDNEK 157

Query:   153 CXXXXXXXXXXXXXXXXXXXLQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL 212
             C                   LQNLCGGPN+VKLLDIVRDQ SKTPSLIFE+VN+ DFKVL
Sbjct:   158 CVIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNKDFKVL 217

Query:   213 YPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP 272
             YPTL+DYD+RYYI+ELLKALD+CHS+GIMHRDVKPHNVMIDHE RKLRLIDWGLAEFYHP
Sbjct:   218 YPTLSDYDVRYYIFELLKALDFCHSRGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP 277

Query:   273 GKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVK 332
             GKEYNVRVASRYFKGPELLVDLQDYDYSLD+WSLGCMFAGMIFRKEPFFYGHDN+DQLVK
Sbjct:   278 GKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVK 337

Query:   333 IAK 335
             IAK
Sbjct:   338 IAK 340

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005829 "cytosol" evidence=IDA

UNIPROTKB|P68399 CSNK2A1 "Casein kinase II subunit alpha" [Bos taurus (taxid:9913)]

 Score = 976 (348.6 bits), Expect = 1.4e-120, Sum P(2) = 1.4e-120
 Identities = 177/244 (72%), Positives = 202/244 (82%)

Query:    92 PAMSKARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNE 151
             P  S+ARVYTDVN  RP+EYWDYES  V+WG+QDDY++VRK+GRGKYSEVFE IN+  NE
Sbjct:     4 PVPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNE 63

Query:   152 RCXXXXXXXXXXXXXXXXXXXLQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKV 211
             +                    L+NL GGPN++ L DIV+D  S+TP+L+FE+VN+TDFK 
Sbjct:    64 KVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQ 123

Query:   212 LYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 271
             LY TLTDYDIR+Y+YE+LKALDYCHS GIMHRDVKPHNVMIDHE RKLRLIDWGLAEFYH
Sbjct:   124 LYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 183

Query:   272 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV 331
             PG+EYNVRVASRYFKGPELLVD Q YDYSLDMWSLGCM A MIFRKEPFF+GHDN+DQLV
Sbjct:   184 PGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLV 243

Query:   332 KIAK 335
             +IAK
Sbjct:   244 RIAK 247

GO:0047485 "protein N-terminus binding" evidence=ISS

GO:0030177 "positive regulation of Wnt receptor signaling pathway" evidence=ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=ISS

GO:0071174 "mitotic spindle checkpoint" evidence=ISS

GO:0043154 "negative regulation of cysteine-type endopeptidase activity involved in apoptotic process" evidence=ISS

GO:0031519 "PcG protein complex" evidence=ISS

GO:0016055 "Wnt receptor signaling pathway" evidence=IEA

GO:0006355 "regulation of transcription, DNA-dependent" evidence=IEA

GO:0006351 "transcription, DNA-dependent" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

UNIPROTKB|E2RHZ1 CSNK2A1 "Uncharacterized protein" [Canis lupus familiaris (taxid:9615)]

 Score = 976 (348.6 bits), Expect = 1.4e-120, Sum P(2) = 1.4e-120
 Identities = 177/244 (72%), Positives = 202/244 (82%)

Query:    92 PAMSKARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNE 151
             P  S+ARVYTDVN  RP+EYWDYES  V+WG+QDDY++VRK+GRGKYSEVFE IN+  NE
Sbjct:     4 PVPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNE 63

Query:   152 RCXXXXXXXXXXXXXXXXXXXLQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKV 211
             +                    L+NL GGPN++ L DIV+D  S+TP+L+FE+VN+TDFK 
Sbjct:    64 KVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQ 123

Query:   212 LYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 271
             LY TLTDYDIR+Y+YE+LKALDYCHS GIMHRDVKPHNVMIDHE RKLRLIDWGLAEFYH
Sbjct:   124 LYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 183

Query:   272 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV 331
             PG+EYNVRVASRYFKGPELLVD Q YDYSLDMWSLGCM A MIFRKEPFF+GHDN+DQLV
Sbjct:   184 PGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLV 243

Query:   332 KIAK 335
             +IAK
Sbjct:   244 RIAK 247

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0071174 "mitotic spindle checkpoint" evidence=IEA

GO:0047485 "protein N-terminus binding" evidence=IEA

GO:0046777 "protein autophosphorylation" evidence=IEA

GO:0043154 "negative regulation of cysteine-type endopeptidase activity involved in apoptotic process" evidence=IEA

GO:0031519 "PcG protein complex" evidence=IEA

GO:0030177 "positive regulation of Wnt receptor signaling pathway" evidence=IEA

GO:0019888 "protein phosphatase regulator activity" evidence=IEA

GO:0016581 "NuRD complex" evidence=IEA

GO:0016580 "Sin3 complex" evidence=IEA

GO:0008013 "beta-catenin binding" evidence=IEA

UNIPROTKB|E7EU96 CSNK2A1 "Casein kinase II subunit alpha" [Homo sapiens (taxid:9606)]

 Score = 976 (348.6 bits), Expect = 1.4e-120, Sum P(2) = 1.4e-120
 Identities = 177/244 (72%), Positives = 202/244 (82%)

Query:    92 PAMSKARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNE 151
             P  S+ARVYTDVN  RP+EYWDYES  V+WG+QDDY++VRK+GRGKYSEVFE IN+  NE
Sbjct:     4 PVPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNE 63

Query:   152 RCXXXXXXXXXXXXXXXXXXXLQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKV 211
             +                    L+NL GGPN++ L DIV+D  S+TP+L+FE+VN+TDFK 
Sbjct:    64 KVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQ 123

Query:   212 LYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 271
             LY TLTDYDIR+Y+YE+LKALDYCHS GIMHRDVKPHNVMIDHE RKLRLIDWGLAEFYH
Sbjct:   124 LYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 183

Query:   272 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV 331
             PG+EYNVRVASRYFKGPELLVD Q YDYSLDMWSLGCM A MIFRKEPFF+GHDN+DQLV
Sbjct:   184 PGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLV 243

Query:   332 KIAK 335
             +IAK
Sbjct:   244 RIAK 247

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

UNIPROTKB|P68400 CSNK2A1 "Casein kinase II subunit alpha" [Homo sapiens (taxid:9606)]

 Score = 976 (348.6 bits), Expect = 1.4e-120, Sum P(2) = 1.4e-120
 Identities = 177/244 (72%), Positives = 202/244 (82%)

Query:    92 PAMSKARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNE 151
             P  S+ARVYTDVN  RP+EYWDYES  V+WG+QDDY++VRK+GRGKYSEVFE IN+  NE
Sbjct:     4 PVPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNE 63

Query:   152 RCXXXXXXXXXXXXXXXXXXXLQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKV 211
             +                    L+NL GGPN++ L DIV+D  S+TP+L+FE+VN+TDFK 
Sbjct:    64 KVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQ 123

Query:   212 LYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 271
             LY TLTDYDIR+Y+YE+LKALDYCHS GIMHRDVKPHNVMIDHE RKLRLIDWGLAEFYH
Sbjct:   124 LYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 183

Query:   272 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV 331
             PG+EYNVRVASRYFKGPELLVD Q YDYSLDMWSLGCM A MIFRKEPFF+GHDN+DQLV
Sbjct:   184 PGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLV 243

Query:   332 KIAK 335
             +IAK
Sbjct:   244 RIAK 247

GO:0005524 "ATP binding" evidence=IEA

GO:0006351 "transcription, DNA-dependent" evidence=IEA

GO:0006355 "regulation of transcription, DNA-dependent" evidence=IEA

GO:0016055 "Wnt receptor signaling pathway" evidence=IEA

GO:0008013 "beta-catenin binding" evidence=IEA

GO:0019888 "protein phosphatase regulator activity" evidence=IEA

GO:0046777 "protein autophosphorylation" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IDA;TAS

GO:0047485 "protein N-terminus binding" evidence=IPI

GO:0005515 "protein binding" evidence=IPI

GO:0045732 "positive regulation of protein catabolic process" evidence=IDA

GO:0006468 "protein phosphorylation" evidence=IDA

GO:0030307 "positive regulation of cell growth" evidence=IDA

GO:0008284 "positive regulation of cell proliferation" evidence=IDA

GO:0031519 "PcG protein complex" evidence=IDA

GO:0071174 "mitotic spindle checkpoint" evidence=IMP

GO:0043154 "negative regulation of cysteine-type endopeptidase activity involved in apoptotic process" evidence=IMP

GO:0030177 "positive regulation of Wnt receptor signaling pathway" evidence=IMP

GO:0051879 "Hsp90 protein binding" evidence=TAS

GO:0061077 "chaperone-mediated protein folding" evidence=TAS

GO:0005634 "nucleus" evidence=IDA

GO:0005886 "plasma membrane" evidence=TAS

GO:0007165 "signal transduction" evidence=TAS

GO:0005829 "cytosol" evidence=TAS

GO:0007411 "axon guidance" evidence=TAS

GO:0016581 "NuRD complex" evidence=IDA

GO:0016580 "Sin3 complex" evidence=IDA

UNIPROTKB|F2Z5I5 CSNK2A1 "Uncharacterized protein" [Sus scrofa (taxid:9823)]

 Score = 976 (348.6 bits), Expect = 1.4e-120, Sum P(2) = 1.4e-120
 Identities = 177/244 (72%), Positives = 202/244 (82%)

Query:    92 PAMSKARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNE 151
             P  S+ARVYTDVN  RP+EYWDYES  V+WG+QDDY++VRK+GRGKYSEVFE IN+  NE
Sbjct:     4 PVPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNE 63

Query:   152 RCXXXXXXXXXXXXXXXXXXXLQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKV 211
             +                    L+NL GGPN++ L DIV+D  S+TP+L+FE+VN+TDFK 
Sbjct:    64 KVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQ 123

Query:   212 LYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 271
             LY TLTDYDIR+Y+YE+LKALDYCHS GIMHRDVKPHNVMIDHE RKLRLIDWGLAEFYH
Sbjct:   124 LYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 183

Query:   272 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV 331
             PG+EYNVRVASRYFKGPELLVD Q YDYSLDMWSLGCM A MIFRKEPFF+GHDN+DQLV
Sbjct:   184 PGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLV 243

Query:   332 KIAK 335
             +IAK
Sbjct:   244 RIAK 247

GO:0071174 "mitotic spindle checkpoint" evidence=IEA

GO:0047485 "protein N-terminus binding" evidence=IEA

GO:0046777 "protein autophosphorylation" evidence=IEA

GO:0043154 "negative regulation of cysteine-type endopeptidase activity involved in apoptotic process" evidence=IEA

GO:0031519 "PcG protein complex" evidence=IEA

GO:0030177 "positive regulation of Wnt receptor signaling pathway" evidence=IEA

GO:0019888 "protein phosphatase regulator activity" evidence=IEA

GO:0016581 "NuRD complex" evidence=IEA

GO:0016580 "Sin3 complex" evidence=IEA

GO:0008013 "beta-catenin binding" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

MGI|MGI:88543 Csnk2a1 "casein kinase 2, alpha 1 polypeptide" [Mus musculus (taxid:10090)]

 Score = 976 (348.6 bits), Expect = 1.4e-120, Sum P(2) = 1.4e-120
 Identities = 177/244 (72%), Positives = 202/244 (82%)

Query:    92 PAMSKARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNE 151
             P  S+ARVYTDVN  RP+EYWDYES  V+WG+QDDY++VRK+GRGKYSEVFE IN+  NE
Sbjct:     4 PVPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNE 63

Query:   152 RCXXXXXXXXXXXXXXXXXXXLQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKV 211
             +                    L+NL GGPN++ L DIV+D  S+TP+L+FE+VN+TDFK 
Sbjct:    64 KVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQ 123

Query:   212 LYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 271
             LY TLTDYDIR+Y+YE+LKALDYCHS GIMHRDVKPHNVMIDHE RKLRLIDWGLAEFYH
Sbjct:   124 LYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 183

Query:   272 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV 331
             PG+EYNVRVASRYFKGPELLVD Q YDYSLDMWSLGCM A MIFRKEPFF+GHDN+DQLV
Sbjct:   184 PGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLV 243

Query:   332 KIAK 335
             +IAK
Sbjct:   244 RIAK 247

GO:0000166 "nucleotide binding" evidence=IEA

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=ISO

GO:0005515 "protein binding" evidence=IPI

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISO

GO:0005956 "protein kinase CK2 complex" evidence=TAS

GO:0006351 "transcription, DNA-dependent" evidence=IEA

GO:0006355 "regulation of transcription, DNA-dependent" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA;ISO;IDA

GO:0006915 "apoptotic process" evidence=IEA

GO:0007049 "cell cycle" evidence=IEA

GO:0008013 "beta-catenin binding" evidence=IDA

GO:0008284 "positive regulation of cell proliferation" evidence=ISO

GO:0016055 "Wnt receptor signaling pathway" evidence=IEA

GO:0016301 "kinase activity" evidence=IDA

GO:0016310 "phosphorylation" evidence=IEA

GO:0016580 "Sin3 complex" evidence=ISO

GO:0016581 "NuRD complex" evidence=ISO

GO:0016740 "transferase activity" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0019888 "protein phosphatase regulator activity" evidence=IDA

GO:0030177 "positive regulation of Wnt receptor signaling pathway" evidence=ISO

GO:0030307 "positive regulation of cell growth" evidence=ISO

GO:0043154 "negative regulation of cysteine-type endopeptidase activity involved in apoptotic process" evidence=ISO

GO:0045732 "positive regulation of protein catabolic process" evidence=ISO

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0047485 "protein N-terminus binding" evidence=ISO

GO:0050790 "regulation of catalytic activity" evidence=IDA

GO:0071174 "mitotic spindle checkpoint" evidence=ISO

RGD|621663 Csnk2a1 "casein kinase 2, alpha 1 polypeptide" [Rattus norvegicus (taxid:10116)]

 Score = 976 (348.6 bits), Expect = 1.4e-120, Sum P(2) = 1.4e-120
 Identities = 177/244 (72%), Positives = 202/244 (82%)

Query:    92 PAMSKARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNE 151
             P  S+ARVYTDVN  RP+EYWDYES  V+WG+QDDY++VRK+GRGKYSEVFE IN+  NE
Sbjct:     4 PVPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNE 63

Query:   152 RCXXXXXXXXXXXXXXXXXXXLQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKV 211
             +                    L+NL GGPN++ L DIV+D  S+TP+L+FE+VN+TDFK 
Sbjct:    64 KVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQ 123

Query:   212 LYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 271
             LY TLTDYDIR+Y+YE+LKALDYCHS GIMHRDVKPHNVMIDHE RKLRLIDWGLAEFYH
Sbjct:   124 LYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 183

Query:   272 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV 331
             PG+EYNVRVASRYFKGPELLVD Q YDYSLDMWSLGCM A MIFRKEPFF+GHDN+DQLV
Sbjct:   184 PGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLV 243

Query:   332 KIAK 335
             +IAK
Sbjct:   244 RIAK 247

GO:0001558 "regulation of cell growth" evidence=NAS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISO;ISS

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISO

GO:0005956 "protein kinase CK2 complex" evidence=TAS

GO:0006351 "transcription, DNA-dependent" evidence=IEA

GO:0006355 "regulation of transcription, DNA-dependent" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=ISO

GO:0008013 "beta-catenin binding" evidence=IEA;ISO

GO:0008284 "positive regulation of cell proliferation" evidence=ISO

GO:0016055 "Wnt receptor signaling pathway" evidence=IEA

GO:0016301 "kinase activity" evidence=ISO

GO:0016580 "Sin3 complex" evidence=IEA;ISO

GO:0016581 "NuRD complex" evidence=IEA;ISO

GO:0019888 "protein phosphatase regulator activity" evidence=IEA;ISO

GO:0030177 "positive regulation of Wnt receptor signaling pathway" evidence=ISO;ISS

GO:0030307 "positive regulation of cell growth" evidence=ISO

GO:0031519 "PcG protein complex" evidence=ISO;ISS

GO:0042127 "regulation of cell proliferation" evidence=NAS

GO:0043154 "negative regulation of cysteine-type endopeptidase activity involved in apoptotic process" evidence=ISO;ISS

GO:0045732 "positive regulation of protein catabolic process" evidence=ISO

GO:0046777 "protein autophosphorylation" evidence=IEA;ISO

GO:0047485 "protein N-terminus binding" evidence=IEA;ISO

GO:0050790 "regulation of catalytic activity" evidence=ISO

GO:0071174 "mitotic spindle checkpoint" evidence=ISO;ISS

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
P19454	CSK22_YEAST	2, ., 7, ., 1, 1, ., 1	0.5862	0.7352	0.8849	yes	no
P21868	CSK21_CHICK	2, ., 7, ., 1, 1, ., 1	0.7352	0.7450	0.7774	yes	no
Q8TG13	CSK2A_NEUCR	2, ., 7, ., 1, 1, ., 1	0.7134	0.7598	0.9226	N/A	no
P68399	CSK21_BOVIN	2, ., 7, ., 1, 1, ., 1	0.7164	0.7671	0.8005	yes	no
P28523	CSK2A_MAIZE	2, ., 7, ., 1, 1, ., 1	0.8825	0.7720	0.9487	N/A	no
P18334	CSK2A_CAEEL	2, ., 7, ., 1, 1, ., 1	0.6716	0.7549	0.8555	yes	no
P08181	CSK2A_DROME	2, ., 7, ., 1, 1, ., 1	0.7358	0.7377	0.8958	yes	no
P19139	CSK21_RAT	2, ., 7, ., 1, 1, ., 1	0.7125	0.7769	0.8107	yes	no
O76484	CSK2A_SPOFR	2, ., 7, ., 1, 1, ., 1	0.7138	0.7377	0.8526	N/A	no
P28547	CSK2A_THEPA	2, ., 7, ., 1, 1, ., 1	0.6542	0.7352	0.8620	yes	no
P68400	CSK21_HUMAN	2, ., 7, ., 1, 1, ., 1	0.7164	0.7671	0.8005	yes	no
P40231	CSK2A_SCHPO	2, ., 7, ., 1, 1, ., 1	0.6635	0.7450	0.9156	yes	no
Q02720	CSK2A_DICDI	2, ., 7, ., 1, 1, ., 1	0.6949	0.7377	0.8931	yes	no
P33674	CSK21_RABIT	2, ., 7, ., 1, 1, ., 1	0.7134	0.7671	0.8005	yes	no
P28020	CSK21_XENLA	2, ., 7, ., 1, 1, ., 1	0.7320	0.7450	0.7755	N/A	no
Q60737	CSK21_MOUSE	2, ., 7, ., 1, 1, ., 1	0.7314	0.7524	0.7851	yes	no
Q08467	CSK21_ARATH	2, ., 7, ., 1, 1, ., 1	0.7846	0.8700	0.8679	yes	no
Q08466	CSK22_ARATH	2, ., 7, ., 1, 1, ., 1	0.7840	0.8799	0.8908	no	no

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	0.991
3rd Layer	2.7.11	0.976

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Your Input: fgenesh2_kg.5__1350__AT3G50000.1 annotation not avaliable (405 aa) (Arabidopsis lyrata)

Predicted Functional Partners:

Sorry, there are no predicted associations at the current settings.

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	408
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	9e-75
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	1e-74
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	3e-62
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	3e-60
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	5e-58
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	2e-55
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	5e-54
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	1e-53
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	2e-52
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	2e-47
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	2e-47
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	4e-47
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	2e-46
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	2e-45
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	5e-45
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	6e-45
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	4e-44
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	3e-43
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	6e-43
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	8e-43
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	1e-42
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	2e-42
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	2e-42
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	4e-42
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	1e-41
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	3e-41
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	3e-40
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	5e-40
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	6e-40
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	7e-40
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	8e-40
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	3e-39
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	3e-39
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	1e-38
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	2e-38
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	2e-38
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	4e-38
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	2e-37
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	1e-36
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	3e-36
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	4e-36
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	4e-35
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	2e-33
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	2e-32
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	2e-32
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	1e-31
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	1e-31
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	9e-31
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	1e-30
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	1e-30
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	9e-30
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	9e-30
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	1e-29
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	1e-29
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	3e-29
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	4e-29
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	5e-29
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	5e-29
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	8e-29
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	4e-28
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	8e-28
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	3e-26
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	2e-25
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	8e-25
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	9e-25
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	1e-24
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	3e-24
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	5e-24
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	8e-24
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	9e-24
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	2e-21
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	9e-21
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	1e-20
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	1e-20
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	3e-20
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	7e-20
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	7e-20
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	1e-19
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	2e-19
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	4e-19
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	5e-19
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	8e-19
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	1e-18
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	2e-18
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	7e-18
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	8e-18
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	9e-18
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	9e-18
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	9e-18
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	3e-17
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	5e-17
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	6e-17
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	6e-17
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	6e-17
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	8e-17
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	3e-16
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	4e-16
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	4e-16
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	5e-16
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	5e-16
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	7e-16
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	7e-16
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	7e-16
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	1e-15
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	1e-15
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	2e-15
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	3e-15
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	4e-15
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	1e-14
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	1e-14
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	1e-14
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	1e-14
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	1e-14
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	1e-14
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	2e-14
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	2e-14
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	2e-14
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	3e-14
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	3e-14
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	4e-14
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	6e-14
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	8e-14
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	1e-13
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	1e-13
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	1e-13
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	1e-13
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	1e-13
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	3e-13
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	3e-13
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	4e-13
PLN03225	566	PLN03225, PLN03225, Serine/threonine-protein kinas	4e-13
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	5e-13
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	6e-13
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	7e-13
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	8e-13
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	9e-13
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	9e-13
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	1e-12
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	2e-12
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	3e-12
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	3e-12
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	4e-12
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	4e-12
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	4e-12
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	6e-12
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	6e-12
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	6e-12
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	7e-12
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	7e-12
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	9e-12
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	9e-12
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	9e-12
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	1e-11
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	1e-11
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	2e-11
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	2e-11
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	2e-11
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	2e-11
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	3e-11
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	4e-11
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	4e-11
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	4e-11
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	4e-11
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	6e-11
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	7e-11
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	7e-11
PTZ00284	467	PTZ00284, PTZ00284, protein kinase; Provisional	7e-11
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	1e-10
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	1e-10
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	1e-10
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	1e-10
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	1e-10
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	2e-10
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	2e-10
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	2e-10
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	3e-10
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	3e-10
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	4e-10
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	5e-10
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	6e-10
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	7e-10
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	8e-10
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	8e-10
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	9e-10
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	1e-09
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	1e-09
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	3e-09
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	3e-09
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	4e-09
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	4e-09
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	4e-09
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	8e-09
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	9e-09
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	3e-08
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	5e-08
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	7e-08
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	8e-08
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	8e-08
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	8e-08
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	2e-07
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	2e-07
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	2e-07
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	2e-07
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	3e-07
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	5e-07
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	5e-07
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	7e-07
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	7e-07
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	2e-06
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	2e-06
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	2e-06
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	2e-06
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	2e-06
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	2e-06
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	3e-06
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	4e-06
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	4e-06
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	5e-06
cd08227	327	cd08227, PK_STRAD_alpha, Pseudokinase domain of ST	1e-05
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	2e-05
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	2e-05
PHA02882	294	PHA02882, PHA02882, putative serine/threonine kina	3e-05
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	3e-05
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	4e-05
cd05120	155	cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot	8e-05
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	9e-05
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	1e-04
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	2e-04
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	2e-04
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	2e-04
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	2e-04
PRK09605	535	PRK09605, PRK09605, bifunctional UGMP family prote	2e-04
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	2e-04
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	3e-04
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	3e-04
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	4e-04
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	4e-04
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	6e-04
pfam01636	238	pfam01636, APH, Phosphotransferase enzyme family	7e-04
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	7e-04
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	7e-04
PRK14879	211	PRK14879, PRK14879, serine/threonine protein kinas	0.001
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	0.001
TIGR03724	199	TIGR03724, arch_bud32, Kae1-associated kinase Bud3	0.002
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	0.002
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	0.003
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	0.003
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	0.003
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	0.003
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	0.003

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  233 bits (596), Expect = 9e-75
 Identities = 94/276 (34%), Positives = 148/276 (53%), Gaps = 29/276 (10%)

Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKK----IKREIKILQNLCGGPNV 182
           YE++ K+G G + +V+   +  T +   IK++K  K KK    I REIKIL+ L   PN+
Sbjct: 1   YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKL-KHPNI 59

Query: 183 VKLLDIVRDQHSKTPSLIFEYVNSTD-FKVL--YPTLTDYDIRYYIYELLKALDYCHSQG 239
           V+L D+  D+      L+ EY    D F +L     L++ + R+Y+ ++L AL+Y HS+G
Sbjct: 60  VRLYDVFEDEDK--LYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYLHSKG 117

Query: 240 IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDY 299
           I+HRD+KP N+++D +   ++L D+GLA    PG++    V +  +  PE+L+  + Y  
Sbjct: 118 IVHRDLKPENILLDED-GHVKLADFGLARQLDPGEKLTTFVGTPEYMAPEVLLG-KGYGK 175

Query: 300 SLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSKFINAD 359
           ++D+WSLG +   ++  K P F G D   +L K                   W       
Sbjct: 176 AVDIWSLGVILYELLTGK-PPFPGDDQLLELFKKIGKPKPPFP------PPEWD------ 222

Query: 360 NQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF 395
               +SPEA D + KLL  D + RLTA EA+ HP+F
Sbjct: 223 ----ISPEAKDLIRKLLVKDPEKRLTAEEALQHPFF 254

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  232 bits (595), Expect = 1e-74
 Identities = 83/278 (29%), Positives = 132/278 (47%), Gaps = 27/278 (9%)

Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIK-----REIKILQNLCGGPN 181
           YE++RK+G G +  V++  +  T +   +KILK   +K  K     REI+IL+ L   PN
Sbjct: 1   YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRL-SHPN 59

Query: 182 VVKLLDIVRDQHSKTPSLIFEYVNSTDFK---VLYPTLTDYDIRYYIYELLKALDYCHSQ 238
           +V+L+D   D       L+ EY    D          L++ + +    ++L+ L+Y HS 
Sbjct: 60  IVRLIDAFED--KDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLHSN 117

Query: 239 GIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPELLVDLQDY 297
           GI+HRD+KP N+++D     +++ D+GLA+            V + ++  PE+L+    Y
Sbjct: 118 GIIHRDLKPENILLDENGV-VKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGGNGY 176

Query: 298 DYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSKFIN 357
              +D+WSLG +   ++  K P F G +  DQL  I      I+          W     
Sbjct: 177 GPKVDVWSLGVILYELLTGKPP-FSGENILDQLQLI----RRILGPPLEFDEPKW----- 226

Query: 358 ADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF 395
                  S EA D + K L  D   R TA E + HP+F
Sbjct: 227 ----SSGSEEAKDLIKKCLNKDPSKRPTAEEILQHPWF 260

Length = 260

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score =  201 bits (514), Expect = 3e-62
 Identities = 97/293 (33%), Positives = 154/293 (52%), Gaps = 35/293 (11%)

Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKK-IK----REIKILQNLCGGPN 181
           YE + K+G G Y  V++  +  T E   +K ++   +++ I     REI +L+ L   PN
Sbjct: 1   YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKEL-KHPN 59

Query: 182 VVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL----YPTLTDYDIRYYIYELLKALDYCHS 237
           +VKLLD++     +   L+FEY +  D K         L+   I+  +Y+LL+ L YCHS
Sbjct: 60  IVKLLDVIH--TERKLYLVFEYCD-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHS 116

Query: 238 QGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDLQD 296
             I+HRD+KP N++I+ +   L+L D+GLA  F  P + Y   V + +++ PE+L+  + 
Sbjct: 117 HRILHRDLKPQNILINRD-GVLKLADFGLARAFGIPLRTYTHEVVTLWYRAPEILLGSKH 175

Query: 297 YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLI---IWCN--------- 344
           Y  ++D+WS+GC+FA MI   +P F G    DQL KI +         W           
Sbjct: 176 YSTAVDIWSVGCIFAEMI-TGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKP 234

Query: 345 --SRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF 395
              +   K   K +       + PE ID L K+L+Y+   R++A+EA+ HPYF
Sbjct: 235 TFPKFPPKDLEKVLPR-----LDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score =  196 bits (501), Expect = 3e-60
 Identities = 96/292 (32%), Positives = 155/292 (53%), Gaps = 28/292 (9%)

Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKK-----IKREIKILQNLCGGPN 181
           YE + ++G G Y +V++  N  T E   +K ++   +K+       REIK+LQ L   PN
Sbjct: 1   YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRH-PN 59

Query: 182 VVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL----YPTLTDYDIRYYIYELLKALDYCHS 237
           +V+L +IV  +   +  ++FEY+   D   L        T+  I+ Y+ +LL+ L Y HS
Sbjct: 60  IVRLKEIVTSKGKGSIYMVFEYM-DHDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHS 118

Query: 238 QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP--GKEYNVRVASRYFKGPELLVDLQ 295
            GI+HRD+K  N++I+++   L+L D+GLA  Y      +Y  RV + +++ PELL+   
Sbjct: 119 NGILHRDIKGSNILINNDGV-LKLADFGLARPYTKRNSADYTNRVITLWYRPPELLLGAT 177

Query: 296 DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDC------------CLIIWC 343
            Y   +DMWS+GC+ A + F  +P F G    +QL KI + C             L  + 
Sbjct: 178 RYGPEVDMWSVGCILAEL-FLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFE 236

Query: 344 NSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF 395
           N +  +    +      +HL+ P A+D LDKLL  D + R++A +A+ H YF
Sbjct: 237 NLKPKKPYKRRLREFF-KHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score =  192 bits (490), Expect = 5e-58
 Identities = 108/308 (35%), Positives = 167/308 (54%), Gaps = 48/308 (15%)

Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIK-ILKPVKK----KKIKREIKILQNLCGGPN 181
           YE+++ +G G Y  V   ++  T  +  IK I          K+I REIK+L++L    N
Sbjct: 2   YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHL-RHEN 60

Query: 182 VVKLLDIVRDQHSKTPS---LIFEYVNSTDF-KVLY--PTLTDYDIRYYIYELLKALDYC 235
           ++ LLDI+R    +  +   ++ E +  TD  KV+     LTD  I+Y++Y++L+ L Y 
Sbjct: 61  IIGLLDILRPPSPEDFNDVYIVTELM-ETDLHKVIKSPQPLTDDHIQYFLYQILRGLKYL 119

Query: 236 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-----EFYHPGK--EYNVRVASRYFKGP 288
           HS  ++HRD+KP N++++     L++ D+GLA     +    G   EY   V +R+++ P
Sbjct: 120 HSANVIHRDLKPSNILVNSNC-DLKICDFGLARGVDPDEDEKGFLTEY---VVTRWYRAP 175

Query: 289 ELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI--------AKDCCLI 340
           ELL+    Y  ++D+WS+GC+FA ++ RK P F G D  DQL  I         +D   I
Sbjct: 176 ELLLSSSRYTKAIDIWSVGCIFAELLTRK-PLFPGRDYIDQLNLIVEVLGTPSEEDLKFI 234

Query: 341 IWCNSR--------HSRKPWSK-FINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA 391
               +R          +KP SK F  A      SPEAID L+K+L +D + R+TA EA+A
Sbjct: 235 TSEKARNYLKSLPKKPKKPLSKLFPGA------SPEAIDLLEKMLVFDPKKRITADEALA 288

Query: 392 HPYFAQVR 399
           HPY AQ+ 
Sbjct: 289 HPYLAQLH 296

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score =  184 bits (468), Expect = 2e-55
 Identities = 100/289 (34%), Positives = 160/289 (55%), Gaps = 26/289 (8%)

Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILK-----PVKKKKIKREIKILQNLCGGPN 181
           Y+ + K+G G Y  V++  +  T E   IK +K         K   REIK+L+ L   PN
Sbjct: 1   YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKEL-NHPN 59

Query: 182 VVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL----YPTLTDYDIRYYIYELLKALDYCHS 237
           ++KLLD+ R +      L+FE++++  +K++       L +  I+ Y+Y+LL+ L +CHS
Sbjct: 60  IIKLLDVFRHK--GDLYLVFEFMDTDLYKLIKDRQRG-LPESLIKSYLYQLLQGLAFCHS 116

Query: 238 QGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDLQD 296
            GI+HRD+KP N++I+ E   L+L D+GLA  F  P + Y   V +R+++ PELL+  + 
Sbjct: 117 HGILHRDLKPENLLINTE-GVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLGDKG 175

Query: 297 YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK---DCCLIIW---CNSRHSRK 350
           Y   +D+WS+GC+FA ++ R+ P F G    DQL KI +        +W    +   + K
Sbjct: 176 YSTPVDIWSVGCIFAELLSRR-PLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYK 234

Query: 351 PWSKFINADNQHLV----SPEAIDFLDKLLRYDHQDRLTAREAMAHPYF 395
                        +    SP+A+D L ++L YD   R+TA +A+AHPYF
Sbjct: 235 FSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score =  180 bits (459), Expect = 5e-54
 Identities = 102/296 (34%), Positives = 143/296 (48%), Gaps = 37/296 (12%)

Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILK-----PVKKKKIKREIKILQNLCGGPN 181
           YEV+  VG G Y  V +  N  T E   IK  K        KK   RE+K+L+ L    N
Sbjct: 3   YEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQL-RHEN 61

Query: 182 VVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL--YPTLTDYD-IRYYIYELLKALDYCHSQ 238
           +V L +  R        L+FEYV  T  ++L   P     D +R YI++LL+A+ YCHS 
Sbjct: 62  IVNLKEAFR--RKGRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSH 119

Query: 239 GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH--PGKEYNVRVASRYFKGPELLVDLQD 296
            I+HRD+KP N+++      L+L D+G A      P       VA+R+++ PELLV   +
Sbjct: 120 NIIHRDIKPENILVSES-GVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDTN 178

Query: 297 YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCL---------IIWCNSRH 347
           Y   +D+W++GC+ A ++   EP F G  + DQL  I K  CL         +   N R 
Sbjct: 179 YGKPVDVWAIGCIMAELL-DGEPLFPGDSDIDQLYLIQK--CLGPLPPSHQELFSSNPRF 235

Query: 348 SRKPWSKFINADNQH--------LVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF 395
           +      F                VS  A+DFL   LR D ++RLT  E + HPYF
Sbjct: 236 AG---VAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score =  179 bits (456), Expect = 1e-53
 Identities = 98/299 (32%), Positives = 152/299 (50%), Gaps = 43/299 (14%)

Query: 126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIK-ILKPVKKKKIK----REIKILQNLCGGP 180
            Y+++ ++G G +  VF+  +  T E   +K +     +  I     REIK LQ  C  P
Sbjct: 1   RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQA-CQHP 59

Query: 181 NVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL----YPTLTDYDIRYYIYELLKALDYCH 236
            VVKLLD+    H     L+ EY+ S   +VL     P L +  ++ Y+  LLK + Y H
Sbjct: 60  YVVKLLDVFP--HGSGFVLVMEYMPSDLSEVLRDEERP-LPEAQVKSYMRMLLKGVAYMH 116

Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE--YNVRVASRYFKGPELLVDL 294
           + GIMHRD+KP N++I      L++ D+GLA  +   +   Y+ +VA+R+++ PELL   
Sbjct: 117 ANGIMHRDLKPANLLIS-ADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGA 175

Query: 295 QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLI---------IWCNS 345
           + YD  +D+W++GC+FA ++    P F G ++ +QL        +           W   
Sbjct: 176 RKYDPGVDLWAVGCIFAELL-NGSPLFPGENDIEQL------AIVFRTLGTPNEETW--P 226

Query: 346 RHSRKP-WSK--FINADNQHL------VSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF 395
             +  P ++K  F  +    L       SPEA+D L  LL YD   RL+A EA+ HPYF
Sbjct: 227 GLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYF 285

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score =  176 bits (450), Expect = 2e-52
 Identities = 97/297 (32%), Positives = 156/297 (52%), Gaps = 39/297 (13%)

Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIK--------REIKILQNLCG 178
           YE  +K+G G Y+ V++  +  T     IK +K  ++K+ K        REIK+LQ L  
Sbjct: 2   YEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQEL-K 60

Query: 179 GPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDY 234
            PN++ LLD+    H    +L+FE++  TD + +       LT  DI+ Y+   L+ L+Y
Sbjct: 61  HPNIIGLLDVF--GHKSNINLVFEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEY 117

Query: 235 CHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY-HPGKEYNVRVASRYFKGPELLVD 293
            HS  I+HRD+KP+N++I  +   L+L D+GLA  +  P ++   +V +R+++ PELL  
Sbjct: 118 LHSNWILHRDLKPNNLLIASD-GVLKLADFGLARSFGSPNRKMTHQVVTRWYRAPELLFG 176

Query: 294 LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDC------------CLII 341
            + Y   +DMWS+GC+FA ++ R  PF  G  + DQL KI +               L  
Sbjct: 177 ARHYGVGVDMWSVGCIFAELLLRV-PFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPD 235

Query: 342 WCNSRHSRKP--WSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFA 396
           +   +          F  A +      +A+D L +LL  +   R+TAR+A+ HPYF+
Sbjct: 236 YVEFKPFPPTPLKQIFPAASD------DALDLLQRLLTLNPNKRITARQALEHPYFS 286

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score =  164 bits (418), Expect = 2e-47
 Identities = 103/308 (33%), Positives = 156/308 (50%), Gaps = 53/308 (17%)

Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKI-------------KREIKIL 173
           YE+++K+G+G Y  V++ I+  T E         V  KKI              REI  L
Sbjct: 9   YEILQKLGKGAYGIVWKAIDRRTKEV--------VALKKIFDAFRNATDAQRTFREIMFL 60

Query: 174 QNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPT-LTDYDIRYYIYELLKAL 232
           Q L   PN+VKLL++++ ++ K   L+FEY+ +    V+    L D   RY +Y+LLKAL
Sbjct: 61  QELGDHPNIVKLLNVIKAENDKDIYLVFEYMETDLHAVIRANILEDVHKRYIMYQLLKAL 120

Query: 233 DYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR------VASRYFK 286
            Y HS  ++HRD+KP N++++ + R ++L D+GLA      +E          VA+R+++
Sbjct: 121 KYIHSGNVIHRDLKPSNILLNSDCR-VKLADFGLARSLSELEENPENPVLTDYVATRWYR 179

Query: 287 GPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI--------AKDC- 337
            PE+L+    Y   +DMWS+GC+   M+  K P F G    +QL KI        A+D  
Sbjct: 180 APEILLGSTRYTKGVDMWSVGCILGEMLLGK-PLFPGTSTLNQLEKIIEVIGPPSAEDIE 238

Query: 338 --------CLIIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREA 389
                    ++    SR  +        A      S +A+D L KLL ++   RLTA EA
Sbjct: 239 SIKSPFAATMLDSLPSRPRKPLDELLPKA------SDDALDLLKKLLVFNPNKRLTAEEA 292

Query: 390 MAHPYFAQ 397
           + HPY AQ
Sbjct: 293 LEHPYVAQ 300

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  160 bits (408), Expect = 2e-47
 Identities = 66/270 (24%), Positives = 113/270 (41%), Gaps = 64/270 (23%)

Query: 133 VGRGKYSEVFEGINVNTNERCIIKILKPVKKKK----IKREIKILQNLCGGPNVVKLLDI 188
           +G G +  V+   +  T ++  IKI+K          + REI+IL+ L   PN+VKL  +
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKL-NHPNIVKLYGV 59

Query: 189 VRDQHSKTPSLIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRD 244
             D+      L+ EY      K L       L++ +I   + ++L+ L+Y HS GI+HRD
Sbjct: 60  FEDE--NHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRD 117

Query: 245 VKPHNVMIDHELRKLRLIDWGLAEFY-HPGKEYNVRVASRYFKGPELLVDLQDYDYSLDM 303
           +KP N+++D +  K++L D+GL++            V +  +  PE+L+    Y    D+
Sbjct: 118 LKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSDI 177

Query: 304 WSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSKFINADNQHL 363
           WSLG +   +                                                  
Sbjct: 178 WSLGVILYEL-------------------------------------------------- 187

Query: 364 VSPEAIDFLDKLLRYDHQDRLTAREAMAHP 393
             PE  D + K+L+ D + R +A+E + H 
Sbjct: 188 --PELKDLIRKMLQKDPEKRPSAKEILEHL 215

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score =  162 bits (412), Expect = 4e-47
 Identities = 101/306 (33%), Positives = 160/306 (52%), Gaps = 47/306 (15%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIK-----------REIKIL 173
           D YE + K+G G Y +V++  + NT +      L  +KK +++           REI +L
Sbjct: 1   DAYEKLEKIGEGTYGKVYKARDKNTGK------LVALKKTRLEMDEEGIPPTALREISLL 54

Query: 174 QNLCGGPNVVKLLDIVR-DQHSKTPSL--IFEYVNSTDFKVLYPT--------LTDYDIR 222
           Q L     +V+LLD+   ++ +  PSL  +FEY+  +D K    +        L    I+
Sbjct: 55  QMLSESIYIVRLLDVEHVEEKNGKPSLYLVFEYL-DSDLKKFMDSNGRGPGRPLPAKTIK 113

Query: 223 YYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKEYNVRVA 281
            ++Y+LLK + +CH  G+MHRD+KP N+++D +   L++ D GL   F  P K Y   + 
Sbjct: 114 SFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIV 173

Query: 282 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLI- 340
           + +++ PE+L+    Y   +D+WS+GC+FA M  RK+P F G     QL+ I K   L+ 
Sbjct: 174 TLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMS-RKQPLFPGDSELQQLLHIFK---LLG 229

Query: 341 -----IWCNSRHSRKPWSKFINADNQHL------VSPEAIDFLDKLLRYDHQDRLTAREA 389
                +W      R  W +F     Q L      +SPE +D L K+LRYD   R++A+ A
Sbjct: 230 TPTEQVWPGVSKLRD-WHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAA 288

Query: 390 MAHPYF 395
           + HPYF
Sbjct: 289 LTHPYF 294

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score =  160 bits (407), Expect = 2e-46
 Identities = 90/302 (29%), Positives = 145/302 (48%), Gaps = 52/302 (17%)

Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIK--------REIKILQNLCG 178
           Y+V++++G G +  V+   N  T E   IK +K    KK          RE+K L+ L  
Sbjct: 1   YKVIKQLGDGTFGSVYLARNKETGELVAIKKMK----KKFYSWEECMNLREVKSLRKLNE 56

Query: 179 GPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYD--------IRYYIYELLK 230
            PN+VKL ++ R+  +     +FEY+       LY  + D          IR  IY++L+
Sbjct: 57  HPNIVKLKEVFRE--NDELYFVFEYMEGN----LYQLMKDRKGKPFSESVIRSIIYQILQ 110

Query: 231 ALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPEL 290
            L + H  G  HRD+KP N+++      +++ D+GLA        Y   V++R+++ PE+
Sbjct: 111 GLAHIHKHGFFHRDLKPENLLVS-GPEVVKIADFGLAREIRSRPPYTDYVSTRWYRAPEI 169

Query: 291 LVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLI------IW-- 342
           L+    Y   +D+W+LGC+ A + +   P F G    DQL KI   C ++       W  
Sbjct: 170 LLRSTSYSSPVDIWALGCIMAEL-YTLRPLFPGSSEIDQLYKI---CSVLGTPTKQDWPE 225

Query: 343 -------CNSRHSRKPWSKFINADNQHL--VSPEAIDFLDKLLRYDHQDRLTAREAMAHP 393
                     R  +   +      +Q +   SPEAID +  +LR+D + R TA +A+ HP
Sbjct: 226 GYKLASKLGFRFPQFAPTSL----HQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHP 281

Query: 394 YF 395
           YF
Sbjct: 282 YF 283

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  160 bits (405), Expect = 2e-45
 Identities = 85/302 (28%), Positives = 141/302 (46%), Gaps = 38/302 (12%)

Query: 126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKK------IKREIKILQNLCGG 179
            Y ++RK+G G + EV+   +    +   +K+L    + K        REI+IL +L   
Sbjct: 1   SYRILRKLGEGSFGEVYLARD---RKLVALKVLAKKLESKSKEVERFLREIQILASLNHP 57

Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY------PTLTDYDIRYYIYELLKALD 233
           PN+VKL D    Q   +  L+ EYV+    + L         L++ +  + + ++L AL+
Sbjct: 58  PNIVKLYDFF--QDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALE 115

Query: 234 YCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY-------HPGKEYNVRVASRYFK 286
           Y HS+GI+HRD+KP N+++D + R ++LID+GLA+               +  V +  + 
Sbjct: 116 YLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYM 175

Query: 287 GPELLVD--LQDYDYSLDMWSLGCMFAGMIFRKEPF--FYGHDNHDQLVKIAKDCCLIIW 342
            PE+L+   L     S D+WSLG     ++    PF          Q +KI  +      
Sbjct: 176 APEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILE------ 229

Query: 343 CNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAE 402
             +     P S      N  L+S  A D L KLL  D ++RL++   ++H   A ++  E
Sbjct: 230 LPTPSLASPLSP----SNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLKLKE 285

Query: 403 SS 404
           S 
Sbjct: 286 SD 287

Length = 384

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score =  156 bits (397), Expect = 5e-45
 Identities = 98/304 (32%), Positives = 156/304 (51%), Gaps = 56/304 (18%)

Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIK-------------REIKIL 173
           Y+ V K+G G Y  V++  +  T E         V  KKI+             REI +L
Sbjct: 1   YQKVEKIGEGTYGVVYKARDKLTGEI--------VALKKIRLETEDEGVPSTAIREISLL 52

Query: 174 QNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFK-----VLYPTLTDYDIRYYIYEL 228
           + L   PN+V+LLD+V  ++     L+FE+++  D K          L    I+ Y+Y+L
Sbjct: 53  KEL-NHPNIVRLLDVVHSENKLY--LVFEFLDL-DLKKYMDSSPLTGLDPPLIKSYLYQL 108

Query: 229 LKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKG 287
           L+ + YCHS  ++HRD+KP N++ID E   L+L D+GLA  F  P + Y   V + +++ 
Sbjct: 109 LQGIAYCHSHRVLHRDLKPQNLLIDRE-GALKLADFGLARAFGVPVRTYTHEVVTLWYRA 167

Query: 288 PELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCL-----IIW 342
           PE+L+  + Y   +D+WS+GC+FA M+ R+ P F G    DQL +I +   L      +W
Sbjct: 168 PEILLGSRQYSTPVDIWSIGCIFAEMVNRR-PLFPGDSEIDQLFRIFR--TLGTPDEDVW 224

Query: 343 --CNS---------RHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA 391
               S         + +R+  SK +       +  + +D L K+L YD   R++A+ A+ 
Sbjct: 225 PGVTSLPDYKPTFPKWARQDLSKVVPN-----LDEDGLDLLSKMLVYDPAKRISAKAALQ 279

Query: 392 HPYF 395
           HPYF
Sbjct: 280 HPYF 283

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  155 bits (395), Expect = 6e-45
 Identities = 82/276 (29%), Positives = 129/276 (46%), Gaps = 30/276 (10%)

Query: 126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKK---IKREIKILQNLCGGPNV 182
            +E++ K+G+G + EV++  +  T +   IK++K   K+K   I  EI+IL+  C  PN+
Sbjct: 1   LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILK-KCKHPNI 59

Query: 183 VKLLDIVRDQHSKTPSLIFEYVN----STDFKVLYPTLTDYDIRYYIYELLKALDYCHSQ 238
           VK              ++ E+ +        K    TLT+  I Y   ELLK L+Y HS 
Sbjct: 60  VKYYGSY--LKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSN 117

Query: 239 GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYD 298
           GI+HRD+K  N+++  +  +++LID+GL+      K  N  V + Y+  PE++   + YD
Sbjct: 118 GIIHRDIKAANILLTSD-GEVKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVING-KPYD 175

Query: 299 YSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSKFINA 358
           Y  D+WSLG     +   K P+         L KIA                        
Sbjct: 176 YKADIWSLGITAIELAEGKPPYSELP-PMKALFKIA--------------TNGPPGL--- 217

Query: 359 DNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPY 394
            N    S E  DFL K L+ + + R TA + + HP+
Sbjct: 218 RNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKHPF 253

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score =  155 bits (393), Expect = 4e-44
 Identities = 95/312 (30%), Positives = 152/312 (48%), Gaps = 47/312 (15%)

Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIK-ILKPVKKKKIK----REIKILQNLCG 178
             DYE++ K+G G + EV++   + T     +K IL   +K        REIKIL+ L  
Sbjct: 7   LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKL-K 65

Query: 179 GPNVVKLLDIV---RDQHSKTPS---LIFEYVNSTDFKVLYP---TLTDYDIRYYIYELL 229
            PNVV L+D+     D+  +      ++  Y++     +L      LT+  I+ Y+ +LL
Sbjct: 66  HPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQLL 125

Query: 230 KALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY--------HPG----KEYN 277
           + ++Y H   I+HRD+K  N++ID++   L++ D+GLA  Y          G    ++Y 
Sbjct: 126 EGINYLHENHILHRDIKAANILIDNQ-GILKIADFGLARPYDGPPPNPKGGGGGGTRKYT 184

Query: 278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDC 337
             V +R+++ PELL+  + Y  ++D+W +GC+FA M  R+ P   G  + DQL  I K C
Sbjct: 185 NLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRR-PILQGKSDIDQLHLIFKLC 243

Query: 338 CLIIWCNSRHSRKPWSKFINADNQHL--------------VSPEAIDFLDKLLRYDHQDR 383
                  +  +   W      +  H               + PE +D L KLL  D   R
Sbjct: 244 GTP----TEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKR 299

Query: 384 LTAREAMAHPYF 395
           LTA +A+ HPYF
Sbjct: 300 LTASDALEHPYF 311

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score =  152 bits (386), Expect = 3e-43
 Identities = 101/301 (33%), Positives = 157/301 (52%), Gaps = 33/301 (10%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK------PVKKKKIKREIKILQNLCG 178
           D YE V K+G G Y  V++  +  TNE   +K ++       V    I REI +L+ +  
Sbjct: 2   DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAI-REISLLKEMQH 60

Query: 179 GPNVVKLLDIVRDQHS-KTPSLIFEYVNSTDFKVLYPTLTDYD-----IRYYIYELLKAL 232
           G N+V+L D+V   HS K   L+FEY++  D K    +  D+      I+ Y+Y++L+ +
Sbjct: 61  G-NIVRLQDVV---HSEKRLYLVFEYLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGI 115

Query: 233 DYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPELL 291
            YCHS  ++HRD+KP N++ID     L+L D+GLA  F  P + +   V + +++ PE+L
Sbjct: 116 AYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVTLWYRAPEIL 175

Query: 292 VDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK-----DCCLIIWCNSR 346
           +  + Y   +D+WS+GC+FA M+ +K P F G    D+L KI +     +        S 
Sbjct: 176 LGSRHYSTPVDIWSVGCIFAEMVNQK-PLFPGDSEIDELFKIFRILGTPNEETWPGVTSL 234

Query: 347 HSRKPWSKFINADNQHL------VSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRA 400
              K  S F     + L      + P  +D L K+LR D   R+TAR A+ H YF  +  
Sbjct: 235 PDYK--SAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDLGD 292

Query: 401 A 401
           A
Sbjct: 293 A 293

Length = 294

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score =  152 bits (387), Expect = 6e-43
 Identities = 93/315 (29%), Positives = 163/315 (51%), Gaps = 44/315 (13%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKIL-----KPVKKKKIKREIKILQNLCGG 179
             Y+ +  +G G Y  V   I+  + ++  IK +      P   K+  RE+KIL++    
Sbjct: 5   SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHF-KH 63

Query: 180 PNVVKLLDIVR--DQHSKTPSLIFEYVNSTDFKVLYP--TLTDYDIRYYIYELLKALDYC 235
            N++ + DI+R      K   ++ + + S    +++    LT+  IRY++Y+LL+ L Y 
Sbjct: 64  DNIIAIRDILRPPGADFKDVYVVMDLMESDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYI 123

Query: 236 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY------HPG--KEYNVRVASRYFKG 287
           HS  ++HRD+KP N++++ +  +LR+ D+G+A         H     EY   VA+R+++ 
Sbjct: 124 HSANVIHRDLKPSNLLVNEDC-ELRIGDFGMARGLSSSPTEHKYFMTEY---VATRWYRA 179

Query: 288 PELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI-------AKDCCLI 340
           PELL+ L +Y  ++DMWS+GC+FA M+ R++  F G +   QL  I       +++    
Sbjct: 180 PELLLSLPEYTTAIDMWSVGCIFAEMLGRRQ-LFPGKNYVHQLKLILSVLGSPSEEVLNR 238

Query: 341 IWCN---------SRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA 391
           I  +          R    PWSK          SPEA+D L ++L++D ++R+T  +A+ 
Sbjct: 239 IGSDRVRKYIQNLPRKQPVPWSKIFPK-----ASPEALDLLSQMLQFDPEERITVEQALQ 293

Query: 392 HPYFAQVRAAESSRT 406
           HP+ AQ    +   T
Sbjct: 294 HPFLAQYHDPDDEPT 308

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score =  151 bits (383), Expect = 8e-43
 Identities = 88/308 (28%), Positives = 152/308 (49%), Gaps = 60/308 (19%)

Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIK-------------REIKIL 173
           YE + ++G G Y  V++  ++NT         + V  KK++             REI +L
Sbjct: 1   YEELAEIGEGAYGTVYKARDLNTG--------RFVALKKVRVPLSEEGIPLSTLREIALL 52

Query: 174 QNL--CGGPNVVKLLDI---VRDQHSKTPSLIFEYVNS--TDF--KVLYPTLTDYDIRYY 224
           + L     PN+V+LLD+    R       +L+FE+V+     +  K   P L    I+  
Sbjct: 53  KQLESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPGLPPETIKDL 112

Query: 225 IYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR----V 280
           + +LL+ +D+ HS  I+HRD+KP N+++  + + +++ D+GLA  Y     + +     V
Sbjct: 113 MRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQ-VKIADFGLARIY----SFEMALTSVV 167

Query: 281 ASRYFKGPELLVDLQD-YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI------ 333
            + +++ PE+L  LQ  Y   +DMWS+GC+FA + FR+ P F G    DQL KI      
Sbjct: 168 VTLWYRAPEVL--LQSSYATPVDMWSVGCIFAEL-FRRRPLFRGTSEADQLDKIFDVIGL 224

Query: 334 ------AKDCCLIIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAR 387
                  ++  L       ++ + +  F+       +  E +D L K+L ++   R++A 
Sbjct: 225 PSEEEWPRNVSLPRSSFPSYTPRSFKSFVPE-----ICEEGLDLLKKMLTFNPHKRISAF 279

Query: 388 EAMAHPYF 395
           EA+ HPYF
Sbjct: 280 EALQHPYF 287

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score =  151 bits (384), Expect = 1e-42
 Identities = 93/306 (30%), Positives = 154/306 (50%), Gaps = 41/306 (13%)

Query: 127 YEVVRKVGRGKYSEVFEGINVNTN--ERCIIKILKPVKKKKIK-----REIKILQNLCGG 179
           YE+++++G+G Y  V    N  T+  E   IK +  V  KKI      RE+K+L++  G 
Sbjct: 2   YELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGH 61

Query: 180 PNVVKL--LDIVRDQHSKTPSLIFEYVNSTDFKVLYPT--LTDYDIRYYIYELLKALDYC 235
            N+  L  +DIV   +     L  E + +   +++     LTD   + +IY++L  L Y 
Sbjct: 62  KNITCLYDMDIVFPGNFNELYLYEELMEADLHQIIRSGQPLTDAHFQSFIYQILCGLKYI 121

Query: 236 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR-----VASRYFKGPEL 290
           HS  ++HRD+KP N++++ +  +L++ D+GLA  +      N       VA+R+++ PE+
Sbjct: 122 HSANVLHRDLKPGNLLVNADC-ELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPEI 180

Query: 291 LVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI----------------- 333
           ++  Q Y  ++D+WS+GC+ A ++ RK P F G D  DQL +I                 
Sbjct: 181 MLSFQSYTKAIDVWSVGCILAELLGRK-PVFKGKDYVDQLNQILQVLGTPDEETLSRIGS 239

Query: 334 AKDCCLIIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHP 393
            K    I    +   +   S F NA      +P A+D L+KLL +D   R++  EA+ HP
Sbjct: 240 PKAQNYIRSLPNIPKKPFESIFPNA------NPLALDLLEKLLAFDPTKRISVEEALEHP 293

Query: 394 YFAQVR 399
           Y A   
Sbjct: 294 YLAIWH 299

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score =  150 bits (380), Expect = 2e-42
 Identities = 84/295 (28%), Positives = 154/295 (52%), Gaps = 39/295 (13%)

Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIK--------REIKILQNLCG 178
           Y+++ K+G G +SEV +  +  T +   IK +K    K  K        REI+ L+ L  
Sbjct: 1   YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMK----KHFKSLEQVNNLREIQALRRLSP 56

Query: 179 GPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL----YPTLTDYDIRYYIYELLKALDY 234
            PN+++L++++ D+ +   +L+FE ++   ++++     P L +  ++ Y+Y+LLK+LD+
Sbjct: 57  HPNILRLIEVLFDRKTGRLALVFELMDMNLYELIKGRKRP-LPEKRVKSYMYQLLKSLDH 115

Query: 235 CHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDL 294
            H  GI HRD+KP N++I  ++  L+L D+G     +    Y   +++R+++ PE L+  
Sbjct: 116 MHRNGIFHRDIKPENILIKDDI--LKLADFGSCRGIYSKPPYTEYISTRWYRAPECLLTD 173

Query: 295 QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSR---HSRKP 351
             Y   +D+W++GC+F  ++    P F G +  DQ+ KI      ++           + 
Sbjct: 174 GYYGPKMDIWAVGCVFFEILSLF-PLFPGTNELDQIAKIHD----VLGTPDAEVLKKFRK 228

Query: 352 WSKFINADNQH-----------LVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF 395
               +N +                S E +D L KLL YD  +R+TA++A+ HPYF
Sbjct: 229 SRH-MNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score =  151 bits (383), Expect = 2e-42
 Identities = 94/305 (30%), Positives = 163/305 (53%), Gaps = 44/305 (14%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKK----KIKREIKILQNLCGGP 180
             Y+ +  +G G Y  V    +  T  +  IK + P + +    +  REIKIL+      
Sbjct: 5   PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRF-KHE 63

Query: 181 NVVKLLDIVRDQHSKTPS---LIFEYVNSTDFKVLYP-TLTDYDIRYYIYELLKALDYCH 236
           N++ +LDI+R    ++ +   ++ E + +  +K++    L++  I+Y++Y++L+ L Y H
Sbjct: 64  NIIGILDIIRPPSFESFNDVYIVQELMETDLYKLIKTQHLSNDHIQYFLYQILRGLKYIH 123

Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-----EFYHPGK--EYNVRVASRYFKGPE 289
           S  ++HRD+KP N++++     L++ D+GLA     E  H G   EY   VA+R+++ PE
Sbjct: 124 SANVLHRDLKPSNLLLNTNC-DLKICDFGLARIADPEHDHTGFLTEY---VATRWYRAPE 179

Query: 290 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI--------AKDCCLII 341
           ++++ + Y  ++D+WS+GC+ A M+  + P F G D   QL  I         +D   II
Sbjct: 180 IMLNSKGYTKAIDIWSVGCILAEMLSNR-PLFPGKDYLHQLNLILGVLGTPSQEDLNCII 238

Query: 342 WCNSR--------HSRKPWSK-FINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH 392
              +R          + PW+K F NAD      P+A+D LDK+L ++   R+T  EA+AH
Sbjct: 239 SLRARNYIKSLPFKPKVPWNKLFPNAD------PKALDLLDKMLTFNPHKRITVEEALAH 292

Query: 393 PYFAQ 397
           PY  Q
Sbjct: 293 PYLEQ 297

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score =  150 bits (382), Expect = 4e-42
 Identities = 93/308 (30%), Positives = 157/308 (50%), Gaps = 46/308 (14%)

Query: 121 WGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKIL-----KPVKKKKIKREIKILQN 175
           W   D Y+ +  VG G Y +V    +  T  +  IK L       +  K+  RE+++L++
Sbjct: 11  WEVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKH 70

Query: 176 LCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYP-------------TLTDYDIR 222
           +    NV+ LLD+       TP+   E  +  D  ++                L+D  I+
Sbjct: 71  MDH-ENVIGLLDVF------TPASSLE--DFQDVYLVTHLMGADLNNIVKCQKLSDDHIQ 121

Query: 223 YYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVAS 282
           + +Y++L+ L Y HS GI+HRD+KP N+ ++ E  +L+++D+GLA   H   E    VA+
Sbjct: 122 FLVYQILRGLKYIHSAGIIHRDLKPSNIAVN-EDCELKILDFGLAR--HTDDEMTGYVAT 178

Query: 283 RYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCC---- 338
           R+++ PE++++   Y+ ++D+WS+GC+ A ++  K   F G D+ DQL +I         
Sbjct: 179 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGK-TLFPGSDHIDQLKRIMNLVGTPDE 237

Query: 339 -LIIWCNSRHSR--------KPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREA 389
            L+   +S  +R         P   F    +    +P AID L+K+L  D   R+TA EA
Sbjct: 238 ELLQKISSESARNYIQSLPQMPKKDFKEVFSGA--NPLAIDLLEKMLVLDPDKRITAAEA 295

Query: 390 MAHPYFAQ 397
           +AHPY A+
Sbjct: 296 LAHPYLAE 303

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score =  148 bits (375), Expect = 1e-41
 Identities = 85/305 (27%), Positives = 160/305 (52%), Gaps = 35/305 (11%)

Query: 121 WGDQ--DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKK-----IKREIKIL 173
           WG +  D ++++ ++G G Y +V++  + +T E   +K ++   +K+       REIKIL
Sbjct: 1   WGKRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKIL 60

Query: 174 QNLCGGPNVVKLLDIVRDQHSKTP--------SLIFEYVNSTDFKVLYPTLTDYD---IR 222
           + L    N+V L +IV D+              L+FEY++     +L   L  +    I+
Sbjct: 61  RQL-NHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIK 119

Query: 223 YYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG--KEYNVRV 280
            ++ +LL+ L+YCH +  +HRD+K  N++++++  +++L D+GLA  Y+    + Y  +V
Sbjct: 120 SFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNK-GQIKLADFGLARLYNSEESRPYTNKV 178

Query: 281 ASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDC--- 337
            + +++ PELL+  + Y  ++D+WS GC+  G +F K+P F  +    QL  I++ C   
Sbjct: 179 ITLWYRPPELLLGEERYGPAIDVWSCGCIL-GELFTKKPIFQANQELAQLELISRLCGSP 237

Query: 338 CLIIW--------CNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREA 389
           C  +W         N+   +K + + +  +   +    A+D LD +L  D   R TA EA
Sbjct: 238 CPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFI-PTPALDLLDHMLTLDPSKRCTAEEA 296

Query: 390 MAHPY 394
           +  P+
Sbjct: 297 LNSPW 301

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score =  147 bits (372), Expect = 3e-41
 Identities = 101/303 (33%), Positives = 158/303 (52%), Gaps = 49/303 (16%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK-------PVKKKKIKREIKILQNLC 177
           + YE + K+G G Y  VF+  N  T +  I+ I K       PV KK   REI++L+ L 
Sbjct: 1   EKYEKLSKIGEGSYGVVFKCRNRETGQ--IVAIKKFVESEDDPVIKKIALREIRMLKQL- 57

Query: 178 GGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL--YPT-LTDYDIRYYIYELLKALDY 234
             PN+V L+++ R    +   L+FEY + T    L   P  + ++ I+  I++ L+A+++
Sbjct: 58  KHPNLVNLIEVFR--RKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNF 115

Query: 235 CHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH-PGKEYNVRVASRYFKGPELLV- 292
           CH    +HRDVKP N++I  +  +++L D+G A     PG +Y   VA+R+++ PELLV 
Sbjct: 116 CHKHNCIHRDVKPENILITKQ-GQIKLCDFGFARILTGPGDDYTDYVATRWYRAPELLVG 174

Query: 293 DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRH----- 347
           D Q Y   +D+W++GC+FA ++   +P + G  + DQL  I K    +I    RH     
Sbjct: 175 DTQ-YGPPVDVWAIGCVFAELL-TGQPLWPGKSDVDQLYLIRKTLGDLI---PRHQQIFS 229

Query: 348 --------------SRKPW-SKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH 392
                         +R+P  SKF N       S  A+ FL   L+ D  +RL+  E + H
Sbjct: 230 TNQFFKGLSIPEPETREPLESKFPNI------SSPALSFLKGCLQMDPTERLSCEELLEH 283

Query: 393 PYF 395
           PYF
Sbjct: 284 PYF 286

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score =  144 bits (364), Expect = 3e-40
 Identities = 92/289 (31%), Positives = 157/289 (54%), Gaps = 26/289 (8%)

Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILK------PVKKKKIKREIKILQNLCGGP 180
           ++ V K+G G Y  V++  N  T E   +K ++       V    I REI +L+ L   P
Sbjct: 2   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAI-REISLLKEL-NHP 59

Query: 181 NVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPT----LTDYDIRYYIYELLKALDYCH 236
           N+VKLLD++  +      L+FE+++    K +  +    +    I+ Y+++LL+ L +CH
Sbjct: 60  NIVKLLDVIHTE--NKLYLVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCH 117

Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPELLVDLQ 295
           S  ++HRD+KP N++I+     ++L D+GLA  F  P + Y   V + +++ PE+L+  +
Sbjct: 118 SHRVLHRDLKPQNLLIN-TEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCK 176

Query: 296 DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCL---IIW--CNSRHSRK 350
            Y  ++D+WSLGC+FA M+ R+   F G    DQL +I +       ++W    S    K
Sbjct: 177 YYSTAVDIWSLGCIFAEMVTRR-ALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYK 235

Query: 351 P-WSKFINADNQHLVSP---EAIDFLDKLLRYDHQDRLTAREAMAHPYF 395
           P + K+   D   +V P   +  D L ++L YD   R++A+ A+AHP+F
Sbjct: 236 PSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  142 bits (361), Expect = 5e-40
 Identities = 78/282 (27%), Positives = 130/282 (46%), Gaps = 34/282 (12%)

Query: 126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIK--ILKPVKKKK---IKREIKILQNLCGGP 180
           ++     +GRG +  V+  ++ +T E   +K   L    +++   ++REI+IL +L   P
Sbjct: 1   EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSL-QHP 59

Query: 181 NVVKLLDIVRDQHSKTPSLIFEYVNS---TDFKVLYPTLTDYDIRYYIYELLKALDYCHS 237
           N+V+     RD+   T ++  EYV+    +     +  L +  IR Y  ++L+ L Y HS
Sbjct: 60  NIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHS 119

Query: 238 QGIMHRDVKPHNVMIDHELRKLRLIDWGLA---EFYHPGKEYNVRVASRYFKGPELLVDL 294
            GI+HRD+K  N+++D +   ++L D+G A        G+       + Y+  PE++   
Sbjct: 120 NGIVHRDIKGANILVDSDGV-VKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRG- 177

Query: 295 QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV-KIAKDCCLIIWCNSRHSRKPWS 353
           ++Y  + D+WSLGC    M   K P +    N    + KI                    
Sbjct: 178 EEYGRAADIWSLGCTVIEMATGKPP-WSELGNPMAALYKIGSSG--------------EP 222

Query: 354 KFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF 395
             I       +S EA DFL K LR D + R TA E + HP+ 
Sbjct: 223 PEIPEH----LSEEAKDFLRKCLRRDPKKRPTADELLQHPFL 260

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score =  143 bits (363), Expect = 6e-40
 Identities = 91/293 (31%), Positives = 146/293 (49%), Gaps = 34/293 (11%)

Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK--------KKKIKREIKILQNLCG 178
           YE + K+G G Y  VF+  N  T+E   I  LK V+             REI +L+ L  
Sbjct: 2   YEKLEKIGEGTYGTVFKAKNRETHE---IVALKRVRLDDDDEGVPSSALREICLLKEL-K 57

Query: 179 GPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDY----DIRYYIYELLKALDY 234
             N+V+L D++      T  L+FEY +  D K  + +         ++ ++++LLK L +
Sbjct: 58  HKNIVRLYDVLHSDKKLT--LVFEYCDQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAF 114

Query: 235 CHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH-PGKEYNVRVASRYFKGPELLVD 293
           CHS  ++HRD+KP N++I+    +L+L D+GLA  +  P + Y+  V + +++ P++L  
Sbjct: 115 CHSHNVLHRDLKPQNLLINKN-GELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFG 173

Query: 294 LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK---DCCLIIWCNSRHSRK 350
            + Y  S+DMWS GC+FA +     P F G+D  DQL +I +         W     S+ 
Sbjct: 174 AKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGV--SKL 231

Query: 351 PWSKFI-----NADNQHLV---SPEAIDFLDKLLRYDHQDRLTAREAMAHPYF 395
           P  K            ++V   +    D L  LL  +   R++A EA+ HPYF
Sbjct: 232 PDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score =  143 bits (362), Expect = 7e-40
 Identities = 94/299 (31%), Positives = 154/299 (51%), Gaps = 43/299 (14%)

Query: 126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIK-------------REIKI 172
           DY  + K+G G Y  V++G N  T         + V  KKI+             REI +
Sbjct: 1   DYTKIEKIGEGTYGVVYKGRNKKTG--------QIVAMKKIRLESEEEGVPSTAIREISL 52

Query: 173 LQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYD------IRYYIY 226
           L+ L   PN+V L D++  Q S+   LIFE++ S D K    +L          ++ Y+Y
Sbjct: 53  LKEL-QHPNIVCLQDVLM-QESRL-YLIFEFL-SMDLKKYLDSLPKGQYMDAELVKSYLY 108

Query: 227 ELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKEYNVRVASRYF 285
           ++L+ + +CHS+ ++HRD+KP N++ID++   ++L D+GLA  F  P + Y   V + ++
Sbjct: 109 QILQGILFCHSRRVLHRDLKPQNLLIDNK-GVIKLADFGLARAFGIPVRVYTHEVVTLWY 167

Query: 286 KGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCL---IIW 342
           + PE+L+    Y   +D+WS+G +FA M  +K P F+G    DQL +I +        +W
Sbjct: 168 RAPEVLLGSPRYSTPVDIWSIGTIFAEMATKK-PLFHGDSEIDQLFRIFRILGTPTEDVW 226

Query: 343 --CNSRHSRKP----WSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF 395
               S    K     W K         +  + +D L+K+L YD   R++A++A+ HPYF
Sbjct: 227 PGVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score =  143 bits (361), Expect = 8e-40
 Identities = 87/296 (29%), Positives = 152/296 (51%), Gaps = 40/296 (13%)

Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK-------KKKIKREIKILQNLCGG 179
           ++ + K+G G Y+ V++G N  T E   I  LK +             REI +++ L   
Sbjct: 2   FKQLEKLGEGTYATVYKGRNRTTGE---IVALKEIHLDAEEGTPSTAIREISLMKEL-KH 57

Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDY------DIRYYIYELLKALD 233
            N+V+L D++  ++     L+FEY++  D K    T           ++ + Y+LLK + 
Sbjct: 58  ENIVRLHDVIHTENKLM--LVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIA 114

Query: 234 YCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPELLV 292
           +CH   ++HRD+KP N++I+     L+L D+GLA  F  P   ++  V + +++ P++L+
Sbjct: 115 FCHENRVLHRDLKPQNLLINKRGE-LKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVLL 173

Query: 293 DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPW 352
             + Y  S+D+WS+GC+ A MI  + P F G +N DQL+KI +    I+   +  +    
Sbjct: 174 GSRTYSTSIDIWSVGCIMAEMITGR-PLFPGTNNEDQLLKIFR----IMGTPTESTWPGI 228

Query: 353 SKFIN----------ADNQHLV---SPEAIDFLDKLLRYDHQDRLTAREAMAHPYF 395
           S+              D Q L     P  ID L +LL+ + + R++A +A+ HP+F
Sbjct: 229 SQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score =  141 bits (358), Expect = 3e-39
 Identities = 92/308 (29%), Positives = 154/308 (50%), Gaps = 50/308 (16%)

Query: 121 WGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIK------------R 168
           +G  + Y+ + K+G G Y+ V++G +  T +         V  K+I+            R
Sbjct: 1   FGKLETYKKLDKLGEGSYATVYKGRSKLTGQL--------VALKEIRLEHEEGAPFTAIR 52

Query: 169 EIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL---YPTLTD-YDIRYY 224
           E  +L++L    N+V L DI+  +  KT +L+FEY++ TD K            +++R +
Sbjct: 53  EASLLKDL-KHANIVTLHDIIHTK--KTLTLVFEYLD-TDLKQYMDDCGGGLSMHNVRLF 108

Query: 225 IYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH-PGKEYNVRVASR 283
           +++LL+ L YCH + ++HRD+KP N++I  E  +L+L D+GLA     P K Y+  V + 
Sbjct: 109 LFQLLRGLAYCHQRRVLHRDLKPQNLLIS-ERGELKLADFGLARAKSVPSKTYSNEVVTL 167

Query: 284 YFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGH-DNHDQLVKI--------- 333
           +++ P++L+   +Y  SLDMW +GC+F  M     P F G  D  DQL KI         
Sbjct: 168 WYRPPDVLLGSTEYSTSLDMWGVGCIFYEMA-TGRPLFPGSTDVEDQLHKIFRVLGTPTE 226

Query: 334 ------AKDCCLIIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAR 387
                 + +     +    +  +P    IN   +    P   +   K L+Y+ + R++A 
Sbjct: 227 ETWPGVSSNPEFKPYSFPFYPPRP---LINHAPRLDRIPHGEELALKFLQYEPKKRISAA 283

Query: 388 EAMAHPYF 395
           EAM HPYF
Sbjct: 284 EAMKHPYF 291

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score =  143 bits (361), Expect = 3e-39
 Identities = 98/308 (31%), Positives = 164/308 (53%), Gaps = 37/308 (12%)

Query: 121 WGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKIL-KPVKK----KKIKREIKILQN 175
           W   + Y  +++VG G Y  V   I+  T E+  IK L +P +     K+  RE+ +L++
Sbjct: 11  WELPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKH 70

Query: 176 LCGGPNVVKLLDIVRDQHS----KTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKA 231
           +    NV+ LLD+     S    +   L+  Y+ +   K++   L++  ++Y +Y++L  
Sbjct: 71  M-QHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDKVQYLVYQMLCG 129

Query: 232 LDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELL 291
           L Y HS GI+HRD+KP N+ ++ +  +L+++D+GLA   H   E    V +R+++ PE++
Sbjct: 130 LKYIHSAGIIHRDLKPGNLAVNEDC-ELKILDFGLAR--HADAEMTGYVVTRWYRAPEVI 186

Query: 292 VDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK--------------DC 337
           ++   Y+ ++D+WS+GC+ A M+  K   F G D  DQL +I K              D 
Sbjct: 187 LNWMHYNQTVDIWSVGCIMAEMLTGKT-LFKGKDYLDQLTQILKVTGVPGPEFVQKLEDK 245

Query: 338 CLIIWCNS--RHSRKPWSK-FINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPY 394
               +  S  ++ RK +S  F  A      SP+A+D L+K+L  D   RLTA EA+ HPY
Sbjct: 246 AAKSYIKSLPKYPRKDFSTLFPKA------SPQAVDLLEKMLELDVDKRLTATEALEHPY 299

Query: 395 FAQVRAAE 402
           F   R A+
Sbjct: 300 FDSFRDAD 307

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score =  141 bits (357), Expect = 1e-38
 Identities = 96/321 (29%), Positives = 170/321 (52%), Gaps = 42/321 (13%)

Query: 111 YWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKIL-KPVKK----KK 165
           Y+  E     W   D Y  +++VG G Y  V   ++  T  +  IK L +P +     K+
Sbjct: 1   YYRQEVNKTIWEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKR 60

Query: 166 IKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYP----------- 214
             RE+++L+++    NV+ LLD+       TP L  +  +  DF ++ P           
Sbjct: 61  AYRELRLLKHM-KHENVIGLLDVF------TPDLSLDRFH--DFYLVMPFMGTDLGKLMK 111

Query: 215 --TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP 272
              L++  I++ +Y++LK L Y H+ GI+HRD+KP N+ ++ +  +L+++D+GLA     
Sbjct: 112 HEKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDC-ELKILDFGLAR--QT 168

Query: 273 GKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVK 332
             E    V +R+++ PE++++   Y  ++D+WS+GC+ A M+  K P F GHD+ DQL++
Sbjct: 169 DSEMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGK-PLFKGHDHLDQLME 227

Query: 333 IAKDCCL--------IIWCNSRHSRKPWSKFINADNQHL---VSPEAIDFLDKLLRYDHQ 381
           I K            +   ++++  K   +F   D + L    +P A++ L+K+L  D +
Sbjct: 228 IMKVTGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAE 287

Query: 382 DRLTAREAMAHPYFAQVRAAE 402
            R+TA EA+AHPYF +    E
Sbjct: 288 SRITAAEALAHPYFEEFHDPE 308

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score =  139 bits (353), Expect = 2e-38
 Identities = 87/307 (28%), Positives = 134/307 (43%), Gaps = 63/307 (20%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP---VKKKK---IKREIKILQNLCG 178
           DD++  + +G G +S V       TN+   IKIL     +K+KK   +K E ++L  L G
Sbjct: 1   DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNG 60

Query: 179 GPNVVKLLDIVRDQHSKTPSLIF--EYVNSTDFKVL---YPTLTDYDIRYYIYELLKALD 233
            P ++KL    +D+ +    L F  EY  + +       Y +L +   R+Y  E+L AL+
Sbjct: 61  HPGIIKLYYTFQDEEN----LYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALE 116

Query: 234 YCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK---------------EYNV 278
           Y HS+GI+HRD+KP N+++D ++  +++ D+G A+   P                     
Sbjct: 117 YLHSKGIIHRDLKPENILLDKDMH-IKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKN 175

Query: 279 RVASRYFKG------PELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVK 332
           R     F G      PELL + +    S D+W+LGC+   M+  K P F G  N     +
Sbjct: 176 RRRFASFVGTAEYVSPELLNE-KPAGKSSDLWALGCIIYQMLTGKPP-FRG-SNEYLTFQ 232

Query: 333 IAKDCCLIIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTA----RE 388
                              +      D        A D ++KLL  D QDRL       E
Sbjct: 233 KILKLEY-----------SFPPNFPPD--------AKDLIEKLLVLDPQDRLGVNEGYDE 273

Query: 389 AMAHPYF 395
             AHP+F
Sbjct: 274 LKAHPFF 280

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score =  139 bits (353), Expect = 2e-38
 Identities = 89/293 (30%), Positives = 150/293 (51%), Gaps = 26/293 (8%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKK---IK--REIKILQNLCGG 179
           D+YE + ++  G Y  V+   +  T E   +K LK  K+K+   I   REI IL  L   
Sbjct: 5   DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKL-QH 63

Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDY----DIRYYIYELLKALDYC 235
           PN+V + ++V   +     ++ EYV   D K L  T+       +++  + +LL  + + 
Sbjct: 64  PNIVTVKEVVVGSNLDKIYMVMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHL 122

Query: 236 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDL 294
           H   I+HRD+K  N+++++    L++ D+GLA E+  P K Y   V + +++ PELL+  
Sbjct: 123 HDNWILHRDLKTSNLLLNNRGI-LKICDFGLAREYGSPLKPYTQLVVTLWYRAPELLLGA 181

Query: 295 QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDC------------CLIIW 342
           ++Y  ++DMWS+GC+FA ++  K+P F G    DQL KI K               L   
Sbjct: 182 KEYSTAIDMWSVGCIFAELL-TKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGA 240

Query: 343 CNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF 395
                ++ P+++         +S    D L++LL YD   R++A +A+ HPYF
Sbjct: 241 KKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score =  138 bits (350), Expect = 4e-38
 Identities = 90/293 (30%), Positives = 149/293 (50%), Gaps = 33/293 (11%)

Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKIL------KPVKKKKIKREIKILQNLCGGP 180
           YE +  VG G Y  V +  +  T +   IK        K VKK  + REI++L+ L    
Sbjct: 3   YENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAM-REIRMLKQL-RHE 60

Query: 181 NVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL--YPTLTDYD-IRYYIYELLKALDYCHS 237
           N+V L+++ R +  K   L+FE+V+ T    L  YP   D   +R Y++++L+ +++CHS
Sbjct: 61  NLVNLIEVFRRK--KRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHS 118

Query: 238 QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH-PGKEYNVRVASRYFKGPELLVDLQD 296
             I+HRD+KP N+++      ++L D+G A     PG+ Y   VA+R+++ PELLV    
Sbjct: 119 HNIIHRDIKPENILVSQS-GVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVGDTK 177

Query: 297 YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRH----SRKP- 351
           Y  ++D+W++GC+   M    EP F G  + DQL  I K  CL      RH     + P 
Sbjct: 178 YGRAVDIWAVGCLVTEM-LTGEPLFPGDSDIDQLYHIIK--CLGNLI-PRHQEIFQKNPL 233

Query: 352 WSKFINADNQHL---------VSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF 395
           ++     + + +         +S   +D   + LR D  DR ++ + + H +F
Sbjct: 234 FAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score =  138 bits (348), Expect = 2e-37
 Identities = 93/304 (30%), Positives = 161/304 (52%), Gaps = 38/304 (12%)

Query: 121 WGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKIL-KP----VKKKKIKREIKILQN 175
           W   + Y+ +  VG G Y  V    +    ++  +K L +P    +  ++  RE+++L++
Sbjct: 11  WEVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKH 70

Query: 176 LCGGPNVVKLLDIVRDQHSKTPSLIFEYVNS---------TDFK--VLYPTLTDYDIRYY 224
           +    NV+ LLD+       TP+   E  N           D    V    L+D  +++ 
Sbjct: 71  M-KHENVIGLLDVF------TPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFL 123

Query: 225 IYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRY 284
           IY+LL+ L Y HS GI+HRD+KP NV ++ +  +LR++D+GLA       E    VA+R+
Sbjct: 124 IYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDC-ELRILDFGLAR--QADDEMTGYVATRW 180

Query: 285 FKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK-----DCCL 339
           ++ PE++++   Y+ ++D+WS+GC+ A ++ + +  F G+D  DQL +I +        +
Sbjct: 181 YRAPEIMLNWMHYNQTVDIWSVGCIMAELL-KGKALFPGNDYIDQLKRIMEVVGTPSPEV 239

Query: 340 IIWCNSRHSRKPWSKFINADNQHL------VSPEAIDFLDKLLRYDHQDRLTAREAMAHP 393
           +   +S H+RK      +   Q L       +P AID L+K+L  D   R++A EA+AHP
Sbjct: 240 LKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHP 299

Query: 394 YFAQ 397
           YF+Q
Sbjct: 300 YFSQ 303

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score =  136 bits (343), Expect = 1e-36
 Identities = 98/297 (32%), Positives = 155/297 (52%), Gaps = 43/297 (14%)

Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIK-ILKP----VKKKKIKREIKILQNLCGGPN 181
           Y  ++ VG G +  V    +  T +   IK I+KP    V  K+  RE+K+L++L    N
Sbjct: 12  YVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHL-RHEN 70

Query: 182 VVKLLDIVRDQHSKTPSLIFEYVN---STDFKVLYPT--LTDYDIRYYIYELLKALDYCH 236
           ++ L DI       +P     +V     TD   L  +  L    I+Y++Y++L+ L Y H
Sbjct: 71  IISLSDIF-----ISPLEDIYFVTELLGTDLHRLLTSRPLEKQFIQYFLYQILRGLKYVH 125

Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD 296
           S G++HRD+KP N++I+ E   L++ D+GLA    P  +    V++RY++ PE+++  Q 
Sbjct: 126 SAGVVHRDLKPSNILIN-ENCDLKICDFGLARIQDP--QMTGYVSTRYYRAPEIMLTWQK 182

Query: 297 YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI----------------AKDCCLI 340
           YD  +D+WS GC+FA M    +P F G D+ +Q   I                +++    
Sbjct: 183 YDVEVDIWSAGCIFAEM-LEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRF 241

Query: 341 IWCNSRHSRKPWS-KFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFA 396
           +    +    P+S KF NAD      P AID L+K+L +D Q R++A EA+AHPY A
Sbjct: 242 VQSLPKREPVPFSEKFKNAD------PSAIDLLEKMLVFDPQKRISAAEALAHPYLA 292

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score =  135 bits (341), Expect = 3e-36
 Identities = 96/302 (31%), Positives = 158/302 (52%), Gaps = 45/302 (14%)

Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKIL-----KPVKKKKIKREIKILQNLCGGPN 181
           Y  ++ +GRG Y  V    N  TNE+  IK +       +  K+  REIK+L++L    N
Sbjct: 7   YVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHL-DHEN 65

Query: 182 VVKLLDIVRDQHSKTPS---LIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYC 235
           V+ + DI+   H +  +   +++E ++ TD   +     TL+D   +Y++Y+LL+ L Y 
Sbjct: 66  VIAIKDIMPPPHREAFNDVYIVYELMD-TDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYI 124

Query: 236 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-------EFYHPGKEYNVRVASRYFKGP 288
           HS  ++HRD+KP N++++     L++ D+GLA       +F     EY   V +R+++ P
Sbjct: 125 HSANVLHRDLKPSNLLLNANC-DLKICDFGLARTTSEKGDFM---TEY---VVTRWYRAP 177

Query: 289 ELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK--------DCCLI 340
           ELL++  +Y  ++D+WS+GC+FA ++ RK P F G D   QL  I +        D   I
Sbjct: 178 ELLLNCSEYTTAIDVWSVGCIFAELLGRK-PLFPGKDYVHQLKLITELLGSPSEEDLGFI 236

Query: 341 IWCNSRHSRKPWSKFINADNQHL------VSPEAIDFLDKLLRYDHQDRLTAREAMAHPY 394
               +  +R+          Q         +P AID L+K+L +D   R+T  EA+AHPY
Sbjct: 237 ---RNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPY 293

Query: 395 FA 396
            A
Sbjct: 294 LA 295

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score =  134 bits (339), Expect = 4e-36
 Identities = 92/304 (30%), Positives = 157/304 (51%), Gaps = 38/304 (12%)

Query: 121 WGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKIL-KP----VKKKKIKREIKILQN 175
           W   + Y+ +  VG G Y  V    +  T  R  +K L +P    +  K+  RE+++L++
Sbjct: 13  WEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKH 72

Query: 176 LCGGPNVVKLLDIVRDQHSKTPSLIFEYVNS---------TDFK--VLYPTLTDYDIRYY 224
           +    NV+ LLD+       TP+   E  N           D    V    LTD  +++ 
Sbjct: 73  M-KHENVIGLLDVF------TPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 125

Query: 225 IYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRY 284
           IY++L+ L Y HS  I+HRD+KP N+ ++ +  +L+++D+GLA   H   E    VA+R+
Sbjct: 126 IYQILRGLKYIHSADIIHRDLKPSNLAVNEDC-ELKILDFGLAR--HTDDEMTGYVATRW 182

Query: 285 FKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK-----DCCL 339
           ++ PE++++   Y+ ++D+WS+GC+ A ++  +   F G D+ DQL  I +        L
Sbjct: 183 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLVGTPGAEL 241

Query: 340 IIWCNSRHSRK-----PWSKFINADNQHL-VSPEAIDFLDKLLRYDHQDRLTAREAMAHP 393
           +   +S  +R           +N  N  +  +P A+D L+K+L  D   R+TA +A+AH 
Sbjct: 242 LKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHA 301

Query: 394 YFAQ 397
           YFAQ
Sbjct: 302 YFAQ 305

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score =  132 bits (333), Expect = 4e-35
 Identities = 86/306 (28%), Positives = 153/306 (50%), Gaps = 44/306 (14%)

Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIK---REIKILQNLCGGPNVV 183
           Y  +R +G G    VF  ++ + ++R  +K +     + +K   REIKI++ L    N+V
Sbjct: 7   YMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRL-DHDNIV 65

Query: 184 KLLDIVRDQHSKTPS------------LIFEYVNSTDFKVL--YPTLTDYDIRYYIYELL 229
           K+ +++    S                ++ EY+  TD   +     L++   R ++Y+LL
Sbjct: 66  KVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYME-TDLANVLEQGPLSEEHARLFMYQLL 124

Query: 230 KALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY----NVRVASRYF 285
           + L Y HS  ++HRD+KP NV I+ E   L++ D+GLA    P   +    +  + ++++
Sbjct: 125 RGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWY 184

Query: 286 KGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK---------- 335
           + P LL+   +Y  ++DMW+ GC+FA M+  K P F G    +Q+  I +          
Sbjct: 185 RSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK-PLFAGAHELEQMQLILESVPVVREEDR 243

Query: 336 DCCL-----IIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAM 390
           +  L      +  +    R+P    +       V+PEA+DFL+++L ++  DRLTA EA+
Sbjct: 244 NELLNVIPSFVRNDGGEPRRPLRDLLPG-----VNPEALDFLEQILTFNPMDRLTAEEAL 298

Query: 391 AHPYFA 396
            HPY +
Sbjct: 299 MHPYMS 304

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score =  126 bits (317), Expect = 2e-33
 Identities = 85/303 (28%), Positives = 156/303 (51%), Gaps = 40/303 (13%)

Query: 121 WGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIK----REIKILQNL 176
           +G    Y  + K+G G Y+ V++GI+    +   +K++    ++ +     RE  +L+ L
Sbjct: 1   FGAATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGL 60

Query: 177 CGGPNVVKLLDIVRDQHSKTPSLIFEYVNS--TDFKVLYPT-LTDYDIRYYIYELLKALD 233
               N+V L DI+  + + T   +FEY+++    + + +P  L  Y++R ++++LL+ L 
Sbjct: 61  -KHANIVLLHDIIHTKETLT--FVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLA 117

Query: 234 YCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH-PGKEYNVRVASRYFKGPELLV 292
           Y H Q I+HRD+KP N++I + L +L+L D+GLA     P + Y+  V + +++ P++L+
Sbjct: 118 YIHGQHILHRDLKPQNLLISY-LGELKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVLL 176

Query: 293 DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDN-HDQLVKI-------AKDCC------ 338
              DY  +LD+W  GC+F  M  + +P F G  +  +QL KI        +D        
Sbjct: 177 GATDYSSALDIWGAGCIFIEM-LQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKL 235

Query: 339 ------LIIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH 392
                   + C  +  R  W +           P+A D   ++L    +DR++A++A+ H
Sbjct: 236 PNYKPEWFLPCKPQQLRVVWKRLSRP-------PKAEDLASQMLMMFPKDRISAQDALLH 288

Query: 393 PYF 395
           PYF
Sbjct: 289 PYF 291

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score =  123 bits (310), Expect = 2e-32
 Identities = 89/298 (29%), Positives = 161/298 (54%), Gaps = 33/298 (11%)

Query: 121 WGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIK----REIKILQNL 176
           +G  + Y  + K+G G Y+ V++G +  T+    +K ++   ++       RE+ +L++L
Sbjct: 2   FGKLETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDL 61

Query: 177 CGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTD-------YDIRYYIYELL 229
               N+V L DI+  +  K+ +L+FEY++    K L   L D       ++++ ++++LL
Sbjct: 62  -KHANIVTLHDIIHTE--KSLTLVFEYLD----KDLKQYLDDCGNSINMHNVKLFLFQLL 114

Query: 230 KALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH-PGKEYNVRVASRYFKGP 288
           + L+YCH + ++HRD+KP N++I+ E  +L+L D+GLA     P K Y+  V + +++ P
Sbjct: 115 RGLNYCHRRKVLHRDLKPQNLLIN-ERGELKLADFGLARAKSIPTKTYSNEVVTLWYRPP 173

Query: 289 ELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK-------DCCLII 341
           ++L+   DY   +DMW +GC+F  M   + P F G    +QL  I +       +    I
Sbjct: 174 DILLGSTDYSTQIDMWGVGCIFYEMSTGR-PLFPGSTVEEQLHFIFRILGTPTEETWPGI 232

Query: 342 WCNSRHSRKPWSKFINADNQHLVSP----EAIDFLDKLLRYDHQDRLTAREAMAHPYF 395
             N       + K+  AD  H  +P    +  + L KLL+++ + R++A EAM HPYF
Sbjct: 233 LSNEEFKSYNYPKY-RADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYF 289

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score =  123 bits (311), Expect = 2e-32
 Identities = 80/303 (26%), Positives = 134/303 (44%), Gaps = 50/303 (16%)

Query: 126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIK--------REIKILQNLC 177
           ++E + ++G G Y  V+   +  + E   I  LK V+    +        REI +L N  
Sbjct: 8   EFEKLNRIGEGTYGIVYRARDTTSGE---IVALKKVRMDNERDGIPISSLREITLLLN-L 63

Query: 178 GGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDY 234
             PN+V+L ++V  +H  +  L+ EY       +L       ++  ++  + +LL+ L Y
Sbjct: 64  RHPNIVELKEVVVGKHLDSIFLVMEYCEQDLASLLDNMPTPFSESQVKCLMLQLLRGLQY 123

Query: 235 CHSQGIMHRDVKPHNV-MIDHELRKLRLIDWGLAEFY-HPGKEYNVRVASRYFKGPELLV 292
            H   I+HRD+K  N+ + D     L++ D+GLA  Y  P K    +V + +++ PELL+
Sbjct: 124 LHENFIIHRDLKVSNLLLTDKGC--LKIADFGLARTYGLPAKPMTPKVVTLWYRAPELLL 181

Query: 293 DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLI------IWCNSR 346
               Y  ++DMW++GC+ A +    +P   G    +QL  I     L+      IW    
Sbjct: 182 GCTTYTTAIDMWAVGCILAEL-LAHKPLLPGKSEIEQLDLI---IQLLGTPNESIWPG-- 235

Query: 347 HSRKPWSKFINADNQHL--------------VSPEAIDFLDKLLRYDHQDRLTAREAMAH 392
                +S         L              +S   +  L+ LL YD + R TA EA+  
Sbjct: 236 -----FSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES 290

Query: 393 PYF 395
            YF
Sbjct: 291 SYF 293

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  120 bits (303), Expect = 1e-31
 Identities = 83/284 (29%), Positives = 127/284 (44%), Gaps = 55/284 (19%)

Query: 133 VGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKR---------EIKILQNLCGGPNVV 183
           +G+G + +V      +T +   +K+LK   KKKI +         E  IL  +   P +V
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKVLK---KKKIIKRKEVEHTLTERNILSRINH-PFIV 56

Query: 184 KLLDIVRDQHS--KTPS---LIFEYVNSTD-FKVLY--PTLTDYDIRYYIYELLKALDYC 235
           KL       H   +T     L+ EY    + F  L      ++   R+Y  E++ AL+Y 
Sbjct: 57  KL-------HYAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYL 109

Query: 236 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDL 294
           HS GI++RD+KP N+++D +   ++L D+GLA E    G   N    +  +  PE+L   
Sbjct: 110 HSLGIIYRDLKPENILLDAD-GHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVL-LG 167

Query: 295 QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSK 354
           + Y  ++D WSLG +   M+  K P FY  D  +   KI KD                  
Sbjct: 168 KGYGKAVDWWSLGVLLYEMLTGKPP-FYAEDRKEIYEKILKD-------------PLRFP 213

Query: 355 FINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREA---MAHPYF 395
                    +SPEA D +  LL+ D   RL +  A    AHP+F
Sbjct: 214 EF-------LSPEARDLISGLLQKDPTKRLGSGGAEEIKAHPFF 250

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score =  124 bits (312), Expect = 1e-31
 Identities = 89/299 (29%), Positives = 157/299 (52%), Gaps = 34/299 (11%)

Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIK-ILKPVKKKKIKREIKILQNLCGGPNVVKL 185
           Y++   +G G +  V+E I ++T+E+  IK +L+  + K   RE+ I++NL    N++ L
Sbjct: 68  YKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKN--RELLIMKNL-NHINIIFL 124

Query: 186 LD------IVRDQHSKTPSLIFEYVNSTDFKVLY------PTLTDYDIRYYIYELLKALD 233
            D        +++ +   +++ E++  T  K +         L  + ++ Y Y+L +AL 
Sbjct: 125 KDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALA 184

Query: 234 YCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD 293
           Y HS+ I HRD+KP N++ID     L+L D+G A+    G+     + SR+++ PEL++ 
Sbjct: 185 YIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICSRFYRAPELMLG 244

Query: 294 LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWS 353
             +Y   +D+WSLGC+ A MI    P F G  + DQLV+I +    ++   +    K  +
Sbjct: 245 ATNYTTHIDLWSLGCIIAEMIL-GYPIFSGQSSVDQLVRIIQ----VLGTPTEDQLKEMN 299

Query: 354 ------KFINADNQHL--VSP-----EAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVR 399
                 KF +   + L  V P     +AI+F+ + L+Y+   RL   EA+A P+F  +R
Sbjct: 300 PNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLR 358

Length = 440

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score =  119 bits (300), Expect = 9e-31
 Identities = 92/305 (30%), Positives = 143/305 (46%), Gaps = 36/305 (11%)

Query: 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIK-ILKPVKKKKIK----REIKILQNLC 177
           +   YE + K+G+G + EVF+  +  T +   +K +L   +K+       REIKILQ L 
Sbjct: 10  EVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLL- 68

Query: 178 GGPNVVKLLDIVRDQHSK------TPSLIFEYVNSTDFKVL----YPTLTDYDIRYYIYE 227
              NVV L++I R + +       +  L+FE+    D   L        T  +I+  +  
Sbjct: 69  KHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKM 127

Query: 228 LLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE-----YNVRVAS 282
           LL  L Y H   I+HRD+K  N++I  +   L+L D+GLA  +   K      Y  RV +
Sbjct: 128 LLNGLYYIHRNKILHRDMKAANILITKD-GILKLADFGLARAFSLSKNSKPNRYTNRVVT 186

Query: 283 RYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLI-- 340
            +++ PELL+  +DY   +DMW  GC+ A M  R  P   G+    QL  I++ C  I  
Sbjct: 187 LWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTR-SPIMQGNTEQHQLTLISQLCGSITP 245

Query: 341 -IWCN------SRHSRKPWSKF--INADNQHLVS-PEAIDFLDKLLRYDHQDRLTAREAM 390
            +W         +    P  +   +    +  V  P A+D +DKLL  D   R+ A  A+
Sbjct: 246 EVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTAL 305

Query: 391 AHPYF 395
            H +F
Sbjct: 306 NHDFF 310

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score =  119 bits (299), Expect = 1e-30
 Identities = 88/296 (29%), Positives = 154/296 (52%), Gaps = 29/296 (9%)

Query: 121 WGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIK----REIKILQNL 176
           +G  + Y  + K+G G Y+ VF+G +  T     +K ++   ++       RE+ +L++L
Sbjct: 2   FGKMETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDL 61

Query: 177 CGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYP----TLTDYDIRYYIYELLKAL 232
               N+V L DIV    S T  L+FEY++  D K         ++ ++++ ++Y++L+ L
Sbjct: 62  -KHANIVTLHDIVHTDKSLT--LVFEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGL 117

Query: 233 DYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH-PGKEYNVRVASRYFKGPELL 291
            YCH + ++HRD+KP N++I+ E  +L+L D+GLA     P K Y+  V + +++ P++L
Sbjct: 118 AYCHRRKVLHRDLKPQNLLIN-ERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVL 176

Query: 292 VDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI-------AKDCCLIIWCN 344
           +   +Y   +DMW +GC+F  M   + P F G    D+L  I        ++    I  N
Sbjct: 177 LGSSEYSTQIDMWGVGCIFFEMASGR-PLFPGSTVEDELHLIFRLLGTPTEETWPGISSN 235

Query: 345 SRHSRKPWSK-----FINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF 395
                  + K      IN   +  +  E I+ L K L+Y+ + R++A EAM H YF
Sbjct: 236 DEFKNYNFPKYKPQPLINHAPR--LDTEGIELLTKFLQYESKKRISAEEAMKHAYF 289

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score =  117 bits (296), Expect = 1e-30
 Identities = 73/275 (26%), Positives = 120/275 (43%), Gaps = 38/275 (13%)

Query: 133 VGRGKYSEVFEGINVNTNERCIIKILKPVKK--------KKIKREIKILQNLCGGPNVVK 184
           +G G +  V+EG+N++  +   +K +             K++++EI +L  L   PN+V+
Sbjct: 8   LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQH-PNIVQ 66

Query: 185 LLDIVRDQHSKTPSLIFEYVNSTDFKVL---YPTLTDYDIRYYIYELLKALDYCHSQGIM 241
            L   R+       +  E V       L   Y +  +  IR Y  ++L  L+Y H +  +
Sbjct: 67  YLGTERE--EDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTV 124

Query: 242 HRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSL 301
           HRD+K  N+++D     ++L D+G+A+             S Y+  PE++     Y  + 
Sbjct: 125 HRDIKGANILVDTN-GVVKLADFGMAKQVVEFSFAKSFKGSPYWMAPEVIAQQGGYGLAA 183

Query: 302 DMWSLGCMFAGMIFRKEPF--FYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSKFINAD 359
           D+WSLGC    M   K P+    G      + KI +                 SK +   
Sbjct: 184 DIWSLGCTVLEMATGKPPWSQLEG---VAAVFKIGR-----------------SKELPPI 223

Query: 360 NQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPY 394
             HL S EA DF+ K L+ D   R TA E + HP+
Sbjct: 224 PDHL-SDEAKDFILKCLQRDPSLRPTAAELLEHPF 257

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score =  115 bits (291), Expect = 9e-30
 Identities = 83/289 (28%), Positives = 130/289 (44%), Gaps = 49/289 (16%)

Query: 133 VGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKR--------EIKILQNLCGGPNVVK 184
           + +G Y  VF     +T +   IK++K  K   I++        E  IL      P VVK
Sbjct: 1   ISKGAYGRVFLAKKKSTGDIYAIKVIK--KADMIRKNQVDQVLTERDILSQ-AQSPYVVK 57

Query: 185 LLDIVRDQHSKTPSLIFEYVNSTDFKVL---YPTLTDYDIRYYIYELLKALDYCHSQGIM 241
           L      Q  K   L+ EY+   D   L     +L +   R YI E++ AL+Y HS GI+
Sbjct: 58  LYYSF--QGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGII 115

Query: 242 HRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASR---------YFKGPELLV 292
           HRD+KP N++ID     L+L D+GL++     ++ N+    +          +  PE+++
Sbjct: 116 HRDLKPDNILIDSN-GHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVIL 174

Query: 293 DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPW 352
             Q +  ++D WSLGC+    +    PF   H    +           I+ N  + +  W
Sbjct: 175 -GQGHSKTVDWWSLGCILYEFLVGIPPF---HGETPE----------EIFQNILNGKIEW 220

Query: 353 SKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAR---EAMAHPYFAQV 398
            + +       VS EAID + KLL  D + RL A+   E   HP+F  +
Sbjct: 221 PEDVE------VSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFFKGI 263

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score =  116 bits (291), Expect = 9e-30
 Identities = 92/298 (30%), Positives = 152/298 (51%), Gaps = 39/298 (13%)

Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIK--------REIKILQNLCG 178
           YE V ++G G Y +VF+  ++    R +   LK V+ +  +        RE+ +L++L  
Sbjct: 3   YECVAEIGEGAYGKVFKARDLKNGGRFVA--LKRVRVQTGEEGMPLSTIREVAVLRHLET 60

Query: 179 --GPNVVKLLDIV---RDQHSKTPSLIFEYVNS--TDF--KVLYPTLTDYDIRYYIYELL 229
              PNVV+L D+    R       +L+FE+V+   T +  KV  P +    I+  +++LL
Sbjct: 61  FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLL 120

Query: 230 KALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 289
           + LD+ HS  ++HRD+KP N+++     +++L D+GLA  Y         V + +++ PE
Sbjct: 121 RGLDFLHSHRVVHRDLKPQNILVTSS-GQIKLADFGLARIYSFQMALTSVVVTLWYRAPE 179

Query: 290 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI------------AKDC 337
           +L+    Y   +D+WS+GC+FA M FR++P F G  + DQL KI             +D 
Sbjct: 180 VLLQ-SSYATPVDLWSVGCIFAEM-FRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDV 237

Query: 338 CLIIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF 395
            L        S +P  KF+  D   L      D L K L ++   R++A  A++HPYF
Sbjct: 238 ALPRQAFHSKSAQPIEKFV-TDIDEL----GKDLLLKCLTFNPAKRISAYSALSHPYF 290

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score =  117 bits (294), Expect = 1e-29
 Identities = 80/284 (28%), Positives = 134/284 (47%), Gaps = 33/284 (11%)

Query: 126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGG 179
           D++++ +VG+G Y +VF     +T E   +K +K        + + +  E  IL      
Sbjct: 2   DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTT-TKS 60

Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYP---TLTDYDIRYYIYELLKALDYCH 236
             +VKLL   +D   +   L  EYV   DF+ L      L++   R+Y+ E+ +A+D  H
Sbjct: 61  EWLVKLLYAFQD--DEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALH 118

Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY-NVRVASRYFKGPELLVDLQ 295
             G +HRD+KP N +ID     ++L D+GL++       Y N  V S  +  PE+L   +
Sbjct: 119 ELGYIHRDLKPENFLID-ASGHIKLTDFGLSK---GIVTYANSVVGSPDYMAPEVLRG-K 173

Query: 296 DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSKF 355
            YD+++D WSLGCM    +    PF       ++            W N ++ ++   + 
Sbjct: 174 GYDFTVDYWSLGCMLYEFLCGFPPF--SGSTPNE-----------TWENLKYWKETLQRP 220

Query: 356 INADNQHLVSPEAIDFLDKLLRYDHQDRLTARE-AMAHPYFAQV 398
           +  D +  +S EA D + KL+  D   R  + E    HP+F +V
Sbjct: 221 VYDDPRFNLSDEAWDLITKLIN-DPSRRFGSLEDIKNHPFFKEV 263

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score =  115 bits (290), Expect = 1e-29
 Identities = 90/293 (30%), Positives = 143/293 (48%), Gaps = 28/293 (9%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK-----KKKIKREIKILQNLCGG 179
           + +EV+  VG G Y  V +  +  T E   IK  K  +     K+   RE+K+L+ L   
Sbjct: 1   NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTL-KQ 59

Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL--YPTLTDYD-IRYYIYELLKALDYCH 236
            N+V+L +  R +      L+FEYV     ++L   P     + +R YIY+L+KA+ +CH
Sbjct: 60  ENIVELKEAFRRRGKLY--LVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCH 117

Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE--YNVRVASRYFKGPELLVDL 294
              I+HRD+KP N++I H    L+L D+G A     G    Y   VA+R+++ PELL+  
Sbjct: 118 KNDIVHRDIKPENLLISHN-DVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLG- 175

Query: 295 QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK-------DCCLIIWCNSRH 347
             Y  ++DMWS+GC+  G +   +P F G    DQL  I K       +   + + N R 
Sbjct: 176 APYGKAVDMWSVGCIL-GELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRF 234

Query: 348 S--RKP---WSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF 395
              R P     + +      ++S   +D +  LL+ +  DR    + + HP F
Sbjct: 235 HGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF 287

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  114 bits (288), Expect = 3e-29
 Identities = 80/295 (27%), Positives = 131/295 (44%), Gaps = 35/295 (11%)

Query: 119 VQWGDQDD-YEVVRKVGRGKYSEVFEGINVNTNERCIIK--ILKPVKKKKIKREIKILQN 175
           V  GD  + Y+ + K+G G   EV++  +  T +   IK   L+   K+ I  EI I+++
Sbjct: 12  VSEGDPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKD 71

Query: 176 LCGGPNVVKLLDIVRDQHSKTPSLIFEYVNS---TDFKVLYPT---LTDYDIRYYIYELL 229
            C  PN+V   D           ++ EY++    TD  ++      + +  I Y   E+L
Sbjct: 72  -CKHPNIVDYYDSYLVG--DELWVVMEYMDGGSLTD--IITQNFVRMNEPQIAYVCREVL 126

Query: 230 KALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGL-AEFYHPGKEYNVRVASRYFKGP 288
           + L+Y HSQ ++HRD+K  N+++  +   ++L D+G  A+      + N  V + Y+  P
Sbjct: 127 QGLEYLHSQNVIHRDIKSDNILLSKDGS-VKLADFGFAAQLTKEKSKRNSVVGTPYWMAP 185

Query: 289 ELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHS 348
           E++   +DY   +D+WSLG M   M    EP +        L  I               
Sbjct: 186 EVIKR-KDYGPKVDIWSLGIMCIEMA-EGEPPYLREPPLRALFLITT------------- 230

Query: 349 RKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAES 403
            K         N    SPE  DFL+K L  D + R +A E + HP+  +    E 
Sbjct: 231 -KGIPPL---KNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPFLKKACPKEE 281

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score =  115 bits (290), Expect = 4e-29
 Identities = 93/314 (29%), Positives = 153/314 (48%), Gaps = 53/314 (16%)

Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPN 181
           Y++   +G+G Y  V   I+ +T E+  IK +  V        +I REIK+L+       
Sbjct: 2   YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLR------- 54

Query: 182 VVKLLDIVRDQHSKTPS---------LIFEYVNSTDFKVLYPT--LTDYDIRYYIYELLK 230
           +++  DIV  +H   P          ++FE + S   +V+     LT    ++++Y+LL+
Sbjct: 55  LLRHPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHHQFFLYQLLR 114

Query: 231 ALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNV----RVASRYFK 286
           AL Y H+  + HRD+KP N++ + +  KL++ D+GLA          +     VA+R+++
Sbjct: 115 ALKYIHTANVFHRDLKPKNILANADC-KLKICDFGLARVAFNDTPTAIFWTDYVATRWYR 173

Query: 287 GPELLVDL-QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI----AKDCCLII 341
            PEL       Y  ++D+WS+GC+FA ++  K P F G +   QL  I           I
Sbjct: 174 APELCGSFFSKYTPAIDIWSIGCIFAEVLTGK-PLFPGKNVVHQLDLITDLLGTPSPETI 232

Query: 342 ----------WCNSRHSRKPW---SKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTARE 388
                     + +S   ++P     KF NAD      P A+  L++LL +D +DR TA E
Sbjct: 233 SRVRNEKARRYLSSMRKKQPVPFSQKFPNAD------PLALRLLERLLAFDPKDRPTAEE 286

Query: 389 AMAHPYFAQVRAAE 402
           A+A PYF  +   E
Sbjct: 287 ALADPYFKGLAKVE 300

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score =  114 bits (286), Expect = 5e-29
 Identities = 84/301 (27%), Positives = 151/301 (50%), Gaps = 39/301 (12%)

Query: 121 WGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIK----REIKILQNL 176
           +G  + Y  + K+G G Y+ VF+G +  T     +K ++   ++       RE+ +L+NL
Sbjct: 1   FGKLETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNL 60

Query: 177 CGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPT----LTDYDIRYYIYELLKAL 232
               N+V L DI+  +   T  L+FEY++S D K         ++ ++++ ++++LL+ L
Sbjct: 61  -KHANIVTLHDIIHTERCLT--LVFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGL 116

Query: 233 DYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH-PGKEYNVRVASRYFKGPELL 291
            YCH + I+HRD+KP N++I+ E  +L+L D+GLA     P K Y+  V + +++ P++L
Sbjct: 117 SYCHKRKILHRDLKPQNLLIN-EKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVL 175

Query: 292 VDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKP 351
           +   +Y   +DMW +GC+   M   + P F G    ++L        LI       + + 
Sbjct: 176 LGSTEYSTPIDMWGVGCILYEMATGR-PMFPGSTVKEEL-------HLIFRLLGTPTEET 227

Query: 352 WSKFINADN-------QHLVSP----------EAIDFLDKLLRYDHQDRLTAREAMAHPY 394
           W    + +        Q+   P          + ID L  LL Y+ + R++A  A+ H Y
Sbjct: 228 WPGITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSY 287

Query: 395 F 395
           F
Sbjct: 288 F 288

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score =  114 bits (286), Expect = 5e-29
 Identities = 82/297 (27%), Positives = 146/297 (49%), Gaps = 38/297 (12%)

Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILK-PVKKKKIK----REIKILQNL--CGG 179
           YE V ++G G Y  V++  + ++     +K ++    +  +     RE+ +L+ L     
Sbjct: 2   YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDH 61

Query: 180 PNVVKLLDIV----RDQHSKTPSLIFEYVNSTDF-----KVLYPTLTDYDIRYYIYELLK 230
           PN+V+L+D+      D+ +K  +L+FE+V+  D      KV  P L    I+  + + L+
Sbjct: 62  PNIVRLMDVCATSRTDRETKV-TLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLR 119

Query: 231 ALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPEL 290
            LD+ H+  I+HRD+KP N+++     +++L D+GLA  Y         V + +++ PE+
Sbjct: 120 GLDFLHANCIVHRDLKPENILVTSG-GQVKLADFGLARIYSCQMALTPVVVTLWYRAPEV 178

Query: 291 LVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI------------AKDCC 338
           L+    Y   +DMWS+GC+FA M FR++P F G+   DQL KI             +D  
Sbjct: 179 LLQ-STYATPVDMWSVGCIFAEM-FRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVT 236

Query: 339 LIIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF 395
           L     S    +P    +       +       L ++L ++   R++A  A+ HP+F
Sbjct: 237 LPRGAFSPRGPRPVQSVVPE-----IEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score =  114 bits (285), Expect = 8e-29
 Identities = 87/310 (28%), Positives = 161/310 (51%), Gaps = 48/310 (15%)

Query: 121 WGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIK----REIKILQNL 176
           +G  D YE + K+G G Y+ V++G +    +   +K+++  +++       RE  +L+ L
Sbjct: 1   FGKADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGL 60

Query: 177 CGGPNVVKLLDIVRDQHSK-TPSLIFEYVNSTDFKVL--YPT-LTDYDIRYYIYELLKAL 232
               N+V L DI+   H+K T +L+FEYV++   + +  +P  L   +++ ++++LL+ L
Sbjct: 61  -KHANIVLLHDII---HTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGL 116

Query: 233 DYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH-PGKEYNVRVASRYFKGPELL 291
            Y H + I+HRD+KP N++I  +  +L+L D+GLA     P   Y+  V + +++ P++L
Sbjct: 117 SYIHQRYILHRDLKPQNLLIS-DTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVL 175

Query: 292 VDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLII-------W-- 342
           +   +Y   LDMW +GC+F  MI     F    D  DQL +I     L++       W  
Sbjct: 176 LGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIF----LVLGTPNEDTWPG 231

Query: 343 --------------CNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTARE 388
                          + ++ R+ W+K    ++       A D   KLL+   ++RL+A+ 
Sbjct: 232 VHSLPHFKPERFTLYSPKNLRQAWNKLSYVNH-------AEDLASKLLQCFPKNRLSAQA 284

Query: 389 AMAHPYFAQV 398
           A++H YF+ +
Sbjct: 285 ALSHEYFSDL 294

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score =  111 bits (278), Expect = 4e-28
 Identities = 77/281 (27%), Positives = 128/281 (45%), Gaps = 36/281 (12%)

Query: 130 VRKVGRGKYSEVFEGINVNTNERCIIKILKP---VKKKKI---KREIKILQNLCGGPNVV 183
           ++ + +G +  V+     +T +   IK+LK    + K ++   K E  I+      P V 
Sbjct: 1   LKPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVA 60

Query: 184 KLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYD---IRYYIYELLKALDYCHSQGI 240
           KL      Q      L+ EY+N  D   L  TL        + YI E++  ++  H +GI
Sbjct: 61  KLYYSF--QSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGI 118

Query: 241 MHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYS 300
           +HRD+KP N++ID +   L+L D+GL+      K++   V +  +  PE ++ + D D  
Sbjct: 119 IHRDIKPENLLID-QTGHLKLTDFGLSRNGLENKKF---VGTPDYLAPETILGVGD-DKM 173

Query: 301 LDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSKFINADN 360
            D WSLGC+    +F   PF      H +           ++ N    R  W + +    
Sbjct: 174 SDWWSLGCVIFEFLFGYPPF------HAETPD-------AVFDNILSRRINWPEEVK--- 217

Query: 361 QHLVSPEAIDFLDKLLRYDHQDRLTA---REAMAHPYFAQV 398
               SPEA+D +++LL  D   RL A   +E  +HP+F  +
Sbjct: 218 -EFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHPFFKSI 257

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score =  111 bits (280), Expect = 8e-28
 Identities = 86/320 (26%), Positives = 143/320 (44%), Gaps = 56/320 (17%)

Query: 127 YEVVRKVGRGKYSEVFE--GINVNTNERCIIKILKPVKKKKIK------REIKILQNLCG 178
           YE+   +GRG Y  V++    N    +   IK  K  K++         REI +L+ L  
Sbjct: 2   YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLREL-K 60

Query: 179 GPNVVKLLDIVRDQHSKTPSLIFEYV----------NSTDFKVLYPTLTDYDIRYYIYEL 228
             NVV L+++  +   K+  L+F+Y           +    +V  P      ++  ++++
Sbjct: 61  HENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSM---VKSLLWQI 117

Query: 229 LKALDYCHSQGIMHRDVKPHN--VMIDHELR-KLRLIDWGLAEFYH----PGKEYNVRVA 281
           L  + Y HS  ++HRD+KP N  VM +   R  +++ D GLA  ++    P  + +  V 
Sbjct: 118 LNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVV 177

Query: 282 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHD---------NHDQLVK 332
           + +++ PELL+  + Y  ++D+W++GC+FA ++   EP F G +           DQL +
Sbjct: 178 TIWYRAPELLLGARHYTKAIDIWAIGCIFAELL-TLEPIFKGREAKIKKSNPFQRDQLER 236

Query: 333 I--------AKDCCLIIWCNSRHSRKPWSKFINADNQHLV---------SPEAIDFLDKL 375
           I         KD   I       +     K     +  L            +  D L KL
Sbjct: 237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKL 296

Query: 376 LRYDHQDRLTAREAMAHPYF 395
           L YD   R+TA EA+ HPYF
Sbjct: 297 LEYDPTKRITAEEALEHPYF 316

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score =  108 bits (271), Expect = 3e-26
 Identities = 84/308 (27%), Positives = 147/308 (47%), Gaps = 47/308 (15%)

Query: 126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGP 180
           D E  R +G G +  V+   +    +R  +K +  V       K++ RE+K+L       
Sbjct: 1   DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKML-CFFKHD 59

Query: 181 NVVKLLDIVRDQHSKTPSLIF---EYVNSTDFKVLY--PTLTDYDIRYYIYELLKALDYC 235
           NV+  LDI++  H      I+   E + S   K++     L+   ++ ++Y++L+ L Y 
Sbjct: 60  NVLSALDILQPPHIDPFEEIYVVTELMQSDLHKIIVSPQPLSSDHVKVFLYQILRGLKYL 119

Query: 236 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP--GKEYNVRVASRYFKGPELLVD 293
           HS GI+HRD+KP N++++     L++ D+GLA    P   K     V ++Y++ PE+L+ 
Sbjct: 120 HSAGILHRDIKPGNLLVNSNCV-LKICDFGLARVEEPDESKHMTQEVVTQYYRAPEILMG 178

Query: 294 LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI------------------AK 335
            + Y  ++D+WS+GC+FA ++ R+   F       QL  I                  A+
Sbjct: 179 SRHYTSAVDIWSVGCIFAELLGRR-ILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGAR 237

Query: 336 DCCLIIWCNSRHSRKPWSK----FINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA 391
              L      R   KP S      +++   H    EA+  L ++L +D   R++A +A+A
Sbjct: 238 AHIL------RGPHKPPSLPVLYTLSSQATH----EAVHLLCRMLVFDPDKRISAADALA 287

Query: 392 HPYFAQVR 399
           HPY  + R
Sbjct: 288 HPYLDEGR 295

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  103 bits (259), Expect = 2e-25
 Identities = 73/282 (25%), Positives = 135/282 (47%), Gaps = 40/282 (14%)

Query: 126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKK-----IKREIKILQNLCGGP 180
           +Y++   +GRG +  V++G+N+ T +   IK +   K K+     I +EI +L+NL   P
Sbjct: 1   NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNL-KHP 59

Query: 181 NVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYD------IRYYIYELLKALDY 234
           N+VK +  +    S +  +I EY    +   L   +  +       +  Y+Y++L+ L Y
Sbjct: 60  NIVKYIGSIET--SDSLYIILEYA---ENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAY 114

Query: 235 CHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVD 293
            H QG++HRD+K  N++   +   ++L D+G+A +     K+    V + Y+  PE+ ++
Sbjct: 115 LHEQGVIHRDIKAANILTTKD-GVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEV-IE 172

Query: 294 LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWS 353
           +     + D+WSLGC    ++    P++   +    L +I +D          H   P  
Sbjct: 173 MSGASTASDIWSLGCTVIELLTGNPPYYDL-NPMAALFRIVQD---------DHPPLPEG 222

Query: 354 KFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF 395
                     +SPE  DFL +  + D   R TA++ + HP+ 
Sbjct: 223 ----------ISPELKDFLMQCFQKDPNLRPTAKQLLKHPWI 254

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score =  101 bits (255), Expect = 8e-25
 Identities = 71/280 (25%), Positives = 134/280 (47%), Gaps = 33/280 (11%)

Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKK--KKIKREIKILQNLCGGPN 181
           ++ ++++ K+G G Y  V++ I+  T +   IK++ PV++  ++I +EI IL+  C  P 
Sbjct: 2   EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVV-PVEEDLQEIIKEISILKQ-CDSPY 59

Query: 182 VVKLL-DIVRDQHSKTPSLIFEYVNSTDF----KVLYPTLTDYDIRYYIYELLKALDYCH 236
           +VK      ++       ++ EY  +       K+   TLT+ +I   +Y+ LK L+Y H
Sbjct: 60  IVKYYGSYFKNTDL---WIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLH 116

Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDLQ 295
           S   +HRD+K  N++++ E  + +L D+G++ +      + N  + + ++  PE++ +  
Sbjct: 117 SNKKIHRDIKAGNILLNEE-GQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQE-I 174

Query: 296 DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSKF 355
            Y+   D+WSLG     M   K P+   H     +  I                KP    
Sbjct: 175 GYNNKADIWSLGITAIEMAEGKPPYSDIHPMR-AIFMIPN--------------KPPPTL 219

Query: 356 INADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF 395
               +    SPE  DF+ K L  D ++R +A + + HP+ 
Sbjct: 220 ---SDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQHPFI 256

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score =  103 bits (258), Expect = 9e-25
 Identities = 77/313 (24%), Positives = 142/313 (45%), Gaps = 59/313 (18%)

Query: 133 VGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIK-----------------REIKILQN 175
           +G G Y +V +  +  T +   IK +K ++                      RE+KI+  
Sbjct: 17  LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNE 76

Query: 176 LCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPT--LTDYDIRYYIYELLKALD 233
           +    N++ L+D+  +      +L+ + + S   KV+     LT+  ++  + ++L  L+
Sbjct: 77  I-KHENIMGLVDVYVEG--DFINLVMDIMASDLKKVVDRKIRLTESQVKCILLQILNGLN 133

Query: 234 YCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA---------------EFYHPGKEYNV 278
             H    MHRD+ P N+ I+ +    ++ D+GLA               E     +E   
Sbjct: 134 VLHKWYFMHRDLSPANIFINSK-GICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTS 192

Query: 279 RVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK--- 335
           +V + +++ PELL+  + Y +++DMWS+GC+FA ++  K P F G +  DQL +I +   
Sbjct: 193 KVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK-PLFPGENEIDQLGRIFELLG 251

Query: 336 ---------DCCLIIWCNSRHSRKPWSK--FINADNQHLVSPEAIDFLDKLLRYDHQDRL 384
                       L ++      +    K  F NA +      +AID L  LL+ +  +R+
Sbjct: 252 TPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASD------DAIDLLQSLLKLNPLERI 305

Query: 385 TAREAMAHPYFAQ 397
           +A+EA+ H YF  
Sbjct: 306 SAKEALKHEYFKS 318

Length = 335

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score =  101 bits (253), Expect = 1e-24
 Identities = 74/282 (26%), Positives = 126/282 (44%), Gaps = 38/282 (13%)

Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKIL---KPVKKKKIK---REIKILQNLCGGP 180
           +E++R +G+G + +V      +T +   +K +   K V+K  ++    E +ILQ L   P
Sbjct: 2   FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQEL-NHP 60

Query: 181 NVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY-----PTLTDYDIRYYIYELLKALDYC 235
            +V L    +D   +   L+ + +   D +  Y        ++  ++++I E++ AL+Y 
Sbjct: 61  FLVNLWYSFQD--EENMYLVVDLLLGGDLR--YHLSQKVKFSEEQVKFWICEIVLALEYL 116

Query: 236 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQ 295
           HS+GI+HRD+KP N+++D E   + + D+ +A    P         +  +  PE+L   Q
Sbjct: 117 HSKGIIHRDIKPDNILLD-EQGHVHITDFNIATKVTPDTLTTSTSGTPGYMAPEVLCR-Q 174

Query: 296 DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSKF 355
            Y  ++D WSLG      +  K P + GH        I                  WS  
Sbjct: 175 GYSVAVDWWSLGVTAYECLRGKRP-YRGHSR-----TIRDQIRAKQETADVLYPATWST- 227

Query: 356 INADNQHLVSPEAIDFLDKLLRYDHQDRL--TAREAMAHPYF 395
                      EAID ++KLL  D Q RL    ++   HPYF
Sbjct: 228 -----------EAIDAINKLLERDPQKRLGDNLKDLKNHPYF 258

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score =  100 bits (251), Expect = 3e-24
 Identities = 84/287 (29%), Positives = 136/287 (47%), Gaps = 52/287 (18%)

Query: 131 RKVGRGKYSEVFEGINVNTNERCIIKILK-----PVKKKKIKREIKILQNLCGGPNVVKL 185
            K+G G + +V+  +N++T E   +K ++     P   K+I  E+K+L+ L   PN+VK 
Sbjct: 6   NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELL-KHPNLVKY 64

Query: 186 --LDIVRDQHSKTPSLIF-EYVN-STDFKVL-YPTLTDYD-IRYYIYELLKALDYCHSQG 239
             +++ R++       IF EY +  T  ++L +  + D   IR Y  +LL+ L Y HS G
Sbjct: 65  YGVEVHREK-----VYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHG 119

Query: 240 IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG---------PEL 290
           I+HRD+KP N+ +DH    ++L D+G A                  +          PE+
Sbjct: 120 IVHRDIKPANIFLDHN-GVIKLGDFGCAVKLKNNT----TTMGEEVQSLAGTPAYMAPEV 174

Query: 291 LV--DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV-KIAKDCCLIIWCNSRH 347
           +     + +  + D+WSLGC+   M   K P +   DN  Q++  +           + H
Sbjct: 175 ITGGKGKGHGRAADIWSLGCVVLEMATGKRP-WSELDNEFQIMFHVG----------AGH 223

Query: 348 SRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPY 394
             KP    I    Q  +SPE  DFLD+ L  D + R TA E + HP+
Sbjct: 224 --KP---PIPDSLQ--LSPEGKDFLDRCLESDPKKRPTASELLQHPF 263

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score = 99.9 bits (250), Expect = 5e-24
 Identities = 64/285 (22%), Positives = 125/285 (43%), Gaps = 42/285 (14%)

Query: 126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKI-----LKPVKKKKIKREIKILQNLCGGP 180
            YE+++++G+G + +V+     +  +  ++K      +   +++    E+KIL+ L   P
Sbjct: 1   KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKL-NHP 59

Query: 181 NVVKLLD-IVRDQHSKTPSLIFEYVNSTD-------FKVLYPTLTDYDIRYYIYELLKAL 232
           N++K  +            ++ EY +  D        K       +  I  +  +L  AL
Sbjct: 60  NIIKYYESFEEKGKL---CIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLAL 116

Query: 233 DYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY-NVRVASRYFKGPELL 291
            Y HS+ I+HRD+KP N+ +      ++L D+G+++      +     V + Y+  PEL 
Sbjct: 117 KYLHSRKILHRDIKPQNIFLTSN-GLVKLGDFGISKVLSSTVDLAKTVVGTPYYLSPELC 175

Query: 292 VDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV-KIAKDCCLIIWCNSRHSRK 350
            + + Y+Y  D+WSLGC+   +   K PF    +N  +L  KI K         S++S  
Sbjct: 176 QN-KPYNYKSDIWSLGCVLYELCTLKHPF--EGENLLELALKILK--GQYPPIPSQYSS- 229

Query: 351 PWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF 395
                           E  + +  LL+ D ++R +  + +  P+ 
Sbjct: 230 ----------------ELRNLVSSLLQKDPEERPSIAQILQSPFI 258

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score =  100 bits (252), Expect = 8e-24
 Identities = 86/316 (27%), Positives = 134/316 (42%), Gaps = 73/316 (23%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP---VKKKKI-----KREIKILQNL 176
           DD+EV++ +GRG + EV+   + +T +   +K+L+    +K+ +I     +R+I    + 
Sbjct: 1   DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADAD- 59

Query: 177 CGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL---YPTLTDYDIRYYIYELLKALD 233
              P +VKL    +D+      L+ EY+   D   L        +   R+YI EL+ ALD
Sbjct: 60  --SPWIVKLYYSFQDEEHLY--LVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALD 115

Query: 234 YCHSQGIMHRDVKPHNVMID---HELRKLRLIDWGLA----------------------- 267
             H  G +HRD+KP N++ID   H    ++L D+GL                        
Sbjct: 116 SVHKLGFIHRDIKPDNILIDADGH----IKLADFGLCKKMNKAKDREYYLNDSHNLLFRD 171

Query: 268 ---EFYHPGKEYNVR----VASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPF 320
                    K+  VR    V +  +  PE+L     Y    D WSLG +   M++   P 
Sbjct: 172 NVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRG-TPYGLECDWWSLGVILYEMLYGFPP- 229

Query: 321 FYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDH 380
           FY     +   KI                  W + +       VSPEAID + +LL  D 
Sbjct: 230 FYSDTLQETYNKI----------------INWKESLRFPPDPPVSPEAIDLICRLLC-DP 272

Query: 381 QDRLT-AREAMAHPYF 395
           +DRL    E  +HP+F
Sbjct: 273 EDRLGSFEEIKSHPFF 288

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 99.3 bits (248), Expect = 9e-24
 Identities = 69/294 (23%), Positives = 120/294 (40%), Gaps = 49/294 (16%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK--KKKIKREIKILQNLCGGPNV 182
             +E+V  +G G Y +V++  +  T +   IKI+  ++  +++IK E  IL+     PN+
Sbjct: 6   GIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNI 65

Query: 183 VKLLDIVRDQHSKTPS----LIFEYVNS---TD----FKVLYPTLTDYDIRYYIYELLKA 231
                    ++         L+ E       TD     +     L +  I Y + E L+ 
Sbjct: 66  ATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRG 125

Query: 232 LDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGL-AEFYHPGKEYNVRVASRYFKGPE- 289
           L Y H   ++HRD+K  N+++      ++L+D+G+ A+        N  + + Y+  PE 
Sbjct: 126 LAYLHENKVIHRDIKGQNILLTKNAE-VKLVDFGVSAQLDSTLGRRNTFIGTPYWMAPEV 184

Query: 290 LLVDLQD---YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSR 346
           +  D Q    YD   D+WSLG     +   K P     D H       +    I     R
Sbjct: 185 IACDEQPDASYDARSDVWSLGITAIELADGKPPLC---DMHPM-----RALFKIP----R 232

Query: 347 H------SRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPY 394
           +      S + WSK  N            DF+ + L  +++ R    E + HP+
Sbjct: 233 NPPPTLKSPENWSKKFN------------DFISECLIKNYEQRPFMEELLEHPF 274

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 92.9 bits (231), Expect = 2e-21
 Identities = 56/211 (26%), Positives = 104/211 (49%), Gaps = 19/211 (9%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK------PVKKKKIKREIKILQNLCG 178
            ++++ +K+G+G++S V++ I +       +K ++         ++   +EI +L+ L  
Sbjct: 2   GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQL-D 60

Query: 179 GPNVVKLLDIVRDQHSKTPSLIFEYVNSTD-------FKVLYPTLTDYDIRYYIYELLKA 231
            PNV+K L    + +     ++ E  ++ D       FK     + +  I  Y  +L  A
Sbjct: 61  HPNVIKYLASFIENNELN--IVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSA 118

Query: 232 LDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK-EYNVRVASRYFKGPEL 290
           L++ HS+ IMHRD+KP NV I      ++L D GL  F+       +  V + Y+  PE 
Sbjct: 119 LEHMHSKRIMHRDIKPANVFITAT-GVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPER 177

Query: 291 LVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 321
           + +   Y++  D+WSLGC+   M   + PF+
Sbjct: 178 IHE-NGYNFKSDIWSLGCLLYEMAALQSPFY 207

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 92.5 bits (230), Expect = 9e-21
 Identities = 73/300 (24%), Positives = 142/300 (47%), Gaps = 36/300 (12%)

Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILK-----PVKKKKIKREIKILQNLCGGPN 181
           Y+ ++ +G G    V    +  T +   IK L          K+  RE+ +++ L    N
Sbjct: 18  YQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMK-LVNHKN 76

Query: 182 VVKLLDIVRDQHS----KTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHS 237
           ++ LL++   Q S    +   L+ E +++   +V+   L    + Y +Y++L  + + HS
Sbjct: 77  IIGLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHS 136

Query: 238 QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDY 297
            GI+HRD+KP N+++  +   L+++D+GLA            V +RY++ PE+++ +  Y
Sbjct: 137 AGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM-GY 194

Query: 298 DYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDC-------------CLIIWCN 344
             ++D+WS+GC+   MI R    F G D+ DQ  KI +                +  +  
Sbjct: 195 KENVDIWSVGCIMGEMI-RGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPTVRNYVE 253

Query: 345 SR--HSRKPWSKFI--------NADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPY 394
           +R  ++   + +          +  +  L + +A D L K+L  D + R++  +A+ HPY
Sbjct: 254 NRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPY 313

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 90.6 bits (225), Expect = 1e-20
 Identities = 73/288 (25%), Positives = 135/288 (46%), Gaps = 51/288 (17%)

Query: 133 VGRGKYSEVFEGINVNTNERCIIKILKPVKK-------------KKIKREIKILQNLCGG 179
           +G+G Y  V+  +NV T E   +K ++                 K ++ EI+ L++L   
Sbjct: 9   IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDL-DH 67

Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYD---IRYYIYELLKALDYCH 236
            N+V+ L     +  +  S+  EYV          T   ++   +R++  ++L+ L Y H
Sbjct: 68  LNIVQYLGFETTE--EYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLH 125

Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGL----AEFYHPGKEYNVRVASRYFKGPELLV 292
           S+GI+HRD+K  N+++D +    ++ D+G+     + Y   +  +++  S ++  PE ++
Sbjct: 126 SKGILHRDLKADNLLVDAD-GICKISDFGISKKSDDIYDNDQNMSMQ-GSVFWMAPE-VI 182

Query: 293 DLQDYDYS--LDMWSLGC----MFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSR 346
                 YS  +D+WSLGC    MFAG    + P+     + + +  + K         ++
Sbjct: 183 HSYSQGYSAKVDIWSLGCVVLEMFAG----RRPW----SDEEAIAAMFK-------LGNK 227

Query: 347 HSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPY 394
            S  P    I  D    +SP A+DFL+     +  +R TARE + HP+
Sbjct: 228 RSAPP----IPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQHPF 271

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 90.3 bits (224), Expect = 1e-20
 Identities = 73/284 (25%), Positives = 127/284 (44%), Gaps = 47/284 (16%)

Query: 133 VGRGKYSEVFEGINVNTNERCIIKIL-------KPVKKKK-----IKREIKILQNLCGGP 180
           +G G +  V+ G+N ++ E   +K +           +K+     + REI +L+ L    
Sbjct: 8   IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKEL-QHE 66

Query: 181 NVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL---YPTLTDYDIRYYIYELLKALDYCHS 237
           N+V+ L    D       +  EYV       L   Y    +  +R ++ ++LK L+Y H+
Sbjct: 67  NIVQYLGSSLDADHLN--IFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHN 124

Query: 238 QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASR-------YFKGPEL 290
           +GI+HRD+K  N+++D++   +++ D+G+++             +R       ++  PE 
Sbjct: 125 RGIIHRDIKGANILVDNK-GGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPE- 182

Query: 291 LVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRK 350
           +V    Y    D+WSLGC+   M+  K PF     +  QL  I K               
Sbjct: 183 VVKQTSYTRKADIWSLGCLVVEMLTGKHPF----PDCTQLQAIFK--------------- 223

Query: 351 PWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPY 394
              +  + +    +S EAIDFL+K    DH  R TA E + HP+
Sbjct: 224 -IGENASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKHPF 266

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 89.5 bits (222), Expect = 3e-20
 Identities = 74/280 (26%), Positives = 123/280 (43%), Gaps = 40/280 (14%)

Query: 133 VGRGKYSEVFEGINVNTNERCIIKIL--KPVKKKKIKR----EIKILQNLCGGPNVVKLL 186
           +G+G + EV       T +    K L  K +KK+K ++    E KIL+       +V L 
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILE-KVSSRFIVSL- 58

Query: 187 DIVRDQHSKTP-SLIFEYVNSTDFK-----VLYPTLTDYDIRYYIYELLKALDYCHSQGI 240
                  +K    L+   +N  D K     V  P   +    +Y  +++  L++ H + I
Sbjct: 59  --AYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRI 116

Query: 241 MHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYS 300
           ++RD+KP NV++D +   +R+ D GLA     GK+   R  +  +  PE+L   + YD+S
Sbjct: 117 VYRDLKPENVLLD-DHGNVRISDLGLAVELKGGKKIKGRAGTPGYMAPEVLQG-EVYDFS 174

Query: 301 LDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSKFINADN 360
           +D ++LGC    MI  + PF        + V+             +   K  +  +  + 
Sbjct: 175 VDWFALGCTLYEMIAGRSPF----RQRKEKVE-------------KEELKRRTLEMAVEY 217

Query: 361 QHLVSPEAIDFLDKLLRYDHQDRL-----TAREAMAHPYF 395
               SPEA D  + LL+ D + RL     +A E   HP F
Sbjct: 218 PDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLF 257

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 89.8 bits (222), Expect = 7e-20
 Identities = 78/301 (25%), Positives = 143/301 (47%), Gaps = 39/301 (12%)

Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKIL-KPVKK----KKIKREIKILQNLCGGPN 181
           Y+ ++ +G G    V    +   +    IK L +P +     K+  RE+ +L       N
Sbjct: 19  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYREL-VLMKCVNHKN 77

Query: 182 VVKLLDIVRDQHS----KTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHS 237
           ++ LL++   Q S    +   L+ E +++   +V+   L    + Y +Y++L  + + HS
Sbjct: 78  IISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHS 137

Query: 238 QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDY 297
            GI+HRD+KP N+++  +   L+++D+GLA            V +RY++ PE+++ +  Y
Sbjct: 138 AGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM-GY 195

Query: 298 DYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWC------------NS 345
             ++D+WS+GC+   M+ R +  F G D  DQ  K+ +   L   C            N 
Sbjct: 196 KENVDIWSVGCIMGEMV-RHKILFPGRDYIDQWNKVIEQ--LGTPCPEFMKKLQPTVRNY 252

Query: 346 RHSRKPWS----------KFINADNQH--LVSPEAIDFLDKLLRYDHQDRLTAREAMAHP 393
             +R  ++              AD++H  L + +A D L K+L  D   R++  EA+ HP
Sbjct: 253 VENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHP 312

Query: 394 Y 394
           Y
Sbjct: 313 Y 313

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 89.7 bits (222), Expect = 7e-20
 Identities = 78/323 (24%), Positives = 149/323 (46%), Gaps = 50/323 (15%)

Query: 113 DYESLTVQWGDQ-----DDYEVVRKVGRGKYSEVFE------GINVNTNERCIIKILKPV 161
           D +  +VQ  D        Y+ ++ +G G    V        GINV      + K+ +P 
Sbjct: 4   DSQFYSVQVADSTFTVLKRYQQLKPIGSGAQGIVCAAFDTVLGINV-----AVKKLSRPF 58

Query: 162 KK----KKIKREIKILQNLCGGPNVVKLLDIVRDQHS----KTPSLIFEYVNSTDFKVLY 213
           +     K+  RE+ +L+ +    N++ LL++   Q S    +   L+ E +++   +V++
Sbjct: 59  QNQTHAKRAYRELVLLKCV-NHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIH 117

Query: 214 PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG 273
             L    + Y +Y++L  + + HS GI+HRD+KP N+++  +   L+++D+GLA      
Sbjct: 118 MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTACTN 176

Query: 274 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI 333
                 V +RY++ PE+++ +  Y  ++D+WS+GC+   ++ +    F G D+ DQ  K+
Sbjct: 177 FMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGELV-KGSVIFQGTDHIDQWNKV 234

Query: 334 AKDC---------CLIIWCNSRHSRKP-------------WSKFINADNQHLVSPEAIDF 371
            +            L     +    +P             W     ++   L + +A D 
Sbjct: 235 IEQLGTPSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDL 294

Query: 372 LDKLLRYDHQDRLTAREAMAHPY 394
           L K+L  D   R++  EA+ HPY
Sbjct: 295 LSKMLVIDPDKRISVDEALRHPY 317

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 89.3 bits (221), Expect = 1e-19
 Identities = 75/299 (25%), Positives = 140/299 (46%), Gaps = 35/299 (11%)

Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKIL-KPVKK----KKIKREIKILQNLCGGPN 181
           Y+ ++ +G G    V    +        IK L +P +     K+  RE+ +L       N
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYREL-VLMKCVNHKN 84

Query: 182 VVKLLDIVRDQHS----KTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHS 237
           ++ LL++   Q S    +   ++ E +++   +V+   L    + Y +Y++L  + + HS
Sbjct: 85  IIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHS 144

Query: 238 QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDY 297
            GI+HRD+KP N+++  +   L+++D+GLA            V +RY++ PE+++ +  Y
Sbjct: 145 AGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM-GY 202

Query: 298 DYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDC-------------CLIIWCN 344
             ++D+WS+GC+   MI      F G D+ DQ  K+ +                +  +  
Sbjct: 203 KENVDIWSVGCIMGEMIKGG-VLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVE 261

Query: 345 SRHSRKPWS-------KFINADNQH--LVSPEAIDFLDKLLRYDHQDRLTAREAMAHPY 394
           +R     +S           AD++H  L + +A D L K+L  D   R++  EA+ HPY
Sbjct: 262 NRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPY 320

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 87.1 bits (216), Expect = 2e-19
 Identities = 68/267 (25%), Positives = 114/267 (42%), Gaps = 35/267 (13%)

Query: 133 VGRGKYSEVFEGINVNTNERCIIKILK----PVKKKKIKREIKILQNLCGG--PNVVKLL 186
           +GRG Y  V+ G +V T     +KI+           I+RE+ +L  L     PN+ K  
Sbjct: 9   IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYY 68

Query: 187 DIVRDQHSKTPSL--IFEYVNSTDFKVLYPT--LTDYDIRYYIYELLKALDYCHSQGIMH 242
                 + K P L  I EY      + L     + +  I   I E+L AL Y H  G++H
Sbjct: 69  G----SYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKYISVIIREVLVALKYIHKVGVIH 124

Query: 243 RDVKPHNVMIDHELRKLRLIDWGL-AEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSL 301
           RD+K  N+++ +    ++L D+G+ A       + +  V + Y+  PE++ + + YD   
Sbjct: 125 RDIKAANILVTNT-GNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITEGKYYDTKA 183

Query: 302 DMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSKFINADNQ 361
           D+WSLG     M     P    + + D    +     LI    S+  R   + +      
Sbjct: 184 DIWSLGITIYEMATGNPP----YSDVDAFRAMM----LIP--KSKPPRLEDNGY------ 227

Query: 362 HLVSPEAIDFLDKLLRYDHQDRLTARE 388
              S    +F+   L  + ++RL+A E
Sbjct: 228 ---SKLLREFVAACLDEEPKERLSAEE 251

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 86.4 bits (215), Expect = 4e-19
 Identities = 76/296 (25%), Positives = 129/296 (43%), Gaps = 58/296 (19%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKIL---KPVKKKK---IKREIKILQNLCG 178
           DD+E ++ +G G +  V    +  + +   +KIL   K VK K+   +  E +ILQ++  
Sbjct: 1   DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRH 60

Query: 179 GPNVVKLLDIVRDQHSKTPSLIFEYVNSTD-FKVL--YPTLTDYDIRYYIYELLKALDYC 235
            P +V L      Q      L+ EYV   + F  L       +   R+Y  +++ AL+Y 
Sbjct: 61  -PFLVNLYG--SFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYL 117

Query: 236 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFK--------G 287
           HS  I++RD+KP N+++D +   +++ D+G A           RV  R +          
Sbjct: 118 HSLDIVYRDLKPENLLLDSD-GYIKITDFGFA----------KRVKGRTYTLCGTPEYLA 166

Query: 288 PELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRH 347
           PE+++  + Y  ++D W+LG +   M+    PFF   DN  Q+ +       I+    R 
Sbjct: 167 PEIIL-SKGYGKAVDWWALGILIYEMLAGYPPFF--DDNPIQIYE------KILEGKVRF 217

Query: 348 SRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRL-----TAREAMAHPYFAQV 398
                            SP+A D +  LL+ D   RL        +   HP+FA +
Sbjct: 218 PSF-------------FSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWFAGI 260

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score = 85.7 bits (213), Expect = 5e-19
 Identities = 68/279 (24%), Positives = 124/279 (44%), Gaps = 32/279 (11%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK----PVKKKKIKREIKILQNLCGGP 180
            D E V+ +G+G    V++  +  T +   +K +        +K++ RE+K L++ C  P
Sbjct: 1   SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRS-CESP 59

Query: 181 NVVKLLDIVRDQHSKTPSLIFEYVNS---TDFKVLYPTLTDYDIRYYIYELLKALDYCHS 237
            VVK             S++ EY++     D       + +  + Y   ++LK LDY H+
Sbjct: 60  YVVKCYGAF--YKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHT 117

Query: 238 Q-GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY-NVRVASRYFKGPELLVDLQ 295
           +  I+HRD+KP N++I+ +  ++++ D+G+++      +  N  V +  +  PE +   +
Sbjct: 118 KRHIIHRDIKPSNLLINSK-GEVKIADFGISKVLENTLDQCNTFVGTVTYMSPERI-QGE 175

Query: 296 DYDYSLDMWSLGCMFAGMIFRKEPF-FYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSK 354
            Y Y+ D+WSLG         K PF   G  +  +L++   D                  
Sbjct: 176 SYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSL------------ 223

Query: 355 FINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHP 393
                     SPE  DF+   L+ D + R +A E + HP
Sbjct: 224 -----PAEEFSPEFRDFISACLQKDPKKRPSAAELLQHP 257

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 86.3 bits (213), Expect = 8e-19
 Identities = 79/313 (25%), Positives = 143/313 (45%), Gaps = 52/313 (16%)

Query: 132 KVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIK----REIKILQNLCGGPNVVKLLD 187
           KVGRG Y  V++    +  +      LK ++   I     REI +L+ L   PNV+ L  
Sbjct: 8   KVGRGTYGHVYKAKRKDGKDEKEYA-LKQIEGTGISMSACREIALLREL-KHPNVIALQK 65

Query: 188 IVRDQHSKTPSLIFEYVNSTDFKVLY-----------PTLTDYDIRYYIYELLKALDYCH 236
           +      +   L+F+Y     + ++              L    ++  +Y++L  + Y H
Sbjct: 66  VFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLH 125

Query: 237 SQGIMHRDVKPHNVMI---DHELRKLRLIDWGLAEFYH----PGKEYNVRVASRYFKGPE 289
           +  ++HRD+KP N+++     E  ++++ D G A  ++    P  + +  V + +++ PE
Sbjct: 126 ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPE 185

Query: 290 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHD---------NHDQLVKI------- 333
           LL+  + Y  ++D+W++GC+FA ++   EP F+            +HDQL +I       
Sbjct: 186 LLLGARHYTKAIDIWAIGCIFAELL-TSEPIFHCRQEDIKTSNPFHHDQLDRIFSVMGFP 244

Query: 334 -AKDCCLI--------IWCNSRHSRKPWSKFINADNQHLVSPEAIDFL--DKLLRYDHQD 382
             KD   I        +  + R +    S  I    +H V P++  FL   KLL  D   
Sbjct: 245 ADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTK 304

Query: 383 RLTAREAMAHPYF 395
           R+T+ +A+  PYF
Sbjct: 305 RITSEQALQDPYF 317

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 84.6 bits (210), Expect = 1e-18
 Identities = 70/277 (25%), Positives = 138/277 (49%), Gaps = 36/277 (12%)

Query: 133 VGRGKYSEVFEGINVNTNE----RCIIK--ILKPVKKKKIKREIKILQNLCGGPNVVKLL 186
           +G G +  V      + N     +C+ K  I++  +++ I  E +IL+  C  P +VKL 
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEE-CNHPFIVKLY 59

Query: 187 DIVRDQHSKTPSLIFEYVNSTD-FKVLYP--TLTDYDIRYYIYELLKALDYCHSQGIMHR 243
              +D+  K   ++ EY    + + +L       +Y  R+YI  ++ A +Y H++GI++R
Sbjct: 60  RTFKDK--KYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYR 117

Query: 244 DVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDM 303
           D+KP N+++D     ++L+D+G A+    G++      +  +  PE++++ + YD+S+D 
Sbjct: 118 DLKPENLLLDSNGY-VKLVDFGFAKKLKSGQKTWTFCGTPEYVAPEIILN-KGYDFSVDY 175

Query: 304 WSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSKFINADNQHL 363
           WSLG +   ++  + PF  G D+ D + +I  D   I+  N +     +  +I       
Sbjct: 176 WSLGILLYELLTGRPPF--GEDDEDPM-EIYND---ILKGNGKLE---FPNYI------- 219

Query: 364 VSPEAIDFLDKLLRYDHQDRL-----TAREAMAHPYF 395
               A D + +LLR + ++RL       ++   H +F
Sbjct: 220 -DKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHKWF 255

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 84.7 bits (209), Expect = 2e-18
 Identities = 78/313 (24%), Positives = 141/313 (45%), Gaps = 52/313 (16%)

Query: 132 KVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIK----REIKILQNLCGGPNVVKLLD 187
           KVGRG Y  V++    +  +      LK ++   I     REI +L+ L   PNV+ L  
Sbjct: 8   KVGRGTYGHVYKAKRKDGKDDRDYA-LKQIEGTGISMSACREIALLREL-KHPNVISLQK 65

Query: 188 IVRDQHSKTPSLIFEYVNSTDFKVLY-----------PTLTDYDIRYYIYELLKALDYCH 236
           +      +   L+F+Y     + ++              L    ++  +Y++L  + Y H
Sbjct: 66  VFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH 125

Query: 237 SQGIMHRDVKPHNVMI---DHELRKLRLIDWGLAEFYH----PGKEYNVRVASRYFKGPE 289
           +  ++HRD+KP N+++     E  ++++ D G A  ++    P  + +  V + +++ PE
Sbjct: 126 ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPE 185

Query: 290 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF------------YGHDNHDQLVKIAKDC 337
           LL+  + Y  ++D+W++GC+FA ++   EP F            Y HD  D++  +    
Sbjct: 186 LLLGARHYTKAIDIWAIGCIFAELL-TSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFP 244

Query: 338 CLIIWCNSR----HS-------RKPWSK--FINADNQHLVSPE--AIDFLDKLLRYDHQD 382
               W + +    HS       R  ++    I    +H V P+  A   L KLL  D   
Sbjct: 245 ADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIK 304

Query: 383 RLTAREAMAHPYF 395
           R+T+ +AM  PYF
Sbjct: 305 RITSEQAMQDPYF 317

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 82.4 bits (204), Expect = 7e-18
 Identities = 67/292 (22%), Positives = 121/292 (41%), Gaps = 45/292 (15%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKI----LKPVKKKKIKREIKILQNLCGGP 180
           DD E + ++G G    V + ++  T +   +K     +    +K+I RE+ IL   C  P
Sbjct: 1   DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHK-CNSP 59

Query: 181 NVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCH 236
            +V       +      S+  EY++      +       + +  +      +LK L Y H
Sbjct: 60  YIVGFYGAFYNNG--DISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLH 117

Query: 237 SQ-GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN----VRVASRYFKGPELL 291
            +  I+HRDVKP N++++    +++L D+G++     G+  N      V +  +  PE +
Sbjct: 118 EKHKIIHRDVKPSNILVNS-RGQIKLCDFGVS-----GQLVNSLAKTFVGTSSYMAPERI 171

Query: 292 VDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNH----DQLVKIAKDCCLIIWCNSRH 347
               DY    D+WSLG     +   + P+   +D      + L  I          N   
Sbjct: 172 QGN-DYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIV---------NEPP 221

Query: 348 SRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVR 399
            R P  KF         SP+  DF++  L  D ++R + +E + HP+  +  
Sbjct: 222 PRLPSGKF---------SPDFQDFVNLCLIKDPRERPSYKELLEHPFIKKYE 264

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 82.3 bits (204), Expect = 8e-18
 Identities = 73/281 (25%), Positives = 129/281 (45%), Gaps = 30/281 (10%)

Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKK---KKIKREIKILQNLCGGP 180
           Q+DYE+++++G G Y +V++  ++ T E   IK++K       + I++EI +L+  C  P
Sbjct: 2   QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKE-CRHP 60

Query: 181 NVVKLLDIVRDQHSKTPSLIFEYV--NSTD--FKVLYPTLTDYDIRYYIYELLKALDYCH 236
           N+V        +      ++ EY    S    ++V    L++  I Y   E LK L Y H
Sbjct: 61  NIVAYFGSYLRRD--KLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLH 118

Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGL-AEFYHPGKEYNVRVASRYFKGPELLVDLQ 295
             G +HRD+K  N+++  E   ++L D+G+ A+      +    + + Y+  PE+    +
Sbjct: 119 ETGKIHRDIKGANILLT-EDGDVKLADFGVSAQLTATIAKRKSFIGTPYWMAPEVAAVER 177

Query: 296 --DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWS 353
              YD   D+W+LG     +   + P F  H          +   LI    S+ +  P  
Sbjct: 178 KGGYDGKCDIWALGITAIELAELQPPMFDLH--------PMRALFLI----SKSNFPPPK 225

Query: 354 KFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPY 394
                 ++   SP   DF+ K L  D + R TA + + HP+
Sbjct: 226 ----LKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQHPF 262

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 82.5 bits (204), Expect = 9e-18
 Identities = 65/232 (28%), Positives = 110/232 (47%), Gaps = 35/232 (15%)

Query: 180 PNVVKLLD--IVRDQHSKTPSLIFEYVNS---TDFKVLYPTLTDYDIRYYIYELLKALDY 234
           PN+V++    +V D+      ++ E++     TD  V +  + +  I      +LKAL +
Sbjct: 76  PNIVEMYSSYLVGDELW----VVMEFLEGGALTDI-VTHTRMNEEQIATVCLAVLKALSF 130

Query: 235 CHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR---VASRYFKGPELL 291
            H+QG++HRD+K  ++++  + R ++L D+G        KE   R   V + Y+  PE++
Sbjct: 131 LHAQGVIHRDIKSDSILLTSDGR-VKLSDFGFCA--QVSKEVPRRKSLVGTPYWMAPEVI 187

Query: 292 VDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKP 351
             L  Y   +D+WSLG M   M+  + P+F     ++  ++  K          R +  P
Sbjct: 188 SRLP-YGTEVDIWSLGIMVIEMVDGEPPYF-----NEPPLQAMK--------RIRDNLPP 233

Query: 352 WSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAES 403
             K     N H VSP    FLD++L  D   R TA E + HP+ A+     S
Sbjct: 234 KLK-----NLHKVSPRLRSFLDRMLVRDPAQRATAAELLNHPFLAKAGPPSS 280

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 82.7 bits (204), Expect = 9e-18
 Identities = 60/200 (30%), Positives = 98/200 (49%), Gaps = 18/200 (9%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKK--KKIKREIKILQNLCGGPNV 182
           D +E++  +G+G Y +V++  N        +KIL P+    ++I+ E  ILQ+L   PNV
Sbjct: 22  DTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNV 81

Query: 183 VKLLDIV--RDQHSKTPS-LIFEYVNSTDFKVLYP-------TLTDYDIRYYIYELLKAL 232
           VK   +    D+       L+ E  N      L          L +  I Y +Y  L  L
Sbjct: 82  VKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGL 141

Query: 233 DYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGL-AEFYHPGKEYNVRVASRYFKGPELL 291
            + H+  I+HRDVK +N+++  E   ++L+D+G+ A+        N  V + ++  PE++
Sbjct: 142 QHLHNNRIIHRDVKGNNILLTTE-GGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVI 200

Query: 292 VDLQDYDYSL----DMWSLG 307
              Q YDYS     D+WSLG
Sbjct: 201 ACEQQYDYSYDARCDVWSLG 220

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 82.3 bits (204), Expect = 9e-18
 Identities = 68/283 (24%), Positives = 124/283 (43%), Gaps = 43/283 (15%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKK----IKREIKILQNLCGGP 180
           + + ++  +G+G + EV++ I+  TN+   IK++   + +     I++EI+ L   C  P
Sbjct: 1   ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQ-CRSP 59

Query: 181 NVVKLLDIVRDQHSKTPSL--IFEYV-NSTDFKVLYP-TLTDYDIRYYIYELLKALDYCH 236
            + K          K   L  I EY    +   +L P  L +  I + + E+L  L+Y H
Sbjct: 60  YITKYYGSF----LKGSKLWIIMEYCGGGSCLDLLKPGKLDETYIAFILREVLLGLEYLH 115

Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDLQ 295
            +G +HRD+K  N+++  E   ++L D+G++ +      + N  V + ++  PE++    
Sbjct: 116 EEGKIHRDIKAANILLSEE-GDVKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEVIKQ-S 173

Query: 296 DYDYSLDMWSLGC----MFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKP 351
            YD   D+WSLG     +  G     EP          L  I K+    +          
Sbjct: 174 GYDEKADIWSLGITAIELAKG-----EPPLSDLHPMRVLFLIPKNNPPSL---------E 219

Query: 352 WSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPY 394
            +KF         S    DF+   L  D ++R +A+E + H +
Sbjct: 220 GNKF---------SKPFKDFVSLCLNKDPKERPSAKELLKHKF 253

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 80.8 bits (199), Expect = 3e-17
 Identities = 55/210 (26%), Positives = 106/210 (50%), Gaps = 19/210 (9%)

Query: 126 DYEVVRKVGRGKYSEVFEGINVNTNERC------IIKILKPVKKKKIKREIKILQNLCGG 179
           ++++ +K+GRG++SEV+    +   +        I +++    ++   +EI +L+ L   
Sbjct: 3   NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQL-NH 61

Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNSTD-------FKVLYPTLTDYDIRYYIYELLKAL 232
           PNV+K LD   + +    +++ E  ++ D       FK     + +  +  Y  +L  A+
Sbjct: 62  PNVIKYLDSFIEDNEL--NIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAV 119

Query: 233 DYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP-GKEYNVRVASRYFKGPELL 291
           ++ HS+ +MHRD+KP NV I      ++L D GL  F+       +  V + Y+  PE +
Sbjct: 120 EHMHSRRVMHRDIKPANVFITAT-GVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERI 178

Query: 292 VDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 321
            +   Y++  D+WSLGC+   M   + PF+
Sbjct: 179 HE-NGYNFKSDIWSLGCLLYEMAALQSPFY 207

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 80.3 bits (198), Expect = 5e-17
 Identities = 73/282 (25%), Positives = 122/282 (43%), Gaps = 41/282 (14%)

Query: 133 VGRGKYSEVFEGINVNTNERCIIKILKPVKKKK---------IKREIKILQNLCGGPNVV 183
           +G G +S  ++  +V T     +K +  V+            +++EI+++  L   P+++
Sbjct: 8   LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARL-NHPHII 66

Query: 184 KLLDIVRDQHSKTPSLIFEYVNSTDFKVL---YPTLTDYDIRYYIYELLKALDYCHSQGI 240
           ++L           +L  E++       L   Y    +  I  Y  +LL+ L Y H   I
Sbjct: 67  RMLGAT--CEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQI 124

Query: 241 MHRDVKPHNVMIDHELRKLRLIDWGLA-----EFYHPGKEYNVRVASRYFKGPELLVDLQ 295
           +HRDVK  N++ID   ++LR+ D+G A     +    G+     + +  F  PE+L   +
Sbjct: 125 IHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRG-E 183

Query: 296 DYDYSLDMWSLGCMFAGMIFRKEPF-FYGHDNHDQLV-KIAKDCCLIIWCNSRHSRKPWS 353
            Y  S D+WS+GC+   M   K P+    H NH  L+ KIA          +     P  
Sbjct: 184 QYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIA--------SATTAPSIP-- 233

Query: 354 KFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF 395
                  +HL SP   D   + L    +DR  +RE + HP F
Sbjct: 234 -------EHL-SPGLRDVTLRCLELQPEDRPPSRELLKHPVF 267

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 80.5 bits (198), Expect = 6e-17
 Identities = 79/294 (26%), Positives = 135/294 (45%), Gaps = 34/294 (11%)

Query: 119 VQWGD-QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIK---ILKPVKKKKIKREIKILQ 174
           V  GD +  Y    K+G+G    VF  I+V T +   IK   + K  KK+ I  EI +++
Sbjct: 12  VSIGDPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMK 71

Query: 175 NLCGGPNVVKLLD--IVRDQHSKTPSLIFEYVNSTDFK--VLYPTLTDYDIRYYIYELLK 230
            L   PN+V  LD  +V D+      ++ EY+        V    + +  I     E L+
Sbjct: 72  EL-KNPNIVNFLDSFLVGDELF----VVMEYLAGGSLTDVVTETCMDEAQIAAVCRECLQ 126

Query: 231 ALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK-EYNVRVASRYFKGPE 289
           AL++ H+  ++HRD+K  NV++  +   ++L D+G      P + + +  V + Y+  PE
Sbjct: 127 ALEFLHANQVIHRDIKSDNVLLGMD-GSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPE 185

Query: 290 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSR 349
           + V  + Y   +D+WSLG M   M+  + P+     N + L  +      +I  N     
Sbjct: 186 V-VTRKAYGPKVDIWSLGIMAIEMVEGEPPYL----NENPLRAL-----YLIATNGTPEL 235

Query: 350 KPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAES 403
           +         N   +SP   DFL++ L  D + R +A+E + HP+    +   S
Sbjct: 236 Q---------NPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQHPFLKLAKPLSS 280

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 80.0 bits (198), Expect = 6e-17
 Identities = 62/229 (27%), Positives = 104/229 (45%), Gaps = 23/229 (10%)

Query: 126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIK-----ILKPVKKKKIKREIKILQNLCGGP 180
           DYEV+  +G+G +  V +    +  +  + K      +   +K+++  E+ IL+ L   P
Sbjct: 1   DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILREL-KHP 59

Query: 181 NVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL---YPTLTDYDIRYYIY----ELLKALD 233
           N+V+  D + D+ ++T  ++ EY    D   L         Y    +I+    +LL AL 
Sbjct: 60  NIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALY 119

Query: 234 YCH-----SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY-NVRVASRYFKG 287
            CH        ++HRD+KP N+ +D     ++L D+GLA+       +    V + Y+  
Sbjct: 120 ECHNRSDPGNTVLHRDLKPANIFLD-ANNNVKLGDFGLAKILGHDSSFAKTYVGTPYYMS 178

Query: 288 PELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKD 336
           PE L     YD   D+WSLGC+   +     P F    N  QL    K+
Sbjct: 179 PEQLNH-MSYDEKSDIWSLGCLIYELCALSPP-FTAR-NQLQLASKIKE 224

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 79.7 bits (197), Expect = 6e-17
 Identities = 54/214 (25%), Positives = 93/214 (43%), Gaps = 51/214 (23%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK----PVKKKKIKREIKILQNLCGGP 180
           DDYE++  +G G  + V+  I +  NE+  IK +          ++++E++ + + C  P
Sbjct: 1   DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAM-SQCNHP 59

Query: 181 NVVK----------------------LLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTD 218
           NVVK                      LLDI++   S  P    +                
Sbjct: 60  NVVKYYTSFVVGDELWLVMPYLSGGSLLDIMK---SSYPRGGLDEAI------------- 103

Query: 219 YDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGL-AEFYHPG---- 273
             I   + E+LK L+Y HS G +HRD+K  N+++  E   +++ D+G+ A     G    
Sbjct: 104 --IATVLKEVLKGLEYLHSNGQIHRDIKAGNILLG-EDGSVKIADFGVSASLADGGDRTR 160

Query: 274 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLG 307
           K     V +  +  PE++  +  YD+  D+WS G
Sbjct: 161 KVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFG 194

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 79.9 bits (197), Expect = 8e-17
 Identities = 80/297 (26%), Positives = 136/297 (45%), Gaps = 40/297 (13%)

Query: 119 VQWGDQD-DYEVVRKVGRGKYSEVFEGINVNTNERCIIK---ILKPVKKKKIKREIKILQ 174
           V  GD    Y    K+G+G    V+  I+V T +   IK   + +  KK+ I  EI +++
Sbjct: 12  VSVGDPKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMR 71

Query: 175 NLCGGPNVVKLLD--IVRDQHSKTPSLIFEYV---NSTDFKVLYPTLTDYDIRYYIYELL 229
                PN+V  LD  +V D+      ++ EY+   + TD  V    + +  I     E L
Sbjct: 72  EN-KHPNIVNYLDSYLVGDELW----VVMEYLAGGSLTDV-VTETCMDEGQIAAVCRECL 125

Query: 230 KALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR---VASRYFK 286
           +AL++ HS  ++HRD+K  N+++  +   ++L D+G      P  E + R   V + Y+ 
Sbjct: 126 QALEFLHSNQVIHRDIKSDNILLGMD-GSVKLTDFGFCAQITP--EQSKRSTMVGTPYWM 182

Query: 287 GPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSR 346
            PE +V  + Y   +D+WSLG M   M+  + P+     N + L  +      +I  N  
Sbjct: 183 APE-VVTRKAYGPKVDIWSLGIMAIEMVEGEPPYL----NENPLRAL-----YLIATNG- 231

Query: 347 HSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAES 403
               P  +  N +     S    DFL++ L  D + R +A+E + HP+    +   S
Sbjct: 232 ---TP--ELQNPEKL---SAIFRDFLNRCLEMDVEKRGSAKELLQHPFLKIAKPLSS 280

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 78.1 bits (192), Expect = 3e-16
 Identities = 56/200 (28%), Positives = 96/200 (48%), Gaps = 18/200 (9%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK--KKKIKREIKILQNLCGGPNV 182
           D +E++  +G+G Y +VF+ +N     +  +KIL P+    ++I+ E  IL+ L   PNV
Sbjct: 18  DTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNV 77

Query: 183 VKLLDIVRDQHSKTPS---LIFEYVNSTDFKVLYP-------TLTDYDIRYYIYELLKAL 232
           VK   +   +  K      L+ E  N      L          + +  I Y ++E L  L
Sbjct: 78  VKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGL 137

Query: 233 DYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGL-AEFYHPGKEYNVRVASRYFKGPELL 291
            + H    +HRDVK +N+++  E   ++L+D+G+ A+        N  V + ++  PE++
Sbjct: 138 QHLHVNKTIHRDVKGNNILLTTE-GGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVI 196

Query: 292 VDLQD----YDYSLDMWSLG 307
              Q     YD   D+WSLG
Sbjct: 197 ACEQQLDSTYDARCDVWSLG 216

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 78.6 bits (193), Expect = 4e-16
 Identities = 74/281 (26%), Positives = 130/281 (46%), Gaps = 37/281 (13%)

Query: 130 VRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKK------IKREIKILQNLCGGPNVV 183
           +R++G G +  V+   +V TNE   IK +    K+       I +E+K LQ +   PN +
Sbjct: 30  LREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRI-KHPNSI 88

Query: 184 KLLDIVRDQHSKTPSLIFEYV--NSTDF-KVLYPTLTDYDIRYYIYELLKALDYCHSQGI 240
           +       +H  T  L+ EY   +++D  +V    L + +I    +  L+ L Y HS  +
Sbjct: 89  EYKGCYLREH--TAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNM 146

Query: 241 MHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD--YD 298
           +HRD+K  N+++  E  +++L D+G A    P   +   V + Y+  PE+++ + +  YD
Sbjct: 147 IHRDIKAGNILLT-EPGQVKLADFGSASIASPANSF---VGTPYWMAPEVILAMDEGQYD 202

Query: 299 YSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSKFINA 358
             +D+WSLG     +  RK P F   +    L  IA++    +  N       WS +   
Sbjct: 203 GKVDVWSLGITCIELAERKPPLF-NMNAMSALYHIAQNESPTLQSNE------WSDYFR- 254

Query: 359 DNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVR 399
                      +F+D  L+   QDR T+ E + H +  + R
Sbjct: 255 -----------NFVDSCLQKIPQDRPTSEELLKHMFVLRER 284

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 78.7 bits (194), Expect = 4e-16
 Identities = 74/293 (25%), Positives = 123/293 (41%), Gaps = 43/293 (14%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP--------VKKKKIKREIKILQNL 176
            D++V   VGRG + EV       T +   +K++K         V   + +R+I  + N 
Sbjct: 1   KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISN- 59

Query: 177 CGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL---YPTLTDYD-IRYYIYELLKAL 232
              P + +L    +D+ +    L+ EY    D   L   Y    D D  ++Y+ EL+ A+
Sbjct: 60  --SPWIPQLQYAFQDKDNLY--LVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAI 115

Query: 233 DYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR--VASRYFKGPEL 290
              H  G +HRD+KP NV+ID     ++L D+G A      K  N +  V +  +  PE+
Sbjct: 116 HSVHQMGYVHRDIKPENVLID-RTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEV 174

Query: 291 LVDLQD-----YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNS 345
           L  +       Y    D WSLG +   MI+ + PF  G  +      I            
Sbjct: 175 LTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEG-TSAKTYNNIMN---------- 223

Query: 346 RHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQV 398
                 + +F+       VS + +D +  LL    ++RL       HP+F+++
Sbjct: 224 ------FQRFLKFPEDPKVSSDFLDLIQSLL-CGQKERLGYEGLCCHPFFSKI 269

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 77.8 bits (191), Expect = 5e-16
 Identities = 56/188 (29%), Positives = 93/188 (49%), Gaps = 21/188 (11%)

Query: 216 LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGL-AEFYHPGK 274
           L +  I      +L+AL Y HSQG++HRD+K  ++++  + R ++L D+G  A+      
Sbjct: 114 LNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGR-VKLSDFGFCAQISKDVP 172

Query: 275 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA 334
           +    V + Y+  PE+ +    Y   +D+WSLG M   M+  + P+F   D+  Q +K  
Sbjct: 173 KRKSLVGTPYWMAPEV-ISRTPYGTEVDIWSLGIMVIEMVDGEPPYF--SDSPVQAMKRL 229

Query: 335 KDCCLIIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPY 394
           +D           S  P        N H +SP   DFL+++L  + Q+R TA+E + HP+
Sbjct: 230 RD-----------SPPP-----KLKNAHKISPVLRDFLERMLTREPQERATAQELLDHPF 273

Query: 395 FAQVRAAE 402
             Q    E
Sbjct: 274 LLQTGLPE 281

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 77.4 bits (191), Expect = 5e-16
 Identities = 48/207 (23%), Positives = 92/207 (44%), Gaps = 19/207 (9%)

Query: 130 VRKVGRGKYSEV----FEGINVNTNERCIIKILK----PVKKKKIKREIKILQNLCGGPN 181
           ++++G G + +V    ++ +  NT E+  +K L        +   +REI+IL+ L    N
Sbjct: 9   IKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTL-DHEN 67

Query: 182 VVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIR----YYIYELLKALDYCHS 237
           +VK   +      ++  LI EY+ S   +       D         +  ++ K +DY  S
Sbjct: 68  IVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGS 127

Query: 238 QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY----NVRVASRYFKGPELLVD 293
           Q  +HRD+   N++++ E   +++ D+GLA+     K+Y        +  ++  PE L  
Sbjct: 128 QRYIHRDLAARNILVESE-DLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRT 186

Query: 294 LQDYDYSLDMWSLGCMFAGMIFRKEPF 320
            +    S D+WS G     +    +P 
Sbjct: 187 SKFSSAS-DVWSFGVTLYELFTYGDPS 212

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 77.1 bits (190), Expect = 7e-16
 Identities = 71/289 (24%), Positives = 133/289 (46%), Gaps = 40/289 (13%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKR---EIKILQNLCGGPN 181
           D +E++ ++G G + +V++  +  T      KI++   +++++    EI IL   C  PN
Sbjct: 5   DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSE-CKHPN 63

Query: 182 VVKLLDIVRDQHSKTPSLIFEY-----VNSTDFKVLYPTLTDYDIRYYIYELLKALDYCH 236
           +V L +     +     ++ E+     ++S   ++    LT+  IRY   ++L+AL++ H
Sbjct: 64  IVGLYEAY--FYENKLWILIEFCDGGALDSIMLELERG-LTEPQIRYVCRQMLEALNFLH 120

Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGL-AEFYHPGKEYNVRVASRYFKGPELLV--- 292
           S  ++HRD+K  N+++  +   ++L D+G+ A+     ++ +  + + Y+  PE++    
Sbjct: 121 SHKVIHRDLKAGNILLTLD-GDVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVACET 179

Query: 293 -DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQ--LVKIAKDCCLIIWCNSRHSR 349
                YDY  D+WSLG     +   + P    H+ +    L+KI K            S 
Sbjct: 180 FKDNPYDYKADIWSLGITLIELAQMEPP---HHELNPMRVLLKILK------------SE 224

Query: 350 KPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQV 398
            P       D     S    DFL   L  D  DR TA E + HP+ +  
Sbjct: 225 PP-----TLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPFVSDQ 268

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 77.4 bits (190), Expect = 7e-16
 Identities = 76/305 (24%), Positives = 142/305 (46%), Gaps = 36/305 (11%)

Query: 114 YESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKR---EI 170
           YE +       + +E++ ++G G + +V++  N  T      K+++   +++++    EI
Sbjct: 1   YEHVRRDLDPNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEI 60

Query: 171 KILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEY-----VNSTDFKVLYPTLTDYDIRYYI 225
           +IL   C  P +VKLL            ++ E+     V++   + L   LT+  I+   
Sbjct: 61  EILAT-CNHPYIVKLLGAF--YWDGKLWIMIEFCPGGAVDAIMLE-LDRGLTEPQIQVIC 116

Query: 226 YELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGL-AEFYHPGKEYNVRVASRY 284
            ++L+AL Y HS  I+HRD+K  NV++  +   ++L D+G+ A+     +  +  + + Y
Sbjct: 117 RQMLEALQYLHSMKIIHRDLKAGNVLLTLD-GDIKLADFGVSAKNVKTLQRRDSFIGTPY 175

Query: 285 FKGPELLV--DLQD--YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLI 340
           +  PE+++   ++D  YDY  D+WSLG     M  + EP  +  +    L+KIAK     
Sbjct: 176 WMAPEVVMCETMKDTPYDYKADIWSLGITLIEMA-QIEPPHHELNPMRVLLKIAKSEPPT 234

Query: 341 IWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRA 400
           +   S+     W            S E  DFL   L    + R +A + + HP+ + V +
Sbjct: 235 LSQPSK-----W------------SMEFRDFLKTALDKHPETRPSAAQLLEHPFVSSVTS 277

Query: 401 AESSR 405
               R
Sbjct: 278 NRPLR 282

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 76.6 bits (188), Expect = 7e-16
 Identities = 60/226 (26%), Positives = 109/226 (48%), Gaps = 19/226 (8%)

Query: 126 DYEVVRKVGRGKYSEVF------EGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGG 179
           ++ + +K+GRG++SEV+      +G+ V   +  I  ++    +    +EI +L+ L   
Sbjct: 3   NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQL-NH 61

Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNSTD-------FKVLYPTLTDYDIRYYIYELLKAL 232
           PNV+K      + +    +++ E  ++ D       FK     + +  +  Y  +L  AL
Sbjct: 62  PNVIKYYASFIEDNEL--NIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSAL 119

Query: 233 DYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG-KEYNVRVASRYFKGPELL 291
           ++ HS+ +MHRD+KP NV I      ++L D GL  F+       +  V + Y+  PE +
Sbjct: 120 EHMHSRRVMHRDIKPANVFIT-ATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERI 178

Query: 292 VDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDC 337
            +   Y++  D+WSLGC+   M   + PF+    N   L K  + C
Sbjct: 179 HE-NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQC 223

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 77.0 bits (189), Expect = 1e-15
 Identities = 71/281 (25%), Positives = 127/281 (45%), Gaps = 37/281 (13%)

Query: 130 VRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKK------IKREIKILQNLCGGPNVV 183
           +R++G G +  V+   +V  +E   IK +    K+       I +E++ LQ L   PN +
Sbjct: 20  LREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKL-RHPNTI 78

Query: 184 KLLDIVRDQHSKTPSLIFEYV--NSTDF-KVLYPTLTDYDIRYYIYELLKALDYCHSQGI 240
           +       +H  T  L+ EY   +++D  +V    L + +I    +  L+ L Y HS  +
Sbjct: 79  QYRGCYLREH--TAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNM 136

Query: 241 MHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD--YD 298
           +HRDVK  N+++  E   ++L D+G A    P   +   V + Y+  PE+++ + +  YD
Sbjct: 137 IHRDVKAGNILLS-EPGLVKLGDFGSASIMAPANXF---VGTPYWMAPEVILAMDEGQYD 192

Query: 299 YSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSKFINA 358
             +D+WSLG     +  RK P F   +    L  IA++    +          WS++   
Sbjct: 193 GKVDVWSLGITCIELAERKPPLF-NMNAMSALYHIAQNESPALQSGH------WSEYFR- 244

Query: 359 DNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVR 399
                      +F+D  L+   QDR T+   + H +  + R
Sbjct: 245 -----------NFVDSCLQKIPQDRPTSEVLLKHRFVLRER 274

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 78.6 bits (193), Expect = 1e-15
 Identities = 65/260 (25%), Positives = 125/260 (48%), Gaps = 44/260 (16%)

Query: 108 PKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKI-----LKPVK 162
           P +Y D ES        ++YEV++K+G G++ EVF   +  T E    K      LK  +
Sbjct: 2   PGKYDDGESRL------NEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKERE 55

Query: 163 KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFK-------VLYPT 215
           K ++  E+ +++ L    N+V+ +D   ++ ++   ++ E+ ++ D          ++  
Sbjct: 56  KSQLVIEVNVMREL-KHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGK 114

Query: 216 LTDYDIRYYIYELLKALDYCHS-------QGIMHRDVKPHNVMIDHELRKL--------- 259
           + ++ I     +LL AL YCH+       + ++HRD+KP N+ +   +R +         
Sbjct: 115 IEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANN 174

Query: 260 -------RLIDWGLAEFYHPGKEYNVRVASRYFKGPELLV-DLQDYDYSLDMWSLGCMFA 311
                  ++ D+GL++        +  V + Y+  PELL+ + + YD   DMW+LGC+  
Sbjct: 175 LNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIY 234

Query: 312 GMIFRKEPFFYGHDNHDQLV 331
            +   K P F+  +N  QL+
Sbjct: 235 ELCSGKTP-FHKANNFSQLI 253

Length = 1021

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 76.0 bits (187), Expect = 2e-15
 Identities = 79/292 (27%), Positives = 135/292 (46%), Gaps = 45/292 (15%)

Query: 126 DYEVVRKVGRGKYSEVF---EGINVNTNERCIIKILKP---VKKKKI----KREIKILQN 175
           ++E++R +G G Y +VF   +    +  +   +K+LK    V+K K     + E ++L+ 
Sbjct: 1   NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEA 60

Query: 176 LCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTD-FKVLYPT--LTDYDIRYYIYELLKAL 232
           +   P +V L      Q      LI +YVN  + F  LY     T+ ++R YI E++ AL
Sbjct: 61  VRRCPFLVTLHYAF--QTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLAL 118

Query: 233 DYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY--NVRVASRYFKGPEL 290
           D+ H  GI++RD+K  N+++D E   + L D+GL++ +   +E        +  +  PE+
Sbjct: 119 DHLHQLGIIYRDIKLENILLDSE-GHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEV 177

Query: 291 LVDLQD-YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSR 349
           +      +D ++D WSLG +   ++    PF               D         ++S+
Sbjct: 178 IRGGSGGHDKAVDWWSLGVLTFELLTGASPF-------------TVD-------GEQNSQ 217

Query: 350 KPWSKFINADN---QHLVSPEAIDFLDKLLRYDHQDRL---TAREAMAHPYF 395
              S+ I          +S EA DF+ KLL  D + RL    A E   HP+F
Sbjct: 218 SEISRRILKSKPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFF 269

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 75.1 bits (184), Expect = 3e-15
 Identities = 57/173 (32%), Positives = 89/173 (51%), Gaps = 25/173 (14%)

Query: 228 LLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR---VASRY 284
           +LKAL   H+QG++HRD+K  ++++ H+ R ++L D+G        KE   R   V + Y
Sbjct: 125 VLKALSVLHAQGVIHRDIKSDSILLTHDGR-VKLSDFGFCA--QVSKEVPRRKSLVGTPY 181

Query: 285 FKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCN 344
           +  PEL+  L  Y   +D+WSLG M   M+  + P+F  ++   + +K+ +D        
Sbjct: 182 WMAPELISRLP-YGPEVDIWSLGIMVIEMVDGEPPYF--NEPPLKAMKMIRD-------- 230

Query: 345 SRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQ 397
              +  P  K     N H VSP    FLD+LL  D   R TA E + HP+ A+
Sbjct: 231 ---NLPPKLK-----NLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAK 275

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 75.2 bits (185), Expect = 4e-15
 Identities = 75/287 (26%), Positives = 123/287 (42%), Gaps = 43/287 (14%)

Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKK------IKREIKILQNLCGGP 180
           +  +R++G G +  V+   +V TNE   IK +    K+       I +E++ LQ     P
Sbjct: 17  FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQ-LRHP 75

Query: 181 NVVKLLDIVRDQHSKTPSLIFEYV--NSTD-FKVLYPTLTDYDIRYYIYELLKALDYCHS 237
           N ++       +H  T  L+ EY   +++D  +V    L + +I    +  L+ L Y HS
Sbjct: 76  NTIEYKGCYLREH--TAWLVMEYCLGSASDILEVHKKPLQEVEIAAICHGALQGLAYLHS 133

Query: 238 QGIMHRDVKPHNVMI-DHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE--LLVDL 294
              +HRD+K  N+++ +    KL   D+G A    P    N  V + Y+  PE  L +D 
Sbjct: 134 HERIHRDIKAGNILLTEPGTVKLA--DFGSASLVSPA---NSFVGTPYWMAPEVILAMDE 188

Query: 295 QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKP--W 352
             YD  +D+WSLG     +  RK P F   +    L  IA+        N   +     W
Sbjct: 189 GQYDGKVDVWSLGITCIELAERKPPLF-NMNAMSALYHIAQ--------NDSPTLSSNDW 239

Query: 353 SKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVR 399
           S                +F+D  L+   QDR ++ E + H +  + R
Sbjct: 240 SD------------YFRNFVDSCLQKIPQDRPSSEELLKHRFVLRER 274

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score = 73.3 bits (181), Expect = 1e-14
 Identities = 47/205 (22%), Positives = 88/205 (42%), Gaps = 37/205 (18%)

Query: 131 RKVGRGKYSEVFEGI---NVNTNERCIIKILK----PVKKKKIKREIKILQNLCGGPNVV 183
           +K+G G + EV++G             +K LK      ++K   +E ++++ L G PNVV
Sbjct: 1   KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKL-GHPNVV 59

Query: 184 KLLDIVRDQHSKTPSLIFEYVNSTDFK------------VLYPTLTDYDIRYYIYELLKA 231
           +LL +  ++      L+ EY+   D                  TL+  D+  +  ++ K 
Sbjct: 60  RLLGVCTEEEP--LYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKG 117

Query: 232 LDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG---- 287
           ++Y  S+  +HRD+   N ++  +L  +++ D+GL+   +    Y  +       G    
Sbjct: 118 MEYLASKKFVHRDLAARNCLVGEDLV-VKISDFGLSRDVYDDDYYRKKT-----GGKLPI 171

Query: 288 ----PELLVDLQDYDYSLDMWSLGC 308
               PE L D   +    D+WS G 
Sbjct: 172 RWMAPESLKD-GIFTSKSDVWSFGV 195

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 74.3 bits (182), Expect = 1e-14
 Identities = 59/211 (27%), Positives = 103/211 (48%), Gaps = 20/211 (9%)

Query: 131 RKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKI---------KREIKILQNLCGGPN 181
           R +GRG Y++V   + +  N++  I  +K VKK+ +         + E  + +     P 
Sbjct: 1   RVIGRGSYAKVLL-VRLKKNDQ--IYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPF 57

Query: 182 VVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYP---TLTDYDIRYYIYELLKALDYCHSQ 238
           +V L      Q +    L+ EYVN  D          L +   R+Y  E+  AL++ H +
Sbjct: 58  LVGLHSCF--QTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHER 115

Query: 239 GIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDLQDY 297
           GI++RD+K  NV++D +   ++L D+G+  E   PG   +    +  +  PE+L   ++Y
Sbjct: 116 GIIYRDLKLDNVLLDAD-GHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRG-EEY 173

Query: 298 DYSLDMWSLGCMFAGMIFRKEPFFYGHDNHD 328
            +S+D W+LG +   M+  + PF    DN D
Sbjct: 174 GFSVDWWALGVLMFEMMAGRSPFDIITDNPD 204

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 73.4 bits (180), Expect = 1e-14
 Identities = 71/287 (24%), Positives = 121/287 (42%), Gaps = 48/287 (16%)

Query: 133 VGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQ 192
           +GRG + EV+     +T +   +K L        K+ IK+ Q      N   +L +V   
Sbjct: 2   IGRGGFGEVYGCRKADTGKMYAMKCLD-------KKRIKMKQGETLALNERIMLSLVSTG 54

Query: 193 HS----------KTP---SLIFEYVNSTDFKV---LYPTLTDYDIRYYIYELLKALDYCH 236
                        TP   S I + +N  D       +   ++ ++R+Y  E++  L++ H
Sbjct: 55  DCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMH 114

Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD 296
           ++ +++RD+KP N+++D E   +R+ D GLA  +   K +   V +  +  PE+L     
Sbjct: 115 NRFVVYRDLKPANILLD-EHGHVRISDLGLACDFSKKKPH-ASVGTHGYMAPEVLQKGVA 172

Query: 297 YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSKFI 356
           YD S D +SLGCM   ++    P F  H   D                 +H     +  +
Sbjct: 173 YDSSADWFSLGCMLFKLLRGHSP-FRQHKTKD-----------------KHEIDRMTLTM 214

Query: 357 NADNQHLVSPEAIDFLDKLLRYDHQDRL-----TAREAMAHPYFAQV 398
             +     SPE    L+ LL+ D   RL      A+E   HP+F  +
Sbjct: 215 AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRSL 261

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 73.2 bits (179), Expect = 1e-14
 Identities = 61/198 (30%), Positives = 104/198 (52%), Gaps = 15/198 (7%)

Query: 130 VRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKK----IKREIKILQNLCGGPNVVKL 185
           + K+G+G + EVF+GI+  T +   IKI+   + +     I++EI +L   C  P V K 
Sbjct: 9   LEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQ-CDSPYVTKY 67

Query: 186 L-DIVRDQHSKTPSLIFEYVNS-TDFKVLYP-TLTDYDIRYYIYELLKALDYCHSQGIMH 242
               ++D       +I EY+   +   +L P  L +  I   + E+LK LDY HS+  +H
Sbjct: 68  YGSYLKDTKL---WIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKKIH 124

Query: 243 RDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSL 301
           RD+K  NV++  E  +++L D+G+A +      + N  V + ++  PE ++    YD   
Sbjct: 125 RDIKAANVLLS-EHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPE-VIKQSAYDSKA 182

Query: 302 DMWSLGCMFAGMIFRKEP 319
           D+WSLG + A  + + EP
Sbjct: 183 DIWSLG-ITAIELAKGEP 199

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 73.1 bits (179), Expect = 1e-14
 Identities = 78/299 (26%), Positives = 136/299 (45%), Gaps = 45/299 (15%)

Query: 106 LRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKK 165
           L P+E+W               E++ ++G G + +V++  N  T      K++    +++
Sbjct: 1   LNPEEFW---------------EIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEE 45

Query: 166 IKR---EIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY--PTLTDYD 220
           ++    EI IL + C  PN+VKLLD    +++    + F    + D  +L     LT+  
Sbjct: 46  LEDYMVEIDILAS-CDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQ 104

Query: 221 IRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGL-AEFYHPGKEYNVR 279
           IR    + L+AL+Y H   I+HRD+K  N++   +   ++L D+G+ A+     +  +  
Sbjct: 105 IRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLD-GDIKLADFGVSAKNTRTIQRRDSF 163

Query: 280 VASRYFKGPELLV----DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK 335
           + + Y+  PE+++      + YDY  D+WSLG     M  + EP  +  +    L+KIAK
Sbjct: 164 IGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMA-QIEPPHHELNPMRVLLKIAK 222

Query: 336 DCCLIIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPY 394
                +   SR     W            S E  DFL K L  +   R T  + + HP+
Sbjct: 223 SEPPTLAQPSR-----W------------SSEFKDFLKKCLEKNVDARWTTTQLLQHPF 264

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 73.6 bits (180), Expect = 1e-14
 Identities = 78/299 (26%), Positives = 132/299 (44%), Gaps = 44/299 (14%)

Query: 119 VQWGD-QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIK---ILKPVKKKKIKREIKILQ 174
           V  GD +  Y    K+G+G    V+  I++ T +   IK   + +  KK+ I  EI +++
Sbjct: 12  VSVGDPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMR 71

Query: 175 NLCGGPNVVKLLD--IVRDQHSKTPSLIFEYVNSTDFK-VLYPTLTDY-DIRYYIYELLK 230
                PN+V  LD  +V D+      ++ EY+       V+  T  D   I     E L+
Sbjct: 72  E-NKNPNIVNYLDSYLVGDELW----VVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQ 126

Query: 231 ALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK-EYNVRVASRYFKGPE 289
           ALD+ HS  ++HRD+K  N+++  +   ++L D+G      P + + +  V + Y+  PE
Sbjct: 127 ALDFLHSNQVIHRDIKSDNILLGMD-GSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPE 185

Query: 290 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSR 349
           + V  + Y   +D+WSLG M   M+   EP +   +    L  IA +             
Sbjct: 186 V-VTRKAYGPKVDIWSLGIMAIEMV-EGEPPYLNENPLRALYLIATN------------- 230

Query: 350 KPWSKFINADNQHLVSPEAI-----DFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAES 403
                        L +PE +     DFL++ L  D   R +A+E + HP+    +   S
Sbjct: 231 ---------GTPELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQHPFLKLAKPLSS 280

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 72.8 bits (178), Expect = 2e-14
 Identities = 69/284 (24%), Positives = 124/284 (43%), Gaps = 36/284 (12%)

Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV--KKKKIKREIKILQNLCGGPNVVK 184
           +E+V  VG G Y +V++G +V T +   IK++     ++++IK+EI +L+      N+  
Sbjct: 8   FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIAT 67

Query: 185 LLDIVRDQHSKTPS----LIFEYVNSTDFKVLYP-----TLTDYDIRYYIYELLKALDYC 235
                  ++         L+ E+  +     L       TL +  I Y   E+L+ L + 
Sbjct: 68  YYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHL 127

Query: 236 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGL-AEFYHPGKEYNVRVASRYFKGPELLVDL 294
           H   ++HRD+K  NV++  E  +++L+D+G+ A+        N  + + Y+  PE++   
Sbjct: 128 HQHKVIHRDIKGQNVLLT-ENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACD 186

Query: 295 QD----YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRK 350
           ++    YD+  D+WSLG     M     P    H     L  I ++         R   K
Sbjct: 187 ENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMR-ALFLIPRNPA------PRLKSK 239

Query: 351 PWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPY 394
            WSK   +            F++  L  +H  R T  + M HP+
Sbjct: 240 KWSKKFQS------------FIESCLVKNHSQRPTTEQLMKHPF 271

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 73.6 bits (180), Expect = 2e-14
 Identities = 67/219 (30%), Positives = 106/219 (48%), Gaps = 32/219 (14%)

Query: 131 RKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKI---------KREIKILQNLCGGPN 181
           R +GRG Y++V   + +   ER  I  +K VKK+ +         + E  + +     P 
Sbjct: 1   RVIGRGSYAKVLL-VRLKKTER--IYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPF 57

Query: 182 VVKLLDIVRDQHS--KTPSLIF---EYVNSTDFKVLYP---TLTDYDIRYYIYELLKALD 233
           +V L       HS  +T S +F   EYVN  D          L +   R+Y  E+  AL+
Sbjct: 58  LVGL-------HSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALN 110

Query: 234 YCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLV 292
           Y H +GI++RD+K  NV++D E   ++L D+G+  E   PG   +    +  +  PE+L 
Sbjct: 111 YLHERGIIYRDLKLDNVLLDSE-GHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILR 169

Query: 293 DLQDYDYSLDMWSLGCMFAGMIFRKEPF--FYGHDNHDQ 329
             +DY +S+D W+LG +   M+  + PF      DN DQ
Sbjct: 170 G-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQ 207

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 73.1 bits (179), Expect = 2e-14
 Identities = 80/290 (27%), Positives = 141/290 (48%), Gaps = 40/290 (13%)

Query: 126 DYEVVRKVGRGKYSEVFEGINV---NTNERCIIKILKP---VKKKKI----KREIKILQN 175
           ++E+++ +G G Y +VF    V   +T +   +K+L+    V+K K     + E  +L++
Sbjct: 1   NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60

Query: 176 LCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTD-FKVLYP--TLTDYDIRYYIYELLKAL 232
           +   P +V L      Q      LI +YV+  + F  LY     ++ ++R+Y  E++ AL
Sbjct: 61  VRQSPFLVTLHYAF--QTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILAL 118

Query: 233 DYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEYNVR-VASRYFKGPEL 290
           ++ H  GI++RD+K  N+++D E   + L D+GL+ EF    KE       +  +  PE+
Sbjct: 119 EHLHKLGIVYRDIKLENILLDSE-GHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEI 177

Query: 291 LVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRK 350
           +     +  ++D WSLG +   ++    PF    + + Q  ++++    I+ C+      
Sbjct: 178 IRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQ-SEVSRR---ILKCDP----- 228

Query: 351 PWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRL-----TAREAMAHPYF 395
           P+  FI         PEA D L KLLR D + RL      A E   HP+F
Sbjct: 229 PFPSFI--------GPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFF 270

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 72.8 bits (178), Expect = 3e-14
 Identities = 57/203 (28%), Positives = 101/203 (49%), Gaps = 18/203 (8%)

Query: 130 VRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKK------KIKREIKILQNLCGGPNVV 183
           + ++G G +  V+   N +TNE   +K +    K+       I +E+K LQ L   PN +
Sbjct: 26  LHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQL-KHPNTI 84

Query: 184 KLLDIVRDQHSKTPSLIFEYV--NSTD-FKVLYPTLTDYDIRYYIYELLKALDYCHSQGI 240
           +       +H  T  L+ EY   +++D  +V    L + +I    +  L+ L Y HS  +
Sbjct: 85  EYKGCYLKEH--TAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNM 142

Query: 241 MHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD--YD 298
           +HRD+K  N+++  E  +++L D+G A    P   +   V + Y+  PE+++ + +  YD
Sbjct: 143 IHRDIKAGNILLT-EPGQVKLADFGSASKSSPANSF---VGTPYWMAPEVILAMDEGQYD 198

Query: 299 YSLDMWSLGCMFAGMIFRKEPFF 321
             +D+WSLG     +  RK P F
Sbjct: 199 GKVDVWSLGITCIELAERKPPLF 221

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 72.5 bits (178), Expect = 3e-14
 Identities = 58/208 (27%), Positives = 101/208 (48%), Gaps = 30/208 (14%)

Query: 131 RKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKK---------IKREIKILQNLCGGPN 181
           R +GRG Y++V   + +    R  I  +K +KK+          ++ E  + +     P 
Sbjct: 1   RVIGRGSYAKVLL-VELKKTRR--IYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPF 57

Query: 182 VVKLLDIVRDQHS--KTPSLIF---EYVNSTDFKVLYP---TLTDYDIRYYIYELLKALD 233
           +V L       HS  +T S +F   E+V+  D          L +   R+Y  E+  AL+
Sbjct: 58  LVGL-------HSCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALN 110

Query: 234 YCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLV 292
           + H +GI++RD+K  NV++D E   ++L D+G+  E   PG   +    +  +  PE+L 
Sbjct: 111 FLHERGIIYRDLKLDNVLLDAE-GHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILR 169

Query: 293 DLQDYDYSLDMWSLGCMFAGMIFRKEPF 320
             +DY +S+D W+LG +   M+  + PF
Sbjct: 170 G-EDYGFSVDWWALGVLMFEMMAGRSPF 196

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 72.5 bits (178), Expect = 4e-14
 Identities = 77/290 (26%), Positives = 131/290 (45%), Gaps = 51/290 (17%)

Query: 130 VRKVGRGKYSEVF---EGINVNTNERCIIKILKPVKKK-----KIKREIKILQNLCGGPN 181
           ++ +G+G + +VF   +    +  +   +K+LK    K     + K E  IL  +   P 
Sbjct: 1   LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEV-NHPF 59

Query: 182 VVKLLDIVRDQHSKTPSLIFEYVNSTDF------KVLYPTLTDYDIRYYIYELLKALDYC 235
           +VKL      Q      LI +++   D       +V++   T+ D+++Y+ EL  ALD+ 
Sbjct: 60  IVKLHYAF--QTEGKLYLILDFLRGGDLFTRLSKEVMF---TEEDVKFYLAELALALDHL 114

Query: 236 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE--FYHPGKEYNVRVASRYFKGPELLVD 293
           HS GI++RD+KP N+++D E   ++L D+GL++    H  K Y+      Y   PE +V+
Sbjct: 115 HSLGIIYRDLKPENILLDEE-GHIKLTDFGLSKESIDHEKKAYSFCGTVEYM-APE-VVN 171

Query: 294 LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWS 353
            + +  S D WS G +   M+    P F G D  + +  I K                 +
Sbjct: 172 RRGHTQSADWWSFGVLMFEMLTGSLP-FQGKDRKETMTMILK-----------------A 213

Query: 354 KFINADNQHLVSPEAIDFLDKLLRYDHQDRLTA-----REAMAHPYFAQV 398
           K         +SPEA   L  L + +  +RL A      E   HP+F+ +
Sbjct: 214 KL---GMPQFLSPEAQSLLRALFKRNPANRLGAGPDGVEEIKRHPFFSTI 260

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 71.2 bits (174), Expect = 6e-14
 Identities = 74/275 (26%), Positives = 129/275 (46%), Gaps = 36/275 (13%)

Query: 132 KVGRGKYSEVFEGINVNTNERCIIKILKPVKKKK----IKREIKILQNLCGGPNVVKLLD 187
           ++G+G + EV++GI+  T E   IKI+   + +     I++EI +L   C  P + +   
Sbjct: 11  RIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQ-CDSPYITRYYG 69

Query: 188 IVRDQHSKTPSL--IFEYVNS-TDFKVLYP-TLTDYDIRYYIYELLKALDYCHSQGIMHR 243
                + K   L  I EY+   +   +L P  L +  I   + E+LK LDY HS+  +HR
Sbjct: 70  ----SYLKGTKLWIIMEYLGGGSALDLLKPGPLEETYIATILREILKGLDYLHSERKIHR 125

Query: 244 DVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLD 302
           D+K  NV++  E   ++L D+G+A +      + N  V + ++  PE ++    YD+  D
Sbjct: 126 DIKAANVLLS-EQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPE-VIKQSAYDFKAD 183

Query: 303 MWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSKFINADNQH 362
           +WSLG + A  + + EP          L  I K+    +    ++S KP+ +F+ A    
Sbjct: 184 IWSLG-ITAIELAKGEPPNSDLHPMRVLFLIPKNSPPTL--EGQYS-KPFKEFVEA---- 235

Query: 363 LVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQ 397
                        L  D + R TA+E + H +  +
Sbjct: 236 ------------CLNKDPRFRPTAKELLKHKFITR 258

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 71.4 bits (175), Expect = 8e-14
 Identities = 75/281 (26%), Positives = 125/281 (44%), Gaps = 41/281 (14%)

Query: 133 VGRGKYSEVFEGINVNTNERCIIKILKP---VKKKKIKR---EIKILQNLCGGPNVVKLL 186
           +G+G + +V       T +   +KILK    + K ++     E ++LQN    P +  L 
Sbjct: 3   LGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQN-TRHPFLTALK 61

Query: 187 DIVRDQHSKTPSLIFEYVNSTD--FKVLYP-TLTDYDIRYYIYELLKALDYCHSQGIMHR 243
              +         + EY N  +  F +      ++   R+Y  E++ AL Y HS  +++R
Sbjct: 62  YSFQTHDRLC--FVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYR 119

Query: 244 DVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLD 302
           D+K  N+M+D +   +++ D+GL  E    G        +  +  PE+L D  DY  ++D
Sbjct: 120 DLKLENLMLDKD-GHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLED-NDYGRAVD 177

Query: 303 MWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSKFINADNQH 362
            W LG +   M+  + P FY  D H++L +      LI+    R  R             
Sbjct: 178 WWGLGVVMYEMMCGRLP-FYNQD-HEKLFE------LILMEEIRFPRT------------ 217

Query: 363 LVSPEAIDFLDKLLRYDHQDRL-----TAREAMAHPYFAQV 398
            +SPEA   L  LL+ D + RL      A+E M H +FA +
Sbjct: 218 -LSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFFASI 257

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 71.2 bits (174), Expect = 1e-13
 Identities = 53/183 (28%), Positives = 90/183 (49%), Gaps = 29/183 (15%)

Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEYNVRV 280
           R+Y  E++ AL+Y HS+ +++RD+K  N+M+D +   +++ D+GL  E    G       
Sbjct: 98  RFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKD-GHIKITDFGLCKEGISDGATMKTFC 156

Query: 281 ASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLI 340
            +  +  PE+L D  DY  ++D W LG +   M+  + PF+  + +H++L +      LI
Sbjct: 157 GTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFY--NQDHERLFE------LI 207

Query: 341 IWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRL-----TAREAMAHPYF 395
           +    R  R              +SPEA   L  LL+ D + RL      A+E M H +F
Sbjct: 208 LMEEIRFPRT-------------LSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFF 254

Query: 396 AQV 398
             +
Sbjct: 255 LSI 257

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score = 70.3 bits (173), Expect = 1e-13
 Identities = 39/162 (24%), Positives = 75/162 (46%), Gaps = 18/162 (11%)

Query: 131 RKVGRGKYSEVFEGI----NVNTNERCIIKILKPVK----KKKIKREIKILQNLCGGPNV 182
           +K+G G + EV++G              +K LK        ++  RE +I++ L   PNV
Sbjct: 5   KKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKL-DHPNV 63

Query: 183 VKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY-----PTLTDYDIRYYIYELLKALDYCHS 237
           VKLL +  ++      ++ EY+   D    Y     P L+  D+  +  ++ + ++Y  S
Sbjct: 64  VKLLGVCTEEEP--LYIVMEYMEGGDLL-SYLRKNRPKLSLSDLLSFALQIARGMEYLES 120

Query: 238 QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR 279
           +  +HRD+   N ++   L  +++ D+GL+   +    Y  R
Sbjct: 121 KNFIHRDLAARNCLVGENLV-VKISDFGLSRDLYDDDYYRKR 161

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 71.2 bits (174), Expect = 1e-13
 Identities = 66/216 (30%), Positives = 104/216 (48%), Gaps = 29/216 (13%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKR-------EIKILQNLC 177
           +DYEVV+ +GRG + EV    + +T +   +K+L   K + IKR       E + +    
Sbjct: 43  EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLS--KFEMIKRSDSAFFWEERDIMAFA 100

Query: 178 GGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDI-----RYYIYELLKAL 232
             P VV+L    +D   +   ++ EY+   D   L   +++YD+     R+Y  E++ AL
Sbjct: 101 NSPWVVQLFYAFQD--DRYLYMVMEYMPGGD---LVNLMSNYDVPEKWARFYTAEVVLAL 155

Query: 233 DYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR----VASRYFKGP 288
           D  HS G +HRDVKP N+++D +   L+L D+G        KE  VR    V +  +  P
Sbjct: 156 DAIHSMGFIHRDVKPDNMLLD-KSGHLKLADFGTC--MKMNKEGMVRCDTAVGTPDYISP 212

Query: 289 ELLVDLQD---YDYSLDMWSLGCMFAGMIFRKEPFF 321
           E+L        Y    D WS+G     M+    PF+
Sbjct: 213 EVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFY 248

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 70.1 bits (171), Expect = 1e-13
 Identities = 54/211 (25%), Positives = 103/211 (48%), Gaps = 15/211 (7%)

Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK--PVKKKKIKREIKILQNLCGGPN 181
           Q+D+E+++++G G Y +V++  NVNT E   IK++K  P +   + ++  I+   C   N
Sbjct: 8   QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSN 67

Query: 182 VVKLLD--IVRDQHSKTPSLIFEYVNSTDFKVLYPT---LTDYDIRYYIYELLKALDYCH 236
           +V      + RD+      +  E+      + +Y     L++  I Y   E L+ L Y H
Sbjct: 68  IVAYFGSYLRRDKL----WICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLH 123

Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGL-AEFYHPGKEYNVRVASRYFKGPELLVDLQ 295
           S+G MHRD+K  N+++      ++L D+G+ A+      +    + + Y+  PE+    +
Sbjct: 124 SKGKMHRDIKGANILLTDN-GHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVER 182

Query: 296 D--YDYSLDMWSLGCMFAGMIFRKEPFFYGH 324
              Y+   D+W++G     +   + P F  H
Sbjct: 183 KGGYNQLCDIWAVGITAIELAELQPPMFDLH 213

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 70.0 bits (171), Expect = 1e-13
 Identities = 66/282 (23%), Positives = 126/282 (44%), Gaps = 39/282 (13%)

Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILK----PVKKKKIKREIKILQNLCGGPNV 182
           YE+++K+G G + +++     + +E C+IK +     PVK+K+  ++  IL      PN+
Sbjct: 2   YEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNI 61

Query: 183 VKLLDIVRDQHSKTPSLIFEYVNSTDFK--------VLYPTLTDYDIRYYIYELLKALDY 234
           V        Q +    ++ EY +  D          VL+   ++  I  +  ++   L +
Sbjct: 62  VTFFASF--QENGRLFIVMEYCDGGDLMKRINRQRGVLF---SEDQILSWFVQISLGLKH 116

Query: 235 CHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY-NVRVASRYFKGPELLVD 293
            H + I+HRD+K  N+ +       +L D+G+A   +   E     V + Y+  PE+  +
Sbjct: 117 IHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGTPYYLSPEICQN 176

Query: 294 LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWS 353
            + Y+   D+WSLGC+   +   K P F G++ H  ++KI         C    +  P S
Sbjct: 177 -RPYNNKTDIWSLGCVLYELCTLKHP-FEGNNLHQLVLKI---------CQGYFA--PIS 223

Query: 354 KFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF 395
              + D + L+S        +L +   +DR +    +  P+ 
Sbjct: 224 PNFSRDLRSLIS--------QLFKVSPRDRPSITSILKRPFL 257

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 69.3 bits (169), Expect = 3e-13
 Identities = 57/186 (30%), Positives = 95/186 (51%), Gaps = 18/186 (9%)

Query: 132 KVGRGKYSEVFEGINVNTNERCIIKILKPVKKKK----IKREIKILQNLCGGPNVVKLLD 187
           ++G+G + EVF+GI+  T +   IKI+   + +     I++EI +L   C  P V K   
Sbjct: 11  RIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQ-CDSPYVTKYYG 69

Query: 188 IVRDQHSKTPSL--IFEYV---NSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMH 242
                + K   L  I EY+   ++ D     P   ++ I   + E+LK LDY HS+  +H
Sbjct: 70  ----SYLKGTKLWIIMEYLGGGSALDLLRAGP-FDEFQIATMLKEILKGLDYLHSEKKIH 124

Query: 243 RDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSL 301
           RD+K  NV++  E   ++L D+G+A +      + N  V + ++  PE ++    YD   
Sbjct: 125 RDIKAANVLLS-EQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPE-VIQQSAYDSKA 182

Query: 302 DMWSLG 307
           D+WSLG
Sbjct: 183 DIWSLG 188

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 68.9 bits (168), Expect = 3e-13
 Identities = 72/281 (25%), Positives = 124/281 (44%), Gaps = 39/281 (13%)

Query: 133 VGRGKYSEVFEGINVNTNERCIIKILK-----PVKKKKIKR---EIKILQNLCGGPNVVK 184
           +G+G +  V+   +V+T      K ++     P   K++     EI++L+NL     +V+
Sbjct: 10  LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNL-QHERIVQ 68

Query: 185 LLDIVRDQHSKTPSLIFEYVNSTDFK---VLYPTLTDYDIRYYIYELLKALDYCHSQGIM 241
               +RD+  KT ++  EY+     K     Y  LT+   R Y  ++L+ + Y HS  I+
Sbjct: 69  YYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIV 128

Query: 242 HRDVKPHNVMIDHELRKLRLIDWG----LAEFYHPGKEYNVRVASRYFKGPELLVDLQDY 297
           HRD+K  N++ D     ++L D+G    L      G        + Y+  PE ++  + Y
Sbjct: 129 HRDIKGANILRD-SAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPE-VISGEGY 186

Query: 298 DYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSKFIN 357
               D+WSLGC    M+  K P +  ++    + KIA                  ++  N
Sbjct: 187 GRKADVWSLGCTVVEMLTEKPP-WAEYEAMAAIFKIA------------------TQPTN 227

Query: 358 ADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQV 398
                 +S  A DFL  +   + + R +A E + HP FAQ+
Sbjct: 228 PQLPSHISEHARDFLGCIF-VEARHRPSAEELLRHP-FAQL 266

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score = 68.7 bits (169), Expect = 4e-13
 Identities = 37/162 (22%), Positives = 75/162 (46%), Gaps = 17/162 (10%)

Query: 131 RKVGRGKYSEVFEGI----NVNTNERCIIKILKPVK----KKKIKREIKILQNLCGGPNV 182
           +K+G G + EV++G              +K LK        ++  RE +I++ L   PN+
Sbjct: 5   KKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKL-DHPNI 63

Query: 183 VKLLDIVRDQHSKTPSLIFEYVNSTDFK-VL----YPTLTDYDIRYYIYELLKALDYCHS 237
           VKLL +  ++      ++ EY+   D    L       L+  D+  +  ++ + ++Y  S
Sbjct: 64  VKLLGVCTEEEP--LMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLES 121

Query: 238 QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR 279
           +  +HRD+   N ++   L  +++ D+GL+   +    Y V+
Sbjct: 122 KNFIHRDLAARNCLVGENLV-VKISDFGLSRDLYDDDYYKVK 162

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional

 Score = 70.6 bits (173), Expect = 4e-13
 Identities = 52/222 (23%), Positives = 82/222 (36%), Gaps = 72/222 (32%)

Query: 221 IRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRV 280
           I+  + ++L ALD  HS GI+HRDVKP N++        ++ID G A         ++RV
Sbjct: 257 IQTIMRQILFALDGLHSTGIVHRDVKPQNIIFSEGSGSFKIIDLGAAA--------DLRV 308

Query: 281 ASRY----------FKGPELLV------------------------DLQDYDYSLDMWSL 306
              Y          +  PE  +                        +L D     D++S 
Sbjct: 309 GINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPD---RFDIYSA 365

Query: 307 GCMFAGMIFRKEPFFYGHDNHDQLVKIAKDC--CLIIWCNSRHSRKPWSKFINADNQHLV 364
           G +F  M F   P      N  Q  +  K     L+ W      R       + D +   
Sbjct: 366 GLIFLQMAF---PNLRSDSNLIQFNRQLKRNDYDLVAWRKLVEPRA------SPDLR--- 413

Query: 365 SPEAIDFLD-----------KLLRYDHQDRLTAREAMAHPYF 395
                + LD            ++R+  + R++A+ A+AHPYF
Sbjct: 414 --RGFEVLDLDGGAGWELLKSMMRFKGRQRISAKAALAHPYF 453

Length = 566

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 69.0 bits (169), Expect = 5e-13
 Identities = 49/184 (26%), Positives = 82/184 (44%), Gaps = 32/184 (17%)

Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEYNVRV 280
           R+Y  E+  AL Y HS  I++RD+KP N+++D +   + L D+GL  E     K  +   
Sbjct: 99  RFYAAEIASALGYLHSLNIIYRDLKPENILLDSQ-GHVVLTDFGLCKEGIEHSKTTSTFC 157

Query: 281 ASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLI 340
            +  +  PE+L   Q YD ++D W LG +   M++   PF+                   
Sbjct: 158 GTPEYLAPEVLRK-QPYDRTVDWWCLGAVLYEMLYGLPPFY------------------- 197

Query: 341 IWCNSRHSRKPWSKFINADNQ--HLVSPEAIDFLDKLLRYDHQDRLTAR----EAMAHPY 394
               SR + + +   +N   +    +S  A   L+ LL+ D   RL A+    E   H +
Sbjct: 198 ----SRDTAEMYDNILNKPLRLKPNISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNHVF 253

Query: 395 FAQV 398
           F+ +
Sbjct: 254 FSSI 257

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 68.9 bits (168), Expect = 6e-13
 Identities = 55/184 (29%), Positives = 91/184 (49%), Gaps = 30/184 (16%)

Query: 222 RYYIYELLKALDYCHSQ-GIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEYNVR 279
           R+Y  E++ ALDY HS+  +++RD+K  N+M+D +   +++ D+GL  E    G      
Sbjct: 98  RFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKD-GHIKITDFGLCKEGIKDGATMKTF 156

Query: 280 VASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCL 339
             +  +  PE+L D  DY  ++D W LG +   M+  + PF+  + +H++L +      L
Sbjct: 157 CGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFY--NQDHEKLFE------L 207

Query: 340 IIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRL-----TAREAMAHPY 394
           I+    R  R              +SPEA   L  LL+ D + RL      A+E M H +
Sbjct: 208 ILMEEIRFPRT-------------LSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKF 254

Query: 395 FAQV 398
           FA +
Sbjct: 255 FAGI 258

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 68.1 bits (166), Expect = 7e-13
 Identities = 52/197 (26%), Positives = 97/197 (49%), Gaps = 17/197 (8%)

Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK--KKKIKREIKILQNLCGGPNVVK 184
           +E+V  VG G Y +V++G +V T +   IK++   +  +++IK EI +L+      N+  
Sbjct: 18  FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIAT 77

Query: 185 LLDIVRDQ----HSKTPSLIFEYVNSTDFKVLYP-----TLTDYDIRYYIYELLKALDYC 235
                  +    H     L+ E+  +     L        L +  I Y   E+L+ L + 
Sbjct: 78  YYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHL 137

Query: 236 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGL-AEFYHPGKEYNVRVASRYFKGPELLVDL 294
           H+  ++HRD+K  NV++  E  +++L+D+G+ A+        N  + + Y+  PE++   
Sbjct: 138 HAHKVIHRDIKGQNVLLT-ENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACD 196

Query: 295 QD----YDYSLDMWSLG 307
           ++    YDY  D+WSLG
Sbjct: 197 ENPDATYDYRSDIWSLG 213

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 67.8 bits (165), Expect = 8e-13
 Identities = 52/203 (25%), Positives = 95/203 (46%), Gaps = 18/203 (8%)

Query: 133 VGRGKYSEVFEGINVNTNERCIIKILK-----PVKKKKIKR---EIKILQNLCGGPNVVK 184
           +G+G +  V+   + +T     +K ++     P   K++     EI++L+NL     +V+
Sbjct: 10  LGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLH-ERIVQ 68

Query: 185 LLDIVRDQHSKTPSLIFEYVNSTDFK---VLYPTLTDYDIRYYIYELLKALDYCHSQGIM 241
               +RD   +T S+  E++     K     Y  LT+   R Y  ++L+ + Y HS  I+
Sbjct: 69  YYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIV 128

Query: 242 HRDVKPHNVMIDHELRKLRLIDWG----LAEFYHPGKEYNVRVASRYFKGPELLVDLQDY 297
           HRD+K  N++ D  +  ++L D+G    L      G        + Y+  PE ++  + Y
Sbjct: 129 HRDIKGANILRD-SVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPE-VISGEGY 186

Query: 298 DYSLDMWSLGCMFAGMIFRKEPF 320
               D+WS+GC    M+  K P+
Sbjct: 187 GRKADIWSVGCTVVEMLTEKPPW 209

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 68.2 bits (166), Expect = 9e-13
 Identities = 75/291 (25%), Positives = 130/291 (44%), Gaps = 44/291 (15%)

Query: 119 VQWGD-QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIK---ILKPVKKKKIKREIKILQ 174
           V  GD +  Y    K+G+G    V+  ++V T +   I+   + +  KK+ I  EI +++
Sbjct: 13  VSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMR 72

Query: 175 NLCGGPNVVKLLD--IVRDQHSKTPSLIFEYVNSTDFK-VLYPTLTDY-DIRYYIYELLK 230
                PN+V  LD  +V D+      ++ EY+       V+  T  D   I     E L+
Sbjct: 73  E-NKNPNIVNYLDSYLVGDELW----VVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQ 127

Query: 231 ALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK-EYNVRVASRYFKGPE 289
           AL++ HS  ++HRD+K  N+++  +   ++L D+G      P + + +  V + Y+  PE
Sbjct: 128 ALEFLHSNQVIHRDIKSDNILLGMD-GSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPE 186

Query: 290 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSR 349
           + V  + Y   +D+WSLG M   MI   EP +   +    L  IA +             
Sbjct: 187 V-VTRKAYGPKVDIWSLGIMAIEMI-EGEPPYLNENPLRALYLIATN------------- 231

Query: 350 KPWSKFINADNQHLVSPEAI-----DFLDKLLRYDHQDRLTAREAMAHPYF 395
                        L +PE +     DFL++ L  D + R +A+E + H + 
Sbjct: 232 ---------GTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFL 273

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 68.3 bits (167), Expect = 9e-13
 Identities = 79/291 (27%), Positives = 131/291 (45%), Gaps = 51/291 (17%)

Query: 130 VRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIK----------ILQNLCGG 179
           ++ +G+G Y +VF+   V   +   I  +K +KK  I R  K          IL+ +   
Sbjct: 1   LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAV-KH 59

Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDI------RYYIYELLKALD 233
           P +V L  I   Q      LI EY++  +   L+  L    I       +Y+ E+  AL+
Sbjct: 60  PFIVDL--IYAFQTGGKLYLILEYLSGGE---LFMHLEREGIFMEDTACFYLSEISLALE 114

Query: 234 YCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLV 292
           + H QGI++RD+KP N+++D +   ++L D+GL  E  H G   +    +  +  PE+L+
Sbjct: 115 HLHQQGIIYRDLKPENILLDAQ-GHVKLTDFGLCKESIHEGTVTHTFCGTIEYMAPEILM 173

Query: 293 DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPW 352
               +  ++D WSLG +   M+    PF    +    + KI K          + +  P+
Sbjct: 174 R-SGHGKAVDWWSLGALMYDMLTGAPPF-TAENRKKTIDKILK---------GKLNLPPY 222

Query: 353 SKFINADNQHLVSPEAIDFLDKLLRYDHQDRL-----TAREAMAHPYFAQV 398
                      ++PEA D L KLL+ +   RL      A E  +HP+F  V
Sbjct: 223 -----------LTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPFFRHV 262

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 67.3 bits (164), Expect = 1e-12
 Identities = 70/285 (24%), Positives = 125/285 (43%), Gaps = 44/285 (15%)

Query: 133 VGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREI--------KILQNLCGGPNVVK 184
           +GRG + EV+     +T +   +K L    KK+IK +         +I+ +L    +   
Sbjct: 2   IGRGGFGEVYGCRKADTGKMYAMKCLD---KKRIKMKQGETLALNERIMLSLVSTGDCPF 58

Query: 185 LLDIVRDQHSKTPS---LIFEYVNSTDFKV---LYPTLTDYDIRYYIYELLKALDYCHSQ 238
           ++ +    H  TP     I + +N  D       +   ++ ++R+Y  E++  L++ H++
Sbjct: 59  IVCMTYAFH--TPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNR 116

Query: 239 GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYD 298
            +++RD+KP N+++D E   +R+ D GLA  +   K +   V +  +  PE+L     YD
Sbjct: 117 FVVYRDLKPANILLD-EHGHVRISDLGLACDFSKKKPH-ASVGTHGYMAPEVLQKGTAYD 174

Query: 299 YSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSKFINA 358
            S D +SLGCM   ++    P F  H   D                 +H     +  +N 
Sbjct: 175 SSADWFSLGCMLFKLLRGHSP-FRQHKTKD-----------------KHEIDRMTLTVNV 216

Query: 359 DNQHLVSPEAIDFLDKLLRYDHQDRL-----TAREAMAHPYFAQV 398
           +     SPE    L+ LL+ D   RL      A+E   H +F  +
Sbjct: 217 ELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVFFKGI 261

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 67.7 bits (165), Expect = 2e-12
 Identities = 73/293 (24%), Positives = 129/293 (44%), Gaps = 61/293 (20%)

Query: 133 VGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQ 192
           +G+G + +V++   V   +   I  +K + KK+I  + ++   + G  N+     +VR  
Sbjct: 1   IGKGTFGQVYQ---VRKKDTRRIYAMKVLSKKEIVAKKEVAHTI-GERNI-----LVRTL 51

Query: 193 HSKTPSLI---FEYVNSTDFKVLYPTLTDY-------------------DIRYYIYELLK 230
             ++P ++   F +   +D   LY  +TDY                     ++YI EL+ 
Sbjct: 52  LDESPFIVGLKFSFQTDSD---LY-LVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVL 107

Query: 231 ALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEF-YHPGKEYNVRVASRYFKGPE 289
           AL++ H   I++RD+KP N+++D     + L D+GL++      K  N    +  +  PE
Sbjct: 108 ALEHLHKYDIVYRDLKPENILLDAT-GHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPE 166

Query: 290 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSR 349
           +L+D + Y   +D WSLG +   M     P FY  D   Q+ +       I +   R  +
Sbjct: 167 VLLDEKGYTKHVDFWSLGVLVFEMCCGWSP-FYAEDTQ-QMYR------NIAFGKVRFPK 218

Query: 350 KPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRL----TAREAMAHPYFAQV 398
                       +++S E   F+  LL  + Q RL     A E   HP+FA +
Sbjct: 219 ------------NVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEHPFFADI 259

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 66.2 bits (161), Expect = 3e-12
 Identities = 56/213 (26%), Positives = 106/213 (49%), Gaps = 19/213 (8%)

Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKK---IKREIKILQNLCGGP 180
           Q DYE++++VG G Y +V++  N++T E   +KI+K         I++EI +++  C   
Sbjct: 8   QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKE-CKHC 66

Query: 181 NVVKLLD--IVRDQHSKTPSLIFEYVNSTDFKVLYPT---LTDYDIRYYIYELLKALDYC 235
           N+V      + R++      +  EY      + +Y     L++  I Y   E L+ L Y 
Sbjct: 67  NIVAYFGSYLSREKL----WICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYL 122

Query: 236 HSQGIMHRDVKPHNVMI-DHELRKLRLIDWGL-AEFYHPGKEYNVRVASRYFKGPELLVD 293
           HS+G MHRD+K  N+++ D+    ++L D+G+ A+      +    + + Y+  PE+   
Sbjct: 123 HSKGKMHRDIKGANILLTDNG--DVKLADFGVAAKITATIAKRKSFIGTPYWMAPEVAAV 180

Query: 294 LQD--YDYSLDMWSLGCMFAGMIFRKEPFFYGH 324
            ++  Y+   D+W++G     +   + P F  H
Sbjct: 181 EKNGGYNQLCDIWAVGITAIELAELQPPMFDLH 213

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 67.0 bits (163), Expect = 3e-12
 Identities = 61/214 (28%), Positives = 104/214 (48%), Gaps = 25/214 (11%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKR-------EIKILQNLC 177
           +DY+VV+ +GRG + EV    + ++ +   +K+L   K + IKR       E + +    
Sbjct: 43  EDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLS--KFEMIKRSDSAFFWEERDIMAFA 100

Query: 178 GGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDI-----RYYIYELLKAL 232
             P VV+L    +D   K   ++ EY+   D   L   +++YD+     ++Y  E++ AL
Sbjct: 101 NSPWVVQLFCAFQDD--KYLYMVMEYMPGGD---LVNLMSNYDVPEKWAKFYTAEVVLAL 155

Query: 233 DYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEY-NVRVASRYFKGPEL 290
           D  HS G++HRDVKP N+++D +   L+L D+G   +    G    +  V +  +  PE+
Sbjct: 156 DAIHSMGLIHRDVKPDNMLLD-KHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEV 214

Query: 291 LVDLQD---YDYSLDMWSLGCMFAGMIFRKEPFF 321
           L        Y    D WS+G     M+    PF+
Sbjct: 215 LKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFY 248

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 66.5 bits (163), Expect = 4e-12
 Identities = 74/320 (23%), Positives = 119/320 (37%), Gaps = 69/320 (21%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP---VKKKKIKR---EIKILQNLCG 178
             ++ ++ +G+G    VF      T +   +K+L     +K+ K+KR   E +IL  L  
Sbjct: 1   KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATL-D 59

Query: 179 GPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPT-----LTDYDIRYYIYELLKALD 233
            P +  L      Q      L+ +Y    +   L        L++   R+Y  E+L AL+
Sbjct: 60  HPFLPTLY--ASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALE 117

Query: 234 YCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGL---------AEFYHPGKEYNVRVASRY 284
           Y H  GI++RD+KP N+++ HE   + L D+ L                K       +  
Sbjct: 118 YLHLLGIVYRDLKPENILL-HESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSI 176

Query: 285 ---------------FKG------PELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYG 323
                          F G      PE++     +  ++D W+LG +   M++   PF  G
Sbjct: 177 PSETFSEEPSFRSNSFVGTEEYIAPEVISG-DGHGSAVDWWTLGILLYEMLYGTTPFK-G 234

Query: 324 HDNHDQLVKIAKDCCLIIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDR 383
            +  +    I K                  K +       VS  A D + KLL  D   R
Sbjct: 235 SNRDETFSNILK------------------KEVTFPGSPPVSSSARDLIRKLLVKDPSKR 276

Query: 384 L----TAREAMAHPYFAQVR 399
           L     A E   HP+F  V 
Sbjct: 277 LGSKRGAAEIKQHPFFRGVN 296

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 66.8 bits (163), Expect = 4e-12
 Identities = 74/330 (22%), Positives = 126/330 (38%), Gaps = 83/330 (25%)

Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKR--------EIKILQNLCG 178
           +  ++ +G G + EV     V+TN    +K L+  K   + R        E  IL     
Sbjct: 3   FVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLR--KADVLMRNQAAHVKAERDILAE-AD 59

Query: 179 GPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYD---IRYYIYELLKALDYC 235
              VVKL    +D+ +     + +Y+   D   L   L  ++    R+YI EL  A++  
Sbjct: 60  NEWVVKLYYSFQDKDNLY--FVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESV 117

Query: 236 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGL---------AEFYHPG------------- 273
           H  G +HRD+KP N++ID +   ++L D+GL         +++Y  G             
Sbjct: 118 HKMGFIHRDIKPDNILIDRD-GHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEE 176

Query: 274 ------------KEYNVR----------VASRYFKGPELLVDLQDYDYSLDMWSLGCMFA 311
                       +    R          V +  +  PE+L+    Y    D WS+G +  
Sbjct: 177 WSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLR-TGYTQLCDWWSVGVILY 235

Query: 312 GMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSKFINADNQHLVSPEAIDF 371
            M+  + PF     +                  ++     W   ++  +Q  +S EA D 
Sbjct: 236 EMLVGQPPF---LADTP--------------AETQLKVINWETTLHIPSQAKLSREASDL 278

Query: 372 LDKLLRYDHQDRL---TAREAMAHPYFAQV 398
           + +L     +DRL    A E  AHP+F  +
Sbjct: 279 ILRLCC-GAEDRLGKNGADEIKAHPFFKGI 307

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 66.6 bits (163), Expect = 4e-12
 Identities = 84/337 (24%), Positives = 132/337 (39%), Gaps = 98/337 (29%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKRE----IKILQNLCG-- 178
           DD+E ++ +GRG + EV      +T     +K L+  K + +++E    ++  +++    
Sbjct: 1   DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLR--KSEMLEKEQVAHVRAERDILAEA 58

Query: 179 -GPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL---YPTLTDYDIRYYIYELLKALDY 234
             P VVKL    +D       LI EY+   D   L     T T+ + R+YI E + A+D 
Sbjct: 59  DNPWVVKLYYSFQD--ENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDS 116

Query: 235 CHSQGIMHRDVKPHNVMID---HELRKLRLIDWGL---------AEFYHPGKEY------ 276
            H  G +HRD+KP N+++D   H    ++L D+GL          EFY            
Sbjct: 117 IHKLGYIHRDIKPDNLLLDAKGH----IKLSDFGLCTGLKKSHRTEFYRILSHALPSNFL 172

Query: 277 -----------------NVRVASRY-------FKGPELLVDLQD-YDYSLDMWSLGCMFA 311
                              R A  Y       +  PE+   LQ  Y+   D WSLG +  
Sbjct: 173 DFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVF--LQTGYNKECDWWSLGVIMY 230

Query: 312 GMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSKFINADNQHLV------- 364
            M+    PF                        S + ++ + K IN   + L        
Sbjct: 231 EMLVGYPPFC-----------------------SDNPQETYRKIINW-KETLQFPDEVPL 266

Query: 365 SPEAIDFLDKLLRYDHQDRL---TAREAMAHPYFAQV 398
           SPEA D + +L   + + RL      E  +HP+F  V
Sbjct: 267 SPEAKDLIKRLC-CEAERRLGNNGVNEIKSHPFFKGV 302

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 65.8 bits (160), Expect = 6e-12
 Identities = 52/205 (25%), Positives = 97/205 (47%), Gaps = 28/205 (13%)

Query: 199 LIFEYVNSTDFKVLYPTLTDYDI---RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE 255
            + EY+N  D      +   +D+    +Y  E++  L + HS+GI++RD+K  N+++D +
Sbjct: 73  FVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTD 132

Query: 256 LRKLRLIDWGLAEFYHPGK-EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMI 314
              +++ D+G+ +    G  +      +  +  PE+L+  Q Y+ S+D WS G +   M+
Sbjct: 133 -GHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLG-QKYNTSVDWWSFGVLLYEML 190

Query: 315 FRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDK 374
             + P F+GHD  +    I  D       N  + R  W           ++ EA D L K
Sbjct: 191 IGQSP-FHGHDEEELFQSIRMD-------NPCYPR--W-----------LTREAKDILVK 229

Query: 375 LLRYDHQDRLTAR-EAMAHPYFAQV 398
           L   + + RL  + +   HP+F ++
Sbjct: 230 LFVREPERRLGVKGDIRQHPFFREI 254

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score = 65.2 bits (160), Expect = 6e-12
 Identities = 51/230 (22%), Positives = 98/230 (42%), Gaps = 36/230 (15%)

Query: 131 RKVGRGKYSEVFEGI----NVNTNERCIIKILKP----VKKKKIKREIKILQNLCGGPNV 182
           +K+G G + EV++G        T  +  +K LK      ++++   E  I++ L   PN+
Sbjct: 5   KKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKL-SHPNI 63

Query: 183 VKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY-----PTLTDYDIRYYIYELLKALDYCHS 237
           V+LL +      +   ++ EY+   D    +       LT  D+     ++ K ++Y  S
Sbjct: 64  VRLLGVCT--QGEPLYIVTEYMPGGDLL-DFLRKHGEKLTLKDLLQMALQIAKGMEYLES 120

Query: 238 QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR---------VASRYFKGP 288
           +  +HRD+   N ++   L  +++ D+GL+   +    Y  R         +A      P
Sbjct: 121 KNFVHRDLAARNCLVTENL-VVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMA------P 173

Query: 289 ELLVDLQDYDYSLDMWSLG-CMFAGMIFRKEPFFYGHDNHDQLVKIAKDC 337
           E L D +    S D+WS G  ++      ++P + G  N + L  +    
Sbjct: 174 ESLKDGKFTSKS-DVWSFGVLLWEIFTLGEQP-YPGMSNEEVLELLEDGY 221

Length = 258

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 66.0 bits (161), Expect = 6e-12
 Identities = 71/295 (24%), Positives = 130/295 (44%), Gaps = 45/295 (15%)

Query: 126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKIL----KPVKKKKIKREIKILQNLCGGPN 181
           + E V ++G G    V++ I+  T     +K++    +   +++I REI+IL+++   PN
Sbjct: 75  ELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDV-NHPN 133

Query: 182 VVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHS 237
           VVK  D+    H+    ++ E+++    +  +      L D        ++L  + Y H 
Sbjct: 134 VVKCHDMF--DHNGEIQVLLEFMDGGSLEGTHIADEQFLADVA-----RQILSGIAYLHR 186

Query: 238 QGIMHRDVKPHNVMIDHELRKLRLIDWG----LAEFYHPGKEYNVRVASRYFKGPELL-V 292
           + I+HRD+KP N++I+   + +++ D+G    LA+   P    N  V +  +  PE +  
Sbjct: 187 RHIVHRDIKPSNLLINSA-KNVKIADFGVSRILAQTMDP---CNSSVGTIAYMSPERINT 242

Query: 293 DLQD--YD-YSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSR 349
           DL    YD Y+ D+WSLG         + PF  G          A   C I  C S+   
Sbjct: 243 DLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQG-----DWASLMCAI--CMSQPPE 295

Query: 350 KPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAESS 404
            P +           S E   F+   L+ +   R +A + + HP+  + +  +  
Sbjct: 296 APAT----------ASREFRHFISCCLQREPAKRWSAMQLLQHPFILRAQPGQGQ 340

Length = 353

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 65.4 bits (159), Expect = 7e-12
 Identities = 40/127 (31%), Positives = 64/127 (50%), Gaps = 7/127 (5%)

Query: 199 LIFEYVNSTDFKV-LY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMID 253
           L+   +N  D K  +Y    P   +    +Y  E+L  L+  H +  ++RD+KP N+++D
Sbjct: 77  LVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLD 136

Query: 254 HELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGM 313
            +   +R+ D GLA     G+    RV +  +  PE+L + Q Y  S D W LGC+   M
Sbjct: 137 -DYGHIRISDLGLAVKIPEGESIRGRVGTVGYMAPEVLNN-QRYTLSPDYWGLGCLIYEM 194

Query: 314 IFRKEPF 320
           I  + PF
Sbjct: 195 IEGQSPF 201

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 65.0 bits (158), Expect = 7e-12
 Identities = 68/287 (23%), Positives = 124/287 (43%), Gaps = 62/287 (21%)

Query: 133 VGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKR---------EIKILQNLCGGPNVV 183
           +G+G + EV   + V    +  +   K + KK++K+         E +IL+ +   P +V
Sbjct: 1   LGKGGFGEVC-AVQVKNTGK--MYACKKLDKKRLKKKSGEKMALLEKEILEKV-NSPFIV 56

Query: 184 KLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIY-------ELLKALDYC- 235
                         +L + + + T   ++   +   D++Y+IY       E+ + + Y  
Sbjct: 57  --------------NLAYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSA 102

Query: 236 ---------HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFK 286
                    HS  I++RD+KP NV++D +    RL D GLA     GK    R  +  + 
Sbjct: 103 QITCGILHLHSMDIVYRDMKPENVLLD-DQGNCRLSDLGLAVELKDGKTITQRAGTNGYM 161

Query: 287 GPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSR 346
            PE+L + + Y Y +D +++GC    M+  + PF     +H +  K+AK+         R
Sbjct: 162 APEILKE-EPYSYPVDWFAMGCSIYEMVAGRTPF----KDHKE--KVAKEELK------R 208

Query: 347 HSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHP 393
            + +   KF + +     + E+ D     L    +DRL +RE    P
Sbjct: 209 RTLEDEVKFEHQN----FTEESKDICRLFLAKKPEDRLGSREKNDDP 251

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 65.0 bits (158), Expect = 9e-12
 Identities = 53/181 (29%), Positives = 81/181 (44%), Gaps = 24/181 (13%)

Query: 223 YYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVAS 282
           +Y  E+   L+  H + I++RD+KP N+++D     +R+ D GLA     G+    RV +
Sbjct: 106 FYAAEICCGLEDLHQERIVYRDLKPENILLDDH-GHIRISDLGLAVHVPEGQTIKGRVGT 164

Query: 283 RYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIW 342
             +  PE +V  + Y +S D W+LGC+   MI  + PF        Q  K  K       
Sbjct: 165 VGYMAPE-VVKNERYTFSPDWWALGCLLYEMIAGQSPF-------QQRKKKIK------- 209

Query: 343 CNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRL-----TAREAMAHPYFAQ 397
              R   +   K +  +     SP+A      LL  D ++RL      ARE   HP F Q
Sbjct: 210 ---REEVERLVKEVQEEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQ 266

Query: 398 V 398
           +
Sbjct: 267 I 267

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 64.5 bits (157), Expect = 9e-12
 Identities = 62/215 (28%), Positives = 100/215 (46%), Gaps = 36/215 (16%)

Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLL 186
           YE +R VGRG +  V         +  IIK + PV++   K E    QN C    V+KLL
Sbjct: 2   YEKIRVVGRGAFGIVHLCRRKADQKLVIIKQI-PVEQMT-KDERLAAQNEC---QVLKLL 56

Query: 187 DIVRDQHSKTPSLIFEYVNSTDFKVL-----YP---TLTDY------------DIRYYIY 226
                 H   P++I  Y N  + K L     Y    TL +Y             I ++  
Sbjct: 57  -----SH---PNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFV 108

Query: 227 ELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEYNVRVASRYF 285
           ++L AL + H++ I+HRD+K  N+++D     +++ D+G++       K Y V V +  +
Sbjct: 109 QILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTV-VGTPCY 167

Query: 286 KGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPF 320
             PE L + + Y+   D+W+LGC+   +   K  F
Sbjct: 168 ISPE-LCEGKPYNQKSDIWALGCVLYELASLKRAF 201

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 64.9 bits (158), Expect = 9e-12
 Identities = 41/143 (28%), Positives = 72/143 (50%), Gaps = 22/143 (15%)

Query: 198 SLIFEYVNSTDFKVLYPTLTDYDIRYYIY-------------------ELLKALDYCHSQ 238
           SL + +   TD  ++   +   D+RY+IY                   +++  L++ H +
Sbjct: 57  SLAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR 116

Query: 239 GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVA-SRYFKGPELLVDLQDY 297
            I++RD+KP NV++D++   +R+ D GLA     G+      A +  F  PELL   ++Y
Sbjct: 117 RIIYRDLKPENVLLDND-GNVRISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQG-EEY 174

Query: 298 DYSLDMWSLGCMFAGMIFRKEPF 320
           D+S+D ++LG     MI  + PF
Sbjct: 175 DFSVDYFALGVTLYEMIAARGPF 197

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 64.8 bits (158), Expect = 1e-11
 Identities = 57/210 (27%), Positives = 95/210 (45%), Gaps = 34/210 (16%)

Query: 131 RKVGRGKYSEVFEGINVNTNERCIIKI------LKPVKKKKIKR---------EIKILQN 175
           R +G+G + EV           C ++        K ++KK+IK+         E +IL+ 
Sbjct: 6   RVLGKGGFGEVCA---------CQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEK 56

Query: 176 LCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKV-LY----PTLTDYDIRYYIYELLK 230
           +     VV L      + +    L+   +N  D K  +Y    P   +    +Y  E+  
Sbjct: 57  V-NSRFVVSLAYAYETKDALC--LVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITC 113

Query: 231 ALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPEL 290
            L+  H + I++RD+KP N+++D +   +R+ D GLA     G+    RV +  +  PE 
Sbjct: 114 GLEDLHRERIVYRDLKPENILLD-DYGHIRISDLGLAVEIPEGETIRGRVGTVGYMAPE- 171

Query: 291 LVDLQDYDYSLDMWSLGCMFAGMIFRKEPF 320
           +V  + Y +S D W LGC+   MI  K PF
Sbjct: 172 VVKNERYTFSPDWWGLGCLIYEMIEGKSPF 201

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 64.1 bits (156), Expect = 1e-11
 Identities = 69/278 (24%), Positives = 124/278 (44%), Gaps = 39/278 (14%)

Query: 133 VGRGKYSEVFEGINVNTNERCIIKILK-----PVKKKKIKR---EIKILQNLCGGPNVVK 184
           +G+G +  V+   +V+T     +K +      P  KK++     EI++L+NL     +V+
Sbjct: 10  LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNL-QHERIVQ 68

Query: 185 LLDIVRDQHSKTPSLIFEYVNSTDFK---VLYPTLTDYDIRYYIYELLKALDYCHSQGIM 241
               +RD   +T S+  EY+     K     Y  LT+   R Y  ++L+ ++Y HS  I+
Sbjct: 69  YYGCLRDD--ETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIV 126

Query: 242 HRDVKPHNVMIDHELRKLRLIDWG----LAEFYHPGKEYNVRVASRYFKGPELLVDLQDY 297
           HRD+K  N++ D     ++L D+G    L      G        + Y+  PE ++  + Y
Sbjct: 127 HRDIKGANILRDSA-GNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPE-VISGEGY 184

Query: 298 DYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSKFIN 357
               D+WS+GC    M+  K P +   +    + KIA               +P +  + 
Sbjct: 185 GRKADVWSVGCTVVEMLTEKPP-WAEFEAMAAIFKIAT--------------QPTNPQLP 229

Query: 358 ADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF 395
           +     VSP+A +FL +    + + R +A E + H + 
Sbjct: 230 SH----VSPDARNFLRRTFVENAKKRPSAEELLRHFFV 263

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 64.3 bits (156), Expect = 2e-11
 Identities = 52/186 (27%), Positives = 88/186 (47%), Gaps = 21/186 (11%)

Query: 211 VLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGL-AEF 269
           V +  + +  I      +L+AL Y H+QG++HRD+K  ++++  + R ++L D+G  A+ 
Sbjct: 110 VTHTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGR-IKLSDFGFCAQV 168

Query: 270 YHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQ 329
                +    V + Y+  PE++  L  Y   +D+WSLG M   MI  + P+F    N   
Sbjct: 169 SKEVPKRKSLVGTPYWMAPEVISRLP-YGTEVDIWSLGIMVIEMIDGEPPYF----NEPP 223

Query: 330 LVKIAKDCCLIIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREA 389
           L  + +          R +  P  K     + H VS     FLD +L  +   R TA+E 
Sbjct: 224 LQAMRR---------IRDNLPPRVK-----DSHKVSSVLRGFLDLMLVREPSQRATAQEL 269

Query: 390 MAHPYF 395
           + HP+ 
Sbjct: 270 LQHPFL 275

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 64.3 bits (157), Expect = 2e-11
 Identities = 67/290 (23%), Positives = 124/290 (42%), Gaps = 54/290 (18%)

Query: 131 RKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKR--------EIKILQNLCGGPNV 182
           + +G+G + +V       T+E   +K+LK  K   ++         E ++L      P +
Sbjct: 1   KVLGKGSFGKVLLAELKGTDELYAVKVLK--KDVILQDDDVECTMTEKRVLALAGKHPFL 58

Query: 183 VKLLDIVRDQHS--KTPSLIF---EYVNSTDFKVLYPTLTDYD---IRYYIYELLKALDY 234
            +L       HS  +T   +F   EYVN  D          +D    R+Y  E++  L +
Sbjct: 59  TQL-------HSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQF 111

Query: 235 CHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVD 293
            H +GI++RD+K  NV++D E   +++ D+G+  E    G   +    +  +  PE+L  
Sbjct: 112 LHERGIIYRDLKLDNVLLDSE-GHIKIADFGMCKEGILGGVTTSTFCGTPDYIAPEILSY 170

Query: 294 LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWS 353
            Q Y  ++D W+LG +   M+  + PF    D+ D+L +           +       + 
Sbjct: 171 -QPYGPAVDWWALGVLLYEMLAGQSPF--EGDDEDELFQ-----------SILEDEVRYP 216

Query: 354 KFINADNQHLVSPEAIDFLDKLLRYDHQDRL----TAREAM-AHPYFAQV 398
           +++        S EA   L   L  + + RL    T  + +  HP+F ++
Sbjct: 217 RWL--------SKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGHPFFREI 258

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 63.8 bits (155), Expect = 2e-11
 Identities = 54/194 (27%), Positives = 92/194 (47%), Gaps = 19/194 (9%)

Query: 130 VRKVGRGKYSEV----FEGINVNTNERCIIKILKPVKKKK----IKREIKILQNLCGGPN 181
           +R +G G + +V    ++    NT E+  +K LKP         +K+EI+IL+NL    N
Sbjct: 9   IRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYH-EN 67

Query: 182 VVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDY----DIRYYIYELLKALDYCHS 237
           +VK   I  +       LI E++ S   K   P   +         Y  ++ K +DY  S
Sbjct: 68  IVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGS 127

Query: 238 QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNV----RVASRYFKGPELLVD 293
           +  +HRD+   NV+++ E  ++++ D+GL +     KEY        +  ++  PE L+ 
Sbjct: 128 RQYVHRDLAARNVLVESE-HQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQ 186

Query: 294 LQDYDYSLDMWSLG 307
            + Y  S D+WS G
Sbjct: 187 SKFYIAS-DVWSFG 199

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 64.9 bits (158), Expect = 2e-11
 Identities = 85/344 (24%), Positives = 136/344 (39%), Gaps = 83/344 (24%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIK-ILKPVKKKK-----IKREIKILQNLCG 178
           +D+  V+ +G+G + EV      +T +   +K +LK    KK     +K E  +L     
Sbjct: 1   EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAE-SD 59

Query: 179 GPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL---YPTLTDYDIRYYIYELLKALDYC 235
            P VV L    +D  ++   LI E++   D   +   Y T ++   R+Y+ E + A++  
Sbjct: 60  SPWVVSLYYSFQD--AQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAV 117

Query: 236 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP------------GKEYNVRVASR 283
           H  G +HRD+KP N++ID     ++L D+GL+  +H             GK    R+ +R
Sbjct: 118 HKLGFIHRDIKPDNILIDRG-GHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNR 176

Query: 284 Y------------------------------------FKGPELLVDLQDYDYSLDMWSLG 307
                                                +  PE+ +  Q Y    D WSLG
Sbjct: 177 NSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQ-QGYGQECDWWSLG 235

Query: 308 C-MFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSKFINADNQHLVSP 366
             MF  +I    P F   ++H+   KI          N R +          D+ HL S 
Sbjct: 236 AIMFECLI--GWPPFCSENSHETYRKII---------NWRET------LYFPDDIHL-SV 277

Query: 367 EAIDFLDKLLRYDHQ--DRLTAREAMAHPYFAQVRAAESSRTRA 408
           EA D + +L+        R  A E  +HP+F  V      + RA
Sbjct: 278 EAEDLIRRLITNAENRLGRGGAHEIKSHPFFRGVDWDTIRQIRA 321

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 63.1 bits (153), Expect = 3e-11
 Identities = 53/203 (26%), Positives = 93/203 (45%), Gaps = 18/203 (8%)

Query: 133 VGRGKYSEVFEGINVNTNERCIIKIL--KPVKKKKIKR------EIKILQNLCGGPNVVK 184
           +GRG + EV+   + +T     +K +   P  ++  K       EI++L+NL     +V+
Sbjct: 10  LGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNL-RHDRIVQ 68

Query: 185 LLDIVRDQHSKTPSLIFEYVNSTDFK---VLYPTLTDYDIRYYIYELLKALDYCHSQGIM 241
               +RD   K  S+  EY+     K     Y  LT+   R Y  ++L+ + Y HS  I+
Sbjct: 69  YYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIV 128

Query: 242 HRDVKPHNVMIDHELRKLRLIDWGLAE----FYHPGKEYNVRVASRYFKGPELLVDLQDY 297
           HRD+K  N++ D     ++L D+G ++        G        + Y+  PE ++  + Y
Sbjct: 129 HRDIKGANILRDSA-GNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPE-VISGEGY 186

Query: 298 DYSLDMWSLGCMFAGMIFRKEPF 320
               D+WS+ C    M+  K P+
Sbjct: 187 GRKADVWSVACTVVEMLTEKPPW 209

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 63.5 bits (154), Expect = 4e-11
 Identities = 52/182 (28%), Positives = 80/182 (43%), Gaps = 28/182 (15%)

Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEYNVRV 280
           R+Y  E+  AL Y HS  I++RD+KP N+++D     + L D+GL  E            
Sbjct: 99  RFYAAEIASALGYLHSINIVYRDLKPENILLD-SQGHVVLTDFGLCKEGIAQSDTTTTFC 157

Query: 281 ASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLI 340
            +  +  PE++   Q YD ++D W LG +   M++   P FY  D  +            
Sbjct: 158 GTPEYLAPEVIRK-QPYDNTVDWWCLGAVLYEMLYGLPP-FYCRDVAE------------ 203

Query: 341 IWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAR----EAMAHPYFA 396
           ++ N  H  KP         +   S  A   L++LL  D Q RL A+    E   HP+F 
Sbjct: 204 MYDNILH--KPLVL------RPGASLTAWSILEELLEKDRQRRLGAKEDFLEIQEHPFFE 255

Query: 397 QV 398
            +
Sbjct: 256 SL 257

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 63.5 bits (154), Expect = 4e-11
 Identities = 61/214 (28%), Positives = 98/214 (45%), Gaps = 22/214 (10%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKIL------KPVKKKKIKREIKILQNLCG 178
           DD+E+++ +GRG + EV      +T     +KIL      K  +    + E  +L N  G
Sbjct: 1   DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVN--G 58

Query: 179 GPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDY---DI-RYYIYELLKALDY 234
               +  L     Q      L+ +Y    D   L     D    D+ R+YI E++ A+  
Sbjct: 59  DCQWITTLHYAF-QDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHS 117

Query: 235 CHSQGIMHRDVKPHNVMIDHELRKLRLIDWG--LAEFYHPGKEYNVRVASRYFKGPELLV 292
            H    +HRD+KP NV++D     +RL D+G  L        + +V V +  +  PE+L 
Sbjct: 118 IHQLHYVHRDIKPDNVLLDMN-GHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQ 176

Query: 293 DLQD----YDYSLDMWSLG-CMFAGMIFRKEPFF 321
            ++D    Y    D WSLG CM+  M++ + PF+
Sbjct: 177 AMEDGMGKYGPECDWWSLGVCMYE-MLYGETPFY 209

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 62.8 bits (153), Expect = 4e-11
 Identities = 54/236 (22%), Positives = 103/236 (43%), Gaps = 39/236 (16%)

Query: 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCI---IKILK----PVKKKKIKREIKILQN 175
            ++D  + R +G G++ +V++G+ ++     I   +K  K    P  ++K  +E  I++ 
Sbjct: 4   QREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQ 63

Query: 176 LCGGPNVVKLLDIVRDQHSKTPSLI------------FEYVNSTDFKVLYPTLTDYDIRY 223
               P++VKL+ ++ +     P  I            +  VN     +    L       
Sbjct: 64  F-DHPHIVKLIGVITEN----PVWIVMELAPLGELRSYLQVNKYSLDLASLIL------- 111

Query: 224 YIYELLKALDYCHSQGIMHRDVKPHNVMI-DHELRKLRLIDWGLAEFYHPGKEYNVRVAS 282
           Y Y+L  AL Y  S+  +HRD+   NV++   +  KL   D+GL+ +      Y      
Sbjct: 112 YSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLG--DFGLSRYLEDESYYKASKGK 169

Query: 283 RYFK--GPELLVDLQDYDYSLDMWSLG-CMFAGMIFRKEPFFYGHDNHDQLVKIAK 335
              K   PE  ++ + +  + D+W  G CM+  ++   +PF  G  N+D + +I  
Sbjct: 170 LPIKWMAPE-SINFRRFTSASDVWMFGVCMWEILMLGVKPFQ-GVKNNDVIGRIEN 223

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 62.5 bits (152), Expect = 4e-11
 Identities = 69/291 (23%), Positives = 119/291 (40%), Gaps = 62/291 (21%)

Query: 127 YEVVRKVGRGKYSE-------------VFEGINVNTNERCIIKILKPVKKKKIKREIKIL 173
           Y  +R +G+G + E             V++ +N        +  L   +++    EI IL
Sbjct: 2   YIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVN--------LTRLSEKERRDALNEIVIL 53

Query: 174 QNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDF--KVLYPTLTDYDIRY---YIYEL 228
             L   PN++   +   D    T  +  EY N      K++      ++      Y++++
Sbjct: 54  SLL-QHPNIIAYYNHFMD--DNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQI 110

Query: 229 LKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLI---DWGLAEFYHPGKEYNVR---VAS 282
           + A+ Y H  GI+HRD+K  N+     L K  LI   D+G+++    G EY++    V +
Sbjct: 111 VSAVSYIHKAGILHRDIKTLNIF----LTKAGLIKLGDFGISKIL--GSEYSMAETVVGT 164

Query: 283 RYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIW 342
            Y+  PE L     Y++  D+W+LGC+   ++  K  F    D  + L         I+ 
Sbjct: 165 PYYMSPE-LCQGVKYNFKSDIWALGCVLYELLTLKRTF----DATNPL----NLVVKIVQ 215

Query: 343 CNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHP 393
            N       +S             E I  +  LL+ D + R TA E +  P
Sbjct: 216 GNYTPVVSVYSS------------ELISLVHSLLQQDPEKRPTADEVLDQP 254

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 62.5 bits (152), Expect = 6e-11
 Identities = 70/310 (22%), Positives = 124/310 (40%), Gaps = 73/310 (23%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQN--------- 175
           +D+E ++ +  G Y  V+   +  T +R  +K        KI ++  IL+N         
Sbjct: 1   EDFETIKLISNGAYGAVYLVRHKETRQRFAMK--------KINKQNLILRNQIQQVFVER 52

Query: 176 ----LCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDI---RYYIYEL 228
                   P VV +      +  +   ++ EYV   D   L   +    +   R Y  E 
Sbjct: 53  DILTFAENPFVVSMF--CSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFAET 110

Query: 229 LKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE---------FYHPGKEYNVR 279
           + AL+Y H+ GI+HRD+KP N++I   +  ++L D+GL++          Y    E ++ 
Sbjct: 111 VLALEYLHNYGIVHRDLKPDNLLIT-SMGHIKLTDFGLSKIGLMSLTTNLY----EGHIE 165

Query: 280 VASRYFK-----------GPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHD 328
             +R F             PE+++  Q Y   +D W++G +    +    PFF G    +
Sbjct: 166 KDTREFLDKQVCGTPEYIAPEVIL-RQGYGKPVDWWAMGIILYEFLVGCVPFF-GDTPEE 223

Query: 329 QLVKIAKDCCLIIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRL---T 385
              ++  D   I W                +    +  +A D + +LLR +  +RL    
Sbjct: 224 LFGQVISD--DIEW---------------PEGDEALPADAQDLISRLLRQNPLERLGTGG 266

Query: 386 AREAMAHPYF 395
           A E   H +F
Sbjct: 267 AFEVKQHRFF 276

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 62.9 bits (153), Expect = 7e-11
 Identities = 71/236 (30%), Positives = 108/236 (45%), Gaps = 37/236 (15%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKR--------EIKILQNL 176
           DD+E+++ +GRG + EV      NT +   +KIL   K + +KR        E  +L N 
Sbjct: 1   DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILN--KWEMLKRAETACFREERDVLVN- 57

Query: 177 CGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDY---DI-RYYIYELLKAL 232
            G    +  L     Q      L+ +Y    D   L     D    D+ R+Y+ E++ A+
Sbjct: 58  -GDRRWITNLHYAF-QDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAI 115

Query: 233 DYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWG--LAEFYHPGKEYNVRVASRYFKGPEL 290
           D  H  G +HRD+KP NV++D     +RL D+G  L        + NV V +  +  PE+
Sbjct: 116 DSVHQLGYVHRDIKPDNVLLDKN-GHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEI 174

Query: 291 LVDLQD----YDYSLDMWSLG-CMFAGMIFRKEPFF-------YG----HDNHDQL 330
           L  ++D    Y    D WSLG CM+  M++ + PF+       YG    H  H Q 
Sbjct: 175 LQAMEDGKGRYGPECDWWSLGVCMYE-MLYGETPFYAESLVETYGKIMNHKEHFQF 229

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 61.7 bits (150), Expect = 7e-11
 Identities = 52/212 (24%), Positives = 95/212 (44%), Gaps = 28/212 (13%)

Query: 126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK--------KKKIKREIKILQNLC 177
           D++V++K+G+G Y  V++   V          LK V         ++    EI+IL ++ 
Sbjct: 1   DFKVLKKLGKGSYGSVYK---VKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASV- 56

Query: 178 GGPNVVK----LLDIVR----DQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELL 229
             PN++      LD  +     +++    L          + L P    +  R +I +LL
Sbjct: 57  NHPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIW--RIFI-QLL 113

Query: 230 KALDYCHSQGIMHRDVKPHNVMI-DHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGP 288
           + L   H Q I+HRD+K  N+++  ++L K+   D G+++           + + ++  P
Sbjct: 114 RGLQALHEQKILHRDLKSANILLVANDLVKIG--DLGISKVLKKNMAKTQ-IGTPHYMAP 170

Query: 289 ELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPF 320
           E+    + Y Y  D+WSLGC+   M     PF
Sbjct: 171 EVWKG-RPYSYKSDIWSLGCLLYEMATFAPPF 201

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional

 Score = 63.1 bits (153), Expect = 7e-11
 Identities = 77/328 (23%), Positives = 140/328 (42%), Gaps = 78/328 (23%)

Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLL 186
           ++++  +G G + +V E  +    E C +KI++ V K    R+ KI          ++ +
Sbjct: 131 FKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPK--YTRDAKI---------EIQFM 179

Query: 187 DIVR--DQHSKTPSLIFE--YVNSTDFKVLY-----PTLTDYDIRY----------YIYE 227
           + VR  D   + P +  +  + N T    +      P L D+ +++           I++
Sbjct: 180 EKVRQADPADRFPLMKIQRYFQNETGHMCIVMPKYGPCLLDWIMKHGPFSHRHLAQIIFQ 239

Query: 228 LLKALDYCHSQ-GIMHRDVKPHNVM-------IDHELRK--------LRLIDWGLAEFYH 271
              ALDY H++  +MH D+KP N++       +D    +        +R+ D G      
Sbjct: 240 TGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLGGC---- 295

Query: 272 PGKEYNVR---VASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHD 328
              E + R   V++R+++ PE+++ L  + YS DMWS+GC+   + +  +  +  HDN +
Sbjct: 296 -CDERHSRTAIVSTRHYRSPEVVLGL-GWMYSTDMWSMGCIIYEL-YTGKLLYDTHDNLE 352

Query: 329 QLVKIAKDCCLII--W---CNSRHSRKPWSKFIN----ADNQHLV-------------SP 366
            L  + K    +   W   C +  +R  ++         D +HL                
Sbjct: 353 HLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDD 412

Query: 367 EAIDFLDKLLRYDHQDRLTAREAMAHPY 394
              D +  LL YD Q RL AR+   HPY
Sbjct: 413 LLCDLIYGLLHYDRQKRLNARQMTTHPY 440

Length = 467

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 62.5 bits (152), Expect = 1e-10
 Identities = 60/216 (27%), Positives = 100/216 (46%), Gaps = 29/216 (13%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKR-------EIKILQNLC 177
           +D++V++ +GRG + EV    + ++ +   +K+L   K + IKR       E + +    
Sbjct: 43  EDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLS--KFEMIKRSDSAFFWEERDIMAHA 100

Query: 178 GGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDI-----RYYIYELLKAL 232
               +V+L    +D   K   ++ EY+   D   L   +++YDI     R+Y  E++ AL
Sbjct: 101 NSEWIVQLHYAFQDD--KYLYMVMEYMPGGDLVNL---MSNYDIPEKWARFYTAEVVLAL 155

Query: 233 DYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR----VASRYFKGP 288
           D  HS G +HRDVKP N+++D     L+L D+G            VR    V +  +  P
Sbjct: 156 DAIHSMGFIHRDVKPDNMLLDKS-GHLKLADFGTC--MKMDANGMVRCDTAVGTPDYISP 212

Query: 289 ELLVDLQ---DYDYSLDMWSLGCMFAGMIFRKEPFF 321
           E+L        Y    D WS+G     M+    PF+
Sbjct: 213 EVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFY 248

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 61.5 bits (149), Expect = 1e-10
 Identities = 55/206 (26%), Positives = 93/206 (45%), Gaps = 19/206 (9%)

Query: 130 VRKVGRGKYSEV----FEGINVNTNERCIIKILK----PVKKKKIKREIKILQNLCGGPN 181
           +R +G G + +V    ++  N  T E   +K LK           K+EI IL+ L    N
Sbjct: 9   IRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTL-YHEN 67

Query: 182 VVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYP--TLTDYDIRYYIYELLKALDYCHSQG 239
           +VK      +Q  K   LI EYV     +   P   L    +  +  ++ + + Y HSQ 
Sbjct: 68  IVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQLLLFAQQICEGMAYLHSQH 127

Query: 240 IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASR-----YFKGPELLVDL 294
            +HRD+   NV++D++ R +++ D+GLA+    G EY  RV        ++   E L + 
Sbjct: 128 YIHRDLAARNVLLDND-RLVKIGDFGLAKAVPEGHEY-YRVREDGDSPVFWYAVECLKEN 185

Query: 295 QDYDYSLDMWSLGCMFAGMIFRKEPF 320
           +   Y+ D+WS G     ++   +  
Sbjct: 186 KFS-YASDVWSFGVTLYELLTHCDSK 210

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 61.7 bits (150), Expect = 1e-10
 Identities = 54/205 (26%), Positives = 92/205 (44%), Gaps = 30/205 (14%)

Query: 200 IFEYVNSTDFKVLYPTLTDYDI---RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEL 256
           + EY+N  D      +   +D    R+Y  E++  L + H +GI++RD+K  NV++D + 
Sbjct: 74  VMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDG 133

Query: 257 RKLRLIDWGLA--EFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMI 314
             +++ D+G+        GK  +    +  +  PE+L   Q Y+ S+D WS G +   M+
Sbjct: 134 H-IKIADFGMCKENMNGEGKA-STFCGTPDYIAPEILKG-QKYNESVDWWSFGVLLYEML 190

Query: 315 FRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDK 374
             + P F+G D  D+L                + R  + ++I        S EA D L K
Sbjct: 191 IGQSP-FHGED-EDEL----------FDS-ILNDRPHFPRWI--------SKEAKDCLSK 229

Query: 375 LLRYDHQDRLTAR-EAMAHPYFAQV 398
           L   D   RL    +   HP+F  +
Sbjct: 230 LFERDPTKRLGVDGDIRQHPFFRGI 254

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 62.0 bits (150), Expect = 1e-10
 Identities = 57/213 (26%), Positives = 97/213 (45%), Gaps = 20/213 (9%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKIL------KPVKKKKIKREIKILQNLCG 178
           +D+E+++ +GRG + EV      N ++   +KIL      K  +    + E  +L N  G
Sbjct: 1   EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVN--G 58

Query: 179 GPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDY---DI-RYYIYELLKALDY 234
               +  L     Q      L+ +Y    D   L     D    D+ R+Y+ E++ A+D 
Sbjct: 59  DNQWITTLHYAF-QDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDS 117

Query: 235 CHSQGIMHRDVKPHNVMIDHELRKLRLIDWG--LAEFYHPGKEYNVRVASRYFKGPELLV 292
            H    +HRD+KP N+++D     +RL D+G  L        + +V V +  +  PE+L 
Sbjct: 118 VHQLHYVHRDIKPDNILMDMN-GHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQ 176

Query: 293 DLQD----YDYSLDMWSLGCMFAGMIFRKEPFF 321
            ++D    Y    D WSLG     M++ + PF+
Sbjct: 177 AMEDGKGKYGPECDWWSLGVCMYEMLYGETPFY 209

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 61.9 bits (150), Expect = 1e-10
 Identities = 49/184 (26%), Positives = 82/184 (44%), Gaps = 27/184 (14%)

Query: 219 YDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE-YN 277
              R+Y  ELL AL+  H   +++RD+KP N+++D++   + L D+GL +      +  N
Sbjct: 93  SRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQ-GHIALCDFGLCKLNMKDDDKTN 151

Query: 278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDC 337
               +  +  PELL+    Y  ++D W+LG +   M+    P FY  + ++   KI ++ 
Sbjct: 152 TFCGTPEYLAPELLLGH-GYTKAVDWWTLGVLLYEMLTGLPP-FYDENVNEMYRKILQE- 208

Query: 338 CLIIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRL---TAREAMAHPY 394
                                D       +A D L  LL  D   RL    A+E   HP+
Sbjct: 209 ----------------PLRFPDG---FDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNHPF 249

Query: 395 FAQV 398
           F+Q+
Sbjct: 250 FSQL 253

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 61.6 bits (149), Expect = 2e-10
 Identities = 58/209 (27%), Positives = 96/209 (45%), Gaps = 32/209 (15%)

Query: 199 LIFEYVNSTD--FKVLYPTLTDYD-IRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE 255
            + EYVN  +  F +    +   D  R+Y  E++ ALDY HS  I++RD+K  N+M+D +
Sbjct: 72  FVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKD 131

Query: 256 LRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMI 314
              +++ D+GL  E             +  +  PE+L D  DY  ++D W LG +   M+
Sbjct: 132 -GHIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMM 189

Query: 315 FRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDK 374
             + PF+  + +H++L +      LI+  + +  R              +S +A   L  
Sbjct: 190 CGRLPFY--NQDHEKLFE------LILMEDIKFPRT-------------LSADAKSLLSG 228

Query: 375 LLRYDHQDRL-----TAREAMAHPYFAQV 398
           LL  D   RL      A+E M H +F  V
Sbjct: 229 LLIKDPNKRLGGGPDDAKEIMRHSFFTGV 257

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 61.3 bits (149), Expect = 2e-10
 Identities = 45/174 (25%), Positives = 85/174 (48%), Gaps = 23/174 (13%)

Query: 228 LLKALDYCHSQ-GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFK 286
           ++KAL+Y HS+  ++HRDVKP NV+I+    +++L D+G++ +        +    + + 
Sbjct: 112 IVKALEYLHSKLSVIHRDVKPSNVLINRN-GQVKLCDFGISGYLVDSVAKTIDAGCKPYM 170

Query: 287 GPELL---VDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWC 343
            PE +   ++ + YD   D+WSLG     +   + P+        QL ++ ++       
Sbjct: 171 APERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEE------- 223

Query: 344 NSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQ 397
                + P  KF         SPE  DF++K L+ ++++R    E + HP+F  
Sbjct: 224 --PSPQLPAEKF---------SPEFQDFVNKCLKKNYKERPNYPELLQHPFFEL 266

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 61.4 bits (149), Expect = 2e-10
 Identities = 70/293 (23%), Positives = 115/293 (39%), Gaps = 62/293 (21%)

Query: 133 VGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKR---------EIKILQNLCGGPNVV 183
           +G+G + +V       T+E   IK+LK   K  I +         E +IL      P + 
Sbjct: 3   LGKGSFGKVMLAELKGTDEVYAIKVLK---KDVILQDDDVDCTMTEKRILALAAKHPFLT 59

Query: 184 KLLDIVRDQHS--KTPSLIF---EYVNSTDFKVLYPTLTDYD---IRYYIYELLKALDYC 235
            L       H   +T   +F   EYVN  D          +D    R+Y  E+  AL + 
Sbjct: 60  AL-------HCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFL 112

Query: 236 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDL 294
           H  G+++RD+K  N+++D E    +L D+G+  E    G        +  +  PE+L + 
Sbjct: 113 HRHGVIYRDLKLDNILLDAE-GHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQE- 170

Query: 295 QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVK--IAKDCCLIIWCNSRHSRKPW 352
            +Y  S+D W+LG +   M+  + PF    DN D L +  +  D    +W          
Sbjct: 171 LEYGPSVDWWALGVLMYEMMAGQPPF--EADNEDDLFESILHDDVLYPVW---------- 218

Query: 353 SKFINADNQHLVSPEAIDFLDKLLRYDHQDRL-------TAREAMAHPYFAQV 398
                      +S EA+  L   +  +   RL              HP+F ++
Sbjct: 219 -----------LSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHPFFKEI 260

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 60.4 bits (146), Expect = 3e-10
 Identities = 65/295 (22%), Positives = 133/295 (45%), Gaps = 43/295 (14%)

Query: 126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKI----------KREIKILQN 175
           ++E+++ +G G Y +VF    V+ ++   +  +K +KK  I          + E ++L++
Sbjct: 1   NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60

Query: 176 LCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDF---KVLYPTLTDYDIRYYIYELLKAL 232
           +   P +V L      Q      LI +Y+N  +            + +++ Y  E++ AL
Sbjct: 61  IRQSPFLVTLHYAF--QTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLAL 118

Query: 233 DYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG---KEYNVRVASRYFKGPE 289
           ++ H  GI++RD+K  N+++D     + L D+GL++ +H     + Y+      Y   P+
Sbjct: 119 EHLHKLGIIYRDIKLENILLDSN-GHVVLTDFGLSKEFHEDEVERAYSFCGTIEYM-APD 176

Query: 290 LLVDLQD-YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHS 348
           ++      +D ++D WS+G +   ++    PF    + + Q  +I++            S
Sbjct: 177 IVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQ-AEISRRIL--------KS 227

Query: 349 RKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRL-----TAREAMAHPYFAQV 398
             P+ + +        S  A D + +LL  D + RL      A E   HP+F ++
Sbjct: 228 EPPYPQEM--------SALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKI 274

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 60.8 bits (147), Expect = 3e-10
 Identities = 63/241 (26%), Positives = 109/241 (45%), Gaps = 50/241 (20%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP---VKKKK---IKREIKILQNLCG 178
           DD+E ++ +GRG + EV      +T     +KIL+    ++K++   I+ E  IL     
Sbjct: 1   DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVE-AD 59

Query: 179 GPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYC 235
           G  VVK+    +D+  +   LI E++   D   L     TL++   ++YI E + A+D  
Sbjct: 60  GAWVVKMFYSFQDK--RNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAI 117

Query: 236 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGL---------AEFY-----HPGKEYNVR-- 279
           H  G +HRD+KP N+++D +   ++L D+GL          EFY     +P  +++ +  
Sbjct: 118 HQLGFIHRDIKPDNLLLDAK-GHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNM 176

Query: 280 --------------------VASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEP 319
                               V +  +  PE+ +    Y+   D WSLG +   M+    P
Sbjct: 177 NSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQ-TGYNKLCDWWSLGVIMYEMLIGYPP 235

Query: 320 F 320
           F
Sbjct: 236 F 236

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 60.1 bits (146), Expect = 4e-10
 Identities = 50/206 (24%), Positives = 102/206 (49%), Gaps = 16/206 (7%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK---PVKKKK---IKREIKILQNLCG 178
           DD E ++ VG G +  V    +  +     +K++     ++ K+   +  E ++L+ +  
Sbjct: 1   DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEV-S 59

Query: 179 GPNVVKLLDIVRDQHSKTPSLIFEYVNSTD-FKVLYP--TLTDYDIRYYIYELLKALDYC 235
            P +++L     DQ      ++ EYV   + F  L      ++    +Y  E++ AL+Y 
Sbjct: 60  HPFIIRLFWTEHDQRFLY--MLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYL 117

Query: 236 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQ 295
           HS+ I++RD+KP N+++D E   ++L D+G A+     + + +     Y   PE++   +
Sbjct: 118 HSKEIVYRDLKPENILLDKE-GHIKLTDFGFAKKLR-DRTWTLCGTPEYL-APEVIQS-K 173

Query: 296 DYDYSLDMWSLGCMFAGMIFRKEPFF 321
            ++ ++D W+LG +   M+    PFF
Sbjct: 174 GHNKAVDWWALGILIYEMLVGYPPFF 199

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 59.4 bits (144), Expect = 5e-10
 Identities = 57/226 (25%), Positives = 106/226 (46%), Gaps = 27/226 (11%)

Query: 126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKR--------EIKILQNLC 177
           D+E++ K+G+G +  VF+ +    ++R  +  +K +   K+ R        E ++L  L 
Sbjct: 1   DFEILNKIGKGSFGVVFKVVR-KADKR--VYAMKQIDLSKMNRREREEAIDEARVLAKL- 56

Query: 178 GGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY------PTLTDYDIRYYIYELLKA 231
               +++  +   D+     +++ EY  + D   L       P   D   R++I  LL  
Sbjct: 57  DSSYIIRYYESFLDK--GKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILL-G 113

Query: 232 LDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY-NVRVASRYFKGPEL 290
           L + HS+ I+HRD+K  N+ +D     +++ D G+A+       + N  V + Y+  PEL
Sbjct: 114 LAHLHSKKILHRDIKSLNLFLDAYD-NVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPEL 172

Query: 291 LVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV-KIAK 335
             D + Y+   D+W+LG +       K PF    +N   L+ KI +
Sbjct: 173 CED-KPYNEKSDVWALGVVLYECCTGKHPF--DANNQGALILKIIR 215

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 59.6 bits (144), Expect = 6e-10
 Identities = 32/101 (31%), Positives = 56/101 (55%), Gaps = 3/101 (2%)

Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEYNVRV 280
           R+Y  E+  A+ Y HS  I++RD+KP N+++D +   + L D+GL  E   P +  +   
Sbjct: 99  RFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQ-GHVVLTDFGLCKEGVEPEETTSTFC 157

Query: 281 ASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 321
            +  +  PE+L   + YD ++D W LG +   M++   PF+
Sbjct: 158 GTPEYLAPEVLRK-EPYDRTVDWWCLGAVLYEMLYGLPPFY 197

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 59.3 bits (144), Expect = 7e-10
 Identities = 48/186 (25%), Positives = 78/186 (41%), Gaps = 27/186 (14%)

Query: 226 YELLKALDYC-HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRY 284
             ++KAL Y     G++HRDVKP N+++D     ++L D+G++      K          
Sbjct: 121 VAIVKALHYLKEKHGVIHRDVKPSNILLD-ASGNVKLCDFGISGRLVDSKAKTRSAGCAA 179

Query: 285 FKGPELLVDLQD----YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLI 340
           +  PE + D  D    YD   D+WSLG     +   + P+       + L KI ++    
Sbjct: 180 YMAPERI-DPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQE---- 234

Query: 341 IWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRA 400
                    +P S           SP+   F+D  L  DH+ R   RE + HP+   +R 
Sbjct: 235 ---------EPPS----LPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPF---IRR 278

Query: 401 AESSRT 406
            E++  
Sbjct: 279 YETAEV 284

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 59.6 bits (144), Expect = 8e-10
 Identities = 48/184 (26%), Positives = 82/184 (44%), Gaps = 32/184 (17%)

Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEYNVRV 280
           R+Y  E+  AL Y HS  I++RD+KP N+++D +   + L D+GL  E        +   
Sbjct: 99  RFYAAEIASALGYLHSLNIVYRDLKPENILLDSQ-GHIVLTDFGLCKENIEHNGTTSTFC 157

Query: 281 ASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLI 340
            +  +  PE+L   Q YD ++D W LG +   M++   PF+                   
Sbjct: 158 GTPEYLAPEVL-HKQPYDRTVDWWCLGAVLYEMLYGLPPFY------------------- 197

Query: 341 IWCNSRHSRKPWSKFINADNQHL--VSPEAIDFLDKLLRYDHQDRLTAR----EAMAHPY 394
               SR++ + +   +N   Q    ++  A   L+ LL+ D   RL A+    E   H +
Sbjct: 198 ----SRNTAEMYDNILNKPLQLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKNHIF 253

Query: 395 FAQV 398
           F+ +
Sbjct: 254 FSPI 257

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 59.2 bits (143), Expect = 8e-10
 Identities = 52/191 (27%), Positives = 87/191 (45%), Gaps = 43/191 (22%)

Query: 219 YDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE--Y 276
           Y   +Y  E++  L + HS+GI++RD+K  NVM+D +   +++ D+G+       KE  +
Sbjct: 96  YRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGH-IKIADFGMC------KENVF 148

Query: 277 NVRVASRY-----FKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV 331
               AS +     +  PE+L  L+ Y +S+D WS G +   M+  + P F+G D+ D+L 
Sbjct: 149 GDNRASTFCGTPDYIAPEILQGLK-YTFSVDWWSFGVLLYEMLIGQSP-FHG-DDEDELF 205

Query: 332 KIAKDCCLIIWCNSRHSRKPWSKFINADNQHL---VSPEAIDFLDKLLRYDHQDRL-TAR 387
           +                       I  D  H    ++ E+ D L+KL   D   RL    
Sbjct: 206 ES----------------------IRVDTPHYPRWITKESKDILEKLFERDPTRRLGVVG 243

Query: 388 EAMAHPYFAQV 398
               HP+F  +
Sbjct: 244 NIRGHPFFKTI 254

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 59.1 bits (143), Expect = 9e-10
 Identities = 44/143 (30%), Positives = 72/143 (50%), Gaps = 11/143 (7%)

Query: 195 KTPSLIF---EYVNSTDFKVLYPTLTDYD---IRYYIYELLKALDYCHSQGIMHRDVKPH 248
           +TP  +F   E+VN  D          +D    R+Y  E+  AL + H +GI++RD+K  
Sbjct: 66  QTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLD 125

Query: 249 NVMIDHELRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLG 307
           NV++DHE    +L D+G+  E    GK  +    +  +  PE+L ++  Y  S+D W++G
Sbjct: 126 NVLLDHE-GHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQEML-YGPSVDWWAMG 183

Query: 308 CMFAGMIFRKEPFFYGHDNHDQL 330
            +   M+    PF    +N D L
Sbjct: 184 VLLYEMLCGHAPF--EAENEDDL 204

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 58.5 bits (141), Expect = 1e-09
 Identities = 32/98 (32%), Positives = 54/98 (55%), Gaps = 2/98 (2%)

Query: 223 YYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVAS 282
           +Y  EL   L+    + I++RD+KP N+++D +   +R+ D GLA     G+    RV +
Sbjct: 106 FYAAELCCGLEDLQRERIVYRDLKPENILLD-DRGHIRISDLGLAVQIPEGETVRGRVGT 164

Query: 283 RYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPF 320
             +  PE++ + + Y +S D W LGC+   MI  + PF
Sbjct: 165 VGYMAPEVINN-EKYTFSPDWWGLGCLIYEMIQGQSPF 201

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 58.7 bits (142), Expect = 1e-09
 Identities = 56/216 (25%), Positives = 101/216 (46%), Gaps = 38/216 (17%)

Query: 126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKR------EIKILQNLCGG 179
           D+E+   +G G +  V    +  T E   IK LK  +  K+K+      E  IL  L   
Sbjct: 19  DFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSH- 77

Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNSTD-FKVL-----YPTLTDYDI-RYYIYELLKAL 232
           P +V ++   +D+       + E+V   + F  L     +P     D+ ++Y  EL+ A 
Sbjct: 78  PFIVNMMCSFQDE--NRVYFLLEFVVGGELFTHLRKAGRFPN----DVAKFYHAELVLAF 131

Query: 233 DYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFK---GPE 289
           +Y HS+ I++RD+KP N+++D++   +++ D+G A+          +V  R F     PE
Sbjct: 132 EYLHSKDIIYRDLKPENLLLDNK-GHVKVTDFGFAK----------KVPDRTFTLCGTPE 180

Query: 290 LL----VDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 321
            L    +  + +  ++D W++G +    I    PFF
Sbjct: 181 YLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFF 216

Length = 329

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 57.3 bits (138), Expect = 3e-09
 Identities = 53/225 (23%), Positives = 102/225 (45%), Gaps = 22/225 (9%)

Query: 126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK-PVKKKKIK--REIKILQNLCGGPNV 182
            Y V+R VG G +       +VN++++  +K ++ P     ++  R+  +L      PN+
Sbjct: 1   QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNI 60

Query: 183 VKLLDIVR-DQHSKTPSLIFEYVNSTDF--KV------LYPTLTDYDIRYYIYELLKALD 233
           V   +    D H     ++ EY +  D   K+      L+P  T   I  +  ++   + 
Sbjct: 61  VAFKESFEADGHL---YIVMEYCDGGDLMQKIKLQRGKLFPEDT---ILQWFVQMCLGVQ 114

Query: 234 YCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY-HPGKEYNVRVASRYFKGPELLV 292
           + H + ++HRD+K  N+ +     K++L D+G A     PG      V + Y+  PE+  
Sbjct: 115 HIHEKRVLHRDIKSKNIFLTQNG-KVKLGDFGSARLLTSPGAYACTYVGTPYYVPPEIWE 173

Query: 293 DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDC 337
           ++  Y+   D+WSLGC+   +   K PF      +  ++K+ +  
Sbjct: 174 NMP-YNNKSDIWSLGCILYELCTLKHPFQANSWKN-LILKVCQGS 216

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 57.7 bits (139), Expect = 3e-09
 Identities = 78/339 (23%), Positives = 134/339 (39%), Gaps = 85/339 (25%)

Query: 130 VRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKR----EIKILQNLCGGPN---V 182
           ++ +G G + EV     V+T+    +K L+  KK  + R     +K  +++    +   V
Sbjct: 6   IKTLGIGAFGEVCLACKVDTHALYAMKTLR--KKDVLNRNQVAHVKAERDILAEADNEWV 63

Query: 183 VKLLDIVRDQHSKTPSLIFEYVNSTDFKVL---YPTLTDYDIRYYIYELLKALDYCHSQG 239
           VKL    +D+ +     + +Y+   D   L        +   R+YI EL  A++  H  G
Sbjct: 64  VKLYYSFQDKDNLY--FVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMG 121

Query: 240 IMHRDVKPHNVMIDHELRKLRLIDWGL---------AEFYHPGKEY-------------- 276
            +HRD+KP N++ID +   ++L D+GL         +++Y  G                 
Sbjct: 122 FIHRDIKPDNILIDLD-GHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDV 180

Query: 277 -NVRVASRY------------------------FKGPELLVDLQDYDYSLDMWSLGCMFA 311
            N R   R                         +  PE+L+  + Y    D WS+G +  
Sbjct: 181 SNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLR-KGYTQLCDWWSVGVILF 239

Query: 312 GMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSKFINADNQHLVSPEAIDF 371
            M+  + PF        QL  I                  W   ++   Q  +SPEA+D 
Sbjct: 240 EMLVGQPPFLAPTPTETQLKVIN-----------------WENTLHIPPQVKLSPEAVDL 282

Query: 372 LDKLLRYDHQDRL---TAREAMAHPYFAQVRAAESSRTR 407
           + KL     ++RL    A +  AHP+F++V  +   RT+
Sbjct: 283 ITKLC-CSAEERLGRNGADDIKAHPFFSEVDFSSDIRTQ 320

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 56.8 bits (137), Expect = 4e-09
 Identities = 58/273 (21%), Positives = 115/273 (42%), Gaps = 31/273 (11%)

Query: 133 VGRGKYSEVFEGINVNTNERCIIKIL----KPVKKKKIKREIKILQNLCGGPNVVKLLD- 187
           +G G    V++  ++ T     +K++        +K+I  E++IL   C  P ++     
Sbjct: 9   LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYK-CDSPYIIGFYGA 67

Query: 188 -IVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVK 246
             V ++     S+  E+++     V Y  + ++ +      ++K L Y  S  I+HRDVK
Sbjct: 68  FFVENR----ISICTEFMDGGSLDV-YRKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVK 122

Query: 247 PHNVMIDHELRKLRLIDWGLAE--FYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMW 304
           P N++++    +++L D+G++        K Y   V +  +  PE +   Q Y    D+W
Sbjct: 123 PSNMLVNTR-GQVKLCDFGVSTQLVNSIAKTY---VGTNAYMAPERISGEQ-YGIHSDVW 177

Query: 305 SLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSKFINADNQHLV 364
           SLG  F  +   + P+     N   L+ +    C++   +      P             
Sbjct: 178 SLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIV---DEDPPVLP---------VGQF 225

Query: 365 SPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQ 397
           S + + F+ + +R   ++R      M HP+  Q
Sbjct: 226 SEKFVHFITQCMRKQPKERPAPENLMDHPFIVQ 258

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 57.0 bits (138), Expect = 4e-09
 Identities = 46/180 (25%), Positives = 77/180 (42%), Gaps = 29/180 (16%)

Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEYNVRV 280
            +Y   ++  L Y H   I++RD+K  N+++D E   +++ D+GL  E    G   +   
Sbjct: 104 VFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTE-GFVKIADFGLCKEGMGFGDRTSTFC 162

Query: 281 ASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLI 340
            +  F  PE+L +   Y  ++D W LG +   M+  + PF  G D  +    I  D    
Sbjct: 163 GTPEFLAPEVLTE-TSYTRAVDWWGLGVLIYEMLVGESPF-PGDDEEEVFDSIVND---- 216

Query: 341 IWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRL-----TAREAMAHPYF 395
                R+ R              +S EAI  + +LLR + + RL      A +    P+F
Sbjct: 217 ---EVRYPR-------------FLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQPFF 260

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 57.1 bits (138), Expect = 4e-09
 Identities = 42/156 (26%), Positives = 75/156 (48%), Gaps = 13/156 (8%)

Query: 160 PVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDY 219
           P  +K+I RE++I ++ C  P +VK      D+ S +  +  EY        +Y  +   
Sbjct: 40  PDLQKQILRELEINKS-CKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKR 98

Query: 220 DIRYYIYEL-------LKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYH 271
             R     L       LK L Y HS+ I+HRD+KP N+++  +  +++L D+G++ E  +
Sbjct: 99  GGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRK-GQVKLCDFGVSGELVN 157

Query: 272 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLG 307
                     + ++  PE +   + Y  + D+WSLG
Sbjct: 158 SLA--GTFTGTSFYMAPERIQG-KPYSITSDVWSLG 190

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 56.0 bits (135), Expect = 8e-09
 Identities = 51/205 (24%), Positives = 90/205 (43%), Gaps = 26/205 (12%)

Query: 133 VGRGKYSEVFEGINVNTNERCIIKILKPVKKKK----IKREIKILQNLCGGPNVVKLLDI 188
           +G+G Y  V+   +++T  R  IK + P +  +    +  EI +   L    N+V+ L  
Sbjct: 16  LGKGTYGIVYAARDLSTQVRIAIKEI-PERDSRYVQPLHEEIALHSYLKHR-NIVQYLG- 72

Query: 189 VRDQHSKTPSLIFEYVNSTDFKVLYPT----LTDYD--IRYYIYELLKALDYCHSQGIMH 242
             D  +    +  E V       L  +    L D +  I +Y  ++L+ L Y H   I+H
Sbjct: 73  -SDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVH 131

Query: 243 RDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG------PELL-VDLQ 295
           RD+K  NV+++     +++ D+G ++     +   +   +  F G      PE++    +
Sbjct: 132 RDIKGDNVLVNTYSGVVKISDFGTSK-----RLAGINPCTETFTGTLQYMAPEVIDKGPR 186

Query: 296 DYDYSLDMWSLGCMFAGMIFRKEPF 320
            Y    D+WSLGC    M   K PF
Sbjct: 187 GYGAPADIWSLGCTIVEMATGKPPF 211

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 56.8 bits (137), Expect = 9e-09
 Identities = 43/151 (28%), Positives = 79/151 (52%), Gaps = 11/151 (7%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK--KKKIKREIKILQN---LCGG 179
           +++ +V+ + RG + +V+ G   N ++   +K++K      K +  +++  ++   L   
Sbjct: 4   EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKS 63

Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYD---IRYYIYELLKALDYCH 236
           P +V L   +  Q +    L+ EY+   D K L      +D      YI E+  ALDY H
Sbjct: 64  PFIVHLYYSL--QSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLH 121

Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLA 267
             GI+HRD+KP N++I +E   ++L D+GL+
Sbjct: 122 RHGIIHRDLKPDNMLISNE-GHIKLTDFGLS 151

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 54.1 bits (131), Expect = 3e-08
 Identities = 48/172 (27%), Positives = 80/172 (46%), Gaps = 22/172 (12%)

Query: 225 IYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRY 284
           I +L++AL+  H   I+H D+K  NV+ D    ++ L D+GL +       Y+  +   Y
Sbjct: 115 IRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPSCYDGTLD--Y 172

Query: 285 FKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCN 344
           F  PE +    +YD S D W++G +   ++  K PF    ++ D+ + +           
Sbjct: 173 FS-PEKIKG-HNYDVSFDWWAVGVLTYELLTGKHPF---KEDEDEELDLES-------LL 220

Query: 345 SRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTA-REAMAHPYF 395
            R  +K    FI       VS  A DF+  +L+Y+   RLT   E + HP+ 
Sbjct: 221 KRQQKKL--PFIKN-----VSKNANDFVQSMLKYNINYRLTNYNEIIKHPFL 265

Length = 267

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 53.3 bits (128), Expect = 5e-08
 Identities = 48/212 (22%), Positives = 103/212 (48%), Gaps = 22/212 (10%)

Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIK-----ILKPVKKKKIKREIKILQNLCGGPN 181
           Y  V+K+G G + +     +    ++ +IK      + P ++++ ++E+ +L N+   PN
Sbjct: 2   YVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNM-KHPN 60

Query: 182 VVKLLDIVRDQHSKTPSLIFEYVNSTD-FK-------VLYPTLTDYDIRYYIYELLKALD 233
           +V+  +    + +    ++ +Y    D +K       VL+P   +  I  +  ++  AL 
Sbjct: 61  IVQYQESF--EENGNLYIVMDYCEGGDLYKKINAQRGVLFP---EDQILDWFVQICLALK 115

Query: 234 YCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY-NVRVASRYFKGPELLV 292
           + H + I+HRD+K  N+ +  +   ++L D+G+A   +   E     + + Y+  PE + 
Sbjct: 116 HVHDRKILHRDIKSQNIFLTKD-GTIKLGDFGIARVLNSTVELARTCIGTPYYLSPE-IC 173

Query: 293 DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGH 324
           + + Y+   D+W+LGC+   M   K  F  G+
Sbjct: 174 ENRPYNNKSDIWALGCVLYEMCTLKHAFEAGN 205

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 53.5 bits (128), Expect = 7e-08
 Identities = 46/151 (30%), Positives = 81/151 (53%), Gaps = 13/151 (8%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP---VKKKK---IKREIKILQNLCG 178
           +D+E ++ +GRG + EV      +T     +KIL+    ++K++   I+ E  IL     
Sbjct: 1   EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVE-AD 59

Query: 179 GPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYC 235
              VVK+    +D+ +    LI E++   D   L     TLT+ + ++YI E + A+D  
Sbjct: 60  SLWVVKMFYSFQDKLNLY--LIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSI 117

Query: 236 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGL 266
           H  G +HRD+KP N+++D +   ++L D+GL
Sbjct: 118 HQLGFIHRDIKPDNLLLDSK-GHVKLSDFGL 147

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 52.6 bits (126), Expect = 8e-08
 Identities = 48/203 (23%), Positives = 91/203 (44%), Gaps = 22/203 (10%)

Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIK--------REIKILQNLCG 178
           Y + +++G+G +  V+   +        +K+LK +   ++         +E ++L  L  
Sbjct: 2   YILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKL-D 60

Query: 179 GPNVVKLLDIVRDQHSKTPSLIFEYVNSTD-------FKVLYPTLTDYDIRYYIYELLKA 231
            P +VK      ++ +    +I EY    D        K    TL++  +  +  +LL  
Sbjct: 61  HPAIVKFHASFLERDAFC--IITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLG 118

Query: 232 LDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY-NVRVASRYFKGPEL 290
           + Y H + I+HRD+K  N+ + + L  L++ D+G++       +       + Y+  PE 
Sbjct: 119 VHYMHQRRILHRDLKAKNIFLKNNL--LKIGDFGVSRLLMGSCDLATTFTGTPYYMSPEA 176

Query: 291 LVDLQDYDYSLDMWSLGCMFAGM 313
           L   Q YD   D+WSLGC+   M
Sbjct: 177 LKH-QGYDSKSDIWSLGCILYEM 198

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 53.2 bits (128), Expect = 8e-08
 Identities = 72/325 (22%), Positives = 124/325 (38%), Gaps = 75/325 (23%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTN---ERCIIKI-LKPVKKKKIKREIKILQNLCGGP 180
           DD+E + ++G G    V + ++  +     R +I + +KP  + +I RE+K+L   C  P
Sbjct: 1   DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHE-CNSP 59

Query: 181 NVVKL---------------------LDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDY 219
            +V                       LD V  +  + P  I   ++              
Sbjct: 60  YIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPENILGKIS-------------- 105

Query: 220 DIRYYIYELLKALDYC---HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY 276
                   +L+ L Y    H   IMHRDVKP N++++    +++L D+G++         
Sbjct: 106 ------IAVLRGLTYLREKHK--IMHRDVKPSNILVNSR-GEIKLCDFGVSGQLIDSMA- 155

Query: 277 NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI--- 333
           N  V +R +  PE L     Y    D+WSLG     M   + P      +  +L  +   
Sbjct: 156 NSFVGTRSYMSPERLQG-THYTVQSDIWSLGLSLVEMAIGRYPI--PPPDAKELEAMFGR 212

Query: 334 ------AKDCCLIIWCNSRHSRKPWSKFINADN----------QHLVSPEAIDFLDKLLR 377
                 AK+    +  +   S +P + F   D               S E  DF+DK L+
Sbjct: 213 PVSEGEAKESHRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLK 272

Query: 378 YDHQDRLTAREAMAHPYFAQVRAAE 402
            + ++R   +E   HP+  +    E
Sbjct: 273 KNPKERADLKELTKHPFIKRAELEE 297

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 53.5 bits (128), Expect = 8e-08
 Identities = 58/228 (25%), Positives = 87/228 (38%), Gaps = 71/228 (31%)

Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGL---------AEFY-- 270
           R+YI EL  A++  H  G +HRD+KP N++ID +   ++L D+GL         +++Y  
Sbjct: 104 RFYIAELTCAVESVHKMGFIHRDIKPDNILIDRD-GHIKLTDFGLCTGFRWTHDSKYYQS 162

Query: 271 --HP-----------GKEYNVRVASRY------------------------FKGPELLVD 293
             H            G   N R   R                         +  PE+L+ 
Sbjct: 163 GDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLR 222

Query: 294 LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWS 353
              Y    D WS+G +   M+  + PF        Q+  I                  W 
Sbjct: 223 -TGYTQLCDWWSVGVILYEMLVGQPPFLAQTPLETQMKVIN-----------------WQ 264

Query: 354 KFINADNQHLVSPEAIDFLDKLLRYDHQDRL---TAREAMAHPYFAQV 398
             ++   Q  +SPEA D + KL R   +DRL    A E  AHP+F  +
Sbjct: 265 TSLHIPPQAKLSPEASDLIIKLCR-GPEDRLGKNGADEIKAHPFFKTI 311

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 52.1 bits (125), Expect = 2e-07
 Identities = 46/167 (27%), Positives = 78/167 (46%), Gaps = 16/167 (9%)

Query: 165 KIKREIKILQNLCGGPNVVKL---------LDIVRDQHSKTPSLIFEYVNSTDFKVLYPT 215
            I  E+ I++     PN+V+          L IV D     P  + E+ NS   K     
Sbjct: 54  DIVSEVTIIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAP--LGEHFNS--LKEKKQR 109

Query: 216 LTDYDIRYYIYELLKALDYCHSQG-IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 274
            T+  I     +++ AL Y H +  I+HRD+ P+N+M+  E  K+ + D+GLA+   P  
Sbjct: 110 FTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLG-EDDKVTITDFGLAKQKQPES 168

Query: 275 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 321
           +    V +  +  PE++ +   Y    D+W+ GC+   M   + PF+
Sbjct: 169 KLTSVVGTILYSCPEIVKNEP-YGEKADVWAFGCILYQMCTLQPPFY 214

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 52.5 bits (126), Expect = 2e-07
 Identities = 31/99 (31%), Positives = 53/99 (53%), Gaps = 3/99 (3%)

Query: 223 YYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEYNVRVA 281
           +Y  E+   L + HS+GI++RD+K  NVM+D E   +++ D+G+  E    GK       
Sbjct: 105 FYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAE-GHIKIADFGMCKENIFGGKTTRTFCG 163

Query: 282 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPF 320
           +  +  PE ++  Q Y  S+D W+ G +   M+  + PF
Sbjct: 164 TPDYIAPE-IIAYQPYGKSVDWWAFGVLLYEMLAGQPPF 201

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 52.3 bits (126), Expect = 2e-07
 Identities = 48/216 (22%), Positives = 82/216 (37%), Gaps = 43/216 (19%)

Query: 221 IRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE-------LRKLRLID----WGLAEF 269
           I + + ++L ALDY HS+G +HR VK  ++++  +       LR    +           
Sbjct: 103 IAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVH 162

Query: 270 YHP-GKEYNVRVASRYFKGPELL-VDLQDYDYSLDMWSLG---CMFAGMIFRKEPFFYGH 324
             P     N+   S     PE+L  +LQ Y+   D++S+G   C  A       PF    
Sbjct: 163 DFPKSSVKNLPWLS-----PEVLQQNLQGYNEKSDIYSVGITACELANGH---VPFK--- 211

Query: 325 DNHDQLVKIAK---------DC--CLIIWCNSRHSRKPWSKFINADNQHLV-----SPEA 368
           D     + + K         D     +   +   SR       N D+         S   
Sbjct: 212 DMPATQMLLEKVRGTVPCLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHF 271

Query: 369 IDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAESS 404
             F++  L+ D + R +A + + H +F Q +   +S
Sbjct: 272 HQFVELCLQRDPESRPSASQLLNHSFFKQCKRRNTS 307

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 51.4 bits (123), Expect = 2e-07
 Identities = 63/278 (22%), Positives = 113/278 (40%), Gaps = 37/278 (13%)

Query: 133 VGRGKYSEVFEGINVNTNERCIIK--ILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVR 190
           +G+G Y  V+ G+  N  +   +K   L        ++E + LQ        +K ++IV+
Sbjct: 8   LGKGAYGTVYCGL-TNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQ 66

Query: 191 D----QHSKTPSLIFEYVNSTDFKVL---YPTLTDYDIRYYIYELLKALDYCHSQGIMHR 243
                    T S+  E+V       +   +  L +     Y  ++L  + Y H+  ++HR
Sbjct: 67  YLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHR 126

Query: 244 DVKPHNVMIDHELRKLRLIDWG----LAEFYHPGKEYNVRVASR---YFKGPELLVDLQD 296
           D+K +NVM+      ++LID+G    LA     G   N+  +     Y+  PE++ +   
Sbjct: 127 DIKGNNVML-MPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINE-SG 184

Query: 297 YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSKFI 356
           Y    D+WS+GC    M   K P      + D+L         + +  +     P     
Sbjct: 185 YGRKSDIWSIGCTVFEMATGKPPL----ASMDRLAA-------MFYIGAHRGLMP----- 228

Query: 357 NADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPY 394
              +    S  AIDF+   L  D  +R +A + + H +
Sbjct: 229 RLPDS--FSAAAIDFVTSCLTRDQHERPSALQLLRHDF 264

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 51.0 bits (122), Expect = 3e-07
 Identities = 67/293 (22%), Positives = 122/293 (41%), Gaps = 34/293 (11%)

Query: 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKIL----KPVKKKKIKREIKILQNLCG 178
             +D E +  +G G    V +  ++ T      K++    K   +K+I RE++I+   C 
Sbjct: 3   RNEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHE-CR 61

Query: 179 GPNVVKLLDIVRDQHSKTPSLIFEYVNSTD--FKVLYPTLTDYDIRYYIYELLKALDYCH 236
            P +V       ++++    + F    S D  +K   P   +  +      +++ L Y +
Sbjct: 62  SPYIVSFYGAFLNENNICMCMEFMDCGSLDRIYKKGGPIPVEI-LGKIAVAVVEGLTYLY 120

Query: 237 S-QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN----VRVASRYFKGPELL 291
           +   IMHRD+KP N++++    +++L D+G++     G+  N      V +  +  PE  
Sbjct: 121 NVHRIMHRDIKPSNILVNSR-GQIKLCDFGVS-----GELINSIADTFVGTSTYMSPE-- 172

Query: 292 VDLQDYDYSL--DMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLI-IWCNSRHS 348
             +Q   Y++  D+WSLG     +   K PF + + + D          L+         
Sbjct: 173 -RIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPP 231

Query: 349 RKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAA 401
           R P S F           +  DF+D  L  D  +R T ++  A P F Q   A
Sbjct: 232 RLPSSDF---------PEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQALRA 275

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 51.0 bits (122), Expect = 5e-07
 Identities = 72/309 (23%), Positives = 123/309 (39%), Gaps = 56/309 (18%)

Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLL 186
           Y V++ +  G    VF        +  ++KI    +K     E  +LQN+   P+V+++ 
Sbjct: 68  YTVIKTLTPGSEGRVFVATKPGQPDPVVLKI---GQKGTTLIEAMLLQNV-NHPSVIRMK 123

Query: 187 DIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIR---YYIYELLKALDYCHSQGIMHR 243
           D +         ++  + +S  +  L        I        ++L+ L Y H+Q I+HR
Sbjct: 124 DTL--VSGAITCMVLPHYSSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHR 181

Query: 244 DVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG---------PELLVDL 294
           DVK  N+ I+    ++ + D G A+F          V +  F G         PE+L   
Sbjct: 182 DVKTENIFINDV-DQVCIGDLGAAQF---------PVVAPAFLGLAGTVETNAPEVLAR- 230

Query: 295 QDYDYSLDMWSLGCMFAGM------IFRKEPFF---YGHDNHDQLVKIAK---------- 335
             Y+   D+WS G +   M      IF   P     Y    H  L+KI            
Sbjct: 231 DKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFP 290

Query: 336 ---DCCLIIWC--NSRHSRKPWSKFINADNQHLVSPEAIDFL-DKLLRYDHQDRLTAREA 389
                 L+      +   R+P++++     Q +  P   +FL  K+L +D   R +A E 
Sbjct: 291 RDPGSRLVRGFIEYASLERQPYTRY--PCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEI 348

Query: 390 MAHPYFAQV 398
           + +P FAQ+
Sbjct: 349 LNYPMFAQL 357

Length = 357

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 51.0 bits (122), Expect = 5e-07
 Identities = 53/208 (25%), Positives = 82/208 (39%), Gaps = 26/208 (12%)

Query: 127 YEVVRKVGRGKYSEVFEGINV--NTNERCIIKILKPVKKKKIKREIKILQNLCGGPNVVK 184
           Y ++  +  G   EVF          ++ I+K +     K   REI IL+ +     ++ 
Sbjct: 94  YNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAV--TGGKTPGREIDILKTI-SHRAIIN 150

Query: 185 LLDIVRDQHSKTPSL------IFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQ 238
           L+   R + +    +      +F YV+ +        L           LL+AL Y H +
Sbjct: 151 LIHAYRWKSTVCMVMPKYKCDLFTYVDRSG------PLPLEQAITIQRRLLEALAYLHGR 204

Query: 239 GIMHRDVKPHNVMIDHELRKLRLIDWGLA-----EFYHPGKEYNVRVASRYFKGPELLVD 293
           GI+HRDVK  N+ +D E     L D+G A         P + Y     +     PELL  
Sbjct: 205 GIIHRDVKTENIFLD-EPENAVLGDFGAACKLDAHPDTP-QCYG-WSGTLETNSPELLA- 260

Query: 294 LQDYDYSLDMWSLGCMFAGMIFRKEPFF 321
           L  Y    D+WS G +   M  +    F
Sbjct: 261 LDPYCAKTDIWSAGLVLFEMSVKNVTLF 288

Length = 392

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 50.0 bits (120), Expect = 7e-07
 Identities = 44/214 (20%), Positives = 88/214 (41%), Gaps = 38/214 (17%)

Query: 123 DQDDYEVVRKVGRGKYSEVFEGI--NVNTNE---RCIIKILKPV----KKKKIKREIKIL 173
            ++   ++R++G+G +  V+EG+   V   E   R  IK +       ++ +   E  ++
Sbjct: 4   PREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVM 63

Query: 174 QNL-CGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKV-------------LYPTLTDY 219
           +   C   +VV+LL +V     +   ++ E +   D K                   T  
Sbjct: 64  KEFNC--HHVVRLLGVVSTG--QPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQ 119

Query: 220 DIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA------EFYHPG 273
                  E+   + Y  ++  +HRD+   N M+  +L  +++ D+G+       ++Y  G
Sbjct: 120 KFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDL-TVKIGDFGMTRDIYETDYYRKG 178

Query: 274 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLG 307
            +  + V  R+   PE L D   +    D+WS G
Sbjct: 179 GKGLLPV--RWM-APESLKD-GVFTTKSDVWSFG 208

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 50.0 bits (119), Expect = 7e-07
 Identities = 53/228 (23%), Positives = 107/228 (46%), Gaps = 29/228 (12%)

Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP--VKKKKIKREIKILQNLCGGPN 181
           ++  ++V+K+G G++ EV+ G   N + +  +K LKP  +  +    E  +++ L     
Sbjct: 5   RESIKLVKKLGAGQFGEVWMGY-YNNSTKVAVKTLKPGTMSVQAFLEEANLMKTL-QHDK 62

Query: 182 VVKLLDIVRDQHSKTPSLIFEYVNS---TDF-------KVLYPTLTDYDIRYYIYELLKA 231
           +V+L  +V  +  +   +I EY+      DF       KVL P L D+       ++ + 
Sbjct: 63  LVRLYAVVTKE--EPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSA-----QIAEG 115

Query: 232 LDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRY---FKGP 288
           + Y   +  +HRD++  NV++  E    ++ D+GLA       EY  R  +++   +  P
Sbjct: 116 MAYIERKNYIHRDLRAANVLVS-ESLMCKIADFGLARVIE-DNEYTAREGAKFPIKWTAP 173

Query: 289 ELLVDLQDYDYSLDMWSLGCMFAGMI-FRKEPFFYGHDNHDQLVKIAK 335
           E  ++   +    D+WS G +   ++ + K P + G  N D +  + +
Sbjct: 174 E-AINFGSFTIKSDVWSFGILLYEIVTYGKIP-YPGMSNSDVMSALQR 219

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 49.2 bits (117), Expect = 2e-06
 Identities = 39/132 (29%), Positives = 64/132 (48%), Gaps = 18/132 (13%)

Query: 199 LIFEYVNSTDFKVLYPTLTDY---DIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE 255
            + EYVN  D       +  +      +Y  E+   L + H +GI++RD+K  NVM+D E
Sbjct: 78  FVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSE 137

Query: 256 LRKLRLIDWGLAEFYHPGKEYNVR-VASRYFKG------PELLVDLQDYDYSLDMWSLGC 308
              +++ D+G+       KE+ V  V +R F G      PE++   Q Y  S+D W+ G 
Sbjct: 138 -GHIKIADFGMC------KEHMVDGVTTRTFCGTPDYIAPEIIA-YQPYGKSVDWWAYGV 189

Query: 309 MFAGMIFRKEPF 320
           +   M+  + PF
Sbjct: 190 LLYEMLAGQPPF 201

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 49.8 bits (119), Expect = 2e-06
 Identities = 39/163 (23%), Positives = 72/163 (44%), Gaps = 24/163 (14%)

Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILK------PVKKKKIKREIKILQNLCGGP 180
           Y+++R +G+G   EV+   +   + R  +K ++      P+ KK+  RE KI  +L   P
Sbjct: 4   YDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIH-P 62

Query: 181 NVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTL-------TDYDIRYYIYELLKALD 233
            +V +  I  D           Y+     K L  ++        +   +  +   L    
Sbjct: 63  GIVPVYSICSD--GDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFH 120

Query: 234 -------YCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEF 269
                  Y HS+G++HRD+KP N+++     ++ ++DWG A F
Sbjct: 121 KICATIEYVHSKGVLHRDLKPDNILLG-LFGEVVILDWGAAIF 162

Length = 932

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 48.4 bits (115), Expect = 2e-06
 Identities = 52/208 (25%), Positives = 92/208 (44%), Gaps = 21/208 (10%)

Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILK-----PVKKKKIKREIKILQNLCGGPN 181
           Y  VR VG+G Y EV    +    ++ +IK L        ++K  ++E ++L  L   PN
Sbjct: 2   YCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQL-KHPN 60

Query: 182 VVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY--------PTLTDYDIRYYIYELLKALD 233
           +V      R+       L++  +   +   LY          L +  +  +  ++  AL 
Sbjct: 61  IV----AYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQ 116

Query: 234 YCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY-NVRVASRYFKGPELLV 292
           Y H + I+HRD+K  NV +      +++ D G+A       +  +  + + Y+  PEL  
Sbjct: 117 YLHEKHILHRDLKTQNVFLTRT-NIIKVGDLGIARVLENQCDMASTLIGTPYYMSPELFS 175

Query: 293 DLQDYDYSLDMWSLGCMFAGMIFRKEPF 320
           + + Y+Y  D+W+LGC    M   K  F
Sbjct: 176 N-KPYNYKSDVWALGCCVYEMATLKHAF 202

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 48.8 bits (116), Expect = 2e-06
 Identities = 65/291 (22%), Positives = 126/291 (43%), Gaps = 47/291 (16%)

Query: 125 DDYEVVRKVGRGKYSEV---------FEGINVNTNERCIIKILKPVKKKKIKREIKILQN 175
           +D+  +R +G G +  V         F  + +   E+   KI+K  +   +  E KIL N
Sbjct: 30  EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKS--KIIKQKQVDHVFSERKIL-N 86

Query: 176 LCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDY--DIR-YYIYELLKAL 232
               P  V L    +D+      L+ E+V   +F         +  D+  +Y  +++   
Sbjct: 87  YINHPFCVNLYGSFKDE--SYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIF 144

Query: 233 DYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLV 292
           +Y  S  I++RD+KP N+++D +   +++ D+G A+     + Y +     Y   PE+L+
Sbjct: 145 EYLQSLNIVYRDLKPENLLLDKD-GFIKMTDFGFAKVVDT-RTYTLCGTPEYI-APEILL 201

Query: 293 DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPW 352
           ++  +  + D W+LG     ++    PF+     ++ L+   K    II+         +
Sbjct: 202 NV-GHGKAADWWTLGIFIYEILVGCPPFY----ANEPLLIYQKILEGIIY---------F 247

Query: 353 SKFINADNQHLVSPEAIDFLDKLLRYDHQDRL-----TAREAMAHPYFAQV 398
            KF++ + +HL        + KLL +D   R       A+    HP+F  +
Sbjct: 248 PKFLDNNCKHL--------MKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNI 290

Length = 340

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 48.8 bits (116), Expect = 2e-06
 Identities = 54/210 (25%), Positives = 95/210 (45%), Gaps = 24/210 (11%)

Query: 126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP---VKKKKIK---REIKILQNLCGG 179
           D+  +  +G+G + +V       T+E   IKILK    ++   ++    E ++L  L G 
Sbjct: 1   DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLA-LSGK 59

Query: 180 PNVVKLLDIVRDQHSKTPSL-----IFEYVNSTDFKVLYPTLTDYD---IRYYIYELLKA 231
           P  +  L      HS   ++     + EYVN  D       +  +      +Y  E+   
Sbjct: 60  PPFLTQL------HSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIG 113

Query: 232 LDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPEL 290
           L + HS+GI++RD+K  NVM+D E   +++ D+G+  E    G        +  +  PE+
Sbjct: 114 LFFLHSKGIIYRDLKLDNVMLDSE-GHIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEI 172

Query: 291 LVDLQDYDYSLDMWSLGCMFAGMIFRKEPF 320
           +   Q Y  S+D W+ G +   M+  + PF
Sbjct: 173 IA-YQPYGKSVDWWAFGVLLYEMLAGQAPF 201

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 48.1 bits (114), Expect = 2e-06
 Identities = 47/193 (24%), Positives = 82/193 (42%), Gaps = 22/193 (11%)

Query: 132 KVGRGKYSEVFEGINVNTNERCIIK----ILKPVKKKKIKREIKILQNLCGGPNVVKLLD 187
           ++GRG + EVF G     N    +K     L P  K K  +E +IL+     PN+V+L+ 
Sbjct: 2   RIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQY-SHPNIVRLIG 60

Query: 188 IVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLK-------ALDYCHSQGI 240
           +   +      ++ E V   DF      L     R  + EL++        ++Y  S+  
Sbjct: 61  VCTQKQPIY--IVMELVQGGDFLTF---LRTEGPRLKVKELIQMVENAAAGMEYLESKHC 115

Query: 241 MHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG---KEYNVRVASRYFKGPELLVDLQDY 297
           +HRD+   N ++  E   L++ D+G++     G       ++     +  PE L +   Y
Sbjct: 116 IHRDLAARNCLVT-EKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEAL-NYGRY 173

Query: 298 DYSLDMWSLGCMF 310
               D+WS G + 
Sbjct: 174 SSESDVWSFGILL 186

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 48.9 bits (116), Expect = 3e-06
 Identities = 31/106 (29%), Positives = 56/106 (52%), Gaps = 5/106 (4%)

Query: 218 DYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN 277
           +Y++    Y+++ ALD  HS+ +MHRD+K  N+ +      ++L D+G ++ Y      +
Sbjct: 168 EYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFL-MPTGIIKLGDFGFSKQYSDSVSLD 226

Query: 278 VRVA---SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPF 320
           V  +   + Y+  PEL  + + Y    DMWSLG +   ++    PF
Sbjct: 227 VASSFCGTPYYLAPELW-ERKRYSKKADMWSLGVILYELLTLHRPF 271

Length = 478

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 48.1 bits (114), Expect = 4e-06
 Identities = 54/223 (24%), Positives = 92/223 (41%), Gaps = 54/223 (24%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTN---ERCIIKI-LKPVKKKKIKREIKILQNLCGGP 180
           DD+E + ++G G    VF+  +  +     R +I + +KP  + +I RE+++L   C  P
Sbjct: 5   DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHE-CNSP 63

Query: 181 NVVKL---------------------LDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDY 219
            +V                       LD V  +  + P  I   V+              
Sbjct: 64  YIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVS-------------- 109

Query: 220 DIRYYIYELLKALDYCHSQ-GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNV 278
                   ++K L Y   +  IMHRDVKP N++++    +++L D+G++         N 
Sbjct: 110 ------IAVIKGLTYLREKHKIMHRDVKPSNILVNSR-GEIKLCDFGVSGQLIDSMA-NS 161

Query: 279 RVASRYFKGPELLVDLQDYDYSL--DMWSLGCMFAGMIFRKEP 319
            V +R +  PE    LQ   YS+  D+WS+G     M   + P
Sbjct: 162 FVGTRSYMSPE---RLQGTHYSVQSDIWSMGLSLVEMAIGRYP 201

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 48.7 bits (116), Expect = 4e-06
 Identities = 33/117 (28%), Positives = 54/117 (46%), Gaps = 19/117 (16%)

Query: 149 TNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS---- 198
           T     IK+L+        ++ + +RE  +   L   PN+V LLD       + P     
Sbjct: 2   TGHEVAIKLLRTDAPEEEHQRARFRRETALCARL-YHPNIVALLD-----SGEAPPGLLF 55

Query: 199 LIFEYVNSTDFKVLYPT---LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMI 252
            +FEYV     + +      L   +    + ++L AL   H+QGI+HRD+KP N+M+
Sbjct: 56  AVFEYVPGRTLREVLAADGALPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMV 112

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 47.5 bits (113), Expect = 5e-06
 Identities = 49/200 (24%), Positives = 96/200 (48%), Gaps = 32/200 (16%)

Query: 130 VRKVGRGKYSEV----FEGINVNTNERCIIKILKPVKKKKI---KREIKILQNLCGGPNV 182
           ++++G+G +  V    ++ +  NT E   +K L+    + +   +REI+IL++L    N+
Sbjct: 9   IQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSL-QHDNI 67

Query: 183 VKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRY-----------YIYELLKA 231
           VK   +      +   L+ EY+        Y +L DY  ++           Y  ++ K 
Sbjct: 68  VKYKGVCYSAGRRNLRLVMEYLP-------YGSLRDYLQKHRERLDHRKLLLYASQICKG 120

Query: 232 LDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE-YNVRVASR---YFKG 287
           ++Y  S+  +HRD+   N++++ E R +++ D+GL +     KE Y VR       ++  
Sbjct: 121 MEYLGSKRYVHRDLATRNILVESENR-VKIGDFGLTKVLPQDKEYYKVREPGESPIFWYA 179

Query: 288 PELLVDLQDYDYSLDMWSLG 307
           PE L +   +  + D+WS G
Sbjct: 180 PESLTE-SKFSVASDVWSFG 198

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha

 Score = 46.9 bits (111), Expect = 1e-05
 Identities = 34/102 (33%), Positives = 55/102 (53%), Gaps = 12/102 (11%)

Query: 216 LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE-------LRK-LRLIDWGL- 266
           +++  I Y +  +LKALDY H  G +HR VK  +++I  +       LR  L +I+ G  
Sbjct: 98  MSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQR 157

Query: 267 AEFYHPGKEYNVRVASRYFKGPELL-VDLQDYDYSLDMWSLG 307
               H   +Y+V+V    +  PE+L  +LQ YD   D++S+G
Sbjct: 158 LRVVHDFPKYSVKVLP--WLSPEVLQQNLQGYDAKSDIYSVG 197

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 46.2 bits (109), Expect = 2e-05
 Identities = 72/297 (24%), Positives = 112/297 (37%), Gaps = 56/297 (18%)

Query: 147 VNTNERCIIKILKPVKKKKI--KREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYV 204
               ER I K +K   +  I  + EI  L  L    N++K+ +I+R     + +  +   
Sbjct: 189 KPKCERLIAKRVKAGSRAAIQLENEILALGRL-NHENILKIEEILR-----SEANTYMIT 242

Query: 205 NSTDFKVLYPTLTDYDI-----------RYYIYELLKALDYCHSQGIMHRDVKPHNVMID 253
              DF  LY  + D              R  + +LL A++Y H + ++HRD+K  N+ ++
Sbjct: 243 QKYDFD-LYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLN 301

Query: 254 HELRKLRLIDWGLAEFYHPGKEYNVRVASRY-------FKGPELLVDLQDYDYSLDMWSL 306
            +  K+ L D+G A  +        R A  Y          PE+L     Y    D+WS 
Sbjct: 302 CD-GKIVLGDFGTAMPFE-----KEREAFDYGWVGTVATNSPEILAG-DGYCEITDIWSC 354

Query: 307 GCMFAGMIFRKE-PFFYGHDN-HDQLVKIAKD------------CCLIIWCNS-RHSRKP 351
           G +   M+     P   G      QL+KI               C L  + +S       
Sbjct: 355 GLILLDMLSHDFCPIGDGGGKPGKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAG 414

Query: 352 WSKFINADNQHLVSPEAIDF-LDKLLRYDHQDRLTAREAMAHPYFAQVRAAESSRTR 407
            S      N  L  P   ++ L K+L +D   R  A E +A P F    +AE     
Sbjct: 415 HSVPPLIRNLGL--PADFEYPLVKMLTFDWHLRPGAAELLALPLF----SAEEEEEI 465

Length = 501

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 45.6 bits (108), Expect = 2e-05
 Identities = 52/226 (23%), Positives = 97/226 (42%), Gaps = 29/226 (12%)

Query: 99  VYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEG-----INVNTNERC 153
           VY D   L     W++    + +G        + +G G + +V E         +   + 
Sbjct: 17  VYIDPTQLPYDLKWEFPRNNLSFG--------KTLGAGAFGKVVEATAYGLSKSDAVMKV 68

Query: 154 IIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDF 209
            +K+LKP     +++ +  E+KI+ +L    N+V LL            +I EY    D 
Sbjct: 69  AVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGAC--TIGGPILVITEYCCYGDL 126

Query: 210 -----KVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDW 264
                +     LT  D+  + Y++ K + +  S+  +HRD+   NV++ H  + +++ D+
Sbjct: 127 LNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHG-KIVKICDF 185

Query: 265 GLAEFYHPGKEYNVRVASRY---FKGPELLVDLQDYDYSLDMWSLG 307
           GLA        Y V+  +R    +  PE + +   Y +  D+WS G
Sbjct: 186 GLARDIMNDSNYVVKGNARLPVKWMAPESIFNCV-YTFESDVWSYG 230

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional

 Score = 44.9 bits (106), Expect = 3e-05
 Identities = 19/50 (38%), Positives = 31/50 (62%), Gaps = 1/50 (2%)

Query: 221 IRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY 270
           I+  + ++L  L+Y H  GI H D+KP N+M+D   R   +ID+G+A  +
Sbjct: 128 IKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGY-IIDYGIASHF 176

Length = 294

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 45.0 bits (106), Expect = 3e-05
 Identities = 48/226 (21%), Positives = 103/226 (45%), Gaps = 26/226 (11%)

Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP--VKKKKIKREIKILQNLCGGPN 181
           ++  ++++K+G G++ EV+ G   N N +  +K LKP  +  +    E +I++ L     
Sbjct: 5   RESLQLIKKLGNGQFGEVWMGT-WNGNTKVAVKTLKPGTMSPESFLEEAQIMKKL-RHDK 62

Query: 182 VVKLLDIVRDQHSKTP-SLIFEYVNSTDFKVLYPTLTDYDIRY--------YIYELLKAL 232
           +V+L  +V    S+ P  ++ EY++      L   L D + R            ++   +
Sbjct: 63  LVQLYAVV----SEEPIYIVTEYMSKGS---LLDFLKDGEGRALKLPNLVDMAAQVAAGM 115

Query: 233 DYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRY---FKGPE 289
            Y      +HRD++  N+++   L   ++ D+GLA       EY  R  +++   +  PE
Sbjct: 116 AYIERMNYIHRDLRSANILVGDGL-VCKIADFGLARLIE-DNEYTARQGAKFPIKWTAPE 173

Query: 290 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK 335
             +    +    D+WS G +   ++ +    + G +N + L ++ +
Sbjct: 174 AAL-YGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVER 218

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 44.8 bits (106), Expect = 4e-05
 Identities = 47/210 (22%), Positives = 96/210 (45%), Gaps = 30/210 (14%)

Query: 131 RKVGRGKYSEVFEGINVNTNER---CIIKILKPVKK----KKIKREIKILQNLCGGPNVV 183
           R +G+G +  V+ G  ++++ +   C +K L  +      ++  +E  I+++    PNV+
Sbjct: 1   RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDF-SHPNVL 59

Query: 184 KLLDIVRDQHSKTPSLIFEYVNSTDFKVLY------PTLTDYDIRYYIYELLKALDYCHS 237
            LL I       +P ++  Y+   D +         PT+ D  +  +  ++ K ++Y  S
Sbjct: 60  SLLGICLPSEG-SPLVVLPYMKHGDLRNFIRSETHNPTVKD--LIGFGLQVAKGMEYLAS 116

Query: 238 QGIMHRDVKPHNVMIDHELRKLRLIDWGLA------EFYHPGKEYNVRVASRYFKGPELL 291
           +  +HRD+   N M+D E   +++ D+GLA      E+Y        ++  ++      L
Sbjct: 117 KKFVHRDLAARNCMLD-ESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMA----L 171

Query: 292 VDLQDYDYSL--DMWSLGCMFAGMIFRKEP 319
             LQ   ++   D+WS G +   ++ R  P
Sbjct: 172 ESLQTQKFTTKSDVWSFGVLLWELMTRGAP 201

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

 Score = 42.4 bits (100), Expect = 8e-05
 Identities = 30/126 (23%), Positives = 52/126 (41%), Gaps = 4/126 (3%)

Query: 148 NTNERCIIKILKP-VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNS 206
             +E  ++KI     K    +RE+ ILQ L      V  + +   +      L+ E++  
Sbjct: 19  TKDEDYVLKINPSREKGADREREVAILQLLARKGLPVPKV-LASGESDGWSYLLMEWIEG 77

Query: 207 TDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGL 266
                +       DI   + ELL  L       + H D+ P N+++D + + L +IDW  
Sbjct: 78  ETLDEV-SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVD-DGKILGIIDWEY 135

Query: 267 AEFYHP 272
           A +  P
Sbjct: 136 AGYGPP 141

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 43.6 bits (103), Expect = 9e-05
 Identities = 30/109 (27%), Positives = 54/109 (49%), Gaps = 5/109 (4%)

Query: 202 EYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRL 261
           EY +  D +    TLT  D+  + Y++ + +++  S+  +HRD+   NV++  +   +++
Sbjct: 115 EYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDH-VMKI 173

Query: 262 IDWGLAEFYHPGKEYNVRVASRY---FKGPELLVDLQDYDYSLDMWSLG 307
            D+GLA   H    Y      R    +  PE L D + Y +  D+WS G
Sbjct: 174 ADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFG 221

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 43.5 bits (102), Expect = 1e-04
 Identities = 29/100 (29%), Positives = 51/100 (51%), Gaps = 7/100 (7%)

Query: 215 TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP-- 272
            LT  D+    Y++ + ++Y  SQ  +HRD+   NV++  +   +++ D+GLA   H   
Sbjct: 130 QLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTED-NVMKIADFGLARDVHNID 188

Query: 273 --GKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMF 310
              K  N R+  ++   PE L D + Y +  D+WS G + 
Sbjct: 189 YYKKTTNGRLPVKWM-APEALFD-RVYTHQSDVWSFGVLL 226

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 42.8 bits (101), Expect = 2e-04
 Identities = 51/227 (22%), Positives = 101/227 (44%), Gaps = 33/227 (14%)

Query: 126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP---VKKKKIKREIKILQNLCGGPNV 182
           ++ + RK+G G + EV+EG+  N   R  IKILK    +K++  ++E++ L+ L    ++
Sbjct: 7   EFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDLLKQQDFQKEVQALKRL-RHKHL 64

Query: 183 VKLLDIVRDQHSKTPSLIF----------EYVNSTDFKVLYPTLTDYDIRYYIYELLKAL 232
           + L  +        P  I            ++ S + +VL P  +  D+   + E    +
Sbjct: 65  ISLFAVCS---VGEPVYIITELMEKGSLLAFLRSPEGQVL-PVASLIDMACQVAE---GM 117

Query: 233 DYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-----EFYHPGKEYNVRVASRYFKG 287
            Y   Q  +HRD+   N+++  +L   ++ D+GLA     + Y      + ++  ++   
Sbjct: 118 AYLEEQNSIHRDLAARNILVGEDL-VCKVADFGLARLIKEDVYLS---SDKKIPYKW-TA 172

Query: 288 PELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA 334
           PE       +    D+WS G +   M    +  + G +NH+   +I 
Sbjct: 173 PEAA-SHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQIT 218

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 43.0 bits (101), Expect = 2e-04
 Identities = 31/89 (34%), Positives = 45/89 (50%), Gaps = 15/89 (16%)

Query: 227 ELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEF--------YHPGKEYNV 278
           +LL A+DY H +GI+HRD+K  NV+++     + L D+G A F        +H G    V
Sbjct: 268 QLLSAIDYIHGEGIIHRDIKTENVLVNGP-EDICLGDFGAACFARGSWSTPFHYGIAGTV 326

Query: 279 RVASRYFKGPELLVDLQDYDYSLDMWSLG 307
                    PE+L     Y  S+D+WS G
Sbjct: 327 DT-----NAPEVLAG-DPYTPSVDIWSAG 349

Length = 461

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 42.1 bits (99), Expect = 2e-04
 Identities = 46/207 (22%), Positives = 96/207 (46%), Gaps = 30/207 (14%)

Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP--VKKKKIKREIKILQNLCGGPN 181
           ++  ++V+K+G G++ EV+ G   N + +  IK LK   +  +    E  +++ L   P 
Sbjct: 5   RETLKLVKKLGAGQFGEVWMGY-YNGHTKVAIKSLKQGSMSPEAFLAEANLMKQL-QHPR 62

Query: 182 VVKLLDIVRDQHSKTPSLIF-EYVNS---TDFKVLYPTLTDYDIRYYIYELL-------K 230
           +V+L  +V    ++ P  I  EY+ +    DF       T   I+  I +L+       +
Sbjct: 63  LVRLYAVV----TQEPIYIITEYMENGSLVDF-----LKTPEGIKLTINKLIDMAAQIAE 113

Query: 231 ALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRY---FKG 287
            + +   +  +HRD++  N+++   L   ++ D+GLA       EY  R  +++   +  
Sbjct: 114 GMAFIERKNYIHRDLRAANILVSETL-CCKIADFGLARLIED-NEYTAREGAKFPIKWTA 171

Query: 288 PELLVDLQDYDYSLDMWSLGCMFAGMI 314
           PE  ++   +    D+WS G +   ++
Sbjct: 172 PE-AINYGTFTIKSDVWSFGILLTEIV 197

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 42.3 bits (99), Expect = 2e-04
 Identities = 28/98 (28%), Positives = 51/98 (52%), Gaps = 7/98 (7%)

Query: 216 LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP--- 272
           +T  D+    Y++ + ++Y  SQ  +HRD+   NV++  E   +++ D+GLA   +    
Sbjct: 134 MTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVT-ENNVMKIADFGLARDVNNIDY 192

Query: 273 -GKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCM 309
             K  N R+  ++   PE L D + Y +  D+WS G +
Sbjct: 193 YKKTTNGRLPVKWM-APEALFD-RVYTHQSDVWSFGVL 228

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|236586 PRK09605, PRK09605, bifunctional UGMP family protein/serine/threonine protein kinase; Validated

 Score = 43.0 bits (102), Expect = 2e-04
 Identities = 19/83 (22%), Positives = 40/83 (48%), Gaps = 9/83 (10%)

Query: 188 IVRDQHSKTPSLIFEYVNSTDFK-VLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVK 246
           ++ D   +  +++ EY+   D K VL            + ++ + +   H  GI+H D+ 
Sbjct: 402 VIYDVDPEEKTIVMEYIGGKDLKDVLEGNPE------LVRKVGEIVAKLHKAGIVHGDLT 455

Query: 247 PHNVMIDHELRKLRLIDWGLAEF 269
             N ++  +  +L LID+GL ++
Sbjct: 456 TSNFIVRDD--RLYLIDFGLGKY 476

Length = 535

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 42.1 bits (99), Expect = 2e-04
 Identities = 39/204 (19%), Positives = 94/204 (46%), Gaps = 30/204 (14%)

Query: 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP--VKKKKIKREIKILQNLCGGP 180
           ++ D  +  K+G G+Y EV+EG+    +    +K LK   ++ ++  +E  +++ +   P
Sbjct: 4   ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI-KHP 62

Query: 181 NVVKLLDIVRDQHSKTPSL-----------IFEYVNSTDFKVLYPTLTDYDIRYYIYELL 229
           N+V+LL +     ++ P             + +Y+   + + +   +    + Y   ++ 
Sbjct: 63  NLVQLLGVC----TREPPFYIITEFMTYGNLLDYLRECNRQEVNAVV----LLYMATQIS 114

Query: 230 KALDYCHSQGIMHRDVKPHNVMI-DHELRKLRLIDWGLAEFYHPGKEYNVRVASRY---F 285
            A++Y   +  +HRD+   N ++ ++ L  +++ D+GL+     G  Y     +++   +
Sbjct: 115 SAMEYLEKKNFIHRDLAARNCLVGENHL--VKVADFGLSRLMT-GDTYTAHAGAKFPIKW 171

Query: 286 KGPELLVDLQDYDYSLDMWSLGCM 309
             PE L     +    D+W+ G +
Sbjct: 172 TAPESLA-YNKFSIKSDVWAFGVL 194

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 42.0 bits (99), Expect = 3e-04
 Identities = 40/209 (19%), Positives = 82/209 (39%), Gaps = 29/209 (13%)

Query: 132 KVGRGKYSEVFEGINVNTNERCI---IKILKPVKKKKIK----REIKILQNLCGGPNVVK 184
           K+G G +  V  G    +  + I   +K LK  K   I     +E  I+ +L    N+++
Sbjct: 2   KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSL-DHENLIR 60

Query: 185 LLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELL--------KALDYCH 236
           L  +V         ++ E         L   L    + +++   L          + Y  
Sbjct: 61  LYGVVLTHPLM---MVTEL---APLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLE 114

Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFK----GPELLV 292
           S+  +HRD+   N+++  +  K+++ D+GL       +++ V             PE L 
Sbjct: 115 SKRFIHRDLAARNILLASD-DKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLR 173

Query: 293 DLQDYDYSLDMWSLG-CMFAGMIFRKEPF 320
               + ++ D+W  G  ++    + +EP+
Sbjct: 174 TRT-FSHASDVWMFGVTLWEMFTYGEEPW 201

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 41.7 bits (98), Expect = 3e-04
 Identities = 46/190 (24%), Positives = 80/190 (42%), Gaps = 21/190 (11%)

Query: 131 RKVGRGKYSEVFEGINVNTNERCIIKI----LKPVKKKKIKREIKILQNLCGGPNVVKLL 186
            K+G+G + +V++G+ +  N    +K     L P  K+K  +E +IL+     PN+VKL+
Sbjct: 1   EKIGKGNFGDVYKGV-LKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQY-DHPNIVKLI 58

Query: 187 DIVRDQHSKTPSLI-FEYVNSTDFKVLYPT----LTDYDIRYYIYELLKALDYCHSQGIM 241
            +      K P  I  E V               LT   +     +    ++Y  S+  +
Sbjct: 59  GVCVQ---KQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCI 115

Query: 242 HRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRY----FKGPELLVDLQDY 297
           HRD+   N ++      L++ D+G++     G  Y V    +     +  PE L +   Y
Sbjct: 116 HRDLAARNCLVGEN-NVLKISDFGMSREEEGG-IYTVSDGLKQIPIKWTAPEAL-NYGRY 172

Query: 298 DYSLDMWSLG 307
               D+WS G
Sbjct: 173 TSESDVWSYG 182

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 41.6 bits (98), Expect = 4e-04
 Identities = 50/200 (25%), Positives = 91/200 (45%), Gaps = 27/200 (13%)

Query: 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP--VKKKKIKREIKILQNLCGGP 180
           D+   +++RK+G G++ EV+EG+  NT     +K LKP  +  K    E +I++ L   P
Sbjct: 4   DRTSIQLLRKLGAGQFGEVWEGLWNNTTP-VAVKTLKPGTMDPKDFLAEAQIMKKL-RHP 61

Query: 181 NVVKLLDIVRDQHS--------KTPSLIFEYVNSTDFKVL-YPTLTDYDIRYYIYELLKA 231
            +++L  +   +          K  SL+ EY+     + L  P L D        ++   
Sbjct: 62  KLIQLYAVCTLEEPIYIVTELMKYGSLL-EYLQGGAGRALKLPQLIDMAA-----QVASG 115

Query: 232 LDYCHSQGIMHRDVKPHNVMI-DHELRKLRLIDWGLAEFYHPGKEYNVRVASRY---FKG 287
           + Y  +Q  +HRD+   NV++ ++ + K  + D+GLA        Y  R  +++   +  
Sbjct: 116 MAYLEAQNYIHRDLAARNVLVGENNICK--VADFGLARVIKE-DIYEAREGAKFPIKWTA 172

Query: 288 PELLVDLQDYDYSLDMWSLG 307
           PE       +    D+WS G
Sbjct: 173 PE-AALYNRFSIKSDVWSFG 191

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 41.5 bits (97), Expect = 4e-04
 Identities = 30/129 (23%), Positives = 60/129 (46%), Gaps = 12/129 (9%)

Query: 185 LLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRD 244
           L + +R +    P   F+     + ++ +  L         Y++ + ++Y  S+  +HRD
Sbjct: 105 LREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSC-----AYQVARGMEYLESRRCIHRD 159

Query: 245 VKPHNVMIDHELRKLRLIDWGLAEFYHP----GKEYNVRVASRYFKGPELLVDLQDYDYS 300
           +   NV++  +   +++ D+GLA   H      K  N R+  ++   PE L D + Y + 
Sbjct: 160 LAARNVLVTED-NVMKIADFGLARGVHDIDYYKKTSNGRLPVKWM-APEALFD-RVYTHQ 216

Query: 301 LDMWSLGCM 309
            D+WS G +
Sbjct: 217 SDVWSFGIL 225

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 41.2 bits (97), Expect = 6e-04
 Identities = 49/216 (22%), Positives = 99/216 (45%), Gaps = 36/216 (16%)

Query: 128 EVVRKVGRGKYSEVFEGINVNTNER-CI---IKILK----PVKKKKIKREIKILQNLCGG 179
           E ++ +G G +  V++G+ +   E+  I   IK+L+    P   K+I  E  ++ +    
Sbjct: 10  EKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMAS-VDH 68

Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYV----------NSTDFKVLYPTLTDYDIRYYIYELL 229
           P+VV+LL I     S    LI + +          N  D       +    +  +  ++ 
Sbjct: 69  PHVVRLLGICL---SSQVQLITQLMPLGCLLDYVRNHKD------NIGSQYLLNWCVQIA 119

Query: 230 KALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG-KEYNV---RVASRYF 285
           K + Y   + ++HRD+   NV++    + +++ D+GLA+      KEY+    +V  ++ 
Sbjct: 120 KGMSYLEEKRLVHRDLAARNVLV-KTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWM 178

Query: 286 KGPELLVDLQDYDYSLDMWSLGC-MFAGMIFRKEPF 320
              E ++  + Y +  D+WS G  ++  M F  +P+
Sbjct: 179 -ALESIL-HRIYTHKSDVWSYGVTVWELMTFGAKPY 212

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|216618 pfam01636, APH, Phosphotransferase enzyme family

 Score = 40.6 bits (95), Expect = 7e-04
 Identities = 13/53 (24%), Positives = 24/53 (45%)

Query: 220 DIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP 272
           ++   +   L AL       ++H D+ P N+++D   R   +ID+  A    P
Sbjct: 147 ELWERLLAALLALLPALPLVLVHGDLHPGNLLVDPGGRVTGVIDFEDAGLGDP 199

This family consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include: aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation. This family also includes homoserine kinase. This family is related to fructosamine kinase pfam03881. Length = 238

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 40.6 bits (95), Expect = 7e-04
 Identities = 51/227 (22%), Positives = 95/227 (41%), Gaps = 35/227 (15%)

Query: 133 VGRGKYSEVFEG-----INVNTNE-RCIIKILK----PVKKKKIKREIKILQNLCGGPNV 182
           +G G + EV+EG     +   +   R  +K L+      +KK+  +E  ++ N    PN+
Sbjct: 3   LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNF-NHPNI 61

Query: 183 VKLLDIVRDQHSKTPSLIFEYVNSTDF----------KVLYPTLTDYDIRYYIYELLKAL 232
           VKLL +      +   +I E +   D           +   P LT  ++     ++ K  
Sbjct: 62  VKLLGVCLLNEPQ--YIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGC 119

Query: 233 DYCHSQGIMHRDVKPHNVMIDHEL----RKLRLIDWGLAEFYHPGKEYNVR----VASRY 284
            Y      +HRD+   N ++  +     R +++ D+GLA   +    Y       +  R+
Sbjct: 120 VYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRW 179

Query: 285 FKGPELLVDLQDYDYSLDMWSLGC-MFAGMIFRKEPFFYGHDNHDQL 330
              PE L+D +    S D+WS G  M+  +   ++P +   +N + L
Sbjct: 180 M-APESLLDGKFTTQS-DVWSFGVLMWEILTLGQQP-YPALNNQEVL 223

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 40.8 bits (95), Expect = 7e-04
 Identities = 26/89 (29%), Positives = 47/89 (52%), Gaps = 7/89 (7%)

Query: 226 YELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP----GKEYNVRVA 281
           Y++ + ++Y  S+  +HRD+   NV++  E   +++ D+GLA   H      K  N R+ 
Sbjct: 147 YQVARGMEYLASKKCIHRDLAARNVLVT-EDNVMKIADFGLARDIHHIDYYKKTTNGRLP 205

Query: 282 SRYFKGPELLVDLQDYDYSLDMWSLGCMF 310
            ++   PE L D + Y +  D+WS G + 
Sbjct: 206 VKWM-APEALFD-RIYTHQSDVWSFGVLL 232

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|237847 PRK14879, PRK14879, serine/threonine protein kinase; Provisional

 Score = 39.9 bits (94), Expect = 0.001
 Identities = 36/151 (23%), Positives = 69/151 (45%), Gaps = 25/151 (16%)

Query: 133 VGRGKYSEVFEGINVNTNERCIIKILKP-----------VKKKKIKREIKIL-QNLCGGP 180
           + RG  +E++ G  +    + +IK   P           +++++ +RE +I+ +    G 
Sbjct: 4   IKRGAEAEIYLGDFLG--IKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGV 61

Query: 181 NV--VKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQ 238
           NV  V  +D           ++ EY+     K L  +    ++     E+ + +   HS 
Sbjct: 62  NVPAVYFVDPENF------IIVMEYIEGEPLKDLINSNGMEELELS-REIGRLVGKLHSA 114

Query: 239 GIMHRDVKPHNVMIDHELRKLRLIDWGLAEF 269
           GI+H D+   N+++     K+ LID+GLAEF
Sbjct: 115 GIIHGDLTTSNMILSG--GKIYLIDFGLAEF 143

Length = 211

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 40.4 bits (94), Expect = 0.001
 Identities = 29/95 (30%), Positives = 47/95 (49%), Gaps = 18/95 (18%)

Query: 228 LLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRV-ASRYF- 285
           +L+A+ Y H   I+HRD+K  N+ I+H    + L D+G A        + V + A++Y+ 
Sbjct: 191 VLRAIQYLHENRIIHRDIKAENIFINHP-GDVCLGDFGAA-------CFPVDINANKYYG 242

Query: 286 -------KGPELLVDLQDYDYSLDMWSLGCMFAGM 313
                    PELL     Y  ++D+WS G +   M
Sbjct: 243 WAGTIATNAPELLAR-DPYGPAVDIWSAGIVLFEM 276

Length = 391

>gnl|CDD|234331 TIGR03724, arch_bud32, Kae1-associated kinase Bud32

 Score = 39.1 bits (92), Expect = 0.002
 Identities = 26/104 (25%), Positives = 49/104 (47%), Gaps = 11/104 (10%)

Query: 167 KREIKILQNLC-GGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYI 225
           + E ++L      G N   + D+  D  +KT  ++ EY+     K +     D      +
Sbjct: 45  RNEARLLSRARKAGVNTPVVYDV--DPDNKT--IVMEYIEGKPLKDVIEEGNDE----LL 96

Query: 226 YELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEF 269
            E+ + +   H  GI+H D+   N+++  +  KL LID+GL ++
Sbjct: 97  REIGRLVGKLHKAGIVHGDLTTSNIIVRDD--KLYLIDFGLGKY 138

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine [Unknown function, General]. Length = 199

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 39.6 bits (92), Expect = 0.002
 Identities = 44/216 (20%), Positives = 81/216 (37%), Gaps = 44/216 (20%)

Query: 133 VGRGKYSEVFEGINVNTNER-----CIIKILK----PVKKKKIKREIKILQNLCGGPNVV 183
           +G G++ +V +        R       +K+LK      + + +  E  +L+ +   P+V+
Sbjct: 8   LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQV-NHPHVI 66

Query: 184 KLLDIVRDQHSKTPSLIFEYV---------------------------NSTDFKVLYPTL 216
           KL             LI EY                            +S         L
Sbjct: 67  KLYGAC--SQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERAL 124

Query: 217 TDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY 276
           T  D+  + +++ + + Y     ++HRD+   NV++  E RK+++ D+GL+   +    Y
Sbjct: 125 TMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLV-AEGRKMKISDFGLSRDVYEEDSY 183

Query: 277 NVRVASRY---FKGPELLVDLQDYDYSLDMWSLGCM 309
             R   R    +   E L D   Y    D+WS G +
Sbjct: 184 VKRSKGRIPVKWMAIESLFD-HIYTTQSDVWSFGVL 218

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 38.9 bits (90), Expect = 0.003
 Identities = 51/224 (22%), Positives = 100/224 (44%), Gaps = 32/224 (14%)

Query: 131 RKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKI----KREIK--ILQNLC----GGP 180
           + +G G++  V EG      +  I+K+   VK  KI    + E++  + + +C      P
Sbjct: 5   KTLGEGEFGSVMEGQL--NQDDSILKV--AVKTMKIAICTRSEMEDFLSEAVCMKEFDHP 60

Query: 181 NVVKLLDI----VRDQHSKTPSLIFEYVNSTDFK--VLYPTLTDYDIRY-------YIYE 227
           NV++L+ +    V  +   +P +I  ++   D    +LY  L D            ++ +
Sbjct: 61  NVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTD 120

Query: 228 LLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNV-RVASRYFK 286
           +   ++Y  S+  +HRD+   N M++  +  + + D+GL++  + G  Y   R+A    K
Sbjct: 121 IASGMEYLSSKSFIHRDLAARNCMLNENM-NVCVADFGLSKKIYNGDYYRQGRIAKMPVK 179

Query: 287 --GPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHD 328
               E L D + Y    D+WS G     +  R +  + G +N +
Sbjct: 180 WIAIESLAD-RVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSE 222

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 39.3 bits (91), Expect = 0.003
 Identities = 29/95 (30%), Positives = 49/95 (51%), Gaps = 8/95 (8%)

Query: 228 LLKALDYCHSQ-GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFK 286
           +L+ L Y   +  IMHRDVKP N++++    +++L D+G++         N  V +R + 
Sbjct: 112 VLRGLAYLREKHQIMHRDVKPSNILVNSR-GEIKLCDFGVSGQLIDSMA-NSFVGTRSYM 169

Query: 287 GPELLVDLQDYDYSL--DMWSLGCMFAGMIFRKEP 319
            PE    LQ   YS+  D+WS+G     +   + P
Sbjct: 170 SPE---RLQGTHYSVQSDIWSMGLSLVELAIGRYP 201

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 38.9 bits (91), Expect = 0.003
 Identities = 43/182 (23%), Positives = 73/182 (40%), Gaps = 23/182 (12%)

Query: 226 YELLKALDYCHSQ-GIMHRDVKPHNVMIDHELRK--LRLIDWGLAEFYHPGKEYNVRVAS 282
              +KAL+Y   +  I+HRDVKP N+++D   R   ++L D+G++               
Sbjct: 114 VATVKALNYLKEELKIIHRDVKPSNILLD---RNGNIKLCDFGISGQLVDSIAKTRDAGC 170

Query: 283 RYFKGPELLV--DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLI 340
           R +  PE +       YD   D+WSLG     +   K P+   +   DQL ++ K     
Sbjct: 171 RPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKG---- 226

Query: 341 IWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRA 400
                           N++ +   SP  ++F++  L  D   R   +E + HP+      
Sbjct: 227 ----------DPPILSNSEERE-FSPSFVNFINLCLIKDESKRPKYKELLEHPFIKDYEE 275

Query: 401 AE 402
             
Sbjct: 276 RN 277

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score = 38.5 bits (90), Expect = 0.003
 Identities = 44/212 (20%), Positives = 82/212 (38%), Gaps = 50/212 (23%)

Query: 133 VGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCG---------GPNVV 183
           +G+G++ +V  G              + V  K +K +    Q              PN+V
Sbjct: 14  IGKGEFGDVMLGDYRG----------QKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLV 63

Query: 184 KLLDIVRD--------QHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYC 235
           +LL +V          ++    SL+ +Y+ S    V+    T      +  ++ + ++Y 
Sbjct: 64  QLLGVVLQGNPLYIVTEYMAKGSLV-DYLRSRGRAVI----TLAQQLGFALDVCEGMEYL 118

Query: 236 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYF----KGPELL 291
             +  +HRD+   NV++  +L   ++ D+GLA      KE +    S         PE L
Sbjct: 119 EEKNFVHRDLAARNVLVSEDLVA-KVSDFGLA------KEASQGQDSGKLPVKWTAPEAL 171

Query: 292 VDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYG 323
              + +    D+WS G      I   E + +G
Sbjct: 172 -REKKFSTKSDVWSFG------ILLWEIYSFG 196

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 38.5 bits (90), Expect = 0.003
 Identities = 38/193 (19%), Positives = 83/193 (43%), Gaps = 24/193 (12%)

Query: 131 RKVGRGKYSEVFEGINVNTNER---CIIKILKPVK----KKKIKREIKILQNLCGGPNVV 183
           +++G G +  V +G+ +  + +     +K LK       KK+  RE  ++  L   P +V
Sbjct: 1   KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQL-DHPCIV 59

Query: 184 KLLDIVRDQHSKTPS--LIFEYVNS---TDFKVLYPTLTDYDIRYYIYELLKALDYCHSQ 238
           +L+ +      K     L+ E         +      +   D++   +++   + Y  S+
Sbjct: 60  RLIGV-----CKGEPLMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESK 114

Query: 239 GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE-YNVRVASRY---FKGPELLVDL 294
             +HRD+   NV++ +   + ++ D+G++     G + Y    A R+   +  PE  ++ 
Sbjct: 115 HFVHRDLAARNVLLVNR-HQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPE-CINY 172

Query: 295 QDYDYSLDMWSLG 307
             +    D+WS G
Sbjct: 173 GKFSSKSDVWSYG 185

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	408
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
PTZ00284	467	protein kinase; Provisional	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
KOG1290	590	consensus Serine/threonine protein kinase [Signal	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
KOG0696	683	consensus Serine/threonine protein kinase [Signal	100.0
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
KOG1167	418	consensus Serine/threonine protein kinase of the C	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	100.0
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
KOG0695	593	consensus Serine/threonine protein kinase [Signal	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
PLN03224	507	probable serine/threonine protein kinase; Provisio	100.0
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	100.0
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
KOG1027	903	consensus Serine/threonine protein kinase and endo	100.0
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG0576	829	consensus Mitogen-activated protein kinase kinase	100.0
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	100.0
KOG1152	772	consensus Signal transduction serine/threonine kin	99.98
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.97
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.97
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.97
PLN00181	793	protein SPA1-RELATED; Provisional	99.96
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.95
PRK09188	365	serine/threonine protein kinase; Provisional	99.94
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.93
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.93
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.92
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.91
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.9
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.89
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.89
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.89
PRK12274	218	serine/threonine protein kinase; Provisional	99.89
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.88
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.87
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.87
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.87
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.87
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.86
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.86
PRK10345	210	hypothetical protein; Provisional	99.84
smart00090	237	RIO RIO-like kinase.	99.82
PRK14879	211	serine/threonine protein kinase; Provisional	99.8
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.78
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.77
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.76
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.76
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.75
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.73
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.72
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.69
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.69
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.56
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.53
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.49
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.42
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.42
KOG1243	690	consensus Protein kinase [General function predict	99.4
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.39
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.39
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.38
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	99.27
KOG3087	229	consensus Serine/threonine protein kinase [General	99.26
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.24
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.23
COG4248	637	Uncharacterized protein with protein kinase and he	99.21
KOG2137	700	consensus Protein kinase [Signal transduction mech	99.11
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	99.03
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	98.91
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.88
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.72
PRK09902	216	hypothetical protein; Provisional	98.65
KOG0576	829	consensus Mitogen-activated protein kinase kinase	98.58
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.58
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.56
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.54
PF01636	239	APH: Phosphotransferase enzyme family This family	98.48
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.48
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	98.4
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.39
KOG1235	538	consensus Predicted unusual protein kinase [Genera	98.35
PLN02876	822	acyl-CoA dehydrogenase	98.34
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	98.26
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	98.18
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	98.15
PRK10593	297	hypothetical protein; Provisional	98.05
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	98.04
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	98.03
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	97.91
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	97.8
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	97.79
PRK09550	401	mtnK methylthioribose kinase; Reviewed	97.68
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	97.64
PRK05231	319	homoserine kinase; Provisional	97.57
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	97.38
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	97.35
KOG2270	520	consensus Serine/threonine protein kinase involved	97.19
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	97.08
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	97.05
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	96.97
KOG1093	725	consensus Predicted protein kinase (contains TBC a	96.97
KOG2268	465	consensus Serine/threonine protein kinase [Signal	96.97
PLN02236	344	choline kinase	96.95
PF01633	211	Choline_kinase: Choline/ethanolamine kinase; Inter	96.68
COG2334	331	Putative homoserine kinase type II (protein kinase	96.66
KOG1236	565	consensus Predicted unusual protein kinase [Genera	96.64
PTZ00384	383	choline kinase; Provisional	96.52
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	96.44
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	96.27
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	95.94
PLN02756	418	S-methyl-5-thioribose kinase	95.88
PRK12396	409	5-methylribose kinase; Reviewed	95.76
PRK06148	1013	hypothetical protein; Provisional	95.34
PRK11768	325	serine/threonine protein kinase; Provisional	95.3
PF07387	308	Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099	94.88
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	94.81
PTZ00296	442	choline kinase; Provisional	94.77
PF03109	119	ABC1: ABC1 family; InterPro: IPR004147 This entry	94.53

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=100.00  E-value=1.4e-64  Score=429.82  Aligned_cols=316  Identities=84%  Similarity=1.332  Sum_probs=301.8

Q ss_pred             CCccCcccccccccCCcccCCCCCcccccCCCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecccchHHHHHHHHH
Q 015374           93 AMSKARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKI  172 (408)
Q Consensus        93 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~E~~~  172 (408)
                      ..+.++++++++...+.++|+|+...+.|+..++|++.+++|+|.+++||.|+...+++.++||++++...+.+.+|+.|
T Consensus         6 v~s~ARvya~vn~~rp~eYWdYE~~~i~wg~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVkkkKIkREikI   85 (338)
T KOG0668|consen    6 VPSVARVYADVNEERPREYWDYESLVIDWGNQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVKKKKIKREIKI   85 (338)
T ss_pred             cchhhhhhhhccccCchhhcchhheeeeccccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHHHHHHHHHHHH
Confidence            45788999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             HHHhcCCCCceEEeeEEEccCCCccEEEEEeecCCChhhhcCCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEE
Q 015374          173 LQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMI  252 (408)
Q Consensus       173 l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl  252 (408)
                      |+.|++||||+++++...++.+..+.|++||+++.++..+.+.++..+++.++.+++.||+|||++||+|||+||.|+++
T Consensus        86 L~nL~gg~NIi~L~DiV~Dp~SktpaLiFE~v~n~Dfk~ly~tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmI  165 (338)
T KOG0668|consen   86 LQNLRGGPNIIKLLDIVKDPESKTPSLIFEYVNNTDFKQLYPTLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMI  165 (338)
T ss_pred             HHhccCCCCeeehhhhhcCccccCchhHhhhhccccHHHHhhhhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeee
Confidence            99998899999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             eCCCCcEEEEecccceeccCCCcceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHH
Q 015374          253 DHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVK  332 (408)
Q Consensus       253 ~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~  332 (408)
                      |.....++|+|||+|.++.++..++.++.+.+|..||.+.+.+.|+++.|+|||||++..|+..+.|||.|.++.|++.+
T Consensus       166 dh~~rkLrlIDWGLAEFYHp~~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVk  245 (338)
T KOG0668|consen  166 DHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVK  245 (338)
T ss_pred             chhhceeeeeecchHhhcCCCceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHH
Confidence            99888999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             HHhhhchhh-----------------hhcCCCCCCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCc
Q 015374          333 IAKDCCLII-----------------WCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF  395 (408)
Q Consensus       333 ~~~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f  395 (408)
                      +.+.+|...                 ...+..+++.|..|.+.+.....++++.||+.++|.+|.++|+||.|++.||||
T Consensus       246 IakVLGt~el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF  325 (338)
T KOG0668|consen  246 IAKVLGTDELYAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYF  325 (338)
T ss_pred             HHHHhChHHHHHHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchH
Confidence            999888433                 234578899999999999999999999999999999999999999999999999


Q ss_pred             cccccchhhhccC
Q 015374          396 AQVRAAESSRTRA  408 (408)
Q Consensus       396 ~~~~~~~~~~~~~  408 (408)
                      ..++.+++++.|+
T Consensus       326 ~~~~~~~~~~~~~  338 (338)
T KOG0668|consen  326 APVREAESSRMRS  338 (338)
T ss_pred             HHHHHHhhcccCC
Confidence            9999988877653

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=3e-56  Score=404.98  Aligned_cols=253  Identities=23%  Similarity=0.414  Sum_probs=220.3

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEe----cccchHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccEE
Q 015374          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKIL----KPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSL  199 (408)
Q Consensus       124 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~----~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l  199 (408)
                      .++.+.++.||+|..|+|||++++.+++.+|+|++    ++...+++.+|++++++. +|||||.+||.|..+.. .+++
T Consensus        78 ~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~-~spyIV~~ygaF~~~~~-~isI  155 (364)
T KOG0581|consen   78 LSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSC-QSPYIVGFYGAFYSNGE-EISI  155 (364)
T ss_pred             HHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhC-CCCCeeeEeEEEEeCCc-eEEe
Confidence            45677788999999999999999999999999999    455678899999999998 99999999999977543 6889


Q ss_pred             EEEeecCCChhhhcCC---CChHHHHHHHHHHHHHHHHHHH-CCcEEecCCCCcEEEeCCCCcEEEEecccceeccCCCc
Q 015374          200 IFEYVNSTDFKVLYPT---LTDYDIRYYIYELLKALDYCHS-QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE  275 (408)
Q Consensus       200 v~e~~~~~~l~~~~~~---l~~~~~~~i~~qi~~~L~~LH~-~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~~~  275 (408)
                      +||||.+|+|+..+..   +++..+..++.++++||.|||+ .+||||||||+|||++.. |.+||||||.+..+.+. .
T Consensus       156 ~mEYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNsk-GeVKicDFGVS~~lvnS-~  233 (364)
T KOG0581|consen  156 CMEYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSK-GEVKICDFGVSGILVNS-I  233 (364)
T ss_pred             ehhhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccC-CCEEeccccccHHhhhh-h
Confidence            9999999999999864   9999999999999999999995 899999999999999998 89999999999887755 6


Q ss_pred             ceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCC----CCHHHHHHHHhhhchhhhhcCCCCCCC
Q 015374          276 YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGH----DNHDQLVKIAKDCCLIIWCNSRHSRKP  351 (408)
Q Consensus       276 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~  351 (408)
                      .++.+||..|||||.+.+ ..|+.++||||||+.++|+.+|+.||....    +..+.+..|+..               
T Consensus       234 a~tfvGT~~YMsPERi~g-~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~---------------  297 (364)
T KOG0581|consen  234 ANTFVGTSAYMSPERISG-ESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDE---------------  297 (364)
T ss_pred             cccccccccccChhhhcC-CcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcC---------------
Confidence            678999999999999998 899999999999999999999999986542    223344444332               


Q ss_pred             ccccccccCCCC-CCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccccc
Q 015374          352 WSKFINADNQHL-VSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRA  400 (408)
Q Consensus       352 ~~~~~~~~~~~~-~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~~~~  400 (408)
                          .++..+.. +|+++++||..||+.||.+|||+.|+++|||++....
T Consensus       298 ----ppP~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~~~  343 (364)
T KOG0581|consen  298 ----PPPRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQHPFIKKFED  343 (364)
T ss_pred             ----CCCCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcCHHHhhccc
Confidence                12223333 7999999999999999999999999999999986544

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.5e-56  Score=409.88  Aligned_cols=261  Identities=27%  Similarity=0.453  Sum_probs=217.4

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecccc----------hHHHHHHHHHHHHhcCCCCceEEeeEEEcc
Q 015374          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK----------KKKIKREIKILQNLCGGPNVVKLLDIVRDQ  192 (408)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~----------~~~~~~E~~~l~~l~~h~niv~l~~~~~~~  192 (408)
                      ..+.|.+.+.||+|+||.|-+|..+.+++.||||++++..          .....+|+++|++| +|||||+++++|+.+
T Consensus       170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL-~HP~IV~~~d~f~~~  248 (475)
T KOG0615|consen  170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKL-SHPNIVRIKDFFEVP  248 (475)
T ss_pred             hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhc-CCCCEEEEeeeeecC
Confidence            5678999999999999999999999999999999996421          12356999999999 999999999999654


Q ss_pred             CCCccEEEEEeecCCChhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCC--CCcEEEEecccc
Q 015374          193 HSKTPSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE--LRKLRLIDWGLA  267 (408)
Q Consensus       193 ~~~~~~lv~e~~~~~~l~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~--~~~~kl~DfG~a  267 (408)
                        ...||||||++||+|.+.+   ..+.+...+.++.|++.|+.|||++||+||||||+|||+..+  .-.+||+|||+|
T Consensus       249 --ds~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlA  326 (475)
T KOG0615|consen  249 --DSSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLA  326 (475)
T ss_pred             --CceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchh
Confidence              5668999999999998886   458888889999999999999999999999999999999765  136899999999


Q ss_pred             eeccCCCcceeeccCccccccccccCC--cCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcC
Q 015374          268 EFYHPGKEYNVRVASRYFKGPELLVDL--QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNS  345 (408)
Q Consensus       268 ~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  345 (408)
                      +.........+.|||+.|.|||++.+.  ..+..++|+||+||+||-+++|..||.....+......+....        
T Consensus       327 K~~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~--------  398 (475)
T KOG0615|consen  327 KVSGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGR--------  398 (475)
T ss_pred             hccccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCc--------
Confidence            999877788899999999999999762  2234588999999999999999999954433332333332210        


Q ss_pred             CCCCCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccccccch
Q 015374          346 RHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAE  402 (408)
Q Consensus       346 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~~~~~~  402 (408)
                       +       .+.+..|..+++++++||.+||..||++|||++|+|+||||+.++...
T Consensus       399 -y-------~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~~~~s  447 (475)
T KOG0615|consen  399 -Y-------AFGPLQWDRISEEALDLINWMLVVDPENRPSADEALNHPWFKDAPCLS  447 (475)
T ss_pred             -c-------cccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhcccccc
Confidence             0       122334455899999999999999999999999999999999777433

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=5.8e-56  Score=391.25  Aligned_cols=271  Identities=33%  Similarity=0.609  Sum_probs=228.7

Q ss_pred             CCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecccc-----hHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccEE
Q 015374          125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK-----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSL  199 (408)
Q Consensus       125 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l  199 (408)
                      +.|+.+.++|+|+||.||+|+++.+|+.||||.+..+.     .+-..+|+++|+++ +|+|+|.++.+|..  .+.++|
T Consensus         2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqL-kH~NLVnLiEVFrr--krklhL   78 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQL-KHENLVNLIEVFRR--KRKLHL   78 (396)
T ss_pred             cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhc-ccchHHHHHHHHHh--cceeEE
Confidence            46888899999999999999999999999999986433     34578999999999 99999999999954  577889


Q ss_pred             EEEeecCCChhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceecc-CCCc
Q 015374          200 IFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH-PGKE  275 (408)
Q Consensus       200 v~e~~~~~~l~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~-~~~~  275 (408)
                      |+|||+..-|..+-   ..++...++.++.|++.|+.|+|+++||||||||+|||++.+ +.+||||||+|+.+. ++..
T Consensus        79 VFE~~dhTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~-gvvKLCDFGFAR~L~~pgd~  157 (396)
T KOG0593|consen   79 VFEYCDHTVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQN-GVVKLCDFGFARTLSAPGDN  157 (396)
T ss_pred             EeeecchHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecC-CcEEeccchhhHhhcCCcch
Confidence            99999998776654   568999999999999999999999999999999999999999 899999999999887 6777


Q ss_pred             ceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhh-hcCCCCCCC---
Q 015374          276 YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIW-CNSRHSRKP---  351 (408)
Q Consensus       276 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~---  351 (408)
                      ++-.+.|++|+|||.+.+...|+..+||||+||++.||++|. |+++|.++.|++..|...+|.... ....+...+   
T Consensus       158 YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~-pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~  236 (396)
T KOG0593|consen  158 YTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGE-PLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFH  236 (396)
T ss_pred             hhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCC-cCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCcee
Confidence            888899999999999999999999999999999999999998 556999999999999999884431 111111111   


Q ss_pred             --------ccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccccccc
Q 015374          352 --------WSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAA  401 (408)
Q Consensus       352 --------~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~~~~~  401 (408)
                              -.+-.+.. -..++.-+.||+.+||..||.+|++.+|+|.||||.+..+.
T Consensus       237 Gv~lP~~~~~epLe~k-~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd~~~er  293 (396)
T KOG0593|consen  237 GVRLPEPEHPEPLERK-YPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFDGFIER  293 (396)
T ss_pred             eeecCCCCCccchhhh-cccchHHHHHHHHHHhcCCccccccHHHHhcChHHHHHHHH
Confidence                    11111111 12356789999999999999999999999999999765443

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=6.2e-54  Score=411.02  Aligned_cols=247  Identities=26%  Similarity=0.523  Sum_probs=219.1

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecc------cchHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCcc
Q 015374          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP------VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP  197 (408)
Q Consensus       124 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~------~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~  197 (408)
                      ..+|...+.||+|||++||.+++..+|+.||+|++.+      ...+.+.+||+|.+.| +|||||+++++|++  ..++
T Consensus        17 ~~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L-~HpnIV~f~~~FED--s~nV   93 (592)
T KOG0575|consen   17 SKRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSL-KHPNIVQFYHFFED--SNNV   93 (592)
T ss_pred             cceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhc-CCCcEEeeeeEeec--CCce
Confidence            3789999999999999999999999999999999853      4467899999999999 99999999999966  5788


Q ss_pred             EEEEEeecCCChhhhcC---CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCC-
Q 015374          198 SLIFEYVNSTDFKVLYP---TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG-  273 (408)
Q Consensus       198 ~lv~e~~~~~~l~~~~~---~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~-  273 (408)
                      |+|.|+|..++|..+++   .++|.+++.++.||+.||.|||+.+|||||||..|++++.+ ..|||+|||+|...... 
T Consensus        94 YivLELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~-~~VKIgDFGLAt~le~~~  172 (592)
T KOG0575|consen   94 YIVLELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNEN-MNVKIGDFGLATQLEYDG  172 (592)
T ss_pred             EEEEEecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCc-CcEEecccceeeeecCcc
Confidence            99999999999988874   69999999999999999999999999999999999999999 68999999999988754 


Q ss_pred             CcceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCCCcc
Q 015374          274 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWS  353 (408)
Q Consensus       274 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  353 (408)
                      ....+.+||+.|.|||++.. ...+..+||||+||+||.||.|+.||. ..+-.+.+..+...                 
T Consensus       173 Erk~TlCGTPNYIAPEVl~k-~gHsfEvDiWSlGcvmYtLL~G~PPFe-tk~vkety~~Ik~~-----------------  233 (592)
T KOG0575|consen  173 ERKKTLCGTPNYIAPEVLNK-SGHSFEVDIWSLGCVMYTLLVGRPPFE-TKTVKETYNKIKLN-----------------  233 (592)
T ss_pred             cccceecCCCcccChhHhcc-CCCCCchhhhhhhhHHHhhhhCCCCcc-cchHHHHHHHHHhc-----------------
Confidence            55677899999999999987 789999999999999999999999983 33334444444432                 


Q ss_pred             ccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcc
Q 015374          354 KFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFA  396 (408)
Q Consensus       354 ~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~  396 (408)
                         +...|..++.++++||++||+.||.+|||++++|.|+||+
T Consensus       234 ---~Y~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h~Ff~  273 (592)
T KOG0575|consen  234 ---EYSMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDHPFFK  273 (592)
T ss_pred             ---CcccccccCHHHHHHHHHHhcCCcccCCCHHHHhcCHhhh
Confidence               2334456899999999999999999999999999999994

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-55  Score=408.45  Aligned_cols=277  Identities=29%  Similarity=0.520  Sum_probs=234.4

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecccc----hHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccE
Q 015374          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS  198 (408)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  198 (408)
                      ..++|.++++||.|+||.||+|+...+++.||||.++..-    .-.-.||++.|++|..||||+++.+++.+.+. .++
T Consensus         8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~-~L~   86 (538)
T KOG0661|consen    8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDR-ILY   86 (538)
T ss_pred             HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCc-eEe
Confidence            3578999999999999999999999999999999987432    22346899999999449999999999987653 899


Q ss_pred             EEEEeecCCChhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCCCc
Q 015374          199 LIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE  275 (408)
Q Consensus       199 lv~e~~~~~~l~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~~~  275 (408)
                      +|||||+....+.+.   +.|++..++.|+.||++||+|+|++|+.|||+||+|||+..+ ..+||+|||+|+.......
T Consensus        87 fVfE~Md~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~-~~iKiaDFGLARev~SkpP  165 (538)
T KOG0661|consen   87 FVFEFMDCNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGN-DVIKIADFGLAREVRSKPP  165 (538)
T ss_pred             eeHHhhhhhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEeccc-ceeEecccccccccccCCC
Confidence            999999987765554   459999999999999999999999999999999999999976 6899999999999999999


Q ss_pred             ceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCC-------
Q 015374          276 YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHS-------  348 (408)
Q Consensus       276 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------  348 (408)
                      ++..+.|++|+|||+++..+.|+.++|+|++||+++|+.+-+ |.|+|.++.|++.+|++.+|.+.+..+...       
T Consensus       166 YTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLr-PLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~~m  244 (538)
T KOG0661|consen  166 YTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLR-PLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLASAM  244 (538)
T ss_pred             cchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhc-ccCCCCcHHHHHHHHHHHhCCCccccchhHHHHHHHh
Confidence            999999999999999999899999999999999999999988 556999999999999999986653332211       


Q ss_pred             CCCccccccc---cCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccccccch
Q 015374          349 RKPWSKFINA---DNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAE  402 (408)
Q Consensus       349 ~~~~~~~~~~---~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~~~~~~  402 (408)
                      ...++.....   ..-..+++++.++|.+||.|||++||||.|+|+||||+......
T Consensus       245 nf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~~~~~  301 (538)
T KOG0661|consen  245 NFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQVGRASG  301 (538)
T ss_pred             ccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCcccccccccc
Confidence            0011111111   11122689999999999999999999999999999999776553

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4.6e-54  Score=402.61  Aligned_cols=272  Identities=33%  Similarity=0.606  Sum_probs=233.9

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecccc-----hHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCcc
Q 015374          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK-----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP  197 (408)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~  197 (408)
                      ..+.|+.+++||+|+||.||+|++..+|+.||+|.+.-..     .....+||.||++| +||||++|.+...+.....+
T Consensus       115 ~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l-~HpNIikL~eivt~~~~~si  193 (560)
T KOG0600|consen  115 RADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRL-DHPNIIKLEEIVTSKLSGSI  193 (560)
T ss_pred             chHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhc-CCCcccceeeEEEecCCceE
Confidence            3567999999999999999999999999999999986332     34577999999999 99999999999987766789


Q ss_pred             EEEEEeecCCChhhhcC---CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCCC
Q 015374          198 SLIFEYVNSTDFKVLYP---TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK  274 (408)
Q Consensus       198 ~lv~e~~~~~~l~~~~~---~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~~  274 (408)
                      |||+|||++........   .|++.+++.++.||+.||+|||++||+|||||.+|||||.+ |.+||+|||||+++....
T Consensus       194 YlVFeYMdhDL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~-G~LKiaDFGLAr~y~~~~  272 (560)
T KOG0600|consen  194 YLVFEYMDHDLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNN-GVLKIADFGLARFYTPSG  272 (560)
T ss_pred             EEEEecccchhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCC-CCEEeccccceeeccCCC
Confidence            99999999876555543   59999999999999999999999999999999999999998 899999999999876554


Q ss_pred             --cceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCCCc
Q 015374          275 --EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPW  352 (408)
Q Consensus       275 --~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  352 (408)
                        .++..+-|.+|+|||+++|...|+.++|+||+||||.||++|+.. +.|.++.+|+..|.+.+|.+....+....-++
T Consensus       273 ~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI-~~G~tEveQl~kIfklcGSP~e~~W~~~kLP~  351 (560)
T KOG0600|consen  273 SAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPI-LQGRTEVEQLHKIFKLCGSPTEDYWPVSKLPH  351 (560)
T ss_pred             CcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCC-cCCccHHHHHHHHHHHhCCCChhccccccCCc
Confidence              577889999999999999999999999999999999999999855 59999999999999999966544443222222


Q ss_pred             ccccc---------ccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccc
Q 015374          353 SKFIN---------ADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQ  397 (408)
Q Consensus       353 ~~~~~---------~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~  397 (408)
                      -..+.         .+....++..+.+|+..||..||.+|.||.++|+|+||..
T Consensus       352 ~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~t  405 (560)
T KOG0600|consen  352 ATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYFTT  405 (560)
T ss_pred             ccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCccccc
Confidence            11111         1124567899999999999999999999999999999953

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=4.3e-54  Score=389.98  Aligned_cols=276  Identities=32%  Similarity=0.586  Sum_probs=233.9

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecccchHHHHHHHHHHHHhcCCCCceEEeeEEEccCCC---ccEEE
Q 015374          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSK---TPSLI  200 (408)
Q Consensus       124 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~---~~~lv  200 (408)
                      .-.|+..+.+|.|+||.||+|....+++.||||..-+. .+.-.+|+++|+.+ .|||||++.-+|....+.   +..||
T Consensus        23 ~i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d-~r~knrEl~im~~l-~HpNIV~L~~~f~~~~~~d~~~lnlV  100 (364)
T KOG0658|consen   23 EISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQD-KRYKNRELQIMRKL-DHPNIVRLLYFFSSSTESDEVYLNLV  100 (364)
T ss_pred             EEEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCC-CCcCcHHHHHHHhc-CCcCeeeEEEEEEecCCCchhHHHHH
Confidence            34688899999999999999999999999999987533 23445899999998 999999999998755444   67799


Q ss_pred             EEeecCCChhhhc------CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCCC
Q 015374          201 FEYVNSTDFKVLY------PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK  274 (408)
Q Consensus       201 ~e~~~~~~l~~~~------~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~~  274 (408)
                      ||||+........      ..++...++.++.||++||.|||+.||+||||||.|+|+|.+++.+||||||.|+....+.
T Consensus       101 leymP~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~e  180 (364)
T KOG0658|consen  101 LEYMPETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKGE  180 (364)
T ss_pred             HHhchHHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCcceeeccCC
Confidence            9999987655543      4688889999999999999999999999999999999999999999999999999999888


Q ss_pred             cceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhh-----cCCCCC
Q 015374          275 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWC-----NSRHSR  349 (408)
Q Consensus       275 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~  349 (408)
                      ...+...|++|+|||.+.+...|+.+.||||.||++.||+-|+. .|+|++..+++.++++.+|.+...     +.....
T Consensus       181 pniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~p-lFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~~y~~  259 (364)
T KOG0658|consen  181 PNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQP-LFPGDSSVDQLVEIIKVLGTPTREDIKSMNPNYTE  259 (364)
T ss_pred             CceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCc-ccCCCCHHHHHHHHHHHhCCCCHHHHhhcCccccc
Confidence            88899999999999999999999999999999999999999985 568999999999999999966522     222112


Q ss_pred             CCccccccc----cCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccccccch
Q 015374          350 KPWSKFINA----DNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAE  402 (408)
Q Consensus       350 ~~~~~~~~~----~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~~~~~~  402 (408)
                      ..++.+...    -....+++++.+|+.++|+++|.+|.|+.|++.||||+..+...
T Consensus       260 ~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~~~  316 (364)
T KOG0658|consen  260 FKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRDPN  316 (364)
T ss_pred             ccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhCcC
Confidence            222221111    13445789999999999999999999999999999999887653

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-53  Score=386.17  Aligned_cols=257  Identities=31%  Similarity=0.538  Sum_probs=226.0

Q ss_pred             CCCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc------chHHHHHHHHHHHHhcCCCCceEEeeEEEccCCC
Q 015374          122 GDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSK  195 (408)
Q Consensus       122 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  195 (408)
                      ...++|++++.||+|+||+||.++...+++.+|+|++++.      ..+....|..||.++ +||.||+++-.|  ++..
T Consensus        22 ~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v-~hPFiv~l~ysF--Qt~~   98 (357)
T KOG0598|consen   22 VGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKI-KHPFIVKLIYSF--QTEE   98 (357)
T ss_pred             CChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhC-CCCcEeeeEEec--ccCC
Confidence            3578999999999999999999999999999999999743      346788999999998 999999999999  5568


Q ss_pred             ccEEEEEeecCCChhhhcC---CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceecc-
Q 015374          196 TPSLIFEYVNSTDFKVLYP---TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH-  271 (408)
Q Consensus       196 ~~~lv~e~~~~~~l~~~~~---~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~-  271 (408)
                      .++||+||++||.|..++.   .|++..++.++.+|+.||.|||++|||||||||+|||+|.+ |.++|+|||+++... 
T Consensus        99 kLylVld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~-GHi~LtDFgL~k~~~~  177 (357)
T KOG0598|consen   99 KLYLVLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQ-GHIKLTDFGLCKEDLK  177 (357)
T ss_pred             eEEEEEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCC-CcEEEeccccchhccc
Confidence            8999999999999999996   59999999999999999999999999999999999999999 899999999998554 


Q ss_pred             CCCcceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCCC
Q 015374          272 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKP  351 (408)
Q Consensus       272 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  351 (408)
                      .+..+.+.+||+.|||||++.+ ..|+..+|.||+|+++|||++|..|| .+.+......++....              
T Consensus       178 ~~~~t~tfcGT~eYmAPEil~~-~gy~~~vDWWsLGillYeML~G~pPF-~~~~~~~~~~~I~~~k--------------  241 (357)
T KOG0598|consen  178 DGDATRTFCGTPEYMAPEILLG-KGYDKAVDWWSLGILLYEMLTGKPPF-YAEDVKKMYDKILKGK--------------  241 (357)
T ss_pred             CCCccccccCCccccChHHHhc-CCCCcccchHhHHHHHHHHhhCCCCC-cCccHHHHHHHHhcCc--------------
Confidence            3455667899999999999998 79999999999999999999999998 5555556666655431              


Q ss_pred             ccccccccCCCCCCHHHHHHHHHhcccCcCCCC----CHHHHhcCCCccccccchh
Q 015374          352 WSKFINADNQHLVSPEAIDFLDKLLRYDHQDRL----TAREAMAHPYFAQVRAAES  403 (408)
Q Consensus       352 ~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rp----t~~elL~hp~f~~~~~~~~  403 (408)
                           ....+..++.+++++++++|+.||++|.    +++++-+||||..+.+...
T Consensus       242 -----~~~~p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~HpfF~~inW~~l  292 (357)
T KOG0598|consen  242 -----LPLPPGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKRHPFFKGINWEKL  292 (357)
T ss_pred             -----CCCCCccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhcCcccccCCHHHH
Confidence                 1223344799999999999999999995    7999999999999988654

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=3.5e-53  Score=367.67  Aligned_cols=270  Identities=36%  Similarity=0.668  Sum_probs=225.9

Q ss_pred             CCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecccch-----HHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccEE
Q 015374          125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKK-----KKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSL  199 (408)
Q Consensus       125 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~-----~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l  199 (408)
                      ++|...++||+|.||.||+|++..+|+.||||.++..+.     -...+|++.|+.+ +|+||+.++++|  .+...+.|
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel-~h~nIi~LiD~F--~~~~~l~l   78 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQEL-KHPNIIELIDVF--PHKSNLSL   78 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHc-cCcchhhhhhhc--cCCCceEE
Confidence            467788899999999999999999999999999975432     3578999999999 999999999999  55667789


Q ss_pred             EEEeecCCChhhhcC----CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCCC-
Q 015374          200 IFEYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK-  274 (408)
Q Consensus       200 v~e~~~~~~l~~~~~----~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~~-  274 (408)
                      |+|||+. +|+..++    .++..+++.++.++++||+|||++.|+||||||.|+|++++ |.+||+|||+|+.+.+.. 
T Consensus        79 VfEfm~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~-g~lKiADFGLAr~f~~p~~  156 (318)
T KOG0659|consen   79 VFEFMPT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSD-GQLKIADFGLARFFGSPNR  156 (318)
T ss_pred             EEEeccc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCC-CcEEeecccchhccCCCCc
Confidence            9999985 5555553    38999999999999999999999999999999999999999 899999999999886543 


Q ss_pred             cceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCC--CCc
Q 015374          275 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSR--KPW  352 (408)
Q Consensus       275 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~  352 (408)
                      .....+.|.+|+|||.+.|...|+..+||||+||++.||+-| .||++|.++-||+..+...+|.+....+..-.  ..+
T Consensus       157 ~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr-~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY  235 (318)
T KOG0659|consen  157 IQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLR-VPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDY  235 (318)
T ss_pred             ccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHcc-CCCCCCCchHHHHHHHHHHcCCCCcccCccccccccH
Confidence            344458999999999999999999999999999999999976 58899999999999999998866533322111  000


Q ss_pred             ccc--cc----ccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccccc
Q 015374          353 SKF--IN----ADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRA  400 (408)
Q Consensus       353 ~~~--~~----~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~~~~  400 (408)
                      .++  .+    ...-...++++.||+.+||.+||.+|+|+.|+|+|+||++.+.
T Consensus       236 ~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~~P~  289 (318)
T KOG0659|consen  236 VKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKSLPL  289 (318)
T ss_pred             HHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhcCCC
Confidence            000  01    1123345788999999999999999999999999999996554

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=8.3e-53  Score=375.85  Aligned_cols=274  Identities=30%  Similarity=0.528  Sum_probs=230.2

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecccchH-----HHHHHHHHHHHhcCCCCceEEeeEEEccCCCccE
Q 015374          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKK-----KIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS  198 (408)
Q Consensus       124 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~-----~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  198 (408)
                      -+.|+.+++|++|+||.||+|+++.+++.||+|.++....+     ...+||.+|.++ +|||||.+-.+....+-..++
T Consensus        75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~-~H~NIV~vkEVVvG~~~d~iy  153 (419)
T KOG0663|consen   75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKA-RHPNIVEVKEVVVGSNMDKIY  153 (419)
T ss_pred             HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhc-CCCCeeeeEEEEeccccceee
Confidence            46799999999999999999999999999999999855432     357999999999 899999999999877777899


Q ss_pred             EEEEeecCCC---hhhhcCCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCC-C
Q 015374          199 LIFEYVNSTD---FKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG-K  274 (408)
Q Consensus       199 lv~e~~~~~~---l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~-~  274 (408)
                      +|||||+...   ++.+-..|...+++-++.|++.|++|||.+.|+|||||++|+|++.. |.+||+|||+|+.+... +
T Consensus       154 ~VMe~~EhDLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~-G~lKiaDFGLAR~ygsp~k  232 (419)
T KOG0663|consen  154 IVMEYVEHDLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHK-GILKIADFGLAREYGSPLK  232 (419)
T ss_pred             eeHHHHHhhHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccC-CcEEecccchhhhhcCCcc
Confidence            9999998753   22222579999999999999999999999999999999999999988 89999999999988654 4


Q ss_pred             cceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCC--------
Q 015374          275 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSR--------  346 (408)
Q Consensus       275 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~--------  346 (408)
                      .++..+-|.+|+|||++++...|+.++|+||+|||+.||++++ |.++|....+++..|...+|.+....+.        
T Consensus       233 ~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~k-Plf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~~  311 (419)
T KOG0663|consen  233 PYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQK-PLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPAV  311 (419)
T ss_pred             cCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcC-CCCCCCchHHHHHHHHHHhCCCccccCCCccccchh
Confidence            5677889999999999999999999999999999999999987 5569999999999999999866532221        


Q ss_pred             ----CCCCCccccccccCC-CCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccccccc
Q 015374          347 ----HSRKPWSKFINADNQ-HLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAA  401 (408)
Q Consensus       347 ----~~~~~~~~~~~~~~~-~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~~~~~  401 (408)
                          ....++..+ ..... ..+++...+|++.+|.+||.+|.||+|.|+|+||...+.+
T Consensus       312 k~~~f~~~pyn~l-r~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~P~p  370 (419)
T KOG0663|consen  312 KKMTFSEHPYNNL-RKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRETPLP  370 (419)
T ss_pred             hccccCCCCchhh-hhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccCCCC
Confidence                111111111 11111 1167999999999999999999999999999999986554

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=6.7e-52  Score=391.07  Aligned_cols=255  Identities=31%  Similarity=0.535  Sum_probs=226.1

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecc------cchHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCc
Q 015374          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP------VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT  196 (408)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~------~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  196 (408)
                      ...+|...+.||.|+|++|++|++..+++.+|||++.+      ...+.+..|-.+|.+|.+||.|++|+-.|.|  ...
T Consensus        71 ~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD--~~s  148 (604)
T KOG0592|consen   71 TPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQD--EES  148 (604)
T ss_pred             ChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeec--ccc
Confidence            46789999999999999999999999999999999853      2345677899999999999999999999965  467


Q ss_pred             cEEEEEeecCCChhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCC
Q 015374          197 PSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG  273 (408)
Q Consensus       197 ~~lv~e~~~~~~l~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~  273 (408)
                      +|+|+||+++|+|..++   ..|++...+.++.||+.||+|||++|||||||||+|||||.| +.++|+|||.|+.+.+.
T Consensus       149 LYFvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~d-mhikITDFGsAK~l~~~  227 (604)
T KOG0592|consen  149 LYFVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKD-GHIKITDFGSAKILSPS  227 (604)
T ss_pred             eEEEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCC-CcEEEeeccccccCChh
Confidence            88999999999999887   469999999999999999999999999999999999999999 89999999999877542


Q ss_pred             Cc--------------ceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhch
Q 015374          274 KE--------------YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCL  339 (408)
Q Consensus       274 ~~--------------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~  339 (408)
                      ..              ....+||-.|.+||++.+ ...++.+|+|+|||++|.|+.|..|| .+.++.-.+++|+..   
T Consensus       228 ~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~-~~~~~~sDiWAlGCilyQmlaG~PPF-ra~NeyliFqkI~~l---  302 (604)
T KOG0592|consen  228 QKSQENPVDPNQASSRRSSFVGTAEYVSPELLND-SPAGPSSDLWALGCILYQMLAGQPPF-RAANEYLIFQKIQAL---  302 (604)
T ss_pred             hccccCccCcccccCcccceeeeecccCHHHhcC-CCCCcccchHHHHHHHHHHhcCCCCC-ccccHHHHHHHHHHh---
Confidence            21              144789999999999988 88999999999999999999999997 777777788888774   


Q ss_pred             hhhhcCCCCCCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccccccch
Q 015374          340 IIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAE  402 (408)
Q Consensus       340 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~~~~~~  402 (408)
                                       ....+...++.+.|||+++|..||.+|+|++|+.+||||..+++..
T Consensus       303 -----------------~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~Vdw~n  348 (604)
T KOG0592|consen  303 -----------------DYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEGVDWEN  348 (604)
T ss_pred             -----------------cccCCCCCCHHHHHHHHHHHccCccccccHHHHhhCcccccCChhh
Confidence                             2334455789999999999999999999999999999999998865

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=3.9e-51  Score=386.07  Aligned_cols=261  Identities=31%  Similarity=0.508  Sum_probs=224.6

Q ss_pred             cCCCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecccc------hHHHHHHHHHHHHhcCCCCceEEeeEEEccCC
Q 015374          121 WGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK------KKKIKREIKILQNLCGGPNVVKLLDIVRDQHS  194 (408)
Q Consensus       121 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~------~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~  194 (408)
                      ....++|+++..||+|+||.||+|+.+.+|..+|+|++++..      .+....|-.+|... .+++||+|+-.|.  +.
T Consensus       137 r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~-ds~~vVKLyYsFQ--D~  213 (550)
T KOG0605|consen  137 RLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEV-DSPWVVKLYYSFQ--DK  213 (550)
T ss_pred             cCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhc-CCCcEEEEEEEec--CC
Confidence            345789999999999999999999999999999999997543      46678899999996 9999999999994  46


Q ss_pred             CccEEEEEeecCCChhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceecc
Q 015374          195 KTPSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH  271 (408)
Q Consensus       195 ~~~~lv~e~~~~~~l~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~  271 (408)
                      .++||||||++||++..++   ..+++..++.++.+++.|++-||+.|+|||||||+|+|||.. |++||+||||+....
T Consensus       214 ~~LYLiMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~-GHiKLSDFGLs~gl~  292 (550)
T KOG0605|consen  214 EYLYLIMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAK-GHIKLSDFGLSTGLD  292 (550)
T ss_pred             CeeEEEEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCC-CCEeeccccccchhh
Confidence            8999999999999999887   459999999999999999999999999999999999999998 999999999984321


Q ss_pred             C-----------------------CCc-------------------------ceeeccCccccccccccCCcCCCccccH
Q 015374          272 P-----------------------GKE-------------------------YNVRVASRYFKGPELLVDLQDYDYSLDM  303 (408)
Q Consensus       272 ~-----------------------~~~-------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv  303 (408)
                      .                       ...                         ....+||+.|+|||++.+ .+|+..+|.
T Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~-kgY~~~cDw  371 (550)
T KOG0605|consen  293 KKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLG-KGYGKECDW  371 (550)
T ss_pred             hhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhc-CCCCccccH
Confidence            1                       000                         012479999999999999 779999999


Q ss_pred             HHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCCCccccccccCCCCCCHHHHHHHHHhcccCcCCC
Q 015374          304 WSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDR  383 (408)
Q Consensus       304 wSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R  383 (408)
                      ||||||+||||.|..|| .+.+..+...+++.                |...........+++++.|||.+||. ||++|
T Consensus       372 WSLG~ImyEmLvGyPPF-~s~tp~~T~rkI~n----------------wr~~l~fP~~~~~s~eA~DLI~rll~-d~~~R  433 (550)
T KOG0605|consen  372 WSLGCIMYEMLVGYPPF-CSETPQETYRKIVN----------------WRETLKFPEEVDLSDEAKDLITRLLC-DPENR  433 (550)
T ss_pred             HHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHH----------------HhhhccCCCcCcccHHHHHHHHHHhc-CHHHh
Confidence            99999999999999997 67777788877766                33333333344578999999999998 99999


Q ss_pred             C---CHHHHhcCCCccccccchhh
Q 015374          384 L---TAREAMAHPYFAQVRAAESS  404 (408)
Q Consensus       384 p---t~~elL~hp~f~~~~~~~~~  404 (408)
                      .   +++|+.+||||+.+.+...+
T Consensus       434 LG~~G~~EIK~HPfF~~v~W~~l~  457 (550)
T KOG0605|consen  434 LGSKGAEEIKKHPFFKGVDWDHLR  457 (550)
T ss_pred             cCcccHHHHhcCCccccCCcchhh
Confidence            8   59999999999999987653

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-51  Score=371.21  Aligned_cols=273  Identities=33%  Similarity=0.601  Sum_probs=230.8

Q ss_pred             ccCCCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEec-----ccchHHHHHHHHHHHHhcCCCCceEEeeEEEc---
Q 015374          120 QWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK-----PVKKKKIKREIKILQNLCGGPNVVKLLDIVRD---  191 (408)
Q Consensus       120 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~-----~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~---  191 (408)
                      .+....+|..++.||+|+||.|+.+.+..+|+.||||.+.     ....++..+|+++|+++ +|+||+.+++.+..   
T Consensus        17 ~~~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~-~HeNIi~l~di~~p~~~   95 (359)
T KOG0660|consen   17 LFEIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHL-RHENIIGLLDIFRPPSR   95 (359)
T ss_pred             EEeccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHh-cCCCcceEEeecccccc
Confidence            3445677777899999999999999999999999999885     23457788999999999 89999999999975   


Q ss_pred             cCCCccEEEEEeecCCChhhhcC---CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccce
Q 015374          192 QHSKTPSLIFEYVNSTDFKVLYP---TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE  268 (408)
Q Consensus       192 ~~~~~~~lv~e~~~~~~l~~~~~---~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~  268 (408)
                      .+.+.+++|+|+| +.+|...++   .+++..++.++.|++.||.|+|+.||+||||||.|+|++.+ ..+||||||+|+
T Consensus        96 ~~f~DvYiV~elM-etDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~-c~lKI~DFGLAR  173 (359)
T KOG0660|consen   96 DKFNDVYLVFELM-ETDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNAD-CDLKICDFGLAR  173 (359)
T ss_pred             cccceeEEehhHH-hhHHHHHHHcCccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccC-CCEEecccccee
Confidence            3446789999999 566666663   38999999999999999999999999999999999999999 789999999999


Q ss_pred             eccC---CCcceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhh---
Q 015374          269 FYHP---GKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIW---  342 (408)
Q Consensus       269 ~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~---  342 (408)
                      ...+   ....+..+.|.+|+|||++.....|+.++||||+|||+.||++|+.. |+|.+..+++..+.+..|.+..   
T Consensus       174 ~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkpl-FpG~d~v~Ql~lI~~~lGtP~~e~l  252 (359)
T KOG0660|consen  174 YLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPL-FPGKDYVHQLQLILELLGTPSEEDL  252 (359)
T ss_pred             eccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCC-CCCCchHHHHHHHHHhcCCCCHHHH
Confidence            8864   33446678999999999999889999999999999999999999855 5999999999999998885541   


Q ss_pred             -------------hcCCCCCCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccccccc
Q 015374          343 -------------CNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAA  401 (408)
Q Consensus       343 -------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~~~~~  401 (408)
                                   ......+.+|...+     ...++.+.||+.+||.+||.+|+|++|+|+||||......
T Consensus       253 ~~i~s~~ar~yi~slp~~p~~~f~~~f-----p~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hdp  319 (359)
T KOG0660|consen  253 QKIRSEKARPYIKSLPQIPKQPFSSIF-----PNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHDP  319 (359)
T ss_pred             HHhccHHHHHHHHhCCCCCCCCHHHHc-----CCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcCC
Confidence                         12223333333332     2468999999999999999999999999999999876543

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=7.1e-51  Score=372.96  Aligned_cols=255  Identities=29%  Similarity=0.516  Sum_probs=217.3

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc-----chHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCcc
Q 015374          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP  197 (408)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~  197 (408)
                      ...+|.+.++||+|+||+||+|+++.++..||||.+...     ..+.+..|+.+|+.| +|||||.++++++.  .+.+
T Consensus         8 ~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel-~H~nIV~l~d~~~~--~~~i   84 (429)
T KOG0595|consen    8 VVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKEL-KHPNIVRLLDCIED--DDFI   84 (429)
T ss_pred             ccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhc-CCcceeeEEEEEec--CCeE
Confidence            356899999999999999999999999999999988644     345678999999999 99999999999966  4688


Q ss_pred             EEEEEeecCCChhhhcC---CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCC--C---CcEEEEeccccee
Q 015374          198 SLIFEYVNSTDFKVLYP---TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE--L---RKLRLIDWGLAEF  269 (408)
Q Consensus       198 ~lv~e~~~~~~l~~~~~---~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~--~---~~~kl~DfG~a~~  269 (408)
                      +||||||.||+|..++.   .+++..++.++.||+.||++||+++||||||||+||||+..  .   -.+||+|||+|+.
T Consensus        85 ~lVMEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~  164 (429)
T KOG0595|consen   85 YLVMEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARF  164 (429)
T ss_pred             EEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhh
Confidence            99999999999999983   68999999999999999999999999999999999999864  1   2589999999999


Q ss_pred             ccCCCcceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCC
Q 015374          270 YHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSR  349 (408)
Q Consensus       270 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  349 (408)
                      ..++....+.+|++.|||||++.. +.|+.|+|+||+|+++|+|++|+.|| ......+.+..+.+...           
T Consensus       165 L~~~~~a~tlcGSplYMAPEV~~~-~~YdAKADLWSiG~Ilyq~l~g~~Pf-~a~t~~eL~~~~~k~~~-----------  231 (429)
T KOG0595|consen  165 LQPGSMAETLCGSPLYMAPEVIMS-QQYDAKADLWSIGTILYQCLTGKPPF-DAETPKELLLYIKKGNE-----------  231 (429)
T ss_pred             CCchhHHHHhhCCccccCHHHHHh-ccccchhhHHHHHHHHHHHHhCCCCc-cccCHHHHHHHHhcccc-----------
Confidence            998888888999999999999986 89999999999999999999999987 44444444442222110           


Q ss_pred             CCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccccc
Q 015374          350 KPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVR  399 (408)
Q Consensus       350 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~~~  399 (408)
                            ..+..+..++....+++...|+.++.+|.+..+-+.|+++..-.
T Consensus       232 ------~~~~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~~p  275 (429)
T KOG0595|consen  232 ------IVPVLPAELSNPLRELLISLLQRNPKDRISFEDFFDHPFLAANP  275 (429)
T ss_pred             ------ccCchhhhccCchhhhhhHHHhcCccccCchHHhhhhhhcccCc
Confidence                  11222233567788999999999999999999999999987654

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-50  Score=356.48  Aligned_cols=253  Identities=24%  Similarity=0.454  Sum_probs=224.6

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecccc------hHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCc
Q 015374          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK------KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT  196 (408)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~------~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  196 (408)
                      ..++|+.++.||.|+||+|.+++.+.++..+|+|+++...      .+...+|..+|+.+ .||+++++++.|.+  ...
T Consensus        42 ~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v-~~PFlv~l~~t~~d--~~~  118 (355)
T KOG0616|consen   42 SLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAV-SHPFLVKLYGTFKD--NSN  118 (355)
T ss_pred             chhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhc-cCceeEEEEEeecc--CCe
Confidence            3578899999999999999999999999999999997533      35677899999999 89999999999955  578


Q ss_pred             cEEEEEeecCCChhhhcC---CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCC
Q 015374          197 PSLIFEYVNSTDFKVLYP---TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG  273 (408)
Q Consensus       197 ~~lv~e~~~~~~l~~~~~---~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~  273 (408)
                      ++|||||.+||.+..+++   +|++..++.++.||+.||+|||+++|++|||||+|||+|.+ |.+||+|||+|+.....
T Consensus       119 lymvmeyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~-G~iKitDFGFAK~v~~r  197 (355)
T KOG0616|consen  119 LYMVMEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQN-GHIKITDFGFAKRVSGR  197 (355)
T ss_pred             EEEEEeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccC-CcEEEEeccceEEecCc
Confidence            999999999999999984   59999999999999999999999999999999999999999 89999999999987643


Q ss_pred             CcceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCCCcc
Q 015374          274 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWS  353 (408)
Q Consensus       274 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  353 (408)
                        +.+.|||+.|+|||++.. .+++.++|.|||||++|||+.|..||+. ++......+|++.                 
T Consensus       198 --T~TlCGTPeYLAPEii~s-k~ynkavDWWalGVLIYEMlaG~pPF~~-~~~~~iY~KI~~~-----------------  256 (355)
T KOG0616|consen  198 --TWTLCGTPEYLAPEIIQS-KGYNKAVDWWALGVLIYEMLAGYPPFYD-DNPIQIYEKILEG-----------------  256 (355)
T ss_pred             --EEEecCCccccChHHhhc-CCCCcchhHHHHHHHHHHHHcCCCCCcC-CChHHHHHHHHhC-----------------
Confidence              677899999999999988 8999999999999999999999999854 4446667777653                 


Q ss_pred             ccccccCCCCCCHHHHHHHHHhcccCcCCCC-----CHHHHhcCCCccccccchh
Q 015374          354 KFINADNQHLVSPEAIDFLDKLLRYDHQDRL-----TAREAMAHPYFAQVRAAES  403 (408)
Q Consensus       354 ~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rp-----t~~elL~hp~f~~~~~~~~  403 (408)
                         ....|..+++++++|++++|+.|-.+|.     ...++..||||+.+.+...
T Consensus       257 ---~v~fP~~fs~~~kdLl~~LL~vD~t~R~gnlknG~~dIk~H~wF~~v~W~~i  308 (355)
T KOG0616|consen  257 ---KVKFPSYFSSDAKDLLKKLLQVDLTKRFGNLKNGVEDIKNHPWFKGVDWEAI  308 (355)
T ss_pred             ---cccCCcccCHHHHHHHHHHHhhhhHhhhcCcCCCccccccCcccccccHHHH
Confidence               2334555899999999999999999993     6789999999999988664

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7e-50  Score=387.34  Aligned_cols=258  Identities=27%  Similarity=0.477  Sum_probs=230.8

Q ss_pred             CCCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc------chHHHHHHHHHHHHhcCCCCceEEeeEEEccCCC
Q 015374          122 GDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSK  195 (408)
Q Consensus       122 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  195 (408)
                      ...++|.+++.||+|+||+|+++..+.+++.+|||++++.      ..+....|-.|+....+||.+++++.+|  +...
T Consensus       365 ~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~f--QT~~  442 (694)
T KOG0694|consen  365 LTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCF--QTKE  442 (694)
T ss_pred             ccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeeccccc--ccCC
Confidence            3568899999999999999999999999999999999853      3467888999999887899999999999  5568


Q ss_pred             ccEEEEEeecCCChhhhc--CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceecc-C
Q 015374          196 TPSLIFEYVNSTDFKVLY--PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH-P  272 (408)
Q Consensus       196 ~~~lv~e~~~~~~l~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~-~  272 (408)
                      ++++||||+.||++..+.  ..|++..++.|+..++.||.|||++||||||||.+|||||.+ |.+||+|||+++... .
T Consensus       443 ~l~fvmey~~Ggdm~~~~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~e-Gh~kiADFGlcKe~m~~  521 (694)
T KOG0694|consen  443 HLFFVMEYVAGGDLMHHIHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTE-GHVKIADFGLCKEGMGQ  521 (694)
T ss_pred             eEEEEEEecCCCcEEEEEecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEccc-CcEEecccccccccCCC
Confidence            999999999999955444  469999999999999999999999999999999999999999 899999999998765 4


Q ss_pred             CCcceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCCCc
Q 015374          273 GKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPW  352 (408)
Q Consensus       273 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  352 (408)
                      +..+.+.+||+.|+|||++.+ +.|+.++|.|||||+||||+.|..|| .|++..+.+..|+..                
T Consensus       522 g~~TsTfCGTpey~aPEil~e-~~Yt~aVDWW~lGVLlyeML~Gq~PF-~gddEee~FdsI~~d----------------  583 (694)
T KOG0694|consen  522 GDRTSTFCGTPEFLAPEVLTE-QSYTRAVDWWGLGVLLYEMLVGESPF-PGDDEEEVFDSIVND----------------  583 (694)
T ss_pred             CCccccccCChhhcChhhhcc-CcccchhhHHHHHHHHHHHHcCCCCC-CCCCHHHHHHHHhcC----------------
Confidence            566788999999999999998 89999999999999999999999997 788888888888764                


Q ss_pred             cccccccCCCCCCHHHHHHHHHhcccCcCCCCC-----HHHHhcCCCccccccchhh
Q 015374          353 SKFINADNQHLVSPEAIDFLDKLLRYDHQDRLT-----AREAMAHPYFAQVRAAESS  404 (408)
Q Consensus       353 ~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt-----~~elL~hp~f~~~~~~~~~  404 (408)
                          +...|..+|.++.++++++|+.||++|..     ++++.+||||+.+.+....
T Consensus       584 ----~~~yP~~ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i~w~~L~  636 (694)
T KOG0694|consen  584 ----EVRYPRFLSKEAIAIMRRLLRKNPEKRLGSGERDAEDIKKHPFFRSIDWDDLL  636 (694)
T ss_pred             ----CCCCCCcccHHHHHHHHHHhccCcccccCCCCCCchhhhhCCccccCCHHHHh
Confidence                33445558999999999999999999994     6899999999999986643

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-50  Score=384.60  Aligned_cols=255  Identities=26%  Similarity=0.493  Sum_probs=219.9

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecc---cchHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccEE
Q 015374          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP---VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSL  199 (408)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~---~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l  199 (408)
                      ....|....+||+|+.|.||.|+...+++.||||.+..   ..++-+.+|+.+|+.. +|+|||++++.|...  ..++.
T Consensus       271 P~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~-~H~NiVnfl~Sylv~--deLWV  347 (550)
T KOG0578|consen  271 PRSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDL-HHPNIVNFLDSYLVG--DELWV  347 (550)
T ss_pred             hhhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhc-cchHHHHHHHHhccc--ceeEE
Confidence            35678889999999999999999999999999999863   3356688999999999 999999999988653  67899


Q ss_pred             EEEeecCCChhhhcC--CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCCC-cc
Q 015374          200 IFEYVNSTDFKVLYP--TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK-EY  276 (408)
Q Consensus       200 v~e~~~~~~l~~~~~--~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~~-~~  276 (408)
                      |||||++|+|.+...  .+++.++..++.+++.||+|||.+||+|||||.+|||++.+ |.+||+|||++..+.... ..
T Consensus       348 VMEym~ggsLTDvVt~~~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~-g~vKltDFGFcaqi~~~~~KR  426 (550)
T KOG0578|consen  348 VMEYMEGGSLTDVVTKTRMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMD-GSVKLTDFGFCAQISEEQSKR  426 (550)
T ss_pred             EEeecCCCchhhhhhcccccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccC-CcEEEeeeeeeeccccccCcc
Confidence            999999999988874  48999999999999999999999999999999999999999 899999999998776554 45


Q ss_pred             eeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCCCccccc
Q 015374          277 NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSKFI  356 (408)
Q Consensus       277 ~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  356 (408)
                      .+.+||++|||||+... ..|++++||||||++++||+.|..||+. .+....+..|.....        .         
T Consensus       427 ~TmVGTPYWMAPEVvtr-k~YG~KVDIWSLGIMaIEMveGEPPYln-E~PlrAlyLIa~ng~--------P---------  487 (550)
T KOG0578|consen  427 STMVGTPYWMAPEVVTR-KPYGPKVDIWSLGIMAIEMVEGEPPYLN-ENPLRALYLIATNGT--------P---------  487 (550)
T ss_pred             ccccCCCCccchhhhhh-cccCccccchhhhhHHHHHhcCCCCccC-CChHHHHHHHhhcCC--------C---------
Confidence            67899999999999987 8899999999999999999999999865 444444554444321        1         


Q ss_pred             cccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccccc
Q 015374          357 NADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRA  400 (408)
Q Consensus       357 ~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~~~~  400 (408)
                      ....+..+|++++||+++||+.|+++|++|.|||+||||+....
T Consensus       488 ~lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~HpFl~~a~p  531 (550)
T KOG0578|consen  488 KLKNPEKLSPELKDFLDRCLVVDVEQRASAKELLEHPFLKMAKP  531 (550)
T ss_pred             CcCCccccCHHHHHHHHHHhhcchhcCCCHHHHhcChhhhhcCC
Confidence            12234458999999999999999999999999999999975543

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=4.5e-50  Score=388.36  Aligned_cols=269  Identities=29%  Similarity=0.530  Sum_probs=218.2

Q ss_pred             CCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecccc--hHHHHHHHHHHHHhcCC-----CCceEEeeEEEccCCCcc
Q 015374          125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK--KKKIKREIKILQNLCGG-----PNVVKLLDIVRDQHSKTP  197 (408)
Q Consensus       125 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~E~~~l~~l~~h-----~niv~l~~~~~~~~~~~~  197 (408)
                      -+|++.+.||+|+||.|.+|.+..+++.||||++++..  ..+...|+.+|..|.+|     -|+|+++++|  ...+++
T Consensus       186 ~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F--~fr~Hl  263 (586)
T KOG0667|consen  186 YRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYF--YFRNHL  263 (586)
T ss_pred             EEEEEEEEecccccceeEEEEecCCCcEEEEEeeccChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecc--ccccce
Confidence            38999999999999999999999999999999998543  36677899999999534     3899999999  446899


Q ss_pred             EEEEEeecCCChhhhc----CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeC-CCCcEEEEecccceeccC
Q 015374          198 SLIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDH-ELRKLRLIDWGLAEFYHP  272 (408)
Q Consensus       198 ~lv~e~~~~~~l~~~~----~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~-~~~~~kl~DfG~a~~~~~  272 (408)
                      |||+|.++....+...    ..++...++.++.||+.||.+||+.+|||+||||+||||.+ +...+||+|||+|.....
T Consensus       264 ciVfELL~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~~q  343 (586)
T KOG0667|consen  264 CIVFELLSTNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFESQ  343 (586)
T ss_pred             eeeehhhhhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEecccccccCC
Confidence            9999999865544333    35899999999999999999999999999999999999964 335899999999986543


Q ss_pred             CCcceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCC---CCC
Q 015374          273 GKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSR---HSR  349 (408)
Q Consensus       273 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~  349 (408)
                      . .+ +.+.++.|+|||++++ ..|+.+.||||||||++||++| .|+|+|.+..|++..|++.+|++......   ...
T Consensus       344 ~-vy-tYiQSRfYRAPEVILG-lpY~~~IDmWSLGCIlAEL~tG-~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~~~~~  419 (586)
T KOG0667|consen  344 R-VY-TYIQSRFYRAPEVILG-LPYDTAIDMWSLGCILAELFTG-EPLFPGDNEYDQLARIIEVLGLPPPKMLDTAKKAH  419 (586)
T ss_pred             c-ce-eeeeccccccchhhcc-CCCCCccceeehhhhHHhHhcC-ccccCCCCHHHHHHHHHHHhCCCCHHHHHhccccc
Confidence            2 23 7899999999999999 8999999999999999999999 57789999999999999999966521111   000


Q ss_pred             CCccc-------c----------------------ccccCC-----------CCCCHHHHHHHHHhcccCcCCCCCHHHH
Q 015374          350 KPWSK-------F----------------------INADNQ-----------HLVSPEAIDFLDKLLRYDHQDRLTAREA  389 (408)
Q Consensus       350 ~~~~~-------~----------------------~~~~~~-----------~~~~~~~~~li~~~L~~dp~~Rpt~~el  389 (408)
                      +.+..       .                      .....+           ..-...+.||+.+||.+||.+|+|+.|+
T Consensus       420 kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~tp~qa  499 (586)
T KOG0667|consen  420 KFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERITPAQA  499 (586)
T ss_pred             eehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCCHHHH
Confidence            00000       0                      000001           0113558999999999999999999999


Q ss_pred             hcCCCccccc
Q 015374          390 MAHPYFAQVR  399 (408)
Q Consensus       390 L~hp~f~~~~  399 (408)
                      |+||||....
T Consensus       500 l~Hpfl~~~~  509 (586)
T KOG0667|consen  500 LNHPFLTGTS  509 (586)
T ss_pred             hcCccccccc
Confidence            9999998443

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.9e-49  Score=376.13  Aligned_cols=252  Identities=31%  Similarity=0.514  Sum_probs=216.4

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc--------chHHHHHHHHHHHHhcCCCCceEEeeEEEccCC
Q 015374          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV--------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHS  194 (408)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~--------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~  194 (408)
                      ..++|.+.+.||+|+||+|+.|.+..++..||+|+++..        ..+.+.+|+.+++++..||||++++.++...  
T Consensus        15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~--   92 (370)
T KOG0583|consen   15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATP--   92 (370)
T ss_pred             ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecC--
Confidence            467899999999999999999999999999999987643        2346678999999994499999999999654  


Q ss_pred             CccEEEEEeecCCChhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceec-
Q 015374          195 KTPSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY-  270 (408)
Q Consensus       195 ~~~~lv~e~~~~~~l~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~-  270 (408)
                      ..+++||||+.+|+|.+++   ..+.+.+++.++.|++.|++|||++||+||||||+|||++.+.+.+||+|||++... 
T Consensus        93 ~~~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~  172 (370)
T KOG0583|consen   93 TKIYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLSAISP  172 (370)
T ss_pred             CeEEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEeccccccccC
Confidence            4589999999999998887   468999999999999999999999999999999999999987568999999999988 


Q ss_pred             cCCCcceeeccCccccccccccCCcCC-CccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCC
Q 015374          271 HPGKEYNVRVASRYFKGPELLVDLQDY-DYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSR  349 (408)
Q Consensus       271 ~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  349 (408)
                      .........+||+.|+|||++.+...| ..++||||+||+||.|++|+.||.. .+.......+..              
T Consensus       173 ~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d-~~~~~l~~ki~~--------------  237 (370)
T KOG0583|consen  173 GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDD-SNVPNLYRKIRK--------------  237 (370)
T ss_pred             CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCC-ccHHHHHHHHhc--------------
Confidence            456677889999999999999985425 4899999999999999999999843 333333333322              


Q ss_pred             CCccccccccCCCCC-CHHHHHHHHHhcccCcCCCCCHHHHhcCCCccc
Q 015374          350 KPWSKFINADNQHLV-SPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQ  397 (408)
Q Consensus       350 ~~~~~~~~~~~~~~~-~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~  397 (408)
                            .....+..+ +.++++|+++||..||.+|+|+.++++||||+.
T Consensus       238 ------~~~~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~  280 (370)
T KOG0583|consen  238 ------GEFKIPSYLLSPEARSLIEKMLVPDPSTRITLLEILEHPWFQK  280 (370)
T ss_pred             ------CCccCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence                  123334446 899999999999999999999999999999997

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5.4e-50  Score=369.68  Aligned_cols=256  Identities=27%  Similarity=0.458  Sum_probs=208.1

Q ss_pred             CCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecccc---hHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccEEEE
Q 015374          125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK---KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIF  201 (408)
Q Consensus       125 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~  201 (408)
                      .++...+.||+|+||+||++.+.++|...|||.+....   .+.+.+|+.+|.++ +|||||+.+|.........++++|
T Consensus        17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l-~~p~IV~~~G~~~~~~~~~~~i~m   95 (313)
T KOG0198|consen   17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRL-NHPNIVQYYGSSSSRENDEYNIFM   95 (313)
T ss_pred             chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhC-CCCCEEeeCCccccccCeeeEeee
Confidence            44666778999999999999999999999999986544   45689999999999 799999999975433224688999


Q ss_pred             EeecCCChhhhcC----CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccC----C
Q 015374          202 EYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP----G  273 (408)
Q Consensus       202 e~~~~~~l~~~~~----~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~----~  273 (408)
                      ||+++|+|..++.    .+++..++.+..||++||+|||++|||||||||+|||++...+.+||+|||++.....    .
T Consensus        96 Ey~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~~~  175 (313)
T KOG0198|consen   96 EYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGTKS  175 (313)
T ss_pred             eccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCccccccccccccc
Confidence            9999999999874    5899999999999999999999999999999999999999337999999999987653    1


Q ss_pred             CcceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCCCcc
Q 015374          274 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWS  353 (408)
Q Consensus       274 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  353 (408)
                      .......||+.|||||++.+......++|||||||++.||+||..||.......+.+..+...                 
T Consensus       176 ~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~-----------------  238 (313)
T KOG0198|consen  176 DSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGRE-----------------  238 (313)
T ss_pred             cccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhcc-----------------
Confidence            223457899999999999852334469999999999999999999984321112222211111                 


Q ss_pred             ccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccccc
Q 015374          354 KFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVR  399 (408)
Q Consensus       354 ~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~~~  399 (408)
                       ...+..+..+++++++|+++||..||++||||+++|+|||.++..
T Consensus       239 -~~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~  283 (313)
T KOG0198|consen  239 -DSLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQNS  283 (313)
T ss_pred             -CCCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhccc
Confidence             012245566899999999999999999999999999999997654

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.9e-49  Score=381.72  Aligned_cols=255  Identities=26%  Similarity=0.464  Sum_probs=224.7

Q ss_pred             CCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc------chHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccE
Q 015374          125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS  198 (408)
Q Consensus       125 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  198 (408)
                      .-|++.+.||.|+-|.|-+|++..||+.+|||++...      ....+++|+.||+-| .|||++++|++++  +..++|
T Consensus        12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi-~HpnVl~LydVwe--~~~~ly   88 (786)
T KOG0588|consen   12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLI-EHPNVLRLYDVWE--NKQHLY   88 (786)
T ss_pred             cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHh-cCCCeeeeeeeec--cCceEE
Confidence            4577888999999999999999999999999998643      246789999999998 9999999999994  468899


Q ss_pred             EEEEeecCCChhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCCCc
Q 015374          199 LIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE  275 (408)
Q Consensus       199 lv~e~~~~~~l~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~~~  275 (408)
                      ||.||+++|.|.+++   ..+++.++.+++.||+.|+.|||..+|+||||||+|+|||.+ +.+||+|||+|..-.++..
T Consensus        89 lvlEyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~-~nIKIADFGMAsLe~~gkl  167 (786)
T KOG0588|consen   89 LVLEYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVK-NNIKIADFGMASLEVPGKL  167 (786)
T ss_pred             EEEEecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcc-cCEeeeccceeecccCCcc
Confidence            999999999998887   569999999999999999999999999999999999999998 5699999999998888888


Q ss_pred             ceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCCCcccc
Q 015374          276 YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSKF  355 (408)
Q Consensus       276 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  355 (408)
                      ..+.||++.|.+||++.|...-+.++||||+|||||.||+|+.||  ++++...+...++.                   
T Consensus       168 LeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPF--dDdNir~LLlKV~~-------------------  226 (786)
T KOG0588|consen  168 LETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPF--DDDNIRVLLLKVQR-------------------  226 (786)
T ss_pred             ccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCC--CCccHHHHHHHHHc-------------------
Confidence            889999999999999999666678999999999999999999999  35555555444443                   


Q ss_pred             ccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccccccchhh
Q 015374          356 INADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAESS  404 (408)
Q Consensus       356 ~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~~~~~~~~  404 (408)
                      ...+.+..++.++++||++||..||++|.|.+|+++|||++.-.....+
T Consensus       227 G~f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~g~~~~~~~  275 (786)
T KOG0588|consen  227 GVFEMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHPFLSGYTSLPSS  275 (786)
T ss_pred             CcccCCCcCCHHHHHHHHHHhccCccccccHHHHhhCchhhcCCCCChh
Confidence            2334456699999999999999999999999999999999877665544

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=9.6e-51  Score=348.46  Aligned_cols=256  Identities=27%  Similarity=0.499  Sum_probs=221.5

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEec-----ccchHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCcc
Q 015374          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK-----PVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP  197 (408)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~-----~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~  197 (408)
                      ..+.|++.+.||+|.|+.||++.+..+|+.+|+|+++     ....+++.+|+.|-+.| +||||+++.+.+.+  ....
T Consensus         9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~L-qHP~IvrL~~ti~~--~~~~   85 (355)
T KOG0033|consen    9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKL-QHPNIVRLHDSIQE--ESFH   85 (355)
T ss_pred             cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhc-CCCcEeehhhhhcc--ccee
Confidence            4678999999999999999999999999999998875     23457889999999999 99999999999844  5678


Q ss_pred             EEEEEeecCCChhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCC--CCcEEEEecccceeccC
Q 015374          198 SLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE--LRKLRLIDWGLAEFYHP  272 (408)
Q Consensus       198 ~lv~e~~~~~~l~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~--~~~~kl~DfG~a~~~~~  272 (408)
                      +||+|+|.|+++..-+   .-+++..+..++.||+++|.|+|++||||||+||+|+|+.+.  .-.+||+|||+|.....
T Consensus        86 ylvFe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~  165 (355)
T KOG0033|consen   86 YLVFDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVND  165 (355)
T ss_pred             EEEEecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeCC
Confidence            8999999999986654   237888899999999999999999999999999999999543  34799999999998886


Q ss_pred             CCcceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCCCc
Q 015374          273 GKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPW  352 (408)
Q Consensus       273 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  352 (408)
                      +......+||+.|||||++.. .+|+..+|||+.||+||-|+.|+.|| .+.+..+.++.|+....              
T Consensus       166 g~~~~G~~GtP~fmaPEvvrk-dpy~kpvDiW~cGViLfiLL~G~~PF-~~~~~~rlye~I~~g~y--------------  229 (355)
T KOG0033|consen  166 GEAWHGFAGTPGYLSPEVLKK-DPYSKPVDIWACGVILYILLVGYPPF-WDEDQHRLYEQIKAGAY--------------  229 (355)
T ss_pred             ccccccccCCCcccCHHHhhc-CCCCCcchhhhhhHHHHHHHhCCCCC-CCccHHHHHHHHhcccc--------------
Confidence            666778899999999999987 88999999999999999999999998 45566677776665421              


Q ss_pred             cccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccccc
Q 015374          353 SKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVR  399 (408)
Q Consensus       353 ~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~~~  399 (408)
                        .++...+..+++++++|+++||..||.+|.|+.|+|+|||+.+-.
T Consensus       230 --d~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~HpWi~~r~  274 (355)
T KOG0033|consen  230 --DYPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALKHPWICNRE  274 (355)
T ss_pred             --CCCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhCCchhcchH
Confidence              133445667999999999999999999999999999999987643

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.3e-48  Score=358.33  Aligned_cols=264  Identities=23%  Similarity=0.395  Sum_probs=217.1

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc----chHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccE
Q 015374          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS  198 (408)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  198 (408)
                      ..+.|++...||.|..++||+|+....++.||||+++-+    ..+.+.+|+..++.+ +||||++++..|..  +..+|
T Consensus        24 n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~-~HPNIv~~~~sFvv--~~~LW  100 (516)
T KOG0582|consen   24 NAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLI-DHPNIVTYHCSFVV--DSELW  100 (516)
T ss_pred             CccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhc-CCCCcceEEEEEEe--cceeE
Confidence            467899999999999999999999999999999999732    347789999999998 99999999999965  46889


Q ss_pred             EEEEeecCCChhhhc-----CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCC
Q 015374          199 LIFEYVNSTDFKVLY-----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG  273 (408)
Q Consensus       199 lv~e~~~~~~l~~~~-----~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~  273 (408)
                      +||.||.+|++.+.+     ..+++..+..+++++++||.|||++|.||||||+.||||+.+ |.|||+|||.+..+..+
T Consensus       101 vVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~d-G~VkLadFgvsa~l~~~  179 (516)
T KOG0582|consen  101 VVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSD-GTVKLADFGVSASLFDS  179 (516)
T ss_pred             EeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCC-CcEEEcCceeeeeeccc
Confidence            999999999988876     358999999999999999999999999999999999999999 89999999987655433


Q ss_pred             Cc-c----eeeccCcccccccc-ccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCC
Q 015374          274 KE-Y----NVRVASRYFKGPEL-LVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRH  347 (408)
Q Consensus       274 ~~-~----~~~~~~~~y~aPE~-~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (408)
                      .. .    ++.+||++|||||+ .....+|+.|+||||||++..||.+|..|| ........+...++...+...     
T Consensus       180 G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf-~k~pPmkvLl~tLqn~pp~~~-----  253 (516)
T KOG0582|consen  180 GDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPF-SKYPPMKVLLLTLQNDPPTLL-----  253 (516)
T ss_pred             CceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCc-ccCChHHHHHHHhcCCCCCcc-----
Confidence            22 1    45589999999999 445578999999999999999999999998 344444444333322111000     


Q ss_pred             CCCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccccccc
Q 015374          348 SRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAA  401 (408)
Q Consensus       348 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~~~~~  401 (408)
                           -...+.+..+..+..+++++..||+.||++||||+++|+|+||+.+...
T Consensus       254 -----t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k~~  302 (516)
T KOG0582|consen  254 -----TSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAKSK  302 (516)
T ss_pred             -----cccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhccch
Confidence                 0111223334467799999999999999999999999999999987643

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=1.5e-48  Score=354.26  Aligned_cols=275  Identities=32%  Similarity=0.590  Sum_probs=223.8

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecccc-----hHHHHHHHHHHHHhcCCCC-ceEEeeEEEccC----
Q 015374          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK-----KKKIKREIKILQNLCGGPN-VVKLLDIVRDQH----  193 (408)
Q Consensus       124 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~~h~n-iv~l~~~~~~~~----  193 (408)
                      ...|+.+++||+|+||+||+|+.+.+|+.||+|.+.-..     .....+|+.++++| +|+| |+++++++...+    
T Consensus        10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L-~~~~~iv~L~dv~~~~~~~~~   88 (323)
T KOG0594|consen   10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRL-SHANHIVRLHDVIHTSNNHRG   88 (323)
T ss_pred             HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHh-CCCcceEEEEeeeeecccccc
Confidence            345677789999999999999999999999999986432     24568999999999 9999 999999997543    


Q ss_pred             CCccEEEEEeecCCChhhhcC-------CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEeccc
Q 015374          194 SKTPSLIFEYVNSTDFKVLYP-------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGL  266 (408)
Q Consensus       194 ~~~~~lv~e~~~~~~l~~~~~-------~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~  266 (408)
                      ...++||+||+... |..++.       .++...++.++.||+.||+|||+++|+||||||+|||++++ |.+||+|||+
T Consensus        89 ~~~l~lvfe~~d~D-L~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~-G~lKlaDFGl  166 (323)
T KOG0594|consen   89 IGKLYLVFEFLDRD-LKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSS-GVLKLADFGL  166 (323)
T ss_pred             cceEEEEEEeeccc-HHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCC-CcEeeeccch
Confidence            13678999999754 444442       35667899999999999999999999999999999999997 8999999999


Q ss_pred             ceecc-CCCcceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcC
Q 015374          267 AEFYH-PGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNS  345 (408)
Q Consensus       267 a~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  345 (408)
                      |+... +...+...++|..|+|||++.+...|+..+||||+||+++||++++ |.|+|..+.+++..+...+|.+....+
T Consensus       167 Ara~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~-~LFpG~se~~ql~~If~~lGtP~e~~W  245 (323)
T KOG0594|consen  167 ARAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRR-PLFPGDSEIDQLFRIFRLLGTPNEKDW  245 (323)
T ss_pred             HHHhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCC-CCCCCCcHHHHHHHHHHHcCCCCccCC
Confidence            98765 5566788899999999999999889999999999999999999976 556899999999999999886653333


Q ss_pred             CCCC--C----Cccccc-cc---cCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccccccch
Q 015374          346 RHSR--K----PWSKFI-NA---DNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAE  402 (408)
Q Consensus       346 ~~~~--~----~~~~~~-~~---~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~~~~~~  402 (408)
                      ....  .    .+..+. ..   ......+++..|++.+||+++|.+|.|++++|+||||+......
T Consensus       246 p~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~~~~  312 (323)
T KOG0594|consen  246 PGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSELPEKS  312 (323)
T ss_pred             CCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhcccccch
Confidence            2111  1    111111 00   11122346899999999999999999999999999999886544

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=8.1e-48  Score=363.76  Aligned_cols=275  Identities=29%  Similarity=0.500  Sum_probs=213.7

Q ss_pred             CCCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecccc----hHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCcc
Q 015374          122 GDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP  197 (408)
Q Consensus       122 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~  197 (408)
                      +..++|++.++||+|+||+||+|++..+++.||+|+++...    ...+.+|+.+++.+ +||||+++++++.+  ....
T Consensus         2 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~--~~~~   78 (303)
T cd07869           2 GKADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGL-KHANIVLLHDIIHT--KETL   78 (303)
T ss_pred             CccccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhC-CCCCcCeEEEEEec--CCeE
Confidence            46789999999999999999999999999999999986322    24577899999999 99999999999965  4678


Q ss_pred             EEEEEeecCCChhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCC-
Q 015374          198 SLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG-  273 (408)
Q Consensus       198 ~lv~e~~~~~~l~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~-  273 (408)
                      ++||||++++.+....   ..+++..++.++.|++.||+|||++||+||||||+|||++.+ +.+||+|||++...... 
T Consensus        79 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~-~~~kl~Dfg~~~~~~~~~  157 (303)
T cd07869          79 TLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDT-GELKLADFGLARAKSVPS  157 (303)
T ss_pred             EEEEECCCcCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCC-CCEEECCCCcceeccCCC
Confidence            9999999765444333   348889999999999999999999999999999999999987 78999999998754322 


Q ss_pred             CcceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCC-------
Q 015374          274 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSR-------  346 (408)
Q Consensus       274 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~-------  346 (408)
                      .......++..|+|||++.+...++.++|||||||++|+|++|..||....+..+.+..+....+........       
T Consensus       158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (303)
T cd07869         158 HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPH  237 (303)
T ss_pred             ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhccc
Confidence            2234467889999999987756789999999999999999999999865455455555555443322111000       


Q ss_pred             CCCCCccccc-----cccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccccc
Q 015374          347 HSRKPWSKFI-----NADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRA  400 (408)
Q Consensus       347 ~~~~~~~~~~-----~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~~~~  400 (408)
                      .....+....     ........++++.+|+++||+.||++|||++|+|+||||+++..
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~~~  296 (303)
T cd07869         238 FKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDLPP  296 (303)
T ss_pred             cccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccccCCh
Confidence            0000000000     00011124578999999999999999999999999999998764

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2e-50  Score=352.91  Aligned_cols=250  Identities=24%  Similarity=0.476  Sum_probs=208.8

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEec-----ccchHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCcc
Q 015374          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK-----PVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP  197 (408)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~-----~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~  197 (408)
                      ...+|++.++||+|+||+||+++...+|..+|.|.++     ...+.....|+.+|++| +|||||++++.-...+...+
T Consensus        17 ~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL-~HpNIVqYy~~~f~~~~evl   95 (375)
T KOG0591|consen   17 TLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQL-NHPNIVQYYAHSFIEDNEVL   95 (375)
T ss_pred             cHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhc-CCchHHHHHHHhhhccchhh
Confidence            3567999999999999999999999999999999875     23456788999999999 99999999993333344568


Q ss_pred             EEEEEeecCCChhhhc-------CCCChHHHHHHHHHHHHHHHHHHH--CC--cEEecCCCCcEEEeCCCCcEEEEeccc
Q 015374          198 SLIFEYVNSTDFKVLY-------PTLTDYDIRYYIYELLKALDYCHS--QG--IMHRDVKPHNVMIDHELRKLRLIDWGL  266 (408)
Q Consensus       198 ~lv~e~~~~~~l~~~~-------~~l~~~~~~~i~~qi~~~L~~LH~--~~--iiH~Dlk~~NILl~~~~~~~kl~DfG~  266 (408)
                      .+|||||..|+|..++       +.+++..+++++.|++.||.++|+  .+  |+||||||.||+++.+ |.+||+|||+
T Consensus        96 nivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~-gvvKLGDfGL  174 (375)
T KOG0591|consen   96 NIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTAN-GVVKLGDFGL  174 (375)
T ss_pred             HHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCC-Cceeeccchh
Confidence            8999999999999887       348999999999999999999999  45  9999999999999988 8999999999


Q ss_pred             ceeccCCCc-ceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcC
Q 015374          267 AEFYHPGKE-YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNS  345 (408)
Q Consensus       267 a~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  345 (408)
                      ++.+..... ..+.+||++||+||.+.+ .+|+.++||||+||++|||.....||+. . +...+.+.+..+...     
T Consensus       175 ~r~l~s~~tfA~S~VGTPyYMSPE~i~~-~~Y~~kSDiWslGCllyEMcaL~~PF~g-~-n~~~L~~KI~qgd~~-----  246 (375)
T KOG0591|consen  175 GRFLSSKTTFAHSLVGTPYYMSPERIHE-SGYNFKSDIWSLGCLLYEMCALQSPFYG-D-NLLSLCKKIEQGDYP-----  246 (375)
T ss_pred             HhHhcchhHHHHhhcCCCcccCHHHHhc-CCCCcchhHHHHHHHHHHHHhcCCCccc-c-cHHHHHHHHHcCCCC-----
Confidence            998875543 356799999999999998 8999999999999999999999999853 3 566666555543211     


Q ss_pred             CCCCCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccccc
Q 015374          346 RHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVR  399 (408)
Q Consensus       346 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~~~  399 (408)
                                  +-.....|.++..++..|+..||+.||+.     +|+++.+.
T Consensus       247 ------------~~p~~~YS~~l~~li~~ci~vd~~~RP~t-----~~~v~di~  283 (375)
T KOG0591|consen  247 ------------PLPDEHYSTDLRELINMCIAVDPEQRPDT-----VPYVQDIQ  283 (375)
T ss_pred             ------------CCcHHHhhhHHHHHHHHHccCCcccCCCc-----chHHHHHH
Confidence                        11113468899999999999999999985     55554443

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=3e-49  Score=373.77  Aligned_cols=247  Identities=29%  Similarity=0.551  Sum_probs=211.5

Q ss_pred             CCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecccch-----HHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccEE
Q 015374          125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKK-----KKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSL  199 (408)
Q Consensus       125 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~-----~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l  199 (408)
                      ++|-+.+.||+|+||.||||+.+.+.+.||+|.+.+..+     +.+.+|++|+++| +||||+.++++|+  ...++++
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~l-kHpniv~m~esfE--t~~~~~v   78 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSL-KHPNIVEMLESFE--TSAHLWV   78 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhc-CCcchhhHHHhhc--ccceEEE
Confidence            567788899999999999999999999999999975544     4488999999999 9999999999994  4689999


Q ss_pred             EEEeecCCChhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCCCcc
Q 015374          200 IFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY  276 (408)
Q Consensus       200 v~e~~~~~~l~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~~~~  276 (408)
                      |.||+.| +|..++   ..++++.++.++.|+..||.|||+.+|+|||+||.|||++.+ +.+|+||||+|+.+..+...
T Consensus        79 Vte~a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~-~~~KlcdFg~Ar~m~~~t~v  156 (808)
T KOG0597|consen   79 VTEYAVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKG-GTLKLCDFGLARAMSTNTSV  156 (808)
T ss_pred             Eehhhhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCC-CceeechhhhhhhcccCcee
Confidence            9999998 777777   469999999999999999999999999999999999999998 89999999999988765443


Q ss_pred             -eeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCCCcccc
Q 015374          277 -NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSKF  355 (408)
Q Consensus       277 -~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  355 (408)
                       ....||+.|||||+..+ +.|+..+|+||+||++|||.+|+.||+.. .-......|..+                   
T Consensus       157 ltsikGtPlYmAPElv~e-~pyd~~sDlWslGcilYE~~~G~PPF~a~-si~~Lv~~I~~d-------------------  215 (808)
T KOG0597|consen  157 LTSIKGTPLYMAPELVEE-QPYDHTSDLWSLGCILYELYVGQPPFYAR-SITQLVKSILKD-------------------  215 (808)
T ss_pred             eeeccCcccccCHHHHcC-CCccchhhHHHHHHHHHHHhcCCCCchHH-HHHHHHHHHhcC-------------------
Confidence             44579999999999987 89999999999999999999999999532 111122222211                   


Q ss_pred             ccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccc
Q 015374          356 INADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQV  398 (408)
Q Consensus       356 ~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~~  398 (408)
                       +...+...+..+.+|++.+|..||.+|.|+.+++.|||.+..
T Consensus       216 -~v~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~HpF~k~~  257 (808)
T KOG0597|consen  216 -PVKPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGHPFWKGK  257 (808)
T ss_pred             -CCCCcccccHHHHHHHHHHhhcChhhcccHHHHhcChHHhhh
Confidence             112223478999999999999999999999999999998754

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=1.5e-47  Score=379.28  Aligned_cols=276  Identities=29%  Similarity=0.505  Sum_probs=217.1

Q ss_pred             CCCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecccchHHHHHHHHHHHHhcCCCCceEEeeEEEcc------CCC
Q 015374          122 GDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQ------HSK  195 (408)
Q Consensus       122 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~------~~~  195 (408)
                      ....+|++.+.||+|+||+||+|++..+++.||||.+... .....+|+.+++.+ +|+||+++++++...      ...
T Consensus        63 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~-~~~~~~Ei~il~~l-~h~niv~l~~~~~~~~~~~~~~~~  140 (440)
T PTZ00036         63 SPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQD-PQYKNRELLIMKNL-NHINIIFLKDYYYTECFKKNEKNI  140 (440)
T ss_pred             CcCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecC-cchHHHHHHHHHhc-CCCCCcceeeeEeecccccCCCce
Confidence            3467899999999999999999999999999999988532 23456799999999 999999999887432      123


Q ss_pred             ccEEEEEeecCCChhhhc------CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEeccccee
Q 015374          196 TPSLIFEYVNSTDFKVLY------PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEF  269 (408)
Q Consensus       196 ~~~lv~e~~~~~~l~~~~------~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~  269 (408)
                      .+++||||++++......      ..+++..++.++.|++.||.|||++||+||||||+|||++.+.+.+||+|||+++.
T Consensus       141 ~l~lvmE~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~DFGla~~  220 (440)
T PTZ00036        141 FLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKN  220 (440)
T ss_pred             EEEEEEecCCccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeeccccchh
Confidence            567999999975433221      35888999999999999999999999999999999999997756799999999987


Q ss_pred             ccCCCcceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcC----
Q 015374          270 YHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNS----  345 (408)
Q Consensus       270 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~----  345 (408)
                      ...........+|+.|+|||++.+...++.++|||||||++|||++|..|| .+.+..+.+..+....+.......    
T Consensus       221 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf-~~~~~~~~~~~i~~~~~~p~~~~~~~~~  299 (440)
T PTZ00036        221 LLAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIF-SGQSSVDQLVRIIQVLGTPTEDQLKEMN  299 (440)
T ss_pred             ccCCCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCC-CCCChHHHHHHHHHHhCCCCHHHHHHhc
Confidence            765555555678999999999887567999999999999999999999887 566667777777766553321100    


Q ss_pred             -CCCCCCccc----cccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccccc
Q 015374          346 -RHSRKPWSK----FINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRA  400 (408)
Q Consensus       346 -~~~~~~~~~----~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~~~~  400 (408)
                       ......++.    ......+...++++.+||.+||++||.+|||+.|+|+||||+.++.
T Consensus       300 ~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~~~  359 (440)
T PTZ00036        300 PNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLRD  359 (440)
T ss_pred             hhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhhhc
Confidence             000000000    0111223346789999999999999999999999999999987654

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=2.8e-47  Score=357.49  Aligned_cols=268  Identities=28%  Similarity=0.566  Sum_probs=212.2

Q ss_pred             CCCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc----chHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCcc
Q 015374          122 GDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP  197 (408)
Q Consensus       122 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~  197 (408)
                      +..++|++.++||.|+||+||+|++..++..||+|.++..    ....+.+|+.+++++ +||||+++++++.+  ....
T Consensus         2 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~--~~~~   78 (288)
T cd07871           2 GKLETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNL-KHANIVTLHDIIHT--ERCL   78 (288)
T ss_pred             CccccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhC-CCCCEeeEEEEEcC--CCeE
Confidence            3567899999999999999999999999999999998632    234677999999999 99999999999954  4678


Q ss_pred             EEEEEeecCCChhhhcC----CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCC
Q 015374          198 SLIFEYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG  273 (408)
Q Consensus       198 ~lv~e~~~~~~l~~~~~----~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~  273 (408)
                      ++||||+++ ++..++.    .+++..+..++.|++.||.|||++||+||||||+|||++.+ +.+||+|||+++.....
T Consensus        79 ~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~-~~~kl~DfG~~~~~~~~  156 (288)
T cd07871          79 TLVFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEK-GELKLADFGLARAKSVP  156 (288)
T ss_pred             EEEEeCCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCC-CCEEECcCcceeeccCC
Confidence            899999986 6665542    37888999999999999999999999999999999999988 79999999998765422


Q ss_pred             C-cceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCC--CCC
Q 015374          274 K-EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRH--SRK  350 (408)
Q Consensus       274 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~  350 (408)
                      . ......++..|+|||++.+...++.++||||+||++|+|++|+.|| .+.+..+.+..+....+.........  ...
T Consensus       157 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (288)
T cd07871         157 TKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMF-PGSTVKEELHLIFRLLGTPTEETWPGITSNE  235 (288)
T ss_pred             CccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHHHhCCCChHHhhccccch
Confidence            2 2334577889999999877567899999999999999999999887 45555666666655544332111110  000


Q ss_pred             Cccccc--------cccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCc
Q 015374          351 PWSKFI--------NADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF  395 (408)
Q Consensus       351 ~~~~~~--------~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f  395 (408)
                      .+....        .......+++++++|+++||++||.+|||++|+|+||||
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f  288 (288)
T cd07871         236 EFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF  288 (288)
T ss_pred             hhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence            000000        011123468899999999999999999999999999998

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=5.9e-49  Score=342.31  Aligned_cols=259  Identities=25%  Similarity=0.467  Sum_probs=218.1

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc-----------chHHHHHHHHHHHHhcCCCCceEEeeEEEcc
Q 015374          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQ  192 (408)
Q Consensus       124 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-----------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~  192 (408)
                      -+.|+..+.||+|..++|-++....++..+|+|++...           -.+.-.+|+.||+++.+||||+.+.++++. 
T Consensus        16 y~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes-   94 (411)
T KOG0599|consen   16 YAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYES-   94 (411)
T ss_pred             HhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccC-
Confidence            34567778899999999999999999999999998521           124456899999999999999999999954 


Q ss_pred             CCCccEEEEEeecCCChhhhcC---CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEeccccee
Q 015374          193 HSKTPSLIFEYVNSTDFKVLYP---TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEF  269 (408)
Q Consensus       193 ~~~~~~lv~e~~~~~~l~~~~~---~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~  269 (408)
                       +...++|+|.|+.|.|.+++.   .+++.+.+.+++|++.|++|||.++||||||||+|||+|+| ..++|+|||+|..
T Consensus        95 -~sF~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn-~~i~isDFGFa~~  172 (411)
T KOG0599|consen   95 -DAFVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDN-MNIKISDFGFACQ  172 (411)
T ss_pred             -cchhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccc-cceEEeccceeec
Confidence             578889999999999999985   48999999999999999999999999999999999999999 6899999999999


Q ss_pred             ccCCCcceeeccCccccccccccC-----CcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhc
Q 015374          270 YHPGKEYNVRVASRYFKGPELLVD-----LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCN  344 (408)
Q Consensus       270 ~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  344 (408)
                      +.++......+||++|.|||.+..     ..+|+..+|+|++||++|.|+.|..||+.... .-++..+++.       .
T Consensus       173 l~~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQ-mlMLR~ImeG-------k  244 (411)
T KOG0599|consen  173 LEPGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQ-MLMLRMIMEG-------K  244 (411)
T ss_pred             cCCchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHH-HHHHHHHHhc-------c
Confidence            998888888999999999999853     35789999999999999999999999953211 1111122111       1


Q ss_pred             CCCCCCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccccccch
Q 015374          345 SRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAE  402 (408)
Q Consensus       345 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~~~~~~  402 (408)
                      ..         +....|.+++.+.+|||.+||+.||.+|.|++|+|+||||.++-+.+
T Consensus       245 yq---------F~speWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q~~~~~  293 (411)
T KOG0599|consen  245 YQ---------FRSPEWADISATVKDLISRLLQVDPTKRITAKEALAHPFFIQIAQQQ  293 (411)
T ss_pred             cc---------cCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcChHHHHHHHhc
Confidence            11         23344556899999999999999999999999999999997765544

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5.3e-48  Score=359.10  Aligned_cols=254  Identities=28%  Similarity=0.545  Sum_probs=214.1

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecccc-----------------hHHHHHHHHHHHHhcCCCCceEE
Q 015374          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK-----------------KKKIKREIKILQNLCGGPNVVKL  185 (408)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-----------------~~~~~~E~~~l~~l~~h~niv~l  185 (408)
                      ..++|++.+.||+|.||.|-+|++..+++.||||++.+..                 .++..+||.||+++ .|||||+|
T Consensus        95 ~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl-~H~nVV~L  173 (576)
T KOG0585|consen   95 QLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKL-HHPNVVKL  173 (576)
T ss_pred             ehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhc-CCcCeeEE
Confidence            3578999999999999999999999999999999985321                 24678999999999 99999999


Q ss_pred             eeEEEccCCCccEEEEEeecCCChhhhc--CC-CChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEE
Q 015374          186 LDIVRDQHSKTPSLIFEYVNSTDFKVLY--PT-LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLI  262 (408)
Q Consensus       186 ~~~~~~~~~~~~~lv~e~~~~~~l~~~~--~~-l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~  262 (408)
                      +.+..+.....+|||+|||..|.+...-  .. +++.+++.|+.++..||+|||.+|||||||||+|+|++.+ |++||+
T Consensus       174 iEvLDDP~s~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~-g~VKIs  252 (576)
T KOG0585|consen  174 IEVLDDPESDKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSD-GTVKIS  252 (576)
T ss_pred             EEeecCcccCceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCC-CcEEee
Confidence            9999999999999999999998876543  23 8999999999999999999999999999999999999999 899999


Q ss_pred             ecccceeccCC------CcceeeccCccccccccccCC---cCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHH
Q 015374          263 DWGLAEFYHPG------KEYNVRVASRYFKGPELLVDL---QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI  333 (408)
Q Consensus       263 DfG~a~~~~~~------~~~~~~~~~~~y~aPE~~~~~---~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~  333 (408)
                      |||.+.....+      ......+||+.|+|||...+.   ...+.+.||||+||+||-|+.|+.||+ ++...+...+|
T Consensus       253 DFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~-~~~~~~l~~KI  331 (576)
T KOG0585|consen  253 DFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFF-DDFELELFDKI  331 (576)
T ss_pred             ccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcc-cchHHHHHHHH
Confidence            99999766322      223447899999999999772   235679999999999999999999984 44445566666


Q ss_pred             HhhhchhhhhcCCCCCCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccc
Q 015374          334 AKDCCLIIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQ  397 (408)
Q Consensus       334 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~  397 (408)
                      +...                  ........+.++++|+|.+||+.||++|.+..++..|||...
T Consensus       332 vn~p------------------L~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~  377 (576)
T KOG0585|consen  332 VNDP------------------LEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTR  377 (576)
T ss_pred             hcCc------------------ccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceecc
Confidence            5531                  011111236789999999999999999999999999999764

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=5e-47  Score=355.25  Aligned_cols=255  Identities=24%  Similarity=0.380  Sum_probs=210.2

Q ss_pred             CEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecccc------hHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccEE
Q 015374          126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK------KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSL  199 (408)
Q Consensus       126 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~------~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l  199 (408)
                      .|+..+.||+|+||+||+|.+..+++.||+|.+....      ...+.+|+.+++++ +|+||+++++++.+  ....++
T Consensus         1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~~~~iv~~~~~~~~--~~~~~l   77 (285)
T cd05631           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKV-NSRFVVSLAYAYET--KDALCL   77 (285)
T ss_pred             CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhc-CCCcEEEEEEEEcc--CCeEEE
Confidence            3788999999999999999999999999999986322      23577899999999 99999999999955  467899


Q ss_pred             EEEeecCCChhhhc-----CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCCC
Q 015374          200 IFEYVNSTDFKVLY-----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK  274 (408)
Q Consensus       200 v~e~~~~~~l~~~~-----~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~~  274 (408)
                      ||||+++++|..++     ..+++..+..++.|++.||+|||+++|+||||||+|||++.+ +.++|+|||++.......
T Consensus        78 v~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~-~~~kl~Dfg~~~~~~~~~  156 (285)
T cd05631          78 VLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDR-GHIRISDLGLAVQIPEGE  156 (285)
T ss_pred             EEEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCC-CCEEEeeCCCcEEcCCCC
Confidence            99999999997665     248889999999999999999999999999999999999987 789999999998765544


Q ss_pred             cceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCCCccc
Q 015374          275 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSK  354 (408)
Q Consensus       275 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  354 (408)
                      ......|+..|+|||++.+ ..++.++|||||||++|+|++|+.||...... .....+......               
T Consensus       157 ~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslGvil~el~~g~~pf~~~~~~-~~~~~~~~~~~~---------------  219 (285)
T cd05631         157 TVRGRVGTVGYMAPEVINN-EKYTFSPDWWGLGCLIYEMIQGQSPFRKRKER-VKREEVDRRVKE---------------  219 (285)
T ss_pred             eecCCCCCCCccCHhhhcC-CCCCcccCchhHHHHHHHHHhCCCCCCCCCcc-hhHHHHHHHhhc---------------
Confidence            4455678999999999987 78999999999999999999999998543322 111111111000               


Q ss_pred             cccccCCCCCCHHHHHHHHHhcccCcCCCCC-----HHHHhcCCCccccccch
Q 015374          355 FINADNQHLVSPEAIDFLDKLLRYDHQDRLT-----AREAMAHPYFAQVRAAE  402 (408)
Q Consensus       355 ~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt-----~~elL~hp~f~~~~~~~  402 (408)
                       .....+..+++++.+|+++||+.||++|||     ++++++||||+++....
T Consensus       220 -~~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~~~~~~  271 (285)
T cd05631         220 -DQEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPIFKNINFKR  271 (285)
T ss_pred             -ccccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcCHhhcCCCHHH
Confidence             011223347899999999999999999997     99999999999987644

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=3.5e-47  Score=361.28  Aligned_cols=245  Identities=20%  Similarity=0.346  Sum_probs=201.4

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCcE-EEEEEecccc-----hHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCcc
Q 015374          124 QDDYEVVRKVGRGKYSEVFEGINVNTNER-CIIKILKPVK-----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP  197 (408)
Q Consensus       124 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~-vavK~~~~~~-----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~  197 (408)
                      .+...+...||+|+||+||+|.+.  |.. ||||++....     .+.|.+|+.+|.++ +|||||+++|+|.++.. ..
T Consensus        40 ~~~l~~~~~iG~G~~g~V~~~~~~--g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l-~HpNIV~f~G~~~~~~~-~~  115 (362)
T KOG0192|consen   40 PDELPIEEVLGSGSFGTVYKGKWR--GTDVVAVKIISDPDFDDESRKAFRREASLLSRL-RHPNIVQFYGACTSPPG-SL  115 (362)
T ss_pred             hHHhhhhhhcccCCceeEEEEEeC--CceeEEEEEecchhcChHHHHHHHHHHHHHHhC-CCCCeeeEEEEEcCCCC-ce
Confidence            344555567999999999999765  344 9999997543     56899999999999 99999999999966432 68


Q ss_pred             EEEEEeecCCChhhhc-----CCCChHHHHHHHHHHHHHHHHHHHCC-cEEecCCCCcEEEeCCCCcEEEEecccceecc
Q 015374          198 SLIFEYVNSTDFKVLY-----PTLTDYDIRYYIYELLKALDYCHSQG-IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH  271 (408)
Q Consensus       198 ~lv~e~~~~~~l~~~~-----~~l~~~~~~~i~~qi~~~L~~LH~~~-iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~  271 (408)
                      ++|||||++|+|..++     ..+++..+..++.||+.||+|||+++ |||||||++|||++.+...+||+|||+++...
T Consensus       116 ~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~  195 (362)
T KOG0192|consen  116 CIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKV  195 (362)
T ss_pred             EEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCccceeec
Confidence            9999999999999988     35899999999999999999999999 99999999999999983399999999998776


Q ss_pred             CC-CcceeeccCccccccccccC-CcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCC
Q 015374          272 PG-KEYNVRVASRYFKGPELLVD-LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSR  349 (408)
Q Consensus       272 ~~-~~~~~~~~~~~y~aPE~~~~-~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  349 (408)
                      .. .......||..|||||++.+ ...|+.++||||||+++|||+||+.||. +.........+....            
T Consensus       196 ~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~-~~~~~~~~~~v~~~~------------  262 (362)
T KOG0192|consen  196 ISKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFE-DLAPVQVASAVVVGG------------  262 (362)
T ss_pred             cccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCC-CCCHHHHHHHHHhcC------------
Confidence            54 33344789999999999985 2689999999999999999999999984 333333333332211            


Q ss_pred             CCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 015374          350 KPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA  391 (408)
Q Consensus       350 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~  391 (408)
                            .++..+..+++.+.+++.+||..||++||+..+++.
T Consensus       263 ------~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~  298 (362)
T KOG0192|consen  263 ------LRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVS  298 (362)
T ss_pred             ------CCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHH
Confidence                  223334447899999999999999999999988864

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.9e-47  Score=357.09  Aligned_cols=250  Identities=24%  Similarity=0.427  Sum_probs=210.5

Q ss_pred             CCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc------chHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccE
Q 015374          125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS  198 (408)
Q Consensus       125 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  198 (408)
                      ++|++.+.||+|+||+||+|.+..+++.||+|+++..      ....+.+|+.+++++ +||||+++++++.+  ....+
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~--~~~~~   77 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEV-SHPFIIRLFWTEHD--QRFLY   77 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhC-CCCcHhhhHhhhcc--CCeEE
Confidence            4789999999999999999999999999999998632      234578899999999 99999999999854  46889


Q ss_pred             EEEEeecCCChhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCCCc
Q 015374          199 LIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE  275 (408)
Q Consensus       199 lv~e~~~~~~l~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~~~  275 (408)
                      +||||+++++|..++   ..+++..+..++.|++.||.|||++||+||||||+|||++.+ +.+||+|||++......  
T Consensus        78 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~-~~~kl~Dfg~~~~~~~~--  154 (291)
T cd05612          78 MLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKE-GHIKLTDFGFAKKLRDR--  154 (291)
T ss_pred             EEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCC-CCEEEEecCcchhccCC--
Confidence            999999999998876   358899999999999999999999999999999999999987 79999999999766432  


Q ss_pred             ceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCCCcccc
Q 015374          276 YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSKF  355 (408)
Q Consensus       276 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  355 (408)
                      .....|++.|+|||++.+ ..++.++|||||||++|+|++|+.||. +.+..+....+...                   
T Consensus       155 ~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~~l~~g~~pf~-~~~~~~~~~~i~~~-------------------  213 (291)
T cd05612         155 TWTLCGTPEYLAPEVIQS-KGHNKAVDWWALGILIYEMLVGYPPFF-DDNPFGIYEKILAG-------------------  213 (291)
T ss_pred             cccccCChhhcCHHHHcC-CCCCchhhHHHHHHHHHHHHhCCCCCC-CCCHHHHHHHHHhC-------------------
Confidence            234578999999999987 678999999999999999999999984 33333333333221                   


Q ss_pred             ccccCCCCCCHHHHHHHHHhcccCcCCCCC-----HHHHhcCCCccccccch
Q 015374          356 INADNQHLVSPEAIDFLDKLLRYDHQDRLT-----AREAMAHPYFAQVRAAE  402 (408)
Q Consensus       356 ~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt-----~~elL~hp~f~~~~~~~  402 (408)
                       ....+..++..+++++++||+.||.+|++     ++|+++||||+.+....
T Consensus       214 -~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~~~~  264 (291)
T cd05612         214 -KLEFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRWFKSVDWDD  264 (291)
T ss_pred             -CcCCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCccccCCCHHH
Confidence             11123346889999999999999999995     99999999999877654

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=1e-46  Score=353.28  Aligned_cols=265  Identities=32%  Similarity=0.572  Sum_probs=210.2

Q ss_pred             CCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc-----chHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccEE
Q 015374          125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSL  199 (408)
Q Consensus       125 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l  199 (408)
                      ++|++.+.||+|+||+||+|++..+++.+|+|+++..     ..+.+.+|+.+++.+ +|+||++++++|..  ....++
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~--~~~~~l   77 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTL-KQENIVELKEAFRR--RGKLYL   77 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhC-CCccccchhhhEec--CCEEEE
Confidence            4799999999999999999999999999999998642     235678999999999 99999999999954  467899


Q ss_pred             EEEeecCCChhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCCC--
Q 015374          200 IFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK--  274 (408)
Q Consensus       200 v~e~~~~~~l~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~~--  274 (408)
                      ||||++++++..+.   ..+++..++.++.|++.||.|||+.+|+||||||+||+++.+ +.+||+|||++.......  
T Consensus        78 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~-~~~kl~Dfg~~~~~~~~~~~  156 (287)
T cd07848          78 VFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHN-DVLKLCDFGFARNLSEGSNA  156 (287)
T ss_pred             EEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCC-CcEEEeeccCcccccccccc
Confidence            99999998877664   358899999999999999999999999999999999999988 799999999998764322  


Q ss_pred             cceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhh-------cCCC
Q 015374          275 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWC-------NSRH  347 (408)
Q Consensus       275 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-------~~~~  347 (408)
                      ......++..|+|||++.+ ..++.++|||||||++|||++|+.|| .+.+..+.+..+....+.....       ....
T Consensus       157 ~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslGvil~el~~g~~pf-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (287)
T cd07848         157 NYTEYVATRWYRSPELLLG-APYGKAVDMWSVGCILGELSDGQPLF-PGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRF  234 (287)
T ss_pred             cccccccccccCCcHHHcC-CCCCCchhHHhHHHHHHHHHhCCCCC-CCCCHHHHHHHHHHhhCCCCHHHHHhhhccchh
Confidence            2233568899999999987 67899999999999999999999887 4455555555444433321110       0000


Q ss_pred             CCCCcccc-----ccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCc
Q 015374          348 SRKPWSKF-----INADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF  395 (408)
Q Consensus       348 ~~~~~~~~-----~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f  395 (408)
                      ....+...     ........++.++.+|+.+||+.||++|||++|+|+||||
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f  287 (287)
T cd07848         235 HGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF  287 (287)
T ss_pred             cccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence            00000000     0111223468899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-46  Score=359.77  Aligned_cols=260  Identities=30%  Similarity=0.569  Sum_probs=223.1

Q ss_pred             CCCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecccc------hHHHHHHHHHHHHhcCCCCceEEeeEEEccCCC
Q 015374          122 GDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK------KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSK  195 (408)
Q Consensus       122 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~------~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  195 (408)
                      ...+.|++.+.||+|.||.||+++.+.+|+.+|+|++++..      ...+.+|+.+|+++.+||||+.+.+.|++.  .
T Consensus        32 ~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~--~  109 (382)
T KOG0032|consen   32 DIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDP--D  109 (382)
T ss_pred             cccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcC--C
Confidence            35678999999999999999999999999999999996432      357899999999995599999999999764  5


Q ss_pred             ccEEEEEeecCCChhhhcCC--CChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCC---CcEEEEecccceec
Q 015374          196 TPSLIFEYVNSTDFKVLYPT--LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEL---RKLRLIDWGLAEFY  270 (408)
Q Consensus       196 ~~~lv~e~~~~~~l~~~~~~--l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~---~~~kl~DfG~a~~~  270 (408)
                      ..++|||++.||.|.+.+..  +++..+..++.|++.++.|||+.||+||||||+|+|+....   +.+|++|||++...
T Consensus       110 ~~~lvmEL~~GGeLfd~i~~~~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~  189 (382)
T KOG0032|consen  110 SVYLVMELCEGGELFDRIVKKHYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFI  189 (382)
T ss_pred             eEEEEEEecCCchHHHHHHHccCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEc
Confidence            78899999999999888744  99999999999999999999999999999999999996542   37999999999998


Q ss_pred             cCCCcceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCC
Q 015374          271 HPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRK  350 (408)
Q Consensus       271 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  350 (408)
                      ..+......+||+.|+|||++.. ..|+..+||||+||++|.|++|..||. +.........+...       ...    
T Consensus       190 ~~~~~~~~~~Gtp~y~APEvl~~-~~y~~~~DiWS~Gvi~yiLL~G~~PF~-~~~~~~~~~~i~~~-------~~~----  256 (382)
T KOG0032|consen  190 KPGERLHTIVGTPEYVAPEVLGG-RPYGDEVDVWSIGVILYILLSGVPPFW-GETEFEIFLAILRG-------DFD----  256 (382)
T ss_pred             cCCceEeeecCCccccCchhhcC-CCCCcccchhHHHHHHHHHhhCCCCCc-CCChhHHHHHHHcC-------CCC----
Confidence            87667788999999999999986 789999999999999999999999984 44444444433322       112    


Q ss_pred             CccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccccccc
Q 015374          351 PWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAA  401 (408)
Q Consensus       351 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~~~~~  401 (408)
                           +....+..++..+++|+++||..||.+|+|+.++|+|||++.....
T Consensus       257 -----f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~HpWi~~~~~~  302 (382)
T KOG0032|consen  257 -----FTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQHPWIKSIGEA  302 (382)
T ss_pred             -----CCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcCccccCCccc
Confidence                 2344455589999999999999999999999999999999876443

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=1.3e-46  Score=359.58  Aligned_cols=250  Identities=24%  Similarity=0.411  Sum_probs=210.2

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc------chHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCcc
Q 015374          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP  197 (408)
Q Consensus       124 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~  197 (408)
                      .++|++.+.||+|+||+||+|++..+++.||+|+++..      ....+.+|+.+++++ +||||+++++++.+  ....
T Consensus        17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~--~~~~   93 (329)
T PTZ00263         17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMEL-SHPFIVNMMCSFQD--ENRV   93 (329)
T ss_pred             chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhC-CCCCCCcEEEEEEc--CCEE
Confidence            57899999999999999999999999999999998643      234678999999999 99999999999965  4678


Q ss_pred             EEEEEeecCCChhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCCC
Q 015374          198 SLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK  274 (408)
Q Consensus       198 ~lv~e~~~~~~l~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~~  274 (408)
                      ++||||+.+++|..++   ..+++..+..++.|++.||.|||++||+||||||+|||++.+ +.+||+|||++...... 
T Consensus        94 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~-~~~kl~Dfg~~~~~~~~-  171 (329)
T PTZ00263         94 YFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNK-GHVKVTDFGFAKKVPDR-  171 (329)
T ss_pred             EEEEcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCC-CCEEEeeccCceEcCCC-
Confidence            9999999999998876   357888999999999999999999999999999999999988 79999999999876432 


Q ss_pred             cceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCCCccc
Q 015374          275 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSK  354 (408)
Q Consensus       275 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  354 (408)
                       .....|++.|+|||++.+ ..++.++|||||||++|+|++|..||.. .+..+....+...                  
T Consensus       172 -~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~-~~~~~~~~~i~~~------------------  230 (329)
T PTZ00263        172 -TFTLCGTPEYLAPEVIQS-KGHGKAVDWWTMGVLLYEFIAGYPPFFD-DTPFRIYEKILAG------------------  230 (329)
T ss_pred             -cceecCChhhcCHHHHcC-CCCCCcceeechHHHHHHHHcCCCCCCC-CCHHHHHHHHhcC------------------
Confidence             234578999999999987 6789999999999999999999999843 3333333332211                  


Q ss_pred             cccccCCCCCCHHHHHHHHHhcccCcCCCCC-----HHHHhcCCCccccccc
Q 015374          355 FINADNQHLVSPEAIDFLDKLLRYDHQDRLT-----AREAMAHPYFAQVRAA  401 (408)
Q Consensus       355 ~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt-----~~elL~hp~f~~~~~~  401 (408)
                        ....+..++..+.+|+.+||+.||.+|++     ++++++||||+.....
T Consensus       231 --~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~hp~f~~~~~~  280 (329)
T PTZ00263        231 --RLKFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYFHGANWD  280 (329)
T ss_pred             --CcCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCccCCCCHH
Confidence              01122336889999999999999999996     7999999999876443

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=2.4e-46  Score=362.15  Aligned_cols=271  Identities=25%  Similarity=0.471  Sum_probs=215.5

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecc-----cchHHHHHHHHHHHHhcCCCCceEEeeEEEccCC---
Q 015374          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP-----VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHS---  194 (408)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~-----~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~---  194 (408)
                      ..++|++.+.||+|+||.||+|++..++..||+|+++.     .....+.+|+.+++.+ +||||+++++++.....   
T Consensus        19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~   97 (359)
T cd07876          19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCV-NHKNIISLLNVFTPQKSLEE   97 (359)
T ss_pred             hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhC-CCCCEeeeeeeeccCCCccc
Confidence            46899999999999999999999999999999999863     2345678899999999 99999999999864322   


Q ss_pred             -CccEEEEEeecCCChhhhcCCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCC
Q 015374          195 -KTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG  273 (408)
Q Consensus       195 -~~~~lv~e~~~~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~  273 (408)
                       ...++||||++++.+......+++..+..++.|++.||.|||++||+||||||+|||++.+ +.+||+|||+++.....
T Consensus        98 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~-~~~kl~Dfg~a~~~~~~  176 (359)
T cd07876          98 FQDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSD-CTLKILDFGLARTACTN  176 (359)
T ss_pred             cceeEEEEeCCCcCHHHHHhccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCC-CCEEEecCCCccccccC
Confidence             3578999999987666655678999999999999999999999999999999999999988 79999999999765544


Q ss_pred             CcceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhh-----------
Q 015374          274 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIW-----------  342 (408)
Q Consensus       274 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~-----------  342 (408)
                      .......+|..|+|||++.+ ..++.++|||||||++|+|++|..||. +.+..+.+..+....+....           
T Consensus       177 ~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~tg~~pf~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (359)
T cd07876         177 FMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGELVKGSVIFQ-GTDHIDQWNKVIEQLGTPSAEFMNRLQPTVR  254 (359)
T ss_pred             ccCCCCcccCCCCCchhccC-CCCCcchhhHHHHHHHHHHHhCCCCCC-CCCHHHHHHHHHHhcCCCcHHHHHHHHHHHH
Confidence            44455678999999999987 789999999999999999999999984 44555555555544332110           


Q ss_pred             ----hcCCCCCCCcccc-------ccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccc
Q 015374          343 ----CNSRHSRKPWSKF-------INADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQ  397 (408)
Q Consensus       343 ----~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~  397 (408)
                          .........+.+.       .........++++++||.+||+.||++|||+.|+|+||||+.
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~  320 (359)
T cd07876         255 NYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITV  320 (359)
T ss_pred             HHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhh
Confidence                0000111111110       011122335788999999999999999999999999999974

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=9.4e-47  Score=359.70  Aligned_cols=245  Identities=27%  Similarity=0.457  Sum_probs=203.8

Q ss_pred             eeeeeeCceEEEEEEEcCCCcEEEEEEeccc------chHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccEEEEEee
Q 015374          131 RKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYV  204 (408)
Q Consensus       131 ~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~  204 (408)
                      +.||+|+||+||+|++..+++.||+|+++..      ....+.+|+.+++++ +||||+++++++..  ....++||||+
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~hp~i~~~~~~~~~--~~~~~lv~e~~   77 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNT-RHPFLTALKYSFQT--HDRLCFVMEYA   77 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhC-CCCCCCCEEEEEEc--CCEEEEEEeCC
Confidence            3699999999999999999999999998742      224577899999999 99999999999955  46789999999


Q ss_pred             cCCChhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccC-CCcceeec
Q 015374          205 NSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP-GKEYNVRV  280 (408)
Q Consensus       205 ~~~~l~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~-~~~~~~~~  280 (408)
                      ++++|..++   ..+++..++.++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+++.... ........
T Consensus        78 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~-~~~kl~DfG~a~~~~~~~~~~~~~~  156 (323)
T cd05571          78 NGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKD-GHIKITDFGLCKEGISDGATMKTFC  156 (323)
T ss_pred             CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCC-CCEEEeeCCCCcccccCCCccccee
Confidence            999998776   358999999999999999999999999999999999999988 7899999999875432 22334567


Q ss_pred             cCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCCCccccccccC
Q 015374          281 ASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSKFINADN  360 (408)
Q Consensus       281 ~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  360 (408)
                      ||..|+|||++.+ ..++.++|||||||++|||++|..||.. .+.......+...                    ....
T Consensus       157 gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~Pf~~-~~~~~~~~~~~~~--------------------~~~~  214 (323)
T cd05571         157 GTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYN-QDHEKLFELILME--------------------EIRF  214 (323)
T ss_pred             cCccccChhhhcC-CCCCccccCcccchhhhhhhcCCCCCCC-CCHHHHHHHHHcC--------------------CCCC
Confidence            9999999999987 7799999999999999999999999843 2222222222110                    1122


Q ss_pred             CCCCCHHHHHHHHHhcccCcCCCC-----CHHHHhcCCCccccccc
Q 015374          361 QHLVSPEAIDFLDKLLRYDHQDRL-----TAREAMAHPYFAQVRAA  401 (408)
Q Consensus       361 ~~~~~~~~~~li~~~L~~dp~~Rp-----t~~elL~hp~f~~~~~~  401 (408)
                      +..+++++.+||.+||+.||++||     ++.++++||||+++...
T Consensus       215 p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h~~f~~~~~~  260 (323)
T cd05571         215 PRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFFASINWQ  260 (323)
T ss_pred             CCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcCCCcCCCCHH
Confidence            344789999999999999999999     89999999999887543

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.6e-46  Score=358.25  Aligned_cols=258  Identities=30%  Similarity=0.504  Sum_probs=212.2

Q ss_pred             CCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc------chHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccE
Q 015374          125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS  198 (408)
Q Consensus       125 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  198 (408)
                      ++|++.+.||+|+||.||+|++..+++.||+|+++..      ....+.+|+.++..+ +||||+++++++.+  ....+
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~iv~~~~~~~~--~~~~~   77 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTT-KSEWLVKLLYAFQD--DEYLY   77 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhC-CCCCCccEEEEEEc--CCEEE
Confidence            4799999999999999999999999999999998743      234677899999999 89999999999965  46789


Q ss_pred             EEEEeecCCChhhhcC---CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCCCc
Q 015374          199 LIFEYVNSTDFKVLYP---TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE  275 (408)
Q Consensus       199 lv~e~~~~~~l~~~~~---~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~~~  275 (408)
                      +||||+++++|..++.   .+++..++.++.|++.||.|||++||+||||||+|||++.+ +.+||+|||++.....  .
T Consensus        78 lv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~-~~~kL~Dfg~a~~~~~--~  154 (333)
T cd05600          78 LAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDAS-GHIKLTDFGLSKGIVT--Y  154 (333)
T ss_pred             EEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCC-CCEEEEeCcCCccccc--c
Confidence            9999999999999873   58899999999999999999999999999999999999988 7999999999976543  3


Q ss_pred             ceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCCCcccc
Q 015374          276 YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSKF  355 (408)
Q Consensus       276 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  355 (408)
                      .....||..|+|||++.+ ..++.++|||||||++|||++|..||. +.+..+....+.......       ....+   
T Consensus       155 ~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~-~~~~~~~~~~i~~~~~~~-------~~~~~---  222 (333)
T cd05600         155 ANSVVGSPDYMAPEVLRG-KGYDFTVDYWSLGCMLYEFLCGFPPFS-GSTPNETWENLKYWKETL-------QRPVY---  222 (333)
T ss_pred             cCCcccCccccChhHhcC-CCCCCccceecchHHHhhhhhCCCCCC-CCCHHHHHHHHHhccccc-------cCCCC---
Confidence            345678999999999987 689999999999999999999999983 444444443332211000       00000   


Q ss_pred             ccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccccccch
Q 015374          356 INADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAE  402 (408)
Q Consensus       356 ~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~~~~~~  402 (408)
                        ......+++++.+|+.+||..+|++|||++|+++||||+.+....
T Consensus       223 --~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h~~~~~~~~~~  267 (333)
T cd05600         223 --DDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNHPFFKEVDWNE  267 (333)
T ss_pred             --CccccccCHHHHHHHHHHhhChhhhcCCHHHHHhCcccCCCCHHH
Confidence              000123689999999999999999999999999999999875543

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=5.7e-46  Score=359.95  Aligned_cols=255  Identities=25%  Similarity=0.411  Sum_probs=206.8

Q ss_pred             CCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc------chHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccE
Q 015374          125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS  198 (408)
Q Consensus       125 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  198 (408)
                      ++|++.+.||+|+||+||+|++..+++.||+|+++..      ....+.+|+.++.++ +|+||+++++.+.+  ....+
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~-~~~~iv~~~~~~~~--~~~~~   77 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEA-DSLWVVKMFYSFQD--KLNLY   77 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhC-CCCCcceEEEEEec--CCeEE
Confidence            4789999999999999999999999999999998642      224577899999999 99999999999965  46789


Q ss_pred             EEEEeecCCChhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCCC-
Q 015374          199 LIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK-  274 (408)
Q Consensus       199 lv~e~~~~~~l~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~~-  274 (408)
                      +||||+++++|..++   ..+++..++.++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+++...... 
T Consensus        78 lv~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~-~~vkL~DFGla~~~~~~~~  156 (363)
T cd05628          78 LIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSK-GHVKLSDFGLCTGLKKAHR  156 (363)
T ss_pred             EEEcCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCC-CCEEEeeccCccccccccc
Confidence            999999999998887   358999999999999999999999999999999999999988 799999999987543211 


Q ss_pred             -----------------------------------cceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCC
Q 015374          275 -----------------------------------EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEP  319 (408)
Q Consensus       275 -----------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~p  319 (408)
                                                         .....+||..|+|||++.+ ..++.++|||||||++|||++|..|
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~~~~~DvwSlGvil~ell~G~~P  235 (363)
T cd05628         157 TEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQ-TGYNKLCDWWSLGVIMYEMLIGYPP  235 (363)
T ss_pred             ccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcC-CCCCCchhhhhhHHHHHHHHhCCCC
Confidence                                               0123478999999999987 7899999999999999999999999


Q ss_pred             CCCCCCCHHHHHHHHhhhchhhhhcCCCCCCCccccccccCCCCCCHHHHHHHHHhcccCcC---CCCCHHHHhcCCCcc
Q 015374          320 FFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQ---DRLTAREAMAHPYFA  396 (408)
Q Consensus       320 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~---~Rpt~~elL~hp~f~  396 (408)
                      |. +.+..+....+......                ........+++++++++.+|+. +|.   .||+++|+++||||+
T Consensus       236 f~-~~~~~~~~~~i~~~~~~----------------~~~p~~~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei~~hp~f~  297 (363)
T cd05628         236 FC-SETPQETYKKVMNWKET----------------LIFPPEVPISEKAKDLILRFCC-EWEHRIGAPGVEEIKTNPFFE  297 (363)
T ss_pred             CC-CCCHHHHHHHHHcCcCc----------------ccCCCcCCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhCCCCCC
Confidence            84 44444444444321100                0001112368999999999775 454   458999999999999


Q ss_pred             ccccch
Q 015374          397 QVRAAE  402 (408)
Q Consensus       397 ~~~~~~  402 (408)
                      .+....
T Consensus       298 ~~~~~~  303 (363)
T cd05628         298 GVDWEH  303 (363)
T ss_pred             CCCHHH
Confidence            887654

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=7.6e-46  Score=347.84  Aligned_cols=267  Identities=30%  Similarity=0.535  Sum_probs=207.8

Q ss_pred             CCEEEEeeeeeeCceEEEEEEEcC-CCcEEEEEEeccc-----chHHHHHHHHHHHHhc--CCCCceEEeeEEEc---cC
Q 015374          125 DDYEVVRKVGRGKYSEVFEGINVN-TNERCIIKILKPV-----KKKKIKREIKILQNLC--GGPNVVKLLDIVRD---QH  193 (408)
Q Consensus       125 ~~y~~~~~lG~G~fg~Vy~~~~~~-~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~--~h~niv~l~~~~~~---~~  193 (408)
                      .+|++.+.||+|+||+||+|++.. ++..||+|.++..     ....+.+|+.+++.+.  +||||++++++|..   ..
T Consensus         1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~   80 (290)
T cd07862           1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR   80 (290)
T ss_pred             CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence            478999999999999999998854 5688999988632     2245667888877763  69999999999853   23


Q ss_pred             CCccEEEEEeecCCChhhhc-----CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccce
Q 015374          194 SKTPSLIFEYVNSTDFKVLY-----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE  268 (408)
Q Consensus       194 ~~~~~lv~e~~~~~~l~~~~-----~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~  268 (408)
                      ....++||||+++ ++..++     ..+++..+..++.|++.||.|||++||+||||||+|||++.+ +.+||+|||++.
T Consensus        81 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~-~~~kl~Dfg~~~  158 (290)
T cd07862          81 ETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSS-GQIKLADFGLAR  158 (290)
T ss_pred             CCcEEEEEccCCC-CHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCC-CCEEEccccceE
Confidence            4568899999985 665555     237889999999999999999999999999999999999988 799999999998


Q ss_pred             eccCCCcceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCC--
Q 015374          269 FYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSR--  346 (408)
Q Consensus       269 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~--  346 (408)
                      ............++..|+|||.+.+ ..++.++|||||||++|||++|..|| .+.++.+.+..+....+........  
T Consensus       159 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~~f-~~~~~~~~~~~i~~~~~~~~~~~~~~~  236 (290)
T cd07862         159 IYSFQMALTSVVVTLWYRAPEVLLQ-SSYATPVDLWSVGCIFAEMFRRKPLF-RGSSDVDQLGKILDVIGLPGEEDWPRD  236 (290)
T ss_pred             eccCCcccccccccccccChHHHhC-CCCCCccchHHHHHHHHHHHcCCCCc-CCCCHHHHHHHHHHHhCCCChhhchhh
Confidence            7665544555678999999999977 67899999999999999999998886 5666667777776654432211110  


Q ss_pred             --CCCCCccccc---cccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCc
Q 015374          347 --HSRKPWSKFI---NADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF  395 (408)
Q Consensus       347 --~~~~~~~~~~---~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f  395 (408)
                        .....+....   .......+++.+.+++.+||+.||++|||+.|+|+||||
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f  290 (290)
T cd07862         237 VALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF  290 (290)
T ss_pred             hcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence              0000000000   001123468889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.4e-46  Score=361.75  Aligned_cols=255  Identities=29%  Similarity=0.490  Sum_probs=208.5

Q ss_pred             CCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc------chHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccE
Q 015374          125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS  198 (408)
Q Consensus       125 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  198 (408)
                      ++|++.+.||+|+||+||+|++..+++.||||+++..      ....+.+|+.++..+ +|+||++++++|.+  +...+
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l-~h~~iv~~~~~~~~--~~~~~   77 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEA-DNPWVVKLYYSFQD--ENYLY   77 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhC-CCCCCcceEEEEEc--CCeEE
Confidence            4799999999999999999999999999999999642      224577899999999 99999999999965  56889


Q ss_pred             EEEEeecCCChhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCCCc
Q 015374          199 LIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE  275 (408)
Q Consensus       199 lv~e~~~~~~l~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~~~  275 (408)
                      +||||+++++|..++   ..+++..++.++.|++.||+|||++||+||||||+|||++.+ +.++|+|||++........
T Consensus        78 lv~E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~-~~~kl~Dfg~~~~~~~~~~  156 (364)
T cd05599          78 LIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAK-GHIKLSDFGLCTGLKKSHR  156 (364)
T ss_pred             EEECCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCC-CCEEEeecccceecccccc
Confidence            999999999998876   358999999999999999999999999999999999999988 7999999999875432110


Q ss_pred             ---------------------------------------ceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhC
Q 015374          276 ---------------------------------------YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFR  316 (408)
Q Consensus       276 ---------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g  316 (408)
                                                             ....+||+.|+|||++.+ ..++.++|||||||++|||++|
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~~G  235 (364)
T cd05599         157 TEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQ-TGYNKECDWWSLGVIMYEMLVG  235 (364)
T ss_pred             ccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcC-CCCCCeeeeecchhHHHHhhcC
Confidence                                                   012468999999999977 7899999999999999999999


Q ss_pred             CCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCC---HHHHhcCC
Q 015374          317 KEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLT---AREAMAHP  393 (408)
Q Consensus       317 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt---~~elL~hp  393 (408)
                      ..||. +.+..+....+....                ..........+++++.+||.+||. +|.+|++   ++|+++||
T Consensus       236 ~~Pf~-~~~~~~~~~~i~~~~----------------~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~  297 (364)
T cd05599         236 YPPFC-SDNPQETYRKIINWK----------------ETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHP  297 (364)
T ss_pred             CCCCC-CCCHHHHHHHHHcCC----------------CccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCC
Confidence            99984 333333333332210                000111112368999999999996 9999998   99999999


Q ss_pred             Cccccccch
Q 015374          394 YFAQVRAAE  402 (408)
Q Consensus       394 ~f~~~~~~~  402 (408)
                      ||+..+...
T Consensus       298 ~~~~~~~~~  306 (364)
T cd05599         298 FFKGVDWEH  306 (364)
T ss_pred             CcCCCCHHH
Confidence            999876543

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.6e-47  Score=327.84  Aligned_cols=249  Identities=26%  Similarity=0.464  Sum_probs=219.1

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecccc------hHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCc
Q 015374          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK------KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT  196 (408)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~------~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  196 (408)
                      .-++|++.+.||+|.||.||.|+.+.++-.||+|++.+++      ..++.+|++|-++| +||||.++|++|.+  ...
T Consensus        20 ~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L-~hpnilrlY~~fhd--~~r   96 (281)
T KOG0580|consen   20 TLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHL-RHPNILRLYGYFHD--SKR   96 (281)
T ss_pred             chhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeeccc-CCccHHhhhhheec--cce
Confidence            4678999999999999999999999999999999986433      46789999999999 99999999999965  578


Q ss_pred             cEEEEEeecCCChhhhcC-----CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceecc
Q 015374          197 PSLIFEYVNSTDFKVLYP-----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH  271 (408)
Q Consensus       197 ~~lv~e~~~~~~l~~~~~-----~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~  271 (408)
                      .||++||..+|.+...+.     .+++.....++.|++.||.|+|.++||||||||+|+|++.+ +.+||+|||-+....
T Consensus        97 iyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~-~~lkiAdfGwsV~~p  175 (281)
T KOG0580|consen   97 IYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSA-GELKIADFGWSVHAP  175 (281)
T ss_pred             eEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCC-CCeeccCCCceeecC
Confidence            899999999999887774     58999999999999999999999999999999999999998 899999999987654


Q ss_pred             CCCcceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCCC
Q 015374          272 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKP  351 (408)
Q Consensus       272 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  351 (408)
                       .....+.+||..|.+||...+ ...+..+|+|++|++.||++.|..||... ...+...++.+.               
T Consensus       176 -~~kR~tlcgt~dyl~pEmv~~-~~hd~~Vd~w~lgvl~yeflvg~ppFes~-~~~etYkrI~k~---------------  237 (281)
T KOG0580|consen  176 -SNKRKTLCGTLDYLPPEMVEG-RGHDKFVDLWSLGVLCYEFLVGLPPFESQ-SHSETYKRIRKV---------------  237 (281)
T ss_pred             -CCCceeeecccccCCHhhcCC-CCccchhhHHHHHHHHHHHHhcCCchhhh-hhHHHHHHHHHc---------------
Confidence             556677899999999999988 78999999999999999999999998443 355666666553               


Q ss_pred             ccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccc
Q 015374          352 WSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQV  398 (408)
Q Consensus       352 ~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~~  398 (408)
                           ....+..++.++.|+|.+||..+|.+|.+..|+++|||....
T Consensus       238 -----~~~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpwI~a~  279 (281)
T KOG0580|consen  238 -----DLKFPSTISGGAADLISRLLVKNPIERLALTEVMDHPWIVAN  279 (281)
T ss_pred             -----cccCCcccChhHHHHHHHHhccCccccccHHHHhhhHHHHhc
Confidence                 223345689999999999999999999999999999997653

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=4.9e-46  Score=356.86  Aligned_cols=251  Identities=21%  Similarity=0.394  Sum_probs=210.0

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCC-cEEEEEEeccc------chHHHHHHHHHHHHhcCCCCceEEeeEEEccCCC
Q 015374          123 DQDDYEVVRKVGRGKYSEVFEGINVNTN-ERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSK  195 (408)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~-~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  195 (408)
                      ..++|++.+.||+|+||.||+|.+..++ ..||+|.+...      ..+.+.+|+.+++.+ +||||+++++++.+  ..
T Consensus        28 ~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~Iv~~~~~~~~--~~  104 (340)
T PTZ00426         28 KYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYI-NHPFCVNLYGSFKD--ES  104 (340)
T ss_pred             ChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhC-CCCCCcceEEEEEe--CC
Confidence            4678999999999999999999876554 68999998532      235677899999999 99999999999965  46


Q ss_pred             ccEEEEEeecCCChhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccC
Q 015374          196 TPSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP  272 (408)
Q Consensus       196 ~~~lv~e~~~~~~l~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~  272 (408)
                      ..++||||+++++|..++   ..+++..+..++.|++.||.|||++||+||||||+|||++.+ +.+||+|||++.....
T Consensus       105 ~~~lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~-~~ikL~DFG~a~~~~~  183 (340)
T PTZ00426        105 YLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKD-GFIKMTDFGFAKVVDT  183 (340)
T ss_pred             EEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCC-CCEEEecCCCCeecCC
Confidence            789999999999998887   358899999999999999999999999999999999999988 7999999999987643


Q ss_pred             CCcceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCCCc
Q 015374          273 GKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPW  352 (408)
Q Consensus       273 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  352 (408)
                        ......||+.|+|||++.+ ..++.++|||||||++|||++|..||. +.+.......+...                
T Consensus       184 --~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~ell~G~~Pf~-~~~~~~~~~~i~~~----------------  243 (340)
T PTZ00426        184 --RTYTLCGTPEYIAPEILLN-VGHGKAADWWTLGIFIYEILVGCPPFY-ANEPLLIYQKILEG----------------  243 (340)
T ss_pred             --CcceecCChhhcCHHHHhC-CCCCccccccchhhHHHHHhcCCCCCC-CCCHHHHHHHHhcC----------------
Confidence              2345678999999999987 678999999999999999999999985 33333333333221                


Q ss_pred             cccccccCCCCCCHHHHHHHHHhcccCcCCCC-----CHHHHhcCCCccccccc
Q 015374          353 SKFINADNQHLVSPEAIDFLDKLLRYDHQDRL-----TAREAMAHPYFAQVRAA  401 (408)
Q Consensus       353 ~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rp-----t~~elL~hp~f~~~~~~  401 (408)
                          ....+..+++++.+++++||+.||++|+     |++|+++||||+++...
T Consensus       244 ----~~~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~~~~~  293 (340)
T PTZ00426        244 ----IIYFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNIDWV  293 (340)
T ss_pred             ----CCCCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCCCcCCCCHH
Confidence                0112344788999999999999999995     89999999999987654

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.8e-46  Score=363.10  Aligned_cols=255  Identities=27%  Similarity=0.467  Sum_probs=206.1

Q ss_pred             CCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc------chHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccE
Q 015374          125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS  198 (408)
Q Consensus       125 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  198 (408)
                      ++|+++++||+|+||+||++++..+++.||||++...      ..+.+.+|+.+++++ +||||++++++|.+  ....+
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~iv~~~~~~~~--~~~~~   77 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAES-DSPWVVSLYYSFQD--AQYLY   77 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhC-CCCCcceEEEEEEc--CCeeE
Confidence            4789999999999999999999999999999998532      235678899999998 99999999999965  46789


Q ss_pred             EEEEeecCCChhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCCCc
Q 015374          199 LIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE  275 (408)
Q Consensus       199 lv~e~~~~~~l~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~~~  275 (408)
                      +||||+++++|..++   ..+++..++.++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+++.......
T Consensus        78 lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~-~~~kl~DfGla~~~~~~~~  156 (377)
T cd05629          78 LIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRG-GHIKLSDFGLSTGFHKQHD  156 (377)
T ss_pred             EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCC-CCEEEeecccccccccccc
Confidence            999999999998876   458889999999999999999999999999999999999988 7999999999863321000


Q ss_pred             ------------------------------------------------ceeeccCccccccccccCCcCCCccccHHHHH
Q 015374          276 ------------------------------------------------YNVRVASRYFKGPELLVDLQDYDYSLDMWSLG  307 (408)
Q Consensus       276 ------------------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG  307 (408)
                                                                      ....+||..|+|||++.+ ..++.++||||||
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG  235 (377)
T cd05629         157 SAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQ-QGYGQECDWWSLG  235 (377)
T ss_pred             cccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHcc-CCCCCceeeEecc
Confidence                                                            012468999999999987 7799999999999


Q ss_pred             HHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCCCccccccccCCCCCCHHHHHHHHHhcccCcCCC---C
Q 015374          308 CMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDR---L  384 (408)
Q Consensus       308 vil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R---p  384 (408)
                      |++|||++|..||. +.+..+.+..+....                ..........++.++.+||.+||. +|.+|   +
T Consensus       236 vil~elltG~~Pf~-~~~~~~~~~~i~~~~----------------~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~  297 (377)
T cd05629         236 AIMFECLIGWPPFC-SENSHETYRKIINWR----------------ETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRG  297 (377)
T ss_pred             hhhhhhhcCCCCCC-CCCHHHHHHHHHccC----------------CccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCC
Confidence            99999999999984 334444444333210                000111122468999999999997 77775   5


Q ss_pred             CHHHHhcCCCccccccch
Q 015374          385 TAREAMAHPYFAQVRAAE  402 (408)
Q Consensus       385 t~~elL~hp~f~~~~~~~  402 (408)
                      |+.|+++||||+++....
T Consensus       298 ~~~~~l~hp~~~~~~~~~  315 (377)
T cd05629         298 GAHEIKSHPFFRGVDWDT  315 (377)
T ss_pred             CHHHHhcCCCcCCCCHHH
Confidence            999999999999875543

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.2e-46  Score=365.37  Aligned_cols=269  Identities=23%  Similarity=0.320  Sum_probs=210.0

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecccchHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccEEEEE
Q 015374          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFE  202 (408)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e  202 (408)
                      ..++|++.+.||+|+||.||+|++..+++.||+|...   ...+.+|+.+++++ +||||++++++|..  ....++|+|
T Consensus        90 ~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~---~~~~~~E~~il~~l-~HpnIv~~~~~~~~--~~~~~lv~e  163 (391)
T PHA03212         90 EKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ---RGGTATEAHILRAI-NHPSIIQLKGTFTY--NKFTCLILP  163 (391)
T ss_pred             ccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh---hhhhHHHHHHHHhC-CCCCCCCEeEEEEE--CCeeEEEEe
Confidence            3568999999999999999999999999999999753   45678999999999 99999999999965  467889999


Q ss_pred             eecCCChhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCC--Ccce
Q 015374          203 YVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG--KEYN  277 (408)
Q Consensus       203 ~~~~~~l~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~--~~~~  277 (408)
                      ++.+ ++..++   ..+++..+..++.|++.||.|||++||+||||||+|||++.+ +.+||+|||++......  ....
T Consensus       164 ~~~~-~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~-~~vkL~DFG~a~~~~~~~~~~~~  241 (391)
T PHA03212        164 RYKT-DLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHP-GDVCLGDFGAACFPVDINANKYY  241 (391)
T ss_pred             cCCC-CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCC-CCEEEEeCCcccccccccccccc
Confidence            9975 554444   458899999999999999999999999999999999999988 78999999999653321  2233


Q ss_pred             eeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCC------CCHHHHHHHHhhhchhhhhcCC-----
Q 015374          278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGH------DNHDQLVKIAKDCCLIIWCNSR-----  346 (408)
Q Consensus       278 ~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~------~~~~~~~~~~~~~~~~~~~~~~-----  346 (408)
                      ...||..|+|||++.+ ..++.++|||||||++|||++|..||+...      +...++..+....|........     
T Consensus       242 ~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~~  320 (391)
T PHA03212        242 GWAGTIATNAPELLAR-DPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQAN  320 (391)
T ss_pred             cccCccCCCChhhhcC-CCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchhHH
Confidence            4579999999999987 789999999999999999999999986543      2234455555444422111000     


Q ss_pred             -----------CCCCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccccccc
Q 015374          347 -----------HSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAA  401 (408)
Q Consensus       347 -----------~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~~~~~  401 (408)
                                 ....+... ........++.++.+||.+||++||++|||++|+|+||||+.+...
T Consensus       321 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~~~  385 (391)
T PHA03212        321 LDEIYIGLAKKSSRKPGSR-PLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDIPDP  385 (391)
T ss_pred             HHHHHHHHHhccCCCCCCC-CCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhccCCCC
Confidence                       00000000 0000111256789999999999999999999999999999987654

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=6.2e-46  Score=356.05  Aligned_cols=272  Identities=32%  Similarity=0.551  Sum_probs=208.5

Q ss_pred             CEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc-----chHHHHHHHHHHHHhcCCCCceEEeeEEEccCC---Ccc
Q 015374          126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHS---KTP  197 (408)
Q Consensus       126 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~---~~~  197 (408)
                      +|++.++||+|+||.||+|++..++..||||.++..     ....+.+|+.+++++ +||||+++++++.....   ...
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~~~~~   79 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLL-RHPDIVEIKHIMLPPSRREFKDI   79 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhC-CCCCEeeecceEeccCCCCCceE
Confidence            589999999999999999999999999999998632     234678999999999 99999999998864322   357


Q ss_pred             EEEEEeecCCChhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCCC
Q 015374          198 SLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK  274 (408)
Q Consensus       198 ~lv~e~~~~~~l~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~~  274 (408)
                      ++||||+++ +|..++   ..+++..+..++.|++.||.|||++||+||||||+|||++.+ +.+||+|||+++......
T Consensus        80 ~lv~e~~~~-~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~-~~~kL~Dfg~~~~~~~~~  157 (338)
T cd07859          80 YVVFELMES-DLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANAD-CKLKICDFGLARVAFNDT  157 (338)
T ss_pred             EEEEecCCC-CHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCC-CcEEEccCcccccccccc
Confidence            999999974 666555   358999999999999999999999999999999999999988 799999999997543221


Q ss_pred             c----ceeeccCccccccccccCC-cCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCC-C
Q 015374          275 E----YNVRVASRYFKGPELLVDL-QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRH-S  348 (408)
Q Consensus       275 ~----~~~~~~~~~y~aPE~~~~~-~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~-~  348 (408)
                      .    .....++..|+|||++.+. ..++.++|||||||++|+|++|+.|| .+.+...++..+....+......... .
T Consensus       158 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf-~~~~~~~~~~~~~~~~~~~~~~~~~~i~  236 (338)
T cd07859         158 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLF-PGKNVVHQLDLITDLLGTPSPETISRVR  236 (338)
T ss_pred             CccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCC-CCCChHHHHHHHHHHhCCCCHHHHHHhh
Confidence            1    1335789999999998642 56889999999999999999999887 44444444444433333211000000 0


Q ss_pred             -----------CCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccccccch
Q 015374          349 -----------RKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAE  402 (408)
Q Consensus       349 -----------~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~~~~~~  402 (408)
                                 ...... ........+++++.+++.+||+.||++|||++|+++||||+.+....
T Consensus       237 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~~~~~  300 (338)
T cd07859         237 NEKARRYLSSMRKKQPV-PFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLAKVE  300 (338)
T ss_pred             hhhHHHHHHhhcccCCC-chHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhcCccc
Confidence                       000000 00011123578899999999999999999999999999999877654

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=3.6e-46  Score=360.40  Aligned_cols=273  Identities=25%  Similarity=0.465  Sum_probs=215.4

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc-----chHHHHHHHHHHHHhcCCCCceEEeeEEEccC----
Q 015374          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQH----  193 (408)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~----  193 (408)
                      ..++|++.+.||+|+||.||++.+..+++.||+|.++..     ....+.+|+.+++.+ +||||+++++++....    
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~   93 (355)
T cd07874          15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCV-NHKNIISLLNVFTPQKSLEE   93 (355)
T ss_pred             hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHh-CCCchhceeeeeeccccccc
Confidence            468999999999999999999999999999999998632     235677899999999 9999999999986432    


Q ss_pred             CCccEEEEEeecCCChhhhcCCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCC
Q 015374          194 SKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG  273 (408)
Q Consensus       194 ~~~~~lv~e~~~~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~  273 (408)
                      ....++||||++++........+++..+..++.|++.||.|||++||+||||||+|||++.+ +.+||+|||+++.....
T Consensus        94 ~~~~~lv~e~~~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~-~~~kl~Dfg~~~~~~~~  172 (355)
T cd07874          94 FQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSD-CTLKILDFGLARTAGTS  172 (355)
T ss_pred             cceeEEEhhhhcccHHHHHhhcCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCC-CCEEEeeCcccccCCCc
Confidence            23578999999987666665678999999999999999999999999999999999999988 79999999999876554


Q ss_pred             CcceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhh----------
Q 015374          274 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWC----------  343 (408)
Q Consensus       274 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~----------  343 (408)
                      .......+|..|+|||++.+ ..++.++|||||||++|+|++|+.|| .+.+..+.+...+...+.....          
T Consensus       173 ~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (355)
T cd07874         173 FMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMVRHKILF-PGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVR  250 (355)
T ss_pred             cccCCccccCCccCHHHHcC-CCCCchhhHHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHHHhCCCCHHHHHhhcHHHH
Confidence            44455688999999999987 77999999999999999999999997 4555555555555443321100          


Q ss_pred             -----cCCCCCCCcccc-------ccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccccc
Q 015374          344 -----NSRHSRKPWSKF-------INADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVR  399 (408)
Q Consensus       344 -----~~~~~~~~~~~~-------~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~~~  399 (408)
                           ........+...       .........+.++.+||.+||+.||++|||+.|+|+||||+...
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~~~  318 (355)
T cd07874         251 NYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINVWY  318 (355)
T ss_pred             HHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhccc
Confidence                 000000000000       01112233467899999999999999999999999999998543

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=9.1e-47  Score=358.02  Aligned_cols=241  Identities=20%  Similarity=0.362  Sum_probs=205.9

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc--chHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccEEEE
Q 015374          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV--KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIF  201 (408)
Q Consensus       124 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~  201 (408)
                      .+.+++++.||+|.||+||.|.+. ....||+|.++..  ..+.|.+|+++|++| +|+|||+++++|..+  ..++|||
T Consensus       205 r~~l~l~~~LG~G~FG~V~~g~~~-~~~~vavk~ik~~~m~~~~f~~Ea~iMk~L-~H~~lV~l~gV~~~~--~piyIVt  280 (468)
T KOG0197|consen  205 REELKLIRELGSGQFGEVWLGKWN-GSTKVAVKTIKEGSMSPEAFLREAQIMKKL-RHEKLVKLYGVCTKQ--EPIYIVT  280 (468)
T ss_pred             HHHHHHHHHhcCCccceEEEEEEc-CCCcccceEEeccccChhHHHHHHHHHHhC-cccCeEEEEEEEecC--CceEEEE
Confidence            445667789999999999999764 4458999999853  357899999999999 999999999999654  4789999


Q ss_pred             EeecCCChhhhcCC-----CChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCCCcc
Q 015374          202 EYVNSTDFKVLYPT-----LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY  276 (408)
Q Consensus       202 e~~~~~~l~~~~~~-----l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~~~~  276 (408)
                      |||+.|+|.++++.     +...+...++.|||+||+||+++++|||||.++|||++++ ..+||+|||+|+... ++.+
T Consensus       281 E~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~-~~vKIsDFGLAr~~~-d~~Y  358 (468)
T KOG0197|consen  281 EYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDED-LVVKISDFGLARLIG-DDEY  358 (468)
T ss_pred             EecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccC-ceEEEcccccccccC-CCce
Confidence            99999999999853     7888899999999999999999999999999999999999 799999999999444 3444


Q ss_pred             eeeccC---ccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCCCcc
Q 015374          277 NVRVAS---RYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWS  353 (408)
Q Consensus       277 ~~~~~~---~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  353 (408)
                      ....+.   ..|.|||++.. ..++.++|||||||+||||+|-...++.+.++.+.+..+...                 
T Consensus       359 ~~~~~~kfPIkWtAPEa~~~-~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~G-----------------  420 (468)
T KOG0197|consen  359 TASEGGKFPIKWTAPEALNY-GKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERG-----------------  420 (468)
T ss_pred             eecCCCCCCceecCHHHHhh-CCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhcc-----------------
Confidence            444333   35999999987 889999999999999999999666666888888887776543                 


Q ss_pred             ccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHh
Q 015374          354 KFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAM  390 (408)
Q Consensus       354 ~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL  390 (408)
                        .+...|..|++++-++|..||..+|++|||.+.+.
T Consensus       421 --yRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~  455 (468)
T KOG0197|consen  421 --YRLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLR  455 (468)
T ss_pred             --CcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHH
Confidence              34556677999999999999999999999998664

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.7e-46  Score=359.44  Aligned_cols=256  Identities=32%  Similarity=0.545  Sum_probs=212.2

Q ss_pred             CCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc------chHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccE
Q 015374          125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS  198 (408)
Q Consensus       125 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  198 (408)
                      ++|++.+.||+|+||+||+|++..+++.||+|+++..      ....+.+|+.++..+ +|+||+++++++.+  ....+
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~--~~~~~   77 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADA-DSPWIVKLYYSFQD--EEHLY   77 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhc-CCCCccchhhheec--CCeEE
Confidence            4799999999999999999999999999999998642      235678899999999 99999999999955  46789


Q ss_pred             EEEEeecCCChhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCCC-
Q 015374          199 LIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK-  274 (408)
Q Consensus       199 lv~e~~~~~~l~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~~-  274 (408)
                      +||||+++++|..++   ..+++..++.++.|++.||+|||++||+||||||+|||++.+ +.+||+|||++....... 
T Consensus        78 lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~-~~~kL~Dfg~~~~~~~~~~  156 (350)
T cd05573          78 LVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDAD-GHIKLADFGLCKKMNKAKD  156 (350)
T ss_pred             EEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCC-CCEEeecCCCCccCcccCc
Confidence            999999999998887   358999999999999999999999999999999999999988 799999999997655433 


Q ss_pred             -----------------------------cceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCC
Q 015374          275 -----------------------------EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHD  325 (408)
Q Consensus       275 -----------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~  325 (408)
                                                   ......||..|+|||++.+ ..++.++|||||||++|||++|+.||... +
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~Pf~~~-~  234 (350)
T cd05573         157 REYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRG-TPYGLECDWWSLGVILYEMLYGFPPFYSD-T  234 (350)
T ss_pred             ccccccccccccccccccccccccccccccccccccCccccCHHHHcC-CCCCCceeeEecchhhhhhccCCCCCCCC-C
Confidence                                         2234578999999999987 68999999999999999999999998533 3


Q ss_pred             CHHHHHHHHhhhchhhhhcCCCCCCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCC-HHHHhcCCCccccccchh
Q 015374          326 NHDQLVKIAKDCCLIIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLT-AREAMAHPYFAQVRAAES  403 (408)
Q Consensus       326 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt-~~elL~hp~f~~~~~~~~  403 (408)
                      ..+....+....                ..........+++++.+||.+||. ||.+|++ ++|+++||||+.++....
T Consensus       235 ~~~~~~~i~~~~----------------~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~~~~~~~~~~  296 (350)
T cd05573         235 LQETYNKIINWK----------------ESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFFKGIDWENL  296 (350)
T ss_pred             HHHHHHHHhccC----------------CcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCCcCCCCHHHH
Confidence            333333333210                001111112268999999999997 9999999 999999999998876543

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=9e-46  Score=358.78  Aligned_cols=272  Identities=25%  Similarity=0.463  Sum_probs=215.8

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc-----chHHHHHHHHHHHHhcCCCCceEEeeEEEccC----
Q 015374          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQH----  193 (408)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~----  193 (408)
                      ..++|++.+.||+|+||.||+|.+..+++.||||+++..     ....+.+|+.+++.+ +||||+++++++....    
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~ii~~~~~~~~~~~~~~  100 (364)
T cd07875          22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCV-NHKNIIGLLNVFTPQKSLEE  100 (364)
T ss_pred             hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhc-CCCCccccceeecccccccc
Confidence            467899999999999999999999999999999998632     235677899999999 9999999999886432    


Q ss_pred             CCccEEEEEeecCCChhhhcCCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCC
Q 015374          194 SKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG  273 (408)
Q Consensus       194 ~~~~~lv~e~~~~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~  273 (408)
                      ....++||||++++........+++..+..++.|++.||.|||++||+||||||+|||++.+ +.+||+|||+++.....
T Consensus       101 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~-~~~kL~DfG~a~~~~~~  179 (364)
T cd07875         101 FQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSD-CTLKILDFGLARTAGTS  179 (364)
T ss_pred             cCeEEEEEeCCCCCHHHHHHhcCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCC-CcEEEEeCCCccccCCC
Confidence            23578999999887666555678899999999999999999999999999999999999988 79999999999876554


Q ss_pred             CcceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhh----------
Q 015374          274 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWC----------  343 (408)
Q Consensus       274 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~----------  343 (408)
                      .......+|..|+|||++.+ ..++.++|||||||++|+|++|+.|| .+.+..+.+..+....+.....          
T Consensus       180 ~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~pf-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (364)
T cd07875         180 FMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMIKGGVLF-PGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVR  257 (364)
T ss_pred             CcccCCcccCCcCCHHHHhC-CCCCchhhHHhHHHHHHHHHhCCCCC-CCCCHHHHHHHHHHhcCCCCHHHHHhhhHHHH
Confidence            44455688999999999987 78999999999999999999999997 5555566666665544421100          


Q ss_pred             -----cCCCCCCCccccc-------cccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccc
Q 015374          344 -----NSRHSRKPWSKFI-------NADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQV  398 (408)
Q Consensus       344 -----~~~~~~~~~~~~~-------~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~~  398 (408)
                           ........+....       ........+.++++||.+||+.||.+|||++|+|+||||+..
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~~  324 (364)
T cd07875         258 TYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVW  324 (364)
T ss_pred             HHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCcccccc
Confidence                 0000000000000       111122245789999999999999999999999999999754

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=1.5e-45  Score=359.37  Aligned_cols=254  Identities=27%  Similarity=0.456  Sum_probs=204.1

Q ss_pred             CEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc------chHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccEE
Q 015374          126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSL  199 (408)
Q Consensus       126 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l  199 (408)
                      .|++++.||+|+||+||+|++..+++.||+|+++..      ....+.+|+.+++++ +|+||+++++++.+  ....++
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l-~h~~iv~l~~~~~~--~~~~~l   78 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEA-DNEWVVKLYYSFQD--KDNLYF   78 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhc-CCCCeeeeEEEEec--CCEEEE
Confidence            688999999999999999999999999999998642      234678899999999 99999999999965  467899


Q ss_pred             EEEeecCCChhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCCC--
Q 015374          200 IFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK--  274 (408)
Q Consensus       200 v~e~~~~~~l~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~~--  274 (408)
                      ||||+++++|..++   ..+++..++.++.|++.||+|||+.||+||||||+|||++.+ +.+||+|||++.......  
T Consensus        79 v~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~-~~~kL~DFGl~~~~~~~~~~  157 (381)
T cd05626          79 VMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLD-GHIKLTDFGLCTGFRWTHNS  157 (381)
T ss_pred             EEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCC-CCEEEeeCcCCccccccccc
Confidence            99999999998876   458889999999999999999999999999999999999987 799999999975321000  


Q ss_pred             ----------------------------------------------cceeeccCccccccccccCCcCCCccccHHHHHH
Q 015374          275 ----------------------------------------------EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGC  308 (408)
Q Consensus       275 ----------------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv  308 (408)
                                                                    .....+||..|+|||++.+ ..++.++|||||||
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~~DiwSlG~  236 (381)
T cd05626         158 KYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLR-KGYTQLCDWWSVGV  236 (381)
T ss_pred             ccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcC-CCCCCccceeehhh
Confidence                                                          0123468999999999987 77999999999999


Q ss_pred             HHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCCCccccccccCCCCCCHHHHHHHHHhccc--CcCCCCCH
Q 015374          309 MFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRY--DHQDRLTA  386 (408)
Q Consensus       309 il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~--dp~~Rpt~  386 (408)
                      ++|||++|..||.... ..+....+....                ..........+++++.+||.+|+..  ++..|+|+
T Consensus       237 il~elltG~~Pf~~~~-~~~~~~~i~~~~----------------~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~  299 (381)
T cd05626         237 ILFEMLVGQPPFLAPT-PTETQLKVINWE----------------NTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGA  299 (381)
T ss_pred             HHHHHHhCCCCCcCCC-HHHHHHHHHccc----------------cccCCCCCCCCCHHHHHHHHHHccCcccccCCCCH
Confidence            9999999999985433 333333322110                0011111224789999999996544  55559999


Q ss_pred             HHHhcCCCccccccc
Q 015374          387 REAMAHPYFAQVRAA  401 (408)
Q Consensus       387 ~elL~hp~f~~~~~~  401 (408)
                      +|+++||||+++...
T Consensus       300 ~~~l~hp~f~~~~~~  314 (381)
T cd05626         300 DDIKAHPFFSEVDFS  314 (381)
T ss_pred             HHHhcCcccCCCChh
Confidence            999999999987653

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=1e-45  Score=352.57  Aligned_cols=246  Identities=26%  Similarity=0.454  Sum_probs=203.7

Q ss_pred             eeeeeeCceEEEEEEEcCCCcEEEEEEeccc------chHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccEEEEEee
Q 015374          131 RKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYV  204 (408)
Q Consensus       131 ~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~  204 (408)
                      +.||+|+||+||++++..++..||+|+++..      ....+.+|+.+++.+ +||||++++++|..  ....++||||+
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~i~~~~~~~~~--~~~~~lv~E~~   77 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT-RHPFLTALKYAFQT--HDRLCFVMEYA   77 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhC-CCCCCcceeeEEec--CCEEEEEEeCC
Confidence            3699999999999999999999999998642      234567899999999 99999999999965  46789999999


Q ss_pred             cCCChhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCC-Ccceeec
Q 015374          205 NSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG-KEYNVRV  280 (408)
Q Consensus       205 ~~~~l~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~-~~~~~~~  280 (408)
                      ++++|..++   ..+++..++.++.|++.||.|||++||+||||||+|||++.+ +.+||+|||++...... .......
T Consensus        78 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~-~~~kL~Dfg~~~~~~~~~~~~~~~~  156 (323)
T cd05595          78 NGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKD-GHIKITDFGLCKEGISDGATMKTFC  156 (323)
T ss_pred             CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCC-CCEEecccHHhccccCCCCcccccc
Confidence            999998776   348999999999999999999999999999999999999988 79999999998754322 2233457


Q ss_pred             cCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCCCccccccccC
Q 015374          281 ASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSKFINADN  360 (408)
Q Consensus       281 ~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  360 (408)
                      |+..|+|||++.+ ..++.++|||||||++|||++|+.||... +..+....+...                    ....
T Consensus       157 gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~ell~g~~Pf~~~-~~~~~~~~~~~~--------------------~~~~  214 (323)
T cd05595         157 GTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQ-DHERLFELILME--------------------EIRF  214 (323)
T ss_pred             CCcCcCCcccccC-CCCCchhchhhhHHHHHHHHhCCCCCCCC-CHHHHHHHHhcC--------------------CCCC
Confidence            8999999999987 78899999999999999999999998533 222222222211                    0112


Q ss_pred             CCCCCHHHHHHHHHhcccCcCCCC-----CHHHHhcCCCccccccch
Q 015374          361 QHLVSPEAIDFLDKLLRYDHQDRL-----TAREAMAHPYFAQVRAAE  402 (408)
Q Consensus       361 ~~~~~~~~~~li~~~L~~dp~~Rp-----t~~elL~hp~f~~~~~~~  402 (408)
                      +..+++++.++|.+||+.||++|+     ++.++++||||.+.....
T Consensus       215 p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h~~~~~~~~~~  261 (323)
T cd05595         215 PRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQD  261 (323)
T ss_pred             CCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcCCCcCCCCHHH
Confidence            334789999999999999999998     899999999999876543

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=3.1e-46  Score=342.58  Aligned_cols=257  Identities=27%  Similarity=0.426  Sum_probs=219.6

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecccc------hHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCc
Q 015374          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK------KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT  196 (408)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~------~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  196 (408)
                      ..++|++++.||.|.-|+||+++...++..+|+|++.+..      ..+.+.|-+||+.+ +||.+++||..|+.  ...
T Consensus        75 ~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~l-DHPFlPTLYa~fet--~~~  151 (459)
T KOG0610|consen   75 GLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLL-DHPFLPTLYASFET--DKY  151 (459)
T ss_pred             CHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhc-CCCccchhhheeec--cce
Confidence            4578899999999999999999999999999999997533      34567799999999 99999999999954  578


Q ss_pred             cEEEEEeecCCChhhhcC-----CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceecc
Q 015374          197 PSLIFEYVNSTDFKVLYP-----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH  271 (408)
Q Consensus       197 ~~lv~e~~~~~~l~~~~~-----~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~  271 (408)
                      .||+||||+||+|..+++     .|++..++.++.+++.||+|||-.|||+|||||+||||.++ |.+.|+||.++....
T Consensus       152 ~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvred-GHIMLsDFDLS~~~~  230 (459)
T KOG0610|consen  152 SCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVRED-GHIMLSDFDLSLRCP  230 (459)
T ss_pred             eEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecC-CcEEeeeccccccCC
Confidence            999999999999998873     49999999999999999999999999999999999999999 899999999873210


Q ss_pred             C---------------------------------C-C-----------------------cceeeccCccccccccccCC
Q 015374          272 P---------------------------------G-K-----------------------EYNVRVASRYFKGPELLVDL  294 (408)
Q Consensus       272 ~---------------------------------~-~-----------------------~~~~~~~~~~y~aPE~~~~~  294 (408)
                      .                                 . .                       .....+||..|.|||++.+ 
T Consensus       231 ~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G-  309 (459)
T KOG0610|consen  231 VSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRG-  309 (459)
T ss_pred             CCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeec-
Confidence            0                                 0 0                       0123478889999999998 


Q ss_pred             cCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCCCccccccccCCCCCCHHHHHHHHH
Q 015374          295 QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDK  374 (408)
Q Consensus       295 ~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  374 (408)
                      ..-+.++|.|+|||++|||+.|..|| .|.++.+.+.+++...-                  .......++.+++|||++
T Consensus       310 ~GHgsAVDWWtfGIflYEmLyG~TPF-KG~~~~~Tl~NIv~~~l------------------~Fp~~~~vs~~akDLIr~  370 (459)
T KOG0610|consen  310 EGHGSAVDWWTFGIFLYEMLYGTTPF-KGSNNKETLRNIVGQPL------------------KFPEEPEVSSAAKDLIRK  370 (459)
T ss_pred             CCCCchhhHHHHHHHHHHHHhCCCCc-CCCCchhhHHHHhcCCC------------------cCCCCCcchhHHHHHHHH
Confidence            67889999999999999999999997 88888888888776411                  001111478899999999


Q ss_pred             hcccCcCCCCC----HHHHhcCCCccccccchh
Q 015374          375 LLRYDHQDRLT----AREAMAHPYFAQVRAAES  403 (408)
Q Consensus       375 ~L~~dp~~Rpt----~~elL~hp~f~~~~~~~~  403 (408)
                      +|.+||++|..    |.|+-+||||+++.++-.
T Consensus       371 LLvKdP~kRlg~~rGA~eIK~HpFF~gVnWaLi  403 (459)
T KOG0610|consen  371 LLVKDPSKRLGSKRGAAEIKRHPFFEGVNWALI  403 (459)
T ss_pred             HhccChhhhhccccchHHhhcCccccCCChhhe
Confidence            99999999997    999999999999988743

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=2.4e-45  Score=350.25  Aligned_cols=251  Identities=25%  Similarity=0.415  Sum_probs=207.7

Q ss_pred             CEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc------chHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccEE
Q 015374          126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSL  199 (408)
Q Consensus       126 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l  199 (408)
                      +|++++.||+|+||.||+|++..+++.||+|+++..      ..+.+..|..++..+.+|++|+++++++.+  ....++
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~--~~~~~l   78 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQT--MDRLYF   78 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEc--CCEEEE
Confidence            588999999999999999999999999999998642      235677899999998445678889998855  467899


Q ss_pred             EEEeecCCChhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceecc-CCCc
Q 015374          200 IFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH-PGKE  275 (408)
Q Consensus       200 v~e~~~~~~l~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~-~~~~  275 (408)
                      ||||+++++|..++   ..+++..+..++.|++.||+|||++||+||||||+|||++.+ +.+||+|||++.... ....
T Consensus        79 v~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~-~~~kL~Dfg~~~~~~~~~~~  157 (324)
T cd05587          79 VMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAE-GHIKIADFGMCKENIFGGKT  157 (324)
T ss_pred             EEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCC-CCEEEeecCcceecCCCCCc
Confidence            99999999998776   358899999999999999999999999999999999999988 799999999987532 2233


Q ss_pred             ceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCCCcccc
Q 015374          276 YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSKF  355 (408)
Q Consensus       276 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  355 (408)
                      .....||..|+|||++.+ ..++.++|||||||++|+|++|+.||. +.+..+....+...                   
T Consensus       158 ~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~elltG~~pf~-~~~~~~~~~~i~~~-------------------  216 (324)
T cd05587         158 TRTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQPPFD-GEDEDELFQSIMEH-------------------  216 (324)
T ss_pred             eeeecCCccccChhhhcC-CCCCcccchhhhHHHHHHHHhCCCCCC-CCCHHHHHHHHHcC-------------------
Confidence            445678999999999987 778999999999999999999999984 44434444433221                   


Q ss_pred             ccccCCCCCCHHHHHHHHHhcccCcCCCCCH-----HHHhcCCCccccccc
Q 015374          356 INADNQHLVSPEAIDFLDKLLRYDHQDRLTA-----REAMAHPYFAQVRAA  401 (408)
Q Consensus       356 ~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~-----~elL~hp~f~~~~~~  401 (408)
                       ....+..++.++.+++.+||..||++|++.     +++++||||+.++..
T Consensus       217 -~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~hp~~~~~~~~  266 (324)
T cd05587         217 -NVSYPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREHAFFRRIDWE  266 (324)
T ss_pred             -CCCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCCcCCCCHH
Confidence             112233478999999999999999999976     899999999987653

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=3e-45  Score=343.31  Aligned_cols=266  Identities=29%  Similarity=0.527  Sum_probs=207.4

Q ss_pred             CEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecccc-----hHHHHHHHHHHHHhc--CCCCceEEeeEEEcc---CCC
Q 015374          126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK-----KKKIKREIKILQNLC--GGPNVVKLLDIVRDQ---HSK  195 (408)
Q Consensus       126 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~--~h~niv~l~~~~~~~---~~~  195 (408)
                      +|++.+.||+|+||+||+|++..+++.||+|.++...     ...+.+|+.+++.+.  +||||+++++++...   ...
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~   80 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET   80 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence            5889999999999999999999999999999986321     235667888877663  699999999998643   234


Q ss_pred             ccEEEEEeecCCChhhhc-----CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceec
Q 015374          196 TPSLIFEYVNSTDFKVLY-----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY  270 (408)
Q Consensus       196 ~~~lv~e~~~~~~l~~~~-----~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~  270 (408)
                      ..+++|||+++ ++..++     ..+++..++.++.|++.||.|||++||+||||||+|||++.+ +.+||+|||++...
T Consensus        81 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~-~~~kl~dfg~~~~~  158 (288)
T cd07863          81 KVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSG-GQVKLADFGLARIY  158 (288)
T ss_pred             eEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCC-CCEEECccCccccc
Confidence            57899999986 555554     238899999999999999999999999999999999999988 79999999999876


Q ss_pred             cCCCcceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCC--
Q 015374          271 HPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHS--  348 (408)
Q Consensus       271 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~--  348 (408)
                      ..........++..|+|||++.+ ..++.++|||||||++|+|++|..|| .+....+.+.++....+..........  
T Consensus       159 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~l~~g~~~f-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (288)
T cd07863         159 SCQMALTPVVVTLWYRAPEVLLQ-STYATPVDMWSVGCIFAEMFRRKPLF-CGNSEADQLGKIFDLIGLPPEDDWPRDVT  236 (288)
T ss_pred             cCcccCCCccccccccCchHhhC-CCCCCcchhhhHHHHHHHHHhCCcCc-CCCCHHHHHHHHHHHhCCCChhhCccccc
Confidence            54444445678889999999987 67999999999999999999998776 555566666666655442221111000  


Q ss_pred             --CCCcccc---ccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCc
Q 015374          349 --RKPWSKF---INADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF  395 (408)
Q Consensus       349 --~~~~~~~---~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f  395 (408)
                        ...+...   ........+++++.+++.+||+.||++|||+.|+++||||
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f  288 (288)
T cd07863         237 LPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF  288 (288)
T ss_pred             ccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence              0000000   0011123467889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=1.5e-45  Score=359.46  Aligned_cols=255  Identities=27%  Similarity=0.454  Sum_probs=206.5

Q ss_pred             CCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc------chHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccE
Q 015374          125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS  198 (408)
Q Consensus       125 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  198 (408)
                      .+|+++++||+|+||+||+|++..+++.+|+|++...      ....+.+|+.+++++ +|+||+++++.|.+  ....+
T Consensus         1 ~~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~-~h~~iv~~~~~~~~--~~~~~   77 (382)
T cd05625           1 SMFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEA-DNEWVVRLYYSFQD--KDNLY   77 (382)
T ss_pred             CCcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhC-CCCcCCeEEEEEEe--CCEEE
Confidence            3689999999999999999999999999999998643      234678899999999 99999999999965  46789


Q ss_pred             EEEEeecCCChhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCC--
Q 015374          199 LIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG--  273 (408)
Q Consensus       199 lv~e~~~~~~l~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~--  273 (408)
                      +||||+++|+|..++   ..+++..++.++.|++.||+|||++||+||||||+|||++.+ +.+||+|||++......  
T Consensus        78 lv~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~-g~~kL~DFGla~~~~~~~~  156 (382)
T cd05625          78 FVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRD-GHIKLTDFGLCTGFRWTHD  156 (382)
T ss_pred             EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCC-CCEEEeECCCCcccccccc
Confidence            999999999998877   347888999999999999999999999999999999999988 89999999997532100  


Q ss_pred             ----------------------------------------------CcceeeccCccccccccccCCcCCCccccHHHHH
Q 015374          274 ----------------------------------------------KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLG  307 (408)
Q Consensus       274 ----------------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG  307 (408)
                                                                    ......+||..|+|||++.+ ..++.++||||||
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~~DiwSlG  235 (382)
T cd05625         157 SKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLR-TGYTQLCDWWSVG  235 (382)
T ss_pred             ccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcC-CCCCCeeeEEech
Confidence                                                          00112468999999999987 7799999999999


Q ss_pred             HHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCC--
Q 015374          308 CMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLT--  385 (408)
Q Consensus       308 vil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt--  385 (408)
                      |++|||++|+.||. +.+..+....+...                ...........+++++.++|.+|+ .||.+|++  
T Consensus       236 vil~elltG~~Pf~-~~~~~~~~~~i~~~----------------~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~  297 (382)
T cd05625         236 VILYEMLVGQPPFL-AQTPLETQMKVINW----------------QTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKN  297 (382)
T ss_pred             HHHHHHHhCCCCCC-CCCHHHHHHHHHcc----------------CCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCC
Confidence            99999999999984 33333333333221                000111112347899999999987 59999997  


Q ss_pred             -HHHHhcCCCccccccch
Q 015374          386 -AREAMAHPYFAQVRAAE  402 (408)
Q Consensus       386 -~~elL~hp~f~~~~~~~  402 (408)
                       ++|+++||||+.+....
T Consensus       298 ~~~ei~~hp~f~~~~~~~  315 (382)
T cd05625         298 GADEIKAHPFFKTIDFSS  315 (382)
T ss_pred             CHHHHhcCCCcCCcChHH
Confidence             99999999999876543

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=1.5e-45  Score=351.03  Aligned_cols=247  Identities=24%  Similarity=0.416  Sum_probs=204.8

Q ss_pred             eeeeeeCceEEEEEEEcCCCcEEEEEEeccc------chHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccEEEEEee
Q 015374          131 RKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYV  204 (408)
Q Consensus       131 ~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~  204 (408)
                      +.||+|+||+||+|++..+++.||+|+++..      ....+..|..++..+.+||||+++++++.+  ....++||||+
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~--~~~~~iv~Ey~   78 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQT--PDRLFFVMEFV   78 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEc--CCEEEEEEcCC
Confidence            3699999999999999999999999998642      234567888888877689999999999955  46789999999


Q ss_pred             cCCChhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccC-CCcceeec
Q 015374          205 NSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP-GKEYNVRV  280 (408)
Q Consensus       205 ~~~~l~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~-~~~~~~~~  280 (408)
                      ++++|..++   ..+++..+..++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+++.... ........
T Consensus        79 ~~g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~-~~~kL~DfG~~~~~~~~~~~~~~~~  157 (320)
T cd05590          79 NGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHE-GHCKLADFGMCKEGIFNGKTTSTFC  157 (320)
T ss_pred             CCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCC-CcEEEeeCCCCeecCcCCCcccccc
Confidence            999998776   458999999999999999999999999999999999999988 7999999999875432 22334457


Q ss_pred             cCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCCCccccccccC
Q 015374          281 ASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSKFINADN  360 (408)
Q Consensus       281 ~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  360 (408)
                      ||..|+|||++.+ ..++.++|||||||++|+|++|+.||. +.+..+....+...                    ....
T Consensus       158 gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~Pf~-~~~~~~~~~~i~~~--------------------~~~~  215 (320)
T cd05590         158 GTPDYIAPEILQE-MLYGPSVDWWAMGVLLYEMLCGHAPFE-AENEDDLFEAILND--------------------EVVY  215 (320)
T ss_pred             cCccccCHHHHcC-CCCCCccchhhhHHHHHHHhhCCCCCC-CCCHHHHHHHHhcC--------------------CCCC
Confidence            8999999999987 778999999999999999999999983 44433443333221                    0112


Q ss_pred             CCCCCHHHHHHHHHhcccCcCCCCCH------HHHhcCCCccccccch
Q 015374          361 QHLVSPEAIDFLDKLLRYDHQDRLTA------REAMAHPYFAQVRAAE  402 (408)
Q Consensus       361 ~~~~~~~~~~li~~~L~~dp~~Rpt~------~elL~hp~f~~~~~~~  402 (408)
                      +..++.++.+++++||+.||++|+++      +++++||||+.+....
T Consensus       216 ~~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h~~f~~~~~~~  263 (320)
T cd05590         216 PTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRHPFFKELDWEK  263 (320)
T ss_pred             CCCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcCCCcCCCCHHH
Confidence            23478999999999999999999998      9999999999876544

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-47  Score=354.65  Aligned_cols=251  Identities=25%  Similarity=0.423  Sum_probs=212.8

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecc----cchHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccEE
Q 015374          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP----VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSL  199 (408)
Q Consensus       124 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~----~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l  199 (408)
                      ...|+..+.||+|+||.||+|.+..+++.||+|++.-    ...+.+.+|+.+|..+ +++||.++|+.+..  +..+++
T Consensus        12 ~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~-~~~~it~yygsyl~--g~~Lwi   88 (467)
T KOG0201|consen   12 ELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQC-DSPNITEYYGSYLK--GTKLWI   88 (467)
T ss_pred             ccccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhc-CcchHHhhhhheee--cccHHH
Confidence            4567777899999999999999999999999999963    3346788999999998 99999999999955  567889


Q ss_pred             EEEeecCCChhhhcCC---CChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCCC-c
Q 015374          200 IFEYVNSTDFKVLYPT---LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK-E  275 (408)
Q Consensus       200 v~e~~~~~~l~~~~~~---l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~~-~  275 (408)
                      +||||.+|++...++.   +.+..+..++++++.||.|||+++.+|||||+.|||+..+ |.+|++|||.+....... .
T Consensus        89 iMey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~-g~vkl~DfgVa~ql~~~~~r  167 (467)
T KOG0201|consen   89 IMEYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSES-GDVKLADFGVAGQLTNTVKR  167 (467)
T ss_pred             HHHHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEecc-CcEEEEecceeeeeechhhc
Confidence            9999999999888843   4888888899999999999999999999999999999999 899999999987665433 2


Q ss_pred             ceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCCCcccc
Q 015374          276 YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSKF  355 (408)
Q Consensus       276 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  355 (408)
                      ..+.+||++|||||++.. ..|+.++||||||++.+||.+|..|+..-+. ...+..|                   ++.
T Consensus       168 r~tfvGTPfwMAPEVI~~-~~Y~~KADIWSLGITaiEla~GePP~s~~hP-mrvlflI-------------------pk~  226 (467)
T KOG0201|consen  168 RKTFVGTPFWMAPEVIKQ-SGYDTKADIWSLGITAIELAKGEPPHSKLHP-MRVLFLI-------------------PKS  226 (467)
T ss_pred             cccccccccccchhhhcc-ccccchhhhhhhhHHHHHHhcCCCCCcccCc-ceEEEec-------------------cCC
Confidence            367899999999999996 8999999999999999999999999833222 1111111                   112


Q ss_pred             ccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccccc
Q 015374          356 INADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVR  399 (408)
Q Consensus       356 ~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~~~  399 (408)
                      .++.....+++.+++||..||..||+.||||.+||+|+|.+...
T Consensus       227 ~PP~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh~FIk~a~  270 (467)
T KOG0201|consen  227 APPRLDGDFSPPFKEFVEACLDKNPEFRPSAKELLKHKFIKRAK  270 (467)
T ss_pred             CCCccccccCHHHHHHHHHHhhcCcccCcCHHHHhhhHHHHhcC
Confidence            23344446899999999999999999999999999999998854

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=2.9e-45  Score=347.24  Aligned_cols=274  Identities=29%  Similarity=0.576  Sum_probs=213.1

Q ss_pred             cCCCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecccc----hHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCc
Q 015374          121 WGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT  196 (408)
Q Consensus       121 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  196 (408)
                      ++..++|++.++||+|+||+||+|++..+++.||+|.++...    ...+.+|+.+++++ +|+||+++++++..  ...
T Consensus         2 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~--~~~   78 (309)
T cd07872           2 FGKMETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDL-KHANIVTLHDIVHT--DKS   78 (309)
T ss_pred             CCCCCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhC-CCCCcceEEEEEee--CCe
Confidence            455688999999999999999999999999999999986322    24577899999999 99999999999965  467


Q ss_pred             cEEEEEeecCCChhhhc----CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccC
Q 015374          197 PSLIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP  272 (408)
Q Consensus       197 ~~lv~e~~~~~~l~~~~----~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~  272 (408)
                      .++||||+++ ++..++    ..+++..+..++.|++.||.|||++||+||||||+|||++.+ +.+||+|||++.....
T Consensus        79 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~-~~~kl~Dfg~~~~~~~  156 (309)
T cd07872          79 LTLVFEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINER-GELKLADFGLARAKSV  156 (309)
T ss_pred             EEEEEeCCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCC-CCEEECccccceecCC
Confidence            8899999987 444443    237888899999999999999999999999999999999988 7999999999876432


Q ss_pred             CC-cceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCC--CCC
Q 015374          273 GK-EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSR--HSR  349 (408)
Q Consensus       273 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~  349 (408)
                      .. ......++..|+|||.+.+...++.++|||||||++|+|++|+.|| .+.+..+.+..+....+........  ...
T Consensus       157 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (309)
T cd07872         157 PTKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLF-PGSTVEDELHLIFRLLGTPTEETWPGISSN  235 (309)
T ss_pred             CccccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCC-CCCChHHHHHHHHHHhCCCCHHHHhhhcch
Confidence            22 2234567889999999877567899999999999999999999887 4555555555555544322111000  000


Q ss_pred             CCc-----ccc---ccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccccc
Q 015374          350 KPW-----SKF---INADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRA  400 (408)
Q Consensus       350 ~~~-----~~~---~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~~~~  400 (408)
                      ..+     ...   ........+++++.+||.+||+.||++|||++|+++||||+....
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~  294 (309)
T cd07872         236 DEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSLGT  294 (309)
T ss_pred             hhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhccc
Confidence            000     000   001112347889999999999999999999999999999997653

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=1.7e-45  Score=351.72  Aligned_cols=245  Identities=26%  Similarity=0.432  Sum_probs=202.9

Q ss_pred             eeeeeeCceEEEEEEEcCCCcEEEEEEeccc------chHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccEEEEEee
Q 015374          131 RKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYV  204 (408)
Q Consensus       131 ~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~  204 (408)
                      +.||+|+||.||++++..+++.||+|+++..      ....+.+|+.+++.+ +||||+++++++.+  ....++||||+
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~--~~~~~lv~Ey~   77 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNT-RHPFLTSLKYSFQT--KDRLCFVMEYV   77 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhC-CCCCCcceEEEEEc--CCEEEEEEeCC
Confidence            3699999999999999999999999998642      235677899999999 99999999999954  46789999999


Q ss_pred             cCCChhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCC-Ccceeec
Q 015374          205 NSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG-KEYNVRV  280 (408)
Q Consensus       205 ~~~~l~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~-~~~~~~~  280 (408)
                      ++++|..++   ..+++..+..++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++..... .......
T Consensus        78 ~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~-~~~kL~DfG~~~~~~~~~~~~~~~~  156 (328)
T cd05593          78 NGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKD-GHIKITDFGLCKEGITDAATMKTFC  156 (328)
T ss_pred             CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCC-CcEEEecCcCCccCCCccccccccc
Confidence            999998776   358899999999999999999999999999999999999988 79999999998754322 2233457


Q ss_pred             cCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCCCccccccccC
Q 015374          281 ASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSKFINADN  360 (408)
Q Consensus       281 ~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  360 (408)
                      ||..|+|||++.+ ..++.++|||||||++|+|++|+.||.. .+..+....+..                    .....
T Consensus       157 gt~~y~aPE~~~~-~~~~~~~DiwslGvil~elltG~~Pf~~-~~~~~~~~~~~~--------------------~~~~~  214 (328)
T cd05593         157 GTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYN-QDHEKLFELILM--------------------EDIKF  214 (328)
T ss_pred             CCcCccChhhhcC-CCCCccCCccccchHHHHHhhCCCCCCC-CCHHHHHHHhcc--------------------CCccC
Confidence            8999999999987 6789999999999999999999999843 222222222111                    01122


Q ss_pred             CCCCCHHHHHHHHHhcccCcCCCC-----CHHHHhcCCCccccccc
Q 015374          361 QHLVSPEAIDFLDKLLRYDHQDRL-----TAREAMAHPYFAQVRAA  401 (408)
Q Consensus       361 ~~~~~~~~~~li~~~L~~dp~~Rp-----t~~elL~hp~f~~~~~~  401 (408)
                      +..+++++.+||++||+.||++|+     ++.|+++||||..+...
T Consensus       215 p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~~~~  260 (328)
T cd05593         215 PRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHSFFTGVNWQ  260 (328)
T ss_pred             CCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcCCCcCCCCHH
Confidence            344789999999999999999997     89999999999886543

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-45  Score=349.82  Aligned_cols=242  Identities=24%  Similarity=0.420  Sum_probs=201.4

Q ss_pred             eeeeCceEEEEEEEcCCCcEEEEEEeccc------chHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccEEEEEeecC
Q 015374          133 VGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNS  206 (408)
Q Consensus       133 lG~G~fg~Vy~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~~  206 (408)
                      ||+|+||+||+|++..+++.||+|+++..      ....+.+|+.++.++ +||||++++++|.+  ....++||||+++
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~--~~~~~lv~e~~~~   77 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQV-NCPFIVPLKFSFQS--PEKLYLVLAFING   77 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhC-CCCcEeceeeEEec--CCeEEEEEcCCCC
Confidence            79999999999999999999999998632      234577899999999 99999999999954  4678999999999


Q ss_pred             CChhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCC-CcceeeccC
Q 015374          207 TDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG-KEYNVRVAS  282 (408)
Q Consensus       207 ~~l~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~-~~~~~~~~~  282 (408)
                      ++|..++   ..+++..+..++.|++.||.|||++||+||||||+|||++.+ +.++|+|||+++..... .......||
T Consensus        78 g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~gt  156 (312)
T cd05585          78 GELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQ-GHIALCDFGLCKLNMKDDDKTNTFCGT  156 (312)
T ss_pred             CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCC-CcEEEEECcccccCccCCCccccccCC
Confidence            9998876   358899999999999999999999999999999999999988 79999999998754322 223445789


Q ss_pred             ccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCCCccccccccCCC
Q 015374          283 RYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSKFINADNQH  362 (408)
Q Consensus       283 ~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  362 (408)
                      ..|+|||++.+ ..++.++|||||||++|+|++|..||.. .+..+....+...                    ....+.
T Consensus       157 ~~y~aPE~~~~-~~~~~~~DvwslGvil~el~tg~~pf~~-~~~~~~~~~~~~~--------------------~~~~~~  214 (312)
T cd05585         157 PEYLAPELLLG-HGYTKAVDWWTLGVLLYEMLTGLPPFYD-ENVNEMYRKILQE--------------------PLRFPD  214 (312)
T ss_pred             cccCCHHHHcC-CCCCCccceechhHHHHHHHhCCCCcCC-CCHHHHHHHHHcC--------------------CCCCCC
Confidence            99999999987 7899999999999999999999999843 3333333322211                    112233


Q ss_pred             CCCHHHHHHHHHhcccCcCCCC---CHHHHhcCCCcccccc
Q 015374          363 LVSPEAIDFLDKLLRYDHQDRL---TAREAMAHPYFAQVRA  400 (408)
Q Consensus       363 ~~~~~~~~li~~~L~~dp~~Rp---t~~elL~hp~f~~~~~  400 (408)
                      .+++++.+|+.+||+.||++||   ++.|+++||||+....
T Consensus       215 ~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~hp~~~~~~~  255 (312)
T cd05585         215 GFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNHPFFSQLSW  255 (312)
T ss_pred             cCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcCCCcCCCCH
Confidence            4789999999999999999997   5899999999998643

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.8e-45  Score=341.25  Aligned_cols=255  Identities=25%  Similarity=0.381  Sum_probs=210.4

Q ss_pred             CEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecccc------hHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccEE
Q 015374          126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK------KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSL  199 (408)
Q Consensus       126 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~------~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l  199 (408)
                      .|++.+.||+|+||+||++.+..+++.||+|.+....      ...+.+|+.+++++ +|+||+++++++..  ....++
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~--~~~~~l   77 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKV-NSRFVVSLAYAYET--KDALCL   77 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhc-CCCCEeeeeeeecC--CCeEEE
Confidence            4888999999999999999999999999999986422      23467899999999 99999999999955  467899


Q ss_pred             EEEeecCCChhhhc-----CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCCC
Q 015374          200 IFEYVNSTDFKVLY-----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK  274 (408)
Q Consensus       200 v~e~~~~~~l~~~~-----~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~~  274 (408)
                      ||||+++++|..++     ..+++..+..++.|++.||.|||+.+|+|+||||+||+++++ +.++|+|||++.......
T Consensus        78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~-~~~~l~Dfg~~~~~~~~~  156 (285)
T cd05605          78 VLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDY-GHIRISDLGLAVEIPEGE  156 (285)
T ss_pred             EEeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCC-CCEEEeeCCCceecCCCC
Confidence            99999999998765     248899999999999999999999999999999999999988 789999999998765554


Q ss_pred             cceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCCCccc
Q 015374          275 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSK  354 (408)
Q Consensus       275 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  354 (408)
                      ......|+..|+|||++.+ ..++.++||||+||++|||++|..||.. .+.......+......               
T Consensus       157 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Diws~G~~l~el~~g~~pf~~-~~~~~~~~~~~~~~~~---------------  219 (285)
T cd05605         157 TIRGRVGTVGYMAPEVVKN-ERYTFSPDWWGLGCLIYEMIEGKSPFRQ-RKEKVKREEVERRVKE---------------  219 (285)
T ss_pred             ccccccCCCCccCcHHhcC-CCCCccccchhHHHHHHHHHHCCCCCCC-CchhhHHHHHHHHhhh---------------
Confidence            4455678999999999987 7789999999999999999999999853 3322222222211100               


Q ss_pred             cccccCCCCCCHHHHHHHHHhcccCcCCCC-----CHHHHhcCCCccccccch
Q 015374          355 FINADNQHLVSPEAIDFLDKLLRYDHQDRL-----TAREAMAHPYFAQVRAAE  402 (408)
Q Consensus       355 ~~~~~~~~~~~~~~~~li~~~L~~dp~~Rp-----t~~elL~hp~f~~~~~~~  402 (408)
                       .....+..++..+.+|+.+||..||++||     +++++++||||.......
T Consensus       220 -~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~~~  271 (285)
T cd05605         220 -DQEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTANFKR  271 (285)
T ss_pred             -cccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcCcCccCCCHHH
Confidence             01112234788999999999999999999     999999999999876554

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=4.1e-45  Score=348.46  Aligned_cols=252  Identities=25%  Similarity=0.396  Sum_probs=208.6

Q ss_pred             CEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecccc------hHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccEE
Q 015374          126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK------KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSL  199 (408)
Q Consensus       126 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~------~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l  199 (408)
                      +|++.+.||+|+||+||+|++..++..||+|+++...      ...+..|..++..+.+|++|+++++++.+  ....++
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~--~~~~~l   78 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQT--MDRLYF   78 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEec--CCEEEE
Confidence            5888999999999999999999999999999986422      23466788888887678999999999965  467899


Q ss_pred             EEEeecCCChhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccC-CCc
Q 015374          200 IFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP-GKE  275 (408)
Q Consensus       200 v~e~~~~~~l~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~-~~~  275 (408)
                      ||||+++++|...+   ..+++..+..++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+++.... ...
T Consensus        79 v~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~-~~~kL~DfG~~~~~~~~~~~  157 (323)
T cd05616          79 VMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSE-GHIKIADFGMCKENMWDGVT  157 (323)
T ss_pred             EEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCC-CcEEEccCCCceecCCCCCc
Confidence            99999999998776   458899999999999999999999999999999999999998 7999999999975432 223


Q ss_pred             ceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCCCcccc
Q 015374          276 YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSKF  355 (408)
Q Consensus       276 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  355 (408)
                      .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||. +.+..+....+...                   
T Consensus       158 ~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~elltg~~Pf~-~~~~~~~~~~i~~~-------------------  216 (323)
T cd05616         158 TKTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQAPFE-GEDEDELFQSIMEH-------------------  216 (323)
T ss_pred             cccCCCChhhcCHHHhcC-CCCCCccchhchhHHHHHHHhCCCCCC-CCCHHHHHHHHHhC-------------------
Confidence            344578999999999987 789999999999999999999999984 33334444433321                   


Q ss_pred             ccccCCCCCCHHHHHHHHHhcccCcCCCCC-----HHHHhcCCCccccccch
Q 015374          356 INADNQHLVSPEAIDFLDKLLRYDHQDRLT-----AREAMAHPYFAQVRAAE  402 (408)
Q Consensus       356 ~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt-----~~elL~hp~f~~~~~~~  402 (408)
                       ....+..++.++.+++.+||+.||++|++     ..++++||||+.+++..
T Consensus       217 -~~~~p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~~~~~~~~~  267 (323)
T cd05616         217 -NVAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEK  267 (323)
T ss_pred             -CCCCCCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcCCCcCCCCHHH
Confidence             11123347899999999999999999997     48999999999877544

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=2e-45  Score=357.84  Aligned_cols=255  Identities=27%  Similarity=0.449  Sum_probs=206.2

Q ss_pred             CCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc------chHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccE
Q 015374          125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS  198 (408)
Q Consensus       125 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  198 (408)
                      ++|++++.||+|+||+||+|++..+++.||+|++...      ....+.+|+.+++++ +|+||+++++.|.+  +..++
T Consensus         1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~h~~iv~~~~~~~~--~~~~~   77 (376)
T cd05598           1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEA-DNEWVVKLYYSFQD--KDNLY   77 (376)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhC-CCCCcceEEEEEEc--CCEEE
Confidence            4799999999999999999999999999999998642      235678899999999 99999999999965  46889


Q ss_pred             EEEEeecCCChhhhcC---CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCC--
Q 015374          199 LIFEYVNSTDFKVLYP---TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG--  273 (408)
Q Consensus       199 lv~e~~~~~~l~~~~~---~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~--  273 (408)
                      +||||+++++|..++.   .+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||++..+...  
T Consensus        78 lv~E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~-~~ikL~DFG~a~~~~~~~~  156 (376)
T cd05598          78 FVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRD-GHIKLTDFGLCTGFRWTHD  156 (376)
T ss_pred             EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCC-CCEEEEeCCCCcccccccc
Confidence            9999999999998873   47888889999999999999999999999999999999988 79999999997532100  


Q ss_pred             ------------------------------------------CcceeeccCccccccccccCCcCCCccccHHHHHHHHH
Q 015374          274 ------------------------------------------KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFA  311 (408)
Q Consensus       274 ------------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~  311 (408)
                                                                ......+||..|+|||++.+ ..++.++|||||||++|
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvily  235 (376)
T cd05598         157 SKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLR-TGYTQLCDWWSVGVILY  235 (376)
T ss_pred             ccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcC-CCCCcceeeeeccceee
Confidence                                                      00112468999999999987 77899999999999999


Q ss_pred             HHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCCCccccccccCCCCCCHHHHHHHHHhcccCcCCCC---CHHH
Q 015374          312 GMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRL---TARE  388 (408)
Q Consensus       312 ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rp---t~~e  388 (408)
                      ||++|+.||.. .+..+....+...                ...........+++++.++|.+|+ .+|.+|+   |+.|
T Consensus       236 ell~G~~Pf~~-~~~~~~~~~i~~~----------------~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~e  297 (376)
T cd05598         236 EMLVGQPPFLA-DTPAETQLKVINW----------------ETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADE  297 (376)
T ss_pred             ehhhCCCCCCC-CCHHHHHHHHhcc----------------CccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHH
Confidence            99999999843 3333333322211                000111112347899999999987 5999999   9999


Q ss_pred             HhcCCCccccccch
Q 015374          389 AMAHPYFAQVRAAE  402 (408)
Q Consensus       389 lL~hp~f~~~~~~~  402 (408)
                      +++||||+.++...
T Consensus       298 ll~h~~~~~~~~~~  311 (376)
T cd05598         298 IKAHPFFKGIDFAS  311 (376)
T ss_pred             HhCCCCcCCCCHHH
Confidence            99999999875543

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=1.7e-45  Score=352.18  Aligned_cols=256  Identities=27%  Similarity=0.439  Sum_probs=210.2

Q ss_pred             CCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc------chHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccE
Q 015374          125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS  198 (408)
Q Consensus       125 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  198 (408)
                      ++|++.+.||+|+||+||+|++..+++.||+|+++..      ..+.+.+|+.+++.+ +|+||+++++++.+  ....+
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~-~~~~i~~~~~~~~~--~~~~~   77 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSIS-NSPWIPQLQYAFQD--KDNLY   77 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhC-CCCCCcceeeEEec--CCeEE
Confidence            4789999999999999999999999999999998743      234578899999998 99999999999965  46789


Q ss_pred             EEEEeecCCChhhhc----CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCCC
Q 015374          199 LIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK  274 (408)
Q Consensus       199 lv~e~~~~~~l~~~~----~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~~  274 (408)
                      +||||+++++|..++    ..+++..++.++.|++.||.|||+.+|+||||||+|||++.+ +.+||+|||++.......
T Consensus        78 lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~-~~~kL~Dfg~a~~~~~~~  156 (330)
T cd05601          78 LVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRT-GHIKLADFGSAARLTANK  156 (330)
T ss_pred             EEECCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCC-CCEEeccCCCCeECCCCC
Confidence            999999999998887    358899999999999999999999999999999999999988 799999999998765433


Q ss_pred             cc--eeeccCccccccccccC-----CcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCC
Q 015374          275 EY--NVRVASRYFKGPELLVD-----LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRH  347 (408)
Q Consensus       275 ~~--~~~~~~~~y~aPE~~~~-----~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (408)
                      ..  ....||..|+|||++..     ...++.++|||||||++|+|++|..||.. .+....+..+.....         
T Consensus       157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~-~~~~~~~~~i~~~~~---------  226 (330)
T cd05601         157 MVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHE-GTSAKTYNNIMNFQR---------  226 (330)
T ss_pred             ceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCC-CCHHHHHHHHHcCCC---------
Confidence            22  23478999999999863     25678999999999999999999999843 333333333332100         


Q ss_pred             CCCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccccccch
Q 015374          348 SRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAE  402 (408)
Q Consensus       348 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~~~~~~  402 (408)
                             .........+++++.+|+++||+ ||.+|||++++++||||+.+....
T Consensus       227 -------~~~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h~~~~~~~~~~  273 (330)
T cd05601         227 -------FLKFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCHPFFSKIDWNN  273 (330)
T ss_pred             -------ccCCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCCCCcCCCCHHH
Confidence                   00111122378999999999998 999999999999999999876544

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=4.3e-45  Score=348.43  Aligned_cols=249  Identities=24%  Similarity=0.432  Sum_probs=205.3

Q ss_pred             EEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecccc------hHHHHHHHHHHH---HhcCCCCceEEeeEEEccCCCcc
Q 015374          127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK------KKKIKREIKILQ---NLCGGPNVVKLLDIVRDQHSKTP  197 (408)
Q Consensus       127 y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~------~~~~~~E~~~l~---~l~~h~niv~l~~~~~~~~~~~~  197 (408)
                      |++.+.||+|+||+||+|.+..+++.||||+++...      .+.+.+|+.++.   ++ +||||+++++++.+  ....
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l-~hp~i~~~~~~~~~--~~~~   77 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSE-RHPFLVNLFACFQT--EDHV   77 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcccc-CCCChhceeeEEEc--CCEE
Confidence            678899999999999999999999999999996432      245666766654   45 79999999999965  4678


Q ss_pred             EEEEEeecCCChhhhcC--CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCC-C
Q 015374          198 SLIFEYVNSTDFKVLYP--TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG-K  274 (408)
Q Consensus       198 ~lv~e~~~~~~l~~~~~--~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~-~  274 (408)
                      ++||||+++++|...+.  .+++..+..++.|++.||.|||++||+||||||+|||++.+ +.+||+|||++...... .
T Consensus        78 ~lv~E~~~~~~L~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~-~~~kL~Dfg~~~~~~~~~~  156 (324)
T cd05589          78 CFVMEYAAGGDLMMHIHTDVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTE-GFVKIADFGLCKEGMGFGD  156 (324)
T ss_pred             EEEEcCCCCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCC-CcEEeCcccCCccCCCCCC
Confidence            99999999999987763  58999999999999999999999999999999999999988 79999999998754322 2


Q ss_pred             cceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCCCccc
Q 015374          275 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSK  354 (408)
Q Consensus       275 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  354 (408)
                      ......|+..|+|||.+.+ ..++.++|||||||++|+|++|+.||. +.+..+....+...                  
T Consensus       157 ~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~G~~pf~-~~~~~~~~~~i~~~------------------  216 (324)
T cd05589         157 RTSTFCGTPEFLAPEVLTE-TSYTRAVDWWGLGVLIYEMLVGESPFP-GDDEEEVFDSIVND------------------  216 (324)
T ss_pred             cccccccCccccCHhHhcC-CCCCcccchhhHHHHHHHHHhCCCCCC-CCCHHHHHHHHHhC------------------
Confidence            2344678999999999987 778999999999999999999999983 33434444333221                  


Q ss_pred             cccccCCCCCCHHHHHHHHHhcccCcCCCC-----CHHHHhcCCCccccccc
Q 015374          355 FINADNQHLVSPEAIDFLDKLLRYDHQDRL-----TAREAMAHPYFAQVRAA  401 (408)
Q Consensus       355 ~~~~~~~~~~~~~~~~li~~~L~~dp~~Rp-----t~~elL~hp~f~~~~~~  401 (408)
                        ....+..+++++.+++.+||+.||++||     ++.++++||||+.+...
T Consensus       217 --~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~~~f~~~~~~  266 (324)
T cd05589         217 --EVRYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQPFFRDINWD  266 (324)
T ss_pred             --CCCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhCCCcCCCCHH
Confidence              0112234789999999999999999999     79999999999987543

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=3.9e-45  Score=349.45  Aligned_cols=248  Identities=25%  Similarity=0.450  Sum_probs=202.8

Q ss_pred             eeeeeeCceEEEEEEEcCCCcEEEEEEeccc------chHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccEEEEEee
Q 015374          131 RKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYV  204 (408)
Q Consensus       131 ~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~  204 (408)
                      +.||+|+||+||+|++..+++.||+|+++..      ....+.+|..++..+.+||||++++++|.+  ....++||||+
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~--~~~~~lv~e~~   78 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQT--ESRLFFVIEFV   78 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEc--CCEEEEEEeCC
Confidence            3699999999999999999999999999742      234577899999998789999999999965  46789999999


Q ss_pred             cCCChhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceecc-CCCcceeec
Q 015374          205 NSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH-PGKEYNVRV  280 (408)
Q Consensus       205 ~~~~l~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~-~~~~~~~~~  280 (408)
                      ++++|..++   ..+++..+..++.|++.||.|||++||+||||||+|||++.+ +.+||+|||+++... .........
T Consensus        79 ~~g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~-~~~kL~Dfg~~~~~~~~~~~~~~~~  157 (329)
T cd05588          79 SGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAE-GHIKLTDYGMCKEGIRPGDTTSTFC  157 (329)
T ss_pred             CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCC-CCEEECcCccccccccCCCcccccc
Confidence            999998765   468999999999999999999999999999999999999988 799999999987532 233344567


Q ss_pred             cCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCC-------CCHHHHHHHHhhhchhhhhcCCCCCCCcc
Q 015374          281 ASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGH-------DNHDQLVKIAKDCCLIIWCNSRHSRKPWS  353 (408)
Q Consensus       281 ~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  353 (408)
                      ||..|+|||++.+ ..++.++|+|||||++|+|++|+.||....       ...+.+...+..                 
T Consensus       158 gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~-----------------  219 (329)
T cd05588         158 GTPNYIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILE-----------------  219 (329)
T ss_pred             CCccccCHHHHcC-CCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHc-----------------
Confidence            8999999999987 788999999999999999999999984211       111111111110                 


Q ss_pred             ccccccCCCCCCHHHHHHHHHhcccCcCCCCC------HHHHhcCCCccccccc
Q 015374          354 KFINADNQHLVSPEAIDFLDKLLRYDHQDRLT------AREAMAHPYFAQVRAA  401 (408)
Q Consensus       354 ~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt------~~elL~hp~f~~~~~~  401 (408)
                        .....+..++.++.+++.+||+.||.+|+|      ++++++||||..+...
T Consensus       220 --~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~~~~~  271 (329)
T cd05588         220 --KQIRIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRNIDWD  271 (329)
T ss_pred             --CCCCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcCCCCCCCCHH
Confidence              011123347899999999999999999987      7899999999886553

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=8.9e-45  Score=347.27  Aligned_cols=270  Identities=20%  Similarity=0.320  Sum_probs=210.2

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc----chHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccE
Q 015374          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS  198 (408)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  198 (408)
                      ..++|++.+.||+|+||.||++++..++..+|+|+++..    ....+.+|+++++++ +||||+++++++.+  ....+
T Consensus         3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~--~~~~~   79 (331)
T cd06649           3 KDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHEC-NSPYIVGFYGAFYS--DGEIS   79 (331)
T ss_pred             CcccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHC-CCCCCCeEEEEEEE--CCEEE
Confidence            468899999999999999999999999999999998643    235688999999999 99999999999965  45788


Q ss_pred             EEEEeecCCChhhhc---CCCChHHHHHHHHHHHHHHHHHHHC-CcEEecCCCCcEEEeCCCCcEEEEecccceeccCCC
Q 015374          199 LIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQ-GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK  274 (408)
Q Consensus       199 lv~e~~~~~~l~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~-~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~~  274 (408)
                      +||||+++++|..++   ..+++..+..++.|++.||.|||+. +|+||||||+|||++.+ +.++|+|||++...... 
T Consensus        80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~-~~~kl~Dfg~~~~~~~~-  157 (331)
T cd06649          80 ICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSR-GEIKLCDFGVSGQLIDS-  157 (331)
T ss_pred             EEeecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCC-CcEEEccCccccccccc-
Confidence            999999999999887   3488899999999999999999986 69999999999999988 78999999998765432 


Q ss_pred             cceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhh------hhcCC--
Q 015374          275 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLII------WCNSR--  346 (408)
Q Consensus       275 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~------~~~~~--  346 (408)
                      ......++..|+|||++.+ ..++.++|||||||++|||++|+.||... + ...+..+........      .....  
T Consensus       158 ~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tg~~p~~~~-~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (331)
T cd06649         158 MANSFVGTRSYMSPERLQG-THYSVQSDIWSMGLSLVELAIGRYPIPPP-D-AKELEAIFGRPVVDGEEGEPHSISPRPR  234 (331)
T ss_pred             ccccCCCCcCcCCHhHhcC-CCCCchHhHHHHHHHHHHHHhCCCCCCCC-C-HHHHHHHhcccccccccCCccccCcccc
Confidence            2344578999999999987 67999999999999999999999998432 2 222222221100000      00000  


Q ss_pred             C----------CCCCcc-----------ccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccccc
Q 015374          347 H----------SRKPWS-----------KFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRA  400 (408)
Q Consensus       347 ~----------~~~~~~-----------~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~~~~  400 (408)
                      .          ......           ...+......+++++++||.+||++||++|||++|+++||||+....
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~~  309 (331)
T cd06649         235 PPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKRSEV  309 (331)
T ss_pred             cccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhhccc
Confidence            0          000000           00000111236789999999999999999999999999999986654

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=6.7e-45  Score=348.27  Aligned_cols=253  Identities=25%  Similarity=0.452  Sum_probs=205.8

Q ss_pred             CEEEEeeeeeeCceEEEEEEEc---CCCcEEEEEEeccc-------chHHHHHHHHHHHHhcCCCCceEEeeEEEccCCC
Q 015374          126 DYEVVRKVGRGKYSEVFEGINV---NTNERCIIKILKPV-------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSK  195 (408)
Q Consensus       126 ~y~~~~~lG~G~fg~Vy~~~~~---~~~~~vavK~~~~~-------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  195 (408)
                      +|++.+.||+|+||+||++++.   .+++.||+|+++..       ..+.+.+|+.++.++.+|+||+++++++..  ..
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~--~~   78 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQT--EA   78 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEec--CC
Confidence            5889999999999999998764   57889999998642       124577899999999779999999999854  46


Q ss_pred             ccEEEEEeecCCChhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccC
Q 015374          196 TPSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP  272 (408)
Q Consensus       196 ~~~lv~e~~~~~~l~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~  272 (408)
                      ..++||||+++++|..++   ..+++..++.++.|++.||.|||++||+||||||+|||++.+ +.+||+|||+++....
T Consensus        79 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~-~~~kl~DfG~~~~~~~  157 (332)
T cd05614          79 KLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSE-GHVVLTDFGLSKEFLS  157 (332)
T ss_pred             EEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCC-CCEEEeeCcCCccccc
Confidence            788999999999998876   458999999999999999999999999999999999999988 7999999999976533


Q ss_pred             CC--cceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCC--CCHHHHHHHHhhhchhhhhcCCCC
Q 015374          273 GK--EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGH--DNHDQLVKIAKDCCLIIWCNSRHS  348 (408)
Q Consensus       273 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~--~~~~~~~~~~~~~~~~~~~~~~~~  348 (408)
                      ..  ......||..|+|||++.+...++.++|||||||++|||++|..||....  .....+......            
T Consensus       158 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~------------  225 (332)
T cd05614         158 EEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILK------------  225 (332)
T ss_pred             cCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhc------------
Confidence            22  22345789999999999874568899999999999999999999984322  222222211110            


Q ss_pred             CCCccccccccCCCCCCHHHHHHHHHhcccCcCCCC-----CHHHHhcCCCcccccc
Q 015374          349 RKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRL-----TAREAMAHPYFAQVRA  400 (408)
Q Consensus       349 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rp-----t~~elL~hp~f~~~~~  400 (408)
                             .....+..+++++.+++.+||+.||++||     +++++++||||+....
T Consensus       226 -------~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~~  275 (332)
T cd05614         226 -------CDPPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGLDW  275 (332)
T ss_pred             -------CCCCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCCCCH
Confidence                   01122344789999999999999999999     8899999999997654

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=4.3e-45  Score=354.43  Aligned_cols=257  Identities=25%  Similarity=0.407  Sum_probs=210.5

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc------chHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCc
Q 015374          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT  196 (408)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  196 (408)
                      ..++|++.++||+|+||+||+|++..++..||+|+++..      ....+.+|+.+++.+ +||||+++++++.+  +..
T Consensus        41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~-~h~~iv~~~~~~~~--~~~  117 (370)
T cd05596          41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHA-NSEWIVQLHYAFQD--DKY  117 (370)
T ss_pred             CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhC-CCCCcceEEEEEec--CCE
Confidence            467899999999999999999999999999999998632      224477899999999 99999999999955  567


Q ss_pred             cEEEEEeecCCChhhhcC--CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCCC
Q 015374          197 PSLIFEYVNSTDFKVLYP--TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK  274 (408)
Q Consensus       197 ~~lv~e~~~~~~l~~~~~--~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~~  274 (408)
                      .++||||+++++|..++.  .+++..+..++.|++.||+|||++||+||||||+|||++.+ +.+||+|||++.......
T Consensus       118 ~~lv~Ey~~gg~L~~~l~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~-~~~kL~DfG~~~~~~~~~  196 (370)
T cd05596         118 LYMVMEYMPGGDLVNLMSNYDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKS-GHLKLADFGTCMKMDANG  196 (370)
T ss_pred             EEEEEcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCC-CCEEEEeccceeeccCCC
Confidence            899999999999998874  47888889999999999999999999999999999999988 799999999997764332


Q ss_pred             --cceeeccCccccccccccCC---cCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCC
Q 015374          275 --EYNVRVASRYFKGPELLVDL---QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSR  349 (408)
Q Consensus       275 --~~~~~~~~~~y~aPE~~~~~---~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  349 (408)
                        ......||+.|+|||++.+.   ..++.++|||||||++|||++|+.||. +.+....+..+.....          .
T Consensus       197 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~-~~~~~~~~~~i~~~~~----------~  265 (370)
T cd05596         197 MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFY-ADSLVGTYSKIMDHKN----------S  265 (370)
T ss_pred             cccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcC-CCCHHHHHHHHHcCCC----------c
Confidence              22345789999999998652   247899999999999999999999984 3333334444332110          0


Q ss_pred             CCccccccccCCCCCCHHHHHHHHHhcccCcCC--CCCHHHHhcCCCcccccc
Q 015374          350 KPWSKFINADNQHLVSPEAIDFLDKLLRYDHQD--RLTAREAMAHPYFAQVRA  400 (408)
Q Consensus       350 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~--Rpt~~elL~hp~f~~~~~  400 (408)
                            ........++.++.+||.+||+.+|.+  |+|++|+++||||+....
T Consensus       266 ------~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~~~~~~~  312 (370)
T cd05596         266 ------LTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHPFFKNDQW  312 (370)
T ss_pred             ------CCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCcccCCCCh
Confidence                  001112236899999999999999988  999999999999987543

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=4.4e-45  Score=347.91  Aligned_cols=246  Identities=24%  Similarity=0.389  Sum_probs=204.2

Q ss_pred             eeeeeeCceEEEEEEEcCCCcEEEEEEeccc------chHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccEEEEEee
Q 015374          131 RKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYV  204 (408)
Q Consensus       131 ~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~  204 (408)
                      +.||+|+||+||+|++..+++.||+|+++..      ....+..|..++..+.+||||+++++++.+  ....++||||+
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~--~~~~~lv~E~~   78 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQT--KDRLFFVMEYV   78 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEc--CCeEEEEEeCC
Confidence            3699999999999999999999999998642      224567888998877689999999999965  46789999999


Q ss_pred             cCCChhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCC-Ccceeec
Q 015374          205 NSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG-KEYNVRV  280 (408)
Q Consensus       205 ~~~~l~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~-~~~~~~~  280 (408)
                      ++++|...+   ..+++..+..++.|++.||.|||++||+||||||+|||++.+ +.+||+|||++...... .......
T Consensus        79 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~-~~~kL~Dfg~~~~~~~~~~~~~~~~  157 (321)
T cd05591          79 NGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAE-GHCKLADFGMCKEGILNGVTTTTFC  157 (321)
T ss_pred             CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCC-CCEEEeecccceecccCCccccccc
Confidence            999998776   458899999999999999999999999999999999999988 79999999998754322 2234457


Q ss_pred             cCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCCCccccccccC
Q 015374          281 ASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSKFINADN  360 (408)
Q Consensus       281 ~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  360 (408)
                      |+..|+|||++.+ ..++.++|||||||++|+|++|+.||. +.+..+.+..+...                    ....
T Consensus       158 gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~Pf~-~~~~~~~~~~i~~~--------------------~~~~  215 (321)
T cd05591         158 GTPDYIAPEILQE-LEYGPSVDWWALGVLMYEMMAGQPPFE-ADNEDDLFESILHD--------------------DVLY  215 (321)
T ss_pred             cCccccCHHHHcC-CCCCCccceechhHHHHHHhcCCCCCC-CCCHHHHHHHHHcC--------------------CCCC
Confidence            8999999999987 789999999999999999999999983 44444444443321                    0111


Q ss_pred             CCCCCHHHHHHHHHhcccCcCCCC-------CHHHHhcCCCccccccc
Q 015374          361 QHLVSPEAIDFLDKLLRYDHQDRL-------TAREAMAHPYFAQVRAA  401 (408)
Q Consensus       361 ~~~~~~~~~~li~~~L~~dp~~Rp-------t~~elL~hp~f~~~~~~  401 (408)
                      +..++.++.+++.+||+.||++|+       +++++++||||..+...
T Consensus       216 p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~hp~~~~~~~~  263 (321)
T cd05591         216 PVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHPFFKEIDWV  263 (321)
T ss_pred             CCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcCCccCCCCHH
Confidence            233689999999999999999999       99999999999887554

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=6.7e-45  Score=345.91  Aligned_cols=262  Identities=26%  Similarity=0.519  Sum_probs=199.1

Q ss_pred             eeeeeeCceEEEEEEEc--CCCcEEEEEEecccc-hHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccEEEEEeecCC
Q 015374          131 RKVGRGKYSEVFEGINV--NTNERCIIKILKPVK-KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNST  207 (408)
Q Consensus       131 ~~lG~G~fg~Vy~~~~~--~~~~~vavK~~~~~~-~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~~~  207 (408)
                      .+||+|+||+||+|++.  .++..+|+|.++... ...+.+|+.+++++ +||||+++++++........+++|||++++
T Consensus         7 ~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~lv~e~~~~~   85 (317)
T cd07868           7 CKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLREL-KHPNVISLQKVFLSHADRKVWLLFDYAEHD   85 (317)
T ss_pred             cccccCCCeEEEEEEEccCCCCceEEEEEECCCCCcHHHHHHHHHHHhc-CCCCCcceeeeEecCCCcEEEEEEeccCCC
Confidence            47999999999999865  467899999987433 35678999999999 999999999999776667889999999864


Q ss_pred             Chhhhc------------CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeC---CCCcEEEEecccceeccC
Q 015374          208 DFKVLY------------PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDH---ELRKLRLIDWGLAEFYHP  272 (408)
Q Consensus       208 ~l~~~~------------~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~---~~~~~kl~DfG~a~~~~~  272 (408)
                       +..++            ..+++..++.++.|++.||.|||++||+||||||+|||++.   ..+.+||+|||+++....
T Consensus        86 -l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~  164 (317)
T cd07868          86 -LWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNS  164 (317)
T ss_pred             -HHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCceeccCC
Confidence             43332            14788889999999999999999999999999999999942   336899999999986643


Q ss_pred             CC----cceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCC--------CHHHHHHHHhhhchh
Q 015374          273 GK----EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHD--------NHDQLVKIAKDCCLI  340 (408)
Q Consensus       273 ~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~--------~~~~~~~~~~~~~~~  340 (408)
                      ..    ......+|..|+|||++.+...++.++||||+||++|+|++|+.||.....        ..+++..+....+..
T Consensus       165 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (317)
T cd07868         165 PLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFP  244 (317)
T ss_pred             CCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHHhcCCC
Confidence            22    223457889999999998756789999999999999999999999853322        134555555544432


Q ss_pred             hhhcCCCC--------------CC-----CccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCc
Q 015374          341 IWCNSRHS--------------RK-----PWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF  395 (408)
Q Consensus       341 ~~~~~~~~--------------~~-----~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f  395 (408)
                      ....+...              ..     ....... ......+.++.+||.+||++||++|||++|+|+||||
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~f  317 (317)
T cd07868         245 ADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYME-KHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF  317 (317)
T ss_pred             ChHHhHHHhhccchhhhhhhhhccccCcccccchHH-hcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence            21111000              00     0000000 1111235679999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=7.1e-45  Score=345.71  Aligned_cols=246  Identities=26%  Similarity=0.452  Sum_probs=202.0

Q ss_pred             eeeeeeCceEEEEEEEcCCCcEEEEEEeccc------chHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccEEEEEee
Q 015374          131 RKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYV  204 (408)
Q Consensus       131 ~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~  204 (408)
                      +.||+|+||+||+|++..+++.||+|+++..      ..+.+..|..++..+.+||||+++++++..  +...++||||+
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~--~~~~~lv~e~~   78 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQT--KEHLFFVMEYL   78 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEc--CCEEEEEEcCC
Confidence            3699999999999999999999999998642      223456677777766689999999999954  46789999999


Q ss_pred             cCCChhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCC-Ccceeec
Q 015374          205 NSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG-KEYNVRV  280 (408)
Q Consensus       205 ~~~~l~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~-~~~~~~~  280 (408)
                      ++++|..++   ..+++..+..++.|++.||.|||+++|+||||||+|||++.+ +.+||+|||+++..... .......
T Consensus        79 ~gg~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~-~~~kL~Dfg~a~~~~~~~~~~~~~~  157 (316)
T cd05592          79 NGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKD-GHIKIADFGMCKENMNGEGKASTFC  157 (316)
T ss_pred             CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCC-CCEEEccCcCCeECCCCCCcccccc
Confidence            999998776   358899999999999999999999999999999999999988 79999999999764322 2334567


Q ss_pred             cCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCCCccccccccC
Q 015374          281 ASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSKFINADN  360 (408)
Q Consensus       281 ~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  360 (408)
                      ||..|+|||++.+ ..++.++|||||||++|||++|..||. +.+..+....+...                    ....
T Consensus       158 gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~G~~Pf~-~~~~~~~~~~i~~~--------------------~~~~  215 (316)
T cd05592         158 GTPDYIAPEILKG-QKYNESVDWWSFGVLLYEMLIGQSPFH-GEDEDELFDSILND--------------------RPHF  215 (316)
T ss_pred             CCccccCHHHHcC-CCCCCcccchhHHHHHHHHHhCCCCCC-CCCHHHHHHHHHcC--------------------CCCC
Confidence            8999999999987 678999999999999999999999984 44433433333221                    1112


Q ss_pred             CCCCCHHHHHHHHHhcccCcCCCCCH-HHHhcCCCccccccc
Q 015374          361 QHLVSPEAIDFLDKLLRYDHQDRLTA-REAMAHPYFAQVRAA  401 (408)
Q Consensus       361 ~~~~~~~~~~li~~~L~~dp~~Rpt~-~elL~hp~f~~~~~~  401 (408)
                      +..++.++.+++.+||+.||++||++ .++++||||..+...
T Consensus       216 ~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~h~~~~~~~~~  257 (316)
T cd05592         216 PRWISKEAKDCLSKLFERDPTKRLGVDGDIRQHPFFRGIDWE  257 (316)
T ss_pred             CCCCCHHHHHHHHHHccCCHHHcCCChHHHHcCcccCCCCHH
Confidence            33478999999999999999999986 588999999987653

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=5.1e-45  Score=352.99  Aligned_cols=255  Identities=27%  Similarity=0.455  Sum_probs=207.4

Q ss_pred             CCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc------chHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccE
Q 015374          125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS  198 (408)
Q Consensus       125 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  198 (408)
                      ++|++.+.||+|+||+||++++..+++.||+|+++..      ....+.+|+.++..+ +|+||+++++.+.+  ....+
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~iv~~~~~~~~--~~~~~   77 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEA-DGAWVVKMFYSFQD--KRNLY   77 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhC-CCCCEeeEEEEEEc--CCEEE
Confidence            4789999999999999999999999999999998632      235677899999999 99999999999954  46789


Q ss_pred             EEEEeecCCChhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCCC-
Q 015374          199 LIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK-  274 (408)
Q Consensus       199 lv~e~~~~~~l~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~~-  274 (408)
                      +||||+++++|..++   ..+++..++.++.|++.||+|||++||+||||||+|||++.+ +.++|+|||++....... 
T Consensus        78 lv~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~-~~vkL~DfG~~~~~~~~~~  156 (360)
T cd05627          78 LIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAK-GHVKLSDFGLCTGLKKAHR  156 (360)
T ss_pred             EEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCC-CCEEEeeccCCcccccccc
Confidence            999999999998886   358999999999999999999999999999999999999988 899999999986442211 


Q ss_pred             -----------------------------------cceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCC
Q 015374          275 -----------------------------------EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEP  319 (408)
Q Consensus       275 -----------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~p  319 (408)
                                                         .....+||..|+|||++.+ ..++.++|||||||++|||++|+.|
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~-~~~~~~~DiwSlGvilyel~tG~~P  235 (360)
T cd05627         157 TEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQ-TGYNKLCDWWSLGVIMYEMLIGYPP  235 (360)
T ss_pred             cccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcC-CCCCCcceeccccceeeecccCCCC
Confidence                                               0113478999999999987 7899999999999999999999999


Q ss_pred             CCCCCCCHHHHHHHHhhhchhhhhcCCCCCCCccccccccCCCCCCHHHHHHHHHhcccCcCCCC---CHHHHhcCCCcc
Q 015374          320 FFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRL---TAREAMAHPYFA  396 (408)
Q Consensus       320 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rp---t~~elL~hp~f~  396 (408)
                      |. +.+..+....+.....                .........+++++++++.+|+ .||.+|+   +++|+++||||+
T Consensus       236 f~-~~~~~~~~~~i~~~~~----------------~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~  297 (360)
T cd05627         236 FC-SETPQETYRKVMNWKE----------------TLVFPPEVPISEKAKDLILRFC-TDSENRIGSNGVEEIKSHPFFE  297 (360)
T ss_pred             CC-CCCHHHHHHHHHcCCC----------------ceecCCCCCCCHHHHHHHHHhc-cChhhcCCCCCHHHHhcCCCCC
Confidence            84 3444444433332100                0000111226889999999987 4999998   589999999999


Q ss_pred             ccccch
Q 015374          397 QVRAAE  402 (408)
Q Consensus       397 ~~~~~~  402 (408)
                      ++....
T Consensus       298 ~~~~~~  303 (360)
T cd05627         298 GVDWGH  303 (360)
T ss_pred             CCCHHH
Confidence            886644

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=8.3e-45  Score=345.23  Aligned_cols=246  Identities=24%  Similarity=0.437  Sum_probs=201.9

Q ss_pred             eeeeeeCceEEEEEEEcCCCcEEEEEEeccc------chHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccEEEEEee
Q 015374          131 RKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYV  204 (408)
Q Consensus       131 ~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~  204 (408)
                      +.||+|+||.||+|++..+++.||+|+++..      .......|..++....+||||+++++++.+  ....++||||+
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~--~~~~~lv~E~~   78 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQT--KEHLFFVMEFL   78 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEe--CCEEEEEECCC
Confidence            3699999999999999999999999998743      234566788888766689999999999965  46889999999


Q ss_pred             cCCChhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccC-CCcceeec
Q 015374          205 NSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP-GKEYNVRV  280 (408)
Q Consensus       205 ~~~~l~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~-~~~~~~~~  280 (408)
                      .+++|..++   ..+++..+..++.|++.||+|||++||+||||||+|||++.+ +.++|+|||+++.... ........
T Consensus        79 ~~g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~  157 (316)
T cd05620          79 NGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRD-GHIKIADFGMCKENVFGDNRASTFC  157 (316)
T ss_pred             CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCC-CCEEeCccCCCeecccCCCceeccC
Confidence            999998776   358889999999999999999999999999999999999988 7999999999875322 22334567


Q ss_pred             cCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCCCccccccccC
Q 015374          281 ASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSKFINADN  360 (408)
Q Consensus       281 ~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  360 (408)
                      ||..|+|||++.+ ..++.++|||||||++|||++|..||. +.+..+....+...                    ....
T Consensus       158 gt~~y~aPE~~~~-~~~~~~~DiwslGvil~el~~g~~Pf~-~~~~~~~~~~~~~~--------------------~~~~  215 (316)
T cd05620         158 GTPDYIAPEILQG-LKYTFSVDWWSFGVLLYEMLIGQSPFH-GDDEDELFESIRVD--------------------TPHY  215 (316)
T ss_pred             CCcCccCHHHHcC-CCCCcccchhhhHHHHHHHHhCCCCCC-CCCHHHHHHHHHhC--------------------CCCC
Confidence            8999999999987 789999999999999999999999984 33333333322111                    1112


Q ss_pred             CCCCCHHHHHHHHHhcccCcCCCCCH-HHHhcCCCccccccc
Q 015374          361 QHLVSPEAIDFLDKLLRYDHQDRLTA-REAMAHPYFAQVRAA  401 (408)
Q Consensus       361 ~~~~~~~~~~li~~~L~~dp~~Rpt~-~elL~hp~f~~~~~~  401 (408)
                      +..++.++.+++.+||+.||++|+++ +++++||||+.+...
T Consensus       216 ~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~~h~~f~~~~~~  257 (316)
T cd05620         216 PRWITKESKDILEKLFERDPTRRLGVVGNIRGHPFFKTINWT  257 (316)
T ss_pred             CCCCCHHHHHHHHHHccCCHHHcCCChHHHHcCCCcCCCCHH
Confidence            23378999999999999999999997 589999999987654

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=6.4e-45  Score=353.85  Aligned_cols=268  Identities=28%  Similarity=0.512  Sum_probs=210.9

Q ss_pred             CEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc-----chHHHHHHHHHHHHhcCCCCceEEeeEEEccCC---Ccc
Q 015374          126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHS---KTP  197 (408)
Q Consensus       126 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~---~~~  197 (408)
                      +|++.+.||+|+||+||+|.+..+++.||+|.+...     ..+.+.+|+.+++.+ +|+||+++++++...+.   ...
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~   79 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFF-KHDNVLSALDILQPPHIDPFEEI   79 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhC-CCCCcCCHhheecCCCccccceE
Confidence            477889999999999999999999999999988532     235688999999999 99999999999965431   267


Q ss_pred             EEEEEeecCCChhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCCC
Q 015374          198 SLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK  274 (408)
Q Consensus       198 ~lv~e~~~~~~l~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~~  274 (408)
                      ++||||+.++ +...+   ..+++..++.++.|++.||.|||++||+||||||+|||++.+ +.+||+|||+++......
T Consensus        80 ~lv~e~~~~~-l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~-~~~kL~Dfg~a~~~~~~~  157 (372)
T cd07853          80 YVVTELMQSD-LHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSN-CVLKICDFGLARVEEPDE  157 (372)
T ss_pred             EEEeeccccC-HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCC-CCEEeccccceeecccCc
Confidence            8999999864 44443   358999999999999999999999999999999999999988 799999999998654322


Q ss_pred             --cceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcC-------
Q 015374          275 --EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNS-------  345 (408)
Q Consensus       275 --~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~-------  345 (408)
                        ......++..|+|||++.+...++.++|||||||++|||++|+.|| .+.+..+++..+....|.......       
T Consensus       158 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf-~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~  236 (372)
T cd07853         158 SKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILF-QAQSPIQQLDLITDLLGTPSLEAMRSACEGA  236 (372)
T ss_pred             cccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCC-CCCCHHHHHHHHHHHcCCCCHHHHHHhhHHH
Confidence              2233467889999999987566899999999999999999999987 555666666666655443221100       


Q ss_pred             ------C-CCCCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccccc
Q 015374          346 ------R-HSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVR  399 (408)
Q Consensus       346 ------~-~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~~~  399 (408)
                            . ........  ........++++.+||.+||+.||++|||++|+|+||||+..+
T Consensus       237 ~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~  295 (372)
T cd07853         237 RAHILRGPHKPPSLPV--LYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEGR  295 (372)
T ss_pred             HHHHHhCCCCCCchHH--hcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCCCc
Confidence                  0 00000000  0112233588999999999999999999999999999998754

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=8.7e-45  Score=346.99  Aligned_cols=247  Identities=26%  Similarity=0.449  Sum_probs=201.9

Q ss_pred             eeeeeeCceEEEEEEEcCCCcEEEEEEeccc------chHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccEEEEEee
Q 015374          131 RKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYV  204 (408)
Q Consensus       131 ~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~  204 (408)
                      +.||+|+||+||+|++..+++.+|+|+++..      ....+.+|+.++.++.+||||+++++++.+  ....++||||+
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~--~~~~~lv~E~~   78 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQT--ESRLFFVIEYV   78 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEe--CCEEEEEEeCC
Confidence            3699999999999999999999999998743      224567899988887689999999999965  46789999999


Q ss_pred             cCCChhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccC-CCcceeec
Q 015374          205 NSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP-GKEYNVRV  280 (408)
Q Consensus       205 ~~~~l~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~-~~~~~~~~  280 (408)
                      ++++|..++   ..+++..++.++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+++.... ........
T Consensus        79 ~~~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~-~~~kL~DfG~~~~~~~~~~~~~~~~  157 (329)
T cd05618          79 NGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSE-GHIKLTDYGMCKEGLRPGDTTSTFC  157 (329)
T ss_pred             CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCC-CCEEEeeCCccccccCCCCcccccc
Confidence            999998775   458999999999999999999999999999999999999988 7999999999875432 22334467


Q ss_pred             cCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCC-------CCHHHHHHHHhhhchhhhhcCCCCCCCcc
Q 015374          281 ASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGH-------DNHDQLVKIAKDCCLIIWCNSRHSRKPWS  353 (408)
Q Consensus       281 ~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  353 (408)
                      ||..|+|||++.+ ..++.++|||||||++|+|++|+.||....       ...+.+...+..                 
T Consensus       158 gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~-----------------  219 (329)
T cd05618         158 GTPNYIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILE-----------------  219 (329)
T ss_pred             CCccccCHHHHcC-CCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhc-----------------
Confidence            8999999999987 788999999999999999999999984211       111111111111                 


Q ss_pred             ccccccCCCCCCHHHHHHHHHhcccCcCCCCC------HHHHhcCCCcccccc
Q 015374          354 KFINADNQHLVSPEAIDFLDKLLRYDHQDRLT------AREAMAHPYFAQVRA  400 (408)
Q Consensus       354 ~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt------~~elL~hp~f~~~~~  400 (408)
                        .....+..++.++.+++.+||+.||++|||      ++++++||||+++..
T Consensus       220 --~~~~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~~~~  270 (329)
T cd05618         220 --KQIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDW  270 (329)
T ss_pred             --CCCCCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcCCCCCCCCH
Confidence              011223447899999999999999999998      589999999988755

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=3.5e-45  Score=349.23  Aligned_cols=245  Identities=27%  Similarity=0.461  Sum_probs=202.3

Q ss_pred             eeeeeeCceEEEEEEEcCCCcEEEEEEeccc------chHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccEEEEEee
Q 015374          131 RKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYV  204 (408)
Q Consensus       131 ~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~  204 (408)
                      +.||+|+||+||++.+..++..||+|+++..      ....+.+|+.++..+ +||||+++++++..  ....++||||+
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~-~hp~i~~~~~~~~~--~~~~~lv~E~~   77 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNS-RHPFLTALKYSFQT--HDRLCFVMEYA   77 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhC-CCCCCCceEEEEEc--CCEEEEEEeCC
Confidence            3699999999999999999999999998743      234567899999998 99999999999955  46789999999


Q ss_pred             cCCChhhhc---CCCChHHHHHHHHHHHHHHHHHHH-CCcEEecCCCCcEEEeCCCCcEEEEecccceeccC-CCcceee
Q 015374          205 NSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHS-QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP-GKEYNVR  279 (408)
Q Consensus       205 ~~~~l~~~~---~~l~~~~~~~i~~qi~~~L~~LH~-~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~-~~~~~~~  279 (408)
                      ++++|..++   ..+++..+..++.|++.||.|||+ .||+||||||+|||++.+ +.+||+|||+++.... .......
T Consensus        78 ~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~-~~~kL~Dfg~~~~~~~~~~~~~~~  156 (325)
T cd05594          78 NGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKD-GHIKITDFGLCKEGIKDGATMKTF  156 (325)
T ss_pred             CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCC-CCEEEecCCCCeecCCCCcccccc
Confidence            999998776   358999999999999999999997 799999999999999988 7999999999875432 2233345


Q ss_pred             ccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCCCcccccccc
Q 015374          280 VASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSKFINAD  359 (408)
Q Consensus       280 ~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  359 (408)
                      .||..|+|||++.+ ..++.++|||||||++|+|++|..||.. .+..+....+...                    ...
T Consensus       157 ~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tG~~Pf~~-~~~~~~~~~i~~~--------------------~~~  214 (325)
T cd05594         157 CGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYN-QDHEKLFELILME--------------------EIR  214 (325)
T ss_pred             cCCcccCCHHHHcc-CCCCCccccccccceeeeeccCCCCCCC-CCHHHHHHHHhcC--------------------CCC
Confidence            78999999999987 7889999999999999999999999843 3322222222110                    111


Q ss_pred             CCCCCCHHHHHHHHHhcccCcCCCC-----CHHHHhcCCCccccccc
Q 015374          360 NQHLVSPEAIDFLDKLLRYDHQDRL-----TAREAMAHPYFAQVRAA  401 (408)
Q Consensus       360 ~~~~~~~~~~~li~~~L~~dp~~Rp-----t~~elL~hp~f~~~~~~  401 (408)
                      .+..+++++.+++.+||+.||++|+     ++.++++||||.++...
T Consensus       215 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~~~~  261 (325)
T cd05594         215 FPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKFFAGIVWQ  261 (325)
T ss_pred             CCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcCCCcCCCCHH
Confidence            2334789999999999999999997     99999999999986543

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.2e-44  Score=349.87  Aligned_cols=268  Identities=22%  Similarity=0.325  Sum_probs=205.4

Q ss_pred             CCCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecccchHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccEEEE
Q 015374          122 GDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIF  201 (408)
Q Consensus       122 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~  201 (408)
                      ....+|++.+.||+|+||.||+|++..++..||+|+...   .....|+.+++++ +|+||+++++++..  ....++||
T Consensus        63 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~---~~~~~E~~~l~~l-~h~~iv~~~~~~~~--~~~~~lv~  136 (357)
T PHA03209         63 VASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQK---GTTLIEAMLLQNV-NHPSVIRMKDTLVS--GAITCMVL  136 (357)
T ss_pred             hhhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCc---cccHHHHHHHHhC-CCCCCcChhheEEe--CCeeEEEE
Confidence            345689999999999999999999999999999998542   3446799999999 99999999999965  45778999


Q ss_pred             EeecCCChhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCCCccee
Q 015374          202 EYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNV  278 (408)
Q Consensus       202 e~~~~~~l~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~~~~~~  278 (408)
                      ||+.+..+..+.   ..+++..+..++.|++.||.|||++||+||||||+|||++.+ +.+||+|||++...........
T Consensus       137 e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~-~~~kl~DfG~a~~~~~~~~~~~  215 (357)
T PHA03209        137 PHYSSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDV-DQVCIGDLGAAQFPVVAPAFLG  215 (357)
T ss_pred             EccCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCC-CCEEEecCccccccccCccccc
Confidence            999764444332   348899999999999999999999999999999999999988 7899999999975443334445


Q ss_pred             eccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCH---------HHHHHHHhhhchhhhhcC----
Q 015374          279 RVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNH---------DQLVKIAKDCCLIIWCNS----  345 (408)
Q Consensus       279 ~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~---------~~~~~~~~~~~~~~~~~~----  345 (408)
                      ..||..|+|||++.+ ..++.++|||||||++|||+++..+++......         ..+..+....+.......    
T Consensus       216 ~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~  294 (357)
T PHA03209        216 LAGTVETNAPEVLAR-DKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRDPG  294 (357)
T ss_pred             ccccccccCCeecCC-CCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCCCCc
Confidence            678999999999987 679999999999999999999877775543221         222233332221111100    


Q ss_pred             -----------CCCCCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccc
Q 015374          346 -----------RHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQV  398 (408)
Q Consensus       346 -----------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~~  398 (408)
                                 ...+.++..+ .......++.++.+||.+||+.||.+|||+.|+|+||||+++
T Consensus       295 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~~  357 (357)
T PHA03209        295 SRLVRGFIEYASLERQPYTRY-PCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQL  357 (357)
T ss_pred             cHHHHHHHhhcccCCCccccc-HHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhccC
Confidence                       0000111110 001112357788999999999999999999999999999874

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=1.2e-44  Score=344.54  Aligned_cols=245  Identities=24%  Similarity=0.434  Sum_probs=203.6

Q ss_pred             eeeeeeCceEEEEEEEcCCCcEEEEEEeccc------chHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccEEEEEee
Q 015374          131 RKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYV  204 (408)
Q Consensus       131 ~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~  204 (408)
                      +.||+|+||+||+|++..++..||+|+++..      ....+.+|..++..+.+||||+++++++.+  ....++||||+
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~--~~~~~lv~e~~   78 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQT--KDRLFFVMEYV   78 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEc--CCEEEEEEcCC
Confidence            3699999999999999999999999998743      234567888999888689999999999965  46789999999


Q ss_pred             cCCChhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccC-CCcceeec
Q 015374          205 NSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP-GKEYNVRV  280 (408)
Q Consensus       205 ~~~~l~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~-~~~~~~~~  280 (408)
                      ++++|..++   ..+++..+..++.|++.||.|||+++|+||||||+|||++.+ +.++|+|||+++.... .......+
T Consensus        79 ~~~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~  157 (318)
T cd05570          79 NGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSE-GHIKIADFGMCKEGILGGVTTSTFC  157 (318)
T ss_pred             CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCC-CcEEecccCCCeecCcCCCccccee
Confidence            999998776   358999999999999999999999999999999999999988 7999999999875322 22233457


Q ss_pred             cCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCCCccccccccC
Q 015374          281 ASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSKFINADN  360 (408)
Q Consensus       281 ~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  360 (408)
                      |+..|+|||++.+ ..++.++|||||||++|+|++|..||. +.+..+....+...                    ....
T Consensus       158 g~~~y~aPE~~~~-~~~~~~~DiwslGvil~~l~~G~~pf~-~~~~~~~~~~i~~~--------------------~~~~  215 (318)
T cd05570         158 GTPDYIAPEILSY-QPYGPAVDWWALGVLLYEMLAGQSPFE-GDDEDELFQSILED--------------------EVRY  215 (318)
T ss_pred             cCccccCHHHhcC-CCCCcchhhhhHHHHHHHHhhCCCCCC-CCCHHHHHHHHHcC--------------------CCCC
Confidence            8999999999987 789999999999999999999999983 33333333332211                    1112


Q ss_pred             CCCCCHHHHHHHHHhcccCcCCCCCH-----HHHhcCCCcccccc
Q 015374          361 QHLVSPEAIDFLDKLLRYDHQDRLTA-----REAMAHPYFAQVRA  400 (408)
Q Consensus       361 ~~~~~~~~~~li~~~L~~dp~~Rpt~-----~elL~hp~f~~~~~  400 (408)
                      +..++.++.+++.+||+.||++|||+     .++++||||+.+..
T Consensus       216 ~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~~~~~~~~~  260 (318)
T cd05570         216 PRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGHPFFREIDW  260 (318)
T ss_pred             CCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcCCCcCCCCH
Confidence            23478999999999999999999999     99999999988754

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=1.2e-44  Score=361.95  Aligned_cols=272  Identities=22%  Similarity=0.403  Sum_probs=205.3

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc--chHHHHHHHHHHHHhcCC------CCceEEeeEEEccCC
Q 015374          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV--KKKKIKREIKILQNLCGG------PNVVKLLDIVRDQHS  194 (408)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~~h------~niv~l~~~~~~~~~  194 (408)
                      ..++|++.++||+|+||+||+|.+..+++.||||+++..  ....+..|+.+++.+ .|      .++++++++|... .
T Consensus       127 ~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~e~~~l~~l-~~~~~~~~~~i~~i~~~~~~~-~  204 (467)
T PTZ00284        127 STQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKV-RQADPADRFPLMKIQRYFQNE-T  204 (467)
T ss_pred             CCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchhhHHHHHHHHHHHHHH-hhcCcccCcceeeeEEEEEcC-C
Confidence            367899999999999999999999999999999999642  234567788888877 44      4588999998654 3


Q ss_pred             CccEEEEEeecCCChhhhc--CCCChHHHHHHHHHHHHHHHHHHH-CCcEEecCCCCcEEEeCCCC--------------
Q 015374          195 KTPSLIFEYVNSTDFKVLY--PTLTDYDIRYYIYELLKALDYCHS-QGIMHRDVKPHNVMIDHELR--------------  257 (408)
Q Consensus       195 ~~~~lv~e~~~~~~l~~~~--~~l~~~~~~~i~~qi~~~L~~LH~-~~iiH~Dlk~~NILl~~~~~--------------  257 (408)
                      .+.|+|||++.+..+..+.  ..+++..+..++.||+.||+|||+ .|||||||||+|||++.+..              
T Consensus       205 ~~~~iv~~~~g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~~~  284 (467)
T PTZ00284        205 GHMCIVMPKYGPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDP  284 (467)
T ss_pred             ceEEEEEeccCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccccCCCC
Confidence            5789999998554443333  358999999999999999999998 59999999999999987521              


Q ss_pred             -cEEEEecccceeccCCCcceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhh
Q 015374          258 -KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKD  336 (408)
Q Consensus       258 -~~kl~DfG~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~  336 (408)
                       .+||+|||.+....  ......+||..|+|||++.+ ..++.++|||||||++|||++|+.|| .+.++.+.+..+...
T Consensus       285 ~~vkl~DfG~~~~~~--~~~~~~~gt~~Y~APE~~~~-~~~~~~~DiwSlGvil~elltG~~pf-~~~~~~~~~~~i~~~  360 (467)
T PTZ00284        285 CRVRICDLGGCCDER--HSRTAIVSTRHYRSPEVVLG-LGWMYSTDMWSMGCIIYELYTGKLLY-DTHDNLEHLHLMEKT  360 (467)
T ss_pred             ceEEECCCCccccCc--cccccccCCccccCcHHhhc-CCCCcHHHHHHHHHHHHHHHhCCCCC-CCCChHHHHHHHHHH
Confidence             48999999875432  23345689999999999987 78999999999999999999999887 566666666666655


Q ss_pred             hchhhhhcCCC--------------C------CCCccccccc--cCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCC
Q 015374          337 CCLIIWCNSRH--------------S------RKPWSKFINA--DNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPY  394 (408)
Q Consensus       337 ~~~~~~~~~~~--------------~------~~~~~~~~~~--~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~  394 (408)
                      .|.........              .      ...+......  ......++.+.|||.+||++||++|||++|+|+|||
T Consensus       361 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~Hp~  440 (467)
T PTZ00284        361 LGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTTHPY  440 (467)
T ss_pred             cCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhcCcc
Confidence            54222100000              0      0000000000  000012466889999999999999999999999999


Q ss_pred             cccccc
Q 015374          395 FAQVRA  400 (408)
Q Consensus       395 f~~~~~  400 (408)
                      |+....
T Consensus       441 ~~~~~~  446 (467)
T PTZ00284        441 VLKYYP  446 (467)
T ss_pred             ccccCC
Confidence            987544

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-45  Score=341.71  Aligned_cols=267  Identities=26%  Similarity=0.411  Sum_probs=227.0

Q ss_pred             CCCCCcccccCCCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecccc------hHHHHHHHHHHHHhcCCCCceEE
Q 015374          112 WDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK------KKKIKREIKILQNLCGGPNVVKL  185 (408)
Q Consensus       112 ~~~~~~~~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~------~~~~~~E~~~l~~l~~h~niv~l  185 (408)
                      .+++.+..+....+.|..-+.||+||||.||-++-..+|+.+|.|.+.+..      .....+|-.||+++ +.+.||.+
T Consensus       172 lQWK~lE~qpvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV-~s~FiVsl  250 (591)
T KOG0986|consen  172 LQWKWLELQPVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKV-SSPFIVSL  250 (591)
T ss_pred             HHHHHHHhhhccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHh-ccCcEEEE
Confidence            345555666667888999999999999999999999999999999885322      24467899999999 89999999


Q ss_pred             eeEEEccCCCccEEEEEeecCCChhhhcC-----CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEE
Q 015374          186 LDIVRDQHSKTPSLIFEYVNSTDFKVLYP-----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLR  260 (408)
Q Consensus       186 ~~~~~~~~~~~~~lv~e~~~~~~l~~~~~-----~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~k  260 (408)
                      --.|+.  ...+|||+..|+||+|..++.     .|++..++.++.+|+.||++||+.+||+||+||+|||+|+. |+++
T Consensus       251 aYAfeT--kd~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~-GhvR  327 (591)
T KOG0986|consen  251 AYAFET--KDALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDH-GHVR  327 (591)
T ss_pred             eeeecC--CCceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccC-CCeE
Confidence            888844  578999999999999999873     58999999999999999999999999999999999999988 8999


Q ss_pred             EEecccceeccCCCcceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCC--CCCHHHHHHHHhhhc
Q 015374          261 LIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYG--HDNHDQLVKIAKDCC  338 (408)
Q Consensus       261 l~DfG~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~--~~~~~~~~~~~~~~~  338 (408)
                      |+|+|+|..+..+.....++||.+|||||++.+ +.|+.+.|.|||||++|||+.|+.||-..  ....+.+......  
T Consensus       328 ISDLGLAvei~~g~~~~~rvGT~GYMAPEvl~n-e~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~--  404 (591)
T KOG0986|consen  328 ISDLGLAVEIPEGKPIRGRVGTVGYMAPEVLQN-EVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLE--  404 (591)
T ss_pred             eeccceEEecCCCCccccccCcccccCHHHHcC-CcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhc--
Confidence            999999999998888888999999999999998 66999999999999999999999999322  2222222222211  


Q ss_pred             hhhhhcCCCCCCCccccccccCCCCCCHHHHHHHHHhcccCcCCCC-----CHHHHhcCCCccccccch
Q 015374          339 LIIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRL-----TAREAMAHPYFAQVRAAE  402 (408)
Q Consensus       339 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rp-----t~~elL~hp~f~~~~~~~  402 (408)
                                       .+.+.++..|++++++.+.+|+.||++|.     +++++-+||||+.+.+..
T Consensus       405 -----------------~~~ey~~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~lnw~r  456 (591)
T KOG0986|consen  405 -----------------DPEEYSDKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDLNWRR  456 (591)
T ss_pred             -----------------chhhcccccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhCcccccCCHhH
Confidence                             23344455899999999999999999998     688999999999987643

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=1.1e-44  Score=349.85  Aligned_cols=253  Identities=23%  Similarity=0.409  Sum_probs=202.6

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc----chHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccEE
Q 015374          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSL  199 (408)
Q Consensus       124 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l  199 (408)
                      .++|+.+++||+|+||+||+|++..+++.||||++...    ....+.+|+.+++++ +|+||+++++++.+  ....++
T Consensus        73 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~--~~~~~l  149 (353)
T PLN00034         73 LSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDV-NHPNVVKCHDMFDH--NGEIQV  149 (353)
T ss_pred             HHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhC-CCCCcceeeeEecc--CCeEEE
Confidence            45688889999999999999999999999999998532    235688999999999 99999999999954  467889


Q ss_pred             EEEeecCCChhhhcCCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCCC-ccee
Q 015374          200 IFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK-EYNV  278 (408)
Q Consensus       200 v~e~~~~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~~-~~~~  278 (408)
                      ||||+.+++|... ....+..+..++.|++.||.|||++||+||||||+|||++.+ +.+||+|||++....... ....
T Consensus       150 v~e~~~~~~L~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~-~~~kL~DfG~~~~~~~~~~~~~~  227 (353)
T PLN00034        150 LLEFMDGGSLEGT-HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSA-KNVKIADFGVSRILAQTMDPCNS  227 (353)
T ss_pred             EEecCCCCccccc-ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCC-CCEEEcccccceecccccccccc
Confidence            9999999998654 235677788899999999999999999999999999999988 799999999998764332 2344


Q ss_pred             eccCccccccccccCC----cCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCCCccc
Q 015374          279 RVASRYFKGPELLVDL----QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSK  354 (408)
Q Consensus       279 ~~~~~~y~aPE~~~~~----~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  354 (408)
                      ..|+..|+|||.+...    ...+.++|||||||++|||++|+.||...... + +.........               
T Consensus       228 ~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~-~-~~~~~~~~~~---------------  290 (353)
T PLN00034        228 SVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQG-D-WASLMCAICM---------------  290 (353)
T ss_pred             cccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCc-c-HHHHHHHHhc---------------
Confidence            6789999999987431    23456899999999999999999998532211 1 1111111000               


Q ss_pred             cccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccc
Q 015374          355 FINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQV  398 (408)
Q Consensus       355 ~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~~  398 (408)
                      ......+..++.++.+||.+||+.||++|||+.|+++||||...
T Consensus       291 ~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp~~~~~  334 (353)
T PLN00034        291 SQPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQHPFILRA  334 (353)
T ss_pred             cCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcCcccccC
Confidence            00112233478999999999999999999999999999999875

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=1.3e-44  Score=350.87  Aligned_cols=257  Identities=26%  Similarity=0.401  Sum_probs=208.4

Q ss_pred             CCCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc------chHHHHHHHHHHHHhcCCCCceEEeeEEEccCCC
Q 015374          122 GDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSK  195 (408)
Q Consensus       122 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  195 (408)
                      ...++|++.+.||+|+||.||++++..+++.+|+|+++..      ....+.+|+.+++.+ +||||+++++++.+  +.
T Consensus        40 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~-~hp~iv~~~~~~~~--~~  116 (370)
T cd05621          40 MKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFA-NSPWVVQLFCAFQD--DK  116 (370)
T ss_pred             CCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhC-CCCCEeeEEEEEEc--CC
Confidence            3467899999999999999999999999999999998632      234577899999998 99999999999955  56


Q ss_pred             ccEEEEEeecCCChhhhcC--CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCC
Q 015374          196 TPSLIFEYVNSTDFKVLYP--TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG  273 (408)
Q Consensus       196 ~~~lv~e~~~~~~l~~~~~--~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~  273 (408)
                      ..++||||+++++|..++.  .+++..+..++.|++.||+|||+++|+||||||+|||++.+ +.+||+|||++......
T Consensus       117 ~~~lv~Ey~~gg~L~~~l~~~~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~-~~~kL~DFG~a~~~~~~  195 (370)
T cd05621         117 YLYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKH-GHLKLADFGTCMKMDET  195 (370)
T ss_pred             EEEEEEcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCC-CCEEEEecccceecccC
Confidence            7899999999999998874  47888899999999999999999999999999999999988 79999999999876433


Q ss_pred             Cc--ceeeccCccccccccccCC---cCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCC
Q 015374          274 KE--YNVRVASRYFKGPELLVDL---QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHS  348 (408)
Q Consensus       274 ~~--~~~~~~~~~y~aPE~~~~~---~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  348 (408)
                      ..  .....||..|+|||++.+.   ..++.++|+|||||++|+|++|..||. +.+.......+......         
T Consensus       196 ~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~-~~~~~~~~~~i~~~~~~---------  265 (370)
T cd05621         196 GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFY-ADSLVGTYSKIMDHKNS---------  265 (370)
T ss_pred             CceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCC-CCCHHHHHHHHHhCCcc---------
Confidence            22  2356799999999999752   237889999999999999999999984 33333444443322110         


Q ss_pred             CCCccccccccCCCCCCHHHHHHHHHhcccCcCC--CCCHHHHhcCCCccccc
Q 015374          349 RKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQD--RLTAREAMAHPYFAQVR  399 (408)
Q Consensus       349 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~--Rpt~~elL~hp~f~~~~  399 (408)
                       .      .......++..+++++.+||+.++.+  |+|++|+++||||+...
T Consensus       266 -~------~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~~~  311 (370)
T cd05621         266 -L------NFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKNDQ  311 (370)
T ss_pred             -c------CCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcCcccCCCC
Confidence             0      01111236899999999999855543  88999999999998753

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=2e-44  Score=342.57  Aligned_cols=246  Identities=25%  Similarity=0.444  Sum_probs=202.3

Q ss_pred             eeeeeeCceEEEEEEEcCCCcEEEEEEeccc------chHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccEEEEEee
Q 015374          131 RKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYV  204 (408)
Q Consensus       131 ~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~  204 (408)
                      +.||+|+||+||+|++..+++.||+|+++..      .......|..++..+.+||||+++++++.+  ....++||||+
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~--~~~~~lv~ey~   78 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQT--KENLFFVMEYL   78 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEe--CCEEEEEEeCC
Confidence            3699999999999999999999999998743      234466788888765599999999999965  46789999999


Q ss_pred             cCCChhhhcC---CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccC-CCcceeec
Q 015374          205 NSTDFKVLYP---TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP-GKEYNVRV  280 (408)
Q Consensus       205 ~~~~l~~~~~---~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~-~~~~~~~~  280 (408)
                      ++++|..++.   .+++..+..++.|++.||.|||++||+||||||+|||++.+ +.+||+|||++..... ........
T Consensus        79 ~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~  157 (316)
T cd05619          79 NGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTD-GHIKIADFGMCKENMLGDAKTCTFC  157 (316)
T ss_pred             CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCC-CCEEEccCCcceECCCCCCceeeec
Confidence            9999988873   58889999999999999999999999999999999999988 7899999999875432 22334567


Q ss_pred             cCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCCCccccccccC
Q 015374          281 ASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSKFINADN  360 (408)
Q Consensus       281 ~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  360 (408)
                      ||..|+|||++.+ ..++.++|||||||++|||++|..||. +.+..+.+..+...                    ....
T Consensus       158 gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~G~~pf~-~~~~~~~~~~i~~~--------------------~~~~  215 (316)
T cd05619         158 GTPDYIAPEILLG-QKYNTSVDWWSFGVLLYEMLIGQSPFH-GHDEEELFQSIRMD--------------------NPCY  215 (316)
T ss_pred             CCccccCHHHHcC-CCCCchhhhhhHHHHHHHHHhCCCCCC-CCCHHHHHHHHHhC--------------------CCCC
Confidence            8999999999987 678999999999999999999999984 33333333322111                    0111


Q ss_pred             CCCCCHHHHHHHHHhcccCcCCCCCHH-HHhcCCCccccccc
Q 015374          361 QHLVSPEAIDFLDKLLRYDHQDRLTAR-EAMAHPYFAQVRAA  401 (408)
Q Consensus       361 ~~~~~~~~~~li~~~L~~dp~~Rpt~~-elL~hp~f~~~~~~  401 (408)
                      +..++.++.+++.+||+.||++||++. ++++||||+.+...
T Consensus       216 ~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~h~~~~~~~~~  257 (316)
T cd05619         216 PRWLTREAKDILVKLFVREPERRLGVKGDIRQHPFFREIDWS  257 (316)
T ss_pred             CccCCHHHHHHHHHHhccCHhhcCCChHHHHcCcccCCCCHH
Confidence            223688999999999999999999996 89999999987654

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=5.9e-46  Score=339.14  Aligned_cols=247  Identities=21%  Similarity=0.482  Sum_probs=216.3

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecccc------hHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCcc
Q 015374          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK------KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP  197 (408)
Q Consensus       124 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~------~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~  197 (408)
                      ..+|++.+.||+|.||+|-+|.....|+.||||.+++..      .-.+.+|++||..| +||||+.++.+|  ++...+
T Consensus        52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsL-NHPhII~IyEVF--ENkdKI  128 (668)
T KOG0611|consen   52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSL-NHPHIIQIYEVF--ENKDKI  128 (668)
T ss_pred             hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhc-CCCceeehhhhh--cCCceE
Confidence            568999999999999999999999999999999987533      23578999999999 999999999999  556778


Q ss_pred             EEEEEeecCCChhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCCC
Q 015374          198 SLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK  274 (408)
Q Consensus       198 ~lv~e~~~~~~l~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~~  274 (408)
                      ++||||..+|.|.+++   ..+++.+.+.+++||..|+.|+|+++++|||||.+|||+|.| +.+||+|||++..+...+
T Consensus       129 vivMEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N-~NiKIADFGLSNly~~~k  207 (668)
T KOG0611|consen  129 VIVMEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQN-NNIKIADFGLSNLYADKK  207 (668)
T ss_pred             EEEEEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCC-CCeeeeccchhhhhcccc
Confidence            9999999999999998   469999999999999999999999999999999999999999 799999999999999888


Q ss_pred             cceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCCCccc
Q 015374          275 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSK  354 (408)
Q Consensus       275 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  354 (408)
                      ..++.+|++.|.+||+..+...-++.+|-|||||+||.|+.|..|| .|.+.......|....         +       
T Consensus       208 fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPF-DG~Dhk~lvrQIs~Ga---------Y-------  270 (668)
T KOG0611|consen  208 FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPF-DGRDHKRLVRQISRGA---------Y-------  270 (668)
T ss_pred             HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhccccc-CCchHHHHHHHhhccc---------c-------
Confidence            8899999999999999999555578999999999999999999998 5665544444443321         1       


Q ss_pred             cccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcc
Q 015374          355 FINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFA  396 (408)
Q Consensus       355 ~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~  396 (408)
                       .++    .-+.++.-||+.||..||++|.|++++-.|=|++
T Consensus       271 -rEP----~~PSdA~gLIRwmLmVNP~RRATieDiAsHWWvN  307 (668)
T KOG0611|consen  271 -REP----ETPSDASGLIRWMLMVNPERRATIEDIASHWWVN  307 (668)
T ss_pred             -cCC----CCCchHHHHHHHHHhcCcccchhHHHHhhhheee
Confidence             111    1356799999999999999999999999998875

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=1.6e-44  Score=345.80  Aligned_cols=270  Identities=20%  Similarity=0.327  Sum_probs=208.7

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc----chHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccE
Q 015374          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS  198 (408)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  198 (408)
                      ..++|++.++||+|+||+||++.+..++..+|+|.++..    ....+.+|+++++++ +|+||++++++|.+  ....+
T Consensus         3 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~--~~~~~   79 (333)
T cd06650           3 KDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHEC-NSPYIVGFYGAFYS--DGEIS   79 (333)
T ss_pred             chhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHC-CCCcccceeEEEEE--CCEEE
Confidence            467899999999999999999999999999999988643    235688999999999 99999999999976  46789


Q ss_pred             EEEEeecCCChhhhcC---CCChHHHHHHHHHHHHHHHHHHHC-CcEEecCCCCcEEEeCCCCcEEEEecccceeccCCC
Q 015374          199 LIFEYVNSTDFKVLYP---TLTDYDIRYYIYELLKALDYCHSQ-GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK  274 (408)
Q Consensus       199 lv~e~~~~~~l~~~~~---~l~~~~~~~i~~qi~~~L~~LH~~-~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~~  274 (408)
                      +||||+++++|..++.   .+++..+..++.|++.||.|||+. +|+|+||||+|||++.+ +.+||+|||++..... .
T Consensus        80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~-~~~kL~Dfg~~~~~~~-~  157 (333)
T cd06650          80 ICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSR-GEIKLCDFGVSGQLID-S  157 (333)
T ss_pred             EEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCC-CCEEEeeCCcchhhhh-h
Confidence            9999999999988873   478888899999999999999985 79999999999999988 7899999999875532 2


Q ss_pred             cceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhc--hhhhhcCC------
Q 015374          275 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCC--LIIWCNSR------  346 (408)
Q Consensus       275 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~--~~~~~~~~------  346 (408)
                      ......++..|+|||++.+ ..++.++|+|||||++|+|++|+.||.....  ..+..+.....  ........      
T Consensus       158 ~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (333)
T cd06650         158 MANSFVGTRSYMSPERLQG-THYSVQSDIWSMGLSLVEMAIGRYPIPPPDA--KELELMFGCPVEGDPAESETSPRPRPP  234 (333)
T ss_pred             ccccCCCCccccCHHHhcC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCcch--hHHHHHhcCcccCCccccccCcccCCc
Confidence            2334578899999999987 6789999999999999999999999843322  22222211000  00000000      


Q ss_pred             --------CCCCCc-------cccc----cccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccccc
Q 015374          347 --------HSRKPW-------SKFI----NADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRA  400 (408)
Q Consensus       347 --------~~~~~~-------~~~~----~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~~~~  400 (408)
                              ...++.       ....    +.......+.++.+|+.+||++||++|||++|+++||||+....
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~~  307 (333)
T cd06650         235 GRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSEA  307 (333)
T ss_pred             cchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcCcc
Confidence                    000000       0000    00001125788999999999999999999999999999987654

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=1.8e-44  Score=344.03  Aligned_cols=244  Identities=28%  Similarity=0.487  Sum_probs=200.6

Q ss_pred             eeeeeeCceEEEEEEEc---CCCcEEEEEEecccc-------hHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccEEE
Q 015374          131 RKVGRGKYSEVFEGINV---NTNERCIIKILKPVK-------KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI  200 (408)
Q Consensus       131 ~~lG~G~fg~Vy~~~~~---~~~~~vavK~~~~~~-------~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  200 (408)
                      +.||+|+||.||++++.   .+++.||+|+++...       ...+.+|+.+++.+ +||||++++++|..  +...++|
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~iv~~~~~~~~--~~~~~lv   78 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAV-KHPFIVDLIYAFQT--GGKLYLI   78 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhC-CCCchhceeeEEec--CCeEEEE
Confidence            57999999999999864   468899999986421       24567899999999 99999999999965  4678999


Q ss_pred             EEeecCCChhhhcC---CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCC-Ccc
Q 015374          201 FEYVNSTDFKVLYP---TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG-KEY  276 (408)
Q Consensus       201 ~e~~~~~~l~~~~~---~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~-~~~  276 (408)
                      |||+++++|..++.   .+.+..+..++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+++..... ...
T Consensus        79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~-~~~kl~Dfg~~~~~~~~~~~~  157 (323)
T cd05584          79 LEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQ-GHVKLTDFGLCKESIHEGTVT  157 (323)
T ss_pred             EeCCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCC-CCEEEeeCcCCeecccCCCcc
Confidence            99999999988763   47888889999999999999999999999999999999988 79999999998754322 223


Q ss_pred             eeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCCCccccc
Q 015374          277 NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSKFI  356 (408)
Q Consensus       277 ~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  356 (408)
                      ....|+..|+|||++.+ ..++.++|||||||++|||++|+.||. +.+.......+...                    
T Consensus       158 ~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~G~~pf~-~~~~~~~~~~~~~~--------------------  215 (323)
T cd05584         158 HTFCGTIEYMAPEILMR-SGHGKAVDWWSLGALMYDMLTGAPPFT-AENRKKTIDKILKG--------------------  215 (323)
T ss_pred             cccCCCccccChhhccC-CCCCCcceecccHHHHHHHhcCCCCCC-CCCHHHHHHHHHcC--------------------
Confidence            34578999999999987 678999999999999999999999984 33333333333221                    


Q ss_pred             cccCCCCCCHHHHHHHHHhcccCcCCCC-----CHHHHhcCCCcccccc
Q 015374          357 NADNQHLVSPEAIDFLDKLLRYDHQDRL-----TAREAMAHPYFAQVRA  400 (408)
Q Consensus       357 ~~~~~~~~~~~~~~li~~~L~~dp~~Rp-----t~~elL~hp~f~~~~~  400 (408)
                      ....+..+++++.+|+.+||+.||++||     +++++++||||.....
T Consensus       216 ~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h~~~~~~~~  264 (323)
T cd05584         216 KLNLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPFFRHVNW  264 (323)
T ss_pred             CCCCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcCCCcCCCCH
Confidence            1122334789999999999999999999     8999999999987643

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=3.7e-44  Score=335.82  Aligned_cols=253  Identities=26%  Similarity=0.440  Sum_probs=208.8

Q ss_pred             CEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecccc------hHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccEE
Q 015374          126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK------KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSL  199 (408)
Q Consensus       126 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~------~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l  199 (408)
                      .|+..+.||+|+||+||++.+..+++.+|+|.+....      ...+.+|+.+++++ +|+|++.+++.+.+  ....++
T Consensus         1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~~~~i~~~~~~~~~--~~~~~l   77 (285)
T cd05630           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKV-NSRFVVSLAYAYET--KDALCL   77 (285)
T ss_pred             CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhC-CCCCeeeeeEEEec--CCEEEE
Confidence            3677889999999999999999999999999986421      23567899999999 99999999999965  467899


Q ss_pred             EEEeecCCChhhhc-----CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCCC
Q 015374          200 IFEYVNSTDFKVLY-----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK  274 (408)
Q Consensus       200 v~e~~~~~~l~~~~-----~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~~  274 (408)
                      ||||+++++|..++     ..+++..+..++.|++.||.|||+.+|+|+||||+||+++.+ +.++|+|||++.......
T Consensus        78 v~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~-~~~~l~Dfg~~~~~~~~~  156 (285)
T cd05630          78 VLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDH-GHIRISDLGLAVHVPEGQ  156 (285)
T ss_pred             EEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCC-CCEEEeeccceeecCCCc
Confidence            99999999998776     248888999999999999999999999999999999999987 789999999997665444


Q ss_pred             cceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCH--HHHHHHHhhhchhhhhcCCCCCCCc
Q 015374          275 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNH--DQLVKIAKDCCLIIWCNSRHSRKPW  352 (408)
Q Consensus       275 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~  352 (408)
                      ......|+..|+|||++.+ ..++.++|||||||++|+|++|..||.......  +.........               
T Consensus       157 ~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~---------------  220 (285)
T cd05630         157 TIKGRVGTVGYMAPEVVKN-ERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEV---------------  220 (285)
T ss_pred             cccCCCCCccccChHHHcC-CCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhh---------------
Confidence            4445678999999999987 679999999999999999999999985433221  1222111110               


Q ss_pred             cccccccCCCCCCHHHHHHHHHhcccCcCCCCC-----HHHHhcCCCccccccch
Q 015374          353 SKFINADNQHLVSPEAIDFLDKLLRYDHQDRLT-----AREAMAHPYFAQVRAAE  402 (408)
Q Consensus       353 ~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt-----~~elL~hp~f~~~~~~~  402 (408)
                          ....+..+++++.+|+.+||+.||++|||     ++|+++||||+.+....
T Consensus       221 ----~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~~~~~~  271 (285)
T cd05630         221 ----QEEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQINFKR  271 (285)
T ss_pred             ----hhhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcChhhhccCHHH
Confidence                11122346889999999999999999999     99999999999875543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=2.8e-44  Score=335.76  Aligned_cols=247  Identities=24%  Similarity=0.385  Sum_probs=200.6

Q ss_pred             eeeeCceEEEEEEEcCCCcEEEEEEecccc------hHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccEEEEEeecC
Q 015374          133 VGRGKYSEVFEGINVNTNERCIIKILKPVK------KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNS  206 (408)
Q Consensus       133 lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~------~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~~  206 (408)
                      ||+|+||+||++.+..+++.+|+|.+....      .+.+..|+.+++.+ +|+||+++.+++..  ....++||||+++
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~~~~i~~~~~~~~~--~~~~~lv~e~~~~   77 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKV-HSRFIVSLAYAFQT--KTDLCLVMTIMNG   77 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhC-CCCcEeeeeEEEcC--CCeEEEEEeCCCC
Confidence            699999999999999999999999986422      24567899999999 99999999999854  4678999999999


Q ss_pred             CChhhhc-------CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCCCc-cee
Q 015374          207 TDFKVLY-------PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE-YNV  278 (408)
Q Consensus       207 ~~l~~~~-------~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~~~-~~~  278 (408)
                      ++|..++       ..+++..+..++.|++.||.|||+++|+||||||+||+++.+ +.++|+|||++........ ...
T Consensus        78 g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~-~~~~l~dfg~~~~~~~~~~~~~~  156 (280)
T cd05608          78 GDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDND-GNVRISDLGLAVELKDGQSKTKG  156 (280)
T ss_pred             CCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCC-CCEEEeeCccceecCCCCccccc
Confidence            9997664       248899999999999999999999999999999999999987 7899999999976544322 234


Q ss_pred             eccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCCCccccccc
Q 015374          279 RVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSKFINA  358 (408)
Q Consensus       279 ~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  358 (408)
                      ..|+..|+|||.+.+ ..++.++|||||||++|+|++|+.||......... ........          .      ...
T Consensus       157 ~~g~~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~-~~~~~~~~----------~------~~~  218 (280)
T cd05608         157 YAGTPGFMAPELLQG-EEYDFSVDYFALGVTLYEMIAARGPFRARGEKVEN-KELKQRIL----------N------DSV  218 (280)
T ss_pred             cCCCcCccCHHHhcC-CCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhH-HHHHHhhc----------c------cCC
Confidence            578899999999987 78899999999999999999999998543322111 11111100          0      011


Q ss_pred             cCCCCCCHHHHHHHHHhcccCcCCCC-----CHHHHhcCCCccccccc
Q 015374          359 DNQHLVSPEAIDFLDKLLRYDHQDRL-----TAREAMAHPYFAQVRAA  401 (408)
Q Consensus       359 ~~~~~~~~~~~~li~~~L~~dp~~Rp-----t~~elL~hp~f~~~~~~  401 (408)
                      ..+..++.++.+++.+||+.||++||     |++++++||||+.+...
T Consensus       219 ~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h~~~~~~~~~  266 (280)
T cd05608         219 TYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTHPLFRDLNWR  266 (280)
T ss_pred             CCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcChhhhcCCHh
Confidence            22334789999999999999999999     89999999999987554

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=3.3e-44  Score=342.77  Aligned_cols=249  Identities=24%  Similarity=0.444  Sum_probs=204.6

Q ss_pred             eeeeeeCceEEEEEEEcCCCcEEEEEEeccc------chHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccEEEEEee
Q 015374          131 RKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYV  204 (408)
Q Consensus       131 ~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~  204 (408)
                      +.||+|+||+||+|.+..+++.+|+|+++..      ..+.+.+|+.++.++.+|+||+.+++++.+  ....++||||+
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~--~~~~~lv~e~~   78 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQT--TSRLFLVIEYV   78 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEe--CCEEEEEEeCC
Confidence            3699999999999999999999999999743      234577899999998789999999999965  46789999999


Q ss_pred             cCCChhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceecc-CCCcceeec
Q 015374          205 NSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH-PGKEYNVRV  280 (408)
Q Consensus       205 ~~~~l~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~-~~~~~~~~~  280 (408)
                      ++++|..++   ..+++..++.++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+++... ........+
T Consensus        79 ~~~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~  157 (327)
T cd05617          79 NGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDAD-GHIKLTDYGMCKEGLGPGDTTSTFC  157 (327)
T ss_pred             CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCC-CCEEEeccccceeccCCCCceeccc
Confidence            999998765   469999999999999999999999999999999999999988 789999999987532 233344567


Q ss_pred             cCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCC-----CCHHHHHHHHhhhchhhhhcCCCCCCCcccc
Q 015374          281 ASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGH-----DNHDQLVKIAKDCCLIIWCNSRHSRKPWSKF  355 (408)
Q Consensus       281 ~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  355 (408)
                      ||..|+|||++.+ ..++.++|||||||++|+|++|..||....     +..+.+......                   
T Consensus       158 gt~~y~aPE~~~~-~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~-------------------  217 (327)
T cd05617         158 GTPNYIAPEILRG-EEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILE-------------------  217 (327)
T ss_pred             CCcccCCHHHHCC-CCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHh-------------------
Confidence            9999999999987 788999999999999999999999984321     112222222111                   


Q ss_pred             ccccCCCCCCHHHHHHHHHhcccCcCCCCC------HHHHhcCCCccccccch
Q 015374          356 INADNQHLVSPEAIDFLDKLLRYDHQDRLT------AREAMAHPYFAQVRAAE  402 (408)
Q Consensus       356 ~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt------~~elL~hp~f~~~~~~~  402 (408)
                      .....+..++..+.+++.+||..||++|++      .+++++||||+.+....
T Consensus       218 ~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h~~f~~~~~~~  270 (327)
T cd05617         218 KPIRIPRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSHTFFRSIDWDL  270 (327)
T ss_pred             CCCCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcCCCCCCCCHHH
Confidence            011223447899999999999999999997      57999999999886543

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=4.5e-44  Score=341.21  Aligned_cols=251  Identities=24%  Similarity=0.393  Sum_probs=206.8

Q ss_pred             CEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc------chHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccEE
Q 015374          126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSL  199 (408)
Q Consensus       126 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l  199 (408)
                      +|+..+.||+|+||+||+|.+..+++.||+|+++..      ..+.+..|..++..+.+|++|+++++++.+  ....++
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~--~~~~~l   78 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQT--VDRLYF   78 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEec--CCEEEE
Confidence            477889999999999999999999999999998642      224567888999888567888899999865  457889


Q ss_pred             EEEeecCCChhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCCC-c
Q 015374          200 IFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK-E  275 (408)
Q Consensus       200 v~e~~~~~~l~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~~-~  275 (408)
                      ||||+++++|..++   ..+++..+..++.|++.||.|||++||+||||||+|||++.+ +.+||+|||+++...... .
T Consensus        79 v~Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~-~~ikL~Dfg~~~~~~~~~~~  157 (323)
T cd05615          79 VMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSE-GHIKIADFGMCKEHMVDGVT  157 (323)
T ss_pred             EEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCC-CCEEEeccccccccCCCCcc
Confidence            99999999998876   458999999999999999999999999999999999999988 799999999987543222 2


Q ss_pred             ceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCCCcccc
Q 015374          276 YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSKF  355 (408)
Q Consensus       276 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  355 (408)
                      .....||..|+|||++.+ ..++.++|||||||++|+|++|..||. +.+.......+...                   
T Consensus       158 ~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~elltG~~pf~-~~~~~~~~~~i~~~-------------------  216 (323)
T cd05615         158 TRTFCGTPDYIAPEIIAY-QPYGKSVDWWAYGVLLYEMLAGQPPFD-GEDEDELFQSIMEH-------------------  216 (323)
T ss_pred             ccCccCCccccCHHHHcC-CCCCCccchhhhHHHHHHHHhCCCCCC-CCCHHHHHHHHHhC-------------------
Confidence            334568999999999987 778999999999999999999999984 33333333333321                   


Q ss_pred             ccccCCCCCCHHHHHHHHHhcccCcCCCCC-----HHHHhcCCCccccccc
Q 015374          356 INADNQHLVSPEAIDFLDKLLRYDHQDRLT-----AREAMAHPYFAQVRAA  401 (408)
Q Consensus       356 ~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt-----~~elL~hp~f~~~~~~  401 (408)
                       ....+..++.++.+++.+||+.||.+|++     .+++++||||+.+...
T Consensus       217 -~~~~p~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~f~~~~~~  266 (323)
T cd05615         217 -NVSYPKSLSKEAVSICKGLMTKHPSKRLGCGPEGERDIREHAFFRRIDWD  266 (323)
T ss_pred             -CCCCCccCCHHHHHHHHHHcccCHhhCCCCCCCCHHHHhcCcccCCCCHH
Confidence             11123347889999999999999999997     5799999999988653

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.7e-44  Score=341.21  Aligned_cols=258  Identities=27%  Similarity=0.416  Sum_probs=206.4

Q ss_pred             CCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc------chHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccE
Q 015374          125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS  198 (408)
Q Consensus       125 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  198 (408)
                      ++|++.+.||+|+||+||++++..+++.||+|+++..      ..+.+.+|+.++..+ +|+||++++++|.+  +...+
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~--~~~~~   77 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNG-DRRWITNLHYAFQD--ENNLY   77 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhC-CCCCCCceEEEEec--CCeEE
Confidence            4799999999999999999999999999999998632      234578899999998 99999999999965  46889


Q ss_pred             EEEEeecCCChhhhcC----CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCCC
Q 015374          199 LIFEYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK  274 (408)
Q Consensus       199 lv~e~~~~~~l~~~~~----~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~~  274 (408)
                      +||||+++++|..++.    .+++..++.++.|++.||+|||+++|+||||||+|||++.+ +.+||+|||++.......
T Consensus        78 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~-~~~kl~Dfg~~~~~~~~~  156 (331)
T cd05597          78 LVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKN-GHIRLADFGSCLRLLADG  156 (331)
T ss_pred             EEEecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCC-CCEEEEECCceeecCCCC
Confidence            9999999999988763    48899999999999999999999999999999999999988 799999999987654433


Q ss_pred             cc--eeeccCccccccccccC----CcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCC
Q 015374          275 EY--NVRVASRYFKGPELLVD----LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHS  348 (408)
Q Consensus       275 ~~--~~~~~~~~y~aPE~~~~----~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  348 (408)
                      ..  ....||..|+|||++..    ...++.++|||||||++|+|++|+.||. +.+..+....+......         
T Consensus       157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~-~~~~~~~~~~i~~~~~~---------  226 (331)
T cd05597         157 TVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFY-AESLVETYGKIMNHKEH---------  226 (331)
T ss_pred             CccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCC-CCCHHHHHHHHHcCCCc---------
Confidence            22  23568999999999863    2457889999999999999999999984 33333433333221100         


Q ss_pred             CCCccccccccCCCCCCHHHHHHHHHhcccCcCC--CCCHHHHhcCCCccccccch
Q 015374          349 RKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQD--RLTAREAMAHPYFAQVRAAE  402 (408)
Q Consensus       349 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~--Rpt~~elL~hp~f~~~~~~~  402 (408)
                       ..     -......+++++++|+++||..++++  |++++++++||||...+...
T Consensus       227 -~~-----~~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~~~~~~  276 (331)
T cd05597         227 -FQ-----FPPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDHPFFEGIDWDN  276 (331)
T ss_pred             -cc-----CCCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCCCCCCCCHHH
Confidence             00     01111237899999999998764443  78999999999998876533

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.6e-44  Score=347.18  Aligned_cols=273  Identities=30%  Similarity=0.540  Sum_probs=211.5

Q ss_pred             CCCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc-----chHHHHHHHHHHHHhcCCCCceEEeeEEEccC---
Q 015374          122 GDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQH---  193 (408)
Q Consensus       122 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~---  193 (408)
                      ...++|++.+.||+|+||+||+|.+..++..||||.++..     ....+.+|+.+++++ +|+||+++++++....   
T Consensus        12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~   90 (343)
T cd07878          12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHM-KHENVIGLLDVFTPATSIE   90 (343)
T ss_pred             hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhc-CCCchhhhhhhhccccccc
Confidence            3467899999999999999999999999999999998642     234577899999999 9999999999885322   


Q ss_pred             -CCccEEEEEeecCCChhhhc--CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceec
Q 015374          194 -SKTPSLIFEYVNSTDFKVLY--PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY  270 (408)
Q Consensus       194 -~~~~~lv~e~~~~~~l~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~  270 (408)
                       ....++++|++ ++++..++  ..+++..+..++.|++.||.|||++||+||||||+|||++.+ +.+||+|||++...
T Consensus        91 ~~~~~~~~~~~~-~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~-~~~kl~Dfg~~~~~  168 (343)
T cd07878          91 NFNEVYLVTNLM-GADLNNIVKCQKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNED-CELRILDFGLARQA  168 (343)
T ss_pred             ccCcEEEEeecC-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCC-CCEEEcCCccceec
Confidence             23568999988 56676665  358999999999999999999999999999999999999988 78999999999865


Q ss_pred             cCCCcceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcC-CCCC
Q 015374          271 HPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNS-RHSR  349 (408)
Q Consensus       271 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~  349 (408)
                      ..  ......+|..|+|||++.+...++.++|||||||++|+|++|..|| .+.+..+.+..+....+....... ....
T Consensus       169 ~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (343)
T cd07878         169 DD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALF-PGNDYIDQLKRIMEVVGTPSPEVLKKISS  245 (343)
T ss_pred             CC--CcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCC-CCCCHHHHHHHHHHHhCCCCHHHHHhcch
Confidence            43  2334578999999999987567899999999999999999999987 445545555555443332211000 0000


Q ss_pred             C----------CccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccccc
Q 015374          350 K----------PWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRA  400 (408)
Q Consensus       350 ~----------~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~~~~  400 (408)
                      .          ..............++.+.+|+.+||..||++|||+.|+|+||||.....
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~~~  306 (343)
T cd07878         246 EHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQYHD  306 (343)
T ss_pred             hhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhccCC
Confidence            0          00000000111235678999999999999999999999999999987643

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=7.5e-44  Score=336.31  Aligned_cols=272  Identities=28%  Similarity=0.568  Sum_probs=211.5

Q ss_pred             CCCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecccc----hHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCcc
Q 015374          122 GDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP  197 (408)
Q Consensus       122 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~  197 (408)
                      +..++|++.++||.|+||.||+|++..++..||+|.++...    ...+.+|+.+++++ +|+||+++++++..  ....
T Consensus         3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~nI~~~~~~~~~--~~~~   79 (301)
T cd07873           3 GKLETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDL-KHANIVTLHDIIHT--EKSL   79 (301)
T ss_pred             ccccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhc-CCCCcceEEEEEec--CCeE
Confidence            45678999999999999999999999999999999986322    34677899999999 99999999999965  4678


Q ss_pred             EEEEEeecCCChhhhc----CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCC
Q 015374          198 SLIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG  273 (408)
Q Consensus       198 ~lv~e~~~~~~l~~~~----~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~  273 (408)
                      ++||||+++ ++..++    ..+++..+..++.|++.||+|||+.+|+|+||||+||+++.+ +.++|+|||++......
T Consensus        80 ~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~-~~~kl~dfg~~~~~~~~  157 (301)
T cd07873          80 TLVFEYLDK-DLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINER-GELKLADFGLARAKSIP  157 (301)
T ss_pred             EEEEecccc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCC-CcEEECcCcchhccCCC
Confidence            999999985 555544    347888999999999999999999999999999999999988 79999999998754322


Q ss_pred             C-cceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCC--CCCC
Q 015374          274 K-EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSR--HSRK  350 (408)
Q Consensus       274 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~  350 (408)
                      . ......++..|+|||.+.+...++.++|||||||++|+|++|+.||. +.+..+.+..+....+......+.  ....
T Consensus       158 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (301)
T cd07873         158 TKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFP-GSTVEEQLHFIFRILGTPTEETWPGILSNE  236 (301)
T ss_pred             CCcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCC-CCCHHHHHHHHHHHcCCCChhhchhhhccc
Confidence            2 22334678899999998775678899999999999999999998874 444455555444433322111000  0000


Q ss_pred             Cccc-----c---ccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccccc
Q 015374          351 PWSK-----F---INADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVR  399 (408)
Q Consensus       351 ~~~~-----~---~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~~~  399 (408)
                      .+..     .   ........+++++.+||.+||+.||.+|||++|+|+||||+..-
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~~  293 (301)
T cd07873         237 EFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLG  293 (301)
T ss_pred             cccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccc
Confidence            0000     0   00112234788999999999999999999999999999998764

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.4e-45  Score=341.43  Aligned_cols=255  Identities=24%  Similarity=0.442  Sum_probs=226.0

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecccc-----hHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccE
Q 015374          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK-----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS  198 (408)
Q Consensus       124 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  198 (408)
                      ..=|.+.+.||+|.|+.|-+|++.-+|+.||||++.+..     ...+.+|+.-|+-+ +|||||++|.+...  ...+|
T Consensus        17 AGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLV-QHpNiVRLYEViDT--QTKly   93 (864)
T KOG4717|consen   17 AGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLV-QHPNIVRLYEVIDT--QTKLY   93 (864)
T ss_pred             eeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHh-cCcCeeeeeehhcc--cceEE
Confidence            345788889999999999999999999999999997543     45788999999998 99999999999854  45688


Q ss_pred             EEEEeecCCChhhhc----CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCCC
Q 015374          199 LIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK  274 (408)
Q Consensus       199 lv~e~~~~~~l~~~~----~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~~  274 (408)
                      ||+|.-.+|+|.+++    ..+.+...++|+.||+.|+.|+|+..+|||||||+|+.+-...|-|||+|||++..+.++.
T Consensus        94 LiLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~  173 (864)
T KOG4717|consen   94 LILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGK  173 (864)
T ss_pred             EEEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccCCCcc
Confidence            999999999999987    4599999999999999999999999999999999999998888999999999999999999


Q ss_pred             cceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCCCccc
Q 015374          275 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSK  354 (408)
Q Consensus       275 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  354 (408)
                      ..++.+|+..|.|||++++....-+++||||||||||.|++|+.|| ...++.+.+..|+..                  
T Consensus       174 kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PF-qeANDSETLTmImDC------------------  234 (864)
T KOG4717|consen  174 KLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPF-QEANDSETLTMIMDC------------------  234 (864)
T ss_pred             hhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCcc-ccccchhhhhhhhcc------------------
Confidence            9999999999999999999555567999999999999999999998 455566666665543                  


Q ss_pred             cccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccccccch
Q 015374          355 FINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAE  402 (408)
Q Consensus       355 ~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~~~~~~  402 (408)
                        ....+..++.++++||..||..||.+|.|.+|+..++|++.++...
T Consensus       235 --KYtvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~~Wlq~~D~~~  280 (864)
T KOG4717|consen  235 --KYTVPSHVSKECRDLIQSMLVRDPKKRASLEEIVSTSWLQAGDRGL  280 (864)
T ss_pred             --cccCchhhhHHHHHHHHHHHhcCchhhccHHHHhccccccCCCCCc
Confidence              2234556899999999999999999999999999999999987643

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=6.4e-44  Score=352.78  Aligned_cols=265  Identities=23%  Similarity=0.316  Sum_probs=204.8

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecccchHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccEEEEEe
Q 015374          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEY  203 (408)
Q Consensus       124 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~  203 (408)
                      ..+|.+.+.||+|+||.||+|.+..+++.||||...   ...+.+|+.+++++ +|+||+++++++..  +...++|||+
T Consensus       168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~---~~~~~~E~~iL~~L-~HpnIv~l~~~~~~--~~~~~lv~e~  241 (461)
T PHA03211        168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW---YASSVHEARLLRRL-SHPAVLALLDVRVV--GGLTCLVLPK  241 (461)
T ss_pred             cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc---ccCHHHHHHHHHHC-CCCCCCcEEEEEEE--CCEEEEEEEc
Confidence            457999999999999999999999999999999643   34567899999999 99999999999865  4677899999


Q ss_pred             ecCCChhhhc----CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCCCc---c
Q 015374          204 VNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE---Y  276 (408)
Q Consensus       204 ~~~~~l~~~~----~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~~~---~  276 (408)
                      +.+ ++..++    ..+++..+..++.|++.||.|||++||+||||||+|||++.+ +.++|+|||+++.......   .
T Consensus       242 ~~~-~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~-~~vkL~DFGla~~~~~~~~~~~~  319 (461)
T PHA03211        242 YRS-DLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGP-EDICLGDFGAACFARGSWSTPFH  319 (461)
T ss_pred             cCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCC-CCEEEcccCCceecccccccccc
Confidence            975 444443    348999999999999999999999999999999999999988 7899999999986643322   1


Q ss_pred             eeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCC------CHHHHHHHHhhhchhhhhcCCC---
Q 015374          277 NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHD------NHDQLVKIAKDCCLIIWCNSRH---  347 (408)
Q Consensus       277 ~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~------~~~~~~~~~~~~~~~~~~~~~~---  347 (408)
                      ....||..|+|||++.+ ..++.++|||||||++|||++|..+++....      ..+++..++...+.........   
T Consensus       320 ~~~~GT~~Y~APE~~~~-~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~~  398 (461)
T PHA03211        320 YGIAGTVDTNAPEVLAG-DPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAGS  398 (461)
T ss_pred             cccCCCcCCcCHHHHcC-CCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcch
Confidence            23468999999999987 6799999999999999999999888765432      2344555554433211000000   


Q ss_pred             ------------CCCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccc
Q 015374          348 ------------SRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQ  397 (408)
Q Consensus       348 ------------~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~  397 (408)
                                  ................++.++.+||.+||++||.+|||+.|+|+||||++
T Consensus       399 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~  460 (461)
T PHA03211        399 RLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQS  460 (461)
T ss_pred             HHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCcccCC
Confidence                        00000000000111135678999999999999999999999999999975

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.3e-44  Score=334.64  Aligned_cols=295  Identities=25%  Similarity=0.397  Sum_probs=236.9

Q ss_pred             ccccCCcccCCCCCcccccCCC-CCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecccc--hHHHHHHHHHHHHhcCC
Q 015374          103 VNVLRPKEYWDYESLTVQWGDQ-DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK--KKKIKREIKILQNLCGG  179 (408)
Q Consensus       103 ~~~~~~~~~~~~~~~~~~~~~~-~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~E~~~l~~l~~h  179 (408)
                      .+....+....|.+..++..+. .+|-+.++||+|.|+|||+|.+..+.+.||+|+.+...  .+....||++|+++..+
T Consensus        55 qE~~~dY~kGGYHpV~IGD~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhYtEaAlDEIklL~~v~~~  134 (590)
T KOG1290|consen   55 QEDPEDYRKGGYHPVRIGDVFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHYTEAALDEIKLLQQVREG  134 (590)
T ss_pred             ccChhhhhcCCCceeeccccccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhHHHHHHHHHHHHHHHHHhc
Confidence            3444556677899999998887 99999999999999999999999999999999998433  46678999999988432


Q ss_pred             -------CCceEEeeEEEc--cCCCccEEEEEeecCCChhhhc----CCCChHHHHHHHHHHHHHHHHHHH-CCcEEecC
Q 015374          180 -------PNVVKLLDIVRD--QHSKTPSLIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHS-QGIMHRDV  245 (408)
Q Consensus       180 -------~niv~l~~~~~~--~~~~~~~lv~e~~~~~~l~~~~----~~l~~~~~~~i~~qi~~~L~~LH~-~~iiH~Dl  245 (408)
                             .+||+|++.|..  .++.++|||+|++....|....    +.++...++.|+.|++.||.|||. +||||.||
T Consensus       135 Dp~~~~~~~VV~LlD~FkhsGpNG~HVCMVfEvLGdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDl  214 (590)
T KOG1290|consen  135 DPNDPGKKCVVQLLDHFKHSGPNGQHVCMVFEVLGDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDL  214 (590)
T ss_pred             CCCCCCCceeeeeeccceecCCCCcEEEEEehhhhhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCC
Confidence                   479999999974  4778999999999988876654    569999999999999999999996 59999999


Q ss_pred             CCCcEEEe------------------------------------------------------------------------
Q 015374          246 KPHNVMID------------------------------------------------------------------------  253 (408)
Q Consensus       246 k~~NILl~------------------------------------------------------------------------  253 (408)
                      ||+|||+.                                                                        
T Consensus       215 KPENvLl~~~e~~~~~~~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~  294 (590)
T KOG1290|consen  215 KPENVLLCSTEIDPAKDAREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGI  294 (590)
T ss_pred             CcceeeeeccccchhhhhhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccc
Confidence            99999983                                                                        


Q ss_pred             ------------------------------------------CC------------------------------------
Q 015374          254 ------------------------------------------HE------------------------------------  255 (408)
Q Consensus       254 ------------------------------------------~~------------------------------------  255 (408)
                                                                .+                                    
T Consensus       295 ~~~~~~~s~n~~~~~n~~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~  374 (590)
T KOG1290|consen  295 EEEPNQESYNNEPRINGNESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTI  374 (590)
T ss_pred             cccccccccccccCCCccccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCcccc
Confidence                                                      00                                    


Q ss_pred             ---------------CCcEEEEecccceeccCCCcceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCC
Q 015374          256 ---------------LRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPF  320 (408)
Q Consensus       256 ---------------~~~~kl~DfG~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf  320 (408)
                                     .-.+||+|||.|....  ..++..+.|..|+|||++++ ..|++.+||||++|++|||+||...|
T Consensus       375 ~~n~~v~p~~~~~~~di~vKIaDlGNACW~~--khFT~DIQTRQYRapEVllG-sgY~~~ADiWS~AC~~FELaTGDyLF  451 (590)
T KOG1290|consen  375 ASNPLVNPDIPLPECDIRVKIADLGNACWVH--KHFTEDIQTRQYRAPEVLLG-SGYSTSADIWSTACMAFELATGDYLF  451 (590)
T ss_pred             ccccccCCCCCCCccceeEEEeeccchhhhh--hhhchhhhhhhccCcceeec-CCCCCchhHHHHHHHHHHhhcCceee
Confidence                           0137899999988764  45666789999999999999 88999999999999999999999988


Q ss_pred             CCC-----CCCHHHHHHHHhhhchhhhh---cCCCCCCC---------------ccccccc----cCCCCCCHHHHHHHH
Q 015374          321 FYG-----HDNHDQLVKIAKDCCLIIWC---NSRHSRKP---------------WSKFINA----DNQHLVSPEAIDFLD  373 (408)
Q Consensus       321 ~~~-----~~~~~~~~~~~~~~~~~~~~---~~~~~~~~---------------~~~~~~~----~~~~~~~~~~~~li~  373 (408)
                      .+-     .-+.+.++.|++.+|.+++.   .+.+++..               |+-..-.    .....-..++.+|+.
T Consensus       452 ePhsG~~Y~rDEDHiA~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~  531 (590)
T KOG1290|consen  452 EPHSGENYSRDEDHIALIMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLS  531 (590)
T ss_pred             cCCCCCCCCccHHHHHHHHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHH
Confidence            542     24678899999999977633   22333222               2111000    001111356899999


Q ss_pred             HhcccCcCCCCCHHHHhcCCCcccccc
Q 015374          374 KLLRYDHQDRLTAREAMAHPYFAQVRA  400 (408)
Q Consensus       374 ~~L~~dp~~Rpt~~elL~hp~f~~~~~  400 (408)
                      -||+++|++||||.++|+||||+.+.-
T Consensus       532 PmLef~PeKR~tA~~cl~hPwLn~~~~  558 (590)
T KOG1290|consen  532 PMLEFDPEKRPTAAQCLKHPWLNPVAG  558 (590)
T ss_pred             HHHhcCccccccHHHHhcCccccCCCC
Confidence            999999999999999999999996643

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=3.6e-44  Score=341.97  Aligned_cols=245  Identities=26%  Similarity=0.447  Sum_probs=198.7

Q ss_pred             eeeeeeCceEEEEEEEcCCCcEEEEEEecccc------hHHHHHHHH-HHHHhcCCCCceEEeeEEEccCCCccEEEEEe
Q 015374          131 RKVGRGKYSEVFEGINVNTNERCIIKILKPVK------KKKIKREIK-ILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEY  203 (408)
Q Consensus       131 ~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~------~~~~~~E~~-~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~  203 (408)
                      +.||+|+||+||+|++..+++.||+|++....      ...+.+|.. +++.+ +||||+++++++.+  ....++||||
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l-~hp~iv~~~~~~~~--~~~~~lv~e~   77 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNV-KHPFLVGLHYSFQT--ADKLYFVLDY   77 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhC-CCCCCCCeeEEEEe--CCEEEEEEcC
Confidence            36999999999999999999999999986422      234455555 45667 99999999999955  4678999999


Q ss_pred             ecCCChhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccC-CCcceee
Q 015374          204 VNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP-GKEYNVR  279 (408)
Q Consensus       204 ~~~~~l~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~-~~~~~~~  279 (408)
                      +++++|..++   ..+++..+..++.||+.||.|||++||+||||||+|||++.+ +.+||+|||++..... .......
T Consensus        78 ~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~-~~~kl~Dfg~~~~~~~~~~~~~~~  156 (323)
T cd05575          78 VNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQ-GHVVLTDFGLCKEGIEHSKTTSTF  156 (323)
T ss_pred             CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCC-CcEEEeccCCCcccccCCCccccc
Confidence            9999998776   358899999999999999999999999999999999999988 7999999999875432 2233445


Q ss_pred             ccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCCCcccccccc
Q 015374          280 VASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSKFINAD  359 (408)
Q Consensus       280 ~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  359 (408)
                      .||..|+|||++.+ ..++.++|||||||++|+|++|..||. +.+..+....+...                    ...
T Consensus       157 ~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~-~~~~~~~~~~i~~~--------------------~~~  214 (323)
T cd05575         157 CGTPEYLAPEVLRK-QPYDRTVDWWCLGAVLYEMLYGLPPFY-SRDTAEMYDNILNK--------------------PLR  214 (323)
T ss_pred             cCChhhcChhhhcC-CCCCccccccccchhhhhhhcCCCCCC-CCCHHHHHHHHHcC--------------------CCC
Confidence            78999999999987 779999999999999999999999984 33333333333221                    011


Q ss_pred             CCCCCCHHHHHHHHHhcccCcCCCCCH----HHHhcCCCccccccc
Q 015374          360 NQHLVSPEAIDFLDKLLRYDHQDRLTA----REAMAHPYFAQVRAA  401 (408)
Q Consensus       360 ~~~~~~~~~~~li~~~L~~dp~~Rpt~----~elL~hp~f~~~~~~  401 (408)
                      .+..++.++.++|.+||+.||.+||++    .|+++||||..+...
T Consensus       215 ~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~il~~~~~~~~~~~  260 (323)
T cd05575         215 LKPNISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNHVFFSSINWD  260 (323)
T ss_pred             CCCCCCHHHHHHHHHHhhcCHHhCCCCCCCHHHHHcCCCcCCCCHH
Confidence            223368999999999999999999987    699999999876643

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.9e-46  Score=356.11  Aligned_cols=257  Identities=26%  Similarity=0.436  Sum_probs=215.5

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecccc---hHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccEE
Q 015374          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK---KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSL  199 (408)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l  199 (408)
                      ..+.++++..||.|+||.||+|..+.++...|.|++....   .+.+.-|+.||..+ .||+||++++.|..  .+.+++
T Consensus        30 P~d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~C-dHP~ivkLl~ayy~--enkLwi  106 (1187)
T KOG0579|consen   30 PRDHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAEC-DHPVIVKLLSAYYF--ENKLWI  106 (1187)
T ss_pred             HHHHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcC-CChHHHHHHHHHhc--cCceEE
Confidence            4566788889999999999999999999999999986433   46678899999998 89999999997744  467889


Q ss_pred             EEEeecCCChhhhc----CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceecc-CCC
Q 015374          200 IFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH-PGK  274 (408)
Q Consensus       200 v~e~~~~~~l~~~~----~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~-~~~  274 (408)
                      +.|||+||..+..+    +.+++.++..++.|++.||.|||+++|||||||+.|||++.+ |.++|+|||.+.... ...
T Consensus       107 liEFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~Tld-GdirLADFGVSAKn~~t~q  185 (1187)
T KOG0579|consen  107 LIEFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLD-GDIRLADFGVSAKNKSTRQ  185 (1187)
T ss_pred             EEeecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEec-CcEeeecccccccchhHHh
Confidence            99999999987765    679999999999999999999999999999999999999999 899999999875432 223


Q ss_pred             cceeeccCccccccccccC----CcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCC
Q 015374          275 EYNVRVASRYFKGPELLVD----LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRK  350 (408)
Q Consensus       275 ~~~~~~~~~~y~aPE~~~~----~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  350 (408)
                      .....+||++|||||+...    ..+|++++||||||++|.||..+..|- ..-+....+.++.+.-.+           
T Consensus       186 kRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPH-helnpMRVllKiaKSePP-----------  253 (1187)
T KOG0579|consen  186 KRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPH-HELNPMRVLLKIAKSEPP-----------  253 (1187)
T ss_pred             hhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCc-cccchHHHHHHHhhcCCC-----------
Confidence            3467899999999999743    368999999999999999999998774 555666666666553211           


Q ss_pred             CccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccccccc
Q 015374          351 PWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAA  401 (408)
Q Consensus       351 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~~~~~  401 (408)
                            ..-.+...+..+.||+.+||..||..||++.++|+||||++++..
T Consensus       254 ------TLlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~~~~Sn  298 (1187)
T KOG0579|consen  254 ------TLLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKHPFVQNAPSN  298 (1187)
T ss_pred             ------cccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhCcccccCCcc
Confidence                  111234467889999999999999999999999999999988754

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-44  Score=345.07  Aligned_cols=256  Identities=20%  Similarity=0.313  Sum_probs=198.1

Q ss_pred             CCCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecccc---hHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccE
Q 015374          122 GDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK---KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS  198 (408)
Q Consensus       122 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  198 (408)
                      .++++|...+.||+|+||+||+|.. .++..||||.++...   ..+|.+|+.++.++ +|||+|+|+|||.+... ..+
T Consensus        72 ~AT~~Fs~~~~ig~Ggfg~VYkG~l-~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l-~H~Nlv~LlGyC~e~~~-~~~  148 (361)
T KOG1187|consen   72 KATNNFSESNLIGEGGFGTVYKGVL-SDGTVVAVKRLSSNSGQGEREFLNEVEILSRL-RHPNLVKLLGYCLEGGE-HRL  148 (361)
T ss_pred             HHHhCCchhcceecCCCeEEEEEEE-CCCCEEEEEEecCCCCcchhHHHHHHHHHhcC-CCcCcccEEEEEecCCc-eEE
Confidence            3578888889999999999999975 445899999987543   46799999999999 89999999999976532 588


Q ss_pred             EEEEeecCCChhhhcC-----CCChHHHHHHHHHHHHHHHHHHHC---CcEEecCCCCcEEEeCCCCcEEEEecccceec
Q 015374          199 LIFEYVNSTDFKVLYP-----TLTDYDIRYYIYELLKALDYCHSQ---GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY  270 (408)
Q Consensus       199 lv~e~~~~~~l~~~~~-----~l~~~~~~~i~~qi~~~L~~LH~~---~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~  270 (408)
                      ||||||++|+|.+++.     .++|..+.+|+.++|.||+|||+.   .|||||||++|||||.+ ..+||+|||+|+..
T Consensus       149 LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~-~~aKlsDFGLa~~~  227 (361)
T KOG1187|consen  149 LVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDED-FNAKLSDFGLAKLG  227 (361)
T ss_pred             EEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCC-CCEEccCccCcccC
Confidence            9999999999999872     579999999999999999999985   39999999999999998 68899999999766


Q ss_pred             cC-CCcceee-ccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCC-HHHHHHHHhhhchhhhhcCCC
Q 015374          271 HP-GKEYNVR-VASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDN-HDQLVKIAKDCCLIIWCNSRH  347 (408)
Q Consensus       271 ~~-~~~~~~~-~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~  347 (408)
                      .. ....... .||.+|+|||++.. +..+.++|||||||+++||++|+.+....... ...+......    .....  
T Consensus       228 ~~~~~~~~~~~~gt~gY~~PEy~~~-g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~----~~~~~--  300 (361)
T KOG1187|consen  228 PEGDTSVSTTVMGTFGYLAPEYAST-GKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKP----LLEEG--  300 (361)
T ss_pred             CccccceeeecCCCCccCChhhhcc-CCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHH----HHHCc--
Confidence            54 3333333 89999999999987 78999999999999999999999877433211 1112211100    00000  


Q ss_pred             CCCCccccccccCC-CCCC-----HHHHHHHHHhcccCcCCCCCHHHHhc
Q 015374          348 SRKPWSKFINADNQ-HLVS-----PEAIDFLDKLLRYDHQDRLTAREAMA  391 (408)
Q Consensus       348 ~~~~~~~~~~~~~~-~~~~-----~~~~~li~~~L~~dp~~Rpt~~elL~  391 (408)
                         ...+++.+... ...+     ..+..+..+|++.+|.+||++.|+++
T Consensus       301 ---~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~  347 (361)
T KOG1187|consen  301 ---KLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVK  347 (361)
T ss_pred             ---chhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHH
Confidence               12222222211 1111     33678889999999999999999743

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=1.2e-43  Score=339.51  Aligned_cols=258  Identities=24%  Similarity=0.412  Sum_probs=206.9

Q ss_pred             CCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc------chHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccE
Q 015374          125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS  198 (408)
Q Consensus       125 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  198 (408)
                      ++|++.++||+|+||+||++++..+++.+|+|++...      ....+.+|+.++..+ +|+||+++++++.+  ....+
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~--~~~~~   77 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNG-DNQWITTLHYAFQD--ENNLY   77 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhC-CCCCEeeEEEEEec--CCEEE
Confidence            4789999999999999999999999999999998632      123477899999998 99999999999965  46789


Q ss_pred             EEEEeecCCChhhhcC----CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCCC
Q 015374          199 LIFEYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK  274 (408)
Q Consensus       199 lv~e~~~~~~l~~~~~----~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~~  274 (408)
                      +||||+++|+|..++.    .+++..++.++.|++.||.|||+++|+||||||+|||++.+ +.+||+|||++.......
T Consensus        78 lv~ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~-~~~kL~DfG~a~~~~~~~  156 (332)
T cd05623          78 LVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMN-GHIRLADFGSCLKLMEDG  156 (332)
T ss_pred             EEEeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCC-CCEEEeecchheecccCC
Confidence            9999999999988873    47888999999999999999999999999999999999987 799999999987654332


Q ss_pred             c--ceeeccCccccccccccC----CcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCC
Q 015374          275 E--YNVRVASRYFKGPELLVD----LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHS  348 (408)
Q Consensus       275 ~--~~~~~~~~~y~aPE~~~~----~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  348 (408)
                      .  .....||..|+|||++..    ...++.++|||||||++|||++|+.||. +.+..+....+....          .
T Consensus       157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~-~~~~~~~~~~i~~~~----------~  225 (332)
T cd05623         157 TVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFY-AESLVETYGKIMNHK----------E  225 (332)
T ss_pred             cceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCC-CCCHHHHHHHHhCCC----------c
Confidence            2  223578999999999862    3468899999999999999999999984 333344444333210          0


Q ss_pred             CCCccccccccCCCCCCHHHHHHHHHhcccCcCC--CCCHHHHhcCCCccccccch
Q 015374          349 RKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQD--RLTAREAMAHPYFAQVRAAE  402 (408)
Q Consensus       349 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~--Rpt~~elL~hp~f~~~~~~~  402 (408)
                      +..+     +.....+++++.+|+++||..++++  |++++|+++||||+++....
T Consensus       226 ~~~~-----p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~~~~~~  276 (332)
T cd05623         226 RFQF-----PAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQHPFFTGIDWDN  276 (332)
T ss_pred             cccC-----CCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCCCCcCCCCHHH
Confidence            0000     1112347899999999999765544  68999999999999876543

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=5.6e-44  Score=334.05  Aligned_cols=266  Identities=31%  Similarity=0.568  Sum_probs=209.5

Q ss_pred             CEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc-----chHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccEEE
Q 015374          126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI  200 (408)
Q Consensus       126 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  200 (408)
                      +|++.+.||+|+||+||+|++..+|+.+|+|.++..     ....+.+|+.+++++ +|+||+++++++.+  ....+++
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l-~h~~i~~~~~~~~~--~~~~~lv   77 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKEL-KHKNIVRLYDVLHS--DKKLTLV   77 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhc-CCCCeeeHHHHhcc--CCceEEE
Confidence            588999999999999999999999999999998632     124577899999999 99999999999955  4678999


Q ss_pred             EEeecCCChhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCC-Ccc
Q 015374          201 FEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG-KEY  276 (408)
Q Consensus       201 ~e~~~~~~l~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~-~~~  276 (408)
                      +||++++.+..+.   ..+++..++.++.||+.||.|||+++|+|+||||+||+++.+ +.++|+|||++...... ...
T Consensus        78 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~-~~~~l~dfg~~~~~~~~~~~~  156 (284)
T cd07839          78 FEYCDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKN-GELKLADFGLARAFGIPVRCY  156 (284)
T ss_pred             EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCC-CcEEECccchhhccCCCCCCc
Confidence            9999865443332   348999999999999999999999999999999999999988 79999999998765432 222


Q ss_pred             eeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcC-----CCCCCC
Q 015374          277 NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNS-----RHSRKP  351 (408)
Q Consensus       277 ~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~  351 (408)
                      ....++..|+|||.+.+...++.++|||||||++|+|++|+.||+.+.+..+.+..+....+.......     ......
T Consensus       157 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (284)
T cd07839         157 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKP  236 (284)
T ss_pred             CCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccccc
Confidence            345678889999998775568999999999999999999999988877766666666554432211000     000000


Q ss_pred             cccccc----ccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCc
Q 015374          352 WSKFIN----ADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF  395 (408)
Q Consensus       352 ~~~~~~----~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f  395 (408)
                      +.....    ......+++++.++|.+||+.||.+|||++|+++||||
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f  284 (284)
T cd07839         237 YPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF  284 (284)
T ss_pred             cCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence            000000    11123468899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=7.9e-44  Score=341.69  Aligned_cols=247  Identities=21%  Similarity=0.354  Sum_probs=195.0

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEc-----CCCcEEEEEEeccc----chHHHHHHHHHHHHhcCCCCceEEeeEEEccC
Q 015374          123 DQDDYEVVRKVGRGKYSEVFEGINV-----NTNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQH  193 (408)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~Vy~~~~~-----~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~  193 (408)
                      ..++|++.++||+|+||.||+|.+.     .++..||+|+++..    ....+.+|+.++.++.+||||++++++|... 
T Consensus         5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~-   83 (338)
T cd05102           5 PRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKP-   83 (338)
T ss_pred             chhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCC-
Confidence            4678999999999999999999752     34568999998642    2356889999999997899999999998654 


Q ss_pred             CCccEEEEEeecCCChhhhcC-----------------------------------------------------------
Q 015374          194 SKTPSLIFEYVNSTDFKVLYP-----------------------------------------------------------  214 (408)
Q Consensus       194 ~~~~~lv~e~~~~~~l~~~~~-----------------------------------------------------------  214 (408)
                      ....++||||+++|+|..++.                                                           
T Consensus        84 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (338)
T cd05102          84 NGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQET  163 (338)
T ss_pred             CCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhc
Confidence            346789999999999987653                                                           


Q ss_pred             ------CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCCCcc---eeeccCccc
Q 015374          215 ------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY---NVRVASRYF  285 (408)
Q Consensus       215 ------~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~~~~---~~~~~~~~y  285 (408)
                            .+++..+..++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+++........   ....++..|
T Consensus       164 ~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~-~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y  242 (338)
T cd05102         164 DDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSEN-NVVKICDFGLARDIYKDPDYVRKGSARLPLKW  242 (338)
T ss_pred             cccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCC-CcEEEeecccccccccCcchhcccCCCCCccc
Confidence                  25667788899999999999999999999999999999988 78999999999765432221   123455789


Q ss_pred             cccccccCCcCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCCCccccccccCCCCC
Q 015374          286 KGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSKFINADNQHLV  364 (408)
Q Consensus       286 ~aPE~~~~~~~~~~~~DvwSlGvil~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  364 (408)
                      +|||++.+ ..++.++|||||||++|||++ |..||.....+ +.+.......        .          ....+..+
T Consensus       243 ~aPE~~~~-~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~-~~~~~~~~~~--------~----------~~~~~~~~  302 (338)
T cd05102         243 MAPESIFD-KVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIN-EEFCQRLKDG--------T----------RMRAPENA  302 (338)
T ss_pred             cCcHHhhc-CCCCcccCHHHHHHHHHHHHhCCCCCCCCCCcc-HHHHHHHhcC--------C----------CCCCCCCC
Confidence            99999987 778999999999999999997 88887432322 2222222110        0          01112346


Q ss_pred             CHHHHHHHHHhcccCcCCCCCHHHHhc
Q 015374          365 SPEAIDFLDKLLRYDHQDRLTAREAMA  391 (408)
Q Consensus       365 ~~~~~~li~~~L~~dp~~Rpt~~elL~  391 (408)
                      ++++.+++.+||+.||++|||+.|+++
T Consensus       303 ~~~l~~li~~cl~~dp~~RPs~~el~~  329 (338)
T cd05102         303 TPEIYRIMLACWQGDPKERPTFSALVE  329 (338)
T ss_pred             CHHHHHHHHHHccCChhhCcCHHHHHH
Confidence            889999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=1.8e-43  Score=329.73  Aligned_cols=249  Identities=24%  Similarity=0.373  Sum_probs=200.4

Q ss_pred             eeeeCceEEEEEEEcCCCcEEEEEEecccc------hHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccEEEEEeecC
Q 015374          133 VGRGKYSEVFEGINVNTNERCIIKILKPVK------KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNS  206 (408)
Q Consensus       133 lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~------~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~~  206 (408)
                      ||+|+||+||++++..+++.+|+|.+....      ...+..|+.+++++ +||||+++++++.+  ....++||||+++
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~i~~~~~~~~~--~~~~~lv~e~~~g   77 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKV-NSPFIVNLAYAFES--KTHLCLVMSLMNG   77 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhc-CCCcEEEEEEEEec--CCeEEEEEecCCC
Confidence            699999999999999999999999986321      23456799999999 99999999999954  4678999999999


Q ss_pred             CChhhhc-----CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCCCcceeecc
Q 015374          207 TDFKVLY-----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVA  281 (408)
Q Consensus       207 ~~l~~~~-----~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~~~~~~~~~  281 (408)
                      ++|..++     ..+++..+..++.|++.||+|||+.||+||||||+||+++.+ +.++|+|||++.............+
T Consensus        78 ~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~-~~~~l~Dfg~~~~~~~~~~~~~~~~  156 (277)
T cd05607          78 GDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQ-GNCRLSDLGLAVELKDGKTITQRAG  156 (277)
T ss_pred             CCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCC-CCEEEeeceeeeecCCCceeeccCC
Confidence            9998765     247888888999999999999999999999999999999988 7899999999987665544455678


Q ss_pred             CccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCCCccccccccCC
Q 015374          282 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSKFINADNQ  361 (408)
Q Consensus       282 ~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  361 (408)
                      +..|+|||++.+ ..++.++|||||||++|+|++|..||......... ..+....   .           ..... ...
T Consensus       157 ~~~y~aPE~~~~-~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~-~~~~~~~---~-----------~~~~~-~~~  219 (277)
T cd05607         157 TNGYMAPEILKE-EPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAK-EELKRRT---L-----------EDEVK-FEH  219 (277)
T ss_pred             CCCccCHHHHcc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhH-HHHHHHh---h-----------ccccc-ccc
Confidence            899999999987 66999999999999999999999998543222111 1111100   0           00000 011


Q ss_pred             CCCCHHHHHHHHHhcccCcCCCCCH----HHHhcCCCccccccch
Q 015374          362 HLVSPEAIDFLDKLLRYDHQDRLTA----REAMAHPYFAQVRAAE  402 (408)
Q Consensus       362 ~~~~~~~~~li~~~L~~dp~~Rpt~----~elL~hp~f~~~~~~~  402 (408)
                      ..+++++.+++.+||+.||++|||+    ++++.||||+.+....
T Consensus       220 ~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~~h~~f~~~~~~~  264 (277)
T cd05607         220 QNFTEESKDICRLFLAKKPEDRLGSREKNDDPRKHEFFKTINFPR  264 (277)
T ss_pred             ccCCHHHHHHHHHHhccCHhhCCCCccchhhhhcChhhcCCCHHH
Confidence            2368899999999999999999999    6788999999876543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=2.5e-44  Score=342.25  Aligned_cols=244  Identities=28%  Similarity=0.479  Sum_probs=201.8

Q ss_pred             eeeeeeCceEEEEEEE---cCCCcEEEEEEecccc-----hHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccEEEEE
Q 015374          131 RKVGRGKYSEVFEGIN---VNTNERCIIKILKPVK-----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFE  202 (408)
Q Consensus       131 ~~lG~G~fg~Vy~~~~---~~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e  202 (408)
                      +.||+|+||+||++++   ..+++.+|+|+++...     ...+.+|+.+++++ +||||+++++++.+  +...++|||
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~--~~~~~lv~e   78 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEV-NHPFIVKLHYAFQT--EGKLYLILD   78 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhC-CCCCcccEEEEEEc--CCEEEEEEc
Confidence            5799999999999876   3578899999987432     34567899999999 99999999999965  467899999


Q ss_pred             eecCCChhhhcC---CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCC-Cccee
Q 015374          203 YVNSTDFKVLYP---TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG-KEYNV  278 (408)
Q Consensus       203 ~~~~~~l~~~~~---~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~-~~~~~  278 (408)
                      |+++++|..++.   .+++..+..++.|++.||.|||++||+||||||+|||++.+ +.+||+|||++...... .....
T Consensus        79 ~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~-~~~kL~Dfg~~~~~~~~~~~~~~  157 (318)
T cd05582          79 FLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEE-GHIKLTDFGLSKESIDHEKKAYS  157 (318)
T ss_pred             CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCC-CcEEEeeccCCcccCCCCCceec
Confidence            999999988763   48999999999999999999999999999999999999988 79999999998765433 22344


Q ss_pred             eccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCCCccccccc
Q 015374          279 RVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSKFINA  358 (408)
Q Consensus       279 ~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  358 (408)
                      ..|+..|+|||.+.+ ..++.++|||||||++|||++|+.||. +.+..+....+...                    ..
T Consensus       158 ~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tg~~p~~-~~~~~~~~~~i~~~--------------------~~  215 (318)
T cd05582         158 FCGTVEYMAPEVVNR-RGHTQSADWWSFGVLMFEMLTGSLPFQ-GKDRKETMTMILKA--------------------KL  215 (318)
T ss_pred             ccCChhhcCHHHHcC-CCCCCccceeccceEeeeeccCCCCCC-CCCHHHHHHHHHcC--------------------CC
Confidence            578999999999987 678999999999999999999999984 33333333333221                    01


Q ss_pred             cCCCCCCHHHHHHHHHhcccCcCCCCC-----HHHHhcCCCcccccc
Q 015374          359 DNQHLVSPEAIDFLDKLLRYDHQDRLT-----AREAMAHPYFAQVRA  400 (408)
Q Consensus       359 ~~~~~~~~~~~~li~~~L~~dp~~Rpt-----~~elL~hp~f~~~~~  400 (408)
                      ..+..+++++.+++++||+.||++|||     ++++++||||+.+..
T Consensus       216 ~~p~~~~~~~~~li~~~l~~~P~~R~~a~~~~~~~~~~~~~~~~~~~  262 (318)
T cd05582         216 GMPQFLSPEAQSLLRALFKRNPANRLGAGPDGVEEIKRHPFFSTIDW  262 (318)
T ss_pred             CCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhCCCCcCCCCH
Confidence            123347899999999999999999999     778999999987754

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=1.3e-43  Score=344.20  Aligned_cols=257  Identities=26%  Similarity=0.402  Sum_probs=207.4

Q ss_pred             CCCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc------chHHHHHHHHHHHHhcCCCCceEEeeEEEccCCC
Q 015374          122 GDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSK  195 (408)
Q Consensus       122 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  195 (408)
                      ...++|++.+.||+|+||.||+|++..+++.+|+|+++..      ....+.+|+.+++.+ +||||+++++++.+  ..
T Consensus        40 ~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~-~hp~iv~~~~~~~~--~~  116 (371)
T cd05622          40 MKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFA-NSPWVVQLFYAFQD--DR  116 (371)
T ss_pred             cchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhC-CCCCCCeEEEEEEc--CC
Confidence            3568999999999999999999999999999999998632      224567899999998 99999999999954  56


Q ss_pred             ccEEEEEeecCCChhhhcC--CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCC
Q 015374          196 TPSLIFEYVNSTDFKVLYP--TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG  273 (408)
Q Consensus       196 ~~~lv~e~~~~~~l~~~~~--~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~  273 (408)
                      ..++||||+++++|..++.  .+++..+..++.|++.||+|||++||+||||||+|||++.+ +.+||+|||++......
T Consensus       117 ~~~lv~Ey~~gg~L~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~-~~ikL~DfG~a~~~~~~  195 (371)
T cd05622         117 YLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKS-GHLKLADFGTCMKMNKE  195 (371)
T ss_pred             EEEEEEcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCC-CCEEEEeCCceeEcCcC
Confidence            7899999999999988874  47888889999999999999999999999999999999988 79999999999876533


Q ss_pred             Cc--ceeeccCccccccccccCC---cCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCC
Q 015374          274 KE--YNVRVASRYFKGPELLVDL---QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHS  348 (408)
Q Consensus       274 ~~--~~~~~~~~~y~aPE~~~~~---~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  348 (408)
                      ..  .....||+.|+|||++.+.   ..++.++|||||||++|||++|..||. +.+.......+......         
T Consensus       196 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~-~~~~~~~~~~i~~~~~~---------  265 (371)
T cd05622         196 GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFY-ADSLVGTYSKIMNHKNS---------  265 (371)
T ss_pred             CcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCC-CCCHHHHHHHHHcCCCc---------
Confidence            22  2356799999999998752   237899999999999999999999984 33333333333321100         


Q ss_pred             CCCccccccccCCCCCCHHHHHHHHHhcccCcCC--CCCHHHHhcCCCccccc
Q 015374          349 RKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQD--RLTAREAMAHPYFAQVR  399 (408)
Q Consensus       349 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~--Rpt~~elL~hp~f~~~~  399 (408)
                             ........++.++.+++..||..++.+  |++++|+++||||++..
T Consensus       266 -------~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~~~  311 (371)
T cd05622         266 -------LTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQ  311 (371)
T ss_pred             -------ccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCcccCCCC
Confidence                   011112347899999999999844433  77999999999998754

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=1e-43  Score=342.97  Aligned_cols=273  Identities=25%  Similarity=0.458  Sum_probs=213.4

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc-----chHHHHHHHHHHHHhcCCCCceEEeeEEEccC----
Q 015374          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQH----  193 (408)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~----  193 (408)
                      ..++|++.+.||+|+||.||+|++..+++.||+|.+...     ....+.+|+.+++++ +|+||++++++|....    
T Consensus        14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~   92 (353)
T cd07850          14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLV-NHKNIIGLLNVFTPQKSLEE   92 (353)
T ss_pred             hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhc-CCCCCcceeeeeccCCCccc
Confidence            468899999999999999999999999999999998531     234677899999999 9999999999986432    


Q ss_pred             CCccEEEEEeecCCChhhhcCCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCC
Q 015374          194 SKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG  273 (408)
Q Consensus       194 ~~~~~lv~e~~~~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~  273 (408)
                      ....++||||+.+.........+++..+..++.|++.||+|||++||+||||||+||+++.+ +.+||+|||++......
T Consensus        93 ~~~~~lv~e~~~~~l~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~-~~~kL~Dfg~~~~~~~~  171 (353)
T cd07850          93 FQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSD-CTLKILDFGLARTAGTS  171 (353)
T ss_pred             cCcEEEEEeccCCCHHHHHhhcCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCC-CCEEEccCccceeCCCC
Confidence            23578999999875444444558999999999999999999999999999999999999998 78999999999876544


Q ss_pred             CcceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhh----------
Q 015374          274 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWC----------  343 (408)
Q Consensus       274 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~----------  343 (408)
                      .......++..|+|||.+.+ ..++.++|||||||++|+|++|+.|| .+.+..+.+..+....+.....          
T Consensus       172 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~~l~~g~~pf-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (353)
T cd07850         172 FMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMIRGTVLF-PGTDHIDQWNKIIEQLGTPSDEFMSRLQPTVR  249 (353)
T ss_pred             CCCCCCcccccccCHHHHhC-CCCCCchhhHhHHHHHHHHHHCCCCC-CCCCHHHHHHHHHHhcCCCCHHHHHHhhhhhh
Confidence            44444567889999999987 78999999999999999999999997 4455556666655544422110          


Q ss_pred             ---c--CCCCCCCcccccc--------ccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccccc
Q 015374          344 ---N--SRHSRKPWSKFIN--------ADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVR  399 (408)
Q Consensus       344 ---~--~~~~~~~~~~~~~--------~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~~~  399 (408)
                         .  .......+.....        ...+...++++.++|.+||+.||++|||+.|+|+||||+...
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~~~~  318 (353)
T cd07850         250 NYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINVWY  318 (353)
T ss_pred             HHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHhhcc
Confidence               0  0000111111110        011223467799999999999999999999999999997543

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=2.3e-43  Score=330.00  Aligned_cols=264  Identities=31%  Similarity=0.585  Sum_probs=204.2

Q ss_pred             CEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc-----chHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccEEE
Q 015374          126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI  200 (408)
Q Consensus       126 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  200 (408)
                      +|++.+.||+|+||+||+|++..++..||+|.++..     ....+.+|+.+++++ +||||+++++++.+  +...++|
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~~~~v   77 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKEL-QHPNIVCLQDVLMQ--ESRLYLI   77 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhc-CCCCEeeeEEEEee--CCeEEEE
Confidence            588899999999999999999999999999998632     235688999999999 89999999999965  4678999


Q ss_pred             EEeecCCChhhhc------CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCC-
Q 015374          201 FEYVNSTDFKVLY------PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG-  273 (408)
Q Consensus       201 ~e~~~~~~l~~~~------~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~-  273 (408)
                      |||+++ ++..++      ..+++..+..++.|++.||.|||++||+|+||||+||+++.+ +.++|+|||++...... 
T Consensus        78 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~-~~~~l~dfg~~~~~~~~~  155 (285)
T cd07861          78 FEFLSM-DLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNK-GVIKLADFGLARAFGIPV  155 (285)
T ss_pred             EecCCC-CHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCC-CcEEECcccceeecCCCc
Confidence            999985 555554      347889999999999999999999999999999999999988 79999999998755322 


Q ss_pred             CcceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcC--------
Q 015374          274 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNS--------  345 (408)
Q Consensus       274 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~--------  345 (408)
                      .......++..|+|||.+.+...++.++|||||||++|+|++|+.||. +....+....+....+......+        
T Consensus       156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (285)
T cd07861         156 RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFH-GDSEIDQLFRIFRILGTPTEDVWPGVTSLPD  234 (285)
T ss_pred             ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCC-CCCHHHHHHHHHHHhCCCChhhhhcchhhHH
Confidence            122334668889999998765668899999999999999999998874 44444444433333221110000        


Q ss_pred             -CCCCCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCc
Q 015374          346 -RHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF  395 (408)
Q Consensus       346 -~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f  395 (408)
                       ......+...........+++++.++|++||+.||++|||+.++++||||
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~  285 (285)
T cd07861         235 YKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF  285 (285)
T ss_pred             HHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence             00000011111111233478999999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=4.1e-43  Score=328.75  Aligned_cols=255  Identities=26%  Similarity=0.384  Sum_probs=208.9

Q ss_pred             CEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecccc------hHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccEE
Q 015374          126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK------KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSL  199 (408)
Q Consensus       126 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~------~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l  199 (408)
                      .|+..+.||+|+||+||+|.+..+++.+|+|.++...      ...+.+|+.+++++ +|+|++.+.+.+..  +...++
T Consensus         1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l-~~~~i~~~~~~~~~--~~~~~l   77 (285)
T cd05632           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKV-NSQFVVNLAYAYET--KDALCL   77 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHc-CCcCceeEEEEEec--CCEEEE
Confidence            3777889999999999999999999999999986432      23467899999999 99999999999855  467899


Q ss_pred             EEEeecCCChhhhc-----CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCCC
Q 015374          200 IFEYVNSTDFKVLY-----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK  274 (408)
Q Consensus       200 v~e~~~~~~l~~~~-----~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~~  274 (408)
                      +|||+++++|..++     ..+++..+..++.|++.||.|||+.||+||||||+||+++.+ +.++|+|||++.......
T Consensus        78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~-~~~kl~Dfg~~~~~~~~~  156 (285)
T cd05632          78 VLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDY-GHIRISDLGLAVKIPEGE  156 (285)
T ss_pred             EEEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCC-CCEEEecCCcceecCCCC
Confidence            99999999998765     248899999999999999999999999999999999999988 789999999997665444


Q ss_pred             cceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCCCccc
Q 015374          275 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSK  354 (408)
Q Consensus       275 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  354 (408)
                      ......|+..|+|||++.+ ..++.++|+|||||++|+|++|..||... .+......+......               
T Consensus       157 ~~~~~~g~~~~~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~P~~~~-~~~~~~~~~~~~~~~---------------  219 (285)
T cd05632         157 SIRGRVGTVGYMAPEVLNN-QRYTLSPDYWGLGCLIYEMIEGQSPFRGR-KEKVKREEVDRRVLE---------------  219 (285)
T ss_pred             cccCCCCCcCccChHHhcC-CCCCcccchHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHHhhhc---------------
Confidence            4445678999999999987 67999999999999999999999998533 222222222211000               


Q ss_pred             cccccCCCCCCHHHHHHHHHhcccCcCCCCC-----HHHHhcCCCccccccch
Q 015374          355 FINADNQHLVSPEAIDFLDKLLRYDHQDRLT-----AREAMAHPYFAQVRAAE  402 (408)
Q Consensus       355 ~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt-----~~elL~hp~f~~~~~~~  402 (408)
                       .....+..++.++.+|+.+||+.||++|||     ++++++|+||..+....
T Consensus       220 -~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~~~  271 (285)
T cd05632         220 -TEEVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNMNFKR  271 (285)
T ss_pred             -cccccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcChhhhcCCHHH
Confidence             001122346889999999999999999999     89999999999886543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=6.9e-44  Score=340.27  Aligned_cols=245  Identities=25%  Similarity=0.435  Sum_probs=198.7

Q ss_pred             eeeeeeCceEEEEEEEcCCCcEEEEEEeccc------chHHHHHHHHH-HHHhcCCCCceEEeeEEEccCCCccEEEEEe
Q 015374          131 RKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKI-LQNLCGGPNVVKLLDIVRDQHSKTPSLIFEY  203 (408)
Q Consensus       131 ~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~-l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~  203 (408)
                      +.||+|+||+||+|++..+++.+|+|++...      ....+..|..+ ++.+ +||||+++++++..  ....++||||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~-~hp~iv~~~~~~~~--~~~~~lv~e~   77 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNV-KHPFLVGLHYSFQT--TEKLYFVLDF   77 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhC-CCCCCccEEEEEec--CCEEEEEEcC
Confidence            3699999999999999999999999998632      22345556554 5566 99999999999965  4678899999


Q ss_pred             ecCCChhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccC-CCcceee
Q 015374          204 VNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP-GKEYNVR  279 (408)
Q Consensus       204 ~~~~~l~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~-~~~~~~~  279 (408)
                      +++++|..++   ..+++..+..++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++.... .......
T Consensus        78 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~-~~~kL~DfG~~~~~~~~~~~~~~~  156 (325)
T cd05604          78 VNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQ-GHVVLTDFGLCKEGIAQSDTTTTF  156 (325)
T ss_pred             CCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCC-CCEEEeecCCcccCCCCCCCcccc
Confidence            9999997776   458999999999999999999999999999999999999988 7999999999875432 2233445


Q ss_pred             ccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCCCcccccccc
Q 015374          280 VASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSKFINAD  359 (408)
Q Consensus       280 ~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  359 (408)
                      .|+..|+|||++.+ ..++.++|||||||++|+|++|..||. +.+..+....+...                    ...
T Consensus       157 ~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~G~~pf~-~~~~~~~~~~~~~~--------------------~~~  214 (325)
T cd05604         157 CGTPEYLAPEVIRK-QPYDNTVDWWCLGAVLYEMLYGLPPFY-CRDVAEMYDNILHK--------------------PLV  214 (325)
T ss_pred             cCChhhCCHHHHcC-CCCCCcCccccccceehhhhcCCCCCC-CCCHHHHHHHHHcC--------------------Ccc
Confidence            78999999999987 778999999999999999999999985 33333333333221                    011


Q ss_pred             CCCCCCHHHHHHHHHhcccCcCCCCCH----HHHhcCCCccccccc
Q 015374          360 NQHLVSPEAIDFLDKLLRYDHQDRLTA----REAMAHPYFAQVRAA  401 (408)
Q Consensus       360 ~~~~~~~~~~~li~~~L~~dp~~Rpt~----~elL~hp~f~~~~~~  401 (408)
                      ....++.++.+++++||+.||++||++    .++++||||+.....
T Consensus       215 ~~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~i~~h~~f~~~~~~  260 (325)
T cd05604         215 LRPGASLTAWSILEELLEKDRQRRLGAKEDFLEIQEHPFFESLSWT  260 (325)
T ss_pred             CCCCCCHHHHHHHHHHhccCHHhcCCCCCCHHHHhcCCCcCCCCHH
Confidence            122368899999999999999999976    599999999986543

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=2.5e-43  Score=329.17  Aligned_cols=257  Identities=20%  Similarity=0.364  Sum_probs=206.5

Q ss_pred             CCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc----chHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccEEE
Q 015374          125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI  200 (408)
Q Consensus       125 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  200 (408)
                      ++|++.+.||+|+||.||+|++..++..+|+|++...    ....+.+|+.+++++ +||||++++++|...  ...++|
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~--~~~~lv   77 (279)
T cd06619           1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKC-DSPYIIGFYGAFFVE--NRISIC   77 (279)
T ss_pred             CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhC-CCCCeeeEEEEEEEC--CEEEEE
Confidence            3678889999999999999999999999999998532    235688999999999 999999999999664  567899


Q ss_pred             EEeecCCChhhhcCCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCCCcceeec
Q 015374          201 FEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRV  280 (408)
Q Consensus       201 ~e~~~~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~~~~~~~~  280 (408)
                      |||++++++..+ ..+++..+..++.|++.||.|||+.+|+|+||||+|||++.+ +.++|+|||++...... ......
T Consensus        78 ~e~~~~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~-~~~~l~dfg~~~~~~~~-~~~~~~  154 (279)
T cd06619          78 TEFMDGGSLDVY-RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTR-GQVKLCDFGVSTQLVNS-IAKTYV  154 (279)
T ss_pred             EecCCCCChHHh-hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCC-CCEEEeeCCcceecccc-cccCCC
Confidence            999999998654 467888899999999999999999999999999999999988 79999999999765432 234457


Q ss_pred             cCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHH--HHHHhhhchhhhhcCCCCCCCccccccc
Q 015374          281 ASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQL--VKIAKDCCLIIWCNSRHSRKPWSKFINA  358 (408)
Q Consensus       281 ~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~  358 (408)
                      ++..|+|||.+.+ ..++.++|+|||||++|+|++|..||..........  ........     .....         .
T Consensus       155 ~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~-----~~~~~---------~  219 (279)
T cd06619         155 GTNAYMAPERISG-EQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIV-----DEDPP---------V  219 (279)
T ss_pred             CChhhcCceeecC-CCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHh-----ccCCC---------C
Confidence            8899999999987 678999999999999999999999985422211110  01110000     00000         0


Q ss_pred             cCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccccccch
Q 015374          359 DNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAE  402 (408)
Q Consensus       359 ~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~~~~~~  402 (408)
                      ......++++.+++.+||+.||++||+++|+++||||.......
T Consensus       220 ~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~~~~~~~~~~  263 (279)
T cd06619         220 LPVGQFSEKFVHFITQCMRKQPKERPAPENLMDHPFIVQYNDGN  263 (279)
T ss_pred             CCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcCcccccccCcc
Confidence            01122578899999999999999999999999999998775544

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=4.6e-43  Score=333.16  Aligned_cols=264  Identities=24%  Similarity=0.500  Sum_probs=196.2

Q ss_pred             eeeeeeCceEEEEEEEcC--CCcEEEEEEecccc-hHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccEEEEEeecCC
Q 015374          131 RKVGRGKYSEVFEGINVN--TNERCIIKILKPVK-KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNST  207 (408)
Q Consensus       131 ~~lG~G~fg~Vy~~~~~~--~~~~vavK~~~~~~-~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~~~  207 (408)
                      .+||+|+||+||+|+...  ++..+|+|.++... ...+.+|+.+++++ +||||+++++++........++||||++++
T Consensus         7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~lv~e~~~~~   85 (317)
T cd07867           7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLREL-KHPNVIALQKVFLSHSDRKVWLLFDYAEHD   85 (317)
T ss_pred             eEeccCCCeeEEEEEecCCCccceEEEEEecCCCCcHHHHHHHHHHHhC-CCCCeeeEEEEEeccCCCeEEEEEeeeCCc
Confidence            579999999999998654  56789999987543 34678999999999 999999999999766667889999999875


Q ss_pred             Chhhhc-----------CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeC---CCCcEEEEecccceeccCC
Q 015374          208 DFKVLY-----------PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDH---ELRKLRLIDWGLAEFYHPG  273 (408)
Q Consensus       208 ~l~~~~-----------~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~---~~~~~kl~DfG~a~~~~~~  273 (408)
                      .+....           ..+++..++.++.|++.||.|||+++|+||||||+|||+..   +.+.+||+|||+++.....
T Consensus        86 l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~  165 (317)
T cd07867          86 LWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSP  165 (317)
T ss_pred             HHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccceeccCCC
Confidence            443321           13788889999999999999999999999999999999942   2368999999999866433


Q ss_pred             C----cceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCC--------HHHHHHHHhhhchhh
Q 015374          274 K----EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDN--------HDQLVKIAKDCCLII  341 (408)
Q Consensus       274 ~----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~--------~~~~~~~~~~~~~~~  341 (408)
                      .    ......+|..|+|||++.+...++.++|||||||++|||++|..||.....+        .+++..+....+...
T Consensus       166 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (317)
T cd07867         166 LKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVMGFPA  245 (317)
T ss_pred             cccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHHhcCCCC
Confidence            2    2234567889999999977566899999999999999999999998543221        233344444333221


Q ss_pred             hhcCCCC--CCCccc--------------c--ccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCc
Q 015374          342 WCNSRHS--RKPWSK--------------F--INADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF  395 (408)
Q Consensus       342 ~~~~~~~--~~~~~~--------------~--~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f  395 (408)
                      ...+...  ...+..              .  .........+..+.+++.+||+.||.+|||++|+|+||||
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~f  317 (317)
T cd07867         246 DKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPYF  317 (317)
T ss_pred             hhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence            1110000  000000              0  0001111235678999999999999999999999999998

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=2.3e-43  Score=353.57  Aligned_cols=253  Identities=21%  Similarity=0.349  Sum_probs=207.9

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc-----chHHHHHHHHHHHHhcCCCCceEEeeEEEccCC---
Q 015374          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHS---  194 (408)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~---  194 (408)
                      ..++|++.+.||+|+||+||+|++..+++.||||+++..     ....+.+|+.++..+ +|+|++++.+.+.....   
T Consensus        30 ~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~-~h~~iv~~~~~~~~~~~~~~  108 (496)
T PTZ00283         30 QAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNC-DFFSIVKCHEDFAKKDPRNP  108 (496)
T ss_pred             cCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcC-CCCcEEEeecceecccccCc
Confidence            357999999999999999999999999999999998532     235678899999998 99999999887753321   


Q ss_pred             ---CccEEEEEeecCCChhhhcC-------CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEec
Q 015374          195 ---KTPSLIFEYVNSTDFKVLYP-------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDW  264 (408)
Q Consensus       195 ---~~~~lv~e~~~~~~l~~~~~-------~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~Df  264 (408)
                         ..+++||||+++|+|..++.       .+++..+..++.|++.||.|||+++|+||||||+|||++.+ +.+||+||
T Consensus       109 ~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~-~~vkL~DF  187 (496)
T PTZ00283        109 ENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSN-GLVKLGDF  187 (496)
T ss_pred             ccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCC-CCEEEEec
Confidence               13679999999999988762       48889999999999999999999999999999999999988 79999999


Q ss_pred             ccceeccCC---CcceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhh
Q 015374          265 GLAEFYHPG---KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLII  341 (408)
Q Consensus       265 G~a~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~  341 (408)
                      |+++.....   .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||. +.+..+.+..+....    
T Consensus       188 Gls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~s~k~DVwSlGvilyeLltG~~Pf~-~~~~~~~~~~~~~~~----  261 (496)
T PTZ00283        188 GFSKMYAATVSDDVGRTFCGTPYYVAPEIWRR-KPYSKKADMFSLGVLLYELLTLKRPFD-GENMEEVMHKTLAGR----  261 (496)
T ss_pred             ccCeeccccccccccccccCCcceeCHHHhCC-CCCCcHHHHHHHHHHHHHHHHCCCCCC-CCCHHHHHHHHhcCC----
Confidence            999765432   12234578999999999987 779999999999999999999999983 333333333322210    


Q ss_pred             hhcCCCCCCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccc
Q 015374          342 WCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQV  398 (408)
Q Consensus       342 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~~  398 (408)
                                     ....+..+++++.+++.+||+.||.+|||+.++++|||++..
T Consensus       262 ---------------~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~~  303 (496)
T PTZ00283        262 ---------------YDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKLF  303 (496)
T ss_pred             ---------------CCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhCHHHHHh
Confidence                           011233478999999999999999999999999999998753

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=6.1e-45  Score=320.99  Aligned_cols=259  Identities=26%  Similarity=0.437  Sum_probs=216.0

Q ss_pred             CCCCEEEEe-eeeeeCceEEEEEEEcCCCcEEEEEEecccchHHHHHHHHHHHHhcCCCCceEEeeEEEcc--CCCccEE
Q 015374          123 DQDDYEVVR-KVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQ--HSKTPSL  199 (408)
Q Consensus       123 ~~~~y~~~~-~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~--~~~~~~l  199 (408)
                      .+++|++.. +||-|-.|.|..+.++.+++.+|+|++.  +....++|+++--...+|||||+++++|+..  +..++.+
T Consensus        59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~--Ds~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLi  136 (400)
T KOG0604|consen   59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLL--DSPKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLI  136 (400)
T ss_pred             chhhheehhhhhccccCCceEEEEeccchhhhHHHHHh--cCHHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEe
Confidence            356676654 6899999999999999999999999995  4556778888877777999999999999743  3456778


Q ss_pred             EEEeecCCChhhhcC-----CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCC--CCcEEEEecccceeccC
Q 015374          200 IFEYVNSTDFKVLYP-----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE--LRKLRLIDWGLAEFYHP  272 (408)
Q Consensus       200 v~e~~~~~~l~~~~~-----~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~--~~~~kl~DfG~a~~~~~  272 (408)
                      |||.|+||.|...+.     .|++.++..|+.||+.|+.|||+.+|.||||||+|+|...+  .-.+||+|||+|+.-..
T Consensus       137 VmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~  216 (400)
T KOG0604|consen  137 VMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQE  216 (400)
T ss_pred             eeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEecccccccccCC
Confidence            999999999988873     39999999999999999999999999999999999999654  24789999999998776


Q ss_pred             CCcceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCC---CHHHHHHHHhhhchhhhhcCCCCC
Q 015374          273 GKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHD---NHDQLVKIAKDCCLIIWCNSRHSR  349 (408)
Q Consensus       273 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~  349 (408)
                      .....+.+.|++|.|||++-. +.|+..+|+||+||++|-|++|..||+..+.   ....-.+|...             
T Consensus       217 ~~~L~TPc~TPyYvaPevlg~-eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~g-------------  282 (400)
T KOG0604|consen  217 PGDLMTPCFTPYYVAPEVLGP-EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTG-------------  282 (400)
T ss_pred             CccccCCcccccccCHHHhCc-hhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhcc-------------
Confidence            677788899999999999866 8899999999999999999999999976543   11222222211             


Q ss_pred             CCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccccc
Q 015374          350 KPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRA  400 (408)
Q Consensus       350 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~~~~  400 (408)
                         ...++..+|..+|++++|+|+.+|..+|.+|.|++|+++|||.++...
T Consensus       283 ---qy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~~~  330 (400)
T KOG0604|consen  283 ---QYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQYEA  330 (400)
T ss_pred             ---CccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhccccc
Confidence               111344455668999999999999999999999999999999986543

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.4e-44  Score=341.76  Aligned_cols=245  Identities=26%  Similarity=0.438  Sum_probs=197.5

Q ss_pred             eeeeCceEEEEEEEcCCCcEEEEEEecccc------hHHHHHHHHHHHHhc--CCCCceEEeeEEEccCCCccEEEEEee
Q 015374          133 VGRGKYSEVFEGINVNTNERCIIKILKPVK------KKKIKREIKILQNLC--GGPNVVKLLDIVRDQHSKTPSLIFEYV  204 (408)
Q Consensus       133 lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~------~~~~~~E~~~l~~l~--~h~niv~l~~~~~~~~~~~~~lv~e~~  204 (408)
                      ||+|+||+||+|++..+++.||+|++....      ...+..|..++..+.  +||||+++++++.+  ....++||||+
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~--~~~~~lv~e~~   78 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQT--DSDLYLVTDYM   78 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEec--CCeEEEEEcCC
Confidence            799999999999999999999999986321      233456777777654  79999999999965  46789999999


Q ss_pred             cCCChhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccC-CCcceeec
Q 015374          205 NSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP-GKEYNVRV  280 (408)
Q Consensus       205 ~~~~l~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~-~~~~~~~~  280 (408)
                      ++++|..++   ..+++..+..++.||+.||+|||++||+||||||+|||++.+ +.++|+|||++..... ........
T Consensus        79 ~~g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~-~~~kl~Dfg~a~~~~~~~~~~~~~~  157 (330)
T cd05586          79 SGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDAT-GHIALCDFGLSKANLTDNKTTNTFC  157 (330)
T ss_pred             CCChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCC-CCEEEecCCcCcCCCCCCCCccCcc
Confidence            999998776   358999999999999999999999999999999999999988 7999999999875432 22334567


Q ss_pred             cCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCCCccccccccC
Q 015374          281 ASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSKFINADN  360 (408)
Q Consensus       281 ~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  360 (408)
                      ||..|+|||++.+...++.++|||||||++|+|++|+.||.. .+..+....+...            ...+       .
T Consensus       158 gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~-~~~~~~~~~i~~~------------~~~~-------~  217 (330)
T cd05586         158 GTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYA-EDTQQMYRNIAFG------------KVRF-------P  217 (330)
T ss_pred             CCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCC-CCHHHHHHHHHcC------------CCCC-------C
Confidence            899999999997755689999999999999999999999843 3333333322211            0000       0


Q ss_pred             CCCCCHHHHHHHHHhcccCcCCCC----CHHHHhcCCCcccccc
Q 015374          361 QHLVSPEAIDFLDKLLRYDHQDRL----TAREAMAHPYFAQVRA  400 (408)
Q Consensus       361 ~~~~~~~~~~li~~~L~~dp~~Rp----t~~elL~hp~f~~~~~  400 (408)
                      ...+++++.+|+.+||+.||++||    +++++++||||.....
T Consensus       218 ~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h~~~~~~~~  261 (330)
T cd05586         218 KNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEHPFFADIDW  261 (330)
T ss_pred             CccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcCccccCCCH
Confidence            112688999999999999999998    7999999999987654

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=3.5e-43  Score=336.21  Aligned_cols=258  Identities=25%  Similarity=0.404  Sum_probs=206.6

Q ss_pred             CCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc------chHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccE
Q 015374          125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS  198 (408)
Q Consensus       125 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  198 (408)
                      ++|++.+.||+|+||+||++++..+++.||+|+++..      ....+.+|..++..+ +|+||+++++++.+  ....+
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~l~~~~~~--~~~~~   77 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNG-DCQWITTLHYAFQD--ENYLY   77 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhC-CCCCEeeEEEEEEc--CCEEE
Confidence            5799999999999999999999999999999998642      223477889999998 99999999999965  46789


Q ss_pred             EEEEeecCCChhhhcC----CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCCC
Q 015374          199 LIFEYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK  274 (408)
Q Consensus       199 lv~e~~~~~~l~~~~~----~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~~  274 (408)
                      +||||+++++|..++.    .+++..+..++.|++.||+|||++||+||||||+|||++.+ +.+||+|||++.......
T Consensus        78 lv~Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~-~~~kl~DfG~a~~~~~~~  156 (331)
T cd05624          78 LVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMN-GHIRLADFGSCLKMNQDG  156 (331)
T ss_pred             EEEeCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCC-CCEEEEeccceeeccCCC
Confidence            9999999999998873    47888999999999999999999999999999999999988 789999999997765433


Q ss_pred             cc--eeeccCccccccccccCC----cCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCC
Q 015374          275 EY--NVRVASRYFKGPELLVDL----QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHS  348 (408)
Q Consensus       275 ~~--~~~~~~~~y~aPE~~~~~----~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  348 (408)
                      ..  ....|+..|+|||++.+.    ..++.++|||||||++|+|++|+.||. +.+..+....+.....          
T Consensus       157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~-~~~~~~~~~~i~~~~~----------  225 (331)
T cd05624         157 TVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFY-AESLVETYGKIMNHEE----------  225 (331)
T ss_pred             ceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCcc-CCCHHHHHHHHHcCCC----------
Confidence            22  235689999999998642    357889999999999999999999984 3333333333322100          


Q ss_pred             CCCccccccccCCCCCCHHHHHHHHHhcccCcCC--CCCHHHHhcCCCccccccch
Q 015374          349 RKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQD--RLTAREAMAHPYFAQVRAAE  402 (408)
Q Consensus       349 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~--Rpt~~elL~hp~f~~~~~~~  402 (408)
                      +..+     +.....+++++.+++.+||..++++  |++++++++||||+.+....
T Consensus       226 ~~~~-----p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~~~~~~  276 (331)
T cd05624         226 RFQF-----PSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEGIDWEN  276 (331)
T ss_pred             cccC-----CCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcCCCcCCCCHHH
Confidence            0001     1112336899999999999876654  46999999999999876543

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=2.7e-43  Score=352.59  Aligned_cols=250  Identities=23%  Similarity=0.371  Sum_probs=205.8

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCC-CcEEEEEEecccc---hHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccEE
Q 015374          124 QDDYEVVRKVGRGKYSEVFEGINVNT-NERCIIKILKPVK---KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSL  199 (408)
Q Consensus       124 ~~~y~~~~~lG~G~fg~Vy~~~~~~~-~~~vavK~~~~~~---~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l  199 (408)
                      ...|.+.+.||+|+||.||+|....+ +..||+|.+....   ...+.+|+.+++.+ +||||++++++|..  ....++
T Consensus        66 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l-~Hpniv~~~~~~~~--~~~~~l  142 (478)
T PTZ00267         66 EHMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAAC-DHFGIVKHFDDFKS--DDKLLL  142 (478)
T ss_pred             ceeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhC-CCCCEeEEEEEEEE--CCEEEE
Confidence            34599999999999999999988877 7888998764322   34577899999999 99999999999965  467899


Q ss_pred             EEEeecCCChhhhcC-------CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccC
Q 015374          200 IFEYVNSTDFKVLYP-------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP  272 (408)
Q Consensus       200 v~e~~~~~~l~~~~~-------~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~  272 (408)
                      ||||+++++|..++.       .+++..+..++.|++.||+|||+++|+||||||+|||++.+ +.+||+|||+++....
T Consensus       143 v~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~-~~~kL~DFgla~~~~~  221 (478)
T PTZ00267        143 IMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPT-GIIKLGDFGFSKQYSD  221 (478)
T ss_pred             EEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCC-CcEEEEeCcCceecCC
Confidence            999999999987652       47888999999999999999999999999999999999988 7999999999987654


Q ss_pred             CCc---ceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCC
Q 015374          273 GKE---YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSR  349 (408)
Q Consensus       273 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  349 (408)
                      ...   ....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||. +.+..+.+..+....         .  
T Consensus       222 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~Pf~-~~~~~~~~~~~~~~~---------~--  288 (478)
T PTZ00267        222 SVSLDVASSFCGTPYYLAPELWER-KRYSKKADMWSLGVILYELLTLHRPFK-GPSQREIMQQVLYGK---------Y--  288 (478)
T ss_pred             ccccccccccCCCccccCHhHhCC-CCCCcHHhHHHHHHHHHHHHhCCCCCC-CCCHHHHHHHHHhCC---------C--
Confidence            322   234568999999999987 789999999999999999999999984 333333333332210         0  


Q ss_pred             CCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccc
Q 015374          350 KPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQV  398 (408)
Q Consensus       350 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~~  398 (408)
                              ...+..++.++.++|.+||..||++|||+++++.|+|++..
T Consensus       289 --------~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~~~~~~~  329 (478)
T PTZ00267        289 --------DPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLHTEFLKYV  329 (478)
T ss_pred             --------CCCCccCCHHHHHHHHHHhccChhhCcCHHHHHhCHHHHHH
Confidence                    01123478899999999999999999999999999998643

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=3.6e-43  Score=364.35  Aligned_cols=258  Identities=25%  Similarity=0.424  Sum_probs=211.5

Q ss_pred             CCCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc-----chHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCc
Q 015374          122 GDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT  196 (408)
Q Consensus       122 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  196 (408)
                      ...++|+++++||+|+||+||+|.+..++..+|+|+++..     ....+..|+.++++| +||||++++++|.+.....
T Consensus        10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L-~HPNIVrl~d~f~de~~~~   88 (1021)
T PTZ00266         10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMREL-KHKNIVRYIDRFLNKANQK   88 (1021)
T ss_pred             cccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHc-CCCCcCeEEEEEEecCCCE
Confidence            3567999999999999999999999999999999998632     345688999999999 9999999999987666677


Q ss_pred             cEEEEEeecCCChhhhc-------CCCChHHHHHHHHHHHHHHHHHHHC-------CcEEecCCCCcEEEeCC-------
Q 015374          197 PSLIFEYVNSTDFKVLY-------PTLTDYDIRYYIYELLKALDYCHSQ-------GIMHRDVKPHNVMIDHE-------  255 (408)
Q Consensus       197 ~~lv~e~~~~~~l~~~~-------~~l~~~~~~~i~~qi~~~L~~LH~~-------~iiH~Dlk~~NILl~~~-------  255 (408)
                      +++||||+++++|..++       ..+++..++.|+.||+.||.|||+.       +||||||||+||||+.+       
T Consensus        89 lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i  168 (1021)
T PTZ00266         89 LYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKI  168 (1021)
T ss_pred             EEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccc
Confidence            89999999999998876       2489999999999999999999984       49999999999999642       


Q ss_pred             ---------CCcEEEEecccceeccCCCcceeeccCccccccccccCC-cCCCccccHHHHHHHHHHHHhCCCCCCCCCC
Q 015374          256 ---------LRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDL-QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHD  325 (408)
Q Consensus       256 ---------~~~~kl~DfG~a~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~DvwSlGvil~ell~g~~pf~~~~~  325 (408)
                               ...+||+|||++.............||+.|+|||++.+. ..++.++|||||||++|+|++|..||... +
T Consensus       169 ~~~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~-~  247 (1021)
T PTZ00266        169 TAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKA-N  247 (1021)
T ss_pred             cccccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcC-C
Confidence                     135899999999876544444556799999999998652 45889999999999999999999998543 3


Q ss_pred             CHHHHHHHHhhhchhhhhcCCCCCCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccccc
Q 015374          326 NHDQLVKIAKDCCLIIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRA  400 (408)
Q Consensus       326 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~~~~  400 (408)
                      +...+...+....                   .......+.++.+||..||+.+|.+|||+.|+|.|||++.+..
T Consensus       248 ~~~qli~~lk~~p-------------------~lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i~~  303 (1021)
T PTZ00266        248 NFSQLISELKRGP-------------------DLPIKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNVGP  303 (1021)
T ss_pred             cHHHHHHHHhcCC-------------------CCCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhcCC
Confidence            3333332222100                   0001225789999999999999999999999999999986644

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=9.9e-43  Score=325.69  Aligned_cols=266  Identities=32%  Similarity=0.575  Sum_probs=209.5

Q ss_pred             CCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc-----chHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccEE
Q 015374          125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSL  199 (408)
Q Consensus       125 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l  199 (408)
                      ++|++.+.||+|+||.||+|++..+++.||+|.+...     ..+.+.+|+.+++++ +|+|++++++++..  ....++
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~--~~~~~~   77 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQL-KHPNLVNLIEVFRR--KRKLHL   77 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhC-CCCCEeeeeeEEee--CCEEEE
Confidence            4799999999999999999999999999999988532     234578999999999 99999999999965  467889


Q ss_pred             EEEeecCCChhhhcC---CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCCC-c
Q 015374          200 IFEYVNSTDFKVLYP---TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK-E  275 (408)
Q Consensus       200 v~e~~~~~~l~~~~~---~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~~-~  275 (408)
                      ||||++++++..+..   .+++..+..++.|++.||+|||+.|++|+||||+||+++.+ +.++|+|||++....... .
T Consensus        78 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~-~~~~l~dfg~~~~~~~~~~~  156 (286)
T cd07847          78 VFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQ-GQIKLCDFGFARILTGPGDD  156 (286)
T ss_pred             EEeccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCC-CcEEECccccceecCCCccc
Confidence            999999999887763   58999999999999999999999999999999999999988 799999999998765433 2


Q ss_pred             ceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhh-cCCCCCCCc--
Q 015374          276 YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWC-NSRHSRKPW--  352 (408)
Q Consensus       276 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~--  352 (408)
                      .....++..|+|||.+.+...++.++|+||||+++|+|++|..|| .+.++.+.+..+....+..... ........+  
T Consensus       157 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (286)
T cd07847         157 YTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLW-PGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFK  235 (286)
T ss_pred             ccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCC-CCCChHHHHHHHHHHhCCCChHHhhhcccccccc
Confidence            333467788999999876566889999999999999999999887 4455555555444433211110 000000000  


Q ss_pred             ------cccc--cccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCc
Q 015374          353 ------SKFI--NADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF  395 (408)
Q Consensus       353 ------~~~~--~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f  395 (408)
                            ....  .......++..+.+|+.+||+.||++|||+.|++.||||
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f  286 (286)
T cd07847         236 GLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF  286 (286)
T ss_pred             cccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence                  0000  001112467889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7e-43  Score=322.73  Aligned_cols=247  Identities=26%  Similarity=0.437  Sum_probs=203.6

Q ss_pred             CCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc--------chHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCc
Q 015374          125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV--------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT  196 (408)
Q Consensus       125 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~--------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  196 (408)
                      ++|++.+.||+|++|.||+|.+..++..+++|.+...        ....+.+|+.+++++ +||||+++++++.+  ...
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~--~~~   78 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNL-QHERIVQYYGCLRD--DET   78 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhC-CCCCeeeeEEEEcc--CCe
Confidence            4688899999999999999999999999999987532        124678899999999 99999999999965  458


Q ss_pred             cEEEEEeecCCChhhhcC---CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCC
Q 015374          197 PSLIFEYVNSTDFKVLYP---TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG  273 (408)
Q Consensus       197 ~~lv~e~~~~~~l~~~~~---~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~  273 (408)
                      .++|+||++++++..++.   .+++..+..++.|++.||.|||+.||+|+||+|+||+++.+ +.++|+|||+++.....
T Consensus        79 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~-~~~~l~dfg~~~~~~~~  157 (263)
T cd06625          79 LSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSA-GNVKLGDFGASKRLQTI  157 (263)
T ss_pred             EEEEEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCC-CCEEEeecccceecccc
Confidence            899999999999988763   57888899999999999999999999999999999999987 79999999998765432


Q ss_pred             Ccc----eeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCC
Q 015374          274 KEY----NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSR  349 (408)
Q Consensus       274 ~~~----~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  349 (408)
                      ...    ....++..|+|||.+.+ ..++.++||||||+++|+|++|+.||... +..+.........            
T Consensus       158 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~p~~~~-~~~~~~~~~~~~~------------  223 (263)
T cd06625         158 CSSGTGMKSVTGTPYWMSPEVISG-EGYGRKADVWSVGCTVVEMLTEKPPWAEF-EAMAAIFKIATQP------------  223 (263)
T ss_pred             ccccccccCCCcCccccCcceecc-CCCCchhhhHHHHHHHHHHHhCCCCcccc-chHHHHHHHhccC------------
Confidence            211    23457788999999987 66899999999999999999999998433 2222222211110            


Q ss_pred             CCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCc
Q 015374          350 KPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF  395 (408)
Q Consensus       350 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f  395 (408)
                            .....+..++.++.+++.+||..||++|||+.|+++||||
T Consensus       224 ------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~  263 (263)
T cd06625         224 ------TNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRHFFV  263 (263)
T ss_pred             ------CCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhCCCC
Confidence                  1112234478899999999999999999999999999998

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=5.1e-43  Score=322.76  Aligned_cols=251  Identities=31%  Similarity=0.549  Sum_probs=204.3

Q ss_pred             EEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecccchH-----HHHHHHHHHHHhcCCCCceEEeeEEEccCCCccEEEE
Q 015374          127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKK-----KIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIF  201 (408)
Q Consensus       127 y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~-----~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~  201 (408)
                      |++.+.||+|+||+||++++..+++.+|+|++......     ...+|+.+++++ +|+||+++++++.+  ....++||
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~--~~~~~~v~   77 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRL-RHPNIVQILDVFQD--DNYLYIVM   77 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHH-TBTTBCHEEEEEEE--SSEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhccccc-cccccccccccccc--cccccccc
Confidence            78999999999999999999999999999999754332     234599999999 99999999999966  56788999


Q ss_pred             EeecCCChhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceec-cCCCcce
Q 015374          202 EYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY-HPGKEYN  277 (408)
Q Consensus       202 e~~~~~~l~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~-~~~~~~~  277 (408)
                      ||+++++|..++   ..+++..+..++.|++.||++||+.+|+|+||||+||+++.+ +.++|+|||.+... .......
T Consensus        78 ~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~-~~~~l~Dfg~~~~~~~~~~~~~  156 (260)
T PF00069_consen   78 EYCPGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDEN-GEVKLIDFGSSVKLSENNENFN  156 (260)
T ss_dssp             EEETTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTT-SEEEESSGTTTEESTSTTSEBS
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccccccccccc-cccccccccccccccccccccc
Confidence            999999998776   468999999999999999999999999999999999999977 79999999999763 3334455


Q ss_pred             eeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCCCcccccc
Q 015374          278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSKFIN  357 (408)
Q Consensus       278 ~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  357 (408)
                      ...++..|+|||++.....++.++|+||+|+++|+|++|..||... ...+....+.............           
T Consensus       157 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~-----------  224 (260)
T PF00069_consen  157 PFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEES-NSDDQLEIIEKILKRPLPSSSQ-----------  224 (260)
T ss_dssp             SSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTS-SHHHHHHHHHHHHHTHHHHHTT-----------
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccc-cchhhhhhhhhccccccccccc-----------
Confidence            6778899999999983378999999999999999999999998533 2223333333222211111000           


Q ss_pred             ccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCc
Q 015374          358 ADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF  395 (408)
Q Consensus       358 ~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f  395 (408)
                        .....+.++.+++.+||+.||++|||+.++++||||
T Consensus       225 --~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~~~~  260 (260)
T PF00069_consen  225 --QSREKSEELRDLIKKMLSKDPEQRPSAEELLKHPWF  260 (260)
T ss_dssp             --SHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTSGGG
T ss_pred             --ccchhHHHHHHHHHHHccCChhHCcCHHHHhcCCCC
Confidence              000123789999999999999999999999999997

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=6.8e-43  Score=341.71  Aligned_cols=271  Identities=22%  Similarity=0.291  Sum_probs=209.5

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEc--CCCcEEEEEEecccchHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccEEE
Q 015374          123 DQDDYEVVRKVGRGKYSEVFEGINV--NTNERCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI  200 (408)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~Vy~~~~~--~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  200 (408)
                      ...+|+++++||+|+||.||+|...  .++..|++|.+...  ....+|+.+++++ +||||+++++++..  ....++|
T Consensus        90 ~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~--~~~~~E~~il~~l-~h~~iv~~~~~~~~--~~~~~lv  164 (392)
T PHA03207         90 VRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG--KTPGREIDILKTI-SHRAIINLIHAYRW--KSTVCMV  164 (392)
T ss_pred             ccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc--ccHHHHHHHHHhc-CCCCccceeeeEee--CCEEEEE
Confidence            3568999999999999999999754  35678999988643  4567899999999 99999999999954  4678999


Q ss_pred             EEeecCCChhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCCCc--
Q 015374          201 FEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE--  275 (408)
Q Consensus       201 ~e~~~~~~l~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~~~--  275 (408)
                      ||++.+. +..++   ..+++..+..++.|++.||.|||++||+||||||+|||++.+ +.++|+|||++........  
T Consensus       165 ~e~~~~~-l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~-~~~~l~DfG~a~~~~~~~~~~  242 (392)
T PHA03207        165 MPKYKCD-LFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEP-ENAVLGDFGAACKLDAHPDTP  242 (392)
T ss_pred             ehhcCCC-HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCC-CCEEEccCccccccCcccccc
Confidence            9999764 44443   458999999999999999999999999999999999999988 7999999999976543322  


Q ss_pred             -ceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCC--CHHHHHHHHhhhchhhhhcCCCC----
Q 015374          276 -YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHD--NHDQLVKIAKDCCLIIWCNSRHS----  348 (408)
Q Consensus       276 -~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~--~~~~~~~~~~~~~~~~~~~~~~~----  348 (408)
                       .....||..|+|||++.+ ..++.++|||||||++|||++|+.||+....  ....+..+....+..........    
T Consensus       243 ~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~  321 (392)
T PHA03207        243 QCYGWSGTLETNSPELLAL-DPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTNL  321 (392)
T ss_pred             cccccccccCccCHhHhcC-CCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccchhH
Confidence             223578999999999987 7799999999999999999999999965433  34555555554443221111000    


Q ss_pred             -----------CCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccccccch
Q 015374          349 -----------RKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAE  402 (408)
Q Consensus       349 -----------~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~~~~~~  402 (408)
                                 +..+. .-........+.++.+||.+||++||++|||+.|+|+||||+..+...
T Consensus       322 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~~~~~  385 (392)
T PHA03207        322 CKHFKQYAIVLRPPYT-IPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKEPINL  385 (392)
T ss_pred             HHHHHhhcccccCCcc-ccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhccchhh
Confidence                       00000 000001123567899999999999999999999999999998766543

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=2.5e-43  Score=335.89  Aligned_cols=245  Identities=24%  Similarity=0.415  Sum_probs=197.2

Q ss_pred             eeeeeeCceEEEEEEEcCCCcEEEEEEecccc------hHHHHHHHH-HHHHhcCCCCceEEeeEEEccCCCccEEEEEe
Q 015374          131 RKVGRGKYSEVFEGINVNTNERCIIKILKPVK------KKKIKREIK-ILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEY  203 (408)
Q Consensus       131 ~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~------~~~~~~E~~-~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~  203 (408)
                      +.||+|+||+||+|++..+++.||+|++....      ...+.+|.. +++.+ +||||+++++++.+  ....++||||
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~-~h~~iv~~~~~~~~--~~~~~lv~e~   77 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNL-KHPFLVGLHYSFQT--AEKLYFVLDY   77 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhC-CCCCccceeeEEEc--CCEEEEEEcC
Confidence            36999999999999999999999999986322      234555554 56677 99999999999955  4678999999


Q ss_pred             ecCCChhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccC-CCcceee
Q 015374          204 VNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP-GKEYNVR  279 (408)
Q Consensus       204 ~~~~~l~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~-~~~~~~~  279 (408)
                      +++++|...+   ..+++..+..++.||+.||.|||++||+||||||+|||++.+ +.+||+|||+++.... .......
T Consensus        78 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~-~~~kl~Dfg~~~~~~~~~~~~~~~  156 (321)
T cd05603          78 VNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQ-GHVVLTDFGLCKEGVEPEETTSTF  156 (321)
T ss_pred             CCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCC-CCEEEccCCCCccCCCCCCccccc
Confidence            9999997766   358889999999999999999999999999999999999988 7999999999875322 2233445


Q ss_pred             ccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCCCcccccccc
Q 015374          280 VASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSKFINAD  359 (408)
Q Consensus       280 ~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  359 (408)
                      .|+..|+|||++.+ ..++.++|||||||++|||++|..||.. .+..+....+...                    ...
T Consensus       157 ~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~-~~~~~~~~~i~~~--------------------~~~  214 (321)
T cd05603         157 CGTPEYLAPEVLRK-EPYDRTVDWWCLGAVLYEMLYGLPPFYS-RDVSQMYDNILHK--------------------PLQ  214 (321)
T ss_pred             cCCcccCCHHHhcC-CCCCCcCcccccchhhhhhhcCCCCCCC-CCHHHHHHHHhcC--------------------CCC
Confidence            78999999999977 7799999999999999999999999843 3322332222211                    111


Q ss_pred             CCCCCCHHHHHHHHHhcccCcCCCCCH----HHHhcCCCccccccc
Q 015374          360 NQHLVSPEAIDFLDKLLRYDHQDRLTA----REAMAHPYFAQVRAA  401 (408)
Q Consensus       360 ~~~~~~~~~~~li~~~L~~dp~~Rpt~----~elL~hp~f~~~~~~  401 (408)
                      .+...+.++.+++.+||+.||.+|+++    .|+++|+||..+...
T Consensus       215 ~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~~~~~~~~~~  260 (321)
T cd05603         215 LPGGKTVAACDLLVGLLHKDQRRRLGAKADFLEIKNHVFFSPINWD  260 (321)
T ss_pred             CCCCCCHHHHHHHHHHccCCHhhcCCCCCCHHHHhCCCCcCCCCHH
Confidence            223367899999999999999999975    599999999876553

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=4.9e-44  Score=293.99  Aligned_cols=268  Identities=31%  Similarity=0.578  Sum_probs=220.5

Q ss_pred             CEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecccc-----hHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccEEE
Q 015374          126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK-----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI  200 (408)
Q Consensus       126 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  200 (408)
                      .|.-.++||+|.||+||+|++..+++.||+|.+.-.+     .....+|+.+++.+ .|+|||+++++...  .+.+-||
T Consensus         3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkel-khknivrl~dvlhs--dkkltlv   79 (292)
T KOG0662|consen    3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKEL-KHKNIVRLHDVLHS--DKKLTLV   79 (292)
T ss_pred             chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHh-hhcceeehhhhhcc--CceeEEe
Confidence            4555779999999999999999999999999986322     36788999999999 99999999999844  4567799


Q ss_pred             EEeecCCChhhhc----CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCC-Cc
Q 015374          201 FEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG-KE  275 (408)
Q Consensus       201 ~e~~~~~~l~~~~----~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~-~~  275 (408)
                      +|||.... ..+.    ..++.+.++.++.|++.||.|+|++++.|||+||.|.|++.| |.+|++|||+++.+.-. ..
T Consensus        80 fe~cdqdl-kkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~n-gelkladfglarafgipvrc  157 (292)
T KOG0662|consen   80 FEFCDQDL-KKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRN-GELKLADFGLARAFGIPVRC  157 (292)
T ss_pred             HHHhhHHH-HHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccC-CcEEecccchhhhcCCceEe
Confidence            99997543 3332    458888999999999999999999999999999999999999 89999999999866432 34


Q ss_pred             ceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCC-----
Q 015374          276 YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRK-----  350 (408)
Q Consensus       276 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----  350 (408)
                      +...+-|.+|++|.++.+..-|+.+.|+||-||++.|+.....|.|+|.+-.+++..+...+|.+....+..-..     
T Consensus       158 ysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk  237 (292)
T KOG0662|consen  158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYK  237 (292)
T ss_pred             eeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCc
Confidence            566788999999999999888999999999999999999988999999999999999999988765444322111     


Q ss_pred             CccccccccCC----CCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccc
Q 015374          351 PWSKFINADNQ----HLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQV  398 (408)
Q Consensus       351 ~~~~~~~~~~~----~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~~  398 (408)
                      .++.+-....+    ..++...+|+++++|..+|.+|.+++++|+||||...
T Consensus       238 ~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf~d~  289 (292)
T KOG0662|consen  238 PYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSDF  289 (292)
T ss_pred             ccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCcccccc
Confidence            11111111111    1234567999999999999999999999999999864

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=8.8e-43  Score=327.53  Aligned_cols=264  Identities=25%  Similarity=0.413  Sum_probs=212.2

Q ss_pred             cccccCCCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecccc---hHHHHHHHHHHHHhcCCCCceEEeeEEEccC
Q 015374          117 LTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK---KKKIKREIKILQNLCGGPNVVKLLDIVRDQH  193 (408)
Q Consensus       117 ~~~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~  193 (408)
                      +.......+.|+++++||.|+||.||+|++..++..+++|.+....   ...+.+|+.+++.+ +|+||+++++++..  
T Consensus         4 ~~~~~~~~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--   80 (292)
T cd06644           4 VRRDLDPNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATC-NHPYIVKLLGAFYW--   80 (292)
T ss_pred             hhcccCcchhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhC-CCCcEeeeEEEEEe--
Confidence            3344456788999999999999999999999999999999986433   35678899999999 99999999999865  


Q ss_pred             CCccEEEEEeecCCChhhhc----CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEeccccee
Q 015374          194 SKTPSLIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEF  269 (408)
Q Consensus       194 ~~~~~lv~e~~~~~~l~~~~----~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~  269 (408)
                      ....++||||++++++..++    ..+++..+..++.|++.||.|||+.+++|+||||+||+++.+ +.++|+|||++..
T Consensus        81 ~~~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~-~~~kl~dfg~~~~  159 (292)
T cd06644          81 DGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLD-GDIKLADFGVSAK  159 (292)
T ss_pred             CCeEEEEEecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCC-CCEEEccCcccee
Confidence            45789999999999987764    348999999999999999999999999999999999999987 7999999999865


Q ss_pred             ccCC-CcceeeccCccccccccccC----CcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhc
Q 015374          270 YHPG-KEYNVRVASRYFKGPELLVD----LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCN  344 (408)
Q Consensus       270 ~~~~-~~~~~~~~~~~y~aPE~~~~----~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  344 (408)
                      .... .......++..|+|||.+.+    ...++.++|+|||||++|+|++|..||... +.......+...        
T Consensus       160 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~-~~~~~~~~~~~~--------  230 (292)
T cd06644         160 NVKTLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHEL-NPMRVLLKIAKS--------  230 (292)
T ss_pred             ccccccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccc-cHHHHHHHHhcC--------
Confidence            4322 22344567889999999852    245788999999999999999999987432 222222222110        


Q ss_pred             CCCCCCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccccccch
Q 015374          345 SRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAE  402 (408)
Q Consensus       345 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~~~~~~  402 (408)
                       .   .+     ....+..++.++.+++.+||..||++||+++|+++||||..+....
T Consensus       231 -~---~~-----~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~~  279 (292)
T cd06644         231 -E---PP-----TLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEHPFVSSVTSNR  279 (292)
T ss_pred             -C---Cc-----cCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccccch
Confidence             0   00     0111234678999999999999999999999999999999877655

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=3.2e-44  Score=339.54  Aligned_cols=252  Identities=25%  Similarity=0.477  Sum_probs=219.0

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecc-----cchHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccE
Q 015374          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP-----VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS  198 (408)
Q Consensus       124 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~-----~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  198 (408)
                      .++|..++.+|+|+||.++.++++.++..+++|.+.-     ..+....+|+.+++++ .|||||.+.+.|... +...+
T Consensus         3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~-~hP~iv~y~ds~~~~-~~~l~   80 (426)
T KOG0589|consen    3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKL-LHPNIVEYKDSFEED-GQLLC   80 (426)
T ss_pred             cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhc-cCCCeeeeccchhcC-CceEE
Confidence            4678899999999999999999999999999999852     2235688999999998 999999999999754 34489


Q ss_pred             EEEEeecCCChhhhcC-----CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCC
Q 015374          199 LIFEYVNSTDFKVLYP-----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG  273 (408)
Q Consensus       199 lv~e~~~~~~l~~~~~-----~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~  273 (408)
                      +||+|++||++...+.     .|+++.+..++.|++.|+.|||+++|+|||||+.||+++.+ +.++|+|||+|+.+.+.
T Consensus        81 Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~-~~VkLgDfGlaK~l~~~  159 (426)
T KOG0589|consen   81 IVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKD-KKVKLGDFGLAKILNPE  159 (426)
T ss_pred             EEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhcccc-CceeecchhhhhhcCCc
Confidence            9999999999998873     48999999999999999999999999999999999999999 67899999999999877


Q ss_pred             C-cceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCCCc
Q 015374          274 K-EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPW  352 (408)
Q Consensus       274 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  352 (408)
                      . ...+.+||+.|+.||.+.+ .+|+.++|||||||++|||++-+.+| .+.+......++.....              
T Consensus       160 ~~~a~tvvGTp~YmcPEil~d-~pYn~KSDiWsLGC~~yEm~~lk~aF-~a~~m~~Li~ki~~~~~--------------  223 (426)
T KOG0589|consen  160 DSLASTVVGTPYYMCPEILSD-IPYNEKSDIWSLGCCLYEMCTLKPAF-KASNMSELILKINRGLY--------------  223 (426)
T ss_pred             hhhhheecCCCcccCHHHhCC-CCCCccCcchhhcchHHHHHhccccc-CccchHHHHHHHhhccC--------------
Confidence            6 5677899999999999998 89999999999999999999999887 55555555555555421              


Q ss_pred             cccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccccc
Q 015374          353 SKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVR  399 (408)
Q Consensus       353 ~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~~~  399 (408)
                           ...+...+.+++.+|..||+.+|+.||++.+||.+|.++...
T Consensus       224 -----~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~P~l~~~~  265 (426)
T KOG0589|consen  224 -----SPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRRPHLLRYL  265 (426)
T ss_pred             -----CCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhChhhhhHH
Confidence                 222344689999999999999999999999999999887543

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=4.2e-43  Score=325.95  Aligned_cols=253  Identities=25%  Similarity=0.433  Sum_probs=204.4

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc--chHHHHHHHHHHHHhcCCCCceEEeeEEEccC----CCc
Q 015374          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV--KKKKIKREIKILQNLCGGPNVVKLLDIVRDQH----SKT  196 (408)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~----~~~  196 (408)
                      ..+.|++.+.||+|+||+||+|.+..+++.+|+|.++..  ....+.+|+.++.++.+|+||++++++|....    ...
T Consensus         4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~   83 (272)
T cd06637           4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQ   83 (272)
T ss_pred             hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcE
Confidence            356788899999999999999999999999999998643  34578899999999867999999999987532    245


Q ss_pred             cEEEEEeecCCChhhhcC-----CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceecc
Q 015374          197 PSLIFEYVNSTDFKVLYP-----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH  271 (408)
Q Consensus       197 ~~lv~e~~~~~~l~~~~~-----~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~  271 (408)
                      .+++|||+++++|..++.     .+++..+..++.|++.||.|||+++|+|+||||+||+++.+ +.++|+|||++....
T Consensus        84 ~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~-~~~~l~Dfg~~~~~~  162 (272)
T cd06637          84 LWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTEN-AEVKLVDFGVSAQLD  162 (272)
T ss_pred             EEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCC-CCEEEccCCCceecc
Confidence            789999999999988763     37888899999999999999999999999999999999988 789999999987654


Q ss_pred             CC-CcceeeccCccccccccccC----CcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCC
Q 015374          272 PG-KEYNVRVASRYFKGPELLVD----LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSR  346 (408)
Q Consensus       272 ~~-~~~~~~~~~~~y~aPE~~~~----~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  346 (408)
                      .. .......|+..|+|||++.+    ...++.++|||||||++|||++|..||..... .........           
T Consensus       163 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~-~~~~~~~~~-----------  230 (272)
T cd06637         163 RTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHP-MRALFLIPR-----------  230 (272)
T ss_pred             cccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCH-HHHHHHHhc-----------
Confidence            32 22334568889999999863    24688899999999999999999999843222 111111100           


Q ss_pred             CCCCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCc
Q 015374          347 HSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF  395 (408)
Q Consensus       347 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f  395 (408)
                      .       .........++.++.+|+.+||..||.+|||+.|++.||||
T Consensus       231 ~-------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~  272 (272)
T cd06637         231 N-------PAPRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI  272 (272)
T ss_pred             C-------CCCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence            0       00111122367899999999999999999999999999997

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=3.3e-43  Score=335.63  Aligned_cols=244  Identities=24%  Similarity=0.442  Sum_probs=198.0

Q ss_pred             eeeeeeCceEEEEEEEcCCCcEEEEEEecccc------hHHHHHHHH-HHHHhcCCCCceEEeeEEEccCCCccEEEEEe
Q 015374          131 RKVGRGKYSEVFEGINVNTNERCIIKILKPVK------KKKIKREIK-ILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEY  203 (408)
Q Consensus       131 ~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~------~~~~~~E~~-~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~  203 (408)
                      +.||+|+||+||+|++..+++.+|+|++....      ...+..|.. +++.+ +|+||+++++++.+  ....++||||
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~-~h~~Iv~~~~~~~~--~~~~~lv~e~   77 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNV-KHPFLVGLHFSFQT--ADKLYFVLDY   77 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhC-CCCCCCceeEEEEc--CCeEEEEEeC
Confidence            36999999999999999999999999986422      223444544 45667 99999999999965  4678899999


Q ss_pred             ecCCChhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccC-CCcceee
Q 015374          204 VNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP-GKEYNVR  279 (408)
Q Consensus       204 ~~~~~l~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~-~~~~~~~  279 (408)
                      +++++|..++   ..+.+..++.++.|++.||.|||++||+||||||+|||++.+ +.+||+|||+++.... .......
T Consensus        78 ~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~-~~~kl~DfG~a~~~~~~~~~~~~~  156 (325)
T cd05602          78 INGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQ-GHIVLTDFGLCKENIEHNGTTSTF  156 (325)
T ss_pred             CCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCC-CCEEEccCCCCcccccCCCCcccc
Confidence            9999998877   347888899999999999999999999999999999999988 7999999999875432 2233456


Q ss_pred             ccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCCCcccccccc
Q 015374          280 VASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSKFINAD  359 (408)
Q Consensus       280 ~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  359 (408)
                      .||..|+|||++.+ ..++.++|||||||++|+|++|..||. +.+..+.+..+...                    ...
T Consensus       157 ~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~-~~~~~~~~~~i~~~--------------------~~~  214 (325)
T cd05602         157 CGTPEYLAPEVLHK-QPYDRTVDWWCLGAVLYEMLYGLPPFY-SRNTAEMYDNILNK--------------------PLQ  214 (325)
T ss_pred             cCCccccCHHHHcC-CCCCCccccccccHHHHHHhcCCCCCC-CCCHHHHHHHHHhC--------------------CcC
Confidence            78999999999987 789999999999999999999999985 33333433333221                    011


Q ss_pred             CCCCCCHHHHHHHHHhcccCcCCCCCHH----HHhcCCCcccccc
Q 015374          360 NQHLVSPEAIDFLDKLLRYDHQDRLTAR----EAMAHPYFAQVRA  400 (408)
Q Consensus       360 ~~~~~~~~~~~li~~~L~~dp~~Rpt~~----elL~hp~f~~~~~  400 (408)
                      ....++..+.+++.+||+.||.+|+++.    ++++|+||.....
T Consensus       215 ~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~i~~~~~~~~~~~  259 (325)
T cd05602         215 LKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKNHIFFSPINW  259 (325)
T ss_pred             CCCCCCHHHHHHHHHHcccCHHHCCCCCCCHHHHhcCcccCCCCH
Confidence            2234789999999999999999999876    8999999987654

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=1e-42  Score=329.84  Aligned_cols=271  Identities=27%  Similarity=0.495  Sum_probs=212.7

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecccc-----hHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCcc
Q 015374          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK-----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP  197 (408)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~  197 (408)
                      ..++|++.+.||+|+||.||+|.+..+++.||+|.++...     ...+.+|+.+++++ +|+|++++++++.+......
T Consensus         5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~   83 (309)
T cd07845           5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNL-RHPNIVELKEVVVGKHLDSI   83 (309)
T ss_pred             cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhC-CCCCCcceEEEEecCCCCeE
Confidence            4678999999999999999999999999999999986322     23466899999999 99999999999976655678


Q ss_pred             EEEEEeecCCChhhhc----CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCC
Q 015374          198 SLIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG  273 (408)
Q Consensus       198 ~lv~e~~~~~~l~~~~----~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~  273 (408)
                      ++||||+++ ++..++    ..+++..+..++.|++.||.|||+.|++|+||||+||+++.+ +.++|+|||++......
T Consensus        84 ~lv~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~-~~~kL~dfg~~~~~~~~  161 (309)
T cd07845          84 FLVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDK-GCLKIADFGLARTYGLP  161 (309)
T ss_pred             EEEEecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCC-CCEEECccceeeecCCc
Confidence            999999986 454443    348999999999999999999999999999999999999988 79999999999876543


Q ss_pred             -CcceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCC------
Q 015374          274 -KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSR------  346 (408)
Q Consensus       274 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~------  346 (408)
                       .......++..|+|||.+.+...++.++|||||||++|+|++|..|| .+.+..+.+..+....+......+.      
T Consensus       162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (309)
T cd07845         162 AKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLL-PGKSEIEQLDLIIQLLGTPNESIWPGFSDLP  240 (309)
T ss_pred             cCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHHhcCCCChhhchhhhccc
Confidence             22233455778999999876567899999999999999999999887 4556666666666654422111100      


Q ss_pred             ------CCCCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccccc
Q 015374          347 ------HSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVR  399 (408)
Q Consensus       347 ------~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~~~  399 (408)
                            .....+...  .......++++.+||.+||++||++|||++|+++||||+...
T Consensus       241 ~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~~  297 (309)
T cd07845         241 LVGKFTLPKQPYNNL--KHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEKP  297 (309)
T ss_pred             ccccccccCCCCCch--HHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccCC
Confidence                  000000000  001122578899999999999999999999999999998553

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=1.1e-43  Score=352.67  Aligned_cols=244  Identities=20%  Similarity=0.385  Sum_probs=207.5

Q ss_pred             cCCCCCEEEEeeeeeeCceEEEEEEEcC-----CCcEEEEEEeccc----chHHHHHHHHHHHHhcCCCCceEEeeEEEc
Q 015374          121 WGDQDDYEVVRKVGRGKYSEVFEGINVN-----TNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRD  191 (408)
Q Consensus       121 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~-----~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~  191 (408)
                      .....+.+..+.||+|.||+||+|+...     ....||||.+|..    ...+|++|++++..| +|||||+++|+|..
T Consensus       482 ~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l-~H~nIVrLlGVC~~  560 (774)
T KOG1026|consen  482 EIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAEL-QHPNIVRLLGVCRE  560 (774)
T ss_pred             EechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhc-cCCCeEEEEEEEcc
Confidence            3456788899999999999999997543     3457999999843    356899999999999 99999999999954


Q ss_pred             cCCCccEEEEEeecCCChhhhcC-------------C----CChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeC
Q 015374          192 QHSKTPSLIFEYVNSTDFKVLYP-------------T----LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDH  254 (408)
Q Consensus       192 ~~~~~~~lv~e~~~~~~l~~~~~-------------~----l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~  254 (408)
                        ++.+|||+|||..|||..++.             .    ++..+...|+.|||.||+||-++.+|||||.++|+|+.+
T Consensus       561 --~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVge  638 (774)
T KOG1026|consen  561 --GDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVGE  638 (774)
T ss_pred             --CCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceecc
Confidence              578899999999999999882             2    778889999999999999999999999999999999999


Q ss_pred             CCCcEEEEecccceeccCCCcceee---ccCccccccccccCCcCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHH
Q 015374          255 ELRKLRLIDWGLAEFYHPGKEYNVR---VASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQL  330 (408)
Q Consensus       255 ~~~~~kl~DfG~a~~~~~~~~~~~~---~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-g~~pf~~~~~~~~~~  330 (408)
                      + ..|||+|||+++.....+.+...   .-+..||+||.+.. ++|+.++|||||||+|||+++ |..|+ .+..+.+.+
T Consensus       639 ~-l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly-~kFTteSDVWs~GVvLWEIFsyG~QPy-~glSn~EVI  715 (774)
T KOG1026|consen  639 N-LVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILY-GKFTTESDVWSFGVVLWEIFSYGKQPY-YGLSNQEVI  715 (774)
T ss_pred             c-eEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhc-CcccchhhhhhhhhhhhhhhccccCcc-cccchHHHH
Confidence            9 69999999999877655544433   33456999999997 899999999999999999998 55565 677778877


Q ss_pred             HHHHhhhchhhhhcCCCCCCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHH
Q 015374          331 VKIAKDCCLIIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREA  389 (408)
Q Consensus       331 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~el  389 (408)
                      +.+.+..                   -...++.++.++.++|..||+.+|.+||+..|+
T Consensus       716 e~i~~g~-------------------lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI  755 (774)
T KOG1026|consen  716 ECIRAGQ-------------------LLSCPENCPTEVYSLMLECWNENPKRRPSFKEI  755 (774)
T ss_pred             HHHHcCC-------------------cccCCCCCCHHHHHHHHHHhhcCcccCCCHHHH
Confidence            7665431                   134466699999999999999999999999987

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=1.9e-42  Score=323.84  Aligned_cols=265  Identities=33%  Similarity=0.584  Sum_probs=211.1

Q ss_pred             CEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecccc-----hHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccEEE
Q 015374          126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK-----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI  200 (408)
Q Consensus       126 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  200 (408)
                      +|++.+.||.|+||.||+|.+..++..|++|++....     ...+.+|+.+++++ +|+||+++++++.+  ....++|
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~--~~~~~~v   77 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQAC-QHPYVVKLLDVFPH--GSGFVLV   77 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhC-CCCCCcceeeEEec--CCeeEEE
Confidence            5889999999999999999999999999999986432     35788999999999 89999999999965  5678899


Q ss_pred             EEeecCCChhhhc----CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCCC--
Q 015374          201 FEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK--  274 (408)
Q Consensus       201 ~e~~~~~~l~~~~----~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~~--  274 (408)
                      |||+ +++|..++    ..+++..++.++.|++.||.|||+.|++|+||||+||+++.+ +.++|+|||++.......  
T Consensus        78 ~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~-~~~~l~dfg~~~~~~~~~~~  155 (286)
T cd07832          78 MEYM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISAD-GVLKIADFGLARLFSEEEPR  155 (286)
T ss_pred             eccc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCC-CcEEEeeeeecccccCCCCC
Confidence            9999 89988776    348999999999999999999999999999999999999987 789999999987665433  


Q ss_pred             cceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCC--CCCCc
Q 015374          275 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRH--SRKPW  352 (408)
Q Consensus       275 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~  352 (408)
                      ......++..|+|||.+.+...++.++||||+|+++|+|++|.. ++.+.++.+.+..+....+.........  ....|
T Consensus       156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (286)
T cd07832         156 LYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSP-LFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDY  234 (286)
T ss_pred             ccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCc-CcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchh
Confidence            23446788899999998765667899999999999999999954 4566666666666665544221100000  00000


Q ss_pred             ccc-----c---cccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcc
Q 015374          353 SKF-----I---NADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFA  396 (408)
Q Consensus       353 ~~~-----~---~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~  396 (408)
                      ...     .   -.......+.++.+++.+||+.||++|||++++++||||.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~  286 (286)
T cd07832         235 NKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT  286 (286)
T ss_pred             hcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence            000     0   0011123578999999999999999999999999999984

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=2.6e-42  Score=323.97  Aligned_cols=269  Identities=31%  Similarity=0.569  Sum_probs=206.0

Q ss_pred             CCCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecccc----hHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCcc
Q 015374          122 GDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP  197 (408)
Q Consensus       122 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~  197 (408)
                      +.-++|++.+.||.|+||+||+|.+..+++.||+|.+....    ...+.+|+.+++++ +|+||+++++++.+  ....
T Consensus         2 ~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~--~~~~   78 (291)
T cd07844           2 GKLETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDL-KHANIVTLHDIIHT--KKTL   78 (291)
T ss_pred             CCccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhC-CCcceeeEEEEEec--CCeE
Confidence            34678999999999999999999999899999999986322    24567899999999 99999999999954  4688


Q ss_pred             EEEEEeecCCChhhhc----CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCC
Q 015374          198 SLIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG  273 (408)
Q Consensus       198 ~lv~e~~~~~~l~~~~----~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~  273 (408)
                      ++||||+++ +|..++    ..+++..++.++.|++.||.|||+.+|+|+||||+||+++.+ +.++|+|||+++.....
T Consensus        79 ~lv~e~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~-~~~kl~dfg~~~~~~~~  156 (291)
T cd07844          79 TLVFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISER-GELKLADFGLARAKSVP  156 (291)
T ss_pred             EEEEecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCC-CCEEECccccccccCCC
Confidence            999999986 676655    247889999999999999999999999999999999999988 78999999998654321


Q ss_pred             -CcceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCC------
Q 015374          274 -KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSR------  346 (408)
Q Consensus       274 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~------  346 (408)
                       .......++..|+|||.+.+...++.++||||+||++|+|++|..||.......+++..+....+........      
T Consensus       157 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (291)
T cd07844         157 SKTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNP  236 (291)
T ss_pred             CccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhcc
Confidence             1122235678899999987656688999999999999999999999854443455555444433321110000      


Q ss_pred             -CCCCCcccccc---ccCCCCCC--HHHHHHHHHhcccCcCCCCCHHHHhcCCCc
Q 015374          347 -HSRKPWSKFIN---ADNQHLVS--PEAIDFLDKLLRYDHQDRLTAREAMAHPYF  395 (408)
Q Consensus       347 -~~~~~~~~~~~---~~~~~~~~--~~~~~li~~~L~~dp~~Rpt~~elL~hp~f  395 (408)
                       .....+.....   ......++  .++.+++.+||+.||++|||+.|+++||||
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f  291 (291)
T cd07844         237 EFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF  291 (291)
T ss_pred             ccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence             00000000000   00111233  789999999999999999999999999998

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=1.9e-42  Score=323.19  Aligned_cols=266  Identities=30%  Similarity=0.539  Sum_probs=205.5

Q ss_pred             EEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecccc----hHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccEEEEE
Q 015374          127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFE  202 (408)
Q Consensus       127 y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e  202 (408)
                      |++.++||+|+||.||+|.+..++..+|+|.++...    .....+|+.++.++.+|+|++++++++.+......++|||
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e   80 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE   80 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence            677899999999999999999999999999986431    2234579999999866999999999998765578899999


Q ss_pred             eecCCChhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCCCcceee
Q 015374          203 YVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR  279 (408)
Q Consensus       203 ~~~~~~l~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~~~~~~~  279 (408)
                      |++++.+....   ..+++..+..++.|++.||.|||+.+++|+||+|+||+++.  +.+||+|||++............
T Consensus        81 ~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~--~~~kl~dfg~~~~~~~~~~~~~~  158 (282)
T cd07831          81 LMDMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD--DILKLADFGSCRGIYSKPPYTEY  158 (282)
T ss_pred             cCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC--CCeEEEecccccccccCCCcCCC
Confidence            99865444433   24899999999999999999999999999999999999998  78999999999876554444445


Q ss_pred             ccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhc----CCCCCCC--cc
Q 015374          280 VASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCN----SRHSRKP--WS  353 (408)
Q Consensus       280 ~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~--~~  353 (408)
                      .++..|+|||.+.....++.++|||||||++|||++|..|| .+.+..+.+..+....+......    .......  +.
T Consensus       159 ~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (282)
T cd07831         159 ISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLF-PGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNYNFP  237 (282)
T ss_pred             CCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCC-CCCCHHHHHHHHHHHcCCCCHHHHHhhcccccccccCc
Confidence            67889999998765466789999999999999999998887 55555555555544333211100    0000000  00


Q ss_pred             cccc---ccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCc
Q 015374          354 KFIN---ADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF  395 (408)
Q Consensus       354 ~~~~---~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f  395 (408)
                      ....   ......++.++.+++.+||+.||++|||++++++||||
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~  282 (282)
T cd07831         238 SKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF  282 (282)
T ss_pred             ccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence            0000   01112468999999999999999999999999999998

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=2.9e-42  Score=323.71  Aligned_cols=250  Identities=26%  Similarity=0.474  Sum_probs=209.9

Q ss_pred             CCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc------chHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccE
Q 015374          125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS  198 (408)
Q Consensus       125 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  198 (408)
                      ++|++.+.||+|+||.||++.+..+++.+|+|+++..      ..+.+.+|+++++++ +||||+++++++.+  +...+
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~~~   77 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSI-RHPFLVNLYGSFQD--DSNLY   77 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhC-CCCCccceeeEEEc--CCeEE
Confidence            4799999999999999999999999999999998642      235678899999999 89999999999955  46789


Q ss_pred             EEEEeecCCChhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCCCc
Q 015374          199 LIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE  275 (408)
Q Consensus       199 lv~e~~~~~~l~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~~~  275 (408)
                      +||||+++++|..++   ..+++..+..++.|++.||.|||+.||+|+||+|+||+++.+ +.+||+|||++......  
T Consensus        78 ~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~-~~~kl~dfg~~~~~~~~--  154 (290)
T cd05580          78 LVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSD-GYIKITDFGFAKRVKGR--  154 (290)
T ss_pred             EEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCC-CCEEEeeCCCccccCCC--
Confidence            999999999998886   458999999999999999999999999999999999999988 78999999999876543  


Q ss_pred             ceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCCCcccc
Q 015374          276 YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSKF  355 (408)
Q Consensus       276 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  355 (408)
                      .....++..|+|||.+.+ ..++.++|+||||+++|+|++|..||... +..+....+...                   
T Consensus       155 ~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~-~~~~~~~~~~~~-------------------  213 (290)
T cd05580         155 TYTLCGTPEYLAPEIILS-KGYGKAVDWWALGILIYEMLAGYPPFFDD-NPIQIYEKILEG-------------------  213 (290)
T ss_pred             CCCCCCCccccChhhhcC-CCCCccccHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHhcC-------------------
Confidence            334568889999999977 67889999999999999999999998433 222223322211                   


Q ss_pred             ccccCCCCCCHHHHHHHHHhcccCcCCCC-----CHHHHhcCCCccccccch
Q 015374          356 INADNQHLVSPEAIDFLDKLLRYDHQDRL-----TAREAMAHPYFAQVRAAE  402 (408)
Q Consensus       356 ~~~~~~~~~~~~~~~li~~~L~~dp~~Rp-----t~~elL~hp~f~~~~~~~  402 (408)
                       ....+..++..+.+++.+||+.||.+|+     +++|+++||||+.+.+..
T Consensus       214 -~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~~~  264 (290)
T cd05580         214 -KVRFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWFAGIDWIA  264 (290)
T ss_pred             -CccCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcCcccccCCHHH
Confidence             1112233678999999999999999999     999999999999887544

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=7.3e-43  Score=333.50  Aligned_cols=267  Identities=20%  Similarity=0.253  Sum_probs=198.3

Q ss_pred             EEeeeeee--CceEEEEEEEcCCCcEEEEEEeccc-----chHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccEEEE
Q 015374          129 VVRKVGRG--KYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIF  201 (408)
Q Consensus       129 ~~~~lG~G--~fg~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~  201 (408)
                      ++++||+|  +||+||++++..+++.||+|.++..     ....+.+|+.+++.+ +||||++++++|...  ...++||
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~~--~~~~lv~   78 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLF-NHPNIVPYRATFIAD--NELWVVT   78 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhc-CCCCeeeEEEEEEEC--CEEEEEE
Confidence            45689999  7899999999999999999998643     234577899999999 999999999999654  5788999


Q ss_pred             EeecCCChhhhc-----CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCCC--
Q 015374          202 EYVNSTDFKVLY-----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK--  274 (408)
Q Consensus       202 e~~~~~~l~~~~-----~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~~--  274 (408)
                      ||++++++..++     ..+++..+..++.|++.||+|||+++|+||||||+|||++.+ +.++++|||.+.......  
T Consensus        79 e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~-~~~~l~~~~~~~~~~~~~~~  157 (327)
T cd08227          79 SFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVD-GKVYLSGLRSNLSMINHGQR  157 (327)
T ss_pred             eccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecC-CcEEEcccchhhcccccccc
Confidence            999999998876     248899999999999999999999999999999999999988 789999998653322111  


Q ss_pred             ------cceeeccCccccccccccCC-cCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhh-----
Q 015374          275 ------EYNVRVASRYFKGPELLVDL-QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIW-----  342 (408)
Q Consensus       275 ------~~~~~~~~~~y~aPE~~~~~-~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~-----  342 (408)
                            ......++..|+|||++.+. ..++.++|||||||++|||++|+.||..... ...........-....     
T Consensus       158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~  236 (327)
T cd08227         158 LRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPA-TQMLLEKLNGTVPCLLDTTTI  236 (327)
T ss_pred             ccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcch-hHHHHHHhcCCccccccccch
Confidence                  01223456779999998753 4688999999999999999999999853322 2222111111000000     


Q ss_pred             --hc--CCCCCCCc-----------------cccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccccc
Q 015374          343 --CN--SRHSRKPW-----------------SKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRA  400 (408)
Q Consensus       343 --~~--~~~~~~~~-----------------~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~~~~  400 (408)
                        ..  .......+                 ...........+++++.+|+.+||++||++|||++|+++||||+++..
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~~~~  315 (327)
T cd08227         237 PAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIKR  315 (327)
T ss_pred             hhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhhcch
Confidence              00  00000000                 000001112235788999999999999999999999999999988654

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=2.1e-42  Score=325.78  Aligned_cols=271  Identities=35%  Similarity=0.584  Sum_probs=211.9

Q ss_pred             CEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecccc--------hHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCcc
Q 015374          126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK--------KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP  197 (408)
Q Consensus       126 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~--------~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~  197 (408)
                      +|++.+.||.|+||.||+|.+..+++.|++|.++...        ...+..|+.+++++ +|+||+++++++.+  ....
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~--~~~~   77 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQEL-KHPNIIGLLDVFGH--KSNI   77 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhc-CCCCChhhhheeec--CCEE
Confidence            5888999999999999999999999999999986432        23467899999999 89999999999965  4678


Q ss_pred             EEEEEeecCCChhhhcC----CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCC
Q 015374          198 SLIFEYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG  273 (408)
Q Consensus       198 ~lv~e~~~~~~l~~~~~----~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~  273 (408)
                      ++||||+ +++|..++.    .+++..+..++.|++.||.|||++||+|+||+|+||+++.+ +.++|+|||++......
T Consensus        78 ~lv~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~-~~~~l~dfg~~~~~~~~  155 (298)
T cd07841          78 NLVFEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASD-GVLKLADFGLARSFGSP  155 (298)
T ss_pred             EEEEccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCC-CCEEEccceeeeeccCC
Confidence            9999999 888888773    48899999999999999999999999999999999999988 79999999999876543


Q ss_pred             C-cceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCC--CCC
Q 015374          274 K-EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRH--SRK  350 (408)
Q Consensus       274 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~  350 (408)
                      . ......++..|+|||.+.+...++.++|+|||||++|+|++|. |++.+.++.+.+..+....+.........  ...
T Consensus       156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (298)
T cd07841         156 NRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRV-PFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLP  234 (298)
T ss_pred             CccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCC-ccccCCccHHHHHHHHHHcCCCchhhhhhccccc
Confidence            2 2333456778999999866567889999999999999999995 54566666666655554433221100000  000


Q ss_pred             Cccc------cccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccccccch
Q 015374          351 PWSK------FINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAE  402 (408)
Q Consensus       351 ~~~~------~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~~~~~~  402 (408)
                      .+..      .........++.++.+|+.+||++||++|||+.|+++||||++.....
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~~~~  292 (298)
T cd07841         235 DYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDPAPT  292 (298)
T ss_pred             ccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCCCCCC
Confidence            0000      000111234578899999999999999999999999999999876644

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=4.5e-42  Score=322.45  Aligned_cols=270  Identities=29%  Similarity=0.504  Sum_probs=206.0

Q ss_pred             CCCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecccc----hHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCcc
Q 015374          122 GDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP  197 (408)
Q Consensus       122 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~  197 (408)
                      +..++|++.+.||+|+||.||+|.+..++..+++|.++...    ...+.+|+.+++.+ +|+||+++++++.+  +...
T Consensus         2 ~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~--~~~~   78 (291)
T cd07870           2 GAATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGL-KHANIVLLHDIIHT--KETL   78 (291)
T ss_pred             CccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhc-CCCCEeEEEEEEec--CCeE
Confidence            45688999999999999999999999999999999986322    23577899999999 99999999999965  4678


Q ss_pred             EEEEEeecCCChhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCC-
Q 015374          198 SLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG-  273 (408)
Q Consensus       198 ~lv~e~~~~~~l~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~-  273 (408)
                      ++||||+.++.+....   ..+++..+..++.|++.||.|||+.||+|+||||+|||++.+ +.++|+|||+++..... 
T Consensus        79 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~-~~~~l~Dfg~~~~~~~~~  157 (291)
T cd07870          79 TFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYL-GELKLADFGLARAKSIPS  157 (291)
T ss_pred             EEEEecccCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCC-CcEEEeccccccccCCCC
Confidence            8999999755444433   236788889999999999999999999999999999999988 79999999998754322 


Q ss_pred             CcceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcC---CCCCC
Q 015374          274 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNS---RHSRK  350 (408)
Q Consensus       274 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~  350 (408)
                      .......++..|+|||.+.+...++.++|||||||++|+|++|..||....+..+.+.++....+.......   .....
T Consensus       158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (291)
T cd07870         158 QTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPN  237 (291)
T ss_pred             CCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhccc
Confidence            222344578889999998764568889999999999999999999986555445555555443332110000   00000


Q ss_pred             Cccccccc---------cCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCc
Q 015374          351 PWSKFINA---------DNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF  395 (408)
Q Consensus       351 ~~~~~~~~---------~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f  395 (408)
                      ....+...         ......+.++.+++.+||..||.+|||++|++.||||
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~  291 (291)
T cd07870         238 YKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF  291 (291)
T ss_pred             ccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence            00000000         0001125789999999999999999999999999998

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=2.3e-42  Score=320.25  Aligned_cols=249  Identities=26%  Similarity=0.433  Sum_probs=201.5

Q ss_pred             CCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc--------chHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCc
Q 015374          125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV--------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT  196 (408)
Q Consensus       125 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~--------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  196 (408)
                      .+|+..+.||+|+||.||+|.+..++..+++|.++..        ....+.+|+.+++++ +|+||+++++++.+.....
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~   80 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNL-QHERIVQYYGCLRDRAEKT   80 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHc-CCCCeeeEEEEEEcCCCCE
Confidence            4688889999999999999999999999999987532        124578899999999 9999999999987655567


Q ss_pred             cEEEEEeecCCChhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCC
Q 015374          197 PSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG  273 (408)
Q Consensus       197 ~~lv~e~~~~~~l~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~  273 (408)
                      .++++||+++++|..++   ..+++.....++.|++.||+|||+.+|+|+||||+||+++.+ +.++|+|||++......
T Consensus        81 ~~l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~-~~~~l~dfg~~~~~~~~  159 (266)
T cd06651          81 LTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSA-GNVKLGDFGASKRLQTI  159 (266)
T ss_pred             EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCC-CCEEEccCCCccccccc
Confidence            88999999999998876   347888899999999999999999999999999999999987 78999999998755321


Q ss_pred             ----CcceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCC
Q 015374          274 ----KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSR  349 (408)
Q Consensus       274 ----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  349 (408)
                          .......++..|+|||.+.+ ..++.++|+|||||++|+|++|+.||... +...........          .  
T Consensus       160 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~i~~el~~g~~pf~~~-~~~~~~~~~~~~----------~--  225 (266)
T cd06651         160 CMSGTGIRSVTGTPYWMSPEVISG-EGYGRKADVWSLGCTVVEMLTEKPPWAEY-EAMAAIFKIATQ----------P--  225 (266)
T ss_pred             cccCCccccCCccccccCHHHhCC-CCCCchhhhHHHHHHHHHHHHCCCCcccc-chHHHHHHHhcC----------C--
Confidence                11223457788999999987 77899999999999999999999998432 222222211110          0  


Q ss_pred             CCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcc
Q 015374          350 KPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFA  396 (408)
Q Consensus       350 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~  396 (408)
                            .....+..+++.+.+++ +||..||++|||++|+++||||+
T Consensus       226 ------~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~hp~~~  265 (266)
T cd06651         226 ------TNPQLPSHISEHARDFL-GCIFVEARHRPSAEELLRHPFAQ  265 (266)
T ss_pred             ------CCCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhcCcccc
Confidence                  01122334678899999 67778999999999999999997

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=3.2e-42  Score=326.35  Aligned_cols=269  Identities=22%  Similarity=0.313  Sum_probs=207.7

Q ss_pred             CCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc----chHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccEEE
Q 015374          125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI  200 (408)
Q Consensus       125 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  200 (408)
                      ++|++.+.||+|+||.||++.+..++..+|+|.++..    ...++.+|+++++++ +||||++++++|.+  ....++|
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~--~~~~~lv   77 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHEC-NSPYIVGFYGAFYS--DGEISIC   77 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEee--CCEEEEE
Confidence            4689999999999999999999999999999998643    235688999999999 99999999999965  4678999


Q ss_pred             EEeecCCChhhhc---CCCChHHHHHHHHHHHHHHHHHHH-CCcEEecCCCCcEEEeCCCCcEEEEecccceeccCCCcc
Q 015374          201 FEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHS-QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY  276 (408)
Q Consensus       201 ~e~~~~~~l~~~~---~~l~~~~~~~i~~qi~~~L~~LH~-~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~~~~  276 (408)
                      |||+++++|..++   ..+++..+..++.|++.||.|||+ .+++|+||||+|||++.+ +.++|+|||++...... ..
T Consensus        78 ~ey~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~-~~~~l~dfg~~~~~~~~-~~  155 (308)
T cd06615          78 MEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSR-GEIKLCDFGVSGQLIDS-MA  155 (308)
T ss_pred             eeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecC-CcEEEccCCCccccccc-cc
Confidence            9999999999887   347888999999999999999997 599999999999999988 78999999998755332 23


Q ss_pred             eeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhch-hhhhcC-------CCC
Q 015374          277 NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCL-IIWCNS-------RHS  348 (408)
Q Consensus       277 ~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~-------~~~  348 (408)
                      ....++..|+|||.+.+ ..++.++|+|||||++|+|++|+.||....  ............. ......       ...
T Consensus       156 ~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~~l~~l~~g~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (308)
T cd06615         156 NSFVGTRSYMSPERLQG-THYTVQSDIWSLGLSLVEMAIGRYPIPPPD--AKELEAMFGRPVSEGEAKESHRPVSGHPPD  232 (308)
T ss_pred             ccCCCCcCccChhHhcC-CCCCccchHHHHHHHHHHHHhCCCCCCCcc--hhhHHHhhcCccccccccCCcccccCCCCC
Confidence            44578889999999876 678999999999999999999999984332  2222222211100 000000       000


Q ss_pred             CCCc---cc----c---ccccC-CCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccccccc
Q 015374          349 RKPW---SK----F---INADN-QHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAA  401 (408)
Q Consensus       349 ~~~~---~~----~---~~~~~-~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~~~~~  401 (408)
                      ...+   ..    .   ..... ...++.++.+|+.+||..||++|||++|+++||||......
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~  296 (308)
T cd06615         233 SPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRAELE  296 (308)
T ss_pred             ccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhhcccc
Confidence            0000   00    0   00001 11257889999999999999999999999999999886554

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=2.4e-42  Score=325.40  Aligned_cols=257  Identities=25%  Similarity=0.444  Sum_probs=210.5

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc---chHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccEE
Q 015374          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV---KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSL  199 (408)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l  199 (408)
                      ...+|++.+.||+|+||.||+|++..++..+++|.+...   ....+.+|+.+++.+ +|+|++++++.|..  +...++
T Consensus        18 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~-~h~~v~~~~~~~~~--~~~~~l   94 (296)
T cd06654          18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMREN-KNPNIVNYLDSYLV--GDELWV   94 (296)
T ss_pred             cccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhC-CCCCEeeEEEEEEe--CCEEEE
Confidence            356899999999999999999999999999999988632   245688899999998 99999999999965  467899


Q ss_pred             EEEeecCCChhhhcC--CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCCCc-c
Q 015374          200 IFEYVNSTDFKVLYP--TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE-Y  276 (408)
Q Consensus       200 v~e~~~~~~l~~~~~--~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~~~-~  276 (408)
                      ||||+++++|..++.  .+++.++..++.|++.||.|||+.||+|+||||+||+++.+ +.++|+|||++........ .
T Consensus        95 v~e~~~~~~L~~~~~~~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~-~~~kl~dfg~~~~~~~~~~~~  173 (296)
T cd06654          95 VMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMD-GSVKLTDFGFCAQITPEQSKR  173 (296)
T ss_pred             eecccCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCC-CCEEECccccchhcccccccc
Confidence            999999999998874  47889999999999999999999999999999999999988 7999999999876543322 2


Q ss_pred             eeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCCCccccc
Q 015374          277 NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSKFI  356 (408)
Q Consensus       277 ~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  356 (408)
                      ....++..|+|||.+.+ ..++.++|||||||++|+|++|+.||.... ..+.+...... +       .         .
T Consensus       174 ~~~~~~~~y~aPE~~~~-~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~-~~~~~~~~~~~-~-------~---------~  234 (296)
T cd06654         174 STMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMIEGEPPYLNEN-PLRALYLIATN-G-------T---------P  234 (296)
T ss_pred             CcccCCccccCHHHHcC-CCCCccchHHHHHHHHHHHHhCCCCCCCCC-HHHhHHHHhcC-C-------C---------C
Confidence            33568889999999987 678899999999999999999999984332 22222211110 0       0         0


Q ss_pred             cccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccccccch
Q 015374          357 NADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAE  402 (408)
Q Consensus       357 ~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~~~~~~  402 (408)
                      ....+..++..+.+++.+||..||++|||+.|+++||||...+...
T Consensus       235 ~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~~~~  280 (296)
T cd06654         235 ELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIAKPLS  280 (296)
T ss_pred             CCCCccccCHHHHHHHHHHCcCCcccCcCHHHHhhChhhhccCCcc
Confidence            0111234678899999999999999999999999999998776543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=5e-42  Score=315.62  Aligned_cols=246  Identities=23%  Similarity=0.391  Sum_probs=205.7

Q ss_pred             CEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc-----chHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccEEE
Q 015374          126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI  200 (408)
Q Consensus       126 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  200 (408)
                      +|++.+.||+|+||.||++.+..++..+|+|.+...     ....+.+|+.+++++ +|+|++++++.+..  ....++|
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~--~~~~~lv   77 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLL-SHPNIIEYYENFLE--DKALMIV   77 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhC-CCCchhheeeeEec--CCEEEEE
Confidence            588999999999999999999999999999998532     345788999999999 99999999999854  4678999


Q ss_pred             EEeecCCChhhhcC-----CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCCCc
Q 015374          201 FEYVNSTDFKVLYP-----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE  275 (408)
Q Consensus       201 ~e~~~~~~l~~~~~-----~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~~~  275 (408)
                      |||+++++|..++.     .+++..+..++.|++.||.|||++|++|+||+|+||+++.+.+.++|+|||++........
T Consensus        78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~  157 (256)
T cd08220          78 MEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSK  157 (256)
T ss_pred             EecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCcc
Confidence            99999999988873     3788899999999999999999999999999999999987656789999999987765444


Q ss_pred             ceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCCCcccc
Q 015374          276 YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSKF  355 (408)
Q Consensus       276 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  355 (408)
                      .....++..|+|||.+.+ ..++.++||||||+++|+|++|..||. +.+.......+....                  
T Consensus       158 ~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~~l~~~~~~~~-~~~~~~~~~~~~~~~------------------  217 (256)
T cd08220         158 AYTVVGTPCYISPELCEG-KPYNQKSDIWALGCVLYELASLKRAFE-AANLPALVLKIMSGT------------------  217 (256)
T ss_pred             ccccccCCcccCchhccC-CCCCcccchHHHHHHHHHHHhCCCCcc-cCchHHHHHHHHhcC------------------
Confidence            445678889999999987 678899999999999999999999973 333333332222110                  


Q ss_pred             ccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCc
Q 015374          356 INADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF  395 (408)
Q Consensus       356 ~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f  395 (408)
                       ....+..++.++.+++.+||+.||++|||++|+++||||
T Consensus       218 -~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~p~~  256 (256)
T cd08220         218 -FAPISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQPIC  256 (256)
T ss_pred             -CCCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhCCCC
Confidence             011123368899999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=3.4e-42  Score=323.59  Aligned_cols=268  Identities=32%  Similarity=0.568  Sum_probs=208.8

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecccc-----hHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccE
Q 015374          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK-----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS  198 (408)
Q Consensus       124 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  198 (408)
                      .++|++.+.||.|+||.||+|.+..+++.+++|.++...     ...+.+|+.+++++ +||||+++++++...+....+
T Consensus         4 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~~~~   82 (293)
T cd07843           4 VDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKL-QHPNIVTVKEVVVGSNLDKIY   82 (293)
T ss_pred             hhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhc-CCCCEEEEEEEEEecCCCcEE
Confidence            357888999999999999999999999999999986432     23467899999999 899999999999766557899


Q ss_pred             EEEEeecCCChhhhc----CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCC-
Q 015374          199 LIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG-  273 (408)
Q Consensus       199 lv~e~~~~~~l~~~~----~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~-  273 (408)
                      +||||+++ +|..++    ..+++..+..++.|++.||.|||+++++|+||||+||+++.+ +.++|+|||++...... 
T Consensus        83 lv~e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~-~~~~l~d~g~~~~~~~~~  160 (293)
T cd07843          83 MVMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNR-GILKICDFGLAREYGSPL  160 (293)
T ss_pred             EEehhcCc-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCC-CcEEEeecCceeeccCCc
Confidence            99999986 665554    248999999999999999999999999999999999999988 89999999998866543 


Q ss_pred             CcceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhc-------CC
Q 015374          274 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCN-------SR  346 (408)
Q Consensus       274 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~-------~~  346 (408)
                      .......++..|+|||.+.+...++.++|+||||+++|+|++|..|| ...+..+....+....+......       ..
T Consensus       161 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (293)
T cd07843         161 KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLF-PGKSEIDQLNKIFKLLGTPTEKIWPGFSELPG  239 (293)
T ss_pred             cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCC-CCCChHHHHHHHHHHhCCCchHHHHHhhccch
Confidence            23344567888999999877556789999999999999999999887 44444555555544333211000       00


Q ss_pred             CCCCCcccc----ccccCCCC-CCHHHHHHHHHhcccCcCCCCCHHHHhcCCCc
Q 015374          347 HSRKPWSKF----INADNQHL-VSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF  395 (408)
Q Consensus       347 ~~~~~~~~~----~~~~~~~~-~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f  395 (408)
                      .....+...    .....+.. +++.+.++|++||+.||++|||+.|+++||||
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f  293 (293)
T cd07843         240 AKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF  293 (293)
T ss_pred             hcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence            000000000    01112222 58889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.4e-44  Score=317.68  Aligned_cols=254  Identities=27%  Similarity=0.467  Sum_probs=217.7

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc------chHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCc
Q 015374          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT  196 (408)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  196 (408)
                      .-++|+.++.||+|.||+|-+++.+.+++.+|+|++++.      ....-..|-++|+.. +||.+..+--.|  +....
T Consensus       166 Tm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~-~HPFLt~LKYsF--Qt~dr  242 (516)
T KOG0690|consen  166 TMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNC-RHPFLTSLKYSF--QTQDR  242 (516)
T ss_pred             ccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhc-cCcHHHHhhhhh--ccCce
Confidence            457899999999999999999999999999999999753      234566789999998 999999998888  44578


Q ss_pred             cEEEEEeecCCChhhhcC---CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccC-
Q 015374          197 PSLIFEYVNSTDFKVLYP---TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP-  272 (408)
Q Consensus       197 ~~lv~e~~~~~~l~~~~~---~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~-  272 (408)
                      +|+||||.+||.|..++.   .|++...+.+-.+|..||.|||+++||+||||.+|.|+|.+ |.+||+|||+++.... 
T Consensus       243 lCFVMeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkD-GHIKitDFGLCKE~I~~  321 (516)
T KOG0690|consen  243 LCFVMEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKD-GHIKITDFGLCKEEIKY  321 (516)
T ss_pred             EEEEEEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccC-CceEeeecccchhcccc
Confidence            999999999999988884   49999999999999999999999999999999999999999 8999999999976543 


Q ss_pred             CCcceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCCCc
Q 015374          273 GKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPW  352 (408)
Q Consensus       273 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  352 (408)
                      +....+.+||+.|.|||++.+ ..|+.++|.|.+||++|||++|+.||+.. +....+..|...                
T Consensus       322 g~t~kTFCGTPEYLAPEVleD-nDYgraVDWWG~GVVMYEMmCGRLPFyn~-dh~kLFeLIl~e----------------  383 (516)
T KOG0690|consen  322 GDTTKTFCGTPEYLAPEVLED-NDYGRAVDWWGVGVVMYEMMCGRLPFYNK-DHEKLFELILME----------------  383 (516)
T ss_pred             cceeccccCChhhcCchhhcc-ccccceeehhhhhHHHHHHHhccCccccc-chhHHHHHHHhh----------------
Confidence            445677899999999999987 89999999999999999999999999543 323333322221                


Q ss_pred             cccccccCCCCCCHHHHHHHHHhcccCcCCCC-----CHHHHhcCCCccccccch
Q 015374          353 SKFINADNQHLVSPEAIDFLDKLLRYDHQDRL-----TAREAMAHPYFAQVRAAE  402 (408)
Q Consensus       353 ~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rp-----t~~elL~hp~f~~~~~~~  402 (408)
                          ....+..++++++.|+..+|..||.+|.     .+.|+.+|+||..+.++.
T Consensus       384 ----d~kFPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h~FF~~v~W~~  434 (516)
T KOG0690|consen  384 ----DLKFPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRHRFFASVDWEA  434 (516)
T ss_pred             ----hccCCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhhhhhccCCHHH
Confidence                2233455899999999999999999997     689999999999998754

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=3.9e-42  Score=323.35  Aligned_cols=272  Identities=33%  Similarity=0.587  Sum_probs=207.9

Q ss_pred             CCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc-----chHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccEE
Q 015374          125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSL  199 (408)
Q Consensus       125 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l  199 (408)
                      ++|++.+.||.|+||+||+|.+..+++.||+|.+...     ..+.+.+|+.+++++ +|+||+++++++.+  ....++
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~~~l   78 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEM-QHGNIVRLQDVVHS--EKRLYL   78 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhc-cCCCEeeEEEEEec--CCeEEE
Confidence            5799999999999999999999999999999988532     235678999999999 99999999999965  468899


Q ss_pred             EEEeecCCChhhhc-C----CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCC-
Q 015374          200 IFEYVNSTDFKVLY-P----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG-  273 (408)
Q Consensus       200 v~e~~~~~~l~~~~-~----~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~-  273 (408)
                      ||||+++ ++...+ .    .+++..+..++.|++.||+|||+++++|+||+|+||+++.+.+.+||+|||++...... 
T Consensus        79 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~  157 (294)
T PLN00009         79 VFEYLDL-DLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV  157 (294)
T ss_pred             EEecccc-cHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCCc
Confidence            9999976 444443 2    25677888899999999999999999999999999999976568999999999755322 


Q ss_pred             CcceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCC--CC---
Q 015374          274 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSR--HS---  348 (408)
Q Consensus       274 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~--~~---  348 (408)
                      .......++..|+|||.+.+...++.++|||||||++|+|++|..||. ..+..+.+.++....+......+.  ..   
T Consensus       158 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (294)
T PLN00009        158 RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFP-GDSEIDELFKIFRILGTPNEETWPGVTSLPD  236 (294)
T ss_pred             cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCC-CCCHHHHHHHHHHHhCCCChhhccccccchh
Confidence            222334677889999998765568899999999999999999998874 344444444444333221110000  00   


Q ss_pred             ----CCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccccccc
Q 015374          349 ----RKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAA  401 (408)
Q Consensus       349 ----~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~~~~~  401 (408)
                          ...+...........+++++.+++.+||+.||++||++.++++||||...+.+
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~~~~~  293 (294)
T PLN00009        237 YKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDLGDA  293 (294)
T ss_pred             hhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhHHhcC
Confidence                00000000011123468889999999999999999999999999999988654

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=6.8e-42  Score=321.71  Aligned_cols=270  Identities=32%  Similarity=0.583  Sum_probs=205.7

Q ss_pred             CCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecccc-----hHHHHHHHHHHHHhcCCCCceEEeeEEEccCC---Cc
Q 015374          125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK-----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHS---KT  196 (408)
Q Consensus       125 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~---~~  196 (408)
                      ++|++.+.||+|+||+||+|.+..+++.||+|.++...     ...+.+|+.+++.+.+|+||+++++++.....   ..
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~   80 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS   80 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence            47899999999999999999999999999999876322     25678899999999667999999999865322   23


Q ss_pred             cEEEEEeecCCChhhhc--------CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccce
Q 015374          197 PSLIFEYVNSTDFKVLY--------PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE  268 (408)
Q Consensus       197 ~~lv~e~~~~~~l~~~~--------~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~  268 (408)
                      .++||||+++ ++..++        ..+++..+..++.|++.||.|||++||+||||+|+||+++.+.+.++|+|||++.
T Consensus        81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~~  159 (295)
T cd07837          81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGR  159 (295)
T ss_pred             EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeecccce
Confidence            7899999997 555543        2378899999999999999999999999999999999999844899999999987


Q ss_pred             eccCC-CcceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCC
Q 015374          269 FYHPG-KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRH  347 (408)
Q Consensus       269 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (408)
                      ..... .......++..|+|||.+.+...++.++|+||||+++|+|++|..|| .+.++.+.+..+....+.........
T Consensus       160 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (295)
T cd07837         160 AFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLF-PGDSELQQLLHIFKLLGTPTEQVWPG  238 (295)
T ss_pred             ecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCC-CCCCHHHHHHHHHHHhCCCChhhCcc
Confidence            65322 22233456788999999876566899999999999999999999887 44555555555444322111000000


Q ss_pred             --CC------CCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcc
Q 015374          348 --SR------KPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFA  396 (408)
Q Consensus       348 --~~------~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~  396 (408)
                        ..      ..+...........+++++.+||.+||..||++|||++|++.||||+
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~  295 (295)
T cd07837         239 VSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD  295 (295)
T ss_pred             hhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence              00      00000000111234788999999999999999999999999999985

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=8.7e-42  Score=314.32  Aligned_cols=246  Identities=24%  Similarity=0.420  Sum_probs=202.6

Q ss_pred             CEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc-----chHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccEEE
Q 015374          126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI  200 (408)
Q Consensus       126 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  200 (408)
                      +|++.+.||+|++|.||++.+..+++.+++|.++..     ..+.+.+|+.+++++ +|+|++++++.+... ....+++
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~-~~~~~lv   78 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQL-KHPNIVAYRESWEGE-DGLLYIV   78 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhC-CCCCeeeeeeeecCC-CCEEEEE
Confidence            589999999999999999999999999999998532     234678899999999 999999999987532 3467899


Q ss_pred             EEeecCCChhhhcC-----CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCCC-
Q 015374          201 FEYVNSTDFKVLYP-----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK-  274 (408)
Q Consensus       201 ~e~~~~~~l~~~~~-----~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~~-  274 (408)
                      |||++++++..++.     .+++.++..++.|++.||+|||++||+|+||||+||+++.+ +.++|+|||++....... 
T Consensus        79 ~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~-~~~~l~df~~~~~~~~~~~  157 (257)
T cd08223          79 MGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRT-NIIKVGDLGIARVLENQCD  157 (257)
T ss_pred             ecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecC-CcEEEecccceEEecccCC
Confidence            99999999987762     37899999999999999999999999999999999999987 799999999998764322 


Q ss_pred             cceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCCCccc
Q 015374          275 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSK  354 (408)
Q Consensus       275 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  354 (408)
                      ......++..|+|||++.+ ..++.++|+||||+++++|++|+.||. +.+..+....+....                 
T Consensus       158 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~~l~~g~~~~~-~~~~~~~~~~~~~~~-----------------  218 (257)
T cd08223         158 MASTLIGTPYYMSPELFSN-KPYNYKSDVWALGCCVYEMATLKHAFN-AKDMNSLVYRIIEGK-----------------  218 (257)
T ss_pred             ccccccCCcCccChhHhcC-CCCCchhhhHHHHHHHHHHHcCCCCCC-CCCHHHHHHHHHhcC-----------------
Confidence            2233467888999999987 778999999999999999999999974 333333322222210                 


Q ss_pred             cccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCc
Q 015374          355 FINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF  395 (408)
Q Consensus       355 ~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f  395 (408)
                        ....+..+++++.+++.+||+.||++|||+.++++||||
T Consensus       219 --~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~  257 (257)
T cd08223         219 --LPPMPKDYSPELGELIATMLSKRPEKRPSVKSILRQPYI  257 (257)
T ss_pred             --CCCCccccCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence              011123468899999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.2e-42  Score=320.59  Aligned_cols=252  Identities=24%  Similarity=0.424  Sum_probs=209.1

Q ss_pred             CCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc----chHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccEEE
Q 015374          125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI  200 (408)
Q Consensus       125 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  200 (408)
                      ++|++.+.||.|+||.||+|++..+++.+++|.+...    ....+.+|+.+++.+ +|+|++++++++.+  +...++|
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~~~~v   77 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQC-RSPYITKYYGSFLK--GSKLWII   77 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHc-CCCCeeeeeEEEEE--CCeEEEE
Confidence            4688889999999999999999999999999998633    235678999999999 89999999999865  4678999


Q ss_pred             EEeecCCChhhhcC--CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCC-Ccce
Q 015374          201 FEYVNSTDFKVLYP--TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG-KEYN  277 (408)
Q Consensus       201 ~e~~~~~~l~~~~~--~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~-~~~~  277 (408)
                      +||+++++|..++.  .+++..+..++.|++.||.|||+++++|+||+|+||+++.+ +.++|+|||+++..... ....
T Consensus        78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~-~~~~l~d~g~~~~~~~~~~~~~  156 (274)
T cd06609          78 MEYCGGGSCLDLLKPGKLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEE-GDVKLADFGVSGQLTSTMSKRN  156 (274)
T ss_pred             EEeeCCCcHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCC-CCEEEcccccceeecccccccc
Confidence            99999999998875  47999999999999999999999999999999999999998 79999999999876543 2233


Q ss_pred             eeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCCCcccccc
Q 015374          278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSKFIN  357 (408)
Q Consensus       278 ~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  357 (408)
                      ...++..|++||.+.+ ..++.++||||||+++|+|++|..||... +.......+...                   ..
T Consensus       157 ~~~~~~~y~~PE~~~~-~~~~~~sDv~slG~il~~l~tg~~p~~~~-~~~~~~~~~~~~-------------------~~  215 (274)
T cd06609         157 TFVGTPFWMAPEVIKQ-SGYDEKADIWSLGITAIELAKGEPPLSDL-HPMRVLFLIPKN-------------------NP  215 (274)
T ss_pred             cccCCccccChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCcccC-chHHHHHHhhhc-------------------CC
Confidence            4567888999999987 66999999999999999999999998432 222222221111                   00


Q ss_pred             ccCCCC-CCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccccccc
Q 015374          358 ADNQHL-VSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAA  401 (408)
Q Consensus       358 ~~~~~~-~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~~~~~  401 (408)
                      ...... +++++.+++.+||..||++|||++++++||||+.....
T Consensus       216 ~~~~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~~~~~~~~~~  260 (274)
T cd06609         216 PSLEGNKFSKPFKDFVSLCLNKDPKERPSAKELLKHKFIKKAKKT  260 (274)
T ss_pred             CCCcccccCHHHHHHHHHHhhCChhhCcCHHHHhhChhhcCCCcc
Confidence            111111 67899999999999999999999999999999887654

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=3.5e-42  Score=321.86  Aligned_cols=264  Identities=32%  Similarity=0.610  Sum_probs=204.7

Q ss_pred             CEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc-----chHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccEEE
Q 015374          126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI  200 (408)
Q Consensus       126 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  200 (408)
                      +|++++.||.|+||.||+|++..++..|+||.++..     ....+.+|+.+++++ +||||+++++++.+  ....++|
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~--~~~~~~v   77 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL-NHPNIVKLLDVIHT--ENKLYLV   77 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhc-CCCCCcchhhhccc--CCcEEEE
Confidence            488899999999999999999999999999988632     225688999999999 99999999999954  5678999


Q ss_pred             EEeecCCChhhhc-----CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCCC-
Q 015374          201 FEYVNSTDFKVLY-----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK-  274 (408)
Q Consensus       201 ~e~~~~~~l~~~~-----~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~~-  274 (408)
                      |||+.+ ++..++     ..+++..+..++.|++.||+|||+.+++|+||+|+||+++.+ +.++|+|||++....... 
T Consensus        78 ~e~~~~-~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~-~~~~l~dfg~~~~~~~~~~  155 (284)
T cd07860          78 FEFLHQ-DLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTE-GAIKLADFGLARAFGVPVR  155 (284)
T ss_pred             eecccc-CHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCC-CCEEEeeccchhhcccCcc
Confidence            999974 566554     347889999999999999999999999999999999999988 799999999987654322 


Q ss_pred             cceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcC---------
Q 015374          275 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNS---------  345 (408)
Q Consensus       275 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~---------  345 (408)
                      ......++..|+|||.+.+...++.++|||||||++|+|++|+.||. +.+..+....+....+.......         
T Consensus       156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (284)
T cd07860         156 TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFP-GDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDY  234 (284)
T ss_pred             ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCC-CCCHHHHHHHHHHHhCCCChhhhhhhhHHHHH
Confidence            22334567889999998775557889999999999999999999974 44444555554444332210000         


Q ss_pred             CCCCCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCc
Q 015374          346 RHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF  395 (408)
Q Consensus       346 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f  395 (408)
                      ......+...........+++++.++|.+||+.||++|||++|+++||||
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f  284 (284)
T cd07860         235 KPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF  284 (284)
T ss_pred             HhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence            00000000000011123468899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=4.6e-44  Score=316.91  Aligned_cols=275  Identities=29%  Similarity=0.543  Sum_probs=217.4

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCc----EEEEEEecccc-----hHHHHHHHHHHHHhcCCCCceEEeeEEEccCC
Q 015374          124 QDDYEVVRKVGRGKYSEVFEGINVNTNE----RCIIKILKPVK-----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHS  194 (408)
Q Consensus       124 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~----~vavK~~~~~~-----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~  194 (408)
                      ...|+++..||+|+||.||+|...+++.    .+|+|.++.+.     ....-+|+.+++.| +|+|++.+..+|... .
T Consensus        23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl-~h~nvi~Lv~Vfl~~-d  100 (438)
T KOG0666|consen   23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLREL-KHPNVISLVKVFLSH-D  100 (438)
T ss_pred             HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHh-cCCcchhHHHHHhcc-C
Confidence            4568889999999999999997665544    68999997542     24577999999999 999999999998654 6


Q ss_pred             CccEEEEEeecCCChhhhc-------CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCC---CCcEEEEec
Q 015374          195 KTPSLIFEYVNSTDFKVLY-------PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE---LRKLRLIDW  264 (408)
Q Consensus       195 ~~~~lv~e~~~~~~l~~~~-------~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~---~~~~kl~Df  264 (408)
                      ..++|++||.+...+....       +.++...++.++.||+.|+.|||++.|+||||||.|||+..+   .|.|||+||
T Consensus       101 ~~v~l~fdYAEhDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaDl  180 (438)
T KOG0666|consen  101 KKVWLLFDYAEHDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIADL  180 (438)
T ss_pred             ceEEEEehhhhhhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeecc
Confidence            7899999999988765443       358889999999999999999999999999999999999754   479999999


Q ss_pred             ccceeccCCC----cceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCC--------CCHHHHHH
Q 015374          265 GLAEFYHPGK----EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGH--------DNHDQLVK  332 (408)
Q Consensus       265 G~a~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~--------~~~~~~~~  332 (408)
                      |+++.+.+.-    .....+-|.+|+|||.+++...|+.+.|||+.|||+.||++....|....        -..+++..
T Consensus       181 GlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~r  260 (438)
T KOG0666|consen  181 GLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDR  260 (438)
T ss_pred             cHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHHH
Confidence            9999876432    23456788999999999998999999999999999999999887764321        13578889


Q ss_pred             HHhhhchhhhhcCCCCCC--Ccccc---ccc------------cCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCc
Q 015374          333 IAKDCCLIIWCNSRHSRK--PWSKF---INA------------DNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF  395 (408)
Q Consensus       333 ~~~~~~~~~~~~~~~~~~--~~~~~---~~~------------~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f  395 (408)
                      |.+.+|.+....+..-.+  .|...   ++.            ...+.-++...+|+.+||++||.+|.|++++|+|+||
T Consensus       261 If~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~yF  340 (438)
T KOG0666|consen  261 IFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHPYF  340 (438)
T ss_pred             HHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhccccc
Confidence            998888665333321111  11000   000            0111124569999999999999999999999999999


Q ss_pred             ccccc
Q 015374          396 AQVRA  400 (408)
Q Consensus       396 ~~~~~  400 (408)
                      ..-+.
T Consensus       341 ~~d~l  345 (438)
T KOG0666|consen  341 TEDPL  345 (438)
T ss_pred             ccCCC
Confidence            87643

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=1e-41  Score=313.54  Aligned_cols=245  Identities=22%  Similarity=0.437  Sum_probs=203.9

Q ss_pred             CEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecc-----cchHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccEEE
Q 015374          126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP-----VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI  200 (408)
Q Consensus       126 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~-----~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  200 (408)
                      +|++.+.||+|+||.||+|++..+++.|++|.+..     .....+.+|+.+++++ +|||++++++++.+  ....++|
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~~~lv   77 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKL-DSSYIIRYYESFLD--KGKLNIV   77 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhc-CCCCeehheeeecc--CCEEEEE
Confidence            47889999999999999999999999999998753     2346788999999999 99999999999955  4678999


Q ss_pred             EEeecCCChhhhc-----CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCCCc
Q 015374          201 FEYVNSTDFKVLY-----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE  275 (408)
Q Consensus       201 ~e~~~~~~l~~~~-----~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~~~  275 (408)
                      |||+++++|..++     ..+++..+..++.|++.||.|||+.|++|+||||+||+++.+ +.++|+|||++........
T Consensus        78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~-~~~~l~df~~~~~~~~~~~  156 (256)
T cd08529          78 MEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAY-DNVKIGDLGVAKLLSDNTN  156 (256)
T ss_pred             EEeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCC-CCEEEcccccceeccCccc
Confidence            9999999998876     347888889999999999999999999999999999999988 7899999999887654332


Q ss_pred             -ceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCCCccc
Q 015374          276 -YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSK  354 (408)
Q Consensus       276 -~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  354 (408)
                       .....++..|+|||++.+ ..++.++|+|||||++|+|++|+.||.. .++.+....+...                  
T Consensus       157 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~-~~~~~~~~~~~~~------------------  216 (256)
T cd08529         157 FANTIVGTPYYLSPELCED-KPYNEKSDVWALGVVLYECCTGKHPFDA-NNQGALILKIIRG------------------  216 (256)
T ss_pred             hhhccccCccccCHHHhcC-CCCCCccchHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHcC------------------
Confidence             233467888999999987 6789999999999999999999999843 3333333322211                  


Q ss_pred             cccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCc
Q 015374          355 FINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF  395 (408)
Q Consensus       355 ~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f  395 (408)
                       ........++.++.+++.+||+.+|++||++.++++|||+
T Consensus       217 -~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~  256 (256)
T cd08529         217 -VFPPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRNPSL  256 (256)
T ss_pred             -CCCCCccccCHHHHHHHHHHccCCcccCcCHHHHhhCCCC
Confidence             0011122467899999999999999999999999999996

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=5.6e-42  Score=322.81  Aligned_cols=254  Identities=27%  Similarity=0.492  Sum_probs=209.8

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc---chHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccEEE
Q 015374          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV---KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI  200 (408)
Q Consensus       124 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  200 (408)
                      ..+|++.+.||.|+||+||+|++..+++.|++|.+...   ..+.+.+|+.+++.+ +|+|++++++++.+  ....++|
T Consensus        18 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~--~~~~~lv   94 (296)
T cd06655          18 KKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKEL-KNPNIVNFLDSFLV--GDELFVV   94 (296)
T ss_pred             cceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhc-CCCceeeeeeeEec--CceEEEE
Confidence            46799999999999999999999999999999988532   345678899999999 99999999999965  4678999


Q ss_pred             EEeecCCChhhhcC--CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCCCc-ce
Q 015374          201 FEYVNSTDFKVLYP--TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE-YN  277 (408)
Q Consensus       201 ~e~~~~~~l~~~~~--~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~~~-~~  277 (408)
                      +||+++++|..++.  .+++.++..++.|++.||+|||+.|++|+||||+||+++.+ +.++|+|||++........ ..
T Consensus        95 ~e~~~~~~L~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~-~~~kl~dfg~~~~~~~~~~~~~  173 (296)
T cd06655          95 MEYLAGGSLTDVVTETCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMD-GSVKLTDFGFCAQITPEQSKRS  173 (296)
T ss_pred             EEecCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCC-CCEEEccCccchhcccccccCC
Confidence            99999999988774  48999999999999999999999999999999999999987 7899999999876543322 23


Q ss_pred             eeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCCCcccccc
Q 015374          278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSKFIN  357 (408)
Q Consensus       278 ~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  357 (408)
                      ...++..|+|||.+.+ ..++.++|+|||||++|+|++|..||... +..+....+... +       .         ..
T Consensus       174 ~~~~~~~y~aPE~~~~-~~~~~~~Dv~slGvil~~lltg~~pf~~~-~~~~~~~~~~~~-~-------~---------~~  234 (296)
T cd06655         174 TMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMVEGEPPYLNE-NPLRALYLIATN-G-------T---------PE  234 (296)
T ss_pred             CcCCCccccCcchhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHhc-C-------C---------cc
Confidence            3467888999999877 67899999999999999999999998433 333322222110 0       0         00


Q ss_pred             ccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccccc
Q 015374          358 ADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRA  400 (408)
Q Consensus       358 ~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~~~~  400 (408)
                      ...+..+++.+.+++.+||..||++|||+.+++.||||+....
T Consensus       235 ~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~~~~~~~~~  277 (296)
T cd06655         235 LQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQHPFLKLAKP  277 (296)
T ss_pred             cCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhChHhhhccc
Confidence            1122347889999999999999999999999999999987654

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=1.4e-41  Score=319.03  Aligned_cols=255  Identities=26%  Similarity=0.448  Sum_probs=205.5

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc--chHHHHHHHHHHHHhcCCCCceEEeeEEEccC---CCcc
Q 015374          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV--KKKKIKREIKILQNLCGGPNVVKLLDIVRDQH---SKTP  197 (408)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~---~~~~  197 (408)
                      ..++|++.+.||+|+||.||++.+..+++.+|+|++...  ....+.+|+.++.++.+|||+++++++|...+   ....
T Consensus        20 ~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~   99 (291)
T cd06639          20 PTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQL   99 (291)
T ss_pred             CCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCee
Confidence            478899999999999999999999999999999998643  34667889999999878999999999987532   2468


Q ss_pred             EEEEEeecCCChhhhc-------CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceec
Q 015374          198 SLIFEYVNSTDFKVLY-------PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY  270 (408)
Q Consensus       198 ~lv~e~~~~~~l~~~~-------~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~  270 (408)
                      ++||||+++++|..++       ..+++..+..++.|++.||+|||+.+|+|+||||+||+++.+ +.++|+|||++...
T Consensus       100 ~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~-~~~kl~dfg~~~~~  178 (291)
T cd06639         100 WLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTE-GGVKLVDFGVSAQL  178 (291)
T ss_pred             EEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCC-CCEEEeecccchhc
Confidence            9999999999998765       347889999999999999999999999999999999999988 78999999998765


Q ss_pred             cCCC-cceeeccCccccccccccCCc----CCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcC
Q 015374          271 HPGK-EYNVRVASRYFKGPELLVDLQ----DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNS  345 (408)
Q Consensus       271 ~~~~-~~~~~~~~~~y~aPE~~~~~~----~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  345 (408)
                      .... ......++..|+|||.+....    .++.++|||||||++|+|++|+.||... +..+.+..+....        
T Consensus       179 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~-~~~~~~~~~~~~~--------  249 (291)
T cd06639         179 TSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDM-HPVKTLFKIPRNP--------  249 (291)
T ss_pred             ccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCC-cHHHHHHHHhcCC--------
Confidence            4322 223456788899999986422    3688999999999999999999998533 2223322221110        


Q ss_pred             CCCCCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcc
Q 015374          346 RHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFA  396 (408)
Q Consensus       346 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~  396 (408)
                         ..      ....+...+..+.+++.+||+.||++|||+.|+++||||+
T Consensus       250 ---~~------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~  291 (291)
T cd06639         250 ---PP------TLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK  291 (291)
T ss_pred             ---CC------CCCcccccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence               00      0011223567899999999999999999999999999995

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=3e-42  Score=322.11  Aligned_cols=253  Identities=25%  Similarity=0.434  Sum_probs=203.7

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc--chHHHHHHHHHHHHhcCCCCceEEeeEEEcc----CCCc
Q 015374          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV--KKKKIKREIKILQNLCGGPNVVKLLDIVRDQ----HSKT  196 (408)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~----~~~~  196 (408)
                      ..+.|++.+.||+|+||+||+|.+..+++.+|+|++...  ....+..|+.+++++.+|+||+++++++...    ....
T Consensus        14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~   93 (282)
T cd06636          14 PAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQ   93 (282)
T ss_pred             hhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCE
Confidence            457889999999999999999999999999999998643  3456888999999987899999999998532    2457


Q ss_pred             cEEEEEeecCCChhhhcC-----CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceecc
Q 015374          197 PSLIFEYVNSTDFKVLYP-----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH  271 (408)
Q Consensus       197 ~~lv~e~~~~~~l~~~~~-----~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~  271 (408)
                      .+++|||+++++|..++.     .+++..+..++.|++.||.|||+.||+|+||+|+||+++.+ +.++|+|||++....
T Consensus        94 ~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~-~~~~l~dfg~~~~~~  172 (282)
T cd06636          94 LWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTEN-AEVKLVDFGVSAQLD  172 (282)
T ss_pred             EEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCC-CCEEEeeCcchhhhh
Confidence            899999999999988763     37788888999999999999999999999999999999988 789999999987553


Q ss_pred             CC-CcceeeccCccccccccccC----CcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCC
Q 015374          272 PG-KEYNVRVASRYFKGPELLVD----LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSR  346 (408)
Q Consensus       272 ~~-~~~~~~~~~~~y~aPE~~~~----~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  346 (408)
                      .. .......++..|+|||.+..    ...++.++|+|||||++|||++|..||.... +......+...          
T Consensus       173 ~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~-~~~~~~~~~~~----------  241 (282)
T cd06636         173 RTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMH-PMRALFLIPRN----------  241 (282)
T ss_pred             ccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccC-HHhhhhhHhhC----------
Confidence            22 22334568889999999863    2467889999999999999999999985332 22221111100          


Q ss_pred             CCCCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCc
Q 015374          347 HSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF  395 (408)
Q Consensus       347 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f  395 (408)
                       .       ........++.++.+||++||+.||.+|||+.|+++||||
T Consensus       242 -~-------~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~  282 (282)
T cd06636         242 -P-------PPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI  282 (282)
T ss_pred             -C-------CCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence             0       0011122368899999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=100.00  E-value=5.9e-44  Score=335.18  Aligned_cols=245  Identities=25%  Similarity=0.476  Sum_probs=217.4

Q ss_pred             eeeeeeCceEEEEEEEcCCCcEEEEEEecc-----cchHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccEEEEEeec
Q 015374          131 RKVGRGKYSEVFEGINVNTNERCIIKILKP-----VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVN  205 (408)
Q Consensus       131 ~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~-----~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~  205 (408)
                      +.||.|.||+||-|++..+|+.||||++.+     ...+++++|+.||+++ .||.||.+-..|+.  ....+.|||-+.
T Consensus       570 evLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l-~HPGiV~le~M~ET--~ervFVVMEKl~  646 (888)
T KOG4236|consen  570 EVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNL-HHPGIVNLECMFET--PERVFVVMEKLH  646 (888)
T ss_pred             hhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhc-CCCCeeEEEEeecC--CceEEEEehhhc
Confidence            579999999999999999999999999863     3457899999999999 99999999999955  467889999999


Q ss_pred             CCChhhhc----CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCC--CCcEEEEecccceeccCCCcceee
Q 015374          206 STDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE--LRKLRLIDWGLAEFYHPGKEYNVR  279 (408)
Q Consensus       206 ~~~l~~~~----~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~--~~~~kl~DfG~a~~~~~~~~~~~~  279 (408)
                      |.-|+..+    ..+++...+.++.||+.||.|||-+||+|+||||+|||+.+.  +-.+||||||+|+++.........
T Consensus       647 GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksFRrsV  726 (888)
T KOG4236|consen  647 GDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSFRRSV  726 (888)
T ss_pred             chHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecchhhhhhhh
Confidence            88887776    458888889999999999999999999999999999999753  568999999999999887777888


Q ss_pred             ccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCCCcccccccc
Q 015374          280 VASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSKFINAD  359 (408)
Q Consensus       280 ~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  359 (408)
                      +||+.|.|||++.+ +.|+.+-|+||+||++|--++|..||..+.+-.|+++...-.                   +++.
T Consensus       727 VGTPAYLaPEVLrn-kGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQIQNAaFM-------------------yPp~  786 (888)
T KOG4236|consen  727 VGTPAYLAPEVLRN-KGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQIQNAAFM-------------------YPPN  786 (888)
T ss_pred             cCCccccCHHHHhh-ccccccccceeeeEEEEEEecccccCCCccchhHHhhccccc-------------------cCCC
Confidence            99999999999998 889999999999999999999999998777777777653322                   3344


Q ss_pred             CCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccc
Q 015374          360 NQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQV  398 (408)
Q Consensus       360 ~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~~  398 (408)
                      .|..+++++.|||+.+|+..-++|.|++..|.|||+++.
T Consensus       787 PW~eis~~AidlIn~LLqVkm~kRysvdk~lsh~Wlq~y  825 (888)
T KOG4236|consen  787 PWSEISPEAIDLINNLLQVKMRKRYSVDKSLSHPWLQDY  825 (888)
T ss_pred             chhhcCHHHHHHHHHHHHHHHHHhcchHhhccchhhhcc
Confidence            455589999999999999999999999999999999864

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=3.6e-42  Score=322.06  Aligned_cols=265  Identities=30%  Similarity=0.524  Sum_probs=208.4

Q ss_pred             CCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc-----chHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccEE
Q 015374          125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSL  199 (408)
Q Consensus       125 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l  199 (408)
                      ++|++.++||+|+||.||+|.+..+++.+|+|.+...     ..+.+.+|+.+++.+ +|+||+++++++.+  ....++
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~~~l   77 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQL-RHENLVNLIEVFRR--KKRLYL   77 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhc-CCcchhhHHHhccc--CCeEEE
Confidence            4789999999999999999999989999999987532     234678899999999 99999999999954  567899


Q ss_pred             EEEeecCCChhhhcC---CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCCC-c
Q 015374          200 IFEYVNSTDFKVLYP---TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK-E  275 (408)
Q Consensus       200 v~e~~~~~~l~~~~~---~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~~-~  275 (408)
                      ||||++++++..+..   .+++..+..++.|++.||.|||+.+|+|+||+|+||+++.+ +.++|+|||++....... .
T Consensus        78 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~-~~~~l~dfg~~~~~~~~~~~  156 (286)
T cd07846          78 VFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQS-GVVKLCDFGFARTLAAPGEV  156 (286)
T ss_pred             EEecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCC-CcEEEEeeeeeeeccCCccc
Confidence            999999999887753   48899999999999999999999999999999999999988 799999999987654332 2


Q ss_pred             ceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhc-----------
Q 015374          276 YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCN-----------  344 (408)
Q Consensus       276 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~-----------  344 (408)
                      .....++..|+|||.+.+...++.++||||||+++|||++|..|| .+....+.+..+....+......           
T Consensus       157 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (286)
T cd07846         157 YTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLF-PGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFA  235 (286)
T ss_pred             cCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCC-CCCchHHHHHHHHHHhCCCchhhHHHhccchHhh
Confidence            233567888999999876556788999999999999999998776 44444555544443322111000           


Q ss_pred             -CCCCCCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCc
Q 015374          345 -SRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF  395 (408)
Q Consensus       345 -~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f  395 (408)
                       .......... ........++..+.+|+.+||+.||++|||+.++++||||
T Consensus       236 ~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~  286 (286)
T cd07846         236 GMRLPEVKEIE-PLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF  286 (286)
T ss_pred             ccccccccCcc-hHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence             0000000000 0011123468899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=4.4e-42  Score=326.04  Aligned_cols=268  Identities=27%  Similarity=0.511  Sum_probs=204.1

Q ss_pred             CEEEEeeeeeeCceEEEEEEEcC--CCcEEEEEEecccc------hHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCcc
Q 015374          126 DYEVVRKVGRGKYSEVFEGINVN--TNERCIIKILKPVK------KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP  197 (408)
Q Consensus       126 ~y~~~~~lG~G~fg~Vy~~~~~~--~~~~vavK~~~~~~------~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~  197 (408)
                      +|++.++||+|+||.||+|.+..  ++..||+|.+....      ...+.+|+.+++++ +||||+++++++.+.+....
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~   79 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLREL-KHENVVSLVEVFLEHADKSV   79 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhc-CCCCccceEEEEeCCCCceE
Confidence            58889999999999999999888  89999999987522      35678899999999 99999999999987655789


Q ss_pred             EEEEEeecCCChhhhc-------CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeC----CCCcEEEEeccc
Q 015374          198 SLIFEYVNSTDFKVLY-------PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDH----ELRKLRLIDWGL  266 (408)
Q Consensus       198 ~lv~e~~~~~~l~~~~-------~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~----~~~~~kl~DfG~  266 (408)
                      ++||||++++.+....       ..+++..+..++.|++.||.|||+.+|+||||||+||+++.    + +.+||+|||+
T Consensus        80 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~-~~~kl~Dfg~  158 (316)
T cd07842          80 YLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPER-GVVKIGDLGL  158 (316)
T ss_pred             EEEEeCCCcCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCcc-ceEEECCCcc
Confidence            9999999875543321       25788899999999999999999999999999999999998    6 7899999999


Q ss_pred             ceeccCCCc----ceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCH--------HHHHHHH
Q 015374          267 AEFYHPGKE----YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNH--------DQLVKIA  334 (408)
Q Consensus       267 a~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~--------~~~~~~~  334 (408)
                      +........    .....++..|+|||++.+...++.++|||||||++|+|++|+.||.......        +.+..+.
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (316)
T cd07842         159 ARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIF  238 (316)
T ss_pred             ccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHH
Confidence            876543322    2334678889999998775678999999999999999999999985332221        2233333


Q ss_pred             hhhchhhhhcC--------------CCCCCCccc-c--ccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCc
Q 015374          335 KDCCLIIWCNS--------------RHSRKPWSK-F--INADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF  395 (408)
Q Consensus       335 ~~~~~~~~~~~--------------~~~~~~~~~-~--~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f  395 (408)
                      ..++.......              ......+.. .  .........+.++.+++.+||+.||++|||+.|+++||||
T Consensus       239 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~f  316 (316)
T cd07842         239 EVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPYF  316 (316)
T ss_pred             HHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCCC
Confidence            33221110000              000000000 0  0001112467889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=3.8e-42  Score=324.15  Aligned_cols=257  Identities=26%  Similarity=0.462  Sum_probs=210.3

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc---chHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccEE
Q 015374          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV---KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSL  199 (408)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l  199 (408)
                      ...+|++.+.||+|+||.||+|.+..+++.||+|.+...   ..+.+.+|+.+++.+ +|+||++++++|..  +...++
T Consensus        17 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~--~~~~~l   93 (297)
T cd06656          17 PKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMREN-KNPNIVNYLDSYLV--GDELWV   93 (297)
T ss_pred             hhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhC-CCCCEeeEEEEEec--CCEEEE
Confidence            357899999999999999999999999999999998632   335678899999998 99999999999965  467899


Q ss_pred             EEEeecCCChhhhcC--CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCCCc-c
Q 015374          200 IFEYVNSTDFKVLYP--TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE-Y  276 (408)
Q Consensus       200 v~e~~~~~~l~~~~~--~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~~~-~  276 (408)
                      ||||+++++|..++.  .+++.++..++.|++.||.|||+.+|+|+||||+|||++.+ +.++|+|||++........ .
T Consensus        94 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~-~~~~l~Dfg~~~~~~~~~~~~  172 (297)
T cd06656          94 VMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMD-GSVKLTDFGFCAQITPEQSKR  172 (297)
T ss_pred             eecccCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCC-CCEEECcCccceEccCCccCc
Confidence            999999999998873  47888999999999999999999999999999999999987 7999999999876543322 2


Q ss_pred             eeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCCCccccc
Q 015374          277 NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSKFI  356 (408)
Q Consensus       277 ~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  356 (408)
                      ....++..|++||.+.+ ..++.++|+|||||++|+|++|..||..... ...+..+...           ..      .
T Consensus       173 ~~~~~~~~y~aPE~~~~-~~~~~~~Di~slGvil~~l~tg~~pf~~~~~-~~~~~~~~~~-----------~~------~  233 (297)
T cd06656         173 STMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMVEGEPPYLNENP-LRALYLIATN-----------GT------P  233 (297)
T ss_pred             CcccCCccccCHHHHcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCc-chheeeeccC-----------CC------C
Confidence            34567888999999987 7789999999999999999999999843322 1211111000           00      0


Q ss_pred             cccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccccccch
Q 015374          357 NADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAE  402 (408)
Q Consensus       357 ~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~~~~~~  402 (408)
                      ....+..++..+.+|+.+||+.||++|||++++++||||+..+...
T Consensus       234 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~~  279 (297)
T cd06656         234 ELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQHPFLKLAKPLS  279 (297)
T ss_pred             CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhccccccc
Confidence            0112234678899999999999999999999999999998776543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=3.8e-42  Score=329.82  Aligned_cols=275  Identities=29%  Similarity=0.554  Sum_probs=208.5

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc----chHHHHHHHHHHHHhcCCCCceEEeeEEEccC---CC
Q 015374          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQH---SK  195 (408)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~---~~  195 (408)
                      ..++|++.+.||+|+||.||+|++..+++.||+|.++..    ....+.+|+.+++++ +|+||+++++++....   ..
T Consensus         3 ~~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~   81 (336)
T cd07849           3 VGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRF-KHENIIGILDIIRPPSFESFN   81 (336)
T ss_pred             cccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhC-CCCCcCchhheeecccccccc
Confidence            357899999999999999999999999999999998642    234577899999999 8999999999876432   24


Q ss_pred             ccEEEEEeecCCChhhhc--CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCC
Q 015374          196 TPSLIFEYVNSTDFKVLY--PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG  273 (408)
Q Consensus       196 ~~~lv~e~~~~~~l~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~  273 (408)
                      ..++++||+.+ ++...+  ..+++..+..++.|++.||.|||+.||+||||||+||+++.+ +.++|+|||++......
T Consensus        82 ~~~lv~e~~~~-~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~-~~~kl~dfg~~~~~~~~  159 (336)
T cd07849          82 DVYIVQELMET-DLYKLIKTQHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTN-CDLKICDFGLARIADPE  159 (336)
T ss_pred             eEEEEehhccc-CHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCC-CCEEECcccceeecccc
Confidence            57899999986 454444  358999999999999999999999999999999999999988 79999999998765432


Q ss_pred             Cc----ceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCC---
Q 015374          274 KE----YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSR---  346 (408)
Q Consensus       274 ~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~---  346 (408)
                      ..    .....++..|+|||.+.+...++.++|||||||++|+|++|+.|| .+.+....+..+....+........   
T Consensus       160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f-~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (336)
T cd07849         160 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLF-PGKDYLHQLNLILGVLGTPSQEDLNCII  238 (336)
T ss_pred             ccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHHHcCCCCHHHHHHhh
Confidence            21    123467888999999866567899999999999999999999887 3444444444333332211100000   


Q ss_pred             -CCCC------Ccccccc-ccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccccccc
Q 015374          347 -HSRK------PWSKFIN-ADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAA  401 (408)
Q Consensus       347 -~~~~------~~~~~~~-~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~~~~~  401 (408)
                       ....      ....... .......++++.+++.+||+.||++|||+.|+++||||+.....
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~~  301 (336)
T cd07849         239 SLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHDP  301 (336)
T ss_pred             chhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCCC
Confidence             0000      0000000 00112357889999999999999999999999999999877543

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-43  Score=322.50  Aligned_cols=275  Identities=26%  Similarity=0.487  Sum_probs=215.7

Q ss_pred             cccCCCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecccc--hHHHHHHHHHHHHhcCC-C----CceEEeeEEEc
Q 015374          119 VQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK--KKKIKREIKILQNLCGG-P----NVVKLLDIVRD  191 (408)
Q Consensus       119 ~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~E~~~l~~l~~h-~----niv~l~~~~~~  191 (408)
                      .+....++|+++.++|+|+||.|-++.+..++..||||+++...  .+...-|+++++++..+ |    -++.+.++|  
T Consensus        83 ~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wF--  160 (415)
T KOG0671|consen   83 VGDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWF--  160 (415)
T ss_pred             eccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhh--
Confidence            33445889999999999999999999999999999999998655  35677899999999322 2    478888888  


Q ss_pred             cCCCccEEEEEeecCCChhhhc----CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCC------------
Q 015374          192 QHSKTPSLIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE------------  255 (408)
Q Consensus       192 ~~~~~~~lv~e~~~~~~l~~~~----~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~------------  255 (408)
                      +-.++.|+|+|.++....+.+-    .+++...++.++.|++.+++|||+.+++|.||||+|||+-+.            
T Consensus       161 dyrghiCivfellG~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~~  240 (415)
T KOG0671|consen  161 DYRGHICIVFELLGLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKKV  240 (415)
T ss_pred             hccCceEEEEeccChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCcc
Confidence            4458999999999765554443    249999999999999999999999999999999999998311            


Q ss_pred             -------CCcEEEEecccceeccCCCcceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHH
Q 015374          256 -------LRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHD  328 (408)
Q Consensus       256 -------~~~~kl~DfG~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~  328 (408)
                             ...++|+|||.|+...  ......+.|..|+|||++++ -+|+.++||||+||||+|+.+|...| .++++.+
T Consensus       241 ~~~r~~ks~~I~vIDFGsAtf~~--e~hs~iVsTRHYRAPEViLg-LGwS~pCDvWSiGCIL~ElytG~~LF-qtHen~E  316 (415)
T KOG0671|consen  241 CFIRPLKSTAIKVIDFGSATFDH--EHHSTIVSTRHYRAPEVILG-LGWSQPCDVWSIGCILVELYTGETLF-QTHENLE  316 (415)
T ss_pred             ceeccCCCcceEEEecCCcceec--cCcceeeeccccCCchheec-cCcCCccCceeeeeEEEEeeccceec-ccCCcHH
Confidence                   1368999999998754  33466789999999999999 78999999999999999999999886 6788889


Q ss_pred             HHHHHHhhhchhhhhcCCCC---------CCCcccccccc---------C--------CCCCCHHHHHHHHHhcccCcCC
Q 015374          329 QLVKIAKDCCLIIWCNSRHS---------RKPWSKFINAD---------N--------QHLVSPEAIDFLDKLLRYDHQD  382 (408)
Q Consensus       329 ~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~---------~--------~~~~~~~~~~li~~~L~~dp~~  382 (408)
                      .+.-+...+|..+.......         +..|++.....         .        .+.-..++.||+++||.+||.+
T Consensus       317 HLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~  396 (415)
T KOG0671|consen  317 HLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPAR  396 (415)
T ss_pred             HHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccc
Confidence            88666666664442221111         11122111110         0        0001245899999999999999


Q ss_pred             CCCHHHHhcCCCccccc
Q 015374          383 RLTAREAMAHPYFAQVR  399 (408)
Q Consensus       383 Rpt~~elL~hp~f~~~~  399 (408)
                      |+|+.|+|.||||+...
T Consensus       397 RiTl~EAL~HpFF~~~~  413 (415)
T KOG0671|consen  397 RITLREALSHPFFARLT  413 (415)
T ss_pred             cccHHHHhcCHHhhcCC
Confidence            99999999999998764

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=8.9e-42  Score=316.03  Aligned_cols=249  Identities=24%  Similarity=0.412  Sum_probs=202.5

Q ss_pred             CCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc--------chHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCc
Q 015374          125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV--------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT  196 (408)
Q Consensus       125 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~--------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  196 (408)
                      ++|++.+.||+|+||.||+|.+..++..|++|.+...        ....+.+|+.+++++ +|+||+++++++.+.....
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~   80 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNL-LHERIVQYYGCLRDPMERT   80 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhc-CCCCeeeEEeEeccCCCce
Confidence            5789999999999999999999999999999987421        124678899999999 9999999999987655567


Q ss_pred             cEEEEEeecCCChhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCC
Q 015374          197 PSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG  273 (408)
Q Consensus       197 ~~lv~e~~~~~~l~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~  273 (408)
                      ++++|||+++++|..++   ..+++..+..++.|++.||+|||+++|+|+||||+||+++.+ +.++|+|||++......
T Consensus        81 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~-~~~~l~Dfg~~~~~~~~  159 (265)
T cd06652          81 LSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSV-GNVKLGDFGASKRLQTI  159 (265)
T ss_pred             EEEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCC-CCEEECcCccccccccc
Confidence            88999999999998876   347888889999999999999999999999999999999987 79999999998754321


Q ss_pred             ----CcceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCC
Q 015374          274 ----KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSR  349 (408)
Q Consensus       274 ----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  349 (408)
                          .......++..|+|||.+.+ ..++.++|+|||||++|+|++|+.||... +...........          .  
T Consensus       160 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~~g~~p~~~~-~~~~~~~~~~~~----------~--  225 (265)
T cd06652         160 CLSGTGMKSVTGTPYWMSPEVISG-EGYGRKADIWSVGCTVVEMLTEKPPWAEF-EAMAAIFKIATQ----------P--  225 (265)
T ss_pred             cccccccccCCCCccccChhhhcC-CCCCcchhHHHHHHHHHHHhhCCCCCCcc-chHHHHHHHhcC----------C--
Confidence                12233457888999999987 67899999999999999999999998432 222222221110          0  


Q ss_pred             CCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcc
Q 015374          350 KPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFA  396 (408)
Q Consensus       350 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~  396 (408)
                            .....+..++..+.+++++|+ .+|++|||++|+++|||+.
T Consensus       226 ------~~~~~~~~~~~~~~~~i~~~l-~~p~~Rp~~~~il~~~~~~  265 (265)
T cd06652         226 ------TNPVLPPHVSDHCRDFLKRIF-VEAKLRPSADELLRHTFVH  265 (265)
T ss_pred             ------CCCCCchhhCHHHHHHHHHHh-cChhhCCCHHHHhcCcccC
Confidence                  011123346788999999999 5999999999999999974

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.1e-44  Score=340.17  Aligned_cols=250  Identities=26%  Similarity=0.414  Sum_probs=208.4

Q ss_pred             CCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc------chHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccE
Q 015374          125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS  198 (408)
Q Consensus       125 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  198 (408)
                      ..|+-++.||.|+||.||.|++..+.+.||||.+.-+      .-.++..|+..|.++ .|||++.+-|+|..  ....+
T Consensus        26 klf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l-~HPntieYkgCyLr--e~TaW  102 (948)
T KOG0577|consen   26 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQL-RHPNTIEYKGCYLR--EHTAW  102 (948)
T ss_pred             HHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhc-cCCCcccccceeec--cchHH
Confidence            4466788999999999999999999999999998522      235688999999999 99999999999955  45678


Q ss_pred             EEEEeecCCC---hhhhcCCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCCCc
Q 015374          199 LIFEYVNSTD---FKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE  275 (408)
Q Consensus       199 lv~e~~~~~~---l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~~~  275 (408)
                      ||||||-|..   +..+.+++.+.++..|+.+.+.||.|||+.+.||||||+.|||+++. |.|||+|||.|....   .
T Consensus       103 LVMEYClGSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~-g~VKLaDFGSAsi~~---P  178 (948)
T KOG0577|consen  103 LVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEP-GLVKLADFGSASIMA---P  178 (948)
T ss_pred             HHHHHHhccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCC-CeeeeccccchhhcC---c
Confidence            9999997642   34445789999999999999999999999999999999999999988 899999999998765   4


Q ss_pred             ceeeccCccccccccccC--CcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCCCcc
Q 015374          276 YNVRVASRYFKGPELLVD--LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWS  353 (408)
Q Consensus       276 ~~~~~~~~~y~aPE~~~~--~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  353 (408)
                      .++.+||++|||||+++.  .+.|+-++||||||++..||..++.|+|.. +....+..|...-.+..      .     
T Consensus       179 AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnM-NAMSALYHIAQNesPtL------q-----  246 (948)
T KOG0577|consen  179 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM-NAMSALYHIAQNESPTL------Q-----  246 (948)
T ss_pred             hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCc-hHHHHHHHHHhcCCCCC------C-----
Confidence            456899999999999863  578999999999999999999999998643 33445555554311110      0     


Q ss_pred             ccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccccc
Q 015374          354 KFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRA  400 (408)
Q Consensus       354 ~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~~~~  400 (408)
                             ....++.+++|+..||+.-|.+|||.+++|.|+|...-+.
T Consensus       247 -------s~eWS~~F~~Fvd~CLqKipqeRptse~ll~H~fv~R~Rp  286 (948)
T KOG0577|consen  247 -------SNEWSDYFRNFVDSCLQKIPQERPTSEELLKHRFVLRERP  286 (948)
T ss_pred             -------CchhHHHHHHHHHHHHhhCcccCCcHHHHhhcchhccCCC
Confidence                   1225789999999999999999999999999999865443

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.6e-42  Score=324.79  Aligned_cols=254  Identities=27%  Similarity=0.433  Sum_probs=208.7

Q ss_pred             CCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc------chHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccE
Q 015374          125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS  198 (408)
Q Consensus       125 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  198 (408)
                      ++|++.+.||+|+||+||+|.+..+++.+|+|.+...      ..+.+.+|++++..+ +|+||+++++.+.+  +...+
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~--~~~~~   77 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATL-DHPFLPTLYASFQT--ETYLC   77 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhC-CCCCchhheeeeec--CCEEE
Confidence            4799999999999999999999999999999998643      234678899999999 89999999999955  46789


Q ss_pred             EEEEeecCCChhhhcC-----CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCC
Q 015374          199 LIFEYVNSTDFKVLYP-----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG  273 (408)
Q Consensus       199 lv~e~~~~~~l~~~~~-----~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~  273 (408)
                      +||||+.+++|..++.     .+++..+..++.|++.||.|||+.|++|+||||+||+++.+ +.++|+|||++......
T Consensus        78 lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~-~~~~l~dfg~~~~~~~~  156 (316)
T cd05574          78 LVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHES-GHIMLSDFDLSKQSDVE  156 (316)
T ss_pred             EEEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCC-CCEEEeecchhhccccc
Confidence            9999999999988863     47889999999999999999999999999999999999988 78999999998654322


Q ss_pred             Cc------------------------------ceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCC
Q 015374          274 KE------------------------------YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYG  323 (408)
Q Consensus       274 ~~------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~  323 (408)
                      ..                              .....|+..|+|||++.+ ..++.++||||||+++|+|++|..||. +
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Di~slG~ll~~l~~g~~pf~-~  234 (316)
T cd05574         157 PPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISG-DGHGSAVDWWTLGILLYEMLYGTTPFK-G  234 (316)
T ss_pred             ccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcC-CCCCchHHHHHHHHHHHHHhhCCCCCC-C
Confidence            11                              112357888999999987 678999999999999999999999984 4


Q ss_pred             CCCHHHHHHHHhhhchhhhhcCCCCCCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCC----HHHHhcCCCccccc
Q 015374          324 HDNHDQLVKIAKDCCLIIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLT----AREAMAHPYFAQVR  399 (408)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt----~~elL~hp~f~~~~  399 (408)
                      .+..+.+..+....            ..+      .....+++++.+++.+||..||++|||    ++|+|+||||++.+
T Consensus       235 ~~~~~~~~~~~~~~------------~~~------~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~~~~~  296 (316)
T cd05574         235 SNRDETFSNILKKE------------VTF------PGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRGVN  296 (316)
T ss_pred             CchHHHHHHHhcCC------------ccC------CCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCchhhcCC
Confidence            44444443332210            000      011116899999999999999999999    99999999999886


Q ss_pred             cch
Q 015374          400 AAE  402 (408)
Q Consensus       400 ~~~  402 (408)
                      ...
T Consensus       297 ~~~  299 (316)
T cd05574         297 WAL  299 (316)
T ss_pred             hhh
Confidence            544

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=8.3e-42  Score=319.08  Aligned_cols=255  Identities=24%  Similarity=0.416  Sum_probs=202.5

Q ss_pred             CCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc----chHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccEEE
Q 015374          125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI  200 (408)
Q Consensus       125 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  200 (408)
                      ++|++.+.||+|+||.||+|++..+++.||+|.++..    ....+..|+.++.+..+||||+++++++..  ....+++
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~--~~~~~lv   78 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFR--EGDVWIC   78 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEec--CCcEEEE
Confidence            4789999999999999999999999999999998643    234566677765554599999999999965  4568899


Q ss_pred             EEeecCCChhhhc-------CCCChHHHHHHHHHHHHHHHHHHHC-CcEEecCCCCcEEEeCCCCcEEEEecccceeccC
Q 015374          201 FEYVNSTDFKVLY-------PTLTDYDIRYYIYELLKALDYCHSQ-GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP  272 (408)
Q Consensus       201 ~e~~~~~~l~~~~-------~~l~~~~~~~i~~qi~~~L~~LH~~-~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~  272 (408)
                      |||+++ +|..++       ..+++..+..++.|++.||.|||++ +++||||||+||+++.+ +.+||+|||++.....
T Consensus        79 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~-~~~kl~dfg~~~~~~~  156 (283)
T cd06617          79 MEVMDT-SLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRN-GQVKLCDFGISGYLVD  156 (283)
T ss_pred             hhhhcc-cHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCC-CCEEEeeccccccccc
Confidence            999985 444333       2478999999999999999999997 99999999999999988 7999999999986654


Q ss_pred             CCcceeeccCccccccccccCC---cCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCC
Q 015374          273 GKEYNVRVASRYFKGPELLVDL---QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSR  349 (408)
Q Consensus       273 ~~~~~~~~~~~~y~aPE~~~~~---~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  349 (408)
                      ........++..|+|||.+.+.   ..++.++|+|||||++|+|++|..||.......+.+........           
T Consensus       157 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~-----------  225 (283)
T cd06617         157 SVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPS-----------  225 (283)
T ss_pred             ccccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcCC-----------
Confidence            3333445688889999988641   45788999999999999999999998544444444433322100           


Q ss_pred             CCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccccccc
Q 015374          350 KPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAA  401 (408)
Q Consensus       350 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~~~~~  401 (408)
                             .......++.++.+++.+||..||++|||++++++||||+.....
T Consensus       226 -------~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~  270 (283)
T cd06617         226 -------PQLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFELHLSK  270 (283)
T ss_pred             -------CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhhhcccc
Confidence                   000012268899999999999999999999999999999986543

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=1.2e-41  Score=314.20  Aligned_cols=247  Identities=27%  Similarity=0.455  Sum_probs=205.8

Q ss_pred             CEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc-----chHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccEEE
Q 015374          126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI  200 (408)
Q Consensus       126 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  200 (408)
                      +|++.+.||.|+||.||++.+..++..+++|.++..     ..+.+.+|+.+++++ +|+||+++++++........+++
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~~~~   79 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILREL-KHPNIVRYYDRIIDRSNQTLYIV   79 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhc-CCCccceeeeeeecCCCCEEEEE
Confidence            588899999999999999999999999999998632     245678899999999 99999999998876666778999


Q ss_pred             EEeecCCChhhhc-------CCCChHHHHHHHHHHHHHHHHHH-----HCCcEEecCCCCcEEEeCCCCcEEEEecccce
Q 015374          201 FEYVNSTDFKVLY-------PTLTDYDIRYYIYELLKALDYCH-----SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE  268 (408)
Q Consensus       201 ~e~~~~~~l~~~~-------~~l~~~~~~~i~~qi~~~L~~LH-----~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~  268 (408)
                      |||+++++|..++       ..+++..+..++.|++.||.|||     +.+++|+||+|+||+++.+ +.+||+|||++.
T Consensus        80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~-~~~kl~d~g~~~  158 (265)
T cd08217          80 MEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDAN-NNVKLGDFGLAK  158 (265)
T ss_pred             ehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecC-CCEEEecccccc
Confidence            9999999998776       34788999999999999999999     8999999999999999987 899999999998


Q ss_pred             eccCCCc-ceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCC
Q 015374          269 FYHPGKE-YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRH  347 (408)
Q Consensus       269 ~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (408)
                      ....... .....++..|++||.+.+ ..++.++|+||||+++|+|++|..||.. .+ .+.+.......          
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~pE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~-~~-~~~~~~~~~~~----------  225 (265)
T cd08217         159 ILGHDSSFAKTYVGTPYYMSPEQLNH-MSYDEKSDIWSLGCLIYELCALSPPFTA-RN-QLQLASKIKEG----------  225 (265)
T ss_pred             cccCCcccccccccCCCccChhhhcC-CCCCchhHHHHHHHHHHHHHHCCCcccC-cC-HHHHHHHHhcC----------
Confidence            7654443 344578889999999987 6789999999999999999999999843 33 22222222110          


Q ss_pred             CCCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCc
Q 015374          348 SRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF  395 (408)
Q Consensus       348 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f  395 (408)
                              .....+..++.++.+++.+||+.+|++|||+.++++|||+
T Consensus       226 --------~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~~~~  265 (265)
T cd08217         226 --------KFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQLPLI  265 (265)
T ss_pred             --------CCCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhCCCC
Confidence                    0011223467899999999999999999999999999996

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-45  Score=323.02  Aligned_cols=254  Identities=24%  Similarity=0.384  Sum_probs=211.8

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecc-cchHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccEEEEE
Q 015374          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP-VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFE  202 (408)
Q Consensus       124 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~-~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e  202 (408)
                      .+-|.++++||+|+||.||+|.++.+|..+|||.+.. .+.+++..|+.|++++ ..|++|++||.+-.  ...+++|||
T Consensus        32 EEVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~sDLQEIIKEISIMQQC-~S~yVVKYYGSYFK--~sDLWIVME  108 (502)
T KOG0574|consen   32 EEVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDTDLQEIIKEISIMQQC-KSKYVVKYYGSYFK--HSDLWIVME  108 (502)
T ss_pred             HHHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccchHHHHHHHHHHHHHc-CCchhhhhhhhhcc--CCceEeehh
Confidence            4557888999999999999999999999999998863 4568899999999998 99999999997743  357899999


Q ss_pred             eecCCChhhhc----CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCC-Ccce
Q 015374          203 YVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG-KEYN  277 (408)
Q Consensus       203 ~~~~~~l~~~~----~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~-~~~~  277 (408)
                      ||..|+..+.+    +.+++.++..++...++||+|||...-||||||+.|||++.+ |.+||+|||.|-.+.+. ...+
T Consensus       109 YCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~-G~AKLADFGVAGQLTDTMAKRN  187 (502)
T KOG0574|consen  109 YCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTD-GIAKLADFGVAGQLTDTMAKRN  187 (502)
T ss_pred             hcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEccc-chhhhhhccccchhhhhHHhhC
Confidence            99999988876    569999999999999999999999999999999999999999 89999999998655433 2356


Q ss_pred             eeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCCCcccccc
Q 015374          278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSKFIN  357 (408)
Q Consensus       278 ~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  357 (408)
                      +.+||+.|||||++.. -.|+.++||||||++..||..|+.||..-+.....+            ..   ..++-+.|  
T Consensus       188 TVIGTPFWMAPEVI~E-IGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIF------------MI---PT~PPPTF--  249 (502)
T KOG0574|consen  188 TVIGTPFWMAPEVIEE-IGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIF------------MI---PTKPPPTF--  249 (502)
T ss_pred             ccccCcccccHHHHHH-hccchhhhHhhhcchhhhhhcCCCCcccccccceeE------------ec---cCCCCCCC--
Confidence            7899999999999987 779999999999999999999999984333221110            00   01111111  


Q ss_pred             ccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccccc
Q 015374          358 ADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRA  400 (408)
Q Consensus       358 ~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~~~~  400 (408)
                       ..++..|.++.||++.||-.+|++|.||-+|++|||.+++.-
T Consensus       250 -~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H~FiknA~g  291 (502)
T KOG0574|consen  250 -KKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEHTFIKNAPG  291 (502)
T ss_pred             -CChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhhhhhcCCCc
Confidence             223346889999999999999999999999999999987653

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=1.4e-41  Score=318.19  Aligned_cols=254  Identities=27%  Similarity=0.460  Sum_probs=204.6

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecccc--hHHHHHHHHHHHHhcCCCCceEEeeEEEc---cCCCcc
Q 015374          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK--KKKIKREIKILQNLCGGPNVVKLLDIVRD---QHSKTP  197 (408)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~E~~~l~~l~~h~niv~l~~~~~~---~~~~~~  197 (408)
                      ..++|++.+.||+|+||.||+|.+..+++.+|+|+++...  ...+.+|+.+++++.+|+||+++++++..   ..+...
T Consensus        16 ~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~   95 (286)
T cd06638          16 PSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQL   95 (286)
T ss_pred             cccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccchHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeE
Confidence            5789999999999999999999999999999999986532  35688899999998679999999998853   234578


Q ss_pred             EEEEEeecCCChhhhc-------CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceec
Q 015374          198 SLIFEYVNSTDFKVLY-------PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY  270 (408)
Q Consensus       198 ~lv~e~~~~~~l~~~~-------~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~  270 (408)
                      ++||||+++++|..++       ..+++..+..++.|++.||.|||+.+|+||||||+||+++.+ +.++|+|||++...
T Consensus        96 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~-~~~kl~dfg~~~~~  174 (286)
T cd06638          96 WLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTE-GGVKLVDFGVSAQL  174 (286)
T ss_pred             EEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCC-CCEEEccCCceeec
Confidence            9999999999998764       347888899999999999999999999999999999999988 78999999998765


Q ss_pred             cCCC-cceeeccCccccccccccC----CcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcC
Q 015374          271 HPGK-EYNVRVASRYFKGPELLVD----LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNS  345 (408)
Q Consensus       271 ~~~~-~~~~~~~~~~y~aPE~~~~----~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  345 (408)
                      .... ......++..|+|||++..    ...++.++|||||||++|+|++|+.||..... ...+......         
T Consensus       175 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~-~~~~~~~~~~---------  244 (286)
T cd06638         175 TSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHP-MRALFKIPRN---------  244 (286)
T ss_pred             ccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCch-hHHHhhcccc---------
Confidence            4332 2234568899999999853    14578899999999999999999999854322 2222111100         


Q ss_pred             CCCCCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCc
Q 015374          346 RHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF  395 (408)
Q Consensus       346 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f  395 (408)
                         ..     .....+..++.++.+++.+||+.||++|||+.|+++|+||
T Consensus       245 ---~~-----~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~  286 (286)
T cd06638         245 ---PP-----PTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI  286 (286)
T ss_pred             ---CC-----CcccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence               00     0011223357889999999999999999999999999997

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=5.4e-42  Score=315.35  Aligned_cols=249  Identities=26%  Similarity=0.467  Sum_probs=206.1

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecccc-hHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccEEEEE
Q 015374          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK-KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFE  202 (408)
Q Consensus       124 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e  202 (408)
                      .++|++.+.||.|+||.||+|++..++..+++|.++... .+.+.+|+.+++++ +|+||+++++++.+  ....++++|
T Consensus         2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~--~~~~~l~~e   78 (256)
T cd06612           2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEIIKEISILKQC-DSPYIVKYYGSYFK--NTDLWIVME   78 (256)
T ss_pred             cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHHHHHHHHHHHHHHhC-CCCcEeeeeeeeec--CCcEEEEEe
Confidence            467899999999999999999998889999999987543 57899999999999 99999999999965  477899999


Q ss_pred             eecCCChhhhc----CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCCC-cce
Q 015374          203 YVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK-EYN  277 (408)
Q Consensus       203 ~~~~~~l~~~~----~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~~-~~~  277 (408)
                      |+++++|..++    ..+++..+..++.|++.||.|||+.+++|+||+|+||+++.+ +.++|+|||++....... ...
T Consensus        79 ~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~-~~~~l~dfg~~~~~~~~~~~~~  157 (256)
T cd06612          79 YCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEE-GQAKLADFGVSGQLTDTMAKRN  157 (256)
T ss_pred             cCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCC-CcEEEcccccchhcccCccccc
Confidence            99999998876    347899999999999999999999999999999999999988 789999999987665433 233


Q ss_pred             eeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCCCcccccc
Q 015374          278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSKFIN  357 (408)
Q Consensus       278 ~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  357 (408)
                      ...++..|++||.+.+ ..++.++||||||+++|+|++|+.||... +..+....+..           ...      ..
T Consensus       158 ~~~~~~~y~~PE~~~~-~~~~~~~Di~s~G~il~~l~~g~~p~~~~-~~~~~~~~~~~-----------~~~------~~  218 (256)
T cd06612         158 TVIGTPFWMAPEVIQE-IGYNNKADIWSLGITAIEMAEGKPPYSDI-HPMRAIFMIPN-----------KPP------PT  218 (256)
T ss_pred             cccCCccccCHHHHhc-CCCCchhhHHHHHHHHHHHHhCCCCCCCc-chhhhhhhhcc-----------CCC------CC
Confidence            4557889999999877 67899999999999999999999998432 22221111000           000      01


Q ss_pred             ccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCc
Q 015374          358 ADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF  395 (408)
Q Consensus       358 ~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f  395 (408)
                      ...+..++.++.+++.+||+.||++|||+.|+|+||||
T Consensus       219 ~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~~~~  256 (256)
T cd06612         219 LSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQHPFI  256 (256)
T ss_pred             CCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhcCCCC
Confidence            11223467899999999999999999999999999997

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=8.4e-42  Score=319.74  Aligned_cols=266  Identities=36%  Similarity=0.591  Sum_probs=210.3

Q ss_pred             CCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc-----chHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccEE
Q 015374          125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSL  199 (408)
Q Consensus       125 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l  199 (408)
                      ++|++.+.||+|+||.||+|.+..+++.|++|.++..     ..+.+.+|+.+++++ +|+||+++++++.+  ....++
T Consensus         1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~--~~~~~i   77 (288)
T cd07833           1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQL-RHENIVNLKEAFRR--KGRLYL   77 (288)
T ss_pred             CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhc-CCCCeeehhheEEE--CCEEEE
Confidence            4799999999999999999999999999999998632     246788999999999 89999999999965  467899


Q ss_pred             EEEeecCCChhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCCC--
Q 015374          200 IFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK--  274 (408)
Q Consensus       200 v~e~~~~~~l~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~~--  274 (408)
                      +|||++++++..+.   ..+++..+..++.|++.||.|||+.+++|+||+|+||+++.+ +.++|+|||++.......  
T Consensus        78 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~-~~~kl~d~g~~~~~~~~~~~  156 (288)
T cd07833          78 VFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSES-GVLKLCDFGFARALRARPAS  156 (288)
T ss_pred             EEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCC-CCEEEEeeecccccCCCccc
Confidence            99999998887665   348899999999999999999999999999999999999987 799999999987765443  


Q ss_pred             cceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhh-------cCCC
Q 015374          275 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWC-------NSRH  347 (408)
Q Consensus       275 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-------~~~~  347 (408)
                      ......++..|+|||++.+...++.++|+||||+++|+|++|..|| .+.+..+.+..+....+.....       ....
T Consensus       157 ~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (288)
T cd07833         157 PLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLF-PGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRF  235 (288)
T ss_pred             cccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHHHhCCCCHHHhhhcccCccc
Confidence            3334567888999999987448899999999999999999999887 4444445544444433211100       0000


Q ss_pred             CCCCc-----cccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCc
Q 015374          348 SRKPW-----SKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF  395 (408)
Q Consensus       348 ~~~~~-----~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f  395 (408)
                      ....+     ........+..++.++.+|+.+||..||++|||++++++||||
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f  288 (288)
T cd07833         236 AGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF  288 (288)
T ss_pred             cccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence            00000     0000111233358899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=1.1e-41  Score=315.43  Aligned_cols=245  Identities=28%  Similarity=0.533  Sum_probs=200.3

Q ss_pred             CEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecccc------------hHHHHHHHHHHHHhcCCCCceEEeeEEEccC
Q 015374          126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK------------KKKIKREIKILQNLCGGPNVVKLLDIVRDQH  193 (408)
Q Consensus       126 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~------------~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~  193 (408)
                      +|.+...||.|+||.||+|.+..++..+|+|.+....            .+.+.+|+.+++++ +||||+++++++.+  
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--   77 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKEL-QHENIVQYLGSSLD--   77 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhc-CCCCeeeEEEEEEe--
Confidence            3667789999999999999998899999999875321            14578899999999 99999999999965  


Q ss_pred             CCccEEEEEeecCCChhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceec
Q 015374          194 SKTPSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY  270 (408)
Q Consensus       194 ~~~~~lv~e~~~~~~l~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~  270 (408)
                      ....+++|||+++++|..++   ..+++..+..++.|++.||+|||+.|++|+||+|+||+++.+ +.++|+|||+++..
T Consensus        78 ~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~-~~~~l~dfg~~~~~  156 (267)
T cd06628          78 ADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNK-GGIKISDFGISKKL  156 (267)
T ss_pred             CCccEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCC-CCEEecccCCCccc
Confidence            46788999999999998887   347888899999999999999999999999999999999988 78999999998766


Q ss_pred             cCCCc-------ceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhh
Q 015374          271 HPGKE-------YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWC  343 (408)
Q Consensus       271 ~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  343 (408)
                      .....       .....++..|+|||.+.+ ..++.++|+|||||++|+|++|..||... +.......+...       
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~-~~~~~~~~~~~~-------  227 (267)
T cd06628         157 EANSLSTKTNGARPSLQGSVFWMAPEVVKQ-TSYTRKADIWSLGCLVVEMLTGKHPFPDC-TQLQAIFKIGEN-------  227 (267)
T ss_pred             ccccccCCccccccccCCCcCccChhHhcc-CCCCchhhhHHHHHHHHHHhhCCCCCCCc-cHHHHHHHHhcc-------
Confidence            42211       112357788999999977 67889999999999999999999998433 222222211110       


Q ss_pred             cCCCCCCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCc
Q 015374          344 NSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF  395 (408)
Q Consensus       344 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f  395 (408)
                                  .....+..++.++.+++.+||+.||++||++.|+++||||
T Consensus       228 ------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~  267 (267)
T cd06628         228 ------------ASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKHPFL  267 (267)
T ss_pred             ------------CCCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence                        1112233478999999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.8e-42  Score=320.42  Aligned_cols=255  Identities=25%  Similarity=0.438  Sum_probs=207.9

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecccc---hHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccEEE
Q 015374          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK---KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI  200 (408)
Q Consensus       124 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  200 (408)
                      .++|++.+.||.|+||+||+|.+..++..+|+|.++...   .+.+.+|+.+++++ +|+||+++++.+..  ....++|
T Consensus         4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~~~lv   80 (280)
T cd06611           4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSEC-KHPNIVGLYEAYFY--ENKLWIL   80 (280)
T ss_pred             hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhC-CCCceeEEEEEEec--CCeEEEE
Confidence            567999999999999999999998899999999986433   35688899999999 89999999999965  4678899


Q ss_pred             EEeecCCChhhhcC----CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCC-Cc
Q 015374          201 FEYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG-KE  275 (408)
Q Consensus       201 ~e~~~~~~l~~~~~----~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~-~~  275 (408)
                      |||+++++|..++.    .+++..+..++.|++.||.|||+++|+|+||||+||+++.+ +.++|+|||++...... ..
T Consensus        81 ~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~-~~~~l~d~g~~~~~~~~~~~  159 (280)
T cd06611          81 IEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLD-GDVKLADFGVSAKNKSTLQK  159 (280)
T ss_pred             eeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCC-CCEEEccCccchhhcccccc
Confidence            99999999988863    48999999999999999999999999999999999999988 79999999988654332 22


Q ss_pred             ceeeccCccccccccccC----CcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCCC
Q 015374          276 YNVRVASRYFKGPELLVD----LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKP  351 (408)
Q Consensus       276 ~~~~~~~~~y~aPE~~~~----~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  351 (408)
                      .....++..|++||.+..    ...++.++|+||||+++|+|++|+.||. +.+..+....+...         ..    
T Consensus       160 ~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~-~~~~~~~~~~~~~~---------~~----  225 (280)
T cd06611         160 RDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHH-ELNPMRVLLKILKS---------EP----  225 (280)
T ss_pred             cceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcc-cCCHHHHHHHHhcC---------CC----
Confidence            344568889999999852    2457889999999999999999999984 33332322222111         00    


Q ss_pred             ccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccccc
Q 015374          352 WSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRA  400 (408)
Q Consensus       352 ~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~~~~  400 (408)
                          .....+..++.++.+++.+||+.||++|||++++++||||.....
T Consensus       226 ----~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~  270 (280)
T cd06611         226 ----PTLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPFVSDQSD  270 (280)
T ss_pred             ----CCcCCcccCCHHHHHHHHHHhccChhhCcCHHHHhcChhhcccch
Confidence                001112346789999999999999999999999999999998744

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=3e-41  Score=316.34  Aligned_cols=260  Identities=22%  Similarity=0.352  Sum_probs=207.2

Q ss_pred             CCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc----chHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccEEE
Q 015374          125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI  200 (408)
Q Consensus       125 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  200 (408)
                      ++|+..+.||.|++|.||+|.+..+++.+|+|.+...    ....+.+|+++++++ +||||++++++|.+.....+++|
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~lv   79 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSC-KSPYIVKYYGAFLDESSSSIGIA   79 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhC-CCCCeeeeeeEEEccCCCeEEEE
Confidence            4789999999999999999999999999999998642    345688999999999 99999999999976666678999


Q ss_pred             EEeecCCChhhhc-------CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCC
Q 015374          201 FEYVNSTDFKVLY-------PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG  273 (408)
Q Consensus       201 ~e~~~~~~l~~~~-------~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~  273 (408)
                      |||+++++|..++       ..+++..+..++.|++.||.|||+.+++|+||+|+||+++.+ +.++|+|||++......
T Consensus        80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~-~~~~l~dfg~~~~~~~~  158 (287)
T cd06621          80 MEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRK-GQVKLCDFGVSGELVNS  158 (287)
T ss_pred             EEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecC-CeEEEeecccccccccc
Confidence            9999999997764       237888899999999999999999999999999999999988 78999999998655432


Q ss_pred             CcceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCC----CHHHHHHHHhhhchhhhhcCCCCC
Q 015374          274 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHD----NHDQLVKIAKDCCLIIWCNSRHSR  349 (408)
Q Consensus       274 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~  349 (408)
                      . .....++..|++||.+.+ ..++.++|||||||++|+|++|..||.....    ..+....+...           ..
T Consensus       159 ~-~~~~~~~~~y~~pE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-----------~~  225 (287)
T cd06621         159 L-AGTFTGTSFYMAPERIQG-KPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNM-----------PN  225 (287)
T ss_pred             c-cccccCCccccCHHHhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcC-----------Cc
Confidence            2 123457788999999877 7789999999999999999999999854421    11221111110           00


Q ss_pred             CCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccccccc
Q 015374          350 KPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAA  401 (408)
Q Consensus       350 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~~~~~  401 (408)
                      .....  ........++++.+|+.+||..||++|||+.|+++||||++....
T Consensus       226 ~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~~~  275 (287)
T cd06621         226 PELKD--EPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQMKK  275 (287)
T ss_pred             hhhcc--CCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCccccccccc
Confidence            00000  011111246789999999999999999999999999999766543

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=5.7e-42  Score=317.56  Aligned_cols=252  Identities=25%  Similarity=0.420  Sum_probs=202.5

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc---chHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccEE
Q 015374          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV---KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSL  199 (408)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l  199 (408)
                      ..++|++.++||+|+||.||+|++..+++.||+|+++..   ....+.+|+.+++++ +||||+++++++..  ....++
T Consensus         7 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~-~h~~ii~~~~~~~~--~~~~~i   83 (267)
T cd06646           7 PQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKEC-KHCNIVAYFGSYLS--REKLWI   83 (267)
T ss_pred             chhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhc-CCCCeeeeeEEEEe--CCEEEE
Confidence            467899999999999999999999999999999998643   235678899999999 99999999999965  467889


Q ss_pred             EEEeecCCChhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCCC-c
Q 015374          200 IFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK-E  275 (408)
Q Consensus       200 v~e~~~~~~l~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~~-~  275 (408)
                      ||||+++++|..++   ..+++..+..++.|++.||.|||+.+|+|+||||+||+++.+ +.++|+|||++....... .
T Consensus        84 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~-~~~~l~dfg~~~~~~~~~~~  162 (267)
T cd06646          84 CMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDN-GDVKLADFGVAAKITATIAK  162 (267)
T ss_pred             EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCC-CCEEECcCccceeecccccc
Confidence            99999999998876   358889999999999999999999999999999999999987 789999999998664322 2


Q ss_pred             ceeeccCccccccccccC--CcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCCCcc
Q 015374          276 YNVRVASRYFKGPELLVD--LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWS  353 (408)
Q Consensus       276 ~~~~~~~~~y~aPE~~~~--~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  353 (408)
                      .....++..|+|||.+..  ...++.++|+|||||++|||++|+.||+..... +....+..         ......   
T Consensus       163 ~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~-~~~~~~~~---------~~~~~~---  229 (267)
T cd06646         163 RKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPM-RALFLMSK---------SNFQPP---  229 (267)
T ss_pred             cCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchh-hhheeeec---------CCCCCC---
Confidence            234567889999999852  245788999999999999999999998533221 11111000         000000   


Q ss_pred             ccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCC
Q 015374          354 KFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPY  394 (408)
Q Consensus       354 ~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~  394 (408)
                         .......++.++.+|+++||+.||++|||++++++|+|
T Consensus       230 ---~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l~  267 (267)
T cd06646         230 ---KLKDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHLF  267 (267)
T ss_pred             ---CCccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCCC
Confidence               00112236789999999999999999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=3.4e-41  Score=318.85  Aligned_cols=256  Identities=25%  Similarity=0.431  Sum_probs=207.4

Q ss_pred             CCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecccc------hHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccE
Q 015374          125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK------KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS  198 (408)
Q Consensus       125 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~------~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  198 (408)
                      ++|++.+.||+|+||.||++.+..+++.|++|.++...      ...+.+|+.+++.+ +||||+++++.+..  +...+
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~--~~~~~   77 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFA-ENPFVVSMFCSFET--KRHLC   77 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhC-CCCCeeeeEEEEec--CCEEE
Confidence            47899999999999999999999999999999986432      34677899999998 99999999999954  46789


Q ss_pred             EEEEeecCCChhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCCCc
Q 015374          199 LIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE  275 (408)
Q Consensus       199 lv~e~~~~~~l~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~~~  275 (408)
                      +||||+++++|..++   ..+++..+..++.|++.||.|||+.+++|+||||+||+++.+ +.++|+|||+++.......
T Consensus        78 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~-~~~~l~dfg~~~~~~~~~~  156 (305)
T cd05609          78 MVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSM-GHIKLTDFGLSKIGLMSLT  156 (305)
T ss_pred             EEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCC-CCEEEeeCCCccccCcCcc
Confidence            999999999999887   347888899999999999999999999999999999999987 7999999999864211100


Q ss_pred             ----------------ceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhch
Q 015374          276 ----------------YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCL  339 (408)
Q Consensus       276 ----------------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~  339 (408)
                                      .....++..|+|||.+.+ ..++.++|+|||||++|||++|..||. +.+..+.+........ 
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~vl~el~~g~~pf~-~~~~~~~~~~~~~~~~-  233 (305)
T cd05609         157 TNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILR-QGYGKPVDWWAMGIILYEFLVGCVPFF-GDTPEELFGQVISDDI-  233 (305)
T ss_pred             ccccccccccchhhccccCCccCccccCchhccC-CCCCchhhHHHHHHHHHHHHhCCCCCC-CCCHHHHHHHHHhccc-
Confidence                            012356778999999887 678999999999999999999999984 3333333333222100 


Q ss_pred             hhhhcCCCCCCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCC---HHHHhcCCCccccccchh
Q 015374          340 IIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLT---AREAMAHPYFAQVRAAES  403 (408)
Q Consensus       340 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt---~~elL~hp~f~~~~~~~~  403 (408)
                                 .     .......++.++.+++.+||+.||++|||   +.++|+||||...+.++.
T Consensus       234 -----------~-----~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~~~~~~~  284 (305)
T cd05609         234 -----------E-----WPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGLDWNGL  284 (305)
T ss_pred             -----------C-----CCCccccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccCCCHHHH
Confidence                       0     00111236889999999999999999997   799999999988877663

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=7.6e-43  Score=333.56  Aligned_cols=245  Identities=16%  Similarity=0.330  Sum_probs=199.3

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecc-----cchHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCcc
Q 015374          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP-----VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP  197 (408)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~-----~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~  197 (408)
                      ..+++.+...||+|+||+||+|++-   -.||||+++.     ...+.|.+|+..+++- +|.||+-+.|+|..+  .. 
T Consensus       390 p~~ev~l~~rIGsGsFGtV~Rg~wh---GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkT-RH~NIlLFMG~~~~p--~~-  462 (678)
T KOG0193|consen  390 PPEEVLLGERIGSGSFGTVYRGRWH---GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKT-RHENILLFMGACMNP--PL-  462 (678)
T ss_pred             CHHHhhccceeccccccceeecccc---cceEEEEEecCCCCHHHHHHHHHHHHHHhhc-chhhheeeehhhcCC--ce-
Confidence            4566788899999999999999874   3699999973     3457899999999998 999999999999653  33 


Q ss_pred             EEEEEeecCCChhhhcC----CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEeccccee---c
Q 015374          198 SLIFEYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEF---Y  270 (408)
Q Consensus       198 ~lv~e~~~~~~l~~~~~----~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~---~  270 (408)
                      .+|..+|+|.+|..++.    +|.....+.|+.||++||.|||.++|||||||..||++.++ ++|||+|||++..   .
T Consensus       463 AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~-~kVkIgDFGLatvk~~w  541 (678)
T KOG0193|consen  463 AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHED-LKVKIGDFGLATVKTRW  541 (678)
T ss_pred             eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccC-CcEEEecccceeeeeee
Confidence            79999999999999884    48888899999999999999999999999999999999998 8999999999853   2


Q ss_pred             cCCCcceeeccCccccccccccC--CcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCC
Q 015374          271 HPGKEYNVRVASRYFKGPELLVD--LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHS  348 (408)
Q Consensus       271 ~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  348 (408)
                      ..........|...|||||++..  ..+|++.+|||||||++|||++|..||.  ..+.|++--++.......       
T Consensus       542 ~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPys--i~~~dqIifmVGrG~l~p-------  612 (678)
T KOG0193|consen  542 SGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYS--IQNRDQIIFMVGRGYLMP-------  612 (678)
T ss_pred             ccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcC--CCChhheEEEecccccCc-------
Confidence            33344556678889999999964  3478999999999999999999999984  555555332222111000       


Q ss_pred             CCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 015374          349 RKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA  391 (408)
Q Consensus       349 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~  391 (408)
                             ........++.++++|+..||.+++++||+..+||.
T Consensus       613 -------d~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~  648 (678)
T KOG0193|consen  613 -------DLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLS  648 (678)
T ss_pred             -------cchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHH
Confidence                   011122336789999999999999999999998886

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=1.2e-41  Score=318.06  Aligned_cols=252  Identities=26%  Similarity=0.426  Sum_probs=204.0

Q ss_pred             CEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecccc---hHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccEEEEE
Q 015374          126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK---KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFE  202 (408)
Q Consensus       126 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e  202 (408)
                      -|++.+.||+|+||.||+|.+..++..+++|.+....   ...+.+|+.+++.+ +|+|+++++++|..  ....++|||
T Consensus         6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l-~h~~ii~~~~~~~~--~~~~~~v~e   82 (282)
T cd06643           6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASC-DHPNIVKLLDAFYY--ENNLWILIE   82 (282)
T ss_pred             HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHC-CCCCeeeEEEEEee--CCEEEEEEE
Confidence            3677889999999999999999999999999986432   35678899999999 99999999999965  467889999


Q ss_pred             eecCCChhhhc----CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCC-Ccce
Q 015374          203 YVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG-KEYN  277 (408)
Q Consensus       203 ~~~~~~l~~~~----~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~-~~~~  277 (408)
                      |++++++..++    ..+++..+..++.|++.||.|||+.||+|+||||+|||++.+ +.++|+|||++...... ....
T Consensus        83 ~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~-~~~kl~dfg~~~~~~~~~~~~~  161 (282)
T cd06643          83 FCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLD-GDIKLADFGVSAKNTRTIQRRD  161 (282)
T ss_pred             ecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccC-CCEEEccccccccccccccccc
Confidence            99999998765    348899999999999999999999999999999999999988 78999999998654322 1223


Q ss_pred             eeccCccccccccccC----CcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCCCcc
Q 015374          278 VRVASRYFKGPELLVD----LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWS  353 (408)
Q Consensus       278 ~~~~~~~y~aPE~~~~----~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  353 (408)
                      ...++..|+|||++..    ...++.++|+|||||++|+|++|+.||. ..+..+....+....         .      
T Consensus       162 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~-~~~~~~~~~~~~~~~---------~------  225 (282)
T cd06643         162 SFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHH-ELNPMRVLLKIAKSE---------P------  225 (282)
T ss_pred             cccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCcc-ccCHHHHHHHHhhcC---------C------
Confidence            4568889999999842    2457889999999999999999999873 333333333322210         0      


Q ss_pred             ccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccccc
Q 015374          354 KFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVR  399 (408)
Q Consensus       354 ~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~~~  399 (408)
                        .....+..++.++.+|+.+||+.||++|||++++++||||+...
T Consensus       226 --~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~  269 (282)
T cd06643         226 --PTLAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHPFVTVNS  269 (282)
T ss_pred             --CCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCCCEeccC
Confidence              00112234678999999999999999999999999999998653

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=4.9e-42  Score=344.89  Aligned_cols=273  Identities=21%  Similarity=0.255  Sum_probs=197.3

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCc-EEEEE------------------Eecc--cchHHHHHHHHHHHHhcCCCC
Q 015374          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNE-RCIIK------------------ILKP--VKKKKIKREIKILQNLCGGPN  181 (408)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~-~vavK------------------~~~~--~~~~~~~~E~~~l~~l~~h~n  181 (408)
                      ..++|+++++||+|+||+||+|....... .+++|                  .++.  .....+.+|+.+++++ +|+|
T Consensus       146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l-~Hpn  224 (501)
T PHA03210        146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRL-NHEN  224 (501)
T ss_pred             hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhC-CCCC
Confidence            35789999999999999999987543221 12222                  1111  1234678999999999 9999


Q ss_pred             ceEEeeEEEccCCCccEEEEEeecCCChhhhcC-------CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeC
Q 015374          182 VVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYP-------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDH  254 (408)
Q Consensus       182 iv~l~~~~~~~~~~~~~lv~e~~~~~~l~~~~~-------~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~  254 (408)
                      |+++++++.+.  ...++|+|++.+..+.....       ......++.++.|++.||.|||++|||||||||+|||++.
T Consensus       225 Iv~l~~~~~~~--~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~  302 (501)
T PHA03210        225 ILKIEEILRSE--ANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNC  302 (501)
T ss_pred             cCcEeEEEEEC--CeeEEEEeccccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECC
Confidence            99999999664  56789999987665544432       1335567789999999999999999999999999999998


Q ss_pred             CCCcEEEEecccceeccCCCc--ceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCC--CCHHHH
Q 015374          255 ELRKLRLIDWGLAEFYHPGKE--YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGH--DNHDQL  330 (408)
Q Consensus       255 ~~~~~kl~DfG~a~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~--~~~~~~  330 (408)
                      + +.+||+|||+++.+.....  .....||..|+|||++.+ ..++.++|||||||++|||++|..+++.+.  +...++
T Consensus       303 ~-~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~  380 (501)
T PHA03210        303 D-GKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAG-DGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQL  380 (501)
T ss_pred             C-CCEEEEeCCCceecCcccccccccccCCcCCCCchhhcC-CCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHH
Confidence            8 7999999999987654322  223578999999999987 779999999999999999999987654332  334555


Q ss_pred             HHHHhhhchhhhhcCCCCCCCc------------cccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccc
Q 015374          331 VKIAKDCCLIIWCNSRHSRKPW------------SKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQV  398 (408)
Q Consensus       331 ~~~~~~~~~~~~~~~~~~~~~~------------~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~~  398 (408)
                      .+++...+.............+            ...........++.++.+++.+||++||.+|||+.|+|+||||+..
T Consensus       381 ~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~f~~~  460 (501)
T PHA03210        381 LKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPLFSAE  460 (501)
T ss_pred             HHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChhhhcC
Confidence            5555443321111000000000            0000001112356788999999999999999999999999999876


Q ss_pred             cc
Q 015374          399 RA  400 (408)
Q Consensus       399 ~~  400 (408)
                      ..
T Consensus       461 ~~  462 (501)
T PHA03210        461 EE  462 (501)
T ss_pred             Cc
Confidence            43

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=2.4e-41  Score=320.02  Aligned_cols=268  Identities=32%  Similarity=0.517  Sum_probs=201.8

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecccc-----hHHHHHHHHHHHHhcCCCCceEEeeEEEccC-----
Q 015374          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK-----KKKIKREIKILQNLCGGPNVVKLLDIVRDQH-----  193 (408)
Q Consensus       124 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~-----  193 (408)
                      -++|++.++||+|+||.||+|.+..+++.||+|.+....     ...+.+|+.+++++ +||||++++++|....     
T Consensus        11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~   89 (310)
T cd07865          11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLL-KHENVVNLIEICRTKATPYNR   89 (310)
T ss_pred             hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhC-CCCCccceEEEEecccccccC
Confidence            467999999999999999999999999999999885321     23457899999999 9999999999986532     


Q ss_pred             -CCccEEEEEeecCCChhhhcC----CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccce
Q 015374          194 -SKTPSLIFEYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE  268 (408)
Q Consensus       194 -~~~~~lv~e~~~~~~l~~~~~----~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~  268 (408)
                       ....++||||+.+ ++...+.    .+++..+..++.|++.||.|||++|++|+||||+||+++.+ +.+||+|||++.
T Consensus        90 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~-~~~kl~dfg~~~  167 (310)
T cd07865          90 YKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKD-GILKLADFGLAR  167 (310)
T ss_pred             CCceEEEEEcCCCc-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCC-CcEEECcCCCcc
Confidence             2356899999986 4444432    58999999999999999999999999999999999999988 799999999997


Q ss_pred             eccCCCc-----ceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhh
Q 015374          269 FYHPGKE-----YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWC  343 (408)
Q Consensus       269 ~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  343 (408)
                      .......     .....++..|+|||.+.+...++.++||||||+++|+|++|..|| .+.+....+..+....+.....
T Consensus       168 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~-~~~~~~~~~~~~~~~~~~~~~~  246 (310)
T cd07865         168 AFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIM-QGNTEQHQLTLISQLCGSITPE  246 (310)
T ss_pred             cccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHHHhCCCChh
Confidence            6543221     123456778999999876556789999999999999999999887 4444444444444433321110


Q ss_pred             cCCCC--CCCccc----------cccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCc
Q 015374          344 NSRHS--RKPWSK----------FINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF  395 (408)
Q Consensus       344 ~~~~~--~~~~~~----------~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f  395 (408)
                      .....  ...+..          ..........+..+.++|.+||..||++|||++|+|+||||
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f  310 (310)
T cd07865         247 VWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF  310 (310)
T ss_pred             hcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence            00000  000000          00000111235778999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=8.9e-42  Score=331.82  Aligned_cols=246  Identities=21%  Similarity=0.368  Sum_probs=194.6

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEE-----cCCCcEEEEEEeccc----chHHHHHHHHHHHHhcCCCCceEEeeEEEccCC
Q 015374          124 QDDYEVVRKVGRGKYSEVFEGIN-----VNTNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHS  194 (408)
Q Consensus       124 ~~~y~~~~~lG~G~fg~Vy~~~~-----~~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~  194 (408)
                      .++|++.+.||+|+||+||+|++     ..++..||||+++..    ..+.+.+|+.++..+.+||||++++++|.+  .
T Consensus        34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~--~  111 (375)
T cd05104          34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTV--G  111 (375)
T ss_pred             hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeecc--C
Confidence            56899999999999999999974     345678999999743    235678999999998789999999999955  4


Q ss_pred             CccEEEEEeecCCChhhhcC------------------------------------------------------------
Q 015374          195 KTPSLIFEYVNSTDFKVLYP------------------------------------------------------------  214 (408)
Q Consensus       195 ~~~~lv~e~~~~~~l~~~~~------------------------------------------------------------  214 (408)
                      ...++||||+++|+|..++.                                                            
T Consensus       112 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~  191 (375)
T cd05104         112 GPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRS  191 (375)
T ss_pred             CcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccccc
Confidence            67889999999999977652                                                            


Q ss_pred             ------------------CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCCCcc
Q 015374          215 ------------------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY  276 (408)
Q Consensus       215 ------------------~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~~~~  276 (408)
                                        .+++..+..++.|++.||.|||+++|+||||||+|||++.+ +.+||+|||+++........
T Consensus       192 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~-~~~kl~DfG~a~~~~~~~~~  270 (375)
T cd05104         192 GSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHG-RITKICDFGLARDIRNDSNY  270 (375)
T ss_pred             ceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECC-CcEEEecCccceeccCcccc
Confidence                              25677788999999999999999999999999999999987 78999999999866543321


Q ss_pred             e---eeccCccccccccccCCcCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCCCc
Q 015374          277 N---VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPW  352 (408)
Q Consensus       277 ~---~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  352 (408)
                      .   ...++..|+|||++.+ ..++.++|||||||++|||++ |..||. +..............               
T Consensus       271 ~~~~~~~~~~~y~aPE~~~~-~~~~~~sDi~slG~~l~ellt~g~~p~~-~~~~~~~~~~~~~~~---------------  333 (375)
T cd05104         271 VVKGNARLPVKWMAPESIFN-CVYTFESDVWSYGILLWEIFSLGSSPYP-GMPVDSKFYKMIKEG---------------  333 (375)
T ss_pred             cccCCCCCCcceeChhHhcC-CCCCCCCCHHHHHHHHHHHHhcCCCCCC-CCCchHHHHHHHHhC---------------
Confidence            1   1234457999999987 789999999999999999998 777763 333333322222210               


Q ss_pred             cccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 015374          353 SKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH  392 (408)
Q Consensus       353 ~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~h  392 (408)
                         .....+...+.++.+++.+||+.||++|||+.|+++.
T Consensus       334 ---~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  370 (375)
T cd05104         334 ---YRMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQL  370 (375)
T ss_pred             ---ccCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence               0111123357899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-43  Score=334.13  Aligned_cols=236  Identities=18%  Similarity=0.291  Sum_probs=198.7

Q ss_pred             EEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecccchHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccEEEEEeecC
Q 015374          127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNS  206 (408)
Q Consensus       127 y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~~  206 (408)
                      ...++.||.|+.|.||+|+.  .++.||||.++    +.-+.+|+-|++| +|+||+.+.|+|  .....+|+|||||..
T Consensus       126 IsELeWlGSGaQGAVF~Grl--~netVAVKKV~----elkETdIKHLRkL-kH~NII~FkGVC--tqsPcyCIiMEfCa~  196 (904)
T KOG4721|consen  126 ISELEWLGSGAQGAVFLGRL--HNETVAVKKVR----ELKETDIKHLRKL-KHPNIITFKGVC--TQSPCYCIIMEFCAQ  196 (904)
T ss_pred             hhhhhhhccCcccceeeeec--cCceehhHHHh----hhhhhhHHHHHhc-cCcceeeEeeee--cCCceeEEeeecccc
Confidence            34466899999999999965  46789999775    3445688999999 999999999999  446789999999999


Q ss_pred             CChhhhcC---CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCCCcceeeccCc
Q 015374          207 TDFKVLYP---TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASR  283 (408)
Q Consensus       207 ~~l~~~~~---~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~  283 (408)
                      |-|...++   .++...+..+..+|+.||.|||.+.|||||||.-||||..+ ..|||+|||-++........-...||.
T Consensus       197 GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~-d~VKIsDFGTS~e~~~~STkMSFaGTV  275 (904)
T KOG4721|consen  197 GQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYD-DVVKISDFGTSKELSDKSTKMSFAGTV  275 (904)
T ss_pred             ccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeecc-ceEEeccccchHhhhhhhhhhhhhhhH
Confidence            99999884   58888889999999999999999999999999999999998 799999999998877666667789999


Q ss_pred             cccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCCCccccccccCCCC
Q 015374          284 YFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSKFINADNQHL  363 (408)
Q Consensus       284 ~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  363 (408)
                      .|||||++.+ .+.+.|+|||||||+|||||||..||- +.+..    .|+...|..              .+....+..
T Consensus       276 aWMAPEvIrn-ePcsEKVDIwSfGVVLWEmLT~EiPYk-dVdss----AIIwGVGsN--------------sL~LpvPst  335 (904)
T KOG4721|consen  276 AWMAPEVIRN-EPCSEKVDIWSFGVVLWEMLTGEIPYK-DVDSS----AIIWGVGSN--------------SLHLPVPST  335 (904)
T ss_pred             hhhCHHHhhc-CCcccccceehhHHHHHHHHhcCCCcc-ccchh----eeEEeccCC--------------cccccCccc
Confidence            9999999998 899999999999999999999999982 22211    111111111              122334556


Q ss_pred             CCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 015374          364 VSPEAIDFLDKLLRYDHQDRLTAREAMAH  392 (408)
Q Consensus       364 ~~~~~~~li~~~L~~dp~~Rpt~~elL~h  392 (408)
                      +++-++=||+.||+-.|.+||+..++|.|
T Consensus       336 cP~GfklL~Kqcw~sKpRNRPSFrqil~H  364 (904)
T KOG4721|consen  336 CPDGFKLLLKQCWNSKPRNRPSFRQILLH  364 (904)
T ss_pred             CchHHHHHHHHHHhcCCCCCccHHHHHHH
Confidence            88999999999999999999999999999

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=7.1e-42  Score=320.25  Aligned_cols=256  Identities=22%  Similarity=0.383  Sum_probs=205.9

Q ss_pred             CCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc----chHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccEEE
Q 015374          125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI  200 (408)
Q Consensus       125 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  200 (408)
                      ++|++++.||+|+||.||++.+..++..+|+|.++..    ....+.+|+.+++++ +|+||+++++++..  ....++|
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~--~~~~~lv   77 (286)
T cd06622           1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKA-VSPYIVDFYGAFFI--EGAVYMC   77 (286)
T ss_pred             ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhc-CCCcHHhhhhheec--CCeEEEE
Confidence            4688899999999999999999999999999988632    235688999999999 99999999999865  4678899


Q ss_pred             EEeecCCChhhhcC------CCChHHHHHHHHHHHHHHHHHHH-CCcEEecCCCCcEEEeCCCCcEEEEecccceeccCC
Q 015374          201 FEYVNSTDFKVLYP------TLTDYDIRYYIYELLKALDYCHS-QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG  273 (408)
Q Consensus       201 ~e~~~~~~l~~~~~------~l~~~~~~~i~~qi~~~L~~LH~-~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~  273 (408)
                      |||+++++|..++.      .+++..+..++.|++.||.|||+ .+|+|+||||+||+++.+ +.++|+|||++......
T Consensus        78 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~-~~~~l~dfg~~~~~~~~  156 (286)
T cd06622          78 MEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGN-GQVKLCDFGVSGNLVAS  156 (286)
T ss_pred             EeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCC-CCEEEeecCCcccccCC
Confidence            99999999988763      58899999999999999999997 599999999999999987 79999999998765422


Q ss_pred             CcceeeccCccccccccccCC-----cCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCC
Q 015374          274 KEYNVRVASRYFKGPELLVDL-----QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHS  348 (408)
Q Consensus       274 ~~~~~~~~~~~y~aPE~~~~~-----~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  348 (408)
                       ......++..|+|||.+.+.     ..++.++|+|||||++|+|++|..||.... .......+.....      .   
T Consensus       157 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~-~~~~~~~~~~~~~------~---  225 (286)
T cd06622         157 -LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPET-YANIFAQLSAIVD------G---  225 (286)
T ss_pred             -ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcc-hhhHHHHHHHHhh------c---
Confidence             23345678889999998542     235889999999999999999999984432 2222221111100      0   


Q ss_pred             CCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccccccch
Q 015374          349 RKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAE  402 (408)
Q Consensus       349 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~~~~~~  402 (408)
                             .....+..+++++.+|+.+||+.||++||+++++++||||...+...
T Consensus       226 -------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~~~~~  272 (286)
T cd06622         226 -------DPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYKNAD  272 (286)
T ss_pred             -------CCCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcChhhhhccCCc
Confidence                   01112233789999999999999999999999999999998776543

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=1.9e-41  Score=313.58  Aligned_cols=252  Identities=23%  Similarity=0.411  Sum_probs=205.4

Q ss_pred             CCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc----chHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccEEE
Q 015374          125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI  200 (408)
Q Consensus       125 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  200 (408)
                      ++|++.+.||.|+||+||+|....++..+++|+++..    ....+.+|+.+++.+ +|+|++++++.+..  ....++|
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~--~~~~~iv   77 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQC-NHPNVVKYYTSFVV--GDELWLV   77 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhc-CCCCEEEEEEEEee--CCEEEEE
Confidence            4789999999999999999998889999999998632    346788999999999 99999999999855  4678899


Q ss_pred             EEeecCCChhhhcC------CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCCC
Q 015374          201 FEYVNSTDFKVLYP------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK  274 (408)
Q Consensus       201 ~e~~~~~~l~~~~~------~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~~  274 (408)
                      |||++++++..++.      .+++..+..++.|++.||.|||+.||+|+||+|+||+++++ +.++|+|||++.......
T Consensus        78 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~-~~~~l~df~~~~~~~~~~  156 (267)
T cd06610          78 MPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGED-GSVKIADFGVSASLADGG  156 (267)
T ss_pred             EeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCC-CCEEEcccchHHHhccCc
Confidence            99999999988862      37888999999999999999999999999999999999988 789999999987665433


Q ss_pred             cc-----eeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCC
Q 015374          275 EY-----NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSR  349 (408)
Q Consensus       275 ~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  349 (408)
                      ..     ....++..|++||.+.....++.++|+|||||++|+|++|..||... +....+.+.....         .  
T Consensus       157 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~-~~~~~~~~~~~~~---------~--  224 (267)
T cd06610         157 DRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKY-PPMKVLMLTLQND---------P--  224 (267)
T ss_pred             cccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCcccc-ChhhhHHHHhcCC---------C--
Confidence            22     33467889999999887447899999999999999999999998432 2223232222210         0  


Q ss_pred             CCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCc
Q 015374          350 KPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF  395 (408)
Q Consensus       350 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f  395 (408)
                         ...........+++++.+++.+||..||++|||++++++||||
T Consensus       225 ---~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~p~~  267 (267)
T cd06610         225 ---PSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKHKFF  267 (267)
T ss_pred             ---CCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence               0000111123468899999999999999999999999999998

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=1.1e-41  Score=331.03  Aligned_cols=246  Identities=22%  Similarity=0.341  Sum_probs=194.5

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCC-----CcEEEEEEecccc----hHHHHHHHHHHHHhcCCCCceEEeeEEEccC
Q 015374          123 DQDDYEVVRKVGRGKYSEVFEGINVNT-----NERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQH  193 (408)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~-----~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~  193 (408)
                      ..++|++.+.||+|+||.||+|++...     +..||+|+++...    ...+.+|+.+++.+.+|+||++++++|.+  
T Consensus        36 ~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~--  113 (374)
T cd05106          36 PRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTH--  113 (374)
T ss_pred             cHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecC--
Confidence            356899999999999999999986443     3579999986432    35678999999998789999999999955  


Q ss_pred             CCccEEEEEeecCCChhhhcC-----------------------------------------------------------
Q 015374          194 SKTPSLIFEYVNSTDFKVLYP-----------------------------------------------------------  214 (408)
Q Consensus       194 ~~~~~lv~e~~~~~~l~~~~~-----------------------------------------------------------  214 (408)
                      ....++||||+++|+|..++.                                                           
T Consensus       114 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  193 (374)
T cd05106         114 GGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQ  193 (374)
T ss_pred             CCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccc
Confidence            467899999999999987652                                                           


Q ss_pred             --------------CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCCCcce---
Q 015374          215 --------------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN---  277 (408)
Q Consensus       215 --------------~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~~~~~---  277 (408)
                                    .+++..+..++.|++.||.|||++||+||||||+|||++.+ +.+||+|||+++.........   
T Consensus       194 ~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~-~~~kL~DfGla~~~~~~~~~~~~~  272 (374)
T cd05106         194 SSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDG-RVAKICDFGLARDIMNDSNYVVKG  272 (374)
T ss_pred             cccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCC-CeEEEeeceeeeeccCCcceeecc
Confidence                          25677888999999999999999999999999999999987 789999999997654332221   


Q ss_pred             eeccCccccccccccCCcCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCCCccccc
Q 015374          278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSKFI  356 (408)
Q Consensus       278 ~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  356 (408)
                      ...++..|+|||++.+ ..++.++|||||||++|||++ |..||...... ..........                  .
T Consensus       273 ~~~~~~~y~aPE~~~~-~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~-~~~~~~~~~~------------------~  332 (374)
T cd05106         273 NARLPVKWMAPESIFD-CVYTVQSDVWSYGILLWEIFSLGKSPYPGILVN-SKFYKMVKRG------------------Y  332 (374)
T ss_pred             CCCCccceeCHHHhcC-CCCCccccHHHHHHHHHHHHhCCCCCCcccccc-HHHHHHHHcc------------------c
Confidence            1234557999999976 779999999999999999997 88888443322 2222222210                  0


Q ss_pred             cccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 015374          357 NADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA  391 (408)
Q Consensus       357 ~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~  391 (408)
                      ....+..+++++.+++.+||+.||++|||+.++++
T Consensus       333 ~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~  367 (374)
T cd05106         333 QMSRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQ  367 (374)
T ss_pred             CccCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            11112336789999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=1.8e-41  Score=314.24  Aligned_cols=251  Identities=26%  Similarity=0.440  Sum_probs=202.9

Q ss_pred             CEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecccc---------hHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCc
Q 015374          126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK---------KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT  196 (408)
Q Consensus       126 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~---------~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  196 (408)
                      +|+..+.||+|+||.||+|.+..+++.+|+|+++...         .+.+.+|+.+++++ +|+||+++++++.+  ...
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~--~~~   77 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARL-NHPHIIRMLGATCE--DSH   77 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHc-CCCceehhhceecc--CCe
Confidence            4677889999999999999999999999999986322         35688999999999 99999999999954  567


Q ss_pred             cEEEEEeecCCChhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCC
Q 015374          197 PSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG  273 (408)
Q Consensus       197 ~~lv~e~~~~~~l~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~  273 (408)
                      .++||||+++++|..++   ..+++..+..++.|++.||.|||++|++|+||+|+||+++.+...++|+|||++......
T Consensus        78 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~  157 (268)
T cd06630          78 FNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAK  157 (268)
T ss_pred             EEEEEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEcccccccccccc
Confidence            88999999999998877   357889999999999999999999999999999999999877457999999998765432


Q ss_pred             C-----cceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCC
Q 015374          274 K-----EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHS  348 (408)
Q Consensus       274 ~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  348 (408)
                      .     ......++..|+|||.+.+ ..++.++|+||+|+++|+|++|..||..... ......+....           
T Consensus       158 ~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~-~~~~~~~~~~~-----------  224 (268)
T cd06630         158 GTGAGEFQGQLLGTIAFMAPEVLRG-EQYGRSCDVWSVGCVIIEMATAKPPWNAEKH-SNHLALIFKIA-----------  224 (268)
T ss_pred             cccCCccccccccccceeCHhHhcc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCC-cchHHHHHHHh-----------
Confidence            1     1123467888999999977 6789999999999999999999999843321 11111111100           


Q ss_pred             CCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcc
Q 015374          349 RKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFA  396 (408)
Q Consensus       349 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~  396 (408)
                          ........+..+++++.+++.+||..||++|||+.|+++||||+
T Consensus       225 ----~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~~~~~  268 (268)
T cd06630         225 ----SATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKHPVFR  268 (268)
T ss_pred             ----ccCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence                00011223334688999999999999999999999999999985

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=1.6e-41  Score=317.73  Aligned_cols=236  Identities=18%  Similarity=0.208  Sum_probs=192.8

Q ss_pred             eeeeeeCceEEEEEEEcCCCcEEEEEEecccc------hHHHHHHHHHHHHhcCCCCceEEeeEEEc--cCCCccEEEEE
Q 015374          131 RKVGRGKYSEVFEGINVNTNERCIIKILKPVK------KKKIKREIKILQNLCGGPNVVKLLDIVRD--QHSKTPSLIFE  202 (408)
Q Consensus       131 ~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~------~~~~~~E~~~l~~l~~h~niv~l~~~~~~--~~~~~~~lv~e  202 (408)
                      ..||+|++|.||+|..  +|+.||||.++...      .+.+.+|+.++.++ +||||+++++++.+  ......++|||
T Consensus        26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~~~g~~~~~~~~~~~~~lv~E  102 (283)
T PHA02988         26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRI-DSNNILKIYGFIIDIVDDLPRLSLILE  102 (283)
T ss_pred             eEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhc-CCCCEEEEeeeEEecccCCCceEEEEE
Confidence            4699999999999976  68899999986432      35677999999999 99999999999976  44457889999


Q ss_pred             eecCCChhhhcC---CCChHHHHHHHHHHHHHHHHHHHC-CcEEecCCCCcEEEeCCCCcEEEEecccceeccCCCccee
Q 015374          203 YVNSTDFKVLYP---TLTDYDIRYYIYELLKALDYCHSQ-GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNV  278 (408)
Q Consensus       203 ~~~~~~l~~~~~---~l~~~~~~~i~~qi~~~L~~LH~~-~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~~~~~~  278 (408)
                      |+++|+|..++.   .+++.....++.|++.||.|||+. +++||||||+|||++.+ +.+||+|||+++.....  ...
T Consensus       103 y~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~-~~~kl~dfg~~~~~~~~--~~~  179 (283)
T PHA02988        103 YCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTEN-YKLKIICHGLEKILSSP--PFK  179 (283)
T ss_pred             eCCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCC-CcEEEcccchHhhhccc--ccc
Confidence            999999999873   478888899999999999999984 99999999999999988 79999999998765432  234


Q ss_pred             eccCccccccccccCC-cCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCCCcccccc
Q 015374          279 RVASRYFKGPELLVDL-QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSKFIN  357 (408)
Q Consensus       279 ~~~~~~y~aPE~~~~~-~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  357 (408)
                      ..++..|+|||++.+. ..++.++|||||||++|||++|..||. +.+..+....+.....                  .
T Consensus       180 ~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~-~~~~~~~~~~i~~~~~------------------~  240 (283)
T PHA02988        180 NVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFE-NLTTKEIYDLIINKNN------------------S  240 (283)
T ss_pred             ccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCC-CCCHHHHHHHHHhcCC------------------C
Confidence            5688899999998652 578999999999999999999999984 3333333333322110                  1


Q ss_pred             ccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 015374          358 ADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA  391 (408)
Q Consensus       358 ~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~  391 (408)
                      ...+..+++++.+++.+||+.||++|||++|+++
T Consensus       241 ~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  274 (283)
T PHA02988        241 LKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILY  274 (283)
T ss_pred             CCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence            1122236889999999999999999999999985

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=3.4e-41  Score=310.31  Aligned_cols=245  Identities=20%  Similarity=0.433  Sum_probs=203.3

Q ss_pred             CEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecc-----cchHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccEEE
Q 015374          126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP-----VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI  200 (408)
Q Consensus       126 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~-----~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  200 (408)
                      +|++.++||+|+||+||++++..+++.+++|.++.     .....+.+|+.+++++ +|+||+++++++..  ....++|
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~--~~~~~lv   77 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNM-KHPNIVQYQESFEE--NGNLYIV   77 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhC-CCCCeeeeEeeecC--CCeEEEE
Confidence            58899999999999999999999999999998853     2235788999999999 99999999999954  4688999


Q ss_pred             EEeecCCChhhhcC-----CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCCCc
Q 015374          201 FEYVNSTDFKVLYP-----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE  275 (408)
Q Consensus       201 ~e~~~~~~l~~~~~-----~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~~~  275 (408)
                      |||+.++++...+.     .+++..+..++.|++.||.|||+++++|+||+|+||+++.+ +.++|+|||++........
T Consensus        78 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~-~~~~l~d~~~~~~~~~~~~  156 (256)
T cd08218          78 MDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKD-GTIKLGDFGIARVLNSTVE  156 (256)
T ss_pred             EecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCC-CCEEEeeccceeecCcchh
Confidence            99999999887763     36888899999999999999999999999999999999988 7899999999976644322


Q ss_pred             -ceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCCCccc
Q 015374          276 -YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSK  354 (408)
Q Consensus       276 -~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  354 (408)
                       .....++..|+|||++.+ ..++.++|+|||||++++|++|..||..+ +..+....+...         ..       
T Consensus       157 ~~~~~~~~~~~~~pe~~~~-~~~~~~~Dv~slG~i~~~l~~g~~~~~~~-~~~~~~~~~~~~---------~~-------  218 (256)
T cd08218         157 LARTCIGTPYYLSPEICEN-RPYNNKSDIWALGCVLYEMCTLKHAFEAG-NMKNLVLKIIRG---------SY-------  218 (256)
T ss_pred             hhhhccCCccccCHHHhCC-CCCCCccchhHHHHHHHHHHcCCCCccCC-CHHHHHHHHhcC---------CC-------
Confidence             223457888999999977 67889999999999999999999998543 223333332211         00       


Q ss_pred             cccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCc
Q 015374          355 FINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF  395 (408)
Q Consensus       355 ~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f  395 (408)
                         ...+..++.++.+++.+||+.+|++||++.++++||||
T Consensus       219 ---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~~~~  256 (256)
T cd08218         219 ---PPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEKNFI  256 (256)
T ss_pred             ---CCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhCcCC
Confidence               11123368899999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=1.3e-41  Score=326.33  Aligned_cols=275  Identities=32%  Similarity=0.568  Sum_probs=210.4

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc-----chHHHHHHHHHHHHhcCCCCceEEeeEEEccCC---
Q 015374          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHS---  194 (408)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~---  194 (408)
                      ..++|++.+.||+|+||+||+|++..++..||+|.++..     ....+.+|+.+++.+ +|+||+++++++.....   
T Consensus         3 ~~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~ni~~~~~~~~~~~~~~~   81 (337)
T cd07858           3 VDTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHL-DHENVIAIKDIMPPPHREAF   81 (337)
T ss_pred             cccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhc-CCCCccchHHheeccccccc
Confidence            356899999999999999999999999999999988632     234677899999999 99999999998865422   


Q ss_pred             CccEEEEEeecCCChhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceecc
Q 015374          195 KTPSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH  271 (408)
Q Consensus       195 ~~~~lv~e~~~~~~l~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~  271 (408)
                      ...++|+||+.+ ++..++   ..+++..+..++.|++.||.|||+++++|+||||+||+++.+ +.+||+|||++....
T Consensus        82 ~~~~lv~e~~~~-~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~-~~~kL~Dfg~~~~~~  159 (337)
T cd07858          82 NDVYIVYELMDT-DLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNAN-CDLKICDFGLARTTS  159 (337)
T ss_pred             CcEEEEEeCCCC-CHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCC-CCEEECcCccccccC
Confidence            357999999974 555554   458999999999999999999999999999999999999988 789999999997654


Q ss_pred             CC-CcceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCC-CC
Q 015374          272 PG-KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRH-SR  349 (408)
Q Consensus       272 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~  349 (408)
                      .. .......++..|+|||.+.+...++.++|+|||||++|+|++|+.|| .+.+.......+....+......... ..
T Consensus       160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (337)
T cd07858         160 EKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLF-PGKDYVHQLKLITELLGSPSEEDLGFIRN  238 (337)
T ss_pred             CCcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCC-CCCChHHHHHHHHHHhCCCChHHhhhcCc
Confidence            33 22234567888999999876456899999999999999999999887 44443444443333332211110000 00


Q ss_pred             CCcccc----------ccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccccccc
Q 015374          350 KPWSKF----------INADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAA  401 (408)
Q Consensus       350 ~~~~~~----------~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~~~~~  401 (408)
                      ..+...          ........+++++.+++++||+.||++|||++|+++||||..+...
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~~  300 (337)
T cd07858         239 EKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHDP  300 (337)
T ss_pred             hhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhcCc
Confidence            000000          0001123478999999999999999999999999999999876544

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=4.1e-41  Score=312.10  Aligned_cols=250  Identities=23%  Similarity=0.387  Sum_probs=199.3

Q ss_pred             CCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc---chHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccEEEE
Q 015374          125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV---KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIF  201 (408)
Q Consensus       125 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~  201 (408)
                      +.+.....||+|+||.||+|++..++..|++|.++..   ..+.+.+|+.+++++ +|+||+++++++..  +...++|+
T Consensus         8 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~--~~~~~lv~   84 (268)
T cd06624           8 DENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYL-KHRNIVQYLGSDSE--NGFFKIFM   84 (268)
T ss_pred             ccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhc-CCCCeeeeeeeecc--CCEEEEEE
Confidence            3334446899999999999999999999999988643   345788999999999 99999999999965  46788999


Q ss_pred             EeecCCChhhhcC----CC--ChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCCCc
Q 015374          202 EYVNSTDFKVLYP----TL--TDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE  275 (408)
Q Consensus       202 e~~~~~~l~~~~~----~l--~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~~~  275 (408)
                      ||+++++|..++.    .+  ++..+..++.|++.||.|||++||+|+||||+||+++.+.+.++|+|||++........
T Consensus        85 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~  164 (268)
T cd06624          85 EQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINP  164 (268)
T ss_pred             ecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheecccCCC
Confidence            9999999988763    24  77788889999999999999999999999999999987547899999999876543222


Q ss_pred             -ceeeccCccccccccccCC-cCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCCCcc
Q 015374          276 -YNVRVASRYFKGPELLVDL-QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWS  353 (408)
Q Consensus       276 -~~~~~~~~~y~aPE~~~~~-~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  353 (408)
                       .....++..|+|||.+.+. ..++.++|+||||+++|+|++|..||................           .     
T Consensus       165 ~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~-----------~-----  228 (268)
T cd06624         165 CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMF-----------K-----  228 (268)
T ss_pred             ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhh-----------c-----
Confidence             2334578899999998652 347889999999999999999999985433222211111000           0     


Q ss_pred             ccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCc
Q 015374          354 KFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF  395 (408)
Q Consensus       354 ~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f  395 (408)
                        .....+..+++++.+|+.+||+.+|++|||+.|++.||||
T Consensus       229 --~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~  268 (268)
T cd06624         229 --IHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQDPFL  268 (268)
T ss_pred             --cCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhCCCC
Confidence              0112234478899999999999999999999999999997

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=1.2e-41  Score=327.08  Aligned_cols=268  Identities=31%  Similarity=0.583  Sum_probs=206.6

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc---chHHHHHHHHHHHHhcCCCCceEEeeEEEccCC------
Q 015374          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV---KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHS------  194 (408)
Q Consensus       124 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~------  194 (408)
                      ..+|++.+.||.|+||+||+|.+..++..||+|.+...   ..+.+.+|+.+++++ +||||+++++++.....      
T Consensus         4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l-~h~~i~~~~~~~~~~~~~~~~~~   82 (342)
T cd07854           4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRL-DHDNIVKVYEVLGPSGSDLTEDV   82 (342)
T ss_pred             CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhc-CCCcchhhHhhhccccccccccc
Confidence            57899999999999999999999999999999988643   245688899999999 99999999987754322      


Q ss_pred             ------CccEEEEEeecCCChhhhc--CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEeccc
Q 015374          195 ------KTPSLIFEYVNSTDFKVLY--PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGL  266 (408)
Q Consensus       195 ------~~~~lv~e~~~~~~l~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~  266 (408)
                            ...++||||+++ ++..++  ..+++..++.++.|++.||.|||+.||+||||||+||+++.+.+.++|+|||+
T Consensus        83 ~~~~~~~~~~lv~e~~~~-~L~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl~dfg~  161 (342)
T cd07854          83 GSLTELNSVYIVQEYMET-DLANVLEQGPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGL  161 (342)
T ss_pred             ccccccceEEEEeecccc-cHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEECCccc
Confidence                  346899999985 666665  35899999999999999999999999999999999999986656899999999


Q ss_pred             ceeccCCC----cceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhh
Q 015374          267 AEFYHPGK----EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIW  342 (408)
Q Consensus       267 a~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~  342 (408)
                      +.......    ......++..|+|||.+.+...++.++|||||||++|+|++|+.||. +.++.+....+.........
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~-~~~~~~~~~~~~~~~~~~~~  240 (342)
T cd07854         162 ARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFA-GAHELEQMQLILESVPVVRE  240 (342)
T ss_pred             ceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCC-CCCHHHHHHHHHHhcCCCCh
Confidence            97653221    11234578889999988665678899999999999999999999984 33334444333332111100


Q ss_pred             ---------------hcCCCCCCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccccc
Q 015374          343 ---------------CNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVR  399 (408)
Q Consensus       343 ---------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~~~  399 (408)
                                     ........+..     .....++.++.+|+.+||+.||++|||++|+++||||+...
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~~~  307 (342)
T cd07854         241 EDRNELLNVIPSFVRNDGGEPRRPLR-----DLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSCYS  307 (342)
T ss_pred             HHhhhhhhhhhhhhhhcccccCCCHH-----HHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCcccccc
Confidence                           00000001100     11224678999999999999999999999999999998543

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=1e-41  Score=326.49  Aligned_cols=275  Identities=31%  Similarity=0.568  Sum_probs=213.7

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc-----chHHHHHHHHHHHHhcCCCCceEEeeEEEcc--CCCc
Q 015374          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQ--HSKT  196 (408)
Q Consensus       124 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~--~~~~  196 (408)
                      .++|++.+.||.|+||.||+|++..++..||+|.+...     ....+.+|+.+++++ +|+||++++++|...  ....
T Consensus         4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~   82 (334)
T cd07855           4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHF-KHDNIIAIRDILRPPGADFKD   82 (334)
T ss_pred             hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhc-CCCCccCHHHhccccCCCCce
Confidence            47899999999999999999999999999999998642     235677899999999 899999999988643  3356


Q ss_pred             cEEEEEeecCCChhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCC
Q 015374          197 PSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG  273 (408)
Q Consensus       197 ~~lv~e~~~~~~l~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~  273 (408)
                      .++||||+.+ ++..++   ..+++..+..++.|++.||.|||+++|+|+||||+||+++.+ +.+||+|||++......
T Consensus        83 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~-~~~kl~dfg~~~~~~~~  160 (334)
T cd07855          83 VYVVMDLMES-DLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNED-CELRIGDFGMARGLSSS  160 (334)
T ss_pred             EEEEEehhhh-hHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCC-CcEEecccccceeeccc
Confidence            8899999975 666665   348999999999999999999999999999999999999988 79999999998765432


Q ss_pred             Cc-----ceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCC
Q 015374          274 KE-----YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHS  348 (408)
Q Consensus       274 ~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  348 (408)
                      ..     .....++..|+|||.+.+...++.++|||||||++|+|++|+.|| .+.+...++..+....|..........
T Consensus       161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf-~~~~~~~~~~~~~~~~g~~~~~~~~~~  239 (334)
T cd07855         161 PTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLF-PGKNYVHQLKLILSVLGSPSEEVLNRI  239 (334)
T ss_pred             CcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCcc-CCCChHHHHHHHHHHhCCChhHhhhhh
Confidence            21     123467888999999876556899999999999999999999997 455555555555555443321111000


Q ss_pred             C-----CCcccccc------ccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccccccch
Q 015374          349 R-----KPWSKFIN------ADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAE  402 (408)
Q Consensus       349 ~-----~~~~~~~~------~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~~~~~~  402 (408)
                      .     ..+..+..      .......++++.++|.+||+.||++|||++++++||||++....+
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~~~~~  304 (334)
T cd07855         240 GSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYHDPD  304 (334)
T ss_pred             chhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhccCCc
Confidence            0     00000000      011133588999999999999999999999999999998665543

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=2.5e-41  Score=313.38  Aligned_cols=244  Identities=14%  Similarity=0.270  Sum_probs=196.0

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEc---CCCcEEEEEEecccc----hHHHHHHHHHHHHhcCCCCceEEeeEEEccCCC
Q 015374          123 DQDDYEVVRKVGRGKYSEVFEGINV---NTNERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSK  195 (408)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~Vy~~~~~---~~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  195 (408)
                      ..++|++.+.||+|+||.||+|.+.   ..+..||+|.++...    ...+.+|+.++.++ +||||+++++++..  +.
T Consensus         3 ~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~--~~   79 (266)
T cd05064           3 DNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQF-DHSNIVRLEGVITR--GN   79 (266)
T ss_pred             chHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcC-CCCCcCeEEEEEec--CC
Confidence            4678999999999999999999765   446689999987432    34688999999999 99999999999954  46


Q ss_pred             ccEEEEEeecCCChhhhcC----CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceecc
Q 015374          196 TPSLIFEYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH  271 (408)
Q Consensus       196 ~~~lv~e~~~~~~l~~~~~----~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~  271 (408)
                      ..++||||+++++|..++.    .+++..+..++.|++.||+|||+++++||||||+|||++.+ +.++++|||.+....
T Consensus        80 ~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~-~~~~l~dfg~~~~~~  158 (266)
T cd05064          80 TMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSD-LVCKISGFRRLQEDK  158 (266)
T ss_pred             CcEEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCC-CcEEECCCccccccc
Confidence            7899999999999988763    47899999999999999999999999999999999999988 789999999876543


Q ss_pred             CCCcce--eeccCccccccccccCCcCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCC
Q 015374          272 PGKEYN--VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHS  348 (408)
Q Consensus       272 ~~~~~~--~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  348 (408)
                      ......  ...++..|+|||.+.+ ..++.++|||||||++||+++ |..||. +.+..+....+...            
T Consensus       159 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~ell~~g~~p~~-~~~~~~~~~~~~~~------------  224 (266)
T cd05064         159 SEAIYTTMSGKSPVLWAAPEAIQY-HHFSSASDVWSFGIVMWEVMSYGERPYW-DMSGQDVIKAVEDG------------  224 (266)
T ss_pred             ccchhcccCCCCceeecCHHHHhh-CCccchhHHHHHHHHHHHHhcCCCCCcC-cCCHHHHHHHHHCC------------
Confidence            222111  1234567999999977 789999999999999999775 888874 33333333332211            


Q ss_pred             CCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 015374          349 RKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA  391 (408)
Q Consensus       349 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~  391 (408)
                             .....+..++..+.+++.+||+.||++|||++++++
T Consensus       225 -------~~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~  260 (266)
T cd05064         225 -------FRLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHS  260 (266)
T ss_pred             -------CCCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHH
Confidence                   011123447889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=6e-41  Score=308.68  Aligned_cols=245  Identities=24%  Similarity=0.455  Sum_probs=204.7

Q ss_pred             CEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecc-----cchHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccEEE
Q 015374          126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP-----VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI  200 (408)
Q Consensus       126 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~-----~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  200 (408)
                      +|+.++.||.|+||.||.+++..++..+++|.+..     .....+.+|+.+++++ +|+||+++++++.+  ....+++
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~--~~~~~~~   77 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLL-QHPNIIAYYNHFMD--DNTLLIE   77 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhC-CCCCeeEEEeEEec--CCeEEEE
Confidence            58999999999999999999999999999998753     2235688999999999 99999999999965  4678999


Q ss_pred             EEeecCCChhhhcC-----CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCCC-
Q 015374          201 FEYVNSTDFKVLYP-----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK-  274 (408)
Q Consensus       201 ~e~~~~~~l~~~~~-----~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~~-  274 (408)
                      |||+++++|..++.     .+++..+..++.|++.||.|||+.|++|+||+|+||+++.+ +.+||+|||++....... 
T Consensus        78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~-~~~kl~d~~~~~~~~~~~~  156 (256)
T cd08221          78 MEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKA-GLIKLGDFGISKILGSEYS  156 (256)
T ss_pred             EEecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCC-CCEEECcCcceEEcccccc
Confidence            99999999988773     37888999999999999999999999999999999999988 789999999998764433 


Q ss_pred             cceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCCCccc
Q 015374          275 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSK  354 (408)
Q Consensus       275 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  354 (408)
                      ......++..|+|||.+.+ ..++.++|+||||+++|+|++|..||. ..+..+....+...         .     +  
T Consensus       157 ~~~~~~~~~~y~ape~~~~-~~~~~~~Dv~slG~i~~~l~~g~~~~~-~~~~~~~~~~~~~~---------~-----~--  218 (256)
T cd08221         157 MAETVVGTPYYMSPELCQG-VKYNFKSDIWALGCVLYELLTLKRTFD-ATNPLNLVVKIVQG---------N-----Y--  218 (256)
T ss_pred             cccccCCCccccCHhhcCC-CCCCCcchhHHHHHHHHHHHHCCCCCC-CCCHHHHHHHHHcC---------C-----C--
Confidence            2334568889999999987 568899999999999999999999873 33333333333211         0     0  


Q ss_pred             cccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCc
Q 015374          355 FINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF  395 (408)
Q Consensus       355 ~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f  395 (408)
                         ......++.++.+++.+||..||++|||++++|+|||+
T Consensus       219 ---~~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~~l  256 (256)
T cd08221         219 ---TPVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQPLL  256 (256)
T ss_pred             ---CCCccccCHHHHHHHHHHcccCcccCCCHHHHhhCcCC
Confidence               01113468899999999999999999999999999996

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=6e-42  Score=316.84  Aligned_cols=253  Identities=23%  Similarity=0.403  Sum_probs=205.4

Q ss_pred             CCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc----chHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccEEE
Q 015374          125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI  200 (408)
Q Consensus       125 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  200 (408)
                      ++|+..+.||.|+||.||++.+..+++.+++|.+...    ....+.+|+++++++ +||||+++++.+..  ....+++
T Consensus         1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~--~~~~~lv   77 (265)
T cd06605           1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKC-NSPYIVGFYGAFYN--NGDISIC   77 (265)
T ss_pred             CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHC-CCCchhhhheeeec--CCEEEEE
Confidence            3677888999999999999999999999999988643    235688999999999 89999999999965  4678999


Q ss_pred             EEeecCCChhhhc----CCCChHHHHHHHHHHHHHHHHHHH-CCcEEecCCCCcEEEeCCCCcEEEEecccceeccCCCc
Q 015374          201 FEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHS-QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE  275 (408)
Q Consensus       201 ~e~~~~~~l~~~~----~~l~~~~~~~i~~qi~~~L~~LH~-~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~~~  275 (408)
                      +||+++++|..++    ..+++..+..++.|++.||.|||+ .+++|+||||+||+++.+ +.++|+|||.+........
T Consensus        78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~-~~~~l~d~g~~~~~~~~~~  156 (265)
T cd06605          78 MEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSR-GQIKLCDFGVSGQLVNSLA  156 (265)
T ss_pred             EEecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCC-CCEEEeecccchhhHHHHh
Confidence            9999999998887    357888999999999999999999 999999999999999997 7899999999876543222


Q ss_pred             ceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCCCcccc
Q 015374          276 YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSKF  355 (408)
Q Consensus       276 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  355 (408)
                      . ...++..|++||.+.+ ..++.++||||||+++|+|++|..||.......+..........     ...         
T Consensus       157 ~-~~~~~~~y~~PE~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~-----~~~---------  220 (265)
T cd06605         157 K-TFVGTSSYMAPERIQG-NDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIV-----NEP---------  220 (265)
T ss_pred             h-cccCChhccCHHHHcC-CCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHh-----cCC---------
Confidence            2 2678888999999987 68899999999999999999999998654322222211111100     000         


Q ss_pred             ccccCCCC-CCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccc
Q 015374          356 INADNQHL-VSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQV  398 (408)
Q Consensus       356 ~~~~~~~~-~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~~  398 (408)
                       ....+.. ++.++.++|.+||..||++|||+.|++.||||+.-
T Consensus       221 -~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~~~~  263 (265)
T cd06605         221 -PPRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEHPFIKKY  263 (265)
T ss_pred             -CCCCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhCchhhcc
Confidence             0011111 68899999999999999999999999999999764

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=7.5e-42  Score=316.78  Aligned_cols=251  Identities=24%  Similarity=0.422  Sum_probs=202.2

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecccc---hHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccEEE
Q 015374          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK---KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI  200 (408)
Q Consensus       124 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  200 (408)
                      .++|++.++||+|+||.||+|++..+++.||+|+++...   ...+.+|+.+++.+ +||||+++++++..  ....++|
T Consensus         8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l-~h~~ii~~~~~~~~--~~~~~lv   84 (267)
T cd06645           8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDC-KHSNIVAYFGSYLR--RDKLWIC   84 (267)
T ss_pred             HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhC-CCCCeeeEEEEEEe--CCEEEEE
Confidence            567888899999999999999999999999999986432   34577899999999 99999999999965  4678899


Q ss_pred             EEeecCCChhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCCC-cc
Q 015374          201 FEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK-EY  276 (408)
Q Consensus       201 ~e~~~~~~l~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~~-~~  276 (408)
                      |||+++++|..++   ..+++..+..++.|++.||.|||+.|++|+||||+||+++.+ +.++|+|||++....... ..
T Consensus        85 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~-~~~~l~dfg~~~~~~~~~~~~  163 (267)
T cd06645          85 MEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDN-GHVKLADFGVSAQITATIAKR  163 (267)
T ss_pred             EeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCC-CCEEECcceeeeEccCccccc
Confidence            9999999999876   358999999999999999999999999999999999999987 789999999987654322 22


Q ss_pred             eeeccCccccccccccC--CcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCCCccc
Q 015374          277 NVRVASRYFKGPELLVD--LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSK  354 (408)
Q Consensus       277 ~~~~~~~~y~aPE~~~~--~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  354 (408)
                      ....|+..|+|||++..  ...++.++|+|||||++|+|++|..||+........ ......         ......+  
T Consensus       164 ~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~-~~~~~~---------~~~~~~~--  231 (267)
T cd06645         164 KSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRAL-FLMTKS---------NFQPPKL--  231 (267)
T ss_pred             ccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhH-Hhhhcc---------CCCCCcc--
Confidence            34578889999999742  246889999999999999999999998644322221 111110         0000000  


Q ss_pred             cccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCC
Q 015374          355 FINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPY  394 (408)
Q Consensus       355 ~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~  394 (408)
                          .....++..+.+++.+||+.||++|||++++++|||
T Consensus       232 ----~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~~~  267 (267)
T cd06645         232 ----KDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQHPF  267 (267)
T ss_pred             ----cccCCCCHHHHHHHHHHccCCchhCcCHHHHhcCCC
Confidence                011135788999999999999999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.9e-41  Score=313.54  Aligned_cols=254  Identities=24%  Similarity=0.414  Sum_probs=205.9

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc--chHHHHHHHHHHHHhcCCCCceEEeeEEEccC----CCc
Q 015374          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV--KKKKIKREIKILQNLCGGPNVVKLLDIVRDQH----SKT  196 (408)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~----~~~  196 (408)
                      .+++|++.+.||+|+||+||+|.+..+++.+++|+++..  ..+.+.+|+.+++++.+|+||++++++|.+..    +..
T Consensus         4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~   83 (275)
T cd06608           4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQ   83 (275)
T ss_pred             chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCchhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceE
Confidence            468999999999999999999999989999999998743  34678899999999877999999999997543    456


Q ss_pred             cEEEEEeecCCChhhhc-------CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEeccccee
Q 015374          197 PSLIFEYVNSTDFKVLY-------PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEF  269 (408)
Q Consensus       197 ~~lv~e~~~~~~l~~~~-------~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~  269 (408)
                      .++||||+++++|..++       ..+++..+..++.|++.||.|||+.+++|+||+|+||+++.+ +.++|+|||++..
T Consensus        84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~-~~~~l~d~~~~~~  162 (275)
T cd06608          84 LWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKN-AEVKLVDFGVSAQ  162 (275)
T ss_pred             EEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccC-CeEEECCCcccee
Confidence            88999999999988765       247889999999999999999999999999999999999988 7899999999876


Q ss_pred             ccCCC-cceeeccCccccccccccC----CcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhc
Q 015374          270 YHPGK-EYNVRVASRYFKGPELLVD----LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCN  344 (408)
Q Consensus       270 ~~~~~-~~~~~~~~~~y~aPE~~~~----~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  344 (408)
                      ..... ......++..|+|||.+..    ...++.++|||||||++|+|++|..||... .....+..+....       
T Consensus       163 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~-~~~~~~~~~~~~~-------  234 (275)
T cd06608         163 LDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDM-HPMRALFKIPRNP-------  234 (275)
T ss_pred             cccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCcccc-chHHHHHHhhccC-------
Confidence            54322 2234568889999998753    235778999999999999999999998532 2223332222110       


Q ss_pred             CCCCCCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCc
Q 015374          345 SRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF  395 (408)
Q Consensus       345 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f  395 (408)
                        .  .      .......++.++.+|+.+||..||++|||++|+++|||+
T Consensus       235 --~--~------~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~  275 (275)
T cd06608         235 --P--P------TLKSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI  275 (275)
T ss_pred             --C--C------CCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence              0  0      011112257899999999999999999999999999996

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=1.5e-41  Score=313.13  Aligned_cols=246  Identities=27%  Similarity=0.487  Sum_probs=206.6

Q ss_pred             CEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc------chHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccEE
Q 015374          126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSL  199 (408)
Q Consensus       126 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l  199 (408)
                      +|++.+.||.|+||.||+|.+..++..+|+|++...      ..+.+.+|+.+++++ +||||+++++++.+  +...++
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~~~l   77 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQEL-NHPFLVNLWYSFQD--EENMYL   77 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhC-CCCChHHHHHhhcC--CCeEEE
Confidence            588999999999999999999999999999998632      246788999999999 99999999999954  567899


Q ss_pred             EEEeecCCChhhhcC---CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCCCcc
Q 015374          200 IFEYVNSTDFKVLYP---TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY  276 (408)
Q Consensus       200 v~e~~~~~~l~~~~~---~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~~~~  276 (408)
                      |+||+.+++|..++.   .+++..+..++.|++.||.|||+++++|+||+|+||+++.+ +.++|+|||++.........
T Consensus        78 v~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~-~~~~l~d~~~~~~~~~~~~~  156 (258)
T cd05578          78 VVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQ-GHVHITDFNIATKVTPDTLT  156 (258)
T ss_pred             EEeCCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCC-CCEEEeecccccccCCCccc
Confidence            999999999988873   58899999999999999999999999999999999999988 79999999998876655444


Q ss_pred             eeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCC-HHHHHHHHhhhchhhhhcCCCCCCCcccc
Q 015374          277 NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDN-HDQLVKIAKDCCLIIWCNSRHSRKPWSKF  355 (408)
Q Consensus       277 ~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  355 (408)
                      ....++..|++||.+.+ ..++.++|+||||+++|+|++|..||...... .+.+......                   
T Consensus       157 ~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~-------------------  216 (258)
T cd05578         157 TSTSGTPGYMAPEVLCR-QGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQET-------------------  216 (258)
T ss_pred             cccCCChhhcCHHHHcc-cCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhcc-------------------
Confidence            55678888999999977 66899999999999999999999998544332 1222111110                   


Q ss_pred             ccccCCCCCCHHHHHHHHHhcccCcCCCCCH--HHHhcCCCc
Q 015374          356 INADNQHLVSPEAIDFLDKLLRYDHQDRLTA--REAMAHPYF  395 (408)
Q Consensus       356 ~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~--~elL~hp~f  395 (408)
                      .....+..++.++.++|.+||+.||.+||++  +|+++||||
T Consensus       217 ~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~~~~~  258 (258)
T cd05578         217 ADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKNHPYF  258 (258)
T ss_pred             ccccCcccCcHHHHHHHHHHccCChhHcCCccHHHHhcCCCC
Confidence            0112223367899999999999999999999  999999998

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=4e-41  Score=314.68  Aligned_cols=265  Identities=36%  Similarity=0.643  Sum_probs=207.0

Q ss_pred             EEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc-----chHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccEEEE
Q 015374          127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIF  201 (408)
Q Consensus       127 y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~  201 (408)
                      |++.++||.|+||.||+|++..+++.+|+|.+...     ....+.+|+.+++++ +|+|++++++++.+......++||
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~~lv~   79 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKL-RHPNIVRLKEIVTSKGKGSIYMVF   79 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhc-cCCCeeeheeeEecCCCCcEEEEe
Confidence            67889999999999999999999999999999754     234678899999999 899999999999765346889999


Q ss_pred             EeecCCChhhhc----CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCCC--c
Q 015374          202 EYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK--E  275 (408)
Q Consensus       202 e~~~~~~l~~~~----~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~~--~  275 (408)
                      ||+++ ++..++    ..+++..+..++.|++.||+|||+.|++|+||+|+||+++++ +.++|+|||++.......  .
T Consensus        80 e~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~-~~~~l~d~g~~~~~~~~~~~~  157 (287)
T cd07840          80 EYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINND-GVLKLADFGLARPYTKRNSAD  157 (287)
T ss_pred             ccccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCC-CCEEEccccceeeccCCCccc
Confidence            99986 555554    258899999999999999999999999999999999999998 799999999998765443  2


Q ss_pred             ceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCC--------
Q 015374          276 YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRH--------  347 (408)
Q Consensus       276 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~--------  347 (408)
                      .....++..|+|||.+.+...++.++||||||+++|+|++|..||. ..+..+.+..+....+.........        
T Consensus       158 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (287)
T cd07840         158 YTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQ-GSTELEQLEKIFELCGSPTDENWPGVSKLPWFE  236 (287)
T ss_pred             ccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCC-CCChHHHHHHHHHHhCCCchhhccccccchhhh
Confidence            3345667889999988765678999999999999999999998874 4444555555544333221110000        


Q ss_pred             ---CCCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCc
Q 015374          348 ---SRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF  395 (408)
Q Consensus       348 ---~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f  395 (408)
                         ................++.++.+++++||+.||++|||++++++||||
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~  287 (287)
T cd07840         237 NLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF  287 (287)
T ss_pred             hccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence               000011111111122248899999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=4.8e-41  Score=317.59  Aligned_cols=250  Identities=18%  Similarity=0.329  Sum_probs=192.4

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcC----------------CCcEEEEEEeccc----chHHHHHHHHHHHHhcCCCCc
Q 015374          123 DQDDYEVVRKVGRGKYSEVFEGINVN----------------TNERCIIKILKPV----KKKKIKREIKILQNLCGGPNV  182 (408)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~Vy~~~~~~----------------~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~ni  182 (408)
                      ..++|++.++||+|+||.||+|.+..                ++..||+|++...    ....+.+|+.++.++ +||||
T Consensus         3 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~ni   81 (304)
T cd05096           3 PRGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRL-KDPNI   81 (304)
T ss_pred             chhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhc-CCCCe
Confidence            35689999999999999999997532                3447999998743    235688999999999 99999


Q ss_pred             eEEeeEEEccCCCccEEEEEeecCCChhhhcC----------------------CCChHHHHHHHHHHHHHHHHHHHCCc
Q 015374          183 VKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYP----------------------TLTDYDIRYYIYELLKALDYCHSQGI  240 (408)
Q Consensus       183 v~l~~~~~~~~~~~~~lv~e~~~~~~l~~~~~----------------------~l~~~~~~~i~~qi~~~L~~LH~~~i  240 (408)
                      +++++++.+.  ...++||||+++++|..++.                      .+++..+..++.|++.||.|||+.||
T Consensus        82 v~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i  159 (304)
T cd05096          82 IRLLGVCVDE--DPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNF  159 (304)
T ss_pred             eEEEEEEecC--CceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCc
Confidence            9999999653  56889999999999987762                      25667788999999999999999999


Q ss_pred             EEecCCCCcEEEeCCCCcEEEEecccceeccCCCcc---eeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhC-
Q 015374          241 MHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFR-  316 (408)
Q Consensus       241 iH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g-  316 (408)
                      +||||||+|||++.+ +.+||+|||+++........   ....++..|+|||++.+ ..++.++|||||||++|||+++ 
T Consensus       160 vH~dlkp~Nill~~~-~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~~~~  237 (304)
T cd05096         160 VHRDLATRNCLVGEN-LTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILM-GKFTTASDVWAFGVTLWEILMLC  237 (304)
T ss_pred             cccCcchhheEEcCC-ccEEECCCccceecccCceeEecCcCCCCccccCHHHHhc-CCCCchhhhHHHHHHHHHHHHcc
Confidence            999999999999988 79999999999765433221   12344678999999877 6799999999999999999874 


Q ss_pred             -CCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHh
Q 015374          317 -KEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAM  390 (408)
Q Consensus       317 -~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL  390 (408)
                       ..||. +.++.+.+........    .   ....     .....+..++..+.+++.+||+.||++|||++|+.
T Consensus       238 ~~~p~~-~~~~~~~~~~~~~~~~----~---~~~~-----~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~  299 (304)
T cd05096         238 KEQPYG-ELTDEQVIENAGEFFR----D---QGRQ-----VYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIH  299 (304)
T ss_pred             CCCCCC-cCCHHHHHHHHHHHhh----h---cccc-----ccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHH
Confidence             45653 3333333322221100    0   0000     00112234688999999999999999999999994

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=4.6e-41  Score=310.60  Aligned_cols=245  Identities=25%  Similarity=0.469  Sum_probs=202.8

Q ss_pred             eeeeCceEEEEEEEcCCCcEEEEEEeccc------chHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccEEEEEeecC
Q 015374          133 VGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNS  206 (408)
Q Consensus       133 lG~G~fg~Vy~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~~  206 (408)
                      ||.|+||.||+|++..++..+++|++...      ..+.+.+|+.+++.+ +|+||+++++.+.+  +...++++||+++
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~~~lv~e~~~~   77 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEEC-NHPFIVKLYRTFKD--KKYIYMLMEYCLG   77 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhC-CCCCEeeeeeeEEc--CCccEEEEecCCC
Confidence            69999999999999999999999998632      235688999999999 99999999999865  4678899999999


Q ss_pred             CChhhhcC---CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCCCcceeeccCc
Q 015374          207 TDFKVLYP---TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASR  283 (408)
Q Consensus       207 ~~l~~~~~---~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~  283 (408)
                      ++|..++.   .+++..+..++.|++.||.|||+++++|+||+|+||+++.+ +.++|+|||++.............++.
T Consensus        78 ~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~-~~~~l~df~~~~~~~~~~~~~~~~~~~  156 (262)
T cd05572          78 GELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSN-GYVKLVDFGFAKKLKSGQKTWTFCGTP  156 (262)
T ss_pred             CcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCC-CCEEEeeCCcccccCcccccccccCCc
Confidence            99988873   47889999999999999999999999999999999999988 799999999998765443334457788


Q ss_pred             cccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCH-HHHHHHHhhhchhhhhcCCCCCCCccccccccCCC
Q 015374          284 YFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNH-DQLVKIAKDCCLIIWCNSRHSRKPWSKFINADNQH  362 (408)
Q Consensus       284 ~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  362 (408)
                      .|++||.+.+ ..++.++|+||||+++|+|++|..||.....+. +....+....                  .....+.
T Consensus       157 ~~~~PE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~------------------~~~~~~~  217 (262)
T cd05572         157 EYVAPEIILN-KGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGN------------------GKLEFPN  217 (262)
T ss_pred             CccChhHhcC-CCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccC------------------CCCCCCc
Confidence            9999999876 678999999999999999999999985544322 2222222100                  0111223


Q ss_pred             CCCHHHHHHHHHhcccCcCCCCC-----HHHHhcCCCcccccc
Q 015374          363 LVSPEAIDFLDKLLRYDHQDRLT-----AREAMAHPYFAQVRA  400 (408)
Q Consensus       363 ~~~~~~~~li~~~L~~dp~~Rpt-----~~elL~hp~f~~~~~  400 (408)
                      .+++++.++|.+||+.||++|||     ++|+++||||++...
T Consensus       218 ~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~  260 (262)
T cd05572         218 YIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHKWFNGFDW  260 (262)
T ss_pred             ccCHHHHHHHHHHccCChhhCcCCcccCHHHHhcChhhhCCCC
Confidence            35789999999999999999999     999999999997644

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=3.3e-41  Score=324.06  Aligned_cols=274  Identities=33%  Similarity=0.599  Sum_probs=210.2

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc-----chHHHHHHHHHHHHhcCCCCceEEeeEEEccCC---
Q 015374          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHS---  194 (408)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~---  194 (408)
                      ..++|.+.+.||+|+||.||+|++..+++.||+|.++..     ....+.+|+.+++++ +|+||++++++|.....   
T Consensus        13 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~   91 (342)
T cd07879          13 LPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHM-QHENVIGLLDVFTSAVSGDE   91 (342)
T ss_pred             cccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhc-CCCCccchhheecccccCCC
Confidence            357899999999999999999999999999999998632     134578899999999 99999999999864321   


Q ss_pred             -CccEEEEEeecCCChhhhcC-CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccC
Q 015374          195 -KTPSLIFEYVNSTDFKVLYP-TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP  272 (408)
Q Consensus       195 -~~~~lv~e~~~~~~l~~~~~-~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~  272 (408)
                       ...++|+||+.. ++..... .+++..+..++.|++.||.|||+.+|+||||||+||+++.+ +.++|+|||+++....
T Consensus        92 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~-~~~kL~dfg~~~~~~~  169 (342)
T cd07879          92 FQDFYLVMPYMQT-DLQKIMGHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNED-CELKILDFGLARHADA  169 (342)
T ss_pred             CceEEEEeccccc-CHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCC-CCEEEeeCCCCcCCCC
Confidence             346899999975 5555544 68999999999999999999999999999999999999988 7999999999876432


Q ss_pred             CCcceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcC---C-CC
Q 015374          273 GKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNS---R-HS  348 (408)
Q Consensus       273 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~---~-~~  348 (408)
                        ......++..|+|||.+.+...++.++|||||||++|||++|+.||. +.+..+.+..+....+.......   . ..
T Consensus       170 --~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (342)
T cd07879         170 --EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFK-GKDYLDQLTQILKVTGVPGPEFVQKLEDKA  246 (342)
T ss_pred             --CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCC-CCCHHHHHHHHHHhcCCCCHHHHHHhcccc
Confidence              22334667889999998764568899999999999999999999984 44444555554443321110000   0 00


Q ss_pred             CCCc----ccccc---ccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccccccch
Q 015374          349 RKPW----SKFIN---ADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAE  402 (408)
Q Consensus       349 ~~~~----~~~~~---~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~~~~~~  402 (408)
                      ...+    .....   .......+.++.+|+.+||+.||++|||++|++.||||+..+...
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~~~  307 (342)
T cd07879         247 AKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRDAD  307 (342)
T ss_pred             hHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccccc
Confidence            0000    00000   001123578899999999999999999999999999999887643

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=4.5e-41  Score=313.98  Aligned_cols=248  Identities=24%  Similarity=0.417  Sum_probs=195.9

Q ss_pred             eeeeeCceEEEEEEEcCCCcEEEEEEecccc------hHHHHHHHHHHHHh--cCCCCceEEeeEEEccCCCccEEEEEe
Q 015374          132 KVGRGKYSEVFEGINVNTNERCIIKILKPVK------KKKIKREIKILQNL--CGGPNVVKLLDIVRDQHSKTPSLIFEY  203 (408)
Q Consensus       132 ~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~------~~~~~~E~~~l~~l--~~h~niv~l~~~~~~~~~~~~~lv~e~  203 (408)
                      .||+|+||.||++.+..+++.+|+|.+....      ...+.+|..++..+  .+|+|++.+++++..  .+..++||||
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~--~~~~~lv~e~   78 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHT--PDKLCFILDL   78 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEec--CCeEEEEEec
Confidence            4899999999999999999999999885321      12344454444332  279999999999965  4578899999


Q ss_pred             ecCCChhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCCCcceeec
Q 015374          204 VNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRV  280 (408)
Q Consensus       204 ~~~~~l~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~~~~~~~~  280 (408)
                      +++++|..++   ..+++..+..++.|++.||+|||+.+|+|+||||+|||++.+ +.++|+|||++...... ......
T Consensus        79 ~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~-~~~~l~dfg~~~~~~~~-~~~~~~  156 (279)
T cd05633          79 MNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEH-GHVRISDLGLACDFSKK-KPHASV  156 (279)
T ss_pred             CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCC-CCEEEccCCcceecccc-CccCcC
Confidence            9999998776   358999999999999999999999999999999999999988 79999999998755432 223457


Q ss_pred             cCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCC-HHHHHHHHhhhchhhhhcCCCCCCCcccccccc
Q 015374          281 ASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDN-HDQLVKIAKDCCLIIWCNSRHSRKPWSKFINAD  359 (408)
Q Consensus       281 ~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  359 (408)
                      ++..|+|||.+.+...++.++|+|||||++|+|++|..||...... ...+......                   ....
T Consensus       157 ~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~-------------------~~~~  217 (279)
T cd05633         157 GTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLT-------------------VNVE  217 (279)
T ss_pred             CCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhhc-------------------CCcC
Confidence            8899999999875456889999999999999999999998543222 2222211100                   1112


Q ss_pred             CCCCCCHHHHHHHHHhcccCcCCCC-----CHHHHhcCCCccccccch
Q 015374          360 NQHLVSPEAIDFLDKLLRYDHQDRL-----TAREAMAHPYFAQVRAAE  402 (408)
Q Consensus       360 ~~~~~~~~~~~li~~~L~~dp~~Rp-----t~~elL~hp~f~~~~~~~  402 (408)
                      .+..++.++.+++.+||..||++|+     |++|+++||||+.+...+
T Consensus       218 ~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~~~~~~~~~~  265 (279)
T cd05633         218 LPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVFFKGIDWQQ  265 (279)
T ss_pred             CccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCccccCCCHhH
Confidence            2344789999999999999999999     699999999999876543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=4.9e-41  Score=310.97  Aligned_cols=246  Identities=24%  Similarity=0.422  Sum_probs=198.8

Q ss_pred             CEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc---------chHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCc
Q 015374          126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV---------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT  196 (408)
Q Consensus       126 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~---------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  196 (408)
                      +|++.+.||.|+||+||+|.. .+++.+|+|.++..         ....+.+|+.+++++ +|+||++++++|.+  ...
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~--~~~   76 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSL-KHVNIVQYLGTCLD--DNT   76 (265)
T ss_pred             CccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhc-CCCCEeeEeeEeec--CCe
Confidence            467788999999999999975 57889999987532         124588899999999 99999999999965  478


Q ss_pred             cEEEEEeecCCChhhhcC---CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCC
Q 015374          197 PSLIFEYVNSTDFKVLYP---TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG  273 (408)
Q Consensus       197 ~~lv~e~~~~~~l~~~~~---~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~  273 (408)
                      .+++|||+++++|..++.   .+++..+..++.|++.||+|||+.+|+|+||+|+||+++.+ +.++|+|||++......
T Consensus        77 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~-~~~~l~dfg~~~~~~~~  155 (265)
T cd06631          77 ISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPN-GIIKLIDFGCARRLAWV  155 (265)
T ss_pred             EEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCC-CeEEeccchhhHhhhhc
Confidence            899999999999998873   47889999999999999999999999999999999999987 79999999998754211


Q ss_pred             -------CcceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCC
Q 015374          274 -------KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSR  346 (408)
Q Consensus       274 -------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  346 (408)
                             .......++..|+|||.+.+ ..++.++|+|||||++|+|++|..||... +.......+....+        
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Dv~slG~~~~~l~~g~~p~~~~-~~~~~~~~~~~~~~--------  225 (265)
T cd06631         156 GLHGTHSNMLKSMHGTPYWMAPEVINE-SGYGRKSDIWSIGCTVFEMATGKPPLASM-DRLAAMFYIGAHRG--------  225 (265)
T ss_pred             cccccccccccccCCCccccChhhhcC-CCCcchhhHHHHHHHHHHHHhCCCccccC-ChHHHHHHhhhccC--------
Confidence                   11223467888999999977 67889999999999999999999998433 22222211111100        


Q ss_pred             CCCCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCc
Q 015374          347 HSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF  395 (408)
Q Consensus       347 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f  395 (408)
                               .....+..++.++.+|+++||+.||++|||+.|+++||||
T Consensus       226 ---------~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~  265 (265)
T cd06631         226 ---------LMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLRHDFL  265 (265)
T ss_pred             ---------CCCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence                     0111233478999999999999999999999999999997

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=5.7e-41  Score=309.82  Aligned_cols=251  Identities=26%  Similarity=0.456  Sum_probs=209.4

Q ss_pred             CCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc----chHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccEEE
Q 015374          125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI  200 (408)
Q Consensus       125 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  200 (408)
                      ++|++.+.||.|++|.||+|++..+++.+++|.+...    ....+.+|+.++.++ +|+|++++++++..  ....++|
T Consensus         1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~--~~~~~lv   77 (264)
T cd06623           1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSC-ESPYVVKCYGAFYK--EGEISIV   77 (264)
T ss_pred             CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhc-CCCCeeeEEEEEcc--CCeEEEE
Confidence            4688999999999999999999999999999998754    356789999999999 89999999999955  4778999


Q ss_pred             EEeecCCChhhhc---CCCChHHHHHHHHHHHHHHHHHHH-CCcEEecCCCCcEEEeCCCCcEEEEecccceeccCCCcc
Q 015374          201 FEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHS-QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY  276 (408)
Q Consensus       201 ~e~~~~~~l~~~~---~~l~~~~~~~i~~qi~~~L~~LH~-~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~~~~  276 (408)
                      |||+++++|..++   ..+++..+..++.|++.||.|||+ .+++|+||+|+||+++.+ +.++|+|||++.........
T Consensus        78 ~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~-~~~~l~df~~~~~~~~~~~~  156 (264)
T cd06623          78 LEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSK-GEVKIADFGISKVLENTLDQ  156 (264)
T ss_pred             EEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCC-CCEEEccCccceecccCCCc
Confidence            9999999999887   358999999999999999999999 999999999999999988 79999999999876543332


Q ss_pred             -eeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCC-CH-HHHHHHHhhhchhhhhcCCCCCCCcc
Q 015374          277 -NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHD-NH-DQLVKIAKDCCLIIWCNSRHSRKPWS  353 (408)
Q Consensus       277 -~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~-~~-~~~~~~~~~~~~~~~~~~~~~~~~~~  353 (408)
                       ....++..|+|||.+.+ ..++.++|+||||+++|+|++|..||..... .. +....+...                 
T Consensus       157 ~~~~~~~~~y~~pE~~~~-~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~-----------------  218 (264)
T cd06623         157 CNTFVGTVTYMSPERIQG-ESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDG-----------------  218 (264)
T ss_pred             ccceeecccccCHhhhCC-CCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcC-----------------
Confidence             24567888999999877 6889999999999999999999999844331 22 222222110                 


Q ss_pred             ccccccCCCC-CCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccccc
Q 015374          354 KFINADNQHL-VSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVR  399 (408)
Q Consensus       354 ~~~~~~~~~~-~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~~~  399 (408)
                        ........ ++..+.+++.+||..+|++|||+.|+++||||+.++
T Consensus       219 --~~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~~~~~~~~  263 (264)
T cd06623         219 --PPPSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQHPFIKKAD  263 (264)
T ss_pred             --CCCCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhCHHHHhcc
Confidence              00111222 678999999999999999999999999999998764

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=5.8e-41  Score=308.71  Aligned_cols=247  Identities=27%  Similarity=0.451  Sum_probs=203.3

Q ss_pred             CEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc--------chHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCcc
Q 015374          126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV--------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP  197 (408)
Q Consensus       126 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~--------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~  197 (408)
                      +|+..+.||+|+||+||+|.+..++..|++|.+...        ..+.+.+|+.+++.+ +|+||+++++++.+  ....
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~--~~~~   77 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKL-QHPNIVQYLGTERE--EDNL   77 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhc-CCCCchheeeeEec--CCeE
Confidence            466678899999999999999889999999988532        235688999999999 99999999999854  4678


Q ss_pred             EEEEEeecCCChhhhcC---CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCCC
Q 015374          198 SLIFEYVNSTDFKVLYP---TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK  274 (408)
Q Consensus       198 ~lv~e~~~~~~l~~~~~---~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~~  274 (408)
                      ++++||+++++|..++.   .+++..+..++.|++.||.|||+.||+|+||+|+||+++.+ +.+||+|||++.......
T Consensus        78 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~-~~~kl~d~~~~~~~~~~~  156 (258)
T cd06632          78 YIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTN-GVVKLADFGMAKQVVEFS  156 (258)
T ss_pred             EEEEEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCC-CCEEEccCccceeccccc
Confidence            89999999999988873   37889999999999999999999999999999999999988 799999999988765444


Q ss_pred             cceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCCCccc
Q 015374          275 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSK  354 (408)
Q Consensus       275 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  354 (408)
                      ......++..|++||.+.....++.++|+||||+++|+|++|..||.... ..+.........                 
T Consensus       157 ~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~-~~~~~~~~~~~~-----------------  218 (258)
T cd06632         157 FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLE-GVAAVFKIGRSK-----------------  218 (258)
T ss_pred             cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCc-HHHHHHHHHhcc-----------------
Confidence            34556788899999998763348999999999999999999999984332 222222211100                 


Q ss_pred             cccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCc
Q 015374          355 FINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF  395 (408)
Q Consensus       355 ~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f  395 (408)
                       .....+..+++++.+++.+||+.||++|||+++++.|||+
T Consensus       219 -~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~  258 (258)
T cd06632         219 -ELPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEHPFV  258 (258)
T ss_pred             -cCCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcCCCC
Confidence             0111233468999999999999999999999999999996

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=3.6e-41  Score=314.19  Aligned_cols=246  Identities=27%  Similarity=0.435  Sum_probs=201.2

Q ss_pred             eeeeCceEEEEEEEcCCCcEEEEEEeccc------chHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccEEEEEeecC
Q 015374          133 VGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNS  206 (408)
Q Consensus       133 lG~G~fg~Vy~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~~  206 (408)
                      ||+|+||+||+|.+..+++.+|+|.+...      ....+.+|+.+++.+ +||||+++++++..  ....++||||+++
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~--~~~~~lv~e~~~~   77 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKV-SSRFIVSLAYAFET--KDDLCLVMTLMNG   77 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhC-CCCCEeeeeeEEec--CCeEEEEEecCCC
Confidence            69999999999999999999999998532      134567899999999 89999999999955  4678999999999


Q ss_pred             CChhhhc---C--CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCCCcceeecc
Q 015374          207 TDFKVLY---P--TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVA  281 (408)
Q Consensus       207 ~~l~~~~---~--~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~~~~~~~~~  281 (408)
                      ++|..++   .  .+++..+..++.|++.||.|||+.|++|+||+|+||+++.+ +.++|+|||.+.............+
T Consensus        78 ~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~-~~~~l~dfg~~~~~~~~~~~~~~~~  156 (277)
T cd05577          78 GDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDH-GNVRISDLGLAVELKGGKKIKGRAG  156 (277)
T ss_pred             CcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCC-CCEEEccCcchhhhccCCccccccC
Confidence            9998776   2  48889999999999999999999999999999999999988 7999999999876654434444567


Q ss_pred             CccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCC--CHHHHHHHHhhhchhhhhcCCCCCCCcccccccc
Q 015374          282 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHD--NHDQLVKIAKDCCLIIWCNSRHSRKPWSKFINAD  359 (408)
Q Consensus       282 ~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  359 (408)
                      +..|++||.+.+ ..++.++|+|||||++|+|++|+.||.....  ..+.+......                   ....
T Consensus       157 ~~~y~~PE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~-------------------~~~~  216 (277)
T cd05577         157 TPGYMAPEVLQG-EVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLE-------------------MAVE  216 (277)
T ss_pred             CCCcCCHHHhcC-CCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhcccc-------------------cccc
Confidence            788999999887 5689999999999999999999999844332  11111111000                   1112


Q ss_pred             CCCCCCHHHHHHHHHhcccCcCCCC-----CHHHHhcCCCccccccch
Q 015374          360 NQHLVSPEAIDFLDKLLRYDHQDRL-----TAREAMAHPYFAQVRAAE  402 (408)
Q Consensus       360 ~~~~~~~~~~~li~~~L~~dp~~Rp-----t~~elL~hp~f~~~~~~~  402 (408)
                      .+..+++++.++|.+||+.||++||     ++.++++||||.......
T Consensus       217 ~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h~~~~~~~~~~  264 (277)
T cd05577         217 YPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLFKDLNWRR  264 (277)
T ss_pred             CCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHhChhhhcCChhh
Confidence            2334689999999999999999999     999999999998877644

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=2.2e-41  Score=315.61  Aligned_cols=251  Identities=26%  Similarity=0.419  Sum_probs=206.4

Q ss_pred             CCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc----chHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccEEE
Q 015374          125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI  200 (408)
Q Consensus       125 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  200 (408)
                      ..|+..++||.|+||.||+|.+..++..||+|+++..    ....+.+|+.+++++ +|+||+++++++.+  +...++|
T Consensus         4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~~~lv   80 (277)
T cd06640           4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQC-DSPYVTKYYGSYLK--GTKLWII   80 (277)
T ss_pred             HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEEE--CCEEEEE
Confidence            4577788999999999999999999999999998632    235688899999999 99999999999965  4678999


Q ss_pred             EEeecCCChhhhcC--CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCCCc-ce
Q 015374          201 FEYVNSTDFKVLYP--TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE-YN  277 (408)
Q Consensus       201 ~e~~~~~~l~~~~~--~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~~~-~~  277 (408)
                      |||+++++|..++.  .+++.++..++.|++.||+|||+.+++|+||+|+||+++.+ +.++|+|||++........ ..
T Consensus        81 ~e~~~~~~L~~~i~~~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~-~~~~l~dfg~~~~~~~~~~~~~  159 (277)
T cd06640          81 MEYLGGGSALDLLRAGPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQ-GDVKLADFGVAGQLTDTQIKRN  159 (277)
T ss_pred             EecCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCC-CCEEEcccccceeccCCccccc
Confidence            99999999988774  48888999999999999999999999999999999999988 7899999999976654332 23


Q ss_pred             eeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCCCcccccc
Q 015374          278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSKFIN  357 (408)
Q Consensus       278 ~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  357 (408)
                      ...++..|+|||.+.+ ..++.++|+|||||++|||++|..||... +.......+...                   ..
T Consensus       160 ~~~~~~~y~apE~~~~-~~~~~~~Dv~slG~il~el~tg~~p~~~~-~~~~~~~~~~~~-------------------~~  218 (277)
T cd06640         160 TFVGTPFWMAPEVIQQ-SAYDSKADIWSLGITAIELAKGEPPNSDM-HPMRVLFLIPKN-------------------NP  218 (277)
T ss_pred             cccCcccccCHhHhcc-CCCccHHHHHHHHHHHHHHHHCCCCCCCc-ChHhHhhhhhcC-------------------CC
Confidence            3467888999999977 67899999999999999999999998432 222221111000                   01


Q ss_pred             ccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccccc
Q 015374          358 ADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRA  400 (408)
Q Consensus       358 ~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~~~~  400 (408)
                      ......++..+.+++.+||+.||++|||++++++||||.....
T Consensus       219 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~  261 (277)
T cd06640         219 PTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHKFIVKNAK  261 (277)
T ss_pred             CCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhChHhhhcch
Confidence            1122336788999999999999999999999999999987765

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.9e-41  Score=310.06  Aligned_cols=251  Identities=27%  Similarity=0.487  Sum_probs=204.1

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc---chHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccEEE
Q 015374          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV---KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI  200 (408)
Q Consensus       124 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  200 (408)
                      .++|++.+.||.|+||.||+|.+..+++.+++|++...   ..+.+.+|+.+++++ +||||+++++++.+  ....+++
T Consensus         2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~--~~~~~l~   78 (262)
T cd06613           2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKEC-RHPNIVAYFGSYLR--RDKLWIV   78 (262)
T ss_pred             ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhC-CCCChhceEEEEEe--CCEEEEE
Confidence            47899999999999999999999999999999998643   346788999999999 99999999999865  4678999


Q ss_pred             EEeecCCChhhhc----CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCCC-c
Q 015374          201 FEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK-E  275 (408)
Q Consensus       201 ~e~~~~~~l~~~~----~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~~-~  275 (408)
                      |||++++++..++    ..+++..+..++.|++.||.|||+.+|+|+||+|+||+++.+ +.++|+|||++....... .
T Consensus        79 ~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~-~~~~l~d~g~~~~~~~~~~~  157 (262)
T cd06613          79 MEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTED-GDVKLADFGVSAQLTATIAK  157 (262)
T ss_pred             EeCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCC-CCEEECccccchhhhhhhhc
Confidence            9999999998876    458999999999999999999999999999999999999988 789999999987654332 2


Q ss_pred             ceeeccCccccccccccCC--cCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCCCcc
Q 015374          276 YNVRVASRYFKGPELLVDL--QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWS  353 (408)
Q Consensus       276 ~~~~~~~~~y~aPE~~~~~--~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  353 (408)
                      .....++..|+|||.+.+.  ..++.++|+||||+++|+|++|..||.... ........... +        ....   
T Consensus       158 ~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~-~~~~~~~~~~~-~--------~~~~---  224 (262)
T cd06613         158 RKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLH-PMRALFLISKS-N--------FPPP---  224 (262)
T ss_pred             cccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHhc-c--------CCCc---
Confidence            2345678889999998762  278899999999999999999999985433 22222221111 0        0000   


Q ss_pred             ccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCC
Q 015374          354 KFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPY  394 (408)
Q Consensus       354 ~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~  394 (408)
                         ........+.++.+|+.+||..||.+|||+.+++.|+|
T Consensus       225 ---~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~  262 (262)
T cd06613         225 ---KLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQHPF  262 (262)
T ss_pred             ---cccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcCCC
Confidence               00112235678999999999999999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=1.6e-41  Score=318.24  Aligned_cols=258  Identities=21%  Similarity=0.374  Sum_probs=201.2

Q ss_pred             CCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc----chHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccEEE
Q 015374          125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI  200 (408)
Q Consensus       125 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  200 (408)
                      ++|+..+.||+|+||+||++.+..++..+|+|.+...    ....+.+|+.++.++.+|+||+++++++..  ....+++
T Consensus         4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~--~~~~~~~   81 (288)
T cd06616           4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFR--EGDCWIC   81 (288)
T ss_pred             HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEec--CCcEEEE
Confidence            3566677899999999999999999999999998642    345678899999999559999999999865  4567799


Q ss_pred             EEeecCCC--hhhhc-----CCCChHHHHHHHHHHHHHHHHHHHC-CcEEecCCCCcEEEeCCCCcEEEEecccceeccC
Q 015374          201 FEYVNSTD--FKVLY-----PTLTDYDIRYYIYELLKALDYCHSQ-GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP  272 (408)
Q Consensus       201 ~e~~~~~~--l~~~~-----~~l~~~~~~~i~~qi~~~L~~LH~~-~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~  272 (408)
                      |||+....  +...+     ..+++..+..++.|++.||+|||+. +|+||||||+||+++.+ +.++|+|||++.....
T Consensus        82 ~e~~~~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~-~~~kl~dfg~~~~~~~  160 (288)
T cd06616          82 MELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRN-GNIKLCDFGISGQLVD  160 (288)
T ss_pred             EecccCCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccC-CcEEEeecchhHHhcc
Confidence            99987532  22211     3588999999999999999999975 99999999999999987 7899999999976654


Q ss_pred             CCcceeeccCccccccccccCC--cCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCC
Q 015374          273 GKEYNVRVASRYFKGPELLVDL--QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRK  350 (408)
Q Consensus       273 ~~~~~~~~~~~~y~aPE~~~~~--~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  350 (408)
                      ........++..|+|||.+.+.  ..++.++|||||||++|+|++|+.||.......+.+......         ...  
T Consensus       161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~---------~~~--  229 (288)
T cd06616         161 SIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKG---------DPP--  229 (288)
T ss_pred             CCccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcCC---------CCC--
Confidence            4444455788899999999764  368999999999999999999999984333111221111110         000  


Q ss_pred             CccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccccc
Q 015374          351 PWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRA  400 (408)
Q Consensus       351 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~~~~  400 (408)
                          .........++.++.+|+.+||+.||++|||++++++||||+....
T Consensus       230 ----~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~~~~  275 (288)
T cd06616         230 ----ILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKDYEE  275 (288)
T ss_pred             ----cCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhchhh
Confidence                0111112347889999999999999999999999999999986543

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-42  Score=334.98  Aligned_cols=246  Identities=22%  Similarity=0.406  Sum_probs=206.9

Q ss_pred             eeeeeCceEEEEEEEcCCCcEEEEEEecccc---hHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccEEEEEeecCCC
Q 015374          132 KVGRGKYSEVFEGINVNTNERCIIKILKPVK---KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTD  208 (408)
Q Consensus       132 ~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~~~~  208 (408)
                      .||+|.||+||.|++..+...+|||-+....   .+-+..|+.+.++| .|.|||+++|+|  ..+++.-+.||-++||+
T Consensus       582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~L-rHkNIVrYLGs~--senGf~kIFMEqVPGGS  658 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTL-RHKNIVRYLGSV--SENGFFKIFMEQVPGGS  658 (1226)
T ss_pred             EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHH-hhHhHHHHhhcc--CCCCeEEEEeecCCCCc
Confidence            5999999999999999999999999985322   34578899999999 999999999998  44578889999999999


Q ss_pred             hhhhcC----CC--ChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccC-CCcceeecc
Q 015374          209 FKVLYP----TL--TDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP-GKEYNVRVA  281 (408)
Q Consensus       209 l~~~~~----~l--~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~-~~~~~~~~~  281 (408)
                      |..+++    ++  .+..+..+..||++||.|||++.|||||||-+|+|++.-.|.+||+|||-++.+.. +..+.+..|
T Consensus       659 LSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~TETFTG  738 (1226)
T KOG4279|consen  659 LSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCTETFTG  738 (1226)
T ss_pred             HHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhccCCcccccccc
Confidence            999884    35  67778889999999999999999999999999999999889999999999876643 334567789


Q ss_pred             CccccccccccC-CcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCCCccccccccC
Q 015374          282 SRYFKGPELLVD-LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSKFINADN  360 (408)
Q Consensus       282 ~~~y~aPE~~~~-~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  360 (408)
                      |..|||||++-. ..+|+.++|||||||++.||.||+.||..-.+.....-    ..|+..              ..+..
T Consensus       739 TLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMF----kVGmyK--------------vHP~i  800 (1226)
T KOG4279|consen  739 TLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMF----KVGMYK--------------VHPPI  800 (1226)
T ss_pred             chhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhh----hhccee--------------cCCCC
Confidence            999999999953 45799999999999999999999999954433322211    112111              23455


Q ss_pred             CCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccc
Q 015374          361 QHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQV  398 (408)
Q Consensus       361 ~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~~  398 (408)
                      +..++.+++.||.+|+..||.+||+|.++|++||++.-
T Consensus       801 Peelsaeak~FilrcFepd~~~R~sA~~LL~DpFlq~~  838 (1226)
T KOG4279|consen  801 PEELSAEAKNFILRCFEPDPCDRPSAKDLLQDPFLQHN  838 (1226)
T ss_pred             cHHHHHHHHHHHHHHcCCCcccCccHHHhccCcccccC
Confidence            66689999999999999999999999999999999865

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=2.5e-41  Score=316.36  Aligned_cols=260  Identities=21%  Similarity=0.363  Sum_probs=206.7

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc----chHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccE
Q 015374          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS  198 (408)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  198 (408)
                      ..++|++.++||+|+||+||++.+..++..+|+|++...    ..+.+.+|+++++.+ +||||+++++++...  ...+
T Consensus         3 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~--~~~~   79 (284)
T cd06620           3 RNEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHEC-RSPYIVSFYGAFLNE--NNIC   79 (284)
T ss_pred             cHHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHc-CCCCcceEeeeEecC--CEEE
Confidence            356788899999999999999999999999999987532    246788999999999 999999999999654  6789


Q ss_pred             EEEEeecCCChhhhcC---CCChHHHHHHHHHHHHHHHHHHH-CCcEEecCCCCcEEEeCCCCcEEEEecccceeccCCC
Q 015374          199 LIFEYVNSTDFKVLYP---TLTDYDIRYYIYELLKALDYCHS-QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK  274 (408)
Q Consensus       199 lv~e~~~~~~l~~~~~---~l~~~~~~~i~~qi~~~L~~LH~-~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~~  274 (408)
                      +||||+++++|..++.   .+++..+..++.+++.||.|||+ .+++|+||+|+||+++.+ +.++|+|||++...... 
T Consensus        80 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~-~~~~l~d~gl~~~~~~~-  157 (284)
T cd06620          80 MCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSR-GQIKLCDFGVSGELINS-  157 (284)
T ss_pred             EEEecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCC-CcEEEccCCcccchhhh-
Confidence            9999999999988763   47889999999999999999997 689999999999999987 78999999998654322 


Q ss_pred             cceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHH------HHHHHHhhhchhhhhcCCCC
Q 015374          275 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHD------QLVKIAKDCCLIIWCNSRHS  348 (408)
Q Consensus       275 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~------~~~~~~~~~~~~~~~~~~~~  348 (408)
                      ......++..|+|||++.+ ..++.++|+|||||++|+|++|+.||.......+      .+.......-       ...
T Consensus       158 ~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~  229 (284)
T cd06620         158 IADTFVGTSTYMSPERIQG-GKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIV-------QEP  229 (284)
T ss_pred             ccCccccCcccCCHHHHcc-CCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHh-------hcc
Confidence            2234578889999999977 6889999999999999999999999854332111      0111111100       000


Q ss_pred             CCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccccccch
Q 015374          349 RKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAE  402 (408)
Q Consensus       349 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~~~~~~  402 (408)
                      ...       .....++.++.+|+.+||+.||++|||+.|+++|+||.+...+.
T Consensus       230 ~~~-------~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~~~~~  276 (284)
T cd06620         230 PPR-------LPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQALRAS  276 (284)
T ss_pred             CCC-------CCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccccccc
Confidence            000       00112578899999999999999999999999999997654433

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=7.1e-41  Score=312.94  Aligned_cols=264  Identities=29%  Similarity=0.579  Sum_probs=204.1

Q ss_pred             CEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc----chHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccEEEE
Q 015374          126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIF  201 (408)
Q Consensus       126 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~  201 (408)
                      +|++.++||.|++|+||+|++..++..||+|.++..    ....+.+|+.+++++ +|+||+++++++.+  ....++||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~--~~~~~lv~   77 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKEL-KHENIVRLHDVIHT--ENKLMLVF   77 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhh-cCCCEeeeeeeEee--CCcEEEEE
Confidence            588999999999999999999999999999998643    235677899999999 99999999999965  46778999


Q ss_pred             EeecCCChhhhc------CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCC-C
Q 015374          202 EYVNSTDFKVLY------PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG-K  274 (408)
Q Consensus       202 e~~~~~~l~~~~------~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~-~  274 (408)
                      ||+++ ++..++      ..+++..+..++.|++.||.|||+.|++|+||||+||+++.+ +.++|+|||++...... .
T Consensus        78 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~-~~~~l~d~g~~~~~~~~~~  155 (284)
T cd07836          78 EYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKR-GELKLADFGLARAFGIPVN  155 (284)
T ss_pred             ecCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCC-CcEEEeecchhhhhcCCcc
Confidence            99996 555543      247899999999999999999999999999999999999987 78999999998754332 1


Q ss_pred             cceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCC--CCCCCc
Q 015374          275 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSR--HSRKPW  352 (408)
Q Consensus       275 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~  352 (408)
                      ......++..|++||.+.+...++.++|+|||||++|+|++|..|| .+.+..+....+.............  .....+
T Consensus       156 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (284)
T cd07836         156 TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLF-PGTNNEDQLLKIFRIMGTPTESTWPGISQLPEY  234 (284)
T ss_pred             ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCC-CCCCcHHHHHHHHHHhCCCChhhHHHHhcCchh
Confidence            2233567788999999877566789999999999999999999887 4445555555544432211100000  000000


Q ss_pred             cccc-------cccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCc
Q 015374          353 SKFI-------NADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF  395 (408)
Q Consensus       353 ~~~~-------~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f  395 (408)
                      ....       .......++.++.+++.+||+.||++|||+.|+++||||
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f  284 (284)
T cd07836         235 KPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF  284 (284)
T ss_pred             cccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence            0000       001112357889999999999999999999999999998

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=8.4e-41  Score=310.15  Aligned_cols=248  Identities=27%  Similarity=0.412  Sum_probs=194.9

Q ss_pred             CCEEEEeee--eeeCceEEEEEEEcCCCcEEEEEEecccchHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccEEEEE
Q 015374          125 DDYEVVRKV--GRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFE  202 (408)
Q Consensus       125 ~~y~~~~~l--G~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e  202 (408)
                      ++|++.+.+  |.|+||.||++++..++..+|+|.++.......  |+.....+.+|+|+++++++|...  ...++|||
T Consensus        14 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~--e~~~~~~~~~h~~iv~~~~~~~~~--~~~~iv~e   89 (267)
T PHA03390         14 KNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI--EPMVHQLMKDNPNFIKLYYSVTTL--KGHVLIMD   89 (267)
T ss_pred             HhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh--hHHHHHHhhcCCCEEEEEEEEecC--CeeEEEEE
Confidence            345555555  999999999999999999999999875433322  333333334799999999999654  57899999


Q ss_pred             eecCCChhhhcC---CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCCCcceee
Q 015374          203 YVNSTDFKVLYP---TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR  279 (408)
Q Consensus       203 ~~~~~~l~~~~~---~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~~~~~~~  279 (408)
                      |+++++|..++.   .+++..+..++.|++.||.|||+.|++|+||||+||+++.+.+.++|+|||++.......   ..
T Consensus        90 ~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~---~~  166 (267)
T PHA03390         90 YIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPS---CY  166 (267)
T ss_pred             cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceecCCCc---cC
Confidence            999999988763   589999999999999999999999999999999999999884489999999987654322   34


Q ss_pred             ccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCCCcccccccc
Q 015374          280 VASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSKFINAD  359 (408)
Q Consensus       280 ~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  359 (408)
                      .++..|+|||++.+ ..++.++|+||||+++|+|++|..||.......-..........                 ....
T Consensus       167 ~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~-----------------~~~~  228 (267)
T PHA03390        167 DGTLDYFSPEKIKG-HNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQ-----------------KKLP  228 (267)
T ss_pred             CCCCcccChhhhcC-CCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhc-----------------ccCC
Confidence            67889999999987 67899999999999999999999998533222111121111100                 0111


Q ss_pred             CCCCCCHHHHHHHHHhcccCcCCCCC-HHHHhcCCCccc
Q 015374          360 NQHLVSPEAIDFLDKLLRYDHQDRLT-AREAMAHPYFAQ  397 (408)
Q Consensus       360 ~~~~~~~~~~~li~~~L~~dp~~Rpt-~~elL~hp~f~~  397 (408)
                      ....+++.+.+||.+||+.||.+|++ ++|+|+||||++
T Consensus       229 ~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h~~~~~  267 (267)
T PHA03390        229 FIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKHPFLKI  267 (267)
T ss_pred             cccccCHHHHHHHHHHhccChhhCCchHHHHhcCCcccC
Confidence            22247899999999999999999996 699999999974

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=1e-40  Score=308.23  Aligned_cols=249  Identities=29%  Similarity=0.518  Sum_probs=202.6

Q ss_pred             CEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc-----chHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccEEE
Q 015374          126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI  200 (408)
Q Consensus       126 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  200 (408)
                      +|++.+.||+|+||.||+|.+..++..+++|.++..     ....+.+|+.+++++ +|+||+++++++.+  ....++|
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~--~~~~~lv   77 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELL-KHPNLVKYYGVEVH--REKVYIF   77 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhC-CCCChhheeeeEec--CCEEEEE
Confidence            588999999999999999999989999999998643     345788999999999 99999999999854  4678899


Q ss_pred             EEeecCCChhhhcC---CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCCCcc-
Q 015374          201 FEYVNSTDFKVLYP---TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY-  276 (408)
Q Consensus       201 ~e~~~~~~l~~~~~---~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~~~~-  276 (408)
                      +||+++++|..++.   .+++..+..++.|++.||.|||+.||+|+||+|+||+++.+ +.+||+|||++......... 
T Consensus        78 ~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~-~~~kl~d~g~~~~~~~~~~~~  156 (264)
T cd06626          78 MEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHN-GVIKLGDFGCAVKLKNNTTTM  156 (264)
T ss_pred             EecCCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCC-CCEEEcccccccccCCCCCcc
Confidence            99999999998873   37888899999999999999999999999999999999987 79999999998776433221 


Q ss_pred             ----eeeccCccccccccccCCc--CCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCC
Q 015374          277 ----NVRVASRYFKGPELLVDLQ--DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRK  350 (408)
Q Consensus       277 ----~~~~~~~~y~aPE~~~~~~--~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  350 (408)
                          ....++..|++||.+.+..  ..+.++||||||+++|+|++|..||....+.......+...           ...
T Consensus       157 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~~-----------~~~  225 (264)
T cd06626         157 GEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAG-----------HKP  225 (264)
T ss_pred             cccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhcC-----------CCC
Confidence                1245678899999987622  37899999999999999999999985443332222221110           000


Q ss_pred             CccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCc
Q 015374          351 PWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF  395 (408)
Q Consensus       351 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f  395 (408)
                      .      ......++..+.+|+.+||+.||++|||++|++.|||+
T Consensus       226 ~------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~~~~  264 (264)
T cd06626         226 P------IPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQHPFV  264 (264)
T ss_pred             C------CCcccccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence            0      00112257899999999999999999999999999996

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=4.4e-41  Score=314.29  Aligned_cols=263  Identities=33%  Similarity=0.641  Sum_probs=202.9

Q ss_pred             EEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecccc-----hHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccEEEE
Q 015374          127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK-----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIF  201 (408)
Q Consensus       127 y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~  201 (408)
                      |++.++||.|++|+||+|.+..++..|++|++....     ...+.+|+.+++++ +|+|++++++++.+  +...+++|
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~iv~~~~~~~~--~~~~~iv~   77 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKEL-NHPNIVRLLDVVHS--ENKLYLVF   77 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhc-CCCCccCHhheecc--CCeEEEEE
Confidence            567889999999999999999999999999986322     35678899999999 99999999999954  47889999


Q ss_pred             EeecCCChhhhc---C--CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCC-Cc
Q 015374          202 EYVNSTDFKVLY---P--TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG-KE  275 (408)
Q Consensus       202 e~~~~~~l~~~~---~--~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~-~~  275 (408)
                      ||++ +++..++   .  .+++..+..++.|++.||+|||+++++|+||+|+||+++.+ +.++|+|||++...... ..
T Consensus        78 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~-~~~~l~df~~~~~~~~~~~~  155 (283)
T cd07835          78 EFLD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDRE-GALKLADFGLARAFGVPVRT  155 (283)
T ss_pred             eccC-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCC-CcEEEeecccccccCCCccc
Confidence            9996 4666665   2  47899999999999999999999999999999999999987 79999999998755322 22


Q ss_pred             ceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcC---------C
Q 015374          276 YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNS---------R  346 (408)
Q Consensus       276 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~---------~  346 (408)
                      .....++..|+|||++.+...++.++|+||||+++|+|++|..||. +.++.+.+..+....+.......         .
T Consensus       156 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (283)
T cd07835         156 YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFP-GDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYK  234 (283)
T ss_pred             cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCC-CCCHHHHHHHHHHHhCCCChHHhhhhhhchhhh
Confidence            2334567889999998764567899999999999999999998874 33444444444333221110000         0


Q ss_pred             CCCCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCc
Q 015374          347 HSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF  395 (408)
Q Consensus       347 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f  395 (408)
                      .....+...........++.++.+++.+||+.||++|||++|+++||||
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~  283 (283)
T cd07835         235 PTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF  283 (283)
T ss_pred             hhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence            0000011111112234467899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=3e-41  Score=323.74  Aligned_cols=274  Identities=34%  Similarity=0.595  Sum_probs=213.3

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecc-----cchHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCcc
Q 015374          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP-----VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP  197 (408)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~-----~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~  197 (408)
                      ..++|++.+.||+|+||.||+|.+..+++.+|+|.+..     .....+.+|+.++.++.+|+||++++++|...+....
T Consensus         5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~   84 (337)
T cd07852           5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI   84 (337)
T ss_pred             hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence            35788999999999999999999998999999998743     2234577899999998789999999999976656678


Q ss_pred             EEEEEeecCCChhhhcC--CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCCC-
Q 015374          198 SLIFEYVNSTDFKVLYP--TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK-  274 (408)
Q Consensus       198 ~lv~e~~~~~~l~~~~~--~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~~-  274 (408)
                      ++||||+++ +|..++.  .+++..+..++.|++.||.|||+.||+|+||||+||+++.+ +.+||+|||++....... 
T Consensus        85 ~lv~e~~~~-~L~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~-~~~kl~d~g~~~~~~~~~~  162 (337)
T cd07852          85 YLVFEYMET-DLHAVIRANILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSD-CRVKLADFGLARSLSELEE  162 (337)
T ss_pred             EEEeccccc-CHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCC-CcEEEeeccchhccccccc
Confidence            999999985 6666653  47888888999999999999999999999999999999988 799999999987654322 


Q ss_pred             -----cceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhh------
Q 015374          275 -----EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWC------  343 (408)
Q Consensus       275 -----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~------  343 (408)
                           ......++..|+|||.+.+...++.++|+||||+++|+|++|+.|| .+..+.+....+....+.....      
T Consensus       163 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf-~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (337)
T cd07852         163 NPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLF-PGTSTLNQLEKIIEVIGPPSAEDIESIK  241 (337)
T ss_pred             cccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCC-CCCChHHHHHHHHHHhCCCCHHHHHHHH
Confidence                 1223467888999999876567889999999999999999999987 4555555555544443321100      


Q ss_pred             -------cCCCCCCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccccccc
Q 015374          344 -------NSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAA  401 (408)
Q Consensus       344 -------~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~~~~~  401 (408)
                             ........... . ......++.++.+++.+||+.||++|||+.++++||||+.....
T Consensus       242 ~~~~~~~~~~~~~~~~~~-~-~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~~~~  304 (337)
T cd07852         242 SPFAATMLDSLPSRPRKP-L-DELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQFHNP  304 (337)
T ss_pred             hhhHHHhhhhcccccccc-h-hhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhhccC
Confidence                   00000000000 0 11112268899999999999999999999999999999887554

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=1.9e-41  Score=318.66  Aligned_cols=254  Identities=22%  Similarity=0.415  Sum_probs=205.5

Q ss_pred             CCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc---chHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccEEEE
Q 015374          125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV---KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIF  201 (408)
Q Consensus       125 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~  201 (408)
                      +.|.....||+|+||.||++.+..++..||||.++..   ..+.+.+|+.+++.+ +|+|++++++.+..  +...++||
T Consensus        22 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~ii~~~~~~~~--~~~~~lv~   98 (292)
T cd06658          22 EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDY-HHENVVDMYNSYLV--GDELWVVM   98 (292)
T ss_pred             HHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhC-CCCcHHHHHHheec--CCeEEEEE
Confidence            3445556899999999999999899999999998632   245688999999999 99999999999865  46789999


Q ss_pred             EeecCCChhhhc--CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCCC-ccee
Q 015374          202 EYVNSTDFKVLY--PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK-EYNV  278 (408)
Q Consensus       202 e~~~~~~l~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~~-~~~~  278 (408)
                      ||++++++..++  ..+++..+..++.|++.||.|||+++|+||||||+||+++.+ +.++|+|||++....... ....
T Consensus        99 e~~~~~~L~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~-~~~kL~dfg~~~~~~~~~~~~~~  177 (292)
T cd06658          99 EFLEGGALTDIVTHTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSD-GRIKLSDFGFCAQVSKEVPKRKS  177 (292)
T ss_pred             eCCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCC-CCEEEccCcchhhcccccccCce
Confidence            999999998876  458899999999999999999999999999999999999988 799999999987543222 2234


Q ss_pred             eccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCCCccccccc
Q 015374          279 RVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSKFINA  358 (408)
Q Consensus       279 ~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  358 (408)
                      ..++..|+|||.+.+ ..++.++|+||||+++|||++|..||.. .+..+.+..+.....         .        ..
T Consensus       178 ~~~~~~y~aPE~~~~-~~~~~~~Dv~slGvil~el~~g~~p~~~-~~~~~~~~~~~~~~~---------~--------~~  238 (292)
T cd06658         178 LVGTPYWMAPEVISR-LPYGTEVDIWSLGIMVIEMIDGEPPYFN-EPPLQAMRRIRDNLP---------P--------RV  238 (292)
T ss_pred             eecCccccCHHHHcc-CCCCchhhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhcCC---------C--------cc
Confidence            568889999999876 6789999999999999999999999853 333333222211100         0        00


Q ss_pred             cCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccccccc
Q 015374          359 DNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAA  401 (408)
Q Consensus       359 ~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~~~~~  401 (408)
                      .....++..+.+++.+||..||++|||++|+++||||......
T Consensus       239 ~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~~~~~~~  281 (292)
T cd06658         239 KDSHKVSSVLRGFLDLMLVREPSQRATAQELLQHPFLKLAGPP  281 (292)
T ss_pred             ccccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhhccCCc
Confidence            0112367889999999999999999999999999999866443

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.9e-41  Score=312.98  Aligned_cols=254  Identities=25%  Similarity=0.432  Sum_probs=204.8

Q ss_pred             CEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc----chHHHHHHHHHHHHhc--CCCCceEEeeEEEccCCCccEE
Q 015374          126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV----KKKKIKREIKILQNLC--GGPNVVKLLDIVRDQHSKTPSL  199 (408)
Q Consensus       126 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~--~h~niv~l~~~~~~~~~~~~~l  199 (408)
                      .|++.+.||.|+||.||+|.+..+++.+++|.++..    ..+.+.+|+.+++++.  .|||+++++++|.+  +...++
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~--~~~~~l   79 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLK--GPRLWI   79 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeee--CCEEEE
Confidence            477788999999999999999999999999998632    2456889999999983  39999999999854  467899


Q ss_pred             EEEeecCCChhhhc--CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCCCc-c
Q 015374          200 IFEYVNSTDFKVLY--PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE-Y  276 (408)
Q Consensus       200 v~e~~~~~~l~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~~~-~  276 (408)
                      ||||+++++|..++  ..+++..+..++.|++.||.|||+.||+|+||+|+||+++.+ +.++|+|||++........ .
T Consensus        80 v~e~~~~~~L~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~-~~~~l~dfg~~~~~~~~~~~~  158 (277)
T cd06917          80 IMEYAEGGSVRTLMKAGPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNT-GNVKLCDFGVAALLNQNSSKR  158 (277)
T ss_pred             EEecCCCCcHHHHHHccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCC-CCEEEccCCceeecCCCcccc
Confidence            99999999998876  357889999999999999999999999999999999999987 7999999999987654332 2


Q ss_pred             eeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCCCccccc
Q 015374          277 NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSKFI  356 (408)
Q Consensus       277 ~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  356 (408)
                      ....++..|+|||.+.+...++.++|+|||||++|+|++|..||.. .+.......+ ..        ...         
T Consensus       159 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~-~~~~~~~~~~-~~--------~~~---------  219 (277)
T cd06917         159 STFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSD-VDAFRAMMLI-PK--------SKP---------  219 (277)
T ss_pred             ccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCC-CChhhhhhcc-cc--------CCC---------
Confidence            3346888899999987645678999999999999999999999832 2221111110 00        000         


Q ss_pred             cccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccccccc
Q 015374          357 NADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAA  401 (408)
Q Consensus       357 ~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~~~~~  401 (408)
                      +.......+.++.+++.+||+.||++|||+.|++.|+||++....
T Consensus       220 ~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~~~~~~~~~~  264 (277)
T cd06917         220 PRLEDNGYSKLLREFVAACLDEEPKERLSAEELLKSKWIKAHSKT  264 (277)
T ss_pred             CCCCcccCCHHHHHHHHHHcCCCcccCcCHHHHhhChHhhccccC
Confidence            000011267899999999999999999999999999999877643

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2.8e-42  Score=331.59  Aligned_cols=253  Identities=24%  Similarity=0.442  Sum_probs=209.5

Q ss_pred             CCCCE-EEEeeeeeeCceEEEEEEEcCCCcEEE---EEEec----ccchHHHHHHHHHHHHhcCCCCceEEeeEEEccCC
Q 015374          123 DQDDY-EVVRKVGRGKYSEVFEGINVNTNERCI---IKILK----PVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHS  194 (408)
Q Consensus       123 ~~~~y-~~~~~lG~G~fg~Vy~~~~~~~~~~va---vK~~~----~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~  194 (408)
                      ...+| .....||+|+|=+||+|.|..+|-.||   ||+-+    +...+.|..|+.+|+.| +|+||+++|+++.+.+.
T Consensus        37 p~gRy~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL-~H~NIirfy~SW~d~~n  115 (632)
T KOG0584|consen   37 PTGRYLKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSL-KHPNIIRFYDSWVDTDN  115 (632)
T ss_pred             CCCceeehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccC-CCCceeeeeeheecCCC
Confidence            34444 334579999999999999999998887   33321    23457899999999999 99999999999998888


Q ss_pred             CccEEEEEeecCCChhhhc---CCCChHHHHHHHHHHHHHHHHHHHC--CcEEecCCCCcEEEeCCCCcEEEEeccccee
Q 015374          195 KTPSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQ--GIMHRDVKPHNVMIDHELRKLRLIDWGLAEF  269 (408)
Q Consensus       195 ~~~~lv~e~~~~~~l~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~--~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~  269 (408)
                      ..+.+|.|.|..|+|..|+   +.++...++.|++||++||.|||++  -|||||||-+||+|+.+.|.|||+|+|+|+.
T Consensus       116 ~~in~iTEL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl  195 (632)
T KOG0584|consen  116 KTINFITELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATL  195 (632)
T ss_pred             ceeeeeeecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHH
Confidence            8899999999999999998   4578888999999999999999987  5999999999999999999999999999998


Q ss_pred             ccCCCcceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCC
Q 015374          270 YHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSR  349 (408)
Q Consensus       270 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  349 (408)
                      ...... ...+||+-|||||++.  ..|+..+||||||..++||+|+..|| ..-.+..++++.+-.+-.+.        
T Consensus       196 ~r~s~a-ksvIGTPEFMAPEmYE--E~YnE~VDVYaFGMCmLEMvT~eYPY-sEC~n~AQIYKKV~SGiKP~--------  263 (632)
T KOG0584|consen  196 LRKSHA-KSVIGTPEFMAPEMYE--ENYNELVDVYAFGMCMLEMVTSEYPY-SECTNPAQIYKKVTSGIKPA--------  263 (632)
T ss_pred             hhcccc-ceeccCccccChHHHh--hhcchhhhhhhhhHHHHHHHhccCCh-hhhCCHHHHHHHHHcCCCHH--------
Confidence            764433 3479999999999986  58999999999999999999999997 44455555444433211111        


Q ss_pred             CCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccc
Q 015374          350 KPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQV  398 (408)
Q Consensus       350 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~~  398 (408)
                               ...+.-++++++||.+||.. .++|+|+.|||.||||..-
T Consensus       264 ---------sl~kV~dPevr~fIekCl~~-~~~R~sa~eLL~d~Ff~~d  302 (632)
T KOG0584|consen  264 ---------ALSKVKDPEVREFIEKCLAT-KSERLSAKELLKDPFFDED  302 (632)
T ss_pred             ---------HhhccCCHHHHHHHHHHhcC-chhccCHHHHhhChhhccc
Confidence                     11111368999999999998 9999999999999999864

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=4.3e-41  Score=316.32  Aligned_cols=257  Identities=26%  Similarity=0.465  Sum_probs=209.4

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc---chHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccEEE
Q 015374          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV---KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI  200 (408)
Q Consensus       124 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  200 (408)
                      .++|++.+.||+|+||.||+|.+..++..+++|.+...   ..+.+.+|+.+++++ +|||+++++++|..  ....++|
T Consensus        18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l-~hp~i~~~~~~~~~--~~~~~lv   94 (293)
T cd06647          18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMREN-KHPNIVNYLDSYLV--GDELWVV   94 (293)
T ss_pred             hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhc-CCCCeeehhheeee--CCcEEEE
Confidence            57899999999999999999998889999999998532   235688899999999 89999999999965  4678899


Q ss_pred             EEeecCCChhhhcC--CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCCCc-ce
Q 015374          201 FEYVNSTDFKVLYP--TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE-YN  277 (408)
Q Consensus       201 ~e~~~~~~l~~~~~--~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~~~-~~  277 (408)
                      +||+++++|..++.  .+++.++..++.|++.||.|||++|++|+||||+||+++.+ +.++|+|||++........ ..
T Consensus        95 ~e~~~~~~L~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~-~~~kL~dfg~~~~~~~~~~~~~  173 (293)
T cd06647          95 MEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMD-GSVKLTDFGFCAQITPEQSKRS  173 (293)
T ss_pred             EecCCCCcHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCC-CCEEEccCcceecccccccccc
Confidence            99999999998874  47888999999999999999999999999999999999988 7899999999875543322 23


Q ss_pred             eeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCCCcccccc
Q 015374          278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSKFIN  357 (408)
Q Consensus       278 ~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  357 (408)
                      ...++..|++||.+.+ ..++.++|+|||||++|++++|..||... +..+.+..+...           ...      .
T Consensus       174 ~~~~~~~y~~PE~~~~-~~~~~~~Dv~slG~ll~~ll~g~~pf~~~-~~~~~~~~~~~~-----------~~~------~  234 (293)
T cd06647         174 TMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMVEGEPPYLNE-NPLRALYLIATN-----------GTP------E  234 (293)
T ss_pred             cccCChhhcCchhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCC-ChhhheeehhcC-----------CCC------C
Confidence            3467888999999977 67899999999999999999999998432 222221111000           000      0


Q ss_pred             ccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccccccchh
Q 015374          358 ADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAES  403 (408)
Q Consensus       358 ~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~~~~~~~  403 (408)
                      ...+..++..+.+++++||..||++||++++++.||||+..+...+
T Consensus       235 ~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h~~~~~~~~~~~  280 (293)
T cd06647         235 LQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHPFLKIAKPLSS  280 (293)
T ss_pred             CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcCccccc
Confidence            1122336788999999999999999999999999999998875443

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=7.7e-41  Score=307.86  Aligned_cols=246  Identities=23%  Similarity=0.474  Sum_probs=202.6

Q ss_pred             CEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc-----chHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccEEE
Q 015374          126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI  200 (408)
Q Consensus       126 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  200 (408)
                      +|++.+.||.|+||.||+|.+..++..+|+|.+...     ..+.+.+|+.+++.+ +|+||+++++.+.+  ....++|
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~-~h~~i~~~~~~~~~--~~~~~lv   77 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKM-KHPNIVTFFASFQE--NGRLFIV   77 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhC-CCCChhhhhheecc--CCeEEEE
Confidence            588999999999999999999999999999998632     345788999999999 99999999999854  4678999


Q ss_pred             EEeecCCChhhhcC-----CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCCCc
Q 015374          201 FEYVNSTDFKVLYP-----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE  275 (408)
Q Consensus       201 ~e~~~~~~l~~~~~-----~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~~~  275 (408)
                      +||+++++|..++.     .+++..+..++.|++.||.|||+.+++|+||||+||+++.+...++|+|||.+........
T Consensus        78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~  157 (257)
T cd08225          78 MEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME  157 (257)
T ss_pred             EecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccCCcc
Confidence            99999999988763     3688899999999999999999999999999999999998745679999999876654332


Q ss_pred             -ceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCCCccc
Q 015374          276 -YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSK  354 (408)
Q Consensus       276 -~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  354 (408)
                       .....++..|+|||.+.+ ..++.++|+||||+++|+|++|..||.. .+..+....+...              .+  
T Consensus       158 ~~~~~~~~~~~~ape~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~-~~~~~~~~~~~~~--------------~~--  219 (257)
T cd08225         158 LAYTCVGTPYYLSPEICQN-RPYNNKTDIWSLGCVLYELCTLKHPFEG-NNLHQLVLKICQG--------------YF--  219 (257)
T ss_pred             cccccCCCccccCHHHHcC-CCCCchhhHHHHHHHHHHHHhCCCCCCC-ccHHHHHHHHhcc--------------cC--
Confidence             223467888999999876 6789999999999999999999999842 2222322222111              00  


Q ss_pred             cccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCc
Q 015374          355 FINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF  395 (408)
Q Consensus       355 ~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f  395 (408)
                         ......++.++.+++.+||..+|++|||+.|+++||||
T Consensus       220 ---~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~~~~  257 (257)
T cd08225         220 ---APISPNFSRDLRSLISQLFKVSPRDRPSITSILKRPFL  257 (257)
T ss_pred             ---CCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhCCCC
Confidence               01122367899999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=9.3e-42  Score=318.04  Aligned_cols=251  Identities=25%  Similarity=0.418  Sum_probs=204.3

Q ss_pred             CCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc----chHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccEEE
Q 015374          125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI  200 (408)
Q Consensus       125 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  200 (408)
                      +.|+..+.||+|+||.||+|.+..++..||+|.++..    ..+.+.+|+.+++++ +|+||+++++++..  +...++|
T Consensus         4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~~~lv   80 (277)
T cd06642           4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQC-DSPYITRYYGSYLK--GTKLWII   80 (277)
T ss_pred             HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcC-CCCccHhhhccccc--CCceEEE
Confidence            3466677899999999999999999999999998632    235688999999999 99999999999965  4678999


Q ss_pred             EEeecCCChhhhcC--CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCCCc-ce
Q 015374          201 FEYVNSTDFKVLYP--TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE-YN  277 (408)
Q Consensus       201 ~e~~~~~~l~~~~~--~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~~~-~~  277 (408)
                      |||++++++..++.  .+++..+..++.|++.||.|||+++++|+||+|+||+++.+ +.++|+|||++........ ..
T Consensus        81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~-~~~~l~dfg~~~~~~~~~~~~~  159 (277)
T cd06642          81 MEYLGGGSALDLLKPGPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQ-GDVKLADFGVAGQLTDTQIKRN  159 (277)
T ss_pred             EEccCCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCC-CCEEEccccccccccCcchhhh
Confidence            99999999988774  47889999999999999999999999999999999999987 7899999999876543322 22


Q ss_pred             eeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCCCcccccc
Q 015374          278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSKFIN  357 (408)
Q Consensus       278 ~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  357 (408)
                      ...++..|+|||.+.+ ..++.++|+|||||++|||++|..||... ........+...                   ..
T Consensus       160 ~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~tg~~p~~~~-~~~~~~~~~~~~-------------------~~  218 (277)
T cd06642         160 TFVGTPFWMAPEVIKQ-SAYDFKADIWSLGITAIELAKGEPPNSDL-HPMRVLFLIPKN-------------------SP  218 (277)
T ss_pred             cccCcccccCHHHhCc-CCCchhhhHHHHHHHHHHHHhCCCCCccc-chhhHHhhhhcC-------------------CC
Confidence            3467888999999987 67899999999999999999999997432 222221111000                   01


Q ss_pred             ccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccccc
Q 015374          358 ADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRA  400 (408)
Q Consensus       358 ~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~~~~  400 (408)
                      ......++.++.+++.+||+.+|++|||+.++++||||.....
T Consensus       219 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~  261 (277)
T cd06642         219 PTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKHKFITRYTK  261 (277)
T ss_pred             CCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHhHHHHHHhh
Confidence            1122336788999999999999999999999999999986544

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.4e-41  Score=346.23  Aligned_cols=246  Identities=21%  Similarity=0.393  Sum_probs=208.3

Q ss_pred             CCCCCEEEEeeeeeeCceEEEEEEEcCCC-----cEEEEEEecc----cchHHHHHHHHHHHHhcCCCCceEEeeEEEcc
Q 015374          122 GDQDDYEVVRKVGRGKYSEVFEGINVNTN-----ERCIIKILKP----VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQ  192 (408)
Q Consensus       122 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~-----~~vavK~~~~----~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~  192 (408)
                      ......++.+.||+|.||.||.|......     ..||||.++.    ....+|.+|..+|+++ +|||||+++|+|.+ 
T Consensus       689 v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f-~HpNiv~liGv~l~-  766 (1025)
T KOG1095|consen  689 VPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKF-DHPNIVSLIGVCLD-  766 (1025)
T ss_pred             CChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcC-CCcceeeEEEeecC-
Confidence            44678889999999999999999865432     2489999874    3457899999999999 99999999999976 


Q ss_pred             CCCccEEEEEeecCCChhhhcC----------CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEE
Q 015374          193 HSKTPSLIFEYVNSTDFKVLYP----------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLI  262 (408)
Q Consensus       193 ~~~~~~lv~e~~~~~~l~~~~~----------~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~  262 (408)
                       ....++++|||.+|+|..+++          .++..++..++.|||+|++||+++++|||||.++|+||+.. ..+||+
T Consensus       767 -~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~-r~VKIa  844 (1025)
T KOG1095|consen  767 -SGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDER-RVVKIA  844 (1025)
T ss_pred             -CCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeeccc-CcEEEc
Confidence             567789999999999999983          37889999999999999999999999999999999999998 799999


Q ss_pred             ecccceeccCCCcceee---ccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhch
Q 015374          263 DWGLAEFYHPGKEYNVR---VASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCL  339 (408)
Q Consensus       263 DfG~a~~~~~~~~~~~~---~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~  339 (408)
                      |||+|+.+.....+...   .-...|||||.+.+ +.++.++|||||||++||++|...+.|.+.++.+.+......   
T Consensus       845 DFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d-~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~g---  920 (1025)
T KOG1095|consen  845 DFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKD-GIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEG---  920 (1025)
T ss_pred             ccchhHhhhhchheeccCccccceecCCHHHHhh-cccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhC---
Confidence            99999955443333222   22346999999998 899999999999999999999777777888888887655443   


Q ss_pred             hhhhcCCCCCCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 015374          340 IIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA  391 (408)
Q Consensus       340 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~  391 (408)
                                      .+...+..|++.+.++|..||+.+|++||+...+++
T Consensus       921 ----------------gRL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~  956 (1025)
T KOG1095|consen  921 ----------------GRLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVE  956 (1025)
T ss_pred             ----------------CccCCCCCCChHHHHHHHHHccCChhhCccHHHHHh
Confidence                            133445669999999999999999999999999986

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=5.4e-41  Score=313.68  Aligned_cols=244  Identities=17%  Similarity=0.338  Sum_probs=197.3

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCC-----cEEEEEEecccc----hHHHHHHHHHHHHhcCCCCceEEeeEEEccCC
Q 015374          124 QDDYEVVRKVGRGKYSEVFEGINVNTN-----ERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHS  194 (408)
Q Consensus       124 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~-----~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~  194 (408)
                      .++|++.+.||+|+||.||+|.+...+     ..+++|.++...    ...+.+|+.++.++ +||||+++++++.+  .
T Consensus         4 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l-~h~~i~~~~~~~~~--~   80 (283)
T cd05048           4 LSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDL-QHPNIVCLLGVCTK--E   80 (283)
T ss_pred             hHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhc-CCcccceEEEEEcC--C
Confidence            357888999999999999999876554     679999986432    35688999999999 99999999999954  4


Q ss_pred             CccEEEEEeecCCChhhhcC-------------------CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCC
Q 015374          195 KTPSLIFEYVNSTDFKVLYP-------------------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE  255 (408)
Q Consensus       195 ~~~~lv~e~~~~~~l~~~~~-------------------~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~  255 (408)
                      ...+++|||+++++|..++.                   .+++..+..++.|++.||.|||+.+++|+||||+||+++.+
T Consensus        81 ~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~~  160 (283)
T cd05048          81 QPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEG  160 (283)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcCC
Confidence            67789999999999988762                   36778889999999999999999999999999999999988


Q ss_pred             CCcEEEEecccceeccCCCc---ceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHH
Q 015374          256 LRKLRLIDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLV  331 (408)
Q Consensus       256 ~~~~kl~DfG~a~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-g~~pf~~~~~~~~~~~  331 (408)
                       +.++|+|||++........   .....++..|+|||.+.+ ..++.++|||||||++|||++ |..||+ +.+..+...
T Consensus       161 -~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDv~slG~il~el~~~g~~p~~-~~~~~~~~~  237 (283)
T cd05048         161 -LTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILY-GKFTTESDIWSFGVVLWEIFSYGLQPYY-GFSNQEVIE  237 (283)
T ss_pred             -CcEEECCCcceeeccccccccccCCCcccccccCHHHhcc-CcCchhhhHHHHHHHHHHHHcCCCCCCC-CCCHHHHHH
Confidence             7899999999976543321   223456778999999877 678999999999999999998 888884 333333333


Q ss_pred             HHHhhhchhhhhcCCCCCCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 015374          332 KIAKDCCLIIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH  392 (408)
Q Consensus       332 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~h  392 (408)
                      .+....                   ....+..+++++.+++.+||+.||.+|||+.|++++
T Consensus       238 ~i~~~~-------------------~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~  279 (283)
T cd05048         238 MIRSRQ-------------------LLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTR  279 (283)
T ss_pred             HHHcCC-------------------cCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            222110                   011234478999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=1.4e-40  Score=312.06  Aligned_cols=252  Identities=20%  Similarity=0.368  Sum_probs=199.4

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcC-----CCcEEEEEEecccc----hHHHHHHHHHHHHhcCCCCceEEeeEEEccC
Q 015374          123 DQDDYEVVRKVGRGKYSEVFEGINVN-----TNERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQH  193 (408)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~Vy~~~~~~-----~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~  193 (408)
                      ..++|++.+.||+|+||.||+|....     .+..||+|.++...    ...+.+|+.+++.+ +|+||+++++++.+  
T Consensus         4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~--   80 (288)
T cd05061           4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGF-TCHHVVRLLGVVSK--   80 (288)
T ss_pred             cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEcC--
Confidence            57889999999999999999997542     34579999886332    24577899999999 99999999999865  


Q ss_pred             CCccEEEEEeecCCChhhhcCC-------------CChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEE
Q 015374          194 SKTPSLIFEYVNSTDFKVLYPT-------------LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLR  260 (408)
Q Consensus       194 ~~~~~lv~e~~~~~~l~~~~~~-------------l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~k  260 (408)
                      ....++||||+++++|..++..             .+...+..++.|++.||.|||+++|+||||||+|||++.+ +.++
T Consensus        81 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~-~~~~  159 (288)
T cd05061          81 GQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHD-FTVK  159 (288)
T ss_pred             CCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCC-CcEE
Confidence            3578899999999999988732             3456778899999999999999999999999999999988 7899


Q ss_pred             EEecccceeccCCCc---ceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHhh
Q 015374          261 LIDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKD  336 (408)
Q Consensus       261 l~DfG~a~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-g~~pf~~~~~~~~~~~~~~~~  336 (408)
                      |+|||+++.......   .....++..|+|||.+.+ ..++.++|+|||||++|||++ |..|| .+.+..+....+...
T Consensus       160 L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~-~~~~~~~DvwslG~~l~el~~~~~~p~-~~~~~~~~~~~~~~~  237 (288)
T cd05061         160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKD-GVFTTSSDMWSFGVVLWEITSLAEQPY-QGLSNEQVLKFVMDG  237 (288)
T ss_pred             ECcCCccccccccccccccCCCcccccccCHHHhcc-CCCChHhHHHHHHHHHHHHHhCCCCCC-CCCCHHHHHHHHHcC
Confidence            999999875533221   112234567999999877 678999999999999999998 56666 444433333322211


Q ss_pred             hchhhhhcCCCCCCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhc------CCCccccc
Q 015374          337 CCLIIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA------HPYFAQVR  399 (408)
Q Consensus       337 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~------hp~f~~~~  399 (408)
                       +                  ....+..+++.+.+++.+||+.||++|||+.++++      ||||..++
T Consensus       238 -~------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~~~  287 (288)
T cd05061         238 -G------------------YLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPEVS  287 (288)
T ss_pred             -C------------------CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCCCC
Confidence             0                  00112235789999999999999999999999987      99999885

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=1e-40  Score=315.91  Aligned_cols=269  Identities=33%  Similarity=0.584  Sum_probs=205.2

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecccc-----hHHHHHHHHHHHHhcCCCCceEEeeEEEccC----
Q 015374          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK-----KKKIKREIKILQNLCGGPNVVKLLDIVRDQH----  193 (408)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~----  193 (408)
                      ..++|++.++||.|+||.||+|++..+++.+++|.+....     ...+.+|+.+++++ +|+||+++++++.+..    
T Consensus         6 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~   84 (311)
T cd07866           6 KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKL-KHPNVVPLIDMAVERPDKSK   84 (311)
T ss_pred             ccccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhc-CCCCccchhhheeccccccc
Confidence            3689999999999999999999999999999999885321     23577899999999 9999999999876433    


Q ss_pred             --CCccEEEEEeecCCChhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccce
Q 015374          194 --SKTPSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE  268 (408)
Q Consensus       194 --~~~~~lv~e~~~~~~l~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~  268 (408)
                        ....++||||+.+..+..+.   ..+++..+..++.|++.||.|||++||+|+||||+||+++.+ +.++|+|||++.
T Consensus        85 ~~~~~~~lv~~~~~~~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~-~~~~l~dfg~~~  163 (311)
T cd07866          85 RKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQ-GILKIADFGLAR  163 (311)
T ss_pred             ccCceEEEEEecCCcCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCC-CCEEECcCccch
Confidence              23578999999875544433   358999999999999999999999999999999999999988 799999999987


Q ss_pred             eccCCCc------------ceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhh
Q 015374          269 FYHPGKE------------YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKD  336 (408)
Q Consensus       269 ~~~~~~~------------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~  336 (408)
                      .......            .....++..|+|||.+.+...++.++|||||||++|+|++|+.|| .+.+.......+...
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~-~~~~~~~~~~~~~~~  242 (311)
T cd07866         164 PYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPIL-QGKSDIDQLHLIFKL  242 (311)
T ss_pred             hccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHHH
Confidence            5543221            122356778999999876556899999999999999999999886 555555555555444


Q ss_pred             hchhhhhcC---C---C-----CCCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCc
Q 015374          337 CCLIIWCNS---R---H-----SRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF  395 (408)
Q Consensus       337 ~~~~~~~~~---~---~-----~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f  395 (408)
                      .+.......   .   .     .......... .....+++++.+|+.+||+.||++|||+.|+++||||
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f  311 (311)
T cd07866         243 CGTPTEETWPGWRSLPGCEGVHSFTNYPRTLE-ERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF  311 (311)
T ss_pred             hCCCChhhchhhhhcccccccccCCCCCccHH-HHcccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence            332110000   0   0     0000000000 0112345789999999999999999999999999998

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=1.2e-40  Score=314.36  Aligned_cols=270  Identities=27%  Similarity=0.537  Sum_probs=207.1

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecccc-----hHHHHHHHHHHHHhcCCCCceEEeeEEEccC----
Q 015374          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK-----KKKIKREIKILQNLCGGPNVVKLLDIVRDQH----  193 (408)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~----  193 (408)
                      ..++|++.+.||+|+||+||+|.+..+++.||+|.++...     ...+.+|+.+++++ +|||++++++++.+..    
T Consensus         5 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l-~h~~i~~~~~~~~~~~~~~~   83 (302)
T cd07864           5 CVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQL-NHRNIVNLKEIVTDKQDALD   83 (302)
T ss_pred             hhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhC-CCCCeeeeeheecCcchhhh
Confidence            4578999999999999999999999999999999986322     24577899999999 9999999999986543    


Q ss_pred             ----CCccEEEEEeecCCChhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEeccc
Q 015374          194 ----SKTPSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGL  266 (408)
Q Consensus       194 ----~~~~~lv~e~~~~~~l~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~  266 (408)
                          ....++|+||++++.+....   ..+++..+..++.|++.||.|||+.||+|+||||+||+++.+ +.+||+|||+
T Consensus        84 ~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~-~~~kl~dfg~  162 (302)
T cd07864          84 FKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNK-GQIKLADFGL  162 (302)
T ss_pred             ccccCCcEEEEEcccCccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCC-CcEEeCcccc
Confidence                23789999999985444433   258999999999999999999999999999999999999988 7999999999


Q ss_pred             ceeccCCC--cceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhc
Q 015374          267 AEFYHPGK--EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCN  344 (408)
Q Consensus       267 a~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  344 (408)
                      +.......  ......++..|++||.+.+...++.++|||||||++|+|++|+.||. ..+..+.+..+....+......
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~-~~~~~~~~~~~~~~~~~~~~~~  241 (302)
T cd07864         163 ARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQ-ANQELAQLELISRLCGSPCPAV  241 (302)
T ss_pred             cccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCC-CCChHHHHHHHHHHhCCCChhh
Confidence            97664333  12233557789999998764567899999999999999999998874 4444555555444333211100


Q ss_pred             CC-CC-CCCcccc--------ccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCc
Q 015374          345 SR-HS-RKPWSKF--------INADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF  395 (408)
Q Consensus       345 ~~-~~-~~~~~~~--------~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f  395 (408)
                      .. .. ...+...        ........++..+.+++.+||+.||++|||+++++.||||
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~  302 (302)
T cd07864         242 WPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL  302 (302)
T ss_pred             cccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence            00 00 0000000        0001223468899999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=2.9e-40  Score=303.51  Aligned_cols=249  Identities=31%  Similarity=0.510  Sum_probs=208.2

Q ss_pred             CEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecccc-----hHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccEEE
Q 015374          126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK-----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI  200 (408)
Q Consensus       126 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  200 (408)
                      +|++.+.||+|++|.||+|.+..++..+++|+++...     .+.+.+|+.+++++ +|+||+++++.+.+......+++
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~~lv   79 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSL-QHPNIVRYYGSERDEEKNTLNIF   79 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHc-CCCCEeeEEEEEecCCCCeEEEE
Confidence            4778899999999999999999899999999987543     56788999999999 89999999999976433678899


Q ss_pred             EEeecCCChhhhcC---CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCCCc--
Q 015374          201 FEYVNSTDFKVLYP---TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE--  275 (408)
Q Consensus       201 ~e~~~~~~l~~~~~---~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~~~--  275 (408)
                      +||+++++|..++.   .+++..+..++.|++.||.|||+.+++|+||+|+||+++.+ +.++|+|||.+........  
T Consensus        80 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~-~~~~l~d~~~~~~~~~~~~~~  158 (260)
T cd06606          80 LEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSD-GVVKLADFGCAKRLGDIETGE  158 (260)
T ss_pred             EEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCC-CCEEEcccccEEecccccccc
Confidence            99999999988773   57899999999999999999999999999999999999987 7999999999987765543  


Q ss_pred             -ceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCCCccc
Q 015374          276 -YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSK  354 (408)
Q Consensus       276 -~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  354 (408)
                       .....++..|++||.+.+ ...+.++||||||+++|+|++|..||....+.......+...                  
T Consensus       159 ~~~~~~~~~~y~~pE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~------------------  219 (260)
T cd06606         159 GTGSVRGTPYWMAPEVIRG-EEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSS------------------  219 (260)
T ss_pred             cccCCCCCccccCHhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhcccc------------------
Confidence             445678889999999977 568999999999999999999999985444222222211100                  


Q ss_pred             cccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCc
Q 015374          355 FINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF  395 (408)
Q Consensus       355 ~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f  395 (408)
                      ......+..++.++.+|+.+||..||++|||+.|+++||||
T Consensus       220 ~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~~~~  260 (260)
T cd06606         220 GEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQHPFL  260 (260)
T ss_pred             CCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhCCCC
Confidence            01112233468999999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.3e-40  Score=320.37  Aligned_cols=275  Identities=31%  Similarity=0.546  Sum_probs=209.2

Q ss_pred             cCCCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc-----chHHHHHHHHHHHHhcCCCCceEEeeEEEccC--
Q 015374          121 WGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQH--  193 (408)
Q Consensus       121 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~--  193 (408)
                      +...++|++.+.||+|+||.||+|.+..+++.||+|.++..     ..+.+.+|+.+++++ +|+||+++++++....  
T Consensus        13 ~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~~iv~~~~~~~~~~~~   91 (345)
T cd07877          13 WEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM-KHENVIGLLDVFTPARSL   91 (345)
T ss_pred             hhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHc-CCCcccceeeeeeecccc
Confidence            34578999999999999999999999999999999998642     135677899999999 9999999999886432  


Q ss_pred             --CCccEEEEEeecCCChhhhc--CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEeccccee
Q 015374          194 --SKTPSLIFEYVNSTDFKVLY--PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEF  269 (408)
Q Consensus       194 --~~~~~lv~e~~~~~~l~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~  269 (408)
                        ....+++++++ ++++..++  ..+++..+..++.|++.||.|||+.||+|+||||+||+++.+ +.++|+|||++..
T Consensus        92 ~~~~~~~lv~~~~-~~~L~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~-~~~kl~dfg~~~~  169 (345)
T cd07877          92 EEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNED-CELKILDFGLARH  169 (345)
T ss_pred             cccccEEEEehhc-ccCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCC-CCEEEeccccccc
Confidence              23467888876 56776665  358999999999999999999999999999999999999988 7899999999876


Q ss_pred             ccCCCcceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhc-CCCC
Q 015374          270 YHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCN-SRHS  348 (408)
Q Consensus       270 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~-~~~~  348 (408)
                      ...  ......++..|+|||.+.+...++.++|||||||++|+|++|+.|| ...+....+..+....+...... ....
T Consensus       170 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf-~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (345)
T cd07877         170 TDD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF-PGTDHIDQLKLILRLVGTPGAELLKKIS  246 (345)
T ss_pred             ccc--cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHHHhCCCCHHHHhhcc
Confidence            532  2334567888999999876567889999999999999999999987 34444444444433322111000 0000


Q ss_pred             CCCc----------cccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccccccc
Q 015374          349 RKPW----------SKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAA  401 (408)
Q Consensus       349 ~~~~----------~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~~~~~  401 (408)
                      ....          ............++++.+||.+||+.||.+|||+.++++||||++....
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~~~~  309 (345)
T cd07877         247 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDP  309 (345)
T ss_pred             cHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhcCCC
Confidence            0000          0000001112357889999999999999999999999999999875543

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=1.8e-40  Score=308.40  Aligned_cols=251  Identities=27%  Similarity=0.500  Sum_probs=199.5

Q ss_pred             CEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc-------------chHHHHHHHHHHHHhcCCCCceEEeeEEEcc
Q 015374          126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-------------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQ  192 (408)
Q Consensus       126 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-------------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~  192 (408)
                      +|.+.+.||.|+||.||+|.+..+++.+|+|.++..             ..+.+.+|+.+++.+ +|+|++++++++.. 
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~-   79 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDL-DHLNIVQYLGFETT-   79 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhc-CCCCcceEEEEecc-
Confidence            577888999999999999999889999999987521             023577899999999 99999999999965 


Q ss_pred             CCCccEEEEEeecCCChhhhcC---CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEeccccee
Q 015374          193 HSKTPSLIFEYVNSTDFKVLYP---TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEF  269 (408)
Q Consensus       193 ~~~~~~lv~e~~~~~~l~~~~~---~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~  269 (408)
                       ....++||||+++++|..++.   .+++..+..++.|++.||.|||+++++|+||+|+||+++.+ +.++|+|||++..
T Consensus        80 -~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~-~~~~l~d~~~~~~  157 (272)
T cd06629          80 -EEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDAD-GICKISDFGISKK  157 (272)
T ss_pred             -CCceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCC-CeEEEeecccccc
Confidence             467889999999999988873   48888899999999999999999999999999999999987 7999999999875


Q ss_pred             ccCCC---cceeeccCccccccccccCCc-CCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcC
Q 015374          270 YHPGK---EYNVRVASRYFKGPELLVDLQ-DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNS  345 (408)
Q Consensus       270 ~~~~~---~~~~~~~~~~y~aPE~~~~~~-~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  345 (408)
                      .....   ......++..|+|||.+.... .++.++|+||||+++|++++|..||.. .+..+...++...         
T Consensus       158 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~-~~~~~~~~~~~~~---------  227 (272)
T cd06629         158 SDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSD-EEAIAAMFKLGNK---------  227 (272)
T ss_pred             ccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcC-cchHHHHHHhhcc---------
Confidence            43221   122345778899999987633 478999999999999999999999842 2222222111110         


Q ss_pred             CCCCCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCc
Q 015374          346 RHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF  395 (408)
Q Consensus       346 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f  395 (408)
                       .....    ........++.++.+++.+||..||++|||++++++||||
T Consensus       228 -~~~~~----~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~  272 (272)
T cd06629         228 -RSAPP----IPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQHPFI  272 (272)
T ss_pred             -ccCCc----CCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence             00001    1111223468999999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-41  Score=328.28  Aligned_cols=244  Identities=22%  Similarity=0.367  Sum_probs=199.4

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCc---E-EEEEEecc------cchHHHHHHHHHHHHhcCCCCceEEeeEEEccC
Q 015374          124 QDDYEVVRKVGRGKYSEVFEGINVNTNE---R-CIIKILKP------VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQH  193 (408)
Q Consensus       124 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~---~-vavK~~~~------~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~  193 (408)
                      .++..+.++||+|+||.||+|+....+.   . ||||..+.      ....+|.+|.++++++ +|||||+++|++..  
T Consensus       156 H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l-~H~NVVr~yGVa~~--  232 (474)
T KOG0194|consen  156 HSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQL-NHPNVVRFYGVAVL--  232 (474)
T ss_pred             ccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhC-CCCCEEEEEEEEcC--
Confidence            5666777899999999999998765422   3 89998873      2356799999999999 99999999999965  


Q ss_pred             CCccEEEEEeecCCChhhhcCC----CChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEeccccee
Q 015374          194 SKTPSLIFEYVNSTDFKVLYPT----LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEF  269 (408)
Q Consensus       194 ~~~~~lv~e~~~~~~l~~~~~~----l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~  269 (408)
                      ...+++|||+|+||+|.+++..    ++..+...++.+++.||+|||++++|||||.++|+|++.+ +.+||+|||+++.
T Consensus       233 ~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~-~~vKISDFGLs~~  311 (474)
T KOG0194|consen  233 EEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKK-GVVKISDFGLSRA  311 (474)
T ss_pred             CCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCC-CeEEeCccccccC
Confidence            4678899999999999999953    8899999999999999999999999999999999999987 6789999999876


Q ss_pred             ccCCCcce-eeccCccccccccccCCcCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHhhhchhhhhcCCC
Q 015374          270 YHPGKEYN-VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRH  347 (408)
Q Consensus       270 ~~~~~~~~-~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (408)
                      ...-.... ...-+..|+|||.+.. ..|+.++|||||||++||+++ |..|| .+....+....+....          
T Consensus       312 ~~~~~~~~~~~klPirWLAPEtl~~-~~~s~kTDV~sfGV~~~Eif~~g~~Py-~g~~~~~v~~kI~~~~----------  379 (474)
T KOG0194|consen  312 GSQYVMKKFLKKLPIRWLAPETLNT-GIFSFKTDVWSFGVLLWEIFENGAEPY-PGMKNYEVKAKIVKNG----------  379 (474)
T ss_pred             CcceeeccccccCcceecChhhhcc-CccccccchhheeeeEEeeeccCCCCC-CCCCHHHHHHHHHhcC----------
Confidence            53111111 2234567999999987 799999999999999999999 67775 6777776666664421          


Q ss_pred             CCCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 015374          348 SRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA  391 (408)
Q Consensus       348 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~  391 (408)
                              .+...+...+.++..++.+|+..||++|||+.++.+
T Consensus       380 --------~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~  415 (474)
T KOG0194|consen  380 --------YRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKK  415 (474)
T ss_pred             --------ccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHH
Confidence                    122222346788999999999999999999988753

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=5.4e-41  Score=320.90  Aligned_cols=274  Identities=34%  Similarity=0.615  Sum_probs=215.1

Q ss_pred             CEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc-----chHHHHHHHHHHHHhcCCCCceEEeeEEEccC---CCcc
Q 015374          126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQH---SKTP  197 (408)
Q Consensus       126 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~---~~~~  197 (408)
                      +|++.+.||.|+||.||+|++..++..+++|.+...     ..+.+.+|+.+++.+ +|+||+++++++....   ....
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~~~~   79 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHL-RHENIIGLLDILRPPSPEDFNDV   79 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhc-CCcchhhhhhhhcccCcccccce
Confidence            588999999999999999999889999999988642     245788999999999 8999999999986542   2367


Q ss_pred             EEEEEeecCCChhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCCC
Q 015374          198 SLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK  274 (408)
Q Consensus       198 ~lv~e~~~~~~l~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~~  274 (408)
                      +++|||+++ ++..++   ..+++..+..++.|++.||.|||+.||+|+||||+|||++.+ +.++|+|||++.......
T Consensus        80 ~lv~e~~~~-~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~-~~~~L~dfg~~~~~~~~~  157 (330)
T cd07834          80 YIVTELMET-DLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSN-CDLKICDFGLARGVDPDE  157 (330)
T ss_pred             EEEecchhh-hHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCC-CCEEEcccCceEeecccc
Confidence            899999995 565554   258899999999999999999999999999999999999998 899999999998765443


Q ss_pred             ----cceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCC-CCC
Q 015374          275 ----EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSR-HSR  349 (408)
Q Consensus       275 ----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~  349 (408)
                          ......++..|+|||.+.+...++.++|+||||+++|+|++|..|| .+.+..+.+..+....+........ ...
T Consensus       158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf-~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  236 (330)
T cd07834         158 DEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLF-PGRDYIDQLNLIVEVLGTPSEEDLKFITS  236 (330)
T ss_pred             cccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCc-CCCCHHHHHHHHHHhcCCCChhHhhhccc
Confidence                2334567888999999988448899999999999999999999887 5555556666655544432211110 000


Q ss_pred             CCccccc----------cccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccccccchh
Q 015374          350 KPWSKFI----------NADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAES  403 (408)
Q Consensus       350 ~~~~~~~----------~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~~~~~~~  403 (408)
                      .....+.          -......++.++.+++.+||++||++|||++++++||||++....+.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~~~  300 (330)
T cd07834         237 EKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDPED  300 (330)
T ss_pred             cchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhccccc
Confidence            0000000          00011236789999999999999999999999999999998877543

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=1.5e-40  Score=309.93  Aligned_cols=250  Identities=26%  Similarity=0.422  Sum_probs=205.0

Q ss_pred             CEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc----chHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccEEEE
Q 015374          126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIF  201 (408)
Q Consensus       126 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~  201 (408)
                      -|++.+.||.|+||.||+|.+..++..+|+|.+...    ....+.+|+.++.++ +|+||+++++++.+  +...++||
T Consensus         5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~--~~~~~lv~   81 (277)
T cd06641           5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQC-DSPYVTKYYGSYLK--DTKLWIIM   81 (277)
T ss_pred             hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhc-CCCCEeEEEEEEEe--CCeEEEEE
Confidence            467788999999999999999889999999997632    235688899999999 99999999999965  46788999


Q ss_pred             EeecCCChhhhcC--CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCCC-ccee
Q 015374          202 EYVNSTDFKVLYP--TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK-EYNV  278 (408)
Q Consensus       202 e~~~~~~l~~~~~--~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~~-~~~~  278 (408)
                      ||++++++..++.  .+++..+..++.|++.||.|||+.|++|+||+|+||+++.+ +.++|+|||++....... ....
T Consensus        82 e~~~~~~l~~~i~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~-~~~~l~dfg~~~~~~~~~~~~~~  160 (277)
T cd06641          82 EYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEH-GEVKLADFGVAGQLTDTQIKRNT  160 (277)
T ss_pred             EeCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCC-CCEEEeecccceecccchhhhcc
Confidence            9999999998874  47899999999999999999999999999999999999988 789999999987654332 1233


Q ss_pred             eccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCCCccccccc
Q 015374          279 RVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSKFINA  358 (408)
Q Consensus       279 ~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  358 (408)
                      ..++..|++||.+.+ ..++.++|+|||||++|+|++|..||.. .........+... +                  ..
T Consensus       161 ~~~~~~y~~PE~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p~~~-~~~~~~~~~~~~~-~------------------~~  219 (277)
T cd06641         161 FVGTPFWMAPEVIKQ-SAYDSKADIWSLGITAIELAKGEPPHSE-LHPMKVLFLIPKN-N------------------PP  219 (277)
T ss_pred             ccCCccccChhhhcc-CCCCchhhHHHHHHHHHHHHcCCCCCCc-cchHHHHHHHhcC-C------------------CC
Confidence            467888999999876 6788999999999999999999999842 2222222221110 0                  01


Q ss_pred             cCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccccc
Q 015374          359 DNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRA  400 (408)
Q Consensus       359 ~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~~~~  400 (408)
                      .....++.++.+++.+||+.||++||++.++++||||.+...
T Consensus       220 ~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~~~~~~  261 (277)
T cd06641         220 TLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFIVRFAK  261 (277)
T ss_pred             CCCcccCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhhhhh
Confidence            112336789999999999999999999999999999987654

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=5.9e-41  Score=321.47  Aligned_cols=248  Identities=21%  Similarity=0.353  Sum_probs=196.3

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcC-----CCcEEEEEEeccc----chHHHHHHHHHHHHhcCCCCceEEeeEEEccC
Q 015374          123 DQDDYEVVRKVGRGKYSEVFEGINVN-----TNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQH  193 (408)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~Vy~~~~~~-----~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~  193 (408)
                      ..++|++.+.||.|+||.||+|++..     +++.||+|+++..    ..+.+.+|+.++.++.+|+||++++++|... 
T Consensus         5 ~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~-   83 (337)
T cd05054           5 PRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKP-   83 (337)
T ss_pred             CHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecC-
Confidence            35789999999999999999997543     4578999998632    2345778999999997899999999988644 


Q ss_pred             CCccEEEEEeecCCChhhhcC-----------------------------------------------------------
Q 015374          194 SKTPSLIFEYVNSTDFKVLYP-----------------------------------------------------------  214 (408)
Q Consensus       194 ~~~~~lv~e~~~~~~l~~~~~-----------------------------------------------------------  214 (408)
                      +..++++|||+++++|..++.                                                           
T Consensus        84 ~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (337)
T cd05054          84 GGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGD  163 (337)
T ss_pred             CCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhh
Confidence            356789999999999987652                                                           


Q ss_pred             -----CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCCCc---ceeeccCcccc
Q 015374          215 -----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE---YNVRVASRYFK  286 (408)
Q Consensus       215 -----~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~~~---~~~~~~~~~y~  286 (408)
                           .+++..+..++.|++.||+|||++||+||||||+|||++.+ +.++|+|||++........   .....++..|+
T Consensus       164 ~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~-~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~  242 (337)
T cd05054         164 ELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSEN-NVVKICDFGLARDIYKDPDYVRKGDARLPLKWM  242 (337)
T ss_pred             HHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCC-CcEEEeccccchhcccCcchhhccCCCCCcccc
Confidence                 46788899999999999999999999999999999999987 7899999999986543222   12234456799


Q ss_pred             ccccccCCcCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCCCccccccccCCCCCC
Q 015374          287 GPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSKFINADNQHLVS  365 (408)
Q Consensus       287 aPE~~~~~~~~~~~~DvwSlGvil~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  365 (408)
                      |||++.+ ..++.++|||||||++|||++ |..||. +....+.+.......                  .....+...+
T Consensus       243 aPE~~~~-~~~~~~~Di~SlGv~l~el~t~g~~p~~-~~~~~~~~~~~~~~~------------------~~~~~~~~~~  302 (337)
T cd05054         243 APESIFD-KVYTTQSDVWSFGVLLWEIFSLGASPYP-GVQIDEEFCRRLKEG------------------TRMRAPEYAT  302 (337)
T ss_pred             CcHHhcC-CCCCccccHHHHHHHHHHHHHcCCCCCC-CCCccHHHHHHHhcc------------------CCCCCCccCC
Confidence            9999987 789999999999999999998 888874 332223332222110                  0011123467


Q ss_pred             HHHHHHHHHhcccCcCCCCCHHHHhcC
Q 015374          366 PEAIDFLDKLLRYDHQDRLTAREAMAH  392 (408)
Q Consensus       366 ~~~~~li~~~L~~dp~~Rpt~~elL~h  392 (408)
                      +++.+++.+||+.+|++|||++|+++|
T Consensus       303 ~~~~~l~~~cl~~~p~~RPs~~ell~~  329 (337)
T cd05054         303 PEIYSIMLDCWHNNPEDRPTFSELVEI  329 (337)
T ss_pred             HHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=1.1e-40  Score=319.52  Aligned_cols=271  Identities=27%  Similarity=0.451  Sum_probs=207.2

Q ss_pred             CCCCEEE-EeeeeeeCceEEEEEEEcCCCcEEEEEEecccch-----------------HHHHHHHHHHHHhcCCCCceE
Q 015374          123 DQDDYEV-VRKVGRGKYSEVFEGINVNTNERCIIKILKPVKK-----------------KKIKREIKILQNLCGGPNVVK  184 (408)
Q Consensus       123 ~~~~y~~-~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~-----------------~~~~~E~~~l~~l~~h~niv~  184 (408)
                      ..++|.. .+.||.|+||+||+|++..+++.||+|.++....                 ..+.+|+.+++++ +|+||++
T Consensus         6 ~~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~   84 (335)
T PTZ00024          6 ISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEI-KHENIMG   84 (335)
T ss_pred             cccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhC-CCcceee
Confidence            3566654 4679999999999999999999999999864321                 1467899999999 9999999


Q ss_pred             EeeEEEccCCCccEEEEEeecCCChhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEE
Q 015374          185 LLDIVRDQHSKTPSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRL  261 (408)
Q Consensus       185 l~~~~~~~~~~~~~lv~e~~~~~~l~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl  261 (408)
                      +++++..  ....++||||+.+ ++..++   ..+++..+..++.|++.||.|||+.||+|+||+|+||+++.+ +.++|
T Consensus        85 ~~~~~~~--~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~-~~~kl  160 (335)
T PTZ00024         85 LVDVYVE--GDFINLVMDIMAS-DLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSK-GICKI  160 (335)
T ss_pred             eeEEEec--CCcEEEEEecccc-CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCC-CCEEE
Confidence            9999954  4688999999985 666655   348899999999999999999999999999999999999988 79999


Q ss_pred             EecccceeccCC---------------CcceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCC
Q 015374          262 IDWGLAEFYHPG---------------KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDN  326 (408)
Q Consensus       262 ~DfG~a~~~~~~---------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~  326 (408)
                      +|||++......               .......++..|+|||.+.+...++.++|+|||||++|+|++|..|| .+.++
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~-~~~~~  239 (335)
T PTZ00024        161 ADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLF-PGENE  239 (335)
T ss_pred             CCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCC-CCCCH
Confidence            999998765411               11223356778999999977556789999999999999999998887 55555


Q ss_pred             HHHHHHHHhhhchhhhhcCCCC-----CCCccccc---cccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccc
Q 015374          327 HDQLVKIAKDCCLIIWCNSRHS-----RKPWSKFI---NADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQV  398 (408)
Q Consensus       327 ~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~---~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~~  398 (408)
                      .+.+..+....+..........     ...+....   ........+.++.+++.+||+.||++|||++|+|.||||+.-
T Consensus       240 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~~~~  319 (335)
T PTZ00024        240 IDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYFKSD  319 (335)
T ss_pred             HHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcccCCC
Confidence            6666666554432211100000     00000000   001123357889999999999999999999999999999865


Q ss_pred             c
Q 015374          399 R  399 (408)
Q Consensus       399 ~  399 (408)
                      .
T Consensus       320 ~  320 (335)
T PTZ00024        320 P  320 (335)
T ss_pred             C
Confidence            4

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=1.3e-40  Score=308.25  Aligned_cols=246  Identities=24%  Similarity=0.458  Sum_probs=201.1

Q ss_pred             CCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecc------cchHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccE
Q 015374          125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP------VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS  198 (408)
Q Consensus       125 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~------~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  198 (408)
                      ++|++.+.||+|+||.||+|++..+++.||+|.++.      .....+.+|+.+++.+ +||||+++++++.+.  ...+
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~--~~~~   78 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQL-NHPNVIKYLDSFIED--NELN   78 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhC-CCcceeeeeeeEEEC--CeEE
Confidence            579999999999999999999999999999998753      1234678899999999 999999999999654  5778


Q ss_pred             EEEEeecCCChhhhcC-------CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceecc
Q 015374          199 LIFEYVNSTDFKVLYP-------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH  271 (408)
Q Consensus       199 lv~e~~~~~~l~~~~~-------~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~  271 (408)
                      +++||+++++|..++.       .+++..+..++.|++.||.|||+++++|+||||+||+++.+ +.++|+|||++....
T Consensus        79 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~-~~~~l~d~g~~~~~~  157 (267)
T cd08228          79 IVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITAT-GVVKLGDLGLGRFFS  157 (267)
T ss_pred             EEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCC-CCEEECccccceecc
Confidence            9999999999987652       37888899999999999999999999999999999999988 789999999988765


Q ss_pred             CCCc-ceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCC
Q 015374          272 PGKE-YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRK  350 (408)
Q Consensus       272 ~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  350 (408)
                      .... .....++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||+....+...+.......+.           
T Consensus       158 ~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~-----------  225 (267)
T cd08228         158 SKTTAAHSLVGTPYYMSPERIHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDY-----------  225 (267)
T ss_pred             chhHHHhcCCCCccccChhhhcc-CCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCC-----------
Confidence            3322 223467888999999987 678999999999999999999999986554443333332221110           


Q ss_pred             CccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 015374          351 PWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH  392 (408)
Q Consensus       351 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~h  392 (408)
                            +......++..+.+++.+||+.||++|||+.++++.
T Consensus       226 ------~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~  261 (267)
T cd08228         226 ------PPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQI  261 (267)
T ss_pred             ------CCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHH
Confidence                  011122357889999999999999999999999863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=1.2e-40  Score=310.49  Aligned_cols=245  Identities=19%  Similarity=0.357  Sum_probs=194.3

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEc-----CCCcEEEEEEeccc----chHHHHHHHHHHHHhcCCCCceEEeeEEEccC
Q 015374          123 DQDDYEVVRKVGRGKYSEVFEGINV-----NTNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQH  193 (408)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~Vy~~~~~-----~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~  193 (408)
                      ..++|++.+.||+|+||.||+|.+.     .++..||+|+++..    ....+.+|+.+++.+ +|+||+++++++.+  
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l-~~~~iv~~~~~~~~--   80 (277)
T cd05062           4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEF-NCHHVVRLLGVVSQ--   80 (277)
T ss_pred             cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEcC--
Confidence            4678999999999999999999764     23567999988632    234678999999999 99999999999954  


Q ss_pred             CCccEEEEEeecCCChhhhcCC-------------CChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEE
Q 015374          194 SKTPSLIFEYVNSTDFKVLYPT-------------LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLR  260 (408)
Q Consensus       194 ~~~~~lv~e~~~~~~l~~~~~~-------------l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~k  260 (408)
                      +...++||||+++++|..++..             +++..+..++.|++.||.|||+.+++|+||||+||+++.+ +.++
T Consensus        81 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~-~~~~  159 (277)
T cd05062          81 GQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAED-FTVK  159 (277)
T ss_pred             CCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCC-CCEE
Confidence            4678999999999999887632             4567788899999999999999999999999999999988 7899


Q ss_pred             EEecccceeccCCCcc---eeeccCccccccccccCCcCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHhh
Q 015374          261 LIDWGLAEFYHPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKD  336 (408)
Q Consensus       261 l~DfG~a~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-g~~pf~~~~~~~~~~~~~~~~  336 (408)
                      |+|||+++........   ....++..|+|||.+.+ ..++.++|||||||++|||++ |..|| .+....+....+...
T Consensus       160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~~~~p~-~~~~~~~~~~~~~~~  237 (277)
T cd05062         160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKD-GVFTTYSDVWSFGVVLWEIATLAEQPY-QGMSNEQVLRFVMEG  237 (277)
T ss_pred             ECCCCCccccCCcceeecCCCCccCHhhcChhHhhc-CCcCchhHHHHHHHHHHHHHcCCCCCC-CCCCHHHHHHHHHcC
Confidence            9999998755432221   11244667999999987 778999999999999999999 56665 444443333322221


Q ss_pred             hchhhhhcCCCCCCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 015374          337 CCLIIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH  392 (408)
Q Consensus       337 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~h  392 (408)
                       +.                  ...+..+++.+.+++.+||+.||++|||+.|++++
T Consensus       238 -~~------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~  274 (277)
T cd05062         238 -GL------------------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS  274 (277)
T ss_pred             -Cc------------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence             00                  01123467899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3e-40  Score=305.71  Aligned_cols=248  Identities=25%  Similarity=0.428  Sum_probs=202.4

Q ss_pred             CCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecc--------cchHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCc
Q 015374          125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP--------VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT  196 (408)
Q Consensus       125 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~--------~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  196 (408)
                      .+|++.+.||+|+||.||+|.+..++..+++|.+..        .....+.+|+.+++++ +|+||+++++++.+.....
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l-~h~~i~~~~~~~~~~~~~~   80 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNL-RHDRIVQYYGCLRDPEEKK   80 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHc-CCCCcceEEEEEEcCCCCE
Confidence            578999999999999999999999999999998742        1234688899999999 9999999999997665567


Q ss_pred             cEEEEEeecCCChhhhcC---CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCC
Q 015374          197 PSLIFEYVNSTDFKVLYP---TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG  273 (408)
Q Consensus       197 ~~lv~e~~~~~~l~~~~~---~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~  273 (408)
                      .++++||+++++|..++.   .+++..+..++.|++.||.|||+.+++|+||||+||+++.+ +.++|+|||+++.....
T Consensus        81 ~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~-~~~~l~dfg~~~~~~~~  159 (264)
T cd06653          81 LSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSA-GNVKLGDFGASKRIQTI  159 (264)
T ss_pred             EEEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCC-CCEEECccccccccccc
Confidence            889999999999988763   47888899999999999999999999999999999999987 78999999999765321


Q ss_pred             ----CcceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCC
Q 015374          274 ----KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSR  349 (408)
Q Consensus       274 ----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  349 (408)
                          .......++..|+|||.+.+ ..++.++|+|||||++|+|++|+.||... ........+...          .  
T Consensus       160 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~-~~~~~~~~~~~~----------~--  225 (264)
T cd06653         160 CMSGTGIKSVTGTPYWMSPEVISG-EGYGRKADVWSVACTVVEMLTEKPPWAEY-EAMAAIFKIATQ----------P--  225 (264)
T ss_pred             cccCccccccCCcccccCHhhhcC-CCCCccccHHHHHHHHHHHHhCCCCCCcc-CHHHHHHHHHcC----------C--
Confidence                11223467888999999987 67899999999999999999999998432 222222221110          0  


Q ss_pred             CCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCc
Q 015374          350 KPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF  395 (408)
Q Consensus       350 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f  395 (408)
                            .....+..+++++.+++.+||+ +|.+|||+.++++|||.
T Consensus       226 ------~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~~~~  264 (264)
T cd06653         226 ------TKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRHPFV  264 (264)
T ss_pred             ------CCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcCCCC
Confidence                  0122344578999999999998 57999999999999984

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=9.5e-41  Score=315.52  Aligned_cols=246  Identities=17%  Similarity=0.305  Sum_probs=194.4

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcE--EEEEEeccc----chHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCc
Q 015374          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNER--CIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT  196 (408)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~--vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  196 (408)
                      ..++|++.+.||+|+||.||+|.+..++..  +++|.++..    ....+.+|+.++.++.+|+||+++++++.+  ...
T Consensus         5 ~~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~--~~~   82 (303)
T cd05088           5 EWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH--RGY   82 (303)
T ss_pred             chhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECC--CCC
Confidence            356899999999999999999998777754  577776532    235678899999999789999999999954  467


Q ss_pred             cEEEEEeecCCChhhhcC-------------------CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCC
Q 015374          197 PSLIFEYVNSTDFKVLYP-------------------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELR  257 (408)
Q Consensus       197 ~~lv~e~~~~~~l~~~~~-------------------~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~  257 (408)
                      .++||||+++++|..++.                   .+++..+..++.|++.||+|||++||+||||||+|||++.+ +
T Consensus        83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~-~  161 (303)
T cd05088          83 LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGEN-Y  161 (303)
T ss_pred             ceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCC-C
Confidence            899999999999988763                   36788899999999999999999999999999999999988 7


Q ss_pred             cEEEEecccceeccCCCcceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHhh
Q 015374          258 KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKD  336 (408)
Q Consensus       258 ~~kl~DfG~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-g~~pf~~~~~~~~~~~~~~~~  336 (408)
                      .+||+|||++..............+..|+|||.+.+ ..++.++|||||||++|||++ |..||. +.+..+....+...
T Consensus       162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~-~~~~~~~~~~~~~~  239 (303)
T cd05088         162 VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYC-GMTCAELYEKLPQG  239 (303)
T ss_pred             cEEeCccccCcccchhhhcccCCCcccccCHHHHhc-cCCcccccchhhhhHHHHHHhcCCCCcc-cCChHHHHHHHhcC
Confidence            899999999864322111222234567999999876 678999999999999999998 888874 33333332221110


Q ss_pred             hchhhhhcCCCCCCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 015374          337 CCLIIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH  392 (408)
Q Consensus       337 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~h  392 (408)
                                         .....+..+++++.+++.+||+.||++|||+++++++
T Consensus       240 -------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  276 (303)
T cd05088         240 -------------------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  276 (303)
T ss_pred             -------------------CcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                               0111223367899999999999999999999999976

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=1.4e-40  Score=325.05  Aligned_cols=246  Identities=22%  Similarity=0.343  Sum_probs=194.2

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCC-----CcEEEEEEecccc----hHHHHHHHHHHHHhcCCCCceEEeeEEEccC
Q 015374          123 DQDDYEVVRKVGRGKYSEVFEGINVNT-----NERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQH  193 (408)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~-----~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~  193 (408)
                      ..++|++.++||+|+||.||+|++...     +..||||+++...    .+.+.+|+.+++++..||||++++++|.+  
T Consensus        35 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~--  112 (400)
T cd05105          35 PRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTK--  112 (400)
T ss_pred             cccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEcc--
Confidence            467899999999999999999986433     3479999996432    35688999999999459999999999954  


Q ss_pred             CCccEEEEEeecCCChhhhcC-----------------------------------------------------------
Q 015374          194 SKTPSLIFEYVNSTDFKVLYP-----------------------------------------------------------  214 (408)
Q Consensus       194 ~~~~~lv~e~~~~~~l~~~~~-----------------------------------------------------------  214 (408)
                      ....++||||+++|+|..++.                                                           
T Consensus       113 ~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  192 (400)
T cd05105         113 SGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPML  192 (400)
T ss_pred             CCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhh
Confidence            467899999999999876641                                                           


Q ss_pred             ----------------------------------------CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeC
Q 015374          215 ----------------------------------------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDH  254 (408)
Q Consensus       215 ----------------------------------------~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~  254 (408)
                                                              .+++..+..++.|++.||.|||+.+|+|+||||+|||++.
T Consensus       193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill~~  272 (400)
T cd05105         193 EIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQ  272 (400)
T ss_pred             hhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEEeC
Confidence                                                    2566777889999999999999999999999999999998


Q ss_pred             CCCcEEEEecccceeccCCCcc---eeeccCccccccccccCCcCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHH
Q 015374          255 ELRKLRLIDWGLAEFYHPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQL  330 (408)
Q Consensus       255 ~~~~~kl~DfG~a~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-g~~pf~~~~~~~~~~  330 (408)
                      + +.+||+|||+++........   ....++..|+|||.+.+ ..++.++|||||||++|||++ |..||.....+....
T Consensus       273 ~-~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~  350 (400)
T cd05105         273 G-KIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFD-NLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFY  350 (400)
T ss_pred             C-CEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcC-CCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHHH
Confidence            8 78999999999865433221   22345678999999987 778999999999999999997 888874332222222


Q ss_pred             HHHHhhhchhhhhcCCCCCCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 015374          331 VKIAKDCCLIIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA  391 (408)
Q Consensus       331 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~  391 (408)
                      ..+...                   .....+..++.++.+++.+||+.||++|||+.++.+
T Consensus       351 ~~~~~~-------------------~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  392 (400)
T cd05105         351 NKIKSG-------------------YRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSD  392 (400)
T ss_pred             HHHhcC-------------------CCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHH
Confidence            221110                   011122347889999999999999999999998865

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=2.7e-40  Score=305.80  Aligned_cols=244  Identities=18%  Similarity=0.355  Sum_probs=199.0

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecccc--hHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccEEE
Q 015374          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK--KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI  200 (408)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  200 (408)
                      ...+|++.++||+|+||.||+|.+..++..+++|.++...  ...+.+|+.+++++ +|+||+++++++..  ....+++
T Consensus         4 ~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~~~lv   80 (263)
T cd05052           4 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI-KHPNLVQLLGVCTR--EPPFYII   80 (263)
T ss_pred             chHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCchHHHHHHHHHHHHHhC-CCCChhheEEEEcC--CCCcEEE
Confidence            3557899999999999999999999999999999987543  35788999999999 99999999999954  4677899


Q ss_pred             EEeecCCChhhhcC-----CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCCCc
Q 015374          201 FEYVNSTDFKVLYP-----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE  275 (408)
Q Consensus       201 ~e~~~~~~l~~~~~-----~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~~~  275 (408)
                      |||+++++|..++.     .+++..+..++.|++.||.|||+++++|+||||+||+++++ +.+||+|||++........
T Consensus        81 ~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~-~~~kl~df~~~~~~~~~~~  159 (263)
T cd05052          81 TEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGEN-HLVKVADFGLSRLMTGDTY  159 (263)
T ss_pred             EEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCC-CcEEeCCCcccccccccee
Confidence            99999999988763     37888899999999999999999999999999999999988 7999999999976643322


Q ss_pred             ce--eeccCccccccccccCCcCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCCCc
Q 015374          276 YN--VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPW  352 (408)
Q Consensus       276 ~~--~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  352 (408)
                      ..  ...++..|+|||.+.+ ..++.++|||||||++|||++ |..|| .+.+..+....+...                
T Consensus       160 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~t~g~~p~-~~~~~~~~~~~~~~~----------------  221 (263)
T cd05052         160 TAHAGAKFPIKWTAPESLAY-NKFSIKSDVWAFGVLLWEIATYGMSPY-PGIDLSQVYELLEKG----------------  221 (263)
T ss_pred             eccCCCCCccccCCHHHhcc-CCCCchhHHHHHHHHHHHHHcCCCCCC-CCCCHHHHHHHHHCC----------------
Confidence            11  1223457999999877 778999999999999999998 77776 444433333322111                


Q ss_pred             cccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 015374          353 SKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA  391 (408)
Q Consensus       353 ~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~  391 (408)
                         .....+..++.++.+++.+||+.||++|||+.++++
T Consensus       222 ---~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~  257 (263)
T cd05052         222 ---YRMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQ  257 (263)
T ss_pred             ---CCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence               111223457899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=6.6e-41  Score=315.69  Aligned_cols=251  Identities=24%  Similarity=0.440  Sum_probs=204.6

Q ss_pred             CEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecc---cchHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccEEEEE
Q 015374          126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP---VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFE  202 (408)
Q Consensus       126 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~---~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e  202 (408)
                      .|+...+||+|+||.||+|.+..++..||+|.++.   ...+.+.+|+.++..+ +|||++++++++..  +...+++||
T Consensus        22 ~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l-~hp~i~~~~~~~~~--~~~~~iv~e   98 (297)
T cd06659          22 LLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDY-QHQNVVEMYKSYLV--GEELWVLME   98 (297)
T ss_pred             hHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhC-CCCchhhhhhheee--CCeEEEEEe
Confidence            34445579999999999999999999999999853   2345688999999999 99999999999965  467889999


Q ss_pred             eecCCChhhhcC--CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCCC-cceee
Q 015374          203 YVNSTDFKVLYP--TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK-EYNVR  279 (408)
Q Consensus       203 ~~~~~~l~~~~~--~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~~-~~~~~  279 (408)
                      |++++++..++.  .+++..+..++.|++.||.|||+.|++|+||||+||+++.+ +.++|+|||++....... .....
T Consensus        99 ~~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~-~~~kL~dfg~~~~~~~~~~~~~~~  177 (297)
T cd06659          99 FLQGGALTDIVSQTRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLD-GRVKLSDFGFCAQISKDVPKRKSL  177 (297)
T ss_pred             cCCCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccC-CcEEEeechhHhhcccccccccce
Confidence            999999988763  58899999999999999999999999999999999999988 799999999987554322 22345


Q ss_pred             ccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCCCcccccccc
Q 015374          280 VASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSKFINAD  359 (408)
Q Consensus       280 ~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  359 (408)
                      .++..|+|||.+.+ ..++.++|||||||++|||++|..||+.. +..+.+..+...           ...      ...
T Consensus       178 ~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~~g~~p~~~~-~~~~~~~~~~~~-----------~~~------~~~  238 (297)
T cd06659         178 VGTPYWMAPEVISR-TPYGTEVDIWSLGIMVIEMVDGEPPYFSD-SPVQAMKRLRDS-----------PPP------KLK  238 (297)
T ss_pred             ecCccccCHHHHcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHhcc-----------CCC------Ccc
Confidence            68889999999977 67899999999999999999999998543 333333222110           000      011


Q ss_pred             CCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccccc
Q 015374          360 NQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVR  399 (408)
Q Consensus       360 ~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~~~  399 (408)
                      ....++.++.+++++||+.||++|||++++++||||....
T Consensus       239 ~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~~~~~~~~  278 (297)
T cd06659         239 NAHKISPVLRDFLERMLTREPQERATAQELLDHPFLLQTG  278 (297)
T ss_pred             ccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhChhhccCC
Confidence            1223678899999999999999999999999999998774

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=1.3e-40  Score=316.52  Aligned_cols=244  Identities=18%  Similarity=0.336  Sum_probs=195.5

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcE----EEEEEeccc----chHHHHHHHHHHHHhcCCCCceEEeeEEEccCC
Q 015374          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNER----CIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHS  194 (408)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~----vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~  194 (408)
                      ...+|++.+.||+|+||+||+|++..++..    ||+|+++..    ....+.+|+.+++.+ +||||++++++|..   
T Consensus         5 ~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~g~~~~---   80 (316)
T cd05108           5 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV-DNPHVCRLLGICLT---   80 (316)
T ss_pred             chhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEcC---
Confidence            456799999999999999999987766654    899998643    235688899999999 99999999999964   


Q ss_pred             CccEEEEEeecCCChhhhcC----CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceec
Q 015374          195 KTPSLIFEYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY  270 (408)
Q Consensus       195 ~~~~lv~e~~~~~~l~~~~~----~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~  270 (408)
                      ...++++||+++|++..++.    .+++..+..++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+++..
T Consensus        81 ~~~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~-~~~kl~DfG~a~~~  159 (316)
T cd05108          81 STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTP-QHVKITDFGLAKLL  159 (316)
T ss_pred             CCceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCC-CcEEEccccccccc
Confidence            34679999999999988763    37788889999999999999999999999999999999988 78999999999876


Q ss_pred             cCCCcce---eeccCccccccccccCCcCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHhhhchhhhhcCC
Q 015374          271 HPGKEYN---VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKDCCLIIWCNSR  346 (408)
Q Consensus       271 ~~~~~~~---~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  346 (408)
                      .......   ...++..|+|||.+.+ ..++.++|||||||++|||++ |..|| .+.. ...+..+.....        
T Consensus       160 ~~~~~~~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slGv~l~el~t~g~~p~-~~~~-~~~~~~~~~~~~--------  228 (316)
T cd05108         160 GADEKEYHAEGGKVPIKWMALESILH-RIYTHQSDVWSYGVTVWELMTFGSKPY-DGIP-ASEISSILEKGE--------  228 (316)
T ss_pred             cCCCcceeccCCccceeecChHHhcc-CCCCchhhhHHHHHHHHHHHcCCCCCC-CCCC-HHHHHHHHhCCC--------
Confidence            5433221   1223557999999987 789999999999999999998 88886 3333 223333322110        


Q ss_pred             CCCCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 015374          347 HSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH  392 (408)
Q Consensus       347 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~h  392 (408)
                                ....+..++.++.+++.+||..||++|||+.+++.+
T Consensus       229 ----------~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~  264 (316)
T cd05108         229 ----------RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIE  264 (316)
T ss_pred             ----------CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence                      011122367889999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=1.4e-40  Score=313.36  Aligned_cols=244  Identities=17%  Similarity=0.303  Sum_probs=193.7

Q ss_pred             CCEEEEeeeeeeCceEEEEEEEcCCCc--EEEEEEeccc----chHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccE
Q 015374          125 DDYEVVRKVGRGKYSEVFEGINVNTNE--RCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS  198 (408)
Q Consensus       125 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~--~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  198 (408)
                      ++|++.+.||+|+||.||+|++..++.  .+++|.++..    ..+.+.+|+.++.++.+||||+++++++..  ....+
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~--~~~~~   79 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACEN--RGYLY   79 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEcc--CCcce
Confidence            578999999999999999998877664  4688887632    235688899999999779999999999954  45688


Q ss_pred             EEEEeecCCChhhhcC-------------------CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcE
Q 015374          199 LIFEYVNSTDFKVLYP-------------------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKL  259 (408)
Q Consensus       199 lv~e~~~~~~l~~~~~-------------------~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~  259 (408)
                      ++|||+++++|..++.                   .+++..+..++.|++.||+|||++||+||||||+|||++.+ +.+
T Consensus        80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~-~~~  158 (297)
T cd05089          80 IAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGEN-LAS  158 (297)
T ss_pred             EEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCC-CeE
Confidence            9999999999987762                   36788899999999999999999999999999999999988 789


Q ss_pred             EEEecccceeccCCCcceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHhhhc
Q 015374          260 RLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKDCC  338 (408)
Q Consensus       260 kl~DfG~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-g~~pf~~~~~~~~~~~~~~~~~~  338 (408)
                      ||+|||++..............+..|+|||.+.+ ..++.++|||||||++|||++ |..||. +....+....+...  
T Consensus       159 kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlG~il~el~t~g~~pf~-~~~~~~~~~~~~~~--  234 (297)
T cd05089         159 KIADFGLSRGEEVYVKKTMGRLPVRWMAIESLNY-SVYTTKSDVWSFGVLLWEIVSLGGTPYC-GMTCAELYEKLPQG--  234 (297)
T ss_pred             EECCcCCCccccceeccCCCCcCccccCchhhcc-CCCCchhhHHHHHHHHHHHHcCCCCCCC-CCCHHHHHHHHhcC--
Confidence            9999999864322111122233456999999876 678999999999999999997 888873 33333333322211  


Q ss_pred             hhhhhcCCCCCCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 015374          339 LIIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH  392 (408)
Q Consensus       339 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~h  392 (408)
                                       .....+..++.++.+|+.+||+.||.+|||++++++.
T Consensus       235 -----------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~  271 (297)
T cd05089         235 -----------------YRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQ  271 (297)
T ss_pred             -----------------CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                             0112233478999999999999999999999999765

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.6e-40  Score=319.41  Aligned_cols=274  Identities=32%  Similarity=0.577  Sum_probs=210.3

Q ss_pred             CCCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc-----chHHHHHHHHHHHHhcCCCCceEEeeEEEccCC--
Q 015374          122 GDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHS--  194 (408)
Q Consensus       122 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~--  194 (408)
                      ...++|++.+.||+|+||.||+|.+..++..||+|.++..     ....+.+|+.+++++ +|+||+++++++.....  
T Consensus        12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~   90 (343)
T cd07880          12 EVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHM-KHENVIGLLDVFTPDLSLD   90 (343)
T ss_pred             ccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhc-CCCCccceeeeecCCcccc
Confidence            3578899999999999999999999999999999998532     134577899999999 99999999999865322  


Q ss_pred             --CccEEEEEeecCCChhhhc--CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceec
Q 015374          195 --KTPSLIFEYVNSTDFKVLY--PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY  270 (408)
Q Consensus       195 --~~~~lv~e~~~~~~l~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~  270 (408)
                        ...++||||+ ++++..++  ..+++..++.++.|++.||.|||+.||+||||||+||+++.+ +.++|+|||++...
T Consensus        91 ~~~~~~lv~e~~-~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~-~~~kl~dfg~~~~~  168 (343)
T cd07880          91 RFHDFYLVMPFM-GTDLGKLMKHEKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNED-CELKILDFGLARQT  168 (343)
T ss_pred             ccceEEEEEecC-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCC-CCEEEeeccccccc
Confidence              2458999999 56777665  468999999999999999999999999999999999999987 78999999999765


Q ss_pred             cCCCcceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhh---cCC-
Q 015374          271 HPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWC---NSR-  346 (408)
Q Consensus       271 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~---~~~-  346 (408)
                      ..  ......++..|++||.+.+...++.++|+|||||++|+|++|..||. +.+.......+....+.....   ... 
T Consensus       169 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (343)
T cd07880         169 DS--EMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFK-GHDHLDQLMEIMKVTGTPSKEFVQKLQS  245 (343)
T ss_pred             cc--CccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCC-CCCHHHHHHHHHHhcCCCCHHHHHhhcc
Confidence            43  22334678889999998764568899999999999999999999974 444444444443322211100   000 


Q ss_pred             CCCCCc----ccc---ccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccccccc
Q 015374          347 HSRKPW----SKF---INADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAA  401 (408)
Q Consensus       347 ~~~~~~----~~~---~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~~~~~  401 (408)
                      .....+    ...   .-......++.++.+++.+||+.||++|||+.+++.||||+.....
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~~~  307 (343)
T cd07880         246 EDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHDP  307 (343)
T ss_pred             hhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhcCc
Confidence            000000    000   0011123467889999999999999999999999999999877554

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=1e-40  Score=311.38  Aligned_cols=263  Identities=37%  Similarity=0.639  Sum_probs=206.2

Q ss_pred             EEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecccc-----hHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccEEEE
Q 015374          127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK-----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIF  201 (408)
Q Consensus       127 y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~  201 (408)
                      |++.+.||.|++|.||+|.+..+++.+++|.++...     ...+.+|+.+++++ +|+||+++++++.+  +...++|+
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~--~~~~~~v~   77 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKEL-NHPNIIKLLDVFRH--KGDLYLVF   77 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHh-cCCCcchHHHhhcc--CCCEEEEE
Confidence            566789999999999999998899999999986432     35688899999999 89999999999965  46788999


Q ss_pred             EeecCCChhhhc----CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCCC-cc
Q 015374          202 EYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK-EY  276 (408)
Q Consensus       202 e~~~~~~l~~~~----~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~~-~~  276 (408)
                      ||+++ ++...+    ..+++..+..++.|++.||.|||+.+|+|+||||+||+++.+ +.++|+|||.+....... ..
T Consensus        78 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~-~~~~l~df~~~~~~~~~~~~~  155 (283)
T cd05118          78 EFMDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTE-GVLKLADFGLARSFGSPVRPY  155 (283)
T ss_pred             eccCC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCC-CcEEEeeeeeeEecCCCcccc
Confidence            99987 444443    258899999999999999999999999999999999999987 789999999997765443 23


Q ss_pred             eeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCC------
Q 015374          277 NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRK------  350 (408)
Q Consensus       277 ~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------  350 (408)
                      ....++..|+|||.+.+...++.++|+||||+++|+|++|+.|| .+.+..+.+..+....+............      
T Consensus       156 ~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (283)
T cd05118         156 THYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLF-PGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYK  234 (283)
T ss_pred             cCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhh
Confidence            33567788999999987447899999999999999999999887 55555666666555443221111000000      


Q ss_pred             -Cc---cccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCc
Q 015374          351 -PW---SKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF  395 (408)
Q Consensus       351 -~~---~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f  395 (408)
                       ..   ...........++.++.+|+.+||+.||.+||++++++.||||
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~  283 (283)
T cd05118         235 FSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF  283 (283)
T ss_pred             hhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence             00   0000011223468899999999999999999999999999997

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=5.3e-41  Score=320.79  Aligned_cols=266  Identities=17%  Similarity=0.251  Sum_probs=197.0

Q ss_pred             eeeee--CceEEEEEEEcCCCcEEEEEEecccc-----hHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccEEEEEee
Q 015374          132 KVGRG--KYSEVFEGINVNTNERCIIKILKPVK-----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYV  204 (408)
Q Consensus       132 ~lG~G--~fg~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~  204 (408)
                      .||+|  +||+||++.+..+++.||+|+++...     .+.+.+|+.+++.+ +||||++++++|..  +...++||||+
T Consensus         5 ~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l-~h~niv~~~~~~~~--~~~~~~v~e~~   81 (328)
T cd08226           5 EIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFF-RHPNIMTSWTVFTT--GSWLWVISPFM   81 (328)
T ss_pred             HhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhC-CCCCcceEeeeEec--CCceEEEEecc
Confidence            56666  99999999999999999999986322     35678899999998 99999999999965  46789999999


Q ss_pred             cCCChhhhcC-----CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCCCc----
Q 015374          205 NSTDFKVLYP-----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE----  275 (408)
Q Consensus       205 ~~~~l~~~~~-----~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~~~----  275 (408)
                      .++++..++.     .+++..+..++.|++.||+|||++||+||||||+|||++.+ +.++++||+.+........    
T Consensus        82 ~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~-~~~~~~~~~~~~~~~~~~~~~~~  160 (328)
T cd08226          82 AYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGD-GLVSLSGLSHLYSLVRNGQKAKV  160 (328)
T ss_pred             cCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCC-CcEEEechHHHhhhhccCccccc
Confidence            9999988763     37888889999999999999999999999999999999988 7899999986533221111    


Q ss_pred             ----ceeeccCccccccccccCC-cCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCC--
Q 015374          276 ----YNVRVASRYFKGPELLVDL-QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHS--  348 (408)
Q Consensus       276 ----~~~~~~~~~y~aPE~~~~~-~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~--  348 (408)
                          .....++..|++||++.+. ..++.++|||||||++|+|++|..||... ...+.............+......  
T Consensus       161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (328)
T cd08226         161 VYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDM-LRTQMLLQKLKGPPYSPLDITTFPCE  239 (328)
T ss_pred             cccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCc-ChHHHHHHHhcCCCCCCccccccchh
Confidence                0112345569999998763 35789999999999999999999998433 333333222221111000000000  


Q ss_pred             --------------------C-----CCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccccccch
Q 015374          349 --------------------R-----KPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAE  402 (408)
Q Consensus       349 --------------------~-----~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~~~~~~  402 (408)
                                          .     ..............+++++.+|+++||++||++|||++|+|+||||+++....
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~~~~~  318 (328)
T cd08226         240 ESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQVKEQT  318 (328)
T ss_pred             hhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHHHHhc
Confidence                                0     00000011112234578899999999999999999999999999999887654

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=3.5e-40  Score=308.93  Aligned_cols=253  Identities=23%  Similarity=0.438  Sum_probs=205.2

Q ss_pred             CEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc---chHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccEEEEE
Q 015374          126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV---KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFE  202 (408)
Q Consensus       126 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e  202 (408)
                      +|...+.||.|++|.||++.+..++..+++|.++..   ..+.+.+|+.+++.+ +|+||+++++++..  ....++++|
T Consensus        20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~-~h~~vv~~~~~~~~--~~~~~~v~e   96 (285)
T cd06648          20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDY-QHPNIVEMYSSYLV--GDELWVVME   96 (285)
T ss_pred             hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHc-CCCChheEEEEEEc--CCeEEEEEe
Confidence            455567999999999999999999999999988532   345678999999999 99999999999865  467899999


Q ss_pred             eecCCChhhhcC--CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCCC-cceee
Q 015374          203 YVNSTDFKVLYP--TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK-EYNVR  279 (408)
Q Consensus       203 ~~~~~~l~~~~~--~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~~-~~~~~  279 (408)
                      |+++++|..++.  .+++..+..++.|++.||.|||++||+||||+|+||+++.+ +.++|+|||.+....... .....
T Consensus        97 ~~~~~~L~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~-~~~~l~d~g~~~~~~~~~~~~~~~  175 (285)
T cd06648          97 FLEGGALTDIVTHTRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSD-GRVKLSDFGFCAQVSKEVPRRKSL  175 (285)
T ss_pred             ccCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCC-CcEEEcccccchhhccCCcccccc
Confidence            999999988773  57888999999999999999999999999999999999988 799999999886544322 12334


Q ss_pred             ccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCCCcccccccc
Q 015374          280 VASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSKFINAD  359 (408)
Q Consensus       280 ~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  359 (408)
                      .++..|+|||.+.+ ..++.++|+|||||++|+|++|..||+.. +.......+... .        .        ....
T Consensus       176 ~~~~~y~aPE~~~~-~~~~~~~Dv~slGv~l~ell~g~~p~~~~-~~~~~~~~~~~~-~--------~--------~~~~  236 (285)
T cd06648         176 VGTPYWMAPEVISR-LPYGTEVDIWSLGIMVIEMVDGEPPYFNE-PPLQAMKRIRDN-L--------P--------PKLK  236 (285)
T ss_pred             cCCccccCHHHhcC-CCCCCcccHHHHHHHHHHHHhCCCCCcCC-CHHHHHHHHHhc-C--------C--------CCCc
Confidence            68889999999877 67899999999999999999999998542 222232222211 0        0        0011


Q ss_pred             CCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccccccc
Q 015374          360 NQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAA  401 (408)
Q Consensus       360 ~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~~~~~  401 (408)
                      ....++..+.+|+++||+.||++|||+.++++||||+..+..
T Consensus       237 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~~  278 (285)
T cd06648         237 NLHKVSPRLRSFLDRMLVRDPAQRATAAELLNHPFLAKAGPP  278 (285)
T ss_pred             ccccCCHHHHHHHHHHcccChhhCcCHHHHccCcccccCCCc
Confidence            122367899999999999999999999999999999887653

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=2.4e-40  Score=304.54  Aligned_cols=242  Identities=20%  Similarity=0.399  Sum_probs=198.7

Q ss_pred             CEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc----chHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccEEEE
Q 015374          126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIF  201 (408)
Q Consensus       126 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~  201 (408)
                      +|++.++||+|+||.||++.+..++..+|+|.++..    ..+.+.+|+.+++.+ +|+||+++++.+.+  ....+++|
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~~~lv~   77 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKM-KHPNIVAFKESFEA--DGHLYIVM   77 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhC-CCCCcceEEEEEEE--CCEEEEEE
Confidence            588999999999999999999999999999988532    235678899999999 99999999999965  46889999


Q ss_pred             EeecCCChhhhcC-----CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCCCc-
Q 015374          202 EYVNSTDFKVLYP-----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE-  275 (408)
Q Consensus       202 e~~~~~~l~~~~~-----~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~~~-  275 (408)
                      ||++++++..++.     .+++..+..++.|++.||.|||++||+|+||||+||+++.+ +.++++|||++........ 
T Consensus        78 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~-~~~~l~dfg~~~~~~~~~~~  156 (255)
T cd08219          78 EYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQN-GKVKLGDFGSARLLTSPGAY  156 (255)
T ss_pred             eeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCC-CcEEEcccCcceeecccccc
Confidence            9999999877652     37888899999999999999999999999999999999988 7999999999976643322 


Q ss_pred             ceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCCCcccc
Q 015374          276 YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSKF  355 (408)
Q Consensus       276 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  355 (408)
                      .....++..|+|||++.+ ..++.++|+||||+++|+|++|..||.. .+.......+...         .         
T Consensus       157 ~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~i~~~l~~g~~p~~~-~~~~~~~~~~~~~---------~---------  216 (255)
T cd08219         157 ACTYVGTPYYVPPEIWEN-MPYNNKSDIWSLGCILYELCTLKHPFQA-NSWKNLILKVCQG---------S---------  216 (255)
T ss_pred             cccccCCccccCHHHHcc-CCcCchhhhhhhchhheehhhccCCCCC-CCHHHHHHHHhcC---------C---------
Confidence            233568888999999877 6789999999999999999999999843 2222222222111         0         


Q ss_pred             ccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 015374          356 INADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH  392 (408)
Q Consensus       356 ~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~h  392 (408)
                       ....+..++..+.+++.+||+.||++|||+.|+++-
T Consensus       217 -~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         217 -YKPLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             -CCCCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence             001123367889999999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=2.3e-40  Score=313.46  Aligned_cols=252  Identities=27%  Similarity=0.433  Sum_probs=201.4

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc------chHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCc
Q 015374          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT  196 (408)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  196 (408)
                      ...+|+..+.||+|+||+||+|.+..+++.||+|.+...      ....+.+|+.+++.+ +|||++++.++|.+  ...
T Consensus        13 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~~~~~~~~--~~~   89 (307)
T cd06607          13 PEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQL-RHPNTIEYKGCYLR--EHT   89 (307)
T ss_pred             cchhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhC-CCCCEEEEEEEEEe--CCe
Confidence            456789999999999999999999999999999988522      224688999999999 99999999999965  456


Q ss_pred             cEEEEEeecCCChhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCC
Q 015374          197 PSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG  273 (408)
Q Consensus       197 ~~lv~e~~~~~~l~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~  273 (408)
                      .++||||+.++.+....   ..+++..+..++.|++.||.|||+.+|+|+||+|+||+++.+ +.++|+|||++......
T Consensus        90 ~~lv~e~~~g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~-~~~kL~dfg~~~~~~~~  168 (307)
T cd06607          90 AWLVMEYCLGSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEP-GTVKLADFGSASLVSPA  168 (307)
T ss_pred             EEEEHHhhCCCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCC-CCEEEeecCcceecCCC
Confidence            78999999865443332   458999999999999999999999999999999999999988 79999999998765432


Q ss_pred             CcceeeccCccccccccccC--CcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCCC
Q 015374          274 KEYNVRVASRYFKGPELLVD--LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKP  351 (408)
Q Consensus       274 ~~~~~~~~~~~y~aPE~~~~--~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  351 (408)
                         ....++..|+|||++.+  ...++.++||||||+++|||++|..||... +.......+...         ..    
T Consensus       169 ---~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~-~~~~~~~~~~~~---------~~----  231 (307)
T cd06607         169 ---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM-NAMSALYHIAQN---------DS----  231 (307)
T ss_pred             ---CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCc-cHHHHHHHHhcC---------CC----
Confidence               23467888999999852  256889999999999999999999998433 222222221110         00    


Q ss_pred             ccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccccc
Q 015374          352 WSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRA  400 (408)
Q Consensus       352 ~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~~~~  400 (408)
                           .......++.++.+++.+||..||++|||+.+++.||||.....
T Consensus       232 -----~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~  275 (307)
T cd06607         232 -----PTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRFVLRERP  275 (307)
T ss_pred             -----CCCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcChhhcccCC
Confidence                 00011225788999999999999999999999999999987654

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=3.8e-40  Score=303.51  Aligned_cols=242  Identities=16%  Similarity=0.290  Sum_probs=195.4

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc--chHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccEEEE
Q 015374          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV--KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIF  201 (408)
Q Consensus       124 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~  201 (408)
                      .++|++.+.||+|+||.||++... ++..+|+|.++..  ....+.+|+.+++++ +||||++++++|..  ....++||
T Consensus         3 ~~~~~~~~~lg~G~~~~vy~~~~~-~~~~~a~K~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~~~iv~   78 (256)
T cd05114           3 PSELTFMKELGSGQFGVVHLGKWR-AQIKVAIKAINEGAMSEEDFIEEAKVMMKL-SHPKLVQLYGVCTQ--QKPLYIVT   78 (256)
T ss_pred             HHHcEEeeEecCCcCceEEEEEec-cCceEEEEecccCCccHHHHHHHHHHHHHC-CCCCceeEEEEEcc--CCCEEEEE
Confidence            467899999999999999999764 4567999987643  346788999999999 99999999999954  46789999


Q ss_pred             EeecCCChhhhcC----CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCCCcce
Q 015374          202 EYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN  277 (408)
Q Consensus       202 e~~~~~~l~~~~~----~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~~~~~  277 (408)
                      ||+++++|..++.    .+++..+..++.|++.||+|||++||+|+||||+||+++.+ +.++|+|||.++.........
T Consensus        79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~-~~~kl~d~g~~~~~~~~~~~~  157 (256)
T cd05114          79 EFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSST-GVVKVSDFGMTRYVLDDEYTS  157 (256)
T ss_pred             EcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCC-CeEEECCCCCccccCCCceec
Confidence            9999999988763    37888899999999999999999999999999999999988 789999999987654322211


Q ss_pred             --eeccCccccccccccCCcCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCCCccc
Q 015374          278 --VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSK  354 (408)
Q Consensus       278 --~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  354 (408)
                        ...++..|+|||.+.+ ..++.++|+||||+++|+|++ |+.|| ...+..+.+..+....                 
T Consensus       158 ~~~~~~~~~y~aPE~~~~-~~~~~~~Di~s~G~~l~el~~~g~~p~-~~~~~~~~~~~i~~~~-----------------  218 (256)
T cd05114         158 SSGAKFPVKWSPPEVFNF-SKYSSKSDVWSFGVLMWEVFTEGKMPF-EKKSNYEVVEMISRGF-----------------  218 (256)
T ss_pred             cCCCCCchhhCChhhccc-CccchhhhhHHHHHHHHHHHcCCCCCC-CCCCHHHHHHHHHCCC-----------------
Confidence              2234557999999876 678999999999999999999 77776 4444444444433210                 


Q ss_pred             cccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 015374          355 FINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA  391 (408)
Q Consensus       355 ~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~  391 (408)
                        ....+...+.++.+++.+||+.||++|||++|+++
T Consensus       219 --~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~  253 (256)
T cd05114         219 --RLYRPKLASMTVYEVMYSCWHEKPEGRPTFAELLR  253 (256)
T ss_pred             --CCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence              01112235788999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=2e-40  Score=312.25  Aligned_cols=259  Identities=23%  Similarity=0.384  Sum_probs=204.7

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc----chHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccE
Q 015374          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS  198 (408)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  198 (408)
                      ..++|++.+.||+|+||+||+|.+..+++.+|||.++..    ....+..|+.++.+..+|+||++++++|.+  ....+
T Consensus        13 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~--~~~~~   90 (296)
T cd06618          13 DLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFIT--DSDVF   90 (296)
T ss_pred             CcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeec--CCeEE
Confidence            457899999999999999999999888999999998643    234566788777777569999999999965  46788


Q ss_pred             EEEEeecCCChhhhc----CCCChHHHHHHHHHHHHHHHHHHH-CCcEEecCCCCcEEEeCCCCcEEEEecccceeccCC
Q 015374          199 LIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHS-QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG  273 (408)
Q Consensus       199 lv~e~~~~~~l~~~~----~~l~~~~~~~i~~qi~~~L~~LH~-~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~  273 (408)
                      ++|||+++ ++..+.    ..+++..+..++.|++.||.|||+ .+|+||||+|+||+++.+ +.++|+|||++......
T Consensus        91 ~v~e~~~~-~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~-~~~kL~dfg~~~~~~~~  168 (296)
T cd06618          91 ICMELMST-CLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDAS-GNVKLCDFGISGRLVDS  168 (296)
T ss_pred             EEeeccCc-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCC-CCEEECccccchhccCC
Confidence            99999875 444433    348888899999999999999997 599999999999999987 79999999998766544


Q ss_pred             CcceeeccCccccccccccCC---cCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCC
Q 015374          274 KEYNVRVASRYFKGPELLVDL---QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRK  350 (408)
Q Consensus       274 ~~~~~~~~~~~y~aPE~~~~~---~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  350 (408)
                      .......++..|+|||.+.+.   +.++.++|+||||+++|+|++|+.||.....+.+.+........         .  
T Consensus       169 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~---------~--  237 (296)
T cd06618         169 KAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEP---------P--  237 (296)
T ss_pred             CcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCC---------C--
Confidence            334445677889999998752   34788999999999999999999998543333333333322110         0  


Q ss_pred             CccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccccccch
Q 015374          351 PWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAE  402 (408)
Q Consensus       351 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~~~~~~  402 (408)
                      .      ......++.++.+|+.+||..||++|||++++++||||+......
T Consensus       238 ~------~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~~  283 (296)
T cd06618         238 S------LPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRYETAE  283 (296)
T ss_pred             C------CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhccchhH
Confidence            0      001113678999999999999999999999999999998765544

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.5e-42  Score=347.34  Aligned_cols=259  Identities=27%  Similarity=0.445  Sum_probs=217.6

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecc------cchHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCc
Q 015374          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP------VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT  196 (408)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~------~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  196 (408)
                      ..++|++++.||+|+||.|..++.+.+++.+|+|++++      ....-|..|-.+|..- +.+.|+++.-.|.  +.++
T Consensus        73 ~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~-ns~Wiv~LhyAFQ--D~~~  149 (1317)
T KOG0612|consen   73 KAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFG-NSEWIVQLHYAFQ--DERY  149 (1317)
T ss_pred             CHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcC-CcHHHHHHHHHhc--Cccc
Confidence            47889999999999999999999999999999999864      2345688899999986 8999999999994  4689


Q ss_pred             cEEEEEeecCCChhhhcCC---CChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCC
Q 015374          197 PSLIFEYVNSTDFKVLYPT---LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG  273 (408)
Q Consensus       197 ~~lv~e~~~~~~l~~~~~~---l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~  273 (408)
                      +|+|||||+||+|-.++..   +++..++.|+.++..||+-||+.|+|||||||+|||+|.. |++||+|||.+-.+..+
T Consensus       150 LYlVMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~-GHikLADFGsClkm~~d  228 (1317)
T KOG0612|consen  150 LYLVMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKS-GHIKLADFGSCLKMDAD  228 (1317)
T ss_pred             eEEEEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEeccc-CcEeeccchhHHhcCCC
Confidence            9999999999999888854   7789999999999999999999999999999999999998 99999999998777644


Q ss_pred             Cc--ceeeccCccccccccccC----CcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCC
Q 015374          274 KE--YNVRVASRYFKGPELLVD----LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRH  347 (408)
Q Consensus       274 ~~--~~~~~~~~~y~aPE~~~~----~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (408)
                      +.  ....+|||.|.+||++..    .+.|+..+|.||+||++|||+.|..|||. +.-.+.+.+|+......       
T Consensus       229 G~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYa-dslveTY~KIm~hk~~l-------  300 (1317)
T KOG0612|consen  229 GTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYA-DSLVETYGKIMNHKESL-------  300 (1317)
T ss_pred             CcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchH-HHHHHHHHHHhchhhhc-------
Confidence            43  355789999999999953    25689999999999999999999999953 33344445554431110       


Q ss_pred             CCCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCC---HHHHhcCCCccccccchh
Q 015374          348 SRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLT---AREAMAHPYFAQVRAAES  403 (408)
Q Consensus       348 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt---~~elL~hp~f~~~~~~~~  403 (408)
                         .    ++  ....+|+++++||++++ .+|+.|..   ++++-.||||.++++...
T Consensus       301 ---~----FP--~~~~VSeeakdLI~~ll-~~~e~RLgrngiedik~HpFF~g~~W~~i  349 (1317)
T KOG0612|consen  301 ---S----FP--DETDVSEEAKDLIEALL-CDREVRLGRNGIEDIKNHPFFEGIDWDNI  349 (1317)
T ss_pred             ---C----CC--cccccCHHHHHHHHHHh-cChhhhcccccHHHHHhCccccCCChhhh
Confidence               0    11  11238999999999999 69999998   999999999999998554

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=8.9e-40  Score=305.73  Aligned_cols=265  Identities=31%  Similarity=0.575  Sum_probs=204.0

Q ss_pred             EEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc-----chHHHHHHHHHHHHhc--CCCCceEEeeEEEccCC---Cc
Q 015374          127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLC--GGPNVVKLLDIVRDQHS---KT  196 (408)
Q Consensus       127 y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~--~h~niv~l~~~~~~~~~---~~  196 (408)
                      |++.+.||+|+||.||+|++..++..+|+|.++..     ....+.+|+.+++++.  +|+|++++++++.+...   ..
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~   80 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK   80 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence            67889999999999999999888999999998632     1235667888887763  59999999999975432   24


Q ss_pred             cEEEEEeecCCChhhhc-----CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceecc
Q 015374          197 PSLIFEYVNSTDFKVLY-----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH  271 (408)
Q Consensus       197 ~~lv~e~~~~~~l~~~~-----~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~  271 (408)
                      .+++|||+++ ++..++     ..+++..+..++.|++.||.|||+.+++|+||+|+||+++.+ +.++|+|||++....
T Consensus        81 ~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~-~~~~l~dfg~~~~~~  158 (287)
T cd07838          81 LTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSD-GQVKIADFGLARIYS  158 (287)
T ss_pred             eEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccC-CCEEEeccCcceecc
Confidence            8899999986 565544     248899999999999999999999999999999999999998 899999999998775


Q ss_pred             CCCcceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCC-CC--
Q 015374          272 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSR-HS--  348 (408)
Q Consensus       272 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~-~~--  348 (408)
                      .........++..|+|||.+.+ ..++.++|+|||||++|+|++|..|| .+....+.+..+....+........ ..  
T Consensus       159 ~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Di~s~G~~l~~l~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (287)
T cd07838         159 FEMALTSVVVTLWYRAPEVLLQ-SSYATPVDMWSVGCIFAELFRRRPLF-RGTSEADQLDKIFDVIGLPSEEEWPRNVSL  236 (287)
T ss_pred             CCcccccccccccccChHHhcc-CCCCCcchhhhHHHHHHHHHhCCCcc-cCCChHHHHHHHHHHcCCCChHhcCCCccc
Confidence            5444444567888999999987 67899999999999999999997776 5555666666665543321100000 00  


Q ss_pred             -CCCcccccc---ccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCc
Q 015374          349 -RKPWSKFIN---ADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF  395 (408)
Q Consensus       349 -~~~~~~~~~---~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f  395 (408)
                       ...+.....   ......+++++.+++.+||+.||++||+++|+++||||
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~  287 (287)
T cd07838         237 PRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF  287 (287)
T ss_pred             chhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence             000000000   11112356789999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=4.6e-40  Score=307.00  Aligned_cols=247  Identities=25%  Similarity=0.417  Sum_probs=195.9

Q ss_pred             eeeeeCceEEEEEEEcCCCcEEEEEEecccc------hHHHHHHHHHH---HHhcCCCCceEEeeEEEccCCCccEEEEE
Q 015374          132 KVGRGKYSEVFEGINVNTNERCIIKILKPVK------KKKIKREIKIL---QNLCGGPNVVKLLDIVRDQHSKTPSLIFE  202 (408)
Q Consensus       132 ~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~------~~~~~~E~~~l---~~l~~h~niv~l~~~~~~~~~~~~~lv~e  202 (408)
                      .||+|+||.||+|.+..+++.||+|.+....      ...+..|..++   +.. +||||+++++++.+  ....++|||
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~i~~~~~~~~~--~~~~~~v~e   77 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG-DCPFIVCMSYAFHT--PDKLSFILD   77 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhC-CCCcEeeeeeeeec--CCEEEEEEe
Confidence            3899999999999999999999999885321      12234444333   334 79999999999965  467889999


Q ss_pred             eecCCChhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCCCcceee
Q 015374          203 YVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR  279 (408)
Q Consensus       203 ~~~~~~l~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~~~~~~~  279 (408)
                      |+++++|..++   ..+++..++.++.|++.||.|||+.+|+|+||||+||+++.+ +.++|+|||++...... .....
T Consensus        78 ~~~g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~-~~~kl~dfg~~~~~~~~-~~~~~  155 (278)
T cd05606          78 LMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEH-GHVRISDLGLACDFSKK-KPHAS  155 (278)
T ss_pred             cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCC-CCEEEccCcCccccCcc-CCcCc
Confidence            99999998876   348999999999999999999999999999999999999988 78999999998755432 23345


Q ss_pred             ccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCC-HHHHHHHHhhhchhhhhcCCCCCCCccccccc
Q 015374          280 VASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDN-HDQLVKIAKDCCLIIWCNSRHSRKPWSKFINA  358 (408)
Q Consensus       280 ~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  358 (408)
                      .|+..|+|||.+.+...++.++||||+||++|+|++|+.||...... ..........                   ...
T Consensus       156 ~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~-------------------~~~  216 (278)
T cd05606         156 VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLT-------------------MAV  216 (278)
T ss_pred             CCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhc-------------------cCC
Confidence            78899999999976456899999999999999999999998543221 1111111110                   111


Q ss_pred             cCCCCCCHHHHHHHHHhcccCcCCCC-----CHHHHhcCCCccccccch
Q 015374          359 DNQHLVSPEAIDFLDKLLRYDHQDRL-----TAREAMAHPYFAQVRAAE  402 (408)
Q Consensus       359 ~~~~~~~~~~~~li~~~L~~dp~~Rp-----t~~elL~hp~f~~~~~~~  402 (408)
                      ..+..++.++.+++.+||..||.+||     ++.++++||||+......
T Consensus       217 ~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~~~~~~~~~~~  265 (278)
T cd05606         217 ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRSLDWQM  265 (278)
T ss_pred             CCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhCccccCCCchH
Confidence            22334689999999999999999999     999999999999887654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=4.8e-40  Score=303.62  Aligned_cols=243  Identities=19%  Similarity=0.343  Sum_probs=196.5

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc--chHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccEEE
Q 015374          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV--KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI  200 (408)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  200 (408)
                      ..++|++.++||+|+||.||+|.+ .++..||+|.++..  ..+.+.+|+.+++++ +|+||+++++++.+  ....+++
T Consensus         4 ~~~~~~~~~~lg~g~~g~v~~~~~-~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~~~lv   79 (261)
T cd05072           4 PRESIKLVKKLGAGQFGEVWMGYY-NNSTKVAVKTLKPGTMSVQAFLEEANLMKTL-QHDKLVRLYAVVTK--EEPIYII   79 (261)
T ss_pred             chHHeEEeeecCCcCCceEEEEEe-cCCceEEEEEccCCchhHHHHHHHHHHHHhC-CCCCeeeEEEEEcC--CCCcEEE
Confidence            457899999999999999999985 45677999988643  346788999999999 99999999999854  4667899


Q ss_pred             EEeecCCChhhhcC-----CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCCCc
Q 015374          201 FEYVNSTDFKVLYP-----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE  275 (408)
Q Consensus       201 ~e~~~~~~l~~~~~-----~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~~~  275 (408)
                      |||+++++|..++.     .+++..+..++.|++.||.|||+.+++|+||||+||+++.+ +.++|+|||++........
T Consensus        80 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~-~~~~l~dfg~~~~~~~~~~  158 (261)
T cd05072          80 TEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSES-LMCKIADFGLARVIEDNEY  158 (261)
T ss_pred             EecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCC-CcEEECCCccceecCCCce
Confidence            99999999988763     37788889999999999999999999999999999999988 7899999999987653322


Q ss_pred             c--eeeccCccccccccccCCcCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCCCc
Q 015374          276 Y--NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPW  352 (408)
Q Consensus       276 ~--~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  352 (408)
                      .  ....++..|+|||.+.+ ..++.++|||||||++|+|++ |..|| .+....+....+....               
T Consensus       159 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~t~g~~p~-~~~~~~~~~~~~~~~~---------------  221 (261)
T cd05072         159 TAREGAKFPIKWTAPEAINF-GSFTIKSDVWSFGILLYEIVTYGKIPY-PGMSNSDVMSALQRGY---------------  221 (261)
T ss_pred             eccCCCccceecCCHHHhcc-CCCChhhhhhhhHHHHHHHHccCCCCC-CCCCHHHHHHHHHcCC---------------
Confidence            1  12234567999999876 678999999999999999998 88776 4444334333332210               


Q ss_pred             cccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 015374          353 SKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA  391 (408)
Q Consensus       353 ~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~  391 (408)
                          .......++.++.+++.+||..||++|||++++++
T Consensus       222 ----~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  256 (261)
T cd05072         222 ----RMPRMENCPDELYDIMKTCWKEKAEERPTFDYLQS  256 (261)
T ss_pred             ----CCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence                01112336889999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=3.5e-40  Score=308.09  Aligned_cols=264  Identities=31%  Similarity=0.550  Sum_probs=205.1

Q ss_pred             EEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc----chHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccEEEEE
Q 015374          127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFE  202 (408)
Q Consensus       127 y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e  202 (408)
                      |++.+.||+|+||+||+|++..+++.|++|.+...    ......+|+..+.++.+|+|++++++++.+  +...++|||
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~--~~~~~lv~e   78 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRE--NDELYFVFE   78 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhc--CCcEEEEEe
Confidence            57788999999999999999889999999998643    223456799999999339999999999965  567899999


Q ss_pred             eecCCChhhhc-----CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCCCcce
Q 015374          203 YVNSTDFKVLY-----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN  277 (408)
Q Consensus       203 ~~~~~~l~~~~-----~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~~~~~  277 (408)
                      |+ ++++...+     ..+++..+..++.|++.+|.|||++|++|+||+|+||+++.+ +.++|+|||++..........
T Consensus        79 ~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~-~~~~l~d~~~~~~~~~~~~~~  156 (283)
T cd07830          79 YM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGP-EVVKIADFGLAREIRSRPPYT  156 (283)
T ss_pred             cC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCC-CCEEEeecccceeccCCCCcC
Confidence            99 66666554     247899999999999999999999999999999999999987 799999999998776554555


Q ss_pred             eeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcC---C----CCCC
Q 015374          278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNS---R----HSRK  350 (408)
Q Consensus       278 ~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~---~----~~~~  350 (408)
                      ...++..|+|||++.+...++.++|+||||+++|+|++|+.|| .+....+....+....+.......   .    ....
T Consensus       157 ~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (283)
T cd07830         157 DYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLF-PGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGF  235 (283)
T ss_pred             CCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCcc-CCCChHHHHHHHHHhcCCCChhhhhhHhhhhccccc
Confidence            5678889999999866567899999999999999999999886 555555665555544332211000   0    0000


Q ss_pred             Cccccc---cccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCc
Q 015374          351 PWSKFI---NADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF  395 (408)
Q Consensus       351 ~~~~~~---~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f  395 (408)
                      .+....   ........+.++.+|+++||+.||++|||++|++.||||
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~  283 (283)
T cd07830         236 RFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF  283 (283)
T ss_pred             cccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence            000000   001111236889999999999999999999999999997

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.4e-40  Score=305.53  Aligned_cols=243  Identities=19%  Similarity=0.355  Sum_probs=193.2

Q ss_pred             EEEEeeeeeeCceEEEEEEEcCC---CcEEEEEEeccc-----chHHHHHHHHHHHHhcCCCCceEEeeEEEccCC----
Q 015374          127 YEVVRKVGRGKYSEVFEGINVNT---NERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHS----  194 (408)
Q Consensus       127 y~~~~~lG~G~fg~Vy~~~~~~~---~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~----  194 (408)
                      |++.+.||+|+||.||+|....+   +..||+|.++..     ....+.+|+.+++.+ +|+||+++++++.....    
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~   79 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDF-DHPNVMKLIGVCFEASSLQKI   79 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhC-CCCCeeeEEeeeccCCccccC
Confidence            45678999999999999987653   478999998642     235688999999999 99999999998864322    


Q ss_pred             CccEEEEEeecCCChhhhc---------CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecc
Q 015374          195 KTPSLIFEYVNSTDFKVLY---------PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWG  265 (408)
Q Consensus       195 ~~~~lv~e~~~~~~l~~~~---------~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG  265 (408)
                      ...+++|||+++++|..++         ..+++..+..++.|++.||.|||+++|+|+||||+||+++++ +.+||+|||
T Consensus        80 ~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~-~~~kl~dfg  158 (273)
T cd05035          80 PKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLRED-MTVCVADFG  158 (273)
T ss_pred             cccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCC-CeEEECCcc
Confidence            3478999999999998775         247888899999999999999999999999999999999988 789999999


Q ss_pred             cceeccCCCcc---eeeccCccccccccccCCcCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHhhhchhh
Q 015374          266 LAEFYHPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKDCCLII  341 (408)
Q Consensus       266 ~a~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~  341 (408)
                      +++........   ....++..|+|||.+.+ ..++.++|||||||++|||++ |..|| .+..+.+....+....    
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Dv~SlG~il~el~~~g~~p~-~~~~~~~~~~~~~~~~----  232 (273)
T cd05035         159 LSKKIYSGDYYRQGRIAKMPVKWIAIESLAD-RVYTSKSDVWAFGVTMWEIATRGQTPY-PGVENHEIYDYLRHGN----  232 (273)
T ss_pred             ceeeccccccccccccccCCccccCHhhccc-CCCCcccchHHHHHHHHHHHhCCCCCC-CCCCHHHHHHHHHcCC----
Confidence            99876543321   12234567999999876 778999999999999999999 66665 4544444433332210    


Q ss_pred             hhcCCCCCCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 015374          342 WCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH  392 (408)
Q Consensus       342 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~h  392 (408)
                                     ....+..+++++.+++.+||+.||++|||+.|++++
T Consensus       233 ---------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~  268 (273)
T cd05035         233 ---------------RLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREV  268 (273)
T ss_pred             ---------------CCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                           111233478899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.6e-41  Score=323.27  Aligned_cols=273  Identities=27%  Similarity=0.466  Sum_probs=227.0

Q ss_pred             CCCCcccccCCCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc------chHHHHHHHHHHHHhcCCCCceEEe
Q 015374          113 DYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLL  186 (408)
Q Consensus       113 ~~~~~~~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~  186 (408)
                      .|..+.....+...|..++.||-|+||+|.+++...+...+|.|.+.+.      .......|-.||... ..+.||+||
T Consensus       617 nYiRLkRaKMdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEA-Dn~WVVrLy  695 (1034)
T KOG0608|consen  617 NYIRLKRAKMDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEA-DNEWVVRLY  695 (1034)
T ss_pred             hHHHHHHhhccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhc-CCcceEEEE
Confidence            4555555556678899999999999999999998889999999998643      235577899999998 999999999


Q ss_pred             eEEEccCCCccEEEEEeecCCChhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEe
Q 015374          187 DIVRDQHSKTPSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLID  263 (408)
Q Consensus       187 ~~~~~~~~~~~~lv~e~~~~~~l~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~D  263 (408)
                      -.|.+  ...+|+||||++||++..++   .-|.+..++.++.++.+|+++.|..|+|||||||+|||||.+ |.+||+|
T Consensus       696 ySFQD--kdnLYFVMdYIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrd-GHIKLTD  772 (1034)
T KOG0608|consen  696 YSFQD--KDNLYFVMDYIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRD-GHIKLTD  772 (1034)
T ss_pred             EEecc--CCceEEEEeccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccC-Cceeeee
Confidence            99955  57889999999999988876   458899999999999999999999999999999999999999 8999999


Q ss_pred             cccceecc---------CCC----------------------------------cceeeccCccccccccccCCcCCCcc
Q 015374          264 WGLAEFYH---------PGK----------------------------------EYNVRVASRYFKGPELLVDLQDYDYS  300 (408)
Q Consensus       264 fG~a~~~~---------~~~----------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~  300 (408)
                      |||+.-+.         .+.                                  .....+||+.|+|||++.. ..|+..
T Consensus       773 FGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r-~g~~q~  851 (1034)
T KOG0608|consen  773 FGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLAR-TGYTQL  851 (1034)
T ss_pred             ccccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcc-cCcccc
Confidence            99985321         100                                  0112479999999999998 889999


Q ss_pred             ccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCCCccccccccCCCCCCHHHHHHHHHhcccCc
Q 015374          301 LDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDH  380 (408)
Q Consensus       301 ~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp  380 (408)
                      +|.||.|||||||+.|+.||..... .+..                .....|..++.......++.++.++|.+++ .++
T Consensus       852 cdwws~gvil~em~~g~~pf~~~tp-~~tq----------------~kv~nw~~~l~~~~~~~ls~e~~~li~kLc-~sa  913 (1034)
T KOG0608|consen  852 CDWWSVGVILYEMLVGQPPFLADTP-GETQ----------------YKVINWRNFLHIPYQGNLSKEALDLIQKLC-CSA  913 (1034)
T ss_pred             chhhHhhHHHHHHhhCCCCccCCCC-Ccce----------------eeeeehhhccccccccccCHHHHHHHHHHh-cCh
Confidence            9999999999999999999843332 2221                223447777777777779999999999977 588


Q ss_pred             CCCC---CHHHHhcCCCccccccchhhhccC
Q 015374          381 QDRL---TAREAMAHPYFAQVRAAESSRTRA  408 (408)
Q Consensus       381 ~~Rp---t~~elL~hp~f~~~~~~~~~~~~~  408 (408)
                      +.|.   .++|+-.||||+.|+....+|.||
T Consensus       914 d~RLGkng~d~vKaHpfFkgIDfsslRkq~A  944 (1034)
T KOG0608|consen  914 DSRLGKNGADQVKAHPFFKGIDFSSLRKQRA  944 (1034)
T ss_pred             hhhhcccchhhhhcCccccccchHhhhhccC
Confidence            8998   477899999999999998888775

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.7e-40  Score=303.50  Aligned_cols=246  Identities=28%  Similarity=0.488  Sum_probs=195.6

Q ss_pred             eeeeeeCceEEEEEEEcCCCcEEEEEEecccc------hHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccEEEEEee
Q 015374          131 RKVGRGKYSEVFEGINVNTNERCIIKILKPVK------KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYV  204 (408)
Q Consensus       131 ~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~------~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~  204 (408)
                      +.||.|+||.||+|.+..+++.||+|+++...      ...+..|..++....+|+|++++++++..  +...++|+||+
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~--~~~~~lv~e~~   79 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQS--KDYLYLVMEYL   79 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEc--CCeEEEEEecc
Confidence            46899999999999999999999999986432      12344555555544489999999999954  46789999999


Q ss_pred             cCCChhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCCCcceeecc
Q 015374          205 NSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVA  281 (408)
Q Consensus       205 ~~~~l~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~~~~~~~~~  281 (408)
                      ++++|..++   ..+++..+..++.|++.||.|||+.+++|+||+|+||+++.+ +.++|+|||++.....   .....+
T Consensus        80 ~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~-~~~~l~dfg~~~~~~~---~~~~~~  155 (260)
T cd05611          80 NGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQT-GHLKLTDFGLSRNGLE---NKKFVG  155 (260)
T ss_pred             CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCC-CcEEEeecccceeccc---cccCCC
Confidence            999999887   358899999999999999999999999999999999999987 7899999999875432   223457


Q ss_pred             CccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCCCccccccccCC
Q 015374          282 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSKFINADNQ  361 (408)
Q Consensus       282 ~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  361 (408)
                      +..|++||.+.+ ..++.++||||||+++|+|++|..||. ..+..+....+...            ...+    .....
T Consensus       156 ~~~y~~pe~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~-~~~~~~~~~~~~~~------------~~~~----~~~~~  217 (260)
T cd05611         156 TPDYLAPETILG-VGDDKMSDWWSLGCVIFEFLFGYPPFH-AETPDAVFDNILSR------------RINW----PEEVK  217 (260)
T ss_pred             CcCccChhhhcC-CCCcchhhhHHHHHHHHHHHHCCCCCC-CCCHHHHHHHHHhc------------ccCC----CCccc
Confidence            788999999987 558999999999999999999999983 33333333322211            0001    11122


Q ss_pred             CCCCHHHHHHHHHhcccCcCCCCC---HHHHhcCCCcccccc
Q 015374          362 HLVSPEAIDFLDKLLRYDHQDRLT---AREAMAHPYFAQVRA  400 (408)
Q Consensus       362 ~~~~~~~~~li~~~L~~dp~~Rpt---~~elL~hp~f~~~~~  400 (408)
                      ..+++++.+++.+||+.||++|||   ++|++.||||+.+..
T Consensus       218 ~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~~~~~~~~~  259 (260)
T cd05611         218 EFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHPFFKSINW  259 (260)
T ss_pred             ccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcChHhhcCCC
Confidence            247899999999999999999995   579999999987653

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=7.1e-40  Score=302.97  Aligned_cols=242  Identities=19%  Similarity=0.316  Sum_probs=194.5

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc--chHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccEEE
Q 015374          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV--KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI  200 (408)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  200 (408)
                      ..++|++.++||+|+||+||+|++..+ ..||+|.++..  ..+.+.+|+.+++++ +|+||+++++.+.+   ...++|
T Consensus         4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~~~~~~~~~E~~~l~~l-~~~~i~~~~~~~~~---~~~~lv   78 (262)
T cd05071           4 PRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFLQEAQVMKKL-RHEKLVQLYAVVSE---EPIYIV   78 (262)
T ss_pred             ChHHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCccCHHHHHHHHHHHHhC-CCCCcceEEEEECC---CCcEEE
Confidence            457899999999999999999987655 46999998743  346789999999999 99999999998743   457899


Q ss_pred             EEeecCCChhhhcC-----CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCCCc
Q 015374          201 FEYVNSTDFKVLYP-----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE  275 (408)
Q Consensus       201 ~e~~~~~~l~~~~~-----~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~~~  275 (408)
                      |||+++++|..++.     .+++..+..++.|++.||.|||+.+|+|+||||+||+++.+ +.++|+|||.+........
T Consensus        79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~-~~~~L~dfg~~~~~~~~~~  157 (262)
T cd05071          79 TEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGEN-LVCKVADFGLARLIEDNEY  157 (262)
T ss_pred             EEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCC-CcEEeccCCceeecccccc
Confidence            99999999988874     37888899999999999999999999999999999999988 7899999999976643322


Q ss_pred             c--eeeccCccccccccccCCcCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCCCc
Q 015374          276 Y--NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPW  352 (408)
Q Consensus       276 ~--~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  352 (408)
                      .  ....++..|++||...+ ..++.++|||||||++|+|++ |..|| .+..+.+....+....               
T Consensus       158 ~~~~~~~~~~~y~~PE~~~~-~~~~~~~DvwslG~~l~ellt~g~~p~-~~~~~~~~~~~~~~~~---------------  220 (262)
T cd05071         158 TARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELTTKGRVPY-PGMVNREVLDQVERGY---------------  220 (262)
T ss_pred             ccccCCcccceecCHhHhcc-CCCCchhhHHHHHHHHHHHHcCCCCCC-CCCChHHHHHHHhcCC---------------
Confidence            1  12345567999999876 678999999999999999999 66665 4444444333322110               


Q ss_pred             cccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 015374          353 SKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA  391 (408)
Q Consensus       353 ~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~  391 (408)
                          .......++..+.+++.+||+.||++|||+.++++
T Consensus       221 ----~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~  255 (262)
T cd05071         221 ----RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQA  255 (262)
T ss_pred             ----CCCCccccCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence                00112336789999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.2e-41  Score=319.00  Aligned_cols=255  Identities=25%  Similarity=0.447  Sum_probs=195.6

Q ss_pred             CCCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEec-----ccchHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCc
Q 015374          122 GDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK-----PVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT  196 (408)
Q Consensus       122 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~-----~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  196 (408)
                      .....|+++++||+||.+.||++.. .+...+|+|.+.     ......|.+|+..|.+|.+|.+|+++++|-..  +..
T Consensus       358 Vkg~~Yeilk~iG~GGSSkV~kV~~-s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~--d~~  434 (677)
T KOG0596|consen  358 VKGREYEILKQIGSGGSSKVFKVLN-SDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVT--DGY  434 (677)
T ss_pred             ECcchhhHHHhhcCCCcceeeeeec-CCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeecc--Cce
Confidence            3466799999999999999999964 455566666543     33456799999999999999999999999854  578


Q ss_pred             cEEEEEeecCCChhhhcC----CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccC
Q 015374          197 PSLIFEYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP  272 (408)
Q Consensus       197 ~~lv~e~~~~~~l~~~~~----~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~  272 (408)
                      +||||||-+ .+|..+++    ..+...++.+..|++.++.++|+.||||.||||.|+|+-.  |.+||+|||.|..+..
T Consensus       435 lYmvmE~Gd-~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlVk--G~LKLIDFGIA~aI~~  511 (677)
T KOG0596|consen  435 LYMVMECGD-IDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLVK--GRLKLIDFGIANAIQP  511 (677)
T ss_pred             EEEEeeccc-ccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEEe--eeEEeeeechhcccCc
Confidence            999999754 56666663    2454588899999999999999999999999999999886  5899999999988775


Q ss_pred             CCc---ceeeccCccccccccccCC----------cCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhch
Q 015374          273 GKE---YNVRVASRYFKGPELLVDL----------QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCL  339 (408)
Q Consensus       273 ~~~---~~~~~~~~~y~aPE~~~~~----------~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~  339 (408)
                      +..   ....+||..||+||.+...          -+.+.++||||||||||+|+.|+.||..-.   ..++++.....+
T Consensus       512 DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~---n~~aKl~aI~~P  588 (677)
T KOG0596|consen  512 DTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQII---NQIAKLHAITDP  588 (677)
T ss_pred             cccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHH---HHHHHHHhhcCC
Confidence            543   3457999999999999641          125679999999999999999999982111   122222211100


Q ss_pred             hhhhcCCCCCCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccccc
Q 015374          340 IIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVR  399 (408)
Q Consensus       340 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~~~  399 (408)
                            . ....++..     +  -..++.++++.||.+||.+|||+.|||+|||++...
T Consensus       589 ------~-~~Iefp~~-----~--~~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~~~  634 (677)
T KOG0596|consen  589 ------N-HEIEFPDI-----P--ENDELIDVMKCCLARDPKKRWSIPELLQHPFLQIQP  634 (677)
T ss_pred             ------C-ccccccCC-----C--CchHHHHHHHHHHhcCcccCCCcHHHhcCccccccc
Confidence                  0 00111110     0  023499999999999999999999999999999744

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=1.1e-39  Score=299.67  Aligned_cols=245  Identities=24%  Similarity=0.486  Sum_probs=203.9

Q ss_pred             CEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc-----chHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccEEE
Q 015374          126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI  200 (408)
Q Consensus       126 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  200 (408)
                      +|++.+.||.|+||.||++.+..++..+++|.+...     ....+.+|+++++.+ +|+|++++++.+..  ....++|
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~~~~~~~~~~~--~~~~~lv   77 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKL-NHPNIIKYYESFEE--KGKLCIV   77 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhc-CCCChhheEEEEec--CCEEEEE
Confidence            588899999999999999999989999999998642     346688999999999 89999999999865  4788899


Q ss_pred             EEeecCCChhhhc-------CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCC
Q 015374          201 FEYVNSTDFKVLY-------PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG  273 (408)
Q Consensus       201 ~e~~~~~~l~~~~-------~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~  273 (408)
                      +||+++++|..++       ..+++..+..++.+++.||.|||+.|++|+||+|+||+++.+ +.++|+|||++......
T Consensus        78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~-~~~~l~d~~~~~~~~~~  156 (258)
T cd08215          78 MEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSN-GLVKLGDFGISKVLSST  156 (258)
T ss_pred             EEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCC-CcEEECCccceeecccC
Confidence            9999999998776       347889999999999999999999999999999999999987 78999999999776544


Q ss_pred             C-cceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCCCc
Q 015374          274 K-EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPW  352 (408)
Q Consensus       274 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  352 (408)
                      . ......++..|+|||.+.+ ..++.++|+||+|+++++|++|..||... +..+.........               
T Consensus       157 ~~~~~~~~~~~~y~~pe~~~~-~~~~~~~Dv~slG~~~~~l~~g~~p~~~~-~~~~~~~~~~~~~---------------  219 (258)
T cd08215         157 VDLAKTVVGTPYYLSPELCQN-KPYNYKSDIWSLGCVLYELCTLKHPFEGE-NLLELALKILKGQ---------------  219 (258)
T ss_pred             cceecceeeeecccChhHhcc-CCCCccccHHHHHHHHHHHHcCCCCCCCC-cHHHHHHHHhcCC---------------
Confidence            3 2234567888999999877 67899999999999999999999997332 2222222221110               


Q ss_pred             cccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCc
Q 015374          353 SKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF  395 (408)
Q Consensus       353 ~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f  395 (408)
                          ....+..++.++.+++.+||..||++|||+.|+|+||||
T Consensus       220 ----~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~  258 (258)
T cd08215         220 ----YPPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQSPFI  258 (258)
T ss_pred             ----CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCCCC
Confidence                011122467899999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=3.4e-40  Score=308.45  Aligned_cols=259  Identities=22%  Similarity=0.330  Sum_probs=197.3

Q ss_pred             CCE-EEEeeeeeeCceEEEEEE----EcCCCcEEEEEEeccc----chHHHHHHHHHHHHhcCCCCceEEeeEEEccCCC
Q 015374          125 DDY-EVVRKVGRGKYSEVFEGI----NVNTNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSK  195 (408)
Q Consensus       125 ~~y-~~~~~lG~G~fg~Vy~~~----~~~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  195 (408)
                      ++| ++.+.||+|+||+||++.    ...++..||+|.++..    ....+.+|+.+++++ +||||+++++++......
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~   81 (283)
T cd05080           3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTL-YHENIVKYKGCCSEQGGK   81 (283)
T ss_pred             hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhC-CCCCEeeEEEEEecCCCc
Confidence            455 889999999999998764    3456788999998743    245688999999999 999999999998766556


Q ss_pred             ccEEEEEeecCCChhhhcC--CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCC
Q 015374          196 TPSLIFEYVNSTDFKVLYP--TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG  273 (408)
Q Consensus       196 ~~~lv~e~~~~~~l~~~~~--~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~  273 (408)
                      ..+++|||+++++|..++.  .+++.++..++.|++.||.|||+++|+|+||||+|||++.+ +.++|+|||+++.....
T Consensus        82 ~~~lv~e~~~~~~l~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~-~~~~l~dfg~~~~~~~~  160 (283)
T cd05080          82 GLQLIMEYVPLGSLRDYLPKHKLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDND-RLVKIGDFGLAKAVPEG  160 (283)
T ss_pred             eEEEEecCCCCCCHHHHHHHcCCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCC-CcEEEeecccccccCCc
Confidence            7889999999999988874  58999999999999999999999999999999999999988 78999999999866533


Q ss_pred             Cc----ceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCC
Q 015374          274 KE----YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSR  349 (408)
Q Consensus       274 ~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  349 (408)
                      ..    .....++..|++||.+.+ ..++.++||||||+++|||++|..||.............  ..+.....  .. .
T Consensus       161 ~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~--~~~~~~~~--~~-~  234 (283)
T cd05080         161 HEYYRVREDGDSPVFWYAVECLKE-NKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGP--KQGQMTVV--RL-I  234 (283)
T ss_pred             chhhccCCCCCCCceeeCHhHhcc-cCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcc--cccccchh--hh-h
Confidence            22    112345567999999876 678999999999999999999999974332221111100  00000000  00 0


Q ss_pred             CCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 015374          350 KPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA  391 (408)
Q Consensus       350 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~  391 (408)
                      ...........+..++.++.+++.+||+.||++|||++++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~  276 (283)
T cd05080         235 ELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP  276 (283)
T ss_pred             hhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence            000000111223457899999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=6e-40  Score=306.81  Aligned_cols=244  Identities=17%  Similarity=0.343  Sum_probs=194.7

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEc----CCCcEEEEEEecccc----hHHHHHHHHHHHHhcCCCCceEEeeEEEccCCC
Q 015374          124 QDDYEVVRKVGRGKYSEVFEGINV----NTNERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSK  195 (408)
Q Consensus       124 ~~~y~~~~~lG~G~fg~Vy~~~~~----~~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  195 (408)
                      .++|++.+.||+|+||+||+|++.    .++..+++|.++...    ...+.+|+.+++++ +||||+++++++..  ..
T Consensus         4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~--~~   80 (283)
T cd05090           4 LSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAEL-HHPNIVCLLGVVTQ--EQ   80 (283)
T ss_pred             hhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhC-CCCCeeeEEEEEec--CC
Confidence            467899999999999999999853    455789999986422    35688999999999 99999999999855  45


Q ss_pred             ccEEEEEeecCCChhhhcC--------------------CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCC
Q 015374          196 TPSLIFEYVNSTDFKVLYP--------------------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE  255 (408)
Q Consensus       196 ~~~lv~e~~~~~~l~~~~~--------------------~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~  255 (408)
                      ..++||||+++++|..++.                    .+++..+..++.|++.||.|||+++|+|+||||+|||++.+
T Consensus        81 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~~  160 (283)
T cd05090          81 PVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQ  160 (283)
T ss_pred             ceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcCC
Confidence            7889999999999988762                    36778888999999999999999999999999999999988


Q ss_pred             CCcEEEEecccceeccCCCc---ceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHH
Q 015374          256 LRKLRLIDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLV  331 (408)
Q Consensus       256 ~~~~kl~DfG~a~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-g~~pf~~~~~~~~~~~  331 (408)
                       +.+||+|||+++.......   .....++..|+|||.+.+ ..++.++|||||||++|||++ |..||. +....+...
T Consensus       161 -~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~~~g~~p~~-~~~~~~~~~  237 (283)
T cd05090         161 -LHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMY-GKFSSDSDIWSFGVVLWEIFSFGLQPYY-GFSNQEVIE  237 (283)
T ss_pred             -CcEEeccccccccccCCcceecccCCCccceecChHHhcc-CCCCchhhhHHHHHHHHHHHcCCCCCCC-CCCHHHHHH
Confidence             7899999999976543321   122344567999999977 678999999999999999998 777773 333333322


Q ss_pred             HHHhhhchhhhhcCCCCCCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 015374          332 KIAKDCCLIIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH  392 (408)
Q Consensus       332 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~h  392 (408)
                      .+... .                  ....+..+++++.+++.+||+.||++||++.+++++
T Consensus       238 ~~~~~-~------------------~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~  279 (283)
T cd05090         238 MVRKR-Q------------------LLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR  279 (283)
T ss_pred             HHHcC-C------------------cCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence            22111 0                  011223478899999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.4e-40  Score=318.16  Aligned_cols=273  Identities=31%  Similarity=0.566  Sum_probs=210.0

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc-----chHHHHHHHHHHHHhcCCCCceEEeeEEEccCC---
Q 015374          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHS---  194 (408)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~---  194 (408)
                      ..++|++.+.||+|+||.||+|++..++..||+|++...     ....+.+|+.+++++ +|+|++++++++.....   
T Consensus        13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~   91 (343)
T cd07851          13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHM-DHENVIGLLDVFTPASSLED   91 (343)
T ss_pred             ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhc-cCCCHHHHHHHhhccccccc
Confidence            467899999999999999999999999999999998632     235577899999999 99999999998754322   


Q ss_pred             -CccEEEEEeecCCChhhhc--CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceecc
Q 015374          195 -KTPSLIFEYVNSTDFKVLY--PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH  271 (408)
Q Consensus       195 -~~~~lv~e~~~~~~l~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~  271 (408)
                       ...++|+||++ ++|..++  ..+++..+..++.|++.||.|||+.||+|+||||+||+++.+ +.++|+|||++....
T Consensus        92 ~~~~~lv~e~~~-~~L~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~-~~~kL~dfg~~~~~~  169 (343)
T cd07851          92 FQDVYLVTHLMG-ADLNNIVKCQKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNED-CELKILDFGLARHTD  169 (343)
T ss_pred             cccEEEEEecCC-CCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCC-CCEEEcccccccccc
Confidence             34789999995 5776665  358999999999999999999999999999999999999988 789999999997654


Q ss_pred             CCCcceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhc-CCCCCC
Q 015374          272 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCN-SRHSRK  350 (408)
Q Consensus       272 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~  350 (408)
                      ..  .....++..|+|||.+.+...++.++|||||||++|+|++|+.||. +.+..+.+..+....+...... ......
T Consensus       170 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~-~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  246 (343)
T cd07851         170 DE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFP-GSDHIDQLKRIMNLVGTPDEELLQKISSE  246 (343)
T ss_pred             cc--ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCC-CCChHHHHHHHHHhcCCCCHHHHhhccch
Confidence            32  3344678889999998764568899999999999999999999984 4444555555544333111000 000000


Q ss_pred             Ccccc---c-------cccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccccccc
Q 015374          351 PWSKF---I-------NADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAA  401 (408)
Q Consensus       351 ~~~~~---~-------~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~~~~~  401 (408)
                      ....+   .       -.......++++.+|+.+||+.||++|||+.|+++||||++....
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~~~~  307 (343)
T cd07851         247 SARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYHDP  307 (343)
T ss_pred             hHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccccCCC
Confidence            00000   0       001112358899999999999999999999999999999876544

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=2.8e-40  Score=308.29  Aligned_cols=243  Identities=21%  Similarity=0.380  Sum_probs=196.4

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcC-----CCcEEEEEEeccc----chHHHHHHHHHHHHhcCCCCceEEeeEEEccCC
Q 015374          124 QDDYEVVRKVGRGKYSEVFEGINVN-----TNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHS  194 (408)
Q Consensus       124 ~~~y~~~~~lG~G~fg~Vy~~~~~~-----~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~  194 (408)
                      .++|.+.+.||+|+||.||+|.+..     ++..||+|.++..    ..+.+.+|+++++++ +|+||+++++++..  .
T Consensus         4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~--~   80 (280)
T cd05049           4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNF-QHENIVKFYGVCTE--G   80 (280)
T ss_pred             hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhc-CCCCchheeeEEec--C
Confidence            4568889999999999999998643     3578999998743    245788999999999 99999999999965  4


Q ss_pred             CccEEEEEeecCCChhhhcC-----------------CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCC
Q 015374          195 KTPSLIFEYVNSTDFKVLYP-----------------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELR  257 (408)
Q Consensus       195 ~~~~lv~e~~~~~~l~~~~~-----------------~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~  257 (408)
                      ...++||||+++++|..++.                 .+++..+..++.|++.||.|||++|++|+||||+||+++.+ +
T Consensus        81 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~-~  159 (280)
T cd05049          81 DPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYD-L  159 (280)
T ss_pred             CCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCC-C
Confidence            67899999999999988763                 26778889999999999999999999999999999999988 8


Q ss_pred             cEEEEecccceeccCCCc---ceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHH
Q 015374          258 KLRLIDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKI  333 (408)
Q Consensus       258 ~~kl~DfG~a~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-g~~pf~~~~~~~~~~~~~  333 (408)
                      .++|+|||++........   .....++..|+|||++.+ ..++.++|||||||++|||++ |..||+. .+..+....+
T Consensus       160 ~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~e~~~~g~~p~~~-~~~~~~~~~~  237 (280)
T cd05049         160 VVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMY-RKFTTESDVWSFGVVLWEIFTYGKQPWYG-LSNEEVIECI  237 (280)
T ss_pred             eEEECCcccceecccCcceecCCCCcccceecChhhhcc-CCcchhhhHHHHHHHHHHHHhcCCCCCCC-CCHHHHHHHH
Confidence            999999999976533221   122345677999999987 779999999999999999998 9988743 3333333322


Q ss_pred             HhhhchhhhhcCCCCCCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 015374          334 AKDCCLIIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA  391 (408)
Q Consensus       334 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~  391 (408)
                      ...         .          ....+..++.++.+++.+||+.||++|||+.|+++
T Consensus       238 ~~~---------~----------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~  276 (280)
T cd05049         238 TQG---------R----------LLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHE  276 (280)
T ss_pred             HcC---------C----------cCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            211         0          01112346899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=7.8e-40  Score=313.26  Aligned_cols=272  Identities=31%  Similarity=0.506  Sum_probs=206.3

Q ss_pred             CEEEEeeeeeeCceEEEEEEEcCC--CcEEEEEEeccc-----chHHHHHHHHHHHHhcCCCCceEEeeEEEcc--CCCc
Q 015374          126 DYEVVRKVGRGKYSEVFEGINVNT--NERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQ--HSKT  196 (408)
Q Consensus       126 ~y~~~~~lG~G~fg~Vy~~~~~~~--~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~--~~~~  196 (408)
                      +|++.+.||+|+||.||++++..+  +..+|+|.+...     ..+.+.+|+.+++++.+|+||+++++.+...  ....
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~   80 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE   80 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence            588899999999999999999887  889999988632     2356788999999996799999999976432  2345


Q ss_pred             cEEEEEeecCCChhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCC
Q 015374          197 PSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG  273 (408)
Q Consensus       197 ~~lv~e~~~~~~l~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~  273 (408)
                      .++++||+++ +|..++   ..+++..++.++.|++.||+|||++||+||||||+||+++.+ +.++|+|||++......
T Consensus        81 ~~~~~e~~~~-~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~-~~~kl~Dfg~a~~~~~~  158 (332)
T cd07857          81 LYLYEELMEA-DLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNAD-CELKICDFGLARGFSEN  158 (332)
T ss_pred             EEEEEecccC-CHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCC-CCEEeCcCCCceecccc
Confidence            7788998875 565554   458899999999999999999999999999999999999988 78999999999765432


Q ss_pred             Cc-----ceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCC--
Q 015374          274 KE-----YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSR--  346 (408)
Q Consensus       274 ~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~--  346 (408)
                      ..     .....++..|+|||.+.+...++.++|+|||||++|+|++|..|| .+.+....+..+....|........  
T Consensus       159 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf-~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (332)
T cd07857         159 PGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVF-KGKDYVDQLNQILQVLGTPDEETLSRI  237 (332)
T ss_pred             cccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCC-CCCCHHHHHHHHHHHhCCCCHHHHHhh
Confidence            21     223467889999999876567899999999999999999999887 4444455555555544422110000  


Q ss_pred             --CC-------CCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccccc
Q 015374          347 --HS-------RKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRA  400 (408)
Q Consensus       347 --~~-------~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~~~~  400 (408)
                        ..       ........-......++.++.+|+.+||+.||++|||+.|++.||||...+.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~~~  300 (332)
T cd07857         238 GSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIWHD  300 (332)
T ss_pred             hhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhhhcC
Confidence              00       0000000000111235789999999999999999999999999999986653

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-41  Score=293.70  Aligned_cols=258  Identities=20%  Similarity=0.360  Sum_probs=211.1

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecc----cchHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccE
Q 015374          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP----VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS  198 (408)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~----~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  198 (408)
                      +.++.+.+..||.|+.|.||+++.+.+|...|||....    .+.+++...+.++..-...|+||+.+|+|...  ...+
T Consensus        90 dindl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n--~dV~  167 (391)
T KOG0983|consen   90 DINDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITN--TDVF  167 (391)
T ss_pred             ChHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeC--chHH
Confidence            45667778899999999999999999999999999853    33456677777777654589999999999764  4456


Q ss_pred             EEEEeecC---CChhhhcCCCChHHHHHHHHHHHHHHHHHHH-CCcEEecCCCCcEEEeCCCCcEEEEecccceeccCCC
Q 015374          199 LIFEYVNS---TDFKVLYPTLTDYDIRYYIYELLKALDYCHS-QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK  274 (408)
Q Consensus       199 lv~e~~~~---~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~~  274 (408)
                      +.||.|..   ..|.....++++.-+-++...+.+||.||-+ ++|||||+||+|||+|.. |.+|+||||.+-.+-++.
T Consensus       168 IcMelMs~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~-GniKlCDFGIsGrlvdSk  246 (391)
T KOG0983|consen  168 ICMELMSTCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDER-GNIKLCDFGISGRLVDSK  246 (391)
T ss_pred             HHHHHHHHHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccC-CCEEeecccccceeeccc
Confidence            77887753   3344445679999899999999999999986 489999999999999988 899999999998887777


Q ss_pred             cceeeccCccccccccccC--CcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCCCc
Q 015374          275 EYNVRVASRYFKGPELLVD--LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPW  352 (408)
Q Consensus       275 ~~~~~~~~~~y~aPE~~~~--~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  352 (408)
                      ..+...|-+.|||||.+--  ...|+.++||||||++++||.||..||..-+.+.+.+..+.+.....            
T Consensus       247 AhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~ePP~------------  314 (391)
T KOG0983|consen  247 AHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEPPL------------  314 (391)
T ss_pred             ccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCCCC------------
Confidence            7777889999999999853  35789999999999999999999999865566778887776642100            


Q ss_pred             cccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccccc
Q 015374          353 SKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRA  400 (408)
Q Consensus       353 ~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~~~~  400 (408)
                         .+.  ....|+.+++|+..||+.|+.+||.-.+||+|||......
T Consensus       315 ---L~~--~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~ye~  357 (391)
T KOG0983|consen  315 ---LPG--HMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEHPFIKRYET  357 (391)
T ss_pred             ---CCc--ccCcCHHHHHHHHHHhhcCcccCcchHHHhcCcceeecch
Confidence               111  1226899999999999999999999999999999875443

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=2.5e-40  Score=314.01  Aligned_cols=264  Identities=19%  Similarity=0.246  Sum_probs=194.7

Q ss_pred             CceEEEEEEEcCCCcEEEEEEeccc-----chHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccEEEEEeecCCChhh
Q 015374          137 KYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKV  211 (408)
Q Consensus       137 ~fg~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~~~~l~~  211 (408)
                      ++|.||.++...+++.||+|+++..     ..+.+.+|+.+++.+ +|+||+++++++.+  ....+++|||++++++..
T Consensus        12 ~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~~i~~~~~~~~~--~~~~~~~~e~~~~~~l~~   88 (314)
T cd08216          12 DLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQL-QHPNILPYVTSFIV--DSELYVVSPLMAYGSCED   88 (314)
T ss_pred             CCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhc-CCcchhhhhheeec--CCeEEEEEeccCCCCHHH
Confidence            4455566666779999999998632     335788999999999 89999999999965  467889999999999988


Q ss_pred             hcC-----CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCCCc--------cee
Q 015374          212 LYP-----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE--------YNV  278 (408)
Q Consensus       212 ~~~-----~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~~~--------~~~  278 (408)
                      ++.     .+++..+..++.|++.||.|||+++|+|+||||+||+++.+ +.++|+|||.+........        ...
T Consensus        89 ~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~-~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~  167 (314)
T cd08216          89 LLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGD-GKVVLSGLRYSVSMIKHGKRQRVVHDFPKS  167 (314)
T ss_pred             HHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecC-CceEEecCccceeecccccccccccccccc
Confidence            763     47888899999999999999999999999999999999987 7999999998865532211        223


Q ss_pred             eccCccccccccccCC-cCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhh------hhcCCCC---
Q 015374          279 RVASRYFKGPELLVDL-QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLII------WCNSRHS---  348 (408)
Q Consensus       279 ~~~~~~y~aPE~~~~~-~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~------~~~~~~~---  348 (408)
                      ..++..|+|||++.+. ..++.++|+|||||++|||++|..||............+........      .......   
T Consensus       168 ~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (314)
T cd08216         168 SVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDSMSQSR  247 (314)
T ss_pred             ccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcCCcCccc
Confidence            4566789999998653 35889999999999999999999998654433333222221111000      0000000   


Q ss_pred             ----CCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccccccchhh
Q 015374          349 ----RKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAESS  404 (408)
Q Consensus       349 ----~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~~~~~~~~  404 (408)
                          ...............++.++.+|+.+||++||++|||++|+|+||||+.++..+.+
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~~~~~~~  307 (314)
T cd08216         248 SSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQCKRRNTS  307 (314)
T ss_pred             ccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhhcccchh
Confidence                00000001111222345789999999999999999999999999999999865543

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.5e-41  Score=308.51  Aligned_cols=255  Identities=25%  Similarity=0.411  Sum_probs=220.7

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecccc------hHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCcc
Q 015374          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK------KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP  197 (408)
Q Consensus       124 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~------~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~  197 (408)
                      ..+|..+..||+|+||+|.+|..+.+.+.+|||++++..      .+--..|-++|.-..+-|.++++..+|+.  -..+
T Consensus       348 ~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQT--mDRL  425 (683)
T KOG0696|consen  348 ATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQT--MDRL  425 (683)
T ss_pred             ecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhh--hhhe
Confidence            467899999999999999999999999999999997532      22234566777766567899999999954  4678


Q ss_pred             EEEEEeecCCChhhhcC---CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceecc-CC
Q 015374          198 SLIFEYVNSTDFKVLYP---TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH-PG  273 (408)
Q Consensus       198 ~lv~e~~~~~~l~~~~~---~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~-~~  273 (408)
                      ++||||+.||+|...++   .+.+..+..++.+|+-||-+||++|||+||||.+|||+|.+ |.+||+|||+++.-. .+
T Consensus       426 yFVMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~e-GHiKi~DFGmcKEni~~~  504 (683)
T KOG0696|consen  426 YFVMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSE-GHIKIADFGMCKENIFDG  504 (683)
T ss_pred             eeEEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccC-CceEeeecccccccccCC
Confidence            89999999999998874   58888899999999999999999999999999999999999 899999999997543 34


Q ss_pred             CcceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCCCcc
Q 015374          274 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWS  353 (408)
Q Consensus       274 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  353 (408)
                      ..+.+.+||+.|+|||++.. ++|+.++|.|||||+||||+.|+.|| .|.+..+.++.|.+.                 
T Consensus       505 ~TTkTFCGTPdYiAPEIi~Y-qPYgksvDWWa~GVLLyEmlaGQpPF-dGeDE~elF~aI~eh-----------------  565 (683)
T KOG0696|consen  505 VTTKTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQPPF-DGEDEDELFQAIMEH-----------------  565 (683)
T ss_pred             cceeeecCCCcccccceEEe-cccccchhHHHHHHHHHHHHcCCCCC-CCCCHHHHHHHHHHc-----------------
Confidence            45677899999999999987 89999999999999999999999997 788888888888774                 


Q ss_pred             ccccccCCCCCCHHHHHHHHHhcccCcCCCCC-----HHHHhcCCCccccccchh
Q 015374          354 KFINADNQHLVSPEAIDFLDKLLRYDHQDRLT-----AREAMAHPYFAQVRAAES  403 (408)
Q Consensus       354 ~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt-----~~elL~hp~f~~~~~~~~  403 (408)
                         +...++.+|.++.++...+|...|.+|..     -+++-.||||..+++...
T Consensus       566 ---nvsyPKslSkEAv~ickg~ltK~P~kRLGcg~~ge~di~~H~FFR~iDWek~  617 (683)
T KOG0696|consen  566 ---NVSYPKSLSKEAVAICKGLLTKHPGKRLGCGPEGERDIREHPFFRRIDWEKL  617 (683)
T ss_pred             ---cCcCcccccHHHHHHHHHHhhcCCccccCCCCccccchhhCcchhhccHHHH
Confidence               34556778999999999999999999983     468899999999998654

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.5e-41  Score=323.85  Aligned_cols=246  Identities=28%  Similarity=0.413  Sum_probs=205.4

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecccchHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccEEEEE
Q 015374          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFE  202 (408)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e  202 (408)
                      +.+.|++...+|.|+|+.|-.+.+..+++..++|++... ..+..+|+.++....+|+|++++.+.+.+  +.+.++|||
T Consensus       320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~-~~~~~~e~~~~~~~~~h~niv~~~~v~~~--~~~~~~v~e  396 (612)
T KOG0603|consen  320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKR-ADDNQDEIPISLLVRDHPNIVKSHDVYED--GKEIYLVME  396 (612)
T ss_pred             cchhhccccccCCCCccceeeeeccccccchhheecccc-ccccccccchhhhhcCCCcceeecceecC--Cceeeeeeh
Confidence            467899999999999999999999999999999999754 45567888888888899999999999955  678899999


Q ss_pred             eecCCChhhhcCCCCh--HHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCCCcceeec
Q 015374          203 YVNSTDFKVLYPTLTD--YDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRV  280 (408)
Q Consensus       203 ~~~~~~l~~~~~~l~~--~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~~~~~~~~  280 (408)
                      .+.++.+...+.....  .++..|+.+|+.++.|||++|||||||||+|||++.+.++++|+|||.++.....  ..+.+
T Consensus       397 ~l~g~ell~ri~~~~~~~~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~--~~tp~  474 (612)
T KOG0603|consen  397 LLDGGELLRRIRSKPEFCSEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS--CDTPA  474 (612)
T ss_pred             hccccHHHHHHHhcchhHHHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhCchh--hcccc
Confidence            9999988776643222  5667799999999999999999999999999999533389999999999877644  45567


Q ss_pred             cCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCCCccccccccC
Q 015374          281 ASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSKFINADN  360 (408)
Q Consensus       281 ~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  360 (408)
                      -|..|.|||++.. ..|+.++|+||||++||+||+|+.||....++.+.... +.   ..                  ..
T Consensus       475 ~t~~y~APEvl~~-~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~-i~---~~------------------~~  531 (612)
T KOG0603|consen  475 LTLQYVAPEVLAI-QEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTR-IQ---MP------------------KF  531 (612)
T ss_pred             hhhcccChhhhcc-CCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHh-hc---CC------------------cc
Confidence            8889999999985 89999999999999999999999998544444222222 11   11                  01


Q ss_pred             CCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcc
Q 015374          361 QHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFA  396 (408)
Q Consensus       361 ~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~  396 (408)
                      ...+|.+++||+++||+.||.+|+++.+++.||||.
T Consensus       532 s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~~  567 (612)
T KOG0603|consen  532 SECVSDEAKDLLQQLLQVDPALRLGADEIGAHPWFL  567 (612)
T ss_pred             ccccCHHHHHHHHHhccCChhhCcChhhhccCcchh
Confidence            134899999999999999999999999999999993

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=8.9e-40  Score=302.78  Aligned_cols=244  Identities=17%  Similarity=0.311  Sum_probs=196.0

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCC---CcEEEEEEeccc----chHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCc
Q 015374          124 QDDYEVVRKVGRGKYSEVFEGINVNT---NERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT  196 (408)
Q Consensus       124 ~~~y~~~~~lG~G~fg~Vy~~~~~~~---~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  196 (408)
                      .++|++.+.||+|+||+||+|.+..+   ...||+|.++..    ....+.+|+.+++++ +|+||+++++++..  ...
T Consensus         3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~   79 (266)
T cd05033           3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQF-DHPNIIRLEGVVTK--SRP   79 (266)
T ss_pred             hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhC-CCCCcceEeEEEec--CCc
Confidence            46799999999999999999987644   457999998643    235688899999999 99999999999854  467


Q ss_pred             cEEEEEeecCCChhhhcC----CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccC
Q 015374          197 PSLIFEYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP  272 (408)
Q Consensus       197 ~~lv~e~~~~~~l~~~~~----~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~  272 (408)
                      .+++|||+++++|..++.    .+++..+..++.|++.||.|||+++|+|+||||+|||++.+ +.++|+|||++.....
T Consensus        80 ~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~-~~~~l~dfg~~~~~~~  158 (266)
T cd05033          80 VMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSN-LVCKVSDFGLSRRLED  158 (266)
T ss_pred             eEEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCC-CCEEECccchhhcccc
Confidence            889999999999998863    47899999999999999999999999999999999999988 7899999999987652


Q ss_pred             CC-cce--eeccCccccccccccCCcCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCC
Q 015374          273 GK-EYN--VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHS  348 (408)
Q Consensus       273 ~~-~~~--~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  348 (408)
                      .. ...  ...++..|+|||.+.+ ..++.++||||||+++|+|++ |..||.. ..+.+....+...            
T Consensus       159 ~~~~~~~~~~~~~~~y~~Pe~~~~-~~~~~~~Dv~slG~~l~~l~~~g~~p~~~-~~~~~~~~~~~~~------------  224 (266)
T cd05033         159 SEATYTTKGGKIPIRWTAPEAIAY-RKFTSASDVWSFGIVMWEVMSYGERPYWD-MSNQDVIKAVEDG------------  224 (266)
T ss_pred             cccceeccCCCCCccccChhhhcc-CCCccccchHHHHHHHHHHHccCCCCCCC-CCHHHHHHHHHcC------------
Confidence            21 111  1234567999999877 678999999999999999998 8888743 3333332222211            


Q ss_pred             CCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 015374          349 RKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH  392 (408)
Q Consensus       349 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~h  392 (408)
                             .....+..+++.+.+++.+||+.||++|||++|++++
T Consensus       225 -------~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~  261 (266)
T cd05033         225 -------YRLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVST  261 (266)
T ss_pred             -------CCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence                   0011123468899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=5.9e-40  Score=303.07  Aligned_cols=239  Identities=23%  Similarity=0.440  Sum_probs=187.5

Q ss_pred             EEEeeeeeeCceEEEEEEEc----CCCcEEEEEEeccc----chHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccEE
Q 015374          128 EVVRKVGRGKYSEVFEGINV----NTNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSL  199 (408)
Q Consensus       128 ~~~~~lG~G~fg~Vy~~~~~----~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l  199 (408)
                      ++.+.||.|.||.||+|...    ..+..|+||.++..    ..+.+.+|+++++++ +||||++++|++..  ....++
T Consensus         2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~g~~~~--~~~~~l   78 (259)
T PF07714_consen    2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKL-RHPNIVKLYGFCIE--NEPLFL   78 (259)
T ss_dssp             EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTH-SBTTBE-EEEEEES--SSSEEE
T ss_pred             EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccc-cccccccccccccc--cccccc
Confidence            56789999999999999887    45668999999642    246889999999999 99999999999973  455889


Q ss_pred             EEEeecCCChhhhc-----CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCCC
Q 015374          200 IFEYVNSTDFKVLY-----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK  274 (408)
Q Consensus       200 v~e~~~~~~l~~~~-----~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~~  274 (408)
                      |+||+++|+|..++     ..+++..+..++.|++.||.|||+++++|+||+++||+++.+ +.+||+|||++.......
T Consensus        79 v~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~-~~~Kl~~f~~~~~~~~~~  157 (259)
T PF07714_consen   79 VMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSN-GQVKLSDFGLSRPISEKS  157 (259)
T ss_dssp             EEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETT-TEEEEESTTTGEETTTSS
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc-cccccccccccccccccc
Confidence            99999999998876     248889999999999999999999999999999999999998 799999999998763222


Q ss_pred             cc---eeeccCccccccccccCCcCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCC
Q 015374          275 EY---NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRK  350 (408)
Q Consensus       275 ~~---~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  350 (408)
                      ..   ........|+|||.+.+ ..++.++||||||+++|||++ |..|| ...+..+....+.+.              
T Consensus       158 ~~~~~~~~~~~~~~~aPE~~~~-~~~~~ksDVysfG~~l~ei~~~~~~p~-~~~~~~~~~~~~~~~--------------  221 (259)
T PF07714_consen  158 KYKNDSSQQLPLRYLAPEVLKD-GEYTKKSDVYSFGMLLYEILTLGKFPF-SDYDNEEIIEKLKQG--------------  221 (259)
T ss_dssp             SEEESTTSESGGGGS-HHHHHH-SEESHHHHHHHHHHHHHHHHTTSSGTT-TTSCHHHHHHHHHTT--------------
T ss_pred             cccccccccccccccccccccc-ccccccccccccccccccccccccccc-ccccccccccccccc--------------
Confidence            22   22345667999999987 668999999999999999999 56776 444444444444221              


Q ss_pred             CccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 015374          351 PWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA  391 (408)
Q Consensus       351 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~  391 (408)
                           .....+..++..+.+++..||..||++|||+.++++
T Consensus       222 -----~~~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~  257 (259)
T PF07714_consen  222 -----QRLPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQ  257 (259)
T ss_dssp             -----EETTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHH
T ss_pred             -----ccceeccchhHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence                 112233447899999999999999999999999974

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=7.6e-40  Score=307.57  Aligned_cols=246  Identities=18%  Similarity=0.359  Sum_probs=196.6

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCC-----CcEEEEEEecccc----hHHHHHHHHHHHHhcCCCCceEEeeEEEccC
Q 015374          123 DQDDYEVVRKVGRGKYSEVFEGINVNT-----NERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQH  193 (408)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~-----~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~  193 (408)
                      ..++|++.+.||+|+||.||++.....     ...+|+|.++...    ...+.+|+.+++++.+|+||+++++++..  
T Consensus        10 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~--   87 (293)
T cd05053          10 PRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQ--   87 (293)
T ss_pred             CHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcC--
Confidence            467899999999999999999987643     3689999986432    24578899999998779999999999954  


Q ss_pred             CCccEEEEEeecCCChhhhcC-------------------CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeC
Q 015374          194 SKTPSLIFEYVNSTDFKVLYP-------------------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDH  254 (408)
Q Consensus       194 ~~~~~lv~e~~~~~~l~~~~~-------------------~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~  254 (408)
                      ....+++|||+++++|..++.                   .+++..+..++.|++.||.|||+.+|+|+||||+||+++.
T Consensus        88 ~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~~~  167 (293)
T cd05053          88 EGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTE  167 (293)
T ss_pred             CCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEEcC
Confidence            467899999999999988762                   3788888999999999999999999999999999999998


Q ss_pred             CCCcEEEEecccceeccCCCcc---eeeccCccccccccccCCcCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHH
Q 015374          255 ELRKLRLIDWGLAEFYHPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQL  330 (408)
Q Consensus       255 ~~~~~kl~DfG~a~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-g~~pf~~~~~~~~~~  330 (408)
                      + +.+||+|||+++........   ....++..|+|||++.+ ..++.++|||||||++|||++ |..|| .+....+..
T Consensus       168 ~-~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~-~~~~~~~~~  244 (293)
T cd05053         168 D-HVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLLWEIFTLGGSPY-PGIPVEELF  244 (293)
T ss_pred             C-CeEEeCccccccccccccceeccCCCCCCccccCHHHhcc-CCcCcccceeehhhHHHHHhcCCCCCC-CCCCHHHHH
Confidence            8 79999999999866533221   11234567999999876 778999999999999999997 88787 343333333


Q ss_pred             HHHHhhhchhhhhcCCCCCCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 015374          331 VKIAKDCCLIIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH  392 (408)
Q Consensus       331 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~h  392 (408)
                      ..+...                   .....+..++.++.+|+.+||..||++|||+.|++++
T Consensus       245 ~~~~~~-------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~  287 (293)
T cd05053         245 KLLKEG-------------------YRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED  287 (293)
T ss_pred             HHHHcC-------------------CcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence            322211                   0111223467899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=7.7e-41  Score=321.25  Aligned_cols=254  Identities=23%  Similarity=0.454  Sum_probs=217.3

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecccc-----hHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCcc
Q 015374          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK-----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP  197 (408)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~  197 (408)
                      ....|.+...||+|.|++|.+|++..++..||||++++..     ...+.+|+++|+.| +|||||+++.+.+.  ...+
T Consensus        54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l-~HPnIvkl~~v~~t--~~~l  130 (596)
T KOG0586|consen   54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSL-NHPNIVKLFSVIET--EATL  130 (596)
T ss_pred             cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhc-CCcceeeeeeeeee--ccee
Confidence            4567999999999999999999999999999999997543     35588999999999 99999999999965  4788


Q ss_pred             EEEEEeecCCChhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCCC
Q 015374          198 SLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK  274 (408)
Q Consensus       198 ~lv~e~~~~~~l~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~~  274 (408)
                      ++||||+.+|.+.+++   ....+..++.++.|+..+++|||+++|||||||++||||+.+ ..+||+|||++..+..+.
T Consensus       131 ylV~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~-mnikIaDfgfS~~~~~~~  209 (596)
T KOG0586|consen  131 YLVMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDEN-MNIKIADFGFSTFFDYGL  209 (596)
T ss_pred             EEEEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccc-cceeeeccccceeecccc
Confidence            9999999999999998   346778889999999999999999999999999999999999 579999999999998888


Q ss_pred             cceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCCCccc
Q 015374          275 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSK  354 (408)
Q Consensus       275 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  354 (408)
                      ...+.+|++.|.|||++.+....++.+|+||+|+++|.|+.|..|| .|.+-.+.-...+                    
T Consensus       210 ~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPF-DG~~lk~Lr~rvl--------------------  268 (596)
T KOG0586|consen  210 MLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPF-DGQNLKELRPRVL--------------------  268 (596)
T ss_pred             cccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeeccccc-CCcccccccchhe--------------------
Confidence            8889999999999999999777789999999999999999999998 3332211111100                    


Q ss_pred             cccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccccccc
Q 015374          355 FINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAA  401 (408)
Q Consensus       355 ~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~~~~~  401 (408)
                      ......+-.++.++.++|+++|-.+|.+|++.++++.|.|.....++
T Consensus       269 ~gk~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~~W~n~~~~~  315 (596)
T KOG0586|consen  269 RGKYRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKDRWRNDLLEA  315 (596)
T ss_pred             eeeecccceeechhHHHHHHhhccCccccCCHHHhhhhcccchhhhh
Confidence            01122233478899999999999999999999999999998765544

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=1.2e-39  Score=300.37  Aligned_cols=243  Identities=16%  Similarity=0.309  Sum_probs=194.8

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecccc--hHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccEEEE
Q 015374          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK--KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIF  201 (408)
Q Consensus       124 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~  201 (408)
                      .++|++.+.||+|+||+||+|.+. ++..+|+|.++...  .+.+.+|+.+++++ +||||+++++++.+  ....+++|
T Consensus         3 ~~~~~~~~~lg~G~~~~vy~~~~~-~~~~~aik~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~~~lv~   78 (256)
T cd05113           3 PKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDEFIEEAKVMMKL-SHEKLVQLYGVCTK--QRPIYIVT   78 (256)
T ss_pred             hHHeEEeeEecCcccceEEEEEec-CCCcEEEEEcCCCcccHHHHHHHHHHHhcC-CCCCeeeEEEEEcc--CCCcEEEE
Confidence            467999999999999999999764 34569999887432  46789999999999 89999999999954  45678999


Q ss_pred             EeecCCChhhhcC----CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCCCcce
Q 015374          202 EYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN  277 (408)
Q Consensus       202 e~~~~~~l~~~~~----~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~~~~~  277 (408)
                      ||+++++|..++.    .+++..+..++.|++.||.|||+.|++|+||||+||+++.+ +.+||+|||.++.........
T Consensus        79 e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~-~~~kl~d~g~~~~~~~~~~~~  157 (256)
T cd05113          79 EYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQ-GCVKVSDFGLSRYVLDDEYTS  157 (256)
T ss_pred             EcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCC-CCEEECCCccceecCCCceee
Confidence            9999999988763    47889999999999999999999999999999999999987 789999999987654332211


Q ss_pred             --eeccCccccccccccCCcCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCCCccc
Q 015374          278 --VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSK  354 (408)
Q Consensus       278 --~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  354 (408)
                        ...++..|++||.+.+ ..++.++|||||||++|+|++ |..||. ..+..+....+....                 
T Consensus       158 ~~~~~~~~~y~~pe~~~~-~~~~~~~Di~slG~~l~~l~~~g~~p~~-~~~~~~~~~~~~~~~-----------------  218 (256)
T cd05113         158 SVGSKFPVRWSPPEVLLY-SKFSSKSDVWAFGVLMWEVYSLGKMPYE-RFNNSETVEKVSQGL-----------------  218 (256)
T ss_pred             cCCCccChhhCCHHHHhc-CcccchhHHHHHHHHHHHHhcCCCCCcC-cCCHHHHHHHHhcCC-----------------
Confidence              1234567999999976 678999999999999999998 888873 333333333332210                 


Q ss_pred             cccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 015374          355 FINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH  392 (408)
Q Consensus       355 ~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~h  392 (408)
                        ....+...++.+.+++.+||+.||++|||+.+++++
T Consensus       219 --~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~  254 (256)
T cd05113         219 --RLYRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSS  254 (256)
T ss_pred             --CCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHh
Confidence              001122257899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=1.3e-39  Score=311.07  Aligned_cols=273  Identities=32%  Similarity=0.532  Sum_probs=208.3

Q ss_pred             CCCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecc-----cchHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCc
Q 015374          122 GDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP-----VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT  196 (408)
Q Consensus       122 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~-----~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  196 (408)
                      ...++|++.+.||.|+||.||+|.+..++..||+|.+..     ...+.+.+|+.+++.+ +||||++++++|... ...
T Consensus         7 ~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~-~~~   84 (328)
T cd07856           7 EITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHL-RHENIISLSDIFISP-LED   84 (328)
T ss_pred             ccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhc-CCCCeeeEeeeEecC-CCc
Confidence            357889999999999999999999999999999998753     2245678999999999 999999999998653 346


Q ss_pred             cEEEEEeecCCChhhhcC--CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCCC
Q 015374          197 PSLIFEYVNSTDFKVLYP--TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK  274 (408)
Q Consensus       197 ~~lv~e~~~~~~l~~~~~--~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~~  274 (408)
                      .++++||++ +++..++.  .+++..+..++.|++.||.|||+.+|+|+||+|+||+++.+ +.++|+|||.+.....  
T Consensus        85 ~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~-~~~~l~dfg~~~~~~~--  160 (328)
T cd07856          85 IYFVTELLG-TDLHRLLTSRPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINEN-CDLKICDFGLARIQDP--  160 (328)
T ss_pred             EEEEeehhc-cCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCC-CCEEeCccccccccCC--
Confidence            789999995 46766653  57888888999999999999999999999999999999987 7899999999875432  


Q ss_pred             cceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcC--CCCCC--
Q 015374          275 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNS--RHSRK--  350 (408)
Q Consensus       275 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~--  350 (408)
                      ......++..|+|||.+.+...++.++|+|||||++|+|++|+.|| .+.+.......+.+..+.......  .....  
T Consensus       161 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (328)
T cd07856         161 QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLF-PGKDHVNQFSIITDLLGTPPDDVINTICSENTL  239 (328)
T ss_pred             CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHHHhCCCCHHHHHhccchhhH
Confidence            2233467788999999866457899999999999999999999887 333333333333333221110000  00000  


Q ss_pred             -Ccc------ccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccccccc
Q 015374          351 -PWS------KFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAA  401 (408)
Q Consensus       351 -~~~------~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~~~~~  401 (408)
                       .+.      ..........+++++.++|.+||+.||++|||+++++.||||......
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~~~~  297 (328)
T cd07856         240 RFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYHDP  297 (328)
T ss_pred             HHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCccccccCC
Confidence             000      000001122467899999999999999999999999999999766543

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=9.9e-40  Score=304.45  Aligned_cols=246  Identities=18%  Similarity=0.339  Sum_probs=195.7

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcC-----CCcEEEEEEeccc----chHHHHHHHHHHHHhcCCCCceEEeeEEEccC
Q 015374          123 DQDDYEVVRKVGRGKYSEVFEGINVN-----TNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQH  193 (408)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~Vy~~~~~~-----~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~  193 (408)
                      ..++|++.+.||+|+||.||+|.+..     ++..|++|.+...    ....+.+|+.+++++ +|+||+++++++.+. 
T Consensus         4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~-   81 (277)
T cd05036           4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKF-NHQNIVRLIGVSFER-   81 (277)
T ss_pred             CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEccC-
Confidence            45789999999999999999999876     6788999988632    234688999999999 999999999988553 


Q ss_pred             CCccEEEEEeecCCChhhhcC----------CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCC--CcEEE
Q 015374          194 SKTPSLIFEYVNSTDFKVLYP----------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEL--RKLRL  261 (408)
Q Consensus       194 ~~~~~lv~e~~~~~~l~~~~~----------~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~--~~~kl  261 (408)
                       ...++||||+++++|..++.          .+++..+..++.||+.||+|||+++++|+||||+||+++.+.  ..+||
T Consensus        82 -~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl  160 (277)
T cd05036          82 -LPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKI  160 (277)
T ss_pred             -CCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEe
Confidence             56789999999999998762          378888999999999999999999999999999999998652  36899


Q ss_pred             EecccceeccCCCcc---eeeccCccccccccccCCcCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHhhh
Q 015374          262 IDWGLAEFYHPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKDC  337 (408)
Q Consensus       262 ~DfG~a~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-g~~pf~~~~~~~~~~~~~~~~~  337 (408)
                      +|||+++........   .....+..|+|||++.+ ..++.++|||||||++|||++ |..|| .+.+..+... .....
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~~g~~pf-~~~~~~~~~~-~~~~~  237 (277)
T cd05036         161 ADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLD-GIFTSKTDVWSFGVLLWEIFSLGYMPY-PGRTNQEVME-FVTGG  237 (277)
T ss_pred             ccCccccccCCccceecCCCCCccHhhCCHHHHhc-CCcCchhHHHHHHHHHHHHHcCCCCCC-CCCCHHHHHH-HHHcC
Confidence            999999866322211   11223457999999987 679999999999999999997 87776 3433333322 22110


Q ss_pred             chhhhhcCCCCCCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 015374          338 CLIIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH  392 (408)
Q Consensus       338 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~h  392 (408)
                      .                  ....+..++.++.+++.+||+.||++|||+.++++|
T Consensus       238 ~------------------~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~  274 (277)
T cd05036         238 G------------------RLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILER  274 (277)
T ss_pred             C------------------cCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            0                  011233468899999999999999999999999976

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=1.8e-39  Score=304.63  Aligned_cols=257  Identities=23%  Similarity=0.427  Sum_probs=204.5

Q ss_pred             CEEEEeeeeeeCceEEEEEEEc---CCCcEEEEEEeccc-------chHHHHHHHHHHHHhcCCCCceEEeeEEEccCCC
Q 015374          126 DYEVVRKVGRGKYSEVFEGINV---NTNERCIIKILKPV-------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSK  195 (408)
Q Consensus       126 ~y~~~~~lG~G~fg~Vy~~~~~---~~~~~vavK~~~~~-------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  195 (408)
                      +|++.+.||.|+||.||++.+.   .++..||+|+++..       ..+.+.+|+.++.++.+|+||+++++++..  +.
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~--~~   78 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT--DT   78 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeec--CC
Confidence            4788999999999999999874   47889999998642       235678899999999779999999999954  46


Q ss_pred             ccEEEEEeecCCChhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccC
Q 015374          196 TPSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP  272 (408)
Q Consensus       196 ~~~lv~e~~~~~~l~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~  272 (408)
                      ..++||||+++++|..++   ..+++..+..++.|++.||.|||+.|++||||+|+|||++.+ +.++|+|||++.....
T Consensus        79 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~-~~~kl~dfg~~~~~~~  157 (290)
T cd05613          79 KLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSN-GHVVLTDFGLSKEFHE  157 (290)
T ss_pred             eEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCC-CCEEEeeCccceeccc
Confidence            788999999999998876   347888999999999999999999999999999999999988 7999999999876543


Q ss_pred             CCc--ceeeccCccccccccccCC-cCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCC
Q 015374          273 GKE--YNVRVASRYFKGPELLVDL-QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSR  349 (408)
Q Consensus       273 ~~~--~~~~~~~~~y~aPE~~~~~-~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  349 (408)
                      ...  .....++..|++||.+.+. ..++.++||||||+++|+|++|..||... ........+......          
T Consensus       158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~-~~~~~~~~~~~~~~~----------  226 (290)
T cd05613         158 DEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVD-GEKNSQAEISRRILK----------  226 (290)
T ss_pred             ccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcC-CccccHHHHHHHhhc----------
Confidence            221  2234678889999998652 35678999999999999999999998422 111112222211000          


Q ss_pred             CCccccccccCCCCCCHHHHHHHHHhcccCcCCCC-----CHHHHhcCCCccccccch
Q 015374          350 KPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRL-----TAREAMAHPYFAQVRAAE  402 (408)
Q Consensus       350 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rp-----t~~elL~hp~f~~~~~~~  402 (408)
                            .....+..++..+.+++.+||+.||++||     ++++++.||||+.+....
T Consensus       227 ------~~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~~~  278 (290)
T cd05613         227 ------SEPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKINWDD  278 (290)
T ss_pred             ------cCCCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccCCHHH
Confidence                  00112234688999999999999999997     899999999999988644

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.4e-41  Score=298.97  Aligned_cols=257  Identities=24%  Similarity=0.432  Sum_probs=206.1

Q ss_pred             eeeeeeCceEEEEEEEcCCCcEEEEEEeccc---chHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccEEEEEeecCC
Q 015374          131 RKVGRGKYSEVFEGINVNTNERCIIKILKPV---KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNST  207 (408)
Q Consensus       131 ~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~~~  207 (408)
                      +.||+|+|+.|-.++...++..+|||++.+.   .+++..+|++++.+.++|+||+.++++|+++  ...|||||-|.||
T Consensus        84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd--~~FYLVfEKm~GG  161 (463)
T KOG0607|consen   84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDD--TRFYLVFEKMRGG  161 (463)
T ss_pred             HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhccc--ceEEEEEecccCc
Confidence            3699999999999999999999999999753   4678899999999999999999999999764  5678999999999


Q ss_pred             ChhhhcC---CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCC--CCcEEEEecccceeccCCC--------
Q 015374          208 DFKVLYP---TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE--LRKLRLIDWGLAEFYHPGK--------  274 (408)
Q Consensus       208 ~l~~~~~---~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~--~~~~kl~DfG~a~~~~~~~--------  274 (408)
                      .+...+.   -|++.++..++.+|+.||+|||.+||.||||||+|||-...  ...+|||||.+...+.-+.        
T Consensus       162 plLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spastP  241 (463)
T KOG0607|consen  162 PLLSHIQKRKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSPASTP  241 (463)
T ss_pred             hHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccCCCCCCCCCc
Confidence            9988873   49999999999999999999999999999999999997543  2468999999875443222        


Q ss_pred             cceeeccCcccccccccc---C-CcCCCccccHHHHHHHHHHHHhCCCCCCC------CCCCHH---H-HHHHHhhhchh
Q 015374          275 EYNVRVASRYFKGPELLV---D-LQDYDYSLDMWSLGCMFAGMIFRKEPFFY------GHDNHD---Q-LVKIAKDCCLI  340 (408)
Q Consensus       275 ~~~~~~~~~~y~aPE~~~---~-~~~~~~~~DvwSlGvil~ell~g~~pf~~------~~~~~~---~-~~~~~~~~~~~  340 (408)
                      ...+.+|+..|||||+..   + ...|+.++|.|||||++|-||+|..||..      |.+..+   . .+.+.+.+   
T Consensus       242 ~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFesI---  318 (463)
T KOG0607|consen  242 ELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESI---  318 (463)
T ss_pred             cccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHHHH---
Confidence            233467788899999963   2 24689999999999999999999999843      111111   0 11111110   


Q ss_pred             hhhcCCCCCCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccccccc
Q 015374          341 IWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAA  401 (408)
Q Consensus       341 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~~~~~  401 (408)
                           ...    ...++...|.++|.+++|+++.+|..|+.+|.++.++++|||++....+
T Consensus       319 -----QEG----kYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~~~e  370 (463)
T KOG0607|consen  319 -----QEG----KYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRCAPE  370 (463)
T ss_pred             -----hcc----CCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCccccccchh
Confidence                 000    0113556677899999999999999999999999999999999987654

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=1.1e-39  Score=302.99  Aligned_cols=242  Identities=17%  Similarity=0.336  Sum_probs=190.4

Q ss_pred             EEEeeeeeeCceEEEEEEEcCCCc--EEEEEEeccc-----chHHHHHHHHHHHHhcCCCCceEEeeEEEcc----CCCc
Q 015374          128 EVVRKVGRGKYSEVFEGINVNTNE--RCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQ----HSKT  196 (408)
Q Consensus       128 ~~~~~lG~G~fg~Vy~~~~~~~~~--~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~----~~~~  196 (408)
                      .+.+.||+|+||.||+|++..++.  .+|+|.++..     ..+.+.+|+.+++.+ +|+||+++++++...    ....
T Consensus         2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~   80 (272)
T cd05075           2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEF-DHPNVMRLIGVCLQTVESEGYPS   80 (272)
T ss_pred             ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhC-CCCCcceEEEEEccCCcccCCCC
Confidence            456789999999999999877765  5899987632     245688899999999 999999999987532    1235


Q ss_pred             cEEEEEeecCCChhhhc---------CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccc
Q 015374          197 PSLIFEYVNSTDFKVLY---------PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA  267 (408)
Q Consensus       197 ~~lv~e~~~~~~l~~~~---------~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a  267 (408)
                      .+++|||+.+++|..++         ..+++..+..++.|++.||.|||+++|+||||||+|||++.+ +.++|+|||++
T Consensus        81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~-~~~kl~Dfg~~  159 (272)
T cd05075          81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNEN-MNVCVADFGLS  159 (272)
T ss_pred             cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCC-CCEEECCCCcc
Confidence            78999999999987765         237888899999999999999999999999999999999987 78999999999


Q ss_pred             eeccCCCcc---eeeccCccccccccccCCcCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHhhhchhhhh
Q 015374          268 EFYHPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKDCCLIIWC  343 (408)
Q Consensus       268 ~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~  343 (408)
                      +........   ....++..|++||.+.+ ..++.++|||||||++|||++ |..|| .+..+.+....+... .     
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Di~slG~il~el~~~g~~p~-~~~~~~~~~~~~~~~-~-----  231 (272)
T cd05075         160 KKIYNGDYYRQGRIAKMPVKWIAIESLAD-RVYTTKSDVWSFGVTMWEIATRGQTPY-PGVENSEIYDYLRQG-N-----  231 (272)
T ss_pred             cccCcccceecCCcccCCcccCCHHHccC-CCcChHHHHHHHHHHHHHHHcCCCCCC-CCCCHHHHHHHHHcC-C-----
Confidence            876433221   12245667999999987 778999999999999999999 66676 444443333322211 0     


Q ss_pred             cCCCCCCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 015374          344 NSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH  392 (408)
Q Consensus       344 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~h  392 (408)
                                   ....+..++..+.+++.+||+.||++|||+.+++++
T Consensus       232 -------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~  267 (272)
T cd05075         232 -------------RLKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCE  267 (272)
T ss_pred             -------------CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence                         001123467889999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=9.4e-41  Score=287.54  Aligned_cols=252  Identities=21%  Similarity=0.322  Sum_probs=199.8

Q ss_pred             CCCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEec---ccchHHHHHHHHHHHHhcCCCCceEEeeEEEcc---CCC
Q 015374          122 GDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK---PVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQ---HSK  195 (408)
Q Consensus       122 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~---~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~---~~~  195 (408)
                      .++++|.+.+.||+|||+-||.+....++..+|+|.+.   ..+.+...+|++..+++ +|||+++++++...+   ...
T Consensus        18 In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf-~s~~vl~l~dh~l~~~~D~~~   96 (302)
T KOG2345|consen   18 INNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKF-NSPNVLRLVDHQLREEKDGKH   96 (302)
T ss_pred             EcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhh-CCcchHHHHHHHHHhhccCce
Confidence            46899999999999999999999999999999999885   34557788999999999 999999999987532   234


Q ss_pred             ccEEEEEeecCCChhhhcC-------CCChHHHHHHHHHHHHHHHHHHHCC--cEEecCCCCcEEEeCCCCcEEEEeccc
Q 015374          196 TPSLIFEYVNSTDFKVLYP-------TLTDYDIRYYIYELLKALDYCHSQG--IMHRDVKPHNVMIDHELRKLRLIDWGL  266 (408)
Q Consensus       196 ~~~lv~e~~~~~~l~~~~~-------~l~~~~~~~i~~qi~~~L~~LH~~~--iiH~Dlk~~NILl~~~~~~~kl~DfG~  266 (408)
                      ..+|++.|...|+|.+.+.       .+++.++..|+.++++||++||+..  +.||||||.|||+.+. +.+++.|||.
T Consensus        97 ~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~-~~~vl~D~GS  175 (302)
T KOG2345|consen   97 EAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDS-GLPVLMDLGS  175 (302)
T ss_pred             eEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCC-CceEEEeccC
Confidence            6889999999999888762       4899999999999999999999998  9999999999999987 7899999999


Q ss_pred             ceeccCCC----------cceeeccCccccccccccC--CcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHH
Q 015374          267 AEFYHPGK----------EYNVRVASRYFKGPELLVD--LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA  334 (408)
Q Consensus       267 a~~~~~~~----------~~~~~~~~~~y~aPE~~~~--~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~  334 (408)
                      ++...-.-          .......|..|+|||.+.-  ....+.++|||||||++|+|+.|..||..          +.
T Consensus       176 ~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~----------~~  245 (302)
T KOG2345|consen  176 ATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFER----------IY  245 (302)
T ss_pred             ccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchH----------Hh
Confidence            86543111          1122356788999999853  24578999999999999999999999932          11


Q ss_pred             hhhchhhhhcCCCCCCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 015374          335 KDCCLIIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH  392 (408)
Q Consensus       335 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~h  392 (408)
                      +..|.... ......      +........|+.+.+++..||+.||.+||++.+++.+
T Consensus       246 ~~GgSlaL-Av~n~q------~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~  296 (302)
T KOG2345|consen  246 QQGGSLAL-AVQNAQ------ISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSK  296 (302)
T ss_pred             hcCCeEEE-eeeccc------cccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence            21221110 000000      1111122278999999999999999999999999864

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.9e-42  Score=298.53  Aligned_cols=275  Identities=31%  Similarity=0.486  Sum_probs=216.2

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecc-c----chHHHHHHHHHHHHhcCCCCceEEeeEEEcc------
Q 015374          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP-V----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQ------  192 (408)
Q Consensus       124 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~-~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~------  192 (408)
                      .+.|+-..+||+|.||+||+|+..++++.||+|+.-- .    -.....+|+++|..| .|+|++.++..|...      
T Consensus        16 ~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~l-kHenv~nliEic~tk~Tp~~r   94 (376)
T KOG0669|consen   16 VSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLL-KHENVVNLIEICRTKATPTNR   94 (376)
T ss_pred             chHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHh-cchhHHHHHHHHhhccCCccc
Confidence            4567778899999999999999999999999876421 1    124567999999999 999999999988632      


Q ss_pred             CCCccEEEEEeecCCC---hhhhcCCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEeccccee
Q 015374          193 HSKTPSLIFEYVNSTD---FKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEF  269 (408)
Q Consensus       193 ~~~~~~lv~e~~~~~~---l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~  269 (408)
                      .....+|||++|+...   |......++..++..++.+++.||.|+|...|+|||+|+.|+|++.+ +.+||+|||+++.
T Consensus        95 ~r~t~ylVf~~cehDLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~d-gilklADFGlar~  173 (376)
T KOG0669|consen   95 DRATFYLVFDFCEHDLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKD-GILKLADFGLARA  173 (376)
T ss_pred             ccceeeeeHHHhhhhHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCC-ceEEeeccccccc
Confidence            2235789999998743   44444679999999999999999999999999999999999999998 8999999999976


Q ss_pred             ccCCC-----cceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhc
Q 015374          270 YHPGK-----EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCN  344 (408)
Q Consensus       270 ~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  344 (408)
                      +....     .++.++-|..|++||.+++...|+++.|||.-||++.||.+|.. .+.+..+..++..|...+|.....-
T Consensus       174 fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrsp-imqgnteqqql~~Is~LcGs~tkev  252 (376)
T KOG0669|consen  174 FSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSP-IMQGNTEQQQLHLISQLCGSITKEV  252 (376)
T ss_pred             eecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCc-cccCChHHHHHHHHHHHhccCCccc
Confidence            54322     24556778999999999999999999999999999999999875 4588888888988888877443111


Q ss_pred             CCC---------------CCCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccccccc
Q 015374          345 SRH---------------SRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAA  401 (408)
Q Consensus       345 ~~~---------------~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~~~~~  401 (408)
                      +..               ....++...+.-.+-.-++++.|++.++|.+||.+|++++++|+|.||..-+.+
T Consensus       253 WP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~kdp~p  324 (376)
T KOG0669|consen  253 WPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWKDPMP  324 (376)
T ss_pred             CCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhcCCcc
Confidence            110               000111111111111225789999999999999999999999999999754443

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.6e-39  Score=298.81  Aligned_cols=243  Identities=20%  Similarity=0.330  Sum_probs=196.2

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc--chHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccEEE
Q 015374          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV--KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI  200 (408)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  200 (408)
                      ..++|++.+.||+|+||.||+|.+. ++..||+|.++..  ..+.+.+|+.+++++ +|+||+++++++..  ....+++
T Consensus         4 ~~~~~~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~~~lv   79 (261)
T cd05068           4 DRTSIQLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGTMDPKDFLAEAQIMKKL-RHPKLIQLYAVCTL--EEPIYIV   79 (261)
T ss_pred             chhheeeEEEecccCCccEEEEEec-CCeEEEEEeeCCCcccHHHHHHHHHHHHHC-CCCCccceeEEEec--CCCeeee
Confidence            4678999999999999999999864 4578999998753  346788999999999 89999999999855  4678899


Q ss_pred             EEeecCCChhhhcC-----CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCCCc
Q 015374          201 FEYVNSTDFKVLYP-----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE  275 (408)
Q Consensus       201 ~e~~~~~~l~~~~~-----~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~~~  275 (408)
                      |||+++++|..++.     .+++..+..++.|++.||.|||++||+|+||||+||+++.+ +.++|+|||++........
T Consensus        80 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~-~~~~l~dfg~~~~~~~~~~  158 (261)
T cd05068          80 TELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGEN-NICKVADFGLARVIKEDIY  158 (261)
T ss_pred             eecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCC-CCEEECCcceEEEccCCcc
Confidence            99999999988863     47889999999999999999999999999999999999988 7899999999987653221


Q ss_pred             c--eeeccCccccccccccCCcCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCCCc
Q 015374          276 Y--NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPW  352 (408)
Q Consensus       276 ~--~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  352 (408)
                      .  .....+..|+|||.+.+ ..++.++|+||||+++|||++ |+.|| .+....+.+..+....               
T Consensus       159 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~-~~~~~~~~~~~~~~~~---------------  221 (261)
T cd05068         159 EAREGAKFPIKWTAPEAALY-NRFSIKSDVWSFGILLTEIVTYGRMPY-PGMTNAEVLQQVDQGY---------------  221 (261)
T ss_pred             cccCCCcCceeccCcccccc-CCCCchhhHHHHHHHHHHHHhcCCCCC-CCCCHHHHHHHHHcCC---------------
Confidence            1  11122347999999877 778999999999999999999 87776 4444333333322110               


Q ss_pred             cccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 015374          353 SKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA  391 (408)
Q Consensus       353 ~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~  391 (408)
                          ....+..+++.+.+++.+||+.||++||++.++++
T Consensus       222 ----~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~  256 (261)
T cd05068         222 ----RMPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQW  256 (261)
T ss_pred             ----CCCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence                01112336789999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=4.6e-40  Score=307.52  Aligned_cols=244  Identities=19%  Similarity=0.325  Sum_probs=194.3

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCC-----CcEEEEEEecccc----hHHHHHHHHHHHHhcCCCCceEEeeEEEccCC
Q 015374          124 QDDYEVVRKVGRGKYSEVFEGINVNT-----NERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHS  194 (408)
Q Consensus       124 ~~~y~~~~~lG~G~fg~Vy~~~~~~~-----~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~  194 (408)
                      ..+|++.++||+|+||+||+|.+..+     +..||+|+++...    ...+.+|+.++..+ +||||+++++++.+.  
T Consensus         4 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~h~~iv~~~~~~~~~--   80 (283)
T cd05091           4 LSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRL-QHPNIVCLLGVVTKE--   80 (283)
T ss_pred             HHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcC-CCCCcCeEEEEEcCC--
Confidence            34577788999999999999987543     5789999987432    35578899999999 999999999999654  


Q ss_pred             CccEEEEEeecCCChhhhcC-------------------CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCC
Q 015374          195 KTPSLIFEYVNSTDFKVLYP-------------------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE  255 (408)
Q Consensus       195 ~~~~lv~e~~~~~~l~~~~~-------------------~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~  255 (408)
                      ...++++||+.+++|..++.                   .+++..+..++.|++.||.|||++||+||||||+|||++++
T Consensus        81 ~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~  160 (283)
T cd05091          81 QPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDK  160 (283)
T ss_pred             CceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecCC
Confidence            56789999999999888762                   36777888999999999999999999999999999999987


Q ss_pred             CCcEEEEecccceeccCCCcc---eeeccCccccccccccCCcCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHH
Q 015374          256 LRKLRLIDWGLAEFYHPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLV  331 (408)
Q Consensus       256 ~~~~kl~DfG~a~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-g~~pf~~~~~~~~~~~  331 (408)
                       +.+||+|||+++........   ....++..|+|||.+.+ ..++.++|||||||++|||++ |..|| .+....+...
T Consensus       161 -~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~~~g~~p~-~~~~~~~~~~  237 (283)
T cd05091         161 -LNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMY-GKFSIDSDIWSYGVVLWEVFSYGLQPY-CGYSNQDVIE  237 (283)
T ss_pred             -CceEecccccccccccchheeeccCccCCccccCHHHHhc-CCCCcchhHHHHHHHHHHHHcCCCCCC-CCCCHHHHHH
Confidence             78999999998765433221   22345678999999976 678999999999999999998 66565 4444444443


Q ss_pred             HHHhhhchhhhhcCCCCCCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 015374          332 KIAKDCCLIIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH  392 (408)
Q Consensus       332 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~h  392 (408)
                      .+....                   ....+..++.++.+++.+||+.||++|||+.++++.
T Consensus       238 ~i~~~~-------------------~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~  279 (283)
T cd05091         238 MIRNRQ-------------------VLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSR  279 (283)
T ss_pred             HHHcCC-------------------cCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHH
Confidence            333210                   011234478999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=1.5e-39  Score=305.09  Aligned_cols=243  Identities=20%  Similarity=0.342  Sum_probs=195.2

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEc-----CCCcEEEEEEeccc---chHHHHHHHHHHHHhcCCCCceEEeeEEEccCCC
Q 015374          124 QDDYEVVRKVGRGKYSEVFEGINV-----NTNERCIIKILKPV---KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSK  195 (408)
Q Consensus       124 ~~~y~~~~~lG~G~fg~Vy~~~~~-----~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  195 (408)
                      ..+|.+.+.||+|+||+||++...     .++..+|+|.++..   ..+.+.+|+.+++++ +|+||+++++++..  ..
T Consensus         4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~   80 (288)
T cd05093           4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNL-QHEHIVKFYGVCVE--GD   80 (288)
T ss_pred             hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhC-CCCCcceEEEEEec--CC
Confidence            567899999999999999999753     34567899988643   245688999999999 99999999999964  46


Q ss_pred             ccEEEEEeecCCChhhhcC----------------CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcE
Q 015374          196 TPSLIFEYVNSTDFKVLYP----------------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKL  259 (408)
Q Consensus       196 ~~~lv~e~~~~~~l~~~~~----------------~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~  259 (408)
                      ..++||||+++++|..++.                .+++..+..++.|++.||+|||++|++||||||+|||++.+ +.+
T Consensus        81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~-~~~  159 (288)
T cd05093          81 PLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGEN-LLV  159 (288)
T ss_pred             ccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccC-CcE
Confidence            7899999999999988763                37889999999999999999999999999999999999988 799


Q ss_pred             EEEecccceeccCCCc---ceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHh
Q 015374          260 RLIDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAK  335 (408)
Q Consensus       260 kl~DfG~a~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-g~~pf~~~~~~~~~~~~~~~  335 (408)
                      +|+|||+++.......   .....++..|+|||.+.+ ..++.++|||||||++|+|++ |..|| ......+....+..
T Consensus       160 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~il~~l~t~g~~p~-~~~~~~~~~~~i~~  237 (288)
T cd05093         160 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMY-RKFTTESDVWSLGVVLWEIFTYGKQPW-YQLSNNEVIECITQ  237 (288)
T ss_pred             EeccCCccccccCCceeecCCCCCccccccCHHHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCC-CCCCHHHHHHHHHc
Confidence            9999999976543221   122334667999999987 778999999999999999998 77776 33344444333322


Q ss_pred             hhchhhhhcCCCCCCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 015374          336 DCCLIIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA  391 (408)
Q Consensus       336 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~  391 (408)
                      ..                   ....+..++.++.+++.+||+.||.+|||+.|+++
T Consensus       238 ~~-------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~  274 (288)
T cd05093         238 GR-------------------VLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHS  274 (288)
T ss_pred             CC-------------------cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            10                   00112336789999999999999999999999954

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=8.1e-40  Score=304.76  Aligned_cols=246  Identities=33%  Similarity=0.570  Sum_probs=202.9

Q ss_pred             CCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc------chHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccE
Q 015374          125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS  198 (408)
Q Consensus       125 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  198 (408)
                      ++|++.+.||+|+||.||+|++..++..+++|+++..      ....+.+|..++.++.+|+||+++++++.+  ....+
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~--~~~~~   78 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQD--EENLY   78 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcC--CceEE
Confidence            4789999999999999999999999999999998642      235678899999999339999999999854  46788


Q ss_pred             EEEEeecCCChhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCCC-
Q 015374          199 LIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK-  274 (408)
Q Consensus       199 lv~e~~~~~~l~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~~-  274 (408)
                      +||||+++++|..++   ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.+ +.++++|||++....... 
T Consensus        79 lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~-~~~~l~df~~~~~~~~~~~  157 (280)
T cd05581          79 FVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKD-MHIKITDFGTAKVLDPNSS  157 (280)
T ss_pred             EEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCC-CCEEecCCccccccCCccc
Confidence            999999999998877   358999999999999999999999999999999999999988 789999999987654322 


Q ss_pred             --------------------cceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHH
Q 015374          275 --------------------EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA  334 (408)
Q Consensus       275 --------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~  334 (408)
                                          ......++..|++||...+ ..++.++|+||||++++++++|..||... +....+..+.
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~-~~~~~~~~~~  235 (280)
T cd05581         158 PESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNE-KPAGKSSDLWALGCIIYQMLTGKPPFRGS-NEYLTFQKIL  235 (280)
T ss_pred             cccCCCCCccccccccccccccccccCCccccCHHHhCC-CCCChhhhHHHHHHHHHHHHhCCCCCCCc-cHHHHHHHHH
Confidence                                1123356788999999877 67889999999999999999999998433 2222222222


Q ss_pred             hhhchhhhhcCCCCCCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCH----HHHhcCCCc
Q 015374          335 KDCCLIIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTA----REAMAHPYF  395 (408)
Q Consensus       335 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~----~elL~hp~f  395 (408)
                      ..                    ....+..+++.+.+|+.+||+.||++|||+    +++++||||
T Consensus       236 ~~--------------------~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~  280 (280)
T cd05581         236 KL--------------------EYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF  280 (280)
T ss_pred             hc--------------------CCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence            10                    111223358899999999999999999999    999999998

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=1.3e-39  Score=307.58  Aligned_cols=246  Identities=21%  Similarity=0.365  Sum_probs=196.4

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEc-----CCCcEEEEEEecccc----hHHHHHHHHHHHHhcCCCCceEEeeEEEccC
Q 015374          123 DQDDYEVVRKVGRGKYSEVFEGINV-----NTNERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQH  193 (408)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~Vy~~~~~-----~~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~  193 (408)
                      ..++|++.+.||+|+||.||+|.+.     .++..+|+|.++...    .+.+.+|+.+++++.+|+||+++++++..  
T Consensus        33 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~--  110 (302)
T cd05055          33 PRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTI--  110 (302)
T ss_pred             cHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEec--
Confidence            4578999999999999999999753     345579999886432    34688999999999679999999999965  


Q ss_pred             CCccEEEEEeecCCChhhhcCC-----CChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccce
Q 015374          194 SKTPSLIFEYVNSTDFKVLYPT-----LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE  268 (408)
Q Consensus       194 ~~~~~lv~e~~~~~~l~~~~~~-----l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~  268 (408)
                      ....+++|||+++++|..++..     +++.++..++.|++.||.|||+++|+|+||||+|||++.+ +.++++|||+++
T Consensus       111 ~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~-~~~~l~dfg~~~  189 (302)
T cd05055         111 GGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHG-KIVKICDFGLAR  189 (302)
T ss_pred             CCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCC-CeEEECCCcccc
Confidence            4578899999999999888632     7889999999999999999999999999999999999987 789999999997


Q ss_pred             eccCCCcc---eeeccCccccccccccCCcCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHhhhchhhhhc
Q 015374          269 FYHPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKDCCLIIWCN  344 (408)
Q Consensus       269 ~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  344 (408)
                      ........   ....++..|+|||.+.+ ..++.++|||||||++|+|++ |..||.. ....+.+.+.....       
T Consensus       190 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslGvil~el~t~g~~p~~~-~~~~~~~~~~~~~~-------  260 (302)
T cd05055         190 DIMNDSNYVVKGNARLPVKWMAPESIFN-CVYTFESDVWSYGILLWEIFSLGSNPYPG-MPVDSKFYKLIKEG-------  260 (302)
T ss_pred             cccCCCceeecCCCCcccccCCHhhhcc-CCCCcHhHHHHHHHHHHHHHhCCCCCcCC-CCchHHHHHHHHcC-------
Confidence            65433221   12234667999999977 678999999999999999998 8888743 33333333322210       


Q ss_pred             CCCCCCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 015374          345 SRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA  391 (408)
Q Consensus       345 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~  391 (408)
                                 .....+...++++.+++.+||..+|++|||+.|+++
T Consensus       261 -----------~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~  296 (302)
T cd05055         261 -----------YRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQ  296 (302)
T ss_pred             -----------CcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence                       011122346789999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=6.9e-40  Score=303.49  Aligned_cols=245  Identities=24%  Similarity=0.462  Sum_probs=198.4

Q ss_pred             CCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc------chHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccE
Q 015374          125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS  198 (408)
Q Consensus       125 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  198 (408)
                      ++|++.+.||+|+||.||+|++..++..++||.+...      ....+.+|+.+++.+ +|+||+++++++.+  +...+
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~--~~~~~   78 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQL-NHPNVIKYYASFIE--DNELN   78 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHc-cCCchhhhhheeEe--CCeEE
Confidence            4678889999999999999999999999999987531      235678899999999 99999999999965  46788


Q ss_pred             EEEEeecCCChhhhcC-------CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceecc
Q 015374          199 LIFEYVNSTDFKVLYP-------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH  271 (408)
Q Consensus       199 lv~e~~~~~~l~~~~~-------~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~  271 (408)
                      ++|||+++++|..++.       .+++..+..++.|++.||.|||++|++|+||||+||+++.+ +.++|+|||++....
T Consensus        79 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~-~~~~l~dfg~~~~~~  157 (267)
T cd08229          79 IVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITAT-GVVKLGDLGLGRFFS  157 (267)
T ss_pred             EEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCC-CCEEECcchhhhccc
Confidence            9999999999988753       37888999999999999999999999999999999999987 789999999987654


Q ss_pred             CCCc-ceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCC
Q 015374          272 PGKE-YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRK  350 (408)
Q Consensus       272 ~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  350 (408)
                      .... .....++..|+|||.+.+ ..++.++|+||||+++|+|++|..||.....+...........        .    
T Consensus       158 ~~~~~~~~~~~~~~~~ape~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~--------~----  224 (267)
T cd08229         158 SKTTAAHSLVGTPYYMSPERIHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQC--------D----  224 (267)
T ss_pred             cCCcccccccCCcCccCHHHhcC-CCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcC--------C----
Confidence            3322 234568889999999977 6788999999999999999999999864433322222211110        0    


Q ss_pred             CccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 015374          351 PWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA  391 (408)
Q Consensus       351 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~  391 (408)
                           .+......+++++.+++.+||..||++|||+.++++
T Consensus       225 -----~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~  260 (267)
T cd08229         225 -----YPPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYD  260 (267)
T ss_pred             -----CCCCCcccccHHHHHHHHHhcCCCcccCCCHHHHHH
Confidence                 011112336789999999999999999999997764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=1.3e-39  Score=299.26  Aligned_cols=236  Identities=20%  Similarity=0.366  Sum_probs=188.0

Q ss_pred             eeeeeeCceEEEEEEEcCCCcEEEEEEeccc----chHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccEEEEEeecC
Q 015374          131 RKVGRGKYSEVFEGINVNTNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNS  206 (408)
Q Consensus       131 ~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~~  206 (408)
                      +.||+|+||+||+|++..+++.+|+|.+...    ....+.+|+.+++++ +|+||++++++|..  ....++||||+++
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~~~lv~e~~~~   77 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQY-SHPNIVRLIGVCTQ--KQPIYIVMELVQG   77 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhC-CCCCcceEEEEEcC--CCCeEEEEeeccC
Confidence            3699999999999999999999999987532    245688999999999 99999999999954  4678899999999


Q ss_pred             CChhhhcC----CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCCCcce---ee
Q 015374          207 TDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN---VR  279 (408)
Q Consensus       207 ~~l~~~~~----~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~~~~~---~~  279 (408)
                      ++|..++.    .+++..+..++.|++.||.|||+++|+|+||||+||+++.+ +.+||+|||++..........   ..
T Consensus        78 ~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~  156 (252)
T cd05084          78 GDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEK-NVLKISDFGMSREEEDGVYASTGGMK  156 (252)
T ss_pred             CcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCC-CcEEECccccCcccccccccccCCCC
Confidence            99998863    37888999999999999999999999999999999999987 789999999987544321111   11


Q ss_pred             ccCccccccccccCCcCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCCCccccccc
Q 015374          280 VASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSKFINA  358 (408)
Q Consensus       280 ~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  358 (408)
                      ..+..|+|||.+.+ ..++.++|||||||++|||++ |..||. .....+... .....                  ...
T Consensus       157 ~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~e~~~~~~~p~~-~~~~~~~~~-~~~~~------------------~~~  215 (252)
T cd05084         157 QIPVKWTAPEALNY-GRYSSESDVWSFGILLWEAFSLGAVPYA-NLSNQQTRE-AIEQG------------------VRL  215 (252)
T ss_pred             CCceeecCchhhcC-CCCChHHHHHHHHHHHHHHHhCCCCCcc-ccCHHHHHH-HHHcC------------------CCC
Confidence            22346999999877 678999999999999999998 776763 222222211 11110                  011


Q ss_pred             cCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 015374          359 DNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA  391 (408)
Q Consensus       359 ~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~  391 (408)
                      ..+..++.++.+++.+||+.||++|||+.++++
T Consensus       216 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~  248 (252)
T cd05084         216 PCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQ  248 (252)
T ss_pred             CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            122346889999999999999999999999974

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=1.5e-39  Score=300.21  Aligned_cols=242  Identities=17%  Similarity=0.340  Sum_probs=195.4

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc--chHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccEEE
Q 015374          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV--KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI  200 (408)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  200 (408)
                      ..++|++.++||+|+||.||+|.+. ++..+|+|.++..  ....+.+|+.+++++ +|+|++++++++..   ...+++
T Consensus         4 ~~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~E~~~l~~l-~~~~i~~~~~~~~~---~~~~lv   78 (260)
T cd05070           4 PRESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTMSPESFLEEAQIMKKL-RHDKLVQLYAVVSE---EPIYIV   78 (260)
T ss_pred             chHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCCCHHHHHHHHHHHHhc-CCCceEEEEeEECC---CCcEEE
Confidence            4678999999999999999999754 5667999998743  346789999999999 99999999998843   457899


Q ss_pred             EEeecCCChhhhcC-----CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCCCc
Q 015374          201 FEYVNSTDFKVLYP-----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE  275 (408)
Q Consensus       201 ~e~~~~~~l~~~~~-----~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~~~  275 (408)
                      |||+++++|..++.     .+++..+..++.|++.||.|||+.+|+|+||||+||+++.+ +.++|+|||++........
T Consensus        79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~-~~~~l~dfg~~~~~~~~~~  157 (260)
T cd05070          79 TEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDG-LVCKIADFGLARLIEDNEY  157 (260)
T ss_pred             EEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCC-ceEEeCCceeeeeccCccc
Confidence            99999999988763     37888999999999999999999999999999999999988 7899999999976643322


Q ss_pred             c--eeeccCccccccccccCCcCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCCCc
Q 015374          276 Y--NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPW  352 (408)
Q Consensus       276 ~--~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  352 (408)
                      .  ....++..|+|||.+.+ ..++.++|+||||+++|+|++ |..|| .+.+..+....+...                
T Consensus       158 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~~g~~p~-~~~~~~~~~~~~~~~----------------  219 (260)
T cd05070         158 TARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELVTKGRVPY-PGMNNREVLEQVERG----------------  219 (260)
T ss_pred             ccccCCCCCccccChHHHhc-CCCcchhhhHHHHHHHHHHHhcCCCCC-CCCCHHHHHHHHHcC----------------
Confidence            1  12234557999999876 678999999999999999999 67676 444444444433211                


Q ss_pred             cccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 015374          353 SKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA  391 (408)
Q Consensus       353 ~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~  391 (408)
                         .....+...+.++.+++.+||..||++|||++++.+
T Consensus       220 ---~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~  255 (260)
T cd05070         220 ---YRMPCPQDCPISLHELMLQCWKKDPEERPTFEYLQS  255 (260)
T ss_pred             ---CCCCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence               011123346789999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.4e-39  Score=303.01  Aligned_cols=244  Identities=19%  Similarity=0.345  Sum_probs=196.0

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCC-----CcEEEEEEecccc----hHHHHHHHHHHHHhcCCCCceEEeeEEEccC
Q 015374          123 DQDDYEVVRKVGRGKYSEVFEGINVNT-----NERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQH  193 (408)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~-----~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~  193 (408)
                      ..++|++.+.||+|+||.||+|.+...     +..||+|.+....    ...+.+|+.+++.+ +|+||+++++++..  
T Consensus         4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~--   80 (277)
T cd05032           4 PREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEF-NCHHVVRLLGVVST--   80 (277)
T ss_pred             chHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhC-CCCceeEEEEEEcC--
Confidence            467899999999999999999987643     3789999986332    34678999999999 99999999999955  


Q ss_pred             CCccEEEEEeecCCChhhhcC-------------CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEE
Q 015374          194 SKTPSLIFEYVNSTDFKVLYP-------------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLR  260 (408)
Q Consensus       194 ~~~~~lv~e~~~~~~l~~~~~-------------~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~k  260 (408)
                      ....++||||+++++|..++.             .+++..+..++.|++.||.|||+.+|+|+||||+||+++.+ +.+|
T Consensus        81 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~-~~~k  159 (277)
T cd05032          81 GQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAED-LTVK  159 (277)
T ss_pred             CCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCC-CCEE
Confidence            467889999999999988763             25677888999999999999999999999999999999998 7999


Q ss_pred             EEecccceeccCCCc---ceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHhh
Q 015374          261 LIDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKD  336 (408)
Q Consensus       261 l~DfG~a~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-g~~pf~~~~~~~~~~~~~~~~  336 (408)
                      |+|||+++.......   .....++..|+|||.+.+ ..++.++|||||||++||+++ |..|| .+.+..+....+. .
T Consensus       160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~t~g~~p~-~~~~~~~~~~~~~-~  236 (277)
T cd05032         160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKD-GVFTTKSDVWSFGVVLWEMATLAEQPY-QGLSNEEVLKFVI-D  236 (277)
T ss_pred             ECCcccchhhccCcccccCCCCCccccccCHHHHhc-CCCCcccchHHHHHHHHHhhccCCCCC-ccCCHHHHHHHHh-c
Confidence            999999876543321   123345678999999876 678999999999999999998 77776 4444333333222 1


Q ss_pred             hchhhhhcCCCCCCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 015374          337 CCLIIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA  391 (408)
Q Consensus       337 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~  391 (408)
                      .+                  ....+..++.++.+++.+||+.+|++|||+.++++
T Consensus       237 ~~------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~  273 (277)
T cd05032         237 GG------------------HLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVS  273 (277)
T ss_pred             CC------------------CCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            00                  01122335789999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=3e-39  Score=295.55  Aligned_cols=246  Identities=34%  Similarity=0.550  Sum_probs=203.4

Q ss_pred             CEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc---chHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccEEEEE
Q 015374          126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV---KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFE  202 (408)
Q Consensus       126 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e  202 (408)
                      +|++.+.||+|++|.||++.+..++..+++|++...   ..+.+.+|+.+++++ +|+|++++++++...  ...++++|
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~--~~~~l~~e   77 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKC-KHPNIVKYYGSYLKK--DELWIVME   77 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhC-CCCCEeEEEEEEecC--CeEEEEEe
Confidence            478889999999999999999889999999998754   346788999999999 899999999999654  67789999


Q ss_pred             eecCCChhhhc----CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCCCccee
Q 015374          203 YVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNV  278 (408)
Q Consensus       203 ~~~~~~l~~~~----~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~~~~~~  278 (408)
                      |+++++|..++    ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.+ +.++|+|||.+...........
T Consensus        78 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~-~~~~l~d~~~~~~~~~~~~~~~  156 (253)
T cd05122          78 FCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSD-GEVKLIDFGLSAQLSDTKARNT  156 (253)
T ss_pred             cCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccC-CeEEEeeccccccccccccccc
Confidence            99999998876    357999999999999999999999999999999999999987 7999999999987665433445


Q ss_pred             eccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCCCccccccc
Q 015374          279 RVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSKFINA  358 (408)
Q Consensus       279 ~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  358 (408)
                      ..++..|++||.+.+ ..++.++|+||||+++|+|++|..||..... .......... .        ...        .
T Consensus       157 ~~~~~~~~~PE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-~~~~~~~~~~-~--------~~~--------~  217 (253)
T cd05122         157 MVGTPYWMAPEVING-KPYDYKADIWSLGITAIELAEGKPPYSELPP-MKALFKIATN-G--------PPG--------L  217 (253)
T ss_pred             eecCCcccCHHHHcC-CCCCccccHHHHHHHHHHHHhCCCCCCCCch-HHHHHHHHhc-C--------CCC--------c
Confidence            678889999999987 5688999999999999999999999843322 2222211110 0        000        0


Q ss_pred             cCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCC
Q 015374          359 DNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPY  394 (408)
Q Consensus       359 ~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~  394 (408)
                      .....++.++.+++.+||+.||++|||+.|+++|||
T Consensus       218 ~~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~~~  253 (253)
T cd05122         218 RNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKHPF  253 (253)
T ss_pred             CcccccCHHHHHHHHHHccCChhhCCCHHHHhcCCC
Confidence            011114788999999999999999999999999998

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=2.4e-39  Score=302.15  Aligned_cols=243  Identities=19%  Similarity=0.332  Sum_probs=194.2

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCc----EEEEEEeccc----chHHHHHHHHHHHHhcCCCCceEEeeEEEccCC
Q 015374          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNE----RCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHS  194 (408)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~----~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~  194 (408)
                      ..++|++.++||+|+||+||+|++..++.    .||+|+++..    ....+.+|+.+++.+ +|+||+++++++..   
T Consensus         5 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~---   80 (279)
T cd05109           5 KETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGV-GSPYVCRLLGICLT---   80 (279)
T ss_pred             chhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhc-CCCCCceEEEEEcC---
Confidence            46789999999999999999998777766    4799998632    235678899999998 99999999999854   


Q ss_pred             CccEEEEEeecCCChhhhcC----CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceec
Q 015374          195 KTPSLIFEYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY  270 (408)
Q Consensus       195 ~~~~lv~e~~~~~~l~~~~~----~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~  270 (408)
                      ...++++||+++|++..++.    .+++..+..++.|++.||.|||+++|+||||||+|||++++ +.+||+|||+++..
T Consensus        81 ~~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~-~~~kL~dfG~~~~~  159 (279)
T cd05109          81 STVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSP-NHVKITDFGLARLL  159 (279)
T ss_pred             CCcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCC-CcEEECCCCceeec
Confidence            34679999999999988873    37889999999999999999999999999999999999887 78999999999876


Q ss_pred             cCCCcc---eeeccCccccccccccCCcCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHhhhchhhhhcCC
Q 015374          271 HPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKDCCLIIWCNSR  346 (408)
Q Consensus       271 ~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  346 (408)
                      ......   ....++..|++||.+.+ ..++.++|||||||++|||++ |..|| ..... +.+........        
T Consensus       160 ~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~-~~~~~-~~~~~~~~~~~--------  228 (279)
T cd05109         160 DIDETEYHADGGKVPIKWMALESILH-RRFTHQSDVWSYGVTVWELMTFGAKPY-DGIPA-REIPDLLEKGE--------  228 (279)
T ss_pred             ccccceeecCCCccchhhCCHHHhcc-CCCCchhHHHHHHHHHHHHHcCCCCCC-CCCCH-HHHHHHHHCCC--------
Confidence            533221   11234567999999977 679999999999999999998 77776 33222 22222222110        


Q ss_pred             CCCCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 015374          347 HSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA  391 (408)
Q Consensus       347 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~  391 (408)
                                ....+..++.++.+++.+||..||++|||+.+++.
T Consensus       229 ----------~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~  263 (279)
T cd05109         229 ----------RLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVD  263 (279)
T ss_pred             ----------cCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                      01112336789999999999999999999999984

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=8.8e-40  Score=301.71  Aligned_cols=243  Identities=33%  Similarity=0.552  Sum_probs=198.5

Q ss_pred             eeeeCceEEEEEEEcCCCcEEEEEEeccc------chHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccEEEEEeecC
Q 015374          133 VGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNS  206 (408)
Q Consensus       133 lG~G~fg~Vy~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~~  206 (408)
                      ||.|+||.||++++..+++.+++|+++..      ....+.+|+.+++++ +|+||+++++.+..  +...+++|||+++
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~--~~~~~lv~e~~~~   77 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQA-QSPYVVKLYYSFQG--KKNLYLVMEYLPG   77 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhC-CCcchhHHHHheec--CcEEEEEEecCCC
Confidence            68999999999999989999999998643      235688899999999 89999999999854  5678999999999


Q ss_pred             CChhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCCC---------
Q 015374          207 TDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK---------  274 (408)
Q Consensus       207 ~~l~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~~---------  274 (408)
                      ++|..++   ..+++..+..++.|++.||.|||+.+++|+||+|+||+++.+ +.++|+|||++.......         
T Consensus        78 ~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~  156 (265)
T cd05579          78 GDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSN-GHLKLTDFGLSKVGLVRRQINLNDDEK  156 (265)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCC-CCEEEEecccchhcccCcccccccccc
Confidence            9998876   358999999999999999999999999999999999999998 799999999987554321         


Q ss_pred             cceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCCCccc
Q 015374          275 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSK  354 (408)
Q Consensus       275 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  354 (408)
                      ......++..|++||...+ ..++.++|+||||+++|+|++|..||... ...+....+...            ...+..
T Consensus       157 ~~~~~~~~~~~~~Pe~~~~-~~~~~~~Dv~slG~~~~~l~~g~~p~~~~-~~~~~~~~~~~~------------~~~~~~  222 (265)
T cd05579         157 EDKRIVGTPDYIAPEVILG-QGHSKTVDWWSLGCILYEFLVGIPPFHGE-TPEEIFQNILNG------------KIEWPE  222 (265)
T ss_pred             cccCcccCccccCHHHhcC-CCCCcchhhHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHhcC------------CcCCCc
Confidence            2233457788999999977 56889999999999999999999998433 333333222210            001111


Q ss_pred             cccccCCCCCCHHHHHHHHHhcccCcCCCCCH---HHHhcCCCccccc
Q 015374          355 FINADNQHLVSPEAIDFLDKLLRYDHQDRLTA---REAMAHPYFAQVR  399 (408)
Q Consensus       355 ~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~---~elL~hp~f~~~~  399 (408)
                            ...++.++.+|+.+||+.+|++|||+   .++|+||||+.+.
T Consensus       223 ------~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~~~~~~~~  264 (265)
T cd05579         223 ------DVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFFKGID  264 (265)
T ss_pred             ------cccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcCccccCCC
Confidence                  11147899999999999999999999   9999999999874

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=4.4e-39  Score=297.86  Aligned_cols=245  Identities=25%  Similarity=0.467  Sum_probs=199.5

Q ss_pred             CCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecc------cchHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccE
Q 015374          125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP------VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS  198 (408)
Q Consensus       125 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~------~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  198 (408)
                      ++|++.+.||+|+||.||+|.+..+++.||+|.++.      ...+.+.+|+++++++ +|+|++++++++.+  ....+
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~-~~~~i~~~~~~~~~--~~~~~   78 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQL-DHPNVIKYLASFIE--NNELN   78 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhC-CCCCeeeeeeeeec--CCeEE
Confidence            579999999999999999999998999999998853      2245788999999999 99999999999965  46778


Q ss_pred             EEEEeecCCChhhhcC-------CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceecc
Q 015374          199 LIFEYVNSTDFKVLYP-------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH  271 (408)
Q Consensus       199 lv~e~~~~~~l~~~~~-------~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~  271 (408)
                      +||||+++++|..++.       .+++..+..++.|++.||.|||+.||+|+||+|+||+++.+ +.++|+|||++....
T Consensus        79 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~-~~~~l~d~~~~~~~~  157 (267)
T cd08224          79 IVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITAT-GVVKLGDLGLGRFFS  157 (267)
T ss_pred             EEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCC-CcEEEeccceeeecc
Confidence            9999999999987762       37888999999999999999999999999999999999988 789999999987654


Q ss_pred             CCC-cceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCC
Q 015374          272 PGK-EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRK  350 (408)
Q Consensus       272 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  350 (408)
                      ... ......++..|+|||.+.+ ..++.++|+|||||++|+|++|..||.....+...+......        ..    
T Consensus       158 ~~~~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~--------~~----  224 (267)
T cd08224         158 SKTTAAHSLVGTPYYMSPERIHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEK--------CD----  224 (267)
T ss_pred             CCCcccceecCCccccCHHHhcc-CCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhc--------CC----
Confidence            332 2234568888999999877 678999999999999999999999985544332222111110        00    


Q ss_pred             CccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 015374          351 PWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA  391 (408)
Q Consensus       351 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~  391 (408)
                           ........++.++.+++.+||..+|++|||+.++++
T Consensus       225 -----~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~  260 (267)
T cd08224         225 -----YPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQ  260 (267)
T ss_pred             -----CCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence                 000111236789999999999999999999999874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=9e-40  Score=314.19  Aligned_cols=248  Identities=21%  Similarity=0.349  Sum_probs=193.8

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEE-----cCCCcEEEEEEecccc----hHHHHHHHHHHHHhcCCCCceEEeeEEEccC
Q 015374          123 DQDDYEVVRKVGRGKYSEVFEGIN-----VNTNERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQH  193 (408)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~Vy~~~~-----~~~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~  193 (408)
                      ..++|++.+.||+|+||+||+|++     ..+++.||||+++...    ...+.+|+.++.++.+|+||++++++|... 
T Consensus         5 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~-   83 (343)
T cd05103           5 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP-   83 (343)
T ss_pred             chhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecC-
Confidence            357899999999999999999974     3467889999986422    345788999999997789999999988654 


Q ss_pred             CCccEEEEEeecCCChhhhcC-----------------------------------------------------------
Q 015374          194 SKTPSLIFEYVNSTDFKVLYP-----------------------------------------------------------  214 (408)
Q Consensus       194 ~~~~~lv~e~~~~~~l~~~~~-----------------------------------------------------------  214 (408)
                      +...+++|||+++++|..++.                                                           
T Consensus        84 ~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (343)
T cd05103          84 GGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEE  163 (343)
T ss_pred             CCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchh
Confidence            356789999999999987652                                                           


Q ss_pred             -----------CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCCCcc---eeec
Q 015374          215 -----------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY---NVRV  280 (408)
Q Consensus       215 -----------~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~~~~---~~~~  280 (408)
                                 .+++..+..++.|++.||.|||+++|+||||||+|||++.+ +.+||+|||++.........   ....
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~  242 (343)
T cd05103         164 EEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEN-NVVKICDFGLARDIYKDPDYVRKGDAR  242 (343)
T ss_pred             hhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCC-CcEEEEecccccccccCcchhhcCCCC
Confidence                       25667778899999999999999999999999999999987 79999999998765332211   1123


Q ss_pred             cCccccccccccCCcCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCCCcccccccc
Q 015374          281 ASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSKFINAD  359 (408)
Q Consensus       281 ~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  359 (408)
                      ++..|+|||.+.+ ..++.++||||||+++|+|++ |..||.......+ .........                  ...
T Consensus       243 ~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~-~~~~~~~~~------------------~~~  302 (343)
T cd05103         243 LPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE-FCRRLKEGT------------------RMR  302 (343)
T ss_pred             CCcceECcHHhcC-CCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHH-HHHHHhccC------------------CCC
Confidence            4567999999877 778999999999999999997 7778743322222 222111100                  011


Q ss_pred             CCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 015374          360 NQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH  392 (408)
Q Consensus       360 ~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~h  392 (408)
                      .+..+++++.+++..||+.||++|||+.|+++|
T Consensus       303 ~~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~  335 (343)
T cd05103         303 APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  335 (343)
T ss_pred             CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            122357889999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-39  Score=304.03  Aligned_cols=263  Identities=35%  Similarity=0.641  Sum_probs=205.3

Q ss_pred             EEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecccc-----hHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccEEEE
Q 015374          127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK-----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIF  201 (408)
Q Consensus       127 y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~  201 (408)
                      |+..+.||+|+||.||+|+...+++.+++|+++...     .+.+.+|+.+++++ +|+|++++++++.+  ....++||
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~--~~~~~~v~   77 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKEL-KHPNIVKLLDVIHT--ERKLYLVF   77 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhc-CCCCHHHHHhhhhc--CCceEEEe
Confidence            566789999999999999999999999999987432     35677899999999 89999999999965  46788999


Q ss_pred             EeecCCChhhhc----CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCCC-cc
Q 015374          202 EYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK-EY  276 (408)
Q Consensus       202 e~~~~~~l~~~~----~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~~-~~  276 (408)
                      ||+++ +|..++    ..+++..+..++.|++.||.|||+.||+|+||+|+||+++.+ +.++|+|||++....... ..
T Consensus        78 e~~~~-~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~-~~~~l~d~g~~~~~~~~~~~~  155 (282)
T cd07829          78 EYCDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRD-GVLKLADFGLARAFGIPLRTY  155 (282)
T ss_pred             cCcCc-CHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCC-CCEEEecCCcccccCCCcccc
Confidence            99985 677666    258899999999999999999999999999999999999998 799999999987654332 23


Q ss_pred             eeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhh---hcCCC---CCC
Q 015374          277 NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIW---CNSRH---SRK  350 (408)
Q Consensus       277 ~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~---~~~~~---~~~  350 (408)
                      ....++..|+|||.+.+...++.++|||||||++|||++|..|| .+.+..+.+..+....+....   .....   ...
T Consensus       156 ~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (282)
T cd07829         156 THEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLF-PGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKP  234 (282)
T ss_pred             CccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCC-CCccHHHHHHHHHHHhCCCcHHHHHhhcccccccc
Confidence            34456778999999977448899999999999999999998776 555555555555544331111   00000   000


Q ss_pred             Ccccc---ccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCc
Q 015374          351 PWSKF---INADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF  395 (408)
Q Consensus       351 ~~~~~---~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f  395 (408)
                      .+..+   ........++.++.+++.+||..||++||++++++.||||
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~  282 (282)
T cd07829         235 TFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF  282 (282)
T ss_pred             cccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence            11110   0111122347889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=1.5e-39  Score=301.99  Aligned_cols=236  Identities=17%  Similarity=0.303  Sum_probs=186.5

Q ss_pred             eeeeeCceEEEEEEEcCCCc--EEEEEEeccc----chHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccEEEEEeec
Q 015374          132 KVGRGKYSEVFEGINVNTNE--RCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVN  205 (408)
Q Consensus       132 ~lG~G~fg~Vy~~~~~~~~~--~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~  205 (408)
                      .||+|+||.||+|++..++.  .+++|.++..    ....+.+|+.++.++.+||||++++++|..  ....++||||++
T Consensus         2 ~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~--~~~~~lv~e~~~   79 (270)
T cd05047           2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH--RGYLYLAIEYAP   79 (270)
T ss_pred             cCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEec--CCCceEEEEeCC
Confidence            58999999999999887775  4688887632    235688899999999789999999999965  456889999999


Q ss_pred             CCChhhhcC-------------------CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEeccc
Q 015374          206 STDFKVLYP-------------------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGL  266 (408)
Q Consensus       206 ~~~l~~~~~-------------------~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~  266 (408)
                      +++|..++.                   .+++..+..++.|++.||+|||+.|++|+||||+|||++.+ +.+||+|||+
T Consensus        80 ~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~-~~~kl~dfgl  158 (270)
T cd05047          80 HGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGEN-YVAKIADFGL  158 (270)
T ss_pred             CCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCC-CeEEECCCCC
Confidence            999988763                   26788899999999999999999999999999999999988 7999999999


Q ss_pred             ceeccCCCcceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHhhhchhhhhcC
Q 015374          267 AEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKDCCLIIWCNS  345 (408)
Q Consensus       267 a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  345 (408)
                      +..............+..|+|||++.+ ..++.++|||||||++|||++ |..||. +.+..+....+...         
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slG~il~el~~~g~~pf~-~~~~~~~~~~~~~~---------  227 (270)
T cd05047         159 SRGQEVYVKKTMGRLPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYC-GMTCAELYEKLPQG---------  227 (270)
T ss_pred             ccccchhhhccCCCCccccCChHHHcc-CCCCchhhHHHHHHHHHHHHcCCCCCcc-ccCHHHHHHHHhCC---------
Confidence            863321111112233556999999876 778999999999999999997 888873 33333333222110         


Q ss_pred             CCCCCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 015374          346 RHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA  391 (408)
Q Consensus       346 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~  391 (408)
                                .....+..++.++.+++.+||..||.+|||+.++++
T Consensus       228 ----------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  263 (270)
T cd05047         228 ----------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILV  263 (270)
T ss_pred             ----------CCCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence                      011122336789999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=1.7e-39  Score=335.74  Aligned_cols=244  Identities=22%  Similarity=0.355  Sum_probs=193.0

Q ss_pred             CCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc------chHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccE
Q 015374          125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS  198 (408)
Q Consensus       125 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  198 (408)
                      ++|++.++||+|+||+||+|++..+++.||+|+++..      ..+.+.+|+.+++++ +||||+++++++.+  +...+
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L-~HPNIVkl~~v~~d--~~~ly   78 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADL-IHPGIVPVYSICSD--GDPVY   78 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhC-CCcCcCeEEEEEee--CCEEE
Confidence            5899999999999999999999999999999998632      235688999999999 99999999999965  46789


Q ss_pred             EEEEeecCCChhhhcC--------------CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEec
Q 015374          199 LIFEYVNSTDFKVLYP--------------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDW  264 (408)
Q Consensus       199 lv~e~~~~~~l~~~~~--------------~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~Df  264 (408)
                      +||||+++++|..++.              .++...+..++.|++.||+|||++||+||||||+|||++.+ +.++|+||
T Consensus        79 LVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~d-g~vKLiDF  157 (932)
T PRK13184         79 YTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLF-GEVVILDW  157 (932)
T ss_pred             EEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCC-CCEEEEec
Confidence            9999999999988763              23455678899999999999999999999999999999988 78999999


Q ss_pred             ccceeccCCC-------------------cceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCC
Q 015374          265 GLAEFYHPGK-------------------EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHD  325 (408)
Q Consensus       265 G~a~~~~~~~-------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~  325 (408)
                      |++.......                   .....+||+.|+|||.+.+ ..++.++|||||||++|||++|+.||.. .+
T Consensus       158 GLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g-~~~S~kSDIWSLGVILyELLTG~~PF~~-~~  235 (932)
T PRK13184        158 GAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLG-VPASESTDIYALGVILYQMLTLSFPYRR-KK  235 (932)
T ss_pred             CcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcC-CCCCcHhHHHHHHHHHHHHHHCCCCCCC-cc
Confidence            9997652110                   0112468999999999987 7789999999999999999999999843 22


Q ss_pred             CHHHHHHHHhhhchhhhhcCCCCCCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 015374          326 NHDQLVKIAKDCCLIIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA  391 (408)
Q Consensus       326 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~  391 (408)
                      ..+....  ....         ...      .......+++.+.+++.+||+.||++|++..+.+.
T Consensus       236 ~~ki~~~--~~i~---------~P~------~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl  284 (932)
T PRK13184        236 GRKISYR--DVIL---------SPI------EVAPYREIPPFLSQIAMKALAVDPAERYSSVQELK  284 (932)
T ss_pred             hhhhhhh--hhcc---------Chh------hccccccCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence            2111111  0000         000      00111247889999999999999999987655443

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=1e-39  Score=306.80  Aligned_cols=249  Identities=24%  Similarity=0.429  Sum_probs=202.9

Q ss_pred             EeeeeeeCceEEEEEEEcCCCcEEEEEEecc---cchHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccEEEEEeecC
Q 015374          130 VRKVGRGKYSEVFEGINVNTNERCIIKILKP---VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNS  206 (408)
Q Consensus       130 ~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~---~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~~  206 (408)
                      ..+||+|+||.||++....++..||+|.+..   .....+.+|+.+++.+ +|+|++++++++..  +...++||||+++
T Consensus        25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~--~~~~~lv~e~~~~  101 (292)
T cd06657          25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDY-QHENVVEMYNSYLV--GDELWVVMEFLEG  101 (292)
T ss_pred             HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhc-CCcchhheeeEEEe--CCEEEEEEecCCC
Confidence            4579999999999999999999999998753   2345688899999999 99999999999965  4678999999999


Q ss_pred             CChhhhc--CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCCC-cceeeccCc
Q 015374          207 TDFKVLY--PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK-EYNVRVASR  283 (408)
Q Consensus       207 ~~l~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~~-~~~~~~~~~  283 (408)
                      ++|..++  ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.+ +.++|+|||++....... ......++.
T Consensus       102 ~~L~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~  180 (292)
T cd06657         102 GALTDIVTHTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHD-GRVKLSDFGFCAQVSKEVPRRKSLVGTP  180 (292)
T ss_pred             CcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCC-CCEEEcccccceecccccccccccccCc
Confidence            9998876  357889999999999999999999999999999999999988 789999999987654322 223356788


Q ss_pred             cccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCCCccccccccCCCC
Q 015374          284 YFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSKFINADNQHL  363 (408)
Q Consensus       284 ~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  363 (408)
                      .|++||.+.+ ..++.++|+||||+++|+|++|..||. +.+..+....+.....           .      .......
T Consensus       181 ~y~~pE~~~~-~~~~~~~Dv~slGvil~el~tg~~p~~-~~~~~~~~~~~~~~~~-----------~------~~~~~~~  241 (292)
T cd06657         181 YWMAPELISR-LPYGPEVDIWSLGIMVIEMVDGEPPYF-NEPPLKAMKMIRDNLP-----------P------KLKNLHK  241 (292)
T ss_pred             cccCHHHhcC-CCCCchhhHHHHHHHHHHHHhCCCCCC-CCCHHHHHHHHHhhCC-----------c------ccCCccc
Confidence            8999999876 678899999999999999999999984 3333333222211100           0      0011223


Q ss_pred             CCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccccccc
Q 015374          364 VSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAA  401 (408)
Q Consensus       364 ~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~~~~~  401 (408)
                      ++.++.+++.+||+.||.+||++.++++||||......
T Consensus       242 ~~~~l~~li~~~l~~~P~~R~~~~~ll~~~~~~~~~~~  279 (292)
T cd06657         242 VSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGPP  279 (292)
T ss_pred             CCHHHHHHHHHHHhCCcccCcCHHHHhcChHHhccCCC
Confidence            67889999999999999999999999999999877643

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=3e-39  Score=298.28  Aligned_cols=242  Identities=18%  Similarity=0.344  Sum_probs=196.2

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc--chHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccEEE
Q 015374          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV--KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI  200 (408)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  200 (408)
                      ..++|++.++||+|+||.||+|.. .+++.+|+|.+...  ....+.+|+.+++++ +|+|++++++++..   ...+++
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~-~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~---~~~~~v   78 (260)
T cd05067           4 PRETLKLVKKLGAGQFGEVWMGYY-NGHTKVAIKSLKQGSMSPEAFLAEANLMKQL-QHPRLVRLYAVVTQ---EPIYII   78 (260)
T ss_pred             chHHceeeeeeccCccceEEeeec-CCCceEEEEEecCCCCcHHHHHHHHHHHHhc-CCcCeeeEEEEEcc---CCcEEE
Confidence            467899999999999999999975 45778999998743  346789999999999 99999999998743   457899


Q ss_pred             EEeecCCChhhhcC-----CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCCCc
Q 015374          201 FEYVNSTDFKVLYP-----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE  275 (408)
Q Consensus       201 ~e~~~~~~l~~~~~-----~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~~~  275 (408)
                      |||+.+++|..++.     .+++..+..++.|++.||+|||+.|++|+||||+||+++.+ +.++|+|||++........
T Consensus        79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~-~~~~l~dfg~~~~~~~~~~  157 (260)
T cd05067          79 TEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSET-LCCKIADFGLARLIEDNEY  157 (260)
T ss_pred             EEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCC-CCEEEccCcceeecCCCCc
Confidence            99999999988763     47888899999999999999999999999999999999988 7899999999977653221


Q ss_pred             c--eeeccCccccccccccCCcCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCCCc
Q 015374          276 Y--NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPW  352 (408)
Q Consensus       276 ~--~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  352 (408)
                      .  ....++..|+|||++.. ..++.++||||||+++|||++ |+.|| .+.+..+....+...                
T Consensus       158 ~~~~~~~~~~~y~~pe~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~-~~~~~~~~~~~~~~~----------------  219 (260)
T cd05067         158 TAREGAKFPIKWTAPEAINY-GTFTIKSDVWSFGILLTEIVTYGRIPY-PGMTNPEVIQNLERG----------------  219 (260)
T ss_pred             ccccCCcccccccCHHHhcc-CCcCcccchHHHHHHHHHHHhCCCCCC-CCCChHHHHHHHHcC----------------
Confidence            1  12344567999999876 678999999999999999998 88887 344444433332211                


Q ss_pred             cccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 015374          353 SKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA  391 (408)
Q Consensus       353 ~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~  391 (408)
                         .....+...+.++.+++.+||+.||++|||++++++
T Consensus       220 ---~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  255 (260)
T cd05067         220 ---YRMPRPDNCPEELYELMRLCWKEKPEERPTFEYLRS  255 (260)
T ss_pred             ---CCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence               011122346789999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=2e-39  Score=304.45  Aligned_cols=241  Identities=19%  Similarity=0.335  Sum_probs=191.4

Q ss_pred             CEEEEeeeeeeCceEEEEEEEcC-----CCcEEEEEEecccc----hHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCc
Q 015374          126 DYEVVRKVGRGKYSEVFEGINVN-----TNERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT  196 (408)
Q Consensus       126 ~y~~~~~lG~G~fg~Vy~~~~~~-----~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  196 (408)
                      +|++.+.||+|+||+||+|++..     +...+++|.+....    ...+.+|+.+++.+ +||||+++++.|..  ...
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~--~~~   77 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQV-NHPHVIKLYGACSQ--DGP   77 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhC-CCCCEeeEEEEEec--CCC
Confidence            47788899999999999998643     33578999886432    35688999999999 99999999999965  456


Q ss_pred             cEEEEEeecCCChhhhcC---------------------------CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCc
Q 015374          197 PSLIFEYVNSTDFKVLYP---------------------------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHN  249 (408)
Q Consensus       197 ~~lv~e~~~~~~l~~~~~---------------------------~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~N  249 (408)
                      .++++||+.+++|..++.                           .+++..+..++.|++.||.|||+.+|+||||||+|
T Consensus        78 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~n  157 (290)
T cd05045          78 LLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARN  157 (290)
T ss_pred             cEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhhe
Confidence            789999999999988752                           26778889999999999999999999999999999


Q ss_pred             EEEeCCCCcEEEEecccceeccCCCc---ceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHh-CCCCCCCCCC
Q 015374          250 VMIDHELRKLRLIDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHD  325 (408)
Q Consensus       250 ILl~~~~~~~kl~DfG~a~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-g~~pf~~~~~  325 (408)
                      ||++++ +.++|+|||+++.......   .....++..|+|||.+.+ ..++.++||||||+++|||++ |..|| .+..
T Consensus       158 ill~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~-~~~~  234 (290)
T cd05045         158 VLVAEG-RKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFD-HIYTTQSDVWSFGVLLWEIVTLGGNPY-PGIA  234 (290)
T ss_pred             EEEcCC-CcEEeccccccccccCccchhcccCCCCCccccCHHHHcc-CCcchHhHHHHHHHHHHHHHhcCCCCC-CCCC
Confidence            999988 7999999999976543322   122344567999999876 678999999999999999998 88776 4443


Q ss_pred             CHHHHHHHHhhhchhhhhcCCCCCCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 015374          326 NHDQLVKIAKDCCLIIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA  391 (408)
Q Consensus       326 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~  391 (408)
                      ..+... .....                  .....+..++.++.+|+.+||+.||++|||+.|+++
T Consensus       235 ~~~~~~-~~~~~------------------~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~  281 (290)
T cd05045         235 PERLFN-LLKTG------------------YRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISK  281 (290)
T ss_pred             HHHHHH-HHhCC------------------CCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence            333322 22110                  011123447889999999999999999999999975

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=2.3e-39  Score=304.21  Aligned_cols=243  Identities=21%  Similarity=0.352  Sum_probs=194.7

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEc-----CCCcEEEEEEecccc---hHHHHHHHHHHHHhcCCCCceEEeeEEEccCCC
Q 015374          124 QDDYEVVRKVGRGKYSEVFEGINV-----NTNERCIIKILKPVK---KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSK  195 (408)
Q Consensus       124 ~~~y~~~~~lG~G~fg~Vy~~~~~-----~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  195 (408)
                      ..+|.+.+.||+|+||.||+|.+.     .++..+++|.++...   .+.+.+|+.+++++ +|+||+++++++..  ..
T Consensus         4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~   80 (291)
T cd05094           4 RRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNL-QHEHIVKFYGVCGD--GD   80 (291)
T ss_pred             hHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcC-CCCCcceEEEEEcc--CC
Confidence            457899999999999999999753     345578999986443   35688999999999 99999999999954  46


Q ss_pred             ccEEEEEeecCCChhhhcC-------------------CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCC
Q 015374          196 TPSLIFEYVNSTDFKVLYP-------------------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEL  256 (408)
Q Consensus       196 ~~~lv~e~~~~~~l~~~~~-------------------~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~  256 (408)
                      ..++||||+++++|..++.                   .+++..+..++.|++.||.|||++||+||||||+|||++.+ 
T Consensus        81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~-  159 (291)
T cd05094          81 PLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGAN-  159 (291)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccC-
Confidence            7899999999999988863                   26788899999999999999999999999999999999988 


Q ss_pred             CcEEEEecccceeccCCCc---ceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHH
Q 015374          257 RKLRLIDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVK  332 (408)
Q Consensus       257 ~~~kl~DfG~a~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-g~~pf~~~~~~~~~~~~  332 (408)
                      +.++|+|||++........   .....++..|+|||.+.+ ..++.++|||||||++|||++ |..||+. .+..+.+..
T Consensus       160 ~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~t~g~~p~~~-~~~~~~~~~  237 (291)
T cd05094         160 LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMY-RKFTTESDVWSFGVILWEIFTYGKQPWFQ-LSNTEVIEC  237 (291)
T ss_pred             CcEEECCCCcccccCCCceeecCCCCCcceeecChHHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCC-CCHHHHHHH
Confidence            7999999999976543221   122345678999999987 778999999999999999998 8888743 333333322


Q ss_pred             HHhhhchhhhhcCCCCCCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 015374          333 IAKDCCLIIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA  391 (408)
Q Consensus       333 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~  391 (408)
                      +...         .          ....+..++..+.+++.+||+.||++|||++++++
T Consensus       238 ~~~~---------~----------~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~  277 (291)
T cd05094         238 ITQG---------R----------VLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYK  277 (291)
T ss_pred             HhCC---------C----------CCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence            2111         0          00112236789999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=4.2e-39  Score=301.14  Aligned_cols=259  Identities=19%  Similarity=0.327  Sum_probs=195.6

Q ss_pred             CCCEEEEeeeeeeCceEEEEEE----EcCCCcEEEEEEecccc---hHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCc
Q 015374          124 QDDYEVVRKVGRGKYSEVFEGI----NVNTNERCIIKILKPVK---KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT  196 (408)
Q Consensus       124 ~~~y~~~~~lG~G~fg~Vy~~~----~~~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  196 (408)
                      ..+|++.+.||+|+||+||+|.    +..++..||+|.++...   .+.+.+|+.+++++ +||||+++++++...+...
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~   81 (284)
T cd05081           3 ERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSL-QHDNIVKYKGVCYSAGRRN   81 (284)
T ss_pred             cccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhC-CCCCeeEEEEEEccCCCCc
Confidence            4578999999999999999997    34678899999986443   35688999999999 9999999999886555567


Q ss_pred             cEEEEEeecCCChhhhcC----CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccC
Q 015374          197 PSLIFEYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP  272 (408)
Q Consensus       197 ~~lv~e~~~~~~l~~~~~----~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~  272 (408)
                      .++||||+++++|..++.    .+++..+..++.|++.||.|||++||+|+||||+||+++.+ +.++|+|||++.....
T Consensus        82 ~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~-~~~~l~dfg~~~~~~~  160 (284)
T cd05081          82 LRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESE-NRVKIGDFGLTKVLPQ  160 (284)
T ss_pred             eEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCC-CeEEECCCcccccccC
Confidence            899999999999998873    37889999999999999999999999999999999999988 7899999999987654


Q ss_pred             CCcc----eeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhc-hhh-hhcCC
Q 015374          273 GKEY----NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCC-LII-WCNSR  346 (408)
Q Consensus       273 ~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~-~~~-~~~~~  346 (408)
                      ....    ....++..|+|||.+.+ ..++.++|||||||++|||++|..++....  ......+..... ... .....
T Consensus       161 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~  237 (284)
T cd05081         161 DKEYYKVREPGESPIFWYAPESLTE-SKFSVASDVWSFGVVLYELFTYSDKSCSPP--AEFMRMMGNDKQGQMIVYHLIE  237 (284)
T ss_pred             CCcceeecCCCCCceEeeCHHHhcc-CCcChHHHHHHHHHHHHHHhhcCCcCCCcc--hhhhhhcccccccccchHHHHH
Confidence            3221    11223446999999977 678999999999999999999887653211  111100000000 000 00000


Q ss_pred             CCCCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 015374          347 HSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA  391 (408)
Q Consensus       347 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~  391 (408)
                      .    .........+..++.++.+++.+||..||++|||+.|+++
T Consensus       238 ~----~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  278 (284)
T cd05081         238 L----LKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELAL  278 (284)
T ss_pred             H----HhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            0    0000011223457889999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.4e-39  Score=294.74  Aligned_cols=245  Identities=28%  Similarity=0.536  Sum_probs=204.3

Q ss_pred             CEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecccc-----hHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccEEE
Q 015374          126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK-----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI  200 (408)
Q Consensus       126 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  200 (408)
                      +|++.+.||+|++|.||++++..+++.+++|.+....     ...+.+|+++++++ +|+|++++++++.+  ....+++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~--~~~~~~v   77 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNL-KHPNIVKYIGSIET--SDSLYII   77 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhC-CCCCccEEEEEEEe--CCEEEEE
Confidence            5888999999999999999999999999999986433     35688999999999 99999999999865  4678899


Q ss_pred             EEeecCCChhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCCCc-c
Q 015374          201 FEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE-Y  276 (408)
Q Consensus       201 ~e~~~~~~l~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~~~-~  276 (408)
                      |||+++++|..++   ..+++..+..++.|++.||.|||+.||+|+||+|+||+++.+ +.++|+|||++........ .
T Consensus        78 ~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~-~~~~l~d~~~~~~~~~~~~~~  156 (254)
T cd06627          78 LEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKD-GVVKLADFGVATKLNDVSKDD  156 (254)
T ss_pred             EecCCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCC-CCEEEeccccceecCCCcccc
Confidence            9999999998877   358999999999999999999999999999999999999987 7999999999987654333 2


Q ss_pred             eeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCCCccccc
Q 015374          277 NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSKFI  356 (408)
Q Consensus       277 ~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  356 (408)
                      ....++..|++||...+ ..++.++|+||+|+++|+|++|..||.... ...........                   .
T Consensus       157 ~~~~~~~~y~~pe~~~~-~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~-~~~~~~~~~~~-------------------~  215 (254)
T cd06627         157 ASVVGTPYWMAPEVIEM-SGASTASDIWSLGCTVIELLTGNPPYYDLN-PMAALFRIVQD-------------------D  215 (254)
T ss_pred             cccccchhhcCHhhhcC-CCCCcchhHHHHHHHHHHHHhCCCCCCCcc-HHHHHHHHhcc-------------------C
Confidence            34567888999999877 558899999999999999999999985333 22222221110                   0


Q ss_pred             cccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCc
Q 015374          357 NADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF  395 (408)
Q Consensus       357 ~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f  395 (408)
                      ....+..+++++.+++.+||..+|++|||+.+++.||||
T Consensus       216 ~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~~  254 (254)
T cd06627         216 HPPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLKHPWI  254 (254)
T ss_pred             CCCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhcCCCC
Confidence            111233468899999999999999999999999999997

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=3.4e-39  Score=306.33  Aligned_cols=250  Identities=26%  Similarity=0.405  Sum_probs=199.3

Q ss_pred             CCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc------chHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccE
Q 015374          125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS  198 (408)
Q Consensus       125 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  198 (408)
                      +.|...++||+|+||+||+|++..++..+++|.+...      ....+.+|+.+++.+ +|+|++++++++.+  ....+
T Consensus        21 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~--~~~~~   97 (313)
T cd06633          21 EIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQL-KHPNTIEYKGCYLK--EHTAW   97 (313)
T ss_pred             HHhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhC-CCCCCccEEEEEEe--CCEEE
Confidence            3466678899999999999999999999999998532      124678899999999 99999999999965  46778


Q ss_pred             EEEEeecCCChhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCCCc
Q 015374          199 LIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE  275 (408)
Q Consensus       199 lv~e~~~~~~l~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~~~  275 (408)
                      +||||+.+..+....   ..+++..+..++.|++.||.|||++|++|+||+|+||+++.+ +.++|+|||++....   .
T Consensus        98 lv~e~~~~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~-~~~kL~dfg~~~~~~---~  173 (313)
T cd06633          98 LVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEP-GQVKLADFGSASKSS---P  173 (313)
T ss_pred             EEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCC-CCEEEeecCCCcccC---C
Confidence            999999765443332   347889999999999999999999999999999999999988 789999999986432   2


Q ss_pred             ceeeccCccccccccccC--CcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCCCcc
Q 015374          276 YNVRVASRYFKGPELLVD--LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWS  353 (408)
Q Consensus       276 ~~~~~~~~~y~aPE~~~~--~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  353 (408)
                      .....++..|+|||++..  ...++.++|||||||++|+|++|..||+.. +.......+....         .      
T Consensus       174 ~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~-~~~~~~~~~~~~~---------~------  237 (313)
T cd06633         174 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM-NAMSALYHIAQND---------S------  237 (313)
T ss_pred             CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCC-ChHHHHHHHHhcC---------C------
Confidence            234567889999999842  256888999999999999999999998543 3333333222110         0      


Q ss_pred             ccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccccc
Q 015374          354 KFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRA  400 (408)
Q Consensus       354 ~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~~~~  400 (408)
                         .......++..+.+|+.+||+.+|++|||+.++++||||...+.
T Consensus       238 ---~~~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~~~~~~~~~  281 (313)
T cd06633         238 ---PTLQSNEWTDSFRGFVDYCLQKIPQERPASAELLRHDFVRRDRP  281 (313)
T ss_pred             ---CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCCch
Confidence               01111235678999999999999999999999999999987554

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=2.9e-39  Score=301.70  Aligned_cols=242  Identities=17%  Similarity=0.302  Sum_probs=191.8

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCc----EEEEEEecccc----hHHHHHHHHHHHHhcCCCCceEEeeEEEccCCC
Q 015374          124 QDDYEVVRKVGRGKYSEVFEGINVNTNE----RCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSK  195 (408)
Q Consensus       124 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~----~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  195 (408)
                      .++|++.+.||+|+||+||+|.+..++.    .+++|.+....    ..++..|+.+++++ +||||+++++++..   .
T Consensus         6 ~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l-~h~~iv~~~~~~~~---~   81 (279)
T cd05111           6 ETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSL-DHAYIVRLLGICPG---A   81 (279)
T ss_pred             HhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcC-CCCCcceEEEEECC---C
Confidence            4678889999999999999999877776    46777775322    24567788888998 99999999998843   3


Q ss_pred             ccEEEEEeecCCChhhhcC----CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceecc
Q 015374          196 TPSLIFEYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH  271 (408)
Q Consensus       196 ~~~lv~e~~~~~~l~~~~~----~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~  271 (408)
                      ..++++||+++++|..++.    .+++..+..++.|++.||.|||+++++|+||||+|||++.+ +.+||+|||+++...
T Consensus        82 ~~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~-~~~kl~Dfg~~~~~~  160 (279)
T cd05111          82 SLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSD-SIVQIADFGVADLLY  160 (279)
T ss_pred             ccEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCC-CcEEEcCCccceecc
Confidence            4679999999999998873    47889999999999999999999999999999999999988 789999999998654


Q ss_pred             CCCc---ceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHhhhchhhhhcCCC
Q 015374          272 PGKE---YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRH  347 (408)
Q Consensus       272 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (408)
                      ....   .....++..|++||.+.+ ..++.++|||||||++|||++ |..||. +... ....++.....         
T Consensus       161 ~~~~~~~~~~~~~~~~y~~pE~~~~-~~~~~~~Dv~slG~il~el~t~g~~p~~-~~~~-~~~~~~~~~~~---------  228 (279)
T cd05111         161 PDDKKYFYSEHKTPIKWMALESILF-GRYTHQSDVWSYGVTVWEMMSYGAEPYA-GMRP-HEVPDLLEKGE---------  228 (279)
T ss_pred             CCCcccccCCCCCcccccCHHHhcc-CCcCchhhHHHHHHHHHHHHcCCCCCCC-CCCH-HHHHHHHHCCC---------
Confidence            3321   223345668999999977 679999999999999999998 888873 3322 22222222110         


Q ss_pred             CCCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 015374          348 SRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA  391 (408)
Q Consensus       348 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~  391 (408)
                               ....+..++.++.+++.+|+..||++|||+.|+++
T Consensus       229 ---------~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~  263 (279)
T cd05111         229 ---------RLAQPQICTIDVYMVMVKCWMIDENVRPTFKELAN  263 (279)
T ss_pred             ---------cCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence                     01112235778999999999999999999999976

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=2.2e-39  Score=303.43  Aligned_cols=255  Identities=28%  Similarity=0.487  Sum_probs=209.1

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecccc--hHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccEEE
Q 015374          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK--KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI  200 (408)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  200 (408)
                      ..+.|+..+.||+|+||.||+|.+..++..+++|+++...  .+.+.+|+.+++.+ +|+|++++++++...  ...+++
T Consensus        17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~--~~~~lv   93 (286)
T cd06614          17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDC-KHPNIVDYYDSYLVG--DELWVV   93 (286)
T ss_pred             ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCchhHHHHHHHHHHHHHC-CCCCeeEEEEEEEEC--CEEEEE
Confidence            4667888999999999999999998889999999997544  56788999999999 999999999999664  678899


Q ss_pred             EEeecCCChhhhcC----CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCCC-c
Q 015374          201 FEYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK-E  275 (408)
Q Consensus       201 ~e~~~~~~l~~~~~----~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~~-~  275 (408)
                      +||+++++|..++.    .+++..+..++.|++.||.|||+.||+|+||+|+||+++.+ +.++|+|||++....... .
T Consensus        94 ~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~-~~~~l~d~~~~~~~~~~~~~  172 (286)
T cd06614          94 MEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKD-GSVKLADFGFAAQLTKEKSK  172 (286)
T ss_pred             EeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCC-CCEEECccchhhhhccchhh
Confidence            99999999998873    68999999999999999999999999999999999999987 789999999986554322 2


Q ss_pred             ceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCCCcccc
Q 015374          276 YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSKF  355 (408)
Q Consensus       276 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  355 (408)
                      .....++..|++||.+.+ ..++.++|+|||||++|+|++|..||.. .++......+... +.                
T Consensus       173 ~~~~~~~~~y~~PE~~~~-~~~~~~~Dv~slGvil~~l~~g~~p~~~-~~~~~~~~~~~~~-~~----------------  233 (286)
T cd06614         173 RNSVVGTPYWMAPEVIKR-KDYGPKVDIWSLGIMCIEMAEGEPPYLR-EPPLRALFLITTK-GI----------------  233 (286)
T ss_pred             hccccCCcccCCHhHhcC-CCCCCccccHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhc-CC----------------
Confidence            233457788999999877 6789999999999999999999999843 2322222222111 00                


Q ss_pred             ccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccccc
Q 015374          356 INADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRA  400 (408)
Q Consensus       356 ~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~~~~  400 (408)
                      ........++.++.+++.+||+.+|.+|||+.++++|+||+..-.
T Consensus       234 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~  278 (286)
T cd06614         234 PPLKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPFLKKACP  278 (286)
T ss_pred             CCCcchhhCCHHHHHHHHHHhccChhhCcCHHHHhhChHhhccCc
Confidence            001112226789999999999999999999999999999998543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=4.3e-39  Score=297.29  Aligned_cols=242  Identities=17%  Similarity=0.308  Sum_probs=193.6

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc--chHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccEEE
Q 015374          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV--KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI  200 (408)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  200 (408)
                      ..++|++.++||+|+||.||+|.+..+ ..+++|.+...  ..+.+.+|+.+++++ +|+|++++++++..   ...+++
T Consensus         4 ~~~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~---~~~~~v   78 (260)
T cd05069           4 PRESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGTMMPEAFLQEAQIMKKL-RHDKLVPLYAVVSE---EPIYIV   78 (260)
T ss_pred             ChHHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCCccHHHHHHHHHHHHhC-CCCCeeeEEEEEcC---CCcEEE
Confidence            346799999999999999999986554 46899988643  236788999999999 99999999998843   457899


Q ss_pred             EEeecCCChhhhcC-----CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCCCc
Q 015374          201 FEYVNSTDFKVLYP-----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE  275 (408)
Q Consensus       201 ~e~~~~~~l~~~~~-----~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~~~  275 (408)
                      |||+++++|..++.     .+++..+..++.|++.||.|||+.|++|+||||+||+++++ +.++|+|||++........
T Consensus        79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~-~~~~l~dfg~~~~~~~~~~  157 (260)
T cd05069          79 TEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDN-LVCKIADFGLARLIEDNEY  157 (260)
T ss_pred             EEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCC-CeEEECCCccceEccCCcc
Confidence            99999999988773     26788899999999999999999999999999999999988 7899999999976643321


Q ss_pred             c--eeeccCccccccccccCCcCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCCCc
Q 015374          276 Y--NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPW  352 (408)
Q Consensus       276 ~--~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  352 (408)
                      .  ....++..|+|||...+ ..++.++|+||||+++|+|++ |..|| .+..+.+....+....               
T Consensus       158 ~~~~~~~~~~~y~~Pe~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~-~~~~~~~~~~~~~~~~---------------  220 (260)
T cd05069         158 TARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELVTKGRVPY-PGMVNREVLEQVERGY---------------  220 (260)
T ss_pred             cccCCCccchhhCCHHHhcc-CCcChHHHHHHHHHHHHHHHhCCCCCC-CCCCHHHHHHHHHcCC---------------
Confidence            1  12235567999999876 678999999999999999999 77776 4444444333322210               


Q ss_pred             cccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 015374          353 SKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA  391 (408)
Q Consensus       353 ~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~  391 (408)
                          ....+..++..+.+++.+||..||++|||++++++
T Consensus       221 ----~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  255 (260)
T cd05069         221 ----RMPCPQGCPESLHELMKLCWKKDPDERPTFEYIQS  255 (260)
T ss_pred             ----CCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence                01122346789999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=3.7e-39  Score=302.25  Aligned_cols=257  Identities=27%  Similarity=0.451  Sum_probs=202.2

Q ss_pred             CEEEEeeeeeeCceEEEEEEEc---CCCcEEEEEEeccc-------chHHHHHHHHHHHHhcCCCCceEEeeEEEccCCC
Q 015374          126 DYEVVRKVGRGKYSEVFEGINV---NTNERCIIKILKPV-------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSK  195 (408)
Q Consensus       126 ~y~~~~~lG~G~fg~Vy~~~~~---~~~~~vavK~~~~~-------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  195 (408)
                      +|++.+.||+|+||.||++++.   .+++.+|||+++..       ..+.+.+|+.++.++.+|+||+++++.+..  +.
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~--~~   78 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQT--DT   78 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeec--CC
Confidence            4788999999999999999754   46788999998632       234577899999999779999999999854  46


Q ss_pred             ccEEEEEeecCCChhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccC
Q 015374          196 TPSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP  272 (408)
Q Consensus       196 ~~~lv~e~~~~~~l~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~  272 (408)
                      ..++||||+++++|..++   ..+++..+..++.|++.||.|||+.+++|+||+|+||+++.+ +.++|+|||++.....
T Consensus        79 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~-~~~~l~dfg~~~~~~~  157 (288)
T cd05583          79 KLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSE-GHVVLTDFGLSKEFLA  157 (288)
T ss_pred             EEEEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCC-CCEEEEECcccccccc
Confidence            788999999999998876   347888999999999999999999999999999999999988 7899999999876543


Q ss_pred             CCc--ceeeccCccccccccccCCc-CCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCC
Q 015374          273 GKE--YNVRVASRYFKGPELLVDLQ-DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSR  349 (408)
Q Consensus       273 ~~~--~~~~~~~~~y~aPE~~~~~~-~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  349 (408)
                      ...  .....++..|++||.+.+.. ..+.++|+||||+++|+|++|..||...... .....+.....    .      
T Consensus       158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~-~~~~~~~~~~~----~------  226 (288)
T cd05583         158 EEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQ-NSQSEISRRIL----K------  226 (288)
T ss_pred             ccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCccc-chHHHHHHHHH----c------
Confidence            322  12345788899999986622 3788999999999999999999998432211 11111111100    0      


Q ss_pred             CCccccccccCCCCCCHHHHHHHHHhcccCcCCCCC---HHHHhcCCCccccccch
Q 015374          350 KPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLT---AREAMAHPYFAQVRAAE  402 (408)
Q Consensus       350 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt---~~elL~hp~f~~~~~~~  402 (408)
                            .....+..++.++.+++.+||+.||++|||   +.++|+||||+++....
T Consensus       227 ------~~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~~~~~  276 (288)
T cd05583         227 ------SKPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGIDWDD  276 (288)
T ss_pred             ------cCCCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCcccccCCHHH
Confidence                  011122336789999999999999999998   57889999999987754

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=1.6e-39  Score=300.00  Aligned_cols=244  Identities=23%  Similarity=0.444  Sum_probs=196.9

Q ss_pred             CEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc--------chHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCcc
Q 015374          126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV--------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP  197 (408)
Q Consensus       126 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~--------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~  197 (408)
                      +|.+.++||+|+||+||++++...+..+++|+++..        ....+..|+.+++++ +||||+++++++.+  ....
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~~   77 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKL-DHPAIVKFHASFLE--RDAF   77 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhC-CCCcHHHHHHHHhc--CCce
Confidence            588899999999999999998887777777776531        223566899999999 99999999999855  4568


Q ss_pred             EEEEEeecCCChhhhc-------CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceec
Q 015374          198 SLIFEYVNSTDFKVLY-------PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY  270 (408)
Q Consensus       198 ~lv~e~~~~~~l~~~~-------~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~  270 (408)
                      ++||||++++++..++       ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.+  .++|+|||++...
T Consensus        78 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~~--~~~l~d~g~~~~~  155 (260)
T cd08222          78 CIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKNN--LLKIGDFGVSRLL  155 (260)
T ss_pred             EEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeecC--CEeecccCceeec
Confidence            8999999999998765       348899999999999999999999999999999999999864  6999999998766


Q ss_pred             cCCCc-ceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCC
Q 015374          271 HPGKE-YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSR  349 (408)
Q Consensus       271 ~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  349 (408)
                      ..... .....++..|+|||.+.+ ..++.++|+||||+++|+|++|..||. +.........+...             
T Consensus       156 ~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Dv~slG~~~~~l~~~~~~~~-~~~~~~~~~~~~~~-------------  220 (260)
T cd08222         156 MGSCDLATTFTGTPYYMSPEALKH-QGYDSKSDIWSLGCILYEMCCLAHAFE-GQNFLSVVLRIVEG-------------  220 (260)
T ss_pred             CCCcccccCCCCCcCccCHHHHcc-CCCCchhhHHHHHHHHHHHHhCCCCCC-CccHHHHHHHHHcC-------------
Confidence            43322 233457888999999876 678899999999999999999999983 33322222222110             


Q ss_pred             CCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCc
Q 015374          350 KPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF  395 (408)
Q Consensus       350 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f  395 (408)
                            .....+..++.++.+++.+||+.||++||++.|+++||||
T Consensus       221 ------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~  260 (260)
T cd08222         221 ------PTPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRNPFI  260 (260)
T ss_pred             ------CCCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhCCCC
Confidence                  0011123467899999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=3.2e-39  Score=297.64  Aligned_cols=234  Identities=19%  Similarity=0.354  Sum_probs=187.5

Q ss_pred             eeeeeCceEEEEEEE--cCCCcEEEEEEeccc-----chHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccEEEEEee
Q 015374          132 KVGRGKYSEVFEGIN--VNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYV  204 (408)
Q Consensus       132 ~lG~G~fg~Vy~~~~--~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~  204 (408)
                      +||+|+||+||+|.+  ..++..+|+|+++..     ..+.+.+|+.+++.+ +|+||+++++++..   ...++||||+
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~---~~~~lv~e~~   77 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQL-DNPYIVRMIGICEA---ESWMLVMELA   77 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhC-CCCCcceEEEEEcC---CCcEEEEecC
Confidence            589999999999964  466789999998633     235688999999999 99999999999843   4568999999


Q ss_pred             cCCChhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCCCcc----e
Q 015374          205 NSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY----N  277 (408)
Q Consensus       205 ~~~~l~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~~~~----~  277 (408)
                      ++++|..++   ..+++..+..++.|++.||+|||++||+|+||||.||+++.+ +.++|+|||+++........    .
T Consensus        78 ~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~  156 (257)
T cd05116          78 ELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQ-HYAKISDFGLSKALGADENYYKAKT  156 (257)
T ss_pred             CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCC-CeEEECCCccccccCCCCCeeeecC
Confidence            999998877   358899999999999999999999999999999999999988 78999999999766443221    1


Q ss_pred             eeccCccccccccccCCcCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCCCccccc
Q 015374          278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSKFI  356 (408)
Q Consensus       278 ~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  356 (408)
                      ...++..|+|||.+.. ..++.++|+|||||++|||++ |..||. +.+..+....+... .                  
T Consensus       157 ~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~-~~~~~~~~~~i~~~-~------------------  215 (257)
T cd05116         157 HGKWPVKWYAPECMNY-YKFSSKSDVWSFGVLMWEAFSYGQKPYK-GMKGNEVTQMIESG-E------------------  215 (257)
T ss_pred             CCCCCccccCHhHhcc-CCcCchhHHHHHHHHHHHHHhCCCCCCC-CCCHHHHHHHHHCC-C------------------
Confidence            1223467999999876 678899999999999999998 888873 33333333322211 0                  


Q ss_pred             cccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 015374          357 NADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA  391 (408)
Q Consensus       357 ~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~  391 (408)
                      ....+..+++++.++|.+||+.||++|||++++..
T Consensus       216 ~~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~  250 (257)
T cd05116         216 RMECPQRCPPEMYDLMKLCWTYGVDERPGFAVVEL  250 (257)
T ss_pred             CCCCCCCCCHHHHHHHHHHhccCchhCcCHHHHHH
Confidence            11123347899999999999999999999998854

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.7e-39  Score=297.91  Aligned_cols=243  Identities=17%  Similarity=0.312  Sum_probs=194.8

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc--chHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccEEEE
Q 015374          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV--KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIF  201 (408)
Q Consensus       124 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~  201 (408)
                      ..+|++.+.||+|+||.||+|.+. ++..+|+|+++..  ....+.+|+.+++++ +|+||+++++++..  ....++||
T Consensus         3 ~~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~--~~~~~lv~   78 (256)
T cd05059           3 PSELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAMSEDDFIEEAKVMMKL-SHPNLVQLYGVCTK--QRPIFIVT   78 (256)
T ss_pred             hHHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCCCHHHHHHHHHHHHhC-CCCCEEEEEEEEcC--CCceEEEE
Confidence            346788899999999999999865 5668999998643  345788999999999 99999999999854  46788999


Q ss_pred             EeecCCChhhhcC----CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCCCcce
Q 015374          202 EYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN  277 (408)
Q Consensus       202 e~~~~~~l~~~~~----~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~~~~~  277 (408)
                      ||+++++|..++.    .+++..+..++.|++.||.|||+.||+|+||||+||+++.+ +.+||+|||+++.........
T Consensus        79 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~-~~~kl~dfg~~~~~~~~~~~~  157 (256)
T cd05059          79 EYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGED-NVVKVSDFGLARYVLDDQYTS  157 (256)
T ss_pred             ecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCC-CcEEECCcccceecccccccc
Confidence            9999999988763    37888999999999999999999999999999999999988 789999999987654322111


Q ss_pred             --eeccCccccccccccCCcCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCCCccc
Q 015374          278 --VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSK  354 (408)
Q Consensus       278 --~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  354 (408)
                        ...++..|+|||.+.+ ..++.++|+||||+++|+|++ |..|| .+.++.+....+...                  
T Consensus       158 ~~~~~~~~~y~~Pe~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~-~~~~~~~~~~~~~~~------------------  217 (256)
T cd05059         158 SQGTKFPVKWAPPEVFDY-SRFSSKSDVWSFGVLMWEVFSEGKMPY-ERFSNSEVVESVSAG------------------  217 (256)
T ss_pred             cCCCCCCccccCHHHhcc-CCCCchhhHHHHHHHHHHHhccCCCCC-CCCCHHHHHHHHHcC------------------
Confidence              1123346999999987 778999999999999999999 67776 344434333332211                  


Q ss_pred             cccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 015374          355 FINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH  392 (408)
Q Consensus       355 ~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~h  392 (408)
                       .....+..++.++.+++.+||..+|++|||+.|+++.
T Consensus       218 -~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~  254 (256)
T cd05059         218 -YRLYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQ  254 (256)
T ss_pred             -CcCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence             0112223478999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=2.7e-39  Score=297.30  Aligned_cols=244  Identities=22%  Similarity=0.447  Sum_probs=202.3

Q ss_pred             CEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc-----chHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccEEE
Q 015374          126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI  200 (408)
Q Consensus       126 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  200 (408)
                      +|++.++||.|+||.||++.+..++..+++|.++..     ....+.+|+.+++++ +|+||+++++++.+  ....++|
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~--~~~~~~v   77 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASV-NHPNIISYKEAFLD--GNKLCIV   77 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhC-CCCCchhhhhhhcc--CCEEEEE
Confidence            588999999999999999999999999999998642     234677899999999 89999999999865  4678899


Q ss_pred             EEeecCCChhhhc-------CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCC
Q 015374          201 FEYVNSTDFKVLY-------PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG  273 (408)
Q Consensus       201 ~e~~~~~~l~~~~-------~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~  273 (408)
                      |||+++++|..++       ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.+ +.+||+|||++......
T Consensus        78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~-~~~kl~d~g~~~~~~~~  156 (256)
T cd08530          78 MEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVAN-DLVKIGDLGISKVLKKN  156 (256)
T ss_pred             ehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecC-CcEEEeeccchhhhccC
Confidence            9999999998876       348888999999999999999999999999999999999987 78999999999776544


Q ss_pred             CcceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCCCcc
Q 015374          274 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWS  353 (408)
Q Consensus       274 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  353 (408)
                       ......++..|++||.+.+ ..++.++|+||||+++|+|++|+.||. ..+..+....+...         .     + 
T Consensus       157 -~~~~~~~~~~~~~Pe~~~~-~~~~~~~D~~slG~~~~~l~~g~~p~~-~~~~~~~~~~~~~~---------~-----~-  218 (256)
T cd08530         157 -MAKTQIGTPHYMAPEVWKG-RPYSYKSDIWSLGCLLYEMATFAPPFE-ARSMQDLRYKVQRG---------K-----Y-  218 (256)
T ss_pred             -CcccccCCccccCHHHHCC-CCCCchhhHHHHHHHHHHHHhCCCCCC-CCCHHHHHHHHhcC---------C-----C-
Confidence             3334567889999999987 778899999999999999999999983 33322222211110         0     0 


Q ss_pred             ccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCc
Q 015374          354 KFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF  395 (408)
Q Consensus       354 ~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f  395 (408)
                          .......+.++.+++.+||..+|++|||+.|+++||++
T Consensus       219 ----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~p~~  256 (256)
T cd08530         219 ----PPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILASPAV  256 (256)
T ss_pred             ----CCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcCCCC
Confidence                01112367889999999999999999999999999985

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=2.3e-39  Score=306.65  Aligned_cols=245  Identities=20%  Similarity=0.347  Sum_probs=194.3

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcC-------CCcEEEEEEeccc----chHHHHHHHHHHHHhcCCCCceEEeeEEEcc
Q 015374          124 QDDYEVVRKVGRGKYSEVFEGINVN-------TNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQ  192 (408)
Q Consensus       124 ~~~y~~~~~lG~G~fg~Vy~~~~~~-------~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~  192 (408)
                      .++|.+.+.||+|+||.||++++..       +...+|+|.++..    ....+.+|+.+++++.+|+||++++++|.. 
T Consensus        17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~-   95 (307)
T cd05098          17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ-   95 (307)
T ss_pred             hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEec-
Confidence            5789999999999999999997643       2346999998743    234677899999999789999999999965 


Q ss_pred             CCCccEEEEEeecCCChhhhcC-------------------CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEe
Q 015374          193 HSKTPSLIFEYVNSTDFKVLYP-------------------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMID  253 (408)
Q Consensus       193 ~~~~~~lv~e~~~~~~l~~~~~-------------------~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~  253 (408)
                       ....++||||+++++|..++.                   .+++..+..++.|++.||+|||++|++|+||||+||+++
T Consensus        96 -~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~  174 (307)
T cd05098          96 -DGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT  174 (307)
T ss_pred             -CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHheEEc
Confidence             457889999999999988873                   267788899999999999999999999999999999999


Q ss_pred             CCCCcEEEEecccceeccCCCcc---eeeccCccccccccccCCcCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHH
Q 015374          254 HELRKLRLIDWGLAEFYHPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQ  329 (408)
Q Consensus       254 ~~~~~~kl~DfG~a~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-g~~pf~~~~~~~~~  329 (408)
                      .+ +.++|+|||++.........   ....++..|+|||.+.+ ..++.++|+|||||++|+|++ |..|| .+.+ .+.
T Consensus       175 ~~-~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~~~g~~p~-~~~~-~~~  250 (307)
T cd05098         175 ED-NVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEIFTLGGSPY-PGVP-VEE  250 (307)
T ss_pred             CC-CcEEECCCcccccccccchhhccccCCCccceeChHHhcc-CCCCcHHHHHHHHHHHHHHHcCCCCCC-CcCC-HHH
Confidence            88 79999999998765432211   11223457999999987 678999999999999999998 66666 3333 333


Q ss_pred             HHHHHhhhchhhhhcCCCCCCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 015374          330 LVKIAKDCCLIIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH  392 (408)
Q Consensus       330 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~h  392 (408)
                      +.......                  .....+..++.++.+++.+||..+|++|||+.+++++
T Consensus       251 ~~~~~~~~------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~  295 (307)
T cd05098         251 LFKLLKEG------------------HRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED  295 (307)
T ss_pred             HHHHHHcC------------------CCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence            32222210                  0112233478899999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=7.2e-40  Score=326.91  Aligned_cols=247  Identities=21%  Similarity=0.341  Sum_probs=196.6

Q ss_pred             CCCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecc---cchHHHHHHHHHHHHhcCCCCceEEeeEEE----ccC-
Q 015374          122 GDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP---VKKKKIKREIKILQNLCGGPNVVKLLDIVR----DQH-  193 (408)
Q Consensus       122 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~---~~~~~~~~E~~~l~~l~~h~niv~l~~~~~----~~~-  193 (408)
                      ....++++.+.|.+|||+.||.|.+...+..+|+|.+-.   ...+...+|+++|++|.+|+|||.+++...    ..+ 
T Consensus        34 Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~  113 (738)
T KOG1989|consen   34 VGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNG  113 (738)
T ss_pred             ECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCc
Confidence            457789999999999999999999988889999998742   334668899999999988999999999322    122 


Q ss_pred             CCccEEEEEeecCCChhhhc-----CCCChHHHHHHHHHHHHHHHHHHHCC--cEEecCCCCcEEEeCCCCcEEEEeccc
Q 015374          194 SKTPSLIFEYVNSTDFKVLY-----PTLTDYDIRYYIYELLKALDYCHSQG--IMHRDVKPHNVMIDHELRKLRLIDWGL  266 (408)
Q Consensus       194 ~~~~~lv~e~~~~~~l~~~~-----~~l~~~~~~~i~~qi~~~L~~LH~~~--iiH~Dlk~~NILl~~~~~~~kl~DfG~  266 (408)
                      .....|+||||.+|.|-+++     ..|++.++.+|+.|+++|+.+||...  |||||||-+||||+.+ +..||||||.
T Consensus       114 ~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~-g~~KLCDFGS  192 (738)
T KOG1989|consen  114 VWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSAD-GNYKLCDFGS  192 (738)
T ss_pred             eeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCC-CCEEeCcccc
Confidence            24577999999988887776     35999999999999999999999886  9999999999999998 7999999999


Q ss_pred             ceeccCCCc----------ceeeccCcccccccccc--CCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHH
Q 015374          267 AEFYHPGKE----------YNVRVASRYFKGPELLV--DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA  334 (408)
Q Consensus       267 a~~~~~~~~----------~~~~~~~~~y~aPE~~~--~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~  334 (408)
                      +........          .-....|+.|++||++.  ....++.|+|||+|||+||-|+....||..+.. .    .| 
T Consensus       193 att~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~-l----aI-  266 (738)
T KOG1989|consen  193 ATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK-L----AI-  266 (738)
T ss_pred             cccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc-e----eE-
Confidence            854322211          11245788999999973  226789999999999999999999999943211 1    11 


Q ss_pred             hhhchhhhhcCCCCCCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 015374          335 KDCCLIIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH  392 (408)
Q Consensus       335 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~h  392 (408)
                              .++.+....+         ...+..+.+||+.||+.||++||++.+++.+
T Consensus       267 --------lng~Y~~P~~---------p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~  307 (738)
T KOG1989|consen  267 --------LNGNYSFPPF---------PNYSDRLKDLIRTMLQPNPDERPNIYQVLEE  307 (738)
T ss_pred             --------EeccccCCCC---------ccHHHHHHHHHHHHhccCcccCCCHHHHHHH
Confidence                    1122222221         2267899999999999999999999998865

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=1.5e-39  Score=300.15  Aligned_cols=242  Identities=19%  Similarity=0.358  Sum_probs=198.4

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecccc---hHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccEEE
Q 015374          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK---KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI  200 (408)
Q Consensus       124 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  200 (408)
                      ..+|++.++||.|+||+||+|.+.. +..+++|+++...   ...+.+|+.+++.+ +|+||+++++++.+  ....++|
T Consensus         5 ~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~--~~~~~lv   80 (261)
T cd05148           5 REEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDLLKQQDFQKEVQALKRL-RHKHLISLFAVCSV--GEPVYII   80 (261)
T ss_pred             HHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccchhhHHHHHHHHHHHhcC-CCcchhheeeeEec--CCCeEEE
Confidence            4568889999999999999998877 8899999987433   46788999999999 99999999999955  4678899


Q ss_pred             EEeecCCChhhhcC-----CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCCCc
Q 015374          201 FEYVNSTDFKVLYP-----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE  275 (408)
Q Consensus       201 ~e~~~~~~l~~~~~-----~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~~~  275 (408)
                      |||+++++|..++.     .+++..+..++.|++.||.|||+.||+|+||||+||+++.+ +.+||+|||.+........
T Consensus        81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~-~~~kl~d~g~~~~~~~~~~  159 (261)
T cd05148          81 TELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGED-LVCKVADFGLARLIKEDVY  159 (261)
T ss_pred             EeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCC-ceEEEccccchhhcCCccc
Confidence            99999999998874     37888999999999999999999999999999999999988 7999999999976543221


Q ss_pred             -ceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCCCcc
Q 015374          276 -YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWS  353 (408)
Q Consensus       276 -~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  353 (408)
                       .....++..|++||.+.+ ..++.++||||||+++|+|++ |..|| .+.+..+.+..+....                
T Consensus       160 ~~~~~~~~~~~~~PE~~~~-~~~~~~~DiwslG~~l~~l~~~g~~p~-~~~~~~~~~~~~~~~~----------------  221 (261)
T cd05148         160 LSSDKKIPYKWTAPEAASH-GTFSTKSDVWSFGILLYEMFTYGQVPY-PGMNNHEVYDQITAGY----------------  221 (261)
T ss_pred             cccCCCCceEecCHHHHcc-CCCCchhhHHHHHHHHHHHHcCCCCCC-CcCCHHHHHHHHHhCC----------------
Confidence             122334567999999877 678999999999999999998 77776 4444444444333210                


Q ss_pred             ccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 015374          354 KFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA  391 (408)
Q Consensus       354 ~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~  391 (408)
                         ....+..+++++.+++.+||+.||++|||+.++++
T Consensus       222 ---~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~  256 (261)
T cd05148         222 ---RMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALRE  256 (261)
T ss_pred             ---cCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence               01122346899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=3.3e-39  Score=301.99  Aligned_cols=259  Identities=22%  Similarity=0.333  Sum_probs=195.9

Q ss_pred             CCEEEEeeeeeeCceEEEEEEE----cCCCcEEEEEEeccc----chHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCc
Q 015374          125 DDYEVVRKVGRGKYSEVFEGIN----VNTNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT  196 (408)
Q Consensus       125 ~~y~~~~~lG~G~fg~Vy~~~~----~~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  196 (408)
                      .-|++++.||+|+||.||++..    ..++..||+|.++..    ....+.+|+.+++.+ +|+|++++++++.+.....
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~   82 (284)
T cd05079           4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNL-YHENIVKYKGICTEDGGNG   82 (284)
T ss_pred             hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhC-CCCCeeeeeeEEecCCCCc
Confidence            4578899999999999999974    457889999998743    235688999999999 9999999999997765567


Q ss_pred             cEEEEEeecCCChhhhcC----CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccC
Q 015374          197 PSLIFEYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP  272 (408)
Q Consensus       197 ~~lv~e~~~~~~l~~~~~----~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~  272 (408)
                      .++||||+++++|..++.    .+++..+..++.|++.||.|||++|++||||||+||+++.+ +.++|+|||++.....
T Consensus        83 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~-~~~~l~dfg~~~~~~~  161 (284)
T cd05079          83 IKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESE-HQVKIGDFGLTKAIET  161 (284)
T ss_pred             eEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCC-CCEEECCCcccccccc
Confidence            899999999999998863    47889999999999999999999999999999999999988 7899999999986654


Q ss_pred             CCcc----eeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhh-chhhhhcCCC
Q 015374          273 GKEY----NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDC-CLIIWCNSRH  347 (408)
Q Consensus       273 ~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~  347 (408)
                      ....    ....++..|+|||++.+ ..++.++|||||||++|+|++++.|+.....   ......... +........ 
T Consensus       162 ~~~~~~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slG~il~ellt~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~-  236 (284)
T cd05079         162 DKEYYTVKDDLDSPVFWYAPECLIQ-SKFYIASDVWSFGVTLYELLTYCDSESSPMT---LFLKMIGPTHGQMTVTRLV-  236 (284)
T ss_pred             CccceeecCCCCCCccccCHHHhcc-CCCCccccchhhhhhhhhhhcCCCCCccccc---hhhhhcccccccccHHHHH-
Confidence            3221    22345667999999887 6789999999999999999998776532111   000000000 000000000 


Q ss_pred             CCCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 015374          348 SRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH  392 (408)
Q Consensus       348 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~h  392 (408)
                        ...........+..++.++.+|+.+||+.||++|||++++++.
T Consensus       237 --~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~  279 (284)
T cd05079         237 --RVLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEG  279 (284)
T ss_pred             --HHHHcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence              0000000111233478999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=3.3e-39  Score=301.44  Aligned_cols=243  Identities=17%  Similarity=0.347  Sum_probs=193.9

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEc-----CCCcEEEEEEecccc---hHHHHHHHHHHHHhcCCCCceEEeeEEEccCCC
Q 015374          124 QDDYEVVRKVGRGKYSEVFEGINV-----NTNERCIIKILKPVK---KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSK  195 (408)
Q Consensus       124 ~~~y~~~~~lG~G~fg~Vy~~~~~-----~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  195 (408)
                      ..+|+..++||+|+||.||++...     .++..+++|.++...   ...+.+|+.+++.+ +|+||+++++++.+  ..
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~   80 (280)
T cd05092           4 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVL-QHQHIVRFYGVCTE--GR   80 (280)
T ss_pred             hHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcC-CCCCCceEEEEEec--CC
Confidence            467888999999999999999642     346688999886432   45788999999999 99999999999965  45


Q ss_pred             ccEEEEEeecCCChhhhcC------------------CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCC
Q 015374          196 TPSLIFEYVNSTDFKVLYP------------------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELR  257 (408)
Q Consensus       196 ~~~lv~e~~~~~~l~~~~~------------------~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~  257 (408)
                      ..+++|||+++++|..++.                  .+++..+..++.|++.||.|||+.|++|+||||+|||++++ +
T Consensus        81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~-~  159 (280)
T cd05092          81 PLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQG-L  159 (280)
T ss_pred             ceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCC-C
Confidence            6789999999999988762                  36788899999999999999999999999999999999987 7


Q ss_pred             cEEEEecccceeccCCCcc---eeeccCccccccccccCCcCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHH
Q 015374          258 KLRLIDWGLAEFYHPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKI  333 (408)
Q Consensus       258 ~~kl~DfG~a~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-g~~pf~~~~~~~~~~~~~  333 (408)
                      .++|+|||++.........   ....++..|+|||.+.+ ..++.++|||||||++|||++ |..||. .....+....+
T Consensus       160 ~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~-~~~~~~~~~~~  237 (280)
T cd05092         160 VVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILY-RKFTTESDIWSFGVVLWEIFTYGKQPWY-QLSNTEAIECI  237 (280)
T ss_pred             CEEECCCCceeEcCCCceeecCCCccccccccCHHHhcc-CCcCchhhHHHHHHHHHHHHcCCCCCCc-cCCHHHHHHHH
Confidence            8999999998765433221   12234567999999987 678999999999999999998 777773 33333333322


Q ss_pred             HhhhchhhhhcCCCCCCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 015374          334 AKDCCLIIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA  391 (408)
Q Consensus       334 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~  391 (408)
                      ...                   .....+..+++.+.+++.+||+.||++||++.|+++
T Consensus       238 ~~~-------------------~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~  276 (280)
T cd05092         238 TQG-------------------RELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS  276 (280)
T ss_pred             HcC-------------------ccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            211                   011122347889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=5.2e-39  Score=305.17  Aligned_cols=245  Identities=18%  Similarity=0.312  Sum_probs=193.7

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcC-------CCcEEEEEEecccc----hHHHHHHHHHHHHhcCCCCceEEeeEEEc
Q 015374          123 DQDDYEVVRKVGRGKYSEVFEGINVN-------TNERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRD  191 (408)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~Vy~~~~~~-------~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~  191 (408)
                      ..++|.+.++||+|+||.||+|++..       ....+|+|.++...    ...+.+|+.+++++.+||||++++++|.+
T Consensus        10 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~   89 (314)
T cd05099          10 PRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQ   89 (314)
T ss_pred             cHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEcc
Confidence            35789999999999999999997532       34578999887432    34678899999998669999999999954


Q ss_pred             cCCCccEEEEEeecCCChhhhcC-------------------CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEE
Q 015374          192 QHSKTPSLIFEYVNSTDFKVLYP-------------------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMI  252 (408)
Q Consensus       192 ~~~~~~~lv~e~~~~~~l~~~~~-------------------~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl  252 (408)
                        ....+++|||+++++|..++.                   .+++..+..++.|++.||.|||++||+|+||||+|||+
T Consensus        90 --~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill  167 (314)
T cd05099          90 --EGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLV  167 (314)
T ss_pred             --CCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeEEE
Confidence              467889999999999988762                   26778888999999999999999999999999999999


Q ss_pred             eCCCCcEEEEecccceeccCCCc---ceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHH
Q 015374          253 DHELRKLRLIDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHD  328 (408)
Q Consensus       253 ~~~~~~~kl~DfG~a~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-g~~pf~~~~~~~~  328 (408)
                      +.+ +.+||+|||+++.......   .....++..|+|||.+.+ ..++.++|||||||++|+|++ |..|| .+.+..+
T Consensus       168 ~~~-~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~~g~~p~-~~~~~~~  244 (314)
T cd05099         168 TED-NVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFD-RVYTHQSDVWSFGILMWEIFTLGGSPY-PGIPVEE  244 (314)
T ss_pred             cCC-CcEEEccccccccccccccccccccCCCCccccCHHHHcc-CCcCccchhhHHHHHHHHHHhCCCCCC-CCCCHHH
Confidence            988 7899999999976543221   111223457999999977 778999999999999999999 77776 4443333


Q ss_pred             HHHHHHhhhchhhhhcCCCCCCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 015374          329 QLVKIAKDCCLIIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA  391 (408)
Q Consensus       329 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~  391 (408)
                      ....+...                   .....+..++.++.+++.+||..||++|||+.|+++
T Consensus       245 ~~~~~~~~-------------------~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~  288 (314)
T cd05099         245 LFKLLREG-------------------HRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVE  288 (314)
T ss_pred             HHHHHHcC-------------------CCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence            33322211                   001122346789999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=5.8e-39  Score=303.36  Aligned_cols=246  Identities=18%  Similarity=0.302  Sum_probs=195.2

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEc-------CCCcEEEEEEeccc----chHHHHHHHHHHHHhcCCCCceEEeeEEEc
Q 015374          123 DQDDYEVVRKVGRGKYSEVFEGINV-------NTNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRD  191 (408)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~Vy~~~~~-------~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~  191 (408)
                      ..++|++.+.||+|+||.||+|+..       .++..+|+|.++..    ....+.+|+.+++.+.+||||+++++++..
T Consensus        13 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~   92 (304)
T cd05101          13 SRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ   92 (304)
T ss_pred             cHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEec
Confidence            4678999999999999999999753       23457999998642    235688999999998789999999999965


Q ss_pred             cCCCccEEEEEeecCCChhhhcC-------------------CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEE
Q 015374          192 QHSKTPSLIFEYVNSTDFKVLYP-------------------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMI  252 (408)
Q Consensus       192 ~~~~~~~lv~e~~~~~~l~~~~~-------------------~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl  252 (408)
                        ....+++|||+++++|..++.                   .+++..+..++.|++.||.|||++||+||||||+||++
T Consensus        93 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nili  170 (304)
T cd05101          93 --DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLV  170 (304)
T ss_pred             --CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccceEEE
Confidence              467789999999999988762                   25677788999999999999999999999999999999


Q ss_pred             eCCCCcEEEEecccceeccCCCc---ceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHH
Q 015374          253 DHELRKLRLIDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHD  328 (408)
Q Consensus       253 ~~~~~~~kl~DfG~a~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-g~~pf~~~~~~~~  328 (408)
                      +.+ +.+||+|||+++.......   .....++..|+|||++.+ ..++.++||||||+++|+|++ |..|| .+.+..+
T Consensus       171 ~~~-~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~-~~~~~~~  247 (304)
T cd05101         171 TEN-NVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLMWEIFTLGGSPY-PGIPVEE  247 (304)
T ss_pred             cCC-CcEEECCCccceecccccccccccCCCCCceeeCchhhcc-CCCCchhhHHHHHHHHHHHHcCCCCCc-ccCCHHH
Confidence            987 7999999999986643222   122345567999999977 678999999999999999998 66665 4444333


Q ss_pred             HHHHHHhhhchhhhhcCCCCCCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 015374          329 QLVKIAKDCCLIIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH  392 (408)
Q Consensus       329 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~h  392 (408)
                      ....+...                   .....+..++.++.+++.+||..+|++|||+.|+++.
T Consensus       248 ~~~~~~~~-------------------~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~  292 (304)
T cd05101         248 LFKLLKEG-------------------HRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVED  292 (304)
T ss_pred             HHHHHHcC-------------------CcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence            33322111                   0011123478999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=6.3e-39  Score=295.41  Aligned_cols=240  Identities=17%  Similarity=0.339  Sum_probs=193.0

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecccc-hHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccEEEEE
Q 015374          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK-KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFE  202 (408)
Q Consensus       124 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e  202 (408)
                      .++|++.+.||+|+||.||++..  .+..+++|.++... .+.+.+|+.+++++ +|+|++++++++... ....+++||
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~--~~~~~~~k~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~-~~~~~lv~e   80 (256)
T cd05082           5 MKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQL-RHSNLVQLLGVIVEE-KGGLYIVTE   80 (256)
T ss_pred             HHhCeeeeeecccCCCeEEEEEE--cCCcEEEEEeCCCchHHHHHHHHHHHHhC-CCCCeeeEEEEEEcC-CCceEEEEE
Confidence            46789999999999999999965  47789999987433 45788999999999 999999999986543 356789999


Q ss_pred             eecCCChhhhcC-----CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCCCcce
Q 015374          203 YVNSTDFKVLYP-----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN  277 (408)
Q Consensus       203 ~~~~~~l~~~~~-----~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~~~~~  277 (408)
                      |+++++|..++.     .+++..+..++.|++.||.|||++||+|+||||+||+++.+ +.+||+|||++.......  .
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~-~~~kl~dfg~~~~~~~~~--~  157 (256)
T cd05082          81 YMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSED-NVAKVSDFGLTKEASSTQ--D  157 (256)
T ss_pred             CCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCC-CcEEecCCccceeccccC--C
Confidence            999999988763     27788889999999999999999999999999999999988 799999999987654322  2


Q ss_pred             eeccCccccccccccCCcCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCCCccccc
Q 015374          278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSKFI  356 (408)
Q Consensus       278 ~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  356 (408)
                      ...++..|+|||++.+ ..++.++|||||||++|+|++ |+.||. ..+..+....+...                   .
T Consensus       158 ~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~i~~~l~~~g~~p~~-~~~~~~~~~~~~~~-------------------~  216 (256)
T cd05082         158 TGKLPVKWTAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPYP-RIPLKDVVPRVEKG-------------------Y  216 (256)
T ss_pred             CCccceeecCHHHHcc-CCCCchhhhHHHHHHHHHHHhCCCCCCC-CCCHHHHHHHHhcC-------------------C
Confidence            2344567999999876 678999999999999999997 888873 22222222222111                   0


Q ss_pred             cccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 015374          357 NADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA  391 (408)
Q Consensus       357 ~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~  391 (408)
                      ....+..+++.+.+++.+||+.||++|||+.++++
T Consensus       217 ~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~  251 (256)
T cd05082         217 KMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLRE  251 (256)
T ss_pred             CCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence            11223347899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=7.4e-39  Score=295.36  Aligned_cols=234  Identities=18%  Similarity=0.341  Sum_probs=186.0

Q ss_pred             eeeeeCceEEEEEEEc--CCCcEEEEEEecccc----hHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccEEEEEeec
Q 015374          132 KVGRGKYSEVFEGINV--NTNERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVN  205 (408)
Q Consensus       132 ~lG~G~fg~Vy~~~~~--~~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~  205 (408)
                      .||+|+||.||+|.+.  .++..||+|+++...    .+.+.+|+.+++++ +|+||+++++++..   ...++||||++
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l-~h~~ii~~~~~~~~---~~~~lv~e~~~   77 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQL-DNPYIVRMIGVCEA---EALMLVMEMAS   77 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhc-CCCCeEEEEEEEcC---CCeEEEEEeCC
Confidence            4899999999999764  445679999986432    35688999999999 99999999999843   46789999999


Q ss_pred             CCChhhhcC----CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCCCcc----e
Q 015374          206 STDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY----N  277 (408)
Q Consensus       206 ~~~l~~~~~----~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~~~~----~  277 (408)
                      +++|..++.    .+++..+..++.|++.||.|||++|++|+||||+|||++.+ +.+||+|||++.........    .
T Consensus        78 ~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~-~~~kl~dfg~~~~~~~~~~~~~~~~  156 (257)
T cd05115          78 GGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQ-HYAKISDFGLSKALGADDSYYKARS  156 (257)
T ss_pred             CCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCC-CcEEeccCCccccccCCccceeccC
Confidence            999998763    48899999999999999999999999999999999999988 78999999999765433221    1


Q ss_pred             eeccCccccccccccCCcCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCCCccccc
Q 015374          278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSKFI  356 (408)
Q Consensus       278 ~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  356 (408)
                      ...++..|+|||.+.+ ..++.++|||||||++|++++ |..||. +....+....+...                   .
T Consensus       157 ~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~-~~~~~~~~~~~~~~-------------------~  215 (257)
T cd05115         157 AGKWPLKWYAPECINF-RKFSSRSDVWSYGITMWEAFSYGQKPYK-KMKGPEVMSFIEQG-------------------K  215 (257)
T ss_pred             CCCCCcccCCHHHHcc-CCCCchhhHHHHHHHHHHHhcCCCCCcC-cCCHHHHHHHHHCC-------------------C
Confidence            1223467999999876 678999999999999999996 888874 33333332222111                   0


Q ss_pred             cccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 015374          357 NADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA  391 (408)
Q Consensus       357 ~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~  391 (408)
                      ....+..+++++.+++.+||..||++||++.++.+
T Consensus       216 ~~~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~  250 (257)
T cd05115         216 RLDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEE  250 (257)
T ss_pred             CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            11223346899999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6e-41  Score=309.39  Aligned_cols=258  Identities=23%  Similarity=0.457  Sum_probs=210.6

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEec--ccc--------hHHHHHHHHHHHHhcCCCCceEEeeEEEcc
Q 015374          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK--PVK--------KKKIKREIKILQNLCGGPNVVKLLDIVRDQ  192 (408)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~--~~~--------~~~~~~E~~~l~~l~~h~niv~l~~~~~~~  192 (408)
                      -+++|-++++||+|||+.||+|.+....+.||+|+-.  +..        .+...+|..|-+.| .||.||++|++|.-.
T Consensus       461 Ln~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeL-DHpRIVKlYDyfslD  539 (775)
T KOG1151|consen  461 LNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKEL-DHPRIVKLYDYFSLD  539 (775)
T ss_pred             hHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhcc-Ccceeeeeeeeeeec
Confidence            4688999999999999999999999999999999853  222        23467899999999 999999999999754


Q ss_pred             CCCccEEEEEeecCCChhhhcC---CCChHHHHHHHHHHHHHHHHHHHC--CcEEecCCCCcEEEeCC--CCcEEEEecc
Q 015374          193 HSKTPSLIFEYVNSTDFKVLYP---TLTDYDIRYYIYELLKALDYCHSQ--GIMHRDVKPHNVMIDHE--LRKLRLIDWG  265 (408)
Q Consensus       193 ~~~~~~lv~e~~~~~~l~~~~~---~l~~~~~~~i~~qi~~~L~~LH~~--~iiH~Dlk~~NILl~~~--~~~~kl~DfG  265 (408)
                       ....|-|+|||+|.+|+.+++   .+++.+++.|+.||..||.||.+.  .|||-||||.|||+-..  .|.+||+|||
T Consensus       540 -tdsFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFG  618 (775)
T KOG1151|consen  540 -TDSFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFG  618 (775)
T ss_pred             -cccceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecc
Confidence             356789999999999999985   489999999999999999999976  69999999999999654  3689999999


Q ss_pred             cceeccCCCc--------ceeeccCccccccccccC---CcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHH
Q 015374          266 LAEFYHPGKE--------YNVRVASRYFKGPELLVD---LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA  334 (408)
Q Consensus       266 ~a~~~~~~~~--------~~~~~~~~~y~aPE~~~~---~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~  334 (408)
                      +++++++...        +....||.+|++||++.-   ...++.++||||+|||+|.++.|+.||.......+.+++  
T Consensus       619 LSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqe--  696 (775)
T KOG1151|consen  619 LSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQE--  696 (775)
T ss_pred             hhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhh--
Confidence            9998875432        234578999999999854   356899999999999999999999999544444444332  


Q ss_pred             hhhchhhhhcCCCCCCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccc
Q 015374          335 KDCCLIIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQ  397 (408)
Q Consensus       335 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~  397 (408)
                        ..........++.           -..++.++++||++||++.-++|..+.+|..||||..
T Consensus       697 --NTIlkAtEVqFP~-----------KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyllP  746 (775)
T KOG1151|consen  697 --NTILKATEVQFPP-----------KPVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLLP  746 (775)
T ss_pred             --hchhcceeccCCC-----------CCccCHHHHHHHHHHHHhhhhhhhhHHHHccCccccc
Confidence              2222222111111           1237899999999999999999999999999999975

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=7e-39  Score=297.43  Aligned_cols=244  Identities=21%  Similarity=0.409  Sum_probs=195.5

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCC---CcEEEEEEeccc----chHHHHHHHHHHHHhcCCCCceEEeeEEEccCCC
Q 015374          123 DQDDYEVVRKVGRGKYSEVFEGINVNT---NERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSK  195 (408)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~---~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  195 (408)
                      ..++|++.+.||+|+||.||+|.+...   ...|++|.....    ..+.+.+|+.+++++ +|+||+++++++.+   .
T Consensus         4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~---~   79 (270)
T cd05056           4 QREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQF-DHPHIVKLIGVITE---N   79 (270)
T ss_pred             chhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhC-CCCchhceeEEEcC---C
Confidence            356789999999999999999987544   346899988643    245788999999999 99999999999864   3


Q ss_pred             ccEEEEEeecCCChhhhcC----CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceecc
Q 015374          196 TPSLIFEYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH  271 (408)
Q Consensus       196 ~~~lv~e~~~~~~l~~~~~----~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~  271 (408)
                      ..++||||+++++|..++.    .+++..+..++.|++.||+|||+.+++|+||||+||+++.+ +.++|+|||+++...
T Consensus        80 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~-~~~~l~d~g~~~~~~  158 (270)
T cd05056          80 PVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSP-DCVKLGDFGLSRYLE  158 (270)
T ss_pred             CcEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecC-CCeEEccCceeeecc
Confidence            4679999999999998873    37899999999999999999999999999999999999988 799999999998765


Q ss_pred             CCCcce--eeccCccccccccccCCcCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCC
Q 015374          272 PGKEYN--VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHS  348 (408)
Q Consensus       272 ~~~~~~--~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  348 (408)
                      ......  ...++..|+|||.+.. ..++.++||||||+++|||++ |..||. +.+..+....+....           
T Consensus       159 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~pf~-~~~~~~~~~~~~~~~-----------  225 (270)
T cd05056         159 DESYYKASKGKLPIKWMAPESINF-RRFTSASDVWMFGVCMWEILMLGVKPFQ-GVKNNDVIGRIENGE-----------  225 (270)
T ss_pred             cccceecCCCCccccccChhhhcc-CCCCchhhhHHHHHHHHHHHHcCCCCCC-CCCHHHHHHHHHcCC-----------
Confidence            432222  1223457999999876 678999999999999999996 888873 434344333322110           


Q ss_pred             CCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 015374          349 RKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH  392 (408)
Q Consensus       349 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~h  392 (408)
                              ....+..++.++.+++.+|+..+|++|||+.++++.
T Consensus       226 --------~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~  261 (270)
T cd05056         226 --------RLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQ  261 (270)
T ss_pred             --------cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                    111233478899999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=4.5e-39  Score=314.26  Aligned_cols=247  Identities=20%  Similarity=0.320  Sum_probs=195.4

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEc-----CCCcEEEEEEecccc----hHHHHHHHHHHHHhcCCCCceEEeeEEEccC
Q 015374          123 DQDDYEVVRKVGRGKYSEVFEGINV-----NTNERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQH  193 (408)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~Vy~~~~~-----~~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~  193 (408)
                      ..++|.+.++||+|+||.||+|++.     .++..||+|+++...    ...+.+|+.++.++..||||++++++|..  
T Consensus        35 ~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~--  112 (401)
T cd05107          35 PRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTK--  112 (401)
T ss_pred             cHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEcc--
Confidence            4678899999999999999999854     345689999997432    24678899999999449999999999955  


Q ss_pred             CCccEEEEEeecCCChhhhcC-----------------------------------------------------------
Q 015374          194 SKTPSLIFEYVNSTDFKVLYP-----------------------------------------------------------  214 (408)
Q Consensus       194 ~~~~~lv~e~~~~~~l~~~~~-----------------------------------------------------------  214 (408)
                      ....++||||+++|+|.+++.                                                           
T Consensus       113 ~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  192 (401)
T cd05107         113 GGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPM  192 (401)
T ss_pred             CCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccch
Confidence            457899999999999987662                                                           


Q ss_pred             ------------------------------------------CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEE
Q 015374          215 ------------------------------------------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMI  252 (408)
Q Consensus       215 ------------------------------------------~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl  252 (408)
                                                                .+++..+..++.|++.||+|||+.+|+||||||+|||+
T Consensus       193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~NiLl  272 (401)
T cd05107         193 QDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLI  272 (401)
T ss_pred             hcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceEEE
Confidence                                                      14556678899999999999999999999999999999


Q ss_pred             eCCCCcEEEEecccceeccCCCc---ceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHH
Q 015374          253 DHELRKLRLIDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHD  328 (408)
Q Consensus       253 ~~~~~~~kl~DfG~a~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-g~~pf~~~~~~~~  328 (408)
                      +.+ +.+||+|||+++.......   .....++..|+|||.+.+ ..++.++|||||||++|||++ |+.|| ......+
T Consensus       273 ~~~-~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslGvil~e~l~~g~~P~-~~~~~~~  349 (401)
T cd05107         273 CEG-KLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFN-NLYTTLSDVWSFGILLWEIFTLGGTPY-PELPMNE  349 (401)
T ss_pred             eCC-CEEEEEecCcceecccccccccCCCcCCCCceeChHHhcC-CCCCcHhHHHHHHHHHHHHHHcCCCCC-CCCCchH
Confidence            987 7999999999976533221   122356678999999987 678999999999999999998 77786 3333344


Q ss_pred             HHHHHHhhhchhhhhcCCCCCCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 015374          329 QLVKIAKDCCLIIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH  392 (408)
Q Consensus       329 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~h  392 (408)
                      .........                  .....+..++.++.+++.+||..||++||+++|+++.
T Consensus       350 ~~~~~~~~~------------------~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~  395 (401)
T cd05107         350 QFYNAIKRG------------------YRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHL  395 (401)
T ss_pred             HHHHHHHcC------------------CCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            333322210                  0111233478999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=5.5e-39  Score=301.06  Aligned_cols=244  Identities=18%  Similarity=0.326  Sum_probs=194.2

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcC-----CCcEEEEEEecccc----hHHHHHHHHHHHHhcCCCCceEEeeEEEccC
Q 015374          123 DQDDYEVVRKVGRGKYSEVFEGINVN-----TNERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQH  193 (408)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~Vy~~~~~~-----~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~  193 (408)
                      ..++|++.+.||+|+||.||+|.+..     ++..+|+|.+....    ...+.+|+.+++++ +||||+++++++.+  
T Consensus         3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l-~h~~iv~~~~~~~~--   79 (288)
T cd05050           3 PRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEF-DHPNIVKLLGVCAV--   79 (288)
T ss_pred             ChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhc-CCCchheEEEEEcC--
Confidence            46789999999999999999998643     57789999986432    45688999999999 99999999999954  


Q ss_pred             CCccEEEEEeecCCChhhhcC-------------------------CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCC
Q 015374          194 SKTPSLIFEYVNSTDFKVLYP-------------------------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPH  248 (408)
Q Consensus       194 ~~~~~lv~e~~~~~~l~~~~~-------------------------~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~  248 (408)
                      ....+++|||+++++|..++.                         .+++..+..++.|++.||.|||+++++||||||+
T Consensus        80 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~  159 (288)
T cd05050          80 GKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATR  159 (288)
T ss_pred             CCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHh
Confidence            457889999999999988763                         2567788899999999999999999999999999


Q ss_pred             cEEEeCCCCcEEEEecccceeccCCCc---ceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHh-CCCCCCCCC
Q 015374          249 NVMIDHELRKLRLIDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGH  324 (408)
Q Consensus       249 NILl~~~~~~~kl~DfG~a~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-g~~pf~~~~  324 (408)
                      ||+++.+ +.++|+|||++........   ......+..|+|||.+.+ ..++.++|||||||++|+|++ |..||+ +.
T Consensus       160 nil~~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~~~~~~p~~-~~  236 (288)
T cd05050         160 NCLVGEN-MVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFY-NRYTTESDVWAYGVVLWEIFSYGMQPYY-GM  236 (288)
T ss_pred             heEecCC-CceEECccccceecccCccccccCCCccChhhcCHHHHhc-CCCCchhHHHHHHHHHHHHHhCCCCCCC-CC
Confidence            9999988 7899999999876543221   112234556999999877 679999999999999999997 777874 33


Q ss_pred             CCHHHHHHHHhhhchhhhhcCCCCCCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 015374          325 DNHDQLVKIAKDCCLIIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA  391 (408)
Q Consensus       325 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~  391 (408)
                      +..+....+... .                  ....+..++.++.+|+.+||+.||++|||+.|+++
T Consensus       237 ~~~~~~~~~~~~-~------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~  284 (288)
T cd05050         237 AHEEVIYYVRDG-N------------------VLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINR  284 (288)
T ss_pred             CHHHHHHHHhcC-C------------------CCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence            323332222111 0                  00112336789999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=1.1e-38  Score=295.67  Aligned_cols=243  Identities=18%  Similarity=0.343  Sum_probs=194.6

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCc---EEEEEEeccc----chHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCc
Q 015374          124 QDDYEVVRKVGRGKYSEVFEGINVNTNE---RCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT  196 (408)
Q Consensus       124 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~---~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  196 (408)
                      .++|+..+.||+|+||.||+|++..++.   .+++|.++..    ....+.+|+.+++++ +|+|++++.+++.+  ...
T Consensus         4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~   80 (268)
T cd05063           4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQF-SHHNIIRLEGVVTK--FKP   80 (268)
T ss_pred             hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcC-CCCCeeEEEEEEcc--CCC
Confidence            5678889999999999999999876554   7899998643    245688999999999 99999999999954  467


Q ss_pred             cEEEEEeecCCChhhhcC----CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccC
Q 015374          197 PSLIFEYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP  272 (408)
Q Consensus       197 ~~lv~e~~~~~~l~~~~~----~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~  272 (408)
                      .++||||+++++|..++.    .+++..+..++.|++.||.|||+.|++|+||||+||+++.+ +.++|+|||++.....
T Consensus        81 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~-~~~kl~dfg~~~~~~~  159 (268)
T cd05063          81 AMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSN-LECKVSDFGLSRVLED  159 (268)
T ss_pred             cEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCC-CcEEECCCccceeccc
Confidence            889999999999988863    47889999999999999999999999999999999999987 7899999999876643


Q ss_pred             CCcce----eeccCccccccccccCCcCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHhhhchhhhhcCCC
Q 015374          273 GKEYN----VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRH  347 (408)
Q Consensus       273 ~~~~~----~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (408)
                      .....    ....+..|+|||++.+ ..++.++|||||||++|||++ |..||.. .+..+....+... .         
T Consensus       160 ~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Dv~slG~il~ell~~g~~p~~~-~~~~~~~~~i~~~-~---------  227 (268)
T cd05063         160 DPEGTYTTSGGKIPIRWTAPEAIAY-RKFTSASDVWSFGIVMWEVMSFGERPYWD-MSNHEVMKAINDG-F---------  227 (268)
T ss_pred             ccccceeccCCCcCceecCHHHhhc-CCcChHhHHHHHHHHHHHHHhCCCCCCCc-CCHHHHHHHHhcC-C---------
Confidence            22211    1122346999999977 678999999999999999997 8988743 3333333333211 0         


Q ss_pred             CCCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 015374          348 SRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA  391 (408)
Q Consensus       348 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~  391 (408)
                               .......++.++.+++.+||+.||++||++.++++
T Consensus       228 ---------~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~  262 (268)
T cd05063         228 ---------RLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVN  262 (268)
T ss_pred             ---------CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence                     01112236789999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=7.5e-39  Score=296.83  Aligned_cols=243  Identities=17%  Similarity=0.328  Sum_probs=194.8

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCc---EEEEEEeccc----chHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCc
Q 015374          124 QDDYEVVRKVGRGKYSEVFEGINVNTNE---RCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT  196 (408)
Q Consensus       124 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~---~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  196 (408)
                      .++|++.+.||+|+||.||+|++..++.   .+|+|.++..    ..+.+.+|+.+++++ +||||+++++++.+  +..
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~   79 (267)
T cd05066           3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQF-DHPNIIHLEGVVTK--SKP   79 (267)
T ss_pred             HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhC-CCCCcceEEEEEec--CCc
Confidence            4678999999999999999998764443   7899988642    235788999999999 99999999999954  467


Q ss_pred             cEEEEEeecCCChhhhcC----CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccC
Q 015374          197 PSLIFEYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP  272 (408)
Q Consensus       197 ~~lv~e~~~~~~l~~~~~----~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~  272 (408)
                      .++||||+++++|..++.    .+++.++..++.|++.||.|||+++++|+||||+|||++.+ +.++|+|||++.....
T Consensus        80 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~-~~~~l~dfg~~~~~~~  158 (267)
T cd05066          80 VMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSN-LVCKVSDFGLSRVLED  158 (267)
T ss_pred             cEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCC-CeEEeCCCCccccccc
Confidence            899999999999988873    47888999999999999999999999999999999999988 7899999999986654


Q ss_pred             CCcce----eeccCccccccccccCCcCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHhhhchhhhhcCCC
Q 015374          273 GKEYN----VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRH  347 (408)
Q Consensus       273 ~~~~~----~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (408)
                      .....    ...++..|++||.+.+ ..++.++|+|||||++|++++ |..||. +.+..+....+.+..          
T Consensus       159 ~~~~~~~~~~~~~~~~y~~pe~~~~-~~~~~~~Dv~slG~~l~ell~~g~~p~~-~~~~~~~~~~~~~~~----------  226 (267)
T cd05066         159 DPEAAYTTRGGKIPIRWTAPEAIAY-RKFTSASDVWSYGIVMWEVMSYGERPYW-EMSNQDVIKAIEEGY----------  226 (267)
T ss_pred             ccceeeecCCCccceeecCHhHhcc-CccCchhhhHHHHHHHHHHhcCCCCCcc-cCCHHHHHHHHhCCC----------
Confidence            32211    1122457999999987 678999999999999999886 888874 333333333332210          


Q ss_pred             CCCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 015374          348 SRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA  391 (408)
Q Consensus       348 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~  391 (408)
                               .......+++.+.+++.+||+.+|++|||+.++++
T Consensus       227 ---------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  261 (267)
T cd05066         227 ---------RLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVS  261 (267)
T ss_pred             ---------cCCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHH
Confidence                     01112336789999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=8.1e-39  Score=300.93  Aligned_cols=251  Identities=19%  Similarity=0.333  Sum_probs=196.3

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCC----------------cEEEEEEeccc----chHHHHHHHHHHHHhcCCCCc
Q 015374          123 DQDDYEVVRKVGRGKYSEVFEGINVNTN----------------ERCIIKILKPV----KKKKIKREIKILQNLCGGPNV  182 (408)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~----------------~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~ni  182 (408)
                      ...+|++.+.||+|+||.||+|.+...+                ..||+|.+...    ..+.+.+|+.+++++ +|+||
T Consensus         3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i   81 (296)
T cd05051           3 PRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRL-SDPNI   81 (296)
T ss_pred             chhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhc-CCCCE
Confidence            3568999999999999999999876543                46899998643    245788999999999 99999


Q ss_pred             eEEeeEEEccCCCccEEEEEeecCCChhhhcC--------------CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCC
Q 015374          183 VKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYP--------------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPH  248 (408)
Q Consensus       183 v~l~~~~~~~~~~~~~lv~e~~~~~~l~~~~~--------------~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~  248 (408)
                      ++++++|..  +...+++|||+++++|..++.              .+++..+..++.|++.||.|||+.||+|+||||+
T Consensus        82 ~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~  159 (296)
T cd05051          82 ARLLGVCTV--DPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATR  159 (296)
T ss_pred             eEEEEEEec--CCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchh
Confidence            999999955  467899999999999988762              4788899999999999999999999999999999


Q ss_pred             cEEEeCCCCcEEEEecccceeccCCCc---ceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHh--CCCCCCCC
Q 015374          249 NVMIDHELRKLRLIDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF--RKEPFFYG  323 (408)
Q Consensus       249 NILl~~~~~~~kl~DfG~a~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~--g~~pf~~~  323 (408)
                      ||+++.+ +.++|+|||+++.......   .....++..|+|||.+.+ ..++.++|||||||++|||++  +..||. .
T Consensus       160 Nili~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~~~~~~~p~~-~  236 (296)
T cd05051         160 NCLVGKN-YTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLL-GKFTTKSDVWAFGVTLWEILTLCREQPYE-H  236 (296)
T ss_pred             ceeecCC-CceEEccccceeecccCcceeecCcCCCCceecCHHHhhc-CCCCccchhhhhHHHHHHHHhcCCCCCCC-C
Confidence            9999988 7999999999876543322   122345678999999877 678999999999999999998  566663 3


Q ss_pred             CCCHHHHHHHHhhhchhhhhcCCCCCCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 015374          324 HDNHDQLVKIAKDCCLIIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA  391 (408)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~  391 (408)
                      .+..+.+.........       ....     .....+..++.++.+++.+||+.||++|||+.|+++
T Consensus       237 ~~~~~~~~~~~~~~~~-------~~~~-----~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~  292 (296)
T cd05051         237 LTDQQVIENAGHFFRD-------DGRQ-----IYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHL  292 (296)
T ss_pred             cChHHHHHHHHhcccc-------cccc-----ccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence            3334443333221000       0000     001122346789999999999999999999999964

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=6.7e-39  Score=331.88  Aligned_cols=141  Identities=29%  Similarity=0.533  Sum_probs=127.1

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecccc------hHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCcc
Q 015374          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK------KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP  197 (408)
Q Consensus       124 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~------~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~  197 (408)
                      .++|++.++||+|+||+||+|.+..+++.||||+++...      ...+.+|+.++..+ +|+||+++++++..  ....
T Consensus         3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l-~hp~Iv~~~~~~~~--~~~~   79 (669)
T cd05610           3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALS-KSPFIVHLYYSLQS--ANNV   79 (669)
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhc-CCCCcCeEEEEEEE--CCEE
Confidence            468999999999999999999999999999999986432      35688899999998 99999999999854  4678


Q ss_pred             EEEEEeecCCChhhhcC---CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccce
Q 015374          198 SLIFEYVNSTDFKVLYP---TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE  268 (408)
Q Consensus       198 ~lv~e~~~~~~l~~~~~---~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~  268 (408)
                      ++||||+.+++|..++.   .+++..++.++.||+.||+|||+++|+||||||+|||++.+ +.+||+|||+++
T Consensus        80 ~lVmEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~-g~vkL~DFGls~  152 (669)
T cd05610          80 YLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNE-GHIKLTDFGLSK  152 (669)
T ss_pred             EEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCC-CCEEEEeCCCCc
Confidence            99999999999988873   47888999999999999999999999999999999999988 799999999875

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=100.00  E-value=8.8e-41  Score=313.52  Aligned_cols=281  Identities=25%  Similarity=0.410  Sum_probs=224.4

Q ss_pred             CCCCCcccccCCCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecccc--hHHHHHHHHHHHHhcC-----CCCceE
Q 015374          112 WDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK--KKKIKREIKILQNLCG-----GPNVVK  184 (408)
Q Consensus       112 ~~~~~~~~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~E~~~l~~l~~-----h~niv~  184 (408)
                      ..|+.+.++..--++|.+..-.|+|-||+|.+|.+..-|..||||++.+..  .+.-..|++||++|..     --|+++
T Consensus       419 EGYYrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~KtGl~EleiLkKL~~AD~Edk~Hclr  498 (752)
T KOG0670|consen  419 EGYYRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMHKTGLKELEILKKLNDADPEDKFHCLR  498 (752)
T ss_pred             cceEEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHhhhhhHHHHHHHHhhccCchhhhHHHH
Confidence            347777788888899999999999999999999999999999999997543  4667899999999932     247899


Q ss_pred             EeeEEEccCCCccEEEEEeecCCChhhhc-----CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcE
Q 015374          185 LLDIVRDQHSKTPSLIFEYVNSTDFKVLY-----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKL  259 (408)
Q Consensus       185 l~~~~~~~~~~~~~lv~e~~~~~~l~~~~-----~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~  259 (408)
                      ++..|  .+.+++|||+|.+.......+.     -.+....++.|+.|+..||..|-.+||+|.||||+|||++.....+
T Consensus       499 l~r~F--~hknHLClVFE~LslNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iL  576 (752)
T KOG0670|consen  499 LFRHF--KHKNHLCLVFEPLSLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNIL  576 (752)
T ss_pred             HHHHh--hhcceeEEEehhhhchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCccee
Confidence            99988  4468999999988765433332     1377788999999999999999999999999999999999988899


Q ss_pred             EEEecccceeccCCCcceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhch
Q 015374          260 RLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCL  339 (408)
Q Consensus       260 kl~DfG~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~  339 (408)
                      ||||||.|.....+ ..+...-+..|+|||+++| -.|++..|+||+||+||||.||+..| +|..+.+++...++..|.
T Consensus       577 KLCDfGSA~~~~en-eitPYLVSRFYRaPEIiLG-~~yd~~iD~WSvgctLYElYtGkIlF-pG~TNN~MLrl~me~KGk  653 (752)
T KOG0670|consen  577 KLCDFGSASFASEN-EITPYLVSRFYRAPEIILG-LPYDYPIDTWSVGCTLYELYTGKILF-PGRTNNQMLRLFMELKGK  653 (752)
T ss_pred             eeccCccccccccc-cccHHHHHHhccCcceeec-CcccCCccceeeceeeEEeeccceec-CCCCcHHHHHHHHHhcCC
Confidence            99999999876543 4455567788999999999 88999999999999999999999886 899999999888888775


Q ss_pred             hhhhcCCCCC---CCcccc-------------------ccccCC------------------CCCCHHHHHHHHHhcccC
Q 015374          340 IIWCNSRHSR---KPWSKF-------------------INADNQ------------------HLVSPEAIDFLDKLLRYD  379 (408)
Q Consensus       340 ~~~~~~~~~~---~~~~~~-------------------~~~~~~------------------~~~~~~~~~li~~~L~~d  379 (408)
                      ++........   .-++..                   +....|                  ..+-.++.+|+.+||..|
T Consensus       654 ~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~Ld  733 (752)
T KOG0670|consen  654 FPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILD  733 (752)
T ss_pred             CcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccC
Confidence            5521111111   000000                   000000                  001245899999999999


Q ss_pred             cCCCCCHHHHhcCCCccc
Q 015374          380 HQDRLTAREAMAHPYFAQ  397 (408)
Q Consensus       380 p~~Rpt~~elL~hp~f~~  397 (408)
                      |++|.|..++|.||||+.
T Consensus       734 P~KRit~nqAL~HpFi~~  751 (752)
T KOG0670|consen  734 PEKRITVNQALKHPFITE  751 (752)
T ss_pred             hhhcCCHHHHhcCCcccC
Confidence            999999999999999974

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=7.6e-39  Score=304.46  Aligned_cols=251  Identities=28%  Similarity=0.432  Sum_probs=200.0

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc------chHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCcc
Q 015374          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP  197 (408)
Q Consensus       124 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~  197 (408)
                      ...|+..+.||+|+||.||+|++..++..+|+|.+...      ....+.+|+.+++++ +|+|++++++++.+  ....
T Consensus        24 ~~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~--~~~~  100 (317)
T cd06635          24 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRI-KHPNSIEYKGCYLR--EHTA  100 (317)
T ss_pred             hhhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhC-CCCCEEEEEEEEee--CCeE
Confidence            34577888999999999999999999999999998532      124678899999999 99999999999965  4567


Q ss_pred             EEEEEeecCCChhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCCC
Q 015374          198 SLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK  274 (408)
Q Consensus       198 ~lv~e~~~~~~l~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~~  274 (408)
                      ++||||+.+..+....   ..+++.++..++.|++.||.|||+.+|+|+||+|+||+++.+ +.++|+|||++.....  
T Consensus       101 ~lv~e~~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~-~~~kl~dfg~~~~~~~--  177 (317)
T cd06635         101 WLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEP-GQVKLADFGSASIASP--  177 (317)
T ss_pred             EEEEeCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCC-CCEEEecCCCccccCC--
Confidence            8999999864433322   348899999999999999999999999999999999999987 7899999999875432  


Q ss_pred             cceeeccCccccccccccC--CcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCCCc
Q 015374          275 EYNVRVASRYFKGPELLVD--LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPW  352 (408)
Q Consensus       275 ~~~~~~~~~~y~aPE~~~~--~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  352 (408)
                       .....++..|+|||.+..  .+.++.++|||||||++|+|++|..||+.. +.......+.....              
T Consensus       178 -~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~-~~~~~~~~~~~~~~--------------  241 (317)
T cd06635         178 -ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM-NAMSALYHIAQNES--------------  241 (317)
T ss_pred             -cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCc-cHHHHHHHHHhccC--------------
Confidence             233567888999999842  256889999999999999999999998543 22333333222100              


Q ss_pred             cccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccccc
Q 015374          353 SKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRA  400 (408)
Q Consensus       353 ~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~~~~  400 (408)
                          .......+++.+.+++.+||+.+|++|||+.++++|+|+.....
T Consensus       242 ----~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~  285 (317)
T cd06635         242 ----PTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRERP  285 (317)
T ss_pred             ----CCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhccCc
Confidence                01112235788999999999999999999999999999865443

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1e-38  Score=293.83  Aligned_cols=239  Identities=18%  Similarity=0.341  Sum_probs=195.1

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecccc--hHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccEEEE
Q 015374          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK--KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIF  201 (408)
Q Consensus       124 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~  201 (408)
                      .++|++.+.||.|+||.||+|..  .++.||+|.++...  .+++.+|+.+++++ +|+||+++++++.+  ....++||
T Consensus         5 ~~~~~~~~~ig~g~~g~v~~~~~--~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~--~~~~~~v~   79 (256)
T cd05039           5 SKELKLGATIGKGEFGDVMLGDY--RGQKVAVKCLKDDSTAAQAFLAEASVMTTL-RHPNLVQLLGVVLQ--GNPLYIVT   79 (256)
T ss_pred             hhhccceeeeecCCCceEEEEEe--cCcEEEEEEeccchhHHHHHHHHHHHHHhc-CCcceeeeEEEEcC--CCCeEEEE
Confidence            56788899999999999999975  47889999997543  46788999999999 99999999999965  46788999


Q ss_pred             EeecCCChhhhcC-----CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCCCcc
Q 015374          202 EYVNSTDFKVLYP-----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY  276 (408)
Q Consensus       202 e~~~~~~l~~~~~-----~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~~~~  276 (408)
                      ||+++++|..++.     .+++..+..++.|++.||.|||+.+++|+||||+||+++.+ +.++|+|||.+........ 
T Consensus        80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~-~~~~l~d~g~~~~~~~~~~-  157 (256)
T cd05039          80 EYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSED-LVAKVSDFGLAKEASQGQD-  157 (256)
T ss_pred             EecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCC-CCEEEcccccccccccccc-
Confidence            9999999988863     47899999999999999999999999999999999999988 7899999999976632222 


Q ss_pred             eeeccCccccccccccCCcCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCCCcccc
Q 015374          277 NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSKF  355 (408)
Q Consensus       277 ~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  355 (408)
                       ....+..|+|||.+.+ ..++.++||||||+++|+|++ |..||. ... .+.+.......                  
T Consensus       158 -~~~~~~~~~ape~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~-~~~-~~~~~~~~~~~------------------  215 (256)
T cd05039         158 -SGKLPVKWTAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPYP-RIP-LKDVVPHVEKG------------------  215 (256)
T ss_pred             -cCCCcccccCchhhcC-CcCCcHHHHHHHHHHHHHHHhcCCCCCC-CCC-HHHHHHHHhcC------------------
Confidence             3344567999999876 678999999999999999997 888873 222 22222222110                  


Q ss_pred             ccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 015374          356 INADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA  391 (408)
Q Consensus       356 ~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~  391 (408)
                      .....+..+++++.+++.+||..+|++|||++|+++
T Consensus       216 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  251 (256)
T cd05039         216 YRMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLRE  251 (256)
T ss_pred             CCCCCccCCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence            011122346899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=8.6e-39  Score=296.67  Aligned_cols=243  Identities=17%  Similarity=0.318  Sum_probs=194.3

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCc---EEEEEEeccc----chHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCc
Q 015374          124 QDDYEVVRKVGRGKYSEVFEGINVNTNE---RCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT  196 (408)
Q Consensus       124 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~---~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  196 (408)
                      ..+|++.+.||+|+||.||+|.+..++.   .||+|.++..    ....+..|+.+++.+ +||||+++++++.+  +..
T Consensus         3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~--~~~   79 (269)
T cd05065           3 VSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQF-DHPNIIHLEGVVTK--SRP   79 (269)
T ss_pred             hHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhC-CCcCcceEEEEECC--CCc
Confidence            3568899999999999999999877664   5999998642    245788999999999 99999999999854  567


Q ss_pred             cEEEEEeecCCChhhhcC----CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccC
Q 015374          197 PSLIFEYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP  272 (408)
Q Consensus       197 ~~lv~e~~~~~~l~~~~~----~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~  272 (408)
                      .++||||+++++|..++.    .+++.++..++.|++.||.|||++|++|+||||+||+++.+ +.++|+|||++.....
T Consensus        80 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~-~~~kl~dfg~~~~~~~  158 (269)
T cd05065          80 VMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSN-LVCKVSDFGLSRFLED  158 (269)
T ss_pred             eEEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCC-CcEEECCCcccccccc
Confidence            889999999999988763    37889999999999999999999999999999999999987 7899999999876543


Q ss_pred             CCcc---eeecc---CccccccccccCCcCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHhhhchhhhhcC
Q 015374          273 GKEY---NVRVA---SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKDCCLIIWCNS  345 (408)
Q Consensus       273 ~~~~---~~~~~---~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  345 (408)
                      ....   ....+   +..|++||.+.+ ..++.++|||||||++|||++ |..||.. .+..+....+...         
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~DvwslG~~l~e~l~~g~~p~~~-~~~~~~~~~i~~~---------  227 (269)
T cd05065         159 DTSDPTYTSSLGGKIPIRWTAPEAIAY-RKFTSASDVWSYGIVMWEVMSYGERPYWD-MSNQDVINAIEQD---------  227 (269)
T ss_pred             CccccccccccCCCcceeecCHhHhcc-CcccchhhhhhhHHHHHHHhcCCCCCCCC-CCHHHHHHHHHcC---------
Confidence            2221   11111   346999999976 778999999999999999886 8888743 3333333332211         


Q ss_pred             CCCCCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 015374          346 RHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA  391 (408)
Q Consensus       346 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~  391 (408)
                                .....+..++..+.+++.+||..+|++||+++++++
T Consensus       228 ----------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  263 (269)
T cd05065         228 ----------YRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVS  263 (269)
T ss_pred             ----------CcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                      011112346789999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=8.1e-39  Score=294.59  Aligned_cols=237  Identities=23%  Similarity=0.412  Sum_probs=195.6

Q ss_pred             eeeeeeCceEEEEEEEcCC---CcEEEEEEecccc----hHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccEEEEEe
Q 015374          131 RKVGRGKYSEVFEGINVNT---NERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEY  203 (408)
Q Consensus       131 ~~lG~G~fg~Vy~~~~~~~---~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~  203 (408)
                      +.||+|+||.||+|.+...   +..+++|.++...    ...+.+|+.++..+ +|+|++++++++.+  ....++||||
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~--~~~~~lv~e~   77 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKL-GHPNVVRLLGVCTE--EEPLYLVLEY   77 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhc-CCCChheeeeeecC--CCceEEEEEe
Confidence            3699999999999998866   8899999997433    46788999999999 79999999999965  5778999999


Q ss_pred             ecCCChhhhcC------------CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceecc
Q 015374          204 VNSTDFKVLYP------------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH  271 (408)
Q Consensus       204 ~~~~~l~~~~~------------~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~  271 (408)
                      +++++|..++.            .+++..+..++.|++.||+|||+++++|+||||+||+++.+ +.++|+|||.+....
T Consensus        78 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~-~~~~l~dfg~~~~~~  156 (262)
T cd00192          78 MEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGED-LVVKISDFGLSRDVY  156 (262)
T ss_pred             ccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCC-CcEEEcccccccccc
Confidence            99999988763            36899999999999999999999999999999999999998 799999999998765


Q ss_pred             CCC---cceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHhhhchhhhhcCCC
Q 015374          272 PGK---EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRH  347 (408)
Q Consensus       272 ~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (408)
                      ...   ......++..|+|||.+.. ..++.++||||||+++|+|++ |..||. ..+..+....+...           
T Consensus       157 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~-~~~~~~~~~~~~~~-----------  223 (262)
T cd00192         157 DDDYYRKKTGGKLPIRWMAPESLKD-GIFTSKSDVWSFGVLLWEIFTLGATPYP-GLSNEEVLEYLRKG-----------  223 (262)
T ss_pred             cccccccccCCCcCccccCHHHhcc-CCcchhhccHHHHHHHHHHHhcCCCCCC-CCCHHHHHHHHHcC-----------
Confidence            432   2233456778999999887 578999999999999999999 577763 33333333333221           


Q ss_pred             CCCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 015374          348 SRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH  392 (408)
Q Consensus       348 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~h  392 (408)
                              .....+..++.++.+++.+||+.||++|||+.|++++
T Consensus       224 --------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~  260 (262)
T cd00192         224 --------YRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVER  260 (262)
T ss_pred             --------CCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHh
Confidence                    1112233468999999999999999999999999875

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=5.6e-39  Score=302.17  Aligned_cols=250  Identities=18%  Similarity=0.347  Sum_probs=192.2

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCC--------------CcEEEEEEeccc----chHHHHHHHHHHHHhcCCCCceEE
Q 015374          124 QDDYEVVRKVGRGKYSEVFEGINVNT--------------NERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKL  185 (408)
Q Consensus       124 ~~~y~~~~~lG~G~fg~Vy~~~~~~~--------------~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l  185 (408)
                      .++|++.+.||+|+||.||++++..+              ...||+|.++..    ....+.+|+++++++ +|+|++++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l-~h~~i~~~   82 (295)
T cd05097           4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRL-KNPNIIRL   82 (295)
T ss_pred             hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhC-CCCCcCeE
Confidence            56899999999999999999976433              235899998643    235688999999999 99999999


Q ss_pred             eeEEEccCCCccEEEEEeecCCChhhhcC---------------CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcE
Q 015374          186 LDIVRDQHSKTPSLIFEYVNSTDFKVLYP---------------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNV  250 (408)
Q Consensus       186 ~~~~~~~~~~~~~lv~e~~~~~~l~~~~~---------------~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NI  250 (408)
                      ++++..  ....++||||+.+++|..++.               .+++..+..++.|++.||.|||+.+++|+||||+||
T Consensus        83 ~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Ni  160 (295)
T cd05097          83 LGVCVS--DDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNC  160 (295)
T ss_pred             EEEEcC--CCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhE
Confidence            999954  467889999999999988762               257788889999999999999999999999999999


Q ss_pred             EEeCCCCcEEEEecccceeccCCCcc---eeeccCccccccccccCCcCCCccccHHHHHHHHHHHHh--CCCCCCCCCC
Q 015374          251 MIDHELRKLRLIDWGLAEFYHPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF--RKEPFFYGHD  325 (408)
Q Consensus       251 Ll~~~~~~~kl~DfG~a~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~--g~~pf~~~~~  325 (408)
                      +++.+ +.+||+|||++.........   ....++..|+|||.+.+ ..++.++|+|||||++|+|++  +..|| ....
T Consensus       161 ll~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlG~~l~el~~~~~~~p~-~~~~  237 (295)
T cd05097         161 LVGNH-YTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILL-GKFTTASDVWAFGVTLWEMFTLCKEQPY-SLLS  237 (295)
T ss_pred             EEcCC-CcEEecccccccccccCcceeccCcCcCceeecChhhhcc-CCcCchhhHHHHHHHHHHHHHcCCCCCC-cccC
Confidence            99987 78999999998765433221   12234567999999877 678999999999999999998  45565 3333


Q ss_pred             CHHHHHHHHhhhchhhhhcCCCCCCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 015374          326 NHDQLVKIAKDCCLIIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA  391 (408)
Q Consensus       326 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~  391 (408)
                      ..+..........    ...   ..     .....+..+++.+.+++.+||+.||++|||++++++
T Consensus       238 ~~~~~~~~~~~~~----~~~---~~-----~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~  291 (295)
T cd05097         238 DEQVIENTGEFFR----NQG---RQ-----IYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH  291 (295)
T ss_pred             hHHHHHHHHHhhh----hcc---cc-----ccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence            3333332222100    000   00     001122336789999999999999999999999964

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.3e-38  Score=293.86  Aligned_cols=243  Identities=18%  Similarity=0.338  Sum_probs=198.4

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecc--cchHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccEEE
Q 015374          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP--VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI  200 (408)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~--~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  200 (408)
                      ..++|++.++||+|+||+||+|.+. ++..+++|.++.  ...+.+.+|+.+++++ +|+||+++++++..  ....++|
T Consensus         4 ~~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~~~~v   79 (261)
T cd05034           4 PRESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGTMSPEAFLQEAQIMKKL-RHDKLVQLYAVCSE--EEPIYIV   79 (261)
T ss_pred             chhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCccCHHHHHHHHHHHhhC-CCCCEeeeeeeeec--CCceEEE
Confidence            4688999999999999999999864 557899999874  3346789999999999 89999999999854  4568899


Q ss_pred             EEeecCCChhhhcC-----CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCCCc
Q 015374          201 FEYVNSTDFKVLYP-----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE  275 (408)
Q Consensus       201 ~e~~~~~~l~~~~~-----~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~~~  275 (408)
                      |||+++++|..++.     .+++..+..++.|++.||.|||++|++|+||||+||+++.+ +.++|+|||++........
T Consensus        80 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~-~~~~l~d~g~~~~~~~~~~  158 (261)
T cd05034          80 TEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGEN-LVCKIADFGLARLIEDDEY  158 (261)
T ss_pred             EeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCC-CCEEECccccceeccchhh
Confidence            99999999988873     47889999999999999999999999999999999999988 7999999999876643211


Q ss_pred             --ceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCCCc
Q 015374          276 --YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPW  352 (408)
Q Consensus       276 --~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  352 (408)
                        .....++..|+|||.+.+ ..++.++|+||||+++|+|++ |+.|| .+.+..+.+..+....               
T Consensus       159 ~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~il~~l~t~g~~p~-~~~~~~~~~~~~~~~~---------------  221 (261)
T cd05034         159 TAREGAKFPIKWTAPEAANY-GRFTIKSDVWSFGILLTEIVTYGRVPY-PGMTNREVLEQVERGY---------------  221 (261)
T ss_pred             hhhhccCCCccccCHHHhcc-CCcCchhHHHHHHHHHHHHHhCCCCCC-CCCCHHHHHHHHHcCC---------------
Confidence              112234567999999987 678999999999999999998 88776 4444444444433210               


Q ss_pred             cccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 015374          353 SKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA  391 (408)
Q Consensus       353 ~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~  391 (408)
                          ....+...+.++.+++.+||+.||++|||++++++
T Consensus       222 ----~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~  256 (261)
T cd05034         222 ----RMPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQS  256 (261)
T ss_pred             ----CCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence                11122335789999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=9.6e-39  Score=298.11  Aligned_cols=245  Identities=18%  Similarity=0.360  Sum_probs=196.1

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcC----CCcEEEEEEeccc----chHHHHHHHHHHHHhcCCCCceEEeeEEEccCC
Q 015374          123 DQDDYEVVRKVGRGKYSEVFEGINVN----TNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHS  194 (408)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~Vy~~~~~~----~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~  194 (408)
                      ..++|++.+.||+|+||.||+|.+..    ++..|++|.++..    ....+.+|+.+++++ +|+||+++++++... +
T Consensus         4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~-~   81 (280)
T cd05043           4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGL-SHQNILPILHVCIED-G   81 (280)
T ss_pred             chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEecC-C
Confidence            46789999999999999999998765    3578999988642    235678899999999 999999999988654 3


Q ss_pred             CccEEEEEeecCCChhhhcC-----------CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEe
Q 015374          195 KTPSLIFEYVNSTDFKVLYP-----------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLID  263 (408)
Q Consensus       195 ~~~~lv~e~~~~~~l~~~~~-----------~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~D  263 (408)
                      ...++++||+++++|..++.           .+++..+..++.|++.||+|||+.+++|+||||+||+++.+ +.+||+|
T Consensus        82 ~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~-~~~kl~d  160 (280)
T cd05043          82 EPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEE-LQVKITD  160 (280)
T ss_pred             CCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCC-CcEEECC
Confidence            56789999999999988762           37888899999999999999999999999999999999988 7999999


Q ss_pred             cccceeccCCCcc---eeeccCccccccccccCCcCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHhhhch
Q 015374          264 WGLAEFYHPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKDCCL  339 (408)
Q Consensus       264 fG~a~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-g~~pf~~~~~~~~~~~~~~~~~~~  339 (408)
                      ||+++.+......   ....++..|+|||++.+ ..++.++|||||||++||+++ |..||. ..+..+. .......  
T Consensus       161 ~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~-~~~~~~~-~~~~~~~--  235 (280)
T cd05043         161 NALSRDLFPMDYHCLGDNENRPVKWMALESLVN-KEYSSASDVWSFGVLLWELMTLGQTPYV-EIDPFEM-AAYLKDG--  235 (280)
T ss_pred             CCCcccccCCceEEeCCCCCcchhccCHHHHhc-CCCCchhhHHHhHHHHHHHhcCCCCCcC-cCCHHHH-HHHHHcC--
Confidence            9999865433221   12345567999999977 678999999999999999999 888873 3333332 2221110  


Q ss_pred             hhhhcCCCCCCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 015374          340 IIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA  391 (408)
Q Consensus       340 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~  391 (408)
                                      .....+..+++++.+++.+||..||++|||+.++++
T Consensus       236 ----------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~  271 (280)
T cd05043         236 ----------------YRLAQPINCPDELFAVMACCWALDPEERPSFSQLVQ  271 (280)
T ss_pred             ----------------CCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence                            011112236789999999999999999999999974

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=100.00  E-value=5.2e-39  Score=325.22  Aligned_cols=274  Identities=21%  Similarity=0.312  Sum_probs=183.2

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCC----CcEEEEEEecccchHHHHHHHHHHHHhcCCCCceEEeeEEE----ccCC
Q 015374          123 DQDDYEVVRKVGRGKYSEVFEGINVNT----NERCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVR----DQHS  194 (408)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~----~~~vavK~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~----~~~~  194 (408)
                      ..++|++.++||+|+||+||+|++..+    +..||+|.++.....+...+.. +.+. .+.++..+...+.    ....
T Consensus       130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~e~~~~e~-l~~~-~~~~~~~~~~~~~~~~~~~~~  207 (566)
T PLN03225        130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAVEIWMNER-VRRA-CPNSCADFVYGFLEPVSSKKE  207 (566)
T ss_pred             ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchhHHHHHHH-HHhh-chhhHHHHHHhhhcccccccC
Confidence            467899999999999999999999888    8999999886433222111111 1121 2223332222211    1344


Q ss_pred             CccEEEEEeecCCChhhhcCCC-----------------------ChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEE
Q 015374          195 KTPSLIFEYVNSTDFKVLYPTL-----------------------TDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVM  251 (408)
Q Consensus       195 ~~~~lv~e~~~~~~l~~~~~~l-----------------------~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NIL  251 (408)
                      ...++||||+++++|..++..-                       ....+..++.|++.||+|||+++|+||||||+|||
T Consensus       208 ~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLKP~NIL  287 (566)
T PLN03225        208 DEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQNII  287 (566)
T ss_pred             CceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCCHHHEE
Confidence            6788999999999998776321                       12335678999999999999999999999999999


Q ss_pred             EeCCCCcEEEEecccceeccCCC--cceeeccCccccccccccCCc---------------------CCCccccHHHHHH
Q 015374          252 IDHELRKLRLIDWGLAEFYHPGK--EYNVRVASRYFKGPELLVDLQ---------------------DYDYSLDMWSLGC  308 (408)
Q Consensus       252 l~~~~~~~kl~DfG~a~~~~~~~--~~~~~~~~~~y~aPE~~~~~~---------------------~~~~~~DvwSlGv  308 (408)
                      ++.+.+.+||+|||+|+......  ......+++.|+|||.+....                     .++.++|||||||
T Consensus       288 l~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSlGv  367 (566)
T PLN03225        288 FSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGL  367 (566)
T ss_pred             EeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHHHH
Confidence            99755789999999997654332  223457889999999764311                     2345679999999


Q ss_pred             HHHHHHhCCCCCCCCCCCHHHHHHHHhhhchh--hhhcCCCCCCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCH
Q 015374          309 MFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLI--IWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTA  386 (408)
Q Consensus       309 il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~  386 (408)
                      ++|||+++..+   ..++...+.......+..  .|................+.....+....+||.+||+.||++|||+
T Consensus       368 iL~el~~~~~~---~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~kR~ta  444 (566)
T PLN03225        368 IFLQMAFPNLR---SDSNLIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQRISA  444 (566)
T ss_pred             HHHHHHhCcCC---CchHHHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCcccCCCH
Confidence            99999986544   333344444444433321  1111111110000000011111234567799999999999999999


Q ss_pred             HHHhcCCCccccccc
Q 015374          387 REAMAHPYFAQVRAA  401 (408)
Q Consensus       387 ~elL~hp~f~~~~~~  401 (408)
                      +|+|+||||+.....
T Consensus       445 ~e~L~Hpff~~~~~~  459 (566)
T PLN03225        445 KAALAHPYFDREGLL  459 (566)
T ss_pred             HHHhCCcCcCCCCcc
Confidence            999999999876543

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=2.2e-39  Score=298.96  Aligned_cols=234  Identities=17%  Similarity=0.265  Sum_probs=185.3

Q ss_pred             eeeeeCceEEEEEEEcCCCc-------EEEEEEecccc---hHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccEEEE
Q 015374          132 KVGRGKYSEVFEGINVNTNE-------RCIIKILKPVK---KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIF  201 (408)
Q Consensus       132 ~lG~G~fg~Vy~~~~~~~~~-------~vavK~~~~~~---~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~  201 (408)
                      .||+|+||+||+|.+...+.       .+++|.+....   .+.+.+|+.+++.+ +|||++++++++..  +...++||
T Consensus         2 ~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~-~h~~iv~~~~~~~~--~~~~~lv~   78 (258)
T cd05078           2 SLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQL-SHKHLVLNYGVCVC--GDESIMVQ   78 (258)
T ss_pred             CCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhC-CCCChhheeeEEEe--CCCcEEEE
Confidence            69999999999998765544       38888876432   35678899999998 99999999999965  35678999


Q ss_pred             EeecCCChhhhcC----CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCC-------cEEEEecccceec
Q 015374          202 EYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELR-------KLRLIDWGLAEFY  270 (408)
Q Consensus       202 e~~~~~~l~~~~~----~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~-------~~kl~DfG~a~~~  270 (408)
                      ||+++++|..++.    .+++..+..++.|++.||+|||++||+||||||+||+++.+..       .++++|||++...
T Consensus        79 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~~  158 (258)
T cd05078          79 EYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITV  158 (258)
T ss_pred             ecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEeccccccccc
Confidence            9999999988873    3788889999999999999999999999999999999987632       2799999998654


Q ss_pred             cCCCcceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCC
Q 015374          271 HPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRK  350 (408)
Q Consensus       271 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  350 (408)
                      ...   ....++..|+|||++.+...++.++|||||||++|+|++|..+++...+....... ...              
T Consensus       159 ~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~-~~~--------------  220 (258)
T cd05078         159 LPK---EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQF-YED--------------  220 (258)
T ss_pred             CCc---hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHH-HHc--------------
Confidence            422   23467788999999987556899999999999999999996555444433322211 110              


Q ss_pred             CccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 015374          351 PWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH  392 (408)
Q Consensus       351 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~h  392 (408)
                            ....+...+.++.+++.+||+.||++|||++++++.
T Consensus       221 ------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  256 (258)
T cd05078         221 ------RHQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRD  256 (258)
T ss_pred             ------cccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHh
Confidence                  011222356789999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.4e-38  Score=293.25  Aligned_cols=235  Identities=18%  Similarity=0.334  Sum_probs=188.2

Q ss_pred             eeeeeeCceEEEEEEEcCCC---cEEEEEEecccc----hHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccEEEEEe
Q 015374          131 RKVGRGKYSEVFEGINVNTN---ERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEY  203 (408)
Q Consensus       131 ~~lG~G~fg~Vy~~~~~~~~---~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~  203 (408)
                      ++||+|+||.||+|++...+   ..+|+|.++...    .+.+.+|+.+++.+ .|+||+++++++..   ...++||||
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~---~~~~~v~e~   76 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQL-DHPCIVRLIGVCKG---EPLMLVMEL   76 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhc-CCCCeeeEEEEEcC---CceEEEEEe
Confidence            36999999999999876555   789999987433    35688999999999 99999999998843   457899999


Q ss_pred             ecCCChhhhcC---CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCCCcce---
Q 015374          204 VNSTDFKVLYP---TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN---  277 (408)
Q Consensus       204 ~~~~~l~~~~~---~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~~~~~---  277 (408)
                      +++++|..++.   .+++..+..++.|++.||.|||+.+++|+||||+|||++.+ +.+||+|||+++.........   
T Consensus        77 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~-~~~kl~df~~~~~~~~~~~~~~~~  155 (257)
T cd05060          77 APLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNR-HQAKISDFGMSRALGAGSDYYRAT  155 (257)
T ss_pred             CCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCC-CcEEeccccccceeecCCcccccc
Confidence            99999998873   48899999999999999999999999999999999999988 789999999998664433211   


Q ss_pred             -eeccCccccccccccCCcCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCCCcccc
Q 015374          278 -VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSKF  355 (408)
Q Consensus       278 -~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  355 (408)
                       ...++..|+|||.+.+ ..++.++|||||||++|+|++ |..||. ..+..+....+...                   
T Consensus       156 ~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~~~~~g~~p~~-~~~~~~~~~~~~~~-------------------  214 (257)
T cd05060         156 TAGRWPLKWYAPECINY-GKFSSKSDVWSYGVTLWEAFSYGAKPYG-EMKGAEVIAMLESG-------------------  214 (257)
T ss_pred             cCccccccccCHHHhcC-CCCCccchHHHHHHHHHHHHcCCCCCcc-cCCHHHHHHHHHcC-------------------
Confidence             1122356999999976 679999999999999999998 888873 33333332222111                   


Q ss_pred             ccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 015374          356 INADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA  391 (408)
Q Consensus       356 ~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~  391 (408)
                      .....+..++.++.+++.+||..||++|||+.++++
T Consensus       215 ~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~  250 (257)
T cd05060         215 ERLPRPEECPQEIYSIMLSCWKYRPEDRPTFSELES  250 (257)
T ss_pred             CcCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence            011223447889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-40  Score=323.41  Aligned_cols=245  Identities=18%  Similarity=0.340  Sum_probs=209.8

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCc---EEEEEEecc----cchHHHHHHHHHHHHhcCCCCceEEeeEEEccCCC
Q 015374          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNE---RCIIKILKP----VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSK  195 (408)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~---~vavK~~~~----~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  195 (408)
                      +.+...+.+.||.|.||.||+|+.+..++   .||||.+|.    ..+.+|..|..||.++ +||||++|-|+.  ...+
T Consensus       627 d~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQF-dHPNIIrLEGVV--Tks~  703 (996)
T KOG0196|consen  627 DPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQF-DHPNIIRLEGVV--TKSK  703 (996)
T ss_pred             ChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccC-CCCcEEEEEEEE--ecCc
Confidence            45678899999999999999999876664   699999984    3457899999999999 999999999999  5567


Q ss_pred             ccEEEEEeecCCChhhhcC----CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceecc
Q 015374          196 TPSLIFEYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH  271 (408)
Q Consensus       196 ~~~lv~e~~~~~~l~~~~~----~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~  271 (408)
                      ..++|.|||++|+|+.+++    +|+..++..++++|+.||.||-++|+|||||.++|||++.| -.+|++|||+++.+.
T Consensus       704 PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsn-LvCKVsDFGLSRvle  782 (996)
T KOG0196|consen  704 PVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSN-LVCKVSDFGLSRVLE  782 (996)
T ss_pred             eeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccc-eEEEeccccceeecc
Confidence            8899999999999999984    48999999999999999999999999999999999999999 589999999999886


Q ss_pred             CCCc--ceeeccC--ccccccccccCCcCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHhhhchhhhhcCC
Q 015374          272 PGKE--YNVRVAS--RYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKDCCLIIWCNSR  346 (408)
Q Consensus       272 ~~~~--~~~~~~~--~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  346 (408)
                      ++..  +++..|.  ..|.|||.+.. .+++.++|||||||+|||.++ |..|| -+..+.|.+..+.+...        
T Consensus       783 dd~~~~ytt~GGKIPiRWTAPEAIa~-RKFTsASDVWSyGIVmWEVmSyGERPY-WdmSNQdVIkaIe~gyR--------  852 (996)
T KOG0196|consen  783 DDPEAAYTTLGGKIPIRWTAPEAIAY-RKFTSASDVWSYGIVMWEVMSYGERPY-WDMSNQDVIKAIEQGYR--------  852 (996)
T ss_pred             cCCCccccccCCccceeecChhHhhh-cccCchhhccccceEEEEecccCCCcc-cccchHHHHHHHHhccC--------
Confidence            5542  2233332  45999999987 899999999999999999776 77776 56777888887766533        


Q ss_pred             CCCCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 015374          347 HSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH  392 (408)
Q Consensus       347 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~h  392 (408)
                                 ...+-+++..+-+|+..||++|-.+||+..|++++
T Consensus       853 -----------LPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~  887 (996)
T KOG0196|consen  853 -----------LPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVST  887 (996)
T ss_pred             -----------CCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHH
Confidence                       33345589999999999999999999999998764

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.5e-41  Score=344.83  Aligned_cols=255  Identities=25%  Similarity=0.424  Sum_probs=210.0

Q ss_pred             CCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc-----chHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccEE
Q 015374          125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSL  199 (408)
Q Consensus       125 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l  199 (408)
                      -+++-..+||.|.||.||.|.+..+|+..|+|-++-.     ..+.+.+|..++..+ +|||+|+.+|+-.+  ....++
T Consensus      1235 ~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~l-nHpNlV~YyGVEvH--Rekv~I 1311 (1509)
T KOG4645|consen 1235 FRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGL-NHPNLVRYYGVEVH--REKVYI 1311 (1509)
T ss_pred             eeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhc-cCccccccCceeec--HHHHHH
Confidence            3566677999999999999999999999999987622     235678999999999 99999999999855  456679


Q ss_pred             EEEeecCCChhhhcCC---CChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCCC--
Q 015374          200 IFEYVNSTDFKVLYPT---LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK--  274 (408)
Q Consensus       200 v~e~~~~~~l~~~~~~---l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~~--  274 (408)
                      .||||++|+|...+..   .++.-.+.+..|++.|+.|||+.|||||||||.||+++.+ |.+|++|||.|..+.++.  
T Consensus      1312 FMEyC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~-g~iK~~DFGsa~ki~~~~~~ 1390 (1509)
T KOG4645|consen 1312 FMEYCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFN-GLIKYGDFGSAVKIKNNAQT 1390 (1509)
T ss_pred             HHHHhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecC-CcEEeecccceeEecCchhc
Confidence            9999999999998742   5666677899999999999999999999999999999999 799999999998876543  


Q ss_pred             ---cceeeccCccccccccccCCc--CCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCC
Q 015374          275 ---EYNVRVASRYFKGPELLVDLQ--DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSR  349 (408)
Q Consensus       275 ---~~~~~~~~~~y~aPE~~~~~~--~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  349 (408)
                         ..+...||+.|||||++.+..  +-.-+.||||+||++.||+||+.||..-+++..........             
T Consensus      1391 ~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~g------------- 1457 (1509)
T KOG4645|consen 1391 MPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAG------------- 1457 (1509)
T ss_pred             CCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhcc-------------
Confidence               234568999999999997732  33458999999999999999999996555554444433221             


Q ss_pred             CCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccccccch
Q 015374          350 KPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAE  402 (408)
Q Consensus       350 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~~~~~~  402 (408)
                            -.+..|..++.+..+||.+||..||.+|+++.|+++|-|=+.-+.+.
T Consensus      1458 ------h~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~f~~~~~d~~ 1504 (1509)
T KOG4645|consen 1458 ------HKPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEHAFGKSCTDED 1504 (1509)
T ss_pred             ------CCCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHhhccccccccc
Confidence                  12334455899999999999999999999999999999977655443

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-38  Score=292.39  Aligned_cols=237  Identities=30%  Similarity=0.524  Sum_probs=197.5

Q ss_pred             eeeeCceEEEEEEEcCCCcEEEEEEeccc------chHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccEEEEEeecC
Q 015374          133 VGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNS  206 (408)
Q Consensus       133 lG~G~fg~Vy~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~~  206 (408)
                      ||.|+||.||++.+..+++.+++|.++..      ....+.+|+.+++++ +|+||+++++.+..  +...+++|||+++
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~~~~v~e~~~~   77 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRI-NHPFIVKLHYAFQT--EEKLYLVLEYAPG   77 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHc-CCCcHHHHHHHeec--CCeeEEEEecCCC
Confidence            69999999999999888999999998643      234788999999999 89999999999854  5788999999999


Q ss_pred             CChhhhcC---CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCC-CcceeeccC
Q 015374          207 TDFKVLYP---TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG-KEYNVRVAS  282 (408)
Q Consensus       207 ~~l~~~~~---~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~-~~~~~~~~~  282 (408)
                      ++|..++.   .+++..+..++.|++.||.|||+.+++|+||+|+||+++.+ +.++|+|||++...... .......++
T Consensus        78 ~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~-~~~~l~d~~~~~~~~~~~~~~~~~~~~  156 (250)
T cd05123          78 GELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDAD-GHIKLTDFGLAKELSSEGSRTNTFCGT  156 (250)
T ss_pred             CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCC-CcEEEeecCcceecccCCCcccCCcCC
Confidence            99988763   47899999999999999999999999999999999999988 79999999998776543 233445678


Q ss_pred             ccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCCCccccccccCCC
Q 015374          283 RYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSKFINADNQH  362 (408)
Q Consensus       283 ~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  362 (408)
                      ..|++||...+ ..++.++|+||||+++|++++|..||. ..+.......+..                    .....+.
T Consensus       157 ~~~~~Pe~~~~-~~~~~~~D~~slG~~~~~l~~g~~p~~-~~~~~~~~~~~~~--------------------~~~~~~~  214 (250)
T cd05123         157 PEYLAPEVLLG-KGYGKAVDWWSLGVLLYEMLTGKPPFY-AEDRKEIYEKILK--------------------DPLRFPE  214 (250)
T ss_pred             ccccChHHhCC-CCCCchhhHHHHHHHHHHHHHCCCCCC-CCCHHHHHHHHhc--------------------CCCCCCC
Confidence            88999999977 668899999999999999999999983 3332222222221                    0112233


Q ss_pred             CCCHHHHHHHHHhcccCcCCCCCH---HHHhcCCCc
Q 015374          363 LVSPEAIDFLDKLLRYDHQDRLTA---REAMAHPYF  395 (408)
Q Consensus       363 ~~~~~~~~li~~~L~~dp~~Rpt~---~elL~hp~f  395 (408)
                      .++.++.+++.+||..||++|||+   +++++||||
T Consensus       215 ~~~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~~~~f  250 (250)
T cd05123         215 FLSPEARDLISGLLQKDPTKRLGSGGAEEIKAHPFF  250 (250)
T ss_pred             CCCHHHHHHHHHHhcCCHhhCCCcccHHHHHhCCCC
Confidence            357899999999999999999999   999999998

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-39  Score=317.48  Aligned_cols=258  Identities=23%  Similarity=0.410  Sum_probs=202.8

Q ss_pred             CCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecc----cchHHHHHHHHHHHHhcCCCCceEEeeEEEccC----CCc
Q 015374          125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP----VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQH----SKT  196 (408)
Q Consensus       125 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~----~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~----~~~  196 (408)
                      .-+...+.||+|+||.||+|+++.+|+.||||.+++    ...+...+|+++++++ +|+|||+++++-++..    ...
T Consensus        13 y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKL-nh~NIVk~f~iee~~~~~~~~~~   91 (732)
T KOG4250|consen   13 YLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKL-NHPNIVKLFDIEETKFLGLVTRL   91 (732)
T ss_pred             cceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHc-CchhhhhhcccCCccccCccccc
Confidence            445556789999999999999999999999999975    3356788999999999 8999999999876655    567


Q ss_pred             cEEEEEeecCCChhhhcC------CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCC---CCcEEEEecccc
Q 015374          197 PSLIFEYVNSTDFKVLYP------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE---LRKLRLIDWGLA  267 (408)
Q Consensus       197 ~~lv~e~~~~~~l~~~~~------~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~---~~~~kl~DfG~a  267 (408)
                      ..+|||||.+|+|...+.      .+++.+++.++.++..||.|||++||+||||||.||++-..   ...-||+|||.|
T Consensus        92 ~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~A  171 (732)
T KOG4250|consen   92 PVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAA  171 (732)
T ss_pred             ceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeeccccc
Confidence            899999999999999984      49999999999999999999999999999999999998433   135799999999


Q ss_pred             eeccCCCcceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCC---HHH-HHHHHhhhchhhh-
Q 015374          268 EFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDN---HDQ-LVKIAKDCCLIIW-  342 (408)
Q Consensus       268 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~---~~~-~~~~~~~~~~~~~-  342 (408)
                      +..+++......+||..|.+||++.....|+..+|.|||||++|+++||..||-+...+   .+. +..+.+....... 
T Consensus       172 rel~d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v~i~  251 (732)
T KOG4250|consen  172 RELDDNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGVAIG  251 (732)
T ss_pred             ccCCCCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCceeEe
Confidence            99999998999999999999999985578999999999999999999999999654332   223 2222222111110 


Q ss_pred             -hcCCCCCCCccccccccCCCCCCH----HHHHHHHHhcccCcCCCCC
Q 015374          343 -CNSRHSRKPWSKFINADNQHLVSP----EAIDFLDKLLRYDHQDRLT  385 (408)
Q Consensus       343 -~~~~~~~~~~~~~~~~~~~~~~~~----~~~~li~~~L~~dp~~Rpt  385 (408)
                       .......-.|...++.  +..++.    .+...+..+|.+||++|..
T Consensus       252 ~~~~eNgpv~~s~~lP~--p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~  297 (732)
T KOG4250|consen  252 AQEEENGPVEWSSTLPQ--PNHLSRGLATRLTKWLASMLEWNPRKRGH  297 (732)
T ss_pred             eecccCCceeeeccCCC--cccccHHHHhhhhHHHHHHHhhhHHHhCC
Confidence             0111112223333222  333333    3567788899999999983

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=7.3e-39  Score=303.34  Aligned_cols=251  Identities=27%  Similarity=0.417  Sum_probs=200.0

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc------chHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCc
Q 015374          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT  196 (408)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  196 (408)
                      ..+.|+..+.||+|+||+||+|++..++..+++|.+...      ....+.+|+.+++.+ +|+|++++++++..  ...
T Consensus        13 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~   89 (308)
T cd06634          13 PEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKL-RHPNTIQYRGCYLR--EHT   89 (308)
T ss_pred             cHHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhC-CCCCcccEEEEEEc--CCe
Confidence            345678888999999999999999999999999987531      124577899999999 99999999999965  467


Q ss_pred             cEEEEEeecCCChhhhc----CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccC
Q 015374          197 PSLIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP  272 (408)
Q Consensus       197 ~~lv~e~~~~~~l~~~~----~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~  272 (408)
                      .++||||+.+ ++...+    ..+++..+..++.|++.||.|||+.+++|+||+|+||+++.+ +.++|+|||++.....
T Consensus        90 ~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~-~~~kl~dfg~~~~~~~  167 (308)
T cd06634          90 AWLVMEYCLG-SASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEP-GLVKLGDFGSASIMAP  167 (308)
T ss_pred             eEEEEEccCC-CHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCC-CcEEECCcccceeecC
Confidence            7899999985 444433    348889999999999999999999999999999999999987 7999999999876543


Q ss_pred             CCcceeeccCccccccccccC--CcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCC
Q 015374          273 GKEYNVRVASRYFKGPELLVD--LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRK  350 (408)
Q Consensus       273 ~~~~~~~~~~~~y~aPE~~~~--~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  350 (408)
                      .   ....++..|+|||.+.+  ...++.++|||||||++|+|++|..||+... ..+....+....            .
T Consensus       168 ~---~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~-~~~~~~~~~~~~------------~  231 (308)
T cd06634         168 A---NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN-AMSALYHIAQNE------------S  231 (308)
T ss_pred             c---ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCcccc-HHHHHHHHhhcC------------C
Confidence            2   23467888999999853  2457889999999999999999999985432 222222221110            0


Q ss_pred             CccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccccc
Q 015374          351 PWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRA  400 (408)
Q Consensus       351 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~~~~  400 (408)
                            .......++..+.++|.+||+.+|++|||++++++|||+...+.
T Consensus       232 ------~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~~~~  275 (308)
T cd06634         232 ------PALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERP  275 (308)
T ss_pred             ------CCcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCccccccCC
Confidence                  01112236788999999999999999999999999999987544

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=1.3e-38  Score=294.01  Aligned_cols=239  Identities=21%  Similarity=0.339  Sum_probs=186.5

Q ss_pred             eeeeeeCceEEEEEEEcC---CCcEEEEEEeccc----chHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccEEEEEe
Q 015374          131 RKVGRGKYSEVFEGINVN---TNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEY  203 (408)
Q Consensus       131 ~~lG~G~fg~Vy~~~~~~---~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~  203 (408)
                      +.||+|+||+||+|.+..   .+..+|+|.+...    ..+.+.+|+.+++.+ +||||+++++++... +...+++|||
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~-~~~~~lv~e~   78 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDF-SHPNVLSLLGICLPS-EGSPLVVLPY   78 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccC-CCCCcceEEEEeecC-CCCcEEEEec
Confidence            368999999999998653   3457999988532    235778899999998 999999999987543 3457899999


Q ss_pred             ecCCChhhhcC----CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCCCc----
Q 015374          204 VNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE----  275 (408)
Q Consensus       204 ~~~~~l~~~~~----~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~~~----  275 (408)
                      +.+++|..++.    ..++..+..++.|++.||.|||+.+++||||||+|||++.+ +.+||+|||+++.......    
T Consensus        79 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~-~~~kl~dfg~~~~~~~~~~~~~~  157 (262)
T cd05058          79 MKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDES-FTVKVADFGLARDIYDKEYYSVH  157 (262)
T ss_pred             CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCC-CcEEECCccccccccCCcceeec
Confidence            99999998863    35677788899999999999999999999999999999988 7899999999875543211    


Q ss_pred             -ceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCCCccc
Q 015374          276 -YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSK  354 (408)
Q Consensus       276 -~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  354 (408)
                       .....++..|+|||.+.+ ..++.++|||||||++|||++|+.|++...+..+....+...                  
T Consensus       158 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~------------------  218 (262)
T cd05058         158 NHTGAKLPVKWMALESLQT-QKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQG------------------  218 (262)
T ss_pred             ccccCcCCccccChhHhcc-CccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcC------------------
Confidence             112234567999999876 678999999999999999999776665554443333222110                  


Q ss_pred             cccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 015374          355 FINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH  392 (408)
Q Consensus       355 ~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~h  392 (408)
                       .....+..+++.+.+++.+||..+|++|||+.|+++.
T Consensus       219 -~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~  255 (262)
T cd05058         219 -RRLLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSR  255 (262)
T ss_pred             -CCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence             0111123367899999999999999999999999853

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=1.4e-38  Score=304.92  Aligned_cols=246  Identities=18%  Similarity=0.318  Sum_probs=194.4

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCC-------CcEEEEEEeccc----chHHHHHHHHHHHHhcCCCCceEEeeEEEc
Q 015374          123 DQDDYEVVRKVGRGKYSEVFEGINVNT-------NERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRD  191 (408)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~-------~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~  191 (408)
                      ...+|++.+.||+|+||.||+|++...       +..||+|.++..    ..+.+.+|+.+++++.+|+||++++++|.+
T Consensus        10 ~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~   89 (334)
T cd05100          10 SRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ   89 (334)
T ss_pred             CHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEcc
Confidence            346799999999999999999976432       236899988642    235788999999999779999999999954


Q ss_pred             cCCCccEEEEEeecCCChhhhcC-------------------CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEE
Q 015374          192 QHSKTPSLIFEYVNSTDFKVLYP-------------------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMI  252 (408)
Q Consensus       192 ~~~~~~~lv~e~~~~~~l~~~~~-------------------~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl  252 (408)
                        ....+++|||+++++|..++.                   .+++..+..++.|++.||.|||++||+||||||+|||+
T Consensus        90 --~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nill  167 (334)
T cd05100          90 --DGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLV  167 (334)
T ss_pred             --CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEE
Confidence              457889999999999988763                   25677788899999999999999999999999999999


Q ss_pred             eCCCCcEEEEecccceeccCCCcc---eeeccCccccccccccCCcCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHH
Q 015374          253 DHELRKLRLIDWGLAEFYHPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHD  328 (408)
Q Consensus       253 ~~~~~~~kl~DfG~a~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-g~~pf~~~~~~~~  328 (408)
                      +.+ +.+||+|||+++........   ....++..|+|||++.+ ..++.++|||||||++|||++ |..|| .+.+..+
T Consensus       168 ~~~-~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~-~~~~~~~  244 (334)
T cd05100         168 TED-NVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLLWEIFTLGGSPY-PGIPVEE  244 (334)
T ss_pred             cCC-CcEEECCcccceecccccccccccCCCcCceEcCHHHhcc-CCcCchhhhHHHHHHHHHHHhcCCCCC-CCCCHHH
Confidence            988 79999999999765432211   12233456999999987 778999999999999999998 66676 4443333


Q ss_pred             HHHHHHhhhchhhhhcCCCCCCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 015374          329 QLVKIAKDCCLIIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH  392 (408)
Q Consensus       329 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~h  392 (408)
                      ....+...                   .....+..++.++.+++.+||+.+|++|||+.|++++
T Consensus       245 ~~~~~~~~-------------------~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~  289 (334)
T cd05100         245 LFKLLKEG-------------------HRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVED  289 (334)
T ss_pred             HHHHHHcC-------------------CCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence            33222111                   0111223467899999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=1.5e-38  Score=299.44  Aligned_cols=250  Identities=17%  Similarity=0.338  Sum_probs=190.9

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcC----------------CCcEEEEEEeccc----chHHHHHHHHHHHHhcCCCCce
Q 015374          124 QDDYEVVRKVGRGKYSEVFEGINVN----------------TNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVV  183 (408)
Q Consensus       124 ~~~y~~~~~lG~G~fg~Vy~~~~~~----------------~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv  183 (408)
                      .++|++.++||+|+||+||++.+..                +...+|+|+++..    ....+.+|+.+++++ +|+||+
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l-~~~~i~   82 (296)
T cd05095           4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRL-KDPNII   82 (296)
T ss_pred             hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhC-CCCCcc
Confidence            5679999999999999999985432                3446899998743    235788999999999 999999


Q ss_pred             EEeeEEEccCCCccEEEEEeecCCChhhhcCC--------------CChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCc
Q 015374          184 KLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPT--------------LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHN  249 (408)
Q Consensus       184 ~l~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~--------------l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~N  249 (408)
                      ++++++.+  ....+++|||+++++|..++..              +++..+..++.|++.||+|||+.||+|+||||+|
T Consensus        83 ~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~N  160 (296)
T cd05095          83 RLLAVCIT--SDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRN  160 (296)
T ss_pred             eEEEEEec--CCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChhe
Confidence            99999965  4567899999999999887632              5567789999999999999999999999999999


Q ss_pred             EEEeCCCCcEEEEecccceeccCCCcc---eeeccCccccccccccCCcCCCccccHHHHHHHHHHHHh--CCCCCCCCC
Q 015374          250 VMIDHELRKLRLIDWGLAEFYHPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF--RKEPFFYGH  324 (408)
Q Consensus       250 ILl~~~~~~~kl~DfG~a~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~--g~~pf~~~~  324 (408)
                      ||++.+ +.++|+|||++.........   ....++..|++||...+ ..++.++|+|||||++|||++  |..||.. .
T Consensus       161 ili~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~DiwSlG~~l~el~~~~~~~p~~~-~  237 (296)
T cd05095         161 CLVGKN-YTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILL-GKFTTASDVWAFGVTLWEILTLCKEQPYSQ-L  237 (296)
T ss_pred             EEEcCC-CCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhc-CCccchhhhhHHHHHHHHHHHhCCCCCccc-c
Confidence            999987 78999999999765433211   11233567999998876 679999999999999999998  6677632 2


Q ss_pred             CCHHHHHHHHhhhchhhhhcCCCCCCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 015374          325 DNHDQLVKIAKDCCLIIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA  391 (408)
Q Consensus       325 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~  391 (408)
                      +..+........    ......  .      .....+..+++.+.+|+.+||+.||++|||+.|+++
T Consensus       238 ~~~~~~~~~~~~----~~~~~~--~------~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~  292 (296)
T cd05095         238 SDEQVIENTGEF----FRDQGR--Q------VYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHA  292 (296)
T ss_pred             ChHHHHHHHHHH----Hhhccc--c------ccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            323322211110    000000  0      001112336789999999999999999999999864

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=3.1e-38  Score=290.57  Aligned_cols=243  Identities=16%  Similarity=0.351  Sum_probs=195.0

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc--chHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccEEEE
Q 015374          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV--KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIF  201 (408)
Q Consensus       124 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~  201 (408)
                      ..+|++.+.||+|+||.||+|.+. .+..+|+|.++..  ....+.+|+++++++ +|||++++++++..  ....++||
T Consensus         3 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~--~~~~~~v~   78 (256)
T cd05112           3 PSELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAMSEEDFIEEAQVMMKL-SHPKLVQLYGVCTE--RSPICLVF   78 (256)
T ss_pred             hhHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCCCHHHHHHHHHHHHhC-CCCCeeeEEEEEcc--CCceEEEE
Confidence            457899999999999999999775 4668999988643  346789999999999 99999999999854  45778999


Q ss_pred             EeecCCChhhhcC----CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCCCc--
Q 015374          202 EYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE--  275 (408)
Q Consensus       202 e~~~~~~l~~~~~----~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~~~--  275 (408)
                      ||+++++|..++.    .+++..+..++.|++.||+|||+.+++|+||||+||+++.+ +.++|+|||++........  
T Consensus        79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~-~~~~l~d~g~~~~~~~~~~~~  157 (256)
T cd05112          79 EFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGEN-QVVKVSDFGMTRFVLDDQYTS  157 (256)
T ss_pred             EcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCC-CeEEECCCcceeecccCcccc
Confidence            9999999988763    37888999999999999999999999999999999999987 7899999999876543221  


Q ss_pred             ceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCCCccc
Q 015374          276 YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSK  354 (408)
Q Consensus       276 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  354 (408)
                      .....++..|+|||.+.+ ..++.++||||||+++|||++ |..||. .....+....+...                  
T Consensus       158 ~~~~~~~~~~~aPe~~~~-~~~~~~~Dv~slG~~l~el~~~g~~p~~-~~~~~~~~~~~~~~------------------  217 (256)
T cd05112         158 STGTKFPVKWSSPEVFSF-SKYSSKSDVWSFGVLMWEVFSEGKTPYE-NRSNSEVVETINAG------------------  217 (256)
T ss_pred             cCCCccchhhcCHhHhcc-CCcChHHHHHHHHHHHHHHHcCCCCCCC-cCCHHHHHHHHhCC------------------
Confidence            112234567999999976 678999999999999999998 888873 33333333332211                  


Q ss_pred             cccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 015374          355 FINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH  392 (408)
Q Consensus       355 ~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~h  392 (408)
                       .....+...+.++.+++.+||+.+|++|||+.|+++.
T Consensus       218 -~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~  254 (256)
T cd05112         218 -FRLYKPRLASQSVYELMQHCWKERPEDRPSFSLLLHQ  254 (256)
T ss_pred             -CCCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHh
Confidence             0111122357899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.7e-38  Score=295.02  Aligned_cols=243  Identities=19%  Similarity=0.323  Sum_probs=194.9

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCc----EEEEEEecccc----hHHHHHHHHHHHHhcCCCCceEEeeEEEccCC
Q 015374          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNE----RCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHS  194 (408)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~----~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~  194 (408)
                      ...+|++.+.||+|+||+||+|.+..++.    .+|+|.++...    ...+.+|+.+++++ +|+||+++++++..   
T Consensus         5 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~---   80 (279)
T cd05057           5 KETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASV-DHPHVVRLLGICLS---   80 (279)
T ss_pred             CHHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhC-CCCCcceEEEEEec---
Confidence            45789999999999999999998876665    58999886432    35688999999999 99999999999965   


Q ss_pred             CccEEEEEeecCCChhhhcC----CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceec
Q 015374          195 KTPSLIFEYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY  270 (408)
Q Consensus       195 ~~~~lv~e~~~~~~l~~~~~----~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~  270 (408)
                      ...++||||+++++|..++.    .+++..+..++.|++.||+|||+++|+|+||||+||+++.+ +.+||+|||+++..
T Consensus        81 ~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~-~~~kL~dfg~~~~~  159 (279)
T cd05057          81 SQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTP-QHVKITDFGLAKLL  159 (279)
T ss_pred             CceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCC-CeEEECCCcccccc
Confidence            56789999999999988763    47899999999999999999999999999999999999987 78999999999876


Q ss_pred             cCCCccee---eccCccccccccccCCcCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHhhhchhhhhcCC
Q 015374          271 HPGKEYNV---RVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKDCCLIIWCNSR  346 (408)
Q Consensus       271 ~~~~~~~~---~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  346 (408)
                      ........   ..++..|++||.+.. ..++.++|+||||+++||+++ |..||. +....+....+...          
T Consensus       160 ~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~-~~~~~~~~~~~~~~----------  227 (279)
T cd05057         160 DVDEKEYHAEGGKVPIKWMALESILH-RIYTHKSDVWSYGVTVWELMTFGAKPYE-GIPAVEIPDLLEKG----------  227 (279)
T ss_pred             cCcccceecCCCcccccccCHHHhhc-CCcCchhhHHHHHHHHHHHhcCCCCCCC-CCCHHHHHHHHhCC----------
Confidence            53322211   223457999999876 778999999999999999998 888873 33333322222211          


Q ss_pred             CCCCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 015374          347 HSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA  391 (408)
Q Consensus       347 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~  391 (408)
                               .....+...+.++.+++.+||..||++|||+.++++
T Consensus       228 ---------~~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~  263 (279)
T cd05057         228 ---------ERLPQPPICTIDVYMVLVKCWMIDAESRPTFKELIN  263 (279)
T ss_pred             ---------CCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence                     011122336788999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=1.8e-38  Score=293.68  Aligned_cols=234  Identities=18%  Similarity=0.266  Sum_probs=180.8

Q ss_pred             eeeeeeCceEEEEEEEcC------------CCcEEEEEEecccc---hHHHHHHHHHHHHhcCCCCceEEeeEEEccCCC
Q 015374          131 RKVGRGKYSEVFEGINVN------------TNERCIIKILKPVK---KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSK  195 (408)
Q Consensus       131 ~~lG~G~fg~Vy~~~~~~------------~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  195 (408)
                      +.||+|+||.||+|+...            ....|++|++....   ...+.+|+.++..+ +||||+++++++..  ..
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l-~hp~iv~~~~~~~~--~~   77 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQV-SHKHIVLLYGVCVR--DV   77 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhC-CCCCEeeEEEEEec--CC
Confidence            368999999999997432            22358899886543   24677899999999 99999999999965  35


Q ss_pred             ccEEEEEeecCCChhhhcC----CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCC------cEEEEecc
Q 015374          196 TPSLIFEYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELR------KLRLIDWG  265 (408)
Q Consensus       196 ~~~lv~e~~~~~~l~~~~~----~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~------~~kl~DfG  265 (408)
                      ..++||||++++++..++.    .+++..+..++.|++.||.|||+++|+||||||+|||++.+..      .++++|||
T Consensus        78 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g  157 (262)
T cd05077          78 ENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPG  157 (262)
T ss_pred             CCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCCC
Confidence            6789999999999887763    3888999999999999999999999999999999999986521      28999999


Q ss_pred             cceeccCCCcceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHhhhchhhhhc
Q 015374          266 LAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKDCCLIIWCN  344 (408)
Q Consensus       266 ~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  344 (408)
                      ++.....   .....++..|+|||.+.+...++.++|||||||++|||++ |..|| ......+. .......       
T Consensus       158 ~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~-~~~~~~~~-~~~~~~~-------  225 (262)
T cd05077         158 IPITVLS---RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPL-KDKTLAEK-ERFYEGQ-------  225 (262)
T ss_pred             CCccccC---cccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCC-CCcchhHH-HHHHhcC-------
Confidence            9865432   2234677889999998754678999999999999999984 66665 33322221 1111100       


Q ss_pred             CCCCCCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 015374          345 SRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH  392 (408)
Q Consensus       345 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~h  392 (408)
                        .           ......++++.+++.+||+.||++||++.+++++
T Consensus       226 --~-----------~~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~  260 (262)
T cd05077         226 --C-----------MLVTPSCKELADLMTHCMNYDPNQRPFFRAIMRD  260 (262)
T ss_pred             --c-----------cCCCCChHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence              0           0011135789999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=3.5e-38  Score=291.19  Aligned_cols=242  Identities=15%  Similarity=0.308  Sum_probs=194.3

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecccc--hHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccEEE
Q 015374          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK--KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI  200 (408)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  200 (408)
                      ..++|++.++||+|+||.||+|.+ ..+..+++|.++...  .+.+.+|+.+++++ +|+||+++++++.+   ...+++
T Consensus         4 ~~~~~~~~~~lg~g~~~~vy~~~~-~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~---~~~~~v   78 (260)
T cd05073           4 PRESLKLEKKLGAGQFGEVWMATY-NKHTKVAVKTMKPGSMSVEAFLAEANVMKTL-QHDKLVKLHAVVTK---EPIYII   78 (260)
T ss_pred             cccceeEEeEecCccceEEEEEEe-cCCccEEEEecCCChhHHHHHHHHHHHHHhc-CCCCcceEEEEEcC---CCeEEE
Confidence            467899999999999999999974 455679999886433  46788999999999 99999999999854   567899


Q ss_pred             EEeecCCChhhhcC-----CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCCCc
Q 015374          201 FEYVNSTDFKVLYP-----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE  275 (408)
Q Consensus       201 ~e~~~~~~l~~~~~-----~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~~~  275 (408)
                      |||+++++|..++.     .+++..+..++.|++.||.|||+.|++|+||||+||+++.+ +.++|+|||.+........
T Consensus        79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~-~~~~l~d~~~~~~~~~~~~  157 (260)
T cd05073          79 TEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSAS-LVCKIADFGLARVIEDNEY  157 (260)
T ss_pred             EEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCC-CcEEECCCcceeeccCCCc
Confidence            99999999988873     26778888999999999999999999999999999999988 7999999999876543221


Q ss_pred             --ceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCCCc
Q 015374          276 --YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPW  352 (408)
Q Consensus       276 --~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  352 (408)
                        .....++..|+|||++.. ..++.++|+|||||++|++++ |..|| .+.+..+....+....               
T Consensus       158 ~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~~l~t~g~~p~-~~~~~~~~~~~~~~~~---------------  220 (260)
T cd05073         158 TAREGAKFPIKWTAPEAINF-GSFTIKSDVWSFGILLMEIVTYGRIPY-PGMSNPEVIRALERGY---------------  220 (260)
T ss_pred             ccccCCcccccccCHhHhcc-CCcCccccchHHHHHHHHHHhcCCCCC-CCCCHHHHHHHHhCCC---------------
Confidence              112234566999999976 678999999999999999998 77776 4444444333322210               


Q ss_pred             cccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 015374          353 SKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA  391 (408)
Q Consensus       353 ~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~  391 (408)
                          ........+.++.+++.+||+.||++||++.++++
T Consensus       221 ----~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~  255 (260)
T cd05073         221 ----RMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQS  255 (260)
T ss_pred             ----CCCCcccCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence                01112346789999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=2.6e-38  Score=290.92  Aligned_cols=239  Identities=23%  Similarity=0.414  Sum_probs=195.1

Q ss_pred             EEEeeeeeeCceEEEEEEEcCCC----cEEEEEEecccc----hHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccEE
Q 015374          128 EVVRKVGRGKYSEVFEGINVNTN----ERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSL  199 (408)
Q Consensus       128 ~~~~~lG~G~fg~Vy~~~~~~~~----~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l  199 (408)
                      ++.+.||.|+||.||++++...+    ..+|+|.++...    .+.+.+|+.++..+ +|+||+++++++.+.  ...++
T Consensus         2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~--~~~~~   78 (258)
T smart00219        2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKL-DHPNIVKLLGVCTEE--EPLMI   78 (258)
T ss_pred             cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhc-CCCchheEEEEEcCC--CeeEE
Confidence            56778999999999999988766    899999997433    45788999999999 999999999999654  67889


Q ss_pred             EEEeecCCChhhhcCC-----CChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCCC
Q 015374          200 IFEYVNSTDFKVLYPT-----LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK  274 (408)
Q Consensus       200 v~e~~~~~~l~~~~~~-----l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~~  274 (408)
                      +|||++++++..++..     +++..+..++.|++.||.|||+.+++|+||||+||+++.+ +.++|+|||++.......
T Consensus        79 i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~-~~~~l~dfg~~~~~~~~~  157 (258)
T smart00219       79 VMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGEN-LVVKISDFGLSRDLYDDD  157 (258)
T ss_pred             EEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccC-CeEEEcccCCceeccccc
Confidence            9999999999887732     8999999999999999999999999999999999999988 799999999998765442


Q ss_pred             ccee--eccCccccccccccCCcCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCCC
Q 015374          275 EYNV--RVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKP  351 (408)
Q Consensus       275 ~~~~--~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  351 (408)
                      ....  ..++..|++||.+.+ ..++.++|+||+|+++|+|++ |..|| ...+..+....+....              
T Consensus       158 ~~~~~~~~~~~~y~~Pe~~~~-~~~~~~~Di~slG~i~~~l~~~g~~p~-~~~~~~~~~~~~~~~~--------------  221 (258)
T smart00219      158 YYKKKGGKLPIRWMAPESLKD-GKFTSKSDVWSFGVLLWEIFTLGESPY-PGMSNEEVLEYLKKGY--------------  221 (258)
T ss_pred             ccccccCCCcccccChHHhcc-CCCCcchhHHHHHHHHHHHHhCCCCCC-CCCCHHHHHHHHhcCC--------------
Confidence            2222  236678999999865 778999999999999999998 55555 4444444433332210              


Q ss_pred             ccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 015374          352 WSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA  391 (408)
Q Consensus       352 ~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~  391 (408)
                           ....+..++.++.+++.+||..||++|||+.|+++
T Consensus       222 -----~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~  256 (258)
T smart00219      222 -----RLPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVE  256 (258)
T ss_pred             -----CCCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHh
Confidence                 01112236889999999999999999999999985

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=1e-38  Score=298.05  Aligned_cols=250  Identities=20%  Similarity=0.352  Sum_probs=198.0

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEc----CCCcEEEEEEecccc----hHHHHHHHHHHHHhcCCCCceEEeeEEEccCCC
Q 015374          124 QDDYEVVRKVGRGKYSEVFEGINV----NTNERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSK  195 (408)
Q Consensus       124 ~~~y~~~~~lG~G~fg~Vy~~~~~----~~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  195 (408)
                      .++|++.+.||+|+||.||+|+..    .++..+|+|+++...    ...+.+|+.+++.+ +|+||+++++++......
T Consensus         3 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l-~~~~i~~~~~~~~~~~~~   81 (284)
T cd05038           3 KRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTL-DHENIVKYKGVCEKPGGR   81 (284)
T ss_pred             hhhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhC-CCCChheEEeeeecCCCC
Confidence            456788899999999999999864    347899999997443    45789999999999 999999999999766567


Q ss_pred             ccEEEEEeecCCChhhhcC----CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceecc
Q 015374          196 TPSLIFEYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH  271 (408)
Q Consensus       196 ~~~lv~e~~~~~~l~~~~~----~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~  271 (408)
                      ..+++|||+++++|..++.    .+++..+..++.|++.||+|||++|++|+||||+||+++.+ +.++|+|||++....
T Consensus        82 ~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~-~~~~l~dfg~~~~~~  160 (284)
T cd05038          82 SLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESE-DLVKISDFGLAKVLP  160 (284)
T ss_pred             ceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCC-CCEEEcccccccccc
Confidence            8899999999999988874    38889999999999999999999999999999999999988 799999999998765


Q ss_pred             CCCcc----eeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHH----------HHHHHhhh
Q 015374          272 PGKEY----NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQ----------LVKIAKDC  337 (408)
Q Consensus       272 ~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~----------~~~~~~~~  337 (408)
                      .....    ....++..|++||.+.+ ..++.++||||||+++|||++|..|+.........          ...+....
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~Pe~~~~-~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (284)
T cd05038         161 EDKDYYYVKEPGESPIFWYAPECLRT-SKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELL  239 (284)
T ss_pred             cCCcceeccCCCCCcccccCcHHHcc-CCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHH
Confidence            33221    12234556999999977 67899999999999999999999997543221100          11111100


Q ss_pred             chhhhhcCCCCCCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 015374          338 CLIIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA  391 (408)
Q Consensus       338 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~  391 (408)
                      .       ..        .....+..++.++.+++.+||+.||++|||+.|+++
T Consensus       240 ~-------~~--------~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  278 (284)
T cd05038         240 K-------EG--------ERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLIL  278 (284)
T ss_pred             H-------cC--------CcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence            0       00        011112346789999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=3.5e-38  Score=289.17  Aligned_cols=234  Identities=21%  Similarity=0.363  Sum_probs=187.1

Q ss_pred             eeeeeCceEEEEEEEcCCCcEEEEEEecccc----hHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccEEEEEeecCC
Q 015374          132 KVGRGKYSEVFEGINVNTNERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNST  207 (408)
Q Consensus       132 ~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~~~  207 (408)
                      .||+|+||.||+|.. .++..+|+|.++...    ...+.+|+.+++++ +||||+++++++..  ....++||||++++
T Consensus         2 ~ig~g~~g~vy~~~~-~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~~~lv~e~~~~~   77 (250)
T cd05085           2 LLGKGNFGEVFKGTL-KDKTPVAVKTCKEDLPQELKIKFLSEARILKQY-DHPNIVKLIGVCTQ--RQPIYIVMELVPGG   77 (250)
T ss_pred             ccCCCCCceEEEEEe-cCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhC-CCCCcCeEEEEEec--CCccEEEEECCCCC
Confidence            689999999999975 568899999986432    34688999999999 99999999999965  45788999999999


Q ss_pred             ChhhhcC----CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCCCcc--eeecc
Q 015374          208 DFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY--NVRVA  281 (408)
Q Consensus       208 ~l~~~~~----~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~~~~--~~~~~  281 (408)
                      +|..++.    .+++..+..++.|++.+|.|||++|++|+||||+||+++.+ +.++|+|||++.........  ....+
T Consensus        78 ~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~-~~~~l~d~g~~~~~~~~~~~~~~~~~~  156 (250)
T cd05085          78 DFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGEN-NVLKISDFGMSRQEDDGIYSSSGLKQI  156 (250)
T ss_pred             cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCC-CeEEECCCccceeccccccccCCCCCC
Confidence            9988763    37888999999999999999999999999999999999988 78999999998754432211  11233


Q ss_pred             CccccccccccCCcCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCCCccccccccC
Q 015374          282 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSKFINADN  360 (408)
Q Consensus       282 ~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  360 (408)
                      +..|+|||++.+ ..++.++||||||+++|++++ |..||. +.........+...                   .....
T Consensus       157 ~~~y~aPE~~~~-~~~~~~~Di~slG~ll~~~~~~g~~p~~-~~~~~~~~~~~~~~-------------------~~~~~  215 (250)
T cd05085         157 PIKWTAPEALNY-GRYSSESDVWSYGILLWETFSLGVCPYP-GMTNQQAREQVEKG-------------------YRMSC  215 (250)
T ss_pred             cccccCHHHhcc-CCCCchhHHHHHHHHHHHHhcCCCCCCC-CCCHHHHHHHHHcC-------------------CCCCC
Confidence            456999999876 678999999999999999998 888873 33333322222111                   01112


Q ss_pred             CCCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 015374          361 QHLVSPEAIDFLDKLLRYDHQDRLTAREAMA  391 (408)
Q Consensus       361 ~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~  391 (408)
                      +..++.++.+++.+||..||++|||+.|+++
T Consensus       216 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  246 (250)
T cd05085         216 PQKCPDDVYKVMQRCWDYKPENRPKFSELQK  246 (250)
T ss_pred             CCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence            2346889999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=100.00  E-value=7e-40  Score=301.90  Aligned_cols=276  Identities=29%  Similarity=0.558  Sum_probs=226.3

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcC---CCcEEEEEEecc-cchHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccEE
Q 015374          124 QDDYEVVRKVGRGKYSEVFEGINVN---TNERCIIKILKP-VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSL  199 (408)
Q Consensus       124 ~~~y~~~~~lG~G~fg~Vy~~~~~~---~~~~vavK~~~~-~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l  199 (408)
                      .+.|..+++||.|+|++||++.+..   ..+.||+|.+.. +....+.+|+++|..+.++.||+++.+++  .++...++
T Consensus        35 ~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p~ri~~El~~L~~~gG~~ni~~~~~~~--rnnd~v~i  112 (418)
T KOG1167|consen   35 SNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSPSRILNELEMLYRLGGSDNIIKLNGCF--RNNDQVAI  112 (418)
T ss_pred             hhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCchHHHHHHHHHHHhccchhhhcchhhh--ccCCeeEE
Confidence            5678899999999999999999877   788999998864 45678999999999999999999999999  44577889


Q ss_pred             EEEeecCCChhhhcCCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceecc--------
Q 015374          200 IFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH--------  271 (408)
Q Consensus       200 v~e~~~~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~--------  271 (408)
                      |+||+++.....++..++..+++.+++.++.||.++|++|||||||||+|+|.+...+.-.|+|||+|....        
T Consensus       113 vlp~~~H~~f~~l~~~l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~~~~~~s  192 (418)
T KOG1167|consen  113 VLPYFEHDRFRDLYRSLSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGYQQTEHS  192 (418)
T ss_pred             EecccCccCHHHHHhcCCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHHHHHhhhhhhhh
Confidence            999999999999999999999999999999999999999999999999999999998899999999986211        


Q ss_pred             ---------C--C---------------C-----------cceeeccCccccccccccCCcCCCccccHHHHHHHHHHHH
Q 015374          272 ---------P--G---------------K-----------EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMI  314 (408)
Q Consensus       272 ---------~--~---------------~-----------~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell  314 (408)
                               +  +               .           ....+.||++|+|||++...+.-++++||||.||+++.++
T Consensus       193 ~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GVI~Lsll  272 (418)
T KOG1167|consen  193 RSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVILLSLL  272 (418)
T ss_pred             hhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeeccceeehhh
Confidence                     0  0               0           0012469999999999999888999999999999999999


Q ss_pred             hCCCCCCCCCCCHHHHHHHHhhhchhhh-----hcCC-----CCC--------CCcccc------------ccccC-CCC
Q 015374          315 FRKEPFFYGHDNHDQLVKIAKDCCLIIW-----CNSR-----HSR--------KPWSKF------------INADN-QHL  363 (408)
Q Consensus       315 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~-----~~~~-----~~~--------~~~~~~------------~~~~~-~~~  363 (408)
                      +++.|||...++.+.+.+++...|....     ..+.     .+.        ..|...            ..... .+.
T Consensus       273 s~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~~~~~~d~  352 (418)
T KOG1167|consen  273 SRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNTEREIGSDV  352 (418)
T ss_pred             ccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccceeecccccc
Confidence            9999999999999988888777663320     0001     000        001111            01111 122


Q ss_pred             CCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccccccc
Q 015374          364 VSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAA  401 (408)
Q Consensus       364 ~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~~~~~  401 (408)
                      .+..+.+|+++||..||.+|.||+++|+||||......
T Consensus       353 ~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~~~~~  390 (418)
T KOG1167|consen  353 FPALLLDLLDKCLELNPQKRITAEDALKHPFFDEADRT  390 (418)
T ss_pred             ccHHHHHHHHHHccCChhhcccHHHHhcCcCCcchhhh
Confidence            34578999999999999999999999999999976554

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=9.3e-39  Score=291.13  Aligned_cols=226  Identities=21%  Similarity=0.323  Sum_probs=184.1

Q ss_pred             eCceEEEEEEEcCCCcEEEEEEecccchHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccEEEEEeecCCChhhhc--
Q 015374          136 GKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY--  213 (408)
Q Consensus       136 G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~~~~l~~~~--  213 (408)
                      |.||+||++++..+++.+|+|.++...  .+.+|...+... .||||+++++++.+  ....+++|||+++++|..++  
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~--~~~~~~~~~~~~-~~~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~   78 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS--EYSRERLTIIPH-CVPNMVCLHKYIVS--EDSVFLVLQHAEGGKLWSHISK   78 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh--hhhhHHHHHHhc-CCCceeehhhheec--CCeEEEEEecCCCCCHHHHHHH
Confidence            899999999999999999999986432  344565556665 79999999999965  46789999999999998776  


Q ss_pred             -CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCCCcceeeccCcccccccccc
Q 015374          214 -PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLV  292 (408)
Q Consensus       214 -~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~y~aPE~~~  292 (408)
                       ..+++..+..++.|++.||+|||+++|+||||||+||+++.+ +.++++|||.+......  .....++..|+|||.+.
T Consensus        79 ~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~-~~~~l~df~~~~~~~~~--~~~~~~~~~y~aPE~~~  155 (237)
T cd05576          79 FLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDR-GHIQLTYFSRWSEVEDS--CDGEAVENMYCAPEVGG  155 (237)
T ss_pred             hcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCC-CCEEEecccchhccccc--cccCCcCccccCCcccC
Confidence             358899999999999999999999999999999999999988 78999999987655432  22345567799999987


Q ss_pred             CCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCCCccccccccCCCCCCHHHHHHH
Q 015374          293 DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSKFINADNQHLVSPEAIDFL  372 (408)
Q Consensus       293 ~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  372 (408)
                      + ..++.++|+||+|+++|||++|..|+......   .                      ........+..+++++.+++
T Consensus       156 ~-~~~~~~~DvwslG~il~el~~g~~~~~~~~~~---~----------------------~~~~~~~~~~~~~~~~~~li  209 (237)
T cd05576         156 I-SEETEACDWWSLGAILFELLTGKTLVECHPSG---I----------------------NTHTTLNIPEWVSEEARSLL  209 (237)
T ss_pred             C-CCCCchhhHHHHHHHHHHHHHCcchhhcCchh---c----------------------ccccccCCcccCCHHHHHHH
Confidence            6 67889999999999999999999876221100   0                      00011123344789999999


Q ss_pred             HHhcccCcCCCCCH-----HHHhcCCCc
Q 015374          373 DKLLRYDHQDRLTA-----REAMAHPYF  395 (408)
Q Consensus       373 ~~~L~~dp~~Rpt~-----~elL~hp~f  395 (408)
                      .+||+.||++|+|+     +|+++||||
T Consensus       210 ~~~l~~dp~~R~~~~~~~~~~~~~h~~~  237 (237)
T cd05576         210 QQLLQFNPTERLGAGVAGVEDIKSHPFF  237 (237)
T ss_pred             HHHccCCHHHhcCCCccchHHHHcCCCC
Confidence            99999999999985     999999998

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=7.4e-39  Score=304.27  Aligned_cols=249  Identities=19%  Similarity=0.351  Sum_probs=198.3

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecccc----hHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccE
Q 015374          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS  198 (408)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  198 (408)
                      ..+...+.++||+|.||.|.+|. ...+..||||++++..    +..|.+|+++|.+| +||||+.++|+|..  .+.+|
T Consensus       536 PRs~L~~~ekiGeGqFGEVhLCe-veg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqL-khPNIveLvGVC~~--DePic  611 (807)
T KOG1094|consen  536 PRSRLRFKEKIGEGQFGEVHLCE-VEGPLKVAVKILRPDATKNARNDFLKEIKILSRL-KHPNIVELLGVCVQ--DDPLC  611 (807)
T ss_pred             chhheehhhhhcCcccceeEEEE-ecCceEEEEeecCcccchhHHHHHHHHHHHHhcc-CCCCeeEEEeeeec--CCchH
Confidence            45678899999999999999996 4557999999998643    46799999999999 99999999999965  46788


Q ss_pred             EEEEeecCCChhhhcCC-----CChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCC
Q 015374          199 LIFEYVNSTDFKVLYPT-----LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG  273 (408)
Q Consensus       199 lv~e~~~~~~l~~~~~~-----l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~  273 (408)
                      +|+|||++|+|..++..     ........|+.||+.||+||.+.++|||||.++|+|+|.+ .++||+|||+++.+..+
T Consensus       612 mI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e-~~iKiadfgmsR~lysg  690 (807)
T KOG1094|consen  612 MITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGE-FTIKIADFGMSRNLYSG  690 (807)
T ss_pred             HHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCc-ccEEecCcccccccccC
Confidence            99999999999998832     3445566799999999999999999999999999999999 69999999999977666


Q ss_pred             Ccceee---ccCccccccccccCCcCCCccccHHHHHHHHHHHH--hCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCC
Q 015374          274 KEYNVR---VASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMI--FRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHS  348 (408)
Q Consensus       274 ~~~~~~---~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell--~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  348 (408)
                      ..+...   +-+..|||+|.++. ++++.++|+|+||+++||++  +...||.. ..+.+...+...    .....   .
T Consensus       691 ~yy~vqgr~vlpiRwmawEsill-gkFttaSDvWafgvTlwE~~~~C~e~Py~~-lt~e~vven~~~----~~~~~---~  761 (807)
T KOG1094|consen  691 DYYRVQGRAVLPIRWMAWESILL-GKFTTASDVWAFGVTLWEVFMLCREQPYSQ-LTDEQVVENAGE----FFRDQ---G  761 (807)
T ss_pred             CceeeecceeeeeeehhHHHHHh-ccccchhhhhhhHHHHHHHHHHHhhCchhh-hhHHHHHHhhhh----hcCCC---C
Confidence            554332   45678999999987 89999999999999999976  46667632 222222222111    11000   0


Q ss_pred             CCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHh
Q 015374          349 RKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAM  390 (408)
Q Consensus       349 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL  390 (408)
                      +.     .-...+..++..+.+++-+||+.|-.+|||.+++-
T Consensus       762 ~~-----~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh  798 (807)
T KOG1094|consen  762 RQ-----VVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLH  798 (807)
T ss_pred             cc-----eeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHH
Confidence            00     12234455889999999999999999999999984

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=7.1e-40  Score=333.82  Aligned_cols=253  Identities=28%  Similarity=0.436  Sum_probs=195.4

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc----chHHHHHHHHHHHHhcCCCCceEEeeEEEcc-------
Q 015374          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQ-------  192 (408)
Q Consensus       124 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~-------  192 (408)
                      .++|+.+..||+||||.||+++++-+|+.+|||.+.-.    ....+.+|+..+++| +|||||+++..+.+.       
T Consensus       478 ~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArL-nHpNVVRYysAWVEs~~~~~~~  556 (1351)
T KOG1035|consen  478 LNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARL-NHPNVVRYYSAWVESTAELTVL  556 (1351)
T ss_pred             hhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhc-CCcceeeeehhhhccCCccccc
Confidence            45788899999999999999999999999999998532    345688999999999 999999998543210       


Q ss_pred             ---------------------------------------------------------------------C----------
Q 015374          193 ---------------------------------------------------------------------H----------  193 (408)
Q Consensus       193 ---------------------------------------------------------------------~----------  193 (408)
                                                                                           +          
T Consensus       557 ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~  636 (1351)
T KOG1035|consen  557 EIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDS  636 (1351)
T ss_pred             cccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccccc
Confidence                                                                                 0          


Q ss_pred             -----------------------C--------CccEEEEEeecCCChhhhcCC--C--ChHHHHHHHHHHHHHHHHHHHC
Q 015374          194 -----------------------S--------KTPSLIFEYVNSTDFKVLYPT--L--TDYDIRYYIYELLKALDYCHSQ  238 (408)
Q Consensus       194 -----------------------~--------~~~~lv~e~~~~~~l~~~~~~--l--~~~~~~~i~~qi~~~L~~LH~~  238 (408)
                                             .        ..+|+-||||+..++..++..  +  .....++++++|++||.|+|++
T Consensus       637 e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~~  716 (1351)
T KOG1035|consen  637 EGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHDQ  716 (1351)
T ss_pred             CCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHhC
Confidence                                   0        235788999999888888743  3  3667889999999999999999


Q ss_pred             CcEEecCCCCcEEEeCCCCcEEEEecccceecc-------------------CCCcceeeccCccccccccccCCc--CC
Q 015374          239 GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH-------------------PGKEYNVRVASRYFKGPELLVDLQ--DY  297 (408)
Q Consensus       239 ~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~-------------------~~~~~~~~~~~~~y~aPE~~~~~~--~~  297 (408)
                      |||||||||.||++|.+ +.|||+|||+|+...                   +....+..+||..|+|||++.+..  .|
T Consensus       717 giIHRDLKP~NIFLd~~-~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Y  795 (1351)
T KOG1035|consen  717 GIIHRDLKPRNIFLDSR-NSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKY  795 (1351)
T ss_pred             ceeeccCCcceeEEcCC-CCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccc
Confidence            99999999999999988 799999999997621                   111345678999999999998755  69


Q ss_pred             CccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCCCccccccccCCCCCCHHHHHHHHHhcc
Q 015374          298 DYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLR  377 (408)
Q Consensus       298 ~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~  377 (408)
                      +.|+|+||+||+++||+.   ||.....-...+..+...            ..+.+    ...+..--+.-..+|+.||+
T Consensus       796 n~KiDmYSLGIVlFEM~y---PF~TsMERa~iL~~LR~g------------~iP~~----~~f~~~~~~~e~slI~~Ll~  856 (1351)
T KOG1035|consen  796 NSKIDMYSLGIVLFEMLY---PFGTSMERASILTNLRKG------------SIPEP----ADFFDPEHPEEASLIRWLLS  856 (1351)
T ss_pred             cchhhhHHHHHHHHHHhc---cCCchHHHHHHHHhcccC------------CCCCC----cccccccchHHHHHHHHHhc
Confidence            999999999999999984   563333222333322210            00100    00011112567899999999


Q ss_pred             cCcCCCCCHHHHhcCCCccc
Q 015374          378 YDHQDRLTAREAMAHPYFAQ  397 (408)
Q Consensus       378 ~dp~~Rpt~~elL~hp~f~~  397 (408)
                      .||.+||||.|||++.||..
T Consensus       857 hdP~kRPtA~eLL~s~llpp  876 (1351)
T KOG1035|consen  857 HDPSKRPTATELLNSELLPP  876 (1351)
T ss_pred             CCCccCCCHHHHhhccCCCc
Confidence            99999999999999999984

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-39  Score=307.93  Aligned_cols=242  Identities=18%  Similarity=0.356  Sum_probs=204.4

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc--chHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccEEEE
Q 015374          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV--KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIF  201 (408)
Q Consensus       124 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~  201 (408)
                      ..+....++||-|.||.||.|.+++-.-.||||.++..  ..++|..|..+|+.| +|||+|+++|+|..  ....|+|.
T Consensus       266 RtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMeveEFLkEAAvMKei-kHpNLVqLLGVCT~--EpPFYIiT  342 (1157)
T KOG4278|consen  266 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI-KHPNLVQLLGVCTH--EPPFYIIT  342 (1157)
T ss_pred             chheeeeeccCCCcccceeeeeeeccceeeehhhhhhcchhHHHHHHHHHHHHhh-cCccHHHHhhhhcc--CCCeEEEE
Confidence            45677788999999999999999999999999999854  457899999999999 99999999999954  56778999


Q ss_pred             EeecCCChhhhcCC-----CChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCCCcc
Q 015374          202 EYVNSTDFKVLYPT-----LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY  276 (408)
Q Consensus       202 e~~~~~~l~~~~~~-----l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~~~~  276 (408)
                      |||.+|+|.++++.     ++..-+..++.||..||+||..+++|||||.++|+|+..+ ..|||+|||+++.+.. +.+
T Consensus       343 EfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEn-hiVKvADFGLsRlMtg-DTY  420 (1157)
T KOG4278|consen  343 EFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGEN-HIVKVADFGLSRLMTG-DTY  420 (1157)
T ss_pred             ecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhcccccc-ceEEeeccchhhhhcC-Cce
Confidence            99999999999864     5555567899999999999999999999999999999998 7999999999998763 444


Q ss_pred             eeeccC---ccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCCCcc
Q 015374          277 NVRVAS---RYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWS  353 (408)
Q Consensus       277 ~~~~~~---~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  353 (408)
                      +...|.   ..|.|||.+.. ..++.++|||+|||+|||+.|-..-.|+|.+-... ..+++.                 
T Consensus       421 TAHAGAKFPIKWTAPEsLAy-NtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqV-Y~LLEk-----------------  481 (1157)
T KOG4278|consen  421 TAHAGAKFPIKWTAPESLAY-NTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV-YGLLEK-----------------  481 (1157)
T ss_pred             ecccCccCcccccCcccccc-cccccchhhHHHHHHHHHHHhcCCCCCCCccHHHH-HHHHhc-----------------
Confidence            444443   45999999976 78999999999999999999855544577664443 333332                 


Q ss_pred             ccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHh
Q 015374          354 KFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAM  390 (408)
Q Consensus       354 ~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL  390 (408)
                       -++.+.+..|++...+|++.||+|.|.+||+.+|+-
T Consensus       482 -gyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiH  517 (1157)
T KOG4278|consen  482 -GYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIH  517 (1157)
T ss_pred             -cccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHH
Confidence             245667788999999999999999999999988873

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=5.2e-38  Score=288.23  Aligned_cols=235  Identities=21%  Similarity=0.384  Sum_probs=187.9

Q ss_pred             eeeeeeCceEEEEEEEcCCCcEEEEEEeccc----chHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccEEEEEeecC
Q 015374          131 RKVGRGKYSEVFEGINVNTNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNS  206 (408)
Q Consensus       131 ~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~~  206 (408)
                      ++||+|+||.||+|.+.. ++.|++|.++..    ....+.+|+++++++ +|+||+++++++.+  ....++||||+++
T Consensus         1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~--~~~~~~v~e~~~~   76 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPPDLKRKFLQEAEILKQY-DHPNIVKLIGVCVQ--KQPIYIVMELVPG   76 (251)
T ss_pred             CccccCCCceEEEEEEeC-CCcEEEEeccccCCHHHHHHHHHHHHHHHhC-CCCCeEEEEEEEec--CCCeEEEEEcCCC
Confidence            369999999999998877 999999988643    345788999999999 99999999999965  4678899999999


Q ss_pred             CChhhhcC----CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCCCcc---eee
Q 015374          207 TDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY---NVR  279 (408)
Q Consensus       207 ~~l~~~~~----~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~~~~---~~~  279 (408)
                      +++..++.    .+++..+..++.+++.||.|||+++++|+||||+||+++.+ +.++|+|||++.........   ...
T Consensus        77 ~~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~-~~~~l~d~g~~~~~~~~~~~~~~~~~  155 (251)
T cd05041          77 GSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGEN-NVLKISDFGMSREEEGGIYTVSDGLK  155 (251)
T ss_pred             CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCC-CcEEEeeccccccccCCcceeccccC
Confidence            99988762    36888889999999999999999999999999999999988 79999999998765422111   112


Q ss_pred             ccCccccccccccCCcCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCCCccccccc
Q 015374          280 VASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSKFINA  358 (408)
Q Consensus       280 ~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  358 (408)
                      ..+..|+|||.+.+ ..++.++|+|||||++|+|++ |..|| .+....+....+...                   ...
T Consensus       156 ~~~~~y~~PE~~~~-~~~~~~~Di~slG~i~~~l~t~~~~p~-~~~~~~~~~~~~~~~-------------------~~~  214 (251)
T cd05041         156 QIPIKWTAPEALNY-GRYTSESDVWSYGILLWETFSLGDTPY-PGMSNQQTRERIESG-------------------YRM  214 (251)
T ss_pred             cceeccCChHhhcc-CCCCcchhHHHHHHHHHHHHhccCCCC-ccCCHHHHHHHHhcC-------------------CCC
Confidence            23456999999876 678999999999999999999 66666 333333322222111                   011


Q ss_pred             cCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 015374          359 DNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA  391 (408)
Q Consensus       359 ~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~  391 (408)
                      ..+..++.++.+++.+||..+|++|||+.|+++
T Consensus       215 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~  247 (251)
T cd05041         215 PAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYN  247 (251)
T ss_pred             CCCccCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence            123346889999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=4e-38  Score=293.02  Aligned_cols=245  Identities=18%  Similarity=0.371  Sum_probs=195.0

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcC-----CCcEEEEEEecccc----hHHHHHHHHHHHHhcCCCCceEEeeEEEccCC
Q 015374          124 QDDYEVVRKVGRGKYSEVFEGINVN-----TNERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHS  194 (408)
Q Consensus       124 ~~~y~~~~~lG~G~fg~Vy~~~~~~-----~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~  194 (408)
                      .++|++...||+|+||+||+|+...     +...+++|.+....    ...+.+|+.+++++ +|+||+++++++.+  .
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~--~   80 (275)
T cd05046           4 RSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKL-SHKNVVRLLGLCRE--A   80 (275)
T ss_pred             hHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhc-CCcceeeeEEEECC--C
Confidence            4688999999999999999998653     34679999886432    35688999999999 99999999999954  4


Q ss_pred             CccEEEEEeecCCChhhhcC------------CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEE
Q 015374          195 KTPSLIFEYVNSTDFKVLYP------------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLI  262 (408)
Q Consensus       195 ~~~~lv~e~~~~~~l~~~~~------------~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~  262 (408)
                      ...++||||+++++|..++.            .+++..+..++.|++.||.|||+.+|+|+||||+||+++.+ +.++++
T Consensus        81 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~-~~~~l~  159 (275)
T cd05046          81 EPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQ-REVKVS  159 (275)
T ss_pred             CcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCC-CcEEEc
Confidence            67789999999999988762            47899999999999999999999999999999999999988 789999


Q ss_pred             ecccceeccCCC--cceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHhhhch
Q 015374          263 DWGLAEFYHPGK--EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKDCCL  339 (408)
Q Consensus       263 DfG~a~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-g~~pf~~~~~~~~~~~~~~~~~~~  339 (408)
                      |||++.......  ......++..|++||.+.+ ..++.++||||||+++|+|++ |..||. +..+.+.+......   
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~~l~~~~~~p~~-~~~~~~~~~~~~~~---  234 (275)
T cd05046         160 LLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQE-DDFSTKSDVWSFGVLMWEVFTQGELPFY-GLSDEEVLNRLQAG---  234 (275)
T ss_pred             ccccccccCcccccccCCceeEEeecChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCcc-ccchHHHHHHHHcC---
Confidence            999986543221  1223455677999999876 678899999999999999998 666763 33333332222110   


Q ss_pred             hhhhcCCCCCCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 015374          340 IIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH  392 (408)
Q Consensus       340 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~h  392 (408)
                               ...|      ..+..++..+.+++.+||+.||++|||+.|+++.
T Consensus       235 ---------~~~~------~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~  272 (275)
T cd05046         235 ---------KLEL------PVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSA  272 (275)
T ss_pred             ---------CcCC------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence                     0001      1123467899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=5.1e-38  Score=291.51  Aligned_cols=240  Identities=19%  Similarity=0.289  Sum_probs=182.0

Q ss_pred             eeeeeCceEEEEEEEcC--CCcEEEEEEecccc----hHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccEEEEEeec
Q 015374          132 KVGRGKYSEVFEGINVN--TNERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVN  205 (408)
Q Consensus       132 ~lG~G~fg~Vy~~~~~~--~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~  205 (408)
                      .||+|+||+||+|....  ....+++|.+....    ...+.+|+.+++.+ +|+||+++++.|.+  ....++||||++
T Consensus         2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l-~h~nii~~~~~~~~--~~~~~lv~e~~~   78 (269)
T cd05042           2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYREL-NHPNVLQCLGQCIE--SIPYLLVLEFCP   78 (269)
T ss_pred             cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhC-CCCCcceEEEEECC--CCceEEEEEeCC
Confidence            68999999999996433  34578888775332    34678899999998 99999999999954  467899999999


Q ss_pred             CCChhhhcCC--------CChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCCCc--
Q 015374          206 STDFKVLYPT--------LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE--  275 (408)
Q Consensus       206 ~~~l~~~~~~--------l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~~~--  275 (408)
                      +++|..++..        .++..+..++.|++.||.|||+++|+||||||+|||++.+ +.+||+|||++........  
T Consensus        79 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~-~~~kl~dfg~~~~~~~~~~~~  157 (269)
T cd05042          79 LGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTAD-LSVKIGDYGLALEQYPEDYYI  157 (269)
T ss_pred             CCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCC-CcEEEeccccccccccchhee
Confidence            9999988632        3566778899999999999999999999999999999988 7999999999865432221  


Q ss_pred             -ceeeccCccccccccccC------CcCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHhhhchhhhhcCCC
Q 015374          276 -YNVRVASRYFKGPELLVD------LQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRH  347 (408)
Q Consensus       276 -~~~~~~~~~y~aPE~~~~------~~~~~~~~DvwSlGvil~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (408)
                       .....++..|+|||++..      ...++.++|||||||++|||++ |..|| ....+.+.+.........        
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~-~~~~~~~~~~~~~~~~~~--------  228 (269)
T cd05042         158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPY-PDLSDEQVLKQVVREQDI--------  228 (269)
T ss_pred             ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCC-CcCCHHHHHHHHhhccCc--------
Confidence             122345567999999743      2457889999999999999999 55565 444444444433332110        


Q ss_pred             CCCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 015374          348 SRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA  391 (408)
Q Consensus       348 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~  391 (408)
                            ..........++..+.+++..|+ .||++|||++|+++
T Consensus       229 ------~~~~~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~  265 (269)
T cd05042         229 ------KLPKPQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHE  265 (269)
T ss_pred             ------cCCCCcccccCCHHHHHHHHHHh-cCcccccCHHHHHH
Confidence                  00111223347888999999998 59999999999875

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=5.6e-38  Score=295.33  Aligned_cols=256  Identities=16%  Similarity=0.188  Sum_probs=183.0

Q ss_pred             ccCCCCCEEEEeeeeeeCceEEEEEEEcCC---CcEEEEEEecccch--------------HHHHHHHHHHHHhcCCCCc
Q 015374          120 QWGDQDDYEVVRKVGRGKYSEVFEGINVNT---NERCIIKILKPVKK--------------KKIKREIKILQNLCGGPNV  182 (408)
Q Consensus       120 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~---~~~vavK~~~~~~~--------------~~~~~E~~~l~~l~~h~ni  182 (408)
                      .....++|++.++||+|+||+||+|.+..+   +..+++|+......              .....+...+..+ +|+|+
T Consensus         7 ~~i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~-~h~~i   85 (294)
T PHA02882          7 IDITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNI-DHLGI   85 (294)
T ss_pred             eccCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccC-CCCCC
Confidence            334568999999999999999999998777   66777876432111              0111223334455 89999


Q ss_pred             eEEeeEEEccCCC--ccEEEEEeecCCCh--hhhcCCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCc
Q 015374          183 VKLLDIVRDQHSK--TPSLIFEYVNSTDF--KVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRK  258 (408)
Q Consensus       183 v~l~~~~~~~~~~--~~~lv~e~~~~~~l--~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~  258 (408)
                      +++++++......  ..++++|++.....  .......++..+..++.|++.||+|||+++|+||||||+|||++.+ +.
T Consensus        86 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~-~~  164 (294)
T PHA02882         86 PKYYGCGSFKRCRMYYRFILLEKLVENTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGN-NR  164 (294)
T ss_pred             CcEEEeeeEecCCceEEEEEEehhccCHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCC-Cc
Confidence            9999976543221  33567776654322  2222346788889999999999999999999999999999999987 78


Q ss_pred             EEEEecccceeccCCC--------cceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHH
Q 015374          259 LRLIDWGLAEFYHPGK--------EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQL  330 (408)
Q Consensus       259 ~kl~DfG~a~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~  330 (408)
                      ++|+|||+|+......        ......||..|+|||++.+ ..++.++|||||||++|||++|..||.......+..
T Consensus       165 ~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~-~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~  243 (294)
T PHA02882        165 GYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNG-ACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLI  243 (294)
T ss_pred             EEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHH
Confidence            9999999997664221        1223468999999999987 779999999999999999999999985443333322


Q ss_pred             HHHHhhhchhhhhcCCCCCCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 015374          331 VKIAKDCCLIIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA  391 (408)
Q Consensus       331 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~  391 (408)
                      .......  ..  ....         .......+++++.++++.|++.+|++||+..++++
T Consensus       244 ~~~~~~~--~~--~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~  291 (294)
T PHA02882        244 HAAKCDF--IK--RLHE---------GKIKIKNANKFIYDFIECVTKLSYEEKPDYDALIK  291 (294)
T ss_pred             HHhHHHH--HH--Hhhh---------hhhccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence            2111110  00  0000         00011235788999999999999999999999875

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=3.7e-38  Score=297.83  Aligned_cols=244  Identities=18%  Similarity=0.304  Sum_probs=193.7

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCc----EEEEEEecccc----hHHHHHHHHHHHHhcCCCCceEEeeEEEccCC
Q 015374          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNE----RCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHS  194 (408)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~----~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~  194 (408)
                      ..++|+..+.||+|+||.||+|.+..++.    .+|+|.+....    ...+.+|+.+++.+ +||||++++++|...  
T Consensus         5 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~h~niv~~~~~~~~~--   81 (303)
T cd05110           5 KETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASM-DHPHLVRLLGVCLSP--   81 (303)
T ss_pred             chhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhC-CCCCcccEEEEEcCC--
Confidence            46788899999999999999999877776    46888876432    23678899999999 999999999998542  


Q ss_pred             CccEEEEEeecCCChhhhcC----CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceec
Q 015374          195 KTPSLIFEYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY  270 (408)
Q Consensus       195 ~~~~lv~e~~~~~~l~~~~~----~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~  270 (408)
                       ..++++||+++|++..++.    .+++..+..++.|++.||.|||+++|+|+||||+||+++.+ +.+||+|||+++..
T Consensus        82 -~~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~-~~~kL~Dfg~~~~~  159 (303)
T cd05110          82 -TIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSP-NHVKITDFGLARLL  159 (303)
T ss_pred             -CceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCC-CceEEccccccccc
Confidence             3569999999999988763    47888899999999999999999999999999999999887 78999999999866


Q ss_pred             cCCCc---ceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHhhhchhhhhcCC
Q 015374          271 HPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKDCCLIIWCNSR  346 (408)
Q Consensus       271 ~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  346 (408)
                      .....   .....++..|++||.+.+ ..++.++|||||||++|||++ |+.||. +.. ............        
T Consensus       160 ~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~DiwslG~~l~el~t~g~~p~~-~~~-~~~~~~~~~~~~--------  228 (303)
T cd05110         160 EGDEKEYNADGGKMPIKWMALECIHY-RKFTHQSDVWSYGVTIWELMTFGGKPYD-GIP-TREIPDLLEKGE--------  228 (303)
T ss_pred             cCcccccccCCCccccccCCHHHhcc-CCCChHHHHHHHHHHHHHHHhCCCCCCC-CCC-HHHHHHHHHCCC--------
Confidence            43322   122334667999999876 778999999999999999997 888873 322 233333322110        


Q ss_pred             CCCCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 015374          347 HSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH  392 (408)
Q Consensus       347 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~h  392 (408)
                                ....+..++..+.+++.+|+..||++||+++++++.
T Consensus       229 ----------~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~  264 (303)
T cd05110         229 ----------RLPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAE  264 (303)
T ss_pred             ----------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                      011122357889999999999999999999998874

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=6.8e-38  Score=290.73  Aligned_cols=240  Identities=17%  Similarity=0.224  Sum_probs=181.6

Q ss_pred             eeeeeCceEEEEEEEc--CCCcEEEEEEecccc----hHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccEEEEEeec
Q 015374          132 KVGRGKYSEVFEGINV--NTNERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVN  205 (408)
Q Consensus       132 ~lG~G~fg~Vy~~~~~--~~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~  205 (408)
                      .||+|+||.||+|...  .++..+++|.++...    ...+.+|+.+++++ +||||+++++++.+  ....++||||++
T Consensus         2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~--~~~~~lv~e~~~   78 (269)
T cd05087           2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSL-QHSNLLQCLGQCTE--VTPYLLVMEFCP   78 (269)
T ss_pred             cccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhC-CCCCEeeEEEEEcC--CCCcEEEEECCC
Confidence            6899999999999754  345678999886432    34688899999999 99999999999955  456789999999


Q ss_pred             CCChhhhcC--------CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCCCc--
Q 015374          206 STDFKVLYP--------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE--  275 (408)
Q Consensus       206 ~~~l~~~~~--------~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~~~--  275 (408)
                      +++|..++.        ..++..+..++.|++.||+|||+.+++|+||||+||+++.+ +.++|+|||++........  
T Consensus        79 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~-~~~kL~dfg~~~~~~~~~~~~  157 (269)
T cd05087          79 LGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTAD-LTVKIGDYGLSHNKYKEDYYV  157 (269)
T ss_pred             CCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCC-CcEEECCccccccccCcceee
Confidence            999988763        24556677899999999999999999999999999999987 7899999999865433221  


Q ss_pred             -ceeeccCccccccccccCC------cCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHhhhchhhhhcCCC
Q 015374          276 -YNVRVASRYFKGPELLVDL------QDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRH  347 (408)
Q Consensus       276 -~~~~~~~~~y~aPE~~~~~------~~~~~~~DvwSlGvil~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (408)
                       .....++..|+|||++.+.      ..++.++|+||||+++|||++ |..||.. ..+.+..........      .. 
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~-~~~~~~~~~~~~~~~------~~-  229 (269)
T cd05087         158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRH-LSDEQVLTYTVREQQ------LK-  229 (269)
T ss_pred             cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCC-CChHHHHHHHhhccc------CC-
Confidence             1223566789999998542      135789999999999999996 8888743 333333222111100      00 


Q ss_pred             CCCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 015374          348 SRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA  391 (408)
Q Consensus       348 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~  391 (408)
                             ..........++.+.+++.+|+ .+|++|||++|++.
T Consensus       230 -------~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~  265 (269)
T cd05087         230 -------LPKPRLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHL  265 (269)
T ss_pred             -------CCCCccCCCCChHHHHHHHHHh-cCcccCCCHHHHHH
Confidence                   0111112235788999999998 68999999999974

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=6.7e-38  Score=288.22  Aligned_cols=238  Identities=15%  Similarity=0.302  Sum_probs=191.4

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc-chHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccEEEEE
Q 015374          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFE  202 (408)
Q Consensus       124 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e  202 (408)
                      -++|++.+.||+|+||.||+|.  .+++.+|+|.++.. ....+.+|+.+++++ +|||++++++++..   ...+++||
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~--~~~~~~~iK~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~---~~~~~v~e   78 (254)
T cd05083           5 LQKLTLGEIIGEGEFGAVLQGE--YTGQKVAVKNIKCDVTAQAFLEETAVMTKL-HHKNLVRLLGVILH---NGLYIVME   78 (254)
T ss_pred             HHHceeeeeeccCCCCceEecc--cCCCceEEEeecCcchHHHHHHHHHHHHhC-CCCCcCeEEEEEcC---CCcEEEEE
Confidence            3568999999999999999995  46788999998743 346788999999999 99999999999854   34689999


Q ss_pred             eecCCChhhhcC-----CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCCCcce
Q 015374          203 YVNSTDFKVLYP-----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN  277 (408)
Q Consensus       203 ~~~~~~l~~~~~-----~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~~~~~  277 (408)
                      |+++++|..++.     .+++..+..++.|++.||.|||+.|++||||||+||+++.+ +.++|+|||++......  ..
T Consensus        79 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~-~~~kl~Dfg~~~~~~~~--~~  155 (254)
T cd05083          79 LMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSED-GVAKVSDFGLARVGSMG--VD  155 (254)
T ss_pred             CCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCC-CcEEECCCccceecccc--CC
Confidence            999999988763     36888889999999999999999999999999999999988 78999999998764322  22


Q ss_pred             eeccCccccccccccCCcCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCCCccccc
Q 015374          278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSKFI  356 (408)
Q Consensus       278 ~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  356 (408)
                      ....+..|+|||.+.+ ..++.++|+|||||++|+|++ |..||. ..+..+....+...                   .
T Consensus       156 ~~~~~~~y~~pe~~~~-~~~~~~~Dv~slG~~l~el~~~g~~p~~-~~~~~~~~~~~~~~-------------------~  214 (254)
T cd05083         156 NSKLPVKWTAPEALKH-KKFSSKSDVWSYGVLLWEVFSYGRAPYP-KMSLKEVKECVEKG-------------------Y  214 (254)
T ss_pred             CCCCCceecCHHHhcc-CCcCchhhHHHHHHHHHHHHhCCCCCCc-cCCHHHHHHHHhCC-------------------C
Confidence            2344567999999876 678999999999999999998 777773 33332222221110                   0


Q ss_pred             cccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 015374          357 NADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA  391 (408)
Q Consensus       357 ~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~  391 (408)
                      .......+++++.+++.+||+.+|++|||++++++
T Consensus       215 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  249 (254)
T cd05083         215 RMEPPEGCPADVYVLMTSCWETEPKKRPSFHKLRE  249 (254)
T ss_pred             CCCCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            01112346889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=4.8e-38  Score=292.76  Aligned_cols=233  Identities=15%  Similarity=0.220  Sum_probs=180.6

Q ss_pred             eeeeeCceEEEEEEEcCC------------------------CcEEEEEEecccc---hHHHHHHHHHHHHhcCCCCceE
Q 015374          132 KVGRGKYSEVFEGINVNT------------------------NERCIIKILKPVK---KKKIKREIKILQNLCGGPNVVK  184 (408)
Q Consensus       132 ~lG~G~fg~Vy~~~~~~~------------------------~~~vavK~~~~~~---~~~~~~E~~~l~~l~~h~niv~  184 (408)
                      +||+|+||.||+|....+                        ...|++|+++...   ...+.+|+.+++.+ +||||++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l-~h~niv~   80 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQV-SHIHLAF   80 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcC-CCCCeee
Confidence            699999999999974321                        2358899886433   34677889999998 9999999


Q ss_pred             EeeEEEccCCCccEEEEEeecCCChhhhcC----CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCC----
Q 015374          185 LLDIVRDQHSKTPSLIFEYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEL----  256 (408)
Q Consensus       185 l~~~~~~~~~~~~~lv~e~~~~~~l~~~~~----~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~----  256 (408)
                      ++++|.+  ....++||||+++++|..++.    .+++..+..++.|++.||+|||+++|+||||||+|||++.+.    
T Consensus        81 ~~~~~~~--~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~~  158 (274)
T cd05076          81 VHGVCVR--GSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEG  158 (274)
T ss_pred             EEEEEEe--CCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCcccC
Confidence            9999965  456789999999999988763    378889999999999999999999999999999999997541    


Q ss_pred             --CcEEEEecccceeccCCCcceeeccCccccccccccCCcCCCccccHHHHHHHHHHHH-hCCCCCCCCCCCHHHHHHH
Q 015374          257 --RKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMI-FRKEPFFYGHDNHDQLVKI  333 (408)
Q Consensus       257 --~~~kl~DfG~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell-~g~~pf~~~~~~~~~~~~~  333 (408)
                        ..++++|||++......   ....++..|+|||.+.+...++.++|||||||++|||+ +|..||. +....+. ...
T Consensus       159 ~~~~~kl~d~g~~~~~~~~---~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~-~~~~~~~-~~~  233 (274)
T cd05076         159 TSPFIKLSDPGVSFTALSR---EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLK-ERTPSEK-ERF  233 (274)
T ss_pred             ccceeeecCCccccccccc---cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCcc-ccChHHH-HHH
Confidence              24899999987644322   22456778999999876567899999999999999985 6787774 3322222 111


Q ss_pred             HhhhchhhhhcCCCCCCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 015374          334 AKDCCLIIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH  392 (408)
Q Consensus       334 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~h  392 (408)
                      ...                    ....+...++++.+++.+||+.+|++|||+.+++++
T Consensus       234 ~~~--------------------~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~  272 (274)
T cd05076         234 YEK--------------------KHRLPEPSCKELATLISQCLTYEPTQRPSFRTILRD  272 (274)
T ss_pred             HHh--------------------ccCCCCCCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence            110                    000111235689999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=4.8e-39  Score=307.40  Aligned_cols=241  Identities=20%  Similarity=0.393  Sum_probs=199.5

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCC----CcEEEEEEecc----cchHHHHHHHHHHHHhcCCCCceEEeeEEEccCCC
Q 015374          124 QDDYEVVRKVGRGKYSEVFEGINVNT----NERCIIKILKP----VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSK  195 (408)
Q Consensus       124 ~~~y~~~~~lG~G~fg~Vy~~~~~~~----~~~vavK~~~~----~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  195 (408)
                      .+..++.++||.|-||.||+|+...-    .-.||||..|.    .+.+.|..|..+++++ +||||++++|+|.+   .
T Consensus       388 Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnf-dHphIikLIGv~~e---~  463 (974)
T KOG4257|consen  388 RELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNF-DHPHIIKLIGVCVE---Q  463 (974)
T ss_pred             hhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhC-CCcchhheeeeeec---c
Confidence            45566677899999999999986433    23589999874    4568899999999999 99999999999976   5


Q ss_pred             ccEEEEEeecCCChhhhcC----CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceecc
Q 015374          196 TPSLIFEYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH  271 (408)
Q Consensus       196 ~~~lv~e~~~~~~l~~~~~----~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~  271 (408)
                      ..++|||.++.|.|..+++    .++...+..++.||+.+|.|||+.++|||||..+|||+.+. .+|||+|||+++.+.
T Consensus       464 P~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp-~CVKLaDFGLSR~~e  542 (974)
T KOG4257|consen  464 PMWIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSP-QCVKLADFGLSRYLE  542 (974)
T ss_pred             ceeEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCc-ceeeecccchhhhcc
Confidence            7899999999999999984    47888888999999999999999999999999999999998 799999999999988


Q ss_pred             CCCcceeecc--CccccccccccCCcCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCC
Q 015374          272 PGKEYNVRVA--SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHS  348 (408)
Q Consensus       272 ~~~~~~~~~~--~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  348 (408)
                      ....+....|  +..|||||.+.- ..++.++|||.|||.+||+++ |..|| .+-.+.|.+..+-+             
T Consensus       543 d~~yYkaS~~kLPIKWmaPESINf-RrFTtASDVWMFgVCmWEIl~lGvkPf-qgvkNsDVI~~iEn-------------  607 (974)
T KOG4257|consen  543 DDAYYKASRGKLPIKWMAPESINF-RRFTTASDVWMFGVCMWEILSLGVKPF-QGVKNSDVIGHIEN-------------  607 (974)
T ss_pred             ccchhhccccccceeecCccccch-hcccchhhHHHHHHHHHHHHHhcCCcc-ccccccceEEEecC-------------
Confidence            7766555443  345999999976 789999999999999999886 77787 44444444322211             


Q ss_pred             CCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHh
Q 015374          349 RKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAM  390 (408)
Q Consensus       349 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL  390 (408)
                            -.+...+..|++.+-.++.+||.+||.+||+..|+.
T Consensus       608 ------GeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~  643 (974)
T KOG4257|consen  608 ------GERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIK  643 (974)
T ss_pred             ------CCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHH
Confidence                  123344566999999999999999999999887764

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=6.2e-38  Score=288.83  Aligned_cols=232  Identities=17%  Similarity=0.244  Sum_probs=183.4

Q ss_pred             eeeeeeCceEEEEEEEcCCC----------cEEEEEEecccc--hHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccE
Q 015374          131 RKVGRGKYSEVFEGINVNTN----------ERCIIKILKPVK--KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS  198 (408)
Q Consensus       131 ~~lG~G~fg~Vy~~~~~~~~----------~~vavK~~~~~~--~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  198 (408)
                      +.||+|+||.||+|.+..++          ..+++|.++...  ...+.+|+.+++++ +|+||+++++++..   ...+
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~---~~~~   76 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQL-SHKHLVKLYGVCVR---DENI   76 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhhHHHHHHHHHHHHcC-CCcchhheeeEEec---CCcE
Confidence            36899999999999987766          357888876433  56788999999999 99999999999865   4568


Q ss_pred             EEEEeecCCChhhhcC----CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCC------cEEEEecccce
Q 015374          199 LIFEYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELR------KLRLIDWGLAE  268 (408)
Q Consensus       199 lv~e~~~~~~l~~~~~----~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~------~~kl~DfG~a~  268 (408)
                      +||||+++++|..++.    .+++..+..++.|++.||.|||++||+|+||||+|||++.+..      .++|+|||++.
T Consensus        77 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a~  156 (259)
T cd05037          77 MVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPI  156 (259)
T ss_pred             EEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCccc
Confidence            9999999999998873    4788889999999999999999999999999999999997721      69999999997


Q ss_pred             eccCCCcceeeccCccccccccccCC-cCCCccccHHHHHHHHHHHHhC-CCCCCCCCCCHHHHHHHHhhhchhhhhcCC
Q 015374          269 FYHPGKEYNVRVASRYFKGPELLVDL-QDYDYSLDMWSLGCMFAGMIFR-KEPFFYGHDNHDQLVKIAKDCCLIIWCNSR  346 (408)
Q Consensus       269 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~DvwSlGvil~ell~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  346 (408)
                      ....   .....++..|+|||++.+. ..++.++|||||||++|+|++| ..||. ..+..+.... ....         
T Consensus       157 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~-~~~~~~~~~~-~~~~---------  222 (259)
T cd05037         157 TVLS---REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLS-TLSSSEKERF-YQDQ---------  222 (259)
T ss_pred             cccc---ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcc-cCCchhHHHH-HhcC---------
Confidence            6543   2234567789999999773 3789999999999999999995 55553 3222221111 1100         


Q ss_pred             CCCCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 015374          347 HSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA  391 (408)
Q Consensus       347 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~  391 (408)
                                 ...+.....++.+++.+||..||++|||+.|+++
T Consensus       223 -----------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  256 (259)
T cd05037         223 -----------HRLPMPDCAELANLINQCWTYDPTKRPSFRAILR  256 (259)
T ss_pred             -----------CCCCCCCchHHHHHHHHHhccChhhCCCHHHHHH
Confidence                       0000112378999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=3.9e-38  Score=292.09  Aligned_cols=235  Identities=20%  Similarity=0.342  Sum_probs=186.8

Q ss_pred             eeeeeCceEEEEEEEcCCC------cEEEEEEeccc----chHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccEEEE
Q 015374          132 KVGRGKYSEVFEGINVNTN------ERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIF  201 (408)
Q Consensus       132 ~lG~G~fg~Vy~~~~~~~~------~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~  201 (408)
                      .||+|+||.||+|++....      ..+++|.+...    ....+.+|+.+++.+ +||||++++++|.+  ....++||
T Consensus         2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~~~~v~   78 (269)
T cd05044           2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNF-NHPNIVKLLGVCLL--NEPQYIIM   78 (269)
T ss_pred             ccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhc-CCCCeeeEeeeecC--CCCeEEEE
Confidence            6899999999999875433      67999987532    346788999999999 99999999999965  45688999


Q ss_pred             EeecCCChhhhcC----------CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCC-----cEEEEeccc
Q 015374          202 EYVNSTDFKVLYP----------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELR-----KLRLIDWGL  266 (408)
Q Consensus       202 e~~~~~~l~~~~~----------~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~-----~~kl~DfG~  266 (408)
                      ||+++++|..++.          .+++..+..++.|++.||.|||+.+++|+||||+||+++.+ +     .++++|||+
T Consensus        79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~-~~~~~~~~~l~dfg~  157 (269)
T cd05044          79 ELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEK-GYDADRVVKIGDFGL  157 (269)
T ss_pred             eccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecC-CCCCCcceEECCccc
Confidence            9999999988763          26778889999999999999999999999999999999987 4     799999999


Q ss_pred             ceeccCCCc---ceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHhhhchhhh
Q 015374          267 AEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKDCCLIIW  342 (408)
Q Consensus       267 a~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~  342 (408)
                      +........   .....++..|+|||.+.+ ..++.++|||||||++|+|++ |..|| ...++.+....+...      
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~ellt~g~~p~-~~~~~~~~~~~~~~~------  229 (269)
T cd05044         158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLD-GKFTTQSDVWSFGVLMWEILTLGQQPY-PALNNQEVLQHVTAG------  229 (269)
T ss_pred             ccccccccccccCcccCCCccccCHHHHcc-CCcccchhHHHHHHHHHHHHHcCCCCC-cccCHHHHHHHHhcC------
Confidence            876543221   112345678999999987 778999999999999999998 88887 333333332222110      


Q ss_pred             hcCCCCCCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 015374          343 CNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA  391 (408)
Q Consensus       343 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~  391 (408)
                                   .....+..++..+.+++.+||..+|++|||++++++
T Consensus       230 -------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  265 (269)
T cd05044         230 -------------GRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQE  265 (269)
T ss_pred             -------------CccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence                         011122346789999999999999999999999864

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.9e-40  Score=286.69  Aligned_cols=266  Identities=27%  Similarity=0.508  Sum_probs=216.8

Q ss_pred             EeeeeeeCceEEEEEEEcCCCcEEEEEEecc-----cchHHHHHHHHHHHHhcCCCCceEEeeEEEccCCC---ccEEEE
Q 015374          130 VRKVGRGKYSEVFEGINVNTNERCIIKILKP-----VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSK---TPSLIF  201 (408)
Q Consensus       130 ~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~-----~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~---~~~lv~  201 (408)
                      .+.||.|+||.||..++..+|+.|++|.+..     ...+.+.+|+++|.-+ +|.|++..++.....+..   .++.+.
T Consensus        58 DRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfF-kHdNVLSaLDILQPph~dfFqEiYV~T  136 (449)
T KOG0664|consen   58 DRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSF-RHDNVLSLLDILQPANPSFFQELYVLT  136 (449)
T ss_pred             CCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhh-ccccHHHHHHhcCCCCchHHHHHHHHH
Confidence            4579999999999999999999999998753     3457889999999999 999999999987543322   345677


Q ss_pred             EeecCCChhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCCC--cc
Q 015374          202 EYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK--EY  276 (408)
Q Consensus       202 e~~~~~~l~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~~--~~  276 (408)
                      |.|... |...+   ..++.+.++-++.||+.||.|||+.+|.||||||.|.|+++| -.+||||||+++..+...  ..
T Consensus       137 ELmQSD-LHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSN-CvLKICDFGLARvee~d~~~hM  214 (449)
T KOG0664|consen  137 ELMQSD-LHKIIVSPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSN-CILKICDFGLARTWDQRDRLNM  214 (449)
T ss_pred             HHHHhh-hhheeccCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccC-ceEEecccccccccchhhhhhh
Confidence            777643 33333   348889999999999999999999999999999999999999 799999999998776543  34


Q ss_pred             eeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhh-------------
Q 015374          277 NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWC-------------  343 (408)
Q Consensus       277 ~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-------------  343 (408)
                      +..+-|.+|+|||++.+...|+.++||||+||++.||+.++..| ...+..++++-+.+.+|.+..+             
T Consensus       215 TqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILF-QAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk~H~  293 (449)
T KOG0664|consen  215 THEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILF-QAAGPIEQLQMIIDLLGTPSQEAMKYACEGAKNHV  293 (449)
T ss_pred             HHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhh-hccChHHHHHHHHHHhCCCcHHHHHHHhhhhHHHh
Confidence            45678899999999999889999999999999999999888776 6777888888888888855422             


Q ss_pred             -cCCCCCCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccccc
Q 015374          344 -NSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVR  399 (408)
Q Consensus       344 -~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~~~  399 (408)
                       ............+....+.+-..+..+++..+|..||++|.+.++++.|+|+..-+
T Consensus       294 LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e~R  350 (449)
T KOG0664|consen  294 LRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEEGR  350 (449)
T ss_pred             hccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccccccccc
Confidence             22223334444555555555667899999999999999999999999999987654

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5.8e-38  Score=310.92  Aligned_cols=257  Identities=25%  Similarity=0.458  Sum_probs=214.6

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc--chHHHHHHHHHHHHhcCCCCceEEeeEEEc---cCCCcc
Q 015374          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV--KKKKIKREIKILQNLCGGPNVVKLLDIVRD---QHSKTP  197 (408)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~~h~niv~l~~~~~~---~~~~~~  197 (408)
                      ..+.|++.+.||.|.+|.||+++.+.+++.+|+|+....  ..++++.|..|++.+..|||++.++|+|.-   .++..+
T Consensus        17 p~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqL   96 (953)
T KOG0587|consen   17 PADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQL   96 (953)
T ss_pred             CCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeE
Confidence            467899999999999999999999999999999998754  457788999999999999999999998862   345679


Q ss_pred             EEEEEeecCCChhhhcC-----CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccC
Q 015374          198 SLIFEYVNSTDFKVLYP-----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP  272 (408)
Q Consensus       198 ~lv~e~~~~~~l~~~~~-----~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~  272 (408)
                      +||||||.+|+.-++.+     .+.|..+..|+..++.||.+||...++|||||-.|||++.+ +.||++|||++.....
T Consensus        97 WLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e-~~VKLvDFGvSaQlds  175 (953)
T KOG0587|consen   97 WLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTEN-AEVKLVDFGVSAQLDS  175 (953)
T ss_pred             EEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEecc-CcEEEeeeeeeeeeec
Confidence            99999999999888874     47888899999999999999999999999999999999999 8999999999876654


Q ss_pred             C-CcceeeccCccccccccccCC----cCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCC
Q 015374          273 G-KEYNVRVASRYFKGPELLVDL----QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRH  347 (408)
Q Consensus       273 ~-~~~~~~~~~~~y~aPE~~~~~----~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (408)
                      . ...++.+||++|||||++...    ..|+..+|+||||++..||-.|..|+...+.....+.               .
T Consensus       176 T~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~---------------I  240 (953)
T KOG0587|consen  176 TVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFL---------------I  240 (953)
T ss_pred             ccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhcc---------------C
Confidence            3 345778999999999999653    3578899999999999999999999865544322211               1


Q ss_pred             CCCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccc
Q 015374          348 SRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQV  398 (408)
Q Consensus       348 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~~  398 (408)
                      .+.+-+....   ++..+.++.+||..||..|-++||+..++|+|||.+.-
T Consensus       241 pRNPPPkLkr---p~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~e~  288 (953)
T KOG0587|consen  241 PRNPPPKLKR---PKKWSKKFNDFISTCLVKDYEQRPSTEELLKHPFITEQ  288 (953)
T ss_pred             CCCCCccccc---hhhHHHHHHHHHHHHHhhccccCcchhhhccCCccccc
Confidence            1222222221   23357899999999999999999999999999999833

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=9.5e-38  Score=289.59  Aligned_cols=244  Identities=21%  Similarity=0.407  Sum_probs=194.8

Q ss_pred             CEEEEeeeeeeCceEEEEEEEcC-CCcEEEEEEeccc-------------chHHHHHHHHHHHHhcCCCCceEEeeEEEc
Q 015374          126 DYEVVRKVGRGKYSEVFEGINVN-TNERCIIKILKPV-------------KKKKIKREIKILQNLCGGPNVVKLLDIVRD  191 (408)
Q Consensus       126 ~y~~~~~lG~G~fg~Vy~~~~~~-~~~~vavK~~~~~-------------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~  191 (408)
                      .|++.+.||+|+||.||+|.+.. +++.+|+|.+...             ...++.+|+.++.+..+|+||+++++++.+
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   80 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE   80 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence            47788899999999999999877 6789999987421             123467788888764499999999999955


Q ss_pred             cCCCccEEEEEeecCCChhhhc-------CCCChHHHHHHHHHHHHHHHHHHH-CCcEEecCCCCcEEEeCCCCcEEEEe
Q 015374          192 QHSKTPSLIFEYVNSTDFKVLY-------PTLTDYDIRYYIYELLKALDYCHS-QGIMHRDVKPHNVMIDHELRKLRLID  263 (408)
Q Consensus       192 ~~~~~~~lv~e~~~~~~l~~~~-------~~l~~~~~~~i~~qi~~~L~~LH~-~~iiH~Dlk~~NILl~~~~~~~kl~D  263 (408)
                        ....+++|||++++++..++       ..+++..+..++.|++.||.|||+ .+++|+||+|+||+++.+ +.++|+|
T Consensus        81 --~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~-~~~~l~d  157 (269)
T cd08528          81 --NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGED-DKVTITD  157 (269)
T ss_pred             --CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCC-CcEEEec
Confidence              46889999999999987765       247888999999999999999996 689999999999999988 7899999


Q ss_pred             cccceeccCCCcceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhh
Q 015374          264 WGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWC  343 (408)
Q Consensus       264 fG~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  343 (408)
                      ||++.............++..|++||.+.+ ..++.++|+||||+++|+|++|+.||... +.......+....      
T Consensus       158 fg~~~~~~~~~~~~~~~~~~~~~~Pe~~~~-~~~~~~~Dv~slG~ll~~l~~g~~p~~~~-~~~~~~~~~~~~~------  229 (269)
T cd08528         158 FGLAKQKQPESKLTSVVGTILYSCPEIVKN-EPYGEKADVWAFGCILYQMCTLQPPFYST-NMLSLATKIVEAV------  229 (269)
T ss_pred             ccceeecccccccccccCcccCcChhhhcC-CCCchHHHHHHHHHHHHHHHhCCCccccc-CHHHHHHHHhhcc------
Confidence            999987655444445678889999999987 67899999999999999999999998432 2222222221110      


Q ss_pred             cCCCCCCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 015374          344 NSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH  392 (408)
Q Consensus       344 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~h  392 (408)
                                  ........+++++.+++.+||+.||++|||+.|+.++
T Consensus       230 ------------~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~  266 (269)
T cd08528         230 ------------YEPLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAM  266 (269)
T ss_pred             ------------CCcCCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHH
Confidence                        0011112367899999999999999999999998754

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=1.5e-37  Score=286.22  Aligned_cols=236  Identities=19%  Similarity=0.292  Sum_probs=189.0

Q ss_pred             eeeeeeCceEEEEEEEcC-CCc--EEEEEEecccc----hHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccEEEEEe
Q 015374          131 RKVGRGKYSEVFEGINVN-TNE--RCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEY  203 (408)
Q Consensus       131 ~~lG~G~fg~Vy~~~~~~-~~~--~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~  203 (408)
                      +.||+|++|.||+|.+.. ++.  .+|+|.++...    .+.+.+|+.+++++ +|+||+++++.+.+   ...++||||
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~---~~~~~v~e~   76 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSL-DHENLIRLYGVVLT---HPLMMVTEL   76 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhc-CCCCccceeEEEcC---CeEEEEEEe
Confidence            368999999999998765 333  68999987533    35788999999999 99999999999865   678899999


Q ss_pred             ecCCChhhhcC-----CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCCCc---
Q 015374          204 VNSTDFKVLYP-----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE---  275 (408)
Q Consensus       204 ~~~~~l~~~~~-----~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~~~---  275 (408)
                      +++++|..++.     .+++..+..++.|++.||.|||+++++|+||||+||+++.+ +.+||+|||++........   
T Consensus        77 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~-~~~kl~dfg~~~~~~~~~~~~~  155 (257)
T cd05040          77 APLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASD-DKVKIGDFGLMRALPQNEDHYV  155 (257)
T ss_pred             cCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecC-CEEEecccccccccccccccee
Confidence            99999988762     47888999999999999999999999999999999999998 7999999999977644221   


Q ss_pred             -ceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCCCcc
Q 015374          276 -YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWS  353 (408)
Q Consensus       276 -~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  353 (408)
                       .....++..|+|||.+.+ ..++.++|||||||++|+|++ |..||. .....+....+... +               
T Consensus       156 ~~~~~~~~~~y~~pE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~-~~~~~~~~~~~~~~-~---------------  217 (257)
T cd05040         156 MEEHLKVPFAWCAPESLRT-RTFSHASDVWMFGVTLWEMFTYGEEPWA-GLSGSQILKKIDKE-G---------------  217 (257)
T ss_pred             cccCCCCCceecCHHHhcc-cCcCchhhhHHHHHHHHHHHhCCCCCCC-CCCHHHHHHHHHhc-C---------------
Confidence             112346678999999876 678999999999999999998 988873 33333333332211 0               


Q ss_pred             ccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 015374          354 KFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA  391 (408)
Q Consensus       354 ~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~  391 (408)
                        .....+..++..+.+++.+||+.+|++|||+.++++
T Consensus       218 --~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~  253 (257)
T cd05040         218 --ERLERPEACPQDIYNVMLQCWAHNPADRPTFAALRE  253 (257)
T ss_pred             --CcCCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHH
Confidence              001112236789999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=100.00  E-value=4.2e-39  Score=286.73  Aligned_cols=269  Identities=26%  Similarity=0.478  Sum_probs=220.1

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecc-----cchHHHHHHHHHHHHhcCCCCceEEeeEEEccC----
Q 015374          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP-----VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQH----  193 (408)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~-----~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~----  193 (408)
                      ...+|.-+..+|.|.- .|..+.+...++.||+|.+..     ...++..+|...+..+ +|+||++++.+|....    
T Consensus        15 v~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v-~~~nii~l~n~ftP~~~l~~   92 (369)
T KOG0665|consen   15 VPKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCV-NHKNIISLLNVFTPQKTLEE   92 (369)
T ss_pred             eeeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhh-cccceeeeeeccCccccHHH
Confidence            4678888999999999 788888999999999998742     2346678999999999 9999999999996432    


Q ss_pred             CCccEEEEEeecCCChhhhcCCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCC
Q 015374          194 SKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG  273 (408)
Q Consensus       194 ~~~~~lv~e~~~~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~  273 (408)
                      ....++|||||........+-.++-..+..+..|++.|+.|||+.||+||||||+||++..+ ..+||.|||+|+.....
T Consensus        93 ~~e~y~v~e~m~~nl~~vi~~elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~-~~lKi~dfg~ar~e~~~  171 (369)
T KOG0665|consen   93 FQEVYLVMELMDANLCQVILMELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSD-CTLKILDFGLARTEDTD  171 (369)
T ss_pred             HHhHHHHHHhhhhHHHHHHHHhcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecch-hheeeccchhhcccCcc
Confidence            23568999999987777666778889999999999999999999999999999999999998 79999999999877665


Q ss_pred             CcceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhh------------
Q 015374          274 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLII------------  341 (408)
Q Consensus       274 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~------------  341 (408)
                      ...+..+.+++|+|||++.+ ..+...+||||+||++.||++|...| +|.+..+++.++.+.+|...            
T Consensus       172 ~~mtpyVvtRyyrapevil~-~~~ke~vdiwSvGci~gEli~~~Vlf-~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r  249 (369)
T KOG0665|consen  172 FMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGELILGTVLF-PGKDHIDQWNKIIEQLGTPDPSFMKQLQPTVR  249 (369)
T ss_pred             cccCchhheeeccCchheec-cCCcccchhhhhhhHHHHHhhceEEe-cCchHHHHHHHHHHHhcCCCHHHHHHhhHHHH
Confidence            45566789999999999999 56999999999999999999999876 69999999999988887443            


Q ss_pred             ---hhcCCCCCCCccccccc-------cCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcc
Q 015374          342 ---WCNSRHSRKPWSKFINA-------DNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFA  396 (408)
Q Consensus       342 ---~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~  396 (408)
                         ..+.++....+.+.++.       +....-...+++++.+||..||++|.+++++|+|||++
T Consensus       250 ~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~  314 (369)
T KOG0665|consen  250 NYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIK  314 (369)
T ss_pred             HHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeee
Confidence               11111111222222111       11112245689999999999999999999999999997

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=2.8e-37  Score=286.59  Aligned_cols=241  Identities=16%  Similarity=0.239  Sum_probs=181.1

Q ss_pred             eeeeeCceEEEEEEEcCC--CcEEEEEEeccc----chHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccEEEEEeec
Q 015374          132 KVGRGKYSEVFEGINVNT--NERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVN  205 (408)
Q Consensus       132 ~lG~G~fg~Vy~~~~~~~--~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~  205 (408)
                      +||+|+||+||+|....+  ...+++|.++..    ..+.+.+|+.+++.+ +||||+++++.|.+  ....++||||++
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l-~h~~iv~~~~~~~~--~~~~~lv~e~~~   78 (268)
T cd05086           2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRIL-QHPNILQCLGQCVE--AIPYLLVFEYCE   78 (268)
T ss_pred             cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhcc-CCcchhheEEEecC--CCccEEEEecCC
Confidence            699999999999975433  335667776532    245788999999999 99999999999965  467889999999


Q ss_pred             CCChhhhcC-------CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCCC---c
Q 015374          206 STDFKVLYP-------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK---E  275 (408)
Q Consensus       206 ~~~l~~~~~-------~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~~---~  275 (408)
                      +++|..++.       ..++..+..++.|++.||+|||+.+++|+||||+|||++.+ +.++|+|||++.......   .
T Consensus        79 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~-~~~~l~Dfg~~~~~~~~~~~~~  157 (268)
T cd05086          79 LGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSD-LTVKVGDYGIGPSRYKEDYIET  157 (268)
T ss_pred             CCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCC-ccEEecccccccccCcchhhhc
Confidence            999988763       24556678899999999999999999999999999999988 789999999975432211   1


Q ss_pred             ceeeccCccccccccccC------CcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCC
Q 015374          276 YNVRVASRYFKGPELLVD------LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSR  349 (408)
Q Consensus       276 ~~~~~~~~~y~aPE~~~~------~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  349 (408)
                      .....++..|+|||++..      ...++.++|||||||++|||+++..+++...++.+.+..+.......         
T Consensus       158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~---------  228 (268)
T cd05086         158 EDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVK---------  228 (268)
T ss_pred             ccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccc---------
Confidence            223467788999999743      12457899999999999999986554444445444444433221100         


Q ss_pred             CCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 015374          350 KPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA  391 (408)
Q Consensus       350 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~  391 (408)
                           ..........++.+.+++..|+ .+|++|||++|+++
T Consensus       229 -----~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~  264 (268)
T cd05086         229 -----LFKPQLELPYSERWYEVLQFCW-LSPEKRATAEEVHR  264 (268)
T ss_pred             -----cCCCccCCCCcHHHHHHHHHHh-hCcccCCCHHHHHH
Confidence                 0111222236788999999999 78999999999964

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=6.5e-38  Score=339.84  Aligned_cols=251  Identities=20%  Similarity=0.310  Sum_probs=188.2

Q ss_pred             CEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecccchHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccEEEEEeec
Q 015374          126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVN  205 (408)
Q Consensus       126 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~  205 (408)
                      .|+..+.||+|+||.||+|++..++..||||.++.... ....|+.+++++ +||||++++++|.+.  ...++||||++
T Consensus       691 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~l~~l-~HpnIv~~~~~~~~~--~~~~lv~Ey~~  766 (968)
T PLN00113        691 SLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS-IPSSEIADMGKL-QHPNIVKLIGLCRSE--KGAYLIHEYIE  766 (968)
T ss_pred             hCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc-ccHHHHHHHhhC-CCCCcceEEEEEEcC--CCCEEEEeCCC
Confidence            45666789999999999999989999999999864332 334678999999 999999999999654  56789999999


Q ss_pred             CCChhhhcCCCChHHHHHHHHHHHHHHHHHH---HCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCCCcceeeccC
Q 015374          206 STDFKVLYPTLTDYDIRYYIYELLKALDYCH---SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVAS  282 (408)
Q Consensus       206 ~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~  282 (408)
                      +++|..++..+++..+..++.|++.||+|||   +.+|+||||||+||+++.+ +..++. ||........   ....++
T Consensus       767 ~g~L~~~l~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~-~~~~~~-~~~~~~~~~~---~~~~~t  841 (968)
T PLN00113        767 GKNLSEVLRNLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGK-DEPHLR-LSLPGLLCTD---TKCFIS  841 (968)
T ss_pred             CCcHHHHHhcCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCC-CceEEE-eccccccccC---CCcccc
Confidence            9999999999999999999999999999999   6699999999999999987 565664 6655433211   223678


Q ss_pred             ccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCCCc-cccccc--c
Q 015374          283 RYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPW-SKFINA--D  359 (408)
Q Consensus       283 ~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~--~  359 (408)
                      ..|+|||++.+ ..++.++|||||||++|||++|+.||.........+.+.......    ..  ....| +.....  .
T Consensus       842 ~~y~aPE~~~~-~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~----~~--~~~~~~~~~~~~~~~  914 (968)
T PLN00113        842 SAYVAPETRET-KDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYS----DC--HLDMWIDPSIRGDVS  914 (968)
T ss_pred             ccccCcccccC-CCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcC----cc--chhheeCccccCCCC
Confidence            89999999987 789999999999999999999999984332222112111111000    00  00000 000000  0


Q ss_pred             CCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 015374          360 NQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH  392 (408)
Q Consensus       360 ~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~h  392 (408)
                      .......++.+++.+|++.||++|||++|+++.
T Consensus       915 ~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  947 (968)
T PLN00113        915 VNQNEIVEVMNLALHCTATDPTARPCANDVLKT  947 (968)
T ss_pred             ccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHH
Confidence            000112457889999999999999999999875

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-39  Score=304.49  Aligned_cols=256  Identities=24%  Similarity=0.410  Sum_probs=225.3

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecc------cchHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCcc
Q 015374          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP------VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP  197 (408)
Q Consensus       124 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~------~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~  197 (408)
                      ..+++.+..||-||||.|=++........+|+|++++      ...+.+..|-.||..+ ..+.||++|..|.+  +++.
T Consensus       419 l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~-~s~fIvrLYrTfrd--~kyv  495 (732)
T KOG0614|consen  419 LSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMEC-RSDFIVRLYRTFRD--SKYV  495 (732)
T ss_pred             hhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhc-CchHHHHHHHHhcc--chhh
Confidence            4567778889999999999887666665688888864      2346688899999998 89999999999965  5889


Q ss_pred             EEEEEeecCCChhhhcC---CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCCC
Q 015374          198 SLIFEYVNSTDFKVLYP---TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK  274 (408)
Q Consensus       198 ~lv~e~~~~~~l~~~~~---~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~~  274 (408)
                      |++||-|-||.+...++   .|++...+.++..+++|++|||++|||+|||||+|.|+|.+ |-+||.|||+|+.+..+.
T Consensus       496 YmLmEaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~-Gy~KLVDFGFAKki~~g~  574 (732)
T KOG0614|consen  496 YMLMEACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNR-GYLKLVDFGFAKKIGSGR  574 (732)
T ss_pred             hhhHHhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccC-CceEEeehhhHHHhccCC
Confidence            99999999999988874   59999999999999999999999999999999999999998 899999999999999999


Q ss_pred             cceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCCCccc
Q 015374          275 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSK  354 (408)
Q Consensus       275 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  354 (408)
                      .+.+.+||+.|.|||++++ ..-+.++|.||||+++|||++|..|| .+.++....+.|.+.+..+.             
T Consensus       575 KTwTFcGTpEYVAPEIILn-KGHD~avDyWaLGIli~ELL~G~pPF-s~~dpmktYn~ILkGid~i~-------------  639 (732)
T KOG0614|consen  575 KTWTFCGTPEYVAPEIILN-KGHDRAVDYWALGILIYELLTGSPPF-SGVDPMKTYNLILKGIDKIE-------------  639 (732)
T ss_pred             ceeeecCCcccccchhhhc-cCcchhhHHHHHHHHHHHHHcCCCCC-CCCchHHHHHHHHhhhhhhh-------------
Confidence            9999999999999999998 77899999999999999999999997 67777788888777654332             


Q ss_pred             cccccCCCCCCHHHHHHHHHhcccCcCCCC-----CHHHHhcCCCccccccchh
Q 015374          355 FINADNQHLVSPEAIDFLDKLLRYDHQDRL-----TAREAMAHPYFAQVRAAES  403 (408)
Q Consensus       355 ~~~~~~~~~~~~~~~~li~~~L~~dp~~Rp-----t~~elL~hp~f~~~~~~~~  403 (408)
                           .|..++..+.++|+++.+.+|.+|.     .+.++-.|.||.+-+++..
T Consensus       640 -----~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~gfdwegl  688 (732)
T KOG0614|consen  640 -----FPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFEGFDWEGL  688 (732)
T ss_pred             -----cccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhhhcCChhhh
Confidence                 2344789999999999999999998     4899999999999888664

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-38  Score=295.17  Aligned_cols=251  Identities=18%  Similarity=0.265  Sum_probs=194.9

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecccchHHHHHHHHHHHHh-cCCCCceEEeeEEEccC--CCccEEE
Q 015374          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNL-CGGPNVVKLLDIVRDQH--SKTPSLI  200 (408)
Q Consensus       124 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l-~~h~niv~l~~~~~~~~--~~~~~lv  200 (408)
                      ....++.+.||+|+||.||||..  +++.||||++...+.+.|.+|-.|++.. -.|+||+++++.-....  ...++||
T Consensus       209 l~pl~l~eli~~Grfg~V~KaqL--~~~~VAVKifp~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLV  286 (534)
T KOG3653|consen  209 LDPLQLLELIGRGRFGCVWKAQL--DNRLVAVKIFPEQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLV  286 (534)
T ss_pred             CCchhhHHHhhcCccceeehhhc--cCceeEEEecCHHHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEE
Confidence            45566778999999999999954  5699999999999999999999998854 27999999999865322  3478999


Q ss_pred             EEeecCCChhhhcC--CCChHHHHHHHHHHHHHHHHHHHC---------CcEEecCCCCcEEEeCCCCcEEEEeccccee
Q 015374          201 FEYVNSTDFKVLYP--TLTDYDIRYYIYELLKALDYCHSQ---------GIMHRDVKPHNVMIDHELRKLRLIDWGLAEF  269 (408)
Q Consensus       201 ~e~~~~~~l~~~~~--~l~~~~~~~i~~qi~~~L~~LH~~---------~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~  269 (408)
                      ++|.+.|+|.+++.  .++|.+..+++..+++||+|||+.         .|+|||||+.|||+..| .++.|+|||+|..
T Consensus       287 t~fh~kGsL~dyL~~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~D-lTccIaDFGLAl~  365 (534)
T KOG3653|consen  287 TEFHPKGSLCDYLKANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKND-LTCCIADFGLALR  365 (534)
T ss_pred             eeeccCCcHHHHHHhccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccC-CcEEeeccceeEE
Confidence            99999999999984  599999999999999999999963         59999999999999999 7899999999988


Q ss_pred             ccCCC---cceeeccCccccccccccCCcCCC-----ccccHHHHHHHHHHHHhCCCCCCCCCC---------------C
Q 015374          270 YHPGK---EYNVRVASRYFKGPELLVDLQDYD-----YSLDMWSLGCMFAGMIFRKEPFFYGHD---------------N  326 (408)
Q Consensus       270 ~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~-----~~~DvwSlGvil~ell~g~~pf~~~~~---------------~  326 (408)
                      +.+..   .....+||..|||||++.+...+.     .+.||||+|.++|||+++..-++++..               .
T Consensus       366 ~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hPt  445 (534)
T KOG3653|consen  366 LEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHPT  445 (534)
T ss_pred             ecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCCC
Confidence            76543   334589999999999997743443     479999999999999998765543222               2


Q ss_pred             HHHHHHHHhhhchhhhhcCCCCCCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHH
Q 015374          327 HDQLVKIAKDCCLIIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREA  389 (408)
Q Consensus       327 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~el  389 (408)
                      .+.+++.+-         ....+..++......   .--.-+++.+..||+.||+-|.|+.=+
T Consensus       446 ~e~mq~~VV---------~kK~RP~~p~~W~~h---~~~~~l~et~EeCWDhDaeARLTA~Cv  496 (534)
T KOG3653|consen  446 LEEMQELVV---------RKKQRPKIPDAWRKH---AGMAVLCETIEECWDHDAEARLTAGCV  496 (534)
T ss_pred             HHHHHHHHH---------hhccCCCChhhhhcC---ccHHHHHHHHHHHcCCchhhhhhhHHH
Confidence            222222211         112222222221111   123568999999999999999997643

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4e-38  Score=281.81  Aligned_cols=256  Identities=25%  Similarity=0.457  Sum_probs=215.2

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecccc------hHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCcc
Q 015374          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK------KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP  197 (408)
Q Consensus       124 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~------~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~  197 (408)
                      .++|.+++.||+|+|++|..++.+++.+.+|+|+++++-      ..=.+.|-.+.....+||.+|-+..+|.  ....+
T Consensus       249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfq--tesrl  326 (593)
T KOG0695|consen  249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQ--TESRL  326 (593)
T ss_pred             cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhc--ccceE
Confidence            578999999999999999999999999999999997432      2335667777887789999999999994  45778


Q ss_pred             EEEEEeecCCChhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceec-cCC
Q 015374          198 SLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY-HPG  273 (408)
Q Consensus       198 ~lv~e~~~~~~l~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~-~~~  273 (408)
                      ++|.||++||+|...+   ++++++.++.+..+|+.||.|||+.|||+||||.+|+|+|.+ |.+|++|+|+++.. .++
T Consensus       327 ffvieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldae-ghikltdygmcke~l~~g  405 (593)
T KOG0695|consen  327 FFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAE-GHIKLTDYGMCKEGLGPG  405 (593)
T ss_pred             EEEEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccC-CceeecccchhhcCCCCC
Confidence            9999999999998776   569999999999999999999999999999999999999999 89999999999754 456


Q ss_pred             CcceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCC-C-----CCCHHHHHHHHhhhchhhhhcCCC
Q 015374          274 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFY-G-----HDNHDQLVKIAKDCCLIIWCNSRH  347 (408)
Q Consensus       274 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~-~-----~~~~~~~~~~~~~~~~~~~~~~~~  347 (408)
                      ..+.+.+||+.|.|||++.+ ..|..++|.|++||+++||+.|+.||.- |     .+..+.+-.++-.           
T Consensus       406 d~tstfcgtpnyiapeilrg-eeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvile-----------  473 (593)
T KOG0695|consen  406 DTTSTFCGTPNYIAPEILRG-EEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILE-----------  473 (593)
T ss_pred             cccccccCCCcccchhhhcc-cccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhh-----------
Confidence            67788999999999999998 8999999999999999999999999932 2     2223333222211           


Q ss_pred             CCCCccccccccCCCCCCHHHHHHHHHhcccCcCCCC------CHHHHhcCCCccccccch
Q 015374          348 SRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRL------TAREAMAHPYFAQVRAAE  402 (408)
Q Consensus       348 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rp------t~~elL~hp~f~~~~~~~  402 (408)
                              .....+..+|-.+..+++..|..||.+|.      ..+++-.|+||..+++.-
T Consensus       474 --------kqiriprslsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~idwd~  526 (593)
T KOG0695|consen  474 --------KQIRIPRSLSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRSIDWDL  526 (593)
T ss_pred             --------hcccccceeehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhhCCHHH
Confidence                    01223344678889999999999999997      578999999999988754

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=2e-37  Score=287.90  Aligned_cols=243  Identities=18%  Similarity=0.331  Sum_probs=188.6

Q ss_pred             EEEEeeeeeeCceEEEEEEEcC---CCcEEEEEEeccc-----chHHHHHHHHHHHHhcCCCCceEEeeEEEccCC----
Q 015374          127 YEVVRKVGRGKYSEVFEGINVN---TNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHS----  194 (408)
Q Consensus       127 y~~~~~lG~G~fg~Vy~~~~~~---~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~----  194 (408)
                      |.+.+.||+|+||+||+|.+..   ++..+|+|+++..     ..+++.+|+.+++.+ +||||+++++++.....    
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~~   79 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEF-DHPNVIKLIGVSLRSRAKGRL   79 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcC-CCCCcceEEEEEccCCCCCcc
Confidence            4567789999999999998643   5688999988642     235688999999999 99999999998864322    


Q ss_pred             CccEEEEEeecCCChhhhcC---------CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecc
Q 015374          195 KTPSLIFEYVNSTDFKVLYP---------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWG  265 (408)
Q Consensus       195 ~~~~lv~e~~~~~~l~~~~~---------~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG  265 (408)
                      ...++++||+.++++..++.         .+++..+..++.|++.||+|||+.||+|+||||+||+++.+ +.+||+|||
T Consensus        80 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~-~~~kl~dfg  158 (273)
T cd05074          80 PIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNEN-MTVCVADFG  158 (273)
T ss_pred             cceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCC-CCEEECccc
Confidence            13468899999999876641         36788889999999999999999999999999999999987 789999999


Q ss_pred             cceeccCCCc---ceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHhhhchhh
Q 015374          266 LAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKDCCLII  341 (408)
Q Consensus       266 ~a~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~  341 (408)
                      +++.......   .....++..|++||.+.+ ..++.++|||||||++|+|++ |..|| .+.+..+....+... .   
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~sDi~slG~il~el~~~g~~p~-~~~~~~~~~~~~~~~-~---  232 (273)
T cd05074         159 LSKKIYSGDYYRQGCASKLPVKWLALESLAD-NVYTTHSDVWAFGVTMWEIMTRGQTPY-AGVENSEIYNYLIKG-N---  232 (273)
T ss_pred             ccccccCCcceecCCCccCchhhcCHhHHhc-CccchhhhhHHHHHHHHHHhhCCCCCC-CCCCHHHHHHHHHcC-C---
Confidence            9886543221   122344567999999876 678899999999999999999 66665 444433332222211 0   


Q ss_pred             hhcCCCCCCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 015374          342 WCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH  392 (408)
Q Consensus       342 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~h  392 (408)
                                     ....+...+..+.+++.+||+.+|++|||+.|+++.
T Consensus       233 ---------------~~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~  268 (273)
T cd05074         233 ---------------RLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQ  268 (273)
T ss_pred             ---------------cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                           011112367899999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-38  Score=305.26  Aligned_cols=249  Identities=18%  Similarity=0.290  Sum_probs=206.0

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCC-c--EEEEEEeccc----chHHHHHHHHHHHHhcCCCCceEEeeEEEccCCC
Q 015374          123 DQDDYEVVRKVGRGKYSEVFEGINVNTN-E--RCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSK  195 (408)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~-~--~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  195 (408)
                      ..++..+.++||+|+||.|++|.+...+ +  .||||.++..    ....|.+|+.+|.+| +|+|+++|||+..+   .
T Consensus       108 pee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L-~H~hliRLyGvVl~---q  183 (1039)
T KOG0199|consen  108 PEEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKL-QHPHLIRLYGVVLD---Q  183 (1039)
T ss_pred             cHHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhc-cCcceeEEeeeecc---c
Confidence            3566777889999999999999877533 2  6899999753    357899999999999 99999999999965   4


Q ss_pred             ccEEEEEeecCCChhhhcCC-----CChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceec
Q 015374          196 TPSLIFEYVNSTDFKVLYPT-----LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY  270 (408)
Q Consensus       196 ~~~lv~e~~~~~~l~~~~~~-----l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~  270 (408)
                      ...||||.++.|+|.+.+..     |....+..|+.||+.||.||.++++|||||.++|+|+-.. ..|||||||+.+.+
T Consensus       184 p~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasp-rtVKI~DFGLmRaL  262 (1039)
T KOG0199|consen  184 PAMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASP-RTVKICDFGLMRAL  262 (1039)
T ss_pred             hhhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheeccc-ceeeeecccceecc
Confidence            56799999999999888754     6677788999999999999999999999999999999886 79999999999988


Q ss_pred             cCCCcceee----ccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCC
Q 015374          271 HPGKEYNVR----VASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSR  346 (408)
Q Consensus       271 ~~~~~~~~~----~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  346 (408)
                      ..+..+...    .-...|.|||.+.. ..++.++|||+|||++|||+++..-.+.|....+.+..+-+.          
T Consensus       263 g~ned~Yvm~p~rkvPfAWCaPEsLrh-~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~----------  331 (1039)
T KOG0199|consen  263 GENEDMYVMAPQRKVPFAWCAPESLRH-RKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAG----------  331 (1039)
T ss_pred             CCCCcceEecCCCcCcccccCHhHhcc-ccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhcccc----------
Confidence            766554322    22335999999987 889999999999999999998554334777777776654321          


Q ss_pred             CCCCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcc
Q 015374          347 HSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFA  396 (408)
Q Consensus       347 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~  396 (408)
                               .....++.|++++.+++..||..+|++|||...|.+.-++.
T Consensus       332 ---------erLpRPk~csedIY~imk~cWah~paDRptFsair~~~~l~  372 (1039)
T KOG0199|consen  332 ---------ERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLVLA  372 (1039)
T ss_pred             ---------ccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhHHHH
Confidence                     23445667999999999999999999999999887665543

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=100.00  E-value=9.7e-37  Score=301.71  Aligned_cols=266  Identities=20%  Similarity=0.327  Sum_probs=184.8

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEc----------------CCCcEEEEEEecccc---hH--------------HHHHH
Q 015374          123 DQDDYEVVRKVGRGKYSEVFEGINV----------------NTNERCIIKILKPVK---KK--------------KIKRE  169 (408)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~Vy~~~~~----------------~~~~~vavK~~~~~~---~~--------------~~~~E  169 (408)
                      ..++|++.++||+|+||+||+|.+.                ..++.||||.++...   .+              ....|
T Consensus       143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE  222 (507)
T PLN03224        143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE  222 (507)
T ss_pred             cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence            4778999999999999999999752                234679999986322   11              23347


Q ss_pred             HHHHHHhcCCCC-----ceEEeeEEEcc------CCCccEEEEEeecCCChhhhcCC-----------------------
Q 015374          170 IKILQNLCGGPN-----VVKLLDIVRDQ------HSKTPSLIFEYVNSTDFKVLYPT-----------------------  215 (408)
Q Consensus       170 ~~~l~~l~~h~n-----iv~l~~~~~~~------~~~~~~lv~e~~~~~~l~~~~~~-----------------------  215 (408)
                      +.++.++ +|.+     +++++++|...      .....+|||||+++++|.+++..                       
T Consensus       223 ~~~l~~l-~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~  301 (507)
T PLN03224        223 AYMCAKI-KRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNM  301 (507)
T ss_pred             HHHHHHh-hcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhc
Confidence            7777777 5554     36777877532      12457899999999999876531                       


Q ss_pred             ----CChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCCCccee--eccCccccccc
Q 015374          216 ----LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNV--RVASRYFKGPE  289 (408)
Q Consensus       216 ----l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~~~~~~--~~~~~~y~aPE  289 (408)
                          +++..++.++.|++.||.|||+.+|+||||||+|||++.+ +.+||+|||++...........  ..+++.|+|||
T Consensus       302 ~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~-~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE  380 (507)
T PLN03224        302 PQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVD-GQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPE  380 (507)
T ss_pred             ccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCC-CcEEEEeCcCccccccCCccCccccCCCcceeChh
Confidence                2455678899999999999999999999999999999988 7899999999976543332222  23478899999


Q ss_pred             cccCCcC-------------------C--CccccHHHHHHHHHHHHhCCC-CCCCCCCCHHHHHHHHhhhchhhhhcCCC
Q 015374          290 LLVDLQD-------------------Y--DYSLDMWSLGCMFAGMIFRKE-PFFYGHDNHDQLVKIAKDCCLIIWCNSRH  347 (408)
Q Consensus       290 ~~~~~~~-------------------~--~~~~DvwSlGvil~ell~g~~-pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (408)
                      .+.....                   +  ..+.||||+||++++|+++.. ||.........+......  ...|.....
T Consensus       381 ~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~--~~~~r~~~~  458 (507)
T PLN03224        381 ELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDND--LNRWRMYKG  458 (507)
T ss_pred             hhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccch--HHHHHhhcc
Confidence            9864211                   1  124799999999999999876 542111111111100000  001111000


Q ss_pred             CCCCccccccccCCCCCCHHHHHHHHHhcccCc---CCCCCHHHHhcCCCcccc
Q 015374          348 SRKPWSKFINADNQHLVSPEAIDFLDKLLRYDH---QDRLTAREAMAHPYFAQV  398 (408)
Q Consensus       348 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp---~~Rpt~~elL~hp~f~~~  398 (408)
                      ..      ........++++++||+.+||..+|   .+|+|++|+|+||||.+.
T Consensus       459 ~~------~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~~~  506 (507)
T PLN03224        459 QK------YDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFLPE  506 (507)
T ss_pred             cC------CCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcCCC
Confidence            01      1122344478999999999999866   689999999999999753

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-39  Score=282.69  Aligned_cols=257  Identities=20%  Similarity=0.332  Sum_probs=204.5

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecc----cchHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccEE
Q 015374          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP----VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSL  199 (408)
Q Consensus       124 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~----~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l  199 (408)
                      .++.+-+..||.|+||+|+|-.++.+|+..|||.+..    .+.+++..|.+...+-.+.||||++||.+-.  ++..++
T Consensus        63 ~~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~--EGdcWi  140 (361)
T KOG1006|consen   63 SDNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFS--EGDCWI  140 (361)
T ss_pred             cchHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhc--CCceee
Confidence            4455556789999999999999999999999999863    2356788899888877789999999998744  356789


Q ss_pred             EEEeecCCChhhhc--------CCCChHHHHHHHHHHHHHHHHHHH-CCcEEecCCCCcEEEeCCCCcEEEEecccceec
Q 015374          200 IFEYVNSTDFKVLY--------PTLTDYDIRYYIYELLKALDYCHS-QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY  270 (408)
Q Consensus       200 v~e~~~~~~l~~~~--------~~l~~~~~~~i~~qi~~~L~~LH~-~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~  270 (408)
                      .||.|.-. ++.++        ..+++.-+-.|..-...||+||-+ .+|||||+||+|||+|.. |.+||||||.+-.+
T Consensus       141 CMELMd~S-lDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~-G~vKLCDFGIcGqL  218 (361)
T KOG1006|consen  141 CMELMDIS-LDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRH-GDVKLCDFGICGQL  218 (361)
T ss_pred             eHHHHhhh-HHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecC-CCEeeecccchHhH
Confidence            99999753 33332        358888888888889999999986 589999999999999998 89999999999777


Q ss_pred             cCCCcceeeccCccccccccccCCc-CCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCC
Q 015374          271 HPGKEYNVRVASRYFKGPELLVDLQ-DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSR  349 (408)
Q Consensus       271 ~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  349 (408)
                      .++-..+...|-..|||||.+.... .|+.++||||||++|+|+.||..|+..-.+-.+++..+...-         +  
T Consensus       219 v~SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gd---------p--  287 (361)
T KOG1006|consen  219 VDSIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGD---------P--  287 (361)
T ss_pred             HHHHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCC---------C--
Confidence            6665666778888999999997644 499999999999999999999999743333344544433221         1  


Q ss_pred             CCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccc
Q 015374          350 KPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQV  398 (408)
Q Consensus       350 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~~  398 (408)
                         +........-..+..++.||.-||..|-++||...+|+.+||+..-
T Consensus       288 ---p~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~y  333 (361)
T KOG1006|consen  288 ---PILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKFPFYRMY  333 (361)
T ss_pred             ---CeecCcccccccCHHHHHHHHHHhhcccccCcchhhhhcCchhhhh
Confidence               1112222233468899999999999999999999999999998744

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=100.00  E-value=1.3e-35  Score=269.46  Aligned_cols=237  Identities=35%  Similarity=0.608  Sum_probs=196.1

Q ss_pred             CceEEEEEEEcCCCcEEEEEEecccc----hHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccEEEEEeecCCChhhh
Q 015374          137 KYSEVFEGINVNTNERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL  212 (408)
Q Consensus       137 ~fg~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~~~~l~~~  212 (408)
                      +||.||+|.+..+++.+++|++....    .+.+.+|++.++++ +|+|++++++++..  ....++++||+++++|..+
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~--~~~~~l~~e~~~~~~L~~~   77 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKL-KHPNIVRLYDVFED--EDKLYLVMEYCDGGDLFDL   77 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhC-CCCcHHHHHhheee--CCEEEEEEeCCCCCCHHHH
Confidence            58999999998889999999987433    57889999999999 99999999999965  3678899999999999888


Q ss_pred             cCC---CChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCCCcceeeccCccccccc
Q 015374          213 YPT---LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE  289 (408)
Q Consensus       213 ~~~---l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~y~aPE  289 (408)
                      +..   +++..+..++.+++.++.|||+.+++|+||+|+||+++.+ +.++|+|||.+.............++..|++||
T Consensus        78 ~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~-~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pE  156 (244)
T smart00220       78 LKKRGRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDED-GHVKLADFGLARQLDPGGLLTTFVGTPEYMAPE  156 (244)
T ss_pred             HHhccCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCC-CcEEEccccceeeeccccccccccCCcCCCCHH
Confidence            743   7889999999999999999999999999999999999998 799999999998776554555667888999999


Q ss_pred             cccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCCCccccccccCCCCCCHHHH
Q 015374          290 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSKFINADNQHLVSPEAI  369 (408)
Q Consensus       290 ~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  369 (408)
                      .+.+ ..++.++|+||||+++++|++|..||....+ .+..........        ..        .......++.++.
T Consensus       157 ~~~~-~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~-~~~~~~~~~~~~--------~~--------~~~~~~~~~~~~~  218 (244)
T smart00220      157 VLLG-KGYGKAVDVWSLGVILYELLTGKPPFPGDDQ-LLELFKKIGKPK--------PP--------FPPPEWKISPEAK  218 (244)
T ss_pred             HHcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCc-HHHHHHHHhccC--------CC--------CccccccCCHHHH
Confidence            9976 6788999999999999999999999854333 333222222100        00        0001111678999


Q ss_pred             HHHHHhcccCcCCCCCHHHHhcCCCc
Q 015374          370 DFLDKLLRYDHQDRLTAREAMAHPYF  395 (408)
Q Consensus       370 ~li~~~L~~dp~~Rpt~~elL~hp~f  395 (408)
                      +++.+||..||++||++.++++||||
T Consensus       219 ~~i~~~l~~~p~~Rp~~~~~~~~~~~  244 (244)
T smart00220      219 DLIRKLLVKDPEKRLTAEEALQHPFF  244 (244)
T ss_pred             HHHHHHccCCchhccCHHHHhhCCCC
Confidence            99999999999999999999999997

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.2e-35  Score=299.48  Aligned_cols=246  Identities=23%  Similarity=0.398  Sum_probs=200.7

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEc---C----CCcEEEEEEecc----cchHHHHHHHHHHHHhcCCCCceEEeeEEEcc
Q 015374          124 QDDYEVVRKVGRGKYSEVFEGINV---N----TNERCIIKILKP----VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQ  192 (408)
Q Consensus       124 ~~~y~~~~~lG~G~fg~Vy~~~~~---~----~~~~vavK~~~~----~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~  192 (408)
                      .++.++.+.||+|.||.||+|...   .    ....||||.++.    .+.+.+..|++++..+..|+||+.++|+|.. 
T Consensus       295 ~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~-  373 (609)
T KOG0200|consen  295 RENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQ-  373 (609)
T ss_pred             hhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeecc-
Confidence            444567779999999999999633   1    245799999873    3356889999999999889999999999965 


Q ss_pred             CCCccEEEEEeecCCChhhhcC--C-----------------CChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEe
Q 015374          193 HSKTPSLIFEYVNSTDFKVLYP--T-----------------LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMID  253 (408)
Q Consensus       193 ~~~~~~lv~e~~~~~~l~~~~~--~-----------------l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~  253 (408)
                       ....++|+||+..|+|..+++  .                 ++..++..++.||+.|++||++.++|||||.++|||+.
T Consensus       374 -~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNVLi~  452 (609)
T KOG0200|consen  374 -DGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNVLIT  452 (609)
T ss_pred             -CCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhEEec
Confidence             678899999999999988872  3                 77888999999999999999999999999999999999


Q ss_pred             CCCCcEEEEecccceeccCCCcceeec----cCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHH
Q 015374          254 HELRKLRLIDWGLAEFYHPGKEYNVRV----ASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQ  329 (408)
Q Consensus       254 ~~~~~~kl~DfG~a~~~~~~~~~~~~~----~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~  329 (408)
                      .+ ..+||+|||+|+...+...+....    -+..|||||.+.. ..|+.++|||||||+|||+++...+.+++......
T Consensus       453 ~~-~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~-~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~~  530 (609)
T KOG0200|consen  453 KN-KVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFD-RVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTEE  530 (609)
T ss_pred             CC-CEEEEccccceeccCCCCceEecCCCCccceeecCHHHhcc-CcccccchhhHHHHHHHHHhhCCCCCCCCCCcHHH
Confidence            98 799999999999766555443222    2345999999998 89999999999999999999976665666553333


Q ss_pred             HHHHHhhhchhhhhcCCCCCCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 015374          330 LVKIAKDCCLIIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA  391 (408)
Q Consensus       330 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~  391 (408)
                      +.+.+..+                  ...+.+..+++++.++++.||+.+|++||+..|+.+
T Consensus       531 l~~~l~~G------------------~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~  574 (609)
T KOG0200|consen  531 LLEFLKEG------------------NRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVE  574 (609)
T ss_pred             HHHHHhcC------------------CCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence            33333221                  344556778999999999999999999999888753

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-35  Score=274.06  Aligned_cols=258  Identities=19%  Similarity=0.281  Sum_probs=191.9

Q ss_pred             cccCCCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecccchHHHHHHHHHHHHh-cCCCCceEEeeEEEccC--CC
Q 015374          119 VQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNL-CGGPNVVKLLDIVRDQH--SK  195 (408)
Q Consensus       119 ~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l-~~h~niv~l~~~~~~~~--~~  195 (408)
                      ++-....+.++.+.||+|.||+||+|.+.  |+.||||++...+...+.+|.+|++.. -+|+||+.+++.=...+  ..
T Consensus       205 VQRTiarqI~L~e~IGkGRyGEVwrG~wr--Ge~VAVKiF~srdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~T  282 (513)
T KOG2052|consen  205 VQRTIARQIVLQEIIGKGRFGEVWRGRWR--GEDVAVKIFSSRDERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWT  282 (513)
T ss_pred             hHHhhhheeEEEEEecCccccceeecccc--CCceEEEEecccchhhhhhHHHHHHHHHhccchhhhhhhccccCCCceE
Confidence            44444678999999999999999999774  789999999988889999999998843 49999999988643222  23


Q ss_pred             ccEEEEEeecCCChhhhcC--CCChHHHHHHHHHHHHHHHHHHHC--------CcEEecCCCCcEEEeCCCCcEEEEecc
Q 015374          196 TPSLIFEYVNSTDFKVLYP--TLTDYDIRYYIYELLKALDYCHSQ--------GIMHRDVKPHNVMIDHELRKLRLIDWG  265 (408)
Q Consensus       196 ~~~lv~e~~~~~~l~~~~~--~l~~~~~~~i~~qi~~~L~~LH~~--------~iiH~Dlk~~NILl~~~~~~~kl~DfG  265 (408)
                      .++||.+|-+.|+|.+++.  .++.....+++..++.||+|||..        .|.|||||+.|||+..| +.+.|+|+|
T Consensus       283 QLwLvTdYHe~GSL~DyL~r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn-~~C~IADLG  361 (513)
T KOG2052|consen  283 QLWLVTDYHEHGSLYDYLNRNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKN-GTCCIADLG  361 (513)
T ss_pred             EEEEeeecccCCcHHHHHhhccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccC-CcEEEeece
Confidence            5789999999999999984  588899999999999999999943        49999999999999999 899999999


Q ss_pred             cceeccCCC-----cceeeccCccccccccccCCcCC---C--ccccHHHHHHHHHHHHhC----------CCCCCCCCC
Q 015374          266 LAEFYHPGK-----EYNVRVASRYFKGPELLVDLQDY---D--YSLDMWSLGCMFAGMIFR----------KEPFFYGHD  325 (408)
Q Consensus       266 ~a~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~---~--~~~DvwSlGvil~ell~g----------~~pf~~~~~  325 (408)
                      +|-......     ..+.++||..|||||++...-..   .  ..+||||||.++||+.-+          ..||+.--+
T Consensus       362 LAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp  441 (513)
T KOG2052|consen  362 LAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVP  441 (513)
T ss_pred             eeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCC
Confidence            997665432     24678999999999999652211   1  368999999999998744          246654333


Q ss_pred             CHHHHHHHHhhhchhhhhcCCCC-CCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHH
Q 015374          326 NHDQLVKIAKDCCLIIWCNSRHS-RKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREA  389 (408)
Q Consensus       326 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~el  389 (408)
                      +...+.++.+......   .++. ...|...       ..-..+..+++.||..||.-|.||-.+
T Consensus       442 ~DPs~eeMrkVVCv~~---~RP~ipnrW~s~-------~~l~~m~klMkeCW~~Np~aRltALri  496 (513)
T KOG2052|consen  442 SDPSFEEMRKVVCVQK---LRPNIPNRWKSD-------PALRVMAKLMKECWYANPAARLTALRI  496 (513)
T ss_pred             CCCCHHHHhcceeecc---cCCCCCcccccC-------HHHHHHHHHHHHhhcCCchhhhHHHHH
Confidence            3323333333211100   0000 0111110       011346788999999999999987544

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-35  Score=291.44  Aligned_cols=242  Identities=19%  Similarity=0.339  Sum_probs=195.4

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCc----EEEEEEecc----cchHHHHHHHHHHHHhcCCCCceEEeeEEEccCCC
Q 015374          124 QDDYEVVRKVGRGKYSEVFEGINVNTNE----RCIIKILKP----VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSK  195 (408)
Q Consensus       124 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~----~vavK~~~~----~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  195 (408)
                      .......+.||.|+||+||+|.+...++    +||+|++..    ....++.+|..+|.++ +|||+++++++|...   
T Consensus       695 Etelkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masl-dHpnl~RLLgvc~~s---  770 (1177)
T KOG1025|consen  695 ETELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASL-DHPNLLRLLGVCMLS---  770 (1177)
T ss_pred             hhhhhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcC-CCchHHHHhhhcccc---
Confidence            3345556789999999999998876665    678888752    3357899999999999 999999999999653   


Q ss_pred             ccEEEEEeecCCChhhhc----CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceecc
Q 015374          196 TPSLIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH  271 (408)
Q Consensus       196 ~~~lv~e~~~~~~l~~~~----~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~  271 (408)
                      .+.||.+||+.|.|.++.    ..+.......|..||++||.|||++++|||||.++|+|+..- +.+||.|||+++...
T Consensus       771 ~~qlvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP-~hvkitdfgla~ll~  849 (1177)
T KOG1025|consen  771 TLQLVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSP-NHVKITDFGLAKLLA  849 (1177)
T ss_pred             hHHHHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCC-CeEEEEecchhhccC
Confidence            377999999999999887    358888899999999999999999999999999999999987 799999999999876


Q ss_pred             CCCc-ceeec--cCccccccccccCCcCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHhhhchhhhhcCCC
Q 015374          272 PGKE-YNVRV--ASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRH  347 (408)
Q Consensus       272 ~~~~-~~~~~--~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (408)
                      +... +....  ..+.|||=|.+.. ..|+.++|||||||++||++| |..|+ .+....+. .++.+..          
T Consensus       850 ~d~~ey~~~~gK~pikwmale~i~~-~~~thqSDVWsfGVtiWElmTFGa~Py-~gi~~~eI-~dlle~g----------  916 (1177)
T KOG1025|consen  850 PDEKEYSAPGGKVPIKWMALESIRI-RKYTHQSDVWSFGVTIWELMTFGAKPY-DGIPAEEI-PDLLEKG----------  916 (1177)
T ss_pred             cccccccccccccCcHHHHHHHhhc-cCCCchhhhhhhhhhHHHHHhcCCCcc-CCCCHHHh-hHHHhcc----------
Confidence            5533 33332  3445999999987 899999999999999999987 77776 44443333 2222211          


Q ss_pred             CCCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 015374          348 SRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA  391 (408)
Q Consensus       348 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~  391 (408)
                              .+..-+..++.++--++.+||..|+..||+++++-.
T Consensus       917 --------eRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~  952 (1177)
T KOG1025|consen  917 --------ERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAE  952 (1177)
T ss_pred             --------ccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHH
Confidence                    123345558899999999999999999999998753

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-35  Score=293.58  Aligned_cols=244  Identities=25%  Similarity=0.379  Sum_probs=187.7

Q ss_pred             EEEEeeeeeeCceE-EEEEEEcCCCcEEEEEEecccchHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccEEEEEeec
Q 015374          127 YEVVRKVGRGKYSE-VFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVN  205 (408)
Q Consensus       127 y~~~~~lG~G~fg~-Vy~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~  205 (408)
                      |...+.+|.|+.|+ ||+|..  .++.||||.+-........+|+..|+.-..|||||++++.-  .+....|+..|.|.
T Consensus       511 ~~~~eilG~Gs~Gt~Vf~G~y--e~R~VAVKrll~e~~~~A~rEi~lL~eSD~H~NviRyyc~E--~d~qF~YIalELC~  586 (903)
T KOG1027|consen  511 FSPKEILGYGSNGTVVFRGVY--EGREVAVKRLLEEFFDFAQREIQLLQESDEHPNVIRYYCSE--QDRQFLYIALELCA  586 (903)
T ss_pred             eccHHHcccCCCCcEEEEEee--CCceehHHHHhhHhHHHHHHHHHHHHhccCCCceEEEEeec--cCCceEEEEehHhh
Confidence            34445689999988 599964  67899999987777788899999999988999999998876  55678899999997


Q ss_pred             CCChhhhcCC-------CChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeC----CCCcEEEEecccceeccCCC
Q 015374          206 STDFKVLYPT-------LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDH----ELRKLRLIDWGLAEFYHPGK  274 (408)
Q Consensus       206 ~~~l~~~~~~-------l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~----~~~~~kl~DfG~a~~~~~~~  274 (408)
                      . +|++++..       ......+..+.|++.||++||+.+||||||||.||||+.    ....++|+|||+++.+..+.
T Consensus       587 ~-sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~  665 (903)
T KOG1027|consen  587 C-SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGK  665 (903)
T ss_pred             h-hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccccCCCc
Confidence            5 34555432       111345678899999999999999999999999999986    23579999999999887654


Q ss_pred             c----ceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhC-CCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCC
Q 015374          275 E----YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFR-KEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSR  349 (408)
Q Consensus       275 ~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  349 (408)
                      .    .....||.+|+|||++.. ..-+.++||||+||++|+.++| .+||  |+. .+.-..|......          
T Consensus       666 sS~~r~s~~sGt~GW~APE~L~~-~~~~~avDiFslGCvfyYvltgG~HpF--Gd~-~~R~~NIl~~~~~----------  731 (903)
T KOG1027|consen  666 SSFSRLSGGSGTSGWQAPEQLRE-DRKTQAVDIFSLGCVFYYVLTGGSHPF--GDS-LERQANILTGNYT----------  731 (903)
T ss_pred             chhhcccCCCCcccccCHHHHhc-cccCcccchhhcCceEEEEecCCccCC--Cch-HHhhhhhhcCccc----------
Confidence            3    344578999999999987 5557799999999999999987 6787  222 2222233322110          


Q ss_pred             CCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcc
Q 015374          350 KPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFA  396 (408)
Q Consensus       350 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~  396 (408)
                        .   ......  ...++.|||.+|+.+||..||+|.++|.||||=
T Consensus       732 --L---~~L~~~--~d~eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW  771 (903)
T KOG1027|consen  732 --L---VHLEPL--PDCEAKDLISRMLNPDPQLRPSATDVLNHPLFW  771 (903)
T ss_pred             --e---eeeccC--chHHHHHHHHHhcCCCcccCCCHHHHhCCCccC
Confidence              0   001111  112899999999999999999999999999983

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=100.00  E-value=2e-34  Score=242.25  Aligned_cols=210  Identities=20%  Similarity=0.398  Sum_probs=178.6

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEec----ccchHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccE
Q 015374          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK----PVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS  198 (408)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~----~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  198 (408)
                      ..++...+..||+|++|.|-+-++..+|...|+|.+.    ....++..+|+.+..+....|.+|.+||....  ....+
T Consensus        44 ~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~r--egdvw  121 (282)
T KOG0984|consen   44 PADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFR--EGDVW  121 (282)
T ss_pred             chhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhc--cccEE
Confidence            4566677788999999999999999999999999886    33456788999998888789999999997744  35678


Q ss_pred             EEEEeecCCChhhhc-------CCCChHHHHHHHHHHHHHHHHHHHC-CcEEecCCCCcEEEeCCCCcEEEEecccceec
Q 015374          199 LIFEYVNSTDFKVLY-------PTLTDYDIRYYIYELLKALDYCHSQ-GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY  270 (408)
Q Consensus       199 lv~e~~~~~~l~~~~-------~~l~~~~~~~i~~qi~~~L~~LH~~-~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~  270 (408)
                      +.||.|.-. ++.+.       ..+++.-+-+|+..+..||+|||++ .+||||+||+|||++.+ |.+|+||||.+-.+
T Consensus       122 IcME~M~tS-ldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~-GqVKiCDFGIsG~L  199 (282)
T KOG0984|consen  122 ICMELMDTS-LDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYD-GQVKICDFGISGYL  199 (282)
T ss_pred             EeHHHhhhh-HHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccC-CcEEEcccccceee
Confidence            999999754 44433       3488888999999999999999986 89999999999999999 89999999999887


Q ss_pred             cCCCcceeeccCccccccccccC---CcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhh
Q 015374          271 HPGKEYNVRVASRYFKGPELLVD---LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKD  336 (408)
Q Consensus       271 ~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~  336 (408)
                      .++-..+...|-..|||||.+..   ...|+.++||||||+++.||.+++.||.....+.+++..+.+.
T Consensus       200 ~dSiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVee  268 (282)
T KOG0984|consen  200 VDSIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVEE  268 (282)
T ss_pred             hhhhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhcC
Confidence            76655555677778999999854   2479999999999999999999999998888888998888775

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=6.4e-35  Score=281.44  Aligned_cols=256  Identities=25%  Similarity=0.439  Sum_probs=207.9

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecc---cchHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccEE
Q 015374          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP---VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSL  199 (408)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~---~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l  199 (408)
                      ..++|+++..+|.|+||.|||+++..+++.+|+|+++-   ...+-..+|+-+++.. +|+||+.++|.+..  ....++
T Consensus        13 P~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc-~h~nivay~gsylr--~dklwi   89 (829)
T KOG0576|consen   13 PQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDC-RHPNIVAYFGSYLR--RDKLWI   89 (829)
T ss_pred             CccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecC-CCcChHHHHhhhhh--hcCcEE
Confidence            47889999999999999999999999999999999873   3456678899999998 99999999998843  467889


Q ss_pred             EEEeecCCChhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCC-Cc
Q 015374          200 IFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG-KE  275 (408)
Q Consensus       200 v~e~~~~~~l~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~-~~  275 (408)
                      .||||.+|+|++.+   ..+++.++...+++.++||+|||++|-+|||||-.|||++++ |.+|++|||.+..+... ..
T Consensus        90 cMEycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~-gDvklaDfgvsaqitati~K  168 (829)
T KOG0576|consen   90 CMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDE-GDVKLADFGVSAQITATIAK  168 (829)
T ss_pred             EEEecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeeccc-CceeecccCchhhhhhhhhh
Confidence            99999999999987   468999999999999999999999999999999999999988 89999999998655322 22


Q ss_pred             ceeeccCcccccccccc--CCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCCCcc
Q 015374          276 YNVRVASRYFKGPELLV--DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWS  353 (408)
Q Consensus       276 ~~~~~~~~~y~aPE~~~--~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  353 (408)
                      ....+||++|||||+..  ..+.|...+|||++|+...|+-....|.|.-+.. ..+.-+-+..         +..    
T Consensus       169 rksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpm-r~l~LmTkS~---------~qp----  234 (829)
T KOG0576|consen  169 RKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPM-RALFLMTKSG---------FQP----  234 (829)
T ss_pred             hhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchH-HHHHHhhccC---------CCC----
Confidence            34579999999999973  2367999999999999999998888776544332 2222111110         000    


Q ss_pred             ccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccc
Q 015374          354 KFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQV  398 (408)
Q Consensus       354 ~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~~  398 (408)
                        ...+.....++.+-+|++.+|..+|.+|||++.+|+|||....
T Consensus       235 --p~lkDk~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~  277 (829)
T KOG0576|consen  235 --PTLKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT  277 (829)
T ss_pred             --CcccCCccchHHHHHHHHHHhcCCCccCCChhhheeceeeccc
Confidence              0111122357889999999999999999999999999997654

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-32  Score=248.43  Aligned_cols=245  Identities=17%  Similarity=0.294  Sum_probs=196.8

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCC-----CcEEEEEEeccc----chHHHHHHHHHHHHhcCCCCceEEeeEEEccC
Q 015374          123 DQDDYEVVRKVGRGKYSEVFEGINVNT-----NERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQH  193 (408)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~-----~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~  193 (408)
                      ..++++....+.+|.||.||.|.+...     .+.|.+|.++..    +...+..|.-.+..+ .|||+..+.+++.+. 
T Consensus       282 ~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~-sH~nll~V~~V~ie~-  359 (563)
T KOG1024|consen  282 QRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGA-SHPNLLSVLGVSIED-  359 (563)
T ss_pred             hhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcC-cCCCccceeEEEeec-
Confidence            457899999999999999999976543     335667777632    235678898899998 899999999998764 


Q ss_pred             CCccEEEEEeecCCChhhhcC-----------CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEE
Q 015374          194 SKTPSLIFEYVNSTDFKVLYP-----------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLI  262 (408)
Q Consensus       194 ~~~~~lv~e~~~~~~l~~~~~-----------~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~  262 (408)
                      ...++.++.+++-|+|..++.           .++..++..++.|++.|++|||+.+|||.||.++|.++|+. -.+||+
T Consensus       360 ~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~-LqVklt  438 (563)
T KOG1024|consen  360 YATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQ-LQVKLT  438 (563)
T ss_pred             cCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhh-eeEEec
Confidence            467788999999999999873           36777888899999999999999999999999999999988 689999


Q ss_pred             ecccceeccCCCcc---eeeccCccccccccccCCcCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHhhhc
Q 015374          263 DWGLAEFYHPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKDCC  338 (408)
Q Consensus       263 DfG~a~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-g~~pf~~~~~~~~~~~~~~~~~~  338 (408)
                      |-.+++...+.+..   .....+..||+||.+.+ ..|+.++|+|||||++|||+| |+.| +...|+.+....+.+.  
T Consensus       439 DsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n-~~yssasDvWsfGVllWELmtlg~~P-yaeIDPfEm~~ylkdG--  514 (563)
T KOG1024|consen  439 DSALSRDLFPGDYHCLGDNENRPVKWMSLEALQN-SHYSSASDVWSFGVLLWELMTLGKLP-YAEIDPFEMEHYLKDG--  514 (563)
T ss_pred             cchhccccCcccccccCCCCCCcccccCHHHHhh-hhhcchhhhHHHHHHHHHHHhcCCCC-ccccCHHHHHHHHhcc--
Confidence            99999877654321   12234556999999998 889999999999999999998 5555 4666666654443332  


Q ss_pred             hhhhhcCCCCCCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 015374          339 LIIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA  391 (408)
Q Consensus       339 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~  391 (408)
                                       .+...+-.+++++..++.-||..+|++||+.+|+..
T Consensus       515 -----------------yRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~  550 (563)
T KOG1024|consen  515 -----------------YRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVI  550 (563)
T ss_pred             -----------------ceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHH
Confidence                             122233448999999999999999999999999864

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.98  E-value=9.6e-33  Score=262.54  Aligned_cols=193  Identities=26%  Similarity=0.504  Sum_probs=170.6

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecccc-----------hHHHHHHHHHHHHhcC---CCCceEEeeEE
Q 015374          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK-----------KKKIKREIKILQNLCG---GPNVVKLLDIV  189 (408)
Q Consensus       124 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-----------~~~~~~E~~~l~~l~~---h~niv~l~~~~  189 (408)
                      -.+|+.+..+|.|+||.|+.|+++.+...|+||.+.++.           ....-.|++||..+ +   |+||++++++|
T Consensus       560 ~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l-~~~sH~NIlKlLdfF  638 (772)
T KOG1152|consen  560 FSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATL-NKHSHENILKLLDFF  638 (772)
T ss_pred             cccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHh-hhcCccchhhhhhee
Confidence            457999999999999999999999999999999986533           12355799999999 6   99999999999


Q ss_pred             EccCCCccEEEEEee-cCCChhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecc
Q 015374          190 RDQHSKTPSLIFEYV-NSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWG  265 (408)
Q Consensus       190 ~~~~~~~~~lv~e~~-~~~~l~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG  265 (408)
                      ++  ..+++|+||-- ++.+|.+++   +.+++.++..|++|++.|+++||++||||||||-+|+.++.+ |.+||+|||
T Consensus       639 Ed--dd~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~-g~~klidfg  715 (772)
T KOG1152|consen  639 ED--DDYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSN-GFVKLIDFG  715 (772)
T ss_pred             ec--CCeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccCceecccccccEEEecC-CeEEEeecc
Confidence            65  57888999976 556777776   569999999999999999999999999999999999999999 899999999


Q ss_pred             cceeccCCCcceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCC
Q 015374          266 LAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF  321 (408)
Q Consensus       266 ~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~  321 (408)
                      .|.... +......+||..|.|||++.+....+...|||++|++||.++....||+
T Consensus       716 saa~~k-sgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy  770 (772)
T KOG1152|consen  716 SAAYTK-SGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY  770 (772)
T ss_pred             chhhhc-CCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence            997655 4567788999999999999986667889999999999999999999985

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.97  E-value=1.3e-32  Score=240.06  Aligned_cols=256  Identities=18%  Similarity=0.303  Sum_probs=195.9

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecc--cchHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccEEEE
Q 015374          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP--VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIF  201 (408)
Q Consensus       124 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~--~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~  201 (408)
                      .+.|.+.+.||+|.||.+-++.++.+++.+++|.+..  ...++|.+|...--.|..|.||+.-|+.-- +....+++++
T Consensus        23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaF-qt~d~YvF~q  101 (378)
T KOG1345|consen   23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTTQADFVREFHYSFFLSPHQHIIDTYEVAF-QTSDAYVFVQ  101 (378)
T ss_pred             hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhhHHHHHHHhccceeeccchhhhHHHHHHh-hcCceEEEee
Confidence            5789999999999999999999999999999999863  456789999887667778999998877432 2345788999


Q ss_pred             EeecCCChhhhcC--CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEE-eCCCCcEEEEecccceeccCCCccee
Q 015374          202 EYVNSTDFKVLYP--TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMI-DHELRKLRLIDWGLAEFYHPGKEYNV  278 (408)
Q Consensus       202 e~~~~~~l~~~~~--~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl-~~~~~~~kl~DfG~a~~~~~~~~~~~  278 (408)
                      ||++.|+|..-..  .+.+...+.++.|++.|++|||++++||||||.+|||+ +.|+..+||||||+++..+  .....
T Consensus       102 E~aP~gdL~snv~~~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g--~tV~~  179 (378)
T KOG1345|consen  102 EFAPRGDLRSNVEAAGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVG--TTVKY  179 (378)
T ss_pred             ccCccchhhhhcCcccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecccccccC--ceehh
Confidence            9999999988774  58888899999999999999999999999999999997 5677799999999987543  22222


Q ss_pred             eccCccccccccccC----CcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCCCccc
Q 015374          279 RVASRYFKGPELLVD----LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSK  354 (408)
Q Consensus       279 ~~~~~~y~aPE~~~~----~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  354 (408)
                      .-.+..|.+||+...    .-...+.+|+|.||+++|.+++|..||.....+.....+..+-.+      ....      
T Consensus       180 ~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~------rk~~------  247 (378)
T KOG1345|consen  180 LEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLK------RKNP------  247 (378)
T ss_pred             hhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhc------ccCc------
Confidence            334556889998743    123567899999999999999999999643332222222222111      1101      


Q ss_pred             cccccCCCCCCHHHHHHHHHhcccCcCCC---CCHHHHhcCCCc
Q 015374          355 FINADNQHLVSPEAIDFLDKLLRYDHQDR---LTAREAMAHPYF  395 (408)
Q Consensus       355 ~~~~~~~~~~~~~~~~li~~~L~~dp~~R---pt~~elL~hp~f  395 (408)
                       ..+..-..+++.+..++++-|..++++|   .++.......|-
T Consensus       248 -~~P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~  290 (378)
T KOG1345|consen  248 -ALPKKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWK  290 (378)
T ss_pred             -cCchhhcccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHHH
Confidence             1112223368999999999999999999   666666666664

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.97  E-value=2.3e-30  Score=229.27  Aligned_cols=205  Identities=33%  Similarity=0.616  Sum_probs=180.3

Q ss_pred             eeeeCceEEEEEEEcCCCcEEEEEEecccch----HHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccEEEEEeecCCC
Q 015374          133 VGRGKYSEVFEGINVNTNERCIIKILKPVKK----KKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTD  208 (408)
Q Consensus       133 lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~~~~  208 (408)
                      ||.|++|.||++.+..+++.+++|++.....    +.+.+|+..++.+ +|++++++++++..  ....++++||+++++
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~--~~~~~~~~e~~~~~~   77 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKL-NHPNIVKLYGVFED--ENHLYLVMEYCEGGS   77 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhc-CCCCeeeEeeeeec--CCeEEEEEecCCCCc
Confidence            6899999999999888899999999986543    6899999999999 89999999999965  367789999999999


Q ss_pred             hhhhcC----CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeC-CCCcEEEEecccceeccCCC-cceeeccC
Q 015374          209 FKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDH-ELRKLRLIDWGLAEFYHPGK-EYNVRVAS  282 (408)
Q Consensus       209 l~~~~~----~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~-~~~~~kl~DfG~a~~~~~~~-~~~~~~~~  282 (408)
                      +..++.    .+++..+..++.+++.+|.+||+.|++|+||+|.||+++. + +.++|+|||.+....... ......+.
T Consensus        78 l~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~-~~~~l~d~~~~~~~~~~~~~~~~~~~~  156 (215)
T cd00180          78 LKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDN-GKVKLADFGLSKLLTSDKSLLKTIVGT  156 (215)
T ss_pred             HHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCC-CcEEEecCCceEEccCCcchhhcccCC
Confidence            998874    4788999999999999999999999999999999999998 5 789999999998665432 13345677


Q ss_pred             ccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCCCccccccccCCC
Q 015374          283 RYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSKFINADNQH  362 (408)
Q Consensus       283 ~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  362 (408)
                      ..|++||.+......+.+.|+|++|+++++|                                                 
T Consensus       157 ~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l-------------------------------------------------  187 (215)
T cd00180         157 PAYMAPEVLLGKGYYSEKSDIWSLGVILYEL-------------------------------------------------  187 (215)
T ss_pred             CCccChhHhcccCCCCchhhhHHHHHHHHHH-------------------------------------------------
Confidence            8899999987633788999999999999998                                                 


Q ss_pred             CCCHHHHHHHHHhcccCcCCCCCHHHHhcCC
Q 015374          363 LVSPEAIDFLDKLLRYDHQDRLTAREAMAHP  393 (408)
Q Consensus       363 ~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp  393 (408)
                         ..+.+++.+|++.||++|||++++++|+
T Consensus       188 ---~~~~~~l~~~l~~~p~~R~~~~~l~~~~  215 (215)
T cd00180         188 ---PELKDLIRKMLQKDPEKRPSAKEILEHL  215 (215)
T ss_pred             ---HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence               3588999999999999999999999885

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.97  E-value=2.4e-29  Score=226.02  Aligned_cols=204  Identities=31%  Similarity=0.586  Sum_probs=172.0

Q ss_pred             EEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc----chHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccEEEEE
Q 015374          127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFE  202 (408)
Q Consensus       127 y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e  202 (408)
                      |.+.+.||.|++|+||++....++..+++|.+...    ..+.+.+|+..+.++ +|+|++++++++..  ....++++|
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~-~~~~i~~~~~~~~~--~~~~~~v~e   77 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKL-KHPNIVKLYGVFED--PEPLYLVME   77 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhC-CCCChhhheeeeec--CCceEEEEe
Confidence            45678999999999999999888999999999754    456788999999999 99999999999854  367789999


Q ss_pred             eecCCChhhhcCC----CChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCCC--cc
Q 015374          203 YVNSTDFKVLYPT----LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK--EY  276 (408)
Q Consensus       203 ~~~~~~l~~~~~~----l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~~--~~  276 (408)
                      |+++++|..++..    +++..+..++.+++.++.+||+.+++|+||++.||+++.+ +.++|+|||.+.......  ..
T Consensus        78 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~-~~~~l~d~g~~~~~~~~~~~~~  156 (225)
T smart00221       78 YCEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMD-GLVKLADFGLARFIHRDLAALL  156 (225)
T ss_pred             ccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCC-CCEEEeeCceeeEecCcccccc
Confidence            9999999888732    7888899999999999999999999999999999999988 799999999998776443  33


Q ss_pred             eeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCH-HHHHHHH
Q 015374          277 NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNH-DQLVKIA  334 (408)
Q Consensus       277 ~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~-~~~~~~~  334 (408)
                      ....++..|++||.+.+...++.++|+|+||+++++|++|+.||....++. ...+.+.
T Consensus       157 ~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~~  215 (225)
T smart00221      157 KTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVWS  215 (225)
T ss_pred             cceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHHh
Confidence            445777889999998433678889999999999999999999994413433 4444433

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.96  E-value=1.8e-30  Score=275.05  Aligned_cols=197  Identities=12%  Similarity=0.150  Sum_probs=142.1

Q ss_pred             CC-CCceEEeeEEEcc-----CCCccEEEEEeecCCChhhhcC----CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCC
Q 015374          178 GG-PNVVKLLDIVRDQ-----HSKTPSLIFEYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKP  247 (408)
Q Consensus       178 ~h-~niv~l~~~~~~~-----~~~~~~lv~e~~~~~~l~~~~~----~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~  247 (408)
                      .| +||++++++|...     ....+++++||+. ++|..++.    .+++.++..++.||+.||+|||++||+||||||
T Consensus        30 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~-~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDlKP  108 (793)
T PLN00181         30 SHIDYVRSLLGSHKEGNLDGLDDDSIVRALECED-VSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNVRP  108 (793)
T ss_pred             hHHHHHHHhhcccCCccccccccchhhhhhccCC-ccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccCCc
Confidence            45 6888899987321     1245677888874 47877773    389999999999999999999999999999999


Q ss_pred             CcEEEeCC------------------CCcEEEEecccceeccCCC-----------------cceeeccCcccccccccc
Q 015374          248 HNVMIDHE------------------LRKLRLIDWGLAEFYHPGK-----------------EYNVRVASRYFKGPELLV  292 (408)
Q Consensus       248 ~NILl~~~------------------~~~~kl~DfG~a~~~~~~~-----------------~~~~~~~~~~y~aPE~~~  292 (408)
                      +||||+..                  .+.+|++|||+++......                 ......+|+.|+|||++.
T Consensus       109 ~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~  188 (793)
T PLN00181        109 SCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEEDN  188 (793)
T ss_pred             hhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhhc
Confidence            99999532                  2456777777765421100                 011235788899999998


Q ss_pred             CCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCCCccccccccCCCCCCHHHHHHH
Q 015374          293 DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSKFINADNQHLVSPEAIDFL  372 (408)
Q Consensus       293 ~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  372 (408)
                      + ..++.++|||||||++|||++|..|+...   ......+....         .         +.... ....+..+++
T Consensus       189 ~-~~~~~~sDVwSlGviL~ELl~~~~~~~~~---~~~~~~~~~~~---------~---------~~~~~-~~~~~~~~~~  245 (793)
T PLN00181        189 G-SSSNCASDVYRLGVLLFELFCPVSSREEK---SRTMSSLRHRV---------L---------PPQIL-LNWPKEASFC  245 (793)
T ss_pred             c-CCCCchhhhhhHHHHHHHHhhCCCchhhH---HHHHHHHHHhh---------c---------Chhhh-hcCHHHHHHH
Confidence            7 77999999999999999999988775211   11111111100         0         00000 0135577899


Q ss_pred             HHhcccCcCCCCCHHHHhcCCCcccc
Q 015374          373 DKLLRYDHQDRLTAREAMAHPYFAQV  398 (408)
Q Consensus       373 ~~~L~~dp~~Rpt~~elL~hp~f~~~  398 (408)
                      .+||+.||.+|||+.|+++||||...
T Consensus       246 ~~~L~~~P~~Rps~~eil~h~~~~~~  271 (793)
T PLN00181        246 LWLLHPEPSCRPSMSELLQSEFINEP  271 (793)
T ss_pred             HHhCCCChhhCcChHHHhhchhhhhh
Confidence            99999999999999999999999864

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.95  E-value=1.4e-27  Score=207.16  Aligned_cols=164  Identities=22%  Similarity=0.239  Sum_probs=123.8

Q ss_pred             CChhhhc----CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCCCcceeeccC
Q 015374          207 TDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVAS  282 (408)
Q Consensus       207 ~~l~~~~----~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~  282 (408)
                      |+|.+++    ..+++..+..++.|++.||.|||+++      ||+|||++.+ +.+++  ||++.......    ..|+
T Consensus         1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~-~~~~~--fG~~~~~~~~~----~~g~   67 (176)
T smart00750        1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWD-GLLKL--DGSVAFKTPEQ----SRVD   67 (176)
T ss_pred             CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCc-cceee--ccceEeecccc----CCCc
Confidence            4555554    24899999999999999999999998      9999999988 78888  99998764322    3688


Q ss_pred             ccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCCCccccccccCCC
Q 015374          283 RYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSKFINADNQH  362 (408)
Q Consensus       283 ~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  362 (408)
                      ..|+|||++.+ ..++.++|||||||++|||++|+.||.........+..+........     ....        ....
T Consensus        68 ~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-----~~~~--------~~~~  133 (176)
T smart00750       68 PYFMAPEVIQG-QSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADD-----PRDR--------SNLE  133 (176)
T ss_pred             ccccChHHhcC-CCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCC-----cccc--------ccHH
Confidence            99999999987 78999999999999999999999998543332333333322211000     0000        0011


Q ss_pred             CCCH--HHHHHHHHhcccCcCCCCCHHHHhcCCCccc
Q 015374          363 LVSP--EAIDFLDKLLRYDHQDRLTAREAMAHPYFAQ  397 (408)
Q Consensus       363 ~~~~--~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~  397 (408)
                      .++.  ++.+++.+||..||++|||+.|+++|+|+..
T Consensus       134 ~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~  170 (176)
T smart00750      134 SVSAARSFADFMRVCASRLPQRREAANHYLAHCRALF  170 (176)
T ss_pred             HHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHH
Confidence            1233  6999999999999999999999999999764

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.94  E-value=7e-26  Score=215.56  Aligned_cols=160  Identities=18%  Similarity=0.236  Sum_probs=126.0

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcC-CCcEEEEEEeccc--------chHHHHHHHHHHHHhcCCCCceEEeeEEEccC
Q 015374          123 DQDDYEVVRKVGRGKYSEVFEGINVN-TNERCIIKILKPV--------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQH  193 (408)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~Vy~~~~~~-~~~~vavK~~~~~--------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~  193 (408)
                      ..++|++.+.||+|+||+||+|++.. +++.+|||.+...        ....+.+|+.+++++ +|+|++..+..+    
T Consensus        16 ~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L-~h~~iv~~l~~~----   90 (365)
T PRK09188         16 LSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTV-RGIGVVPQLLAT----   90 (365)
T ss_pred             ccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhc-cCCCCCcEEEEc----
Confidence            36789999999999999999998776 6778899986422        245689999999999 899998533222    


Q ss_pred             CCccEEEEEeecCCChhhhcCCCChHHHHHHHHHHHHHHHHHHHCCcEEecC-CCCcEEEeCCCCcEEEEecccceeccC
Q 015374          194 SKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDV-KPHNVMIDHELRKLRLIDWGLAEFYHP  272 (408)
Q Consensus       194 ~~~~~lv~e~~~~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dl-k~~NILl~~~~~~~kl~DfG~a~~~~~  272 (408)
                       ...++||||+++++|... ....   ...++.|++.+|.|||++||+|||| ||+|||++.+ +.++|+|||+|+....
T Consensus        91 -~~~~LVmE~~~G~~L~~~-~~~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~-~~ikLiDFGlA~~~~~  164 (365)
T PRK09188         91 -GKDGLVRGWTEGVPLHLA-RPHG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPD-GEAAVIDFQLASVFRR  164 (365)
T ss_pred             -CCcEEEEEccCCCCHHHh-Cccc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCC-CCEEEEECccceeccc
Confidence             246899999999999743 2111   2467899999999999999999999 9999999877 7899999999987654


Q ss_pred             CCc---------ceeeccCccccccccccC
Q 015374          273 GKE---------YNVRVASRYFKGPELLVD  293 (408)
Q Consensus       273 ~~~---------~~~~~~~~~y~aPE~~~~  293 (408)
                      ...         .....++..|++||.+..
T Consensus       165 ~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~  194 (365)
T PRK09188        165 RGALYRIAAYEDLRHLLKHKRTYAPDALTP  194 (365)
T ss_pred             CcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence            331         123456677999999853

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.93  E-value=3.6e-27  Score=238.46  Aligned_cols=255  Identities=24%  Similarity=0.369  Sum_probs=189.4

Q ss_pred             EEEeeeeeeCceEEEEEEEcCCCcEEEEEEec----ccc-h----HHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccE
Q 015374          128 EVVRKVGRGKYSEVFEGINVNTNERCIIKILK----PVK-K----KKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS  198 (408)
Q Consensus       128 ~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~----~~~-~----~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  198 (408)
                      ...+.+|.|++|.|+........+..+.|.+.    +.. .    ..+..|..+-..+ .|+|++..+..+.+..  ...
T Consensus       321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l-~h~~~~e~l~~~~~~~--~~~  397 (601)
T KOG0590|consen  321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSL-SHPNIIETLDIVQEID--GIL  397 (601)
T ss_pred             CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccc-cCCchhhhHHHHhhcc--cch
Confidence            34568999999988888777666655555432    111 1    1244566666777 8999988777765432  222


Q ss_pred             EEEEeecCCChhhhcC---CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCCCc
Q 015374          199 LIFEYVNSTDFKVLYP---TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE  275 (408)
Q Consensus       199 lv~e~~~~~~l~~~~~---~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~~~  275 (408)
                      -.|||+++ +|..++.   .++..++..++.|++.|+.|||+.||.|||+|++|+++..+ +.+||+|||.+........
T Consensus       398 ~~mE~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~-g~lki~Dfg~~~vf~~~~e  475 (601)
T KOG0590|consen  398 QSMEYCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTEN-GILKIIDFGAASVFRYPWE  475 (601)
T ss_pred             hhhhcccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecC-CceEEeecCcceeeccCcc
Confidence            34999999 8777763   48899999999999999999999999999999999999998 7999999999876643322


Q ss_pred             -----ceeeccCccccccccccCCcCCC-ccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCC
Q 015374          276 -----YNVRVASRYFKGPELLVDLQDYD-YSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSR  349 (408)
Q Consensus       276 -----~~~~~~~~~y~aPE~~~~~~~~~-~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  349 (408)
                           ....+|+..|+|||++.+ ..|+ ...||||.|+++..|++|+.||-......+++....            ...
T Consensus       476 ~~~~~~~g~~gS~pY~apE~~~~-~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~------------~~~  542 (601)
T KOG0590|consen  476 KNIHESSGIVGSDPYLAPEVLTG-KEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNN------------YSD  542 (601)
T ss_pred             hhhhhhcCcccCCcCcCcccccc-cccCcchhhhhhccceEEEEecCCCccccccccccchhhhc------------ccc
Confidence                 344678899999999988 5555 579999999999999999999955443333321110            011


Q ss_pred             CCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccccc
Q 015374          350 KPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRA  400 (408)
Q Consensus       350 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~~~~  400 (408)
                      ..............++.+.+.+|.+||++||.+|.|++++++++||+.+..
T Consensus       543 ~~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i~~  593 (601)
T KOG0590|consen  543 QRNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRSIEC  593 (601)
T ss_pred             ccccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhChHhhhcce
Confidence            111111122233446788999999999999999999999999999998864

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.93  E-value=5.6e-24  Score=200.82  Aligned_cols=258  Identities=31%  Similarity=0.542  Sum_probs=198.0

Q ss_pred             EEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc------chHHHHHHHHHHHHhcCCC-CceEEeeEEEccCCCccEE
Q 015374          127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGP-NVVKLLDIVRDQHSKTPSL  199 (408)
Q Consensus       127 y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~-niv~l~~~~~~~~~~~~~l  199 (408)
                      |.+...||.|+||.||++.+.   ..+++|.+...      ....+.+|+.++..+ .|+ +++++++.+..  ....++
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~-~~~~~i~~~~~~~~~--~~~~~~   75 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASL-NHPPNIVKLYDFFQD--EGSLYL   75 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHc-cCCcceeeEEEEEec--CCEEEE
Confidence            678889999999999999876   78889988632      245688999999999 666 89999999944  344789


Q ss_pred             EEEeecCCChhhhcC------CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCC
Q 015374          200 IFEYVNSTDFKVLYP------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG  273 (408)
Q Consensus       200 v~e~~~~~~l~~~~~------~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~  273 (408)
                      +++++.++++..+..      .+.......++.|++.++.|+|+.+++|||+||+||+++.....++++|||.++.....
T Consensus        76 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~  155 (384)
T COG0515          76 VMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDP  155 (384)
T ss_pred             EEecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCC
Confidence            999999999986653      58888999999999999999999999999999999999988337999999999765543


Q ss_pred             C-------cceeeccCccccccccccCC--cCCCccccHHHHHHHHHHHHhCCCCCCCCCC--CHHHHHHHHhhhchhhh
Q 015374          274 K-------EYNVRVASRYFKGPELLVDL--QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHD--NHDQLVKIAKDCCLIIW  342 (408)
Q Consensus       274 ~-------~~~~~~~~~~y~aPE~~~~~--~~~~~~~DvwSlGvil~ell~g~~pf~~~~~--~~~~~~~~~~~~~~~~~  342 (408)
                      .       ......++..|++||.+.+.  ...+...|+||+|++++++++|..||.....  ................ 
T Consensus       156 ~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~-  234 (384)
T COG0515         156 GSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPS-  234 (384)
T ss_pred             CccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCcc-
Confidence            3       24567899999999999873  4788999999999999999999999643332  1233333322211110 


Q ss_pred             hcCCCCCCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccccc
Q 015374          343 CNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRA  400 (408)
Q Consensus       343 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~~~~  400 (408)
                           .....    ...........+.+++.+|+..+|..|.+..+...++|......
T Consensus       235 -----~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~~~~  283 (384)
T COG0515         235 -----LASPL----SPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLKL  283 (384)
T ss_pred             -----ccccc----CccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhhCccc
Confidence                 00000    00000112367999999999999999999999998877655443

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.92  E-value=9.1e-26  Score=218.68  Aligned_cols=236  Identities=26%  Similarity=0.399  Sum_probs=193.3

Q ss_pred             eeeeCceEEEEEEE---cCCCcEEEEEEecccc-----hHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccEEEEEee
Q 015374          133 VGRGKYSEVFEGIN---VNTNERCIIKILKPVK-----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYV  204 (408)
Q Consensus       133 lG~G~fg~Vy~~~~---~~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~  204 (408)
                      +|+|+||.|++++.   ...+..+|.|++++..     ......|..++..+.+||.++++.-.++.  ....++++++.
T Consensus         2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt--~~kl~l~ld~~   79 (612)
T KOG0603|consen    2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQT--DGKLYLILDFL   79 (612)
T ss_pred             CCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeecc--ccchhHhhhhc
Confidence            79999999987642   3456678888876322     22456688889998679999999999955  45667999999


Q ss_pred             cCCChhhhcC---CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCCCcceeecc
Q 015374          205 NSTDFKVLYP---TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVA  281 (408)
Q Consensus       205 ~~~~l~~~~~---~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~~~~~~~~~  281 (408)
                      .++++...+.   .+++.....+...++.+++++|+.+|+|||+|++||+++.+ |.+++.|||+++..-..+..   +|
T Consensus        80 rgg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~-Ghi~~tdfglske~v~~~~~---cg  155 (612)
T KOG0603|consen   80 RGGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLE-GHIKLTDFGLSKEAVKEKIA---CG  155 (612)
T ss_pred             ccchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeeccc-CccccCCchhhhHhHhhhhc---cc
Confidence            9999888774   37777888899999999999999999999999999999999 89999999999876544333   99


Q ss_pred             CccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCCCccccccccCC
Q 015374          282 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSKFINADNQ  361 (408)
Q Consensus       282 ~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  361 (408)
                      |..|||||++.+   .+..+|.||||++++||++|..||..     +....|...                    ....+
T Consensus       156 t~eymApEI~~g---h~~a~D~ws~gvl~felltg~~pf~~-----~~~~~Il~~--------------------~~~~p  207 (612)
T KOG0603|consen  156 TYEYRAPEIING---HLSAADWWSFGVLAFELLTGTLPFGG-----DTMKRILKA--------------------ELEMP  207 (612)
T ss_pred             chhhhhhHhhhc---cCCcccchhhhhhHHHHhhCCCCCch-----HHHHHHhhh--------------------ccCCc
Confidence            999999999973   57789999999999999999999954     444444432                    22334


Q ss_pred             CCCCHHHHHHHHHhcccCcCCCC-----CHHHHhcCCCccccccch
Q 015374          362 HLVSPEAIDFLDKLLRYDHQDRL-----TAREAMAHPYFAQVRAAE  402 (408)
Q Consensus       362 ~~~~~~~~~li~~~L~~dp~~Rp-----t~~elL~hp~f~~~~~~~  402 (408)
                      ..++..++++++.++..+|.+|.     .+.|+++|+||+.+.+.+
T Consensus       208 ~~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik~h~f~~~i~~~~  253 (612)
T KOG0603|consen  208 RELSAEARSLFRQLFKRNPENRLGAGPDGVDEIKQHEFFQSIDWNE  253 (612)
T ss_pred             hhhhHHHHHHHHHHHhhCHHHHhccCcchhHHHhccchheeeeHhh
Confidence            44788999999999999999998     457999999999999874

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.91  E-value=1.1e-22  Score=193.67  Aligned_cols=247  Identities=21%  Similarity=0.241  Sum_probs=181.5

Q ss_pred             CEEEEeeeeeeCceEEEEEEEcCCC-cEEEEEEecccch---HHHHHHHHHHHHhcC---CCCceEEeeEEEccCCCccE
Q 015374          126 DYEVVRKVGRGKYSEVFEGINVNTN-ERCIIKILKPVKK---KKIKREIKILQNLCG---GPNVVKLLDIVRDQHSKTPS  198 (408)
Q Consensus       126 ~y~~~~~lG~G~fg~Vy~~~~~~~~-~~vavK~~~~~~~---~~~~~E~~~l~~l~~---h~niv~l~~~~~~~~~~~~~  198 (408)
                      +|.+.++||+|+||.||.+.+..++ ..+|+|+-.....   ..+..|+.++..+..   -+++..+++... .....-+
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~-~~~~~~~   97 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGR-STEDFNF   97 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEecc-CCCceeE
Confidence            8999999999999999999987775 6788888754322   268889999999842   358888888874 2345678


Q ss_pred             EEEEeecCCChhhhc-----CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCC----CcEEEEecccce-
Q 015374          199 LIFEYVNSTDFKVLY-----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEL----RKLRLIDWGLAE-  268 (408)
Q Consensus       199 lv~e~~~~~~l~~~~-----~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~----~~~kl~DfG~a~-  268 (408)
                      +||+.+.... .++.     +.++...+..++.|++.+|++||+.|++||||||.|+++....    ..+.|.|||+++ 
T Consensus        98 iVM~l~G~sL-~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar~  176 (322)
T KOG1164|consen   98 IVMSLLGPSL-EDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLARR  176 (322)
T ss_pred             EEEeccCccH-HHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCCcc
Confidence            9998876544 3333     4689999999999999999999999999999999999998652    469999999998 


Q ss_pred             -eccCCC--------c-ceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhc
Q 015374          269 -FYHPGK--------E-YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCC  338 (408)
Q Consensus       269 -~~~~~~--------~-~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~  338 (408)
                       .+....        . .....||..|.++.+..+ ...+.+.|+||++.++.+++.|..||........ ..+......
T Consensus       177 ~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~-~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~-~~~~~~~~~  254 (322)
T KOG1164|consen  177 FKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLG-IEQGRRDDLESLFYMLLELLKGSLPWEALEMTDL-KSKFEKDPR  254 (322)
T ss_pred             ccccCCCCcccccCCCCccCCCCccccccHHHhCC-CccCCchhhhhHHHHHHHHhcCCCCCccccccch-HHHHHHHhh
Confidence             321111        1 123459999999999988 7889999999999999999999999844332222 222221110


Q ss_pred             hhhhhcCCCCCCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 015374          339 LIIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA  391 (408)
Q Consensus       339 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~  391 (408)
                      ....               .......+.++.++...+-..+..++|....+..
T Consensus       255 ~~~~---------------~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~  292 (322)
T KOG1164|consen  255 KLLT---------------DRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAE  292 (322)
T ss_pred             hhcc---------------ccccCCChHHHHHHHHHhhccCCcCCCCHHHHHH
Confidence            0000               0011224567788887777788888887665543

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.90  E-value=2.8e-23  Score=184.40  Aligned_cols=169  Identities=14%  Similarity=0.187  Sum_probs=131.4

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecccc---h---H------HHHHHHHHHHHhcCCCCceEEeeEEE
Q 015374          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK---K---K------KIKREIKILQNLCGGPNVVKLLDIVR  190 (408)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~---~---~------~~~~E~~~l~~l~~h~niv~l~~~~~  190 (408)
                      -.++|.+++.||.|+||.||...+  ++..+|+|++.+..   .   .      .+.+|+..+.++ .|++|..+.+++.
T Consensus        29 l~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL-~~~GI~~~~d~~~  105 (232)
T PRK10359         29 LSYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRV-RSEGLASLNDFYL  105 (232)
T ss_pred             hhCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHH-HHCCCCcceEeee
Confidence            378999999999999999999744  46689999996432   1   1      167999999999 9999999999876


Q ss_pred             ccC------CCccEEEEEeecCCChhhhcCCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEec
Q 015374          191 DQH------SKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDW  264 (408)
Q Consensus       191 ~~~------~~~~~lv~e~~~~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~Df  264 (408)
                      ...      ....+|+|||++|.+|..+. .+++    ....+++.+|..||+.|++|||+||+||+++++ + ++|+||
T Consensus       106 ~~~~~~~~~~~~~~lvmEyi~G~tL~~~~-~~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~-g-i~liDf  178 (232)
T PRK10359        106 LAERKTLRYAHTYIMLIEYIEGVELNDMP-EISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVSKN-G-LRIIDL  178 (232)
T ss_pred             ecccccccccCCeEEEEEEECCccHHHhh-hccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEeCC-C-EEEEEC
Confidence            432      23578999999999997763 2333    245699999999999999999999999999987 6 999999


Q ss_pred             ccceeccCCCcceeeccCccccccccccCCcCCCccccHHHHHHHHHHH
Q 015374          265 GLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGM  313 (408)
Q Consensus       265 G~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~el  313 (408)
                      |.............           ..+. ..++.++|+||||+++..+
T Consensus       179 g~~~~~~e~~a~d~-----------~vle-r~y~~~~di~~lg~~~~~~  215 (232)
T PRK10359        179 SGKRCTAQRKAKDR-----------IDLE-RHYGIKNEIKDLGYYLLIY  215 (232)
T ss_pred             CCcccccchhhHHH-----------HHHH-hHhcccccccceeEeehHH
Confidence            98865532221111           2222 4567899999999987654

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.89  E-value=8.1e-23  Score=176.18  Aligned_cols=197  Identities=22%  Similarity=0.367  Sum_probs=160.7

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecc-cchHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccEEEE
Q 015374          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP-VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIF  201 (408)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~-~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~  201 (408)
                      ..+.|.++++||.|+||.+|.|....+|+.||||+-+. ....++..|..++..|++...|..+..+..+  ..+-.|||
T Consensus        13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e--~~ynvlVM   90 (341)
T KOG1163|consen   13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKHPQLLYESKVYRILQGGVGIPHIRHYGTE--KDYNVLVM   90 (341)
T ss_pred             eccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCCcchhHHHHHHHHhccCCCCchhhhhccc--cccceeee
Confidence            46789999999999999999999999999999998653 3456788999999999767788888888743  46677999


Q ss_pred             EeecCCChhhhc----CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCC--CCcEEEEecccceeccCCCc
Q 015374          202 EYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE--LRKLRLIDWGLAEFYHPGKE  275 (408)
Q Consensus       202 e~~~~~~l~~~~----~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~--~~~~kl~DfG~a~~~~~~~~  275 (408)
                      |.+.- +|+++.    +.++...+..++-|++.-++|+|.+++|||||||+|+|..-+  ...+.++|||+|+.+.+...
T Consensus        91 dLLGP-sLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~t  169 (341)
T KOG1163|consen   91 DLLGP-SLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIRT  169 (341)
T ss_pred             eccCc-cHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhhhccccc
Confidence            98854 444443    679999999999999999999999999999999999997543  35789999999987754322


Q ss_pred             --------ceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCC
Q 015374          276 --------YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYG  323 (408)
Q Consensus       276 --------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~  323 (408)
                              .....||..|.+-....+ ..-+.+.|+-|+|.++....-|..||..-
T Consensus       170 ~~HIpyre~r~ltGTaRYASinAh~g-~eqSRRDDmeSvgYvLmYfnrG~LPWQgl  224 (341)
T KOG1163|consen  170 RQHIPYREDRNLTGTARYASINAHLG-IEQSRRDDMESVGYVLMYFNRGSLPWQGL  224 (341)
T ss_pred             cccCccccCCccceeeeehhhhhhhh-hhhhhhhhhhhhcceeeeeecCCCccccc
Confidence                    122357777877766665 45677899999999999999999998543

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.89  E-value=1.1e-22  Score=178.32  Aligned_cols=132  Identities=17%  Similarity=0.262  Sum_probs=104.5

Q ss_pred             eeeeeeCceEEEEEEEcCCCcEEEEEEecccch------------HH-----------------HHHHHHHHHHhcCCCC
Q 015374          131 RKVGRGKYSEVFEGINVNTNERCIIKILKPVKK------------KK-----------------IKREIKILQNLCGGPN  181 (408)
Q Consensus       131 ~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~------------~~-----------------~~~E~~~l~~l~~h~n  181 (408)
                      ..||+|+||.||+|.+. +|+.||||++++...            ..                 ..+|+.++.++ .+++
T Consensus         3 ~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~   80 (190)
T cd05147           3 GCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRL-VTAG   80 (190)
T ss_pred             CccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHH-HHCC
Confidence            57999999999999876 899999999974321            12                 23499999999 7777


Q ss_pred             ceEEeeEEEccCCCccEEEEEeecCCChhhh-c--CCCChHHHHHHHHHHHHHHHHH-HHCCcEEecCCCCcEEEeCCCC
Q 015374          182 VVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL-Y--PTLTDYDIRYYIYELLKALDYC-HSQGIMHRDVKPHNVMIDHELR  257 (408)
Q Consensus       182 iv~l~~~~~~~~~~~~~lv~e~~~~~~l~~~-~--~~l~~~~~~~i~~qi~~~L~~L-H~~~iiH~Dlk~~NILl~~~~~  257 (408)
                      +.....+...    ..++||||++++++... +  ..++...+..++.|++.+|.|| |+.||+||||||+|||++.  +
T Consensus        81 v~~p~~~~~~----~~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~~--~  154 (190)
T cd05147          81 IPCPEPILLK----SHVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYHD--G  154 (190)
T ss_pred             CCCCcEEEec----CCEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEEC--C
Confidence            6443332211    22799999999876543 2  4588889999999999999999 7999999999999999994  5


Q ss_pred             cEEEEecccceec
Q 015374          258 KLRLIDWGLAEFY  270 (408)
Q Consensus       258 ~~kl~DfG~a~~~  270 (408)
                      .++|+|||+|...
T Consensus       155 ~v~LiDFG~a~~~  167 (190)
T cd05147         155 KLYIIDVSQSVEH  167 (190)
T ss_pred             cEEEEEccccccC
Confidence            7999999999754

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.89  E-value=5.3e-23  Score=188.89  Aligned_cols=192  Identities=20%  Similarity=0.299  Sum_probs=139.0

Q ss_pred             cCCCCceEEeeEEEcc-------------------------CCCccEEEEEeecCCChhhhc-CCCChHHHHHHHHHHHH
Q 015374          177 CGGPNVVKLLDIVRDQ-------------------------HSKTPSLIFEYVNSTDFKVLY-PTLTDYDIRYYIYELLK  230 (408)
Q Consensus       177 ~~h~niv~l~~~~~~~-------------------------~~~~~~lv~e~~~~~~l~~~~-~~l~~~~~~~i~~qi~~  230 (408)
                      ..|||||++++.|.+.                         ++..+++||..........+. +..+....+.++.|+++
T Consensus       273 a~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~tLr~yl~~~~~s~r~~~~~laQlLE  352 (598)
T KOG4158|consen  273 AKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQTLREYLWTRHRSYRTGRVILAQLLE  352 (598)
T ss_pred             CCCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchhhHHHHHhcCCCchHHHHHHHHHHHH
Confidence            4799999999988652                         345678888877765444433 45777788889999999


Q ss_pred             HHHHHHHCCcEEecCCCCcEEEeCC---CCcEEEEecccceeccC-------CCcceeeccCccccccccccCCcC----
Q 015374          231 ALDYCHSQGIMHRDVKPHNVMIDHE---LRKLRLIDWGLAEFYHP-------GKEYNVRVASRYFKGPELLVDLQD----  296 (408)
Q Consensus       231 ~L~~LH~~~iiH~Dlk~~NILl~~~---~~~~kl~DfG~a~~~~~-------~~~~~~~~~~~~y~aPE~~~~~~~----  296 (408)
                      |+.|||++||.|||+|++|||+.-+   --.+.|+|||.+-..+.       ........|....||||+......    
T Consensus       353 av~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~av  432 (598)
T KOG4158|consen  353 AVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNAV  432 (598)
T ss_pred             HHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCCCcee
Confidence            9999999999999999999998432   23689999998743221       112233456677999999854211    


Q ss_pred             C-CccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCCCccccccccCCCCCCHHHHHHHHHh
Q 015374          297 Y-DYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKL  375 (408)
Q Consensus       297 ~-~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  375 (408)
                      . -.+.|.|+.|.+.||+++...|||.....   .                ...+.+.+..-+..++.+++.+++++..+
T Consensus       433 vny~kAD~WA~GalaYEIfg~~NPFY~rGem---~----------------L~~r~Yqe~qLPalp~~vpp~~rqlV~~l  493 (598)
T KOG4158|consen  433 VNYEKADTWAAGALAYEIFGRSNPFYKRGEM---L----------------LDTRTYQESQLPALPSRVPPVARQLVFDL  493 (598)
T ss_pred             eccchhhhhhhhhhHHHHhccCCcccccchh---e----------------echhhhhhhhCCCCcccCChHHHHHHHHH
Confidence            1 13899999999999999999999751110   0                01111233333455667899999999999


Q ss_pred             cccCcCCCCCHH
Q 015374          376 LRYDHQDRLTAR  387 (408)
Q Consensus       376 L~~dp~~Rpt~~  387 (408)
                      |+.||++|+++.
T Consensus       494 L~r~pskRvsp~  505 (598)
T KOG4158|consen  494 LKRDPSKRVSPN  505 (598)
T ss_pred             hcCCccccCCcc
Confidence            999999999754

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.89  E-value=3.8e-22  Score=173.50  Aligned_cols=181  Identities=17%  Similarity=0.145  Sum_probs=138.3

Q ss_pred             EEeeeeeeCceEEEEEEEcCCCcEEEEEEecccch-------HHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccEEEE
Q 015374          129 VVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKK-------KKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIF  201 (408)
Q Consensus       129 ~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~-------~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~  201 (408)
                      +...|++|+||+||.+..  .+..++.+.++....       ..+.+|+++|++|.+|+++++++++.      ..+++|
T Consensus         6 ~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~~------~~~lvm   77 (218)
T PRK12274          6 VNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHWD------GRHLDR   77 (218)
T ss_pred             cceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEEc------CEEEEE
Confidence            356899999999998743  677888777763322       25789999999996678899999862      247999


Q ss_pred             EeecCCChhhhcCCCChHHHHHHHHHHHHHHHHHHHCCcEEecC-CCCcEEEeCCCCcEEEEecccceeccCCCc-----
Q 015374          202 EYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDV-KPHNVMIDHELRKLRLIDWGLAEFYHPGKE-----  275 (408)
Q Consensus       202 e~~~~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dl-k~~NILl~~~~~~~kl~DfG~a~~~~~~~~-----  275 (408)
                      ||+.|.+|......    ....++.|++.+|.++|++||+|||| ||+|||++.+ +.++|+|||+|........     
T Consensus        78 eyI~G~~L~~~~~~----~~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~-g~i~LIDFG~A~~~~~~~~~~r~L  152 (218)
T PRK12274         78 SYLAGAAMYQRPPR----GDLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQED-GSPAVIDFQLAVRGNPRARWMRLL  152 (218)
T ss_pred             eeecCccHHhhhhh----hhHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCC-CCEEEEECCCceecCCcchHHHHH
Confidence            99999998755422    12357889999999999999999999 7999999987 7899999999986554331     


Q ss_pred             ---------ceeeccCccccccccccCCcCCC-ccccHHHHHHHHHHHHhCCCCCCC
Q 015374          276 ---------YNVRVASRYFKGPELLVDLQDYD-YSLDMWSLGCMFAGMIFRKEPFFY  322 (408)
Q Consensus       276 ---------~~~~~~~~~y~aPE~~~~~~~~~-~~~DvwSlGvil~ell~g~~pf~~  322 (408)
                               ......++.+++|+...-....+ ...+.++-|+-+|.++|++.+.+.
T Consensus       153 ~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~  209 (218)
T PRK12274        153 AREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWE  209 (218)
T ss_pred             HHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccc
Confidence                     01123566677777654322333 567888999999999999988753

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.88  E-value=6.7e-23  Score=208.13  Aligned_cols=226  Identities=28%  Similarity=0.486  Sum_probs=167.0

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecccchHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccEEEEE
Q 015374          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFE  202 (408)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e  202 (408)
                      ..++|+.++.|-.|+||.||..+++.+.+.+|+|+-++   .-+.+-  |+... ..|.+|                   
T Consensus        81 ~e~df~~IklisngAygavylvrh~~trqrfa~kiNkq---~lilRn--ilt~a-~npfvv-------------------  135 (1205)
T KOG0606|consen   81 SESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQ---NLILRN--ILTFA-GNPFVV-------------------  135 (1205)
T ss_pred             CccccceeEeeccCCCCceeeeeccccccchhhccccc---chhhhc--ccccc-CCccee-------------------
Confidence            36789999999999999999999999999999965321   111110  11111 222222                   


Q ss_pred             eecCCChhhhcC---CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCCCc----
Q 015374          203 YVNSTDFKVLYP---TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE----  275 (408)
Q Consensus       203 ~~~~~~l~~~~~---~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~~~----  275 (408)
                          |+....++   .++...        +.+++|||+.||+|||+||+|.+|+.- |.+|++|||+++..-....    
T Consensus       136 ----gDc~tllk~~g~lPvdm--------vla~Eylh~ygivhrdlkpdnllIT~m-GhiKlTDfgLsk~GLms~atnl~  202 (1205)
T KOG0606|consen  136 ----GDCATLLKNIGPLPVDM--------VLAVEYLHSYGIVHRDLKPDNLLITSM-GHIKLTDFGLSKKGLMSLATNLK  202 (1205)
T ss_pred             ----chhhhhcccCCCCcchh--------hHHhHhhccCCeecCCCCCCcceeeec-ccccccchhhhhhhhhhccchhh
Confidence                33333333   333322        679999999999999999999999987 8999999999865422111    


Q ss_pred             ------------ceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhh
Q 015374          276 ------------YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWC  343 (408)
Q Consensus       276 ------------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  343 (408)
                                  ....+||+.|+|||++.. +.|...+|.|++|+++||.+.|+.||| ++...+.+...+....     
T Consensus       203 eg~I~k~t~Ef~dKqvcgTPeyiaPeVilr-qgygkpvdwwamGiIlyeFLVgcvpff-Gdtpeelfg~visd~i-----  275 (1205)
T KOG0606|consen  203 EGHIEKDTHEFQDKQVCGTPEYIAPEVILR-QGYGKPVDWWAMGIILYEFLVGCVPFF-GDTPEELFGQVISDDI-----  275 (1205)
T ss_pred             hcchHHHHHHhhhccccCCccccChhhhhh-hccCCCccHHHHHHHHHHHheeeeecc-CCCHHHHHhhhhhhhc-----
Confidence                        122489999999999987 889999999999999999999999984 5555666655554321     


Q ss_pred             cCCCCCCCccccccccCCCCCCHHHHHHHHHhcccCcCCCC---CHHHHhcCCCccccccchhhh
Q 015374          344 NSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRL---TAREAMAHPYFAQVRAAESSR  405 (408)
Q Consensus       344 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rp---t~~elL~hp~f~~~~~~~~~~  405 (408)
                             .|.     +....+++++++++.++|+.+|..|.   .+-++.+|+||+..++....|
T Consensus       276 -------~wp-----E~dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~LDw~~llR  328 (1205)
T KOG0606|consen  276 -------EWP-----EEDEALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQLLDWKSLLR  328 (1205)
T ss_pred             -------ccc-----ccCcCCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceeecccchhhh
Confidence                   111     12334679999999999999999997   577899999999998875433

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.87  E-value=1.2e-21  Score=172.16  Aligned_cols=134  Identities=17%  Similarity=0.202  Sum_probs=106.7

Q ss_pred             EeeeeeeCceEEEEEEEcCCCcEEEEEEecccc-----------------------------hHHHHHHHHHHHHhcCCC
Q 015374          130 VRKVGRGKYSEVFEGINVNTNERCIIKILKPVK-----------------------------KKKIKREIKILQNLCGGP  180 (408)
Q Consensus       130 ~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-----------------------------~~~~~~E~~~l~~l~~h~  180 (408)
                      .+.||+|+||+||+|++. +|+.||||++++..                             ...+..|...+.++ .|+
T Consensus         2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~   79 (190)
T cd05145           2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRL-YEA   79 (190)
T ss_pred             CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHH-HhC
Confidence            357999999999999876 89999999987431                             11235789999999 888


Q ss_pred             CceEEeeEEEccCCCccEEEEEeecCCChhhh-c--CCCChHHHHHHHHHHHHHHHHHHH-CCcEEecCCCCcEEEeCCC
Q 015374          181 NVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL-Y--PTLTDYDIRYYIYELLKALDYCHS-QGIMHRDVKPHNVMIDHEL  256 (408)
Q Consensus       181 niv~l~~~~~~~~~~~~~lv~e~~~~~~l~~~-~--~~l~~~~~~~i~~qi~~~L~~LH~-~~iiH~Dlk~~NILl~~~~  256 (408)
                      ++.....+...    ..+|||||++++++... +  ..++......++.|++.+|.+||+ .||+||||||+|||++ + 
T Consensus        80 ~i~~p~~~~~~----~~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~-  153 (190)
T cd05145          80 GVPVPEPILLK----KNVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-D-  153 (190)
T ss_pred             CCCCceEEEec----CCEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-C-
Confidence            87544444322    23799999998854322 2  346778889999999999999999 9999999999999999 5 


Q ss_pred             CcEEEEecccceecc
Q 015374          257 RKLRLIDWGLAEFYH  271 (408)
Q Consensus       257 ~~~kl~DfG~a~~~~  271 (408)
                      +.++|+|||++....
T Consensus       154 ~~~~liDFG~a~~~~  168 (190)
T cd05145         154 GKPYIIDVSQAVELD  168 (190)
T ss_pred             CCEEEEEcccceecC
Confidence            789999999997654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.87  E-value=1.1e-21  Score=176.56  Aligned_cols=195  Identities=19%  Similarity=0.362  Sum_probs=165.3

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEec-ccchHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccEEEEE
Q 015374          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK-PVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFE  202 (408)
Q Consensus       124 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~-~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e  202 (408)
                      .-.|.+.++||+|+||..+.|++.-+++.||||.-. ++...++..|...++.|.+.++|...+-+-  +.+.+-.||+|
T Consensus        27 G~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~APQLrdEYr~YKlL~g~~GIP~vYYFG--qeG~~NiLVid  104 (449)
T KOG1165|consen   27 GPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSEAPQLRDEYRTYKLLGGTEGIPQVYYFG--QEGKYNILVID  104 (449)
T ss_pred             cccceeccccccCcceeeecccccccCceEEEEeccccCCcchHHHHHHHHHHHcCCCCCCceeeec--cccchhhhhhh
Confidence            457999999999999999999999999999999864 355678999999999998889999988776  44667779999


Q ss_pred             eecCCChhhhc----CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeC----CCCcEEEEecccceeccCCC
Q 015374          203 YVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDH----ELRKLRLIDWGLAEFYHPGK  274 (408)
Q Consensus       203 ~~~~~~l~~~~----~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~----~~~~~kl~DfG~a~~~~~~~  274 (408)
                      .+.- +|+++.    +.|+...+..++.|++.-++|+|++..|.|||||+|+||..    +.+.+.|+|||+|+.+.+..
T Consensus       105 LLGP-SLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp~  183 (449)
T KOG1165|consen  105 LLGP-SLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDPK  183 (449)
T ss_pred             hhCc-CHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhhhcCcc
Confidence            8854 344433    67999999999999999999999999999999999999963    23478999999999876543


Q ss_pred             c--------ceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCC
Q 015374          275 E--------YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFY  322 (408)
Q Consensus       275 ~--------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~  322 (408)
                      .        .....||..||+-...++ ..-+.+.|+-|+|=+++..|-|..||..
T Consensus       184 TkqHIPYrE~KSLsGTARYMSINTHlG-rEQSRRDDLEaLGHvFmYFLRGsLPWQG  238 (449)
T KOG1165|consen  184 TKQHIPYREHKSLSGTARYMSINTHLG-REQSRRDDLEALGHVFMYFLRGSLPWQG  238 (449)
T ss_pred             ccccCccccccccccceeeeEeecccc-chhhhhhhHHHhhhhhhhhccCCCcccc
Confidence            2        233568999999888888 6778899999999999999999999954

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.87  E-value=1e-21  Score=179.56  Aligned_cols=229  Identities=21%  Similarity=0.300  Sum_probs=141.4

Q ss_pred             CEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecc------cchHHHHHHHHHHHHhcC---------CCCceEEeeEEE
Q 015374          126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP------VKKKKIKREIKILQNLCG---------GPNVVKLLDIVR  190 (408)
Q Consensus       126 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~------~~~~~~~~E~~~l~~l~~---------h~niv~l~~~~~  190 (408)
                      .+...+.||.|+++.||.+++..+++.+|+|++--      ...+++.+|.-....+.+         |-.++-.++...
T Consensus        13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~   92 (288)
T PF14531_consen   13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR   92 (288)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred             EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence            45667789999999999999999999999999741      223556666544444311         223333333332


Q ss_pred             ccC----------CC-----ccEEEEEeecCCChhhhcC------CC----ChHHHHHHHHHHHHHHHHHHHCCcEEecC
Q 015374          191 DQH----------SK-----TPSLIFEYVNSTDFKVLYP------TL----TDYDIRYYIYELLKALDYCHSQGIMHRDV  245 (408)
Q Consensus       191 ~~~----------~~-----~~~lv~e~~~~~~l~~~~~------~l----~~~~~~~i~~qi~~~L~~LH~~~iiH~Dl  245 (408)
                      ..+          ..     ..+++|+-+. ++|..+..      ..    .......+..|+++.+++||+.|++|+||
T Consensus        93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~-~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi  171 (288)
T PF14531_consen   93 IPGKPPFFERGPGQSIYWVLNRFLLMPRAQ-GDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDI  171 (288)
T ss_dssp             ETTS-SEEEECETTEEEEEESEEEEEE--S-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-
T ss_pred             EcCCCcceecCCCCccceeehhhhccchhh-hcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEeccc
Confidence            111          11     2355666664 45555432      11    12223445689999999999999999999


Q ss_pred             CCCcEEEeCCCCcEEEEecccceeccCCCcceeeccCccccccccccCC-------cCCCccccHHHHHHHHHHHHhCCC
Q 015374          246 KPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDL-------QDYDYSLDMWSLGCMFAGMIFRKE  318 (408)
Q Consensus       246 k~~NILl~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~y~aPE~~~~~-------~~~~~~~DvwSlGvil~ell~g~~  318 (408)
                      +|+|++++.+ |.+.|+||+.......  .......+..|.+||.....       ..++.+.|.|++|+++|.|.+++.
T Consensus       172 ~~~nfll~~~-G~v~Lg~F~~~~r~g~--~~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~l  248 (288)
T PF14531_consen  172 KPENFLLDQD-GGVFLGDFSSLVRAGT--RYRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRL  248 (288)
T ss_dssp             SGGGEEE-TT-S-EEE--GGGEEETTE--EEEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-
T ss_pred             ceeeEEEcCC-CCEEEcChHHHeecCc--eeeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccC
Confidence            9999999999 8999999988765432  22224455778999976431       357889999999999999999999


Q ss_pred             CCCCCCCCHHHHHHHHhhhchhhhhcCCCCCCCccccccccCCCCCCHHHHHHHHHhcccCcCCC
Q 015374          319 PFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDR  383 (408)
Q Consensus       319 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R  383 (408)
                      ||.........                     .+  .+....  .+++..+++|+.+|+.||++|
T Consensus       249 Pf~~~~~~~~~---------------------~~--~f~~C~--~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  249 PFGLSSPEADP---------------------EW--DFSRCR--DMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             STCCCGGGSTS---------------------GG--GGTTSS-----HHHHHHHHHHT-SSGGGS
T ss_pred             CCCCCCccccc---------------------cc--cchhcC--CcCHHHHHHHHHHccCCcccC
Confidence            98322110000                     00  011111  578999999999999999988

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.87  E-value=1.2e-22  Score=177.97  Aligned_cols=237  Identities=17%  Similarity=0.219  Sum_probs=177.8

Q ss_pred             CCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc-----chHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccEE
Q 015374          125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSL  199 (408)
Q Consensus       125 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l  199 (408)
                      .+..++.+|.....|+.|+|++.  |..+++|+++..     ....|..|.-.|+-+ .||||..+++.|..  ...+.+
T Consensus       190 ~~lnl~tkl~e~hsgelwrgrwq--gndivakil~vr~~t~risrdfneefp~lrif-shpnilpvlgacns--ppnlv~  264 (448)
T KOG0195|consen  190 SSLNLITKLAESHSGELWRGRWQ--GNDIVAKILNVREVTARISRDFNEEFPALRIF-SHPNILPVLGACNS--PPNLVI  264 (448)
T ss_pred             hhhhhhhhhccCCCccccccccc--CcchhhhhhhhhhcchhhcchhhhhCcceeee-cCCchhhhhhhccC--CCCceE
Confidence            44566778999999999999874  445667777532     246788999999888 99999999999954  567889


Q ss_pred             EEEeecCCChhhhcCC-----CChHHHHHHHHHHHHHHHHHHHCC--cEEecCCCCcEEEeCCCCcEEEEecccceeccC
Q 015374          200 IFEYVNSTDFKVLYPT-----LTDYDIRYYIYELLKALDYCHSQG--IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP  272 (408)
Q Consensus       200 v~e~~~~~~l~~~~~~-----l~~~~~~~i~~qi~~~L~~LH~~~--iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~  272 (408)
                      +..||+.|+|...+..     .+..++.+++.+++.|+.|||+..  |----|.+..+++|++ -+.+|+ .+-+++.  
T Consensus       265 isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmided-ltaris-mad~kfs--  340 (448)
T KOG0195|consen  265 ISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDED-LTARIS-MADTKFS--  340 (448)
T ss_pred             eeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecch-hhhhee-cccceee--
Confidence            9999999999998854     566788999999999999999863  5555788999999988 455553 1112211  


Q ss_pred             CCcceeeccCccccccccccCCcCC--CccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCC
Q 015374          273 GKEYNVRVASRYFKGPELLVDLQDY--DYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRK  350 (408)
Q Consensus       273 ~~~~~~~~~~~~y~aPE~~~~~~~~--~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  350 (408)
                       .........+.||+||.+......  -.++|+|||++++|||.|+..|| .+..+.+--.++.-               
T Consensus       341 -fqe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpf-adlspmecgmkial---------------  403 (448)
T KOG0195|consen  341 -FQEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPF-ADLSPMECGMKIAL---------------  403 (448)
T ss_pred             -eeccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhcccccc-ccCCchhhhhhhhh---------------
Confidence             122345667889999999763222  24799999999999999999998 34444333222221               


Q ss_pred             CccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHh
Q 015374          351 PWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAM  390 (408)
Q Consensus       351 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL  390 (408)
                         +-.+...+..++..+..++.-|+..||.+||..+.++
T Consensus       404 ---eglrv~ippgis~hm~klm~icmnedpgkrpkfdmiv  440 (448)
T KOG0195|consen  404 ---EGLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIV  440 (448)
T ss_pred             ---ccccccCCCCccHHHHHHHHHHhcCCCCcCCCcceeh
Confidence               1134556667899999999999999999999877653

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.86  E-value=1.8e-22  Score=205.28  Aligned_cols=243  Identities=19%  Similarity=0.374  Sum_probs=166.8

Q ss_pred             CEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecccc----hHHHHHHHHHHH-HhcCCCCceEEeeEEEccCCCccEEE
Q 015374          126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK----KKKIKREIKILQ-NLCGGPNVVKLLDIVRDQHSKTPSLI  200 (408)
Q Consensus       126 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~E~~~l~-~l~~h~niv~l~~~~~~~~~~~~~lv  200 (408)
                      +|...+-||.+.|=+|.+|++.++  .|+||++-+..    .+.+.++++-++ .+.++||++.+.-+...  .+..+||
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~eG--~vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t--~kAAylv   99 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDREG--LVVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVT--DKAAYLV   99 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCCc--eEEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHh--hHHHHHH
Confidence            677788999999999999976543  38899984322    244444333222 23489999988877533  4666788


Q ss_pred             EEeecCCChhhhc--CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceec--cCCC--
Q 015374          201 FEYVNSTDFKVLY--PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY--HPGK--  274 (408)
Q Consensus       201 ~e~~~~~~l~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~--~~~~--  274 (408)
                      -+|..+...+..-  +-+...+.+.|+.|++.||.-+|..||+|||||.+|||++.- +-+.|+||..-+..  ..+.  
T Consensus       100 RqyvkhnLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSW-NW~~LtDFAsFKPtYLPeDNPa  178 (1431)
T KOG1240|consen  100 RQYVKHNLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSW-NWLYLTDFASFKPTYLPEDNPA  178 (1431)
T ss_pred             HHHHhhhhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeee-chhhhhcccccCCccCCCCCcc
Confidence            8888765544332  336777889999999999999999999999999999999998 67899999865432  1111  


Q ss_pred             cce----eeccCccccccccccCCc----------CCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchh
Q 015374          275 EYN----VRVASRYFKGPELLVDLQ----------DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLI  340 (408)
Q Consensus       275 ~~~----~~~~~~~y~aPE~~~~~~----------~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~  340 (408)
                      .+.    +...-.+|.|||.+....          ..+++.||||+||+++||++-+.|.|.    ..++-+......  
T Consensus       179 df~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~----LSQL~aYr~~~~--  252 (1431)
T KOG1240|consen  179 DFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFT----LSQLLAYRSGNA--  252 (1431)
T ss_pred             cceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCccc----HHHHHhHhccCc--
Confidence            222    233445799999986521          156789999999999999886444431    222211111000  


Q ss_pred             hhhcCCCCCCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 015374          341 IWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH  392 (408)
Q Consensus       341 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~h  392 (408)
                            ..   ....++.    --+..++.++..|++.||++|.+|++.|+-
T Consensus       253 ------~~---~e~~Le~----Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~  291 (1431)
T KOG1240|consen  253 ------DD---PEQLLEK----IEDVSLRNLILSMIQRDPSKRLSAEDYLQK  291 (1431)
T ss_pred             ------cC---HHHHHHh----CcCccHHHHHHHHHccCchhccCHHHHHHh
Confidence                  00   0000000    013468999999999999999999999975

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.86  E-value=5.7e-21  Score=197.53  Aligned_cols=193  Identities=20%  Similarity=0.403  Sum_probs=156.9

Q ss_pred             cCCCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecccchHHHHHHHHHHHHhcC---CCCceEEeeEEEccCCCcc
Q 015374          121 WGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCG---GPNVVKLLDIVRDQHSKTP  197 (408)
Q Consensus       121 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~---h~niv~l~~~~~~~~~~~~  197 (408)
                      ......|.+.+.||+|+||+||+|...+ ++.||+|+-++....+|.-=.+++.+| +   -+-|..+...+.-.+  .-
T Consensus       694 ~~~~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WEfYI~~q~~~RL-k~~~~~~~~~~~~a~~~~~--~S  769 (974)
T KOG1166|consen  694 EVGGEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWEFYICLQVMERL-KPQMLPSIMHISSAHVFQN--AS  769 (974)
T ss_pred             eecceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCceeeeehHHHHHhh-chhhhcchHHHHHHHccCC--cc
Confidence            3457789999999999999999998766 999999999887776665555556666 3   123344444333333  34


Q ss_pred             EEEEEeecCCChhhhcC---CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeC------CCCcEEEEecccce
Q 015374          198 SLIFEYVNSTDFKVLYP---TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDH------ELRKLRLIDWGLAE  268 (408)
Q Consensus       198 ~lv~e~~~~~~l~~~~~---~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~------~~~~~kl~DfG~a~  268 (408)
                      +||+||.+.|+|.+++.   .+++..+..++.|++.-+++||..+|||+||||+|.||..      +.-.++|+|||.+-
T Consensus       770 ~lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~si  849 (974)
T KOG1166|consen  770 VLVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSI  849 (974)
T ss_pred             eeeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEecccce
Confidence            59999999999999884   4888889999999999999999999999999999999942      23468999999984


Q ss_pred             e---ccCCCcceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCC
Q 015374          269 F---YHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKE  318 (408)
Q Consensus       269 ~---~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~  318 (408)
                      .   +.++......++|..+-.+|...| ..|++.+|.|.++.+++-||.|+.
T Consensus       850 Dm~lfp~~~~F~~~~~td~f~C~EM~~g-rpWtYq~DyfGlAa~~h~mLFG~y  901 (974)
T KOG1166|consen  850 DMKLFPDGTKFKAVWHTDLFDCIEMREG-RPWTYQIDYFGLAATVHVMLFGKY  901 (974)
T ss_pred             eeeEcCCCcEEeeeeccccchhHHHhcC-CCCchhhhhHHHHHHHHHHHHHHH
Confidence            3   344445677889999999999998 899999999999999999999873

>PRK10345 hypothetical protein; Provisional

Probab=99.84  E-value=2.2e-20  Score=165.23  Aligned_cols=133  Identities=19%  Similarity=0.239  Sum_probs=103.9

Q ss_pred             EeeeeeeCceEEEEEEEcCCCcEEEEEEeccc---chHHHHHHHHHHHHhc----CCCCceEEeeEEEccCC-Cc-cEEE
Q 015374          130 VRKVGRGKYSEVFEGINVNTNERCIIKILKPV---KKKKIKREIKILQNLC----GGPNVVKLLDIVRDQHS-KT-PSLI  200 (408)
Q Consensus       130 ~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~----~h~niv~l~~~~~~~~~-~~-~~lv  200 (408)
                      ...||+|+||.||.  +..+... +||+....   ..+.+.+|+.+++.+.    .||||++++|++++..+ +. ..+|
T Consensus         7 ~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I   83 (210)
T PRK10345          7 QSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVI   83 (210)
T ss_pred             cceecCCCceEEEE--CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEE
Confidence            35799999999996  6666655 68987643   4567899999999993    47999999999986532 23 3378


Q ss_pred             EEe--ecCCChhhhcCC--CChHHHHHHHHHHHHHH-HHHHHCCcEEecCCCCcEEEeCC---CCcEEEEecccc
Q 015374          201 FEY--VNSTDFKVLYPT--LTDYDIRYYIYELLKAL-DYCHSQGIMHRDVKPHNVMIDHE---LRKLRLIDWGLA  267 (408)
Q Consensus       201 ~e~--~~~~~l~~~~~~--l~~~~~~~i~~qi~~~L-~~LH~~~iiH~Dlk~~NILl~~~---~~~~kl~DfG~a  267 (408)
                      +||  +.+++|.+++..  +++.  ..++.|++.++ +|||+++|+||||||+|||++.+   ...++|+||+.+
T Consensus        84 ~e~~G~~~~tL~~~l~~~~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~  156 (210)
T PRK10345         84 ADFDGKPSITLTEFAEQCRYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIGE  156 (210)
T ss_pred             ecCCCCcchhHHHHHHcccccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence            999  457899998853  4444  35678888888 99999999999999999999753   237999995444

>smart00090 RIO RIO-like kinase

Probab=99.82  E-value=1.1e-19  Score=164.52  Aligned_cols=136  Identities=15%  Similarity=0.216  Sum_probs=107.7

Q ss_pred             CEEEEeeeeeeCceEEEEEE-EcCCCcEEEEEEecccc---------------------------hHHHHHHHHHHHHhc
Q 015374          126 DYEVVRKVGRGKYSEVFEGI-NVNTNERCIIKILKPVK---------------------------KKKIKREIKILQNLC  177 (408)
Q Consensus       126 ~y~~~~~lG~G~fg~Vy~~~-~~~~~~~vavK~~~~~~---------------------------~~~~~~E~~~l~~l~  177 (408)
                      -|++.+.||+|+||.||+|. +..+|+.||+|+++...                           ...+.+|+.++.++ 
T Consensus        29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L-  107 (237)
T smart00090       29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRL-  107 (237)
T ss_pred             hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHH-
Confidence            47788899999999999998 67889999999986421                           02356899999999 


Q ss_pred             CCC--CceEEeeEEEccCCCccEEEEEeecCCChhhhc---CCCChHHHHHHHHHHHHHHHHHHHCC-cEEecCCCCcEE
Q 015374          178 GGP--NVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQG-IMHRDVKPHNVM  251 (408)
Q Consensus       178 ~h~--niv~l~~~~~~~~~~~~~lv~e~~~~~~l~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~-iiH~Dlk~~NIL  251 (408)
                      .+.  .+.+++++   .   ..++||||++++++....   ..+.......++.|++.+|.+||+.| |+|+||||+||+
T Consensus       108 ~~~~i~~p~~~~~---~---~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIl  181 (237)
T smart00090      108 YEAGVPVPKPIAW---R---RNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNIL  181 (237)
T ss_pred             HhcCCCCCeeeEe---c---CceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEE
Confidence            542  23444442   1   237999999998876543   23455566789999999999999999 999999999999


Q ss_pred             EeCCCCcEEEEecccceec
Q 015374          252 IDHELRKLRLIDWGLAEFY  270 (408)
Q Consensus       252 l~~~~~~~kl~DfG~a~~~  270 (408)
                      ++ + +.++|+|||.+...
T Consensus       182 i~-~-~~i~LiDFg~a~~~  198 (237)
T smart00090      182 VH-D-GKVVIIDVSQSVEL  198 (237)
T ss_pred             EE-C-CCEEEEEChhhhcc
Confidence            99 4 68999999998643

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.80  E-value=7.7e-19  Score=156.91  Aligned_cols=131  Identities=25%  Similarity=0.380  Sum_probs=109.3

Q ss_pred             eeeeeeCceEEEEEEEcCCCcEEEEEEecccc-----------hHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccEE
Q 015374          131 RKVGRGKYSEVFEGINVNTNERCIIKILKPVK-----------KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSL  199 (408)
Q Consensus       131 ~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-----------~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l  199 (408)
                      +.||+|++|.||+|.+  .+..+++|+.....           ...+.+|+.++..+ .|+++.....++.+.  ...++
T Consensus         2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~i~~p~~~~~~~--~~~~l   76 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRA-RKAGVNVPAVYFVDP--ENFII   76 (211)
T ss_pred             cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHH-HHCCCCCCeEEEEeC--CCCEE
Confidence            4799999999999976  66788999764321           23577899999999 888887776666443  45679


Q ss_pred             EEEeecCCChhhhcCCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEeccccee
Q 015374          200 IFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEF  269 (408)
Q Consensus       200 v~e~~~~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~  269 (408)
                      +|||++|++|...+..... ....++.+++.+|.+||+.+++|+|++|.|||++ + +.++|+|||.+..
T Consensus        77 v~e~~~G~~L~~~~~~~~~-~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~-~~~~liDf~~a~~  143 (211)
T PRK14879         77 VMEYIEGEPLKDLINSNGM-EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-G-GKIYLIDFGLAEF  143 (211)
T ss_pred             EEEEeCCcCHHHHHHhccH-HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-C-CCEEEEECCcccC
Confidence            9999999999988866555 7788999999999999999999999999999999 4 6899999999865

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.78  E-value=2.5e-18  Score=152.07  Aligned_cols=134  Identities=20%  Similarity=0.351  Sum_probs=105.8

Q ss_pred             CEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecccc-------------------------hHHHHHHHHHHHHhcCCC
Q 015374          126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK-------------------------KKKIKREIKILQNLCGGP  180 (408)
Q Consensus       126 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-------------------------~~~~~~E~~~l~~l~~h~  180 (408)
                      .|.+.+.||+|+||.||+|.. .+++.||||++....                         ......|+.++..+ .|.
T Consensus        16 ~~~~~~~i~~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~   93 (198)
T cd05144          16 VESLGNQIGVGKESDVYLALD-PDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKAL-YEE   93 (198)
T ss_pred             hhhcCCccccCcceEEEEEEc-CCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHH-HHc
Confidence            377778999999999999976 479999999865321                         11356788999988 666


Q ss_pred             C--ceEEeeEEEccCCCccEEEEEeecCCChhhhcCCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCc
Q 015374          181 N--VVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRK  258 (408)
Q Consensus       181 n--iv~l~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~  258 (408)
                      +  +...++.      ...++||||++++++......   .....++.+++.++.++|+.||+|+||||+||+++.+ +.
T Consensus        94 ~i~v~~~~~~------~~~~lv~e~~~g~~L~~~~~~---~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~-~~  163 (198)
T cd05144          94 GFPVPKPIDW------NRHAVVMEYIDGVELYRVRVL---EDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDD-EK  163 (198)
T ss_pred             CCCCCceeec------CCceEEEEEeCCcchhhcccc---ccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCC-Cc
Confidence            3  4444432      234799999999998765431   3456788999999999999999999999999999987 79


Q ss_pred             EEEEecccceecc
Q 015374          259 LRLIDWGLAEFYH  271 (408)
Q Consensus       259 ~kl~DfG~a~~~~  271 (408)
                      ++|+|||++....
T Consensus       164 ~~liDfg~~~~~~  176 (198)
T cd05144         164 IYIIDWPQMVSTD  176 (198)
T ss_pred             EEEEECCccccCC
Confidence            9999999986443

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.77  E-value=1.8e-18  Score=168.04  Aligned_cols=201  Identities=21%  Similarity=0.322  Sum_probs=148.7

Q ss_pred             HHhcCCCCceEEeeEEEccCCCccEEEEEeecCCChhhhcC----CCChHHHHHHHHHHHHHHHHHHHCCc-EEecCCCC
Q 015374          174 QNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGI-MHRDVKPH  248 (408)
Q Consensus       174 ~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~~~~l~~~~~----~l~~~~~~~i~~qi~~~L~~LH~~~i-iH~Dlk~~  248 (408)
                      +.+ .|.|+.+++|.+.+.  ...+.|.+||+.|+|.+.+.    .+++.-...++++|+.||.|||.-.| .|+.+++.
T Consensus         2 ~~l-~h~n~~~f~g~~~~~--~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~   78 (484)
T KOG1023|consen    2 RQL-DHDNLNKFIGASVDG--PEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSS   78 (484)
T ss_pred             ccc-chhhhhhheeeEecC--CceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccc
Confidence            456 899999999999765  67889999999999999884    37777778899999999999998755 99999999


Q ss_pred             cEEEeCCCCcEEEEecccceeccCC---CcceeeccCccccccccccCC--c----CCCccccHHHHHHHHHHHHhCCCC
Q 015374          249 NVMIDHELRKLRLIDWGLAEFYHPG---KEYNVRVASRYFKGPELLVDL--Q----DYDYSLDMWSLGCMFAGMIFRKEP  319 (408)
Q Consensus       249 NILl~~~~~~~kl~DfG~a~~~~~~---~~~~~~~~~~~y~aPE~~~~~--~----~~~~~~DvwSlGvil~ell~g~~p  319 (408)
                      |.++|.. ..+||+|||+.......   .......-...|.|||.+.+.  .    ..+.+.|+||||++++|+++...|
T Consensus        79 nClvd~~-w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~  157 (484)
T KOG1023|consen   79 NCLVDSR-WVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGP  157 (484)
T ss_pred             cceeeee-EEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCc
Confidence            9999998 79999999998766421   111222334469999999762  1    146789999999999999999999


Q ss_pred             CCCCCCCHH--HHHHHHhhhchhhhhcCCCCCCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHh
Q 015374          320 FFYGHDNHD--QLVKIAKDCCLIIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAM  390 (408)
Q Consensus       320 f~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL  390 (408)
                      |.......+  .+...++..       +....++.-   ....  .+.+++..+++.||..+|++||+++++-
T Consensus       158 ~~~~~~~~~~~eii~~~~~~-------~~~~~rP~i---~~~~--e~~~~l~~l~~~cw~e~P~~rPs~~~i~  218 (484)
T KOG1023|consen  158 FDLRNLVEDPDEIILRVKKG-------GSNPFRPSI---ELLN--ELPPELLLLVARCWEEIPEKRPSIEQIR  218 (484)
T ss_pred             cccccccCChHHHHHHHHhc-------CCCCcCcch---hhhh--hcchHHHHHHHHhcccChhhCccHHHHH
Confidence            965433332  222222210       111111111   1010  2456899999999999999999988763

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.76  E-value=5.9e-18  Score=171.77  Aligned_cols=134  Identities=19%  Similarity=0.358  Sum_probs=106.2

Q ss_pred             CCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEe--cc---------cchHHHHHHHHHHHHhcCCCCceEEeeEEEccC
Q 015374          125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKIL--KP---------VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQH  193 (408)
Q Consensus       125 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~--~~---------~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~  193 (408)
                      ..|...++||+|+||+||+|.+....  +++|+.  +.         ...+.+.+|++++..+ +|++++....++.+. 
T Consensus       333 ~~~~~~~~iG~G~~g~Vy~~~~~~~~--~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~i~~p~~~~~~~-  408 (535)
T PRK09605        333 RRKIPDHLIGKGAEADIKKGEYLGRD--AVIKERVPKGYRHPELDERLRTERTRAEARLLSEA-RRAGVPTPVIYDVDP-  408 (535)
T ss_pred             cccCccceeccCCcEEEEEEeecCcc--ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhh-cccCCCeeEEEEEeC-
Confidence            34566789999999999999765443  333322  11         1124578899999999 899998877776543 


Q ss_pred             CCccEEEEEeecCCChhhhcCCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceec
Q 015374          194 SKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY  270 (408)
Q Consensus       194 ~~~~~lv~e~~~~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~  270 (408)
                       ...++||||+++++|..++.     ....++.+++.+|.|||+.|++||||||+|||++ + +.++|+|||+++..
T Consensus       409 -~~~~lv~E~~~g~~L~~~l~-----~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl~-~-~~~~liDFGla~~~  477 (535)
T PRK09605        409 -EEKTIVMEYIGGKDLKDVLE-----GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIVR-D-DRLYLIDFGLGKYS  477 (535)
T ss_pred             -CCCEEEEEecCCCcHHHHHH-----HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEEE-C-CcEEEEeCcccccC
Confidence             34679999999999988765     4567899999999999999999999999999995 3 58999999999753

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.76  E-value=8.3e-18  Score=148.82  Aligned_cols=127  Identities=21%  Similarity=0.396  Sum_probs=99.9

Q ss_pred             eeeeeCceEEEEEEEcCCCcEEEEEEeccc-----------chHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccEEE
Q 015374          132 KVGRGKYSEVFEGINVNTNERCIIKILKPV-----------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI  200 (408)
Q Consensus       132 ~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-----------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  200 (408)
                      .||+|+||+||+|.  .++..+++|.....           ....+.+|+.++..+ .|+++.....++.+.  ...++|
T Consensus         1 ~ig~G~~~~vy~~~--~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~i~~p~~~~~~~--~~~~lv   75 (199)
T TIGR03724         1 LIAKGAEAIIYLGD--FLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRA-RKAGVNTPVVYDVDP--DNKTIV   75 (199)
T ss_pred             CCCCCceEEEEEee--cCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHH-HHCCCCCCEEEEEEC--CCCEEE
Confidence            38999999999997  35678999985421           124567899999999 777654443333333  345799


Q ss_pred             EEeecCCChhhhcCCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEeccccee
Q 015374          201 FEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEF  269 (408)
Q Consensus       201 ~e~~~~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~  269 (408)
                      |||++|+++...+.....    .++.+++.+|.+||+.|++|+|++|+||+++ + +.++++|||++..
T Consensus        76 ~e~~~g~~l~~~~~~~~~----~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~-~~~~liDfg~a~~  138 (199)
T TIGR03724        76 MEYIEGKPLKDVIEEGND----ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-D-DKLYLIDFGLGKY  138 (199)
T ss_pred             EEEECCccHHHHHhhcHH----HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-C-CcEEEEECCCCcC
Confidence            999999999887643221    7899999999999999999999999999999 4 7899999999865

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.75  E-value=4.2e-19  Score=169.46  Aligned_cols=174  Identities=20%  Similarity=0.344  Sum_probs=133.3

Q ss_pred             ccEEEEEeecCCChhhhcC------CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEeccccee
Q 015374          196 TPSLIFEYVNSTDFKVLYP------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEF  269 (408)
Q Consensus       196 ~~~lv~e~~~~~~l~~~~~------~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~  269 (408)
                      ++++.|++|...+|.+++.      ..++.....++.|++.|++|   ++.+|+|+||.||.+..+ ..+||.|||+...
T Consensus       330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d-~q~kIgDFgl~ts  405 (516)
T KOG1033|consen  330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDD-DQLKIGDFGLVTS  405 (516)
T ss_pred             chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccc-hhhhhhhhhheee
Confidence            5789999999999999983      35667788899999999999   999999999999999888 6899999999876


Q ss_pred             ccCCC-------cceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhh
Q 015374          270 YHPGK-------EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIW  342 (408)
Q Consensus       270 ~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~  342 (408)
                      .....       ..+...||..||+||.+.+ ..|+.++||||||++++|++.   +|.........+..+.        
T Consensus       406 ~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g-~~y~~kvdIyaLGlil~EL~~---~f~T~~er~~t~~d~r--------  473 (516)
T KOG1033|consen  406 QDKDETVAPAAASHTQQVGTLLYMSPEQIRG-QQYSEKVDIYALGLILAELLI---QFSTQFERIATLTDIR--------  473 (516)
T ss_pred             cccCCcccchhhhhhhcccccccCCHHHHhh-hhhhhhcchhhHHHHHHHHHH---HhccHHHHHHhhhhhh--------
Confidence            65544       4566789999999999998 899999999999999999996   2311111111111111        


Q ss_pred             hcCCCCCCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcc
Q 015374          343 CNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFA  396 (408)
Q Consensus       343 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~  396 (408)
                            ...|+.    ..... .++-.+|+..||...|.+||++.+.-.|.|++
T Consensus       474 ------~g~ip~----~~~~d-~p~e~~ll~~lls~~p~~RP~~~~~~~~~~~~  516 (516)
T KOG1033|consen  474 ------DGIIPP----EFLQD-YPEEYTLLQQLLSPSPEERPSAIEVALHEFLQ  516 (516)
T ss_pred             ------cCCCCh----HHhhc-CcHHHHHHHHhcCCCcccCchHHHHhhhhhcC
Confidence                  111110    00011 24567999999999999999888888888753

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.73  E-value=2.1e-19  Score=182.11  Aligned_cols=255  Identities=22%  Similarity=0.369  Sum_probs=195.0

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcC-CCcEEEEEEecccc-----hHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCcc
Q 015374          124 QDDYEVVRKVGRGKYSEVFEGINVN-TNERCIIKILKPVK-----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP  197 (408)
Q Consensus       124 ~~~y~~~~~lG~G~fg~Vy~~~~~~-~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~  197 (408)
                      ...|.+.+.||+|+|+.|-...... ....+|+|.+....     ......|..+-..+.+|+|++++++...+  ....
T Consensus        19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~--~~~~   96 (601)
T KOG0590|consen   19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSS--PRSY   96 (601)
T ss_pred             cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCC--Cccc
Confidence            4556677789999999998876533 33456666664322     23445588887787559999999999844  5677


Q ss_pred             EEEEEeecCCChhhhc-C----CCChHHHHHHHHHHHHHHHHHH-HCCcEEecCCCCcEEEeCCCC-cEEEEecccceec
Q 015374          198 SLIFEYVNSTDFKVLY-P----TLTDYDIRYYIYELLKALDYCH-SQGIMHRDVKPHNVMIDHELR-KLRLIDWGLAEFY  270 (408)
Q Consensus       198 ~lv~e~~~~~~l~~~~-~----~l~~~~~~~i~~qi~~~L~~LH-~~~iiH~Dlk~~NILl~~~~~-~~kl~DfG~a~~~  270 (408)
                      +++++|..++++..-. .    ..+......++.|+..++.|+| ..++.|+|+||+|.+++.. + .++++|||+|..+
T Consensus        97 ~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s-~~~l~~~df~~At~~  175 (601)
T KOG0590|consen   97 LLSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDES-GSALKIADFGLATAY  175 (601)
T ss_pred             ccccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccC-CCcccCCCchhhccc
Confidence            7999999999887766 2    3566778889999999999999 9999999999999999988 5 8999999999877


Q ss_pred             cC-CCc---ceeecc-CccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcC
Q 015374          271 HP-GKE---YNVRVA-SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNS  345 (408)
Q Consensus       271 ~~-~~~---~~~~~~-~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  345 (408)
                      .. +..   ....+| +..|+|||...+........|+||.|+++..+++|..|+................         
T Consensus       176 ~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~---------  246 (601)
T KOG0590|consen  176 RNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSN---------  246 (601)
T ss_pred             cccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeeccc---------
Confidence            65 222   234577 8999999999875566789999999999999999999985433322111111100         


Q ss_pred             CCCCCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccc
Q 015374          346 RHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQ  397 (408)
Q Consensus       346 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~  397 (408)
                             ........+..++....+++.+++..+|..|.+.+++..+||+..
T Consensus       247 -------~~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~  291 (601)
T KOG0590|consen  247 -------KGRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS  291 (601)
T ss_pred             -------ccccccCccccCChhhhhcccccccCCchhccccccccccccccc
Confidence                   011123334557889999999999999999999999999999988

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.72  E-value=5.2e-17  Score=142.20  Aligned_cols=132  Identities=20%  Similarity=0.315  Sum_probs=96.0

Q ss_pred             EeeeeeeCceEEEEEEEcCCCcEEEEEEecccch-----HHH----------------------HHHHHHHHHhcCCC--
Q 015374          130 VRKVGRGKYSEVFEGINVNTNERCIIKILKPVKK-----KKI----------------------KREIKILQNLCGGP--  180 (408)
Q Consensus       130 ~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~-----~~~----------------------~~E~~~l~~l~~h~--  180 (408)
                      .+.||+|+||+||+|.+. +++.||||++++...     ...                      ..|...+.++ .+.  
T Consensus         2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~~   79 (187)
T cd05119           2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRL-YEAGV   79 (187)
T ss_pred             CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHH-HHcCC
Confidence            357999999999999865 789999999864321     111                      3466666666 332  


Q ss_pred             CceEEeeEEEccCCCccEEEEEeecCCChhh-hcCCCCh-HHHHHHHHHHHHHHHHHHH-CCcEEecCCCCcEEEeCCCC
Q 015374          181 NVVKLLDIVRDQHSKTPSLIFEYVNSTDFKV-LYPTLTD-YDIRYYIYELLKALDYCHS-QGIMHRDVKPHNVMIDHELR  257 (408)
Q Consensus       181 niv~l~~~~~~~~~~~~~lv~e~~~~~~l~~-~~~~l~~-~~~~~i~~qi~~~L~~LH~-~~iiH~Dlk~~NILl~~~~~  257 (408)
                      .+.+.+++.      ..++||||++++.+.. .+..... .+...++.+++.++.++|+ .+|+|+||||+||+++ + +
T Consensus        80 ~~~~~~~~~------~~~lv~e~~~g~~~~~~~l~~~~~~~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~-~  151 (187)
T cd05119          80 PVPKPIDLN------RHVLVMEFIGGDGIPAPRLKDVRLLEDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-D-G  151 (187)
T ss_pred             CCCceEecC------CCEEEEEEeCCCCccChhhhhhhhcccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-C-C
Confidence            234444432      3479999999954321 1222222 6678899999999999999 9999999999999999 5 7


Q ss_pred             cEEEEecccceecc
Q 015374          258 KLRLIDWGLAEFYH  271 (408)
Q Consensus       258 ~~kl~DfG~a~~~~  271 (408)
                      .++|+|||.+....
T Consensus       152 ~~~liDfg~a~~~~  165 (187)
T cd05119         152 KVYIIDVPQAVEID  165 (187)
T ss_pred             cEEEEECccccccc
Confidence            89999999996543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.69  E-value=3.7e-16  Score=141.83  Aligned_cols=130  Identities=17%  Similarity=0.314  Sum_probs=100.4

Q ss_pred             eee-eeCceEEEEEEEcCCCcEEEEEEecc----------------cchHHHHHHHHHHHHhcCCCCc--eEEeeEEEcc
Q 015374          132 KVG-RGKYSEVFEGINVNTNERCIIKILKP----------------VKKKKIKREIKILQNLCGGPNV--VKLLDIVRDQ  192 (408)
Q Consensus       132 ~lG-~G~fg~Vy~~~~~~~~~~vavK~~~~----------------~~~~~~~~E~~~l~~l~~h~ni--v~l~~~~~~~  192 (408)
                      .|| .||.|+||++..  .+..++||.+..                .....+.+|+.++.++ .|+++  +..+++....
T Consensus        38 ~lg~~~g~gtv~~v~~--~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L-~~~gi~vP~pl~~~~~~  114 (239)
T PRK01723         38 VVGSAKGRGTTWFVQT--PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQL-YEAGLPVPRPIAARVVR  114 (239)
T ss_pred             eeecCCCCccEEEEEe--CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHH-HhCCCCCceeEeeeeee
Confidence            577 889999999854  367888887742                1224578899999999 77774  6777765433


Q ss_pred             CCC--ccEEEEEeecC-CChhhhcCC--CChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccc
Q 015374          193 HSK--TPSLIFEYVNS-TDFKVLYPT--LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA  267 (408)
Q Consensus       193 ~~~--~~~lv~e~~~~-~~l~~~~~~--l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a  267 (408)
                      ...  ..++|||++++ .+|..++..  +++.    .+.+++.+|.+||+.||+|+||||+|||++.+ +.++|+|||.+
T Consensus       115 ~~~~~~~~lV~e~l~G~~~L~~~l~~~~l~~~----~~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~-~~v~LIDfg~~  189 (239)
T PRK01723        115 HGLFYRADILIERIEGARDLVALLQEAPLSEE----QWQAIGQLIARFHDAGVYHADLNAHNILLDPD-GKFWLIDFDRG  189 (239)
T ss_pred             cCcceeeeEEEEecCCCCCHHHHHhcCCCCHH----HHHHHHHHHHHHHHCCCCCCCCCchhEEEcCC-CCEEEEECCCc
Confidence            222  23599999997 688877644  3332    36789999999999999999999999999987 68999999998


Q ss_pred             ee
Q 015374          268 EF  269 (408)
Q Consensus       268 ~~  269 (408)
                      ..
T Consensus       190 ~~  191 (239)
T PRK01723        190 EL  191 (239)
T ss_pred             cc
Confidence            65

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.69  E-value=4.4e-16  Score=130.66  Aligned_cols=132  Identities=22%  Similarity=0.327  Sum_probs=109.7

Q ss_pred             EEeeeeeeCceEEEEEEEcCCCcEEEEEEecccc-hHHHHHHHHHHHHhcCC-CCceEEeeEEEccCCCccEEEEEeecC
Q 015374          129 VVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK-KKKIKREIKILQNLCGG-PNVVKLLDIVRDQHSKTPSLIFEYVNS  206 (408)
Q Consensus       129 ~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~E~~~l~~l~~h-~niv~l~~~~~~~~~~~~~lv~e~~~~  206 (408)
                      +++.||.|.++.||++....  ..+++|..+... ...+.+|+.+++.+.++ .++.++++++..  ....+++|||+++
T Consensus         2 ~~~~i~~g~~~~v~~~~~~~--~~~~iK~~~~~~~~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~--~~~~~~v~e~~~g   77 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTKD--EDYVLKINPSREKGADREREVAILQLLARKGLPVPKVLASGES--DGWSYLLMEWIEG   77 (155)
T ss_pred             cceecccccccceEEEEecC--CeEEEEecCCCCchhHHHHHHHHHHHHHHcCCCCCeEEEEcCC--CCccEEEEEecCC
Confidence            35689999999999997643  789999986543 36789999999999433 588899888854  3567899999999


Q ss_pred             CChhhhcCCCChHHHHHHHHHHHHHHHHHHHC---CcEEecCCCCcEEEeCCCCcEEEEeccccee
Q 015374          207 TDFKVLYPTLTDYDIRYYIYELLKALDYCHSQ---GIMHRDVKPHNVMIDHELRKLRLIDWGLAEF  269 (408)
Q Consensus       207 ~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~  269 (408)
                      +.+..+    +......++.+++.+|.+||..   +++|+|++|+||+++.. +.++++|||.+..
T Consensus        78 ~~~~~~----~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~-~~~~l~Df~~~~~  138 (155)
T cd05120          78 ETLDEV----SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDG-KILGIIDWEYAGY  138 (155)
T ss_pred             eecccC----CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECC-cEEEEEecccccC
Confidence            877654    5666778899999999999985   69999999999999986 7899999999864

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.56  E-value=4.8e-15  Score=144.40  Aligned_cols=250  Identities=20%  Similarity=0.235  Sum_probs=190.4

Q ss_pred             CCCEEEEeeeee--eCceEEEEEEE--cCCCcEEEEEEec-----ccchHHHHHHHHHHHHhcCCCCceEEeeEEEccCC
Q 015374          124 QDDYEVVRKVGR--GKYSEVFEGIN--VNTNERCIIKILK-----PVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHS  194 (408)
Q Consensus       124 ~~~y~~~~~lG~--G~fg~Vy~~~~--~~~~~~vavK~~~-----~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~  194 (408)
                      ...+.+...+|.  |.+|.||.+..  ..++..+|+|.-+     +.....-.+|+...+++..|+|.++....++.  .
T Consensus       113 ~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~--~  190 (524)
T KOG0601|consen  113 DQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEG--S  190 (524)
T ss_pred             hhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCccccc--C
Confidence            456677788999  99999999988  7888899998743     12334556788888888889999998888844  5


Q ss_pred             CccEEEEEeecCCChhhhc----CCCChHHHHHHHHHHHH----HHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEeccc
Q 015374          195 KTPSLIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLK----ALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGL  266 (408)
Q Consensus       195 ~~~~lv~e~~~~~~l~~~~----~~l~~~~~~~i~~qi~~----~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~  266 (408)
                      ...++-.|++.+ ++..+.    ..+++..++....+...    ||.++|+.+++|-|+||.||+...+....+++|||+
T Consensus       191 ~~lfiqtE~~~~-sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~df~~  269 (524)
T KOG0601|consen  191 GILFIQTELCGE-SLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTDFGL  269 (524)
T ss_pred             Ccceeeeccccc-hhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCCcce
Confidence            677788888884 444433    23788888999999999    999999999999999999999998855789999999


Q ss_pred             ceeccCCCcc-eee-----ccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchh
Q 015374          267 AEFYHPGKEY-NVR-----VASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLI  340 (408)
Q Consensus       267 a~~~~~~~~~-~~~-----~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~  340 (408)
                      ...+.++... ...     -+...|++||...+  -++...|+|++|.++.+..++..++-.+..+.  +..        
T Consensus       270 v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~--l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~--W~~--------  337 (524)
T KOG0601|consen  270 VSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG--LATFASDIFSLGEVILEAILGSHLPSVGKNSS--WSQ--------  337 (524)
T ss_pred             eEEccCCccccceeeeecCCCCceEeChhhhcc--ccchHhhhcchhhhhHhhHhhcccccCCCCCC--ccc--------
Confidence            8887655421 122     56667999999875  68889999999999999999888774442210  000        


Q ss_pred             hhhcCCCCCCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccc
Q 015374          341 IWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQV  398 (408)
Q Consensus       341 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~~  398 (408)
                             .+..   +.+.+.-...+.++...+..|++.++..|++++.+++|++....
T Consensus       338 -------~r~~---~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~  385 (524)
T KOG0601|consen  338 -------LRQG---YIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSK  385 (524)
T ss_pred             -------cccc---cCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccch
Confidence                   0000   01222233356677779999999999999999999999997643

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.53  E-value=7e-14  Score=137.75  Aligned_cols=137  Identities=17%  Similarity=0.279  Sum_probs=95.3

Q ss_pred             eeeeeeCceEEEEEEEcCCCcEEEEEEecccchHH-------------------------------------------HH
Q 015374          131 RKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKK-------------------------------------------IK  167 (408)
Q Consensus       131 ~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~-------------------------------------------~~  167 (408)
                      +.||.|++|.||+|+. .+|+.||||+.++...+.                                           +.
T Consensus       123 ~plasaSigQVh~A~l-~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~  201 (437)
T TIGR01982       123 KPLAAASIAQVHRARL-VDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR  201 (437)
T ss_pred             cceeeeehhheEEEEe-cCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence            4699999999999975 578999999987643322                                           23


Q ss_pred             HHHHHHHHhc---CCCCceEEeeEEEccCCCccEEEEEeecCCChhhhcCC--CChHHHHHHHHHHHH-HHHHHHHCCcE
Q 015374          168 REIKILQNLC---GGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPT--LTDYDIRYYIYELLK-ALDYCHSQGIM  241 (408)
Q Consensus       168 ~E~~~l~~l~---~h~niv~l~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~--l~~~~~~~i~~qi~~-~L~~LH~~~ii  241 (408)
                      +|...+.++.   ++.+-+.+-..+.+.. ...+|||||++|+++.+....  ... ....++.+++. .+..+|..|++
T Consensus       202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~-~~~vLvmE~i~G~~L~~~~~~~~~~~-~~~~ia~~~~~~~l~ql~~~g~~  279 (437)
T TIGR01982       202 REAANASELGENFKNDPGVYVPEVYWDRT-SERVLTMEWIDGIPLSDIAALDEAGL-DRKALAENLARSFLNQVLRDGFF  279 (437)
T ss_pred             HHHHHHHHHHHhcCCCCCEEeCCEehhhc-CCceEEEEeECCcccccHHHHHhcCC-CHHHHHHHHHHHHHHHHHhCCce
Confidence            3444444431   2223344444443222 345799999999988776421  111 23456666665 47889999999


Q ss_pred             EecCCCCcEEEeCCCCcEEEEecccceecc
Q 015374          242 HRDVKPHNVMIDHELRKLRLIDWGLAEFYH  271 (408)
Q Consensus       242 H~Dlk~~NILl~~~~~~~kl~DfG~a~~~~  271 (408)
                      |+|+||.||+++.+ +.++++|||++....
T Consensus       280 H~D~hPgNilv~~~-g~i~liDfG~~~~l~  308 (437)
T TIGR01982       280 HADLHPGNIFVLKD-GKIIALDFGIVGRLS  308 (437)
T ss_pred             eCCCCcccEEECCC-CcEEEEeCCCeeECC
Confidence            99999999999887 789999999997665

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.49  E-value=2.8e-13  Score=116.51  Aligned_cols=126  Identities=21%  Similarity=0.273  Sum_probs=95.5

Q ss_pred             EeeeeeeCceEEEEEEEcCCCcEEEEEEecccc--hHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccEEEEEeecCC
Q 015374          130 VRKVGRGKYSEVFEGINVNTNERCIIKILKPVK--KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNST  207 (408)
Q Consensus       130 ~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~~~  207 (408)
                      ++.|+.|.++.||+++..  +..+++|+.....  ...+.+|+.+++.+.+...+.+++.+..    ...++||||+++.
T Consensus         3 ~~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~~~~~~P~~~~~~~----~~~~lv~e~i~G~   76 (170)
T cd05151           3 ISPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTELLINRENEAENSKLAAEAGIGPKLYYFDP----ETGVLITEFIEGS   76 (170)
T ss_pred             eeecCCcccCceEEEEEC--CeEEEEEeCCCCcccccCHHHHHHHHHHHHHhCCCCceEEEeC----CCCeEEEEecCCC
Confidence            457899999999999753  7789999986543  3457889999999843333445665542    2246999999998


Q ss_pred             ChhhhcCCCChHHHHHHHHHHHHHHHHHHHCCc-----EEecCCCCcEEEeCCCCcEEEEecccce
Q 015374          208 DFKVLYPTLTDYDIRYYIYELLKALDYCHSQGI-----MHRDVKPHNVMIDHELRKLRLIDWGLAE  268 (408)
Q Consensus       208 ~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~i-----iH~Dlk~~NILl~~~~~~~kl~DfG~a~  268 (408)
                      ++...     ......++.+++.+|..||+.++     +|+|++|.||+++ + +.++++|||.+.
T Consensus        77 ~l~~~-----~~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~-~~~~liDf~~a~  135 (170)
T cd05151          77 ELLTE-----DFSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-D-GRLWLIDWEYAG  135 (170)
T ss_pred             ccccc-----cccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-C-CeEEEEeccccc
Confidence            87643     11123457899999999999875     9999999999999 4 578999999875

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.42  E-value=4.1e-14  Score=144.91  Aligned_cols=259  Identities=23%  Similarity=0.333  Sum_probs=184.8

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecc------cchHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCc
Q 015374          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP------VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT  196 (408)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~------~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  196 (408)
                      ..+.+.+.+-+-+|.++.++.+.-..++...++|+...      ...+....+-.++-.. .+|-++...-.+  .....
T Consensus       802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p-~~P~v~~~~~s~--~~rsP  878 (1205)
T KOG0606|consen  802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITP-RSPAVVRSFPSF--PCRSP  878 (1205)
T ss_pred             CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccC-CCCceecccCCC--CCCCC
Confidence            45778888899999999999987666776666665431      1122233333322222 445555544443  22345


Q ss_pred             cEEEEEeecCCChhhhcCC---CChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceecc--
Q 015374          197 PSLIFEYVNSTDFKVLYPT---LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH--  271 (408)
Q Consensus       197 ~~lv~e~~~~~~l~~~~~~---l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~--  271 (408)
                      ..|+++|++++++...+..   .+.+-.+.++..+..+++|||+..++|+|++|.|+|...+ +..+++|||......  
T Consensus       879 ~~L~~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~-gh~~l~~~~t~~~vg~~  957 (1205)
T KOG0606|consen  879 LPLVGHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYD-GHRPLTDFGTLSKVGLI  957 (1205)
T ss_pred             cchhhHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccchhhcccccccchhhccc-CCcccCccccccccccc
Confidence            6799999999998887754   5556677788889999999999999999999999999988 788999998432110  


Q ss_pred             ----CC--------------------------CcceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCC
Q 015374          272 ----PG--------------------------KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF  321 (408)
Q Consensus       272 ----~~--------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~  321 (408)
                          ..                          .......+|+.|.+||...+ ..-...+|.|++|++++|.++|..|| 
T Consensus       958 ~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg-~~hgs~ad~~~~g~~l~e~l~g~pp~- 1035 (1205)
T KOG0606|consen  958 PPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLG-RRHGSAADWWSSGVCLFEVLTGIPPF- 1035 (1205)
T ss_pred             cCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCccccc-ccCCCcchhhhhhhhhhhhhcCCCCC-
Confidence                00                          00122468889999999998 66778899999999999999999987 


Q ss_pred             CCCCCHHHHHHHHhhhchhhhhcCCCCCCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHH---HHhcCCCcccc
Q 015374          322 YGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAR---EAMAHPYFAQV  398 (408)
Q Consensus       322 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~---elL~hp~f~~~  398 (408)
                      ........+..+..            ...+|.     .-+...+.++++++.++|..+|.+|..+.   ++-.|+||+.+
T Consensus      1036 na~tpq~~f~ni~~------------~~~~~p-----~g~~~~s~~aq~~~~~ll~~~~~qr~~a~~~~e~k~~~~~~~~ 1098 (1205)
T KOG0606|consen 1036 NAETPQQIFENILN------------RDIPWP-----EGPEEGSYEAQDLINRLLTEEPTQRLGAKGAAEVKGHPFFQDV 1098 (1205)
T ss_pred             CCcchhhhhhcccc------------CCCCCC-----CCccccChhhhhhhhhhhccCchhccCcccccccccCCccCCC
Confidence            33333333333322            112222     22334678999999999999999999877   99999999999


Q ss_pred             ccchhh
Q 015374          399 RAAESS  404 (408)
Q Consensus       399 ~~~~~~  404 (408)
                      .++...
T Consensus      1099 ~~~~l~ 1104 (1205)
T KOG0606|consen 1099 DWENLA 1104 (1205)
T ss_pred             Cccccc
Confidence            887643

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.42  E-value=3.6e-12  Score=111.03  Aligned_cols=133  Identities=17%  Similarity=0.273  Sum_probs=97.5

Q ss_pred             eeeeeeCceEEEEEEEcC------CCcEEEEEEecccc-------------------------hHHH----HHHHHHHHH
Q 015374          131 RKVGRGKYSEVFEGINVN------TNERCIIKILKPVK-------------------------KKKI----KREIKILQN  175 (408)
Q Consensus       131 ~~lG~G~fg~Vy~~~~~~------~~~~vavK~~~~~~-------------------------~~~~----~~E~~~l~~  175 (408)
                      ..||.|.-+.||.|....      .+..+|||+.+...                         ...+    ++|...|++
T Consensus         3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r   82 (197)
T cd05146           3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR   82 (197)
T ss_pred             CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence            469999999999997543      35789999974210                         1122    379999998


Q ss_pred             hcCC-CCceEEeeEEEccCCCccEEEEEeecCCChh-hhcC--CCChHHHHHHHHHHHHHHHHH-HHCCcEEecCCCCcE
Q 015374          176 LCGG-PNVVKLLDIVRDQHSKTPSLIFEYVNSTDFK-VLYP--TLTDYDIRYYIYELLKALDYC-HSQGIMHRDVKPHNV  250 (408)
Q Consensus       176 l~~h-~niv~l~~~~~~~~~~~~~lv~e~~~~~~l~-~~~~--~l~~~~~~~i~~qi~~~L~~L-H~~~iiH~Dlk~~NI  250 (408)
                      +... -++...+++.      .-+|||||++++.+. ..+.  .++..+...+..+++.+|..| |+.|+||+||++.||
T Consensus        83 l~~~Gv~vP~pi~~~------~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~NI  156 (197)
T cd05146          83 MQKAGIPCPEVVVLK------KHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYNM  156 (197)
T ss_pred             HHHcCCCCCeEEEec------CCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHE
Confidence            8433 4666777642      235999999875432 1222  244456677889999999999 899999999999999


Q ss_pred             EEeCCCCcEEEEecccceecc
Q 015374          251 MIDHELRKLRLIDWGLAEFYH  271 (408)
Q Consensus       251 Ll~~~~~~~kl~DfG~a~~~~  271 (408)
                      |+++  +.+.|+|||.+....
T Consensus       157 L~~~--~~v~iIDF~qav~~~  175 (197)
T cd05146         157 LWHD--GKVWFIDVSQSVEPT  175 (197)
T ss_pred             EEEC--CcEEEEECCCceeCC
Confidence            9985  478999999886543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.40  E-value=4.2e-12  Score=125.30  Aligned_cols=165  Identities=20%  Similarity=0.342  Sum_probs=127.4

Q ss_pred             EEEEcCCCcEEEEEEecccch---HHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccEEEEEeecCCChhhhcCCCChH
Q 015374          143 EGINVNTNERCIIKILKPVKK---KKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDY  219 (408)
Q Consensus       143 ~~~~~~~~~~vavK~~~~~~~---~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~l~~~  219 (408)
                      .|..+.++.+|.|.+++....   ....+-++.|+.+ +||||+++++.++.  ....|||.|-+.-  |..++..++..
T Consensus        30 ~~t~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtl-RHP~Il~yL~t~e~--~~~~ylvTErV~P--l~~~lk~l~~~  104 (690)
T KOG1243|consen   30 DGTRKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTL-RHPNILSYLDTTEE--EGTLYLVTERVRP--LETVLKELGKE  104 (690)
T ss_pred             ccceeccCCceEEEEEeCCCchhhHHHHHHHHHhhhc-cCchhhhhhhhhcc--cCceEEEeecccc--HHHHHHHhHHH
Confidence            466678888898888875443   5567788899999 99999999999955  4578899998753  45566677788


Q ss_pred             HHHHHHHHHHHHHHHHH-HCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCCCc-ceeeccCccccccccccCCcCC
Q 015374          220 DIRYYIYELLKALDYCH-SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE-YNVRVASRYFKGPELLVDLQDY  297 (408)
Q Consensus       220 ~~~~i~~qi~~~L~~LH-~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~  297 (408)
                      .+...+.||+.||.||| +++++|++|....|+++.. |..||++|.++........ ......-..|..|+.+.. .  
T Consensus       105 ~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~-GeWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~~~-s--  180 (690)
T KOG1243|consen  105 EVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNES-GEWKLGGLELVSKASGFNAPAKSLYLIESFDDPEEIDP-S--  180 (690)
T ss_pred             HHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCC-CcEEEeeeEEEeccccCCcccccchhhhcccChhhcCc-c--
Confidence            88999999999999998 5789999999999999998 8999999998754432221 111122223666766543 1  


Q ss_pred             CccccHHHHHHHHHHHHhC
Q 015374          298 DYSLDMWSLGCMFAGMIFR  316 (408)
Q Consensus       298 ~~~~DvwSlGvil~ell~g  316 (408)
                      +...|.|-|||+++|++.|
T Consensus       181 ~~s~D~~~Lg~li~el~ng  199 (690)
T KOG1243|consen  181 EWSIDSWGLGCLIEELFNG  199 (690)
T ss_pred             ccchhhhhHHHHHHHHhCc
Confidence            2467999999999999988

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.39  E-value=2.7e-12  Score=128.20  Aligned_cols=141  Identities=12%  Similarity=0.232  Sum_probs=90.6

Q ss_pred             CEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecccchH-----------------------------------------
Q 015374          126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKK-----------------------------------------  164 (408)
Q Consensus       126 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~-----------------------------------------  164 (408)
                      .|+. +.||.|++|.||+|+...+|+.||||+.++.-.+                                         
T Consensus       121 ~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~  199 (537)
T PRK04750        121 DFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHD  199 (537)
T ss_pred             hcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHH
Confidence            3454 6899999999999998888999999999754211                                         


Q ss_pred             --HHHHHHHHHHHhc---CCCCceEEeeEEEccCCCccEEEEEeecCCChhhhc--C--CCChHHHHHHHHHHHH-HHHH
Q 015374          165 --KIKREIKILQNLC---GGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY--P--TLTDYDIRYYIYELLK-ALDY  234 (408)
Q Consensus       165 --~~~~E~~~l~~l~---~h~niv~l~~~~~~~~~~~~~lv~e~~~~~~l~~~~--~--~l~~~~~~~i~~qi~~-~L~~  234 (408)
                        ++.+|...+.++.   .+.+.+.+-.++.+- ....+|||||+.|+.+.+..  .  ..+...   ++...+. -+.-
T Consensus       200 ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~-st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~---la~~~v~~~~~Q  275 (537)
T PRK04750        200 ELDLMREAANASQLRRNFEDSDMLYVPEVYWDY-CSETVMVMERMYGIPVSDVAALRAAGTDMKL---LAERGVEVFFTQ  275 (537)
T ss_pred             hhCHHHHHHHHHHHHHHccCCCCeecceeeccc-CCCceEEEeeecCccHHhHHHHHhcCCCHHH---HHHHHHHHHHHH
Confidence              1233444444331   233334444444332 23457999999999886532  1  111111   2211111 1233


Q ss_pred             HHHCCcEEecCCCCcEEEeCCCC----cEEEEecccceeccC
Q 015374          235 CHSQGIMHRDVKPHNVMIDHELR----KLRLIDWGLAEFYHP  272 (408)
Q Consensus       235 LH~~~iiH~Dlk~~NILl~~~~~----~~kl~DfG~a~~~~~  272 (408)
                      +...|++|+|+||.||+++.+ +    .+++.|||++.....
T Consensus       276 if~~GffHaDpHPGNIlv~~~-g~~~~~i~llDFGivg~l~~  316 (537)
T PRK04750        276 VFRDGFFHADMHPGNIFVSYD-PPENPRYIALDFGIVGSLNK  316 (537)
T ss_pred             HHhCCeeeCCCChHHeEEecC-CCCCCeEEEEecceEEECCH
Confidence            346899999999999999987 5    899999999876643

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.39  E-value=3.8e-13  Score=121.77  Aligned_cols=205  Identities=20%  Similarity=0.203  Sum_probs=140.5

Q ss_pred             HHHHHhcCCCCceEEeeEEEccC---CCccEEEEEeecCCChhhhcC-------CCChHHHHHHHHHHHHHHHHHHHC--
Q 015374          171 KILQNLCGGPNVVKLLDIVRDQH---SKTPSLIFEYVNSTDFKVLYP-------TLTDYDIRYYIYELLKALDYCHSQ--  238 (408)
Q Consensus       171 ~~l~~l~~h~niv~l~~~~~~~~---~~~~~lv~e~~~~~~l~~~~~-------~l~~~~~~~i~~qi~~~L~~LH~~--  238 (408)
                      .-|-.+ -|.|||++..|+.+..   .....++.|||..|++..+++       .+.....++++.||+.||.|||+.  
T Consensus       119 dnllql-vHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~P  197 (458)
T KOG1266|consen  119 DNLLQL-VHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDP  197 (458)
T ss_pred             HHHHHH-HHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCC
Confidence            334455 6899999999986542   235678999999999998884       367777889999999999999987  


Q ss_pred             CcEEecCCCCcEEEeCCCCcEEEEecccceecc-----CCCcceeeccCccccccccccCCcCCCccccHHHHHHHHHHH
Q 015374          239 GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH-----PGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGM  313 (408)
Q Consensus       239 ~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~-----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~el  313 (408)
                      -|+|+++..+.|++..+ +-+|+.--.-.....     .........+-++|.+||.=.. ...+-++|||+||....||
T Consensus       198 piihgnlTc~tifiq~n-gLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~-tn~~~a~dIy~fgmcAlem  275 (458)
T KOG1266|consen  198 PIIHGNLTCDTIFIQHN-GLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTT-TNTTGASDIYKFGMCALEM  275 (458)
T ss_pred             ccccCCcchhheeecCC-ceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcc-cccccchhhhhhhHHHHHH
Confidence            59999999999999977 666664211111000     0111223345678999997543 4567789999999999999


Q ss_pred             HhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCC
Q 015374          314 IFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHP  393 (408)
Q Consensus       314 l~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp  393 (408)
                      .-+..--..+....+.-..+....                  ...     -..--++++.+||+-.|+.||++.+++.||
T Consensus       276 ailEiq~tnseS~~~~ee~ia~~i------------------~~l-----en~lqr~~i~kcl~~eP~~rp~ar~llfHp  332 (458)
T KOG1266|consen  276 AILEIQSTNSESKVEVEENIANVI------------------IGL-----ENGLQRGSITKCLEGEPNGRPDARLLLFHP  332 (458)
T ss_pred             HHheeccCCCcceeehhhhhhhhe------------------eec-----cCccccCcCcccccCCCCCCcchhhhhcCc
Confidence            887654322222211111111100                  000     012235789999999999999999999999


Q ss_pred             Cccccccc
Q 015374          394 YFAQVRAA  401 (408)
Q Consensus       394 ~f~~~~~~  401 (408)
                      .+=++...
T Consensus       333 llfeVhsl  340 (458)
T KOG1266|consen  333 LLFEVHSL  340 (458)
T ss_pred             eeeecchH
Confidence            87666543

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.38  E-value=3.4e-13  Score=131.57  Aligned_cols=248  Identities=19%  Similarity=0.112  Sum_probs=180.2

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEc-CCCcEEEEEEecccc-----hHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCc
Q 015374          123 DQDDYEVVRKVGRGKYSEVFEGINV-NTNERCIIKILKPVK-----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT  196 (408)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  196 (408)
                      ...+|..+..||.|.|+.|++.... .++..+++|-+.+..     ...-..|+.+...+..|.+++..+..+...  ..
T Consensus       263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~--r~  340 (524)
T KOG0601|consen  263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQL--RQ  340 (524)
T ss_pred             ecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccc--cc
Confidence            3568999999999999999987644 678889998775322     223346888888887899999887776433  44


Q ss_pred             cEEEEEeecCCChhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCC
Q 015374          197 PSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG  273 (408)
Q Consensus       197 ~~lv~e~~~~~~l~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~  273 (408)
                      .++-.||+.+++.....   ..+.+...+.+..|++.++.++|++.++|+|+||+||++..+.+..+++|||.+..+.  
T Consensus       341 ~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~--  418 (524)
T KOG0601|consen  341 GYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLA--  418 (524)
T ss_pred             ccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhccccccccccc--
Confidence            55889999998876654   3478888899999999999999999999999999999998864567999999986422  


Q ss_pred             CcceeeccCcccc-ccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCCCc
Q 015374          274 KEYNVRVASRYFK-GPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPW  352 (408)
Q Consensus       274 ~~~~~~~~~~~y~-aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  352 (408)
                      ........+..++ ..|.+.....+..+.|++|||..+.+.+++...-..    ..++..+...                
T Consensus       419 ~~~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~----~~~~~~i~~~----------------  478 (524)
T KOG0601|consen  419 FSSGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSES----GVQSLTIRSG----------------  478 (524)
T ss_pred             eecccccccccccccchhhccccccccccccccccccccccccCcccCcc----cccceeeecc----------------
Confidence            1112233444455 366666557788899999999999999988643211    1111111110                


Q ss_pred             cccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccc
Q 015374          353 SKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQV  398 (408)
Q Consensus       353 ~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~~  398 (408)
                          ..........++..+...+...|+..||.+.++..|.=|...
T Consensus       479 ----~~p~~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~~~  520 (524)
T KOG0601|consen  479 ----DTPNLPGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEFYRD  520 (524)
T ss_pred             ----cccCCCchHHhhhhhhhhhcCCccccchhhhhhcccchhhhh
Confidence                011111234778899999999999999999999988766543

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=99.27  E-value=2e-10  Score=110.27  Aligned_cols=209  Identities=15%  Similarity=0.231  Sum_probs=152.1

Q ss_pred             CceEEEEEEEcCCCcEEEEEEecc---cchHHHHHHHHHHHHhcCCCCceEEeeEEEcc--CCCccEEEEEeecC-CChh
Q 015374          137 KYSEVFEGINVNTNERCIIKILKP---VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQ--HSKTPSLIFEYVNS-TDFK  210 (408)
Q Consensus       137 ~fg~Vy~~~~~~~~~~vavK~~~~---~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~--~~~~~~lv~e~~~~-~~l~  210 (408)
                      -..+.|++....+|..+++|.++.   .....-..-+++++++ .|+|+|.+.++|...  +...++|||+|.++ .+|.
T Consensus       288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl-~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~  366 (655)
T KOG3741|consen  288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKL-CHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLY  366 (655)
T ss_pred             ccceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHh-ccCceeehhhhhhhhccCcceEEEEEecCCCCchHH
Confidence            346789999999999999999942   2222334567889999 999999999988622  34568899999987 3454


Q ss_pred             hhc------------------CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccC
Q 015374          211 VLY------------------PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP  272 (408)
Q Consensus       211 ~~~------------------~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~  272 (408)
                      ++.                  ...++..++.++.|+..||.++|+.|...+-|.+.+||++.+ ..++|+..|.......
T Consensus       367 d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~-~RIriS~C~i~Dvl~~  445 (655)
T KOG3741|consen  367 DLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGK-MRIRISGCGIMDVLQE  445 (655)
T ss_pred             HHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCc-ceEEEecccceeeecC
Confidence            432                  126778899999999999999999999999999999999987 4788888887766654


Q ss_pred             CCcceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHH-HHHHHhhhchhhhhcCCCCCCC
Q 015374          273 GKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQ-LVKIAKDCCLIIWCNSRHSRKP  351 (408)
Q Consensus       273 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~  351 (408)
                      +..             |-+.+    -.+-|.=.||.+++.|.+|...-...+..... +..+.                 
T Consensus       446 d~~-------------~~le~----~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~~~~I~-----------------  491 (655)
T KOG3741|consen  446 DPT-------------EPLES----QQQNDLRDLGLLLLALATGTENSNRTDSTQSSHLTRIT-----------------  491 (655)
T ss_pred             CCC-------------cchhH----HhhhhHHHHHHHHHHHhhcccccccccchHHHHHHHhh-----------------
Confidence            431             11111    23568889999999999997653222222221 12111                 


Q ss_pred             ccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 015374          352 WSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH  392 (408)
Q Consensus       352 ~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~h  392 (408)
                                ...+.++++++.-+...++++ -++.+++.+
T Consensus       492 ----------~~yS~D~rn~v~yl~s~~~~~-ksI~~llp~  521 (655)
T KOG3741|consen  492 ----------TTYSTDLRNVVEYLESLNFRE-KSIQDLLPM  521 (655)
T ss_pred             ----------hhhhHHHHHHHHHHHhcCccc-ccHHHHHHH
Confidence                      125778889999988888887 688888765

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.26  E-value=9.9e-11  Score=98.37  Aligned_cols=136  Identities=19%  Similarity=0.294  Sum_probs=98.8

Q ss_pred             EEeeeeeeCceEEEEEEEcCCCcEEEEEEecc-----------cchHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCcc
Q 015374          129 VVRKVGRGKYSEVFEGINVNTNERCIIKILKP-----------VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP  197 (408)
Q Consensus       129 ~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~-----------~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~  197 (408)
                      .+..+-+|+-+.|+++.  -.|+.++||---+           -...+..+|++.+.++ .--.|.-..-+|.+..++  
T Consensus        11 ~l~likQGAEArv~~~~--~~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~-~~~GI~~P~l~~~D~~~~--   85 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGS--FSGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKC-RALGIPAPRLIFIDTYGG--   85 (229)
T ss_pred             cceeeeccceeeEeeec--cCCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHH-HHhCCCCceEEEEecCCC--
Confidence            35678999999999995  4678878875321           1235677899999988 433444434445454444  


Q ss_pred             EEEEEeecC-CChhhhc----C-CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcE--EEEeccccee
Q 015374          198 SLIFEYVNS-TDFKVLY----P-TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKL--RLIDWGLAEF  269 (408)
Q Consensus       198 ~lv~e~~~~-~~l~~~~----~-~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~--kl~DfG~a~~  269 (408)
                      +|+|||+++ .++..++    . .........++.+|-..+.-||..+|||+||.++||++.++.+.+  .++|||++..
T Consensus        86 ~i~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~  165 (229)
T KOG3087|consen   86 QIYMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV  165 (229)
T ss_pred             eEEEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhc
Confidence            499999988 3455544    2 233333367889999999999999999999999999998775554  8999999864

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.24  E-value=1.3e-10  Score=98.14  Aligned_cols=125  Identities=20%  Similarity=0.345  Sum_probs=92.2

Q ss_pred             eeeeeCceEEEEEEEcCCCcEEEEEEeccc-----------chHHHHHHHHHHHHhcCCC--CceEEeeEEEccCCCccE
Q 015374          132 KVGRGKYSEVFEGINVNTNERCIIKILKPV-----------KKKKIKREIKILQNLCGGP--NVVKLLDIVRDQHSKTPS  198 (408)
Q Consensus       132 ~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-----------~~~~~~~E~~~l~~l~~h~--niv~l~~~~~~~~~~~~~  198 (408)
                      .+++|+-+.+|.+..  -|..+++|.--+.           ......+|..++.++ .--  +...++++.  +.  ...
T Consensus         3 ~i~~GAEa~i~~~~~--~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a-~~~GV~~P~v~dvD--~~--~~~   75 (204)
T COG3642           3 LIKQGAEAIIYLTDF--LGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKA-REAGVPVPIVYDVD--PD--NGL   75 (204)
T ss_pred             hhhCCcceeEEeeec--cCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHH-HHcCCCCCeEEEEc--CC--CCE
Confidence            578999999999854  2334677753211           134567899999987 333  334444443  43  345


Q ss_pred             EEEEeecCCChhhhcCCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEeccccee
Q 015374          199 LIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEF  269 (408)
Q Consensus       199 lv~e~~~~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~  269 (408)
                      ++|||.+|..+.+.+..-    ...++..+-.-+.-||..||+|+||.++||++..+  .+.++|||++..
T Consensus        76 I~me~I~G~~lkd~l~~~----~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~--~i~~IDfGLg~~  140 (204)
T COG3642          76 IVMEYIEGELLKDALEEA----RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGG--RIYFIDFGLGEF  140 (204)
T ss_pred             EEEEEeCChhHHHHHHhc----chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCC--cEEEEECCcccc
Confidence            999999999998777554    24566777788889999999999999999999976  489999999864

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.23  E-value=1.4e-10  Score=103.97  Aligned_cols=138  Identities=25%  Similarity=0.411  Sum_probs=104.2

Q ss_pred             eeeeeeCceEEEEEEEcCCCcEEEEEEecccc----hHHHHHHHHHHHHhcC-CCCceEEeeEEEccC-CCccEEEEEee
Q 015374          131 RKVGRGKYSEVFEGINVNTNERCIIKILKPVK----KKKIKREIKILQNLCG-GPNVVKLLDIVRDQH-SKTPSLIFEYV  204 (408)
Q Consensus       131 ~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~-h~niv~l~~~~~~~~-~~~~~lv~e~~  204 (408)
                      +.||.|.++.||++... +|..+++|+.....    ...+.+|..+++.+.. +.++.+++.+..... .+..++||||+
T Consensus         4 ~~l~~G~~n~~~~v~~~-~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i   82 (223)
T cd05154           4 RQLSGGQSNLTYLLTAG-GGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERV   82 (223)
T ss_pred             eecCCCccceEEEEEec-CCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEe
Confidence            46899999999999753 35789999976432    4678899999999933 234567777764321 12568999999


Q ss_pred             cCCChhhhc--CCCChHHHHHHHHHHHHHHHHHHH---------------------------------------------
Q 015374          205 NSTDFKVLY--PTLTDYDIRYYIYELLKALDYCHS---------------------------------------------  237 (408)
Q Consensus       205 ~~~~l~~~~--~~l~~~~~~~i~~qi~~~L~~LH~---------------------------------------------  237 (408)
                      ++.++...+  ..++..+...++.+++..|..||+                                             
T Consensus        83 ~G~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (223)
T cd05154          83 DGRVLRDRLLRPELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERLLR  162 (223)
T ss_pred             CCEecCCCCCCCCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHHHH
Confidence            999887765  356777777778888888888873                                             


Q ss_pred             -----------CCcEEecCCCCcEEEeCC-CCcEEEEeccccee
Q 015374          238 -----------QGIMHRDVKPHNVMIDHE-LRKLRLIDWGLAEF  269 (408)
Q Consensus       238 -----------~~iiH~Dlk~~NILl~~~-~~~~kl~DfG~a~~  269 (408)
                                 ..++|+|+++.||+++.+ .+.+.|+||+.+..
T Consensus       163 ~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         163 WLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             HHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                       236999999999999983 25689999998864

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=99.21  E-value=5e-10  Score=105.16  Aligned_cols=251  Identities=16%  Similarity=0.204  Sum_probs=155.9

Q ss_pred             EeeeeeeCceEEEEEEEcCCCcEEEEEEecccchHHHHHHHHHHHHhcCCCCceEEee----EEEcc-CCCccEEEEEee
Q 015374          130 VRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLLD----IVRDQ-HSKTPSLIFEYV  204 (408)
Q Consensus       130 ~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~----~~~~~-~~~~~~lv~e~~  204 (408)
                      .+.||+|+-+.+|..-.   -...+.|++..--...-.+.+..|.+...||-+-.-+.    ..... .+....+.|..+
T Consensus        16 gr~LgqGgea~ly~l~e---~~d~VAKIYh~Pppa~~aqk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflmP~v   92 (637)
T COG4248          16 GRPLGQGGEADLYTLGE---VRDQVAKIYHAPPPAAQAQKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLMPKV   92 (637)
T ss_pred             CccccCCccceeeecch---hhchhheeecCCCchHHHHHHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEecccC
Confidence            45799999999996421   22345677753332222334444555555664332111    11111 223366777776


Q ss_pred             cCCC-hhhh---------cCCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCCC
Q 015374          205 NSTD-FKVL---------YPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK  274 (408)
Q Consensus       205 ~~~~-l~~~---------~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~~  274 (408)
                      ++.. ...+         .+.+.|.-+.+.++.++.+...||..|.+-+|+.++|+|++++ +.+.|.|-..-....++.
T Consensus        93 ~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~-~~V~LVdsDsfqi~~ng~  171 (637)
T COG4248          93 SGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDD-SKVVLVDSDSFQINANGT  171 (637)
T ss_pred             CCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecC-ceEEEEcccceeeccCCc
Confidence            6542 1111         1347888899999999999999999999999999999999988 789999866555445556


Q ss_pred             cceeeccCcccccccccc-C---CcCCCccccHHHHHHHHHHHHhC-CCCCCC---CCCCHHHHH-HHHhhhchhhhhcC
Q 015374          275 EYNVRVASRYFKGPELLV-D---LQDYDYSLDMWSLGCMFAGMIFR-KEPFFY---GHDNHDQLV-KIAKDCCLIIWCNS  345 (408)
Q Consensus       275 ~~~~~~~~~~y~aPE~~~-~---~~~~~~~~DvwSlGvil~ell~g-~~pf~~---~~~~~~~~~-~~~~~~~~~~~~~~  345 (408)
                      .+...+|...|.+||.-. +   ...-+...|.|.||+++|+++.| ++||..   ..+...-+. .|... -.......
T Consensus       172 ~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g-~f~ya~~~  250 (637)
T COG4248         172 LHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHG-RFAYASDQ  250 (637)
T ss_pred             eEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcc-eeeechhc
Confidence            667788999999999864 1   13456789999999999999987 888732   111111111 11111 01111111


Q ss_pred             CCCCCCccccccccCCCCCCHHHHHHHHHhccc--CcCCCCCHHH
Q 015374          346 RHSRKPWSKFINADNQHLVSPEAIDFLDKLLRY--DHQDRLTARE  388 (408)
Q Consensus       346 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~--dp~~Rpt~~e  388 (408)
                      ....++-+   ....+..+++++..++.+|+..  ++.-|||++.
T Consensus       251 ~~g~~p~P---~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~a  292 (637)
T COG4248         251 RRGLKPPP---RSIPLSMLPPDVQALFQQAFTESGVATPRPTAKA  292 (637)
T ss_pred             cCCCCCCC---CCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHH
Confidence            11111111   1112233688999999999976  4568999764

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.11  E-value=3.5e-11  Score=119.35  Aligned_cols=159  Identities=16%  Similarity=0.198  Sum_probs=115.1

Q ss_pred             HHHHHHHHHHHH-CCcEEecCCCCcEEEeCCCCcEEEEecccceeccCCCccee----------eccCccccccccccCC
Q 015374          226 YELLKALDYCHS-QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNV----------RVASRYFKGPELLVDL  294 (408)
Q Consensus       226 ~qi~~~L~~LH~-~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~~~~~~----------~~~~~~y~aPE~~~~~  294 (408)
                      .+.+.||.|+|. .++||++|.|++|.++.+ +..||+.|+++....+...+..          ......|.|||++.+ 
T Consensus       106 ~~v~dgl~flh~sAk~VH~ni~p~~i~~na~-~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~-  183 (700)
T KOG2137|consen  106 GNVADGLAFLHRSAKVVHGNIQPEAIVVNAN-GDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG-  183 (700)
T ss_pred             hcccchhhhhccCcceeecccchhheeeccC-cceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc-
Confidence            344489999996 599999999999999998 8999999999865544222211          123345999999988 


Q ss_pred             cCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCCCccccccccCCCCCCHHHHHHHHH
Q 015374          295 QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDK  374 (408)
Q Consensus       295 ~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  374 (408)
                      ...+.++|+||+||++|.+..|+.+.+...........-....+                .........+++++++-+.+
T Consensus       184 ~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~----------------~~~~~~s~~~p~el~~~l~k  247 (700)
T KOG2137|consen  184 TTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLN----------------AGAFGYSNNLPSELRESLKK  247 (700)
T ss_pred             ccccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcccc----------------cccccccccCcHHHHHHHHH
Confidence            77889999999999999998666655443332221111111100                01111224488999999999


Q ss_pred             hcccCcCCCCCHHHHhcCCCccccccch
Q 015374          375 LLRYDHQDRLTAREAMAHPYFAQVRAAE  402 (408)
Q Consensus       375 ~L~~dp~~Rpt~~elL~hp~f~~~~~~~  402 (408)
                      ++..++..||++.+++..|||+......
T Consensus       248 ~l~~~~~~rp~~~~l~~~~ff~D~~~~a  275 (700)
T KOG2137|consen  248 LLNGDSAVRPTLDLLLSIPFFSDPGLKA  275 (700)
T ss_pred             HhcCCcccCcchhhhhcccccCCchhhh
Confidence            9999999999999999999998765543

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.03  E-value=4.3e-09  Score=91.36  Aligned_cols=123  Identities=24%  Similarity=0.382  Sum_probs=81.4

Q ss_pred             EEEEEEEcCCCcEEEEEEeccc-----------------------------chHHHHHHHHHHHHhcCC-CCceEEeeEE
Q 015374          140 EVFEGINVNTNERCIIKILKPV-----------------------------KKKKIKREIKILQNLCGG-PNVVKLLDIV  189 (408)
Q Consensus       140 ~Vy~~~~~~~~~~vavK~~~~~-----------------------------~~~~~~~E~~~l~~l~~h-~niv~l~~~~  189 (408)
                      .||.|.. .++..+|+|+.+..                             ......+|...|.++... -++.+++++-
T Consensus         1 ~Vy~~~~-~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~   79 (188)
T PF01163_consen    1 DVYHAID-PDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN   79 (188)
T ss_dssp             EEEEEEE-CTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred             CEEEEEC-CCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence            3888864 56779999987411                             012356899999999333 2567777653


Q ss_pred             EccCCCccEEEEEeec--CCChhhhcCC-CChHHHHHHHHHHHHHHHH-HHHCCcEEecCCCCcEEEeCCCCcEEEEecc
Q 015374          190 RDQHSKTPSLIFEYVN--STDFKVLYPT-LTDYDIRYYIYELLKALDY-CHSQGIMHRDVKPHNVMIDHELRKLRLIDWG  265 (408)
Q Consensus       190 ~~~~~~~~~lv~e~~~--~~~l~~~~~~-l~~~~~~~i~~qi~~~L~~-LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG  265 (408)
                            .-++||||++  |..+..+... ++..+...++.+++..+.. +|..||+|+||.+.|||++.+  .+.|+|||
T Consensus        80 ------~~~ivME~I~~~G~~~~~l~~~~~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~--~~~iIDf~  151 (188)
T PF01163_consen   80 ------RNVIVMEYIGEDGVPLPRLKDVDLSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG--KVYIIDFG  151 (188)
T ss_dssp             ------TTEEEEE--EETTEEGGCHHHCGGGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT--CEEE--GT
T ss_pred             ------CCEEEEEecCCCccchhhHHhccccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc--eEEEEecC
Confidence                  1259999999  6555443322 2356667788888886666 579999999999999999986  78999999


Q ss_pred             cceecc
Q 015374          266 LAEFYH  271 (408)
Q Consensus       266 ~a~~~~  271 (408)
                      .+....
T Consensus       152 qav~~~  157 (188)
T PF01163_consen  152 QAVDSS  157 (188)
T ss_dssp             TEEETT
T ss_pred             cceecC
Confidence            886543

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=98.91  E-value=1.8e-08  Score=92.70  Aligned_cols=126  Identities=18%  Similarity=0.154  Sum_probs=88.7

Q ss_pred             EEEEEEcCCCcEEEEEEecccc--------------hHHHHHHHHHHHHhcCCCCc--eEEeeEEEccC---CCccEEEE
Q 015374          141 VFEGINVNTNERCIIKILKPVK--------------KKKIKREIKILQNLCGGPNV--VKLLDIVRDQH---SKTPSLIF  201 (408)
Q Consensus       141 Vy~~~~~~~~~~vavK~~~~~~--------------~~~~~~E~~~l~~l~~h~ni--v~l~~~~~~~~---~~~~~lv~  201 (408)
                      |++..  -+|+.+.||......              ...+.+|...+.++ ...+|  ...+++.+...   ...-+||+
T Consensus        38 vvr~~--~~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L-~~~GIptP~pVa~~e~~~~~~~~~s~LVt  114 (268)
T PRK15123         38 TLRFE--LAGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRL-HEVGVDTMTGVAFGERGSNPATRTSFIIT  114 (268)
T ss_pred             EEEEE--ECCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHH-HHcCCCCCCeeEEEEecCCCccceeEEEE
Confidence            44543  245677788653222              11477899988888 33333  34455553221   23467999


Q ss_pred             EeecCC-ChhhhcC-----CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeC------CCCcEEEEeccccee
Q 015374          202 EYVNST-DFKVLYP-----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDH------ELRKLRLIDWGLAEF  269 (408)
Q Consensus       202 e~~~~~-~l~~~~~-----~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~------~~~~~kl~DfG~a~~  269 (408)
                      |++++. ++.+++.     ..+......++.+++..+.-||+.||+|+|+++.|||++.      +...+.++||+.+..
T Consensus       115 e~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~~  194 (268)
T PRK15123        115 EDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQI  194 (268)
T ss_pred             eeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCcccc
Confidence            999986 7777753     2455567789999999999999999999999999999985      235899999998853

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.88  E-value=1.7e-08  Score=90.46  Aligned_cols=132  Identities=23%  Similarity=0.389  Sum_probs=96.8

Q ss_pred             EEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecc-------------------------cchHHHHHHHHHHHHhcCC-C
Q 015374          127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP-------------------------VKKKKIKREIKILQNLCGG-P  180 (408)
Q Consensus       127 y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~-------------------------~~~~~~~~E~~~l~~l~~h-~  180 (408)
                      +.+..+||-|.-|.||.|.+. .|.++|||.=+-                         ..+...++|.++|.+|... -
T Consensus        93 e~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~  171 (304)
T COG0478          93 EAIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV  171 (304)
T ss_pred             HhhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence            445678999999999999754 688999997320                         0123467899999999333 2


Q ss_pred             CceEEeeEEEccCCCccEEEEEeecCCChhhhcCCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEE
Q 015374          181 NVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLR  260 (408)
Q Consensus       181 niv~l~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~k  260 (408)
                      .+.+.+++      +..++||||++|..|....  ++......++..|+.-+.-+-..||||+|++.-||+++++ |.+.
T Consensus       172 ~VP~P~~~------nRHaVvMe~ieG~eL~~~r--~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~d-g~~~  242 (304)
T COG0478         172 KVPKPIAW------NRHAVVMEYIEGVELYRLR--LDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTED-GDIV  242 (304)
T ss_pred             CCCCcccc------ccceeeeehcccceeeccc--CcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecC-CCEE
Confidence            56666664      3346999999997665442  1345555566666666666668999999999999999998 7899


Q ss_pred             EEecccce
Q 015374          261 LIDWGLAE  268 (408)
Q Consensus       261 l~DfG~a~  268 (408)
                      ++||--+.
T Consensus       243 vIDwPQ~v  250 (304)
T COG0478         243 VIDWPQAV  250 (304)
T ss_pred             EEeCcccc
Confidence            99997654

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.72  E-value=2e-07  Score=82.82  Aligned_cols=107  Identities=24%  Similarity=0.342  Sum_probs=82.1

Q ss_pred             hHHHHHHHHHHHHhcCCC--CceEEeeEEEccCC--CccEEEEEeecCC-ChhhhcCC---CChHHHHHHHHHHHHHHHH
Q 015374          163 KKKIKREIKILQNLCGGP--NVVKLLDIVRDQHS--KTPSLIFEYVNST-DFKVLYPT---LTDYDIRYYIYELLKALDY  234 (408)
Q Consensus       163 ~~~~~~E~~~l~~l~~h~--niv~l~~~~~~~~~--~~~~lv~e~~~~~-~l~~~~~~---l~~~~~~~i~~qi~~~L~~  234 (408)
                      .....+|...+..+ ...  .....+++.+...+  ...+||+|++++. +|..++..   .+......++.+++..+.-
T Consensus        55 ~~ra~~E~~~~~~L-~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~  133 (206)
T PF06293_consen   55 RSRAKREWRNLQRL-REAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAK  133 (206)
T ss_pred             chHHHHHHHHHHHH-HHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHH
Confidence            45678888888877 322  34556666554222  2347999999884 78887754   5677778899999999999


Q ss_pred             HHHCCcEEecCCCCcEEEeCCC--CcEEEEecccceec
Q 015374          235 CHSQGIMHRDVKPHNVMIDHEL--RKLRLIDWGLAEFY  270 (408)
Q Consensus       235 LH~~~iiH~Dlk~~NILl~~~~--~~~kl~DfG~a~~~  270 (408)
                      ||+.||+|+|+++.|||++.+.  ..+.++||+.++..
T Consensus       134 lH~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~  171 (206)
T PF06293_consen  134 LHDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR  171 (206)
T ss_pred             HHHCcCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence            9999999999999999999872  27899999988653

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>PRK09902 hypothetical protein; Provisional

Probab=98.65  E-value=6e-07  Score=78.64  Aligned_cols=133  Identities=17%  Similarity=0.147  Sum_probs=94.6

Q ss_pred             eeeeCceEEEEEEEcCCCcEEEEEEec---------ccchHHHHHHHHHHHHhcCC-CCceEEeeEEE---ccCCCccEE
Q 015374          133 VGRGKYSEVFEGINVNTNERCIIKILK---------PVKKKKIKREIKILQNLCGG-PNVVKLLDIVR---DQHSKTPSL  199 (408)
Q Consensus       133 lG~G~fg~Vy~~~~~~~~~~vavK~~~---------~~~~~~~~~E~~~l~~l~~h-~niv~l~~~~~---~~~~~~~~l  199 (408)
                      -|+||-+.|+.-..  .|..+-+|.-.         +.....|.+|...|.++... -.+.+.. ++.   ......-+|
T Consensus        26 ~~rgG~SgV~r~~~--~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~L  102 (216)
T PRK09902         26 YRRNGMSGVQCVER--NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALL  102 (216)
T ss_pred             cCCCCcceEEEEEe--CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEE
Confidence            36788888988642  23356677543         44567899999999988321 1244444 332   112223568


Q ss_pred             EEEeecC-CChhhhcC-----CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCc--EEEEeccccee
Q 015374          200 IFEYVNS-TDFKVLYP-----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRK--LRLIDWGLAEF  269 (408)
Q Consensus       200 v~e~~~~-~~l~~~~~-----~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~--~kl~DfG~a~~  269 (408)
                      |.|-+++ .+|..++.     ..+......++.+++..+.-||+.|+.|+|+.+.|||++.+ +.  ++++||.-++.
T Consensus       103 VTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~-g~~~v~lIDlEk~r~  179 (216)
T PRK09902        103 VTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTE-GKAEAGFLDLEKSRR  179 (216)
T ss_pred             EEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCC-CCeeEEEEEhhccch
Confidence            9997765 57777653     34666677899999999999999999999999999999865 45  99999987754

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=98.58  E-value=1.3e-08  Score=100.44  Aligned_cols=242  Identities=15%  Similarity=0.103  Sum_probs=164.3

Q ss_pred             CCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecccchHHHHHHHHHHHHhcCCCC-ceEEeeEEEccCCCccEEEEEe
Q 015374          125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPN-VVKLLDIVRDQHSKTPSLIFEY  203 (408)
Q Consensus       125 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~h~n-iv~l~~~~~~~~~~~~~lv~e~  203 (408)
                      .-++..+-+++|++++++|.+...+...+ .+++...  ....-++++|.++ +||| .+..++.+  +.+.+.++++++
T Consensus       242 kws~~fh~fvK~altknpKkRptaeklL~-h~fvs~~--l~~rl~~eLLdK~-n~P~~~v~~~~d~--~~E~~~~i~~~i  315 (829)
T KOG0576|consen  242 KWSEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT--LSRRLAIELLDKV-NNPNPVVRYLEDY--DGEDYLWIPMRI  315 (829)
T ss_pred             cchHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc--hhhHHHHHHHHHc-cCCCCcccccccC--Ccccccchhhhh
Confidence            34555667899999999999876666555 6666433  4455688999999 9999 55555555  445678899999


Q ss_pred             ecCC-Chhhhc----CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCCCccee
Q 015374          204 VNST-DFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNV  278 (408)
Q Consensus       204 ~~~~-~l~~~~----~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~~~~~~  278 (408)
                      +..+ +-....    -.+...+...+.+.-+++|++||+..=+|+|    ||+..++  ..+..||+....+........
T Consensus       316 ~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~~--~~~~~~~~v~~~L~~~~~~~t  389 (829)
T KOG0576|consen  316 CSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSEE--EVKLLDFAVPPQLTRTMKPRT  389 (829)
T ss_pred             hcCCccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----ccccccc--ccccccccCCcccCccccccc
Confidence            9887 221111    1244445556677788899999998778888    8888764  679999999887776666677


Q ss_pred             eccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCCC-cccccc
Q 015374          279 RVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKP-WSKFIN  357 (408)
Q Consensus       279 ~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~  357 (408)
                      ..+++.|++||+... ..+....|.|++|+-..++--|..|-..   ....+              ......+ ......
T Consensus       390 ~~~~~~~~~pev~~~-~~~~~~p~~~~~~~~~~~~ap~~pPr~~---P~~~~--------------~~~g~~p~s~~L~~  451 (829)
T KOG0576|consen  390 AIGTPEPLAPEVIQE-NTIDGCPDSGSLAVSAIQMAPGLPPRSS---PPAVL--------------PMIGNGPNSPMLTD  451 (829)
T ss_pred             CCCCCCCCCchhhcc-cccccCCCccCCCcchhhcCCCCCCCCC---Ccccc--------------CCCCCCCCccccch
Confidence            889999999999877 7788999999999866666666555311   00000              0000000 000000


Q ss_pred             ccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccc
Q 015374          358 ADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQV  398 (408)
Q Consensus       358 ~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~~  398 (408)
                      ...+..  ..-.++...|+...|..|++..+++-|.+|+.-
T Consensus       452 ~~aw~~--~~~~~~~~~~~~g~P~~pkv~mgacfsKvfngC  490 (829)
T KOG0576|consen  452 KSAWSP--VFHRDFPAPCLNGLPPTPKVHMGACFSKVFNGC  490 (829)
T ss_pred             hhhcCc--ccccCCcccccCCCCCCCcchhhHHHHHHhccC
Confidence            011110  111258889999999999999999999998753

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.58  E-value=1.3e-06  Score=77.72  Aligned_cols=132  Identities=15%  Similarity=0.231  Sum_probs=92.9

Q ss_pred             eeeeeeCceEEEEEEEcCCCcEEEEEEecccch----------------------HH-----HHHHHHHHHHhc-CCCCc
Q 015374          131 RKVGRGKYSEVFEGINVNTNERCIIKILKPVKK----------------------KK-----IKREIKILQNLC-GGPNV  182 (408)
Q Consensus       131 ~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~----------------------~~-----~~~E~~~l~~l~-~h~ni  182 (408)
                      ..|.+|.-+.||+|. ..++..+|+|+++....                      .+     ..+|..-|.++. .+-.+
T Consensus        54 g~istGKEA~Vy~a~-~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrv  132 (268)
T COG1718          54 GCISTGKEANVYLAE-TGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRV  132 (268)
T ss_pred             eeecCCcceEEEeec-cCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCC
Confidence            367888889999995 46788999999863211                      01     235777777762 23455


Q ss_pred             eEEeeEEEccCCCccEEEEEeecCCC-hhhhcCC--CChHHHHHHHHHHHHHHHHHHH-CCcEEecCCCCcEEEeCCCCc
Q 015374          183 VKLLDIVRDQHSKTPSLIFEYVNSTD-FKVLYPT--LTDYDIRYYIYELLKALDYCHS-QGIMHRDVKPHNVMIDHELRK  258 (408)
Q Consensus       183 v~l~~~~~~~~~~~~~lv~e~~~~~~-l~~~~~~--l~~~~~~~i~~qi~~~L~~LH~-~~iiH~Dlk~~NILl~~~~~~  258 (408)
                      .+.+++.  .    -.|||||++... -.-.++.  +...+...+..++++.+.-|-. .++||+||+.-|||+..  +.
T Consensus       133 P~Pi~~~--~----nVLvMEfIg~~g~pAP~LkDv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~~--~~  204 (268)
T COG1718         133 PEPIAFR--N----NVLVMEFIGDDGLPAPRLKDVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVHD--GE  204 (268)
T ss_pred             CCceeec--C----CeEEEEeccCCCCCCCCcccCCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEEC--Ce
Confidence            5666665  1    249999997752 1222222  2333577788889998888876 89999999999999994  58


Q ss_pred             EEEEecccceecc
Q 015374          259 LRLIDWGLAEFYH  271 (408)
Q Consensus       259 ~kl~DfG~a~~~~  271 (408)
                      +.|+|||-|....
T Consensus       205 p~iID~~QaV~~~  217 (268)
T COG1718         205 PYIIDVSQAVTID  217 (268)
T ss_pred             EEEEECccccccC
Confidence            8999999886544

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.56  E-value=5.7e-07  Score=89.71  Aligned_cols=135  Identities=16%  Similarity=0.353  Sum_probs=87.7

Q ss_pred             eeeeeeCceEEEEEEEcCCCcEEEEEEecccchHH-------------------------------------------HH
Q 015374          131 RKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKK-------------------------------------------IK  167 (408)
Q Consensus       131 ~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~-------------------------------------------~~  167 (408)
                      +.|+.++-|.||+|+. .+|+.||||+..|.-.+.                                           +.
T Consensus       131 ~PiAsASIaQVH~A~L-~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~  209 (517)
T COG0661         131 EPIASASIAQVHRAVL-KSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR  209 (517)
T ss_pred             CchhhhhHhhheeEEe-cCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence            4689999999999985 459999999986533222                                           23


Q ss_pred             HHHHHHHHhc----CCCCceEEeeEEEccCCCccEEEEEeecCCChhhhc--C--CCChHHHHHHHHHHHH-HHHHHHHC
Q 015374          168 REIKILQNLC----GGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY--P--TLTDYDIRYYIYELLK-ALDYCHSQ  238 (408)
Q Consensus       168 ~E~~~l~~l~----~h~niv~l~~~~~~~~~~~~~lv~e~~~~~~l~~~~--~--~l~~~~~~~i~~qi~~-~L~~LH~~  238 (408)
                      +|...+.++.    +.++ +.+-.+|++- ...-+|+|||+.|..+.+..  +  .++...   ++..++. .+..+=..
T Consensus       210 ~EA~n~~~~~~nf~~~~~-v~VP~V~we~-t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~---ia~~~~~~f~~q~~~d  284 (517)
T COG0661         210 REAANAERFRENFKDDPD-VYVPKVYWEY-TTRRVLTMEWIDGIKISDIAALKSAGIDRKE---LAELLVRAFLRQLLRD  284 (517)
T ss_pred             HHHHHHHHHHHHcCCCCC-eEeceeehhc-cCCcEEEEEeeCCEecccHHHHHhcCCCHHH---HHHHHHHHHHHHHHhc
Confidence            3444444331    2233 3333344322 13456999999998776653  2  344333   3333332 23333357


Q ss_pred             CcEEecCCCCcEEEeCCCCcEEEEecccceeccC
Q 015374          239 GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP  272 (408)
Q Consensus       239 ~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~  272 (408)
                      |++|.|.+|.||+++.+ +.+.+.|||+.....+
T Consensus       285 gffHaDpHpGNi~v~~~-g~i~~lDfGi~g~l~~  317 (517)
T COG0661         285 GFFHADPHPGNILVRSD-GRIVLLDFGIVGRLDP  317 (517)
T ss_pred             CccccCCCccceEEecC-CcEEEEcCcceecCCH
Confidence            99999999999999999 8999999999866543

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.54  E-value=1.4e-06  Score=78.43  Aligned_cols=131  Identities=19%  Similarity=0.267  Sum_probs=81.4

Q ss_pred             eeeeeeCceEEEEEEEcCCCcEEEEEEecccc-hHHHHHHHHHHHHhcCCC-CceEEeeEEEccCCCccEEEEEeecCCC
Q 015374          131 RKVGRGKYSEVFEGINVNTNERCIIKILKPVK-KKKIKREIKILQNLCGGP-NVVKLLDIVRDQHSKTPSLIFEYVNSTD  208 (408)
Q Consensus       131 ~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~E~~~l~~l~~h~-niv~l~~~~~~~~~~~~~lv~e~~~~~~  208 (408)
                      ..||.|..+.||+.    .+..+++|...+.. .....+|.+++..+.... .+.+.+++..+  +....+|||+++|..
T Consensus         7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~~~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~--~~~~glv~e~i~G~~   80 (226)
T TIGR02172         7 TQTGEGGNGESYTH----KTGKWMLKLYNPGFDKETIKREFDASRKVFSLGIPTPHPFDLVED--GGRLGLIYELIVGKR   80 (226)
T ss_pred             eeecCCCCcceeEe----cCCCEEEEeCCCCCCHHHHHHHHHHHHHHHHcCCCCCceEEEEec--CCeeeeeeeecCCcc
Confidence            46899999999984    24467789886533 456789999999884332 24677777744  344678999999963


Q ss_pred             -hhhhc---------------------CCC-----ChHHH-HHHHH----------HHHH-HHHHHHH----CCcEEecC
Q 015374          209 -FKVLY---------------------PTL-----TDYDI-RYYIY----------ELLK-ALDYCHS----QGIMHRDV  245 (408)
Q Consensus       209 -l~~~~---------------------~~l-----~~~~~-~~i~~----------qi~~-~L~~LH~----~~iiH~Dl  245 (408)
                       +....                     ..+     ..... ..+-.          .+.. ...+|.+    ..++|+|+
T Consensus        81 ~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~  160 (226)
T TIGR02172        81 SFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDF  160 (226)
T ss_pred             chhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCC
Confidence             11111                     111     10000 00100          0111 1222221    24789999


Q ss_pred             CCCcEEEeCCCCcEEEEeccccee
Q 015374          246 KPHNVMIDHELRKLRLIDWGLAEF  269 (408)
Q Consensus       246 k~~NILl~~~~~~~kl~DfG~a~~  269 (408)
                      .|.||+++.+ + +.|+||+.+..
T Consensus       161 ~~~Nii~~~~-~-~~iIDwe~a~~  182 (226)
T TIGR02172       161 QIGNLITSGK-G-TYWIDLGDFGY  182 (226)
T ss_pred             CCCcEEEcCC-C-cEEEechhcCc
Confidence            9999999987 5 89999998753

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.48  E-value=4.5e-06  Score=75.17  Aligned_cols=138  Identities=21%  Similarity=0.413  Sum_probs=83.5

Q ss_pred             EeeeeeeCceEEEEEEEcCCCcEEEEEEeccc-chHHHHHHHHHHHHhcCC-CCceEEeeEEEcc-CCCccEEEEEeecC
Q 015374          130 VRKVGRGKYSEVFEGINVNTNERCIIKILKPV-KKKKIKREIKILQNLCGG-PNVVKLLDIVRDQ-HSKTPSLIFEYVNS  206 (408)
Q Consensus       130 ~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~E~~~l~~l~~h-~niv~l~~~~~~~-~~~~~~lv~e~~~~  206 (408)
                      ++.|+.|..+.||+.....  ..+++|..... ....+.+|..+++.+.++ ..+.+++.+.... .....+++|+++++
T Consensus         2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g   79 (239)
T PF01636_consen    2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPPDAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPG   79 (239)
T ss_dssp             EEEEEESSSSEEEEEEETT--SEEEEEEESSHHHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESS
T ss_pred             CccCCCCCeeeEEEEEECC--cEEEEEEeCCCCCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEecc
Confidence            4679999999999997544  48999998765 557788999999988433 2356677654332 23346899999999


Q ss_pred             CChhhh----------------c---C----C---CChHH------HHH---H------------HHHHHH-HHHHHHH-
Q 015374          207 TDFKVL----------------Y---P----T---LTDYD------IRY---Y------------IYELLK-ALDYCHS-  237 (408)
Q Consensus       207 ~~l~~~----------------~---~----~---l~~~~------~~~---i------------~~qi~~-~L~~LH~-  237 (408)
                      ..+...                +   .    .   +....      ...   .            ...+.. .+..+++ 
T Consensus        80 ~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (239)
T PF01636_consen   80 RPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEAL  159 (239)
T ss_dssp             EEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHH
T ss_pred             ccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHhh
Confidence            887760                0   0    0   00000      000   0            111222 3333432 


Q ss_pred             ------CCcEEecCCCCcEEEeCCCCcEEEEeccccee
Q 015374          238 ------QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEF  269 (408)
Q Consensus       238 ------~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~  269 (408)
                            ..++|+|+.+.|||++.+.+.+.|+||+.+..
T Consensus       160 ~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~  197 (239)
T PF01636_consen  160 LPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW  197 (239)
T ss_dssp             HHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred             hccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence                  35999999999999994335667999998753

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.48  E-value=2.2e-06  Score=78.21  Aligned_cols=132  Identities=20%  Similarity=0.184  Sum_probs=83.1

Q ss_pred             eeeeCc-eEEEEEEEcCCCcEEEEEEecccchHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccEEEEEeecCCChhh
Q 015374          133 VGRGKY-SEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKV  211 (408)
Q Consensus       133 lG~G~f-g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~~~~l~~  211 (408)
                      |-.|.+ +.||+...  .+..+.+|+..........+|+.+++.+.++--+.+++++....  ...++|||+++|..+..
T Consensus         6 ~~~g~~~~~v~~~~~--~~~~~~vk~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~--~~~~lv~e~i~G~~l~~   81 (244)
T cd05150           6 VTEGQSGATVYRLDG--KNPGLYLKIAPSGPTYELEREAERLRWLAGKLPVPEVIDYGSDD--GRAWLLTSAVPGVPAAA   81 (244)
T ss_pred             cCCCCCcCeEEEEcC--CCCcEEEEecCCCcccchHHHHHHHHHHHhcCCCCeEEEEEecC--CccEEEEEeeCCccHhH
Confidence            333444 78999853  34678889876544556788999999986565566788777443  45679999999987654


Q ss_pred             hc-------------------CCCCh-----H-HHHHHHHH-----------------------HHHHHHHHH-------
Q 015374          212 LY-------------------PTLTD-----Y-DIRYYIYE-----------------------LLKALDYCH-------  236 (408)
Q Consensus       212 ~~-------------------~~l~~-----~-~~~~i~~q-----------------------i~~~L~~LH-------  236 (408)
                      ..                   ..++.     . .......+                       +...+..|-       
T Consensus        82 ~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~  161 (244)
T cd05150          82 LWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAEE  161 (244)
T ss_pred             hhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCcC
Confidence            31                   11110     0 00000000                       111122221       


Q ss_pred             HCCcEEecCCCCcEEEeCCCCcEEEEeccccee
Q 015374          237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEF  269 (408)
Q Consensus       237 ~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~  269 (408)
                      ...++|+|+.|.|||++++ +.+.|+||+.+..
T Consensus       162 ~~~l~HgD~~~~Nil~~~~-~~~~iIDwe~a~~  193 (244)
T cd05150         162 DLVVTHGDACLPNIIVDPG-KFSGFIDLGRLGV  193 (244)
T ss_pred             ceEEECCCCCCccEEEeCC-cEEEEEEcccccc
Confidence            1248999999999999986 6678999998753

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=98.40  E-value=9.9e-07  Score=92.84  Aligned_cols=202  Identities=18%  Similarity=0.229  Sum_probs=139.2

Q ss_pred             HHHHHHHHHHhcCCCCceEEeeEEEccCCCc--cEEEEEeecCCChhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCc
Q 015374          166 IKREIKILQNLCGGPNVVKLLDIVRDQHSKT--PSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGI  240 (408)
Q Consensus       166 ~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~--~~lv~e~~~~~~l~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~i  240 (408)
                      .+-|...+.++ .|+|++.++.|-.......  ..+..+++...++...+   ...+....+.+..++.+||.|+|+...
T Consensus       229 ~E~e~~~l~k~-~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h~~~l  307 (1351)
T KOG1035|consen  229 TEIELESLSKI-AHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLHSLSL  307 (1351)
T ss_pred             HHHHHHHHHhh-ccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHHHhcc
Confidence            34577778888 9999999988865432211  22344677666665555   457888889999999999999999866


Q ss_pred             EEecCCCC---cEEEeCCCCcEEEE--ecccceeccCCCcceeeccCccccccccccCCcCCCc--cccHHHHHHHHHHH
Q 015374          241 MHRDVKPH---NVMIDHELRKLRLI--DWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDY--SLDMWSLGCMFAGM  313 (408)
Q Consensus       241 iH~Dlk~~---NILl~~~~~~~kl~--DfG~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~--~~DvwSlGvil~el  313 (408)
                      .|.-+..+   +-..+.+ +.+.++  ||+.+..............+..+.++|.... ..++.  ..|+|.+|.....+
T Consensus       308 ~~v~L~~s~~~~~~~~~e-~~~~~sl~~~~ss~~l~d~~~~~~~~~~~~~~~~e~~~~-~~~~~~r~~dL~~lgll~~~~  385 (1351)
T KOG1035|consen  308 EHVVLSASSSKESTVDGE-GVVAISLSDFDSSKPLPDNEKSFSDLLAEIRNADEDLKE-NTAKKSRLTDLWCLGLLLLQL  385 (1351)
T ss_pred             ceeEEecccccccccCcc-ceeecchhhhcccccCCCcccchhhcCcccccccccccc-ccchhhhhhHHHHHHHHHhhh
Confidence            66555554   3333444 455666  8888877766555556667777888888765 33443  47999999999999


Q ss_pred             HhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCC
Q 015374          314 IFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHP  393 (408)
Q Consensus       314 l~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp  393 (408)
                      ..|..+-....    ....+..                          .....+..+++.+|+.-|+++|+++.+++.|+
T Consensus       386 ~~~~~i~~~~~----~~~~~l~--------------------------~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~  435 (1351)
T KOG1035|consen  386 SQGEDISEKSA----VPVSLLD--------------------------VLSTSELLDALPKCLDEDSEERLSALELLTHP  435 (1351)
T ss_pred             hhcCccccccc----chhhhhc--------------------------cccchhhhhhhhhhcchhhhhccchhhhhhch
Confidence            88765531111    1111100                          01122688999999999999999999999999


Q ss_pred             Ccccccc
Q 015374          394 YFAQVRA  400 (408)
Q Consensus       394 ~f~~~~~  400 (408)
                      |.+.-..
T Consensus       436 f~~~~~~  442 (1351)
T KOG1035|consen  436 FLRFPTD  442 (1351)
T ss_pred             hcccccc
Confidence            9875444

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.39  E-value=7.1e-06  Score=72.25  Aligned_cols=137  Identities=15%  Similarity=0.251  Sum_probs=88.5

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecccch------------HHHHHHHHHHHHhc--CCCCceEEeeE
Q 015374          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKK------------KKIKREIKILQNLC--GGPNVVKLLDI  188 (408)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~------------~~~~~E~~~l~~l~--~h~niv~l~~~  188 (408)
                      ...+|.+.+.+-......|.+-  .-++..+++|..++...            ....+++..+.++.  +-.....++-+
T Consensus        29 ~~~~~~~~kv~k~~~r~~ValI--ei~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~  106 (229)
T PF06176_consen   29 LDNNYKIIKVFKNTKRNYVALI--EIDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLA  106 (229)
T ss_pred             HhCCceEEEeecCCCccEEEEE--EECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceee
Confidence            3577888888877776666665  34567888998764321            11234444444441  22233333333


Q ss_pred             EEccC---CCccEEEEEeecCCChhhhcCCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecc
Q 015374          189 VRDQH---SKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWG  265 (408)
Q Consensus       189 ~~~~~---~~~~~lv~e~~~~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG  265 (408)
                      .+-..   ....+|+|||++|..+.+.. .+++    .+...+..++.-||+.|+.|+|.+|.|++++.+  .+++.||+
T Consensus       107 ~ekk~~~~~~~~~ll~EYIeG~~l~d~~-~i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~--~i~iID~~  179 (229)
T PF06176_consen  107 AEKKIFRYTSSYVLLMEYIEGVELNDIE-DIDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNN--GIRIIDTQ  179 (229)
T ss_pred             eeeeeccceeEEEEEEEEecCeecccch-hcCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEECC--cEEEEECc
Confidence            22111   13446899999998776542 2222    244567788999999999999999999999965  58999998


Q ss_pred             cce
Q 015374          266 LAE  268 (408)
Q Consensus       266 ~a~  268 (408)
                      ..+
T Consensus       180 ~k~  182 (229)
T PF06176_consen  180 GKR  182 (229)
T ss_pred             ccc
Confidence            764

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=98.35  E-value=4e-06  Score=83.46  Aligned_cols=137  Identities=20%  Similarity=0.273  Sum_probs=86.6

Q ss_pred             eeeeeeCceEEEEEEEcCCCcEEEEEEecccchH----------------------------------------HHHHHH
Q 015374          131 RKVGRGKYSEVFEGINVNTNERCIIKILKPVKKK----------------------------------------KIKREI  170 (408)
Q Consensus       131 ~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~----------------------------------------~~~~E~  170 (408)
                      +.||..+.|.||+|+.+. |+.||||+-++.-.+                                        +|.+|.
T Consensus       167 ~piaaASlaQVhrA~L~~-G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA  245 (538)
T KOG1235|consen  167 EPIAAASLAQVHRARLKN-GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA  245 (538)
T ss_pred             chhhhcchhheEEEEecC-CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence            369999999999998655 999999996542211                                        133344


Q ss_pred             HHHHHhc---CCCC---ceEEeeEEEccCCCccEEEEEeecCCChhhhc----CCCChHHHHHHHHHHHHHHHHHHHCCc
Q 015374          171 KILQNLC---GGPN---VVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGI  240 (408)
Q Consensus       171 ~~l~~l~---~h~n---iv~l~~~~~~~~~~~~~lv~e~~~~~~l~~~~----~~l~~~~~~~i~~qi~~~L~~LH~~~i  240 (408)
                      +-..++.   .|-+   -|.+-.++++- ....+|+||||+|.-+.+..    ..++...+..-+.++..  +-|=..|+
T Consensus       246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~~-st~RVLtME~~~G~~i~Dl~~i~~~gi~~~~i~~~l~~~~~--~qIf~~Gf  322 (538)
T KOG1235|consen  246 KNAERFRENFKDFSLLTYVLVPKVYWDL-STKRVLTMEYVDGIKINDLDAIDKRGISPHDILNKLVEAYL--EQIFKTGF  322 (538)
T ss_pred             HhHHHHHHHHHhcccccceeCCeehhhc-CcceEEEEEecCCccCCCHHHHHHcCCCHHHHHHHHHHHHH--HHHHhcCC
Confidence            3333321   3344   12233344332 23557999999997655442    34666554443333322  22335689


Q ss_pred             EEecCCCCcEEEeC---CCCcEEEEecccceecc
Q 015374          241 MHRDVKPHNVMIDH---ELRKLRLIDWGLAEFYH  271 (408)
Q Consensus       241 iH~Dlk~~NILl~~---~~~~~kl~DfG~a~~~~  271 (408)
                      +|+|-+|.||++++   ....+.+-|||+.....
T Consensus       323 fHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is  356 (538)
T KOG1235|consen  323 FHADPHPGNILVRPNPEGDEEIVLLDHGLYAVIS  356 (538)
T ss_pred             ccCCCCCCcEEEecCCCCCccEEEEccccccccc
Confidence            99999999999994   24689999999987654

>PLN02876 acyl-CoA dehydrogenase

Probab=98.34  E-value=9.7e-06  Score=86.78  Aligned_cols=143  Identities=21%  Similarity=0.353  Sum_probs=91.1

Q ss_pred             EeeeeeeCceEEEEEEEcCCC--cEEEEEEeccc----chHHHHHHHHHHHHhcCCCCc--eEEeeEEEccC-CCccEEE
Q 015374          130 VRKVGRGKYSEVFEGINVNTN--ERCIIKILKPV----KKKKIKREIKILQNLCGGPNV--VKLLDIVRDQH-SKTPSLI  200 (408)
Q Consensus       130 ~~~lG~G~fg~Vy~~~~~~~~--~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~ni--v~l~~~~~~~~-~~~~~lv  200 (408)
                      +..++.|.++.+|+.....++  ..+++|+..+.    ....+.+|..+++.+..|.++  .+++.+|.+.. .+..++|
T Consensus        43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV  122 (822)
T PLN02876         43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI  122 (822)
T ss_pred             EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence            567899999999998654432  35777775432    235788999999999446665  77888886532 2457899


Q ss_pred             EEeecCCChhhh-----------------------cCCCCh----------------HHHHHHHH---------------
Q 015374          201 FEYVNSTDFKVL-----------------------YPTLTD----------------YDIRYYIY---------------  226 (408)
Q Consensus       201 ~e~~~~~~l~~~-----------------------~~~l~~----------------~~~~~i~~---------------  226 (408)
                      |||++|..+...                       +..++.                .++..+..               
T Consensus       123 ME~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~  202 (822)
T PLN02876        123 MEYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQYLASTGEGKPPRNP  202 (822)
T ss_pred             EEecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHHHHhhcccCCCCCh
Confidence            999998653210                       011110                11211111               


Q ss_pred             HHHHHHHHHHH-----------CCcEEecCCCCcEEEeCCC-CcEEEEecccceeccC
Q 015374          227 ELLKALDYCHS-----------QGIMHRDVKPHNVMIDHEL-RKLRLIDWGLAEFYHP  272 (408)
Q Consensus       227 qi~~~L~~LH~-----------~~iiH~Dlk~~NILl~~~~-~~~kl~DfG~a~~~~~  272 (408)
                      .+...+++|..           ..+||+|+++.|||++.+. ...-|.||+++...++
T Consensus       203 ~~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~GdP  260 (822)
T PLN02876        203 KMLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTEDRVIGILDWELSTLGNQ  260 (822)
T ss_pred             hHHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCCCeEEEEEeeeccccCCh
Confidence            12233556642           2499999999999998642 3457999999876543

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=98.26  E-value=2.5e-05  Score=68.00  Aligned_cols=125  Identities=23%  Similarity=0.297  Sum_probs=91.9

Q ss_pred             CCEEEEeeeeeeCc-eEEEEEEEcCCCcEEEEEEecc------------------------cchHHHHHHHHHHHHhc--
Q 015374          125 DDYEVVRKVGRGKY-SEVFEGINVNTNERCIIKILKP------------------------VKKKKIKREIKILQNLC--  177 (408)
Q Consensus       125 ~~y~~~~~lG~G~f-g~Vy~~~~~~~~~~vavK~~~~------------------------~~~~~~~~E~~~l~~l~--  177 (408)
                      .+++.++.||.|.- |.||++..  +|..+|+|+++.                        .....|..|++...+|.  
T Consensus        37 ~~I~flefLg~g~~~~~V~kv~I--~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~  114 (207)
T PF13095_consen   37 DDIEFLEFLGHGSHDGYVFKVEI--DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA  114 (207)
T ss_pred             CcEeeeeecCCCCceeEEEEEEE--CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence            78999999999999 99999954  577999999320                        01134778999988883  


Q ss_pred             CCCCc--eEEeeEEEcc----------------CCCccEEEEEeecCCChhhhcCCCChHHHHHHHHHHHHHHHHHHHCC
Q 015374          178 GGPNV--VKLLDIVRDQ----------------HSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQG  239 (408)
Q Consensus       178 ~h~ni--v~l~~~~~~~----------------~~~~~~lv~e~~~~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~  239 (408)
                      ++.++  |+.+||..-.                ......+|.||.+...      .+...    -+.++..-|..+|..|
T Consensus       115 ~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~------~~~~~----~~~~~~~dl~~~~k~g  184 (207)
T PF13095_consen  115 GREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP------PLQIR----DIPQMLRDLKILHKLG  184 (207)
T ss_pred             cccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc------ccchh----HHHHHHHHHHHHHHCC
Confidence            33455  8999987421                1123457888887654      22333    3567888899999999


Q ss_pred             cEEecCCCCcEEEeCCCCcEEEEecccc
Q 015374          240 IMHRDVKPHNVMIDHELRKLRLIDWGLA  267 (408)
Q Consensus       240 iiH~Dlk~~NILl~~~~~~~kl~DfG~a  267 (408)
                      |+-+|+++.|..   +   -+|+|||.+
T Consensus       185 I~~~Dv~~~ny~---~---G~lvDfs~~  206 (207)
T PF13095_consen  185 IVPRDVKPRNYR---G---GKLVDFSSS  206 (207)
T ss_pred             eeeccCcccccc---C---CEEEecccC
Confidence            999999999986   2   289999964

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=98.18  E-value=1.4e-05  Score=67.46  Aligned_cols=129  Identities=21%  Similarity=0.322  Sum_probs=90.4

Q ss_pred             EEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecc-cchHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccEEEEEeec
Q 015374          127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP-VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVN  205 (408)
Q Consensus       127 y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~-~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~  205 (408)
                      .+....||+|++|.||+|.+.  +..+|+|+-+. ..+..+..|.++|..+..-.--.+++.+-.+      ++.|||..
T Consensus        24 ~~v~~~L~KG~~s~Vyl~~~~--~~~~a~Kvrr~ds~r~~l~kEakiLeil~g~~~~p~vy~yg~~------~i~me~i~   95 (201)
T COG2112          24 LRVEKELAKGTTSVVYLGEWR--GGEVALKVRRRDSPRRNLEKEAKILEILAGEGVTPEVYFYGED------FIRMEYID   95 (201)
T ss_pred             hhhhhhhhcccccEEEEeecc--CceEEEEEecCCcchhhHHHHHHHHHHhhhcCCCceEEEechh------hhhhhhhc
Confidence            344567999999999999654  55889998764 4467899999999998433333456666422      25699999


Q ss_pred             CCChhhhcCCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCC--CcEEEeCCCCcEEEEeccccee
Q 015374          206 STDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKP--HNVMIDHELRKLRLIDWGLAEF  269 (408)
Q Consensus       206 ~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~--~NILl~~~~~~~kl~DfG~a~~  269 (408)
                      |-.|.......+...+    ..++..---|-..||-|+.|.-  .||++.+  +.+.|+||..|+.
T Consensus        96 G~~L~~~~~~~~rk~l----~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~--~~~~iIDFd~At~  155 (201)
T COG2112          96 GRPLGKLEIGGDRKHL----LRVLEKAYKLDRLGIEHGELSRPWKNVLVND--RDVYIIDFDSATF  155 (201)
T ss_pred             CcchhhhhhcccHHHH----HHHHHHHHHHHHhccchhhhcCCceeEEecC--CcEEEEEccchhh
Confidence            9888776544433333    3445554445667999998873  4666665  3789999999873

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=98.15  E-value=2.4e-05  Score=70.95  Aligned_cols=75  Identities=12%  Similarity=0.174  Sum_probs=47.2

Q ss_pred             eeeeeeCce-EEEEEEEcCCCcEEEEEEeccc-chHHHHHHHHHHHHhcCCC--CceEEeeEEEccCC-CccEEEEEeec
Q 015374          131 RKVGRGKYS-EVFEGINVNTNERCIIKILKPV-KKKKIKREIKILQNLCGGP--NVVKLLDIVRDQHS-KTPSLIFEYVN  205 (408)
Q Consensus       131 ~~lG~G~fg-~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~E~~~l~~l~~h~--niv~l~~~~~~~~~-~~~~lv~e~~~  205 (408)
                      +.|+.|+.. .||+.     +..+++|+.+.. ....+.+|.+++..+.++-  -+...++.....+. ...+++|++++
T Consensus         3 ~~~~~gG~~n~vy~~-----~~~~VlR~~~~~~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i~   77 (235)
T cd05155           3 EPVDSGGTDNATFRL-----GDDMSVRLPSAAGYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWLE   77 (235)
T ss_pred             eeccCCCcccceEEc-----CCceEEEcCCccchHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEeec
Confidence            457767766 48875     235778886643 3457889999999884331  23444444322211 24578999999


Q ss_pred             CCChh
Q 015374          206 STDFK  210 (408)
Q Consensus       206 ~~~l~  210 (408)
                      |.++.
T Consensus        78 G~~l~   82 (235)
T cd05155          78 GETAT   82 (235)
T ss_pred             CCCCC
Confidence            97763

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>PRK10593 hypothetical protein; Provisional

Probab=98.05  E-value=9.6e-05  Score=69.47  Aligned_cols=80  Identities=9%  Similarity=0.143  Sum_probs=58.5

Q ss_pred             EEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc-chHHHHHHHHHHHHhcCC--CCceEEeeEEEcc-CCCccEEEEEe
Q 015374          128 EVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-KKKKIKREIKILQNLCGG--PNVVKLLDIVRDQ-HSKTPSLIFEY  203 (408)
Q Consensus       128 ~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~E~~~l~~l~~h--~niv~l~~~~~~~-~~~~~~lv~e~  203 (408)
                      .-.+.||.|..+.||+... .++ .+.+|..+.. ....+..|...++.+.++  -.+.+++++|.+. ..+..+||||+
T Consensus        17 ~~~~~i~~G~~~~vy~~~~-~~~-~~~~k~~~~~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~   94 (297)
T PRK10593         17 SRVECISEQPYAALWALYD-SQG-NPMPLMARSFSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLER   94 (297)
T ss_pred             heeeecCCccceeEEEEEc-CCC-CEEEEEecccccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEec
Confidence            3356799999999999843 233 4667876542 456899999999999554  3678899888643 23457899999


Q ss_pred             ecCCCh
Q 015374          204 VNSTDF  209 (408)
Q Consensus       204 ~~~~~l  209 (408)
                      +++.++
T Consensus        95 i~G~~~  100 (297)
T PRK10593         95 LRGVSV  100 (297)
T ss_pred             cCCEec
Confidence            998654

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=98.04  E-value=0.00013  Score=63.96  Aligned_cols=124  Identities=19%  Similarity=0.377  Sum_probs=87.6

Q ss_pred             eeeeeeCceEEEEEEEcCCCcEEEEEEecccc-------------------hHHHHHHHHHHHHhc-----CCCCceEEe
Q 015374          131 RKVGRGKYSEVFEGINVNTNERCIIKILKPVK-------------------KKKIKREIKILQNLC-----GGPNVVKLL  186 (408)
Q Consensus       131 ~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-------------------~~~~~~E~~~l~~l~-----~h~niv~l~  186 (408)
                      ..||+|+.=.||.-   ..+....||+..+..                   .++..+|+.-...+.     .+.+|.+++
T Consensus         7 ~~i~~G~~R~cy~H---P~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~   83 (199)
T PF10707_consen    7 DLIAQGGERDCYQH---PDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY   83 (199)
T ss_pred             cccccCCCceEEEC---CCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence            36999999999974   344556799988766                   577888988888772     267899999


Q ss_pred             eEEEccCCCccEEEEEeecCC------ChhhhcC--CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCC--
Q 015374          187 DIVRDQHSKTPSLIFEYVNST------DFKVLYP--TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEL--  256 (408)
Q Consensus       187 ~~~~~~~~~~~~lv~e~~~~~------~l~~~~~--~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~--  256 (408)
                      |+.+..  .-+.+|+|.+.+.      +|.+++.  .++. .   +...+-.-..||-+.+|+.+|++|.||++..+.  
T Consensus        84 G~veT~--~G~Glv~e~I~d~dG~~s~TL~~~l~~~~~~~-~---~~~~L~~f~~~l~~~~Iv~~dl~~~NIv~~~~~~~  157 (199)
T PF10707_consen   84 GFVETN--LGLGLVVELIRDADGNISPTLEDYLKEGGLTE-E---LRQALDEFKRYLLDHHIVIRDLNPHNIVVQRRDSG  157 (199)
T ss_pred             EEEecC--CceEEEEEEEECCCCCcCccHHHHHHcCCccH-H---HHHHHHHHHHHHHHcCCeecCCCcccEEEEecCCC
Confidence            999654  4567999987543      3455543  2433 2   233333445677889999999999999996542  


Q ss_pred             C-cEEEEe
Q 015374          257 R-KLRLID  263 (408)
Q Consensus       257 ~-~~kl~D  263 (408)
                      . .+.|+|
T Consensus       158 ~~~lvlID  165 (199)
T PF10707_consen  158 EFRLVLID  165 (199)
T ss_pred             ceEEEEEe
Confidence            2 467776

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=98.03  E-value=3.4e-05  Score=67.28  Aligned_cols=97  Identities=23%  Similarity=0.214  Sum_probs=78.8

Q ss_pred             HHHHHHHHHhcCCCCceEEeeEEEccCCCccEEEEEeecCCChh------hhcCCCChHHHHHHHHHHHHHHHHHHH---
Q 015374          167 KREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFK------VLYPTLTDYDIRYYIYELLKALDYCHS---  237 (408)
Q Consensus       167 ~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~~~~l~------~~~~~l~~~~~~~i~~qi~~~L~~LH~---  237 (408)
                      ..|.-+++.+.+.+++.+++|+|  .  .  .+|.||.+.+++.      ..+...+|..+.+++.+++..+++|+.   
T Consensus         7 ~~E~lll~~l~~~~~~pk~lG~C--G--~--~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~   80 (188)
T PF12260_consen    7 NNEPLLLQLLQGSEPFPKLLGSC--G--R--FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPL   80 (188)
T ss_pred             ccHHHHHHHcCCCCCCCCeeeEC--C--C--EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCC
Confidence            35888899985557999999999  2  2  3799999977553      122346899999999999999999997   


Q ss_pred             CCcEEecCCCCcEEEeCCCCcEEEEecccceec
Q 015374          238 QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY  270 (408)
Q Consensus       238 ~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~  270 (408)
                      ..+.-+|++++|+-++++ +.+|++|.......
T Consensus        81 ~~~~lcDv~~~nfgv~~~-~~lk~iDld~v~~~  112 (188)
T PF12260_consen   81 GFFYLCDVSPDNFGVNDD-GRLKLIDLDDVFVE  112 (188)
T ss_pred             CcEEEeecchHHeEEeCC-CcEEEEechhcchh
Confidence            358889999999999987 78999999876443

Proteins in this uncharacterised family are described as transmembrane proteins.

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=97.91  E-value=0.00016  Score=65.43  Aligned_cols=74  Identities=16%  Similarity=0.297  Sum_probs=49.8

Q ss_pred             EeeeeeeCceEEEEEEEcC-CCcEEEEEEecccch--HHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccEEEEEeecC
Q 015374          130 VRKVGRGKYSEVFEGINVN-TNERCIIKILKPVKK--KKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNS  206 (408)
Q Consensus       130 ~~~lG~G~fg~Vy~~~~~~-~~~~vavK~~~~~~~--~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~~  206 (408)
                      ++.|..|-...+|+..... ++..+++|+......  -...+|+.++..+..+.-..++++.+  .+    .++|||++|
T Consensus         3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~~~d~~~E~~~~~~l~~~gl~P~v~~~~--~~----~~l~e~i~G   76 (235)
T cd05157           3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTELIIDRERELRIHKLLSKHGLAPKLYATF--QN----GLIYEFIPG   76 (235)
T ss_pred             EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCccceecHHHHHHHHHHHHhCCCCCeEEEEe--CC----cEEEEeeCC
Confidence            3567888888999985433 356788998764322  22357999999885444455666554  21    389999998


Q ss_pred             CCh
Q 015374          207 TDF  209 (408)
Q Consensus       207 ~~l  209 (408)
                      ..+
T Consensus        77 ~~l   79 (235)
T cd05157          77 RTL   79 (235)
T ss_pred             CcC
Confidence            765

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>TIGR02721 ycfN_thiK thiamine kinase

Probab=97.80  E-value=0.00021  Score=65.67  Aligned_cols=128  Identities=22%  Similarity=0.256  Sum_probs=76.9

Q ss_pred             eeeeCceEEEEEEEcCCCcEEEEEEecccch---HHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccEEEEEeecCCCh
Q 015374          133 VGRGKYSEVFEGINVNTNERCIIKILKPVKK---KKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDF  209 (408)
Q Consensus       133 lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~~~~l  209 (408)
                      +..|-.+.+|+..  .++..+++|+......   -...+|..+++.+..+.-..+++..+  .    -++||||++|..+
T Consensus         4 ~~~G~tn~~y~~~--~~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~--~----~~~v~e~i~G~~~   75 (256)
T TIGR02721         4 LSGGLTNRSWRIE--HPGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVN--E----HWLLVEWLEGEVI   75 (256)
T ss_pred             CCCcCcCCeEEEE--eCCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEe--C----CEEEEEeccCccc
Confidence            4567788899885  4566788887653322   14578999999984443334455543  2    2599999998765


Q ss_pred             hhh-------c----------CC-------CChH-HHHHHHHHH---------HHHHHHHHH--------CCcEEecCCC
Q 015374          210 KVL-------Y----------PT-------LTDY-DIRYYIYEL---------LKALDYCHS--------QGIMHRDVKP  247 (408)
Q Consensus       210 ~~~-------~----------~~-------l~~~-~~~~i~~qi---------~~~L~~LH~--------~~iiH~Dlk~  247 (408)
                      ...       .          ..       ++.. .+..+..++         ..-+..+-.        ..++|+|+.|
T Consensus        76 ~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~  155 (256)
T TIGR02721        76 TLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHA  155 (256)
T ss_pred             ccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCc
Confidence            321       0          11       1111 111211111         111222221        1489999999


Q ss_pred             CcEEEeCCCCcEEEEecccceec
Q 015374          248 HNVMIDHELRKLRLIDWGLAEFY  270 (408)
Q Consensus       248 ~NILl~~~~~~~kl~DfG~a~~~  270 (408)
                      .||+++.+ + +.|+||+.+...
T Consensus       156 ~Nil~~~~-~-~~lIDwE~a~~g  176 (256)
T TIGR02721       156 YNLVVTPQ-G-LKLIDWEYASDG  176 (256)
T ss_pred             CcEEEeCC-C-CEEEeccccCcC
Confidence            99999987 4 789999988643

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=97.79  E-value=0.00013  Score=68.49  Aligned_cols=137  Identities=14%  Similarity=0.191  Sum_probs=84.5

Q ss_pred             EeeeeeeCceEEEEEEEcCCCcEEEEEEecccchHHHHHHHHHHHHhcCCC-CceEEeeEEEc----cCCCccEEEEEee
Q 015374          130 VRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGP-NVVKLLDIVRD----QHSKTPSLIFEYV  204 (408)
Q Consensus       130 ~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~h~-niv~l~~~~~~----~~~~~~~lv~e~~  204 (408)
                      ++.|..|....+|+...  ++..+++|+...........|+.++..+.++- .+.+++.....    ...+..+.|++|+
T Consensus        19 i~~i~~G~~n~~y~v~~--~~~~~vLr~~~~~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~~i   96 (296)
T cd05153          19 FEGISAGIENTNYFVTT--DSGRYVLTLFEKVSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVEFL   96 (296)
T ss_pred             eecccCccccceEEEEe--CCCcEEEEEcCCCChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEEeC
Confidence            45678888889999853  33468889887655567888999999884331 24454442110    1123567899999


Q ss_pred             cCCChhhh----c--------------CCC----------ChHHH--H--------HHHHHHHHHHHHHHH-------CC
Q 015374          205 NSTDFKVL----Y--------------PTL----------TDYDI--R--------YYIYELLKALDYCHS-------QG  239 (408)
Q Consensus       205 ~~~~l~~~----~--------------~~l----------~~~~~--~--------~i~~qi~~~L~~LH~-------~~  239 (408)
                      +|..+...    .              ..+          .+...  .        .....+...+.++.+       .+
T Consensus        97 ~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~~~  176 (296)
T cd05153          97 AGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLPRG  176 (296)
T ss_pred             CCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCCCc
Confidence            98765320    0              011          10000  0        011112334455543       36


Q ss_pred             cEEecCCCCcEEEeCCCCcEEEEeccccee
Q 015374          240 IMHRDVKPHNVMIDHELRKLRLIDWGLAEF  269 (408)
Q Consensus       240 iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~  269 (408)
                      ++|+|+.|.|||++.+ +.+.|.||+.+..
T Consensus       177 l~HgD~~~~Nil~~~~-~~~~iIDfe~a~~  205 (296)
T cd05153         177 VIHADLFRDNVLFDGD-ELSGVIDFYFACT  205 (296)
T ss_pred             CCccCcCcccEEEeCC-ceEEEeehhhhcC
Confidence            9999999999999986 5668999998753

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=97.68  E-value=0.00052  Score=66.70  Aligned_cols=74  Identities=18%  Similarity=0.239  Sum_probs=52.8

Q ss_pred             EeeeeeeCceEEEEEEEcCCCcEEEEEEecc----------cchHHHHHHHHHHHHhcCC--CCceEEeeEEEccCCCcc
Q 015374          130 VRKVGRGKYSEVFEGINVNTNERCIIKILKP----------VKKKKIKREIKILQNLCGG--PNVVKLLDIVRDQHSKTP  197 (408)
Q Consensus       130 ~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~----------~~~~~~~~E~~~l~~l~~h--~niv~l~~~~~~~~~~~~  197 (408)
                      .+.||.|.+..||++.+..+++.++||.-.+          ...+....|...|..+..+  .++.+++.+-  .  ...
T Consensus        31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D--~--~~~  106 (401)
T PRK09550         31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYD--E--ELA  106 (401)
T ss_pred             eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEEC--C--CCC
Confidence            4579999999999998765446899997431          1345677788888876433  4577777774  2  345


Q ss_pred             EEEEEeecCC
Q 015374          198 SLIFEYVNST  207 (408)
Q Consensus       198 ~lv~e~~~~~  207 (408)
                      ++||||+++.
T Consensus       107 ~lVME~L~~~  116 (401)
T PRK09550        107 VTVMEDLSDH  116 (401)
T ss_pred             EEEEecCCCc
Confidence            6999999864

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=97.64  E-value=0.00048  Score=64.93  Aligned_cols=75  Identities=17%  Similarity=0.232  Sum_probs=50.1

Q ss_pred             EeeeeeeCceEEEEEEEcC------CCcEEEEEEecccc--hHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccEEEE
Q 015374          130 VRKVGRGKYSEVFEGINVN------TNERCIIKILKPVK--KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIF  201 (408)
Q Consensus       130 ~~~lG~G~fg~Vy~~~~~~------~~~~vavK~~~~~~--~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~  201 (408)
                      ++.|..|-...||+.....      .++.+++|+.....  .....+|..++..+..+.-..++++++.  +    .+|+
T Consensus         3 i~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~--~----~~v~   76 (302)
T cd05156           3 VSKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVELLIDRERELVVFARLSERNLGPKLYGIFP--N----GRIE   76 (302)
T ss_pred             EEEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCcceechHHHHHHHHHHHhCCCCCceEEEeC--C----Cchh
Confidence            3456677777899886433      25788999976532  2456789999998854444456666662  2    2689


Q ss_pred             EeecCCChh
Q 015374          202 EYVNSTDFK  210 (408)
Q Consensus       202 e~~~~~~l~  210 (408)
                      ||++|..+.
T Consensus        77 e~i~G~~l~   85 (302)
T cd05156          77 EFIPSRTLT   85 (302)
T ss_pred             heeCCCcCC
Confidence            999887653

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>PRK05231 homoserine kinase; Provisional

Probab=97.57  E-value=0.00084  Score=63.79  Aligned_cols=137  Identities=13%  Similarity=0.211  Sum_probs=77.1

Q ss_pred             EeeeeeeCceEEEEEEEcCCCcEEEEEEecccchHHHHHHHHHHHHhcCC-CCceEEeeEE----EccCCCccEEEEEee
Q 015374          130 VRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGG-PNVVKLLDIV----RDQHSKTPSLIFEYV  204 (408)
Q Consensus       130 ~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~h-~niv~l~~~~----~~~~~~~~~lv~e~~  204 (408)
                      ++.|+.|...++|+... .++ .+++|++.....+....|..++..|..+ -.+.+.+...    .....+..+++++|+
T Consensus        27 ~~~l~~G~~n~~y~v~t-~~g-~~vLK~~~~~~~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~~l  104 (319)
T PRK05231         27 LKGIAEGIENSNFFLTT-TQG-EYVLTLFERLTAEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVTFL  104 (319)
T ss_pred             cchhccccccceEEEEe-CCC-cEEEEEeccCChHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEEec
Confidence            34577888889999853 334 6788987633445566677777776322 1233433211    001124568999999


Q ss_pred             cCCChhh-----h------c-------CCC----------Ch-HHHHH------------HHHH-HHHHHHHHH------
Q 015374          205 NSTDFKV-----L------Y-------PTL----------TD-YDIRY------------YIYE-LLKALDYCH------  236 (408)
Q Consensus       205 ~~~~l~~-----~------~-------~~l----------~~-~~~~~------------i~~q-i~~~L~~LH------  236 (408)
                      +|..+..     .      +       ..+          .+ .....            .+.+ +...++.+.      
T Consensus       105 ~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~  184 (319)
T PRK05231        105 EGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASAAWPA  184 (319)
T ss_pred             CCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhcccccc
Confidence            9875321     1      0       111          01 01000            1111 111223332      


Q ss_pred             -HCCcEEecCCCCcEEEeCCCCcEEEEeccccee
Q 015374          237 -SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEF  269 (408)
Q Consensus       237 -~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~  269 (408)
                       ..++||+|+.+.|||++.+ ...-|+||+.+..
T Consensus       185 lp~~liHgD~~~~Nil~~~~-~~~~iIDf~~~~~  217 (319)
T PRK05231        185 LPRGVIHADLFRDNVLFEGD-RLSGFIDFYFACN  217 (319)
T ss_pred             CCcccCCCCCCCCcEEEECC-ceEEEEecccccC
Confidence             1379999999999999966 4457999998853

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=97.38  E-value=6e-05  Score=81.78  Aligned_cols=207  Identities=12%  Similarity=-0.035  Sum_probs=133.7

Q ss_pred             HHHHHHHHHhcCCCCceEEeeEEEccCCCccEEEEEeecCCChhhhcC-------CCChHHHHHHHHHHHHHHHHHHHC-
Q 015374          167 KREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYP-------TLTDYDIRYYIYELLKALDYCHSQ-  238 (408)
Q Consensus       167 ~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~~~~l~~~~~-------~l~~~~~~~i~~qi~~~L~~LH~~-  238 (408)
                      ..|...++.. .|+++...+.-.....+...+..++|+..|.+...+-       .+...-+.....+...+..-+|+. 
T Consensus      1277 l~e~de~~~~-~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~t 1355 (2724)
T KOG1826|consen 1277 LSERDELREA-KHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLT 1355 (2724)
T ss_pred             hhhhhhhhhh-hceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcc
Confidence            3455555566 8998888777665555566678999999999887761       122223333333436666666654 


Q ss_pred             ----CcEEecCCCCcEEEeCCCCcEEEEecccceeccCC-CcceeeccCccccccccccCCcCCCccccHHHHHHHHHHH
Q 015374          239 ----GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG-KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGM  313 (408)
Q Consensus       239 ----~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~el  313 (408)
                          --+|+++|+-|.++..+ ..++++++|+.+...+. .......+++.|+.|+.... -.++.++|+|+.|+-+|+.
T Consensus      1356 nlg~T~v~~~Lkf~lpmIVtn-y~v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N~-ik~t~rsdilr~s~~ly~r 1433 (2724)
T KOG1826|consen 1356 NLGNTNVSKSLKFTLPMIVTN-YNVKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKNE-IKFTKRSDILRRSLSLYLR 1433 (2724)
T ss_pred             cCCccchhhhhhhhccceecC-CcccccccccccccCchHhhhhhhhCCHHHHHHHHHHH-HhhhhHHHHHHHHHHHHHH
Confidence                17899999999999988 57899999999843322 23345678888999999876 6788889999999999998


Q ss_pred             HhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCC
Q 015374          314 IFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHP  393 (408)
Q Consensus       314 l~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp  393 (408)
                      --|..+|      ...++...+..-         ....     ....+...+.++-.....+|-+.-..||.-...+.-+
T Consensus      1434 s~~n~~f------i~flq~~Lkgii---------dn~t-----f~sIe~l~pgdaNve~~~~Ll~K~~~rp~q~isls~d 1493 (2724)
T KOG1826|consen 1434 SDGNAYF------IFFLQPALKGII---------DNHT-----FFSIEKLKPGDANVEALHRLLWKYMERPGQYISLSRD 1493 (2724)
T ss_pred             hcccHHH------HHHHHHHHcCcc---------cccc-----cccccccCCCcccHHHHHHHHHHhhhcchhhhhcccc
Confidence            8777665      233333222110         0000     0011111223333444445556667788888887777


Q ss_pred             Ccc
Q 015374          394 YFA  396 (408)
Q Consensus       394 ~f~  396 (408)
                      .|.
T Consensus      1494 ~~a 1496 (2724)
T KOG1826|consen 1494 HFA 1496 (2724)
T ss_pred             ccc
Confidence            664

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=97.35  E-value=0.0018  Score=61.27  Aligned_cols=138  Identities=18%  Similarity=0.271  Sum_probs=82.1

Q ss_pred             EEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc-chHHHHHHHHHHHHhcCC-CCceEEeeEEE----ccCCCccEEEEE
Q 015374          129 VVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-KKKKIKREIKILQNLCGG-PNVVKLLDIVR----DQHSKTPSLIFE  202 (408)
Q Consensus       129 ~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~E~~~l~~l~~h-~niv~l~~~~~----~~~~~~~~lv~e  202 (408)
                      .+..++.|....+|+... .++ .+++|+.... .......|..++..|.++ -.+.+++....    ....+..+++++
T Consensus        26 ~i~~~~~G~~n~~y~v~t-~~~-~~vLK~~~~~~~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e  103 (307)
T TIGR00938        26 SLKGIAEGVENSNYLLTT-DVG-RYILTLYEKRVKAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVE  103 (307)
T ss_pred             eccccCCccccceEEEEe-CCC-cEEEEEecCCCCHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEE
Confidence            355677887789998853 344 5778887543 245667788888887322 12444444221    111345689999


Q ss_pred             eecCCChhhh-----------c-------CCCCh-------HHHH----------------HHHHHHHHHHHHHHH----
Q 015374          203 YVNSTDFKVL-----------Y-------PTLTD-------YDIR----------------YYIYELLKALDYCHS----  237 (408)
Q Consensus       203 ~~~~~~l~~~-----------~-------~~l~~-------~~~~----------------~i~~qi~~~L~~LH~----  237 (408)
                      |++|..+...           +       ..++.       ....                .....+...++++..    
T Consensus       104 ~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~  183 (307)
T TIGR00938       104 FLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPR  183 (307)
T ss_pred             eCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhh
Confidence            9988653210           0       11100       0000                001123334555542    


Q ss_pred             ---CCcEEecCCCCcEEEeCCCCcEEEEeccccee
Q 015374          238 ---QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEF  269 (408)
Q Consensus       238 ---~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~  269 (408)
                         .+++|+|+.+.||+++.+ +.+.|+||+.+..
T Consensus       184 ~~~~~l~HgD~~~~Nvl~~~~-~~~~vIDfd~~~~  217 (307)
T TIGR00938       184 DLPRGVIHADLFPDNVLFDGD-SVKGVIDFYFACT  217 (307)
T ss_pred             cCCCccCCCCCCcCcEEEECC-ceEEEeecccccC
Confidence               579999999999999987 5668999998753

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=97.19  E-value=0.0048  Score=58.34  Aligned_cols=133  Identities=18%  Similarity=0.268  Sum_probs=91.4

Q ss_pred             EEeeeeeeCceEEEEEEEcCCCcEEEEEEecccc------------------------hHH-----HHHHHHHHHHhcCC
Q 015374          129 VVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK------------------------KKK-----IKREIKILQNLCGG  179 (408)
Q Consensus       129 ~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~------------------------~~~-----~~~E~~~l~~l~~h  179 (408)
                      +-.+|..|.-+.||.+. ..+|..+|||+++.+-                        ...     .+.|+.-|+++ +.
T Consensus       148 inGCiSTGKEANVYHat-~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl-~~  225 (520)
T KOG2270|consen  148 INGCISTGKEANVYHAT-EEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRL-NN  225 (520)
T ss_pred             cccccccCccceeEeee-cCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHH-Hh
Confidence            34578899999999996 5667789999986321                        011     34688888887 33


Q ss_pred             CCceEEeeEEEccCCCccEEEEEeecCCChhhh-c--CCCChHHHHHHHHHHHHHHHHHH-HCCcEEecCCCCcEEEeCC
Q 015374          180 PNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL-Y--PTLTDYDIRYYIYELLKALDYCH-SQGIMHRDVKPHNVMIDHE  255 (408)
Q Consensus       180 ~niv~l~~~~~~~~~~~~~lv~e~~~~~~l~~~-~--~~l~~~~~~~i~~qi~~~L~~LH-~~~iiH~Dlk~~NILl~~~  255 (408)
                      -.|...--...    ...+|||+++....+..- +  -.++...+..+-.|++.-+.-|- .++.||.||.=-|+|+.. 
T Consensus       226 aGIP~PePIlL----k~hVLVM~FlGrdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Lyhd-  300 (520)
T KOG2270|consen  226 AGIPCPEPILL----KNHVLVMEFLGRDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLYHD-  300 (520)
T ss_pred             cCCCCCCceee----ecceEeeeeccCCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheEEC-
Confidence            33332222221    123599999986554322 2  24666777877788887777774 579999999999999986 


Q ss_pred             CCcEEEEeccccee
Q 015374          256 LRKLRLIDWGLAEF  269 (408)
Q Consensus       256 ~~~~kl~DfG~a~~  269 (408)
                       |.+.|+|-+-+..
T Consensus       301 -G~lyiIDVSQSVE  313 (520)
T KOG2270|consen  301 -GKLYIIDVSQSVE  313 (520)
T ss_pred             -CEEEEEEcccccc
Confidence             5899999887643

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=97.08  E-value=0.0046  Score=59.05  Aligned_cols=138  Identities=17%  Similarity=0.244  Sum_probs=79.9

Q ss_pred             CCEEEEeeeeeeCceEEEEEEEcCC---CcEEEEEEecccchH--HHHHHHHHHHHhcCCCCceEEeeEEEccCCCccEE
Q 015374          125 DDYEVVRKVGRGKYSEVFEGINVNT---NERCIIKILKPVKKK--KIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSL  199 (408)
Q Consensus       125 ~~y~~~~~lG~G~fg~Vy~~~~~~~---~~~vavK~~~~~~~~--~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l  199 (408)
                      +..++. .|..|-...+|+......   +..+++|+.......  .-.+|..+++.+..+.--.++++++  .++    +
T Consensus        15 ~~i~i~-~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~~IdR~~E~~il~~l~~~gl~P~~l~~~--~~G----~   87 (330)
T PLN02421         15 SDFSVE-RISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDYVIDRERELQAIKYLSAAGFGAKLLGVF--GNG----M   87 (330)
T ss_pred             CceEEE-EeCCcccceEEEEEecCCCCCCceEEEEEecCCcCeEechHHHHHHHHHHHhcCCCCceeEEe--CCc----E
Confidence            344444 444477778898854332   337889987643221  2357888999884443335677766  322    6


Q ss_pred             EEEeecCCChhhh-------c----------CC--------C-ChHHHHHHHHHH----------------------HHH
Q 015374          200 IFEYVNSTDFKVL-------Y----------PT--------L-TDYDIRYYIYEL----------------------LKA  231 (408)
Q Consensus       200 v~e~~~~~~l~~~-------~----------~~--------l-~~~~~~~i~~qi----------------------~~~  231 (408)
                      |.+|+++..+...       +          ..        . .+..+..+..++                      ..-
T Consensus        88 i~~fi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  167 (330)
T PLN02421         88 IQSFINARTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDE  167 (330)
T ss_pred             eehhhcCCCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHH
Confidence            8999977655221       0          00        1 112222222221                      111


Q ss_pred             HHHHH----HC----CcEEecCCCCcEEEeCCCCcEEEEeccccee
Q 015374          232 LDYCH----SQ----GIMHRDVKPHNVMIDHELRKLRLIDWGLAEF  269 (408)
Q Consensus       232 L~~LH----~~----~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~  269 (408)
                      +..+.    +.    -++|.|+.+.|||++++.+.++++||..|..
T Consensus       168 ~~~l~~~~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~  213 (330)
T PLN02421        168 IVELKEITDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY  213 (330)
T ss_pred             HHHHHHHhccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence            22221    11    2799999999999986546899999998854

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=97.05  E-value=0.012  Score=55.32  Aligned_cols=124  Identities=19%  Similarity=0.323  Sum_probs=73.7

Q ss_pred             CcEEEEEEec-----ccchHHHHHHHHHHHHhcC-CCCceEEeeEEEccCCCccEEEEEeecCCChhhhcCCCCh-----
Q 015374          150 NERCIIKILK-----PVKKKKIKREIKILQNLCG-GPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTD-----  218 (408)
Q Consensus       150 ~~~vavK~~~-----~~~~~~~~~E~~~l~~l~~-h~niv~l~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~l~~-----  218 (408)
                      ++.++++ ..     ........+|..+++.+.. ---+...+++|.+..-..++.||+|+.|..........+.     
T Consensus        48 ~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veGe~~~~~~~~~~~~~~~~  126 (321)
T COG3173          48 GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEGEVVWSALPPESLGRQFA  126 (321)
T ss_pred             CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecceeccCcCCcccchHHHH
Confidence            6667776 22     1233566788899988732 1233456677754432467899999998433222211000     


Q ss_pred             ------------------------------HHHHHHHHH--------------HHHHHHHHHHC--------CcEEecCC
Q 015374          219 ------------------------------YDIRYYIYE--------------LLKALDYCHSQ--------GIMHRDVK  246 (408)
Q Consensus       219 ------------------------------~~~~~i~~q--------------i~~~L~~LH~~--------~iiH~Dlk  246 (408)
                                                    .++..+..+              ...-..+|+..        .++|+|+.
T Consensus       127 ~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl~~~~p~~~~~~~lvHGD~~  206 (321)
T COG3173         127 LDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWLEANRPPWAGPPVLVHGDYR  206 (321)
T ss_pred             HHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHHHhcCCCcCCCceeeeCCcc
Confidence                                          111111111              12234455432        48999999


Q ss_pred             CCcEEEeCCCCcEEEEecccceeccCCCc
Q 015374          247 PHNVMIDHELRKLRLIDWGLAEFYHPGKE  275 (408)
Q Consensus       247 ~~NILl~~~~~~~kl~DfG~a~~~~~~~~  275 (408)
                      +.|++++++ +.+-|.||+++...++...
T Consensus       207 ~gNlii~~~-~~~gVlDwe~~~lGDP~~D  234 (321)
T COG3173         207 PGNLIIDPG-RPTGVLDWELATLGDPLED  234 (321)
T ss_pred             cCCEEEeCC-CeeEEEeccccccCCcHHH
Confidence            999999998 5689999999987665433

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=96.97  E-value=0.0098  Score=55.26  Aligned_cols=32  Identities=34%  Similarity=0.631  Sum_probs=25.8

Q ss_pred             CcEEecCCCCcEEEeCCCCcEEEEecccceec
Q 015374          239 GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY  270 (408)
Q Consensus       239 ~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~  270 (408)
                      .++|+|+++.|||++++....-|.||+.+...
T Consensus       186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~iG  217 (276)
T cd05152         186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKVG  217 (276)
T ss_pred             eeEeCCCCCCcEEEeCCCCEEEEECcHhcccC
Confidence            48999999999999975234579999998643

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only]

Probab=96.97  E-value=0.0011  Score=65.03  Aligned_cols=176  Identities=18%  Similarity=0.145  Sum_probs=102.5

Q ss_pred             hHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccEEEEEeecCCChhhhcCCCChHHHHHHHHHHHHHHHHHHHCCcEE
Q 015374          163 KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMH  242 (408)
Q Consensus       163 ~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH  242 (408)
                      ..++.-..++++.+ +|+|+...+++.+.... ...+|||++...+-.......  ..       ..+++    .+++.|
T Consensus        26 s~~ilgr~~~lktl-~~~~l~~yl~~~r~~~~-r~IVV~e~~~~Sled~~~~~~--l~-------~~s~~----~~~~~~   90 (725)
T KOG1093|consen   26 SIQILGRFQYLKSL-QHDNLCQYLDFSRGKHE-RVIVVMEHYTMSLEDILKTGN--LK-------DESLL----AHGVLH   90 (725)
T ss_pred             HHHHhhhhHHHHhh-cCccceeeEeeecCccc-eEEEEehhhccchHHHHHhcc--cc-------hhhhc----ccccce
Confidence            34566778889998 99999999998865543 478899998755433222111  00       00111    222222


Q ss_pred             ecCCCCcEEEeCCCCcEEEEecccceeccCCCcceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCC
Q 015374          243 RDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFY  322 (408)
Q Consensus       243 ~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~  322 (408)
                      -             +..+++| -++..    .             |      ....+++||||+|.++.++.-|...+ .
T Consensus        91 ~-------------~~~~~td-~~~t~----~-------------~------~~~~pKsdVwsl~~i~~el~L~~~l~-~  132 (725)
T KOG1093|consen   91 L-------------NIIYITD-HFLTK----Y-------------P------SPIGPKSDVWSLGFIILELYLGISLE-A  132 (725)
T ss_pred             e-------------hhhhccc-ccccc----C-------------C------CCCCcchhhhhHHHHHHHHHHhhHHH-H
Confidence            2             2234444 11100    0             0      11225999999999999999988765 3


Q ss_pred             CCCCHHHHHHHHhhhchhhhhcCCCCCCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccccc
Q 015374          323 GHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVR  399 (408)
Q Consensus       323 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~~~  399 (408)
                      .....+++..+.+...... ..     ....  ........++...+++..+|+-..|..||...++.+++-|.++-
T Consensus       133 ~~~~s~~l~~i~k~~~~d~-~~-----~~~a--~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~k~~i~~ev~  201 (725)
T KOG1093|consen  133 ELTESEYLEILLKYYTDDQ-EL-----LSTA--MEHLIQLLADKKRLPLLKKCLWLEPIIRPLPMELSKRCSFTEVY  201 (725)
T ss_pred             HHHHHHHHHHHHHhccCch-hH-----HHHH--HHHHHHHhhhHhHHHHhccCCccccccccchhHHhcCccHHHHH
Confidence            3333444433333211100 00     0000  00011223567789999999999999999999999999987653

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=96.97  E-value=0.0012  Score=61.28  Aligned_cols=131  Identities=19%  Similarity=0.306  Sum_probs=90.2

Q ss_pred             CEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEec-------cc--c----------------hHHHHHHHHHHHHhcCCC
Q 015374          126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK-------PV--K----------------KKKIKREIKILQNLCGGP  180 (408)
Q Consensus       126 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~-------~~--~----------------~~~~~~E~~~l~~l~~h~  180 (408)
                      -+.+.+.||-|.-+-||.+.+ ..|++.++|+-.       ..  .                +-...+|...|+.|..|.
T Consensus        93 v~svGnqIGVGKESDIY~v~d-~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~g  171 (465)
T KOG2268|consen   93 VESVGNQIGVGKESDIYVVAD-EEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERG  171 (465)
T ss_pred             hhhhccccccccccceEEEec-CCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcC
Confidence            467788999999999999964 457778887521       00  0                112457888888885443


Q ss_pred             C-ceEEeeEEEccCCCccEEEEEeecCCChhhhcCCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcE
Q 015374          181 N-VVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKL  259 (408)
Q Consensus       181 n-iv~l~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~  259 (408)
                      . +.+.+++.      ..|+|||++.+-.+.....-.+...+   ...+..-+--|-..|+||+|..--||+++++ +.+
T Consensus       172 fpVPkpiD~~------RH~Vvmelv~g~Pl~~v~~v~d~~~l---y~~lm~~Iv~la~~GlIHgDFNEFNimv~dd-~~i  241 (465)
T KOG2268|consen  172 FPVPKPIDHN------RHCVVMELVDGYPLRQVRHVEDPPTL---YDDLMGLIVRLANHGLIHGDFNEFNIMVKDD-DKI  241 (465)
T ss_pred             CCCCCccccc------ceeeHHHhhcccceeeeeecCChHHH---HHHHHHHHHHHHHcCceecccchheeEEecC-CCE
Confidence            3 33455543      34789999988776655443344333   3344444556678999999999999999987 789


Q ss_pred             EEEecccc
Q 015374          260 RLIDWGLA  267 (408)
Q Consensus       260 kl~DfG~a  267 (408)
                      +++||--.
T Consensus       242 ~vIDFPQm  249 (465)
T KOG2268|consen  242 VVIDFPQM  249 (465)
T ss_pred             EEeechHh
Confidence            99999743

>PLN02236 choline kinase

Probab=96.95  E-value=0.01  Score=56.99  Aligned_cols=134  Identities=18%  Similarity=0.272  Sum_probs=80.6

Q ss_pred             eeeeeeCceEEEEEEEcC----CCcEEEEEEecccchH--HHHHHHHHHHHhcCCCCceEEeeEEEccCCCccEEEEEee
Q 015374          131 RKVGRGKYSEVFEGINVN----TNERCIIKILKPVKKK--KIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYV  204 (408)
Q Consensus       131 ~~lG~G~fg~Vy~~~~~~----~~~~vavK~~~~~~~~--~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~  204 (408)
                      ..|-.|-...+|+.....    .++.+++|+.......  .-.+|..+++.+..+.--.++++.+  .++    .|.+|+
T Consensus        42 ~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~idR~~E~~~~~~l~~~gl~P~~~~~~--~~g----~v~efi  115 (344)
T PLN02236         42 IPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFDRDDEIRTFECMSRHGQGPRLLGRF--PNG----RVEEFI  115 (344)
T ss_pred             EEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeechHHHHHHHHHHHHcCCCCceEEEE--CCc----eEEEee
Confidence            345557778889875432    2467889988643221  1257999999885554445677776  322    689999


Q ss_pred             cCCChhhh-------c----------CC--------C-ChHHHHHHHHH-----------------HHHHHHHHH-----
Q 015374          205 NSTDFKVL-------Y----------PT--------L-TDYDIRYYIYE-----------------LLKALDYCH-----  236 (408)
Q Consensus       205 ~~~~l~~~-------~----------~~--------l-~~~~~~~i~~q-----------------i~~~L~~LH-----  236 (408)
                      ++.++...       .          ..        . .+..+..+..+                 +...+..|.     
T Consensus       116 ~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~  195 (344)
T PLN02236        116 HARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSG  195 (344)
T ss_pred             CCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhcc
Confidence            87665321       0          00        1 11222222211                 111122222     


Q ss_pred             ---HCCcEEecCCCCcEEEeCCCCcEEEEecccceec
Q 015374          237 ---SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY  270 (408)
Q Consensus       237 ---~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~  270 (408)
                         ...++|+|+++.|||++++.+.+.++||..+...
T Consensus       196 ~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~~  232 (344)
T PLN02236        196 DDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASYN  232 (344)
T ss_pred             cCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhcccc
Confidence               1258999999999999875467999999988643

>PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2

Probab=96.68  E-value=0.0085  Score=53.24  Aligned_cols=113  Identities=18%  Similarity=0.273  Sum_probs=59.1

Q ss_pred             CcEEEEEEecccc--hHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccEEEEEeecCCChhhh--c------------
Q 015374          150 NERCIIKILKPVK--KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL--Y------------  213 (408)
Q Consensus       150 ~~~vavK~~~~~~--~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~~~~l~~~--~------------  213 (408)
                      ++.|+||+.....  .-.-..|..+++.+..+..-.++++++  .++    +|.+|+++..+...  .            
T Consensus         2 ~~~~~~Ri~g~~t~~~idr~~E~~~~~~l~~~g~~p~~~~~~--~~g----~v~e~i~g~~l~~~~~~~~~~~~~iA~~l   75 (211)
T PF01633_consen    2 PEKYLVRIPGEGTENFIDRENENEALKLLSEAGLGPKIIYFF--ENG----RVEEFIEGRTLSPEDFRNPEILKRIAKLL   75 (211)
T ss_dssp             TSEEEEEEEESCGCSHHHHHHHHHHHHHHHHTTSSS-EEEEE--TTE----EEEE--SSEE--CGGGGSHHHHHHHHHHH
T ss_pred             CCEEEEEeCCCCcccccCHHHHHHHHHHHHHcCCCCeEEEEc--CCC----cEEEEecccccChhhccChHHHHHHHHHH
Confidence            4578888886542  234557888888886565667788877  322    78899977664321  0            


Q ss_pred             ---CCC----------ChHHHHHH----------------------HHHHHHHHHHHHH--------CCcEEecCCCCcE
Q 015374          214 ---PTL----------TDYDIRYY----------------------IYELLKALDYCHS--------QGIMHRDVKPHNV  250 (408)
Q Consensus       214 ---~~l----------~~~~~~~i----------------------~~qi~~~L~~LH~--------~~iiH~Dlk~~NI  250 (408)
                         ...          -+..+..+                      +.++..-+..+.+        ..++|+|+.+.||
T Consensus        76 ~~lH~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~~v~cHnDl~~~Ni  155 (211)
T PF01633_consen   76 AKLHSIPISPNSKKPDLWDRIDKYMNKKSEFLFKRKKKKKSIDKEDLEDLQEELEELEKLLEKSNSPLVFCHNDLNPGNI  155 (211)
T ss_dssp             HHHHTHHHTTSSSS-HHHHHHHHHHHHHHTCCCCHHTTTCHHHHHHHHHHHHHHHHHHHHHHTSCGGEEEE-S--SGGGE
T ss_pred             HHHhhcccccccCcchHHHHhhhhccchhhhhhhhhhhccccccCCHHHHHHHHhhhhhhhhccCCCceEeeccCccccE
Confidence               000          00111111                      1112222333221        2489999999999


Q ss_pred             EE-eCCCCcEEEEeccccee
Q 015374          251 MI-DHELRKLRLIDWGLAEF  269 (408)
Q Consensus       251 Ll-~~~~~~~kl~DfG~a~~  269 (408)
                      |+ +.+ +.++++||..|..
T Consensus       156 l~~~~~-~~~~lIDfEya~~  174 (211)
T PF01633_consen  156 LINNKD-GEVKLIDFEYAGY  174 (211)
T ss_dssp             EETSSS-SCEEE--GTT-EE
T ss_pred             EeccCC-CeEEEecHHHHhh
Confidence            99 444 7999999998854

7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B ....

>COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only]

Probab=96.66  E-value=0.016  Score=55.03  Aligned_cols=133  Identities=25%  Similarity=0.314  Sum_probs=82.0

Q ss_pred             eeeeCceEEEEEEEcCCCcEEEEEEeccc-chHHHHHHHHHHHHhcCCCC-----ceEEeeEEEccCCC--ccEEEEEee
Q 015374          133 VGRGKYSEVFEGINVNTNERCIIKILKPV-KKKKIKREIKILQNLCGGPN-----VVKLLDIVRDQHSK--TPSLIFEYV  204 (408)
Q Consensus       133 lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~E~~~l~~l~~h~n-----iv~l~~~~~~~~~~--~~~lv~e~~  204 (408)
                      |.+ .-..||+... .+++. ++|+..+. ...++.-|+..+..|..+.-     +..+=|-....-..  ...-+++|+
T Consensus        34 l~s-~eN~~f~~~~-~~g~~-iLki~~~~~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~~l  110 (331)
T COG2334          34 LNS-EENSNFRVQT-EDGRY-ILKIYRPGWTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFEYL  110 (331)
T ss_pred             ccc-ccCceEEEEe-cCCCe-EEEEecCCCCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEEec
Confidence            444 5567888853 33444 89999875 66788889999998844321     22222211111123  667889999


Q ss_pred             cCCChhh-hc------------------CC-----------CChH----HH---------HHHHHHHHHHHHHHHHC---
Q 015374          205 NSTDFKV-LY------------------PT-----------LTDY----DI---------RYYIYELLKALDYCHSQ---  238 (408)
Q Consensus       205 ~~~~l~~-~~------------------~~-----------l~~~----~~---------~~i~~qi~~~L~~LH~~---  238 (408)
                      +|..+.. ..                  +.           ..|.    ..         .....++...++.+.+.   
T Consensus       111 ~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~~~  190 (331)
T COG2334         111 PGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARLPA  190 (331)
T ss_pred             CCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhchh
Confidence            9988772 11                  11           1221    00         11234455555555532   


Q ss_pred             -----C--cEEecCCCCcEEEeCCCCcEEEEecccce
Q 015374          239 -----G--IMHRDVKPHNVMIDHELRKLRLIDWGLAE  268 (408)
Q Consensus       239 -----~--iiH~Dlk~~NILl~~~~~~~kl~DfG~a~  268 (408)
                           +  +||+|+.+.||+++.+...+.+.|||-+.
T Consensus       191 ~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~  227 (331)
T COG2334         191 HLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG  227 (331)
T ss_pred             hCCcccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence                 3  99999999999999883347899999874

>KOG1236 consensus Predicted unusual protein kinase [General function prediction only]

Probab=96.64  E-value=0.0064  Score=58.26  Aligned_cols=124  Identities=20%  Similarity=0.198  Sum_probs=76.7

Q ss_pred             eeeeeCceEEEEEEE---------------cCCCcEEEEEEecccchHHHHHHHHHHHHhcCCCCceEEeeEEEc-----
Q 015374          132 KVGRGKYSEVFEGIN---------------VNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRD-----  191 (408)
Q Consensus       132 ~lG~G~fg~Vy~~~~---------------~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~-----  191 (408)
                      .||.|+-+.||+|..               ..+.+.+|+|+.++...+++.....||.....-+|++.-..+..-     
T Consensus       196 PIGsG~IAQVY~atl~~a~lekd~~~~~~~~~~tq~~AiKv~Hp~V~~~ir~Dl~Il~f~Akl~~~vP~l~wL~l~~~vk  275 (565)
T KOG1236|consen  196 PIGSGCIAQVYRATLKTAYLEKDSGKEYVQKLGTQSCAIKVLHPNVEKQIRLDLGILGFGAKLINNVPDLSWLSLPLEVK  275 (565)
T ss_pred             ccccchhhhhhhhhhhHHHhhcccchhhhcCCccceeeeeccCccHHHHHHHHHHHHhhhhhhhhhcCccccccCcchHH
Confidence            699999999999862               223457999999887777777766666644322222221111100     


Q ss_pred             ---------------------------------------cCCCccEEEEEeecCCChhhhcCC--CChHHHHHHHHHHHH
Q 015374          192 ---------------------------------------QHSKTPSLIFEYVNSTDFKVLYPT--LTDYDIRYYIYELLK  230 (408)
Q Consensus       192 ---------------------------------------~~~~~~~lv~e~~~~~~l~~~~~~--l~~~~~~~i~~qi~~  230 (408)
                                                             +-.....|+=+|+.|.++..++..  .++.-.+.++.--..
T Consensus       276 qF~v~ln~QvdL~~EA~hL~rF~~NF~~s~~V~fP~P~~~~~~~~vl~E~~~~Gl~v~~~v~~~~~pe~l~kkva~lg~~  355 (565)
T KOG1236|consen  276 QFSVGLNAQVDLRQEALHLPRFTNNFSGSKKVLFPKPIAPLHTDLVLVETYERGLSVLRFVKWKSQPEALVKKVAKLGVN  355 (565)
T ss_pred             HHHHHHHhhcchhhhhhhhHHHHHhcccceeecCCcccccccccceeeeeccccccHHhhhhcccChHHHHHHHHHHHHH
Confidence                                                   001123455567888777777644  444344555544445


Q ss_pred             HHHHH-HHCCcEEecCCCCcEEEeCC
Q 015374          231 ALDYC-HSQGIMHRDVKPHNVMIDHE  255 (408)
Q Consensus       231 ~L~~L-H~~~iiH~Dlk~~NILl~~~  255 (408)
                      +|.-+ --.+++|.|+.|.||++..+
T Consensus       356 AllkMl~vDNFvHaDlHPGNVlirf~  381 (565)
T KOG1236|consen  356 ALLKMLIVDNFVHADLHPGNVLIRFN  381 (565)
T ss_pred             HHHHHHHhhcceecccCCCcEEEEec
Confidence            54433 34689999999999999654

>PTZ00384 choline kinase; Provisional

Probab=96.52  E-value=0.035  Score=54.05  Aligned_cols=74  Identities=16%  Similarity=0.176  Sum_probs=46.7

Q ss_pred             eeeeeeCceEEEEEEEcCCC-c-----EEEEEEecccch--HHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccEEEEE
Q 015374          131 RKVGRGKYSEVFEGINVNTN-E-----RCIIKILKPVKK--KKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFE  202 (408)
Q Consensus       131 ~~lG~G~fg~Vy~~~~~~~~-~-----~vavK~~~~~~~--~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e  202 (408)
                      ..|..|-...+|++...... .     .|.+++......  -.-.+|+.+++.+..+..=.++++.+  .+    +++.|
T Consensus        56 ~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f--~~----g~l~e  129 (383)
T PTZ00384         56 KKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTYNSLVIDNDLQYNIAKLLGDNNFGPKIIGRF--GD----FTIQE  129 (383)
T ss_pred             EEeCCcccceEEEEEecCCCCCccccceEEEEeccCCCceEeccHHHHHHHHHHHhCCCCCeEEEec--CC----EEEEE
Confidence            35555888899998643321 1     245554322111  12356899999996665667788887  32    39999


Q ss_pred             eecCCChh
Q 015374          203 YVNSTDFK  210 (408)
Q Consensus       203 ~~~~~~l~  210 (408)
                      |++|..+.
T Consensus       130 fIeGr~l~  137 (383)
T PTZ00384        130 WVEGNTMG  137 (383)
T ss_pred             EeccccCC
Confidence            99987654

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=96.44  E-value=0.031  Score=53.47  Aligned_cols=72  Identities=18%  Similarity=0.275  Sum_probs=46.0

Q ss_pred             eeeeeCceEEEEEEEcCCCcEEEEEEecc----------cchHHHHHHHHHHHHhcCC-C-CceEEeeEEEccCCCccEE
Q 015374          132 KVGRGKYSEVFEGINVNTNERCIIKILKP----------VKKKKIKREIKILQNLCGG-P-NVVKLLDIVRDQHSKTPSL  199 (408)
Q Consensus       132 ~lG~G~fg~Vy~~~~~~~~~~vavK~~~~----------~~~~~~~~E~~~l~~l~~h-~-niv~l~~~~~~~~~~~~~l  199 (408)
                      .||.|....||++.+..+++.++||--.+          -..++..-|...|+..... | .+.+++.+-    .....+
T Consensus         2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~D----~e~~~~   77 (370)
T TIGR01767         2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHFD----TEMAVT   77 (370)
T ss_pred             cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEEc----ccccee
Confidence            47999999999998754446789986421          1234455677777765322 3 455566553    234458


Q ss_pred             EEEeecCC
Q 015374          200 IFEYVNST  207 (408)
Q Consensus       200 v~e~~~~~  207 (408)
                      |||+++..
T Consensus        78 vMEdL~~~   85 (370)
T TIGR01767        78 VMEDLSHH   85 (370)
T ss_pred             hHhhCccc
Confidence            99998653

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=96.27  E-value=0.036  Score=51.67  Aligned_cols=77  Identities=14%  Similarity=0.190  Sum_probs=49.9

Q ss_pred             EEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecccchHHHHHHHHHHHHhc--CCCCceEEeeEEEccCCCccEEEEEee
Q 015374          127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLC--GGPNVVKLLDIVRDQHSKTPSLIFEYV  204 (408)
Q Consensus       127 y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~--~h~niv~l~~~~~~~~~~~~~lv~e~~  204 (408)
                      .+-.+.++.|....+|+..  .++..+.||+-.......|..|..-|+.|.  .--.+.+.+++....  ...+|||||+
T Consensus        19 i~~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~--~~~fLlle~l   94 (288)
T PF03881_consen   19 ITSIEPVSGGDINEAYRLD--TDGGSYFVKVNSESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYD--DDAFLLLEFL   94 (288)
T ss_dssp             --EEEEE--SSSSEEEEEE--TTS-EEEEEEEEGGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-S--SCCEEEEE--
T ss_pred             eeeeEecCCCChhheEEEE--CCCccEEEEecChhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeec--CCceEEEEee
Confidence            4456689999999999985  677789999987666778999999999883  233567888877554  3447999999


Q ss_pred             cCC
Q 015374          205 NST  207 (408)
Q Consensus       205 ~~~  207 (408)
                      +.+
T Consensus        95 ~~~   97 (288)
T PF03881_consen   95 EMG   97 (288)
T ss_dssp             ---
T ss_pred             cCC
Confidence            877

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=95.94  E-value=0.047  Score=51.62  Aligned_cols=30  Identities=20%  Similarity=0.338  Sum_probs=26.7

Q ss_pred             CcEEecCCCCcEEEeCCCCcEEEEeccccee
Q 015374          239 GIMHRDVKPHNVMIDHELRKLRLIDWGLAEF  269 (408)
Q Consensus       239 ~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~  269 (408)
                      ++||+|+.++|+|++.+ +.+-++||..+..
T Consensus       197 ~lcHgD~~~~Nvl~~~~-~~~~iIDfd~~~~  226 (309)
T TIGR02904       197 VLVHGKLSLSHFLYDET-RGGYFINFEKASF  226 (309)
T ss_pred             eeeCCCCcHHhEEEcCC-CCEEEEEhhhccc
Confidence            69999999999999887 6789999998854

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>PLN02756 S-methyl-5-thioribose kinase

Probab=95.88  E-value=0.097  Score=51.04  Aligned_cols=71  Identities=18%  Similarity=0.296  Sum_probs=48.8

Q ss_pred             EeeeeeeCceEEEEEEEcCCCcEEEEEEecc----------cchHHHHHHHHHHHHhcC--CCCceEEeeEEEccCCCcc
Q 015374          130 VRKVGRGKYSEVFEGINVNTNERCIIKILKP----------VKKKKIKREIKILQNLCG--GPNVVKLLDIVRDQHSKTP  197 (408)
Q Consensus       130 ~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~----------~~~~~~~~E~~~l~~l~~--h~niv~l~~~~~~~~~~~~  197 (408)
                      .+.||.|....||+..+  .+..++||.-.+          ....+...|...|+.+..  -.++.+++.++.+    .-
T Consensus        37 ~~eiggGn~N~VyrV~~--~~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~ded----~~  110 (418)
T PLN02756         37 IKEVGDGNLNFVYIVVS--SSGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDRT----MA  110 (418)
T ss_pred             EEEcCCCceeeEEEEEc--CCccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECCC----CC
Confidence            56789999999999875  344688887531          123444556777766522  2478889998843    34


Q ss_pred             EEEEEeecC
Q 015374          198 SLIFEYVNS  206 (408)
Q Consensus       198 ~lv~e~~~~  206 (408)
                      +++|||+++
T Consensus       111 vlvME~L~~  119 (418)
T PLN02756        111 LIGMRYLEP  119 (418)
T ss_pred             EEEEeecCC
Confidence            689999977

>PRK12396 5-methylribose kinase; Reviewed

Probab=95.76  E-value=0.031  Score=54.14  Aligned_cols=73  Identities=21%  Similarity=0.249  Sum_probs=47.7

Q ss_pred             EeeeeeeCceEEEEEEEcCCCcEEEEEEec---------ccchHHHHHHHHHHHHhcC-CC-CceEEeeEEEccCCCccE
Q 015374          130 VRKVGRGKYSEVFEGINVNTNERCIIKILK---------PVKKKKIKREIKILQNLCG-GP-NVVKLLDIVRDQHSKTPS  198 (408)
Q Consensus       130 ~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~---------~~~~~~~~~E~~~l~~l~~-h~-niv~l~~~~~~~~~~~~~  198 (408)
                      ++.||.|.-..||++.+..++..|+||--.         +-..++..-|...|+.... -| .+.+++.+=.    ....
T Consensus        34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~D~----e~~~  109 (409)
T PRK12396         34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLFDS----VMNC  109 (409)
T ss_pred             eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEECc----HHhh
Confidence            567899999999999874445678888642         1223556667777776532 23 4556666532    3345


Q ss_pred             EEEEeecC
Q 015374          199 LIFEYVNS  206 (408)
Q Consensus       199 lv~e~~~~  206 (408)
                      +|||+++.
T Consensus       110 ~vMEdL~~  117 (409)
T PRK12396        110 CVMEDLSD  117 (409)
T ss_pred             HHHHhCcc
Confidence            88998864

>PRK06148 hypothetical protein; Provisional

Probab=95.34  E-value=0.25  Score=54.44  Aligned_cols=136  Identities=18%  Similarity=0.294  Sum_probs=76.5

Q ss_pred             eeeeeeCceEEEEEEEcCCCcEEEEEEecccc-hHHHHHHHHHHHHhcCC-CC--ceEEee--------EEEccCC-Ccc
Q 015374          131 RKVGRGKYSEVFEGINVNTNERCIIKILKPVK-KKKIKREIKILQNLCGG-PN--VVKLLD--------IVRDQHS-KTP  197 (408)
Q Consensus       131 ~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~E~~~l~~l~~h-~n--iv~l~~--------~~~~~~~-~~~  197 (408)
                      +.|+ |..-.+|+.. ..++..+++|+.++.. ......|...+..|..+ +.  +.+.+-        .+....+ ...
T Consensus        31 ~~L~-s~~d~nf~v~-~~~g~~yVLKi~~~~~~~~~~~~q~~~L~hL~~~~~glpvP~~i~t~~G~~~~~v~~~~G~~~~  108 (1013)
T PRK06148         31 TPLD-GERDLNFRLT-TDDGADYILKIVNPSEPRVESDFQTAALDHLAAVAPDLPVPRLIPSLSGASLASAQDPDGEPRL  108 (1013)
T ss_pred             eecC-CcCCceEEEE-eCCCCeEEEEEcCCccchhHHHHHHHHHHHHHhhCCCCCcCeeeecCCCCeEEEeecCCCceEE
Confidence            3454 3456778874 4566789999998543 34555677777766332 22  223221        1111112 245


Q ss_pred             EEEEEeecCCChhhhc---------------------C---------CCChH-----------------HHHHHHHHHHH
Q 015374          198 SLIFEYVNSTDFKVLY---------------------P---------TLTDY-----------------DIRYYIYELLK  230 (408)
Q Consensus       198 ~lv~e~~~~~~l~~~~---------------------~---------~l~~~-----------------~~~~i~~qi~~  230 (408)
                      +-+++|++|..+....                     .         .+.|.                 ..+.++.+++.
T Consensus       109 vrLl~~l~G~~l~~~~~~t~~~~~~lG~~larlh~al~~F~~p~~~r~~~Wdl~~~~~l~~~l~~i~d~~~r~~l~~~~~  188 (1013)
T PRK06148        109 LRLLSWLPGTPLAEAAPRTEALLDNLGRALGRLDRALQGFMHPGALRDLDWDLRHAGRARDRLHFIDDPEDRALVERFLA  188 (1013)
T ss_pred             EEEEeccCCCcHHhccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccccccccccchhhhhhhhhcCCHHHHHHHHHHHH
Confidence            6789999997765410                     0         01111                 11222333333


Q ss_pred             HHHH-----HHH--CCcEEecCCCCcEEEeCCCC-cE-EEEecccce
Q 015374          231 ALDY-----CHS--QGIMHRDVKPHNVMIDHELR-KL-RLIDWGLAE  268 (408)
Q Consensus       231 ~L~~-----LH~--~~iiH~Dlk~~NILl~~~~~-~~-kl~DfG~a~  268 (408)
                      .++-     +.+  .++||+|+.+.|||++.+.. .+ -|+|||-+.
T Consensus       189 ~~~~~v~p~l~~Lp~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~  235 (1013)
T PRK06148        189 RFERNVAPRLAALPAQVIHNDANDYNILVDADDGERISGLIDFGDAV  235 (1013)
T ss_pred             HHHHHHHHHHhcCCcceECCCCCcccEEEcCCCCcceEEEEECcccc
Confidence            3221     211  47999999999999997631 34 499999874

>PRK11768 serine/threonine protein kinase; Provisional

Probab=95.30  E-value=0.33  Score=46.24  Aligned_cols=72  Identities=17%  Similarity=0.161  Sum_probs=43.3

Q ss_pred             eCceEEEEEEEcCCCcEEEEEEeccc--chHHHHHHHHHHHHhcCCC-CceEEe---e-EEEccCCCccEEEEEeecCCC
Q 015374          136 GKYSEVFEGINVNTNERCIIKILKPV--KKKKIKREIKILQNLCGGP-NVVKLL---D-IVRDQHSKTPSLIFEYVNSTD  208 (408)
Q Consensus       136 G~fg~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~~h~-niv~l~---~-~~~~~~~~~~~lv~e~~~~~~  208 (408)
                      +.-..||+.. ..++..+++|+.++.  ....+..|+..+..|..+. .++...   | .+. ..++..+.++++++|..
T Consensus        36 s~eN~vy~v~-~~~~~~~vlKv~r~~~~~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~-~~~g~~~~l~~~~~G~~  113 (325)
T PRK11768         36 SYENRVYQFG-DEDGRRVVAKFYRPERWSDAQILEEHAFALELAEAEIPVVAPLAFNGQTLH-EHQGFRFALFPRRGGRA  113 (325)
T ss_pred             cccceEEEEe-cCCCCEEEEEEcCcccCCHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEE-EECCEEEEEEeeeCCCC
Confidence            3456788885 455667999998754  3566778888888774321 122211   1 111 11245677899998764


Q ss_pred             h
Q 015374          209 F  209 (408)
Q Consensus       209 l  209 (408)
                      .
T Consensus       114 ~  114 (325)
T PRK11768        114 P  114 (325)
T ss_pred             C
Confidence            3

>PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length

Probab=94.88  E-value=0.15  Score=45.16  Aligned_cols=111  Identities=19%  Similarity=0.248  Sum_probs=70.4

Q ss_pred             eCceEEEEEEEcCCCcEEEEEEeccc----chHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccEEEEEeecCCChhh
Q 015374          136 GKYSEVFEGINVNTNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKV  211 (408)
Q Consensus       136 G~fg~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~~~~l~~  211 (408)
                      |+-++.-.+...- | ...+|.+...    ...-+..+.+++.++   -.|+++..    .++..+.++.|+|.....  
T Consensus        73 ~gNsTl~~~kt~i-G-~L~lKKi~slp~~~~~~~y~nky~v~Arm---hGilrL~N----Dn~~~yGvIlE~Cy~~~i--  141 (308)
T PF07387_consen   73 NGNSTLLIGKTKI-G-PLFLKKIRSLPCCINDALYFNKYRVFARM---HGILRLKN----DNNYKYGVILERCYKIKI--  141 (308)
T ss_pred             CCceEEEEecccc-c-hhhhhhccCCCcccchhhhhhhhhHHHHh---hheeEeec----CCCceeEEEEeeccCccc--
Confidence            4445554443222 3 3345544321    345678899999987   25777762    344566789998864221  


Q ss_pred             hcCCCChHHHHHHHHHHHHHHHHHHH--CCcEEecCCCCcEEEeCCCCcEEEEeccc
Q 015374          212 LYPTLTDYDIRYYIYELLKALDYCHS--QGIMHRDVKPHNVMIDHELRKLRLIDWGL  266 (408)
Q Consensus       212 ~~~~l~~~~~~~i~~qi~~~L~~LH~--~~iiH~Dlk~~NILl~~~~~~~kl~DfG~  266 (408)
                             .. ..++.-=++.|.-.|+  .+.+|+|..|+||+-|.. |-+||.|-+.
T Consensus       142 -------~~-~N~i~agi~~L~~fH~~~~~~lHGD~np~NiM~D~~-G~lKlVDP~~  189 (308)
T PF07387_consen  142 -------NF-SNFITAGIKDLMDFHSENQHCLHGDCNPDNIMCDKF-GYLKLVDPVC  189 (308)
T ss_pred             -------ch-hHHHHHhHHHHHHhhccCCCeecCCCChhheeecCC-CCEEecChhh
Confidence                   11 1122222466788884  479999999999999998 8999999875

The function of this family is unknown.

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=94.81  E-value=0.12  Score=49.21  Aligned_cols=104  Identities=18%  Similarity=0.259  Sum_probs=67.7

Q ss_pred             CccEEEEEeecCCChhhhcCCCChHHHHHHHHHHHHHHHHHHHC-CcEEecCCCCcEEEeCCCCcEEEEecccceeccCC
Q 015374          195 KTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQ-GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG  273 (408)
Q Consensus       195 ~~~~lv~e~~~~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~-~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~  273 (408)
                      .+.+++|++-.+  -...++.-.+.++..++.+.+.-++-+..+ ..=|||+...||||+ + |.+.|+||-+++.-.++
T Consensus       299 ~y~yl~~kdhgt--~is~ik~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~-GnvtLIDfklsRl~~~q  374 (488)
T COG5072         299 LYLYLHFKDHGT--PISIIKADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-E-GNVTLIDFKLSRLSYSQ  374 (488)
T ss_pred             eEEEEEEecCCc--eeeeeecccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-c-CceEEEEeeeeecccCC
Confidence            344555554332  222344566788888888888877777765 689999999999999 5 79999999999854433


Q ss_pred             CcceeeccCccccccccccCCcCCCccccHHHHHH
Q 015374          274 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGC  308 (408)
Q Consensus       274 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv  308 (408)
                      .....    ...--|-.+.|  .-+..-|||-+--
T Consensus       375 ~~isy----~rldhp~lF~G--~dd~QFeIYrlMr  403 (488)
T COG5072         375 GIISY----NRLDHPDLFNG--VDDYQFEIYRLMR  403 (488)
T ss_pred             ceeec----cccCchhhhcC--ccceeeeHHHHHH
Confidence            22111    12223444544  3366778876533

>PTZ00296 choline kinase; Provisional

Probab=94.77  E-value=0.43  Score=47.39  Aligned_cols=78  Identities=17%  Similarity=0.204  Sum_probs=49.2

Q ss_pred             CCEEEEeeeeeeCceEEEEEEEcCC--------CcEEEEEEecccchH--HHHHHHHHHHHhcCCCCceEEeeEEEccCC
Q 015374          125 DDYEVVRKVGRGKYSEVFEGINVNT--------NERCIIKILKPVKKK--KIKREIKILQNLCGGPNVVKLLDIVRDQHS  194 (408)
Q Consensus       125 ~~y~~~~~lG~G~fg~Vy~~~~~~~--------~~~vavK~~~~~~~~--~~~~E~~~l~~l~~h~niv~l~~~~~~~~~  194 (408)
                      ++. -++.|..|-.-.+|++.....        ++.|++++.......  .-.+|..+++.+..+.-=.++++.+  .+ 
T Consensus       106 ~~I-~i~~l~gGlTN~~f~v~~~~~~~~~~~~~~~~~lvRiyG~~te~lIdR~~E~~v~~~ls~~gi~P~l~~~f--~g-  181 (442)
T PTZ00296        106 DDV-RVNQILSGLTNQLFEVSLKEETANNYPSIRRRVLFRIYGKDVDELYNPISEFEVYKTMSKYRIAPQLLNTF--SG-  181 (442)
T ss_pred             ccE-EEEEecCcccCceEEEEecCCCCccccCcCceEEEEecCCCccceeCHHHHHHHHHHHHHCCCCCceEEEe--CC-
Confidence            344 456677777788898864422        467889987543321  2346888888874443334677766  22 


Q ss_pred             CccEEEEEeecCCCh
Q 015374          195 KTPSLIFEYVNSTDF  209 (408)
Q Consensus       195 ~~~~lv~e~~~~~~l  209 (408)
                         +.|.||++|..+
T Consensus       182 ---g~I~efi~g~~l  193 (442)
T PTZ00296        182 ---GRIEEWLYGDPL  193 (442)
T ss_pred             ---CEEEEeeCCccC
Confidence               268999998744

>PF03109 ABC1: ABC1 family; InterPro: IPR004147 This entry includes ABC1 from yeast [] and AarF from Escherichia coli []

Probab=94.53  E-value=0.019  Score=45.99  Aligned_cols=45  Identities=18%  Similarity=0.379  Sum_probs=39.5

Q ss_pred             eeeeeeCceEEEEEEEcCCCcEEEEEEecccchHHHHHHHHHHHHh
Q 015374          131 RKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNL  176 (408)
Q Consensus       131 ~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l  176 (408)
                      +.||.|+.|.||+|+. .+|+.||||+.++.-.+.+...+.+++.+
T Consensus        17 ~PlasASiaQVh~a~l-~~g~~VaVKV~rP~i~~~i~~Dl~~l~~~   61 (119)
T PF03109_consen   17 EPLASASIAQVHRARL-KDGEEVAVKVQRPGIEEQIEADLRILRRL   61 (119)
T ss_pred             chhhheehhhheeeee-cccchhhhhhcchHHHHHHHHHHHHHHHH
Confidence            3699999999999975 45999999999998888898888888876

These proteins have a nuclear or mitochondrial subcellular location in eukaryotes. The exact molecular functions of these proteins is not clear, however yeast ABC1 suppresses a cytochrome b mRNA translation defect and is essential for the electron transfer in the bc 1 complex [] and E. coli AarF is required for ubiquinone production []. It has been suggested that members of the ABC1 family are novel chaperonins []. These proteins are unrelated to the ABC transporter proteins.

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	408
1ds5_A	332	Dimeric Crystal Structure Of The Alpha Subunit In C		1e-159
4anm_A	335	Complex Of Ck2 With A Cdc7 Inhibitor Length = 335		1e-159
2qc6_A	332	Protein Kinase Ck2 In Complex With Dbc Length = 332		1e-158
2pvh_A	352	Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri		1e-158
3pvg_A	331	Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C		1e-158
1daw_A	327	Crystal Structure Of A Binary Complex Of Protein Ki		1e-156
1m2p_A	325	Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra		1e-155
3kxg_A	327	Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun		1e-155
4dgm_A	326	Crystal Structure Of Maize Ck2 In Complex With The		1e-155
4dgn_A	326	Crystal Structure Of Maize Ck2 In Complex With The		1e-155
1na7_A	329	Crystal Structure Of The Catalytic Subunit Of Human		1e-127
3juh_A	335	Crystal Structure Of A Mutant Of Human Protein Kina		1e-127
2zjw_A	340	Crystal Structure Of Human Ck2 Alpha Complexed With		1e-127
3u87_A	349	Structure Of A Chimeric Construct Of Human Ck2alpha		1e-127
3nga_A	333	Human Ck2 Catalytic Domain In Complex With Cx-4945		1e-127
2r7i_A	335	Crystal Structure Of Catalytic Subunit Of Protein K		1e-127
3h30_A	334	Crystal Structure Of The Catalytic Subunit Of Human		1e-127
1jwh_A	337	Crystal Structure Of Human Protein Kinase Ck2 Holoe		1e-127
1pjk_A	334	Crystal Structure Of A C-terminal Deletion Mutant O		1e-127
3q9w_A	336	Crystal Structure Of Human Ck2 Alpha In Complex Wit		1e-127
3bqc_A	335	High Ph-Value Crystal Structure Of Emodin In Comple		1e-127
3nsz_A	330	Human Ck2 Catalytic Domain In Complex With Amppn Le		1e-127
3mb6_A	331	Human Ck2 Catalytic Domain In Complex With A Difura		1e-127
3q04_A	328	Crystal Structure Of The Apo-Form Of Human Ck2 Alph		1e-126
4dgl_C	335	Crystal Structure Of The Ck2 Tetrameric Holoenzyme		1e-126
3e3b_X	339	Crystal Structure Of Catalytic Subunit Of Human Pro		1e-121
3ofm_A	350	Structure Of A Human Ck2alpha Prime, The Paralog Is		1e-120
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		2e-32
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		3e-32
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		5e-32
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		5e-32
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		5e-32
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		6e-32
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		6e-32
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		7e-32
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		7e-32
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		8e-32
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		1e-31
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		1e-31
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		1e-31
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		1e-31
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		1e-31
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		1e-31
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		1e-31
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		1e-31
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		1e-31
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		2e-31
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		2e-31
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		3e-31
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		3e-31
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		3e-31
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		4e-31
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		4e-31
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		4e-31
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		4e-31
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		4e-31
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		5e-31
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		5e-31
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		6e-31
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		6e-31
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		6e-31
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		7e-31
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		7e-31
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		2e-30
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		2e-30
3eb0_A	383	Crystal Structure Of Cgd4_240 From Cryptosporidium		2e-30
4exu_A	371	Mapk13, Inactive Form Length = 371		1e-27
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		1e-27
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		1e-27
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		1e-27
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		2e-27
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		2e-27
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		2e-27
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		2e-27
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		2e-27
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		2e-27
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		2e-27
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		2e-27
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		2e-27
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		2e-27
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		2e-27
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		2e-27
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		2e-27
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		3e-27
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		3e-27
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		3e-27
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		3e-27
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		3e-27
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		3e-27
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		3e-27
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		4e-27
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		4e-27
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		5e-27
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		5e-27
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		1e-26
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		1e-26
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		2e-26
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		2e-26
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		3e-26
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		3e-26
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		3e-26
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		4e-26
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		2e-25
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-25
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		3e-25
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		3e-25
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		3e-25
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		3e-25
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		3e-25
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		4e-25
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		4e-25
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		4e-25
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		4e-25
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		4e-25
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		4e-25
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		4e-25
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		4e-25
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		4e-25
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		4e-25
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		5e-25
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		5e-25
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		5e-25
2oza_B	366	Structure Of P38alpha Complex Length = 366		5e-25
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		5e-25
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		5e-25
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		5e-25
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		5e-25
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		5e-25
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		5e-25
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		5e-25
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		5e-25
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		6e-25
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		6e-25
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		6e-25
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		6e-25
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		6e-25
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		6e-25
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		6e-25
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		6e-25
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		6e-25
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		6e-25
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		6e-25
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		6e-25
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		6e-25
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		6e-25
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		6e-25
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		6e-25
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		6e-25
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		6e-25
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		6e-25
3hec_A	348	P38 In Complex With Imatinib Length = 348		6e-25
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		6e-25
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		6e-25
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		7e-25
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		7e-25
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		7e-25
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		7e-25
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		7e-25
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		7e-25
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		7e-25
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		7e-25
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		7e-25
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		8e-25
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		9e-25
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		9e-25
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		9e-25
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		9e-25
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		9e-25
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		9e-25
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		9e-25
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		9e-25
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		9e-25
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		9e-25
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		9e-25
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		9e-25
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		1e-24
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		1e-24
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		1e-24
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		1e-24
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		1e-24
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		1e-24
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-24
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		1e-24
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		2e-24
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		2e-24
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-24
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		2e-24
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		3e-24
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		5e-24
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		2e-23
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		6e-23
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		9e-23
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		1e-22
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		2e-22
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		7e-22
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		2e-21
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		3e-21
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		3e-21
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		3e-21
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		3e-21
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		3e-21
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		3e-21
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		4e-20
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		4e-20
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		7e-20
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		1e-19
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		4e-19
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		5e-19
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		7e-19
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		8e-19
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		9e-19
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		1e-18
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		1e-18
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		1e-18
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		1e-18
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		1e-18
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		2e-18
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		2e-18
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		2e-18
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		2e-18
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		2e-18
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		2e-18
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		2e-18
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		3e-18
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		4e-18
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		4e-18
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		4e-18
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		4e-18
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		4e-18
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		4e-18
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		4e-18
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		4e-18
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		4e-18
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		5e-18
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		5e-18
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		5e-18
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		6e-18
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		8e-18
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		1e-17
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		2e-17
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		4e-17
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		4e-17
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		5e-17
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		1e-16
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		2e-16
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		4e-16
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		6e-16
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		6e-16
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		2e-15
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		2e-15
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		2e-15
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		3e-15
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		3e-15
4fie_A	423	Full-Length Human Pak4 Length = 423		5e-15
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		8e-15
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		8e-15
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		8e-15
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		8e-15
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		8e-15
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		1e-14
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		1e-14
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		1e-14
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		1e-14
4f99_A	361	Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti		1e-14
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		1e-14
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		2e-14
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		2e-14
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		2e-14
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		2e-14
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		2e-14
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		2e-14
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		3e-14
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		3e-14
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		3e-14
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		3e-14
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		3e-14
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		4e-14
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		4e-14
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		4e-14
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		4e-14
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		4e-14
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		4e-14
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		5e-14
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		5e-14
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		5e-14
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		5e-14
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		5e-14
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		5e-14
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		5e-14
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		6e-14
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		6e-14
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		6e-14
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		7e-14
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		7e-14
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		7e-14
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		7e-14
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		7e-14
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		7e-14
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		7e-14
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		8e-14
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		8e-14
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		8e-14
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		9e-14
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		9e-14
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		1e-13
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		1e-13
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		1e-13
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		1e-13
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		1e-13
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		2e-13
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		2e-13
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		2e-13
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		2e-13
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		3e-13
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		3e-13
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		3e-13
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		3e-13
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		3e-13
2wu6_A	381	Crystal Structure Of The Human Clk3 In Complex With		4e-13
2eu9_A	355	Crystal Structure Of Clk3 Length = 355		4e-13
2exe_A	357	Crystal Structure Of The Phosphorylated Clk3 Length		4e-13
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		4e-13
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		5e-13
3soa_A	444	Full-Length Human Camkii Length = 444		5e-13
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		5e-13
3nr9_A	368	Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length		5e-13
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		6e-13
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		6e-13
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		7e-13
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		8e-13
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		9e-13
3kvw_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		1e-12
3kk8_A	284	Camkii Substrate Complex A Length = 284		1e-12
3kk9_A	282	Camkii Substrate Complex B Length = 282		1e-12
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		1e-12
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		1e-12
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		1e-12
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		1e-12
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		1e-12
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		1e-12
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		1e-12
4azf_A	417	Human Dyrk2 In Complex With Leucettine L41 Length =		1e-12
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		1e-12
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		1e-12
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		1e-12
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		2e-12
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		2e-12
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		2e-12
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		2e-12
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-12
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		2e-12
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		2e-12
3k2l_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		2e-12
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		2e-12
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		2e-12
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		2e-12
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		2e-12
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		2e-12
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		2e-12
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		2e-12
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		2e-12
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		3e-12
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		3e-12
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		3e-12
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		3e-12
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		3e-12
3g51_A	325	Structural Diversity Of The Active Conformation Of		3e-12
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		3e-12
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		3e-12
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		3e-12
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		3e-12
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		3e-12
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		3e-12
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		3e-12
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		3e-12
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		3e-12
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		3e-12
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		3e-12
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		3e-12
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		3e-12
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		3e-12
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-12
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		3e-12
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		3e-12
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		4e-12
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		4e-12
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		4e-12
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		4e-12
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		4e-12
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		4e-12
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		4e-12
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		4e-12
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		4e-12
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		4e-12
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		4e-12
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		4e-12
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		4e-12
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		4e-12
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		4e-12
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		4e-12
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		4e-12
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		5e-12
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		5e-12
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		5e-12
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		5e-12
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		5e-12
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		5e-12
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		5e-12
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		6e-12
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		6e-12
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		6e-12
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		7e-12
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		7e-12
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		7e-12
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		7e-12
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		7e-12
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		7e-12
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		7e-12
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		7e-12
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		7e-12
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		7e-12
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		8e-12
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		8e-12
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		8e-12
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		8e-12
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		8e-12
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		8e-12
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		8e-12
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		9e-12
2oza_A	356	Structure Of P38alpha Complex Length = 356		9e-12
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		9e-12
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		9e-12
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		9e-12
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		9e-12
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		1e-11
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		1e-11
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		1e-11
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		1e-11
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		1e-11
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		1e-11
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		1e-11
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		1e-11
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		1e-11
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		1e-11
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		1e-11
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		1e-11
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		1e-11
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		2e-11
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		2e-11
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		2e-11
1z57_A	339	Crystal Structure Of Human Clk1 In Complex With 10z		2e-11
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		2e-11
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		2e-11
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		2e-11
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		2e-11
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-11
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		4e-11
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		4e-11
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		4e-11
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		4e-11
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		5e-11
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		5e-11
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		5e-11
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		7e-11
2vag_A	339	Crystal Structure Of Di-Phosphorylated Human Clk1 I		7e-11
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		9e-11
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		1e-10
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		1e-10
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		1e-10
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		1e-10
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		1e-10
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		1e-10
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		1e-10
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		1e-10
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		1e-10
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		2e-10
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		2e-10
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		2e-10
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		2e-10
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		2e-10
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		2e-10
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		2e-10
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		2e-10
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		2e-10
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		2e-10
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		2e-10
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		2e-10
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-10
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		2e-10
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		2e-10
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		2e-10
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		2e-10
3anq_A	368	Human Dyrk1aINHIBITOR COMPLEX Length = 368		2e-10
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-10
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		2e-10
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		2e-10
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-10
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		2e-10
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		2e-10
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		2e-10
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		2e-10
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		2e-10
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		2e-10
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		2e-10
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		2e-10
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		2e-10
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		2e-10
2vx3_A	382	Crystal Structure Of The Human Dual Specificity Tyr		2e-10
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		2e-10
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-10
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		2e-10
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		2e-10
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		2e-10
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-10
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		3e-10
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		3e-10
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		3e-10
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		3e-10
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		3e-10
4aze_A	382	Human Dyrk1a In Complex With Leucettine L41 Length		3e-10
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		3e-10
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		3e-10
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		3e-10
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		3e-10
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		3e-10
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		3e-10
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		3e-10
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		3e-10
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		3e-10
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		3e-10
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		4e-10
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		4e-10
3a7f_A	303	Human Mst3 Kinase Length = 303		4e-10
3llt_A	360	Crystal Structure Of Pf14_0431, Kinase Domain Lengt		4e-10
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		4e-10
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		4e-10
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		4e-10
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		5e-10
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		5e-10
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		5e-10
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		5e-10
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		6e-10
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		7e-10
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		7e-10
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		9e-10
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		1e-09
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		1e-09
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		1e-09
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		1e-09
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		1e-09
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		1e-09
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		1e-09
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		1e-09
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		1e-09
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		2e-09
4alu_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		2e-09
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		2e-09
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		2e-09
1nxk_A	400	Crystal Structure Of Staurosporine Bound To Map Kap		3e-09
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		3e-09
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		4e-09
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		4e-09
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		4e-09
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		5e-09
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		6e-09
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		6e-09
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		1e-08
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		1e-08
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		1e-08
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		1e-08
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		1e-08
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		2e-08
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		2e-08
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		2e-08
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		2e-08
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		2e-08
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		2e-08
3kga_A	299	Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe		3e-08
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		4e-08
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		4e-08
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		5e-08
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		5e-08
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		5e-08
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		5e-08
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		5e-08
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		6e-08
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		6e-08
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		6e-08
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		7e-08
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		7e-08
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		8e-08
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		9e-08
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		1e-07
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		2e-07
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		2e-07
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		2e-07
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		2e-07
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		2e-07
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		2e-07
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		2e-07
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		2e-07
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		2e-07
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		2e-07
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		3e-07
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		3e-07
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		3e-07
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		4e-07
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		4e-07
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		5e-07
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		5e-07
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		5e-07
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		5e-07
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		5e-07
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		5e-07
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		5e-07
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		6e-07
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		6e-07
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		7e-07
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		7e-07
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		8e-07
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		8e-07
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		9e-07
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		9e-07
1q8y_A	373	The Structure Of The Yeast Sr Protein Kinase, Sky1p		9e-07
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		9e-07
1how_A	373	The X-Ray Crystal Structure Of Sky1p, An Sr Protein		1e-06
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		1e-06
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		1e-06
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		1e-06
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		1e-06
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		1e-06
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		1e-06
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		1e-06
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		1e-06
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		1e-06
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		1e-06
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		2e-06
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		2e-06
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		2e-06
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		2e-06
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		2e-06
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		2e-06
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		2e-06
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		2e-06
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		2e-06
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		2e-06
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		2e-06
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		2e-06
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		2e-06
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		2e-06
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		2e-06
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		2e-06
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		2e-06
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		2e-06
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		2e-06
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		2e-06
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		2e-06
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		2e-06
4ae6_A	343	Structure And Function Of The Human Sperm-specific		2e-06
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		2e-06
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		2e-06
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		2e-06
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		2e-06
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		2e-06
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		2e-06
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		2e-06
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		2e-06
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		2e-06
4ae9_A	343	Structure And Function Of The Human Sperm-specific		2e-06
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		2e-06
2pzi_A	681	Crystal Structure Of Protein Kinase Pkng From Mycob		2e-06
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		2e-06
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		2e-06
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		2e-06
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		2e-06
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		3e-06
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		3e-06
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		3e-06
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		4e-06
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		4e-06
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		5e-06
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		5e-06
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		6e-06
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		8e-06
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		8e-06
3a4o_X	286	Lyn Kinase Domain Length = 286		1e-05
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		1e-05
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		2e-05
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		2e-05
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		2e-05
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		2e-05
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		2e-05
3lj0_A	434	Ire1 Complexed With Adp And Quercetin Length = 434		2e-05
3sv0_A	483	Crystal Structure Of Casein Kinase-1 Like Protein I		2e-05
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		2e-05
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		3e-05
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		3e-05
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		3e-05
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		3e-05
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		3e-05
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		3e-05
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		4e-05
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		5e-05
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		5e-05
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		6e-05
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		7e-05
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		8e-05
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		8e-05
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		8e-05
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		8e-05
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		8e-05
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		8e-05
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		8e-05
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		9e-05
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		9e-05
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		1e-04
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-04
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		1e-04
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		2e-04
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		2e-04
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		2e-04
4h58_A	275	Braf In Complex With Compound 3 Length = 275		2e-04
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-04
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		2e-04
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		2e-04
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		2e-04
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		2e-04
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		2e-04
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		2e-04
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		2e-04
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		2e-04
2wtk_B	373	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		2e-04
3gni_B	389	Structure Of Strad And Mo25 Length = 389		2e-04
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		2e-04
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-04
3b2t_A	311	Structure Of Phosphotransferase Length = 311		3e-04
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-04
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		3e-04
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		3e-04
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		3e-04
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-04
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		3e-04
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-04
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-04
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		3e-04
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		3e-04
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-04
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		3e-04
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		3e-04
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		3e-04
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		4e-04
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		4e-04
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		4e-04
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		4e-04
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		4e-04
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		4e-04
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		5e-04
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		5e-04
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		6e-04
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		6e-04
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		6e-04
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		6e-04
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		6e-04
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		7e-04
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		7e-04
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		7e-04
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		7e-04
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		7e-04
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		7e-04
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		8e-04
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		8e-04
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		8e-04
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		8e-04
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		8e-04
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		8e-04
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		8e-04
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		8e-04
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		9e-04
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		9e-04

>pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332

Iteration: 1
 Score =  559 bits (1440), Expect = e-159,   Method: Compositional matrix adjust.
 Identities = 274/332 (82%), Positives = 284/332 (85%), Gaps = 17/332 (5%)
Query: 94  MSKARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERC 153
           MSKARVY DVNVLRPKEYWDYE+LTVQWG+QDDYEVVRKVGRGKYSEVFEGINVN NE+C
Sbjct: 1   MSKARVYADVNVLRPKEYWDYEALTVQWGEQDDYEVVRKVGRGKYSEVFEGINVNNNEKC 60
Query: 154 XXXXXXXXXXXXXXXXXXXLQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY 213
                              LQNLCGGPN+VKLLDIVRDQHSKTPSLIFEYVN+TDFKVLY
Sbjct: 61  IIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVLY 120
Query: 214 PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG 273
           PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG
Sbjct: 121 PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG 180
Query: 274 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI 333
           KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI
Sbjct: 181 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI 240
Query: 334 AK---DCCLIIWCN--------------SRHSRKPWSKFINADNQHLVSPEAIDFLDKLL 376
           AK      L ++ N               RHSRKPW KF+NADNQHLVSPEAIDFLDKLL
Sbjct: 241 AKVLGTDGLNVYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLL 300
Query: 377 RYDHQDRLTAREAMAHPYFAQVRAAESSRTRA 408
           RYDHQ+RLTA EAM HPYF QVRAAE+SRTRA
Sbjct: 301 RYDHQERLTALEAMTHPYFQQVRAAENSRTRA 332

>pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335

Iteration: 1
 Score =  556 bits (1433), Expect = e-159,   Method: Compositional matrix adjust.
 Identities = 273/331 (82%), Positives = 283/331 (85%), Gaps = 17/331 (5%)
Query: 95  SKARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCX 154
           SKARVY DVNVLRPKEYWDYE+LTVQWG+QDDYEVVRKVGRGKYSEVFEGINVN NE+C 
Sbjct: 3   SKARVYADVNVLRPKEYWDYEALTVQWGEQDDYEVVRKVGRGKYSEVFEGINVNNNEKCI 62
Query: 155 XXXXXXXXXXXXXXXXXXLQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYP 214
                             LQNLCGGPN+VKLLDIVRDQHSKTPSLIFEYVN+TDFKVLYP
Sbjct: 63  IKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVLYP 122
Query: 215 TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 274
           TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK
Sbjct: 123 TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 182
Query: 275 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA 334
           EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA
Sbjct: 183 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA 242
Query: 335 K---DCCLIIWCN--------------SRHSRKPWSKFINADNQHLVSPEAIDFLDKLLR 377
           K      L ++ N               RHSRKPW KF+NADNQHLVSPEAIDFLDKLLR
Sbjct: 243 KVLGTDGLNVYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLR 302
Query: 378 YDHQDRLTAREAMAHPYFAQVRAAESSRTRA 408
           YDHQ+RLTA EAM HPYF QVRAAE+SRTRA
Sbjct: 303 YDHQERLTALEAMTHPYFQQVRAAENSRTRA 333

>pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332

Iteration: 1
 Score =  555 bits (1431), Expect = e-158,   Method: Compositional matrix adjust.
 Identities = 273/332 (82%), Positives = 283/332 (85%), Gaps = 17/332 (5%)
Query: 94  MSKARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERC 153
           MSKARVY DVNVLRPKEYWDYE+LTVQWG+QDDYEVVRKVGRGKYSEVFEGINVN NE+C
Sbjct: 1   MSKARVYADVNVLRPKEYWDYEALTVQWGEQDDYEVVRKVGRGKYSEVFEGINVNNNEKC 60
Query: 154 XXXXXXXXXXXXXXXXXXXLQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY 213
                              LQNL GGPN+VKLLDIVRDQHSKTPSLIFEYVN+TDFKVLY
Sbjct: 61  IIKILKPVKKKKIKREIKILQNLXGGPNIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVLY 120
Query: 214 PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG 273
           PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG
Sbjct: 121 PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG 180
Query: 274 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI 333
           KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI
Sbjct: 181 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI 240
Query: 334 AK---DCCLIIWCN--------------SRHSRKPWSKFINADNQHLVSPEAIDFLDKLL 376
           AK      L ++ N               RHSRKPW KF+NADNQHLVSPEAIDFLDKLL
Sbjct: 241 AKVLGTDGLNVYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLL 300
Query: 377 RYDHQDRLTAREAMAHPYFAQVRAAESSRTRA 408
           RYDHQ+RLTA EAM HPYF QVRAAE+SRTRA
Sbjct: 301 RYDHQERLTALEAMTHPYFQQVRAAENSRTRA 332

>pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352

Iteration: 1
 Score =  553 bits (1426), Expect = e-158,   Method: Compositional matrix adjust.
 Identities = 273/332 (82%), Positives = 282/332 (84%), Gaps = 17/332 (5%)
Query: 94  MSKARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERC 153
           MSKARVY DVNVLRPKEYWDYE+LTVQWG+QDDYEVVRKVGRGKYSEVFEGINVN NE+C
Sbjct: 21  MSKARVYADVNVLRPKEYWDYEALTVQWGEQDDYEVVRKVGRGKYSEVFEGINVNNNEKC 80
Query: 154 XXXXXXXXXXXXXXXXXXXLQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY 213
                              LQNL GGPN+VKLLDIVRDQHSKTPSLIFEYVN+TDFKVLY
Sbjct: 81  IIKILKPVKKKKIKREIKILQNLXGGPNIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVLY 140
Query: 214 PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG 273
           PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG
Sbjct: 141 PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG 200
Query: 274 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI 333
           KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI
Sbjct: 201 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI 260
Query: 334 AKDCC---LIIWCN--------------SRHSRKPWSKFINADNQHLVSPEAIDFLDKLL 376
           AK      L  + N               RHSRKPW KF+NADNQHLVSPEAIDFLDKLL
Sbjct: 261 AKVLGTDGLNAYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLL 320
Query: 377 RYDHQDRLTAREAMAHPYFAQVRAAESSRTRA 408
           RYDHQ+RLTA EAM HPYF QVRAAE+SRTRA
Sbjct: 321 RYDHQERLTALEAMTHPYFQQVRAAENSRTRA 352

>pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331

Iteration: 1
 Score =  553 bits (1425), Expect = e-158,   Method: Compositional matrix adjust.
 Identities = 272/331 (82%), Positives = 282/331 (85%), Gaps = 17/331 (5%)
Query: 95  SKARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCX 154
           SKARVY DVNVLRPKEYWDYE+LTVQWG+QDDYEVVRKVGRGKYSEVFEGINVN NE+C 
Sbjct: 1   SKARVYADVNVLRPKEYWDYEALTVQWGEQDDYEVVRKVGRGKYSEVFEGINVNNNEKCI 60
Query: 155 XXXXXXXXXXXXXXXXXXLQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYP 214
                             LQNL GGPN+VKLLDIVRDQHSKTPSLIFEYVN+TDFKVLYP
Sbjct: 61  IKILKPVKKKKIKREIKILQNLXGGPNIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVLYP 120
Query: 215 TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 274
           TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK
Sbjct: 121 TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 180
Query: 275 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA 334
           EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA
Sbjct: 181 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA 240
Query: 335 K---DCCLIIWCN--------------SRHSRKPWSKFINADNQHLVSPEAIDFLDKLLR 377
           K      L ++ N               RHSRKPW KF+NADNQHLVSPEAIDFLDKLLR
Sbjct: 241 KVLGTDGLNVYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLR 300
Query: 378 YDHQDRLTAREAMAHPYFAQVRAAESSRTRA 408
           YDHQ+RLTA EAM HPYF QVRAAE+SRTRA
Sbjct: 301 YDHQERLTALEAMTHPYFQQVRAAENSRTRA 331

>pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327

Iteration: 1
 Score =  548 bits (1411), Expect = e-156,   Method: Compositional matrix adjust.
 Identities = 269/327 (82%), Positives = 279/327 (85%), Gaps = 17/327 (5%)
Query: 95  SKARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCX 154
           SKARVY DVNVLRPKEYWDYE+LTVQWG+QDDYEVVRKVGRGKYSEVFEGINVN NE+C 
Sbjct: 1   SKARVYADVNVLRPKEYWDYEALTVQWGEQDDYEVVRKVGRGKYSEVFEGINVNNNEKCI 60
Query: 155 XXXXXXXXXXXXXXXXXXLQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYP 214
                             LQNLCGGPN+VKLLDIVRDQHSKTPSLIFEYVN+TDFKVLYP
Sbjct: 61  IKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVLYP 120
Query: 215 TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 274
           TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK
Sbjct: 121 TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 180
Query: 275 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA 334
           EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA
Sbjct: 181 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA 240
Query: 335 K---DCCLIIWCN--------------SRHSRKPWSKFINADNQHLVSPEAIDFLDKLLR 377
           K      L ++ N               RHSRKPW KF+NADNQHLVSPEAIDFLDKLLR
Sbjct: 241 KVLGTDGLNVYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLR 300
Query: 378 YDHQDRLTAREAMAHPYFAQVRAAESS 404
           YDHQ+RLTA EAM HPYF QVRAAE+S
Sbjct: 301 YDHQERLTALEAMTHPYFQQVRAAENS 327

>pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325

Iteration: 1
 Score =  545 bits (1405), Expect = e-155,   Method: Compositional matrix adjust.
 Identities = 268/325 (82%), Positives = 277/325 (85%), Gaps = 17/325 (5%)
Query: 95  SKARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCX 154
           SKARVY DVNVLRPKEYWDYE+LTVQWG+QDDYEVVRKVGRGKYSEVFEGINVN NE+C 
Sbjct: 1   SKARVYADVNVLRPKEYWDYEALTVQWGEQDDYEVVRKVGRGKYSEVFEGINVNNNEKCI 60
Query: 155 XXXXXXXXXXXXXXXXXXLQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYP 214
                             LQNLCGGPN+VKLLDIVRDQHSKTPSLIFEYVN+TDFKVLYP
Sbjct: 61  IKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVLYP 120
Query: 215 TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 274
           TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK
Sbjct: 121 TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 180
Query: 275 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA 334
           EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA
Sbjct: 181 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA 240
Query: 335 K---DCCLIIWCN--------------SRHSRKPWSKFINADNQHLVSPEAIDFLDKLLR 377
           K      L ++ N               RHSRKPW KF+NADNQHLVSPEAIDFLDKLLR
Sbjct: 241 KVLGTDGLNVYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLR 300
Query: 378 YDHQDRLTAREAMAHPYFAQVRAAE 402
           YDHQ+RLTA EAM HPYF QVRAAE
Sbjct: 301 YDHQERLTALEAMTHPYFQQVRAAE 325

>pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327

Iteration: 1
 Score =  545 bits (1403), Expect = e-155,   Method: Compositional matrix adjust.
 Identities = 268/327 (81%), Positives = 278/327 (85%), Gaps = 17/327 (5%)
Query: 95  SKARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCX 154
           SKARVY DVNVLRPKEYWDYE+LTVQWG+QDDYEVVRKVGRGKYSEVFEGINVN NE+C 
Sbjct: 1   SKARVYADVNVLRPKEYWDYEALTVQWGEQDDYEVVRKVGRGKYSEVFEGINVNNNEKCI 60
Query: 155 XXXXXXXXXXXXXXXXXXLQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYP 214
                             LQNL GGPN+VKLLDIVRDQHSKTPSLIFEYVN+TDFKVLYP
Sbjct: 61  IKILKPVKKKKIKREIKILQNLXGGPNIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVLYP 120
Query: 215 TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 274
           TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK
Sbjct: 121 TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 180
Query: 275 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA 334
           EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA
Sbjct: 181 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA 240
Query: 335 K---DCCLIIWCN--------------SRHSRKPWSKFINADNQHLVSPEAIDFLDKLLR 377
           K      L ++ N               RHSRKPW KF+NADNQHLVSPEAIDFLDKLLR
Sbjct: 241 KVLGTDGLNVYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLR 300
Query: 378 YDHQDRLTAREAMAHPYFAQVRAAESS 404
           YDHQ+RLTA EAM HPYF QVRAAE+S
Sbjct: 301 YDHQERLTALEAMTHPYFQQVRAAENS 327

>pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326

Iteration: 1
 Score =  543 bits (1400), Expect = e-155,   Method: Compositional matrix adjust.
 Identities = 267/326 (81%), Positives = 277/326 (84%), Gaps = 17/326 (5%)
Query: 95  SKARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCX 154
           SKARVY DVNVLRPKEYWDYE+LTVQWG+QDDYEVVRKVGRGKYSEVFEGINVN NE+C 
Sbjct: 1   SKARVYADVNVLRPKEYWDYEALTVQWGEQDDYEVVRKVGRGKYSEVFEGINVNNNEKCI 60
Query: 155 XXXXXXXXXXXXXXXXXXLQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYP 214
                             LQNL GGPN+VKLLDIVRDQHSKTPSLIFEYVN+TDFKVLYP
Sbjct: 61  IKILKPVKKKKIKREIKILQNLMGGPNIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVLYP 120
Query: 215 TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 274
           TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK
Sbjct: 121 TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 180
Query: 275 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA 334
           EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA
Sbjct: 181 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA 240
Query: 335 KDC---CLIIWCN--------------SRHSRKPWSKFINADNQHLVSPEAIDFLDKLLR 377
           K      L ++ N               RHSRKPW KF+NADNQHLVSPEAIDFLDKLLR
Sbjct: 241 KVLGTDGLNVYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLR 300
Query: 378 YDHQDRLTAREAMAHPYFAQVRAAES 403
           YDHQ+RLTA EAM HPYF QVRAAE+
Sbjct: 301 YDHQERLTALEAMTHPYFQQVRAAEN 326

>pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326

Iteration: 1
 Score =  543 bits (1399), Expect = e-155,   Method: Compositional matrix adjust.
 Identities = 267/326 (81%), Positives = 277/326 (84%), Gaps = 17/326 (5%)
Query: 95  SKARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCX 154
           SKARVY DVNVLRPKEYWDYE+LTVQWG+QDDYEVVRKVGRGKYSEVFEGINVN NE+C 
Sbjct: 1   SKARVYADVNVLRPKEYWDYEALTVQWGEQDDYEVVRKVGRGKYSEVFEGINVNNNEKCI 60
Query: 155 XXXXXXXXXXXXXXXXXXLQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYP 214
                             LQNL GGPN+VKLLDIVRDQHSKTPSLIFEYVN+TDFKVLYP
Sbjct: 61  IKILKPVKKKKIKREIKILQNLXGGPNIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVLYP 120
Query: 215 TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 274
           TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK
Sbjct: 121 TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 180
Query: 275 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA 334
           EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA
Sbjct: 181 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA 240
Query: 335 K---DCCLIIWCN--------------SRHSRKPWSKFINADNQHLVSPEAIDFLDKLLR 377
           K      L ++ N               RHSRKPW KF+NADNQHLVSPEAIDFLDKLLR
Sbjct: 241 KVLGTDGLNVYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLR 300
Query: 378 YDHQDRLTAREAMAHPYFAQVRAAES 403
           YDHQ+RLTA EAM HPYF QVRAAE+
Sbjct: 301 YDHQERLTALEAMTHPYFQQVRAAEN 326

>pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329

Iteration: 1
 Score =  452 bits (1163), Expect = e-127,   Method: Compositional matrix adjust.
 Identities = 219/324 (67%), Positives = 251/324 (77%), Gaps = 17/324 (5%)
Query: 92  PAMSKARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNE 151
           P  S+ARVYTDVN  RP+EYWDY S  V+WG+QDDY++VRK+GRGKYSEVFE IN+  NE
Sbjct: 4   PVPSRARVYTDVNTHRPREYWDYASHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNE 63
Query: 152 RCXXXXXXXXXXXXXXXXXXXLQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKV 211
           +                    L+NL GGPN++ L DIV+D  S+TP+L+FE+VN+TDFK 
Sbjct: 64  KVVVKILKPVKKNKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQ 123
Query: 212 LYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 271
           LY TLTDYDIR+Y+YE+LKALDYCHS GIMHRDVKPHNVMIDHE RKLRLIDWGLAEFYH
Sbjct: 124 LYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 183
Query: 272 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV 331
           PG+EYNVRVASRYFKGPELLVD Q YDYSLDMWSLGCM A MIFRKEPFF+GHDN+DQLV
Sbjct: 184 PGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLV 243
Query: 332 KIAK--------------DCCLIIWCN---SRHSRKPWSKFINADNQHLVSPEAIDFLDK 374
           +IAK              +  L    N    RHSRK W +F++++NQHLVSPEA+DFLDK
Sbjct: 244 RIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDK 303
Query: 375 LLRYDHQDRLTAREAMAHPYFAQV 398
           LLRYDHQ RLTAREAM HPYF  V
Sbjct: 304 LLRYDHQSRLTAREAMEHPYFYTV 327

>pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335

Iteration: 1
 Score =  451 bits (1160), Expect = e-127,   Method: Compositional matrix adjust.
 Identities = 219/324 (67%), Positives = 252/324 (77%), Gaps = 17/324 (5%)
Query: 92  PAMSKARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNE 151
           P  S+ARVYTDVN  RP+EYWDYES  V+WG+QDDY++VRK+GRGKYSEVFE IN+  NE
Sbjct: 4   PVPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNE 63
Query: 152 RCXXXXXXXXXXXXXXXXXXXLQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKV 211
           +                    L+NL GGPN++ L DIV+D  S+TP+L+FE+VN+TDFK 
Sbjct: 64  KVAVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQ 123
Query: 212 LYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 271
           LY TLTDYDIR+Y+YE+LKALDYCHS GIMHRDVKPHNV+IDHE RKLRLIDWGLAEFYH
Sbjct: 124 LYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVLIDHEHRKLRLIDWGLAEFYH 183
Query: 272 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV 331
           PG+EYNVRVASRYFKGPELLVD Q YDYSLDMWSLGCM A MIFRKEPFF+GHDN+DQLV
Sbjct: 184 PGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLV 243
Query: 332 KIAK--------------DCCLIIWCN---SRHSRKPWSKFINADNQHLVSPEAIDFLDK 374
           +IAK              +  L    N    RHSRK W +F++++NQHLVSPEA+DFLDK
Sbjct: 244 RIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDK 303
Query: 375 LLRYDHQDRLTAREAMAHPYFAQV 398
           LLRYDHQ RLTAREAM HPYF  V
Sbjct: 304 LLRYDHQSRLTAREAMEHPYFYTV 327

>pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340

Iteration: 1
 Score =  451 bits (1160), Expect = e-127,   Method: Compositional matrix adjust.
 Identities = 221/330 (66%), Positives = 254/330 (76%), Gaps = 17/330 (5%)
Query: 86  LAEIPLPAMSKARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGI 145
           L  +  P  S+ARVYTDVN  RP+EYWDYES  V+WG+QDDY++VRK+GRGKYSEVFE I
Sbjct: 3   LGSMSGPVPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAI 62
Query: 146 NVNTNERCXXXXXXXXXXXXXXXXXXXLQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVN 205
           N+  NE+                    L+NL GGPN++ L DIV+D  S+TP+L+FE+VN
Sbjct: 63  NITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVN 122
Query: 206 STDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWG 265
           +TDFK LY TLTDYDIR+Y+YE+LKALDYCHS GIMHRDVKPHNVMIDHE RKLRLIDWG
Sbjct: 123 NTDFKQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWG 182
Query: 266 LAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHD 325
           LAEFYHPG+EYNVRVASRYFKGPELLVD Q YDYSLDMWSLGCM A MIFRKEPFF+GHD
Sbjct: 183 LAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHD 242
Query: 326 NHDQLVKIAK--------------DCCLIIWCN---SRHSRKPWSKFINADNQHLVSPEA 368
           N+DQLV+IAK              +  L    N    RHSRK W +F++++NQHLVSPEA
Sbjct: 243 NYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEA 302
Query: 369 IDFLDKLLRYDHQDRLTAREAMAHPYFAQV 398
           +DFLDKLLRYDHQ RLTAREAM HPYF  V
Sbjct: 303 LDFLDKLLRYDHQSRLTAREAMEHPYFYTV 332

>pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349

Iteration: 1
 Score =  451 bits (1159), Expect = e-127,   Method: Compositional matrix adjust.
 Identities = 221/330 (66%), Positives = 254/330 (76%), Gaps = 17/330 (5%)
Query: 92  PAMSKARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNE 151
           P  S+ARVYTDVN  RP+EYWDYES  V+WG+QDDY++VRK+GRGKYSEVFE IN+  NE
Sbjct: 4   PVPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNE 63
Query: 152 RCXXXXXXXXXXXXXXXXXXXLQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKV 211
           +                    L+NL GGPN++ L DIV+D  S+TP+L+FE+VN+TDFK 
Sbjct: 64  KVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQ 123
Query: 212 LYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 271
           LY TLTDYDIR+Y+YE+LKALDYCHS GIMHRDVKPHNVMIDHE RKLRLIDWGLAEFYH
Sbjct: 124 LYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 183
Query: 272 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV 331
           PG+EYNVRVASRYFKGPELLVD Q YDYSLDMWSLGCM A MIFRKEPFF+GHDN+DQLV
Sbjct: 184 PGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLV 243
Query: 332 KIAK--------------DCCLIIWCN---SRHSRKPWSKFINADNQHLVSPEAIDFLDK 374
           +IAK              +  L    N    RHSRK W +F++++NQHLVSPEA+DFLDK
Sbjct: 244 RIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDK 303
Query: 375 LLRYDHQDRLTAREAMAHPYFAQVRAAESS 404
           LLRYDHQ RLTAREAM HPYF  V   +S 
Sbjct: 304 LLRYDHQSRLTAREAMEHPYFYPVVKEQSQ 333

>pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333

Iteration: 1
 Score =  451 bits (1159), Expect = e-127,   Method: Compositional matrix adjust.
 Identities = 220/324 (67%), Positives = 252/324 (77%), Gaps = 17/324 (5%)
Query: 92  PAMSKARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNE 151
           P  S+ARVYTDVN  RP+EYWDYES  V+WG+QDDY++VRK+GRGKYSEVFE IN+  NE
Sbjct: 4   PVPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNE 63
Query: 152 RCXXXXXXXXXXXXXXXXXXXLQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKV 211
           +                    L+NL GGPN++ L DIV+D  S+TP+L+FE+VN+TDFK 
Sbjct: 64  KVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQ 123
Query: 212 LYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 271
           LY TLTDYDIR+Y+YE+LKALDYCHS GIMHRDVKPHNVMIDHE RKLRLIDWGLAEFYH
Sbjct: 124 LYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 183
Query: 272 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV 331
           PG+EYNVRVASRYFKGPELLVD Q YDYSLDMWSLGCM A MIFRKEPFF+GHDN+DQLV
Sbjct: 184 PGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLV 243
Query: 332 KIAK--------------DCCLIIWCN---SRHSRKPWSKFINADNQHLVSPEAIDFLDK 374
           +IAK              +  L    N    RHSRK W +F++++NQHLVSPEA+DFLDK
Sbjct: 244 RIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDK 303
Query: 375 LLRYDHQDRLTAREAMAHPYFAQV 398
           LLRYDHQ RLTAREAM HPYF  V
Sbjct: 304 LLRYDHQSRLTAREAMEHPYFYTV 327

>pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score =  451 bits (1159), Expect = e-127,   Method: Compositional matrix adjust.
 Identities = 220/324 (67%), Positives = 252/324 (77%), Gaps = 17/324 (5%)
Query: 92  PAMSKARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNE 151
           P  S+ARVYTDVN  RP+EYWDYES  V+WG+QDDY++VRK+GRGKYSEVFE IN+  NE
Sbjct: 4   PVPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNE 63
Query: 152 RCXXXXXXXXXXXXXXXXXXXLQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKV 211
           +                    L+NL GGPN++ L DIV+D  S+TP+L+FE+VN+TDFK 
Sbjct: 64  KVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQ 123
Query: 212 LYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 271
           LY TLTDYDIR+Y+YE+LKALDYCHS GIMHRDVKPHNVMIDHE RKLRLIDWGLAEFYH
Sbjct: 124 LYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 183
Query: 272 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV 331
           PG+EYNVRVASRYFKGPELLVD Q YDYSLDMWSLGCM A MIFRKEPFF+GHDN+DQLV
Sbjct: 184 PGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLV 243
Query: 332 KIAK--------------DCCLIIWCN---SRHSRKPWSKFINADNQHLVSPEAIDFLDK 374
           +IAK              +  L    N    RHSRK W +F++++NQHLVSPEA+DFLDK
Sbjct: 244 RIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDK 303
Query: 375 LLRYDHQDRLTAREAMAHPYFAQV 398
           LLRYDHQ RLTAREAM HPYF  V
Sbjct: 304 LLRYDHQSRLTAREAMEHPYFYTV 327

>pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334

Iteration: 1
 Score =  451 bits (1159), Expect = e-127,   Method: Compositional matrix adjust.
 Identities = 220/324 (67%), Positives = 252/324 (77%), Gaps = 17/324 (5%)
Query: 92  PAMSKARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNE 151
           P  S+ARVYTDVN  RP+EYWDYES  V+WG+QDDY++VRK+GRGKYSEVFE IN+  NE
Sbjct: 4   PVPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNE 63
Query: 152 RCXXXXXXXXXXXXXXXXXXXLQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKV 211
           +                    L+NL GGPN++ L DIV+D  S+TP+L+FE+VN+TDFK 
Sbjct: 64  KVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQ 123
Query: 212 LYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 271
           LY TLTDYDIR+Y+YE+LKALDYCHS GIMHRDVKPHNVMIDHE RKLRLIDWGLAEFYH
Sbjct: 124 LYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 183
Query: 272 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV 331
           PG+EYNVRVASRYFKGPELLVD Q YDYSLDMWSLGCM A MIFRKEPFF+GHDN+DQLV
Sbjct: 184 PGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLV 243
Query: 332 KIAK--------------DCCLIIWCN---SRHSRKPWSKFINADNQHLVSPEAIDFLDK 374
           +IAK              +  L    N    RHSRK W +F++++NQHLVSPEA+DFLDK
Sbjct: 244 RIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDK 303
Query: 375 LLRYDHQDRLTAREAMAHPYFAQV 398
           LLRYDHQ RLTAREAM HPYF  V
Sbjct: 304 LLRYDHQSRLTAREAMEHPYFYTV 327

>pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337

Iteration: 1
 Score =  451 bits (1159), Expect = e-127,   Method: Compositional matrix adjust.
 Identities = 220/324 (67%), Positives = 252/324 (77%), Gaps = 17/324 (5%)
Query: 92  PAMSKARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNE 151
           P  S+ARVYTDVN  RP+EYWDYES  V+WG+QDDY++VRK+GRGKYSEVFE IN+  NE
Sbjct: 4   PVPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNE 63
Query: 152 RCXXXXXXXXXXXXXXXXXXXLQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKV 211
           +                    L+NL GGPN++ L DIV+D  S+TP+L+FE+VN+TDFK 
Sbjct: 64  KVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQ 123
Query: 212 LYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 271
           LY TLTDYDIR+Y+YE+LKALDYCHS GIMHRDVKPHNVMIDHE RKLRLIDWGLAEFYH
Sbjct: 124 LYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 183
Query: 272 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV 331
           PG+EYNVRVASRYFKGPELLVD Q YDYSLDMWSLGCM A MIFRKEPFF+GHDN+DQLV
Sbjct: 184 PGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLV 243
Query: 332 KIAK--------------DCCLIIWCN---SRHSRKPWSKFINADNQHLVSPEAIDFLDK 374
           +IAK              +  L    N    RHSRK W +F++++NQHLVSPEA+DFLDK
Sbjct: 244 RIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDK 303
Query: 375 LLRYDHQDRLTAREAMAHPYFAQV 398
           LLRYDHQ RLTAREAM HPYF  V
Sbjct: 304 LLRYDHQSRLTAREAMEHPYFYTV 327

>pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334

Iteration: 1
 Score =  451 bits (1159), Expect = e-127,   Method: Compositional matrix adjust.
 Identities = 220/324 (67%), Positives = 252/324 (77%), Gaps = 17/324 (5%)
Query: 92  PAMSKARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNE 151
           P  S+ARVYTDVN  RP+EYWDYES  V+WG+QDDY++VRK+GRGKYSEVFE IN+  NE
Sbjct: 3   PVPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNE 62
Query: 152 RCXXXXXXXXXXXXXXXXXXXLQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKV 211
           +                    L+NL GGPN++ L DIV+D  S+TP+L+FE+VN+TDFK 
Sbjct: 63  KVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQ 122
Query: 212 LYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 271
           LY TLTDYDIR+Y+YE+LKALDYCHS GIMHRDVKPHNVMIDHE RKLRLIDWGLAEFYH
Sbjct: 123 LYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 182
Query: 272 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV 331
           PG+EYNVRVASRYFKGPELLVD Q YDYSLDMWSLGCM A MIFRKEPFF+GHDN+DQLV
Sbjct: 183 PGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLV 242
Query: 332 KIAK--------------DCCLIIWCN---SRHSRKPWSKFINADNQHLVSPEAIDFLDK 374
           +IAK              +  L    N    RHSRK W +F++++NQHLVSPEA+DFLDK
Sbjct: 243 RIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDK 302
Query: 375 LLRYDHQDRLTAREAMAHPYFAQV 398
           LLRYDHQ RLTAREAM HPYF  V
Sbjct: 303 LLRYDHQSRLTAREAMEHPYFYTV 326

>pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336

Iteration: 1
 Score =  451 bits (1159), Expect = e-127,   Method: Compositional matrix adjust.
 Identities = 220/324 (67%), Positives = 252/324 (77%), Gaps = 17/324 (5%)
Query: 92  PAMSKARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNE 151
           P  S+ARVYTDVN  RP+EYWDYES  V+WG+QDDY++VRK+GRGKYSEVFE IN+  NE
Sbjct: 4   PVPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNE 63
Query: 152 RCXXXXXXXXXXXXXXXXXXXLQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKV 211
           +                    L+NL GGPN++ L DIV+D  S+TP+L+FE+VN+TDFK 
Sbjct: 64  KVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQ 123
Query: 212 LYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 271
           LY TLTDYDIR+Y+YE+LKALDYCHS GIMHRDVKPHNVMIDHE RKLRLIDWGLAEFYH
Sbjct: 124 LYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 183
Query: 272 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV 331
           PG+EYNVRVASRYFKGPELLVD Q YDYSLDMWSLGCM A MIFRKEPFF+GHDN+DQLV
Sbjct: 184 PGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLV 243
Query: 332 KIAK--------------DCCLIIWCN---SRHSRKPWSKFINADNQHLVSPEAIDFLDK 374
           +IAK              +  L    N    RHSRK W +F++++NQHLVSPEA+DFLDK
Sbjct: 244 RIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDK 303
Query: 375 LLRYDHQDRLTAREAMAHPYFAQV 398
           LLRYDHQ RLTAREAM HPYF  V
Sbjct: 304 LLRYDHQSRLTAREAMEHPYFYTV 327

>pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score =  450 bits (1158), Expect = e-127,   Method: Compositional matrix adjust.
 Identities = 220/324 (67%), Positives = 252/324 (77%), Gaps = 17/324 (5%)
Query: 92  PAMSKARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNE 151
           P  S+ARVYTDVN  RP+EYWDYES  V+WG+QDDY++VRK+GRGKYSEVFE IN+  NE
Sbjct: 4   PVPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNE 63
Query: 152 RCXXXXXXXXXXXXXXXXXXXLQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKV 211
           +                    L+NL GGPN++ L DIV+D  S+TP+L+FE+VN+TDFK 
Sbjct: 64  KVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQ 123
Query: 212 LYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 271
           LY TLTDYDIR+Y+YE+LKALDYCHS GIMHRDVKPHNVMIDHE RKLRLIDWGLAEFYH
Sbjct: 124 LYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 183
Query: 272 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV 331
           PG+EYNVRVASRYFKGPELLVD Q YDYSLDMWSLGCM A MIFRKEPFF+GHDN+DQLV
Sbjct: 184 PGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLV 243
Query: 332 KIAK--------------DCCLIIWCN---SRHSRKPWSKFINADNQHLVSPEAIDFLDK 374
           +IAK              +  L    N    RHSRK W +F++++NQHLVSPEA+DFLDK
Sbjct: 244 RIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDK 303
Query: 375 LLRYDHQDRLTAREAMAHPYFAQV 398
           LLRYDHQ RLTAREAM HPYF  V
Sbjct: 304 LLRYDHQSRLTAREAMEHPYFYTV 327

>pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330

Iteration: 1
 Score =  450 bits (1158), Expect = e-127,   Method: Compositional matrix adjust.
 Identities = 220/324 (67%), Positives = 252/324 (77%), Gaps = 17/324 (5%)
Query: 92  PAMSKARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNE 151
           P  S+ARVYTDVN  RP+EYWDYES  V+WG+QDDY++VRK+GRGKYSEVFE IN+  NE
Sbjct: 3   PVPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNE 62
Query: 152 RCXXXXXXXXXXXXXXXXXXXLQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKV 211
           +                    L+NL GGPN++ L DIV+D  S+TP+L+FE+VN+TDFK 
Sbjct: 63  KVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQ 122
Query: 212 LYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 271
           LY TLTDYDIR+Y+YE+LKALDYCHS GIMHRDVKPHNVMIDHE RKLRLIDWGLAEFYH
Sbjct: 123 LYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 182
Query: 272 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV 331
           PG+EYNVRVASRYFKGPELLVD Q YDYSLDMWSLGCM A MIFRKEPFF+GHDN+DQLV
Sbjct: 183 PGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLV 242
Query: 332 KIAK--------------DCCLIIWCN---SRHSRKPWSKFINADNQHLVSPEAIDFLDK 374
           +IAK              +  L    N    RHSRK W +F++++NQHLVSPEA+DFLDK
Sbjct: 243 RIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDK 302
Query: 375 LLRYDHQDRLTAREAMAHPYFAQV 398
           LLRYDHQ RLTAREAM HPYF  V
Sbjct: 303 LLRYDHQSRLTAREAMEHPYFYTV 326

>pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331

Iteration: 1
 Score =  450 bits (1158), Expect = e-127,   Method: Compositional matrix adjust.
 Identities = 220/324 (67%), Positives = 252/324 (77%), Gaps = 17/324 (5%)
Query: 92  PAMSKARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNE 151
           P  S+ARVYTDVN  RP+EYWDYES  V+WG+QDDY++VRK+GRGKYSEVFE IN+  NE
Sbjct: 4   PVPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNE 63
Query: 152 RCXXXXXXXXXXXXXXXXXXXLQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKV 211
           +                    L+NL GGPN++ L DIV+D  S+TP+L+FE+VN+TDFK 
Sbjct: 64  KVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQ 123
Query: 212 LYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 271
           LY TLTDYDIR+Y+YE+LKALDYCHS GIMHRDVKPHNVMIDHE RKLRLIDWGLAEFYH
Sbjct: 124 LYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 183
Query: 272 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV 331
           PG+EYNVRVASRYFKGPELLVD Q YDYSLDMWSLGCM A MIFRKEPFF+GHDN+DQLV
Sbjct: 184 PGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLV 243
Query: 332 KIAK--------------DCCLIIWCN---SRHSRKPWSKFINADNQHLVSPEAIDFLDK 374
           +IAK              +  L    N    RHSRK W +F++++NQHLVSPEA+DFLDK
Sbjct: 244 RIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDK 303
Query: 375 LLRYDHQDRLTAREAMAHPYFAQV 398
           LLRYDHQ RLTAREAM HPYF  V
Sbjct: 304 LLRYDHQSRLTAREAMEHPYFYTV 327

>pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328

Iteration: 1
 Score =  449 bits (1156), Expect = e-126,   Method: Compositional matrix adjust.
 Identities = 220/324 (67%), Positives = 252/324 (77%), Gaps = 17/324 (5%)
Query: 92  PAMSKARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNE 151
           P  S+ARVYTDVN  RP+EYWDYES  V+WG+QDDY++VRK+GRGKYSEVFE IN+  NE
Sbjct: 2   PVPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNE 61
Query: 152 RCXXXXXXXXXXXXXXXXXXXLQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKV 211
           +                    L+NL GGPN++ L DIV+D  S+TP+L+FE+VN+TDFK 
Sbjct: 62  KVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQ 121
Query: 212 LYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 271
           LY TLTDYDIR+Y+YE+LKALDYCHS GIMHRDVKPHNVMIDHE RKLRLIDWGLAEFYH
Sbjct: 122 LYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 181
Query: 272 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV 331
           PG+EYNVRVASRYFKGPELLVD Q YDYSLDMWSLGCM A MIFRKEPFF+GHDN+DQLV
Sbjct: 182 PGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLV 241
Query: 332 KIAK--------------DCCLIIWCN---SRHSRKPWSKFINADNQHLVSPEAIDFLDK 374
           +IAK              +  L    N    RHSRK W +F++++NQHLVSPEA+DFLDK
Sbjct: 242 RIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDK 301
Query: 375 LLRYDHQDRLTAREAMAHPYFAQV 398
           LLRYDHQ RLTAREAM HPYF  V
Sbjct: 302 LLRYDHQSRLTAREAMEHPYFYTV 325

>pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335

Iteration: 1
 Score =  447 bits (1150), Expect = e-126,   Method: Compositional matrix adjust.
 Identities = 219/324 (67%), Positives = 251/324 (77%), Gaps = 17/324 (5%)
Query: 92  PAMSKARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNE 151
           P  S+ARVYTDVN  RP+EYWDYES  V+WG+QDDY++VRK+GRGKYSEVFE IN+  NE
Sbjct: 4   PVPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNE 63
Query: 152 RCXXXXXXXXXXXXXXXXXXXLQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKV 211
           +                    L+NL GGPN++ L DIV+D  S+TP+L+FE+VN+TDFK 
Sbjct: 64  KVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQ 123
Query: 212 LYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 271
           L  TLTDYDIR+Y+YE+LKALDYCHS GIMHRDVKPHNVMIDHE RKLRLIDWGLAEFYH
Sbjct: 124 LRQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 183
Query: 272 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV 331
           PG+EYNVRVASRYFKGPELLVD Q YDYSLDMWSLGCM A MIFRKEPFF+GHDN+DQLV
Sbjct: 184 PGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLV 243
Query: 332 KIAK--------------DCCLIIWCN---SRHSRKPWSKFINADNQHLVSPEAIDFLDK 374
           +IAK              +  L    N    RHSRK W +F++++NQHLVSPEA+DFLDK
Sbjct: 244 RIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDK 303
Query: 375 LLRYDHQDRLTAREAMAHPYFAQV 398
           LLRYDHQ RLTAREAM HPYF  V
Sbjct: 304 LLRYDHQSRLTAREAMEHPYFYTV 327

>pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339

Iteration: 1
 Score =  431 bits (1107), Expect = e-121,   Method: Compositional matrix adjust.
 Identities = 211/337 (62%), Positives = 250/337 (74%), Gaps = 18/337 (5%)
Query: 86  LAEIPLPAM-SKARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEG 144
           L  +P PA  S+ARVY +VN LR +EYWDYE+    WG+QDDY++VRK+GRGKYSEVFE 
Sbjct: 3   LGSMPGPAAGSRARVYAEVNSLRSREYWDYEAHVPSWGNQDDYQLVRKLGRGKYSEVFEA 62
Query: 145 INVNTNERCXXXXXXXXXXXXXXXXXXXLQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYV 204
           IN+  NER                    L+NL GG N++KL+D V+D  SKTP+L+FEY+
Sbjct: 63  INITNNERVVVKILKPVKKKKIKREVKILENLRGGTNIIKLIDTVKDPVSKTPALVFEYI 122
Query: 205 NSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDW 264
           N+TDFK LY  LTD+DIR+Y+YELLKALDYCHS+GIMHRDVKPHNVMIDH+ +KLRLIDW
Sbjct: 123 NNTDFKQLYQILTDFDIRFYMYELLKALDYCHSKGIMHRDVKPHNVMIDHQQKKLRLIDW 182
Query: 265 GLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGH 324
           GLAEFYHP +EYNVRVASRYFKGPELLVD Q YDYSLDMWSLGCM A MIFR+EPFF+G 
Sbjct: 183 GLAEFYHPAQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRREPFFHGQ 242
Query: 325 DNHDQLVKIAKDCC---LIIWCN--------------SRHSRKPWSKFINADNQHLVSPE 367
           DN+DQLV+IAK      L  +                 +HSRK W  FI+++N+HLVSPE
Sbjct: 243 DNYDQLVRIAKVLGTEELYGYLKKYHIDLDPHFNDILGQHSRKRWENFIHSENRHLVSPE 302
Query: 368 AIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAESS 404
           A+D LDKLLRYDHQ RLTA+EAM HPYF  V   +S 
Sbjct: 303 ALDLLDKLLRYDHQQRLTAKEAMEHPYFYPVVKEQSQ 339

>pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350

Iteration: 1
 Score =  429 bits (1104), Expect = e-120,   Method: Compositional matrix adjust.
 Identities = 210/334 (62%), Positives = 249/334 (74%), Gaps = 18/334 (5%)
Query: 89  IPLPAM-SKARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINV 147
           +P PA  S+ARVY +VN LR +EYWDYE+    WG+QDDY++VRK+GRGKYSEVFE IN+
Sbjct: 1   MPGPAAGSRARVYAEVNSLRSREYWDYEAHVPSWGNQDDYQLVRKLGRGKYSEVFEAINI 60
Query: 148 NTNERCXXXXXXXXXXXXXXXXXXXLQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNST 207
             NER                    L+NL GG N++KL+D V+D  SKTP+L+FEY+N+T
Sbjct: 61  TNNERVVVKILKPVKKKKIKREVKILENLRGGTNIIKLIDTVKDPVSKTPALVFEYINNT 120
Query: 208 DFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA 267
           DFK LY  LTD+DIR+Y+YELLKALDYCHS+GIMHRDVKPHNVMIDH+ +KLRLIDWGLA
Sbjct: 121 DFKQLYQILTDFDIRFYMYELLKALDYCHSKGIMHRDVKPHNVMIDHQQKKLRLIDWGLA 180
Query: 268 EFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNH 327
           EFYHP +EYNVRVASRYFKGPELLVD Q YDYSLDMWSLGCM A MIFR+EPFF+G DN+
Sbjct: 181 EFYHPAQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRREPFFHGQDNY 240
Query: 328 DQLVKIAKDCC---LIIWCN--------------SRHSRKPWSKFINADNQHLVSPEAID 370
           DQLV+IAK      L  +                 +HSRK W  FI+++N+HLVSPEA+D
Sbjct: 241 DQLVRIAKVLGTEELYGYLKKYHIDLDPHFNDILGQHSRKRWENFIHSENRHLVSPEALD 300
Query: 371 FLDKLLRYDHQDRLTAREAMAHPYFAQVRAAESS 404
            LDKLLRYDHQ RLTA+EAM HPYF  V   +S 
Sbjct: 301 LLDKLLRYDHQQRLTAKEAMEHPYFYPVVKEQSQ 334

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score =  136 bits (342), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 98/304 (32%), Positives = 150/304 (49%), Gaps = 34/304 (11%)
Query: 115 ESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTN----ERCXXXXXXXXXXXXXXXXX 170
           E+L  Q G  + Y+ + KVG G Y  V++  +        +R                  
Sbjct: 12  ENLYFQ-GLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREI 70
Query: 171 XXLQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL---YPTLTDYDIRYYIYE 227
             L+ L   PN+V L+D++  +   T  L+FE++     KVL      L D  I+ Y+Y+
Sbjct: 71  SLLKEL-HHPNIVSLIDVIHSERCLT--LVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQ 127
Query: 228 LLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKEYNVRVASRYFK 286
           LL+ + +CH   I+HRD+KP N++I+ +   L+L D+GLA  F  P + Y   V + +++
Sbjct: 128 LLRGVAHCHQHRILHRDLKPQNLLINSD-GALKLADFGLARAFGIPVRSYTHEVVTLWYR 186
Query: 287 GPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCC-------- 338
            P++L+  + Y  S+D+WS+GC+FA MI  K P F G  + DQL KI             
Sbjct: 187 APDVLMGSKKYSTSVDIWSIGCIFAEMITGK-PLFPGVTDDDQLPKIFSILGTPNPREWP 245
Query: 339 ----LIIWCNSRHS---RKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA 391
               L +W         +KPWS  I    Q     E ID L  +L +D   R++AR+AM 
Sbjct: 246 QVQELPLWKQRTFQVFEKKPWSSIIPGFCQ-----EGIDLLSNMLCFDPNKRISARDAMN 300
Query: 392 HPYF 395
           HPYF
Sbjct: 301 HPYF 304

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score =  136 bits (342), Expect = 3e-32,   Method: Compositional matrix adjust.
 Identities = 98/304 (32%), Positives = 150/304 (49%), Gaps = 34/304 (11%)
Query: 115 ESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTN----ERCXXXXXXXXXXXXXXXXX 170
           E+L  Q G  + Y+ + KVG G Y  V++  +        +R                  
Sbjct: 12  ENLYFQ-GLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREI 70
Query: 171 XXLQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL---YPTLTDYDIRYYIYE 227
             L+ L   PN+V L+D++  +   T  L+FE++     KVL      L D  I+ Y+Y+
Sbjct: 71  SLLKEL-HHPNIVSLIDVIHSERCLT--LVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQ 127
Query: 228 LLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKEYNVRVASRYFK 286
           LL+ + +CH   I+HRD+KP N++I+ +   L+L D+GLA  F  P + Y   V + +++
Sbjct: 128 LLRGVAHCHQHRILHRDLKPQNLLINSD-GALKLADFGLARAFGIPVRSYTHEVVTLWYR 186
Query: 287 GPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCC-------- 338
            P++L+  + Y  S+D+WS+GC+FA MI  K P F G  + DQL KI             
Sbjct: 187 APDVLMGSKKYSTSVDIWSIGCIFAEMITGK-PLFPGVTDDDQLPKIFSILGTPNPREWP 245
Query: 339 ----LIIWCNSRHS---RKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA 391
               L +W         +KPWS  I    Q     E ID L  +L +D   R++AR+AM 
Sbjct: 246 QVQELPLWKQRTFQVFEKKPWSSIIPGFCQ-----EGIDLLSNMLCFDPNKRISARDAMN 300
Query: 392 HPYF 395
           HPYF
Sbjct: 301 HPYF 304

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score =  135 bits (339), Expect = 5e-32,   Method: Compositional matrix adjust.
 Identities = 91/296 (30%), Positives = 151/296 (51%), Gaps = 24/296 (8%)
Query: 122 GDQDDYEVVRKVGRGKYSEVFEGINVNTNE----RCXXXXXXXXXXXXXXXXXXXLQNLC 177
           G  ++++ V K+G G Y  V++  N  T E    +                    L    
Sbjct: 3   GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 62
Query: 178 GGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY--PTLTDYD---IRYYIYELLKAL 232
             PN+VKLLD++  ++     L+FE++ S D K       LT      I+ Y+++LL+ L
Sbjct: 63  NHPNIVKLLDVIHTENKL--YLVFEFL-SMDLKKFMDASALTGIPLPLIKSYLFQLLQGL 119
Query: 233 DYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPELL 291
            +CHS  ++HRD+KP N++I+ E   ++L D+GLA  F  P + Y   V + +++ PE+L
Sbjct: 120 AFCHSHRVLHRDLKPENLLINTE-GAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEIL 178
Query: 292 VDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCL---IIW--CNSR 346
           +  + Y  ++D+WSLGC+FA M+ R+   F G    DQL +I +       ++W    S 
Sbjct: 179 LGCKYYSTAVDIWSLGCIFAEMVTRRA-LFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM 237
Query: 347 HSRKP-WSKFINADNQHLVSP---EAIDFLDKLLRYDHQDRLTAREAMAHPYFAQV 398
              KP + K+   D   +V P   +    L ++L YD   R++A+ A+AHP+F  V
Sbjct: 238 PDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 293

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score =  135 bits (339), Expect = 5e-32,   Method: Compositional matrix adjust.
 Identities = 93/313 (29%), Positives = 147/313 (46%), Gaps = 41/313 (13%)
Query: 120 QWGDQDD--YEVVRKVGRGKYSEVFEGINVNTNERCXXXXXXXXXXXXXXXXXXXLQNLC 177
           + G+Q +  Y   + +G G +  VF+   V ++E                     +  + 
Sbjct: 33  KTGEQREIAYTNCKVIGNGSFGVVFQAKLVESDE---VAIKKVLQDKRFKNRELQIMRIV 89
Query: 178 GGPNVVKLLDIVRDQHSKTP----SLIFEYVNSTDFKV------LYPTLTDYDIRYYIYE 227
             PNVV L         K      +L+ EYV  T ++       L  T+    I+ Y+Y+
Sbjct: 90  KHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQ 149
Query: 228 LLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG 287
           LL++L Y HS GI HRD+KP N+++D     L+LID+G A+    G+     + SRY++ 
Sbjct: 150 LLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSXICSRYYRA 209
Query: 288 PELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRH 347
           PEL+    +Y  ++D+WS GC+ A ++ + +P F G    DQLV+I K    ++   SR 
Sbjct: 210 PELIFGATNYTTNIDIWSTGCVMAELM-QGQPLFPGESGIDQLVEIIK----VLGTPSRE 264
Query: 348 SRK-----------------PWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAM 390
             K                 P+SK           P+AID + +LL Y    RLTA EA+
Sbjct: 265 QIKTMNPNYMEHKFPQIRPHPFSKVFRPR----TPPDAIDLISRLLEYTPSARLTAIEAL 320
Query: 391 AHPYFAQVRAAES 403
            HP+F ++R  E+
Sbjct: 321 CHPFFDELRTGEA 333

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score =  135 bits (339), Expect = 5e-32,   Method: Compositional matrix adjust.
 Identities = 91/296 (30%), Positives = 151/296 (51%), Gaps = 24/296 (8%)
Query: 122 GDQDDYEVVRKVGRGKYSEVFEGINVNTNE----RCXXXXXXXXXXXXXXXXXXXLQNLC 177
           G  ++++ V K+G G Y  V++  N  T E    +                    L    
Sbjct: 1   GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 60
Query: 178 GGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY--PTLTDYD---IRYYIYELLKAL 232
             PN+VKLLD++  ++     L+FE++ S D K       LT      I+ Y+++LL+ L
Sbjct: 61  NHPNIVKLLDVIHTENKL--YLVFEFL-SMDLKKFMDASALTGIPLPLIKSYLFQLLQGL 117
Query: 233 DYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPELL 291
            +CHS  ++HRD+KP N++I+ E   ++L D+GLA  F  P + Y   V + +++ PE+L
Sbjct: 118 AFCHSHRVLHRDLKPENLLINTE-GAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEIL 176
Query: 292 VDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCL---IIW--CNSR 346
           +  + Y  ++D+WSLGC+FA M+ R+   F G    DQL +I +       ++W    S 
Sbjct: 177 LGCKYYSTAVDIWSLGCIFAEMVTRRA-LFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM 235
Query: 347 HSRKP-WSKFINADNQHLVSP---EAIDFLDKLLRYDHQDRLTAREAMAHPYFAQV 398
              KP + K+   D   +V P   +    L ++L YD   R++A+ A+AHP+F  V
Sbjct: 236 PDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 291

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score =  135 bits (339), Expect = 6e-32,   Method: Compositional matrix adjust.
 Identities = 90/296 (30%), Positives = 151/296 (51%), Gaps = 24/296 (8%)
Query: 122 GDQDDYEVVRKVGRGKYSEVFEGINVNTNE----RCXXXXXXXXXXXXXXXXXXXLQNLC 177
           G  ++++ V K+G G Y  V++  N  T E    +                    L    
Sbjct: 3   GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 62
Query: 178 GGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY--PTLTDYD---IRYYIYELLKAL 232
             PN+VKLLD++  ++     L+FE+++  D K       LT      I+ Y+++LL+ L
Sbjct: 63  NHPNIVKLLDVIHTENKL--YLVFEFLHQ-DLKTFMDASALTGIPLPLIKSYLFQLLQGL 119
Query: 233 DYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPELL 291
            +CHS  ++HRD+KP N++I+ E   ++L D+GLA  F  P + Y   V + +++ PE+L
Sbjct: 120 AFCHSHRVLHRDLKPQNLLINTE-GAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEIL 178
Query: 292 VDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCL---IIW--CNSR 346
           +  + Y  ++D+WSLGC+FA M+ R+   F G    DQL +I +       ++W    S 
Sbjct: 179 LGCKYYSTAVDIWSLGCIFAEMVTRRA-LFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM 237
Query: 347 HSRKP-WSKFINADNQHLVSP---EAIDFLDKLLRYDHQDRLTAREAMAHPYFAQV 398
              KP + K+   D   +V P   +    L ++L YD   R++A+ A+AHP+F  V
Sbjct: 238 PDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 293

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score =  134 bits (338), Expect = 6e-32,   Method: Compositional matrix adjust.
 Identities = 90/295 (30%), Positives = 151/295 (51%), Gaps = 22/295 (7%)
Query: 122 GDQDDYEVVRKVGRGKYSEVFEGINVNTNE----RCXXXXXXXXXXXXXXXXXXXLQNLC 177
           G  ++++ V K+G G Y  V++  N  T E    +                    L    
Sbjct: 3   GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 62
Query: 178 GGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL-YPTLTDYD---IRYYIYELLKALD 233
             PN+VKLLD++  ++     L+FE+V+    K +    LT      I+ Y+++LL+ L 
Sbjct: 63  NHPNIVKLLDVIHTENKL--YLVFEHVDQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA 120
Query: 234 YCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPELLV 292
           +CHS  ++HRD+KP N++I+ E   ++L D+GLA  F  P + Y   V + +++ PE+L+
Sbjct: 121 FCHSHRVLHRDLKPQNLLINTE-GAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILL 179
Query: 293 DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCL---IIW--CNSRH 347
             + Y  ++D+WSLGC+FA M+ R+   F G    DQL +I +       ++W    S  
Sbjct: 180 GCKYYSTAVDIWSLGCIFAEMVTRRA-LFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMP 238
Query: 348 SRKP-WSKFINADNQHLVSP---EAIDFLDKLLRYDHQDRLTAREAMAHPYFAQV 398
             KP + K+   D   +V P   +    L ++L YD   R++A+ A+AHP+F  V
Sbjct: 239 DYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 293

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score =  134 bits (338), Expect = 7e-32,   Method: Compositional matrix adjust.
 Identities = 89/295 (30%), Positives = 151/295 (51%), Gaps = 22/295 (7%)
Query: 122 GDQDDYEVVRKVGRGKYSEVFEGINVNTNE----RCXXXXXXXXXXXXXXXXXXXLQNLC 177
           G  ++++ V K+G G Y  V++  N  T E    +                    L    
Sbjct: 1   GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 60
Query: 178 GGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL-YPTLTDYD---IRYYIYELLKALD 233
             PN+VKLLD++  ++     L+FE+++    K +    LT      I+ Y+++LL+ L 
Sbjct: 61  NHPNIVKLLDVIHTENKL--YLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA 118
Query: 234 YCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPELLV 292
           +CHS  ++HRD+KP N++I+ E   ++L D+GLA  F  P + Y   V + +++ PE+L+
Sbjct: 119 FCHSHRVLHRDLKPQNLLINTE-GAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILL 177
Query: 293 DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCL---IIW--CNSRH 347
             + Y  ++D+WSLGC+FA M+ R+   F G    DQL +I +       ++W    S  
Sbjct: 178 GCKYYSTAVDIWSLGCIFAEMVTRRA-LFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMP 236
Query: 348 SRKP-WSKFINADNQHLVSP---EAIDFLDKLLRYDHQDRLTAREAMAHPYFAQV 398
             KP + K+   D   +V P   +    L ++L YD   R++A+ A+AHP+F  V
Sbjct: 237 DYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 291

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score =  134 bits (338), Expect = 7e-32,   Method: Compositional matrix adjust.
 Identities = 91/296 (30%), Positives = 151/296 (51%), Gaps = 24/296 (8%)
Query: 122 GDQDDYEVVRKVGRGKYSEVFEGINVNTNE----RCXXXXXXXXXXXXXXXXXXXLQNLC 177
           G  ++++ V K+G G Y  V++  N  T E    +                    L    
Sbjct: 3   GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 62
Query: 178 GGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY--PTLTDYD---IRYYIYELLKAL 232
             PN+VKLLD++  ++     L+FE++ S D K       LT      I+ Y+++LL+ L
Sbjct: 63  NHPNIVKLLDVIHTENKL--YLVFEFL-SMDLKDFMDASALTGIPLPLIKSYLFQLLQGL 119
Query: 233 DYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPELL 291
            +CHS  ++HRD+KP N++I+ E   ++L D+GLA  F  P + Y   V + +++ PE+L
Sbjct: 120 AFCHSHRVLHRDLKPQNLLINTE-GAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEIL 178
Query: 292 VDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCL---IIW--CNSR 346
           +  + Y  ++D+WSLGC+FA M+ R+   F G    DQL +I +       ++W    S 
Sbjct: 179 LGCKYYSTAVDIWSLGCIFAEMVTRRA-LFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM 237
Query: 347 HSRKP-WSKFINADNQHLVSP---EAIDFLDKLLRYDHQDRLTAREAMAHPYFAQV 398
              KP + K+   D   +V P   +    L ++L YD   R++A+ A+AHP+F  V
Sbjct: 238 PDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 293

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score =  134 bits (338), Expect = 8e-32,   Method: Compositional matrix adjust.
 Identities = 91/296 (30%), Positives = 151/296 (51%), Gaps = 24/296 (8%)
Query: 122 GDQDDYEVVRKVGRGKYSEVFEGINVNTNE----RCXXXXXXXXXXXXXXXXXXXLQNLC 177
           G  ++++ V K+G G Y  V++  N  T E    +                    L    
Sbjct: 2   GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 61
Query: 178 GGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY--PTLTDYD---IRYYIYELLKAL 232
             PN+VKLLD++  ++     L+FE++ S D K       LT      I+ Y+++LL+ L
Sbjct: 62  NHPNIVKLLDVIHTENKL--YLVFEFL-SMDLKDFMDASALTGIPLPLIKSYLFQLLQGL 118
Query: 233 DYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPELL 291
            +CHS  ++HRD+KP N++I+ E   ++L D+GLA  F  P + Y   V + +++ PE+L
Sbjct: 119 AFCHSHRVLHRDLKPQNLLINTE-GAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEIL 177
Query: 292 VDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCL---IIW--CNSR 346
           +  + Y  ++D+WSLGC+FA M+ R+   F G    DQL +I +       ++W    S 
Sbjct: 178 LGCKYYSTAVDIWSLGCIFAEMVTRRA-LFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM 236
Query: 347 HSRKP-WSKFINADNQHLVSP---EAIDFLDKLLRYDHQDRLTAREAMAHPYFAQV 398
              KP + K+   D   +V P   +    L ++L YD   R++A+ A+AHP+F  V
Sbjct: 237 PDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 292

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score =  134 bits (337), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 89/295 (30%), Positives = 151/295 (51%), Gaps = 22/295 (7%)
Query: 122 GDQDDYEVVRKVGRGKYSEVFEGINVNTNE----RCXXXXXXXXXXXXXXXXXXXLQNLC 177
           G  ++++ V K+G G Y  V++  N  T E    +                    L    
Sbjct: 3   GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 62
Query: 178 GGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL-YPTLTDYD---IRYYIYELLKALD 233
             PN+VKLLD++  ++     L+FE+++    K +    LT      I+ Y+++LL+ L 
Sbjct: 63  NHPNIVKLLDVIHTENKL--YLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA 120
Query: 234 YCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPELLV 292
           +CHS  ++HRD+KP N++I+ E   ++L D+GLA  F  P + Y   V + +++ PE+L+
Sbjct: 121 FCHSHRVLHRDLKPQNLLINTE-GAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILL 179
Query: 293 DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCL---IIW--CNSRH 347
             + Y  ++D+WSLGC+FA M+ R+   F G    DQL +I +       ++W    S  
Sbjct: 180 GCKYYSTAVDIWSLGCIFAEMVTRRA-LFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMP 238
Query: 348 SRKP-WSKFINADNQHLVSP---EAIDFLDKLLRYDHQDRLTAREAMAHPYFAQV 398
             KP + K+   D   +V P   +    L ++L YD   R++A+ A+AHP+F  V
Sbjct: 239 DYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 293

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score =  134 bits (337), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 89/295 (30%), Positives = 151/295 (51%), Gaps = 22/295 (7%)
Query: 122 GDQDDYEVVRKVGRGKYSEVFEGINVNTNE----RCXXXXXXXXXXXXXXXXXXXLQNLC 177
           G  ++++ V K+G G Y  V++  N  T E    +                    L    
Sbjct: 3   GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 62
Query: 178 GGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL-YPTLTDYD---IRYYIYELLKALD 233
             PN+VKLLD++  ++     L+FE+++    K +    LT      I+ Y+++LL+ L 
Sbjct: 63  NHPNIVKLLDVIHTENKL--YLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA 120
Query: 234 YCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPELLV 292
           +CHS  ++HRD+KP N++I+ E   ++L D+GLA  F  P + Y   V + +++ PE+L+
Sbjct: 121 FCHSHRVLHRDLKPQNLLINTE-GAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILL 179
Query: 293 DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCL---IIW--CNSRH 347
             + Y  ++D+WSLGC+FA M+ R+   F G    DQL +I +       ++W    S  
Sbjct: 180 GCKYYSTAVDIWSLGCIFAEMVTRRA-LFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMP 238
Query: 348 SRKP-WSKFINADNQHLVSP---EAIDFLDKLLRYDHQDRLTAREAMAHPYFAQV 398
             KP + K+   D   +V P   +    L ++L YD   R++A+ A+AHP+F  V
Sbjct: 239 DYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 293

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score =  134 bits (337), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 89/295 (30%), Positives = 151/295 (51%), Gaps = 22/295 (7%)
Query: 122 GDQDDYEVVRKVGRGKYSEVFEGINVNTNE----RCXXXXXXXXXXXXXXXXXXXLQNLC 177
           G  ++++ V K+G G Y  V++  N  T E    +                    L    
Sbjct: 2   GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 61
Query: 178 GGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL-YPTLTDYD---IRYYIYELLKALD 233
             PN+VKLLD++  ++     L+FE+++    K +    LT      I+ Y+++LL+ L 
Sbjct: 62  NHPNIVKLLDVIHTENKL--YLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA 119
Query: 234 YCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPELLV 292
           +CHS  ++HRD+KP N++I+ E   ++L D+GLA  F  P + Y   V + +++ PE+L+
Sbjct: 120 FCHSHRVLHRDLKPQNLLINTE-GAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILL 178
Query: 293 DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCL---IIW--CNSRH 347
             + Y  ++D+WSLGC+FA M+ R+   F G    DQL +I +       ++W    S  
Sbjct: 179 GCKYYSTAVDIWSLGCIFAEMVTRRA-LFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMP 237
Query: 348 SRKP-WSKFINADNQHLVSP---EAIDFLDKLLRYDHQDRLTAREAMAHPYFAQV 398
             KP + K+   D   +V P   +    L ++L YD   R++A+ A+AHP+F  V
Sbjct: 238 DYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 292

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score =  134 bits (336), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 89/295 (30%), Positives = 151/295 (51%), Gaps = 22/295 (7%)
Query: 122 GDQDDYEVVRKVGRGKYSEVFEGINVNTNE----RCXXXXXXXXXXXXXXXXXXXLQNLC 177
           G  ++++ V K+G G Y  V++  N  T E    +                    L    
Sbjct: 4   GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 63
Query: 178 GGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL-YPTLTDYD---IRYYIYELLKALD 233
             PN+VKLLD++  ++     L+FE+++    K +    LT      I+ Y+++LL+ L 
Sbjct: 64  NHPNIVKLLDVIHTENKL--YLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA 121
Query: 234 YCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPELLV 292
           +CHS  ++HRD+KP N++I+ E   ++L D+GLA  F  P + Y   V + +++ PE+L+
Sbjct: 122 FCHSHRVLHRDLKPQNLLINTE-GAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILL 180
Query: 293 DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCL---IIW--CNSRH 347
             + Y  ++D+WSLGC+FA M+ R+   F G    DQL +I +       ++W    S  
Sbjct: 181 GCKYYSTAVDIWSLGCIFAEMVTRRA-LFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMP 239
Query: 348 SRKP-WSKFINADNQHLVSP---EAIDFLDKLLRYDHQDRLTAREAMAHPYFAQV 398
             KP + K+   D   +V P   +    L ++L YD   R++A+ A+AHP+F  V
Sbjct: 240 DYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 294

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score =  134 bits (336), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 89/295 (30%), Positives = 151/295 (51%), Gaps = 22/295 (7%)
Query: 122 GDQDDYEVVRKVGRGKYSEVFEGINVNTNE----RCXXXXXXXXXXXXXXXXXXXLQNLC 177
           G  ++++ V K+G G Y  V++  N  T E    +                    L    
Sbjct: 2   GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 61
Query: 178 GGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL-YPTLTDYD---IRYYIYELLKALD 233
             PN+VKLLD++  ++     L+FE+++    K +    LT      I+ Y+++LL+ L 
Sbjct: 62  NHPNIVKLLDVIHTENKL--YLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA 119
Query: 234 YCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPELLV 292
           +CHS  ++HRD+KP N++I+ E   ++L D+GLA  F  P + Y   V + +++ PE+L+
Sbjct: 120 FCHSHRVLHRDLKPQNLLINTE-GAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILL 178
Query: 293 DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCL---IIW--CNSRH 347
             + Y  ++D+WSLGC+FA M+ R+   F G    DQL +I +       ++W    S  
Sbjct: 179 GCKYYSTAVDIWSLGCIFAEMVTRRA-LFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMP 237
Query: 348 SRKP-WSKFINADNQHLVSP---EAIDFLDKLLRYDHQDRLTAREAMAHPYFAQV 398
             KP + K+   D   +V P   +    L ++L YD   R++A+ A+AHP+F  V
Sbjct: 238 DYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 292

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score =  134 bits (336), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 89/294 (30%), Positives = 151/294 (51%), Gaps = 22/294 (7%)
Query: 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNE----RCXXXXXXXXXXXXXXXXXXXLQNLCG 178
           D ++++ V K+G G Y  V++  N  T E    +                    L     
Sbjct: 5   DMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 64
Query: 179 GPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL-YPTLTDYD---IRYYIYELLKALDY 234
            PN+VKLLD++  ++     L+FE+++    K +    LT      I+ Y+++LL+ L +
Sbjct: 65  HPNIVKLLDVIHTENKL--YLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAF 122
Query: 235 CHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPELLVD 293
           CHS  ++HRD+KP N++I+ E   ++L D+GLA  F  P + Y   V + +++ PE+L+ 
Sbjct: 123 CHSHRVLHRDLKPQNLLINTE-GAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG 181
Query: 294 LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCL---IIW--CNSRHS 348
            + Y  ++D+WSLGC+FA M+ R+   F G    DQL +I +       ++W    S   
Sbjct: 182 CKYYSTAVDIWSLGCIFAEMVTRRA-LFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPD 240
Query: 349 RKP-WSKFINADNQHLVSP---EAIDFLDKLLRYDHQDRLTAREAMAHPYFAQV 398
            KP + K+   D   +V P   +    L ++L YD   R++A+ A+AHP+F  V
Sbjct: 241 YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 294

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score =  134 bits (336), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 89/295 (30%), Positives = 151/295 (51%), Gaps = 22/295 (7%)
Query: 122 GDQDDYEVVRKVGRGKYSEVFEGINVNTNE----RCXXXXXXXXXXXXXXXXXXXLQNLC 177
           G  ++++ V K+G G Y  V++  N  T E    +                    L    
Sbjct: 1   GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 60
Query: 178 GGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL-YPTLTDYD---IRYYIYELLKALD 233
             PN+VKLLD++  ++     L+FE+++    K +    LT      I+ Y+++LL+ L 
Sbjct: 61  NHPNIVKLLDVIHTENKL--YLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA 118
Query: 234 YCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPELLV 292
           +CHS  ++HRD+KP N++I+ E   ++L D+GLA  F  P + Y   V + +++ PE+L+
Sbjct: 119 FCHSHRVLHRDLKPQNLLINTE-GAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILL 177
Query: 293 DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCL---IIW--CNSRH 347
             + Y  ++D+WSLGC+FA M+ R+   F G    DQL +I +       ++W    S  
Sbjct: 178 GCKYYSTAVDIWSLGCIFAEMVTRRA-LFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMP 236
Query: 348 SRKP-WSKFINADNQHLVSP---EAIDFLDKLLRYDHQDRLTAREAMAHPYFAQV 398
             KP + K+   D   +V P   +    L ++L YD   R++A+ A+AHP+F  V
Sbjct: 237 DYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 291

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score =  133 bits (335), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 89/295 (30%), Positives = 151/295 (51%), Gaps = 22/295 (7%)
Query: 122 GDQDDYEVVRKVGRGKYSEVFEGINVNTNE----RCXXXXXXXXXXXXXXXXXXXLQNLC 177
           G  ++++ V K+G G Y  V++  N  T E    +                    L    
Sbjct: 2   GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 61
Query: 178 GGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL-YPTLTDYD---IRYYIYELLKALD 233
             PN+VKLLD++  ++     L+FE+++    K +    LT      I+ Y+++LL+ L 
Sbjct: 62  NHPNIVKLLDVIHTENKL--YLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA 119
Query: 234 YCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPELLV 292
           +CHS  ++HRD+KP N++I+ E   ++L D+GLA  F  P + Y   V + +++ PE+L+
Sbjct: 120 FCHSHRVLHRDLKPENLLINTE-GAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILL 178
Query: 293 DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCL---IIW--CNSRH 347
             + Y  ++D+WSLGC+FA M+ R+   F G    DQL +I +       ++W    S  
Sbjct: 179 GCKYYSTAVDIWSLGCIFAEMVTRRA-LFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMP 237
Query: 348 SRKP-WSKFINADNQHLVSP---EAIDFLDKLLRYDHQDRLTAREAMAHPYFAQV 398
             KP + K+   D   +V P   +    L ++L YD   R++A+ A+AHP+F  V
Sbjct: 238 DYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 292

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score =  133 bits (335), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 89/295 (30%), Positives = 151/295 (51%), Gaps = 22/295 (7%)
Query: 122 GDQDDYEVVRKVGRGKYSEVFEGINVNTNE----RCXXXXXXXXXXXXXXXXXXXLQNLC 177
           G  ++++ V K+G G Y  V++  N  T E    +                    L    
Sbjct: 1   GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 60
Query: 178 GGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL-YPTLTDYD---IRYYIYELLKALD 233
             PN+VKLLD++  ++     L+FE+++    K +    LT      I+ Y+++LL+ L 
Sbjct: 61  NHPNIVKLLDVIHTENKL--YLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA 118
Query: 234 YCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPELLV 292
           +CHS  ++HRD+KP N++I+ E   ++L D+GLA  F  P + Y   V + +++ PE+L+
Sbjct: 119 FCHSHRVLHRDLKPENLLINTE-GAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILL 177
Query: 293 DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCL---IIW--CNSRH 347
             + Y  ++D+WSLGC+FA M+ R+   F G    DQL +I +       ++W    S  
Sbjct: 178 GCKYYSTAVDIWSLGCIFAEMVTRRA-LFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMP 236
Query: 348 SRKP-WSKFINADNQHLVSP---EAIDFLDKLLRYDHQDRLTAREAMAHPYFAQV 398
             KP + K+   D   +V P   +    L ++L YD   R++A+ A+AHP+F  V
Sbjct: 237 DYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 291

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score =  133 bits (335), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 90/293 (30%), Positives = 150/293 (51%), Gaps = 24/293 (8%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNE----RCXXXXXXXXXXXXXXXXXXXLQNLCGGP 180
           ++++ V K+G G Y  V++  N  T E    +                    L      P
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 181 NVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY--PTLTDYD---IRYYIYELLKALDYC 235
           N+VKLLD++  ++     L+FE+V+  D K       LT      I+ Y+++LL+ L +C
Sbjct: 62  NIVKLLDVIHTENKL--YLVFEHVHQ-DLKTFMDASALTGIPLPLIKSYLFQLLQGLAFC 118
Query: 236 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPELLVDL 294
           HS  ++HRD+KP N++I+ E   ++L D+GLA  F  P + Y   V + +++ PE+L+  
Sbjct: 119 HSHRVLHRDLKPQNLLINTE-GAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGC 177
Query: 295 QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCL---IIW--CNSRHSR 349
           + Y  ++D+WSLGC+FA M+ R+   F G    DQL +I +       ++W    S    
Sbjct: 178 KYYSTAVDIWSLGCIFAEMVTRRA-LFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 236
Query: 350 KP-WSKFINADNQHLVSP---EAIDFLDKLLRYDHQDRLTAREAMAHPYFAQV 398
           KP + K+   D   +V P   +    L ++L YD   R++A+ A+AHP+F  V
Sbjct: 237 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 289

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score =  133 bits (334), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 89/295 (30%), Positives = 151/295 (51%), Gaps = 22/295 (7%)
Query: 122 GDQDDYEVVRKVGRGKYSEVFEGINVNTNE----RCXXXXXXXXXXXXXXXXXXXLQNLC 177
           G  ++++ V K+G G Y  V++  N  T E    +                    L    
Sbjct: 1   GHMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 60
Query: 178 GGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL-YPTLTDYD---IRYYIYELLKALD 233
             PN+VKLLD++  ++     L+FE+++    K +    LT      I+ Y+++LL+ L 
Sbjct: 61  NHPNIVKLLDVIHTENKL--YLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA 118
Query: 234 YCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPELLV 292
           +CHS  ++HRD+KP N++I+ E   ++L D+GLA  F  P + Y   V + +++ PE+L+
Sbjct: 119 FCHSHRVLHRDLKPQNLLINTE-GAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILL 177
Query: 293 DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCL---IIW--CNSRH 347
             + Y  ++D+WSLGC+FA M+ R+   F G    DQL +I +       ++W    S  
Sbjct: 178 GCKYYSTAVDIWSLGCIFAEMVTRRA-LFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMP 236
Query: 348 SRKP-WSKFINADNQHLVSP---EAIDFLDKLLRYDHQDRLTAREAMAHPYFAQV 398
             KP + K+   D   +V P   +    L ++L YD   R++A+ A+AHP+F  V
Sbjct: 237 DYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 291

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score =  132 bits (333), Expect = 3e-31,   Method: Compositional matrix adjust.
 Identities = 88/292 (30%), Positives = 150/292 (51%), Gaps = 22/292 (7%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNE----RCXXXXXXXXXXXXXXXXXXXLQNLCGGP 180
           ++++ V K+G G Y  V++  N  T E    +                    L      P
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 181 NVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL-YPTLTDYD---IRYYIYELLKALDYCH 236
           N+VKLLD++  ++     L+FE+++    K +    LT      I+ Y+++LL+ L +CH
Sbjct: 63  NIVKLLDVIHTENKL--YLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLSFCH 120
Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPELLVDLQ 295
           S  ++HRD+KP N++I+ E   ++L D+GLA  F  P + Y   V + +++ PE+L+  +
Sbjct: 121 SHRVLHRDLKPQNLLINTE-GAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCK 179
Query: 296 DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCL---IIW--CNSRHSRK 350
            Y  ++D+WSLGC+FA M+ R+   F G    DQL +I +       ++W    S    K
Sbjct: 180 YYSTAVDIWSLGCIFAEMVTRRA-LFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYK 238
Query: 351 P-WSKFINADNQHLVSP---EAIDFLDKLLRYDHQDRLTAREAMAHPYFAQV 398
           P + K+   D   +V P   +    L ++L YD   R++A+ A+AHP+F  V
Sbjct: 239 PSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 290

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score =  132 bits (333), Expect = 3e-31,   Method: Compositional matrix adjust.
 Identities = 88/292 (30%), Positives = 150/292 (51%), Gaps = 22/292 (7%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNE----RCXXXXXXXXXXXXXXXXXXXLQNLCGGP 180
           ++++ V K+G G Y  V++  N  T E    +                    L      P
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 181 NVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL-YPTLTDYD---IRYYIYELLKALDYCH 236
           N+VKLLD++  ++     L+FE+++    K +    LT      I+ Y+++LL+ L +CH
Sbjct: 63  NIVKLLDVIHTENKL--YLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 120
Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPELLVDLQ 295
           S  ++HRD+KP N++I+ E   ++L D+GLA  F  P + Y   V + +++ PE+L+  +
Sbjct: 121 SHRVLHRDLKPQNLLINTE-GAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGXK 179
Query: 296 DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCL---IIW--CNSRHSRK 350
            Y  ++D+WSLGC+FA M+ R+   F G    DQL +I +       ++W    S    K
Sbjct: 180 YYSTAVDIWSLGCIFAEMVTRRA-LFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYK 238
Query: 351 P-WSKFINADNQHLVSP---EAIDFLDKLLRYDHQDRLTAREAMAHPYFAQV 398
           P + K+   D   +V P   +    L ++L YD   R++A+ A+AHP+F  V
Sbjct: 239 PSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 290

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score =  132 bits (333), Expect = 3e-31,   Method: Compositional matrix adjust.
 Identities = 88/292 (30%), Positives = 150/292 (51%), Gaps = 22/292 (7%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNE----RCXXXXXXXXXXXXXXXXXXXLQNLCGGP 180
           ++++ V K+G G Y  V++  N  T E    +                    L      P
Sbjct: 10  ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 69
Query: 181 NVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL-YPTLTDYD---IRYYIYELLKALDYCH 236
           N+VKLLD++  ++     L+FE+++    K +    LT      I+ Y+++LL+ L +CH
Sbjct: 70  NIVKLLDVIHTENKL--YLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 127
Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPELLVDLQ 295
           S  ++HRD+KP N++I+ E   ++L D+GLA  F  P + Y   V + +++ PE+L+  +
Sbjct: 128 SHRVLHRDLKPQNLLINTE-GAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGXK 186
Query: 296 DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCL---IIW--CNSRHSRK 350
            Y  ++D+WSLGC+FA M+ R+   F G    DQL +I +       ++W    S    K
Sbjct: 187 YYSTAVDIWSLGCIFAEMVTRRA-LFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYK 245
Query: 351 P-WSKFINADNQHLVSP---EAIDFLDKLLRYDHQDRLTAREAMAHPYFAQV 398
           P + K+   D   +V P   +    L ++L YD   R++A+ A+AHP+F  V
Sbjct: 246 PSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 297

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score =  132 bits (331), Expect = 4e-31,   Method: Compositional matrix adjust.
 Identities = 88/292 (30%), Positives = 150/292 (51%), Gaps = 22/292 (7%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNE----RCXXXXXXXXXXXXXXXXXXXLQNLCGGP 180
           ++++ V K+G G Y  V++  N  T E    +                    L      P
Sbjct: 10  ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 69
Query: 181 NVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL-YPTLTDYD---IRYYIYELLKALDYCH 236
           N+VKLLD++  ++     L+FE+++    K +    LT      I+ Y+++LL+ L +CH
Sbjct: 70  NIVKLLDVIHTENKL--YLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 127
Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPELLVDLQ 295
           S  ++HRD+KP N++I+ E   ++L D+GLA  F  P + Y   V + +++ PE+L+  +
Sbjct: 128 SHRVLHRDLKPQNLLINTE-GAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCK 186
Query: 296 DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCL---IIW--CNSRHSRK 350
            Y  ++D+WSLGC+FA M+ R+   F G    DQL +I +       ++W    S    K
Sbjct: 187 YYSTAVDIWSLGCIFAEMVTRRA-LFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYK 245
Query: 351 P-WSKFINADNQHLVSP---EAIDFLDKLLRYDHQDRLTAREAMAHPYFAQV 398
           P + K+   D   +V P   +    L ++L YD   R++A+ A+AHP+F  V
Sbjct: 246 PSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 297

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score =  132 bits (331), Expect = 4e-31,   Method: Compositional matrix adjust.
 Identities = 88/292 (30%), Positives = 150/292 (51%), Gaps = 22/292 (7%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNE----RCXXXXXXXXXXXXXXXXXXXLQNLCGGP 180
           ++++ V K+G G Y  V++  N  T E    +                    L      P
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 181 NVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL-YPTLTDYD---IRYYIYELLKALDYCH 236
           N+VKLLD++  ++     L+FE+++    K +    LT      I+ Y+++LL+ L +CH
Sbjct: 62  NIVKLLDVIHTENKL--YLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPELLVDLQ 295
           S  ++HRD+KP N++I+ E   ++L D+GLA  F  P + Y   V + +++ PE+L+  +
Sbjct: 120 SHRVLHRDLKPQNLLINTE-GAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCK 178
Query: 296 DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCL---IIW--CNSRHSRK 350
            Y  ++D+WSLGC+FA M+ R+   F G    DQL +I +       ++W    S    K
Sbjct: 179 YYSTAVDIWSLGCIFAEMVTRRA-LFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYK 237
Query: 351 P-WSKFINADNQHLVSP---EAIDFLDKLLRYDHQDRLTAREAMAHPYFAQV 398
           P + K+   D   +V P   +    L ++L YD   R++A+ A+AHP+F  V
Sbjct: 238 PSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 289

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score =  132 bits (331), Expect = 4e-31,   Method: Compositional matrix adjust.
 Identities = 88/292 (30%), Positives = 150/292 (51%), Gaps = 22/292 (7%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNE----RCXXXXXXXXXXXXXXXXXXXLQNLCGGP 180
           ++++ V K+G G Y  V++  N  T E    +                    L      P
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 181 NVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL-YPTLTDYD---IRYYIYELLKALDYCH 236
           N+VKLLD++  ++     L+FE+++    K +    LT      I+ Y+++LL+ L +CH
Sbjct: 63  NIVKLLDVIHTENKL--YLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 120
Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPELLVDLQ 295
           S  ++HRD+KP N++I+ E   ++L D+GLA  F  P + Y   V + +++ PE+L+  +
Sbjct: 121 SHRVLHRDLKPQNLLINTE-GAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCK 179
Query: 296 DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCL---IIW--CNSRHSRK 350
            Y  ++D+WSLGC+FA M+ R+   F G    DQL +I +       ++W    S    K
Sbjct: 180 YYSTAVDIWSLGCIFAEMVTRRA-LFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYK 238
Query: 351 P-WSKFINADNQHLVSP---EAIDFLDKLLRYDHQDRLTAREAMAHPYFAQV 398
           P + K+   D   +V P   +    L ++L YD   R++A+ A+AHP+F  V
Sbjct: 239 PSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 290

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score =  132 bits (331), Expect = 4e-31,   Method: Compositional matrix adjust.
 Identities = 88/292 (30%), Positives = 150/292 (51%), Gaps = 22/292 (7%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNE----RCXXXXXXXXXXXXXXXXXXXLQNLCGGP 180
           ++++ V K+G G Y  V++  N  T E    +                    L      P
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 181 NVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL-YPTLTDYD---IRYYIYELLKALDYCH 236
           N+VKLLD++  ++     L+FE+++    K +    LT      I+ Y+++LL+ L +CH
Sbjct: 63  NIVKLLDVIHTENKL--YLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 120
Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPELLVDLQ 295
           S  ++HRD+KP N++I+ E   ++L D+GLA  F  P + Y   V + +++ PE+L+  +
Sbjct: 121 SHRVLHRDLKPQNLLINTE-GAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCK 179
Query: 296 DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCL---IIW--CNSRHSRK 350
            Y  ++D+WSLGC+FA M+ R+   F G    DQL +I +       ++W    S    K
Sbjct: 180 YYSTAVDIWSLGCIFAEMVTRRA-LFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYK 238
Query: 351 P-WSKFINADNQHLVSP---EAIDFLDKLLRYDHQDRLTAREAMAHPYFAQV 398
           P + K+   D   +V P   +    L ++L YD   R++A+ A+AHP+F  V
Sbjct: 239 PSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 290

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score =  132 bits (331), Expect = 4e-31,   Method: Compositional matrix adjust.
 Identities = 88/292 (30%), Positives = 150/292 (51%), Gaps = 22/292 (7%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNE----RCXXXXXXXXXXXXXXXXXXXLQNLCGGP 180
           ++++ V K+G G Y  V++  N  T E    +                    L      P
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 181 NVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL-YPTLTDYD---IRYYIYELLKALDYCH 236
           N+VKLLD++  ++     L+FE+++    K +    LT      I+ Y+++LL+ L +CH
Sbjct: 62  NIVKLLDVIHTENKL--YLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPELLVDLQ 295
           S  ++HRD+KP N++I+ E   ++L D+GLA  F  P + Y   V + +++ PE+L+  +
Sbjct: 120 SHRVLHRDLKPQNLLINTE-GAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCK 178
Query: 296 DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCL---IIW--CNSRHSRK 350
            Y  ++D+WSLGC+FA M+ R+   F G    DQL +I +       ++W    S    K
Sbjct: 179 YYSTAVDIWSLGCIFAEMVTRRA-LFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYK 237
Query: 351 P-WSKFINADNQHLVSP---EAIDFLDKLLRYDHQDRLTAREAMAHPYFAQV 398
           P + K+   D   +V P   +    L ++L YD   R++A+ A+AHP+F  V
Sbjct: 238 PSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 289

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score =  132 bits (331), Expect = 5e-31,   Method: Compositional matrix adjust.
 Identities = 89/293 (30%), Positives = 152/293 (51%), Gaps = 24/293 (8%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNE-----RCXXXXXXXXXXXXXXXXXXXLQNLCGG 179
           ++++ V K+G G Y  V++  N  T E     +                    L+ L   
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKEL-NH 61
Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL-YPTLTDYD---IRYYIYELLKALDYC 235
           PN+VKLLD++  ++     L+FE+++    K +    LT      I+ Y+++LL+ L +C
Sbjct: 62  PNIVKLLDVIHTENKL--YLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 119
Query: 236 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPELLVDL 294
           HS  ++HRD+KP N++I+ E   ++L D+GLA  F  P + Y   V + +++ PE+L+  
Sbjct: 120 HSHRVLHRDLKPQNLLINTE-GAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGC 178
Query: 295 QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCL---IIW--CNSRHSR 349
           + Y  ++D+WSLGC+FA M+ R+   F G    DQL +I +       ++W    S    
Sbjct: 179 KYYSTAVDIWSLGCIFAEMVTRRA-LFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 237
Query: 350 KP-WSKFINADNQHLVSP---EAIDFLDKLLRYDHQDRLTAREAMAHPYFAQV 398
           KP + K+   D   +V P   +    L ++L YD   R++A+ A+AHP+F  V
Sbjct: 238 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 290

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score =  132 bits (331), Expect = 5e-31,   Method: Compositional matrix adjust.
 Identities = 89/293 (30%), Positives = 152/293 (51%), Gaps = 24/293 (8%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNE-----RCXXXXXXXXXXXXXXXXXXXLQNLCGG 179
           ++++ V K+G G Y  V++  N  T E     +                    L+ L   
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKEL-NH 60
Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL-YPTLTDYD---IRYYIYELLKALDYC 235
           PN+VKLLD++  ++     L+FE+++    K +    LT      I+ Y+++LL+ L +C
Sbjct: 61  PNIVKLLDVIHTENKL--YLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 118
Query: 236 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPELLVDL 294
           HS  ++HRD+KP N++I+ E   ++L D+GLA  F  P + Y   V + +++ PE+L+  
Sbjct: 119 HSHRVLHRDLKPQNLLINTE-GAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGC 177
Query: 295 QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCL---IIW--CNSRHSR 349
           + Y  ++D+WSLGC+FA M+ R+   F G    DQL +I +       ++W    S    
Sbjct: 178 KYYSTAVDIWSLGCIFAEMVTRRA-LFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 236
Query: 350 KP-WSKFINADNQHLVSP---EAIDFLDKLLRYDHQDRLTAREAMAHPYFAQV 398
           KP + K+   D   +V P   +    L ++L YD   R++A+ A+AHP+F  V
Sbjct: 237 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 289

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score =  131 bits (330), Expect = 6e-31,   Method: Compositional matrix adjust.
 Identities = 88/292 (30%), Positives = 150/292 (51%), Gaps = 22/292 (7%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNE----RCXXXXXXXXXXXXXXXXXXXLQNLCGGP 180
           ++++ V K+G G Y  V++  N  T E    +                    L      P
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 181 NVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL-YPTLTDYD---IRYYIYELLKALDYCH 236
           N+VKLLD++  ++     L+FE+++    K +    LT      I+ Y+++LL+ L +CH
Sbjct: 63  NIVKLLDVIHTENKL--YLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 120
Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPELLVDLQ 295
           S  ++HRD+KP N++I+ E   ++L D+GLA  F  P + Y   V + +++ PE+L+  +
Sbjct: 121 SHRVLHRDLKPQNLLINTE-GAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCK 179
Query: 296 DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCL---IIW--CNSRHSRK 350
            Y  ++D+WSLGC+FA M+ R+   F G    DQL +I +       ++W    S    K
Sbjct: 180 YYSTAVDIWSLGCIFAEMVTRRA-LFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYK 238
Query: 351 P-WSKFINADNQHLVSP---EAIDFLDKLLRYDHQDRLTAREAMAHPYFAQV 398
           P + K+   D   +V P   +    L ++L YD   R++A+ A+AHP+F  V
Sbjct: 239 PSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 290

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score =  131 bits (330), Expect = 6e-31,   Method: Compositional matrix adjust.
 Identities = 88/292 (30%), Positives = 150/292 (51%), Gaps = 22/292 (7%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNE----RCXXXXXXXXXXXXXXXXXXXLQNLCGGP 180
           ++++ V K+G G Y  V++  N  T E    +                    L      P
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 181 NVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL-YPTLTDYD---IRYYIYELLKALDYCH 236
           N+VKLLD++  ++     L+FE+++    K +    LT      I+ Y+++LL+ L +CH
Sbjct: 63  NIVKLLDVIHTENKL--YLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 120
Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPELLVDLQ 295
           S  ++HRD+KP N++I+ E   ++L D+GLA  F  P + Y   V + +++ PE+L+  +
Sbjct: 121 SHRVLHRDLKPQNLLINTE-GAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCK 179
Query: 296 DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCL---IIW--CNSRHSRK 350
            Y  ++D+WSLGC+FA M+ R+   F G    DQL +I +       ++W    S    K
Sbjct: 180 YYSTAVDIWSLGCIFAEMVTRRA-LFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYK 238
Query: 351 P-WSKFINADNQHLVSP---EAIDFLDKLLRYDHQDRLTAREAMAHPYFAQV 398
           P + K+   D   +V P   +    L ++L YD   R++A+ A+AHP+F  V
Sbjct: 239 PSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 290

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score =  131 bits (330), Expect = 6e-31,   Method: Compositional matrix adjust.
 Identities = 88/292 (30%), Positives = 150/292 (51%), Gaps = 22/292 (7%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNE----RCXXXXXXXXXXXXXXXXXXXLQNLCGGP 180
           ++++ V K+G G Y  V++  N  T E    +                    L      P
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 181 NVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL-YPTLTDYD---IRYYIYELLKALDYCH 236
           N+VKLLD++  ++     L+FE+++    K +    LT      I+ Y+++LL+ L +CH
Sbjct: 63  NIVKLLDVIHTENKL--YLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 120
Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPELLVDLQ 295
           S  ++HRD+KP N++I+ E   ++L D+GLA  F  P + Y   V + +++ PE+L+  +
Sbjct: 121 SHRVLHRDLKPQNLLINTE-GAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCK 179
Query: 296 DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCL---IIW--CNSRHSRK 350
            Y  ++D+WSLGC+FA M+ R+   F G    DQL +I +       ++W    S    K
Sbjct: 180 YYSTAVDIWSLGCIFAEMVTRRA-LFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYK 238
Query: 351 P-WSKFINADNQHLVSP---EAIDFLDKLLRYDHQDRLTAREAMAHPYFAQV 398
           P + K+   D   +V P   +    L ++L YD   R++A+ A+AHP+F  V
Sbjct: 239 PSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 290

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score =  131 bits (329), Expect = 7e-31,   Method: Compositional matrix adjust.
 Identities = 88/292 (30%), Positives = 150/292 (51%), Gaps = 22/292 (7%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNE----RCXXXXXXXXXXXXXXXXXXXLQNLCGGP 180
           ++++ V K+G G Y  V++  N  T E    +                    L      P
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 181 NVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL-YPTLTDYD---IRYYIYELLKALDYCH 236
           N+VKLLD++  ++     L+FE+++    K +    LT      I+ Y+++LL+ L +CH
Sbjct: 62  NIVKLLDVIHTENKL--YLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPELLVDLQ 295
           S  ++HRD+KP N++I+ E   ++L D+GLA  F  P + Y   V + +++ PE+L+  +
Sbjct: 120 SHRVLHRDLKPQNLLINTE-GAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCK 178
Query: 296 DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCL---IIW--CNSRHSRK 350
            Y  ++D+WSLGC+FA M+ R+   F G    DQL +I +       ++W    S    K
Sbjct: 179 YYSTAVDIWSLGCIFAEMVTRRA-LFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYK 237
Query: 351 P-WSKFINADNQHLVSP---EAIDFLDKLLRYDHQDRLTAREAMAHPYFAQV 398
           P + K+   D   +V P   +    L ++L YD   R++A+ A+AHP+F  V
Sbjct: 238 PSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 289

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score =  131 bits (329), Expect = 7e-31,   Method: Compositional matrix adjust.
 Identities = 88/292 (30%), Positives = 150/292 (51%), Gaps = 22/292 (7%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNE----RCXXXXXXXXXXXXXXXXXXXLQNLCGGP 180
           ++++ V K+G G Y  V++  N  T E    +                    L      P
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 181 NVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL-YPTLTDYD---IRYYIYELLKALDYCH 236
           N+VKLLD++  ++     L+FE+++    K +    LT      I+ Y+++LL+ L +CH
Sbjct: 62  NIVKLLDVIHTENKL--YLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPELLVDLQ 295
           S  ++HRD+KP N++I+ E   ++L D+GLA  F  P + Y   V + +++ PE+L+  +
Sbjct: 120 SHRVLHRDLKPQNLLINTE-GAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCK 178
Query: 296 DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCL---IIW--CNSRHSRK 350
            Y  ++D+WSLGC+FA M+ R+   F G    DQL +I +       ++W    S    K
Sbjct: 179 YYSTAVDIWSLGCIFAEMVTRRA-LFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYK 237
Query: 351 P-WSKFINADNQHLVSP---EAIDFLDKLLRYDHQDRLTAREAMAHPYFAQV 398
           P + K+   D   +V P   +    L ++L YD   R++A+ A+AHP+F  V
Sbjct: 238 PSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 289

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score =  130 bits (327), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 89/293 (30%), Positives = 150/293 (51%), Gaps = 24/293 (8%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNE----RCXXXXXXXXXXXXXXXXXXXLQNLCGGP 180
           ++++ V K+G G Y  V++  N  T E    +                    L      P
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 181 NVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY--PTLTDYD---IRYYIYELLKALDYC 235
           N+VKLLD++  ++     L+FE+++  D K       LT      I+ Y+++LL+ L +C
Sbjct: 63  NIVKLLDVIHTENKL--YLVFEFLHQ-DLKDFMDASALTGIPLPLIKSYLFQLLQGLAFC 119
Query: 236 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPELLVDL 294
           HS  ++HRD+KP N++I+ E   ++L D+GLA  F  P + Y   V + +++ PE+L+  
Sbjct: 120 HSHRVLHRDLKPENLLINTE-GAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGC 178
Query: 295 QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCL---IIW--CNSRHSR 349
           + Y  ++D+WSLGC+FA M+ R+   F G    DQL +I +       ++W    S    
Sbjct: 179 KYYSTAVDIWSLGCIFAEMVTRRA-LFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 237
Query: 350 KP-WSKFINADNQHLVSP---EAIDFLDKLLRYDHQDRLTAREAMAHPYFAQV 398
           KP + K+   D   +V P   +    L ++L YD   R++A+ A+AHP+F  V
Sbjct: 238 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 290

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score =  130 bits (326), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 87/289 (30%), Positives = 149/289 (51%), Gaps = 22/289 (7%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNE----RCXXXXXXXXXXXXXXXXXXXLQNLCGGP 180
           ++++ V K+G G Y  V++  N  T E    +                    L      P
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 181 NVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL-YPTLTDYD---IRYYIYELLKALDYCH 236
           N+VKLLD++  ++     L+FE+++    K +    LT      I+ Y+++LL+ L +CH
Sbjct: 63  NIVKLLDVIHTENKL--YLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 120
Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPELLVDLQ 295
           S  ++HRD+KP N++I+ E   ++L D+GLA  F  P + Y   V + +++ PE+L+  +
Sbjct: 121 SHRVLHRDLKPQNLLINTE-GAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCK 179
Query: 296 DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCL---IIW--CNSRHSRK 350
            Y  ++D+WSLGC+FA M+ R+   F G    DQL +I +       ++W    S    K
Sbjct: 180 YYSTAVDIWSLGCIFAEMVTRRA-LFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYK 238
Query: 351 P-WSKFINADNQHLVSP---EAIDFLDKLLRYDHQDRLTAREAMAHPYF 395
           P + K+   D   +V P   +    L ++L YD   R++A+ A+AHP+F
Sbjct: 239 PSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 287

>pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383

Iteration: 1
 Score =  130 bits (326), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 79/239 (33%), Positives = 125/239 (52%), Gaps = 24/239 (10%)
Query: 188 IVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYD------IRYYIYELLKALDYCHSQGIM 241
           IV    +K  ++I EYV  T  KVL   +          I  YIY+L +A+ + HS GI 
Sbjct: 104 IVNPSQNKYLNVIMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGIC 163
Query: 242 HRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSL 301
           HRD+KP N++++ +   L+L D+G A+   P +     + SR+++ PEL++   +Y  S+
Sbjct: 164 HRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAXICSRFYRAPELMLGATEYTPSI 223
Query: 302 DMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCL-----IIWCNSRHSR------- 349
           D+WS+GC+F  +I  K P F G  + DQLV+I +         +I  N  ++        
Sbjct: 224 DLWSIGCVFGELILGK-PLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLK 282
Query: 350 -KPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAESSRTR 407
            K W K +      L    AID L+++LRY+   R+   EAMAHP+F  +R +  S  +
Sbjct: 283 AKDWRKILPEGTPSL----AIDLLEQILRYEPDLRINPYEAMAHPFFDHLRNSYESEVK 337

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score =  120 bits (301), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 83/319 (26%), Positives = 146/319 (45%), Gaps = 23/319 (7%)
Query: 103 VNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXXXXX 162
           ++++R K ++  +     W     Y     VG G Y  V   I+  + E+          
Sbjct: 20  MSLIRKKGFYKQDVNKTAWELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF 79
Query: 163 XXXXXXXXXXLQNLC----GGPNVVKLLDIVRDQHSKTP----SLIFEYVNSTDFKVLYP 214
                      + L        NV+ LLD+     S        L+  ++ +   K++  
Sbjct: 80  QSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGM 139
Query: 215 TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 274
             ++  I+Y +Y++LK L Y HS G++HRD+KP N+ ++ +  +L+++D+GLA   H   
Sbjct: 140 EFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDC-ELKILDFGLAR--HADA 196
Query: 275 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA 334
           E    V +R+++ PE+++    Y+ ++D+WS+GC+ A M+  K   F G D  DQL +I 
Sbjct: 197 EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKT-LFKGKDYLDQLTQIL 255
Query: 335 K-----DCCLIIWCNSRHSRKPWSKFINADNQHLV------SPEAIDFLDKLLRYDHQDR 383
           K         +   N + ++           +         SP+A D L+K+L  D   R
Sbjct: 256 KVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKR 315
Query: 384 LTAREAMAHPYFAQVRAAE 402
           LTA +A+ HP+F   R  E
Sbjct: 316 LTAAQALTHPFFEPFRDPE 334

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score =  120 bits (301), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 85/288 (29%), Positives = 142/288 (49%), Gaps = 22/288 (7%)
Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCXXXXXXXXXXXXXXXXXXXLQNLC-----GGPN 181
           YE + K+G G Y  VF+  N  T+E                     L+ +C        N
Sbjct: 4   YEKLEKIGEGTYGTVFKAKNRETHE-IVALKRVRLDDDDEGVPSSALREICLLKELKHKN 62
Query: 182 VVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYD---IRYYIYELLKALDYCHSQ 238
           +V+L D++     K  +L+FE+ +    K       D D   ++ ++++LLK L +CHS+
Sbjct: 63  IVRLHDVL--HSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSR 120
Query: 239 GIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPELLVDLQDY 297
            ++HRD+KP N++I+    +L+L D+GLA  F  P + Y+  V + +++ P++L   + Y
Sbjct: 121 NVLHRDLKPQNLLINRN-GELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLY 179
Query: 298 DYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLII---WCNSRH--SRKPW 352
             S+DMWS GC+FA +     P F G+D  DQL +I +         W +       KP+
Sbjct: 180 STSIDMWSAGCIFAELANAARPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPY 239
Query: 353 SKFINADNQHLVSPE----AIDFLDKLLRYDHQDRLTAREAMAHPYFA 396
             +    +   V P+      D L  LL+ +   R++A EA+ HPYF+
Sbjct: 240 PMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFS 287

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score =  120 bits (301), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 84/325 (25%), Positives = 148/325 (45%), Gaps = 35/325 (10%)
Query: 103 VNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXXXXX 162
           ++++R K ++  +     W     Y     VG G Y  V   I+  + E+          
Sbjct: 2   LSLIRKKGFYKQDVNKTAWELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF 61
Query: 163 XXXXXXXXXXLQNLC----GGPNVVKLLDIVRDQHSKTPS----------LIFEYVNSTD 208
                      + L        NV+ LLD+       TP+          L+  ++ +  
Sbjct: 62  QSEIFAKRAYRELLLLKHMQHENVIGLLDVF------TPASSLRNFYDFYLVMPFMQTDL 115
Query: 209 FKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE 268
            K++    ++  I+Y +Y++LK L Y HS G++HRD+KP N+ ++ +  +L+++D+GLA 
Sbjct: 116 QKIMGLKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDC-ELKILDFGLAR 174
Query: 269 FYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHD 328
             H   E    V +R+++ PE+++    Y+ ++D+WS+GC+ A M+  K   F G D  D
Sbjct: 175 --HADAEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKT-LFKGKDYLD 231
Query: 329 QLVKIAK-----DCCLIIWCNSRHSRKPWSKFINADNQHLV------SPEAIDFLDKLLR 377
           QL +I K         +   N + ++           +         SP+A D L+K+L 
Sbjct: 232 QLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLE 291
Query: 378 YDHQDRLTAREAMAHPYFAQVRAAE 402
            D   RLTA +A+ HP+F   R  E
Sbjct: 292 LDVDKRLTAAQALTHPFFEPFRDPE 316

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score =  120 bits (301), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 73/225 (32%), Positives = 113/225 (50%), Gaps = 32/225 (14%)
Query: 198 SLIFEYVNSTDFKVL------YPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVM 251
           +L+ +YV  T ++V         TL    ++ Y+Y+L ++L Y HS GI HRD+KP N++
Sbjct: 129 NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLL 188
Query: 252 IDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFA 311
           +D +   L+L D+G A+    G+     + SRY++ PEL+    DY  S+D+WS GC+ A
Sbjct: 189 LDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLA 248
Query: 312 GMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRK-----------------PWSK 354
            ++   +P F G    DQLV+I K    ++   +R   +                 PW+K
Sbjct: 249 ELLL-GQPIFPGDSGVDQLVEIIK----VLGTPTREQIREMNPNYTEFKFPQIKAHPWTK 303
Query: 355 FINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVR 399
                      PEAI    +LL Y    RLT  EA AH +F ++R
Sbjct: 304 VFRPRT----PPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR 344

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score =  120 bits (301), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 73/225 (32%), Positives = 114/225 (50%), Gaps = 32/225 (14%)
Query: 198 SLIFEYVNSTDFKVL------YPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVM 251
           +L+ +YV +T ++V         TL    ++ Y+Y+L ++L Y HS GI HRD+KP N++
Sbjct: 95  NLVLDYVPATVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLL 154
Query: 252 IDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFA 311
           +D +   L+L D+G A+    G+     + SRY++ PEL+    DY  S+D+WS GC+ A
Sbjct: 155 LDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLA 214
Query: 312 GMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRK-----------------PWSK 354
            ++   +P F G    DQLV+I K    ++   +R   +                 PW+K
Sbjct: 215 ELLL-GQPIFPGDSGVDQLVEIIK----VLGTPTREQIREMNPNYTEFAFPQIKAHPWTK 269
Query: 355 FINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVR 399
                      PEAI    +LL Y    RLT  EA AH +F ++R
Sbjct: 270 VFRPRT----PPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR 310

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score =  120 bits (300), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 83/296 (28%), Positives = 139/296 (46%), Gaps = 35/296 (11%)
Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCXXXXXXXXXXXXXXXXXXXLQNLC--------G 178
           YE V ++G G Y +VF+  ++    R                    ++ +          
Sbjct: 13  YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFE 72
Query: 179 GPNVVKLLDIV---RDQHSKTPSLIFEYVNS--TDF--KVLYPTLTDYDIRYYIYELLKA 231
            PNVV+L D+    R       +L+FE+V+   T +  KV  P +    I+  +++LL+ 
Sbjct: 73  HPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRG 132
Query: 232 LDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELL 291
           LD+ HS  ++HRD+KP N+++     +++L D+GLA  Y         V + +++ PE+L
Sbjct: 133 LDFLHSHRVVHRDLKPQNILVTSS-GQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVL 191
Query: 292 VDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI------------AKDCCL 339
           +    Y   +D+WS+GC+FA M FR++P F G  + DQL KI             +D  L
Sbjct: 192 LQ-SSYATPVDLWSVGCIFAEM-FRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVAL 249
Query: 340 IIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF 395
                   S +P  KF+       +     D L K L ++   R++A  A++HPYF
Sbjct: 250 PRQAFHSKSAQPIEKFVTD-----IDELGKDLLLKCLTFNPAKRISAYSALSHPYF 300

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score =  120 bits (300), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 83/296 (28%), Positives = 139/296 (46%), Gaps = 35/296 (11%)
Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCXXXXXXXXXXXXXXXXXXXLQNLC--------G 178
           YE V ++G G Y +VF+  ++    R                    ++ +          
Sbjct: 13  YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFE 72
Query: 179 GPNVVKLLDIV---RDQHSKTPSLIFEYVNS--TDF--KVLYPTLTDYDIRYYIYELLKA 231
            PNVV+L D+    R       +L+FE+V+   T +  KV  P +    I+  +++LL+ 
Sbjct: 73  HPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRG 132
Query: 232 LDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELL 291
           LD+ HS  ++HRD+KP N+++     +++L D+GLA  Y         V + +++ PE+L
Sbjct: 133 LDFLHSHRVVHRDLKPQNILVTSS-GQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVL 191
Query: 292 VDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI------------AKDCCL 339
           +    Y   +D+WS+GC+FA M FR++P F G  + DQL KI             +D  L
Sbjct: 192 LQ-SSYATPVDLWSVGCIFAEM-FRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVAL 249
Query: 340 IIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF 395
                   S +P  KF+       +     D L K L ++   R++A  A++HPYF
Sbjct: 250 PRQAFHSKSAQPIEKFVTD-----IDELGKDLLLKCLTFNPAKRISAYSALSHPYF 300

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score =  120 bits (300), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 73/225 (32%), Positives = 113/225 (50%), Gaps = 32/225 (14%)
Query: 198 SLIFEYVNSTDFKVL------YPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVM 251
           +L+ +YV  T ++V         TL    ++ Y+Y+L ++L Y HS GI HRD+KP N++
Sbjct: 107 NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLL 166
Query: 252 IDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFA 311
           +D +   L+L D+G A+    G+     + SRY++ PEL+    DY  S+D+WS GC+ A
Sbjct: 167 LDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLA 226
Query: 312 GMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRK-----------------PWSK 354
            ++   +P F G    DQLV+I K    ++   +R   +                 PW+K
Sbjct: 227 ELLL-GQPIFPGDSGVDQLVEIIK----VLGTPTREQIREMNPNYTEFKFPQIKAHPWTK 281
Query: 355 FINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVR 399
                      PEAI    +LL Y    RLT  EA AH +F ++R
Sbjct: 282 VFRPRT----PPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR 322

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score =  120 bits (300), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 83/296 (28%), Positives = 139/296 (46%), Gaps = 35/296 (11%)
Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCXXXXXXXXXXXXXXXXXXXLQNLC--------G 178
           YE V ++G G Y +VF+  ++    R                    ++ +          
Sbjct: 13  YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFE 72
Query: 179 GPNVVKLLDIV---RDQHSKTPSLIFEYVNS--TDF--KVLYPTLTDYDIRYYIYELLKA 231
            PNVV+L D+    R       +L+FE+V+   T +  KV  P +    I+  +++LL+ 
Sbjct: 73  HPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRG 132
Query: 232 LDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELL 291
           LD+ HS  ++HRD+KP N+++     +++L D+GLA  Y         V + +++ PE+L
Sbjct: 133 LDFLHSHRVVHRDLKPQNILVTSS-GQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVL 191
Query: 292 VDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI------------AKDCCL 339
           +    Y   +D+WS+GC+FA M FR++P F G  + DQL KI             +D  L
Sbjct: 192 LQ-SSYATPVDLWSVGCIFAEM-FRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVAL 249
Query: 340 IIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF 395
                   S +P  KF+       +     D L K L ++   R++A  A++HPYF
Sbjct: 250 PRQAFHSKSAQPIEKFVTD-----IDELGKDLLLKCLTFNPAKRISAYSALSHPYF 300

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score =  119 bits (299), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 73/225 (32%), Positives = 114/225 (50%), Gaps = 32/225 (14%)
Query: 198 SLIFEYVNSTDFKVL------YPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVM 251
           +L+ +YV  T ++V         TL    ++ Y+Y+L ++L Y HS GI HRD+KP N++
Sbjct: 133 NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLL 192
Query: 252 IDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFA 311
           +D +   L+L D+G A+    G+     + SRY++ PEL+    DY  S+D+WS GC+ A
Sbjct: 193 LDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLA 252
Query: 312 GMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRK-----------------PWSK 354
            ++   +P F G    DQLV+I K    ++   +R   +                 PW+K
Sbjct: 253 ELLL-GQPIFPGDSGVDQLVEIIK----VLGTPTREQIREMNPNYTEFKFPQIKAHPWTK 307
Query: 355 FINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVR 399
                 +    PEAI    +LL Y    RLT  EA AH +F ++R
Sbjct: 308 VF----RPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR 348

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score =  119 bits (299), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 73/225 (32%), Positives = 113/225 (50%), Gaps = 32/225 (14%)
Query: 198 SLIFEYVNSTDFKVL------YPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVM 251
           +L+ +YV  T ++V         TL    ++ Y+Y+L ++L Y HS GI HRD+KP N++
Sbjct: 107 NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLL 166
Query: 252 IDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFA 311
           +D +   L+L D+G A+    G+     + SRY++ PEL+    DY  S+D+WS GC+ A
Sbjct: 167 LDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLA 226
Query: 312 GMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRK-----------------PWSK 354
            ++   +P F G    DQLV+I K    ++   +R   +                 PW+K
Sbjct: 227 ELLL-GQPIFPGDSGVDQLVEIIK----VLGTPTREQIREMNPNYTEFKFPQIKAHPWTK 281
Query: 355 FINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVR 399
                      PEAI    +LL Y    RLT  EA AH +F ++R
Sbjct: 282 VFRPRT----PPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR 322

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score =  119 bits (299), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 73/225 (32%), Positives = 113/225 (50%), Gaps = 32/225 (14%)
Query: 198 SLIFEYVNSTDFKVL------YPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVM 251
           +L+ +YV  T ++V         TL    ++ Y+Y+L ++L Y HS GI HRD+KP N++
Sbjct: 131 NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLL 190
Query: 252 IDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFA 311
           +D +   L+L D+G A+    G+     + SRY++ PEL+    DY  S+D+WS GC+ A
Sbjct: 191 LDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLA 250
Query: 312 GMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRK-----------------PWSK 354
            ++   +P F G    DQLV+I K    ++   +R   +                 PW+K
Sbjct: 251 ELLL-GQPIFPGDSGVDQLVEIIK----VLGTPTREQIREMNPNYTEFKFPQIKAHPWTK 305
Query: 355 FINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVR 399
                      PEAI    +LL Y    RLT  EA AH +F ++R
Sbjct: 306 VFRPR----TPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR 346

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score =  119 bits (299), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 73/225 (32%), Positives = 113/225 (50%), Gaps = 32/225 (14%)
Query: 198 SLIFEYVNSTDFKVL------YPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVM 251
           +L+ +YV  T ++V         TL    ++ Y+Y+L ++L Y HS GI HRD+KP N++
Sbjct: 103 NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLL 162
Query: 252 IDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFA 311
           +D +   L+L D+G A+    G+     + SRY++ PEL+    DY  S+D+WS GC+ A
Sbjct: 163 LDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLA 222
Query: 312 GMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRK-----------------PWSK 354
            ++   +P F G    DQLV+I K    ++   +R   +                 PW+K
Sbjct: 223 ELLL-GQPIFPGDSGVDQLVEIIK----VLGTPTREQIREMNPNYTEFKFPQIKAHPWTK 277
Query: 355 FINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVR 399
                      PEAI    +LL Y    RLT  EA AH +F ++R
Sbjct: 278 VFRPRT----PPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR 318

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score =  119 bits (299), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 73/225 (32%), Positives = 113/225 (50%), Gaps = 32/225 (14%)
Query: 198 SLIFEYVNSTDFKVL------YPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVM 251
           +L+ +YV  T ++V         TL    ++ Y+Y+L ++L Y HS GI HRD+KP N++
Sbjct: 114 NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLL 173
Query: 252 IDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFA 311
           +D +   L+L D+G A+    G+     + SRY++ PEL+    DY  S+D+WS GC+ A
Sbjct: 174 LDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLA 233
Query: 312 GMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRK-----------------PWSK 354
            ++   +P F G    DQLV+I K    ++   +R   +                 PW+K
Sbjct: 234 ELLL-GQPIFPGDSGVDQLVEIIK----VLGTPTREQIREMNPNYTEFKFPQIKAHPWTK 288
Query: 355 FINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVR 399
                      PEAI    +LL Y    RLT  EA AH +F ++R
Sbjct: 289 VFRPRT----PPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR 329

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score =  119 bits (299), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 73/225 (32%), Positives = 113/225 (50%), Gaps = 32/225 (14%)
Query: 198 SLIFEYVNSTDFKVL------YPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVM 251
           +L+ +YV  T ++V         TL    ++ Y+Y+L ++L Y HS GI HRD+KP N++
Sbjct: 99  NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLL 158
Query: 252 IDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFA 311
           +D +   L+L D+G A+    G+     + SRY++ PEL+    DY  S+D+WS GC+ A
Sbjct: 159 LDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLA 218
Query: 312 GMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRK-----------------PWSK 354
            ++   +P F G    DQLV+I K    ++   +R   +                 PW+K
Sbjct: 219 ELLL-GQPIFPGDSGVDQLVEIIK----VLGTPTREQIREMNPNYTEFKFPQIKAHPWTK 273
Query: 355 FINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVR 399
                      PEAI    +LL Y    RLT  EA AH +F ++R
Sbjct: 274 VFRPRT----PPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR 314

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score =  119 bits (299), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 73/225 (32%), Positives = 113/225 (50%), Gaps = 32/225 (14%)
Query: 198 SLIFEYVNSTDFKVL------YPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVM 251
           +L+ +YV  T ++V         TL    ++ Y+Y+L ++L Y HS GI HRD+KP N++
Sbjct: 95  NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLL 154
Query: 252 IDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFA 311
           +D +   L+L D+G A+    G+     + SRY++ PEL+    DY  S+D+WS GC+ A
Sbjct: 155 LDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLA 214
Query: 312 GMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRK-----------------PWSK 354
            ++   +P F G    DQLV+I K    ++   +R   +                 PW+K
Sbjct: 215 ELLL-GQPIFPGDSGVDQLVEIIK----VLGTPTREQIREMNPNYTEFKFPQIKAHPWTK 269
Query: 355 FINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVR 399
                      PEAI    +LL Y    RLT  EA AH +F ++R
Sbjct: 270 VFRPRT----PPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR 310

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score =  119 bits (299), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 73/225 (32%), Positives = 113/225 (50%), Gaps = 32/225 (14%)
Query: 198 SLIFEYVNSTDFKVL------YPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVM 251
           +L+ +YV  T ++V         TL    ++ Y+Y+L ++L Y HS GI HRD+KP N++
Sbjct: 129 NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLL 188
Query: 252 IDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFA 311
           +D +   L+L D+G A+    G+     + SRY++ PEL+    DY  S+D+WS GC+ A
Sbjct: 189 LDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLA 248
Query: 312 GMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRK-----------------PWSK 354
            ++   +P F G    DQLV+I K    ++   +R   +                 PW+K
Sbjct: 249 ELLL-GQPIFPGDSGVDQLVEIIK----VLGTPTREQIREMNPNYTEFKFPQIKAHPWTK 303
Query: 355 FINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVR 399
                      PEAI    +LL Y    RLT  EA AH +F ++R
Sbjct: 304 VFRPRT----PPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR 344

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score =  119 bits (299), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 73/225 (32%), Positives = 113/225 (50%), Gaps = 32/225 (14%)
Query: 198 SLIFEYVNSTDFKVL------YPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVM 251
           +L+ +YV  T ++V         TL    ++ Y+Y+L ++L Y HS GI HRD+KP N++
Sbjct: 123 NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLL 182
Query: 252 IDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFA 311
           +D +   L+L D+G A+    G+     + SRY++ PEL+    DY  S+D+WS GC+ A
Sbjct: 183 LDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLA 242
Query: 312 GMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRK-----------------PWSK 354
            ++   +P F G    DQLV+I K    ++   +R   +                 PW+K
Sbjct: 243 ELLL-GQPIFPGDSGVDQLVEIIK----VLGTPTREQIREMNPNYTEFKFPQIKAHPWTK 297
Query: 355 FINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVR 399
                      PEAI    +LL Y    RLT  EA AH +F ++R
Sbjct: 298 VFRPRT----PPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR 338

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score =  119 bits (299), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 73/225 (32%), Positives = 113/225 (50%), Gaps = 32/225 (14%)
Query: 198 SLIFEYVNSTDFKVL------YPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVM 251
           +L+ +YV  T ++V         TL    ++ Y+Y+L ++L Y HS GI HRD+KP N++
Sbjct: 174 NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLL 233
Query: 252 IDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFA 311
           +D +   L+L D+G A+    G+     + SRY++ PEL+    DY  S+D+WS GC+ A
Sbjct: 234 LDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLA 293
Query: 312 GMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRK-----------------PWSK 354
            ++   +P F G    DQLV+I K    ++   +R   +                 PW+K
Sbjct: 294 ELLL-GQPIFPGDSGVDQLVEIIK----VLGTPTREQIREMNPNYTEFKFPQIKAHPWTK 348
Query: 355 FINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVR 399
                      PEAI    +LL Y    RLT  EA AH +F ++R
Sbjct: 349 VFRPR----TPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR 389

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score =  119 bits (298), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 73/225 (32%), Positives = 113/225 (50%), Gaps = 32/225 (14%)
Query: 198 SLIFEYVNSTDFKVL------YPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVM 251
           +L+ +YV  T ++V         TL    ++ Y+Y+L ++L Y HS GI HRD+KP N++
Sbjct: 100 NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLL 159
Query: 252 IDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFA 311
           +D +   L+L D+G A+    G+     + SRY++ PEL+    DY  S+D+WS GC+ A
Sbjct: 160 LDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLA 219
Query: 312 GMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRK-----------------PWSK 354
            ++   +P F G    DQLV+I K    ++   +R   +                 PW+K
Sbjct: 220 ELLL-GQPIFPGDSGVDQLVEIIK----VLGTPTREQIREMNPNYTEFKFPQIKAHPWTK 274
Query: 355 FINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVR 399
                      PEAI    +LL Y    RLT  EA AH +F ++R
Sbjct: 275 VFRPRT----PPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR 315

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score =  119 bits (298), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 73/225 (32%), Positives = 113/225 (50%), Gaps = 32/225 (14%)
Query: 198 SLIFEYVNSTDFKVL------YPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVM 251
           +L+ +YV  T ++V         TL    ++ Y+Y+L ++L Y HS GI HRD+KP N++
Sbjct: 95  NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLL 154
Query: 252 IDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFA 311
           +D +   L+L D+G A+    G+     + SRY++ PEL+    DY  S+D+WS GC+ A
Sbjct: 155 LDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLA 214
Query: 312 GMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRK-----------------PWSK 354
            ++   +P F G    DQLV+I K    ++   +R   +                 PW+K
Sbjct: 215 ELLL-GQPIFPGDSGVDQLVEIIK----VLGTPTREQIREMNPNYTEFKFPQIKAHPWTK 269
Query: 355 FINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVR 399
                      PEAI    +LL Y    RLT  EA AH +F ++R
Sbjct: 270 VFRPRT----PPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR 310

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score =  119 bits (298), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 73/225 (32%), Positives = 113/225 (50%), Gaps = 32/225 (14%)
Query: 198 SLIFEYVNSTDFKVL------YPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVM 251
           +L+ +YV  T ++V         TL    ++ Y+Y+L ++L Y HS GI HRD+KP N++
Sbjct: 95  NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLL 154
Query: 252 IDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFA 311
           +D +   L+L D+G A+    G+     + SRY++ PEL+    DY  S+D+WS GC+ A
Sbjct: 155 LDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLA 214
Query: 312 GMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRK-----------------PWSK 354
            ++   +P F G    DQLV+I K    ++   +R   +                 PW+K
Sbjct: 215 ELLL-GQPIFPGDSGVDQLVEIIK----VLGTPTREQIREMNPNYTEFKFPQIKAHPWTK 269
Query: 355 FINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVR 399
                      PEAI    +LL Y    RLT  EA AH +F ++R
Sbjct: 270 VFRPRT----PPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR 310

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score =  119 bits (298), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 73/225 (32%), Positives = 113/225 (50%), Gaps = 32/225 (14%)
Query: 198 SLIFEYVNSTDFKVL------YPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVM 251
           +L+ +YV  T ++V         TL    ++ Y+Y+L ++L Y HS GI HRD+KP N++
Sbjct: 96  NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLL 155
Query: 252 IDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFA 311
           +D +   L+L D+G A+    G+     + SRY++ PEL+    DY  S+D+WS GC+ A
Sbjct: 156 LDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLA 215
Query: 312 GMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRK-----------------PWSK 354
            ++   +P F G    DQLV+I K    ++   +R   +                 PW+K
Sbjct: 216 ELLL-GQPIFPGDSGVDQLVEIIK----VLGTPTREQIREMNPNYTEFKFPQIKAHPWTK 270
Query: 355 FINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVR 399
                      PEAI    +LL Y    RLT  EA AH +F ++R
Sbjct: 271 VFRPRT----PPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR 311

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score =  119 bits (298), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 73/225 (32%), Positives = 113/225 (50%), Gaps = 32/225 (14%)
Query: 198 SLIFEYVNSTDFKVL------YPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVM 251
           +L+ +YV  T ++V         TL    ++ Y+Y+L ++L Y HS GI HRD+KP N++
Sbjct: 95  NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLL 154
Query: 252 IDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFA 311
           +D +   L+L D+G A+    G+     + SRY++ PEL+    DY  S+D+WS GC+ A
Sbjct: 155 LDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLA 214
Query: 312 GMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRK-----------------PWSK 354
            ++   +P F G    DQLV+I K    ++   +R   +                 PW+K
Sbjct: 215 ELLL-GQPIFPGDSGVDQLVEIIK----VLGTPTREQIREMNPNYTEFAFPQIKAHPWTK 269
Query: 355 FINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVR 399
                      PEAI    +LL Y    RLT  EA AH +F ++R
Sbjct: 270 VFRPRT----PPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR 310

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score =  119 bits (297), Expect = 4e-27,   Method: Compositional matrix adjust.
 Identities = 73/225 (32%), Positives = 113/225 (50%), Gaps = 32/225 (14%)
Query: 198 SLIFEYVNSTDFKVL------YPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVM 251
           +L+ +YV  T ++V         TL    ++ Y+Y+L ++L Y HS GI HRD+KP N++
Sbjct: 108 NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLL 167
Query: 252 IDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFA 311
           +D +   L+L D+G A+    G+     + SRY++ PEL+    DY  S+D+WS GC+ A
Sbjct: 168 LDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLA 227
Query: 312 GMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRK-----------------PWSK 354
            ++   +P F G    DQLV+I K    ++   +R   +                 PW+K
Sbjct: 228 ELLL-GQPIFPGDSGVDQLVEIIK----VLGTPTREQIREMNPNYTEFKFPQIKAHPWTK 282
Query: 355 FINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVR 399
                      PEAI    +LL Y    RLT  EA AH +F ++R
Sbjct: 283 VFRPRT----PPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR 323

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score =  119 bits (297), Expect = 4e-27,   Method: Compositional matrix adjust.
 Identities = 73/225 (32%), Positives = 113/225 (50%), Gaps = 32/225 (14%)
Query: 198 SLIFEYVNSTDFKVL------YPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVM 251
           +L+ +YV  T ++V         TL    ++ Y+Y+L ++L Y HS GI HRD+KP N++
Sbjct: 95  NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLL 154
Query: 252 IDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFA 311
           +D +   L+L D+G A+    G+     + SRY++ PEL+    DY  S+D+WS GC+ A
Sbjct: 155 LDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLA 214
Query: 312 GMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRK-----------------PWSK 354
            ++   +P F G    DQLV+I K    ++   +R   +                 PW+K
Sbjct: 215 ELLL-GQPIFPGDSGVDQLVEIIK----VLGTPTREQIREMNPNYTEFKFPQIKAHPWTK 269
Query: 355 FINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVR 399
                      PEAI    +LL Y    RLT  EA AH +F ++R
Sbjct: 270 VFRPRT----PPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR 310

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score =  118 bits (296), Expect = 5e-27,   Method: Compositional matrix adjust.
 Identities = 73/225 (32%), Positives = 113/225 (50%), Gaps = 32/225 (14%)
Query: 198 SLIFEYVNSTDFKVL------YPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVM 251
           +L+ +YV  T ++V         TL    ++ Y+Y+L ++L Y HS GI HRD+KP N++
Sbjct: 95  NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLL 154
Query: 252 IDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFA 311
           +D +   L+L D+G A+    G+     + SRY++ PEL+    DY  S+D+WS GC+ A
Sbjct: 155 LDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLA 214
Query: 312 GMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRK-----------------PWSK 354
            ++   +P F G    DQLV+I K    ++   +R   +                 PW+K
Sbjct: 215 ELLL-GQPIFPGDSGVDQLVEIIK----VLGTPTREQIREMNPNYTEFKFPQIKAHPWTK 269
Query: 355 FINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVR 399
                      PEAI    +LL Y    RLT  EA AH +F ++R
Sbjct: 270 VFRPRT----PPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR 310

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score =  118 bits (296), Expect = 5e-27,   Method: Compositional matrix adjust.
 Identities = 84/288 (29%), Positives = 142/288 (49%), Gaps = 22/288 (7%)
Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCXXXXXXXXXXXXXXXXXXXLQNLC-----GGPN 181
           YE + K+G G Y  VF+  N  T+E                     L+ +C        N
Sbjct: 4   YEKLEKIGEGTYGTVFKAKNRETHE-IVALKRVRLDDDDEGVPSSALREICLLKELKHKN 62
Query: 182 VVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYD---IRYYIYELLKALDYCHSQ 238
           +V+L D++     K  +L+FE+ +    K       D D   ++ ++++LLK L +CHS+
Sbjct: 63  IVRLHDVL--HSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSR 120
Query: 239 GIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPELLVDLQDY 297
            ++HRD+KP N++I+    +L+L ++GLA  F  P + Y+  V + +++ P++L   + Y
Sbjct: 121 NVLHRDLKPQNLLINRN-GELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLY 179
Query: 298 DYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLII---WCNSRH--SRKPW 352
             S+DMWS GC+FA +     P F G+D  DQL +I +         W +       KP+
Sbjct: 180 STSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPY 239
Query: 353 SKFINADNQHLVSPE----AIDFLDKLLRYDHQDRLTAREAMAHPYFA 396
             +    +   V P+      D L  LL+ +   R++A EA+ HPYF+
Sbjct: 240 PMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFS 287

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score =  117 bits (292), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 84/330 (25%), Positives = 148/330 (44%), Gaps = 67/330 (20%)
Query: 127 YEVVRKVGRGKYSEVFEGINVNTNE-----RCXXXXXXXXXXXXXXXXXXXLQNLCGGPN 181
           YE+V+K+G+G Y  V++ I+  T E     +                    L  L G  N
Sbjct: 11  YELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHEN 70
Query: 182 VVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTD-YDIRYYIYELLKALDYCHSQGI 240
           +V LL+++R  + +   L+F+Y+ +    V+   + +    +Y +Y+L+K + Y HS G+
Sbjct: 71  IVNLLNVLRADNDRDVYLVFDYMETDLHAVIRANILEPVHKQYVVYQLIKVIKYLHSGGL 130
Query: 241 MHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR--------------------- 279
           +HRD+KP N++++ E   +++ D+GL+  +      N+R                     
Sbjct: 131 LHRDMKPSNILLNAECH-VKVADFGLSRSF-----VNIRRVTNNIPLSINENTENFDDDQ 184
Query: 280 ------VASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI 333
                 VA+R+++ PE+L+    Y   +DMWSLGC+  G I   +P F G    +QL +I
Sbjct: 185 PILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCIL-GEILCGKPIFPGSSTMNQLERI 243
Query: 334 A--------------------------KDCCLIIWCNSRHSRKPWSKFINADNQHL-VSP 366
                                      K+   I   N R     W   +   N     + 
Sbjct: 244 IGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNE 303
Query: 367 EAIDFLDKLLRYDHQDRLTAREAMAHPYFA 396
           EA+D LDKLL+++   R++A +A+ HP+ +
Sbjct: 304 EALDLLDKLLQFNPNKRISANDALKHPFVS 333

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score =  117 bits (292), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 76/244 (31%), Positives = 128/244 (52%), Gaps = 42/244 (17%)
Query: 181 NVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY----------------PTLTDYDIRYY 224
           NV+ LLD+       TP+   E     DF  +Y                  L+D  +++ 
Sbjct: 88  NVIGLLDVF------TPATSIE-----DFSEVYLVTTLMGADLNNIVKSQALSDEHVQFL 136
Query: 225 IYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRY 284
           +Y+LL+ L Y HS GI+HRD+KP NV ++ +  +LR++D+GLA      +E    VA+R+
Sbjct: 137 VYQLLRGLKYIHSAGIIHRDLKPSNVAVNED-SELRILDFGLAR--QADEEMTGYVATRW 193
Query: 285 FKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCC-----L 339
           ++ PE++++   Y+ ++D+WS+GC+ A ++ + +  F G D  DQL +I +        +
Sbjct: 194 YRAPEIMLNWMHYNQTVDIWSVGCIMAELL-QGKALFPGSDYIDQLKRIMEVVGTPSPEV 252
Query: 340 IIWCNSRHSRKPWSKFINADNQHLVS------PEAIDFLDKLLRYDHQDRLTAREAMAHP 393
           +   +S H+R           + L S      P AID L ++L  D   R++A EA+AH 
Sbjct: 253 LAKISSEHARTYIQSLPPMPQKDLSSIFRGANPLAIDLLGRMLVLDSDQRVSAAEALAHA 312
Query: 394 YFAQ 397
           YF+Q
Sbjct: 313 YFSQ 316

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score =  116 bits (291), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 76/244 (31%), Positives = 128/244 (52%), Gaps = 42/244 (17%)
Query: 181 NVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY----------------PTLTDYDIRYY 224
           NV+ LLD+       TP+   E     DF  +Y                  L+D  +++ 
Sbjct: 88  NVIGLLDVF------TPATSIE-----DFSEVYLVTTLMGADLNNIVKCQALSDEHVQFL 136
Query: 225 IYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRY 284
           +Y+LL+ L Y HS GI+HRD+KP NV ++ +  +LR++D+GLA      +E    VA+R+
Sbjct: 137 VYQLLRGLKYIHSAGIIHRDLKPSNVAVNED-SELRILDFGLAR--QADEEMTGYVATRW 193
Query: 285 FKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCC-----L 339
           ++ PE++++   Y+ ++D+WS+GC+ A ++ + +  F G D  DQL +I +        +
Sbjct: 194 YRAPEIMLNWMHYNQTVDIWSVGCIMAELL-QGKALFPGSDYIDQLKRIMEVVGTPSPEV 252
Query: 340 IIWCNSRHSRKPWSKFINADNQHLVS------PEAIDFLDKLLRYDHQDRLTAREAMAHP 393
           +   +S H+R           + L S      P AID L ++L  D   R++A EA+AH 
Sbjct: 253 LAKISSEHARTYIQSLPPMPQKDLSSIFRGANPLAIDLLGRMLVLDSDQRVSAAEALAHA 312
Query: 394 YFAQ 397
           YF+Q
Sbjct: 313 YFSQ 316

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score =  116 bits (290), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 95/333 (28%), Positives = 155/333 (46%), Gaps = 41/333 (12%)
Query: 93  AMSKARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNER 152
           A S A  +T  +  RP  Y    + T+ W   + Y+ +  VG G Y  V    +V +  +
Sbjct: 20  AGSAAAPFTMSHKERPTFYRQELNKTI-WEVPERYQTLSPVGSGAYGSVCSSYDVKSGLK 78
Query: 153 CXXXXXX----XXXXXXXXXXXXXLQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVN--- 205
                                   L       NV+ LLD+       TP+   E  N   
Sbjct: 79  IAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVF------TPATSLEEFNDVY 132
Query: 206 ------STDFK--VLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELR 257
                   D    V    LTD  +++ IY++L+ L Y HS  I+HRD+KP N+ ++ +  
Sbjct: 133 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDC- 191
Query: 258 KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRK 317
           +L+++D+GLA   H   E    VA+R+++ PE++++   Y+ ++D+WS+GC+ A ++  +
Sbjct: 192 ELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHYNMTVDIWSVGCIMAELLTGR 249
Query: 318 EPFFYGHDNHDQLVKIAK-----DCCLIIWCNSRHSRK--------PWSKFINADNQHLV 364
              F G D+ +QL +I +        +I    S  +R         P   F  AD     
Sbjct: 250 T-LFPGTDHINQLQQIMRLTGTPPASVISRMPSHEARNYINSLPQMPKRNF--ADVFIGA 306
Query: 365 SPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQ 397
           +P A+D L+K+L  D   R+TA EA+AHPYF+Q
Sbjct: 307 NPLAVDLLEKMLVLDTDKRITASEALAHPYFSQ 339

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score =  116 bits (290), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 71/235 (30%), Positives = 124/235 (52%), Gaps = 27/235 (11%)
Query: 181 NVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL---YPTLTDYDIRYYIYELLKALDYCHS 237
           N+VKL D++  +  K   L+FE+++    K+L      L     + ++ +LL  + YCH 
Sbjct: 61  NIVKLYDVIHTK--KRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHD 118
Query: 238 QGIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPELLVDLQD 296
           + ++HRD+KP N++I+ E  +L++ D+GLA  F  P ++Y   V + +++ P++L+  + 
Sbjct: 119 RRVLHRDLKPQNLLINRE-GELKIADFGLARAFGIPVRKYTHEVVTLWYRAPDVLMGSKK 177
Query: 297 YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCL---IIWCNSRHSRK--- 350
           Y  ++D+WS+GC+FA M+    P F G    DQL++I +         W N     K   
Sbjct: 178 YSTTIDIWSVGCIFAEMV-NGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDP 236
Query: 351 --------PWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQ 397
                   PW  F+       +    ID L K+L+ D   R+TA++A+ H YF +
Sbjct: 237 NFTVYEPLPWESFLKG-----LDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score =  115 bits (289), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 71/235 (30%), Positives = 124/235 (52%), Gaps = 27/235 (11%)
Query: 181 NVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL---YPTLTDYDIRYYIYELLKALDYCHS 237
           N+VKL D++  +  K   L+FE+++    K+L      L     + ++ +LL  + YCH 
Sbjct: 61  NIVKLYDVIHTK--KRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHD 118
Query: 238 QGIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPELLVDLQD 296
           + ++HRD+KP N++I+ E  +L++ D+GLA  F  P ++Y   V + +++ P++L+  + 
Sbjct: 119 RRVLHRDLKPQNLLINRE-GELKIADFGLARAFGIPVRKYTHEVVTLWYRAPDVLMGSKK 177
Query: 297 YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCL---IIWCNSRHSRK--- 350
           Y  ++D+WS+GC+FA M+    P F G    DQL++I +         W N     K   
Sbjct: 178 YSTTIDIWSVGCIFAEMV-NGAPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDP 236
Query: 351 --------PWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQ 397
                   PW  F+       +    ID L K+L+ D   R+TA++A+ H YF +
Sbjct: 237 NFTVYEPLPWESFLKG-----LDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score =  115 bits (289), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 65/194 (33%), Positives = 113/194 (58%), Gaps = 15/194 (7%)
Query: 215 TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 274
            L+D  +++ +Y+LL+ L Y HS GI+HRD+KP NV ++ +  +LR++D+GLA      +
Sbjct: 119 ALSDEHVQFLVYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDC-ELRILDFGLAR--QADE 175
Query: 275 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA 334
           E    VA+R+++ PE++++   Y+ ++D+WS+GC+ A ++ + +  F G D  DQL +I 
Sbjct: 176 EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL-QGKALFPGSDYIDQLKRIM 234
Query: 335 KDCC-----LIIWCNSRHSRKPWSKFINADNQHLVS------PEAIDFLDKLLRYDHQDR 383
           +        ++   +S H+R           + L S      P AID L ++L  D   R
Sbjct: 235 EVVGTPSPEVLAKISSEHARTYIQSLPPMPQKDLSSIFRGANPLAIDLLGRMLVLDSDQR 294
Query: 384 LTAREAMAHPYFAQ 397
           ++A EA+AH YF+Q
Sbjct: 295 VSAAEALAHAYFSQ 308

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score =  115 bits (288), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 70/235 (29%), Positives = 124/235 (52%), Gaps = 27/235 (11%)
Query: 181 NVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL---YPTLTDYDIRYYIYELLKALDYCHS 237
           N+VKL D++  +  K   L+FE+++    K+L      L     + ++ +LL  + YCH 
Sbjct: 61  NIVKLYDVIHTK--KRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHD 118
Query: 238 QGIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPELLVDLQD 296
           + ++HRD+KP N++I+ E  +L++ D+GLA  F  P ++Y   + + +++ P++L+  + 
Sbjct: 119 RRVLHRDLKPQNLLINRE-GELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKK 177
Query: 297 YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCL---IIWCNSRHSRK--- 350
           Y  ++D+WS+GC+FA M+    P F G    DQL++I +         W N     K   
Sbjct: 178 YSTTIDIWSVGCIFAEMV-NGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDP 236
Query: 351 --------PWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQ 397
                   PW  F+       +    ID L K+L+ D   R+TA++A+ H YF +
Sbjct: 237 NFTVYEPLPWESFLKG-----LDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score =  113 bits (282), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 88/313 (28%), Positives = 145/313 (46%), Gaps = 29/313 (9%)
Query: 107 RPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXX----XXX 162
           RP  Y    + T+ W   + Y+ +  VG G Y  V    +  T  R              
Sbjct: 1   RPTFYRQELAKTI-WEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSII 59
Query: 163 XXXXXXXXXXLQNLCGGPNVVKLLDI---VRDQHSKTPSLIFEYVNSTDFK--VLYPTLT 217
                     L       NV+ LLD+    R         +  ++   D    V    LT
Sbjct: 60  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCAKLT 119
Query: 218 DYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN 277
           D  +++ IY++L+ L Y HS  I+HRD+KP N+ ++ +  +L+++D+GLA   H   E  
Sbjct: 120 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDC-ELKILDFGLAR--HTDDEMT 176
Query: 278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK-- 335
             VA+R+++ PE++++   Y+ ++D+WS+GC+ A ++  +   F G D+ DQL  I +  
Sbjct: 177 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLV 235
Query: 336 ---DCCLIIWCNSRHSRK--------PWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRL 384
                 L+   +S  +R         P   F N       +P A+D L+K+L  D   R+
Sbjct: 236 GTPGAELLKKISSESARNYIQSLAQMPKMNFANVFIG--ANPLAVDLLEKMLVLDSDKRI 293
Query: 385 TAREAMAHPYFAQ 397
           TA +A+AH YFAQ
Sbjct: 294 TAAQALAHAYFAQ 306

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score =  113 bits (282), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 73/242 (30%), Positives = 135/242 (55%), Gaps = 33/242 (13%)
Query: 181 NVVKLLDIVRD---QHSKTPSLIFEYVNSTDFKVLYPT-LTDYDIRYYIYELLKALDYCH 236
           N++ + DI+R    +  K   ++ + + +  +K+L    L++  I Y++Y++L+ L Y H
Sbjct: 84  NIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH 143
Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY----NVRVASRYFKGPELLV 292
           S  ++HRD+KP N++++     L++ D+GLA    P  ++       VA+R+++ PE+++
Sbjct: 144 SANVLHRDLKPSNLLLNTTC-DLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 202
Query: 293 DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI--------AKDCCLIIWCN 344
           + + Y  S+D+WS+GC+ A M+  + P F G    DQL  I         +D   II   
Sbjct: 203 NSKGYTKSIDIWSVGCILAEMLSNR-PIFPGKHYLDQLNHILGILGSPSQEDLNCIINLK 261
Query: 345 SRH--------SRKPWSK-FINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF 395
           +R+        ++ PW++ F NAD++      A+D LDK+L ++   R+   +A+AHPY 
Sbjct: 262 ARNYLLSLPHKNKVPWNRLFPNADSK------ALDLLDKMLTFNPHKRIEVEQALAHPYL 315
Query: 396 AQ 397
           AQ
Sbjct: 316 AQ 317

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score =  112 bits (281), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 85/311 (27%), Positives = 143/311 (45%), Gaps = 25/311 (8%)
Query: 107 RPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXX----XXX 162
           RP  Y    + T+ W   + Y+ +  VG G Y  V    +  T  R              
Sbjct: 12  RPTFYRQELNKTI-WEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII 70
Query: 163 XXXXXXXXXXLQNLCGGPNVVKLLDI---VRDQHSKTPSLIFEYVNSTDFK--VLYPTLT 217
                     L       NV+ LLD+    R         +  ++   D    V    LT
Sbjct: 71  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 130
Query: 218 DYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN 277
           D  +++ IY++L+ L Y HS  I+HRD+KP N+ ++ +  +L+++D+GLA   H   E  
Sbjct: 131 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDC-ELKILDFGLAR--HTADEMT 187
Query: 278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK-- 335
             VA+R+++ PE++++   Y+ ++D+WS+GC+ A ++  +   F G D+ DQL  I +  
Sbjct: 188 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLV 246
Query: 336 ---DCCLIIWCNSRHSRKPWSKFINADNQHL------VSPEAIDFLDKLLRYDHQDRLTA 386
                 L+   +S  +R            +        +P A+D L+K+L  D   R+TA
Sbjct: 247 GTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITA 306
Query: 387 REAMAHPYFAQ 397
            +A+AH YFAQ
Sbjct: 307 AQALAHAYFAQ 317

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score =  112 bits (281), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 85/311 (27%), Positives = 143/311 (45%), Gaps = 25/311 (8%)
Query: 107 RPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXX----XXX 162
           RP  Y    + T+ W   + Y+ +  VG G Y  V    +  T  R              
Sbjct: 12  RPTFYRQELNKTI-WEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII 70
Query: 163 XXXXXXXXXXLQNLCGGPNVVKLLDI---VRDQHSKTPSLIFEYVNSTDFK--VLYPTLT 217
                     L       NV+ LLD+    R         +  ++   D    V    LT
Sbjct: 71  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 130
Query: 218 DYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN 277
           D  +++ IY++L+ L Y HS  I+HRD+KP N+ ++ +  +L+++D+GLA   H   E  
Sbjct: 131 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDC-ELKILDFGLAR--HTADEMT 187
Query: 278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK-- 335
             VA+R+++ PE++++   Y+ ++D+WS+GC+ A ++  +   F G D+ DQL  I +  
Sbjct: 188 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLV 246
Query: 336 ---DCCLIIWCNSRHSRKPWSKFINADNQHL------VSPEAIDFLDKLLRYDHQDRLTA 386
                 L+   +S  +R            +        +P A+D L+K+L  D   R+TA
Sbjct: 247 GTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITA 306
Query: 387 REAMAHPYFAQ 397
            +A+AH YFAQ
Sbjct: 307 AQALAHAYFAQ 317

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score =  112 bits (281), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 85/311 (27%), Positives = 143/311 (45%), Gaps = 25/311 (8%)
Query: 107 RPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXX----XXX 162
           RP  Y    + T+ W   + Y+ +  VG G Y  V    +  T  R              
Sbjct: 12  RPTFYRQELNKTI-WEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII 70
Query: 163 XXXXXXXXXXLQNLCGGPNVVKLLDI---VRDQHSKTPSLIFEYVNSTDFK--VLYPTLT 217
                     L       NV+ LLD+    R         +  ++   D    V    LT
Sbjct: 71  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 130
Query: 218 DYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN 277
           D  +++ IY++L+ L Y HS  I+HRD+KP N+ ++ +  +L+++D+GLA   H   E  
Sbjct: 131 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDC-ELKILDFGLAR--HTADEMT 187
Query: 278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK-- 335
             VA+R+++ PE++++   Y+ ++D+WS+GC+ A ++  +   F G D+ DQL  I +  
Sbjct: 188 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLV 246
Query: 336 ---DCCLIIWCNSRHSRKPWSKFINADNQHL------VSPEAIDFLDKLLRYDHQDRLTA 386
                 L+   +S  +R            +        +P A+D L+K+L  D   R+TA
Sbjct: 247 GTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITA 306
Query: 387 REAMAHPYFAQ 397
            +A+AH YFAQ
Sbjct: 307 AQALAHAYFAQ 317

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score =  112 bits (281), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 85/311 (27%), Positives = 143/311 (45%), Gaps = 25/311 (8%)
Query: 107 RPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXX----XXX 162
           RP  Y    + T+ W   + Y+ +  VG G Y  V    +  T  R              
Sbjct: 5   RPTFYRQELNKTI-WEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII 63
Query: 163 XXXXXXXXXXLQNLCGGPNVVKLLDI---VRDQHSKTPSLIFEYVNSTDFK--VLYPTLT 217
                     L       NV+ LLD+    R         +  ++   D    V    LT
Sbjct: 64  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKXQKLT 123
Query: 218 DYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN 277
           D  +++ IY++L+ L Y HS  I+HRD+KP N+ ++ +  +L+++D+GLA   H   E  
Sbjct: 124 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNED-XELKILDFGLAR--HTDDEMT 180
Query: 278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK-- 335
             VA+R+++ PE++++   Y+ ++D+WS+GC+ A ++  +   F G D+ DQL  I +  
Sbjct: 181 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLV 239
Query: 336 ---DCCLIIWCNSRHSRKPWSKFINADNQHL------VSPEAIDFLDKLLRYDHQDRLTA 386
                 L+   +S  +R            +        +P A+D L+K+L  D   R+TA
Sbjct: 240 GTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITA 299
Query: 387 REAMAHPYFAQ 397
            +A+AH YFAQ
Sbjct: 300 AQALAHAYFAQ 310

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score =  112 bits (280), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 73/242 (30%), Positives = 133/242 (54%), Gaps = 33/242 (13%)
Query: 181 NVVKLLDIVRD---QHSKTPSLIFEYVNSTDFKVLYPT-LTDYDIRYYIYELLKALDYCH 236
           N++ + DI+R    +  K   L+   + +  +K+L    L++  I Y++Y++L+ L Y H
Sbjct: 102 NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIH 161
Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNV----RVASRYFKGPELLV 292
           S  ++HRD+KP N++++     L++ D+GLA    P  ++       VA+R+++ PE+++
Sbjct: 162 SANVLHRDLKPSNLLLN-TTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 220
Query: 293 DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI--------AKDCCLIIWCN 344
           + + Y  S+D+WS+GC+ A M+  + P F G    DQL  I         +D   II   
Sbjct: 221 NSKGYTKSIDIWSVGCILAEMLSNR-PIFPGKHYLDQLNHILGILGSPSQEDLNCIINLK 279
Query: 345 SRH--------SRKPWSK-FINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF 395
           +R+        ++ PW++ F NAD++      A+D LDK+L ++   R+   +A+AHPY 
Sbjct: 280 ARNYLLSLPHKNKVPWNRLFPNADSK------ALDLLDKMLTFNPHKRIEVEQALAHPYL 333
Query: 396 AQ 397
            Q
Sbjct: 334 EQ 335

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score =  112 bits (280), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 88/313 (28%), Positives = 145/313 (46%), Gaps = 29/313 (9%)
Query: 107 RPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXX----XXX 162
           RP  Y    + T+ W   + Y+ +  VG G Y  V    +  T  R              
Sbjct: 25  RPTFYRQELNKTI-WEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSII 83
Query: 163 XXXXXXXXXXLQNLCGGPNVVKLLDI---VRDQHSKTPSLIFEYVNSTDFK--VLYPTLT 217
                     L       NV+ LLD+    R         +  ++   D    V    LT
Sbjct: 84  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 143
Query: 218 DYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN 277
           D  +++ IY++L+ L Y HS  I+HRD+KP N+ ++ +  +L+++D+GLA   H   E  
Sbjct: 144 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDC-ELKILDFGLAR--HTDDEMX 200
Query: 278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK-- 335
             VA+R+++ PE++++   Y+ ++D+WS+GC+ A ++  +   F G D+ DQL  I +  
Sbjct: 201 GXVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLV 259
Query: 336 ---DCCLIIWCNSRHSRK--------PWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRL 384
                 L+   +S  +R         P   F N       +P A+D L+K+L  D   R+
Sbjct: 260 GTPGAELLKKISSESARNYIQSLAQMPKMNFANVFIG--ANPLAVDLLEKMLVLDSDKRI 317
Query: 385 TAREAMAHPYFAQ 397
           TA +A+AH YFAQ
Sbjct: 318 TAAQALAHAYFAQ 330

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score =  112 bits (280), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 88/313 (28%), Positives = 145/313 (46%), Gaps = 29/313 (9%)
Query: 107 RPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXX----XXX 162
           RP  Y    + T+ W   + Y+ +  VG G Y  V    +  T  R              
Sbjct: 1   RPTFYRQELNKTI-WEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSII 59
Query: 163 XXXXXXXXXXLQNLCGGPNVVKLLDI---VRDQHSKTPSLIFEYVNSTDFK--VLYPTLT 217
                     L       NV+ LLD+    R         +  ++   D    V    LT
Sbjct: 60  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 119
Query: 218 DYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN 277
           D  +++ IY++L+ L Y HS  I+HRD+KP N+ ++ +  +L+++D+GLA   H   E  
Sbjct: 120 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDC-ELKILDFGLAR--HTDDEMT 176
Query: 278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK-- 335
             VA+R+++ PE++++   Y+ ++D+WS+GC+ A ++  +   F G D+ DQL  I +  
Sbjct: 177 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLV 235
Query: 336 ---DCCLIIWCNSRHSRK--------PWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRL 384
                 L+   +S  +R         P   F N       +P A+D L+K+L  D   R+
Sbjct: 236 GTPGAELLKKISSESARNYIQSLAQMPKMNFANVFIG--ANPLAVDLLEKMLVLDSDKRI 293
Query: 385 TAREAMAHPYFAQ 397
           TA +A+AH YFAQ
Sbjct: 294 TAAQALAHAYFAQ 306

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score =  112 bits (280), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 88/313 (28%), Positives = 145/313 (46%), Gaps = 29/313 (9%)
Query: 107 RPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXX----XXX 162
           RP  Y    + T+ W   + Y+ +  VG G Y  V    +  T  R              
Sbjct: 24  RPTFYRQELNKTI-WEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSII 82
Query: 163 XXXXXXXXXXLQNLCGGPNVVKLLDI---VRDQHSKTPSLIFEYVNSTDFK--VLYPTLT 217
                     L       NV+ LLD+    R         +  ++   D    V    LT
Sbjct: 83  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 142
Query: 218 DYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN 277
           D  +++ IY++L+ L Y HS  I+HRD+KP N+ ++ +  +L+++D+GLA   H   E  
Sbjct: 143 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDC-ELKILDFGLAR--HTDDEMT 199
Query: 278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK-- 335
             VA+R+++ PE++++   Y+ ++D+WS+GC+ A ++  +   F G D+ DQL  I +  
Sbjct: 200 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLV 258
Query: 336 ---DCCLIIWCNSRHSRK--------PWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRL 384
                 L+   +S  +R         P   F N       +P A+D L+K+L  D   R+
Sbjct: 259 GTPGAELLKKISSESARNYIQSLAQMPKMNFANVFIG--ANPLAVDLLEKMLVLDSDKRI 316
Query: 385 TAREAMAHPYFAQ 397
           TA +A+AH YFAQ
Sbjct: 317 TAAQALAHAYFAQ 329

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score =  112 bits (280), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 85/311 (27%), Positives = 143/311 (45%), Gaps = 25/311 (8%)
Query: 107 RPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXX----XXX 162
           RP  Y    + T+ W   + Y+ +  VG G Y  V    +  T  R              
Sbjct: 5   RPTFYRQELNKTI-WEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII 63
Query: 163 XXXXXXXXXXLQNLCGGPNVVKLLDI---VRDQHSKTPSLIFEYVNSTDFK--VLYPTLT 217
                     L       NV+ LLD+    R         +  ++   D    V    LT
Sbjct: 64  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 123
Query: 218 DYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN 277
           D  +++ IY++L+ L Y HS  I+HRD+KP N+ ++ +  +L+++D+GLA   H   E  
Sbjct: 124 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDC-ELKILDFGLAR--HTDDEMT 180
Query: 278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK-- 335
             VA+R+++ PE++++   Y+ ++D+WS+GC+ A ++  +   F G D+ DQL  I +  
Sbjct: 181 GYVATRWYRAPEIMLNAMHYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLV 239
Query: 336 ---DCCLIIWCNSRHSRKPWSKFINADNQHL------VSPEAIDFLDKLLRYDHQDRLTA 386
                 L+   +S  +R            +        +P A+D L+K+L  D   R+TA
Sbjct: 240 GTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITA 299
Query: 387 REAMAHPYFAQ 397
            +A+AH YFAQ
Sbjct: 300 AQALAHAYFAQ 310

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score =  112 bits (280), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 85/311 (27%), Positives = 143/311 (45%), Gaps = 25/311 (8%)
Query: 107 RPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXX----XXX 162
           RP  Y    + T+ W   + Y+ +  VG G Y  V    +  T  R              
Sbjct: 5   RPTFYRQELNKTI-WEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII 63
Query: 163 XXXXXXXXXXLQNLCGGPNVVKLLDI---VRDQHSKTPSLIFEYVNSTDFK--VLYPTLT 217
                     L       NV+ LLD+    R         +  ++   D    V    LT
Sbjct: 64  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 123
Query: 218 DYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN 277
           D  +++ IY++L+ L Y HS  I+HRD+KP N+ ++ +  +L+++D+GLA   H   E  
Sbjct: 124 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDC-ELKILDFGLAR--HTDDEMT 180
Query: 278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK-- 335
             VA+R+++ PE++++   Y+ ++D+WS+GC+ A ++  +   F G D+ DQL  I +  
Sbjct: 181 GXVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLV 239
Query: 336 ---DCCLIIWCNSRHSRKPWSKFINADNQHL------VSPEAIDFLDKLLRYDHQDRLTA 386
                 L+   +S  +R            +        +P A+D L+K+L  D   R+TA
Sbjct: 240 GTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITA 299
Query: 387 REAMAHPYFAQ 397
            +A+AH YFAQ
Sbjct: 300 AQALAHAYFAQ 310

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score =  112 bits (280), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 74/246 (30%), Positives = 126/246 (51%), Gaps = 36/246 (14%)
Query: 181 NVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYP-------------TLTDYDIRYYIYE 227
           NV+ LLD+       TP    +  + TDF ++ P              L +  I++ +Y+
Sbjct: 85  NVIGLLDVF------TPDETLD--DFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQ 136
Query: 228 LLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG 287
           +LK L Y H+ GI+HRD+KP N+ ++ +  +L+++D+GLA       E    V +R+++ 
Sbjct: 137 MLKGLRYIHAAGIIHRDLKPGNLAVNEDC-ELKILDFGLAR--QADSEMXGXVVTRWYRA 193
Query: 288 PELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCC-----LIIW 342
           PE++++   Y  ++D+WS+GC+ A MI  K   F G D+ DQL +I K         +  
Sbjct: 194 PEVILNWMRYTQTVDIWSVGCIMAEMITGKT-LFKGSDHLDQLKEIMKVTGTPPAEFVQR 252
Query: 343 CNSRHSRKPWSKFINADNQHL------VSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFA 396
             S  ++         + +         SP A++ L+K+L  D + R+TA EA+AHPYF 
Sbjct: 253 LQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFE 312
Query: 397 QVRAAE 402
            +   E
Sbjct: 313 SLHDTE 318

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score =  112 bits (280), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 88/313 (28%), Positives = 145/313 (46%), Gaps = 29/313 (9%)
Query: 107 RPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXX----XXX 162
           RP  Y    + T+ W   + Y+ +  VG G Y  V    +  T  R              
Sbjct: 25  RPTFYRQELNKTI-WEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSII 83
Query: 163 XXXXXXXXXXLQNLCGGPNVVKLLDI---VRDQHSKTPSLIFEYVNSTDFK--VLYPTLT 217
                     L       NV+ LLD+    R         +  ++   D    V    LT
Sbjct: 84  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 143
Query: 218 DYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN 277
           D  +++ IY++L+ L Y HS  I+HRD+KP N+ ++ +  +L+++D+GLA   H   E  
Sbjct: 144 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDC-ELKILDFGLAR--HTDDEMT 200
Query: 278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK-- 335
             VA+R+++ PE++++   Y+ ++D+WS+GC+ A ++  +   F G D+ DQL  I +  
Sbjct: 201 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLV 259
Query: 336 ---DCCLIIWCNSRHSRK--------PWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRL 384
                 L+   +S  +R         P   F N       +P A+D L+K+L  D   R+
Sbjct: 260 GTPGAELLKKISSESARNYIQSLAQMPKMNFANVFIG--ANPLAVDLLEKMLVLDSDKRI 317
Query: 385 TAREAMAHPYFAQ 397
           TA +A+AH YFAQ
Sbjct: 318 TAAQALAHAYFAQ 330

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score =  112 bits (279), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 85/311 (27%), Positives = 143/311 (45%), Gaps = 25/311 (8%)
Query: 107 RPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXX----XXX 162
           RP  Y    + T+ W   + Y+ +  VG G Y  V    +  T  R              
Sbjct: 5   RPTFYRQELNKTI-WEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII 63
Query: 163 XXXXXXXXXXLQNLCGGPNVVKLLDI---VRDQHSKTPSLIFEYVNSTDFK--VLYPTLT 217
                     L       NV+ LLD+    R         +  ++   D    V    LT
Sbjct: 64  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKXQKLT 123
Query: 218 DYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN 277
           D  +++ IY++L+ L Y HS  I+HRD+KP N+ ++ +  +L+++D+GLA   H   E  
Sbjct: 124 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDC-ELKILDFGLAR--HTDDEMT 180
Query: 278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK-- 335
             VA+R+++ PE++++   Y+ ++D+WS+GC+ A ++  +   F G D+ DQL  I +  
Sbjct: 181 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLV 239
Query: 336 ---DCCLIIWCNSRHSRKPWSKFINADNQHL------VSPEAIDFLDKLLRYDHQDRLTA 386
                 L+   +S  +R            +        +P A+D L+K+L  D   R+TA
Sbjct: 240 GTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITA 299
Query: 387 REAMAHPYFAQ 397
            +A+AH YFAQ
Sbjct: 300 AQALAHAYFAQ 310

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score =  112 bits (279), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 85/311 (27%), Positives = 143/311 (45%), Gaps = 25/311 (8%)
Query: 107 RPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXX----XXX 162
           RP  Y    + T+ W   + Y+ +  VG G Y  V    +  T  R              
Sbjct: 7   RPTFYRQELNKTI-WEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII 65
Query: 163 XXXXXXXXXXLQNLCGGPNVVKLLDI---VRDQHSKTPSLIFEYVNSTDFK--VLYPTLT 217
                     L       NV+ LLD+    R         +  ++   D    V    LT
Sbjct: 66  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 125
Query: 218 DYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN 277
           D  +++ IY++L+ L Y HS  I+HRD+KP N+ ++ +  +L+++D+GLA   H   E  
Sbjct: 126 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNED-SELKILDFGLAR--HTDDEMT 182
Query: 278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK-- 335
             VA+R+++ PE++++   Y+ ++D+WS+GC+ A ++  +   F G D+ DQL  I +  
Sbjct: 183 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLV 241
Query: 336 ---DCCLIIWCNSRHSRKPWSKFINADNQHL------VSPEAIDFLDKLLRYDHQDRLTA 386
                 L+   +S  +R            +        +P A+D L+K+L  D   R+TA
Sbjct: 242 GTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITA 301
Query: 387 REAMAHPYFAQ 397
            +A+AH YFAQ
Sbjct: 302 AQALAHAYFAQ 312

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score =  112 bits (279), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 88/313 (28%), Positives = 145/313 (46%), Gaps = 29/313 (9%)
Query: 107 RPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXX----XXX 162
           RP  Y    + T+ W   + Y+ +  VG G Y  V    +  T  R              
Sbjct: 5   RPTFYRQELNKTI-WEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSII 63
Query: 163 XXXXXXXXXXLQNLCGGPNVVKLLDI---VRDQHSKTPSLIFEYVNSTDFK--VLYPTLT 217
                     L       NV+ LLD+    R         +  ++   D    V    LT
Sbjct: 64  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 123
Query: 218 DYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN 277
           D  +++ IY++L+ L Y HS  I+HRD+KP N+ ++ +  +L+++D+GLA   H   E  
Sbjct: 124 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDC-ELKILDFGLAR--HTDDEMT 180
Query: 278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK-- 335
             VA+R+++ PE++++   Y+ ++D+WS+GC+ A ++  +   F G D+ DQL  I +  
Sbjct: 181 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLV 239
Query: 336 ---DCCLIIWCNSRHSRK--------PWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRL 384
                 L+   +S  +R         P   F N       +P A+D L+K+L  D   R+
Sbjct: 240 GTPGAELLKKISSESARNYIQSLAQMPKMNFANVFIG--ANPLAVDLLEKMLVLDSDKRI 297
Query: 385 TAREAMAHPYFAQ 397
           TA +A+AH YFAQ
Sbjct: 298 TAAQALAHAYFAQ 310

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score =  112 bits (279), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 85/311 (27%), Positives = 143/311 (45%), Gaps = 25/311 (8%)
Query: 107 RPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXX----XXX 162
           RP  Y    + T+ W   + Y+ +  VG G Y  V    +  T  R              
Sbjct: 11  RPTFYRQELNKTI-WEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII 69
Query: 163 XXXXXXXXXXLQNLCGGPNVVKLLDI---VRDQHSKTPSLIFEYVNSTDFK--VLYPTLT 217
                     L       NV+ LLD+    R         +  ++   D    V    LT
Sbjct: 70  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 129
Query: 218 DYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN 277
           D  +++ IY++L+ L Y HS  I+HRD+KP N+ ++ +  +L+++D+GLA   H   E  
Sbjct: 130 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNED-SELKILDFGLAR--HTDDEMT 186
Query: 278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK-- 335
             VA+R+++ PE++++   Y+ ++D+WS+GC+ A ++  +   F G D+ DQL  I +  
Sbjct: 187 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLV 245
Query: 336 ---DCCLIIWCNSRHSRKPWSKFINADNQHL------VSPEAIDFLDKLLRYDHQDRLTA 386
                 L+   +S  +R            +        +P A+D L+K+L  D   R+TA
Sbjct: 246 GTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITA 305
Query: 387 REAMAHPYFAQ 397
            +A+AH YFAQ
Sbjct: 306 AQALAHAYFAQ 316

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score =  112 bits (279), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 72/242 (29%), Positives = 134/242 (55%), Gaps = 33/242 (13%)
Query: 181 NVVKLLDIVRD---QHSKTPSLIFEYVNSTDFKVLYPT-LTDYDIRYYIYELLKALDYCH 236
           N++ + DI+R    +  K   ++ + + +  +K+L    L++  I Y++Y++L+ L Y H
Sbjct: 82  NIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH 141
Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY----NVRVASRYFKGPELLV 292
           S  ++HRD+KP N++++     L++ D+GLA    P  ++       VA+R+++ PE+++
Sbjct: 142 SANVLHRDLKPSNLLLN-TTXDLKIXDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 200
Query: 293 DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI--------AKDCCLIIWCN 344
           + + Y  S+D+WS+GC+ A M+  + P F G    DQL  I         +D   II   
Sbjct: 201 NSKGYTKSIDIWSVGCILAEMLSNR-PIFPGKHYLDQLNHILGILGSPSQEDLNXIINLK 259
Query: 345 SRH--------SRKPWSK-FINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF 395
           +R+        ++ PW++ F NAD++      A+D LDK+L ++   R+   +A+AHPY 
Sbjct: 260 ARNYLLSLPHKNKVPWNRLFPNADSK------ALDLLDKMLTFNPHKRIEVEQALAHPYL 313
Query: 396 AQ 397
            Q
Sbjct: 314 EQ 315

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score =  112 bits (279), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 85/311 (27%), Positives = 143/311 (45%), Gaps = 25/311 (8%)
Query: 107 RPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXX----XXX 162
           RP  Y    + T+ W   + Y+ +  VG G Y  V    +  T  R              
Sbjct: 3   RPTFYRQELNKTI-WEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII 61
Query: 163 XXXXXXXXXXLQNLCGGPNVVKLLDI---VRDQHSKTPSLIFEYVNSTDFK--VLYPTLT 217
                     L       NV+ LLD+    R         +  ++   D    V    LT
Sbjct: 62  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 121
Query: 218 DYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN 277
           D  +++ IY++L+ L Y HS  I+HRD+KP N+ ++ +  +L+++D+GLA   H   E  
Sbjct: 122 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDC-ELKILDFGLAR--HTDDEMT 178
Query: 278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK-- 335
             VA+R+++ PE++++   Y+ ++D+WS+GC+ A ++  +   F G D+ DQL  I +  
Sbjct: 179 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLV 237
Query: 336 ---DCCLIIWCNSRHSRKPWSKFINADNQHL------VSPEAIDFLDKLLRYDHQDRLTA 386
                 L+   +S  +R            +        +P A+D L+K+L  D   R+TA
Sbjct: 238 GTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITA 297
Query: 387 REAMAHPYFAQ 397
            +A+AH YFAQ
Sbjct: 298 AQALAHAYFAQ 308

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score =  112 bits (279), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 88/313 (28%), Positives = 145/313 (46%), Gaps = 29/313 (9%)
Query: 107 RPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXX----XXX 162
           RP  Y    + T+ W   + Y+ +  VG G Y  V    +  T  R              
Sbjct: 11  RPTFYRQELNKTI-WEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSII 69
Query: 163 XXXXXXXXXXLQNLCGGPNVVKLLDI---VRDQHSKTPSLIFEYVNSTDFK--VLYPTLT 217
                     L       NV+ LLD+    R         +  ++   D    V    LT
Sbjct: 70  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 129
Query: 218 DYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN 277
           D  +++ IY++L+ L Y HS  I+HRD+KP N+ ++ +  +L+++D+GLA   H   E  
Sbjct: 130 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDC-ELKILDFGLAR--HTDDEMT 186
Query: 278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK-- 335
             VA+R+++ PE++++   Y+ ++D+WS+GC+ A ++  +   F G D+ DQL  I +  
Sbjct: 187 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLV 245
Query: 336 ---DCCLIIWCNSRHSRK--------PWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRL 384
                 L+   +S  +R         P   F N       +P A+D L+K+L  D   R+
Sbjct: 246 GTPGAELLKKISSESARNYIQSLAQMPKMNFANVFIG--ANPLAVDLLEKMLVLDSDKRI 303
Query: 385 TAREAMAHPYFAQ 397
           TA +A+AH YFAQ
Sbjct: 304 TAAQALAHAYFAQ 316

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score =  112 bits (279), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 85/311 (27%), Positives = 143/311 (45%), Gaps = 25/311 (8%)
Query: 107 RPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXXXXXXXXX 166
           RP  Y    + T+ W   + Y+ +  VG G Y  V    +  T  R              
Sbjct: 17  RPTFYRQELNKTI-WEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSKPFQSII 75
Query: 167 XXXXX----XLQNLCGGPNVVKLLDI---VRDQHSKTPSLIFEYVNSTDFK--VLYPTLT 217
                     L       NV+ LLD+    R         +  ++   D    V    LT
Sbjct: 76  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 135
Query: 218 DYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN 277
           D  +++ IY++L+ L Y HS  I+HRD+KP N+ ++ +  +L+++D+GLA   H   E  
Sbjct: 136 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDC-ELKILDFGLAR--HTDDEMT 192
Query: 278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK-- 335
             VA+R+++ PE++++   Y+ ++D+WS+GC+ A ++  +   F G D+ DQL  I +  
Sbjct: 193 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLV 251
Query: 336 ---DCCLIIWCNSRHSRKPWSKFINADNQHL------VSPEAIDFLDKLLRYDHQDRLTA 386
                 L+   +S  +R            +        +P A+D L+K+L  D   R+TA
Sbjct: 252 GTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITA 311
Query: 387 REAMAHPYFAQ 397
            +A+AH YFAQ
Sbjct: 312 AQALAHAYFAQ 322

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score =  112 bits (279), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 85/311 (27%), Positives = 143/311 (45%), Gaps = 25/311 (8%)
Query: 107 RPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXX----XXX 162
           RP  Y    + T+ W   + Y+ +  VG G Y  V    +  T  R              
Sbjct: 10  RPTFYRQELNKTI-WEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII 68
Query: 163 XXXXXXXXXXLQNLCGGPNVVKLLDI---VRDQHSKTPSLIFEYVNSTDFK--VLYPTLT 217
                     L       NV+ LLD+    R         +  ++   D    V    LT
Sbjct: 69  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 128
Query: 218 DYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN 277
           D  +++ IY++L+ L Y HS  I+HRD+KP N+ ++ +  +L+++D+GLA   H   E  
Sbjct: 129 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNED-XELKILDFGLAR--HTDDEMT 185
Query: 278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK-- 335
             VA+R+++ PE++++   Y+ ++D+WS+GC+ A ++  +   F G D+ DQL  I +  
Sbjct: 186 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLV 244
Query: 336 ---DCCLIIWCNSRHSRKPWSKFINADNQHL------VSPEAIDFLDKLLRYDHQDRLTA 386
                 L+   +S  +R            +        +P A+D L+K+L  D   R+TA
Sbjct: 245 GTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITA 304
Query: 387 REAMAHPYFAQ 397
            +A+AH YFAQ
Sbjct: 305 AQALAHAYFAQ 315

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score =  112 bits (279), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 85/311 (27%), Positives = 143/311 (45%), Gaps = 25/311 (8%)
Query: 107 RPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXX----XXX 162
           RP  Y    + T+ W   + Y+ +  VG G Y  V    +  T  R              
Sbjct: 5   RPTFYRQELNKTI-WEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII 63
Query: 163 XXXXXXXXXXLQNLCGGPNVVKLLDI---VRDQHSKTPSLIFEYVNSTDFK--VLYPTLT 217
                     L       NV+ LLD+    R         +  ++   D    V    LT
Sbjct: 64  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 123
Query: 218 DYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN 277
           D  +++ IY++L+ L Y HS  I+HRD+KP N+ ++ +  +L+++D+GLA   H   E  
Sbjct: 124 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDC-ELKILDYGLAR--HTDDEMT 180
Query: 278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK-- 335
             VA+R+++ PE++++   Y+ ++D+WS+GC+ A ++  +   F G D+ DQL  I +  
Sbjct: 181 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLV 239
Query: 336 ---DCCLIIWCNSRHSRKPWSKFINADNQHL------VSPEAIDFLDKLLRYDHQDRLTA 386
                 L+   +S  +R            +        +P A+D L+K+L  D   R+TA
Sbjct: 240 GTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITA 299
Query: 387 REAMAHPYFAQ 397
            +A+AH YFAQ
Sbjct: 300 AQALAHAYFAQ 310

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score =  112 bits (279), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 85/311 (27%), Positives = 143/311 (45%), Gaps = 25/311 (8%)
Query: 107 RPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXX----XXX 162
           RP  Y    + T+ W   + Y+ +  VG G Y  V    +  T  R              
Sbjct: 17  RPTFYRQELNKTI-WEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII 75
Query: 163 XXXXXXXXXXLQNLCGGPNVVKLLDI---VRDQHSKTPSLIFEYVNSTDFK--VLYPTLT 217
                     L       NV+ LLD+    R         +  ++   D    V    LT
Sbjct: 76  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 135
Query: 218 DYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN 277
           D  +++ IY++L+ L Y HS  I+HRD+KP N+ ++ +  +L+++D+GLA   H   E  
Sbjct: 136 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDC-ELKILDFGLAR--HTDDEMT 192
Query: 278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK-- 335
             VA+R+++ PE++++   Y+ ++D+WS+GC+ A ++  +   F G D+ DQL  I +  
Sbjct: 193 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLV 251
Query: 336 ---DCCLIIWCNSRHSRKPWSKFINADNQHL------VSPEAIDFLDKLLRYDHQDRLTA 386
                 L+   +S  +R            +        +P A+D L+K+L  D   R+TA
Sbjct: 252 GTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITA 311
Query: 387 REAMAHPYFAQ 397
            +A+AH YFAQ
Sbjct: 312 AQALAHAYFAQ 322

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score =  112 bits (279), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 85/311 (27%), Positives = 143/311 (45%), Gaps = 25/311 (8%)
Query: 107 RPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXX----XXX 162
           RP  Y    + T+ W   + Y+ +  VG G Y  V    +  T  R              
Sbjct: 5   RPTFYRQELNKTI-WEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII 63
Query: 163 XXXXXXXXXXLQNLCGGPNVVKLLDI---VRDQHSKTPSLIFEYVNSTDFK--VLYPTLT 217
                     L       NV+ LLD+    R         +  ++   D    V    LT
Sbjct: 64  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 123
Query: 218 DYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN 277
           D  +++ IY++L+ L Y HS  I+HRD+KP N+ ++ +  +L+++D+GLA   H   E  
Sbjct: 124 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDC-ELKILDFGLAR--HTDDEMT 180
Query: 278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK-- 335
             VA+R+++ PE++++   Y+ ++D+WS+GC+ A ++  +   F G D+ DQL  I +  
Sbjct: 181 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLV 239
Query: 336 ---DCCLIIWCNSRHSRKPWSKFINADNQHL------VSPEAIDFLDKLLRYDHQDRLTA 386
                 L+   +S  +R            +        +P A+D L+K+L  D   R+TA
Sbjct: 240 GTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITA 299
Query: 387 REAMAHPYFAQ 397
            +A+AH YFAQ
Sbjct: 300 AQALAHAYFAQ 310

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score =  112 bits (279), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 88/313 (28%), Positives = 145/313 (46%), Gaps = 29/313 (9%)
Query: 107 RPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXX----XXX 162
           RP  Y    + T+ W   + Y+ +  VG G Y  V    +  T  R              
Sbjct: 15  RPTFYRQELNKTI-WEVPERYQNLAPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSII 73
Query: 163 XXXXXXXXXXLQNLCGGPNVVKLLDI---VRDQHSKTPSLIFEYVNSTDFK--VLYPTLT 217
                     L       NV+ LLD+    R         +  ++   D    V    LT
Sbjct: 74  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 133
Query: 218 DYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN 277
           D  +++ IY++L+ L Y HS  I+HRD+KP N+ ++ +  +L+++D+GLA   H   E  
Sbjct: 134 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDC-ELKILDFGLAR--HTDDEMT 190
Query: 278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK-- 335
             VA+R+++ PE++++   Y+ ++D+WS+GC+ A ++  +   F G D+ DQL  I +  
Sbjct: 191 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLV 249
Query: 336 ---DCCLIIWCNSRHSRK--------PWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRL 384
                 L+   +S  +R         P   F N       +P A+D L+K+L  D   R+
Sbjct: 250 GTPGAELLKKISSESARNYIQSLAQMPKMNFANVFIG--ANPLAVDLLEKMLVLDSDKRI 307
Query: 385 TAREAMAHPYFAQ 397
           TA +A+AH YFAQ
Sbjct: 308 TAAQALAHAYFAQ 320

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score =  112 bits (279), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 85/311 (27%), Positives = 143/311 (45%), Gaps = 25/311 (8%)
Query: 107 RPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXX----XXX 162
           RP  Y    + T+ W   + Y+ +  VG G Y  V    +  T  R              
Sbjct: 17  RPTFYRQELNKTI-WEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII 75
Query: 163 XXXXXXXXXXLQNLCGGPNVVKLLDI---VRDQHSKTPSLIFEYVNSTDFK--VLYPTLT 217
                     L       NV+ LLD+    R         +  ++   D    V    LT
Sbjct: 76  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 135
Query: 218 DYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN 277
           D  +++ IY++L+ L Y HS  I+HRD+KP N+ ++ +  +L+++D+GLA   H   E  
Sbjct: 136 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDC-ELKILDFGLAR--HTDDEMT 192
Query: 278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK-- 335
             VA+R+++ PE++++   Y+ ++D+WS+GC+ A ++  +   F G D+ DQL  I +  
Sbjct: 193 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLV 251
Query: 336 ---DCCLIIWCNSRHSRKPWSKFINADNQHL------VSPEAIDFLDKLLRYDHQDRLTA 386
                 L+   +S  +R            +        +P A+D L+K+L  D   R+TA
Sbjct: 252 GTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITA 311
Query: 387 REAMAHPYFAQ 397
            +A+AH YFAQ
Sbjct: 312 AQALAHAYFAQ 322

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score =  112 bits (279), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 85/311 (27%), Positives = 143/311 (45%), Gaps = 25/311 (8%)
Query: 107 RPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXX----XXX 162
           RP  Y    + T+ W   + Y+ +  VG G Y  V    +  T  R              
Sbjct: 16  RPTFYRQELNKTI-WEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII 74
Query: 163 XXXXXXXXXXLQNLCGGPNVVKLLDI---VRDQHSKTPSLIFEYVNSTDFK--VLYPTLT 217
                     L       NV+ LLD+    R         +  ++   D    V    LT
Sbjct: 75  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 134
Query: 218 DYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN 277
           D  +++ IY++L+ L Y HS  I+HRD+KP N+ ++ +  +L+++D+GLA   H   E  
Sbjct: 135 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNED-XELKILDFGLAR--HTDDEMT 191
Query: 278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK-- 335
             VA+R+++ PE++++   Y+ ++D+WS+GC+ A ++  +   F G D+ DQL  I +  
Sbjct: 192 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLV 250
Query: 336 ---DCCLIIWCNSRHSRKPWSKFINADNQHL------VSPEAIDFLDKLLRYDHQDRLTA 386
                 L+   +S  +R            +        +P A+D L+K+L  D   R+TA
Sbjct: 251 GTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITA 310
Query: 387 REAMAHPYFAQ 397
            +A+AH YFAQ
Sbjct: 311 AQALAHAYFAQ 321

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score =  112 bits (279), Expect = 6e-25,   Method: Compositional matrix adjust.
 Identities = 85/311 (27%), Positives = 143/311 (45%), Gaps = 25/311 (8%)
Query: 107 RPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXX----XXX 162
           RP  Y    + T+ W   + Y+ +  VG G Y  V    +  T  R              
Sbjct: 5   RPTFYRQELNKTI-WEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII 63
Query: 163 XXXXXXXXXXLQNLCGGPNVVKLLDI---VRDQHSKTPSLIFEYVNSTDFK--VLYPTLT 217
                     L       NV+ LLD+    R         +  ++   D    V    LT
Sbjct: 64  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 123
Query: 218 DYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN 277
           D  +++ IY++L+ L Y HS  I+HRD+KP N+ ++ +  +L+++D+GLA   H   E  
Sbjct: 124 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDC-ELKILDFGLAR--HTDDEMT 180
Query: 278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK-- 335
             VA+R+++ PE++++   Y+ ++D+WS+GC+ A ++  +   F G D+ DQL  I +  
Sbjct: 181 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLV 239
Query: 336 ---DCCLIIWCNSRHSRKPWSKFINADNQHL------VSPEAIDFLDKLLRYDHQDRLTA 386
                 L+   +S  +R            +        +P A+D L+K+L  D   R+TA
Sbjct: 240 GTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITA 299
Query: 387 REAMAHPYFAQ 397
            +A+AH YFAQ
Sbjct: 300 AQALAHAYFAQ 310

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score =  111 bits (278), Expect = 6e-25,   Method: Compositional matrix adjust.
 Identities = 85/311 (27%), Positives = 143/311 (45%), Gaps = 25/311 (8%)
Query: 107 RPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXX----XXX 162
           RP  Y    + T+ W   + Y+ +  VG G Y  V    +  T  R              
Sbjct: 7   RPTFYRQELNKTI-WEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII 65
Query: 163 XXXXXXXXXXLQNLCGGPNVVKLLDI---VRDQHSKTPSLIFEYVNSTDFK--VLYPTLT 217
                     L       NV+ LLD+    R         +  ++   D    V    LT
Sbjct: 66  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 125
Query: 218 DYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN 277
           D  +++ IY++L+ L Y HS  I+HRD+KP N+ ++ +  +L+++D+GLA   H   E  
Sbjct: 126 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDC-ELKILDFGLAR--HTDDEMT 182
Query: 278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK-- 335
             VA+R+++ PE++++   Y+ ++D+WS+GC+ A ++  +   F G D+ DQL  I +  
Sbjct: 183 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLV 241
Query: 336 ---DCCLIIWCNSRHSRKPWSKFINADNQHL------VSPEAIDFLDKLLRYDHQDRLTA 386
                 L+   +S  +R            +        +P A+D L+K+L  D   R+TA
Sbjct: 242 GTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITA 301
Query: 387 REAMAHPYFAQ 397
            +A+AH YFAQ
Sbjct: 302 AQALAHAYFAQ 312

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score =  111 bits (278), Expect = 6e-25,   Method: Compositional matrix adjust.
 Identities = 85/311 (27%), Positives = 143/311 (45%), Gaps = 25/311 (8%)
Query: 107 RPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXX----XXX 162
           RP  Y    + T+ W   + Y+ +  VG G Y  V    +  T  R              
Sbjct: 2   RPTFYRQELNKTI-WEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII 60
Query: 163 XXXXXXXXXXLQNLCGGPNVVKLLDI---VRDQHSKTPSLIFEYVNSTDFK--VLYPTLT 217
                     L       NV+ LLD+    R         +  ++   D    V    LT
Sbjct: 61  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 120
Query: 218 DYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN 277
           D  +++ IY++L+ L Y HS  I+HRD+KP N+ ++ +  +L+++D+GLA   H   E  
Sbjct: 121 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDC-ELKILDFGLAR--HTDDEMT 177
Query: 278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK-- 335
             VA+R+++ PE++++   Y+ ++D+WS+GC+ A ++  +   F G D+ DQL  I +  
Sbjct: 178 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLV 236
Query: 336 ---DCCLIIWCNSRHSRKPWSKFINADNQHL------VSPEAIDFLDKLLRYDHQDRLTA 386
                 L+   +S  +R            +        +P A+D L+K+L  D   R+TA
Sbjct: 237 GTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITA 296
Query: 387 REAMAHPYFAQ 397
            +A+AH YFAQ
Sbjct: 297 AQALAHAYFAQ 307

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score =  111 bits (278), Expect = 6e-25,   Method: Compositional matrix adjust.
 Identities = 85/311 (27%), Positives = 143/311 (45%), Gaps = 25/311 (8%)
Query: 107 RPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXX----XXX 162
           RP  Y    + T+ W   + Y+ +  VG G Y  V    +  T  R              
Sbjct: 5   RPTFYRQELNKTI-WEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII 63
Query: 163 XXXXXXXXXXLQNLCGGPNVVKLLDI---VRDQHSKTPSLIFEYVNSTDFK--VLYPTLT 217
                     L       NV+ LLD+    R         +  ++   D    V    LT
Sbjct: 64  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 123
Query: 218 DYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN 277
           D  +++ IY++L+ L Y HS  I+HRD+KP N+ ++ +  +L+++D+GLA   H   E  
Sbjct: 124 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDC-ELKILDFGLAR--HTDDEMT 180
Query: 278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK-- 335
             VA+R+++ PE++++   Y+ ++D+WS+GC+ A ++  +   F G D+ DQL  I +  
Sbjct: 181 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLV 239
Query: 336 ---DCCLIIWCNSRHSRKPWSKFINADNQHL------VSPEAIDFLDKLLRYDHQDRLTA 386
                 L+   +S  +R            +        +P A+D L+K+L  D   R+TA
Sbjct: 240 GTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITA 299
Query: 387 REAMAHPYFAQ 397
            +A+AH YFAQ
Sbjct: 300 AQALAHAYFAQ 310

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score =  111 bits (278), Expect = 6e-25,   Method: Compositional matrix adjust.
 Identities = 72/242 (29%), Positives = 134/242 (55%), Gaps = 33/242 (13%)
Query: 181 NVVKLLDIVRD---QHSKTPSLIFEYVNSTDFKVLYPT-LTDYDIRYYIYELLKALDYCH 236
           N++ + DI+R    +  K   ++ + + +  +K+L    L++  I Y++Y++L+ L Y H
Sbjct: 82  NIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH 141
Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY----NVRVASRYFKGPELLV 292
           S  ++HRD+KP N++++     L++ D+GLA    P  ++       VA+R+++ PE+++
Sbjct: 142 SANVLHRDLKPSNLLLN-TTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 200
Query: 293 DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI--------AKDCCLIIWCN 344
           + + Y  S+D+WS+GC+ A M+  + P F G    DQL  I         +D   II   
Sbjct: 201 NSKGYTKSIDIWSVGCILAEMLSNR-PIFPGKHYLDQLNHILGILGSPSQEDLNXIINLK 259
Query: 345 SRH--------SRKPWSK-FINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF 395
           +R+        ++ PW++ F NAD++      A+D LDK+L ++   R+   +A+AHPY 
Sbjct: 260 ARNYLLSLPHKNKVPWNRLFPNADSK------ALDLLDKMLTFNPHKRIEVEQALAHPYL 313
Query: 396 AQ 397
            Q
Sbjct: 314 EQ 315

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score =  111 bits (278), Expect = 6e-25,   Method: Compositional matrix adjust.
 Identities = 85/311 (27%), Positives = 143/311 (45%), Gaps = 25/311 (8%)
Query: 107 RPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXX----XXX 162
           RP  Y    + T+ W   + Y+ +  VG G Y  V    +  T  R              
Sbjct: 5   RPTFYRQELNKTI-WEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII 63
Query: 163 XXXXXXXXXXLQNLCGGPNVVKLLDI---VRDQHSKTPSLIFEYVNSTDFK--VLYPTLT 217
                     L       NV+ LLD+    R         +  ++   D    V    LT
Sbjct: 64  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 123
Query: 218 DYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN 277
           D  +++ IY++L+ L Y HS  I+HRD+KP N+ ++ +  +L+++D+GLA   H   E  
Sbjct: 124 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDC-ELKILDFGLAR--HTDDEMT 180
Query: 278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK-- 335
             VA+R+++ PE++++   Y+ ++D+WS+GC+ A ++  +   F G D+ DQL  I +  
Sbjct: 181 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLV 239
Query: 336 ---DCCLIIWCNSRHSRKPWSKFINADNQHL------VSPEAIDFLDKLLRYDHQDRLTA 386
                 L+   +S  +R            +        +P A+D L+K+L  D   R+TA
Sbjct: 240 GTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITA 299
Query: 387 REAMAHPYFAQ 397
            +A+AH YFAQ
Sbjct: 300 AQALAHAYFAQ 310

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score =  111 bits (278), Expect = 6e-25,   Method: Compositional matrix adjust.
 Identities = 85/311 (27%), Positives = 143/311 (45%), Gaps = 25/311 (8%)
Query: 107 RPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXX----XXX 162
           RP  Y    + T+ W   + Y+ +  VG G Y  V    +  T  R              
Sbjct: 10  RPTFYRQELNKTI-WEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII 68
Query: 163 XXXXXXXXXXLQNLCGGPNVVKLLDI---VRDQHSKTPSLIFEYVNSTDFK--VLYPTLT 217
                     L       NV+ LLD+    R         +  ++   D    V    LT
Sbjct: 69  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 128
Query: 218 DYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN 277
           D  +++ IY++L+ L Y HS  I+HRD+KP N+ ++ +  +L+++D+GLA   H   E  
Sbjct: 129 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDC-ELKILDFGLAR--HTDDEMT 185
Query: 278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK-- 335
             VA+R+++ PE++++   Y+ ++D+WS+GC+ A ++  +   F G D+ DQL  I +  
Sbjct: 186 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLV 244
Query: 336 ---DCCLIIWCNSRHSRKPWSKFINADNQHL------VSPEAIDFLDKLLRYDHQDRLTA 386
                 L+   +S  +R            +        +P A+D L+K+L  D   R+TA
Sbjct: 245 GTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITA 304
Query: 387 REAMAHPYFAQ 397
            +A+AH YFAQ
Sbjct: 305 AQALAHAYFAQ 315

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score =  111 bits (278), Expect = 6e-25,   Method: Compositional matrix adjust.
 Identities = 85/311 (27%), Positives = 143/311 (45%), Gaps = 25/311 (8%)
Query: 107 RPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXX----XXX 162
           RP  Y    + T+ W   + Y+ +  VG G Y  V    +  T  R              
Sbjct: 4   RPTFYRQELNKTI-WEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII 62
Query: 163 XXXXXXXXXXLQNLCGGPNVVKLLDI---VRDQHSKTPSLIFEYVNSTDFK--VLYPTLT 217
                     L       NV+ LLD+    R         +  ++   D    V    LT
Sbjct: 63  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 122
Query: 218 DYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN 277
           D  +++ IY++L+ L Y HS  I+HRD+KP N+ ++ +  +L+++D+GLA   H   E  
Sbjct: 123 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDC-ELKILDFGLAR--HTDDEMT 179
Query: 278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK-- 335
             VA+R+++ PE++++   Y+ ++D+WS+GC+ A ++  +   F G D+ DQL  I +  
Sbjct: 180 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLV 238
Query: 336 ---DCCLIIWCNSRHSRKPWSKFINADNQHL------VSPEAIDFLDKLLRYDHQDRLTA 386
                 L+   +S  +R            +        +P A+D L+K+L  D   R+TA
Sbjct: 239 GTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITA 298
Query: 387 REAMAHPYFAQ 397
            +A+AH YFAQ
Sbjct: 299 AQALAHAYFAQ 309

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score =  111 bits (278), Expect = 6e-25,   Method: Compositional matrix adjust.
 Identities = 85/311 (27%), Positives = 143/311 (45%), Gaps = 25/311 (8%)
Query: 107 RPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXX----XXX 162
           RP  Y    + T+ W   + Y+ +  VG G Y  V    +  T  R              
Sbjct: 10  RPTFYRQELNKTI-WEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII 68
Query: 163 XXXXXXXXXXLQNLCGGPNVVKLLDI---VRDQHSKTPSLIFEYVNSTDFK--VLYPTLT 217
                     L       NV+ LLD+    R         +  ++   D    V    LT
Sbjct: 69  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 128
Query: 218 DYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN 277
           D  +++ IY++L+ L Y HS  I+HRD+KP N+ ++ +  +L+++D+GLA   H   E  
Sbjct: 129 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDC-ELKILDFGLAR--HTDDEMT 185
Query: 278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK-- 335
             VA+R+++ PE++++   Y+ ++D+WS+GC+ A ++  +   F G D+ DQL  I +  
Sbjct: 186 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLV 244
Query: 336 ---DCCLIIWCNSRHSRKPWSKFINADNQHL------VSPEAIDFLDKLLRYDHQDRLTA 386
                 L+   +S  +R            +        +P A+D L+K+L  D   R+TA
Sbjct: 245 GTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITA 304
Query: 387 REAMAHPYFAQ 397
            +A+AH YFAQ
Sbjct: 305 AQALAHAYFAQ 315

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score =  111 bits (278), Expect = 6e-25,   Method: Compositional matrix adjust.
 Identities = 85/311 (27%), Positives = 143/311 (45%), Gaps = 25/311 (8%)
Query: 107 RPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXX----XXX 162
           RP  Y    + T+ W   + Y+ +  VG G Y  V    +  T  R              
Sbjct: 25  RPTFYRQELNKTI-WEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII 83
Query: 163 XXXXXXXXXXLQNLCGGPNVVKLLDI---VRDQHSKTPSLIFEYVNSTDFK--VLYPTLT 217
                     L       NV+ LLD+    R         +  ++   D    V    LT
Sbjct: 84  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 143
Query: 218 DYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN 277
           D  +++ IY++L+ L Y HS  I+HRD+KP N+ ++ +  +L+++D+GLA   H   E  
Sbjct: 144 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDC-ELKILDFGLAR--HTDDEMT 200
Query: 278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK-- 335
             VA+R+++ PE++++   Y+ ++D+WS+GC+ A ++  +   F G D+ DQL  I +  
Sbjct: 201 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLV 259
Query: 336 ---DCCLIIWCNSRHSRKPWSKFINADNQHL------VSPEAIDFLDKLLRYDHQDRLTA 386
                 L+   +S  +R            +        +P A+D L+K+L  D   R+TA
Sbjct: 260 GTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITA 319
Query: 387 REAMAHPYFAQ 397
            +A+AH YFAQ
Sbjct: 320 AQALAHAYFAQ 330

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score =  111 bits (278), Expect = 6e-25,   Method: Compositional matrix adjust.
 Identities = 85/311 (27%), Positives = 143/311 (45%), Gaps = 25/311 (8%)
Query: 107 RPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXX----XXX 162
           RP  Y    + T+ W   + Y+ +  VG G Y  V    +  T  R              
Sbjct: 24  RPTFYRQELNKTI-WEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII 82
Query: 163 XXXXXXXXXXLQNLCGGPNVVKLLDI---VRDQHSKTPSLIFEYVNSTDFK--VLYPTLT 217
                     L       NV+ LLD+    R         +  ++   D    V    LT
Sbjct: 83  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 142
Query: 218 DYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN 277
           D  +++ IY++L+ L Y HS  I+HRD+KP N+ ++ +  +L+++D+GLA   H   E  
Sbjct: 143 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDC-ELKILDFGLAR--HTDDEMT 199
Query: 278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK-- 335
             VA+R+++ PE++++   Y+ ++D+WS+GC+ A ++  +   F G D+ DQL  I +  
Sbjct: 200 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLV 258
Query: 336 ---DCCLIIWCNSRHSRKPWSKFINADNQHL------VSPEAIDFLDKLLRYDHQDRLTA 386
                 L+   +S  +R            +        +P A+D L+K+L  D   R+TA
Sbjct: 259 GTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITA 318
Query: 387 REAMAHPYFAQ 397
            +A+AH YFAQ
Sbjct: 319 AQALAHAYFAQ 329

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score =  111 bits (278), Expect = 6e-25,   Method: Compositional matrix adjust.
 Identities = 85/311 (27%), Positives = 143/311 (45%), Gaps = 25/311 (8%)
Query: 107 RPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXX----XXX 162
           RP  Y    + T+ W   + Y+ +  VG G Y  V    +  T  R              
Sbjct: 11  RPTFYRQELNKTI-WEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII 69
Query: 163 XXXXXXXXXXLQNLCGGPNVVKLLDI---VRDQHSKTPSLIFEYVNSTDFK--VLYPTLT 217
                     L       NV+ LLD+    R         +  ++   D    V    LT
Sbjct: 70  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 129
Query: 218 DYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN 277
           D  +++ IY++L+ L Y HS  I+HRD+KP N+ ++ +  +L+++D+GLA   H   E  
Sbjct: 130 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDC-ELKILDFGLAR--HTDDEMT 186
Query: 278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK-- 335
             VA+R+++ PE++++   Y+ ++D+WS+GC+ A ++  +   F G D+ DQL  I +  
Sbjct: 187 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLV 245
Query: 336 ---DCCLIIWCNSRHSRKPWSKFINADNQHL------VSPEAIDFLDKLLRYDHQDRLTA 386
                 L+   +S  +R            +        +P A+D L+K+L  D   R+TA
Sbjct: 246 GTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITA 305
Query: 387 REAMAHPYFAQ 397
            +A+AH YFAQ
Sbjct: 306 AQALAHAYFAQ 316

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score =  111 bits (278), Expect = 6e-25,   Method: Compositional matrix adjust.
 Identities = 85/311 (27%), Positives = 143/311 (45%), Gaps = 25/311 (8%)
Query: 107 RPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXX----XXX 162
           RP  Y    + T+ W   + Y+ +  VG G Y  V    +  T  R              
Sbjct: 5   RPTFYRQELNKTI-WEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII 63
Query: 163 XXXXXXXXXXLQNLCGGPNVVKLLDI---VRDQHSKTPSLIFEYVNSTDFK--VLYPTLT 217
                     L       NV+ LLD+    R         +  ++   D    V    LT
Sbjct: 64  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 123
Query: 218 DYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN 277
           D  +++ IY++L+ L Y HS  I+HRD+KP N+ ++ +  +L+++D+GLA   H   E  
Sbjct: 124 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDC-ELKILDFGLAR--HTDDEMT 180
Query: 278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK-- 335
             VA+R+++ PE++++   Y+ ++D+WS+GC+ A ++  +   F G D+ DQL  I +  
Sbjct: 181 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLV 239
Query: 336 ---DCCLIIWCNSRHSRKPWSKFINADNQHL------VSPEAIDFLDKLLRYDHQDRLTA 386
                 L+   +S  +R            +        +P A+D L+K+L  D   R+TA
Sbjct: 240 GTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITA 299
Query: 387 REAMAHPYFAQ 397
            +A+AH YFAQ
Sbjct: 300 AQALAHAYFAQ 310

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score =  111 bits (278), Expect = 6e-25,   Method: Compositional matrix adjust.
 Identities = 85/311 (27%), Positives = 143/311 (45%), Gaps = 25/311 (8%)
Query: 107 RPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXX----XXX 162
           RP  Y    + T+ W   + Y+ +  VG G Y  V    +  T  R              
Sbjct: 12  RPTFYRQELNKTI-WEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII 70
Query: 163 XXXXXXXXXXLQNLCGGPNVVKLLDI---VRDQHSKTPSLIFEYVNSTDFK--VLYPTLT 217
                     L       NV+ LLD+    R         +  ++   D    V    LT
Sbjct: 71  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 130
Query: 218 DYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN 277
           D  +++ IY++L+ L Y HS  I+HRD+KP N+ ++ +  +L+++D+GLA   H   E  
Sbjct: 131 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDC-ELKILDFGLAR--HTDDEMT 187
Query: 278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK-- 335
             VA+R+++ PE++++   Y+ ++D+WS+GC+ A ++  +   F G D+ DQL  I +  
Sbjct: 188 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLV 246
Query: 336 ---DCCLIIWCNSRHSRKPWSKFINADNQHL------VSPEAIDFLDKLLRYDHQDRLTA 386
                 L+   +S  +R            +        +P A+D L+K+L  D   R+TA
Sbjct: 247 GTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITA 306
Query: 387 REAMAHPYFAQ 397
            +A+AH YFAQ
Sbjct: 307 AQALAHAYFAQ 317

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score =  111 bits (278), Expect = 6e-25,   Method: Compositional matrix adjust.
 Identities = 88/313 (28%), Positives = 145/313 (46%), Gaps = 29/313 (9%)
Query: 107 RPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXX----XXX 162
           RP  Y    + T+ W   + Y+ +  VG G Y  V    +  T  R              
Sbjct: 1   RPTFYRQELNKTI-WEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSII 59
Query: 163 XXXXXXXXXXLQNLCGGPNVVKLLDI---VRDQHSKTPSLIFEYVNSTDFK--VLYPTLT 217
                     L       NV+ LLD+    R         +  ++   D    V    LT
Sbjct: 60  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 119
Query: 218 DYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN 277
           D  +++ IY++L+ L Y HS  I+HRD+KP N+ ++ +  +L+++D+GLA   H   E  
Sbjct: 120 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDC-ELKILDFGLAR--HTDDEMA 176
Query: 278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK-- 335
             VA+R+++ PE++++   Y+ ++D+WS+GC+ A ++  +   F G D+ DQL  I +  
Sbjct: 177 GFVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLV 235
Query: 336 ---DCCLIIWCNSRHSRK--------PWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRL 384
                 L+   +S  +R         P   F N       +P A+D L+K+L  D   R+
Sbjct: 236 GTPGAELLKKISSESARNYIQSLAQMPKMNFANVFIG--ANPLAVDLLEKMLVLDSDKRI 293
Query: 385 TAREAMAHPYFAQ 397
           TA +A+AH YFAQ
Sbjct: 294 TAAQALAHAYFAQ 306

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score =  111 bits (278), Expect = 6e-25,   Method: Compositional matrix adjust.
 Identities = 72/242 (29%), Positives = 134/242 (55%), Gaps = 33/242 (13%)
Query: 181 NVVKLLDIVRD---QHSKTPSLIFEYVNSTDFKVLYPT-LTDYDIRYYIYELLKALDYCH 236
           N++ + DI+R    +  K   ++ + + +  +K+L    L++  I Y++Y++L+ L Y H
Sbjct: 86  NIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH 145
Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN----VRVASRYFKGPELLV 292
           S  ++HRD+KP N++++     L++ D+GLA    P  ++       VA+R+++ PE+++
Sbjct: 146 SANVLHRDLKPSNLLLNTTC-DLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIML 204
Query: 293 DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI--------AKDCCLIIWCN 344
           + + Y  S+D+WS+GC+ A M+  + P F G    DQL  I         +D   II   
Sbjct: 205 NSKGYTKSIDIWSVGCILAEMLSNR-PIFPGKHYLDQLNHILGILGSPSQEDLNCIINLK 263
Query: 345 SRH--------SRKPWSK-FINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF 395
           +R+        ++ PW++ F NAD++      A+D LDK+L ++   R+   +A+AHPY 
Sbjct: 264 ARNYLLSLPHKNKVPWNRLFPNADSK------ALDLLDKMLTFNPHKRIEVEQALAHPYL 317
Query: 396 AQ 397
            Q
Sbjct: 318 EQ 319

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score =  111 bits (278), Expect = 6e-25,   Method: Compositional matrix adjust.
 Identities = 72/242 (29%), Positives = 134/242 (55%), Gaps = 33/242 (13%)
Query: 181 NVVKLLDIVRD---QHSKTPSLIFEYVNSTDFKVLYPT-LTDYDIRYYIYELLKALDYCH 236
           N++ + DI+R    +  K   ++ + + +  +K+L    L++  I Y++Y++L+ L Y H
Sbjct: 87  NIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH 146
Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN----VRVASRYFKGPELLV 292
           S  ++HRD+KP N++++     L++ D+GLA    P  ++       VA+R+++ PE+++
Sbjct: 147 SANVLHRDLKPSNLLLNTTC-DLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIML 205
Query: 293 DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI--------AKDCCLIIWCN 344
           + + Y  S+D+WS+GC+ A M+  + P F G    DQL  I         +D   II   
Sbjct: 206 NSKGYTKSIDIWSVGCILAEMLSNR-PIFPGKHYLDQLNHILGILGSPSQEDLNCIINLK 264
Query: 345 SRH--------SRKPWSK-FINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF 395
           +R+        ++ PW++ F NAD++      A+D LDK+L ++   R+   +A+AHPY 
Sbjct: 265 ARNYLLSLPHKNKVPWNRLFPNADSK------ALDLLDKMLTFNPHKRIEVEQALAHPYL 318
Query: 396 AQ 397
            Q
Sbjct: 319 EQ 320

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score =  111 bits (278), Expect = 6e-25,   Method: Compositional matrix adjust.
 Identities = 85/311 (27%), Positives = 143/311 (45%), Gaps = 25/311 (8%)
Query: 107 RPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXX----XXX 162
           RP  Y    + T+ W   + Y+ +  VG G Y  V    +  T  R              
Sbjct: 2   RPTFYRQELNKTI-WEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII 60
Query: 163 XXXXXXXXXXLQNLCGGPNVVKLLDI---VRDQHSKTPSLIFEYVNSTDFK--VLYPTLT 217
                     L       NV+ LLD+    R         +  ++   D    V    LT
Sbjct: 61  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 120
Query: 218 DYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN 277
           D  +++ IY++L+ L Y HS  I+HRD+KP N+ ++ +  +L+++D+GLA   H   E  
Sbjct: 121 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDC-ELKILDFGLAR--HTDDEMT 177
Query: 278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK-- 335
             VA+R+++ PE++++   Y+ ++D+WS+GC+ A ++  +   F G D+ DQL  I +  
Sbjct: 178 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLV 236
Query: 336 ---DCCLIIWCNSRHSRKPWSKFINADNQHL------VSPEAIDFLDKLLRYDHQDRLTA 386
                 L+   +S  +R            +        +P A+D L+K+L  D   R+TA
Sbjct: 237 GTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITA 296
Query: 387 REAMAHPYFAQ 397
            +A+AH YFAQ
Sbjct: 297 AQALAHAYFAQ 307

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score =  111 bits (278), Expect = 6e-25,   Method: Compositional matrix adjust.
 Identities = 85/311 (27%), Positives = 143/311 (45%), Gaps = 25/311 (8%)
Query: 107 RPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXX----XXX 162
           RP  Y    + T+ W   + Y+ +  VG G Y  V    +  T  R              
Sbjct: 28  RPTFYRQELNKTI-WEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII 86
Query: 163 XXXXXXXXXXLQNLCGGPNVVKLLDI---VRDQHSKTPSLIFEYVNSTDFK--VLYPTLT 217
                     L       NV+ LLD+    R         +  ++   D    V    LT
Sbjct: 87  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 146
Query: 218 DYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN 277
           D  +++ IY++L+ L Y HS  I+HRD+KP N+ ++ +  +L+++D+GLA   H   E  
Sbjct: 147 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDC-ELKILDFGLAR--HTDDEMT 203
Query: 278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK-- 335
             VA+R+++ PE++++   Y+ ++D+WS+GC+ A ++  +   F G D+ DQL  I +  
Sbjct: 204 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLV 262
Query: 336 ---DCCLIIWCNSRHSRKPWSKFINADNQHL------VSPEAIDFLDKLLRYDHQDRLTA 386
                 L+   +S  +R            +        +P A+D L+K+L  D   R+TA
Sbjct: 263 GTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITA 322
Query: 387 REAMAHPYFAQ 397
            +A+AH YFAQ
Sbjct: 323 AQALAHAYFAQ 333

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score =  111 bits (278), Expect = 6e-25,   Method: Compositional matrix adjust.
 Identities = 85/311 (27%), Positives = 143/311 (45%), Gaps = 25/311 (8%)
Query: 107 RPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXX----XXX 162
           RP  Y    + T+ W   + Y+ +  VG G Y  V    +  T  R              
Sbjct: 1   RPTFYRQELNKTI-WEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII 59
Query: 163 XXXXXXXXXXLQNLCGGPNVVKLLDI---VRDQHSKTPSLIFEYVNSTDFK--VLYPTLT 217
                     L       NV+ LLD+    R         +  ++   D    V    LT
Sbjct: 60  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 119
Query: 218 DYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN 277
           D  +++ IY++L+ L Y HS  I+HRD+KP N+ ++ +  +L+++D+GLA   H   E  
Sbjct: 120 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDC-ELKILDFGLAR--HTDDEMT 176
Query: 278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK-- 335
             VA+R+++ PE++++   Y+ ++D+WS+GC+ A ++  +   F G D+ DQL  I +  
Sbjct: 177 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLV 235
Query: 336 ---DCCLIIWCNSRHSRKPWSKFINADNQHL------VSPEAIDFLDKLLRYDHQDRLTA 386
                 L+   +S  +R            +        +P A+D L+K+L  D   R+TA
Sbjct: 236 GTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITA 295
Query: 387 REAMAHPYFAQ 397
            +A+AH YFAQ
Sbjct: 296 AQALAHAYFAQ 306

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score =  111 bits (278), Expect = 6e-25,   Method: Compositional matrix adjust.
 Identities = 85/311 (27%), Positives = 143/311 (45%), Gaps = 25/311 (8%)
Query: 107 RPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXX----XXX 162
           RP  Y    + T+ W   + Y+ +  VG G Y  V    +  T  R              
Sbjct: 5   RPTFYRQELNKTI-WEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII 63
Query: 163 XXXXXXXXXXLQNLCGGPNVVKLLDI---VRDQHSKTPSLIFEYVNSTDFK--VLYPTLT 217
                     L       NV+ LLD+    R         +  ++   D    V    LT
Sbjct: 64  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 123
Query: 218 DYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN 277
           D  +++ IY++L+ L Y HS  I+HRD+KP N+ ++ +  +L+++D+GLA   H   E  
Sbjct: 124 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDC-ELKILDFGLAR--HTDDEMT 180
Query: 278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK-- 335
             VA+R+++ PE++++   Y+ ++D+WS+GC+ A ++  +   F G D+ DQL  I +  
Sbjct: 181 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLV 239
Query: 336 ---DCCLIIWCNSRHSRKPWSKFINADNQHL------VSPEAIDFLDKLLRYDHQDRLTA 386
                 L+   +S  +R            +        +P A+D L+K+L  D   R+TA
Sbjct: 240 GTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITA 299
Query: 387 REAMAHPYFAQ 397
            +A+AH YFAQ
Sbjct: 300 AQALAHAYFAQ 310

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score =  111 bits (278), Expect = 6e-25,   Method: Compositional matrix adjust.
 Identities = 85/311 (27%), Positives = 143/311 (45%), Gaps = 25/311 (8%)
Query: 107 RPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXX----XXX 162
           RP  Y    + T+ W   + Y+ +  VG G Y  V    +  T  R              
Sbjct: 16  RPTFYRQELNKTI-WEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII 74
Query: 163 XXXXXXXXXXLQNLCGGPNVVKLLDI---VRDQHSKTPSLIFEYVNSTDFK--VLYPTLT 217
                     L       NV+ LLD+    R         +  ++   D    V    LT
Sbjct: 75  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 134
Query: 218 DYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN 277
           D  +++ IY++L+ L Y HS  I+HRD+KP N+ ++ +  +L+++D+GLA   H   E  
Sbjct: 135 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDC-ELKILDFGLAR--HTDDEMT 191
Query: 278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK-- 335
             VA+R+++ PE++++   Y+ ++D+WS+GC+ A ++  +   F G D+ DQL  I +  
Sbjct: 192 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLV 250
Query: 336 ---DCCLIIWCNSRHSRKPWSKFINADNQHL------VSPEAIDFLDKLLRYDHQDRLTA 386
                 L+   +S  +R            +        +P A+D L+K+L  D   R+TA
Sbjct: 251 GTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITA 310
Query: 387 REAMAHPYFAQ 397
            +A+AH YFAQ
Sbjct: 311 AQALAHAYFAQ 321

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score =  111 bits (278), Expect = 7e-25,   Method: Compositional matrix adjust.
 Identities = 85/311 (27%), Positives = 143/311 (45%), Gaps = 25/311 (8%)
Query: 107 RPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXX----XXX 162
           RP  Y    + T+ W   + Y+ +  VG G Y  V    +  T  R              
Sbjct: 5   RPTFYRQELNKTI-WEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII 63
Query: 163 XXXXXXXXXXLQNLCGGPNVVKLLDI---VRDQHSKTPSLIFEYVNSTDFK--VLYPTLT 217
                     L       NV+ LLD+    R         +  ++   D    V    LT
Sbjct: 64  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 123
Query: 218 DYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN 277
           D  +++ IY++L+ L Y HS  I+HRD+KP N+ ++ +  +L+++D+GLA   H   E  
Sbjct: 124 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDC-ELKILDFGLAR--HTDDEMT 180
Query: 278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK-- 335
             VA+R+++ PE++++   Y+ ++D+WS+GC+ A ++  +   F G D+ DQL  I +  
Sbjct: 181 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLV 239
Query: 336 ---DCCLIIWCNSRHSRKPWSKFINADNQHL------VSPEAIDFLDKLLRYDHQDRLTA 386
                 L+   +S  +R            +        +P A+D L+K+L  D   R+TA
Sbjct: 240 GTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITA 299
Query: 387 REAMAHPYFAQ 397
            +A+AH YFAQ
Sbjct: 300 AQALAHAYFAQ 310

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score =  111 bits (278), Expect = 7e-25,   Method: Compositional matrix adjust.
 Identities = 85/311 (27%), Positives = 143/311 (45%), Gaps = 25/311 (8%)
Query: 107 RPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXX----XXX 162
           RP  Y    + T+ W   + Y+ +  VG G Y  V    +  T  R              
Sbjct: 5   RPTFYRQELNKTI-WEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSII 63
Query: 163 XXXXXXXXXXLQNLCGGPNVVKLLDI---VRDQHSKTPSLIFEYVNSTDFK--VLYPTLT 217
                     L       NV+ LLD+    R         +  ++   D    V    LT
Sbjct: 64  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 123
Query: 218 DYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN 277
           D  +++ IY++L+ L Y HS  I+HRD+KP N+ ++ +  +L+++D+GLA   H   E  
Sbjct: 124 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDC-ELKILDFGLAR--HTDDEMA 180
Query: 278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK-- 335
             VA+R+++ PE++++   Y+ ++D+WS+GC+ A ++  +   F G D+ DQL  I +  
Sbjct: 181 GFVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLV 239
Query: 336 ---DCCLIIWCNSRHSRKPWSKFINADNQHL------VSPEAIDFLDKLLRYDHQDRLTA 386
                 L+   +S  +R            +        +P A+D L+K+L  D   R+TA
Sbjct: 240 GTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITA 299
Query: 387 REAMAHPYFAQ 397
            +A+AH YFAQ
Sbjct: 300 AQALAHAYFAQ 310

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score =  111 bits (278), Expect = 7e-25,   Method: Compositional matrix adjust.
 Identities = 85/311 (27%), Positives = 143/311 (45%), Gaps = 25/311 (8%)
Query: 107 RPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXX----XXX 162
           RP  Y    + T+ W   + Y+ +  VG G Y  V    +  T  R              
Sbjct: 7   RPTFYRQELNKTI-WEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII 65
Query: 163 XXXXXXXXXXLQNLCGGPNVVKLLDI---VRDQHSKTPSLIFEYVNSTDFK--VLYPTLT 217
                     L       NV+ LLD+    R         +  ++   D    V    LT
Sbjct: 66  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 125
Query: 218 DYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN 277
           D  +++ IY++L+ L Y HS  I+HRD+KP N+ ++ +  +L+++D+GLA   H   E  
Sbjct: 126 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDC-ELKILDFGLAR--HTDDEMT 182
Query: 278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK-- 335
             VA+R+++ PE++++   Y+ ++D+WS+GC+ A ++  +   F G D+ DQL  I +  
Sbjct: 183 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLV 241
Query: 336 ---DCCLIIWCNSRHSRKPWSKFINADNQHL------VSPEAIDFLDKLLRYDHQDRLTA 386
                 L+   +S  +R            +        +P A+D L+K+L  D   R+TA
Sbjct: 242 GTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITA 301
Query: 387 REAMAHPYFAQ 397
            +A+AH YFAQ
Sbjct: 302 AQALAHAYFAQ 312

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score =  111 bits (278), Expect = 7e-25,   Method: Compositional matrix adjust.
 Identities = 85/311 (27%), Positives = 143/311 (45%), Gaps = 25/311 (8%)
Query: 107 RPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXX----XXX 162
           RP  Y    + T+ W   + Y+ +  VG G Y  V    +  T  R              
Sbjct: 7   RPTFYRQELNKTI-WEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII 65
Query: 163 XXXXXXXXXXLQNLCGGPNVVKLLDI---VRDQHSKTPSLIFEYVNSTDFK--VLYPTLT 217
                     L       NV+ LLD+    R         +  ++   D    V    LT
Sbjct: 66  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 125
Query: 218 DYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN 277
           D  +++ IY++L+ L Y HS  I+HRD+KP N+ ++ +  +L+++D+GLA   H   E  
Sbjct: 126 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDC-ELKILDFGLAR--HTDDEMT 182
Query: 278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK-- 335
             VA+R+++ PE++++   Y+ ++D+WS+GC+ A ++  +   F G D+ DQL  I +  
Sbjct: 183 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLV 241
Query: 336 ---DCCLIIWCNSRHSRKPWSKFINADNQHL------VSPEAIDFLDKLLRYDHQDRLTA 386
                 L+   +S  +R            +        +P A+D L+K+L  D   R+TA
Sbjct: 242 GTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITA 301
Query: 387 REAMAHPYFAQ 397
            +A+AH YFAQ
Sbjct: 302 AQALAHAYFAQ 312

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score =  111 bits (278), Expect = 7e-25,   Method: Compositional matrix adjust.
 Identities = 84/311 (27%), Positives = 143/311 (45%), Gaps = 25/311 (8%)
Query: 107 RPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXX----XXX 162
           RP  Y    + T+ W   + Y+ +  +G G Y  V    +  T  R              
Sbjct: 10  RPTFYRQELNKTI-WEVPERYQNLSPIGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII 68
Query: 163 XXXXXXXXXXLQNLCGGPNVVKLLDI---VRDQHSKTPSLIFEYVNSTDFK--VLYPTLT 217
                     L       NV+ LLD+    R         +  ++   D    V    LT
Sbjct: 69  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 128
Query: 218 DYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN 277
           D  +++ IY++L+ L Y HS  I+HRD+KP N+ ++ +  +L+++D+GLA   H   E  
Sbjct: 129 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNED-XELKILDFGLAR--HTDDEMT 185
Query: 278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK-- 335
             VA+R+++ PE++++   Y+ ++D+WS+GC+ A ++  +   F G D+ DQL  I +  
Sbjct: 186 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLV 244
Query: 336 ---DCCLIIWCNSRHSRKPWSKFINADNQHL------VSPEAIDFLDKLLRYDHQDRLTA 386
                 L+   +S  +R            +        +P A+D L+K+L  D   R+TA
Sbjct: 245 GTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITA 304
Query: 387 REAMAHPYFAQ 397
            +A+AH YFAQ
Sbjct: 305 AQALAHAYFAQ 315

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score =  111 bits (278), Expect = 7e-25,   Method: Compositional matrix adjust.
 Identities = 72/242 (29%), Positives = 134/242 (55%), Gaps = 33/242 (13%)
Query: 181 NVVKLLDIVRD---QHSKTPSLIFEYVNSTDFKVLYPT-LTDYDIRYYIYELLKALDYCH 236
           N++ + DI+R    +  K   ++ + + +  +K+L    L++  I Y++Y++L+ L Y H
Sbjct: 86  NIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH 145
Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY----NVRVASRYFKGPELLV 292
           S  ++HRD+KP N++++     L++ D+GLA    P  ++       VA+R+++ PE+++
Sbjct: 146 SANVLHRDLKPSNLLLN-TTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 204
Query: 293 DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI--------AKDCCLIIWCN 344
           + + Y  S+D+WS+GC+ A M+  + P F G    DQL  I         +D   II   
Sbjct: 205 NSKGYTKSIDIWSVGCILAEMLSNR-PIFPGKHYLDQLNHILGILGSPSQEDLNCIINLK 263
Query: 345 SRH--------SRKPWSK-FINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF 395
           +R+        ++ PW++ F NAD++      A+D LDK+L ++   R+   +A+AHPY 
Sbjct: 264 ARNYLLSLPHKNKVPWNRLFPNADSK------ALDLLDKMLTFNPHKRIEVEQALAHPYL 317
Query: 396 AQ 397
            Q
Sbjct: 318 EQ 319

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score =  111 bits (278), Expect = 7e-25,   Method: Compositional matrix adjust.
 Identities = 72/242 (29%), Positives = 134/242 (55%), Gaps = 33/242 (13%)
Query: 181 NVVKLLDIVRD---QHSKTPSLIFEYVNSTDFKVLYPT-LTDYDIRYYIYELLKALDYCH 236
           N++ + DI+R    +  K   ++ + + +  +K+L    L++  I Y++Y++L+ L Y H
Sbjct: 82  NIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH 141
Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY----NVRVASRYFKGPELLV 292
           S  ++HRD+KP N++++     L++ D+GLA    P  ++       VA+R+++ PE+++
Sbjct: 142 SANVLHRDLKPSNLLLN-TTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 200
Query: 293 DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI--------AKDCCLIIWCN 344
           + + Y  S+D+WS+GC+ A M+  + P F G    DQL  I         +D   II   
Sbjct: 201 NSKGYTKSIDIWSVGCILAEMLSNR-PIFPGKHYLDQLNHILGILGSPSQEDLNCIINLK 259
Query: 345 SRH--------SRKPWSK-FINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF 395
           +R+        ++ PW++ F NAD++      A+D LDK+L ++   R+   +A+AHPY 
Sbjct: 260 ARNYLLSLPHKNKVPWNRLFPNADSK------ALDLLDKMLTFNPHKRIEVEQALAHPYL 313
Query: 396 AQ 397
            Q
Sbjct: 314 EQ 315

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score =  111 bits (277), Expect = 7e-25,   Method: Compositional matrix adjust.
 Identities = 88/313 (28%), Positives = 145/313 (46%), Gaps = 29/313 (9%)
Query: 107 RPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXX----XXX 162
           RP  Y    + T+ W   + Y+ +  VG G Y  V    +  T  R              
Sbjct: 5   RPTFYRQELNKTI-WEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSII 63
Query: 163 XXXXXXXXXXLQNLCGGPNVVKLLDI---VRDQHSKTPSLIFEYVNSTDFK--VLYPTLT 217
                     L       NV+ LLD+    R         +  ++   D    V    LT
Sbjct: 64  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 123
Query: 218 DYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN 277
           D  +++ IY++L+ L Y HS  I+HRD+KP N+ ++ +  +L+++D+GLA   H   E  
Sbjct: 124 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDC-ELKILDFGLAR--HTDDEMA 180
Query: 278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK-- 335
             VA+R+++ PE++++   Y+ ++D+WS+GC+ A ++  +   F G D+ DQL  I +  
Sbjct: 181 GFVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLV 239
Query: 336 ---DCCLIIWCNSRHSRK--------PWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRL 384
                 L+   +S  +R         P   F N       +P A+D L+K+L  D   R+
Sbjct: 240 GTPGAELLKKISSESARNYIQSLAQMPKMNFANVFIG--ANPLAVDLLEKMLVLDSDKRI 297
Query: 385 TAREAMAHPYFAQ 397
           TA +A+AH YFAQ
Sbjct: 298 TAAQALAHAYFAQ 310

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score =  111 bits (277), Expect = 7e-25,   Method: Compositional matrix adjust.
 Identities = 72/242 (29%), Positives = 134/242 (55%), Gaps = 33/242 (13%)
Query: 181 NVVKLLDIVRD---QHSKTPSLIFEYVNSTDFKVLYPT-LTDYDIRYYIYELLKALDYCH 236
           N++ + DI+R    +  K   ++ + + +  +K+L    L++  I Y++Y++L+ L Y H
Sbjct: 86  NIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH 145
Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY----NVRVASRYFKGPELLV 292
           S  ++HRD+KP N++++     L++ D+GLA    P  ++       VA+R+++ PE+++
Sbjct: 146 SANVLHRDLKPSNLLLN-TTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 204
Query: 293 DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI--------AKDCCLIIWCN 344
           + + Y  S+D+WS+GC+ A M+  + P F G    DQL  I         +D   II   
Sbjct: 205 NSKGYTKSIDIWSVGCILAEMLSNR-PIFPGKHYLDQLNHILGILGSPSQEDLNCIINLK 263
Query: 345 SRH--------SRKPWSK-FINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF 395
           +R+        ++ PW++ F NAD++      A+D LDK+L ++   R+   +A+AHPY 
Sbjct: 264 ARNYLLSLPHKNKVPWNRLFPNADSK------ALDLLDKMLTFNPHKRIEVEQALAHPYL 317
Query: 396 AQ 397
            Q
Sbjct: 318 EQ 319

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score =  111 bits (277), Expect = 8e-25,   Method: Compositional matrix adjust.
 Identities = 72/242 (29%), Positives = 134/242 (55%), Gaps = 33/242 (13%)
Query: 181 NVVKLLDIVRD---QHSKTPSLIFEYVNSTDFKVLYPT-LTDYDIRYYIYELLKALDYCH 236
           N++ + DI+R    +  K   ++ + + +  +K+L    L++  I Y++Y++L+ L Y H
Sbjct: 102 NIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH 161
Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY----NVRVASRYFKGPELLV 292
           S  ++HRD+KP N++++     L++ D+GLA    P  ++       VA+R+++ PE+++
Sbjct: 162 SANVLHRDLKPSNLLLNTTC-DLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 220
Query: 293 DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI--------AKDCCLIIWCN 344
           + + Y  S+D+WS+GC+ A M+  + P F G    DQL  I         +D   II   
Sbjct: 221 NSKGYTKSIDIWSVGCILAEMLSNR-PIFPGKHYLDQLNHILGILGSPSQEDLNCIINLK 279
Query: 345 SRH--------SRKPWSK-FINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF 395
           +R+        ++ PW++ F NAD++      A+D LDK+L ++   R+   +A+AHPY 
Sbjct: 280 ARNYLLSLPHKNKVPWNRLFPNADSK------ALDLLDKMLTFNPHKRIEVEQALAHPYL 333
Query: 396 AQ 397
            Q
Sbjct: 334 EQ 335

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score =  111 bits (277), Expect = 9e-25,   Method: Compositional matrix adjust.
 Identities = 83/290 (28%), Positives = 139/290 (47%), Gaps = 25/290 (8%)
Query: 127 YEVVRKVGRGKYSEVFEGINVNTNE-------RCXXXXXXXXXXXXXXXXXXXLQNLCGG 179
           YE +  +G G+++ V++  + NTN+       +                    L      
Sbjct: 12  YEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSH 71
Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYC 235
           PN++ LLD     H    SL+F+++  TD +V+       LT   I+ Y+   L+ L+Y 
Sbjct: 72  PNIIGLLDAF--GHKSNISLVFDFM-ETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYL 128
Query: 236 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPELLVDL 294
           H   I+HRD+KP+N+++D E   L+L D+GLA+ F  P + Y  +V +R+++ PELL   
Sbjct: 129 HQHWILHRDLKPNNLLLD-ENGVLKLADFGLAKSFGSPNRAYXHQVVTRWYRAPELLFGA 187
Query: 295 QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLII---WCN--SRHSR 349
           + Y   +DMW++GC+ A ++ R  PF  G  + DQL +I +         W +  S    
Sbjct: 188 RMYGVGVDMWAVGCILAELLLRV-PFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDY 246
Query: 350 KPWSKFINADNQHLVSPEAIDFLD---KLLRYDHQDRLTAREAMAHPYFA 396
             +  F      H+ S    D LD    L  ++   R+TA +A+   YF+
Sbjct: 247 VTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFS 296

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score =  111 bits (277), Expect = 9e-25,   Method: Compositional matrix adjust.
 Identities = 85/311 (27%), Positives = 143/311 (45%), Gaps = 25/311 (8%)
Query: 107 RPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXX----XXX 162
           RP  Y    + T+ W   + Y+ +  VG G Y  V    +  T  R              
Sbjct: 11  RPTFYRQELNKTI-WEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII 69
Query: 163 XXXXXXXXXXLQNLCGGPNVVKLLDI---VRDQHSKTPSLIFEYVNSTDFK--VLYPTLT 217
                     L       NV+ LLD+    R         +  ++   D    V    LT
Sbjct: 70  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 129
Query: 218 DYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN 277
           D  +++ IY++L+ L Y HS  I+HRD+KP N+ ++ +  +L+++D+GLA   H   E  
Sbjct: 130 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDC-ELKILDFGLAR--HTDDEMT 186
Query: 278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK-- 335
             VA+R+++ PE++++   Y+ ++D+WS+GC+ A ++  +   F G D+ DQL  I +  
Sbjct: 187 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLV 245
Query: 336 ---DCCLIIWCNSRHSRKPWSKFINADNQHL------VSPEAIDFLDKLLRYDHQDRLTA 386
                 L+   +S  +R            +        +P A+D L+K+L  D   R+TA
Sbjct: 246 GTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITA 305
Query: 387 REAMAHPYFAQ 397
            +A+AH YFAQ
Sbjct: 306 AQALAHAYFAQ 316

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score =  111 bits (277), Expect = 9e-25,   Method: Compositional matrix adjust.
 Identities = 72/242 (29%), Positives = 134/242 (55%), Gaps = 33/242 (13%)
Query: 181 NVVKLLDIVRD---QHSKTPSLIFEYVNSTDFKVLYPT-LTDYDIRYYIYELLKALDYCH 236
           N++ + DI+R    +  K   ++ + + +  +K+L    L++  I Y++Y++L+ L Y H
Sbjct: 84  NIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH 143
Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY----NVRVASRYFKGPELLV 292
           S  ++HRD+KP N++++     L++ D+GLA    P  ++       VA+R+++ PE+++
Sbjct: 144 SANVLHRDLKPSNLLLNTTC-DLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 202
Query: 293 DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI--------AKDCCLIIWCN 344
           + + Y  S+D+WS+GC+ A M+  + P F G    DQL  I         +D   II   
Sbjct: 203 NSKGYTKSIDIWSVGCILAEMLSNR-PIFPGKHYLDQLNHILGILGSPSQEDLNCIINLK 261
Query: 345 SRH--------SRKPWSK-FINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF 395
           +R+        ++ PW++ F NAD++      A+D LDK+L ++   R+   +A+AHPY 
Sbjct: 262 ARNYLLSLPHKNKVPWNRLFPNADSK------ALDLLDKMLTFNPHKRIEVEQALAHPYL 315
Query: 396 AQ 397
            Q
Sbjct: 316 EQ 317

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score =  111 bits (277), Expect = 9e-25,   Method: Compositional matrix adjust.
 Identities = 72/242 (29%), Positives = 134/242 (55%), Gaps = 33/242 (13%)
Query: 181 NVVKLLDIVRD---QHSKTPSLIFEYVNSTDFKVLYPT-LTDYDIRYYIYELLKALDYCH 236
           N++ + DI+R    +  K   ++ + + +  +K+L    L++  I Y++Y++L+ L Y H
Sbjct: 82  NIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH 141
Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY----NVRVASRYFKGPELLV 292
           S  ++HRD+KP N++++     L++ D+GLA    P  ++       VA+R+++ PE+++
Sbjct: 142 SANVLHRDLKPSNLLLNTTC-DLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 200
Query: 293 DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI--------AKDCCLIIWCN 344
           + + Y  S+D+WS+GC+ A M+  + P F G    DQL  I         +D   II   
Sbjct: 201 NSKGYTKSIDIWSVGCILAEMLSNR-PIFPGKHYLDQLNHILGILGSPSQEDLNCIINLK 259
Query: 345 SRH--------SRKPWSK-FINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF 395
           +R+        ++ PW++ F NAD++      A+D LDK+L ++   R+   +A+AHPY 
Sbjct: 260 ARNYLLSLPHKNKVPWNRLFPNADSK------ALDLLDKMLTFNPHKRIEVEQALAHPYL 313
Query: 396 AQ 397
            Q
Sbjct: 314 EQ 315

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score =  111 bits (277), Expect = 9e-25,   Method: Compositional matrix adjust.
 Identities = 72/242 (29%), Positives = 134/242 (55%), Gaps = 33/242 (13%)
Query: 181 NVVKLLDIVRD---QHSKTPSLIFEYVNSTDFKVLYPT-LTDYDIRYYIYELLKALDYCH 236
           N++ + DI+R    +  K   ++ + + +  +K+L    L++  I Y++Y++L+ L Y H
Sbjct: 90  NIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH 149
Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY----NVRVASRYFKGPELLV 292
           S  ++HRD+KP N++++     L++ D+GLA    P  ++       VA+R+++ PE+++
Sbjct: 150 SANVLHRDLKPSNLLLNTTC-DLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 208
Query: 293 DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI--------AKDCCLIIWCN 344
           + + Y  S+D+WS+GC+ A M+  + P F G    DQL  I         +D   II   
Sbjct: 209 NSKGYTKSIDIWSVGCILAEMLSNR-PIFPGKHYLDQLNHILGILGSPSQEDLNCIINLK 267
Query: 345 SRH--------SRKPWSK-FINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF 395
           +R+        ++ PW++ F NAD++      A+D LDK+L ++   R+   +A+AHPY 
Sbjct: 268 ARNYLLSLPHKNKVPWNRLFPNADSK------ALDLLDKMLTFNPHKRIEVEQALAHPYL 321
Query: 396 AQ 397
            Q
Sbjct: 322 EQ 323

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score =  111 bits (277), Expect = 9e-25,   Method: Compositional matrix adjust.
 Identities = 72/242 (29%), Positives = 134/242 (55%), Gaps = 33/242 (13%)
Query: 181 NVVKLLDIVRD---QHSKTPSLIFEYVNSTDFKVLYPT-LTDYDIRYYIYELLKALDYCH 236
           N++ + DI+R    +  K   ++ + + +  +K+L    L++  I Y++Y++L+ L Y H
Sbjct: 82  NIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH 141
Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY----NVRVASRYFKGPELLV 292
           S  ++HRD+KP N++++     L++ D+GLA    P  ++       VA+R+++ PE+++
Sbjct: 142 SANVLHRDLKPSNLLLNTTC-DLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 200
Query: 293 DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI--------AKDCCLIIWCN 344
           + + Y  S+D+WS+GC+ A M+  + P F G    DQL  I         +D   II   
Sbjct: 201 NSKGYTKSIDIWSVGCILAEMLSNR-PIFPGKHYLDQLNHILGILGSPSQEDLNCIINLK 259
Query: 345 SRH--------SRKPWSK-FINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF 395
           +R+        ++ PW++ F NAD++      A+D LDK+L ++   R+   +A+AHPY 
Sbjct: 260 ARNYLLSLPHKNKVPWNRLFPNADSK------ALDLLDKMLTFNPHKRIEVEQALAHPYL 313
Query: 396 AQ 397
            Q
Sbjct: 314 EQ 315

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score =  111 bits (277), Expect = 9e-25,   Method: Compositional matrix adjust.
 Identities = 72/242 (29%), Positives = 134/242 (55%), Gaps = 33/242 (13%)
Query: 181 NVVKLLDIVRD---QHSKTPSLIFEYVNSTDFKVLYPT-LTDYDIRYYIYELLKALDYCH 236
           N++ + DI+R    +  K   ++ + + +  +K+L    L++  I Y++Y++L+ L Y H
Sbjct: 87  NIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH 146
Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY----NVRVASRYFKGPELLV 292
           S  ++HRD+KP N++++     L++ D+GLA    P  ++       VA+R+++ PE+++
Sbjct: 147 SANVLHRDLKPSNLLLNTTC-DLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 205
Query: 293 DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI--------AKDCCLIIWCN 344
           + + Y  S+D+WS+GC+ A M+  + P F G    DQL  I         +D   II   
Sbjct: 206 NSKGYTKSIDIWSVGCILAEMLSNR-PIFPGKHYLDQLNHILGILGSPSQEDLNCIINLK 264
Query: 345 SRH--------SRKPWSK-FINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF 395
           +R+        ++ PW++ F NAD++      A+D LDK+L ++   R+   +A+AHPY 
Sbjct: 265 ARNYLLSLPHKNKVPWNRLFPNADSK------ALDLLDKMLTFNPHKRIEVEQALAHPYL 318
Query: 396 AQ 397
            Q
Sbjct: 319 EQ 320

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score =  111 bits (277), Expect = 9e-25,   Method: Compositional matrix adjust.
 Identities = 72/242 (29%), Positives = 134/242 (55%), Gaps = 33/242 (13%)
Query: 181 NVVKLLDIVRD---QHSKTPSLIFEYVNSTDFKVLYPT-LTDYDIRYYIYELLKALDYCH 236
           N++ + DI+R    +  K   ++ + + +  +K+L    L++  I Y++Y++L+ L Y H
Sbjct: 80  NIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH 139
Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY----NVRVASRYFKGPELLV 292
           S  ++HRD+KP N++++     L++ D+GLA    P  ++       VA+R+++ PE+++
Sbjct: 140 SANVLHRDLKPSNLLLNTTC-DLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 198
Query: 293 DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI--------AKDCCLIIWCN 344
           + + Y  S+D+WS+GC+ A M+  + P F G    DQL  I         +D   II   
Sbjct: 199 NSKGYTKSIDIWSVGCILAEMLSNR-PIFPGKHYLDQLNHILGILGSPEQEDLNCIINLK 257
Query: 345 SRH--------SRKPWSK-FINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF 395
           +R+        ++ PW++ F NAD++      A+D LDK+L ++   R+   +A+AHPY 
Sbjct: 258 ARNYLLSLPHKNKVPWNRLFPNADSK------ALDLLDKMLTFNPHKRIEVEQALAHPYL 311
Query: 396 AQ 397
            Q
Sbjct: 312 EQ 313

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score =  111 bits (277), Expect = 9e-25,   Method: Compositional matrix adjust.
 Identities = 72/242 (29%), Positives = 134/242 (55%), Gaps = 33/242 (13%)
Query: 181 NVVKLLDIVRD---QHSKTPSLIFEYVNSTDFKVLYPT-LTDYDIRYYIYELLKALDYCH 236
           N++ + DI+R    +  K   ++ + + +  +K+L    L++  I Y++Y++L+ L Y H
Sbjct: 88  NIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH 147
Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY----NVRVASRYFKGPELLV 292
           S  ++HRD+KP N++++     L++ D+GLA    P  ++       VA+R+++ PE+++
Sbjct: 148 SANVLHRDLKPSNLLLNTTC-DLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 206
Query: 293 DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI--------AKDCCLIIWCN 344
           + + Y  S+D+WS+GC+ A M+  + P F G    DQL  I         +D   II   
Sbjct: 207 NSKGYTKSIDIWSVGCILAEMLSNR-PIFPGKHYLDQLNHILGILGSPSQEDLNCIINLK 265
Query: 345 SRH--------SRKPWSK-FINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF 395
           +R+        ++ PW++ F NAD++      A+D LDK+L ++   R+   +A+AHPY 
Sbjct: 266 ARNYLLSLPHKNKVPWNRLFPNADSK------ALDLLDKMLTFNPHKRIEVEQALAHPYL 319
Query: 396 AQ 397
            Q
Sbjct: 320 EQ 321

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score =  111 bits (277), Expect = 9e-25,   Method: Compositional matrix adjust.
 Identities = 72/242 (29%), Positives = 134/242 (55%), Gaps = 33/242 (13%)
Query: 181 NVVKLLDIVRD---QHSKTPSLIFEYVNSTDFKVLYPT-LTDYDIRYYIYELLKALDYCH 236
           N++ + DI+R    +  K   ++ + + +  +K+L    L++  I Y++Y++L+ L Y H
Sbjct: 79  NIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH 138
Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY----NVRVASRYFKGPELLV 292
           S  ++HRD+KP N++++     L++ D+GLA    P  ++       VA+R+++ PE+++
Sbjct: 139 SANVLHRDLKPSNLLLNTTC-DLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 197
Query: 293 DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI--------AKDCCLIIWCN 344
           + + Y  S+D+WS+GC+ A M+  + P F G    DQL  I         +D   II   
Sbjct: 198 NSKGYTKSIDIWSVGCILAEMLSNR-PIFPGKHYLDQLNHILGILGSPSQEDLNCIINLK 256
Query: 345 SRH--------SRKPWSK-FINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF 395
           +R+        ++ PW++ F NAD++      A+D LDK+L ++   R+   +A+AHPY 
Sbjct: 257 ARNYLLSLPHKNKVPWNRLFPNADSK------ALDLLDKMLTFNPHKRIEVEQALAHPYL 310
Query: 396 AQ 397
            Q
Sbjct: 311 EQ 312

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score =  111 bits (277), Expect = 9e-25,   Method: Compositional matrix adjust.
 Identities = 72/242 (29%), Positives = 134/242 (55%), Gaps = 33/242 (13%)
Query: 181 NVVKLLDIVRD---QHSKTPSLIFEYVNSTDFKVLYPT-LTDYDIRYYIYELLKALDYCH 236
           N++ + DI+R    +  K   ++ + + +  +K+L    L++  I Y++Y++L+ L Y H
Sbjct: 86  NIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH 145
Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY----NVRVASRYFKGPELLV 292
           S  ++HRD+KP N++++     L++ D+GLA    P  ++       VA+R+++ PE+++
Sbjct: 146 SANVLHRDLKPSNLLLNTTC-DLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 204
Query: 293 DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI--------AKDCCLIIWCN 344
           + + Y  S+D+WS+GC+ A M+  + P F G    DQL  I         +D   II   
Sbjct: 205 NSKGYTKSIDIWSVGCILAEMLSNR-PIFPGKHYLDQLNHILGILGSPSQEDLNCIINLK 263
Query: 345 SRH--------SRKPWSK-FINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF 395
           +R+        ++ PW++ F NAD++      A+D LDK+L ++   R+   +A+AHPY 
Sbjct: 264 ARNYLLSLPHKNKVPWNRLFPNADSK------ALDLLDKMLTFNPHKRIEVEQALAHPYL 317
Query: 396 AQ 397
            Q
Sbjct: 318 EQ 319

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score =  111 bits (277), Expect = 9e-25,   Method: Compositional matrix adjust.
 Identities = 72/242 (29%), Positives = 134/242 (55%), Gaps = 33/242 (13%)
Query: 181 NVVKLLDIVRD---QHSKTPSLIFEYVNSTDFKVLYPT-LTDYDIRYYIYELLKALDYCH 236
           N++ + DI+R    +  K   ++ + + +  +K+L    L++  I Y++Y++L+ L Y H
Sbjct: 80  NIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH 139
Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY----NVRVASRYFKGPELLV 292
           S  ++HRD+KP N++++     L++ D+GLA    P  ++       VA+R+++ PE+++
Sbjct: 140 SANVLHRDLKPSNLLLNTTC-DLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 198
Query: 293 DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI--------AKDCCLIIWCN 344
           + + Y  S+D+WS+GC+ A M+  + P F G    DQL  I         +D   II   
Sbjct: 199 NSKGYTKSIDIWSVGCILAEMLSNR-PIFPGKHYLDQLNHILGILGSPSQEDLNCIINLK 257
Query: 345 SRH--------SRKPWSK-FINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF 395
           +R+        ++ PW++ F NAD++      A+D LDK+L ++   R+   +A+AHPY 
Sbjct: 258 ARNYLLSLPHKNKVPWNRLFPNADSK------ALDLLDKMLTFNPHKRIEVEQALAHPYL 311
Query: 396 AQ 397
            Q
Sbjct: 312 EQ 313

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score =  110 bits (276), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 72/242 (29%), Positives = 134/242 (55%), Gaps = 33/242 (13%)
Query: 181 NVVKLLDIVRD---QHSKTPSLIFEYVNSTDFKVLYPT-LTDYDIRYYIYELLKALDYCH 236
           N++ + DI+R    +  K   ++ + + +  +K+L    L++  I Y++Y++L+ L Y H
Sbjct: 86  NIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH 145
Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY----NVRVASRYFKGPELLV 292
           S  ++HRD+KP N++++     L++ D+GLA    P  ++       VA+R+++ PE+++
Sbjct: 146 SANVLHRDLKPSNLLLNTTC-DLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 204
Query: 293 DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI--------AKDCCLIIWCN 344
           + + Y  S+D+WS+GC+ A M+  + P F G    DQL  I         +D   II   
Sbjct: 205 NSKGYTKSIDIWSVGCILAEMLSNR-PIFPGKHYLDQLNHILGILGSPSQEDLNCIINLK 263
Query: 345 SRH--------SRKPWSK-FINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF 395
           +R+        ++ PW++ F NAD++      A+D LDK+L ++   R+   +A+AHPY 
Sbjct: 264 ARNYLLSLPHKNKVPWNRLFPNADSK------ALDLLDKMLTFNPHKRIEVEQALAHPYL 317
Query: 396 AQ 397
            Q
Sbjct: 318 EQ 319

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score =  110 bits (276), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 85/311 (27%), Positives = 143/311 (45%), Gaps = 25/311 (8%)
Query: 107 RPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXX----XXX 162
           RP  Y    + T+ W   + Y+ +  VG G Y  V    +  T  R              
Sbjct: 28  RPTFYRQELNKTI-WEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII 86
Query: 163 XXXXXXXXXXLQNLCGGPNVVKLLDI---VRDQHSKTPSLIFEYVNSTDFK--VLYPTLT 217
                     L       NV+ LLD+    R         +  ++   D    V    LT
Sbjct: 87  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 146
Query: 218 DYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN 277
           D  +++ IY++L+ L Y HS  I+HRD+KP N+ ++ +  +L+++D+GLA   H   E  
Sbjct: 147 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDC-ELKILDFGLAR--HTDDEMX 203
Query: 278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK-- 335
             VA+R+++ PE++++   Y+ ++D+WS+GC+ A ++  +   F G D+ DQL  I +  
Sbjct: 204 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLV 262
Query: 336 ---DCCLIIWCNSRHSRKPWSKFINADNQHL------VSPEAIDFLDKLLRYDHQDRLTA 386
                 L+   +S  +R            +        +P A+D L+K+L  D   R+TA
Sbjct: 263 GTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITA 322
Query: 387 REAMAHPYFAQ 397
            +A+AH YFAQ
Sbjct: 323 AQALAHAYFAQ 333

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score =  110 bits (276), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 74/242 (30%), Positives = 130/242 (53%), Gaps = 33/242 (13%)
Query: 181 NVVKLLDIVRDQ--HSKTPSLIFEYVNSTDFKVLYPT--LTDYDIRYYIYELLKALDYCH 236
           NV+ + DI+R     +     I + +  TD   L  +  L++  I Y++Y++L+ L Y H
Sbjct: 102 NVIGIRDILRASTLEAMRDVYIVQDLMETDLYKLLKSQQLSNDHICYFLYQILRGLKYIH 161
Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY----NVRVASRYFKGPELLV 292
           S  ++HRD+KP N++I+     L++ D+GLA    P  ++       VA+R+++ PE+++
Sbjct: 162 SANVLHRDLKPSNLLINTTC-DLKICDFGLARIADPEHDHTGFLTEXVATRWYRAPEIML 220
Query: 293 DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI--------AKDCCLIIWCN 344
           + + Y  S+D+WS+GC+ A M+  + P F G    DQL  I         +D   II   
Sbjct: 221 NSKGYTKSIDIWSVGCILAEMLSNR-PIFPGKHYLDQLNHILGILGSPSQEDLNCIINMK 279
Query: 345 SRH--------SRKPWSK-FINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF 395
           +R+        ++  W+K F  +D++      A+D LD++L ++   R+T  EA+AHPY 
Sbjct: 280 ARNYLQSLPSKTKVAWAKLFPKSDSK------ALDLLDRMLTFNPNKRITVEEALAHPYL 333
Query: 396 AQ 397
            Q
Sbjct: 334 EQ 335

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score =  110 bits (276), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 83/311 (26%), Positives = 143/311 (45%), Gaps = 25/311 (8%)
Query: 107 RPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXX----XXX 162
           RP  Y    + T+ W   + Y+ +  VG G Y  V    +  T  R              
Sbjct: 5   RPTFYRQELNKTI-WEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII 63
Query: 163 XXXXXXXXXXLQNLCGGPNVVKLLDI---VRDQHSKTPSLIFEYVNSTDFKVLYPT--LT 217
                     L       NV+ LLD+    R         +  ++   D   +  +  LT
Sbjct: 64  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKSQKLT 123
Query: 218 DYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN 277
           D  +++ IY++L+ L Y HS  I+HRD+KP N+ ++ +  +L+++D+GL    H   E  
Sbjct: 124 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNED-SELKILDFGLCR--HTDDEMT 180
Query: 278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK-- 335
             VA+R+++ PE++++   Y+ ++D+WS+GC+ A ++  +   F G D+ DQL  I +  
Sbjct: 181 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLV 239
Query: 336 ---DCCLIIWCNSRHSRKPWSKFINADNQHL------VSPEAIDFLDKLLRYDHQDRLTA 386
                 L+   +S  +R            +        +P A+D L+K+L  D   R+TA
Sbjct: 240 GTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITA 299
Query: 387 REAMAHPYFAQ 397
            +A+AH YFAQ
Sbjct: 300 AQALAHAYFAQ 310

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score =  110 bits (276), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 72/242 (29%), Positives = 134/242 (55%), Gaps = 33/242 (13%)
Query: 181 NVVKLLDIVRD---QHSKTPSLIFEYVNSTDFKVLYPT-LTDYDIRYYIYELLKALDYCH 236
           N++ + DI+R    +  K   ++ + + +  +K+L    L++  I Y++Y++L+ L Y H
Sbjct: 84  NIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH 143
Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY----NVRVASRYFKGPELLV 292
           S  ++HRD+KP N++++     L++ D+GLA    P  ++       VA+R+++ PE+++
Sbjct: 144 SANVLHRDLKPSNLLLN-TTSDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 202
Query: 293 DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI--------AKDCCLIIWCN 344
           + + Y  S+D+WS+GC+ A M+  + P F G    DQL  I         +D    I   
Sbjct: 203 NSKGYTKSIDIWSVGCILAEMLSNR-PIFPGKHYLDQLNHILGILGSPSQEDLNCGINLK 261
Query: 345 SRH--------SRKPWSK-FINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF 395
           +R+        ++ PW++ F NAD++      A+D LDK+L ++   R+   +A+AHPY 
Sbjct: 262 ARNYLLSLPHKNKVPWNRLFPNADSK------ALDLLDKMLTFNPHKRIEVEQALAHPYL 315
Query: 396 AQ 397
           AQ
Sbjct: 316 AQ 317

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score =  110 bits (276), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 74/233 (31%), Positives = 126/233 (54%), Gaps = 26/233 (11%)
Query: 181 NVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTD-------YDIRYYIYELLKALD 233
           N+V L DI+  + S T  L+FEY++    K L   L D       ++++ ++++LL+ L 
Sbjct: 61  NIVTLHDIIHTEKSLT--LVFEYLD----KDLKQYLDDCGNIINMHNVKLFLFQLLRGLA 114
Query: 234 YCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH-PGKEYNVRVASRYFKGPELLV 292
           YCH Q ++HRD+KP N++I+ E  +L+L D+GLA     P K Y+  V + +++ P++L+
Sbjct: 115 YCHRQKVLHRDLKPQNLLIN-ERGELKLADFGLARAKSIPTKTYDNEVVTLWYRPPDILL 173
Query: 293 DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI-------AKDCCLIIWCNS 345
              DY   +DMW +GC+F  M   + P F G    +QL  I        ++    I  N 
Sbjct: 174 GSTDYSTQIDMWGVGCIFYEMATGR-PLFPGSTVEEQLHFIFRILGTPTEETWPGILSNE 232
Query: 346 RHSRKPWSKF-INADNQHL--VSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF 395
                 + K+   A   H   +  +  D L KLL+++ ++R++A +AM HP+F
Sbjct: 233 EFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFF 285

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score =  110 bits (275), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 85/311 (27%), Positives = 142/311 (45%), Gaps = 25/311 (8%)
Query: 107 RPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXX----XXX 162
           RP  Y    + T+ W   + Y+ +  VG G Y  V    +  T  R              
Sbjct: 5   RPTFYRQELNKTI-WEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII 63
Query: 163 XXXXXXXXXXLQNLCGGPNVVKLLDI---VRDQHSKTPSLIFEYVNSTDFK--VLYPTLT 217
                     L       NV+ LLD+    R         +  ++   D    V    LT
Sbjct: 64  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 123
Query: 218 DYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN 277
           D  +++ IY++L+ L Y HS  I+HRD+KP N+ ++ +  +L+++D GLA   H   E  
Sbjct: 124 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDC-ELKILDGGLAR--HTDDEMT 180
Query: 278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK-- 335
             VA+R+++ PE++++   Y+ ++D+WS+GC+ A ++  +   F G D+ DQL  I +  
Sbjct: 181 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLV 239
Query: 336 ---DCCLIIWCNSRHSRKPWSKFINADNQHL------VSPEAIDFLDKLLRYDHQDRLTA 386
                 L+   +S  +R            +        +P A+D L+K+L  D   R+TA
Sbjct: 240 GTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITA 299
Query: 387 REAMAHPYFAQ 397
            +A+AH YFAQ
Sbjct: 300 AQALAHAYFAQ 310

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score =  110 bits (275), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 85/311 (27%), Positives = 142/311 (45%), Gaps = 25/311 (8%)
Query: 107 RPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXX----XXX 162
           RP  Y    + T+ W   + Y+ +  VG G Y  V    +  T  R              
Sbjct: 5   RPTFYRQELNKTI-WEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII 63
Query: 163 XXXXXXXXXXLQNLCGGPNVVKLLDI---VRDQHSKTPSLIFEYVNSTDFK--VLYPTLT 217
                     L       NV+ LLD+    R         +  ++   D    V    LT
Sbjct: 64  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 123
Query: 218 DYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN 277
           D  +++ IY++L+ L Y HS  I+HRD+KP N+ ++ +  +L+++D GLA   H   E  
Sbjct: 124 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDC-ELKILDAGLAR--HTDDEMT 180
Query: 278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK-- 335
             VA+R+++ PE++++   Y+ ++D+WS+GC+ A ++  +   F G D+ DQL  I +  
Sbjct: 181 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLV 239
Query: 336 ---DCCLIIWCNSRHSRKPWSKFINADNQHL------VSPEAIDFLDKLLRYDHQDRLTA 386
                 L+   +S  +R            +        +P A+D L+K+L  D   R+TA
Sbjct: 240 GTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITA 299
Query: 387 REAMAHPYFAQ 397
            +A+AH YFAQ
Sbjct: 300 AQALAHAYFAQ 310

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score =  110 bits (275), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 80/298 (26%), Positives = 144/298 (48%), Gaps = 32/298 (10%)
Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCXXXXX---XXXXXXXXXXXXXXLQNLCGGPNVV 183
           ++ + K+G G Y+ V++G+N  T                          L       N+V
Sbjct: 7   FKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIV 66
Query: 184 KLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYD---------IRYYIYELLKALDY 234
           +L D++  ++  T  L+FE++++ D K    + T  +         ++Y+ ++LL+ L +
Sbjct: 67  RLYDVIHTENKLT--LVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAF 123
Query: 235 CHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPELLVD 293
           CH   I+HRD+KP N++I+    +L+L D+GLA  F  P   ++  V + +++ P++L+ 
Sbjct: 124 CHENKILHRDLKPQNLLINKR-GQLKLGDFGLARAFGIPVNTFSSEVVTLWYRAPDVLMG 182
Query: 294 LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQL---VKIAKDCCLIIWC------- 343
            + Y  S+D+WS GC+ A MI  K P F G ++ +QL     I       +W        
Sbjct: 183 SRTYSTSIDIWSCGCILAEMITGK-PLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLPK 241
Query: 344 -NSRHSRKPWSKFINADNQHLVSP---EAIDFLDKLLRYDHQDRLTAREAMAHPYFAQ 397
            N    ++P          H   P     +DFL  LL+ +   RL+A++A+ HP+FA+
Sbjct: 242 YNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAE 299

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score =  110 bits (274), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 72/242 (29%), Positives = 134/242 (55%), Gaps = 33/242 (13%)
Query: 181 NVVKLLDIVRD---QHSKTPSLIFEYVNSTDFKVLY-PTLTDYDIRYYIYELLKALDYCH 236
           N++ + DI+R    +  K   ++ + + +  +K+L    L++  I Y++Y++L+ L Y H
Sbjct: 86  NIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKCQHLSNDHICYFLYQILRGLKYIH 145
Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY----NVRVASRYFKGPELLV 292
           S  ++HRD+KP N++++     L++ D+GLA    P  ++       VA+R+++ PE+++
Sbjct: 146 SANVLHRDLKPSNLLLNTTC-DLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 204
Query: 293 DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI--------AKDCCLIIWCN 344
           + + Y  S+D+WS+GC+ A M+  + P F G    DQL  I         +D   II   
Sbjct: 205 NSKGYTKSIDIWSVGCILAEMLSNR-PIFPGKHYLDQLNHILGILGSPSQEDLNCIINLK 263
Query: 345 SRH--------SRKPWSK-FINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF 395
           +R+        ++ PW++ F NAD++      A+D LDK+L ++   R+   +A+AHPY 
Sbjct: 264 ARNYLLSLPHKNKVPWNRLFPNADSK------ALDLLDKMLTFNPHKRIEVEQALAHPYL 317
Query: 396 AQ 397
            Q
Sbjct: 318 EQ 319

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score =  110 bits (274), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 85/311 (27%), Positives = 142/311 (45%), Gaps = 25/311 (8%)
Query: 107 RPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXX----XXX 162
           RP  Y    + T+ W   + Y+ +  VG G Y  V    +  T  R              
Sbjct: 5   RPTFYRQELNKTI-WEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII 63
Query: 163 XXXXXXXXXXLQNLCGGPNVVKLLDI---VRDQHSKTPSLIFEYVNSTDFK--VLYPTLT 217
                     L       NV+ LLD+    R         +  ++   D    V    LT
Sbjct: 64  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 123
Query: 218 DYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN 277
           D  +++ IY++L+ L Y HS  I+HRD+KP N+ ++ +  +L+++D GLA   H   E  
Sbjct: 124 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDC-ELKILDRGLAR--HTDDEMT 180
Query: 278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK-- 335
             VA+R+++ PE++++   Y+ ++D+WS+GC+ A ++  +   F G D+ DQL  I +  
Sbjct: 181 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLV 239
Query: 336 ---DCCLIIWCNSRHSRKPWSKFINADNQHL------VSPEAIDFLDKLLRYDHQDRLTA 386
                 L+   +S  +R            +        +P A+D L+K+L  D   R+TA
Sbjct: 240 GTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITA 299
Query: 387 REAMAHPYFAQ 397
            +A+AH YFAQ
Sbjct: 300 AQALAHAYFAQ 310

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score =  110 bits (274), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 62/197 (31%), Positives = 108/197 (54%), Gaps = 25/197 (12%)
Query: 221 IRYYIYELLKALDYCH--SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNV 278
           I+ ++++L++++   H  S  + HRD+KPHNV+++     L+L D+G A+   P +    
Sbjct: 131 IKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVA 190
Query: 279 RVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCC 338
            + SRY++ PEL+   Q Y  ++D+WS+GC+FA M+   EP F G ++  QL +I +   
Sbjct: 191 YICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMML-GEPIFRGDNSAGQLHEIVR--- 246
Query: 339 LIIWCNSRHSRK-----------------PWSKFINADNQHLVSPEAIDFLDKLLRYDHQ 381
            ++ C SR   +                 PWS  + +D+    + EA D L  LL+Y  +
Sbjct: 247 -VLGCPSREVLRKLNPSHTDVDLYNSKGIPWSN-VFSDHSLKDAKEAYDLLSALLQYLPE 304
Query: 382 DRLTAREAMAHPYFAQV 398
           +R+   EA+ HPYF ++
Sbjct: 305 ERMKPYEALCHPYFDEL 321

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score =  109 bits (272), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 84/311 (27%), Positives = 142/311 (45%), Gaps = 25/311 (8%)
Query: 107 RPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXX----XXX 162
           RP  Y    + T+ W   + Y+ +  VG G Y  V    +  T  R              
Sbjct: 5   RPTFYRQELNKTI-WEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII 63
Query: 163 XXXXXXXXXXLQNLCGGPNVVKLLDI---VRDQHSKTPSLIFEYVNSTDFK--VLYPTLT 217
                     L       NV+ LLD+    R         +  ++   D    V    LT
Sbjct: 64  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 123
Query: 218 DYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN 277
           D  +++ IY++L+ L Y HS  I+HRD+KP N+ ++ +  +L+++ +GLA   H   E  
Sbjct: 124 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDC-ELKILGFGLAR--HTDDEMT 180
Query: 278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK-- 335
             VA+R+++ PE++++   Y+ ++D+WS+GC+ A ++  +   F G D+ DQL  I +  
Sbjct: 181 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLV 239
Query: 336 ---DCCLIIWCNSRHSRKPWSKFINADNQHL------VSPEAIDFLDKLLRYDHQDRLTA 386
                 L+   +S  +R            +        +P A+D L+K+L  D   R+TA
Sbjct: 240 GTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITA 299
Query: 387 REAMAHPYFAQ 397
            +A+AH YFAQ
Sbjct: 300 AQALAHAYFAQ 310

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score =  108 bits (270), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 84/311 (27%), Positives = 142/311 (45%), Gaps = 25/311 (8%)
Query: 107 RPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXX----XXX 162
           RP  Y    + T+ W   + Y+ +  VG G Y  V    +  T  R              
Sbjct: 5   RPTFYRQELNKTI-WEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSII 63
Query: 163 XXXXXXXXXXLQNLCGGPNVVKLLDI---VRDQHSKTPSLIFEYVNSTDFK--VLYPTLT 217
                     L       NV+ LLD+    R         +  ++   D    V    LT
Sbjct: 64  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 123
Query: 218 DYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN 277
           D  +++ IY++L+ L Y HS  I+HRD+KP N+ ++ +  +L+++D+ LA   H   E  
Sbjct: 124 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDC-ELKILDFYLAR--HTDDEMT 180
Query: 278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK-- 335
             VA+R+++ PE++++   Y+ ++D+WS+GC+ A ++  +   F G D+ DQL  I +  
Sbjct: 181 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLV 239
Query: 336 ---DCCLIIWCNSRHSRKPWSKFINADNQHL------VSPEAIDFLDKLLRYDHQDRLTA 386
                 L+   +S  +R            +        +P A+D L+K+L  D   R+TA
Sbjct: 240 GTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITA 299
Query: 387 REAMAHPYFAQ 397
            +A+AH YFAQ
Sbjct: 300 AQALAHAYFAQ 310

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score =  107 bits (266), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 69/240 (28%), Positives = 120/240 (50%), Gaps = 29/240 (12%)
Query: 179 GPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYC 235
           GP+  +L D V          I +    TD   +    P L ++  R ++Y+LL+ L Y 
Sbjct: 78  GPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEH-ARLFMYQLLRGLKYI 136
Query: 236 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVA----SRYFKGPELL 291
           HS  ++HRD+KP N+ I+ E   L++ D+GLA    P   +   ++    +++++ P LL
Sbjct: 137 HSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLL 196
Query: 292 VDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLI----------- 340
           +   +Y  ++DMW+ GC+FA M+  K   F G    +Q+  I +   ++           
Sbjct: 197 LSPNNYTKAIDMWAAGCIFAEMLTGKT-LFAGAHELEQMQLILESIPVVHEEDRQELLSV 255
Query: 341 ----IWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFA 396
               I  +     KP ++ +       +S EA+DFL+++L +   DRLTA EA++HPY +
Sbjct: 256 IPVYIRNDMTEPHKPLTQLLPG-----ISREAVDFLEQILTFSPMDRLTAEEALSHPYMS 310

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score =  105 bits (261), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 79/295 (26%), Positives = 142/295 (48%), Gaps = 26/295 (8%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNE-----RCXXXXXXXXXXXXXXXXXXXLQNLCGG 179
           D Y  + K+G G Y EV++ I+  TNE     R                    L+ L   
Sbjct: 34  DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHR 93
Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL--YPTLTDYDIRYYIYELLKALDYCHS 237
            N+++L  ++   H+    LIFEY  +   K +   P ++   I+ ++Y+L+  +++CHS
Sbjct: 94  -NIIELKSVI--HHNHRLHLIFEYAENDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHS 150
Query: 238 QGIMHRDVKPHNVMID----HELRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPELLV 292
           +  +HRD+KP N+++      E   L++ D+GLA  F  P +++   + + +++ PE+L+
Sbjct: 151 RRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLWYRPPEILL 210
Query: 293 DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCL---IIWCNSRHS- 348
             + Y  S+D+WS+ C++A M+  K P F G    DQL KI +   L     W       
Sbjct: 211 GSRHYSTSVDIWSIACIWAEMLM-KTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTALP 269
Query: 349 --RKPWSKFINADNQHLVSPEAIDFL----DKLLRYDHQDRLTAREAMAHPYFAQ 397
             ++ + KF     + ++     D        +L  D   R++A+ A+ HPYF+ 
Sbjct: 270 DWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSH 324

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score =  104 bits (259), Expect = 9e-23,   Method: Compositional matrix adjust.
 Identities = 83/301 (27%), Positives = 141/301 (46%), Gaps = 31/301 (10%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNE-----RCXXXXXXXXXXXXXXXXXXXLQNLCGG 179
           + YE + K+G G Y  VF+  N +T +     +                    L+ L   
Sbjct: 3   EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQL-KH 61
Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL---YPTLTDYDIRYYIYELLKALDYCH 236
           PN+V LL++ R +  +   L+FEY + T    L      + ++ ++   ++ L+A+++CH
Sbjct: 62  PNLVNLLEVFRRK--RRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCH 119
Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY-HPGKEYNVRVASRYFKGPELLVDLQ 295
               +HRDVKP N++I      ++L D+G A     P   Y+  VA+R+++ PELLV   
Sbjct: 120 KHNCIHRDVKPENILITKH-SVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVGDT 178
Query: 296 DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRH-----SRK 350
            Y   +D+W++GC+FA ++    P + G  + DQL  I K    +I    RH     + +
Sbjct: 179 QYGPPVDVWAIGCVFAELL-SGVPLWPGKSDVDQLYLIRKTLGDLI---PRHQQVFSTNQ 234
Query: 351 PWSKFINADNQHL---------VSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAA 401
            +S     D + +         +S  A+  L   L  D  +RLT  + + HPYF  +R  
Sbjct: 235 YFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIREI 294
Query: 402 E 402
           E
Sbjct: 295 E 295

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score =  103 bits (258), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 78/317 (24%), Positives = 147/317 (46%), Gaps = 46/317 (14%)
Query: 116 SLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXXXX----XXXXXXXXXX 171
           S  V +   D+YE++  +G G Y  V       T ++                       
Sbjct: 45  SFDVTFDVGDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLREL 104
Query: 172 XLQNLCGGPNVVKLLDIVRDQ----HSKTPSLIFEYVNSTDFKVLYPT--LTDYDIRYYI 225
            +       N++ + DI+R        K+  ++ + + S   ++++ +  LT   +RY++
Sbjct: 105 KILKHFKHDNIIAIKDILRPTVPYGEFKSVYVVLDLMESDLHQIIHSSQPLTLEHVRYFL 164
Query: 226 YELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA--------EFYHPGKEYN 277
           Y+LL+ L Y HS  ++HRD+KP N++++    +L++ D+G+A        E  +   EY 
Sbjct: 165 YQLLRGLKYMHSAQVIHRDLKPSNLLVNENC-ELKIGDFGMARGLCTSPAEHQYFMTEY- 222
Query: 278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI---- 333
             VA+R+++ PEL++ L +Y  ++D+WS+GC+F  M+ R++  F G +   QL  I    
Sbjct: 223 --VATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQ-LFPGKNYVHQLQLIMMVL 279
Query: 334 -AKDCCLIIWCNSRHSRK-----------PWSK-FINADNQHLVSPEAIDFLDKLLRYDH 380
                 +I    +   R            PW   +  AD Q      A+  L ++LR++ 
Sbjct: 280 GTPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQ------ALSLLGRMLRFEP 333
Query: 381 QDRLTAREAMAHPYFAQ 397
             R++A  A+ HP+ A+
Sbjct: 334 SARISAAAALRHPFLAK 350

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score =  103 bits (257), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 78/317 (24%), Positives = 147/317 (46%), Gaps = 46/317 (14%)
Query: 116 SLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXXXX----XXXXXXXXXX 171
           S  V +   D+YE++  +G G Y  V       T ++                       
Sbjct: 46  SFDVTFDVGDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLREL 105
Query: 172 XLQNLCGGPNVVKLLDIVRDQ----HSKTPSLIFEYVNSTDFKVLYPT--LTDYDIRYYI 225
            +       N++ + DI+R        K+  ++ + + S   ++++ +  LT   +RY++
Sbjct: 106 KILKHFKHDNIIAIKDILRPTVPYGEFKSVYVVLDLMESDLHQIIHSSQPLTLEHVRYFL 165
Query: 226 YELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA--------EFYHPGKEYN 277
           Y+LL+ L Y HS  ++HRD+KP N++++    +L++ D+G+A        E  +   EY 
Sbjct: 166 YQLLRGLKYMHSAQVIHRDLKPSNLLVNENC-ELKIGDFGMARGLCTSPAEHQYFMTEY- 223
Query: 278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI---- 333
             VA+R+++ PEL++ L +Y  ++D+WS+GC+F  M+ R++  F G +   QL  I    
Sbjct: 224 --VATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQ-LFPGKNYVHQLQLIMMVL 280
Query: 334 -AKDCCLIIWCNSRHSRK-----------PWSK-FINADNQHLVSPEAIDFLDKLLRYDH 380
                 +I    +   R            PW   +  AD Q      A+  L ++LR++ 
Sbjct: 281 GTPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQ------ALSLLGRMLRFEP 334
Query: 381 QDRLTAREAMAHPYFAQ 397
             R++A  A+ HP+ A+
Sbjct: 335 SARISAAAALRHPFLAK 351

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score =  101 bits (252), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 56/157 (35%), Positives = 95/157 (60%), Gaps = 8/157 (5%)
Query: 181 NVVKLLDIVRDQHSKTPSLIFEYVNST--DFKVLYPTLTDYDI-RYYIYELLKALDYCHS 237
           N+V LL++ + +  K   L+FE+V+ T  D   L+P   DY + + Y+++++  + +CHS
Sbjct: 85  NLVNLLEVCKKK--KRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHS 142
Query: 238 QGIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPELLVDLQD 296
             I+HRD+KP N+++      ++L D+G A     PG+ Y+  VA+R+++ PELLV    
Sbjct: 143 HNIIHRDIKPENILVSQS-GVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVGDVK 201
Query: 297 YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI 333
           Y  ++D+W++GC+   M F  EP F G  + DQL  I
Sbjct: 202 YGKAVDVWAIGCLVTEM-FMGEPLFPGDSDIDQLYHI 237

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 99.8 bits (247), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 66/221 (29%), Positives = 110/221 (49%), Gaps = 27/221 (12%)
Query: 200 IFEYVNSTDFKVLYPT--LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELR 257
           I + +  TD   +  T  L+D  I+Y+IY+ L+A+   H   ++HRD+KP N++I+    
Sbjct: 91  IIQELMQTDLHRVISTQMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNC- 149
Query: 258 KLRLIDWGLAEFYHPGKEYNVR-----------VASRYFKGPELLVDLQDYDYSLDMWSL 306
            L++ D+GLA         N             VA+R+++ PE+++    Y  ++D+WS 
Sbjct: 150 DLKVCDFGLARIIDESAADNSEPTGQQSGMTEXVATRWYRAPEVMLTSAKYSRAMDVWSC 209
Query: 307 GCMFAGMIFRKEPFFYGHDNHDQLVKI---------AKDCCLIIWCNSRHSRKPWSKFIN 357
           GC+ A +  R+ P F G D   QL+ I           D   I    +R   K    +  
Sbjct: 210 GCILAELFLRR-PIFPGRDYRHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPA 268
Query: 358 ADNQHL---VSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF 395
           A  + +   V+P+ ID L ++L +D   R+TA+EA+ HPY 
Sbjct: 269 APLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYL 309

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 99.8 bits (247), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 66/221 (29%), Positives = 110/221 (49%), Gaps = 27/221 (12%)
Query: 200 IFEYVNSTDFKVLYPT--LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELR 257
           I + +  TD   +  T  L+D  I+Y+IY+ L+A+   H   ++HRD+KP N++I+    
Sbjct: 91  IIQELMQTDLHRVISTQMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNC- 149
Query: 258 KLRLIDWGLAEFYHPGKEYNVR-----------VASRYFKGPELLVDLQDYDYSLDMWSL 306
            L++ D+GLA         N             VA+R+++ PE+++    Y  ++D+WS 
Sbjct: 150 DLKVCDFGLARIIDESAADNSEPTGQQSGMTEYVATRWYRAPEVMLTSAKYSRAMDVWSC 209
Query: 307 GCMFAGMIFRKEPFFYGHDNHDQLVKI---------AKDCCLIIWCNSRHSRKPWSKFIN 357
           GC+ A +  R+ P F G D   QL+ I           D   I    +R   K    +  
Sbjct: 210 GCILAELFLRR-PIFPGRDYRHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPA 268
Query: 358 ADNQHL---VSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF 395
           A  + +   V+P+ ID L ++L +D   R+TA+EA+ HPY 
Sbjct: 269 APLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYL 309

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 99.8 bits (247), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 66/221 (29%), Positives = 110/221 (49%), Gaps = 27/221 (12%)
Query: 200 IFEYVNSTDFKVLYPT--LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELR 257
           I + +  TD   +  T  L+D  I+Y+IY+ L+A+   H   ++HRD+KP N++I+    
Sbjct: 91  IIQELMQTDLHRVISTQMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNC- 149
Query: 258 KLRLIDWGLAEFYHPGKEYNVR-----------VASRYFKGPELLVDLQDYDYSLDMWSL 306
            L++ D+GLA         N             VA+R+++ PE+++    Y  ++D+WS 
Sbjct: 150 DLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSC 209
Query: 307 GCMFAGMIFRKEPFFYGHDNHDQLVKI---------AKDCCLIIWCNSRHSRKPWSKFIN 357
           GC+ A +  R+ P F G D   QL+ I           D   I    +R   K    +  
Sbjct: 210 GCILAELFLRR-PIFPGRDYRHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPA 268
Query: 358 ADNQHL---VSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF 395
           A  + +   V+P+ ID L ++L +D   R+TA+EA+ HPY 
Sbjct: 269 APLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYL 309

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 99.8 bits (247), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 82/313 (26%), Positives = 141/313 (45%), Gaps = 33/313 (10%)
Query: 114 YESLTVQWGDQ-DDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXXXXXXXX----XXX 168
           Y+S+   + D+   YE + K+G+G + EVF+  +  T ++                    
Sbjct: 6   YDSVECPFCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITAL 65
Query: 169 XXXXLQNLCGGPNVVKLLDIVRDQHS------KTPSLIFEYVNSTDFKVLYPTLTDY--- 219
               +  L    NVV L++I R + S       +  L+F++       +L   L  +   
Sbjct: 66  REIKILQLLKHENVVNLIEICRTKASPYNRCKASIYLVFDFCEHDLAGLLSNVLVKFTLS 125
Query: 220 DIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE---- 275
           +I+  +  LL  L Y H   I+HRD+K  NV+I  +   L+L D+GLA  +   K     
Sbjct: 126 EIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRD-GVLKLADFGLARAFSLAKNSQPN 184
Query: 276 -YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA 334
            Y  RV + +++ PELL+  +DY   +D+W  GC+ A M + + P   G+    QL  I+
Sbjct: 185 RYXNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEM-WTRSPIMQGNTEQHQLALIS 243
Query: 335 KDCCLI---IWCNSRH---------SRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQD 382
           + C  I   +W N  +          +    K  +    ++  P A+D +DKLL  D   
Sbjct: 244 QLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQ 303
Query: 383 RLTAREAMAHPYF 395
           R+ + +A+ H +F
Sbjct: 304 RIDSDDALNHDFF 316

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 99.4 bits (246), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 82/313 (26%), Positives = 141/313 (45%), Gaps = 33/313 (10%)
Query: 114 YESLTVQWGDQ-DDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXXXXXXXX----XXX 168
           Y+S+   + D+   YE + K+G+G + EVF+  +  T ++                    
Sbjct: 6   YDSVECPFCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITAL 65
Query: 169 XXXXLQNLCGGPNVVKLLDIVRDQHS------KTPSLIFEYVNSTDFKVLYPTLTDY--- 219
               +  L    NVV L++I R + S       +  L+F++       +L   L  +   
Sbjct: 66  REIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLS 125
Query: 220 DIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE---- 275
           +I+  +  LL  L Y H   I+HRD+K  NV+I  +   L+L D+GLA  +   K     
Sbjct: 126 EIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRD-GVLKLADFGLARAFSLAKNSQPN 184
Query: 276 -YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA 334
            Y  RV + +++ PELL+  +DY   +D+W  GC+ A M + + P   G+    QL  I+
Sbjct: 185 RYXNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEM-WTRSPIMQGNTEQHQLALIS 243
Query: 335 KDCCLI---IWCNSRH---------SRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQD 382
           + C  I   +W N  +          +    K  +    ++  P A+D +DKLL  D   
Sbjct: 244 QLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQ 303
Query: 383 RLTAREAMAHPYF 395
           R+ + +A+ H +F
Sbjct: 304 RIDSDDALNHDFF 316

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 99.4 bits (246), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 82/313 (26%), Positives = 141/313 (45%), Gaps = 33/313 (10%)
Query: 114 YESLTVQWGDQ-DDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXXXXXXXX----XXX 168
           Y+S+   + D+   YE + K+G+G + EVF+  +  T ++                    
Sbjct: 5   YDSVECPFCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITAL 64
Query: 169 XXXXLQNLCGGPNVVKLLDIVRDQHS------KTPSLIFEYVNSTDFKVLYPTLTDY--- 219
               +  L    NVV L++I R + S       +  L+F++       +L   L  +   
Sbjct: 65  REIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLS 124
Query: 220 DIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE---- 275
           +I+  +  LL  L Y H   I+HRD+K  NV+I  +   L+L D+GLA  +   K     
Sbjct: 125 EIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRD-GVLKLADFGLARAFSLAKNSQPN 183
Query: 276 -YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA 334
            Y  RV + +++ PELL+  +DY   +D+W  GC+ A M + + P   G+    QL  I+
Sbjct: 184 RYXNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEM-WTRSPIMQGNTEQHQLALIS 242
Query: 335 KDCCLI---IWCNSRH---------SRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQD 382
           + C  I   +W N  +          +    K  +    ++  P A+D +DKLL  D   
Sbjct: 243 QLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQ 302
Query: 383 RLTAREAMAHPYF 395
           R+ + +A+ H +F
Sbjct: 303 RIDSDDALNHDFF 315

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 99.4 bits (246), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 82/313 (26%), Positives = 141/313 (45%), Gaps = 33/313 (10%)
Query: 114 YESLTVQWGDQ-DDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXXXXXXXX----XXX 168
           Y+S+   + D+   YE + K+G+G + EVF+  +  T ++                    
Sbjct: 6   YDSVECPFCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITAL 65
Query: 169 XXXXLQNLCGGPNVVKLLDIVRDQHS------KTPSLIFEYVNSTDFKVLYPTLTDY--- 219
               +  L    NVV L++I R + S       +  L+F++       +L   L  +   
Sbjct: 66  REIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLS 125
Query: 220 DIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE---- 275
           +I+  +  LL  L Y H   I+HRD+K  NV+I  +   L+L D+GLA  +   K     
Sbjct: 126 EIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRD-GVLKLADFGLARAFSLAKNSQPN 184
Query: 276 -YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA 334
            Y  RV + +++ PELL+  +DY   +D+W  GC+ A M + + P   G+    QL  I+
Sbjct: 185 RYXNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEM-WTRSPIMQGNTEQHQLALIS 243
Query: 335 KDCCLI---IWCNSRH---------SRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQD 382
           + C  I   +W N  +          +    K  +    ++  P A+D +DKLL  D   
Sbjct: 244 QLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQ 303
Query: 383 RLTAREAMAHPYF 395
           R+ + +A+ H +F
Sbjct: 304 RIDSDDALNHDFF 316

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 95.9 bits (237), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 67/236 (28%), Positives = 111/236 (47%), Gaps = 29/236 (12%)
Query: 180 PNVVKLLDIV---RDQHSKTPSLIFEYVNSTDF-----KVLYPTLTDYDIRYYIYELLKA 231
           PNVV+L+D+    R       +L+FE+V+  D      K   P L    I+  + + L+ 
Sbjct: 74  PNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFLRG 132
Query: 232 LDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELL 291
           LD+ H+  I+HRD+KP N+++      ++L D+GLA  Y         V + +++ PE+L
Sbjct: 133 LDFLHANCIVHRDLKPENILVTSG-GTVKLADFGLARIYSYQMALTPVVVTLWYRAPEVL 191
Query: 292 VDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI------------AKDCCL 339
           +    Y   +DMWS+GC+FA M FR++P F G+   DQL KI             +D  L
Sbjct: 192 LQ-STYATPVDMWSVGCIFAEM-FRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVSL 249
Query: 340 IIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF 395
                     +P    +    +          L ++L ++   R++A  A+ H Y 
Sbjct: 250 PRGAFPPRGPRPVQSVVPEMEE-----SGAQLLLEMLTFNPHKRISAFRALQHSYL 300

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 95.9 bits (237), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 67/236 (28%), Positives = 112/236 (47%), Gaps = 29/236 (12%)
Query: 180 PNVVKLLDIV---RDQHSKTPSLIFEYVNSTDF-----KVLYPTLTDYDIRYYIYELLKA 231
           PNVV+L+D+    R       +L+FE+V+  D      K   P L    I+  + + L+ 
Sbjct: 66  PNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFLRG 124
Query: 232 LDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELL 291
           LD+ H+  I+HRD+KP N+++      ++L D+GLA  Y      +  V + +++ PE+L
Sbjct: 125 LDFLHANCIVHRDLKPENILVTSG-GTVKLADFGLARIYSYQMALDPVVVTLWYRAPEVL 183
Query: 292 VDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI------------AKDCCL 339
           +    Y   +DMWS+GC+FA M FR++P F G+   DQL KI             +D  L
Sbjct: 184 LQ-STYATPVDMWSVGCIFAEM-FRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVSL 241
Query: 340 IIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF 395
                     +P    +    +          L ++L ++   R++A  A+ H Y 
Sbjct: 242 PRGAFPPRGPRPVQSVVPEMEE-----SGAQLLLEMLTFNPHKRISAFRALQHSYL 292

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 95.1 bits (235), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 67/236 (28%), Positives = 111/236 (47%), Gaps = 29/236 (12%)
Query: 180 PNVVKLLDIV---RDQHSKTPSLIFEYVNSTDF-----KVLYPTLTDYDIRYYIYELLKA 231
           PNVV+L+D+    R       +L+FE+V+  D      K   P L    I+  + + L+ 
Sbjct: 66  PNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFLRG 124
Query: 232 LDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELL 291
           LD+ H+  I+HRD+KP N+++      ++L D+GLA  Y         V + +++ PE+L
Sbjct: 125 LDFLHANCIVHRDLKPENILVTSG-GTVKLADFGLARIYSYQMALAPVVVTLWYRAPEVL 183
Query: 292 VDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI------------AKDCCL 339
           +    Y   +DMWS+GC+FA M FR++P F G+   DQL KI             +D  L
Sbjct: 184 LQ-STYATPVDMWSVGCIFAEM-FRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVSL 241
Query: 340 IIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF 395
                     +P    +    +          L ++L ++   R++A  A+ H Y 
Sbjct: 242 PRGAFPPRGPRPVQSVVPEMEE-----SGAQLLLEMLTFNPHKRISAFRALQHSYL 292

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 66/236 (27%), Positives = 111/236 (47%), Gaps = 29/236 (12%)
Query: 180 PNVVKLLDIV---RDQHSKTPSLIFEYVNSTDFKVLY-----PTLTDYDIRYYIYELLKA 231
           PNVV+L+D+    R       +L+FE+V+  D +        P L    I+  + + L+ 
Sbjct: 66  PNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFLRG 124
Query: 232 LDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELL 291
           LD+ H+  I+HRD+KP N+++      ++L D+GLA  Y         V + +++ PE+L
Sbjct: 125 LDFLHANCIVHRDLKPENILVTSG-GTVKLADFGLARIYSYQMALFPVVVTLWYRAPEVL 183
Query: 292 VDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI------------AKDCCL 339
           +    Y   +DMWS+GC+FA M FR++P F G+   DQL KI             +D  L
Sbjct: 184 LQ-STYATPVDMWSVGCIFAEM-FRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVSL 241
Query: 340 IIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF 395
                     +P    +    +          L ++L ++   R++A  A+ H Y 
Sbjct: 242 PRGAFPPRGPRPVQSVVPEMEE-----SGAQLLLEMLTFNPHKRISAFRALQHSYL 292

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 64/249 (25%), Positives = 121/249 (48%), Gaps = 29/249 (11%)
Query: 173 LQNLCGGPNVVKLLDIVRDQHS----KTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYEL 228
           L  +    N++ LL++   Q S    +   ++ E +++   +V+   L    + Y +Y++
Sbjct: 76  LMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQM 135
Query: 229 LKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGP 288
           L  + + HS GI+HRD+KP N+++  +   L+++D+GLA            V +RY++ P
Sbjct: 136 LVGIKHLHSAGIIHRDLKPSNIVVKSD-ATLKILDFGLARTAGTSFMMTPYVVTRYYRAP 194
Query: 289 ELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDC----------- 337
           E+++ +  Y  ++D+WS+GC+   MI +    F G D+ DQ  K+ +             
Sbjct: 195 EVILGM-GYKENVDIWSVGCIMGEMI-KGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKL 252
Query: 338 --CLIIWCNSRHSRKPWS-------KFINADNQH--LVSPEAIDFLDKLLRYDHQDRLTA 386
              +  +  +R     +S           AD++H  L + +A D L K+L  D   R++ 
Sbjct: 253 QPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISV 312
Query: 387 REAMAHPYF 395
            EA+ HPY 
Sbjct: 313 DEALQHPYI 321

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 92.0 bits (227), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 63/241 (26%), Positives = 119/241 (49%), Gaps = 29/241 (12%)
Query: 181 NVVKLLDIVRDQHS----KTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCH 236
           N++ LL++   Q S    +   ++ E +++   +V+   L    + Y +Y++L  + + H
Sbjct: 84  NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH 143
Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD 296
           S GI+HRD+KP N+++  +   L+++D+GLA            V +RY++ PE+++ +  
Sbjct: 144 SAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPEVVTRYYRAPEVILGM-G 201
Query: 297 YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDC-------------CLIIWC 343
           Y  ++D+WS+GC+   MI +    F G D+ DQ  K+ +                +  + 
Sbjct: 202 YKENVDIWSVGCIMGEMI-KGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYV 260
Query: 344 NSRHSRKPWS-------KFINADNQH--LVSPEAIDFLDKLLRYDHQDRLTAREAMAHPY 394
            +R     +S           AD++H  L + +A D L K+L  D   R++  EA+ HPY
Sbjct: 261 ENRPKYAGYSFEKLFPDVLFPADSEHNALKASQARDLLSKMLVIDASKRISVDEALQHPY 320
Query: 395 F 395
Sbjct: 321 I 321

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 91.7 bits (226), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 64/249 (25%), Positives = 121/249 (48%), Gaps = 29/249 (11%)
Query: 173 LQNLCGGPNVVKLLDIVRDQHS----KTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYEL 228
           L  +    N++ LL++   Q S    +   ++ E +++   +V+   L    + Y +Y++
Sbjct: 76  LMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQM 135
Query: 229 LKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGP 288
           L  + + HS GI+HRD+KP N+++  +   L+++D+GLA            V +RY++ P
Sbjct: 136 LCGIKHLHSAGIIHRDLKPSNIVVKSD-ATLKILDFGLARTAGTSFMMTPYVVTRYYRAP 194
Query: 289 ELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDC----------- 337
           E+++ +  Y  ++D+WS+GC+   MI +    F G D+ DQ  K+ +             
Sbjct: 195 EVILGM-GYKENVDIWSVGCIMGEMI-KGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKL 252
Query: 338 --CLIIWCNSRHSRKPWS-------KFINADNQH--LVSPEAIDFLDKLLRYDHQDRLTA 386
              +  +  +R     +S           AD++H  L + +A D L K+L  D   R++ 
Sbjct: 253 QPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISV 312
Query: 387 REAMAHPYF 395
            EA+ HPY 
Sbjct: 313 DEALQHPYI 321

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 91.3 bits (225), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 63/241 (26%), Positives = 119/241 (49%), Gaps = 29/241 (12%)
Query: 181 NVVKLLDIVRDQHS----KTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCH 236
           N++ LL++   Q S    +   ++ E +++   +V+   L    + Y +Y++L  + + H
Sbjct: 84  NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLCGIKHLH 143
Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD 296
           S GI+HRD+KP N+++  +   L+++D+GLA            V +RY++ PE+++ +  
Sbjct: 144 SAGIIHRDLKPSNIVVKSD-ATLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM-G 201
Query: 297 YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDC-------------CLIIWC 343
           Y  ++D+WS+GC+   MI +    F G D+ DQ  K+ +                +  + 
Sbjct: 202 YKENVDIWSVGCIMGEMI-KGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQPTVRTYV 260
Query: 344 NSRHSRKPWS-------KFINADNQH--LVSPEAIDFLDKLLRYDHQDRLTAREAMAHPY 394
            +R     +S           AD++H  L + +A D L K+L  D   R++  EA+ HPY
Sbjct: 261 ENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPY 320
Query: 395 F 395
Sbjct: 321 I 321

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 91.3 bits (225), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 63/241 (26%), Positives = 119/241 (49%), Gaps = 29/241 (12%)
Query: 181 NVVKLLDIVRDQHS----KTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCH 236
           N++ LL++   Q S    +   ++ E +++   +V+   L    + Y +Y++L  + + H
Sbjct: 84  NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLCGIKHLH 143
Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD 296
           S GI+HRD+KP N+++  +   L+++D+GLA            V +RY++ PE+++ +  
Sbjct: 144 SAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM-G 201
Query: 297 YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDC-------------CLIIWC 343
           Y  ++D+WS+GC+   MI +    F G D+ DQ  K+ +                +  + 
Sbjct: 202 YKENVDIWSVGCIMGEMI-KGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQPTVRTYV 260
Query: 344 NSRHSRKPWS-------KFINADNQH--LVSPEAIDFLDKLLRYDHQDRLTAREAMAHPY 394
            +R     +S           AD++H  L + +A D L K+L  D   R++  EA+ HPY
Sbjct: 261 ENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPY 320
Query: 395 F 395
Sbjct: 321 I 321

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 63/241 (26%), Positives = 118/241 (48%), Gaps = 29/241 (12%)
Query: 181 NVVKLLDIVRDQHS----KTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCH 236
           N++ LL++   Q S    +   ++ E +++   +V+   L    + Y +Y++L  + + H
Sbjct: 84  NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH 143
Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD 296
           S GI+HRD+KP N+++  +   L+++D+GLA            V +RY++ PE+++ +  
Sbjct: 144 SAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMEPEVVTRYYRAPEVILGM-G 201
Query: 297 YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDC-------------CLIIWC 343
           Y  ++D+WS+GC+   M+  K   F G D  DQ  K+ +                +  + 
Sbjct: 202 YKENVDLWSVGCIMGEMVCHK-ILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRTYV 260
Query: 344 NSRHSRKPWS-------KFINADNQH--LVSPEAIDFLDKLLRYDHQDRLTAREAMAHPY 394
            +R     +S           AD++H  L + +A D L K+L  D   R++  EA+ HPY
Sbjct: 261 ENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPY 320
Query: 395 F 395
Sbjct: 321 I 321

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 63/241 (26%), Positives = 119/241 (49%), Gaps = 29/241 (12%)
Query: 181 NVVKLLDIVRDQHS----KTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCH 236
           N++ LL++   Q S    +   ++ E +++   +V+   L    + Y +Y++L  + + H
Sbjct: 85  NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH 144
Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD 296
           S GI+HRD+KP N+++  +   L+++D+GLA            V +RY++ PE+++ +  
Sbjct: 145 SAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM-G 202
Query: 297 YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDC-------------CLIIWC 343
           Y  ++D+WS+GC+   MI +    F G D+ DQ  K+ +                +  + 
Sbjct: 203 YKENVDIWSVGCIMGEMI-KGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYV 261
Query: 344 NSRHSRKPWS-------KFINADNQH--LVSPEAIDFLDKLLRYDHQDRLTAREAMAHPY 394
            +R     +S           AD++H  L + +A D L K+L  D   R++  EA+ HPY
Sbjct: 262 ENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPY 321
Query: 395 F 395
Sbjct: 322 I 322

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 63/241 (26%), Positives = 119/241 (49%), Gaps = 29/241 (12%)
Query: 181 NVVKLLDIVRDQHS----KTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCH 236
           N++ LL++   Q S    +   ++ E +++   +V+   L    + Y +Y++L  + + H
Sbjct: 84  NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH 143
Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD 296
           S GI+HRD+KP N+++  +   L+++D+GLA            V +RY++ PE+++ +  
Sbjct: 144 SAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM-G 201
Query: 297 YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDC-------------CLIIWC 343
           Y  ++D+WS+GC+   MI +    F G D+ DQ  K+ +                +  + 
Sbjct: 202 YKENVDIWSVGCIMGEMI-KGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQPTVRTYV 260
Query: 344 NSRHSRKPWS-------KFINADNQH--LVSPEAIDFLDKLLRYDHQDRLTAREAMAHPY 394
            +R     +S           AD++H  L + +A D L K+L  D   R++  EA+ HPY
Sbjct: 261 ENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPY 320
Query: 395 F 395
Sbjct: 321 I 321

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 63/241 (26%), Positives = 119/241 (49%), Gaps = 29/241 (12%)
Query: 181 NVVKLLDIVRDQHS----KTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCH 236
           N++ LL++   Q S    +   ++ E +++   +V+   L    + Y +Y++L  + + H
Sbjct: 84  NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH 143
Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD 296
           S GI+HRD+KP N+++  +   L+++D+GLA            V +RY++ PE+++ +  
Sbjct: 144 SAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM-G 201
Query: 297 YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDC-------------CLIIWC 343
           Y  ++D+WS+GC+   MI +    F G D+ DQ  K+ +                +  + 
Sbjct: 202 YKENVDIWSVGCIMGEMI-KGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYV 260
Query: 344 NSRHSRKPWS-------KFINADNQH--LVSPEAIDFLDKLLRYDHQDRLTAREAMAHPY 394
            +R     +S           AD++H  L + +A D L K+L  D   R++  EA+ HPY
Sbjct: 261 ENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPY 320
Query: 395 F 395
Sbjct: 321 I 321

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 65/243 (26%), Positives = 120/243 (49%), Gaps = 33/243 (13%)
Query: 181 NVVKLLDIVRDQHS----KTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCH 236
           N++ LL++   Q S    +   ++ E +++   +V+   L    + Y +Y++L  + + H
Sbjct: 84  NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH 143
Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD 296
           S GI+HRD+KP N+++  +   L+++D+GLA            V +RY++ PE+++ +  
Sbjct: 144 SAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMEPEVVTRYYRAPEVILGM-G 201
Query: 297 YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWC------------N 344
           Y  ++D+WS+GC+   M+  K   F G D  DQ  K+ +   L   C            N
Sbjct: 202 YKENVDIWSVGCIMGEMVCHK-ILFPGRDYIDQWNKVIEQ--LGTPCPAFMKKLQPTVRN 258
Query: 345 SRHSRKPWSKF----------INADNQH--LVSPEAIDFLDKLLRYDHQDRLTAREAMAH 392
              +R  ++ +            AD++H  L + +A D L K+L  D   R++  EA+ H
Sbjct: 259 YVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318
Query: 393 PYF 395
           PY 
Sbjct: 319 PYI 321

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 63/241 (26%), Positives = 118/241 (48%), Gaps = 29/241 (12%)
Query: 181 NVVKLLDIVRDQHS----KTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCH 236
           N++ LL++   Q S    +   ++ E +++   +V+   L    + Y +Y++L  + + H
Sbjct: 89  NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH 148
Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD 296
           S GI+HRD+KP N+++  +   L+++D+GLA            V +RY++ PE+++ +  
Sbjct: 149 SAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM-G 206
Query: 297 YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDC-------------CLIIWC 343
           Y  ++D+WS+GC+   M+  K   F G D  DQ  K+ +                +  + 
Sbjct: 207 YKENVDLWSVGCIMGEMVCHK-ILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRTYV 265
Query: 344 NSRHSRKPWS-------KFINADNQH--LVSPEAIDFLDKLLRYDHQDRLTAREAMAHPY 394
            +R     +S           AD++H  L + +A D L K+L  D   R++  EA+ HPY
Sbjct: 266 ENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPY 325
Query: 395 F 395
Sbjct: 326 I 326

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 83/348 (23%), Positives = 145/348 (41%), Gaps = 74/348 (21%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXXXXXXX----XXXXXXXXLQNLCGGP 180
           D+YE+   +GRG Y  V+   + N N+                         + N     
Sbjct: 28  DNYEIKHLIGRGSYGYVYLAYDKNANKNVAIKKVNRMFEDLIDCKRILREITILNRLKSD 87
Query: 181 NVVKLLDIV--RDQHSKTPSLIFEYVNSTDFKVLYPT---LTDYDIRYYIYELLKALDYC 235
            +++L D++   D        I   +  +D K L+ T   LT+  ++  +Y LL    + 
Sbjct: 88  YIIRLHDLIIPEDLLKFDELYIVLEIADSDLKKLFKTPIFLTEQHVKTILYNLLLGEKFI 147
Query: 236 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH-------------------PG--- 273
           H  GI+HRD+KP N +++ +   +++ D+GLA   +                   PG   
Sbjct: 148 HESGIIHRDLKPANCLLNQDC-SVKICDFGLARTINSDKDIHIVNDLEEKEENEEPGPHN 206
Query: 274 ----KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMI----------FRKEP 319
               K+    V +R+++ PEL++  ++Y  S+D+WS GC+FA ++            + P
Sbjct: 207 KNLKKQLTSHVVTRWYRAPELILLQENYTNSIDIWSTGCIFAELLNMMKSHINNPTNRFP 266
Query: 320 FFYG---------HDNHDQLVKIAKDCCLIIW------------CNSRHSRKPWSK-FIN 357
            F G         H++     K  +D   II+            C ++     + K F  
Sbjct: 267 LFPGSSCFPLSPDHNSKKVHEKSNRDQLNIIFNVIGTPPEEDLKCITKQEVIKYIKLFPT 326
Query: 358 ADNQHL------VSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVR 399
            D   L      +S E ID L+ +LR++ Q R+T  +A++HPY   VR
Sbjct: 327 RDGIDLSKKYSSISKEGIDLLESMLRFNAQKRITIDKALSHPYLKDVR 374

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 64/243 (26%), Positives = 120/243 (49%), Gaps = 33/243 (13%)
Query: 181 NVVKLLDIVRDQHS----KTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCH 236
           N++ LL++   Q +    +   L+ E +++   +V+   L    + Y +Y++L  + + H
Sbjct: 77  NIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSYLLYQMLXGIKHLH 136
Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD 296
           S GI+HRD+KP N+++  +   L+++D+GLA            V +RY++ PE+++ +  
Sbjct: 137 SAGIIHRDLKPSNIVVKSD-XTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM-G 194
Query: 297 YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWC------------N 344
           Y  ++D+WS+GC+   M+ R +  F G D  DQ  K+ +   L   C            N
Sbjct: 195 YKENVDIWSVGCIMGEMV-RHKILFPGRDYIDQWNKVIEQ--LGTPCPEFMKKLQPTVRN 251
Query: 345 SRHSRKPWS----------KFINADNQH--LVSPEAIDFLDKLLRYDHQDRLTAREAMAH 392
              +R  ++              AD++H  L + +A D L K+L  D   R++  +A+ H
Sbjct: 252 YVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311
Query: 393 PYF 395
           PY 
Sbjct: 312 PYI 314

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 63/241 (26%), Positives = 118/241 (48%), Gaps = 29/241 (12%)
Query: 181 NVVKLLDIVRDQHS----KTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCH 236
           N++ LL++   Q S    +   ++ E +++   +V+   L    + Y +Y++L  + + H
Sbjct: 78  NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH 137
Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD 296
           S GI+HRD+KP N+++  +   L+++D+GLA            V +RY++ PE+++ +  
Sbjct: 138 SAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM-G 195
Query: 297 YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDC-------------CLIIWC 343
           Y  ++D+WS+GC+   M+  K   F G D  DQ  K+ +                +  + 
Sbjct: 196 YKENVDLWSVGCIMGEMVCHK-ILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRTYV 254
Query: 344 NSRHSRKPWS-------KFINADNQH--LVSPEAIDFLDKLLRYDHQDRLTAREAMAHPY 394
            +R     +S           AD++H  L + +A D L K+L  D   R++  EA+ HPY
Sbjct: 255 ENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPY 314
Query: 395 F 395
Sbjct: 315 I 315

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 63/241 (26%), Positives = 119/241 (49%), Gaps = 29/241 (12%)
Query: 181 NVVKLLDIVRDQHS----KTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCH 236
           N++ LL++   Q S    +   ++ E +++   +V+   L    + Y +Y++L  + + H
Sbjct: 86  NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH 145
Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD 296
           S GI+HRD+KP N+++  +   L+++D+GLA            V +RY++ PE+++ +  
Sbjct: 146 SAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMVPFVVTRYYRAPEVILGM-G 203
Query: 297 YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDC-------------CLIIWC 343
           Y  ++D+WS+GC+   MI +    F G D+ DQ  K+ +                +  + 
Sbjct: 204 YKENVDIWSVGCIMGEMI-KGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYV 262
Query: 344 NSRHSRKPWS-------KFINADNQH--LVSPEAIDFLDKLLRYDHQDRLTAREAMAHPY 394
            +R     +S           AD++H  L + +A D L K+L  D   R++  EA+ HPY
Sbjct: 263 ENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPY 322
Query: 395 F 395
Sbjct: 323 I 323

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 64/243 (26%), Positives = 120/243 (49%), Gaps = 33/243 (13%)
Query: 181 NVVKLLDIVRDQHS----KTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCH 236
           N++ LL++   Q +    +   L+ E +++   +V+   L    + Y +Y++L  + + H
Sbjct: 84  NIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSYLLYQMLXGIKHLH 143
Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD 296
           S GI+HRD+KP N+++  +   L+++D+GLA            V +RY++ PE+++ +  
Sbjct: 144 SAGIIHRDLKPSNIVVKSD-XTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM-G 201
Query: 297 YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWC------------N 344
           Y  ++D+WS+GC+   M+ R +  F G D  DQ  K+ +   L   C            N
Sbjct: 202 YKENVDIWSVGCIMGEMV-RHKILFPGRDYIDQWNKVIEQ--LGTPCPEFMKKLQPTVRN 258
Query: 345 SRHSRKPWS----------KFINADNQH--LVSPEAIDFLDKLLRYDHQDRLTAREAMAH 392
              +R  ++              AD++H  L + +A D L K+L  D   R++  +A+ H
Sbjct: 259 YVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 318
Query: 393 PYF 395
           PY 
Sbjct: 319 PYI 321

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 64/243 (26%), Positives = 120/243 (49%), Gaps = 33/243 (13%)
Query: 181 NVVKLLDIVRDQHS----KTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCH 236
           N++ LL++   Q +    +   L+ E +++   +V+   L    + Y +Y++L  + + H
Sbjct: 84  NIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSYLLYQMLXGIKHLH 143
Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD 296
           S GI+HRD+KP N+++  +   L+++D+GLA            V +RY++ PE+++ +  
Sbjct: 144 SAGIIHRDLKPSNIVVKSD-XTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM-G 201
Query: 297 YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWC------------N 344
           Y  ++D+WS+GC+   M+ R +  F G D  DQ  K+ +   L   C            N
Sbjct: 202 YKENVDIWSVGCIMGEMV-RHKILFPGRDYIDQWNKVIEQ--LGTPCPEFMKKLQPTVRN 258
Query: 345 SRHSRKPWS----------KFINADNQH--LVSPEAIDFLDKLLRYDHQDRLTAREAMAH 392
              +R  ++              AD++H  L + +A D L K+L  D   R++  +A+ H
Sbjct: 259 YVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 318
Query: 393 PYF 395
           PY 
Sbjct: 319 PYI 321

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 64/243 (26%), Positives = 120/243 (49%), Gaps = 33/243 (13%)
Query: 181 NVVKLLDIVRDQHS----KTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCH 236
           N++ LL++   Q +    +   L+ E +++   +V+   L    + Y +Y++L  + + H
Sbjct: 122 NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH 181
Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD 296
           S GI+HRD+KP N+++  +   L+++D+GLA            V +RY++ PE+++ +  
Sbjct: 182 SAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM-G 239
Query: 297 YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWC------------N 344
           Y  ++D+WS+GC+   M+ R +  F G D  DQ  K+ +   L   C            N
Sbjct: 240 YKENVDIWSVGCIMGEMV-RHKILFPGRDYIDQWNKVIEQ--LGTPCPEFMKKLQPTVRN 296
Query: 345 SRHSRKPWS----------KFINADNQH--LVSPEAIDFLDKLLRYDHQDRLTAREAMAH 392
              +R  ++              AD++H  L + +A D L K+L  D   R++  +A+ H
Sbjct: 297 YVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 356
Query: 393 PYF 395
           PY 
Sbjct: 357 PYI 359

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 63/249 (25%), Positives = 120/249 (48%), Gaps = 29/249 (11%)
Query: 173 LQNLCGGPNVVKLLDIVRDQHS----KTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYEL 228
           L  +    N++ LL++   Q S    +   ++ E +++   +V+   L    + Y +Y++
Sbjct: 76  LMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQM 135
Query: 229 LKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGP 288
           L  + + HS GI+HRD+KP N+++  +   L+++D+GLA            V +RY++ P
Sbjct: 136 LVGIKHLHSAGIIHRDLKPSNIVVKSD-ATLKILDFGLARTAGTSFMMTPYVVTRYYRAP 194
Query: 289 ELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDC----------- 337
           E+++ +  Y  ++D+WS+G +   MI +    F G D+ DQ  K+ +             
Sbjct: 195 EVILGM-GYKENVDIWSVGVIMGEMI-KGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKL 252
Query: 338 --CLIIWCNSRHSRKPWS-------KFINADNQH--LVSPEAIDFLDKLLRYDHQDRLTA 386
              +  +  +R     +S           AD++H  L + +A D L K+L  D   R++ 
Sbjct: 253 QPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISV 312
Query: 387 REAMAHPYF 395
            EA+ HPY 
Sbjct: 313 DEALQHPYI 321

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 63/249 (25%), Positives = 120/249 (48%), Gaps = 29/249 (11%)
Query: 173 LQNLCGGPNVVKLLDIVRDQHS----KTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYEL 228
           L  +    N++ LL++   Q S    +   ++ E +++   +V+   L    + Y +Y++
Sbjct: 76  LMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQM 135
Query: 229 LKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGP 288
           L  + + HS GI+HRD+KP N+++  +   L+++D+GLA            V +RY++ P
Sbjct: 136 LVGIKHLHSAGIIHRDLKPSNIVVKSD-ATLKILDFGLARTAGTSFMMTPYVVTRYYRAP 194
Query: 289 ELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDC----------- 337
           E+++ +  Y  ++D+WS+G +   MI +    F G D+ DQ  K+ +             
Sbjct: 195 EVILGM-GYKENVDIWSVGVIMGEMI-KGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKL 252
Query: 338 --CLIIWCNSRHSRKPWS-------KFINADNQH--LVSPEAIDFLDKLLRYDHQDRLTA 386
              +  +  +R     +S           AD++H  L + +A D L K+L  D   R++ 
Sbjct: 253 QPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISV 312
Query: 387 REAMAHPYF 395
            EA+ HPY 
Sbjct: 313 DEALQHPYI 321

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 64/243 (26%), Positives = 120/243 (49%), Gaps = 33/243 (13%)
Query: 181 NVVKLLDIVRDQHS----KTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCH 236
           N++ LL++   Q +    +   L+ E +++   +V+   L    + Y +Y++L  + + H
Sbjct: 122 NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH 181
Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD 296
           S GI+HRD+KP N+++  +   L+++D+GLA            V +RY++ PE+++ +  
Sbjct: 182 SAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM-G 239
Query: 297 YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWC------------N 344
           Y  ++D+WS+GC+   M+ R +  F G D  DQ  K+ +   L   C            N
Sbjct: 240 YKENVDIWSVGCIMGEMV-RHKILFPGRDYIDQWNKVIEQ--LGTPCPEFMKKLQPTVRN 296
Query: 345 SRHSRKPWS----------KFINADNQH--LVSPEAIDFLDKLLRYDHQDRLTAREAMAH 392
              +R  ++              AD++H  L + +A D L K+L  D   R++  +A+ H
Sbjct: 297 YVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 356
Query: 393 PYF 395
           PY 
Sbjct: 357 PYI 359

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 64/243 (26%), Positives = 120/243 (49%), Gaps = 33/243 (13%)
Query: 181 NVVKLLDIVRDQHS----KTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCH 236
           N++ LL++   Q +    +   L+ E +++   +V+   L    + Y +Y++L  + + H
Sbjct: 85  NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH 144
Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD 296
           S GI+HRD+KP N+++  +   L+++D+GLA            V +RY++ PE+++ +  
Sbjct: 145 SAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM-G 202
Query: 297 YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWC------------N 344
           Y  ++D+WS+GC+   M+ R +  F G D  DQ  K+ +   L   C            N
Sbjct: 203 YKENVDIWSVGCIMGEMV-RHKILFPGRDYIDQWNKVIEQ--LGTPCPEFMKKLQPTVRN 259
Query: 345 SRHSRKPWS----------KFINADNQH--LVSPEAIDFLDKLLRYDHQDRLTAREAMAH 392
              +R  ++              AD++H  L + +A D L K+L  D   R++  +A+ H
Sbjct: 260 YVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 319
Query: 393 PYF 395
           PY 
Sbjct: 320 PYI 322

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 64/243 (26%), Positives = 120/243 (49%), Gaps = 33/243 (13%)
Query: 181 NVVKLLDIVRDQHS----KTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCH 236
           N++ LL++   Q +    +   L+ E +++   +V+   L    + Y +Y++L  + + H
Sbjct: 84  NIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSYLLYQMLCGIKHLH 143
Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD 296
           S GI+HRD+KP N+++  +   L+++D+GLA            V +RY++ PE+++ +  
Sbjct: 144 SAGIIHRDLKPSNIVVKSD-XTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM-G 201
Query: 297 YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWC------------N 344
           Y  ++D+WS+GC+   M+ R +  F G D  DQ  K+ +   L   C            N
Sbjct: 202 YKENVDIWSVGCIMGEMV-RHKILFPGRDYIDQWNKVIEQ--LGTPCPEFMKKLQPTVRN 258
Query: 345 SRHSRKPWS----------KFINADNQH--LVSPEAIDFLDKLLRYDHQDRLTAREAMAH 392
              +R  ++              AD++H  L + +A D L K+L  D   R++  +A+ H
Sbjct: 259 YVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 318
Query: 393 PYF 395
           PY 
Sbjct: 319 PYI 321

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 64/243 (26%), Positives = 120/243 (49%), Gaps = 33/243 (13%)
Query: 181 NVVKLLDIVRDQHS----KTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCH 236
           N++ LL++   Q +    +   L+ E +++   +V+   L    + Y +Y++L  + + H
Sbjct: 84  NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH 143
Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD 296
           S GI+HRD+KP N+++  +   L+++D+GLA            V +RY++ PE+++ +  
Sbjct: 144 SAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM-G 201
Query: 297 YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWC------------N 344
           Y  ++D+WS+GC+   M+ R +  F G D  DQ  K+ +   L   C            N
Sbjct: 202 YKENVDIWSVGCIMGEMV-RHKILFPGRDYIDQWNKVIEQ--LGTPCPEFMKKLQPTVRN 258
Query: 345 SRHSRKPWS----------KFINADNQH--LVSPEAIDFLDKLLRYDHQDRLTAREAMAH 392
              +R  ++              AD++H  L + +A D L K+L  D   R++  +A+ H
Sbjct: 259 YVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 318
Query: 393 PYF 395
           PY 
Sbjct: 319 PYI 321

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 64/243 (26%), Positives = 120/243 (49%), Gaps = 33/243 (13%)
Query: 181 NVVKLLDIVRDQHS----KTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCH 236
           N++ LL++   Q +    +   L+ E +++   +V+   L    + Y +Y++L  + + H
Sbjct: 78  NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH 137
Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD 296
           S GI+HRD+KP N+++  +   L+++D+GLA            V +RY++ PE+++ +  
Sbjct: 138 SAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM-G 195
Query: 297 YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWC------------N 344
           Y  ++D+WS+GC+   M+ R +  F G D  DQ  K+ +   L   C            N
Sbjct: 196 YKENVDIWSVGCIMGEMV-RHKILFPGRDYIDQWNKVIEQ--LGTPCPEFMKKLQPTVRN 252
Query: 345 SRHSRKPWS----------KFINADNQH--LVSPEAIDFLDKLLRYDHQDRLTAREAMAH 392
              +R  ++              AD++H  L + +A D L K+L  D   R++  +A+ H
Sbjct: 253 YVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 312
Query: 393 PYF 395
           PY 
Sbjct: 313 PYI 315

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 64/243 (26%), Positives = 120/243 (49%), Gaps = 33/243 (13%)
Query: 181 NVVKLLDIVRDQHS----KTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCH 236
           N++ LL++   Q +    +   L+ E +++   +V+   L    + Y +Y++L  + + H
Sbjct: 83  NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH 142
Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD 296
           S GI+HRD+KP N+++  +   L+++D+GLA            V +RY++ PE+++ +  
Sbjct: 143 SAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM-G 200
Query: 297 YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWC------------N 344
           Y  ++D+WS+GC+   M+ R +  F G D  DQ  K+ +   L   C            N
Sbjct: 201 YKENVDIWSVGCIMGEMV-RHKILFPGRDYIDQWNKVIEQ--LGTPCPEFMKKLQPTVRN 257
Query: 345 SRHSRKPWS----------KFINADNQH--LVSPEAIDFLDKLLRYDHQDRLTAREAMAH 392
              +R  ++              AD++H  L + +A D L K+L  D   R++  +A+ H
Sbjct: 258 YVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 317
Query: 393 PYF 395
           PY 
Sbjct: 318 PYI 320

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 64/243 (26%), Positives = 120/243 (49%), Gaps = 33/243 (13%)
Query: 181 NVVKLLDIVRDQHS----KTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCH 236
           N++ LL++   Q +    +   L+ E +++   +V+   L    + Y +Y++L  + + H
Sbjct: 84  NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH 143
Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD 296
           S GI+HRD+KP N+++  +   L+++D+GLA            V +RY++ PE+++ +  
Sbjct: 144 SAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM-G 201
Query: 297 YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWC------------N 344
           Y  ++D+WS+GC+   M+ R +  F G D  DQ  K+ +   L   C            N
Sbjct: 202 YKENVDIWSVGCIMGEMV-RHKILFPGRDYIDQWNKVIEQ--LGTPCPEFMKKLQPTVRN 258
Query: 345 SRHSRKPWS----------KFINADNQH--LVSPEAIDFLDKLLRYDHQDRLTAREAMAH 392
              +R  ++              AD++H  L + +A D L K+L  D   R++  +A+ H
Sbjct: 259 YVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 318
Query: 393 PYF 395
           PY 
Sbjct: 319 PYI 321

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 89.0 bits (219), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 64/243 (26%), Positives = 120/243 (49%), Gaps = 33/243 (13%)
Query: 181 NVVKLLDIVRDQHS----KTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCH 236
           N++ LL++   Q +    +   L+ E +++   +V+   L    + Y +Y++L  + + H
Sbjct: 85  NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH 144
Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD 296
           S GI+HRD+KP N+++  +   L+++D+GLA            V +RY++ PE+++ +  
Sbjct: 145 SAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM-G 202
Query: 297 YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWC------------N 344
           Y  ++D+WS+GC+   M+ R +  F G D  DQ  K+ +   L   C            N
Sbjct: 203 YKENVDIWSVGCIMGEMV-RHKILFPGRDYIDQWNKVIEQ--LGTPCPEFMKKLQPTVRN 259
Query: 345 SRHSRKPWS----------KFINADNQH--LVSPEAIDFLDKLLRYDHQDRLTAREAMAH 392
              +R  ++              AD++H  L + +A D L K+L  D   R++  +A+ H
Sbjct: 260 YVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 319
Query: 393 PYF 395
           PY 
Sbjct: 320 PYI 322

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 89.0 bits (219), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 64/243 (26%), Positives = 120/243 (49%), Gaps = 33/243 (13%)
Query: 181 NVVKLLDIVRDQHS----KTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCH 236
           N++ LL++   Q +    +   L+ E +++   +V+   L    + Y +Y++L  + + H
Sbjct: 77  NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH 136
Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD 296
           S GI+HRD+KP N+++  +   L+++D+GLA            V +RY++ PE+++ +  
Sbjct: 137 SAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM-G 194
Query: 297 YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWC------------N 344
           Y  ++D+WS+GC+   M+ R +  F G D  DQ  K+ +   L   C            N
Sbjct: 195 YKENVDIWSVGCIMGEMV-RHKILFPGRDYIDQWNKVIEQ--LGTPCPEFMKKLQPTVRN 251
Query: 345 SRHSRKPWS----------KFINADNQH--LVSPEAIDFLDKLLRYDHQDRLTAREAMAH 392
              +R  ++              AD++H  L + +A D L K+L  D   R++  +A+ H
Sbjct: 252 YVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311
Query: 393 PYF 395
           PY 
Sbjct: 312 PYI 314

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 88.6 bits (218), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 64/243 (26%), Positives = 120/243 (49%), Gaps = 33/243 (13%)
Query: 181 NVVKLLDIVRDQHS----KTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCH 236
           N++ LL++   Q +    +   L+ E +++   +V+   L    + Y +Y++L  + + H
Sbjct: 78  NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH 137
Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD 296
           S GI+HRD+KP N+++  +   L+++D+GLA            V +RY++ PE+++ +  
Sbjct: 138 SAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM-G 195
Query: 297 YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWC------------N 344
           Y  ++D+WS+GC+   M+ R +  F G D  DQ  K+ +   L   C            N
Sbjct: 196 YKENVDIWSVGCIMGEMV-RHKILFPGRDYIDQWNKVIEQ--LGTPCPEFMKKLQPTVRN 252
Query: 345 SRHSRKPWS----------KFINADNQH--LVSPEAIDFLDKLLRYDHQDRLTAREAMAH 392
              +R  ++              AD++H  L + +A D L K+L  D   R++  +A+ H
Sbjct: 253 YVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 312
Query: 393 PYF 395
           PY 
Sbjct: 313 PYI 315

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 88.6 bits (218), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 64/243 (26%), Positives = 120/243 (49%), Gaps = 33/243 (13%)
Query: 181 NVVKLLDIVRDQHS----KTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCH 236
           N++ LL++   Q +    +   L+ E +++   +V+   L    + Y +Y++L  + + H
Sbjct: 84  NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH 143
Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD 296
           S GI+HRD+KP N+++  +   L+++D+GLA            V +RY++ PE+++ +  
Sbjct: 144 SAGIIHRDLKPSNIVVKSD-XTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM-G 201
Query: 297 YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWC------------N 344
           Y  ++D+WS+GC+   M+ R +  F G D  DQ  K+ +   L   C            N
Sbjct: 202 YKENVDIWSVGCIMGEMV-RHKILFPGRDYIDQWNKVIEQ--LGTPCPEFMKKLQPTVRN 258
Query: 345 SRHSRKPWS----------KFINADNQH--LVSPEAIDFLDKLLRYDHQDRLTAREAMAH 392
              +R  ++              AD++H  L + +A D L K+L  D   R++  +A+ H
Sbjct: 259 YVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 318
Query: 393 PYF 395
           PY 
Sbjct: 319 PYI 321

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score = 88.2 bits (217), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 90/365 (24%), Positives = 146/365 (40%), Gaps = 89/365 (24%)
Query: 121 WGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXXXXXXXXXXXXXXXLQ-----N 175
           W   D YE+   +G G Y  V E  +    +R                    L+     N
Sbjct: 49  WQIPDRYEIRHLIGTGSYGHVCEAYD-KLEKRVVAIKKILRVFEDLIDCKRILREIAILN 107
Query: 176 LCGGPNVVKLLDIV--RDQHSKTPSLIFEYVNSTDFKVLYPT---LTDYDIRYYIYELLK 230
                +VVK+LDIV  +D        +   +  +DFK L+ T   LT+  I+  +Y LL 
Sbjct: 108 RLNHDHVVKVLDIVIPKDVEKFDELYVVLEIADSDFKKLFRTPVYLTELHIKTLLYNLLV 167
Query: 231 ALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE---------------------- 268
            + Y HS GI+HRD+KP N +++ +   +++ D+GLA                       
Sbjct: 168 GVKYVHSAGILHRDLKPANCLVNQDC-SVKVCDFGLARTVDYPENGNSQLPISPREDDMN 226
Query: 269 ---FYHP---GKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMI-------- 314
              F H     ++    V +R+++ PEL++  ++Y  ++D+WS+GC+FA ++        
Sbjct: 227 LVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVA 286
Query: 315 --FRKEPFFYGHD--------------------NHDQLVKIAKDCCLIIWCNSRHSRKPW 352
               + P F G                      N DQL  I      I+   S    +  
Sbjct: 287 YHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFN----ILGTPSEEDIEAL 342
Query: 353 SK---------FINADNQHLV------SPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQ 397
            K         F   +   L       S +AI  L ++L ++   R+T  E +AHP+F +
Sbjct: 343 EKEDAKRYIRIFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKE 402
Query: 398 VRAAE 402
           VR AE
Sbjct: 403 VRIAE 407

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 59/242 (24%), Positives = 116/242 (47%), Gaps = 29/242 (11%)
Query: 181 NVVKLLDIVRDQHS----KTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCH 236
           N++ LL++   Q +    +   L+ E +++   +V++  L    + Y +Y++L  + + H
Sbjct: 82  NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLCGIKHLH 141
Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD 296
           S GI+HRD+KP N+++  +   L+++D+GLA            V +RY++ PE+++ +  
Sbjct: 142 SAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTASTNFMMTPYVVTRYYRAPEVILGM-G 199
Query: 297 YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKD---------CCLIIWCNSRH 347
           Y  ++D+WS+GC+  G + +    F G D+ DQ  K+ +            L     +  
Sbjct: 200 YKENVDIWSVGCIM-GELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMAALQPTVRNYV 258
Query: 348 SRKP-------------WSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPY 394
             +P             W     ++   + + +A D L K+L  D   R++  EA+ HPY
Sbjct: 259 ENRPAYPGIAFEELFPDWIFPSESERDKIKTSQARDLLSKMLVIDPDKRISVDEALRHPY 318
Query: 395 FA 396
Sbjct: 319 IT 320

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 67/292 (22%), Positives = 128/292 (43%), Gaps = 40/292 (13%)
Query: 127 YEVVRKVGRGKYSEVF----EGINVNTNERCXXXXXXXXXXXXXXXXXXXLQNLCGGPNV 182
           Y+ V+K+G G Y EV     +  +V    +                    +  L   PN+
Sbjct: 39  YQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNI 98
Query: 183 VKLLDIVRDQHS--------KTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDY 234
           +KL D   D+ +        K   L  E ++   F        + D    I ++L  + Y
Sbjct: 99  MKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKF-------NEVDAAVIIKQVLSGVTY 151
Query: 235 CHSQGIMHRDVKPHNVMIDHELRK--LRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLV 292
            H   I+HRD+KP N++++ + +   ++++D+GL+  +   K+   R+ + Y+  PE+L 
Sbjct: 152 LHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVL- 210
Query: 293 DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPW 352
             + YD   D+WS+G +   ++    P F G  + + L K+ K                W
Sbjct: 211 -RKKYDEKCDVWSIGVILF-ILLAGYPPFGGQTDQEILRKVEK-------GKYTFDSPEW 261
Query: 353 SKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAESS 404
                      VS  A D + ++L++D Q R++A++A+ HP+  ++ + + S
Sbjct: 262 KN---------VSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKEMCSKKES 304

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 62/242 (25%), Positives = 117/242 (48%), Gaps = 36/242 (14%)
Query: 180 PNVVKLLDIVRDQHSKTPS-----LIFEYVNSTDFKVLYP---TLTDYDIRYYIYELLKA 231
           PN++ L DI    H + P+     L+ E + +   +V++     ++   I+Y++Y +L  
Sbjct: 89  PNILGLRDIF--VHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYHILLG 146
Query: 232 LDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELL 291
           L   H  G++HRD+ P N+++      + + D+ LA            V  R+++ PEL+
Sbjct: 147 LHVLHEAGVVHRDLHPGNILLADN-NDITICDFNLAREDTADANKTHYVTHRWYRAPELV 205
Query: 292 VDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCL-----IIWCNSR 346
           +  + +   +DMWS GC+ A M F ++  F G   ++QL KI +         ++  +S 
Sbjct: 206 MQFKGFTKLVDMWSAGCVMAEM-FNRKALFRGSTFYNQLNKIVEVVGTPKIEDVVMFSSP 264
Query: 347 HSR------------KPWSKFI-NADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHP 393
            +R            + W+  +  AD      P A+D + K+L ++ Q R++  +A+ HP
Sbjct: 265 SARDYLRNSLSNVPARAWTAVVPTAD------PVALDLIAKMLEFNPQRRISTEQALRHP 318
Query: 394 YF 395
           YF
Sbjct: 319 YF 320

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 62/242 (25%), Positives = 117/242 (48%), Gaps = 36/242 (14%)
Query: 180 PNVVKLLDIVRDQHSKTPS-----LIFEYVNSTDFKVLYP---TLTDYDIRYYIYELLKA 231
           PN++ L DI    H + P+     L+ E + +   +V++     ++   I+Y++Y +L  
Sbjct: 89  PNILGLRDIF--VHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYHILLG 146
Query: 232 LDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELL 291
           L   H  G++HRD+ P N+++      + + D+ LA            V  R+++ PEL+
Sbjct: 147 LHVLHEAGVVHRDLHPGNILLADN-NDITICDFNLAREDTADANKTHYVTHRWYRAPELV 205
Query: 292 VDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCL-----IIWCNSR 346
           +  + +   +DMWS GC+ A M F ++  F G   ++QL KI +         ++  +S 
Sbjct: 206 MQFKGFTKLVDMWSAGCVMAEM-FNRKALFRGSTFYNQLNKIVEVVGTPKIEDVVMFSSP 264
Query: 347 HSR------------KPWSKFI-NADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHP 393
            +R            + W+  +  AD      P A+D + K+L ++ Q R++  +A+ HP
Sbjct: 265 SARDYLRNSLSNVPARAWTAVVPTAD------PVALDLIAKMLEFNPQRRISTEQALRHP 318
Query: 394 YF 395
           YF
Sbjct: 319 YF 320

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 60/242 (24%), Positives = 119/242 (49%), Gaps = 29/242 (11%)
Query: 181 NVVKLLDIVRDQHS----KTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCH 236
           N++ LL++   Q +    +   L+ E +++   +V++  L    + Y +Y++L  + + H
Sbjct: 84  NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLCGIKHLH 143
Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD 296
           S GI+HRD+KP N+++  +   L+++D+GLA            V +RY++ PE+++ +  
Sbjct: 144 SAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTACTNFMMTPYVVTRYYRAPEVILGM-G 201
Query: 297 YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI-------AKDCCLIIWCNSRH-- 347
           Y  ++D+WS+GC+  G + +    F G D+ DQ  K+       + +    +    R+  
Sbjct: 202 YAANVDIWSVGCIM-GELVKGCVIFQGTDHIDQWNKVIEQLGTPSAEFMAALQPTVRNYV 260
Query: 348 ---SRKPWSKF----------INADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPY 394
               + P  KF            ++   + + +A D L K+L  D   R++  EA+ HPY
Sbjct: 261 ENRPKYPGIKFEELFPDWIFPSESERDKIKTSQARDLLSKMLVIDPDKRISVDEALRHPY 320
Query: 395 FA 396
Sbjct: 321 IT 322

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 81/348 (23%), Positives = 144/348 (41%), Gaps = 71/348 (20%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXXXXXXX----XXXXXXXXLQNLCGGP 180
           D+Y +   +GRG Y  V+   + NT +                         + N     
Sbjct: 26  DNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSD 85
Query: 181 NVVKLLD-IVRDQHSKTPSL-IFEYVNSTDFKVLYPT---LTDYDIRYYIYELLKALDYC 235
            +++L D I+ D   K   L I   +  +D K L+ T   LT+  I+  +Y LL   ++ 
Sbjct: 86  YIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLFKTPIFLTEEHIKTILYNLLLGENFI 145
Query: 236 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNV----------------- 278
           H  GI+HRD+KP N +++ +   +++ D+GLA   +  K+ N+                 
Sbjct: 146 HESGIIHRDLKPANCLLNQDC-SVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNL 204
Query: 279 ------RVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMI----------FRKEPFFY 322
                  V +R+++ PEL++  ++Y  S+D+WS GC+FA ++            + P F 
Sbjct: 205 KKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPLFP 264
Query: 323 G-----------------HDNHDQLVKIAKDCCLIIWCNSRHSRK----------PWSKF 355
           G                   N DQL  I          + ++  K          P  K 
Sbjct: 265 GSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKP 324
Query: 356 INADNQH-LVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAE 402
           IN   ++  +S + I+ L+ +L+++   R+T  +A+ HPY   VR  +
Sbjct: 325 INLKQKYPSISDDGINLLESMLKFNPNKRITIDQALDHPYLKDVRKKK 372

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 76/284 (26%), Positives = 124/284 (43%), Gaps = 33/284 (11%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXXXXXXXXXXXXXXXLQNLCGGPNVVK 184
           D Y V   +G G YSE    ++  TN                      L+     PN++ 
Sbjct: 27  DGYVVKETIGVGSYSECKRCVHKATNMEYAVKVIDKSKRDPSEEIEILLR-YGQHPNIIT 85
Query: 185 LLDIVRDQHSKTPSLIFEYVNSTDF--KVLYPTL-TDYDIRYYIYELLKALDYCHSQGIM 241
           L D+  D   K   L+ E +   +   K+L     ++ +  + ++ + K ++Y HSQG++
Sbjct: 86  LKDVYDD--GKHVYLVTELMRGGELLDKILRQKFFSEREASFVLHTIGKTVEYLHSQGVV 143
Query: 242 HRDVKPHNVMIDHELRK---LRLIDWGLAEFYHPGKEYNVRVASRY---FKGPELLVDLQ 295
           HRD+KP N++   E      LR+ D+G A+      E  + +   Y   F  PE+L   Q
Sbjct: 144 HRDLKPSNILYVDESGNPECLRICDFGFAKQLR--AENGLLMTPCYTANFVAPEVL-KRQ 200
Query: 296 DYDYSLDMWSLGCMFAGMIFRKEPFFYG-HDNHDQLVKIAKDCCLIIWCNSRHSRKPWSK 354
            YD   D+WSLG +   M+    PF  G  D  ++++                +R    K
Sbjct: 201 GYDEGCDIWSLGILLYTMLAGYTPFANGPSDTPEEIL----------------TRIGSGK 244
Query: 355 F-INADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQ 397
           F ++  N + VS  A D + K+L  D   RLTA++ + HP+  Q
Sbjct: 245 FTLSGGNWNTVSETAKDLVSKMLHVDPHQRLTAKQVLQHPWVTQ 288

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 76/284 (26%), Positives = 124/284 (43%), Gaps = 33/284 (11%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXXXXXXXXXXXXXXXLQNLCGGPNVVK 184
           D Y V   +G G YSE    ++  TN                      L+     PN++ 
Sbjct: 27  DGYVVKETIGVGSYSECKRCVHKATNMEYAVKVIDKSKRDPSEEIEILLR-YGQHPNIIT 85
Query: 185 LLDIVRDQHSKTPSLIFEYVNSTDF--KVLYPTL-TDYDIRYYIYELLKALDYCHSQGIM 241
           L D+  D   K   L+ E +   +   K+L     ++ +  + ++ + K ++Y HSQG++
Sbjct: 86  LKDVYDD--GKHVYLVTELMRGGELLDKILRQKFFSEREASFVLHTIGKTVEYLHSQGVV 143
Query: 242 HRDVKPHNVMIDHELRK---LRLIDWGLAEFYHPGKEYNVRVASRY---FKGPELLVDLQ 295
           HRD+KP N++   E      LR+ D+G A+      E  + +   Y   F  PE+L   Q
Sbjct: 144 HRDLKPSNILYVDESGNPECLRICDFGFAKQLR--AENGLLMTPCYTANFVAPEVL-KRQ 200
Query: 296 DYDYSLDMWSLGCMFAGMIFRKEPFFYG-HDNHDQLVKIAKDCCLIIWCNSRHSRKPWSK 354
            YD   D+WSLG +   M+    PF  G  D  ++++                +R    K
Sbjct: 201 GYDEGCDIWSLGILLYTMLAGYTPFANGPSDTPEEIL----------------TRIGSGK 244
Query: 355 F-INADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQ 397
           F ++  N + VS  A D + K+L  D   RLTA++ + HP+  Q
Sbjct: 245 FTLSGGNWNTVSETAKDLVSKMLHVDPHQRLTAKQVLQHPWVTQ 288

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 71/295 (24%), Positives = 128/295 (43%), Gaps = 36/295 (12%)
Query: 115 ESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXXXXXXXXXXXXXXXLQ 174
           E+L  Q G  D Y+ V+K+G G Y EV    +  T                       L 
Sbjct: 12  ENLYFQ-GLSDRYQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLD 70
Query: 175 NLC-----GGPNVVKLLDIVRDQHSKTPSLIFEYVNST---DFKVLYPTLTDYDIRYYIY 226
            +        PN++KL +   D+  +   L+ E        D  +L    ++ D    + 
Sbjct: 71  EVAVLKQLDHPNIMKLYEFFEDK--RNYYLVMEVYRGGELFDEIILRQKFSEVDAAVIMK 128
Query: 227 ELLKALDYCHSQGIMHRDVKPHNVMIDHELRK--LRLIDWGLAEFYHPGKEYNVRVASRY 284
           ++L    Y H   I+HRD+KP N++++ + R   ++++D+GL+  +  G +   R+ + Y
Sbjct: 129 QVLSGTTYLHKHNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKERLGTAY 188
Query: 285 FKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCN 344
           +  PE+L   + YD   D+WS G +   ++    P F G  + + L ++ K         
Sbjct: 189 YIAPEVL--RKKYDEKCDVWSCGVILY-ILLCGYPPFGGQTDQEILKRVEK--------- 236
Query: 345 SRHSRKP--WSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQ 397
            + S  P  W++         VS EA   +  +L Y+   R++A EA+ HP+  +
Sbjct: 237 GKFSFDPPDWTQ---------VSDEAKQLVKLMLTYEPSKRISAEEALNHPWIVK 282

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 61/241 (25%), Positives = 115/241 (47%), Gaps = 31/241 (12%)
Query: 173 LQNLCGGPNVVKLLDIVRDQHSKTPSL-------IFEYVNSTDFKVLYPTLTDYDIRYYI 225
           + N    P ++ L D   D++     L       +F+ + + D+K     +++ ++  Y+
Sbjct: 101 IMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYK-----MSEAEVINYM 155
Query: 226 YELLKALDYCHSQGIMHRDVKPHNVMID-HELRKLRLIDWGLAEFYHPGKEYNVRVASRY 284
            +  + L + H   I+H D+KP N+M +  +   +++ID+GLA   +P +   V  A+  
Sbjct: 156 RQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAE 215
Query: 285 FKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCN 344
           F  PE+ VD +   +  DMW++G +   ++    PF  G D+ + L  + +       C+
Sbjct: 216 FAAPEI-VDREPVGFYTDMWAIGVLGYVLLSGLSPF-AGEDDLETLQNVKR-------CD 266
Query: 345 SRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAESS 404
                  W    + D    VSPEA DF+  LL+ + + RLT  +A+ HP+     +  +S
Sbjct: 267 -------WE--FDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSNLTS 317
Query: 405 R 405
           R
Sbjct: 318 R 318

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 68/288 (23%), Positives = 124/288 (43%), Gaps = 35/288 (12%)
Query: 122 GDQDDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXXXXXXXXXXXXXXXLQNLC---- 177
           G  D Y+ V+K+G G Y EV    +  T                       L  +     
Sbjct: 1   GLSDRYQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQ 60
Query: 178 -GGPNVVKLLDIVRDQHSKTPSLIFEYVNST---DFKVLYPTLTDYDIRYYIYELLKALD 233
              PN++KL +   D+  +   L+ E        D  +L    ++ D    + ++L    
Sbjct: 61  LDHPNIMKLYEFFEDK--RNYYLVMEVYRGGELFDEIILRQKFSEVDAAVIMKQVLSGTT 118
Query: 234 YCHSQGIMHRDVKPHNVMIDHELRK--LRLIDWGLAEFYHPGKEYNVRVASRYFKGPELL 291
           Y H   I+HRD+KP N++++ + R   ++++D+GL+  +  G +   R+ + Y+  PE+L
Sbjct: 119 YLHKHNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKERLGTAYYIAPEVL 178
Query: 292 VDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKP 351
              + YD   D+WS G +   ++    P F G  + + L ++ K          + S  P
Sbjct: 179 --RKKYDEKCDVWSCGVILY-ILLCGYPPFGGQTDQEILKRVEK---------GKFSFDP 226
Query: 352 --WSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQ 397
             W++         VS EA   +  +L Y+   R++A EA+ HP+  +
Sbjct: 227 PDWTQ---------VSDEAKQLVKLMLTYEPSKRISAEEALNHPWIVK 265

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 70/319 (21%), Positives = 144/319 (45%), Gaps = 36/319 (11%)
Query: 91  LPAMSKARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRK---VGRGKYSEVFEGINV 147
           +P  SK      V++  P   +D+  +T + G  + +  V K   +G G++ +V +    
Sbjct: 52  MPVKSKRTSALAVDIPAPPAPFDHRIVTAKQGAVNSFYTVSKTEILGGGRFGQVHKCEET 111
Query: 148 NTNERCXXXXXXXXXXXXXXXXXXXLQ--NLCGGPNVVKLLDIVRDQHSKTPSLIFEYVN 205
            T  +                    +   N     N+++L D    ++     L+ EYV+
Sbjct: 112 ATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIV--LVMEYVD 169
Query: 206 STDF--KVLYPT--LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVM-IDHELRKLR 260
             +   +++  +  LT+ D   ++ ++ + + + H   I+H D+KP N++ ++ + ++++
Sbjct: 170 GGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIK 229
Query: 261 LIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYD---YSLDMWSLGCMFAGMIFRK 317
           +ID+GLA  Y P ++  V   +  F  PE++    +YD   +  DMWS+G +   ++   
Sbjct: 230 IIDFGLARRYKPREKLKVNFGTPEFLAPEVV----NYDFVSFPTDMWSVGVIAYMLLSGL 285
Query: 318 EPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLR 377
            PF   +D        A+    I+ C        W   +  +    +S EA +F+ KLL 
Sbjct: 286 SPFLGDND--------AETLNNILACR-------WD--LEDEEFQDISEEAKEFISKLLI 328
Query: 378 YDHQDRLTAREAMAHPYFA 396
            +   R++A EA+ HP+ +
Sbjct: 329 KEKSWRISASEALKHPWLS 347

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 57/231 (24%), Positives = 114/231 (49%), Gaps = 28/231 (12%)
Query: 173 LQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNST---DFKVLYPTLTDYDIRYYIYELL 229
           L+ + G P+++ L+D    + S    L+F+ +      D+      L++ + R  +  LL
Sbjct: 153 LRQVAGHPHIITLIDSY--ESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLL 210
Query: 230 KALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 289
           +A+ + H+  I+HRD+KP N+++D  + ++RL D+G +    PG++      +  +  PE
Sbjct: 211 EAVSFLHANNIVHRDLKPENILLDDNM-QIRLSDFGFSCHLEPGEKLRELCGTPGYLAPE 269
Query: 290 LLVDLQD-----YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCN 344
           +L    D     Y   +D+W+ G +   ++    PF++      Q++ +     +I+   
Sbjct: 270 ILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWH----RRQILMLR----MIMEGQ 321
Query: 345 SRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF 395
            + S   W      D++   S    D + +LL+ D + RLTA +A+ HP+F
Sbjct: 322 YQFSSPEW------DDR---SSTVKDLISRLLQVDPEARLTAEQALQHPFF 363

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 63/301 (20%), Positives = 129/301 (42%), Gaps = 38/301 (12%)
Query: 115 ESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNE----RCXXXXXXXXXXXXXXXXX 170
           E+L  Q    + Y +V  +G+G + EV +  +  T +    +                  
Sbjct: 12  ENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILRE 71
Query: 171 XXLQNLCGGPNVVKLLDIVRDQHS-------KTPSLIFEYVNSTDFKVLYPTLTDYDIRY 223
             L      PN++KL +I+ D  S        T   +F+ +      +     +++D   
Sbjct: 72  VELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEI------IKRKRFSEHDAAR 125
Query: 224 YIYELLKALDYCHSQGIMHRDVKPHNVMIDHELR--KLRLIDWGLAEFYHPGKEYNVRVA 281
            I ++   + Y H   I+HRD+KP N++++ + +   +++ID+GL+  +    +   R+ 
Sbjct: 126 IIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIG 185
Query: 282 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLII 341
           + Y+  PE+L     YD   D+WS G +   ++    P FYG + +D L ++        
Sbjct: 186 TAYYIAPEVLRGT--YDEKCDVWSAGVILY-ILLSGTPPFYGKNEYDILKRVE------- 235
Query: 342 WCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAA 401
               +++        +      +S +A D + K+L +    R+TA + + HP+  +  + 
Sbjct: 236 --TGKYA-------FDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSSE 286
Query: 402 E 402
           E
Sbjct: 287 E 287

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 57/188 (30%), Positives = 93/188 (49%), Gaps = 21/188 (11%)
Query: 216 LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGL-AEFYHPGK 274
           L +  I      +L+AL Y H+QG++HRD+K  ++++  + R ++L D+G  A+      
Sbjct: 138 LNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGR-VKLSDFGFCAQISKDVP 196
Query: 275 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA 334
           +    V + Y+  PE+ +    Y   +D+WSLG M   M+  + P+F   D+  Q +K  
Sbjct: 197 KRKXLVGTPYWMAPEV-ISRSLYATEVDIWSLGIMVIEMVDGEPPYF--SDSPVQAMKRL 253
Query: 335 KDCCLIIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPY 394
           +D              P  K     N H VSP   DFL+++L  D Q+R TA+E + HP+
Sbjct: 254 RD-------------SPPPKL---KNSHKVSPVLRDFLERMLVRDPQERATAQELLDHPF 297
Query: 395 FAQVRAAE 402
             Q    E
Sbjct: 298 LLQTGLPE 305

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 99/203 (48%), Gaps = 25/203 (12%)
Query: 199 LIFEYVNS---TDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE 255
           ++ E++     TD  V +  + +  I      +L+AL   H+QG++HRD+K  ++++ H+
Sbjct: 225 VVMEFLEGGALTDI-VTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHD 283
Query: 256 LRKLRLIDWGL-AEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMI 314
            R ++L D+G  A+           V + Y+  PEL+  L  Y   +D+WSLG M   M+
Sbjct: 284 GR-VKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRL-PYGPEVDIWSLGIMVIEMV 341
Query: 315 FRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDK 374
             + P+F  ++   + +K+ +D              P  K     N H VSP    FLD+
Sbjct: 342 DGEPPYF--NEPPLKAMKMIRDNL-----------PPRLK-----NLHKVSPSLKGFLDR 383
Query: 375 LLRYDHQDRLTAREAMAHPYFAQ 397
           LL  D   R TA E + HP+ A+
Sbjct: 384 LLVRDPAQRATAAELLKHPFLAK 406

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 63/263 (23%), Positives = 120/263 (45%), Gaps = 46/263 (17%)
Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY-----------PTLTDYDIRYYIYEL 228
           PNV+ L  +      +   L+F+Y     + ++              L    ++  +Y++
Sbjct: 78  PNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQI 137
Query: 229 LKALDYCHSQGIMHRDVKPHNVMI---DHELRKLRLIDWGLAEFYH----PGKEYNVRVA 281
           L  + Y H+  ++HRD+KP N+++     E  ++++ D G A  ++    P  + +  V 
Sbjct: 138 LDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV 197
Query: 282 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF------------YGHDNHDQ 329
           + +++ PELL+  + Y  ++D+W++GC+FA ++   EP F            Y HD  D+
Sbjct: 198 TFWYRAPELLLGARHYTKAIDIWAIGCIFAELL-TSEPIFHCRQEDIKTSNPYHHDQLDR 256
Query: 330 LVKIAKDCCLIIWCNSR----HS-------RKPWS--KFINADNQHLVSPEAIDF--LDK 374
           +  +        W + +    HS       R  ++    I    +H V P++  F  L K
Sbjct: 257 IFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQK 316
Query: 375 LLRYDHQDRLTAREAMAHPYFAQ 397
           LL  D   R+T+ +AM  PYF +
Sbjct: 317 LLTMDPIKRITSEQAMQDPYFLE 339

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 56/188 (29%), Positives = 93/188 (49%), Gaps = 21/188 (11%)
Query: 211 VLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGL-AEF 269
           V +  + +  I      +L+AL   H+QG++HRD+K  ++++ H+ R ++L D+G  A+ 
Sbjct: 119 VTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGR-VKLSDFGFCAQV 177
Query: 270 YHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQ 329
                     V + Y+  PEL+  L  Y   +D+WSLG M   M+  + P+F  ++   +
Sbjct: 178 SKEVPRRKXLVGTPYWMAPELISRL-PYGPEVDIWSLGIMVIEMVDGEPPYF--NEPPLK 234
Query: 330 LVKIAKDCCLIIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREA 389
            +K+ +D           +  P  K     N H VSP    FLD+LL  D   R TA E 
Sbjct: 235 AMKMIRD-----------NLPPRLK-----NLHKVSPSLKGFLDRLLVRDPAQRATAAEL 278
Query: 390 MAHPYFAQ 397
           + HP+ A+
Sbjct: 279 LKHPFLAK 286

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 100/209 (47%), Gaps = 25/209 (11%)
Query: 199 LIFEYVNS---TDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE 255
           ++ E++     TD  V +  + +  I      +L+AL   H+QG++HRD+K  ++++ H+
Sbjct: 148 VVMEFLEGGALTDI-VTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHD 206
Query: 256 LRKLRLIDWGL-AEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMI 314
            R ++L D+G  A+           V + Y+  PEL+  L  Y   +D+WSLG M   M+
Sbjct: 207 GR-VKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRL-PYGPEVDIWSLGIMVIEMV 264
Query: 315 FRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDK 374
             + P+F  ++   + +K+ +D              P  K     N H VSP    FLD+
Sbjct: 265 DGEPPYF--NEPPLKAMKMIRDNL-----------PPRLK-----NLHKVSPSLKGFLDR 306
Query: 375 LLRYDHQDRLTAREAMAHPYFAQVRAAES 403
           LL  D   R TA E + HP+ A+     S
Sbjct: 307 LLVRDPAQRATAAELLKHPFLAKAGPPAS 335

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 62/296 (20%), Positives = 127/296 (42%), Gaps = 38/296 (12%)
Query: 115 ESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNE----RCXXXXXXXXXXXXXXXXX 170
           E+L  Q    + Y +V  +G+G + EV +  +  T +    +                  
Sbjct: 12  ENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILRE 71
Query: 171 XXLQNLCGGPNVVKLLDIVRDQHS-------KTPSLIFEYVNSTDFKVLYPTLTDYDIRY 223
             L      PN++KL +I+ D  S        T   +F+ +      +     +++D   
Sbjct: 72  VELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEI------IKRKRFSEHDAAR 125
Query: 224 YIYELLKALDYCHSQGIMHRDVKPHNVMIDHELR--KLRLIDWGLAEFYHPGKEYNVRVA 281
            I ++   + Y H   I+HRD+KP N++++ + +   +++ID+GL+  +    +   R+ 
Sbjct: 126 IIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIG 185
Query: 282 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLII 341
           + Y+  PE+L     YD   D+WS G +   ++    P FYG + +D L ++        
Sbjct: 186 TAYYIAPEVLRGT--YDEKCDVWSAGVILY-ILLSGTPPFYGKNEYDILKRVE------- 235
Query: 342 WCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQ 397
               +++        +      +S +A D + K+L +    R+TA + + HP+  +
Sbjct: 236 --TGKYA-------FDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQK 282

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 56/188 (29%), Positives = 93/188 (49%), Gaps = 21/188 (11%)
Query: 211 VLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGL-AEF 269
           V +  + +  I      +L+AL   H+QG++HRD+K  ++++ H+ R ++L D+G  A+ 
Sbjct: 117 VTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGR-VKLSDFGFCAQV 175
Query: 270 YHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQ 329
                     V + Y+  PEL+  L  Y   +D+WSLG M   M+  + P+F  ++   +
Sbjct: 176 SKEVPRRKXLVGTPYWMAPELISRL-PYGPEVDIWSLGIMVIEMVDGEPPYF--NEPPLK 232
Query: 330 LVKIAKDCCLIIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREA 389
            +K+ +D           +  P  K     N H VSP    FLD+LL  D   R TA E 
Sbjct: 233 AMKMIRD-----------NLPPRLK-----NLHKVSPSLKGFLDRLLVRDPAQRATAAEL 276
Query: 390 MAHPYFAQ 397
           + HP+ A+
Sbjct: 277 LKHPFLAK 284

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 56/188 (29%), Positives = 93/188 (49%), Gaps = 21/188 (11%)
Query: 211 VLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGL-AEF 269
           V +  + +  I      +L+AL   H+QG++HRD+K  ++++ H+ R ++L D+G  A+ 
Sbjct: 108 VTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGR-VKLSDFGFCAQV 166
Query: 270 YHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQ 329
                     V + Y+  PEL+  L  Y   +D+WSLG M   M+  + P+F  ++   +
Sbjct: 167 SKEVPRRKXLVGTPYWMAPELISRL-PYGPEVDIWSLGIMVIEMVDGEPPYF--NEPPLK 223
Query: 330 LVKIAKDCCLIIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREA 389
            +K+ +D           +  P  K     N H VSP    FLD+LL  D   R TA E 
Sbjct: 224 AMKMIRD-----------NLPPRLK-----NLHKVSPSLKGFLDRLLVRDPAQRATAAEL 267
Query: 390 MAHPYFAQ 397
           + HP+ A+
Sbjct: 268 LKHPFLAK 275

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 56/188 (29%), Positives = 93/188 (49%), Gaps = 21/188 (11%)
Query: 211 VLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGL-AEF 269
           V +  + +  I      +L+AL   H+QG++HRD+K  ++++ H+ R ++L D+G  A+ 
Sbjct: 112 VTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGR-VKLSDFGFCAQV 170
Query: 270 YHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQ 329
                     V + Y+  PEL+  L  Y   +D+WSLG M   M+  + P+F  ++   +
Sbjct: 171 SKEVPRRKXLVGTPYWMAPELISRL-PYGPEVDIWSLGIMVIEMVDGEPPYF--NEPPLK 227
Query: 330 LVKIAKDCCLIIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREA 389
            +K+ +D           +  P  K     N H VSP    FLD+LL  D   R TA E 
Sbjct: 228 AMKMIRD-----------NLPPRLK-----NLHKVSPSLKGFLDRLLVRDPAQRATAAEL 271
Query: 390 MAHPYFAQ 397
           + HP+ A+
Sbjct: 272 LKHPFLAK 279

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 67/284 (23%), Positives = 120/284 (42%), Gaps = 39/284 (13%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXXXXXXXXXXXXXXXLQNL-----CGG 179
           D Y+  R +G+G + EV    +  T + C                   L+ +        
Sbjct: 32  DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDH 91
Query: 180 PNVVKLLDIVRDQ-------HSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKAL 232
           PN++KL +   D+          T   +F+ + S          ++ D    I ++L  +
Sbjct: 92  PNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISR------KRFSEVDAARIIRQVLSGI 145
Query: 233 DYCHSQGIMHRDVKPHNVMIDHELR--KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPEL 290
            Y H   I+HRD+KP N++++ + +   +R+ID+GL+  +   K+   ++ + Y+  PE+
Sbjct: 146 TYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEV 205
Query: 291 LVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRK 350
           L     YD   D+WS G +   ++    P F G + +D L K+ K               
Sbjct: 206 LHGT--YDEKCDVWSTGVILY-ILLSGCPPFNGANEYDILKKVEKG-------KYTFELP 255
Query: 351 PWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPY 394
            W K         VS  A D + K+L Y    R++AR+A+ H +
Sbjct: 256 QWKK---------VSESAKDLIRKMLTYVPSMRISARDALDHEW 290

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 67/293 (22%), Positives = 129/293 (44%), Gaps = 30/293 (10%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNE----RCXXXXXXXXXXXXXXXXXXXLQNLCGGP 180
           D+Y++  ++G+G +S V   + + T +    +                    +  L   P
Sbjct: 4   DEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKHP 63
Query: 181 NVVKLLDIVRDQHSKTPSLIFEYVNSTDF---KVLYPTLTDYDIRYYIYELLKALDYCHS 237
           N+V+L D + ++      L+F+ V   +     V     ++ D  + I ++L+++++CH 
Sbjct: 64  NIVRLHDSISEEGFHY--LVFDLVTGGELFEDIVAREYYSEADASHCIQQILESVNHCHL 121
Query: 238 QGIMHRDVKPHNVMIDHELR--KLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDL 294
            GI+HRD+KP N+++  + +   ++L D+GLA E     + +     +  +  PE+L   
Sbjct: 122 NGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVLRK- 180
Query: 295 QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSK 354
             Y   +DMW+ G +   ++    P F+  D H    +I                K  + 
Sbjct: 181 DPYGKPVDMWACGVILY-ILLVGYPPFWDEDQHRLYQQI----------------KAGAY 223
Query: 355 FINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAESSRTR 407
              +     V+PEA D ++K+L  +   R+TA EA+ HP+  Q     S   R
Sbjct: 224 DFPSPEWDTVTPEAKDLINKMLTINPAKRITASEALKHPWICQRSTVASMMHR 276

>pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 67/256 (26%), Positives = 103/256 (40%), Gaps = 63/256 (24%)
Query: 203 YVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLI 262
           Y+    F  +  +L+  ++R Y+  L KAL   H  GI+HRDVKP N + +  L+K  L+
Sbjct: 101 YLEHESFLDILNSLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALV 160
Query: 263 DWGLAEFYHPGK-----------------------------EYNVRVASRYFKGPELLVD 293
           D+GLA+  H  K                             +   R  +  F+ PE+L  
Sbjct: 161 DFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTK 220
Query: 294 LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI------------AKDCCLII 341
             +   ++DMWS G +F  ++  + PF+   D+   L +I            AK     I
Sbjct: 221 CPNQTTAIDMWSAGVIFLSLLSGRYPFYKASDDLTALAQIMTIRGSRETIQAAKTFGKSI 280
Query: 342 WCNSRHSRKPWSKF----------------------INADNQHLVSPEAIDFLDKLLRYD 379
            C+     +   K                        N +  + V  EA D LDKLL  +
Sbjct: 281 LCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEAYDLLDKLLDLN 340
Query: 380 HQDRLTAREAMAHPYF 395
              R+TA EA+ HP+F
Sbjct: 341 PASRITAEEALLHPFF 356

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 65/283 (22%), Positives = 127/283 (44%), Gaps = 30/283 (10%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNE----RCXXXXXXXXXXXXXXXXXXXLQNLCGGP 180
           D+Y++  ++G+G +S V   + + T +    +                    +  L   P
Sbjct: 4   DEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKHP 63
Query: 181 NVVKLLDIVRDQHSKTPSLIFEYVNSTDF---KVLYPTLTDYDIRYYIYELLKALDYCHS 237
           N+V+L D + ++      L+F+ V   +     V     ++ D  + I ++L+++++CH 
Sbjct: 64  NIVRLHDSISEEGFHY--LVFDLVTGGELFEDIVAREYYSEADASHCIQQILESVNHCHL 121
Query: 238 QGIMHRDVKPHNVMIDHELR--KLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDL 294
            GI+HRD+KP N+++  + +   ++L D+GLA E     + +     +  +  PE+L   
Sbjct: 122 NGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVLRK- 180
Query: 295 QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSK 354
             Y   +DMW+ G +   ++    P F+  D H    +I                K  + 
Sbjct: 181 DPYGKPVDMWACGVILY-ILLVGYPPFWDEDQHRLYQQI----------------KAGAY 223
Query: 355 FINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQ 397
              +     V+PEA D ++K+L  +   R+TA EA+ HP+  Q
Sbjct: 224 DFPSPEWDTVTPEAKDLINKMLTINPAKRITASEALKHPWICQ 266

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 67/285 (23%), Positives = 120/285 (42%), Gaps = 39/285 (13%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXXXXXXXXXXXXXXXLQNL-----CGG 179
           D Y+  R +G+G + EV    +  T + C                   L+ +        
Sbjct: 26  DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDH 85
Query: 180 PNVVKLLDIVRDQ-------HSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKAL 232
           PN++KL +   D+          T   +F+ + S          ++ D    I ++L  +
Sbjct: 86  PNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISR------KRFSEVDAARIIRQVLSGI 139
Query: 233 DYCHSQGIMHRDVKPHNVMIDHELR--KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPEL 290
            Y H   I+HRD+KP N++++ + +   +R+ID+GL+  +   K+   ++ + Y+  PE+
Sbjct: 140 TYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEV 199
Query: 291 LVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRK 350
           L     YD   D+WS G +   ++    P F G + +D L K+ K               
Sbjct: 200 LHGT--YDEKCDVWSTGVILY-ILLSGCPPFNGANEYDILKKVEK-------GKYTFELP 249
Query: 351 PWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF 395
            W K         VS  A D + K+L Y    R++AR+A+ H + 
Sbjct: 250 QWKK---------VSESAKDLIRKMLTYVPSMRISARDALDHEWI 285

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 53/188 (28%), Positives = 91/188 (48%), Gaps = 36/188 (19%)
Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY---NV 278
           R+Y  E++ AL+Y H +GI+HRD+KP N++++ ++  +++ D+G A+   P  +    N 
Sbjct: 135 RFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANX 193
Query: 279 RVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDN--HDQLVKIAKD 336
            V +  +  PELL + +    S D+W+LGC+   ++    PF  G++     +++K+  D
Sbjct: 194 FVGTAQYVSPELLTE-KSAXKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYD 252
Query: 337 CCLIIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREA------M 390
                            KF          P+A D ++KLL  D   RL   E        
Sbjct: 253 FP--------------EKFF---------PKARDLVEKLLVLDATKRLGCEEMEGYGPLK 289
Query: 391 AHPYFAQV 398
           AHP+F  V
Sbjct: 290 AHPFFESV 297

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 67/285 (23%), Positives = 120/285 (42%), Gaps = 39/285 (13%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXXXXXXXXXXXXXXXLQNL-----CGG 179
           D Y+  R +G+G + EV    +  T + C                   L+ +        
Sbjct: 49  DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDH 108
Query: 180 PNVVKLLDIVRDQ-------HSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKAL 232
           PN++KL +   D+          T   +F+ + S          ++ D    I ++L  +
Sbjct: 109 PNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISR------KRFSEVDAARIIRQVLSGI 162
Query: 233 DYCHSQGIMHRDVKPHNVMIDHELR--KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPEL 290
            Y H   I+HRD+KP N++++ + +   +R+ID+GL+  +   K+   ++ + Y+  PE+
Sbjct: 163 TYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEV 222
Query: 291 LVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRK 350
           L     YD   D+WS G +   ++    P F G + +D L K+ K               
Sbjct: 223 LHGT--YDEKCDVWSTGVILY-ILLSGCPPFNGANEYDILKKVEK-------GKYTFELP 272
Query: 351 PWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF 395
            W K         VS  A D + K+L Y    R++AR+A+ H + 
Sbjct: 273 QWKK---------VSESAKDLIRKMLTYVPSMRISARDALDHEWI 308

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 67/285 (23%), Positives = 120/285 (42%), Gaps = 39/285 (13%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXXXXXXXXXXXXXXXLQNL-----CGG 179
           D Y+  R +G+G + EV    +  T + C                   L+ +        
Sbjct: 50  DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDH 109
Query: 180 PNVVKLLDIVRDQ-------HSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKAL 232
           PN++KL +   D+          T   +F+ + S          ++ D    I ++L  +
Sbjct: 110 PNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISR------KRFSEVDAARIIRQVLSGI 163
Query: 233 DYCHSQGIMHRDVKPHNVMIDHELR--KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPEL 290
            Y H   I+HRD+KP N++++ + +   +R+ID+GL+  +   K+   ++ + Y+  PE+
Sbjct: 164 TYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEV 223
Query: 291 LVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRK 350
           L     YD   D+WS G +   ++    P F G + +D L K+ K               
Sbjct: 224 LHGT--YDEKCDVWSTGVILY-ILLSGCPPFNGANEYDILKKVEK-------GKYTFELP 273
Query: 351 PWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF 395
            W K         VS  A D + K+L Y    R++AR+A+ H + 
Sbjct: 274 QWKK---------VSESAKDLIRKMLTYVPSMRISARDALDHEWI 309

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 69/292 (23%), Positives = 126/292 (43%), Gaps = 40/292 (13%)
Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTNER-------CXXXXXXXXXXXXXXXXXXXLQNL 176
           +D YE+   +G+G +S V   IN  T ++                           + ++
Sbjct: 23  EDVYELCEVIGKGAFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHM 82
Query: 177 CGGPNVVKLLDIVRD--------QHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYEL 228
              P++V+LL+            +      L FE V   D   +Y   ++    +Y+ ++
Sbjct: 83  LKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVY---SEAVASHYMRQI 139
Query: 229 LKALDYCHSQGIMHRDVKPHNVMIDHELRK--LRLIDWGLA-EFYHPGKEYNVRVASRYF 285
           L+AL YCH   I+HRDVKP NV++  +     ++L D+G+A +    G     RV + +F
Sbjct: 140 LEALRYCHDNNIIHRDVKPENVLLASKENSAPVKLGDFGVAIQLGESGLVAGGRVGTPHF 199
Query: 286 KGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNS 345
             PE +V  + Y   +D+W  G +   ++    PF+      ++L +       II    
Sbjct: 200 MAPE-VVKREPYGKPVDVWGCGVILFILLSGCLPFY---GTKERLFE------GIIKGKY 249
Query: 346 RHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQ 397
           + + + WS          +S  A D + ++L  D  +R+T  EA+ HP+  +
Sbjct: 250 KMNPRQWSH---------ISESAKDLVRRMLMLDPAERITVYEALNHPWLKE 292

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 104/202 (51%), Gaps = 30/202 (14%)
Query: 200 IFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRK- 258
           IFE +N++ F+     L + +I  Y++++ +AL + HS  I H D++P N++  ++ R+ 
Sbjct: 88  IFERINTSAFE-----LNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENII--YQTRRS 140
Query: 259 --LRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD-YDYSLDMWSLGCMFAGMIF 315
             +++I++G A    PG  + +   +  +  PE  V   D    + DMWSLG +   ++ 
Sbjct: 141 STIKIIEFGQARQLKPGDNFRLLFTAPEYYAPE--VHQHDVVSTATDMWSLGTLVYVLLS 198
Query: 316 RKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKL 375
              PF    + + Q+++           N+ ++        + +    +S EA+DF+D+L
Sbjct: 199 GINPFLA--ETNQQIIENI--------MNAEYT-------FDEEAFKEISIEAMDFVDRL 241
Query: 376 LRYDHQDRLTAREAMAHPYFAQ 397
           L  + + R+TA EA+ HP+  Q
Sbjct: 242 LVKERKSRMTASEALQHPWLKQ 263

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 53/188 (28%), Positives = 91/188 (48%), Gaps = 36/188 (19%)
Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY---NV 278
           R+Y  E++ AL+Y H +GI+HRD+KP N++++ ++  +++ D+G A+   P  +    N 
Sbjct: 135 RFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANS 193
Query: 279 RVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDN--HDQLVKIAKD 336
            V +  +  PELL + +    S D+W+LGC+   ++    PF  G++     +++K+  D
Sbjct: 194 FVGTAQYVSPELLTE-KSASKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYD 252
Query: 337 CCLIIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREA------M 390
                            KF          P+A D ++KLL  D   RL   E        
Sbjct: 253 FP--------------EKFF---------PKARDLVEKLLVLDATKRLGCEEMEGYGPLK 289
Query: 391 AHPYFAQV 398
           AHP+F  V
Sbjct: 290 AHPFFESV 297

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 62/296 (20%), Positives = 125/296 (42%), Gaps = 38/296 (12%)
Query: 115 ESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNE----RCXXXXXXXXXXXXXXXXX 170
           E+L  Q    + Y +V  +G+G + EV +  +  T +    +                  
Sbjct: 12  ENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILRE 71
Query: 171 XXLQNLCGGPNVVKLLDIVRDQHS-------KTPSLIFEYVNSTDFKVLYPTLTDYDIRY 223
             L      PN++KL +I+ D  S        T   +F+ +      +     +++D   
Sbjct: 72  VELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEI------IKRKRFSEHDAAR 125
Query: 224 YIYELLKALDYCHSQGIMHRDVKPHNVMIDHELR--KLRLIDWGLAEFYHPGKEYNVRVA 281
            I ++   + Y H   I+HRD+KP N++++ + +   +++ID+GL+  +    +   R+ 
Sbjct: 126 IIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIG 185
Query: 282 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLII 341
           + Y+  PE+L     YD   D+WS G +   ++    P FYG + +D L ++        
Sbjct: 186 TAYYIAPEVLRGT--YDEKCDVWSAGVILY-ILLSGTPPFYGKNEYDILKRV-------- 234
Query: 342 WCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQ 397
                   +      +      +S +A D + K+L +    R+TA + + HP+  +
Sbjct: 235 --------ETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQK 282

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 103/225 (45%), Gaps = 26/225 (11%)
Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNST---DFKVLYPTLTDYDIRYYIYELLKALDYCH 236
           PN++ L D+  ++      LI E V+     DF     +L++ +   +I ++L  ++Y H
Sbjct: 75  PNIITLHDVYENRTDVV--LILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLH 132
Query: 237 SQGIMHRDVKPHNVMI---DHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD 293
           ++ I H D+KP N+M+   +  +  ++LID+GLA     G E+     +  F  PE +V+
Sbjct: 133 TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPE-IVN 191
Query: 294 LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWS 353
            +      DMWS+G +   ++    PF  G    + L  I                   S
Sbjct: 192 YEPLGLEADMWSIGVITYILLSGASPFL-GDTKQETLANIT----------------AVS 234
Query: 354 KFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQV 398
              + +     S  A DF+ KLL  + + RLT +EA+ HP+   V
Sbjct: 235 YDFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPV 279

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 53/188 (28%), Positives = 91/188 (48%), Gaps = 36/188 (19%)
Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY---NV 278
           R+Y  E++ AL+Y H +GI+HRD+KP N++++ ++  +++ D+G A+   P  +    N 
Sbjct: 135 RFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANX 193
Query: 279 RVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDN--HDQLVKIAKD 336
            V +  +  PELL + +    S D+W+LGC+   ++    PF  G++     +++K+  D
Sbjct: 194 FVGTAQYVSPELLTE-KSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYD 252
Query: 337 CCLIIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREA------M 390
                            KF          P+A D ++KLL  D   RL   E        
Sbjct: 253 FP--------------EKFF---------PKARDLVEKLLVLDATKRLGCEEMEGYGPLK 289
Query: 391 AHPYFAQV 398
           AHP+F  V
Sbjct: 290 AHPFFESV 297

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 58/238 (24%), Positives = 110/238 (46%), Gaps = 28/238 (11%)
Query: 173 LQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNST---DFKVLYPTLTDYDIRYYIYELL 229
           L+ + G PN+++L D    + +    L+F+ +      D+     TL++ + R  +  LL
Sbjct: 77  LRKVSGHPNIIQLKDTY--ETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALL 134
Query: 230 KALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 289
           + +   H   I+HRD+KP N+++D ++  ++L D+G +    PG++      +  +  PE
Sbjct: 135 EVICALHKLNIVHRDLKPENILLDDDM-NIKLTDFGFSCQLDPGEKLRSVCGTPSYLAPE 193
Query: 290 LL-VDLQD----YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCN 344
           ++   + D    Y   +DMWS G +   ++    PF++      Q++ +     +I+  N
Sbjct: 194 IIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWH----RKQMLMLR----MIMSGN 245
Query: 345 SRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAE 402
            +     W  +         S    D + + L    Q R TA EA+AHP+F Q    E
Sbjct: 246 YQFGSPEWDDY---------SDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYVVEE 294

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 59/223 (26%), Positives = 102/223 (45%), Gaps = 26/223 (11%)
Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNSTDF--KVLYP-TLTDYDIRYYIYELLKALDYCH 236
           PN+++L +   D       L+ E     +   +V++     + D    + ++L A+ YCH
Sbjct: 66  PNIIRLYETFEDNTDIY--LVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCH 123
Query: 237 SQGIMHRDVKPHNVMI--DHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDL 294
              + HRD+KP N +   D     L+LID+GLA  + PGK    +V + Y+  P++L  L
Sbjct: 124 KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVLEGL 183
Query: 295 QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSK 354
             Y    D WS G M   ++    PF    D  + ++KI +               P   
Sbjct: 184 --YGPECDEWSAGVMMYVLLCGYPPFSAPTD-XEVMLKIREGTFTF----------PEKD 230
Query: 355 FINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQ 397
           ++N      VSP+A   + +LL    + R+T+ +A+ H +F +
Sbjct: 231 WLN------VSPQAESLIRRLLTKSPKQRITSLQALEHEWFEK 267

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 58/224 (25%), Positives = 111/224 (49%), Gaps = 27/224 (12%)
Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNS---TDFKVLYPTLTDYDIRYYIYELLKALDYCH 236
           PNVVKL++++ D +     ++FE VN     +   L P L++   R+Y  +L+K ++Y H
Sbjct: 96  PNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKP-LSEDQARFYFQDLIKGIEYLH 154
Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDLQ 295
            Q I+HRD+KP N+++  +   +++ D+G++ EF       +  V +  F  PE L + +
Sbjct: 155 YQKIIHRDIKPSNLLVGED-GHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETR 213
Query: 296 DY--DYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWS 353
                 +LD+W++G      +F + PF       D+ +      CL       HS K  S
Sbjct: 214 KIFSGKALDVWAMGVTLYCFVFGQCPFM------DERI-----MCL-------HS-KIKS 254
Query: 354 KFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQ 397
           + +   +Q  ++ +  D + ++L  + + R+   E   HP+  +
Sbjct: 255 QALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVTR 298

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 53/188 (28%), Positives = 92/188 (48%), Gaps = 36/188 (19%)
Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY---NV 278
           R+Y  E++ AL+Y H +GI+HRD+KP N++++ ++  +++ D+G A+   P  +    N 
Sbjct: 138 RFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANX 196
Query: 279 RVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDN--HDQLVKIAKD 336
            V +  +  PELL + +    S D+W+LGC+   ++    PF  G++     +++K+  D
Sbjct: 197 FVGTAQYVSPELLTE-KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYD 255
Query: 337 CCLIIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREA------M 390
                         P + F          P+A D ++KLL  D   RL   E        
Sbjct: 256 F-------------PAAFF----------PKARDLVEKLLVLDATKRLGCEEMEGYGPLK 292
Query: 391 AHPYFAQV 398
           AHP+F  V
Sbjct: 293 AHPFFESV 300

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 58/238 (24%), Positives = 110/238 (46%), Gaps = 28/238 (11%)
Query: 173 LQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNST---DFKVLYPTLTDYDIRYYIYELL 229
           L+ + G PN+++L D    + +    L+F+ +      D+     TL++ + R  +  LL
Sbjct: 77  LRKVSGHPNIIQLKDTY--ETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALL 134
Query: 230 KALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 289
           + +   H   I+HRD+KP N+++D ++  ++L D+G +    PG++      +  +  PE
Sbjct: 135 EVICALHKLNIVHRDLKPENILLDDDM-NIKLTDFGFSCQLDPGEKLREVCGTPSYLAPE 193
Query: 290 LL-VDLQD----YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCN 344
           ++   + D    Y   +DMWS G +   ++    PF++      Q++ +     +I+  N
Sbjct: 194 IIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWH----RKQMLMLR----MIMSGN 245
Query: 345 SRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAE 402
            +     W  +         S    D + + L    Q R TA EA+AHP+F Q    E
Sbjct: 246 YQFGSPEWDDY---------SDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYVVEE 294

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 71/294 (24%), Positives = 123/294 (41%), Gaps = 32/294 (10%)
Query: 115 ESLTVQWGDQDD----YEVVRKVGRGKYSEVFEGINVNTNERCXXXXXXXXXXXXXXXXX 170
           E+L  Q   + D    Y +   +GRG + EV   +   T  R                  
Sbjct: 12  ENLYFQGSTKGDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFK 71
Query: 171 XXLQNL--CGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDF--KVLYP-TLTDYDIRYYI 225
             ++ +     PN+++L +   D       L+ E     +   +V++     + D    +
Sbjct: 72  QEIEIMKSLDHPNIIRLYETFEDNTDIY--LVMELCTGGELFERVVHKRVFRESDAARIM 129
Query: 226 YELLKALDYCHSQGIMHRDVKPHNVMI--DHELRKLRLIDWGLAEFYHPGKEYNVRVASR 283
            ++L A+ YCH   + HRD+KP N +   D     L+LID+GLA  + PGK    +V + 
Sbjct: 130 KDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTP 189
Query: 284 YFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWC 343
           Y+  P++L  L  Y    D WS G M   ++    PF    D  + ++KI +        
Sbjct: 190 YYVSPQVLEGL--YGPECDEWSAGVMMYVLLCGYPPFSAPTD-XEVMLKIREGTFTF--- 243
Query: 344 NSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQ 397
                  P   ++N      VSP+A   + +LL    + R+T+ +A+ H +F +
Sbjct: 244 -------PEKDWLN------VSPQAESLIRRLLTKSPKQRITSLQALEHEWFEK 284

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 57/233 (24%), Positives = 109/233 (46%), Gaps = 28/233 (12%)
Query: 173 LQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNST---DFKVLYPTLTDYDIRYYIYELL 229
           L+ + G PN+++L D    + +    L+F+ +      D+     TL++ + R  +  LL
Sbjct: 64  LRKVSGHPNIIQLKDTY--ETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALL 121
Query: 230 KALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 289
           + +   H   I+HRD+KP N+++D ++  ++L D+G +    PG++      +  +  PE
Sbjct: 122 EVICALHKLNIVHRDLKPENILLDDDM-NIKLTDFGFSCQLDPGEKLREVCGTPSYLAPE 180
Query: 290 LL-VDLQD----YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCN 344
           ++   + D    Y   +DMWS G +   ++    PF++      Q++ +     +I+  N
Sbjct: 181 IIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWH----RKQMLMLR----MIMSGN 232
Query: 345 SRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQ 397
            +     W  +         S    D + + L    Q R TA EA+AHP+F Q
Sbjct: 233 YQFGSPEWDDY---------SDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ 276

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 55/277 (19%), Positives = 119/277 (42%), Gaps = 31/277 (11%)
Query: 126 DYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXXXXXXXXXXXXXXXLQN-----LCGGP 180
           +Y++V+ +G G + +V    +  T ++                     +      L   P
Sbjct: 9   NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHP 68
Query: 181 NVVKLLDIVRDQHSKTPSLIFEYVNST--DFKVLYPTLTDYDIRYYIYELLKALDYCHSQ 238
           +++KL D+++ +      ++ EY  +   D+ V    +++ + R +  +++ A++YCH  
Sbjct: 69  HIIKLYDVIKSKDEII--MVIEYAGNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRH 126
Query: 239 GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYD 298
            I+HRD+KP N+++D  L  +++ D+GL+     G        S  +  PE++       
Sbjct: 127 KIVHRDLKPENLLLDEHL-NVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAG 185
Query: 299 YSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSKFINA 358
             +D+WS G +   M+ R+ PF               +   +++ N  +      KF+  
Sbjct: 186 PEVDVWSCGVILYVMLCRRLPF-------------DDESIPVLFKNISNGVYTLPKFL-- 230
Query: 359 DNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF 395
                 SP A   + ++L  +  +R++  E M   +F
Sbjct: 231 ------SPGAAGLIKRMLIVNPLNRISIHEIMQDDWF 261

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 108/216 (50%), Gaps = 26/216 (12%)
Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNSTD-FKVLYP--TLTDYDIRYYIYELLKALDYCH 236
           PN++KL D+  D+  K   L+ E+    + F+ +       + D    + ++L  + Y H
Sbjct: 106 PNIIKLFDVFEDK--KYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLH 163
Query: 237 SQGIMHRDVKPHNVMIDHE--LRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDL 294
              I+HRD+KP N++++++  L  ++++D+GL+ F+    +   R+ + Y+  PE+L   
Sbjct: 164 KHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVLK-- 221
Query: 295 QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSK 354
           + Y+   D+WS G +   ++    P F G ++ D + K+ K              K +  
Sbjct: 222 KKYNEKCDVWSCGVIMY-ILLCGYPPFGGQNDQDIIKKVEKG-------------KYYFD 267
Query: 355 FINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAM 390
           F +  N   +S EA + +  +L YD+  R TA EA+
Sbjct: 268 FNDWKN---ISDEAKELIKLMLTYDYNKRCTAEEAL 300

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 55/277 (19%), Positives = 119/277 (42%), Gaps = 31/277 (11%)
Query: 126 DYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXXXXXXXXXXXXXXXLQN-----LCGGP 180
           +Y++V+ +G G + +V    +  T ++                     +      L   P
Sbjct: 15  NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHP 74
Query: 181 NVVKLLDIVRDQHSKTPSLIFEYVNST--DFKVLYPTLTDYDIRYYIYELLKALDYCHSQ 238
           +++KL D+++ +      ++ EY  +   D+ V    +++ + R +  +++ A++YCH  
Sbjct: 75  HIIKLYDVIKSKDEII--MVIEYAGNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRH 132
Query: 239 GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYD 298
            I+HRD+KP N+++D  L  +++ D+GL+     G        S  +  PE++       
Sbjct: 133 KIVHRDLKPENLLLDEHL-NVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAG 191
Query: 299 YSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSKFINA 358
             +D+WS G +   M+ R+ PF               +   +++ N  +      KF+  
Sbjct: 192 PEVDVWSCGVILYVMLCRRLPF-------------DDESIPVLFKNISNGVYTLPKFL-- 236
Query: 359 DNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF 395
                 SP A   + ++L  +  +R++  E M   +F
Sbjct: 237 ------SPGAAGLIKRMLIVNPLNRISIHEIMQDDWF 267

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 67/285 (23%), Positives = 118/285 (41%), Gaps = 39/285 (13%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXXXXXXXXXXXXXXXLQNL-----CGG 179
           D Y+  R +G+G + EV    +  T + C                   L+ +        
Sbjct: 26  DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDH 85
Query: 180 PNVVKLLDIVRDQ-------HSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKAL 232
           PN+ KL +   D+          T   +F+ + S          ++ D    I ++L  +
Sbjct: 86  PNIXKLYEFFEDKGYFYLVGEVYTGGELFDEIISR------KRFSEVDAARIIRQVLSGI 139
Query: 233 DYCHSQGIMHRDVKPHNVMIDHELR--KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPEL 290
            Y H   I+HRD+KP N++++ + +   +R+ID+GL+  +   K+   ++ + Y+  PE+
Sbjct: 140 TYXHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKXKDKIGTAYYIAPEV 199
Query: 291 LVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRK 350
           L     YD   D+WS G +   ++    P F G + +D L K+ K               
Sbjct: 200 LHGT--YDEKCDVWSTGVILY-ILLSGCPPFNGANEYDILKKVEK-------GKYTFELP 249
Query: 351 PWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF 395
            W K         VS  A D + K L Y    R++AR+A+ H + 
Sbjct: 250 QWKK---------VSESAKDLIRKXLTYVPSXRISARDALDHEWI 285

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 53/188 (28%), Positives = 91/188 (48%), Gaps = 36/188 (19%)
Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY---NV 278
           R+Y  E++ AL+Y H +GI+HRD+KP N++++ ++  +++ D+G A+   P  +    N 
Sbjct: 133 RFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANA 191
Query: 279 RVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDN--HDQLVKIAKD 336
            V +  +  PELL + +    S D+W+LGC+   ++    PF  G++     +++K+  D
Sbjct: 192 FVGTAQYVSPELLTE-KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYD 250
Query: 337 CCLIIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREA------M 390
                            KF          P+A D ++KLL  D   RL   E        
Sbjct: 251 FP--------------EKFF---------PKARDLVEKLLVLDATKRLGCEEMEGYGPLK 287
Query: 391 AHPYFAQV 398
           AHP+F  V
Sbjct: 288 AHPFFESV 295

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 55/277 (19%), Positives = 119/277 (42%), Gaps = 31/277 (11%)
Query: 126 DYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXXXXXXXXXXXXXXXLQN-----LCGGP 180
           +Y++V+ +G G + +V    +  T ++                     +      L   P
Sbjct: 5   NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHP 64
Query: 181 NVVKLLDIVRDQHSKTPSLIFEYVNST--DFKVLYPTLTDYDIRYYIYELLKALDYCHSQ 238
           +++KL D+++ +      ++ EY  +   D+ V    +++ + R +  +++ A++YCH  
Sbjct: 65  HIIKLYDVIKSKDEII--MVIEYAGNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRH 122
Query: 239 GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYD 298
            I+HRD+KP N+++D  L  +++ D+GL+     G        S  +  PE++       
Sbjct: 123 KIVHRDLKPENLLLDEHL-NVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAG 181
Query: 299 YSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSKFINA 358
             +D+WS G +   M+ R+ PF               +   +++ N  +      KF+  
Sbjct: 182 PEVDVWSCGVILYVMLCRRLPF-------------DDESIPVLFKNISNGVYTLPKFL-- 226
Query: 359 DNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF 395
                 SP A   + ++L  +  +R++  E M   +F
Sbjct: 227 ------SPGAAGLIKRMLIVNPLNRISIHEIMQDDWF 257

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 55/277 (19%), Positives = 119/277 (42%), Gaps = 31/277 (11%)
Query: 126 DYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXXXXXXXXXXXXXXXLQN-----LCGGP 180
           +Y++V+ +G G + +V    +  T ++                     +      L   P
Sbjct: 14  NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHP 73
Query: 181 NVVKLLDIVRDQHSKTPSLIFEYVNST--DFKVLYPTLTDYDIRYYIYELLKALDYCHSQ 238
           +++KL D+++ +      ++ EY  +   D+ V    +++ + R +  +++ A++YCH  
Sbjct: 74  HIIKLYDVIKSKDEII--MVIEYAGNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRH 131
Query: 239 GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYD 298
            I+HRD+KP N+++D  L  +++ D+GL+     G        S  +  PE++       
Sbjct: 132 KIVHRDLKPENLLLDEHL-NVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAG 190
Query: 299 YSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSKFINA 358
             +D+WS G +   M+ R+ PF               +   +++ N  +      KF+  
Sbjct: 191 PEVDVWSCGVILYVMLCRRLPF-------------DDESIPVLFKNISNGVYTLPKFL-- 235
Query: 359 DNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF 395
                 SP A   + ++L  +  +R++  E M   +F
Sbjct: 236 ------SPGAAGLIKRMLIVNPLNRISIHEIMQDDWF 266

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 53/188 (28%), Positives = 91/188 (48%), Gaps = 36/188 (19%)
Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY---NV 278
           R+Y  E++ AL+Y H +GI+HRD+KP N++++ ++  +++ D+G A+   P  +    N 
Sbjct: 136 RFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANX 194
Query: 279 RVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDN--HDQLVKIAKD 336
            V +  +  PELL + +    S D+W+LGC+   ++    PF  G++     +++K+  D
Sbjct: 195 FVGTAQYVSPELLTE-KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYD 253
Query: 337 CCLIIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREA------M 390
                            KF          P+A D ++KLL  D   RL   E        
Sbjct: 254 FP--------------EKFF---------PKARDLVEKLLVLDATKRLGCEEMEGYGPLK 290
Query: 391 AHPYFAQV 398
           AHP+F  V
Sbjct: 291 AHPFFESV 298

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 53/188 (28%), Positives = 91/188 (48%), Gaps = 36/188 (19%)
Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY---NV 278
           R+Y  E++ AL+Y H +GI+HRD+KP N++++ ++  +++ D+G A+   P  +    N 
Sbjct: 135 RFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANX 193
Query: 279 RVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDN--HDQLVKIAKD 336
            V +  +  PELL + +    S D+W+LGC+   ++    PF  G++     +++K+  D
Sbjct: 194 FVGTAQYVSPELLTE-KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYD 252
Query: 337 CCLIIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREA------M 390
                            KF          P+A D ++KLL  D   RL   E        
Sbjct: 253 FP--------------EKFF---------PKARDLVEKLLVLDATKRLGCEEMEGYGPLK 289
Query: 391 AHPYFAQV 398
           AHP+F  V
Sbjct: 290 AHPFFESV 297

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 53/188 (28%), Positives = 91/188 (48%), Gaps = 36/188 (19%)
Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY---NV 278
           R+Y  E++ AL+Y H +GI+HRD+KP N++++ ++  +++ D+G A+   P  +    N 
Sbjct: 113 RFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANX 171
Query: 279 RVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDN--HDQLVKIAKD 336
            V +  +  PELL + +    S D+W+LGC+   ++    PF  G++     +++K+  D
Sbjct: 172 FVGTAQYVSPELLTE-KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYD 230
Query: 337 CCLIIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREA------M 390
                            KF          P+A D ++KLL  D   RL   E        
Sbjct: 231 FP--------------EKFF---------PKARDLVEKLLVLDATKRLGCEEMEGYGPLK 267
Query: 391 AHPYFAQV 398
           AHP+F  V
Sbjct: 268 AHPFFESV 275

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 53/188 (28%), Positives = 91/188 (48%), Gaps = 36/188 (19%)
Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY---NV 278
           R+Y  E++ AL+Y H +GI+HRD+KP N++++ ++  +++ D+G A+   P  +    N 
Sbjct: 136 RFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANS 194
Query: 279 RVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDN--HDQLVKIAKD 336
            V +  +  PELL + +    S D+W+LGC+   ++    PF  G++     +++K+  D
Sbjct: 195 FVGTAQYVSPELLTE-KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYD 253
Query: 337 CCLIIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREA------M 390
                            KF          P+A D ++KLL  D   RL   E        
Sbjct: 254 FP--------------EKFF---------PKARDLVEKLLVLDATKRLGCEEMEGYGPLK 290
Query: 391 AHPYFAQV 398
           AHP+F  V
Sbjct: 291 AHPFFESV 298

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 53/188 (28%), Positives = 91/188 (48%), Gaps = 36/188 (19%)
Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY---NV 278
           R+Y  E++ AL+Y H +GI+HRD+KP N++++ ++  +++ D+G A+   P  +    N 
Sbjct: 135 RFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANX 193
Query: 279 RVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDN--HDQLVKIAKD 336
            V +  +  PELL + +    S D+W+LGC+   ++    PF  G++     +++K+  D
Sbjct: 194 FVGTAQYVSPELLTE-KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYD 252
Query: 337 CCLIIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREA------M 390
                            KF          P+A D ++KLL  D   RL   E        
Sbjct: 253 FP--------------EKFF---------PKARDLVEKLLVLDATKRLGCEEMEGYGPLK 289
Query: 391 AHPYFAQV 398
           AHP+F  V
Sbjct: 290 AHPFFESV 297

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 53/188 (28%), Positives = 91/188 (48%), Gaps = 36/188 (19%)
Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY---NV 278
           R+Y  E++ AL+Y H +GI+HRD+KP N++++ ++  +++ D+G A+   P  +    N 
Sbjct: 135 RFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANX 193
Query: 279 RVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDN--HDQLVKIAKD 336
            V +  +  PELL + +    S D+W+LGC+   ++    PF  G++     +++K+  D
Sbjct: 194 FVGTAQYVSPELLTE-KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYD 252
Query: 337 CCLIIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREA------M 390
                            KF          P+A D ++KLL  D   RL   E        
Sbjct: 253 FP--------------EKFF---------PKARDLVEKLLVLDATKRLGCEEMEGYGPLK 289
Query: 391 AHPYFAQV 398
           AHP+F  V
Sbjct: 290 AHPFFESV 297

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 53/188 (28%), Positives = 91/188 (48%), Gaps = 36/188 (19%)
Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY---NV 278
           R+Y  E++ AL+Y H +GI+HRD+KP N++++ ++  +++ D+G A+   P  +    N 
Sbjct: 133 RFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANX 191
Query: 279 RVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDN--HDQLVKIAKD 336
            V +  +  PELL + +    S D+W+LGC+   ++    PF  G++     +++K+  D
Sbjct: 192 FVGTAQYVSPELLTE-KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYD 250
Query: 337 CCLIIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREA------M 390
                            KF          P+A D ++KLL  D   RL   E        
Sbjct: 251 FP--------------EKFF---------PKARDLVEKLLVLDATKRLGCEEMEGYGPLK 287
Query: 391 AHPYFAQV 398
           AHP+F  V
Sbjct: 288 AHPFFESV 295

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 53/188 (28%), Positives = 91/188 (48%), Gaps = 36/188 (19%)
Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY---NV 278
           R+Y  E++ AL+Y H +GI+HRD+KP N++++ ++  +++ D+G A+   P  +    N 
Sbjct: 112 RFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANX 170
Query: 279 RVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDN--HDQLVKIAKD 336
            V +  +  PELL + +    S D+W+LGC+   ++    PF  G++     +++K+  D
Sbjct: 171 FVGTAQYVSPELLTE-KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYD 229
Query: 337 CCLIIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREA------M 390
                            KF          P+A D ++KLL  D   RL   E        
Sbjct: 230 FP--------------EKFF---------PKARDLVEKLLVLDATKRLGCEEMEGYGPLK 266
Query: 391 AHPYFAQV 398
           AHP+F  V
Sbjct: 267 AHPFFESV 274

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 53/188 (28%), Positives = 91/188 (48%), Gaps = 36/188 (19%)
Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY---NV 278
           R+Y  E++ AL+Y H +GI+HRD+KP N++++ ++  +++ D+G A+   P  +    N 
Sbjct: 133 RFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANX 191
Query: 279 RVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDN--HDQLVKIAKD 336
            V +  +  PELL + +    S D+W+LGC+   ++    PF  G++     +++K+  D
Sbjct: 192 FVGTAQYVSPELLTE-KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYD 250
Query: 337 CCLIIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREA------M 390
                            KF          P+A D ++KLL  D   RL   E        
Sbjct: 251 FP--------------EKFF---------PKARDLVEKLLVLDATKRLGCEEMEGYGPLK 287
Query: 391 AHPYFAQV 398
           AHP+F  V
Sbjct: 288 AHPFFESV 295

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 53/188 (28%), Positives = 91/188 (48%), Gaps = 36/188 (19%)
Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY---NV 278
           R+Y  E++ AL+Y H +GI+HRD+KP N++++ ++  +++ D+G A+   P  +    N 
Sbjct: 133 RFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANX 191
Query: 279 RVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDN--HDQLVKIAKD 336
            V +  +  PELL + +    S D+W+LGC+   ++    PF  G++     +++K+  D
Sbjct: 192 FVGTAQYVSPELLTE-KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYD 250
Query: 337 CCLIIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREA------M 390
                            KF          P+A D ++KLL  D   RL   E        
Sbjct: 251 FP--------------EKFF---------PKARDLVEKLLVLDATKRLGCEEMEGYGPLK 287
Query: 391 AHPYFAQV 398
           AHP+F  V
Sbjct: 288 AHPFFESV 295

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 53/188 (28%), Positives = 91/188 (48%), Gaps = 36/188 (19%)
Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY---NV 278
           R+Y  E++ AL+Y H +GI+HRD+KP N++++ ++  +++ D+G A+   P  +    N 
Sbjct: 110 RFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANX 168
Query: 279 RVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDN--HDQLVKIAKD 336
            V +  +  PELL + +    S D+W+LGC+   ++    PF  G++     +++K+  D
Sbjct: 169 FVGTAQYVSPELLTE-KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYD 227
Query: 337 CCLIIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREA------M 390
                            KF          P+A D ++KLL  D   RL   E        
Sbjct: 228 FP--------------EKFF---------PKARDLVEKLLVLDATKRLGCEEMEGYGPLK 264
Query: 391 AHPYFAQV 398
           AHP+F  V
Sbjct: 265 AHPFFESV 272

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 59/228 (25%), Positives = 104/228 (45%), Gaps = 29/228 (12%)
Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNSTDF--KVL--YPTLTDYDIRYYIYELLKALDYC 235
           P +V L D   D +     +I+E+++  +   KV   +  +++ +   Y+ ++ K L + 
Sbjct: 214 PTLVNLHDAFEDDNEMV--MIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHM 271
Query: 236 HSQGIMHRDVKPHNVMIDHE-LRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDL 294
           H    +H D+KP N+M   +   +L+LID+GL     P +   V   +  F  PE+  + 
Sbjct: 272 HENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEV-AEG 330
Query: 295 QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSK 354
           +   Y  DMWS+G +   ++    PF  G +N D+ ++  K C              W  
Sbjct: 331 KPVGYYTDMWSVGVLSYILLSGLSPF--GGENDDETLRNVKSC-------------DW-- 373
Query: 355 FINADNQHL--VSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRA 400
             N D+     +S +  DF+ KLL  D   R+T  +A+ HP+     A
Sbjct: 374 --NMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNA 419

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 53/188 (28%), Positives = 91/188 (48%), Gaps = 36/188 (19%)
Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY---NV 278
           R+Y  E++ AL+Y H +GI+HRD+KP N++++ ++  +++ D+G A+   P  +    N 
Sbjct: 111 RFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANX 169
Query: 279 RVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDN--HDQLVKIAKD 336
            V +  +  PELL + +    S D+W+LGC+   ++    PF  G++     +++K+  D
Sbjct: 170 FVGTAQYVSPELLTE-KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYD 228
Query: 337 CCLIIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREA------M 390
                            KF          P+A D ++KLL  D   RL   E        
Sbjct: 229 FP--------------EKFF---------PKARDLVEKLLVLDATKRLGCEEMEGYGPLK 265
Query: 391 AHPYFAQV 398
           AHP+F  V
Sbjct: 266 AHPFFESV 273

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 53/188 (28%), Positives = 91/188 (48%), Gaps = 36/188 (19%)
Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY---NV 278
           R+Y  E++ AL+Y H +GI+HRD+KP N++++ ++  +++ D+G A+   P  +    N 
Sbjct: 140 RFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANX 198
Query: 279 RVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDN--HDQLVKIAKD 336
            V +  +  PELL + +    S D+W+LGC+   ++    PF  G++     +++K+  D
Sbjct: 199 FVGTAQYVSPELLTE-KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYD 257
Query: 337 CCLIIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREA------M 390
                            KF          P+A D ++KLL  D   RL   E        
Sbjct: 258 FP--------------EKFF---------PKARDLVEKLLVLDATKRLGCEEMEGYGPLK 294
Query: 391 AHPYFAQV 398
           AHP+F  V
Sbjct: 295 AHPFFESV 302

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 53/188 (28%), Positives = 91/188 (48%), Gaps = 36/188 (19%)
Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY---NV 278
           R+Y  E++ AL+Y H +GI+HRD+KP N++++ ++  +++ D+G A+   P  +    N 
Sbjct: 117 RFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANX 175
Query: 279 RVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDN--HDQLVKIAKD 336
            V +  +  PELL + +    S D+W+LGC+   ++    PF  G++     +++K+  D
Sbjct: 176 FVGTAQYVSPELLTE-KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYD 234
Query: 337 CCLIIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREA------M 390
                            KF          P+A D ++KLL  D   RL   E        
Sbjct: 235 FP--------------EKFF---------PKARDLVEKLLVLDATKRLGCEEMEGYGPLK 271
Query: 391 AHPYFAQV 398
           AHP+F  V
Sbjct: 272 AHPFFESV 279

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 68/292 (23%), Positives = 125/292 (42%), Gaps = 40/292 (13%)
Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTNER-------CXXXXXXXXXXXXXXXXXXXLQNL 176
           +D YE+   +G+G +S V   IN  T ++                           + ++
Sbjct: 25  EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHM 84
Query: 177 CGGPNVVKLLDIVRD--------QHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYEL 228
              P++V+LL+            +      L FE V   D   +Y   ++    +Y+ ++
Sbjct: 85  LKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVY---SEAVASHYMRQI 141
Query: 229 LKALDYCHSQGIMHRDVKPHNVMIDHELRK--LRLIDWGLA-EFYHPGKEYNVRVASRYF 285
           L+AL YCH   I+HRDVKPH V++  +     ++L  +G+A +    G     RV + +F
Sbjct: 142 LEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHF 201
Query: 286 KGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNS 345
             PE +V  + Y   +D+W  G +   ++    PF+      ++L +       II    
Sbjct: 202 MAPE-VVKREPYGKPVDVWGCGVILFILLSGCLPFY---GTKERLFE------GIIKGKY 251
Query: 346 RHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQ 397
           + + + WS          +S  A D + ++L  D  +R+T  EA+ HP+  +
Sbjct: 252 KMNPRQWSH---------ISESAKDLVRRMLMLDPAERITVYEALNHPWLKE 294

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 72/281 (25%), Positives = 120/281 (42%), Gaps = 31/281 (11%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXXXXXXXXXXXXXXXLQNLCGGPNVVK 184
           D YEV   +G G YS     I+  TN                      L+     PN++ 
Sbjct: 22  DGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEEIEILLR-YGQHPNIIT 80
Query: 185 LLDIVRDQHSKTPSLIFEYVNSTDF--KVLYPTL-TDYDIRYYIYELLKALDYCHSQGIM 241
           L D+  D   K   ++ E +   +   K+L     ++ +    ++ + K ++Y H+QG++
Sbjct: 81  LKDVYDD--GKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVV 138
Query: 242 HRDVKPHNVMIDHEL---RKLRLIDWGLAEFYHPGKEYNVRVASRY---FKGPELLVDLQ 295
           HRD+KP N++   E      +R+ D+G A+      E  + +   Y   F  PE+L + Q
Sbjct: 139 HRDLKPSNILYVDESGNPESIRICDFGFAKQLR--AENGLLMTPCYTANFVAPEVL-ERQ 195
Query: 296 DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSKF 355
            YD + D+WSLG +   M+    PF  G D+  + +                +R    KF
Sbjct: 196 GYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEIL---------------ARIGSGKF 240
Query: 356 -INADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF 395
            ++    + VS  A D + K+L  D   RLTA   + HP+ 
Sbjct: 241 SLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWI 281

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 53/188 (28%), Positives = 91/188 (48%), Gaps = 36/188 (19%)
Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY---NV 278
           R+Y  E++ AL+Y H +GI+HRD+KP N++++ ++  +++ D+G A+   P  +    N 
Sbjct: 132 RFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANX 190
Query: 279 RVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDN--HDQLVKIAKD 336
            V +  +  PELL + +    S D+W+LGC+   ++    PF  G++     +++K+  D
Sbjct: 191 FVGTAQYVSPELLTE-KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYD 249
Query: 337 CCLIIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREA------M 390
                            KF          P+A D ++KLL  D   RL   E        
Sbjct: 250 FP--------------EKFF---------PKARDLVEKLLVLDATKRLGCEEMEGYGPLK 286
Query: 391 AHPYFAQV 398
           AHP+F  V
Sbjct: 287 AHPFFESV 294

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 67/294 (22%), Positives = 127/294 (43%), Gaps = 30/294 (10%)
Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTNE----RCXXXXXXXXXXXXXXXXXXXLQNLCGG 179
           Q  Y++  ++G+G +S V   + V   +    +                    +  L   
Sbjct: 21  QSMYQLFEELGKGAFSVVRRCVKVLAGQEYAAKIINTKKLSARDHQKLEREARICRLLKH 80
Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNSTDF---KVLYPTLTDYDIRYYIYELLKALDYCH 236
           PN+V+L D + ++      LIF+ V   +     V     ++ D  + I ++L+A+ +CH
Sbjct: 81  PNIVRLHDSISEEGHHY--LIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCH 138
Query: 237 SQGIMHRDVKPHNVMIDHELR--KLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVD 293
             G++HRD+KP N+++  +L+   ++L D+GLA E     + +     +  +  PE+L  
Sbjct: 139 QMGVVHRDLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRK 198
Query: 294 LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWS 353
              Y   +D+W+ G +   ++    P F+  D H    +I                K  +
Sbjct: 199 -DPYGKPVDLWACGVILY-ILLVGYPPFWDEDQHRLYQQI----------------KAGA 240
Query: 354 KFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAESSRTR 407
               +     V+PEA D ++K+L  +   R+TA EA+ HP+ +      S   R
Sbjct: 241 YDFPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALKHPWISHRSTVASCMHR 294

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 53/188 (28%), Positives = 91/188 (48%), Gaps = 36/188 (19%)
Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY---NV 278
           R+Y  E++ AL+Y H +GI+HRD+KP N++++ ++  +++ D+G A+   P  +    N 
Sbjct: 132 RFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANS 190
Query: 279 RVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDN--HDQLVKIAKD 336
            V +  +  PELL + +    S D+W+LGC+   ++    PF  G++     +++K+  D
Sbjct: 191 FVGTAQYVSPELLTE-KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYD 249
Query: 337 CCLIIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREA------M 390
                            KF          P+A D ++KLL  D   RL   E        
Sbjct: 250 FP--------------EKFF---------PKARDLVEKLLVLDATKRLGCEEMEGYGPLK 286
Query: 391 AHPYFAQV 398
           AHP+F  V
Sbjct: 287 AHPFFESV 294

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 68/292 (23%), Positives = 125/292 (42%), Gaps = 40/292 (13%)
Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTNER-------CXXXXXXXXXXXXXXXXXXXLQNL 176
           +D YE+   +G+G +S V   IN  T ++                           + ++
Sbjct: 23  EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHM 82
Query: 177 CGGPNVVKLLDIVRD--------QHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYEL 228
              P++V+LL+            +      L FE V   D   +Y   ++    +Y+ ++
Sbjct: 83  LKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVY---SEAVASHYMRQI 139
Query: 229 LKALDYCHSQGIMHRDVKPHNVMIDHELRK--LRLIDWGLA-EFYHPGKEYNVRVASRYF 285
           L+AL YCH   I+HRDVKPH V++  +     ++L  +G+A +    G     RV + +F
Sbjct: 140 LEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHF 199
Query: 286 KGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNS 345
             PE +V  + Y   +D+W  G +   ++    PF+      ++L +       II    
Sbjct: 200 MAPE-VVKREPYGKPVDVWGCGVILFILLSGCLPFY---GTKERLFE------GIIKGKY 249
Query: 346 RHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQ 397
           + + + WS          +S  A D + ++L  D  +R+T  EA+ HP+  +
Sbjct: 250 KMNPRQWSH---------ISESAKDLVRRMLMLDPAERITVYEALNHPWLKE 292

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 59/228 (25%), Positives = 104/228 (45%), Gaps = 29/228 (12%)
Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNSTDF--KVL--YPTLTDYDIRYYIYELLKALDYC 235
           P +V L D   D +     +I+E+++  +   KV   +  +++ +   Y+ ++ K L + 
Sbjct: 108 PTLVNLHDAFEDDNEMV--MIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHM 165
Query: 236 HSQGIMHRDVKPHNVMIDHE-LRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDL 294
           H    +H D+KP N+M   +   +L+LID+GL     P +   V   +  F  PE+  + 
Sbjct: 166 HENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEV-AEG 224
Query: 295 QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSK 354
           +   Y  DMWS+G +   ++    PF  G +N D+ ++  K C              W  
Sbjct: 225 KPVGYYTDMWSVGVLSYILLSGLSPF--GGENDDETLRNVKSC-------------DW-- 267
Query: 355 FINADNQHL--VSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRA 400
             N D+     +S +  DF+ KLL  D   R+T  +A+ HP+     A
Sbjct: 268 --NMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNA 313

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 67/285 (23%), Positives = 120/285 (42%), Gaps = 35/285 (12%)
Query: 120 QWGDQDDYEVVRKVGRGKYSEVFEGINVNTN-----ERCXXXXXXXXXXXXXXXXXXXLQ 174
           QW   +D+E+ R +G+GK+  V+     N+      +                     +Q
Sbjct: 4   QWA-LEDFEIGRPLGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQ 62
Query: 175 NLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYD---IRYYIYELLKA 231
           +    PN+++L     D  S    LI EY            L+ +D      YI EL  A
Sbjct: 63  SHLRHPNILRLYGYFHD--STRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA 120
Query: 232 LDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELL 291
           L YCHS+ ++HRD+KP N+++     +L++ D+G +  + P         +  +  PE +
Sbjct: 121 LSYCHSKKVIHRDIKPENLLLG-SAGELKIADFGWS-VHAPSSRRAALCGTLDYLPPE-M 177
Query: 292 VDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKP 351
           ++ + +D  +D+WSLG +    +  K P F  +   D   +I++                
Sbjct: 178 IEGRMHDEKVDLWSLGVLCYEFLVGKPP-FEANTYQDTYKRISR---------------- 220
Query: 352 WSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFA 396
             +F   D    V+  A D + +LL+++   R   RE + HP+  
Sbjct: 221 -VEFTFPD---FVTEGARDLISRLLKHNPSQRPMLREVLEHPWIT 261

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 104/226 (46%), Gaps = 26/226 (11%)
Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNST---DFKVLYPTLTDYDIRYYIYELLKALDYCH 236
           PN++ L DI  ++      LI E V+     DF     +LT+ +   ++ ++L  + Y H
Sbjct: 68  PNIITLHDIFENKTDVV--LILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLH 125
Query: 237 SQGIMHRDVKPHNVM-IDHEL--RKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD 293
           S+ I H D+KP N+M +D  +   +++LID+G+A     G E+     +  F  PE +V+
Sbjct: 126 SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPE-IVN 184
Query: 294 LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWS 353
            +      DMWS+G +   ++    PF  G    + L  I+         N     + +S
Sbjct: 185 YEPLGLEADMWSIGVITYILLSGASPFL-GETKQETLTNISA-------VNYDFDEEYFS 236
Query: 354 KFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVR 399
                      S  A DF+ +LL  D + R+T  +++ H +   +R
Sbjct: 237 N---------TSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIR 273

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 60/224 (26%), Positives = 104/224 (46%), Gaps = 26/224 (11%)
Query: 181 NVVKLLDIVRDQHSKTPSLIFEYVNST---DFKVLYPTLTDYDIRYYIYELLKALDYCHS 237
           NV+ L D+  ++      LI E V+     DF     +L++ +   +I ++L  ++Y H+
Sbjct: 76  NVITLHDVYENRTDVV--LILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHT 133
Query: 238 QGIMHRDVKPHNVMI---DHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDL 294
           + I H D+KP N+M+   +  +  ++LID+GLA     G E+     +  F  PE +V+ 
Sbjct: 134 KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPE-IVNY 192
Query: 295 QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSK 354
           +      DMWS+G +   ++    PF  G    + L  I          +     + +S+
Sbjct: 193 EPLGLEADMWSIGVITYILLSGASPFL-GDTKQETLANITA-------VSYDFDEEFFSQ 244
Query: 355 FINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQV 398
                     S  A DF+ KLL  + + RLT +EA+ HP+   V
Sbjct: 245 ---------TSELAKDFIRKLLVKETRKRLTIQEALRHPWITPV 279

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 61/226 (26%), Positives = 103/226 (45%), Gaps = 30/226 (13%)
Query: 181 NVVKLLDIVRDQHSKTPSLIFEYVNST---DFKVLYPTLTDYDIRYYIYELLKALDYCHS 237
           NV+ L D+  ++      LI E V+     DF     +L++ +   +I ++L  ++Y H+
Sbjct: 76  NVITLHDVYENRTDVV--LILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHT 133
Query: 238 QGIMHRDVKPHNVMI---DHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDL 294
           + I H D+KP N+M+   +  +  ++LID+GLA     G E+     +  F  PE +V+ 
Sbjct: 134 KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPE-IVNY 192
Query: 295 QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSK 354
           +      DMWS+G +   ++    PF  G    + L  I                   S 
Sbjct: 193 EPLGLEADMWSIGVITYILLSGASPFL-GDTKQETLANIT------------------SV 233
Query: 355 FINADNQHL--VSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQV 398
             + D +     S  A DF+ KLL  + + RLT +EA+ HP+   V
Sbjct: 234 SYDFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPV 279

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 61/226 (26%), Positives = 103/226 (45%), Gaps = 30/226 (13%)
Query: 181 NVVKLLDIVRDQHSKTPSLIFEYVNST---DFKVLYPTLTDYDIRYYIYELLKALDYCHS 237
           NV+ L D+  ++      LI E V+     DF     +L++ +   +I ++L  ++Y H+
Sbjct: 76  NVITLHDVYENRTDVV--LILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHT 133
Query: 238 QGIMHRDVKPHNVMI---DHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDL 294
           + I H D+KP N+M+   +  +  ++LID+GLA     G E+     +  F  PE +V+ 
Sbjct: 134 KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPE-IVNY 192
Query: 295 QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSK 354
           +      DMWS+G +   ++    PF  G    + L  I                   S 
Sbjct: 193 EPLGLEADMWSIGVITYILLSGASPFL-GDTKQETLANIT------------------SV 233
Query: 355 FINADNQHL--VSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQV 398
             + D +     S  A DF+ KLL  + + RLT +EA+ HP+   V
Sbjct: 234 SYDFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPV 279

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 60/224 (26%), Positives = 104/224 (46%), Gaps = 26/224 (11%)
Query: 181 NVVKLLDIVRDQHSKTPSLIFEYVNST---DFKVLYPTLTDYDIRYYIYELLKALDYCHS 237
           NV+ L D+  ++      LI E V+     DF     +L++ +   +I ++L  ++Y H+
Sbjct: 76  NVITLHDVYENRTDVV--LILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHT 133
Query: 238 QGIMHRDVKPHNVMI---DHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDL 294
           + I H D+KP N+M+   +  +  ++LID+GLA     G E+     +  F  PE +V+ 
Sbjct: 134 KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPE-IVNY 192
Query: 295 QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSK 354
           +      DMWS+G +   ++    PF  G    + L  I          +     + +S+
Sbjct: 193 EPLGLEADMWSIGVITYILLSGASPFL-GDTKQETLANITA-------VSYDFDEEFFSQ 244
Query: 355 FINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQV 398
                     S  A DF+ KLL  + + RLT +EA+ HP+   V
Sbjct: 245 ---------TSELAKDFIRKLLVKETRKRLTIQEALRHPWITPV 279

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 61/226 (26%), Positives = 103/226 (45%), Gaps = 30/226 (13%)
Query: 181 NVVKLLDIVRDQHSKTPSLIFEYVNST---DFKVLYPTLTDYDIRYYIYELLKALDYCHS 237
           NV+ L D+  ++      LI E V+     DF     +L++ +   +I ++L  ++Y H+
Sbjct: 76  NVITLHDVYENRTDVV--LILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHT 133
Query: 238 QGIMHRDVKPHNVMI---DHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDL 294
           + I H D+KP N+M+   +  +  ++LID+GLA     G E+     +  F  PE +V+ 
Sbjct: 134 KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPE-IVNY 192
Query: 295 QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSK 354
           +      DMWS+G +   ++    PF  G    + L  I                   S 
Sbjct: 193 EPLGLEADMWSIGVITYILLSGASPFL-GDTKQETLANIT------------------SV 233
Query: 355 FINADNQHL--VSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQV 398
             + D +     S  A DF+ KLL  + + RLT +EA+ HP+   V
Sbjct: 234 SYDFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPV 279

>pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 64/248 (25%), Positives = 111/248 (44%), Gaps = 54/248 (21%)
Query: 201 FEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVM-IDHELRKL 259
           FE++   +F+  YP      +R+  Y+L  AL + H   + H D+KP N++ ++ E   L
Sbjct: 141 FEFLKENNFQP-YPLP---HVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETL 196
Query: 260 -----------------RLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLD 302
                            R+ D+G A F H  + +   VA+R+++ PE++++L  +    D
Sbjct: 197 YNEHKSCEEKSVKNTSIRVADFGSATFDH--EHHTTIVATRHYRPPEVILEL-GWAQPCD 253
Query: 303 MWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLI-------------------IW- 342
           +WS+GC+     +R    F  H+N + LV + K    I                   +W 
Sbjct: 254 VWSIGCILFE-YYRGFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWD 312
Query: 343 CNSRHSR------KPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFA 396
            NS   R      KP   ++  D+  L   +  D + ++L +D   R+T  EA+ HP+FA
Sbjct: 313 ENSSDGRYVKENCKPLKSYMLQDS--LEHVQLFDLMRRMLEFDPAQRITLAEALLHPFFA 370
Query: 397 QVRAAESS 404
            +   E S
Sbjct: 371 GLTPEERS 378

>pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 64/248 (25%), Positives = 111/248 (44%), Gaps = 54/248 (21%)
Query: 201 FEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVM-IDHELRKL 259
           FE++   +F+  YP      +R+  Y+L  AL + H   + H D+KP N++ ++ E   L
Sbjct: 109 FEFLKENNFQP-YPLP---HVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETL 164
Query: 260 -----------------RLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLD 302
                            R+ D+G A F H  + +   VA+R+++ PE++++L  +    D
Sbjct: 165 YNEHKSCEEKSVKNTSIRVADFGSATFDH--EHHTTIVATRHYRPPEVILEL-GWAQPCD 221
Query: 303 MWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLI-------------------IW- 342
           +WS+GC+     +R    F  H+N + LV + K    I                   +W 
Sbjct: 222 VWSIGCILFEY-YRGFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWD 280
Query: 343 CNSRHSR------KPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFA 396
            NS   R      KP   ++  D+  L   +  D + ++L +D   R+T  EA+ HP+FA
Sbjct: 281 ENSSDGRYVKENCKPLKSYMLQDS--LEHVQLFDLMRRMLEFDPAQRITLAEALLHPFFA 338
Query: 397 QVRAAESS 404
            +   E S
Sbjct: 339 GLTPEERS 346

>pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 64/248 (25%), Positives = 111/248 (44%), Gaps = 54/248 (21%)
Query: 201 FEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVM-IDHELRKL 259
           FE++   +F+  YP      +R+  Y+L  AL + H   + H D+KP N++ ++ E   L
Sbjct: 118 FEFLKENNFQP-YPLP---HVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETL 173
Query: 260 -----------------RLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLD 302
                            R+ D+G A F H  + +   VA+R+++ PE++++L  +    D
Sbjct: 174 YNEHKSCEEKSVKNTSIRVADFGSATFDH--EHHTTIVATRHYRPPEVILEL-GWAQPCD 230
Query: 303 MWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLI-------------------IW- 342
           +WS+GC+     +R    F  H+N + LV + K    I                   +W 
Sbjct: 231 VWSIGCILFEY-YRGFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWD 289
Query: 343 CNSRHSR------KPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFA 396
            NS   R      KP   ++  D+  L   +  D + ++L +D   R+T  EA+ HP+FA
Sbjct: 290 ENSSDGRYVKENCKPLKSYMLQDS--LEHVQLFDLMRRMLEFDPAQRITLAEALLHPFFA 347
Query: 397 QVRAAESS 404
            +   E S
Sbjct: 348 GLTPEERS 355

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 55/186 (29%), Positives = 91/186 (48%), Gaps = 29/186 (15%)
Query: 223 YYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEYNVRVA 281
           +Y+ E+  AL + H +GI++RD+KP N+M++H+   ++L D+GL  E  H G   +    
Sbjct: 125 FYLAEISMALGHLHQKGIIYRDLKPENIMLNHQ-GHVKLTDFGLCKESIHDGTVTHTFCG 183
Query: 282 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLII 341
           +  +  PE+L+    ++ ++D WSLG +   M+    P F G +    + KI K C L +
Sbjct: 184 TIEYMAPEILMR-SGHNRAVDWWSLGALMYDMLTGAPP-FTGENRKKTIDKILK-CKLNL 240
Query: 342 WCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLT-----AREAMAHPYFA 396
                    P+           ++ EA D L KLL+ +   RL      A E  AHP+F 
Sbjct: 241 --------PPY-----------LTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFR 281
Query: 397 QVRAAE 402
            +   E
Sbjct: 282 HINWEE 287

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 65/293 (22%), Positives = 127/293 (43%), Gaps = 30/293 (10%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXXXXXXXX----XXXXXXXLQNLCGGP 180
           ++Y++  ++G+G +S V   + V   +                         +  L   P
Sbjct: 11  EEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHP 70
Query: 181 NVVKLLDIVRDQHSKTPSLIFEYVNSTDF---KVLYPTLTDYDIRYYIYELLKALDYCHS 237
           N+V+L D + ++      LIF+ V   +     V     ++ D  + I ++L+A+ +CH 
Sbjct: 71  NIVRLHDSISEEGHHY--LIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQ 128
Query: 238 QGIMHRDVKPHNVMIDHELR--KLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDL 294
            G++HR++KP N+++  +L+   ++L D+GLA E     + +     +  +  PE+L   
Sbjct: 129 MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRK- 187
Query: 295 QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSK 354
             Y   +D+W+ G +   ++    P F+  D H    +I                K  + 
Sbjct: 188 DPYGKPVDLWACGVILYILLVGYPP-FWDEDQHRLYQQI----------------KAGAY 230
Query: 355 FINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAESSRTR 407
              +     V+PEA D ++K+L  +   R+TA EA+ HP+ +      S   R
Sbjct: 231 DFPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALKHPWISHRSTVASCMHR 283

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 66/290 (22%), Positives = 122/290 (42%), Gaps = 35/290 (12%)
Query: 115 ESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTN-----ERCXXXXXXXXXXXXXXXX 169
           ES   QW   +D+E+ R +G+GK+  V+      +      +                  
Sbjct: 4   ESKKRQWA-LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRR 62
Query: 170 XXXLQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYD---IRYYIY 226
              +Q+    PN+++L     D  +    LI EY    +       L+ +D      YI 
Sbjct: 63  EVEIQSHLRHPNILRLYGYFHD--ATRVYLILEYAPRGEVYKELQKLSKFDEQRTATYIT 120
Query: 227 ELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFK 286
           EL  AL YCHS+ ++HRD+KP N+++     +L++ D+G +  + P         +  + 
Sbjct: 121 ELANALSYCHSKRVIHRDIKPENLLLG-SAGELKIADFGWS-VHAPSSRRTTLCGTLDYL 178
Query: 287 GPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSR 346
            PE +++ + +D  +D+WSLG +    +  K P F  +   +   +I++           
Sbjct: 179 PPE-MIEGRMHDEKVDLWSLGVLCYEFLVGKPP-FEANTYQETYKRISR----------- 225
Query: 347 HSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFA 396
                  +F   D    V+  A D + +LL+++   R   RE + HP+  
Sbjct: 226 ------VEFTFPD---FVTEGARDLISRLLKHNPSQRPMLREVLEHPWIT 266

>pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 56/228 (24%), Positives = 107/228 (46%), Gaps = 54/228 (23%)
Query: 219 YDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMI---DHEL---------------RKLR 260
           + +R+  ++L +A+ + H   + H D+KP N++    D+EL                 +R
Sbjct: 137 HQVRHMAFQLCQAVKFLHDNKLTHTDLKPENILFVNSDYELTYNLEKKRDERSVKSTAVR 196
Query: 261 LIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCM----FAGMIFR 316
           ++D+G A F H  + ++  V++R+++ PE++++L  +    D+WS+GC+    + G    
Sbjct: 197 VVDFGSATFDH--EHHSTIVSTRHYRAPEVILEL-GWSQPCDVWSIGCIIFEYYVGFT-- 251
Query: 317 KEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKP---------WSKFINADN------- 360
               F  HDN + L  + +    I     R +RK          W +  +A         
Sbjct: 252 ---LFQTHDNREHLAMMERILGPIPSRMIRKTRKQKYFYRGRLDWDENTSAGRYVRENCK 308
Query: 361 --QHLVSPEA------IDFLDKLLRYDHQDRLTAREAMAHPYFAQVRA 400
             +  ++ EA       D ++ +L Y+   RLT  EA+ HP+FA++RA
Sbjct: 309 PLRRYLTSEAEEHHQLFDLIESMLEYEPAKRLTLGEALQHPFFARLRA 356

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 44/202 (21%), Positives = 97/202 (48%), Gaps = 10/202 (4%)
Query: 126 DYEVVRKVGRGKYSEVFEGINVNTNE----RCXXXXXXXXXXXXXXXXXXXLQNLCGGPN 181
           +Y +++ +G+G +++V    ++ T +    R                    +  +   PN
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPN 74
Query: 182 VVKLLDIVRDQHSKTPSLIFEYVNST---DFKVLYPTLTDYDIRYYIYELLKALDYCHSQ 238
           +VKL +++  +  KT  L+ EY +     D+ V +  + + + R    +++ A+ YCH +
Sbjct: 75  IVKLFEVIETE--KTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQK 132
Query: 239 GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYD 298
            I+HRD+K  N+++D ++  +++ D+G +  +  G + +    S  +  PEL    +   
Sbjct: 133 FIVHRDLKAENLLLDADM-NIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKKYDG 191
Query: 299 YSLDMWSLGCMFAGMIFRKEPF 320
             +D+WSLG +   ++    PF
Sbjct: 192 PEVDVWSLGVILYTLVSGSLPF 213

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 105/217 (48%), Gaps = 22/217 (10%)
Query: 176 LCGG-PNVVKLLDIVRDQ-HSKTPSLIFEYVNSTD-FKVLYPT--LTDYDIRYYIYELLK 230
           LC G PN+VKL ++  DQ H+    L+ E +N  + F+ +      ++ +  Y + +L+ 
Sbjct: 61  LCEGHPNIVKLHEVFHDQLHT---FLVMELLNGGELFERIKKKKHFSETEASYIMRKLVS 117
Query: 231 ALDYCHSQGIMHRDVKPHNVMIDHELRKL--RLIDWGLAEFYHPGKE-YNVRVASRYFKG 287
           A+ + H  G++HRD+KP N++   E   L  ++ID+G A    P  +       + ++  
Sbjct: 118 AVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAA 177
Query: 288 PELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRH 347
           PELL +   YD S D+WSLG +   M+  + PF     +HD+ +     C   +    + 
Sbjct: 178 PELL-NQNGYDESCDLWSLGVILYTMLSGQVPF----QSHDRSLT----CTSAVEIMKKI 228
Query: 348 SRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRL 384
            +  +S     +    VS EA D +  LL  D   RL
Sbjct: 229 KKGDFS--FEGEAWKNVSQEAKDLIQGLLTVDPNKRL 263

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 55/186 (29%), Positives = 91/186 (48%), Gaps = 29/186 (15%)
Query: 223 YYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEYNVRVA 281
           +Y+ E+  AL + H +GI++RD+KP N+M++H+   ++L D+GL  E  H G   +    
Sbjct: 125 FYLAEISMALGHLHQKGIIYRDLKPENIMLNHQ-GHVKLTDFGLCKESIHDGTVTHXFCG 183
Query: 282 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLII 341
           +  +  PE+L+    ++ ++D WSLG +   M+    P F G +    + KI K C L +
Sbjct: 184 TIEYMAPEILMR-SGHNRAVDWWSLGALMYDMLTGAPP-FTGENRKKTIDKILK-CKLNL 240
Query: 342 WCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLT-----AREAMAHPYFA 396
                    P+           ++ EA D L KLL+ +   RL      A E  AHP+F 
Sbjct: 241 --------PPY-----------LTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFR 281
Query: 397 QVRAAE 402
            +   E
Sbjct: 282 HINWEE 287

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 39/144 (27%), Positives = 77/144 (53%), Gaps = 6/144 (4%)
Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNST---DFKVLYPTLTDYDIRYYIYELLKALDYCH 236
           PN+VKL +++  +  KT  LI EY +     D+ V +  + + + R    +++ A+ YCH
Sbjct: 71  PNIVKLFEVIETE--KTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCH 128
Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD 296
            + I+HRD+K  N+++D ++  +++ D+G +  +  G + +    S  +  PEL    + 
Sbjct: 129 QKRIVHRDLKAENLLLDADM-NIKIADFGFSNEFTVGGKLDTFCGSPPYAAPELFQGKKY 187
Query: 297 YDYSLDMWSLGCMFAGMIFRKEPF 320
               +D+WSLG +   ++    PF
Sbjct: 188 DGPEVDVWSLGVILYTLVSGSLPF 211

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 54/224 (24%), Positives = 98/224 (43%), Gaps = 33/224 (14%)
Query: 180 PNVVKLLDIVRDQHSKTPSLIF---EYVNST---DFKVLYPTLTDYDIRYYIYELLKALD 233
           P+++KL  ++      TPS IF   EYV+     D+      L + + R    ++L  +D
Sbjct: 76  PHIIKLYQVI-----STPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVD 130
Query: 234 YCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD 293
           YCH   ++HRD+KP NV++D  +   ++ D+GL+     G+       S  +  PE++  
Sbjct: 131 YCHRHMVVHRDLKPENVLLDAHMNA-KIADFGLSNMMSDGEFLRXSCGSPNYAAPEVISG 189
Query: 294 LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWS 353
                  +D+WS G +   ++    PF     + D +  + K  C  I+   ++      
Sbjct: 190 RLYAGPEVDIWSSGVILYALLCGTLPF-----DDDHVPTLFKKICDGIFYTPQY------ 238
Query: 354 KFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQ 397
                     ++P  I  L  +L+ D   R T ++   H +F Q
Sbjct: 239 ----------LNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQ 272

>pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 58/236 (24%), Positives = 105/236 (44%), Gaps = 48/236 (20%)
Query: 200 IFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRK- 258
           ++E +    F+     L    +R + + +L+ LD  H   I+H D+KP N+++  + R  
Sbjct: 185 LYELIKKNKFQGFSLPL----VRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSG 240
Query: 259 LRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKE 318
           +++ID+G + + H  +     + SR+++ PE+++  + Y   +DMWSLGC+ A ++    
Sbjct: 241 IKVIDFGSSCYEH--QRVYTXIQSRFYRAPEVILGAR-YGMPIDMWSLGCILAELL-TGY 296
Query: 319 PFFYGHDNHDQLV-----------------KIAKD----------CCLI------IWCNS 345
           P   G D  DQL                  K AK+          C +       +  N 
Sbjct: 297 PLLPGEDEGDQLACMIELLGMPSQKLLDASKRAKNFVSXKGYPRYCTVTTLSDGSVVLNG 356
Query: 346 RHSRK------PWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF 395
             SR+      P S+      +    P  +DFL + L +D   R+T  +A+ HP+ 
Sbjct: 357 GRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQALRHPWL 412

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/281 (22%), Positives = 124/281 (44%), Gaps = 29/281 (10%)
Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTN-ERCXXXXXXXXXXXXXXXXXXXLQNLCGG--- 179
            D+Y+V  ++G+G +S V   ++  T  E                        +C     
Sbjct: 5   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64
Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNSTDF---KVLYPTLTDYDIRYYIYELLKALDYCH 236
           PN+V+L D ++++      L+F+ V   +     V     ++ D  + I ++L+++ YCH
Sbjct: 65  PNIVRLHDSIQEESFHY--LVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCH 122
Query: 237 SQGIMHRDVKPHNVMIDHELR--KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDL 294
           S GI+HR++KP N+++  + +   ++L D+GLA   +  + ++    +  +  PE+L   
Sbjct: 123 SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKK- 181
Query: 295 QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSK 354
             Y   +D+W+ G +   ++    P F+  D H    +I             +    W  
Sbjct: 182 DPYSKPVDIWACGVILYILLVGYPP-FWDEDQHRLYAQIKAGA-------YDYPSPEWDT 233
Query: 355 FINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF 395
                    V+PEA   +D +L  + + R+TA +A+  P+ 
Sbjct: 234 ---------VTPEAKSLIDSMLTVNPKKRITADQALKVPWI 265

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 63/281 (22%), Positives = 122/281 (43%), Gaps = 29/281 (10%)
Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTN-ERCXXXXXXXXXXXXXXXXXXXLQNLCGG--- 179
            D+Y+V  ++G+G +S V   ++  T  E                        +C     
Sbjct: 4   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 63
Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNSTDF---KVLYPTLTDYDIRYYIYELLKALDYCH 236
           PN+V+L D +  Q      L+F+ V   +     V     ++ D  + I ++L+++ YCH
Sbjct: 64  PNIVRLHDSI--QEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCH 121
Query: 237 SQGIMHRDVKPHNVMIDHELR--KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDL 294
           S GI+HR++KP N+++  + +   ++L D+GLA   +  + ++    +  +  PE+L   
Sbjct: 122 SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVL-KK 180
Query: 295 QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSK 354
             Y   +D+W+ G +   ++    P F+  D H    +I             +    W  
Sbjct: 181 DPYSKPVDIWACGVILYILLVGYPP-FWDEDQHRLYAQIKAGA-------YDYPSPEWDT 232
Query: 355 FINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF 395
                    V+PEA   +D +L  + + R+TA +A+  P+ 
Sbjct: 233 ---------VTPEAKSLIDSMLTVNPKKRITADQALKVPWI 264

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 103/226 (45%), Gaps = 26/226 (11%)
Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNST---DFKVLYPTLTDYDIRYYIYELLKALDYCH 236
           PN++ L DI  ++      LI E V+     DF     +LT+ +   ++ ++L  + Y H
Sbjct: 89  PNIITLHDIFENKTDVV--LILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLH 146
Query: 237 SQGIMHRDVKPHNVM-IDHEL--RKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD 293
           S+ I H D+KP N+M +D  +   +++LID+G+A     G E+     +  F  PE +V+
Sbjct: 147 SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPE-IVN 205
Query: 294 LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWS 353
            +      DMWS+G +   ++    PF  G    + L  I+         N     + +S
Sbjct: 206 YEPLGLEADMWSIGVITYILLSGASPFL-GETKQETLTNISA-------VNYDFDEEYFS 257
Query: 354 KFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVR 399
                      S  A DF+ +LL  D + R+   +++ H +   +R
Sbjct: 258 N---------TSELAKDFIRRLLVKDPKRRMXIAQSLEHSWIKAIR 294

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/281 (22%), Positives = 124/281 (44%), Gaps = 29/281 (10%)
Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTN-ERCXXXXXXXXXXXXXXXXXXXLQNLCGG--- 179
            D+Y+V  ++G+G +S V   ++  T  E                        +C     
Sbjct: 5   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64
Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNSTDF---KVLYPTLTDYDIRYYIYELLKALDYCH 236
           PN+V+L D ++++      L+F+ V   +     V     ++ D  + I ++L+++ YCH
Sbjct: 65  PNIVRLHDSIQEESFHY--LVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCH 122
Query: 237 SQGIMHRDVKPHNVMIDHELR--KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDL 294
           S GI+HR++KP N+++  + +   ++L D+GLA   +  + ++    +  +  PE+L   
Sbjct: 123 SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKK- 181
Query: 295 QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSK 354
             Y   +D+W+ G +   ++    P F+  D H    +I             +    W  
Sbjct: 182 DPYSKPVDIWACGVILYILLVGYPP-FWDEDQHRLYAQIKAGA-------YDYPSPEWDT 233
Query: 355 FINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF 395
                    V+PEA   +D +L  + + R+TA +A+  P+ 
Sbjct: 234 ---------VTPEAKSLIDSMLTVNPKKRITADQALKVPWI 265

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 66/290 (22%), Positives = 122/290 (42%), Gaps = 35/290 (12%)
Query: 115 ESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTN-----ERCXXXXXXXXXXXXXXXX 169
           ES   QW   +D+E+ R +G+GK+  V+      +      +                  
Sbjct: 4   ESKKRQWA-LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRR 62
Query: 170 XXXLQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYD---IRYYIY 226
              +Q+    PN+++L     D  +    LI EY    +       L+ +D      YI 
Sbjct: 63  EVEIQSHLRHPNILRLYGYFHD--ATRVYLILEYAPRGEVYKELQKLSKFDEQRTATYIT 120
Query: 227 ELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFK 286
           EL  AL YCHS+ ++HRD+KP N+++     +L++ D+G +  + P         +  + 
Sbjct: 121 ELANALSYCHSKRVIHRDIKPENLLLG-SAGELKIADFGWS-VHAPSSRRXXLXGTLDYL 178
Query: 287 GPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSR 346
            PE +++ + +D  +D+WSLG +    +  K P F  +   +   +I++           
Sbjct: 179 PPE-MIEGRMHDEKVDLWSLGVLCYEFLVGKPP-FEANTYQETYKRISR----------- 225
Query: 347 HSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFA 396
                  +F   D    V+  A D + +LL+++   R   RE + HP+  
Sbjct: 226 ------VEFTFPD---FVTEGARDLISRLLKHNPSQRPMLREVLEHPWIT 266

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/223 (27%), Positives = 106/223 (47%), Gaps = 29/223 (13%)
Query: 186 LDIVRDQHSKTPSLIFEYVNST--DFK-VLYPTLTDYDIRYYIYELLKALDYCHSQGIMH 242
           +D+V+ Q    P    E +N +   F+  L     +  I   + ++  AL Y H+QGI H
Sbjct: 132 MDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICH 191
Query: 243 RDVKPHNVMID-HELRKLRLIDWGLA-EFY--HPGKEYNV--RVASRYFKGPELL-VDLQ 295
           RD+KP N +   ++  +++L+D+GL+ EFY  + G+ Y +  +  + YF  PE+L    +
Sbjct: 192 RDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNE 251
Query: 296 DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI-AKDCCLIIWCNSRHSRKPWSK 354
            Y    D WS G +   ++    P F G ++ D + ++  K  C            P   
Sbjct: 252 SYGPKCDAWSAGVLLHLLLMGAVP-FPGVNDADTISQVLNKKLCF---------ENP--- 298
Query: 355 FINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQ 397
                N +++SP A D L  LL  +  +R  A  A+ HP+ +Q
Sbjct: 299 -----NYNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWISQ 336

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 38/144 (26%), Positives = 77/144 (53%), Gaps = 6/144 (4%)
Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNST---DFKVLYPTLTDYDIRYYIYELLKALDYCH 236
           PN+VKL +++  +  KT  L+ EY +     D+ V +  + + + R    +++ A+ YCH
Sbjct: 74  PNIVKLFEVI--ETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCH 131
Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD 296
            + I+HRD+K  N+++D ++  +++ D+G +  +  G + +    S  +  PEL    + 
Sbjct: 132 QKYIVHRDLKAENLLLDGDM-NIKIADFGFSNEFTVGNKLDTFCGSPPYAAPELFQGKKY 190
Query: 297 YDYSLDMWSLGCMFAGMIFRKEPF 320
               +D+WSLG +   ++    PF
Sbjct: 191 DGPEVDVWSLGVILYTLVSGSLPF 214

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 43/202 (21%), Positives = 97/202 (48%), Gaps = 10/202 (4%)
Query: 126 DYEVVRKVGRGKYSEVFEGINVNTNE----RCXXXXXXXXXXXXXXXXXXXLQNLCGGPN 181
           +Y +++ +G+G +++V    ++ T +    +                    +  +   PN
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPN 74
Query: 182 VVKLLDIVRDQHSKTPSLIFEYVNST---DFKVLYPTLTDYDIRYYIYELLKALDYCHSQ 238
           +VKL +++  +  KT  L+ EY +     D+ V +  + + + R    +++ A+ YCH +
Sbjct: 75  IVKLFEVIETE--KTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQK 132
Query: 239 GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYD 298
            I+HRD+K  N+++D ++  +++ D+G +  +  G + +    S  +  PEL    +   
Sbjct: 133 FIVHRDLKAENLLLDADM-NIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKKYDG 191
Query: 299 YSLDMWSLGCMFAGMIFRKEPF 320
             +D+WSLG +   ++    PF
Sbjct: 192 PEVDVWSLGVILYTLVSGSLPF 213

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 70/285 (24%), Positives = 122/285 (42%), Gaps = 36/285 (12%)
Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTNE----RCXXXXXXXXXXXXXXXXXXXLQNLCGG 179
           +D Y+    +G G +SEV    +  T +    +C                   L  +   
Sbjct: 17  RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKI-KH 75
Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNST---DFKVLYPTLTDYDIRYYIYELLKALDYCH 236
           PN+V L DI   +      LI + V+     D  V     T+ D    I+++L A+ Y H
Sbjct: 76  PNIVALDDIY--ESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLH 133
Query: 237 SQGIMHRDVKPHNVM---IDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD 293
             GI+HRD+KP N++   +D E  K+ + D+GL++   PG   +    +  +  PE+L  
Sbjct: 134 DLGIVHRDLKPENLLYYSLD-EDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQ 192
Query: 294 LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNH--DQLVKIAKDCCLIIWCNSRHSRKP 351
            + Y  ++D WS+G +   ++    PF+  +D    +Q++K   +     W +       
Sbjct: 193 -KPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDD------- 244
Query: 352 WSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFA 396
                       +S  A DF+  L+  D + R T  +A+ HP+ A
Sbjct: 245 ------------ISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIA 277

>pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 58/236 (24%), Positives = 105/236 (44%), Gaps = 48/236 (20%)
Query: 200 IFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRK- 258
           ++E +    F+     L    +R + + +L+ LD  H   I+H D+KP N+++  + R  
Sbjct: 185 LYELIKKNKFQGFSLPL----VRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSG 240
Query: 259 LRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKE 318
           +++ID+G + + H  +     + SR+++ PE+++  + Y   +DMWSLGC+ A ++    
Sbjct: 241 IKVIDFGSSCYEH--QRVYTXIQSRFYRAPEVILGAR-YGMPIDMWSLGCILAELL-TGY 296
Query: 319 PFFYGHDNHDQLV-----------------KIAKD----------CCLI------IWCNS 345
           P   G D  DQL                  K AK+          C +       +  N 
Sbjct: 297 PLLPGEDEGDQLACMIELLGMPSQKLLDASKRAKNFVSXKGYPRYCTVTTLSDGSVVLNG 356
Query: 346 RHSRK------PWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF 395
             SR+      P S+      +    P  +DFL + L +D   R+T  +A+ HP+ 
Sbjct: 357 GRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQALRHPWL 412

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 44/202 (21%), Positives = 97/202 (48%), Gaps = 10/202 (4%)
Query: 126 DYEVVRKVGRGKYSEVFEGINVNTNE----RCXXXXXXXXXXXXXXXXXXXLQNLCGGPN 181
           +Y +++ +G+G +++V    ++ T +    R                    +  +   PN
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPN 74
Query: 182 VVKLLDIVRDQHSKTPSLIFEYVNST---DFKVLYPTLTDYDIRYYIYELLKALDYCHSQ 238
           +VKL +++  +  KT  L+ EY +     D+ V +  + + + R    +++ A+ YCH +
Sbjct: 75  IVKLFEVIETE--KTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQK 132
Query: 239 GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYD 298
            I+HRD+K  N+++D ++  +++ D+G +  +  G + +    S  +  PEL    +   
Sbjct: 133 FIVHRDLKAENLLLDADM-NIKIADFGFSNEFTFGNKLDEFCGSPPYAAPELFQGKKYDG 191
Query: 299 YSLDMWSLGCMFAGMIFRKEPF 320
             +D+WSLG +   ++    PF
Sbjct: 192 PEVDVWSLGVILYTLVSGSLPF 213

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/280 (22%), Positives = 124/280 (44%), Gaps = 29/280 (10%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTN-ERCXXXXXXXXXXXXXXXXXXXLQNLCGG---P 180
           D+Y+V  ++G+G +S V   ++  T  E                        +C     P
Sbjct: 29  DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHP 88
Query: 181 NVVKLLDIVRDQHSKTPSLIFEYVNSTDF---KVLYPTLTDYDIRYYIYELLKALDYCHS 237
           N+V+L D ++++      L+F+ V   +     V     ++ D  + I ++L+++ YCHS
Sbjct: 89  NIVRLHDSIQEESFHY--LVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHS 146
Query: 238 QGIMHRDVKPHNVMIDHELR--KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQ 295
            GI+HR++KP N+++  + +   ++L D+GLA   +  + ++    +  +  PE+L    
Sbjct: 147 NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKK-D 205
Query: 296 DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSKF 355
            Y   +D+W+ G +   ++    P F+  D H    +I             +    W   
Sbjct: 206 PYSKPVDIWACGVILY-ILLVGYPPFWDEDQHRLYAQIKAGA-------YDYPSPEWD-- 255
Query: 356 INADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF 395
                   V+PEA   +D +L  + + R+TA +A+  P+ 
Sbjct: 256 -------TVTPEAKSLIDSMLTVNPKKRITADQALKVPWI 288

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 38/144 (26%), Positives = 77/144 (53%), Gaps = 6/144 (4%)
Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNST---DFKVLYPTLTDYDIRYYIYELLKALDYCH 236
           PN+VKL +++  +  KT  LI EY +     D+ V +  + + + R    +++ A+ YCH
Sbjct: 74  PNIVKLFEVIETE--KTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCH 131
Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD 296
            + I+HRD+K  N+++D ++  +++ D+G +  +  G + +    +  +  PEL    + 
Sbjct: 132 QKRIVHRDLKAENLLLDADM-NIKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQGKKY 190
Query: 297 YDYSLDMWSLGCMFAGMIFRKEPF 320
               +D+WSLG +   ++    PF
Sbjct: 191 DGPEVDVWSLGVILYTLVSGSLPF 214

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 66/290 (22%), Positives = 121/290 (41%), Gaps = 35/290 (12%)
Query: 115 ESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTN-----ERCXXXXXXXXXXXXXXXX 169
           ES   QW   +D+E+ R +G+GK+  V+      +      +                  
Sbjct: 4   ESKKRQWA-LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRR 62
Query: 170 XXXLQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYD---IRYYIY 226
              +Q+    PN+++L     D  +    LI EY            L+ +D      YI 
Sbjct: 63  EVEIQSHLRHPNILRLYGYFHD--ATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT 120
Query: 227 ELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFK 286
           EL  AL YCHS+ ++HRD+KP N+++     +L++ D+G +  + P         +  + 
Sbjct: 121 ELANALSYCHSKRVIHRDIKPENLLLG-SAGELKIADFGWS-VHAPSSRRTTLCGTLDYL 178
Query: 287 GPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSR 346
            PE +++ + +D  +D+WSLG +    +  K P F  +   +   +I++           
Sbjct: 179 PPE-MIEGRMHDEKVDLWSLGVLCYEFLVGKPP-FEANTYQETYKRISR----------- 225
Query: 347 HSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFA 396
                  +F   D    V+  A D + +LL+++   R   RE + HP+  
Sbjct: 226 ------VEFTFPD---FVTEGARDLISRLLKHNPSQRPMLREVLEHPWIT 266

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/227 (25%), Positives = 101/227 (44%), Gaps = 21/227 (9%)
Query: 126 DYEVVRKVGRGKYSEVF------EGINVNTNERCXXXXXXXXXXXXXXXXXXXLQNLCGG 179
           ++ + +K+GRG++SEV+      +G+ V   +                     L+ L   
Sbjct: 33  NFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQL-NH 91
Query: 180 PNVVKL-LDIVRDQHSKTPSLIFEYVNSTD-------FKVLYPTLTDYDIRYYIYELLKA 231
           PNV+K     + D      +++ E  ++ D       FK     + +  +  Y  +L  A
Sbjct: 92  PNVIKYYASFIEDNEL---NIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSA 148
Query: 232 LDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP-GKEYNVRVASRYFKGPEL 290
           L++ HS+ +MHRD+KP NV I      ++L D GL  F+       +  V + Y+  PE 
Sbjct: 149 LEHMHSRRVMHRDIKPANVFIT-ATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPER 207
Query: 291 LVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDC 337
           + +   Y++  D+WSLGC+   M   + PF+    N   L K  + C
Sbjct: 208 IHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQC 253

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 69/285 (24%), Positives = 122/285 (42%), Gaps = 36/285 (12%)
Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTNE----RCXXXXXXXXXXXXXXXXXXXLQNLCGG 179
           +D Y+    +G G +SEV    +  T +    +C                   L  +   
Sbjct: 17  RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKI-KH 75
Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNST---DFKVLYPTLTDYDIRYYIYELLKALDYCH 236
           PN+V L DI   +      LI + V+     D  V     T+ D    I+++L A+ Y H
Sbjct: 76  PNIVALDDIY--ESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLH 133
Query: 237 SQGIMHRDVKPHNVM---IDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD 293
             GI+HRD+KP N++   +D +  K+ + D+GL++   PG   +    +  +  PE+L  
Sbjct: 134 DLGIVHRDLKPENLLYYSLDED-SKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQ 192
Query: 294 LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNH--DQLVKIAKDCCLIIWCNSRHSRKP 351
            + Y  ++D WS+G +   ++    PF+  +D    +Q++K   +     W +       
Sbjct: 193 -KPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDD------- 244
Query: 352 WSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFA 396
                       +S  A DF+  L+  D + R T  +A+ HP+ A
Sbjct: 245 ------------ISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIA 277

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 66/290 (22%), Positives = 121/290 (41%), Gaps = 35/290 (12%)
Query: 115 ESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTN-----ERCXXXXXXXXXXXXXXXX 169
           ES   QW   +D+E+ R +G+GK+  V+      +      +                  
Sbjct: 25  ESKKRQWA-LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRR 83
Query: 170 XXXLQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYD---IRYYIY 226
              +Q+    PN+++L     D  +    LI EY            L+ +D      YI 
Sbjct: 84  EVEIQSHLRHPNILRLYGYFHD--ATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT 141
Query: 227 ELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFK 286
           EL  AL YCHS+ ++HRD+KP N+++     +L++ D+G +  + P         +  + 
Sbjct: 142 ELANALSYCHSKRVIHRDIKPENLLLG-SAGELKIADFGWS-VHAPSSRRTTLCGTLDYL 199
Query: 287 GPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSR 346
            PE +++ + +D  +D+WSLG +    +  K P F  +   +   +I++           
Sbjct: 200 PPE-MIEGRMHDEKVDLWSLGVLCYEFLVGKPP-FEANTYQETYKRISR----------- 246
Query: 347 HSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFA 396
                  +F   D    V+  A D + +LL+++   R   RE + HP+  
Sbjct: 247 ------VEFTFPD---FVTEGARDLISRLLKHNPSQRPMLREVLEHPWIT 287

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 43/202 (21%), Positives = 97/202 (48%), Gaps = 10/202 (4%)
Query: 126 DYEVVRKVGRGKYSEVFEGINVNTNE----RCXXXXXXXXXXXXXXXXXXXLQNLCGGPN 181
           +Y +++ +G+G +++V    ++ T +    +                    +  +   PN
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPN 74
Query: 182 VVKLLDIVRDQHSKTPSLIFEYVNST---DFKVLYPTLTDYDIRYYIYELLKALDYCHSQ 238
           +VKL +++  +  KT  L+ EY +     D+ V +  + + + R    +++ A+ YCH +
Sbjct: 75  IVKLFEVIETE--KTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQK 132
Query: 239 GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYD 298
            I+HRD+K  N+++D ++  +++ D+G +  +  G + +    S  +  PEL    +   
Sbjct: 133 FIVHRDLKAENLLLDADM-NIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKKYDG 191
Query: 299 YSLDMWSLGCMFAGMIFRKEPF 320
             +D+WSLG +   ++    PF
Sbjct: 192 PEVDVWSLGVILYTLVSGSLPF 213

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 54/189 (28%), Positives = 92/189 (48%), Gaps = 29/189 (15%)
Query: 216 LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGL-AEFYHPGK 274
            T+   R+Y  E++ AL+Y HS+ +++RD+K  N+M+D +   +++ D+GL  E    G 
Sbjct: 102 FTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKD-GHIKITDFGLCKEGISDGA 160
Query: 275 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA 334
                  +  +  PE+L D  DY  ++D W LG +   M+  + PF+  + +H++L +  
Sbjct: 161 TMKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFY--NQDHERLFE-- 215
Query: 335 KDCCLIIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLT-----AREA 389
               LI+    R  R              +SPEA   L  LL+ D + RL      A+E 
Sbjct: 216 ----LILMEEIRFPRT-------------LSPEAKSLLAGLLKKDPKQRLGGGPSDAKEV 258
Query: 390 MAHPYFAQV 398
           M H +F  +
Sbjct: 259 MEHRFFLSI 267

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 69/285 (24%), Positives = 122/285 (42%), Gaps = 36/285 (12%)
Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTNE----RCXXXXXXXXXXXXXXXXXXXLQNLCGG 179
           +D Y+    +G G +SEV    +  T +    +C                   L  +   
Sbjct: 17  RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKI-KH 75
Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNST---DFKVLYPTLTDYDIRYYIYELLKALDYCH 236
           PN+V L DI   +      LI + V+     D  V     T+ D    I+++L A+ Y H
Sbjct: 76  PNIVALDDIY--ESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLH 133
Query: 237 SQGIMHRDVKPHNVM---IDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD 293
             GI+HRD+KP N++   +D +  K+ + D+GL++   PG   +    +  +  PE+L  
Sbjct: 134 DLGIVHRDLKPENLLYYSLDED-SKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQ 192
Query: 294 LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNH--DQLVKIAKDCCLIIWCNSRHSRKP 351
            + Y  ++D WS+G +   ++    PF+  +D    +Q++K   +     W +       
Sbjct: 193 -KPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDD------- 244
Query: 352 WSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFA 396
                       +S  A DF+  L+  D + R T  +A+ HP+ A
Sbjct: 245 ------------ISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIA 277

>pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/236 (24%), Positives = 105/236 (44%), Gaps = 48/236 (20%)
Query: 200 IFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRK- 258
           ++E +    F+     L    +R + + +L+ LD  H   I+H D+KP N+++  + R  
Sbjct: 185 LYELIKKNKFQGFSLPL----VRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSG 240
Query: 259 LRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKE 318
           +++ID+G + + H  +     + SR+++ PE+++  + Y   +DMWSLGC+ A ++    
Sbjct: 241 IKVIDFGSSCYEH--QRVYXXIQSRFYRAPEVILGAR-YGMPIDMWSLGCILAELL-TGY 296
Query: 319 PFFYGHDNHDQLV-----------------KIAKD----------CCLI------IWCNS 345
           P   G D  DQL                  K AK+          C +       +  N 
Sbjct: 297 PLLPGEDEGDQLACMIELLGMPXQKLLDASKRAKNFVSXKGYPRYCTVTTLSDGSVVLNG 356
Query: 346 RHSRK------PWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF 395
             SR+      P S+      +    P  +DFL + L +D   R+T  +A+ HP+ 
Sbjct: 357 GRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQALRHPWL 412

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 66/290 (22%), Positives = 121/290 (41%), Gaps = 35/290 (12%)
Query: 115 ESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTN-----ERCXXXXXXXXXXXXXXXX 169
           ES   QW   +D+E+ R +G+GK+  V+      +      +                  
Sbjct: 2   ESKKRQWA-LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRR 60
Query: 170 XXXLQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYD---IRYYIY 226
              +Q+    PN+++L     D  +    LI EY            L+ +D      YI 
Sbjct: 61  EVEIQSHLRHPNILRLYGYFHD--ATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT 118
Query: 227 ELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFK 286
           EL  AL YCHS+ ++HRD+KP N+++     +L++ D+G +  + P         +  + 
Sbjct: 119 ELANALSYCHSKRVIHRDIKPENLLLG-SAGELKIADFGWS-VHAPSSRRTTLCGTLDYL 176
Query: 287 GPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSR 346
            PE +++ + +D  +D+WSLG +    +  K P F  +   +   +I++           
Sbjct: 177 PPE-MIEGRMHDEKVDLWSLGVLCYEFLVGKPP-FEANTYQETYKRISR----------- 223
Query: 347 HSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFA 396
                  +F   D    V+  A D + +LL+++   R   RE + HP+  
Sbjct: 224 ------VEFTFPD---FVTEGARDLISRLLKHNPSQRPMLREVLEHPWIT 264

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 54/189 (28%), Positives = 92/189 (48%), Gaps = 29/189 (15%)
Query: 216 LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGL-AEFYHPGK 274
            T+   R+Y  E++ AL+Y HS+ +++RD+K  N+M+D +   +++ D+GL  E    G 
Sbjct: 102 FTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKD-GHIKITDFGLCKEGISDGA 160
Query: 275 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA 334
                  +  +  PE+L D  DY  ++D W LG +   M+  + PF+  + +H++L +  
Sbjct: 161 TMKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFY--NQDHERLFE-- 215
Query: 335 KDCCLIIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLT-----AREA 389
               LI+    R  R              +SPEA   L  LL+ D + RL      A+E 
Sbjct: 216 ----LILMEEIRFPRT-------------LSPEAKSLLAGLLKKDPKQRLGGGPSDAKEV 258
Query: 390 MAHPYFAQV 398
           M H +F  +
Sbjct: 259 MEHRFFLSI 267

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 54/189 (28%), Positives = 92/189 (48%), Gaps = 29/189 (15%)
Query: 216 LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGL-AEFYHPGK 274
            T+   R+Y  E++ AL+Y HS+ +++RD+K  N+M+D +   +++ D+GL  E    G 
Sbjct: 105 FTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKD-GHIKITDFGLCKEGISDGA 163
Query: 275 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA 334
                  +  +  PE+L D  DY  ++D W LG +   M+  + PF+  + +H++L +  
Sbjct: 164 TMKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFY--NQDHERLFE-- 218
Query: 335 KDCCLIIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLT-----AREA 389
               LI+    R  R              +SPEA   L  LL+ D + RL      A+E 
Sbjct: 219 ----LILMEEIRFPRT-------------LSPEAKSLLAGLLKKDPKQRLGGGPSDAKEV 261
Query: 390 MAHPYFAQV 398
           M H +F  +
Sbjct: 262 MEHRFFLSI 270

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 71/283 (25%), Positives = 120/283 (42%), Gaps = 32/283 (11%)
Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTNE----RCXXXXXXXXXXXXXXXXXXXLQNLCGG 179
           +D Y+    +G G +SEV    +  T +    +C                   L  +   
Sbjct: 17  RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKI-KH 75
Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNST---DFKVLYPTLTDYDIRYYIYELLKALDYCH 236
           PN+V L DI   +      LI + V+     D  V     T+ D    I+++L A+ Y H
Sbjct: 76  PNIVALDDIY--ESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLH 133
Query: 237 SQGIMHRDVKPHNVM---IDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD 293
             GI+HRD+KP N++   +D +  K+ + D+GL++   PG   +    +  +  PE+L  
Sbjct: 134 DLGIVHRDLKPENLLYYSLDED-SKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQ 192
Query: 294 LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWS 353
            + Y  ++D WS+G +   ++    PF+   D +D     AK    I+          W 
Sbjct: 193 -KPYSKAVDCWSIGVIAYILLCGYPPFY---DEND-----AKLFEQILKAEYEFDSPYWD 243
Query: 354 KFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFA 396
                     +S  A DF+  L+  D + R T  +A+ HP+ A
Sbjct: 244 D---------ISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIA 277

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 66/290 (22%), Positives = 121/290 (41%), Gaps = 35/290 (12%)
Query: 115 ESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTN-----ERCXXXXXXXXXXXXXXXX 169
           ES   QW   +D+E+ R +G+GK+  V+      +      +                  
Sbjct: 16  ESKKRQWA-LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRR 74
Query: 170 XXXLQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYD---IRYYIY 226
              +Q+    PN+++L     D  +    LI EY            L+ +D      YI 
Sbjct: 75  EVEIQSHLRHPNILRLYGYFHD--ATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT 132
Query: 227 ELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFK 286
           EL  AL YCHS+ ++HRD+KP N+++     +L++ D+G +  + P         +  + 
Sbjct: 133 ELANALSYCHSKRVIHRDIKPENLLLG-SAGELKIADFGWS-VHAPSSRRTTLCGTLDYL 190
Query: 287 GPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSR 346
            PE +++ + +D  +D+WSLG +    +  K P F  +   +   +I++           
Sbjct: 191 PPE-MIEGRMHDEKVDLWSLGVLCYEFLVGKPP-FEANTYQETYKRISR----------- 237
Query: 347 HSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFA 396
                  +F   D    V+  A D + +LL+++   R   RE + HP+  
Sbjct: 238 ------VEFTFPD---FVTEGARDLISRLLKHNPSQRPMLREVLEHPWIT 278

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 66/290 (22%), Positives = 121/290 (41%), Gaps = 35/290 (12%)
Query: 115 ESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTN-----ERCXXXXXXXXXXXXXXXX 169
           ES   QW   +D+E+ R +G+GK+  V+      +      +                  
Sbjct: 2   ESKKRQWA-LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRR 60
Query: 170 XXXLQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYD---IRYYIY 226
              +Q+    PN+++L     D  +    LI EY            L+ +D      YI 
Sbjct: 61  EVEIQSHLRHPNILRLYGYFHD--ATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT 118
Query: 227 ELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFK 286
           EL  AL YCHS+ ++HRD+KP N+++     +L++ D+G +  + P         +  + 
Sbjct: 119 ELANALSYCHSKRVIHRDIKPENLLLG-SAGELKIADFGWS-VHAPSSRRTTLCGTLDYL 176
Query: 287 GPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSR 346
            PE +++ + +D  +D+WSLG +    +  K P F  +   +   +I++           
Sbjct: 177 PPE-MIEGRMHDEKVDLWSLGVLCYEFLVGKPP-FEANTYQETYKRISR----------- 223
Query: 347 HSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFA 396
                  +F   D    V+  A D + +LL+++   R   RE + HP+  
Sbjct: 224 ------VEFTFPD---FVTEGARDLISRLLKHNPSQRPMLREVLEHPWIT 264

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 69/279 (24%), Positives = 114/279 (40%), Gaps = 27/279 (9%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXXXXXXXXXXXXXXXLQNLCGGPNVVK 184
           D YEV   +G G YS     I+  TN                      L+     PN++ 
Sbjct: 22  DGYEVKEDIGVGSYSVCKRCIHKATNXEFAVKIIDKSKRDPTEEIEILLR-YGQHPNIIT 80
Query: 185 LLDIVRDQHSKTPSLIFEYVNSTDF--KVLYPTL-TDYDIRYYIYELLKALDYCHSQGIM 241
           L D+  D   K   ++ E     +   K+L     ++ +    ++ + K ++Y H+QG++
Sbjct: 81  LKDVYDD--GKYVYVVTELXKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVV 138
Query: 242 HRDVKPHNVMIDHEL---RKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDLQDY 297
           HRD+KP N++   E      +R+ D+G A +             +  F  PE+L + Q Y
Sbjct: 139 HRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLXTPCYTANFVAPEVL-ERQGY 197
Query: 298 DYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSKF-I 356
           D + D+WSLG +    +    PF  G D+  + +                +R    KF +
Sbjct: 198 DAACDIWSLGVLLYTXLTGYTPFANGPDDTPEEIL---------------ARIGSGKFSL 242
Query: 357 NADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF 395
           +    + VS  A D + K L  D   RLTA   + HP+ 
Sbjct: 243 SGGYWNSVSDTAKDLVSKXLHVDPHQRLTAALVLRHPWI 281

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 48/188 (25%), Positives = 82/188 (43%), Gaps = 28/188 (14%)
Query: 216 LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRK--LRLIDWGLAEFYHPG 273
           L +   + Y Y++L A+ Y H  GI+HRD+KP NV++  +     +++ D+G ++     
Sbjct: 110 LKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET 169
Query: 274 KEYNVRVASRYFKGPELLVDL--QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNH---- 327
                   +  +  PE+LV +    Y+ ++D WSLG +   +     P F  H       
Sbjct: 170 SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILF-ICLSGYPPFSEHRTQVSLK 228
Query: 328 DQLVKIAKDCCLIIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAR 387
           DQ+     +    +W                     VS +A+D + KLL  D + R T  
Sbjct: 229 DQITSGKYNFIPEVWAE-------------------VSEKALDLVKKLLVVDPKARFTTE 269
Query: 388 EAMAHPYF 395
           EA+ HP+ 
Sbjct: 270 EALRHPWL 277

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 48/188 (25%), Positives = 82/188 (43%), Gaps = 28/188 (14%)
Query: 216 LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRK--LRLIDWGLAEFYHPG 273
           L +   + Y Y++L A+ Y H  GI+HRD+KP NV++  +     +++ D+G ++     
Sbjct: 117 LKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET 176
Query: 274 KEYNVRVASRYFKGPELLVDL--QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNH---- 327
                   +  +  PE+LV +    Y+ ++D WSLG +   +     P F  H       
Sbjct: 177 SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILF-ICLSGYPPFSEHRTQVSLK 235
Query: 328 DQLVKIAKDCCLIIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAR 387
           DQ+     +    +W                     VS +A+D + KLL  D + R T  
Sbjct: 236 DQITSGKYNFIPEVWAE-------------------VSEKALDLVKKLLVVDPKARFTTE 276
Query: 388 EAMAHPYF 395
           EA+ HP+ 
Sbjct: 277 EALRHPWL 284

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 48/188 (25%), Positives = 82/188 (43%), Gaps = 28/188 (14%)
Query: 216 LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRK--LRLIDWGLAEFYHPG 273
           L +   + Y Y++L A+ Y H  GI+HRD+KP NV++  +     +++ D+G ++     
Sbjct: 111 LKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET 170
Query: 274 KEYNVRVASRYFKGPELLVDL--QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNH---- 327
                   +  +  PE+LV +    Y+ ++D WSLG +   +     P F  H       
Sbjct: 171 SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILF-ICLSGYPPFSEHRTQVSLK 229
Query: 328 DQLVKIAKDCCLIIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAR 387
           DQ+     +    +W                     VS +A+D + KLL  D + R T  
Sbjct: 230 DQITSGKYNFIPEVWAE-------------------VSEKALDLVKKLLVVDPKARFTTE 270
Query: 388 EAMAHPYF 395
           EA+ HP+ 
Sbjct: 271 EALRHPWL 278

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 48/188 (25%), Positives = 82/188 (43%), Gaps = 28/188 (14%)
Query: 216 LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRK--LRLIDWGLAEFYHPG 273
           L +   + Y Y++L A+ Y H  GI+HRD+KP NV++  +     +++ D+G ++     
Sbjct: 111 LKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET 170
Query: 274 KEYNVRVASRYFKGPELLVDL--QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNH---- 327
                   +  +  PE+LV +    Y+ ++D WSLG +   +     P F  H       
Sbjct: 171 SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILF-ICLSGYPPFSEHRTQVSLK 229
Query: 328 DQLVKIAKDCCLIIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAR 387
           DQ+     +    +W                     VS +A+D + KLL  D + R T  
Sbjct: 230 DQITSGKYNFIPEVWAE-------------------VSEKALDLVKKLLVVDPKARFTTE 270
Query: 388 EAMAHPYF 395
           EA+ HP+ 
Sbjct: 271 EALRHPWL 278

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 43/202 (21%), Positives = 97/202 (48%), Gaps = 10/202 (4%)
Query: 126 DYEVVRKVGRGKYSEVFEGINVNTNE----RCXXXXXXXXXXXXXXXXXXXLQNLCGGPN 181
           +Y +++ +G+G +++V    ++ T +    +                    +  +   PN
Sbjct: 8   NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPN 67
Query: 182 VVKLLDIVRDQHSKTPSLIFEYVNST---DFKVLYPTLTDYDIRYYIYELLKALDYCHSQ 238
           +VKL +++  +  KT  L+ EY +     D+ V +  + + + R    +++ A+ YCH +
Sbjct: 68  IVKLFEVIETE--KTLYLVMEYASGGEVFDYLVAHGWMKEKEARAKFRQIVSAVQYCHQK 125
Query: 239 GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYD 298
            I+HRD+K  N+++D ++  +++ D+G +  +  G + +    S  +  PEL    +   
Sbjct: 126 FIVHRDLKAENLLLDADM-NIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKKYDG 184
Query: 299 YSLDMWSLGCMFAGMIFRKEPF 320
             +D+WSLG +   ++    PF
Sbjct: 185 PEVDVWSLGVILYTLVSGSLPF 206

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 48/188 (25%), Positives = 82/188 (43%), Gaps = 28/188 (14%)
Query: 216 LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRK--LRLIDWGLAEFYHPG 273
           L +   + Y Y++L A+ Y H  GI+HRD+KP NV++  +     +++ D+G ++     
Sbjct: 111 LKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET 170
Query: 274 KEYNVRVASRYFKGPELLVDL--QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNH---- 327
                   +  +  PE+LV +    Y+ ++D WSLG +   +     P F  H       
Sbjct: 171 SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILF-ICLSGYPPFSEHRTQVSLK 229
Query: 328 DQLVKIAKDCCLIIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAR 387
           DQ+     +    +W                     VS +A+D + KLL  D + R T  
Sbjct: 230 DQITSGKYNFIPEVWAE-------------------VSEKALDLVKKLLVVDPKARFTTE 270
Query: 388 EAMAHPYF 395
           EA+ HP+ 
Sbjct: 271 EALRHPWL 278

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 54/190 (28%), Positives = 87/190 (45%), Gaps = 31/190 (16%)
Query: 216 LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE--FYHPG 273
            T+ D+++Y+ EL  ALD+ HS GI++RD+KP N+++D E   ++L D+GL++    H  
Sbjct: 123 FTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEE-GHIKLTDFGLSKESIDHEK 181
Query: 274 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI 333
           K Y+      Y   PE +V+ + +  S D WS G +   M+    P F G D  + +  I
Sbjct: 182 KAYSFCGTVEYM-APE-VVNRRGHTQSADWWSFGVLMFEMLTGTLP-FQGKDRKETMTMI 238
Query: 334 AKDCCLIIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTA-----RE 388
            K                            +SPEA   L  L + +  +RL A      E
Sbjct: 239 LK--------------------AKLGMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEE 278
Query: 389 AMAHPYFAQV 398
              H +F+ +
Sbjct: 279 IKRHSFFSTI 288

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 72/299 (24%), Positives = 126/299 (42%), Gaps = 38/299 (12%)
Query: 113 DYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXXXXXXXXXXXXXXX 172
           D +SLT Q   ++ ++V+ K+G G Y  V++ I+  T +                     
Sbjct: 19  DEDSLTKQ--PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIKEIS 76
Query: 173 LQNLCGGPNVVKLLDIVRDQHSKTPSL--IFEYVNSTD----FKVLYPTLTDYDIRYYIY 226
           +   C  P+VVK        + K   L  + EY  +       ++   TLT+ +I   + 
Sbjct: 77  IMQQCDSPHVVKYYG----SYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQ 132
Query: 227 ELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEYNVRVASRYF 285
             LK L+Y H    +HRD+K  N++++ E    +L D+G+A +      + N  + + ++
Sbjct: 133 STLKGLEYLHFMRKIHRDIKAGNILLNTE-GHAKLADFGVAGQLTDXMAKRNXVIGTPFW 191
Query: 286 KGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNS 345
             PE++ ++  Y+   D+WSLG     M   K P+   H               +I  N 
Sbjct: 192 MAPEVIQEI-GYNCVADIWSLGITAIEMAEGKPPYADIHPMR---------AIFMIPTNP 241
Query: 346 RHS-RKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAES 403
             + RKP           L S    DF+ + L    + R TA + + HP+   VR+A+ 
Sbjct: 242 PPTFRKP----------ELWSDNFTDFVKQCLVKSPEQRATATQLLQHPF---VRSAKG 287

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 66/290 (22%), Positives = 120/290 (41%), Gaps = 35/290 (12%)
Query: 115 ESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTN-----ERCXXXXXXXXXXXXXXXX 169
           ES   QW   +D+E+ R +G+GK+  V+      +      +                  
Sbjct: 4   ESKKRQWA-LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRR 62
Query: 170 XXXLQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYD---IRYYIY 226
              +Q+    PN+++L     D  +    LI EY            L+ +D      YI 
Sbjct: 63  EVEIQSHLRHPNILRLYGYFHD--ATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT 120
Query: 227 ELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFK 286
           EL  AL YCHS+ ++HRD+KP N+++     +L++ D+G +  + P         +  + 
Sbjct: 121 ELANALSYCHSKRVIHRDIKPENLLLG-SAGELKIADFGWS-VHAPSSRRTTLCGTLDYL 178
Query: 287 GPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSR 346
            PE  ++ + +D  +D+WSLG +    +  K P F  +   +   +I++           
Sbjct: 179 PPE-XIEGRXHDEKVDLWSLGVLCYEFLVGKPP-FEANTYQETYKRISR----------- 225
Query: 347 HSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFA 396
                  +F   D    V+  A D + +LL+++   R   RE + HP+  
Sbjct: 226 ------VEFTFPD---FVTEGARDLISRLLKHNPSQRPXLREVLEHPWIT 266

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 54/190 (28%), Positives = 87/190 (45%), Gaps = 31/190 (16%)
Query: 216 LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE--FYHPG 273
            T+ D+++Y+ EL  ALD+ HS GI++RD+KP N+++D E   ++L D+GL++    H  
Sbjct: 124 FTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEE-GHIKLTDFGLSKESIDHEK 182
Query: 274 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI 333
           K Y+      Y   PE +V+ + +  S D WS G +   M+    P F G D  + +  I
Sbjct: 183 KAYSFCGTVEYM-APE-VVNRRGHTQSADWWSFGVLMFEMLTGTLP-FQGKDRKETMTMI 239
Query: 334 AKDCCLIIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTA-----RE 388
            K                            +SPEA   L  L + +  +RL A      E
Sbjct: 240 LK--------------------AKLGMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEE 279
Query: 389 AMAHPYFAQV 398
              H +F+ +
Sbjct: 280 IKRHSFFSTI 289

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 72/283 (25%), Positives = 118/283 (41%), Gaps = 27/283 (9%)
Query: 125 DDYEVVRKV-GRGKYSEVFEGINVNTNERCXXXXXXXXXXXXXXXXXXXLQNLCGGPNVV 183
           DDY++ ++V G G   +V E  +  T ++C                        GGP++V
Sbjct: 9   DDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQEVDHHW--QASGGPHIV 66
Query: 184 KLLDIVRDQHSKTPSL--IFEYVNSTD-FKVLYP----TLTDYDIRYYIYELLKALDYCH 236
            +LD+  + H     L  I E +   + F  +        T+ +    + ++  A+ + H
Sbjct: 67  CILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLH 126
Query: 237 SQGIMHRDVKPHNVMIDHELRK--LRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDL 294
           S  I HRDVKP N++   + +   L+L D+G A+             + Y+  PE+L   
Sbjct: 127 SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAK-ETTQNALQTPCYTPYYVAPEVL-GP 184
Query: 295 QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSK 354
           + YD S DMWSLG +   ++    PF+    N  Q +              R  R     
Sbjct: 185 EKYDKSCDMWSLGVIMYILLCGFPPFY---SNTGQAISPGM---------KRRIRLGQYG 232
Query: 355 FINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQ 397
           F N +    VS +A   +  LL+ D  +RLT  + M HP+  Q
Sbjct: 233 FPNPEWSE-VSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQ 274

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 54/189 (28%), Positives = 92/189 (48%), Gaps = 29/189 (15%)
Query: 216 LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGL-AEFYHPGK 274
            T+   R+Y  E++ AL+Y HS+ +++RD+K  N+M+D +   +++ D+GL  E    G 
Sbjct: 102 FTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKD-GHIKITDFGLCKEGISDGA 160
Query: 275 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA 334
                  +  +  PE+L D  DY  ++D W LG +   M+  + PF+  + +H++L +  
Sbjct: 161 TMKXFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFY--NQDHERLFE-- 215
Query: 335 KDCCLIIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLT-----AREA 389
               LI+    R  R              +SPEA   L  LL+ D + RL      A+E 
Sbjct: 216 ----LILMEEIRFPRT-------------LSPEAKSLLAGLLKKDPKQRLGGGPSDAKEV 258
Query: 390 MAHPYFAQV 398
           M H +F  +
Sbjct: 259 MEHRFFLSI 267

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 54/189 (28%), Positives = 92/189 (48%), Gaps = 29/189 (15%)
Query: 216 LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGL-AEFYHPGK 274
            T+   R+Y  E++ AL+Y HS+ +++RD+K  N+M+D +   +++ D+GL  E    G 
Sbjct: 102 FTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKD-GHIKITDFGLCKEGISDGA 160
Query: 275 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA 334
                  +  +  PE+L D  DY  ++D W LG +   M+  + PF+  + +H++L +  
Sbjct: 161 TMKXFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFY--NQDHERLFE-- 215
Query: 335 KDCCLIIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLT-----AREA 389
               LI+    R  R              +SPEA   L  LL+ D + RL      A+E 
Sbjct: 216 ----LILMEEIRFPRT-------------LSPEAKSLLAGLLKKDPKQRLGGGPSDAKEV 258
Query: 390 MAHPYFAQV 398
           M H +F  +
Sbjct: 259 MEHRFFLSI 267

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 72/283 (25%), Positives = 118/283 (41%), Gaps = 27/283 (9%)
Query: 125 DDYEVVRKV-GRGKYSEVFEGINVNTNERCXXXXXXXXXXXXXXXXXXXLQNLCGGPNVV 183
           DDY++ ++V G G   +V E  +  T ++C                        GGP++V
Sbjct: 28  DDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQEVDHHW--QASGGPHIV 85
Query: 184 KLLDIVRDQHSKTPSL--IFEYVNSTD-FKVLYP----TLTDYDIRYYIYELLKALDYCH 236
            +LD+  + H     L  I E +   + F  +        T+ +    + ++  A+ + H
Sbjct: 86  CILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLH 145
Query: 237 SQGIMHRDVKPHNVMIDHELRK--LRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDL 294
           S  I HRDVKP N++   + +   L+L D+G A+             + Y+  PE+L   
Sbjct: 146 SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAK-ETTQNALQTPCYTPYYVAPEVL-GP 203
Query: 295 QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSK 354
           + YD S DMWSLG +   ++    PF+    N  Q +              R  R     
Sbjct: 204 EKYDKSCDMWSLGVIMYILLCGFPPFY---SNTGQAISPGM---------KRRIRLGQYG 251
Query: 355 FINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQ 397
           F N +    VS +A   +  LL+ D  +RLT  + M HP+  Q
Sbjct: 252 FPNPEWSE-VSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQ 293

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 43/122 (35%), Positives = 67/122 (54%), Gaps = 19/122 (15%)
Query: 227 ELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH-------------PG 273
           ++L+AL Y HSQGI+HRD+KP N+ ID E R +++ D+GLA+  H             PG
Sbjct: 124 QILEALSYIHSQGIIHRDLKPMNIFID-ESRNVKIGDFGLAKNVHRSLDILKLDSQNLPG 182
Query: 274 KEYNVR--VASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV 331
              N+   + +  +   E+L     Y+  +DM+SLG +F  MI+   PF  G +  + L 
Sbjct: 183 SSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVNILK 239
Query: 332 KI 333
           K+
Sbjct: 240 KL 241

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 66/290 (22%), Positives = 121/290 (41%), Gaps = 35/290 (12%)
Query: 115 ESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTN-----ERCXXXXXXXXXXXXXXXX 169
           ES   QW   +D+E+ R +G+GK+  V+      +      +                  
Sbjct: 1   ESKKRQWA-LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRR 59
Query: 170 XXXLQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYD---IRYYIY 226
              +Q+    PN+++L     D  +    LI EY            L+ +D      YI 
Sbjct: 60  EVEIQSHLRHPNILRLYGYFHD--ATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT 117
Query: 227 ELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFK 286
           EL  AL YCHS+ ++HRD+KP N+++     +L++ D+G +  + P         +  + 
Sbjct: 118 ELANALSYCHSKRVIHRDIKPENLLLG-SAGELKIADFGWS-VHAPSSRRXXLCGTLDYL 175
Query: 287 GPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSR 346
            PE +++ + +D  +D+WSLG +    +  K P F  +   +   +I++           
Sbjct: 176 PPE-MIEGRMHDEKVDLWSLGVLCYEFLVGKPP-FEANTYQETYKRISR----------- 222
Query: 347 HSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFA 396
                  +F   D    V+  A D + +LL+++   R   RE + HP+  
Sbjct: 223 ------VEFTFPD---FVTEGARDLISRLLKHNPSQRPMLREVLEHPWIT 263

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 43/122 (35%), Positives = 67/122 (54%), Gaps = 19/122 (15%)
Query: 227 ELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH-------------PG 273
           ++L+AL Y HSQGI+HRD+KP N+ ID E R +++ D+GLA+  H             PG
Sbjct: 124 QILEALSYIHSQGIIHRDLKPMNIFID-ESRNVKIGDFGLAKNVHRSLDILKLDSQNLPG 182
Query: 274 KEYNVR--VASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV 331
              N+   + +  +   E+L     Y+  +DM+SLG +F  MI+   PF  G +  + L 
Sbjct: 183 SSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVNILK 239
Query: 332 KI 333
           K+
Sbjct: 240 KL 241

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 54/189 (28%), Positives = 92/189 (48%), Gaps = 29/189 (15%)
Query: 216 LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGL-AEFYHPGK 274
            T+   R+Y  E++ AL+Y HS+ +++RD+K  N+M+D +   +++ D+GL  E    G 
Sbjct: 107 FTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKD-GHIKITDFGLCKEGISDGA 165
Query: 275 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA 334
                  +  +  PE+L D  DY  ++D W LG +   M+  + PF+  + +H++L +  
Sbjct: 166 TMKXFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFY--NQDHERLFE-- 220
Query: 335 KDCCLIIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLT-----AREA 389
               LI+    R  R              +SPEA   L  LL+ D + RL      A+E 
Sbjct: 221 ----LILMEEIRFPRT-------------LSPEAKSLLAGLLKKDPKQRLGGGPSDAKEV 263
Query: 390 MAHPYFAQV 398
           M H +F  +
Sbjct: 264 MEHRFFLSI 272

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 54/190 (28%), Positives = 87/190 (45%), Gaps = 31/190 (16%)
Query: 216 LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE--FYHPG 273
            T+ D+++Y+ EL  ALD+ HS GI++RD+KP N+++D E   ++L D+GL++    H  
Sbjct: 123 FTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEE-GHIKLTDFGLSKESIDHEK 181
Query: 274 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI 333
           K Y+      Y   PE +V+ + +  S D WS G +   M+    P F G D  + +  I
Sbjct: 182 KAYSFCGTVEYM-APE-VVNRRGHTQSADWWSFGVLMFEMLTGTLP-FQGKDRKETMTMI 238
Query: 334 AKDCCLIIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTA-----RE 388
            K                            +SPEA   L  L + +  +RL A      E
Sbjct: 239 LK--------------------AKLGMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEE 278
Query: 389 AMAHPYFAQV 398
              H +F+ +
Sbjct: 279 IKRHSFFSTI 288

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 94/212 (44%), Gaps = 28/212 (13%)
Query: 199 LIFEYVNSTDFKVLYP---TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE 255
            + EYVN  D          L +   R+Y  E+  AL+Y H +GI++RD+K  NV++D E
Sbjct: 130 FVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSE 189
Query: 256 LRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMI 314
              ++L D+G+  E   PG   +    +  +  PE+L   +DY +S+D W+LG +   M+
Sbjct: 190 -GHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRG-EDYGFSVDWWALGVLMFEMM 247
Query: 315 FRKEPF--FYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSKFINADNQHLVSPEAIDFL 372
             + PF      DN DQ      +  L      +  R P S          +S +A   L
Sbjct: 248 AGRSPFDIVGSSDNPDQ----NTEDYLFQVILEKQIRIPRS----------LSVKAASVL 293
Query: 373 DKLLRYDHQDRLTAR------EAMAHPYFAQV 398
              L  D ++RL         +   HP+F  V
Sbjct: 294 KSFLNKDPKERLGCHPQTGFADIQGHPFFRNV 325

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 66/287 (22%), Positives = 120/287 (41%), Gaps = 43/287 (14%)
Query: 120 QWGDQDDYEVVRKVGRGKYSEVFEGINVNTN-----ERCXXXXXXXXXXXXXXXXXXXLQ 174
           QW   +D+++ R +G+GK+  V+      +      +                     +Q
Sbjct: 8   QW-TLEDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQ 66
Query: 175 NLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYD---IRYYIYELLKA 231
           +    PN+++L     D  +    LI EY            L+ +D      YI EL  A
Sbjct: 67  SHLRHPNILRLYGYFHD--ATRVYLILEYAPLGTVYRELQKLSRFDEQRTATYITELANA 124
Query: 232 LDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELL 291
           L YCHS+ ++HRD+KP N+++     +L++ D+G +  + P         +  +  PE +
Sbjct: 125 LSYCHSKRVIHRDIKPENLLLGSN-GELKIADFGWS-VHAPSSRRTTLCGTLDYLPPE-M 181
Query: 292 VDLQDYDYSLDMWSLGCM----FAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRH 347
           ++ + +D  +D+WSLG +      GM     P F  H   +   +I++            
Sbjct: 182 IEGRMHDEKVDLWSLGVLCYEFLVGM-----PPFEAHTYQETYRRISR------------ 224
Query: 348 SRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPY 394
                 +F   D    V+  A D + +LL+++   RLT  E + HP+
Sbjct: 225 -----VEFTFPD---FVTEGARDLISRLLKHNASQRLTLAEVLEHPW 263

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 42/202 (20%), Positives = 97/202 (48%), Gaps = 10/202 (4%)
Query: 126 DYEVVRKVGRGKYSEVFEGINVNTNE----RCXXXXXXXXXXXXXXXXXXXLQNLCGGPN 181
           +Y +++ +G+G +++V    ++ T +    +                    +  +   PN
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPN 74
Query: 182 VVKLLDIVRDQHSKTPSLIFEYVNST---DFKVLYPTLTDYDIRYYIYELLKALDYCHSQ 238
           +VKL +++  +  KT  L+ EY +     D+ V +  + + + R    +++ A+ YCH +
Sbjct: 75  IVKLFEVIETE--KTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQK 132
Query: 239 GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYD 298
            I+HRD+K  N+++D ++  +++ D+G +  +  G + +    +  +  PEL    +   
Sbjct: 133 FIVHRDLKAENLLLDADM-NIKIADFGFSNEFTFGNKLDAFCGAPPYAAPELFQGKKYDG 191
Query: 299 YSLDMWSLGCMFAGMIFRKEPF 320
             +D+WSLG +   ++    PF
Sbjct: 192 PEVDVWSLGVILYTLVSGSLPF 213

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 102/221 (46%), Gaps = 26/221 (11%)
Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNST---DFKVLYPTLTDYDIRYYIYELLKALDYCH 236
           PNV+ L ++  ++      LI E V      DF     +LT+ +   ++ ++L  + Y H
Sbjct: 74  PNVITLHEVYENKTDVI--LILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH 131
Query: 237 SQGIMHRDVKPHNVM-IDHELRK--LRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD 293
           S  I H D+KP N+M +D  + K  +++ID+GLA     G E+     +  F  PE +V+
Sbjct: 132 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPAFVAPE-IVN 190
Query: 294 LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWS 353
            +      DMWS+G +   ++    PF  G    + L  ++         N     + +S
Sbjct: 191 YEPLGLEADMWSIGVITYILLSGASPFL-GDTKQETLANVSA-------VNYEFEDEYFS 242
Query: 354 KFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPY 394
                      S  A DF+ +LL  D + R+T ++++ HP+
Sbjct: 243 N---------TSALAKDFIRRLLVKDPKKRMTIQDSLQHPW 274

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 102/221 (46%), Gaps = 26/221 (11%)
Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNST---DFKVLYPTLTDYDIRYYIYELLKALDYCH 236
           PNV+ L ++  ++      LI E V      DF     +LT+ +   ++ ++L  + Y H
Sbjct: 74  PNVITLHEVYENKTDVI--LILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH 131
Query: 237 SQGIMHRDVKPHNVM-IDHELRK--LRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD 293
           S  I H D+KP N+M +D  + K  +++ID+GLA     G E+     +  F  PE +V+
Sbjct: 132 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPE-IVN 190
Query: 294 LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWS 353
            +      DMWS+G +   ++    PF  G    + L  ++         N     + +S
Sbjct: 191 YEPLGLEADMWSIGVITYILLSGASPFL-GDTKQETLANVSA-------VNYEFEDEYFS 242
Query: 354 KFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPY 394
                      S  A DF+ +LL  D + R+T ++++ HP+
Sbjct: 243 N---------TSALAKDFIRRLLVKDPKKRMTIQDSLQHPW 274

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 66/287 (22%), Positives = 121/287 (42%), Gaps = 43/287 (14%)
Query: 120 QWGDQDDYEVVRKVGRGKYSEVFEGINVNTN-----ERCXXXXXXXXXXXXXXXXXXXLQ 174
           QW   +D+++ R +G+GK+  V+      +      +                     +Q
Sbjct: 8   QW-TLEDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQ 66
Query: 175 NLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYD---IRYYIYELLKA 231
           +    PN+++L     D  +    LI EY            L+ +D      YI EL  A
Sbjct: 67  SHLRHPNILRLYGYFHD--ATRVYLILEYAPLGTVYRELQKLSRFDEQRTATYITELANA 124
Query: 232 LDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELL 291
           L YCHS+ ++HRD+KP N+++     +L++ D+G +  + P    +    +  +  PE +
Sbjct: 125 LSYCHSKRVIHRDIKPENLLLGSN-GELKIADFGWS-VHAPSSRRDTLCGTLDYLPPE-M 181
Query: 292 VDLQDYDYSLDMWSLGCM----FAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRH 347
           ++ + +D  +D+WSLG +      GM     P F  H   +   +I++            
Sbjct: 182 IEGRMHDEKVDLWSLGVLCYEFLVGM-----PPFEAHTYQETYRRISR------------ 224
Query: 348 SRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPY 394
                 +F   D    V+  A D + +LL+++   RLT  E + HP+
Sbjct: 225 -----VEFTFPD---FVTEGARDLISRLLKHNASQRLTLAEVLEHPW 263

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 54/189 (28%), Positives = 92/189 (48%), Gaps = 29/189 (15%)
Query: 216 LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGL-AEFYHPGK 274
            T+   R+Y  E++ AL+Y HS+ +++RD+K  N+M+D +   +++ D+GL  E    G 
Sbjct: 102 FTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKD-GHIKITDFGLCKEGISDGA 160
Query: 275 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA 334
                  +  +  PE+L D  DY  ++D W LG +   M+  + PF+  + +H++L +  
Sbjct: 161 TMKXFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFY--NQDHERLFE-- 215
Query: 335 KDCCLIIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLT-----AREA 389
               LI+    R  R              +SPEA   L  LL+ D + RL      A+E 
Sbjct: 216 ----LILMEEIRFPRT-------------LSPEAKSLLAGLLKKDPKQRLGGGPSDAKEV 258
Query: 390 MAHPYFAQV 398
           M H +F  +
Sbjct: 259 MEHRFFLSI 267

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 43/191 (22%), Positives = 93/191 (48%), Gaps = 28/191 (14%)
Query: 216 LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGK 274
            ++ + R+++++++  + Y HS GI+HRD+   N+++   +  +++ D+GLA +   P +
Sbjct: 109 FSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNM-NIKIADFGLATQLKMPHE 167
Query: 275 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA 334
           ++     +  +  PE+      +    D+WSLGCMF  ++  + PF              
Sbjct: 168 KHYTLCGTPNYISPEIATR-SAHGLESDVWSLGCMFYTLLIGRPPF-------------- 212
Query: 335 KDCCLIIWCNSRHSRKPWSKFINADNQ--HLVSPEAIDFLDKLLRYDHQDRLTAREAMAH 392
                    ++   +   +K + AD +    +S EA D + +LLR +  DRL+    + H
Sbjct: 213 ---------DTDTVKNTLNKVVLADYEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDH 263
Query: 393 PYFAQVRAAES 403
           P+ ++  + +S
Sbjct: 264 PFMSRNSSTKS 274

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 102/221 (46%), Gaps = 26/221 (11%)
Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNST---DFKVLYPTLTDYDIRYYIYELLKALDYCH 236
           PNV+ L ++  ++      LI E V      DF     +LT+ +   ++ ++L  + Y H
Sbjct: 74  PNVITLHEVYENKTDVI--LILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH 131
Query: 237 SQGIMHRDVKPHNVM-IDHELRK--LRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD 293
           S  I H D+KP N+M +D  + K  +++ID+GLA     G E+     +  F  PE +V+
Sbjct: 132 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPE-IVN 190
Query: 294 LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWS 353
            +      DMWS+G +   ++    PF  G    + L  ++         N     + +S
Sbjct: 191 YEPLGLEADMWSIGVITYILLSGASPFL-GDTKQETLANVSA-------VNYEFEDEYFS 242
Query: 354 KFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPY 394
                      S  A DF+ +LL  D + R+T ++++ HP+
Sbjct: 243 N---------TSALAKDFIRRLLVKDPKKRMTIQDSLQHPW 274

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 102/221 (46%), Gaps = 26/221 (11%)
Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNST---DFKVLYPTLTDYDIRYYIYELLKALDYCH 236
           PNV+ L ++  ++      LI E V      DF     +LT+ +   ++ ++L  + Y H
Sbjct: 74  PNVITLHEVYENKTDVI--LILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH 131
Query: 237 SQGIMHRDVKPHNVM-IDHELRK--LRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD 293
           S  I H D+KP N+M +D  + K  +++ID+GLA     G E+     +  F  PE +V+
Sbjct: 132 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPE-IVN 190
Query: 294 LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWS 353
            +      DMWS+G +   ++    PF  G    + L  ++         N     + +S
Sbjct: 191 YEPLGLEADMWSIGVITYILLSGASPFL-GDTKQETLANVSA-------VNYEFEDEYFS 242
Query: 354 KFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPY 394
                      S  A DF+ +LL  D + R+T ++++ HP+
Sbjct: 243 N---------TSALAKDFIRRLLVKDPKKRMTIQDSLQHPW 274

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 64/285 (22%), Positives = 120/285 (42%), Gaps = 35/285 (12%)
Query: 120 QWGDQDDYEVVRKVGRGKYSEVFEGINVNTN-----ERCXXXXXXXXXXXXXXXXXXXLQ 174
           QW   +D+E+ R +G+GK+  V+      +      +                     +Q
Sbjct: 5   QWA-LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQ 63
Query: 175 NLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYD---IRYYIYELLKA 231
           +    PN+++L     D  +    LI EY            L+ +D      YI EL  A
Sbjct: 64  SHLRHPNILRLYGYFHD--ATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA 121
Query: 232 LDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELL 291
           L YCHS+ ++HRD+KP N+++     +L++ D+G +  + P    +    +  +  PE +
Sbjct: 122 LSYCHSKRVIHRDIKPENLLLG-SAGELKIADFGWS-VHAPSSRRDTLCGTLDYLPPE-M 178
Query: 292 VDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKP 351
           ++ + +D  +D+WSLG +    +  K P F  +   +   +I++                
Sbjct: 179 IEGRMHDEKVDLWSLGVLCYEFLVGKPP-FEANTYQETYKRISR---------------- 221
Query: 352 WSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFA 396
             +F   D    V+  A D + +LL+++   R   RE + HP+  
Sbjct: 222 -VEFTFPD---FVTEGARDLISRLLKHNPSQRPMLREVLEHPWIT 262

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 79/325 (24%), Positives = 140/325 (43%), Gaps = 48/325 (14%)
Query: 93  AMSKARVYTDVNV-LRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNE 151
           +M K+R Y  V   L P E W               E+V ++G G + +V++  N  T  
Sbjct: 1   SMRKSREYEHVRRDLDPNEVW---------------EIVGELGDGAFGKVYKAKNKETGA 45
Query: 152 RCXXXXXXXXXXXXXXXXXXXLQNL--CGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDF 209
                                ++ L  C  P +VKLL      H     ++ E+      
Sbjct: 46  LAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAY--YHDGKLWIMIEFCPGGAV 103
Query: 210 KVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWG 265
             +       LT+  I+    ++L+AL++ HS+ I+HRD+K  NV++  E   +RL D+G
Sbjct: 104 DAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLE-GDIRLADFG 162
Query: 266 L-AEFYHPGKEYNVRVASRYFKGPELLV--DLQD--YDYSLDMWSLGCMFAGMIFRKEPF 320
           + A+     ++ +  + + Y+  PE+++   ++D  YDY  D+WSLG     M  + EP 
Sbjct: 163 VSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMA-QIEPP 221
Query: 321 FYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDH 380
            +  +    L+KIAK     +   S+     WS             E  DFL   L  + 
Sbjct: 222 HHELNPMRVLLKIAKSDPPTLLTPSK-----WSV------------EFRDFLKIALDKNP 264
Query: 381 QDRLTAREAMAHPYFAQVRAAESSR 405
           + R +A + + HP+ + + + ++ R
Sbjct: 265 ETRPSAAQLLEHPFVSSITSNKALR 289

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 66/290 (22%), Positives = 122/290 (42%), Gaps = 35/290 (12%)
Query: 115 ESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTN-----ERCXXXXXXXXXXXXXXXX 169
           ES   QW   +D+E+ R +G+GK+  V+      +      +                  
Sbjct: 25  ESKKRQWA-LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRR 83
Query: 170 XXXLQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYD---IRYYIY 226
              +Q+    PN+++L     D  +    LI EY            L+ +D      YI 
Sbjct: 84  EVEIQSHLRHPNILRLYGYFHD--ATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT 141
Query: 227 ELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFK 286
           EL  AL YCHS+ ++HRD+KP N+++     +L++ D+G +  + P    +    +  + 
Sbjct: 142 ELANALSYCHSKRVIHRDIKPENLLLG-SAGELKIADFGWS-VHAPSSRRDDLCGTLDYL 199
Query: 287 GPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSR 346
            PE +++ + +D  +D+WSLG +    +  K P F  +   +   +I++           
Sbjct: 200 PPE-MIEGRMHDEKVDLWSLGVLCYEFLVGKPP-FEANTYQETYKRISR----------- 246
Query: 347 HSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFA 396
                  +F   D    V+  A D + +LL+++   R   RE + HP+  
Sbjct: 247 ------VEFTFPD---FVTEGARDLISRLLKHNPSQRPMLREVLEHPWIT 287

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 102/221 (46%), Gaps = 26/221 (11%)
Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNST---DFKVLYPTLTDYDIRYYIYELLKALDYCH 236
           PNV+ L ++  ++      LI E V      DF     +LT+ +   ++ ++L  + Y H
Sbjct: 74  PNVITLHEVYENKTDVI--LILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH 131
Query: 237 SQGIMHRDVKPHNVM-IDHELRK--LRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD 293
           S  I H D+KP N+M +D  + K  +++ID+GLA     G E+     +  F  PE +V+
Sbjct: 132 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPE-IVN 190
Query: 294 LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWS 353
            +      DMWS+G +   ++    PF  G    + L  ++         N     + +S
Sbjct: 191 YEPLGLEADMWSIGVITYILLSGASPFL-GDTKQETLANVSA-------VNYEFEDEYFS 242
Query: 354 KFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPY 394
                      S  A DF+ +LL  D + R+T ++++ HP+
Sbjct: 243 N---------TSALAKDFIRRLLVKDPKKRMTIQDSLQHPW 274

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 102/221 (46%), Gaps = 26/221 (11%)
Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNST---DFKVLYPTLTDYDIRYYIYELLKALDYCH 236
           PNV+ L ++  ++      LI E V      DF     +LT+ +   ++ ++L  + Y H
Sbjct: 74  PNVITLHEVYENKTDVI--LILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH 131
Query: 237 SQGIMHRDVKPHNVM-IDHELRK--LRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD 293
           S  I H D+KP N+M +D  + K  +++ID+GLA     G E+     +  F  PE +V+
Sbjct: 132 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPE-IVN 190
Query: 294 LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWS 353
            +      DMWS+G +   ++    PF  G    + L  ++         N     + +S
Sbjct: 191 YEPLGLEADMWSIGVITYILLSGASPFL-GDTKQETLANVSA-------VNYEFEDEYFS 242
Query: 354 KFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPY 394
                      S  A DF+ +LL  D + R+T ++++ HP+
Sbjct: 243 N---------TSALAKDFIRRLLVKDPKKRMTIQDSLQHPW 274

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 102/221 (46%), Gaps = 26/221 (11%)
Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNST---DFKVLYPTLTDYDIRYYIYELLKALDYCH 236
           PNV+ L ++  ++      LI E V      DF     +LT+ +   ++ ++L  + Y H
Sbjct: 74  PNVITLHEVYENKTDVI--LILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH 131
Query: 237 SQGIMHRDVKPHNVM-IDHELRK--LRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD 293
           S  I H D+KP N+M +D  + K  +++ID+GLA     G E+     +  F  PE +V+
Sbjct: 132 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPE-IVN 190
Query: 294 LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWS 353
            +      DMWS+G +   ++    PF  G    + L  ++         N     + +S
Sbjct: 191 YEPLGLEADMWSIGVITYILLSGASPFL-GDTKQETLANVSA-------VNYEFEDEYFS 242
Query: 354 KFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPY 394
                      S  A DF+ +LL  D + R+T ++++ HP+
Sbjct: 243 N---------TSALAKDFIRRLLVKDPKKRMTIQDSLQHPW 274

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 64/285 (22%), Positives = 119/285 (41%), Gaps = 35/285 (12%)
Query: 120 QWGDQDDYEVVRKVGRGKYSEVFEGINVNTN-----ERCXXXXXXXXXXXXXXXXXXXLQ 174
           QW   +D+E+ R +G+GK+  V+      +      +                     +Q
Sbjct: 4   QWA-LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQ 62
Query: 175 NLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYD---IRYYIYELLKA 231
           +    PN+++L     D  +    LI EY            L+ +D      YI EL  A
Sbjct: 63  SHLRHPNILRLYGYFHD--ATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA 120
Query: 232 LDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELL 291
           L YCHS+ ++HRD+KP N+++     +L++ D+G +  + P         +  +  PE +
Sbjct: 121 LSYCHSKRVIHRDIKPENLLLG-SAGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPE-M 177
Query: 292 VDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKP 351
           ++ + +D  +D+WSLG +    +  K P F  +   +   +I++                
Sbjct: 178 IEGRMHDEKVDLWSLGVLCYEFLVGKPP-FEANTYQETYKRISR---------------- 220
Query: 352 WSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFA 396
             +F   D    V+  A D + +LL+++   R   RE + HP+  
Sbjct: 221 -VEFTFPD---FVTEGARDLISRLLKHNPSQRPMLREVLEHPWIT 261

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 102/221 (46%), Gaps = 26/221 (11%)
Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNST---DFKVLYPTLTDYDIRYYIYELLKALDYCH 236
           PNV+ L ++  ++      LI E V      DF     +LT+ +   ++ ++L  + Y H
Sbjct: 74  PNVITLHEVYENKTDVI--LILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH 131
Query: 237 SQGIMHRDVKPHNVM-IDHELRK--LRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD 293
           S  I H D+KP N+M +D  + K  +++ID+GLA     G E+     +  F  PE +V+
Sbjct: 132 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPE-IVN 190
Query: 294 LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWS 353
            +      DMWS+G +   ++    PF  G    + L  ++         N     + +S
Sbjct: 191 YEPLGLEADMWSIGVITYILLSGASPFL-GDTKQETLANVSA-------VNYEFEDEYFS 242
Query: 354 KFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPY 394
                      S  A DF+ +LL  D + R+T ++++ HP+
Sbjct: 243 N---------TSALAKDFIRRLLVKDPKKRMTIQDSLQHPW 274

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 102/221 (46%), Gaps = 26/221 (11%)
Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNST---DFKVLYPTLTDYDIRYYIYELLKALDYCH 236
           PNV+ L ++  ++      LI E V      DF     +LT+ +   ++ ++L  + Y H
Sbjct: 73  PNVITLHEVYENKTDVI--LILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH 130
Query: 237 SQGIMHRDVKPHNVM-IDHELRK--LRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD 293
           S  I H D+KP N+M +D  + K  +++ID+GLA     G E+     +  F  PE +V+
Sbjct: 131 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPE-IVN 189
Query: 294 LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWS 353
            +      DMWS+G +   ++    PF  G    + L  ++         N     + +S
Sbjct: 190 YEPLGLEADMWSIGVITYILLSGASPFL-GDTKQETLANVSA-------VNYEFEDEYFS 241
Query: 354 KFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPY 394
                      S  A DF+ +LL  D + R+T ++++ HP+
Sbjct: 242 N---------TSALAKDFIRRLLVKDPKKRMTIQDSLQHPW 273

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 64/285 (22%), Positives = 119/285 (41%), Gaps = 35/285 (12%)
Query: 120 QWGDQDDYEVVRKVGRGKYSEVFEGINVNTN-----ERCXXXXXXXXXXXXXXXXXXXLQ 174
           QW   +D+E+ R +G+GK+  V+      +      +                     +Q
Sbjct: 3   QWA-LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQ 61
Query: 175 NLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYD---IRYYIYELLKA 231
           +    PN+++L     D  +    LI EY            L+ +D      YI EL  A
Sbjct: 62  SHLRHPNILRLYGYFHD--ATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA 119
Query: 232 LDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELL 291
           L YCHS+ ++HRD+KP N+++     +L++ D+G +  + P         +  +  PE +
Sbjct: 120 LSYCHSKRVIHRDIKPENLLLG-SAGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPE-M 176
Query: 292 VDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKP 351
           ++ + +D  +D+WSLG +    +  K P F  +   +   +I++                
Sbjct: 177 IEGRMHDEKVDLWSLGVLCYEFLVGKPP-FEANTYQETYKRISR---------------- 219
Query: 352 WSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFA 396
             +F   D    V+  A D + +LL+++   R   RE + HP+  
Sbjct: 220 -VEFTFPD---FVTEGARDLISRLLKHNPSQRPMLREVLEHPWIT 260

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 102/221 (46%), Gaps = 26/221 (11%)
Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNST---DFKVLYPTLTDYDIRYYIYELLKALDYCH 236
           PNV+ L ++  ++      LI E V      DF     +LT+ +   ++ ++L  + Y H
Sbjct: 74  PNVITLHEVYENKTDVI--LILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH 131
Query: 237 SQGIMHRDVKPHNVM-IDHELRK--LRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD 293
           S  I H D+KP N+M +D  + K  +++ID+GLA     G E+     +  F  PE +V+
Sbjct: 132 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPE-IVN 190
Query: 294 LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWS 353
            +      DMWS+G +   ++    PF  G    + L  ++         N     + +S
Sbjct: 191 YEPLGLEADMWSIGVITYILLSGASPFL-GDTKQETLANVSA-------VNYEFEDEYFS 242
Query: 354 KFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPY 394
                      S  A DF+ +LL  D + R+T ++++ HP+
Sbjct: 243 N---------TSALAKDFIRRLLVKDPKKRMTIQDSLQHPW 274

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 102/221 (46%), Gaps = 26/221 (11%)
Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNST---DFKVLYPTLTDYDIRYYIYELLKALDYCH 236
           PNV+ L ++  ++      LI E V      DF     +LT+ +   ++ ++L  + Y H
Sbjct: 73  PNVITLHEVYENKTDVI--LILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH 130
Query: 237 SQGIMHRDVKPHNVM-IDHELRK--LRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD 293
           S  I H D+KP N+M +D  + K  +++ID+GLA     G E+     +  F  PE +V+
Sbjct: 131 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPE-IVN 189
Query: 294 LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWS 353
            +      DMWS+G +   ++    PF  G    + L  ++         N     + +S
Sbjct: 190 YEPLGLEADMWSIGVITYILLSGASPFL-GDTKQETLANVSA-------VNYEFEDEYFS 241
Query: 354 KFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPY 394
                      S  A DF+ +LL  D + R+T ++++ HP+
Sbjct: 242 N---------TSALAKDFIRRLLVKDPKKRMTIQDSLQHPW 273

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 69/290 (23%), Positives = 122/290 (42%), Gaps = 35/290 (12%)
Query: 115 ESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTN-----ERCXXXXXXXXXXXXXXXX 169
           ES   QW   +D+E+ R +G+GK+  V+      +      +                  
Sbjct: 2   ESKKRQWA-LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRR 60
Query: 170 XXXLQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYD---IRYYIY 226
              +Q+    PN+++L     D  +    LI EY            L+ +D      YI 
Sbjct: 61  EVEIQSHLRHPNILRLYGYFHD--ATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT 118
Query: 227 ELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFK 286
           EL  AL YCHS+ ++HRD+KP N+++     +L++ D+G +  + P         +  + 
Sbjct: 119 ELANALSYCHSKRVIHRDIKPENLLLG-SAGELKIADFGWS-VHAPSSRRXXLCGTLDYL 176
Query: 287 GPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSR 346
            PE +++ + +D  +D+WSLG +    +  K PF    + + +  K             R
Sbjct: 177 PPE-MIEGRMHDEKVDLWSLGVLCYEFLVGKPPF--EANTYQETYK-------------R 220
Query: 347 HSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFA 396
            SR    +F   D    V+  A D + +LL+++   R   RE + HP+  
Sbjct: 221 ISR---VEFTFPD---FVTEGARDLISRLLKHNPSQRPMLREVLEHPWIT 264

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 102/221 (46%), Gaps = 26/221 (11%)
Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNST---DFKVLYPTLTDYDIRYYIYELLKALDYCH 236
           PNV+ L ++  ++      LI E V      DF     +LT+ +   ++ ++L  + Y H
Sbjct: 74  PNVITLHEVYENKTDVI--LILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH 131
Query: 237 SQGIMHRDVKPHNVM-IDHELRK--LRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD 293
           S  I H D+KP N+M +D  + K  +++ID+GLA     G E+     +  F  PE +V+
Sbjct: 132 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPE-IVN 190
Query: 294 LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWS 353
            +      DMWS+G +   ++    PF  G    + L  ++         N     + +S
Sbjct: 191 YEPLGLEADMWSIGVITYILLSGASPFL-GDTKQETLANVSA-------VNYEFEDEYFS 242
Query: 354 KFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPY 394
                      S  A DF+ +LL  D + R+T ++++ HP+
Sbjct: 243 N---------TSALAKDFIRRLLVKDPKKRMTIQDSLQHPW 274

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 102/221 (46%), Gaps = 26/221 (11%)
Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNST---DFKVLYPTLTDYDIRYYIYELLKALDYCH 236
           PNV+ L ++  ++      LI E V      DF     +LT+ +   ++ ++L  + Y H
Sbjct: 74  PNVITLHEVYENKTDVI--LILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH 131
Query: 237 SQGIMHRDVKPHNVM-IDHELRK--LRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD 293
           S  I H D+KP N+M +D  + K  +++ID+GLA     G E+     +  F  PE +V+
Sbjct: 132 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPE-IVN 190
Query: 294 LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWS 353
            +      DMWS+G +   ++    PF  G    + L  ++         N     + +S
Sbjct: 191 YEPLGLEADMWSIGVITYILLSGASPFL-GDTKQETLANVSA-------VNYEFEDEYFS 242
Query: 354 KFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPY 394
                      S  A DF+ +LL  D + R+T ++++ HP+
Sbjct: 243 N---------TSALAKDFIRRLLVKDPKKRMTIQDSLQHPW 274

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 51/221 (23%), Positives = 98/221 (44%), Gaps = 32/221 (14%)
Query: 180 PNVVKLLDIVRDQHSKTPS---LIFEYVNST--DFKVLYPTLTDYDIRYYIYELLKALDY 234
           P+++KL D++      TP+   ++ EY      D+ V    +T+ + R +  +++ A++Y
Sbjct: 69  PHIIKLYDVI-----TTPTDIVMVIEYAGGELFDYIVEKKRMTEDEGRRFFQQIICAIEY 123
Query: 235 CHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDL 294
           CH   I+HRD+KP N+++D  L  +++ D+GL+     G        S  +  PE++   
Sbjct: 124 CHRHKIVHRDLKPENLLLDDNL-NVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVINGK 182
Query: 295 QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSK 354
                 +D+WS G +   M+  + PF    +    L K    C  ++             
Sbjct: 183 LYAGPEVDVWSCGIVLYVMLVGRLPF--DDEFIPNLFKKVNSCVYVM------------- 227
Query: 355 FINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF 395
                    +SP A   + +++  D   R+T +E    P+F
Sbjct: 228 ------PDFLSPGAQSLIRRMIVADPMQRITIQEIRRDPWF 262

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 63/293 (21%), Positives = 126/293 (43%), Gaps = 30/293 (10%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNE----RCXXXXXXXXXXXXXXXXXXXLQNLCGGP 180
           D+Y++   +G+G +S V   + + T      +                    +  L    
Sbjct: 4   DEYQLYEDIGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSARDHQKLEREARICRLLKHS 63
Query: 181 NVVKLLDIVRDQHSKTPSLIFEYVNSTDF---KVLYPTLTDYDIRYYIYELLKALDYCHS 237
           N+V+L D + ++      L+F+ V   +     V     ++ D  + I ++L+A+ +CH 
Sbjct: 64  NIVRLHDSISEEGFHY--LVFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQ 121
Query: 238 QGIMHRDVKPHNVMIDHELR--KLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDL 294
            G++HRD+KP N+++  + +   ++L D+GLA E     + +     +  +  PE+L   
Sbjct: 122 MGVVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVLRK- 180
Query: 295 QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSK 354
           + Y   +D+W+ G +   ++    P F+  D H    +I                K  + 
Sbjct: 181 EAYGKPVDIWACGVILY-ILLVGYPPFWDEDQHKLYQQI----------------KAGAY 223
Query: 355 FINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAESSRTR 407
              +     V+PEA + ++++L  +   R+TA EA+ HP+  Q     S   R
Sbjct: 224 DFPSPEWDTVTPEAKNLINQMLTINPAKRITAHEALKHPWVCQRSTVASMMHR 276

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 65/290 (22%), Positives = 121/290 (41%), Gaps = 35/290 (12%)
Query: 115 ESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTN-----ERCXXXXXXXXXXXXXXXX 169
           ES   QW   +D+E+ R +G+GK+  V+      +      +                  
Sbjct: 1   ESKKRQWA-LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRR 59
Query: 170 XXXLQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYD---IRYYIY 226
              +Q+    PN+++L     D  +    LI EY            L+ +D      YI 
Sbjct: 60  EVEIQSHLRHPNILRLYGYFHD--ATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT 117
Query: 227 ELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFK 286
           EL  AL YCHS+ ++HRD+KP N+++     +L++ ++G +  + P         +  + 
Sbjct: 118 ELANALSYCHSKRVIHRDIKPENLLLG-SAGELKIANFGWS-VHAPSSRRTTLCGTLDYL 175
Query: 287 GPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSR 346
            PE +++ + +D  +D+WSLG +    +  K P F  +   +   +I++           
Sbjct: 176 PPE-MIEGRMHDEKVDLWSLGVLCYEFLVGKPP-FEANTYQETYKRISR----------- 222
Query: 347 HSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFA 396
                  +F   D    V+  A D + +LL+++   R   RE + HP+  
Sbjct: 223 ------VEFTFPD---FVTEGARDLISRLLKHNPSQRPMLREVLEHPWIT 263

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 64/285 (22%), Positives = 119/285 (41%), Gaps = 35/285 (12%)
Query: 120 QWGDQDDYEVVRKVGRGKYSEVFEGINVNTN-----ERCXXXXXXXXXXXXXXXXXXXLQ 174
           QW   +D+E+ R +G+GK+  V+      +      +                     +Q
Sbjct: 8   QWA-LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQ 66
Query: 175 NLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYD---IRYYIYELLKA 231
           +    PN+++L     D  +    LI EY            L+ +D      YI EL  A
Sbjct: 67  SHLRHPNILRLYGYFHD--ATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA 124
Query: 232 LDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELL 291
           L YCHS+ ++HRD+KP N+++     +L++ D+G +  + P         +  +  PE +
Sbjct: 125 LSYCHSKRVIHRDIKPENLLLG-SAGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPE-M 181
Query: 292 VDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKP 351
           ++ + +D  +D+WSLG +    +  K P F  +   +   +I++                
Sbjct: 182 IEGRMHDEKVDLWSLGVLCYEFLVGKPP-FEANTYQETYKRISR---------------- 224
Query: 352 WSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFA 396
             +F   D    V+  A D + +LL+++   R   RE + HP+  
Sbjct: 225 -VEFTFPD---FVTEGARDLISRLLKHNPSQRPMLREVLEHPWIT 265

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 65/290 (22%), Positives = 121/290 (41%), Gaps = 35/290 (12%)
Query: 115 ESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTN-----ERCXXXXXXXXXXXXXXXX 169
           ES   QW   +D+E+ R +G+GK+  V+      +      +                  
Sbjct: 2   ESKKRQWA-LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRR 60
Query: 170 XXXLQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYD---IRYYIY 226
              +Q+    PN+++L     D  +    LI EY            L+ +D      YI 
Sbjct: 61  EVEIQSHLRHPNILRLYGYFHD--ATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT 118
Query: 227 ELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFK 286
           EL  AL YCHS+ ++HRD+KP N+++     +L++ ++G +  + P         +  + 
Sbjct: 119 ELANALSYCHSKRVIHRDIKPENLLLG-SAGELKIANFGWS-VHAPSSRRTTLCGTLDYL 176
Query: 287 GPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSR 346
            PE +++ + +D  +D+WSLG +    +  K P F  +   +   +I++           
Sbjct: 177 PPE-MIEGRMHDEKVDLWSLGVLCYEFLVGKPP-FEANTYQETYKRISR----------- 223
Query: 347 HSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFA 396
                  +F   D    V+  A D + +LL+++   R   RE + HP+  
Sbjct: 224 ------VEFTFPD---FVTEGARDLISRLLKHNPSQRPMLREVLEHPWIT 264

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 67/285 (23%), Positives = 120/285 (42%), Gaps = 35/285 (12%)
Query: 120 QWGDQDDYEVVRKVGRGKYSEVFEGINVNTN-----ERCXXXXXXXXXXXXXXXXXXXLQ 174
           QW   +D+E+ R +G+GK+  V+      +      +                     +Q
Sbjct: 4   QWA-LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQ 62
Query: 175 NLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYD---IRYYIYELLKA 231
           +    PN+++L     D  +    LI EY            L+ +D      YI EL  A
Sbjct: 63  SHLRHPNILRLYGYFHD--ATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA 120
Query: 232 LDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELL 291
           L YCHS+ ++HRD+KP N+++     +L++ D+G +  + P         +  +  PE +
Sbjct: 121 LSYCHSKRVIHRDIKPENLLLG-SAGELKIADFGWS-VHAPSSRRAALCGTLDYLPPE-M 177
Query: 292 VDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKP 351
           ++ + +D  +D+WSLG +    +  K PF    + + +  K             R SR  
Sbjct: 178 IEGRMHDEKVDLWSLGVLCYEFLVGKPPF--EANTYQETYK-------------RISR-- 220
Query: 352 WSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFA 396
             +F   D    V+  A D + +LL+++   R   RE + HP+  
Sbjct: 221 -VEFTFPD---FVTEGARDLISRLLKHNPSQRPMLREVLEHPWIT 261

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 71/285 (24%), Positives = 117/285 (41%), Gaps = 30/285 (10%)
Query: 125 DDYEVVRKV-GRGKYSEVFEGINVNTNERCXXXXXXXXXXXXXXXXXXXLQNLCGGPNVV 183
           DDY+V  +V G G   +V +  N  T E+                      + C  P++V
Sbjct: 31  DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQC--PHIV 88
Query: 184 KLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYI----YELLK----ALDYC 235
           +++D+  + ++    L+   +   D   L+  + D   + +      E++K    A+ Y 
Sbjct: 89  RIVDVYENLYAGRKCLLI-VMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYL 147
Query: 236 HSQGIMHRDVKPHNVMIDHELRK--LRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD 293
           HS  I HRDVKP N++   +     L+L D+G A+             + Y+  PE+L  
Sbjct: 148 HSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVL-G 206
Query: 294 LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKP-W 352
            + YD S DMWSLG +   ++    PF+  H      + I+      I         P W
Sbjct: 207 PEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG-----LAISPGMKTRIRMGQYEFPNPEW 261
Query: 353 SKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQ 397
           S+         VS E    +  LL+ +   R+T  E M HP+  Q
Sbjct: 262 SE---------VSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQ 297

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 71/285 (24%), Positives = 117/285 (41%), Gaps = 30/285 (10%)
Query: 125 DDYEVVRKV-GRGKYSEVFEGINVNTNERCXXXXXXXXXXXXXXXXXXXLQNLCGGPNVV 183
           DDY+V  +V G G   +V +  N  T E+                      + C  P++V
Sbjct: 15  DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQC--PHIV 72
Query: 184 KLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYI----YELLK----ALDYC 235
           +++D+  + ++    L+   +   D   L+  + D   + +      E++K    A+ Y 
Sbjct: 73  RIVDVYENLYAGRKCLLI-VMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYL 131
Query: 236 HSQGIMHRDVKPHNVMIDHELRK--LRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD 293
           HS  I HRDVKP N++   +     L+L D+G A+             + Y+  PE+L  
Sbjct: 132 HSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVL-G 190
Query: 294 LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKP-W 352
            + YD S DMWSLG +   ++    PF+  H      + I+      I         P W
Sbjct: 191 PEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG-----LAISPGMKTRIRMGQYEFPNPEW 245
Query: 353 SKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQ 397
           S+         VS E    +  LL+ +   R+T  E M HP+  Q
Sbjct: 246 SE---------VSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQ 281

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 71/285 (24%), Positives = 117/285 (41%), Gaps = 30/285 (10%)
Query: 125 DDYEVVRKV-GRGKYSEVFEGINVNTNERCXXXXXXXXXXXXXXXXXXXLQNLCGGPNVV 183
           DDY+V  +V G G   +V +  N  T E+                      + C  P++V
Sbjct: 16  DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQC--PHIV 73
Query: 184 KLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYI----YELLK----ALDYC 235
           +++D+  + ++    L+   +   D   L+  + D   + +      E++K    A+ Y 
Sbjct: 74  RIVDVYENLYAGRKCLLI-VMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYL 132
Query: 236 HSQGIMHRDVKPHNVMIDHELRK--LRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD 293
           HS  I HRDVKP N++   +     L+L D+G A+             + Y+  PE+L  
Sbjct: 133 HSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVL-G 191
Query: 294 LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKP-W 352
            + YD S DMWSLG +   ++    PF+  H      + I+      I         P W
Sbjct: 192 PEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG-----LAISPGMKTRIRMGQYEFPNPEW 246
Query: 353 SKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQ 397
           S+         VS E    +  LL+ +   R+T  E M HP+  Q
Sbjct: 247 SE---------VSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQ 282

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 48/188 (25%), Positives = 82/188 (43%), Gaps = 28/188 (14%)
Query: 216 LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRK--LRLIDWGLAEFYHPG 273
           L +   + Y Y++L A+ Y H  GI+HRD+KP NV++  +     +++ D+G ++     
Sbjct: 250 LKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET 309
Query: 274 KEYNVRVASRYFKGPELLVDL--QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNH---- 327
                   +  +  PE+LV +    Y+ ++D WSLG +   +     P F  H       
Sbjct: 310 SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILF-ICLSGYPPFSEHRTQVSLK 368
Query: 328 DQLVKIAKDCCLIIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAR 387
           DQ+     +    +W                     VS +A+D + KLL  D + R T  
Sbjct: 369 DQITSGKYNFIPEVWAE-------------------VSEKALDLVKKLLVVDPKARFTTE 409
Query: 388 EAMAHPYF 395
           EA+ HP+ 
Sbjct: 410 EALRHPWL 417

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 64/285 (22%), Positives = 119/285 (41%), Gaps = 35/285 (12%)
Query: 120 QWGDQDDYEVVRKVGRGKYSEVFEGINVNTN-----ERCXXXXXXXXXXXXXXXXXXXLQ 174
           QW   +D+E+ R +G+GK+  V+      +      +                     +Q
Sbjct: 4   QWA-LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQ 62
Query: 175 NLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYD---IRYYIYELLKA 231
           +    PN+++L     D  +    LI EY            L+ +D      YI EL  A
Sbjct: 63  SHLRHPNILRLYGYFHD--ATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA 120
Query: 232 LDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELL 291
           L YCHS+ ++HRD+KP N+++     +L++ D+G +  + P         +  +  PE +
Sbjct: 121 LSYCHSKRVIHRDIKPENLLLG-SAGELKIADFGWS-VHAPSSRRTXLCGTLDYLPPE-M 177
Query: 292 VDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKP 351
           ++ + +D  +D+WSLG +    +  K P F  +   +   +I++                
Sbjct: 178 IEGRMHDEKVDLWSLGVLCYEFLVGKPP-FEANTYQETYKRISR---------------- 220
Query: 352 WSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFA 396
             +F   D    V+  A D + +LL+++   R   RE + HP+  
Sbjct: 221 -VEFTFPD---FVTEGARDLISRLLKHNPSQRPMLREVLEHPWIT 261

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 45/137 (32%), Positives = 71/137 (51%), Gaps = 8/137 (5%)
Query: 199 LIFEYVNSTDFKVLYP---TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE 255
            + EYVN  D          L +   R+Y  E+  AL+Y H +GI++RD+K  NV++D E
Sbjct: 98  FVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSE 157
Query: 256 LRKLRLIDWGL-AEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMI 314
              ++L D+G+  E   PG   +    +  +  PE+L   +DY +S+D W+LG +   M+
Sbjct: 158 -GHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEILRG-EDYGFSVDWWALGVLMFEMM 215
Query: 315 FRKEPF--FYGHDNHDQ 329
             + PF      DN DQ
Sbjct: 216 AGRSPFDIVGSSDNPDQ 232

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 70/290 (24%), Positives = 130/290 (44%), Gaps = 32/290 (11%)
Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCXXXXXXXXXXXXXXXXXXXLQNL--CGGPNVVK 184
           +E+V ++G G + +V++  N  T                       ++ L  C  P +VK
Sbjct: 13  WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVK 72
Query: 185 LLDIVRDQHSKTPSLIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGI 240
           LL      H     ++ E+        +       LT+  I+    ++L+AL++ HS+ I
Sbjct: 73  LLGAY--YHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRI 130
Query: 241 MHRDVKPHNVMIDHELRKLRLIDWGL-AEFYHPGKEYNVRVASRYFKGPELLV--DLQD- 296
           +HRD+K  NV++  E   +RL D+G+ A+     ++ +  + + Y+  PE+++   ++D 
Sbjct: 131 IHRDLKAGNVLMTLE-GDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDT 189
Query: 297 -YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSKF 355
            YDY  D+WSLG     M  + EP  +  +    L+KIAK     +   S+     WS  
Sbjct: 190 PYDYKADIWSLGITLIEMA-QIEPPHHELNPMRVLLKIAKSDPPTLLTPSK-----WSV- 242
Query: 356 INADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAESSR 405
                      E  DFL   L  + + R +A + + HP+ + + + ++ R
Sbjct: 243 -----------EFRDFLKIALDKNPETRPSAAQLLEHPFVSSITSNKALR 281

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 71/285 (24%), Positives = 117/285 (41%), Gaps = 30/285 (10%)
Query: 125 DDYEVVRKV-GRGKYSEVFEGINVNTNERCXXXXXXXXXXXXXXXXXXXLQNLCGGPNVV 183
           DDY+V  +V G G   +V +  N  T E+                      + C  P++V
Sbjct: 22  DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQC--PHIV 79
Query: 184 KLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYI----YELLK----ALDYC 235
           +++D+  + ++    L+   +   D   L+  + D   + +      E++K    A+ Y 
Sbjct: 80  RIVDVYENLYAGRKCLLI-VMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYL 138
Query: 236 HSQGIMHRDVKPHNVMIDHELRK--LRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD 293
           HS  I HRDVKP N++   +     L+L D+G A+             + Y+  PE+L  
Sbjct: 139 HSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVL-G 197
Query: 294 LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKP-W 352
            + YD S DMWSLG +   ++    PF+  H      + I+      I         P W
Sbjct: 198 PEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG-----LAISPGMKTRIRMGQYEFPNPEW 252
Query: 353 SKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQ 397
           S+         VS E    +  LL+ +   R+T  E M HP+  Q
Sbjct: 253 SE---------VSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQ 288

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 94/212 (44%), Gaps = 28/212 (13%)
Query: 199 LIFEYVNSTDFKVLYP---TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE 255
            + EYVN  D          L +   R+Y  E+  AL+Y H +GI++RD+K  NV++D E
Sbjct: 83  FVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSE 142
Query: 256 LRKLRLIDWGL-AEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMI 314
              ++L D+G+  E   PG   +    +  +  PE+L   +DY +S+D W+LG +   M+
Sbjct: 143 -GHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEILRG-EDYGFSVDWWALGVLMFEMM 200
Query: 315 FRKEPF--FYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSKFINADNQHLVSPEAIDFL 372
             + PF      DN DQ      +  L      +  R P S          +S +A   L
Sbjct: 201 AGRSPFDIVGSSDNPDQ----NTEDYLFQVILEKQIRIPRS----------LSVKAASVL 246
Query: 373 DKLLRYDHQDRLTAR------EAMAHPYFAQV 398
              L  D ++RL         +   HP+F  V
Sbjct: 247 KSFLNKDPKERLGCHPQTGFADIQGHPFFRNV 278

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 48/188 (25%), Positives = 82/188 (43%), Gaps = 28/188 (14%)
Query: 216 LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRK--LRLIDWGLAEFYHPG 273
           L +   + Y Y++L A+ Y H  GI+HRD+KP NV++  +     +++ D+G ++     
Sbjct: 236 LKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET 295
Query: 274 KEYNVRVASRYFKGPELLVDL--QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNH---- 327
                   +  +  PE+LV +    Y+ ++D WSLG +   +     P F  H       
Sbjct: 296 SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILF-ICLSGYPPFSEHRTQVSLK 354
Query: 328 DQLVKIAKDCCLIIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAR 387
           DQ+     +    +W                     VS +A+D + KLL  D + R T  
Sbjct: 355 DQITSGKYNFIPEVWAE-------------------VSEKALDLVKKLLVVDPKARFTTE 395
Query: 388 EAMAHPYF 395
           EA+ HP+ 
Sbjct: 396 EALRHPWL 403

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 57/221 (25%), Positives = 101/221 (45%), Gaps = 26/221 (11%)
Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNST---DFKVLYPTLTDYDIRYYIYELLKALDYCH 236
           PN++ L DI  ++      LI E V+     DF     +LT+ +   ++ ++L  + Y H
Sbjct: 75  PNIITLHDIFENKTDVV--LILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLH 132
Query: 237 SQGIMHRDVKPHNVM-IDHEL--RKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD 293
           S+ I H D+KP N+M +D  +   +++LID+G+A     G E+     +  F  PE +V+
Sbjct: 133 SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPE-IVN 191
Query: 294 LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWS 353
            +      DMWS+G +   ++    PF  G    + L  I+         N     + +S
Sbjct: 192 YEPLGLEADMWSIGVITYILLSGASPFL-GETKQETLTNISA-------VNYDFDEEYFS 243
Query: 354 KFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPY 394
                      S  A DF+ +LL  D + R+   +++ H +
Sbjct: 244 N---------TSELAKDFIRRLLVKDPKRRMXIAQSLEHSW 275

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 64/285 (22%), Positives = 119/285 (41%), Gaps = 35/285 (12%)
Query: 120 QWGDQDDYEVVRKVGRGKYSEVFEGINVNTN-----ERCXXXXXXXXXXXXXXXXXXXLQ 174
           QW   +D+E+ R +G+GK+  V+      +      +                     +Q
Sbjct: 7   QWA-LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQ 65
Query: 175 NLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYD---IRYYIYELLKA 231
           +    PN+++L     D  +    LI EY            L+ +D      YI EL  A
Sbjct: 66  SHLRHPNILRLYGYFHD--ATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA 123
Query: 232 LDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELL 291
           L YCHS+ ++HRD+KP N+++     +L++ D+G +  + P         +  +  PE +
Sbjct: 124 LSYCHSKRVIHRDIKPENLLLG-SAGELKIADFGWS-VHAPSSRRAALCGTLDYLPPE-M 180
Query: 292 VDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKP 351
           ++ + +D  +D+WSLG +    +  K P F  +   +   +I++                
Sbjct: 181 IEGRMHDEKVDLWSLGVLCYEFLVGKPP-FEANTYQETYKRISR---------------- 223
Query: 352 WSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFA 396
             +F   D    V+  A D + +LL+++   R   RE + HP+  
Sbjct: 224 -VEFTFPD---FVTEGARDLISRLLKHNPSQRPMLREVLEHPWIT 264

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 42/122 (34%), Positives = 68/122 (55%), Gaps = 6/122 (4%)
Query: 216 LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE--FYHPG 273
            T+ D+++Y+ EL   LD+ HS GI++RD+KP N+++D E   ++L D+GL++    H  
Sbjct: 127 FTEEDVKFYLAELALGLDHLHSLGIIYRDLKPENILLDEE-GHIKLTDFGLSKEAIDHEK 185
Query: 274 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI 333
           K Y+      Y   PE +V+ Q + +S D WS G +   M+    P F G D  + +  I
Sbjct: 186 KAYSFCGTVEYM-APE-VVNRQGHSHSADWWSYGVLMFEMLTGSLP-FQGKDRKETMTLI 242
Query: 334 AK 335
            K
Sbjct: 243 LK 244

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 71/285 (24%), Positives = 117/285 (41%), Gaps = 30/285 (10%)
Query: 125 DDYEVVRKV-GRGKYSEVFEGINVNTNERCXXXXXXXXXXXXXXXXXXXLQNLCGGPNVV 183
           DDY+V  +V G G   +V +  N  T E+                      + C  P++V
Sbjct: 23  DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQC--PHIV 80
Query: 184 KLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYI----YELLK----ALDYC 235
           +++D+  + ++    L+   +   D   L+  + D   + +      E++K    A+ Y 
Sbjct: 81  RIVDVYENLYAGRKCLLI-VMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYL 139
Query: 236 HSQGIMHRDVKPHNVMIDHELRK--LRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD 293
           HS  I HRDVKP N++   +     L+L D+G A+             + Y+  PE+L  
Sbjct: 140 HSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVL-G 198
Query: 294 LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKP-W 352
            + YD S DMWSLG +   ++    PF+  H      + I+      I         P W
Sbjct: 199 PEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG-----LAISPGMKTRIRMGQYEFPNPEW 253
Query: 353 SKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQ 397
           S+         VS E    +  LL+ +   R+T  E M HP+  Q
Sbjct: 254 SE---------VSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQ 289

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 71/285 (24%), Positives = 117/285 (41%), Gaps = 30/285 (10%)
Query: 125 DDYEVVRKV-GRGKYSEVFEGINVNTNERCXXXXXXXXXXXXXXXXXXXLQNLCGGPNVV 183
           DDY+V  +V G G   +V +  N  T E+                      + C  P++V
Sbjct: 21  DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQC--PHIV 78
Query: 184 KLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYI----YELLK----ALDYC 235
           +++D+  + ++    L+   +   D   L+  + D   + +      E++K    A+ Y 
Sbjct: 79  RIVDVYENLYAGRKCLLI-VMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYL 137
Query: 236 HSQGIMHRDVKPHNVMIDHELRK--LRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD 293
           HS  I HRDVKP N++   +     L+L D+G A+             + Y+  PE+L  
Sbjct: 138 HSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVL-G 196
Query: 294 LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKP-W 352
            + YD S DMWSLG +   ++    PF+  H      + I+      I         P W
Sbjct: 197 PEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG-----LAISPGMKTRIRMGQYEFPNPEW 251
Query: 353 SKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQ 397
           S+         VS E    +  LL+ +   R+T  E M HP+  Q
Sbjct: 252 SE---------VSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQ 287

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 71/285 (24%), Positives = 117/285 (41%), Gaps = 30/285 (10%)
Query: 125 DDYEVVRKV-GRGKYSEVFEGINVNTNERCXXXXXXXXXXXXXXXXXXXLQNLCGGPNVV 183
           DDY+V  +V G G   +V +  N  T E+                      + C  P++V
Sbjct: 61  DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQC--PHIV 118
Query: 184 KLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYI----YELLK----ALDYC 235
           +++D+  + ++    L+   +   D   L+  + D   + +      E++K    A+ Y 
Sbjct: 119 RIVDVYENLYAGRKCLLI-VMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYL 177
Query: 236 HSQGIMHRDVKPHNVMIDHELRK--LRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD 293
           HS  I HRDVKP N++   +     L+L D+G A+             + Y+  PE+L  
Sbjct: 178 HSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVL-G 236
Query: 294 LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKP-W 352
            + YD S DMWSLG +   ++    PF+  H      + I+      I         P W
Sbjct: 237 PEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG-----LAISPGMKTRIRMGQYEFPNPEW 291
Query: 353 SKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQ 397
           S+         VS E    +  LL+ +   R+T  E M HP+  Q
Sbjct: 292 SE---------VSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQ 327

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 94/212 (44%), Gaps = 28/212 (13%)
Query: 199 LIFEYVNSTDFKVLYP---TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE 255
            + EYVN  D          L +   R+Y  E+  AL+Y H +GI++RD+K  NV++D E
Sbjct: 87  FVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSE 146
Query: 256 LRKLRLIDWGL-AEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMI 314
              ++L D+G+  E   PG   +    +  +  PE+L   +DY +S+D W+LG +   M+
Sbjct: 147 -GHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEILRG-EDYGFSVDWWALGVLMFEMM 204
Query: 315 FRKEPF--FYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSKFINADNQHLVSPEAIDFL 372
             + PF      DN DQ      +  L      +  R P S          +S +A   L
Sbjct: 205 AGRSPFDIVGSSDNPDQ----NTEDYLFQVILEKQIRIPRS----------LSVKAASVL 250
Query: 373 DKLLRYDHQDRLTAR------EAMAHPYFAQV 398
              L  D ++RL         +   HP+F  V
Sbjct: 251 KSFLNKDPKERLGCHPQTGFADIQGHPFFRNV 282

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 53/186 (28%), Positives = 88/186 (47%), Gaps = 21/186 (11%)
Query: 211 VLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGL-AEF 269
           V +  + +  I      +L+AL Y H+QG++HRD+K  ++++  + R ++L D+G  A+ 
Sbjct: 133 VTHTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGR-IKLSDFGFCAQV 191
Query: 270 YHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQ 329
                +    V + Y+  PE++  L  Y   +D+WSLG M   MI  + P+F    N   
Sbjct: 192 SKEVPKRKXLVGTPYWMAPEVISRL-PYGTEVDIWSLGIMVIEMIDGEPPYF----NEPP 246
Query: 330 LVKIAKDCCLIIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREA 389
           L  + +          R S  P  K     + H VS     FLD +L  +   R TA+E 
Sbjct: 247 LQAMRR---------IRDSLPPRVK-----DLHKVSSVLRGFLDLMLVREPSQRATAQEL 292
Query: 390 MAHPYF 395
           + HP+ 
Sbjct: 293 LGHPFL 298

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 71/285 (24%), Positives = 117/285 (41%), Gaps = 30/285 (10%)
Query: 125 DDYEVVRKV-GRGKYSEVFEGINVNTNERCXXXXXXXXXXXXXXXXXXXLQNLCGGPNVV 183
           DDY+V  +V G G   +V +  N  T E+                      + C  P++V
Sbjct: 17  DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQC--PHIV 74
Query: 184 KLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYI----YELLK----ALDYC 235
           +++D+  + ++    L+   +   D   L+  + D   + +      E++K    A+ Y 
Sbjct: 75  RIVDVYENLYAGRKCLLI-VMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYL 133
Query: 236 HSQGIMHRDVKPHNVMIDHELRK--LRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD 293
           HS  I HRDVKP N++   +     L+L D+G A+             + Y+  PE+L  
Sbjct: 134 HSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVL-G 192
Query: 294 LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKP-W 352
            + YD S DMWSLG +   ++    PF+  H      + I+      I         P W
Sbjct: 193 PEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG-----LAISPGMKTRIRMGQYEFPNPEW 247
Query: 353 SKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQ 397
           S+         VS E    +  LL+ +   R+T  E M HP+  Q
Sbjct: 248 SE---------VSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQ 283

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 71/285 (24%), Positives = 117/285 (41%), Gaps = 30/285 (10%)
Query: 125 DDYEVVRKV-GRGKYSEVFEGINVNTNERCXXXXXXXXXXXXXXXXXXXLQNLCGGPNVV 183
           DDY+V  +V G G   +V +  N  T E+                      + C  P++V
Sbjct: 17  DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQC--PHIV 74
Query: 184 KLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYI----YELLK----ALDYC 235
           +++D+  + ++    L+   +   D   L+  + D   + +      E++K    A+ Y 
Sbjct: 75  RIVDVYENLYAGRKCLLI-VMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYL 133
Query: 236 HSQGIMHRDVKPHNVMIDHELRK--LRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD 293
           HS  I HRDVKP N++   +     L+L D+G A+             + Y+  PE+L  
Sbjct: 134 HSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVL-G 192
Query: 294 LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKP-W 352
            + YD S DMWSLG +   ++    PF+  H      + I+      I         P W
Sbjct: 193 PEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG-----LAISPGMKTRIRMGQYEFPNPEW 247
Query: 353 SKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQ 397
           S+         VS E    +  LL+ +   R+T  E M HP+  Q
Sbjct: 248 SE---------VSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQ 283

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 64/285 (22%), Positives = 119/285 (41%), Gaps = 35/285 (12%)
Query: 120 QWGDQDDYEVVRKVGRGKYSEVFEGINVNTN-----ERCXXXXXXXXXXXXXXXXXXXLQ 174
           QW   +D+E+ R +G+GK+  V+      +      +                     +Q
Sbjct: 4   QWA-LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQ 62
Query: 175 NLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYD---IRYYIYELLKA 231
           +    PN+++L     D  +    LI EY            L+ +D      YI EL  A
Sbjct: 63  SHLRHPNILRLYGYFHD--ATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA 120
Query: 232 LDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELL 291
           L YCHS+ ++HRD+KP N+++     +L++ D+G +  + P         +  +  PE +
Sbjct: 121 LSYCHSKRVIHRDIKPENLLLG-SAGELKIADFGWS-VHAPSSRRTELCGTLDYLPPE-M 177
Query: 292 VDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKP 351
           ++ + +D  +D+WSLG +    +  K P F  +   +   +I++                
Sbjct: 178 IEGRMHDEKVDLWSLGVLCYEFLVGKPP-FEANTYQETYKRISR---------------- 220
Query: 352 WSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFA 396
             +F   D    V+  A D + +LL+++   R   RE + HP+  
Sbjct: 221 -VEFTFPD---FVTEGARDLISRLLKHNPSQRPMLREVLEHPWIT 261

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 102/221 (46%), Gaps = 26/221 (11%)
Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNST---DFKVLYPTLTDYDIRYYIYELLKALDYCH 236
           PNV+ L ++  ++      LI E V      DF     +LT+ +   ++ ++L  + Y H
Sbjct: 74  PNVITLHEVYENKTDVI--LIGELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH 131
Query: 237 SQGIMHRDVKPHNVM-IDHELRK--LRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD 293
           S  I H D+KP N+M +D  + K  +++ID+GLA     G E+     +  F  PE +V+
Sbjct: 132 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPE-IVN 190
Query: 294 LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWS 353
            +      DMWS+G +   ++    PF  G    + L  ++         N     + +S
Sbjct: 191 YEPLGLEADMWSIGVITYILLSGASPFL-GDTKQETLANVSA-------VNYEFEDEYFS 242
Query: 354 KFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPY 394
                      S  A DF+ +LL  D + R+T ++++ HP+
Sbjct: 243 N---------TSALAKDFIRRLLVKDPKKRMTIQDSLQHPW 274

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 71/285 (24%), Positives = 117/285 (41%), Gaps = 30/285 (10%)
Query: 125 DDYEVVRKV-GRGKYSEVFEGINVNTNERCXXXXXXXXXXXXXXXXXXXLQNLCGGPNVV 183
           DDY+V  +V G G   +V +  N  T E+                      + C  P++V
Sbjct: 67  DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQC--PHIV 124
Query: 184 KLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYI----YELLK----ALDYC 235
           +++D+  + ++    L+   +   D   L+  + D   + +      E++K    A+ Y 
Sbjct: 125 RIVDVYENLYAGRKCLLI-VMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYL 183
Query: 236 HSQGIMHRDVKPHNVMIDHELRK--LRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD 293
           HS  I HRDVKP N++   +     L+L D+G A+             + Y+  PE+L  
Sbjct: 184 HSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVL-G 242
Query: 294 LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKP-W 352
            + YD S DMWSLG +   ++    PF+  H      + I+      I         P W
Sbjct: 243 PEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG-----LAISPGMKTRIRMGQYEFPNPEW 297
Query: 353 SKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQ 397
           S+         VS E    +  LL+ +   R+T  E M HP+  Q
Sbjct: 298 SE---------VSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQ 333

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 72/290 (24%), Positives = 124/290 (42%), Gaps = 28/290 (9%)
Query: 114 YESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXXXXXXXXXXXXXXXL 173
           YE +T     +D +E++ ++G G + +V++  N  T+                      +
Sbjct: 26  YEHVTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEI 85
Query: 174 QNL--CGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPT--LTDYDIRYYIYELL 229
             L  C  PN+VKLLD    +++    + F    + D  +L     LT+  I+    + L
Sbjct: 86  DILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTL 145
Query: 230 KALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGL-AEFYHPGKEYNVRVASRYFKGP 288
            AL+Y H   I+HRD+K  N++   +   ++L D+G+ A+     +  +  + + Y+  P
Sbjct: 146 DALNYLHDNKIIHRDLKAGNILFTLD-GDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAP 204
Query: 289 ELLV----DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCN 344
           E+++      + YDY  D+WSLG     M    EP  +  +    L+KIAK     +   
Sbjct: 205 EVVMCETSKDRPYDYKADVWSLGITLIEMA-EIEPPHHELNPMRVLLKIAKSEPPTLAQP 263
Query: 345 SRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPY 394
           SR     WS                DFL K L  +   R T  + + HP+
Sbjct: 264 SR-----WSSNFK------------DFLKKCLEKNVDARWTTSQLLQHPF 296

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 54/184 (29%), Positives = 90/184 (48%), Gaps = 30/184 (16%)
Query: 222 RYYIYELLKALDYCHSQ-GIMHRDVKPHNVMIDHELRKLRLIDWGL-AEFYHPGKEYNVR 279
           R+Y  E++ ALDY HS+  +++RD+K  N+M+D +   +++ D+GL  E    G      
Sbjct: 251 RFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKD-GHIKITDFGLCKEGIKDGATMKTF 309
Query: 280 VASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCL 339
             +  +  PE+L D  DY  ++D W LG +   M+  + PF+  + +H++L +      L
Sbjct: 310 CGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFY--NQDHEKLFE------L 360
Query: 340 IIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLT-----AREAMAHPY 394
           I+    R  R              + PEA   L  LL+ D + RL      A+E M H +
Sbjct: 361 ILMEEIRFPR-------------TLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRF 407
Query: 395 FAQV 398
           FA +
Sbjct: 408 FAGI 411

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 54/184 (29%), Positives = 90/184 (48%), Gaps = 30/184 (16%)
Query: 222 RYYIYELLKALDYCHSQ-GIMHRDVKPHNVMIDHELRKLRLIDWGL-AEFYHPGKEYNVR 279
           R+Y  E++ ALDY HS+  +++RD+K  N+M+D +   +++ D+GL  E    G      
Sbjct: 254 RFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKD-GHIKITDFGLCKEGIKDGATMKTF 312
Query: 280 VASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCL 339
             +  +  PE+L D  DY  ++D W LG +   M+  + PF+  + +H++L +      L
Sbjct: 313 CGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFY--NQDHEKLFE------L 363
Query: 340 IIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLT-----AREAMAHPY 394
           I+    R  R              + PEA   L  LL+ D + RL      A+E M H +
Sbjct: 364 ILMEEIRFPR-------------TLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRF 410
Query: 395 FAQV 398
           FA +
Sbjct: 411 FAGI 414

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 64/285 (22%), Positives = 119/285 (41%), Gaps = 35/285 (12%)
Query: 120 QWGDQDDYEVVRKVGRGKYSEVFEGINVNTN-----ERCXXXXXXXXXXXXXXXXXXXLQ 174
           QW   +D+E+ R +G+GK+  V+      +      +                     +Q
Sbjct: 4   QWA-LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQ 62
Query: 175 NLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYD---IRYYIYELLKA 231
           +    PN+++L     D  +    LI EY            L+ +D      YI EL  A
Sbjct: 63  SHLRHPNILRLYGYFHD--ATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA 120
Query: 232 LDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELL 291
           L YCHS+ ++HRD+KP N+++     +L++ D+G +  + P         +  +  PE +
Sbjct: 121 LSYCHSKRVIHRDIKPENLLLG-SAGELKIADFGWS-VHAPSSRRXXLCGTLDYLPPE-M 177
Query: 292 VDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKP 351
           ++ + +D  +D+WSLG +    +  K P F  +   +   +I++                
Sbjct: 178 IEGRMHDEKVDLWSLGVLCYEFLVGKPP-FEANTYQETYKRISR---------------- 220
Query: 352 WSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFA 396
             +F   D    V+  A D + +LL+++   R   RE + HP+  
Sbjct: 221 -VEFTFPD---FVTEGARDLISRLLKHNPSQRPMLREVLEHPWIT 261

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 64/285 (22%), Positives = 119/285 (41%), Gaps = 35/285 (12%)
Query: 120 QWGDQDDYEVVRKVGRGKYSEVFEGINVNTN-----ERCXXXXXXXXXXXXXXXXXXXLQ 174
           QW   +D+E+ R +G+GK+  V+      +      +                     +Q
Sbjct: 5   QWA-LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQ 63
Query: 175 NLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYD---IRYYIYELLKA 231
           +    PN+++L     D  +    LI EY            L+ +D      YI EL  A
Sbjct: 64  SHLRHPNILRLYGYFHD--ATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA 121
Query: 232 LDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELL 291
           L YCHS+ ++HRD+KP N+++     +L++ D+G +  + P         +  +  PE +
Sbjct: 122 LSYCHSKRVIHRDIKPENLLLG-SAGELKIADFGWS-CHAPSSRRTTLSGTLDYLPPE-M 178
Query: 292 VDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKP 351
           ++ + +D  +D+WSLG +    +  K P F  +   +   +I++                
Sbjct: 179 IEGRMHDEKVDLWSLGVLCYEFLVGKPP-FEANTYQETYKRISR---------------- 221
Query: 352 WSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFA 396
             +F   D    V+  A D + +LL+++   R   RE + HP+  
Sbjct: 222 -VEFTFPD---FVTEGARDLISRLLKHNPSQRPMLREVLEHPWIT 262

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 72/290 (24%), Positives = 124/290 (42%), Gaps = 28/290 (9%)
Query: 114 YESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXXXXXXXXXXXXXXXL 173
           YE +T     +D +E++ ++G G + +V++  N  T+                      +
Sbjct: 26  YEHVTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEI 85
Query: 174 QNL--CGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPT--LTDYDIRYYIYELL 229
             L  C  PN+VKLLD    +++    + F    + D  +L     LT+  I+    + L
Sbjct: 86  DILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTL 145
Query: 230 KALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGL-AEFYHPGKEYNVRVASRYFKGP 288
            AL+Y H   I+HRD+K  N++   +   ++L D+G+ A+     +  +  + + Y+  P
Sbjct: 146 DALNYLHDNKIIHRDLKAGNILFTLD-GDIKLADFGVSAKNTRXIQRRDXFIGTPYWMAP 204
Query: 289 ELLV----DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCN 344
           E+++      + YDY  D+WSLG     M    EP  +  +    L+KIAK     +   
Sbjct: 205 EVVMCETSKDRPYDYKADVWSLGITLIEMA-EIEPPHHELNPMRVLLKIAKSEPPTLAQP 263
Query: 345 SRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPY 394
           SR     WS                DFL K L  +   R T  + + HP+
Sbjct: 264 SR-----WSSNFK------------DFLKKCLEKNVDARWTTSQLLQHPF 296

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 64/285 (22%), Positives = 119/285 (41%), Gaps = 35/285 (12%)
Query: 120 QWGDQDDYEVVRKVGRGKYSEVFEGINVNTN-----ERCXXXXXXXXXXXXXXXXXXXLQ 174
           QW   +D+E+ R +G+GK+  V+      +      +                     +Q
Sbjct: 4   QWA-LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQ 62
Query: 175 NLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYD---IRYYIYELLKA 231
           +    PN+++L     D  +    LI EY            L+ +D      YI EL  A
Sbjct: 63  SHLRHPNILRLYGYFHD--ATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA 120
Query: 232 LDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELL 291
           L YCHS+ ++HRD+KP N+++     +L++ D+G +  + P         +  +  PE +
Sbjct: 121 LSYCHSKRVIHRDIKPENLLLG-SAGELKIADFGWS-VHAPSSRRTDLCGTLDYLPPE-M 177
Query: 292 VDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKP 351
           ++ + +D  +D+WSLG +    +  K P F  +   +   +I++                
Sbjct: 178 IEGRMHDEKVDLWSLGVLCYEFLVGKPP-FEANTYQETYKRISR---------------- 220
Query: 352 WSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFA 396
             +F   D    V+  A D + +LL+++   R   RE + HP+  
Sbjct: 221 -VEFTFPD---FVTEGARDLISRLLKHNPSQRPMLREVLEHPWIT 261

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 64/285 (22%), Positives = 118/285 (41%), Gaps = 35/285 (12%)
Query: 120 QWGDQDDYEVVRKVGRGKYSEVFEGINVNTN-----ERCXXXXXXXXXXXXXXXXXXXLQ 174
           QW   +D+E+ R +G+GK+  V+             +                     +Q
Sbjct: 1   QWA-LEDFEIGRPLGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQ 59
Query: 175 NLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYD---IRYYIYELLKA 231
           +    PN+++L     D  +    LI EY            L+ +D      YI EL  A
Sbjct: 60  SHLRHPNILRLYGYFHD--ATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA 117
Query: 232 LDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELL 291
           L YCHS+ ++HRD+KP N+++     +L++ D+G +  + P         +  +  PE +
Sbjct: 118 LSYCHSKRVIHRDIKPENLLLG-SAGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPE-M 174
Query: 292 VDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKP 351
           ++ + +D  +D+WSLG +    +  K P F  +   +   +I++                
Sbjct: 175 IEGRMHDEKVDLWSLGVLCYEFLVGKPP-FEANTYQETYKRISR---------------- 217
Query: 352 WSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFA 396
             +F   D    V+  A D + +LL+++   R   RE + HP+  
Sbjct: 218 -VEFTFPD---FVTEGARDLISRLLKHNPSQRPMLREVLEHPWIT 258

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 64/285 (22%), Positives = 120/285 (42%), Gaps = 35/285 (12%)
Query: 120 QWGDQDDYEVVRKVGRGKYSEVFEGINVNTN-----ERCXXXXXXXXXXXXXXXXXXXLQ 174
           QW   +D+E+ R +G+GK+  V+      +      +                     +Q
Sbjct: 7   QWA-LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQ 65
Query: 175 NLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYD---IRYYIYELLKA 231
           +    PN+++L     D  +    LI EY            L+ +D      YI EL  A
Sbjct: 66  SHLRHPNILRLYGYFHD--ATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA 123
Query: 232 LDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELL 291
           L YCHS+ ++HRD+KP N+++     +L++ D+G +  + P    +    +  +  PE +
Sbjct: 124 LSYCHSKRVIHRDIKPENLLLG-SAGELKIADFGWS-VHAPSSRRDDLCGTLDYLPPE-M 180
Query: 292 VDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKP 351
           ++ + +D  +D+WSLG +    +  K P F  +   +   +I++                
Sbjct: 181 IEGRMHDEKVDLWSLGVLCYEFLVGKPP-FEANTYQETYKRISR---------------- 223
Query: 352 WSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFA 396
             +F   D    V+  A D + +LL+++   R   RE + HP+  
Sbjct: 224 -VEFTFPD---FVTEGARDLISRLLKHNPSQRPMLREVLEHPWIT 264

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 64/285 (22%), Positives = 119/285 (41%), Gaps = 35/285 (12%)
Query: 120 QWGDQDDYEVVRKVGRGKYSEVFEGINVNTN-----ERCXXXXXXXXXXXXXXXXXXXLQ 174
           QW   +D+E+ R +G+GK+  V+      +      +                     +Q
Sbjct: 9   QWA-LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQ 67
Query: 175 NLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYD---IRYYIYELLKA 231
           +    PN+++L     D  +    LI EY            L+ +D      YI EL  A
Sbjct: 68  SHLRHPNILRLYGYFHD--ATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA 125
Query: 232 LDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELL 291
           L YCHS+ ++HRD+KP N+++     +L++ D+G +  + P         +  +  PE +
Sbjct: 126 LSYCHSKRVIHRDIKPENLLLG-SAGELKIADFGWS-VHAPSSRRTDLCGTLDYLPPE-M 182
Query: 292 VDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKP 351
           ++ + +D  +D+WSLG +    +  K P F  +   +   +I++                
Sbjct: 183 IEGRMHDEKVDLWSLGVLCYEFLVGKPP-FEANTYQETYKRISR---------------- 225
Query: 352 WSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFA 396
             +F   D    V+  A D + +LL+++   R   RE + HP+  
Sbjct: 226 -VEFTFPD---FVTEGARDLISRLLKHNPSQRPMLREVLEHPWIT 266

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 64/285 (22%), Positives = 119/285 (41%), Gaps = 35/285 (12%)
Query: 120 QWGDQDDYEVVRKVGRGKYSEVFEGINVNTN-----ERCXXXXXXXXXXXXXXXXXXXLQ 174
           QW   +D+E+ R +G+GK+  V+      +      +                     +Q
Sbjct: 4   QWA-LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQ 62
Query: 175 NLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYD---IRYYIYELLKA 231
           +    PN+++L     D  +    LI EY            L+ +D      YI EL  A
Sbjct: 63  SHLRHPNILRLYGYFHD--ATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA 120
Query: 232 LDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELL 291
           L YCHS+ ++HRD+KP N+++     +L++ D+G +  + P         +  +  PE +
Sbjct: 121 LSYCHSKRVIHRDIKPENLLLG-SAGELKIADFGWS-VHAPSSRRTDLCGTLDYLPPE-M 177
Query: 292 VDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKP 351
           ++ + +D  +D+WSLG +    +  K P F  +   +   +I++                
Sbjct: 178 IEGRMHDEKVDLWSLGVLCYEFLVGKPP-FEANTYQETYKRISR---------------- 220
Query: 352 WSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFA 396
             +F   D    V+  A D + +LL+++   R   RE + HP+  
Sbjct: 221 -VEFTFPD---FVTEGARDLISRLLKHNPSQRPMLREVLEHPWIT 261

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 64/285 (22%), Positives = 119/285 (41%), Gaps = 35/285 (12%)
Query: 120 QWGDQDDYEVVRKVGRGKYSEVFEGINVNTN-----ERCXXXXXXXXXXXXXXXXXXXLQ 174
           QW   +D+E+ R +G+GK+  V+      +      +                     +Q
Sbjct: 5   QWA-LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQ 63
Query: 175 NLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYD---IRYYIYELLKA 231
           +    PN+++L     D  +    LI EY            L+ +D      YI EL  A
Sbjct: 64  SHLRHPNILRLYGYFHD--ATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA 121
Query: 232 LDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELL 291
           L YCHS+ ++HRD+KP N+++     +L++ D+G +  + P         +  +  PE +
Sbjct: 122 LSYCHSKRVIHRDIKPENLLLG-SAGELKIADFGWS-VHAPSSRRTDLCGTLDYLPPE-M 178
Query: 292 VDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKP 351
           ++ + +D  +D+WSLG +    +  K P F  +   +   +I++                
Sbjct: 179 IEGRMHDEKVDLWSLGVLCYEFLVGKPP-FEANTYQETYKRISR---------------- 221
Query: 352 WSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFA 396
             +F   D    V+  A D + +LL+++   R   RE + HP+  
Sbjct: 222 -VEFTFPD---FVTEGARDLISRLLKHNPSQRPMLREVLEHPWIT 262

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 72/290 (24%), Positives = 124/290 (42%), Gaps = 28/290 (9%)
Query: 114 YESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXXXXXXXXXXXXXXXL 173
           YE +T     +D +E++ ++G G + +V++  N  T+                      +
Sbjct: 26  YEHVTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEI 85
Query: 174 QNL--CGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPT--LTDYDIRYYIYELL 229
             L  C  PN+VKLLD    +++    + F    + D  +L     LT+  I+    + L
Sbjct: 86  DILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTL 145
Query: 230 KALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGL-AEFYHPGKEYNVRVASRYFKGP 288
            AL+Y H   I+HRD+K  N++   +   ++L D+G+ A+     +  +  + + Y+  P
Sbjct: 146 DALNYLHDNKIIHRDLKAGNILFTLD-GDIKLADFGVSAKNTRXIQRRDSFIGTPYWMAP 204
Query: 289 ELLV----DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCN 344
           E+++      + YDY  D+WSLG     M    EP  +  +    L+KIAK     +   
Sbjct: 205 EVVMCETSKDRPYDYKADVWSLGITLIEMA-EIEPPHHELNPMRVLLKIAKSEPPTLAQP 263
Query: 345 SRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPY 394
           SR     WS                DFL K L  +   R T  + + HP+
Sbjct: 264 SR-----WSSNFK------------DFLKKCLEKNVDARWTTSQLLQHPF 296

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 71/285 (24%), Positives = 117/285 (41%), Gaps = 30/285 (10%)
Query: 125 DDYEVVRKV-GRGKYSEVFEGINVNTNERCXXXXXXXXXXXXXXXXXXXLQNLCGGPNVV 183
           DDY+V  +V G G   +V +  N  T E+                      + C  P++V
Sbjct: 15  DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQC--PHIV 72
Query: 184 KLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYI----YELLK----ALDYC 235
           +++D+  + ++    L+   +   D   L+  + D   + +      E++K    A+ Y 
Sbjct: 73  RIVDVYENLYAGRKCLLI-VMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYL 131
Query: 236 HSQGIMHRDVKPHNVMIDHELRK--LRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD 293
           HS  I HRDVKP N++   +     L+L D+G A+             + Y+  PE+L  
Sbjct: 132 HSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTEPCYTPYYVAPEVL-G 190
Query: 294 LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKP-W 352
            + YD S DMWSLG +   ++    PF+  H      + I+      I         P W
Sbjct: 191 PEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG-----LAISPGMKTRIRMGQYEFPNPEW 245
Query: 353 SKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQ 397
           S+         VS E    +  LL+ +   R+T  E M HP+  Q
Sbjct: 246 SE---------VSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQ 281

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 54/184 (29%), Positives = 90/184 (48%), Gaps = 30/184 (16%)
Query: 222 RYYIYELLKALDYCHSQ-GIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEYNVR 279
           R+Y  E++ ALDY HS+  +++RD+K  N+M+D +   +++ D+GL  E    G      
Sbjct: 111 RFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKD-GHIKITDFGLCKEGIKDGATMKXF 169
Query: 280 VASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCL 339
             +  +  PE+L D  DY  ++D W LG +   M+  + PF+  + +H++L +      L
Sbjct: 170 CGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFY--NQDHEKLFE------L 220
Query: 340 IIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLT-----AREAMAHPY 394
           I+    R  R              + PEA   L  LL+ D + RL      A+E M H +
Sbjct: 221 ILMEEIRFPRT-------------LGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRF 267
Query: 395 FAQV 398
           FA +
Sbjct: 268 FAGI 271

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 54/184 (29%), Positives = 90/184 (48%), Gaps = 30/184 (16%)
Query: 222 RYYIYELLKALDYCHSQ-GIMHRDVKPHNVMIDHELRKLRLIDWGL-AEFYHPGKEYNVR 279
           R+Y  E++ ALDY HS+  +++RD+K  N+M+D +   +++ D+GL  E    G      
Sbjct: 113 RFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKD-GHIKITDFGLCKEGIKDGATMKXF 171
Query: 280 VASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCL 339
             +  +  PE+L D  DY  ++D W LG +   M+  + PF+  + +H++L +      L
Sbjct: 172 CGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFY--NQDHEKLFE------L 222
Query: 340 IIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLT-----AREAMAHPY 394
           I+    R  R              + PEA   L  LL+ D + RL      A+E M H +
Sbjct: 223 ILMEEIRFPRT-------------LGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRF 269
Query: 395 FAQV 398
           FA +
Sbjct: 270 FAGI 273

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 54/184 (29%), Positives = 90/184 (48%), Gaps = 30/184 (16%)
Query: 222 RYYIYELLKALDYCHSQ-GIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEYNVR 279
           R+Y  E++ ALDY HS+  +++RD+K  N+M+D +   +++ D+GL  E    G      
Sbjct: 112 RFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKD-GHIKITDFGLCKEGIKDGATMKXF 170
Query: 280 VASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCL 339
             +  +  PE+L D  DY  ++D W LG +   M+  + PF+  + +H++L +      L
Sbjct: 171 CGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFY--NQDHEKLFE------L 221
Query: 340 IIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLT-----AREAMAHPY 394
           I+    R  R              + PEA   L  LL+ D + RL      A+E M H +
Sbjct: 222 ILMEEIRFPRT-------------LGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRF 268
Query: 395 FAQV 398
           FA +
Sbjct: 269 FAGI 272

>pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 75/342 (21%), Positives = 141/342 (41%), Gaps = 64/342 (18%)
Query: 117 LTVQWGD--QDDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXXXXXXXXXXXXXXXLQ 174
           L  Q GD     YE+V  +G G + +V E I+     R                    +Q
Sbjct: 4   LICQSGDVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQ 63
Query: 175 NL----CGGPN----VVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL-----YPTLTDYDI 221
            L       PN     V++L+    +H     ++FE +  + +  +      P   D+ I
Sbjct: 64  VLEHLNTTDPNSTFRCVQMLEWF--EHHGHICIVFELLGLSTYDFIKENGFLPFRLDH-I 120
Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVM-------------IDHELRKL-----RLID 263
           R   Y++ K++++ HS  + H D+KP N++             I  + R L     +++D
Sbjct: 121 RKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVD 180
Query: 264 WGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYG 323
           +G A +    + ++  V++R+++ PE+++ L  +    D+WS+GC+     +     F  
Sbjct: 181 FGSATY--DDEHHSTLVSTRHYRAPEVILAL-GWSQPCDVWSIGCILIEY-YLGFTVFPT 236
Query: 324 HDNHDQLVKIAKDCC-----LIIWCNSR----HSRKPWSKFINAD--------------- 359
           HD+ + L  + +        +I     R    H R  W +  +A                
Sbjct: 237 HDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFML 296
Query: 360 NQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAA 401
           +Q +      D + K+L YD   R+T REA+ HP+F  ++ +
Sbjct: 297 SQDVEHERLFDLIQKMLEYDPAKRITLREALKHPFFDLLKKS 338

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 51/181 (28%), Positives = 83/181 (45%), Gaps = 24/181 (13%)
Query: 223 YYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVAS 282
           +Y  E+   L+  H + I++RD+KP N+++D     +R+ D GLA     G+    RV +
Sbjct: 290 FYAAEICCGLEDLHRERIVYRDLKPENILLDDH-GHIRISDLGLAVHVPEGQTIKGRVGT 348
Query: 283 RYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIW 342
             +  PE++ + + Y +S D W+LGC+   MI  + PF        Q  K  K       
Sbjct: 349 VGYMAPEVVKN-ERYTFSPDWWALGCLLYEMIAGQSPF-------QQRKKKIK------- 393
Query: 343 CNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRL-----TAREAMAHPYFAQ 397
              R   +   K +  +     SP+A     +LL  D  +RL     +ARE   HP F +
Sbjct: 394 ---REEVERLVKEVPEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKK 450
Query: 398 V 398
           +
Sbjct: 451 L 451

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/228 (24%), Positives = 107/228 (46%), Gaps = 33/228 (14%)
Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNSTD-FKVLYPTL----TDYDIRYYIYELLKALDY 234
           P V+ L ++   +++    LI EY    + F +  P L    ++ D+   I ++L+ + Y
Sbjct: 89  PRVINLHEVY--ENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYY 146
Query: 235 CHSQGIMHRDVKPHNVMID--HELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLV 292
            H   I+H D+KP N+++   + L  ++++D+G++       E    + +  +  PE+L 
Sbjct: 147 LHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPEIL- 205
Query: 293 DLQDYD---YSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSR 349
              +YD    + DMW++G + A M+      F G DN +  + I++        N  +S 
Sbjct: 206 ---NYDPITTATDMWNIG-IIAYMLLTHTSPFVGEDNQETYLNISQ-------VNVDYSE 254
Query: 350 KPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQ 397
           + +S          VS  A DF+  LL  + + R TA   ++H +  Q
Sbjct: 255 ETFSS---------VSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQ 293

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 51/181 (28%), Positives = 83/181 (45%), Gaps = 24/181 (13%)
Query: 223 YYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVAS 282
           +Y  E+   L+  H + I++RD+KP N+++D     +R+ D GLA     G+    RV +
Sbjct: 290 FYAAEICCGLEDLHRERIVYRDLKPENILLDDH-GHIRISDLGLAVHVPEGQTIKGRVGT 348
Query: 283 RYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIW 342
             +  PE++ + + Y +S D W+LGC+   MI  + PF        Q  K  K       
Sbjct: 349 VGYMAPEVVKN-ERYTFSPDWWALGCLLYEMIAGQSPF-------QQRKKKIK------- 393
Query: 343 CNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRL-----TAREAMAHPYFAQ 397
              R   +   K +  +     SP+A     +LL  D  +RL     +ARE   HP F +
Sbjct: 394 ---REEVERLVKEVPEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKK 450
Query: 398 V 398
           +
Sbjct: 451 L 451

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 48/227 (21%), Positives = 100/227 (44%), Gaps = 31/227 (13%)
Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNSTDF-------KVLYPTLTDYDIRYYIYELLKAL 232
           PN++K+ ++  D H+    ++ E     +        +     L++  +   + +++ AL
Sbjct: 80  PNIIKIFEVFEDYHNMY--IVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNAL 137
Query: 233 DYCHSQGIMHRDVKPHNVMIDHEL--RKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPEL 290
            Y HSQ ++H+D+KP N++         +++ID+GLAE +   +       +  +  PE+
Sbjct: 138 AYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPEV 197
Query: 291 LVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRK 350
               +D  +  D+WS G +   ++    PF        Q     K+    + C      +
Sbjct: 198 FK--RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVEC------R 249
Query: 351 PWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQ 397
           P            ++P+A+D L ++L  D + R +A + + H +F Q
Sbjct: 250 P------------LTPQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQ 284

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 42/202 (20%), Positives = 95/202 (47%), Gaps = 10/202 (4%)
Query: 126 DYEVVRKVGRGKYSEVFEGINVNTNE----RCXXXXXXXXXXXXXXXXXXXLQNLCGGPN 181
           +Y +++ +G+G +++V    ++ T +    +                    +  +   PN
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIXKVLNHPN 74
Query: 182 VVKLLDIVRDQHSKTPSLIFEYVNST---DFKVLYPTLTDYDIRYYIYELLKALDYCHSQ 238
           +VKL +++  +  KT  L+ EY +     D+ V +    + + R    +++ A+ YCH +
Sbjct: 75  IVKLFEVIETE--KTLYLVXEYASGGEVFDYLVAHGRXKEKEARAKFRQIVSAVQYCHQK 132
Query: 239 GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYD 298
            I+HRD+K  N+++D +   +++ D+G +  +  G + +    +  +  PEL    +   
Sbjct: 133 FIVHRDLKAENLLLDAD-XNIKIADFGFSNEFTFGNKLDAFCGAPPYAAPELFQGKKYDG 191
Query: 299 YSLDMWSLGCMFAGMIFRKEPF 320
             +D+WSLG +   ++    PF
Sbjct: 192 PEVDVWSLGVILYTLVSGSLPF 213

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 47/181 (25%), Positives = 79/181 (43%), Gaps = 29/181 (16%)
Query: 178 GGPNVVKLLDIVRDQHSKTPSL--------IFEYVNSTDFKVLYPTLTDYDIRYYIYELL 229
           G P V++LLD    Q      L        +F+Y+           L +   R +  +++
Sbjct: 96  GHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKG------PLGEGPSRCFFGQVV 149
Query: 230 KALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 289
            A+ +CHS+G++HRD+K  N++ID      +LID+G     H  + Y     +R +  PE
Sbjct: 150 AAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLH-DEPYTDFDGTRVYSPPE 208
Query: 290 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV---------KIAKDCCLI 340
            +   Q +     +WSLG +   M+    PF       DQ +          ++ DCC +
Sbjct: 209 WISRHQYHALPATVWSLGILLYDMVCGDIPF-----ERDQEILEAELHFPAHVSPDCCAL 263
Query: 341 I 341
           I
Sbjct: 264 I 264

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 56/219 (25%), Positives = 100/219 (45%), Gaps = 28/219 (12%)
Query: 192 QHSKTPSLIFEYVNSTDFKVLYPTLTDYDIR---YYIYELLKALDYCHSQGIMHRDVKPH 248
           Q  +    + EY+N  D      +   +D+    +Y  E++  L + HS+GI++RD+K  
Sbjct: 88  QTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLD 147
Query: 249 NVMIDHELRKLRLIDWGLAEFYHPG-KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLG 307
           N+++D +   +++ D+G+ +    G  + N    +  +  PE+L+  Q Y++S+D WS G
Sbjct: 148 NILLDKD-GHIKIADFGMCKENMLGDAKTNXFCGTPDYIAPEILLG-QKYNHSVDWWSFG 205
Query: 308 CMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSKFINADNQHLVSPE 367
            +   M+  + P F+G D  +    I  D       N  + R  W           +  E
Sbjct: 206 VLLYEMLIGQSP-FHGQDEEELFHSIRMD-------NPFYPR--W-----------LEKE 244
Query: 368 AIDFLDKLLRYDHQDRLTAR-EAMAHPYFAQVRAAESSR 405
           A D L KL   + + RL  R +   HP F ++   E  R
Sbjct: 245 AKDLLVKLFVREPEKRLGVRGDIRQHPLFREINWEELER 283

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 56/226 (24%), Positives = 99/226 (43%), Gaps = 44/226 (19%)
Query: 198 SLIFEYVNSTDFKVLYPTLTDYDIRYYIY-------------------ELLKALDYCHSQ 238
           SL + +   TD  ++   +   DIRY+IY                   +++  L++ H +
Sbjct: 249 SLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR 308
Query: 239 GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASR-YFKGPELLVDLQDY 297
            I++RD+KP NV++D +   +R+ D GLA     G+      A    F  PELL+  ++Y
Sbjct: 309 NIIYRDLKPENVLLDDD-GNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLG-EEY 366
Query: 298 DYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSKFIN 357
           D+S+D ++LG     MI  + PF    +  +               N    ++   + + 
Sbjct: 367 DFSVDYFALGVTLYEMIAARGPFRARGEKVE---------------NKELKQRVLEQAVT 411
Query: 358 ADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAM-----AHPYFAQV 398
             ++   SP + DF + LL+ D + RL  R+        HP F  +
Sbjct: 412 YPDK--FSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDI 455

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 56/226 (24%), Positives = 99/226 (43%), Gaps = 44/226 (19%)
Query: 198 SLIFEYVNSTDFKVLYPTLTDYDIRYYIY-------------------ELLKALDYCHSQ 238
           SL + +   TD  ++   +   DIRY+IY                   +++  L++ H +
Sbjct: 249 SLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR 308
Query: 239 GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASR-YFKGPELLVDLQDY 297
            I++RD+KP NV++D +   +R+ D GLA     G+      A    F  PELL+  ++Y
Sbjct: 309 NIIYRDLKPENVLLDDD-GNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLG-EEY 366
Query: 298 DYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSKFIN 357
           D+S+D ++LG     MI  + PF    +  +               N    ++   + + 
Sbjct: 367 DFSVDYFALGVTLYEMIAARGPFRARGEKVE---------------NKELKQRVLEQAVT 411
Query: 358 ADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAM-----AHPYFAQV 398
             ++   SP + DF + LL+ D + RL  R+        HP F  +
Sbjct: 412 YPDK--FSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDI 455

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 56/226 (24%), Positives = 99/226 (43%), Gaps = 44/226 (19%)
Query: 198 SLIFEYVNSTDFKVLYPTLTDYDIRYYIY-------------------ELLKALDYCHSQ 238
           SL + +   TD  ++   +   DIRY+IY                   +++  L++ H +
Sbjct: 249 SLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR 308
Query: 239 GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASR-YFKGPELLVDLQDY 297
            I++RD+KP NV++D +   +R+ D GLA     G+      A    F  PELL+  ++Y
Sbjct: 309 NIIYRDLKPENVLLDDD-GNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLG-EEY 366
Query: 298 DYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSKFIN 357
           D+S+D ++LG     MI  + PF    +  +               N    ++   + + 
Sbjct: 367 DFSVDYFALGVTLYEMIAARGPFRARGEKVE---------------NKELKQRVLEQAVT 411
Query: 358 ADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAM-----AHPYFAQV 398
             ++   SP + DF + LL+ D + RL  R+        HP F  +
Sbjct: 412 YPDK--FSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDI 455

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 56/226 (24%), Positives = 99/226 (43%), Gaps = 44/226 (19%)
Query: 198 SLIFEYVNSTDFKVLYPTLTDYDIRYYIY-------------------ELLKALDYCHSQ 238
           SL + +   TD  ++   +   DIRY+IY                   +++  L++ H +
Sbjct: 249 SLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR 308
Query: 239 GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASR-YFKGPELLVDLQDY 297
            I++RD+KP NV++D +   +R+ D GLA     G+      A    F  PELL+  ++Y
Sbjct: 309 NIIYRDLKPENVLLDDD-GNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLG-EEY 366
Query: 298 DYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSKFIN 357
           D+S+D ++LG     MI  + PF    +  +               N    ++   + + 
Sbjct: 367 DFSVDYFALGVTLYEMIAARGPFRARGEKVE---------------NKELKQRVLEQAVT 411
Query: 358 ADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAM-----AHPYFAQV 398
             ++   SP + DF + LL+ D + RL  R+        HP F  +
Sbjct: 412 YPDK--FSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDI 455

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 56/219 (25%), Positives = 100/219 (45%), Gaps = 28/219 (12%)
Query: 192 QHSKTPSLIFEYVNSTDFKVLYPTLTDYDIR---YYIYELLKALDYCHSQGIMHRDVKPH 248
           Q  +    + EY+N  D      +   +D+    +Y  E++  L + HS+GI++RD+K  
Sbjct: 89  QTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLD 148
Query: 249 NVMIDHELRKLRLIDWGLAEFYHPG-KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLG 307
           N+++D +   +++ D+G+ +    G  + N    +  +  PE+L+  Q Y++S+D WS G
Sbjct: 149 NILLDKD-GHIKIADFGMCKENMLGDAKTNEFCGTPDYIAPEILLG-QKYNHSVDWWSFG 206
Query: 308 CMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSKFINADNQHLVSPE 367
            +   M+  + P F+G D  +    I  D       N  + R  W           +  E
Sbjct: 207 VLLYEMLIGQSP-FHGQDEEELFHSIRMD-------NPFYPR--W-----------LEKE 245
Query: 368 AIDFLDKLLRYDHQDRLTAR-EAMAHPYFAQVRAAESSR 405
           A D L KL   + + RL  R +   HP F ++   E  R
Sbjct: 246 AKDLLVKLFVREPEKRLGVRGDIRQHPLFREINWEELER 284

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 63/293 (21%), Positives = 126/293 (43%), Gaps = 30/293 (10%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVN-TNERCXXXXXXXXXXXXXXXXXXXLQNLC---GGP 180
           DDY++  ++G+G +S V   +    T E                        +C     P
Sbjct: 31  DDYQLFEELGKGAFSVVRRCVKKTPTQEYAAKIINTKKLSARDHQKLEREARICRLLKHP 90
Query: 181 NVVKLLDIVRDQHSKTPSLIFEYVNSTDF---KVLYPTLTDYDIRYYIYELLKALDYCHS 237
           N+V+L D + ++      L+F+ V   +     V     ++ D  + I+++L+++++ H 
Sbjct: 91  NIVRLHDSISEEGFHY--LVFDLVTGGELFEDIVAREYYSEADASHCIHQILESVNHIHQ 148
Query: 238 QGIMHRDVKPHNVMIDHELR--KLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDL 294
             I+HRD+KP N+++  + +   ++L D+GLA E     + +     +  +  PE+L   
Sbjct: 149 HDIVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGEQQAWFGFAGTPGYLSPEVLRK- 207
Query: 295 QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSK 354
             Y   +D+W+ G +   ++    P F+  D H    +I                K  + 
Sbjct: 208 DPYGKPVDIWACGVILYILLVGYPP-FWDEDQHKLYQQI----------------KAGAY 250
Query: 355 FINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAESSRTR 407
              +     V+PEA + ++++L  +   R+TA +A+ HP+  Q     S   R
Sbjct: 251 DFPSPEWDTVTPEAKNLINQMLTINPAKRITADQALKHPWVCQRSTVASMMHR 303

>pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 75/342 (21%), Positives = 139/342 (40%), Gaps = 64/342 (18%)
Query: 117 LTVQWGD--QDDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXXXXXXXXXXXXXXXLQ 174
           L  Q GD     YE+V  +G G + +V E I+     R                    +Q
Sbjct: 4   LICQSGDVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQ 63
Query: 175 NL----CGGPN----VVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL-----YPTLTDYDI 221
            L       PN     V++L+    +H     ++FE +  + +  +      P   D+ I
Sbjct: 64  VLEHLNTTDPNSTFRCVQMLEWF--EHHGHICIVFELLGLSTYDFIKENGFLPFRLDH-I 120
Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVM-------------IDHELRKL-----RLID 263
           R   Y++ K++++ HS  + H D+KP N++             I  + R L     +++D
Sbjct: 121 RKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVD 180
Query: 264 WGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYG 323
           +G A +    + ++  V  R+++ PE+++ L  +    D+WS+GC+     +     F  
Sbjct: 181 FGSATY--DDEHHSTLVXXRHYRAPEVILAL-GWSQPCDVWSIGCILIEY-YLGFTVFPT 236
Query: 324 HDNHDQLVKIAKDCC-----LIIWCNSR----HSRKPWSKFINAD--------------- 359
           HD+ + L  + +        +I     R    H R  W +  +A                
Sbjct: 237 HDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFML 296
Query: 360 NQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAA 401
           +Q +      D + K+L YD   R+T REA+ HP+F  ++ +
Sbjct: 297 SQDVEHERLFDLIQKMLEYDPAKRITLREALKHPFFDLLKKS 338

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 37/147 (25%), Positives = 73/147 (49%), Gaps = 12/147 (8%)
Query: 180 PNVVKLLDIVRDQHSKTPS---LIFEYVNST---DFKVLYPTLTDYDIRYYIYELLKALD 233
           P+++KL  ++      TP+   ++ EYV+     D+   +  + + + R    ++L A+D
Sbjct: 71  PHIIKLYQVI-----STPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVD 125
Query: 234 YCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD 293
           YCH   ++HRD+KP NV++D  +   ++ D+GL+     G+       S  +  PE++  
Sbjct: 126 YCHRHMVVHRDLKPENVLLDAHMNA-KIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISG 184
Query: 294 LQDYDYSLDMWSLGCMFAGMIFRKEPF 320
                  +D+WS G +   ++    PF
Sbjct: 185 RLYAGPEVDIWSCGVILYALLCGTLPF 211

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 92/206 (44%), Gaps = 28/206 (13%)
Query: 198 SLIFEYVNSTDFK---VLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDH 254
           S I + +N  D       +   ++ D+R+Y  E++  L++ H++ +++RD+KP N+++D 
Sbjct: 267 SFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLD- 325
Query: 255 ELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMI 314
           E   +R+ D GLA  +   K +   V +  +  PE+L     YD S D +SLGCM   ++
Sbjct: 326 EHGHVRISDLGLACDFSKKKPH-ASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLL 384
Query: 315 FRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDK 374
               P F  H   D                 +H     +  +  +     SPE    L+ 
Sbjct: 385 RGHSP-FRQHKTKD-----------------KHEIDRMTLTMAVELPDSFSPELRSLLEG 426
Query: 375 LLRYDHQDRL-----TAREAMAHPYF 395
           LL+ D   RL      A+E    P+F
Sbjct: 427 LLQRDVNRRLGCLGRGAQEVKESPFF 452

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 92/206 (44%), Gaps = 28/206 (13%)
Query: 198 SLIFEYVNSTDFK---VLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDH 254
           S I + +N  D       +   ++ D+R+Y  E++  L++ H++ +++RD+KP N+++D 
Sbjct: 268 SFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLD- 326
Query: 255 ELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMI 314
           E   +R+ D GLA  +   K +   V +  +  PE+L     YD S D +SLGCM   ++
Sbjct: 327 EHGHVRISDLGLACDFSKKKPH-ASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLL 385
Query: 315 FRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDK 374
               P F  H   D                 +H     +  +  +     SPE    L+ 
Sbjct: 386 RGHSP-FRQHKTKD-----------------KHEIDRMTLTMAVELPDSFSPELRSLLEG 427
Query: 375 LLRYDHQDRL-----TAREAMAHPYF 395
           LL+ D   RL      A+E    P+F
Sbjct: 428 LLQRDVNRRLGCLGRGAQEVKESPFF 453

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 92/206 (44%), Gaps = 28/206 (13%)
Query: 198 SLIFEYVNSTDFK---VLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDH 254
           S I + +N  D       +   ++ D+R+Y  E++  L++ H++ +++RD+KP N+++D 
Sbjct: 268 SFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLD- 326
Query: 255 ELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMI 314
           E   +R+ D GLA  +   K +   V +  +  PE+L     YD S D +SLGCM   ++
Sbjct: 327 EHGHVRISDLGLACDFSKKKPH-ASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLL 385
Query: 315 FRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDK 374
               P F  H   D                 +H     +  +  +     SPE    L+ 
Sbjct: 386 RGHSP-FRQHKTKD-----------------KHEIDRMTLTMAVELPDSFSPELRSLLEG 427
Query: 375 LLRYDHQDRL-----TAREAMAHPYF 395
           LL+ D   RL      A+E    P+F
Sbjct: 428 LLQRDVNRRLGCLGRGAQEVKESPFF 453

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 92/206 (44%), Gaps = 28/206 (13%)
Query: 198 SLIFEYVNSTDFK---VLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDH 254
           S I + +N  D       +   ++ D+R+Y  E++  L++ H++ +++RD+KP N+++D 
Sbjct: 268 SFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLD- 326
Query: 255 ELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMI 314
           E   +R+ D GLA  +   K +   V +  +  PE+L     YD S D +SLGCM   ++
Sbjct: 327 EHGHVRISDLGLACDFSKKKPH-ASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLL 385
Query: 315 FRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDK 374
               P F  H   D                 +H     +  +  +     SPE    L+ 
Sbjct: 386 RGHSP-FRQHKTKD-----------------KHEIDRMTLTMAVELPDSFSPELRSLLEG 427
Query: 375 LLRYDHQDRL-----TAREAMAHPYF 395
           LL+ D   RL      A+E    P+F
Sbjct: 428 LLQRDVNRRLGCLGRGAQEVKESPFF 453

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 62/253 (24%), Positives = 106/253 (41%), Gaps = 33/253 (13%)
Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTN----------ERCXXXXXXXXXXXXXXXXXXXL 173
           +  Y+V   +G G +  V+ GI V+ N          +R                     
Sbjct: 7   ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLK 66
Query: 174 QNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNST----DFKVLYPTLTDYDIRYYIYELL 229
           +   G   V++LLD      S    LI E +       DF      L +   R + +++L
Sbjct: 67  KVSSGFSGVIRLLDWFERPDSFV--LILERMEPVQDLFDFITERGALQEELARSFFWQVL 124
Query: 230 KALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 289
           +A+ +CH+ G++HRD+K  N++ID    +L+LID+G          Y     +R +  PE
Sbjct: 125 EAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTDFDGTRVYSPPE 183
Query: 290 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV---------KIAKDCC-L 339
            +   + +  S  +WSLG +   M+    PF      HD+ +         +++ +C  L
Sbjct: 184 WIRYHRYHGRSAAVWSLGILLYDMVCGDIPF-----EHDEEIIRGQVFFRQRVSSECQHL 238
Query: 340 IIWCNS-RHSRKP 351
           I WC + R S +P
Sbjct: 239 IRWCLALRPSDRP 251

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 58/243 (23%), Positives = 104/243 (42%), Gaps = 21/243 (8%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXXXXXXX---XXXXXXXXLQNLCGGPN 181
           +D+++V+ +G G Y EV   +N  T E                        +  +    N
Sbjct: 6   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 65
Query: 182 VVKLLDIVRDQHSKTPSLIFEYVNSTD-FKVLYP--TLTDYDIRYYIYELLKALDYCHSQ 238
           VVK     R+ + +   L  EY +  + F  + P   + + D + + ++L+  + Y H  
Sbjct: 66  VVKFYGHRREGNIQY--LFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 123
Query: 239 GIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKE--YNVRVASRYFKGPELLVDLQ 295
           GI HRD+KP N+++D E   L++ D+GLA  F +  +E   N    +  +  PELL   +
Sbjct: 124 GITHRDIKPENLLLD-ERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRRE 182
Query: 296 DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSKF 355
            +   +D+WS G +   M+  + P+    D+  +            W   +    PW K 
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSXQEYSD---------WKEKKTYLNPWKKI 233
Query: 356 INA 358
            +A
Sbjct: 234 DSA 236

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/243 (24%), Positives = 105/243 (43%), Gaps = 21/243 (8%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXXXXXXX---XXXXXXXXLQNLCGGPN 181
           +D+++V+ +G G Y EV   +N  T E                        +  +    N
Sbjct: 6   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHEN 65
Query: 182 VVKLLDIVRDQHSKTPSLIFEYVNSTD-FKVLYP--TLTDYDIRYYIYELLKALDYCHSQ 238
           VVK     R+ + +   L  EY +  + F  + P   + + D + + ++L+  + Y H  
Sbjct: 66  VVKFYGHRREGNIQY--LFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 123
Query: 239 GIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKE--YNVRVASRYFKGPELLVDLQ 295
           GI HRD+KP N+++D E   L++ D+GLA  F +  +E   N    +  +  PELL   +
Sbjct: 124 GITHRDIKPENLLLD-ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 182
Query: 296 DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSKF 355
            +   +D+WS G +   M+  + P+    D+  +            W   +    PW K 
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSD---------WKEKKTYLNPWKKI 233
Query: 356 INA 358
            +A
Sbjct: 234 DSA 236

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 58/243 (23%), Positives = 104/243 (42%), Gaps = 21/243 (8%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXXXXXXX---XXXXXXXXLQNLCGGPN 181
           +D+++V+ +G G Y EV   +N  T E                        +  +    N
Sbjct: 5   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64
Query: 182 VVKLLDIVRDQHSKTPSLIFEYVNSTD-FKVLYP--TLTDYDIRYYIYELLKALDYCHSQ 238
           VVK     R+ + +   L  EY +  + F  + P   + + D + + ++L+  + Y H  
Sbjct: 65  VVKFYGHRREGNIQY--LFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 122
Query: 239 GIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKE--YNVRVASRYFKGPELLVDLQ 295
           GI HRD+KP N+++D E   L++ D+GLA  F +  +E   N    +  +  PELL   +
Sbjct: 123 GITHRDIKPENLLLD-ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 181
Query: 296 DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSKF 355
            +   +D+WS G +   M+  + P+    D+  +            W   +    PW K 
Sbjct: 182 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSD---------WKEKKTYLNPWKKI 232
Query: 356 INA 358
            +A
Sbjct: 233 DSA 235

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/243 (24%), Positives = 105/243 (43%), Gaps = 21/243 (8%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXXXXXXX---XXXXXXXXLQNLCGGPN 181
           +D+++V+ +G G Y EV   +N  T E                        +  +    N
Sbjct: 7   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHEN 66
Query: 182 VVKLLDIVRDQHSKTPSLIFEYVNSTD-FKVLYP--TLTDYDIRYYIYELLKALDYCHSQ 238
           VVK     R+ + +   L  EY +  + F  + P   + + D + + ++L+  + Y H  
Sbjct: 67  VVKFYGHRREGNIQY--LFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 124
Query: 239 GIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKE--YNVRVASRYFKGPELLVDLQ 295
           GI HRD+KP N+++D E   L++ D+GLA  F +  +E   N    +  +  PELL   +
Sbjct: 125 GITHRDIKPENLLLD-ERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRRE 183
Query: 296 DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSKF 355
            +   +D+WS G +   M+  + P+    D+  +            W   +    PW K 
Sbjct: 184 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSD---------WKEKKTYLNPWKKI 234
Query: 356 INA 358
            +A
Sbjct: 235 DSA 237

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/243 (24%), Positives = 105/243 (43%), Gaps = 21/243 (8%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXXXXXXX---XXXXXXXXLQNLCGGPN 181
           +D+++V+ +G G Y EV   +N  T E                        +  +    N
Sbjct: 6   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHEN 65
Query: 182 VVKLLDIVRDQHSKTPSLIFEYVNSTD-FKVLYP--TLTDYDIRYYIYELLKALDYCHSQ 238
           VVK     R+ + +   L  EY +  + F  + P   + + D + + ++L+  + Y H  
Sbjct: 66  VVKFYGHRREGNIQY--LFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 123
Query: 239 GIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKE--YNVRVASRYFKGPELLVDLQ 295
           GI HRD+KP N+++D E   L++ D+GLA  F +  +E   N    +  +  PELL   +
Sbjct: 124 GITHRDIKPENLLLD-ERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRRE 182
Query: 296 DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSKF 355
            +   +D+WS G +   M+  + P+    D+  +            W   +    PW K 
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSD---------WKEKKTYLNPWKKI 233
Query: 356 INA 358
            +A
Sbjct: 234 DSA 236

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/243 (23%), Positives = 104/243 (42%), Gaps = 21/243 (8%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXXXXXXX---XXXXXXXXLQNLCGGPN 181
           +D+++V+ +G G Y EV   +N  T E                        +  +    N
Sbjct: 6   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 65
Query: 182 VVKLLDIVRDQHSKTPSLIFEYVNSTD-FKVLYP--TLTDYDIRYYIYELLKALDYCHSQ 238
           VVK     R+ + +   L  EY +  + F  + P   + + D + + ++L+  + Y H  
Sbjct: 66  VVKFYGHRREGNIQY--LFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 123
Query: 239 GIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKE--YNVRVASRYFKGPELLVDLQ 295
           GI HRD+KP N+++D E   L++ D+GLA  F +  +E   N    +  +  PELL   +
Sbjct: 124 GITHRDIKPENLLLD-ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 182
Query: 296 DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSKF 355
            +   +D+WS G +   M+  + P+    D+  +            W   +    PW K 
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSD---------WKEKKTYLNPWKKI 233
Query: 356 INA 358
            +A
Sbjct: 234 DSA 236

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/243 (23%), Positives = 104/243 (42%), Gaps = 21/243 (8%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXXXXXXX---XXXXXXXXLQNLCGGPN 181
           +D+++V+ +G G Y EV   +N  T E                        +  +    N
Sbjct: 7   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 66
Query: 182 VVKLLDIVRDQHSKTPSLIFEYVNSTD-FKVLYP--TLTDYDIRYYIYELLKALDYCHSQ 238
           VVK     R+ + +   L  EY +  + F  + P   + + D + + ++L+  + Y H  
Sbjct: 67  VVKFYGHRREGNIQY--LFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 124
Query: 239 GIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKE--YNVRVASRYFKGPELLVDLQ 295
           GI HRD+KP N+++D E   L++ D+GLA  F +  +E   N    +  +  PELL   +
Sbjct: 125 GITHRDIKPENLLLD-ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183
Query: 296 DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSKF 355
            +   +D+WS G +   M+  + P+    D+  +            W   +    PW K 
Sbjct: 184 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSD---------WKEKKTYLNPWKKI 234
Query: 356 INA 358
            +A
Sbjct: 235 DSA 237

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/243 (23%), Positives = 104/243 (42%), Gaps = 21/243 (8%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXXXXXXX---XXXXXXXXLQNLCGGPN 181
           +D+++V+ +G G Y EV   +N  T E                        +  +    N
Sbjct: 6   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 65
Query: 182 VVKLLDIVRDQHSKTPSLIFEYVNSTD-FKVLYP--TLTDYDIRYYIYELLKALDYCHSQ 238
           VVK     R+ + +   L  EY +  + F  + P   + + D + + ++L+  + Y H  
Sbjct: 66  VVKFYGHRREGNIQY--LFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 123
Query: 239 GIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKE--YNVRVASRYFKGPELLVDLQ 295
           GI HRD+KP N+++D E   L++ D+GLA  F +  +E   N    +  +  PELL   +
Sbjct: 124 GITHRDIKPENLLLD-ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 182
Query: 296 DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSKF 355
            +   +D+WS G +   M+  + P+    D+  +            W   +    PW K 
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSD---------WKEKKTYLNPWKKI 233
Query: 356 INA 358
            +A
Sbjct: 234 DSA 236

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/243 (23%), Positives = 104/243 (42%), Gaps = 21/243 (8%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXXXXXXX---XXXXXXXXLQNLCGGPN 181
           +D+++V+ +G G Y EV   +N  T E                        +  +    N
Sbjct: 6   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 65
Query: 182 VVKLLDIVRDQHSKTPSLIFEYVNSTD-FKVLYP--TLTDYDIRYYIYELLKALDYCHSQ 238
           VVK     R+ + +   L  EY +  + F  + P   + + D + + ++L+  + Y H  
Sbjct: 66  VVKFYGHRREGNIQY--LFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 123
Query: 239 GIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKE--YNVRVASRYFKGPELLVDLQ 295
           GI HRD+KP N+++D E   L++ D+GLA  F +  +E   N    +  +  PELL   +
Sbjct: 124 GITHRDIKPENLLLD-ERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRRE 182
Query: 296 DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSKF 355
            +   +D+WS G +   M+  + P+    D+  +            W   +    PW K 
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSD---------WKEKKTYLNPWKKI 233
Query: 356 INA 358
            +A
Sbjct: 234 DSA 236

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/243 (23%), Positives = 104/243 (42%), Gaps = 21/243 (8%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXXXXXXX---XXXXXXXXLQNLCGGPN 181
           +D+++V+ +G G Y EV   +N  T E                        +  +    N
Sbjct: 7   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 66
Query: 182 VVKLLDIVRDQHSKTPSLIFEYVNSTD-FKVLYP--TLTDYDIRYYIYELLKALDYCHSQ 238
           VVK     R+ + +   L  EY +  + F  + P   + + D + + ++L+  + Y H  
Sbjct: 67  VVKFYGHRREGNIQY--LFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 124
Query: 239 GIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKE--YNVRVASRYFKGPELLVDLQ 295
           GI HRD+KP N+++D E   L++ D+GLA  F +  +E   N    +  +  PELL   +
Sbjct: 125 GITHRDIKPENLLLD-ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183
Query: 296 DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSKF 355
            +   +D+WS G +   M+  + P+    D+  +            W   +    PW K 
Sbjct: 184 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSD---------WKEKKTYLNPWKKI 234
Query: 356 INA 358
            +A
Sbjct: 235 DSA 237

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/243 (23%), Positives = 104/243 (42%), Gaps = 21/243 (8%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXXXXXXX---XXXXXXXXLQNLCGGPN 181
           +D+++V+ +G G Y EV   +N  T E                        +  +    N
Sbjct: 7   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 66
Query: 182 VVKLLDIVRDQHSKTPSLIFEYVNSTD-FKVLYP--TLTDYDIRYYIYELLKALDYCHSQ 238
           VVK     R+ + +   L  EY +  + F  + P   + + D + + ++L+  + Y H  
Sbjct: 67  VVKFYGHRREGNIQY--LFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 124
Query: 239 GIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKE--YNVRVASRYFKGPELLVDLQ 295
           GI HRD+KP N+++D E   L++ D+GLA  F +  +E   N    +  +  PELL   +
Sbjct: 125 GITHRDIKPENLLLD-ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183
Query: 296 DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSKF 355
            +   +D+WS G +   M+  + P+    D+  +            W   +    PW K 
Sbjct: 184 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSD---------WKEKKTYLNPWKKI 234
Query: 356 INA 358
            +A
Sbjct: 235 DSA 237

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/243 (23%), Positives = 104/243 (42%), Gaps = 21/243 (8%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXXXXXXX---XXXXXXXXLQNLCGGPN 181
           +D+++V+ +G G Y EV   +N  T E                        +  +    N
Sbjct: 7   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 66
Query: 182 VVKLLDIVRDQHSKTPSLIFEYVNSTD-FKVLYP--TLTDYDIRYYIYELLKALDYCHSQ 238
           VVK     R+ + +   L  EY +  + F  + P   + + D + + ++L+  + Y H  
Sbjct: 67  VVKFYGHRREGNIQY--LFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 124
Query: 239 GIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKE--YNVRVASRYFKGPELLVDLQ 295
           GI HRD+KP N+++D E   L++ D+GLA  F +  +E   N    +  +  PELL   +
Sbjct: 125 GITHRDIKPENLLLD-ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183
Query: 296 DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSKF 355
            +   +D+WS G +   M+  + P+    D+  +            W   +    PW K 
Sbjct: 184 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSD---------WKEKKTYLNPWKKI 234
Query: 356 INA 358
            +A
Sbjct: 235 DSA 237

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/253 (24%), Positives = 105/253 (41%), Gaps = 33/253 (13%)
Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTN----------ERCXXXXXXXXXXXXXXXXXXXL 173
           +  Y+V   +G G +  V+ GI V+ N          +R                     
Sbjct: 3   ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLK 62
Query: 174 QNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNST----DFKVLYPTLTDYDIRYYIYELL 229
           +   G   V++LLD      S    LI E         DF      L +   R + +++L
Sbjct: 63  KVSSGFSGVIRLLDWFERPDSFV--LILERPEPVQDLFDFITERGALQEELARSFFWQVL 120
Query: 230 KALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 289
           +A+ +CH+ G++HRD+K  N++ID    +L+LID+G          Y     +R +  PE
Sbjct: 121 EAVRHCHNXGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTDFDGTRVYSPPE 179
Query: 290 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV---------KIAKDCC-L 339
            +   + +  S  +WSLG +   M+    PF      HD+ +         +++ +C  L
Sbjct: 180 WIRYHRYHGRSAAVWSLGILLYDMVCGDIPF-----EHDEEIIRGQVFFRQRVSXECQHL 234
Query: 340 IIWCNS-RHSRKP 351
           I WC + R S +P
Sbjct: 235 IRWCLALRPSDRP 247

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/253 (24%), Positives = 105/253 (41%), Gaps = 33/253 (13%)
Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTN----------ERCXXXXXXXXXXXXXXXXXXXL 173
           +  Y+V   +G G +  V+ GI V+ N          +R                     
Sbjct: 22  ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLK 81
Query: 174 QNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNST----DFKVLYPTLTDYDIRYYIYELL 229
           +   G   V++LLD      S    LI E         DF      L +   R + +++L
Sbjct: 82  KVSSGFSGVIRLLDWFERPDSFV--LILERPEPVQDLFDFITERGALQEELARSFFWQVL 139
Query: 230 KALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 289
           +A+ +CH+ G++HRD+K  N++ID    +L+LID+G          Y     +R +  PE
Sbjct: 140 EAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTDFDGTRVYSPPE 198
Query: 290 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV---------KIAKDCC-L 339
            +   + +  S  +WSLG +   M+    PF      HD+ +         +++ +C  L
Sbjct: 199 WIRYHRYHGRSAAVWSLGILLYDMVCGDIPF-----EHDEEIIRGQVFFRQRVSSECQHL 253
Query: 340 IIWCNS-RHSRKP 351
           I WC + R S +P
Sbjct: 254 IRWCLALRPSDRP 266

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/243 (23%), Positives = 104/243 (42%), Gaps = 21/243 (8%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXXXXXXX---XXXXXXXXLQNLCGGPN 181
           +D+++V+ +G G Y EV   +N  T E                        +  +    N
Sbjct: 6   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 65
Query: 182 VVKLLDIVRDQHSKTPSLIFEYVNSTD-FKVLYP--TLTDYDIRYYIYELLKALDYCHSQ 238
           VVK     R+ + +   L  EY +  + F  + P   + + D + + ++L+  + Y H  
Sbjct: 66  VVKFYGHRREGNIQY--LFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 123
Query: 239 GIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKE--YNVRVASRYFKGPELLVDLQ 295
           GI HRD+KP N+++D E   L++ D+GLA  F +  +E   N    +  +  PELL   +
Sbjct: 124 GITHRDIKPENLLLD-ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 182
Query: 296 DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSKF 355
            +   +D+WS G +   M+  + P+    D+  +            W   +    PW K 
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSD---------WKEKKTYLNPWKKI 233
Query: 356 INA 358
            +A
Sbjct: 234 DSA 236

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/243 (23%), Positives = 104/243 (42%), Gaps = 21/243 (8%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXXXXXXX---XXXXXXXXLQNLCGGPN 181
           +D+++V+ +G G Y EV   +N  T E                        +  +    N
Sbjct: 7   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 66
Query: 182 VVKLLDIVRDQHSKTPSLIFEYVNSTD-FKVLYP--TLTDYDIRYYIYELLKALDYCHSQ 238
           VVK     R+ + +   L  EY +  + F  + P   + + D + + ++L+  + Y H  
Sbjct: 67  VVKFYGHRREGNIQY--LFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 124
Query: 239 GIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKE--YNVRVASRYFKGPELLVDLQ 295
           GI HRD+KP N+++D E   L++ D+GLA  F +  +E   N    +  +  PELL   +
Sbjct: 125 GITHRDIKPENLLLD-ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183
Query: 296 DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSKF 355
            +   +D+WS G +   M+  + P+    D+  +            W   +    PW K 
Sbjct: 184 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSD---------WKEKKTYLNPWKKI 234
Query: 356 INA 358
            +A
Sbjct: 235 DSA 237

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 40/122 (32%), Positives = 65/122 (53%), Gaps = 19/122 (15%)
Query: 227 ELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH-------------PG 273
           ++L+AL Y HSQGI+HR++KP N+ ID E R +++ D+GLA+  H             PG
Sbjct: 124 QILEALSYIHSQGIIHRNLKPXNIFID-ESRNVKIGDFGLAKNVHRSLDILKLDSQNLPG 182
Query: 274 KEYNVR--VASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV 331
              N+   + +  +   E+L     Y+  +D +SLG +F   I+   PF  G +  + L 
Sbjct: 183 SSDNLTSAIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFFEXIY---PFSTGXERVNILK 239
Query: 332 KI 333
           K+
Sbjct: 240 KL 241

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/253 (24%), Positives = 105/253 (41%), Gaps = 33/253 (13%)
Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTN----------ERCXXXXXXXXXXXXXXXXXXXL 173
           +  Y+V   +G G +  V+ GI V+ N          +R                     
Sbjct: 35  ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLK 94
Query: 174 QNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNST----DFKVLYPTLTDYDIRYYIYELL 229
           +   G   V++LLD      S    LI E         DF      L +   R + +++L
Sbjct: 95  KVSSGFSGVIRLLDWFERPDSFV--LILERPEPVQDLFDFITERGALQEELARSFFWQVL 152
Query: 230 KALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 289
           +A+ +CH+ G++HRD+K  N++ID    +L+LID+G          Y     +R +  PE
Sbjct: 153 EAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTDFDGTRVYSPPE 211
Query: 290 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV---------KIAKDCC-L 339
            +   + +  S  +WSLG +   M+    PF      HD+ +         +++ +C  L
Sbjct: 212 WIRYHRYHGRSAAVWSLGILLYDMVCGDIPF-----EHDEEIIGGQVFFRQRVSSECQHL 266
Query: 340 IIWCNS-RHSRKP 351
           I WC + R S +P
Sbjct: 267 IRWCLALRPSDRP 279

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/243 (23%), Positives = 104/243 (42%), Gaps = 21/243 (8%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXXXXXXX---XXXXXXXXLQNLCGGPN 181
           +D+++V+ +G G Y EV   +N  T E                        +  +    N
Sbjct: 6   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 65
Query: 182 VVKLLDIVRDQHSKTPSLIFEYVNSTD-FKVLYP--TLTDYDIRYYIYELLKALDYCHSQ 238
           VVK     R+ + +   L  EY +  + F  + P   + + D + + ++L+  + Y H  
Sbjct: 66  VVKFYGHRREGNIQY--LFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 123
Query: 239 GIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKE--YNVRVASRYFKGPELLVDLQ 295
           GI HRD+KP N+++D E   L++ D+GLA  F +  +E   N    +  +  PELL   +
Sbjct: 124 GITHRDIKPENLLLD-ERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRRE 182
Query: 296 DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSKF 355
            +   +D+WS G +   M+  + P+    D+  +            W   +    PW K 
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSD---------WKEKKTYLNPWKKI 233
Query: 356 INA 358
            +A
Sbjct: 234 DSA 236

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/243 (23%), Positives = 104/243 (42%), Gaps = 21/243 (8%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXXXXXXX---XXXXXXXXLQNLCGGPN 181
           +D+++V+ +G G Y EV   +N  T E                        +  +    N
Sbjct: 6   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 65
Query: 182 VVKLLDIVRDQHSKTPSLIFEYVNSTD-FKVLYP--TLTDYDIRYYIYELLKALDYCHSQ 238
           VVK     R+ + +   L  EY +  + F  + P   + + D + + ++L+  + Y H  
Sbjct: 66  VVKFYGHRREGNIQY--LFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 123
Query: 239 GIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKE--YNVRVASRYFKGPELLVDLQ 295
           GI HRD+KP N+++D E   L++ D+GLA  F +  +E   N    +  +  PELL   +
Sbjct: 124 GITHRDIKPENLLLD-ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 182
Query: 296 DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSKF 355
            +   +D+WS G +   M+  + P+    D+  +            W   +    PW K 
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSD---------WKEKKTYLNPWKKI 233
Query: 356 INA 358
            +A
Sbjct: 234 DSA 236

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/253 (24%), Positives = 105/253 (41%), Gaps = 33/253 (13%)
Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTN----------ERCXXXXXXXXXXXXXXXXXXXL 173
           +  Y+V   +G G +  V+ GI V+ N          +R                     
Sbjct: 35  ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLK 94
Query: 174 QNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNST----DFKVLYPTLTDYDIRYYIYELL 229
           +   G   V++LLD      S    LI E         DF      L +   R + +++L
Sbjct: 95  KVSSGFSGVIRLLDWFERPDSFV--LILERPEPVQDLFDFITERGALQEELARSFFWQVL 152
Query: 230 KALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 289
           +A+ +CH+ G++HRD+K  N++ID    +L+LID+G          Y     +R +  PE
Sbjct: 153 EAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTDFDGTRVYSPPE 211
Query: 290 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV---------KIAKDCC-L 339
            +   + +  S  +WSLG +   M+    PF      HD+ +         +++ +C  L
Sbjct: 212 WIRYHRYHGRSAAVWSLGILLYDMVCGDIPF-----EHDEEIIRGQVFFRQRVSSECQHL 266
Query: 340 IIWCNS-RHSRKP 351
           I WC + R S +P
Sbjct: 267 IRWCLALRPSDRP 279

>pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 40/139 (28%), Positives = 79/139 (56%), Gaps = 11/139 (7%)
Query: 200 IFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQ--GIMHRDVKPHNVMIDHELR 257
           +++ + +T+F+ +   LT    R +  ++  AL +  +    I+H D+KP N+++ +  R
Sbjct: 123 LYDLLRNTNFRGVSLNLT----RKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKR 178
Query: 258 K-LRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFR 316
             ++++D+G +     G+     + SR+++ PE+L+ +  YD ++DMWSLGC+   M   
Sbjct: 179 SAIKIVDFGSS--CQLGQRIYQXIQSRFYRSPEVLLGM-PYDLAIDMWSLGCILVEM-HT 234
Query: 317 KEPFFYGHDNHDQLVKIAK 335
            EP F G +  DQ+ KI +
Sbjct: 235 GEPLFSGANEVDQMNKIVE 253

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/253 (24%), Positives = 105/253 (41%), Gaps = 33/253 (13%)
Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTN----------ERCXXXXXXXXXXXXXXXXXXXL 173
           +  Y+V   +G G +  V+ GI V+ N          +R                     
Sbjct: 36  ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLK 95
Query: 174 QNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNST----DFKVLYPTLTDYDIRYYIYELL 229
           +   G   V++LLD      S    LI E         DF      L +   R + +++L
Sbjct: 96  KVSSGFSGVIRLLDWFERPDSFV--LILERPEPVQDLFDFITERGALQEELARSFFWQVL 153
Query: 230 KALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 289
           +A+ +CH+ G++HRD+K  N++ID    +L+LID+G          Y     +R +  PE
Sbjct: 154 EAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTDFDGTRVYSPPE 212
Query: 290 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV---------KIAKDCC-L 339
            +   + +  S  +WSLG +   M+    PF      HD+ +         +++ +C  L
Sbjct: 213 WIRYHRYHGRSAAVWSLGILLYDMVCGDIPF-----EHDEEIIGGQVFFRQRVSSECQHL 267
Query: 340 IIWCNS-RHSRKP 351
           I WC + R S +P
Sbjct: 268 IRWCLALRPSDRP 280

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/253 (24%), Positives = 105/253 (41%), Gaps = 33/253 (13%)
Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTN----------ERCXXXXXXXXXXXXXXXXXXXL 173
           +  Y+V   +G G +  V+ GI V+ N          +R                     
Sbjct: 35  ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLK 94
Query: 174 QNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNST----DFKVLYPTLTDYDIRYYIYELL 229
           +   G   V++LLD      S    LI E         DF      L +   R + +++L
Sbjct: 95  KVSSGFSGVIRLLDWFERPDSFV--LILERPEPVQDLFDFITERGALQEELARSFFWQVL 152
Query: 230 KALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 289
           +A+ +CH+ G++HRD+K  N++ID    +L+LID+G          Y     +R +  PE
Sbjct: 153 EAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTDFDGTRVYSPPE 211
Query: 290 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV---------KIAKDCC-L 339
            +   + +  S  +WSLG +   M+    PF      HD+ +         +++ +C  L
Sbjct: 212 WIRYHRYHGRSAAVWSLGILLYDMVCGDIPF-----EHDEEIIGGQVFFRQRVSSECQHL 266
Query: 340 IIWCNS-RHSRKP 351
           I WC + R S +P
Sbjct: 267 IRWCLALRPSDRP 279

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/253 (24%), Positives = 105/253 (41%), Gaps = 33/253 (13%)
Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTN----------ERCXXXXXXXXXXXXXXXXXXXL 173
           +  Y+V   +G G +  V+ GI V+ N          +R                     
Sbjct: 8   ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLK 67
Query: 174 QNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNST----DFKVLYPTLTDYDIRYYIYELL 229
           +   G   V++LLD      S    LI E         DF      L +   R + +++L
Sbjct: 68  KVSSGFSGVIRLLDWFERPDSFV--LILERPEPVQDLFDFITERGALQEELARSFFWQVL 125
Query: 230 KALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 289
           +A+ +CH+ G++HRD+K  N++ID    +L+LID+G          Y     +R +  PE
Sbjct: 126 EAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTDFDGTRVYSPPE 184
Query: 290 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV---------KIAKDCC-L 339
            +   + +  S  +WSLG +   M+    PF      HD+ +         +++ +C  L
Sbjct: 185 WIRYHRYHGRSAAVWSLGILLYDMVCGDIPF-----EHDEEIIRGQVFFRQRVSSECQHL 239
Query: 340 IIWCNS-RHSRKP 351
           I WC + R S +P
Sbjct: 240 IRWCLALRPSDRP 252

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/253 (24%), Positives = 105/253 (41%), Gaps = 33/253 (13%)
Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTN----------ERCXXXXXXXXXXXXXXXXXXXL 173
           +  Y+V   +G G +  V+ GI V+ N          +R                     
Sbjct: 36  ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLK 95
Query: 174 QNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNST----DFKVLYPTLTDYDIRYYIYELL 229
           +   G   V++LLD      S    LI E         DF      L +   R + +++L
Sbjct: 96  KVSSGFSGVIRLLDWFERPDSFV--LILERPEPVQDLFDFITERGALQEELARSFFWQVL 153
Query: 230 KALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 289
           +A+ +CH+ G++HRD+K  N++ID    +L+LID+G          Y     +R +  PE
Sbjct: 154 EAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTDFDGTRVYSPPE 212
Query: 290 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV---------KIAKDCC-L 339
            +   + +  S  +WSLG +   M+    PF      HD+ +         +++ +C  L
Sbjct: 213 WIRYHRYHGRSAAVWSLGILLYDMVCGDIPF-----EHDEEIIGGQVFFRQRVSSECQHL 267
Query: 340 IIWCNS-RHSRKP 351
           I WC + R S +P
Sbjct: 268 IRWCLALRPSDRP 280

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/253 (24%), Positives = 105/253 (41%), Gaps = 33/253 (13%)
Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTN----------ERCXXXXXXXXXXXXXXXXXXXL 173
           +  Y+V   +G G +  V+ GI V+ N          +R                     
Sbjct: 23  ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLK 82
Query: 174 QNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNST----DFKVLYPTLTDYDIRYYIYELL 229
           +   G   V++LLD      S    LI E         DF      L +   R + +++L
Sbjct: 83  KVSSGFSGVIRLLDWFERPDSFV--LILERPEPVQDLFDFITERGALQEELARSFFWQVL 140
Query: 230 KALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 289
           +A+ +CH+ G++HRD+K  N++ID    +L+LID+G          Y     +R +  PE
Sbjct: 141 EAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTDFDGTRVYSPPE 199
Query: 290 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV---------KIAKDCC-L 339
            +   + +  S  +WSLG +   M+    PF      HD+ +         +++ +C  L
Sbjct: 200 WIRYHRYHGRSAAVWSLGILLYDMVCGDIPF-----EHDEEIIRGQVFFRQRVSSECQHL 254
Query: 340 IIWCNS-RHSRKP 351
           I WC + R S +P
Sbjct: 255 IRWCLALRPSDRP 267

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/253 (24%), Positives = 105/253 (41%), Gaps = 33/253 (13%)
Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTN----------ERCXXXXXXXXXXXXXXXXXXXL 173
           +  Y+V   +G G +  V+ GI V+ N          +R                     
Sbjct: 42  ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLK 101
Query: 174 QNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNST----DFKVLYPTLTDYDIRYYIYELL 229
           +   G   V++LLD      S    LI E         DF      L +   R + +++L
Sbjct: 102 KVSSGFSGVIRLLDWFERPDSFV--LILERPEPVQDLFDFITERGALQEELARSFFWQVL 159
Query: 230 KALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 289
           +A+ +CH+ G++HRD+K  N++ID    +L+LID+G          Y     +R +  PE
Sbjct: 160 EAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTDFDGTRVYSPPE 218
Query: 290 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV---------KIAKDCC-L 339
            +   + +  S  +WSLG +   M+    PF      HD+ +         +++ +C  L
Sbjct: 219 WIRYHRYHGRSAAVWSLGILLYDMVCGDIPF-----EHDEEIIRGQVFFRQRVSSECQHL 273
Query: 340 IIWCNS-RHSRKP 351
           I WC + R S +P
Sbjct: 274 IRWCLALRPSDRP 286

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/243 (23%), Positives = 104/243 (42%), Gaps = 21/243 (8%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXXXXXXX---XXXXXXXXLQNLCGGPN 181
           +D+++V+ +G G Y EV   +N  T E                        +  +    N
Sbjct: 7   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 66
Query: 182 VVKLLDIVRDQHSKTPSLIFEYVNSTD-FKVLYP--TLTDYDIRYYIYELLKALDYCHSQ 238
           VVK     R+ + +   L  EY +  + F  + P   + + D + + ++L+  + Y H  
Sbjct: 67  VVKFYGHRREGNIQY--LFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 124
Query: 239 GIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKE--YNVRVASRYFKGPELLVDLQ 295
           GI HRD+KP N+++D E   L++ D+GLA  F +  +E   N    +  +  PELL   +
Sbjct: 125 GITHRDIKPENLLLD-ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183
Query: 296 DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSKF 355
            +   +D+WS G +   M+  + P+    D+  +            W   +    PW K 
Sbjct: 184 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSD---------WKEKKTYLNPWKKI 234
Query: 356 INA 358
            +A
Sbjct: 235 DSA 237

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/243 (23%), Positives = 104/243 (42%), Gaps = 21/243 (8%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXXXXXXX---XXXXXXXXLQNLCGGPN 181
           +D+++V+ +G G Y EV   +N  T E                        +  +    N
Sbjct: 6   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 65
Query: 182 VVKLLDIVRDQHSKTPSLIFEYVNSTD-FKVLYP--TLTDYDIRYYIYELLKALDYCHSQ 238
           VVK     R+ + +   L  EY +  + F  + P   + + D + + ++L+  + Y H  
Sbjct: 66  VVKFYGHRREGNIQY--LFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 123
Query: 239 GIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKE--YNVRVASRYFKGPELLVDLQ 295
           GI HRD+KP N+++D E   L++ D+GLA  F +  +E   N    +  +  PELL   +
Sbjct: 124 GITHRDIKPENLLLD-ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 182
Query: 296 DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSKF 355
            +   +D+WS G +   M+  + P+    D+  +            W   +    PW K 
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSD---------WKEKKTYLNPWKKI 233
Query: 356 INA 358
            +A
Sbjct: 234 DSA 236

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 69/279 (24%), Positives = 115/279 (41%), Gaps = 30/279 (10%)
Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXXXXXXXXXXXXXXXLQNLCGGPNVV 183
            D +EV  ++GRG  S V+      T +                     +      PN++
Sbjct: 52  SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRTEIGVLLRLSHPNII 111
Query: 184 KLLDIVRDQHSKTP---SLIFEYVNST---DFKVLYPTLTDYDIRYYIYELLKALDYCHS 237
           KL +I      +TP   SL+ E V      D  V     ++ D    + ++L+A+ Y H 
Sbjct: 112 KLKEIF-----ETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHE 166
Query: 238 QGIMHRDVKPHNVMIDHEL--RKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQ 295
            GI+HRD+KP N++         L++ D+GL++             +  +  PE+L    
Sbjct: 167 NGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEILRGCA 226
Query: 296 DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSKF 355
            Y   +DMWS+G +   ++   EPF+   +  DQ +        I+ C        W + 
Sbjct: 227 -YGPEVDMWSVGIITYILLCGFEPFY--DERGDQFM-----FRRILNCEYYFISPWWDE- 277
Query: 356 INADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPY 394
                   VS  A D + KL+  D + RLT  +A+ HP+
Sbjct: 278 --------VSLNAKDLVRKLIVLDPKKRLTTFQALQHPW 308

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/243 (23%), Positives = 104/243 (42%), Gaps = 21/243 (8%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXXXXXXX---XXXXXXXXLQNLCGGPN 181
           +D+++V+ +G G Y EV   +N  T E                        +  +    N
Sbjct: 6   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 65
Query: 182 VVKLLDIVRDQHSKTPSLIFEYVNSTD-FKVLYP--TLTDYDIRYYIYELLKALDYCHSQ 238
           VVK     R+ + +   L  EY +  + F  + P   + + D + + ++L+  + Y H  
Sbjct: 66  VVKFYGHRREGNIQY--LFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 123
Query: 239 GIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKE--YNVRVASRYFKGPELLVDLQ 295
           GI HRD+KP N+++D E   L++ D+GLA  F +  +E   N    +  +  PELL   +
Sbjct: 124 GITHRDIKPENLLLD-ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 182
Query: 296 DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSKF 355
            +   +D+WS G +   M+  + P+    D+  +            W   +    PW K 
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSD---------WKEKKTYLNPWKKI 233
Query: 356 INA 358
            +A
Sbjct: 234 DSA 236

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/253 (24%), Positives = 105/253 (41%), Gaps = 33/253 (13%)
Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTN----------ERCXXXXXXXXXXXXXXXXXXXL 173
           +  Y+V   +G G +  V+ GI V+ N          +R                     
Sbjct: 50  ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLK 109
Query: 174 QNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNST----DFKVLYPTLTDYDIRYYIYELL 229
           +   G   V++LLD      S    LI E         DF      L +   R + +++L
Sbjct: 110 KVSSGFSGVIRLLDWFERPDSFV--LILERPEPVQDLFDFITERGALQEELARSFFWQVL 167
Query: 230 KALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 289
           +A+ +CH+ G++HRD+K  N++ID    +L+LID+G          Y     +R +  PE
Sbjct: 168 EAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTDFDGTRVYSPPE 226
Query: 290 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV---------KIAKDCC-L 339
            +   + +  S  +WSLG +   M+    PF      HD+ +         +++ +C  L
Sbjct: 227 WIRYHRYHGRSAAVWSLGILLYDMVCGDIPF-----EHDEEIIRGQVFFRQRVSSECQHL 281
Query: 340 IIWCNS-RHSRKP 351
           I WC + R S +P
Sbjct: 282 IRWCLALRPSDRP 294

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 50/195 (25%), Positives = 87/195 (44%), Gaps = 20/195 (10%)
Query: 216 LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDH--ELRKLRLIDWGLAEFYH-- 271
             + +    + ++  ALD+ H++GI HRD+KP N++ +H  ++  +++ D+GL       
Sbjct: 108 FNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFGLGSGIKLN 167
Query: 272 ------PGKEYNVRVASRYFKGPELLVDLQD----YDYSLDMWSLGCMFAGMIFRKEPFF 321
                    E      S  +  PE++    +    YD   D+WSLG +   ++    P F
Sbjct: 168 GDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILY-ILLSGYPPF 226
Query: 322 YGHDNHDQLVKIAKDC--CLIIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYD 379
            G    D      + C  C  +   S    K   +F + D  H +S  A D + KLL  D
Sbjct: 227 VGRCGSDCGWDRGEACPACQNMLFESIQEGK--YEFPDKDWAH-ISCAAKDLISKLLVRD 283
Query: 380 HQDRLTAREAMAHPY 394
            + RL+A + + HP+
Sbjct: 284 AKQRLSAAQVLQHPW 298

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/253 (24%), Positives = 105/253 (41%), Gaps = 33/253 (13%)
Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTN----------ERCXXXXXXXXXXXXXXXXXXXL 173
           +  Y+V   +G G +  V+ GI V+ N          +R                     
Sbjct: 22  ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLK 81
Query: 174 QNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNST----DFKVLYPTLTDYDIRYYIYELL 229
           +   G   V++LLD      S    LI E         DF      L +   R + +++L
Sbjct: 82  KVSSGFSGVIRLLDWFERPDSFV--LILERPEPVQDLFDFITERGALQEELARSFFWQVL 139
Query: 230 KALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 289
           +A+ +CH+ G++HRD+K  N++ID    +L+LID+G          Y     +R +  PE
Sbjct: 140 EAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTDFDGTRVYSPPE 198
Query: 290 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV---------KIAKDCC-L 339
            +   + +  S  +WSLG +   M+    PF      HD+ +         +++ +C  L
Sbjct: 199 WIRYHRYHGRSAAVWSLGILLYDMVCGDIPF-----EHDEEIIRGQVFFRQRVSXECQHL 253
Query: 340 IIWCNS-RHSRKP 351
           I WC + R S +P
Sbjct: 254 IRWCLALRPSDRP 266

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 47/184 (25%), Positives = 84/184 (45%), Gaps = 24/184 (13%)
Query: 217 TDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMI--DHELRKLRLIDWGLAEFYHPGK 274
           T+ D    I ++L A+ Y H  GI+HRD+KP N++     E  K+ + D+GL++    G 
Sbjct: 118 TEKDASTLIRQVLDAVYYLHRMGIVHRDLKPENLLYYSQDEESKIMISDFGLSKMEGKGD 177
Query: 275 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNH--DQLVK 332
             +    +  +  PE+L   + Y  ++D WS+G +   ++    PF+  +D+   +Q++K
Sbjct: 178 VMSTACGTPGYVAPEVLAQ-KPYSKAVDCWSIGVIAYILLCGYPPFYDENDSKLFEQILK 236
Query: 333 IAKDCCLIIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH 392
              +     W +                   +S  A DF+  L+  D   R T  +A  H
Sbjct: 237 AEYEFDSPYWDD-------------------ISDSAKDFIRNLMEKDPNKRYTCEQAARH 277
Query: 393 PYFA 396
           P+ A
Sbjct: 278 PWIA 281

>pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 40/139 (28%), Positives = 79/139 (56%), Gaps = 11/139 (7%)
Query: 200 IFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQ--GIMHRDVKPHNVMIDHELR 257
           +++ + +T+F+ +   LT    R +  ++  AL +  +    I+H D+KP N+++ +  R
Sbjct: 142 LYDLLRNTNFRGVSLNLT----RKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKR 197
Query: 258 K-LRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFR 316
             ++++D+G +     G+     + SR+++ PE+L+ +  YD ++DMWSLGC+   M   
Sbjct: 198 SAIKIVDFGSS--CQLGQRIYQXIQSRFYRSPEVLLGM-PYDLAIDMWSLGCILVEM-HT 253
Query: 317 KEPFFYGHDNHDQLVKIAK 335
            EP F G +  DQ+ KI +
Sbjct: 254 GEPLFSGANEVDQMNKIVE 272

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/253 (24%), Positives = 105/253 (41%), Gaps = 33/253 (13%)
Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTN----------ERCXXXXXXXXXXXXXXXXXXXL 173
           +  Y+V   +G G +  V+ GI V+ N          +R                     
Sbjct: 50  ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLK 109
Query: 174 QNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNST----DFKVLYPTLTDYDIRYYIYELL 229
           +   G   V++LLD      S    LI E         DF      L +   R + +++L
Sbjct: 110 KVSSGFSGVIRLLDWFERPDSFV--LILERPEPVQDLFDFITERGALQEELARSFFWQVL 167
Query: 230 KALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 289
           +A+ +CH+ G++HRD+K  N++ID    +L+LID+G          Y     +R +  PE
Sbjct: 168 EAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTDFDGTRVYSPPE 226
Query: 290 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV---------KIAKDCC-L 339
            +   + +  S  +WSLG +   M+    PF      HD+ +         +++ +C  L
Sbjct: 227 WIRYHRYHGRSAAVWSLGILLYDMVCGDIPF-----EHDEEIIRGQVFFRQRVSXECQHL 281
Query: 340 IIWCNS-RHSRKP 351
           I WC + R S +P
Sbjct: 282 IRWCLALRPSDRP 294

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/253 (24%), Positives = 105/253 (41%), Gaps = 33/253 (13%)
Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTN----------ERCXXXXXXXXXXXXXXXXXXXL 173
           +  Y+V   +G G +  V+ GI V+ N          +R                     
Sbjct: 36  ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLK 95
Query: 174 QNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNST----DFKVLYPTLTDYDIRYYIYELL 229
           +   G   V++LLD      S    LI E         DF      L +   R + +++L
Sbjct: 96  KVSSGFSGVIRLLDWFERPDSFV--LILERPEPVQDLFDFITERGALQEELARSFFWQVL 153
Query: 230 KALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 289
           +A+ +CH+ G++HRD+K  N++ID    +L+LID+G          Y     +R +  PE
Sbjct: 154 EAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTDFDGTRVYSPPE 212
Query: 290 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV---------KIAKDCC-L 339
            +   + +  S  +WSLG +   M+    PF      HD+ +         +++ +C  L
Sbjct: 213 WIRYHRYHGRSAAVWSLGILLYDMVCGDIPF-----EHDEEIIGGQVFFRQRVSXECQHL 267
Query: 340 IIWCNS-RHSRKP 351
           I WC + R S +P
Sbjct: 268 IRWCLALRPSDRP 280

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/253 (24%), Positives = 105/253 (41%), Gaps = 33/253 (13%)
Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTN----------ERCXXXXXXXXXXXXXXXXXXXL 173
           +  Y+V   +G G +  V+ GI V+ N          +R                     
Sbjct: 23  ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLK 82
Query: 174 QNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNST----DFKVLYPTLTDYDIRYYIYELL 229
           +   G   V++LLD      S    LI E         DF      L +   R + +++L
Sbjct: 83  KVSSGFSGVIRLLDWFERPDSFV--LILERPEPVQDLFDFITERGALQEELARSFFWQVL 140
Query: 230 KALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 289
           +A+ +CH+ G++HRD+K  N++ID    +L+LID+G          Y     +R +  PE
Sbjct: 141 EAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTDFDGTRVYSPPE 199
Query: 290 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV---------KIAKDCC-L 339
            +   + +  S  +WSLG +   M+    PF      HD+ +         +++ +C  L
Sbjct: 200 WIRYHRYHGRSAAVWSLGILLYDMVCGDIPF-----EHDEEIIRGQVFFRQRVSXECQHL 254
Query: 340 IIWCNS-RHSRKP 351
           I WC + R S +P
Sbjct: 255 IRWCLALRPSDRP 267

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/253 (24%), Positives = 105/253 (41%), Gaps = 33/253 (13%)
Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTN----------ERCXXXXXXXXXXXXXXXXXXXL 173
           +  Y+V   +G G +  V+ GI V+ N          +R                     
Sbjct: 35  ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLK 94
Query: 174 QNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNST----DFKVLYPTLTDYDIRYYIYELL 229
           +   G   V++LLD      S    LI E         DF      L +   R + +++L
Sbjct: 95  KVSSGFSGVIRLLDWFERPDSFV--LILERPEPVQDLFDFITERGALQEELARSFFWQVL 152
Query: 230 KALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 289
           +A+ +CH+ G++HRD+K  N++ID    +L+LID+G          Y     +R +  PE
Sbjct: 153 EAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTDFDGTRVYSPPE 211
Query: 290 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV---------KIAKDCC-L 339
            +   + +  S  +WSLG +   M+    PF      HD+ +         +++ +C  L
Sbjct: 212 WIRYHRYHGRSAAVWSLGILLYDMVCGDIPF-----EHDEEIIGGQVFFRQRVSXECQHL 266
Query: 340 IIWCNS-RHSRKP 351
           I WC + R S +P
Sbjct: 267 IRWCLALRPSDRP 279

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/253 (24%), Positives = 105/253 (41%), Gaps = 33/253 (13%)
Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTN----------ERCXXXXXXXXXXXXXXXXXXXL 173
           +  Y+V   +G G +  V+ GI V+ N          +R                     
Sbjct: 8   ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLK 67
Query: 174 QNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNST----DFKVLYPTLTDYDIRYYIYELL 229
           +   G   V++LLD      S    LI E         DF      L +   R + +++L
Sbjct: 68  KVSSGFSGVIRLLDWFERPDSFV--LILERPEPVQDLFDFITERGALQEELARSFFWQVL 125
Query: 230 KALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 289
           +A+ +CH+ G++HRD+K  N++ID    +L+LID+G          Y     +R +  PE
Sbjct: 126 EAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTDFDGTRVYSPPE 184
Query: 290 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV---------KIAKDCC-L 339
            +   + +  S  +WSLG +   M+    PF      HD+ +         +++ +C  L
Sbjct: 185 WIRYHRYHGRSAAVWSLGILLYDMVCGDIPF-----EHDEEIIRGQVFFRQRVSSECQHL 239
Query: 340 IIWCNS-RHSRKP 351
           I WC + R S +P
Sbjct: 240 IRWCLALRPSDRP 252

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/253 (24%), Positives = 105/253 (41%), Gaps = 33/253 (13%)
Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTN----------ERCXXXXXXXXXXXXXXXXXXXL 173
           +  Y+V   +G G +  V+ GI V+ N          +R                     
Sbjct: 36  ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLK 95
Query: 174 QNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNST----DFKVLYPTLTDYDIRYYIYELL 229
           +   G   V++LLD      S    LI E         DF      L +   R + +++L
Sbjct: 96  KVSSGFSGVIRLLDWFERPDSFV--LILERPEPVQDLFDFITERGALQEELARSFFWQVL 153
Query: 230 KALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 289
           +A+ +CH+ G++HRD+K  N++ID    +L+LID+G          Y     +R +  PE
Sbjct: 154 EAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTDFDGTRVYSPPE 212
Query: 290 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV---------KIAKDCC-L 339
            +   + +  S  +WSLG +   M+    PF      HD+ +         +++ +C  L
Sbjct: 213 WIRYHRYHGRSAAVWSLGILLYDMVCGDIPF-----EHDEEIIGGQVFFRQRVSXECQHL 267
Query: 340 IIWCNS-RHSRKP 351
           I WC + R S +P
Sbjct: 268 IRWCLALRPSDRP 280

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 60/236 (25%), Positives = 101/236 (42%), Gaps = 25/236 (10%)
Query: 178 GGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRY---YIYELLKALDY 234
           G  N+++L++   D       L+FE +              ++ R     + ++  ALD+
Sbjct: 69  GNKNILELIEFFED--DTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDF 126
Query: 235 CHSQGIMHRDVKPHNVMID--HELRKLRLIDWGLAEFYH--------PGKEYNVRVASRY 284
            H++GI HRD+KP N++ +   ++  +++ D+ L                E      S  
Sbjct: 127 LHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAE 186
Query: 285 FKGPELLVDLQD----YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDC--C 338
           +  PE++    D    YD   D+WSLG +   M+    PF  GH   D      + C  C
Sbjct: 187 YMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFV-GHCGADCGWDRGEVCRVC 245
Query: 339 LIIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPY 394
                 S    K   +F + D  H +S EA D + KLL  D + RL+A + + HP+
Sbjct: 246 QNKLFESIQEGK--YEFPDKDWAH-ISSEAKDLISKLLVRDAKQRLSAAQVLQHPW 298

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 62/253 (24%), Positives = 105/253 (41%), Gaps = 33/253 (13%)
Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTN----------ERCXXXXXXXXXXXXXXXXXXXL 173
           +  Y+V   +G G +  V+ GI V+ N          +R                     
Sbjct: 8   ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLK 67
Query: 174 QNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNST----DFKVLYPTLTDYDIRYYIYELL 229
           +   G   V++LLD      S    LI E         DF      L +   R + +++L
Sbjct: 68  KVSSGFSGVIRLLDWFERPDSFV--LILERPEPVQDLFDFITERGALQEELARSFFWQVL 125
Query: 230 KALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 289
           +A+ +CH+ G++HRD+K  N++ID    +L+LID+G          Y     +R +  PE
Sbjct: 126 EAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTDFDGTRVYSPPE 184
Query: 290 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV---------KIAKDCC-L 339
            +   + +  S  +WSLG +   M+    PF      HD+ +         +++ +C  L
Sbjct: 185 WIRYHRYHGRSAAVWSLGILLYDMVCGDIPF-----EHDEEIIRGQVFFRQRVSSECQHL 239
Query: 340 IIWCNS-RHSRKP 351
           I WC + R S +P
Sbjct: 240 IRWCLALRPSDRP 252

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 62/253 (24%), Positives = 105/253 (41%), Gaps = 33/253 (13%)
Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTN----------ERCXXXXXXXXXXXXXXXXXXXL 173
           +  Y+V   +G G +  V+ GI V+ N          +R                     
Sbjct: 55  ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLK 114
Query: 174 QNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNST----DFKVLYPTLTDYDIRYYIYELL 229
           +   G   V++LLD      S    LI E         DF      L +   R + +++L
Sbjct: 115 KVSSGFSGVIRLLDWFERPDSFV--LILERPEPVQDLFDFITERGALQEELARSFFWQVL 172
Query: 230 KALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 289
           +A+ +CH+ G++HRD+K  N++ID    +L+LID+G          Y     +R +  PE
Sbjct: 173 EAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTDFDGTRVYSPPE 231
Query: 290 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV---------KIAKDCC-L 339
            +   + +  S  +WSLG +   M+    PF      HD+ +         +++ +C  L
Sbjct: 232 WIRYHRYHGRSAAVWSLGILLYDMVCGDIPF-----EHDEEIIRGQVFFRQRVSXECQHL 286
Query: 340 IIWCNS-RHSRKP 351
           I WC + R S +P
Sbjct: 287 IRWCLALRPSDRP 299

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 62/253 (24%), Positives = 105/253 (41%), Gaps = 33/253 (13%)
Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTN----------ERCXXXXXXXXXXXXXXXXXXXL 173
           +  Y+V   +G G +  V+ GI V+ N          +R                     
Sbjct: 7   ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLK 66
Query: 174 QNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNST----DFKVLYPTLTDYDIRYYIYELL 229
           +   G   V++LLD      S    LI E         DF      L +   R + +++L
Sbjct: 67  KVSSGFSGVIRLLDWFERPDSFV--LILERPEPVQDLFDFITERGALQEELARSFFWQVL 124
Query: 230 KALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 289
           +A+ +CH+ G++HRD+K  N++ID    +L+LID+G          Y     +R +  PE
Sbjct: 125 EAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTDFDGTRVYSPPE 183
Query: 290 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV---------KIAKDCC-L 339
            +   + +  S  +WSLG +   M+    PF      HD+ +         +++ +C  L
Sbjct: 184 WIRYHRYHGRSAAVWSLGILLYDMVCGDIPF-----EHDEEIIRGQVFFRQRVSSECQHL 238
Query: 340 IIWCNS-RHSRKP 351
           I WC + R S +P
Sbjct: 239 IRWCLALRPSDRP 251

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 58/243 (23%), Positives = 104/243 (42%), Gaps = 21/243 (8%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXXXXXXX---XXXXXXXXLQNLCGGPN 181
           +D+++V+ +G G Y EV   +N  T E                        +  +    N
Sbjct: 7   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINAMLNHEN 66
Query: 182 VVKLLDIVRDQHSKTPSLIFEYVNSTD-FKVLYP--TLTDYDIRYYIYELLKALDYCHSQ 238
           VVK     R+ + +   L  EY +  + F  + P   + + D + + ++L+  + Y H  
Sbjct: 67  VVKFYGHRREGNIQY--LFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 124
Query: 239 GIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKE--YNVRVASRYFKGPELLVDLQ 295
           GI HRD+KP N+++D E   L++ D+GLA  F +  +E   N    +  +  PELL   +
Sbjct: 125 GITHRDIKPENLLLD-ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183
Query: 296 DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSKF 355
            +   +D+WS G +   M+  + P+    D+  +            W   +    PW K 
Sbjct: 184 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSD---------WKEKKTYLNPWKKI 234
Query: 356 INA 358
            +A
Sbjct: 235 DSA 237

>pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 40/139 (28%), Positives = 79/139 (56%), Gaps = 11/139 (7%)
Query: 200 IFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQ--GIMHRDVKPHNVMIDHELR 257
           +++ + +T+F+ +   LT    R +  ++  AL +  +    I+H D+KP N+++ +  R
Sbjct: 142 LYDLLRNTNFRGVSLNLT----RKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKR 197
Query: 258 K-LRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFR 316
             ++++D+G +     G+     + SR+++ PE+L+ +  YD ++DMWSLGC+   M   
Sbjct: 198 XAIKIVDFGSS--CQLGQRIYQXIQSRFYRSPEVLLGM-PYDLAIDMWSLGCILVEM-HT 253
Query: 317 KEPFFYGHDNHDQLVKIAK 335
            EP F G +  DQ+ KI +
Sbjct: 254 GEPLFSGANEVDQMNKIVE 272

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 37/147 (25%), Positives = 73/147 (49%), Gaps = 12/147 (8%)
Query: 180 PNVVKLLDIVRDQHSKTPS---LIFEYVNST---DFKVLYPTLTDYDIRYYIYELLKALD 233
           P+++KL  ++      TP+   ++ EYV+     D+   +  + + + R    ++L A+D
Sbjct: 71  PHIIKLYQVI-----STPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVD 125
Query: 234 YCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD 293
           YCH   ++HRD+KP NV++D  +   ++ D+GL+     G+       S  +  PE++  
Sbjct: 126 YCHRHMVVHRDLKPENVLLDAHMNA-KIADFGLSNMMSDGEFLRDSCGSPNYAAPEVISG 184
Query: 294 LQDYDYSLDMWSLGCMFAGMIFRKEPF 320
                  +D+WS G +   ++    PF
Sbjct: 185 RLYAGPEVDIWSCGVILYALLCGTLPF 211

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 59/244 (24%), Positives = 100/244 (40%), Gaps = 32/244 (13%)
Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTN----------ERCXXXXXXXXXXXXXXXXXXXL 173
           +  Y+V   +G G +  V+ GI V+ N          +R                     
Sbjct: 23  ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLK 82
Query: 174 QNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNST----DFKVLYPTLTDYDIRYYIYELL 229
           +   G   V++LLD      S    LI E         DF      L +   R + +++L
Sbjct: 83  KVSSGFSGVIRLLDWFERPDSFV--LILERPEPVQDLFDFITERGALQEELARSFFWQVL 140
Query: 230 KALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 289
           +A+ +CH+ G++HRD+K  N++ID    +L+LID+G          Y     +R +  PE
Sbjct: 141 EAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTDFDGTRVYSPPE 199
Query: 290 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV---------KIAKDCC-L 339
            +   + +  S  +WSLG +   M+    PF      HD+ +         +++ +C  L
Sbjct: 200 WIRYHRYHGRSAAVWSLGILLYDMVCGDIPF-----EHDEEIIRGQVFFRQRVSXECQHL 254
Query: 340 IIWC 343
           I WC
Sbjct: 255 IRWC 258

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 100/213 (46%), Gaps = 14/213 (6%)
Query: 115 ESLTVQWGDQDD-YEVVRKVGRGKYSEVFEGINVNTNERCXXXX---XXXXXXXXXXXXX 170
           E+L  Q  D ++ +  + K+G+G + EVF+GI+  T +                      
Sbjct: 16  ENLYFQSMDPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQE 75
Query: 171 XXLQNLCGGPNVVKLL-DIVRDQHSKTPSLIFEYVNS-TDFKVLYPT-LTDYDIRYYIYE 227
             + + C  P V K     ++D       +I EY+   +   +L P  L +  I   + E
Sbjct: 76  ITVLSQCDSPYVTKYYGSYLKDTKL---WIIMEYLGGGSALDLLEPGPLDETQIATILRE 132
Query: 228 LLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEYNVRVASRYFK 286
           +LK LDY HS+  +HRD+K  NV++  E  +++L D+G+A +      + N  V + ++ 
Sbjct: 133 ILKGLDYLHSEKKIHRDIKAANVLLS-EHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWM 191
Query: 287 GPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEP 319
            PE ++    YD   D+WSLG   A  + R EP
Sbjct: 192 APE-VIKQSAYDSKADIWSLGIT-AIELARGEP 222

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 43/173 (24%), Positives = 83/173 (47%), Gaps = 23/173 (13%)
Query: 228 LLKALDYCHSQ-GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFK 286
           ++KAL++ HS+  ++HRDVKP NV+I+  L ++++ D+G++ +        +    + + 
Sbjct: 162 IVKALEHLHSKLSVIHRDVKPSNVLIN-ALGQVKMCDFGISGYLVDSVAKTIDAGCKPYM 220
Query: 287 GPELL---VDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWC 343
            PE +   ++ + Y    D+WSLG     +   + P+        QL ++ ++       
Sbjct: 221 APERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEE------- 273
Query: 344 NSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFA 396
                + P  KF         S E +DF  + L+ + ++R T  E M HP+F 
Sbjct: 274 --PSPQLPADKF---------SAEFVDFTSQCLKKNSKERPTYPELMQHPFFT 315

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 62/253 (24%), Positives = 105/253 (41%), Gaps = 33/253 (13%)
Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTN----------ERCXXXXXXXXXXXXXXXXXXXL 173
           +  Y+V   +G G +  V+ GI V+ N          +R                     
Sbjct: 3   ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLK 62
Query: 174 QNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNST----DFKVLYPTLTDYDIRYYIYELL 229
           +   G   V++LLD      S    LI E         DF      L +   R + +++L
Sbjct: 63  KVSSGFSGVIRLLDWFERPDSFV--LILERPEPVQDLFDFITERGALQEELARSFFWQVL 120
Query: 230 KALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 289
           +A+ +CH+ G++HRD+K  N++ID    +L+LID+G          Y     +R +  PE
Sbjct: 121 EAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTDFDGTRVYSPPE 179
Query: 290 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV---------KIAKDCC-L 339
            +   + +  S  +WSLG +   M+    PF      HD+ +         +++ +C  L
Sbjct: 180 WIRYHRYHGRSAAVWSLGILLYDMVCGDIPF-----EHDEEIIRGQVFFRQRVSSECQHL 234
Query: 340 IIWCNS-RHSRKP 351
           I WC + R S +P
Sbjct: 235 IRWCLALRPSDRP 247

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 42/144 (29%), Positives = 71/144 (49%), Gaps = 7/144 (4%)
Query: 181 NVVKLLDIVRDQHSKTPSLIFEYVNST----DFKVLYPTLTDYDIRYYIYELLKALDYCH 236
           N++K+LDI  +Q      L+ E   S      F   +P L +    Y   +L+ A+ Y  
Sbjct: 90  NIIKVLDIFENQGFF--QLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLR 147
Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD 296
            + I+HRD+K  N++I  +   ++LID+G A +   GK +     +  +  PE+L+    
Sbjct: 148 LKDIIHRDIKDENIVIAEDF-TIKLIDFGSAAYLERGKLFYTFCGTIEYCAPEVLMGNPY 206
Query: 297 YDYSLDMWSLGCMFAGMIFRKEPF 320
               L+MWSLG     ++F + PF
Sbjct: 207 RGPELEMWSLGVTLYTLVFEENPF 230

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 62/253 (24%), Positives = 105/253 (41%), Gaps = 33/253 (13%)
Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTN----------ERCXXXXXXXXXXXXXXXXXXXL 173
           +  Y+V   +G G +  V+ GI V+ N          +R                     
Sbjct: 3   ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLK 62
Query: 174 QNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNST----DFKVLYPTLTDYDIRYYIYELL 229
           +   G   V++LLD      S    LI E         DF      L +   R + +++L
Sbjct: 63  KVSSGFSGVIRLLDWFERPDSFV--LILERPEPVQDLFDFITERGALQEELARSFFWQVL 120
Query: 230 KALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 289
           +A+ +CH+ G++HRD+K  N++ID    +L+LID+G          Y     +R +  PE
Sbjct: 121 EAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTDFDGTRVYSPPE 179
Query: 290 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV---------KIAKDCC-L 339
            +   + +  S  +WSLG +   M+    PF      HD+ +         +++ +C  L
Sbjct: 180 WIRYHRYHGRSAAVWSLGILLYDMVCGDIPF-----EHDEEIIGGQVFFRQRVSSECQHL 234
Query: 340 IIWCNS-RHSRKP 351
           I WC + R S +P
Sbjct: 235 IRWCLALRPSDRP 247

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 62/253 (24%), Positives = 105/253 (41%), Gaps = 33/253 (13%)
Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTN----------ERCXXXXXXXXXXXXXXXXXXXL 173
           +  Y+V   +G G +  V+ GI V+ N          +R                     
Sbjct: 6   ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLK 65
Query: 174 QNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNST----DFKVLYPTLTDYDIRYYIYELL 229
           +   G   V++LLD      S    LI E         DF      L +   R + +++L
Sbjct: 66  KVSSGFSGVIRLLDWFERPDSFV--LILERPEPVQDLFDFITERGALQEELARSFFWQVL 123
Query: 230 KALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 289
           +A+ +CH+ G++HRD+K  N++ID    +L+LID+G          Y     +R +  PE
Sbjct: 124 EAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTDFDGTRVYSPPE 182
Query: 290 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV---------KIAKDCC-L 339
            +   + +  S  +WSLG +   M+    PF      HD+ +         +++ +C  L
Sbjct: 183 WIRYHRYHGRSAAVWSLGILLYDMVCGDIPF-----EHDEEIIRGQVFFRQRVSSECQHL 237
Query: 340 IIWCNS-RHSRKP 351
           I WC + R S +P
Sbjct: 238 IRWCLALRPSDRP 250

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 94/200 (47%), Gaps = 13/200 (6%)
Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCXXX---XXXXXXXXXXXXXXXXLQNLCGGPNVV 183
           +  + K+G+G + EVF+GI+  T +                        + + C  P V 
Sbjct: 9   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 68
Query: 184 KLL-DIVRDQHSKTPSLIFEYVNS-TDFKVLYPT-LTDYDIRYYIYELLKALDYCHSQGI 240
           K     ++D       +I EY+   +   +L P  L +  I   + E+LK LDY HS+  
Sbjct: 69  KYYGSYLKDTKL---WIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKK 125
Query: 241 MHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDLQDYDY 299
           +HRD+K  NV++  E  +++L D+G+A +      + N  V + ++  PE ++    YD 
Sbjct: 126 IHRDIKAANVLLS-EHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPE-VIKQSAYDS 183
Query: 300 SLDMWSLGCMFAGMIFRKEP 319
             D+WSLG + A  + R EP
Sbjct: 184 KADIWSLG-ITAIELARGEP 202

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 62/253 (24%), Positives = 105/253 (41%), Gaps = 33/253 (13%)
Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTN----------ERCXXXXXXXXXXXXXXXXXXXL 173
           +  Y+V   +G G +  V+ GI V+ N          +R                     
Sbjct: 30  ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLK 89
Query: 174 QNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNST----DFKVLYPTLTDYDIRYYIYELL 229
           +   G   V++LLD      S    LI E         DF      L +   R + +++L
Sbjct: 90  KVSSGFSGVIRLLDWFERPDSFV--LILERPEPVQDLFDFITERGALQEELARSFFWQVL 147
Query: 230 KALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 289
           +A+ +CH+ G++HRD+K  N++ID    +L+LID+G          Y     +R +  PE
Sbjct: 148 EAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTDFDGTRVYSPPE 206
Query: 290 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV---------KIAKDCC-L 339
            +   + +  S  +WSLG +   M+    PF      HD+ +         +++ +C  L
Sbjct: 207 WIRYHRYHGRSAAVWSLGILLYDMVCGDIPF-----EHDEEIIRGQVFFRQRVSXECQHL 261
Query: 340 IIWCNS-RHSRKP 351
           I WC + R S +P
Sbjct: 262 IRWCLALRPSDRP 274

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 77/320 (24%), Positives = 130/320 (40%), Gaps = 44/320 (13%)
Query: 90  PLPAMSKARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNT 149
           P+PA  +A    D +V       D E L         +  +R++G G +  V+   +V  
Sbjct: 28  PMPAGGRAGSLKDPDVAELFFKDDPEKL---------FSDLREIGHGSFGAVYFARDVRN 78
Query: 150 NERCXXXXXXXXXXXXXXXXXXXLQNL-----CGGPNVVKLLDIVRDQHSKTPSLIFEYV 204
           +E                     ++ +        PN ++       +H  T  L+ EY 
Sbjct: 79  SEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREH--TAWLVMEYC 136
Query: 205 --NSTDF-KVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRL 261
             +++D  +V    L + +I    +  L+ L Y HS  ++HRDVK  N+++  E   ++L
Sbjct: 137 LGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLS-EPGLVKL 195
Query: 262 IDWGLAEFYHPGKEYNVRVASRYFKGPE--LLVDLQDYDYSLDMWSLGCMFAGMIFRKEP 319
            D+G A    P    N  V + Y+  PE  L +D   YD  +D+WSLG     +  RK P
Sbjct: 196 GDFGSASIMAPA---NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP 252
Query: 320 FFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYD 379
            F   +    L  IA++    +   S H    WS++              +F+D  L+  
Sbjct: 253 LF-NMNAMSALYHIAQNESPAL--QSGH----WSEYFR------------NFVDSCLQKI 293
Query: 380 HQDRLTAREAMAHPYFAQVR 399
            QDR T+   + H +  + R
Sbjct: 294 PQDRPTSEVLLKHRFVLRER 313

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 67/290 (23%), Positives = 118/290 (40%), Gaps = 42/290 (14%)
Query: 119 VQWGD-QDDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXXXXXXXXXXXXXXXLQNL- 176
           V  GD +  Y    K+G+G    V+  ++V T +                     +  + 
Sbjct: 13  VSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMR 72
Query: 177 -CGGPNVVKLLD--IVRDQHSKTPSLIFEYVNSTDFK--VLYPTLTDYDIRYYIYELLKA 231
               PN+V  LD  +V D+      ++ EY+        V    + +  I     E L+A
Sbjct: 73  ENKNPNIVNYLDSYLVGDELW----VVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQA 128
Query: 232 LDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK-EYNVRVASRYFKGPEL 290
           L++ HS  ++HRD+K  N+++  +   ++L D+G      P + + +  V + Y+  PE+
Sbjct: 129 LEFLHSNQVIHRDIKSDNILLGMD-GSVKLTDFGFCAQITPEQSKRSXMVGTPYWMAPEV 187
Query: 291 LVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRK 350
            V  + Y   +D+WSLG M   MI   EP +   +    L  IA +              
Sbjct: 188 -VTRKAYGPKVDIWSLGIMAIEMI-EGEPPYLNENPLRALYLIATN-------------- 231
Query: 351 PWSKFINADNQHLVSPEAI-----DFLDKLLRYDHQDRLTAREAMAHPYF 395
                       L +PE +     DFL++ L  D + R +A+E + H + 
Sbjct: 232 --------GTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQFL 273

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 94/200 (47%), Gaps = 13/200 (6%)
Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCXXXX---XXXXXXXXXXXXXXXLQNLCGGPNVV 183
           +  + K+G+G + EVF+GI+  T +                        + + C  P V 
Sbjct: 24  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83
Query: 184 KLL-DIVRDQHSKTPSLIFEYVNS-TDFKVLYPT-LTDYDIRYYIYELLKALDYCHSQGI 240
           K     ++D       +I EY+   +   +L P  L +  I   + E+LK LDY HS+  
Sbjct: 84  KYYGSYLKDTKL---WIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKK 140
Query: 241 MHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDLQDYDY 299
           +HRD+K  NV++  E  +++L D+G+A +      + N  V + ++  PE ++    YD 
Sbjct: 141 IHRDIKAANVLLS-EHGEVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPE-VIKQSAYDS 198
Query: 300 SLDMWSLGCMFAGMIFRKEP 319
             D+WSLG + A  + R EP
Sbjct: 199 KADIWSLG-ITAIELARGEP 217

>pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 95/202 (47%), Gaps = 41/202 (20%)
Query: 199 LIFEYVNSTDFKVL----YPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDH 254
           LIFE +  + ++++    Y      DI+ Y  E+LKAL+Y     + H D+KP N+++D 
Sbjct: 113 LIFEPLGPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDD 172
Query: 255 --------ELRK----------------LRLIDWGLAEF---YHPGKEYNVRVASRYFKG 287
                    +R+                ++LID+G A F   YH        + +R ++ 
Sbjct: 173 PYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYHGS-----IINTRQYRA 227
Query: 288 PELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRH 347
           PE++++L  +D S DMWS GC+ A + +     F  H++ + L  + +     I  N  +
Sbjct: 228 PEVILNL-GWDVSSDMWSFGCVLAEL-YTGSLLFRTHEHMEHLA-MMESIIQPIPKNMLY 284
Query: 348 --SRKPWSKFINADNQHLVSPE 367
             ++   SK++N D   L  PE
Sbjct: 285 EATKTNGSKYVNKDELKLAWPE 306

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 67/290 (23%), Positives = 118/290 (40%), Gaps = 42/290 (14%)
Query: 119 VQWGD-QDDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXXXXXXXXXXXXXXXLQNL- 176
           V  GD +  Y    K+G+G    V+  ++V T +                     +  + 
Sbjct: 14  VSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMR 73
Query: 177 -CGGPNVVKLLD--IVRDQHSKTPSLIFEYVNSTDFK--VLYPTLTDYDIRYYIYELLKA 231
               PN+V  LD  +V D+      ++ EY+        V    + +  I     E L+A
Sbjct: 74  ENKNPNIVNYLDSYLVGDELW----VVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQA 129
Query: 232 LDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK-EYNVRVASRYFKGPEL 290
           L++ HS  ++HRD+K  N+++  +   ++L D+G      P + + +  V + Y+  PE+
Sbjct: 130 LEFLHSNQVIHRDIKSDNILLGMD-GSVKLTDFGFCAQITPEQSKRSXMVGTPYWMAPEV 188
Query: 291 LVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRK 350
            V  + Y   +D+WSLG M   MI   EP +   +    L  IA +              
Sbjct: 189 -VTRKAYGPKVDIWSLGIMAIEMI-EGEPPYLNENPLRALYLIATN-------------- 232
Query: 351 PWSKFINADNQHLVSPEAI-----DFLDKLLRYDHQDRLTAREAMAHPYF 395
                       L +PE +     DFL++ L  D + R +A+E + H + 
Sbjct: 233 --------GTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELIQHQFL 274

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 43/184 (23%), Positives = 84/184 (45%), Gaps = 24/184 (13%)
Query: 215 TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPG 273
            LT+ + RYY+ +++    Y H   ++HRD+K  N+ ++ +L ++++ D+GLA +  + G
Sbjct: 135 ALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDL-EVKIGDFGLATKVEYDG 193
Query: 274 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI 333
           +   V   +  +  PE+L   + + + +D+WS+GC+   ++  K PF             
Sbjct: 194 ERKKVLCGTPNYIAPEVLSK-KGHSFEVDVWSIGCIMYTLLVGKPPF------------- 239
Query: 334 AKDCCLIIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHP 393
              C    +   + +     K IN        P A   + K+L+ D   R T  E +   
Sbjct: 240 ETSCLKETYLRIKKNEYSIPKHIN--------PVAASLIQKMLQTDPTARPTINELLNDE 291
Query: 394 YFAQ 397
           +F  
Sbjct: 292 FFTS 295

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 67/290 (23%), Positives = 118/290 (40%), Gaps = 42/290 (14%)
Query: 119 VQWGD-QDDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXXXXXXXXXXXXXXXLQNL- 176
           V  GD +  Y    K+G+G    V+  ++V T +                     +  + 
Sbjct: 13  VSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMR 72
Query: 177 -CGGPNVVKLLD--IVRDQHSKTPSLIFEYVNSTDFK--VLYPTLTDYDIRYYIYELLKA 231
               PN+V  LD  +V D+      ++ EY+        V    + +  I     E L+A
Sbjct: 73  ENKNPNIVNYLDSYLVGDELW----VVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQA 128
Query: 232 LDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK-EYNVRVASRYFKGPEL 290
           L++ HS  ++HRD+K  N+++  +   ++L D+G      P + + +  V + Y+  PE+
Sbjct: 129 LEFLHSNQVIHRDIKSDNILLGMD-GSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEV 187
Query: 291 LVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRK 350
            V  + Y   +D+WSLG M   MI   EP +   +    L  IA +              
Sbjct: 188 -VTRKAYGPKVDIWSLGIMAIEMI-EGEPPYLNENPLRALYLIATN-------------- 231
Query: 351 PWSKFINADNQHLVSPEAI-----DFLDKLLRYDHQDRLTAREAMAHPYF 395
                       L +PE +     DFL++ L  D + R +A+E + H + 
Sbjct: 232 --------GTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFL 273

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 43/184 (23%), Positives = 84/184 (45%), Gaps = 24/184 (13%)
Query: 215 TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPG 273
            LT+ + RYY+ +++    Y H   ++HRD+K  N+ ++ +L ++++ D+GLA +  + G
Sbjct: 137 ALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDL-EVKIGDFGLATKVEYDG 195
Query: 274 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI 333
           +   V   +  +  PE+L   + + + +D+WS+GC+   ++  K PF             
Sbjct: 196 ERKKVLCGTPNYIAPEVLSK-KGHSFEVDVWSIGCIMYTLLVGKPPF------------- 241
Query: 334 AKDCCLIIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHP 393
              C    +   + +     K IN        P A   + K+L+ D   R T  E +   
Sbjct: 242 ETSCLKETYLRIKKNEYSIPKHIN--------PVAASLIQKMLQTDPTARPTINELLNDE 293
Query: 394 YFAQ 397
           +F  
Sbjct: 294 FFTS 297

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 93/200 (46%), Gaps = 13/200 (6%)
Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCXXX---XXXXXXXXXXXXXXXXLQNLCGGPNVV 183
           +  + K+G+G + EVF+GI+  T +                        + + C  P V 
Sbjct: 9   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 68
Query: 184 KLL-DIVRDQHSKTPSLIFEYVNS-TDFKVLYPT-LTDYDIRYYIYELLKALDYCHSQGI 240
           K     ++D       +I EY+   +   +L P  L +  I   + E+LK LDY HS+  
Sbjct: 69  KYYGSYLKDTKL---WIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKK 125
Query: 241 MHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDLQDYDY 299
           +HRD+K  NV++  E  +++L D+G+A +      + N  V + ++  PE ++    YD 
Sbjct: 126 IHRDIKAANVLLS-EHGEVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPE-VIKQSAYDS 183
Query: 300 SLDMWSLGCMFAGMIFRKEP 319
             D+WSLG   A  + R EP
Sbjct: 184 KADIWSLGIT-AIELARGEP 202

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 55/226 (24%), Positives = 97/226 (42%), Gaps = 36/226 (15%)
Query: 181 NVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL-------YPTLTDYDIRYYIYELLKALD 233
           NV++L+D++ ++  +   ++ EY      ++L       +P    +    Y  +L+  L+
Sbjct: 67  NVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHG---YFCQLIDGLE 123
Query: 234 YCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP-GKEYNVRVA--SRYFKGPEL 290
           Y HSQGI+H+D+KP N+++      L++   G+AE  HP   +   R +  S  F+ PE+
Sbjct: 124 YLHSQGIVHKDIKPGNLLLTTG-GTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEI 182
Query: 291 LVDLQDYD-YSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSR 349
              L  +  + +D+WS G     +     P F G + +     I K              
Sbjct: 183 ANGLDTFSGFKVDIWSAGVTLYNITTGLYP-FEGDNIYKLFENIGKG------------- 228
Query: 350 KPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF 395
              S  I  D      P   D L  +L Y+   R + R+   H +F
Sbjct: 229 ---SYAIPGD----CGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWF 267

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 43/173 (24%), Positives = 84/173 (48%), Gaps = 23/173 (13%)
Query: 228 LLKALDYCHSQ-GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFK 286
           ++KAL++ HS+  ++HRDVKP NV+I + L ++++ D+G++ +       ++    + + 
Sbjct: 118 IVKALEHLHSKLSVIHRDVKPSNVLI-NALGQVKMCDFGISGYLVDDVAKDIDAGCKPYM 176
Query: 287 GPELL---VDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWC 343
            PE +   ++ + Y    D+WSLG     +   + P+        QL ++ ++       
Sbjct: 177 APERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEE------- 229
Query: 344 NSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFA 396
                + P  KF         S E +DF  + L+ + ++R T  E M HP+F 
Sbjct: 230 --PSPQLPADKF---------SAEFVDFTSQCLKKNSKERPTYPELMQHPFFT 271

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 43/184 (23%), Positives = 84/184 (45%), Gaps = 24/184 (13%)
Query: 215 TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPG 273
            LT+ + RYY+ +++    Y H   ++HRD+K  N+ ++ +L ++++ D+GLA +  + G
Sbjct: 111 ALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDL-EVKIGDFGLATKVEYDG 169
Query: 274 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI 333
           +   V   +  +  PE+L   + + + +D+WS+GC+   ++  K PF             
Sbjct: 170 ERKKVLCGTPNYIAPEVLSK-KGHSFEVDVWSIGCIMYTLLVGKPPF------------- 215
Query: 334 AKDCCLIIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHP 393
              C    +   + +     K IN        P A   + K+L+ D   R T  E +   
Sbjct: 216 ETSCLKETYLRIKKNEYSIPKHIN--------PVAASLIQKMLQTDPTARPTINELLNDE 267
Query: 394 YFAQ 397
           +F  
Sbjct: 268 FFTS 271

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 66/292 (22%), Positives = 119/292 (40%), Gaps = 42/292 (14%)
Query: 117 LTVQWGD-QDDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXXXXXXXXXXXXXXXLQN 175
           + V  GD +  Y    K+G+G    V+  ++V T +                     +  
Sbjct: 12  IIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILV 71
Query: 176 L--CGGPNVVKLLD--IVRDQHSKTPSLIFEYVNSTDFK--VLYPTLTDYDIRYYIYELL 229
           +     PN+V  LD  +V D+      ++ EY+        V    + +  I     E L
Sbjct: 72  MRENKNPNIVNYLDSYLVGDELW----VVMEYLAGGSLTDVVTETCMDEGQIAAVCRECL 127
Query: 230 KALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK-EYNVRVASRYFKGP 288
           +AL++ HS  ++HR++K  N+++  +   ++L D+G      P + + +  V + Y+  P
Sbjct: 128 QALEFLHSNQVIHRNIKSDNILLGMD-GSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAP 186
Query: 289 ELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHS 348
           E+ V  + Y   +D+WSLG M   MI   EP +   +    L  IA +            
Sbjct: 187 EV-VTRKAYGPKVDIWSLGIMAIEMI-EGEPPYLNENPLRALYLIATN------------ 232
Query: 349 RKPWSKFINADNQHLVSPEAI-----DFLDKLLRYDHQDRLTAREAMAHPYF 395
                         L +PE +     DFL++ L  D + R +A+E + H + 
Sbjct: 233 ----------GTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELIQHQFL 274

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 62/225 (27%), Positives = 101/225 (44%), Gaps = 30/225 (13%)
Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYV--NSTDF-KVLYPTLTDYDIRYYIYELLKALDYCH 236
           PN ++       +H  T  L+ EY   +++D  +V    L + +I    +  L+ L Y H
Sbjct: 75  PNTIQYRGCYLREH--TAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH 132
Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE--LLVDL 294
           S  ++HRDVK  N+++  E   ++L D+G A    P    N  V + Y+  PE  L +D 
Sbjct: 133 SHNMIHRDVKAGNILLS-EPGLVKLGDFGSASIMAPA---NXFVGTPYWMAPEVILAMDE 188
Query: 295 QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSK 354
             YD  +D+WSLG     +  RK P F   +    L  IA++    +   S H    WS+
Sbjct: 189 GQYDGKVDVWSLGITCIELAERKPPLF-NMNAMSALYHIAQNESPAL--QSGH----WSE 241
Query: 355 FINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVR 399
           +              +F+D  L+   QDR T+   + H +  + R
Sbjct: 242 YFR------------NFVDSCLQKIPQDRPTSEVLLKHRFVLRER 274

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 90/214 (42%), Gaps = 25/214 (11%)
Query: 125 DDYEVVRKVGRGKYSEV-----FEGINVNTNERCXXXXXXXXXXXXXXXXXXXLQNLCGG 179
           +DYEVV+ +GRG + EV          V   +                     +      
Sbjct: 69  EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANS 128
Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDI-----RYYIYELLKALDY 234
           P VV+L    +D   +   ++ EY+   D   L   +++YD+     R+Y  E++ ALD 
Sbjct: 129 PWVVQLFYAFQDD--RYLYMVMEYMPGGD---LVNLMSNYDVPEKWARFYTAEVVLALDA 183
Query: 235 CHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR----VASRYFKGPEL 290
            HS G +HRDVKP N+++D     L+L D+G        KE  VR    V +  +  PE+
Sbjct: 184 IHSMGFIHRDVKPDNMLLDKS-GHLKLADFGTC--MKMNKEGMVRCDTAVGTPDYISPEV 240
Query: 291 LVDLQD---YDYSLDMWSLGCMFAGMIFRKEPFF 321
           L        Y    D WS+G     M+    PF+
Sbjct: 241 LKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFY 274

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 90/214 (42%), Gaps = 25/214 (11%)
Query: 125 DDYEVVRKVGRGKYSEV-----FEGINVNTNERCXXXXXXXXXXXXXXXXXXXLQNLCGG 179
           +DYEVV+ +GRG + EV          V   +                     +      
Sbjct: 74  EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANS 133
Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDI-----RYYIYELLKALDY 234
           P VV+L    +D   +   ++ EY+   D   L   +++YD+     R+Y  E++ ALD 
Sbjct: 134 PWVVQLFYAFQDD--RYLYMVMEYMPGGD---LVNLMSNYDVPEKWARFYTAEVVLALDA 188
Query: 235 CHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR----VASRYFKGPEL 290
            HS G +HRDVKP N+++D     L+L D+G        KE  VR    V +  +  PE+
Sbjct: 189 IHSMGFIHRDVKPDNMLLDKS-GHLKLADFGTC--MKMNKEGMVRCDTAVGTPDYISPEV 245
Query: 291 LVDLQD---YDYSLDMWSLGCMFAGMIFRKEPFF 321
           L        Y    D WS+G     M+    PF+
Sbjct: 246 LKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFY 279

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 90/214 (42%), Gaps = 25/214 (11%)
Query: 125 DDYEVVRKVGRGKYSEV-----FEGINVNTNERCXXXXXXXXXXXXXXXXXXXLQNLCGG 179
           +DYEVV+ +GRG + EV          V   +                     +      
Sbjct: 74  EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANS 133
Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDI-----RYYIYELLKALDY 234
           P VV+L    +D   +   ++ EY+   D   L   +++YD+     R+Y  E++ ALD 
Sbjct: 134 PWVVQLFYAFQDD--RYLYMVMEYMPGGD---LVNLMSNYDVPEKWARFYTAEVVLALDA 188
Query: 235 CHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR----VASRYFKGPEL 290
            HS G +HRDVKP N+++D     L+L D+G        KE  VR    V +  +  PE+
Sbjct: 189 IHSMGFIHRDVKPDNMLLDKS-GHLKLADFGTC--MKMNKEGMVRCDTAVGTPDYISPEV 245
Query: 291 LVDLQD---YDYSLDMWSLGCMFAGMIFRKEPFF 321
           L        Y    D WS+G     M+    PF+
Sbjct: 246 LKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFY 279

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 70/276 (25%), Positives = 121/276 (43%), Gaps = 38/276 (13%)
Query: 132 KVGRGKYSEVFEGINVNTNERCXXXX---XXXXXXXXXXXXXXXLQNLCGGPNVVKLLDI 188
           ++G+G + EV++GI+ +T E                        + + C  P + +    
Sbjct: 26  RIGKGSFGEVYKGIDNHTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYFG- 84
Query: 189 VRDQHSKTPSL--IFEYVNS-TDFKVLYPT-LTDYDIRYYIYELLKALDYCHSQGIMHRD 244
               + K+  L  I EY+   +   +L P  L +  I   + E+LK LDY HS+  +HRD
Sbjct: 85  ---SYLKSTKLWIIMEYLGGGSALDLLKPGPLEETYIATILREILKGLDYLHSERKIHRD 141
Query: 245 VKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDM 303
           +K  NV++  E   ++L D+G+A +      + N  V + ++  PE ++    YD+  D+
Sbjct: 142 IKAANVLLS-EQGDVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPE-VIKQSAYDFKADI 199
Query: 304 WSLGCMFAGMIFRKEPFFYGHDNHDQ--LVKIAKDCCLIIWCNSRHSRKPWSKFINADNQ 361
           WSLG   A  + + EP     D H    L  I K+    +    +HS KP+ +F+ A   
Sbjct: 200 WSLGIT-AIELAKGEP--PNSDLHPMRVLFLIPKNSPPTL--EGQHS-KPFKEFVEA--- 250
Query: 362 HLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQ 397
                         L  D + R TA+E + H +  +
Sbjct: 251 -------------CLNKDPRFRPTAKELLKHKFITR 273

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 67/290 (23%), Positives = 116/290 (40%), Gaps = 42/290 (14%)
Query: 119 VQWGD-QDDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXXXXXXXXXXXXXXXLQNL- 176
           V  GD +  Y    K+G+G    V+  ++V T +                     +  + 
Sbjct: 13  VSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMR 72
Query: 177 -CGGPNVVKLLD--IVRDQHSKTPSLIFEYVNSTDFK--VLYPTLTDYDIRYYIYELLKA 231
               PN+V  LD  +V D+      ++ EY+        V    + +  I     E L+A
Sbjct: 73  ENKNPNIVNYLDSYLVGDELW----VVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQA 128
Query: 232 LDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR-VASRYFKGPEL 290
           L++ HS  ++HRD+K  N+++  +   ++L D+G      P +      V + Y+  PE+
Sbjct: 129 LEFLHSNQVIHRDIKSDNILLGMD-GSVKLTDFGFCAQITPEQSKRSEMVGTPYWMAPEV 187
Query: 291 LVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRK 350
            V  + Y   +D+WSLG M   MI   EP +   +    L  IA +              
Sbjct: 188 -VTRKAYGPKVDIWSLGIMAIEMI-EGEPPYLNENPLRALYLIATN-------------- 231
Query: 351 PWSKFINADNQHLVSPEAI-----DFLDKLLRYDHQDRLTAREAMAHPYF 395
                       L +PE +     DFL++ L  D + R +A+E + H + 
Sbjct: 232 --------GTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFL 273

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 42/183 (22%), Positives = 83/183 (45%), Gaps = 24/183 (13%)
Query: 216 LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGK 274
           LT+ + RYY+ +++    Y H   ++HRD+K  N+ ++ +L ++++ D+GLA +  + G+
Sbjct: 118 LTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDL-EVKIGDFGLATKVEYDGE 176
Query: 275 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA 334
                  +  +  PE+L   + + + +D+WS+GC+   ++  K PF              
Sbjct: 177 RKKTLCGTPNYIAPEVLSK-KGHSFEVDVWSIGCIMYTLLVGKPPF-------------E 222
Query: 335 KDCCLIIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPY 394
             C    +   + +     K IN        P A   + K+L+ D   R T  E +   +
Sbjct: 223 TSCLKETYLRIKKNEYSIPKHIN--------PVAASLIQKMLQTDPTARPTINELLNDEF 274
Query: 395 FAQ 397
           F  
Sbjct: 275 FTS 277

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/243 (23%), Positives = 103/243 (42%), Gaps = 21/243 (8%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXXXXXXX---XXXXXXXXLQNLCGGPN 181
           +D+++V+ +G G   EV   +N  T E                        +  +    N
Sbjct: 6   EDWDLVQTLGEGAAGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 65
Query: 182 VVKLLDIVRDQHSKTPSLIFEYVNSTD-FKVLYP--TLTDYDIRYYIYELLKALDYCHSQ 238
           VVK     R+ + +   L  EY +  + F  + P   + + D + + ++L+  + Y H  
Sbjct: 66  VVKFYGHRREGNIQY--LFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 123
Query: 239 GIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKE--YNVRVASRYFKGPELLVDLQ 295
           GI HRD+KP N+++D E   L++ D+GLA  F +  +E   N    +  +  PELL   +
Sbjct: 124 GITHRDIKPENLLLD-ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 182
Query: 296 DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSKF 355
            +   +D+WS G +   M+  + P+    D+  +            W   +    PW K 
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSD---------WKEKKTYLNPWKKI 233
Query: 356 INA 358
            +A
Sbjct: 234 DSA 236

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 42/183 (22%), Positives = 83/183 (45%), Gaps = 24/183 (13%)
Query: 216 LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGK 274
           LT+ + RYY+ +++    Y H   ++HRD+K  N+ ++ +L ++++ D+GLA +  + G+
Sbjct: 114 LTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDL-EVKIGDFGLATKVEYDGE 172
Query: 275 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA 334
                  +  +  PE+L   + + + +D+WS+GC+   ++  K PF              
Sbjct: 173 RKKTLCGTPNYIAPEVLSK-KGHSFEVDVWSIGCIMYTLLVGKPPF-------------E 218
Query: 335 KDCCLIIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPY 394
             C    +   + +     K IN        P A   + K+L+ D   R T  E +   +
Sbjct: 219 TSCLKETYLRIKKNEYSIPKHIN--------PVAASLIQKMLQTDPTARPTINELLNDEF 270
Query: 395 FAQ 397
           F  
Sbjct: 271 FTS 273

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 42/183 (22%), Positives = 83/183 (45%), Gaps = 24/183 (13%)
Query: 216 LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGK 274
           LT+ + RYY+ +++    Y H   ++HRD+K  N+ ++ +L ++++ D+GLA +  + G+
Sbjct: 114 LTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDL-EVKIGDFGLATKVEYDGE 172
Query: 275 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA 334
                  +  +  PE+L   + + + +D+WS+GC+   ++  K PF              
Sbjct: 173 RKKTLCGTPNYIAPEVLSK-KGHSFEVDVWSIGCIMYTLLVGKPPF-------------E 218
Query: 335 KDCCLIIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPY 394
             C    +   + +     K IN        P A   + K+L+ D   R T  E +   +
Sbjct: 219 TSCLKETYLRIKKNEYSIPKHIN--------PVAASLIQKMLQTDPTARPTINELLNDEF 270
Query: 395 FAQ 397
           F  
Sbjct: 271 FTS 273

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 47/181 (25%), Positives = 83/181 (45%), Gaps = 23/181 (12%)
Query: 217 TDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNV--MIDHELRKLRLIDWGLAEFYHPGK 274
           T+ D    I ++L A+ Y H  GI+HRD+KP N+  +   E  K+ + D+GL++    G 
Sbjct: 104 TEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGI 163
Query: 275 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA 334
             +    +  +  PE+L   + Y  ++D WS+G +   ++    PF+   +   +L +  
Sbjct: 164 -MSTACGTPGYVAPEVLAQ-KPYSKAVDCWSIGVITYILLCGYPPFY--EETESKLFEKI 219
Query: 335 KDCCLIIWCNSRHSRKP-WSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHP 393
           K+              P W           +S  A DF+  LL  D  +R T  +A++HP
Sbjct: 220 KE-------GYYEFESPFWDD---------ISESAKDFICHLLEKDPNERYTCEKALSHP 263
Query: 394 Y 394
           +
Sbjct: 264 W 264

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 49/184 (26%), Positives = 87/184 (47%), Gaps = 5/184 (2%)
Query: 221 IRYYIYELLKALDYCHSQ-GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR 279
           I+  I  +L +  Y H++  I HRDVKP N+++D   R ++L D+G +E Y   K+    
Sbjct: 153 IKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGR-VKLSDFGESE-YMVDKKIKGS 210
Query: 280 VASRYFKGPELLVDLQDYDYS-LDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCC 338
             +  F  PE   +   Y+ + +D+WSLG     M +   PF     +  +L    +   
Sbjct: 211 RGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKI-SLVELFNNIRTKN 269
Query: 339 LIIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQV 398
           +    +  H   P +   +  + + +S E IDFL   LR +  +R+T+ +A+ H + A  
Sbjct: 270 IEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADT 329
Query: 399 RAAE 402
              +
Sbjct: 330 NIED 333

>pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 52/189 (27%), Positives = 87/189 (46%), Gaps = 23/189 (12%)
Query: 178 GGPNVVKLLDIVRDQHSKTPSLIFEYVNST----DFKVLYPTLTDYDIRYYIYELLKALD 233
           G   V++LLD      S    LI E         DF      L +   R + +++L+A+ 
Sbjct: 114 GFSGVIRLLDWFERPDSFV--LILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 171
Query: 234 YCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD 293
           +CH+ G++HRD+K  N++ID    +L+LID+G          Y     +R +  PE +  
Sbjct: 172 HCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTDFDGTRVYSPPEWIRY 230
Query: 294 LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV---------KIAKDCC-LIIWC 343
            + +  S  +WSLG +   M+    PF      HD+ +         +++ +C  LI WC
Sbjct: 231 HRYHGRSAAVWSLGILLYDMVCGDIPF-----EHDEEIIRGQVFFRQRVSSECQHLIRWC 285
Query: 344 NS-RHSRKP 351
            + R S +P
Sbjct: 286 LALRPSDRP 294

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 49/195 (25%), Positives = 86/195 (44%), Gaps = 20/195 (10%)
Query: 216 LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDH--ELRKLRLIDWGLAEFYH-- 271
             + +    + ++  ALD+ H++GI HRD+KP N++ +H  ++  +++ D+ L       
Sbjct: 108 FNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLN 167
Query: 272 ------PGKEYNVRVASRYFKGPELLVDLQD----YDYSLDMWSLGCMFAGMIFRKEPFF 321
                    E      S  +  PE++    +    YD   D+WSLG +   ++    P F
Sbjct: 168 GDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILY-ILLSGYPPF 226
Query: 322 YGHDNHDQLVKIAKDC--CLIIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYD 379
            G    D      + C  C  +   S    K   +F + D  H +S  A D + KLL  D
Sbjct: 227 VGRCGSDCGWDRGEACPACQNMLFESIQEGK--YEFPDKDWAH-ISCAAKDLISKLLVRD 283
Query: 380 HQDRLTAREAMAHPY 394
            + RL+A + + HP+
Sbjct: 284 AKQRLSAAQVLQHPW 298

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/284 (20%), Positives = 120/284 (42%), Gaps = 46/284 (16%)
Query: 125 DDYEVVRKVGRGKYSEVF-----EGINVNTNERCXXXXXXXXXXXXXXXXXXXLQNLCGG 179
           DD+++VR +G+GK+  V+     +   +   +                     +Q+    
Sbjct: 14  DDFDIVRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 73
Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRY-------YIYELLKAL 232
           PN++++ +   D+  K   L+ E+    +   LY  L  +  R+       ++ EL  AL
Sbjct: 74  PNILRMYNYFHDR--KRIYLMLEFAPRGE---LYKELQKHG-RFDEQRSATFMEELADAL 127
Query: 233 DYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLV 292
            YCH + ++HRD+KP N+++ ++  +L++ D+G +  + P         +  +  PE ++
Sbjct: 128 HYCHERKVIHRDIKPENLLMGYK-GELKIADFGWS-VHAPSLRRRXMCGTLDYLPPE-MI 184
Query: 293 DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPW 352
           + + +D  +D+W  G +    +    PF                       +S    +  
Sbjct: 185 EGKTHDEKVDLWCAGVLCYEFLVGMPPF-----------------------DSPSHTETH 221
Query: 353 SKFINADNQH--LVSPEAIDFLDKLLRYDHQDRLTAREAMAHPY 394
            + +N D +    +S  + D + KLLRY    RL  +  M HP+
Sbjct: 222 RRIVNVDLKFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPW 265

>pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 70/285 (24%), Positives = 113/285 (39%), Gaps = 30/285 (10%)
Query: 125 DDYEVVRKV-GRGKYSEVFEGINVNTNERCXXXXXXXXXXXXXXXXXXXLQNLCGGPNVV 183
           DDY+V  +V G G   +V +  N  T E+                      + C  P++V
Sbjct: 61  DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKXLQDCPKARREVELHWRASQC--PHIV 118
Query: 184 KLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYI----YELLK----ALDYC 235
           +++D+  + ++    L+       D   L+  + D   + +      E+ K    A+ Y 
Sbjct: 119 RIVDVYENLYAGRKCLLI-VXECLDGGELFSRIQDRGDQAFTEREASEIXKSIGEAIQYL 177
Query: 236 HSQGIMHRDVKPHNVMIDHELRK--LRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD 293
           HS  I HRDVKP N++   +     L+L D+G A+             + Y+  PE+L  
Sbjct: 178 HSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVL-G 236
Query: 294 LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKP-W 352
            + YD S D WSLG +   ++    PF+  H      + I+      I         P W
Sbjct: 237 PEKYDKSCDXWSLGVIXYILLCGYPPFYSNHG-----LAISPGXKTRIRXGQYEFPNPEW 291
Query: 353 SKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQ 397
           S+         VS E    +  LL+ +   R T  E   HP+  Q
Sbjct: 292 SE---------VSEEVKXLIRNLLKTEPTQRXTITEFXNHPWIXQ 327

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 47/184 (25%), Positives = 84/184 (45%), Gaps = 34/184 (18%)
Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVA 281
           ++Y  E+  AL+Y HS+ I++RD+KP N+++D     +++ D+G A+ Y P   Y +   
Sbjct: 109 KFYAAEVCLALEYLHSKDIIYRDLKPENILLDKN-GHIKITDFGFAK-YVPDVTYXLCGT 166
Query: 282 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLII 341
             Y   PE +V  + Y+ S+D WS G +   M+    PF+                    
Sbjct: 167 PDYI-APE-VVSTKPYNKSIDWWSFGILIYEMLAGYTPFY-------------------- 204
Query: 342 WCNSRHSRKPWSKFINADNQH--LVSPEAIDFLDKLLRYDHQDRL-----TAREAMAHPY 394
                ++ K + K +NA+ +     + +  D L +L+  D   RL        +   HP+
Sbjct: 205 ---DSNTMKTYEKILNAELRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPW 261
Query: 395 FAQV 398
           F +V
Sbjct: 262 FKEV 265

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 54/213 (25%), Positives = 94/213 (44%), Gaps = 23/213 (10%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXXXXXXXXXXXXXXX------LQNLCG 178
           +DY+VV+ +GRG + EV + +    +++                          +     
Sbjct: 75  EDYDVVKVIGRGAFGEV-QLVRHKASQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFAN 133
Query: 179 GPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDI-----RYYIYELLKALD 233
            P VV+L    +D   K   ++ EY+   D   L   +++YD+     ++Y  E++ ALD
Sbjct: 134 SPWVVQLFCAFQDD--KYLYMVMEYMPGGD---LVNLMSNYDVPEKWAKFYTAEVVLALD 188
Query: 234 YCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEY-NVRVASRYFKGPELL 291
             HS G++HRDVKP N+++D     L+L D+G   +    G  + +  V +  +  PE+L
Sbjct: 189 AIHSMGLIHRDVKPDNMLLDKH-GHLKLADFGTCMKMDETGMVHCDTAVGTPDYISPEVL 247
Query: 292 VDLQD---YDYSLDMWSLGCMFAGMIFRKEPFF 321
                   Y    D WS+G     M+    PF+
Sbjct: 248 KSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFY 280

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 42/155 (27%), Positives = 77/155 (49%), Gaps = 17/155 (10%)
Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLT--------DYDIRYYIYELLKA 231
           PN+V+  D + D+ + T  ++ EY    D   +    T        ++ +R  + +L  A
Sbjct: 65  PNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRV-MTQLTLA 123
Query: 232 LDYCHSQG-----IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR-VASRYF 285
           L  CH +      ++HRD+KP NV +D + + ++L D+GLA   +  +++    V + Y+
Sbjct: 124 LKECHRRSDGGHTVLHRDLKPANVFLDGK-QNVKLGDFGLARILNHDEDFAKEFVGTPYY 182
Query: 286 KGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPF 320
             PE + +   Y+   D+WSLGC+   +     PF
Sbjct: 183 MSPEQM-NRMSYNEKSDIWSLGCLLYELCALMPPF 216

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 42/173 (24%), Positives = 82/173 (47%), Gaps = 23/173 (13%)
Query: 228 LLKALDYCHSQ-GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFK 286
           ++KAL++ HS+  ++HRDVKP NV+I+  L +++  D+G++ +       ++    + + 
Sbjct: 145 IVKALEHLHSKLSVIHRDVKPSNVLIN-ALGQVKXCDFGISGYLVDDVAKDIDAGCKPYX 203
Query: 287 GPELL---VDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWC 343
            PE +   ++ + Y    D+WSLG     +   + P+        QL ++ ++       
Sbjct: 204 APERINPELNQKGYSVKSDIWSLGITXIELAILRFPYDSWGTPFQQLKQVVEE------- 256
Query: 344 NSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFA 396
                + P  KF         S E +DF  + L+ + ++R T  E   HP+F 
Sbjct: 257 --PSPQLPADKF---------SAEFVDFTSQCLKKNSKERPTYPELXQHPFFT 298

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 43/155 (27%), Positives = 74/155 (47%), Gaps = 17/155 (10%)
Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLT--------DYDIRYYIYELLKA 231
           PN+V+  D + D+ + T  ++ EY    D   +    T        ++ +R  + +L  A
Sbjct: 65  PNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRV-MTQLTLA 123
Query: 232 LDYCHSQG-----IMHRDVKPHNVMIDHELRKLRLIDWGLAEFY-HPGKEYNVRVASRYF 285
           L  CH +      ++HRD+KP NV +D + + ++L D+GLA    H        V + Y+
Sbjct: 124 LKECHRRSDGGHTVLHRDLKPANVFLDGK-QNVKLGDFGLARILNHDTSFAKTFVGTPYY 182
Query: 286 KGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPF 320
             PE + +   Y+   D+WSLGC+   +     PF
Sbjct: 183 MSPEQM-NRMSYNEKSDIWSLGCLLYELCALMPPF 216

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 43/155 (27%), Positives = 74/155 (47%), Gaps = 17/155 (10%)
Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLT--------DYDIRYYIYELLKA 231
           PN+V+  D + D+ + T  ++ EY    D   +    T        ++ +R  + +L  A
Sbjct: 65  PNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRV-MTQLTLA 123
Query: 232 LDYCHSQG-----IMHRDVKPHNVMIDHELRKLRLIDWGLAEFY-HPGKEYNVRVASRYF 285
           L  CH +      ++HRD+KP NV +D + + ++L D+GLA    H        V + Y+
Sbjct: 124 LKECHRRSDGGHTVLHRDLKPANVFLDGK-QNVKLGDFGLARILNHDTSFAKAFVGTPYY 182
Query: 286 KGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPF 320
             PE + +   Y+   D+WSLGC+   +     PF
Sbjct: 183 MSPEQM-NRMSYNEKSDIWSLGCLLYELCALMPPF 216

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 47/186 (25%), Positives = 80/186 (43%), Gaps = 25/186 (13%)
Query: 215 TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGL-AEFYHPG 273
           TL +  I Y   E+L+ L + H   ++HRD+K  NV++  E  +++L+D+G+ A+     
Sbjct: 125 TLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLT-ENAEVKLVDFGVSAQLDRTV 183
Query: 274 KEYNVRVASRYFKGPELLVDLQD----YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQ 329
              N  + + Y+  PE++   ++    YD+  D+WSLG     M     P    H     
Sbjct: 184 GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMR-A 242
Query: 330 LVKIAKDCCLIIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREA 389
           L  I ++         R   K WSK   +            F++  L  +H  R    + 
Sbjct: 243 LFLIPRNPA------PRLKSKKWSKKFQS------------FIESCLVKNHSQRPATEQL 284
Query: 390 MAHPYF 395
           M HP+ 
Sbjct: 285 MKHPFI 290

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/227 (23%), Positives = 100/227 (44%), Gaps = 35/227 (15%)
Query: 180 PNVVKLLDIVRDQHSKTPS---LIFEYVNSTDFKVLYPTL------TDYDIRYYIYELLK 230
           PN+V+  +++      TP+   +I EY +  +   LY  +      ++ + R++  +LL 
Sbjct: 76  PNIVRFKEVIL-----TPTHLAIIMEYASGGE---LYERICNAGRFSEDEARFFFQQLLS 127
Query: 231 ALDYCHSQGIMHRDVKPHNVMIDHE-LRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 289
            + YCHS  I HRD+K  N ++D     +L++ D+G ++      +    V +  +  PE
Sbjct: 128 GVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPE 187
Query: 290 LLVDLQDYDYSL-DMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHS 348
           +L+  Q+YD  + D+WS G     M+    PF    +  D    I +   +         
Sbjct: 188 VLLR-QEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSV--------- 237
Query: 349 RKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF 395
                K+   D+   +SPE    + ++   D   R++  E   H +F
Sbjct: 238 -----KYSIPDDIR-ISPECCHLISRIFVADPATRISIPEIKTHSWF 278

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 28/98 (28%), Positives = 52/98 (53%), Gaps = 7/98 (7%)
Query: 216 LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE 275
           L +  I   + E+L+ L+Y H  G +HRDVK  N+++  +   +++ D+G++ F   G +
Sbjct: 118 LDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGED-GSVQIADFGVSAFLATGGD 176
Query: 276 YNVRVASRYFKG------PELLVDLQDYDYSLDMWSLG 307
                  + F G      PE++  ++ YD+  D+WS G
Sbjct: 177 ITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFG 214

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 28/98 (28%), Positives = 52/98 (53%), Gaps = 7/98 (7%)
Query: 216 LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE 275
           L +  I   + E+L+ L+Y H  G +HRDVK  N+++  +   +++ D+G++ F   G +
Sbjct: 113 LDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGED-GSVQIADFGVSAFLATGGD 171
Query: 276 YNVRVASRYFKG------PELLVDLQDYDYSLDMWSLG 307
                  + F G      PE++  ++ YD+  D+WS G
Sbjct: 172 ITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFG 209

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 27/106 (25%), Positives = 62/106 (58%), Gaps = 3/106 (2%)
Query: 216 LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGK 274
           +T+ + RY++ + ++ + Y H+  ++HRD+K  N+ ++ ++  +++ D+GLA +    G+
Sbjct: 139 VTEPEARYFMRQTIQGVQYLHNNRVIHRDLKLGNLFLNDDM-DVKIGDFGLATKIEFDGE 197
Query: 275 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPF 320
                  +  +  PE+L   + + + +D+WSLGC+   ++  K PF
Sbjct: 198 RKKTLCGTPNYIAPEVLCK-KGHSFEVDIWSLGCILYTLLVGKPPF 242

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/187 (26%), Positives = 85/187 (45%), Gaps = 38/187 (20%)
Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVA 281
           R+Y  E+  AL Y HS  I++RD+KP N+++D +   + L D+GL +      E+N    
Sbjct: 142 RFYAAEIASALGYLHSLNIVYRDLKPENILLDSQ-GHIVLTDFGLCK---ENIEHN-STT 196
Query: 282 SRYFKGPELL----VDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDC 337
           S +   PE L    +  Q YD ++D W LG +   M++   PF+                
Sbjct: 197 STFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFY---------------- 240
Query: 338 CLIIWCNSRHSRKPWSKFINADNQHL--VSPEAIDFLDKLLRYDHQDRLTAR----EAMA 391
                  SR++ + +   +N   Q    ++  A   L+ LL+ D   RL A+    E  +
Sbjct: 241 -------SRNTAEMYDNILNKPLQLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKS 293
Query: 392 HPYFAQV 398
           H +F+ +
Sbjct: 294 HVFFSLI 300

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 40/158 (25%), Positives = 75/158 (47%), Gaps = 19/158 (12%)
Query: 181 NVVKLLDIVRD-QHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRY---------------Y 224
           NV K L I++  +H    +L + + +  D  ++   L   D+RY               +
Sbjct: 61  NVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLF 120
Query: 225 IYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRY 284
           I EL+ ALDY  +Q I+HRD+KP N+++D E   + + D+ +A       +      ++ 
Sbjct: 121 ICELVMALDYLQNQRIIHRDMKPDNILLD-EHGHVHITDFNIAAMLPRETQITTMAGTKP 179
Query: 285 FKGPELLVDLQ--DYDYSLDMWSLGCMFAGMIFRKEPF 320
           +  PE+    +   Y +++D WSLG     ++  + P+
Sbjct: 180 YMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPY 217

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/284 (20%), Positives = 119/284 (41%), Gaps = 46/284 (16%)
Query: 125 DDYEVVRKVGRGKYSEVF-----EGINVNTNERCXXXXXXXXXXXXXXXXXXXLQNLCGG 179
           DD+++ R +G+GK+  V+     +   +   +                     +Q+    
Sbjct: 15  DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 74
Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRY-------YIYELLKAL 232
           PN++++ +   D+  K   L+ E+    +   LY  L  +  R+       ++ EL  AL
Sbjct: 75  PNILRMYNYFHDR--KRIYLMLEFAPRGE---LYKELQKHG-RFDEQRSATFMEELADAL 128
Query: 233 DYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLV 292
            YCH + ++HRD+KP N+++ ++  +L++ D+G +  + P         +  +  PE ++
Sbjct: 129 HYCHERKVIHRDIKPENLLMGYK-GELKIADFGWS-VHAPSLRRRXMCGTLDYLPPE-MI 185
Query: 293 DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPW 352
           + + +D  +D+W  G +    +    PF                       +S    +  
Sbjct: 186 EGKTHDEKVDLWCAGVLCYEFLVGMPPF-----------------------DSPSHTETH 222
Query: 353 SKFINADNQH--LVSPEAIDFLDKLLRYDHQDRLTAREAMAHPY 394
            + +N D +    +S  + D + KLLRY    RL  +  M HP+
Sbjct: 223 RRIVNVDLKFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPW 266

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 27/106 (25%), Positives = 62/106 (58%), Gaps = 3/106 (2%)
Query: 216 LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGK 274
           +T+ + RY++ + ++ + Y H+  ++HRD+K  N+ ++ ++  +++ D+GLA +    G+
Sbjct: 139 VTEPEARYFMRQTIQGVQYLHNNRVIHRDLKLGNLFLNDDM-DVKIGDFGLATKIEFDGE 197
Query: 275 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPF 320
                  +  +  PE+L   + + + +D+WSLGC+   ++  K PF
Sbjct: 198 RKKXLCGTPNYIAPEVLCK-KGHSFEVDIWSLGCILYTLLVGKPPF 242

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/191 (25%), Positives = 85/191 (44%), Gaps = 16/191 (8%)
Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCXXXX---XXXXXXXXXXXXXXXLQNLCGGPNVV 183
           +  + ++G+G + EVF+GI+  T +                        + + C    V 
Sbjct: 25  FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSSYVT 84
Query: 184 KLLDIVRDQHSKTPSL--IFEYV---NSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQ 238
           K        + K   L  I EY+   ++ D     P   ++ I   + E+LK LDY HS+
Sbjct: 85  KYYG----SYLKGSKLWIIMEYLGGGSALDLLRAGP-FDEFQIATMLKEILKGLDYLHSE 139
Query: 239 GIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDLQDY 297
             +HRD+K  NV++  E   ++L D+G+A +      + N  V + ++  PE ++    Y
Sbjct: 140 KKIHRDIKAANVLLS-EQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPE-VIQQSAY 197
Query: 298 DYSLDMWSLGC 308
           D   D+WSLG 
Sbjct: 198 DSKADIWSLGI 208

>pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 69/285 (24%), Positives = 111/285 (38%), Gaps = 51/285 (17%)
Query: 125 DDYEVVRKV-GRGKYSEVFEGINVNTNERCXXXXXXXXXXXXXXXXXXXLQNLCGGPNVV 183
           DDY+V  +V G G   +V +  N  T E+                      + C  P++V
Sbjct: 17  DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQC--PHIV 74
Query: 184 KLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYI----YELLK----ALDYC 235
           +++D+  + ++    L+   +   D   L+  + D   + +      E++K    A+ Y 
Sbjct: 75  RIVDVYENLYAGRKCLLI-VMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYL 133
Query: 236 HSQGIMHRDVKPHNVMIDHELRK--LRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD 293
           HS  I HRDVKP N++   +     L+L D+G A      KE                  
Sbjct: 134 HSINIAHRDVKPENLLYTSKRPNAILKLTDFGFA------KETTG--------------- 172
Query: 294 LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKP-W 352
            + YD S DMWSLG +   ++    PF+  H      + I+      I         P W
Sbjct: 173 -EKYDKSCDMWSLGVIMYILLCGYPPFYSNHG-----LAISPGMKTRIRMGQYEFPNPEW 226
Query: 353 SKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQ 397
           S+         VS E    +  LL+ +   R+T  E M HP+  Q
Sbjct: 227 SE---------VSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQ 262

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 39/133 (29%), Positives = 67/133 (50%), Gaps = 9/133 (6%)
Query: 195 KTPSLIF---EYVNSTDFKVLYPTLTDYD---IRYYIYELLKALDYCHSQGIMHRDVKPH 248
           +TP  +F   E+VN  D          +D    R+Y  E++ AL + H +GI++RD+K  
Sbjct: 94  QTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLD 153
Query: 249 NVMIDHELRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLG 307
           NV++DHE    +L D+G+  E    G        +  +  PE+L ++  Y  ++D W++G
Sbjct: 154 NVLLDHE-GHCKLADFGMCKEGICNGVTTATFCGTPDYIAPEILQEML-YGPAVDWWAMG 211
Query: 308 CMFAGMIFRKEPF 320
            +   M+    PF
Sbjct: 212 VLLYEMLCGHAPF 224

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 27/107 (25%), Positives = 62/107 (57%), Gaps = 3/107 (2%)
Query: 215 TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPG 273
            +T+ + RY++ + ++ + Y H+  ++HRD+K  N+ ++ ++  +++ D+GLA +    G
Sbjct: 138 AVTEPEARYFMRQTIQGVQYLHNNRVIHRDLKLGNLFLNDDM-DVKIGDFGLATKIEFDG 196
Query: 274 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPF 320
           +       +  +  PE+L   + + + +D+WSLGC+   ++  K PF
Sbjct: 197 ERKKDLCGTPNYIAPEVLCK-KGHSFEVDIWSLGCILYTLLVGKPPF 242

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 50/186 (26%), Positives = 79/186 (42%), Gaps = 33/186 (17%)
Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR-- 279
           + Y   +L+A+   H  GI+H D+KP N +I   +  L+LID+G+A    P     V+  
Sbjct: 114 KSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDGM--LKLIDFGIANQMQPDTTSVVKDS 171
Query: 280 -VASRYFKGPELLVDLQD----------YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHD 328
            V +  +  PE + D+                 D+WSLGC+   M + K PF        
Sbjct: 172 QVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF-------Q 224
Query: 329 QLVKIAKDCCLIIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTARE 388
           Q++        II  N         +F +   + L      D L   L+ D + R++  E
Sbjct: 225 QIINQISKLHAIIDPNHE------IEFPDIPEKDLQ-----DVLKCCLKRDPKQRISIPE 273
Query: 389 AMAHPY 394
            +AHPY
Sbjct: 274 LLAHPY 279

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 50/186 (26%), Positives = 79/186 (42%), Gaps = 33/186 (17%)
Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR-- 279
           + Y   +L+A+   H  GI+H D+KP N +I   +  L+LID+G+A    P     V+  
Sbjct: 158 KSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDGM--LKLIDFGIANQMQPDTTSVVKDS 215
Query: 280 -VASRYFKGPELLVDLQD----------YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHD 328
            V +  +  PE + D+                 D+WSLGC+   M + K PF        
Sbjct: 216 QVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF-------Q 268
Query: 329 QLVKIAKDCCLIIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTARE 388
           Q++        II  N         +F +   + L      D L   L+ D + R++  E
Sbjct: 269 QIINQISKLHAIIDPNHE------IEFPDIPEKDLQ-----DVLKCCLKRDPKQRISIPE 317
Query: 389 AMAHPY 394
            +AHPY
Sbjct: 318 LLAHPY 323

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 50/186 (26%), Positives = 79/186 (42%), Gaps = 33/186 (17%)
Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR-- 279
           + Y   +L+A+   H  GI+H D+KP N +I   +  L+LID+G+A    P     V+  
Sbjct: 110 KSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDGM--LKLIDFGIANQMQPDTTSVVKDS 167
Query: 280 -VASRYFKGPELLVDLQD----------YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHD 328
            V +  +  PE + D+                 D+WSLGC+   M + K PF        
Sbjct: 168 QVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF-------Q 220
Query: 329 QLVKIAKDCCLIIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTARE 388
           Q++        II  N         +F +   + L      D L   L+ D + R++  E
Sbjct: 221 QIINQISKLHAIIDPNHE------IEFPDIPEKDLQ-----DVLKCCLKRDPKQRISIPE 269
Query: 389 AMAHPY 394
            +AHPY
Sbjct: 270 LLAHPY 275

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 50/186 (26%), Positives = 79/186 (42%), Gaps = 33/186 (17%)
Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR-- 279
           + Y   +L+A+   H  GI+H D+KP N +I   +  L+LID+G+A    P     V+  
Sbjct: 158 KSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDGM--LKLIDFGIANQMQPDTTSVVKDS 215
Query: 280 -VASRYFKGPELLVDLQD----------YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHD 328
            V +  +  PE + D+                 D+WSLGC+   M + K PF        
Sbjct: 216 QVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF-------Q 268
Query: 329 QLVKIAKDCCLIIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTARE 388
           Q++        II  N         +F +   + L      D L   L+ D + R++  E
Sbjct: 269 QIINQISKLHAIIDPNHE------IEFPDIPEKDLQ-----DVLKCCLKRDPKQRISIPE 317
Query: 389 AMAHPY 394
            +AHPY
Sbjct: 318 LLAHPY 323

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 27/106 (25%), Positives = 62/106 (58%), Gaps = 3/106 (2%)
Query: 216 LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGK 274
           +T+ + RY++ + ++ + Y H+  ++HRD+K  N+ ++ ++  +++ D+GLA +    G+
Sbjct: 123 VTEPEARYFMRQTIQGVQYLHNNRVIHRDLKLGNLFLNDDM-DVKIGDFGLATKIEFDGE 181
Query: 275 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPF 320
                  +  +  PE+L   + + + +D+WSLGC+   ++  K PF
Sbjct: 182 RKKDLCGTPNYIAPEVLCK-KGHSFEVDIWSLGCILYTLLVGKPPF 226

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 50/186 (26%), Positives = 79/186 (42%), Gaps = 33/186 (17%)
Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR-- 279
           + Y   +L+A+   H  GI+H D+KP N +I   +  L+LID+G+A    P     V+  
Sbjct: 111 KSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDGM--LKLIDFGIANQMQPDTTSVVKDS 168
Query: 280 -VASRYFKGPELLVDLQD----------YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHD 328
            V +  +  PE + D+                 D+WSLGC+   M + K PF        
Sbjct: 169 QVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF-------Q 221
Query: 329 QLVKIAKDCCLIIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTARE 388
           Q++        II  N         +F +   + L      D L   L+ D + R++  E
Sbjct: 222 QIINQISKLHAIIDPNHE------IEFPDIPEKDLQ-----DVLKCCLKRDPKQRISIPE 270
Query: 389 AMAHPY 394
            +AHPY
Sbjct: 271 LLAHPY 276

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 50/186 (26%), Positives = 79/186 (42%), Gaps = 33/186 (17%)
Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR-- 279
           + Y   +L+A+   H  GI+H D+KP N +I   +  L+LID+G+A    P     V+  
Sbjct: 158 KSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDGM--LKLIDFGIANQMQPDTTSVVKDS 215
Query: 280 -VASRYFKGPELLVDLQD----------YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHD 328
            V +  +  PE + D+                 D+WSLGC+   M + K PF        
Sbjct: 216 QVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF-------Q 268
Query: 329 QLVKIAKDCCLIIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTARE 388
           Q++        II  N         +F +   + L      D L   L+ D + R++  E
Sbjct: 269 QIINQISKLHAIIDPNHE------IEFPDIPEKDLQ-----DVLKCCLKRDPKQRISIPE 317
Query: 389 AMAHPY 394
            +AHPY
Sbjct: 318 LLAHPY 323

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 50/186 (26%), Positives = 79/186 (42%), Gaps = 33/186 (17%)
Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR-- 279
           + Y   +L+A+   H  GI+H D+KP N +I   +  L+LID+G+A    P     V+  
Sbjct: 130 KSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDGM--LKLIDFGIANQMQPDTTSVVKDS 187
Query: 280 -VASRYFKGPELLVDLQD----------YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHD 328
            V +  +  PE + D+                 D+WSLGC+   M + K PF        
Sbjct: 188 QVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF-------Q 240
Query: 329 QLVKIAKDCCLIIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTARE 388
           Q++        II  N         +F +   + L      D L   L+ D + R++  E
Sbjct: 241 QIINQISKLHAIIDPNHE------IEFPDIPEKDLQ-----DVLKCCLKRDPKQRISIPE 289
Query: 389 AMAHPY 394
            +AHPY
Sbjct: 290 LLAHPY 295

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 42/154 (27%), Positives = 68/154 (44%), Gaps = 13/154 (8%)
Query: 180 PNVVKLLDIVRDQHSKTPS----LIFEYVNSTDFKVLYPT------LTDYDIRYYIYELL 229
           PNVV   ++        P+    L  EY    D +           L +  IR  + ++ 
Sbjct: 73  PNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDIS 132
Query: 230 KALDYCHSQGIMHRDVKPHNVMIDHELRKL--RLIDWGLAEFYHPGKEYNVRVASRYFKG 287
            AL Y H   I+HRD+KP N+++    ++L  ++ID G A+    G+     V +  +  
Sbjct: 133 SALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLA 192
Query: 288 PELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 321
           PELL + + Y  ++D WS G +    I    PF 
Sbjct: 193 PELL-EQKKYTVTVDYWSFGTLAFECITGFRPFL 225

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 50/186 (26%), Positives = 79/186 (42%), Gaps = 33/186 (17%)
Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR-- 279
           + Y   +L+A+   H  GI+H D+KP N +I   +  L+LID+G+A    P     V+  
Sbjct: 130 KSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDGM--LKLIDFGIANQMQPDXXXVVKDS 187
Query: 280 -VASRYFKGPELLVDLQD----------YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHD 328
            V +  +  PE + D+                 D+WSLGC+   M + K PF        
Sbjct: 188 QVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF-------Q 240
Query: 329 QLVKIAKDCCLIIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTARE 388
           Q++        II  N         +F +   + L      D L   L+ D + R++  E
Sbjct: 241 QIINQISKLHAIIDPNHE------IEFPDIPEKDLQ-----DVLKCCLKRDPKQRISIPE 289
Query: 389 AMAHPY 394
            +AHPY
Sbjct: 290 LLAHPY 295

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 42/154 (27%), Positives = 68/154 (44%), Gaps = 13/154 (8%)
Query: 180 PNVVKLLDIVRDQHSKTPS----LIFEYVNSTDFKVLYPT------LTDYDIRYYIYELL 229
           PNVV   ++        P+    L  EY    D +           L +  IR  + ++ 
Sbjct: 72  PNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDIS 131
Query: 230 KALDYCHSQGIMHRDVKPHNVMIDHELRKL--RLIDWGLAEFYHPGKEYNVRVASRYFKG 287
            AL Y H   I+HRD+KP N+++    ++L  ++ID G A+    G+     V +  +  
Sbjct: 132 SALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLA 191
Query: 288 PELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 321
           PELL + + Y  ++D WS G +    I    PF 
Sbjct: 192 PELL-EQKKYTVTVDYWSFGTLAFECITGFRPFL 224

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 32/105 (30%), Positives = 54/105 (51%), Gaps = 6/105 (5%)
Query: 221 IRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE---FYHPGKEYN 277
           I +Y  ++L+ L Y H   I+HRD+K  NV+I+     L++ D+G ++     +P  E  
Sbjct: 124 IGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTE-- 181
Query: 278 VRVASRYFKGPELL-VDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 321
               +  +  PE++    + Y  + D+WSLGC    M   K PF+
Sbjct: 182 TFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFY 226

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 32/105 (30%), Positives = 54/105 (51%), Gaps = 6/105 (5%)
Query: 221 IRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE---FYHPGKEYN 277
           I +Y  ++L+ L Y H   I+HRD+K  NV+I+     L++ D+G ++     +P  E  
Sbjct: 110 IGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTE-- 167
Query: 278 VRVASRYFKGPELL-VDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 321
               +  +  PE++    + Y  + D+WSLGC    M   K PF+
Sbjct: 168 TFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFY 212

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 35/132 (26%), Positives = 63/132 (47%), Gaps = 11/132 (8%)
Query: 197 PSLIFEYVNSTDFKVLYPT---LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMID 253
           P ++ EYV+    + +  T   +T       I +  +AL++ H  GI+HRDVKP N+MI 
Sbjct: 91  PYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMIS 150
Query: 254 HELRKLRLIDWGLAEFYHPGKEYNVRVA-----SRYFKGPELLVDLQDYDYSLDMWSLGC 308
                ++++D+G+A           + A     ++Y    +   D    D   D++SLGC
Sbjct: 151 -ATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGD--SVDARSDVYSLGC 207
Query: 309 MFAGMIFRKEPF 320
           +   ++  + PF
Sbjct: 208 VLYEVLTGEPPF 219

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/213 (24%), Positives = 90/213 (42%), Gaps = 18/213 (8%)
Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXXXXXXXXXXXXXXXLQN-----LCG 178
           ++D+E+++ +GRG + EV   + +   ER                     +      + G
Sbjct: 73  REDFEIIKVIGRGAFGEV-AVVKMKNTERIYAMKILNKWEMLKRAETACFREERDVLVNG 131
Query: 179 GPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDY---DI-RYYIYELLKALDY 234
               +  L     Q      L+ +Y    D   L     D    D+ R+YI E++ A+D 
Sbjct: 132 DCQWITALHYAF-QDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMVLAIDS 190
Query: 235 CHSQGIMHRDVKPHNVMIDHELRKLRLIDWG--LAEFYHPGKEYNVRVASRYFKGPELLV 292
            H    +HRD+KP NV++D     +RL D+G  L        + +V V +  +  PE+L 
Sbjct: 191 IHQLHYVHRDIKPDNVLLDVN-GHIRLADFGSCLKMNDDGTVQSSVAVGTPDYISPEILQ 249
Query: 293 DLQD----YDYSLDMWSLGCMFAGMIFRKEPFF 321
            ++D    Y    D WSLG     M++ + PF+
Sbjct: 250 AMEDGMGKYGPECDWWSLGVCMYEMLYGETPFY 282

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 35/132 (26%), Positives = 63/132 (47%), Gaps = 11/132 (8%)
Query: 197 PSLIFEYVNSTDFKVLYPT---LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMID 253
           P ++ EYV+    + +  T   +T       I +  +AL++ H  GI+HRDVKP N+MI 
Sbjct: 91  PYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMIS 150
Query: 254 HELRKLRLIDWGLAEFYHPGKEYNVRVA-----SRYFKGPELLVDLQDYDYSLDMWSLGC 308
                ++++D+G+A           + A     ++Y    +   D    D   D++SLGC
Sbjct: 151 -ATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGD--SVDARSDVYSLGC 207
Query: 309 MFAGMIFRKEPF 320
           +   ++  + PF
Sbjct: 208 VLYEVLTGEPPF 219

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 35/132 (26%), Positives = 63/132 (47%), Gaps = 11/132 (8%)
Query: 197 PSLIFEYVNSTDFKVLYPT---LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMID 253
           P ++ EYV+    + +  T   +T       I +  +AL++ H  GI+HRDVKP N+MI 
Sbjct: 91  PYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMIS 150
Query: 254 HELRKLRLIDWGLAEFYHPGKEYNVRVA-----SRYFKGPELLVDLQDYDYSLDMWSLGC 308
                ++++D+G+A           + A     ++Y    +   D    D   D++SLGC
Sbjct: 151 -ATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGD--SVDARSDVYSLGC 207
Query: 309 MFAGMIFRKEPF 320
           +   ++  + PF
Sbjct: 208 VLYEVLTGEPPF 219

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 35/132 (26%), Positives = 63/132 (47%), Gaps = 11/132 (8%)
Query: 197 PSLIFEYVNSTDFKVLYPT---LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMID 253
           P ++ EYV+    + +  T   +T       I +  +AL++ H  GI+HRDVKP N+MI 
Sbjct: 91  PYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMIS 150
Query: 254 HELRKLRLIDWGLAEFYHPGKEYNVRVA-----SRYFKGPELLVDLQDYDYSLDMWSLGC 308
                ++++D+G+A           + A     ++Y    +   D    D   D++SLGC
Sbjct: 151 -ATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGD--SVDARSDVYSLGC 207
Query: 309 MFAGMIFRKEPF 320
           +   ++  + PF
Sbjct: 208 VLYEVLTGEPPF 219

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 30/100 (30%), Positives = 58/100 (58%), Gaps = 4/100 (4%)
Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVA 281
           R+Y  +++   +Y HS  +++RD+KP N+MID +   +++ D+GLA+    G+ + +   
Sbjct: 144 RFYAAQIVLTFEYLHSLDLIYRDLKPENLMIDQQ-GYIKVTDFGLAKRVK-GRTWXLCGT 201
Query: 282 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 321
             Y   PE+++  + Y+ ++D W+LG +   M     PFF
Sbjct: 202 PEYL-APEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF 239

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/213 (24%), Positives = 90/213 (42%), Gaps = 18/213 (8%)
Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXXXXXXXXXXXXXXXLQN-----LCG 178
           ++D+E+++ +GRG + EV   + +   ER                     +      + G
Sbjct: 89  REDFEIIKVIGRGAFGEV-AVVKMKNTERIYAMKILNKWEMLKRAETACFREERDVLVNG 147
Query: 179 GPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDY---DI-RYYIYELLKALDY 234
               +  L     Q      L+ +Y    D   L     D    D+ R+YI E++ A+D 
Sbjct: 148 DCQWITALHYAF-QDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMVLAIDS 206
Query: 235 CHSQGIMHRDVKPHNVMIDHELRKLRLIDWG--LAEFYHPGKEYNVRVASRYFKGPELLV 292
            H    +HRD+KP NV++D     +RL D+G  L        + +V V +  +  PE+L 
Sbjct: 207 IHQLHYVHRDIKPDNVLLDVN-GHIRLADFGSCLKMNDDGTVQSSVAVGTPDYISPEILQ 265
Query: 293 DLQD----YDYSLDMWSLGCMFAGMIFRKEPFF 321
            ++D    Y    D WSLG     M++ + PF+
Sbjct: 266 AMEDGMGKYGPECDWWSLGVCMYEMLYGETPFY 298

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 35/132 (26%), Positives = 63/132 (47%), Gaps = 11/132 (8%)
Query: 197 PSLIFEYVNSTDFKVLYPT---LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMID 253
           P ++ EYV+    + +  T   +T       I +  +AL++ H  GI+HRDVKP N+MI 
Sbjct: 108 PYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMIS 167
Query: 254 HELRKLRLIDWGLAEFYHPGKEYNVRVA-----SRYFKGPELLVDLQDYDYSLDMWSLGC 308
                ++++D+G+A           + A     ++Y    +   D    D   D++SLGC
Sbjct: 168 -ATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGD--SVDARSDVYSLGC 224
Query: 309 MFAGMIFRKEPF 320
           +   ++  + PF
Sbjct: 225 VLYEVLTGEPPF 236

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 44/207 (21%), Positives = 93/207 (44%), Gaps = 15/207 (7%)
Query: 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXXXXXXXXXXXXXXXLQNLC-GGPN 181
           D D YE+V+ +G G +       +  +NE                     + +     PN
Sbjct: 17  DSDRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKIAANVKREIINHRSLRHPN 76
Query: 182 VVKLLDIVRDQHSKTPS---LIFEYVNSTD-FKVLYPT--LTDYDIRYYIYELLKALDYC 235
           +V+  +++      TP+   ++ EY +  + F+ +      ++ + R++  +L+  + YC
Sbjct: 77  IVRFKEVIL-----TPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYC 131
Query: 236 HSQGIMHRDVKPHNVMIDHE-LRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDL 294
           H+  + HRD+K  N ++D     +L++ D+G ++      +    V +  +  PE+L+  
Sbjct: 132 HAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLK- 190
Query: 295 QDYDYSL-DMWSLGCMFAGMIFRKEPF 320
           ++YD  + D+WS G     M+    PF
Sbjct: 191 KEYDGKVADVWSCGVTLYVMLVGAYPF 217

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 30/100 (30%), Positives = 58/100 (58%), Gaps = 4/100 (4%)
Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVA 281
           R+Y  +++   +Y HS  +++RD+KP N+MID +   +++ D+GLA+    G+ + +   
Sbjct: 144 RFYAAQIVLTFEYLHSLDLIYRDLKPENLMIDQQ-GYIQVTDFGLAKRVK-GRTWXLCGT 201
Query: 282 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 321
             Y   PE+++  + Y+ ++D W+LG +   M     PFF
Sbjct: 202 PEYL-APEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF 239

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 44/207 (21%), Positives = 93/207 (44%), Gaps = 15/207 (7%)
Query: 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXXXXXXXXXXXXXXXLQNLC-GGPN 181
           D D YE+V+ +G G +       +  +NE                     + +     PN
Sbjct: 16  DSDRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKIDENVKREIINHRSLRHPN 75
Query: 182 VVKLLDIVRDQHSKTPS---LIFEYVNSTD-FKVLYPT--LTDYDIRYYIYELLKALDYC 235
           +V+  +++      TP+   ++ EY +  + F+ +      ++ + R++  +L+  + YC
Sbjct: 76  IVRFKEVIL-----TPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYC 130
Query: 236 HSQGIMHRDVKPHNVMIDHE-LRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDL 294
           H+  + HRD+K  N ++D     +L++ D+G ++      +    V +  +  PE+L+  
Sbjct: 131 HAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLK- 189
Query: 295 QDYDYSL-DMWSLGCMFAGMIFRKEPF 320
           ++YD  + D+WS G     M+    PF
Sbjct: 190 KEYDGKVADVWSCGVTLYVMLVGAYPF 216

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 61/278 (21%), Positives = 117/278 (42%), Gaps = 34/278 (12%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTN-----ERCXXXXXXXXXXXXXXXXXXXLQNLCGG 179
           DD+E+ R +G+GK+  V+      ++     +                     +Q     
Sbjct: 23  DDFEIGRPLGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEHQLRREIEIQAHLHH 82
Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNSTD-FKVLYPTLTDYDIRY--YIYELLKALDYCH 236
           PN+++L +   D+  +   LI EY    + +K L  + T  + R    + EL  AL YCH
Sbjct: 83  PNILRLYNYFYDR--RRIYLILEYAPRGELYKELQKSCTFDEQRTATIMEELADALMYCH 140
Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD 296
            + ++HRD+KP N+++     +L++ D+G +  + P         +  +  PE+ ++ + 
Sbjct: 141 GKKVIHRDIKPENLLLG-LKGELKIADFGWS-VHAPSLRRKTMCGTLDYLPPEM-IEGRM 197
Query: 297 YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSKFI 356
           ++  +D+W +G +   ++    PF     N      +  D                 KF 
Sbjct: 198 HNEKVDLWCIGVLCYELLVGNPPFESASHNETYRRIVKVDL----------------KFP 241
Query: 357 NADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPY 394
            +     V   A D + KLLR++  +RL   +  AHP+
Sbjct: 242 AS-----VPTGAQDLISKLLRHNPSERLPLAQVSAHPW 274

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 56/233 (24%), Positives = 101/233 (43%), Gaps = 40/233 (17%)
Query: 180 PNVVKLLDIVRDQHSK------TPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALD 233
           PNV++     +D+  +        + + EYV   DF  L       +    + +    L 
Sbjct: 78  PNVIRYFCTEKDRQFQYIAIELCAATLQEYVEQKDFAHL-----GLEPITLLQQTTSGLA 132
Query: 234 YCHSQGIMHRDVKPHNVMID----HELRKLRLIDWGLAEFYHPGKEYNVRVA----SRYF 285
           + HS  I+HRD+KPHN++I     H   K  + D+GL +    G+    R +    +  +
Sbjct: 133 HLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGW 192
Query: 286 KGPELLVD--LQDYDYSLDMWSLGCMFAGMIFR-KEPFFYGHDNHDQLVKIAKDCCLIIW 342
             PE+L +   ++  Y++D++S GC+F  +I     PF  G     Q   +   C L   
Sbjct: 193 IAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPF--GKSLQRQANILLGACSLDCL 250
Query: 343 CNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF 395
              +H             + +++ E I   +K++  D Q R +A+  + HP+F
Sbjct: 251 HPEKH-------------EDVIARELI---EKMIAMDPQKRPSAKHVLKHPFF 287

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 33/131 (25%), Positives = 64/131 (48%), Gaps = 9/131 (6%)
Query: 197 PSLIFEYVNSTDFKVLYPT---LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMID 253
           P ++ EYV+    + +  T   +T       I +  +AL++ H  GI+HRDVKP N++I 
Sbjct: 91  PYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANILIS 150
Query: 254 HELRKLRLIDWG----LAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCM 309
                ++++D+G    +A+  +   +    + +  +  PE        D   D++SLGC+
Sbjct: 151 -ATNAVKVVDFGIARAIADSGNSVXQTAAVIGTAQYLSPEQARG-DSVDARSDVYSLGCV 208
Query: 310 FAGMIFRKEPF 320
              ++  + PF
Sbjct: 209 LYEVLTGEPPF 219

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 32/106 (30%), Positives = 55/106 (51%), Gaps = 7/106 (6%)
Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWG--LAEFYHPGKEYNVR 279
           R+Y+ E++ A+D  H    +HRD+KP N+++D     +RL D+G  L        + +V 
Sbjct: 178 RFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMN-GHIRLADFGSCLKLMEDGTVQSSVA 236
Query: 280 VASRYFKGPELLVDLQD----YDYSLDMWSLGCMFAGMIFRKEPFF 321
           V +  +  PE+L  ++     Y    D WSLG     M++ + PF+
Sbjct: 237 VGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFY 282

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 29/100 (29%), Positives = 57/100 (57%), Gaps = 4/100 (4%)
Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVA 281
           R+Y  +++   +Y HS  +++RD+KP N+MID +   +++ D+G A+    G+ + +   
Sbjct: 145 RFYAAQIVLTFEYLHSLDLIYRDLKPENLMIDQQ-GYIKVTDFGFAKRVK-GRTWXLCGT 202
Query: 282 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 321
             Y   PE+++  + Y+ ++D W+LG +   M     PFF
Sbjct: 203 PEYL-APEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF 240

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 29/100 (29%), Positives = 57/100 (57%), Gaps = 4/100 (4%)
Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVA 281
           R+Y  +++   +Y HS  +++RD+KP N+MID +   +++ D+G A+    G+ + +   
Sbjct: 145 RFYAAQIVLTFEYLHSLDLIYRDLKPENLMIDQQ-GYIKVTDFGFAKRVK-GRTWXLCGT 202
Query: 282 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 321
             Y   PE+++  + Y+ ++D W+LG +   M     PFF
Sbjct: 203 PEYL-APEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF 240

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 29/100 (29%), Positives = 57/100 (57%), Gaps = 4/100 (4%)
Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVA 281
           R+Y  +++   +Y HS  +++RD+KP N+MID +   +++ D+G A+    G+ + +   
Sbjct: 144 RFYAAQIVLTFEYLHSLDLIYRDLKPENLMIDQQ-GYIKVTDFGFAKRVK-GRTWXLCGT 201
Query: 282 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 321
             Y   PE+++  + Y+ ++D W+LG +   M     PFF
Sbjct: 202 PEYL-APEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF 239

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 29/100 (29%), Positives = 57/100 (57%), Gaps = 4/100 (4%)
Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVA 281
           R+Y  +++   +Y HS  +++RD+KP N+MID +   +++ D+G A+    G+ + +   
Sbjct: 144 RFYAAQIVLTFEYLHSLDLIYRDLKPENLMIDQQ-GYIKVTDFGFAKRVK-GRTWXLCGT 201
Query: 282 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 321
             Y   PE+++  + Y+ ++D W+LG +   M     PFF
Sbjct: 202 PEYL-APEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF 239

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 29/100 (29%), Positives = 57/100 (57%), Gaps = 4/100 (4%)
Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVA 281
           R+Y  +++   +Y HS  +++RD+KP N+MID +   +++ D+G A+    G+ + +   
Sbjct: 145 RFYAAQIVLTFEYLHSLDLIYRDLKPENLMIDQQ-GYIKVTDFGFAKRVK-GRTWXLCGT 202
Query: 282 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 321
             Y   PE+++  + Y+ ++D W+LG +   M     PFF
Sbjct: 203 PEYL-APEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF 240

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 29/100 (29%), Positives = 57/100 (57%), Gaps = 4/100 (4%)
Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVA 281
           R+Y  +++   +Y HS  +++RD+KP N+MID +   +++ D+G A+    G+ + +   
Sbjct: 145 RFYAAQIVLTFEYLHSLDLIYRDLKPENLMIDQQ-GYIKVTDFGFAKRVK-GRTWXLCGT 202
Query: 282 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 321
             Y   PE+++  + Y+ ++D W+LG +   M     PFF
Sbjct: 203 PEYL-APEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF 240

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 42/171 (24%), Positives = 74/171 (43%), Gaps = 20/171 (11%)
Query: 229 LKALDYCHSQ-GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG 287
           +KAL++      I+HRD+KP N+++D     ++L D+G++               R +  
Sbjct: 135 VKALNHLKENLKIIHRDIKPSNILLDRS-GNIKLCDFGISGQLVDSIAKTRDAGCRPYMA 193
Query: 288 PELL---VDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCN 344
           PE +      Q YD   D+WSLG     +   + P+   +   DQL ++ K         
Sbjct: 194 PERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVK--------- 244
Query: 345 SRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF 395
                 P  +  N++ +   SP  I+F++  L  D   R   +E + HP+ 
Sbjct: 245 ---GDPP--QLSNSEEREF-SPSFINFVNLCLTKDESKRPKYKELLKHPFI 289

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 37/133 (27%), Positives = 70/133 (52%), Gaps = 8/133 (6%)
Query: 181 NVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYP--TLTDYDIRYYIYELLKALDYCHSQ 238
           +++K      DQ  K+  L+ EYV     +   P  ++    +  +  ++ + + Y HSQ
Sbjct: 77  HIIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQICEGMAYLHSQ 136
Query: 239 GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE-YNVRV---ASRYFKGPELLVDL 294
             +HR++   NV++D++ R +++ D+GLA+    G E Y VR    +  ++  PE L + 
Sbjct: 137 HYIHRNLAARNVLLDND-RLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEY 195
Query: 295 QDYDYSLDMWSLG 307
           + Y Y+ D+WS G
Sbjct: 196 KFY-YASDVWSFG 207

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 30/102 (29%), Positives = 56/102 (54%), Gaps = 10/102 (9%)
Query: 227 ELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGL-AEFYHPGKEYNVRVASRYF 285
           ++ K +DY HS+ ++HRD+KP N+ +  + +++++ D+GL     + GK    +   RY 
Sbjct: 144 QITKGVDYIHSKKLIHRDLKPSNIFL-VDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYM 202
Query: 286 KGPELLVDLQDYDYSLDMWSLGCMFAGMI------FRKEPFF 321
             PE  +  QDY   +D+++LG + A ++      F    FF
Sbjct: 203 -SPE-QISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFF 242

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 29/100 (29%), Positives = 57/100 (57%), Gaps = 4/100 (4%)
Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVA 281
           R+Y  +++   +Y HS  +++RD+KP N+MID +   +++ D+G A+    G+ + +   
Sbjct: 144 RFYAAQIVLTFEYLHSLDLIYRDLKPENLMIDQQ-GYIQVTDFGFAKRVK-GRTWXLCGT 201
Query: 282 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 321
             Y   PE+++  + Y+ ++D W+LG +   M     PFF
Sbjct: 202 PEYL-APEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF 239

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 28/100 (28%), Positives = 57/100 (57%), Gaps = 4/100 (4%)
Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVA 281
           R+Y  +++   +Y HS  +++RD+KP N++ID +   +++ D+G A+    G+ + +   
Sbjct: 144 RFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQ-GYIQVTDFGFAKRVK-GRTWXLXGT 201
Query: 282 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 321
             Y   PE+++  + Y+ ++D W+LG +   M     PFF
Sbjct: 202 PEYL-APEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF 239

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 28/100 (28%), Positives = 57/100 (57%), Gaps = 4/100 (4%)
Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVA 281
           R+Y  +++   +Y HS  +++RD+KP N++ID +   +++ D+G A+    G+ + +   
Sbjct: 144 RFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQ-GYIQVTDFGFAKRVK-GRTWXLAGT 201
Query: 282 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 321
             Y   PE+++  + Y+ ++D W+LG +   M     PFF
Sbjct: 202 PEYL-APEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF 239

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 51/207 (24%), Positives = 80/207 (38%), Gaps = 24/207 (11%)
Query: 132 KVGRGKYSEVFEGINVNTNERCXXXXXXXXXXXXXXXXXXXLQNLCGG---PNVVKLLDI 188
           ++GRG + EV    +  T  +C                       C G   P +V L   
Sbjct: 100 RLGRGSFGEVHRMEDKQTGFQCAVKKVRLEVFRAEELMA------CAGLTSPRIVPLYGA 153
Query: 189 VRDQHSKTPSLIFEYVNSTDFKVLYP---TLTDYDIRYYIYELLKALDYCHSQGIMHRDV 245
           VR+      ++  E +       L      L +    YY+ + L+ L+Y HS+ I+H DV
Sbjct: 154 VRE--GPWVNIFMELLEGGSLGQLVKEQGCLPEDRALYYLGQALEGLEYLHSRRILHGDV 211
Query: 246 KPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG------PELLVDLQDYDY 299
           K  NV++  +     L D+G A    P       +   Y  G      PE+++  +  D 
Sbjct: 212 KADNVLLSSDGSHAALCDFGHAVCLQPDGLGKSLLTGDYIPGTETHMAPEVVLG-RSCDA 270
Query: 300 SLDMWSLGCMFAGMIFRKEP---FFYG 323
            +D+WS  CM   M+    P   FF G
Sbjct: 271 KVDVWSSCCMMLHMLNGCHPWTQFFRG 297

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 50/217 (23%), Positives = 94/217 (43%), Gaps = 28/217 (12%)
Query: 124 QDDYEVVRKVGRGKYSEVFEGI-------NVNTNERCXXXXXXXXXXXXXXXXXXXLQNL 176
           ++D  + R +G G + EV+EG+        +N   +                    ++NL
Sbjct: 23  REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNL 82
Query: 177 CGGPNVVKLLDIVRDQHSKTPSLIFEYV--------NSTDFKVLYPTLTDYDIRYYIYEL 228
              P++VKL+ I+ ++ +     ++ Y         N    KVL  TL  Y +     ++
Sbjct: 83  -DHPHIVKLIGIIEEEPTWIIMELYPYGELGHYLERNKNSLKVL--TLVLYSL-----QI 134
Query: 229 LKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFK-- 286
            KA+ Y  S   +HRD+   N+++      ++L D+GL+ +      Y   V     K  
Sbjct: 135 CKAMAYLESINCVHRDIAVRNILVASP-ECVKLGDFGLSRYIEDEDYYKASVTRLPIKWM 193
Query: 287 GPELLVDLQDYDYSLDMWSLG-CMFAGMIFRKEPFFY 322
            PE  ++ + +  + D+W    CM+  + F K+PFF+
Sbjct: 194 SPE-SINFRRFTTASDVWMFAVCMWEILSFGKQPFFW 229

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 49/217 (22%), Positives = 92/217 (42%), Gaps = 28/217 (12%)
Query: 124 QDDYEVVRKVGRGKYSEVFEGI-------NVNTNERCXXXXXXXXXXXXXXXXXXXLQNL 176
           ++D  + R +G G + EV+EG+        +N   +                    ++NL
Sbjct: 7   REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNL 66
Query: 177 CGGPNVVKLLDIVRDQHSKTPSLIFEYV--------NSTDFKVLYPTLTDYDIRYYIYEL 228
              P++VKL+ I+ ++ +     ++ Y         N    KVL   L       Y  ++
Sbjct: 67  -DHPHIVKLIGIIEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVL-------YSLQI 118
Query: 229 LKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFK-- 286
            KA+ Y  S   +HRD+   N+++      ++L D+GL+ +      Y   V     K  
Sbjct: 119 CKAMAYLESINCVHRDIAVRNILVASP-ECVKLGDFGLSRYIEDEDYYKASVTRLPIKWM 177
Query: 287 GPELLVDLQDYDYSLDMWSLG-CMFAGMIFRKEPFFY 322
            PE  ++ + +  + D+W    CM+  + F K+PFF+
Sbjct: 178 SPE-SINFRRFTTASDVWMFAVCMWEILSFGKQPFFW 213

>pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 52/216 (24%), Positives = 96/216 (44%), Gaps = 42/216 (19%)
Query: 227 ELLKALDYCHSQ-GIMHRDVKPHNVMID-----HELRKLRLIDWGLAEFYHPGKEYNVRV 280
           +LL  LDY H + GI+H D+KP NV+++       L ++++ D G A +Y   + Y   +
Sbjct: 139 QLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYD--EHYTNSI 196
Query: 281 ASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMI---FRKEP----FFYGHDNH-DQLVK 332
            +R ++ PE+L+    +    D+WS  C+   +I   F  EP     +   D+H  Q+++
Sbjct: 197 QTREYRSPEVLLG-APWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIE 255
Query: 333 IAKDCCLIIWCNSRHSR---------------KPW-------SKFINADNQHLVSPEAID 370
           +  +    +  N +++R               K W        K+  + ++   + E  D
Sbjct: 256 LLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDE---AKEISD 312
Query: 371 FLDKLLRYDHQDRLTAREAMAHPYFAQVRAAESSRT 406
           FL  +L+ D + R  A   + HP+       E  R 
Sbjct: 313 FLSPMLQLDPRKRADAGGLVNHPWLKDTLGMEEIRV 348

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 48/200 (24%), Positives = 77/200 (38%), Gaps = 19/200 (9%)
Query: 132 KVGRGKYSEVFEGINVNTNERCXXXXXXXXXXXXXXXXXXXLQNLCGG---PNVVKLLDI 188
           +VGRG + EV    +  T  +C                       C G   P +V L   
Sbjct: 65  RVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVEELVA------CAGLSSPRIVPLYGA 118
Query: 189 VRDQHSKTPSLIFEYVNSTDFKVL---YPTLTDYDIRYYIYELLKALDYCHSQGIMHRDV 245
           VR+      ++  E +       L      L +    YY+ + L+ L+Y H++ I+H DV
Sbjct: 119 VRE--GPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDV 176
Query: 246 KPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPEL-----LVDLQDYDYS 300
           K  NV++  +  +  L D+G A    P       +   Y  G E      +V  +  D  
Sbjct: 177 KADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAK 236
Query: 301 LDMWSLGCMFAGMIFRKEPF 320
           +D+WS  CM   M+    P+
Sbjct: 237 VDIWSSCCMMLHMLNGCHPW 256

>pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 52/216 (24%), Positives = 96/216 (44%), Gaps = 42/216 (19%)
Query: 227 ELLKALDYCHSQ-GIMHRDVKPHNVMID-----HELRKLRLIDWGLAEFYHPGKEYNVRV 280
           +LL  LDY H + GI+H D+KP NV+++       L ++++ D G A +Y   + Y   +
Sbjct: 139 QLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYD--EHYTNSI 196
Query: 281 ASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMI---FRKEP----FFYGHDNH-DQLVK 332
            +R ++ PE+L+    +    D+WS  C+   +I   F  EP     +   D+H  Q+++
Sbjct: 197 QTREYRSPEVLLG-APWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIE 255
Query: 333 IAKDCCLIIWCNSRHSR---------------KPW-------SKFINADNQHLVSPEAID 370
           +  +    +  N +++R               K W        K+  + ++   + E  D
Sbjct: 256 LLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDE---AKEISD 312
Query: 371 FLDKLLRYDHQDRLTAREAMAHPYFAQVRAAESSRT 406
           FL  +L+ D + R  A   + HP+       E  R 
Sbjct: 313 FLSPMLQLDPRKRADAGGLVNHPWLKDTLGMEEIRV 348

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 48/200 (24%), Positives = 77/200 (38%), Gaps = 19/200 (9%)
Query: 132 KVGRGKYSEVFEGINVNTNERCXXXXXXXXXXXXXXXXXXXLQNLCGG---PNVVKLLDI 188
           +VGRG + EV    +  T  +C                       C G   P +V L   
Sbjct: 81  RVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVEELVA------CAGLSSPRIVPLYGA 134
Query: 189 VRDQHSKTPSLIFEYVNSTDFKVL---YPTLTDYDIRYYIYELLKALDYCHSQGIMHRDV 245
           VR+      ++  E +       L      L +    YY+ + L+ L+Y H++ I+H DV
Sbjct: 135 VRE--GPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDV 192
Query: 246 KPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPEL-----LVDLQDYDYS 300
           K  NV++  +  +  L D+G A    P       +   Y  G E      +V  +  D  
Sbjct: 193 KADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAK 252
Query: 301 LDMWSLGCMFAGMIFRKEPF 320
           +D+WS  CM   M+    P+
Sbjct: 253 VDIWSSCCMMLHMLNGCHPW 272

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 49/217 (22%), Positives = 92/217 (42%), Gaps = 28/217 (12%)
Query: 124 QDDYEVVRKVGRGKYSEVFEGI-------NVNTNERCXXXXXXXXXXXXXXXXXXXLQNL 176
           ++D  + R +G G + EV+EG+        +N   +                    ++NL
Sbjct: 11  REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNL 70
Query: 177 CGGPNVVKLLDIVRDQHSKTPSLIFEYV--------NSTDFKVLYPTLTDYDIRYYIYEL 228
              P++VKL+ I+ ++ +     ++ Y         N    KVL   L       Y  ++
Sbjct: 71  -DHPHIVKLIGIIEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVL-------YSLQI 122
Query: 229 LKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFK-- 286
            KA+ Y  S   +HRD+   N+++      ++L D+GL+ +      Y   V     K  
Sbjct: 123 CKAMAYLESINCVHRDIAVRNILVASP-ECVKLGDFGLSRYIEDEDYYKASVTRLPIKWM 181
Query: 287 GPELLVDLQDYDYSLDMWSLG-CMFAGMIFRKEPFFY 322
            PE  ++ + +  + D+W    CM+  + F K+PFF+
Sbjct: 182 SPE-SINFRRFTTASDVWMFAVCMWEILSFGKQPFFW 217

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 51/207 (24%), Positives = 80/207 (38%), Gaps = 24/207 (11%)
Query: 132 KVGRGKYSEVFEGINVNTNERCXXXXXXXXXXXXXXXXXXXLQNLCGG---PNVVKLLDI 188
           ++GRG + EV    +  T  +C                       C G   P +V L   
Sbjct: 81  RLGRGSFGEVHRMEDKQTGFQCAVKKVRLEVFRAEELMA------CAGLTSPRIVPLYGA 134
Query: 189 VRDQHSKTPSLIFEYVNSTDFKVLYP---TLTDYDIRYYIYELLKALDYCHSQGIMHRDV 245
           VR+      ++  E +       L      L +    YY+ + L+ L+Y HS+ I+H DV
Sbjct: 135 VRE--GPWVNIFMELLEGGSLGQLVKEQGCLPEDRALYYLGQALEGLEYLHSRRILHGDV 192
Query: 246 KPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG------PELLVDLQDYDY 299
           K  NV++  +     L D+G A    P       +   Y  G      PE+++  +  D 
Sbjct: 193 KADNVLLSSDGSHAALCDFGHAVCLQPDGLGKDLLTGDYIPGTETHMAPEVVLG-RSCDA 251
Query: 300 SLDMWSLGCMFAGMIFRKEP---FFYG 323
            +D+WS  CM   M+    P   FF G
Sbjct: 252 KVDVWSSCCMMLHMLNGCHPWTQFFRG 278

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 28/100 (28%), Positives = 57/100 (57%), Gaps = 4/100 (4%)
Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVA 281
           R+Y  +++   +Y HS  +++RD+KP N++ID +   +++ D+G A+    G+ + +   
Sbjct: 144 RFYAAQIVLTFEYLHSLDLIYRDLKPENLIIDQQ-GYIQVTDFGFAKRVK-GRTWXLCGT 201
Query: 282 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 321
             Y   PE+++  + Y+ ++D W+LG +   M     PFF
Sbjct: 202 PEYL-APEIIIS-KGYNKAVDWWALGVLIYEMAAGYPPFF 239

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 36/133 (27%), Positives = 70/133 (52%), Gaps = 8/133 (6%)
Query: 181 NVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYP--TLTDYDIRYYIYELLKALDYCHSQ 238
           +++K      DQ  K+  L+ EYV     +   P  ++    +  +  ++ + + Y H+Q
Sbjct: 77  HIIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQICEGMAYLHAQ 136
Query: 239 GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE-YNVRV---ASRYFKGPELLVDL 294
             +HR++   NV++D++ R +++ D+GLA+    G E Y VR    +  ++  PE L + 
Sbjct: 137 HYIHRNLAARNVLLDND-RLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEY 195
Query: 295 QDYDYSLDMWSLG 307
           + Y Y+ D+WS G
Sbjct: 196 KFY-YASDVWSFG 207

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 28/100 (28%), Positives = 57/100 (57%), Gaps = 4/100 (4%)
Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVA 281
           R+Y  +++   +Y HS  +++RD+KP N++ID +   +++ D+G A+    G+ + +   
Sbjct: 145 RFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQ-GYIQVTDFGFAKRVK-GRTWTLCGT 202
Query: 282 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 321
             Y   PE+++  + Y+ ++D W+LG +   M     PFF
Sbjct: 203 PEYL-APEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF 240

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 40/166 (24%), Positives = 77/166 (46%), Gaps = 28/166 (16%)
Query: 181 NVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRY----------YIYELLK 230
           N+V ++D+  D+      L+ EY+         PTL++Y   +          +  ++L 
Sbjct: 72  NIVSMIDV--DEEDDCYYLVMEYIEG-------PTLSEYIESHGPLSVDTAINFTNQILD 122
Query: 231 ALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK--EYNVRVASRYFKGP 288
            + + H   I+HRD+KP N++ID   + L++ D+G+A+        + N  + +  +  P
Sbjct: 123 GIKHAHDMRIVHRDIKPQNILIDSN-KTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSP 181
Query: 289 ELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA 334
           E     +  D   D++S+G +   M+  + PF     N +  V IA
Sbjct: 182 E-QAKGEATDECTDIYSIGIVLYEMLVGEPPF-----NGETAVSIA 221

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 28/100 (28%), Positives = 57/100 (57%), Gaps = 4/100 (4%)
Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVA 281
           R+Y  +++   +Y HS  +++RD+KP N++ID +   +++ D+G A+    G+ + +   
Sbjct: 130 RFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQ-GYIQVTDFGFAKRVK-GRTWTLCGT 187
Query: 282 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 321
             Y   PE+++  + Y+ ++D W+LG +   M     PFF
Sbjct: 188 PEYL-APEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF 225

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 28/100 (28%), Positives = 57/100 (57%), Gaps = 4/100 (4%)
Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVA 281
           R+Y  +++   +Y HS  +++RD+KP N++ID +   +++ D+G A+    G+ + +   
Sbjct: 144 RFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQ-GYIQVTDFGFAKRVK-GRTWXLCGT 201
Query: 282 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 321
             Y   PE+++  + Y+ ++D W+LG +   M     PFF
Sbjct: 202 PEYL-APEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF 239

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 28/100 (28%), Positives = 57/100 (57%), Gaps = 4/100 (4%)
Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVA 281
           R+Y  +++   +Y HS  +++RD+KP N++ID +   +++ D+G A+    G+ + +   
Sbjct: 144 RFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQ-GYIKVADFGFAKRVK-GRTWXLCGT 201
Query: 282 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 321
             Y   PE+++  + Y+ ++D W+LG +   M     PFF
Sbjct: 202 PEYL-APEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF 239

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 28/100 (28%), Positives = 57/100 (57%), Gaps = 4/100 (4%)
Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVA 281
           R+Y  +++   +Y HS  +++RD+KP N++ID +   +++ D+G A+    G+ + +   
Sbjct: 144 RFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQ-GYIQVTDFGFAKRVK-GRTWXLCGT 201
Query: 282 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 321
             Y   PE+++  + Y+ ++D W+LG +   M     PFF
Sbjct: 202 PEYL-APEIILS-KGYNKAVDWWALGVLIYQMAAGYPPFF 239

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 28/100 (28%), Positives = 57/100 (57%), Gaps = 4/100 (4%)
Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVA 281
           R+Y  +++   +Y HS  +++RD+KP N++ID +   +++ D+G A+    G+ + +   
Sbjct: 145 RFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQ-GYIKVADFGFAKRVK-GRTWXLCGT 202
Query: 282 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 321
             Y   PE+++  + Y+ ++D W+LG +   M     PFF
Sbjct: 203 PEYL-APEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF 240

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 28/100 (28%), Positives = 57/100 (57%), Gaps = 4/100 (4%)
Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVA 281
           R+Y  +++   +Y HS  +++RD+KP N++ID +   +++ D+G A+    G+ + +   
Sbjct: 165 RFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQ-GYIQVTDFGFAKRVK-GRTWXLCGT 222
Query: 282 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 321
             Y   PE+++  + Y+ ++D W+LG +   M     PFF
Sbjct: 223 PEYL-APEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF 260

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 28/100 (28%), Positives = 57/100 (57%), Gaps = 4/100 (4%)
Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVA 281
           R+Y  +++   +Y HS  +++RD+KP N++ID +   +++ D+G A+    G+ + +   
Sbjct: 144 RFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQ-GYIQVTDFGFAKRVK-GRTWXLCGT 201
Query: 282 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 321
             Y   PE+++  + Y+ ++D W+LG +   M     PFF
Sbjct: 202 PEYL-APEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF 239

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 50/211 (23%), Positives = 95/211 (45%), Gaps = 29/211 (13%)
Query: 199 LIFEYVNSTDFKVLYPT---LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE 255
           LI +Y+N  +           T+++++ Y+ E++ AL++ H  GI++RD+K  N+++D  
Sbjct: 136 LILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSN 195
Query: 256 LRKLRLIDWGLA-EFYHPGKE--YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAG 312
              + L D+GL+ EF     E  Y+      Y     +      +D ++D WSLG +   
Sbjct: 196 -GHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYE 254
Query: 313 MIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSKFINADNQHLVSPEAIDFL 372
           ++    PF    + + Q  +I++            S  P+ + ++A         A D +
Sbjct: 255 LLTGASPFTVDGEKNSQ-AEISRRIL--------KSEPPYPQEMSA--------LAKDLI 297
Query: 373 DKLLRYDHQDRLT-----AREAMAHPYFAQV 398
            +LL  D + RL      A E   H +F ++
Sbjct: 298 QRLLMKDPKKRLGCGPRDADEIKEHLFFQKI 328

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 28/100 (28%), Positives = 57/100 (57%), Gaps = 4/100 (4%)
Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVA 281
           R+Y  +++   +Y HS  +++RD+KP N++ID +   +++ D+G A+    G+ + +   
Sbjct: 144 RFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQ-GYIKVADFGFAKRVK-GRTWXLCGT 201
Query: 282 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 321
             Y   PE+++  + Y+ ++D W+LG +   M     PFF
Sbjct: 202 PEYL-APEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF 239

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 29/100 (29%), Positives = 57/100 (57%), Gaps = 4/100 (4%)
Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVA 281
           R+Y  +++   +Y HS  +++RD+KP N++ID E   +++ D+G A+    G+ + +   
Sbjct: 131 RFYAAQIVLTFEYLHSLDLIYRDLKPENLLID-EQGYIQVTDFGFAKRVK-GRTWXLCGT 188
Query: 282 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 321
             Y   PE+++  + Y+ ++D W+LG +   M     PFF
Sbjct: 189 PEYL-APEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF 226

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 28/100 (28%), Positives = 57/100 (57%), Gaps = 4/100 (4%)
Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVA 281
           R+Y  +++   +Y HS  +++RD+KP N++ID +   +++ D+G A+    G+ + +   
Sbjct: 144 RFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQ-GYIQVTDFGFAKRVK-GRTWXLCGT 201
Query: 282 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 321
             Y   PE+++  + Y+ ++D W+LG +   M     PFF
Sbjct: 202 PEYL-APEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF 239

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 28/100 (28%), Positives = 57/100 (57%), Gaps = 4/100 (4%)
Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVA 281
           R+Y  +++   +Y HS  +++RD+KP N++ID +   +++ D+G A+    G+ + +   
Sbjct: 145 RFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQ-GYIQVTDFGFAKRVK-GRTWXLCGT 202
Query: 282 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 321
             Y   PE+++  + Y+ ++D W+LG +   M     PFF
Sbjct: 203 PEYL-APEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF 240

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 28/100 (28%), Positives = 57/100 (57%), Gaps = 4/100 (4%)
Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVA 281
           R+Y  +++   +Y HS  +++RD+KP N++ID +   +++ D+G A+    G+ + +   
Sbjct: 144 RFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQ-GYIKVADFGFAKRVK-GRTWXLCGT 201
Query: 282 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 321
             Y   PE+++  + Y+ ++D W+LG +   M     PFF
Sbjct: 202 PEYL-APEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF 239

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 28/100 (28%), Positives = 57/100 (57%), Gaps = 4/100 (4%)
Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVA 281
           R+Y  +++   +Y HS  +++RD+KP N++ID +   +++ D+G A+    G+ + +   
Sbjct: 144 RFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQ-GYIQVTDFGFAKRVK-GRTWXLCGT 201
Query: 282 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 321
             Y   PE+++  + Y+ ++D W+LG +   M     PFF
Sbjct: 202 PEYL-APEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF 239

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 28/100 (28%), Positives = 57/100 (57%), Gaps = 4/100 (4%)
Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVA 281
           R+Y  +++   +Y HS  +++RD+KP N++ID +   +++ D+G A+    G+ + +   
Sbjct: 144 RFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQ-GYIQVTDFGFAKRVK-GRTWXLCGT 201
Query: 282 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 321
             Y   PE+++  + Y+ ++D W+LG +   M     PFF
Sbjct: 202 PEYL-APEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF 239

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 28/100 (28%), Positives = 57/100 (57%), Gaps = 4/100 (4%)
Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVA 281
           R+Y  +++   +Y HS  +++RD+KP N++ID +   +++ D+G A+    G+ + +   
Sbjct: 145 RFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQ-GYIQVTDFGFAKRVK-GRTWXLCGT 202
Query: 282 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 321
             Y   PE+++  + Y+ ++D W+LG +   M     PFF
Sbjct: 203 PEYL-APEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF 240

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 28/100 (28%), Positives = 57/100 (57%), Gaps = 4/100 (4%)
Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVA 281
           R+Y  +++   +Y HS  +++RD+KP N++ID +   +++ D+G A+    G+ + +   
Sbjct: 144 RFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQ-GYIQVTDFGFAKRVK-GRTWXLCGT 201
Query: 282 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 321
             Y   PE+++  + Y+ ++D W+LG +   M     PFF
Sbjct: 202 PEYL-APEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF 239

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 28/100 (28%), Positives = 57/100 (57%), Gaps = 4/100 (4%)
Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVA 281
           R+Y  +++   +Y HS  +++RD+KP N++ID +   +++ D+G A+    G+ + +   
Sbjct: 145 RFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQ-GYIQVTDFGFAKRVK-GRTWXLCGT 202
Query: 282 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 321
             Y   PE+++  + Y+ ++D W+LG +   M     PFF
Sbjct: 203 PEYL-APEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF 240

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 28/100 (28%), Positives = 57/100 (57%), Gaps = 4/100 (4%)
Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVA 281
           R+Y  +++   +Y HS  +++RD+KP N++ID +   +++ D+G A+    G+ + +   
Sbjct: 144 RFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQ-GYIQVTDFGFAKRVK-GRTWXLCGT 201
Query: 282 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 321
             Y   PE+++  + Y+ ++D W+LG +   M     PFF
Sbjct: 202 PEYL-APEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF 239

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 28/100 (28%), Positives = 57/100 (57%), Gaps = 4/100 (4%)
Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVA 281
           R+Y  +++   +Y HS  +++RD+KP N++ID +   +++ D+G A+    G+ + +   
Sbjct: 145 RFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQ-GYIQVTDFGFAKRVK-GRTWXLCGT 202
Query: 282 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 321
             Y   PE+++  + Y+ ++D W+LG +   M     PFF
Sbjct: 203 PEYL-APEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF 240

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 28/100 (28%), Positives = 57/100 (57%), Gaps = 4/100 (4%)
Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVA 281
           R+Y  +++   +Y HS  +++RD+KP N++ID +   +++ D+G A+    G+ + +   
Sbjct: 144 RFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQ-GYIQVTDFGFAKRVK-GRTWXLCGT 201
Query: 282 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 321
             Y   PE+++  + Y+ ++D W+LG +   M     PFF
Sbjct: 202 PEYL-APEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF 239

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 28/100 (28%), Positives = 57/100 (57%), Gaps = 4/100 (4%)
Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVA 281
           R+Y  +++   +Y HS  +++RD+KP N++ID +   +++ D+G A+    G+ + +   
Sbjct: 145 RFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQ-GYIQVTDFGFAKRVK-GRTWXLCGT 202
Query: 282 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 321
             Y   PE+++  + Y+ ++D W+LG +   M     PFF
Sbjct: 203 PEYL-APEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF 240

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 28/100 (28%), Positives = 57/100 (57%), Gaps = 4/100 (4%)
Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVA 281
           R+Y  +++   +Y HS  +++RD+KP N++ID +   +++ D+G A+    G+ + +   
Sbjct: 144 RFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQ-GYIQVTDFGFAKRVK-GRTWXLCGT 201
Query: 282 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 321
             Y   PE+++  + Y+ ++D W+LG +   M     PFF
Sbjct: 202 PEYL-APEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF 239

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 28/100 (28%), Positives = 57/100 (57%), Gaps = 4/100 (4%)
Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVA 281
           R+Y  +++   +Y HS  +++RD+KP N++ID +   +++ D+G A+    G+ + +   
Sbjct: 144 RFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQ-GYIQVTDFGFAKRVK-GRTWXLCGT 201
Query: 282 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 321
             Y   PE+++  + Y+ ++D W+LG +   M     PFF
Sbjct: 202 PEYL-APEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF 239

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 28/100 (28%), Positives = 57/100 (57%), Gaps = 4/100 (4%)
Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVA 281
           R+Y  +++   +Y HS  +++RD+KP N++ID +   +++ D+G A+    G+ + +   
Sbjct: 144 RFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQ-GYIQVTDFGFAKRVK-GRTWXLCGT 201
Query: 282 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 321
             Y   PE+++  + Y+ ++D W+LG +   M     PFF
Sbjct: 202 PEYL-APEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF 239

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 28/100 (28%), Positives = 57/100 (57%), Gaps = 4/100 (4%)
Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVA 281
           R+Y  +++   +Y HS  +++RD+KP N++ID +   +++ D+G A+    G+ + +   
Sbjct: 137 RFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQ-GYIQVTDFGFAKRVK-GRTWXLCGT 194
Query: 282 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 321
             Y   PE+++  + Y+ ++D W+LG +   M     PFF
Sbjct: 195 PEYL-APEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF 232

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 28/100 (28%), Positives = 57/100 (57%), Gaps = 4/100 (4%)
Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVA 281
           R+Y  +++   +Y HS  +++RD+KP N++ID +   +++ D+G A+    G+ + +   
Sbjct: 144 RFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQ-GYIQVTDFGFAKRVK-GRTWXLCGT 201
Query: 282 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 321
             Y   PE+++  + Y+ ++D W+LG +   M     PFF
Sbjct: 202 PEYL-APEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF 239

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 28/100 (28%), Positives = 57/100 (57%), Gaps = 4/100 (4%)
Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVA 281
           R+Y  +++   +Y HS  +++RD+KP N++ID +   +++ D+G A+    G+ + +   
Sbjct: 144 RFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQ-GYIQVTDFGFAKRVK-GRTWXLCGT 201
Query: 282 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 321
             Y   PE+++  + Y+ ++D W+LG +   M     PFF
Sbjct: 202 PEYL-APEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF 239

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 28/100 (28%), Positives = 57/100 (57%), Gaps = 4/100 (4%)
Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVA 281
           R+Y  +++   +Y HS  +++RD+KP N++ID +   +++ D+G A+    G+ + +   
Sbjct: 165 RFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQ-GYIQVTDFGFAKRVK-GRTWXLCGT 222
Query: 282 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 321
             Y   PE+++  + Y+ ++D W+LG +   M     PFF
Sbjct: 223 PEYL-APEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF 260

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 28/100 (28%), Positives = 57/100 (57%), Gaps = 4/100 (4%)
Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVA 281
           R+Y  +++   +Y HS  +++RD+KP N++ID +   +++ D+G A+    G+ + +   
Sbjct: 145 RFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQ-GYIQVTDFGFAKRVK-GRTWXLCGT 202
Query: 282 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 321
             Y   PE+++  + Y+ ++D W+LG +   M     PFF
Sbjct: 203 PEYL-APEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF 240

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 28/100 (28%), Positives = 57/100 (57%), Gaps = 4/100 (4%)
Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVA 281
           R+Y  +++   +Y HS  +++RD+KP N++ID +   +++ D+G A+    G+ + +   
Sbjct: 144 RFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQ-GYIQVTDFGFAKRVK-GRTWXLCGT 201
Query: 282 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 321
             Y   PE+++  + Y+ ++D W+LG +   M     PFF
Sbjct: 202 PEYL-APEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF 239

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 28/100 (28%), Positives = 57/100 (57%), Gaps = 4/100 (4%)
Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVA 281
           R+Y  +++   +Y HS  +++RD+KP N++ID +   +++ D+G A+    G+ + +   
Sbjct: 144 RFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQ-GYIQVTDFGFAKRVK-GRTWXLCGT 201
Query: 282 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 321
             Y   PE+++  + Y+ ++D W+LG +   M     PFF
Sbjct: 202 PEYL-APEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF 239

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 28/100 (28%), Positives = 57/100 (57%), Gaps = 4/100 (4%)
Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVA 281
           R+Y  +++   +Y HS  +++RD+KP N++ID +   +++ D+G A+    G+ + +   
Sbjct: 144 RFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQ-GYIQVTDFGFAKRVK-GRTWXLCGT 201
Query: 282 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 321
             Y   PE+++  + Y+ ++D W+LG +   M     PFF
Sbjct: 202 PEYL-APEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF 239

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 28/100 (28%), Positives = 57/100 (57%), Gaps = 4/100 (4%)
Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVA 281
           R+Y  +++   +Y HS  +++RD+KP N++ID +   +++ D+G A+    G+ + +   
Sbjct: 144 RFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQ-GYIQVTDFGFAKRVK-GRTWXLCGT 201
Query: 282 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 321
             Y   PE+++  + Y+ ++D W+LG +   M     PFF
Sbjct: 202 PEYL-APEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF 239

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 28/100 (28%), Positives = 57/100 (57%), Gaps = 4/100 (4%)
Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVA 281
           R+Y  +++   +Y HS  +++RD+KP N++ID +   +++ D+G A+    G+ + +   
Sbjct: 144 RFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQ-GYIQVTDFGFAKRVK-GRTWXLCGT 201
Query: 282 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 321
             Y   PE+++  + Y+ ++D W+LG +   M     PFF
Sbjct: 202 PEYL-APEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF 239

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 28/100 (28%), Positives = 57/100 (57%), Gaps = 4/100 (4%)
Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVA 281
           R+Y  +++   +Y HS  +++RD+KP N++ID +   +++ D+G A+    G+ + +   
Sbjct: 137 RFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQ-GYIQVTDFGFAKRVK-GRTWXLCGT 194
Query: 282 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 321
             Y   PE+++  + Y+ ++D W+LG +   M     PFF
Sbjct: 195 PEYL-APEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF 232

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 28/100 (28%), Positives = 57/100 (57%), Gaps = 4/100 (4%)
Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVA 281
           R+Y  +++   +Y HS  +++RD+KP N++ID +   +++ D+G A+    G+ + +   
Sbjct: 139 RFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQ-GYIQVTDFGFAKRVK-GRTWXLCGT 196
Query: 282 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 321
             Y   PE+++  + Y+ ++D W+LG +   M     PFF
Sbjct: 197 PEYL-APEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF 234

>pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 41/175 (23%), Positives = 79/175 (45%), Gaps = 25/175 (14%)
Query: 180 PNVVKLLDIVR--DQHSKTPS-LIFEYVNSTDFK-VLYPTLTDYDIRYYIYELLKALDYC 235
           P++V++ + V   D+H      ++ EYV     K      L   +   Y+ E+L AL Y 
Sbjct: 139 PSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQKLPVAEAIAYLLEILPALSYL 198
Query: 236 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQ 295
           HS G+++ D+KP N+M+  E  +L+LID G     +    +     +  F+ PE++    
Sbjct: 199 HSIGLVYNDLKPENIMLTEE--QLKLIDLGAVSRIN---SFGYLYGTPGFQAPEIV--RT 251
Query: 296 DYDYSLDMWSLGCMFAGMIF--------------RKEPFFYGHDNHDQLVKIAKD 336
               + D++++G   A +                  +P    +D++ +L++ A D
Sbjct: 252 GPTVATDIYTVGRTLAALTLDLPTRNGRYVDGLPEDDPVLKTYDSYGRLLRRAID 306

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 37/133 (27%), Positives = 68/133 (51%), Gaps = 8/133 (6%)
Query: 181 NVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYP--TLTDYDIRYYIYELLKALDYCHSQ 238
           ++VK      DQ  K+  L+ EYV     +   P   +    +  +  ++ + + Y H+Q
Sbjct: 72  HIVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYLPRHCVGLAQLLLFAQQICEGMAYLHAQ 131
Query: 239 GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE-YNVRV---ASRYFKGPELLVDL 294
             +HR +   NV++D++ R +++ D+GLA+    G E Y VR    +  ++  PE L + 
Sbjct: 132 HYIHRALAARNVLLDND-RLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEC 190
Query: 295 QDYDYSLDMWSLG 307
           + Y Y+ D+WS G
Sbjct: 191 KFY-YASDVWSFG 202

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 37/133 (27%), Positives = 68/133 (51%), Gaps = 8/133 (6%)
Query: 181 NVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYP--TLTDYDIRYYIYELLKALDYCHSQ 238
           ++VK      DQ  K+  L+ EYV     +   P   +    +  +  ++ + + Y H+Q
Sbjct: 71  HIVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYLPRHCVGLAQLLLFAQQICEGMAYLHAQ 130
Query: 239 GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE-YNVRV---ASRYFKGPELLVDL 294
             +HR +   NV++D++ R +++ D+GLA+    G E Y VR    +  ++  PE L + 
Sbjct: 131 HYIHRALAARNVLLDND-RLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEC 189
Query: 295 QDYDYSLDMWSLG 307
           + Y Y+ D+WS G
Sbjct: 190 KFY-YASDVWSFG 201

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 28/100 (28%), Positives = 56/100 (56%), Gaps = 4/100 (4%)
Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVA 281
           R+Y  +++   +Y HS  +++RD+KP N++ID +   +++ D+G A+    G  + +   
Sbjct: 165 RFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQ-GYIQVTDFGFAKRVK-GATWTLCGT 222
Query: 282 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 321
             Y   PE+++  + Y+ ++D W+LG +   M     PFF
Sbjct: 223 PEYL-APEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF 260

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 41/151 (27%), Positives = 73/151 (48%), Gaps = 16/151 (10%)
Query: 216 LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWG---LAEFYHP 272
           LT+  I + +  + + L+  H++G  HRD+KP N+++  E + + L+D G    A  +  
Sbjct: 131 LTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPV-LMDLGSMNQACIHVE 189
Query: 273 G-------KEYNVRVASRYFKGPELLVDLQDY---DYSLDMWSLGCMFAGMIFRKEPFFY 322
           G       +++  +  +  ++ PEL   +Q +   D   D+WSLGC+   M+F + P+  
Sbjct: 190 GSRQALTLQDWAAQRCTISYRAPELF-SVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDM 248
Query: 323 GHDNHDQLVKIAKDCCLIIWCNSRHSRKPWS 353
                D  V +A    L I  + RHS   W 
Sbjct: 249 VFQKGDS-VALAVQNQLSIPQSPRHSSALWQ 278

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 43/207 (20%), Positives = 92/207 (44%), Gaps = 15/207 (7%)
Query: 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXXXXXXXXXXXXXXXLQNLC-GGPN 181
           D D YE+V+ +G G +       +  +NE                     + +     PN
Sbjct: 17  DSDRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKIDENVKREIINHRSLRHPN 76
Query: 182 VVKLLDIVRDQHSKTPS---LIFEYVNSTD-FKVLYPT--LTDYDIRYYIYELLKALDYC 235
           +V+  +++      TP+   ++ EY +  + F+ +      ++ + R++  +L+  + YC
Sbjct: 77  IVRFKEVIL-----TPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYC 131
Query: 236 HSQGIMHRDVKPHNVMIDHE-LRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDL 294
           H+  + HRD+K  N ++D     +L++  +G ++      +    V +  +  PE+L+  
Sbjct: 132 HAMQVCHRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQPKSTVGTPAYIAPEVLLK- 190
Query: 295 QDYDYSL-DMWSLGCMFAGMIFRKEPF 320
           ++YD  + D+WS G     M+    PF
Sbjct: 191 KEYDGKVADVWSCGVTLYVMLVGAYPF 217

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 47/200 (23%), Positives = 77/200 (38%), Gaps = 19/200 (9%)
Query: 132 KVGRGKYSEVFEGINVNTNERCXXXXXXXXXXXXXXXXXXXLQNLCGG---PNVVKLLDI 188
           ++GRG + EV    +  T  +C                       C G   P +V L   
Sbjct: 79  RLGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVEELVA------CAGLSSPRIVPLYGA 132
Query: 189 VRDQHSKTPSLIFEYVNSTDFKVL---YPTLTDYDIRYYIYELLKALDYCHSQGIMHRDV 245
           VR+      ++  E +       L      L +    YY+ + L+ L+Y H++ I+H DV
Sbjct: 133 VRE--GPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDV 190
Query: 246 KPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPEL-----LVDLQDYDYS 300
           K  NV++  +  +  L D+G A    P       +   Y  G E      +V  +  D  
Sbjct: 191 KADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAK 250
Query: 301 LDMWSLGCMFAGMIFRKEPF 320
           +D+WS  CM   M+    P+
Sbjct: 251 VDIWSSCCMMLHMLNGCHPW 270

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 29/102 (28%), Positives = 56/102 (54%), Gaps = 10/102 (9%)
Query: 227 ELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGL-AEFYHPGKEYNVRVASRYF 285
           ++ K +DY HS+ +++RD+KP N+ +  + +++++ D+GL     + GK    +   RY 
Sbjct: 130 QITKGVDYIHSKKLINRDLKPSNIFL-VDTKQVKIGDFGLVTSLKNDGKRXRSKGTLRYM 188
Query: 286 KGPELLVDLQDYDYSLDMWSLGCMFAGMI------FRKEPFF 321
             PE  +  QDY   +D+++LG + A ++      F    FF
Sbjct: 189 -SPE-QISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFF 228

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 43/207 (20%), Positives = 91/207 (43%), Gaps = 15/207 (7%)
Query: 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXXXXXXXXXXXXXXXLQNLC-GGPN 181
           D D YE+V+ +G G +       +   NE                     + +     PN
Sbjct: 17  DSDRYELVKDIGAGNFGVARLMRDKQANELVAVKYIERGEKIDENVKREIINHRSLRHPN 76
Query: 182 VVKLLDIVRDQHSKTPS---LIFEYVNSTD-FKVL--YPTLTDYDIRYYIYELLKALDYC 235
           +V+  +++      TP+   ++ EY +  + F+ +      ++ + R++  +L+  + Y 
Sbjct: 77  IVRFKEVIL-----TPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYA 131
Query: 236 HSQGIMHRDVKPHNVMIDHE-LRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDL 294
           H+  + HRD+K  N ++D     +L++ D+G ++      +    V +  +  PE+L+  
Sbjct: 132 HAMQVAHRDLKLENTLLDGSPAPRLKIADFGYSKASVLHSQPKSAVGTPAYIAPEVLLK- 190
Query: 295 QDYDYSL-DMWSLGCMFAGMIFRKEPF 320
           ++YD  + D+WS G     M+    PF
Sbjct: 191 KEYDGKVADVWSCGVTLYVMLVGAYPF 217

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 35/133 (26%), Positives = 69/133 (51%), Gaps = 8/133 (6%)
Query: 181 NVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYP--TLTDYDIRYYIYELLKALDYCHSQ 238
           +++K      D  + +  L+ EYV     +   P  ++    +  +  ++ + + Y H+Q
Sbjct: 94  HIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQICEGMAYLHAQ 153
Query: 239 GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE-YNVRV---ASRYFKGPELLVDL 294
             +HRD+   NV++D++ R +++ D+GLA+    G E Y VR    +  ++  PE L + 
Sbjct: 154 HYIHRDLAARNVLLDND-RLVKIGDFGLAKAVPEGHEXYRVREDGDSPVFWYAPECLKEY 212
Query: 295 QDYDYSLDMWSLG 307
           + Y Y+ D+WS G
Sbjct: 213 KFY-YASDVWSFG 224

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 38/132 (28%), Positives = 64/132 (48%), Gaps = 18/132 (13%)
Query: 199 LIFEYVNSTDFKVLYPTLTDY---DIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE 255
            + EYVN  D       +  +      +Y  E+   L + H +GI++RD+K  NVM+D E
Sbjct: 97  FVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISIGLFFLHKRGIIYRDLKLDNVMLDSE 156
Query: 256 LRKLRLIDWGLAEFYHPGKEYNV-RVASRYFKG------PELLVDLQDYDYSLDMWSLGC 308
              +++ D+G+       KE+ +  V +R F G      PE++   Q Y  S+D W+ G 
Sbjct: 157 -GHIKIADFGMC------KEHMMDGVTTREFCGTPDYIAPEIIA-YQPYGKSVDWWAYGV 208
Query: 309 MFAGMIFRKEPF 320
           +   M+  + PF
Sbjct: 209 LLYEMLAGQPPF 220

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 43/207 (20%), Positives = 92/207 (44%), Gaps = 15/207 (7%)
Query: 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXXXXXXXXXXXXXXXLQNLC-GGPN 181
           D D YE+V+ +G G +       +  +NE                     + +     PN
Sbjct: 17  DSDRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKIDENVKREIINHRSLRHPN 76
Query: 182 VVKLLDIVRDQHSKTPS---LIFEYVNSTD-FKVLYPT--LTDYDIRYYIYELLKALDYC 235
           +V+  +++      TP+   ++ EY +  + F+ +      ++ + R++  +L+  + YC
Sbjct: 77  IVRFKEVIL-----TPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYC 131
Query: 236 HSQGIMHRDVKPHNVMIDHE-LRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDL 294
           H+  + HRD+K  N ++D     +L++  +G ++      +    V +  +  PE+L+  
Sbjct: 132 HAMQVCHRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQPKDTVGTPAYIAPEVLLK- 190
Query: 295 QDYDYSL-DMWSLGCMFAGMIFRKEPF 320
           ++YD  + D+WS G     M+    PF
Sbjct: 191 KEYDGKVADVWSCGVTLYVMLVGAYPF 217

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 29/108 (26%), Positives = 56/108 (51%), Gaps = 20/108 (18%)
Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVA 281
           R+Y  +++   +Y HS  +++RD+KP N++ID +   +++ D+G A+          RV 
Sbjct: 144 RFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQ-GYIQVTDFGFAK----------RVK 192
Query: 282 SRYFK--------GPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 321
            R +          PE+++  + Y+ ++D W+LG +   M     PFF
Sbjct: 193 GRTWXLCGTPEALAPEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF 239

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 34/126 (26%), Positives = 59/126 (46%), Gaps = 6/126 (4%)
Query: 199 LIFEYVNSTDFKVLYPTLTDYD---IRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE 255
            + EYVN  D       +  +      +Y  E+   L +  S+GI++RD+K  NVM+D E
Sbjct: 419 FVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSE 478
Query: 256 LRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMI 314
              +++ D+G+  E    G        +  +  PE++   Q Y  S+D W+ G +   M+
Sbjct: 479 -GHIKIADFGMCKENIWDGVTTKXFCGTPDYIAPEIIA-YQPYGKSVDWWAFGVLLYEML 536
Query: 315 FRKEPF 320
             + PF
Sbjct: 537 AGQAPF 542

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 27/100 (27%), Positives = 56/100 (56%), Gaps = 4/100 (4%)
Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVA 281
           R+Y  +++   +Y HS  +++RD+KP N++ID +   +++ D+G A+    G+ + +   
Sbjct: 144 RFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQ-GYIQVTDFGFAKRVK-GRTWXLCGT 201
Query: 282 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 321
             Y   P +++  + Y+ ++D W+LG +   M     PFF
Sbjct: 202 PEYL-APAIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF 239

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 47/237 (19%), Positives = 99/237 (41%), Gaps = 26/237 (10%)
Query: 112 WDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXXXXXXXXXXXXXX 171
           WD ++  +    ++  ++V+++G G++ EV+ G   N+ +                    
Sbjct: 3   WDKDAWEIP---RESIKLVKRLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEA 59
Query: 172 XLQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNST---DF-------KVLYPTLTDYDI 221
            L        +V+L  +V     +   +I EY+      DF       KVL P L D+  
Sbjct: 60  NLMKTLQHDKLVRLYAVV--TREEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSA 117
Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVA 281
                ++ + + Y   +  +HRD++  NV++   L   ++ D+GLA       EY  R  
Sbjct: 118 -----QIAEGMAYIERKNYIHRDLRAANVLVSESLM-CKIADFGLARVIE-DNEYTAREG 170
Query: 282 SRY---FKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK 335
           +++   +  PE  ++   +    D+WS G +   ++   +  + G  N D +  +++
Sbjct: 171 AKFPIKWTAPE-AINFGCFTIKSDVWSFGILLYEIVTYGKIPYPGRTNADVMTALSQ 226

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 34/126 (26%), Positives = 59/126 (46%), Gaps = 6/126 (4%)
Query: 199 LIFEYVNSTDFKVLYPTLTDYD---IRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE 255
            + EYVN  D       +  +      +Y  E+   L +  S+GI++RD+K  NVM+D E
Sbjct: 98  FVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSE 157
Query: 256 LRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMI 314
              +++ D+G+  E    G        +  +  PE++   Q Y  S+D W+ G +   M+
Sbjct: 158 -GHIKIADFGMCKENIWDGVTTKXFCGTPDYIAPEIIA-YQPYGKSVDWWAFGVLLYEML 215
Query: 315 FRKEPF 320
             + PF
Sbjct: 216 AGQAPF 221

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 30/136 (22%), Positives = 70/136 (51%), Gaps = 10/136 (7%)
Query: 212 LYPTLTDYDIRYYI---YELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE 268
           L+ + T ++++  I    +  + +DY H++ I+HRD+K +N+ + HE   +++ D+GLA 
Sbjct: 98  LHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFL-HEDNTVKIGDFGLAT 156
Query: 269 F---YHPGKEYNVRVASRYFKGPEL--LVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYG 323
               +    ++     S  +  PE+  + D   Y +  D+++ G +   ++  + P +  
Sbjct: 157 VKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLP-YSN 215
Query: 324 HDNHDQLVKIAKDCCL 339
            +N DQ++++     L
Sbjct: 216 INNRDQIIEMVGRGSL 231

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 45/202 (22%), Positives = 87/202 (43%), Gaps = 40/202 (19%)
Query: 218 DYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELR----------KLRLI--DWG 265
           +Y+    + ++   + + HS  I+HRD+KP N+++    R           LR++  D+G
Sbjct: 114 EYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFG 173
Query: 266 LAEFYHPGKE-----YNVRVASRYFKGPELLVDLQDYDY------SLDMWSLGCMFAGMI 314
           L +    G+       N    +  ++ PELL +  +         S+D++S+GC+F  ++
Sbjct: 174 LCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYIL 233
Query: 315 FR-KEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLD 373
            + K PF    D + +   I +    +      H R              +  EA D + 
Sbjct: 234 SKGKHPF---GDKYSRESNIIRGIFSLDEMKCLHDRS-------------LIAEATDLIS 277
Query: 374 KLLRYDHQDRLTAREAMAHPYF 395
           +++ +D   R TA + + HP F
Sbjct: 278 QMIDHDPLKRPTAMKVLRHPLF 299

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 45/198 (22%), Positives = 87/198 (43%), Gaps = 36/198 (18%)
Query: 218 DYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELR----------KLRLI--DWG 265
           +Y+    + ++   + + HS  I+HRD+KP N+++    R           LR++  D+G
Sbjct: 132 EYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFG 191
Query: 266 LAEFYHPGK-----EYNVRVASRYFKGPELLVDL--QDYDYSLDMWSLGCMFAGMIFR-K 317
           L +    G+       N    +  ++ PELL +   +    S+D++S+GC+F  ++ + K
Sbjct: 192 LCKKLDSGQXXFRXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGK 251
Query: 318 EPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLR 377
            PF    D + +   I +    +      H R              +  EA D + +++ 
Sbjct: 252 HPF---GDKYSRESNIIRGIFSLDEMKCLHDRS-------------LIAEATDLISQMID 295
Query: 378 YDHQDRLTAREAMAHPYF 395
           +D   R TA + + HP F
Sbjct: 296 HDPLKRPTAMKVLRHPLF 313

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 47/178 (26%), Positives = 76/178 (42%), Gaps = 17/178 (9%)
Query: 228 LLKALDYCHSQ-GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFK 286
           ++K L Y   +  IMHRDVKP N++++    +++L D+G++         N  V +R + 
Sbjct: 113 VIKGLTYLREKHKIMHRDVKPSNILVNSR-GEIKLCDFGVSGQLIDSMA-NSFVGTRSYM 170
Query: 287 GPELLVDLQDYDYSL--DMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCN 344
            PE    LQ   YS+  D+WS+G     M   + P        D    +A    L    N
Sbjct: 171 SPE---RLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKEDSRPPMAIFELLDYIVN 227
Query: 345 SRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAE 402
               + P   F         S E  DF++K L  +  +R   ++ M H +  +  A E
Sbjct: 228 EPPPKLPSGVF---------SLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDAEE 276

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 45/198 (22%), Positives = 87/198 (43%), Gaps = 36/198 (18%)
Query: 218 DYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELR----------KLRLI--DWG 265
           +Y+    + ++   + + HS  I+HRD+KP N+++    R           LR++  D+G
Sbjct: 132 EYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFG 191
Query: 266 LAEFYHPGK-----EYNVRVASRYFKGPELLVDL--QDYDYSLDMWSLGCMFAGMIFR-K 317
           L +    G+       N    +  ++ PELL +   +    S+D++S+GC+F  ++ + K
Sbjct: 192 LCKKLDSGQXXFRXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGK 251
Query: 318 EPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLR 377
            PF    D + +   I +    +      H R              +  EA D + +++ 
Sbjct: 252 HPF---GDKYSRESNIIRGIFSLDEMKCLHDRS-------------LIAEATDLISQMID 295
Query: 378 YDHQDRLTAREAMAHPYF 395
           +D   R TA + + HP F
Sbjct: 296 HDPLKRPTAMKVLRHPLF 313

>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 44/193 (22%), Positives = 83/193 (43%), Gaps = 40/193 (20%)
Query: 227 ELLKALDYCHSQGIMHRDVKPHNVMIDHELR----------KLRLI--DWGLAEFYHPGK 274
           ++   + + HS  I+HRD+KP N+++    R           LR++  D+GL +    G+
Sbjct: 123 QIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQ 182
Query: 275 -----EYNVRVASRYFKGPELLVDLQDYDY------SLDMWSLGCMFAGMIFR-KEPFFY 322
                  N    +  ++ PELL +  +         S+D++S+GC+F  ++ + K PF  
Sbjct: 183 XXFRXNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPF-- 240
Query: 323 GHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQD 382
             D + +   I +    +      H R              +  EA D + +++ +D   
Sbjct: 241 -GDKYSRESNIIRGIFSLDEMKCLHDRS-------------LIAEATDLISQMIDHDPLK 286
Query: 383 RLTAREAMAHPYF 395
           R TA + + HP F
Sbjct: 287 RPTAMKVLRHPLF 299

>pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant Length = 483

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 35/152 (23%), Positives = 67/152 (44%), Gaps = 8/152 (5%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNE----RCXXXXXXXXXXXXXXXXXXXLQNLCGGP 180
           + + + RK+G G + E++ G N+ TNE    +                    LQ   G P
Sbjct: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQGGTGIP 66
Query: 181 NVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGI 240
           NV +   +  D +     L+   +    F      L+   +     +++  +++ HS+  
Sbjct: 67  NV-RWFGVEGDYNVLVMDLLGPSLEDL-FNFCSRKLSLKTVLMLADQMINRVEFVHSKSF 124
Query: 241 MHRDVKPHNVMIDHELR--KLRLIDWGLAEFY 270
           +HRD+KP N ++    R  ++ +ID+GLA+ Y
Sbjct: 125 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY 156

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 31/143 (21%), Positives = 73/143 (51%), Gaps = 10/143 (6%)
Query: 205 NSTDFKVLYPTLTDYDIRYYI---YELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRL 261
            S+ +  L+ + T ++++  I    +  + +DY H++ I+HRD+K +N+ + HE   +++
Sbjct: 103 GSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFL-HEDNTVKI 161
Query: 262 IDWGLA---EFYHPGKEYNVRVASRYFKGPEL--LVDLQDYDYSLDMWSLGCMFAGMIFR 316
            D+GLA     +    ++     S  +  PE+  + D   Y +  D+++ G +   ++  
Sbjct: 162 GDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTG 221
Query: 317 KEPFFYGHDNHDQLVKIAKDCCL 339
           + P +   +N DQ++++     L
Sbjct: 222 QLP-YSNINNRDQIIEMVGRGSL 243

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 31/114 (27%), Positives = 57/114 (50%), Gaps = 6/114 (5%)
Query: 228 LLKALDYCHSQ-GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFK 286
           ++KAL Y   + G++HRDVKP N+++D E  +++L D+G++      K  +       + 
Sbjct: 133 IVKALYYLKEKHGVIHRDVKPSNILLD-ERGQIKLCDFGISGRLVDDKAKDRSAGCAAYM 191
Query: 287 GPELL----VDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKD 336
            PE +        DYD   D+WSLG     +   + P+     + + L K+ ++
Sbjct: 192 APERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQE 245

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 30/136 (22%), Positives = 70/136 (51%), Gaps = 10/136 (7%)
Query: 212 LYPTLTDYDIRYYI---YELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA- 267
           L+ + T ++++  I    +  + +DY H++ I+HRD+K +N+ + HE   +++ D+GLA 
Sbjct: 110 LHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFL-HEDNTVKIGDFGLAT 168
Query: 268 --EFYHPGKEYNVRVASRYFKGPEL--LVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYG 323
               +    ++     S  +  PE+  + D   Y +  D+++ G +   ++  + P +  
Sbjct: 169 EKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLP-YSN 227
Query: 324 HDNHDQLVKIAKDCCL 339
            +N DQ++++     L
Sbjct: 228 INNRDQIIEMVGRGSL 243

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 36/136 (26%), Positives = 65/136 (47%), Gaps = 12/136 (8%)
Query: 181 NVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTD-----YDIRYYIYELLKALDYC 235
           N+VK   I  +       LI E++ S   K   P   +       ++Y + ++ K +DY 
Sbjct: 84  NIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAV-QICKGMDYL 142
Query: 236 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNV----RVASRYFKGPELL 291
            S+  +HRD+   NV+++ E  ++++ D+GL +     KE       R +  ++  PE L
Sbjct: 143 GSRQYVHRDLAARNVLVESE-HQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECL 201
Query: 292 VDLQDYDYSLDMWSLG 307
           +  + Y  S D+WS G
Sbjct: 202 MQSKFYIAS-DVWSFG 216

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 36/136 (26%), Positives = 65/136 (47%), Gaps = 12/136 (8%)
Query: 181 NVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTD-----YDIRYYIYELLKALDYC 235
           N+VK   I  +       LI E++ S   K   P   +       ++Y + ++ K +DY 
Sbjct: 72  NIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAV-QICKGMDYL 130
Query: 236 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNV----RVASRYFKGPELL 291
            S+  +HRD+   NV+++ E  ++++ D+GL +     KE       R +  ++  PE L
Sbjct: 131 GSRQYVHRDLAARNVLVESE-HQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECL 189
Query: 292 VDLQDYDYSLDMWSLG 307
           +  + Y  S D+WS G
Sbjct: 190 MQSKFYIAS-DVWSFG 204

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 33/134 (24%), Positives = 71/134 (52%), Gaps = 18/134 (13%)
Query: 212 LYPTLTDYDIRYYIYELL-------KALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDW 264
           LY  L   + ++ +++L+       + +DY H++ I+HRD+K +N+ + HE   +++ D+
Sbjct: 118 LYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFL-HEGLTVKIGDF 176
Query: 265 GLAEF---YHPGKEYNVRVASRYFKGPELLVDLQD---YDYSLDMWSLGCMFAGMIFRKE 318
           GLA     +   ++      S  +  PE ++ +QD   + +  D++S G +   ++  + 
Sbjct: 177 GLATVKSRWSGSQQVEQPTGSVLWMAPE-VIRMQDNNPFSFQSDVYSYGIVLYELMTGEL 235
Query: 319 PFFYGH-DNHDQLV 331
           P  Y H +N DQ++
Sbjct: 236 P--YSHINNRDQII 247

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 30/93 (32%), Positives = 47/93 (50%), Gaps = 3/93 (3%)
Query: 215 TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 274
           +L +  +  Y+ + L AL + HSQG++H DVKP N+ +    R  +L D+GL        
Sbjct: 153 SLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGR-CKLGDFGLLVELGTAG 211
Query: 275 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLG 307
              V+     +  PELL     Y  + D++SLG
Sbjct: 212 AGEVQEGDPRYMAPELLQG--SYGTAADVFSLG 242

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 47/178 (26%), Positives = 77/178 (43%), Gaps = 23/178 (12%)
Query: 228 LLKALDYCHSQ-GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFK 286
           ++K L Y   +  IMHRDVKP N++++    +++L D+G++         N  V +R + 
Sbjct: 132 VIKGLTYLREKHKIMHRDVKPSNILVNSR-GEIKLCDFGVSGQLIDSMA-NSFVGTRSYM 189
Query: 287 GPELLVDLQDYDYSL--DMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCN 344
            PE    LQ   YS+  D+WS+G     M   + P   G  +      +A    L    N
Sbjct: 190 SPE---RLQGTHYSVQSDIWSMGLSLVEMAVGRYPIGSGSGS------MAIFELLDYIVN 240
Query: 345 SRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAE 402
               + P   F         S E  DF++K L  +  +R   ++ M H +  +  A E
Sbjct: 241 EPPPKLPSGVF---------SLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDAEE 289

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 41/223 (18%), Positives = 93/223 (41%), Gaps = 19/223 (8%)
Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXXXXXXXXXXXXXXXLQNLCGGPNVV 183
           ++  ++V+K+G G++ EV+ G   N+ +                     L        +V
Sbjct: 11  RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLV 70
Query: 184 KLLDIVRDQHS-------KTPSLIFEYVNSTDF-KVLYPTLTDYDIRYYIYELLKALDYC 235
           +L  +V  +              + +++ S +  KVL P L D+       ++ + + Y 
Sbjct: 71  RLYAVVTKEEPIYIITEFMAKGSLLDFLKSDEGGKVLLPKLIDFSA-----QIAEGMAYI 125
Query: 236 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRY---FKGPELLV 292
             +  +HRD++  NV++   L   ++ D+GLA       EY  R  +++   +  PE  +
Sbjct: 126 ERKNYIHRDLRAANVLVSESLM-CKIADFGLARVIE-DNEYTAREGAKFPIKWTAPE-AI 182
Query: 293 DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK 335
           +   +    ++WS G +   ++   +  + G  N D +  +++
Sbjct: 183 NFGCFTIKSNVWSFGILLYEIVTYGKIPYPGRTNADVMSALSQ 225

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 52/233 (22%), Positives = 97/233 (41%), Gaps = 28/233 (12%)
Query: 122 GDQDDYEVVRK-------VGRGKYSEVFEGINVN-TNERCXXXXXXXXXXXXXXXXXXXL 173
           G   DYE+ R+       +G G++ +V +GI ++  N                      L
Sbjct: 3   GSTRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFL 62
Query: 174 QNLCGG-----PNVVKLLDIVRDQHSKTPS-LIFEYVNSTDFKVLYP----TLTDYDIRY 223
           Q          P++VKL+ ++    ++ P  +I E     + +        +L    +  
Sbjct: 63  QEALTMRQFDHPHIVKLIGVI----TENPVWIIMELCTLGELRSFLQVRKYSLDLASLIL 118
Query: 224 YIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASR 283
           Y Y+L  AL Y  S+  +HRD+   NV++      ++L D+GL+ +      Y       
Sbjct: 119 YAYQLSTALAYLESKRFVHRDIAARNVLVSSN-DCVKLGDFGLSRYMEDSTYYKASKGKL 177
Query: 284 YFK--GPELLVDLQDYDYSLDMWSLG-CMFAGMIFRKEPFFYGHDNHDQLVKI 333
             K   PE  ++ + +  + D+W  G CM+  ++   +P F G  N+D + +I
Sbjct: 178 PIKWMAPE-SINFRRFTSASDVWMFGVCMWEILMHGVKP-FQGVKNNDVIGRI 228

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 31/108 (28%), Positives = 53/108 (49%), Gaps = 9/108 (8%)
Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWG-LAEFYHPGKEYN-VR 279
           R+Y+ E++ A+D  H  G +HRD+KP N+++D     +RL D+G   +    G   + V 
Sbjct: 165 RFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDR-CGHIRLADFGSCLKLRADGTVRSLVA 223
Query: 280 VASRYFKGPELLVDLQDYDY------SLDMWSLGCMFAGMIFRKEPFF 321
           V +  +  PE+L  +             D W+LG     M + + PF+
Sbjct: 224 VGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFY 271

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 37/153 (24%), Positives = 70/153 (45%), Gaps = 20/153 (13%)
Query: 180 PNVVKLLDI-VRDQHSKTPSLIFEYVNSTDFKVLY------PTLTDYDIRYYIYELLKAL 232
           PNV+ LL I +R + S  P ++  Y+   D +         PT+ D  +  +  ++ K +
Sbjct: 83  PNVLSLLGICLRSEGS--PLVVLPYMKHGDLRNFIRNETHNPTVKD--LIGFGLQVAKGM 138
Query: 233 DYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA------EFYHPGKEYNVRVASRYFK 286
            Y  S+  +HRD+   N M+D +   +++ D+GLA      E+Y    +   ++  ++  
Sbjct: 139 KYLASKKFVHRDLAARNCMLDEKF-TVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMA 197
Query: 287 GPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEP 319
              L    Q +    D+WS G +   ++ R  P
Sbjct: 198 LESL--QTQKFTTKSDVWSFGVLLWELMTRGAP 228

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 45.1 bits (105), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 26/94 (27%), Positives = 49/94 (52%), Gaps = 3/94 (3%)
Query: 231 ALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY-NVRVASRYFKGPE 289
           AL + H + I+HRD+K  N+ +  +   ++L D+G+A   +   E     + + Y+  PE
Sbjct: 137 ALKHVHDRKILHRDIKSQNIFLTKD-GTVQLGDFGIARVLNSTVELARACIGTPYYLSPE 195
Query: 290 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYG 323
           +  + + Y+   D+W+LGC+   +   K  F  G
Sbjct: 196 ICEN-KPYNNKSDIWALGCVLYELCTLKHAFEAG 228

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 45.1 bits (105), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 40/160 (25%), Positives = 74/160 (46%), Gaps = 31/160 (19%)
Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRY-------YIYELLKAL 232
           PNV+K + ++     K  + I EY+     + +  ++   D +Y       +  ++   +
Sbjct: 67  PNVLKFIGVL--YKDKRLNFITEYIKGGTLRGIIKSM---DSQYPWSQRVSFAKDIASGM 121
Query: 233 DYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-----EFYHP-----------GKEY 276
            Y HS  I+HRD+  HN ++  E + + + D+GLA     E   P            K Y
Sbjct: 122 AYLHSMNIIHRDLNSHNCLV-RENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRY 180
Query: 277 NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFR 316
            V V + Y+  PE +++ + YD  +D++S G +   +I R
Sbjct: 181 TV-VGNPYWMAPE-MINGRSYDEKVDVFSFGIVLCEIIGR 218

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 45.1 bits (105), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 37/153 (24%), Positives = 70/153 (45%), Gaps = 20/153 (13%)
Query: 180 PNVVKLLDI-VRDQHSKTPSLIFEYVNSTDFKVLY------PTLTDYDIRYYIYELLKAL 232
           PNV+ LL I +R + S  P ++  Y+   D +         PT+ D  +  +  ++ K +
Sbjct: 91  PNVLSLLGICLRSEGS--PLVVLPYMKHGDLRNFIRNETHNPTVKD--LIGFGLQVAKGM 146
Query: 233 DYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA------EFYHPGKEYNVRVASRYFK 286
            Y  S+  +HRD+   N M+D +   +++ D+GLA      E+Y    +   ++  ++  
Sbjct: 147 KYLASKKFVHRDLAARNCMLDEKF-TVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMA 205
Query: 287 GPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEP 319
              L    Q +    D+WS G +   ++ R  P
Sbjct: 206 LESL--QTQKFTTKSDVWSFGVLLWELMTRGAP 236

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 45.1 bits (105), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 37/153 (24%), Positives = 70/153 (45%), Gaps = 20/153 (13%)
Query: 180 PNVVKLLDI-VRDQHSKTPSLIFEYVNSTDFKVLY------PTLTDYDIRYYIYELLKAL 232
           PNV+ LL I +R + S  P ++  Y+   D +         PT+ D  +  +  ++ K +
Sbjct: 109 PNVLSLLGICLRSEGS--PLVVLPYMKHGDLRNFIRNETHNPTVKD--LIGFGLQVAKGM 164
Query: 233 DYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA------EFYHPGKEYNVRVASRYFK 286
            Y  S+  +HRD+   N M+D +   +++ D+GLA      E+Y    +   ++  ++  
Sbjct: 165 KYLASKKFVHRDLAARNCMLDEKF-TVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMA 223
Query: 287 GPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEP 319
              L    Q +    D+WS G +   ++ R  P
Sbjct: 224 LESL--QTQKFTTKSDVWSFGVLLWELMTRGAP 254

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 45.1 bits (105), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 37/153 (24%), Positives = 70/153 (45%), Gaps = 20/153 (13%)
Query: 180 PNVVKLLDI-VRDQHSKTPSLIFEYVNSTDFKVLY------PTLTDYDIRYYIYELLKAL 232
           PNV+ LL I +R + S  P ++  Y+   D +         PT+ D  +  +  ++ K +
Sbjct: 110 PNVLSLLGICLRSEGS--PLVVLPYMKHGDLRNFIRNETHNPTVKD--LIGFGLQVAKGM 165
Query: 233 DYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA------EFYHPGKEYNVRVASRYFK 286
            Y  S+  +HRD+   N M+D +   +++ D+GLA      E+Y    +   ++  ++  
Sbjct: 166 KYLASKKFVHRDLAARNCMLDEKF-TVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMA 224
Query: 287 GPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEP 319
              L    Q +    D+WS G +   ++ R  P
Sbjct: 225 LESL--QTQKFTTKSDVWSFGVLLWELMTRGAP 255

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 44.7 bits (104), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 37/153 (24%), Positives = 70/153 (45%), Gaps = 20/153 (13%)
Query: 180 PNVVKLLDI-VRDQHSKTPSLIFEYVNSTDFKVLY------PTLTDYDIRYYIYELLKAL 232
           PNV+ LL I +R + S  P ++  Y+   D +         PT+ D  +  +  ++ K +
Sbjct: 89  PNVLSLLGICLRSEGS--PLVVLPYMKHGDLRNFIRNETHNPTVKD--LIGFGLQVAKGM 144
Query: 233 DYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA------EFYHPGKEYNVRVASRYFK 286
            Y  S+  +HRD+   N M+D +   +++ D+GLA      E+Y    +   ++  ++  
Sbjct: 145 KYLASKKFVHRDLAARNCMLDEKF-TVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMA 203
Query: 287 GPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEP 319
              L    Q +    D+WS G +   ++ R  P
Sbjct: 204 LESL--QTQKFTTKSDVWSFGVLLWELMTRGAP 234

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 44.7 bits (104), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 37/153 (24%), Positives = 70/153 (45%), Gaps = 20/153 (13%)
Query: 180 PNVVKLLDI-VRDQHSKTPSLIFEYVNSTDFKVLY------PTLTDYDIRYYIYELLKAL 232
           PNV+ LL I +R + S  P ++  Y+   D +         PT+ D  +  +  ++ K +
Sbjct: 88  PNVLSLLGICLRSEGS--PLVVLPYMKHGDLRNFIRNETHNPTVKD--LIGFGLQVAKGM 143
Query: 233 DYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA------EFYHPGKEYNVRVASRYFK 286
            Y  S+  +HRD+   N M+D +   +++ D+GLA      E+Y    +   ++  ++  
Sbjct: 144 KYLASKKFVHRDLAARNCMLDEKF-TVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMA 202
Query: 287 GPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEP 319
              L    Q +    D+WS G +   ++ R  P
Sbjct: 203 LESL--QTQKFTTKSDVWSFGVLLWELMTRGAP 233

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 37/153 (24%), Positives = 70/153 (45%), Gaps = 20/153 (13%)
Query: 180 PNVVKLLDI-VRDQHSKTPSLIFEYVNSTDFKVLY------PTLTDYDIRYYIYELLKAL 232
           PNV+ LL I +R + S  P ++  Y+   D +         PT+ D  +  +  ++ K +
Sbjct: 90  PNVLSLLGICLRSEGS--PLVVLPYMKHGDLRNFIRNETHNPTVKD--LIGFGLQVAKGM 145
Query: 233 DYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA------EFYHPGKEYNVRVASRYFK 286
            Y  S+  +HRD+   N M+D +   +++ D+GLA      E+Y    +   ++  ++  
Sbjct: 146 KYLASKKFVHRDLAARNCMLDEKF-TVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMA 204
Query: 287 GPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEP 319
              L    Q +    D+WS G +   ++ R  P
Sbjct: 205 LESL--QTQKFTTKSDVWSFGVLLWELMTRGAP 235

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 37/153 (24%), Positives = 70/153 (45%), Gaps = 20/153 (13%)
Query: 180 PNVVKLLDI-VRDQHSKTPSLIFEYVNSTDFKVLY------PTLTDYDIRYYIYELLKAL 232
           PNV+ LL I +R + S  P ++  Y+   D +         PT+ D  +  +  ++ K +
Sbjct: 91  PNVLSLLGICLRSEGS--PLVVLPYMKHGDLRNFIRNETHNPTVKD--LIGFGLQVAKGM 146
Query: 233 DYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA------EFYHPGKEYNVRVASRYFK 286
            Y  S+  +HRD+   N M+D +   +++ D+GLA      E+Y    +   ++  ++  
Sbjct: 147 KYLASKKFVHRDLAARNCMLDEKF-TVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMA 205
Query: 287 GPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEP 319
              L    Q +    D+WS G +   ++ R  P
Sbjct: 206 LESL--QTQKFTTKSDVWSFGVLLWELMTRGAP 236

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 37/153 (24%), Positives = 70/153 (45%), Gaps = 20/153 (13%)
Query: 180 PNVVKLLDI-VRDQHSKTPSLIFEYVNSTDFKVLY------PTLTDYDIRYYIYELLKAL 232
           PNV+ LL I +R + S  P ++  Y+   D +         PT+ D  +  +  ++ K +
Sbjct: 86  PNVLSLLGICLRSEGS--PLVVLPYMKHGDLRNFIRNETHNPTVKD--LIGFGLQVAKGM 141
Query: 233 DYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA------EFYHPGKEYNVRVASRYFK 286
            Y  S+  +HRD+   N M+D +   +++ D+GLA      E+Y    +   ++  ++  
Sbjct: 142 KYLASKKFVHRDLAARNCMLDEKF-TVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMA 200
Query: 287 GPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEP 319
              L    Q +    D+WS G +   ++ R  P
Sbjct: 201 LESL--QTQKFTTKSDVWSFGVLLWELMTRGAP 231

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 31/101 (30%), Positives = 53/101 (52%), Gaps = 11/101 (10%)
Query: 216 LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA------EF 269
           +T  D+    Y+L + ++Y  SQ  +HRD+   NV++  E   +R+ D+GLA      ++
Sbjct: 154 MTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLV-TENNVMRIADFGLARDINNIDY 212
Query: 270 YHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMF 310
           Y   K  N R+  ++   PE L D + Y +  D+WS G + 
Sbjct: 213 YK--KTTNGRLPVKWM-APEALFD-RVYTHQSDVWSFGVLM 249

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 51/229 (22%), Positives = 96/229 (41%), Gaps = 28/229 (12%)
Query: 126 DYEVVRK-------VGRGKYSEVFEGINVN-TNERCXXXXXXXXXXXXXXXXXXXLQNLC 177
           DYE+ R+       +G G++ +V +GI ++  N                      LQ   
Sbjct: 6   DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEAL 65
Query: 178 GG-----PNVVKLLDIVRDQHSKTPS-LIFEYVNSTDFKVLYP----TLTDYDIRYYIYE 227
                  P++VKL+ ++    ++ P  +I E     + +        +L    +  Y Y+
Sbjct: 66  TMRQFDHPHIVKLIGVI----TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQ 121
Query: 228 LLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFK- 286
           L  AL Y  S+  +HRD+   NV++      ++L D+GL+ +      Y         K 
Sbjct: 122 LSTALAYLESKRFVHRDIAARNVLVSSN-DCVKLGDFGLSRYMEDSTYYKASKGKLPIKW 180
Query: 287 -GPELLVDLQDYDYSLDMWSLG-CMFAGMIFRKEPFFYGHDNHDQLVKI 333
             PE  ++ + +  + D+W  G CM+  ++   +P F G  N+D + +I
Sbjct: 181 MAPE-SINFRRFTSASDVWMFGVCMWEILMHGVKP-FQGVKNNDVIGRI 227

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 30/101 (29%), Positives = 53/101 (52%), Gaps = 11/101 (10%)
Query: 216 LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA------EF 269
           +T  D+    Y+L + ++Y  SQ  +HRD+   NV++  E   +++ D+GLA      ++
Sbjct: 200 MTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLV-TENNVMKIADFGLARDINNIDY 258
Query: 270 YHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMF 310
           Y   K  N R+  ++   PE L D + Y +  D+WS G + 
Sbjct: 259 YK--KTTNGRLPVKWM-APEALFD-RVYTHQSDVWSFGVLM 295

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 51/229 (22%), Positives = 96/229 (41%), Gaps = 28/229 (12%)
Query: 126 DYEVVRK-------VGRGKYSEVFEGINVN-TNERCXXXXXXXXXXXXXXXXXXXLQNLC 177
           DYE+ R+       +G G++ +V +GI ++  N                      LQ   
Sbjct: 9   DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEAL 68
Query: 178 GG-----PNVVKLLDIVRDQHSKTPS-LIFEYVNSTDFKVLYP----TLTDYDIRYYIYE 227
                  P++VKL+ ++    ++ P  +I E     + +        +L    +  Y Y+
Sbjct: 69  TMRQFDHPHIVKLIGVI----TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQ 124
Query: 228 LLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFK- 286
           L  AL Y  S+  +HRD+   NV++      ++L D+GL+ +      Y         K 
Sbjct: 125 LSTALAYLESKRFVHRDIAARNVLVSSN-DCVKLGDFGLSRYMEDSTYYKASKGKLPIKW 183
Query: 287 -GPELLVDLQDYDYSLDMWSLG-CMFAGMIFRKEPFFYGHDNHDQLVKI 333
             PE  ++ + +  + D+W  G CM+  ++   +P F G  N+D + +I
Sbjct: 184 MAPE-SINFRRFTSASDVWMFGVCMWEILMHGVKP-FQGVKNNDVIGRI 230

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 27/108 (25%), Positives = 59/108 (54%), Gaps = 9/108 (8%)
Query: 230 KALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEF---YHPGKEYNVRVASRYFK 286
           + +DY H++ I+HRD+K +N+ + HE   +++ D+GLA     +    ++     S  + 
Sbjct: 115 QGMDYLHAKSIIHRDLKSNNIFL-HEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWM 173
Query: 287 GPELLVDLQD---YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV 331
            PE ++ +QD   Y +  D+++ G +   ++  + P +   +N DQ++
Sbjct: 174 APE-VIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP-YSNINNRDQII 219

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 27/108 (25%), Positives = 59/108 (54%), Gaps = 9/108 (8%)
Query: 230 KALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEF---YHPGKEYNVRVASRYFK 286
           + +DY H++ I+HRD+K +N+ + HE   +++ D+GLA     +    ++     S  + 
Sbjct: 115 QGMDYLHAKSIIHRDLKSNNIFL-HEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWM 173
Query: 287 GPELLVDLQD---YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV 331
            PE ++ +QD   Y +  D+++ G +   ++  + P +   +N DQ++
Sbjct: 174 APE-VIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP-YSNINNRDQII 219

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 51/229 (22%), Positives = 96/229 (41%), Gaps = 28/229 (12%)
Query: 126 DYEVVRK-------VGRGKYSEVFEGINVN-TNERCXXXXXXXXXXXXXXXXXXXLQNLC 177
           DYE+ R+       +G G++ +V +GI ++  N                      LQ   
Sbjct: 4   DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEAL 63
Query: 178 GG-----PNVVKLLDIVRDQHSKTPS-LIFEYVNSTDFKVLYP----TLTDYDIRYYIYE 227
                  P++VKL+ ++    ++ P  +I E     + +        +L    +  Y Y+
Sbjct: 64  TMRQFDHPHIVKLIGVI----TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQ 119
Query: 228 LLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFK- 286
           L  AL Y  S+  +HRD+   NV++      ++L D+GL+ +      Y         K 
Sbjct: 120 LSTALAYLESKRFVHRDIAARNVLVSSN-DCVKLGDFGLSRYMEDSTYYKASKGKLPIKW 178
Query: 287 -GPELLVDLQDYDYSLDMWSLG-CMFAGMIFRKEPFFYGHDNHDQLVKI 333
             PE  ++ + +  + D+W  G CM+  ++   +P F G  N+D + +I
Sbjct: 179 MAPE-SINFRRFTSASDVWMFGVCMWEILMHGVKP-FQGVKNNDVIGRI 225

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 27/108 (25%), Positives = 59/108 (54%), Gaps = 9/108 (8%)
Query: 230 KALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEF---YHPGKEYNVRVASRYFK 286
           + +DY H++ I+HRD+K +N+ + HE   +++ D+GLA     +    ++     S  + 
Sbjct: 120 QGMDYLHAKSIIHRDLKSNNIFL-HEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWM 178
Query: 287 GPELLVDLQD---YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV 331
            PE ++ +QD   Y +  D+++ G +   ++  + P +   +N DQ++
Sbjct: 179 APE-VIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP-YSNINNRDQII 224

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 27/108 (25%), Positives = 59/108 (54%), Gaps = 9/108 (8%)
Query: 230 KALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEF---YHPGKEYNVRVASRYFK 286
           + +DY H++ I+HRD+K +N+ + HE   +++ D+GLA     +    ++     S  + 
Sbjct: 117 QGMDYLHAKSIIHRDLKSNNIFL-HEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWM 175
Query: 287 GPELLVDLQD---YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV 331
            PE ++ +QD   Y +  D+++ G +   ++  + P +   +N DQ++
Sbjct: 176 APE-VIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP-YSNINNRDQII 221

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 32/123 (26%), Positives = 60/123 (48%), Gaps = 10/123 (8%)
Query: 192 QHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVM 251
           Q  + P L F +  S + +     L+  D+    Y++ + ++Y  S+  +HRD+   NV+
Sbjct: 126 QARRPPGLEFSFNPSHNPE---EQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVL 182
Query: 252 IDHELRKLRLIDWGLAEFYH----PGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLG 307
           +  +   +++ D+GLA   H      K  N R+  ++   PE L D + Y +  D+WS G
Sbjct: 183 VTED-NVMKIADFGLARDIHHIDXXKKTTNGRLPVKWM-APEALFD-RIYTHQSDVWSFG 239
Query: 308 CMF 310
            + 
Sbjct: 240 VLL 242

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 51/229 (22%), Positives = 96/229 (41%), Gaps = 28/229 (12%)
Query: 126 DYEVVRK-------VGRGKYSEVFEGINVN-TNERCXXXXXXXXXXXXXXXXXXXLQNLC 177
           DYE+ R+       +G G++ +V +GI ++  N                      LQ   
Sbjct: 4   DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEAL 63
Query: 178 GG-----PNVVKLLDIVRDQHSKTPS-LIFEYVNSTDFKVLYP----TLTDYDIRYYIYE 227
                  P++VKL+ ++    ++ P  +I E     + +        +L    +  Y Y+
Sbjct: 64  TMRQFDHPHIVKLIGVI----TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQ 119
Query: 228 LLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFK- 286
           L  AL Y  S+  +HRD+   NV++      ++L D+GL+ +      Y         K 
Sbjct: 120 LSTALAYLESKRFVHRDIAARNVLVSSN-DCVKLGDFGLSRYMEDSTYYKASKGKLPIKW 178
Query: 287 -GPELLVDLQDYDYSLDMWSLG-CMFAGMIFRKEPFFYGHDNHDQLVKI 333
             PE  ++ + +  + D+W  G CM+  ++   +P F G  N+D + +I
Sbjct: 179 MAPE-SINFRRFTSASDVWMFGVCMWEILMHGVKP-FQGVKNNDVIGRI 225

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 51/229 (22%), Positives = 96/229 (41%), Gaps = 28/229 (12%)
Query: 126 DYEVVRK-------VGRGKYSEVFEGINVN-TNERCXXXXXXXXXXXXXXXXXXXLQNLC 177
           DYE+ R+       +G G++ +V +GI ++  N                      LQ   
Sbjct: 1   DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEAL 60
Query: 178 GG-----PNVVKLLDIVRDQHSKTPS-LIFEYVNSTDFKVLYP----TLTDYDIRYYIYE 227
                  P++VKL+ ++    ++ P  +I E     + +        +L    +  Y Y+
Sbjct: 61  TMRQFDHPHIVKLIGVI----TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQ 116
Query: 228 LLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFK- 286
           L  AL Y  S+  +HRD+   NV++      ++L D+GL+ +      Y         K 
Sbjct: 117 LSTALAYLESKRFVHRDIAARNVLVSSN-DCVKLGDFGLSRYMEDSTYYKASKGKLPIKW 175
Query: 287 -GPELLVDLQDYDYSLDMWSLG-CMFAGMIFRKEPFFYGHDNHDQLVKI 333
             PE  ++ + +  + D+W  G CM+  ++   +P F G  N+D + +I
Sbjct: 176 MAPE-SINFRRFTSASDVWMFGVCMWEILMHGVKP-FQGVKNNDVIGRI 222

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 27/108 (25%), Positives = 59/108 (54%), Gaps = 9/108 (8%)
Query: 230 KALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEF---YHPGKEYNVRVASRYFK 286
           + +DY H++ I+HRD+K +N+ + HE   +++ D+GLA     +    ++     S  + 
Sbjct: 142 QGMDYLHAKSIIHRDLKSNNIFL-HEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWM 200
Query: 287 GPELLVDLQD---YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV 331
            PE ++ +QD   Y +  D+++ G +   ++  + P +   +N DQ++
Sbjct: 201 APE-VIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP-YSNINNRDQII 246

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 51/229 (22%), Positives = 96/229 (41%), Gaps = 28/229 (12%)
Query: 126 DYEVVRK-------VGRGKYSEVFEGINVN-TNERCXXXXXXXXXXXXXXXXXXXLQNLC 177
           DYE+ R+       +G G++ +V +GI ++  N                      LQ   
Sbjct: 32  DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEAL 91
Query: 178 GG-----PNVVKLLDIVRDQHSKTPS-LIFEYVNSTDFKVLYP----TLTDYDIRYYIYE 227
                  P++VKL+ ++    ++ P  +I E     + +        +L    +  Y Y+
Sbjct: 92  TMRQFDHPHIVKLIGVI----TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQ 147
Query: 228 LLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFK- 286
           L  AL Y  S+  +HRD+   NV++      ++L D+GL+ +      Y         K 
Sbjct: 148 LSTALAYLESKRFVHRDIAARNVLVSSN-DCVKLGDFGLSRYMEDSTYYKASKGKLPIKW 206
Query: 287 -GPELLVDLQDYDYSLDMWSLG-CMFAGMIFRKEPFFYGHDNHDQLVKI 333
             PE  ++ + +  + D+W  G CM+  ++   +P F G  N+D + +I
Sbjct: 207 MAPE-SINFRRFTSASDVWMFGVCMWEILMHGVKP-FQGVKNNDVIGRI 253

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 27/108 (25%), Positives = 59/108 (54%), Gaps = 9/108 (8%)
Query: 230 KALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEF---YHPGKEYNVRVASRYFK 286
           + +DY H++ I+HRD+K +N+ + HE   +++ D+GLA     +    ++     S  + 
Sbjct: 120 QGMDYLHAKSIIHRDLKSNNIFL-HEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWM 178
Query: 287 GPELLVDLQD---YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV 331
            PE ++ +QD   Y +  D+++ G +   ++  + P +   +N DQ++
Sbjct: 179 APE-VIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP-YSNINNRDQII 224

>pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 34/115 (29%), Positives = 56/115 (48%), Gaps = 12/115 (10%)
Query: 216 LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELR--------KLRLIDWGLA 267
           + +  I Y +  +LKALDY H  G +HR VK  +++I  + +         L +I  G  
Sbjct: 109 MNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQR 168
Query: 268 E-FYHPGKEYNVRVASRYFKGPELL-VDLQDYDYSLDMWSLGCMFAGMIFRKEPF 320
           +   H   +Y+V+V    +  PE+L  +LQ YD   D++S+G     +     PF
Sbjct: 169 QRVVHDFPKYSVKVLP--WLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPF 221

>pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 34/115 (29%), Positives = 56/115 (48%), Gaps = 12/115 (10%)
Query: 216 LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELR--------KLRLIDWGLA 267
           + +  I Y +  +LKALDY H  G +HR VK  +++I  + +         L +I  G  
Sbjct: 125 MNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQR 184
Query: 268 E-FYHPGKEYNVRVASRYFKGPELL-VDLQDYDYSLDMWSLGCMFAGMIFRKEPF 320
           +   H   +Y+V+V    +  PE+L  +LQ YD   D++S+G     +     PF
Sbjct: 185 QRVVHDFPKYSVKVLP--WLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPF 237

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 27/108 (25%), Positives = 59/108 (54%), Gaps = 9/108 (8%)
Query: 230 KALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEF---YHPGKEYNVRVASRYFK 286
           + +DY H++ I+HRD+K +N+ + HE   +++ D+GLA     +    ++     S  + 
Sbjct: 143 QGMDYLHAKSIIHRDLKSNNIFL-HEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWM 201
Query: 287 GPELLVDLQD---YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV 331
            PE ++ +QD   Y +  D+++ G +   ++  + P +   +N DQ++
Sbjct: 202 APE-VIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP-YSNINNRDQII 247

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 51/229 (22%), Positives = 96/229 (41%), Gaps = 28/229 (12%)
Query: 126 DYEVVRK-------VGRGKYSEVFEGINVN-TNERCXXXXXXXXXXXXXXXXXXXLQNLC 177
           DYE+ R+       +G G++ +V +GI ++  N                      LQ   
Sbjct: 4   DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEAL 63
Query: 178 GG-----PNVVKLLDIVRDQHSKTPS-LIFEYVNSTDFKVLYP----TLTDYDIRYYIYE 227
                  P++VKL+ ++    ++ P  +I E     + +        +L    +  Y Y+
Sbjct: 64  TMRQFDHPHIVKLIGVI----TENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQ 119
Query: 228 LLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFK- 286
           L  AL Y  S+  +HRD+   NV++      ++L D+GL+ +      Y         K 
Sbjct: 120 LSTALAYLESKRFVHRDIAARNVLVSAT-DCVKLGDFGLSRYMEDSTYYKASKGKLPIKW 178
Query: 287 -GPELLVDLQDYDYSLDMWSLG-CMFAGMIFRKEPFFYGHDNHDQLVKI 333
             PE  ++ + +  + D+W  G CM+  ++   +P F G  N+D + +I
Sbjct: 179 MAPE-SINFRRFTSASDVWMFGVCMWEILMHGVKP-FQGVKNNDVIGRI 225

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 30/101 (29%), Positives = 53/101 (52%), Gaps = 11/101 (10%)
Query: 216 LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA------EF 269
           +T  D+    Y+L + ++Y  SQ  +HRD+   NV++  E   +++ D+GLA      ++
Sbjct: 141 MTFKDLVSCTYQLARGMEYLASQKCIHRDLTARNVLV-TENNVMKIADFGLARDINNIDY 199
Query: 270 YHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMF 310
           Y   K  N R+  ++   PE L D + Y +  D+WS G + 
Sbjct: 200 YK--KTTNGRLPVKWM-APEALFD-RVYTHQSDVWSFGVLM 236

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 30/101 (29%), Positives = 53/101 (52%), Gaps = 11/101 (10%)
Query: 216 LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA------EF 269
           +T  D+    Y+L + ++Y  SQ  +HRD+   NV++  E   +++ D+GLA      ++
Sbjct: 154 MTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLV-TENNVMKIADFGLARDINNIDY 212
Query: 270 YHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMF 310
           Y   K  N R+  ++   PE L D + Y +  D+WS G + 
Sbjct: 213 YK--KTTNGRLPVKWM-APEALFD-RVYTHQSDVWSFGVLM 249

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 51/229 (22%), Positives = 96/229 (41%), Gaps = 28/229 (12%)
Query: 126 DYEVVRK-------VGRGKYSEVFEGINVN-TNERCXXXXXXXXXXXXXXXXXXXLQNLC 177
           DYE+ R+       +G G++ +V +GI ++  N                      LQ   
Sbjct: 384 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEAL 443
Query: 178 G-----GPNVVKLLDIVRDQHSKTPS-LIFEYVNSTDFKVLYP----TLTDYDIRYYIYE 227
                  P++VKL+ ++    ++ P  +I E     + +        +L    +  Y Y+
Sbjct: 444 TMRQFDHPHIVKLIGVI----TENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQ 499
Query: 228 LLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFK- 286
           L  AL Y  S+  +HRD+   NV++      ++L D+GL+ +      Y         K 
Sbjct: 500 LSTALAYLESKRFVHRDIAARNVLVSSN-DCVKLGDFGLSRYMEDSTYYKASKGKLPIKW 558
Query: 287 -GPELLVDLQDYDYSLDMWSLG-CMFAGMIFRKEPFFYGHDNHDQLVKI 333
             PE  ++ + +  + D+W  G CM+  ++   +P F G  N+D + +I
Sbjct: 559 MAPE-SINFRRFTSASDVWMFGVCMWEILMHGVKP-FQGVKNNDVIGRI 605

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 55/277 (19%), Positives = 103/277 (37%), Gaps = 32/277 (11%)
Query: 132 KVGRGKYSEVFEGINVNTNERCX--XXXXXXXXXXXXXXXXXXLQNLCG--GPNVVKLLD 187
           ++GRG +  V++G++  T                          + L G   PN+V+  D
Sbjct: 33  EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEXLKGLQHPNIVRFYD 92
Query: 188 IVRD--QHSKTPSLIFEYVNSTDFKVLYPTLTDYDI---RYYIYELLKALDYCHSQG--I 240
                 +  K   L+ E   S   K          I   R +  ++LK L + H++   I
Sbjct: 93  SWESTVKGKKCIVLVTELXTSGTLKTYLKRFKVXKIKVLRSWCRQILKGLQFLHTRTPPI 152
Query: 241 MHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYS 300
           +HRD+K  N+ I      +++ D GLA          V + +  F  PE     + YD S
Sbjct: 153 IHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAV-IGTPEFXAPEXYE--EKYDES 209
Query: 301 LDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSKFINADN 360
           +D+++ G         + P+     N  Q+                  R+  S    A  
Sbjct: 210 VDVYAFGXCXLEXATSEYPYSECQ-NAAQIY-----------------RRVTSGVKPASF 251
Query: 361 QHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQ 397
             +  PE  + ++  +R +  +R + ++ + H +F +
Sbjct: 252 DKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 30/101 (29%), Positives = 53/101 (52%), Gaps = 11/101 (10%)
Query: 216 LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA------EF 269
           +T  D+    Y+L + ++Y  SQ  +HRD+   NV++  E   +++ D+GLA      ++
Sbjct: 143 MTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLV-TENNVMKIADFGLARDINNIDY 201
Query: 270 YHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMF 310
           Y   K  N R+  ++   PE L D + Y +  D+WS G + 
Sbjct: 202 YK--KTTNGRLPVKWM-APEALFD-RVYTHQSDVWSFGVLM 238

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 30/101 (29%), Positives = 53/101 (52%), Gaps = 11/101 (10%)
Query: 216 LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA------EF 269
           +T  D+    Y+L + ++Y  SQ  +HRD+   NV++  E   +++ D+GLA      ++
Sbjct: 154 MTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLV-TENNVMKIADFGLARDINNIDY 212
Query: 270 YHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMF 310
           Y   K  N R+  ++   PE L D + Y +  D+WS G + 
Sbjct: 213 YK--KTTNGRLPVKWM-APEALFD-RVYTHQSDVWSFGVLM 249

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 30/101 (29%), Positives = 53/101 (52%), Gaps = 11/101 (10%)
Query: 216 LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA------EF 269
           +T  D+    Y+L + ++Y  SQ  +HRD+   NV++  E   +++ D+GLA      ++
Sbjct: 146 MTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLV-TENNVMKIADFGLARDINNIDY 204
Query: 270 YHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMF 310
           Y   K  N R+  ++   PE L D + Y +  D+WS G + 
Sbjct: 205 YK--KTTNGRLPVKWM-APEALFD-RVYTHQSDVWSFGVLM 241

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 30/101 (29%), Positives = 53/101 (52%), Gaps = 11/101 (10%)
Query: 216 LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA------EF 269
           +T  D+    Y+L + ++Y  SQ  +HRD+   NV++  E   +++ D+GLA      ++
Sbjct: 154 MTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLV-TENNVMKIADFGLARDINNIDY 212
Query: 270 YHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMF 310
           Y   K  N R+  ++   PE L D + Y +  D+WS G + 
Sbjct: 213 YK--KTTNGRLPVKWM-APEALFD-RVYTHQSDVWSFGVLM 249

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 30/101 (29%), Positives = 53/101 (52%), Gaps = 11/101 (10%)
Query: 216 LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA------EF 269
           +T  D+    Y+L + ++Y  SQ  +HRD+   NV++  E   +++ D+GLA      ++
Sbjct: 154 MTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLV-TENNVMKIADFGLARDINNIDY 212
Query: 270 YHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMF 310
           Y   K  N R+  ++   PE L D + Y +  D+WS G + 
Sbjct: 213 YK--KTTNGRLPVKWM-APEALFD-RVYTHQSDVWSFGVLM 249

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 27/108 (25%), Positives = 59/108 (54%), Gaps = 9/108 (8%)
Query: 230 KALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA---EFYHPGKEYNVRVASRYFK 286
           + +DY H++ I+HRD+K +N+ + HE   +++ D+GLA     +    ++     S  + 
Sbjct: 115 QGMDYLHAKSIIHRDLKSNNIFL-HEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWM 173
Query: 287 GPELLVDLQD---YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV 331
            PE ++ +QD   Y +  D+++ G +   ++  + P +   +N DQ++
Sbjct: 174 APE-VIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP-YSNINNRDQII 219

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 27/108 (25%), Positives = 59/108 (54%), Gaps = 9/108 (8%)
Query: 230 KALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA---EFYHPGKEYNVRVASRYFK 286
           + +DY H++ I+HRD+K +N+ + HE   +++ D+GLA     +    ++     S  + 
Sbjct: 135 QGMDYLHAKSIIHRDLKSNNIFL-HEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWM 193
Query: 287 GPELLVDLQD---YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV 331
            PE ++ +QD   Y +  D+++ G +   ++  + P +   +N DQ++
Sbjct: 194 APE-VIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP-YSNINNRDQII 239

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 30/101 (29%), Positives = 53/101 (52%), Gaps = 11/101 (10%)
Query: 216 LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA------EF 269
           +T  D+    Y+L + ++Y  SQ  +HRD+   NV++  E   +++ D+GLA      ++
Sbjct: 154 MTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLV-TENNVMKIADFGLARDINNIDY 212
Query: 270 YHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMF 310
           Y   K  N R+  ++   PE L D + Y +  D+WS G + 
Sbjct: 213 YK--KTTNGRLPVKWM-APEALFD-RVYTHQSDVWSFGVLM 249

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 27/108 (25%), Positives = 59/108 (54%), Gaps = 9/108 (8%)
Query: 230 KALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA---EFYHPGKEYNVRVASRYFK 286
           + +DY H++ I+HRD+K +N+ + HE   +++ D+GLA     +    ++     S  + 
Sbjct: 143 QGMDYLHAKSIIHRDLKSNNIFL-HEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWM 201
Query: 287 GPELLVDLQD---YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV 331
            PE ++ +QD   Y +  D+++ G +   ++  + P +   +N DQ++
Sbjct: 202 APE-VIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP-YSNINNRDQII 247

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 29/94 (30%), Positives = 52/94 (55%), Gaps = 12/94 (12%)
Query: 234 YCHSQG----IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK---EYNVRVASRYFK 286
           +C  +G    I HRD K  NV++  +L  + L D+GLA  + PGK   + + +V +R + 
Sbjct: 134 WCRGEGHKPSIAHRDFKSKNVLLKSDLTAV-LADFGLAVRFEPGKPPGDTHGQVGTRRYM 192
Query: 287 GPELL---VDLQ-DYDYSLDMWSLGCMFAGMIFR 316
            PE+L   ++ Q D    +DM+++G +   ++ R
Sbjct: 193 APEVLEGAINFQRDAFLRIDMYAMGLVLWELVSR 226

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 51/229 (22%), Positives = 96/229 (41%), Gaps = 28/229 (12%)
Query: 126 DYEVVRK-------VGRGKYSEVFEGINVN-TNERCXXXXXXXXXXXXXXXXXXXLQNLC 177
           DYE+ R+       +G G++ +V +GI ++  N                      LQ   
Sbjct: 384 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEAL 443
Query: 178 G-----GPNVVKLLDIVRDQHSKTPS-LIFEYVNSTDFKVLYP----TLTDYDIRYYIYE 227
                  P++VKL+ ++    ++ P  +I E     + +        +L    +  Y Y+
Sbjct: 444 TMRQFDHPHIVKLIGVI----TENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQ 499
Query: 228 LLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFK- 286
           L  AL Y  S+  +HRD+   NV++      ++L D+GL+ +      Y         K 
Sbjct: 500 LSTALAYLESKRFVHRDIAARNVLVS-ATDCVKLGDFGLSRYMEDSTYYKASKGKLPIKW 558
Query: 287 -GPELLVDLQDYDYSLDMWSLG-CMFAGMIFRKEPFFYGHDNHDQLVKI 333
             PE  ++ + +  + D+W  G CM+  ++   +P F G  N+D + +I
Sbjct: 559 MAPE-SINFRRFTSASDVWMFGVCMWEILMHGVKP-FQGVKNNDVIGRI 605

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 46/218 (21%), Positives = 88/218 (40%), Gaps = 28/218 (12%)
Query: 131 RKVGRGKYSEVFEGINVNTNE---RCXXXXXXXXXXXXXXXXXXXLQNLCGG---PNVVK 184
           R +G+G +  V+ G  ++  +   +C                      L  G   PNV+ 
Sbjct: 27  RVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLA 86
Query: 185 LLDIVRDQHSKTPSLIFEYVNSTDFKVLY------PTLTDYDIRYYIYELLKALDYCHSQ 238
           L+ I+       P ++  Y+   D           PT+ D  +  +  ++ + ++Y   Q
Sbjct: 87  LIGIMLPPEG-LPHVLLPYMCHGDLLQFIRSPQRNPTVKD--LISFGLQVARGMEYLAEQ 143
Query: 239 GIMHRDVKPHNVMIDHELRKLRLIDWGLA------EFYHPGKEYNVRVASRYFKGPELLV 292
             +HRD+   N M+D     +++ D+GLA      E+Y   +  + R+  ++      L 
Sbjct: 144 KFVHRDLAARNCMLDESF-TVKVADFGLARDILDREYYSVQQHRHARLPVKWTA----LE 198
Query: 293 DLQDYDYSL--DMWSLGCMFAGMIFRKEPFFYGHDNHD 328
            LQ Y ++   D+WS G +   ++ R  P +   D  D
Sbjct: 199 SLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFD 236

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 32/123 (26%), Positives = 60/123 (48%), Gaps = 10/123 (8%)
Query: 192 QHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVM 251
           Q  + P L + Y  S + +     L+  D+    Y++ + ++Y  S+  +HRD+   NV+
Sbjct: 119 QARRPPGLEYSYNPSHNPE---EQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVL 175
Query: 252 IDHELRKLRLIDWGLAEFYHP----GKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLG 307
           +  +   +++ D+GLA   H      K  N R+  ++   PE L D + Y +  D+WS G
Sbjct: 176 VTED-NVMKIADFGLARDIHHIDYYKKTTNGRLPVKWM-APEALFD-RIYTHQSDVWSFG 232
Query: 308 CMF 310
            + 
Sbjct: 233 VLL 235

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 32/123 (26%), Positives = 60/123 (48%), Gaps = 10/123 (8%)
Query: 192 QHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVM 251
           Q  + P L + Y  S + +     L+  D+    Y++ + ++Y  S+  +HRD+   NV+
Sbjct: 118 QARRPPGLEYSYNPSHNPE---EQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVL 174
Query: 252 IDHELRKLRLIDWGLAEFYHP----GKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLG 307
           +  +   +++ D+GLA   H      K  N R+  ++   PE L D + Y +  D+WS G
Sbjct: 175 VTED-NVMKIADFGLARDIHHIDYYKKTTNGRLPVKWM-APEALFD-RIYTHQSDVWSFG 231
Query: 308 CMF 310
            + 
Sbjct: 232 VLL 234

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 32/123 (26%), Positives = 60/123 (48%), Gaps = 10/123 (8%)
Query: 192 QHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVM 251
           Q  + P L + Y  S + +     L+  D+    Y++ + ++Y  S+  +HRD+   NV+
Sbjct: 126 QARRPPGLEYSYNPSHNPE---EQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVL 182
Query: 252 IDHELRKLRLIDWGLAEFYHP----GKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLG 307
           +  +   +++ D+GLA   H      K  N R+  ++   PE L D + Y +  D+WS G
Sbjct: 183 VTED-NVMKIADFGLARDIHHIDYYKKTTNGRLPVKWM-APEALFD-RIYTHQSDVWSFG 239
Query: 308 CMF 310
            + 
Sbjct: 240 VLL 242

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 32/123 (26%), Positives = 60/123 (48%), Gaps = 10/123 (8%)
Query: 192 QHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVM 251
           Q  + P L + Y  S + +     L+  D+    Y++ + ++Y  S+  +HRD+   NV+
Sbjct: 115 QARRPPGLEYSYNPSHNPE---EQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVL 171
Query: 252 IDHELRKLRLIDWGLAEFYHP----GKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLG 307
           +  +   +++ D+GLA   H      K  N R+  ++   PE L D + Y +  D+WS G
Sbjct: 172 VTED-NVMKIADFGLARDIHHIDYYKKTTNGRLPVKWM-APEALFD-RIYTHQSDVWSFG 228
Query: 308 CMF 310
            + 
Sbjct: 229 VLL 231

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 29/99 (29%), Positives = 51/99 (51%), Gaps = 7/99 (7%)
Query: 216 LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH---- 271
           +T  D+    Y+L + ++Y  SQ  +HRD+   NV++  E   +++ D+GLA   +    
Sbjct: 154 MTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLV-TENNVMKIADFGLARDINNIDX 212
Query: 272 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMF 310
             K  N R+  ++   PE L D + Y +  D+WS G + 
Sbjct: 213 XKKTTNGRLPVKWM-APEALFD-RVYTHQSDVWSFGVLM 249

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 30/96 (31%), Positives = 49/96 (51%), Gaps = 8/96 (8%)
Query: 228 LLKALDYCHSQ-GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFK 286
           ++K L Y   +  IMHRDVKP N++++    +++L D+G++         N  V +R + 
Sbjct: 175 VIKGLTYLREKHKIMHRDVKPSNILVNSR-GEIKLCDFGVSGQLI-DSMANSFVGTRSYM 232
Query: 287 GPELLVDLQDYDYSL--DMWSLGCMFAGMIFRKEPF 320
            PE    LQ   YS+  D+WS+G     M   + P 
Sbjct: 233 SPE---RLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 265

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 29/99 (29%), Positives = 51/99 (51%), Gaps = 7/99 (7%)
Query: 216 LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH---- 271
           +T  D+    Y+L + ++Y  SQ  +HRD+   NV++  E   +++ D+GLA   +    
Sbjct: 154 MTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLV-TENNVMKIADFGLARDINNIDX 212
Query: 272 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMF 310
             K  N R+  ++   PE L D + Y +  D+WS G + 
Sbjct: 213 XKKTTNGRLPVKWM-APEALFD-RVYTHQSDVWSFGVLM 249

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 32/123 (26%), Positives = 60/123 (48%), Gaps = 10/123 (8%)
Query: 192 QHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVM 251
           Q  + P L + Y  S + +     L+  D+    Y++ + ++Y  S+  +HRD+   NV+
Sbjct: 126 QAREPPGLEYSYNPSHNPE---EQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVL 182
Query: 252 IDHELRKLRLIDWGLAEFYHP----GKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLG 307
           +  +   +++ D+GLA   H      K  N R+  ++   PE L D + Y +  D+WS G
Sbjct: 183 VTED-NVMKIADFGLARDIHHIDYYKKTTNGRLPVKWM-APEALFD-RIYTHQSDVWSFG 239
Query: 308 CMF 310
            + 
Sbjct: 240 VLL 242

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 32/123 (26%), Positives = 60/123 (48%), Gaps = 10/123 (8%)
Query: 192 QHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVM 251
           Q  + P L + Y  S + +     L+  D+    Y++ + ++Y  S+  +HRD+   NV+
Sbjct: 167 QARRPPGLEYSYNPSHNPE---EQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVL 223
Query: 252 IDHELRKLRLIDWGLAEFYHP----GKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLG 307
           +  +   +++ D+GLA   H      K  N R+  ++   PE L D + Y +  D+WS G
Sbjct: 224 VTED-NVMKIADFGLARDIHHIDYYKKTTNGRLPVKWM-APEALFD-RIYTHQSDVWSFG 280
Query: 308 CMF 310
            + 
Sbjct: 281 VLL 283

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 27/99 (27%), Positives = 51/99 (51%), Gaps = 7/99 (7%)
Query: 216 LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP--- 272
           L+  D+    Y++ + ++Y  S+  +HRD+   NV++  +   +++ D+GLA   H    
Sbjct: 132 LSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTED-NVMKIADFGLARDIHHIDY 190
Query: 273 -GKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMF 310
             K  N R+  ++   PE L D + Y +  D+WS G + 
Sbjct: 191 YKKTTNGRLPVKWM-APEALFD-RIYTHQSDVWSFGVLL 227

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 50/229 (21%), Positives = 95/229 (41%), Gaps = 28/229 (12%)
Query: 126 DYEVVRK-------VGRGKYSEVFEGINVN-TNERCXXXXXXXXXXXXXXXXXXXLQNLC 177
           DYE+ R+       +G G++ +V +GI ++  N                      LQ   
Sbjct: 4   DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEAL 63
Query: 178 GG-----PNVVKLLDIVRDQHSKTPS-LIFEYVNSTDFKVLYP----TLTDYDIRYYIYE 227
                  P++VKL+ ++    ++ P  +I E     + +        +L    +  Y Y+
Sbjct: 64  TMRQFDHPHIVKLIGVI----TENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQ 119
Query: 228 LLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFK- 286
           L  AL Y  S+  +HRD+   NV++      ++L D+GL+ +                K 
Sbjct: 120 LSTALAYLESKRFVHRDIAARNVLVSSN-DCVKLGDFGLSRYMEDSTXXKASKGKLPIKW 178
Query: 287 -GPELLVDLQDYDYSLDMWSLG-CMFAGMIFRKEPFFYGHDNHDQLVKI 333
             PE  ++ + +  + D+W  G CM+  ++   +P F G  N+D + +I
Sbjct: 179 MAPE-SINFRRFTSASDVWMFGVCMWEILMHGVKP-FQGVKNNDVIGRI 225

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 28/94 (29%), Positives = 51/94 (54%), Gaps = 8/94 (8%)
Query: 224 YIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK---EYNVRV 280
           Y++E +  L   H   I HRD+K  NV++ + L    + D+GLA  +  GK   + + +V
Sbjct: 136 YLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTAC-IADFGLALKFEAGKSAGDTHGQV 194
Query: 281 ASRYFKGPELL---VDLQ-DYDYSLDMWSLGCMF 310
            +R +  PE+L   ++ Q D    +DM+++G + 
Sbjct: 195 GTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVL 228

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 42.0 bits (97), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 36/134 (26%), Positives = 61/134 (45%), Gaps = 15/134 (11%)
Query: 185 LLDIVRDQHSKTPSLIFEYVNST------DFKVLYPTLTDYDIRYYIYELLKALDYCHSQ 238
           LL+ +R +  K      EY N        D  VL    T  D+  + Y++ K +++   +
Sbjct: 136 LLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVL----TFEDLLCFAYQVAKGMEFLEFK 191
Query: 239 GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRY---FKGPELLVDLQ 295
             +HRD+   NV++ H  + +++ D+GLA        Y VR  +R    +  PE L +  
Sbjct: 192 SCVHRDLAARNVLVTHG-KVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFE-G 249
Query: 296 DYDYSLDMWSLGCM 309
            Y    D+WS G +
Sbjct: 250 IYTIKSDVWSYGIL 263

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 42.0 bits (97), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 30/96 (31%), Positives = 49/96 (51%), Gaps = 8/96 (8%)
Query: 228 LLKALDYCHSQ-GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFK 286
           ++K L Y   +  IMHRDVKP N++++    +++L D+G++         N  V +R + 
Sbjct: 113 VIKGLTYLREKHKIMHRDVKPSNILVNSR-GEIKLCDFGVSGQLIDSMA-NSFVGTRSYM 170
Query: 287 GPELLVDLQDYDYSL--DMWSLGCMFAGMIFRKEPF 320
            PE    LQ   YS+  D+WS+G     M   + P 
Sbjct: 171 SPE---RLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 203

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 41.6 bits (96), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 30/96 (31%), Positives = 49/96 (51%), Gaps = 8/96 (8%)
Query: 228 LLKALDYCHSQ-GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFK 286
           ++K L Y   +  IMHRDVKP N++++    +++L D+G++         N  V +R + 
Sbjct: 140 VIKGLTYLREKHKIMHRDVKPSNILVNSR-GEIKLCDFGVSGQLIDSM-ANSFVGTRSYM 197
Query: 287 GPELLVDLQDYDYSL--DMWSLGCMFAGMIFRKEPF 320
            PE    LQ   YS+  D+WS+G     M   + P 
Sbjct: 198 SPE---RLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 230

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 41.6 bits (96), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 30/96 (31%), Positives = 49/96 (51%), Gaps = 8/96 (8%)
Query: 228 LLKALDYCHSQ-GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFK 286
           ++K L Y   +  IMHRDVKP N++++    +++L D+G++         N  V +R + 
Sbjct: 113 VIKGLTYLREKHKIMHRDVKPSNILVNSR-GEIKLCDFGVSGQLIDSMA-NSFVGTRSYM 170
Query: 287 GPELLVDLQDYDYSL--DMWSLGCMFAGMIFRKEPF 320
            PE    LQ   YS+  D+WS+G     M   + P 
Sbjct: 171 SPE---RLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 203

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 41.6 bits (96), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 42/217 (19%), Positives = 89/217 (41%), Gaps = 35/217 (16%)
Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLK-------AL 232
           PN+++L  +V     +   ++ EY+ +         L  +D ++ I +L+         +
Sbjct: 110 PNIIRLEGVV--TRGRLAMIVTEYMENGSLDTF---LRTHDGQFTIMQLVGMLRGVGAGM 164
Query: 233 DYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH--PGKEYNV---RVASRYFKG 287
            Y    G +HRD+   NV++D  L   ++ D+GL+      P   Y     ++  R+   
Sbjct: 165 RYLSDLGYVHRDLAARNVLVDSNL-VCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRW-TA 222
Query: 288 PELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK------------ 335
           PE +   + +  + D+WS G +   ++   E  ++   N D +  + +            
Sbjct: 223 PEAIA-FRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRLPAPMGCPH 281
Query: 336 ---DCCLIIWCNSRHSRKPWSKFINADNQHLVSPEAI 369
                 L  W   R  R  +S+ ++  +  + SPE++
Sbjct: 282 ALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPESL 318

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 41.6 bits (96), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 36/153 (23%), Positives = 69/153 (45%), Gaps = 20/153 (13%)
Query: 180 PNVVKLLDI-VRDQHSKTPSLIFEYVNSTDFKVLY------PTLTDYDIRYYIYELLKAL 232
           PNV+ LL I +R + S  P ++  Y+   D +         PT+ D  +  +  ++ K +
Sbjct: 150 PNVLSLLGICLRSEGS--PLVVLPYMKHGDLRNFIRNETHNPTVKD--LIGFGLQVAKGM 205
Query: 233 DYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA------EFYHPGKEYNVRVASRYFK 286
            +  S+  +HRD+   N M+D +   +++ D+GLA      EF     +   ++  ++  
Sbjct: 206 KFLASKKFVHRDLAARNCMLDEKF-TVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMA 264
Query: 287 GPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEP 319
              L    Q +    D+WS G +   ++ R  P
Sbjct: 265 LESL--QTQKFTTKSDVWSFGVLLWELMTRGAP 295

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 41.6 bits (96), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 30/96 (31%), Positives = 49/96 (51%), Gaps = 8/96 (8%)
Query: 228 LLKALDYCHSQ-GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFK 286
           ++K L Y   +  IMHRDVKP N++++    +++L D+G++         N  V +R + 
Sbjct: 113 VIKGLTYLREKHKIMHRDVKPSNILVNSR-GEIKLCDFGVSGQLIDSMA-NSFVGTRSYM 170
Query: 287 GPELLVDLQDYDYSL--DMWSLGCMFAGMIFRKEPF 320
            PE    LQ   YS+  D+WS+G     M   + P 
Sbjct: 171 SPE---RLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 203

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 41.6 bits (96), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 30/96 (31%), Positives = 49/96 (51%), Gaps = 8/96 (8%)
Query: 228 LLKALDYCHSQ-GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFK 286
           ++K L Y   +  IMHRDVKP N++++    +++L D+G++         N  V +R + 
Sbjct: 113 VIKGLTYLREKHKIMHRDVKPSNILVNSR-GEIKLCDFGVSGQLIDSMA-NSFVGTRSYM 170
Query: 287 GPELLVDLQDYDYSL--DMWSLGCMFAGMIFRKEPF 320
            PE    LQ   YS+  D+WS+G     M   + P 
Sbjct: 171 SPE---RLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 203

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 41.6 bits (96), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 36/153 (23%), Positives = 69/153 (45%), Gaps = 20/153 (13%)
Query: 180 PNVVKLLDI-VRDQHSKTPSLIFEYVNSTDFKVLY------PTLTDYDIRYYIYELLKAL 232
           PNV+ LL I +R + S  P ++  Y+   D +         PT+ D  +  +  ++ K +
Sbjct: 91  PNVLSLLGICLRSEGS--PLVVLPYMKHGDLRNFIRNETHNPTVKD--LIGFGLQVAKGM 146
Query: 233 DYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA------EFYHPGKEYNVRVASRYFK 286
            +  S+  +HRD+   N M+D +   +++ D+GLA      EF     +   ++  ++  
Sbjct: 147 KFLASKKFVHRDLAARNCMLDEKF-TVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMA 205
Query: 287 GPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEP 319
              L    Q +    D+WS G +   ++ R  P
Sbjct: 206 LESL--QTQKFTTKSDVWSFGVLLWELMTRGAP 236

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 41.6 bits (96), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 36/153 (23%), Positives = 69/153 (45%), Gaps = 20/153 (13%)
Query: 180 PNVVKLLDI-VRDQHSKTPSLIFEYVNSTDFKVLY------PTLTDYDIRYYIYELLKAL 232
           PNV+ LL I +R + S  P ++  Y+   D +         PT+ D  +  +  ++ K +
Sbjct: 92  PNVLSLLGICLRSEGS--PLVVLPYMKHGDLRNFIRNETHNPTVKD--LIGFGLQVAKGM 147
Query: 233 DYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA------EFYHPGKEYNVRVASRYFK 286
            +  S+  +HRD+   N M+D +   +++ D+GLA      EF     +   ++  ++  
Sbjct: 148 KFLASKKFVHRDLAARNCMLDEKF-TVKVADFGLARDMLDKEFDSVHNKTGAKLPVKWMA 206
Query: 287 GPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEP 319
              L    Q +    D+WS G +   ++ R  P
Sbjct: 207 LESL--QTQKFTTKSDVWSFGVLLWELMTRGAP 237

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 41.6 bits (96), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 30/95 (31%), Positives = 50/95 (52%), Gaps = 8/95 (8%)
Query: 228 LLKALDYCHSQ-GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFK 286
           ++K L Y   +  IMHRDVKP N++++    +++L D+G++      +  N  V +R + 
Sbjct: 116 VIKGLTYLREKHKIMHRDVKPSNILVNSR-GEIKLCDFGVSGQLID-EMANEFVGTRSYM 173
Query: 287 GPELLVDLQDYDYSL--DMWSLGCMFAGMIFRKEP 319
            PE    LQ   YS+  D+WS+G     M   + P
Sbjct: 174 SPE---RLQGTHYSVQSDIWSMGLSLVEMAVGRYP 205

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 41.6 bits (96), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 36/153 (23%), Positives = 69/153 (45%), Gaps = 20/153 (13%)
Query: 180 PNVVKLLDI-VRDQHSKTPSLIFEYVNSTDFKVLY------PTLTDYDIRYYIYELLKAL 232
           PNV+ LL I +R + S  P ++  Y+   D +         PT+ D  +  +  ++ K +
Sbjct: 92  PNVLSLLGICLRSEGS--PLVVLPYMKHGDLRNFIRNETHNPTVKD--LIGFGLQVAKGM 147
Query: 233 DYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA------EFYHPGKEYNVRVASRYFK 286
            +  S+  +HRD+   N M+D +   +++ D+GLA      EF     +   ++  ++  
Sbjct: 148 KFLASKKFVHRDLAARNCMLDEKF-TVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMA 206
Query: 287 GPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEP 319
              L    Q +    D+WS G +   ++ R  P
Sbjct: 207 LESL--QTQKFTTKSDVWSFGVLLWELMTRGAP 237

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 41.6 bits (96), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 27/99 (27%), Positives = 51/99 (51%), Gaps = 7/99 (7%)
Query: 216 LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP--- 272
           L+  D+    Y++ + ++Y  S+  +HRD+   NV++  +   +++ D+GLA   H    
Sbjct: 147 LSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTED-NVMKIADFGLARDIHHIDY 205
Query: 273 -GKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMF 310
             K  N R+  ++   PE L D + Y +  D+WS G + 
Sbjct: 206 YKKTTNGRLPVKWM-APEALFD-RIYTHQSDVWSFGVLL 242

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 41.6 bits (96), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 36/153 (23%), Positives = 69/153 (45%), Gaps = 20/153 (13%)
Query: 180 PNVVKLLDI-VRDQHSKTPSLIFEYVNSTDFKVLY------PTLTDYDIRYYIYELLKAL 232
           PNV+ LL I +R + S  P ++  Y+   D +         PT+ D  +  +  ++ K +
Sbjct: 91  PNVLSLLGICLRSEGS--PLVVLPYMKHGDLRNFIRNETHNPTVKD--LIGFGLQVAKGM 146
Query: 233 DYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA------EFYHPGKEYNVRVASRYFK 286
            +  S+  +HRD+   N M+D +   +++ D+GLA      EF     +   ++  ++  
Sbjct: 147 KFLASKKFVHRDLAARNCMLDEKF-TVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMA 205
Query: 287 GPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEP 319
              L    Q +    D+WS G +   ++ R  P
Sbjct: 206 LESL--QTQKFTTKSDVWSFGVLLWELMTRGAP 236

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 41.6 bits (96), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 36/153 (23%), Positives = 69/153 (45%), Gaps = 20/153 (13%)
Query: 180 PNVVKLLDI-VRDQHSKTPSLIFEYVNSTDFKVLY------PTLTDYDIRYYIYELLKAL 232
           PNV+ LL I +R + S  P ++  Y+   D +         PT+ D  +  +  ++ K +
Sbjct: 89  PNVLSLLGICLRSEGS--PLVVLPYMKHGDLRNFIRNETHNPTVKD--LIGFGLQVAKGM 144
Query: 233 DYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA------EFYHPGKEYNVRVASRYFK 286
            +  S+  +HRD+   N M+D +   +++ D+GLA      EF     +   ++  ++  
Sbjct: 145 KFLASKKFVHRDLAARNCMLDEKF-TVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMA 203
Query: 287 GPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEP 319
              L    Q +    D+WS G +   ++ R  P
Sbjct: 204 LESL--QTQKFTTKSDVWSFGVLLWELMTRGAP 234

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 41.6 bits (96), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 36/153 (23%), Positives = 69/153 (45%), Gaps = 20/153 (13%)
Query: 180 PNVVKLLDI-VRDQHSKTPSLIFEYVNSTDFKVLY------PTLTDYDIRYYIYELLKAL 232
           PNV+ LL I +R + S  P ++  Y+   D +         PT+ D  +  +  ++ K +
Sbjct: 96  PNVLSLLGICLRSEGS--PLVVLPYMKHGDLRNFIRNETHNPTVKD--LIGFGLQVAKGM 151
Query: 233 DYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA------EFYHPGKEYNVRVASRYFK 286
            +  S+  +HRD+   N M+D +   +++ D+GLA      EF     +   ++  ++  
Sbjct: 152 KFLASKKFVHRDLAARNCMLDEKF-TVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMA 210
Query: 287 GPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEP 319
              L    Q +    D+WS G +   ++ R  P
Sbjct: 211 LESL--QTQKFTTKSDVWSFGVLLWELMTRGAP 241

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	408
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	0.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	6e-72
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	8e-70
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	3e-68
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	4e-66
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	1e-63
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	2e-62
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	3e-62
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	6e-62
3o0g_A	292	Cell division protein kinase 5; kinase activator c	2e-61
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	3e-61
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	9e-61
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	1e-60
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	4e-60
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	4e-60
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	8e-60
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	1e-59
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	2e-59
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	4e-59
3niz_A	311	Rhodanese family protein; structural genomics, str	5e-59
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	4e-58
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	7e-58
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	7e-58
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	1e-57
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	3e-57
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	7e-56
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	2e-55
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	1e-54
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	4e-51
3rp9_A	458	Mitogen-activated protein kinase; structural genom	5e-51
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	2e-50
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	2e-50
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	6e-50
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	6e-50
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	1e-49
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	2e-49
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	2e-49
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	4e-49
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	5e-49
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	5e-49
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	6e-49
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	1e-48
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	2e-48
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	2e-48
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	3e-48
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	5e-48
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	5e-48
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	3e-47
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	3e-47
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	4e-47
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	8e-47
3bhy_A	283	Death-associated protein kinase 3; death associate	8e-47
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	1e-46
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	1e-46
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	1e-46
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	2e-46
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	3e-46
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	3e-46
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	4e-46
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	5e-46
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	1e-45
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	3e-45
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	6e-45
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	9e-45
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	2e-44
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	4e-44
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	5e-44
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	7e-43
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	7e-43
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	1e-42
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	1e-42
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	1e-42
2a19_B	284	Interferon-induced, double-stranded RNA-activated	2e-42
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	2e-42
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	2e-42
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	8e-41
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	2e-40
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	1e-39
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	1e-39
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	3e-39
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	4e-39
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	3e-38
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	5e-38
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	1e-37
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	1e-37
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	2e-37
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	2e-37
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	4e-37
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	5e-37
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	7e-37
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	2e-36
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	2e-36
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	2e-36
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	3e-36
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	3e-36
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	6e-36
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	6e-36
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	1e-35
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	6e-35
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	1e-34
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	2e-34
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	3e-34
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	6e-33
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	9e-33
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	1e-32
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	4e-32
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	6e-32
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	3e-31
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	1e-30
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	5e-30
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	5e-30
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	5e-30
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	2e-29
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	4e-29
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	5e-29
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	9e-29
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	1e-28
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	2e-28
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	2e-28
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	2e-28
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	2e-28
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	3e-28
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	9e-28
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	2e-27
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	3e-27
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	5e-27
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	9e-27
2dyl_A	318	Dual specificity mitogen-activated protein kinase	1e-26
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	2e-26
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	6e-25
3aln_A	327	Dual specificity mitogen-activated protein kinase;	1e-24
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	2e-24
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	2e-24
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	2e-24
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	1e-23
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	1e-23
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	2e-23
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	2e-23
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	5e-23
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	6e-23
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	8e-23
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	1e-22
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	1e-22
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	2e-22
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	2e-22
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	4e-22
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	4e-22
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	4e-22
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	6e-22
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	7e-22
3fme_A	290	Dual specificity mitogen-activated protein kinase;	4e-21
3an0_A	340	Dual specificity mitogen-activated protein kinase;	1e-20
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	5e-19
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	3e-17
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	1e-16
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	2e-16
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	2e-16
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	2e-16
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	4e-16
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	7e-16
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	1e-15
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	3e-15
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	8e-15
3ork_A	311	Serine/threonine protein kinase; structural genomi	1e-14
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	1e-14
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	9e-14
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	1e-13
3uqc_A	286	Probable conserved transmembrane protein; structur	1e-13
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	9e-13
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	2e-12
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	3e-12
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	4e-12
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	2e-11
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	3e-11
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	5e-11
3q4u_A	301	Activin receptor type-1; structural genomics conso	5e-11
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	1e-10
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	6e-10
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	7e-10
3soc_A	322	Activin receptor type-2A; structural genomics cons	2e-09
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	3e-09
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	4e-09
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	9e-09
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	1e-08
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	1e-08
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	2e-08
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	4e-08
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	1e-07
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	1e-07
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	2e-07
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	2e-07
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	3e-07
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	3e-07
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	3e-07
3pls_A	298	Macrophage-stimulating protein receptor; protein k	5e-07
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	8e-07
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	1e-06
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	1e-06
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	1e-06
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	2e-06
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	3e-06
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	3e-06
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	4e-06
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	5e-06
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	8e-06
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	1e-05
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	1e-05
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	1e-05
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	1e-05
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	1e-05
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	2e-05
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	3e-05
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	3e-05
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	3e-05
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	4e-05
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	5e-05
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	5e-05
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	6e-05
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	6e-05
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	9e-05
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	9e-05
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	1e-04
4aoj_A	329	High affinity nerve growth factor receptor; transf	3e-04
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	4e-04
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	4e-04
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	5e-04
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	7e-04
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	7e-04
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	8e-04

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score =  524 bits (1353), Expect = 0.0
 Identities = 235/328 (71%), Positives = 271/328 (82%), Gaps = 17/328 (5%)

Query: 92  PAMSKARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNE 151
           P  S+ARVYTDVN  RP+EYWDYES  V+WG+QDDY++VRK+GRGKYSEVFE IN+  NE
Sbjct: 3   PVPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNE 62

Query: 152 RCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKV 211
           + ++KILKPVKKKKIKREIKIL+NL GGPN++ L DIV+D  S+TP+L+FE+VN+TDFK 
Sbjct: 63  KVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQ 122

Query: 212 LYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 271
           LY TLTDYDIR+Y+YE+LKALDYCHS GIMHRDVKPHNVMIDHE RKLRLIDWGLAEFYH
Sbjct: 123 LYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 182

Query: 272 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV 331
           PG+EYNVRVASRYFKGPELLVD Q YDYSLDMWSLGCM A MIFRKEPFF+GHDN+DQLV
Sbjct: 183 PGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLV 242

Query: 332 KIAK-------DCCLIIWCNS----------RHSRKPWSKFINADNQHLVSPEAIDFLDK 374
           +IAK          +  +             RHSRK W +F++++NQHLVSPEA+DFLDK
Sbjct: 243 RIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDK 302

Query: 375 LLRYDHQDRLTAREAMAHPYFAQVRAAE 402
           LLRYDHQ RLTAREAM HPYF  V   +
Sbjct: 303 LLRYDHQSRLTAREAMEHPYFYTVVKDQ 330

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score =  230 bits (589), Expect = 6e-72
 Identities = 91/296 (30%), Positives = 143/296 (48%), Gaps = 30/296 (10%)

Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLL 186
           Y   + +G G +  V++    ++ E   IK +   K+ K  RE++I++ L    N+V+L 
Sbjct: 56  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN-RELQIMRKL-DHCNIVRLR 113

Query: 187 DIVRDQHSKTPS----LIFEYVNSTDFKVLYP------TLTDYDIRYYIYELLKALDYCH 236
                   K       L+ +YV  T ++V         TL    ++ Y+Y+L ++L Y H
Sbjct: 114 YFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH 173

Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD 296
           S GI HRD+KP N+++D +   L+L D+G A+    G+     + SRY++ PEL+    D
Sbjct: 174 SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATD 233

Query: 297 YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK-----DCCLIIWCNSRHS--- 348
           Y  S+D+WS GC+ A ++  + P F G    DQLV+I K         I   N  ++   
Sbjct: 234 YTSSIDVWSAGCVLAELLLGQ-PIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFK 292

Query: 349 -----RKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVR 399
                  PW+K           PEAI    +LL Y    RLT  EA AH +F ++R
Sbjct: 293 FPQIKAHPWTKVFRPR----TPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR 344

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score =  224 bits (573), Expect = 8e-70
 Identities = 96/299 (32%), Positives = 150/299 (50%), Gaps = 31/299 (10%)

Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNVV 183
           +  Y   + +G G +  VF+   V ++E  I K+L+   K+   RE++I++ +   PNVV
Sbjct: 39  EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQD--KRFKNRELQIMRIV-KHPNVV 95

Query: 184 KLLDIVRDQHSKTPS----LIFEYVNSTDFKVL--YP----TLTDYDIRYYIYELLKALD 233
            L         K       L+ EYV  T ++    Y     T+    I+ Y+Y+LL++L 
Sbjct: 96  DLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLA 155

Query: 234 YCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD 293
           Y HS GI HRD+KP N+++D     L+LID+G A+    G+     + SRY++ PEL+  
Sbjct: 156 YIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYICSRYYRAPELIFG 215

Query: 294 LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK-----DCCLIIWCNSRHS 348
             +Y  ++D+WS GC+ A ++  + P F G    DQLV+I K         I   N  + 
Sbjct: 216 ATNYTTNIDIWSTGCVMAELMQGQ-PLFPGESGIDQLVEIIKVLGTPSREQIKTMNPNYM 274

Query: 349 --------RKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVR 399
                     P+SK           P+AID + +LL Y    RLTA EA+ HP+F ++R
Sbjct: 275 EHKFPQIRPHPFSKVFRPR----TPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELR 329

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score =  219 bits (560), Expect = 3e-68
 Identities = 82/303 (27%), Positives = 144/303 (47%), Gaps = 31/303 (10%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIK--ILKPVKKKKIKREIKILQNLCGGPNV 182
           D ++V R  G+G +  V  G   +T     IK  I  P  + +  + ++ L  L   PN+
Sbjct: 23  DRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVL-HHPNI 81

Query: 183 VKLLDIVRDQHSKTPS-----LIFEYVNSTDFKVL--YP----TLTDYDIRYYIYELLKA 231
           V+L         +        ++ EYV  T  +    Y           I+ ++++L+++
Sbjct: 82  VQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRS 141

Query: 232 LDYCH--SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 289
           +   H  S  + HRD+KPHNV+++     L+L D+G A+   P +     + SRY++ PE
Sbjct: 142 IGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYICSRYYRAPE 201

Query: 290 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK-----DCCLIIWCN 344
           L+   Q Y  ++D+WS+GC+FA M+  + P F G ++  QL +I +        ++   N
Sbjct: 202 LIFGNQHYTTAVDIWSVGCIFAEMMLGE-PIFRGDNSAGQLHEIVRVLGCPSREVLRKLN 260

Query: 345 SRHSRK--------PWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFA 396
             H+          PWS   +  +    + EA D L  LL+Y  ++R+   EA+ HPYF 
Sbjct: 261 PSHTDVDLYNSKGIPWSNVFSDHSLKD-AKEAYDLLSALLQYLPEERMKPYEALCHPYFD 319

Query: 397 QVR 399
           ++ 
Sbjct: 320 ELH 322

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score =  214 bits (547), Expect = 4e-66
 Identities = 89/329 (27%), Positives = 148/329 (44%), Gaps = 64/329 (19%)

Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLL 186
           Y + + +G G +  V E  ++ + +R  +K +    + K  RE+ I++ L    N++KL+
Sbjct: 9   YSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKN-RELDIMKVLDH-VNIIKLV 66

Query: 187 DIVRDQHSKTPS------------------------------------LIFEYVNSTDFK 210
           D       + P                                     +I EYV  T  K
Sbjct: 67  DYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHK 126

Query: 211 VLYP------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDW 264
           VL        ++    I  YIY+L +A+ + HS GI HRD+KP N++++ +   L+L D+
Sbjct: 127 VLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNTLKLCDF 186

Query: 265 GLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGH 324
           G A+   P +     + SR+++ PEL++   +Y  S+D+WS+GC+F  +I  K P F G 
Sbjct: 187 GSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGK-PLFSGE 245

Query: 325 DNHDQLVKIAK--------DCCLIIWCNSRHS-----RKPWSK-FINADNQHLVSPEAID 370
            + DQLV+I +            +    +         K W K              AID
Sbjct: 246 TSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTP-----SLAID 300

Query: 371 FLDKLLRYDHQDRLTAREAMAHPYFAQVR 399
            L+++LRY+   R+   EAMAHP+F  +R
Sbjct: 301 LLEQILRYEPDLRINPYEAMAHPFFDHLR 329

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score =  205 bits (525), Expect = 1e-63
 Identities = 86/306 (28%), Positives = 138/306 (45%), Gaps = 41/306 (13%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIK-------------REIK 171
           + YE + K+G G Y  VF+  N +T +   IK        K               REI+
Sbjct: 3   EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIK--------KFLESEDDPVIKKIALREIR 54

Query: 172 ILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL--YPT-LTDYDIRYYIYEL 228
           +L+ L   PN+V LL++ R    +   L+FEY + T    L  Y   + ++ ++   ++ 
Sbjct: 55  MLKQLKH-PNLVNLLEVFR--RKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQT 111

Query: 229 LKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKG 287
           L+A+++CH    +HRDVKP N++I      ++L D+G A     P   Y+  VA+R+++ 
Sbjct: 112 LQAVNFCHKHNCIHRDVKPENILITKH-SVIKLCDFGFARLLTGPSDYYDDEVATRWYRS 170

Query: 288 PELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDC---CLIIW-- 342
           PELLV    Y   +D+W++GC+FA ++    P + G  + DQL  I K            
Sbjct: 171 PELLVGDTQYGPPVDVWAIGCVFAELL-SGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQV 229

Query: 343 ---CNSRHSRKPWSKFINADNQHLV---SPEAIDFLDKLLRYDHQDRLTAREAMAHPYFA 396
                     K          +      S  A+  L   L  D  +RLT  + + HPYF 
Sbjct: 230 FSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFE 289

Query: 397 QVRAAE 402
            +R  E
Sbjct: 290 NIREIE 295

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score =  203 bits (518), Expect = 2e-62
 Identities = 88/307 (28%), Positives = 141/307 (45%), Gaps = 35/307 (11%)

Query: 121 WGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKK-IK----REIKILQN 175
           +   + YE +  VG G Y  V +  N +T     IK        K +K    REIK+L+ 
Sbjct: 21  FQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQ 80

Query: 176 LCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL--YPT-LTDYDIRYYIYELLKAL 232
           L    N+V LL++ +    K   L+FE+V+ T    L  +P  L    ++ Y+++++  +
Sbjct: 81  LRH-ENLVNLLEVCK--KKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGI 137

Query: 233 DYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELL 291
            +CHS  I+HRD+KP N+++      ++L D+G A     PG+ Y+  VA+R+++ PELL
Sbjct: 138 GFCHSHNIIHRDIKPENILVSQS-GVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELL 196

Query: 292 VDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDC------------CL 339
           V    Y  ++D+W++GC+   M F  EP F G  + DQL  I                  
Sbjct: 197 VGDVKYGKAVDVWAIGCLVTEM-FMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKN 255

Query: 340 IIWCNSR----HSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF 395
            ++   R      R+P  +         +S   ID   K L  D   R    E + H +F
Sbjct: 256 PVFAGVRLPEIKEREPLERRYPK-----LSEVVIDLAKKCLHIDPDKRPFCAELLHHDFF 310

Query: 396 AQVRAAE 402
                AE
Sbjct: 311 QMDGFAE 317

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score =  202 bits (517), Expect = 3e-62
 Identities = 83/307 (27%), Positives = 149/307 (48%), Gaps = 44/307 (14%)

Query: 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIK-------------RE 169
             D Y  + K+G G Y EV++ I+  TNE         V  K+I+             RE
Sbjct: 32  SIDRYRRITKLGEGTYGEVYKAIDTVTNET--------VAIKRIRLEHEEEGVPGTAIRE 83

Query: 170 IKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL---YPTLTDYDIRYYIY 226
           + +L+ L    N+++L  ++   H     LIFEY    D K      P ++   I+ ++Y
Sbjct: 84  VSLLKELQH-RNIIELKSVIHHNHRLH--LIFEYA-ENDLKKYMDKNPDVSMRVIKSFLY 139

Query: 227 ELLKALDYCHSQGIMHRDVKPHNVMIDHELRK----LRLIDWGLAEFYH-PGKEYNVRVA 281
           +L+  +++CHS+  +HRD+KP N+++          L++ D+GLA  +  P +++   + 
Sbjct: 140 QLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEII 199

Query: 282 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDC---C 338
           + +++ PE+L+  + Y  S+D+WS+ C++A M+  K P F G    DQL KI +      
Sbjct: 200 TLWYRPPEILLGSRHYSTSVDIWSIACIWAEML-MKTPLFPGDSEIDQLFKIFEVLGLPD 258

Query: 339 LIIW---CNSRHSRKPWSKFINADNQHLV----SPEAIDFLDKLLRYDHQDRLTAREAMA 391
              W         ++ + KF     + ++      E +D L  +L  D   R++A+ A+ 
Sbjct: 259 DTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE 318

Query: 392 HPYFAQV 398
           HPYF+  
Sbjct: 319 HPYFSHN 325

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score =  201 bits (513), Expect = 6e-62
 Identities = 81/310 (26%), Positives = 136/310 (43%), Gaps = 51/310 (16%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIK----------------R 168
             YE V ++G G Y  V++  + ++           V  K ++                R
Sbjct: 9   SRYEPVAEIGVGAYGTVYKARDPHSGHF--------VALKSVRVPNGGGGGGGLPISTVR 60

Query: 169 EIKILQNLCGG--PNVVKLLDIVRDQHSKTPS---LIFEYVNSTDFKVL-----YPTLTD 218
           E+ +L+ L     PNVV+L+D+     +       L+FE+V   D +        P L  
Sbjct: 61  EVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYLDKAPPPGLPA 119

Query: 219 YDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNV 278
             I+  + + L+ LD+ H+  I+HRD+KP N+++      ++L D+GLA  Y        
Sbjct: 120 ETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSG-GTVKLADFGLARIYSYQMALTP 178

Query: 279 RVASRYFKGPELLVDLQD-YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDC 337
            V + +++ PE+L  LQ  Y   +DMWS+GC+FA M FR++P F G+   DQL KI    
Sbjct: 179 VVVTLWYRAPEVL--LQSTYATPVDMWSVGCIFAEM-FRRKPLFCGNSEADQLGKIFDLI 235

Query: 338 ---CLIIWCNSRHSRKPWSKFINADNQHL------VSPEAIDFLDKLLRYDHQDRLTARE 388
                  W   R    P   F     + +      +       L ++L ++   R++A  
Sbjct: 236 GLPPEDDW--PRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFR 293

Query: 389 AMAHPYFAQV 398
           A+ H Y  + 
Sbjct: 294 ALQHSYLHKD 303

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score =  199 bits (509), Expect = 2e-61
 Identities = 85/301 (28%), Positives = 145/301 (48%), Gaps = 40/301 (13%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIK-------------REIK 171
             YE + K+G G Y  VF+  N  T+E         V  K+++             REI 
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEI--------VALKRVRLDDDDEGVPSSALREIC 53

Query: 172 ILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL----YPTLTDYDIRYYIYE 227
           +L+ L    N+V+L D++      T  L+FE+    D K         L    ++ ++++
Sbjct: 54  LLKELKH-KNIVRLHDVLHSDKKLT--LVFEFC-DQDLKKYFDSCNGDLDPEIVKSFLFQ 109

Query: 228 LLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH-PGKEYNVRVASRYFK 286
           LLK L +CHS+ ++HRD+KP N++I+    +L+L ++GLA  +  P + Y+  V + +++
Sbjct: 110 LLKGLGFCHSRNVLHRDLKPQNLLINRN-GELKLANFGLARAFGIPVRCYSAEVVTLWYR 168

Query: 287 GPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDC---CLIIWC 343
            P++L   + Y  S+DMWS GC+FA +     P F G+D  DQL +I +         W 
Sbjct: 169 PPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWP 228

Query: 344 NSR-----HSRKPWSKFINADNQ-HLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQ 397
           +            +    +  N    ++    D L  LL+ +   R++A EA+ HPYF+ 
Sbjct: 229 SMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSD 288

Query: 398 V 398
            
Sbjct: 289 F 289

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score =  198 bits (506), Expect = 9e-61
 Identities = 79/309 (25%), Positives = 151/309 (48%), Gaps = 48/309 (15%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIK------------REIKI 172
             ++ + K+G G Y+ V++G+N  T           V  K++K            REI +
Sbjct: 5   SQFKQLEKLGNGTYATVYKGLNKTTGVY--------VALKEVKLDSEEGTPSTAIREISL 56

Query: 173 LQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYV--------NSTDFKVLYPTLTDYDIRYY 224
           ++ L    N+V+L D++  ++  T  L+FE++        +S         L    ++Y+
Sbjct: 57  MKELKH-ENIVRLYDVIHTENKLT--LVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYF 113

Query: 225 IYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH-PGKEYNVRVASR 283
            ++LL+ L +CH   I+HRD+KP N++I+   + L+L D+GLA  +  P   ++  V + 
Sbjct: 114 QWQLLQGLAFCHENKILHRDLKPQNLLINKRGQ-LKLGDFGLARAFGIPVNTFSSEVVTL 172

Query: 284 YFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDC---CLI 340
           +++ P++L+  + Y  S+D+WS GC+ A MI   +P F G ++ +QL  I          
Sbjct: 173 WYRAPDVLMGSRTYSTSIDIWSCGCILAEMI-TGKPLFPGTNDEEQLKLIFDIMGTPNES 231

Query: 341 IW-----------CNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREA 389
           +W              +   +   + +    +  +    +DFL  LL+ +   RL+A++A
Sbjct: 232 LWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQA 291

Query: 390 MAHPYFAQV 398
           + HP+FA+ 
Sbjct: 292 LHHPWFAEY 300

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score =  198 bits (506), Expect = 1e-60
 Identities = 87/307 (28%), Positives = 145/307 (47%), Gaps = 47/307 (15%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIK-------------REIK 171
             YE V ++G G Y +VF+  ++    R        V  K+++             RE+ 
Sbjct: 11  QQYECVAEIGEGAYGKVFKARDLKNGGRF-------VALKRVRVQTGEEGMPLSTIREVA 63

Query: 172 ILQNLCGG--PNVVKLLDIVRDQHSKTPS---LIFEYVNSTDFKVL-----YPTLTDYDI 221
           +L++L     PNVV+L D+     +   +   L+FE+V   D          P +    I
Sbjct: 64  VLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETI 122

Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVA 281
           +  +++LL+ LD+ HS  ++HRD+KP N+++     +++L D+GLA  Y         V 
Sbjct: 123 KDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSS-GQIKLADFGLARIYSFQMALTSVVV 181

Query: 282 SRYFKGPELLVDLQD-YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDC--- 337
           + +++ PE+L  LQ  Y   +D+WS+GC+FA M FR++P F G  + DQL KI       
Sbjct: 182 TLWYRAPEVL--LQSSYATPVDLWSVGCIFAEM-FRRKPLFRGSSDVDQLGKILDVIGLP 238

Query: 338 CLIIWCNSRHSRKPWSKFINADNQHL------VSPEAIDFLDKLLRYDHQDRLTAREAMA 391
               W   R    P   F +   Q +      +     D L K L ++   R++A  A++
Sbjct: 239 GEEDW--PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 296

Query: 392 HPYFAQV 398
           HPYF  +
Sbjct: 297 HPYFQDL 303

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score =  197 bits (504), Expect = 4e-60
 Identities = 88/323 (27%), Positives = 160/323 (49%), Gaps = 39/323 (12%)

Query: 104 NVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIK-ILKPVK 162
           +++R K ++  +     W     Y     VG G Y  V   I+  + E+  IK + +P +
Sbjct: 3   SLIRKKGFYKQDVNKTAWELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQ 62

Query: 163 K----KKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS----LIFEYVNSTDFKVLYP 214
                K+  RE+ +L+++    NV+ LLD+     S        L+  ++ +   K++  
Sbjct: 63  SEIFAKRAYRELLLLKHMQH-ENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGL 121

Query: 215 TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 274
             ++  I+Y +Y++LK L Y HS G++HRD+KP N+ ++ +  +L+++D+GLA       
Sbjct: 122 KFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDC-ELKILDFGLARHADAEM 180

Query: 275 -EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI 333
             Y   V +R+++ PE+++    Y+ ++D+WS+GC+ A M+  K   F G D  DQL +I
Sbjct: 181 TGY---VVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK-TLFKGKDYLDQLTQI 236

Query: 334 --------AKDCCLIIWCNSR--------HSRKPWSK-FINADNQHLVSPEAIDFLDKLL 376
                    +    +    ++          RK +++ F  A       P+A D L+K+L
Sbjct: 237 LKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRAS------PQAADLLEKML 290

Query: 377 RYDHQDRLTAREAMAHPYFAQVR 399
             D   RLTA +A+ HP+F   R
Sbjct: 291 ELDVDKRLTAAQALTHPFFEPFR 313

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score =  195 bits (499), Expect = 4e-60
 Identities = 82/301 (27%), Positives = 143/301 (47%), Gaps = 42/301 (13%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIK-------------REIK 171
           + Y  + K+G G Y  V++  N N  E            KKI+             REI 
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQN-NYGET--------FALKKIRLEKEDEGIPSTTIREIS 52

Query: 172 ILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL----YPTLTDYDIRYYIYE 227
           IL+ L    N+VKL D++  +      L+FE++   D K L       L     + ++ +
Sbjct: 53  ILKELKH-SNIVKLYDVIHTKKRLV--LVFEHL-DQDLKKLLDVCEGGLESVTAKSFLLQ 108

Query: 228 LLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH-PGKEYNVRVASRYFK 286
           LL  + YCH + ++HRD+KP N++I+ E  +L++ D+GLA  +  P ++Y   + + +++
Sbjct: 109 LLNGIAYCHDRRVLHRDLKPQNLLINRE-GELKIADFGLARAFGIPVRKYTHEIVTLWYR 167

Query: 287 GPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDC---CLIIW- 342
            P++L+  + Y  ++D+WS+GC+FA M+    P F G    DQL++I +         W 
Sbjct: 168 APDVLMGSKKYSTTIDIWSVGCIFAEMV-NGTPLFPGVSEADQLMRIFRILGTPNSKNWP 226

Query: 343 -----CNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQ 397
                     +   +           +    ID L K+L+ D   R+TA++A+ H YF +
Sbjct: 227 NVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286

Query: 398 V 398
            
Sbjct: 287 N 287

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score =  196 bits (500), Expect = 8e-60
 Identities = 82/301 (27%), Positives = 151/301 (50%), Gaps = 41/301 (13%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIK------------REIKI 172
           + Y  + K+G G Y+ V++G +  T+          V  K+I+            RE+ +
Sbjct: 2   ETYIKLDKLGEGTYATVYKGKSKLTDNL--------VALKEIRLEHEEGAPCTAIREVSL 53

Query: 173 LQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL----YPTLTDYDIRYYIYEL 228
           L++L    N+V L DI+  + S T  L+FEY++  D K         +  ++++ ++++L
Sbjct: 54  LKDLKH-ANIVTLHDIIHTEKSLT--LVFEYLD-KDLKQYLDDCGNIINMHNVKLFLFQL 109

Query: 229 LKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH-PGKEYNVRVASRYFKG 287
           L+ L YCH Q ++HRD+KP N++I+    +L+L D+GLA     P K Y+  V + +++ 
Sbjct: 110 LRGLAYCHRQKVLHRDLKPQNLLINER-GELKLADFGLARAKSIPTKTYDNEVVTLWYRP 168

Query: 288 PELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDC---CLIIWCN 344
           P++L+   DY   +DMW +GC+F  M   + P F G    +QL  I +         W  
Sbjct: 169 PDILLGSTDYSTQIDMWGVGCIFYEMATGR-PLFPGSTVEEQLHFIFRILGTPTEETWPG 227

Query: 345 -------SRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQ 397
                    ++   +       +   +  +  D L KLL+++ ++R++A +AM HP+F  
Sbjct: 228 ILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLS 287

Query: 398 V 398
           +
Sbjct: 288 L 288

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score =  195 bits (498), Expect = 1e-59
 Identities = 81/307 (26%), Positives = 142/307 (46%), Gaps = 44/307 (14%)

Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKIL---KPVKKKKIKREIKILQNLCGGPNVV 183
           Y  ++ +G G    VF  ++ + ++R  IK +    P   K   REIKI++ L    N+V
Sbjct: 13  YMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRL-DHDNIV 71

Query: 184 KLLDIVRDQHSKTPSLIFEYVNSTDFKVLYP-------------TLTDYDIRYYIYELLK 230
           K+ +I+    S+    +          ++                L +   R ++Y+LL+
Sbjct: 72  KVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHARLFMYQLLR 131

Query: 231 ALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR----VASRYFK 286
            L Y HS  ++HRD+KP N+ I+ E   L++ D+GLA    P   +       + +++++
Sbjct: 132 GLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYR 191

Query: 287 GPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI--------AKDCC 338
            P LL+   +Y  ++DMW+ GC+FA M+  K   F G    +Q+  I         +D  
Sbjct: 192 SPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK-TLFAGAHELEQMQLILESIPVVHEEDRQ 250

Query: 339 LI-------IWCNSRHSRKPWSK-FINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAM 390
            +       I  +     KP ++             EA+DFL+++L +   DRLTA EA+
Sbjct: 251 ELLSVIPVYIRNDMTEPHKPLTQLLPGIS------REAVDFLEQILTFSPMDRLTAEEAL 304

Query: 391 AHPYFAQ 397
           +HPY + 
Sbjct: 305 SHPYMSI 311

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score =  195 bits (499), Expect = 2e-59
 Identities = 87/313 (27%), Positives = 137/313 (43%), Gaps = 56/313 (17%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIK-------------REIK 171
             YE + K+G+G + EVF+  +  T ++        V  KK+              REIK
Sbjct: 17  SKYEKLAKIGQGTFGEVFKARHRKTGQK--------VALKKVLMENEKEGFPITALREIK 68

Query: 172 ILQNLCGGPNVVKLLDIVRDQHSKTPS------LIFEYVNSTDFKVL----YPTLTDYDI 221
           ILQ L    NVV L++I R + S          L+F++    D   L        T  +I
Sbjct: 69  ILQLL-KHENVVNLIEICRTKASPYNRCKGSIYLVFDFC-EHDLAGLLSNVLVKFTLSEI 126

Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH-----PGKEY 276
           +  +  LL  L Y H   I+HRD+K  NV+I  +   L+L D+GLA  +          Y
Sbjct: 127 KRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGV-LKLADFGLARAFSLAKNSQPNRY 185

Query: 277 NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKD 336
             RV + +++ PELL+  +DY   +D+W  GC+ A M + + P   G+    QL  I++ 
Sbjct: 186 TNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEM-WTRSPIMQGNTEQHQLALISQL 244

Query: 337 C---CLIIWCNSRHSRKPWSKFINADNQH-----------LVSPEAIDFLDKLLRYDHQD 382
           C      +W N         + +                 +  P A+D +DKLL  D   
Sbjct: 245 CGSITPEVWPN--VDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQ 302

Query: 383 RLTAREAMAHPYF 395
           R+ + +A+ H +F
Sbjct: 303 RIDSDDALNHDFF 315

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score =  195 bits (497), Expect = 4e-59
 Identities = 87/293 (29%), Positives = 148/293 (50%), Gaps = 29/293 (9%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIK--------REIKILQNL 176
             YE +  +G G+++ V++  + NTN+   IK +K   + + K        REIK+LQ L
Sbjct: 10  KRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQEL 69

Query: 177 CGGPNVVKLLDIVRDQHSKTP-SLIFEYVNSTDFKVL----YPTLTDYDIRYYIYELLKA 231
              PN++ LLD       K+  SL+F+++  TD +V+       LT   I+ Y+   L+ 
Sbjct: 70  SH-PNIIGLLDAF---GHKSNISLVFDFME-TDLEVIIKDNSLVLTPSHIKAYMLMTLQG 124

Query: 232 LDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPEL 290
           L+Y H   I+HRD+KP+N+++D     L+L D+GLA  F  P + Y  +V +R+++ PEL
Sbjct: 125 LEYLHQHWILHRDLKPNNLLLDEN-GVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPEL 183

Query: 291 LVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDC---CLIIWCNSR- 346
           L   + Y   +DMW++GC+ A ++ R  PF  G  + DQL +I +         W +   
Sbjct: 184 LFGARMYGVGVDMWAVGCILAELLLRV-PFLPGDSDLDQLTRIFETLGTPTEEQWPDMCS 242

Query: 347 ----HSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF 395
                + K +              + +D +  L  ++   R+TA +A+   YF
Sbjct: 243 LPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYF 295

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score =  193 bits (493), Expect = 5e-59
 Identities = 96/310 (30%), Positives = 152/310 (49%), Gaps = 53/310 (17%)

Query: 122 GDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIK-------------R 168
           G  + Y+ + KVG G Y  V++  + +            V  K+I+             R
Sbjct: 18  GLMEKYQKLEKVGEGTYGVVYKAKD-SQGRI--------VALKRIRLDAEDEGIPSTAIR 68

Query: 169 EIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL----YPTLTDYDIRYY 224
           EI +L+ L   PN+V L+D++  +   T  L+FE++   D K +       L D  I+ Y
Sbjct: 69  EISLLKELHH-PNIVSLIDVIHSERCLT--LVFEFM-EKDLKKVLDENKTGLQDSQIKIY 124

Query: 225 IYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH-PGKEYNVRVASR 283
           +Y+LL+ + +CH   I+HRD+KP N++I+ +   L+L D+GLA  +  P + Y   V + 
Sbjct: 125 LYQLLRGVAHCHQHRILHRDLKPQNLLINSDGA-LKLADFGLARAFGIPVRSYTHEVVTL 183

Query: 284 YFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDC---CLI 340
           +++ P++L+  + Y  S+D+WS+GC+FA MI  K P F G  + DQL KI          
Sbjct: 184 WYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGK-PLFPGVTDDDQLPKIFSILGTPNPR 242

Query: 341 IWCN------------SRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTARE 388
            W                  +KPWS  I          E ID L  +L +D   R++AR+
Sbjct: 243 EWPQVQELPLWKQRTFQVFEKKPWSSIIPG-----FCQEGIDLLSNMLCFDPNKRISARD 297

Query: 389 AMAHPYFAQV 398
           AM HPYF  +
Sbjct: 298 AMNHPYFKDL 307

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score =  192 bits (491), Expect = 4e-58
 Identities = 85/318 (26%), Positives = 147/318 (46%), Gaps = 46/318 (14%)

Query: 119 VQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKK----KKIKREIKILQ 174
           + +    D+++   +G G Y  V    +  T E   IK ++P  K     +  REIKIL+
Sbjct: 5   IVYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILK 64

Query: 175 NLCGGPNVVKLLDIVRDQHSKTPS---LIFEYVNSTDFKVLYP-TLTDYDIRYYIYELLK 230
           +     N++ + +I R    +  +   +I E + +   +V+    L+D  I+Y+IY+ L+
Sbjct: 65  HF-KHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTLR 123

Query: 231 ALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR----------- 279
           A+   H   ++HRD+KP N++I+     L++ D+GLA         N             
Sbjct: 124 AVKVLHGSNVIHRDLKPSNLLINSNC-DLKVCDFGLARIIDESAADNSEPTGQQSGMVEF 182

Query: 280 VASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK---- 335
           VA+R+++ PE+++    Y  ++D+WS GC+ A +  R+ P F G D   QL+ I      
Sbjct: 183 VATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR-PIFPGRDYRHQLLLIFGIIGT 241

Query: 336 -----DCCLIIWCNSR--------HSRKPWSK-FINADNQHLVSPEAIDFLDKLLRYDHQ 381
                D   I    +R        +   P  K F   +      P+ ID L ++L +D  
Sbjct: 242 PHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVN------PKGIDLLQRMLVFDPA 295

Query: 382 DRLTAREAMAHPYFAQVR 399
            R+TA+EA+ HPY     
Sbjct: 296 KRITAKEALEHPYLQTYH 313

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score =  192 bits (490), Expect = 7e-58
 Identities = 85/303 (28%), Positives = 157/303 (51%), Gaps = 40/303 (13%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIK-ILKPVKK----KKIKREIKILQNLCGG 179
             Y  ++ VG G Y  V   ++  T  +  IK + +P +     K+  RE+++L+++   
Sbjct: 25  AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRH- 83

Query: 180 PNVVKLLDIVRDQHSKTPS----LIFEYVNSTDFKVLYP-TLTDYDIRYYIYELLKALDY 234
            NV+ LLD+     +        L+  ++ +   K++    L +  I++ +Y++LK L Y
Sbjct: 84  ENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRY 143

Query: 235 CHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK-EYNVRVASRYFKGPELLVD 293
            H+ GI+HRD+KP N+ ++ +  +L+++D+GLA         Y   V +R+++ PE++++
Sbjct: 144 IHAAGIIHRDLKPGNLAVNEDC-ELKILDFGLARQADSEMTGY---VVTRWYRAPEVILN 199

Query: 294 LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI--------AKDCCLIIWCNS 345
              Y  ++D+WS+GC+ A MI  K   F G D+ DQL +I        A+    +    +
Sbjct: 200 WMRYTQTVDIWSVGCIMAEMITGK-TLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEA 258

Query: 346 R--------HSRKPWSK-FINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFA 396
           +          +K ++    NA      SP A++ L+K+L  D + R+TA EA+AHPYF 
Sbjct: 259 KNYMKGLPELEKKDFASILTNA------SPLAVNLLEKMLVLDAEQRVTAGEALAHPYFE 312

Query: 397 QVR 399
            + 
Sbjct: 313 SLH 315

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score =  192 bits (490), Expect = 7e-58
 Identities = 88/319 (27%), Positives = 158/319 (49%), Gaps = 40/319 (12%)

Query: 109 KEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKIL-----KPVKK 163
             ++  E     W   + Y+ +  VG G Y  V    +  T  R  +K L       +  
Sbjct: 13  PTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA 72

Query: 164 KKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS----LIFEYVNSTDFKVLYP-TLTD 218
           K+  RE+++L+++    NV+ LLD+     S        L+   + +    ++    LTD
Sbjct: 73  KRTYRELRLLKHMKH-ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTD 131

Query: 219 YDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK-EYN 277
             +++ IY++L+ L Y HS  I+HRD+KP N+ ++ +  +L+++D+GLA         Y 
Sbjct: 132 DHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDC-ELKILDFGLARHTADEMTGY- 189

Query: 278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK-- 335
             VA+R+++ PE++++   Y+ ++D+WS+GC+ A ++  +   F G D+ DQL  I +  
Sbjct: 190 --VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR-TLFPGTDHIDQLKLILRLV 246

Query: 336 ---DCCLIIWCNSRHSR-----------KPWSK-FINADNQHLVSPEAIDFLDKLLRYDH 380
                 L+   +S  +R             ++  FI A+      P A+D L+K+L  D 
Sbjct: 247 GTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGAN------PLAVDLLEKMLVLDS 300

Query: 381 QDRLTAREAMAHPYFAQVR 399
             R+TA +A+AH YFAQ  
Sbjct: 301 DKRITAAQALAHAYFAQYH 319

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score =  191 bits (488), Expect = 1e-57
 Identities = 78/331 (23%), Positives = 140/331 (42%), Gaps = 48/331 (14%)

Query: 107 RPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIK-ILKPVKK-- 163
              E    + +      Q  Y V R +  G Y  V  G++ +      IK +   V    
Sbjct: 4   AKGEAAMRDLIAELHAMQSPYTVQRFISSGSYGAVCAGVD-SEGIPVAIKRVFNTVSDGR 62

Query: 164 -----------KKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS---LIFEYVNSTDF 209
                      K++ REI++L +    PN++ L DI             L+ E + +   
Sbjct: 63  TVNILSDSFLCKRVLREIRLLNHF-HHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLA 121

Query: 210 KVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGL 266
           +V++     ++   I+Y++Y +L  L   H  G++HRD+ P N+++      + + D+ L
Sbjct: 122 QVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNN-DITICDFNL 180

Query: 267 AEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDN 326
           A            V  R+++ PEL++  + +   +DMWS GC+ A M  RK   F G   
Sbjct: 181 AREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK-ALFRGSTF 239

Query: 327 HDQLVKI--------AKDCCLIIWCNSR---------HSRKPWSK-FINADNQHLVSPEA 368
           ++QL KI         +D  +    ++R            + W+     AD      P A
Sbjct: 240 YNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTAD------PVA 293

Query: 369 IDFLDKLLRYDHQDRLTAREAMAHPYFAQVR 399
           +D + K+L ++ Q R++  +A+ HPYF  + 
Sbjct: 294 LDLIAKMLEFNPQRRISTEQALRHPYFESLF 324

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score =  190 bits (485), Expect = 3e-57
 Identities = 86/304 (28%), Positives = 153/304 (50%), Gaps = 38/304 (12%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKK----KKIKREIKILQNLCGGP 180
             Y  +  +G G Y  V    +     R  IK + P +     ++  REIKIL       
Sbjct: 27  PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRF-RHE 85

Query: 181 NVVKLLDIVRDQHSKTPS---LIFEYVNSTDFKVLY-PTLTDYDIRYYIYELLKALDYCH 236
           N++ + DI+R    +      ++ + + +  +K+L    L++  I Y++Y++L+ L Y H
Sbjct: 86  NIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH 145

Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR----VASRYFKGPELLV 292
           S  ++HRD+KP N++++     L++ D+GLA    P  ++       VA+R+++ PE+++
Sbjct: 146 SANVLHRDLKPSNLLLNTTC-DLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 204

Query: 293 DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI--------AKDCCLIIWCN 344
           + + Y  S+D+WS+GC+ A M+  + P F G    DQL  I         +D   II   
Sbjct: 205 NSKGYTKSIDIWSVGCILAEMLSNR-PIFPGKHYLDQLNHILGILGSPSQEDLNCIINLK 263

Query: 345 SR--------HSRKPWSK-FINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF 395
           +R         ++ PW++ F NAD       +A+D LDK+L ++   R+   +A+AHPY 
Sbjct: 264 ARNYLLSLPHKNKVPWNRLFPNAD------SKALDLLDKMLTFNPHKRIEVEQALAHPYL 317

Query: 396 AQVR 399
            Q  
Sbjct: 318 EQYY 321

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score =  187 bits (477), Expect = 7e-56
 Identities = 72/322 (22%), Positives = 141/322 (43%), Gaps = 35/322 (10%)

Query: 107 RPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIK-ILKPVKK-- 163
           R   ++  E     +     Y+ ++ +G G    V    +        IK + +P +   
Sbjct: 7   RDNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQT 66

Query: 164 --KKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS----LIFEYVNSTDFKVLYPTLT 217
             K+  RE+ +++ +    N++ LL++   Q S        ++ E +++   +V+   L 
Sbjct: 67  HAKRAYRELVLMKCV-NHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELD 125

Query: 218 DYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN 277
              + Y +Y++L  + + HS GI+HRD+KP N+++  +   L+++D+GLA          
Sbjct: 126 HERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMT 184

Query: 278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK-- 335
             V +RY++ PE+++    Y  ++D+WS+GC+   MI      F G D+ DQ  K+ +  
Sbjct: 185 PYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMIKGG-VLFPGTDHIDQWNKVIEQL 242

Query: 336 ---DCCLIIWCNSR----------HSRKPWSK-FINADN------QHLVSPEAIDFLDKL 375
                  +                ++   + K F +           L + +A D L K+
Sbjct: 243 GTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKM 302

Query: 376 LRYDHQDRLTAREAMAHPYFAQ 397
           L  D   R++  EA+ HPY   
Sbjct: 303 LVIDASKRISVDEALQHPYINV 324

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score =  186 bits (474), Expect = 2e-55
 Identities = 88/330 (26%), Positives = 155/330 (46%), Gaps = 57/330 (17%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIK-ILKPVKK----KKIKREIKILQNLCGG 179
             YE+V+K+G+G Y  V++ I+  T E   +K I    +     ++  REI IL  L G 
Sbjct: 9   RKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGH 68

Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY-PTLTDYDIRYYIYELLKALDYCHSQ 238
            N+V LL+++R  + +   L+F+Y+ +    V+    L     +Y +Y+L+K + Y HS 
Sbjct: 69  ENIVNLLNVLRADNDRDVYLVFDYMETDLHAVIRANILEPVHKQYVVYQLIKVIKYLHSG 128

Query: 239 GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR------------------- 279
           G++HRD+KP N++++ E   +++ D+GL+  +   +                        
Sbjct: 129 GLLHRDMKPSNILLNAEC-HVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPIL 187

Query: 280 ---VASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI--- 333
              VA+R+++ PE+L+    Y   +DMWSLGC+   ++  K P F G    +QL +I   
Sbjct: 188 TDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK-PIFPGSSTMNQLERIIGV 246

Query: 334 ----------------AKDCCL-------IIWCNSRHSRKPWSK-FINADNQHLVSPEAI 369
                           AK           I   N R     W    +  + +   + EA+
Sbjct: 247 IDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEAL 306

Query: 370 DFLDKLLRYDHQDRLTAREAMAHPYFAQVR 399
           D LDKLL+++   R++A +A+ HP+ +   
Sbjct: 307 DLLDKLLQFNPNKRISANDALKHPFVSIFH 336

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score =  186 bits (475), Expect = 1e-54
 Identities = 71/324 (21%), Positives = 145/324 (44%), Gaps = 41/324 (12%)

Query: 108 PKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIK-ILKPVKK--- 163
             +++  E     +     Y+ ++ +G G    V    +   +    IK + +P +    
Sbjct: 45  DNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTH 104

Query: 164 -KKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS----LIFEYVNSTDFKVLYPTLTD 218
            K+  RE+ +++ +    N++ LL++   Q +        L+ E +++   +V+   L  
Sbjct: 105 AKRAYRELVLMKCV-NHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDH 163

Query: 219 YDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK---E 275
             + Y +Y++L  + + HS GI+HRD+KP N+++  +   L+++D+GLA           
Sbjct: 164 ERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTP 222

Query: 276 YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK 335
           Y   V +RY++ PE+++    Y  ++D+WS+GC+   M+  K   F G D  DQ  K+ +
Sbjct: 223 Y---VVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMVRHK-ILFPGRDYIDQWNKVIE 277

Query: 336 -----DCCLIIWCNSR----------HSRKPWSK-FINAD------NQHLVSPEAIDFLD 373
                    +                ++   + K F ++       +  L + +A D L 
Sbjct: 278 QLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLS 337

Query: 374 KLLRYDHQDRLTAREAMAHPYFAQ 397
           K+L  D   R++  +A+ HPY   
Sbjct: 338 KMLVIDPAKRISVDDALQHPYINV 361

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  177 bits (452), Expect = 4e-51
 Identities = 72/291 (24%), Positives = 136/291 (46%), Gaps = 32/291 (10%)

Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKI-----LKPVKKKKIKREIKILQNLCG 178
            + Y+ V+K+G G Y EV    +  T+    IKI     +      K+  E+ +L+ L  
Sbjct: 36  SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLL-D 94

Query: 179 GPNVVKLLDIVRDQHSKTPSLIFEYVNST---DFKVLYPTLTDYDIRYYIYELLKALDYC 235
            PN++KL D   D+ +    L+ E        D  +      + D    I ++L  + Y 
Sbjct: 95  HPNIMKLYDFFEDKRNY--YLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYL 152

Query: 236 HSQGIMHRDVKPHNVMID--HELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD 293
           H   I+HRD+KP N++++   +   ++++D+GL+  +   K+   R+ + Y+  PE+L  
Sbjct: 153 HKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVL-- 210

Query: 294 LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWS 353
            + YD   D+WS+G +   ++    P F G  + + L K+ K                W 
Sbjct: 211 RKKYDEKCDVWSIGVILFILLAGYPP-FGGQTDQEILRKVEK-------GKYTFDSPEWK 262

Query: 354 KFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAESS 404
                     VS  A D + ++L++D Q R++A++A+ HP+  ++ + + S
Sbjct: 263 N---------VSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKEMCSKKES 304

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score =  176 bits (449), Expect = 5e-51
 Identities = 91/378 (24%), Positives = 155/378 (41%), Gaps = 95/378 (25%)

Query: 108 PKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIK-ILKPVKK--- 163
            K           W   D YE+   +G G Y  V E  +        IK IL+  +    
Sbjct: 36  SKPTASMPRPHSDWQIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLID 95

Query: 164 -KKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS---LIFEYVNSTDF-KVLY--PTL 216
            K+I REI IL  L    +VVK+LDIV  +  +      ++ E  + +DF K+      L
Sbjct: 96  CKRILREIAILNRL-NHDHVVKVLDIVIPKDVEKFDELYVVLEIAD-SDFKKLFRTPVYL 153

Query: 217 TDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY 276
           T+  I+  +Y LL  + Y HS GI+HRD+KP N +++ +   +++ D+GLA      +  
Sbjct: 154 TELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDC-SVKVCDFGLARTVDYPENG 212

Query: 277 NVR----------------------------VASRYFKGPELLVDLQDYDYSLDMWSLGC 308
           N +                            V +R+++ PEL++  ++Y  ++D+WS+GC
Sbjct: 213 NSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGC 272

Query: 309 MFAGMI----------FRKEPFFYGHD--------------------NHDQLVKI----- 333
           +FA ++            + P F G                      N DQL  I     
Sbjct: 273 IFAELLNMIKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILG 332

Query: 334 ---AKDCCLIIWCNSR--------HSRKPWSK-FINADNQHLVSPEAIDFLDKLLRYDHQ 381
               +D   +   +++              ++ F  +        +AI  L ++L ++  
Sbjct: 333 TPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFPASS------ADAIHLLKRMLVFNPN 386

Query: 382 DRLTAREAMAHPYFAQVR 399
            R+T  E +AHP+F +VR
Sbjct: 387 KRITINECLAHPFFKEVR 404

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  171 bits (435), Expect = 2e-50
 Identities = 65/291 (22%), Positives = 113/291 (38%), Gaps = 44/291 (15%)

Query: 126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKI-----LKPVKKKKIKREIKILQNLCGG- 179
            Y +++++G G  S+VF+ +N    +   IK               + EI  L  L    
Sbjct: 29  IYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 87

Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL--YPTLTDYDIRYYIYELLKALDYCHS 237
             +++L D       +   ++ E  N      L    ++  ++ + Y   +L+A+   H 
Sbjct: 88  DKIIRLYDYEIT--DQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ 145

Query: 238 QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR---VASRYFKGPELLVDL 294
            GI+H D+KP N +I      L+LID+G+A    P     V+   V +  +  PE + D+
Sbjct: 146 HGIVHSDLKPANFLIVD--GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDM 203

Query: 295 ----------QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCN 344
                            D+WSLGC+   M + K PF    +   +L  I          +
Sbjct: 204 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAII---------D 254

Query: 345 SRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF 395
             H  +                +  D L   L+ D + R++  E +AHPY 
Sbjct: 255 PNHEIEFPDI---------PEKDLQDVLKCCLKRDPKQRISIPELLAHPYV 296

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score =  173 bits (441), Expect = 2e-50
 Identities = 77/330 (23%), Positives = 136/330 (41%), Gaps = 65/330 (19%)

Query: 124 QDDYEVVR-KVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIK---------REIKIL 173
           +D +E    KVGRG Y  V++    +  +     +      K+I+         REI +L
Sbjct: 19  EDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYAL------KQIEGTGISMSACREIALL 72

Query: 174 QNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL------------YPTLTDYDI 221
           + L   PNV+ L  +      +   L+F+Y    D   +               L    +
Sbjct: 73  RELKH-PNVISLQKVFLSHADRKVWLLFDYA-EHDLWHIIKFHRASKANKKPVQLPRGMV 130

Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRK---LRLIDWGLA-EFYHPGKEY- 276
           +  +Y++L  + Y H+  ++HRD+KP N+++  E  +   +++ D G A  F  P K   
Sbjct: 131 KSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLA 190

Query: 277 --NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHD--------- 325
             +  V + +++ PELL+  + Y  ++D+W++GC+FA ++   EP F+            
Sbjct: 191 DLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELL-TSEPIFHCRQEDIKTSNPY 249

Query: 326 NHDQLVKIAKDC---CLIIW-----------CNSRHSRKPWSKFINADNQHLV----SPE 367
           +HDQL +I           W                 R  ++                 +
Sbjct: 250 HHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSK 309

Query: 368 AIDFLDKLLRYDHQDRLTAREAMAHPYFAQ 397
           A   L KLL  D   R+T+ +AM  PYF +
Sbjct: 310 AFHLLQKLLTMDPIKRITSEQAMQDPYFLE 339

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  174 bits (444), Expect = 6e-50
 Identities = 73/292 (25%), Positives = 132/292 (45%), Gaps = 33/292 (11%)

Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK------PVKKKKIKREIKILQNLC 177
            D Y+  R +G+G + EV    +  T + C +K++          K+ + RE+++L+ L 
Sbjct: 25  SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQL- 83

Query: 178 GGPNVVKLLDIVRDQHSKTPSLIFEYVNST---DFKVLYPTLTDYDIRYYIYELLKALDY 234
             PN++KL +   D+      L+ E        D  +     ++ D    I ++L  + Y
Sbjct: 84  DHPNIMKLYEFFEDKGYF--YLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITY 141

Query: 235 CHSQGIMHRDVKPHNVMID--HELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLV 292
            H   I+HRD+KP N++++   +   +R+ID+GL+  +   K+   ++ + Y+  PE+L 
Sbjct: 142 MHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVL- 200

Query: 293 DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPW 352
               YD   D+WS G +   ++    P F G + +D L K+ K                W
Sbjct: 201 -HGTYDEKCDVWSTGVILYILLSGCPP-FNGANEYDILKKVEK-------GKYTFELPQW 251

Query: 353 SKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAESS 404
            K         VS  A D + K+L Y    R++AR+A+ H +       + S
Sbjct: 252 KK---------VSESAKDLIRKMLTYVPSMRISARDALDHEWIQTYTKEQIS 294

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  171 bits (434), Expect = 6e-50
 Identities = 65/291 (22%), Positives = 112/291 (38%), Gaps = 44/291 (15%)

Query: 126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKI-----LKPVKKKKIKREIKILQNLCGG- 179
            Y +++++G G  S+VF+ +N    +   IK               + EI  L  L    
Sbjct: 10  IYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 68

Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL--YPTLTDYDIRYYIYELLKALDYCHS 237
             +++L D       +   ++ E  N      L    ++  ++ + Y   +L+A+   H 
Sbjct: 69  DKIIRLYDYEIT--DQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ 126

Query: 238 QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR---VASRYFKGPELLVD- 293
            GI+H D+KP N +I      L+LID+G+A    P     V+   V +  +  PE + D 
Sbjct: 127 HGIVHSDLKPANFLIVD--GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDM 184

Query: 294 ---------LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCN 344
                            D+WSLGC+   M + K PF    +   +L  I          +
Sbjct: 185 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAI---------ID 235

Query: 345 SRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF 395
             H  +                +  D L   L+ D + R++  E +AHPY 
Sbjct: 236 PNHEIEFPDI---------PEKDLQDVLKCCLKRDPKQRISIPELLAHPYV 277

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score =  172 bits (438), Expect = 1e-49
 Identities = 81/353 (22%), Positives = 146/353 (41%), Gaps = 87/353 (24%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIK-ILKPVKK----KKIKREIKILQNLCGG 179
           D+Y +   +GRG Y  V+   + NT +   IK + +  +     K+I REI IL  L   
Sbjct: 26  DNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRL-KS 84

Query: 180 PNVVKLLDIVRDQHSKTPS---LIFEYVNSTDF-KVLYP--TLTDYDIRYYIYELLKALD 233
             +++L D++            ++ E  + +D  K+      LT+  I+  +Y LL   +
Sbjct: 85  DYIIRLYDLIIPDDLLKFDELYIVLEIAD-SDLKKLFKTPIFLTEEHIKTILYNLLLGEN 143

Query: 234 YCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR-------------- 279
           + H  GI+HRD+KP N +++ +   +++ D+GLA   +  K+ N+               
Sbjct: 144 FIHESGIIHRDLKPANCLLNQDC-SVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNK 202

Query: 280 ---------VASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMI----------FRKEPF 320
                    V +R+++ PEL++  ++Y  S+D+WS GC+FA ++            + P 
Sbjct: 203 NLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPL 262

Query: 321 FYG-----------------HDNHDQLVKI--------AKDCCLIIWCNSR--------H 347
           F G                   N DQL  I          D   I               
Sbjct: 263 FPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHR 322

Query: 348 SRKPWSK-FINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVR 399
                 + + +       S + I+ L+ +L+++   R+T  +A+ HPY   VR
Sbjct: 323 KPINLKQKYPSI------SDDGINLLESMLKFNPNKRITIDQALDHPYLKDVR 369

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  168 bits (427), Expect = 2e-49
 Identities = 60/291 (20%), Positives = 125/291 (42%), Gaps = 44/291 (15%)

Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK----PVKKKKIKREIKILQNLCGG 179
            D +   RK+G G + +V      ++    +IK +      V  ++I+ EI++L++L   
Sbjct: 21  DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSL-DH 79

Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNS-------TDFKVLYPTLTDYDIRYYIYELLKAL 232
           PN++K+ ++  D H+    ++ E              +     L++  +   + +++ AL
Sbjct: 80  PNIIKIFEVFEDYHNM--YIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNAL 137

Query: 233 DYCHSQGIMHRDVKPHNVMID--HELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPEL 290
            Y HSQ ++H+D+KP N++         +++ID+GLAE +   +       +  +  PE+
Sbjct: 138 AYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPEV 197

Query: 291 LVDLQDYDYSLDMWSLGC----MFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSR 346
               +D  +  D+WS G     +  G        F G    +   K              
Sbjct: 198 F--KRDVTFKCDIWSAGVVMYFLLTGC-----LPFTGTSLEEVQQKATY-------KEPN 243

Query: 347 HSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQ 397
           ++ +             ++P+A+D L ++L  D + R +A + + H +F Q
Sbjct: 244 YAVECRP----------LTPQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQ 284

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  173 bits (440), Expect = 2e-49
 Identities = 67/298 (22%), Positives = 132/298 (44%), Gaps = 46/298 (15%)

Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKI-----LKPVKKKKIKREIKILQNLCG 178
            + Y +V  +G+G + EV +  +  T +   +K+      K      I RE+++L+ L  
Sbjct: 21  AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKL-D 79

Query: 179 GPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY------PTLTDYDIRYYIYELLKAL 232
            PN++KL +I+ D  S    ++ E     +   L+         +++D    I ++   +
Sbjct: 80  HPNIMKLFEILEDSSSF--YIVGELYTGGE---LFDEIIKRKRFSEHDAARIIKQVFSGI 134

Query: 233 DYCHSQGIMHRDVKPHNVMID--HELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPEL 290
            Y H   I+HRD+KP N++++   +   +++ID+GL+  +    +   R+ + Y+  PE+
Sbjct: 135 TYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEV 194

Query: 291 LVDLQDYDYSLDMWSLGC----MFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSR 346
           L     YD   D+WS G     + +G      P FYG + +D L ++             
Sbjct: 195 L--RGTYDEKCDVWSAGVILYILLSG-----TPPFYGKNEYDILKRVET-------GKYA 240

Query: 347 HSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAESS 404
                W           +S +A D + K+L +    R+TA + + HP+  +  +   +
Sbjct: 241 FDLPQWRT---------ISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSSETPT 289

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  171 bits (434), Expect = 4e-49
 Identities = 56/284 (19%), Positives = 110/284 (38%), Gaps = 35/284 (12%)

Query: 126 DYEVVRKVGRGKYSE-VFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNVVK 184
            +     +G G     V+ G+    N    +K + P       RE+++L+     PNV++
Sbjct: 25  SFCPKDVLGHGAEGTIVYRGMF--DNRDVAVKRILPECFSFADREVQLLRESDEHPNVIR 82

Query: 185 LLDIVRDQHSKTPSLIFEYVNSTDFKVL---YPTLTDYDIRYYIYELLKALDYCHSQGIM 241
                +D+  +   +  E   +T  + +          +    + +    L + HS  I+
Sbjct: 83  YFCTEKDRQFQ--YIAIELCAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIV 140

Query: 242 HRDVKPHNVMIDHE----LRKLRLIDWGLAEFYHPGKEYNVR----VASRYFKGPELLVD 293
           HRD+KPHN++I         K  + D+GL +    G+    R      +  +  PE+L +
Sbjct: 141 HRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSE 200

Query: 294 L--QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKP 351
              ++  Y++D++S GC+F  +I      F         + +           S     P
Sbjct: 201 DCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGA--------CSLDCLHP 252

Query: 352 WSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF 395
                           A + ++K++  D Q R +A+  + HP+F
Sbjct: 253 EKH---------EDVIARELIEKMIAMDPQKRPSAKHVLKHPFF 287

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score =  168 bits (428), Expect = 5e-49
 Identities = 73/292 (25%), Positives = 123/292 (42%), Gaps = 35/292 (11%)

Query: 124 QDDYEVVRKV-GRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNV 182
            DDY++ ++V G G   +V E  +  T ++C +K+L      K ++E+       GGP++
Sbjct: 27  TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLY--DSPKARQEVDHHWQASGGPHI 84

Query: 183 VKLLDIVRDQHSKTPS--LIFEYVNSTD-----FKVLYPTLTDYDIRYYIYELLKALDYC 235
           V +LD+  + H       +I E +   +      +      T+ +    + ++  A+ + 
Sbjct: 85  VCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFL 144

Query: 236 HSQGIMHRDVKPHNVMIDH--ELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD 293
           HS  I HRDVKP N++     +   L+L D+G A+             + Y+  PE+L  
Sbjct: 145 HSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTP-CYTPYYVAPEVL-G 202

Query: 294 LQDYDYSLDMWSLGC----MFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSR 349
            + YD S DMWSLG     +  G      P FY +        + +    I         
Sbjct: 203 PEKYDKSCDMWSLGVIMYILLCGF-----PPFYSNTGQAISPGMKRR---IRLGQYGFPN 254

Query: 350 KPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAA 401
             WS+         VS +A   +  LL+ D  +RLT  + M HP+  Q    
Sbjct: 255 PEWSE---------VSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSMVV 297

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score =  168 bits (427), Expect = 5e-49
 Identities = 64/298 (21%), Positives = 129/298 (43%), Gaps = 46/298 (15%)

Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKIL--KPVKKKKIKREIKILQNLCGGPN 181
            + Y +   +GRG++  V   +  ++ +  + K +  K   +  +K+EI IL       N
Sbjct: 4   YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIA-RHRN 62

Query: 182 VVKLLDIVRDQHSKTPSLIFEYVN---------STDFKVLYPTLTDYDIRYYIYELLKAL 232
           ++ L +           +IFE+++         ++ F+     L + +I  Y++++ +AL
Sbjct: 63  ILHLHESFESMEELV--MIFEFISGLDIFERINTSAFE-----LNEREIVSYVHQVCEAL 115

Query: 233 DYCHSQGIMHRDVKPHNVM-IDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELL 291
            + HS  I H D++P N++        +++I++G A    PG  + +   +  +  PE+ 
Sbjct: 116 QFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVH 175

Query: 292 VDLQDYDYSLDMWSLGC----MFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRH 347
                   + DMWSLG     + +G+       F    N   +  I              
Sbjct: 176 -QHDVVSTATDMWSLGTLVYVLLSGI-----NPFLAETNQQIIENIMN-------AEYTF 222

Query: 348 SRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAESSR 405
             + + +         +S EA+DF+D+LL  + + R+TA EA+ HP+  Q     S++
Sbjct: 223 DEEAFKE---------ISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQKIERVSTK 271

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  169 bits (430), Expect = 6e-49
 Identities = 73/299 (24%), Positives = 136/299 (45%), Gaps = 47/299 (15%)

Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERC---IIKILKPVKKKKIKREIKILQNLCGGP 180
            D Y+++ ++G G +  V   +   T        I    P+ K  +K EI I+  L   P
Sbjct: 50  YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHH-P 108

Query: 181 NVVKLLDIVRDQHSKTPSLIFEYVN---------STDFKVLYPTLTDYDIRYYIYELLKA 231
            ++ L D   D++     LI E+++         + D+K     +++ ++  Y+ +  + 
Sbjct: 109 KLINLHDAFEDKYEMV--LILEFLSGGELFDRIAAEDYK-----MSEAEVINYMRQACEG 161

Query: 232 LDYCHSQGIMHRDVKPHNVMI-DHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPEL 290
           L + H   I+H D+KP N+M    +   +++ID+GLA   +P +   V  A+  F  PE+
Sbjct: 162 LKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEI 221

Query: 291 LVDLQDYDYSLDMWSLGC----MFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSR 346
           + D +   +  DMW++G     + +G+       F G D+ + L  + +       C+  
Sbjct: 222 V-DREPVGFYTDMWAIGVLGYVLLSGL-----SPFAGEDDLETLQNVKR-------CDWE 268

Query: 347 HSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAESSR 405
                +S          VSPEA DF+  LL+ + + RLT  +A+ HP+     +  +SR
Sbjct: 269 FDEDAFSS---------VSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSNLTSR 318

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score =  167 bits (424), Expect = 1e-48
 Identities = 65/299 (21%), Positives = 125/299 (41%), Gaps = 41/299 (13%)

Query: 124 QDDYEVVRKV-GRGKYSEVFEGINVNTNERCIIKI-----LKPVKKKKIKREIKILQNLC 177
            + Y +  K  GRGK++ V + I+ +T +    K           + +I  EI +L+   
Sbjct: 27  NNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAK 86

Query: 178 GGPNVVKLLDIVRDQHSKTPSLIFEYVNSTD-F----KVLYPTLTDYDIRYYIYELLKAL 232
             P V+ L ++  +       LI EY    + F      L   +++ D+   I ++L+ +
Sbjct: 87  SCPRVINLHEVYENTSEII--LILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGV 144

Query: 233 DYCHSQGIMHRDVKPHNVMID--HELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPEL 290
            Y H   I+H D+KP N+++   + L  ++++D+G++       E    + +  +  PE+
Sbjct: 145 YYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPEI 204

Query: 291 LVDLQDYDYSLDMWSLG----CMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSR 346
           L +      + DMW++G     +           F G DN +  + I++        N  
Sbjct: 205 L-NYDPITTATDMWNIGIIAYMLLTHT-----SPFVGEDNQETYLNISQ-------VNVD 251

Query: 347 HSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAESSR 405
           +S + +S          VS  A DF+  LL  + + R TA   ++H +  Q        
Sbjct: 252 YSEETFSS---------VSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDFENLFH 301

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  168 bits (427), Expect = 2e-48
 Identities = 65/291 (22%), Positives = 111/291 (38%), Gaps = 44/291 (15%)

Query: 126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKI-----LKPVKKKKIKREIKILQNLCG-G 179
            Y +++++G G  S+VF+ +N    +   IK               + EI  L  L    
Sbjct: 57  IYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 115

Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL--YPTLTDYDIRYYIYELLKALDYCHS 237
             +++L D       +   ++ E  N      L    ++  ++ + Y   +L+A+   H 
Sbjct: 116 DKIIRLYDYEIT--DQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ 173

Query: 238 QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR---VASRYFKGPELLVD- 293
            GI+H D+KP N +I      L+LID+G+A    P     V+   V +  +  PE + D 
Sbjct: 174 HGIVHSDLKPANFLIVD--GMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDM 231

Query: 294 ---------LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCN 344
                            D+WSLGC+   M + K PF    +   +L  I      I    
Sbjct: 232 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEI---- 287

Query: 345 SRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF 395
                  +              +  D L   L+ D + R++  E +AHPY 
Sbjct: 288 ------EFPDIP--------EKDLQDVLKCCLKRDPKQRISIPELLAHPYV 324

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score =  166 bits (422), Expect = 2e-48
 Identities = 74/304 (24%), Positives = 137/304 (45%), Gaps = 44/304 (14%)

Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK---------PVKKKKIKREIKILQ 174
           +D Y++  ++G G+++ V +    +T      K +K          V +++I+RE+ IL+
Sbjct: 11  EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILR 70

Query: 175 NLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNST---DFKVLYPTLTDYDIRYYIYELLKA 231
            +    NV+ L D+  ++      LI E V+     DF     +L++ +   +I ++L  
Sbjct: 71  QV-LHHNVITLHDVYENRTDVV--LILELVSGGELFDFLAQKESLSEEEATSFIKQILDG 127

Query: 232 LDYCHSQGIMHRDVKPHNVMI---DHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGP 288
           ++Y H++ I H D+KP N+M+   +  +  ++LID+GLA     G E+     +  F  P
Sbjct: 128 VNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAP 187

Query: 289 ELLVDLQDYDYSLDMWSLGC----MFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCN 344
           E++ + +      DMWS+G     + +G        F G    + L  I          +
Sbjct: 188 EIV-NYEPLGLEADMWSIGVITYILLSGA-----SPFLGDTKQETLANITS-------VS 234

Query: 345 SRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAESS 404
                + +S           S  A DF+ KLL  + + RLT +EA+ HP+   V   ++ 
Sbjct: 235 YDFDEEFFSH---------TSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDNQQAM 285

Query: 405 RTRA 408
             R 
Sbjct: 286 VRRE 289

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score =  168 bits (427), Expect = 3e-48
 Identities = 70/293 (23%), Positives = 120/293 (40%), Gaps = 34/293 (11%)

Query: 123 DQDDYEVVRKV-GRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPN 181
             DDY+V  +V G G   +V +  N  T E+  +K+L+     K +RE+++       P+
Sbjct: 59  IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ--DCPKARREVELHWRASQCPH 116

Query: 182 VVKLLDIVRDQHSKTPS--LIFEYVNSTD-----FKVLYPTLTDYDIRYYIYELLKALDY 234
           +V+++D+  + ++      ++ E ++  +             T+ +    +  + +A+ Y
Sbjct: 117 IVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQY 176

Query: 235 CHSQGIMHRDVKPHNVMIDH--ELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLV 292
            HS  I HRDVKP N++         L+L D+G A+             + Y+  PE+L 
Sbjct: 177 LHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVL- 235

Query: 293 DLQDYDYSLDMWSLGC----MFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHS 348
             + YD S DMWSLG     +  G      P FY +        +      I        
Sbjct: 236 GPEKYDKSCDMWSLGVIMYILLCGY-----PPFYSNHGLAISPGMKT---RIRMGQYEFP 287

Query: 349 RKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAA 401
              WS+         VS E    +  LL+ +   R+T  E M HP+  Q    
Sbjct: 288 NPEWSE---------VSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKV 331

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  169 bits (431), Expect = 5e-48
 Identities = 71/294 (24%), Positives = 132/294 (44%), Gaps = 43/294 (14%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK----------------PVKKKKIKR 168
           + Y  VRK+G G Y EV      N +    IK++K                    ++I  
Sbjct: 36  ESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYN 95

Query: 169 EIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTD-FK--VLYPTLTDYDIRYYI 225
           EI +L++L   PN++KL D+  D+      L+ E+    + F+  +      + D    +
Sbjct: 96  EISLLKSL-DHPNIIKLFDVFEDKKYF--YLVTEFYEGGELFEQIINRHKFDECDAANIM 152

Query: 226 YELLKALDYCHSQGIMHRDVKPHNVMID--HELRKLRLIDWGLAEFYHPGKEYNVRVASR 283
            ++L  + Y H   I+HRD+KP N++++  + L  ++++D+GL+ F+    +   R+ + 
Sbjct: 153 KQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTA 212

Query: 284 YFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWC 343
           Y+  PE+L   + Y+   D+WS G +   ++    P F G ++ D + K+ K        
Sbjct: 213 YYIAPEVL--KKKYNEKCDVWSCGVIMYILLCGYPP-FGGQNDQDIIKKVEK-------G 262

Query: 344 NSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQ 397
                   W           +S EA + +  +L YD+  R TA EA+   +  +
Sbjct: 263 KYYFDFNDWKN---------ISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKK 307

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  171 bits (434), Expect = 5e-48
 Identities = 66/355 (18%), Positives = 133/355 (37%), Gaps = 48/355 (13%)

Query: 69  TTVVYEGAIIDKIEERNLAEIPLPAMSKARVYTDVNVLRPKEYWDYESLTVQWGD-QDDY 127
             +  +     +  + +     +          D  V    + +  + + ++     D Y
Sbjct: 100 VLIPGDERKRRRGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHY 159

Query: 128 EVVRKVGRGKYSEVFEGINVNTNERC---IIKILKPVKKKKIKREIKILQNLCGGPNVVK 184
           ++  ++G G +  V       T        +       K+ +++EI+ +  L   P +V 
Sbjct: 160 DIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVL-RHPTLVN 218

Query: 185 LLDIVRDQHSKTPSLIFEYVN---------STDFKVLYPTLTDYDIRYYIYELLKALDYC 235
           L D   D +     +I+E+++             K     +++ +   Y+ ++ K L + 
Sbjct: 219 LHDAFEDDNEMV--MIYEFMSGGELFEKVADEHNK-----MSEDEAVEYMRQVCKGLCHM 271

Query: 236 HSQGIMHRDVKPHNVMI-DHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDL 294
           H    +H D+KP N+M       +L+LID+GL     P +   V   +  F  PE+  + 
Sbjct: 272 HENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVA-EG 330

Query: 295 QDYDYSLDMWSLGC----MFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRK 350
           +   Y  DMWS+G     + +G+       F G ++ + L  +         C+      
Sbjct: 331 KPVGYYTDMWSVGVLSYILLSGL-----SPFGGENDDETLRNVKS-------CDWNMDDS 378

Query: 351 PWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAESSR 405
            +S          +S +  DF+ KLL  D   R+T  +A+ HP+     A     
Sbjct: 379 AFSG---------ISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDS 424

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  161 bits (411), Expect = 3e-47
 Identities = 70/286 (24%), Positives = 119/286 (41%), Gaps = 38/286 (13%)

Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKIL---KPVKKKKIKREIKILQNLCGGP 180
              Y +   +GRG + EV   +   T  R   K +         + K+EI+I+++L   P
Sbjct: 8   NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSL-DHP 66

Query: 181 NVVKLLDIVRDQHSKTPSLIFEYVNST---DFKVLYPTLTDYDIRYYIYELLKALDYCHS 237
           N+++L +   D       L+ E        +  V      + D    + ++L A+ YCH 
Sbjct: 67  NIIRLYETFEDNTDI--YLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHK 124

Query: 238 QGIMHRDVKPHNVMID--HELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQ 295
             + HRD+KP N +         L+LID+GLA  + PGK    +V + Y+  P++L    
Sbjct: 125 LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVL--EG 182

Query: 296 DYDYSLDMWSLGC----MFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKP 351
            Y    D WS G     +  G      P F    + + ++KI +              K 
Sbjct: 183 LYGPECDEWSAGVMMYVLLCGY-----PPFSAPTDSEVMLKIRE-------GTFTFPEKD 230

Query: 352 WSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQ 397
           W           VSP+A   + +LL    + R+T+ +A+ H +F +
Sbjct: 231 WLN---------VSPQAESLIRRLLTKSPKQRITSLQALEHEWFEK 267

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  162 bits (413), Expect = 3e-47
 Identities = 72/303 (23%), Positives = 124/303 (40%), Gaps = 48/303 (15%)

Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK------------PVKKKKIKREIK 171
            ++YE    +GRG  S V   I+  T +   +KI+                ++   +E+ 
Sbjct: 16  YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVD 75

Query: 172 ILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNST---DFKVLYPTLTDYDIRYYIYEL 228
           IL+ + G PN+++L D           L+F+ +      D+     TL++ + R  +  L
Sbjct: 76  ILRKVSGHPNIIQLKDTYETNTFF--FLVFDLMKKGELFDYLTEKVTLSEKETRKIMRAL 133

Query: 229 LKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGP 288
           L+ +   H   I+HRD+KP N+++D ++  ++L D+G +    PG++      +  +  P
Sbjct: 134 LEVICALHKLNIVHRDLKPENILLDDDM-NIKLTDFGFSCQLDPGEKLREVCGTPSYLAP 192

Query: 289 ELL-----VDLQDYDYSLDMWSLGC----MFAGMIFRKEPFFYGHDNHDQLVKIAKDCCL 339
           E++      +   Y   +DMWS G     + AG      P F+       L  I      
Sbjct: 193 EIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGS-----PPFWHRKQMLMLRMIMS---- 243

Query: 340 IIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVR 399
               N +     W            S    D + + L    Q R TA EA+AHP+F Q  
Sbjct: 244 ---GNYQFGSPEWDD---------YSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYV 291

Query: 400 AAE 402
             E
Sbjct: 292 VEE 294

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  162 bits (411), Expect = 4e-47
 Identities = 68/293 (23%), Positives = 131/293 (44%), Gaps = 40/293 (13%)

Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKI-----LKPVKKKKIKREIKILQNLCG 178
            + Y +V  +G+G + EV +  +  T +   +K+      K      I RE+++L+ L  
Sbjct: 21  AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKL-D 79

Query: 179 GPNVVKLLDIVRDQHSKTPSLIFEYVNST---DFKVLYPTLTDYDIRYYIYELLKALDYC 235
            PN++KL +I+ D  S    ++ E        D  +     +++D    I ++   + Y 
Sbjct: 80  HPNIMKLFEILEDSSSF--YIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYM 137

Query: 236 HSQGIMHRDVKPHNVMIDH--ELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD 293
           H   I+HRD+KP N++++   +   +++ID+GL+  +    +   R+ + Y+  PE+L  
Sbjct: 138 HKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVL-- 195

Query: 294 LQDYDYSLDMWSLGC----MFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSR 349
              YD   D+WS G     + +G      P FYG + +D L ++                
Sbjct: 196 RGTYDEKCDVWSAGVILYILLSGT-----PPFYGKNEYDILKRVET-------GKYAFDL 243

Query: 350 KPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAE 402
             W           +S +A D + K+L +    R+TA + + HP+  +  + E
Sbjct: 244 PQWRT---------ISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSSEE 287

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score =  163 bits (414), Expect = 8e-47
 Identities = 74/303 (24%), Positives = 139/303 (45%), Gaps = 44/303 (14%)

Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK---------PVKKKKIKREIKILQ 174
           +D Y++  ++G G+++ V +    +T      K +K          V +++I+RE+ IL+
Sbjct: 11  EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILR 70

Query: 175 NLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNST---DFKVLYPTLTDYDIRYYIYELLKA 231
            +   PN++ L D+  ++      LI E V+     DF     +L++ +   +I ++L  
Sbjct: 71  QV-LHPNIITLHDVYENRTDVV--LILELVSGGELFDFLAQKESLSEEEATSFIKQILDG 127

Query: 232 LDYCHSQGIMHRDVKPHNVMI---DHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGP 288
           ++Y H++ I H D+KP N+M+   +  +  ++LID+GLA     G E+     +  F  P
Sbjct: 128 VNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAP 187

Query: 289 ELLVDLQDYDYSLDMWSLGC----MFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCN 344
           E++ + +      DMWS+G     + +G        F G    + L  I          +
Sbjct: 188 EIV-NYEPLGLEADMWSIGVITYILLSGA-----SPFLGDTKQETLANITA-------VS 234

Query: 345 SRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAESS 404
                + +S+          S  A DF+ KLL  + + RLT +EA+ HP+   V   ++ 
Sbjct: 235 YDFDEEFFSQ---------TSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDTQQAM 285

Query: 405 RTR 407
             R
Sbjct: 286 VRR 288

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score =  160 bits (408), Expect = 8e-47
 Identities = 72/299 (24%), Positives = 134/299 (44%), Gaps = 48/299 (16%)

Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK---------PVKKKKIKREIKILQ 174
           +D YE+  ++G G+++ V +     T +    K +K          V +++I+RE+ IL+
Sbjct: 4   EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILR 63

Query: 175 NLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNST-----DFKVLYPTLTDYDIRYYIYELL 229
            +   PN++ L DI  ++      LI E V  +     DF     +LT+ +   ++ ++L
Sbjct: 64  EI-RHPNIITLHDIFENKTDVV--LILELV--SGGELFDFLAEKESLTEDEATQFLKQIL 118

Query: 230 KALDYCHSQGIMHRDVKPHNVMI---DHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFK 286
             + Y HS+ I H D+KP N+M+   +    +++LID+G+A     G E+     +  F 
Sbjct: 119 DGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFV 178

Query: 287 GPELLVDLQDYDYSLDMWSLGC----MFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIW 342
            PE++ + +      DMWS+G     + +G        F G    + L  I+        
Sbjct: 179 APEIV-NYEPLGLEADMWSIGVITYILLSGA-----SPFLGETKQETLTNISA------- 225

Query: 343 CNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAA 401
            N     + +S           S  A DF+ +LL  D + R+T  +++ H +   +R  
Sbjct: 226 VNYDFDEEYFSN---------TSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRRR 275

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  161 bits (409), Expect = 1e-46
 Identities = 58/282 (20%), Positives = 98/282 (34%), Gaps = 35/282 (12%)

Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK-----PVKKKKIKREIKILQNLCG 178
           Q  ++ + ++G G Y EVF+  +        +K        P  + +   E+   + +  
Sbjct: 56  QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQ 115

Query: 179 GPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYC 235
            P  V+L      +      L  E    +  +       +L +  +  Y+ + L AL + 
Sbjct: 116 HPCCVRLEQ--AWEEGGILYLQTELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHL 173

Query: 236 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQ 295
           HSQG++H DVKP N+ +    R  +L D+GL           V+     +  PELL    
Sbjct: 174 HSQGLVHLDVKPANIFLGPRGR-CKLGDFGLLVELGTAGAGEVQEGDPRYMAPELLQG-- 230

Query: 296 DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSKF 355
            Y  + D++SLG     +    E    G                          +  +  
Sbjct: 231 SYGTAADVFSLGLTILEVACNMELPHGGEGWQQLRQGYLPP-------------EFTAGL 277

Query: 356 INADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQ 397
                    S E    L  +L  D + R TA   +A P   Q
Sbjct: 278 ---------SSELRSVLVMMLEPDPKLRATAEALLALPVLRQ 310

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score =  161 bits (410), Expect = 1e-46
 Identities = 69/299 (23%), Positives = 132/299 (44%), Gaps = 44/299 (14%)

Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK---------PVKKKKIKREIKILQ 174
            D Y+   ++G G+++ V +    +T  +   K +K          V ++ I+RE+ IL+
Sbjct: 10  DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69

Query: 175 NLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNST---DFKVLYPTLTDYDIRYYIYELLKA 231
            +   PNV+ L ++  ++      LI E V      DF     +LT+ +   ++ ++L  
Sbjct: 70  EI-QHPNVITLHEVYENKTDVI--LILELVAGGELFDFLAEKESLTEEEATEFLKQILNG 126

Query: 232 LDYCHSQGIMHRDVKPHNVMI---DHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGP 288
           + Y HS  I H D+KP N+M+   +    ++++ID+GLA     G E+     +  F  P
Sbjct: 127 VYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAP 186

Query: 289 ELLVDLQDYDYSLDMWSLGC----MFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCN 344
           E++ + +      DMWS+G     + +G        F G    + L  ++         N
Sbjct: 187 EIV-NYEPLGLEADMWSIGVITYILLSGA-----SPFLGDTKQETLANVSA-------VN 233

Query: 345 SRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAES 403
                + +S           S  A DF+ +LL  D + R+T ++++ HP+       ++
Sbjct: 234 YEFEDEYFSN---------TSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQA 283

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  162 bits (413), Expect = 1e-46
 Identities = 74/336 (22%), Positives = 148/336 (44%), Gaps = 46/336 (13%)

Query: 90  PLPAMSKARVYTDVNVLRPKEYWDYESLTVQWGD-QDDYEVVRK--VGRGKYSEVFEGIN 146
            +P  SK      V++  P   +D+  +T + G     Y V +   +G G++ +V +   
Sbjct: 51  RMPVKSKRTSALAVDIPAPPAPFDHRIVTAKQGAVNSFYTVSKTEILGGGRFGQVHKCEE 110

Query: 147 VNTNERC---IIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEY 203
             T  +    IIK      K+++K EI ++  L    N+++L D    ++     L+ EY
Sbjct: 111 TATGLKLAAKIIKTRGMKDKEEVKNEISVMNQL-DHANLIQLYDAFESKNDIV--LVMEY 167

Query: 204 VNS-------TDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVM-IDHE 255
           V+         D        T+ D   ++ ++ + + + H   I+H D+KP N++ ++ +
Sbjct: 168 VDGGELFDRIIDESYNL---TELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRD 224

Query: 256 LRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLG----CMFA 311
            +++++ID+GLA  Y P ++  V   +  F  PE++ +     +  DMWS+G     + +
Sbjct: 225 AKQIKIIDFGLARRYKPREKLKVNFGTPEFLAPEVV-NYDFVSFPTDMWSVGVIAYMLLS 283

Query: 312 GMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSKFINADNQHLVSPEAIDF 371
           G+       F G ++ + L  I         C      + +           +S EA +F
Sbjct: 284 GL-----SPFLGDNDAETLNNILA-------CRWDLEDEEFQD---------ISEEAKEF 322

Query: 372 LDKLLRYDHQDRLTAREAMAHPYFAQVRAAESSRTR 407
           + KLL  +   R++A EA+ HP+ +  +       +
Sbjct: 323 ISKLLIKEKSWRISASEALKHPWLSDHKLHSRLSAQ 358

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  160 bits (407), Expect = 2e-46
 Identities = 64/304 (21%), Positives = 113/304 (37%), Gaps = 53/304 (17%)

Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK--PVKKKKIKREIKILQNLCGGPN 181
             D+E +  +G+G + +V +  N   +    IK ++    K   I  E+ +L +L     
Sbjct: 5   ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASL-NHQY 63

Query: 182 VVKLLDIVRDQHSKTPS-----------LIFEYVNS---TDFKVLYPTLTDYD-IRYYIY 226
           VV+      ++ +               +  EY  +    D           D       
Sbjct: 64  VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFR 123

Query: 227 ELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFK 286
           ++L+AL Y HSQGI+HRD+KP N+ ID   R +++ D+GLA+  H   +     +     
Sbjct: 124 QILEALSYIHSQGIIHRDLKPMNIFIDES-RNVKIGDFGLAKNVHRSLDILKLDSQNLPG 182

Query: 287 G---------------PELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV 331
                            E+L     Y+  +DM+SLG +F  MI+   PF  G +  + L 
Sbjct: 183 SSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVNILK 239

Query: 332 KIAKDCCLIIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA 391
           K+            R     +    + +            +  L+ +D   R  AR  + 
Sbjct: 240 KL------------RSVSIEFPPDFDDN----KMKVEKKIIRLLIDHDPNKRPGARTLLN 283

Query: 392 HPYF 395
             + 
Sbjct: 284 SGWL 287

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  161 bits (409), Expect = 3e-46
 Identities = 68/332 (20%), Positives = 123/332 (37%), Gaps = 78/332 (23%)

Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK--------PVKKKKIKREIKILQN 175
           Q  Y +   +G+G Y  V   I   T     IKI+         P   ++IK E+++++ 
Sbjct: 25  QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKK 84

Query: 176 LCGGPNVVKLLDIVRDQHSKTPSLIFEYV------------------------------- 204
           L   PN+ +L ++  D+      L+ E                                 
Sbjct: 85  LHH-PNIARLYEVYEDEQYI--CLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICP 141

Query: 205 ------------NSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMI 252
                            + L     +  I   + ++  AL Y H+QGI HRD+KP N + 
Sbjct: 142 CPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLF 201

Query: 253 DH-ELRKLRLIDWGLAEFYHPGKE-----YNVRVASRYFKGPELL-VDLQDYDYSLDMWS 305
              +  +++L+D+GL++ ++            +  + YF  PE+L    + Y    D WS
Sbjct: 202 STNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWS 261

Query: 306 LGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSKFINADNQHLVS 365
            G +   ++    P F G ++ D + ++                  ++          +S
Sbjct: 262 AGVLLHLLLMGAVP-FPGVNDADTISQVLN-------KKLCFENPNYNV---------LS 304

Query: 366 PEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQ 397
           P A D L  LL  +  +R  A  A+ HP+ +Q
Sbjct: 305 PLARDLLSNLLNRNVDERFDAMRALQHPWISQ 336

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  160 bits (407), Expect = 3e-46
 Identities = 53/299 (17%), Positives = 109/299 (36%), Gaps = 29/299 (9%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKK----IKREIKILQNLCGGP 180
             + +   +G+G  + VF G +  T +   IK+   +   +      RE ++L+ L    
Sbjct: 9   HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNH-K 67

Query: 181 NVVKLLDIVRDQHSKTPSLIFEYVNSTD-FKVL-----YPTLTDYDIRYYIYELLKALDY 234
           N+VKL  I  +  ++   LI E+      + VL        L + +    + +++  +++
Sbjct: 68  NIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNH 127

Query: 235 CHSQGIMHRDVKPHNVMIDHELRK---LRLIDWGLAEFYHPGKEYNVRVASRYFKGPELL 291
               GI+HR++KP N+M           +L D+G A      +++     +  +  P++ 
Sbjct: 128 LRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMY 187

Query: 292 -------VDLQDYDYSLDMWSLGCMFAGMIFRKEPF---FYGHDNHDQLVKIAK---DCC 338
                     + Y  ++D+WS+G  F        PF        N + + KI        
Sbjct: 188 ERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGA 247

Query: 339 LIIWCNSRHSRKPWSKFINADNQ--HLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF 395
           +     + +    WS  +         +       L  +L  D +      +  A    
Sbjct: 248 ISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSD 306

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  161 bits (409), Expect = 4e-46
 Identities = 70/294 (23%), Positives = 134/294 (45%), Gaps = 39/294 (13%)

Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKI-----LKPVKKKKIKREIKILQNLCG 178
            D+Y+V  ++G+G +S V   ++  T      KI     L     +K++RE +I + L  
Sbjct: 28  SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 87

Query: 179 GPNVVKLLDIVRDQHSKTPSLIFEYVNST---DFKVLYPTLTDYDIRYYIYELLKALDYC 235
            PN+V+L D ++++      L+F+ V      +  V     ++ D  + I ++L+++ YC
Sbjct: 88  -PNIVRLHDSIQEESFH--YLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYC 144

Query: 236 HSQGIMHRDVKPHNVMIDHELR--KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD 293
           HS GI+HR++KP N+++  + +   ++L D+GLA   +  + ++    +  +  PE+L  
Sbjct: 145 HSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVL-K 203

Query: 294 LQDYDYSLDMWSLGCMF----AGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSR 349
              Y   +D+W+ G +      G      P F+  D H    +I             +  
Sbjct: 204 KDPYSKPVDIWACGVILYILLVGY-----PPFWDEDQHRLYAQIKA-------GAYDYPS 251

Query: 350 KPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAES 403
             W           V+PEA   +D +L  + + R+TA +A+  P+        S
Sbjct: 252 PEWDT---------VTPEAKSLIDSMLTVNPKKRITADQALKVPWICNRERVAS 296

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  163 bits (413), Expect = 5e-46
 Identities = 55/305 (18%), Positives = 110/305 (36%), Gaps = 52/305 (17%)

Query: 124 QDDYEVVRKVGRGKYSEV-FEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNV 182
           ++     + +G G    V F+G          +K +          EIK+L      PNV
Sbjct: 14  KNLVVSEKILGYGSSGTVVFQGSF--QGRPVAVKRMLIDFCDIALMEIKLLTESDDHPNV 71

Query: 183 VKLLDIVRDQHSKTPSLIFEYVNST---------DFKVLYPTLTDYDIRYYIYELLKALD 233
           ++              +  E  N                     +Y+    + ++   + 
Sbjct: 72  IRYYCSETTDRFL--YIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVA 129

Query: 234 YCHSQGIMHRDVKPHNVMID------------HELRKLRLIDWGLAEFYHPGKEY----- 276
           + HS  I+HRD+KP N+++              E  ++ + D+GL +    G+       
Sbjct: 130 HLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNL 189

Query: 277 NVRVASRYFKGPELLVDLQD------YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQL 330
           N    +  ++ PELL +  +         S+D++S+GC+F  ++ + +  F   D + + 
Sbjct: 190 NNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFG--DKYSRE 247

Query: 331 VKIAKDCCLIIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAM 390
             I +     I+                     +  EA D + +++ +D   R TA + +
Sbjct: 248 SNIIRG----IFSLDEMKCLHDRS---------LIAEATDLISQMIDHDPLKRPTAMKVL 294

Query: 391 AHPYF 395
            HP F
Sbjct: 295 RHPLF 299

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  158 bits (401), Expect = 1e-45
 Identities = 70/294 (23%), Positives = 134/294 (45%), Gaps = 39/294 (13%)

Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKI-----LKPVKKKKIKREIKILQNLCG 178
            D+Y+V  ++G+G +S V   ++  T      KI     L     +K++RE +I + L  
Sbjct: 5   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64

Query: 179 GPNVVKLLDIVRDQHSKTPSLIFEYVNST---DFKVLYPTLTDYDIRYYIYELLKALDYC 235
            PN+V+L D ++++      L+F+ V      +  V     ++ D  + I ++L+++ YC
Sbjct: 65  -PNIVRLHDSIQEESFH--YLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYC 121

Query: 236 HSQGIMHRDVKPHNVMIDHELR--KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD 293
           HS GI+HR++KP N+++  + +   ++L D+GLA   +  + ++    +  +  PE+L  
Sbjct: 122 HSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVL-K 180

Query: 294 LQDYDYSLDMWSLGC----MFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSR 349
              Y   +D+W+ G     +  G      P F+  D H    +I             +  
Sbjct: 181 KDPYSKPVDIWACGVILYILLVGY-----PPFWDEDQHRLYAQIKA-------GAYDYPS 228

Query: 350 KPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAES 403
             W           V+PEA   +D +L  + + R+TA +A+  P+        S
Sbjct: 229 PEWDT---------VTPEAKSLIDSMLTVNPKKRITADQALKVPWICNRERVAS 273

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  159 bits (404), Expect = 3e-45
 Identities = 49/319 (15%), Positives = 86/319 (26%), Gaps = 54/319 (16%)

Query: 126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKIL------KPVKKKKIKREIKILQNL--- 176
             ++V  +  G  S VF   +V   E   +K+          + +++         L   
Sbjct: 63  KLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGE 122

Query: 177 --------------------CGGPNVVKLLDIVRDQHSKTPSLIFEYVNST--------- 207
                                  P   +L     D       L+    +           
Sbjct: 123 SPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLD 182

Query: 208 DFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA 267
              V         +     +L++      S+G++H    P N+ I  + R L L D    
Sbjct: 183 FVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGR-LMLGDVSAL 241

Query: 268 EFYHPGKEYNVRVASRYFKGPELL-VDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDN 326
             +  G           +   E L      + ++L+ W LG     +     PF      
Sbjct: 242 --WKVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPG 299

Query: 327 HDQLVKIAKDCCLIIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTA 386
                K             R        F +      +       + + L +D + RL  
Sbjct: 300 IKGSWKRPSL---------RVPGTDSLAFGSCTP---LPDFVKTLIGRFLNFDRRRRLLP 347

Query: 387 REAMAHPYFAQVRAAESSR 405
            EAM  P F Q++   SS 
Sbjct: 348 LEAMETPEFLQLQNEISSS 366

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score =  158 bits (401), Expect = 6e-45
 Identities = 68/296 (22%), Positives = 126/296 (42%), Gaps = 47/296 (15%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKK-----------KIKREIKIL 173
             Y+    +GRG  S V   ++  T     +KI++   ++             +RE  IL
Sbjct: 94  QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHIL 153

Query: 174 QNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNST---DFKVLYPTLTDYDIRYYIYELLK 230
           + + G P+++ L+D           L+F+ +      D+      L++ + R  +  LL+
Sbjct: 154 RQVAGHPHIITLIDSYESSSFM--FLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLE 211

Query: 231 ALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPEL 290
           A+ + H+  I+HRD+KP N+++D  + ++RL D+G +    PG++      +  +  PE+
Sbjct: 212 AVSFLHANNIVHRDLKPENILLDDNM-QIRLSDFGFSCHLEPGEKLRELCGTPGYLAPEI 270

Query: 291 L-----VDLQDYDYSLDMWSLGC----MFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLII 341
           L          Y   +D+W+ G     + AG      P F+       L  I +      
Sbjct: 271 LKCSMDETHPGYGKEVDLWACGVILFTLLAGS-----PPFWHRRQILMLRMIME------ 319

Query: 342 WCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQ 397
               + S   W            S    D + +LL+ D + RLTA +A+ HP+F +
Sbjct: 320 -GQYQFSSPEWDD---------RSSTVKDLISRLLQVDPEARLTAEQALQHPFFER 365

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score =  157 bits (398), Expect = 9e-45
 Identities = 69/298 (23%), Positives = 125/298 (41%), Gaps = 36/298 (12%)

Query: 124 QDDYEV---VRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGP 180
              Y++    + +G G +S   + ++  +N+   +KI+    +   ++EI  L+   G P
Sbjct: 7   YQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKEITALKLCEGHP 66

Query: 181 NVVKLLDIVRDQHSKTPSLIFEYVNSTD-F-----KVLYPTLTDYDIRYYIYELLKALDY 234
           N+VKL ++  DQ      L+ E +N  + F     K  +   ++ +  Y + +L+ A+ +
Sbjct: 67  NIVKLHEVFHDQLHT--FLVMELLNGGELFERIKKKKHF---SETEASYIMRKLVSAVSH 121

Query: 235 CHSQGIMHRDVKPHNVMIDH--ELRKLRLIDWGLAEFYHP-GKEYNVRVASRYFKGPELL 291
            H  G++HRD+KP N++     +  ++++ID+G A    P  +       + ++  PELL
Sbjct: 122 MHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELL 181

Query: 292 VDLQDYDYSLDMWSLGC----MFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRH 347
            +   YD S D+WSLG     M +G        F  HD         +    I   +   
Sbjct: 182 -NQNGYDESCDLWSLGVILYTMLSGQ-----VPFQSHDRSLTCTSAVEIMKKIKKGDFSF 235

Query: 348 SRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAESSR 405
             + W           VS EA D +  LL  D   RL       + +        S+ 
Sbjct: 236 EGEAWKN---------VSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQLSSNP 284

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  157 bits (398), Expect = 2e-44
 Identities = 71/302 (23%), Positives = 132/302 (43%), Gaps = 48/302 (15%)

Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK--------PVKKKKIKREIKILQN 175
           +D YE+   +G+G +S V   IN  T ++  +KI+          +  + +KRE  I   
Sbjct: 23  EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHM 82

Query: 176 LCGGPNVVKLLDIVRDQHSKTPSLIFEYVNS-------TDFKVLYPTLTDYDIRYYIYEL 228
           L   P++V+LL+           ++FE+++                  ++    +Y+ ++
Sbjct: 83  L-KHPHIVELLETYSSDGML--YMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQI 139

Query: 229 LKALDYCHSQGIMHRDVKPHNVMID--HELRKLRLIDWGLA-EFYHPGKEYNVRVASRYF 285
           L+AL YCH   I+HRDVKPH V++        ++L  +G+A +    G     RV + +F
Sbjct: 140 LEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHF 199

Query: 286 KGPELLVDLQDYDYSLDMWSLG----CMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLII 341
             PE++   + Y   +D+W  G     + +G      PF   +   ++L +       II
Sbjct: 200 MAPEVV-KREPYGKPVDVWGCGVILFILLSGC----LPF---YGTKERLFE------GII 245

Query: 342 WCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAA 401
               + + + WS          +S  A D + ++L  D  +R+T  EA+ HP+  +    
Sbjct: 246 KGKYKMNPRQWSH---------ISESAKDLVRRMLMLDPAERITVYEALNHPWLKERDRY 296

Query: 402 ES 403
             
Sbjct: 297 AY 298

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  157 bits (399), Expect = 4e-44
 Identities = 69/302 (22%), Positives = 123/302 (40%), Gaps = 46/302 (15%)

Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKIL-----------KPVKKKKIKREIKI 172
           +D+Y + + +G G   EV       T ++  I+I+           +      ++ EI+I
Sbjct: 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEI 193

Query: 173 LQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNS---TDFKVLYPTLTDYDIRYYIYELL 229
           L+ L   P ++K+ +    +      ++ E +      D  V    L +   + Y Y++L
Sbjct: 194 LKKL-NHPCIIKIKNFFDAEDY---YIVLELMEGGELFDKVVGNKRLKEATCKLYFYQML 249

Query: 230 KALDYCHSQGIMHRDVKPHNVMID--HELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG 287
            A+ Y H  GI+HRD+KP NV++    E   +++ D+G ++             +  +  
Sbjct: 250 LAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLA 309

Query: 288 PELLVDLQD--YDYSLDMWSLGC----MFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLII 341
           PE+LV +    Y+ ++D WSLG       +G      P F  H     L         I 
Sbjct: 310 PEVLVSVGTAGYNRAVDCWSLGVILFICLSGY-----PPFSEHRTQVSLKDQ------IT 358

Query: 342 WCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAA 401
                   + W++         VS +A+D + KLL  D + R T  EA+ HP+       
Sbjct: 359 SGKYNFIPEVWAE---------VSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMK 409

Query: 402 ES 403
             
Sbjct: 410 RK 411

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score =  155 bits (394), Expect = 5e-44
 Identities = 76/289 (26%), Positives = 122/289 (42%), Gaps = 38/289 (13%)

Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIK-ILKPVKKKKIKREIKILQNLCGGPNV 182
            D +EV  ++GRG  S V+      T +   +K + K V KK ++ EI +L  L   PN+
Sbjct: 52  SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRTEIGVLLRLSH-PNI 110

Query: 183 VKLLDIVRDQHSKTPSLIFEYVNST-----DFKVLYPTLTDYDIRYYIYELLKALDYCHS 237
           +KL +I         SL+ E V  T     D  V     ++ D    + ++L+A+ Y H 
Sbjct: 111 IKLKEIFETPTEI--SLVLELV--TGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHE 166

Query: 238 QGIMHRDVKPHNVMIDHELR--KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQ 295
            GI+HRD+KP N++         L++ D+GL++             +  +  PE+L    
Sbjct: 167 NGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEILRG-C 225

Query: 296 DYDYSLDMWSLGCMF----AGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKP 351
            Y   +DMWS+G +      G        FY       + +       I+ C        
Sbjct: 226 AYGPEVDMWSVGIITYILLCGF-----EPFYDERGDQFMFRR------ILNCEYYFISPW 274

Query: 352 WSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRA 400
           W +         VS  A D + KL+  D + RLT  +A+ HP+     A
Sbjct: 275 WDE---------VSLNAKDLVRKLIVLDPKKRLTTFQALQHPWVTGKAA 314

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  153 bits (389), Expect = 7e-43
 Identities = 53/296 (17%), Positives = 108/296 (36%), Gaps = 29/296 (9%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK----KKKIKREIKILQNLCGGP 180
             + +   +G+G  + VF G +  T +   IK+   +          RE ++L+ L    
Sbjct: 9   HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNH-K 67

Query: 181 NVVKLLDIVRDQHSKTPSLIFEYVNSTD-FKVL-----YPTLTDYDIRYYIYELLKALDY 234
           N+VKL  I  +  ++   LI E+      + VL        L + +    + +++  +++
Sbjct: 68  NIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNH 127

Query: 235 CHSQGIMHRDVKPHNVMIDHELRK---LRLIDWGLAEFYHPGKEYNVRVASRYFKGPELL 291
               GI+HR++KP N+M           +L D+G A      +++     +  +  P++ 
Sbjct: 128 LRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMY 187

Query: 292 -------VDLQDYDYSLDMWSLGCMFAGMIFRKEPF---FYGHDNHDQLVKIAK---DCC 338
                     + Y  ++D+WS+G  F        PF        N + + KI        
Sbjct: 188 ERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGA 247

Query: 339 LIIWCNSRHSRKPWSKFINADNQ--HLVSPEAIDFLDKLLRYDHQDRLTAREAMAH 392
           +     + +    WS  +         +       L  +L  D +      +  A 
Sbjct: 248 ISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAE 303

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  151 bits (383), Expect = 7e-43
 Identities = 68/294 (23%), Positives = 117/294 (39%), Gaps = 42/294 (14%)

Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKIL---KPVKKKKIKREIKILQNLCGGP 180
           +  +  +  +G G +SEVF      T +   +K +      +   ++ EI +L+ +    
Sbjct: 8   RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKH-E 66

Query: 181 NVVKLLDIVRDQHSKTPSLIFEYVNST-----DFKVLYPTLTDYDIRYYIYELLKALDYC 235
           N+V L DI          L+ + V  +     D  +     T+ D    I ++L A+ Y 
Sbjct: 67  NIVTLEDIYESTTHY--YLVMQLV--SGGELFDRILERGVYTEKDASLVIQQVLSAVKYL 122

Query: 236 HSQGIMHRDVKPHNVMIDH--ELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD 293
           H  GI+HRD+KP N++     E  K+ + D+GL++    G   +    +  +  PE+L  
Sbjct: 123 HENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGI-MSTACGTPGYVAPEVLAQ 181

Query: 294 LQDYDYSLDMWSLGC----MFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSR 349
            + Y  ++D WS+G     +  G      P FY         KI +              
Sbjct: 182 -KPYSKAVDCWSIGVITYILLCGY-----PPFYEETESKLFEKIKE-------GYYEFES 228

Query: 350 KPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAES 403
             W           +S  A DF+  LL  D  +R T  +A++HP+     A   
Sbjct: 229 PFWDD---------ISESAKDFICHLLEKDPNERYTCEKALSHPWIDGNTALHR 273

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score =  150 bits (381), Expect = 1e-42
 Identities = 67/294 (22%), Positives = 113/294 (38%), Gaps = 55/294 (18%)

Query: 122 GDQDDYEVVRKV-GRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGP 180
              DDY+V  +V G G   +V +  N  T E+  +K+L+     K +RE+++       P
Sbjct: 14  AIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ--DCPKARREVELHWRASQCP 71

Query: 181 NVVKLLDIVRDQHSKTPS--LIFEYVNSTD-----FKVLYPTLTDYDIRYYIYELLKALD 233
           ++V+++D+  + ++      ++ E ++  +             T+ +    +  + +A+ 
Sbjct: 72  HIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQ 131

Query: 234 YCHSQGIMHRDVKPHNVMIDH--ELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELL 291
           Y HS  I HRDVKP N++         L+L D+G A                     E  
Sbjct: 132 YLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFA--------------------KETT 171

Query: 292 VDLQDYDYSLDMWSLGC----MFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRH 347
              + YD S DMWSLG     +  G      P FY +        +      I       
Sbjct: 172 --GEKYDKSCDMWSLGVIMYILLCGY-----PPFYSNHGLAISPGMKT---RIRMGQYEF 221

Query: 348 SRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAA 401
               WS+         VS E    +  LL+ +   R+T  E M HP+  Q    
Sbjct: 222 PNPEWSE---------VSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKV 266

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score =  151 bits (383), Expect = 1e-42
 Identities = 67/310 (21%), Positives = 129/310 (41%), Gaps = 55/310 (17%)

Query: 124 QDDYEVVRKV-GRGKYSEVFEGINVNTNERCIIKIL---KPVKKKKIKREIKILQNLCGG 179
           +D Y++   V G G ++ V   IN+ T++   +KI+       + ++ RE+++L    G 
Sbjct: 11  EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGH 70

Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNSTD-F-----KVLYPTLTDYDIRYYIYELLKALD 233
            NV++L++   ++      L+FE +           +  +    + +    + ++  ALD
Sbjct: 71  RNVLELIEFFEEEDRF--YLVFEKMRGGSILSHIHKRRHF---NELEASVVVQDVASALD 125

Query: 234 YCHSQGIMHRDVKPHNVMIDH--ELRKLRLIDWGLAEFYHPGKEYNV--------RVASR 283
           + H++GI HRD+KP N++ +H  ++  +++ D+ L        + +            S 
Sbjct: 126 FLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSA 185

Query: 284 YFKGPELL----VDLQDYDYSLDMWSLGC----MFAGMIFRKEPFFYGHDNHDQLVKIAK 335
            +  PE++     +   YD   D+WSLG     + +G      P F G    D      +
Sbjct: 186 EYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGY-----PPFVGRCGSDCGWDRGE 240

Query: 336 DCCL--------IIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAR 387
            C          I         K W+          +S  A D + KLL  D + RL+A 
Sbjct: 241 ACPACQNMLFESIQEGKYEFPDKDWAH---------ISCAAKDLISKLLVRDAKQRLSAA 291

Query: 388 EAMAHPYFAQ 397
           + + HP+   
Sbjct: 292 QVLQHPWVQG 301

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score =  151 bits (383), Expect = 1e-42
 Identities = 71/296 (23%), Positives = 123/296 (41%), Gaps = 46/296 (15%)

Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK-----------KKKIKREIKI 172
           +D+Y + + +G G   EV       T ++  IKI+   K              ++ EI+I
Sbjct: 9   RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEI 68

Query: 173 LQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNST---DFKVLYPTLTDYDIRYYIYELL 229
           L+ L   P ++K+ +    +      ++ E +      D  V    L +   + Y Y++L
Sbjct: 69  LKKL-NHPCIIKIKNFFDAEDY---YIVLELMEGGELFDKVVGNKRLKEATCKLYFYQML 124

Query: 230 KALDYCHSQGIMHRDVKPHNVMID--HELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG 287
            A+ Y H  GI+HRD+KP NV++    E   +++ D+G ++             +  +  
Sbjct: 125 LAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLA 184

Query: 288 PELLVDLQD--YDYSLDMWSLGC----MFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLII 341
           PE+LV +    Y+ ++D WSLG       +G      P F  H     L         I 
Sbjct: 185 PEVLVSVGTAGYNRAVDCWSLGVILFICLSGY-----PPFSEHRTQVSLKDQ------IT 233

Query: 342 WCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQ 397
                   + W++         VS +A+D + KLL  D + R T  EA+ HP+   
Sbjct: 234 SGKYNFIPEVWAE---------VSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 280

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  149 bits (379), Expect = 2e-42
 Identities = 53/305 (17%), Positives = 107/305 (35%), Gaps = 50/305 (16%)

Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNVV 183
             D++ +  +G G + +VF+  +    +  +IK +K    +K +RE+K L  L    N+V
Sbjct: 10  GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVK-YNNEKAEREVKALAKLDH-VNIV 67

Query: 184 KLLDIVRDQHSKTPSLIFEYVNSTDFKVLY--------------------PTLTDYDIRY 223
                         +       S   K L+                      L       
Sbjct: 68  HYNGCWDGFDYDPETSSKNSSRSKT-KCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALE 126

Query: 224 YIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASR 283
              ++ K +DY HS+ +++RD+KP N+ +    +++++ D+GL        +      + 
Sbjct: 127 LFEQITKGVDYIHSKKLINRDLKPSNIFLVDT-KQVKIGDFGLVTSLKNDGKRTRSKGTL 185

Query: 284 YFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWC 343
            +  PE +   QDY   +D+++LG + A ++   +  F                    + 
Sbjct: 186 RYMSPEQISS-QDYGKEVDLYALGLILAELLHVCDTAFETSK---------------FFT 229

Query: 344 NSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAES 403
           + R                +   +    L KLL    +DR    E +      +    ++
Sbjct: 230 DLRDGIIS----------DIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKN 279

Query: 404 SRTRA 408
            R  A
Sbjct: 280 ERHTA 284

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score =  151 bits (383), Expect = 2e-42
 Identities = 74/288 (25%), Positives = 118/288 (40%), Gaps = 33/288 (11%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNVVK 184
           D YEV   +G G YS     I+  TN    +KI+    K+    EI+IL      PN++ 
Sbjct: 22  DGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIID-KSKRDPTEEIEILLRYGQHPNIIT 80

Query: 185 LLDIVRDQHSKTPSLIFEYVNST---DFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIM 241
           L D+  D       ++ E +      D  +     ++ +    ++ + K ++Y H+QG++
Sbjct: 81  LKDVYDDGKYV--YVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVV 138

Query: 242 HRDVKPHNVMI---DHELRKLRLIDWGLAEFYHPGKE-YNVRVASRYFKGPELLVDLQDY 297
           HRD+KP N++          +R+ D+G A+              +  F  PE+L + Q Y
Sbjct: 139 HRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEVL-ERQGY 197

Query: 298 DYSLDMWSLGC----MFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWS 353
           D + D+WSLG     M  G      PF  G D+  + +        I       S   W+
Sbjct: 198 DAACDIWSLGVLLYTMLTGY----TPFANGPDDTPEEILAR-----IGSGKFSLSGGYWN 248

Query: 354 KFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAA 401
                     VS  A D + K+L  D   RLTA   + HP+       
Sbjct: 249 S---------VSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHWDQL 287

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score =  153 bits (389), Expect = 2e-42
 Identities = 71/296 (23%), Positives = 133/296 (44%), Gaps = 44/296 (14%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKI-----LKPVKKKKIKREIKILQNLCGG 179
           ++Y++  ++G+G +S V   + V   +     I     L     +K++RE +I + L   
Sbjct: 11  EEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLL-KH 69

Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNST-----DFKVLYPTLTDYDIRYYIYELLKALDY 234
           PN+V+L D + ++      LIF+ V  T     +  V     ++ D  + I ++L+A+ +
Sbjct: 70  PNIVRLHDSISEEGHH--YLIFDLV--TGGELFEDIVAREYYSEADASHCIQQILEAVLH 125

Query: 235 CHSQGIMHRDVKPHNVMIDHELR--KLRLIDWGLAEFYH-PGKEYNVRVASRYFKGPELL 291
           CH  G++HR++KP N+++  +L+   ++L D+GLA       + +     +  +  PE+L
Sbjct: 126 CHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVL 185

Query: 292 VDLQDYDYSLDMWSLGCMF----AGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRH 347
                Y   +D+W+ G +      G      P F+  D H    +I              
Sbjct: 186 -RKDPYGKPVDLWACGVILYILLVGY-----PPFWDEDQHRLYQQIKA-------GAYDF 232

Query: 348 SRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAES 403
               W           V+PEA D ++K+L  +   R+TA EA+ HP+ +      S
Sbjct: 233 PSPEWDT---------VTPEAKDLINKMLTINPSKRITAAEALKHPWISHRSTVAS 279

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  152 bits (385), Expect = 8e-41
 Identities = 67/294 (22%), Positives = 121/294 (41%), Gaps = 23/294 (7%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK----PVKKKKIKREIKILQNLCGGP 180
             +E+  ++G G +  V   I+ +T E+  IK  +    P  +++   EI+I++ L   P
Sbjct: 14  GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKL-NHP 72

Query: 181 NVVKLLDIVRDQHSKTPS----LIFEYVNSTD-FKVL-----YPTLTDYDIRYYIYELLK 230
           NVV   ++        P+    L  EY    D  K L        L +  IR  + ++  
Sbjct: 73  NVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISS 132

Query: 231 ALDYCHSQGIMHRDVKPHNVMID--HELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGP 288
           AL Y H   I+HRD+KP N+++    +    ++ID G A+    G+     V +  +  P
Sbjct: 133 ALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAP 192

Query: 289 ELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI--AKDCCLIIWCNSR 346
           ELL + + Y  ++D WS G +    I    P F  +    Q       K    I+  +  
Sbjct: 193 ELL-EQKKYTVTVDYWSFGTLAFECITGFRP-FLPNWQPVQWHGKVREKSNEHIVVYDDL 250

Query: 347 HSRKPWSKFINADNQ--HLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQV 398
                +S  +   N    +++ +   +L  +L +  + R T  +      F  +
Sbjct: 251 TGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQAL 304

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score =  147 bits (373), Expect = 2e-40
 Identities = 74/338 (21%), Positives = 146/338 (43%), Gaps = 67/338 (19%)

Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKK--KKIKREIKILQNLC-----GG 179
           YEV++ +G+G + +V +  +   ++   +K+++  K+  ++   EI+IL++L        
Sbjct: 99  YEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNT 158

Query: 180 PNVVKLLD---------IVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLK 230
            NV+ +L+         +  +  S   +L +E +    F+     L    +R + + +L+
Sbjct: 159 MNVIHMLENFTFRNHICMTFELLS--MNL-YELIKKNKFQGFSLPL----VRKFAHSILQ 211

Query: 231 ALDYCHSQGIMHRDVKPHNVMIDHELR-KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 289
            LD  H   I+H D+KP N+++  + R  +++ID+G + + H  + Y   + SR+++ PE
Sbjct: 212 CLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEH-QRVYTY-IQSRFYRAPE 269

Query: 290 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA--------------- 334
           +++    Y   +DMWSLGC+ A +     P   G D  DQL  +                
Sbjct: 270 VILGA-RYGMPIDMWSLGCILAEL-LTGYPLLPGEDEGDQLACMIELLGMPSQKLLDASK 327

Query: 335 ------KDCCLIIWC------------NSRHSRK------PWSKFINADNQHLVSPEAID 370
                        +C            N   SR+      P S+      +    P  +D
Sbjct: 328 RAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLD 387

Query: 371 FLDKLLRYDHQDRLTAREAMAHPYFAQVRAAESSRTRA 408
           FL + L +D   R+T  +A+ HP+  +      +  + 
Sbjct: 388 FLKQCLEWDPAVRMTPGQALRHPWLRRRLPKPPTGEKT 425

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  142 bits (360), Expect = 1e-39
 Identities = 55/320 (17%), Positives = 114/320 (35%), Gaps = 62/320 (19%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK----PVKKKKIKREIKILQNLCGGP 180
            D+E ++ +GRG +  VFE  N   +    IK ++     + ++K+ RE+K L  L   P
Sbjct: 5   TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEH-P 63

Query: 181 NVVKLLDIVRDQHSKTPS----------LIFEYVNSTDFKVL------YPTLTDYDIRYY 224
            +V+  +   ++++              +  +     + K                  + 
Sbjct: 64  GIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHI 123

Query: 225 IYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-------EFYHPGKEYN 277
             ++ +A+++ HS+G+MHRD+KP N+    +   +++ D+GL        E         
Sbjct: 124 FLQIAEAVEFLHSKGLMHRDLKPSNIFFTMD-DVVKVGDFGLVTAMDQDEEEQTVLTPMP 182

Query: 278 VRVASRYFKG------PELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV 331
                    G      PE +     Y + +D++SLG +   +++   PF    +    L 
Sbjct: 183 AYARHTGQVGTKLYMSPEQIHG-NSYSHKVDIFSLGLILFELLY---PFSTQMERVRTLT 238

Query: 332 KIAKDCCLIIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA 391
            +          N +       K           P     +  +L     +R  A   + 
Sbjct: 239 DV---------RNLKFPPLFTQK----------YPCEYVMVQDMLSPSPMERPEAINIIE 279

Query: 392 HPYFAQV----RAAESSRTR 407
           +  F  +    +     R+R
Sbjct: 280 NAVFEDLDFPGKTVLRQRSR 299

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  142 bits (359), Expect = 1e-39
 Identities = 62/292 (21%), Positives = 118/292 (40%), Gaps = 43/292 (14%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKI-----LKPVKKKKIKREIKILQNLCGG 179
           +DYEV+  +G G Y    +    +  +  + K      +   +K+ +  E+ +L+ L   
Sbjct: 6   EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELK-H 64

Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNSTD-------FKVLYPTLTDYDIRYYIYELLKAL 232
           PN+V+  D + D+ + T  ++ EY    D              L +  +   + +L  AL
Sbjct: 65  PNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 124

Query: 233 DYCHSQG-----IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY-NVRVASRYFK 286
             CH +      ++HRD+KP NV +D + + ++L D+GLA   +    +    V + Y+ 
Sbjct: 125 KECHRRSDGGHTVLHRDLKPANVFLDGK-QNVKLGDFGLARILNHDTSFAKTFVGTPYYM 183

Query: 287 GPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV-KIAKDCCLIIWCNS 345
            PE +     Y+   D+WSLGC+   +     PF     +  +L  KI +          
Sbjct: 184 SPEQMNR-MSYNEKSDIWSLGCLLYELCALMPPFT--AFSQKELAGKIREG--------- 231

Query: 346 RHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQ 397
               +              S E  + + ++L      R +  E + +P   +
Sbjct: 232 --KFRRIPYRY--------SDELNEIITRMLNLKDYHRPSVEEILENPLILE 273

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  142 bits (360), Expect = 3e-39
 Identities = 59/287 (20%), Positives = 102/287 (35%), Gaps = 41/287 (14%)

Query: 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNV 182
           +        +VGRG + EV    +  T  +C +K ++   +     E+     L   P +
Sbjct: 56  EVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVR--LEVFRVEELVACAGLSS-PRI 112

Query: 183 VKLLDIVRDQHSKTPSLIFEYVNS---TDFKVLYPTLTDYDIRYYIYELLKALDYCHSQG 239
           V L   VR+      ++  E +              L +    YY+ + L+ L+Y H++ 
Sbjct: 113 VPLYGAVREGP--WVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRR 170

Query: 240 IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG------PELLVD 293
           I+H DVK  NV++  +  +  L D+G A    P       +   Y  G      PE +V 
Sbjct: 171 ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPE-VVM 229

Query: 294 LQDYDYSLDMWSLGC----MFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSR 349
            +  D  +D+WS  C    M  G        +  +      +KIA +             
Sbjct: 230 GKPCDAKVDIWSSCCMMLHMLNG-----CHPWTQYFRGPLCLKIASE------------P 272

Query: 350 KPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFA 396
            P       +     +P     + + LR +   R +A E       A
Sbjct: 273 PP-----IREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKA 314

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  140 bits (356), Expect = 4e-39
 Identities = 52/304 (17%), Positives = 99/304 (32%), Gaps = 54/304 (17%)

Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK-----PVKKKKIKREIKILQNLCG 178
             ++  + K+G G++  VF+ +         IK  K      V ++   RE+     L  
Sbjct: 10  TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69

Query: 179 GPNVVKLLDIVRDQHSKTPSLIF-EYVNS-------TDFKVLYPTLTDYDIRYYIYELLK 230
             +VV+      +       LI  EY N        ++   +     + +++  + ++ +
Sbjct: 70  HSHVVRYFSAWAEDDH---MLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGR 126

Query: 231 ALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY-------------- 276
            L Y HS  ++H D+KP N+ I          + G  + +   K                
Sbjct: 127 GLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISS 186

Query: 277 -NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK 335
             V      F   E+L +   +    D+++L          +     G   H    +I +
Sbjct: 187 PQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQWH----EIRQ 242

Query: 336 DCCLIIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF 395
                     R  R P         Q L S E  + L  ++  D + R +A   + H   
Sbjct: 243 ---------GRLPRIP---------QVL-SQEFTELLKVMIHPDPERRPSAMALVKHSVL 283

Query: 396 AQVR 399
               
Sbjct: 284 LSAS 287

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  138 bits (350), Expect = 3e-38
 Identities = 65/291 (22%), Positives = 127/291 (43%), Gaps = 58/291 (19%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKK--------KIKREIKILQNL 176
           +D+E+ R +G+GK+  V+      +     +K+L   K +        +++RE++I  +L
Sbjct: 9   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLF--KAQLEKAGVEHQLRREVEIQSHL 66

Query: 177 CGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTD-FKVLYPT--LTDYDIRYYIYELLKALD 233
              PN+++L     D  +    LI EY      ++ L       +     YI EL  AL 
Sbjct: 67  RH-PNILRLYGYFHD--ATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALS 123

Query: 234 YCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK--------EYNVRVASRYF 285
           YCHS+ ++HRD+KP N+++      L++ D+G +      +        +Y   +     
Sbjct: 124 YCHSKRVIHRDIKPENLLLGSAGE-LKIADFGWSVHAPSSRRTDLCGTLDY---LP---- 175

Query: 286 KGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV-KIAKDCCLIIWCN 344
             PE++   + +D  +D+WSLG +    +  K PF    + + +   +I++         
Sbjct: 176 --PEMIEG-RMHDEKVDLWSLGVLCYEFLVGKPPFE--ANTYQETYKRISR--------- 221

Query: 345 SRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF 395
              +   +           V+  A D + +LL+++   R   RE + HP+ 
Sbjct: 222 VEFTFPDF-----------VTEGARDLISRLLKHNPSQRPMLREVLEHPWI 261

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  138 bits (350), Expect = 5e-38
 Identities = 56/329 (17%), Positives = 120/329 (36%), Gaps = 49/329 (14%)

Query: 94  MSKARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERC 153
           M  +  +   +  R   Y  ++   V   ++  Y  ++K+G G +S V     ++     
Sbjct: 1   MGSSHHHHHHSSGRENLY--FQGHMVIIDNKH-YLFIQKLGEGGFSYVDLVEGLHDGHFY 57

Query: 154 IIKIL---KPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS--LIFEYVNSTD 208
            +K +   +   +++ +RE  + +     PN+++L+     +        L+  +     
Sbjct: 58  ALKRILCHEQQDREEAQREADMHRLF-NHPNILRLVAYCLRERGAKHEAWLLLPFFKRGT 116

Query: 209 -------FKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRL 261
                   K     LT+  I + +  + + L+  H++G  HRD+KP N+++  E  +  L
Sbjct: 117 LWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDE-GQPVL 175

Query: 262 IDWGLAEFYHPGKEYNVRVASR----------YFKGPELLVDLQDY---DYSLDMWSLGC 308
           +D G         E + +  +            ++ PE L  +Q +   D   D+WSLGC
Sbjct: 176 MDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPE-LFSVQSHCVIDERTDVWSLGC 234

Query: 309 MFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSKFINADNQHLVSPEA 368
           +   M+F + P+       D +              ++ S     +          S   
Sbjct: 235 VLYAMMFGEGPYDMVFQKGDSVALA---------VQNQLSIPQSPRH---------SSAL 276

Query: 369 IDFLDKLLRYDHQDRLTAREAMAHPYFAQ 397
              L+ ++  D   R      ++     Q
Sbjct: 277 WQLLNSMMTVDPHQRPHIPLLLSQLEALQ 305

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  138 bits (350), Expect = 1e-37
 Identities = 55/285 (19%), Positives = 121/285 (42%), Gaps = 38/285 (13%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKI-----LKPVKKKKIKREIKILQNLCGG 179
           + Y  ++K+G G + +     +     + +IK      +   ++++ +RE+ +L N+   
Sbjct: 24  EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKH- 82

Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNSTD-FKVL----YPTLTDYDIRYYIYELLKALDY 234
           PN+V+  +   +  + +  ++ +Y    D FK +         +  I  +  ++  AL +
Sbjct: 83  PNIVQYRESFEE--NGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKH 140

Query: 235 CHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY-NVRVASRYFKGPELLVD 293
            H + I+HRD+K  N+ +  +   ++L D+G+A   +   E     + + Y+  PE+  +
Sbjct: 141 VHDRKILHRDIKSQNIFLTKD-GTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICEN 199

Query: 294 LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV-KIAKDCCLIIWCNSRHSRKPW 352
            + Y+   D+W+LGC+   +   K  F     +   LV KI              S  P 
Sbjct: 200 -KPYNNKSDIWALGCVLYELCTLKHAFE--AGSMKNLVLKIISG-----------SFPPV 245

Query: 353 SKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQ 397
           S           S +    + +L + + +DR +    +   + A+
Sbjct: 246 SLHY--------SYDLRSLVSQLFKRNPRDRPSVNSILEKGFIAK 282

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score =  138 bits (350), Expect = 1e-37
 Identities = 73/332 (21%), Positives = 138/332 (41%), Gaps = 56/332 (16%)

Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKK--KKIKREIKILQNLC------- 177
           Y +VRK+G G +S V+   ++  N    +KI++  K   +  + EIK+LQ +        
Sbjct: 21  YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKE 80

Query: 178 ---GGPNVVKLLD--IVRDQHSKTPSLIFEYVNSTDFKVL----YPTLTDYDIRYYIYEL 228
              G  +++KLLD    +  +     ++FE +      ++    +  +    ++    +L
Sbjct: 81  DSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQL 140

Query: 229 LKALDYCHSQ-GIMHRDVKPHNVMIDHELR-----KLRLIDWGLAEFYHPGKEYNVRVAS 282
           L  LDY H + GI+H D+KP NV+++         ++++ D G A +Y   + Y   + +
Sbjct: 141 LLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYD--EHYTNSIQT 198

Query: 283 RYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHD------NHDQLVKIAKD 336
           R ++ PE+L+    +    D+WS  C+   +I      F   +      + D + +I + 
Sbjct: 199 REYRSPEVLLGAP-WGCGADIWSTACLIFELITGD-FLFEPDEGHSYTKDDDHIAQIIEL 256

Query: 337 CCLI------------IWCNSRHSRKPWSKF-------INADNQHLVSPEA---IDFLDK 374
              +             + NSR   +  SK        +  +       EA    DFL  
Sbjct: 257 LGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSP 316

Query: 375 LLRYDHQDRLTAREAMAHPYFAQVRAAESSRT 406
           +L+ D + R  A   + HP+       E  R 
Sbjct: 317 MLQLDPRKRADAGGLVNHPWLKDTLGMEEIRV 348

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score =  138 bits (349), Expect = 2e-37
 Identities = 68/334 (20%), Positives = 132/334 (39%), Gaps = 76/334 (22%)

Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKK--KKIKREIKILQNL----CGGP 180
           + V+RK+G G +  V    +++  +   +K+++ +KK  +  K E  IL+ +        
Sbjct: 37  FLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNN 96

Query: 181 NVVKLLD---------IVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKA 231
           N+VK            ++ +     PSL +E +   ++   +       I+ Y  E+LKA
Sbjct: 97  NIVKYHGKFMYYDHMCLIFEPLG--PSL-YEIITRNNYNGFHIED----IKLYCIEILKA 149

Query: 232 LDYCHSQGIMHRDVKPHNVMIDHELRK------------------------LRLIDWGLA 267
           L+Y     + H D+KP N+++D    +                        ++LID+G A
Sbjct: 150 LNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCA 209

Query: 268 EFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNH 327
            F       ++ + +R ++ PE++++L  +D S DMWS GC+ A + +     F  H++ 
Sbjct: 210 TFKSD-YHGSI-INTRQYRAPEVILNLG-WDVSSDMWSFGCVLAEL-YTGSLLFRTHEHM 265

Query: 328 DQLVKI------------------------AKDCCLIIWCNSRHSRKPWSKFINADNQHL 363
           + L  +                         KD   + W  +  S             + 
Sbjct: 266 EHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYK 325

Query: 364 VS--PEAIDFLDKLLRYDHQDRLTAREAMAHPYF 395
           +       DFL  +L+ D   R +  E + H + 
Sbjct: 326 IIKHELFCDFLYSILQIDPTLRPSPAELLKHKFL 359

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  136 bits (344), Expect = 2e-37
 Identities = 56/278 (20%), Positives = 113/278 (40%), Gaps = 34/278 (12%)

Query: 132 KVGRGKYSEVFEGINVNTNERCIIKILKPVKKKK-----IKREIKILQNLCGGPNVVKLL 186
           ++GRG +  V++G++  T        L+  K  K      K E ++L+ L   PN+V+  
Sbjct: 33  EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQH-PNIVRFY 91

Query: 187 DIVRDQHSKTPSLIF--EYVNS---TDFKVLYPTLTDYDIRYYIYELLKALDYCHSQG-- 239
           D           ++   E + S     +   +  +    +R +  ++LK L + H++   
Sbjct: 92  DSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPP 151

Query: 240 IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDY 299
           I+HRD+K  N+ I      +++ D GLA          V + +  F  PE+    + YD 
Sbjct: 152 IIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAV-IGTPEFMAPEMY--EEKYDE 208

Query: 300 SLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSKFINAD 359
           S+D+++ G     M   + P+     N  Q+ +                    S    A 
Sbjct: 209 SVDVYAFGMCMLEMATSEYPY-SECQNAAQIYRRVT-----------------SGVKPAS 250

Query: 360 NQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQ 397
              +  PE  + ++  +R +  +R + ++ + H +F +
Sbjct: 251 FDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score =  137 bits (348), Expect = 4e-37
 Identities = 67/334 (20%), Positives = 138/334 (41%), Gaps = 74/334 (22%)

Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKK--KKIKREIKILQNLC-----GG 179
           YE+   +G+G + +V +  +    E   IKI+K  K    + + E+++L+ +        
Sbjct: 56  YEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMK 115

Query: 180 PNVVKLLD---------IVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLK 230
             +V L           +V +  S   +L ++ + +T+F+ +   L     R +  ++  
Sbjct: 116 YYIVHLKRHFMFRNHLCLVFEMLS--YNL-YDLLRNTNFRGVSLNL----TRKFAQQMCT 168

Query: 231 ALDYCHSQ--GIMHRDVKPHNVMIDHELR-KLRLIDWGLAEFYHPGKEYNVRVASRYFKG 287
           AL +  +    I+H D+KP N+++ +  R  ++++D+G +      +     + SR+++ 
Sbjct: 169 ALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLG--QRIYQYIQSRFYRS 226

Query: 288 PELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI-------------- 333
           PE+L+ +  YD ++DMWSLGC+   M    EP F G +  DQ+ KI              
Sbjct: 227 PEVLLGM-PYDLAIDMWSLGCILVEM-HTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQ 284

Query: 334 ----------AKDCCLIIWCNSRHSRK---PWSKFINAD---------NQHLVSPEA--- 368
                       D    +       R+   P ++ ++            +          
Sbjct: 285 APKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVA 344

Query: 369 -----IDFLDKLLRYDHQDRLTAREAMAHPYFAQ 397
                 D + ++L YD + R+    A+ H +F +
Sbjct: 345 DYLKFKDLILRMLDYDPKTRIQPYYALQHSFFKK 378

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  135 bits (343), Expect = 5e-37
 Identities = 65/296 (21%), Positives = 118/296 (39%), Gaps = 38/296 (12%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIK------ILKPVKKKKIKREIKILQNLCG 178
            ++ + +K+GRG++SEV+    +       +K      ++    +    +EI +L+ L  
Sbjct: 32  ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91

Query: 179 GPNVVKLLDIVRDQHSKTPSLIFEYVNSTD-------FKVLYPTLTDYDIRYYIYELLKA 231
            PNV+K      + +    +++ E  ++ D       FK     + +  +  Y  +L  A
Sbjct: 92  -PNVIKYYASFIEDN--ELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSA 148

Query: 232 LDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY-NVRVASRYFKGPEL 290
           L++ HS+ +MHRD+KP NV I      ++L D GL  F+       +  V + Y+  PE 
Sbjct: 149 LEHMHSRRVMHRDIKPANVFITAT-GVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPER 207

Query: 291 LVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV-KIAKDCCLIIWCNSRHSR 349
           + +   Y++  D+WSLGC+   M   + PF+    N   L  KI             +  
Sbjct: 208 IHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKI---------EQCDYPP 257

Query: 350 KPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAESSR 405
            P   +         S E    ++  +  D + R                 A S  
Sbjct: 258 LPSDHY---------SEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTASSLE 304

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score =  136 bits (345), Expect = 7e-37
 Identities = 73/347 (21%), Positives = 144/347 (41%), Gaps = 78/347 (22%)

Query: 127 YEVVRKVGRGKYSEVFEGI-NVNTNERCIIKILKPVKK--KKIKREIKILQNLC-----G 178
           YE+V  +G G + +V E + +     +  +KI++ V K  +  + EI +L+ +       
Sbjct: 21  YEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKEN 80

Query: 179 GPNVVKLLD---------IVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELL 229
               V + D         I  +      +  FE++   +F+          +R+  Y+L 
Sbjct: 81  KFLCVLMSDWFNFHGHMCIAFELLG--KNT-FEFLKENNFQPYPLPH----VRHMAYQLC 133

Query: 230 KALDYCHSQGIMHRDVKPHNVMIDHELRK------------------LRLIDWGLAEFYH 271
            AL + H   + H D+KP N++  +   +                  +R+ D+G A F H
Sbjct: 134 HALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDH 193

Query: 272 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV 331
                 + VA+R+++ PE++++L  +    D+WS+GC+     +R    F  H+N + LV
Sbjct: 194 E-HHTTI-VATRHYRPPEVILELG-WAQPCDVWSIGCILFEY-YRGFTLFQTHENREHLV 249

Query: 332 KIAK-------------------DCCLIIWCN-------SRHSRKPWSKFINADNQHLVS 365
            + K                       ++W          + + KP   ++  D+     
Sbjct: 250 MMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEH-- 307

Query: 366 PEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQV----RAAESSRTRA 408
            +  D + ++L +D   R+T  EA+ HP+FA +    R+  +SR  +
Sbjct: 308 VQLFDLMRRMLEFDPAQRITLAEALLHPFFAGLTPEERSFHTSRNPS 354

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score =  134 bits (340), Expect = 2e-36
 Identities = 68/292 (23%), Positives = 113/292 (38%), Gaps = 52/292 (17%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKIL---------KPVKKKKIKREIKILQN 175
             Y+V   +G G +  V+ GI V+ N    IK +         +     ++  E+ +L+ 
Sbjct: 43  SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 102

Query: 176 LC-GGPNVVKLLDIVRDQHSKTPS---LIFEYVNST----DFKVLYPTLTDYDIRYYIYE 227
           +  G   V++LLD       + P    LI E         DF      L +   R + ++
Sbjct: 103 VSSGFSGVIRLLDWF-----ERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQ 157

Query: 228 LLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG 287
           +L+A+ +CH+ G++HRD+K  N++ID    +L+LID+G          Y     +R +  
Sbjct: 158 VLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV-YTDFDGTRVYSP 216

Query: 288 PELLVDLQDYD-YSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSR 346
           PE +     Y   S  +WSLG +   M+    PF     +     +I            +
Sbjct: 217 PEWIRY-HRYHGRSAAVWSLGILLYDMVCGDIPF---EHDE----EI---------IRGQ 259

Query: 347 HSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQV 398
              +             VS E    +   L     DR T  E   HP+   V
Sbjct: 260 VFFRQR-----------VSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 300

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  135 bits (342), Expect = 2e-36
 Identities = 48/331 (14%), Positives = 97/331 (29%), Gaps = 78/331 (23%)

Query: 126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKK------KKIKREIKILQNL--- 176
                  +G+       E  +  T E   + +    ++      K++K E+  L+ L   
Sbjct: 74  TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGI 133

Query: 177 ---------------------CGGPNVVKLLDIVRDQHSKTPSLIFEYVNST-------- 207
                                     ++++    RD    +   ++  + S         
Sbjct: 134 KNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVL 193

Query: 208 -DFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGL 266
                 + +L  +       ++++ L   H  G++H  ++P ++++D     + L  +  
Sbjct: 194 LSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGG-VFLTGFEH 252

Query: 267 AEFYHPGKEYNVRVASRYFKGPELLVDLQD----------YDYSLDMWSLGCMFAGMIFR 316
                      V   SR F+ PEL                  +S D W+LG +   +   
Sbjct: 253 L---VRDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCA 309

Query: 317 KEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLL 376
             P             I + C                          +       L+  L
Sbjct: 310 DLP-ITKDAALGGSEWIFRSC------------------------KNIPQPVRALLEGFL 344

Query: 377 RYDHQDRLTAREAMAHPYFAQVRAAESSRTR 407
           RY  +DRL   +AM  P + Q+R   S+   
Sbjct: 345 RYPKEDRLLPLQAMETPEYEQLRTELSAALP 375

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  133 bits (336), Expect = 2e-36
 Identities = 62/294 (21%), Positives = 133/294 (45%), Gaps = 57/294 (19%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKIL------KPVKKKKIKREIKILQNLCG 178
           +D++V   +G+G ++ V+   +++T     IK++      K    ++++ E+KI   L  
Sbjct: 11  EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKH 70

Query: 179 GPNVVKLLDIVRDQHSKTPSLIFEYVNSTD-FKVLYP---TLTDYDIRYYIYELLKALDY 234
            P++++L +   D  S    L+ E  ++ +  + L       ++ + R+++++++  + Y
Sbjct: 71  -PSILELYNYFED--SNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLY 127

Query: 235 CHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE----------YNVRVASRY 284
            HS GI+HRD+   N+++   +  +++ D+GLA       E          Y   ++   
Sbjct: 128 LHSHGILHRDLTLSNLLLTRNMN-IKIADFGLATQLKMPHEKHYTLCGTPNY---IS--- 180

Query: 285 FKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV-KIAKDCCLIIWC 343
              PE+      +    D+WSLGCMF  ++  + PF    D     + K+          
Sbjct: 181 ---PEIATR-SAHGLESDVWSLGCMFYTLLIGRPPFD--TDTVKNTLNKVVL-------- 226

Query: 344 NSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQ 397
            + +    +           +S EA D + +LLR +  DRL+    + HP+ ++
Sbjct: 227 -ADYEMPSF-----------LSIEAKDLIHQLLRRNPADRLSLSSVLDHPFMSR 268

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  134 bits (340), Expect = 3e-36
 Identities = 65/307 (21%), Positives = 125/307 (40%), Gaps = 41/307 (13%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK--------------------PVKKK 164
           +DY ++R + +GK++++        N+   +K  +                      K  
Sbjct: 31  NDYRIIRTLNQGKFNKIILC--EKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYD 88

Query: 165 KIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYV-----------NSTDFKVLY 213
             K E++I+ ++      +    I+ +       +I+EY+                K   
Sbjct: 89  DFKNELQIITDIKN-EYCLTCEGIITN--YDEVYIIYEYMENDSILKFDEYFFVLDKNYT 145

Query: 214 PTLTDYDIRYYIYELLKALDYCHSQ-GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP 272
             +    I+  I  +L +  Y H++  I HRDVKP N+++D   R ++L D+G +E Y  
Sbjct: 146 CFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGR-VKLSDFGESE-YMV 203

Query: 273 GKEYNVRVASRYFKGPELLVDLQDYD-YSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV 331
            K+      +  F  PE   +   Y+   +D+WSLG     M +   PF     +  +L 
Sbjct: 204 DKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPF-SLKISLVELF 262

Query: 332 KIAKDCCLIIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA 391
              +   +    +  H   P +   +  + + +S E IDFL   LR +  +R+T+ +A+ 
Sbjct: 263 NNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK 322

Query: 392 HPYFAQV 398
           H + A  
Sbjct: 323 HEWLADT 329

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  133 bits (336), Expect = 3e-36
 Identities = 64/292 (21%), Positives = 125/292 (42%), Gaps = 60/292 (20%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKK--------KIKREIKILQNL 176
           DD+++ R +G+GK+  V+            +K+L   K +        +++REI+I  +L
Sbjct: 14  DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLF--KSQLEKEGVEHQLRREIEIQSHL 71

Query: 177 CGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTD-FKVL--YPTLTDYDIRYYIYELLKALD 233
              PN++++ +   D   K   L+ E+    + +K L  +    +     ++ EL  AL 
Sbjct: 72  RH-PNILRMYNYFHD--RKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALH 128

Query: 234 YCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK---------EYNVRVASRY 284
           YCH + ++HRD+KP N+++ ++   L++ D+G +  + P           +Y   +    
Sbjct: 129 YCHERKVIHRDIKPENLLMGYKGE-LKIADFGWS-VHAPSLRRRTMCGTLDY---LP--- 180

Query: 285 FKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV-KIAKDCCLIIWC 343
              PE++   + +D  +D+W  G +    +    PF     +H +   +I          
Sbjct: 181 ---PEMIEG-KTHDEKVDLWCAGVLCYEFLVGMPPFD--SPSHTETHRRIVN-------- 226

Query: 344 NSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF 395
                  P+           +S  + D + KLLRY    RL  +  M HP+ 
Sbjct: 227 -VDLKFPPF-----------LSDGSKDLISKLLRYHPPQRLPLKGVMEHPWV 266

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  132 bits (334), Expect = 6e-36
 Identities = 63/290 (21%), Positives = 118/290 (40%), Gaps = 54/290 (18%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKIL------KPVKKKKIKREIKILQNLCG 178
             Y   R +G+G +++ FE  + +T E    KI+      KP +++K+  EI I ++L  
Sbjct: 15  RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAH 74

Query: 179 GPNVVKLLDIVRDQHSKTPSLIFEYVNS---TDFKVLYPTLTDYDIRYYIYELLKALDYC 235
             +VV       D  +    ++ E        +       LT+ + RYY+ +++    Y 
Sbjct: 75  -QHVVGFHGFFED--NDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYL 131

Query: 236 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE----------YNVRVASRYF 285
           H   ++HRD+K  N+ ++ +L  +++ D+GLA       E          Y   +A    
Sbjct: 132 HRNRVIHRDLKLGNLFLNEDLE-VKIGDFGLATKVEYDGERKKVLCGTPNY---IA---- 183

Query: 286 KGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNS 345
             PE+L   + + + +D+WS+GC+   ++  K PF        +     K     I    
Sbjct: 184 --PEVLSK-KGHSFEVDVWSIGCIMYTLLVGKPPFE--TSCLKETYLRIKKNEYSI---- 234

Query: 346 RHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF 395
                             ++P A   + K+L+ D   R T  E +   +F
Sbjct: 235 ----PKH-----------INPVAASLIQKMLQTDPTARPTINELLNDEFF 269

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score =  133 bits (337), Expect = 6e-36
 Identities = 68/338 (20%), Positives = 136/338 (40%), Gaps = 82/338 (24%)

Query: 127 YEVVRKVGRGKYSEVFEGINVNTN-ERCIIKILKPVKK--KKIKREIKILQNLC-----G 178
           YE+V  +G G + +V E I+         +KI+K V +  +  + EI++L++L       
Sbjct: 16  YEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNS 75

Query: 179 GPNVVKLLD---------IVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELL 229
               V++L+         IV +      S  ++++    F           IR   Y++ 
Sbjct: 76  TFRCVQMLEWFEHHGHICIVFELLG--LST-YDFIKENGFLPFRLDH----IRKMAYQIC 128

Query: 230 KALDYCHSQGIMHRDVKPHNVMIDHELR------------------KLRLIDWGLAEFYH 271
           K++++ HS  + H D+KP N++                         ++++D+G A +  
Sbjct: 129 KSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDD 188

Query: 272 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGC----MFAGMIFRKEPFFYGHDNH 327
                 + V++R+++ PE+++ L  +    D+WS+GC     + G        F  HD+ 
Sbjct: 189 E-HHSTL-VSTRHYRAPEVILALG-WSQPCDVWSIGCILIEYYLG-----FTVFPTHDSK 240

Query: 328 DQLVKIAK-------------------DCCLIIWCNSRHSR-------KPWSKFINADNQ 361
           + L  + +                       + W     +        KP  +F+ + + 
Sbjct: 241 EHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDV 300

Query: 362 HLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVR 399
                   D + K+L YD   R+T REA+ HP+F  ++
Sbjct: 301 EH--ERLFDLIQKMLEYDPAKRITLREALKHPFFDLLK 336

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  133 bits (336), Expect = 1e-35
 Identities = 64/291 (21%), Positives = 123/291 (42%), Gaps = 56/291 (19%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKIL------KPVKKKKIKREIKILQNLCG 178
             Y   R +G+G +++ FE  + +T E    KI+      KP +++K+  EI I ++L  
Sbjct: 41  RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAH 100

Query: 179 GPNVVKLLDIVRDQHSKTPSLIFEYVNS---TDFKVLYPTLTDYDIRYYIYELLKALDYC 235
             +VV       D  +    ++ E        +       LT+ + RYY+ +++    Y 
Sbjct: 101 -QHVVGFHGFFED--NDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYL 157

Query: 236 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE----------YNVRVASRYF 285
           H   ++HRD+K  N+ ++ +L  +++ D+GLA       E          Y   +A    
Sbjct: 158 HRNRVIHRDLKLGNLFLNEDLE-VKIGDFGLATKVEYDGERKKVLCGTPNY---IA---- 209

Query: 286 KGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQL-VKIAKDCCLIIWCN 344
             PE+L   + + + +D+WS+GC+   ++  K PF        +  ++I K         
Sbjct: 210 --PEVLSK-KGHSFEVDVWSIGCIMYTLLVGKPPFE--TSCLKETYLRIKK--------- 255

Query: 345 SRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF 395
           + +S               ++P A   + K+L+ D   R T  E +   +F
Sbjct: 256 NEYSIPKH-----------INPVAASLIQKMLQTDPTARPTINELLNDEFF 295

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  131 bits (330), Expect = 6e-35
 Identities = 60/299 (20%), Positives = 119/299 (39%), Gaps = 57/299 (19%)

Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKIL---KPVKKKKIKREIKILQNLCGGPNVV 183
             V R +  G ++ V+E  +V +     +K L   +  K + I +E+  ++ L G PN+V
Sbjct: 30  LRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIV 89

Query: 184 KLLD--IVRDQHSKTPSLIF----EYVNSTDFKVLYPT-----LTDYDIRYYIYELLKAL 232
           +      +  + S T    F    E       + L        L+   +    Y+  +A+
Sbjct: 90  QFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAV 149

Query: 233 DYCHSQG--IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASR------- 283
            + H Q   I+HRD+K  N+++ ++   ++L D+G A       +Y+     R       
Sbjct: 150 QHMHRQKPPIIHRDLKVENLLLSNQ-GTIKLCDFGSATTISHYPDYSWSAQRRALVEEEI 208

Query: 284 ------YFKGPELLVDL---QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA 334
                  ++ PE ++DL          D+W+LGC+   + FR+ PF    ++  +L +I 
Sbjct: 209 TRNTTPMYRTPE-IIDLYSNFPIGEKQDIWALGCILYLLCFRQHPF----EDGAKL-RI- 261

Query: 335 KDCCLIIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHP 393
                    N ++S  P                    +  +L+ + ++RL+  E +   
Sbjct: 262 --------VNGKYSIPPHDTQ---------YTVFHSLIRAMLQVNPEERLSIAEVVHQL 303

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score =  130 bits (328), Expect = 1e-34
 Identities = 68/288 (23%), Positives = 120/288 (41%), Gaps = 48/288 (16%)

Query: 126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK-----------PVKKKKIKREIKILQ 174
            Y  +  +G G +  V+  ++   N+  ++K +K             K  K+  EI IL 
Sbjct: 25  KYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILS 84

Query: 175 NLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNST----DFKVLYPTLTDYDIRYYIYELLK 230
            +    N++K+LDI  +Q      L+ E   S      F   +P L +    Y   +L+ 
Sbjct: 85  RVEH-ANIIKVLDIFENQ--GFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVS 141

Query: 231 ALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPEL 290
           A+ Y   + I+HRD+K  N++I  +   ++LID+G A +   GK +     +  +  PE+
Sbjct: 142 AVGYLRLKDIIHRDIKDENIVIAEDFT-IKLIDFGSAAYLERGKLFYTFCGTIEYCAPEV 200

Query: 291 LVDLQDYD-YSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSR 349
           L+    Y    L+MWSLG     ++F + PF        +L +  +              
Sbjct: 201 LMG-NPYRGPELEMWSLGVTLYTLVFEENPF-------CELEETVE----------AAIH 242

Query: 350 KPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQ 397
            P          +LVS E +  +  LL+   + R T  + +  P+  Q
Sbjct: 243 PP----------YLVSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQ 280

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  128 bits (324), Expect = 2e-34
 Identities = 59/309 (19%), Positives = 110/309 (35%), Gaps = 78/309 (25%)

Query: 133 VGRGKYSEVFEGINVNTNERCIIKILKPVKK---KKIKREIKILQNLCGGPNVVKLLDIV 189
           +G+G Y  V+ G +++   R  IK +        + +  EI + ++L    N+V+ L   
Sbjct: 30  LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKH-KNIVQYLGSF 88

Query: 190 RDQHSKTPSLIFEYVN----STDFKVLYPTLTDYD--IRYYIYELLKALDYCHSQGIMHR 243
            +       +  E V     S   +  +  L D +  I +Y  ++L+ L Y H   I+HR
Sbjct: 89  SENG--FIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHR 146

Query: 244 DVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG------PE-LLVDLQD 296
           D+K  NV+I+     L++ D+G +      +   +   +  F G      PE +    + 
Sbjct: 147 DIKGDNVLINTYSGVLKISDFGTS-----KRLAGINPCTETFTGTLQYMAPEIIDKGPRG 201

Query: 297 YDYSLDMWSLGC----MFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPW 352
           Y  + D+WSLGC    M  G                                    + P+
Sbjct: 202 YGKAADIWSLGCTIIEMATG------------------------------------KPPF 225

Query: 353 SKF---------INADNQH-----LVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQV 398
            +          +     H      +S EA  F+ K    D   R  A + +   +    
Sbjct: 226 YELGEPQAAMFKVGMFKVHPEIPESMSAEAKAFILKCFEPDPDKRACANDLLVDEFLKVS 285

Query: 399 RAAESSRTR 407
              + ++ +
Sbjct: 286 SKKKKTQPK 294

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score =  128 bits (324), Expect = 3e-34
 Identities = 61/295 (20%), Positives = 107/295 (36%), Gaps = 62/295 (21%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKIL---------KPVKKKKIKREIKILQN 175
            +Y +   +G+G +  VF G  +    +  IK++                   E+ +L  
Sbjct: 31  AEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWK 90

Query: 176 LCGG---PNVVKLLDIVRDQHSKTPS---LIFEYVNST----DFKVLYPTLTDYDIRYYI 225
           +  G   P V++LLD       +T     L+ E         D+      L +   R + 
Sbjct: 91  VGAGGGHPGVIRLLDWF-----ETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFF 145

Query: 226 YELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYF 285
            +++ A+ +CHS+G++HRD+K  N++ID      +LID+G     H    Y     +R +
Sbjct: 146 GQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEP-YTDFDGTRVY 204

Query: 286 KGPELLVDLQDYD-YSLDMWSLG----CMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLI 340
             PE +     Y      +WSLG     M  G I    PF       ++  +I       
Sbjct: 205 SPPEWISR-HQYHALPATVWSLGILLYDMVCGDI----PF-------ERDQEI------- 245

Query: 341 IWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF 395
               +                  VSP+    + + L      R +  E +  P+ 
Sbjct: 246 --LEAELHFPAH-----------VSPDCCALIRRCLAPKPSSRPSLEEILLDPWM 287

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score =  123 bits (312), Expect = 6e-33
 Identities = 64/289 (22%), Positives = 119/289 (41%), Gaps = 48/289 (16%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKK----KKIKREIKILQNLCGGP 180
           +D+++V+ +G G Y EV   +N  T E   +KI+   +     + IK+EI I + L    
Sbjct: 7   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNH-E 65

Query: 181 NVVKLLDIVRDQHSKTPSLIF---EYVNST---DFKVLYPTLTDYDIRYYIYELLKALDY 234
           NVVK          +  ++ +   EY +     D       + + D + + ++L+  + Y
Sbjct: 66  NVVKFYGHR-----REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVY 120

Query: 235 CHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNV---RVASRYFKGPELL 291
            H  GI HRD+KP N+++D     L++ D+GLA  +       +      +  +  PELL
Sbjct: 121 LHGIGITHRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 179

Query: 292 VDLQDYD-YSLDMWSLG----CMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSR 346
              +++    +D+WS G     M AG +    P+    D+  +     +          +
Sbjct: 180 KR-REFHAEPVDVWSCGIVLTAMLAGEL----PWDQPSDSCQEYSDWKE---------KK 225

Query: 347 HSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF 395
               PW K              +  L K+L  +   R+T  +     ++
Sbjct: 226 TYLNPWKKI---------DSAPLALLHKILVENPSARITIPDIKKDRWY 265

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  125 bits (316), Expect = 9e-33
 Identities = 47/316 (14%), Positives = 109/316 (34%), Gaps = 47/316 (14%)

Query: 123 DQDDYEVVRKVGRGKYSEVFEGINVNTN-----ERCIIKILKPVKKKKIKREIKILQNLC 177
                 V   +G G +++V+E    + N     ++ ++K+ KP    +     ++++ L 
Sbjct: 63  GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLK 122

Query: 178 GG--PNVVKLLDIVRDQHSKTPSLIFEYVNSTDF--------KVLYPTLTDYDIRYYIYE 227
                  +K       Q+     L+ E  +                  +    +  +   
Sbjct: 123 PSMQHMFMKFYSAHLFQNGS--VLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMR 180

Query: 228 LLKALDYCHSQGIMHRDVKPHNVMIDHELR----------KLRLIDWGLA---EFYHPGK 274
           +L  ++  H   I+H D+KP N ++ +              L LID G +   + +  G 
Sbjct: 181 MLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGT 240

Query: 275 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA 334
            +  +  +  F+  E+L + + ++Y +D + +      M+F             +   + 
Sbjct: 241 IFTAKCETSGFQCVEMLSN-KPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLF 299

Query: 335 KDCCLIIWCNSRHSRKPWSKFI----NADNQHLVSPEAIDFLDKLLRYDHQDRLTAR-EA 389
           +                W++F     N  + H     ++D L + L+   Q   T +  A
Sbjct: 300 RR---------LPHLDMWNEFFHVMLNIPDCH--HLPSLDLLRQKLKKVFQQHYTNKIRA 348

Query: 390 MAHPYFAQVRAAESSR 405
           + +     +   + SR
Sbjct: 349 LRNRLIVLLLECKRSR 364

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score =  124 bits (314), Expect = 1e-32
 Identities = 63/282 (22%), Positives = 129/282 (45%), Gaps = 41/282 (14%)

Query: 126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKI-----LKPVKKKKIKREIKILQNLCGGP 180
           +Y +++ +G+G +++V    ++ T     IKI     L P   +K+ RE++I++ L   P
Sbjct: 16  NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNH-P 74

Query: 181 NVVKLLDIVRDQHSKTPS---LIFEYVNST---DFKVLYPTLTDYDIRYYIYELLKALDY 234
           N+VKL +++     +T     LI EY +     D+ V +  + + + R    +++ A+ Y
Sbjct: 75  NIVKLFEVI-----ETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQY 129

Query: 235 CHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDL 294
           CH + I+HRD+K  N+++D ++  +++ D+G +  +  G + +    +  +  PEL    
Sbjct: 130 CHQKRIVHRDLKAENLLLDADM-NIKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQG- 187

Query: 295 QDYD-YSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWS 353
           + YD   +D+WSLG +   ++    PF     N  +L +        I          + 
Sbjct: 188 KKYDGPEVDVWSLGVILYTLVSGSLPF--DGQNLKELRERVLRGKYRI--------PFY- 236

Query: 354 KFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF 395
                     +S +  + L + L  +   R T  + M   + 
Sbjct: 237 ----------MSTDCENLLKRFLVLNPIKRGTLEQIMKDRWI 268

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score =  122 bits (308), Expect = 4e-32
 Identities = 70/285 (24%), Positives = 120/285 (42%), Gaps = 40/285 (14%)

Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILK-------PVKKKKIKREIKILQNLCGG 179
           Y +   +G G Y +V E ++  T  R  +KILK       P  +  +K+EI++L+ L   
Sbjct: 7   YLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRH- 65

Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNSTDF----KVLYPTLTDYDIRYYIYELLKALDYC 235
            NV++L+D++ ++  +   ++ EY           V            Y  +L+  L+Y 
Sbjct: 66  KNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYL 125

Query: 236 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNV---RVASRYFKGPELLV 292
           HSQGI+H+D+KP N+++      L++   G+AE  HP    +       S  F+ PE+  
Sbjct: 126 HSQGIVHKDIKPGNLLLTTGGT-LKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIAN 184

Query: 293 DLQDYD-YSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV-KIAKDCCLIIWCNSRHSRK 350
            L  +  + +D+WS G     +     PF    DN  +L   I K           ++  
Sbjct: 185 GLDTFSGFKVDIWSAGVTLYNITTGLYPFE--GDNIYKLFENIGK---------GSYAIP 233

Query: 351 PWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF 395
                          P   D L  +L Y+   R + R+   H +F
Sbjct: 234 GD-----------CGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWF 267

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score =  122 bits (308), Expect = 6e-32
 Identities = 64/289 (22%), Positives = 119/289 (41%), Gaps = 48/289 (16%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKK----KKIKREIKILQNLCGGP 180
           +D+++V+ +G G Y EV   +N  T E   +KI+   +     + IK+EI I + L    
Sbjct: 7   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNH-E 65

Query: 181 NVVKLLDIVRDQHSKTPSLIF---EYVNST---DFKVLYPTLTDYDIRYYIYELLKALDY 234
           NVVK          +  ++ +   EY +     D       + + D + + ++L+  + Y
Sbjct: 66  NVVKFYGHR-----REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVY 120

Query: 235 CHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNV---RVASRYFKGPELL 291
            H  GI HRD+KP N+++D     L++ D+GLA  +       +      +  +  PELL
Sbjct: 121 LHGIGITHRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 179

Query: 292 VDLQDYD-YSLDMWSLG----CMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSR 346
              +++    +D+WS G     M AG +    P+    D+  +     +          +
Sbjct: 180 KR-REFHAEPVDVWSCGIVLTAMLAGEL----PWDQPSDSCQEYSDWKE---------KK 225

Query: 347 HSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF 395
               PW K              +  L K+L  +   R+T  +     ++
Sbjct: 226 TYLNPWKKI---------DSAPLALLHKILVENPSARITIPDIKKDRWY 265

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  120 bits (303), Expect = 3e-31
 Identities = 68/305 (22%), Positives = 124/305 (40%), Gaps = 48/305 (15%)

Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKI--LKPVKKKKIKREIKILQNLCGGPN 181
              +E+V  VG G Y +V++G +V T +   IK+  +   ++++IK+EI +L+      N
Sbjct: 23  AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRN 82

Query: 182 VVKLLDIVRDQHSKTPS----LIFEY---------VNSTDFKVLYPTLTDYDIRYYIYEL 228
           +         ++         L+ E+         + +T       TL +  I Y   E+
Sbjct: 83  IATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGN----TLKEEWIAYICREI 138

Query: 229 LKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGL-AEFYHPGKEYNVRVASRYFKG 287
           L+ L + H   ++HRD+K  NV++     +++L+D+G+ A+        N  + + Y+  
Sbjct: 139 LRGLSHLHQHKVIHRDIKGQNVLLTEN-AEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMA 197

Query: 288 PELLVDLQD----YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNH--DQLVKIAKDCCLII 341
           PE++   ++    YD+  D+WSLG     M     P     D H    L  I +      
Sbjct: 198 PEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLC---DMHPMRALFLIPR------ 248

Query: 342 WCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAA 401
             N     K   K+         S +   F++  L  +H  R    + M HP+       
Sbjct: 249 --NPAPRLKS-KKW---------SKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQPNE 296

Query: 402 ESSRT 406
              R 
Sbjct: 297 RQVRI 301

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score =  119 bits (301), Expect = 1e-30
 Identities = 62/285 (21%), Positives = 119/285 (41%), Gaps = 40/285 (14%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKIL--KPVKKKKIKREIKILQNLCGGPNV 182
           D Y+ V+ +G G +       +  T E   +K +       + ++REI   ++L   PN+
Sbjct: 20  DRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRH-PNI 78

Query: 183 VKLLDIVRDQHSKTPSLIF---EYVNST---DFKVLYPTLTDYDIRYYIYELLKALDYCH 236
           V+  +++      TP+ +    EY +     +        ++ + R++  +LL  + YCH
Sbjct: 79  VRFKEVI-----LTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCH 133

Query: 237 SQGIMHRDVKPHNVMID-HELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQ 295
           S  I HRD+K  N ++D     +L++ D+G ++      +    V +  +  PE+L+  Q
Sbjct: 134 SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLR-Q 192

Query: 296 DYD-YSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSK 354
           +YD    D+WS G     M+    PF    D  +                 R  RK   +
Sbjct: 193 EYDGKIADVWSCGVTLYVMLVGAYPF---EDPEE----------------PRDYRKTIQR 233

Query: 355 FINAD----NQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF 395
            ++      +   +SPE    + ++   D   R++  E   H +F
Sbjct: 234 ILSVKYSIPDDIRISPECCHLISRIFVADPATRISIPEIKTHSWF 278

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  119 bits (298), Expect = 5e-30
 Identities = 47/329 (14%), Positives = 96/329 (29%), Gaps = 75/329 (22%)

Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKK------KKIKREIKILQNLCGGP 180
                 +G+       E  +  T E   + +    ++      K++K E+  L+ L G  
Sbjct: 80  LVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIK 139

Query: 181 NVVKLLDIVRD-------QHSKTPSLIFEYVNSTDFKVLY-------------------- 213
           N  +    +R        +  +   +I   ++  D  VL                     
Sbjct: 140 NQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLL 199

Query: 214 ------PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA 267
                  +L  +       ++++ L   H  G++H  ++P ++++D     + L  +   
Sbjct: 200 SHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGG-VFLTGFEHL 258

Query: 268 EFYHPGKEYNVRVASRY----FKGPELLVDLQD----YDYSLDMWSLGCMFAGMIFRKEP 319
                G      +   +         +L   Q       ++ D W+LG     +     P
Sbjct: 259 V--RDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLP 316

Query: 320 FFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYD 379
                        I + C                          +       L+  LRY 
Sbjct: 317 -NTDDAALGGSEWIFRSC------------------------KNIPQPVRALLEGFLRYP 351

Query: 380 HQDRLTAREAMAHPYFAQVRAAESSRTRA 408
            +DRL   +AM  P + Q+R   S+    
Sbjct: 352 KEDRLLPLQAMETPEYEQLRTELSAALPL 380

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score =  116 bits (293), Expect = 5e-30
 Identities = 67/305 (21%), Positives = 133/305 (43%), Gaps = 59/305 (19%)

Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKIL---KPVKKK------------------- 164
           Y +  ++G+G Y  V    N N N    +K+L   K +++                    
Sbjct: 15  YTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCI 74

Query: 165 -------KIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTD-FKVLYPT- 215
                  ++ +EI IL+     PNVVKL++++ D +     ++FE VN     +V     
Sbjct: 75  QPRGPIEQVYQEIAILK-KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKP 133

Query: 216 LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE 275
           L++   R+Y  +L+K ++Y H Q I+HRD+KP N+++  +   +++ D+G++  +     
Sbjct: 134 LSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGH-IKIADFGVSNEFKGSDA 192

Query: 276 Y-NVRVASRYFKGPELLVDL-QDYD-YSLDMWSLGC-MFAGMIFRKEPFFYGHDNHDQL- 330
             +  V +  F  PE L +  + +   +LD+W++G  ++   +F + PF    +    L 
Sbjct: 193 LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYC-FVFGQCPFM--DERIMCLH 249

Query: 331 VKIAKDCCLIIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAM 390
            KI                 P        +Q  ++ +  D + ++L  + + R+   E  
Sbjct: 250 SKIKSQ----------ALEFP--------DQPDIAEDLKDLITRMLDKNPESRIVVPEIK 291

Query: 391 AHPYF 395
            HP+ 
Sbjct: 292 LHPWV 296

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  116 bits (293), Expect = 5e-30
 Identities = 65/326 (19%), Positives = 122/326 (37%), Gaps = 67/326 (20%)

Query: 115 ESLTVQW-GDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK----PVKKKKIKRE 169
           +S  + W  ++DDYE+   +G G  + V         E+  IK +          ++ +E
Sbjct: 4   DSSALPWSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKE 63

Query: 170 IKILQNLCGGPNVVK----------------------LLDIVRDQHSKTPSLIFEYVNST 207
           I+ +   C  PN+V                       +LDI++   +K            
Sbjct: 64  IQAMS-QCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHK-------- 114

Query: 208 DFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA 267
                   L +  I   + E+L+ L+Y H  G +HRDVK  N+++  +   +++ D+G++
Sbjct: 115 -----SGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDG-SVQIADFGVS 168

Query: 268 EFYHPGKEYNVRVASRYFKG------PELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 321
            F   G +       + F G      PE++  ++ YD+  D+WS G     +     P+ 
Sbjct: 169 AFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPY- 227

Query: 322 YGHDNH--DQLVKIAKDC--CLIIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLR 377
             H       L+   ++    L      +   K + K                 +   L+
Sbjct: 228 --HKYPPMKVLMLTLQNDPPSLETGVQDKEMLKKYGKSFR------------KMISLCLQ 273

Query: 378 YDHQDRLTAREAMAHPYFAQVRAAES 403
            D + R TA E + H +F + +  E 
Sbjct: 274 KDPEKRPTAAELLRHKFFQKAKNKEF 299

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  115 bits (289), Expect = 2e-29
 Identities = 70/290 (24%), Positives = 125/290 (43%), Gaps = 37/290 (12%)

Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKK-KKIKREIKILQNLCGGPNV 182
           ++ ++V+ K+G G Y  V++ I+  T +   IK +      ++I +EI I+Q  C  P+V
Sbjct: 28  EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIKEISIMQQ-CDSPHV 86

Query: 183 VKLLDIVRDQHSKTPSL--IFEYVNS---TD-FKVLYPTLTDYDIRYYIYELLKALDYCH 236
           VK        + K   L  + EY  +   +D  ++   TLT+ +I   +   LK L+Y H
Sbjct: 87  VKYYG----SYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLH 142

Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGL-AEFYHPGKEYNVRVASRYFKGPELLVDLQ 295
               +HRD+K  N++++ E    +L D+G+  +      + N  + + ++  PE++ +  
Sbjct: 143 FMRKIHRDIKAGNILLNTE-GHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQE-I 200

Query: 296 DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNH--DQLVKIAKDCCLIIWCNSRHSRKPWS 353
            Y+   D+WSLG     M   K P+    D H    +  I                 P  
Sbjct: 201 GYNCVADIWSLGITAIEMAEGKPPYA---DIHPMRAIFMIPT--------------NPPP 243

Query: 354 KFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAES 403
            F       L S    DF+ + L    + R TA + + HP+    +    
Sbjct: 244 TF---RKPELWSDNFTDFVKQCLVKSPEQRATATQLLQHPFVRSAKGVSI 290

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  114 bits (288), Expect = 4e-29
 Identities = 57/353 (16%), Positives = 118/353 (33%), Gaps = 103/353 (29%)

Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKIL----KPVKKKKIKREIKILQNLCGG 179
             D+E ++ +GRG +  VFE  N   +    IK +    + + ++K+ RE+K L  L   
Sbjct: 5   LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKL-EH 63

Query: 180 PNVVKLLD----------------------------------------IVRDQHSKTPSL 199
           P +V+  +                                        I R     T + 
Sbjct: 64  PGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNT 123

Query: 200 IFEYVNSTDFKVLY--------PTLTDY-------------DIRYYIYELLKALDYCHSQ 238
           + +   S+    LY          L D+                +   ++ +A+++ HS+
Sbjct: 124 VGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSK 183

Query: 239 GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG----------- 287
           G+MHRD+KP N+    +   +++ D+GL       +E    +                  
Sbjct: 184 GLMHRDLKPSNIFFTMD-DVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLY 242

Query: 288 --PELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNS 345
             PE +    +Y + +D++SLG +   +++    F    +    +  +          N 
Sbjct: 243 MSPEQIHG-NNYSHKVDIFSLGLILFELLY---SFSTQMERVRIITDV---------RNL 289

Query: 346 RHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQV 398
           +       K           P+    +  +L     +R  A + + +  F  +
Sbjct: 290 KFPLLFTQK----------YPQEHMMVQDMLSPSPTERPEATDIIENAIFENL 332

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score =  113 bits (284), Expect = 5e-29
 Identities = 66/283 (23%), Positives = 120/283 (42%), Gaps = 44/283 (15%)

Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK------KKKIKREIKILQNLCGGP 180
           Y +   +G G + +V  G +  T  +  +KIL   K        KIKREI+ L+     P
Sbjct: 13  YVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRH-P 71

Query: 181 NVVKLLDIVRDQHSKTPSLIF---EYVNST---DFKVLYPTLTDYDIRYYIYELLKALDY 234
           +++KL  ++      TP+  F   EYV+     D+   +  + + + R    ++L A+DY
Sbjct: 72  HIIKLYQVI-----STPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDY 126

Query: 235 CHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDL 294
           CH   ++HRD+KP NV++D  +   ++ D+GL+     G+       S  +  PE++   
Sbjct: 127 CHRHMVVHRDLKPENVLLDAHM-NAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISG- 184

Query: 295 QDYD-YSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV-KIAKDCCLIIWCNSRHSRKPW 352
           + Y    +D+WS G +   ++    PF    ++   L  KI                  +
Sbjct: 185 RLYAGPEVDIWSCGVILYALLCGTLPF--DDEHVPTLFKKIRG---------GVFYIPEY 233

Query: 353 SKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF 395
                      ++      L  +L+ D   R T ++   H +F
Sbjct: 234 -----------LNRSVATLLMHMLQVDPLKRATIKDIREHEWF 265

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  112 bits (283), Expect = 1e-28
 Identities = 71/291 (24%), Positives = 128/291 (43%), Gaps = 39/291 (13%)

Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKIL---KPVKKKKIKREIKILQNLCGGP 180
           +  Y    K+G+G    V+  ++V T +   I+ +   +  KK+ I  EI +++     P
Sbjct: 19  KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRE-NKNP 77

Query: 181 NVVKLLDIVRDQHSKTPSL--IFEYVNS---TDFKVLYPTLTDYDIRYYIYELLKALDYC 235
           N+V  LD     +     L  + EY+     TD  V    + +  I     E L+AL++ 
Sbjct: 78  NIVNYLD----SYLVGDELWVVMEYLAGGSLTDV-VTETCMDEGQIAAVCRECLQALEFL 132

Query: 236 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGL-AEFYHPGKEYNVRVASRYFKGPELLVDL 294
           HS  ++HRD+K  N+++  +   ++L D+G  A+      + +  V + Y+  PE +V  
Sbjct: 133 HSNQVIHRDIKSDNILLGMD-GSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPE-VVTR 190

Query: 295 QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNH--DQLVKIAKDCCLIIWCNSRHSRKPW 352
           + Y   +D+WSLG M   MI  + P+    + +    L  IA             +  P 
Sbjct: 191 KAYGPKVDIWSLGIMAIEMIEGEPPYL---NENPLRALYLIAT------------NGTPE 235

Query: 353 SKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAES 403
            +     N   +S    DFL++ L  D + R +A+E + H +    +   S
Sbjct: 236 LQ-----NPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQFLKIAKPLSS 281

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  114 bits (286), Expect = 2e-28
 Identities = 58/332 (17%), Positives = 111/332 (33%), Gaps = 58/332 (17%)

Query: 123 DQDDYEVVRKVGRG--KYSEVFEGINVNTNERCIIKILKPVKKKK-----IKREIKILQN 175
           +   YE++  +G+G      V       T E   ++ +            ++ E+ + + 
Sbjct: 23  EGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSK- 81

Query: 176 LCGGPNVVKLLD--IVRDQHSKTPSL--IFEYVNS---TDF-KVLYP-TLTDYDIRYYIY 226
           L   PN+V      I  ++      L  +  ++      D     +   + +  I Y + 
Sbjct: 82  LFNHPNIVPYRATFIADNE------LWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQ 135

Query: 227 ELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE--FYHPGKEYNVRVASRY 284
            +LKALDY H  G +HR VK  +++I  +  K+ L           H  ++  V    +Y
Sbjct: 136 GVLKALDYIHHMGYVHRSVKASHILISVD-GKVYLSGLRSNLSMISHGQRQRVVHDFPKY 194

Query: 285 FKG------PELLV-DLQDYDYSLDMWSLGCM----------FAG--------MIFRKEP 319
                    PE+L  +LQ YD   D++S+G            F                 
Sbjct: 195 SVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTV 254

Query: 320 -------FFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSKFINADNQHLVSPEAIDFL 372
                       +      +   +  L     +   R       +       SP    F+
Sbjct: 255 PCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFV 314

Query: 373 DKLLRYDHQDRLTAREAMAHPYFAQVRAAESS 404
           ++ L+ +   R +A   + H +F Q++   S 
Sbjct: 315 EQCLQRNPDARPSASTLLNHSFFKQIKRRASE 346

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score =  113 bits (284), Expect = 2e-28
 Identities = 64/283 (22%), Positives = 123/283 (43%), Gaps = 45/283 (15%)

Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKIL------KPVKKKKIKREIKILQNLCGGP 180
           Y +   +G G + +V    +  T ++  +K +      K     +++REI  L+ L   P
Sbjct: 11  YIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRH-P 69

Query: 181 NVVKLLDIVRDQHSKTPSLIF---EYVNST--DFKVLYPTLTDYDIRYYIYELLKALDYC 235
           +++KL D++      TP+ I    EY      D+ V    +T+ + R +  +++ A++YC
Sbjct: 70  HIIKLYDVI-----TTPTDIVMVIEYAGGELFDYIVEKKRMTEDEGRRFFQQIICAIEYC 124

Query: 236 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQ 295
           H   I+HRD+KP N+++D  L  +++ D+GL+     G        S  +  PE++   +
Sbjct: 125 HRHKIVHRDLKPENLLLDDNL-NVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVING-K 182

Query: 296 DYD-YSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQ--LVKIAKDCCLIIWCNSRHSRKPW 352
            Y    +D+WS G +   M+  + PF    D        K+             +    +
Sbjct: 183 LYAGPEVDVWSCGIVLYVMLVGRLPF---DDEFIPNLFKKVNS---------CVYVMPDF 230

Query: 353 SKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF 395
                      +SP A   + +++  D   R+T +E    P+F
Sbjct: 231 -----------LSPGAQSLIRRMIVADPMQRITIQEIRRDPWF 262

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  112 bits (283), Expect = 2e-28
 Identities = 70/293 (23%), Positives = 133/293 (45%), Gaps = 43/293 (14%)

Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKIL---KPVKKKKIKREIKILQNLCGGP 180
           +   +   K+G G    V      ++  +  +K++   K  +++ +  E+ I+++     
Sbjct: 44  RLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRD-YQHF 102

Query: 181 NVVKLLD--IVRDQHSKTPSL--IFEYVNS---TDFKVLYPTLTDYDIRYYIYELLKALD 233
           NVV++    +V ++      L  + E++     TD  V    L +  I      +L+AL 
Sbjct: 103 NVVEMYKSYLVGEE------LWVLMEFLQGGALTDI-VSQVRLNEEQIATVCEAVLQALA 155

Query: 234 YCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGL-AEFYHPGKEYNVRVASRYFKGPELLV 292
           Y H+QG++HRD+K  ++++  +  +++L D+G  A+      +    V + Y+  PE++ 
Sbjct: 156 YLHAQGVIHRDIKSDSILLTLD-GRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVIS 214

Query: 293 DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNH--DQLVKIAKDCCLIIWCNSRHSRK 350
               Y   +D+WSLG M   M+  + P+F    +     + ++              S  
Sbjct: 215 R-SLYATEVDIWSLGIMVIEMVDGEPPYF---SDSPVQAMKRLRD------------SPP 258

Query: 351 PWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAES 403
           P  K     N H VSP   DFL+++L  D Q+R TA+E + HP+  Q    E 
Sbjct: 259 PKLK-----NSHKVSPVLRDFLERMLVRDPQERATAQELLDHPFLLQTGLPEC 306

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  112 bits (281), Expect = 2e-28
 Identities = 72/296 (24%), Positives = 135/296 (45%), Gaps = 42/296 (14%)

Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV---KKKKIKREIKILQNLCGGP 180
            + +E+V ++G G + +V++  N  T      K+++     + +    EI+IL   C  P
Sbjct: 18  NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILAT-CDHP 76

Query: 181 NVVKLLDIVRDQHSKTPSL--IFEYVNS---TD-FKVLYPTLTDYDIRYYIYELLKALDY 234
            +VKLL      +     L  + E+            L   LT+  I+    ++L+AL++
Sbjct: 77  YIVKLLG----AYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNF 132

Query: 235 CHSQGIMHRDVKPHNVMIDHELRKLRLIDWGL-AEFYHPGKEYNVRVASRYFKGPELLVD 293
            HS+ I+HRD+K  NV++  E   +RL D+G+ A+     ++ +  + + Y+  PE+++ 
Sbjct: 133 LHSKRIIHRDLKAGNVLMTLE-GDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMC 191

Query: 294 LQ----DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNH--DQLVKIAKDCCLIIWCNSRH 347
                  YDY  D+WSLG     M   + P     + +    L+KIAK        +   
Sbjct: 192 ETMKDTPYDYKADIWSLGITLIEMAQIEPPHH---ELNPMRVLLKIAK--------SDPP 240

Query: 348 SRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAES 403
           +    SK+         S E  DFL   L  + + R +A + + HP+ + + + ++
Sbjct: 241 TLLTPSKW---------SVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSITSNKA 287

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score =  115 bits (290), Expect = 3e-28
 Identities = 76/351 (21%), Positives = 137/351 (39%), Gaps = 61/351 (17%)

Query: 79  DKIEERNLAEIPLPAMSKARVYTDVNVLRPKEYWDYESLTVQWG-------DQDDYEVVR 131
            ++E+    ++          Y  V          Y +  +QW         ++ +   R
Sbjct: 131 QRLEQGPCKDLFQELTRLTHEYLSVAPFADYLDSIYFNRFLQWKWLERQPVTKNTFRQYR 190

Query: 132 KVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKR---------EIKILQNLCGGPNV 182
            +G+G + EV       T +    K L+   KK+IK+         E +IL+       V
Sbjct: 191 VLGKGGFGEVCACQVRATGKMYACKKLE---KKRIKKRKGEAMALNEKQILE-KVNSRFV 246

Query: 183 VKLLDIVRDQHS--KTPS---LIFEYVNSTD-----FKVLYPTLTDYDIRYYIYELLKAL 232
           V L           +T     L+   +N  D     + +      +    +Y  E+   L
Sbjct: 247 VSL-------AYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGL 299

Query: 233 DYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLV 292
           +  H + I++RD+KP N+++D     +R+ D GLA     G+    RV +  +  PE++ 
Sbjct: 300 EDLHRERIVYRDLKPENILLDDH-GHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVK 358

Query: 293 DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPW 352
           + + Y +S D W+LGC+   MI  + P F       +  ++ +   L+      +S +  
Sbjct: 359 N-ERYTFSPDWWALGCLLYEMIAGQSP-FQQRKKKIKREEVER---LVKEVPEEYSER-- 411

Query: 353 SKFINADNQHLVSPEAIDFLDKLLRYDHQDRL-----TAREAMAHPYFAQV 398
                       SP+A     +LL  D  +RL     +ARE   HP F ++
Sbjct: 412 -----------FSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKL 451

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  111 bits (279), Expect = 9e-28
 Identities = 65/299 (21%), Positives = 121/299 (40%), Gaps = 53/299 (17%)

Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKK------IKREIKILQNLC 177
           +  +  +R++G G +  V+   +V  +E   IK +    K+       I +E++ LQ   
Sbjct: 53  EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQK-L 111

Query: 178 GGPNVVKLLDIVRDQHSKTPSL--IFEYVN---STDFKVLYPTLTDYDIRYYIYELLKAL 232
             PN ++        + +  +   + EY     S   +V    L + +I    +  L+ L
Sbjct: 112 RHPNTIQYRG----CYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGL 167

Query: 233 DYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLV 292
            Y HS  ++HRDVK  N+++      ++L D+G A    P   +   V + Y+  PE+++
Sbjct: 168 AYLHSHNMIHRDVKAGNILLSEP-GLVKLGDFGSASIMAPANSF---VGTPYWMAPEVIL 223

Query: 293 DLQD--YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNH--DQLVKIAKDCCLIIWCNSRHS 348
            + +  YD  +D+WSLG     +  RK P F   + +    L  IA+             
Sbjct: 224 AMDEGQYDGKVDVWSLGITCIELAERKPPLF---NMNAMSALYHIAQ------------- 267

Query: 349 RKP----WSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAES 403
            +        +         S    +F+D  L+   QDR T+   + H +  + R    
Sbjct: 268 NESPALQSGHW---------SEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPPTV 317

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  109 bits (274), Expect = 2e-27
 Identities = 71/285 (24%), Positives = 125/285 (43%), Gaps = 40/285 (14%)

Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK----PVKKKKIKREIKILQNLCGG 179
           ++ +  + K+G+G + EVF+GI+  T +   IKI+       + + I++EI +L   C  
Sbjct: 21  EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQ-CDS 79

Query: 180 PNVVKLLDIVRDQHSKTPSL--IFEYVN--STDFKVLYPTLTDYDIRYYIYELLKALDYC 235
           P V K        + K   L  I EY+   S    +    L +  I   + E+LK LDY 
Sbjct: 80  PYVTKYYG----SYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYL 135

Query: 236 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGL-AEFYHPGKEYNVRVASRYFKGPELLVDL 294
           HS+  +HRD+K  NV++     +++L D+G+  +      + N  V + ++  PE++   
Sbjct: 136 HSEKKIHRDIKAANVLLSEH-GEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQ- 193

Query: 295 QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNH--DQLVKIAKDCCLIIWCNSRHSRKPW 352
             YD   D+WSLG     +   + P     + H    L  I K+       N       +
Sbjct: 194 SAYDSKADIWSLGITAIELARGEPPHS---ELHPMKVLFLIPKN-------NPPTLEGNY 243

Query: 353 SKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQ 397
           SK +             +F++  L  +   R TA+E + H +  +
Sbjct: 244 SKPLK------------EFVEACLNKEPSFRPTAKELLKHKFILR 276

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score =  111 bits (280), Expect = 3e-27
 Identities = 70/282 (24%), Positives = 121/282 (42%), Gaps = 42/282 (14%)

Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK------KKKIKREIKILQNLCGGP 180
           Y +   +G G + +V  G +  T  +  +KIL   K        KI+REI+ L+     P
Sbjct: 18  YILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRH-P 76

Query: 181 NVVKLLDIVRDQHSKTPSLIF---EYVNST---DFKVLYPTLTDYDIRYYIYELLKALDY 234
           +++KL  ++      TPS IF   EYV+     D+      L + + R    ++L  +DY
Sbjct: 77  HIIKLYQVI-----STPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDY 131

Query: 235 CHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDL 294
           CH   ++HRD+KP NV++D  +   ++ D+GL+     G+       S  +  PE++   
Sbjct: 132 CHRHMVVHRDLKPENVLLDAHM-NAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISG- 189

Query: 295 QDYD-YSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWS 353
           + Y    +D+WS G +   ++    PF    D+   L K   D               + 
Sbjct: 190 RLYAGPEVDIWSSGVILYALLCGTLPF--DDDHVPTLFKKICDGIFYT--------PQY- 238

Query: 354 KFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF 395
                     ++P  I  L  +L+ D   R T ++   H +F
Sbjct: 239 ----------LNPSVISLLKHMLQVDPMKRATIKDIREHEWF 270

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score =  111 bits (280), Expect = 5e-27
 Identities = 75/360 (20%), Positives = 135/360 (37%), Gaps = 64/360 (17%)

Query: 73  YEGAIIDKIEERNLAEIPLPAMSKARVYTDVNVLRPKEYWDYESLTVQWGDQ-------D 125
            +   + +        +  P +     +      +      Y    +QW          D
Sbjct: 126 LDAETVARARAGAGDGLFQPLLRAVLAHLGQAPFQEFLDSLYFLRFLQWKWLEAQPMGED 185

Query: 126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKR---------EIKILQNL 176
            +   R +GRG + EVF      T +    K L    KK++K+         E KIL   
Sbjct: 186 WFLDFRVLGRGGFGEVFACQMKATGKLYACKKLN---KKRLKKRKGYQGAMVEKKILA-K 241

Query: 177 CGGPNVVKLLDIVRDQHS--KTPS---LIFEYVNSTDFKV-LYPTLTDYDI------RYY 224
                +V L           +T +   L+   +N  D +  +Y    D          +Y
Sbjct: 242 VHSRFIVSL-------AYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFY 294

Query: 225 IYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEYNVRVASR 283
             +++  L++ H + I++RD+KP NV++D +   +R+ D GLA E      +      + 
Sbjct: 295 TAQIVSGLEHLHQRNIIYRDLKPENVLLDDD-GNVRISDLGLAVELKAGQTKTKGYAGTP 353

Query: 284 YFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWC 343
            F  PELL+  ++YD+S+D ++LG     MI  + P F       +  ++ +    ++  
Sbjct: 354 GFMAPELLLG-EEYDFSVDYFALGVTLYEMIAARGP-FRARGEKVENKELKQ---RVLEQ 408

Query: 344 NSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRL-----TAREAMAHPYFAQV 398
              +  K              SP + DF + LL+ D + RL     +      HP F  +
Sbjct: 409 AVTYPDK-------------FSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDI 455

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score =  111 bits (280), Expect = 9e-27
 Identities = 71/299 (23%), Positives = 124/299 (41%), Gaps = 56/299 (18%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKR---------EIKILQ- 174
           +D+ V R +GRG + EV+     +T +   +K L    KK+IK          E  +L  
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLD---KKRIKMKQGETLALNERIMLSL 245

Query: 175 -NLCGGPNVVKLLDIVRDQHS--KTPS---LIFEYVNSTD-FKVLY--PTLTDYDIRYYI 225
            +    P +V +            TP     I + +N  D    L      ++ D+R+Y 
Sbjct: 246 VSTGDCPFIVCM-------SYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYA 298

Query: 226 YELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYF 285
            E++  L++ H++ +++RD+KP N+++D     +R+ D GLA      K+ +  V +  +
Sbjct: 299 AEIILGLEHMHNRFVVYRDLKPANILLDEH-GHVRISDLGLAC-DFSKKKPHASVGTHGY 356

Query: 286 KGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF-YGHDNHDQLVKIAKDCCLIIWCN 344
             PE+L     YD S D +SLGCM   ++    PF  +   +  ++ +            
Sbjct: 357 MAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDR-----------M 405

Query: 345 SRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRL-----TAREAMAHPYFAQV 398
           +                   SPE    L+ LL+ D   RL      A+E    P+F  +
Sbjct: 406 TLTMAVELPDSF--------SPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSL 456

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  107 bits (270), Expect = 1e-26
 Identities = 52/292 (17%), Positives = 107/292 (36%), Gaps = 32/292 (10%)

Query: 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKIL----KPVKKKKIKREIKILQNLCG 178
           + +D E + ++G G   +V++     T     +K +       + K+I  ++ ++     
Sbjct: 23  EINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHD 82

Query: 179 GPNVVKLLDIVRDQHSKTPSLIFEYVN--STDFKVLYP-TLTDYDIRYYIYELLKALDYC 235
            P +V+              +  E +   +   K      + +  +      ++KAL Y 
Sbjct: 83  CPYIVQCFGTFITNTDV--FIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYL 140

Query: 236 HSQ-GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE----L 290
             + G++HRDVKP N+++D    +++L D+G++      K  +       +  PE     
Sbjct: 141 KEKHGVIHRDVKPSNILLDER-GQIKLCDFGISGRLVDDKAKDRSAGCAAYMAPERIDPP 199

Query: 291 LVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRK 350
                DYD   D+WSLG     +   + P+     + + L K+ +               
Sbjct: 200 DPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQ--------EEPPLLP 251

Query: 351 PWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAE 402
               F         S +   F+   L  DH+ R    + + H +  +    E
Sbjct: 252 GHMGF---------SGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRYETLE 294

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score =  106 bits (268), Expect = 2e-26
 Identities = 73/300 (24%), Positives = 127/300 (42%), Gaps = 60/300 (20%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP---VKKKKI---KREIKILQNLCG 178
           +D++  + +G G +S V     + T+    IKIL+    +K+ K+    RE  ++  L  
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-D 88

Query: 179 GPNVVKLLDIVRDQHS-KTPS---LIFEYVNSTD-FKVLYP--TLTDYDIRYYIYELLKA 231
            P  VKL        + +          Y  + +  K +    +  +   R+Y  E++ A
Sbjct: 89  HPFFVKLY------FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSA 142

Query: 232 LDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG---- 287
           L+Y H +GI+HRD+KP N++++ ++  +++ D+G A+     +    R  S  F G    
Sbjct: 143 LEYLHGKGIIHRDLKPENILLNEDMH-IQITDFGTAK-VLSPESKQARANS--FVGTAQY 198

Query: 288 --PELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV-KIAKDCCLIIWCN 344
             PELL + +    S D+W+LGC+   ++    PF     N   +  KI K         
Sbjct: 199 VSPELLTE-KSACKSSDLWALGCIIYQLVAGLPPFR--AGNEYLIFQKIIKL-------- 247

Query: 345 SRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLT------AREAMAHPYFAQV 398
                  + +           P+A D ++KLL  D   RL            AHP+F  V
Sbjct: 248 ----EYDFPEKF--------FPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV 295

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score =  104 bits (262), Expect = 6e-25
 Identities = 73/308 (23%), Positives = 120/308 (38%), Gaps = 68/308 (22%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKR--------EIKILQNL 176
           DD+E+++ +GRG +SEV       T +   +KI+   K   +KR        E  +L N 
Sbjct: 61  DDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMN--KWDMLKRGEVSCFREERDVLVN- 117

Query: 177 CGGPNVVKLLDIVRDQHS-KTPS---LIFEYVNSTD-FKVLY---PTLTDYDIRYYIYEL 228
                + +L        + +  +   L+ EY    D   +L      +     R+Y+ E+
Sbjct: 118 GDRRWITQL------HFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEI 171

Query: 229 LKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNV--RVASRYFK 286
           + A+D  H  G +HRD+KP N+++D     +RL D+G         +      V S    
Sbjct: 172 VMAIDSVHRLGYVHRDIKPDNILLDRC-GHIRLADFGSC------LKLRADGTVRSLVAV 224

Query: 287 G------PELL------VDLQDYDYSLDMWSLG-CMFAGMIFRKEPFFYGHDNHDQLVKI 333
           G      PE+L           Y    D W+LG   +  M + + PF+   D+  +    
Sbjct: 225 GTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYE-MFYGQTPFY--ADSTAET--- 278

Query: 334 AKDCCLIIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLT---AREAM 390
                 I+        K        D    V  EA DF+ +LL    + RL    A +  
Sbjct: 279 ---YGKIV------HYKEHLSLPLVDEG--VPEEARDFIQRLLC-PPETRLGRGGAGDFR 326

Query: 391 AHPYFAQV 398
            HP+F  +
Sbjct: 327 THPFFFGL 334

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  102 bits (256), Expect = 1e-24
 Identities = 56/313 (17%), Positives = 114/313 (36%), Gaps = 73/313 (23%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKIL----KPVKKKKIKREIKILQNLCGGP 180
           +D + + ++GRG Y  V + ++  + +   +K +       ++K++  ++ ++      P
Sbjct: 22  EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCP 81

Query: 181 NVVK---------------------LLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDY 219
            +V+                          +  +S    +I E +               
Sbjct: 82  YIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEI--------------- 126

Query: 220 DIRYYIYELLKALDYCHSQG-IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNV 278
            +       +KAL++      I+HRD+KP N+++D     ++L D+G++       +   
Sbjct: 127 -LGKITLATVKALNHLKENLKIIHRDIKPSNILLDRS-GNIKLCDFGIS------GQLVD 178

Query: 279 RVASRYFKG------PELL---VDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQ 329
            +A     G      PE +      Q YD   D+WSLG     +   + P+   +   DQ
Sbjct: 179 SIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQ 238

Query: 330 LVKIAKDCCLIIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREA 389
           L ++ K          + S     +F         SP  I+F++  L  D   R   +E 
Sbjct: 239 LTQVVKGDPP------QLSNSEEREF---------SPSFINFVNLCLTKDESKRPKYKEL 283

Query: 390 MAHPYFAQVRAAE 402
           + HP+        
Sbjct: 284 LKHPFILMYEERA 296

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score =  103 bits (258), Expect = 2e-24
 Identities = 67/306 (21%), Positives = 121/306 (39%), Gaps = 66/306 (21%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKR--------EIKILQNL 176
           +D+E+++ +GRG + EV      N ++   +KIL   K + +KR        E  +L N 
Sbjct: 74  EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILN--KWEMLKRAETACFREERDVLVN- 130

Query: 177 CGGPNVVKLLDIVRDQHS--KTPS---LIFEYVNSTD-FKVLY---PTLTDYDIRYYIYE 227
                +  L       H   +  +   L+ +Y    D   +L      L +   R+Y+ E
Sbjct: 131 GDSKWITTL-------HYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAE 183

Query: 228 LLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE--YNVRVASRYF 285
           ++ A+D  H    +HRD+KP N+++D     +RL D+G         +   +  V S   
Sbjct: 184 MVIAIDSVHQLHYVHRDIKPDNILMDMN-GHIRLADFGSC------LKLMEDGTVQSSVA 236

Query: 286 KG------PELLVDLQD----YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK 335
            G      PE+L  ++     Y    D WSLG     M++ + PF+   ++  +      
Sbjct: 237 VGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFY--AESLVET----- 289

Query: 336 DCCLIIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLT---AREAMAH 392
               I+    R         +        S  A D + +L+    + RL      +   H
Sbjct: 290 -YGKIMNHKERFQFPTQVTDV--------SENAKDLIRRLIC-SREHRLGQNGIEDFKKH 339

Query: 393 PYFAQV 398
           P+F+ +
Sbjct: 340 PFFSGI 345

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  102 bits (255), Expect = 2e-24
 Identities = 61/313 (19%), Positives = 113/313 (36%), Gaps = 45/313 (14%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKI----LKPVKKKKIKREIKILQNLCGGP 180
           DD+E + ++G G    VF+  +  +      K+    +KP  + +I RE+++L   C  P
Sbjct: 33  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE-CNSP 91

Query: 181 NVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYD---IRYYIYELLKALDYCHS 237
            +V              S+  E+++      +           +      ++K L Y   
Sbjct: 92  YIVGFYGAF--YSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLRE 149

Query: 238 QG-IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK----EYNVRVASRYFKGPELLV 292
           +  IMHRDVKP N++++    +++L D+G++     G+      N  V +R +  PE L 
Sbjct: 150 KHKIMHRDVKPSNILVNSR-GEIKLCDFGVS-----GQLIDSMANSFVGTRSYMSPERL- 202

Query: 293 DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPW 352
               Y    D+WS+G     M   + P         +L+   +          R      
Sbjct: 203 QGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGR 262

Query: 353 SKFINADNQHLV-----------------------SPEAIDFLDKLLRYDHQDRLTAREA 389
                  +                           S E  DF++K L  +  +R   ++ 
Sbjct: 263 PLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQL 322

Query: 390 MAHPYFAQVRAAE 402
           M H +  +  A E
Sbjct: 323 MVHAFIKRSDAEE 335

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score =  102 bits (256), Expect = 2e-24
 Identities = 55/298 (18%), Positives = 111/298 (37%), Gaps = 58/298 (19%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK--PVKKKK----IKREIKILQNLCG 178
           D +E++R +G+G + +V      +T +   +K +      ++     + +E++I+Q L  
Sbjct: 15  DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGL-E 73

Query: 179 GPNVVKLLDIVRDQHS--KTPS---LIFEYVNSTD-FKVLY--PTLTDYDIRYYIYELLK 230
            P +V L           +      ++ + +   D    L       +  ++ +I EL+ 
Sbjct: 74  HPFLVNL-------WYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVM 126

Query: 231 ALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG--- 287
           ALDY  +Q I+HRD+KP N+++D     + + D+ +A                   G   
Sbjct: 127 ALDYLQNQRIIHRDMKPDNILLDEH-GHVHITDFNIA------AMLPRETQITTMAGTKP 179

Query: 288 ---PELLVD--LQDYDYSLDMWSLGCMFAGMIFRKEPFF-YGHDNHDQLVKIAKDCCLII 341
              PE+        Y +++D WSLG     ++  + P+      +  ++V          
Sbjct: 180 YMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVH--------- 230

Query: 342 WCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRL-TAREAMAHPYFAQV 398
                 +   +            S E +  L KLL  +   R     +    PY   +
Sbjct: 231 --TFETTVVTYPSAW--------SQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMNDI 278

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score =  100 bits (251), Expect = 1e-23
 Identities = 74/303 (24%), Positives = 122/303 (40%), Gaps = 64/303 (21%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP---VKKKKIKR---EIKILQNLCG 178
           +DYEVV+ +GRG + EV    + +T +   +K+L     +K+        E  I+     
Sbjct: 69  EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANS 128

Query: 179 GPNVVKLLDIVRDQHS-KTPS---LIFEYVNSTDFKVLYPTLTDYDI-----RYYIYELL 229
            P VV+L       ++ +      ++ EY+   D   L   +++YD+     R+Y  E++
Sbjct: 129 -PWVVQL------FYAFQDDRYLYMVMEYMPGGD---LVNLMSNYDVPEKWARFYTAEVV 178

Query: 230 KALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNV--RVASRYFKG 287
            ALD  HS G +HRDVKP N+++D     L+L D+G         + N    V      G
Sbjct: 179 LALDAIHSMGFIHRDVKPDNMLLDKS-GHLKLADFGTC------MKMNKEGMVRCDTAVG 231

Query: 288 ------PELLVD---LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCC 338
                 PE+L        Y    D WS+G     M+    PF+   D+            
Sbjct: 232 TPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFY--ADSLVGT------YS 283

Query: 339 LIIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLT---AREAMAHPYF 395
            I+     + +   +   + D    +S EA + +   L  D + RL      E   H +F
Sbjct: 284 KIM-----NHKNSLTFPDDND----ISKEAKNLICAFLT-DREVRLGRNGVEEIKRHLFF 333

Query: 396 AQV 398
              
Sbjct: 334 KND 336

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score =  100 bits (250), Expect = 1e-23
 Identities = 71/304 (23%), Positives = 121/304 (39%), Gaps = 71/304 (23%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKR--------EIKILQNL 176
            D+  ++ +G+G + +V    +        +K+L+  KK  +K+        E  +L   
Sbjct: 38  SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQ--KKAILKKKEEKHIMSERNVLLKN 95

Query: 177 CGGPNVVKLLDIVRDQHS--KTPS---LIFEYVNSTD-FKVLY--PTLTDYDIRYYIYEL 228
              P +V L       H   +T      + +Y+N  + F  L       +   R+Y  E+
Sbjct: 96  VKHPFLVGL-------HFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEI 148

Query: 229 LKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGK---------EYNV 278
             AL Y HS  I++RD+KP N+++D +   + L D+GL  E               EY  
Sbjct: 149 ASALGYLHSLNIVYRDLKPENILLDSQ-GHIVLTDFGLCKENIEHNSTTSTFCGTPEY-- 205

Query: 279 RVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCC 338
            +A      PE+L   Q YD ++D W LG +   M++   PF+    N  ++        
Sbjct: 206 -LA------PEVLHK-QPYDRTVDWWCLGAVLYEMLYGLPPFY--SRNTAEMYD------ 249

Query: 339 LIIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRL----TAREAMAHPY 394
            I   N     KP            ++  A   L+ LL+ D   RL       E  +H +
Sbjct: 250 NI--LNKPLQLKPN-----------ITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVF 296

Query: 395 FAQV 398
           F+ +
Sbjct: 297 FSLI 300

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 98.8 bits (247), Expect = 2e-23
 Identities = 79/304 (25%), Positives = 134/304 (44%), Gaps = 71/304 (23%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKR--------EIKILQNL 176
           +D++ ++ +G+G + +V       T     +KIL+  K+  I +        E ++LQN 
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILR--KEVIIAKDEVAHTVTESRVLQN- 61

Query: 177 CGGPNVVKLLDIVRDQHS--KTPS---LIFEYVNSTD-FKVLY--PTLTDYDIRYYIYEL 228
              P +  L           +T      + EY N  + F  L      T+   R+Y  E+
Sbjct: 62  TRHPFLTAL-------KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEI 114

Query: 229 LKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE---YNVRVASRYF 285
           + AL+Y HS+ +++RD+K  N+M+D +   +++ D+GL       KE       + +  F
Sbjct: 115 VSALEYLHSRDVVYRDIKLENLMLDKD-GHIKITDFGLC------KEGISDGATMKT--F 165

Query: 286 KG------PELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCL 339
            G      PE+L D  DY  ++D W LG +   M+  + P FY   +H++L +      L
Sbjct: 166 CGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLP-FYN-QDHERLFE------L 216

Query: 340 IIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRL-----TAREAMAHPY 394
           I+    R  R              +SPEA   L  LL+ D + RL      A+E M H +
Sbjct: 217 ILMEEIRFPRT-------------LSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRF 263

Query: 395 FAQV 398
           F  +
Sbjct: 264 FLSI 267

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 99.3 bits (248), Expect = 2e-23
 Identities = 68/297 (22%), Positives = 119/297 (40%), Gaps = 60/297 (20%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK--PVKKKK----IKREIKILQNLCG 178
           D ++ ++ +G G +  V    +  +     +KIL    V K K       E +ILQ    
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA-VN 99

Query: 179 GPNVVKLLDIVRDQHSKTPS---LIFEYVNSTD-FKVLY--PTLTDYDIRYYIYELLKAL 232
            P +VKL     +   K  S   ++ EYV   + F  L      ++   R+Y  +++   
Sbjct: 100 FPFLVKL-----EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 154

Query: 233 DYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG----- 287
           +Y HS  +++RD+KP N++ID +   +++ D+G A      K    R  +    G     
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQ-GYIQVTDFGFA------KRVKGRTWT--LCGTPEAL 205

Query: 288 -PELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSR 346
            PE+++  + Y+ ++D W+LG +   M     PFF   D   Q+ +       I+    R
Sbjct: 206 APEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF--ADQPIQIYE------KIVSGKVR 256

Query: 347 HSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRL-----TAREAMAHPYFAQV 398
                +            S +  D L  LL+ D   R         +   H +FA  
Sbjct: 257 -----FPSHF--------SSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATT 300

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 98.5 bits (246), Expect = 5e-23
 Identities = 69/310 (22%), Positives = 119/310 (38%), Gaps = 82/310 (26%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKI---------KREIKILQN 175
            D+  +  +G+G + +V       T+E   +KILK   K  +           E ++L  
Sbjct: 20  TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILK---KDVVIQDDDVECTMVEKRVLAL 76

Query: 176 LCGGPNVVKLLDIVRDQHS--KTPS---LIFEYVNSTD-FKVLYPT--LTDYDIRYYIYE 227
               P + +L       HS  +T      + EYVN  D    +       +    +Y  E
Sbjct: 77  PGKPPFLTQL-------HSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAE 129

Query: 228 LLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGK---------EYN 277
           +   L +  S+GI++RD+K  NVM+D E   +++ D+G+  E    G          +Y 
Sbjct: 130 IAIGLFFLQSKGIIYRDLKLDNVMLDSE-GHIKIADFGMCKENIWDGVTTKTFCGTPDY- 187

Query: 278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGC----MFAGMIFRKEPFFYGHDNHDQLVKI 333
             +A      PE++   Q Y  S+D W+ G     M AG     +  F G ++ D+L + 
Sbjct: 188 --IA------PEIIAY-QPYGKSVDWWAFGVLLYEMLAG-----QAPFEG-EDEDELFQ- 231

Query: 334 AKDCCLIIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRL-----TARE 388
                 I+  N  + +              +S EA+     L+      RL       R+
Sbjct: 232 -----SIMEHNVAYPKS-------------MSKEAVAICKGLMTKHPGKRLGCGPEGERD 273

Query: 389 AMAHPYFAQV 398
              H +F  +
Sbjct: 274 IKEHAFFRYI 283

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 98.8 bits (246), Expect = 6e-23
 Identities = 78/392 (19%), Positives = 142/392 (36%), Gaps = 106/392 (27%)

Query: 102 DVNVLRPKEYWDYESLTVQWGD--QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK 159
           D     P +Y       V+ GD     Y V+RK+G G +S V+   ++   +   +K++K
Sbjct: 12  DDEQEDPNDYCKGGYHLVKIGDLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVK 71

Query: 160 PVKK--KKIKREIKILQNLC-------GGPNVVKLLDI--VRDQHSKTPSLIFEY--VNS 206
             +   +    EI++L+++            VV+LLD   +   +     ++FE    + 
Sbjct: 72  SAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGVNGTHICMVFEVLGHHL 131

Query: 207 TDFKVLYPT--LTDYDIRYYIYELLKALDYCHSQ-GIMHRDVKPHNVMI----------- 252
             + +      L    ++  I ++L+ LDY H++  I+H D+KP N+++           
Sbjct: 132 LKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLA 191

Query: 253 -------------------------------------DHELRKLRLIDWGLAEFYHPGKE 275
                                                + E  K+++ D G A      K 
Sbjct: 192 AEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNA--CWVHKH 249

Query: 276 YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVK--- 332
           +   + +R ++  E+L+    Y+   D+WS  CM    +   +  F  H   +       
Sbjct: 250 FTEDIQTRQYRSLEVLIGS-GYNTPADIWSTACMAFE-LATGDYLFEPHSGEEYTRDEDH 307

Query: 333 IAKDCCLII----------WCNSRHSR---------------KPWSKFINADNQHLVSPE 367
           IA    LII              ++S+               KPW  F     ++  S E
Sbjct: 308 IA----LIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQE 363

Query: 368 ----AIDFLDKLLRYDHQDRLTAREAMAHPYF 395
                 DFL  +L    + R TA E + HP+ 
Sbjct: 364 EAAGFTDFLLPMLELIPEKRATAAECLRHPWL 395

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 97.3 bits (243), Expect = 8e-23
 Identities = 77/312 (24%), Positives = 128/312 (41%), Gaps = 76/312 (24%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK--PVKKKK----IKREIKILQNLCG 178
            D++++R +GRG Y++V       T+    +K++K   V   +    ++ E  + +    
Sbjct: 9   QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASN 68

Query: 179 GPNVVKLLDIVRDQHS--KTPS---LIFEYVNSTD-FKVLY--PTLTDYDIRYYIYELLK 230
            P +V L       HS  +T S    + EYVN  D    +     L +   R+Y  E+  
Sbjct: 69  HPFLVGL-------HSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISL 121

Query: 231 ALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGK---------EYNVRV 280
           AL+Y H +GI++RD+K  NV++D E   ++L D+G+  E   PG           Y   +
Sbjct: 122 ALNYLHERGIIYRDLKLDNVLLDSE-GHIKLTDYGMCKEGLRPGDTTSTFCGTPNY---I 177

Query: 281 ASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGH-------DNHDQLV-K 332
           A      PE+L   +DY +S+D W+LG +   M+  + PF           +  D L   
Sbjct: 178 A------PEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQV 230

Query: 333 IAKDCCLIIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRL------TA 386
           I +    I                       +S +A   L   L  D ++RL        
Sbjct: 231 ILEKQIRI---------PRS-----------LSVKAASVLKSFLNKDPKERLGCHPQTGF 270

Query: 387 REAMAHPYFAQV 398
            +   HP+F  V
Sbjct: 271 ADIQGHPFFRNV 282

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 97.3 bits (243), Expect = 1e-22
 Identities = 67/307 (21%), Positives = 119/307 (38%), Gaps = 75/307 (24%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKI---------KREIKILQN 175
           D++E +R +G+G + +V       T +   +K+LK   K  I           E +IL  
Sbjct: 23  DNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLK---KDVILQDDDVECTMTEKRILSL 79

Query: 176 LCGGPNVVKLLDIVRDQHS--KTPS---LIFEYVNSTD-FKVLYPT--LTDYDIRYYIYE 227
               P + +L           +TP     + E+VN  D    +  +    +   R+Y  E
Sbjct: 80  ARNHPFLTQL-------FCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAE 132

Query: 228 LLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGK---------EYN 277
           ++ AL + H +GI++RD+K  NV++DHE    +L D+G+  E    G          +Y 
Sbjct: 133 IISALMFLHDKGIIYRDLKLDNVLLDHE-GHCKLADFGMCKEGICNGVTTATFCGTPDY- 190

Query: 278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDC 337
             +A      PE+L +   Y  ++D W++G +   M+    P F   +  D    I  D 
Sbjct: 191 --IA------PEILQE-MLYGPAVDWWAMGVLLYEMLCGHAP-FEAENEDDLFEAILNDE 240

Query: 338 CLIIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRL------TAREAMA 391
            +            W           +  +A   L   +  +   RL           + 
Sbjct: 241 VVY---------PTW-----------LHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR 280

Query: 392 HPYFAQV 398
           HP+F ++
Sbjct: 281 HPFFKEI 287

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 96.5 bits (241), Expect = 1e-22
 Identities = 77/308 (25%), Positives = 130/308 (42%), Gaps = 77/308 (25%)

Query: 125 DDYEVVRKVGRGKYSEVF---EGINVNTNERCIIKILKPVKKKKIKR--------EIKIL 173
             +E+++ +G+G + +VF   +    +  +   +K+LK   K  +K         E  IL
Sbjct: 24  SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLK---KATLKVRDRVRTKMERDIL 80

Query: 174 QNLCGGPNVVKLLDIVRDQHS--KTPS---LIFEYVNSTD-FKVLY--PTLTDYDIRYYI 225
                 P +VKL       H   +T     LI +++   D F  L      T+ D+++Y+
Sbjct: 81  VE-VNHPFIVKL-------HYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYL 132

Query: 226 YELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGK---------E 275
            EL  ALD+ HS GI++RD+KP N+++D E   ++L D+GL+ E     K         E
Sbjct: 133 AELALALDHLHSLGIIYRDLKPENILLDEE-GHIKLTDFGLSKESIDHEKKAYSFCGTVE 191

Query: 276 YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK 335
           Y   +A      PE++   + +  S D WS G +   M+    P F G D  + +  I K
Sbjct: 192 Y---MA------PEVVNR-RGHTQSADWWSFGVLMFEMLTGTLP-FQGKDRKETMTMILK 240

Query: 336 DCCLIIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRL-----TAREAM 390
               +           +           +SPEA   L  L + +  +RL        E  
Sbjct: 241 AKLGM---------PQF-----------LSPEAQSLLRMLFKRNPANRLGAGPDGVEEIK 280

Query: 391 AHPYFAQV 398
            H +F+ +
Sbjct: 281 RHSFFSTI 288

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 96.5 bits (241), Expect = 2e-22
 Identities = 67/299 (22%), Positives = 121/299 (40%), Gaps = 64/299 (21%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK--PVKKKK----IKREIKILQNLCG 178
           +D+ + + +G+G + +VF      TN+   IK LK   V           E ++L     
Sbjct: 17  EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 76

Query: 179 GPNVVKLLDIVRDQHS--KTPS---LIFEYVNSTD-FKVLYP--TLTDYDIRYYIYELLK 230
            P +  +           +T      + EY+N  D    +            +Y  E++ 
Sbjct: 77  HPFLTHM-------FCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIIL 129

Query: 231 ALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGK---------EYNVRV 280
            L + HS+GI++RD+K  N+++D +   +++ D+G+  E               +Y   +
Sbjct: 130 GLQFLHSKGIVYRDLKLDNILLDKD-GHIKIADFGMCKENMLGDAKTNTFCGTPDY---I 185

Query: 281 ASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLI 340
           A      PE+L+  Q Y++S+D WS G +   M+  + P F+G  + ++L         I
Sbjct: 186 A------PEILLG-QKYNHSVDWWSFGVLLYEMLIGQSP-FHG-QDEEELFH------SI 230

Query: 341 IWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREA-MAHPYFAQV 398
              N  + R              +  EA D L KL   + + RL  R     HP F ++
Sbjct: 231 RMDNPFYPRW-------------LEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREI 276

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 96.1 bits (240), Expect = 2e-22
 Identities = 84/311 (27%), Positives = 135/311 (43%), Gaps = 81/311 (26%)

Query: 125 DDYEVVRKVGRGKYSEVF---EGINVNTNERCIIKILKP---VKKKK----IKREIKILQ 174
           + +E++R +G+G Y +VF   +    NT +   +K+LK    V+  K     K E  IL+
Sbjct: 17  ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILE 76

Query: 175 NLCGGPNVVKLLDIVRDQHS--KTPS---LIFEYVNSTD-FKVLY--PTLTDYDIRYYIY 226
                P +V L           +T     LI EY++  + F  L       +    +Y+ 
Sbjct: 77  E-VKHPFIVDL-------IYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLA 128

Query: 227 ELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGK---------EY 276
           E+  AL + H +GI++RD+KP N+M++H+   ++L D+GL  E  H G          EY
Sbjct: 129 EISMALGHLHQKGIIYRDLKPENIMLNHQ-GHVKLTDFGLCKESIHDGTVTHTFCGTIEY 187

Query: 277 NVRVASRYFKGPELLVDLQDYDYSLDMWSLGC----MFAGMIFRKEPFFYGHDNHDQLVK 332
              +A      PE+L+    ++ ++D WSLG     M  G      P F G +    + K
Sbjct: 188 ---MA------PEILMR-SGHNRAVDWWSLGALMYDMLTG-----APPFTGENRKKTIDK 232

Query: 333 IAKDCCLIIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRL-----TAR 387
           I K    +          P+           ++ EA D L KLL+ +   RL      A 
Sbjct: 233 ILKCKLNL---------PPY-----------LTQEARDLLKKLLKRNAASRLGAGPGDAG 272

Query: 388 EAMAHPYFAQV 398
           E  AHP+F  +
Sbjct: 273 EVQAHPFFRHI 283

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 96.3 bits (240), Expect = 4e-22
 Identities = 76/312 (24%), Positives = 128/312 (41%), Gaps = 76/312 (24%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK--PVKKKK----IKREIKILQNLCG 178
            D++++R +GRG Y++V       T+    ++++K   V   +    ++ E  + +    
Sbjct: 52  QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASN 111

Query: 179 GPNVVKLLDIVRDQHS--KTPS---LIFEYVNSTD-FKVLY--PTLTDYDIRYYIYELLK 230
            P +V L       HS  +T S    + EYVN  D    +     L +   R+Y  E+  
Sbjct: 112 HPFLVGL-------HSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISL 164

Query: 231 ALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGK---------EYNVRV 280
           AL+Y H +GI++RD+K  NV++D E   ++L D+G+  E   PG           Y   +
Sbjct: 165 ALNYLHERGIIYRDLKLDNVLLDSE-GHIKLTDYGMCKEGLRPGDTTSTFCGTPNY---I 220

Query: 281 ASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGH-------DNHDQLV-K 332
           A      PE+L   +DY +S+D W+LG +   M+  + PF           +  D L   
Sbjct: 221 A------PEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQV 273

Query: 333 IAKDCCLIIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRL------TA 386
           I +    I                       +S +A   L   L  D ++RL        
Sbjct: 274 ILEKQIRI---------PRS-----------LSVKAASVLKSFLNKDPKERLGCHPQTGF 313

Query: 387 REAMAHPYFAQV 398
            +   HP+F  V
Sbjct: 314 ADIQGHPFFRNV 325

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 96.7 bits (241), Expect = 4e-22
 Identities = 76/297 (25%), Positives = 133/297 (44%), Gaps = 56/297 (18%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKR--------EIKILQNL 176
           +++E ++ +G+G + +V       T     +KILK  K+  + +        E ++LQN 
Sbjct: 148 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILK--KEVIVAKDEVAHTLTENRVLQN- 204

Query: 177 CGGPNVVKLLDIVRDQHS--KTPS---LIFEYVNSTD-FKVLY--PTLTDYDIRYYIYEL 228
              P +  L           +T      + EY N  + F  L      ++   R+Y  E+
Sbjct: 205 SRHPFLTAL-------KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEI 257

Query: 229 LKALDYCHSQ-GIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEYNVRVASRYFK 286
           + ALDY HS+  +++RD+K  N+M+D +   +++ D+GL  E    G        +  + 
Sbjct: 258 VSALDYLHSEKNVVYRDLKLENLMLDKD-GHIKITDFGLCKEGIKDGATMKTFCGTPEYL 316

Query: 287 GPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSR 346
            PE+L D  DY  ++D W LG +   M+  + PF+  + +H++L +      LI+    R
Sbjct: 317 APEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFY--NQDHEKLFE------LILMEEIR 367

Query: 347 HSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRL-----TAREAMAHPYFAQV 398
             R              + PEA   L  LL+ D + RL      A+E M H +FA +
Sbjct: 368 FPRT-------------LGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGI 411

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 94.9 bits (237), Expect = 4e-22
 Identities = 61/300 (20%), Positives = 118/300 (39%), Gaps = 66/300 (22%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK--PVKKKK----IKREIKILQNLCG 178
            D++++R +G G +  V    + +      +K+LK   V + K       E  +L  +  
Sbjct: 6   QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIV-T 64

Query: 179 GPNVVKLLDIVRDQHS--KTPS---LIFEYVNSTD-FKVLY--PTLTDYDIRYYIYELLK 230
            P ++++           +      +I +Y+   + F +L       +   ++Y  E+  
Sbjct: 65  HPFIIRM-------WGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCL 117

Query: 231 ALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG--- 287
           AL+Y HS+ I++RD+KP N+++D     +++ D+G A      K       +    G   
Sbjct: 118 ALEYLHSKDIIYRDLKPENILLDKN-GHIKITDFGFA------KYVPDVTYT--LCGTPD 168

Query: 288 ---PELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV-KIAKDCCLIIWC 343
              PE++   + Y+ S+D WS G +   M+    PF+    N  +   KI          
Sbjct: 169 YIAPEVVST-KPYNKSIDWWSFGILIYEMLAGYTPFY--DSNTMKTYEKILNA------- 218

Query: 344 NSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRL-----TAREAMAHPYFAQV 398
                   +  F         + +  D L +L+  D   RL        +   HP+F +V
Sbjct: 219 -----ELRFPPFF--------NEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEV 265

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 95.0 bits (237), Expect = 6e-22
 Identities = 73/312 (23%), Positives = 139/312 (44%), Gaps = 75/312 (24%)

Query: 125 DDYEVVRKVGRGKYSEVF---EGINVNTNERCIIKILKP---VKKKK----IKREIKILQ 174
           +++E+++ +G G Y +VF   +    +T +   +K+LK    V+K K     + E ++L+
Sbjct: 54  ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 113

Query: 175 NLCGGPNVVKLLDIVRDQHS--KTPS---LIFEYVNSTD-FKVLY--PTLTDYDIRYYIY 226
           ++   P +V L       H   +T +   LI +Y+N  + F  L      T+++++ Y+ 
Sbjct: 114 HIRQSPFLVTL-------HYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVG 166

Query: 227 ELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE----YNVRVAS 282
           E++ AL++ H  GI++RD+K  N+++D     + L D+GL+      KE       R   
Sbjct: 167 EIVLALEHLHKLGIIYRDIKLENILLDSN-GHVVLTDFGLS------KEFVADETERAYD 219

Query: 283 RYFKG------PELLVDL-QDYDYSLDMWSLGC----MFAGMIFRKEPFFYGHDNHDQLV 331
             F G      P+++      +D ++D WSLG     +  G        F      +   
Sbjct: 220 --FCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGA-----SPFTVDGEKNSQA 272

Query: 332 KIAKDCCLIIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRL-----TA 386
           +I++    I+      S  P+ + +        S  A D + +LL  D + RL      A
Sbjct: 273 EISR---RIL-----KSEPPYPQEM--------SALAKDLIQRLLMKDPKKRLGCGPRDA 316

Query: 387 REAMAHPYFAQV 398
            E   H +F ++
Sbjct: 317 DEIKEHLFFQKI 328

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 97.0 bits (241), Expect = 7e-22
 Identities = 68/304 (22%), Positives = 114/304 (37%), Gaps = 70/304 (23%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKR--------EIKILQNL 176
            D+  +  +G+G + +V       T+E   +KILK  K   I+         E ++L   
Sbjct: 341 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILK--KDVVIQDDDVECTMVEKRVLALP 398

Query: 177 CGGPNVVKLLDIVRDQHS--KTPS---LIFEYVNSTD-FKVLYPT--LTDYDIRYYIYEL 228
              P + +L       HS  +T      + EYVN  D    +       +    +Y  E+
Sbjct: 399 GKPPFLTQL-------HSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEI 451

Query: 229 LKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE---YNVRVASRYF 285
              L +  S+GI++RD+K  NVM+D E   +++ D+G+       KE     V   +  F
Sbjct: 452 AIGLFFLQSKGIIYRDLKLDNVMLDSE-GHIKIADFGMC------KENIWDGVTTKT--F 502

Query: 286 KG------PELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCL 339
            G      PE++   Q Y  S+D W+ G +   M+  + P F G D  +    I +    
Sbjct: 503 CGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQAP-FEGEDEDELFQSIMEHNVA 560

Query: 340 IIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRL-----TAREAMAHPY 394
                                   +S EA+     L+      RL       R+   H +
Sbjct: 561 Y---------PKS-----------MSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAF 600

Query: 395 FAQV 398
           F  +
Sbjct: 601 FRYI 604

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score = 91.5 bits (228), Expect = 4e-21
 Identities = 61/294 (20%), Positives = 122/294 (41%), Gaps = 39/294 (13%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKI----LKPVKKKKIKREIKILQNLCGGP 180
           DD E + ++GRG Y  V +  +V + +   +K     +   ++K++  ++ I       P
Sbjct: 7   DDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCP 66

Query: 181 NVVKLLDIVRDQHSKTPSLIFEYVN-STD-----FKVLYPTLTDYDIRYYIYELLKALDY 234
             V     +  +      +  E ++ S D           T+ +  +      ++KAL++
Sbjct: 67  FTVTFYGALFREG--DVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEH 124

Query: 235 CHSQG-IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE---L 290
            HS+  ++HRDVKP NV+I+    ++++ D+G++ +       ++    + +  PE    
Sbjct: 125 LHSKLSVIHRDVKPSNVLINAL-GQVKMCDFGISGYLVDDVAKDIDAGCKPYMAPERINP 183

Query: 291 LVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNH--DQLVKIAKDCCLIIWCNSRHS 348
            ++ + Y    D+WSLG     +   + P  Y        QL ++               
Sbjct: 184 ELNQKGYSVKSDIWSLGITMIELAILRFP--YDSWGTPFQQLKQV---------VEEPSP 232

Query: 349 RKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAE 402
           + P  KF         S E +DF  + L+ + ++R T  E M HP+F    +  
Sbjct: 233 QLPADKF---------SAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLHESKG 277

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score = 88.4 bits (219), Expect = 5e-19
 Identities = 45/212 (21%), Positives = 86/212 (40%), Gaps = 17/212 (8%)

Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCI-IKILKPVK----KKKIKREIKILQNLCGGPN 181
           YEV   +  G    ++  ++ N N R + +K L        +     E + L  +   P+
Sbjct: 82  YEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEV-VHPS 140

Query: 182 VVKLLDIVRDQHSKTPSLIF---EYVNSTDFK-VLYPTLTDYDIRYYIYELLKALDYCHS 237
           +V++ + V         + +   EYV     K      L   +   Y+ E+L AL Y HS
Sbjct: 141 IVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQKLPVAEAIAYLLEILPALSYLHS 200

Query: 238 QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDY 297
            G+++ D+KP N+M+  E  +L+LID G          +     +  F+ PE++      
Sbjct: 201 IGLVYNDLKPENIMLTEE--QLKLIDLGAV---SRINSFGYLYGTPGFQAPEIVRTGPT- 254

Query: 298 DYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQ 329
             + D++++G   A +          + +   
Sbjct: 255 VAT-DIYTVGRTLAALTLDLPTRNGRYVDGLP 285

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 80.9 bits (200), Expect = 3e-17
 Identities = 37/156 (23%), Positives = 71/156 (45%), Gaps = 18/156 (11%)

Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILK-PVKKKKIKREIKILQNLCGGPNVVKL 185
           + V +K+G G + E+  G N+ TNE   IK+     +  ++  E +  + L  G  + ++
Sbjct: 11  FRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGDGIPQV 70

Query: 186 LDIVRDQHSKT-------PSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQ 238
                             PSL  E +    F +   T +   +     +L+  ++Y HS+
Sbjct: 71  YYFGPCGKYNAMVLELLGPSL--EDL----FDLCDRTFSLKTVLMIAIQLISRMEYVHSK 124

Query: 239 GIMHRDVKPHNVMI----DHELRKLRLIDWGLAEFY 270
            +++RDVKP N +I    +   + + +ID+ LA+ Y
Sbjct: 125 NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEY 160

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 79.3 bits (196), Expect = 1e-16
 Identities = 36/154 (23%), Positives = 69/154 (44%), Gaps = 16/154 (10%)

Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP-VKKKKIKREIKILQNLCGGPNVVKL 185
           Y + RK+G G + +++ G ++   E   IK+     K  ++  E KI + + GG  +  +
Sbjct: 11  YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTI 70

Query: 186 LDIVRDQHSKT-------PSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQ 238
                +            PSL  E +    F       +   +     +++  ++Y HS+
Sbjct: 71  RWCGAEGDYNVMVMELLGPSL--EDL----FNFCSRKFSLKTVLLLADQMISRIEYIHSK 124

Query: 239 GIMHRDVKPHNVMI--DHELRKLRLIDWGLAEFY 270
             +HRDVKP N ++    +   + +ID+GLA+ Y
Sbjct: 125 NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 78.6 bits (194), Expect = 2e-16
 Identities = 31/156 (19%), Positives = 67/156 (42%), Gaps = 18/156 (11%)

Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP-VKKKKIKREIKILQNLCGGPNVVKL 185
           Y+V R++G G +  +FEG N+  N++  IK         +++ E +  + L G   +  +
Sbjct: 12  YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNV 71

Query: 186 LDIVRDQHSKT-------PSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQ 238
               ++            PSL  E +      +     +   +     ++L  +   H +
Sbjct: 72  YYFGQEGLHNVLVIDLLGPSL--EDL----LDLCGRKFSVKTVAMAAKQMLARVQSIHEK 125

Query: 239 GIMHRDVKPHNVMI----DHELRKLRLIDWGLAEFY 270
            +++RD+KP N +I          + ++D+G+ +FY
Sbjct: 126 SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY 161

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score = 78.0 bits (193), Expect = 2e-16
 Identities = 36/150 (24%), Positives = 68/150 (45%), Gaps = 13/150 (8%)

Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILK------PVKKKKIKREIKILQNLCGGP 180
           Y++V K+G G  S V+   +   N +  IK +           K+ +RE+     L    
Sbjct: 13  YKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQL-SHQ 71

Query: 181 NVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL---YPTLTDYDIRYYIYELLKALDYCHS 237
           N+V ++D+  +       L+ EY+           +  L+      +  ++L  + + H 
Sbjct: 72  NIVSMIDVDEEDD--CYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHD 129

Query: 238 QGIMHRDVKPHNVMIDHELRKLRLIDWGLA 267
             I+HRD+KP N++ID     L++ D+G+A
Sbjct: 130 MRIVHRDIKPQNILIDSNKT-LKIFDFGIA 158

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 79.0 bits (195), Expect = 2e-16
 Identities = 27/169 (15%), Positives = 62/169 (36%), Gaps = 21/169 (12%)

Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILK--PVKKKKIKREIKILQNLCGGPNVVK 184
           + + +K+G G +  ++     N  E+    ++K    +   +  E+K  Q +     + K
Sbjct: 39  WVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKK 98

Query: 185 LLDIVRDQHSKTPSLIF---EYVNSTDFKV-----LYPTLTDYDIRY----------YIY 226
            ++  +  +   P              ++      L   L     +              
Sbjct: 99  WIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQNGTFKKSTVLQLGI 158

Query: 227 ELLKALDYCHSQGIMHRDVKPHNVMIDHE-LRKLRLIDWGLAEFYHPGK 274
            +L  L+Y H    +H D+K  N+++ ++   ++ L D+GL+  Y P  
Sbjct: 159 RMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNG 207

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score = 77.4 bits (191), Expect = 4e-16
 Identities = 50/261 (19%), Positives = 92/261 (35%), Gaps = 53/261 (20%)

Query: 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV---KKKKIKREIKILQNLCGG 179
              D      +G+G + +  +  +  T E  ++K L       ++   +E+K+++ L   
Sbjct: 8   RPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEH- 66

Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLK-ALD----- 233
           PNV+K + ++     K  + I EY+       L   +   D +Y   + +  A D     
Sbjct: 67  PNVLKFIGVLY--KDKRLNFITEYIKGGT---LRGIIKSMDSQYPWSQRVSFAKDIASGM 121

Query: 234 -YCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEF---------YHPGKEYNVRVASR 283
            Y HS  I+HRD+  HN ++      + + D+GLA                +   R    
Sbjct: 122 AYLHSMNIIHRDLNSHNCLVRENKN-VVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRY 180

Query: 284 YFKG------PELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYG-------------- 323
              G      PE++   + YD  +D++S G +   +I R                     
Sbjct: 181 TVVGNPYWMAPEMING-RSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGF 239

Query: 324 ------HDNHDQLVKIAKDCC 338
                  +       I   CC
Sbjct: 240 LDRYCPPNCPPSFFPITVRCC 260

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score = 76.6 bits (189), Expect = 7e-16
 Identities = 48/217 (22%), Positives = 86/217 (39%), Gaps = 38/217 (17%)

Query: 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK-KKKIKREIKILQNLCGGPN 181
           D  + EV   VGRG +  V +       +   IK ++    +K    E++ L  +   PN
Sbjct: 6   DYKEIEVEEVVGRGAFGVVCKAKW--RAKDVAIKQIESESERKAFIVELRQLSRVNH-PN 62

Query: 182 VVKLLDIVRDQHSKTPSLIFEYV-NSTDFKVLY-----PTLTDYDIRYYIYELLKALDYC 235
           +VKL             L+ EY    + + VL+     P  T      +  +  + + Y 
Sbjct: 63  IVKLYGACL----NPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYL 118

Query: 236 HS---QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG----- 287
           HS   + ++HRD+KP N+++      L++ D+G A                +        
Sbjct: 119 HSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTA-----------CDIQTHMTNNKGSA 167

Query: 288 ----PELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPF 320
               PE+     +Y    D++S G +   +I R++PF
Sbjct: 168 AWMAPEVFEG-SNYSEKCDVFSWGIILWEVITRRKPF 203

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 77.4 bits (190), Expect = 1e-15
 Identities = 39/154 (25%), Positives = 72/154 (46%), Gaps = 16/154 (10%)

Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP-VKKKKIKREIKILQNLCGGPNVVKL 185
           + + RK+G G + E++ G N+ TNE   IK+     K  ++  E KI + L GG  +  +
Sbjct: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQGGTGIPNV 68

Query: 186 LDIVRDQHSKT-------PSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQ 238
                +            PSL  E +    F      L+   +     +++  +++ HS+
Sbjct: 69  RWFGVEGDYNVLVMDLLGPSL--EDL----FNFCSRKLSLKTVLMLADQMINRVEFVHSK 122

Query: 239 GIMHRDVKPHNVMI--DHELRKLRLIDWGLAEFY 270
             +HRD+KP N ++       ++ +ID+GLA+ Y
Sbjct: 123 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY 156

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score = 75.0 bits (185), Expect = 3e-15
 Identities = 38/153 (24%), Positives = 67/153 (43%), Gaps = 19/153 (12%)

Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILK------PVKKKKIKREIKI---LQNLC 177
           Y + R VGRG   +V+E  +        +K++       PV + +++RE +    LQ   
Sbjct: 36  YRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQE-- 93

Query: 178 GGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL---YPTLTDYDIRYYIYELLKALDY 234
             P+VV + D    +      +    +N  D   +      L        + ++  ALD 
Sbjct: 94  --PHVVPIHD--FGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDA 149

Query: 235 CHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA 267
            H+ G  HRDVKP N+++  +     L+D+G+A
Sbjct: 150 AHAAGATHRDVKPENILVSAD-DFAYLVDFGIA 181

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score = 73.5 bits (181), Expect = 8e-15
 Identities = 49/231 (21%), Positives = 90/231 (38%), Gaps = 52/231 (22%)

Query: 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV----------KKKKIKREIKI 172
             ++ E  +++G+G +  V +G  V       IK L             K ++ +RE+ I
Sbjct: 17  ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76

Query: 173 LQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLK-A 231
           + NL   PN+VKL  ++ +     P ++ E+V   D   LY  L D          L+  
Sbjct: 77  MSNLN-HPNIVKLYGLMHNP----PRMVMEFVPCGD---LYHRLLDKAHPIKWSVKLRLM 128

Query: 232 LD------YCHSQG--IMHRDVKPHNVMIDHELRK----LRLIDWGLAEFYHPGKEYNVR 279
           LD      Y  +Q   I+HRD++  N+ +           ++ D+GL+           +
Sbjct: 129 LDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLS-----------Q 177

Query: 280 VASRYFKG---------PELLVDLQD-YDYSLDMWSLGCMFAGMIFRKEPF 320
            +     G         PE +   ++ Y    D +S   +   ++  + PF
Sbjct: 178 QSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPF 228

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score = 73.1 bits (180), Expect = 1e-14
 Identities = 39/152 (25%), Positives = 70/152 (46%), Gaps = 13/152 (8%)

Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILK------PVKKKKIKREIKILQNLCGGP 180
           YE+   +G G  SEV    ++  +    +K+L+      P    + +RE +    L   P
Sbjct: 14  YELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAAL-NHP 72

Query: 181 NVVKLLDI--VRDQHSKTPSLIFEYVNSTDFKVL---YPTLTDYDIRYYIYELLKALDYC 235
            +V + D           P ++ EYV+    + +      +T       I +  +AL++ 
Sbjct: 73  AIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFS 132

Query: 236 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA 267
           H  GI+HRDVKP N+MI      ++++D+G+A
Sbjct: 133 HQNGIIHRDVKPANIMISATNA-VKVMDFGIA 163

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score = 72.3 bits (178), Expect = 1e-14
 Identities = 41/208 (19%), Positives = 78/208 (37%), Gaps = 27/208 (12%)

Query: 117 LTVQWG-DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREI 170
           +    G D      + K+      E+++G     +   ++K+LK       K +    E 
Sbjct: 1   MNKHSGIDFKQLNFLTKLNENHSGELWKGRWQGND--IVVKVLKVRDWSTRKSRDFNEEC 58

Query: 171 KILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYV-NSTDFKVLY---PTLTDYDIRYYI- 225
             L+     PNV+ +L   +   +  P+LI  ++   + + VL+     + D        
Sbjct: 59  PRLRIFSH-PNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFA 117

Query: 226 YELLKALDYCHSQG--IMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEYNVR-VA 281
            ++ + + + H+    I    +   +VMID ++   R+    +   F  PG+ Y    VA
Sbjct: 118 LDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMT-ARISMADVKFSFQSPGRMYAPAWVA 176

Query: 282 SRYFKGPELLVDLQDYDYSL--DMWSLG 307
                 PE L    +       DMWS  
Sbjct: 177 ------PEALQKKPEDTNRRSADMWSFA 198

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 71.1 bits (173), Expect = 9e-14
 Identities = 42/344 (12%), Positives = 86/344 (25%), Gaps = 92/344 (26%)

Query: 120 QWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKIL-----------KPVKKKKIKR 168
                +  +   K+G G + EVF+ I    +    IKI+                ++I  
Sbjct: 15  HCLPTEKLQRCEKIGEGVFGEVFQTI--ADHTPVAIKIIAIEGPDLVNGSHQKTFEEILP 72

Query: 169 EIKILQNLCG--------GPNVVKLLD--IVRDQHSK----------------------- 195
           EI I + L              + L     V+  +                         
Sbjct: 73  EIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFF 132

Query: 196 ---TPSLIFEYVNSTD--FKVLYPTLTDYDIRYYIYELLKALDYCHSQ-GIMHRDVKPHN 249
                 ++ E+        ++     +    +  +++L  +L    +     HRD+   N
Sbjct: 133 KDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGN 192

Query: 250 VMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCM 309
           V++               +       Y +   S       L V + DY  S        +
Sbjct: 193 VLLK--------------KTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDGIVV 238

Query: 310 FAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRH------------------SRKP 351
           F  +    E  F G    D    I +                               +  
Sbjct: 239 FCDV-SMDEDLFTGD--GDYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMT 295

Query: 352 WSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF 395
           +    N      +  +  +F   +L +      +A + +     
Sbjct: 296 FKTKCNTPAMKQIKRKIQEFHRTMLNFS-----SATDLLCQHSL 334

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 71.0 bits (174), Expect = 1e-13
 Identities = 29/173 (16%), Positives = 69/173 (39%), Gaps = 26/173 (15%)

Query: 127 YEVVRKVGRGKYSEVFEGI-----NVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPN 181
           ++V   +G+G +  ++        +V ++  C++K+ +P     +  E+K  Q       
Sbjct: 37  WKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKV-EPSDNGPLFTELKFYQRAAKPEQ 95

Query: 182 VVKLLDIVRDQHSKTPSLIF---EYVNSTDFKVLYPTLTDYDIRYYI------------- 225
           + K +   + ++   P          N   ++ +       D++                
Sbjct: 96  IQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKRFSRKTVL 155

Query: 226 ---YELLKALDYCHSQGIMHRDVKPHNVMIDHE-LRKLRLIDWGLAEFYHPGK 274
                +L  L+Y H    +H D+K  N++++++   ++ L+D+GLA  Y P  
Sbjct: 156 QLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEG 208

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 69.8 bits (171), Expect = 1e-13
 Identities = 23/190 (12%), Positives = 57/190 (30%), Gaps = 38/190 (20%)

Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP------VKKKKIKREIKILQNLCGGP 180
           Y ++   G     + ++ ++   + +  +  + P         ++       L  +   P
Sbjct: 33  YRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRI-DKP 91

Query: 181 NVVKLLDIVRDQHSKTPSLIFEYVNSTDFK-VLYPTLTDYDIRYYIYELLKALDYCHSQG 239
            V ++LD+V  +      ++ E++     + V   + +       +  L  A D  H  G
Sbjct: 92  GVARVLDVVHTRA--GGLVVAEWIRGGSLQEVADTSPSPVGAIRAMQSLAAAADAAHRAG 149

Query: 240 IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDY 299
           +      P  V +  +         G           +V +A                + 
Sbjct: 150 VALSIDHPSRVRVSID---------G-----------DVVLAYPATMPDA--------NP 181

Query: 300 SLDMWSLGCM 309
             D+  +G  
Sbjct: 182 QDDIRGIGAS 191

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score = 67.8 bits (166), Expect = 9e-13
 Identities = 46/223 (20%), Positives = 88/223 (39%), Gaps = 35/223 (15%)

Query: 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK-----PVKKKKIKREIKILQNLC 177
             +  E+   +G+G++ +V+ G     +    I+++        + K  KRE+   +   
Sbjct: 31  PFEQLEIGELIGKGRFGQVYHGR---WHGEVAIRLIDIERDNEDQLKAFKREVMAYRQTR 87

Query: 178 GGPNVVKLLDIVRDQHSKTPSL--IFEYV-NSTDFKVLYPTLTDYDIRYYI---YELLKA 231
              NVV  +          P L  I       T + V+       D+        E++K 
Sbjct: 88  H-ENVVLFMGAC----MSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKG 142

Query: 232 LDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG---- 287
           + Y H++GI+H+D+K  NV  D+   K+ + D+GL       +        R   G    
Sbjct: 143 MGYLHAKGILHKDLKSKNVFYDN--GKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCH 200

Query: 288 --PELL--------VDLQDYDYSLDMWSLGCMFAGMIFRKEPF 320
             PE++         D   +    D+++LG ++  +  R+ PF
Sbjct: 201 LAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPF 243

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score = 66.7 bits (163), Expect = 2e-12
 Identities = 37/214 (17%), Positives = 83/214 (38%), Gaps = 30/214 (14%)

Query: 119 VQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCI-IKILKPVKKKKIKREIKILQ-NL 176
           VQ        +   +G+G++ EV+ G         + +KI    +++   RE +I Q  +
Sbjct: 36  VQRTIARTIVLQESIGKGRFGEVWRGK---WRGEEVAVKIFSSREERSWFREAEIYQTVM 92

Query: 177 CGGPNVVKLLDIVRDQHSKTP--SLIFEYV-NSTDFKVLYPTLTDYDIRYYI-YELLKAL 232
               N++  +      +       L+ +Y  + + F  L       +    +       L
Sbjct: 93  LRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGL 152

Query: 233 DYCHSQ--------GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRY 284
            + H +         I HRD+K  N+++        + D GLA  +    +  + +A  +
Sbjct: 153 AHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGT-CCIADLGLAVRHDSATDT-IDIAPNH 210

Query: 285 FKG------PELL---VDLQDYDYSL--DMWSLG 307
             G      PE+L   ++++ ++     D++++G
Sbjct: 211 RVGTKRYMAPEVLDDSINMKHFESFKRADIYAMG 244

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score = 65.8 bits (161), Expect = 3e-12
 Identities = 41/230 (17%), Positives = 96/230 (41%), Gaps = 37/230 (16%)

Query: 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK-----PVKKKKIKREIKILQNLC 177
                 V +++G G +  V++G     +    +K+L      P + +  K E+ +L+   
Sbjct: 22  PDGQITVGQRIGSGSFGTVYKGK---WHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTR 78

Query: 178 GGPNVVKLLDIVRDQHSKTPSLIFEYV-NSTDFKVLYPTLTDYDIRYYIYELLK-ALD-- 233
              N++  +           +++ ++   S+    LY  L   + ++ + +L+  A    
Sbjct: 79  H-VNILLFMGYSTAPQ---LAIVTQWCEGSS----LYHHLHASETKFEMKKLIDIARQTA 130

Query: 234 ----YCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG-- 287
               Y H++ I+HRD+K +N+ +  +   +++ D+GLA         +         G  
Sbjct: 131 RGMDYLHAKSIIHRDLKSNNIFLHEDN-TVKIGDFGLATEKSRWSGSHQFEQL---SGSI 186

Query: 288 ----PELLVDLQDYDYSL--DMWSLGCMFAGMIFRKEPFFYGHDNHDQLV 331
               PE++       YS   D+++ G +   ++  + P+    +N DQ++
Sbjct: 187 LWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYS-NINNRDQII 235

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score = 65.5 bits (160), Expect = 4e-12
 Identities = 47/216 (21%), Positives = 85/216 (39%), Gaps = 28/216 (12%)

Query: 116 SLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQ- 174
            L VQ       ++V+++G+G+Y EV+ G      E+  +K+    ++    RE +I Q 
Sbjct: 28  PLLVQRTIAKQIQMVKQIGKGRYGEVWMGKW--RGEKVAVKVFFTTEEASWFRETEIYQT 85

Query: 175 NLCGGPNVVKLLDIVRDQHSKTP--SLIFEYV-NSTDFKVLYPTLTDYDIRYYI-YELLK 230
            L    N++  +              LI +Y  N + +  L  T  D      + Y  + 
Sbjct: 86  VLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKSTTLDAKSMLKLAYSSVS 145

Query: 231 ALDYCHSQ--------GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVAS 282
            L + H++         I HRD+K  N+++        + D GLA  +       V +  
Sbjct: 146 GLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGT-CCIADLGLAVKFISDTN-EVDIPP 203

Query: 283 RYFKG------PELL---VDLQDYDYSL--DMWSLG 307
               G      PE+L   ++   +   +  DM+S G
Sbjct: 204 NTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFG 239

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score = 63.9 bits (156), Expect = 2e-11
 Identities = 43/204 (21%), Positives = 92/204 (45%), Gaps = 31/204 (15%)

Query: 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK-----KKKIKREIKILQNLC 177
              D  +  K+G G +  V       ++    +KIL           +  RE+ I++ L 
Sbjct: 35  PWCDLNIKEKIGAGSFGTVHRAEWHGSD--VAVKILMEQDFHAERVNEFLREVAIMKRLR 92

Query: 178 GGPNVVKLLDIVRDQHSKTPSLIFEYV-NSTDFKVLY-----PTLTDYDIRYYIYELLKA 231
             PN+V  +  V        S++ EY+   + +++L+       L +       Y++ K 
Sbjct: 93  H-PNIVLFMGAVTQP--PNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKG 149

Query: 232 LDYCHSQG--IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG-- 287
           ++Y H++   I+HR++K  N+++D +   +++ D+GL+       + +  ++S+   G  
Sbjct: 150 MNYLHNRNPPIVHRNLKSPNLLVDKKYT-VKVCDFGLSRL-----KASTFLSSKSAAGTP 203

Query: 288 ----PELLVDLQDYDYSLDMWSLG 307
               PE+L D +  +   D++S G
Sbjct: 204 EWMAPEVLRD-EPSNEKSDVYSFG 226

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 63.2 bits (154), Expect = 3e-11
 Identities = 28/176 (15%), Positives = 58/176 (32%), Gaps = 30/176 (17%)

Query: 127 YEVVRKVGRGKYSEVFEGINVNT--------NERCIIKILKPVKKKKIKREIKILQNLCG 178
           +++     R     ++E    +T         ++  +K+    K  ++  E    Q    
Sbjct: 44  WKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDA--KDGRLFNEQNFFQRAAK 101

Query: 179 GPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKV-----LYPTLTDYDIRYY--------- 224
              V K   +        P+ +   V+   ++      L  +L    +            
Sbjct: 102 PLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGRSLQSA-LDVSPKHVLSERS 160

Query: 225 ----IYELLKALDYCHSQGIMHRDVKPHNVMIDHE-LRKLRLIDWGLAEFYHPGKE 275
                  LL AL++ H    +H +V   N+ +D E   ++ L  +G A  Y P  +
Sbjct: 161 VLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGK 216

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score = 62.4 bits (152), Expect = 5e-11
 Identities = 46/204 (22%), Positives = 78/204 (38%), Gaps = 28/204 (13%)

Query: 128 EVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQ-NLCGGPNVVKLL 186
            ++  VG+G+Y EV+ G     N    +KI     +K   RE ++    +    N++  +
Sbjct: 11  TLLECVGKGRYGEVWRGSWQGEN--VAVKIFSSRDEKSWFRETELYNTVMLRHENILGFI 68

Query: 187 --DIVRDQHSKTPSLIFEYV-NSTDFKVLYPTLTDYDIRYYI-YELLKALDYCHSQ---- 238
             D+     S    LI  Y    + +  L  T  D      I   +   L + H +    
Sbjct: 69  ASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGT 128

Query: 239 ----GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG------P 288
                I HRD+K  N+++    +   + D GLA  +       + V +    G      P
Sbjct: 129 QGKPAIAHRDLKSKNILVKKNGQ-CCIADLGLAVMHSQSTNQ-LDVGNNPRVGTKRYMAP 186

Query: 289 ELL-----VDLQDYDYSLDMWSLG 307
           E+L     VD  D    +D+W+ G
Sbjct: 187 EVLDETIQVDCFDSYKRVDIWAFG 210

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score = 60.4 bits (147), Expect = 1e-10
 Identities = 41/223 (18%), Positives = 88/223 (39%), Gaps = 38/223 (17%)

Query: 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK-------KKKIKREIKILQN 175
           D  +  +   +G G + +V+    +       +K  +           + +++E K+   
Sbjct: 5   DFAELTLEEIIGIGGFGKVYRAFWIGDE--VAVKAARHDPDEDISQTIENVRQEAKLFAM 62

Query: 176 LCGGPNVVKLLDIVRDQHSKTPSLIFEYV-NSTDFKVLYPTLTDYDIRYYI-YELLKALD 233
           L   PN++ L  +   +      L+ E+       +VL       DI      ++ + ++
Sbjct: 63  LKH-PNIIALRGVCLKE--PNLCLVMEFARGGPLNRVLSGKRIPPDILVNWAVQIARGMN 119

Query: 234 YCHSQG---IMHRDVKPHNVMIDHELRK-------LRLIDWGLAEFYHPGKEYNVRVASR 283
           Y H +    I+HRD+K  N++I  ++         L++ D+GLA  +H   + +      
Sbjct: 120 YLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMS------ 173

Query: 284 YFKG------PELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPF 320
              G      PE++     +    D+WS G +   ++  + PF
Sbjct: 174 -AAGAYAWMAPEVIRA-SMFSKGSDVWSYGVLLWELLTGEVPF 214

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score = 59.1 bits (143), Expect = 7e-10
 Identities = 41/230 (17%), Positives = 88/230 (38%), Gaps = 46/230 (20%)

Query: 113 DYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCI-IKILKPVKKKKIKREIK 171
                ++     D+ +++  +GRG+Y  V++G     +ER + +K+     ++    E  
Sbjct: 4   AASEPSLDL---DNLKLLELIGRGRYGAVYKGS---LDERPVAVKVFSFANRQNFINEKN 57

Query: 172 I-----LQNLCGGPNVVKLL--DIVRDQHSKTP-SLIFEYV-NSTDFKVLYPTLTDYDIR 222
           I     +++     N+ + +  D       +    L+ EY  N +  K L    +D+   
Sbjct: 58  IYRVPLMEH----DNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTSDWVSS 113

Query: 223 YYI-YELLKALDYCHSQ---------GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP 272
             + + + + L Y H++          I HRD+   NV++ ++     + D+GL+     
Sbjct: 114 CRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGT-CVISDFGLSMRLTG 172

Query: 273 GKEYNVRVASRYFKG---------PELL------VDLQDYDYSLDMWSLG 307
            +                      PE+L       D +     +DM++LG
Sbjct: 173 NRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALG 222

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score = 57.4 bits (139), Expect = 2e-09
 Identities = 44/220 (20%), Positives = 84/220 (38%), Gaps = 32/220 (14%)

Query: 112 WDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKK--KIKRE 169
              E+L  Q       +++    RG++  V++      NE   +KI     K+  + + E
Sbjct: 14  LGTENLYFQS---MPLQLLEVKARGRFGCVWKA--QLLNEYVAVKIFPIQDKQSWQNEYE 68

Query: 170 IKILQNLCGGPNVVKLL--DIVRDQHSKTPSLIFEYV-NSTDFKVLYPTLTDYDIRYYI- 225
           +  L  +    N+++ +  +           LI  +    +    L   +  ++   +I 
Sbjct: 69  VYSLPGMKH-ENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANVVSWNELCHIA 127

Query: 226 YELLKALDYCHSQ----------GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE 275
             + + L Y H             I HRD+K  NV++ + L    + D+GLA  +  GK 
Sbjct: 128 ETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLT-ACIADFGLALKFEAGKS 186

Query: 276 YNVRVAS----RYFKGPELLVD----LQDYDYSLDMWSLG 307
                      RY   PE+L       +D    +DM+++G
Sbjct: 187 AGDTHGQVGTRRYM-APEVLEGAINFQRDAFLRIDMYAMG 225

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score = 56.9 bits (138), Expect = 3e-09
 Identities = 45/167 (26%), Positives = 78/167 (46%), Gaps = 16/167 (9%)

Query: 123 DQDDYEVVRKVGRGKYSEVFEGI----NVNTNERCIIKILKP----VKKKKIKREIKILQ 174
           ++   + +R +G G + +V          NT E+  +K LKP         +K+EI+IL+
Sbjct: 19  EKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILR 78

Query: 175 NLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY-----PTLTDYDIRYYIYELL 229
           NL    N+VK   I  +       LI E++ S   K  Y       +       Y  ++ 
Sbjct: 79  NLYH-ENIVKYKGICTEDGGNGIKLIMEFLPSGSLKE-YLPKNKNKINLKQQLKYAVQIC 136

Query: 230 KALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY 276
           K +DY  S+  +HRD+   NV+++ E + +++ D+GL +     KEY
Sbjct: 137 KGMDYLGSRQYVHRDLAARNVLVESEHQ-VKIGDFGLTKAIETDKEY 182

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score = 56.6 bits (137), Expect = 4e-09
 Identities = 47/192 (24%), Positives = 88/192 (45%), Gaps = 17/192 (8%)

Query: 130 VRKVGRGKYSEVFEGI----NVNTNERCIIKILK----PVKKKKIKREIKILQNLCGGPN 181
           +R +G G + +V        N  T E   +K LK    P  +   K+EI IL+ L    +
Sbjct: 36  IRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYH-EH 94

Query: 182 VVKLLDIVRDQHSKTPSLIFEYVNSTDFK--VLYPTLTDYDIRYYIYELLKALDYCHSQG 239
           ++K      D  + +  L+ EYV     +  +   ++    +  +  ++ + + Y H+Q 
Sbjct: 95  IIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQICEGMAYLHAQH 154

Query: 240 IMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEYNVRVASRY-FK--GPELLVDLQ 295
            +HRD+   NV++D++   +++ D+GLA       + Y VR           PE L + +
Sbjct: 155 YIHRDLAARNVLLDNDR-LVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYK 213

Query: 296 DYDYSLDMWSLG 307
            + Y+ D+WS G
Sbjct: 214 -FYYASDVWSFG 224

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score = 55.7 bits (135), Expect = 9e-09
 Identities = 51/231 (22%), Positives = 90/231 (38%), Gaps = 28/231 (12%)

Query: 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP----VKKKKIKREIKILQNLCG 178
           + +D  +  ++GRG + EVF G     N    +K  +       K K  +E +IL+    
Sbjct: 112 NHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYS- 170

Query: 179 GPNVVKLLDIVRDQHSKTPSLI-FEYVNSTDFKVLY-----PTLTDYDIRYYIYELLKAL 232
            PN+V+L+ +   +    P  I  E V   DF   +       L    +   + +    +
Sbjct: 171 HPNIVRLIGVCTQKQ---PIYIVMELVQGGDFLT-FLRTEGARLRVKTLLQMVGDAAAGM 226

Query: 233 DYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYF--K--GP 288
           +Y  S+  +HRD+   N ++  +   L++ D+G++     G  Y      R    K   P
Sbjct: 227 EYLESKCCIHRDLAARNCLVTEKNV-LKISDFGMSREEADG-VYAASGGLRQVPVKWTAP 284

Query: 289 ELLVDLQDYDYSL--DMWSLG-CMFAGMIFRKEPFFYGHDNHDQLVKIAKD 336
           E L   +   YS   D+WS G  ++        P +    N      + K 
Sbjct: 285 EALNYGR---YSSESDVWSFGILLWETFSLGASP-YPNLSNQQTREFVEKG 331

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score = 55.5 bits (134), Expect = 1e-08
 Identities = 54/310 (17%), Positives = 113/310 (36%), Gaps = 31/310 (10%)

Query: 40  APIAHHPILRTPCRSSTYNLNIITDTIAATTVVYEGAIIDKIEERNLAEIPLPAMSKARV 99
            P+ HH       R+S     ++         +     +     +      L       V
Sbjct: 5   DPMGHHHHHHGRRRASVAAGILVPRGSPGLDGICSIEELSTSLYKKAGSENLYFQGANTV 64

Query: 100 YTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCI---IK 156
           + D++ L P+     + + +             +GRG +  V+ G  ++ + + I   +K
Sbjct: 65  HIDLSALNPELVQAVQHVVIG-PSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVK 123

Query: 157 ILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL 212
            L  +    +  +   E  I+++    PNV+ LL I        P ++  Y+   D +  
Sbjct: 124 SLNRITDIGEVSQFLTEGIIMKDFS-HPNVLSLLGICLRSEGS-PLVVLPYMKHGDLRN- 180

Query: 213 Y-----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA 267
           +        T  D+  +  ++ K + +  S+  +HRD+   N M+D +   +++ D+GLA
Sbjct: 181 FIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKF-TVKVADFGLA 239

Query: 268 EFYHPGKEYNVRVASRYFKG--------PELLVDLQDYDYSLDMWSLG-CMFAGMIFRKE 318
              +  +  +V   +              E L   Q +    D+WS G  ++  M     
Sbjct: 240 RDMYDKEFDSVHNKT---GAKLPVKWMALESLQT-QKFTTKSDVWSFGVLLWELMTRGAP 295

Query: 319 PFFYGHDNHD 328
           P +   +  D
Sbjct: 296 P-YPDVNTFD 304

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score = 55.5 bits (134), Expect = 1e-08
 Identities = 44/229 (19%), Positives = 101/229 (44%), Gaps = 20/229 (8%)

Query: 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP--VKKKKIKREIKILQNLCGGP 180
           ++ D  +  K+G G+Y EV+EG+    +    +K LK   ++ ++  +E  +++ +   P
Sbjct: 218 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIK-HP 276

Query: 181 NVVKLLDIVRDQHSKTPSLI-FEYVNS---TDF--KVLYPTLTDYDIRYYIYELLKALDY 234
           N+V+LL +   +    P  I  E++      D+  +     ++   + Y   ++  A++Y
Sbjct: 277 NLVQLLGVCTREP---PFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEY 333

Query: 235 CHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRY---FKGPELL 291
              +  +HR++   N ++      +++ D+GL+     G  Y     +++   +  PE L
Sbjct: 334 LEKKNFIHRNLAARNCLVGENH-LVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESL 391

Query: 292 VDLQDYDYSLDMWSLG-CMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCL 339
                +    D+W+ G  ++    +   P + G D       + KD  +
Sbjct: 392 AY-NKFSIKSDVWAFGVLLWEIATYGMSP-YPGIDLSQVYELLEKDYRM 438

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score = 54.3 bits (131), Expect = 2e-08
 Identities = 38/165 (23%), Positives = 79/165 (47%), Gaps = 13/165 (7%)

Query: 123 DQDDYEVVRKVGRGKYSEVFEGI----NVNTNERCIIKILK---PVKKKKIKREIKILQN 175
           ++   + + ++G+G +  V          NT     +K L+   P +++  +REI+IL+ 
Sbjct: 21  EERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKA 80

Query: 176 LCGGPNVVKLLDIVRDQHSKTPSLIFEYVNS---TDF-KVLYPTLTDYDIRYYIYELLKA 231
           L     +VK   +      ++  L+ EY+ S    DF +     L    +  Y  ++ K 
Sbjct: 81  L-HSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKG 139

Query: 232 LDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY 276
           ++Y  S+  +HRD+   N++++ E   +++ D+GLA+     K+Y
Sbjct: 140 MEYLGSRRCVHRDLAARNILVESEAH-VKIADFGLAKLLPLDKDY 183

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score = 53.5 bits (129), Expect = 4e-08
 Identities = 46/230 (20%), Positives = 104/230 (45%), Gaps = 25/230 (10%)

Query: 100 YTDVNVLRPKEYWDYESLTVQWGDQDDYEV-------VRKVGRGKYSEVFEG----INVN 148
           + D ++   +  +   ++   + D+D  +        ++++G+G +  V       +  N
Sbjct: 9   HHDYDIPTTENLYFQGAMGSAFEDRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDN 68

Query: 149 TNERCIIKILKPVKKKKIK---REIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVN 205
           T E   +K L+   ++ ++   REI+IL++L    N+VK   +      +   LI EY+ 
Sbjct: 69  TGEVVAVKKLQHSTEEHLRDFEREIEILKSLQH-DNIVKYKGVCYSAGRRNLKLIMEYLP 127

Query: 206 S---TDF-KVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRL 261
                D+ +     +    +  Y  ++ K ++Y  ++  +HRD+   N+++++E R +++
Sbjct: 128 YGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENR-VKI 186

Query: 262 IDWGLA-EFYHPGKEYNVRVASRY-FK--GPELLVDLQDYDYSLDMWSLG 307
            D+GL        + Y V+           PE L + + +  + D+WS G
Sbjct: 187 GDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESK-FSVASDVWSFG 235

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score = 52.3 bits (126), Expect = 1e-07
 Identities = 46/225 (20%), Positives = 93/225 (41%), Gaps = 26/225 (11%)

Query: 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCI---IKILKPV----KKKKIKREIKILQN 175
                     +GRG +  V+ G  ++ + + I   +K L  +    +  +   E  I+++
Sbjct: 23  SSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKD 82

Query: 176 LCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY-----PTLTDYDIRYYIYELLK 230
               PNV+ LL I       +P ++  Y+   D +  +        T  D+  +  ++ K
Sbjct: 83  FS-HPNVLSLLGICLRSEG-SPLVVLPYMKHGDLRN-FIRNETHNPTVKDLIGFGLQVAK 139

Query: 231 ALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA------EFYHPGKEYNVRVASRY 284
            + Y  S+  +HRD+   N M+D +   +++ D+GLA      E+Y    +   ++  ++
Sbjct: 140 GMKYLASKKFVHRDLAARNCMLDEKF-TVKVADFGLARDMYDKEYYSVHNKTGAKLPVKW 198

Query: 285 FKGPELLVDLQDYDYSLDMWSLG-CMFAGMIFRKEPFFYGHDNHD 328
               E L   Q +    D+WS G  ++  M     P +   +  D
Sbjct: 199 M-ALESLQT-QKFTTKSDVWSFGVLLWELMTRGAPP-YPDVNTFD 240

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score = 51.9 bits (125), Expect = 1e-07
 Identities = 42/200 (21%), Positives = 94/200 (47%), Gaps = 18/200 (9%)

Query: 123 DQDDYEVVRKVGRGKYSEVFEG----INVNTNERCIIKILKPVKKKKIK---REIKILQN 175
           ++   + ++++G+G +  V       +  NT E   +K L+   ++ ++   REI+IL++
Sbjct: 8   EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKS 67

Query: 176 LCGGPNVVKLLDIVRDQHSKTPSLIFEYVNS---TDF-KVLYPTLTDYDIRYYIYELLKA 231
           L    N+VK   +      +   LI EY+      D+ +     +    +  Y  ++ K 
Sbjct: 68  LQH-DNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKG 126

Query: 232 LDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEYNVRVASRY-FK--G 287
           ++Y  ++  +HRD+   N+++++E R +++ D+GL        + + V+           
Sbjct: 127 MEYLGTKRYIHRDLATRNILVENENR-VKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYA 185

Query: 288 PELLVDLQDYDYSLDMWSLG 307
           PE L + + +  + D+WS G
Sbjct: 186 PESLTESK-FSVASDVWSFG 204

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score = 52.2 bits (125), Expect = 2e-07
 Identities = 48/225 (21%), Positives = 94/225 (41%), Gaps = 22/225 (9%)

Query: 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP--VKKKKIKREIKILQNLCGGP 180
            ++   +  K+G+G + EV+ G   N   R  IK LKP  +  +   +E ++++ L    
Sbjct: 265 PRESLRLEVKLGQGCFGEVWMGT-WNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLR-HE 322

Query: 181 NVVKLLDIVRDQHSKTPSLI-FEYVNSTDF-----KVLYPTLTDYDIRYYIYELLKALDY 234
            +V+L  +V    S+ P  I  EY++               L    +     ++   + Y
Sbjct: 323 KLVQLYAVV----SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAY 378

Query: 235 CHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRY-FK--GPELL 291
                 +HRD++  N+++   L   ++ D+GLA       EY  R  +++  K   PE  
Sbjct: 379 VERMNYVHRDLRAANILVGENL-VCKVADFGLARLIE-DNEYTARQGAKFPIKWTAPEAA 436

Query: 292 VDLQDYDYSLDMWSLG-CMFAGMIFRKEPFFYGHDNHDQLVKIAK 335
           +    +    D+WS G  +       + P + G  N + L ++ +
Sbjct: 437 LY-GRFTIKSDVWSFGILLTELTTKGRVP-YPGMVNREVLDQVER 479

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score = 52.2 bits (125), Expect = 2e-07
 Identities = 53/233 (22%), Positives = 102/233 (43%), Gaps = 32/233 (13%)

Query: 124 QDDYEV-------VRKVGRGKYSEVFEGINVNTNERCI---IKILKP----VKKKKIKRE 169
             DYE+        R +G G++ +V +GI ++     +   IK  K       ++K  +E
Sbjct: 382 TRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQE 441

Query: 170 IKILQNLCGGPNVVKLLDIVRDQHSKTPSLI-FEYVNSTDFKVLY-----PTLTDYDIRY 223
              ++     P++VKL+ ++    ++ P  I  E     + +  +      +L    +  
Sbjct: 442 ALTMRQFDH-PHIVKLIGVI----TENPVWIIMELCTLGELRS-FLQVRKFSLDLASLIL 495

Query: 224 YIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASR 283
           Y Y+L  AL Y  S+  +HRD+   NV++      ++L D+GL+ +      Y       
Sbjct: 496 YAYQLSTALAYLESKRFVHRDIAARNVLVSSND-CVKLGDFGLSRYMEDSTYYKASKGKL 554

Query: 284 YFKG--PELLVDLQDYDYSLDMWSLG-CMFAGMIFRKEPFFYGHDNHDQLVKI 333
             K   PE +   + +  + D+W  G CM+  ++   +P F G  N+D + +I
Sbjct: 555 PIKWMAPESINF-RRFTSASDVWMFGVCMWEILMHGVKP-FQGVKNNDVIGRI 605

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score = 50.7 bits (122), Expect = 3e-07
 Identities = 39/163 (23%), Positives = 74/163 (45%), Gaps = 25/163 (15%)

Query: 124 QDDYEV-------VRKVGRGKYSEVFEGINVNTNERCI---IKILKP----VKKKKIKRE 169
             DYE+        R +G G++ +V +GI ++     +   IK  K       ++K  +E
Sbjct: 7   TRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQE 66

Query: 170 IKILQNLCGGPNVVKLLDIVRDQHSKTPSLI-FEYVNSTDF----KVLYPTLTDYDIRYY 224
              ++     P++VKL+ ++    ++ P  I  E     +     +V   +L    +  Y
Sbjct: 67  ALTMRQFD-HPHIVKLIGVI----TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILY 121

Query: 225 IYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA 267
            Y+L  AL Y  S+  +HRD+   NV++      ++L D+GL+
Sbjct: 122 AYQLSTALAYLESKRFVHRDIAARNVLVSSND-CVKLGDFGLS 163

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score = 51.3 bits (123), Expect = 3e-07
 Identities = 47/225 (20%), Positives = 94/225 (41%), Gaps = 22/225 (9%)

Query: 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP--VKKKKIKREIKILQNLCGGP 180
            ++   +  K+G+G + EV+ G   N   R  IK LKP  +  +   +E ++++ L    
Sbjct: 182 PRESLRLEVKLGQGCFGEVWMGT-WNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLR-HE 239

Query: 181 NVVKLLDIVRDQHSKTPSLI-FEYVNSTDF-----KVLYPTLTDYDIRYYIYELLKALDY 234
            +V+L  +V    S+ P  I  EY++               L    +     ++   + Y
Sbjct: 240 KLVQLYAVV----SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAY 295

Query: 235 CHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRY---FKGPELL 291
                 +HRD++  N+++   L   ++ D+GLA       EY  R  +++   +  PE  
Sbjct: 296 VERMNYVHRDLRAANILVGENL-VCKVADFGLARLIE-DNEYTARQGAKFPIKWTAPEAA 353

Query: 292 VDLQDYDYSLDMWSLG-CMFAGMIFRKEPFFYGHDNHDQLVKIAK 335
           +    +    D+WS G  +       + P + G  N + L ++ +
Sbjct: 354 LY-GRFTIKSDVWSFGILLTELTTKGRVP-YPGMVNREVLDQVER 396

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score = 50.7 bits (122), Expect = 3e-07
 Identities = 40/163 (24%), Positives = 71/163 (43%), Gaps = 25/163 (15%)

Query: 124 QDDYEV-------VRKVGRGKYSEVFEGINVNTNERCI---IKILKP----VKKKKIKRE 169
              Y +        R +G G + EV+EG+  N     I   +K  K       K+K   E
Sbjct: 4   GPQYGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSE 63

Query: 170 IKILQNLCGGPNVVKLLDIVRDQHSKTPSLI-FEYVNSTDF----KVLYPTLTDYDIRYY 224
             I++NL   P++VKL+ I+     + P+ I  E     +     +    +L    +  Y
Sbjct: 64  AVIMKNLD-HPHIVKLIGII----EEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLY 118

Query: 225 IYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA 267
             ++ KA+ Y  S   +HRD+   N+++      ++L D+GL+
Sbjct: 119 SLQICKAMAYLESINCVHRDIAVRNILVASPE-CVKLGDFGLS 160

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score = 50.0 bits (120), Expect = 5e-07
 Identities = 45/226 (19%), Positives = 87/226 (38%), Gaps = 28/226 (12%)

Query: 123 DQDDYEVVRKVGRGKYSEVFEGI---NVNTNERCIIKILKPV----KKKKIKREIKILQN 175
           ++      R +G+G +  V+ G          +C IK L  +    + +   RE  +++ 
Sbjct: 19  ERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRG 78

Query: 176 LCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFK----VLYPTLTDYDIRYYIYELLKA 231
           L   PNV+ L+ I+       P ++  Y+   D            T  D+  +  ++ + 
Sbjct: 79  LNH-PNVLALIGIMLPPEG-LPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARG 136

Query: 232 LDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG---- 287
           ++Y   Q  +HRD+   N M+D     +++ D+GLA      + Y+V+            
Sbjct: 137 MEYLAEQKFVHRDLAARNCMLDESF-TVKVADFGLARDILDREYYSVQQHR---HARLPV 192

Query: 288 ----PELLVDLQDYDYSLDMWSLG-CMFAGMIFRKEPFFYGHDNHD 328
                E L     +    D+WS G  ++  +     P +   D  D
Sbjct: 193 KWTALESLQT-YRFTTKSDVWSFGVLLWELLTRGAPP-YRHIDPFD 236

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score = 49.2 bits (118), Expect = 8e-07
 Identities = 31/238 (13%), Positives = 78/238 (32%), Gaps = 39/238 (16%)

Query: 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCI-------IKILKPV---KKKKIKREIKI 172
             +D      +G+G ++++F+G+     +          +K+L        +       +
Sbjct: 6   RNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASM 65

Query: 173 LQNLCGGPNVVKLLDIVRDQHSKTPSLI-FEYVNSTDFKVLY-----PTLTDYDIRYYIY 226
           +  L    ++V    +         +++  E+V        Y       +          
Sbjct: 66  MSKLS-HKHLVLNYGVCVCGD---ENILVQEFVKFGSLD-TYLKKNKNCINILWKLEVAK 120

Query: 227 ELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLI-------DWGLAEFYHPGKEYNVR 279
           +L  A+ +     ++H +V   N+++  E  +           D G++    P      R
Sbjct: 121 QLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQER 180

Query: 280 V---ASRYFKGPELLVDLQDYDYSLDMWSLG-CMFAGMIFRKEPFFYGHDNHDQLVKI 333
           +          PE + + ++ + + D WS G  ++       +P     D+  +L   
Sbjct: 181 IPWVP------PECIENPKNLNLATDKWSFGTTLWEICSGGDKP-LSALDSQRKLQFY 231

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score = 49.3 bits (118), Expect = 1e-06
 Identities = 46/236 (19%), Positives = 92/236 (38%), Gaps = 36/236 (15%)

Query: 125 DDYEV-------VRKVGRGKYSEVFEGINVNTNERCI---IKILKP-----VKKKKIKRE 169
           +D  +        R +G+G++  V E      +   +   +K+LK         ++  RE
Sbjct: 16  EDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLRE 75

Query: 170 IKILQNLCGGPNVVKLLDIVRDQHSKTPS----LIFEYVNSTDFK---------VLYPTL 216
              ++     P+V KL+ +     +K       +I  ++   D                L
Sbjct: 76  AACMKEFDH-PHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNL 134

Query: 217 TDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY 276
               +  ++ ++   ++Y  S+  +HRD+   N M+  +   + + D+GL+   + G  Y
Sbjct: 135 PLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAED-MTVCVADFGLSRKIYSGDYY 193

Query: 277 NVRVASRY-FK--GPELLVDLQDYDYSLDMWSLG-CMFAGMIFRKEPFFYGHDNHD 328
               AS+   K    E L D   Y    D+W+ G  M+  M   + P + G +N +
Sbjct: 194 RQGCASKLPVKWLALESLAD-NLYTVHSDVWAFGVTMWEIMTRGQTP-YAGIENAE 247

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score = 48.8 bits (117), Expect = 1e-06
 Identities = 46/228 (20%), Positives = 100/228 (43%), Gaps = 26/228 (11%)

Query: 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP--VKKKKIKREIKILQNLCGGP 180
           ++ D  +  K+G G+Y EV+EG+    +    +K LK   ++ ++  +E  +++ +   P
Sbjct: 11  ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIK-HP 69

Query: 181 NVVKLLDIVRDQHSKTPSLI-FEYVNSTDFKVLY------PTLTDYDIRYYIYELLKALD 233
           N+V+LL +   +    P  I  E++   +    Y        ++   + Y   ++  A++
Sbjct: 70  NLVQLLGVCTREP---PFYIITEFMTYGNLLD-YLRECNRQEVSAVVLLYMATQISSAME 125

Query: 234 YCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRY-FK--GPEL 290
           Y   +  +HRD+   N ++      +++ D+GL+     G  Y     +++  K   PE 
Sbjct: 126 YLEKKNFIHRDLAARNCLVGENH-LVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPES 183

Query: 291 LVDLQDYDYSL--DMWSLG-CMFAGMIFRKEPFFYGHDNHDQLVKIAK 335
              L    +S+  D+W+ G  ++    +   P + G D       + K
Sbjct: 184 ---LAYNKFSIKSDVWAFGVLLWEIATYGMSP-YPGIDLSQVYELLEK 227

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score = 48.4 bits (116), Expect = 1e-06
 Identities = 37/213 (17%), Positives = 86/213 (40%), Gaps = 33/213 (15%)

Query: 125 DDYEV-------VRKVGRGKYSEVFEGINVNTNERCI---IKILKP-----VKKKKIKRE 169
           +D  +        + +G G++  V EG     +   +   +K +K       + ++   E
Sbjct: 27  EDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSE 86

Query: 170 IKILQNLCGGPNVVKLLDIVRD---QHSKTPSLIFEYVNSTDFK---------VLYPTLT 217
              +++    PNV++LL +  +   Q    P +I  ++   D                + 
Sbjct: 87  AACMKDFS-HPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIP 145

Query: 218 DYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN 277
              +  ++ ++   ++Y  ++  +HRD+   N M+  ++  + + D+GL++  + G  Y 
Sbjct: 146 LQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDM-TVCVADFGLSKKIYSGDYYR 204

Query: 278 VRVASRY-FK--GPELLVDLQDYDYSLDMWSLG 307
               ++   K    E L D + Y    D+W+ G
Sbjct: 205 QGRIAKMPVKWIAIESLAD-RVYTSKSDVWAFG 236

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score = 48.4 bits (116), Expect = 2e-06
 Identities = 46/223 (20%), Positives = 88/223 (39%), Gaps = 41/223 (18%)

Query: 123 DQDDYEV-------VRKVGRGKYSEVFEGI-----NVNTNERCIIKILKP----VKKKKI 166
           D   +E         + +GRG + +V E          T     +K+LK      + + +
Sbjct: 18  DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRAL 77

Query: 167 KREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYV-------------------NST 207
             E+KIL ++    NVV LL     +      +I E+                       
Sbjct: 78  MSELKILIHIGHHLNVVNLLGAC-TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVA 136

Query: 208 DFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA 267
              +    LT   +  Y +++ K +++  S+  +HRD+   N+++  +   +++ D+GLA
Sbjct: 137 PEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEK-NVVKICDFGLA 195

Query: 268 EFYHPGKEYNVRVASRY-FK--GPELLVDLQDYDYSLDMWSLG 307
              +   +Y  +  +R   K   PE + D + Y    D+WS G
Sbjct: 196 RDIYKDPDYVRKGDARLPLKWMAPETIFD-RVYTIQSDVWSFG 237

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score = 47.7 bits (114), Expect = 3e-06
 Identities = 23/147 (15%), Positives = 59/147 (40%), Gaps = 17/147 (11%)

Query: 123 DQDDYEVVRKVGRGKYSEVFEGI-NVNTNERCI---IKILKP----VKKKKIKREIKILQ 174
                   + +G G++ EV++G+   ++ ++ +   IK LK      ++     E  I+ 
Sbjct: 42  HPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMG 101

Query: 175 NLCGGPNVVKLLDIVRDQHSKTPSLI-FEYVNSTDF----KVLYPTLTDYDIRYYIYELL 229
                 N+++L  ++       P +I  EY+ +       +      +   +   +  + 
Sbjct: 102 QFS-HHNIIRLEGVISKYK---PMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIA 157

Query: 230 KALDYCHSQGIMHRDVKPHNVMIDHEL 256
             + Y  +   +HRD+   N++++  L
Sbjct: 158 AGMKYLANMNYVHRDLAARNILVNSNL 184

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score = 47.7 bits (114), Expect = 3e-06
 Identities = 31/146 (21%), Positives = 60/146 (41%), Gaps = 16/146 (10%)

Query: 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCI---IKILKP----VKKKKIKREIKILQN 175
           D  +  + + VG G++ EV  G     +++ I   IK LK      +++    E  I+  
Sbjct: 43  DATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQ 102

Query: 176 LCGGPNVVKLLDIVRDQHSKTPSLI-FEYVNSTDF----KVLYPTLTDYDIRYYIYELLK 230
               PN+++L  +V       P +I  EY+ +       +      T   +   +  +  
Sbjct: 103 FD-HPNIIRLEGVVTKSK---PVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIAS 158

Query: 231 ALDYCHSQGIMHRDVKPHNVMIDHEL 256
            + Y    G +HRD+   N++I+  L
Sbjct: 159 GMKYLSDMGYVHRDLAARNILINSNL 184

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score = 47.3 bits (113), Expect = 4e-06
 Identities = 29/172 (16%), Positives = 67/172 (38%), Gaps = 33/172 (19%)

Query: 125 DDYEV-------VRKVGRGKYSEVFEGINVNTNE-----RCIIKILKP----VKKKKIKR 168
           D++EV        R++G+G +  V+EG+     +     R  IK +       ++ +   
Sbjct: 18  DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLN 77

Query: 169 EIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYV-------------NSTDFKVLYPT 215
           E  +++      +VV+LL +V         +I E +              +     +   
Sbjct: 78  EASVMKEF-NCHHVVRLLGVVSQGQP--TLVIMELMTRGDLKSYLRSLRPAMANNPVLAP 134

Query: 216 LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA 267
            +   +     E+   + Y ++   +HRD+   N M+  +   +++ D+G+ 
Sbjct: 135 PSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAED-FTVKIGDFGMT 185

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 47.9 bits (113), Expect = 5e-06
 Identities = 46/340 (13%), Positives = 94/340 (27%), Gaps = 67/340 (19%)

Query: 57  YNLNIITDTIAATTVVYEGAIIDKIEERNLAEIPLPAMSKARVYTDVNVLRPKEYWDYES 116
            N   +   I              IE+R+         +  +V+   NV R + Y     
Sbjct: 89  INYKFLMSPIKTEQRQPSMMTRMYIEQRD------RLYNDNQVFAKYNVSRLQPYLKLRQ 142

Query: 117 LTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCI-IKI--LKPVKKKKIKREIKIL 173
             ++     +  +   +G GK     +       +  +  KI  L        +  +++L
Sbjct: 143 ALLELRPAKNVLIDGVLGSGKTWVALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEML 202

Query: 174 QNLCG--GPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKA 231
           Q L     PN     D     HS    L                     I+  +  LLK+
Sbjct: 203 QKLLYQIDPNWTSRSD-----HSSNIKLRIH-----------------SIQAELRRLLKS 240

Query: 232 LDYCHSQGIMHRDVKPHNV--MIDHELRKL---RLIDWGLAEFYHPGKEYNVRVASRYFK 286
             Y +   ++  +V+        +   + L   R     + +F       ++ +      
Sbjct: 241 KPYENCLLVL-LNVQNAKAWNAFNLSCKILLTTR--FKQVTDFLSAATTTHISL------ 291

Query: 287 GPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSR 346
             +        D    +      +     +  P         +++        II  + R
Sbjct: 292 --DHHSMTLTPDEVKSLLLK---YLDCRPQDLP--------REVLTTNPRRLSIIAESIR 338

Query: 347 HSRKPWS--KFINADNQHLVSPEAID-FLDKLLRYDHQDR 383
                W   K +N D         I+  L+ L   +++  
Sbjct: 339 DGLATWDNWKHVNCDKLT----TIIESSLNVLEPAEYRKM 374

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score = 46.5 bits (111), Expect = 8e-06
 Identities = 44/229 (19%), Positives = 100/229 (43%), Gaps = 23/229 (10%)

Query: 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCI----IKILK----PVKKKKIKREIKILQ 174
            + +++ ++ +G G +  V++G+ +   E+      IK L+    P   K+I  E  ++ 
Sbjct: 13  KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMA 72

Query: 175 NLCGGPNVVKLLDIVRDQHSKTPSLIFEYV---NSTDF-KVLYPTLTDYDIRYYIYELLK 230
           ++   P+V +LL I       T  LI + +      D+ +     +    +  +  ++ K
Sbjct: 73  SVD-NPHVCRLLGICLTS---TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAK 128

Query: 231 ALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRY-FK--G 287
            ++Y   + ++HRD+   NV++      +++ D+GLA+     ++       +   K   
Sbjct: 129 GMNYLEDRRLVHRDLAARNVLVKTPQ-HVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 187

Query: 288 PELLVDLQDYDYSLDMWSLG-CMFAGMIFRKEPFFYGHDNHDQLVKIAK 335
            E ++    Y +  D+WS G  ++  M F  +P+  G    +    + K
Sbjct: 188 LESILHRI-YTHQSDVWSYGVTVWELMTFGSKPYD-GIPASEISSILEK 234

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score = 46.1 bits (110), Expect = 1e-05
 Identities = 29/146 (19%), Positives = 56/146 (38%), Gaps = 16/146 (10%)

Query: 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCI---IKILKP----VKKKKIKREIKILQN 175
           +     + + +G G   EV  G      +R +   IK LK      +++    E  I+  
Sbjct: 47  EASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQ 106

Query: 176 LCGGPNVVKLLDIVRDQHSKTPSLI-FEYVNSTDF----KVLYPTLTDYDIRYYIYELLK 230
               PN+++L  +V        ++I  EY+ +       +      T   +   +  +  
Sbjct: 107 FDH-PNIIRLEGVVTRGR---LAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGA 162

Query: 231 ALDYCHSQGIMHRDVKPHNVMIDHEL 256
            + Y    G +HRD+   NV++D  L
Sbjct: 163 GMRYLSDLGYVHRDLAARNVLVDSNL 188

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score = 45.7 bits (109), Expect = 1e-05
 Identities = 40/199 (20%), Positives = 88/199 (44%), Gaps = 26/199 (13%)

Query: 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP--VKKKKIKREIKILQNLCGGP 180
            ++  ++V ++G G++ EV+ G   N + +  +K LK   +       E  +++ L    
Sbjct: 11  PRETLKLVERLGAGQFGEVWMGY-YNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQ-HQ 68

Query: 181 NVVKLLDIVRDQHSKTPSLI-FEYVNSTDFKVLY------PTLTDYDIRYYIYELLKALD 233
            +V+L  +V    ++ P  I  EY+ +      +        LT   +     ++ + + 
Sbjct: 69  RLVRLYAVV----TQEPIYIITEYMENGSLVD-FLKTPSGIKLTINKLLDMAAQIAEGMA 123

Query: 234 YCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRY-FK--GPEL 290
           +   +  +HRD++  N+++   L   ++ D+GLA       EY  R  +++  K   PE 
Sbjct: 124 FIEERNYIHRDLRAANILVSDTL-SCKIADFGLARLIE-DNEYTAREGAKFPIKWTAPEA 181

Query: 291 LVDLQDYDYSL--DMWSLG 307
           +       +++  D+WS G
Sbjct: 182 INYGT---FTIKSDVWSFG 197

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score = 45.8 bits (109), Expect = 1e-05
 Identities = 38/231 (16%), Positives = 95/231 (41%), Gaps = 27/231 (11%)

Query: 123 DQDDYEVVRKVGRGKYSEVFEGI----NVNTNERCIIKILK----PVKKKKIKREIKILQ 174
            + +   ++ +G G +  V +G+      +      IK+++        + +   +  + 
Sbjct: 11  KETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIG 70

Query: 175 NLCGGPNVVKLLDIVRDQHSKTPSLIFEYV---NSTDF-KVLYPTLTDYDIRYYIYELLK 230
           +L    ++V+LL +       +  L+ +Y+   +  D  +     L    +  +  ++ K
Sbjct: 71  SLDH-AHIVRLLGLCPGS---SLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAK 126

Query: 231 ALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRY-FK--G 287
            + Y    G++HR++   NV++     ++++ D+G+A+   P  +  +   ++   K   
Sbjct: 127 GMYYLEEHGMVHRNLAARNVLLKSPS-QVQVADFGVADLLPPDDKQLLYSEAKTPIKWMA 185

Query: 288 PELLVDLQDYDYSL--DMWSLG-CMFAGMIFRKEPFFYGHDNHDQLVKIAK 335
            E    +    Y+   D+WS G  ++  M F  EP+  G    +    + K
Sbjct: 186 LE---SIHFGKYTHQSDVWSYGVTVWELMTFGAEPYA-GLRLAEVPDLLEK 232

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score = 45.3 bits (108), Expect = 1e-05
 Identities = 27/153 (17%), Positives = 69/153 (45%), Gaps = 15/153 (9%)

Query: 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP--VKKKKIKREIKILQNLCGGP 180
            +++  +++++G G++  V  G          +K++K   + + +  +E + +  L   P
Sbjct: 6   KREEITLLKELGSGQFGVVKLGK-WKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLS-HP 63

Query: 181 NVVKLLDIVRDQHSKTPSLI-FEYVNSTDFKVLY-----PTLTDYDIRYYIYELLKALDY 234
            +VK   +   ++   P  I  EY+++      Y       L    +    Y++ + + +
Sbjct: 64  KLVKFYGVCSKEY---PIYIVTEYISNGCLLN-YLRSHGKGLEPSQLLEMCYDVCEGMAF 119

Query: 235 CHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA 267
             S   +HRD+   N ++D +L  +++ D+G+ 
Sbjct: 120 LESHQFIHRDLAARNCLVDRDL-CVKVSDFGMT 151

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* Length = 540

 Score = 46.2 bits (110), Expect = 1e-05
 Identities = 31/193 (16%), Positives = 71/193 (36%), Gaps = 32/193 (16%)

Query: 94  MSKARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVR----KVGRGKYSEVFEGINVNT 149
           M K   +  ++  +    +  + + V W  +   +  +     +G+G  +++     ++ 
Sbjct: 301 MHKNGRWMSLDETKIIPNYRTDMVEVNWIKEIKGKKRKIPEHLIGKGAEADIKRDSYLDF 360

Query: 150 NERCIIKILKP-----------VKKKKIKREIKILQNL--CGGPNVVKLLDIVRDQHSKT 196
           +   IIK               ++K +  RE + L  +   G P        + D     
Sbjct: 361 D--VIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPA-----PYIFDVDLDN 413

Query: 197 PSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEL 256
             ++  Y+N    K +     D       Y++ + +   H   ++H D+   N + D   
Sbjct: 414 KRIMMSYINGKLAKDVIEDNLDI-----AYKIGEIVGKLHKNDVIHNDLTTSNFIFD--- 465

Query: 257 RKLRLIDWGLAEF 269
           + L +ID+GL + 
Sbjct: 466 KDLYIIDFGLGKI 478

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score = 45.3 bits (108), Expect = 2e-05
 Identities = 30/152 (19%), Positives = 68/152 (44%), Gaps = 13/152 (8%)

Query: 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP--VKKKKIKREIKILQNLCGGP 180
           D  D   ++++G G++  V  G          IK++K   + + +   E K++ NL    
Sbjct: 22  DPKDLTFLKELGTGQFGVVKYGK-WRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLS-HE 79

Query: 181 NVVKLLDIVRDQHSKTPSLI-FEYVNSTDF----KVLYPTLTDYDIRYYIYELLKALDYC 235
            +V+L  +   Q    P  I  EY+ +       + +        +     ++ +A++Y 
Sbjct: 80  KLVQLYGVCTKQR---PIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYL 136

Query: 236 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA 267
            S+  +HRD+   N +++ +   +++ D+GL+
Sbjct: 137 ESKQFLHRDLAARNCLVNDQG-VVKVSDFGLS 167

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score = 45.1 bits (107), Expect = 3e-05
 Identities = 43/227 (18%), Positives = 101/227 (44%), Gaps = 26/227 (11%)

Query: 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP--VKKKKIKREIKILQNLCGGP 180
            ++  ++ +K+G G++ EV+     N + +  +K +KP  +  +    E  +++ L    
Sbjct: 186 PRESLKLEKKLGAGQFGEVWMAT-YNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQ-HD 243

Query: 181 NVVKLLDIVRDQHSKTPSLI-FEYV---NSTDF--KVLYPTLTDYDIRYYIYELLKALDY 234
            +VKL  +V    +K P  I  E++   +  DF             +  +  ++ + + +
Sbjct: 244 KLVKLHAVV----TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAF 299

Query: 235 CHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRY-FK--GPELL 291
              +  +HRD++  N+++   L   ++ D+GLA       EY  R  +++  K   PE +
Sbjct: 300 IEQRNYIHRDLRAANILVSASL-VCKIADFGLARVIE-DNEYTAREGAKFPIKWTAPEAI 357

Query: 292 VDLQDYDYSL--DMWSLG-CMFAGMIFRKEPFFYGHDNHDQLVKIAK 335
                  +++  D+WS G  +   + + + P + G  N + +  + +
Sbjct: 358 NFGS---FTIKSDVWSFGILLMEIVTYGRIP-YPGMSNPEVIRALER 400

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score = 44.5 bits (106), Expect = 3e-05
 Identities = 46/221 (20%), Positives = 84/221 (38%), Gaps = 40/221 (18%)

Query: 125 DDYEV-------VRKVGRGKYSEVFEG-----INVNTNERCIIKILKP----VKKKKIKR 168
             +E         + +G G + +V E      I  +      +K+LKP     +++ +  
Sbjct: 16  HKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMS 75

Query: 169 EIKILQNLCGGPNVVKLLDIVRDQH-------------------SKTPSLIFEYVNSTDF 209
           E+K+L  L    N+V LL                           K  S I    +    
Sbjct: 76  ELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIM 135

Query: 210 KVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEF 269
           +     L   D+  + Y++ K + +  S+  +HRD+   N+++    R  ++ D+GLA  
Sbjct: 136 EDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLT-HGRITKICDFGLARD 194

Query: 270 YHPGKEYNVRVASRY-FK--GPELLVDLQDYDYSLDMWSLG 307
                 Y V+  +R   K   PE + +   Y +  D+WS G
Sbjct: 195 IKNDSNYVVKGNARLPVKWMAPESIFN-CVYTFESDVWSYG 234

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score = 44.6 bits (106), Expect = 3e-05
 Identities = 31/173 (17%), Positives = 64/173 (36%), Gaps = 33/173 (19%)

Query: 125 DDYEVVRKVGRGKYSEVFEGI-------NVNTNERCIIKILKP----VKKKKIKREIKIL 173
           D   + + +G G + +V                    +K+LK          +  E++++
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94

Query: 174 QNLCGGPNVVKLLDIVRDQHSKTPSLIFEYV-------------------NSTDFKVLYP 214
           + +    N++ LL            +I EY                    +    +V   
Sbjct: 95  KMIGKHKNIINLLGACTQDGP--LYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEE 152

Query: 215 TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA 267
            +T  D+    Y+L + ++Y  SQ  +HRD+   NV++      +++ D+GLA
Sbjct: 153 QMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTEN-NVMKIADFGLA 204

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score = 44.2 bits (105), Expect = 4e-05
 Identities = 44/229 (19%), Positives = 100/229 (43%), Gaps = 23/229 (10%)

Query: 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCI----IKILK----PVKKKKIKREIKILQ 174
            + +++ ++ +G G +  V++G+ +   E+      IK L+    P   K+I  E  ++ 
Sbjct: 13  KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMA 72

Query: 175 NLCGGPNVVKLLDIVRDQHSKTPSLIFEYV---NSTDF-KVLYPTLTDYDIRYYIYELLK 230
           ++   P+V +LL I       T  LI + +      D+ +     +    +  +  ++ K
Sbjct: 73  SVD-NPHVCRLLGICLTS---TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAK 128

Query: 231 ALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRY-FK--G 287
            ++Y   + ++HRD+   NV++      +++ D+GLA+     ++       +   K   
Sbjct: 129 GMNYLEDRRLVHRDLAARNVLVKTPQ-HVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 187

Query: 288 PELLVDLQDYDYSLDMWSLG-CMFAGMIFRKEPFFYGHDNHDQLVKIAK 335
            E ++    Y +  D+WS G  ++  M F  +P+  G    +    + K
Sbjct: 188 LESILHRI-YTHQSDVWSYGVTVWELMTFGSKPYD-GIPASEISSILEK 234

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score = 43.8 bits (104), Expect = 5e-05
 Identities = 47/213 (22%), Positives = 87/213 (40%), Gaps = 35/213 (16%)

Query: 125 DDYEVVRKVGRGKYSEVFEGI-----NVNTNERCIIKILKP----VKKKKIKREIKILQN 175
           ++ +  + +G G + +V E         +   +  +K+LK      +K+ +  E+KI+ +
Sbjct: 46  NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 105

Query: 176 LCGGPNVVKLLDIVRDQHSKTPSL-IFEYV-----------------NSTDFKVLYPTLT 217
           L    N+V LL          P L I EY                      F +   T +
Sbjct: 106 LGQHENIVNLLGACTHGG---PVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTAS 162

Query: 218 DYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN 277
             D+ ++  ++ + + +  S+  +HRDV   NV++ +     ++ D+GLA        Y 
Sbjct: 163 TRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNG-HVAKIGDFGLARDIMNDSNYI 221

Query: 278 VRVASRY-FK--GPELLVDLQDYDYSLDMWSLG 307
           V+  +R   K   PE + D   Y    D+WS G
Sbjct: 222 VKGNARLPVKWMAPESIFD-CVYTVQSDVWSYG 253

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score = 43.3 bits (103), Expect = 5e-05
 Identities = 39/226 (17%), Positives = 89/226 (39%), Gaps = 24/226 (10%)

Query: 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP--VKKKKIKREIKILQNLCGGP 180
           D  +   V+++G G++  V  G      ++  IK ++   + ++    E +++  L   P
Sbjct: 6   DPSELTFVQEIGSGQFGLVHLGY-WLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLS-HP 63

Query: 181 NVVKLLDIVRDQHSKTPSLI-FEYVNSTDF----KVLYPTLTDYDIRYYIYELLKALDYC 235
            +V+L  +  +Q    P  +  E++         +          +     ++ + + Y 
Sbjct: 64  KLVQLYGVCLEQA---PICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYL 120

Query: 236 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRY-FK--GPELLV 292
               ++HRD+   N ++      +++ D+G+  F     +Y     +++  K   PE+  
Sbjct: 121 EEACVIHRDLAARNCLVGENQ-VIKVSDFGMTRFVL-DDQYTSSTGTKFPVKWASPEV-- 176

Query: 293 DLQDYDYSL--DMWSLG-CMFAGMIFRKEPFFYGHDNHDQLVKIAK 335
                 YS   D+WS G  M+      K P +    N + +  I+ 
Sbjct: 177 -FSFSRYSSKSDVWSFGVLMWEVFSEGKIP-YENRSNSEVVEDIST 220

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score = 43.4 bits (103), Expect = 6e-05
 Identities = 46/240 (19%), Positives = 91/240 (37%), Gaps = 41/240 (17%)

Query: 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCI---IKILKP------VKKKKIKREIKIL 173
            + D  ++ K+G G +  V  G     + + +   +K LKP             RE+  +
Sbjct: 16  GEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAM 75

Query: 174 QNLCGGPNVVKLLDIVRDQHSKTPSLI----------FEYVNSTDFKVLYPTLTDYDIRY 223
            +L    N+++L  +V       P  +           + +       L  TL+      
Sbjct: 76  HSLD-HRNLIRLYGVV----LTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSR----- 125

Query: 224 YIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEYNVRVAS 282
           Y  ++ + + Y  S+  +HRD+   N+++      +++ D+GL          Y ++   
Sbjct: 126 YAVQVAEGMGYLESKRFIHRDLAARNLLLATRD-LVKIGDFGLMRALPQNDDHYVMQEHR 184

Query: 283 RY-FK--GPELLVDLQDYDYSL--DMWSLG-CMFAGMIFRKEPFFYGHDNHDQLVKIAKD 336
           +  F    PE L       +S   D W  G  ++    + +EP + G +    L KI K+
Sbjct: 185 KVPFAWCAPESLKTRT---FSHASDTWMFGVTLWEMFTYGQEP-WIGLNGSQILHKIDKE 240

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score = 43.4 bits (103), Expect = 6e-05
 Identities = 27/153 (17%), Positives = 69/153 (45%), Gaps = 15/153 (9%)

Query: 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP-VKKKKIKREIKILQNLCGGPN 181
           +  + ++++ +G+G++ +V  G       +  +K +K     +    E  ++  L    N
Sbjct: 19  NMKELKLLQTIGKGEFGDVMLGDYRGN--KVAVKCIKNDATAQAFLAEASVMTQLR-HSN 75

Query: 182 VVKLLDIVRDQHSKTPSL--IFEYV---NSTDF--KVLYPTLTDYDIRYYIYELLKALDY 234
           +V+LL ++ ++      L  + EY+   +  D+        L    +  +  ++ +A++Y
Sbjct: 76  LVQLLGVIVEEK---GGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEY 132

Query: 235 CHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA 267
                 +HRD+   NV++  +    ++ D+GL 
Sbjct: 133 LEGNNFVHRDLAARNVLVSEDN-VAKVSDFGLT 164

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score = 43.0 bits (102), Expect = 9e-05
 Identities = 31/187 (16%), Positives = 63/187 (33%), Gaps = 40/187 (21%)

Query: 108 PKEYW--DYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGI--NVNTNERCIIKILKP--- 160
           P  Y   D+  +  Q            +G G + +V +             IK +K    
Sbjct: 16  PTIYPVLDWNDIKFQ----------DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYAS 65

Query: 161 -VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYV--------------- 204
               +    E+++L  L   PN++ LL     +      L  EY                
Sbjct: 66  KDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGY--LYLAIEYAPHGNLLDFLRKSRVL 123

Query: 205 ----NSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLR 260
                         TL+   + ++  ++ + +DY   +  +HRD+   N+++       +
Sbjct: 124 ETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY-VAK 182

Query: 261 LIDWGLA 267
           + D+GL+
Sbjct: 183 IADFGLS 189

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score = 43.1 bits (102), Expect = 9e-05
 Identities = 31/173 (17%), Positives = 64/173 (36%), Gaps = 33/173 (19%)

Query: 125 DDYEVVRKVGRGKYSEVFEGI-------NVNTNERCIIKILKP----VKKKKIKREIKIL 173
           D   + + +G G + +V                    +K+LK          +  E++++
Sbjct: 81  DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 140

Query: 174 QNLCGGPNVVKLLDIVRDQHSKTPSLIFEYV-------------------NSTDFKVLYP 214
           + +    N++ LL            +I EY                    +    +V   
Sbjct: 141 KMIGKHKNIINLLGACTQDGP--LYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEE 198

Query: 215 TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA 267
            +T  D+    Y+L + ++Y  SQ  +HRD+   NV++      +++ D+GLA
Sbjct: 199 QMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTEN-NVMKIADFGLA 250

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score = 42.7 bits (101), Expect = 1e-04
 Identities = 29/173 (16%), Positives = 65/173 (37%), Gaps = 33/173 (19%)

Query: 125 DDYEVVRKVGRGKYSEVFEGI-------NVNTNERCIIKILKP----VKKKKIKREIKIL 173
           D   + + +G G + +V             N   +  +K+LK          +  E++++
Sbjct: 69  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 128

Query: 174 QNLCGGPNVVKLLDIVRDQHSKTPSLIFEYV-------------------NSTDFKVLYP 214
           + +    N++ LL            +I EY                    +         
Sbjct: 129 KMIGKHKNIINLLGACTQDGP--LYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEE 186

Query: 215 TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA 267
            L+  D+    Y++ + ++Y  S+  +HRD+   NV++  +   +++ D+GLA
Sbjct: 187 QLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTED-NVMKIADFGLA 238

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score = 41.1 bits (97), Expect = 3e-04
 Identities = 28/182 (15%), Positives = 63/182 (34%), Gaps = 32/182 (17%)

Query: 104 NVLRPKEYWD--YESLTVQWG-DQDDYEVVRKVGRGKYSEVFEGI--NVNTNERCI---I 155
           + L+     +  Y S        + D  +  ++G G + +VF     N+   +  +   +
Sbjct: 17  SGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAV 76

Query: 156 KILKPVKKKKIK---REIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYV-------- 204
           K LK   +   +   RE ++L  L    ++V+   +  +   +   ++FEY+        
Sbjct: 77  KALKEASESARQDFQREAELLTMLQ-HQHIVRFFGVCTE--GRPLLMVFEYMRHGDLNRF 133

Query: 205 ----------NSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDH 254
                      +    V    L    +     ++   + Y      +HRD+   N ++  
Sbjct: 134 LRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQ 193

Query: 255 EL 256
            L
Sbjct: 194 GL 195

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* Length = 282

 Score = 41.1 bits (96), Expect = 4e-04
 Identities = 28/168 (16%), Positives = 64/168 (38%), Gaps = 36/168 (21%)

Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP---------------------VKKKK 165
             + + +G GK S VF   +      C++K  K                      +  + 
Sbjct: 92  DAIGKLMGEGKESAVFNCYSEK-FGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRS 150

Query: 166 IKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYI 225
            + E + LQ L G   V K+     +      +++ E +++ +       +   +    +
Sbjct: 151 ARNEFRALQKLQGLA-VPKVYAWEGN------AVLMELIDAKEL----YRVRVENPDEVL 199

Query: 226 YELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHP 272
             +L+ +   + +GI+H D+  +NV++  E   + +ID+  + E    
Sbjct: 200 DMILEEVAKFYHRGIVHGDLSQYNVLVSEE--GIWIIDFPQSVEVGEE 245

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score = 41.2 bits (97), Expect = 4e-04
 Identities = 27/162 (16%), Positives = 72/162 (44%), Gaps = 15/162 (9%)

Query: 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP-VKKKKIKREIKILQNLCGGPN 181
           +  + ++++ +G+G++ +V  G       +  +K +K     +    E  ++  L    N
Sbjct: 191 NMKELKLLQTIGKGEFGDVMLGDYRGN--KVAVKCIKNDATAQAFLAEASVMTQLR-HSN 247

Query: 182 VVKLLDIVRDQHSKTPSL--IFEYV---NSTDF--KVLYPTLTDYDIRYYIYELLKALDY 234
           +V+LL ++ ++      L  + EY+   +  D+        L    +  +  ++ +A++Y
Sbjct: 248 LVQLLGVIVEEK---GGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEY 304

Query: 235 CHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY 276
                 +HRD+   NV++  +    ++ D+GL +     ++ 
Sbjct: 305 LEGNNFVHRDLAARNVLVSEDN-VAKVSDFGLTKEASSTQDT 345

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score = 40.7 bits (96), Expect = 5e-04
 Identities = 46/221 (20%), Positives = 86/221 (38%), Gaps = 42/221 (19%)

Query: 125 DDYEVVRKVGRGKYSEVFEGI-----NVNTNERCIIKILKP----VKKKKIKREIKILQN 175
           ++ E  + +G G + +V             + +  +K+LK      +++ +  E+K++  
Sbjct: 45  ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 104

Query: 176 LCGGPNVVKLLDIVRDQHSKTPSLIFEYV--------------------------NSTDF 209
           L    N+V LL            LIFEY                              + 
Sbjct: 105 LGSHENIVNLLGACTLSGP--IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEE 162

Query: 210 KVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEF 269
           +     LT  D+  + Y++ K +++   +  +HRD+   NV++    + +++ D+GLA  
Sbjct: 163 EEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVT-HGKVVKICDFGLARD 221

Query: 270 YHPGKEYNVRVASRY-FK--GPELLVDLQDYDYSLDMWSLG 307
                 Y VR  +R   K   PE L +   Y    D+WS G
Sbjct: 222 IMSDSNYVVRGNARLPVKWMAPESLFE-GIYTIKSDVWSYG 261

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score = 40.3 bits (95), Expect = 7e-04
 Identities = 39/240 (16%), Positives = 95/240 (39%), Gaps = 46/240 (19%)

Query: 125 DDYEVVR--------KVGRGKYSEVFEGI-NVNTNERCI-IKILKP----VKKKKIKREI 170
               + R        ++G G +  V +G+  +   +  + IK+LK        +++ RE 
Sbjct: 2   KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREA 61

Query: 171 KILQNLCGGPNVVKLLDIVRDQHSKTPSLI----------FEYVNSTDFKVLYPTLTDYD 220
           +I+  L   P +V+L+ +          ++           +++     ++    + +  
Sbjct: 62  QIMHQLD-NPYIVRLIGVC----QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAE-- 114

Query: 221 IRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEYNVR 279
               ++++   + Y   +  +HRD+   NV++ +     ++ D+GL+         Y  R
Sbjct: 115 ---LLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRH-YAKISDFGLSKALGADDSYYTAR 170

Query: 280 VASRY-FK--GPELLVDLQDYDYSL--DMWSLG-CMFAGMIFRKEPFFYGHDNHDQLVKI 333
            A ++  K   PE    +    +S   D+WS G  M+  + + ++P +      + +  I
Sbjct: 171 SAGKWPLKWYAPE---CINFRKFSSRSDVWSYGVTMWEALSYGQKP-YKKMKGPEVMAFI 226

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score = 40.3 bits (95), Expect = 7e-04
 Identities = 43/224 (19%), Positives = 89/224 (39%), Gaps = 30/224 (13%)

Query: 131 RKVGRGKYSEVFEGINVNTNERCI---IKILK-----PVKKKKIKREIKILQNLCGGPNV 182
           +++G G +  V +G      +      +KILK     P  K ++  E  ++Q L   P +
Sbjct: 23  KELGSGNFGTVKKGY-YQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLD-NPYI 80

Query: 183 VKLLDIVRDQHSKTPS-LIFEYVNS---TDFKVLYPTLTDYDIRYYIYELLKALDYCHSQ 238
           V+++ I           L+ E         +      + D +I   ++++   + Y    
Sbjct: 81  VRMIGIC----EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEES 136

Query: 239 GIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEYNVRVASRY-FK--GPELLVDL 294
             +HRD+   NV++  +    ++ D+GL+         Y  +   ++  K   PE    +
Sbjct: 137 NFVHRDLAARNVLLVTQH-YAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPEC---I 192

Query: 295 QDYDYSL--DMWSLG-CMFAGMIFRKEPFFYGHDNHDQLVKIAK 335
             Y +S   D+WS G  M+    + ++P + G    +    + K
Sbjct: 193 NYYKFSSKSDVWSFGVLMWEAFSYGQKP-YRGMKGSEVTAMLEK 235

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 40.3 bits (94), Expect = 8e-04
 Identities = 26/121 (21%), Positives = 53/121 (43%), Gaps = 5/121 (4%)

Query: 190 RDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHN 249
                +  SL           +    LT   +  Y +++ K +++  S+  +HRD+   N
Sbjct: 164 SSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARN 223

Query: 250 VMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRY-FK--GPELLVDLQDYDYSLDMWSL 306
           +++  +   +++ D+GLA   +   +Y  +  +R   K   PE + D + Y    D+WS 
Sbjct: 224 ILLSEK-NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD-RVYTIQSDVWSF 281

Query: 307 G 307
           G
Sbjct: 282 G 282

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	408
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.97
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.95
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.92
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.88
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.75
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.47
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.35
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.26
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	99.14
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.95
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.78
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.77
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.57
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.51
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.45
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	98.28
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	97.95
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.94
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.8
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.74
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.68
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	97.67
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.61
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.55
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	97.51
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	97.33
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	97.22
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	97.19
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	96.83
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	96.79
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	96.6
3mes_A	424	Choline kinase; malaria, structural genomics, stru	96.23
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	95.84
3cxl_A	463	N-chimerin; SH2, RHO-GAP, structural genomics cons	82.86

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=4.9e-62  Score=462.40  Aligned_cols=253  Identities=24%  Similarity=0.417  Sum_probs=218.7

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecc---cchHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccEEE
Q 015374          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP---VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI  200 (408)
Q Consensus       124 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~---~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  200 (408)
                      .+.|+++++||+|+||+||+|++..+|+.||||+++.   ...+.+.+|+.+|+++ +|||||+++++|.+  ...+|||
T Consensus        73 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l-~HpnIV~l~~~~~~--~~~~~iv  149 (346)
T 4fih_A           73 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDY-QHENVVEMYNSYLV--GDELWVV  149 (346)
T ss_dssp             GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHC-CCTTBCCEEEEEEE--TTEEEEE
T ss_pred             hHhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhC-CCCCCCcEEEEEEE--CCEEEEE
Confidence            3569999999999999999999999999999999963   3346788999999999 99999999999976  4678999


Q ss_pred             EEeecCCChhhhc--CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCC-Ccce
Q 015374          201 FEYVNSTDFKVLY--PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG-KEYN  277 (408)
Q Consensus       201 ~e~~~~~~l~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~-~~~~  277 (408)
                      ||||++|+|..++  ..+++.+++.++.||+.||+|||++|||||||||+|||++.+ +.+||+|||+|+..... ....
T Consensus       150 mEy~~gg~L~~~l~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~-g~vKl~DFGla~~~~~~~~~~~  228 (346)
T 4fih_A          150 MEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHD-GRVKLSDFGFCAQVSKEVPRRK  228 (346)
T ss_dssp             ECCCTTEEHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT-CCEEECCCTTCEECCSSSCCBC
T ss_pred             EeCCCCCcHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCC-CCEEEecCcCceecCCCCCccc
Confidence            9999999999887  569999999999999999999999999999999999999988 89999999999877544 3455


Q ss_pred             eeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCCCcccccc
Q 015374          278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSKFIN  357 (408)
Q Consensus       278 ~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  357 (408)
                      ..+||+.|||||++.+ ..|+.++|||||||++|||++|+.||. +.+..+.+..+.....                 ..
T Consensus       229 ~~~GTp~YmAPEvl~~-~~y~~~~DiWSlGvilyeml~G~~PF~-~~~~~~~~~~i~~~~~-----------------~~  289 (346)
T 4fih_A          229 SLVGTPYWMAPELISR-LPYGPEVDIWSLGIMVIEMVDGEPPYF-NEPPLKAMKMIRDNLP-----------------PR  289 (346)
T ss_dssp             CCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCTTT-TSCHHHHHHHHHHSSC-----------------CC
T ss_pred             ccccCcCcCCHHHHCC-CCCCcHHHHHHHHHHHHHHHHCCCCCC-CcCHHHHHHHHHcCCC-----------------CC
Confidence            6799999999999987 789999999999999999999999984 4455555555443210                 01


Q ss_pred             ccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccccc
Q 015374          358 ADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVR  399 (408)
Q Consensus       358 ~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~~~  399 (408)
                      ...+..+++++++||.+||+.||++|||++|+|+||||++..
T Consensus       290 ~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~Hp~~~~~~  331 (346)
T 4fih_A          290 LKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAG  331 (346)
T ss_dssp             CSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred             CCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhcCCC
Confidence            122334799999999999999999999999999999998754

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=4.4e-62  Score=456.08  Aligned_cols=255  Identities=28%  Similarity=0.488  Sum_probs=221.8

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc------chHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCcc
Q 015374          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP  197 (408)
Q Consensus       124 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~  197 (408)
                      .++|++.+.||+|+||+||+|++..+++.||||+++..      ..+.+.+|+++++++ +|||||+++++|++  ...+
T Consensus        31 ~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~--~~~~  107 (311)
T 4aw0_A           31 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-DHPFFVKLYFTFQD--DEKL  107 (311)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTC-CCTTBCCEEEEEEC--SSEE
T ss_pred             ccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEEe--CCEE
Confidence            46799999999999999999999999999999999632      346789999999999 99999999999965  4678


Q ss_pred             EEEEEeecCCChhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCCC
Q 015374          198 SLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK  274 (408)
Q Consensus       198 ~lv~e~~~~~~l~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~~  274 (408)
                      ++||||+++|+|..++   ..+++..++.++.||+.||+|||++|||||||||+|||++.+ +.+||+|||+|+......
T Consensus       108 yivmEy~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~-g~vKl~DFGla~~~~~~~  186 (311)
T 4aw0_A          108 YFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNED-MHIQITDFGTAKVLSPES  186 (311)
T ss_dssp             EEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTT-SCEEECCCTTCEECCTTT
T ss_pred             EEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCC-CCEEEEEcCCceecCCCC
Confidence            9999999999999887   469999999999999999999999999999999999999988 899999999999875332


Q ss_pred             ---cceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCCC
Q 015374          275 ---EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKP  351 (408)
Q Consensus       275 ---~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  351 (408)
                         .....+||+.|||||++.+ ..|+.++||||+||++|||++|+.|| .+.+..+.+..+...               
T Consensus       187 ~~~~~~~~~GTp~YmAPEvl~~-~~y~~~~DiWSlGvilyeml~G~~PF-~~~~~~~~~~~i~~~---------------  249 (311)
T 4aw0_A          187 KQARANSFVGTAQYVSPELLTE-KSACKSSDLWALGCIIYQLVAGLPPF-RAGNEGLIFAKIIKL---------------  249 (311)
T ss_dssp             TCCCBCCCCSCGGGCCHHHHHH-SCBCHHHHHHHHHHHHHHHHHSSCSS-CCSSHHHHHHHHHHT---------------
T ss_pred             CcccccCcccCcccCCHHHHcC-CCCCcHHHHHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHcC---------------
Confidence               3456789999999999987 78999999999999999999999998 455555555555442               


Q ss_pred             ccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHH------HhcCCCccccccchhh
Q 015374          352 WSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTARE------AMAHPYFAQVRAAESS  404 (408)
Q Consensus       352 ~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e------lL~hp~f~~~~~~~~~  404 (408)
                           ....+..+++++++||.+||+.||++|||++|      +++||||+++++....
T Consensus       250 -----~~~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~idw~~l~  303 (311)
T 4aw0_A          250 -----EYDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLH  303 (311)
T ss_dssp             -----CCCCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCTTGG
T ss_pred             -----CCCCCcccCHHHHHHHHHHccCCHhHCcChHHHcCCHHHHCCCCcCCCCHHHhc
Confidence                 11223458999999999999999999999988      6899999999876643

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=1.3e-60  Score=463.46  Aligned_cols=253  Identities=23%  Similarity=0.414  Sum_probs=219.4

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecc---cchHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccEEE
Q 015374          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP---VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI  200 (408)
Q Consensus       124 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~---~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  200 (408)
                      .+.|+++++||+|+||+||+|++..+|+.||||+++.   ...+.+.+|+.+|+++ +|||||+++++|.+  ...+|||
T Consensus       150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l-~HpnIV~l~~~~~~--~~~~~iV  226 (423)
T 4fie_A          150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDY-QHENVVEMYNSYLV--GDELWVV  226 (423)
T ss_dssp             GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHC-CCTTBCCEEEEEEE--TTEEEEE
T ss_pred             hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhC-CCCCCCceEEEEEE--CCEEEEE
Confidence            4679999999999999999999999999999999863   3456789999999999 99999999999976  4678999


Q ss_pred             EEeecCCChhhhc--CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCC-Ccce
Q 015374          201 FEYVNSTDFKVLY--PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG-KEYN  277 (408)
Q Consensus       201 ~e~~~~~~l~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~-~~~~  277 (408)
                      ||||++|+|..++  ..+++.+++.++.||+.||+|||++|||||||||+||||+.+ +.+||+|||+|+..... ....
T Consensus       227 mEy~~gG~L~~~i~~~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~-g~vKl~DFGla~~~~~~~~~~~  305 (423)
T 4fie_A          227 MEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHD-GRVKLSDFGFCAQVSKEVPRRK  305 (423)
T ss_dssp             EECCTTEEHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTT-CCEEECCCTTCEECCSSCCCBC
T ss_pred             EeCCCCCcHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCC-CCEEEecCccceECCCCCcccc
Confidence            9999999999887  569999999999999999999999999999999999999988 89999999999877544 3455


Q ss_pred             eeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCCCcccccc
Q 015374          278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSKFIN  357 (408)
Q Consensus       278 ~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  357 (408)
                      ..+||+.|||||++.+ ..|+.++|||||||++|||++|+.|| .+.+..+.+..+.....                 ..
T Consensus       306 ~~~GTp~YmAPEvl~~-~~y~~~~DiWSlGvilyeml~G~~PF-~~~~~~~~~~~i~~~~~-----------------~~  366 (423)
T 4fie_A          306 SLVGTPYWMAPELISR-LPYGPEVDIWSLGIMVIEMVDGEPPY-FNEPPLKAMKMIRDNLP-----------------PR  366 (423)
T ss_dssp             CCEECTTTCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCTT-TTSCHHHHHHHHHHSCC-----------------CC
T ss_pred             ccccCcCcCCHHHHCC-CCCCcHHHHHHHHHHHHHHHHCCCCC-CCcCHHHHHHHHHcCCC-----------------CC
Confidence            6799999999999987 78999999999999999999999998 44555555555443210                 01


Q ss_pred             ccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccccc
Q 015374          358 ADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVR  399 (408)
Q Consensus       358 ~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~~~  399 (408)
                      ...+..+++++++||.+||+.||++|||++|+|+||||+...
T Consensus       367 ~~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~Hp~~~~~~  408 (423)
T 4fie_A          367 LKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAG  408 (423)
T ss_dssp             CSCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred             CcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHHhcCCC
Confidence            122345799999999999999999999999999999998754

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=1.6e-60  Score=443.15  Aligned_cols=254  Identities=22%  Similarity=0.418  Sum_probs=211.5

Q ss_pred             CCCCCE-EEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc-----chHHHHHHHHHHHHhcCCCCceEEeeEEEcc--C
Q 015374          122 GDQDDY-EVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQ--H  193 (408)
Q Consensus       122 ~~~~~y-~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~--~  193 (408)
                      ....+| ++.++||+|+||+||+|++..++..||+|++...     ..+.+.+|+.+++++ +|||||+++++|.+.  .
T Consensus        22 ~~~gr~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l-~HpnIV~~~~~~~~~~~~  100 (290)
T 3fpq_A           22 SNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGL-QHPNIVRFYDSWESTVKG  100 (290)
T ss_dssp             CTTSSEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEEEEETT
T ss_pred             CCCCceEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhC-CCCCCCcEEEEEeeccCC
Confidence            344565 7778899999999999999999999999998632     245789999999999 999999999999653  3


Q ss_pred             CCccEEEEEeecCCChhhhc---CCCChHHHHHHHHHHHHHHHHHHHCC--cEEecCCCCcEEEeCCCCcEEEEecccce
Q 015374          194 SKTPSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQG--IMHRDVKPHNVMIDHELRKLRLIDWGLAE  268 (408)
Q Consensus       194 ~~~~~lv~e~~~~~~l~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~--iiH~Dlk~~NILl~~~~~~~kl~DfG~a~  268 (408)
                      ...++||||||++|+|..++   ..+++..++.++.||+.||+|||++|  ||||||||+|||++...+.+||+|||+|+
T Consensus       101 ~~~~~lvmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~  180 (290)
T 3fpq_A          101 KKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT  180 (290)
T ss_dssp             EEEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred             CcEEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCE
Confidence            45689999999999999987   46999999999999999999999998  99999999999998644799999999998


Q ss_pred             eccCCCcceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCC
Q 015374          269 FYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHS  348 (408)
Q Consensus       269 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  348 (408)
                      ... .......+||+.|||||++.+  .|+.++|||||||++|||++|+.||. +.++...+...+....          
T Consensus       181 ~~~-~~~~~~~~GTp~YmAPE~~~~--~y~~~~DiwSlGvilyelltg~~Pf~-~~~~~~~~~~~i~~~~----------  246 (290)
T 3fpq_A          181 LKR-ASFAKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYS-ECQNAAQIYRRVTSGV----------  246 (290)
T ss_dssp             GCC-TTSBEESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTTT-TCSSHHHHHHHHTTTC----------
T ss_pred             eCC-CCccCCcccCccccCHHHcCC--CCCcHHHHHHHHHHHHHHHHCCCCCC-CCCcHHHHHHHHHcCC----------
Confidence            644 344556789999999999864  69999999999999999999999984 4444444433332210          


Q ss_pred             CCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccc
Q 015374          349 RKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQ  397 (408)
Q Consensus       349 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~  397 (408)
                             .+...+..+++++.+||.+||+.||++|||++|+|+||||++
T Consensus       247 -------~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~Hp~~~~  288 (290)
T 3fpq_A          247 -------KPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE  288 (290)
T ss_dssp             -------CCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred             -------CCCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccC
Confidence                   011223347889999999999999999999999999999985

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=2e-61  Score=458.89  Aligned_cols=250  Identities=19%  Similarity=0.401  Sum_probs=210.4

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc-----chHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCcc
Q 015374          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP  197 (408)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~  197 (408)
                      .-++|+++++||+|+||+||+|++..+|+.||||+++..     ..+.+.+|+.++++| +|||||+++++|.+  ...+
T Consensus        22 sme~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l-~HpnIV~~~~~~~~--~~~~   98 (350)
T 4b9d_A           22 SMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANM-KHPNIVQYRESFEE--NGSL   98 (350)
T ss_dssp             CCCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEEE--TTEE
T ss_pred             cccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHC-CCCCCCcEEEEEEE--CCEE
Confidence            357999999999999999999999999999999998632     346789999999999 99999999999965  4678


Q ss_pred             EEEEEeecCCChhhhcC-----CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccC
Q 015374          198 SLIFEYVNSTDFKVLYP-----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP  272 (408)
Q Consensus       198 ~lv~e~~~~~~l~~~~~-----~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~  272 (408)
                      +||||||++|+|..++.     .+++.+++.++.||+.||+|||++|||||||||+|||++.+ +.+||+|||+|+....
T Consensus        99 yiVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~-g~vKl~DFGla~~~~~  177 (350)
T 4b9d_A           99 YIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKD-GTVQLGDFGIARVLNS  177 (350)
T ss_dssp             EEEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTT-CCEEECSTTEESCCCH
T ss_pred             EEEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCC-CCEEEcccccceeecC
Confidence            99999999999998872     36889999999999999999999999999999999999988 8999999999987653


Q ss_pred             CC-cceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCCC
Q 015374          273 GK-EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKP  351 (408)
Q Consensus       273 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  351 (408)
                      .. .....+||+.|||||++.+ ..|+.++|||||||++|||++|+.|| .+.+..+.+..+....              
T Consensus       178 ~~~~~~~~~GT~~YmAPE~l~~-~~y~~~~DiwSlGvilyemltG~~PF-~~~~~~~~~~~i~~~~--------------  241 (350)
T 4b9d_A          178 TVELARACIGTPYYLSPEICEN-KPYNNKSDIWALGCVLYELCTLKHAF-EAGSMKNLVLKIISGS--------------  241 (350)
T ss_dssp             HHHHHHHHHSCCTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCSC-CCSSHHHHHHHHHHTC--------------
T ss_pred             CcccccccCCCccccCHHHHCC-CCCCcHHHHHHHHHHHHHHHHCCCCC-CCcCHHHHHHHHHcCC--------------
Confidence            32 2345689999999999988 78999999999999999999999998 4555555555554421              


Q ss_pred             ccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccc
Q 015374          352 WSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQ  397 (408)
Q Consensus       352 ~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~  397 (408)
                           ....+..+++++.+||.+||+.||++|||++|+|+||||+.
T Consensus       242 -----~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~  282 (350)
T 4b9d_A          242 -----FPPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGFIAK  282 (350)
T ss_dssp             -----CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHT
T ss_pred             -----CCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCHHhhc
Confidence                 01123447999999999999999999999999999999975

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=5.1e-61  Score=442.77  Aligned_cols=247  Identities=23%  Similarity=0.499  Sum_probs=196.8

Q ss_pred             CCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc------chHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccE
Q 015374          125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS  198 (408)
Q Consensus       125 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  198 (408)
                      ++|++.+.||+|+||+||+|++..+++.||||+++..      ....+.+|+.+++++ +||||+++++++.+  ...++
T Consensus        13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~~~~~~~~--~~~~~   89 (275)
T 3hyh_A           13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLL-RHPHIIKLYDVIKS--KDEII   89 (275)
T ss_dssp             -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHC-CCTTBCCEEEEEEC--SSEEE
T ss_pred             eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHC-CCCCCCeEEEEEEE--CCEEE
Confidence            6899999999999999999999999999999998632      245789999999999 99999999999965  46789


Q ss_pred             EEEEeecCCChhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCCCc
Q 015374          199 LIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE  275 (408)
Q Consensus       199 lv~e~~~~~~l~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~~~  275 (408)
                      +||||++ |+|..++   ..+++.+++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+|+.......
T Consensus        90 ivmEy~~-g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~-~~vkl~DFGla~~~~~~~~  167 (275)
T 3hyh_A           90 MVIEYAG-NELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEH-LNVKIADFGLSNIMTDGNF  167 (275)
T ss_dssp             EEEECCC-EEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTT-CCEEECCSSCC--------
T ss_pred             EEEeCCC-CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCC-CCEEEeecCCCeecCCCCc
Confidence            9999995 5666655   469999999999999999999999999999999999999988 8999999999988766666


Q ss_pred             ceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCCCcccc
Q 015374          276 YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSKF  355 (408)
Q Consensus       276 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  355 (408)
                      ....+||+.|||||++.+...++.++||||+||++|+|++|+.||. +.+..+.+..+...                   
T Consensus       168 ~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~-~~~~~~~~~~i~~~-------------------  227 (275)
T 3hyh_A          168 LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFD-DESIPVLFKNISNG-------------------  227 (275)
T ss_dssp             -------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSC-CSSHHHHHHHHHHT-------------------
T ss_pred             cCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCC-CCCHHHHHHHHHcC-------------------
Confidence            6678999999999999884445689999999999999999999983 44433444433321                   


Q ss_pred             ccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccc
Q 015374          356 INADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQ  397 (408)
Q Consensus       356 ~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~  397 (408)
                       ....+..+|+++++||.+||+.||++|||++|+|+||||+.
T Consensus       228 -~~~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hpw~k~  268 (275)
T 3hyh_A          228 -VYTLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQDDWFKV  268 (275)
T ss_dssp             -CCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHCHHHHT
T ss_pred             -CCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHcCccccc
Confidence             11123457999999999999999999999999999999973

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=9.1e-61  Score=447.00  Aligned_cols=255  Identities=27%  Similarity=0.474  Sum_probs=212.0

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEc---CCCcEEEEEEeccc-----chHHHHHHHHHHHHhcCCCCceEEeeEEEccCC
Q 015374          123 DQDDYEVVRKVGRGKYSEVFEGINV---NTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHS  194 (408)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~Vy~~~~~---~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~  194 (408)
                      +.++|++++.||+|+||+||+|++.   .+++.||||+++..     ....+.+|+.+++++ +|||||+++++|.+  .
T Consensus        22 ~p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~--~   98 (304)
T 3ubd_A           22 DPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEV-NHPFIVKLHYAFQT--E   98 (304)
T ss_dssp             CGGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCC-CCTTEECEEEEEEE--T
T ss_pred             CccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHC-CCCCCCeEEEEEEE--C
Confidence            3478999999999999999999874   46789999998642     235688999999999 99999999999966  4


Q ss_pred             CccEEEEEeecCCChhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceecc
Q 015374          195 KTPSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH  271 (408)
Q Consensus       195 ~~~~lv~e~~~~~~l~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~  271 (408)
                      ..+++|||||++|+|..++   ..+++.+++.++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+|+...
T Consensus        99 ~~~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~-g~vKl~DFGla~~~~  177 (304)
T 3ubd_A           99 GKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEE-GHIKLTDFGLSKESI  177 (304)
T ss_dssp             TEEEEEECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTT-SCEEEESSEEEEC--
T ss_pred             CEEEEEEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCC-CCEEecccccceecc
Confidence            6789999999999998887   469999999999999999999999999999999999999998 899999999998654


Q ss_pred             CC-CcceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCC
Q 015374          272 PG-KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRK  350 (408)
Q Consensus       272 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  350 (408)
                      .. ......+||+.|||||++.+ ..|+.++|||||||++|||++|+.|| .+.+..+.+..+...              
T Consensus       178 ~~~~~~~~~~GT~~YmAPE~~~~-~~y~~~~DiwSlGvilyemltG~~PF-~~~~~~~~~~~i~~~--------------  241 (304)
T 3ubd_A          178 DHEKKAYSFCGTVEYMAPEVVNR-RGHTQSADWWSFGVLMFEMLTGTLPF-QGKDRKETMTMILKA--------------  241 (304)
T ss_dssp             ---CCCCSCCCCGGGCCHHHHHT-SCCCTHHHHHHHHHHHHHHHHSSCSS-CCSSHHHHHHHHHHC--------------
T ss_pred             CCCccccccccCcccCCHHHhcc-CCCCCCCcccchHHHHHHHHhCCCCC-CCcCHHHHHHHHHcC--------------
Confidence            33 33456789999999999987 78999999999999999999999998 455555555555432              


Q ss_pred             CccccccccCCCCCCHHHHHHHHHhcccCcCCCCC-----HHHHhcCCCccccccchh
Q 015374          351 PWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLT-----AREAMAHPYFAQVRAAES  403 (408)
Q Consensus       351 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt-----~~elL~hp~f~~~~~~~~  403 (408)
                            ....+..+|+++.+||.+||+.||++|||     ++|+++||||+.+++...
T Consensus       242 ------~~~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~idw~~l  293 (304)
T 3ubd_A          242 ------KLGMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTIDWNKL  293 (304)
T ss_dssp             ------CCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTSGGGTTCCHHHH
T ss_pred             ------CCCCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcCccccCCCHHHH
Confidence                  11223458999999999999999999998     589999999999987553

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=6.6e-60  Score=453.89  Aligned_cols=274  Identities=28%  Similarity=0.469  Sum_probs=226.0

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEc---CCCcEEEEEEeccc-chHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccEE
Q 015374          124 QDDYEVVRKVGRGKYSEVFEGINV---NTNERCIIKILKPV-KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSL  199 (408)
Q Consensus       124 ~~~y~~~~~lG~G~fg~Vy~~~~~---~~~~~vavK~~~~~-~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l  199 (408)
                      .++|++.++||+|+||+||+|++.   .+++.||+|.+.+. ...++.+|+++++.+.+||||++++++|.+  ..++++
T Consensus        20 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~--~~~~~l   97 (361)
T 4f9c_A           20 SNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSHPIRIAAELQCLTVAGGQDNVMGVKYCFRK--NDHVVI   97 (361)
T ss_dssp             GGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSCHHHHHHHHHHHHHTCSBTTBCCCSEEEEE--TTEEEE
T ss_pred             cCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccCHHHHHHHHHHHHHhcCCCCCceEEEEEEE--CCEEEE
Confidence            578999999999999999999864   46789999988643 456788999999998789999999999965  468899


Q ss_pred             EEEeecCCChhhhcCCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCCC-----
Q 015374          200 IFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK-----  274 (408)
Q Consensus       200 v~e~~~~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~~-----  274 (408)
                      ||||+++++|..+++.+++.+++.++.|++.||+|||++|||||||||+|||++.+.+.+||+|||+|+......     
T Consensus        98 vmE~~~g~~L~~~~~~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~~~~~~~  177 (361)
T 4f9c_A           98 AMPYLEHESFLDILNSLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKIELLK  177 (361)
T ss_dssp             EEECCCCCCHHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECTTCSCGGGG
T ss_pred             EEeCCCcccHHHHHcCCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCccccccc
Confidence            999999999999999999999999999999999999999999999999999999877899999999997654321     


Q ss_pred             ------------------------cceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHH
Q 015374          275 ------------------------EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQL  330 (408)
Q Consensus       275 ------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~  330 (408)
                                              .....+||+.|+|||++.+...|+.++||||+||++|||++|+.||+.+.++.+++
T Consensus       178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~~~~~~~l  257 (361)
T 4f9c_A          178 FVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKASDDLTAL  257 (361)
T ss_dssp             GC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHH
T ss_pred             cccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCCCCHHHHH
Confidence                                    12345799999999999886679999999999999999999999999999999999


Q ss_pred             HHHHhhhchhhhhcC------------CCCCC----------------------CccccccccCCCCCCHHHHHHHHHhc
Q 015374          331 VKIAKDCCLIIWCNS------------RHSRK----------------------PWSKFINADNQHLVSPEAIDFLDKLL  376 (408)
Q Consensus       331 ~~~~~~~~~~~~~~~------------~~~~~----------------------~~~~~~~~~~~~~~~~~~~~li~~~L  376 (408)
                      ..+....|.......            .....                      ..........+..++++++|||++||
T Consensus       258 ~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~a~DLl~~lL  337 (361)
T 4f9c_A          258 AQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEAYDLLDKLL  337 (361)
T ss_dssp             HHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCHHHHHHHHHHT
T ss_pred             HHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHHHHHHHHHHC
Confidence            988887664321100            00000                      00001122334568999999999999


Q ss_pred             ccCcCCCCCHHHHhcCCCccccc
Q 015374          377 RYDHQDRLTAREAMAHPYFAQVR  399 (408)
Q Consensus       377 ~~dp~~Rpt~~elL~hp~f~~~~  399 (408)
                      ++||++|+|++|+|+||||+++.
T Consensus       338 ~~dP~~R~ta~eaL~Hp~f~~i~  360 (361)
T 4f9c_A          338 DLNPASRITAEEALLHPFFKDMS  360 (361)
T ss_dssp             CSCTTTSCCHHHHHTSGGGTTC-
T ss_pred             cCChhHCcCHHHHhcCcccCCCC
Confidence            99999999999999999999874

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=8e-59  Score=451.14  Aligned_cols=270  Identities=29%  Similarity=0.556  Sum_probs=224.1

Q ss_pred             CCCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc-----chHHHHHHHHHHHHhcCCCCceEEeeEEEcc----
Q 015374          122 GDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQ----  192 (408)
Q Consensus       122 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~----  192 (408)
                      ...++|++++.||+|+||+||+|++..+|+.||||+++..     ..+.+.+|+.+|+++ +|||||++++++...    
T Consensus        51 ~i~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~  129 (398)
T 4b99_A           51 DVGDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHF-KHDNIIAIKDILRPTVPYG  129 (398)
T ss_dssp             CCCSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHC-CCTTBCCEEEECCCSSCTT
T ss_pred             CCCCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhc-CCCCcceEeeeeecccccc
Confidence            3467899999999999999999999999999999999642     235688999999999 999999999998643    


Q ss_pred             CCCccEEEEEeecCCChhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEeccccee
Q 015374          193 HSKTPSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEF  269 (408)
Q Consensus       193 ~~~~~~lv~e~~~~~~l~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~  269 (408)
                      ....+|||||||++ +|..++   ..+++..++.++.||+.||+|||++|||||||||+|||++.+ +.+||+|||+|+.
T Consensus       130 ~~~~~~ivmE~~~g-~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~-~~~Ki~DFGla~~  207 (398)
T 4b99_A          130 EFKSVYVVLDLMES-DLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNEN-CELKIGDFGMARG  207 (398)
T ss_dssp             TCCCEEEEEECCSE-EHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTT-CCEEECCCTTCBC
T ss_pred             cCCEEEEEEeCCCC-CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCC-CCEEEeecceeee
Confidence            33678999999975 566665   459999999999999999999999999999999999999988 8999999999986


Q ss_pred             ccCC-----CcceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhc
Q 015374          270 YHPG-----KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCN  344 (408)
Q Consensus       270 ~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  344 (408)
                      +...     ......+||+.|+|||++.+...++.++||||+||++|||++|+.|| .+.+..+++..+....|.+....
T Consensus       208 ~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF-~g~~~~~~l~~I~~~~g~p~~~~  286 (398)
T 4b99_A          208 LCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLF-PGKNYVHQLQLIMMVLGTPSPAV  286 (398)
T ss_dssp             C-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSS-CCSSHHHHHHHHHHHHCCCCGGG
T ss_pred             cccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCC-CCCCHHHHHHHHHHhcCCCChHH
Confidence            5432     22345789999999999988667899999999999999999999987 67888888988888776544322


Q ss_pred             CCC----------------CCCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccccc
Q 015374          345 SRH----------------SRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRA  400 (408)
Q Consensus       345 ~~~----------------~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~~~~  400 (408)
                      ...                ....|..     ....++++++|||.+||++||++|||++|+|+||||+....
T Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~  353 (398)
T 4b99_A          287 IQAVGAERVRAYIQSLPPRQPVPWET-----VYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYHD  353 (398)
T ss_dssp             TC-----CHHHHHHSSCCCCCCCHHH-----HSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTTCC
T ss_pred             hhhhhhhhhhhhhhcCCCcCCCCHHH-----hCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcCCC
Confidence            211                0111111     12347899999999999999999999999999999997654

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=2.9e-59  Score=442.03  Aligned_cols=256  Identities=23%  Similarity=0.338  Sum_probs=213.3

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecccchHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccEEEEEe
Q 015374          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEY  203 (408)
Q Consensus       124 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~  203 (408)
                      .+.|++.++||+|+||+||+|++..+|+.||||+++...  ...+|+.+++++ +|||||+++++|.+  ...++|||||
T Consensus        57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~--~~~~E~~il~~l-~HpnIV~l~~~~~~--~~~~~ivmEy  131 (336)
T 4g3f_A           57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEV--FRVEELVACAGL-SSPRIVPLYGAVRE--GPWVNIFMEL  131 (336)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT--CCTHHHHTTTTC-CCTTBCCEEEEEEE--TTEEEEEECC
T ss_pred             hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHH--hHHHHHHHHHhC-CCCCCCcEEEEEEE--CCEEEEEEec
Confidence            467999999999999999999999999999999997432  235799999999 99999999999965  4678999999


Q ss_pred             ecCCChhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCCCc-----
Q 015374          204 VNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE-----  275 (408)
Q Consensus       204 ~~~~~l~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~~~-----  275 (408)
                      |++|+|..++   ..+++..++.++.||+.||+|||++|||||||||+|||++.+...+||+|||+|+.......     
T Consensus       132 ~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~~~~  211 (336)
T 4g3f_A          132 LEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLL  211 (336)
T ss_dssp             CTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC----------
T ss_pred             cCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCccccee
Confidence            9999999987   46999999999999999999999999999999999999998844699999999987754322     


Q ss_pred             -ceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCCCccc
Q 015374          276 -YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSK  354 (408)
Q Consensus       276 -~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  354 (408)
                       ....+||+.|||||++.+ ..|+.++|||||||++|||++|+.||. +.+..+.+..+.....            +   
T Consensus       212 ~~~~~~GT~~YmAPE~~~~-~~y~~~~DiwSlGvilyemltG~~Pf~-~~~~~~~~~~i~~~~~------------~---  274 (336)
T 4g3f_A          212 TGDYIPGTETHMAPEVVMG-KPCDAKVDIWSSCCMMLHMLNGCHPWT-QYFRGPLCLKIASEPP------------P---  274 (336)
T ss_dssp             --CCCCCCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSST-TTCCSCCHHHHHHSCC------------G---
T ss_pred             cCCccccCccccCHHHHCC-CCCCcHHHHHHHHHHHHHHHHCcCCCC-CCCHHHHHHHHHcCCC------------C---
Confidence             123579999999999988 789999999999999999999999984 4444444444433210            0   


Q ss_pred             cccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHH-------------hcCCCccccccchh
Q 015374          355 FINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREA-------------MAHPYFAQVRAAES  403 (408)
Q Consensus       355 ~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~el-------------L~hp~f~~~~~~~~  403 (408)
                        ....+..+++++.+||.+||+.||++|||+.|+             |+|||++...+...
T Consensus       275 --~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~~~~Pr~  334 (336)
T 4g3f_A          275 --IREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGEYKEPRG  334 (336)
T ss_dssp             --GGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSSCCCCCC
T ss_pred             --chhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCCCCCCCC
Confidence              112345589999999999999999999999997             68999988765543

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=2.7e-58  Score=431.50  Aligned_cols=252  Identities=20%  Similarity=0.363  Sum_probs=193.4

Q ss_pred             CCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc----chHHHHHHHHHHHHhcCCCCceEEeeEEEccCC------
Q 015374          125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHS------  194 (408)
Q Consensus       125 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~------  194 (408)
                      ++|++++.||+|+||+||+|++..+++.||||+++..    ..+.+.+|+.+++++ +|||||+++++|.+.+.      
T Consensus         5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l-~HpnIV~~~~~~~~~~~~~~~~~   83 (299)
T 4g31_A            5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKL-EHPGIVRYFNAWLEKNTTEKLQP   83 (299)
T ss_dssp             HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEEEEC-------
T ss_pred             hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEEecCccccccc
Confidence            4699999999999999999999999999999998632    235688999999999 99999999999975432      


Q ss_pred             ----CccEEEEEeecCCChhhhcCC------CChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEec
Q 015374          195 ----KTPSLIFEYVNSTDFKVLYPT------LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDW  264 (408)
Q Consensus       195 ----~~~~lv~e~~~~~~l~~~~~~------l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~Df  264 (408)
                          ..+++|||||++|+|..++..      ..+..++.++.||+.||+|||++|||||||||+|||++.+ +.+||+||
T Consensus        84 ~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~-~~vKl~DF  162 (299)
T 4g31_A           84 SSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMD-DVVKVGDF  162 (299)
T ss_dssp             ---CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT-CCEEECCC
T ss_pred             cCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCC-CcEEEccC
Confidence                246899999999999998742      3445678899999999999999999999999999999988 79999999


Q ss_pred             ccceeccCCCc-------------ceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHH
Q 015374          265 GLAEFYHPGKE-------------YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV  331 (408)
Q Consensus       265 G~a~~~~~~~~-------------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~  331 (408)
                      |+|+.......             ....+||+.|||||++.+ ..|+.++|||||||++|||++   ||..   ..+...
T Consensus       163 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~-~~y~~~~DiwSlGvilyell~---Pf~~---~~~~~~  235 (299)
T 4g31_A          163 GLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHG-NSYSHKVDIFSLGLILFELLY---PFST---QMERVR  235 (299)
T ss_dssp             CCC--------------------------CCCTTSCHHHHTT-CCCCTHHHHHHHHHHHHHHHS---CCSS---HHHHHH
T ss_pred             ccceecCCCccccccccccccccccCCcccCccccCHHHHcC-CCCCCHHHHHHHHHHHHHHcc---CCCC---ccHHHH
Confidence            99987654321             233579999999999987 789999999999999999996   7632   122222


Q ss_pred             HHHhhhchhhhhcCCCCCCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccccccc
Q 015374          332 KIAKDCCLIIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAA  401 (408)
Q Consensus       332 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~~~~~  401 (408)
                      .+.....      .     .++     ......++++.+||.+||+.||++|||+.|+|+||||++++..
T Consensus       236 ~~~~~~~------~-----~~p-----~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~~~~p  289 (299)
T 4g31_A          236 TLTDVRN------L-----KFP-----PLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFP  289 (299)
T ss_dssp             HHHHHHT------T-----CCC-----HHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCCC---
T ss_pred             HHHHHhc------C-----CCC-----CCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCCCCCC
Confidence            2211100      0     000     0111235778999999999999999999999999999998763

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=8.4e-58  Score=427.58  Aligned_cols=252  Identities=19%  Similarity=0.337  Sum_probs=208.7

Q ss_pred             CCCCCEEEEeeeeeeCceEEEEEEEc-----CCCcEEEEEEeccc---chHHHHHHHHHHHHhcCCCCceEEeeEEEccC
Q 015374          122 GDQDDYEVVRKVGRGKYSEVFEGINV-----NTNERCIIKILKPV---KKKKIKREIKILQNLCGGPNVVKLLDIVRDQH  193 (408)
Q Consensus       122 ~~~~~y~~~~~lG~G~fg~Vy~~~~~-----~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~  193 (408)
                      ...++|.+.++||+|+||+||+|++.     .++..||||+++..   ..++|.+|+.+++++ +|||||+++|+|.+  
T Consensus        10 I~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l-~HpnIV~l~g~~~~--   86 (299)
T 4asz_A           10 IKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNL-QHEHIVKFYGVCVE--   86 (299)
T ss_dssp             CCGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEECS--
T ss_pred             cCHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhC-CCCCCccEEEEEee--
Confidence            34678999999999999999999865     35788999999753   346799999999999 99999999999955  


Q ss_pred             CCccEEEEEeecCCChhhhcC----------------CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCC
Q 015374          194 SKTPSLIFEYVNSTDFKVLYP----------------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELR  257 (408)
Q Consensus       194 ~~~~~lv~e~~~~~~l~~~~~----------------~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~  257 (408)
                      +...+||||||++|+|..++.                .+++.++..++.||+.||+|||+++||||||||+|||++.+ +
T Consensus        87 ~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~-~  165 (299)
T 4asz_A           87 GDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGEN-L  165 (299)
T ss_dssp             SSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGG-G
T ss_pred             CCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCC-C
Confidence            467899999999999998872                48999999999999999999999999999999999999998 7


Q ss_pred             cEEEEecccceeccCCCcc---eeeccCccccccccccCCcCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHH
Q 015374          258 KLRLIDWGLAEFYHPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKI  333 (408)
Q Consensus       258 ~~kl~DfG~a~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-g~~pf~~~~~~~~~~~~~  333 (408)
                      .+||+|||+|+........   ....||+.|||||++.+ ..|+.++|||||||++|||+| |+.|| .+.++.+.+..+
T Consensus       166 ~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~-~~~~~k~DVwS~Gvvl~Ellt~G~~Pf-~~~~~~~~~~~i  243 (299)
T 4asz_A          166 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMY-RKFTTESDVWSLGVVLWEIFTYGKQPW-YQLSNNEVIECI  243 (299)
T ss_dssp             CEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCTT-TTSCHHHHHHHH
T ss_pred             cEEECCcccceecCCCCceeecCceecChhhcCHHHHcC-CCCCchhhHHHHHHHHHHHHcCCCCCC-CCCCHHHHHHHH
Confidence            9999999999866543322   23468999999999987 789999999999999999998 88887 444545554444


Q ss_pred             HhhhchhhhhcCCCCCCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccccc
Q 015374          334 AKDCCLIIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRA  400 (408)
Q Consensus       334 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~~~~  400 (408)
                      ....                   ....+..+++++.+|+.+||+.||++|||++|+  ++||+++..
T Consensus       244 ~~~~-------------------~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i--~~~L~~~~~  289 (299)
T 4asz_A          244 TQGR-------------------VLQRPRTCPQEVYELMLGCWQREPHMRKNIKGI--HTLLQNLAK  289 (299)
T ss_dssp             HHTC-------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH--HHHHHHHHH
T ss_pred             HcCC-------------------CCCCCccchHHHHHHHHHHcCCChhHCcCHHHH--HHHHHHHHh
Confidence            3320                   112344589999999999999999999999999  567776643

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=1.5e-56  Score=420.87  Aligned_cols=246  Identities=18%  Similarity=0.298  Sum_probs=205.3

Q ss_pred             CCCCCEEEEeeeeeeCceEEEEEEEc-----CCCcEEEEEEeccc----chHHHHHHHHHHHHhcCCCCceEEeeEEEcc
Q 015374          122 GDQDDYEVVRKVGRGKYSEVFEGINV-----NTNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQ  192 (408)
Q Consensus       122 ~~~~~y~~~~~lG~G~fg~Vy~~~~~-----~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~  192 (408)
                      ...+++++.++||+|+||+||+|+..     .+++.||||+++..    ..+.|.+|+.+++++ +|||||+++|+|.+ 
T Consensus        23 i~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l-~HpNIV~l~g~~~~-  100 (308)
T 4gt4_A           23 ISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARL-QHPNVVCLLGVVTK-  100 (308)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHC-CCTTBCCEEEEECS-
T ss_pred             CCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhC-CCCCCCCcceEEEE-
Confidence            34567899999999999999999853     46789999999643    346899999999999 99999999999954 


Q ss_pred             CCCccEEEEEeecCCChhhhcC-------------------CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEe
Q 015374          193 HSKTPSLIFEYVNSTDFKVLYP-------------------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMID  253 (408)
Q Consensus       193 ~~~~~~lv~e~~~~~~l~~~~~-------------------~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~  253 (408)
                       ...++||||||++|+|..++.                   .+++.++..++.||+.||+|||+++||||||||+|||++
T Consensus       101 -~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~  179 (308)
T 4gt4_A          101 -DQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVY  179 (308)
T ss_dssp             -SSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC
T ss_pred             -CCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEEC
Confidence             467899999999999998872                   388999999999999999999999999999999999999


Q ss_pred             CCCCcEEEEecccceeccCCC---cceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHH
Q 015374          254 HELRKLRLIDWGLAEFYHPGK---EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQ  329 (408)
Q Consensus       254 ~~~~~~kl~DfG~a~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-g~~pf~~~~~~~~~  329 (408)
                      .+ +.+||+|||+|+......   ......||+.|||||++.+ ..|+.++|||||||++|||+| |..|| .+.++.+.
T Consensus       180 ~~-~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~-~~~s~ksDVwSfGvvl~El~t~g~~Pf-~~~~~~~~  256 (308)
T 4gt4_A          180 DK-LNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMY-GKFSIDSDIWSYGVVLWEVFSYGLQPY-CGYSNQDV  256 (308)
T ss_dssp             GG-GCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCTT-TTCCHHHH
T ss_pred             CC-CCEEECCcccceeccCCCceeEecccccCCcccCHHHHhC-CCCCccchhhhHHHHHHHHHhCCCCCC-CCCCHHHH
Confidence            98 799999999998664332   2334578999999999987 789999999999999999998 78887 55555554


Q ss_pred             HHHHHhhhchhhhhcCCCCCCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 015374          330 LVKIAKDCCLIIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH  392 (408)
Q Consensus       330 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~h  392 (408)
                      ...+...                   .....+..+++++.+++.+||+.||++|||++|++++
T Consensus       257 ~~~i~~~-------------------~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~  300 (308)
T 4gt4_A          257 VEMIRNR-------------------QVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSR  300 (308)
T ss_dssp             HHHHHTT-------------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHcC-------------------CCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            4443321                   0112344589999999999999999999999999875

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=2.5e-56  Score=423.17  Aligned_cols=245  Identities=17%  Similarity=0.321  Sum_probs=199.4

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEc-----CCCcEEEEEEecccc---hHHHHHHHHHHHHhcCCCCceEEeeEEEccCC
Q 015374          123 DQDDYEVVRKVGRGKYSEVFEGINV-----NTNERCIIKILKPVK---KKKIKREIKILQNLCGGPNVVKLLDIVRDQHS  194 (408)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~Vy~~~~~-----~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~  194 (408)
                      ..++|.+.++||+|+||+||+|++.     .++..||||+++...   .+.|.+|+.+|+++ +|||||+++|+|.+  .
T Consensus        39 ~~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l-~HpnIV~l~g~~~~--~  115 (329)
T 4aoj_A           39 KRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTML-QHQHIVRFFGVCTE--G  115 (329)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTC-CCTTBCCEEEEECS--S
T ss_pred             CHHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhC-CCCCCCcEEEEEEE--C
Confidence            4578999999999999999999865     367899999997433   46799999999999 99999999999954  5


Q ss_pred             CccEEEEEeecCCChhhhcC------------------CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCC
Q 015374          195 KTPSLIFEYVNSTDFKVLYP------------------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEL  256 (408)
Q Consensus       195 ~~~~lv~e~~~~~~l~~~~~------------------~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~  256 (408)
                      ..++||||||++|+|..++.                  .+++.++..++.|++.||+|||+++||||||||+|||++.+ 
T Consensus       116 ~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~~~-  194 (329)
T 4aoj_A          116 RPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQG-  194 (329)
T ss_dssp             SSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETT-
T ss_pred             CEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEECCC-
Confidence            67899999999999998862                  38899999999999999999999999999999999999998 


Q ss_pred             CcEEEEecccceeccCCCc---ceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHH
Q 015374          257 RKLRLIDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVK  332 (408)
Q Consensus       257 ~~~kl~DfG~a~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-g~~pf~~~~~~~~~~~~  332 (408)
                      +.+||+|||+|+.......   .....||+.|||||++.+ ..++.++|||||||++|||+| |+.|| .+.++.+.+..
T Consensus       195 ~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~-~~~~~~sDvwS~Gvvl~Ellt~G~~Pf-~~~~~~~~~~~  272 (329)
T 4aoj_A          195 LVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILY-RKFTTESDVWSFGVVLWEIFTYGKQPW-YQLSNTEAIDC  272 (329)
T ss_dssp             TEEEECCCC----------------CCCCGGGCCHHHHTT-CCCCHHHHHHHHHHHHHHHHTTSCCTT-CSSCHHHHHHH
T ss_pred             CcEEEcccccceeccCCCcceecCcccccccccChhhhcC-CCCCccccccchHHHHHHHHcCCCCCC-CCCCHHHHHHH
Confidence            7999999999987644332   234578999999999987 789999999999999999999 88887 44444555444


Q ss_pred             HHhhhchhhhhcCCCCCCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 015374          333 IAKDCCLIIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH  392 (408)
Q Consensus       333 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~h  392 (408)
                      +...                   .....+..+++++.+|+.+||+.||++|||++|++++
T Consensus       273 i~~g-------------------~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~  313 (329)
T 4aoj_A          273 ITQG-------------------RELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHAR  313 (329)
T ss_dssp             HHHT-------------------CCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHH
T ss_pred             HHcC-------------------CCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence            4332                   1122344589999999999999999999999999864

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=2.4e-55  Score=418.23  Aligned_cols=309  Identities=76%  Similarity=1.249  Sum_probs=270.3

Q ss_pred             CCccCcccccccccCCcccCCCCCcccccCCCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecccchHHHHHHHHH
Q 015374           93 AMSKARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKI  172 (408)
Q Consensus        93 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~E~~~  172 (408)
                      ..+.++...+.+...+.+++++......+...++|++.++||+|+||+||+|++..+++.||+|+++....+.+.+|+.+
T Consensus         4 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~   83 (330)
T 3nsz_A            4 VPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKI   83 (330)
T ss_dssp             CCCCCSSSTTTTTTSCHHHHCGGGCCCCCEEGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCCHHHHHHHHHH
T ss_pred             CCCceeEeccccccCchhHHHhhhhhhcccCCCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccchHHHHHHHHH
Confidence            34566777888888888899988888888889999999999999999999999999999999999998888999999999


Q ss_pred             HHHhcCCCCceEEeeEEEccCCCccEEEEEeecCCChhhhcCCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEE
Q 015374          173 LQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMI  252 (408)
Q Consensus       173 l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl  252 (408)
                      ++++.+||||+++++++.+......++||||+++++|..++..+++..+..++.|++.||.|||++||+||||||+|||+
T Consensus        84 l~~l~~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~  163 (330)
T 3nsz_A           84 LENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMI  163 (330)
T ss_dssp             HHHHTTSTTBCCEEEEEECTTTCCEEEEEECCCCCCHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE
T ss_pred             HHHcCCCCCEEEeeeeeccCCCCceEEEEeccCchhHHHHHHhCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEE
Confidence            99995599999999999876677889999999999999999999999999999999999999999999999999999999


Q ss_pred             eCCCCcEEEEecccceeccCCCcceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHH
Q 015374          253 DHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVK  332 (408)
Q Consensus       253 ~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~  332 (408)
                      +.+...+||+|||+++............++..|+|||++.+...++.++|||||||++|+|++|+.||+.+.++.+.+..
T Consensus       164 ~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~  243 (330)
T 3nsz_A          164 DHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVR  243 (330)
T ss_dssp             ETTTTEEEECCCTTCEECCTTCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHH
T ss_pred             cCCCCEEEEEeCCCceEcCCCCccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHH
Confidence            98745899999999988776666677789999999999987677999999999999999999999999888888888877


Q ss_pred             HHhhhchhhh-----------------hcCCCCCCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCc
Q 015374          333 IAKDCCLIIW-----------------CNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF  395 (408)
Q Consensus       333 ~~~~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f  395 (408)
                      +....+....                 .........|..+.....+..+++++.+||.+||++||++|||++|+|+||||
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f  323 (330)
T 3nsz_A          244 IAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF  323 (330)
T ss_dssp             HHHHHCHHHHHHHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGG
T ss_pred             HHHhcCCchhhhHHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccH
Confidence            7766553321                 11223344555555666666689999999999999999999999999999999


Q ss_pred             cccccc
Q 015374          396 AQVRAA  401 (408)
Q Consensus       396 ~~~~~~  401 (408)
                      +++...
T Consensus       324 ~~~~~~  329 (330)
T 3nsz_A          324 YTVVKD  329 (330)
T ss_dssp             TTCC--
T ss_pred             hhhccC
Confidence            988653

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=5.2e-56  Score=415.78  Aligned_cols=246  Identities=14%  Similarity=0.291  Sum_probs=198.6

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecc-----cchHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCcc
Q 015374          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP-----VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP  197 (408)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~-----~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~  197 (408)
                      ..+++++.++||+|+||+||+|++.   ..||||+++.     ...+.|.+|+.+++++ +|||||+++|+|.+   ..+
T Consensus        34 ~~~~l~l~~~iG~G~fG~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l-~HpNIV~l~g~~~~---~~~  106 (307)
T 3omv_A           34 EASEVMLSTRIGSGSFGTVYKGKWH---GDVAVKILKVVDPTPEQFQAFRNEVAVLRKT-RHVNILLFMGYMTK---DNL  106 (307)
T ss_dssp             CTTSCCEEEECCCCSSSEEEEEESS---SEEEEEECCCSSCCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEECS---SSC
T ss_pred             cHHHeEEeeEEeeCCCcEEEEEEEC---CcEEEEEEEecCCCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEEC---CeE
Confidence            4678899999999999999999753   3599999863     2346789999999999 99999999999843   357


Q ss_pred             EEEEEeecCCChhhhc----CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCC
Q 015374          198 SLIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG  273 (408)
Q Consensus       198 ~lv~e~~~~~~l~~~~----~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~  273 (408)
                      +||||||++|+|..++    ..+++.++..++.||+.||+|||+++||||||||+|||++.+ +.+||+|||+|+.....
T Consensus       107 ~iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~-~~~Ki~DFGla~~~~~~  185 (307)
T 3omv_A          107 AIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEG-LTVKIGDFGLATVKSRW  185 (307)
T ss_dssp             EEEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETT-EEEEECCCSSCBC----
T ss_pred             EEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCC-CcEEEeeccCceecccC
Confidence            8999999999999887    358999999999999999999999999999999999999988 79999999999865432


Q ss_pred             C---cceeeccCccccccccccC--CcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCC
Q 015374          274 K---EYNVRVASRYFKGPELLVD--LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHS  348 (408)
Q Consensus       274 ~---~~~~~~~~~~y~aPE~~~~--~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  348 (408)
                      .   .....+||+.|||||++.+  ...|+.++|||||||++|||+||+.|| .+.++.+.+..++.....         
T Consensus       186 ~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf-~~~~~~~~~~~~~~~~~~---------  255 (307)
T 3omv_A          186 SGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPY-SHINNRDQIIFMVGRGYA---------  255 (307)
T ss_dssp             --------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTT-TTCCCHHHHHHHHHTTCC---------
T ss_pred             CcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCC-CCCChHHHHHHHHhcCCC---------
Confidence            2   2345689999999999964  246899999999999999999999998 455555555544432110         


Q ss_pred             CCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 015374          349 RKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA  391 (408)
Q Consensus       349 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~  391 (408)
                      ..     .....+..+++++.+|+.+||+.||++|||+.|+++
T Consensus       256 ~p-----~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~  293 (307)
T 3omv_A          256 SP-----DLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILS  293 (307)
T ss_dssp             CC-----CSTTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHH
T ss_pred             CC-----CcccccccchHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence            00     011234458899999999999999999999998743

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=5.6e-55  Score=443.67  Aligned_cols=256  Identities=24%  Similarity=0.445  Sum_probs=222.4

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc---chHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccEEE
Q 015374          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV---KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI  200 (408)
Q Consensus       124 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  200 (408)
                      .++|++.+.||+|+||+||+|++..+|+.||+|+++..   ..+.+.+|+.+|+.+ +||||++++++|.+  ...++||
T Consensus       156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~--~~~~~iv  232 (573)
T 3uto_A          156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVL-RHPTLVNLHDAFED--DNEMVMI  232 (573)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHT-CCTTBCCEEEEEEC--SSEEEEE
T ss_pred             ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhC-CCCCCCeEEEEEEE--CCEEEEE
Confidence            36899999999999999999999999999999998643   346788999999999 99999999999965  5788999


Q ss_pred             EEeecCCChhhhcC----CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCC-CCcEEEEecccceeccCCCc
Q 015374          201 FEYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE-LRKLRLIDWGLAEFYHPGKE  275 (408)
Q Consensus       201 ~e~~~~~~l~~~~~----~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~-~~~~kl~DfG~a~~~~~~~~  275 (408)
                      ||||++|+|..++.    .+++.+++.++.||+.||+|||++||+||||||+|||++.+ .+.+||+|||+|+.......
T Consensus       233 ~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~~  312 (573)
T 3uto_A          233 YEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS  312 (573)
T ss_dssp             EECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTSE
T ss_pred             EeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEccCCCc
Confidence            99999999988762    48999999999999999999999999999999999999864 36899999999999887777


Q ss_pred             ceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCCCcccc
Q 015374          276 YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSKF  355 (408)
Q Consensus       276 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  355 (408)
                      ....+||+.|||||++.+ ..|+.++|||||||++|||++|..|| .+.+..+.+..+.....       .         
T Consensus       313 ~~~~~GT~~y~APEv~~~-~~y~~~~DiWSlGvilyeml~G~~Pf-~~~~~~~~~~~i~~~~~-------~---------  374 (573)
T 3uto_A          313 VKVTTGTAEFAAPEVAEG-KPVGYYTDMWSVGVLSYILLSGLSPF-GGENDDETLRNVKSCDW-------N---------  374 (573)
T ss_dssp             EEEECSSGGGCCHHHHTT-CCBCHHHHHHHHHHHHHHHHHSCCSS-CCSSHHHHHHHHHTTCC-------C---------
T ss_pred             eeeeEECccccCHHHhCC-CCCCcHHHHHHHHHHHHHHHHCCCCC-CCcCHHHHHHHHHhCCC-------C---------
Confidence            778899999999999988 78999999999999999999999998 45555566655543211       0         


Q ss_pred             ccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccccc
Q 015374          356 INADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRA  400 (408)
Q Consensus       356 ~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~~~~  400 (408)
                      .....+..+++++++||.+||+.||++|||++|+|+||||+....
T Consensus       375 ~~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~Hpw~~~~~~  419 (573)
T 3uto_A          375 MDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNA  419 (573)
T ss_dssp             CCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTSCCCC
T ss_pred             CCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcCcCCCCC
Confidence            112233458999999999999999999999999999999997654

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=3e-55  Score=419.10  Aligned_cols=249  Identities=20%  Similarity=0.351  Sum_probs=206.7

Q ss_pred             CCCCCEEEEeeeeeeCceEEEEEEEcCC-----CcEEEEEEeccc----chHHHHHHHHHHHHhcCCCCceEEeeEEEcc
Q 015374          122 GDQDDYEVVRKVGRGKYSEVFEGINVNT-----NERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQ  192 (408)
Q Consensus       122 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~-----~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~  192 (408)
                      ...++|++.++||+|+||+||+|++...     ++.||||.++..    ..+.+.+|+.+|.++.+|||||+++|+|.+.
T Consensus        61 i~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~  140 (353)
T 4ase_A           61 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP  140 (353)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCT
T ss_pred             ecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEec
Confidence            3568999999999999999999987654     357999999743    2456899999999995569999999999643


Q ss_pred             CCCccEEEEEeecCCChhhhcC-------------------CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEe
Q 015374          193 HSKTPSLIFEYVNSTDFKVLYP-------------------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMID  253 (408)
Q Consensus       193 ~~~~~~lv~e~~~~~~l~~~~~-------------------~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~  253 (408)
                       +..+++|||||++|+|..++.                   .+++.++..++.||+.||+|||+++||||||||+|||++
T Consensus       141 -~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NILl~  219 (353)
T 4ase_A          141 -GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS  219 (353)
T ss_dssp             -TSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC
T ss_pred             -CCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccceeeC
Confidence             356789999999999998873                   278899999999999999999999999999999999999


Q ss_pred             CCCCcEEEEecccceeccCCCcc---eeeccCccccccccccCCcCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHH
Q 015374          254 HELRKLRLIDWGLAEFYHPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQ  329 (408)
Q Consensus       254 ~~~~~~kl~DfG~a~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-g~~pf~~~~~~~~~  329 (408)
                      .+ +.+||+|||+|+........   ....||+.|||||++.+ ..|+.++|||||||++|||+| |+.||. +.+..+.
T Consensus       220 ~~-~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~-~~y~~ksDVwS~Gv~l~El~t~G~~Pf~-~~~~~~~  296 (353)
T 4ase_A          220 EK-NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYP-GVKIDEE  296 (353)
T ss_dssp             GG-GCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHTTTSCCSST-TCCCSHH
T ss_pred             CC-CCEEECcchhhhhcccCCCceeeccccccccccCHHHHhc-CCCCCcccEeehHHHHHHHHhCCCCCCC-CCCHHHH
Confidence            98 79999999999876544332   33578999999999988 789999999999999999998 888874 4433333


Q ss_pred             HHHHHhhhchhhhhcCCCCCCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 015374          330 LVKIAKDCCLIIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH  392 (408)
Q Consensus       330 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~h  392 (408)
                      +...+...                  .....+..+++++.+++.+||+.||++|||++|+++|
T Consensus       297 ~~~~i~~g------------------~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~  341 (353)
T 4ase_A          297 FCRRLKEG------------------TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  341 (353)
T ss_dssp             HHHHHHHT------------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHcC------------------CCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence            33333321                  1122344588999999999999999999999999998

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=1e-54  Score=440.47  Aligned_cols=257  Identities=25%  Similarity=0.426  Sum_probs=213.8

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecccc------hHHHHHH---HHHHHHhcCCCCceEEeeEEEccC
Q 015374          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK------KKKIKRE---IKILQNLCGGPNVVKLLDIVRDQH  193 (408)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~------~~~~~~E---~~~l~~l~~h~niv~l~~~~~~~~  193 (408)
                      .-++|++++.||+|+||+||+|++..+|+.||||++++..      .....+|   +.+++.+ +|||||+++++|.+  
T Consensus       187 slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~-~HP~IV~l~~~f~~--  263 (689)
T 3v5w_A          187 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG-DCPFIVCMSYAFHT--  263 (689)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSS-CCTTBCCEEEEEEC--
T ss_pred             chHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhC-CCCCEeEEEEEEEE--
Confidence            3578999999999999999999999999999999996422      2334444   4555566 89999999999965  


Q ss_pred             CCccEEEEEeecCCChhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceec
Q 015374          194 SKTPSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY  270 (408)
Q Consensus       194 ~~~~~lv~e~~~~~~l~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~  270 (408)
                      ...+||||||++||+|..++   ..+++..++.|+.||+.||+|||++|||||||||+|||++.+ |.+||+|||+|+..
T Consensus       264 ~~~lylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~-G~vKL~DFGlA~~~  342 (689)
T 3v5w_A          264 PDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEH-GHVRISDLGLACDF  342 (689)
T ss_dssp             SSEEEEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTT-SCEEECCCTTCEEC
T ss_pred             CCEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCC-CCEEecccceeeec
Confidence            46889999999999999887   469999999999999999999999999999999999999998 89999999999877


Q ss_pred             cCCCcceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCC-CHHHHHHHHhhhchhhhhcCCCCC
Q 015374          271 HPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHD-NHDQLVKIAKDCCLIIWCNSRHSR  349 (408)
Q Consensus       271 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~  349 (408)
                      ... ...+.+||+.|||||++.+...|+.++|+|||||++|||++|..||..... +...+......             
T Consensus       343 ~~~-~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~-------------  408 (689)
T 3v5w_A          343 SKK-KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLT-------------  408 (689)
T ss_dssp             SSC-CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHH-------------
T ss_pred             CCC-CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcC-------------
Confidence            543 345579999999999997546799999999999999999999999954322 22222221111             


Q ss_pred             CCccccccccCCCCCCHHHHHHHHHhcccCcCCCCC-----HHHHhcCCCccccccchh
Q 015374          350 KPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLT-----AREAMAHPYFAQVRAAES  403 (408)
Q Consensus       350 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt-----~~elL~hp~f~~~~~~~~  403 (408)
                            .....+..+|+++++||.+||+.||.+|++     ++|+++||||+++++...
T Consensus       409 ------~~~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~idW~~l  461 (689)
T 3v5w_A          409 ------MAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMV  461 (689)
T ss_dssp             ------CCCCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTTCCHHHH
T ss_pred             ------CCCCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCccccCCCHHHH
Confidence                  112234458999999999999999999998     899999999999987653

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=2.6e-52  Score=392.34  Aligned_cols=257  Identities=18%  Similarity=0.209  Sum_probs=194.2

Q ss_pred             CCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecccchHHHHH--HHHHHHHhcCCCCceEEeeEEEccCC--CccEEE
Q 015374          125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKR--EIKILQNLCGGPNVVKLLDIVRDQHS--KTPSLI  200 (408)
Q Consensus       125 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~--E~~~l~~l~~h~niv~l~~~~~~~~~--~~~~lv  200 (408)
                      .+|.+.++||+|+||+||+|++  +|+.||||+++......+.+  |+..+.++ +|||||+++++|.+.+.  ..++||
T Consensus         3 r~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~~~~~~~e~Ei~~~~~l-~HpNIv~l~g~~~~~~~~~~~~~lV   79 (303)
T 3hmm_A            3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVML-RHENILGFIAADNKDNGTWTQLWLV   79 (303)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHTSTTC-CCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccchhhHHHHHHHHHHhcC-CCCCCCcEEEEEEecCCCceEEEEE
Confidence            4689999999999999999986  58899999998766655554  45555677 99999999999976543  357899


Q ss_pred             EEeecCCChhhhc--CCCChHHHHHHHHHHHHHHHHHHHC--------CcEEecCCCCcEEEeCCCCcEEEEecccceec
Q 015374          201 FEYVNSTDFKVLY--PTLTDYDIRYYIYELLKALDYCHSQ--------GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY  270 (408)
Q Consensus       201 ~e~~~~~~l~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~--------~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~  270 (408)
                      ||||++|+|..++  ..+++..+..++.|++.||+|||++        +||||||||+|||++.+ +.+||+|||+|+..
T Consensus        80 ~Ey~~~gsL~~~l~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~-~~~Ki~DFGla~~~  158 (303)
T 3hmm_A           80 SDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKN-GTCCIADLGLAVRH  158 (303)
T ss_dssp             EECCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTT-SCEEECCCTTCEEE
T ss_pred             ecCCCCCcHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCC-CCEEEEeCCCCccc
Confidence            9999999999988  4689999999999999999999987        99999999999999998 79999999999877


Q ss_pred             cCCCcc-----eeeccCccccccccccCC-----cCCCccccHHHHHHHHHHHHhCCCCCCCCC-------------CCH
Q 015374          271 HPGKEY-----NVRVASRYFKGPELLVDL-----QDYDYSLDMWSLGCMFAGMIFRKEPFFYGH-------------DNH  327 (408)
Q Consensus       271 ~~~~~~-----~~~~~~~~y~aPE~~~~~-----~~~~~~~DvwSlGvil~ell~g~~pf~~~~-------------~~~  327 (408)
                      ......     ...+||+.|||||++.+.     ..++.++|||||||++|||+||..||....             ...
T Consensus       159 ~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~  238 (303)
T 3hmm_A          159 DSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSV  238 (303)
T ss_dssp             ETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCH
T ss_pred             cCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccchH
Confidence            644322     235799999999999752     146789999999999999999987652211             122


Q ss_pred             HHHHHHHhhhchhhhhcCCCCCCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccccc
Q 015374          328 DQLVKIAKDCCLIIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVR  399 (408)
Q Consensus       328 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~~~  399 (408)
                      +.+.......+         .+...+.   ......++..+.+++.+||+.||++|||+.|+++.  ++++.
T Consensus       239 ~~~~~~~~~~~---------~rp~~p~---~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~--L~~l~  296 (303)
T 3hmm_A          239 EEMRKVVCEQK---------LRPNIPN---RWQSCEALRVMAKIMRECWYANGAARLTALRIKKT--LSQLS  296 (303)
T ss_dssp             HHHHHHHTTSC---------CCCCCCG---GGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH--HHHHH
T ss_pred             HHHHHHHhccc---------CCCCCCc---cccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHH--HHHHH
Confidence            22222221100         0000000   00011134578999999999999999999999875  44443

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=4e-51  Score=389.09  Aligned_cols=252  Identities=22%  Similarity=0.457  Sum_probs=216.0

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc-----chHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccE
Q 015374          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS  198 (408)
Q Consensus       124 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  198 (408)
                      .++|++.+.||+|+||+||+|++..+++.||||++...     ..+.+.+|+.+++.+ +||||+++++++.+  ....+
T Consensus        14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~--~~~~~   90 (328)
T 3fe3_A           14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKIL-NHPNIVKLFEVIET--EKTLY   90 (328)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEEC--SSEEE
T ss_pred             cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEEE--CCEEE
Confidence            56899999999999999999999999999999998643     245688999999999 99999999999965  46789


Q ss_pred             EEEEeecCCChhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCCCc
Q 015374          199 LIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE  275 (408)
Q Consensus       199 lv~e~~~~~~l~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~~~  275 (408)
                      +||||+++++|..++   ..+++..++.++.|++.||+|||++||+||||||+|||++.+ +.+||+|||++........
T Consensus        91 lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~-~~~kl~DFG~a~~~~~~~~  169 (328)
T 3fe3_A           91 LIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDAD-MNIKIADFGFSNEFTVGGK  169 (328)
T ss_dssp             EEECCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTT-SCEEECSTTCCGGGSSSCG
T ss_pred             EEEECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCC-CCEEEeeccCceecCCCCc
Confidence            999999999998876   569999999999999999999999999999999999999988 7999999999987766666


Q ss_pred             ceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCCCcccc
Q 015374          276 YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSKF  355 (408)
Q Consensus       276 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  355 (408)
                      ....+||+.|+|||++.+....+.++|||||||++|+|++|+.|| .+.+..+....+...                   
T Consensus       170 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf-~~~~~~~~~~~i~~~-------------------  229 (328)
T 3fe3_A          170 LDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPF-DGQNLKELRERVLRG-------------------  229 (328)
T ss_dssp             GGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSS-CCSSHHHHHHHHHHC-------------------
T ss_pred             cccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCC-CCCCHHHHHHHHHhC-------------------
Confidence            667789999999999988443458999999999999999999998 444434443333321                   


Q ss_pred             ccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccccc
Q 015374          356 INADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRA  400 (408)
Q Consensus       356 ~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~~~~  400 (408)
                       ....+..+++++.+|+++||+.||.+|||++|+++||||+....
T Consensus       230 -~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~~~  273 (328)
T 3fe3_A          230 -KYRIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKDRWINAGHE  273 (328)
T ss_dssp             -CCCCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTCTTTTTTCT
T ss_pred             -CCCCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcCHhhcCCCc
Confidence             11123347899999999999999999999999999999986543

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=8.6e-51  Score=380.42  Aligned_cols=271  Identities=30%  Similarity=0.548  Sum_probs=222.5

Q ss_pred             CCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc-----chHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccEE
Q 015374          125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSL  199 (408)
Q Consensus       125 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l  199 (408)
                      ++|++.++||+|+||+||+|++..+++.||+|+++..     ....+.+|+.+++++ +||||+++++++.+  ....++
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~--~~~~~l   78 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKEL-KHKNIVRLHDVLHS--DKKLTL   78 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTC-CCTTBCCEEEEEEE--TTEEEE
T ss_pred             CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcC-CCCCEeeEEeEEEe--CCEEEE
Confidence            5899999999999999999999999999999998632     236788999999999 99999999999965  467899


Q ss_pred             EEEeecCCChhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCC-Cc
Q 015374          200 IFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG-KE  275 (408)
Q Consensus       200 v~e~~~~~~l~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~-~~  275 (408)
                      ||||++++.+..+.   ..+++..++.++.|++.||.|||++||+||||||+|||++.+ +.+||+|||++...... ..
T Consensus        79 v~e~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~-~~~kl~Dfg~~~~~~~~~~~  157 (292)
T 3o0g_A           79 VFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRN-GELKLANFGLARAFGIPVRC  157 (292)
T ss_dssp             EEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT-SCEEECCCTTCEECCSCCSC
T ss_pred             EEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCC-CCEEEeecccceecCCcccc
Confidence            99999987666554   469999999999999999999999999999999999999988 79999999999876533 33


Q ss_pred             ceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCC-----CC
Q 015374          276 YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHS-----RK  350 (408)
Q Consensus       276 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~  350 (408)
                      .....+|..|+|||++.+...++.++|||||||++|+|++|..||+.+.+..+.+..+....+..........     ..
T Consensus       158 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  237 (292)
T 3o0g_A          158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYK  237 (292)
T ss_dssp             CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCC
T ss_pred             ccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhccccccc
Confidence            4456889999999999875568999999999999999999999998888888888887776554322111100     00


Q ss_pred             Cccc----cccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccccc
Q 015374          351 PWSK----FINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVR  399 (408)
Q Consensus       351 ~~~~----~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~~~  399 (408)
                      .+..    .........+++++.+|+.+||+.||++|||++|+|+||||++..
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  290 (292)
T 3o0g_A          238 PYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFC  290 (292)
T ss_dssp             CCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTC-
T ss_pred             ccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCcccccCC
Confidence            0000    001122334789999999999999999999999999999999763

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=1.4e-51  Score=410.11  Aligned_cols=273  Identities=25%  Similarity=0.442  Sum_probs=219.5

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc-----chHHHHHHHHHHHHhcCCCCceEEeeEEEccC----
Q 015374          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQH----  193 (408)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~----  193 (408)
                      ..++|+++++||+|+||+||+|++..+++.||||++...     ..+.+.+|+.+++.+ +||||++++++|....    
T Consensus        60 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~~  138 (464)
T 3ttj_A           60 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCV-NHKNIISLLNVFTPQKTLEE  138 (464)
T ss_dssp             EETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHC-CCTTBCCCSEEECSCCSTTT
T ss_pred             ecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhC-CCCCCCcEEEEEccCCcccc
Confidence            368999999999999999999999999999999998632     346788999999999 9999999999996532    


Q ss_pred             CCccEEEEEeecCCChhhhcCCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCC
Q 015374          194 SKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG  273 (408)
Q Consensus       194 ~~~~~lv~e~~~~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~  273 (408)
                      ....++||||++++.+......+++..++.++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+++.....
T Consensus       139 ~~~~~lv~E~~~~~l~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~-~~~kl~DFG~a~~~~~~  217 (464)
T 3ttj_A          139 FQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSD-CTLKILDFGLARTAGTS  217 (464)
T ss_dssp             CCEEEEEEECCSEEHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT-SCEEECCCCCC-----C
T ss_pred             CCeEEEEEeCCCCCHHHHHhhcCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCC-CCEEEEEEEeeeecCCC
Confidence            24579999999998777777789999999999999999999999999999999999999998 79999999999887766


Q ss_pred             CcceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcC--------
Q 015374          274 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNS--------  345 (408)
Q Consensus       274 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~--------  345 (408)
                      ......+||+.|+|||++.+ ..++.++|||||||++|||++|+.|| .+.+..+++..+...+|.......        
T Consensus       218 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~pF-~g~~~~~~~~~i~~~lg~p~~~~~~~~~~~~~  295 (464)
T 3ttj_A          218 FMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMVRHKILF-PGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVR  295 (464)
T ss_dssp             CCC----CCCTTCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCSS-CCSSHHHHHHHHHHHHCSCCHHHHTTSCHHHH
T ss_pred             cccCCCcccccccCHHHHcC-CCCCHHHHHHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHHhcCCCCHHHHHHcchhhh
Confidence            56667899999999999988 78999999999999999999999987 677788888888887764321111        


Q ss_pred             -------CCCCCCccccccccCC-------CCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccccc
Q 015374          346 -------RHSRKPWSKFINADNQ-------HLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVR  399 (408)
Q Consensus       346 -------~~~~~~~~~~~~~~~~-------~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~~~  399 (408)
                             ......+....+....       ...++++.+||.+||++||++|||++|+|+||||+...
T Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~~~~  363 (464)
T 3ttj_A          296 NYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWY  363 (464)
T ss_dssp             HHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGC
T ss_pred             hHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhhhcc
Confidence                   0111111111111100       01156799999999999999999999999999998643

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=6.1e-51  Score=392.63  Aligned_cols=257  Identities=27%  Similarity=0.465  Sum_probs=219.7

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc---------chHHHHHHHHHHHHhcCCCCceEEeeEEEccC
Q 015374          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV---------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQH  193 (408)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~---------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~  193 (408)
                      ..++|++.+.||+|+||+||+|++..+++.||+|+++..         ..+.+.+|+.+++++ +||||++++++|.+  
T Consensus        10 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~--   86 (361)
T 2yab_A           10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQV-LHPNIITLHDVYEN--   86 (361)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTC-CCTTBCCEEEEEEC--
T ss_pred             hhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhC-CCcCCCcEEEEEEe--
Confidence            367899999999999999999999999999999998642         236789999999999 89999999999965  


Q ss_pred             CCccEEEEEeecCCChhhhcC---CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCC---cEEEEecccc
Q 015374          194 SKTPSLIFEYVNSTDFKVLYP---TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELR---KLRLIDWGLA  267 (408)
Q Consensus       194 ~~~~~lv~e~~~~~~l~~~~~---~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~---~~kl~DfG~a  267 (408)
                      ....++||||+++++|..++.   .+++..+..++.|++.||.|||++||+||||||+|||++.+..   .+||+|||++
T Consensus        87 ~~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a  166 (361)
T 2yab_A           87 RTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA  166 (361)
T ss_dssp             SSEEEEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSC
T ss_pred             CCEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCc
Confidence            467899999999999998873   4899999999999999999999999999999999999987732   7999999999


Q ss_pred             eeccCCCcceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCC
Q 015374          268 EFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRH  347 (408)
Q Consensus       268 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (408)
                      .............||+.|+|||++.+ ..++.++|||||||++|+|++|..|| .+.+..+.+..+.....         
T Consensus       167 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~~ll~g~~Pf-~~~~~~~~~~~i~~~~~---------  235 (361)
T 2yab_A          167 HEIEDGVEFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPF-LGDTKQETLANITAVSY---------  235 (361)
T ss_dssp             EECCTTCCCCCCCSCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSCCSS-CCSSHHHHHHHHHTTCC---------
T ss_pred             eEcCCCCccccCCCCccEECchHHcC-CCCCccccHHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHhcCC---------
Confidence            88776656666789999999999987 78999999999999999999999998 44444455554433210         


Q ss_pred             CCCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccccc
Q 015374          348 SRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRA  400 (408)
Q Consensus       348 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~~~~  400 (408)
                         .    .....+..+++++.+||.+||..||++|||++|+|+||||+.+..
T Consensus       236 ---~----~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~~  281 (361)
T 2yab_A          236 ---D----FDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDT  281 (361)
T ss_dssp             ---C----CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTSCSSH
T ss_pred             ---C----CCchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhcCcCcCCCch
Confidence               0    111223457899999999999999999999999999999997754

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=6e-51  Score=391.60  Aligned_cols=255  Identities=24%  Similarity=0.424  Sum_probs=214.1

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc------chHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCc
Q 015374          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT  196 (408)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  196 (408)
                      ..++|++++.||+|+||+||+|++..+++.||+|+++..      ....+.+|..++..+.+||||++++++|.+  ...
T Consensus        21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~--~~~   98 (353)
T 3txo_A           21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQT--PDR   98 (353)
T ss_dssp             --CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEEC--SSE
T ss_pred             chhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEe--CCE
Confidence            357899999999999999999999999999999999743      235678899999988789999999999965  467


Q ss_pred             cEEEEEeecCCChhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccC-
Q 015374          197 PSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP-  272 (408)
Q Consensus       197 ~~lv~e~~~~~~l~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~-  272 (408)
                      .++||||+++++|..++   ..+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++.... 
T Consensus        99 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~-g~ikL~DFG~a~~~~~~  177 (353)
T 3txo_A           99 LFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHE-GHCKLADFGMCKEGICN  177 (353)
T ss_dssp             EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTT-SCEEECCCTTCBCSCC-
T ss_pred             EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCC-CCEEEccccceeecccC
Confidence            89999999999998887   569999999999999999999999999999999999999988 8999999999986432 


Q ss_pred             CCcceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCCCc
Q 015374          273 GKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPW  352 (408)
Q Consensus       273 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  352 (408)
                      .......+||+.|+|||++.+ ..++.++|||||||++|||++|..|| .+.+..+.+..+...                
T Consensus       178 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~G~~Pf-~~~~~~~~~~~i~~~----------------  239 (353)
T 3txo_A          178 GVTTATFCGTPDYIAPEILQE-MLYGPAVDWWAMGVLLYEMLCGHAPF-EAENEDDLFEAILND----------------  239 (353)
T ss_dssp             --------CCGGGCCHHHHHH-HHCTTHHHHHHHHHHHHHHHHSSCSS-CCSSHHHHHHHHHHC----------------
T ss_pred             CccccccCCCcCeEChhhcCC-CCcCCccCCCcchHHHHHHHhCCCCC-CCCCHHHHHHHHHcC----------------
Confidence            233455689999999999987 77999999999999999999999998 445555555555432                


Q ss_pred             cccccccCCCCCCHHHHHHHHHhcccCcCCCCCH------HHHhcCCCccccccch
Q 015374          353 SKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTA------REAMAHPYFAQVRAAE  402 (408)
Q Consensus       353 ~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~------~elL~hp~f~~~~~~~  402 (408)
                          ....+..+++++.+||.+||+.||++||++      +|+++||||+.+++..
T Consensus       240 ----~~~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~~~w~~  291 (353)
T 3txo_A          240 ----EVVYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEIDWAQ  291 (353)
T ss_dssp             ----CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSGGGTTCCHHH
T ss_pred             ----CCCCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhCCcccCCCHHH
Confidence                111233478999999999999999999998      8999999999987654

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=2.5e-50  Score=380.94  Aligned_cols=273  Identities=32%  Similarity=0.576  Sum_probs=215.1

Q ss_pred             CCCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecccc-----hHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCc
Q 015374          122 GDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK-----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT  196 (408)
Q Consensus       122 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  196 (408)
                      ...++|+++++||+|+||+||+|++. +++.||+|+++...     ...+.+|+.+++++ +||||+++++++.+  ...
T Consensus        18 ~l~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~--~~~   93 (311)
T 3niz_A           18 GLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGIPSTAIREISLLKEL-HHPNIVSLIDVIHS--ERC   93 (311)
T ss_dssp             CSSCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC------CHHHHHHHHHHHHHHC-CCTTBCCEEEEECC--SSC
T ss_pred             chHhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccccchhhHHHHHHHHHHHHc-CCCCEeeeeeEEcc--CCE
Confidence            45789999999999999999999874 58899999986322     35688999999999 99999999999954  567


Q ss_pred             cEEEEEeecCCChhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCC
Q 015374          197 PSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG  273 (408)
Q Consensus       197 ~~lv~e~~~~~~l~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~  273 (408)
                      .++||||++++.+..+.   ..+++..+..++.|++.||.|||++||+||||||+|||++.+ +.+||+|||+++.....
T Consensus        94 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~-~~~kl~Dfg~a~~~~~~  172 (311)
T 3niz_A           94 LTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSD-GALKLADFGLARAFGIP  172 (311)
T ss_dssp             EEEEEECCSEEHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTT-CCEEECCCTTCEETTSC
T ss_pred             EEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCC-CCEEEccCcCceecCCC
Confidence            89999999975444333   238999999999999999999999999999999999999988 79999999999876533


Q ss_pred             -CcceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCC-----
Q 015374          274 -KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRH-----  347 (408)
Q Consensus       274 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~-----  347 (408)
                       .......+|..|+|||++.+...++.++|||||||++|+|++|+.|| .+..+.+.+..+....+.........     
T Consensus       173 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf-~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  251 (311)
T 3niz_A          173 VRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLF-PGVTDDDQLPKIFSILGTPNPREWPQVQELP  251 (311)
T ss_dssp             CC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSC-CCSSTTTHHHHHHHHHCCCCTTTSGGGTTSH
T ss_pred             cccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCC-CCCChHHHHHHHHHHHCCCChHHhhhhhccc
Confidence             33445678999999999987567899999999999999999999997 55555666666666554322111000     


Q ss_pred             -----CCCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccccc
Q 015374          348 -----SRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRA  400 (408)
Q Consensus       348 -----~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~~~~  400 (408)
                           ................+++++.+||.+||++||++|||++|+|+||||++++.
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~  309 (311)
T 3niz_A          252 LWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDLDP  309 (311)
T ss_dssp             HHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTSCT
T ss_pred             hhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcccccCCc
Confidence                 00000000011122346889999999999999999999999999999998764

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=3.5e-50  Score=383.87  Aligned_cols=253  Identities=26%  Similarity=0.474  Sum_probs=216.4

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc------chHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCcc
Q 015374          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP  197 (408)
Q Consensus       124 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~  197 (408)
                      .++|++++.||+|+||+||+|++..+++.||+|+++..      ....+.+|+.+++.+ +||||++++++|.+  ....
T Consensus         4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~~--~~~~   80 (337)
T 1o6l_A            4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT-RHPFLTALKYAFQT--HDRL   80 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSC-CCTTBCCEEEEEEC--SSEE
T ss_pred             hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhC-CCCcCcceEEEEEe--CCEE
Confidence            46899999999999999999999999999999999642      345688999999999 99999999999965  4678


Q ss_pred             EEEEEeecCCChhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccC-C
Q 015374          198 SLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP-G  273 (408)
Q Consensus       198 ~lv~e~~~~~~l~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~-~  273 (408)
                      ++||||+++++|..++   ..+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++.... .
T Consensus        81 ~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~-g~vkL~DFG~a~~~~~~~  159 (337)
T 1o6l_A           81 CFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKD-GHIKITDFGLCKEGISDG  159 (337)
T ss_dssp             EEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTT-SCEEECCCTTCBCSCCTT
T ss_pred             EEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCC-CCEEEeeccchhhcccCC
Confidence            9999999999998877   468999999999999999999999999999999999999988 7999999999986432 3


Q ss_pred             CcceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCCCcc
Q 015374          274 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWS  353 (408)
Q Consensus       274 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  353 (408)
                      ......+||+.|+|||++.+ ..++.++|+|||||++|||++|..||. +.+..+....+...                 
T Consensus       160 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~-~~~~~~~~~~i~~~-----------------  220 (337)
T 1o6l_A          160 ATMKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFY-NQDHERLFELILME-----------------  220 (337)
T ss_dssp             CCBCCCEECGGGCCGGGGSS-SCBCTTHHHHHHHHHHHHHHHSSCSSC-CSSHHHHHHHHHHC-----------------
T ss_pred             CcccccccChhhCChhhhcC-CCCCchhhcccchhHHHHHhcCCCCCC-CCCHHHHHHHHHcC-----------------
Confidence            34456789999999999987 789999999999999999999999984 33333333333321                 


Q ss_pred             ccccccCCCCCCHHHHHHHHHhcccCcCCCC-----CHHHHhcCCCccccccch
Q 015374          354 KFINADNQHLVSPEAIDFLDKLLRYDHQDRL-----TAREAMAHPYFAQVRAAE  402 (408)
Q Consensus       354 ~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rp-----t~~elL~hp~f~~~~~~~  402 (408)
                         ....+..+++++.+||.+||+.||++||     +++|+++||||+.+.+..
T Consensus       221 ---~~~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~~f~~~~~~~  271 (337)
T 1o6l_A          221 ---EIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQD  271 (337)
T ss_dssp             ---CCCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHHH
T ss_pred             ---CCCCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcCCCcCCCCHHH
Confidence               1112334789999999999999999999     999999999999887654

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=6.4e-51  Score=396.79  Aligned_cols=274  Identities=29%  Similarity=0.572  Sum_probs=214.0

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecc-----cchHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccE
Q 015374          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP-----VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS  198 (408)
Q Consensus       124 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~-----~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  198 (408)
                      .++|++.+.||+|+||+||+|++..+++.||||++..     .....+.+|+.++.++.+||||+++++++...+....+
T Consensus         8 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~   87 (388)
T 3oz6_A            8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVY   87 (388)
T ss_dssp             HTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEE
T ss_pred             cCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEE
Confidence            5789999999999999999999999999999999853     23456789999999995599999999999876667889


Q ss_pred             EEEEeecCCChhhhc--CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCC---
Q 015374          199 LIFEYVNSTDFKVLY--PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG---  273 (408)
Q Consensus       199 lv~e~~~~~~l~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~---  273 (408)
                      +||||+++ +|..++  ..+++..+..++.|++.||+|||+.||+||||||+|||++.+ +.+||+|||+++.....   
T Consensus        88 lv~e~~~~-~L~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~-~~~kl~DFG~a~~~~~~~~~  165 (388)
T 3oz6_A           88 LVFDYMET-DLHAVIRANILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAE-CHVKVADFGLSRSFVNIRRV  165 (388)
T ss_dssp             EEEECCSE-EHHHHHHHTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTT-CCEEECCCTTCEESSSCCCC
T ss_pred             EEecccCc-CHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCC-CCEEecCCcccccccccccc
Confidence            99999995 666655  458999999999999999999999999999999999999998 79999999999865321   


Q ss_pred             -------------------CcceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHH
Q 015374          274 -------------------KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA  334 (408)
Q Consensus       274 -------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~  334 (408)
                                         ......+||+.|+|||++.+...++.++|||||||++|||++|+.|| .+.+..+++..+.
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf-~~~~~~~~~~~i~  244 (388)
T 3oz6_A          166 TNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIF-PGSSTMNQLERII  244 (388)
T ss_dssp             CCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSC-CCSSHHHHHHHHH
T ss_pred             cccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHH
Confidence                               11234579999999999987678999999999999999999999887 6777788888887


Q ss_pred             hhhchhhhhcCCCC-------------------CCCccccc--------cccCCCCCCHHHHHHHHHhcccCcCCCCCHH
Q 015374          335 KDCCLIIWCNSRHS-------------------RKPWSKFI--------NADNQHLVSPEAIDFLDKLLRYDHQDRLTAR  387 (408)
Q Consensus       335 ~~~~~~~~~~~~~~-------------------~~~~~~~~--------~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~  387 (408)
                      ...+.+........                   ...+....        .......+++++.+||.+||++||++|||++
T Consensus       245 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t~~  324 (388)
T 3oz6_A          245 GVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISAN  324 (388)
T ss_dssp             HHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCCHH
T ss_pred             HhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCCCHH
Confidence            76664432111000                   00000000        0112235789999999999999999999999


Q ss_pred             HHhcCCCcccccc
Q 015374          388 EAMAHPYFAQVRA  400 (408)
Q Consensus       388 elL~hp~f~~~~~  400 (408)
                      |+|+||||+....
T Consensus       325 e~l~Hp~~~~~~~  337 (388)
T 3oz6_A          325 DALKHPFVSIFHN  337 (388)
T ss_dssp             HHTTSTTTTTTCC
T ss_pred             HHhCCHHHHHhcC
Confidence            9999999987644

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=3.4e-50  Score=391.24  Aligned_cols=257  Identities=26%  Similarity=0.464  Sum_probs=216.6

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecccc------hHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCc
Q 015374          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK------KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT  196 (408)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~------~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  196 (408)
                      ..++|++++.||+|+||+||+|++..+++.||+|+++...      ...+.+|..++.++.+||||++++++|.+  ...
T Consensus        50 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~--~~~  127 (396)
T 4dc2_A           50 GLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQT--ESR  127 (396)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEEC--SSE
T ss_pred             ChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEE--CCE
Confidence            3578999999999999999999999999999999997432      24578999999988789999999999965  567


Q ss_pred             cEEEEEeecCCChhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceec-cC
Q 015374          197 PSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY-HP  272 (408)
Q Consensus       197 ~~lv~e~~~~~~l~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~-~~  272 (408)
                      .++||||+++++|..++   ..+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++.. ..
T Consensus       128 ~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~-g~ikL~DFGla~~~~~~  206 (396)
T 4dc2_A          128 LFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSE-GHIKLTDYGMCKEGLRP  206 (396)
T ss_dssp             EEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTT-SCEEECCCTTCBCCCCT
T ss_pred             EEEEEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCC-CCEEEeecceeeecccC
Confidence            89999999999998877   469999999999999999999999999999999999999998 89999999999863 33


Q ss_pred             CCcceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCC-------CCHHHHHHHHhhhchhhhhcC
Q 015374          273 GKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGH-------DNHDQLVKIAKDCCLIIWCNS  345 (408)
Q Consensus       273 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~-------~~~~~~~~~~~~~~~~~~~~~  345 (408)
                      .......+||+.|+|||++.+ ..++.++|||||||++|||++|+.||....       ...+.+...+..         
T Consensus       207 ~~~~~~~~gt~~Y~aPE~l~~-~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~---------  276 (396)
T 4dc2_A          207 GDTTSTFCGTPNYIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILE---------  276 (396)
T ss_dssp             TCCBCCCCBCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHH---------
T ss_pred             CCccccccCCcccCCchhhcC-CCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhc---------
Confidence            445566789999999999988 789999999999999999999999985321       112222222211         


Q ss_pred             CCCCCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCH------HHHhcCCCccccccch
Q 015374          346 RHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTA------REAMAHPYFAQVRAAE  402 (408)
Q Consensus       346 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~------~elL~hp~f~~~~~~~  402 (408)
                                .....+..+++++.+||++||+.||++||++      +|+++||||+++++..
T Consensus       277 ----------~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~i~w~~  329 (396)
T 4dc2_A          277 ----------KQIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDM  329 (396)
T ss_dssp             ----------CCCCCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTTCCHHH
T ss_pred             ----------cccCCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccCCCHHH
Confidence                      1122334578999999999999999999985      8999999999987654

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=3.2e-50  Score=377.80  Aligned_cols=256  Identities=25%  Similarity=0.454  Sum_probs=216.3

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecc---cchHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccEEE
Q 015374          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP---VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI  200 (408)
Q Consensus       124 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~---~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  200 (408)
                      .++|++.+.||+|+||+||+|++..+++.||+|++..   ...+.+.+|+.+++++ +||||++++++|.+  ....++|
T Consensus        19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~--~~~~~lv   95 (297)
T 3fxz_A           19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMREN-KNPNIVNYLDSYLV--GDELWVV   95 (297)
T ss_dssp             GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHC-CCTTBCCEEEEEEE--TTEEEEE
T ss_pred             hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcC-CCCCCCeEeEEEEE--CCEEEEE
Confidence            5689999999999999999999999999999999863   2356788999999999 99999999999965  4678999


Q ss_pred             EEeecCCChhhhc--CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCCC-cce
Q 015374          201 FEYVNSTDFKVLY--PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK-EYN  277 (408)
Q Consensus       201 ~e~~~~~~l~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~~-~~~  277 (408)
                      |||+++++|..++  ..+++..+..++.|++.||.|||++||+||||||+|||++.+ +.+||+|||++....... ...
T Consensus        96 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~-~~~kl~Dfg~~~~~~~~~~~~~  174 (297)
T 3fxz_A           96 MEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMD-GSVKLTDFGFCAQITPEQSKRS  174 (297)
T ss_dssp             EECCTTCBHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT-CCEEECCCTTCEECCSTTCCBC
T ss_pred             EECCCCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCC-CCEEEeeCCCceecCCcccccC
Confidence            9999999999887  458999999999999999999999999999999999999988 799999999998765433 334


Q ss_pred             eeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCCCcccccc
Q 015374          278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSKFIN  357 (408)
Q Consensus       278 ~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  357 (408)
                      ...||+.|+|||++.+ ..++.++|||||||++|+|++|..||. +.+..+....+.....                 ..
T Consensus       175 ~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~-~~~~~~~~~~~~~~~~-----------------~~  235 (297)
T 3fxz_A          175 TMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMIEGEPPYL-NENPLRALYLIATNGT-----------------PE  235 (297)
T ss_dssp             CCCSCGGGCCHHHHHC-SCBCTHHHHHHHHHHHHHHHHSSCTTT-TSCHHHHHHHHHHHCS-----------------CC
T ss_pred             CccCCcCccChhhhcC-CCCCcHHHHHHHHHHHHHHHhCCCCCC-CCCHHHHHHHHHhCCC-----------------CC
Confidence            5689999999999987 789999999999999999999999984 3343444333332210                 01


Q ss_pred             ccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccccccch
Q 015374          358 ADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAE  402 (408)
Q Consensus       358 ~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~~~~~~  402 (408)
                      ...+..+++.+.+|+.+||+.||++|||++|+++||||+......
T Consensus       236 ~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~~~  280 (297)
T 3fxz_A          236 LQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQFLKIAKPLS  280 (297)
T ss_dssp             CSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCCCGG
T ss_pred             CCCccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhcccCccc
Confidence            112334789999999999999999999999999999999765443

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=5.4e-50  Score=377.90  Aligned_cols=275  Identities=27%  Similarity=0.461  Sum_probs=216.1

Q ss_pred             CCCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecccc--------hHHHHHHHHHHHHhc--CCCCceEEeeEEEc
Q 015374          122 GDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK--------KKKIKREIKILQNLC--GGPNVVKLLDIVRD  191 (408)
Q Consensus       122 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~--------~~~~~~E~~~l~~l~--~h~niv~l~~~~~~  191 (408)
                      ...++|++.++||+|+||+||+|++..+++.||+|+++...        ...+.+|+.+++++.  +||||++++++|..
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~   85 (308)
T 3g33_A            6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCAT   85 (308)
T ss_dssp             ----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEE
T ss_pred             ccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeec
Confidence            45789999999999999999999999999999999986322        346778888888773  49999999999976


Q ss_pred             cCCC---ccEEEEEeecCCChhhhcC-----CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEe
Q 015374          192 QHSK---TPSLIFEYVNSTDFKVLYP-----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLID  263 (408)
Q Consensus       192 ~~~~---~~~lv~e~~~~~~l~~~~~-----~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~D  263 (408)
                      ....   ..++||||+.+ +|..++.     .+++..+..++.|++.||+|||++||+||||||+|||++.+ +.+||+|
T Consensus        86 ~~~~~~~~~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~-~~~kl~D  163 (308)
T 3g33_A           86 SRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSG-GTVKLAD  163 (308)
T ss_dssp             CCSSSEEEEEEEEECCCC-BHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTT-SCEEECS
T ss_pred             cCCCCceeEEEEehhhhc-CHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCC-CCEEEee
Confidence            4322   57899999985 7766652     28999999999999999999999999999999999999988 7999999


Q ss_pred             cccceeccCCCcceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhh
Q 015374          264 WGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWC  343 (408)
Q Consensus       264 fG~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  343 (408)
                      ||+++............+|+.|+|||++.+ ..++.++|||||||++|+|++|+.|| .+.+..+.+..+....+.....
T Consensus       164 fg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~~g~~pf-~~~~~~~~~~~i~~~~~~~~~~  241 (308)
T 3g33_A          164 FGLARIYSYQMALTPVVVTLWYRAPEVLLQ-STYATPVDMWSVGCIFAEMFRRKPLF-CGNSEADQLGKIFDLIGLPPED  241 (308)
T ss_dssp             CSCTTTSTTCCCSGGGGCCCSSCCHHHHHT-SCCCSTHHHHHHHHHHHHTTTSSCSC-CCSSHHHHHHHHHHHHCCCCTT
T ss_pred             CccccccCCCcccCCccccccccCchHHcC-CCCCchHHHHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHHHhCCCChh
Confidence            999987765555666789999999999987 77999999999999999999999987 5666677777777765543322


Q ss_pred             cCCCCCCCccccc-------cccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccccc
Q 015374          344 NSRHSRKPWSKFI-------NADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRA  400 (408)
Q Consensus       344 ~~~~~~~~~~~~~-------~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~~~~  400 (408)
                      .............       .......+++++.+||.+||++||++|||++|+|+||||++...
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~~~~  305 (308)
T 3g33_A          242 DWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKDEG  305 (308)
T ss_dssp             TSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC-----
T ss_pred             hccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccCCCC
Confidence            1111000000000       01122357899999999999999999999999999999997643

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.7e-50  Score=382.41  Aligned_cols=257  Identities=25%  Similarity=0.461  Sum_probs=219.1

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc--chHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccEEE
Q 015374          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV--KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI  200 (408)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  200 (408)
                      ..++|++.+.||+|+||+||+|++..+++.+|+|+++..  ....+.+|+.+++.+ +||||+++++++.+  ....++|
T Consensus         3 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~--~~~~~lv   79 (321)
T 1tki_A            3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIA-RHRNILHLHESFES--MEELVMI   79 (321)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHS-CCTTBCCEEEEEEE--TTEEEEE
T ss_pred             hhhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCcccHHHHHHHHHHHHhC-CCCCCCeEeEEEec--CCEEEEE
Confidence            367899999999999999999999999999999998643  345688999999999 99999999999965  4678999


Q ss_pred             EEeecCCChhhhcC----CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCC-CCcEEEEecccceeccCCCc
Q 015374          201 FEYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE-LRKLRLIDWGLAEFYHPGKE  275 (408)
Q Consensus       201 ~e~~~~~~l~~~~~----~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~-~~~~kl~DfG~a~~~~~~~~  275 (408)
                      |||+++++|..++.    .+++..+..++.|++.||.|||++||+||||||+|||++.+ .+.+||+|||++........
T Consensus        80 ~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~  159 (321)
T 1tki_A           80 FEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN  159 (321)
T ss_dssp             ECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCE
T ss_pred             EEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCCc
Confidence            99999999988873    48999999999999999999999999999999999999872 37899999999998877666


Q ss_pred             ceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCCCcccc
Q 015374          276 YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSKF  355 (408)
Q Consensus       276 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  355 (408)
                      .....+|+.|+|||++.+ ..++.++|||||||++|+|++|..||. +.+..+.+..+......                
T Consensus       160 ~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~-~~~~~~~~~~i~~~~~~----------------  221 (321)
T 1tki_A          160 FRLLFTAPEYYAPEVHQH-DVVSTATDMWSLGTLVYVLLSGINPFL-AETNQQIIENIMNAEYT----------------  221 (321)
T ss_dssp             EEEEESCGGGSCHHHHTT-CEECHHHHHHHHHHHHHHHHHSSCTTC-CSSHHHHHHHHHHTCCC----------------
T ss_pred             cccccCChhhcCcHHhcC-CCCCchhhHHHHHHHHHHHHhCCCCCc-CCCHHHHHHHHHcCCCC----------------
Confidence            677889999999999987 678999999999999999999999983 44444444444432110                


Q ss_pred             ccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccccc
Q 015374          356 INADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRA  400 (408)
Q Consensus       356 ~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~~~~  400 (408)
                      .....+..+++++.+|+.+||..||++|||++|+|+||||++...
T Consensus       222 ~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~  266 (321)
T 1tki_A          222 FDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQKIE  266 (321)
T ss_dssp             CCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSCGG
T ss_pred             CChhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhcChhhccCcc
Confidence            011122347899999999999999999999999999999986543

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=4.7e-50  Score=384.10  Aligned_cols=256  Identities=25%  Similarity=0.436  Sum_probs=218.3

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc------chHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCc
Q 015374          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT  196 (408)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  196 (408)
                      ..++|++.+.||+|+||+||+|++..+++.||+|+++..      ....+..|..++..+.+||||+++++++.+  ...
T Consensus        15 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~--~~~   92 (345)
T 1xjd_A           15 KIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQT--KEN   92 (345)
T ss_dssp             -CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEEC--SSE
T ss_pred             ChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEe--CCE
Confidence            468999999999999999999999999999999999743      345678899999987699999999999965  467


Q ss_pred             cEEEEEeecCCChhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccC-
Q 015374          197 PSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP-  272 (408)
Q Consensus       197 ~~lv~e~~~~~~l~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~-  272 (408)
                      .++||||+++++|..++   ..+++..++.++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+++.... 
T Consensus        93 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~-g~vkL~DFG~a~~~~~~  171 (345)
T 1xjd_A           93 LFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKD-GHIKIADFGMCKENMLG  171 (345)
T ss_dssp             EEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTT-SCEEECCCTTCBCCCCT
T ss_pred             EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCC-CCEEEeEChhhhhcccC
Confidence            89999999999998887   469999999999999999999999999999999999999988 7999999999976432 


Q ss_pred             CCcceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCCCc
Q 015374          273 GKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPW  352 (408)
Q Consensus       273 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  352 (408)
                      .......+||+.|+|||++.+ ..++.++|+|||||++|||++|..||. +.+..+.+..+...                
T Consensus       172 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~-~~~~~~~~~~i~~~----------------  233 (345)
T 1xjd_A          172 DAKTNTFCGTPDYIAPEILLG-QKYNHSVDWWSFGVLLYEMLIGQSPFH-GQDEEELFHSIRMD----------------  233 (345)
T ss_dssp             TCCBCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSC-CSSHHHHHHHHHHC----------------
T ss_pred             CCcccCCCCCcccCChhhhcC-CCCCChhhhHHHHHHHHHHhcCCCCCC-CCCHHHHHHHHHhC----------------
Confidence            234456789999999999987 789999999999999999999999983 44444444444331                


Q ss_pred             cccccccCCCCCCHHHHHHHHHhcccCcCCCCCHH-HHhcCCCccccccchh
Q 015374          353 SKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAR-EAMAHPYFAQVRAAES  403 (408)
Q Consensus       353 ~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~-elL~hp~f~~~~~~~~  403 (408)
                          ....+..+++++.+||.+||+.||++|||+. |+++||||+.+.+...
T Consensus       234 ----~~~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~hp~f~~~~w~~l  281 (345)
T 1xjd_A          234 ----NPFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREINWEEL  281 (345)
T ss_dssp             ----CCCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTCCHHHH
T ss_pred             ----CCCCCcccCHHHHHHHHHHhcCCHhHcCCChHHHHcCccccCCCHHHH
Confidence                1112234789999999999999999999998 9999999999876543

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=7.3e-50  Score=378.77  Aligned_cols=272  Identities=28%  Similarity=0.551  Sum_probs=206.7

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc----chHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccEE
Q 015374          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSL  199 (408)
Q Consensus       124 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l  199 (408)
                      .++|++++.||+|+||+||+|++..+++.||+|+++..    ..+.+.+|+.+++++ +||||+++++++.+  ....++
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~--~~~~~l   80 (317)
T 2pmi_A            4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKEL-KHENIVRLYDVIHT--ENKLTL   80 (317)
T ss_dssp             ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTC-CBTTBCCEEEEECC--TTEEEE
T ss_pred             ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhc-CCCCcceEEEEEEE--CCeEEE
Confidence            56899999999999999999999999999999998632    236788999999999 99999999999954  567899


Q ss_pred             EEEeecCCChhhhc---------CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceec
Q 015374          200 IFEYVNSTDFKVLY---------PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY  270 (408)
Q Consensus       200 v~e~~~~~~l~~~~---------~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~  270 (408)
                      ||||+++ +|..++         ..+++..++.++.|++.||.|||++||+||||||+|||++.+ +.+||+|||+++..
T Consensus        81 v~e~~~~-~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~-~~~kl~Dfg~~~~~  158 (317)
T 2pmi_A           81 VFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKR-GQLKLGDFGLARAF  158 (317)
T ss_dssp             EEECCCC-BHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTT-CCEEECCCSSCEET
T ss_pred             EEEecCC-CHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCC-CCEEECcCccceec
Confidence            9999995 666654         248899999999999999999999999999999999999988 79999999999876


Q ss_pred             cCC-CcceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCC---
Q 015374          271 HPG-KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSR---  346 (408)
Q Consensus       271 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~---  346 (408)
                      ... .......+|..|+|||++.+...++.++|||||||++|+|++|+.|| .+.++.+.+..+....+........   
T Consensus       159 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf-~~~~~~~~~~~i~~~~~~~~~~~~~~~~  237 (317)
T 2pmi_A          159 GIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLF-PGTNDEEQLKLIFDIMGTPNESLWPSVT  237 (317)
T ss_dssp             TSCCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSC-CCSSHHHHHHHHHHHHCSCCTTTCGGGG
T ss_pred             CCCcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCC-CCCChHHHHHHHHHHhCCCChhHhhhhh
Confidence            533 23345678999999999987567899999999999999999999997 5566666777766655432211000   


Q ss_pred             -----------CCCCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccccccc
Q 015374          347 -----------HSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAA  401 (408)
Q Consensus       347 -----------~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~~~~~  401 (408)
                                 .....+...........++.++.+||.+||+.||++|||++|+|+||||++....
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~  303 (317)
T 2pmi_A          238 KLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYYHH  303 (317)
T ss_dssp             GCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCC-
T ss_pred             hhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhcccch
Confidence                       0001111112233344578999999999999999999999999999999987663

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=1.3e-49  Score=376.99  Aligned_cols=251  Identities=22%  Similarity=0.454  Sum_probs=216.5

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc------chHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCcc
Q 015374          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP  197 (408)
Q Consensus       124 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~  197 (408)
                      .++|++.+.||+|+||+||+|++..+++.||+|+++..      ..+.+.+|+.+++.+ +||||+++++++.+  ....
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~Iv~~~~~~~~--~~~~   81 (318)
T 1fot_A            5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIV-THPFIIRMWGTFQD--AQQI   81 (318)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSC-CBTTBCCEEEEEEC--SSEE
T ss_pred             hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhC-CCCCCceEeEEEEe--CCEE
Confidence            56899999999999999999999999999999999643      345678899999999 99999999999965  4678


Q ss_pred             EEEEEeecCCChhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCCC
Q 015374          198 SLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK  274 (408)
Q Consensus       198 ~lv~e~~~~~~l~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~~  274 (408)
                      ++||||+++++|..++   ..+++..++.++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+++....  
T Consensus        82 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~-g~~kL~Dfg~a~~~~~--  158 (318)
T 1fot_A           82 FMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKN-GHIKITDFGFAKYVPD--  158 (318)
T ss_dssp             EEEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTT-SCEEECCCSSCEECSS--
T ss_pred             EEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCC-CCEEEeecCcceecCC--
Confidence            9999999999999887   458999999999999999999999999999999999999988 8999999999987643  


Q ss_pred             cceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCCCccc
Q 015374          275 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSK  354 (408)
Q Consensus       275 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  354 (408)
                      .....+||+.|+|||++.+ ..++.++|+|||||++|||++|..||. +.+..+....+...                  
T Consensus       159 ~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~-~~~~~~~~~~i~~~------------------  218 (318)
T 1fot_A          159 VTYTLCGTPDYIAPEVVST-KPYNKSIDWWSFGILIYEMLAGYTPFY-DSNTMKTYEKILNA------------------  218 (318)
T ss_dssp             CBCCCCSCTTTCCHHHHTT-CCBCTTHHHHHHHHHHHHHHHSSCTTC-CSSHHHHHHHHHHC------------------
T ss_pred             ccccccCCccccCHhHhcC-CCCCcccchhhhHHHHHHHHhCCCCCC-CCCHHHHHHHHHhC------------------
Confidence            3345689999999999987 789999999999999999999999984 34444444444432                  


Q ss_pred             cccccCCCCCCHHHHHHHHHhcccCcCCCC-----CHHHHhcCCCccccccch
Q 015374          355 FINADNQHLVSPEAIDFLDKLLRYDHQDRL-----TAREAMAHPYFAQVRAAE  402 (408)
Q Consensus       355 ~~~~~~~~~~~~~~~~li~~~L~~dp~~Rp-----t~~elL~hp~f~~~~~~~  402 (408)
                        ....+..+++++.++|.+||+.||++||     +++|+++||||+.+.+..
T Consensus       219 --~~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~hp~f~~~~~~~  269 (318)
T 1fot_A          219 --ELRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWEK  269 (318)
T ss_dssp             --CCCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCCHHH
T ss_pred             --CCCCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcCccccCCCHHH
Confidence              0112234789999999999999999999     999999999999887654

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=9.8e-50  Score=379.39  Aligned_cols=255  Identities=25%  Similarity=0.459  Sum_probs=217.1

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc---------chHHHHHHHHHHHHhcCCCCceEEeeEEEccCC
Q 015374          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV---------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHS  194 (408)
Q Consensus       124 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~---------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~  194 (408)
                      .++|++.+.||+|+||+||+|++..+++.||+|+++..         ..+.+.+|+.+++++ +||||+++++++.+  .
T Consensus        10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~--~   86 (326)
T 2y0a_A           10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI-QHPNVITLHEVYEN--K   86 (326)
T ss_dssp             HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHC-CCTTBCCEEEEEEC--S
T ss_pred             ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhC-CCCCCCcEEEEEEe--C
Confidence            46799999999999999999999999999999998642         246789999999999 99999999999965  4


Q ss_pred             CccEEEEEeecCCChhhhcC---CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCC----cEEEEecccc
Q 015374          195 KTPSLIFEYVNSTDFKVLYP---TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELR----KLRLIDWGLA  267 (408)
Q Consensus       195 ~~~~lv~e~~~~~~l~~~~~---~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~----~~kl~DfG~a  267 (408)
                      ...++||||+++++|..++.   .+++..+..++.|++.||.|||++||+||||||+|||++.+ +    .+||+|||++
T Consensus        87 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~-~~~~~~~kl~Dfg~a  165 (326)
T 2y0a_A           87 TDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDR-NVPKPRIKIIDFGLA  165 (326)
T ss_dssp             SEEEEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCS-SSSSCCEEECCCTTC
T ss_pred             CEEEEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecC-CCCCCCEEEEECCCC
Confidence            67899999999999998874   48999999999999999999999999999999999999877 4    7999999999


Q ss_pred             eeccCCCcceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCC
Q 015374          268 EFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRH  347 (408)
Q Consensus       268 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (408)
                      .............||+.|+|||++.+ ..++.++|||||||++|+|++|..||. +.+..+.+..+......        
T Consensus       166 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~-~~~~~~~~~~~~~~~~~--------  235 (326)
T 2y0a_A          166 HKIDFGNEFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFL-GDTKQETLANVSAVNYE--------  235 (326)
T ss_dssp             EECCTTSCCCCCCSCTTTCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSCCSSC-CSSHHHHHHHHHHTCCC--------
T ss_pred             eECCCCCccccccCCcCcCCceeecC-CCCCcHHHHHHHHHHHHHHHHCcCCCC-CCCHHHHHHHHHhcCCC--------
Confidence            88765555566789999999999977 789999999999999999999999984 44444444443332100        


Q ss_pred             CCCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccccc
Q 015374          348 SRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRA  400 (408)
Q Consensus       348 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~~~~  400 (408)
                              .....+..+++++.+||.+||+.||++|||++|+|+||||+....
T Consensus       236 --------~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~  280 (326)
T 2y0a_A          236 --------FEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDT  280 (326)
T ss_dssp             --------CCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTSCCSH
T ss_pred             --------cCccccccCCHHHHHHHHHHccCChhhCCCHHHHhcCCCccCCcc
Confidence                    011122347899999999999999999999999999999997654

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.5e-49  Score=373.11  Aligned_cols=253  Identities=26%  Similarity=0.499  Sum_probs=208.0

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecccc-----------------------------hHHHHHHHHHHH
Q 015374          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK-----------------------------KKKIKREIKILQ  174 (408)
Q Consensus       124 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-----------------------------~~~~~~E~~~l~  174 (408)
                      .++|++.+.||+|+||+||+|++..+++.||||+++...                             .+.+.+|+.+++
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~   91 (298)
T 2zv2_A           12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK   91 (298)
T ss_dssp             ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred             ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence            578999999999999999999999999999999986432                             246889999999


Q ss_pred             HhcCCCCceEEeeEEEccCCCccEEEEEeecCCChhhhc--CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEE
Q 015374          175 NLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY--PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMI  252 (408)
Q Consensus       175 ~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~~~~l~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl  252 (408)
                      ++ +||||+++++++.+.+....++||||+++++|..+.  ..+++..+..++.|++.||.|||++||+||||||+|||+
T Consensus        92 ~l-~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~  170 (298)
T 2zv2_A           92 KL-DHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLV  170 (298)
T ss_dssp             TC-CCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE
T ss_pred             hC-CCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEE
Confidence            99 999999999999876667899999999999988775  358999999999999999999999999999999999999


Q ss_pred             eCCCCcEEEEecccceeccCCC-cceeeccCccccccccccCCcC--CCccccHHHHHHHHHHHHhCCCCCCCCCCCHHH
Q 015374          253 DHELRKLRLIDWGLAEFYHPGK-EYNVRVASRYFKGPELLVDLQD--YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQ  329 (408)
Q Consensus       253 ~~~~~~~kl~DfG~a~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~--~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~  329 (408)
                      +.+ +.+||+|||+++...... ......||..|+|||++.+...  ++.++|||||||++|+|++|..||.. .+....
T Consensus       171 ~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~-~~~~~~  248 (298)
T 2zv2_A          171 GED-GHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMD-ERIMCL  248 (298)
T ss_dssp             CTT-SCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCC-SSHHHH
T ss_pred             CCC-CCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCC-ccHHHH
Confidence            988 799999999998765433 2345679999999999976332  47889999999999999999999843 222222


Q ss_pred             HHHHHhhhchhhhhcCCCCCCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccc
Q 015374          330 LVKIAKDCCLIIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQ  397 (408)
Q Consensus       330 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~  397 (408)
                      ...+... .                 ........+++++.++|.+||+.||++|||++|+++||||+.
T Consensus       249 ~~~~~~~-~-----------------~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~~~~  298 (298)
T 2zv2_A          249 HSKIKSQ-A-----------------LEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVTR  298 (298)
T ss_dssp             HHHHHHC-C-----------------CCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHHHHC
T ss_pred             HHHHhcc-c-----------------CCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcCccccC
Confidence            2222211 0                 001112347899999999999999999999999999999963

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=1.6e-49  Score=381.64  Aligned_cols=256  Identities=23%  Similarity=0.381  Sum_probs=218.2

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc------chHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCc
Q 015374          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT  196 (408)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  196 (408)
                      ..++|++++.||+|+||+||+|++..+++.||+|+++..      ....+.+|..++..+.+||||+++++++.+  ...
T Consensus        18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~--~~~   95 (353)
T 2i0e_A           18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQT--MDR   95 (353)
T ss_dssp             -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEEC--SSE
T ss_pred             chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEc--CCE
Confidence            467899999999999999999999999999999999643      235678899999987789999999999965  467


Q ss_pred             cEEEEEeecCCChhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccC-
Q 015374          197 PSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP-  272 (408)
Q Consensus       197 ~~lv~e~~~~~~l~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~-  272 (408)
                      .++||||+++++|..++   ..+++..++.++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+++.... 
T Consensus        96 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~-g~vkL~DFG~a~~~~~~  174 (353)
T 2i0e_A           96 LYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSE-GHIKIADFGMCKENIWD  174 (353)
T ss_dssp             EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTT-SCEEECCCTTCBCCCCT
T ss_pred             EEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCC-CcEEEEeCCcccccccC
Confidence            89999999999998887   469999999999999999999999999999999999999988 7999999999986432 


Q ss_pred             CCcceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCCCc
Q 015374          273 GKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPW  352 (408)
Q Consensus       273 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  352 (408)
                      .......+||+.|+|||++.+ ..++.++|+|||||++|||++|+.|| .+.+..+....+...                
T Consensus       175 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~G~~Pf-~~~~~~~~~~~i~~~----------------  236 (353)
T 2i0e_A          175 GVTTKTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQAPF-EGEDEDELFQSIMEH----------------  236 (353)
T ss_dssp             TCCBCCCCSCGGGCCHHHHTT-CCBSTHHHHHHHHHHHHHHHHSSCSS-CCSSHHHHHHHHHHC----------------
T ss_pred             CcccccccCCccccChhhhcC-CCcCCcccccchHHHHHHHHcCCCCC-CCCCHHHHHHHHHhC----------------
Confidence            334456789999999999987 78999999999999999999999998 344444555554432                


Q ss_pred             cccccccCCCCCCHHHHHHHHHhcccCcCCCC-----CHHHHhcCCCccccccchh
Q 015374          353 SKFINADNQHLVSPEAIDFLDKLLRYDHQDRL-----TAREAMAHPYFAQVRAAES  403 (408)
Q Consensus       353 ~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rp-----t~~elL~hp~f~~~~~~~~  403 (408)
                          ....+..+++++.+||.+||+.||++||     +++|+++||||+.+++...
T Consensus       237 ----~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~~~w~~l  288 (353)
T 2i0e_A          237 ----NVAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKL  288 (353)
T ss_dssp             ----CCCCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTSGGGTTCCHHHH
T ss_pred             ----CCCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCccccCCCHHHH
Confidence                1112334789999999999999999999     4799999999999877553

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=1.7e-49  Score=377.24  Aligned_cols=256  Identities=24%  Similarity=0.394  Sum_probs=212.3

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecccc----hHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccE
Q 015374          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS  198 (408)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  198 (408)
                      ..++|++.+.||+|+||+||+|++..+++.||+|+++...    .+.+.+|+.+++.+ +||||+++++++.+  ....+
T Consensus         5 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~--~~~~~   81 (323)
T 3tki_A            5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML-NHENVVKFYGHRRE--GNIQY   81 (323)
T ss_dssp             TTTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHC-CCTTBCCEEEEEEC--SSEEE
T ss_pred             HhhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhC-CCCCCCeEEEEEec--CCeEE
Confidence            4679999999999999999999999999999999986332    35688999999999 99999999999965  56788


Q ss_pred             EEEEeecCCChhhhcC---CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCCC-
Q 015374          199 LIFEYVNSTDFKVLYP---TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK-  274 (408)
Q Consensus       199 lv~e~~~~~~l~~~~~---~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~~-  274 (408)
                      +||||+++++|..++.   .+++..+..++.|++.||+|||++||+||||||+|||++.+ +.+||+|||++....... 
T Consensus        82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~-~~~kl~Dfg~a~~~~~~~~  160 (323)
T 3tki_A           82 LFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDER-DNLKISDFGLATVFRYNNR  160 (323)
T ss_dssp             EEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTT-CCEEECCCTTCEECEETTE
T ss_pred             EEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCC-CCEEEEEeeccceeccCCc
Confidence            9999999999998874   48999999999999999999999999999999999999988 799999999998654322 


Q ss_pred             --cceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCCCc
Q 015374          275 --EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPW  352 (408)
Q Consensus       275 --~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  352 (408)
                        ......||+.|+|||++.+...++.++|||||||++|+|++|+.||.................         .     
T Consensus       161 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~---------~-----  226 (323)
T 3tki_A          161 ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKK---------T-----  226 (323)
T ss_dssp             ECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTC---------T-----
T ss_pred             ccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhccc---------c-----
Confidence              233567999999999998744457899999999999999999999855444333333222210         0     


Q ss_pred             cccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccccc
Q 015374          353 SKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRA  400 (408)
Q Consensus       353 ~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~~~~  400 (408)
                          .......+++++.+|+.+||+.||++|||++|+++||||+....
T Consensus       227 ----~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~~~  270 (323)
T 3tki_A          227 ----YLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLK  270 (323)
T ss_dssp             ----TSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCCC
T ss_pred             ----cCCccccCCHHHHHHHHHHccCChhhCcCHHHHhhChhhccccc
Confidence                01112347899999999999999999999999999999986543

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=2.4e-49  Score=369.93  Aligned_cols=267  Identities=30%  Similarity=0.572  Sum_probs=210.0

Q ss_pred             CCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecccc-----hHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccEE
Q 015374          125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK-----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSL  199 (408)
Q Consensus       125 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l  199 (408)
                      ++|++.+.||+|+||+||+|++ .+++.||+|+++...     ...+.+|+.+++++ +||||+++++++.+  ....++
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~--~~~~~l   77 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKEL-KHSNIVKLYDVIHT--KKRLVL   77 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGC-CCTTBCCEEEEEEC--SSCEEE
T ss_pred             ccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHHHHhc-CCCCEeeeeeEEcc--CCeEEE
Confidence            5899999999999999999988 678999999986322     36788999999999 99999999999965  467899


Q ss_pred             EEEeecCCChhhhc----CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCC-C
Q 015374          200 IFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG-K  274 (408)
Q Consensus       200 v~e~~~~~~l~~~~----~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~-~  274 (408)
                      ||||+++ ++..++    ..+++..+..++.|++.||.|||++||+||||||+|||++.+ +.+||+|||++...... .
T Consensus        78 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~-~~~kl~Dfg~~~~~~~~~~  155 (288)
T 1ob3_A           78 VFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINRE-GELKIADFGLARAFGIPVR  155 (288)
T ss_dssp             EEECCSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTT-SCEEECCTTHHHHHCC---
T ss_pred             EEEecCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCC-CCEEEeECccccccCcccc
Confidence            9999997 555554    358999999999999999999999999999999999999988 79999999999766432 2


Q ss_pred             cceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCC-------
Q 015374          275 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRH-------  347 (408)
Q Consensus       275 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~-------  347 (408)
                      ......+|..|+|||++.+...++.++|||||||++|+|++|..|| .+.+..+.+..+....+.........       
T Consensus       156 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (288)
T 1ob3_A          156 KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLF-PGVSEADQLMRIFRILGTPNSKNWPNVTELPKY  234 (288)
T ss_dssp             ------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSC-CCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTC
T ss_pred             ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHHHHCCCChhhchhhhccccc
Confidence            3345678999999999987567899999999999999999999997 45556666666666544322111100       


Q ss_pred             --CCCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccc
Q 015374          348 --SRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQV  398 (408)
Q Consensus       348 --~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~~  398 (408)
                        ....+...........+++++.+||.+||+.||++|||++|+|+||||++.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~  287 (288)
T 1ob3_A          235 DPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKEN  287 (288)
T ss_dssp             CTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC-
T ss_pred             ccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhc
Confidence              000000000112234578999999999999999999999999999999864

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=3.4e-49  Score=378.41  Aligned_cols=257  Identities=26%  Similarity=0.464  Sum_probs=214.7

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc------chHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCc
Q 015374          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT  196 (408)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  196 (408)
                      ..++|++.+.||+|+||+||+|++..+++.||+|+++..      ....+.+|..++.++.+||||++++++|.+  ...
T Consensus         7 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~--~~~   84 (345)
T 3a8x_A            7 GLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQT--ESR   84 (345)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC--SSE
T ss_pred             chhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEe--CCE
Confidence            357899999999999999999999999999999999643      234578899999987789999999999965  467


Q ss_pred             cEEEEEeecCCChhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceecc-C
Q 015374          197 PSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH-P  272 (408)
Q Consensus       197 ~~lv~e~~~~~~l~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~-~  272 (408)
                      .++||||+++++|..++   ..+++..++.++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+++... .
T Consensus        85 ~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~-g~~kL~DFG~a~~~~~~  163 (345)
T 3a8x_A           85 LFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSE-GHIKLTDYGMCKEGLRP  163 (345)
T ss_dssp             EEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTT-SCEEECCGGGCBCSCCT
T ss_pred             EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCC-CCEEEEeccccccccCC
Confidence            89999999999998877   469999999999999999999999999999999999999988 799999999998643 2


Q ss_pred             CCcceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCC-------CCHHHHHHHHhhhchhhhhcC
Q 015374          273 GKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGH-------DNHDQLVKIAKDCCLIIWCNS  345 (408)
Q Consensus       273 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~-------~~~~~~~~~~~~~~~~~~~~~  345 (408)
                      .......+||+.|+|||++.+ ..++.++|+|||||++|||++|+.||....       ...+.+...+...        
T Consensus       164 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~--------  234 (345)
T 3a8x_A          164 GDTTSTFCGTPNYIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK--------  234 (345)
T ss_dssp             TCCBCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHC--------
T ss_pred             CCcccccCCCccccCccccCC-CCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcC--------
Confidence            334556789999999999987 789999999999999999999999985321       1122222111110        


Q ss_pred             CCCCCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCH------HHHhcCCCccccccch
Q 015374          346 RHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTA------REAMAHPYFAQVRAAE  402 (408)
Q Consensus       346 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~------~elL~hp~f~~~~~~~  402 (408)
                                 ....+..++.++.++|.+||+.||++|||+      +|+++||||+++++..
T Consensus       235 -----------~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~~~w~~  286 (345)
T 3a8x_A          235 -----------QIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDM  286 (345)
T ss_dssp             -----------CCCCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTTCCHHH
T ss_pred             -----------CCCCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCCCCHHH
Confidence                       111234478999999999999999999995      8999999999987644

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=1.5e-49  Score=391.60  Aligned_cols=262  Identities=24%  Similarity=0.380  Sum_probs=219.9

Q ss_pred             CCCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecccc------hHHHHHHHHHHHHhcCCCCceEEeeEEEccCCC
Q 015374          122 GDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK------KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSK  195 (408)
Q Consensus       122 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~------~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  195 (408)
                      ...++|++.++||+|+||+||+|++..+++.||+|+++...      ...+.+|..++..+ +||||++++++|.+  ..
T Consensus        71 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~-~hp~Iv~l~~~~~~--~~  147 (437)
T 4aw2_A           71 LHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNG-DSKWITTLHYAFQD--DN  147 (437)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHS-CTTTBCCEEEEEEC--SS
T ss_pred             CChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhC-CCCCEEEEEEEEee--CC
Confidence            35689999999999999999999999999999999996422      23488999999998 99999999999965  56


Q ss_pred             ccEEEEEeecCCChhhhc----CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceecc
Q 015374          196 TPSLIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH  271 (408)
Q Consensus       196 ~~~lv~e~~~~~~l~~~~----~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~  271 (408)
                      ..++||||+++|+|..++    ..+++..++.++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+++...
T Consensus       148 ~~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~-g~vkL~DFGla~~~~  226 (437)
T 4aw2_A          148 NLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMN-GHIRLADFGSCLKLM  226 (437)
T ss_dssp             EEEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT-SCEEECCCTTCEECC
T ss_pred             EEEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCC-CCEEEcchhhhhhcc
Confidence            789999999999999887    358999999999999999999999999999999999999988 799999999998765


Q ss_pred             CCCcc--eeeccCccccccccccC----CcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcC
Q 015374          272 PGKEY--NVRVASRYFKGPELLVD----LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNS  345 (408)
Q Consensus       272 ~~~~~--~~~~~~~~y~aPE~~~~----~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  345 (408)
                      .....  ...+||+.|+|||++..    ...++.++|||||||++|||++|+.||. +.+..+....+........    
T Consensus       227 ~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~-~~~~~~~~~~i~~~~~~~~----  301 (437)
T 4aw2_A          227 EDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFY-AESLVETYGKIMNHKERFQ----  301 (437)
T ss_dssp             TTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTC-CSSHHHHHHHHHTHHHHCC----
T ss_pred             cCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCC-CCChhHHHHhhhhcccccc----
Confidence            44332  33589999999999972    3578999999999999999999999984 5555566665554321110    


Q ss_pred             CCCCCCccccccccCCCCCCHHHHHHHHHhcccCcCC--CCCHHHHhcCCCccccccchh
Q 015374          346 RHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQD--RLTAREAMAHPYFAQVRAAES  403 (408)
Q Consensus       346 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~--Rpt~~elL~hp~f~~~~~~~~  403 (408)
                                 -+.....+++++++||++||..+|++  |++++|+++||||+++++...
T Consensus       302 -----------~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~i~w~~l  350 (437)
T 4aw2_A          302 -----------FPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGIDWDNI  350 (437)
T ss_dssp             -----------CCSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTTCCTTTG
T ss_pred             -----------CCcccccCCHHHHHHHHHHhcccccccCCCCHHHHhCCCccCCCCHHHH
Confidence                       01112347899999999999999988  999999999999999877654

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=5.4e-50  Score=394.10  Aligned_cols=275  Identities=31%  Similarity=0.518  Sum_probs=220.7

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecccchHHHHHHHHHHHHhcCCCCceEEeeEEEcc----CCCccEE
Q 015374          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQ----HSKTPSL  199 (408)
Q Consensus       124 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~----~~~~~~l  199 (408)
                      ..+|++.+.||+|+||+||+|++..+++.||||++... .....+|+.+++++ +||||++++++|...    +...+++
T Consensus        53 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~-~~~~~~E~~il~~l-~hpniv~l~~~~~~~~~~~~~~~~~l  130 (420)
T 1j1b_A           53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-KRFKNRELQIMRKL-DHCNIVRLRYFFYSSGEKKDEVYLNL  130 (420)
T ss_dssp             EEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC-TTSCCHHHHHHHTC-CCTTBCCEEEEEEEEETTTTEEEEEE
T ss_pred             cceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEeccc-chhHHHHHHHHHHc-CCCCccceeeEEeccCCCCcceeEEe
Confidence            45799999999999999999999999999999998643 33455899999999 999999999998542    2234679


Q ss_pred             EEEeecCCChhhhc------CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCC
Q 015374          200 IFEYVNSTDFKVLY------PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG  273 (408)
Q Consensus       200 v~e~~~~~~l~~~~------~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~  273 (408)
                      ||||++++.+....      ..+++..++.++.||+.||.|||++||+||||||+|||++.+.+.+||+|||+++.....
T Consensus       131 v~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~~~~  210 (420)
T 1j1b_A          131 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG  210 (420)
T ss_dssp             EEECCCEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCTTCEECCTT
T ss_pred             ehhcccccHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccchhhhhcccC
Confidence            99999985443322      458999999999999999999999999999999999999977578899999999887655


Q ss_pred             CcceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhh-----cCCCC
Q 015374          274 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWC-----NSRHS  348 (408)
Q Consensus       274 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~  348 (408)
                      .......+|+.|+|||++.+...++.++|||||||++|||++|+.|| .+.+..+++.+++...|.....     .....
T Consensus       211 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf-~~~~~~~~l~~i~~~lg~p~~~~~~~~~~~~~  289 (420)
T 1j1b_A          211 EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF-PGDSGVDQLVEIIKVLGTPTREQIREMNPNYT  289 (420)
T ss_dssp             CCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSS-CCSSHHHHHHHHHHHHCSCCHHHHHHHCSCCC
T ss_pred             CCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHHHhCCCCHHHHHhhChhhh
Confidence            55566789999999999987567999999999999999999999987 5667778888888766643211     11111


Q ss_pred             CCCcccc----ccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccccccc
Q 015374          349 RKPWSKF----INADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAA  401 (408)
Q Consensus       349 ~~~~~~~----~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~~~~~  401 (408)
                      ...+...    ........+++++.+||.+||++||.+|||+.|+++||||+.++..
T Consensus       290 ~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~  346 (420)
T 1j1b_A          290 EFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDP  346 (420)
T ss_dssp             CCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGCT
T ss_pred             hhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhcccccc
Confidence            1111110    0011223468999999999999999999999999999999887654

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=1.7e-49  Score=392.08  Aligned_cols=281  Identities=29%  Similarity=0.533  Sum_probs=219.4

Q ss_pred             cccCCCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc-----chHHHHHHHHHHHHhcCCCCceEEeeEEEccC
Q 015374          119 VQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQH  193 (408)
Q Consensus       119 ~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~  193 (408)
                      ..+...++|++.+.||+|+||+||+|++..+++.||||+++..     ..+.+.+|+.+++++ +|+||+++++++....
T Consensus        20 ~~~~i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~   98 (432)
T 3n9x_A           20 KNVHVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRL-KSDYIIRLYDLIIPDD   98 (432)
T ss_dssp             GGCCCCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHC-CCTTBCCEEEECCCSC
T ss_pred             CcceecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHc-CCCCcceEEEEEecCC
Confidence            3445678999999999999999999999999999999999642     246788999999999 9999999999996542


Q ss_pred             C---CccEEEEEeecCCChhhhcC---CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccc
Q 015374          194 S---KTPSLIFEYVNSTDFKVLYP---TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA  267 (408)
Q Consensus       194 ~---~~~~lv~e~~~~~~l~~~~~---~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a  267 (408)
                      .   ...++||||+++ +|..++.   .+++..++.++.||+.||.|||++||+||||||+|||++.+ +.+||+|||++
T Consensus        99 ~~~~~~~~lv~e~~~~-~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~-~~~kL~DFGla  176 (432)
T 3n9x_A           99 LLKFDELYIVLEIADS-DLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQD-CSVKVCDFGLA  176 (432)
T ss_dssp             TTTCCCEEEEEECCSE-EHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTT-CCEEECCCTTC
T ss_pred             CCcCCeEEEEEecCCc-CHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCC-CCEEEccCCCc
Confidence            2   568999999985 7766663   38999999999999999999999999999999999999988 79999999999


Q ss_pred             eeccCCCc-----------------------ceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhC--------
Q 015374          268 EFYHPGKE-----------------------YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFR--------  316 (408)
Q Consensus       268 ~~~~~~~~-----------------------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g--------  316 (408)
                      +.......                       ....+||+.|+|||++.....++.++|||||||++|||++|        
T Consensus       177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~  256 (432)
T 3n9x_A          177 RTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDP  256 (432)
T ss_dssp             EEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSG
T ss_pred             ccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccccccc
Confidence            87654321                       25568899999999986657899999999999999999974        


Q ss_pred             --CCCCCCCCC-----------------CHHHHHHHHhhhchhhhhcCCCCCC-Cc----------cccccccCCCCCCH
Q 015374          317 --KEPFFYGHD-----------------NHDQLVKIAKDCCLIIWCNSRHSRK-PW----------SKFINADNQHLVSP  366 (408)
Q Consensus       317 --~~pf~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~~~-~~----------~~~~~~~~~~~~~~  366 (408)
                        +.|++.+.+                 ..+++..+....|.+.......... ..          ...........+++
T Consensus       257 ~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~  336 (432)
T 3n9x_A          257 TNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISD  336 (432)
T ss_dssp             GGCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCH
T ss_pred             ccccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCH
Confidence              555555554                 2566667766666443211100000 00          00000011234789


Q ss_pred             HHHHHHHHhcccCcCCCCCHHHHhcCCCccccccch
Q 015374          367 EAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAE  402 (408)
Q Consensus       367 ~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~~~~~~  402 (408)
                      ++.+||.+||++||++|||++|+|+||||++++...
T Consensus       337 ~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~~  372 (432)
T 3n9x_A          337 DGINLLESMLKFNPNKRITIDQALDHPYLKDVRKKK  372 (432)
T ss_dssp             HHHHHHHHHSCSSTTTSCCHHHHHTCGGGTTTCCTT
T ss_pred             HHHHHHHHHhcCCcccCCCHHHHhcChhhhhccCcc
Confidence            999999999999999999999999999999887644

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=1.2e-49  Score=389.43  Aligned_cols=259  Identities=26%  Similarity=0.393  Sum_probs=218.4

Q ss_pred             CCCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc------chHHHHHHHHHHHHhcCCCCceEEeeEEEccCCC
Q 015374          122 GDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSK  195 (408)
Q Consensus       122 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  195 (408)
                      ...++|++.+.||+|+||+||+|++..+++.||+|+++..      ....+.+|+.+++.+ +||||++++++|.+  ..
T Consensus        66 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~--~~  142 (410)
T 3v8s_A           66 MKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFA-NSPWVVQLFYAFQD--DR  142 (410)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHC-CCTTBCCEEEEEEC--SS
T ss_pred             cCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhC-CCCCCCeEEEEEEE--CC
Confidence            3578999999999999999999999999999999998642      234588999999999 99999999999965  56


Q ss_pred             ccEEEEEeecCCChhhhc--CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCC
Q 015374          196 TPSLIFEYVNSTDFKVLY--PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG  273 (408)
Q Consensus       196 ~~~lv~e~~~~~~l~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~  273 (408)
                      ..++||||+++|+|..++  ..+++..++.++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+++.....
T Consensus       143 ~~~lV~E~~~gg~L~~~l~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~-g~ikL~DFG~a~~~~~~  221 (410)
T 3v8s_A          143 YLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKS-GHLKLADFGTCMKMNKE  221 (410)
T ss_dssp             EEEEEECCCTTEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT-SCEEECCCTTCEECCTT
T ss_pred             EEEEEEeCCCCCcHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCC-CCEEEeccceeEeeccC
Confidence            789999999999998887  458999999999999999999999999999999999999988 89999999999876544


Q ss_pred             Cc--ceeeccCccccccccccCCc---CCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCC
Q 015374          274 KE--YNVRVASRYFKGPELLVDLQ---DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHS  348 (408)
Q Consensus       274 ~~--~~~~~~~~~y~aPE~~~~~~---~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  348 (408)
                      ..  ....+||+.|+|||++.+..   .++.++|||||||++|||++|+.||. +.+..+....+.......        
T Consensus       222 ~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~-~~~~~~~~~~i~~~~~~~--------  292 (410)
T 3v8s_A          222 GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFY-ADSLVGTYSKIMNHKNSL--------  292 (410)
T ss_dssp             SEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTC-CSSHHHHHHHHHTHHHHC--------
T ss_pred             CcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCC-CCChhhHHHHHHhccccc--------
Confidence            32  33568999999999997632   27899999999999999999999984 455555555555431110        


Q ss_pred             CCCccccccccCCCCCCHHHHHHHHHhcccCcCC--CCCHHHHhcCCCccccccc
Q 015374          349 RKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQD--RLTAREAMAHPYFAQVRAA  401 (408)
Q Consensus       349 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~--Rpt~~elL~hp~f~~~~~~  401 (408)
                              .......+++++++||.+||+.+|.+  |++++|+++||||+++.+.
T Consensus       293 --------~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~~~w~  339 (410)
T 3v8s_A          293 --------TFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQWA  339 (410)
T ss_dssp             --------CCCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCCSSCC
T ss_pred             --------cCCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcCccccCCCHH
Confidence                    11112347899999999999999988  9999999999999998653

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=4.9e-49  Score=381.74  Aligned_cols=257  Identities=21%  Similarity=0.444  Sum_probs=219.2

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc------chHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCc
Q 015374          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT  196 (408)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  196 (408)
                      ..++|++++.||+|+||+||+|++..+++.||+|+++..      ....+.+|+.+++.+ +||||++++++|.+  ...
T Consensus        13 ~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~--~~~   89 (384)
T 4fr4_A           13 NFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGL-EHPFLVNLWYSFQD--EED   89 (384)
T ss_dssp             CGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTC-CCTTBCCEEEEEEC--SSE
T ss_pred             ChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhC-CCCCCCcEEEEEEe--CCE
Confidence            467899999999999999999999999999999998642      235788999999999 99999999999965  467


Q ss_pred             cEEEEEeecCCChhhhcC---CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCC
Q 015374          197 PSLIFEYVNSTDFKVLYP---TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG  273 (408)
Q Consensus       197 ~~lv~e~~~~~~l~~~~~---~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~  273 (408)
                      .++||||+.+++|..++.   .+++..++.++.|++.||.|||++||+||||||+|||++.+ +.+||+|||++......
T Consensus        90 ~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~-g~vkL~DFG~a~~~~~~  168 (384)
T 4fr4_A           90 MFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEH-GHVHITDFNIAAMLPRE  168 (384)
T ss_dssp             EEEEECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT-SCEEECCCTTCEECCTT
T ss_pred             EEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCC-CCEEEeccceeeeccCC
Confidence            899999999999988873   58999999999999999999999999999999999999988 89999999999987766


Q ss_pred             CcceeeccCccccccccccC--CcCCCccccHHHHHHHHHHHHhCCCCCCCCCC-CHHHHHHHHhhhchhhhhcCCCCCC
Q 015374          274 KEYNVRVASRYFKGPELLVD--LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHD-NHDQLVKIAKDCCLIIWCNSRHSRK  350 (408)
Q Consensus       274 ~~~~~~~~~~~y~aPE~~~~--~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~  350 (408)
                      ......+||+.|+|||++.+  ...++.++|||||||++|+|++|..||..... ....+......              
T Consensus       169 ~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~--------------  234 (384)
T 4fr4_A          169 TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFET--------------  234 (384)
T ss_dssp             CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHH--------------
T ss_pred             CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhh--------------
Confidence            66677899999999999974  24589999999999999999999999854322 22222222211              


Q ss_pred             CccccccccCCCCCCHHHHHHHHHhcccCcCCCCC-HHHHhcCCCccccccch
Q 015374          351 PWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLT-AREAMAHPYFAQVRAAE  402 (408)
Q Consensus       351 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt-~~elL~hp~f~~~~~~~  402 (408)
                           .....+..+++++.+||.+||+.||++||+ ++++++||||+.+.+..
T Consensus       235 -----~~~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~hp~f~~~~w~~  282 (384)
T 4fr4_A          235 -----TVVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMNDINWDA  282 (384)
T ss_dssp             -----CCCCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHTSGGGTTCCHHH
T ss_pred             -----cccCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHcChhhhcCCHHH
Confidence                 011223447899999999999999999998 99999999999987754

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=4.5e-49  Score=382.94  Aligned_cols=255  Identities=26%  Similarity=0.487  Sum_probs=217.4

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc---chHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccEEE
Q 015374          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV---KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI  200 (408)
Q Consensus       124 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  200 (408)
                      .++|++.+.||+|+||+||+|++..+++.||+|+++..   ....+.+|+.+++++ +||||++++++|.+  ....++|
T Consensus        50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~~~~~~~~--~~~~~lv  126 (387)
T 1kob_A           50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQL-HHPKLINLHDAFED--KYEMVLI  126 (387)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTC-CSTTBCCEEEEEEC--SSEEEEE
T ss_pred             ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhC-CCcCCCeEEEEEEe--CCEEEEE
Confidence            46899999999999999999999999999999998643   345788999999999 99999999999965  4678999


Q ss_pred             EEeecCCChhhhcC----CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCC-CCcEEEEecccceeccCCCc
Q 015374          201 FEYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE-LRKLRLIDWGLAEFYHPGKE  275 (408)
Q Consensus       201 ~e~~~~~~l~~~~~----~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~-~~~~kl~DfG~a~~~~~~~~  275 (408)
                      |||+++++|..++.    .+++..+..++.|++.||+|||++||+||||||+|||++.+ .+.+||+|||+++.......
T Consensus       127 ~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~~  206 (387)
T 1kob_A          127 LEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI  206 (387)
T ss_dssp             EECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSC
T ss_pred             EEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecCCCcc
Confidence            99999999988873    48999999999999999999999999999999999999853 36799999999998876666


Q ss_pred             ceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCCCcccc
Q 015374          276 YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSKF  355 (408)
Q Consensus       276 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  355 (408)
                      .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||. +.+..+.+..+....       ..         
T Consensus       207 ~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~Pf~-~~~~~~~~~~i~~~~-------~~---------  268 (387)
T 1kob_A          207 VKVTTATAEFAAPEIVDR-EPVGFYTDMWAIGVLGYVLLSGLSPFA-GEDDLETLQNVKRCD-------WE---------  268 (387)
T ss_dssp             EEEECSSGGGCCHHHHTT-CCBCHHHHHHHHHHHHHHHHHSCCSSC-CSSHHHHHHHHHHCC-------CC---------
T ss_pred             eeeeccCCCccCchhccC-CCCCCcccEeeHhHHHHHHHhCCCCCC-CCCHHHHHHHHHhCC-------CC---------
Confidence            667789999999999987 789999999999999999999999984 444444444433210       00         


Q ss_pred             ccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccccc
Q 015374          356 INADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVR  399 (408)
Q Consensus       356 ~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~~~  399 (408)
                      ........+++++.+||.+||+.||++|||++|+|+||||+...
T Consensus       269 ~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~  312 (387)
T 1kob_A          269 FDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDH  312 (387)
T ss_dssp             CCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSCC
T ss_pred             CCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCccccCCc
Confidence            11222345789999999999999999999999999999998653

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=8.9e-50  Score=388.08  Aligned_cols=274  Identities=30%  Similarity=0.533  Sum_probs=221.3

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecccchHHHHHHHHHHHHhcCCCCceEEeeEEEcc----------
Q 015374          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQ----------  192 (408)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~----------  192 (408)
                      ..++|++.+.||+|+||+||+|++..+++.||||++... .....+|+.+++.+ +||||++++++|...          
T Consensus         5 ~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~-~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~~~~~~~   82 (383)
T 3eb0_A            5 SSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQD-PRYKNRELDIMKVL-DHVNIIKLVDYFYTTGDEEPKPPQP   82 (383)
T ss_dssp             -CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECC-TTSCCHHHHHHTTC-CCTTBCCEEEEEEEC----------
T ss_pred             ccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecC-cchHHHHHHHHHHc-CCCCccchhheeeecCccccccccc
Confidence            467899999999999999999999999999999998643 33445899999999 999999999998542          


Q ss_pred             --------------------------CCCccEEEEEeecCCChhhhc-------CCCChHHHHHHHHHHHHHHHHHHHCC
Q 015374          193 --------------------------HSKTPSLIFEYVNSTDFKVLY-------PTLTDYDIRYYIYELLKALDYCHSQG  239 (408)
Q Consensus       193 --------------------------~~~~~~lv~e~~~~~~l~~~~-------~~l~~~~~~~i~~qi~~~L~~LH~~~  239 (408)
                                                .....++||||+++ +|...+       ..+++..++.++.|++.||.|||++|
T Consensus        83 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g  161 (383)
T 3eb0_A           83 PDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLG  161 (383)
T ss_dssp             ---------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT
T ss_pred             ccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCc
Confidence                                      23457899999996 444333       45899999999999999999999999


Q ss_pred             cEEecCCCCcEEEeCCCCcEEEEecccceeccCCCcceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCC
Q 015374          240 IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEP  319 (408)
Q Consensus       240 iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~p  319 (408)
                      |+||||||+|||++.+.+.+||+|||+++............+|..|+|||++.+...++.++|||||||++|||++|+.|
T Consensus       162 i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~p  241 (383)
T 3eb0_A          162 ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPL  241 (383)
T ss_dssp             EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred             CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHhCCCC
Confidence            99999999999998544899999999999877666666778999999999998756799999999999999999999988


Q ss_pred             CCCCCCCHHHHHHHHhhhchhhhh-----cCCCCCCCccc----cccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHh
Q 015374          320 FFYGHDNHDQLVKIAKDCCLIIWC-----NSRHSRKPWSK----FINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAM  390 (408)
Q Consensus       320 f~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~----~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL  390 (408)
                      | .+.+..+++..++...|.....     ........+..    ......+..+++++.+||.+||++||++|||+.|+|
T Consensus       242 f-~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l  320 (383)
T 3eb0_A          242 F-SGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPYEAM  320 (383)
T ss_dssp             S-CCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHH
T ss_pred             C-CCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCCHHHHh
Confidence            7 6677778888888776643211     11111111110    011223445789999999999999999999999999


Q ss_pred             cCCCcccccc
Q 015374          391 AHPYFAQVRA  400 (408)
Q Consensus       391 ~hp~f~~~~~  400 (408)
                      +||||+.++.
T Consensus       321 ~hp~f~~~~~  330 (383)
T 3eb0_A          321 AHPFFDHLRN  330 (383)
T ss_dssp             TSGGGHHHHH
T ss_pred             cCHHHHHHHh
Confidence            9999998764

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=5.3e-49  Score=371.40  Aligned_cols=274  Identities=31%  Similarity=0.532  Sum_probs=212.3

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecccc-----hHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccE
Q 015374          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK-----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS  198 (408)
Q Consensus       124 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  198 (408)
                      .++|++.++||+|+||+||+|++..+++.||+|++....     .+.+.+|+.+++++ +||||+++++++.+  ....+
T Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~--~~~~~   78 (311)
T 4agu_A            2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQL-KHPNLVNLLEVFRR--KRRLH   78 (311)
T ss_dssp             -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHC-CCTTBCCEEEEEEE--TTEEE
T ss_pred             cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhC-CCCCccchhheeec--CCeEE
Confidence            368999999999999999999999999999999885322     35678999999999 99999999999965  46788


Q ss_pred             EEEEeecCCChhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCC-C
Q 015374          199 LIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG-K  274 (408)
Q Consensus       199 lv~e~~~~~~l~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~-~  274 (408)
                      +||||++++++..++   ..+++..+..++.|++.||.|||++||+||||||+|||++.+ +.+||+|||++...... .
T Consensus        79 lv~e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~-~~~kl~Dfg~~~~~~~~~~  157 (311)
T 4agu_A           79 LVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKH-SVIKLCDFGFARLLTGPSD  157 (311)
T ss_dssp             EEEECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT-SCEEECCCTTCEECC----
T ss_pred             EEEEeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCC-CCEEEeeCCCchhccCccc
Confidence            999999999988875   458999999999999999999999999999999999999988 79999999999876533 2


Q ss_pred             cceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhh------hcC-CC
Q 015374          275 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIW------CNS-RH  347 (408)
Q Consensus       275 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~------~~~-~~  347 (408)
                      ......+|..|+|||++.+...++.++||||||+++|+|++|..|| .+.+..+....+....+....      ... ..
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (311)
T 4agu_A          158 YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLW-PGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYF  236 (311)
T ss_dssp             --------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSC-CCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGG
T ss_pred             ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHHHhccccccccccccccccc
Confidence            3345688999999999987677899999999999999999999987 555556666555544332110      000 00


Q ss_pred             CCCCccc--c--ccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccccccch
Q 015374          348 SRKPWSK--F--INADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAE  402 (408)
Q Consensus       348 ~~~~~~~--~--~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~~~~~~  402 (408)
                      .......  .  ........+++++.+|+.+||+.||++|||++|+|+||||++++..+
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~  295 (311)
T 4agu_A          237 SGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIREIE  295 (311)
T ss_dssp             TTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTCC---
T ss_pred             ccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhccCHH
Confidence            0000000  0  00011134789999999999999999999999999999999987654

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=4.8e-49  Score=378.04  Aligned_cols=252  Identities=23%  Similarity=0.402  Sum_probs=217.3

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc------chHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCc
Q 015374          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT  196 (408)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  196 (408)
                      ..++|++++.||+|+||+||+|++..+++.||+|+++..      ..+.+.+|+.+++.+ +||||+++++++.+  ...
T Consensus        39 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~--~~~  115 (350)
T 1rdq_E           39 QLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVKLEFSFKD--NSN  115 (350)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTC-CCTTBCCEEEEEEC--SSE
T ss_pred             CHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEEc--CCE
Confidence            357899999999999999999999999999999998643      235688999999999 99999999999965  467


Q ss_pred             cEEEEEeecCCChhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCC
Q 015374          197 PSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG  273 (408)
Q Consensus       197 ~~lv~e~~~~~~l~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~  273 (408)
                      .++||||+++++|..++   ..+++..++.++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+++.....
T Consensus       116 ~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~-g~~kL~DFg~a~~~~~~  194 (350)
T 1rdq_E          116 LYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQ-GYIQVTDFGFAKRVKGR  194 (350)
T ss_dssp             EEEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT-SCEEECCCTTCEECSSC
T ss_pred             EEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCC-CCEEEcccccceeccCC
Confidence            89999999999998887   469999999999999999999999999999999999999988 79999999999876532


Q ss_pred             CcceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCCCcc
Q 015374          274 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWS  353 (408)
Q Consensus       274 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  353 (408)
                        ....+||+.|+|||++.+ ..++.++|||||||++|||++|..||. +.+..+....+...                 
T Consensus       195 --~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~-~~~~~~~~~~i~~~-----------------  253 (350)
T 1rdq_E          195 --TWTLCGTPEALAPEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF-ADQPIQIYEKIVSG-----------------  253 (350)
T ss_dssp             --BCCCEECGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSC-CSSHHHHHHHHHHC-----------------
T ss_pred             --cccccCCccccCHHHhcC-CCCCCcCCEecccHhHhHHhhCCCCCC-CCCHHHHHHHHHcC-----------------
Confidence              345689999999999987 789999999999999999999999984 44444444444331                 


Q ss_pred             ccccccCCCCCCHHHHHHHHHhcccCcCCCCC-----HHHHhcCCCccccccch
Q 015374          354 KFINADNQHLVSPEAIDFLDKLLRYDHQDRLT-----AREAMAHPYFAQVRAAE  402 (408)
Q Consensus       354 ~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt-----~~elL~hp~f~~~~~~~  402 (408)
                         ....+..+++++.++|.+||+.||++||+     ++|+++||||+.+++..
T Consensus       254 ---~~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~~f~~~~w~~  304 (350)
T 1rdq_E          254 ---KVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIA  304 (350)
T ss_dssp             ---CCCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCCHHH
T ss_pred             ---CCCCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhCcCcCCCCHHH
Confidence               11123347899999999999999999998     99999999999887654

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=1.9e-49  Score=394.66  Aligned_cols=277  Identities=32%  Similarity=0.545  Sum_probs=203.2

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc-----chHHHHHHHHHHHHhcCCCCceEEeeEEEccC---C
Q 015374          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQH---S  194 (408)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~---~  194 (408)
                      ..++|++.+.||+|+||+||+|++..+++.||||++...     ..+.+.+|+.+++++ +||||++++++|....   .
T Consensus        51 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~  129 (458)
T 3rp9_A           51 IPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRL-NHDHVVKVLDIVIPKDVEKF  129 (458)
T ss_dssp             SCTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHC-CCTTBCCEEEECCCSCTTTC
T ss_pred             cCCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhC-CCCCCCceEEEEecCCcccC
Confidence            468999999999999999999999999999999998642     346788999999999 9999999999985432   2


Q ss_pred             CccEEEEEeecCCChhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceecc
Q 015374          195 KTPSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH  271 (408)
Q Consensus       195 ~~~~lv~e~~~~~~l~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~  271 (408)
                      ...++||||++ ++|..++   ..+++..++.++.||+.||.|||++||+||||||+|||++.+ +.+||+|||+++...
T Consensus       130 ~~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~-~~~kl~DFGla~~~~  207 (458)
T 3rp9_A          130 DELYVVLEIAD-SDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQD-CSVKVCDFGLARTVD  207 (458)
T ss_dssp             CCEEEEECCCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTT-CCEEECCCTTCBCTT
T ss_pred             ceEEEEEeccc-cchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCC-CCEeecccccchhcc
Confidence            56899999986 4565555   348999999999999999999999999999999999999998 799999999998764


Q ss_pred             CCC----------------------------cceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhC-------
Q 015374          272 PGK----------------------------EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFR-------  316 (408)
Q Consensus       272 ~~~----------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g-------  316 (408)
                      ...                            .....+||+.|+|||++.....++.++|||||||++|||++|       
T Consensus       208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~~  287 (458)
T 3rp9_A          208 YPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAY  287 (458)
T ss_dssp             SCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCSS
T ss_pred             CccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccccccc
Confidence            221                            223457899999999886657899999999999999999984       


Q ss_pred             ---CCCCCCCCC--------------------CHHHHHHHHhhhchhhhhcCCCCC-----------CCccccccccCCC
Q 015374          317 ---KEPFFYGHD--------------------NHDQLVKIAKDCCLIIWCNSRHSR-----------KPWSKFINADNQH  362 (408)
Q Consensus       317 ---~~pf~~~~~--------------------~~~~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~  362 (408)
                         +.|+|.+.+                    +.+++..+....|...........           .............
T Consensus       288 ~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  367 (458)
T 3rp9_A          288 HADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFP  367 (458)
T ss_dssp             GGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGGST
T ss_pred             cccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHHCC
Confidence               334445543                    245566666655533311100000           0000000112223


Q ss_pred             CCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccccccch
Q 015374          363 LVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAE  402 (408)
Q Consensus       363 ~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~~~~~~  402 (408)
                      .+++++.+||.+||.+||++|||++|+|+||||++++...
T Consensus       368 ~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~~~~~  407 (458)
T 3rp9_A          368 ASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEVRIAE  407 (458)
T ss_dssp             TSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTCCGG
T ss_pred             CCCHHHHHHHHHHhccCccccCCHHHHhcCHhhhhcCCCc
Confidence            4689999999999999999999999999999999886644

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=3e-49  Score=379.52  Aligned_cols=257  Identities=28%  Similarity=0.414  Sum_probs=199.8

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc-chHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccEEEEE
Q 015374          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFE  202 (408)
Q Consensus       124 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e  202 (408)
                      .++|++.+.||+|+||+||+|++..+++.||||+++.. ..+.+.+|+.+++++ +||||++++++|.+  ....++|||
T Consensus        52 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~--~~~~~lv~e  128 (349)
T 2w4o_A           52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRTEIGVLLRL-SHPNIIKLKEIFET--PTEISLVLE  128 (349)
T ss_dssp             GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC----------CHHHHHC-CCTTBCCEEEEEEC--SSEEEEEEC
T ss_pred             cCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccchhHHHHHHHHHHHHhC-CCCCCcceeeeEec--CCeEEEEEE
Confidence            57899999999999999999999999999999999754 346688999999999 99999999999965  467889999


Q ss_pred             eecCCChhhhcC---CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeC--CCCcEEEEecccceeccCCCcce
Q 015374          203 YVNSTDFKVLYP---TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDH--ELRKLRLIDWGLAEFYHPGKEYN  277 (408)
Q Consensus       203 ~~~~~~l~~~~~---~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~--~~~~~kl~DfG~a~~~~~~~~~~  277 (408)
                      |+++++|..++.   .+++..+..++.|++.||.|||++||+||||||+|||++.  +.+.+||+|||+++.........
T Consensus       129 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~~  208 (349)
T 2w4o_A          129 LVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMK  208 (349)
T ss_dssp             CCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC------------
T ss_pred             eCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccCcccccc
Confidence            999999988774   4899999999999999999999999999999999999975  23789999999998776554555


Q ss_pred             eeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCCCcccccc
Q 015374          278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSKFIN  357 (408)
Q Consensus       278 ~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  357 (408)
                      ...||+.|+|||++.+ ..++.++|||||||++|||++|..||.........+..+.....       .         ..
T Consensus       209 ~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~-------~---------~~  271 (349)
T 2w4o_A          209 TVCGTPGYCAPEILRG-CAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEY-------Y---------FI  271 (349)
T ss_dssp             ----CGGGSCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCC-------C---------CC
T ss_pred             cccCCCCccCHHHhcC-CCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCC-------c---------cC
Confidence            6789999999999987 67999999999999999999999998655444334444433210       0         01


Q ss_pred             ccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccccc
Q 015374          358 ADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRA  400 (408)
Q Consensus       358 ~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~~~~  400 (408)
                      ...+..++.++.+||.+||+.||++|||++|+|+||||+....
T Consensus       272 ~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~  314 (349)
T 2w4o_A          272 SPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPWVTGKAA  314 (349)
T ss_dssp             TTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTTSTTC
T ss_pred             CchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCCcc
Confidence            1122347899999999999999999999999999999987654

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=2.8e-49  Score=381.51  Aligned_cols=254  Identities=26%  Similarity=0.494  Sum_probs=214.1

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc-----chHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccE
Q 015374          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS  198 (408)
Q Consensus       124 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  198 (408)
                      .++|++.+.||+|+||+||+|++..+++.||+|+++..     ..+.+.+|+.+++++ +||||+++++++.+  ....+
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~~~~~~~~--~~~~~  104 (362)
T 2bdw_A           28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKL-QHPNIVRLHDSIQE--ESFHY  104 (362)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEEC--SSEEE
T ss_pred             ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEEe--CCEEE
Confidence            46899999999999999999999999999999998642     235688999999999 99999999999965  46789


Q ss_pred             EEEEeecCCChhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCC--CcEEEEecccceeccCC
Q 015374          199 LIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEL--RKLRLIDWGLAEFYHPG  273 (408)
Q Consensus       199 lv~e~~~~~~l~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~--~~~kl~DfG~a~~~~~~  273 (408)
                      +||||+.+++|...+   ..+++..+..++.|++.||.|||++||+||||||+|||++.+.  +.+||+|||++......
T Consensus       105 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~  184 (362)
T 2bdw_A          105 LVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS  184 (362)
T ss_dssp             EEECCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTC
T ss_pred             EEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecCC
Confidence            999999999998776   3489999999999999999999999999999999999998652  36999999999877655


Q ss_pred             CcceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCCCcc
Q 015374          274 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWS  353 (408)
Q Consensus       274 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  353 (408)
                      .......||+.|+|||++.+ ..++.++|||||||++|+|++|..||. +.+..+....+.....       ..      
T Consensus       185 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~Pf~-~~~~~~~~~~i~~~~~-------~~------  249 (362)
T 2bdw_A          185 EAWHGFAGTPGYLSPEVLKK-DPYSKPVDIWACGVILYILLVGYPPFW-DEDQHRLYAQIKAGAY-------DY------  249 (362)
T ss_dssp             CSCCCSCSCTTTCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSSC-CSSHHHHHHHHHHTCC-------CC------
T ss_pred             cccccCCCCccccCHHHHcc-CCCCchhhHHHHHHHHHHHHHCCCCCC-CCCHHHHHHHHHhCCC-------CC------
Confidence            55566789999999999987 789999999999999999999999984 3343444444333210       01      


Q ss_pred             ccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccc
Q 015374          354 KFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQV  398 (408)
Q Consensus       354 ~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~~  398 (408)
                         +...+..+++++.+||.+||+.||++|||++|+|+||||+..
T Consensus       250 ---~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~  291 (362)
T 2bdw_A          250 ---PSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNR  291 (362)
T ss_dssp             ---CTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTSHHHHTH
T ss_pred             ---CcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcccCCC
Confidence               111223478999999999999999999999999999999754

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=2.5e-49  Score=377.66  Aligned_cols=248  Identities=22%  Similarity=0.434  Sum_probs=208.6

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc------chHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCcc
Q 015374          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP  197 (408)
Q Consensus       124 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~  197 (408)
                      .++|++.+.||+|+||+||+|++..+++.||+|+++..      ....+.+|+.+++.+ +||||+++++++.+  ....
T Consensus         8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~--~~~~   84 (336)
T 3h4j_B            8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLL-RHPHIIKLYDVITT--PTDI   84 (336)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTC-CCTTBCCEEEEEEC--SSEE
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhC-CCCCCCeEEEEEEe--CCEE
Confidence            57899999999999999999999999999999998642      235788999999999 99999999999965  4678


Q ss_pred             EEEEEeecCCChhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCCC
Q 015374          198 SLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK  274 (408)
Q Consensus       198 ~lv~e~~~~~~l~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~~  274 (408)
                      ++||||++ |++..++   ..+++..++.++.|++.||.|||++||+||||||+|||++.+ +.+||+|||++.......
T Consensus        85 ~lv~E~~~-g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~-~~~kl~DFG~s~~~~~~~  162 (336)
T 3h4j_B           85 VMVIEYAG-GELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDN-LNVKIADFGLSNIMTDGN  162 (336)
T ss_dssp             EEEECCCC-EEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTT-CCEEECCSSCTBTTTTSB
T ss_pred             EEEEECCC-CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCC-CCEEEEEeccceeccCCc
Confidence            99999994 5665554   569999999999999999999999999999999999999988 799999999998877666


Q ss_pred             cceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCCCccc
Q 015374          275 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSK  354 (408)
Q Consensus       275 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  354 (408)
                      .....+||+.|+|||++.+....+.++|||||||++|+|++|..||...... +..               ..     ..
T Consensus       163 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~-~~~---------------~~-----i~  221 (336)
T 3h4j_B          163 FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIP-NLF---------------KK-----VN  221 (336)
T ss_dssp             TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSST-TCB---------------CC-----CC
T ss_pred             ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHH-HHH---------------HH-----HH
Confidence            6677889999999999987444478999999999999999999998422110 000               00     00


Q ss_pred             cccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccc
Q 015374          355 FINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQ  397 (408)
Q Consensus       355 ~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~  397 (408)
                      ......+..+++++.+|+++||+.||.+|||++|+++||||+.
T Consensus       222 ~~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~  264 (336)
T 3h4j_B          222 SCVYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDPWFNV  264 (336)
T ss_dssp             SSCCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTCHHHHT
T ss_pred             cCCCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhChhhcc
Confidence            0112234557899999999999999999999999999999975

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5.3e-49  Score=380.35  Aligned_cols=269  Identities=32%  Similarity=0.562  Sum_probs=216.6

Q ss_pred             CCCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc-----chHHHHHHHHHHHHhcCCCCceEEeeEEEccCC--
Q 015374          122 GDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHS--  194 (408)
Q Consensus       122 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~--  194 (408)
                      ...++|++.+.||+|+||+||+|++..+++.||||++...     ..+.+.+|+.+++++ +||||+++++++.....  
T Consensus        22 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~  100 (367)
T 1cm8_A           22 EVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHM-RHENVIGLLDVFTPDETLD  100 (367)
T ss_dssp             CCBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHC-CBTTBCCCSEEECSCSSTT
T ss_pred             eecceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhC-CCcCCCCceeeEecCCccc
Confidence            4568999999999999999999999999999999998532     245688999999999 89999999999965422  


Q ss_pred             --CccEEEEEeecCCChhhhc--CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceec
Q 015374          195 --KTPSLIFEYVNSTDFKVLY--PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY  270 (408)
Q Consensus       195 --~~~~lv~e~~~~~~l~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~  270 (408)
                        ...++||||+ +++|..++  ..+++..+..++.|++.||.|||++||+||||||+|||++.+ +.+||+|||+++..
T Consensus       101 ~~~~~~lv~e~~-~~~L~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~-~~~kl~Dfg~a~~~  178 (367)
T 1cm8_A          101 DFTDFYLVMPFM-GTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNED-CELKILDFGLARQA  178 (367)
T ss_dssp             TCCCCEEEEECC-SEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTT-CCEEECCCTTCEEC
T ss_pred             cCceEEEEEecC-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCC-CCEEEEeeeccccc
Confidence              3568999999 77887776  468999999999999999999999999999999999999988 79999999999876


Q ss_pred             cCCCcceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhc------
Q 015374          271 HPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCN------  344 (408)
Q Consensus       271 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~------  344 (408)
                      ..  ......+|..|+|||++.+...++.++|||||||++|||++|+.|| .+.+..+++..+....|......      
T Consensus       179 ~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf-~~~~~~~~l~~i~~~~g~~~~~~~~~~~~  255 (367)
T 1cm8_A          179 DS--EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLF-KGSDHLDQLKEIMKVTGTPPAEFVQRLQS  255 (367)
T ss_dssp             CS--SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSS-CCSSHHHHHHHHHHHHCCCCHHHHHTCSC
T ss_pred             cc--ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHHhcCCCCHHHHHHhhh
Confidence            43  3345688999999999987667999999999999999999999997 56677788888877666432111      


Q ss_pred             ----------CCCCCCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccccccc
Q 015374          345 ----------SRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAA  401 (408)
Q Consensus       345 ----------~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~~~~~  401 (408)
                                .......+.     .....+++++.+|+.+||+.||++|||++|+|+||||+.....
T Consensus       256 ~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~~~  317 (367)
T 1cm8_A          256 DEAKNYMKGLPELEKKDFA-----SILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDT  317 (367)
T ss_dssp             HHHHHHHHHSCCCCCCCGG-----GTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC--
T ss_pred             HHHHHHHHhCCCCCCCCHH-----HHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhcCC
Confidence                      011111111     1223468999999999999999999999999999999987543

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=2.3e-49  Score=374.36  Aligned_cols=248  Identities=23%  Similarity=0.286  Sum_probs=201.3

Q ss_pred             CCCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc-----chHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCc
Q 015374          122 GDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT  196 (408)
Q Consensus       122 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  196 (408)
                      ...++|++.++||+|+||+||+|++..+++.||||++...     .......|+..+.++.+|+||++++++|.+  +..
T Consensus        54 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~--~~~  131 (311)
T 3p1a_A           54 FFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEE--GGI  131 (311)
T ss_dssp             HHHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE--TTE
T ss_pred             hhhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEe--CCE
Confidence            3457899999999999999999999999999999998532     234456677777776699999999999965  577


Q ss_pred             cEEEEEeecCCChhhhc----CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccC
Q 015374          197 PSLIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP  272 (408)
Q Consensus       197 ~~lv~e~~~~~~l~~~~----~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~  272 (408)
                      .++||||+++ +|..++    ..+++..+..++.|++.||+|||+++|+||||||+|||++.+ +.+||+|||++.....
T Consensus       132 ~~lv~e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~-~~~kl~DFG~a~~~~~  209 (311)
T 3p1a_A          132 LYLQTELCGP-SLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPR-GRCKLGDFGLLVELGT  209 (311)
T ss_dssp             EEEEEECCCC-BHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGG-GCEEECCCTTCEECC-
T ss_pred             EEEEEeccCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCC-CCEEEccceeeeeccc
Confidence            8999999954 555554    359999999999999999999999999999999999999988 7999999999987766


Q ss_pred             CCcceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCCCc
Q 015374          273 GKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPW  352 (408)
Q Consensus       273 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  352 (408)
                      ........||..|+|||++.+  .++.++|||||||++|||++|..||+..    +....+....               
T Consensus       210 ~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~el~~g~~~~~~~----~~~~~~~~~~---------------  268 (311)
T 3p1a_A          210 AGAGEVQEGDPRYMAPELLQG--SYGTAADVFSLGLTILEVACNMELPHGG----EGWQQLRQGY---------------  268 (311)
T ss_dssp             -----CCCCCGGGCCGGGGGT--CCSTHHHHHHHHHHHHHHHHTCCCCSSH----HHHHHHTTTC---------------
T ss_pred             CCCCcccCCCccccCHhHhcC--CCCchhhHHHHHHHHHHHHhCCCCCCCc----cHHHHHhccC---------------
Confidence            555566779999999999875  6899999999999999999998777432    2222221110               


Q ss_pred             cccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccc
Q 015374          353 SKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQ  397 (408)
Q Consensus       353 ~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~  397 (408)
                         .....+..+++++.+|+.+||+.||++|||++|+|+||||++
T Consensus       269 ---~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~  310 (311)
T 3p1a_A          269 ---LPPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLALPVLRQ  310 (311)
T ss_dssp             ---CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGSC
T ss_pred             ---CCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHHhCccccC
Confidence               111223447899999999999999999999999999999985

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.7e-49  Score=377.37  Aligned_cols=271  Identities=28%  Similarity=0.551  Sum_probs=211.1

Q ss_pred             CCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecccch----HHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccEEE
Q 015374          125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKK----KKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI  200 (408)
Q Consensus       125 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  200 (408)
                      ++|++.++||+|+||+||+|++..+++.||+|+++....    ..+.+|+.+++++ +||||+++++++.+  ....++|
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~--~~~~~lv   78 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDL-KHANIVTLHDIIHT--EKSLTLV   78 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCC-CCTTBCCEEEEEEC--SSCEEEE
T ss_pred             CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhc-CCCCCCeeeeEEee--CCEEEEE
Confidence            589999999999999999999999999999999864332    2455799999999 99999999999965  4678999


Q ss_pred             EEeecCCChhhhc----CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCC-Cc
Q 015374          201 FEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG-KE  275 (408)
Q Consensus       201 ~e~~~~~~l~~~~----~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~-~~  275 (408)
                      |||+++ ++..++    ..+++..++.++.|++.||.|||++||+||||||+|||++.+ +.+||+|||++...... ..
T Consensus        79 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~-~~~kl~Dfg~a~~~~~~~~~  156 (324)
T 3mtl_A           79 FEYLDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINER-GELKLADFGLARAKSIPTKT  156 (324)
T ss_dssp             EECCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTT-CCEEECSSSEEECC------
T ss_pred             eccccc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCC-CCEEEccCcccccccCCccc
Confidence            999996 555544    348899999999999999999999999999999999999988 79999999999765432 23


Q ss_pred             ceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCC--------
Q 015374          276 YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRH--------  347 (408)
Q Consensus       276 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~--------  347 (408)
                      .....+|..|+|||++.+...++.++|||||||++|+|++|+.|| .+.+..+.+..+....+.........        
T Consensus       157 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf-~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  235 (324)
T 3mtl_A          157 YDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLF-PGSTVEEQLHFIFRILGTPTEETWPGILSNEEFK  235 (324)
T ss_dssp             ------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSC-CCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHH
T ss_pred             cccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHHHhCCCChHhchhhhcchhhc
Confidence            345678999999999987667899999999999999999999887 56666677777766655332111100        


Q ss_pred             --CCCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccccccc
Q 015374          348 --SRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAA  401 (408)
Q Consensus       348 --~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~~~~~  401 (408)
                        ....+...........+++++.+||.+||++||++|||++|+|+||||+++...
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~  291 (324)
T 3mtl_A          236 TYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGER  291 (324)
T ss_dssp             HTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCST
T ss_pred             ccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhcccc
Confidence              000000000111233578999999999999999999999999999999987654

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=4.7e-49  Score=389.23  Aligned_cols=254  Identities=25%  Similarity=0.476  Sum_probs=212.2

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc-----chHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccE
Q 015374          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS  198 (408)
Q Consensus       124 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  198 (408)
                      .++|++.+.||+|+||+||+|++..+++.+|+|+++..     ..+.+.+|+.+++++ +||||+++++++.+  ....+
T Consensus        10 ~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~--~~~~~   86 (444)
T 3soa_A           10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLL-KHPNIVRLHDSISE--EGHHY   86 (444)
T ss_dssp             HHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHC-CBTTBCCEEEEEEC--SSEEE
T ss_pred             cCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhC-CCcCCCeEEEEEEE--CCEEE
Confidence            57899999999999999999999999999999998642     245688999999999 99999999999965  56789


Q ss_pred             EEEEeecCCChhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCC--CCcEEEEecccceeccCC
Q 015374          199 LIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE--LRKLRLIDWGLAEFYHPG  273 (408)
Q Consensus       199 lv~e~~~~~~l~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~--~~~~kl~DfG~a~~~~~~  273 (408)
                      +||||+.+++|...+   ..+++..+..++.|++.||.|||++||+||||||+|||++.+  .+.+||+|||++......
T Consensus        87 lv~E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~  166 (444)
T 3soa_A           87 LIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGE  166 (444)
T ss_dssp             EEECCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTT
T ss_pred             EEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEecCC
Confidence            999999999998776   569999999999999999999999999999999999999852  368999999999776543


Q ss_pred             Cc-ceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCCCc
Q 015374          274 KE-YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPW  352 (408)
Q Consensus       274 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  352 (408)
                      .. .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||. +.+..+....+.....       .      
T Consensus       167 ~~~~~~~~gt~~Y~APE~l~~-~~~~~~~DIwSlGvilyell~G~~Pf~-~~~~~~~~~~i~~~~~-------~------  231 (444)
T 3soa_A          167 QQAWFGFAGTPGYLSPEVLRK-DPYGKPVDLWACGVILYILLVGYPPFW-DEDQHRLYQQIKAGAY-------D------  231 (444)
T ss_dssp             CCBCCCSCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSCC-CSSHHHHHHHHHHTCC-------C------
T ss_pred             CceeecccCCcccCCHHHhcC-CCCCCccccHHHHHHHHHHHhCCCCCC-CccHHHHHHHHHhCCC-------C------
Confidence            32 345689999999999987 789999999999999999999999983 4444444444433211       0      


Q ss_pred             cccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccc
Q 015374          353 SKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQV  398 (408)
Q Consensus       353 ~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~~  398 (408)
                         .+...+..+++++.+||.+||+.||++|||++|+|+||||+..
T Consensus       232 ---~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~hp~~~~~  274 (444)
T 3soa_A          232 ---FPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALKHPWISHR  274 (444)
T ss_dssp             ---CCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSCTTHHH
T ss_pred             ---CCccccccCCHHHHHHHHHHcCCChhHCCCHHHHhcCccccCC
Confidence               1112234578999999999999999999999999999999754

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=4.7e-49  Score=378.50  Aligned_cols=254  Identities=27%  Similarity=0.468  Sum_probs=211.6

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc--------chHHHHHHHHHHHHhcCCCCceEEeeEEEccCCC
Q 015374          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV--------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSK  195 (408)
Q Consensus       124 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~--------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  195 (408)
                      .++|++.+.||+|+||+||+|++..+++.||||+++..        ..+.+.+|+.+++.+ +||||+++++++.+  ..
T Consensus        23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~--~~   99 (351)
T 3c0i_A           23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHML-KHPHIVELLETYSS--DG   99 (351)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHC-CCTTBCCEEEEEEE--TT
T ss_pred             ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhC-CCCCCCcEEEEEEe--CC
Confidence            56899999999999999999999999999999998632        356789999999999 99999999999965  46


Q ss_pred             ccEEEEEeecCCChhhhcC-------CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCC--CcEEEEeccc
Q 015374          196 TPSLIFEYVNSTDFKVLYP-------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEL--RKLRLIDWGL  266 (408)
Q Consensus       196 ~~~lv~e~~~~~~l~~~~~-------~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~--~~~kl~DfG~  266 (408)
                      ..++||||+++++|...+.       .+++..+..++.|++.||.|||++||+||||||+|||++.+.  ..+||+|||+
T Consensus       100 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~  179 (351)
T 3c0i_A          100 MLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGV  179 (351)
T ss_dssp             EEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred             EEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCcc
Confidence            7899999999999976652       389999999999999999999999999999999999998652  3499999999


Q ss_pred             ceeccCCCc-ceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcC
Q 015374          267 AEFYHPGKE-YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNS  345 (408)
Q Consensus       267 a~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  345 (408)
                      +........ .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||...  +.+....+.....       
T Consensus       180 a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~--~~~~~~~i~~~~~-------  249 (351)
T 3c0i_A          180 AIQLGESGLVAGGRVGTPHFMAPEVVKR-EPYGKPVDVWGCGVILFILLSGCLPFYGT--KERLFEGIIKGKY-------  249 (351)
T ss_dssp             CEECCTTSCBCCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCSS--HHHHHHHHHHTCC-------
T ss_pred             eeEecCCCeeecCCcCCcCccCHHHHcC-CCCCchHhhHHHHHHHHHHHHCCCCCCCc--HHHHHHHHHcCCC-------
Confidence            987765433 345689999999999987 67999999999999999999999998532  2233333322110       


Q ss_pred             CCCCCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccccc
Q 015374          346 RHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVR  399 (408)
Q Consensus       346 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~~~  399 (408)
                        .       .....+..+++++.+||.+||+.||++|||+.|+|+||||+...
T Consensus       250 --~-------~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~~  294 (351)
T 3c0i_A          250 --K-------MNPRQWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKERD  294 (351)
T ss_dssp             --C-------CCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTHH
T ss_pred             --C-------CCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcChhhcCCc
Confidence              0       01112234789999999999999999999999999999998754

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=2e-48  Score=362.52  Aligned_cols=260  Identities=26%  Similarity=0.485  Sum_probs=217.9

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecccc-----hHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCcc
Q 015374          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK-----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP  197 (408)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~  197 (408)
                      ..++|++.+.||+|+||+||+|.+..+++.||+|+++...     ...+.+|+.+++++ +||||+++++++.+  ....
T Consensus         4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~~   80 (284)
T 3kk8_A            4 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKL-QHPNIVRLHDSIQE--ESFH   80 (284)
T ss_dssp             TTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEEC--SSEE
T ss_pred             hhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHc-CCCCcCeEEEEEEc--CCEE
Confidence            4789999999999999999999999999999999986432     35678999999999 99999999999954  4677


Q ss_pred             EEEEEeecCCChhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCC--CcEEEEecccceeccC
Q 015374          198 SLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEL--RKLRLIDWGLAEFYHP  272 (408)
Q Consensus       198 ~lv~e~~~~~~l~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~--~~~kl~DfG~a~~~~~  272 (408)
                      ++||||+++++|...+   ..+++..+..++.|++.||.|||++||+||||||+||+++.+.  +.+||+|||++.....
T Consensus        81 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~  160 (284)
T 3kk8_A           81 YLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND  160 (284)
T ss_dssp             EEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCS
T ss_pred             EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEccc
Confidence            8999999999987765   4589999999999999999999999999999999999998652  3499999999987776


Q ss_pred             CCcceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCCCc
Q 015374          273 GKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPW  352 (408)
Q Consensus       273 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  352 (408)
                      ........+|+.|+|||++.+ ..++.++||||||+++|+|++|+.||. +.+..+....+.....       .      
T Consensus       161 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~-~~~~~~~~~~~~~~~~-------~------  225 (284)
T 3kk8_A          161 SEAWHGFAGTPGYLSPEVLKK-DPYSKPVDIWACGVILYILLVGYPPFW-DEDQHRLYAQIKAGAY-------D------  225 (284)
T ss_dssp             SCBCCCSCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSC-CSSHHHHHHHHHHTCC-------C------
T ss_pred             CccccCCCCCcCCcCchhhcC-CCCCcccchHHHHHHHHHHHHCCCCCC-CCchhHHHHHHHhccc-------c------
Confidence            665566789999999999987 778999999999999999999999984 3333344333332210       0      


Q ss_pred             cccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccccccchh
Q 015374          353 SKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAES  403 (408)
Q Consensus       353 ~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~~~~~~~  403 (408)
                         ........+++++.+|+.+||+.||++|||++|+|+||||++.....+
T Consensus       226 ---~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~~~~  273 (284)
T 3kk8_A          226 ---YPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNRERVAS  273 (284)
T ss_dssp             ---CCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTSHHHHSCCCGGG
T ss_pred             ---CCchhhcccCHHHHHHHHHHcccChhhCCCHHHHhcCccccCChhHHh
Confidence               011122347899999999999999999999999999999998766554

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=8.2e-49  Score=383.63  Aligned_cols=261  Identities=26%  Similarity=0.384  Sum_probs=217.2

Q ss_pred             CCCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc------chHHHHHHHHHHHHhcCCCCceEEeeEEEccCCC
Q 015374          122 GDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSK  195 (408)
Q Consensus       122 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  195 (408)
                      ...++|++.+.||+|+||+||+|++..+++.||+|++++.      ....+.+|..++..+ +||||++++++|.+  ..
T Consensus        58 ~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~-~hp~Iv~l~~~~~~--~~  134 (412)
T 2vd5_A           58 LQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNG-DRRWITQLHFAFQD--EN  134 (412)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHS-CTTTBCCEEEEEEC--SS
T ss_pred             CChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhc-CCCCeeeEEEEEee--CC
Confidence            3568999999999999999999999999999999999642      234588999999998 99999999999965  46


Q ss_pred             ccEEEEEeecCCChhhhc----CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceecc
Q 015374          196 TPSLIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH  271 (408)
Q Consensus       196 ~~~lv~e~~~~~~l~~~~----~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~  271 (408)
                      ..++||||+++++|..++    ..+++..++.++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+++...
T Consensus       135 ~~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~-g~vkL~DFGla~~~~  213 (412)
T 2vd5_A          135 YLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRC-GHIRLADFGSCLKLR  213 (412)
T ss_dssp             EEEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT-SCEEECCCTTCEECC
T ss_pred             EEEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCC-CCEEEeechhheecc
Confidence            789999999999999887    368999999999999999999999999999999999999988 899999999998775


Q ss_pred             CCCcc--eeeccCccccccccccC------CcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhh
Q 015374          272 PGKEY--NVRVASRYFKGPELLVD------LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWC  343 (408)
Q Consensus       272 ~~~~~--~~~~~~~~y~aPE~~~~------~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  343 (408)
                      .....  ...+||+.|+|||++..      ...++.++|||||||++|||++|+.||. +.+..+....+........  
T Consensus       214 ~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~-~~~~~~~~~~i~~~~~~~~--  290 (412)
T 2vd5_A          214 ADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFY-ADSTAETYGKIVHYKEHLS--  290 (412)
T ss_dssp             TTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTC-CSSHHHHHHHHHTHHHHCC--
T ss_pred             CCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCC-CCCHHHHHHHHHhcccCcC--
Confidence            54332  34589999999999973      2568999999999999999999999984 4444555555543211000  


Q ss_pred             cCCCCCCCccccccccCCCCCCHHHHHHHHHhcccCcCCC---CCHHHHhcCCCccccccchh
Q 015374          344 NSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDR---LTAREAMAHPYFAQVRAAES  403 (408)
Q Consensus       344 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R---pt~~elL~hp~f~~~~~~~~  403 (408)
                                   .+.....+++++++||++||+ +|.+|   ++++|+++||||+.+++...
T Consensus       291 -------------~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~i~w~~l  339 (412)
T 2vd5_A          291 -------------LPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFGLDWDGL  339 (412)
T ss_dssp             -------------CC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTTCCSTTS
T ss_pred             -------------CCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCCCCHHHH
Confidence                         011123479999999999999 99998   59999999999999887654

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=4.6e-49  Score=375.24  Aligned_cols=274  Identities=28%  Similarity=0.568  Sum_probs=212.4

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecccc-----hHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCcc
Q 015374          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK-----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP  197 (408)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~  197 (408)
                      ..++|++.++||+|+||+||+|++..+++.||||+++...     ...+.+|+.+++++ +||||+++++++.+  ....
T Consensus        32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~--~~~~  108 (329)
T 3gbz_A           32 SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKEL-QHRNIIELKSVIHH--NHRL  108 (329)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGC-CCTTBCCEEEEEEE--TTEE
T ss_pred             chhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHc-CCCCcceEEEEEec--CCEE
Confidence            3578999999999999999999999999999999996432     34577999999999 99999999999965  4678


Q ss_pred             EEEEEeecCCChhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCC----CCcEEEEecccceec
Q 015374          198 SLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE----LRKLRLIDWGLAEFY  270 (408)
Q Consensus       198 ~lv~e~~~~~~l~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~----~~~~kl~DfG~a~~~  270 (408)
                      ++||||+++ +|..++   ..+++..++.++.|++.||.|||++||+||||||+|||++.+    .+.+||+|||++...
T Consensus       109 ~lv~e~~~~-~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~  187 (329)
T 3gbz_A          109 HLIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAF  187 (329)
T ss_dssp             EEEEECCSE-EHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHH
T ss_pred             EEEEecCCC-CHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCcccc
Confidence            999999996 666665   358999999999999999999999999999999999999633    246999999999766


Q ss_pred             cCC-CcceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCC--
Q 015374          271 HPG-KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRH--  347 (408)
Q Consensus       271 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~--  347 (408)
                      ... .......+|..|+|||++.+...++.++|||||||++|+|++|..|| .+.+..+.+..+....+.........  
T Consensus       188 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf-~~~~~~~~~~~~~~~~~~~~~~~~~~~~  266 (329)
T 3gbz_A          188 GIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLF-PGDSEIDQLFKIFEVLGLPDDTTWPGVT  266 (329)
T ss_dssp             C-----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSS-CCSSHHHHHHHHHHHHCCCCTTTSTTGG
T ss_pred             CCcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCc-CCCCHHHHHHHHHHHhCCCchhhhhhhh
Confidence            432 23445678999999999987566899999999999999999999987 56666677777776655332111100  


Q ss_pred             CCCCcccc--------ccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccccccc
Q 015374          348 SRKPWSKF--------INADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAA  401 (408)
Q Consensus       348 ~~~~~~~~--------~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~~~~~  401 (408)
                      ....|...        ........+++++.+||.+||+.||++|||++|+|+||||++....
T Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~  328 (329)
T 3gbz_A          267 ALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHNDFD  328 (329)
T ss_dssp             GSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSSCSC
T ss_pred             hhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCCCCCC
Confidence            00011110        0111123368999999999999999999999999999999987653

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=9.8e-49  Score=381.44  Aligned_cols=273  Identities=19%  Similarity=0.260  Sum_probs=208.8

Q ss_pred             CCCCEEEEeeeeee--CceEEEEEEEcCCCcEEEEEEecccc-----hHHHHHHHHHHHHhcCCCCceEEeeEEEccCCC
Q 015374          123 DQDDYEVVRKVGRG--KYSEVFEGINVNTNERCIIKILKPVK-----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSK  195 (408)
Q Consensus       123 ~~~~y~~~~~lG~G--~fg~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  195 (408)
                      ..++|++.++||+|  +||+||+|++..+++.||||+++...     .+.+.+|+.+++++ +||||++++++|.+  ..
T Consensus        23 ~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~--~~   99 (389)
T 3gni_B           23 EGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLF-NHPNIVPYRATFIA--DN   99 (389)
T ss_dssp             CGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEEE--TT
T ss_pred             CCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhC-CCCCCCcEeEEEEE--CC
Confidence            57789999999999  99999999999999999999996432     35678899999999 99999999999965  46


Q ss_pred             ccEEEEEeecCCChhhhc-----CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceec
Q 015374          196 TPSLIFEYVNSTDFKVLY-----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY  270 (408)
Q Consensus       196 ~~~lv~e~~~~~~l~~~~-----~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~  270 (408)
                      ..++||||+++++|..++     ..+++..+..++.|++.||.|||++||+||||||+|||++.+ +.+||+|||++...
T Consensus       100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~-~~~kl~dfg~~~~~  178 (389)
T 3gni_B          100 ELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVD-GKVYLSGLRSNLSM  178 (389)
T ss_dssp             EEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT-CCEEECCGGGCEEC
T ss_pred             EEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCC-CCEEEcccccceee
Confidence            789999999999998886     458999999999999999999999999999999999999988 79999999998654


Q ss_pred             cCCC--------cceeeccCccccccccccCC-cCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhh
Q 015374          271 HPGK--------EYNVRVASRYFKGPELLVDL-QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLII  341 (408)
Q Consensus       271 ~~~~--------~~~~~~~~~~y~aPE~~~~~-~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~  341 (408)
                      ....        ......||..|+|||++.+. ..++.++|||||||++|+|++|+.||.. .+..+.+..+........
T Consensus       179 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~-~~~~~~~~~~~~~~~~~~  257 (389)
T 3gni_B          179 ISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKD-MPATQMLLEKLNGTVPCL  257 (389)
T ss_dssp             EETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTT-CCSTTHHHHC--------
T ss_pred             ccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCC-CCHHHHHHHHhcCCCCcc
Confidence            3221        12234788899999999763 4689999999999999999999999844 333333322221100000


Q ss_pred             hh--------------------------cCCCCCCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCc
Q 015374          342 WC--------------------------NSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF  395 (408)
Q Consensus       342 ~~--------------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f  395 (408)
                      ..                          .................+..+++++.+||.+||+.||++|||++|+|+||||
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~f  337 (389)
T 3gni_B          258 LDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFF  337 (389)
T ss_dssp             ------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGGG
T ss_pred             ccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHHH
Confidence            00                          0000000001111122345578999999999999999999999999999999


Q ss_pred             ccccc
Q 015374          396 AQVRA  400 (408)
Q Consensus       396 ~~~~~  400 (408)
                      +++..
T Consensus       338 ~~~~~  342 (389)
T 3gni_B          338 KQIKR  342 (389)
T ss_dssp             GGC--
T ss_pred             HHHhh
Confidence            98765

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=4.3e-49  Score=380.15  Aligned_cols=256  Identities=23%  Similarity=0.431  Sum_probs=198.9

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc--chHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccEEE
Q 015374          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV--KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI  200 (408)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  200 (408)
                      ..++|++.+.||+|+||+||+|++..+++.||+|++...  ..+.+.+|+.+++++ +||||+++++++.+  ....++|
T Consensus        18 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~--~~~~~lv   94 (361)
T 3uc3_A           18 DSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSL-RHPNIVRFKEVILT--PTHLAII   94 (361)
T ss_dssp             CTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSCHHHHHHHHHHHHC-CCTTBCCEEEEEEC--SSEEEEE
T ss_pred             CCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccccHHHHHHHHHHHhC-CCCCCCcEEEEEee--CCEEEEE
Confidence            478999999999999999999999999999999999743  346788999999999 99999999999965  4678999


Q ss_pred             EEeecCCChhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCC-CcEEEEecccceeccCCCcc
Q 015374          201 FEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEL-RKLRLIDWGLAEFYHPGKEY  276 (408)
Q Consensus       201 ~e~~~~~~l~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~-~~~kl~DfG~a~~~~~~~~~  276 (408)
                      |||+++++|..++   ..+++..++.++.|++.||.|||++||+||||||+|||++.+. +.+||+|||+++........
T Consensus        95 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~~~  174 (361)
T 3uc3_A           95 MEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP  174 (361)
T ss_dssp             EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC---------
T ss_pred             EEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCccccccccCCC
Confidence            9999999998876   4699999999999999999999999999999999999998762 24999999999865544455


Q ss_pred             eeeccCccccccccccCCcCCCc-cccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCCCcccc
Q 015374          277 NVRVASRYFKGPELLVDLQDYDY-SLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSKF  355 (408)
Q Consensus       277 ~~~~~~~~y~aPE~~~~~~~~~~-~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  355 (408)
                      ....||+.|+|||++.+ ..++. ++|||||||++|+|++|+.||........ ..........     ..         
T Consensus       175 ~~~~gt~~y~aPE~~~~-~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~-~~~~~~~~~~-----~~---------  238 (361)
T 3uc3_A          175 KSTVGTPAYIAPEVLLR-QEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRD-YRKTIQRILS-----VK---------  238 (361)
T ss_dssp             ------CTTSCHHHHHC-SSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCC-HHHHHHHHHT-----TC---------
T ss_pred             CCCcCCCCcCChhhhcC-CCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHH-HHHHHHHHhc-----CC---------
Confidence            56789999999999987 45544 48999999999999999999854332211 1111111000     00         


Q ss_pred             ccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccc
Q 015374          356 INADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQ  397 (408)
Q Consensus       356 ~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~  397 (408)
                      ........+++++.+||.+||+.||++|||++|+++||||..
T Consensus       239 ~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~  280 (361)
T 3uc3_A          239 YSIPDDIRISPECCHLISRIFVADPATRISIPEIKTHSWFLK  280 (361)
T ss_dssp             CCCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSHHHHT
T ss_pred             CCCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhCcchhc
Confidence            011112247899999999999999999999999999999954

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=4.7e-49  Score=381.43  Aligned_cols=254  Identities=25%  Similarity=0.459  Sum_probs=209.6

Q ss_pred             EEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc---chHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccEEEEEee
Q 015374          128 EVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV---KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYV  204 (408)
Q Consensus       128 ~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~  204 (408)
                      ...+.||+|+||+||+|++..+++.||+|+++..   ..+.+.+|+.+++++ +||||++++++|.+  ....++||||+
T Consensus        92 ~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~--~~~~~lv~E~~  168 (373)
T 2x4f_A           92 SKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQL-DHANLIQLYDAFES--KNDIVLVMEYV  168 (373)
T ss_dssp             EEEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEEC--SSEEEEEEECC
T ss_pred             ecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhC-CCCCCCeEEEEEEE--CCEEEEEEeCC
Confidence            3367899999999999999999999999999753   456789999999999 99999999999965  46789999999


Q ss_pred             cCCChhhhc----CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeC-CCCcEEEEecccceeccCCCcceee
Q 015374          205 NSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDH-ELRKLRLIDWGLAEFYHPGKEYNVR  279 (408)
Q Consensus       205 ~~~~l~~~~----~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~-~~~~~kl~DfG~a~~~~~~~~~~~~  279 (408)
                      ++++|..++    ..+++..+..++.|++.||.|||++||+||||||+|||++. +.+.+||+|||+++...........
T Consensus       169 ~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~~~~~  248 (373)
T 2x4f_A          169 DGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVN  248 (373)
T ss_dssp             TTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCBCCCC
T ss_pred             CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccccccc
Confidence            999987766    24899999999999999999999999999999999999942 3368999999999987766666667


Q ss_pred             ccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCCCcccccccc
Q 015374          280 VASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSKFINAD  359 (408)
Q Consensus       280 ~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  359 (408)
                      .||+.|+|||++.+ ..++.++|||||||++|||++|..|| .+.++.+.+..+.....       .         ....
T Consensus       249 ~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf-~~~~~~~~~~~i~~~~~-------~---------~~~~  310 (373)
T 2x4f_A          249 FGTPEFLAPEVVNY-DFVSFPTDMWSVGVIAYMLLSGLSPF-LGDNDAETLNNILACRW-------D---------LEDE  310 (373)
T ss_dssp             CSSCTTCCHHHHTT-CBCCHHHHHHHHHHHHHHHHHSSCTT-CCSSHHHHHHHHHHTCC-------C---------SCSG
T ss_pred             cCCCcEeChhhccC-CCCCcHHhHHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHhccC-------C---------CChh
Confidence            89999999999976 78999999999999999999999998 44555555555544211       0         1112


Q ss_pred             CCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccccccch
Q 015374          360 NQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAE  402 (408)
Q Consensus       360 ~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~~~~~~  402 (408)
                      ....+++++.+||.+||+.||++|||++|+|+||||+..+...
T Consensus       311 ~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~hp~~~~~~~~~  353 (373)
T 2x4f_A          311 EFQDISEEAKEFISKLLIKEKSWRISASEALKHPWLSDHKLHS  353 (373)
T ss_dssp             GGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHCHHHHH
T ss_pred             hhccCCHHHHHHHHHHcCCChhhCCCHHHHhcCcCcCCCchhh
Confidence            2334789999999999999999999999999999999876543

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=7.5e-49  Score=382.86  Aligned_cols=275  Identities=32%  Similarity=0.555  Sum_probs=219.0

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecccchHHHHHHHHHHHHhcCCCCceEEeeEEEccC----CCccEE
Q 015374          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQH----SKTPSL  199 (408)
Q Consensus       124 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~----~~~~~l  199 (408)
                      ..+|++.+.||+|+||+||+|++..++. +|+|.+.. ......+|+.+++.+ +||||++++++|....    ....++
T Consensus        39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~-~~~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~~~~~~~l  115 (394)
T 4e7w_A           39 EIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQ-DKRFKNRELQIMRIV-KHPNVVDLKAFFYSNGDKKDEVFLNL  115 (394)
T ss_dssp             EEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEEC-CTTSCCHHHHHHHTC-CCTTBCCEEEEEEEESSSSSCEEEEE
T ss_pred             cceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEec-CcchHHHHHHHHHhC-CCCCcceEEEEEEecCCCCCceEEEE
Confidence            5679999999999999999999877776 77776642 223345799999999 9999999999996532    224789


Q ss_pred             EEEeecCCChhhhc------CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCC
Q 015374          200 IFEYVNSTDFKVLY------PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG  273 (408)
Q Consensus       200 v~e~~~~~~l~~~~------~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~  273 (408)
                      ||||++++.+....      ..+++..++.++.|++.||.|||++||+||||||+|||++.+.+.+||+|||+++.....
T Consensus       116 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~~~  195 (394)
T 4e7w_A          116 VLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAG  195 (394)
T ss_dssp             EEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECCTT
T ss_pred             EeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEeeCCCcccccCC
Confidence            99999987665443      468999999999999999999999999999999999999944489999999999887666


Q ss_pred             CcceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhh-----cCCCC
Q 015374          274 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWC-----NSRHS  348 (408)
Q Consensus       274 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~  348 (408)
                      .......+|+.|+|||++.+...++.++|||||||++|||++|+.|| .+.+..+++..+....|.....     .....
T Consensus       196 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf-~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~  274 (394)
T 4e7w_A          196 EPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLF-PGESGIDQLVEIIKVLGTPSREQIKTMNPNYM  274 (394)
T ss_dssp             CCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSS-CCSSHHHHHHHHHHHHCCCCHHHHHHHCGGGS
T ss_pred             CCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHHHhCCCCHHHHHhhChhhh
Confidence            66666789999999999987567999999999999999999999997 6667778888887766533211     00000


Q ss_pred             CCCcc----ccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccccccch
Q 015374          349 RKPWS----KFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAE  402 (408)
Q Consensus       349 ~~~~~----~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~~~~~~  402 (408)
                      ...+.    .......+..+++++.+||.+||++||++|||+.|+++||||+.++...
T Consensus       275 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~  332 (394)
T 4e7w_A          275 EHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELRTGE  332 (394)
T ss_dssp             SSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTTSSC
T ss_pred             hhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhcccc
Confidence            00000    0011122344789999999999999999999999999999999886643

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=1.4e-48  Score=394.25  Aligned_cols=257  Identities=25%  Similarity=0.427  Sum_probs=220.1

Q ss_pred             CCCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc------chHHHHHHHHHHHHhcCCCCceEEeeEEEccCCC
Q 015374          122 GDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSK  195 (408)
Q Consensus       122 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  195 (408)
                      ...++|++.+.||+|+||+||+|++..+++.||+|+++..      ....+.+|+.+++++ +||||++++++|.+  ..
T Consensus       181 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~~~~--~~  257 (576)
T 2acx_A          181 VTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKV-NSRFVVSLAYAYET--KD  257 (576)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHC-CCTTBCCEEEEEEC--SS
T ss_pred             ccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHc-CCCCEeeEEEEEee--CC
Confidence            4568899999999999999999999999999999998642      235678999999999 99999999999965  46


Q ss_pred             ccEEEEEeecCCChhhhcC-----CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceec
Q 015374          196 TPSLIFEYVNSTDFKVLYP-----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY  270 (408)
Q Consensus       196 ~~~lv~e~~~~~~l~~~~~-----~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~  270 (408)
                      ..++||||+++++|..++.     .+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++..
T Consensus       258 ~l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~-g~vKL~DFGla~~~  336 (576)
T 2acx_A          258 ALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDH-GHIRISDLGLAVHV  336 (576)
T ss_dssp             EEEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTT-SCEEECCCTTCEEC
T ss_pred             EEEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCC-CCeEEEecccceec
Confidence            7899999999999988763     38999999999999999999999999999999999999988 89999999999887


Q ss_pred             cCCCcceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCC--CHHHHHHHHhhhchhhhhcCCCC
Q 015374          271 HPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHD--NHDQLVKIAKDCCLIIWCNSRHS  348 (408)
Q Consensus       271 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~--~~~~~~~~~~~~~~~~~~~~~~~  348 (408)
                      .........+||+.|+|||++.+ ..++.++|||||||++|||++|..||.....  ..+.+...+...           
T Consensus       337 ~~~~~~~~~~GT~~Y~APEvl~~-~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~-----------  404 (576)
T 2acx_A          337 PEGQTIKGRVGTVGYMAPEVVKN-ERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEV-----------  404 (576)
T ss_dssp             CTTCCEECCCSCGGGCCHHHHTT-CEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHC-----------
T ss_pred             ccCccccccCCCccccCHHHHcC-CCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcc-----------
Confidence            76666666799999999999987 7799999999999999999999999854332  333333332221           


Q ss_pred             CCCccccccccCCCCCCHHHHHHHHHhcccCcCCCC-----CHHHHhcCCCccccccch
Q 015374          349 RKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRL-----TAREAMAHPYFAQVRAAE  402 (408)
Q Consensus       349 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rp-----t~~elL~hp~f~~~~~~~  402 (408)
                              ....+..+++++.+||.+||+.||.+||     |++|+++||||+.+++..
T Consensus       405 --------~~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~i~w~~  455 (576)
T 2acx_A          405 --------PEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKLNFKR  455 (576)
T ss_dssp             --------CCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTTCCHHH
T ss_pred             --------cccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhChhhccCCHHH
Confidence                    1122344789999999999999999999     899999999999987644

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=1.6e-48  Score=371.15  Aligned_cols=254  Identities=29%  Similarity=0.495  Sum_probs=206.7

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEc---CCCcEEEEEEeccc-------chHHHHHHHHHHHHhcCCCCceEEeeEEEcc
Q 015374          123 DQDDYEVVRKVGRGKYSEVFEGINV---NTNERCIIKILKPV-------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQ  192 (408)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~Vy~~~~~---~~~~~vavK~~~~~-------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~  192 (408)
                      ..++|++.+.||+|+||+||+|++.   .+++.||+|+++..       ....+.+|+.+++++ +||||+++++++.+ 
T Consensus        15 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~-   92 (327)
T 3a62_A           15 RPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEV-KHPFIVDLIYAFQT-   92 (327)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHC-CCTTBCCEEEEEEC-
T ss_pred             CHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhC-CCCCccceeEEEEc-
Confidence            4678999999999999999999875   68899999998743       234577899999999 99999999999965 


Q ss_pred             CCCccEEEEEeecCCChhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEeccccee
Q 015374          193 HSKTPSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEF  269 (408)
Q Consensus       193 ~~~~~~lv~e~~~~~~l~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~  269 (408)
                       ....++||||+++++|..++   ..+++..+..++.|++.||.|||++||+||||||+|||++.+ +.+||+|||+++.
T Consensus        93 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~-~~~kl~Dfg~~~~  170 (327)
T 3a62_A           93 -GGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQ-GHVKLTDFGLCKE  170 (327)
T ss_dssp             -SSCEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTT-SCEEECCCSCC--
T ss_pred             -CCEEEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCC-CcEEEEeCCcccc
Confidence             46789999999999998877   458999999999999999999999999999999999999988 7999999999975


Q ss_pred             ccCC-CcceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCC
Q 015374          270 YHPG-KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHS  348 (408)
Q Consensus       270 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  348 (408)
                      .... .......||..|+|||++.+ ..++.++|||||||++|+|++|..||. +.+..+.+..+...            
T Consensus       171 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~-~~~~~~~~~~i~~~------------  236 (327)
T 3a62_A          171 SIHDGTVTHTFCGTIEYMAPEILMR-SGHNRAVDWWSLGALMYDMLTGAPPFT-GENRKKTIDKILKC------------  236 (327)
T ss_dssp             --------CTTSSCCTTSCHHHHTT-SCCCTHHHHHHHHHHHHHHHHSSCSCC-CSSHHHHHHHHHHT------------
T ss_pred             cccCCccccccCCCcCccCHhhCcC-CCCCCcccchhHHHHHHHHHHCCCCCC-CCCHHHHHHHHHhC------------
Confidence            4322 23344678999999999987 778999999999999999999999983 44444444444332            


Q ss_pred             CCCccccccccCCCCCCHHHHHHHHHhcccCcCCCC-----CHHHHhcCCCccccccch
Q 015374          349 RKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRL-----TAREAMAHPYFAQVRAAE  402 (408)
Q Consensus       349 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rp-----t~~elL~hp~f~~~~~~~  402 (408)
                              ....+..+++++.+||.+||+.||++||     +++|+++||||+.+...+
T Consensus       237 --------~~~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~~~~~~  287 (327)
T 3a62_A          237 --------KLNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHINWEE  287 (327)
T ss_dssp             --------CCCCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSSCCHHH
T ss_pred             --------CCCCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcccCCCHHH
Confidence                    1112234789999999999999999999     899999999999886644

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=1.1e-48  Score=371.34  Aligned_cols=258  Identities=27%  Similarity=0.464  Sum_probs=218.2

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc---------chHHHHHHHHHHHHhcCCCCceEEeeEEEccCC
Q 015374          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV---------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHS  194 (408)
Q Consensus       124 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~---------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~  194 (408)
                      .++|++.+.||+|+||+||+|++..+++.||+|+++..         ..+.+.+|+.+++++ +||||+++++++.+  .
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~--~   87 (321)
T 2a2a_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQV-LHHNVITLHDVYEN--R   87 (321)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHC-CCTTBCCEEEEEEC--S
T ss_pred             hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhC-CCCCcceEEEEEec--C
Confidence            56899999999999999999999999999999998642         246789999999999 99999999999965  4


Q ss_pred             CccEEEEEeecCCChhhhcC---CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCC---cEEEEecccce
Q 015374          195 KTPSLIFEYVNSTDFKVLYP---TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELR---KLRLIDWGLAE  268 (408)
Q Consensus       195 ~~~~lv~e~~~~~~l~~~~~---~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~---~~kl~DfG~a~  268 (408)
                      ...++||||+++++|..++.   .+++..+..++.|++.||.|||++||+||||||+|||++.+..   .+||+|||++.
T Consensus        88 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~  167 (321)
T 2a2a_A           88 TDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH  167 (321)
T ss_dssp             SEEEEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCE
T ss_pred             CEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCccce
Confidence            67899999999999998873   4789999999999999999999999999999999999998732   79999999998


Q ss_pred             eccCCCcceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCC
Q 015374          269 FYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHS  348 (408)
Q Consensus       269 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  348 (408)
                      ............||+.|+|||++.+ ..++.++|||||||++|+|++|..||. +.+..+.+..+.....          
T Consensus       168 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~-~~~~~~~~~~i~~~~~----------  235 (321)
T 2a2a_A          168 EIEDGVEFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFL-GDTKQETLANITSVSY----------  235 (321)
T ss_dssp             ECCTTCCCCCCCSCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSCCSSC-CSSHHHHHHHHHTTCC----------
T ss_pred             ecCccccccccCCCCCccCcccccC-CCCCCccccHHHHHHHHHHHHCCCCCC-CCCHHHHHHHHHhccc----------
Confidence            8776555566789999999999987 788999999999999999999999983 4444444444332110          


Q ss_pred             CCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccccccch
Q 015374          349 RKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAE  402 (408)
Q Consensus       349 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~~~~~~  402 (408)
                        .    ........+++++.+||.+||+.||++|||++|+++||||+.+....
T Consensus       236 --~----~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~~~~~~~~~  283 (321)
T 2a2a_A          236 --D----FDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDNQQ  283 (321)
T ss_dssp             --C----CCHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHSTTTSCSSHHH
T ss_pred             --c----cChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhcCccccCCCccc
Confidence              0    11112234789999999999999999999999999999999876544

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=8.8e-49  Score=382.98  Aligned_cols=256  Identities=26%  Similarity=0.430  Sum_probs=203.6

Q ss_pred             CCCEEEE-eeeeeeCceEEEEEEEcCCCcEEEEEEecccchHHHHHHHHHHHHhcCCCCceEEeeEEEc--cCCCccEEE
Q 015374          124 QDDYEVV-RKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRD--QHSKTPSLI  200 (408)
Q Consensus       124 ~~~y~~~-~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~--~~~~~~~lv  200 (408)
                      .++|.+. +.||+|+||+||+|++..+++.||||+++  ....+.+|+.++.++.+||||++++++|..  .+...+++|
T Consensus        60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~--~~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~lv  137 (400)
T 1nxk_A           60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ--DCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIV  137 (400)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEE--CSHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEE
T ss_pred             cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeC--cchhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEEE
Confidence            4578777 68999999999999999999999999996  345678999998777699999999999864  234678999


Q ss_pred             EEeecCCChhhhcC-----CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCC--CCcEEEEecccceeccCC
Q 015374          201 FEYVNSTDFKVLYP-----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE--LRKLRLIDWGLAEFYHPG  273 (408)
Q Consensus       201 ~e~~~~~~l~~~~~-----~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~--~~~~kl~DfG~a~~~~~~  273 (408)
                      |||+++++|..++.     .+++..+..++.|++.||.|||++||+||||||+|||++.+  .+.+||+|||+++.....
T Consensus       138 ~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~~  217 (400)
T 1nxk_A          138 MECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH  217 (400)
T ss_dssp             EECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCTTCEECC--
T ss_pred             EEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEecccccccCCC
Confidence            99999999988873     38999999999999999999999999999999999999973  378999999999877655


Q ss_pred             CcceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCH---HHHHHHHhhhchhhhhcCCCCCC
Q 015374          274 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNH---DQLVKIAKDCCLIIWCNSRHSRK  350 (408)
Q Consensus       274 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~  350 (408)
                      ......+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.......   .....+....       ..    
T Consensus       218 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~-------~~----  285 (400)
T 1nxk_A          218 NSLTTPCYTPYYVAPEVLGP-EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQ-------YE----  285 (400)
T ss_dssp             ---------CTTCCGGGSCC-CCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTC-------CC----
T ss_pred             CccccCCCCCCccCHhhcCC-CCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCc-------cc----
Confidence            55567789999999999977 789999999999999999999999985433211   1122221110       00    


Q ss_pred             CccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccc
Q 015374          351 PWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQV  398 (408)
Q Consensus       351 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~~  398 (408)
                           .....+..+++++.+||++||+.||++|||++|+++||||.+.
T Consensus       286 -----~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~  328 (400)
T 1nxk_A          286 -----FPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS  328 (400)
T ss_dssp             -----CCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHTT
T ss_pred             -----CCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccCC
Confidence                 1112234578999999999999999999999999999999754

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=2e-48  Score=363.30  Aligned_cols=252  Identities=23%  Similarity=0.453  Sum_probs=203.5

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc----chHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccEE
Q 015374          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSL  199 (408)
Q Consensus       124 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l  199 (408)
                      .++|++.++||+|+||+||+|++..++..+|+|++...    ..+.+.+|+.+++++ +||||+++++++.+  ....++
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~--~~~~~l   97 (285)
T 3is5_A           21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSL-DHPNIIKIFEVFED--YHNMYI   97 (285)
T ss_dssp             HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTC-CCTTBCCEEEEEEC--SSEEEE
T ss_pred             hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhC-CCchHHhHHHheec--CCeEEE
Confidence            57899999999999999999999999999999998643    346789999999999 99999999999965  467899


Q ss_pred             EEEeecCCChhhhc-------CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCC--CCcEEEEecccceec
Q 015374          200 IFEYVNSTDFKVLY-------PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE--LRKLRLIDWGLAEFY  270 (408)
Q Consensus       200 v~e~~~~~~l~~~~-------~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~--~~~~kl~DfG~a~~~  270 (408)
                      ||||+++++|..++       ..+++..+..++.|++.||+|||++||+||||||+|||++.+  .+.+||+|||++...
T Consensus        98 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~  177 (285)
T 3is5_A           98 VMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELF  177 (285)
T ss_dssp             EECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-
T ss_pred             EEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecceec
Confidence            99999999998876       569999999999999999999999999999999999999542  267999999999877


Q ss_pred             cCCCcceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCC
Q 015374          271 HPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRK  350 (408)
Q Consensus       271 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  350 (408)
                      ..........+|..|+|||++.  ..++.++||||||+++|+|++|+.||. +.+..+.........       ..    
T Consensus       178 ~~~~~~~~~~~t~~y~aPE~~~--~~~~~~~Di~slG~il~~ll~g~~pf~-~~~~~~~~~~~~~~~-------~~----  243 (285)
T 3is5_A          178 KSDEHSTNAAGTALYMAPEVFK--RDVTFKCDIWSAGVVMYFLLTGCLPFT-GTSLEEVQQKATYKE-------PN----  243 (285)
T ss_dssp             ---------CTTGGGCCHHHHT--TCCCHHHHHHHHHHHHHHHHHSSCSSC-CSSHHHHHHHHHHCC-------CC----
T ss_pred             CCcccCcCcccccCcCChHHhc--cCCCcccCeehHHHHHHHHHhCCCCCC-CCCHHHHHhhhccCC-------cc----
Confidence            6655566678999999999985  468999999999999999999999983 333333222221110       00    


Q ss_pred             CccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccc
Q 015374          351 PWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQV  398 (408)
Q Consensus       351 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~~  398 (408)
                            .......+++++.+|+.+||+.||++|||++|+|+||||+++
T Consensus       244 ------~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~f~~a  285 (285)
T 3is5_A          244 ------YAVECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQA  285 (285)
T ss_dssp             ------CCC--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGGC-
T ss_pred             ------cccccCcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHhhcC
Confidence                  001112268999999999999999999999999999999864

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=2.5e-48  Score=373.27  Aligned_cols=276  Identities=30%  Similarity=0.470  Sum_probs=215.7

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc-----chHHHHHHHHHHHHhcCCCCceEEeeEEEccC-----
Q 015374          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQH-----  193 (408)
Q Consensus       124 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~-----  193 (408)
                      .++|++.++||+|+||+||+|++..+++.||+|++...     ....+.+|+.+++.+ +||||+++++++....     
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~   94 (351)
T 3mi9_A           16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLL-KHENVVNLIEICRTKASPYNR   94 (351)
T ss_dssp             GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHC-CCTTBCCEEEEEEEC------
T ss_pred             ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhc-cCCCcccHhheeecccccccc
Confidence            57899999999999999999999999999999998532     235688999999999 8999999999997643     


Q ss_pred             -CCccEEEEEeecCCChhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEeccccee
Q 015374          194 -SKTPSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEF  269 (408)
Q Consensus       194 -~~~~~lv~e~~~~~~l~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~  269 (408)
                       ....++||||++++.+..+.   ..+++..++.++.|++.||.|||++||+||||||+|||++.+ +.+||+|||++..
T Consensus        95 ~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~-~~~kl~Dfg~a~~  173 (351)
T 3mi9_A           95 CKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRD-GVLKLADFGLARA  173 (351)
T ss_dssp             --CEEEEEEECCSEEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT-SCEEECCCTTCEE
T ss_pred             CCceEEEEEeccCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCC-CCEEEccchhccc
Confidence             35689999999975544443   458999999999999999999999999999999999999988 7999999999987


Q ss_pred             ccCC-----CcceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhc
Q 015374          270 YHPG-----KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCN  344 (408)
Q Consensus       270 ~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  344 (408)
                      ....     .......||+.|+|||++.+...++.++|||||||++|+|++|..|| .+.+..+.+..+....+......
T Consensus       174 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf-~~~~~~~~~~~i~~~~~~~~~~~  252 (351)
T 3mi9_A          174 FSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIM-QGNTEQHQLALISQLCGSITPEV  252 (351)
T ss_dssp             CCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSC-CCSSHHHHHHHHHHHHCCCCTTT
T ss_pred             ccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCC-CCCChHHHHHHHHHHhCCCChhh
Confidence            6422     22344578999999999987567899999999999999999999887 55666666666666544332111


Q ss_pred             CCCC-CCCccccccccC-----------CCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccccccch
Q 015374          345 SRHS-RKPWSKFINADN-----------QHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAE  402 (408)
Q Consensus       345 ~~~~-~~~~~~~~~~~~-----------~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~~~~~~  402 (408)
                      .... ............           ....++++.+||.+||+.||++|||++|+|+||||+......
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~  322 (351)
T 3mi9_A          253 WPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPMPS  322 (351)
T ss_dssp             STTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGSSSCCC
T ss_pred             ccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCCCCCcc
Confidence            0000 000000000000           001267899999999999999999999999999998765543

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=5.8e-49  Score=376.34  Aligned_cols=257  Identities=29%  Similarity=0.477  Sum_probs=211.8

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecccchHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccEEEEEe
Q 015374          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEY  203 (408)
Q Consensus       124 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~  203 (408)
                      .++|++.+.||+|+||+||+|++..+++.||+|+++... ....+|+.++.++.+||||+++++++.+  ....++||||
T Consensus        21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~-~~~~~E~~~l~~~~~hp~iv~~~~~~~~--~~~~~lv~E~   97 (342)
T 2qr7_A           21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSK-RDPTEEIEILLRYGQHPNIITLKDVYDD--GKYVYVVTEL   97 (342)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTT-CCCHHHHHHHHHHTTSTTBCCEEEEEEC--SSEEEEEECC
T ss_pred             cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEccc-CChHHHHHHHHHhcCCCCcCeEEEEEEc--CCEEEEEEeC
Confidence            568999999999999999999999999999999997543 3456899999998789999999999965  5788999999


Q ss_pred             ecCCChhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCC---cEEEEecccceeccCCC-cc
Q 015374          204 VNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELR---KLRLIDWGLAEFYHPGK-EY  276 (408)
Q Consensus       204 ~~~~~l~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~---~~kl~DfG~a~~~~~~~-~~  276 (408)
                      +++++|..++   ..+++..+..++.|++.||+|||++||+||||||+|||+..+.+   .+||+|||+++...... ..
T Consensus        98 ~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~  177 (342)
T 2qr7_A           98 MKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLL  177 (342)
T ss_dssp             CCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCTTCCB
T ss_pred             CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCCCCce
Confidence            9999998876   35899999999999999999999999999999999999855422   59999999998765432 34


Q ss_pred             eeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCC-CCHHH-HHHHHhhhchhhhhcCCCCCCCccc
Q 015374          277 NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGH-DNHDQ-LVKIAKDCCLIIWCNSRHSRKPWSK  354 (408)
Q Consensus       277 ~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~-~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~  354 (408)
                      ...++|+.|+|||++.+ ..++.++|||||||++|+|++|..||.... ++.+. +..+... .        ..      
T Consensus       178 ~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~-~--------~~------  241 (342)
T 2qr7_A          178 MTPCYTANFVAPEVLER-QGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSG-K--------FS------  241 (342)
T ss_dssp             CCSSCCSSCCCHHHHHH-HHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHC-C--------CC------
T ss_pred             eccCCCccccCHHHhcC-CCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccC-C--------cc------
Confidence            55688999999999987 678999999999999999999999986432 23333 3332221 0        00      


Q ss_pred             cccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccccc
Q 015374          355 FINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRA  400 (408)
Q Consensus       355 ~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~~~~  400 (408)
                       .....+..+++++.+||++||+.||++|||++|+++||||.....
T Consensus       242 -~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~~~  286 (342)
T 2qr7_A          242 -LSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHWDQ  286 (342)
T ss_dssp             -CCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHTGGG
T ss_pred             -cCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCeecCccc
Confidence             112223457999999999999999999999999999999976543

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=3.2e-49  Score=375.71  Aligned_cols=257  Identities=25%  Similarity=0.445  Sum_probs=193.2

Q ss_pred             CCEEEE---eeeeeeCceEEEEEEEcCCCcEEEEEEecccchHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccEEEE
Q 015374          125 DDYEVV---RKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIF  201 (408)
Q Consensus       125 ~~y~~~---~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~  201 (408)
                      ++|++.   +.||+|+||+||+|++..+++.||||+++......+.+|+.+++.+.+||||+++++++.+  ....++||
T Consensus         8 ~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~e~~~l~~l~~h~niv~~~~~~~~--~~~~~lv~   85 (325)
T 3kn6_A            8 QHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKEITALKLCEGHPNIVKLHEVFHD--QLHTFLVM   85 (325)
T ss_dssp             HHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGGGHHHHHHHHHHHHHTTTCTTBCCEEEEEEC--SSEEEEEE
T ss_pred             hccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChhhhhhHHHHHHHHHHhcCCCCeeEEEEEEEc--CCEEEEEE
Confidence            345554   6799999999999999999999999999877778899999999999569999999999965  46789999


Q ss_pred             EeecCCChhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCC--CcEEEEecccceeccCCC-c
Q 015374          202 EYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEL--RKLRLIDWGLAEFYHPGK-E  275 (408)
Q Consensus       202 e~~~~~~l~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~--~~~kl~DfG~a~~~~~~~-~  275 (408)
                      ||+++++|..++   ..+++..+..++.|++.||+|||++||+||||||+|||++.+.  ..+||+|||+++...... .
T Consensus        86 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~  165 (325)
T 3kn6_A           86 ELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQP  165 (325)
T ss_dssp             CCCCSCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC----
T ss_pred             EccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCCc
Confidence            999999998877   4589999999999999999999999999999999999998652  279999999998665432 3


Q ss_pred             ceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCC-----C-HHHHHHHHhhhchhhhhcCCCCC
Q 015374          276 YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHD-----N-HDQLVKIAKDCCLIIWCNSRHSR  349 (408)
Q Consensus       276 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~-----~-~~~~~~~~~~~~~~~~~~~~~~~  349 (408)
                      .....+|..|+|||++.+ ..++.++|||||||++|+|++|..||.....     . .+.+..+...         ..  
T Consensus       166 ~~~~~~t~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~---------~~--  233 (325)
T 3kn6_A          166 LKTPCFTLHYAAPELLNQ-NGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKG---------DF--  233 (325)
T ss_dssp             -------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTT---------CC--
T ss_pred             ccccCCCcCccCHHHhcC-CCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcC---------CC--
Confidence            345678999999999987 7899999999999999999999999843221     1 1122221110         00  


Q ss_pred             CCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccccc
Q 015374          350 KPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRA  400 (408)
Q Consensus       350 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~~~~  400 (408)
                       .    .....+..+++++.+||.+||+.||++|||++|+++||||++...
T Consensus       234 -~----~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~~~  279 (325)
T 3kn6_A          234 -S----FEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQ  279 (325)
T ss_dssp             -C----CCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTTCC
T ss_pred             -C----CCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhccCcc
Confidence             0    111222347899999999999999999999999999999986543

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=1.1e-48  Score=378.30  Aligned_cols=255  Identities=24%  Similarity=0.432  Sum_probs=209.4

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecccc------hHHHHHHHHHH-HHhcCCCCceEEeeEEEccCCC
Q 015374          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK------KKKIKREIKIL-QNLCGGPNVVKLLDIVRDQHSK  195 (408)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~------~~~~~~E~~~l-~~l~~h~niv~l~~~~~~~~~~  195 (408)
                      ..++|++++.||+|+||+||+|++..+++.||+|+++...      ...+.+|..++ +.+ +||||++++++|.+  ..
T Consensus        36 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~-~hp~Iv~l~~~~~~--~~  112 (373)
T 2r5t_A           36 KPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNV-KHPFLVGLHFSFQT--AD  112 (373)
T ss_dssp             CGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCC-CCTTBCCEEEEEEC--SS
T ss_pred             ChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhC-CCCCCCCEEEEEEe--CC
Confidence            4678999999999999999999999999999999996432      23456677664 555 99999999999965  46


Q ss_pred             ccEEEEEeecCCChhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceecc-
Q 015374          196 TPSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH-  271 (408)
Q Consensus       196 ~~~lv~e~~~~~~l~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~-  271 (408)
                      ..++||||+++++|..++   ..+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++... 
T Consensus       113 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~-g~ikL~DFG~a~~~~~  191 (373)
T 2r5t_A          113 KLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQ-GHIVLTDFGLCKENIE  191 (373)
T ss_dssp             EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT-SCEEECCCCBCGGGBC
T ss_pred             EEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCC-CCEEEeeCcccccccc
Confidence            889999999999998877   458999999999999999999999999999999999999988 899999999998643 


Q ss_pred             CCCcceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCCC
Q 015374          272 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKP  351 (408)
Q Consensus       272 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  351 (408)
                      ........+||+.|+|||++.+ ..++.++|+|||||++|||++|..||. +.+..+....+...               
T Consensus       192 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~G~~Pf~-~~~~~~~~~~i~~~---------------  254 (373)
T 2r5t_A          192 HNSTTSTFCGTPEYLAPEVLHK-QPYDRTVDWWCLGAVLYEMLYGLPPFY-SRNTAEMYDNILNK---------------  254 (373)
T ss_dssp             CCCCCCSBSCCCCCCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCTTC-CSBHHHHHHHHHHS---------------
T ss_pred             CCCccccccCCccccCHHHhCC-CCCCchhhhHHHHHHHHHHHcCCCCCC-CCCHHHHHHHHHhc---------------
Confidence            2334556789999999999987 789999999999999999999999984 44444555544432               


Q ss_pred             ccccccccCCCCCCHHHHHHHHHhcccCcCCCCCH----HHHhcCCCccccccchh
Q 015374          352 WSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTA----REAMAHPYFAQVRAAES  403 (408)
Q Consensus       352 ~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~----~elL~hp~f~~~~~~~~  403 (408)
                           ....+..++.++.+||.+||+.||.+||++    +|+++||||+.+++...
T Consensus       255 -----~~~~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h~~f~~~~w~~l  305 (373)
T 2r5t_A          255 -----PLQLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSLINWDDL  305 (373)
T ss_dssp             -----CCCCCSSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHHHTSGGGTTCCHHHH
T ss_pred             -----ccCCCCCCCHHHHHHHHHHcccCHHhCCCCCCCHHHHhCCccccCCCHHHH
Confidence                 111223478999999999999999999986    69999999999887553

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=6.3e-49  Score=389.64  Aligned_cols=254  Identities=26%  Similarity=0.462  Sum_probs=207.4

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc------chHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCc
Q 015374          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT  196 (408)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  196 (408)
                      ..++|++.+.||+|+||+||+|++..+++.||||+++..      ....+.+|+.+++++ +||||++++++|.+  ...
T Consensus       146 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~l~~~~~~--~~~  222 (446)
T 4ejn_A          146 TMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNS-RHPFLTALKYSFQT--HDR  222 (446)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCC-SCTTSCCEEEEEEE--TTE
T ss_pred             ChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhC-CCCeEeeEEEEEee--CCE
Confidence            357899999999999999999999999999999998643      234577899999998 99999999999965  467


Q ss_pred             cEEEEEeecCCChhhhc---CCCChHHHHHHHHHHHHHHHHHHH-CCcEEecCCCCcEEEeCCCCcEEEEecccceeccC
Q 015374          197 PSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHS-QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP  272 (408)
Q Consensus       197 ~~lv~e~~~~~~l~~~~---~~l~~~~~~~i~~qi~~~L~~LH~-~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~  272 (408)
                      .++||||+++++|..++   ..+++..+..++.|++.||+|||+ +||+||||||+|||++.+ +.+||+|||+++....
T Consensus       223 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~-~~~kl~DFG~a~~~~~  301 (446)
T 4ejn_A          223 LCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKD-GHIKITDFGLCKEGIK  301 (446)
T ss_dssp             EEEEECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSS-SCEEECCCCCCCTTCC
T ss_pred             EEEEEeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCC-CCEEEccCCCceeccC
Confidence            89999999999998877   468999999999999999999998 999999999999999988 7999999999976432


Q ss_pred             -CCcceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCCC
Q 015374          273 -GKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKP  351 (408)
Q Consensus       273 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  351 (408)
                       .......+||+.|+|||++.+ ..++.++|||||||++|||++|+.||. +.+..+....+...               
T Consensus       302 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~-~~~~~~~~~~i~~~---------------  364 (446)
T 4ejn_A          302 DGATMKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFY-NQDHEKLFELILME---------------  364 (446)
T ss_dssp             -----CCSSSCGGGCCHHHHHT-SCCCTHHHHHHHHHHHHHHHHSSCSSC-CSSHHHHHHHHHHC---------------
T ss_pred             CCcccccccCCccccCHhhcCC-CCCCCccchhhhHHHHHHHhhCCCCCC-CCCHHHHHHHHHhC---------------
Confidence             233455789999999999987 789999999999999999999999984 33333343333321               


Q ss_pred             ccccccccCCCCCCHHHHHHHHHhcccCcCCCC-----CHHHHhcCCCccccccch
Q 015374          352 WSKFINADNQHLVSPEAIDFLDKLLRYDHQDRL-----TAREAMAHPYFAQVRAAE  402 (408)
Q Consensus       352 ~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rp-----t~~elL~hp~f~~~~~~~  402 (408)
                           ....+..+++++.+||.+||+.||++||     |++|+++||||+++....
T Consensus       365 -----~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp~f~~~~~~~  415 (446)
T 4ejn_A          365 -----EIRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQH  415 (446)
T ss_dssp             -----CCCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHHH
T ss_pred             -----CCCCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCccccCCCHHH
Confidence                 1112334789999999999999999999     999999999999987644

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=3.6e-48  Score=368.70  Aligned_cols=259  Identities=24%  Similarity=0.419  Sum_probs=212.5

Q ss_pred             CCCCEEEE-eeeeeeCceEEEEEEEcCCCcEEEEEEeccc-----chHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCc
Q 015374          123 DQDDYEVV-RKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT  196 (408)
Q Consensus       123 ~~~~y~~~-~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  196 (408)
                      ..++|.+. +.||+|+||+||+|++..+++.||+|+++..     ....+.+|+.+++.+.+||||+++++++.+  ...
T Consensus        26 ~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~--~~~  103 (327)
T 3lm5_A           26 FNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYEN--TSE  103 (327)
T ss_dssp             HHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEEC--SSE
T ss_pred             hhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEe--CCe
Confidence            36678888 8899999999999999999999999998642     246789999999999778999999999964  567


Q ss_pred             cEEEEEeecCCChhhhc-----CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCC--CCcEEEEeccccee
Q 015374          197 PSLIFEYVNSTDFKVLY-----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE--LRKLRLIDWGLAEF  269 (408)
Q Consensus       197 ~~lv~e~~~~~~l~~~~-----~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~--~~~~kl~DfG~a~~  269 (408)
                      .++||||+.+++|..++     ..+++..+..++.|++.||+|||++||+||||||+|||++..  .+.+||+|||++..
T Consensus       104 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~  183 (327)
T 3lm5_A          104 IILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRK  183 (327)
T ss_dssp             EEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGGCEE
T ss_pred             EEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCccccc
Confidence            89999999999998886     348999999999999999999999999999999999999871  27899999999988


Q ss_pred             ccCCCcceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCC
Q 015374          270 YHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSR  349 (408)
Q Consensus       270 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  349 (408)
                      ...........||+.|+|||++.+ ..++.++|||||||++|+|++|+.|| .+.+..+....+.....       .   
T Consensus       184 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf-~~~~~~~~~~~i~~~~~-------~---  251 (327)
T 3lm5_A          184 IGHACELREIMGTPEYLAPEILNY-DPITTATDMWNIGIIAYMLLTHTSPF-VGEDNQETYLNISQVNV-------D---  251 (327)
T ss_dssp             C---------CCCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSS-CCSSHHHHHHHHHHTCC-------C---
T ss_pred             cCCccccccccCCcCccCCeeecC-CCCCchhhHHHHHHHHHHHHhCCCCC-CCCCchHHHHHHHhccc-------c---
Confidence            766555566789999999999987 78999999999999999999999998 34444444444333211       0   


Q ss_pred             CCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccccccc
Q 015374          350 KPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAA  401 (408)
Q Consensus       350 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~~~~~  401 (408)
                            ........+++++.+||.+||+.||++|||++|+|+||||++....
T Consensus       252 ------~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~~~~~  297 (327)
T 3lm5_A          252 ------YSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDFE  297 (327)
T ss_dssp             ------CCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGGGCCCCTT
T ss_pred             ------cCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCCHhhcccccc
Confidence                  1112223478999999999999999999999999999999987653

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=5.9e-49  Score=380.68  Aligned_cols=274  Identities=25%  Similarity=0.436  Sum_probs=207.9

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc-----chHHHHHHHHHHHHhcCCCCceEEeeEEEccC----
Q 015374          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQH----  193 (408)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~----  193 (408)
                      ..++|++.+.||+|+||+||+|++..+++.||||+++..     ....+.+|+.+++.+ +||||+++++++....    
T Consensus        23 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~~  101 (371)
T 2xrw_A           23 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCV-NHKNIIGLLNVFTPQKSLEE  101 (371)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHC-CCTTBCCEEEEECSCCSTTT
T ss_pred             hhhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhc-CCCCccceEEeecccccccc
Confidence            357899999999999999999999999999999998632     235688999999999 9999999999996543    


Q ss_pred             CCccEEEEEeecCCChhhhcCCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCC
Q 015374          194 SKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG  273 (408)
Q Consensus       194 ~~~~~lv~e~~~~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~  273 (408)
                      ....++||||++++.+......+++..+..++.|++.||.|||++||+||||||+|||++.+ +.+||+|||+++.....
T Consensus       102 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~-~~~kl~Dfg~a~~~~~~  180 (371)
T 2xrw_A          102 FQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSD-CTLKILDFGLARTAGTS  180 (371)
T ss_dssp             CCEEEEEEECCSEEHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTT-SCEEECCCCC-------
T ss_pred             ccceEEEEEcCCCCHHHHHhhccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCC-CCEEEEEeecccccccc
Confidence            13679999999976555555679999999999999999999999999999999999999988 79999999999876655


Q ss_pred             CcceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhc---------
Q 015374          274 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCN---------  344 (408)
Q Consensus       274 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~---------  344 (408)
                      .......||..|+|||++.+ ..++.++|||||||++|+|++|+.|| .+.+..+.+..+....+......         
T Consensus       181 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf-~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  258 (371)
T 2xrw_A          181 FMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMIKGGVLF-PGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVR  258 (371)
T ss_dssp             ---------CTTCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCSS-CCSSHHHHHHHHHC-CCCCCHHHHTTSCHHHH
T ss_pred             cccCCceecCCccCHHHhcC-CCCCchHhHHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHH
Confidence            44556789999999999987 78999999999999999999999997 56666677777766544321100         


Q ss_pred             ------CCCCCCCccccccccC-------CCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccccc
Q 015374          345 ------SRHSRKPWSKFINADN-------QHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRA  400 (408)
Q Consensus       345 ------~~~~~~~~~~~~~~~~-------~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~~~~  400 (408)
                            .......+....+...       ....++++.+||.+||+.||++|||++|+|+||||+....
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~~  327 (371)
T 2xrw_A          259 TYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYD  327 (371)
T ss_dssp             HHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTTCC
T ss_pred             HHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhhhcC
Confidence                  0001111111111000       0112567999999999999999999999999999986543

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=1.7e-48  Score=384.41  Aligned_cols=270  Identities=24%  Similarity=0.457  Sum_probs=214.3

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecccc--hHHHHHHHHHHHHhc-----CCCCceEEeeEEEccCCC
Q 015374          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK--KKKIKREIKILQNLC-----GGPNVVKLLDIVRDQHSK  195 (408)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~E~~~l~~l~-----~h~niv~l~~~~~~~~~~  195 (408)
                      ...+|++.+.||+|+||+||+|++..+++.||||+++...  ...+.+|+.+++.+.     +|+||+++++++..  ..
T Consensus        95 ~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~--~~  172 (429)
T 3kvw_A           95 VAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTF--RN  172 (429)
T ss_dssp             ETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEE--TT
T ss_pred             ccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeeccc--CC
Confidence            3678999999999999999999999999999999997543  366788999998873     56799999999965  46


Q ss_pred             ccEEEEEeecCCChhhhc-----CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCc--EEEEecccce
Q 015374          196 TPSLIFEYVNSTDFKVLY-----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRK--LRLIDWGLAE  268 (408)
Q Consensus       196 ~~~lv~e~~~~~~l~~~~-----~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~--~kl~DfG~a~  268 (408)
                      ..++||||+.+ +|..++     ..+++..++.++.|++.||+|||++||+||||||+|||++.+ +.  +||+|||++.
T Consensus       173 ~~~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~-~~~~vkL~DFG~a~  250 (429)
T 3kvw_A          173 HICMTFELLSM-NLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQ-GRSGIKVIDFGSSC  250 (429)
T ss_dssp             EEEEEECCCCC-BHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESST-TSCCEEECCCTTCE
T ss_pred             eEEEEEeccCC-CHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccC-CCcceEEeecccce
Confidence            88999999985 555554     248999999999999999999999999999999999999987 44  9999999997


Q ss_pred             eccCCCcceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCC
Q 015374          269 FYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHS  348 (408)
Q Consensus       269 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  348 (408)
                      ....  ......+|+.|+|||++.+ ..++.++|||||||++|||++|..|| .+.+..+++..+....+..........
T Consensus       251 ~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltG~~pf-~~~~~~~~l~~i~~~~~~p~~~~~~~~  326 (429)
T 3kvw_A          251 YEHQ--RVYTYIQSRFYRAPEVILG-ARYGMPIDMWSLGCILAELLTGYPLL-PGEDEGDQLACMIELLGMPSQKLLDAS  326 (429)
T ss_dssp             ETTC--CCCSSCSCGGGCCHHHHHT-BCCCTHHHHHHHHHHHHHHHHSSCSS-CCSSHHHHHHHHHHHHCCCCHHHHHTB
T ss_pred             ecCC--cccccCCCCCccChHHHhC-CCCCchHHHHhHHHHHHHHHhCCCCC-CCCCHHHHHHHHHHHcCCCCHHHHHhh
Confidence            6542  3345688999999999988 77999999999999999999999886 677777888888776664431110000


Q ss_pred             C--------CCcc-------------------------------ccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHH
Q 015374          349 R--------KPWS-------------------------------KFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREA  389 (408)
Q Consensus       349 ~--------~~~~-------------------------------~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~el  389 (408)
                      .        ..+.                               ...........++++.+||.+||++||++|||++|+
T Consensus       327 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta~e~  406 (429)
T 3kvw_A          327 KRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQA  406 (429)
T ss_dssp             TTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred             hhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCHHHH
Confidence            0        0000                               000011122347889999999999999999999999


Q ss_pred             hcCCCcccccc
Q 015374          390 MAHPYFAQVRA  400 (408)
Q Consensus       390 L~hp~f~~~~~  400 (408)
                      |+||||+....
T Consensus       407 L~Hpw~~~~~~  417 (429)
T 3kvw_A          407 LRHPWLRRRLP  417 (429)
T ss_dssp             HTSTTTC----
T ss_pred             hCChhhccCCC
Confidence            99999997644

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=1.9e-48  Score=375.39  Aligned_cols=269  Identities=24%  Similarity=0.405  Sum_probs=212.2

Q ss_pred             cCCCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc--chHHHHHHHHHHHHhc----CCCCceEEeeEEEccCC
Q 015374          121 WGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV--KKKKIKREIKILQNLC----GGPNVVKLLDIVRDQHS  194 (408)
Q Consensus       121 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~----~h~niv~l~~~~~~~~~  194 (408)
                      ....++|++.++||+|+||+||+|++..+++.||||+++..  ....+..|+.+++.+.    +||||+++++++..  .
T Consensus        31 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~--~  108 (360)
T 3llt_A           31 MLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMY--Y  108 (360)
T ss_dssp             CEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEE--T
T ss_pred             eEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccchhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeE--C
Confidence            34578999999999999999999999999999999999742  3466788999999983    39999999999965  4


Q ss_pred             CccEEEEEeecCCChhhhcC-----CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeC---------------
Q 015374          195 KTPSLIFEYVNSTDFKVLYP-----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDH---------------  254 (408)
Q Consensus       195 ~~~~lv~e~~~~~~l~~~~~-----~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~---------------  254 (408)
                      ...++||||+ +++|..++.     .+++..++.++.|++.||.|||++||+||||||+|||++.               
T Consensus       109 ~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~  187 (360)
T 3llt_A          109 DHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTD  187 (360)
T ss_dssp             TEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEEECTTT
T ss_pred             CeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccchhcccc
Confidence            6789999999 888877762     4899999999999999999999999999999999999975               


Q ss_pred             ---------CCCcEEEEecccceeccCCCcceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCC
Q 015374          255 ---------ELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHD  325 (408)
Q Consensus       255 ---------~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~  325 (408)
                               +.+.+||+|||++.....  ......||..|+|||++.+ ..++.++|||||||++|+|++|+.|| .+.+
T Consensus       188 ~~~~~~~~~~~~~~kl~DFG~a~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf-~~~~  263 (360)
T 3llt_A          188 GKKIQIYRTKSTGIKLIDFGCATFKSD--YHGSIINTRQYRAPEVILN-LGWDVSSDMWSFGCVLAELYTGSLLF-RTHE  263 (360)
T ss_dssp             CCEEEEEEESCCCEEECCCTTCEETTS--CCCSCCSCGGGCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCSC-CCSS
T ss_pred             cccccccccCCCCEEEEeccCceecCC--CCcCccCcccccCcHHHcC-CCCCCccchHHHHHHHHHHHHCCCCC-CCCc
Confidence                     237899999999986543  3345678999999999987 78999999999999999999999998 4555


Q ss_pred             CHHHHHHHHhhhchhhhhc--------------CCCCCCCcccccc------------ccCCCCCCHHHHHHHHHhcccC
Q 015374          326 NHDQLVKIAKDCCLIIWCN--------------SRHSRKPWSKFIN------------ADNQHLVSPEAIDFLDKLLRYD  379 (408)
Q Consensus       326 ~~~~~~~~~~~~~~~~~~~--------------~~~~~~~~~~~~~------------~~~~~~~~~~~~~li~~~L~~d  379 (408)
                      ..+.+..+....+......              .......|.....            .......++++.+||.+||+.|
T Consensus       264 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~d  343 (360)
T 3llt_A          264 HMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQID  343 (360)
T ss_dssp             HHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCCSS
T ss_pred             HHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHhcCC
Confidence            5566655555433221100              0000000110000            0001113477889999999999


Q ss_pred             cCCCCCHHHHhcCCCcc
Q 015374          380 HQDRLTAREAMAHPYFA  396 (408)
Q Consensus       380 p~~Rpt~~elL~hp~f~  396 (408)
                      |++|||++|+|+||||+
T Consensus       344 P~~Rpta~elL~hp~f~  360 (360)
T 3llt_A          344 PTLRPSPAELLKHKFLE  360 (360)
T ss_dssp             GGGSCCHHHHTTSGGGC
T ss_pred             hhhCCCHHHHhcCcccC
Confidence            99999999999999996

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=2.6e-48  Score=386.46  Aligned_cols=250  Identities=24%  Similarity=0.450  Sum_probs=216.2

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc------chHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCc
Q 015374          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT  196 (408)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  196 (408)
                      ..++|.+.+.||+|+||+||+|++..+|+.||||+++..      ....+.+|+.+++.+ +||||+++++++.+  ...
T Consensus        14 ~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~--~~~   90 (476)
T 2y94_A           14 KIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLF-RHPHIIKLYQVIST--PSD   90 (476)
T ss_dssp             EETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTC-CCTTBCCEEEEEEC--SSE
T ss_pred             eecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhC-CCCCCCcEEEEEEE--CCE
Confidence            357899999999999999999999999999999999643      235688999999999 99999999999965  467


Q ss_pred             cEEEEEeecCCChhhhcC---CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCC
Q 015374          197 PSLIFEYVNSTDFKVLYP---TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG  273 (408)
Q Consensus       197 ~~lv~e~~~~~~l~~~~~---~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~  273 (408)
                      .++||||+++++|..++.   .+++..++.++.|++.||+|||++||+||||||+|||++.+ +.+||+|||++......
T Consensus        91 ~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~-~~vkL~DFG~a~~~~~~  169 (476)
T 2y94_A           91 IFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAH-MNAKIADFGLSNMMSDG  169 (476)
T ss_dssp             EEEEEECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTT-CCEEECCCSSCEECCTT
T ss_pred             EEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecC-CCeEEEeccchhhcccc
Confidence            899999999999998874   48999999999999999999999999999999999999988 79999999999987766


Q ss_pred             CcceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCCCcc
Q 015374          274 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWS  353 (408)
Q Consensus       274 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  353 (408)
                      ......+||+.|+|||++.+....+.++|||||||++|+|++|..|| .+.+..+....+....                
T Consensus       170 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf-~~~~~~~~~~~i~~~~----------------  232 (476)
T 2y94_A          170 EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPF-DDDHVPTLFKKICDGI----------------  232 (476)
T ss_dssp             CCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSS-CCSSSHHHHHHHHTTC----------------
T ss_pred             ccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCC-CCCCHHHHHHHHhcCC----------------
Confidence            65667789999999999987444578999999999999999999998 4444555554443321                


Q ss_pred             ccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccc
Q 015374          354 KFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQ  397 (408)
Q Consensus       354 ~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~  397 (408)
                          ...+..+++++.+||.+||+.||++|||++|+++||||+.
T Consensus       233 ----~~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~  272 (476)
T 2y94_A          233 ----FYTPQYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQ  272 (476)
T ss_dssp             ----CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHT
T ss_pred             ----cCCCccCCHHHHHHHHHHcCCCchhCcCHHHHHhCHHhhh
Confidence                1123347899999999999999999999999999999975

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5.4e-48  Score=370.40  Aligned_cols=272  Identities=29%  Similarity=0.534  Sum_probs=213.1

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecccc--------hHHHHHHHHHHHHhcCCCCceEEeeEEEccCC
Q 015374          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK--------KKKIKREIKILQNLCGGPNVVKLLDIVRDQHS  194 (408)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~--------~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~  194 (408)
                      ..++|++.+.||+|+||+||+|++..+++.||||+++...        ...+.+|+.+++++ +||||++++++|.+  .
T Consensus         8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~--~   84 (346)
T 1ua2_A            8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQEL-SHPNIIGLLDAFGH--K   84 (346)
T ss_dssp             -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHC-CCTTBCCEEEEECC--T
T ss_pred             HhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhC-CCCCCCeEEEEEee--C
Confidence            3578999999999999999999999999999999986321        24678999999999 99999999999954  5


Q ss_pred             CccEEEEEeecCCChhhhcC----CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceec
Q 015374          195 KTPSLIFEYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY  270 (408)
Q Consensus       195 ~~~~lv~e~~~~~~l~~~~~----~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~  270 (408)
                      ...++||||+++ ++..++.    .+++..+..++.|++.||.|||++||+||||||+|||++.+ +.+||+|||+++..
T Consensus        85 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~-~~~kl~Dfg~a~~~  162 (346)
T 1ua2_A           85 SNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDEN-GVLKLADFGLAKSF  162 (346)
T ss_dssp             TCCEEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT-CCEEECCCGGGSTT
T ss_pred             CceEEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCC-CCEEEEecccceec
Confidence            678899999997 5555542    48899999999999999999999999999999999999988 79999999999876


Q ss_pred             cCC-CcceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCC-
Q 015374          271 HPG-KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHS-  348 (408)
Q Consensus       271 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~-  348 (408)
                      ... .......+|+.|+|||++.+...++.++|||||||++|+|++|..|| .+.++.+.+..+....+......+... 
T Consensus       163 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~-~~~~~~~~~~~i~~~~~~~~~~~~~~~~  241 (346)
T 1ua2_A          163 GSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFL-PGDSDLDQLTRIFETLGTPTEEQWPDMC  241 (346)
T ss_dssp             TSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSS-CCSSHHHHHHHHHHHHCCCCTTTSSSTT
T ss_pred             cCCcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCC-CCCCHHHHHHHHHHHcCCCChhhhhhhc
Confidence            433 23445688999999999977566899999999999999999998765 666777777777776553321111100 


Q ss_pred             -CCCcccc------ccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccccc
Q 015374          349 -RKPWSKF------INADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRA  400 (408)
Q Consensus       349 -~~~~~~~------~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~~~~  400 (408)
                       ...+..+      ........+++++.+||.+||+.||++|||++|+|+||||++...
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~~~  300 (346)
T 1ua2_A          242 SLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPG  300 (346)
T ss_dssp             SSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSC
T ss_pred             cCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcCCC
Confidence             0000000      000112456899999999999999999999999999999987654

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=3.6e-48  Score=359.64  Aligned_cols=256  Identities=26%  Similarity=0.490  Sum_probs=216.3

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecc---cchHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccEEE
Q 015374          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP---VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI  200 (408)
Q Consensus       124 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~---~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  200 (408)
                      .++|++.+.||+|+||+||+|++..++..+|+|++..   ...+.+.+|+.+++++ +||||++++++|.+  ....++|
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~--~~~~~lv   84 (277)
T 3f3z_A            8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSL-DHPNIIRLYETFED--NTDIYLV   84 (277)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTC-CCTTBCCEEEEEEC--SSEEEEE
T ss_pred             hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhC-CCCCEeeEEEEEec--CCeEEEE
Confidence            5689999999999999999999999999999999864   3457789999999999 99999999999965  4678999


Q ss_pred             EEeecCCChhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEE---eCCCCcEEEEecccceeccCCC
Q 015374          201 FEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMI---DHELRKLRLIDWGLAEFYHPGK  274 (408)
Q Consensus       201 ~e~~~~~~l~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl---~~~~~~~kl~DfG~a~~~~~~~  274 (408)
                      |||+++++|..++   ..+++..+..++.|++.||.|||++||+|+||||+|||+   +.+ +.++|+|||++.......
T Consensus        85 ~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~-~~~~l~Dfg~~~~~~~~~  163 (277)
T 3f3z_A           85 MELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPD-SPLKLIDFGLAARFKPGK  163 (277)
T ss_dssp             EECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTT-CCEEECCCTTCEECCTTS
T ss_pred             EeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCC-CcEEEEecccceeccCcc
Confidence            9999999998776   458999999999999999999999999999999999999   555 789999999998877666


Q ss_pred             cceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCCCccc
Q 015374          275 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSK  354 (408)
Q Consensus       275 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  354 (408)
                      ......+|+.|+|||++.+  .++.++||||||+++|+|++|..||. +.++.+....+......               
T Consensus       164 ~~~~~~~t~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~p~~-~~~~~~~~~~~~~~~~~---------------  225 (277)
T 3f3z_A          164 MMRTKVGTPYYVSPQVLEG--LYGPECDEWSAGVMMYVLLCGYPPFS-APTDSEVMLKIREGTFT---------------  225 (277)
T ss_dssp             CBCCCCSCTTTCCHHHHTT--CBCTTHHHHHHHHHHHHHHHSSCSSC-CSSHHHHHHHHHHCCCC---------------
T ss_pred             chhccCCCCCccChHHhcc--cCCchhhehhHHHHHHHHHHCCCCCC-CCCHHHHHHHHHhCCCC---------------
Confidence            6677789999999999865  48999999999999999999999984 44444444443332100               


Q ss_pred             cccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccccccch
Q 015374          355 FINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAE  402 (408)
Q Consensus       355 ~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~~~~~~  402 (408)
                       ........+++++.+++.+||+.||++|||+.|+|+||||++.....
T Consensus       226 -~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~~~~  272 (277)
T 3f3z_A          226 -FPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALEHEWFEKQLSSS  272 (277)
T ss_dssp             -CCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHHHHCCS
T ss_pred             -CCchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcccccc
Confidence             01111224689999999999999999999999999999998765443

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=2.1e-48  Score=376.06  Aligned_cols=268  Identities=30%  Similarity=0.547  Sum_probs=205.6

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc-----chHHHHHHHHHHHHhcCCCCceEEeeEEEcc----C
Q 015374          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQ----H  193 (408)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~----~  193 (408)
                      ..++|++++.||+|+||+||+|.+..+++.||||++...     ..+.+.+|+.+++.+ +||||+++++++...    .
T Consensus        27 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~~  105 (367)
T 2fst_X           27 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM-KHENVIGLLDVFTPARSLEE  105 (367)
T ss_dssp             EETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHC-CCTTBCCCSEEECSCSSGGG
T ss_pred             CCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhC-CCCCCCcEEEEEecCCcccc
Confidence            468999999999999999999999999999999998632     346788999999999 899999999999643    2


Q ss_pred             CCccEEEEEeecCCChhhhc--CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceecc
Q 015374          194 SKTPSLIFEYVNSTDFKVLY--PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH  271 (408)
Q Consensus       194 ~~~~~lv~e~~~~~~l~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~  271 (408)
                      ....++|+||+ +++|..++  ..+++..+..++.|++.||.|||++||+||||||+|||++.+ +.+||+|||+++...
T Consensus       106 ~~~~~lv~e~~-~~~L~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~-~~~kL~DFG~a~~~~  183 (367)
T 2fst_X          106 FNDVYLVTHLM-GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNED-CELKILDFGLARHTA  183 (367)
T ss_dssp             CCCCEEEEECC-CEECC-----CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT-CCEEECC--------
T ss_pred             CCeEEEEeccc-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCC-CCEEEeecccccccc
Confidence            25678999999 56777666  458999999999999999999999999999999999999988 799999999998654


Q ss_pred             CCCcceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCC----
Q 015374          272 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRH----  347 (408)
Q Consensus       272 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~----  347 (408)
                      .  ......+|..|+|||++.+...++.++|||||||++|||++|+.|| .+.+..+++..+....|.........    
T Consensus       184 ~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf-~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~  260 (367)
T 2fst_X          184 D--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF-PGTDHIDQLKLILRLVGTPGAELLKKISSE  260 (367)
T ss_dssp             ---------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSC-CCSSHHHHHHHHHHHHCSCCHHHHTTCCCH
T ss_pred             c--cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHHHhCCCCHHHHHHhhhH
Confidence            3  2345688999999999987678999999999999999999999997 66777788888877666432111110    


Q ss_pred             ------------CCCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccccccc
Q 015374          348 ------------SRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAA  401 (408)
Q Consensus       348 ------------~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~~~~~  401 (408)
                                  ....+.     .....+++++.+||.+||+.||++|||++|+|+||||+.....
T Consensus       261 ~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~~~~  321 (367)
T 2fst_X          261 SARNYIQSLTQMPKMNFA-----NVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDP  321 (367)
T ss_dssp             HHHHHHHTSCCCCCCCHH-----HHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCG
T ss_pred             HHHHHHhccCCCCCCCHH-----HHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhccCC
Confidence                        111111     1123468999999999999999999999999999999976543

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=8.8e-48  Score=365.15  Aligned_cols=253  Identities=23%  Similarity=0.429  Sum_probs=212.1

Q ss_pred             CEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc---chHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccEEEEE
Q 015374          126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV---KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFE  202 (408)
Q Consensus       126 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e  202 (408)
                      .|+..++||+|+||+||+|++..+|+.||||+++..   ..+.+.+|+.+++++ +||||+++++++..  ....++|||
T Consensus        46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~--~~~~~lv~e  122 (321)
T 2c30_A           46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDY-QHFNVVEMYKSYLV--GEELWVLME  122 (321)
T ss_dssp             HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTC-CCTTBCCEEEEEEE--TTEEEEEEC
T ss_pred             hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEEE--CCEEEEEEe
Confidence            478888999999999999999999999999998643   346788999999999 99999999999965  457889999


Q ss_pred             eecCCChhhhcC--CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCCC-cceee
Q 015374          203 YVNSTDFKVLYP--TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK-EYNVR  279 (408)
Q Consensus       203 ~~~~~~l~~~~~--~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~~-~~~~~  279 (408)
                      |+++++|..++.  .+++..+..++.|++.||.|||++||+||||||+|||++.+ +.+||+|||++....... .....
T Consensus       123 ~~~~~~L~~~l~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~-~~~kl~Dfg~~~~~~~~~~~~~~~  201 (321)
T 2c30_A          123 FLQGGALTDIVSQVRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLD-GRVKLSDFGFCAQISKDVPKRKSL  201 (321)
T ss_dssp             CCCSCBHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT-CCEEECCCTTCEECCSSSCCBCCC
T ss_pred             cCCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCC-CcEEEeeeeeeeecccCccccccc
Confidence            999999999875  58999999999999999999999999999999999999988 799999999998765432 23456


Q ss_pred             ccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCCCcccccccc
Q 015374          280 VASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSKFINAD  359 (408)
Q Consensus       280 ~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  359 (408)
                      .||..|+|||++.+ ..++.++|||||||++|+|++|+.||. +.+..+....+....         ..        ...
T Consensus       202 ~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~~g~~pf~-~~~~~~~~~~~~~~~---------~~--------~~~  262 (321)
T 2c30_A          202 VGTPYWMAPEVISR-SLYATEVDIWSLGIMVIEMVDGEPPYF-SDSPVQAMKRLRDSP---------PP--------KLK  262 (321)
T ss_dssp             CSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCTTT-TSCHHHHHHHHHHSS---------CC--------CCT
T ss_pred             cCCccccCHhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCC-CCCHHHHHHHHhcCC---------CC--------CcC
Confidence            79999999999987 789999999999999999999999984 333333333332210         00        001


Q ss_pred             CCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccccccc
Q 015374          360 NQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAA  401 (408)
Q Consensus       360 ~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~~~~~  401 (408)
                      ....+++++.+++.+||+.||++|||++|+++||||++....
T Consensus       263 ~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~~~~  304 (321)
T 2c30_A          263 NSHKVSPVLRDFLERMLVRDPQERATAQELLDHPFLLQTGLP  304 (321)
T ss_dssp             TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGGGCCCG
T ss_pred             ccccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhccCCCc
Confidence            122368999999999999999999999999999999876543

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=1.9e-48  Score=382.92  Aligned_cols=258  Identities=24%  Similarity=0.430  Sum_probs=203.6

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecccc-----------hHHHHHHHHHHHHhcCCCCceEEeeEEEcc
Q 015374          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK-----------KKKIKREIKILQNLCGGPNVVKLLDIVRDQ  192 (408)
Q Consensus       124 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-----------~~~~~~E~~~l~~l~~h~niv~l~~~~~~~  192 (408)
                      .++|++.+.||+|+||+||+|.+..+++.||||++....           ...+.+|+.+++++ +||||+++++++.. 
T Consensus       134 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~-  211 (419)
T 3i6u_A          134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKL-NHPCIIKIKNFFDA-  211 (419)
T ss_dssp             HTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHC-CCTTBCCCCEEEES-
T ss_pred             hccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhC-CCCCEeeEEEEEec-
Confidence            578999999999999999999999999999999986432           12478999999999 99999999999854 


Q ss_pred             CCCccEEEEEeecCCChhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCC--CcEEEEecccc
Q 015374          193 HSKTPSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEL--RKLRLIDWGLA  267 (408)
Q Consensus       193 ~~~~~~lv~e~~~~~~l~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~--~~~kl~DfG~a  267 (408)
                        ...++||||+++++|..++   ..+++..+..++.|++.||.|||++||+||||||+|||++.+.  ..+||+|||++
T Consensus       212 --~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a  289 (419)
T 3i6u_A          212 --EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHS  289 (419)
T ss_dssp             --SEEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTT
T ss_pred             --CceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeecccc
Confidence              3468999999999998876   3589999999999999999999999999999999999997541  35999999999


Q ss_pred             eeccCCCcceeeccCccccccccccC--CcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcC
Q 015374          268 EFYHPGKEYNVRVASRYFKGPELLVD--LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNS  345 (408)
Q Consensus       268 ~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  345 (408)
                      +............||+.|+|||++.+  ...++.++|||||||++|+|++|..||............+....        
T Consensus       290 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~--------  361 (419)
T 3i6u_A          290 KILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGK--------  361 (419)
T ss_dssp             TSCC-----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTC--------
T ss_pred             eecCCCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCC--------
Confidence            87765555566789999999999853  35688899999999999999999999854333222222222110        


Q ss_pred             CCCCCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccccccc
Q 015374          346 RHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAA  401 (408)
Q Consensus       346 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~~~~~  401 (408)
                       .   .    .....+..+++++.+|+.+||+.||++|||++|+|+||||+.....
T Consensus       362 -~---~----~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~~~  409 (419)
T 3i6u_A          362 -Y---N----FIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMK  409 (419)
T ss_dssp             -C---C----CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCCHHHH
T ss_pred             -C---C----CCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhCCcccCChhHH
Confidence             0   0    0112223478999999999999999999999999999999876543

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=3.2e-48  Score=360.96  Aligned_cols=260  Identities=26%  Similarity=0.479  Sum_probs=213.3

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc---------chHHHHHHHHHHHHhcCCCCceEEeeEEEccCC
Q 015374          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV---------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHS  194 (408)
Q Consensus       124 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~---------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~  194 (408)
                      .++|++.+.||+|+||+||+|++..+++.||+|+++..         ..+.+.+|+.+++++ +||||+++++++.+  .
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~--~   80 (283)
T 3bhy_A            4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREI-RHPNIITLHDIFEN--K   80 (283)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHC-CCTTBCCEEEEEEC--S
T ss_pred             hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhC-CCCCeeehhheecC--C
Confidence            35799999999999999999999999999999998642         256789999999999 89999999999965  4


Q ss_pred             CccEEEEEeecCCChhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCC---CcEEEEecccce
Q 015374          195 KTPSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEL---RKLRLIDWGLAE  268 (408)
Q Consensus       195 ~~~~lv~e~~~~~~l~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~---~~~kl~DfG~a~  268 (408)
                      ...++||||+++++|..++   ..+++..+..++.|++.||.|||++||+|+||||+||+++.+.   ..+||+|||++.
T Consensus        81 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~  160 (283)
T 3bhy_A           81 TDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAH  160 (283)
T ss_dssp             SEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred             CeEEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecccce
Confidence            6789999999999999887   4589999999999999999999999999999999999998762   179999999998


Q ss_pred             eccCCCcceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCC
Q 015374          269 FYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHS  348 (408)
Q Consensus       269 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  348 (408)
                      ............++..|+|||++.+ ..++.++||||||+++|+|++|..||. +.+..+.+..+.....          
T Consensus       161 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~-~~~~~~~~~~~~~~~~----------  228 (283)
T 3bhy_A          161 KIEAGNEFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFL-GETKQETLTNISAVNY----------  228 (283)
T ss_dssp             ECC--------CCCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCTTC-CSSHHHHHHHHHTTCC----------
T ss_pred             eccCCCcccccCCCcCccCcceecC-CCCCcchhhhhHHHHHHHHHHCCCCCC-CcchHHHHHHhHhccc----------
Confidence            7765555556679999999999987 779999999999999999999999983 4443444433322100          


Q ss_pred             CCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccccccchhh
Q 015374          349 RKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAESS  404 (408)
Q Consensus       349 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~~~~~~~~  404 (408)
                        .    ........+++++.+++.+||+.||++|||++|+++||||+.++....+
T Consensus       229 --~----~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~~~~~  278 (283)
T 3bhy_A          229 --D----FDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRRRNVR  278 (283)
T ss_dssp             --C----CCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHHHCCC-
T ss_pred             --C----CcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHHHHhhh
Confidence              0    0111223478999999999999999999999999999999988776544

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=2.4e-47  Score=357.74  Aligned_cols=261  Identities=26%  Similarity=0.429  Sum_probs=216.3

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecccc------------hHHHHHHHHHHHHhcCCCCceEEeeEEE
Q 015374          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK------------KKKIKREIKILQNLCGGPNVVKLLDIVR  190 (408)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~------------~~~~~~E~~~l~~l~~h~niv~l~~~~~  190 (408)
                      ..++|++.+.||+|+||.||+|++..+++.||||+++...            .+.+.+|+.+++++.+||||+++++++.
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~   94 (298)
T 1phk_A           15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE   94 (298)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred             hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence            4689999999999999999999999999999999986321            3567899999999956999999999995


Q ss_pred             ccCCCccEEEEEeecCCChhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccc
Q 015374          191 DQHSKTPSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA  267 (408)
Q Consensus       191 ~~~~~~~~lv~e~~~~~~l~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a  267 (408)
                      +  ....++||||+++++|..++   ..+++..+..++.|++.||.|||++||+|+||||+||+++.+ +.+||+|||++
T Consensus        95 ~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~-~~~kl~dfg~~  171 (298)
T 1phk_A           95 T--NTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDD-MNIKLTDFGFS  171 (298)
T ss_dssp             C--SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTT-CCEEECCCTTC
T ss_pred             c--CCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCC-CcEEEecccch
Confidence            4  56789999999999998887   368999999999999999999999999999999999999988 78999999999


Q ss_pred             eeccCCCcceeeccCccccccccccC-----CcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhh
Q 015374          268 EFYHPGKEYNVRVASRYFKGPELLVD-----LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIW  342 (408)
Q Consensus       268 ~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~  342 (408)
                      .............++..|+|||++.+     ...++.++||||||+++|+|++|..||. +.+..+....+.....    
T Consensus       172 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~-~~~~~~~~~~~~~~~~----  246 (298)
T 1phk_A          172 CQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFW-HRKQMLMLRMIMSGNY----  246 (298)
T ss_dssp             EECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSC-CSSHHHHHHHHHHTCC----
T ss_pred             hhcCCCcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCc-CccHHHHHHHHhcCCc----
Confidence            88776666666789999999999852     3568899999999999999999999984 3333333333332110    


Q ss_pred             hcCCCCCCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccccccchh
Q 015374          343 CNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAES  403 (408)
Q Consensus       343 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~~~~~~~  403 (408)
                         ..         .......+++++.+++.+||+.||++|||++|+++||||++....+.
T Consensus       247 ---~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~~~  295 (298)
T 1phk_A          247 ---QF---------GSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYVVEEV  295 (298)
T ss_dssp             ---CC---------CTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTTC----
T ss_pred             ---cc---------CcccccccCHHHHHHHHHHccCCcccCCCHHHHHhChHhhhccchhh
Confidence               00         11112347899999999999999999999999999999998876654

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=4.6e-48  Score=359.43  Aligned_cols=253  Identities=25%  Similarity=0.465  Sum_probs=210.7

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc------chHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCc
Q 015374          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT  196 (408)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  196 (408)
                      ..++|++.+.||+|+||+||+|.+..++..||+|++...      ....+.+|+.+++++ +||||+++++++.+  ...
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~   83 (279)
T 3fdn_A            7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL-RHPNILRLYGYFHD--ATR   83 (279)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTC-CCTTBCCEEEEEEC--SSE
T ss_pred             ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcC-CCCCCcchhheEec--CCE
Confidence            467899999999999999999999999999999998532      245688999999999 89999999999965  467


Q ss_pred             cEEEEEeecCCChhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCC
Q 015374          197 PSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG  273 (408)
Q Consensus       197 ~~lv~e~~~~~~l~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~  273 (408)
                      .++||||+++++|..++   ..+++..+..++.|++.||.|||++||+|+||||+|||++.+ +.++|+|||++......
T Consensus        84 ~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~-~~~~l~Dfg~~~~~~~~  162 (279)
T 3fdn_A           84 VYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSA-GELKIADFGWSVHAPSS  162 (279)
T ss_dssp             EEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTT-SCEEECSCCEESCC---
T ss_pred             EEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCC-CCEEEEeccccccCCcc
Confidence            88999999999998876   468999999999999999999999999999999999999988 79999999998654432


Q ss_pred             CcceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCCCcc
Q 015374          274 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWS  353 (408)
Q Consensus       274 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  353 (408)
                       ......++..|+|||.+.+ ..++.++||||||+++|+|++|..||. +.+..+....+...                 
T Consensus       163 -~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~-~~~~~~~~~~~~~~-----------------  222 (279)
T 3fdn_A          163 -RRTDLCGTLDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFLVGKPPFE-ANTYQETYKRISRV-----------------  222 (279)
T ss_dssp             ------CCCCTTCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCTTC-CSSHHHHHHHHHHT-----------------
T ss_pred             -cccccCCCCCccCHhHhcc-CCCCccchhHhHHHHHHHHHHCCCCCC-CCcHHHHHHHHHhC-----------------
Confidence             3345678999999999987 788999999999999999999999983 33333333333221                 


Q ss_pred             ccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccccccch
Q 015374          354 KFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAE  402 (408)
Q Consensus       354 ~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~~~~~~  402 (408)
                         ....+..+++++.+|+.+||+.||++|||++|+++||||+......
T Consensus       223 ---~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~~~~~~~~~~  268 (279)
T 3fdn_A          223 ---EFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKP  268 (279)
T ss_dssp             ---CCCCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCHHHHHHCSSC
T ss_pred             ---CCCCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhCccccCCccCc
Confidence               1122334789999999999999999999999999999998765543

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=2.2e-48  Score=369.95  Aligned_cols=250  Identities=19%  Similarity=0.352  Sum_probs=200.8

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecc----cchHHHHHHHHHHHHhcCCCCceEEeeEEEccCC-----
Q 015374          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP----VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHS-----  194 (408)
Q Consensus       124 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~----~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~-----  194 (408)
                      .++|++.+.||+|+||+||+|++..+++.||||+++.    ...+.+.+|+.+++++ +||||++++++|.+...     
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~~~~   83 (332)
T 3qd2_B            5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKL-EHPGIVRYFNAWLETPPEKWQE   83 (332)
T ss_dssp             HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSC-CCTTBCCEEEEEEECCSCHHHH
T ss_pred             hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhC-CCCCEeeEEEEEEEeccchhhh
Confidence            3579999999999999999999999999999999863    2346789999999999 99999999999865432     


Q ss_pred             --------------------------------------------------CccEEEEEeecCCChhhhcCC------CCh
Q 015374          195 --------------------------------------------------KTPSLIFEYVNSTDFKVLYPT------LTD  218 (408)
Q Consensus       195 --------------------------------------------------~~~~lv~e~~~~~~l~~~~~~------l~~  218 (408)
                                                                        ...++||||+++++|..++..      .++
T Consensus        84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~  163 (332)
T 3qd2_B           84 EMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREH  163 (332)
T ss_dssp             HHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCH
T ss_pred             hhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhh
Confidence                                                              237899999999999998732      455


Q ss_pred             HHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCCC-------------cceeeccCccc
Q 015374          219 YDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK-------------EYNVRVASRYF  285 (408)
Q Consensus       219 ~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~~-------------~~~~~~~~~~y  285 (408)
                      ..+..++.|++.||.|||++||+||||||+|||++.+ +.+||+|||+++......             ......||..|
T Consensus       164 ~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~-~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y  242 (332)
T 3qd2_B          164 GVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMD-DVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLY  242 (332)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTT-CCEEECCCTTCEECSCC--------------CCCSCC-CGGG
T ss_pred             HHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCC-CCEEEeecCcccccccchhhccccccccccccccccCCCcCc
Confidence            6688999999999999999999999999999999988 799999999998775442             12335799999


Q ss_pred             cccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCCCccccccccCCCCCC
Q 015374          286 KGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSKFINADNQHLVS  365 (408)
Q Consensus       286 ~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  365 (408)
                      +|||++.+ ..++.++|||||||++|+|++|..|+.   +...........              .+     .......+
T Consensus       243 ~aPE~~~~-~~~~~~~Di~slG~il~el~~~~~~~~---~~~~~~~~~~~~--------------~~-----~~~~~~~~  299 (332)
T 3qd2_B          243 MSPEQIHG-NNYSHKVDIFSLGLILFELLYSFSTQM---ERVRIITDVRNL--------------KF-----PLLFTQKY  299 (332)
T ss_dssp             SCHHHHHC-CCCCTHHHHHHHHHHHHHHHSCCCCHH---HHHHHHHHHHTT--------------CC-----CHHHHHHC
T ss_pred             cChHHhcC-CCCcchhhHHHHHHHHHHHHHcCCChh---HHHHHHHHhhcc--------------CC-----CcccccCC
Confidence            99999987 789999999999999999999866541   111111111110              00     00111246


Q ss_pred             HHHHHHHHHhcccCcCCCCCHHHHhcCCCcccc
Q 015374          366 PEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQV  398 (408)
Q Consensus       366 ~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~~  398 (408)
                      +++.+|+.+||+.||++|||++|+|+||||+++
T Consensus       300 ~~~~~li~~~l~~~p~~Rps~~~~l~~~~f~~~  332 (332)
T 3qd2_B          300 PQEHMMVQDMLSPSPTERPEATDIIENAIFENL  332 (332)
T ss_dssp             HHHHHHHHHHHCSSGGGSCCHHHHHHSTTCCCC
T ss_pred             hhHHHHHHHHccCCCCcCCCHHHHhhchhhhcC
Confidence            788999999999999999999999999999875

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=6.5e-48  Score=372.38  Aligned_cols=269  Identities=29%  Similarity=0.558  Sum_probs=218.9

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc----chHHHHHHHHHHHHhcCCCCceEEeeEEEccC---CC
Q 015374          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQH---SK  195 (408)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~---~~  195 (408)
                      ..++|++.+.||+|+||+||+|++..++..||||++...    ....+.+|+.+++++ +||||+++++++....   ..
T Consensus        25 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~  103 (364)
T 3qyz_A           25 VGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRF-RHENIIGINDIIRAPTIEQMK  103 (364)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHC-CCTTBCCCCEEECCSSTTTCC
T ss_pred             ccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhc-CCCCCccceeEEecCCccccc
Confidence            357999999999999999999999999999999998642    236688999999999 9999999999996432   24


Q ss_pred             ccEEEEEeecCCChhhhc--CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCC
Q 015374          196 TPSLIFEYVNSTDFKVLY--PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG  273 (408)
Q Consensus       196 ~~~lv~e~~~~~~l~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~  273 (408)
                      ..++||||+++ +|..++  ..+++..+..++.|++.||.|||++||+||||||+|||++.+ +.+||+|||++......
T Consensus       104 ~~~iv~e~~~~-~L~~~l~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~-~~~kl~Dfg~a~~~~~~  181 (364)
T 3qyz_A          104 DVYIVQDLMET-DLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTT-CDLKICDFGLARVADPD  181 (364)
T ss_dssp             CEEEEEECCSE-EHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTT-CCEEECCCTTCEECCGG
T ss_pred             eEEEEEcccCc-CHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCC-CCEEEEeCcceEecCCC
Confidence            67899999996 666655  468999999999999999999999999999999999999988 78999999999876533


Q ss_pred             Cc----ceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhc-----
Q 015374          274 KE----YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCN-----  344 (408)
Q Consensus       274 ~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~-----  344 (408)
                      ..    .....||+.|+|||++.+...++.++|||||||++|+|++|+.|| .+.+..+.+..+....+......     
T Consensus       182 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf-~~~~~~~~~~~i~~~~~~~~~~~~~~~~  260 (364)
T 3qyz_A          182 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF-PGKHYLDQLNHILGILGSPSQEDLNCII  260 (364)
T ss_dssp             GCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSS-CCSSGGGHHHHHHHHHCSCCHHHHHTCC
T ss_pred             CCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCC-CCCChHHHHHHHHHHhCCCCHHHHHHhh
Confidence            22    234588999999999877567899999999999999999999887 56666667777666544332110     


Q ss_pred             -----------CCCCCCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccccc
Q 015374          345 -----------SRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRA  400 (408)
Q Consensus       345 -----------~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~~~~  400 (408)
                                 .......|.     .....+++++.+||.+||++||++|||++|+|+||||++...
T Consensus       261 ~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~~  322 (364)
T 3qyz_A          261 NLKARNYLLSLPHKNKVPWN-----RLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD  322 (364)
T ss_dssp             CHHHHHHHHTSCCCCCCCHH-----HHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTTCC
T ss_pred             hhhHHHHHHhcCCccCCCHH-----HhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhccC
Confidence                       011111111     112346899999999999999999999999999999998644

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=6.2e-48  Score=399.79  Aligned_cols=256  Identities=23%  Similarity=0.387  Sum_probs=220.3

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc------chHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCc
Q 015374          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT  196 (408)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  196 (408)
                      ..++|++++.||+|+||+||+|++..+++.||||+++..      ....+..|..++..+.+||||+++++++.+  ...
T Consensus       339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~--~~~  416 (674)
T 3pfq_A          339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQT--MDR  416 (674)
T ss_dssp             -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBC--SSE
T ss_pred             cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEe--CCE
Confidence            357899999999999999999999999999999998742      235678899999988789999999999954  567


Q ss_pred             cEEEEEeecCCChhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceecc-C
Q 015374          197 PSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH-P  272 (408)
Q Consensus       197 ~~lv~e~~~~~~l~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~-~  272 (408)
                      ++|||||+++++|..++   ..+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++... .
T Consensus       417 ~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~-g~ikL~DFGla~~~~~~  495 (674)
T 3pfq_A          417 LYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSE-GHIKIADFGMCKENIWD  495 (674)
T ss_dssp             EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSS-SCEEECCCTTCEECCCT
T ss_pred             EEEEEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCC-CcEEEeecceeeccccC
Confidence            89999999999999887   469999999999999999999999999999999999999998 899999999998643 3


Q ss_pred             CCcceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCCCc
Q 015374          273 GKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPW  352 (408)
Q Consensus       273 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  352 (408)
                      .......+||+.|+|||++.+ ..++.++|||||||++|||++|..|| .+.+..+.+..+...                
T Consensus       496 ~~~~~~~~GT~~Y~APE~l~~-~~~~~~~DvwSlGvilyelltG~~Pf-~~~~~~~~~~~i~~~----------------  557 (674)
T 3pfq_A          496 GVTTKTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQAPF-EGEDEDELFQSIMEH----------------  557 (674)
T ss_dssp             TCCBCCCCSCSSSCCHHHHTC-CCBSTHHHHHHHHHHHHHHHHSSCSS-CCSSHHHHHHHHHSS----------------
T ss_pred             CcccccccCCCcccCHhhhcC-CCCCccceEechHHHHHHHHcCCCCC-CCCCHHHHHHHHHhC----------------
Confidence            334556789999999999987 78999999999999999999999998 455555555555432                


Q ss_pred             cccccccCCCCCCHHHHHHHHHhcccCcCCCCCH-----HHHhcCCCccccccchh
Q 015374          353 SKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTA-----REAMAHPYFAQVRAAES  403 (408)
Q Consensus       353 ~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~-----~elL~hp~f~~~~~~~~  403 (408)
                          ....+..+++++.+||++||+.||++||++     +|+++||||+.+++...
T Consensus       558 ----~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~i~w~~l  609 (674)
T 3pfq_A          558 ----NVAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKL  609 (674)
T ss_dssp             ----CCCCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSSGGGSSCCHHHH
T ss_pred             ----CCCCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcCccccCCCHHHH
Confidence                112234579999999999999999999997     99999999999887553

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=4.4e-48  Score=370.41  Aligned_cols=258  Identities=26%  Similarity=0.481  Sum_probs=210.2

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc--------chHHHHHHHHHHHHhcCCCCceEEeeEEEccCCC
Q 015374          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV--------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSK  195 (408)
Q Consensus       124 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~--------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  195 (408)
                      .++|++.+.||+|+||+||+|++..++..||+|+++..        ..+.+.+|+.+++++ +||||++++++|.+  ..
T Consensus        25 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~--~~  101 (345)
T 3hko_A           25 QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKL-HHPNIARLYEVYED--EQ  101 (345)
T ss_dssp             HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHC-CCTTBCCEEEEEEC--SS
T ss_pred             hhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhC-CCCCcceeehhhcc--CC
Confidence            57899999999999999999999999999999998632        336788999999999 99999999999965  56


Q ss_pred             ccEEEEEeecCCChhhhcCC-------------------------------------------CChHHHHHHHHHHHHHH
Q 015374          196 TPSLIFEYVNSTDFKVLYPT-------------------------------------------LTDYDIRYYIYELLKAL  232 (408)
Q Consensus       196 ~~~lv~e~~~~~~l~~~~~~-------------------------------------------l~~~~~~~i~~qi~~~L  232 (408)
                      ..++||||+++++|..++..                                           +++..++.++.|++.||
T Consensus       102 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l  181 (345)
T 3hko_A          102 YICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSAL  181 (345)
T ss_dssp             EEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHH
T ss_pred             eEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHH
Confidence            78999999999999888731                                           25667788999999999


Q ss_pred             HHHHHCCcEEecCCCCcEEEeCCC-CcEEEEecccceeccCCC-----cceeeccCccccccccccCC-cCCCccccHHH
Q 015374          233 DYCHSQGIMHRDVKPHNVMIDHEL-RKLRLIDWGLAEFYHPGK-----EYNVRVASRYFKGPELLVDL-QDYDYSLDMWS  305 (408)
Q Consensus       233 ~~LH~~~iiH~Dlk~~NILl~~~~-~~~kl~DfG~a~~~~~~~-----~~~~~~~~~~y~aPE~~~~~-~~~~~~~DvwS  305 (408)
                      .|||++||+||||||+|||++.+. ..+||+|||++.......     ......||+.|+|||++.+. ..++.++||||
T Consensus       182 ~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Diws  261 (345)
T 3hko_A          182 HYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWS  261 (345)
T ss_dssp             HHHHHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHH
T ss_pred             HHHHHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHH
Confidence            999999999999999999998762 279999999998654321     23456799999999999642 57899999999


Q ss_pred             HHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCC
Q 015374          306 LGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLT  385 (408)
Q Consensus       306 lGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt  385 (408)
                      |||++|+|++|+.|| .+.+..+....+......                ........+++++.+||.+||+.||++|||
T Consensus       262 lG~il~el~~g~~pf-~~~~~~~~~~~~~~~~~~----------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps  324 (345)
T 3hko_A          262 AGVLLHLLLMGAVPF-PGVNDADTISQVLNKKLC----------------FENPNYNVLSPLARDLLSNLLNRNVDERFD  324 (345)
T ss_dssp             HHHHHHHHHHSSCSS-CCSSHHHHHHHHHHCCCC----------------TTSGGGGGSCHHHHHHHHHHSCSCTTTSCC
T ss_pred             HHHHHHHHHHCCCCC-CCCChHHHHHHHHhcccc----------------cCCcccccCCHHHHHHHHHHcCCChhHCCC
Confidence            999999999999998 444445555444432110                011112236899999999999999999999


Q ss_pred             HHHHhcCCCccccccc
Q 015374          386 AREAMAHPYFAQVRAA  401 (408)
Q Consensus       386 ~~elL~hp~f~~~~~~  401 (408)
                      +.|+|+||||++....
T Consensus       325 ~~~~l~hp~~~~~~~~  340 (345)
T 3hko_A          325 AMRALQHPWISQFSDK  340 (345)
T ss_dssp             HHHHHHSHHHHTTSSC
T ss_pred             HHHHhcChhhccChHh
Confidence            9999999999987653

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=3.2e-48  Score=367.65  Aligned_cols=270  Identities=19%  Similarity=0.316  Sum_probs=215.3

Q ss_pred             CCCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc----chHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCcc
Q 015374          122 GDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP  197 (408)
Q Consensus       122 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~  197 (408)
                      ...++|++.+.||+|+||+||+|++..+++.||||+++..    ..+.+.+|+.+++++ +||||+++++++.+......
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~   84 (319)
T 4euu_A            6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKL-NHKNIVKLFAIEEETTTRHK   84 (319)
T ss_dssp             CSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHC-CCTTBCCEEEEEECTTTCCE
T ss_pred             CCCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhc-CCCCcceEEEEeecCCCceE
Confidence            3578899999999999999999999999999999999743    246688999999999 89999999999987766788


Q ss_pred             EEEEEeecCCChhhhcCC------CChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEE----eCCCCcEEEEecccc
Q 015374          198 SLIFEYVNSTDFKVLYPT------LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMI----DHELRKLRLIDWGLA  267 (408)
Q Consensus       198 ~lv~e~~~~~~l~~~~~~------l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl----~~~~~~~kl~DfG~a  267 (408)
                      ++||||+++++|..++..      +++..+..++.|++.||.|||++||+||||||+|||+    +.+ +.+||+|||++
T Consensus        85 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~-~~~kL~Dfg~a  163 (319)
T 4euu_A           85 VLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQ-SVYKLTDFGAA  163 (319)
T ss_dssp             EEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSC-EEEEECCCTTC
T ss_pred             EEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCC-ceEEEccCCCc
Confidence            999999999999988743      8999999999999999999999999999999999998    554 67999999999


Q ss_pred             eeccCCCcceeeccCccccccccccC-------CcCCCccccHHHHHHHHHHHHhCCCCCCCCC---CCHHHHHHHHhhh
Q 015374          268 EFYHPGKEYNVRVASRYFKGPELLVD-------LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGH---DNHDQLVKIAKDC  337 (408)
Q Consensus       268 ~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~~DvwSlGvil~ell~g~~pf~~~~---~~~~~~~~~~~~~  337 (408)
                      +............||..|+|||++..       ...++.++|||||||++|||++|..||....   ...+.+..+....
T Consensus       164 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~  243 (319)
T 4euu_A          164 RELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGK  243 (319)
T ss_dssp             EECCTTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHHC
T ss_pred             eecCCCCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcCC
Confidence            98776666666789999999999862       2678999999999999999999999985432   2344444444332


Q ss_pred             chhhhhcC---CCCCCCcccccc--ccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCC
Q 015374          338 CLIIWCNS---RHSRKPWSKFIN--ADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHP  393 (408)
Q Consensus       338 ~~~~~~~~---~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp  393 (408)
                      ....+...   ......|....+  ......++..+.+++++||+.||++|||++|+|+||
T Consensus       244 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~  304 (319)
T 4euu_A          244 PSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAET  304 (319)
T ss_dssp             CTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHH
T ss_pred             CcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhcc
Confidence            11110000   000011111111  112233457799999999999999999999999997

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=8e-48  Score=372.73  Aligned_cols=270  Identities=32%  Similarity=0.571  Sum_probs=215.9

Q ss_pred             CCCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc-----chHHHHHHHHHHHHhcCCCCceEEeeEEEccCCC-
Q 015374          122 GDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSK-  195 (408)
Q Consensus       122 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~-  195 (408)
                      ...++|.+.+.||+|+||+||+|++..+++.||||+++..     ..+.+.+|+.+++.+ +||||++++++|...... 
T Consensus        39 ~l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~  117 (371)
T 4exu_A           39 ELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHM-QHENVIGLLDVFTPASSLR  117 (371)
T ss_dssp             EEETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHC-CCTTBCCCSEEECSCSSST
T ss_pred             cccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhc-CCCCchhhhhheeccCCcc
Confidence            3468999999999999999999999999999999998642     246788999999999 999999999999654322 


Q ss_pred             ---ccEEEEEeecCCChhhhc-CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceecc
Q 015374          196 ---TPSLIFEYVNSTDFKVLY-PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH  271 (408)
Q Consensus       196 ---~~~lv~e~~~~~~l~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~  271 (408)
                         ..++||||+.+ +|...+ ..+++..+..++.|++.||.|||++||+||||||+|||++.+ +.+||+|||+++...
T Consensus       118 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~-~~~kL~Dfg~a~~~~  195 (371)
T 4exu_A          118 NFYDFYLVMPFMQT-DLQKIMGMEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNED-CELKILDFGLARHAD  195 (371)
T ss_dssp             TCCCCEEEEECCCE-EHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTT-CCEEECSTTCC----
T ss_pred             cceeEEEEEccccc-cHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCC-CCEEEEecCcccccc
Confidence               24899999995 555554 569999999999999999999999999999999999999988 799999999997654


Q ss_pred             CCCcceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCC-----
Q 015374          272 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSR-----  346 (408)
Q Consensus       272 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~-----  346 (408)
                      .  ......+|+.|+|||++.+...++.++|||||||++|+|++|+.|| .+.+..+.+..+....+........     
T Consensus       196 ~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf-~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  272 (371)
T 4exu_A          196 A--EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLF-KGKDYLDQLTQILKVTGVPGTEFVQKLNDK  272 (371)
T ss_dssp             ------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSC-CCSSHHHHHHHHHHHHCCCCHHHHTTCSCH
T ss_pred             c--CcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCC-CCCChHHHHHHHHHHhCCCcHHHHHHhhhh
Confidence            2  3345678999999999987678999999999999999999999997 5666667777776655433211100     


Q ss_pred             -----------CCCCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccccccch
Q 015374          347 -----------HSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAE  402 (408)
Q Consensus       347 -----------~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~~~~~~  402 (408)
                                 .....+     ......+++++.+||.+||+.||++|||++|+|+||||+......
T Consensus       273 ~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~  334 (371)
T 4exu_A          273 AAKSYIQSLPQTPRKDF-----TQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRDPE  334 (371)
T ss_dssp             HHHHHHHHSCCCCCCCH-----HHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTCCGG
T ss_pred             hhhhhhhccCCCcchhH-----HHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccccCCCcc
Confidence                       001111     111234689999999999999999999999999999999876543

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=7.3e-48  Score=387.74  Aligned_cols=256  Identities=27%  Similarity=0.509  Sum_probs=215.6

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc----------------chHHHHHHHHHHHHhcCCCCceEEe
Q 015374          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV----------------KKKKIKREIKILQNLCGGPNVVKLL  186 (408)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~----------------~~~~~~~E~~~l~~l~~h~niv~l~  186 (408)
                      ..++|+++++||+|+||+||+|++..+++.||+|+++..                ..+.+.+|+.+++++ +||||++++
T Consensus        34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~  112 (504)
T 3q5i_A           34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSL-DHPNIIKLF  112 (504)
T ss_dssp             GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTC-CCTTBCCEE
T ss_pred             cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhC-CCCCCCeEE
Confidence            367899999999999999999999999999999998642                235688999999999 999999999


Q ss_pred             eEEEccCCCccEEEEEeecCCChhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCC--cEEE
Q 015374          187 DIVRDQHSKTPSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELR--KLRL  261 (408)
Q Consensus       187 ~~~~~~~~~~~~lv~e~~~~~~l~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~--~~kl  261 (408)
                      ++|.+  ....++||||+++++|..++   ..+++..+..++.|++.||.|||++||+||||||+|||++.+..  .+||
T Consensus       113 ~~~~~--~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl  190 (504)
T 3q5i_A          113 DVFED--KKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKI  190 (504)
T ss_dssp             EEEEC--SSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEE
T ss_pred             EEEEc--CCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEE
Confidence            99965  56789999999999998776   56999999999999999999999999999999999999987632  6999


Q ss_pred             EecccceeccCCCcceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhh
Q 015374          262 IDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLII  341 (408)
Q Consensus       262 ~DfG~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~  341 (408)
                      +|||++.............||+.|+|||++.+  .++.++|||||||++|+|++|..|| .+.+..+.+..+......  
T Consensus       191 ~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf-~~~~~~~~~~~i~~~~~~--  265 (504)
T 3q5i_A          191 VDFGLSSFFSKDYKLRDRLGTAYYIAPEVLKK--KYNEKCDVWSCGVIMYILLCGYPPF-GGQNDQDIIKKVEKGKYY--  265 (504)
T ss_dssp             CCCTTCEECCTTSCBCCCCSCTTTCCHHHHTT--CBCTHHHHHHHHHHHHHHHHSSCSS-CCSSHHHHHHHHHHCCCC--
T ss_pred             EECCCCEEcCCCCccccccCCcCCCCHHHhcc--CCCchHHHHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHcCCCC--
Confidence            99999998876666667789999999999864  6999999999999999999999998 445545555544432100  


Q ss_pred             hhcCCCCCCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccccc
Q 015374          342 WCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRA  400 (408)
Q Consensus       342 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~~~~  400 (408)
                                    .....+..+++++.+||.+||+.||.+|||++|+|+||||+....
T Consensus       266 --------------~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~  310 (504)
T 3q5i_A          266 --------------FDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYAN  310 (504)
T ss_dssp             --------------CCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHTCC
T ss_pred             --------------CCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhchh
Confidence                          111223447899999999999999999999999999999986543

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=3.8e-48  Score=377.48  Aligned_cols=286  Identities=22%  Similarity=0.353  Sum_probs=218.9

Q ss_pred             cccCCCCCcccccCCCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecccc--hHHHHHHHHHHHHhc-------CC
Q 015374          109 KEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK--KKKIKREIKILQNLC-------GG  179 (408)
Q Consensus       109 ~~~~~~~~~~~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~E~~~l~~l~-------~h  179 (408)
                      +....+..+..+....++|++.++||+|+||+||+|++..+++.||||+++...  .+.+.+|+.+++.+.       +|
T Consensus        21 ~~~~~~~~~~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~  100 (397)
T 1wak_A           21 YCKGGYHLVKIGDLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNR  100 (397)
T ss_dssp             -CC--CCSSCTTCEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHSCTTCGGG
T ss_pred             CCCCCceEEehhhhcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCCcchHHHHHHHHHHHHHhhcCCCCCCc
Confidence            333455666666666789999999999999999999999999999999997533  467889999999983       27


Q ss_pred             CCceEEeeEEEcc--CCCccEEEEEeecCCChhhhc----CCCChHHHHHHHHHHHHHHHHHHHC-CcEEecCCCCcEEE
Q 015374          180 PNVVKLLDIVRDQ--HSKTPSLIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQ-GIMHRDVKPHNVMI  252 (408)
Q Consensus       180 ~niv~l~~~~~~~--~~~~~~lv~e~~~~~~l~~~~----~~l~~~~~~~i~~qi~~~L~~LH~~-~iiH~Dlk~~NILl  252 (408)
                      +||++++++|...  .....++||||+.++++..+.    ..+++..++.++.||+.||.|||++ ||+||||||+|||+
T Consensus       101 ~~iv~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll  180 (397)
T 1wak_A          101 EMVVQLLDDFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILL  180 (397)
T ss_dssp             GGBCCEEEEEEEEETTEEEEEEEECCCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEE
T ss_pred             ceeeeeecceeecCCCCceEEEEEeccCccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeE
Confidence            8899999998632  456789999999777666654    3489999999999999999999998 99999999999999


Q ss_pred             eCCC------------------------------------------------CcEEEEecccceeccCCCcceeeccCcc
Q 015374          253 DHEL------------------------------------------------RKLRLIDWGLAEFYHPGKEYNVRVASRY  284 (408)
Q Consensus       253 ~~~~------------------------------------------------~~~kl~DfG~a~~~~~~~~~~~~~~~~~  284 (408)
                      +.+.                                                ..+||+|||++.....  ......||..
T Consensus       181 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~--~~~~~~gt~~  258 (397)
T 1wak_A          181 SVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHK--HFTEDIQTRQ  258 (397)
T ss_dssp             CCCHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTB--CSCSCCSCGG
T ss_pred             eccchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccc--cCccCCCCCc
Confidence            8762                                                2799999999987653  3445688999


Q ss_pred             ccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCC-----CHHHHHHHHhhhchhhhh---cCCCCCC------
Q 015374          285 FKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHD-----NHDQLVKIAKDCCLIIWC---NSRHSRK------  350 (408)
Q Consensus       285 y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~-----~~~~~~~~~~~~~~~~~~---~~~~~~~------  350 (408)
                      |+|||++.+ ..++.++|||||||++|+|++|+.||.....     +.+.+..+....+.....   .......      
T Consensus       259 y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~  337 (397)
T 1wak_A          259 YRSLEVLIG-SGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKG  337 (397)
T ss_dssp             GCCHHHHHT-SCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTS
T ss_pred             ccCChhhcC-CCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCcc
Confidence            999999988 6799999999999999999999999854332     334555555544432210   0000000      


Q ss_pred             Cccccc-------------cccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccc
Q 015374          351 PWSKFI-------------NADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQ  397 (408)
Q Consensus       351 ~~~~~~-------------~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~  397 (408)
                      .+....             ....+...+.++.+||.+||+.||++|||++|+|+||||++
T Consensus       338 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~  397 (397)
T 1wak_A          338 DLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLNS  397 (397)
T ss_dssp             SBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGGC
T ss_pred             ccccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCccccC
Confidence            000000             00112223567899999999999999999999999999974

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=2.7e-48  Score=370.82  Aligned_cols=244  Identities=26%  Similarity=0.457  Sum_probs=209.4

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc-----------chHHHHHHHHHHHHhcCCCCceEEeeEEEcc
Q 015374          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQ  192 (408)
Q Consensus       124 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-----------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~  192 (408)
                      .++|++.+.||+|+||+||+|++..+++.||||+++..           ....+.+|+.+++++ +||||++++++|.+ 
T Consensus        23 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~~~~~~~~-  100 (335)
T 3dls_A           23 SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRV-EHANIIKVLDIFEN-  100 (335)
T ss_dssp             HHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTC-CCTTBCCEEEEEEC-
T ss_pred             ccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhC-CCCCEeeEEEEEee-
Confidence            56899999999999999999999999999999998643           234677899999999 99999999999954 


Q ss_pred             CCCccEEEEEeecCC-Chhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccce
Q 015374          193 HSKTPSLIFEYVNST-DFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE  268 (408)
Q Consensus       193 ~~~~~~lv~e~~~~~-~l~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~  268 (408)
                       ....++||||+.+| +|..++   ..+++..+..++.|++.||.|||++||+||||||+|||++.+ +.+||+|||++.
T Consensus       101 -~~~~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~-~~~kL~Dfg~a~  178 (335)
T 3dls_A          101 -QGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAED-FTIKLIDFGSAA  178 (335)
T ss_dssp             -SSEEEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTT-SCEEECCCTTCE
T ss_pred             -CCEEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCC-CcEEEeecccce
Confidence             56788999999776 888776   358999999999999999999999999999999999999988 799999999999


Q ss_pred             eccCCCcceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCC
Q 015374          269 FYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHS  348 (408)
Q Consensus       269 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  348 (408)
                      ............||..|+|||++.+...++.++|||||||++|+|++|..||.....       ..           .  
T Consensus       179 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-------~~-----------~--  238 (335)
T 3dls_A          179 YLERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE-------TV-----------E--  238 (335)
T ss_dssp             ECCTTCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG-------GT-----------T--
T ss_pred             ECCCCCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH-------HH-----------h--
Confidence            887666666778999999999998744448899999999999999999999842100       00           0  


Q ss_pred             CCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccc
Q 015374          349 RKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQV  398 (408)
Q Consensus       349 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~~  398 (408)
                             .....+..+++++.+||.+||+.||++|||++|+++||||++.
T Consensus       239 -------~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~  281 (335)
T 3dls_A          239 -------AAIHPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQP  281 (335)
T ss_dssp             -------TCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHCTTTTCC
T ss_pred             -------hccCCCcccCHHHHHHHHHHccCChhhCcCHHHHhcCccccCC
Confidence                   0111233478999999999999999999999999999999763

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=1.6e-47  Score=369.86  Aligned_cols=254  Identities=25%  Similarity=0.475  Sum_probs=213.5

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecccc-----------hHHHHHHHHHHHHhcCCCCceEEeeEEEcc
Q 015374          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK-----------KKKIKREIKILQNLCGGPNVVKLLDIVRDQ  192 (408)
Q Consensus       124 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-----------~~~~~~E~~~l~~l~~h~niv~l~~~~~~~  192 (408)
                      .++|++.+.||+|+||.||+|++..+|+.||||+++...           .+.+.+|+.+++++.+||||+++++++.. 
T Consensus        93 ~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~-  171 (365)
T 2y7j_A           93 YQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYES-  171 (365)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEB-
T ss_pred             hhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEee-
Confidence            467999999999999999999999999999999986432           35678899999998779999999999965 


Q ss_pred             CCCccEEEEEeecCCChhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEeccccee
Q 015374          193 HSKTPSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEF  269 (408)
Q Consensus       193 ~~~~~~lv~e~~~~~~l~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~  269 (408)
                       ....++||||+++++|..++   ..+++..+..++.|++.||.|||+.||+|+||||+|||++.+ +.++|+|||++..
T Consensus       172 -~~~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~-~~ikl~DfG~~~~  249 (365)
T 2y7j_A          172 -SSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDN-MQIRLSDFGFSCH  249 (365)
T ss_dssp             -SSEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTT-CCEEECCCTTCEE
T ss_pred             -CCEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCC-CCEEEEecCcccc
Confidence             46789999999999998887   469999999999999999999999999999999999999988 7999999999988


Q ss_pred             ccCCCcceeeccCccccccccccC-----CcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhc
Q 015374          270 YHPGKEYNVRVASRYFKGPELLVD-----LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCN  344 (408)
Q Consensus       270 ~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  344 (408)
                      ...........||+.|+|||++.+     ...++.++|||||||++|+|++|..||. +.+..+.+..+......     
T Consensus       250 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~-~~~~~~~~~~i~~~~~~-----  323 (365)
T 2y7j_A          250 LEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFW-HRRQILMLRMIMEGQYQ-----  323 (365)
T ss_dssp             CCTTCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSC-CSSHHHHHHHHHHTCCC-----
T ss_pred             cCCCcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCC-CCCHHHHHHHHHhCCCC-----
Confidence            776666667789999999999863     1358899999999999999999999984 33333333333321100     


Q ss_pred             CCCCCCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccc
Q 015374          345 SRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQ  397 (408)
Q Consensus       345 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~  397 (408)
                                 .....+..++.++.+|+.+||+.||++|||++|+|+||||+.
T Consensus       324 -----------~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~r  365 (365)
T 2y7j_A          324 -----------FSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFER  365 (365)
T ss_dssp             -----------CCHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred             -----------CCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcccCC
Confidence                       001112346889999999999999999999999999999973

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=1.6e-47  Score=385.30  Aligned_cols=256  Identities=25%  Similarity=0.398  Sum_probs=216.2

Q ss_pred             CCCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc------chHHHHHHHHHHHHhcCCCCceEEeeEEEccCCC
Q 015374          122 GDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSK  195 (408)
Q Consensus       122 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  195 (408)
                      ...++|++.+.||+|+||+||+|++..+++.||+|+++..      ....+.+|+.+++++ +||||++++++|.+  ..
T Consensus       182 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~~~~--~~  258 (543)
T 3c4z_A          182 MGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKV-HSRFIVSLAYAFET--KT  258 (543)
T ss_dssp             CCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHC-CCTTBCCEEEEEEC--SS
T ss_pred             CChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhc-CCCCEeeEEEEEee--CC
Confidence            3468899999999999999999999999999999999643      235688999999999 99999999999965  46


Q ss_pred             ccEEEEEeecCCChhhhcC-------CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccce
Q 015374          196 TPSLIFEYVNSTDFKVLYP-------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE  268 (408)
Q Consensus       196 ~~~lv~e~~~~~~l~~~~~-------~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~  268 (408)
                      ..++||||+++++|..++.       .+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++
T Consensus       259 ~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~-g~vkL~DFGla~  337 (543)
T 3c4z_A          259 DLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDD-GNVRISDLGLAV  337 (543)
T ss_dssp             EEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTT-SCEEECCCTTCE
T ss_pred             EEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCC-CCEEEeecceee
Confidence            7899999999999988762       48999999999999999999999999999999999999988 899999999998


Q ss_pred             eccCCCc-ceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCC--CHHHH-HHHHhhhchhhhhc
Q 015374          269 FYHPGKE-YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHD--NHDQL-VKIAKDCCLIIWCN  344 (408)
Q Consensus       269 ~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~--~~~~~-~~~~~~~~~~~~~~  344 (408)
                      ....... ....+||+.|+|||++.+ ..++.++|||||||++|||++|..||.....  ....+ ..+...        
T Consensus       338 ~~~~~~~~~~~~~GT~~Y~APE~l~~-~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~--------  408 (543)
T 3c4z_A          338 ELKAGQTKTKGYAGTPGFMAPELLLG-EEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQ--------  408 (543)
T ss_dssp             ECCTTCCCBCCCCSCTTTSCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHC--------
T ss_pred             eccCCCcccccccCCccccChhhhcC-CCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhc--------
Confidence            7765443 334589999999999987 7899999999999999999999999854332  22222 222221        


Q ss_pred             CCCCCCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCC-----HHHHhcCCCccccccch
Q 015374          345 SRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLT-----AREAMAHPYFAQVRAAE  402 (408)
Q Consensus       345 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt-----~~elL~hp~f~~~~~~~  402 (408)
                                  ....+..+++++.+||.+||+.||++||+     ++++++||||+.+.+..
T Consensus       409 ------------~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~i~w~~  459 (543)
T 3c4z_A          409 ------------AVTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDISWRQ  459 (543)
T ss_dssp             ------------CCCCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTTCCHHH
T ss_pred             ------------ccCCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccCCCHHH
Confidence                        11123447899999999999999999995     58999999999987654

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=5.7e-48  Score=387.60  Aligned_cols=254  Identities=27%  Similarity=0.527  Sum_probs=212.7

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc-----chHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccE
Q 015374          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS  198 (408)
Q Consensus       124 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  198 (408)
                      .++|+++++||+|+||+||+|++..++..||+|+++..     ....+.+|+.+++.+ +||||++++++|.+  ....+
T Consensus        36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~--~~~~~  112 (494)
T 3lij_A           36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLL-DHPNIMKLYDFFED--KRNYY  112 (494)
T ss_dssp             HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTC-CCTTBCCEEEEEEC--SSEEE
T ss_pred             hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhC-CCCCCCeEEEEEEe--CCEEE
Confidence            45799999999999999999999999999999998632     346789999999999 99999999999965  46789


Q ss_pred             EEEEeecCCChhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCC--CCcEEEEecccceeccCC
Q 015374          199 LIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE--LRKLRLIDWGLAEFYHPG  273 (408)
Q Consensus       199 lv~e~~~~~~l~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~--~~~~kl~DfG~a~~~~~~  273 (408)
                      +||||+++++|...+   ..+++..+..++.|++.||.|||++||+||||||+|||++.+  .+.+||+|||++......
T Consensus       113 lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~  192 (494)
T 3lij_A          113 LVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQ  192 (494)
T ss_dssp             EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTT
T ss_pred             EEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCC
Confidence            999999999997765   468999999999999999999999999999999999999764  245999999999888766


Q ss_pred             CcceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCCCcc
Q 015374          274 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWS  353 (408)
Q Consensus       274 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  353 (408)
                      .......||+.|+|||++.+  .++.++|||||||++|+|++|..|| .+.+..+.+..+.....       .       
T Consensus       193 ~~~~~~~gt~~y~aPE~l~~--~~~~~~DiwslG~il~~ll~g~~pf-~~~~~~~~~~~i~~~~~-------~-------  255 (494)
T 3lij_A          193 KKMKERLGTAYYIAPEVLRK--KYDEKCDVWSIGVILFILLAGYPPF-GGQTDQEILRKVEKGKY-------T-------  255 (494)
T ss_dssp             BCBCCCCSCTTTCCHHHHTT--CBCTHHHHHHHHHHHHHHHHSSCSS-CCSSHHHHHHHHHHTCC-------C-------
T ss_pred             ccccccCCCcCeeCHHHHcc--cCCCchhHHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHhCCC-------C-------
Confidence            66667789999999999864  6999999999999999999999998 44444555554443211       0       


Q ss_pred             ccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccccc
Q 015374          354 KFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVR  399 (408)
Q Consensus       354 ~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~~~  399 (408)
                        .....+..+++++.+||.+||+.||.+|||++|+|+||||+...
T Consensus       256 --~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~  299 (494)
T 3lij_A          256 --FDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKEMC  299 (494)
T ss_dssp             --CCSGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHHHH
T ss_pred             --CCchhcccCCHHHHHHHHHHCCCChhhCccHHHHhcCcccccCc
Confidence              11122345789999999999999999999999999999998754

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=3.5e-48  Score=369.38  Aligned_cols=277  Identities=29%  Similarity=0.484  Sum_probs=216.5

Q ss_pred             cCCCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecccc-----hHHHHHHHHHHHHhcCCCCceEEeeEEEccCCC
Q 015374          121 WGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK-----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSK  195 (408)
Q Consensus       121 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  195 (408)
                      +...++|++.+.||+|+||+||+|++..+++.||+|++....     .+.+.+|+.+++++ +||||+++++++.+  ..
T Consensus        21 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~--~~   97 (331)
T 4aaa_A           21 FQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQL-RHENLVNLLEVCKK--KK   97 (331)
T ss_dssp             CBCGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEEE--TT
T ss_pred             hhhhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhC-CCCCEeeEEEEeec--CC
Confidence            345789999999999999999999999999999999985322     34577999999999 89999999999965  46


Q ss_pred             ccEEEEEeecCCChhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccC
Q 015374          196 TPSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP  272 (408)
Q Consensus       196 ~~~lv~e~~~~~~l~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~  272 (408)
                      ..++||||++++++..+.   ..+++..+..++.|++.||.|||++||+||||||+|||++.+ +.+||+|||++.....
T Consensus        98 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~-~~~kl~Dfg~~~~~~~  176 (331)
T 4aaa_A           98 RWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQS-GVVKLCDFGFARTLAA  176 (331)
T ss_dssp             EEEEEEECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT-SCEEECCCTTC-----
T ss_pred             EEEEEEecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCC-CcEEEEeCCCceeecC
Confidence            789999999999998875   568999999999999999999999999999999999999988 7999999999976543


Q ss_pred             C-CcceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhh-------hc
Q 015374          273 G-KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIW-------CN  344 (408)
Q Consensus       273 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~-------~~  344 (408)
                      . .......++..|+|||++.+...++.++|||||||++|+|++|+.|| .+.++.+.+..+....+....       ..
T Consensus       177 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (331)
T 4aaa_A          177 PGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLF-PGDSDIDQLYHIMMCLGNLIPRHQELFNKN  255 (331)
T ss_dssp             -------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSC-CCSSHHHHHHHHHHHHCSCCHHHHHHHHHC
T ss_pred             CccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCC-CCCCcHHHHHHHHHHhCCCChhhhhHhhhc
Confidence            2 33445678999999999987557899999999999999999999887 555556666655554332110       00


Q ss_pred             CCCCCCCcccc----ccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccccccch
Q 015374          345 SRHSRKPWSKF----INADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAE  402 (408)
Q Consensus       345 ~~~~~~~~~~~----~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~~~~~~  402 (408)
                      .......+...    ........+++++.+|+.+||+.||++|||++|+|+||||+.....+
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~  317 (331)
T 4aaa_A          256 PVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMDGFAE  317 (331)
T ss_dssp             GGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHGGGHHH
T ss_pred             cccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhccCChhh
Confidence            00000000000    01112234789999999999999999999999999999999765544

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=6.1e-48  Score=386.62  Aligned_cols=255  Identities=25%  Similarity=0.524  Sum_probs=214.2

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecc-----cchHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccE
Q 015374          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP-----VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS  198 (408)
Q Consensus       124 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~-----~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  198 (408)
                      .++|++.+.||+|+||+||+|++..+++.||||+++.     .....+.+|+.+++++ +||||+++++++.+  ....+
T Consensus        21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~--~~~~~   97 (486)
T 3mwu_A           21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKL-DHPNIMKLFEILED--SSSFY   97 (486)
T ss_dssp             HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHC-CCTTBCCEEEEEEC--SSEEE
T ss_pred             hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhC-CCCCcCeEEEEEEc--CCEEE
Confidence            5789999999999999999999999999999999853     2356789999999999 99999999999965  56789


Q ss_pred             EEEEeecCCChhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCC--CCcEEEEecccceeccCC
Q 015374          199 LIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE--LRKLRLIDWGLAEFYHPG  273 (408)
Q Consensus       199 lv~e~~~~~~l~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~--~~~~kl~DfG~a~~~~~~  273 (408)
                      +||||+.+++|...+   ..+++..+..++.|++.||.|||++||+||||||+|||++.+  .+.+||+|||+++.....
T Consensus        98 lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~  177 (486)
T 3mwu_A           98 IVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN  177 (486)
T ss_dssp             EEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC
T ss_pred             EEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCC
Confidence            999999999997766   569999999999999999999999999999999999999643  257999999999877666


Q ss_pred             CcceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCCCcc
Q 015374          274 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWS  353 (408)
Q Consensus       274 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  353 (408)
                      ......+||+.|+|||++.+  .++.++|||||||++|+|++|..|| .+.+..+.+..+.....       .       
T Consensus       178 ~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf-~~~~~~~~~~~i~~~~~-------~-------  240 (486)
T 3mwu_A          178 TKMKDRIGTAYYIAPEVLRG--TYDEKCDVWSAGVILYILLSGTPPF-YGKNEYDILKRVETGKY-------A-------  240 (486)
T ss_dssp             ----CCTTGGGGCCGGGGGS--CCCHHHHHHHHHHHHHHHHHSSCSS-CCSSHHHHHHHHHHTCC-------C-------
T ss_pred             CccCCCcCCCCCCCHHHhCC--CCCchhhHHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHhCCC-------C-------
Confidence            66666789999999999975  5999999999999999999999998 44454555554433210       0       


Q ss_pred             ccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccccc
Q 015374          354 KFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRA  400 (408)
Q Consensus       354 ~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~~~~  400 (408)
                        .....+..+++++.+||.+||+.||++|||+.|+|+||||+....
T Consensus       241 --~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~~~  285 (486)
T 3mwu_A          241 --FDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSS  285 (486)
T ss_dssp             --SCSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHCHHHHHTCC
T ss_pred             --CCCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCHhhccCcc
Confidence              011223347899999999999999999999999999999987544

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=4.6e-48  Score=372.39  Aligned_cols=277  Identities=28%  Similarity=0.482  Sum_probs=210.4

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc--chHHHHHHHHHHHHhcCCCCceEEeeEEEccCC-----Cc
Q 015374          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV--KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHS-----KT  196 (408)
Q Consensus       124 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~-----~~  196 (408)
                      .++|++.+.||+|+||+||+|++..+++.||||++...  ......+|+..+..+ +||||++++++|.....     ..
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~  100 (360)
T 3e3p_A           22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVL-HHPNIVQLQSYFYTLGERDRRDIY  100 (360)
T ss_dssp             HTTEEEC----------CEEEEETTTCCEEEEEEEECCTTCCCHHHHHHHHHHHH-CCTTBCCEEEEEEEECSSCTTCEE
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccccHHHHHHHHHHHhc-CCCCcccHHHhhhcccccccccee
Confidence            57899999999999999999999999999999988532  345677888889998 99999999999965322     23


Q ss_pred             cEEEEEeecCCChhhhc------CCCChHHHHHHHHHHHHHHHHHH--HCCcEEecCCCCcEEEeCCCCcEEEEecccce
Q 015374          197 PSLIFEYVNSTDFKVLY------PTLTDYDIRYYIYELLKALDYCH--SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE  268 (408)
Q Consensus       197 ~~lv~e~~~~~~l~~~~------~~l~~~~~~~i~~qi~~~L~~LH--~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~  268 (408)
                      .++||||++++.+..+.      ..+++..+..++.|++.||.|||  ++||+||||||+|||++...+.+||+|||++.
T Consensus       101 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~kl~Dfg~a~  180 (360)
T 3e3p_A          101 LNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAK  180 (360)
T ss_dssp             EEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEEECCCTTCB
T ss_pred             EEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEEEeeCCCce
Confidence            78999999987544332      35888999999999999999999  99999999999999999733899999999998


Q ss_pred             eccCCCcceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhc----
Q 015374          269 FYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCN----  344 (408)
Q Consensus       269 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~----  344 (408)
                      ............||..|+|||++.+...++.++|||||||++|+|++|..|| .+.+..+.+..+....+......    
T Consensus       181 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf-~~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (360)
T 3e3p_A          181 KLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIF-RGDNSAGQLHEIVRVLGCPSREVLRKL  259 (360)
T ss_dssp             CCCTTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSS-CCSSHHHHHHHHHHHHCCCCHHHHHHH
T ss_pred             ecCCCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCc-CCCChHHHHHHHHHHcCCCCHHHHHhc
Confidence            8776666666788999999999977566899999999999999999999997 55566666666666544322110    


Q ss_pred             ---------CCCCCCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccccccchh
Q 015374          345 ---------SRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAES  403 (408)
Q Consensus       345 ---------~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~~~~~~~  403 (408)
                               .......|.... .......++++.+||.+||+.||++|||+.|+|+||||+++.....
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~~~  326 (360)
T 3e3p_A          260 NPSHTDVDLYNSKGIPWSNVF-SDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELHDPAT  326 (360)
T ss_dssp             CTTCCCGGGGCCCCCCHHHHT-TTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGGCTTC
T ss_pred             ccchhhccccccccCCccccc-chhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccCCccc
Confidence                     001111121111 1122235688999999999999999999999999999998876543

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=9.2e-48  Score=370.79  Aligned_cols=275  Identities=27%  Similarity=0.457  Sum_probs=208.3

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecccc--------------hHHHHHHHHHHHHhcCCCCceEEeeE
Q 015374          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK--------------KKKIKREIKILQNLCGGPNVVKLLDI  188 (408)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~--------------~~~~~~E~~~l~~l~~h~niv~l~~~  188 (408)
                      ..++|++.+.||+|+||+||+|++.. +..||||++....              .+.+.+|+.+++++ +||||++++++
T Consensus        20 ~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~   97 (362)
T 3pg1_A           20 MQSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHF-HHPNILGLRDI   97 (362)
T ss_dssp             TTCSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHC-CCTTBCCCSEE
T ss_pred             hccceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhC-CCcCccceeee
Confidence            47899999999999999999998754 8999999985321              26789999999999 99999999999


Q ss_pred             EEcc---CCCccEEEEEeecCCChhhhcC---CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEE
Q 015374          189 VRDQ---HSKTPSLIFEYVNSTDFKVLYP---TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLI  262 (408)
Q Consensus       189 ~~~~---~~~~~~lv~e~~~~~~l~~~~~---~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~  262 (408)
                      +...   .....++||||++++.+..+..   .+++..+..++.|++.||.|||++||+||||||+|||++.+ +.+||+
T Consensus        98 ~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~-~~~kl~  176 (362)
T 3pg1_A           98 FVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADN-NDITIC  176 (362)
T ss_dssp             EEECCTTTCCEEEEEEECCSEEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT-CCEEEC
T ss_pred             EEeccCCCcceEEEEEccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCC-CCEEEE
Confidence            8642   3346799999999654444432   48999999999999999999999999999999999999988 799999


Q ss_pred             ecccceeccCCCcceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhh
Q 015374          263 DWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIW  342 (408)
Q Consensus       263 DfG~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~  342 (408)
                      |||++.............+|..|+|||++.+...++.++|||||||++|+|++|+.|| .+.+..+.+..+....+....
T Consensus       177 Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf-~~~~~~~~~~~i~~~~~~~~~  255 (362)
T 3pg1_A          177 DFNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALF-RGSTFYNQLNKIVEVVGTPKI  255 (362)
T ss_dssp             CTTC---------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSC-CCSSHHHHHHHHHHHHCCCCH
T ss_pred             ecCcccccccccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCC-CCCCHHHHHHHHHHHcCCCCh
Confidence            9999986665555566789999999999987667999999999999999999999997 455556666666665443221


Q ss_pred             hcC------------CCCCCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccccccc
Q 015374          343 CNS------------RHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAA  401 (408)
Q Consensus       343 ~~~------------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~~~~~  401 (408)
                      ...            ..................+++.+.+||.+||+.||++|||++|+|+||||+++...
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~  326 (362)
T 3pg1_A          256 EDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESLFDP  326 (362)
T ss_dssp             HHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTTCCG
T ss_pred             HHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhccCc
Confidence            100            00000000001112233468899999999999999999999999999999987543

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=2.4e-47  Score=353.59  Aligned_cols=257  Identities=24%  Similarity=0.389  Sum_probs=212.7

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc----chHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccEE
Q 015374          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSL  199 (408)
Q Consensus       124 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l  199 (408)
                      .++|++.+.||+|+||+||+|++..+++.||+|+++..    ..+.+.+|+.+++.+ +||||+++++++.+  ....++
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~~~l   82 (276)
T 2yex_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML-NHENVVKFYGHRRE--GNIQYL   82 (276)
T ss_dssp             HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTC-CCTTBCCEEEEEEE--TTEEEE
T ss_pred             ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhc-CCCCceeeeeEEEc--CCEEEE
Confidence            36799999999999999999999999999999998643    246788999999999 99999999999965  467889


Q ss_pred             EEEeecCCChhhhcC---CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCCC--
Q 015374          200 IFEYVNSTDFKVLYP---TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK--  274 (408)
Q Consensus       200 v~e~~~~~~l~~~~~---~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~~--  274 (408)
                      ||||+++++|..++.   .+++..+..++.|++.||.|||++||+|+||||+||+++.+ +.+||+|||++.......  
T Consensus        83 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~-~~~kl~dfg~~~~~~~~~~~  161 (276)
T 2yex_A           83 FLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDER-DNLKISDFGLATVFRYNNRE  161 (276)
T ss_dssp             EEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTT-CCEEECCCTTCEECEETTEE
T ss_pred             EEEecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccC-CCEEEeeCCCccccCCCcch
Confidence            999999999988874   48999999999999999999999999999999999999988 789999999997654322  


Q ss_pred             -cceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCCCcc
Q 015374          275 -EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWS  353 (408)
Q Consensus       275 -~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  353 (408)
                       ......++..|+|||++.+...++.++||||||+++|+|++|..||.................         ..     
T Consensus       162 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~---------~~-----  227 (276)
T 2yex_A          162 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKK---------TY-----  227 (276)
T ss_dssp             CCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTC---------TT-----
T ss_pred             hcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcc---------cc-----
Confidence             234457899999999998744447899999999999999999999865444433333322210         00     


Q ss_pred             ccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccccccch
Q 015374          354 KFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAE  402 (408)
Q Consensus       354 ~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~~~~~~  402 (408)
                          ......+++++.+++.+||+.||++|||++|+++||||+......
T Consensus       228 ----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~~  272 (276)
T 2yex_A          228 ----LNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKKG  272 (276)
T ss_dssp             ----STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCCC--
T ss_pred             ----cCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhcCccccChhhcc
Confidence                011234789999999999999999999999999999999875544

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=4.9e-48  Score=387.20  Aligned_cols=255  Identities=27%  Similarity=0.502  Sum_probs=216.7

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecc------cchHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCcc
Q 015374          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP------VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP  197 (408)
Q Consensus       124 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~------~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~  197 (408)
                      .++|++.+.||+|+||+||+|++..+++.||||++..      .....+.+|+.+++++ +||||++++++|.+  ....
T Consensus        25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~--~~~~  101 (484)
T 3nyv_A           25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQL-DHPNIMKLYEFFED--KGYF  101 (484)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTC-CCTTBCCEEEEEEC--SSEE
T ss_pred             cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhC-CCCCCCcEEEEEEe--CCEE
Confidence            5789999999999999999999999999999999853      2356789999999999 99999999999965  5678


Q ss_pred             EEEEEeecCCChhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeC--CCCcEEEEecccceeccC
Q 015374          198 SLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDH--ELRKLRLIDWGLAEFYHP  272 (408)
Q Consensus       198 ~lv~e~~~~~~l~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~--~~~~~kl~DfG~a~~~~~  272 (408)
                      ++||||+.+++|...+   ..+++..+..++.|++.||.|||++||+||||||+|||++.  ..+.+||+|||++.....
T Consensus       102 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~  181 (484)
T 3nyv_A          102 YLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA  181 (484)
T ss_dssp             EEEECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCC
T ss_pred             EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEccc
Confidence            9999999999998776   46899999999999999999999999999999999999952  237899999999988776


Q ss_pred             CCcceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCCCc
Q 015374          273 GKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPW  352 (408)
Q Consensus       273 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  352 (408)
                      ........||+.|+|||++.+  .++.++|||||||++|+|++|..|| .+.+..+.+..+.....       .      
T Consensus       182 ~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf-~~~~~~~~~~~i~~~~~-------~------  245 (484)
T 3nyv_A          182 SKKMKDKIGTAYYIAPEVLHG--TYDEKCDVWSTGVILYILLSGCPPF-NGANEYDILKKVEKGKY-------T------  245 (484)
T ss_dssp             CCSHHHHTTGGGTCCHHHHHT--CCCTHHHHHHHHHHHHHHHHSSCSS-CCSSHHHHHHHHHHCCC-------C------
T ss_pred             ccccccCCCCccccCceeecC--CCCCcceeHHHHHHHHHHHHCCCCC-CCCCHHHHHHHHHcCCC-------C------
Confidence            666667789999999999875  6899999999999999999999998 45555555554443210       0      


Q ss_pred             cccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccccc
Q 015374          353 SKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRA  400 (408)
Q Consensus       353 ~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~~~~  400 (408)
                         .....+..+++++.+||.+||+.||++|||++|+|+||||+....
T Consensus       246 ---~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~~~~~~~  290 (484)
T 3nyv_A          246 ---FELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQTYTK  290 (484)
T ss_dssp             ---CCSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHHHTC
T ss_pred             ---CCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhhChhhccccc
Confidence               011223347899999999999999999999999999999986543

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=1.5e-47  Score=355.70  Aligned_cols=253  Identities=23%  Similarity=0.487  Sum_probs=187.8

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecccc------hHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCcc
Q 015374          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK------KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP  197 (408)
Q Consensus       124 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~------~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~  197 (408)
                      .++|++.+.||+|+||+||+|++..+++.||+|++....      .+.+.+|+.+++++ +||||+++++++.+  ....
T Consensus        10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~~   86 (278)
T 3cok_A           10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQL-KHPSILELYNYFED--SNYV   86 (278)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTB-CCTTBCCEEEEEEC--SSEE
T ss_pred             cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhC-CCCCeEeEEEEEcc--CCeE
Confidence            467999999999999999999999999999999986432      36788999999999 99999999999965  4678


Q ss_pred             EEEEEeecCCChhhhcC----CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCC
Q 015374          198 SLIFEYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG  273 (408)
Q Consensus       198 ~lv~e~~~~~~l~~~~~----~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~  273 (408)
                      ++||||+++++|..++.    .+++..+..++.|++.||.|||++||+|+||||+||+++.+ +.+||+|||++......
T Consensus        87 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~-~~~kl~dfg~~~~~~~~  165 (278)
T 3cok_A           87 YLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRN-MNIKIADFGLATQLKMP  165 (278)
T ss_dssp             EEEEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTT-CCEEECCCTTCEECC--
T ss_pred             EEEEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCC-CCEEEEeecceeeccCC
Confidence            99999999999988863    48999999999999999999999999999999999999988 79999999999876532


Q ss_pred             C-cceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCCCc
Q 015374          274 K-EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPW  352 (408)
Q Consensus       274 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  352 (408)
                      . ......++..|+|||.+.+ ..++.++||||||+++|+|++|+.||...... +.+..+.                  
T Consensus       166 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-~~~~~~~------------------  225 (278)
T 3cok_A          166 HEKHYTLCGTPNYISPEIATR-SAHGLESDVWSLGCMFYTLLIGRPPFDTDTVK-NTLNKVV------------------  225 (278)
T ss_dssp             ---------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC------CC------------------
T ss_pred             CCcceeccCCCCcCCcchhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCChhHH-HHHHHHh------------------
Confidence            2 2334578999999999987 67899999999999999999999998433221 1111100                  


Q ss_pred             cccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccccccch
Q 015374          353 SKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAE  402 (408)
Q Consensus       353 ~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~~~~~~  402 (408)
                        ......+..++.++.+++.+||+.||++|||++|+++||||+......
T Consensus       226 --~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~~~  273 (278)
T 3cok_A          226 --LADYEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDHPFMSRNSSTK  273 (278)
T ss_dssp             --SSCCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSTTTC------
T ss_pred             --hcccCCccccCHHHHHHHHHHcccCHhhCCCHHHHhcCccccCCCCcc
Confidence              001122345789999999999999999999999999999998765543

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=5.8e-47  Score=353.94  Aligned_cols=254  Identities=22%  Similarity=0.400  Sum_probs=209.1

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc-----chHHHHHHHHHHHHhcCCCCceEEeeEEEcc--CCC
Q 015374          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQ--HSK  195 (408)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~--~~~  195 (408)
                      ....|++.+.||+|+||+||+|.+..++..||+|++...     ..+.+.+|+.+++++ +||||+++++++...  ...
T Consensus        24 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~  102 (290)
T 1t4h_A           24 DGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGL-QHPNIVRFYDSWESTVKGKK  102 (290)
T ss_dssp             TSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEEEESSSCE
T ss_pred             CceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhC-CCCCeeeeeeeeccccCCCc
Confidence            355689999999999999999999999999999998632     345688999999999 999999999998653  345


Q ss_pred             ccEEEEEeecCCChhhhc---CCCChHHHHHHHHHHHHHHHHHHHCC--cEEecCCCCcEEEeCCCCcEEEEecccceec
Q 015374          196 TPSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQG--IMHRDVKPHNVMIDHELRKLRLIDWGLAEFY  270 (408)
Q Consensus       196 ~~~lv~e~~~~~~l~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~--iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~  270 (408)
                      ..++||||+++++|..++   ..+++..+..++.|++.||.|||+.+  |+|+||||+|||++.+.+.+||+|||++...
T Consensus       103 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~  182 (290)
T 1t4h_A          103 CIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK  182 (290)
T ss_dssp             EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred             eEEEEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCcccc
Confidence            689999999999999887   46899999999999999999999999  9999999999999844479999999999754


Q ss_pred             cCCCcceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCC
Q 015374          271 HPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRK  350 (408)
Q Consensus       271 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  350 (408)
                      .. .......||..|+|||++.+  .++.++|||||||++|+|++|+.||... .+............            
T Consensus       183 ~~-~~~~~~~~t~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~pf~~~-~~~~~~~~~~~~~~------------  246 (290)
T 1t4h_A          183 RA-SFAKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSEC-QNAAQIYRRVTSGV------------  246 (290)
T ss_dssp             CT-TSBEESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTTTTC-SSHHHHHHHHTTTC------------
T ss_pred             cc-cccccccCCcCcCCHHHHhc--cCCCcchHHHHHHHHHHHHhCCCCCCCc-CcHHHHHHHHhccC------------
Confidence            43 33455679999999998864  5899999999999999999999998443 33333332222110            


Q ss_pred             CccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccc
Q 015374          351 PWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQV  398 (408)
Q Consensus       351 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~~  398 (408)
                           .....+...++++.+++.+||+.||++|||++|+++||||++.
T Consensus       247 -----~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~f~~~  289 (290)
T 1t4h_A          247 -----KPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQEE  289 (290)
T ss_dssp             -----CCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC--
T ss_pred             -----CccccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhCcccccC
Confidence                 0112233467899999999999999999999999999999863

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=6.8e-47  Score=354.21  Aligned_cols=256  Identities=23%  Similarity=0.418  Sum_probs=215.6

Q ss_pred             ccCCCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc------chHHHHHHHHHHHHhcCCCCceEEeeEEEccC
Q 015374          120 QWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQH  193 (408)
Q Consensus       120 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~  193 (408)
                      .....++|++.+.||+|+||+||+|.+..+++.+|+|++...      ..+.+.+|+.+++++ +||||+++++++.+  
T Consensus        10 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~--   86 (294)
T 2rku_A           10 DPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSL-AHQHVVGFHGFFED--   86 (294)
T ss_dssp             ETTTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEEC--
T ss_pred             CCCcccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhC-CCCCEeeeeeeecc--
Confidence            344678999999999999999999999999999999998532      346688999999999 99999999999965  


Q ss_pred             CCccEEEEEeecCCChhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceec
Q 015374          194 SKTPSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY  270 (408)
Q Consensus       194 ~~~~~lv~e~~~~~~l~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~  270 (408)
                      ....++||||+++++|..++   ..+++..+..++.|++.||+|||++||+|+||||+|||++.+ +.+||+|||++...
T Consensus        87 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~-~~~kl~dfg~~~~~  165 (294)
T 2rku_A           87 NDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNED-LEVKIGDFGLATKV  165 (294)
T ss_dssp             SSEEEEEEECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTT-CCEEECCCTTCEEC
T ss_pred             CCEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCC-CCEEEEeccCceec
Confidence            46789999999999998876   468999999999999999999999999999999999999988 79999999999876


Q ss_pred             cCC-CcceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCC
Q 015374          271 HPG-KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSR  349 (408)
Q Consensus       271 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  349 (408)
                      ... .......++..|+|||++.+ ..++.++||||||+++|+|++|..||. +....+....+...             
T Consensus       166 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~-~~~~~~~~~~~~~~-------------  230 (294)
T 2rku_A          166 EYDGERKKVLCGTPNYIAPEVLSK-KGHSFEVDVWSIGCIMYTLLVGKPPFE-TSCLKETYLRIKKN-------------  230 (294)
T ss_dssp             CSTTCCBCCCCSCCSSCCHHHHTT-SCBCTHHHHHHHHHHHHHHHHSSCTTC-CSSHHHHHHHHHTT-------------
T ss_pred             ccCccccccccCCCCcCCcchhcc-CCCCchhhHHHHHHHHHHHHhCCCCCC-CCCHHHHHHHHhhc-------------
Confidence            532 23445678999999999987 778999999999999999999999983 33333333322211             


Q ss_pred             CCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccccccc
Q 015374          350 KPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAA  401 (408)
Q Consensus       350 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~~~~~  401 (408)
                             ....+..+++++.+++.+||+.||++|||++|+++||||++....
T Consensus       231 -------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~~~  275 (294)
T 2rku_A          231 -------EYSIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIP  275 (294)
T ss_dssp             -------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSCCC
T ss_pred             -------cCCCccccCHHHHHHHHHHcccChhhCcCHHHHhhChheecCCcC
Confidence                   111233478999999999999999999999999999999876543

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=7.1e-48  Score=377.40  Aligned_cols=273  Identities=25%  Similarity=0.510  Sum_probs=200.6

Q ss_pred             CCEEEE-eeeeeeCceEEEEEEEc--CCCcEEEEEEecccc-hHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccEEE
Q 015374          125 DDYEVV-RKVGRGKYSEVFEGINV--NTNERCIIKILKPVK-KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI  200 (408)
Q Consensus       125 ~~y~~~-~~lG~G~fg~Vy~~~~~--~~~~~vavK~~~~~~-~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  200 (408)
                      +.|++. ++||+|+||+||+|++.  .++..||||+++... ...+.+|+.+++++ +||||++++++|........++|
T Consensus        20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~~~lv   98 (405)
T 3rgf_A           20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLREL-KHPNVISLQKVFLSHADRKVWLL   98 (405)
T ss_dssp             HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCCHHHHHHHHHHHHC-CCTTBCCCCEEEEETTTTEEEEE
T ss_pred             hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCCHHHHHHHHHHHhc-CCCCeeeEeeEEecCCCCeEEEE
Confidence            446653 47999999999999965  578899999997543 46788999999999 99999999999987667789999


Q ss_pred             EEeecCCChhhhc-----------CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEE----eCCCCcEEEEecc
Q 015374          201 FEYVNSTDFKVLY-----------PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMI----DHELRKLRLIDWG  265 (408)
Q Consensus       201 ~e~~~~~~l~~~~-----------~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl----~~~~~~~kl~DfG  265 (408)
                      |||++++.+....           ..+++..++.++.||+.||.|||++||+||||||+|||+    +.+ +.+||+|||
T Consensus        99 ~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~-~~~kl~Dfg  177 (405)
T 3rgf_A           99 FDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPER-GRVKIADMG  177 (405)
T ss_dssp             EECCSEEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTT-TCEEECCTT
T ss_pred             EeCCCCCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCC-CcEEEEECC
Confidence            9999875433322           138999999999999999999999999999999999999    444 789999999


Q ss_pred             cceeccCC----CcceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCC--------CHHHHHHH
Q 015374          266 LAEFYHPG----KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHD--------NHDQLVKI  333 (408)
Q Consensus       266 ~a~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~--------~~~~~~~~  333 (408)
                      +++.....    ......+||..|+|||++.+...++.++|||||||++|+|++|..||.....        ..+++..+
T Consensus       178 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~~i  257 (405)
T 3rgf_A          178 FARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRI  257 (405)
T ss_dssp             CCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHHHH
T ss_pred             CceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHHHH
Confidence            99876532    2234568899999999998756699999999999999999999999854332        24677777


Q ss_pred             HhhhchhhhhcCCCCC--------------C-----CccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCC
Q 015374          334 AKDCCLIIWCNSRHSR--------------K-----PWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPY  394 (408)
Q Consensus       334 ~~~~~~~~~~~~~~~~--------------~-----~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~  394 (408)
                      ...+|......+....              .     ...... .......++++.+||.+||++||.+|||++|+|+|||
T Consensus       258 ~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~hp~  336 (405)
T 3rgf_A          258 FNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYM-EKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPY  336 (405)
T ss_dssp             HHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHH-HTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred             HHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhH-hhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChh
Confidence            7766643321111000              0     000000 0111123678999999999999999999999999999


Q ss_pred             cccccc
Q 015374          395 FAQVRA  400 (408)
Q Consensus       395 f~~~~~  400 (408)
                      |+..+.
T Consensus       337 f~~~~~  342 (405)
T 3rgf_A          337 FLEDPL  342 (405)
T ss_dssp             GTSSSC
T ss_pred             hccCCC
Confidence            987654

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=2e-47  Score=361.35  Aligned_cols=263  Identities=23%  Similarity=0.401  Sum_probs=202.5

Q ss_pred             CCCCEEEE-eeeeeeCceEEEEEEEcCCCcEEEEEEeccc---chHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccE
Q 015374          123 DQDDYEVV-RKVGRGKYSEVFEGINVNTNERCIIKILKPV---KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS  198 (408)
Q Consensus       123 ~~~~y~~~-~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  198 (408)
                      ..++|++. +.||+|+||+||+|++..+++.||||+++..   ....+.+|+.++.++.+||||+++++++.+  ....+
T Consensus        10 ~~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~--~~~~~   87 (316)
T 2ac3_A           10 FEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEE--EDRFY   87 (316)
T ss_dssp             TTTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEE--TTEEE
T ss_pred             cceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEee--CCEEE
Confidence            46789885 6899999999999999999999999998643   356789999999996589999999999965  46789


Q ss_pred             EEEEeecCCChhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCC--cEEEEecccceeccCC
Q 015374          199 LIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELR--KLRLIDWGLAEFYHPG  273 (408)
Q Consensus       199 lv~e~~~~~~l~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~--~~kl~DfG~a~~~~~~  273 (408)
                      +||||+++++|..++   ..+++..+..++.|++.||.|||++||+||||||+|||++.+..  .+||+|||++......
T Consensus        88 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~  167 (316)
T 2ac3_A           88 LVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLN  167 (316)
T ss_dssp             EEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-----
T ss_pred             EEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCccccccC
Confidence            999999999998887   46899999999999999999999999999999999999987622  3999999998765322


Q ss_pred             C--------cceeeccCccccccccccC----CcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCH-------------H
Q 015374          274 K--------EYNVRVASRYFKGPELLVD----LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNH-------------D  328 (408)
Q Consensus       274 ~--------~~~~~~~~~~y~aPE~~~~----~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~-------------~  328 (408)
                      .        ......||..|+|||++.+    ...++.++|||||||++|+|++|+.||.......             .
T Consensus       168 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  247 (316)
T 2ac3_A          168 GDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQN  247 (316)
T ss_dssp             --------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHH
T ss_pred             CccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHHH
Confidence            1        1223468999999999864    1357899999999999999999999985432211             1


Q ss_pred             HHHHHHhhhchhhhhcCCCCCCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccccccch
Q 015374          329 QLVKIAKDCCLIIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAE  402 (408)
Q Consensus       329 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~~~~~~  402 (408)
                      .+...+...        .   ..    .+......+++++.+|+.+||+.||++|||++|+|+||||++.....
T Consensus       248 ~~~~~i~~~--------~---~~----~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~~~~  306 (316)
T 2ac3_A          248 MLFESIQEG--------K---YE----FPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPEN  306 (316)
T ss_dssp             HHHHHHHHC--------C---CC----CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC------
T ss_pred             HHHHHHhcc--------C---cc----cCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhcCCCCcc
Confidence            111111110        0   00    01111234789999999999999999999999999999999865443

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=7.9e-47  Score=358.74  Aligned_cols=275  Identities=29%  Similarity=0.514  Sum_probs=219.2

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEc-CCCcEEEEEEecccc-----hHHHHHHHHHHHHhc--CCCCceEEeeEEEc---
Q 015374          123 DQDDYEVVRKVGRGKYSEVFEGINV-NTNERCIIKILKPVK-----KKKIKREIKILQNLC--GGPNVVKLLDIVRD---  191 (408)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~--~h~niv~l~~~~~~---  191 (408)
                      ..++|++.+.||+|+||+||+|++. .+++.||+|+++...     ...+.+|+.+++.+.  +||||++++++|..   
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~   88 (326)
T 1blx_A            9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT   88 (326)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred             chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence            3578999999999999999999985 678999999986432     246778888887764  79999999999862   


Q ss_pred             cCCCccEEEEEeecCCChhhhcC-----CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEeccc
Q 015374          192 QHSKTPSLIFEYVNSTDFKVLYP-----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGL  266 (408)
Q Consensus       192 ~~~~~~~lv~e~~~~~~l~~~~~-----~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~  266 (408)
                      ......++||||+++ +|..++.     .+++..+..++.|++.||.|||++||+||||||+|||++.+ +.+||+|||+
T Consensus        89 ~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~-~~~kl~Dfg~  166 (326)
T 1blx_A           89 DRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSS-GQIKLADFGL  166 (326)
T ss_dssp             SSEEEEEEEEECCSC-BHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT-CCEEECSCCS
T ss_pred             CCCceEEEEEecCCC-CHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCC-CCEEEecCcc
Confidence            234678899999995 7766652     38999999999999999999999999999999999999988 7999999999


Q ss_pred             ceeccCCCcceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCC
Q 015374          267 AEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSR  346 (408)
Q Consensus       267 a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  346 (408)
                      +.............++..|+|||++.+ ..++.++|||||||++|+|++|+.|| .+.+..+.+..+....+........
T Consensus       167 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf-~~~~~~~~~~~i~~~~~~~~~~~~~  244 (326)
T 1blx_A          167 ARIYSFQMALTSVVVTLWYRAPEVLLQ-SSYATPVDLWSVGCIFAEMFRRKPLF-RGSSDVDQLGKILDVIGLPGEEDWP  244 (326)
T ss_dssp             CCCCCGGGGGCCCCCCCTTCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSC-CCSSHHHHHHHHHHHHCCCCGGGSC
T ss_pred             cccccCCCCccccccccceeCHHHHhc-CCCCcchhHHHHHHHHHHHHcCCCCC-CCCCHHHHHHHHHHHcCCCCcccCc
Confidence            987654444556788999999999987 67999999999999999999999997 5556666777776655433211111


Q ss_pred             CCCC----Cc---cccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccccccc
Q 015374          347 HSRK----PW---SKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAA  401 (408)
Q Consensus       347 ~~~~----~~---~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~~~~~  401 (408)
                      ....    .+   ...........+++++.+|+.+||+.||++|||++|+++||||+.++..
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~~  306 (326)
T 1blx_A          245 RDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLERC  306 (326)
T ss_dssp             TTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCCC
T ss_pred             cccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCccccccchh
Confidence            0000    00   0000112334578999999999999999999999999999999987654

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=1.7e-47  Score=357.22  Aligned_cols=255  Identities=22%  Similarity=0.384  Sum_probs=193.9

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecccc----hHHHH-HHHHHHHHhcCCCCceEEeeEEEccCCCcc
Q 015374          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK----KKKIK-REIKILQNLCGGPNVVKLLDIVRDQHSKTP  197 (408)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~----~~~~~-~E~~~l~~l~~h~niv~l~~~~~~~~~~~~  197 (408)
                      ..++|++.+.||+|+||+||+|++..+++.||+|+++...    ..... ++...++.+ +||||+++++++.+  ....
T Consensus         5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~-~h~~iv~~~~~~~~--~~~~   81 (290)
T 3fme_A            5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTV-DCPFTVTFYGALFR--EGDV   81 (290)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEEC--SSSE
T ss_pred             cHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhC-CCCeEEEEeeeeec--cCCE
Confidence            4688999999999999999999999999999999986432    22233 344445666 99999999999965  4678


Q ss_pred             EEEEEeecCCChhhhc-------CCCChHHHHHHHHHHHHHHHHHHHC-CcEEecCCCCcEEEeCCCCcEEEEeccccee
Q 015374          198 SLIFEYVNSTDFKVLY-------PTLTDYDIRYYIYELLKALDYCHSQ-GIMHRDVKPHNVMIDHELRKLRLIDWGLAEF  269 (408)
Q Consensus       198 ~lv~e~~~~~~l~~~~-------~~l~~~~~~~i~~qi~~~L~~LH~~-~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~  269 (408)
                      ++||||+++ ++..++       ..+++..+..++.|++.||.|||++ ||+||||||+|||++.+ +.+||+|||++..
T Consensus        82 ~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~-~~~kl~Dfg~~~~  159 (290)
T 3fme_A           82 WICMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINAL-GQVKMCDFGISGY  159 (290)
T ss_dssp             EEEEECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTT-CCEEBCCC-----
T ss_pred             EEEEehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCC-CCEEEeecCCccc
Confidence            999999986 554443       3699999999999999999999998 99999999999999988 7999999999987


Q ss_pred             ccCCCcceeeccCccccccccc---cCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCC
Q 015374          270 YHPGKEYNVRVASRYFKGPELL---VDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSR  346 (408)
Q Consensus       270 ~~~~~~~~~~~~~~~y~aPE~~---~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  346 (408)
                      ...........+|..|+|||++   .....++.++|||||||++|+|++|+.||.........+........        
T Consensus       160 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~--------  231 (290)
T 3fme_A          160 LVDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPS--------  231 (290)
T ss_dssp             ----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCC--------
T ss_pred             ccccccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCC--------
Confidence            7665555666899999999997   23367899999999999999999999998544444444444333210        


Q ss_pred             CCCCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccccc
Q 015374          347 HSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRA  400 (408)
Q Consensus       347 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~~~~  400 (408)
                                .......+++++.+++.+||+.||++|||++|+++||||+....
T Consensus       232 ----------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~~~~  275 (290)
T 3fme_A          232 ----------PQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLHES  275 (290)
T ss_dssp             ----------CCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHHH
T ss_pred             ----------CCcccccCCHHHHHHHHHHhhcChhhCcCHHHHHhCcccccCcc
Confidence                      01112346899999999999999999999999999999986543

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=8.5e-47  Score=362.61  Aligned_cols=277  Identities=28%  Similarity=0.509  Sum_probs=217.1

Q ss_pred             CCCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecccc----hHHHHHHHHHHHHhcCCCCceEEeeEEEcc---CC
Q 015374          122 GDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQ---HS  194 (408)
Q Consensus       122 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~---~~  194 (408)
                      ...++|++.+.||+|+||+||+|++..+++.||||+++...    ...+.+|+.+++++ +||||+++++++...   ..
T Consensus         8 ~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~   86 (353)
T 2b9h_A            8 NISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHF-KHENIITIFNIQRPDSFENF   86 (353)
T ss_dssp             CSCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHC-CCTTBCCEEEECCCSCSTTC
T ss_pred             ccccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhC-cCCCcCCeeeeecccccCcc
Confidence            45789999999999999999999999999999999986432    35677999999999 999999999988643   23


Q ss_pred             CccEEEEEeecCCChhhhc--CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccC
Q 015374          195 KTPSLIFEYVNSTDFKVLY--PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP  272 (408)
Q Consensus       195 ~~~~lv~e~~~~~~l~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~  272 (408)
                      ...++||||+.+ +|..++  ..+++..+..++.|++.||.|||++||+||||||+|||++.+ +.+||+|||++.....
T Consensus        87 ~~~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~-~~~kl~Dfg~a~~~~~  164 (353)
T 2b9h_A           87 NEVYIIQELMQT-DLHRVISTQMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSN-CDLKVCDFGLARIIDE  164 (353)
T ss_dssp             CCEEEEECCCSE-EHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTT-CCEEECCCTTCEECC-
T ss_pred             ceEEEEEeccCc-cHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCC-CcEEEEeccccccccc
Confidence            578999999985 666665  459999999999999999999999999999999999999988 7999999999987653


Q ss_pred             CCc-----------ceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhh
Q 015374          273 GKE-----------YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLII  341 (408)
Q Consensus       273 ~~~-----------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~  341 (408)
                      ...           .....||..|+|||++.+...++.++|||||||++|+|++|..|| .+.+..+.+..+....+...
T Consensus       165 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf-~~~~~~~~~~~~~~~~~~~~  243 (353)
T 2b9h_A          165 SAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIF-PGRDYRHQLLLIFGIIGTPH  243 (353)
T ss_dssp             ---------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSC-CCSSHHHHHHHHHHHHCCCC
T ss_pred             ccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCC-CCCCcHHHHHHHHHHhCCCc
Confidence            221           122468999999999876578999999999999999999999987 45555566666555444322


Q ss_pred             hhcCCCCCC------------CccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccccccch
Q 015374          342 WCNSRHSRK------------PWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAE  402 (408)
Q Consensus       342 ~~~~~~~~~------------~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~~~~~~  402 (408)
                      .........            .............+++++.+||.+||+.||++|||++|+|+||||+......
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~  316 (353)
T 2b9h_A          244 SDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYHDPN  316 (353)
T ss_dssp             STTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCTT
T ss_pred             hhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccccCCcc
Confidence            111000000            0000000111235789999999999999999999999999999999876543

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=2.1e-47  Score=362.45  Aligned_cols=257  Identities=25%  Similarity=0.433  Sum_probs=208.8

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecccc-----------hHHHHHHHHHHHHhcCCCCceEEeeEEEcc
Q 015374          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK-----------KKKIKREIKILQNLCGGPNVVKLLDIVRDQ  192 (408)
Q Consensus       124 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-----------~~~~~~E~~~l~~l~~h~niv~l~~~~~~~  192 (408)
                      .++|++.+.||+|+||+||+|++..+++.||||+++...           ...+.+|+.+++++ +||||+++++++...
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~   87 (322)
T 2ycf_A            9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKL-NHPCIIKIKNFFDAE   87 (322)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHC-CCTTBCCEEEEEESS
T ss_pred             hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhC-CCCCCceEeeEEcCC
Confidence            468999999999999999999999999999999986422           23578999999999 999999999999653


Q ss_pred             CCCccEEEEEeecCCChhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCC--CcEEEEecccc
Q 015374          193 HSKTPSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEL--RKLRLIDWGLA  267 (408)
Q Consensus       193 ~~~~~~lv~e~~~~~~l~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~--~~~kl~DfG~a  267 (408)
                         ..++||||+++++|..++   ..+++..+..++.|++.||.|||++||+||||||+|||++.+.  ..+||+|||++
T Consensus        88 ---~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~  164 (322)
T 2ycf_A           88 ---DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHS  164 (322)
T ss_dssp             ---SEEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTC
T ss_pred             ---ceEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCccc
Confidence               378999999999998876   3589999999999999999999999999999999999998752  24999999999


Q ss_pred             eeccCCCcceeeccCcccccccccc--CCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcC
Q 015374          268 EFYHPGKEYNVRVASRYFKGPELLV--DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNS  345 (408)
Q Consensus       268 ~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  345 (408)
                      .............||..|+|||++.  +...++.++|||||||++|+|++|..||............+....        
T Consensus       165 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~--------  236 (322)
T 2ycf_A          165 KILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGK--------  236 (322)
T ss_dssp             EECCCCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTC--------
T ss_pred             eecccccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCc--------
Confidence            8776544445567899999999984  236789999999999999999999999854433322222222110        


Q ss_pred             CCCCCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccccc
Q 015374          346 RHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRA  400 (408)
Q Consensus       346 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~~~~  400 (408)
                       .   .    .....+..+++++.+|+.+||+.||++|||++|+|+||||+....
T Consensus       237 -~---~----~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~~~~  283 (322)
T 2ycf_A          237 -Y---N----FIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDM  283 (322)
T ss_dssp             -C---C----CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCCHHH
T ss_pred             -c---c----cCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCcCCHHH
Confidence             0   0    011122347899999999999999999999999999999987654

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=5.3e-47  Score=351.45  Aligned_cols=251  Identities=24%  Similarity=0.420  Sum_probs=202.7

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecccc------hHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCc
Q 015374          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK------KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT  196 (408)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~------~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  196 (408)
                      ..++|++.+.||+|+||+||+|++..+++.||+|+++...      .+.+.+|+.+++.+ +||||+++++++.+  ...
T Consensus         9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~   85 (276)
T 2h6d_A            9 KIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLF-RHPHIIKLYQVIST--PTD   85 (276)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTC-CCTTBCCEEEEEEC--SSE
T ss_pred             eeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcC-CCCCEeEEEEEEec--CCe
Confidence            3578999999999999999999999999999999986432      35788999999999 99999999999965  467


Q ss_pred             cEEEEEeecCCChhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCC
Q 015374          197 PSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG  273 (408)
Q Consensus       197 ~~lv~e~~~~~~l~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~  273 (408)
                      .++||||+++++|..++   ..+++..+..++.|++.||.|||++||+|+||||+||+++.+ +.++|+|||++......
T Consensus        86 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~-~~~~l~dfg~~~~~~~~  164 (276)
T 2h6d_A           86 FFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAH-MNAKIADFGLSNMMSDG  164 (276)
T ss_dssp             EEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTT-SCEEECCCCGGGCCCC-
T ss_pred             EEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCC-CCEEEeecccccccCCC
Confidence            89999999999998877   468999999999999999999999999999999999999988 78999999999877655


Q ss_pred             CcceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCCCcc
Q 015374          274 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWS  353 (408)
Q Consensus       274 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  353 (408)
                      .......++..|+|||.+.+....+.++||||||+++|+|++|..||. +.+..+....+...                 
T Consensus       165 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~-~~~~~~~~~~~~~~-----------------  226 (276)
T 2h6d_A          165 EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFD-DEHVPTLFKKIRGG-----------------  226 (276)
T ss_dssp             ------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSC-CSSHHHHHHHHHHC-----------------
T ss_pred             cceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCC-CCcHHHHHHHhhcC-----------------
Confidence            545566889999999999874344689999999999999999999983 33333333332221                 


Q ss_pred             ccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccc
Q 015374          354 KFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQV  398 (408)
Q Consensus       354 ~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~~  398 (408)
                         ....+..++.++.+++.+||+.||++|||++|+++||||++.
T Consensus       227 ---~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h~~~~~~  268 (276)
T 2h6d_A          227 ---VFYIPEYLNRSVATLLMHMLQVDPLKRATIKDIREHEWFKQD  268 (276)
T ss_dssp             ---CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHTT
T ss_pred             ---cccCchhcCHHHHHHHHHHccCChhhCCCHHHHHhChhhccC
Confidence               011223468999999999999999999999999999999864

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=7.3e-47  Score=360.91  Aligned_cols=254  Identities=23%  Similarity=0.420  Sum_probs=215.2

Q ss_pred             cCCCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc------chHHHHHHHHHHHHhcCCCCceEEeeEEEccCC
Q 015374          121 WGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHS  194 (408)
Q Consensus       121 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~  194 (408)
                      ....++|++.+.||+|+||+||++++..+++.+|+|++...      ..+.+.+|+.+++++ +|+||+++++++.+  .
T Consensus        37 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~--~  113 (335)
T 2owb_A           37 PRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSL-AHQHVVGFHGFFED--N  113 (335)
T ss_dssp             TTTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEEC--S
T ss_pred             cccCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEec--C
Confidence            34578899999999999999999999999999999998643      346788999999999 99999999999965  4


Q ss_pred             CccEEEEEeecCCChhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceecc
Q 015374          195 KTPSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH  271 (408)
Q Consensus       195 ~~~~lv~e~~~~~~l~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~  271 (408)
                      ...++||||+++++|..++   ..+++..+..++.|++.||.|||++||+||||||+|||++.+ +.+||+|||++....
T Consensus       114 ~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~-~~~kl~Dfg~~~~~~  192 (335)
T 2owb_A          114 DFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNED-LEVKIGDFGLATKVE  192 (335)
T ss_dssp             SEEEEEECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTT-CCEEECCCTTCEECC
T ss_pred             CeEEEEEecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCC-CCEEEeeccCceecc
Confidence            6789999999999998876   458999999999999999999999999999999999999988 789999999998765


Q ss_pred             CC-CcceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCC
Q 015374          272 PG-KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRK  350 (408)
Q Consensus       272 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  350 (408)
                      .. .......|+..|+|||++.+ ..++.++||||||+++|+|++|..||. +....+....+...              
T Consensus       193 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~-~~~~~~~~~~~~~~--------------  256 (335)
T 2owb_A          193 YDGERKKVLCGTPNYIAPEVLSK-KGHSFEVDVWSIGCIMYTLLVGKPPFE-TSCLKETYLRIKKN--------------  256 (335)
T ss_dssp             STTCCBCCCCSCCSSCCHHHHHT-SCBCTHHHHHHHHHHHHHHHHSSCTTC-CSSHHHHHHHHHHT--------------
T ss_pred             cCcccccccCCCccccCHHHhcc-CCCCchhhHHHHHHHHHHHHHCcCCCC-CCCHHHHHHHHhcC--------------
Confidence            32 33445678999999999987 778999999999999999999999983 33333333332221              


Q ss_pred             CccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccccc
Q 015374          351 PWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRA  400 (408)
Q Consensus       351 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~~~~  400 (408)
                            ....+..+++++.+||.+||+.||++|||++|+++||||++...
T Consensus       257 ------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~~~~~~~~~  300 (335)
T 2owb_A          257 ------EYSIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYI  300 (335)
T ss_dssp             ------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSCC
T ss_pred             ------CCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccCCCc
Confidence                  01122347899999999999999999999999999999987654

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=1.1e-46  Score=362.27  Aligned_cols=272  Identities=31%  Similarity=0.562  Sum_probs=214.7

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc-----chHHHHHHHHHHHHhcCCCCceEEeeEEEccCC---
Q 015374          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHS---  194 (408)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~---  194 (408)
                      ..++|.+.+.||+|+||+||+|++..+++.||||++...     ..+.+.+|+.+++++ +||||+++++++.....   
T Consensus        22 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~  100 (353)
T 3coi_A           22 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHM-QHENVIGLLDVFTPASSLRN  100 (353)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHC-CCTTBCCCSEEECSCSSGGG
T ss_pred             cCceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhc-CCCCcccHhheEeccccccc
Confidence            357899999999999999999999999999999998642     235688999999999 99999999999965432   


Q ss_pred             -CccEEEEEeecCCChhhhc-CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccC
Q 015374          195 -KTPSLIFEYVNSTDFKVLY-PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP  272 (408)
Q Consensus       195 -~~~~lv~e~~~~~~l~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~  272 (408)
                       ...++||||+.+ +|..++ ..+++..+..++.|++.||.|||++||+||||||+|||++.+ +.+||+|||++.....
T Consensus       101 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~-~~~kl~Dfg~~~~~~~  178 (353)
T 3coi_A          101 FYDFYLVMPFMQT-DLQKIMGLKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNED-CELKILDFGLARHADA  178 (353)
T ss_dssp             CCCCEEEEECCSE-EGGGTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTT-CCEEECSTTCTTC---
T ss_pred             ceeEEEEeccccC-CHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCC-CcEEEeecccccCCCC
Confidence             235899999985 665555 469999999999999999999999999999999999999988 7999999999976542


Q ss_pred             CCcceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCC-----
Q 015374          273 GKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRH-----  347 (408)
Q Consensus       273 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~-----  347 (408)
                        ......+|..|+|||++.+...++.++|||||||++|+|++|..|| .+.+..+.+..+....+.........     
T Consensus       179 --~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf-~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  255 (353)
T 3coi_A          179 --EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLF-KGKDYLDQLTQILKVTGVPGTEFVQKLNDKA  255 (353)
T ss_dssp             -------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSS-BSSCHHHHHHHHHHHHCBCCHHHHTTCSCHH
T ss_pred             --CccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHHHhCCCCHHHHHHHhhHH
Confidence              2345678999999999987567899999999999999999999997 45555666666666544322110000     


Q ss_pred             --------CCCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccccccch
Q 015374          348 --------SRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAE  402 (408)
Q Consensus       348 --------~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~~~~~~  402 (408)
                              .......  -......+++++.+||.+||+.||++|||++|+|+||||+..+..+
T Consensus       256 ~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~~~~  316 (353)
T 3coi_A          256 AKSYIQSLPQTPRKD--FTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRDPE  316 (353)
T ss_dssp             HHHHHHTSCBCSSCC--TTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTCCGG
T ss_pred             HHHHHHhCcCCCCcc--HHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhccCcc
Confidence                    0000000  0112234789999999999999999999999999999999876544

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=6.8e-47  Score=352.42  Aligned_cols=250  Identities=23%  Similarity=0.452  Sum_probs=212.1

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc------chHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCc
Q 015374          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT  196 (408)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  196 (408)
                      ..++|++.+.||+|+||+||+|++..++..||+|++...      ....+.+|+.+++++ +||||+++++++.+  ...
T Consensus        12 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~   88 (284)
T 2vgo_A           12 TIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHL-RHPNILRMYNYFHD--RKR   88 (284)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTC-CCTTBCCEEEEEEC--SSE
T ss_pred             hhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcC-CCCCEeeEEEEEEc--CCE
Confidence            457899999999999999999999999999999998632      235788999999999 99999999999965  467


Q ss_pred             cEEEEEeecCCChhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCC
Q 015374          197 PSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG  273 (408)
Q Consensus       197 ~~lv~e~~~~~~l~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~  273 (408)
                      .++||||+++++|..++   ..+++..+..++.|++.||.|||++||+|+||||+||+++.+ +.++|+|||++......
T Consensus        89 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~-~~~kl~Dfg~~~~~~~~  167 (284)
T 2vgo_A           89 IYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYK-GELKIADFGWSVHAPSL  167 (284)
T ss_dssp             EEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTT-CCEEECCCTTCEECSSS
T ss_pred             EEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCC-CCEEEecccccccCccc
Confidence            89999999999998876   458999999999999999999999999999999999999988 79999999998765432


Q ss_pred             CcceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCCCcc
Q 015374          274 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWS  353 (408)
Q Consensus       274 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  353 (408)
                       ......++..|+|||++.+ ..++.++||||||+++|+|++|..||. ..+..+....+...                 
T Consensus       168 -~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~-~~~~~~~~~~~~~~-----------------  227 (284)
T 2vgo_A          168 -RRRTMCGTLDYLPPEMIEG-KTHDEKVDLWCAGVLCYEFLVGMPPFD-SPSHTETHRRIVNV-----------------  227 (284)
T ss_dssp             -CBCCCCSCGGGCCHHHHTT-CCBCTTHHHHHHHHHHHHHHHSSCTTC-CSSHHHHHHHHHTT-----------------
T ss_pred             -ccccccCCCCcCCHHHhcc-CCCCcccchhhHHHHHHHHHHCCCCCC-CCCHhHHHHHHhcc-----------------
Confidence             3345678999999999987 778999999999999999999999983 33333333333221                 


Q ss_pred             ccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccccc
Q 015374          354 KFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVR  399 (408)
Q Consensus       354 ~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~~~  399 (408)
                         ....+..+++++.+++.+||+.||++|||++|+++||||+...
T Consensus       228 ---~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~~~~~  270 (284)
T 2vgo_A          228 ---DLKFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKANS  270 (284)
T ss_dssp             ---CCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTCHHHHHHC
T ss_pred             ---ccCCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhCHHHHhhc
Confidence               1112234789999999999999999999999999999998654

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=8.6e-47  Score=351.50  Aligned_cols=248  Identities=18%  Similarity=0.236  Sum_probs=204.2

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc-----chHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccE
Q 015374          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS  198 (408)
Q Consensus       124 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  198 (408)
                      .++|++.+.||+|+||+||+|++..+++.||+|+++..     ....+.+|+.++..+.+||||+++++++.+  ....+
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~--~~~~~   87 (289)
T 1x8b_A           10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAE--DDHML   87 (289)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEE--TTEEE
T ss_pred             cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeec--CCeEE
Confidence            57899999999999999999999999999999998642     346788899999998789999999999965  46789


Q ss_pred             EEEEeecCCChhhhc-------CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCC----------------
Q 015374          199 LIFEYVNSTDFKVLY-------PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE----------------  255 (408)
Q Consensus       199 lv~e~~~~~~l~~~~-------~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~----------------  255 (408)
                      +||||+++++|..++       ..+++..+..++.|++.||.|||++||+||||||+|||++.+                
T Consensus        88 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~  167 (289)
T 1x8b_A           88 IQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWA  167 (289)
T ss_dssp             EEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC------------------
T ss_pred             EEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCccccccccccccc
Confidence            999999999999887       348999999999999999999999999999999999999843                


Q ss_pred             --CCcEEEEecccceeccCCCcceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHH
Q 015374          256 --LRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI  333 (408)
Q Consensus       256 --~~~~kl~DfG~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~  333 (408)
                        ...+||+|||++......   ....+|..|+|||++.+...++.++|||||||++|+|++|..++...    +....+
T Consensus       168 ~~~~~~kl~Dfg~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~----~~~~~~  240 (289)
T 1x8b_A          168 SNKVMFKIGDLGHVTRISSP---QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNG----DQWHEI  240 (289)
T ss_dssp             --CCCEEECCCTTCEETTCS---CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSS----HHHHHH
T ss_pred             CCceEEEEcccccccccCCc---cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcch----hHHHHH
Confidence              247999999999876543   23468999999999987556778999999999999999998765322    222222


Q ss_pred             HhhhchhhhhcCCCCCCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccccc
Q 015374          334 AKDCCLIIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVR  399 (408)
Q Consensus       334 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~~~  399 (408)
                      ...                   .....+..+++++.+++.+||+.||++|||++|+++||||++..
T Consensus       241 ~~~-------------------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  287 (289)
T 1x8b_A          241 RQG-------------------RLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSAS  287 (289)
T ss_dssp             HTT-------------------CCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC----
T ss_pred             HcC-------------------CCCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhhhhc
Confidence            211                   01122345789999999999999999999999999999998753

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=6.3e-47  Score=355.55  Aligned_cols=268  Identities=25%  Similarity=0.426  Sum_probs=213.5

Q ss_pred             CCCCcccccCCCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc---chHHHHHHHHHHHHhcCCCCceEEeeEE
Q 015374          113 DYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV---KKKKIKREIKILQNLCGGPNVVKLLDIV  189 (408)
Q Consensus       113 ~~~~~~~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~h~niv~l~~~~  189 (408)
                      +|+.........++|++.+.||+|+||+||+|++..++..||+|++...   ..+.+.+|+.+++++ +||||+++++++
T Consensus         7 ~~~~~~~~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~   85 (302)
T 2j7t_A            7 EYEHVRRDLDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATC-DHPYIVKLLGAY   85 (302)
T ss_dssp             ---CCBSSSCGGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHC-CCTTBCCEEEEE
T ss_pred             hhcccccccCCccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcC-CCCCEeeeeeee
Confidence            3444555556688999999999999999999999999999999998643   346788999999999 999999999999


Q ss_pred             EccCCCccEEEEEeecCCChhhhc----CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecc
Q 015374          190 RDQHSKTPSLIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWG  265 (408)
Q Consensus       190 ~~~~~~~~~lv~e~~~~~~l~~~~----~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG  265 (408)
                      .+  ....++||||+++++|..++    ..+++..+..++.|++.||.|||++||+|+||||+|||++.+ +.+||+|||
T Consensus        86 ~~--~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~-~~~kl~Dfg  162 (302)
T 2j7t_A           86 YH--DGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLE-GDIRLADFG  162 (302)
T ss_dssp             EC--C-CEEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTT-SCEEECCCH
T ss_pred             ee--CCeEEEEEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCC-CCEEEEECC
Confidence            65  46789999999999998875    459999999999999999999999999999999999999988 789999999


Q ss_pred             cceeccCC-CcceeeccCcccccccccc----CCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchh
Q 015374          266 LAEFYHPG-KEYNVRVASRYFKGPELLV----DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLI  340 (408)
Q Consensus       266 ~a~~~~~~-~~~~~~~~~~~y~aPE~~~----~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~  340 (408)
                      ++...... .......++..|+|||++.    ....++.++||||||+++|+|++|..||. ..+..+....+....   
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~-~~~~~~~~~~~~~~~---  238 (302)
T 2j7t_A          163 VSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHH-ELNPMRVLLKIAKSD---  238 (302)
T ss_dssp             HHHHHHHHHHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTT-TSCHHHHHHHHHHSC---
T ss_pred             CCccccccccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCc-cCCHHHHHHHHhccC---
Confidence            87543211 1223457899999999984    23678999999999999999999999984 333333333332210   


Q ss_pred             hhhcCCCCCCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccccccch
Q 015374          341 IWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAE  402 (408)
Q Consensus       341 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~~~~~~  402 (408)
                            ..        ....+..++.++.+++.+||+.||++|||++|+++||||+.+....
T Consensus       239 ------~~--------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~~  286 (302)
T 2j7t_A          239 ------PP--------TLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSITSNK  286 (302)
T ss_dssp             ------CC--------CCSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTSTTTTTCCCCH
T ss_pred             ------Cc--------ccCCccccCHHHHHHHHHHcccChhhCCCHHHHhcChHHhhhccch
Confidence                  00        0112234688999999999999999999999999999999887644

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.1e-47  Score=365.58  Aligned_cols=259  Identities=22%  Similarity=0.413  Sum_probs=210.9

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEc---CCCcEEEEEEeccc-------chHHHHHHHHHHHHhcCCCCceEEeeEEEcc
Q 015374          123 DQDDYEVVRKVGRGKYSEVFEGINV---NTNERCIIKILKPV-------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQ  192 (408)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~Vy~~~~~---~~~~~vavK~~~~~-------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~  192 (408)
                      ..++|++.+.||+|+||+||+|++.   .+++.||||+++..       ....+.+|+.+++++.+||||+++++++.+ 
T Consensus        52 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~-  130 (355)
T 1vzo_A           52 GIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT-  130 (355)
T ss_dssp             CGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE-
T ss_pred             cccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEee-
Confidence            3578999999999999999999884   58899999998642       235677899999999779999999999965 


Q ss_pred             CCCccEEEEEeecCCChhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEeccccee
Q 015374          193 HSKTPSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEF  269 (408)
Q Consensus       193 ~~~~~~lv~e~~~~~~l~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~  269 (408)
                       ....++||||+++++|..++   ..+++..+..++.|++.||.|||++||+||||||+|||++.+ +.+||+|||+++.
T Consensus       131 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~-~~~kl~DfG~a~~  208 (355)
T 1vzo_A          131 -ETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSN-GHVVLTDFGLSKE  208 (355)
T ss_dssp             -TTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT-SCEEESCSSEEEE
T ss_pred             -CceEEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCC-CcEEEeeCCCCee
Confidence             46788999999999998887   468999999999999999999999999999999999999988 7999999999986


Q ss_pred             ccCCC--cceeeccCccccccccccC-CcCCCccccHHHHHHHHHHHHhCCCCCCCCCC--CHHHHHHHHhhhchhhhhc
Q 015374          270 YHPGK--EYNVRVASRYFKGPELLVD-LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHD--NHDQLVKIAKDCCLIIWCN  344 (408)
Q Consensus       270 ~~~~~--~~~~~~~~~~y~aPE~~~~-~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~--~~~~~~~~~~~~~~~~~~~  344 (408)
                      .....  ......||..|+|||++.+ ...++.++|||||||++|||++|+.||.....  ....+......        
T Consensus       209 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~--------  280 (355)
T 1vzo_A          209 FVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILK--------  280 (355)
T ss_dssp             CCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHH--------
T ss_pred             cccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhc--------
Confidence            54322  2234579999999999975 24578999999999999999999999854322  22222211111        


Q ss_pred             CCCCCCCccccccccCCCCCCHHHHHHHHHhcccCcCCCC-----CHHHHhcCCCccccccchh
Q 015374          345 SRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRL-----TAREAMAHPYFAQVRAAES  403 (408)
Q Consensus       345 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rp-----t~~elL~hp~f~~~~~~~~  403 (408)
                                 .....+..++..+.+||.+||..||++||     |++|+++||||+.+.+...
T Consensus       281 -----------~~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~~~~~~l  333 (355)
T 1vzo_A          281 -----------SEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWDDL  333 (355)
T ss_dssp             -----------CCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCCHHHH
T ss_pred             -----------cCCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhcCChhHh
Confidence                       01122344789999999999999999999     9999999999998876543

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=9.1e-47  Score=355.13  Aligned_cols=253  Identities=25%  Similarity=0.434  Sum_probs=210.4

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc---chHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccEEE
Q 015374          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV---KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI  200 (408)
Q Consensus       124 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  200 (408)
                      .++|++.+.||+|+||+||+|++..+++.||+|+++..   ..+.+.+|+.+++++ +||||+++++++.+  ....++|
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~~~lv   84 (304)
T 2jam_A            8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKI-KHENIVTLEDIYES--TTHYYLV   84 (304)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHC-CCTTBCCEEEEEEC--SSEEEEE
T ss_pred             hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhC-CCCCeeehhhhccc--CCEEEEE
Confidence            56899999999999999999999999999999998743   345688999999999 99999999999965  4678999


Q ss_pred             EEeecCCChhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEE---eCCCCcEEEEecccceeccCCC
Q 015374          201 FEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMI---DHELRKLRLIDWGLAEFYHPGK  274 (408)
Q Consensus       201 ~e~~~~~~l~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl---~~~~~~~kl~DfG~a~~~~~~~  274 (408)
                      |||+++++|..++   ..+++..+..++.|++.||.|||++||+|+||||+||++   +.+ +.++|+|||++..... .
T Consensus        85 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~-~~~kl~Dfg~~~~~~~-~  162 (304)
T 2jam_A           85 MQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEEN-SKIMITDFGLSKMEQN-G  162 (304)
T ss_dssp             ECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTT-CCEEBCSCSTTCCCCC-B
T ss_pred             EEcCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCC-CCEEEccCCcceecCC-C
Confidence            9999999998776   468999999999999999999999999999999999999   555 7899999999976442 2


Q ss_pred             cceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCCCccc
Q 015374          275 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSK  354 (408)
Q Consensus       275 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  354 (408)
                      ......|+..|+|||++.+ ..++.++|||||||++|+|++|..||. +.+..+....+.....       .        
T Consensus       163 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~-~~~~~~~~~~i~~~~~-------~--------  225 (304)
T 2jam_A          163 IMSTACGTPGYVAPEVLAQ-KPYSKAVDCWSIGVITYILLCGYPPFY-EETESKLFEKIKEGYY-------E--------  225 (304)
T ss_dssp             TTHHHHSCCCBCCTTTBSS-CSCCHHHHHHHHHHHHHHHHHSSCTTT-TSCHHHHHHHHHHCCC-------C--------
T ss_pred             ccccccCCCCccChHHhcc-CCCCchhhHHHHHHHHHHHHHCCCCCC-CCCHHHHHHHHHcCCC-------C--------
Confidence            3344578999999999987 789999999999999999999999984 3333444444333210       0        


Q ss_pred             cccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccccc
Q 015374          355 FINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVR  399 (408)
Q Consensus       355 ~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~~~  399 (408)
                       .....+..+++++.+|+.+||+.||++|||++|+++||||+...
T Consensus       226 -~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~  269 (304)
T 2jam_A          226 -FESPFWDDISESAKDFICHLLEKDPNERYTCEKALSHPWIDGNT  269 (304)
T ss_dssp             -CCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHSSC
T ss_pred             -CCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCccccCCC
Confidence             01122344789999999999999999999999999999998654

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.3e-46  Score=355.67  Aligned_cols=260  Identities=23%  Similarity=0.413  Sum_probs=208.4

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecc--cchHHHHHHHHHHHHhcCCCCceEEeeEEEccC----CCc
Q 015374          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP--VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQH----SKT  196 (408)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~--~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~----~~~  196 (408)
                      ..++|++.+.||+|+||+||+|++..+++.||||++..  .....+.+|+.+++++.+||||+++++++....    ...
T Consensus        22 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~  101 (326)
T 2x7f_A           22 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQ  101 (326)
T ss_dssp             CTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCCE
T ss_pred             CCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccce
Confidence            57899999999999999999999999999999999864  345788999999999978999999999997643    467


Q ss_pred             cEEEEEeecCCChhhhc-----CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceecc
Q 015374          197 PSLIFEYVNSTDFKVLY-----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH  271 (408)
Q Consensus       197 ~~lv~e~~~~~~l~~~~-----~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~  271 (408)
                      .++||||+++++|..++     ..+++..+..++.|++.||.|||++||+|+||||+|||++.+ +.+||+|||++....
T Consensus       102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~-~~~kl~Dfg~~~~~~  180 (326)
T 2x7f_A          102 LWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTEN-AEVKLVDFGVSAQLD  180 (326)
T ss_dssp             EEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTT-CCEEECCCTTTC---
T ss_pred             EEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCC-CCEEEeeCcCceecC
Confidence            89999999999998887     358899999999999999999999999999999999999988 789999999987654


Q ss_pred             CCC-cceeeccCccccccccccC----CcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCC
Q 015374          272 PGK-EYNVRVASRYFKGPELLVD----LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSR  346 (408)
Q Consensus       272 ~~~-~~~~~~~~~~y~aPE~~~~----~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  346 (408)
                      ... ......++..|+|||++..    ...++.++|||||||++|+|++|..||. +.+..+....+....         
T Consensus       181 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~-~~~~~~~~~~~~~~~---------  250 (326)
T 2x7f_A          181 RTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLC-DMHPMRALFLIPRNP---------  250 (326)
T ss_dssp             ----------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTT-TSCHHHHHHHHHHSC---------
T ss_pred             cCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCC-CCcHHHHHHHhhcCc---------
Confidence            322 2344578999999999862    2568899999999999999999999984 333333332222110         


Q ss_pred             CCCCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccccccch
Q 015374          347 HSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAE  402 (408)
Q Consensus       347 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~~~~~~  402 (408)
                               ........+++++.+||.+||..||++|||++|+++||||+......
T Consensus       251 ---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~~~~  297 (326)
T 2x7f_A          251 ---------APRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQPNER  297 (326)
T ss_dssp             ---------CCCCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHCCTTHH
T ss_pred             ---------cccCCccccCHHHHHHHHHHhccChhhCCCHHHHhhChHHhhCcccc
Confidence                     00111234689999999999999999999999999999999876543

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=1.1e-46  Score=361.17  Aligned_cols=271  Identities=22%  Similarity=0.399  Sum_probs=214.8

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecccch--------------------HHHHHHHHHHHHhcCCCCce
Q 015374          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKK--------------------KKIKREIKILQNLCGGPNVV  183 (408)
Q Consensus       124 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~--------------------~~~~~E~~~l~~l~~h~niv  183 (408)
                      .++|++.+.||+|+||+||+|++  +++.||+|++.....                    +.+.+|+.+++++ +||||+
T Consensus        30 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~  106 (348)
T 2pml_X           30 INDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDI-KNEYCL  106 (348)
T ss_dssp             ETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTC-CCTTBC
T ss_pred             cCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhC-CCCCcc
Confidence            57999999999999999999988  899999999863221                    7899999999999 899999


Q ss_pred             EEeeEEEccCCCccEEEEEeecCCChhhh------c-----CCCChHHHHHHHHHHHHHHHHHHH-CCcEEecCCCCcEE
Q 015374          184 KLLDIVRDQHSKTPSLIFEYVNSTDFKVL------Y-----PTLTDYDIRYYIYELLKALDYCHS-QGIMHRDVKPHNVM  251 (408)
Q Consensus       184 ~l~~~~~~~~~~~~~lv~e~~~~~~l~~~------~-----~~l~~~~~~~i~~qi~~~L~~LH~-~~iiH~Dlk~~NIL  251 (408)
                      ++++++.+  ....++||||+++++|..+      +     ..+++..+..++.|++.||.|||+ +||+|+||||+|||
T Consensus       107 ~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Nil  184 (348)
T 2pml_X          107 TCEGIITN--YDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNIL  184 (348)
T ss_dssp             CCSEEEES--SSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGEE
T ss_pred             eEEEEEee--CCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhEE
Confidence            99999965  4678999999999999887      4     348999999999999999999999 99999999999999


Q ss_pred             EeCCCCcEEEEecccceeccCCCcceeeccCccccccccccCCcCCCc-cccHHHHHHHHHHHHhCCCCCCCCCCCHHHH
Q 015374          252 IDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDY-SLDMWSLGCMFAGMIFRKEPFFYGHDNHDQL  330 (408)
Q Consensus       252 l~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~~DvwSlGvil~ell~g~~pf~~~~~~~~~~  330 (408)
                      ++.+ +.+||+|||++...... ......++..|+|||++.+...++. ++|||||||++|+|++|..||.......+..
T Consensus       185 ~~~~-~~~kl~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~  262 (348)
T 2pml_X          185 MDKN-GRVKLSDFGESEYMVDK-KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELF  262 (348)
T ss_dssp             ECTT-SCEEECCCTTCEECBTT-EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHHH
T ss_pred             EcCC-CcEEEeccccccccccc-cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHH
Confidence            9988 79999999999876543 4455678999999999987436666 9999999999999999999985544445555


Q ss_pred             HHHHhhhchhhhhcCCCCCCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccccccch
Q 015374          331 VKIAKDCCLIIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAE  402 (408)
Q Consensus       331 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~~~~~~  402 (408)
                      ..+........... ......+...........+++++.+|+.+||+.||++|||++|+++||||++....+
T Consensus       263 ~~i~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~~~~~~~  333 (348)
T 2pml_X          263 NNIRTKNIEYPLDR-NHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADTNIED  333 (348)
T ss_dssp             HHHTSCCCCCCCSS-SSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGTTCCHHH
T ss_pred             HHHhccCcCCccch-hhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCccccCCCHHH
Confidence            44432211000000 000000000011112245789999999999999999999999999999999887654

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=8.3e-47  Score=362.34  Aligned_cols=250  Identities=28%  Similarity=0.419  Sum_probs=206.5

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc------chHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCcc
Q 015374          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP  197 (408)
Q Consensus       124 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~  197 (408)
                      .++|++.+.||+|+||+||+|++..+++.||||+++..      ..+.+.+|+.+++++ +||||++++++|.+  ....
T Consensus        53 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~--~~~~  129 (348)
T 1u5q_A           53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKL-RHPNTIQYRGCYLR--EHTA  129 (348)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEEE--TTEE
T ss_pred             hhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhC-CCCCEeeEEEEEEE--CCeE
Confidence            45699999999999999999999999999999998632      235688999999999 99999999999965  4678


Q ss_pred             EEEEEeecCCChhhhc----CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCC
Q 015374          198 SLIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG  273 (408)
Q Consensus       198 ~lv~e~~~~~~l~~~~----~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~  273 (408)
                      ++||||+.++ +..++    ..+++..+..++.|++.||.|||++||+||||||+|||++.+ +.+||+|||++..... 
T Consensus       130 ~lv~e~~~g~-l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~-~~~kL~DfG~a~~~~~-  206 (348)
T 1u5q_A          130 WLVMEYCLGS-ASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEP-GLVKLGDFGSASIMAP-  206 (348)
T ss_dssp             EEEEECCSEE-HHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETT-TEEEECCCTTCBSSSS-
T ss_pred             EEEEecCCCC-HHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCC-CCEEEeeccCceecCC-
Confidence            8999999854 44433    468999999999999999999999999999999999999988 8999999999976543 


Q ss_pred             CcceeeccCccccccccccC--CcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCCC
Q 015374          274 KEYNVRVASRYFKGPELLVD--LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKP  351 (408)
Q Consensus       274 ~~~~~~~~~~~y~aPE~~~~--~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  351 (408)
                        .....||+.|+|||++.+  ...++.++|||||||++|||++|+.||.. .+..+.+..+....         .    
T Consensus       207 --~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~-~~~~~~~~~~~~~~---------~----  270 (348)
T 1u5q_A          207 --ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN-MNAMSALYHIAQNE---------S----  270 (348)
T ss_dssp             --BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTT-SCHHHHHHHHHHSC---------C----
T ss_pred             --CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCC-CChHHHHHHHHhcC---------C----
Confidence              234679999999999852  36789999999999999999999999843 33334443333211         0    


Q ss_pred             ccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccccc
Q 015374          352 WSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRA  400 (408)
Q Consensus       352 ~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~~~~  400 (408)
                           .......+++++.+||.+||+.||++|||++++++||||.....
T Consensus       271 -----~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~~~~~~~  314 (348)
T 1u5q_A          271 -----PALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERP  314 (348)
T ss_dssp             -----CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSCCC
T ss_pred             -----CCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHhhChhhhccCC
Confidence                 01112346899999999999999999999999999999976543

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=2.8e-47  Score=360.42  Aligned_cols=272  Identities=30%  Similarity=0.546  Sum_probs=209.6

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc---chHHHHHHHHHHHHhcCCCCceEEeeEEEcc-------
Q 015374          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV---KKKKIKREIKILQNLCGGPNVVKLLDIVRDQ-------  192 (408)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~-------  192 (408)
                      ..++|++.+.||+|+||+||+|++..+++.||+|++...   ..+.+.+|+.+++++ +||||+++++++...       
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~   87 (320)
T 2i6l_A            9 LGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRL-DHDNIVKVFEILGPSGSQLTDD   87 (320)
T ss_dssp             ETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTC-CCTTBCCEEEEECTTSCBCCC-
T ss_pred             cCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhc-CCCCeeEEEEeccccccccccc
Confidence            468999999999999999999999999999999998643   346788999999999 999999999988532       


Q ss_pred             -----CCCccEEEEEeecCCChhhhcC--CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecc
Q 015374          193 -----HSKTPSLIFEYVNSTDFKVLYP--TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWG  265 (408)
Q Consensus       193 -----~~~~~~lv~e~~~~~~l~~~~~--~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG  265 (408)
                           .....++||||++ ++|..++.  .+++..++.++.|++.||+|||++||+||||||+|||++.+.+.+||+|||
T Consensus        88 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~Dfg  166 (320)
T 2i6l_A           88 VGSLTELNSVYIVQEYME-TDLANVLEQGPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFG  166 (320)
T ss_dssp             ---CCSCSEEEEEEECCS-EEHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTEEEECCCT
T ss_pred             cccccccCceeEEeeccC-CCHHHHhhcCCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCeEEEccCc
Confidence                 2356789999998 47877764  488999999999999999999999999999999999998654799999999


Q ss_pred             cceeccCC----CcceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhh
Q 015374          266 LAEFYHPG----KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLII  341 (408)
Q Consensus       266 ~a~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~  341 (408)
                      ++......    .......++..|+|||.+.+...++.++|||||||++|+|++|+.|| .+.+..+....+....+...
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf-~~~~~~~~~~~~~~~~~~~~  245 (320)
T 2i6l_A          167 LARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLF-AGAHELEQMQLILESIPVVH  245 (320)
T ss_dssp             TCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSS-CCSSHHHHHHHHHHHSCCCC
T ss_pred             cccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCC-CCCCHHHHHHHHHHhcCCCc
Confidence            99866432    12234567889999999876577999999999999999999999998 44455555555554332111


Q ss_pred             h---------------hcCCCCCCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccccccch
Q 015374          342 W---------------CNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAE  402 (408)
Q Consensus       342 ~---------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~~~~~~  402 (408)
                      .               .........+     ......++.++.+|+.+||+.||++|||++|+|+||||+......
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~p~  316 (320)
T 2i6l_A          246 EEDRQELLSVIPVYIRNDMTEPHKPL-----TQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIYSFPM  316 (320)
T ss_dssp             HHHHHHHHTTSCHHHHHHTTSCCCCH-----HHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTTCC--
T ss_pred             hhhhhhhhhcCcccccccccCCCCCh-----hHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCcccccccCcc
Confidence            0               0000001111     112234789999999999999999999999999999999876654

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=1.3e-46  Score=361.03  Aligned_cols=277  Identities=25%  Similarity=0.446  Sum_probs=213.0

Q ss_pred             cccCCCCCEEEEeeeeeeCceEEEEEEEcCCC-cEEEEEEeccc--chHHHHHHHHHHHHhcCCCC------ceEEeeEE
Q 015374          119 VQWGDQDDYEVVRKVGRGKYSEVFEGINVNTN-ERCIIKILKPV--KKKKIKREIKILQNLCGGPN------VVKLLDIV  189 (408)
Q Consensus       119 ~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~-~~vavK~~~~~--~~~~~~~E~~~l~~l~~h~n------iv~l~~~~  189 (408)
                      .+....++|++.+.||+|+||+||+|++..++ ..||+|+++..  ..+.+.+|+.+++++ +|++      ++.+++++
T Consensus        13 ~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~~~~~~~~~~~~~~~~~~   91 (355)
T 2eu9_A           13 IGDWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKI-KEKDKENKFLCVLMSDWF   91 (355)
T ss_dssp             TTCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCHHHHHHHHHHHHHHHHH-HHHCTTSCSCBCCEEEEE
T ss_pred             cCceecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccccchhHHHHHHHHHHHH-hhcCCCCceeEEEeeeee
Confidence            33345789999999999999999999998776 78999999753  346788899999998 5555      89999998


Q ss_pred             EccCCCccEEEEEeecCCChhhhc----CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEE-------------
Q 015374          190 RDQHSKTPSLIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMI-------------  252 (408)
Q Consensus       190 ~~~~~~~~~lv~e~~~~~~l~~~~----~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl-------------  252 (408)
                      ..  ....++||||++++++..+.    ..+++..+..++.|++.||.|||++||+||||||+|||+             
T Consensus        92 ~~--~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~  169 (355)
T 2eu9_A           92 NF--HGHMCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHK  169 (355)
T ss_dssp             EE--TTEEEEEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC-
T ss_pred             ee--CCeEEEEEeccCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecccccccccccc
Confidence            65  46789999999666655544    258999999999999999999999999999999999999             


Q ss_pred             ------eCCCCcEEEEecccceeccCCCcceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCC
Q 015374          253 ------DHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDN  326 (408)
Q Consensus       253 ------~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~  326 (408)
                            +.+ +.+||+|||+++....  ......||..|+|||++.+ ..++.++|||||||++|||++|..|| .+.+.
T Consensus       170 ~~~~~~~~~-~~~kl~Dfg~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~pf-~~~~~  244 (355)
T 2eu9_A          170 SCEEKSVKN-TSIRVADFGSATFDHE--HHTTIVATRHYRPPEVILE-LGWAQPCDVWSIGCILFEYYRGFTLF-QTHEN  244 (355)
T ss_dssp             CCCEEEESC-CCEEECCCTTCEETTS--CCCSSCSCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSC-CCSSH
T ss_pred             cccccccCC-CcEEEeecCccccccc--cccCCcCCCcccCCeeeec-CCCCCccchHHHHHHHHHHHhCCCCC-CCCCH
Confidence                  444 7899999999986543  3345678999999999987 78999999999999999999999998 44455


Q ss_pred             HHHHHHHHhhhchhhhhcCCCCC---------CCccccc---------------cccCCCCCCHHHHHHHHHhcccCcCC
Q 015374          327 HDQLVKIAKDCCLIIWCNSRHSR---------KPWSKFI---------------NADNQHLVSPEAIDFLDKLLRYDHQD  382 (408)
Q Consensus       327 ~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~---------------~~~~~~~~~~~~~~li~~~L~~dp~~  382 (408)
                      .+.+..+....+..+........         ..|....               ........+.++.+||.+||+.||++
T Consensus       245 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~  324 (355)
T 2eu9_A          245 REHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQ  324 (355)
T ss_dssp             HHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTT
T ss_pred             HHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhh
Confidence            55555555544422211000000         0000000               00001112457899999999999999


Q ss_pred             CCCHHHHhcCCCccccccchh
Q 015374          383 RLTAREAMAHPYFAQVRAAES  403 (408)
Q Consensus       383 Rpt~~elL~hp~f~~~~~~~~  403 (408)
                      |||++|+|+||||++++..+.
T Consensus       325 Rpt~~e~l~hp~f~~~~~~~~  345 (355)
T 2eu9_A          325 RITLAEALLHPFFAGLTPEER  345 (355)
T ss_dssp             SCCHHHHTTSGGGGGCCHHHH
T ss_pred             CcCHHHHhcChhhcCCChhhc
Confidence            999999999999999877553

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=2.8e-46  Score=363.29  Aligned_cols=271  Identities=23%  Similarity=0.380  Sum_probs=211.4

Q ss_pred             CCCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecccc--hHHHHHHHHHHHHhcCCCC-----ceEEeeEEEccCC
Q 015374          122 GDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK--KKKIKREIKILQNLCGGPN-----VVKLLDIVRDQHS  194 (408)
Q Consensus       122 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~E~~~l~~l~~h~n-----iv~l~~~~~~~~~  194 (408)
                      ...++|++.+.||+|+||+||+|++..+++.||||+++...  ...+.+|+.+++.+..|+|     ++++++++..  .
T Consensus        51 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~--~  128 (382)
T 2vx3_A           51 KWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMF--R  128 (382)
T ss_dssp             EETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEE--T
T ss_pred             EeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeecc--C
Confidence            34689999999999999999999999999999999997443  4667889999998855664     8999999965  4


Q ss_pred             CccEEEEEeecCCChhhhc-----CCCChHHHHHHHHHHHHHHHHHH--HCCcEEecCCCCcEEEeC-CCCcEEEEeccc
Q 015374          195 KTPSLIFEYVNSTDFKVLY-----PTLTDYDIRYYIYELLKALDYCH--SQGIMHRDVKPHNVMIDH-ELRKLRLIDWGL  266 (408)
Q Consensus       195 ~~~~lv~e~~~~~~l~~~~-----~~l~~~~~~~i~~qi~~~L~~LH--~~~iiH~Dlk~~NILl~~-~~~~~kl~DfG~  266 (408)
                      ...++||||+++ +|..++     ..+++..++.++.|++.||.|||  +.||+||||||+|||++. +.+.+||+|||+
T Consensus       129 ~~~~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~  207 (382)
T 2vx3_A          129 NHLCLVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGS  207 (382)
T ss_dssp             TEEEEEEECCCC-BHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECCCTT
T ss_pred             CceEEEEecCCC-CHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEeccC
Confidence            688999999976 666655     34899999999999999999999  579999999999999964 236899999999


Q ss_pred             ceeccCCCcceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCC
Q 015374          267 AEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSR  346 (408)
Q Consensus       267 a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  346 (408)
                      ++....  ......+|+.|+|||++.+ ..++.++|||||||++|||++|+.|| .+.+..+.+..+....+........
T Consensus       208 a~~~~~--~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~pf-~~~~~~~~~~~i~~~~~~~~~~~~~  283 (382)
T 2vx3_A          208 SCQLGQ--RIYQYIQSRFYRSPEVLLG-MPYDLAIDMWSLGCILVEMHTGEPLF-SGANEVDQMNKIVEVLGIPPAHILD  283 (382)
T ss_dssp             CEETTC--CCCSSCSCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSS-CCSSHHHHHHHHHHHHCSCCHHHHT
T ss_pred             ceeccc--ccccccCCccccChHHHcC-CCCCcHHHHHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHHHhCCCCHHHHH
Confidence            987643  3345688999999999988 67999999999999999999999997 5666677777777765533211110


Q ss_pred             C-----------CCCCcccc---------cccc--------------------CCC----CCCHHHHHHHHHhcccCcCC
Q 015374          347 H-----------SRKPWSKF---------INAD--------------------NQH----LVSPEAIDFLDKLLRYDHQD  382 (408)
Q Consensus       347 ~-----------~~~~~~~~---------~~~~--------------------~~~----~~~~~~~~li~~~L~~dp~~  382 (408)
                      .           ....|...         ....                    ...    ..++++.+||.+||++||++
T Consensus       284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~  363 (382)
T 2vx3_A          284 QAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKT  363 (382)
T ss_dssp             TCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSCTTT
T ss_pred             hhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCCChhh
Confidence            0           00011000         0000                    000    00147899999999999999


Q ss_pred             CCCHHHHhcCCCccccc
Q 015374          383 RLTAREAMAHPYFAQVR  399 (408)
Q Consensus       383 Rpt~~elL~hp~f~~~~  399 (408)
                      |||++|+|+||||+...
T Consensus       364 Rpta~e~L~hp~f~~~~  380 (382)
T 2vx3_A          364 RIQPYYALQHSFFKKTA  380 (382)
T ss_dssp             SCCHHHHTTSGGGCC--
T ss_pred             CCCHHHHhcCcccccCC
Confidence            99999999999998764

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=2.2e-47  Score=368.01  Aligned_cols=274  Identities=21%  Similarity=0.317  Sum_probs=212.1

Q ss_pred             cCCCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc----chHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCc
Q 015374          121 WGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT  196 (408)
Q Consensus       121 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  196 (408)
                      ....++|++.+.||+|+||+||+|++..++..||+|+++..    ..+.+.+|+.+++++ +||||+++++++.+  ...
T Consensus        29 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~--~~~  105 (360)
T 3eqc_A           29 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHEC-NSPYIVGFYGAFYS--DGE  105 (360)
T ss_dssp             CCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGC-CCTTBCCEEEEEEE--TTE
T ss_pred             ccccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHC-CCCCEEEEeEEEEE--CCE
Confidence            34578999999999999999999999999999999998643    246788999999999 99999999999965  467


Q ss_pred             cEEEEEeecCCChhhhc---CCCChHHHHHHHHHHHHHHHHHHHC-CcEEecCCCCcEEEeCCCCcEEEEecccceeccC
Q 015374          197 PSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQ-GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP  272 (408)
Q Consensus       197 ~~lv~e~~~~~~l~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~-~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~  272 (408)
                      .++||||+++++|..++   ..+++..+..++.|++.||.|||+. ||+||||||+|||++.+ +.+||+|||++.....
T Consensus       106 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~-~~~kl~Dfg~~~~~~~  184 (360)
T 3eqc_A          106 ISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSR-GEIKLCDFGVSGQLID  184 (360)
T ss_dssp             EEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTT-CCEEECCCCCCHHHHH
T ss_pred             EEEEEECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCC-CCEEEEECCCCccccc
Confidence            89999999999999887   3689999999999999999999996 99999999999999988 7999999999865532


Q ss_pred             CCcceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhc--hhhhh--cCCCC
Q 015374          273 GKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCC--LIIWC--NSRHS  348 (408)
Q Consensus       273 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~--~~~~~--~~~~~  348 (408)
                      . ......||..|+|||++.+ ..++.++|||||||++|+|++|+.||...  +.+.+..+.....  .....  .....
T Consensus       185 ~-~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~  260 (360)
T 3eqc_A          185 S-MANSFVGTRSYMSPERLQG-THYSVQSDIWSMGLSLVEMAVGRYPIPPP--DAKELELMFGCQVEGDAAETPPRPRTP  260 (360)
T ss_dssp             H-C----CCCCTTCCHHHHTT-CCCSHHHHHHHHHHHHHHHHHTSCCSSCC--CHHHHHHHHC-----------------
T ss_pred             c-cccCCCCCCCeECHHHHcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCC--CHHHHHHHhcccccccCCCCCCCcccC
Confidence            2 2344578999999999987 78999999999999999999999998432  2222222221100  00000  00000


Q ss_pred             CCCcc---------------------ccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccccccch
Q 015374          349 RKPWS---------------------KFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAE  402 (408)
Q Consensus       349 ~~~~~---------------------~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~~~~~~  402 (408)
                      ...+.                     ..........++.++.+||.+||+.||++|||++|+|+||||+.....+
T Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~  335 (360)
T 3eqc_A          261 GRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDAEE  335 (360)
T ss_dssp             -------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHHHHHSC
T ss_pred             CCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhcchHhh
Confidence            00000                     0001111234688999999999999999999999999999999776543

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=8.8e-48  Score=373.23  Aligned_cols=252  Identities=17%  Similarity=0.248  Sum_probs=199.7

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc------chHHHHHHHHH---HHHhcCCCCceEEe-------
Q 015374          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKI---LQNLCGGPNVVKLL-------  186 (408)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~---l~~l~~h~niv~l~-------  186 (408)
                      ..++|++.+.||+|+||+||+|++..+++.||||+++..      ..+.+.+|+.+   ++++ +||||++++       
T Consensus        71 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l-~hpniv~~~~~~~~~~  149 (377)
T 3byv_A           71 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGI-KNQKQAKVHLRFIFPF  149 (377)
T ss_dssp             CCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTC-CSHHHHHHHHCBCCCS
T ss_pred             CCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhcccc-CCHHHHHHHhhhhhhh
Confidence            367899999999999999999999899999999998632      34678899954   4455 899999998       


Q ss_pred             eEEEccCC----------C-----ccEEEEEeecCCChhhhcC---CCCh-------HHHHHHHHHHHHHHHHHHHCCcE
Q 015374          187 DIVRDQHS----------K-----TPSLIFEYVNSTDFKVLYP---TLTD-------YDIRYYIYELLKALDYCHSQGIM  241 (408)
Q Consensus       187 ~~~~~~~~----------~-----~~~lv~e~~~~~~l~~~~~---~l~~-------~~~~~i~~qi~~~L~~LH~~~ii  241 (408)
                      +++.+.+.          .     ..++||||+ +|+|..++.   .+++       ..+..++.|++.||+|||++||+
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iv  228 (377)
T 3byv_A          150 DLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLV  228 (377)
T ss_dssp             EEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred             hhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCee
Confidence            66654321          1     378999999 578888774   3444       77778999999999999999999


Q ss_pred             EecCCCCcEEEeCCCCcEEEEecccceeccCCCcceeeccCccccccccccCC----------cCCCccccHHHHHHHHH
Q 015374          242 HRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDL----------QDYDYSLDMWSLGCMFA  311 (408)
Q Consensus       242 H~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~y~aPE~~~~~----------~~~~~~~DvwSlGvil~  311 (408)
                      ||||||+|||++.+ +.+||+|||+++...  .......| ..|+|||++.+.          ..++.++|||||||++|
T Consensus       229 HrDikp~NIll~~~-~~~kL~DFG~a~~~~--~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~  304 (377)
T 3byv_A          229 HTYLRPVDIVLDQR-GGVFLTGFEHLVRDG--ARVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIY  304 (377)
T ss_dssp             CSCCCGGGEEECTT-CCEEECCGGGCEETT--CEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHH
T ss_pred             cCCCCHHHEEEcCC-CCEEEEechhheecC--CcccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHH
Confidence            99999999999988 799999999998643  33445567 999999999872          27999999999999999


Q ss_pred             HHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 015374          312 GMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA  391 (408)
Q Consensus       312 ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~  391 (408)
                      ||++|+.||... +..+...                      .  .......+++++.+||.+||+.||++|||+.|+++
T Consensus       305 elltg~~Pf~~~-~~~~~~~----------------------~--~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  359 (377)
T 3byv_A          305 WIWCADLPITKD-AALGGSE----------------------W--IFRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAME  359 (377)
T ss_dssp             HHHHSSCCC-------CCSG----------------------G--GGSSCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred             HHHHCCCCCccc-ccccchh----------------------h--hhhhccCCCHHHHHHHHHHcCCCchhCCCHHHHhh
Confidence            999999998321 1111000                      0  00112357899999999999999999999999999


Q ss_pred             CCCccccccchhhh
Q 015374          392 HPYFAQVRAAESSR  405 (408)
Q Consensus       392 hp~f~~~~~~~~~~  405 (408)
                      ||||++++...++.
T Consensus       360 hp~f~~~~~~~~~~  373 (377)
T 3byv_A          360 TPEYEQLRTELSAA  373 (377)
T ss_dssp             SHHHHHHHHHHHHH
T ss_pred             ChHHHHHHHHHHHh
Confidence            99999987765544

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=1.1e-46  Score=349.82  Aligned_cols=255  Identities=24%  Similarity=0.422  Sum_probs=211.0

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc-----chHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCcc
Q 015374          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP  197 (408)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~  197 (408)
                      ..++|++.+.||+|+||+||+|++..+++.||+|+++..     ..+.+.+|+.+++++ +||||+++++++.+......
T Consensus         4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~   82 (279)
T 2w5a_A            4 RAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLREL-KHPNIVRYYDRIIDRTNTTL   82 (279)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEEEGGGTEE
T ss_pred             chhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhc-CCCCCCeEEEEEecCCCceE
Confidence            357899999999999999999999999999999998632     346688999999999 99999999999876666788


Q ss_pred             EEEEEeecCCChhhhcC-------CCChHHHHHHHHHHHHHHHHHHHCC-----cEEecCCCCcEEEeCCCCcEEEEecc
Q 015374          198 SLIFEYVNSTDFKVLYP-------TLTDYDIRYYIYELLKALDYCHSQG-----IMHRDVKPHNVMIDHELRKLRLIDWG  265 (408)
Q Consensus       198 ~lv~e~~~~~~l~~~~~-------~l~~~~~~~i~~qi~~~L~~LH~~~-----iiH~Dlk~~NILl~~~~~~~kl~DfG  265 (408)
                      ++||||+++++|..++.       .+++..+..++.|++.||+|||+.+     |+|+||||+|||++.+ +.+||+|||
T Consensus        83 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~-~~~kl~dfg  161 (279)
T 2w5a_A           83 YIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGK-QNVKLGDFG  161 (279)
T ss_dssp             EEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSS-SCEEECCCC
T ss_pred             EEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCC-CCEEEecCc
Confidence            99999999999988873       2899999999999999999999999     9999999999999988 799999999


Q ss_pred             cceeccCCCc-ceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhc
Q 015374          266 LAEFYHPGKE-YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCN  344 (408)
Q Consensus       266 ~a~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  344 (408)
                      ++........ .....++..|+|||++.+ ..++.++||||||+++|+|++|..||. +.+..+....+....       
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~-~~~~~~~~~~i~~~~-------  232 (279)
T 2w5a_A          162 LARILNHDTSFAKTFVGTPYYMSPEQMNR-MSYNEKSDIWSLGCLLYELCALMPPFT-AFSQKELAGKIREGK-------  232 (279)
T ss_dssp             HHHHC---CHHHHHHHSCCTTCCHHHHHC-C-CCHHHHHHHHHHHHHHHHHSSCSSC-CSSHHHHHHHHHHTC-------
T ss_pred             hheeeccccccccccCCCccccChHHhcc-CCCCchhhHHHHHHHHHHHHHCCCCCc-ccCHHHHHHHHhhcc-------
Confidence            9976553322 234578999999999987 678999999999999999999999984 333333333332210       


Q ss_pred             CCCCCCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccccc
Q 015374          345 SRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRA  400 (408)
Q Consensus       345 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~~~~  400 (408)
                                  ....+..+++++.+++.+||+.||++|||++|+++|+|+++-+.
T Consensus       233 ------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~~  276 (279)
T 2w5a_A          233 ------------FRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILEHHH  276 (279)
T ss_dssp             ------------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGGGS
T ss_pred             ------------cccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhhhcc
Confidence                        01122347899999999999999999999999999999987543

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=1.6e-46  Score=363.36  Aligned_cols=246  Identities=19%  Similarity=0.308  Sum_probs=202.4

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEc-------CCCcEEEEEEeccc----chHHHHHHHHHHHHhcCCCCceEEeeEEEc
Q 015374          123 DQDDYEVVRKVGRGKYSEVFEGINV-------NTNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRD  191 (408)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~Vy~~~~~-------~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~  191 (408)
                      ..++|++.+.||+|+||+||+|++.       .++..||||+++..    ..+.+.+|+.+++++.+||||++++++|.+
T Consensus        79 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~  158 (370)
T 2psq_A           79 PRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ  158 (370)
T ss_dssp             CGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECS
T ss_pred             cHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEcc
Confidence            4678999999999999999999864       34567999999743    235688999999999789999999999954


Q ss_pred             cCCCccEEEEEeecCCChhhhcC-------------------CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEE
Q 015374          192 QHSKTPSLIFEYVNSTDFKVLYP-------------------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMI  252 (408)
Q Consensus       192 ~~~~~~~lv~e~~~~~~l~~~~~-------------------~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl  252 (408)
                        ....++||||+++++|..++.                   .+++..+..++.|++.||+|||++||+||||||+|||+
T Consensus       159 --~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll  236 (370)
T 2psq_A          159 --DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLV  236 (370)
T ss_dssp             --SSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE
T ss_pred             --CCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhEEE
Confidence              567899999999999988862                   37888999999999999999999999999999999999


Q ss_pred             eCCCCcEEEEecccceeccCCCc---ceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHH
Q 015374          253 DHELRKLRLIDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHD  328 (408)
Q Consensus       253 ~~~~~~~kl~DfG~a~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-g~~pf~~~~~~~~  328 (408)
                      +.+ +.+||+|||+++.......   .....+|..|+|||++.+ ..++.++|||||||++|||++ |..|| .+.+..+
T Consensus       237 ~~~-~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DvwslG~il~ellt~g~~p~-~~~~~~~  313 (370)
T 2psq_A          237 TEN-NVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLMWEIFTLGGSPY-PGIPVEE  313 (370)
T ss_dssp             CTT-CCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHT-CCCCHHHHHHHHHHHHHHHHTTSCCSS-TTCCGGG
T ss_pred             CCC-CCEEEccccCCcccCcccceecccCCCcccceECHhHhcC-CCCCcHHHHHHHHHHHHHHHcCCCCCC-CCCCHHH
Confidence            988 7999999999987654322   223456778999999987 789999999999999999999 88887 4444333


Q ss_pred             HHHHHHhhhchhhhhcCCCCCCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 015374          329 QLVKIAKDCCLIIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH  392 (408)
Q Consensus       329 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~h  392 (408)
                      ....+...                   .....+..+++++.+++.+||+.||++|||+.|++++
T Consensus       314 ~~~~~~~~-------------------~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~  358 (370)
T 2psq_A          314 LFKLLKEG-------------------HRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED  358 (370)
T ss_dssp             HHHHHHTT-------------------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHhcC-------------------CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            33322221                   1112334578999999999999999999999999874

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=1.2e-46  Score=351.31  Aligned_cols=256  Identities=24%  Similarity=0.522  Sum_probs=213.5

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc-----chHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccE
Q 015374          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS  198 (408)
Q Consensus       124 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  198 (408)
                      .++|++.+.||+|+||+||+|++..+++.||+|+++..     ....+.+|+.+++++ +||||+++++++.+  ....+
T Consensus        21 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~~~   97 (287)
T 2wei_A           21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKL-DHPNIMKLFEILED--SSSFY   97 (287)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTC-CCTTBCCEEEEEEC--SSEEE
T ss_pred             hhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhc-cCCCccEEEEEEeC--CCeEE
Confidence            56899999999999999999999999999999998532     346788999999999 99999999999965  46788


Q ss_pred             EEEEeecCCChhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCC--CcEEEEecccceeccCC
Q 015374          199 LIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEL--RKLRLIDWGLAEFYHPG  273 (408)
Q Consensus       199 lv~e~~~~~~l~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~--~~~kl~DfG~a~~~~~~  273 (408)
                      +||||+++++|...+   ..+++..+..++.|++.||.|||++||+|+||||+||+++.+.  +.+||+|||++......
T Consensus        98 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~  177 (287)
T 2wei_A           98 IVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN  177 (287)
T ss_dssp             EEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCC
T ss_pred             EEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeecCC
Confidence            999999999997765   5689999999999999999999999999999999999997642  36999999999877655


Q ss_pred             CcceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCCCcc
Q 015374          274 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWS  353 (408)
Q Consensus       274 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  353 (408)
                      .......++..|+|||.+.+  .++.++||||||+++|+|++|..||. +.+..+....+....         ..     
T Consensus       178 ~~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~p~~-~~~~~~~~~~~~~~~---------~~-----  240 (287)
T 2wei_A          178 TKMKDRIGTAYYIAPEVLRG--TYDEKCDVWSAGVILYILLSGTPPFY-GKNEYDILKRVETGK---------YA-----  240 (287)
T ss_dssp             SSCSCHHHHHTTCCHHHHTT--CCCTHHHHHHHHHHHHHHHHSSCSSC-CSSHHHHHHHHHHCC---------CC-----
T ss_pred             CccccccCcccccChHHhcC--CCCCchhhHhHHHHHHHHHhCCCCCC-CCCHHHHHHHHHcCC---------CC-----
Confidence            55555678999999999875  58999999999999999999999984 333334333332210         00     


Q ss_pred             ccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccccccc
Q 015374          354 KFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAA  401 (408)
Q Consensus       354 ~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~~~~~  401 (408)
                        ........+++++.+++.+||+.||++|||++|+|+||||++...+
T Consensus       241 --~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~~~~~~~~  286 (287)
T 2wei_A          241 --FDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSSE  286 (287)
T ss_dssp             --CCSGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHHHCCC
T ss_pred             --CCchhhhhcCHHHHHHHHHHcccChhhCcCHHHHhcCHHHhccccC
Confidence              0111123478999999999999999999999999999999877553

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=7.1e-47  Score=366.04  Aligned_cols=264  Identities=18%  Similarity=0.206  Sum_probs=194.3

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecccc------hHHHHHHHHHHHHhc-CCCCceEEe-------eEE
Q 015374          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK------KKKIKREIKILQNLC-GGPNVVKLL-------DIV  189 (408)
Q Consensus       124 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~------~~~~~~E~~~l~~l~-~h~niv~l~-------~~~  189 (408)
                      ..+|++.+.||+|+||+||+|++..+++.||||+++...      .+.+.+|+.+++.+. +||||++++       +++
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~  140 (371)
T 3q60_A           61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV  140 (371)
T ss_dssp             EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred             ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence            345999999999999999999999999999999997532      356778877777774 499988755       454


Q ss_pred             EccCC---------------CccEEEEEeecCCChhhhcC----CCChHHH------HHHHHHHHHHHHHHHHCCcEEec
Q 015374          190 RDQHS---------------KTPSLIFEYVNSTDFKVLYP----TLTDYDI------RYYIYELLKALDYCHSQGIMHRD  244 (408)
Q Consensus       190 ~~~~~---------------~~~~lv~e~~~~~~l~~~~~----~l~~~~~------~~i~~qi~~~L~~LH~~~iiH~D  244 (408)
                      .....               ...++||||++ ++|..++.    .+.+..+      ..++.|++.||+|||++||+|||
T Consensus       141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrD  219 (371)
T 3q60_A          141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGH  219 (371)
T ss_dssp             EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETT
T ss_pred             ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCc
Confidence            43222               34799999999 78888874    3455555      56779999999999999999999


Q ss_pred             CCCCcEEEeCCCCcEEEEecccceeccCCCcceeeccCccccccccccC-CcCCCccccHHHHHHHHHHHHhCCCCCCCC
Q 015374          245 VKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD-LQDYDYSLDMWSLGCMFAGMIFRKEPFFYG  323 (408)
Q Consensus       245 lk~~NILl~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~~DvwSlGvil~ell~g~~pf~~~  323 (408)
                      |||+|||++.+ +.+||+|||+++....  ......+|..|+|||++.+ ...++.++|||||||++|||++|+.||...
T Consensus       220 ikp~NIll~~~-~~~kL~DFG~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~  296 (371)
T 3q60_A          220 FTPDNLFIMPD-GRLMLGDVSALWKVGT--RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLV  296 (371)
T ss_dssp             CSGGGEEECTT-SCEEECCGGGEEETTC--EEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTBC
T ss_pred             CCHHHEEECCC-CCEEEEecceeeecCC--CccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCCc
Confidence            99999999988 7999999999987642  2224567799999999964 246899999999999999999999998543


Q ss_pred             CCCHHHHHHHHhhhchhhhhcCCCCCCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccccccchh
Q 015374          324 HDNHDQLVKIAKDCCLIIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAES  403 (408)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~~~~~~~  403 (408)
                      ......           .+...... ..............+++++.+||.+||+.||++|||++|+|+||||+++....+
T Consensus       297 ~~~~~~-----------~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~~~  364 (371)
T 3q60_A          297 TPGIKG-----------SWKRPSLR-VPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQLQNEIS  364 (371)
T ss_dssp             CTTCTT-----------CCCBCCTT-SCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHHHHHHHHH
T ss_pred             Cccccc-----------chhhhhhh-hccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHHHHHHHHh
Confidence            221000           00000000 000001112223467999999999999999999999999999999999877543

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=3.6e-46  Score=350.78  Aligned_cols=253  Identities=26%  Similarity=0.418  Sum_probs=213.2

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc----chHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccE
Q 015374          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS  198 (408)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  198 (408)
                      ..++|++.+.||+|+||+||+|++..+++.||+|+++..    ..+.+.+|+.+++++ +||||+++++++.+  ....+
T Consensus        20 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~~~   96 (303)
T 3a7i_A           20 PEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQC-DSPYVTKYYGSYLK--DTKLW   96 (303)
T ss_dssp             GGGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHC-CCTTBCCEEEEEEE--TTEEE
T ss_pred             hHHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhC-CCCCEeEEEEEEec--CCeEE
Confidence            357799999999999999999999999999999998632    346789999999999 99999999999965  46788


Q ss_pred             EEEEeecCCChhhhcC--CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCCC-c
Q 015374          199 LIFEYVNSTDFKVLYP--TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK-E  275 (408)
Q Consensus       199 lv~e~~~~~~l~~~~~--~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~~-~  275 (408)
                      +||||+++++|..++.  .+++..+..++.|++.||.|||+.||+|+||||+||+++.+ +.+||+|||++....... .
T Consensus        97 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~-~~~kl~Dfg~~~~~~~~~~~  175 (303)
T 3a7i_A           97 IIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEH-GEVKLADFGVAGQLTDTQIK  175 (303)
T ss_dssp             EEEECCTTEEHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT-SCEEECCCTTCEECBTTBCC
T ss_pred             EEEEeCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCC-CCEEEeecccceecCccccc
Confidence            9999999999998874  58999999999999999999999999999999999999988 799999999998765433 2


Q ss_pred             ceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCCCcccc
Q 015374          276 YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSKF  355 (408)
Q Consensus       276 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  355 (408)
                      .....++..|+|||++.+ ..++.++||||||+++|+|++|..||. .....+....+...                   
T Consensus       176 ~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~-~~~~~~~~~~~~~~-------------------  234 (303)
T 3a7i_A          176 RNTFVGTPFWMAPEVIKQ-SAYDSKADIWSLGITAIELARGEPPHS-ELHPMKVLFLIPKN-------------------  234 (303)
T ss_dssp             BCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCTTT-TSCHHHHHHHHHHS-------------------
T ss_pred             cCccCCCcCccCHHHHhc-CCCCchhhhHHHHHHHHHHccCCCCCC-CcCHHHHHHHhhcC-------------------
Confidence            345678999999999987 788999999999999999999999984 33333332222111                   


Q ss_pred             ccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccccc
Q 015374          356 INADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRA  400 (408)
Q Consensus       356 ~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~~~~  400 (408)
                      ........++.++.+++.+||+.||++|||++|+++||||.....
T Consensus       235 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~  279 (303)
T 3a7i_A          235 NPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILRNAK  279 (303)
T ss_dssp             CCCCCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCHHHHHHCC
T ss_pred             CCCCCccccCHHHHHHHHHHcCCChhhCcCHHHHhhChhhhcCCC
Confidence            011223347899999999999999999999999999999975543

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=2.4e-47  Score=358.25  Aligned_cols=265  Identities=20%  Similarity=0.360  Sum_probs=190.6

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc----chHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccE
Q 015374          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS  198 (408)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  198 (408)
                      ..++|++.+.||+|+||+||+|++..+++.||||+++..    ..+.+.+|+.+++++ +||||+++++++...  ...+
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~--~~~~   89 (303)
T 2vwi_A           13 NRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQC-HHPNIVSYYTSFVVK--DELW   89 (303)
T ss_dssp             CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCC-CCTTBCCEEEEEESS--SCEE
T ss_pred             chhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhc-CCCCEeeEEEEEeec--CCcE
Confidence            478999999999999999999999889999999998642    345678999999999 999999999999654  5688


Q ss_pred             EEEEeecCCChhhhcC-----------CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccc
Q 015374          199 LIFEYVNSTDFKVLYP-----------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA  267 (408)
Q Consensus       199 lv~e~~~~~~l~~~~~-----------~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a  267 (408)
                      +||||+++++|..++.           .+++..+..++.|++.||.|||++||+|+||||+||+++.+ +.+||+|||++
T Consensus        90 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~-~~~kl~dfg~~  168 (303)
T 2vwi_A           90 LVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGED-GSVQIADFGVS  168 (303)
T ss_dssp             EEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTT-CCEEECCCHHH
T ss_pred             EEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCC-CCEEEEeccch
Confidence            9999999999988763           38999999999999999999999999999999999999988 79999999998


Q ss_pred             eeccCCC------cceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhh
Q 015374          268 EFYHPGK------EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLII  341 (408)
Q Consensus       268 ~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~  341 (408)
                      .......      ......+|..|+|||++.+...++.++||||||+++|+|++|..||... +..+.........    
T Consensus       169 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~-~~~~~~~~~~~~~----  243 (303)
T 2vwi_A          169 AFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKY-PPMKVLMLTLQND----  243 (303)
T ss_dssp             HHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTS-CGGGHHHHHHTSS----
T ss_pred             heeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccC-chhhHHHHHhccC----
Confidence            7654322      1234578999999999876456899999999999999999999998433 3323222222110    


Q ss_pred             hhcCCCCCCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccccccch
Q 015374          342 WCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAE  402 (408)
Q Consensus       342 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~~~~~~  402 (408)
                            ................+++++.+++.+||+.||++|||++|+++||||++....+
T Consensus       244 ------~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~~  298 (303)
T 2vwi_A          244 ------PPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAKNKE  298 (303)
T ss_dssp             ------CCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC-------
T ss_pred             ------CCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhcCCCCc
Confidence                  0000011112223345789999999999999999999999999999999887654

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=1.6e-46  Score=365.81  Aligned_cols=252  Identities=25%  Similarity=0.426  Sum_probs=200.8

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc-----chHHHHHHHHHHHHhcC-CCCceEEeeEEEccCCCcc
Q 015374          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCG-GPNVVKLLDIVRDQHSKTP  197 (408)
Q Consensus       124 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~-h~niv~l~~~~~~~~~~~~  197 (408)
                      ..+|++.+.||+|+||+||+|.+.. ++.||||+++..     ....+.+|+.+++++.+ |+||+++++++..  ....
T Consensus        55 ~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~--~~~~  131 (390)
T 2zmd_A           55 GRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT--DQYI  131 (390)
T ss_dssp             TEEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC--SSEE
T ss_pred             CCceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEec--CCEE
Confidence            5679999999999999999998754 889999998532     23678899999999943 6999999999965  4568


Q ss_pred             EEEEEeecCCChhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCCC
Q 015374          198 SLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK  274 (408)
Q Consensus       198 ~lv~e~~~~~~l~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~~  274 (408)
                      ++||| +.+++|..++   ..+++..+..++.||+.||.|||++||+||||||+|||+++  +.+||+|||+++......
T Consensus       132 ~lv~E-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~--~~~kl~DFG~a~~~~~~~  208 (390)
T 2zmd_A          132 YMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD--GMLKLIDFGIANQMQPDT  208 (390)
T ss_dssp             EEEEE-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEESS--SCEEECCCSSSCCC----
T ss_pred             EEEEe-cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEEC--CeEEEEecCccccccCCC
Confidence            99999 5677887776   45888899999999999999999999999999999999964  689999999998765432


Q ss_pred             c---ceeeccCccccccccccC----------CcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhh
Q 015374          275 E---YNVRVASRYFKGPELLVD----------LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLII  341 (408)
Q Consensus       275 ~---~~~~~~~~~y~aPE~~~~----------~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~  341 (408)
                      .   ....+||+.|+|||++.+          ...++.++|||||||++|||++|..||....+....+..+....    
T Consensus       209 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~----  284 (390)
T 2zmd_A          209 TSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPN----  284 (390)
T ss_dssp             -----CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCTT----
T ss_pred             ccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCcc----
Confidence            2   234679999999999864          13688999999999999999999999854433333443333210    


Q ss_pred             hhcCCCCCCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccccc
Q 015374          342 WCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVR  399 (408)
Q Consensus       342 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~~~  399 (408)
                                    .....+...+.++.+||.+||+.||++|||+.|+|+||||+...
T Consensus       285 --------------~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~~  328 (390)
T 2zmd_A          285 --------------HEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT  328 (390)
T ss_dssp             --------------SCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCC
T ss_pred             --------------ccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhCcCccccC
Confidence                          01112233578999999999999999999999999999997543

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.6e-46  Score=359.68  Aligned_cols=251  Identities=25%  Similarity=0.433  Sum_probs=199.4

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc-----chHHHHHHHHHHHHhcCC--CCceEEeeEEEccCCC
Q 015374          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGG--PNVVKLLDIVRDQHSK  195 (408)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h--~niv~l~~~~~~~~~~  195 (408)
                      ..++|++.+.||+|+||+||+|.+ .+++.||||+++..     ..+.+.+|+.++.++ +|  +||+++++++.+  ..
T Consensus         7 ~~~~y~i~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~~~iv~~~~~~~~--~~   82 (343)
T 3dbq_A            7 KGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKL-QQHSDKIIRLYDYEIT--DQ   82 (343)
T ss_dssp             SSCEEEEEEEESCCSSEEEEEEEC-TTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHH-TTTCTTBCCEEEEEEC--SS
T ss_pred             ecCEEEEEEEEecCCCeEEEEEEe-CCCCEEEEEEeeccccchHHHHHHHHHHHHHHhh-hhcCCceEEEeeeEee--CC
Confidence            467899999999999999999986 56889999998632     236688999999999 55  999999999965  46


Q ss_pred             ccEEEEEeecCCChhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccC
Q 015374          196 TPSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP  272 (408)
Q Consensus       196 ~~~lv~e~~~~~~l~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~  272 (408)
                      ..++||| +.+++|..++   ..+++..+..++.|++.||.|||++||+||||||+|||+++  +.+||+|||+++....
T Consensus        83 ~~~lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~~--~~~kl~DFG~a~~~~~  159 (343)
T 3dbq_A           83 YIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD--GMLKLIDFGIANQMQP  159 (343)
T ss_dssp             EEEEEEC-CCSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEET--TEEEECCCSSSCCC--
T ss_pred             EEEEEEe-CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEEC--CcEEEeecccccccCc
Confidence            8899999 5667887776   46899999999999999999999999999999999999984  5899999999987654


Q ss_pred             CCc---ceeeccCccccccccccC----------CcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhch
Q 015374          273 GKE---YNVRVASRYFKGPELLVD----------LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCL  339 (408)
Q Consensus       273 ~~~---~~~~~~~~~y~aPE~~~~----------~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~  339 (408)
                      ...   .....||+.|+|||++.+          ...++.++|||||||++|+|++|+.||....+....+..+....  
T Consensus       160 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~--  237 (343)
T 3dbq_A          160 DTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPN--  237 (343)
T ss_dssp             ----------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTT--
T ss_pred             ccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhcCC--
Confidence            322   235679999999999853          25688999999999999999999999854333333333332210  


Q ss_pred             hhhhcCCCCCCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccc
Q 015374          340 IIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQV  398 (408)
Q Consensus       340 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~~  398 (408)
                                      .....+...+.++.+|+.+||+.||++|||+.|+|+||||+..
T Consensus       238 ----------------~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~  280 (343)
T 3dbq_A          238 ----------------HEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ  280 (343)
T ss_dssp             ----------------SCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSC
T ss_pred             ----------------cccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCcccccc
Confidence                            1112233357899999999999999999999999999999743

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=1.1e-46  Score=353.28  Aligned_cols=259  Identities=25%  Similarity=0.395  Sum_probs=204.8

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc--chHHHHHHHHHHHHhcCCCCceEEeeEEEcc---------
Q 015374          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV--KKKKIKREIKILQNLCGGPNVVKLLDIVRDQ---------  192 (408)
Q Consensus       124 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~---------  192 (408)
                      .++|++.+.||+|+||+||+|++..+++.||||+++..  ..+.+.+|+.+++++ +||||+++++++.+.         
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~~~~~   83 (303)
T 1zy4_A            5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASL-NHQYVVRYYAAWLERRNFVKPMTA   83 (303)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEEECCCCCC----
T ss_pred             cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccHHHHHHHHHHHHHHHhc-CchHHHHHHHHHHhhcchhhhhcc
Confidence            46799999999999999999999999999999998643  346788999999999 999999999988653         


Q ss_pred             --CCCccEEEEEeecCCChhhhcC----CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEeccc
Q 015374          193 --HSKTPSLIFEYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGL  266 (408)
Q Consensus       193 --~~~~~~lv~e~~~~~~l~~~~~----~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~  266 (408)
                        .....++||||+++++|..++.    .+++..+..++.|++.||.|||++||+|+||||+|||++.+ +.+||+|||+
T Consensus        84 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~-~~~kl~dfg~  162 (303)
T 1zy4_A           84 VKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDES-RNVKIGDFGL  162 (303)
T ss_dssp             --CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTT-SCEEECCCCC
T ss_pred             cccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCC-CCEEEeeCcc
Confidence              2356889999999999998873    36778899999999999999999999999999999999988 7899999999


Q ss_pred             ceeccCC---------------CcceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHH
Q 015374          267 AEFYHPG---------------KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV  331 (408)
Q Consensus       267 a~~~~~~---------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~  331 (408)
                      +......               .......++..|+|||++.+...++.++|||||||++|+|++   ||..+.+..+...
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~~~~  239 (303)
T 1zy4_A          163 AKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVNILK  239 (303)
T ss_dssp             CSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHHH
T ss_pred             hhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHHHHHH
Confidence            9765422               122345788999999999875579999999999999999998   6543322222222


Q ss_pred             HHHhhhchhhhhcCCCCCCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccccccchh
Q 015374          332 KIAKDCCLIIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAES  403 (408)
Q Consensus       332 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~~~~~~~  403 (408)
                      .+...            ...    .+.......++.+.+++.+||+.||++|||++|+++||||+...+.+.
T Consensus       240 ~~~~~------------~~~----~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~~~  295 (303)
T 1zy4_A          240 KLRSV------------SIE----FPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVKHQDEV  295 (303)
T ss_dssp             HHHST------------TCC----CCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSCCCCHHHH
T ss_pred             hcccc------------ccc----cCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcCCCChHHH
Confidence            22111            000    112233446788999999999999999999999999999987766543

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=2.6e-46  Score=356.47  Aligned_cols=270  Identities=23%  Similarity=0.463  Sum_probs=209.5

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEE-cCCCcEEEEEEecccc--hHHHHHHHHHHHHhcCCC------CceEEeeEEEccC
Q 015374          123 DQDDYEVVRKVGRGKYSEVFEGIN-VNTNERCIIKILKPVK--KKKIKREIKILQNLCGGP------NVVKLLDIVRDQH  193 (408)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~Vy~~~~-~~~~~~vavK~~~~~~--~~~~~~E~~~l~~l~~h~------niv~l~~~~~~~~  193 (408)
                      ..++|++.+.||+|+||+||+|.+ ..+++.||||+++...  .+.+.+|+.+++.+ +|+      +++++++++.+  
T Consensus        12 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l-~~~~~~~~~~i~~~~~~~~~--   88 (339)
T 1z57_A           12 LSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHL-NTTDPNSTFRCVQMLEWFEH--   88 (339)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSHHHHHHHHHHHHHHHHH-HHHCTTCTTCBCCEEEEEEE--
T ss_pred             ccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCCchhHHHHHHHHHHHHh-hhcCCCCceeeEeeeccccc--
Confidence            467999999999999999999998 5688999999997533  46788999999988 554      59999999965  


Q ss_pred             CCccEEEEEeecCCChhhhcC-----CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCC-------------
Q 015374          194 SKTPSLIFEYVNSTDFKVLYP-----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE-------------  255 (408)
Q Consensus       194 ~~~~~lv~e~~~~~~l~~~~~-----~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~-------------  255 (408)
                      ....++||||+ ++++..++.     .+++..+..++.|++.||+|||++||+||||||+|||++.+             
T Consensus        89 ~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~  167 (339)
T 1z57_A           89 HGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRD  167 (339)
T ss_dssp             TTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC----CE
T ss_pred             CCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCccccc
Confidence            46889999999 667766652     47899999999999999999999999999999999999873             


Q ss_pred             -----CCcEEEEecccceeccCCCcceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHH
Q 015374          256 -----LRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQL  330 (408)
Q Consensus       256 -----~~~~kl~DfG~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~  330 (408)
                           .+.+||+|||++.....  ......||..|+|||++.+ ..++.++|||||||++|||++|..|| .+.+..+..
T Consensus       168 ~~~~~~~~~kl~Dfg~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~pf-~~~~~~~~~  243 (339)
T 1z57_A          168 ERTLINPDIKVVDFGSATYDDE--HHSTLVSTRHYRAPEVILA-LGWSQPCDVWSIGCILIEYYLGFTVF-PTHDSKEHL  243 (339)
T ss_dssp             EEEESCCCEEECCCSSCEETTS--CCCSSCSCGGGCCHHHHTT-SCCCTHHHHHHHHHHHHHHHHSSCSC-CCSCHHHHH
T ss_pred             cccccCCCceEeeCcccccCcc--ccccccCCccccChHHhhC-CCCCcchhhHHHHHHHHHHHhCCCCC-CCCChHHHH
Confidence                 25799999999987543  3345678999999999987 78999999999999999999999998 445555555


Q ss_pred             HHHHhhhchhhhhcCCC---------CCCCccccc---------------cccCCCCCCHHHHHHHHHhcccCcCCCCCH
Q 015374          331 VKIAKDCCLIIWCNSRH---------SRKPWSKFI---------------NADNQHLVSPEAIDFLDKLLRYDHQDRLTA  386 (408)
Q Consensus       331 ~~~~~~~~~~~~~~~~~---------~~~~~~~~~---------------~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~  386 (408)
                      ..+....+.........         ....|....               ........++++.+||.+||+.||++|||+
T Consensus       244 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~  323 (339)
T 1z57_A          244 AMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITL  323 (339)
T ss_dssp             HHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCH
T ss_pred             HHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccCH
Confidence            55444433221100000         000010000               001112235779999999999999999999


Q ss_pred             HHHhcCCCcccccc
Q 015374          387 REAMAHPYFAQVRA  400 (408)
Q Consensus       387 ~elL~hp~f~~~~~  400 (408)
                      +|+++||||+.++.
T Consensus       324 ~ell~hp~f~~~~~  337 (339)
T 1z57_A          324 REALKHPFFDLLKK  337 (339)
T ss_dssp             HHHTTSGGGGGGGC
T ss_pred             HHHhcCHHHHHHhc
Confidence            99999999998754

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=4e-47  Score=358.87  Aligned_cols=256  Identities=21%  Similarity=0.349  Sum_probs=205.3

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecccc------hHHHHHHHHHHHHhcCCCCceEEeeEEEccCC--
Q 015374          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK------KKKIKREIKILQNLCGGPNVVKLLDIVRDQHS--  194 (408)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~------~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~--  194 (408)
                      ..++|++.+.||+|+||+||+|++..+++.||||+++...      ...+.+|+.+++++ +||||+++++++.....  
T Consensus        10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~   88 (311)
T 3ork_A           10 LSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAAL-NHPAIVAVYDTGEAETPAG   88 (311)
T ss_dssp             ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCC-CCTTBCCEEEEEEEEETTE
T ss_pred             ecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcC-CCCCcceEEEeeeccCCCC
Confidence            3678999999999999999999999999999999996432      24688999999999 99999999999875432  


Q ss_pred             CccEEEEEeecCCChhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceecc
Q 015374          195 KTPSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH  271 (408)
Q Consensus       195 ~~~~lv~e~~~~~~l~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~  271 (408)
                      ...++||||+++++|..++   ..+++..+..++.|++.||.|||++||+||||||+|||++.+ +.+||+|||++....
T Consensus        89 ~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~-~~~kl~Dfg~a~~~~  167 (311)
T 3ork_A           89 PLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISAT-NAVKVMDFGIARAIA  167 (311)
T ss_dssp             EEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETT-SCEEECCCSCC----
T ss_pred             cccEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCC-CCEEEeeccCccccc
Confidence            2458999999999999887   458999999999999999999999999999999999999988 799999999997664


Q ss_pred             CCC----cceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCC
Q 015374          272 PGK----EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRH  347 (408)
Q Consensus       272 ~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (408)
                      ...    ......||..|+|||++.+ ..++.++|||||||++|+|++|+.|| .+.+..+...........        
T Consensus       168 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~~l~~ll~g~~pf-~~~~~~~~~~~~~~~~~~--------  237 (311)
T 3ork_A          168 DSGNSVTQTAAVIGTAQYLSPEQARG-DSVDARSDVYSLGCVLYEVLTGEPPF-TGDSPVSVAYQHVREDPI--------  237 (311)
T ss_dssp             --------------CCTTCCHHHHHT-CCCCHHHHHHHHHHHHHHHHHSSCSC-CCSSHHHHHHHHHHCCCC--------
T ss_pred             ccccccccccccCcCcccCCHHHhcC-CCCCchHhHHHHHHHHHHHHhCCCCC-CCCChHHHHHHHhcCCCC--------
Confidence            332    2233568999999999987 78999999999999999999999998 344433433333322110        


Q ss_pred             CCCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccc
Q 015374          348 SRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQV  398 (408)
Q Consensus       348 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~~  398 (408)
                              ........+++++.+++.+||+.||++||++.+++.|+|++..
T Consensus       238 --------~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~  280 (311)
T 3ork_A          238 --------PPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH  280 (311)
T ss_dssp             --------CHHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred             --------CcccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHh
Confidence                    0111223478999999999999999999999999999998743

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=5.6e-46  Score=351.13  Aligned_cols=256  Identities=25%  Similarity=0.420  Sum_probs=208.5

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc-chHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccEEEE
Q 015374          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIF  201 (408)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~  201 (408)
                      ..++|++.+.||+|+||+||+|++..+++.||+|.++.. ....+.+|+.+++++ +||||+++++++.+  ....++||
T Consensus        27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~~~lv~  103 (314)
T 3com_A           27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIKEISIMQQC-DSPHVVKYYGSYFK--NTDLWIVM  103 (314)
T ss_dssp             ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSCCHHHHHHHHHHHTC-CCTTBCCEEEEEEE--TTEEEEEE
T ss_pred             chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHHHHHHHHHHHHHHhC-CCCCCccEEEEEEe--CCEEEEEe
Confidence            467899999999999999999999999999999998743 357789999999999 99999999999965  46788999


Q ss_pred             EeecCCChhhhc----CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCCC-cc
Q 015374          202 EYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK-EY  276 (408)
Q Consensus       202 e~~~~~~l~~~~----~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~~-~~  276 (408)
                      ||+++++|..++    ..+++..+..++.|++.||.|||+.||+|+||||+||+++.+ +.+||+|||++....... ..
T Consensus       104 e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~-~~~kl~dfg~~~~~~~~~~~~  182 (314)
T 3com_A          104 EYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTE-GHAKLADFGVAGQLTDTMAKR  182 (314)
T ss_dssp             ECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT-CCEEECCCTTCEECBTTBSCB
T ss_pred             ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCC-CCEEEeecccchhhhhhcccc
Confidence            999999998876    358999999999999999999999999999999999999988 799999999997765432 23


Q ss_pred             eeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCCCccccc
Q 015374          277 NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSKFI  356 (408)
Q Consensus       277 ~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  356 (408)
                      ....++..|+|||++.+ ..++.++||||||+++|+|++|..||.. .+..+....+....         ..        
T Consensus       183 ~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~-~~~~~~~~~~~~~~---------~~--------  243 (314)
T 3com_A          183 NTVIGTPFWMAPEVIQE-IGYNCVADIWSLGITAIEMAEGKPPYAD-IHPMRAIFMIPTNP---------PP--------  243 (314)
T ss_dssp             CCCCSCGGGCCHHHHSS-SCBCTTHHHHHHHHHHHHHHHSSCTTTT-SCHHHHHHHHHHSC---------CC--------
T ss_pred             CccCCCCCccChhhcCC-CCCCccccHHHHHHHHHHHHhCCCCCCC-CChHHHHHHHhcCC---------Cc--------
Confidence            45678999999999987 6799999999999999999999999843 33223222221110         00        


Q ss_pred             cccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccccccc
Q 015374          357 NADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAA  401 (408)
Q Consensus       357 ~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~~~~~  401 (408)
                      ....+..+++++.+++.+||..||++|||++++++||||+.....
T Consensus       244 ~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~~~~~~~~~~  288 (314)
T 3com_A          244 TFRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQHPFVRSAKGV  288 (314)
T ss_dssp             CCSSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHTCCCG
T ss_pred             ccCCcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhcCCcc
Confidence            011123368999999999999999999999999999999987643

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=2.7e-46  Score=351.72  Aligned_cols=254  Identities=26%  Similarity=0.446  Sum_probs=206.4

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc-------chHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCc
Q 015374          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT  196 (408)
Q Consensus       124 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  196 (408)
                      .++|++.+.||+|+||.||+|.+..++..||+|+++..       ....+.+|+.+++++ +||||+++++++.+.....
T Consensus         4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~   82 (305)
T 2wtk_C            4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRL-RHKNVIQLVDVLYNEEKQK   82 (305)
T ss_dssp             -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTC-CCTTBCCEEEEEECC---C
T ss_pred             ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhc-CCCCeeEEEEEEEcCCCCe
Confidence            46799999999999999999999999999999999643       246788999999999 9999999999997666678


Q ss_pred             cEEEEEeecCCChhhhc----CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccC
Q 015374          197 PSLIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP  272 (408)
Q Consensus       197 ~~lv~e~~~~~~l~~~~----~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~  272 (408)
                      .++||||++++....+.    ..+++..+..++.|++.||.|||++||+||||||+|||++.+ +.+||+|||++.....
T Consensus        83 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~-~~~kl~dfg~~~~~~~  161 (305)
T 2wtk_C           83 MYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTG-GTLKISALGVAEALHP  161 (305)
T ss_dssp             EEEEEECCSEEHHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTT-CCEEECCCTTCEECCT
T ss_pred             EEEEehhccCCHHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCC-CcEEeeccccccccCc
Confidence            89999999988333222    358999999999999999999999999999999999999988 7999999999987643


Q ss_pred             C---CcceeeccCccccccccccCC-cCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCC
Q 015374          273 G---KEYNVRVASRYFKGPELLVDL-QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHS  348 (408)
Q Consensus       273 ~---~~~~~~~~~~~y~aPE~~~~~-~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  348 (408)
                      .   .......++..|+|||++.+. ..++.++||||||+++|+|++|..||. +.+..+....+...            
T Consensus       162 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~-~~~~~~~~~~i~~~------------  228 (305)
T 2wtk_C          162 FAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFE-GDNIYKLFENIGKG------------  228 (305)
T ss_dssp             TCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCC-CSSHHHHHHHHHHC------------
T ss_pred             cccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCC-CchHHHHHHHHhcC------------
Confidence            2   223445789999999998762 234789999999999999999999984 33333333332221            


Q ss_pred             CCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccccc
Q 015374          349 RKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRA  400 (408)
Q Consensus       349 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~~~~  400 (408)
                              ....+..+++++.+|+.+||+.||++|||++|+++||||+....
T Consensus       229 --------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~  272 (305)
T 2wtk_C          229 --------SYAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHP  272 (305)
T ss_dssp             --------CCCCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSCCC
T ss_pred             --------CCCCCCccCHHHHHHHHHHccCChhhCCCHHHHhcCcccccCCC
Confidence                    01123347899999999999999999999999999999986654

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=3.9e-46  Score=349.43  Aligned_cols=258  Identities=21%  Similarity=0.344  Sum_probs=204.5

Q ss_pred             ccCCCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecc------cchHHHHHHHHHHHHhcCCCCceEEeeEEEccC
Q 015374          120 QWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP------VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQH  193 (408)
Q Consensus       120 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~------~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~  193 (408)
                      +....++|++.+.||+|+||+||+|++..++..||+|++..      ...+.+.+|+.+++++ +||||+++++++.+  
T Consensus         6 g~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~--   82 (294)
T 4eqm_A            6 GKIINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQL-SHQNIVSMIDVDEE--   82 (294)
T ss_dssp             SSCEETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTC-CBTTBCCEEEEEEC--
T ss_pred             hhHhhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcC-CCCCCceEEEeeee--
Confidence            33457899999999999999999999999999999999842      2236788999999999 99999999999954  


Q ss_pred             CCccEEEEEeecCCChhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceec
Q 015374          194 SKTPSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY  270 (408)
Q Consensus       194 ~~~~~lv~e~~~~~~l~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~  270 (408)
                      ....++||||+++++|..++   ..+++..+..++.|++.||.|||++||+||||||+|||++.+ +.+||+|||++...
T Consensus        83 ~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~-~~~kl~Dfg~~~~~  161 (294)
T 4eqm_A           83 DDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSN-KTLKIFDFGIAKAL  161 (294)
T ss_dssp             SSEEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT-SCEEECCCSSSTTC
T ss_pred             CCeEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCC-CCEEEEeCCCcccc
Confidence            56789999999999999887   458999999999999999999999999999999999999988 79999999999765


Q ss_pred             cCCC--cceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCC
Q 015374          271 HPGK--EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHS  348 (408)
Q Consensus       271 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  348 (408)
                      ....  ......||+.|+|||.+.+ ..++.++||||||+++|+|++|+.||. +.+..+..........          
T Consensus       162 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~~l~~ll~g~~pf~-~~~~~~~~~~~~~~~~----------  229 (294)
T 4eqm_A          162 SETSLTQTNHVLGTVQYFSPEQAKG-EATDECTDIYSIGIVLYEMLVGEPPFN-GETAVSIAIKHIQDSV----------  229 (294)
T ss_dssp             -------------CCSSCCHHHHHT-CCCCTTHHHHHHHHHHHHHHHSSCSSC-SSCHHHHHHHHHSSCC----------
T ss_pred             ccccccccCccccCccccCHhHhcC-CCCCchHhHHHHHHHHHHHHhCCCCCC-CCChHHHHHHHhhccC----------
Confidence            4332  2234578999999999987 778999999999999999999999983 3333333222222100          


Q ss_pred             CCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccc
Q 015374          349 RKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQV  398 (408)
Q Consensus       349 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~~  398 (408)
                       .    .........+++.+.+++.+||+.||++||+..+.+.+.|.+-.
T Consensus       230 -~----~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~  274 (294)
T 4eqm_A          230 -P----NVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVL  274 (294)
T ss_dssp             -C----CHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSS
T ss_pred             -C----CcchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHH
Confidence             0    01122334578999999999999999999966666666664433

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=6.3e-46  Score=357.36  Aligned_cols=248  Identities=20%  Similarity=0.333  Sum_probs=204.2

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEE-----EcCCCcEEEEEEeccc----chHHHHHHHHHHHHhcCCCCceEEeeEEEccC
Q 015374          123 DQDDYEVVRKVGRGKYSEVFEGI-----NVNTNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQH  193 (408)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~Vy~~~-----~~~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~  193 (408)
                      ..++|++.+.||+|+||.||+|+     +..+++.||||+++..    ..+.+.+|+.++.++.+||||++++++|.+. 
T Consensus        20 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~-   98 (359)
T 3vhe_A           20 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP-   98 (359)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST-
T ss_pred             cccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecC-
Confidence            57899999999999999999998     4566789999999743    2356889999999998899999999999654 


Q ss_pred             CCccEEEEEeecCCChhhhcCC----------------------------------------------------------
Q 015374          194 SKTPSLIFEYVNSTDFKVLYPT----------------------------------------------------------  215 (408)
Q Consensus       194 ~~~~~lv~e~~~~~~l~~~~~~----------------------------------------------------------  215 (408)
                      +...++||||+++++|..++..                                                          
T Consensus        99 ~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  178 (359)
T 3vhe_A           99 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEE  178 (359)
T ss_dssp             TSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-------------------------------------------------
T ss_pred             CCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhh
Confidence            3458899999999999888632                                                          


Q ss_pred             -----------CChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCCCc---ceeecc
Q 015374          216 -----------LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE---YNVRVA  281 (408)
Q Consensus       216 -----------l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~~~---~~~~~~  281 (408)
                                 +++..+..++.|++.||.|||++||+||||||+|||++.+ +.+||+|||++........   .....+
T Consensus       179 ~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~-~~~kl~Dfg~a~~~~~~~~~~~~~~~~~  257 (359)
T 3vhe_A          179 EEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEK-NVVKICDFGLARDIYKDPDYVRKGDARL  257 (359)
T ss_dssp             -----CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGG-GCEEECCCGGGSCTTSCTTCEEC--CEE
T ss_pred             cccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCC-CcEEEEeccceeeecccccchhccccCC
Confidence                       7888999999999999999999999999999999999988 7899999999986643322   234567


Q ss_pred             CccccccccccCCcCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCCCccccccccC
Q 015374          282 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSKFINADN  360 (408)
Q Consensus       282 ~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  360 (408)
                      |..|+|||++.+ ..++.++|||||||++|||++ |..||............+...                   .....
T Consensus       258 t~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~-------------------~~~~~  317 (359)
T 3vhe_A          258 PLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEG-------------------TRMRA  317 (359)
T ss_dssp             CGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHT-------------------CCCCC
T ss_pred             CceeEChhhhcC-CCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcC-------------------CCCCC
Confidence            888999999987 789999999999999999998 998884444343333332221                   11122


Q ss_pred             CCCCCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 015374          361 QHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH  392 (408)
Q Consensus       361 ~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~h  392 (408)
                      +..+++++.+++.+||+.||++|||++|+++|
T Consensus       318 ~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  349 (359)
T 3vhe_A          318 PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  349 (359)
T ss_dssp             CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCCCHHHHHHHHHHccCChhhCCCHHHHHHH
Confidence            34478999999999999999999999999986

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=2e-45  Score=347.09  Aligned_cols=250  Identities=19%  Similarity=0.355  Sum_probs=197.0

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc-----chHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCcc
Q 015374          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP  197 (408)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~  197 (408)
                      ..++|++.+.||+|+||+||+|++  ++..||||++...     ..+.+.+|+.+++++ +||||+++++++.+  ....
T Consensus        35 ~~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~--~~~~  109 (309)
T 3p86_A           35 PWCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRL-RHPNIVLFMGAVTQ--PPNL  109 (309)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHC-CCTTBCCEEEEECS--TTCC
T ss_pred             ChhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEEE--CCce
Confidence            467899999999999999999976  5888999998643     235688999999999 89999999999954  4678


Q ss_pred             EEEEEeecCCChhhhcCC------CChHHHHHHHHHHHHHHHHHHHCC--cEEecCCCCcEEEeCCCCcEEEEeccccee
Q 015374          198 SLIFEYVNSTDFKVLYPT------LTDYDIRYYIYELLKALDYCHSQG--IMHRDVKPHNVMIDHELRKLRLIDWGLAEF  269 (408)
Q Consensus       198 ~lv~e~~~~~~l~~~~~~------l~~~~~~~i~~qi~~~L~~LH~~~--iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~  269 (408)
                      ++||||+++++|..++..      +++..+..++.|++.||.|||++|  |+||||||+|||++.+ +.+||+|||+++.
T Consensus       110 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~-~~~kL~Dfg~a~~  188 (309)
T 3p86_A          110 SIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKK-YTVKVCDFGLSRL  188 (309)
T ss_dssp             EEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTT-CCEEECCCC----
T ss_pred             EEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCC-CcEEECCCCCCcc
Confidence            899999999999988743      889999999999999999999999  9999999999999988 7999999999976


Q ss_pred             ccCCC-cceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCC
Q 015374          270 YHPGK-EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHS  348 (408)
Q Consensus       270 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  348 (408)
                      ..... ......||..|+|||++.+ ..++.++|||||||++|+|++|+.||. +.+..+....+....           
T Consensus       189 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~Pf~-~~~~~~~~~~~~~~~-----------  255 (309)
T 3p86_A          189 KASTFLSSKSAAGTPEWMAPEVLRD-EPSNEKSDVYSFGVILWELATLQQPWG-NLNPAQVVAAVGFKC-----------  255 (309)
T ss_dssp             -------------CCTTSCHHHHTT-CCCCTTHHHHHHHHHHHHHHHCCCTTT-TSCHHHHHHHHHHSC-----------
T ss_pred             ccccccccccCCCCccccChhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCC-CCCHHHHHHHHHhcC-----------
Confidence            54332 2345678999999999987 778999999999999999999999983 333333333222110           


Q ss_pred             CCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhc--CCCcccc
Q 015374          349 RKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA--HPYFAQV  398 (408)
Q Consensus       349 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~--hp~f~~~  398 (408)
                             .....+..+++++.+++.+||+.||++|||++|+++  .++++..
T Consensus       256 -------~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~  300 (309)
T 3p86_A          256 -------KRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSA  300 (309)
T ss_dssp             -------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC--
T ss_pred             -------CCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhC
Confidence                   112233457899999999999999999999999987  5666544

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=7.1e-46  Score=347.04  Aligned_cols=254  Identities=22%  Similarity=0.371  Sum_probs=200.7

Q ss_pred             EeeeeeeCceEEEEEEEcCCCcEEEEEEeccc---chHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccEEEEEeecC
Q 015374          130 VRKVGRGKYSEVFEGINVNTNERCIIKILKPV---KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNS  206 (408)
Q Consensus       130 ~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~~  206 (408)
                      ...||+|+||+||+|++..++..||+|.++..   ..+.+.+|+.+++.+ +||||+++++++.+  ....++||||+++
T Consensus        27 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~--~~~~~lv~e~~~~  103 (295)
T 2clq_A           27 RVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHL-KHKNIVQYLGSFSE--NGFIKIFMEQVPG  103 (295)
T ss_dssp             BCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTC-CCTTBCCEEEEEEE--TTEEEEEEECCSE
T ss_pred             cEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhC-CCCCEeeEeeEEEe--CCcEEEEEEeCCC
Confidence            44799999999999999999999999998643   246788999999999 99999999999965  4678899999999


Q ss_pred             CChhhhcC------CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCCC-cceee
Q 015374          207 TDFKVLYP------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK-EYNVR  279 (408)
Q Consensus       207 ~~l~~~~~------~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~~-~~~~~  279 (408)
                      ++|..++.      .+++..+..++.|++.||.|||++||+|+||||+||+++.+.+.+||+|||++....... .....
T Consensus       104 ~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~  183 (295)
T 2clq_A          104 GSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETF  183 (295)
T ss_dssp             EEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC-----CCC
T ss_pred             CCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeecccccccCCCCCccccc
Confidence            99988873      356888889999999999999999999999999999999844899999999998765432 23445


Q ss_pred             ccCccccccccccCC-cCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCCCccccccc
Q 015374          280 VASRYFKGPELLVDL-QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSKFINA  358 (408)
Q Consensus       280 ~~~~~y~aPE~~~~~-~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  358 (408)
                      .|+..|+|||++.+. ..++.++||||||+++|+|++|+.||................                  ....
T Consensus       184 ~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~------------------~~~~  245 (295)
T 2clq_A          184 TGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMF------------------KVHP  245 (295)
T ss_dssp             CCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHH------------------CCCC
T ss_pred             CCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccc------------------cccc
Confidence            789999999999752 247899999999999999999999985333222222111110                  0112


Q ss_pred             cCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccccccchhh
Q 015374          359 DNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAESS  404 (408)
Q Consensus       359 ~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~~~~~~~~  404 (408)
                      ..+..+++++.+++.+||+.||++|||++|+|+||||+........
T Consensus       246 ~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~~~~  291 (295)
T 2clq_A          246 EIPESMSAEAKAFILKCFEPDPDKRACANDLLVDEFLKVSSKKKKT  291 (295)
T ss_dssp             CCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTSGGGCC-------
T ss_pred             cccccCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhhccccCCC
Confidence            2334578999999999999999999999999999999977654443

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=9.5e-46  Score=349.13  Aligned_cols=253  Identities=19%  Similarity=0.316  Sum_probs=206.6

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecc---cchHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccEE
Q 015374          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP---VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSL  199 (408)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~---~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l  199 (408)
                      ..++|++.+.||+|+||+||+|++..+++.||+|++..   ...+.+.+|+.+++++ +||||+++++++.+  ....++
T Consensus         8 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~--~~~~~l   84 (310)
T 3s95_A            8 RPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCL-EHPNVLKFIGVLYK--DKRLNF   84 (310)
T ss_dssp             CGGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEEE--TTEEEE
T ss_pred             ChhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhC-CCcCcccEEEEEec--CCeeEE
Confidence            46889999999999999999999999999999998854   3356788999999999 89999999999965  467889


Q ss_pred             EEEeecCCChhhhc----CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCCCc
Q 015374          200 IFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE  275 (408)
Q Consensus       200 v~e~~~~~~l~~~~----~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~~~  275 (408)
                      ||||+++++|..++    ..+++..+..++.|++.||.|||++||+||||||+|||++.+ +.+||+|||++........
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~-~~~kl~Dfg~~~~~~~~~~  163 (310)
T 3s95_A           85 ITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVREN-KNVVVADFGLARLMVDEKT  163 (310)
T ss_dssp             EEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTT-SCEEECCCTTCEECC----
T ss_pred             EEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCC-CCEEEeecccceecccccc
Confidence            99999999999887    358999999999999999999999999999999999999988 7899999999987643322


Q ss_pred             c---------------eeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchh
Q 015374          276 Y---------------NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLI  340 (408)
Q Consensus       276 ~---------------~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~  340 (408)
                      .               ....||+.|+|||++.+ ..++.++||||||+++|+|++|..||...........         
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~---------  233 (310)
T 3s95_A          164 QPEGLRSLKKPDRKKRYTVVGNPYWMAPEMING-RSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFG---------  233 (310)
T ss_dssp             ----------------CCCCSCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSS---------
T ss_pred             cccccccccccccccccccCCCcceeCHHHhcC-CCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHh---------
Confidence            1               14578999999999987 7899999999999999999999988743221110000         


Q ss_pred             hhhcCCCCCCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccccc
Q 015374          341 IWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRA  400 (408)
Q Consensus       341 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~~~~  400 (408)
                               ...........+..+++++.+++.+||+.||++|||++|+++  ||+.+..
T Consensus       234 ---------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~--~L~~l~~  282 (310)
T 3s95_A          234 ---------LNVRGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEH--WLETLRM  282 (310)
T ss_dssp             ---------BCHHHHHHHTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHH--HHHHHHH
T ss_pred             ---------hhhhccccccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH--HHHHHHH
Confidence                     000001112223457889999999999999999999999987  6665543

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=1.4e-45  Score=350.59  Aligned_cols=245  Identities=16%  Similarity=0.305  Sum_probs=200.9

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCc---EEEEEEeccc----chHHHHHHHHHHHHhcCCCCceEEeeEEEccCCC
Q 015374          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNE---RCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSK  195 (408)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~---~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  195 (408)
                      ..++|++.+.||+|+||+||+|++..++.   .||||+++..    ..+.+.+|+.+++++ +||||++++++|.+  ..
T Consensus        47 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~--~~  123 (325)
T 3kul_A           47 EASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQF-DHPNIIRLEGVVTR--GR  123 (325)
T ss_dssp             CGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEECG--GG
T ss_pred             ChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhC-CCCCCCcEEEEEEe--CC
Confidence            46789999999999999999999886555   5999999743    245788999999999 99999999999954  46


Q ss_pred             ccEEEEEeecCCChhhhc----CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceecc
Q 015374          196 TPSLIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH  271 (408)
Q Consensus       196 ~~~lv~e~~~~~~l~~~~----~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~  271 (408)
                      ..++||||+++++|..++    ..+++..+..++.|++.||.|||++||+||||||+|||++.+ +.+||+|||+++...
T Consensus       124 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~-~~~kl~Dfg~a~~~~  202 (325)
T 3kul_A          124 LAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSN-LVCKVSDFGLSRVLE  202 (325)
T ss_dssp             CCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTT-CCEEECCCSSCEECC
T ss_pred             ccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCC-CCEEECCCCcccccc
Confidence            788999999999999887    358999999999999999999999999999999999999988 799999999998765


Q ss_pred             CCCc----ceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHhhhchhhhhcCC
Q 015374          272 PGKE----YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKDCCLIIWCNSR  346 (408)
Q Consensus       272 ~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  346 (408)
                      ....    .....+|..|+|||++.+ ..++.++|||||||++|+|++ |..|| .+....+....+...          
T Consensus       203 ~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~ell~~g~~p~-~~~~~~~~~~~~~~~----------  270 (325)
T 3kul_A          203 DDPDAAYTTTGGKIPIRWTAPEAIAF-RTFSSASDVWSFGVVMWEVLAYGERPY-WNMTNRDVISSVEEG----------  270 (325)
T ss_dssp             ----CCEECC---CCGGGSCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCTT-TTSCHHHHHHHHHTT----------
T ss_pred             cCccceeeccCCCCcccccCHhHhcC-CCCCcHHHHHHHHHHHHHHHcCCCCCc-ccCCHHHHHHHHHcC----------
Confidence            4322    122345667999999987 679999999999999999999 88887 344444444433321          


Q ss_pred             CCCCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 015374          347 HSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH  392 (408)
Q Consensus       347 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~h  392 (408)
                               .....+..+++++.+++.+||+.||++|||++|+++.
T Consensus       271 ---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~  307 (325)
T 3kul_A          271 ---------YRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSV  307 (325)
T ss_dssp             ---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ---------CCCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence                     1112234478999999999999999999999999863

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=1.7e-45  Score=349.29  Aligned_cols=251  Identities=26%  Similarity=0.415  Sum_probs=208.7

Q ss_pred             cCCCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecccc---------hHHHHHHHHHHHHhc-CCCCceEEeeEEE
Q 015374          121 WGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK---------KKKIKREIKILQNLC-GGPNVVKLLDIVR  190 (408)
Q Consensus       121 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~---------~~~~~~E~~~l~~l~-~h~niv~l~~~~~  190 (408)
                      ....++|++.+.||+|+||+||+|++..+++.||||+++...         ...+.+|+.+++++. .|+||+++++++.
T Consensus        39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~  118 (320)
T 3a99_A           39 EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFE  118 (320)
T ss_dssp             -CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEE
T ss_pred             CCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEe
Confidence            345789999999999999999999999999999999986432         245778999999994 2699999999996


Q ss_pred             ccCCCccEEEEEeecC-CChhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEeccc
Q 015374          191 DQHSKTPSLIFEYVNS-TDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGL  266 (408)
Q Consensus       191 ~~~~~~~~lv~e~~~~-~~l~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~  266 (408)
                      +  ....++|||++.+ ++|..++   ..+++..+..++.|++.||.|||++||+||||||+|||++.+.+.+||+|||+
T Consensus       119 ~--~~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~Dfg~  196 (320)
T 3a99_A          119 R--PDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGS  196 (320)
T ss_dssp             C--SSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTT
T ss_pred             c--CCcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEeeCcc
Confidence            5  4678899999976 8888776   46899999999999999999999999999999999999995448999999999


Q ss_pred             ceeccCCCcceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCC
Q 015374          267 AEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSR  346 (408)
Q Consensus       267 a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  346 (408)
                      +...... ......||..|+|||++.+...++.++|||||||++|||++|+.||...    +.   +...          
T Consensus       197 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~----~~---~~~~----------  258 (320)
T 3a99_A          197 GALLKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD----EE---IIRG----------  258 (320)
T ss_dssp             CEECCSS-CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH----HH---HHHC----------
T ss_pred             ccccccc-cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCCh----hh---hhcc----------
Confidence            9876533 3345678999999999987444578899999999999999999998321    11   1110          


Q ss_pred             CCCCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccccccc
Q 015374          347 HSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAA  401 (408)
Q Consensus       347 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~~~~~  401 (408)
                                ....+..+++++.+|+.+||+.||++|||++|+++||||+++...
T Consensus       259 ----------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~~~  303 (320)
T 3a99_A          259 ----------QVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLP  303 (320)
T ss_dssp             ----------CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCCCH
T ss_pred             ----------cccccccCCHHHHHHHHHHccCChhhCcCHHHHhcCHhhcCccCc
Confidence                      011223478999999999999999999999999999999987653

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=1.4e-45  Score=349.97  Aligned_cols=257  Identities=18%  Similarity=0.331  Sum_probs=190.0

Q ss_pred             CCCCCEEEEeeeeeeCceEEEEEEEcCCCc---EEEEEEeccc-----chHHHHHHHHHHHHhcCCCCceEEeeEEEccC
Q 015374          122 GDQDDYEVVRKVGRGKYSEVFEGINVNTNE---RCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQH  193 (408)
Q Consensus       122 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~---~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~  193 (408)
                      ...++|++.+.||+|+||+||+|++..++.   .||||+++..     ..+.+.+|+.+++++ +||||+++++++....
T Consensus        20 i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~   98 (323)
T 3qup_A           20 IPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEF-DHPHVAKLVGVSLRSR   98 (323)
T ss_dssp             CC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTC-CCTTBCCCCEEEECC-
T ss_pred             cChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHC-CCCceehhhceeeccc
Confidence            457899999999999999999999877765   8999998642     346788999999999 9999999999997543


Q ss_pred             CC----ccEEEEEeecCCChhhhcC---------CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEE
Q 015374          194 SK----TPSLIFEYVNSTDFKVLYP---------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLR  260 (408)
Q Consensus       194 ~~----~~~lv~e~~~~~~l~~~~~---------~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~k  260 (408)
                      ..    ..++||||+.+++|..++.         .+++..+..++.|++.||.|||++||+||||||+|||++.+ +.+|
T Consensus        99 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~-~~~k  177 (323)
T 3qup_A           99 AKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAED-MTVC  177 (323)
T ss_dssp             ------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTT-SCEE
T ss_pred             cccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCC-CCEE
Confidence            22    2389999999999988872         48999999999999999999999999999999999999988 7999


Q ss_pred             EEecccceeccCCCcc---eeeccCccccccccccCCcCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHhh
Q 015374          261 LIDWGLAEFYHPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKD  336 (408)
Q Consensus       261 l~DfG~a~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-g~~pf~~~~~~~~~~~~~~~~  336 (408)
                      |+|||+++........   ....++..|+|||.+.+ ..++.++|||||||++|+|++ |..|| .+.+..+....+...
T Consensus       178 l~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ell~~g~~p~-~~~~~~~~~~~~~~~  255 (323)
T 3qup_A          178 VADFGLSRKIYSGDYYRQGCASKLPVKWLALESLAD-NLYTVHSDVWAFGVTMWEIMTRGQTPY-AGIENAEIYNYLIGG  255 (323)
T ss_dssp             ECCCCC-----------------CCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTT-TTCCGGGHHHHHHTT
T ss_pred             EeeccccccccccccccccccccCcccccCchhhcC-CCCCCccchhhHHHHHHHHHhCCCCCc-cccChHHHHHHHhcC
Confidence            9999999866443322   23456678999999987 779999999999999999999 77776 444444444443322


Q ss_pred             hchhhhhcCCCCCCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCC-------HHHHhcCCCccccccc
Q 015374          337 CCLIIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLT-------AREAMAHPYFAQVRAA  401 (408)
Q Consensus       337 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt-------~~elL~hp~f~~~~~~  401 (408)
                      .                   ....+..+++++.+++.+||+.||++|||       .+++++|||+....+.
T Consensus       256 ~-------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~~~~  308 (323)
T 3qup_A          256 N-------------------RLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLSTSQD  308 (323)
T ss_dssp             C-------------------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC---------
T ss_pred             C-------------------CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCCCCC
Confidence            1                   11223347899999999999999999999       8999999999876553

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=5.4e-46  Score=359.33  Aligned_cols=250  Identities=17%  Similarity=0.288  Sum_probs=203.3

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEE-----EcCCCcEEEEEEeccc----chHHHHHHHHHHHHhcCCCCceEEeeEEEccC
Q 015374          123 DQDDYEVVRKVGRGKYSEVFEGI-----NVNTNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQH  193 (408)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~Vy~~~-----~~~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~  193 (408)
                      ..++|++.+.||+|+||+||+|+     +..++..||||+++..    ....+.+|+.+++++ +||||+++++++.+  
T Consensus        69 ~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~--  145 (367)
T 3l9p_A           69 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKF-NHQNIVRCIGVSLQ--  145 (367)
T ss_dssp             CGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEECS--
T ss_pred             CHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhC-CCCCCCeEEEEEec--
Confidence            46789999999999999999998     4457789999998632    345688999999999 99999999999954  


Q ss_pred             CCccEEEEEeecCCChhhhcC----------CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCC--CCcEEE
Q 015374          194 SKTPSLIFEYVNSTDFKVLYP----------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE--LRKLRL  261 (408)
Q Consensus       194 ~~~~~lv~e~~~~~~l~~~~~----------~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~--~~~~kl  261 (408)
                      ....++||||+++++|..++.          .+++..+..++.|++.||.|||++||+||||||+|||++.+  ...+||
T Consensus       146 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~kL  225 (367)
T 3l9p_A          146 SLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKI  225 (367)
T ss_dssp             SSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEE
T ss_pred             CCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceEEE
Confidence            467789999999999988872          38899999999999999999999999999999999999854  135999


Q ss_pred             EecccceeccCC---CcceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHhhh
Q 015374          262 IDWGLAEFYHPG---KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKDC  337 (408)
Q Consensus       262 ~DfG~a~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-g~~pf~~~~~~~~~~~~~~~~~  337 (408)
                      +|||+++.....   .......+|..|+|||++.+ ..++.++|||||||++|||++ |..|| .+.+..+....+....
T Consensus       226 ~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DvwslG~il~ellt~g~~pf-~~~~~~~~~~~i~~~~  303 (367)
T 3l9p_A          226 GDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFME-GIFTSKTDTWSFGVLLWEIFSLGYMPY-PSKSNQEVLEFVTSGG  303 (367)
T ss_dssp             CCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSS-TTCCHHHHHHHHHTTC
T ss_pred             CCCccccccccccccccCCCcCCcccEECHHHhcC-CCCCcHHHHHHHHHHHHHHHhCCCCCC-CCCCHHHHHHHHHcCC
Confidence            999999754221   22334567889999999987 789999999999999999998 87776 4444444443333211


Q ss_pred             chhhhhcCCCCCCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcc
Q 015374          338 CLIIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFA  396 (408)
Q Consensus       338 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~  396 (408)
                                         ....+..+++++.+++.+||+.||++|||++|++++.++-
T Consensus       304 -------------------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~  343 (367)
T 3l9p_A          304 -------------------RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC  343 (367)
T ss_dssp             -------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -------------------CCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence                               1122344789999999999999999999999999997754

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=1.9e-45  Score=344.55  Aligned_cols=262  Identities=17%  Similarity=0.284  Sum_probs=199.8

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEE----EcCCCcEEEEEEecccc---hHHHHHHHHHHHHhcCCCCceEEeeEEEccCCC
Q 015374          123 DQDDYEVVRKVGRGKYSEVFEGI----NVNTNERCIIKILKPVK---KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSK  195 (408)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~Vy~~~----~~~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  195 (408)
                      ..++|++.++||+|+||+||+|+    +..+++.||||+++...   .+.+.+|+.+++++ +||||++++++|......
T Consensus         8 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~   86 (295)
T 3ugc_A            8 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSL-QHDNIVKYKGVCYSAGRR   86 (295)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEECHHHHT
T ss_pred             CHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEecCCCC
Confidence            57899999999999999999998    56789999999987543   35688999999999 999999999999765556


Q ss_pred             ccEEEEEeecCCChhhhcC----CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceecc
Q 015374          196 TPSLIFEYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH  271 (408)
Q Consensus       196 ~~~lv~e~~~~~~l~~~~~----~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~  271 (408)
                      ..++||||+++++|..++.    .+++..+..++.|++.||.|||++||+||||||+|||++.+ +.+||+|||++....
T Consensus        87 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~-~~~kl~Dfg~~~~~~  165 (295)
T 3ugc_A           87 NLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENE-NRVKIGDFGLTKVLP  165 (295)
T ss_dssp             SCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEET-TEEEECCCCSCC---
T ss_pred             ceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCC-CeEEEccCccccccc
Confidence            7899999999999998873    38999999999999999999999999999999999999988 799999999998765


Q ss_pred             CCCc----ceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCC
Q 015374          272 PGKE----YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRH  347 (408)
Q Consensus       272 ~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (408)
                      ....    .....++..|+|||++.+ ..++.++||||||+++|+|++|..||...   .................... 
T Consensus       166 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~~~~~~---~~~~~~~~~~~~~~~~~~~~-  240 (295)
T 3ugc_A          166 QDKEFFKVKEPGESPIFWYAPESLTE-SKFSVASDVWSFGVVLYELFTYIEKSKSP---PAEFMRMIGNDKQGQMIVFH-  240 (295)
T ss_dssp             ----------CTTCGGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHHTTCTTCSH---HHHHHHHHCTTCCTHHHHHH-
T ss_pred             CCcceeeeccCCCCccceeCcHHhcC-CCCChHHHHHHHHHHHHHHHhcccccCCC---hHHHHhhhcCccccchhHHH-
Confidence            4322    223456677999999987 78999999999999999999999887321   11111111000000000000 


Q ss_pred             CCCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 015374          348 SRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA  391 (408)
Q Consensus       348 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~  391 (408)
                      .............+..+++++.+++.+||+.||++|||++|+++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~  284 (295)
T 3ugc_A          241 LIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL  284 (295)
T ss_dssp             HHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             HHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            00000000112234457899999999999999999999999985

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=6.8e-46  Score=358.86  Aligned_cols=275  Identities=25%  Similarity=0.425  Sum_probs=211.5

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc--chHHHHHHHHHHHHhc----------CCCCceEEeeEEE
Q 015374          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV--KKKKIKREIKILQNLC----------GGPNVVKLLDIVR  190 (408)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~----------~h~niv~l~~~~~  190 (408)
                      ..++|++.+.||+|+||+||+|++..+++.||||+++..  ....+.+|+.+++++.          +|+||+++++++.
T Consensus        17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~   96 (373)
T 1q8y_A           17 KDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN   96 (373)
T ss_dssp             TTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred             cCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence            467999999999999999999999999999999999743  3467889999999883          2899999999997


Q ss_pred             cc--CCCccEEEEEeecCCChhhhc-----CCCChHHHHHHHHHHHHHHHHHHHC-CcEEecCCCCcEEEeCC-----CC
Q 015374          191 DQ--HSKTPSLIFEYVNSTDFKVLY-----PTLTDYDIRYYIYELLKALDYCHSQ-GIMHRDVKPHNVMIDHE-----LR  257 (408)
Q Consensus       191 ~~--~~~~~~lv~e~~~~~~l~~~~-----~~l~~~~~~~i~~qi~~~L~~LH~~-~iiH~Dlk~~NILl~~~-----~~  257 (408)
                      ..  +....++||||+ +++|..++     ..+++..+..++.|++.||.|||++ ||+||||||+|||++.+     .+
T Consensus        97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~~~~~~  175 (373)
T 1q8y_A           97 HKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLI  175 (373)
T ss_dssp             EEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEE
T ss_pred             ccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCCCcCcc
Confidence            54  234788999999 77777765     2489999999999999999999998 99999999999999632     24


Q ss_pred             cEEEEecccceeccCCCcceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCC-----CCHHHHHH
Q 015374          258 KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGH-----DNHDQLVK  332 (408)
Q Consensus       258 ~~kl~DfG~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~-----~~~~~~~~  332 (408)
                      .+||+|||++.....  ......+|..|+|||++.+ ..++.++|||||||++|||++|..||....     .+.+.+..
T Consensus       176 ~~kl~Dfg~a~~~~~--~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~  252 (373)
T 1q8y_A          176 QIKIADLGNACWYDE--HYTNSIQTREYRSPEVLLG-APWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQ  252 (373)
T ss_dssp             EEEECCCTTCEETTB--CCCSCCSCGGGCCHHHHHT-CCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHH
T ss_pred             eEEEcccccccccCC--CCCCCCCCccccCcHHHhC-CCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHHHH
Confidence            799999999987653  3344678999999999987 779999999999999999999999985332     13344555


Q ss_pred             HHhhhchhhhhc---CCC------CCCCcccc-------------ccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHh
Q 015374          333 IAKDCCLIIWCN---SRH------SRKPWSKF-------------INADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAM  390 (408)
Q Consensus       333 ~~~~~~~~~~~~---~~~------~~~~~~~~-------------~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL  390 (408)
                      +....+......   ...      ....+...             .....+..+++++.+||.+||+.||++|||++|+|
T Consensus       253 ~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell  332 (373)
T 1q8y_A          253 IIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLV  332 (373)
T ss_dssp             HHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHH
T ss_pred             HHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHHHHh
Confidence            555444322100   000      00000000             00112223467899999999999999999999999


Q ss_pred             cCCCccccccc
Q 015374          391 AHPYFAQVRAA  401 (408)
Q Consensus       391 ~hp~f~~~~~~  401 (408)
                      +||||++....
T Consensus       333 ~hp~f~~~~~~  343 (373)
T 1q8y_A          333 NHPWLKDTLGM  343 (373)
T ss_dssp             TCGGGTTCTTC
T ss_pred             hChhhhcccCc
Confidence            99999987543

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=2.8e-45  Score=338.76  Aligned_cols=244  Identities=16%  Similarity=0.348  Sum_probs=203.1

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc--chHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccEEE
Q 015374          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV--KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI  200 (408)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  200 (408)
                      ..++|++.+.||+|+||+||+|++. ++..||+|+++..  ..+.+.+|+.+++++ +||||+++++++.+  ....++|
T Consensus         8 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~--~~~~~lv   83 (269)
T 4hcu_A            8 DPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKL-SHPKLVQLYGVCLE--QAPICLV   83 (269)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHHTC-CCTTBCCEEEEECS--SSSEEEE
T ss_pred             ChhhceeeheecCCCccEEEEEEec-CCCeEEEEEecccccCHHHHHHHHHHHHhC-CCCCEeeEEEEEec--CCceEEE
Confidence            4678999999999999999999876 5778999999743  457799999999999 89999999999954  4678999


Q ss_pred             EEeecCCChhhhcC----CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCCC--
Q 015374          201 FEYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK--  274 (408)
Q Consensus       201 ~e~~~~~~l~~~~~----~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~~--  274 (408)
                      |||+++++|..++.    .+++..+..++.|++.||.|||++||+||||||+||+++.+ +.+||+|||++.......  
T Consensus        84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~-~~~kl~Dfg~~~~~~~~~~~  162 (269)
T 4hcu_A           84 FEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGEN-QVIKVSDFGMTRFVLDDQYT  162 (269)
T ss_dssp             EECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGG-GCEEECCTTGGGGBCCHHHH
T ss_pred             EEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCC-CCEEeccccccccccccccc
Confidence            99999999998873    38999999999999999999999999999999999999988 799999999997654322  


Q ss_pred             cceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCCCcc
Q 015374          275 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWS  353 (408)
Q Consensus       275 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  353 (408)
                      ......++..|+|||++.+ ..++.++||||||+++|+|++ |..|| .+.+..+....+...                 
T Consensus       163 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~ll~~g~~p~-~~~~~~~~~~~~~~~-----------------  223 (269)
T 4hcu_A          163 SSTGTKFPVKWASPEVFSF-SRYSSKSDVWSFGVLMWEVFSEGKIPY-ENRSNSEVVEDISTG-----------------  223 (269)
T ss_dssp             STTSTTCCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTT-TTCCHHHHHHHHHTT-----------------
T ss_pred             cccCcccccccCCHHHhcC-CCCCchhhhHHHHHHHHHHhcCCCCCC-CCCCHHHHHHHHhcC-----------------
Confidence            1223456678999999987 779999999999999999999 78776 444444444433321                 


Q ss_pred             ccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 015374          354 KFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH  392 (408)
Q Consensus       354 ~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~h  392 (408)
                        .....+..+++++.+++.+||+.||++|||++|+++|
T Consensus       224 --~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~  260 (269)
T 4hcu_A          224 --FRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQ  260 (269)
T ss_dssp             --CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             --ccCCCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence              1112233468999999999999999999999999976

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=1.3e-45  Score=352.43  Aligned_cols=261  Identities=26%  Similarity=0.425  Sum_probs=184.8

Q ss_pred             CCCCCEEEEe-eeeeeCceEEEEEEEcCCCcEEEEEEecccchHHHHHHHHHHHHhcCCCCceEEeeEEEcc--CCCccE
Q 015374          122 GDQDDYEVVR-KVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQ--HSKTPS  198 (408)
Q Consensus       122 ~~~~~y~~~~-~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~--~~~~~~  198 (408)
                      ...++|++.+ .||+|+||+||+|++..+++.||||++...  ....+|+..+.+..+||||+++++++...  .....+
T Consensus        25 ~~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~  102 (336)
T 3fhr_A           25 AVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS--PKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLL  102 (336)
T ss_dssp             CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS--HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred             cccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc--HHHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEE
Confidence            3478899966 599999999999999999999999998643  33445555544444999999999999652  235588


Q ss_pred             EEEEeecCCChhhhcC-----CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCC--CCcEEEEecccceecc
Q 015374          199 LIFEYVNSTDFKVLYP-----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE--LRKLRLIDWGLAEFYH  271 (408)
Q Consensus       199 lv~e~~~~~~l~~~~~-----~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~--~~~~kl~DfG~a~~~~  271 (408)
                      +||||+++++|..++.     .+++..+..++.|++.||.|||++||+||||||+|||++.+  .+.+||+|||++....
T Consensus       103 lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~  182 (336)
T 3fhr_A          103 IIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETT  182 (336)
T ss_dssp             EEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC-
T ss_pred             EEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEeccccceecc
Confidence            9999999999988872     48999999999999999999999999999999999999864  2469999999998665


Q ss_pred             CCCcceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCCC
Q 015374          272 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKP  351 (408)
Q Consensus       272 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  351 (408)
                      . .......+|+.|+|||++.+ ..++.++|||||||++|+|++|..||...... ............            
T Consensus       183 ~-~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-~~~~~~~~~~~~------------  247 (336)
T 3fhr_A          183 Q-NALQTPCYTPYYVAPEVLGP-EKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQ-AISPGMKRRIRL------------  247 (336)
T ss_dssp             -----------------------CHHHHHHHHHHHHHHHHHHHHSSCCC-------------------------------
T ss_pred             c-cccccCCCCcCccChhhhCC-CCCCchhhHHHHHHHHHHHHHCCCCCCCccch-hhhhhHHHhhhc------------
Confidence            3 33445678999999999976 77899999999999999999999998433221 111110000000            


Q ss_pred             ccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccccc
Q 015374          352 WSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVR  399 (408)
Q Consensus       352 ~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~~~  399 (408)
                      .........+..+++++.+|+.+||+.||++|||++|+|+||||++..
T Consensus       248 ~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~  295 (336)
T 3fhr_A          248 GQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSM  295 (336)
T ss_dssp             ---CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTGG
T ss_pred             cccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccccc
Confidence            000011222345789999999999999999999999999999998654

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=1.7e-45  Score=357.20  Aligned_cols=244  Identities=20%  Similarity=0.351  Sum_probs=201.5

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc----chHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccE
Q 015374          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS  198 (408)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  198 (408)
                      ..++|++.+.||+|+||+||+|++..+++.||||+++..    ....+.+|+.+++++ +||||++++++|.+  ....+
T Consensus       112 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~--~~~~~  188 (377)
T 3cbl_A          112 NHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQY-SHPNIVRLIGVCTQ--KQPIY  188 (377)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTC-CCTTBCCEEEEECS--SSSCE
T ss_pred             chHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhC-CCCCEEEEEEEEec--CCCcE
Confidence            467899999999999999999999999999999998743    235688999999999 99999999999954  46788


Q ss_pred             EEEEeecCCChhhhcC----CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCCC
Q 015374          199 LIFEYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK  274 (408)
Q Consensus       199 lv~e~~~~~~l~~~~~----~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~~  274 (408)
                      +||||+++++|..++.    .+++..+..++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+++......
T Consensus       189 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~-~~~kl~DfG~s~~~~~~~  267 (377)
T 3cbl_A          189 IVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEK-NVLKISDFGMSREEADGV  267 (377)
T ss_dssp             EEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTT-CCEEECCGGGCEECTTSE
T ss_pred             EEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCC-CcEEECcCCCceecCCCc
Confidence            9999999999988873    48999999999999999999999999999999999999988 799999999998654322


Q ss_pred             cc---eeeccCccccccccccCCcCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCC
Q 015374          275 EY---NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRK  350 (408)
Q Consensus       275 ~~---~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  350 (408)
                      ..   ....++..|+|||++.+ ..++.++|||||||++|||++ |..|| .+.++.+... .+...             
T Consensus       268 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~el~t~g~~p~-~~~~~~~~~~-~~~~~-------------  331 (377)
T 3cbl_A          268 YAASGGLRQVPVKWTAPEALNY-GRYSSESDVWSFGILLWETFSLGASPY-PNLSNQQTRE-FVEKG-------------  331 (377)
T ss_dssp             EECCSSCCEEEGGGSCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTSCCSS-TTSCHHHHHH-HHHTT-------------
T ss_pred             eeecCCCCCCCcCcCCHhHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCC-CCCCHHHHHH-HHHcC-------------
Confidence            11   11234667999999987 678999999999999999998 88776 4444333322 22211             


Q ss_pred             CccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 015374          351 PWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA  391 (408)
Q Consensus       351 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~  391 (408)
                           .....+..+++++.+++.+||+.||++|||++++++
T Consensus       332 -----~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~  367 (377)
T 3cbl_A          332 -----GRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQ  367 (377)
T ss_dssp             -----CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             -----CCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence                 011223447899999999999999999999999975

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=6e-46  Score=362.67  Aligned_cols=269  Identities=19%  Similarity=0.318  Sum_probs=212.5

Q ss_pred             CCCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc----chHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCcc
Q 015374          122 GDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP  197 (408)
Q Consensus       122 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~  197 (408)
                      ...++|++.+.||+|+||+||+|++..+++.||||+++..    ..+.+.+|+.+++++ +||||+++++++.+......
T Consensus         6 ~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~~   84 (396)
T 4eut_A            6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKL-NHKNIVKLFAIEEETTTRHK   84 (396)
T ss_dssp             CSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHC-CCTTBCCEEEEEECTTTCCE
T ss_pred             CCCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhc-CCCCCCeEEEeeccCCCCee
Confidence            3578999999999999999999999999999999999743    246678999999999 99999999999987766688


Q ss_pred             EEEEEeecCCChhhhcCC------CChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEE----eCCCCcEEEEecccc
Q 015374          198 SLIFEYVNSTDFKVLYPT------LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMI----DHELRKLRLIDWGLA  267 (408)
Q Consensus       198 ~lv~e~~~~~~l~~~~~~------l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl----~~~~~~~kl~DfG~a  267 (408)
                      ++||||+++++|..++..      +++..+..++.|++.||.|||++||+||||||+|||+    +.+ +.+||+|||++
T Consensus        85 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~-~~~kL~DFG~a  163 (396)
T 4eut_A           85 VLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQ-SVYKLTDFGAA  163 (396)
T ss_dssp             EEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSC-EEEEECCGGGC
T ss_pred             EEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCc-eeEEEecCCCc
Confidence            999999999999998853      8999999999999999999999999999999999998    544 67999999999


Q ss_pred             eeccCCCcceeeccCccccccccccCC-------cCCCccccHHHHHHHHHHHHhCCCCCCCC---CCCHHHHHHHHhhh
Q 015374          268 EFYHPGKEYNVRVASRYFKGPELLVDL-------QDYDYSLDMWSLGCMFAGMIFRKEPFFYG---HDNHDQLVKIAKDC  337 (408)
Q Consensus       268 ~~~~~~~~~~~~~~~~~y~aPE~~~~~-------~~~~~~~DvwSlGvil~ell~g~~pf~~~---~~~~~~~~~~~~~~  337 (408)
                      +............||..|+|||++.+.       ..++.++|||||||++|||++|+.||...   ....+.+..+....
T Consensus       164 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~  243 (396)
T 4eut_A          164 RELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGK  243 (396)
T ss_dssp             EECCCGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHSC
T ss_pred             eEccCCCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcCC
Confidence            887766556667899999999998641       45788999999999999999999998542   33445555544432


Q ss_pred             chhhhhcC---CCCCCCccccccc--cCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 015374          338 CLIIWCNS---RHSRKPWSKFINA--DNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH  392 (408)
Q Consensus       338 ~~~~~~~~---~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~h  392 (408)
                      ....+...   ......|....+.  .....++..+.+++++||++||++|||++|++++
T Consensus       244 p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~  303 (396)
T 4eut_A          244 PSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAE  303 (396)
T ss_dssp             CTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHH
T ss_pred             CcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHH
Confidence            11111000   0001111111111  1122345678999999999999999999998543

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=1.1e-44  Score=334.49  Aligned_cols=244  Identities=16%  Similarity=0.293  Sum_probs=202.6

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc--chHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccEEE
Q 015374          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV--KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI  200 (408)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  200 (408)
                      ..++|++.+.||+|+||+||+|.+. ++..||+|+++..  ..+.+.+|+.++.++ +||||+++++++.+  ....++|
T Consensus         6 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~--~~~~~lv   81 (268)
T 3sxs_A            6 KREEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSMSEDEFFQEAQTMMKL-SHPKLVKFYGVCSK--EYPIYIV   81 (268)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTBCHHHHHHHHHHHHHC-CCTTBCCEEEEECS--SSSEEEE
T ss_pred             chhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCCcHHHHHHHHHHHHhC-CCCCEeeEEEEEcc--CCceEEE
Confidence            4688999999999999999999765 5778999999753  456789999999999 89999999999944  5678999


Q ss_pred             EEeecCCChhhhcC----CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCCCcc
Q 015374          201 FEYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY  276 (408)
Q Consensus       201 ~e~~~~~~l~~~~~----~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~~~~  276 (408)
                      |||+++++|..++.    .+++..+..++.|++.||.|||++||+||||||+|||++.+ +.++|+|||++.........
T Consensus        82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~-~~~~l~Dfg~~~~~~~~~~~  160 (268)
T 3sxs_A           82 TEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRD-LCVKVSDFGMTRYVLDDQYV  160 (268)
T ss_dssp             EECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTT-CCEEECCTTCEEECCTTCEE
T ss_pred             EEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCC-CCEEEccCccceecchhhhh
Confidence            99999999988873    48999999999999999999999999999999999999988 79999999999876544322


Q ss_pred             --eeeccCccccccccccCCcCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCCCcc
Q 015374          277 --NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWS  353 (408)
Q Consensus       277 --~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  353 (408)
                        ....++..|+|||.+.+ ..++.++||||||+++|+|++ |..|| .+.+..+....+...                 
T Consensus       161 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~-~~~~~~~~~~~~~~~-----------------  221 (268)
T 3sxs_A          161 SSVGTKFPVKWSAPEVFHY-FKYSSKSDVWAFGILMWEVFSLGKMPY-DLYTNSEVVLKVSQG-----------------  221 (268)
T ss_dssp             ECCSCCCCGGGCCHHHHHH-SEEETTHHHHHHHHHHHHHHTTTCCTT-TTSCHHHHHHHHHTT-----------------
T ss_pred             cccCCCcCcccCCHHHHhc-cCCchhhhhHHHHHHHHHHHcCCCCCc-cccChHHHHHHHHcC-----------------
Confidence              22345567999999987 678999999999999999999 88887 344444443333221                 


Q ss_pred             ccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 015374          354 KFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH  392 (408)
Q Consensus       354 ~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~h  392 (408)
                        .....+..+++++.+++.+||+.||++|||++|++++
T Consensus       222 --~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~  258 (268)
T 3sxs_A          222 --HRLYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSS  258 (268)
T ss_dssp             --CCCCCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             --CCCCCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence              0111233468899999999999999999999999976

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=8.6e-45  Score=352.83  Aligned_cols=247  Identities=18%  Similarity=0.320  Sum_probs=203.9

Q ss_pred             CCCCCEEEEeeeeeeCceEEEEEEEcC-------CCcEEEEEEeccc----chHHHHHHHHHHHHhcCCCCceEEeeEEE
Q 015374          122 GDQDDYEVVRKVGRGKYSEVFEGINVN-------TNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVR  190 (408)
Q Consensus       122 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~-------~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~  190 (408)
                      ...++|++.+.||+|+||+||+|++..       .+..||||+++..    ....+.+|+.+++++.+||||++++++|.
T Consensus        66 i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~  145 (382)
T 3tt0_A           66 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT  145 (382)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             cchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeec
Confidence            356899999999999999999998754       3357999999743    23568899999999988999999999995


Q ss_pred             ccCCCccEEEEEeecCCChhhhcC-------------------CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEE
Q 015374          191 DQHSKTPSLIFEYVNSTDFKVLYP-------------------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVM  251 (408)
Q Consensus       191 ~~~~~~~~lv~e~~~~~~l~~~~~-------------------~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NIL  251 (408)
                      +  ....++||||+++++|..++.                   .+++..+..++.|++.||.|||++||+||||||+|||
T Consensus       146 ~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIl  223 (382)
T 3tt0_A          146 Q--DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVL  223 (382)
T ss_dssp             S--SSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEE
T ss_pred             c--CCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcceEE
Confidence            4  567899999999999998872                   3899999999999999999999999999999999999


Q ss_pred             EeCCCCcEEEEecccceeccCCC---cceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCH
Q 015374          252 IDHELRKLRLIDWGLAEFYHPGK---EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNH  327 (408)
Q Consensus       252 l~~~~~~~kl~DfG~a~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-g~~pf~~~~~~~  327 (408)
                      ++.+ +.+||+|||+++......   ......+|..|+|||++.+ ..++.++|||||||++|+|++ |..|| .+.+..
T Consensus       224 l~~~-~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwslG~il~ellt~g~~p~-~~~~~~  300 (382)
T 3tt0_A          224 VTED-NVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEIFTLGGSPY-PGVPVE  300 (382)
T ss_dssp             ECTT-CCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHS-CCCCHHHHHHHHHHHHHHHHTTSCCSS-TTCCHH
T ss_pred             EcCC-CcEEEcccCcccccccccccccccCCCCCcceeCHHHhcC-CCCCchhHHHHHHHHHHHHHhCCCCCC-CCCCHH
Confidence            9988 799999999998665432   2233456788999999987 789999999999999999999 88887 444433


Q ss_pred             HHHHHHHhhhchhhhhcCCCCCCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 015374          328 DQLVKIAKDCCLIIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH  392 (408)
Q Consensus       328 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~h  392 (408)
                      +....+...                   .....+..+++++.+++.+||+.||++|||++|++++
T Consensus       301 ~~~~~~~~~-------------------~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  346 (382)
T 3tt0_A          301 ELFKLLKEG-------------------HRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED  346 (382)
T ss_dssp             HHHHHHHTT-------------------CCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHcC-------------------CCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            333332221                   1112234578999999999999999999999999986

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.2e-44  Score=346.44  Aligned_cols=250  Identities=20%  Similarity=0.341  Sum_probs=204.7

Q ss_pred             CCCCCEEEEeeeeeeCceEEEEEEEc-----CCCcEEEEEEeccc----chHHHHHHHHHHHHhcCCCCceEEeeEEEcc
Q 015374          122 GDQDDYEVVRKVGRGKYSEVFEGINV-----NTNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQ  192 (408)
Q Consensus       122 ~~~~~y~~~~~lG~G~fg~Vy~~~~~-----~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~  192 (408)
                      ...++|++.+.||+|+||+||+|++.     .++..||+|+++..    ..+.+.+|+.++.++.+||||+++++++.+ 
T Consensus        42 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~-  120 (344)
T 1rjb_A           42 FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTL-  120 (344)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred             cCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEee-
Confidence            35689999999999999999999873     45678999998642    346789999999999789999999999955 


Q ss_pred             CCCccEEEEEeecCCChhhhcCC--------------------------CChHHHHHHHHHHHHHHHHHHHCCcEEecCC
Q 015374          193 HSKTPSLIFEYVNSTDFKVLYPT--------------------------LTDYDIRYYIYELLKALDYCHSQGIMHRDVK  246 (408)
Q Consensus       193 ~~~~~~lv~e~~~~~~l~~~~~~--------------------------l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk  246 (408)
                       ....++||||+++++|..++..                          +++..+..++.|++.||.|||++||+|||||
T Consensus       121 -~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dik  199 (344)
T 1rjb_A          121 -SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLA  199 (344)
T ss_dssp             -SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCS
T ss_pred             -CCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCC
Confidence             4678999999999999888732                          6888999999999999999999999999999


Q ss_pred             CCcEEEeCCCCcEEEEecccceeccCCCcc---eeeccCccccccccccCCcCCCccccHHHHHHHHHHHHh-CCCCCCC
Q 015374          247 PHNVMIDHELRKLRLIDWGLAEFYHPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFY  322 (408)
Q Consensus       247 ~~NILl~~~~~~~kl~DfG~a~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-g~~pf~~  322 (408)
                      |+|||++.+ +.+||+|||++.........   ....+|..|+|||++.+ ..++.++|||||||++|+|++ |..||..
T Consensus       200 p~NIll~~~-~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~el~t~g~~p~~~  277 (344)
T 1rjb_A          200 ARNVLVTHG-KVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFE-GIYTIKSDVWSYGILLWEIFSLGVNPYPG  277 (344)
T ss_dssp             GGGEEEETT-TEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred             hhhEEEcCC-CcEEeCCCccCcccccCccceeccCccCccCccCHHHhcc-CCCChhHhHHHHHHHHHHHHcCCCCCccc
Confidence            999999988 79999999999866543322   23456778999999987 779999999999999999998 8888744


Q ss_pred             CCCCHHHHHHHHhhhchhhhhcCCCCCCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCC
Q 015374          323 GHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPY  394 (408)
Q Consensus       323 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~  394 (408)
                      .... +.+.......                  .....+..+++++.+++.+||+.||.+|||+.|+++|-.
T Consensus       278 ~~~~-~~~~~~~~~~------------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~  330 (344)
T 1rjb_A          278 IPVD-ANFYKLIQNG------------------FKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG  330 (344)
T ss_dssp             CCCS-HHHHHHHHTT------------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             CCcH-HHHHHHHhcC------------------CCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHH
Confidence            4333 3333332211                  111223347899999999999999999999999998754

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=2.2e-45  Score=344.71  Aligned_cols=254  Identities=22%  Similarity=0.295  Sum_probs=201.6

Q ss_pred             CCCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecccchHHHHHHHHHHHH--hcCCCCceEEeeEEEcc--CCCcc
Q 015374          122 GDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQN--LCGGPNVVKLLDIVRDQ--HSKTP  197 (408)
Q Consensus       122 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~--l~~h~niv~l~~~~~~~--~~~~~  197 (408)
                      ...++|++.+.||+|+||+||+|++  +++.||||++.......+.+|.+++..  + +||||+++++++.+.  .....
T Consensus         5 ~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~e~~~~~~~~l-~h~niv~~~~~~~~~~~~~~~~   81 (301)
T 3q4u_A            5 TVARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSRDEKSWFRETELYNTVML-RHENILGFIASDMTSRHSSTQL   81 (301)
T ss_dssp             CCGGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHHHTCC-CCTTBCCEEEEEEEEETTEEEE
T ss_pred             cccCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEeccccchhhHHHHHHHHHhhc-cCcCeeeEEEeeccccCCCcee
Confidence            3578999999999999999999976  688999999988777888888888887  5 899999999987643  23568


Q ss_pred             EEEEEeecCCChhhhcC--CCChHHHHHHHHHHHHHHHHHH--------HCCcEEecCCCCcEEEeCCCCcEEEEecccc
Q 015374          198 SLIFEYVNSTDFKVLYP--TLTDYDIRYYIYELLKALDYCH--------SQGIMHRDVKPHNVMIDHELRKLRLIDWGLA  267 (408)
Q Consensus       198 ~lv~e~~~~~~l~~~~~--~l~~~~~~~i~~qi~~~L~~LH--------~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a  267 (408)
                      ++||||+++++|..++.  .+++..+..++.|++.||.|||        +++|+||||||+|||++.+ +.+||+|||++
T Consensus        82 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~-~~~kl~Dfg~a  160 (301)
T 3q4u_A           82 WLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKN-GQCCIADLGLA  160 (301)
T ss_dssp             EEEECCCTTCBHHHHHTTCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTT-SCEEECCCTTC
T ss_pred             EEehhhccCCCHHHHHhhcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCC-CCEEEeeCCCe
Confidence            89999999999999884  5899999999999999999999        9999999999999999988 79999999999


Q ss_pred             eeccCCCcc-----eeeccCccccccccccCCc-----CCCccccHHHHHHHHHHHHhC----------CCCCCCCCC--
Q 015374          268 EFYHPGKEY-----NVRVASRYFKGPELLVDLQ-----DYDYSLDMWSLGCMFAGMIFR----------KEPFFYGHD--  325 (408)
Q Consensus       268 ~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~-----~~~~~~DvwSlGvil~ell~g----------~~pf~~~~~--  325 (408)
                      +........     ....||..|+|||++.+..     .++.++|||||||++|||++|          ..||.....  
T Consensus       161 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~~  240 (301)
T 3q4u_A          161 VMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPND  240 (301)
T ss_dssp             EEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSS
T ss_pred             eecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCCCC
Confidence            776543322     2347899999999998732     345799999999999999999          888754332  


Q ss_pred             -CHHHHHHHHhhhchhhhhcCCCCCCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 015374          326 -NHDQLVKIAKDCCLIIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA  391 (408)
Q Consensus       326 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~  391 (408)
                       ..+.........+         ......   .......+++++.+++.+||+.||++|||++|+++
T Consensus       241 ~~~~~~~~~~~~~~---------~~~~~~---~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~  295 (301)
T 3q4u_A          241 PSFEDMRKVVCVDQ---------QRPNIP---NRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKK  295 (301)
T ss_dssp             CCHHHHHHHHTTSC---------CCCCCC---GGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred             cchhhhhHHHhccC---------CCCCCC---hhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHH
Confidence             2233332221100         000000   11111224578999999999999999999999985

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=1.1e-45  Score=351.36  Aligned_cols=259  Identities=20%  Similarity=0.378  Sum_probs=183.6

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc----chHHHHHHHH-HHHHhcCCCCceEEeeEEEccCCCcc
Q 015374          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV----KKKKIKREIK-ILQNLCGGPNVVKLLDIVRDQHSKTP  197 (408)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~E~~-~l~~l~~h~niv~l~~~~~~~~~~~~  197 (408)
                      ..++|++.+.||+|+||+||+|.+..+++.||||+++..    ....+..|+. +++.+ +||||+++++++.+  ....
T Consensus        20 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~-~h~niv~~~~~~~~--~~~~   96 (327)
T 3aln_A           20 TAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSS-DCPYIVQFYGALFR--EGDC   96 (327)
T ss_dssp             CSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSC-CCTTBCCEEEEEEC--SSEE
T ss_pred             CHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcC-CCCcEeeeeeEEEe--CCce
Confidence            468899999999999999999999999999999998643    2345566666 44555 99999999999965  4678


Q ss_pred             EEEEEeecCCChhhhc--------CCCChHHHHHHHHHHHHHHHHHHHC-CcEEecCCCCcEEEeCCCCcEEEEecccce
Q 015374          198 SLIFEYVNSTDFKVLY--------PTLTDYDIRYYIYELLKALDYCHSQ-GIMHRDVKPHNVMIDHELRKLRLIDWGLAE  268 (408)
Q Consensus       198 ~lv~e~~~~~~l~~~~--------~~l~~~~~~~i~~qi~~~L~~LH~~-~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~  268 (408)
                      ++||||+++ ++..++        ..+++..+..++.|++.||.|||+. ||+||||||+|||++.+ +.+||+|||++.
T Consensus        97 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~-~~~kl~Dfg~~~  174 (327)
T 3aln_A           97 WICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRS-GNIKLCDFGISG  174 (327)
T ss_dssp             EEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETT-TEEEECCCSSSC
T ss_pred             EEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCC-CCEEEccCCCce
Confidence            899999997 443332        4589999999999999999999998 99999999999999988 799999999998


Q ss_pred             eccCCCcceeeccCcccccccccc---CCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcC
Q 015374          269 FYHPGKEYNVRVASRYFKGPELLV---DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNS  345 (408)
Q Consensus       269 ~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  345 (408)
                      ............||..|+|||++.   ....++.++|||||||++|+|++|+.||.......+.+..+.           
T Consensus       175 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~-----------  243 (327)
T 3aln_A          175 QLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVV-----------  243 (327)
T ss_dssp             C------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCC-----------
T ss_pred             ecccccccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHh-----------
Confidence            776554455568999999999984   225689999999999999999999999843322212111100           


Q ss_pred             CCCCCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccccccc
Q 015374          346 RHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAA  401 (408)
Q Consensus       346 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~~~~~  401 (408)
                         . .............+++++.+|+.+||+.||++|||++|+++||||....+.
T Consensus       244 ---~-~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~~~~  295 (327)
T 3aln_A          244 ---K-GDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMYEER  295 (327)
T ss_dssp             ---C-SCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHHHS
T ss_pred             ---c-CCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHHhHhh
Confidence               0 000011122234578999999999999999999999999999999866543

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=2.1e-44  Score=336.03  Aligned_cols=245  Identities=18%  Similarity=0.293  Sum_probs=201.9

Q ss_pred             CCCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecccc----------hHHHHHHHHHHHHhcCCCCceEEeeEEEc
Q 015374          122 GDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK----------KKKIKREIKILQNLCGGPNVVKLLDIVRD  191 (408)
Q Consensus       122 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~----------~~~~~~E~~~l~~l~~h~niv~l~~~~~~  191 (408)
                      ...++|++.+.||+|+||+||+|++..+++.||+|++....          .+.+.+|+.+++++ +||||+++++++.+
T Consensus        16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~   94 (287)
T 4f0f_A           16 LADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNL-NHPNIVKLYGLMHN   94 (287)
T ss_dssp             CCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTC-CCTTBCCEEEEETT
T ss_pred             hhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhC-CCCCchhhheeecC
Confidence            45789999999999999999999999999999999985321          16788999999999 99999999999943


Q ss_pred             cCCCccEEEEEeecCCChhhhc----CCCChHHHHHHHHHHHHHHHHHHHCC--cEEecCCCCcEEEeCCCCc-----EE
Q 015374          192 QHSKTPSLIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQG--IMHRDVKPHNVMIDHELRK-----LR  260 (408)
Q Consensus       192 ~~~~~~~lv~e~~~~~~l~~~~----~~l~~~~~~~i~~qi~~~L~~LH~~~--iiH~Dlk~~NILl~~~~~~-----~k  260 (408)
                      .    .++||||+++++|...+    ..+++..+..++.|++.||.|||++|  |+||||||+|||++.+ +.     +|
T Consensus        95 ~----~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~-~~~~~~~~k  169 (287)
T 4f0f_A           95 P----PRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSL-DENAPVCAK  169 (287)
T ss_dssp             T----TEEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCC-CTTCSCCEE
T ss_pred             C----CeEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEecc-CCCCceeEE
Confidence            2    26999999999997765    35899999999999999999999999  9999999999999876 44     99


Q ss_pred             EEecccceeccCCCcceeeccCccccccccccC-CcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhch
Q 015374          261 LIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD-LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCL  339 (408)
Q Consensus       261 l~DfG~a~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~  339 (408)
                      |+|||+++...  .......+|..|+|||++.+ ...++.++|||||||++|+|++|+.||.................+ 
T Consensus       170 l~Dfg~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~-  246 (287)
T 4f0f_A          170 VADFGLSQQSV--HSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEG-  246 (287)
T ss_dssp             ECCCTTCBCCS--SCEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHSC-
T ss_pred             eCCCCcccccc--ccccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhccC-
Confidence            99999997543  33455679999999999843 256789999999999999999999998554444433332222211 


Q ss_pred             hhhhcCCCCCCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 015374          340 IIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA  391 (408)
Q Consensus       340 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~  391 (408)
                                      .....+..+++++.+++.+||+.||++|||++|+++
T Consensus       247 ----------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  282 (287)
T 4f0f_A          247 ----------------LRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVK  282 (287)
T ss_dssp             ----------------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ----------------CCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence                            112233457899999999999999999999999985

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=5e-45  Score=344.95  Aligned_cols=255  Identities=20%  Similarity=0.328  Sum_probs=189.1

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecccc----hHH-HHHHHHHHHHhcCCCCceEEeeEEEccCCCcc
Q 015374          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK----KKK-IKREIKILQNLCGGPNVVKLLDIVRDQHSKTP  197 (408)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~----~~~-~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~  197 (408)
                      ..++|++.+.||+|+||+||+|++..+++.||||+++...    ... +.++..+++.+ +||||+++++++.+  ....
T Consensus        23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~-~h~~i~~~~~~~~~--~~~~   99 (318)
T 2dyl_A           23 EINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSH-DCPYIVQCFGTFIT--NTDV   99 (318)
T ss_dssp             CGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTT-TCTTBCCEEEEEEC--SSEE
T ss_pred             hhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhc-CCCceeeEEEEEec--CCcE
Confidence            3578999999999999999999999999999999986432    122 33444556666 99999999999965  4678


Q ss_pred             EEEEEeecCCChhhhc----CCCChHHHHHHHHHHHHHHHHHHHC-CcEEecCCCCcEEEeCCCCcEEEEecccceeccC
Q 015374          198 SLIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQ-GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP  272 (408)
Q Consensus       198 ~lv~e~~~~~~l~~~~----~~l~~~~~~~i~~qi~~~L~~LH~~-~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~  272 (408)
                      ++||||+ ++++..+.    ..+++..+..++.|++.||.|||++ ||+|+||||+|||++.+ +.+||+|||++.....
T Consensus       100 ~lv~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~-~~~kl~dfg~~~~~~~  177 (318)
T 2dyl_A          100 FIAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDER-GQIKLCDFGISGRLVD  177 (318)
T ss_dssp             EEEECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTT-SCEEECCCTTC-----
T ss_pred             EEEEecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCC-CCEEEEECCCchhccC
Confidence            9999999 44444443    4689999999999999999999995 99999999999999988 7999999999987665


Q ss_pred             CCcceeeccCccccccccccC----CcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCC
Q 015374          273 GKEYNVRVASRYFKGPELLVD----LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHS  348 (408)
Q Consensus       273 ~~~~~~~~~~~~y~aPE~~~~----~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  348 (408)
                      ........++..|+|||++.+    ...++.++|||||||++|+|++|..||.....+.+.+..+.....         .
T Consensus       178 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~---------~  248 (318)
T 2dyl_A          178 DKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEP---------P  248 (318)
T ss_dssp             ---------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCC---------C
T ss_pred             CccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCC---------C
Confidence            555556689999999999952    356889999999999999999999998654554455544443210         0


Q ss_pred             CCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccccc
Q 015374          349 RKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVR  399 (408)
Q Consensus       349 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~~~  399 (408)
                              .......+++++.+++.+||+.||.+|||++|+++||||+...
T Consensus       249 --------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  291 (318)
T 2dyl_A          249 --------LLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRYE  291 (318)
T ss_dssp             --------CCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHHHH
T ss_pred             --------CCCccCCCCHHHHHHHHHHccCChhHCcCHHHHhhCHHHHhcc
Confidence                    0011224789999999999999999999999999999998654

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=4.3e-45  Score=340.87  Aligned_cols=243  Identities=14%  Similarity=0.250  Sum_probs=201.7

Q ss_pred             CCCCCEEEEeeeeeeCceEEEEEEEcCCC-------cEEEEEEeccc---chHHHHHHHHHHHHhcCCCCceEEeeEEEc
Q 015374          122 GDQDDYEVVRKVGRGKYSEVFEGINVNTN-------ERCIIKILKPV---KKKKIKREIKILQNLCGGPNVVKLLDIVRD  191 (408)
Q Consensus       122 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~-------~~vavK~~~~~---~~~~~~~E~~~l~~l~~h~niv~l~~~~~~  191 (408)
                      ...++|++.+.||+|+||+||+|++..++       ..||+|+++..   ..+.+.+|+.+++++ +||||+++++++.+
T Consensus         5 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~   83 (289)
T 4fvq_A            5 IRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKL-SHKHLVLNYGVCVC   83 (289)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTS-CCTTBCCEEEEECC
T ss_pred             echhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhC-CCCCEeEEEEEEEe
Confidence            35789999999999999999999988777       46999998643   346788999999999 99999999999955


Q ss_pred             cCCCccEEEEEeecCCChhhhcC----CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCc--------E
Q 015374          192 QHSKTPSLIFEYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRK--------L  259 (408)
Q Consensus       192 ~~~~~~~lv~e~~~~~~l~~~~~----~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~--------~  259 (408)
                        ....++||||+++++|..++.    .+++..+..++.|++.||.|||++||+||||||+|||++.+ +.        +
T Consensus        84 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~-~~~~~~~~~~~  160 (289)
T 4fvq_A           84 --GDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIRE-EDRKTGNPPFI  160 (289)
T ss_dssp             --TTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEEC-CBGGGTBCCEE
T ss_pred             --CCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecC-Cccccccccee
Confidence              467789999999999998873    28999999999999999999999999999999999999887 44        9


Q ss_pred             EEEecccceeccCCCcceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhch
Q 015374          260 RLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCL  339 (408)
Q Consensus       260 kl~DfG~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~  339 (408)
                      ||+|||++.....   .....++..|+|||++.+...++.++|||||||++|+|++|..|++...+..........    
T Consensus       161 kl~Dfg~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~~~----  233 (289)
T 4fvq_A          161 KLSDPGISITVLP---KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYED----  233 (289)
T ss_dssp             EECCCCSCTTTSC---HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHT----
T ss_pred             eeccCcccccccC---ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHhhc----
Confidence            9999999865432   233567889999999987567999999999999999999987777655554333322211    


Q ss_pred             hhhhcCCCCCCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 015374          340 IIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH  392 (408)
Q Consensus       340 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~h  392 (408)
                                       ....+...++++.+++.+||+.||++|||++|+++|
T Consensus       234 -----------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  269 (289)
T 4fvq_A          234 -----------------RHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRD  269 (289)
T ss_dssp             -----------------TCCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred             -----------------cCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence                             011122356789999999999999999999999976

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=2.4e-44  Score=339.49  Aligned_cols=247  Identities=21%  Similarity=0.346  Sum_probs=204.1

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEE-----cCCCcEEEEEEeccc----chHHHHHHHHHHHHhcCCCCceEEeeEEEccC
Q 015374          123 DQDDYEVVRKVGRGKYSEVFEGIN-----VNTNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQH  193 (408)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~Vy~~~~-----~~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~  193 (408)
                      ..++|++.+.||+|+||+||+|++     ..++..||+|+++..    ..+.+.+|+.+++++.+||||+++++++.+  
T Consensus        21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~--   98 (313)
T 1t46_A           21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTI--   98 (313)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS--
T ss_pred             ChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEec--
Confidence            467999999999999999999985     456789999999743    346788999999999889999999999954  


Q ss_pred             CCccEEEEEeecCCChhhhcC---------------------CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEE
Q 015374          194 SKTPSLIFEYVNSTDFKVLYP---------------------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMI  252 (408)
Q Consensus       194 ~~~~~lv~e~~~~~~l~~~~~---------------------~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl  252 (408)
                      ....++||||+++++|..++.                     .+++..+..++.|++.||.|||++||+||||||+|||+
T Consensus        99 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~  178 (313)
T 1t46_A           99 GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILL  178 (313)
T ss_dssp             SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred             CCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEE
Confidence            467889999999999988862                     38899999999999999999999999999999999999


Q ss_pred             eCCCCcEEEEecccceeccCCCcc---eeeccCccccccccccCCcCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHH
Q 015374          253 DHELRKLRLIDWGLAEFYHPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHD  328 (408)
Q Consensus       253 ~~~~~~~kl~DfG~a~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-g~~pf~~~~~~~~  328 (408)
                      +.+ +.+||+|||++.........   ....+|..|+|||++.+ ..++.++||||||+++|+|++ |..||...... +
T Consensus       179 ~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~-~  255 (313)
T 1t46_A          179 THG-RITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFN-CVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD-S  255 (313)
T ss_dssp             ETT-TEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS-H
T ss_pred             cCC-CCEEEccccccccccccccceeccCCCCcceeeChHHhcC-CCCChHHHHHHHHHHHHHHHhCCCCCCCcccch-h
Confidence            988 79999999999876544332   23456778999999987 789999999999999999999 88887443333 3


Q ss_pred             HHHHHHhhhchhhhhcCCCCCCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 015374          329 QLVKIAKDCCLIIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH  392 (408)
Q Consensus       329 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~h  392 (408)
                      .........                  .....+..+++++.+++.+||+.||.+|||++|++++
T Consensus       256 ~~~~~~~~~------------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  301 (313)
T 1t46_A          256 KFYKMIKEG------------------FRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL  301 (313)
T ss_dssp             HHHHHHHHT------------------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHhccC------------------CCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence            333332221                  0111223478999999999999999999999999875

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=7.2e-45  Score=347.66  Aligned_cols=245  Identities=18%  Similarity=0.335  Sum_probs=201.5

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEc-----CCCcEEEEEEecccc----hHHHHHHHHHHHHhcCCCCceEEeeEEEccC
Q 015374          123 DQDDYEVVRKVGRGKYSEVFEGINV-----NTNERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQH  193 (408)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~Vy~~~~~-----~~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~  193 (408)
                      ..++|++.+.||+|+||+||+|++.     .+++.||+|+++...    .+.+.+|+.+++++ +||||++++++|.+  
T Consensus        45 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~--  121 (343)
T 1luf_A           45 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEF-DNPNIVKLLGVCAV--  121 (343)
T ss_dssp             CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEECS--
T ss_pred             cHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhC-CCCCEEEEEEEEcc--
Confidence            5688999999999999999999886     345899999997432    45688999999999 99999999999954  


Q ss_pred             CCccEEEEEeecCCChhhhc---------------------------CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCC
Q 015374          194 SKTPSLIFEYVNSTDFKVLY---------------------------PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVK  246 (408)
Q Consensus       194 ~~~~~lv~e~~~~~~l~~~~---------------------------~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk  246 (408)
                      ....++||||+++++|..++                           ..+++.++..++.|++.||.|||++||+|||||
T Consensus       122 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlk  201 (343)
T 1luf_A          122 GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLA  201 (343)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCS
T ss_pred             CCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCC
Confidence            56789999999999998876                           348889999999999999999999999999999


Q ss_pred             CCcEEEeCCCCcEEEEecccceeccCCC---cceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHh-CCCCCCC
Q 015374          247 PHNVMIDHELRKLRLIDWGLAEFYHPGK---EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFY  322 (408)
Q Consensus       247 ~~NILl~~~~~~~kl~DfG~a~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-g~~pf~~  322 (408)
                      |+|||++.+ +.+||+|||++.......   ......+|..|+|||++.+ ..++.++|||||||++|+|++ |..||. 
T Consensus       202 p~NIl~~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~el~t~g~~p~~-  278 (343)
T 1luf_A          202 TRNCLVGEN-MVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFY-NRYTTESDVWAYGVVLWEIFSYGLQPYY-  278 (343)
T ss_dssp             GGGEEECGG-GCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCTTT-
T ss_pred             cceEEECCC-CeEEEeecCCCcccccCccccccCCCcccceecChhhhcc-CCcCcccccHHHHHHHHHHHhcCCCcCC-
Confidence            999999988 799999999997654322   2234567888999999987 679999999999999999999 888873 


Q ss_pred             CCCCHHHHHHHHhhhchhhhhcCCCCCCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 015374          323 GHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH  392 (408)
Q Consensus       323 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~h  392 (408)
                      +.+..+....+...         .          ....+..+++++.+++.+||+.||++|||+.+++++
T Consensus       279 ~~~~~~~~~~~~~~---------~----------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~  329 (343)
T 1luf_A          279 GMAHEEVIYYVRDG---------N----------ILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRI  329 (343)
T ss_dssp             TSCHHHHHHHHHTT---------C----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCChHHHHHHHhCC---------C----------cCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHH
Confidence            33333333332221         0          011234578999999999999999999999999864

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=8.1e-45  Score=343.00  Aligned_cols=249  Identities=23%  Similarity=0.408  Sum_probs=198.9

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecccc---------hHHHHHHHHHHHHhc---CCCCceEEeeEEE
Q 015374          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK---------KKKIKREIKILQNLC---GGPNVVKLLDIVR  190 (408)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~---------~~~~~~E~~~l~~l~---~h~niv~l~~~~~  190 (408)
                      ..++|++.+.||+|+||+||+|++..+++.||||+++...         ...+.+|+.++.++.   +|+||+++++++.
T Consensus        29 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~  108 (312)
T 2iwi_A           29 FEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFE  108 (312)
T ss_dssp             ----CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC-
T ss_pred             hhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEe
Confidence            4678999999999999999999999999999999996432         234567999999885   7999999999996


Q ss_pred             ccCCCccEEEEEe-ecCCChhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEeccc
Q 015374          191 DQHSKTPSLIFEY-VNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGL  266 (408)
Q Consensus       191 ~~~~~~~~lv~e~-~~~~~l~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~  266 (408)
                      +  ....++|||| +.+++|..++   ..+++..+..++.|++.||.|||++||+||||||+||+++.+.+.+||+|||+
T Consensus       109 ~--~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~dfg~  186 (312)
T 2iwi_A          109 T--QEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGS  186 (312)
T ss_dssp             ------CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEECCCSS
T ss_pred             c--CCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEEEEcch
Confidence            5  4567899999 7889998887   35899999999999999999999999999999999999994338999999999


Q ss_pred             ceeccCCCcceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCC
Q 015374          267 AEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSR  346 (408)
Q Consensus       267 a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  346 (408)
                      +...... ......++..|+|||++.+....+.++|||||||++|+|++|+.||...    ..   +...          
T Consensus       187 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~----~~---~~~~----------  248 (312)
T 2iwi_A          187 GALLHDE-PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERD----QE---ILEA----------  248 (312)
T ss_dssp             CEECCSS-CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH----HH---HHHT----------
T ss_pred             hhhcccC-cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCCh----HH---Hhhh----------
Confidence            9876543 3445678999999999977344456899999999999999999998321    11   1110          


Q ss_pred             CCCCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccccccc
Q 015374          347 HSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAA  401 (408)
Q Consensus       347 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~~~~~  401 (408)
                                ....+..++.++.+++.+||+.||++|||++|+++||||+.....
T Consensus       249 ----------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~~~~~  293 (312)
T 2iwi_A          249 ----------ELHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPAED  293 (312)
T ss_dssp             ----------CCCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC----
T ss_pred             ----------ccCCcccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhcCchhc
Confidence                      011223478999999999999999999999999999999987653

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=9.5e-45  Score=345.10  Aligned_cols=245  Identities=18%  Similarity=0.324  Sum_probs=195.8

Q ss_pred             CCCCCEEEEeeeeeeCceEEEEEEEcCCCcE----EEEEEecc----cchHHHHHHHHHHHHhcCCCCceEEeeEEEccC
Q 015374          122 GDQDDYEVVRKVGRGKYSEVFEGINVNTNER----CIIKILKP----VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQH  193 (408)
Q Consensus       122 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~----vavK~~~~----~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~  193 (408)
                      ...++|++.+.||+|+||+||+|++..+++.    ||+|.++.    ...+.+.+|+.+++++ +||||++++++|.+. 
T Consensus        12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~-   89 (327)
T 3poz_A           12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV-DNPHVCRLLGICLTS-   89 (327)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHC-CBTTBCCEEEEEESS-
T ss_pred             cCHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhC-CCCCEeEEEEEEecC-
Confidence            4578899999999999999999998887765    47777753    2346789999999999 999999999999753 


Q ss_pred             CCccEEEEEeecCCChhhhc----CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEeccccee
Q 015374          194 SKTPSLIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEF  269 (408)
Q Consensus       194 ~~~~~lv~e~~~~~~l~~~~----~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~  269 (408)
                        ..++|+||+.+++|..++    ..+++..+..++.|++.||.|||++||+||||||+|||++.+ +.+||+|||+++.
T Consensus        90 --~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~-~~~kl~Dfg~a~~  166 (327)
T 3poz_A           90 --TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTP-QHVKITDFGLAKL  166 (327)
T ss_dssp             --SEEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEET-TEEEECCTTHHHH
T ss_pred             --CeEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCC-CCEEEccCcceeE
Confidence              367999999999998876    348999999999999999999999999999999999999988 7999999999987


Q ss_pred             ccCCCcc---eeeccCccccccccccCCcCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHhhhchhhhhcC
Q 015374          270 YHPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKDCCLIIWCNS  345 (408)
Q Consensus       270 ~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  345 (408)
                      .......   ....+|..|+|||++.+ ..++.++|||||||++|||++ |..|| .+.+..+. .......        
T Consensus       167 ~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~-~~~~~~~~-~~~~~~~--------  235 (327)
T 3poz_A          167 LGAEEKEYHAEGGKVPIKWMALESILH-RIYTHQSDVWSYGVTVWELMTFGSKPY-DGIPASEI-SSILEKG--------  235 (327)
T ss_dssp             HTTTCC-------CCCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTT-TTCCGGGH-HHHHHTT--------
T ss_pred             ccCCcccccccCCCccccccChHHhcc-CCCCchhhhhhhHHHHHHHHhcCCCCc-cCCCHHHH-HHHHHcC--------
Confidence            6543322   23455778999999987 789999999999999999999 88887 33333332 2222211        


Q ss_pred             CCCCCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 015374          346 RHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH  392 (408)
Q Consensus       346 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~h  392 (408)
                                .....+..++.++.+++.+||+.||++|||+.|++++
T Consensus       236 ----------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~  272 (327)
T 3poz_A          236 ----------ERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIE  272 (327)
T ss_dssp             ----------CCCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHH
T ss_pred             ----------CCCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence                      0111233468899999999999999999999999876

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=1.3e-44  Score=336.71  Aligned_cols=244  Identities=18%  Similarity=0.317  Sum_probs=200.1

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc--chHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccEEE
Q 015374          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV--KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI  200 (408)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  200 (408)
                      ..++|++.+.||+|+||+||+|.+. ++..||+|+++..  ..+.+.+|+.+++++ +||||+++++++.+  ....++|
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~--~~~~~lv   97 (283)
T 3gen_A           22 DPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDEFIEEAKVMMNL-SHEKLVQLYGVCTK--QRPIFII   97 (283)
T ss_dssp             CGGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHHTC-CCTTBCCEEEEECS--SSSEEEE
T ss_pred             CHHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCCCHHHHHHHHHHHhcC-CCCCEeeEEEEEec--CCCeEEE
Confidence            4779999999999999999999765 6778999999753  457799999999999 89999999999954  5678999


Q ss_pred             EEeecCCChhhhc----CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCCCc-
Q 015374          201 FEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE-  275 (408)
Q Consensus       201 ~e~~~~~~l~~~~----~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~~~-  275 (408)
                      |||+++++|..++    ..+++..+..++.|++.||.|||++||+||||||+|||++.+ +.+||+|||++........ 
T Consensus        98 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~-~~~kl~Dfg~~~~~~~~~~~  176 (283)
T 3gen_A           98 TEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQ-GVVKVSDFGLSRYVLDDEYT  176 (283)
T ss_dssp             ECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTT-SCEEECSTTGGGGBCCHHHH
T ss_pred             EeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCC-CCEEEccccccccccccccc
Confidence            9999999998887    358999999999999999999999999999999999999988 7999999999976543221 


Q ss_pred             -ceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCCCcc
Q 015374          276 -YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWS  353 (408)
Q Consensus       276 -~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  353 (408)
                       .....+|..|+|||++.+ ..++.++||||||+++|+|++ |+.|| .+.+..+....+...                 
T Consensus       177 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~~l~t~g~~p~-~~~~~~~~~~~~~~~-----------------  237 (283)
T 3gen_A          177 SSVGSKFPVRWSPPEVLMY-SKFSSKSDIWAFGVLMWEIYSLGKMPY-ERFTNSETAEHIAQG-----------------  237 (283)
T ss_dssp             STTSTTSCGGGCCHHHHHH-CCCSHHHHHHHHHHHHHHHHTTTCCTT-TTSCHHHHHHHHHTT-----------------
T ss_pred             cccCCccCcccCCHHHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCc-cccChhHHHHHHhcc-----------------
Confidence             223345677999999987 679999999999999999998 88887 344444443333321                 


Q ss_pred             ccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 015374          354 KFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH  392 (408)
Q Consensus       354 ~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~h  392 (408)
                        .....+..+++++.+++.+||+.||++|||++|+++|
T Consensus       238 --~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~  274 (283)
T 3gen_A          238 --LRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSN  274 (283)
T ss_dssp             --CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             --cCCCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence              1112233468999999999999999999999999976

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=1.1e-44  Score=342.10  Aligned_cols=245  Identities=18%  Similarity=0.330  Sum_probs=202.0

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEc-----CCCcEEEEEEeccc----chHHHHHHHHHHHHhcCCCCceEEeeEEEccC
Q 015374          123 DQDDYEVVRKVGRGKYSEVFEGINV-----NTNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQH  193 (408)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~Vy~~~~~-----~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~  193 (408)
                      ..++|++.+.||+|+||+||+|++.     .++..||+|+++..    ..+.+.+|+.+++++ +||||+++++++.+  
T Consensus        21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~--   97 (314)
T 2ivs_A           21 PRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQV-NHPHVIKLYGACSQ--   97 (314)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEECS--
T ss_pred             chhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhC-CCCceeeEEEEEec--
Confidence            4688999999999999999999873     45689999999643    236688999999999 99999999999954  


Q ss_pred             CCccEEEEEeecCCChhhhcCC---------------------------CChHHHHHHHHHHHHHHHHHHHCCcEEecCC
Q 015374          194 SKTPSLIFEYVNSTDFKVLYPT---------------------------LTDYDIRYYIYELLKALDYCHSQGIMHRDVK  246 (408)
Q Consensus       194 ~~~~~lv~e~~~~~~l~~~~~~---------------------------l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk  246 (408)
                      ....++||||+++++|..++..                           +++..+..++.|++.||.|||++||+|||||
T Consensus        98 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dik  177 (314)
T 2ivs_A           98 DGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLA  177 (314)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECCCCS
T ss_pred             CCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCcccccc
Confidence            5678999999999999888732                           7888999999999999999999999999999


Q ss_pred             CCcEEEeCCCCcEEEEecccceeccCCCcc---eeeccCccccccccccCCcCCCccccHHHHHHHHHHHHh-CCCCCCC
Q 015374          247 PHNVMIDHELRKLRLIDWGLAEFYHPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFY  322 (408)
Q Consensus       247 ~~NILl~~~~~~~kl~DfG~a~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-g~~pf~~  322 (408)
                      |+|||++.+ +.+||+|||++.........   ....++..|+|||.+.+ ..++.++|||||||++|+|++ |..|| .
T Consensus       178 p~NIli~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~t~g~~p~-~  254 (314)
T 2ivs_A          178 ARNILVAEG-RKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFD-HIYTTQSDVWSFGVLLWEIVTLGGNPY-P  254 (314)
T ss_dssp             GGGEEEETT-TEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCSS-T
T ss_pred             hheEEEcCC-CCEEEccccccccccccccceeccCCCCcccccChhhhcC-CCcCchhhHHHHHHHHHHHHhCCCCCC-C
Confidence            999999988 79999999999876543322   23456778999999987 778999999999999999999 88887 3


Q ss_pred             CCCCHHHHHHHHhhhchhhhhcCCCCCCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 015374          323 GHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH  392 (408)
Q Consensus       323 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~h  392 (408)
                      +.+..+....+...                   .....+..+++++.+++.+||+.||++|||++|++++
T Consensus       255 ~~~~~~~~~~~~~~-------------------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~  305 (314)
T 2ivs_A          255 GIPPERLFNLLKTG-------------------HRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKD  305 (314)
T ss_dssp             TCCGGGHHHHHHTT-------------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCHHHHHHHhhcC-------------------CcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            33333333222211                   0112234578999999999999999999999999875

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=9.9e-45  Score=337.36  Aligned_cols=244  Identities=22%  Similarity=0.392  Sum_probs=191.1

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCC---CcEEEEEEeccc----chHHHHHHHHHHHHhcCCCCceEEeeEEEccCCC
Q 015374          123 DQDDYEVVRKVGRGKYSEVFEGINVNT---NERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSK  195 (408)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~---~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  195 (408)
                      ..++|++.+.||+|+||+||+|++..+   +..||+|+++..    ..+.+.+|+.+++++ +||||+++++++.+   .
T Consensus        13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~---~   88 (281)
T 1mp8_A           13 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQF-DHPHIVKLIGVITE---N   88 (281)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTC-CCTTBCCEEEEECS---S
T ss_pred             ehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhC-CCCccceEEEEEcc---C
Confidence            468999999999999999999998654   456999998642    245688999999999 99999999999843   4


Q ss_pred             ccEEEEEeecCCChhhhcC----CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceecc
Q 015374          196 TPSLIFEYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH  271 (408)
Q Consensus       196 ~~~lv~e~~~~~~l~~~~~----~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~  271 (408)
                      ..++||||+++++|..++.    .+++..+..++.|++.||.|||++||+||||||+|||++.+ +.+||+|||+++...
T Consensus        89 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~-~~~kl~Dfg~~~~~~  167 (281)
T 1mp8_A           89 PVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSN-DCVKLGDFGLSRYME  167 (281)
T ss_dssp             SCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEET-TEEEECC--------
T ss_pred             ccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCC-CCEEECccccccccC
Confidence            6789999999999988873    58999999999999999999999999999999999999988 799999999998765


Q ss_pred             CCCc--ceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCC
Q 015374          272 PGKE--YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHS  348 (408)
Q Consensus       272 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  348 (408)
                      ....  .....++..|+|||++.+ ..++.++|||||||++|+|++ |..|| .+....+....+....           
T Consensus       168 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~ell~~g~~pf-~~~~~~~~~~~i~~~~-----------  234 (281)
T 1mp8_A          168 DSTYYKASKGKLPIKWMAPESINF-RRFTSASDVWMFGVCMWEILMHGVKPF-QGVKNNDVIGRIENGE-----------  234 (281)
T ss_dssp             -----------CCGGGCCHHHHHH-CCCSHHHHHHHHHHHHHHHHTTSCCTT-TTCCGGGHHHHHHTTC-----------
T ss_pred             cccccccccCCCcccccChhhccc-CCCCCccCchHHHHHHHHHHhcCCCCC-CcCCHHHHHHHHHcCC-----------
Confidence            4332  223456678999999986 779999999999999999997 88787 4444444443332210           


Q ss_pred             CCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 015374          349 RKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH  392 (408)
Q Consensus       349 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~h  392 (408)
                              ....+..+++++.+++.+||+.||++|||+.|++++
T Consensus       235 --------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~  270 (281)
T 1mp8_A          235 --------RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ  270 (281)
T ss_dssp             --------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             --------CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence                    111234578999999999999999999999999864

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=2.5e-45  Score=348.35  Aligned_cols=254  Identities=18%  Similarity=0.261  Sum_probs=198.3

Q ss_pred             CCCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecccch--HHHHHHHHHHHHhcCCCCceEEeeEEEccC--CCcc
Q 015374          122 GDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKK--KKIKREIKILQNLCGGPNVVKLLDIVRDQH--SKTP  197 (408)
Q Consensus       122 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~E~~~l~~l~~h~niv~l~~~~~~~~--~~~~  197 (408)
                      ...++|++.++||+|+||+||+|++.  ++.||||+++....  ....+|+.+++++ +||||+++++++.+..  ....
T Consensus        21 ~~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~~~~   97 (322)
T 3soc_A           21 FQSMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQDKQSWQNEYEVYSLPGM-KHENILQFIGAEKRGTSVDVDL   97 (322)
T ss_dssp             ETTEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGGHHHHHHHHHHHTSTTC-CCTTBCCEEEEEEEECSSSEEE
T ss_pred             cchhhchhhheecccCceEEEEEEEC--CCEEEEEEeecCchHHHHHHHHHHHHhcC-CCCCchhhcceeccCCCCCceE
Confidence            35789999999999999999999764  78999999975443  4456788889999 9999999999997643  3357


Q ss_pred             EEEEEeecCCChhhhc--CCCChHHHHHHHHHHHHHHHHHHHC----------CcEEecCCCCcEEEeCCCCcEEEEecc
Q 015374          198 SLIFEYVNSTDFKVLY--PTLTDYDIRYYIYELLKALDYCHSQ----------GIMHRDVKPHNVMIDHELRKLRLIDWG  265 (408)
Q Consensus       198 ~lv~e~~~~~~l~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~----------~iiH~Dlk~~NILl~~~~~~~kl~DfG  265 (408)
                      ++||||+++++|..++  ..+++..+..++.|++.||.|||+.          ||+||||||+|||++.+ +.+||+|||
T Consensus        98 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~-~~~kL~DFg  176 (322)
T 3soc_A           98 WLITAFHEKGSLSDFLKANVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNN-LTACIADFG  176 (322)
T ss_dssp             EEEEECCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTT-CCEEECCCT
T ss_pred             EEEEecCCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCC-CeEEEccCC
Confidence            8999999999999987  4589999999999999999999999          99999999999999988 799999999


Q ss_pred             cceeccCCCc---ceeeccCccccccccccCC----cCCCccccHHHHHHHHHHHHhCCCCCCCCCCC------------
Q 015374          266 LAEFYHPGKE---YNVRVASRYFKGPELLVDL----QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDN------------  326 (408)
Q Consensus       266 ~a~~~~~~~~---~~~~~~~~~y~aPE~~~~~----~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~------------  326 (408)
                      +++.......   .....||..|+|||++.+.    ..++.++|||||||++|||++|+.||....+.            
T Consensus       177 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~  256 (322)
T 3soc_A          177 LALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQH  256 (322)
T ss_dssp             TCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSS
T ss_pred             cccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccC
Confidence            9987654332   2335789999999999762    34567889999999999999999998543221            


Q ss_pred             --HHHHHHHHhhhchhhhhcCCCCCCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 015374          327 --HDQLVKIAKDCCLIIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA  391 (408)
Q Consensus       327 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~  391 (408)
                        .+.+......         ..........   ......++++.+|+.+||+.||++|||++|+++
T Consensus       257 ~~~~~~~~~~~~---------~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~  311 (322)
T 3soc_A          257 PSLEDMQEVVVH---------KKKRPVLRDY---WQKHAGMAMLCETIEECWDHDAEARLSAGCVGE  311 (322)
T ss_dssp             CCHHHHHHHHTT---------SCCCCCCCGG---GGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             Cchhhhhhhhhc---------ccCCCCcccc---ccccchHHHHHHHHHHHccCChhhCcCHHHHHH
Confidence              1111111110         0011111110   011113466999999999999999999999986

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=1.4e-44  Score=336.18  Aligned_cols=246  Identities=20%  Similarity=0.327  Sum_probs=207.9

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecccchHHHHHHHHHHHHhcCCCCceEEeeEEEc-----------
Q 015374          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRD-----------  191 (408)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~-----------  191 (408)
                      ..++|++.+.||+|+||.||+|++..+++.||+|+++.. ...+.+|+.+++++ +||||+++++++..           
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~~~~~~   86 (284)
T 2a19_B            9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYN-NEKAEREVKALAKL-DHVNIVHYNGCWDGFDYDPETSSKN   86 (284)
T ss_dssp             HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECC-SGGGHHHHHHHHHC-CCTTBCCEEEEEEEEEEC-------
T ss_pred             hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEeccc-cHHHHHHHHHHHhC-CCCCEEEEeeeEeccccCccccccc
Confidence            356899999999999999999999999999999999743 35678999999999 99999999998854           


Q ss_pred             ---cCCCccEEEEEeecCCChhhhc-----CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEe
Q 015374          192 ---QHSKTPSLIFEYVNSTDFKVLY-----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLID  263 (408)
Q Consensus       192 ---~~~~~~~lv~e~~~~~~l~~~~-----~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~D  263 (408)
                         ......++||||+++++|..++     ..+++..+..++.|++.||.|||++||+|+||||+|||++.+ +.+||+|
T Consensus        87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~-~~~kl~D  165 (284)
T 2a19_B           87 SSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDT-KQVKIGD  165 (284)
T ss_dssp             --CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEET-TEEEECC
T ss_pred             ccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCC-CCEEECc
Confidence               1234578999999999999887     358999999999999999999999999999999999999988 7999999


Q ss_pred             cccceeccCCCcceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhh
Q 015374          264 WGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWC  343 (408)
Q Consensus       264 fG~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  343 (408)
                      ||++.............++..|+|||++.+ ..++.++||||||+++|+|++|..||+..   ......+..        
T Consensus       166 fg~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~~~~~~~~---~~~~~~~~~--------  233 (284)
T 2a19_B          166 FGLVTSLKNDGKRTRSKGTLRYMSPEQISS-QDYGKEVDLYALGLILAELLHVCDTAFET---SKFFTDLRD--------  233 (284)
T ss_dssp             CTTCEESSCCSCCCCCCSCCTTSCHHHHHC-SCCCTHHHHHHHHHHHHHHHSCCSSHHHH---HHHHHHHHT--------
T ss_pred             chhheeccccccccccCCcccccChhhhcc-CCCcchhhhHHHHHHHHHHHhcCCcchhH---HHHHHHhhc--------
Confidence            999988766555566789999999999987 77899999999999999999999887311   111111100        


Q ss_pred             cCCCCCCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccc
Q 015374          344 NSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQ  397 (408)
Q Consensus       344 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~  397 (408)
                                    ...+..++.++.+++.+||+.||++|||+.|+++|.+.-.
T Consensus       234 --------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~  273 (284)
T 2a19_B          234 --------------GIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWK  273 (284)
T ss_dssp             --------------TCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHT
T ss_pred             --------------ccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence                          1112336889999999999999999999999999987543

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=8.5e-45  Score=345.12  Aligned_cols=245  Identities=17%  Similarity=0.287  Sum_probs=198.4

Q ss_pred             CCCCCEEEEeeeeeeCceEEEEEEEcCCCcE----EEEEEeccc----chHHHHHHHHHHHHhcCCCCceEEeeEEEccC
Q 015374          122 GDQDDYEVVRKVGRGKYSEVFEGINVNTNER----CIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQH  193 (408)
Q Consensus       122 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~----vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~  193 (408)
                      ...++|++.+.||+|+||+||+|++..++..    ||+|.+...    ....+.+|+.+++++ +||||++++++|.+  
T Consensus        10 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~--   86 (325)
T 3kex_A           10 FKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSL-DHAHIVRLLGLCPG--   86 (325)
T ss_dssp             CCTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTC-CCTTBCCEEEEECB--
T ss_pred             cCHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcC-CCCCcCeEEEEEcC--
Confidence            3578999999999999999999999888876    777776432    235678899999999 99999999999853  


Q ss_pred             CCccEEEEEeecCCChhhhc----CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEeccccee
Q 015374          194 SKTPSLIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEF  269 (408)
Q Consensus       194 ~~~~~lv~e~~~~~~l~~~~----~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~  269 (408)
                       ...++||||+.+++|..++    ..+++..+..++.|++.||.|||++||+||||||+|||++.+ +.+||+|||+++.
T Consensus        87 -~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~-~~~kl~Dfg~a~~  164 (325)
T 3kex_A           87 -SSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSP-SQVQVADFGVADL  164 (325)
T ss_dssp             -SSEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSS-SCEEECSCSGGGG
T ss_pred             -CccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCC-CeEEECCCCcccc
Confidence             4678999999999998876    258899999999999999999999999999999999999988 7999999999987


Q ss_pred             ccCCC---cceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHhhhchhhhhcC
Q 015374          270 YHPGK---EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKDCCLIIWCNS  345 (408)
Q Consensus       270 ~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  345 (408)
                      .....   ......++..|+|||++.+ ..++.++|||||||++|+|++ |..||. +....+....+...         
T Consensus       165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~-~~~~~~~~~~~~~~---------  233 (325)
T 3kex_A          165 LPPDDKQLLYSEAKTPIKWMALESIHF-GKYTHQSDVWSYGVTVWELMTFGAEPYA-GLRLAEVPDLLEKG---------  233 (325)
T ss_dssp             SCCCTTCCC-----CCTTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTT-TSCTTHHHHHHHTT---------
T ss_pred             cCcccccccccCCCCcccccChHHhcc-CCCChhhHhHHhHHHHHHHHhCCCCCcc-ccCHHHHHHHHHcC---------
Confidence            65432   2344567778999999987 779999999999999999999 998874 33333333222211         


Q ss_pred             CCCCCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 015374          346 RHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH  392 (408)
Q Consensus       346 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~h  392 (408)
                                .....+..++.++.+++.+||+.||++|||+.|++++
T Consensus       234 ----------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~  270 (325)
T 3kex_A          234 ----------ERLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANE  270 (325)
T ss_dssp             ----------CBCCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHH
T ss_pred             ----------CCCCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                      0112223367789999999999999999999999876

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=3e-44  Score=336.48  Aligned_cols=250  Identities=15%  Similarity=0.234  Sum_probs=205.4

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecc-cchHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccEEEE
Q 015374          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP-VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIF  201 (408)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~-~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~  201 (408)
                      ..++|++.+.||+|+||+||+|++..+++.||+|++.. .....+.+|+.+++.+.+|+|++++++++.+  ....++||
T Consensus         8 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~--~~~~~lv~   85 (298)
T 1csn_A            8 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQE--GLHNVLVI   85 (298)
T ss_dssp             ETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEEEE--TTEEEEEE
T ss_pred             cccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCccHHHHHHHHHHHHHhcCCCCCeEEeecCC--CceeEEEE
Confidence            46789999999999999999999999999999999864 3446789999999999889999999999954  46788999


Q ss_pred             EeecCCChhhhcC----CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCc-----EEEEecccceeccC
Q 015374          202 EYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRK-----LRLIDWGLAEFYHP  272 (408)
Q Consensus       202 e~~~~~~l~~~~~----~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~-----~kl~DfG~a~~~~~  272 (408)
                      ||+ +++|..++.    .+++..+..++.|++.||.|||++||+||||||+|||++.+ +.     +||+|||++.....
T Consensus        86 e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~-~~~~~~~~kl~Dfg~~~~~~~  163 (298)
T 1csn_A           86 DLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRP-NSKNANMIYVVDFGMVKFYRD  163 (298)
T ss_dssp             ECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCS-SSTTTTCEEECCCTTCEESBC
T ss_pred             Eec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccC-CCCCCCeEEEEECcccccccc
Confidence            999 899988873    58999999999999999999999999999999999999876 33     99999999987654


Q ss_pred             CCc--------ceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCC--CHHHHHHHHhhhchhhh
Q 015374          273 GKE--------YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHD--NHDQLVKIAKDCCLIIW  342 (408)
Q Consensus       273 ~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~--~~~~~~~~~~~~~~~~~  342 (408)
                      ...        .....||..|+|||++.+ ..++.++|||||||++|+|++|+.||.....  ..+.+..+........ 
T Consensus       164 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-  241 (298)
T 1csn_A          164 PVTKQHIPYREKKNLSGTARYMSINTHLG-REQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTP-  241 (298)
T ss_dssp             TTTCCBCCCCCCCCCCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSC-
T ss_pred             ccccccccccCccCCCCCcccCCchhhcC-CCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCcc-
Confidence            322        244578999999999987 7789999999999999999999999854332  2223333322211000 


Q ss_pred             hcCCCCCCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 015374          343 CNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH  392 (408)
Q Consensus       343 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~h  392 (408)
                                    .......+++++.+++.+||+.||++|||++++++.
T Consensus       242 --------------~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~  277 (298)
T 1csn_A          242 --------------LRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGL  277 (298)
T ss_dssp             --------------HHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHH
T ss_pred             --------------HHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence                          011122478999999999999999999999998754

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=2.8e-44  Score=332.17  Aligned_cols=244  Identities=17%  Similarity=0.342  Sum_probs=192.4

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc-------chHHHHHHHHHHHHhcCCCCceEEeeEEEccCCC
Q 015374          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSK  195 (408)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  195 (408)
                      ..++|++.+.||+|+||+||+|.+.  ++.||||+++..       ..+.+.+|+.+++.+ +||||+++++++.+  ..
T Consensus         5 ~~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~   79 (271)
T 3dtc_A            5 DFAELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAML-KHPNIIALRGVCLK--EP   79 (271)
T ss_dssp             CTTSEEEEEEEEEETTEEEEEEEET--TEEEEEEEC----------CHHHHHHHHHHHHHC-CCTTBCCEEEEECC--C-
T ss_pred             chhheeeeeeeccCCCeEEEEEEEc--CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhc-CCCCEeeEEEEEec--CC
Confidence            4678999999999999999999864  889999998632       235688999999999 99999999999954  46


Q ss_pred             ccEEEEEeecCCChhhhc--CCCChHHHHHHHHHHHHHHHHHHHCC---cEEecCCCCcEEEeCC-------CCcEEEEe
Q 015374          196 TPSLIFEYVNSTDFKVLY--PTLTDYDIRYYIYELLKALDYCHSQG---IMHRDVKPHNVMIDHE-------LRKLRLID  263 (408)
Q Consensus       196 ~~~lv~e~~~~~~l~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~Dlk~~NILl~~~-------~~~~kl~D  263 (408)
                      ..++||||+++++|..++  ..+++..+..++.|++.||.|||++|   |+||||||+|||++.+       .+.+||+|
T Consensus        80 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~D  159 (271)
T 3dtc_A           80 NLCLVMEFARGGPLNRVLSGKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITD  159 (271)
T ss_dssp             -CEEEEECCTTEEHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECC
T ss_pred             ceEEEEEcCCCCCHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEcc
Confidence            789999999999999887  46899999999999999999999999   9999999999999862       36899999


Q ss_pred             cccceeccCCCcceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhh
Q 015374          264 WGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWC  343 (408)
Q Consensus       264 fG~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  343 (408)
                      ||++....... .....|+..|+|||.+.+ ..++.++||||||+++|+|++|+.||. +.+............      
T Consensus       160 fg~~~~~~~~~-~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~-~~~~~~~~~~~~~~~------  230 (271)
T 3dtc_A          160 FGLAREWHRTT-KMSAAGAYAWMAPEVIRA-SMFSKGSDVWSYGVLLWELLTGEVPFR-GIDGLAVAYGVAMNK------  230 (271)
T ss_dssp             CCC--------------CCGGGSCHHHHHH-CCCSHHHHHHHHHHHHHHHHHCCCTTT-TSCHHHHHHHHHTSC------
T ss_pred             CCccccccccc-ccCCCCccceeCHHHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCC-CCCHHHHHHhhhcCC------
Confidence            99998665332 334678999999999987 779999999999999999999999984 333333322222110      


Q ss_pred             cCCCCCCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 015374          344 NSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH  392 (408)
Q Consensus       344 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~h  392 (408)
                                  .....+..+++++.+++.+||+.||++|||++|++++
T Consensus       231 ------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~  267 (271)
T 3dtc_A          231 ------------LALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQ  267 (271)
T ss_dssp             ------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ------------CCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence                        1112234578999999999999999999999999874

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=2.7e-44  Score=339.65  Aligned_cols=256  Identities=24%  Similarity=0.423  Sum_probs=199.4

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc-----chHHHHHHHHHHHHhcC-CCCceEEeeEEEccCCCc
Q 015374          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCG-GPNVVKLLDIVRDQHSKT  196 (408)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~-h~niv~l~~~~~~~~~~~  196 (408)
                      ..++|++.+.||+|+||+||+|.+. +++.||+|+++..     ..+.+.+|+.++.++.+ |+||+++++++.+  ...
T Consensus        26 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~--~~~  102 (313)
T 3cek_A           26 KGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT--DQY  102 (313)
T ss_dssp             TTEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEEC--SSE
T ss_pred             ccceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeec--CCE
Confidence            4678999999999999999999874 5889999998532     34678899999999943 6999999999965  467


Q ss_pred             cEEEEEeecCCChhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCC
Q 015374          197 PSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG  273 (408)
Q Consensus       197 ~~lv~e~~~~~~l~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~  273 (408)
                      .++||| +.+++|..++   ..+++..+..++.|++.||.|||++||+||||||+|||+++  +.+||+|||++......
T Consensus       103 ~~lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~--~~~kL~Dfg~~~~~~~~  179 (313)
T 3cek_A          103 IYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD--GMLKLIDFGIANQMQPD  179 (313)
T ss_dssp             EEEEEC-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEET--TEEEECCCSSSCC----
T ss_pred             EEEEEe-cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEEC--CeEEEeeccccccccCc
Confidence            899999 6677887776   45899999999999999999999999999999999999975  68999999999866433


Q ss_pred             Cc---ceeeccCccccccccccCC----------cCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchh
Q 015374          274 KE---YNVRVASRYFKGPELLVDL----------QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLI  340 (408)
Q Consensus       274 ~~---~~~~~~~~~y~aPE~~~~~----------~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~  340 (408)
                      ..   .....|+..|+|||++.+.          ..++.++|||||||++|+|++|+.||....+....+..+....   
T Consensus       180 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~---  256 (313)
T 3cek_A          180 TTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPN---  256 (313)
T ss_dssp             ----------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTT---
T ss_pred             cccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHHhcc---
Confidence            22   2345789999999998641          3688899999999999999999999854444333333322210   


Q ss_pred             hhhcCCCCCCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccccccch
Q 015374          341 IWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAE  402 (408)
Q Consensus       341 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~~~~~~  402 (408)
                                     .....+...++++.+++.+||+.||++|||++|+++||||+......
T Consensus       257 ---------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~~~  303 (313)
T 3cek_A          257 ---------------HEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPV  303 (313)
T ss_dssp             ---------------SCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHCC----
T ss_pred             ---------------cccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCccccCCCCch
Confidence                           01112233578999999999999999999999999999998765443

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=7.6e-44  Score=339.40  Aligned_cols=254  Identities=19%  Similarity=0.329  Sum_probs=206.4

Q ss_pred             CCCCCEEEEeeeeeeCceEEEEEEEcCCCc-----EEEEEEeccc----chHHHHHHHHHHHHhcCCCCceEEeeEEEcc
Q 015374          122 GDQDDYEVVRKVGRGKYSEVFEGINVNTNE-----RCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQ  192 (408)
Q Consensus       122 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~-----~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~  192 (408)
                      ...++|++.+.||+|+||+||+|.+..++.     .||+|+++..    ..+.+.+|+.+++++.+||||++++++|.+ 
T Consensus        43 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~-  121 (333)
T 2i1m_A           43 FPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTH-  121 (333)
T ss_dssp             CCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred             CCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEec-
Confidence            457899999999999999999999876654     7999998743    346788999999999789999999999954 


Q ss_pred             CCCccEEEEEeecCCChhhhcC-----------------CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCC
Q 015374          193 HSKTPSLIFEYVNSTDFKVLYP-----------------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE  255 (408)
Q Consensus       193 ~~~~~~lv~e~~~~~~l~~~~~-----------------~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~  255 (408)
                       ....++||||+++++|..++.                 .+++..+..++.|++.||.|||++||+||||||+|||++.+
T Consensus       122 -~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~  200 (333)
T 2i1m_A          122 -GGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNG  200 (333)
T ss_dssp             -SSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEEGG
T ss_pred             -CCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEECCC
Confidence             567899999999999988762                 36889999999999999999999999999999999999988


Q ss_pred             CCcEEEEecccceeccCCCcc---eeeccCccccccccccCCcCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHH
Q 015374          256 LRKLRLIDWGLAEFYHPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLV  331 (408)
Q Consensus       256 ~~~~kl~DfG~a~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-g~~pf~~~~~~~~~~~  331 (408)
                       +.+||+|||++.........   ....+|..|+|||++.+ ..++.++|||||||++|+|++ |..||. +....+.+.
T Consensus       201 -~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~t~g~~p~~-~~~~~~~~~  277 (333)
T 2i1m_A          201 -HVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFD-CVYTVQSDVWSYGILLWEIFSLGLNPYP-GILVNSKFY  277 (333)
T ss_dssp             -GEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHTTTSCCSST-TCCSSHHHH
T ss_pred             -CeEEECccccccccccccceeecCCCCCCccccCHHHhcc-CCCChHHHHHHHHHHHHHHHcCCCCCCc-ccchhHHHH
Confidence             79999999999866433322   23456778999999987 779999999999999999998 777874 333333333


Q ss_pred             HHHhhhchhhhhcCCCCCCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccccc
Q 015374          332 KIAKDCCLIIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRA  400 (408)
Q Consensus       332 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~~~~  400 (408)
                      ......                  .....+..+++++.+++.+||+.||.+|||++|+++  +|+.+..
T Consensus       278 ~~~~~~------------------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~--~L~~~~~  326 (333)
T 2i1m_A          278 KLVKDG------------------YQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICS--FLQEQAQ  326 (333)
T ss_dssp             HHHHHT------------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH--HHHHHHH
T ss_pred             HHHhcC------------------CCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHH--HHHHHHH
Confidence            333221                  011123346899999999999999999999999997  4554433

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=9.4e-45  Score=344.99  Aligned_cols=253  Identities=19%  Similarity=0.291  Sum_probs=205.3

Q ss_pred             CCCCCEEEEeeeeeeCceEEEEEE----EcCCCcEEEEEEecccc---hHHHHHHHHHHHHhcCCCCceEEeeEEEccCC
Q 015374          122 GDQDDYEVVRKVGRGKYSEVFEGI----NVNTNERCIIKILKPVK---KKKIKREIKILQNLCGGPNVVKLLDIVRDQHS  194 (408)
Q Consensus       122 ~~~~~y~~~~~lG~G~fg~Vy~~~----~~~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~  194 (408)
                      ...++|++.+.||+|+||+||+|+    +..+++.||||+++...   .+.+.+|+.+++++ +||||+++++++.....
T Consensus        20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~   98 (327)
T 3lxl_A           20 FEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKAL-HSDFIVKYRGVSYGPGR   98 (327)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEECSSS
T ss_pred             hchhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhc-CCCceeEEEEEEecCCC
Confidence            356899999999999999999998    56789999999997543   35688999999999 99999999999987667


Q ss_pred             CccEEEEEeecCCChhhhcC----CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceec
Q 015374          195 KTPSLIFEYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY  270 (408)
Q Consensus       195 ~~~~lv~e~~~~~~l~~~~~----~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~  270 (408)
                      ...++||||+++++|..++.    .+++..+..++.|++.||.|||++||+||||||+|||++.+ +.+||+|||++...
T Consensus        99 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~-~~~kl~Dfg~~~~~  177 (327)
T 3lxl_A           99 QSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESE-AHVKIADFGLAKLL  177 (327)
T ss_dssp             CEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEET-TEEEECCGGGCEEC
T ss_pred             ceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCC-CCEEEcccccceec
Confidence            78899999999999988873    48999999999999999999999999999999999999988 79999999999876


Q ss_pred             cCCCc----ceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHH----------HHHHHHhh
Q 015374          271 HPGKE----YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHD----------QLVKIAKD  336 (408)
Q Consensus       271 ~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~----------~~~~~~~~  336 (408)
                      .....    .....+|..|+|||++.+ ..++.++|||||||++|+|++|+.||........          ....+...
T Consensus       178 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (327)
T 3lxl_A          178 PLDKDYYVVREPGQSPIFWYAPESLSD-NIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLEL  256 (327)
T ss_dssp             CTTCSEEECSSCCCSCGGGSCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHH
T ss_pred             ccCCccceeeccCCccccccCHHHhcc-CCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHH
Confidence            54432    223457778999999987 6789999999999999999999999843211000          00000000


Q ss_pred             hchhhhhcCCCCCCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 015374          337 CCLIIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH  392 (408)
Q Consensus       337 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~h  392 (408)
                      .               ........+..+++++.+++.+||+.||++|||++|++++
T Consensus       257 ~---------------~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  297 (327)
T 3lxl_A          257 L---------------EEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQ  297 (327)
T ss_dssp             H---------------HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             h---------------hcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            0               0001122244578999999999999999999999999644

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=1.4e-44  Score=344.37  Aligned_cols=248  Identities=19%  Similarity=0.261  Sum_probs=201.6

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecc-cchHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccEEEE
Q 015374          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP-VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIF  201 (408)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~-~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~  201 (408)
                      ..++|++.+.||+|+||+||+|++..+++.||||++.. ...+.+.+|+.+++++.+||||+++++++.+  ....++||
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~--~~~~~lv~   84 (330)
T 2izr_A            7 VGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGDGIPQVYYFGPC--GKYNAMVL   84 (330)
T ss_dssp             ETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSSCCHHHHHHHHHHHCSCTTSCCEEEEEEE--TTEEEEEE
T ss_pred             EcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHhhCCCCCCEEEEEEec--CCccEEEE
Confidence            35789999999999999999999999999999999864 3345789999999999889999999999966  46788999


Q ss_pred             EeecCCChhhhc----CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCc-----EEEEecccceeccC
Q 015374          202 EYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRK-----LRLIDWGLAEFYHP  272 (408)
Q Consensus       202 e~~~~~~l~~~~----~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~-----~kl~DfG~a~~~~~  272 (408)
                      ||+ +++|..++    ..+++..+..++.|++.||+|||++||+||||||+|||++.+ +.     +||+|||+++....
T Consensus        85 e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~-~~~~~~~~kl~DFg~a~~~~~  162 (330)
T 2izr_A           85 ELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRP-GNKTQQVIHIIDFALAKEYID  162 (330)
T ss_dssp             ECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCG-GGTCTTSEEECCCTTCEESBC
T ss_pred             EeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccC-CCCCCceEEEEEcccceeeec
Confidence            999 88888876    369999999999999999999999999999999999999987 55     99999999987654


Q ss_pred             CCc--------ceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCC-CH-HHHHHHHhhhchhhh
Q 015374          273 GKE--------YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHD-NH-DQLVKIAKDCCLIIW  342 (408)
Q Consensus       273 ~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~-~~-~~~~~~~~~~~~~~~  342 (408)
                      ...        .....||..|+|||++.+ ..++.++|||||||++|||++|..||..... +. +.+..+........ 
T Consensus       163 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~-  240 (330)
T 2izr_A          163 PETKKHIPYREHKSLTGTARYMSINTHLG-KEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATP-  240 (330)
T ss_dssp             TTTCCBCCCCCCCCCCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHSC-
T ss_pred             CCCCccccccccCCcCCCccccChHHHcC-CCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccCC-
Confidence            322        245679999999999988 7899999999999999999999999854322 22 22222222110000 


Q ss_pred             hcCCCCCCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 015374          343 CNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA  391 (408)
Q Consensus       343 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~  391 (408)
                                    .......++ ++.+++..||+.||.+|||++++++
T Consensus       241 --------------~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~  274 (330)
T 2izr_A          241 --------------IEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRK  274 (330)
T ss_dssp             --------------HHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred             --------------HHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHH
Confidence                          000011134 8999999999999999999998876

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=5.3e-44  Score=340.89  Aligned_cols=247  Identities=19%  Similarity=0.303  Sum_probs=201.8

Q ss_pred             CCCCCEEEEeeeeeeCceEEEEEEEc-------CCCcEEEEEEeccc----chHHHHHHHHHHHHhcCCCCceEEeeEEE
Q 015374          122 GDQDDYEVVRKVGRGKYSEVFEGINV-------NTNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVR  190 (408)
Q Consensus       122 ~~~~~y~~~~~lG~G~fg~Vy~~~~~-------~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~  190 (408)
                      ...++|++.+.||+|+||+||+|++.       .++..||+|+++..    ....+.+|+.+++++.+||||++++++|.
T Consensus        32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~  111 (334)
T 2pvf_A           32 FPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT  111 (334)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             CCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEc
Confidence            35689999999999999999999875       45678999999743    23568899999999978999999999995


Q ss_pred             ccCCCccEEEEEeecCCChhhhcC-------------------CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEE
Q 015374          191 DQHSKTPSLIFEYVNSTDFKVLYP-------------------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVM  251 (408)
Q Consensus       191 ~~~~~~~~lv~e~~~~~~l~~~~~-------------------~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NIL  251 (408)
                      +  ....++||||+++++|..++.                   .+++..+..++.|++.||.|||++||+||||||+|||
T Consensus       112 ~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIl  189 (334)
T 2pvf_A          112 Q--DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVL  189 (334)
T ss_dssp             S--SSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEE
T ss_pred             c--CCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccceEE
Confidence            4  567899999999999988873                   2788899999999999999999999999999999999


Q ss_pred             EeCCCCcEEEEecccceeccCCCc---ceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCH
Q 015374          252 IDHELRKLRLIDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNH  327 (408)
Q Consensus       252 l~~~~~~~kl~DfG~a~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-g~~pf~~~~~~~  327 (408)
                      ++.+ +.+||+|||++........   .....++..|+|||++.+ ..++.++|||||||++|+|++ |..|| .+.+..
T Consensus       190 l~~~-~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~-~~~~~~  266 (334)
T 2pvf_A          190 VTEN-NVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLMWEIFTLGGSPY-PGIPVE  266 (334)
T ss_dssp             ECTT-CCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCSS-TTCCHH
T ss_pred             EcCC-CCEEEccccccccccccccccccCCCCcccceeChHHhcC-CCcChHHHHHHHHHHHHHHHhCCCCCc-CcCCHH
Confidence            9988 7999999999987654332   223456778999999987 678999999999999999999 88887 344433


Q ss_pred             HHHHHHHhhhchhhhhcCCCCCCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 015374          328 DQLVKIAKDCCLIIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH  392 (408)
Q Consensus       328 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~h  392 (408)
                      +....+...                   .....+..++.++.+++.+||+.||++|||++|++++
T Consensus       267 ~~~~~~~~~-------------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  312 (334)
T 2pvf_A          267 ELFKLLKEG-------------------HRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED  312 (334)
T ss_dssp             HHHHHHHHT-------------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHhcC-------------------CCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            333332221                   0112233478999999999999999999999999875

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=2.4e-44  Score=339.97  Aligned_cols=248  Identities=20%  Similarity=0.332  Sum_probs=204.1

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEE-----cCCCcEEEEEEeccc----chHHHHHHHHHHHHhcCCCCceEEeeEEEccC
Q 015374          123 DQDDYEVVRKVGRGKYSEVFEGIN-----VNTNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQH  193 (408)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~Vy~~~~-----~~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~  193 (408)
                      ..++|++.+.||+|+||+||+|++     ..+++.||||+++..    ....+.+|+.++.++.+||||+++++++... 
T Consensus        25 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~-  103 (316)
T 2xir_A           25 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP-  103 (316)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCT-
T ss_pred             chhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecC-
Confidence            468999999999999999999985     356789999998743    2356889999999997799999999998654 


Q ss_pred             CCccEEEEEeecCCChhhhcCC-------------------CChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeC
Q 015374          194 SKTPSLIFEYVNSTDFKVLYPT-------------------LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDH  254 (408)
Q Consensus       194 ~~~~~lv~e~~~~~~l~~~~~~-------------------l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~  254 (408)
                      +...++||||+++++|..++..                   +++..+..++.|++.||.|||++||+||||||+|||++.
T Consensus       104 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~  183 (316)
T 2xir_A          104 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSE  183 (316)
T ss_dssp             TSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECG
T ss_pred             CCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECC
Confidence            3568999999999999988732                   788899999999999999999999999999999999998


Q ss_pred             CCCcEEEEecccceeccCCCc---ceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHH
Q 015374          255 ELRKLRLIDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQL  330 (408)
Q Consensus       255 ~~~~~kl~DfG~a~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-g~~pf~~~~~~~~~~  330 (408)
                      + +.+||+|||++........   .....+|..|+|||++.+ ..++.++|||||||++|+|++ |..||..........
T Consensus       184 ~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~  261 (316)
T 2xir_A          184 K-NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC  261 (316)
T ss_dssp             G-GCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHH
T ss_pred             C-CCEEECCCccccccccCccceeccCCCcceeecCchhhcc-ccccchhHHHHHHHHHHHHHhCCCCCCcccchhHHHH
Confidence            8 7899999999987654332   223467788999999987 789999999999999999998 888875444444333


Q ss_pred             HHHHhhhchhhhhcCCCCCCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 015374          331 VKIAKDCCLIIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH  392 (408)
Q Consensus       331 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~h  392 (408)
                      ..+....                   ....+..+++++.+++.+||+.||.+|||++|+++|
T Consensus       262 ~~~~~~~-------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  304 (316)
T 2xir_A          262 RRLKEGT-------------------RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  304 (316)
T ss_dssp             HHHHHTC-------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHhccCc-------------------cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            3332210                   111233478999999999999999999999999986

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=7.1e-44  Score=353.59  Aligned_cols=242  Identities=17%  Similarity=0.330  Sum_probs=200.6

Q ss_pred             CCCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc-chHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccEEE
Q 015374          122 GDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI  200 (408)
Q Consensus       122 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  200 (408)
                      ...++|++.+.||+|+||+||+|.+.  ++.||||+++.. ..+.+.+|+.+++++ +||||+++++++.+. ....++|
T Consensus       190 i~~~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~-~~~~~iv  265 (450)
T 1k9a_A          190 LNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDATAQAFLAEASVMTQL-RHSNLVQLLGVIVEE-KGGLYIV  265 (450)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCTTSHHHHHHHHHHHTC-CCTTBCCEEEEEECT-TSCEEEE
T ss_pred             cChHHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCchHHHHHHHHHHHHHhc-cCCCEEEEEEEEEcC-CCceEEE
Confidence            35678999999999999999999764  779999999754 457799999999999 999999999998654 2468899


Q ss_pred             EEeecCCChhhhcC-----CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCCCc
Q 015374          201 FEYVNSTDFKVLYP-----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE  275 (408)
Q Consensus       201 ~e~~~~~~l~~~~~-----~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~~~  275 (408)
                      |||+++++|..++.     .+++..+..++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+++.....  
T Consensus       266 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~-~~~kl~DfG~a~~~~~~--  342 (450)
T 1k9a_A          266 TEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSED-NVAKVSDFGLTKEASST--  342 (450)
T ss_dssp             EECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTT-SCEEECCCTTCEECC----
T ss_pred             EEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCC-CCEEEeeCCCccccccc--
Confidence            99999999998873     27889999999999999999999999999999999999988 79999999999865422  


Q ss_pred             ceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCCCccc
Q 015374          276 YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSK  354 (408)
Q Consensus       276 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  354 (408)
                      .....++..|+|||++.+ ..++.++|||||||++|||++ |..|| .+.+..+....+...                  
T Consensus       343 ~~~~~~~~~y~aPE~~~~-~~~~~~sDvwslG~~l~el~t~g~~P~-~~~~~~~~~~~i~~~------------------  402 (450)
T 1k9a_A          343 QDTGKLPVKWTAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPY-PRIPLKDVVPRVEKG------------------  402 (450)
T ss_dssp             ----CCCTTTSCHHHHHS-SCCCHHHHHHHHHHHHHHHHTTTCCSS-TTSCTTTHHHHHHTT------------------
T ss_pred             ccCCCCCcceeCHHHhcC-CCCCcHHHHHHHHHHHHHHHhCCCCCC-CCCCHHHHHHHHHcC------------------
Confidence            223467788999999987 789999999999999999998 88887 444444443333221                  


Q ss_pred             cccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 015374          355 FINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA  391 (408)
Q Consensus       355 ~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~  391 (408)
                       .....+..+++++.++|.+||+.||++|||+.++++
T Consensus       403 -~~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~  438 (450)
T 1k9a_A          403 -YKMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLRE  438 (450)
T ss_dssp             -CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             -CCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence             112234458899999999999999999999999975

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=4.7e-44  Score=335.93  Aligned_cols=260  Identities=21%  Similarity=0.324  Sum_probs=201.2

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEE----EcCCCcEEEEEEeccc----chHHHHHHHHHHHHhcCCCCceEEeeEEEccCC
Q 015374          123 DQDDYEVVRKVGRGKYSEVFEGI----NVNTNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHS  194 (408)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~Vy~~~----~~~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~  194 (408)
                      ...+|++.+.||+|+||+||+|+    +..+++.||+|+++..    ....+.+|+.+++++ +||||+++++++.+...
T Consensus        19 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~   97 (302)
T 4e5w_A           19 EKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNL-YHENIVKYKGICTEDGG   97 (302)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTC-CCTTBCCEEEEEEC---
T ss_pred             hhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhC-CCCCeeeeeeEEecCCC
Confidence            46679999999999999999998    5678999999998743    346789999999999 99999999999987666


Q ss_pred             CccEEEEEeecCCChhhhc----CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceec
Q 015374          195 KTPSLIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY  270 (408)
Q Consensus       195 ~~~~lv~e~~~~~~l~~~~----~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~  270 (408)
                      ...++||||+++++|..++    ..+++..+..++.|++.||.|||++||+||||||+|||++.+ +.+||+|||++...
T Consensus        98 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~-~~~kl~Dfg~~~~~  176 (302)
T 4e5w_A           98 NGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESE-HQVKIGDFGLTKAI  176 (302)
T ss_dssp             CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEET-TEEEECCCTTCEEC
T ss_pred             ceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCC-CCEEECcccccccc
Confidence            7789999999999999887    458999999999999999999999999999999999999988 79999999999877


Q ss_pred             cCCCc----ceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhc-hhhhhcC
Q 015374          271 HPGKE----YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCC-LIIWCNS  345 (408)
Q Consensus       271 ~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~-~~~~~~~  345 (408)
                      .....    .....+|..|+|||++.+ ..++.++||||||+++|+|++|..|+...   ............ .......
T Consensus       177 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~---~~~~~~~~~~~~~~~~~~~~  252 (302)
T 4e5w_A          177 ETDKEYYTVKDDRDSPVFWYAPECLMQ-SKFYIASDVWSFGVTLHELLTYCDSDSSP---MALFLKMIGPTHGQMTVTRL  252 (302)
T ss_dssp             CTTCCEEECCCCTTCCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTTCGGGSH---HHHHHHHHCSCCGGGHHHHH
T ss_pred             cCCCcceeccCCCCCCccccCCeeecC-CCCCcchhHHHHHHHHHHHHHccCCCcch---hhHHhhccCCcccccCHHHH
Confidence            65432    223467778999999987 67889999999999999999999875211   111111000000 0000000


Q ss_pred             CCCCCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 015374          346 RHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA  391 (408)
Q Consensus       346 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~  391 (408)
                         ............+..+++++.+++.+||+.||++|||++|+++
T Consensus       253 ---~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  295 (302)
T 4e5w_A          253 ---VNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE  295 (302)
T ss_dssp             ---HHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred             ---HHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence               0000000112233457899999999999999999999999985

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=3.6e-44  Score=346.19  Aligned_cols=254  Identities=14%  Similarity=0.194  Sum_probs=195.7

Q ss_pred             CCCCCEEEEeeeeeeCceEEEEEEEcCC-----CcEEEEEEecccchHHHHHHHH---------------HHHHhcCCCC
Q 015374          122 GDQDDYEVVRKVGRGKYSEVFEGINVNT-----NERCIIKILKPVKKKKIKREIK---------------ILQNLCGGPN  181 (408)
Q Consensus       122 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~-----~~~vavK~~~~~~~~~~~~E~~---------------~l~~l~~h~n  181 (408)
                      ...++|++.+.||+|+||+||+|.+..+     ++.||||++.... ..+.+|+.               .+..+ +|+|
T Consensus        32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~e~~~~~~~~~~~~~~e~~~~~~l-~h~~  109 (364)
T 3op5_A           32 MAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDN-GPLFTELKFYQRAAKPEQIQKWIRTRKL-KYLG  109 (364)
T ss_dssp             TTCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTC-HHHHHHHHHHHHHCCHHHHHHHHHHTTC-SCCC
T ss_pred             cCCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccc-hhHHHHHHHHHhhhhhHHHHHHHHHhhc-cCCC
Confidence            4577999999999999999999988765     5789999986433 23344444               44444 6999


Q ss_pred             ceEEeeEEEccC--CCccEEEEEeecCCChhhhc----CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEe--
Q 015374          182 VVKLLDIVRDQH--SKTPSLIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMID--  253 (408)
Q Consensus       182 iv~l~~~~~~~~--~~~~~lv~e~~~~~~l~~~~----~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~--  253 (408)
                      |+++++++....  ....++||||+ +++|..++    ..+++..+..++.|++.||.|||++||+||||||+|||++  
T Consensus       110 iv~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~  188 (364)
T 3op5_A          110 VPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYK  188 (364)
T ss_dssp             SCCEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESS
T ss_pred             CCeEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecC
Confidence            999999987542  25689999999 89998887    4589999999999999999999999999999999999999  


Q ss_pred             CCCCcEEEEecccceeccCCCc--------ceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCC
Q 015374          254 HELRKLRLIDWGLAEFYHPGKE--------YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHD  325 (408)
Q Consensus       254 ~~~~~~kl~DfG~a~~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~  325 (408)
                      .+ +.+||+|||+++.......        .....||..|+|||++.+ ..++.++|||||||++|||++|+.||.....
T Consensus       189 ~~-~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~  266 (364)
T 3op5_A          189 NP-DQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNG-VAPSRRGDLEILGYCMIQWLTGHLPWEDNLK  266 (364)
T ss_dssp             CT-TCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSCCTTGGGTT
T ss_pred             CC-CeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCC-CCCCchhhHHHHHHHHHHHHhCCCCcccccc
Confidence            65 7999999999977643221        123459999999999987 6799999999999999999999999864444


Q ss_pred             CHHHHHHHHhhhchhhhhcCCCCCCCccccccc-cCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 015374          326 NHDQLVKIAKDCCLIIWCNSRHSRKPWSKFINA-DNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA  391 (408)
Q Consensus       326 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~  391 (408)
                      +...............           ...... -....+++++.+++..||+.||++|||++++++
T Consensus       267 ~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~  322 (364)
T 3op5_A          267 DPKYVRDSKIRYRENI-----------ASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRD  322 (364)
T ss_dssp             CHHHHHHHHHHHHHCH-----------HHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             CHHHHHHHHHHhhhhH-----------HHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHH
Confidence            4433322222111000           000000 011346899999999999999999999999875

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=2.3e-44  Score=361.16  Aligned_cols=244  Identities=18%  Similarity=0.350  Sum_probs=204.1

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc--chHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccEEE
Q 015374          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV--KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI  200 (408)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  200 (408)
                      ..++|++.++||+|+||+||+|++..++..||||+++..  ..+.+.+|+.+++++ +||||++++++|.+  ....++|
T Consensus       218 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~--~~~~~lv  294 (495)
T 1opk_A          218 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI-KHPNLVQLLGVCTR--EPPFYII  294 (495)
T ss_dssp             CGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSCHHHHHHHHHHHHHC-CCTTBCCEEEEECS--SSSCEEE
T ss_pred             CHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccchHHHHHHHHHHHhc-CCCCEeeEEEEEec--CCcEEEE
Confidence            457899999999999999999999999999999999743  457899999999999 99999999999954  4678899


Q ss_pred             EEeecCCChhhhcC-----CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCCCc
Q 015374          201 FEYVNSTDFKVLYP-----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE  275 (408)
Q Consensus       201 ~e~~~~~~l~~~~~-----~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~~~  275 (408)
                      |||+++++|..++.     .+++..+..++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+++.......
T Consensus       295 ~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~-~~~kl~DFG~a~~~~~~~~  373 (495)
T 1opk_A          295 TEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGEN-HLVKVADFGLSRLMTGDTY  373 (495)
T ss_dssp             EECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGG-GCEEECCTTCEECCTTCCE
T ss_pred             EEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCC-CcEEEeecccceeccCCce
Confidence            99999999998873     48889999999999999999999999999999999999988 7999999999987653322


Q ss_pred             c--eeeccCccccccccccCCcCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCCCc
Q 015374          276 Y--NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPW  352 (408)
Q Consensus       276 ~--~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  352 (408)
                      .  ....++..|+|||++.+ ..++.++|||||||++|||++ |..|| .+.+..+....+...                
T Consensus       374 ~~~~~~~~~~~y~aPE~~~~-~~~~~~sDvwSlG~~l~el~t~g~~p~-~~~~~~~~~~~~~~~----------------  435 (495)
T 1opk_A          374 TAHAGAKFPIKWTAPESLAY-NKFSIKSDVWAFGVLLWEIATYGMSPY-PGIDLSQVYELLEKD----------------  435 (495)
T ss_dssp             ECCTTCCCCGGGCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCSS-TTCCGGGHHHHHHTT----------------
T ss_pred             eecCCCcCCcceeCHhHHhc-CCCCcHHhHHhHHHHHHHHHhCCCCCC-CCCCHHHHHHHHHcC----------------
Confidence            1  22345668999999987 779999999999999999999 77776 444443333322211                


Q ss_pred             cccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 015374          353 SKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA  391 (408)
Q Consensus       353 ~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~  391 (408)
                         .....+..+++++.++|.+||+.||++|||++++++
T Consensus       436 ---~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~  471 (495)
T 1opk_A          436 ---YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ  471 (495)
T ss_dssp             ---CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ---CCCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHH
Confidence               112234457899999999999999999999999975

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=2.3e-44  Score=335.80  Aligned_cols=244  Identities=18%  Similarity=0.353  Sum_probs=204.5

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc--chHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccEEE
Q 015374          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV--KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI  200 (408)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  200 (408)
                      ..++|++.+.||+|+||+||+|++..++..||+|+++..  ..+.+.+|+.+++++ +||||+++++++.+  ....++|
T Consensus        11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~--~~~~~~v   87 (288)
T 3kfa_A           11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI-KHPNLVQLLGVCTR--EPPFYII   87 (288)
T ss_dssp             CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCSTHHHHHHHHHHHHHHC-CCTTBCCEEEEECS--SSSEEEE
T ss_pred             cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEcc--CCCEEEE
Confidence            578899999999999999999999999999999999753  346789999999999 99999999999954  5678999


Q ss_pred             EEeecCCChhhhcC-----CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCCCc
Q 015374          201 FEYVNSTDFKVLYP-----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE  275 (408)
Q Consensus       201 ~e~~~~~~l~~~~~-----~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~~~  275 (408)
                      |||+++++|..++.     .+++..+..++.|++.||.|||++||+|+||||+||+++.+ +.++|+|||++........
T Consensus        88 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~-~~~~l~Dfg~~~~~~~~~~  166 (288)
T 3kfa_A           88 TEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGEN-HLVKVADFGLSRLMTGDTY  166 (288)
T ss_dssp             EECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGG-GCEEECCCCGGGTSCSSSS
T ss_pred             EEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCC-CCEEEccCccceeccCCcc
Confidence            99999999988873     38999999999999999999999999999999999999988 7899999999986654332


Q ss_pred             --ceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCCCc
Q 015374          276 --YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPW  352 (408)
Q Consensus       276 --~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  352 (408)
                        .....++..|+|||.+.+ ..++.++||||||+++|+|++ |..|| .+.+..+....+...                
T Consensus       167 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~ll~~g~~p~-~~~~~~~~~~~~~~~----------------  228 (288)
T 3kfa_A          167 TAHAGAKFPIKWTAPESLAY-NKFSIKSDVWAFGVLLWEIATYGMSPY-PGIDLSQVYELLEKD----------------  228 (288)
T ss_dssp             EEETTEEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSS-TTCCGGGHHHHHHTT----------------
T ss_pred             ccccCCccccCcCChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCC-CCCCHHHHHHHHhcc----------------
Confidence              223456778999999987 679999999999999999999 77776 443333333322211                


Q ss_pred             cccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 015374          353 SKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA  391 (408)
Q Consensus       353 ~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~  391 (408)
                         .....+..+++++.+++.+||+.||++|||++|+++
T Consensus       229 ---~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~  264 (288)
T 3kfa_A          229 ---YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ  264 (288)
T ss_dssp             ---CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ---CCCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHH
Confidence               112233457899999999999999999999999976

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.2e-44  Score=357.01  Aligned_cols=256  Identities=21%  Similarity=0.327  Sum_probs=194.4

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecccchHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccEEEEE
Q 015374          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFE  202 (408)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e  202 (408)
                      ...+|++.+.||+|+||+||.. ...+++.||||++.......+.+|+.+++++.+||||+++++++.+  ....++|||
T Consensus        22 ~~~~y~~~~~LG~G~~G~V~~~-~~~~~~~vAvK~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~--~~~~~lv~E   98 (432)
T 3p23_A           22 GKISFCPKDVLGHGAEGTIVYR-GMFDNRDVAVKRILPECFSFADREVQLLRESDEHPNVIRYFCTEKD--RQFQYIAIE   98 (432)
T ss_dssp             TTEEEEEEEEEEECGGGCEEEE-EESSSSEEEEEEECTTTEEECHHHHHHHHHSCCCTTBCCEEEEEEE--TTEEEEEEE
T ss_pred             ccEEEecCCeeecCcCEEEEEE-EEeCCeEEEEEEECHHHHHHHHHHHHHHHhccCCCCcCeEEEEEec--CCEEEEEEE
Confidence            4568999999999999997643 3567899999999876666788999999998779999999999965  467899999


Q ss_pred             eecCCChhhhcC----CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCC----CCcEEEEecccceeccCCC
Q 015374          203 YVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE----LRKLRLIDWGLAEFYHPGK  274 (408)
Q Consensus       203 ~~~~~~l~~~~~----~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~----~~~~kl~DfG~a~~~~~~~  274 (408)
                      |+++ +|..++.    .+.+..+..++.|++.||.|||++||+||||||+|||++.+    ...+||+|||+++......
T Consensus        99 ~~~g-~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~  177 (432)
T 3p23_A           99 LCAA-TLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGR  177 (432)
T ss_dssp             CCSE-EHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC----
T ss_pred             CCCC-CHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCCC
Confidence            9985 7766652    25566778899999999999999999999999999999532    1358899999998765332


Q ss_pred             ----cceeeccCccccccccccC--CcCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHhhhchhhhhcCCC
Q 015374          275 ----EYNVRVASRYFKGPELLVD--LQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRH  347 (408)
Q Consensus       275 ----~~~~~~~~~~y~aPE~~~~--~~~~~~~~DvwSlGvil~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (408)
                          ......||+.|+|||++.+  ...++.++|||||||++|||++ |..|| .... ......+....          
T Consensus       178 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf-~~~~-~~~~~~~~~~~----------  245 (432)
T 3p23_A          178 HSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPF-GKSL-QRQANILLGAC----------  245 (432)
T ss_dssp             --------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTT-BSTT-THHHHHHTTCC----------
T ss_pred             cceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCc-chhh-HHHHHHHhccC----------
Confidence                2344679999999999974  2567889999999999999999 77776 2222 22222211110          


Q ss_pred             CCCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccccc
Q 015374          348 SRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRA  400 (408)
Q Consensus       348 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~~~~  400 (408)
                      ....      .......+..+.+||.+||+.||++|||++|+++||||..+..
T Consensus       246 ~~~~------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~~~~~  292 (432)
T 3p23_A          246 SLDC------LHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSLEK  292 (432)
T ss_dssp             CCTT------SCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTCCHHH
T ss_pred             Cccc------cCccccccHHHHHHHHHHHhCCHhhCCCHHHHHhCccccChHH
Confidence            0000      0011123566899999999999999999999999999987643

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=4.2e-44  Score=343.19  Aligned_cols=257  Identities=14%  Similarity=0.156  Sum_probs=198.0

Q ss_pred             CCCCCEEEEeeeeeeCceEEEEEEEcC---CCcEEEEEEecccc--------------hHHHHHHHHHHHHhcCCCCceE
Q 015374          122 GDQDDYEVVRKVGRGKYSEVFEGINVN---TNERCIIKILKPVK--------------KKKIKREIKILQNLCGGPNVVK  184 (408)
Q Consensus       122 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~---~~~~vavK~~~~~~--------------~~~~~~E~~~l~~l~~h~niv~  184 (408)
                      ...++|++.+.||+|+||+||+|++..   ++..+|+|++....              ...+.+|+.++..+ +||||++
T Consensus        34 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l-~h~ni~~  112 (345)
T 2v62_A           34 MEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQL-DYLGIPL  112 (345)
T ss_dssp             TTSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTC-SCCCCCC
T ss_pred             ccCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccc-cccCcce
Confidence            456899999999999999999999987   78899999986432              12356788888888 9999999


Q ss_pred             EeeEEEcc--CCCccEEEEEeecCCChhhhcC---CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCC--
Q 015374          185 LLDIVRDQ--HSKTPSLIFEYVNSTDFKVLYP---TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELR--  257 (408)
Q Consensus       185 l~~~~~~~--~~~~~~lv~e~~~~~~l~~~~~---~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~--  257 (408)
                      +++++.+.  .....++||||+ +++|..++.   .+++..+..++.|++.||.|||++||+||||||+|||++.+ +  
T Consensus       113 ~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~-~~~  190 (345)
T 2v62_A          113 FYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYK-NPD  190 (345)
T ss_dssp             EEEEEEEESSSCEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESS-STT
T ss_pred             eecccccccCCCcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccC-CCC
Confidence            99999762  256789999999 999999885   58999999999999999999999999999999999999977 5  


Q ss_pred             cEEEEecccceeccCCC--------cceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHH
Q 015374          258 KLRLIDWGLAEFYHPGK--------EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQ  329 (408)
Q Consensus       258 ~~kl~DfG~a~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~  329 (408)
                      .+||+|||+++......        ......||..|+|||++.+ ..++.++|||||||++|||++|+.||.....+...
T Consensus       191 ~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~  269 (345)
T 2v62_A          191 QVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKG-VALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVA  269 (345)
T ss_dssp             SEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHT-CCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHH
T ss_pred             cEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcC-CCCCchhhHHHHHHHHHHHHhCCCCccccccccHH
Confidence            89999999998764321        1234578999999999987 67999999999999999999999998554444444


Q ss_pred             HHHHHhhhchhhhhcCCCCCCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 015374          330 LVKIAKDCCLIIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH  392 (408)
Q Consensus       330 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~h  392 (408)
                      .............          ...........+++++.+++.+||+.||++|||++++++.
T Consensus       270 ~~~~~~~~~~~~~----------~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~  322 (345)
T 2v62_A          270 VQTAKTNLLDELP----------QSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKI  322 (345)
T ss_dssp             HHHHHHHHHHTTT----------HHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHH
T ss_pred             HHHHHHhhccccc----------HHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHH
Confidence            3333222110000          0000001112478999999999999999999999998753

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=9.7e-44  Score=335.29  Aligned_cols=249  Identities=24%  Similarity=0.446  Sum_probs=194.3

Q ss_pred             CCCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecc------cchHHHHHHHHHHHHhcCCCCceEEeeEEEccCCC
Q 015374          122 GDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP------VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSK  195 (408)
Q Consensus       122 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~------~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  195 (408)
                      ...++|++.+.||+|+||+||+|.+..+++.||+|+++.      .....+.+|+.+++++ +||||+++++++.+  ..
T Consensus        29 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~--~~  105 (310)
T 2wqm_A           29 NTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQL-NHPNVIKYYASFIE--DN  105 (310)
T ss_dssp             SSGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEEE--TT
T ss_pred             ccccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEEc--CC
Confidence            456789999999999999999999999999999999863      2245688999999999 99999999999965  46


Q ss_pred             ccEEEEEeecCCChhhhcC-------CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccce
Q 015374          196 TPSLIFEYVNSTDFKVLYP-------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE  268 (408)
Q Consensus       196 ~~~lv~e~~~~~~l~~~~~-------~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~  268 (408)
                      ..++||||+++++|..++.       .+++..+..++.|++.||.|||++||+|+||||+||+++.+ +.+||+|||++.
T Consensus       106 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~-~~~kl~Dfg~~~  184 (310)
T 2wqm_A          106 ELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITAT-GVVKLGDLGLGR  184 (310)
T ss_dssp             EEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT-SCEEECCC----
T ss_pred             cEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCC-CCEEEEecccee
Confidence            7889999999999988763       38999999999999999999999999999999999999988 799999999987


Q ss_pred             eccCCC-cceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCC
Q 015374          269 FYHPGK-EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRH  347 (408)
Q Consensus       269 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (408)
                      ...... ......++..|+|||++.+ ..++.++||||||+++|+|++|..||.....+...+.........        
T Consensus       185 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~--------  255 (310)
T 2wqm_A          185 FFSSKTTAAHSLVGTPYYMSPERIHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDY--------  255 (310)
T ss_dssp             --------------CCSSCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTCS--------
T ss_pred             eecCCCccccccCCCeeEeChHHhCC-CCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcccC--------
Confidence            654332 2334578999999999987 789999999999999999999999986554444443333222110        


Q ss_pred             CCCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 015374          348 SRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH  392 (408)
Q Consensus       348 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~h  392 (408)
                               .......+++++.+++.+||+.||++|||+++++++
T Consensus       256 ---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~  291 (310)
T 2wqm_A          256 ---------PPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDV  291 (310)
T ss_dssp             ---------CCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ---------CCCcccccCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence                     011123478999999999999999999999999863

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=1.9e-44  Score=349.09  Aligned_cols=244  Identities=18%  Similarity=0.337  Sum_probs=189.9

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEc---CCCcEEEEEEeccc----chHHHHHHHHHHHHhcCCCCceEEeeEEEccCCC
Q 015374          123 DQDDYEVVRKVGRGKYSEVFEGINV---NTNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSK  195 (408)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~Vy~~~~~---~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  195 (408)
                      ..++|++.+.||+|+||+||+|++.   .++..||||+++..    ..+.+.+|+.+++++ +||||++++++|.+  ..
T Consensus        43 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~--~~  119 (373)
T 2qol_A           43 DATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQF-DHPNIIRLEGVVTK--SK  119 (373)
T ss_dssp             CGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEECS--SS
T ss_pred             CHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEee--CC
Confidence            4578999999999999999999876   46778999998743    345788999999999 99999999999954  56


Q ss_pred             ccEEEEEeecCCChhhhcC----CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceecc
Q 015374          196 TPSLIFEYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH  271 (408)
Q Consensus       196 ~~~lv~e~~~~~~l~~~~~----~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~  271 (408)
                      ..++||||+++++|..++.    .+++..+..++.|++.||.|||++||+||||||+|||++.+ +.+||+|||+++...
T Consensus       120 ~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~-~~~kl~Dfg~a~~~~  198 (373)
T 2qol_A          120 PVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSN-LVCKVSDFGLGRVLE  198 (373)
T ss_dssp             SCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTT-CCEEECCC-------
T ss_pred             ceEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCC-CCEEECcCccccccc
Confidence            7899999999999999873    48999999999999999999999999999999999999988 799999999998765


Q ss_pred             CCCcc----eeeccCccccccccccCCcCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHhhhchhhhhcCC
Q 015374          272 PGKEY----NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKDCCLIIWCNSR  346 (408)
Q Consensus       272 ~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  346 (408)
                      .....    ....++..|+|||++.+ ..++.++|||||||++|||++ |..||. +.+..+....+...          
T Consensus       199 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~SlG~il~ellt~g~~P~~-~~~~~~~~~~i~~~----------  266 (373)
T 2qol_A          199 DDPEAAYTTRGGKIPIRWTSPEAIAY-RKFTSASDVWSYGIVLWEVMSYGERPYW-EMSNQDVIKAVDEG----------  266 (373)
T ss_dssp             ---------------CTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTC-CTTT-TCCHHHHHHHHHTT----------
T ss_pred             cCCccceeccCCCcCCCccChhhhcc-CCcCchhcHHHHHHHHHHHHhCCCCCCC-CCCHHHHHHHHHcC----------
Confidence            43221    12234667999999987 789999999999999999998 888874 33333333332221          


Q ss_pred             CCCCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 015374          347 HSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA  391 (408)
Q Consensus       347 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~  391 (408)
                               .....+..++.++.+++.+||+.||++|||++|+++
T Consensus       267 ---------~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~  302 (373)
T 2qol_A          267 ---------YRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVS  302 (373)
T ss_dssp             ---------EECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ---------CCCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHH
Confidence                     011122347899999999999999999999999876

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=5.2e-44  Score=355.03  Aligned_cols=243  Identities=15%  Similarity=0.292  Sum_probs=202.6

Q ss_pred             CCCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc--chHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccEE
Q 015374          122 GDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV--KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSL  199 (408)
Q Consensus       122 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l  199 (408)
                      ...++|++.+.||+|+||+||+|.+. ++..||||+++..  ..+.+.+|+.+++++ +||||+++++++.   ....++
T Consensus       185 i~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~---~~~~~l  259 (454)
T 1qcf_A          185 IPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSMSVEAFLAEANVMKTL-QHDKLVKLHAVVT---KEPIYI  259 (454)
T ss_dssp             CCGGGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHTTC-CCTTBCCEEEEEC---SSSCEE
T ss_pred             echHHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCCccHHHHHHHHHHHhhC-CCCCEeeEEEEEe---CCccEE
Confidence            35788999999999999999999874 5678999999753  457899999999999 9999999999985   356789


Q ss_pred             EEEeecCCChhhhcC-----CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCCC
Q 015374          200 IFEYVNSTDFKVLYP-----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK  274 (408)
Q Consensus       200 v~e~~~~~~l~~~~~-----~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~~  274 (408)
                      ||||+.+++|..++.     .+++..+..++.|++.||+|||+++|+||||||+|||++.+ +.+||+|||+++......
T Consensus       260 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~-~~~kl~DFG~a~~~~~~~  338 (454)
T 1qcf_A          260 ITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSAS-LVCKIADFGLARVIEDNE  338 (454)
T ss_dssp             EECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTT-CCEEECSTTGGGGBCCHH
T ss_pred             EEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCC-CcEEEeeCCCceEcCCCc
Confidence            999999999999874     58889999999999999999999999999999999999988 799999999998664321


Q ss_pred             c--ceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCCC
Q 015374          275 E--YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKP  351 (408)
Q Consensus       275 ~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  351 (408)
                      .  .....++..|+|||++.. ..++.++|||||||++|||++ |+.|| .+.+..+....+....              
T Consensus       339 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~t~g~~P~-~~~~~~~~~~~i~~~~--------------  402 (454)
T 1qcf_A          339 YTAREGAKFPIKWTAPEAINF-GSFTIKSDVWSFGILLMEIVTYGRIPY-PGMSNPEVIRALERGY--------------  402 (454)
T ss_dssp             HHTTCSSSSCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSS-TTCCHHHHHHHHHHTC--------------
T ss_pred             eeccCCCcccccccCHHHhcc-CCCCcHHHHHhHHHHHHHHHhCCCCCC-CCCCHHHHHHHHHcCC--------------
Confidence            1  123345678999999986 779999999999999999999 88887 4555445444433220              


Q ss_pred             ccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 015374          352 WSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA  391 (408)
Q Consensus       352 ~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~  391 (408)
                           ....+..+++++.+++.+||+.||++|||++++++
T Consensus       403 -----~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~  437 (454)
T 1qcf_A          403 -----RMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQS  437 (454)
T ss_dssp             -----CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             -----CCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHH
Confidence                 11223457899999999999999999999999875

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=2.4e-44  Score=355.37  Aligned_cols=256  Identities=21%  Similarity=0.306  Sum_probs=193.9

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecccchHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccEEEEE
Q 015374          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFE  202 (408)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e  202 (408)
                      ..+.|.+.+.||+|+||+||.+ ...+|+.||||++.....+.+.+|+.++.++.+||||+++++++.+  ....++|||
T Consensus        13 l~~~~~~~~~LG~G~~g~V~~~-~~~~g~~vAvK~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~--~~~~~lv~E   89 (434)
T 2rio_A           13 LKNLVVSEKILGYGSSGTVVFQ-GSFQGRPVAVKRMLIDFCDIALMEIKLLTESDDHPNVIRYYCSETT--DRFLYIALE   89 (434)
T ss_dssp             CSSCEEEEEEEEECSTTCEEEE-EESSSSEEEEEEEEGGGHHHHHHHHHHHHHHTTSTTBCCEEEEEEC--SSEEEEEEC
T ss_pred             hhheeeccCeEeeCCCeEEEEE-EEECCeEEEEEEEcHHHHHHHHHHHHHHHhccCCCCcCeEEEEEec--CCeEEEEEe
Confidence            4567778889999999999875 4567999999999877777889999999987689999999999954  567899999


Q ss_pred             eecCCChhhhcCC----------CChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCC------------CCcEE
Q 015374          203 YVNSTDFKVLYPT----------LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE------------LRKLR  260 (408)
Q Consensus       203 ~~~~~~l~~~~~~----------l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~------------~~~~k  260 (408)
                      |++ ++|..++..          .++..+..++.|++.||+|||++||+||||||+|||++.+            ...+|
T Consensus        90 ~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~k  168 (434)
T 2rio_A           90 LCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRIL  168 (434)
T ss_dssp             CCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEE
T ss_pred             cCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCCceEEE
Confidence            997 588887732          1333456799999999999999999999999999999753            24899


Q ss_pred             EEecccceeccCCCc-----ceeeccCccccccccccC------CcCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHH
Q 015374          261 LIDWGLAEFYHPGKE-----YNVRVASRYFKGPELLVD------LQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHD  328 (408)
Q Consensus       261 l~DfG~a~~~~~~~~-----~~~~~~~~~y~aPE~~~~------~~~~~~~~DvwSlGvil~ell~-g~~pf~~~~~~~~  328 (408)
                      |+|||+++.......     .....||+.|+|||++.+      ...++.++|||||||++|||++ |..||.. ....+
T Consensus       169 L~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~-~~~~~  247 (434)
T 2rio_A          169 ISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGD-KYSRE  247 (434)
T ss_dssp             ECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCS-TTTHH
T ss_pred             EcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCC-chhhH
Confidence            999999987754332     234579999999999965      2568999999999999999999 8888733 22222


Q ss_pred             HHHHHHhhhchhhhhcCCCCCCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccc
Q 015374          329 QLVKIAKDCCLIIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQV  398 (408)
Q Consensus       329 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~~  398 (408)
                        ..+....         ......    .......+++++.+++.+||+.||++|||+.|+++||||...
T Consensus       248 --~~i~~~~---------~~~~~~----~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f~~~  302 (434)
T 2rio_A          248 --SNIIRGI---------FSLDEM----KCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWPK  302 (434)
T ss_dssp             --HHHHHTC---------CCCCCC----TTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSCH
T ss_pred             --HHHhcCC---------CCcccc----cccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCccCCc
Confidence              1222110         000000    000112246789999999999999999999999999999754

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=5.6e-44  Score=338.62  Aligned_cols=253  Identities=19%  Similarity=0.333  Sum_probs=205.8

Q ss_pred             CCCCCEEEEeeeeeeCceEEEEEEEc-----CCCcEEEEEEeccc----chHHHHHHHHHHHHhcCCCCceEEeeEEEcc
Q 015374          122 GDQDDYEVVRKVGRGKYSEVFEGINV-----NTNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQ  192 (408)
Q Consensus       122 ~~~~~y~~~~~lG~G~fg~Vy~~~~~-----~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~  192 (408)
                      ...++|++.+.||+|+||+||+|++.     .++..||+|+++..    ....+.+|+.+++++ +||||+++++++.+ 
T Consensus        22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~-   99 (322)
T 1p4o_A           22 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEF-NCHHVVRLLGVVSQ-   99 (322)
T ss_dssp             CCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGC-CCTTBCCEEEEECS-
T ss_pred             chhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhc-CCCCEeeeEEEEcc-
Confidence            35689999999999999999999876     45788999998643    234688999999999 99999999999954 


Q ss_pred             CCCccEEEEEeecCCChhhhcC-------------CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcE
Q 015374          193 HSKTPSLIFEYVNSTDFKVLYP-------------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKL  259 (408)
Q Consensus       193 ~~~~~~lv~e~~~~~~l~~~~~-------------~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~  259 (408)
                       ....++||||+++++|..++.             .+++..+..++.|++.||.|||++||+||||||+|||++.+ +.+
T Consensus       100 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~-~~~  177 (322)
T 1p4o_A          100 -GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAED-FTV  177 (322)
T ss_dssp             -SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTT-CCE
T ss_pred             -CCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCC-CeE
Confidence             567889999999999988763             46889999999999999999999999999999999999988 799


Q ss_pred             EEEecccceeccCCCc---ceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHh
Q 015374          260 RLIDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAK  335 (408)
Q Consensus       260 kl~DfG~a~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-g~~pf~~~~~~~~~~~~~~~  335 (408)
                      ||+|||++........   .....+|..|+|||++.+ ..++.++|||||||++|+|++ |..|| .+.+..+....+..
T Consensus       178 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~-~~~~~~~~~~~~~~  255 (322)
T 1p4o_A          178 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKD-GVFTTYSDVWSFGVVLWEIATLAEQPY-QGLSNEQVLRFVME  255 (322)
T ss_dssp             EECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHHTSCCTT-TTSCHHHHHHHHHT
T ss_pred             EECcCccccccccccccccccCCCCCCCccChhhhcc-CCCCchhhHHHHHHHHHHHHhcCCCcc-ccCCHHHHHHHHHc
Confidence            9999999976543321   223456788999999987 779999999999999999999 67776 44443343333322


Q ss_pred             hhchhhhhcCCCCCCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcC------CCccccc
Q 015374          336 DCCLIIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH------PYFAQVR  399 (408)
Q Consensus       336 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~h------p~f~~~~  399 (408)
                      . .                  ....+..+++++.+++.+||+.||++|||+.|++++      ++|+.+.
T Consensus       256 ~-~------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~~~~~~~~  306 (322)
T 1p4o_A          256 G-G------------------LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREVS  306 (322)
T ss_dssp             T-C------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTTHHHHC
T ss_pred             C-C------------------cCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhccCCcccc
Confidence            1 0                  011233478999999999999999999999999987      6665544

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=1e-43  Score=327.65  Aligned_cols=244  Identities=16%  Similarity=0.335  Sum_probs=201.9

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc--chHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccEEE
Q 015374          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV--KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI  200 (408)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  200 (408)
                      ..++|++.+.||+|+||+||+|.+. ++..||+|+++..  ..+.+.+|+.+++++ +||||+++++++.+  ....++|
T Consensus         6 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~~~lv   81 (267)
T 3t9t_A            6 DPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKL-SHPKLVQLYGVCLE--QAPICLV   81 (267)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTBCHHHHHHHHHHHHTC-CCTTBCCEEEEECS--SSSCEEE
T ss_pred             chhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCCCHHHHHHHHHHHHhC-CCCCEeeEEEEEcc--CCCeEEE
Confidence            4678999999999999999999875 6778999999753  457899999999999 99999999999954  4678899


Q ss_pred             EEeecCCChhhhcC----CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCCC--
Q 015374          201 FEYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK--  274 (408)
Q Consensus       201 ~e~~~~~~l~~~~~----~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~~--  274 (408)
                      |||+++++|..++.    .+++..+..++.|++.||.|||++||+|+||||+||+++.+ +.+||+|||++.......  
T Consensus        82 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~-~~~kl~dfg~~~~~~~~~~~  160 (267)
T 3t9t_A           82 TEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGEN-QVIKVSDFGMTRFVLDDQYT  160 (267)
T ss_dssp             ECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGG-GCEEECCTTGGGGBCCHHHH
T ss_pred             EeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCC-CCEEEccccccccccccccc
Confidence            99999999988873    48999999999999999999999999999999999999988 789999999997654321  


Q ss_pred             cceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCCCcc
Q 015374          275 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWS  353 (408)
Q Consensus       275 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  353 (408)
                      ......++..|+|||++.+ ..++.++||||||+++|+|++ |..|| .+.+..+....+...                 
T Consensus       161 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~-~~~~~~~~~~~i~~~-----------------  221 (267)
T 3t9t_A          161 SSTGTKFPVKWASPEVFSF-SRYSSKSDVWSFGVLMWEVFSEGKIPY-ENRSNSEVVEDISTG-----------------  221 (267)
T ss_dssp             STTSTTCCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTT-TTCCHHHHHHHHHTT-----------------
T ss_pred             ccccccccccccChhhhcC-CCccchhchhhhHHHHHHHhccCCCCC-CCCCHHHHHHHHhcC-----------------
Confidence            1223456678999999987 678999999999999999999 78776 444434443333221                 


Q ss_pred             ccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 015374          354 KFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH  392 (408)
Q Consensus       354 ~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~h  392 (408)
                        .....+..+++++.+++.+||+.||++|||++|++++
T Consensus       222 --~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~  258 (267)
T 3t9t_A          222 --FRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQ  258 (267)
T ss_dssp             --CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             --CcCCCCccCcHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence              0111233468999999999999999999999999874

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=2.3e-43  Score=327.57  Aligned_cols=242  Identities=17%  Similarity=0.319  Sum_probs=201.5

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc--chHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccEEE
Q 015374          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV--KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI  200 (408)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  200 (408)
                      ..++|++.+.||+|+||+||+|.+. ++..||+|+++..  ..+.+.+|+.+++++ +||||+++++++.+   ...++|
T Consensus        11 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~---~~~~~v   85 (279)
T 1qpc_A           11 PRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMSPDAFLAEANLMKQL-QHQRLVRLYAVVTQ---EPIYII   85 (279)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSCHHHHHHHHHHHHHC-CCTTBCCEEEEECS---SSCEEE
T ss_pred             CHHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCcccHHHHHHHHHHHHhC-CCcCcceEEEEEcC---CCcEEE
Confidence            4689999999999999999999864 5678999998743  457789999999999 99999999999853   457899


Q ss_pred             EEeecCCChhhhcC-----CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCCCc
Q 015374          201 FEYVNSTDFKVLYP-----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE  275 (408)
Q Consensus       201 ~e~~~~~~l~~~~~-----~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~~~  275 (408)
                      |||+++++|..++.     .+++..+..++.|++.||.|||++||+||||||+|||++.+ +.+||+|||++........
T Consensus        86 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~-~~~kl~Dfg~~~~~~~~~~  164 (279)
T 1qpc_A           86 TEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDT-LSCKIADFGLARLIEDNEY  164 (279)
T ss_dssp             EECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTT-SCEEECCCTTCEECSSSCE
T ss_pred             EecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCC-CCEEECCCcccccccCccc
Confidence            99999999999885     58999999999999999999999999999999999999988 7999999999987654332


Q ss_pred             c--eeeccCccccccccccCCcCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCCCc
Q 015374          276 Y--NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPW  352 (408)
Q Consensus       276 ~--~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  352 (408)
                      .  ....++..|+|||++.+ ..++.++||||||+++|+|++ |..|| .+.+..+....+...                
T Consensus       165 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~-~~~~~~~~~~~~~~~----------------  226 (279)
T 1qpc_A          165 TAREGAKFPIKWTAPEAINY-GTFTIKSDVWSFGILLTEIVTHGRIPY-PGMTNPEVIQNLERG----------------  226 (279)
T ss_dssp             ECCTTCCCCTTTSCHHHHHH-CEECHHHHHHHHHHHHHHHHTTTCCSS-TTCCHHHHHHHHHTT----------------
T ss_pred             ccccCCCCccCccChhhhcc-CCCCchhhhHHHHHHHHHHHhCCCCCC-cccCHHHHHHHHhcc----------------
Confidence            1  22345678999999976 678999999999999999999 78776 444444444333221                


Q ss_pred             cccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 015374          353 SKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA  391 (408)
Q Consensus       353 ~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~  391 (408)
                         .....+..+++++.+++.+||+.||++|||++++++
T Consensus       227 ---~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~  262 (279)
T 1qpc_A          227 ---YRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRS  262 (279)
T ss_dssp             ---CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ---cCCCCcccccHHHHHHHHHHhccChhhCCCHHHHHH
Confidence               011223447899999999999999999999999986

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=1.1e-43  Score=330.19  Aligned_cols=244  Identities=23%  Similarity=0.404  Sum_probs=197.7

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCC---CcEEEEEEeccc----chHHHHHHHHHHHHhcCCCCceEEeeEEEccCCC
Q 015374          123 DQDDYEVVRKVGRGKYSEVFEGINVNT---NERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSK  195 (408)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~---~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  195 (408)
                      ..++|++.+.||+|+||+||+|++..+   +..||+|+++..    ..+.+.+|+.+++++ +||||+++++++.+   .
T Consensus        10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~---~   85 (281)
T 3cc6_A           10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNL-DHPHIVKLIGIIEE---E   85 (281)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHH-CCTTBCCEEEEECS---S
T ss_pred             cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhC-CCCCcceEEEEEcC---C
Confidence            467899999999999999999986543   346999998753    356788999999999 99999999999854   3


Q ss_pred             ccEEEEEeecCCChhhhc----CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceecc
Q 015374          196 TPSLIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH  271 (408)
Q Consensus       196 ~~~lv~e~~~~~~l~~~~----~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~  271 (408)
                      ..++||||+++++|..++    ..+++..+..++.|++.||.|||++||+||||||+|||++.+ +.+||+|||++....
T Consensus        86 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~-~~~kl~Dfg~~~~~~  164 (281)
T 3cc6_A           86 PTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASP-ECVKLGDFGLSRYIE  164 (281)
T ss_dssp             SCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEET-TEEEECCCCGGGCC-
T ss_pred             CCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCC-CcEEeCccCCCcccc
Confidence            468999999999998887    348999999999999999999999999999999999999988 799999999997665


Q ss_pred             CCCc--ceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCC
Q 015374          272 PGKE--YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHS  348 (408)
Q Consensus       272 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  348 (408)
                      ....  .....++..|+|||++.+ ..++.++||||||+++|+|++ |+.||... +..+....+....           
T Consensus       165 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~llt~g~~p~~~~-~~~~~~~~~~~~~-----------  231 (281)
T 3cc6_A          165 DEDYYKASVTRLPIKWMSPESINF-RRFTTASDVWMFAVCMWEILSFGKQPFFWL-ENKDVIGVLEKGD-----------  231 (281)
T ss_dssp             --------CCCCCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCTTTTS-CGGGHHHHHHHTC-----------
T ss_pred             cccccccccCCCCcceeCchhhcc-CCCCchhccHHHHHHHHHHHhCCCCCcccC-ChHHHHHHHhcCC-----------
Confidence            4322  233456778999999976 779999999999999999998 99998533 2233322222210           


Q ss_pred             CCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 015374          349 RKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH  392 (408)
Q Consensus       349 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~h  392 (408)
                              ....+..+++.+.+++.+||+.||++|||+.|++++
T Consensus       232 --------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~  267 (281)
T 3cc6_A          232 --------RLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCS  267 (281)
T ss_dssp             --------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             --------CCCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHH
Confidence                    111233478999999999999999999999999875

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.3e-43  Score=330.77  Aligned_cols=246  Identities=17%  Similarity=0.328  Sum_probs=202.8

Q ss_pred             CCCCEEEEe-eeeeeCceEEEEEEEc--CCCcEEEEEEeccc----chHHHHHHHHHHHHhcCCCCceEEeeEEEccCCC
Q 015374          123 DQDDYEVVR-KVGRGKYSEVFEGINV--NTNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSK  195 (408)
Q Consensus       123 ~~~~y~~~~-~lG~G~fg~Vy~~~~~--~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  195 (408)
                      ..++|.+.+ .||+|+||+||+|++.  .++..||+|+++..    ..+.+.+|+.+++++ +||||+++++++..   .
T Consensus         7 ~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~---~   82 (287)
T 1u59_A            7 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQL-DNPYIVRLIGVCQA---E   82 (287)
T ss_dssp             CGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEES---S
T ss_pred             cHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhC-CCCCEeEEEEEecC---C
Confidence            467888887 9999999999999854  46788999999753    346688999999999 99999999999943   4


Q ss_pred             ccEEEEEeecCCChhhhc----CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceecc
Q 015374          196 TPSLIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH  271 (408)
Q Consensus       196 ~~~lv~e~~~~~~l~~~~----~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~  271 (408)
                      ..++||||+++++|..++    ..+++..+..++.|++.||.|||+.||+||||||+|||++.+ +.+||+|||++....
T Consensus        83 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~-~~~kl~Dfg~~~~~~  161 (287)
T 1u59_A           83 ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNR-HYAKISDFGLSKALG  161 (287)
T ss_dssp             SEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEET-TEEEECCCTTCEECT
T ss_pred             CcEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCC-CCEEECcccceeeec
Confidence            578999999999999887    348999999999999999999999999999999999999988 799999999998765


Q ss_pred             CCCcc----eeeccCccccccccccCCcCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHhhhchhhhhcCC
Q 015374          272 PGKEY----NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKDCCLIIWCNSR  346 (408)
Q Consensus       272 ~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  346 (408)
                      .....    ....+|..|+|||++.+ ..++.++||||||+++|+|++ |..|| .+.+..+....+...          
T Consensus       162 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~-~~~~~~~~~~~i~~~----------  229 (287)
T 1u59_A          162 ADDSYYTARSAGKWPLKWYAPECINF-RKFSSRSDVWSYGVTMWEALSYGQKPY-KKMKGPEVMAFIEQG----------  229 (287)
T ss_dssp             TCSCEECCCCSSCCCGGGCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCTT-TTCCTHHHHHHHHTT----------
T ss_pred             cCcceeeccccccccccccCHHHhcc-CCCCchhhHHHHHHHHHHHHcCCCCCc-ccCCHHHHHHHHhcC----------
Confidence            43322    22345788999999976 678999999999999999998 99887 444444444333221          


Q ss_pred             CCCCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCC
Q 015374          347 HSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPY  394 (408)
Q Consensus       347 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~  394 (408)
                               .....+..+++++.+++.+||+.||++|||+.|++++.+
T Consensus       230 ---------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~  268 (287)
T 1u59_A          230 ---------KRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMR  268 (287)
T ss_dssp             ---------CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred             ---------CcCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence                     011223457899999999999999999999999998744

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=7.4e-44  Score=336.54  Aligned_cols=248  Identities=19%  Similarity=0.314  Sum_probs=193.6

Q ss_pred             CCCCCEEEEeeeeeeCceEEEEEEEcC---CCcEEEEEEeccc-----chHHHHHHHHHHHHhcCCCCceEEeeEEEccC
Q 015374          122 GDQDDYEVVRKVGRGKYSEVFEGINVN---TNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQH  193 (408)
Q Consensus       122 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~---~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~  193 (408)
                      ...++|++.+.||+|+||+||+|.+..   ++..||+|+++..     ..+.+.+|+.+++++ +||||+++++++.+..
T Consensus        31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~  109 (313)
T 3brb_A           31 IDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDF-SHPNVIRLLGVCIEMS  109 (313)
T ss_dssp             CCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTC-CCTTBCCCCEEEEC--
T ss_pred             cCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcC-CCCCeeeeeEEEeecc
Confidence            357899999999999999999998765   4558999998632     235688999999999 9999999999997643


Q ss_pred             CC---ccEEEEEeecCCChhhhc---------CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEE
Q 015374          194 SK---TPSLIFEYVNSTDFKVLY---------PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRL  261 (408)
Q Consensus       194 ~~---~~~lv~e~~~~~~l~~~~---------~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl  261 (408)
                      ..   ..++||||+++++|..++         ..+++..+..++.|++.||.|||++||+||||||+|||++.+ +.+||
T Consensus       110 ~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~-~~~kl  188 (313)
T 3brb_A          110 SQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDD-MTVCV  188 (313)
T ss_dssp             -----CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTT-SCEEE
T ss_pred             ccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCC-CcEEE
Confidence            32   458999999999998886         358999999999999999999999999999999999999988 79999


Q ss_pred             EecccceeccCCCc---ceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHhhh
Q 015374          262 IDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKDC  337 (408)
Q Consensus       262 ~DfG~a~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-g~~pf~~~~~~~~~~~~~~~~~  337 (408)
                      +|||++........   .....++..|+|||.+.+ ..++.++||||||+++|+|++ |..|| .+.+..+....+....
T Consensus       189 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~-~~~~~~~~~~~~~~~~  266 (313)
T 3brb_A          189 ADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLAD-RVYTSKSDVWAFGVTMWEIATRGMTPY-PGVQNHEMYDYLLHGH  266 (313)
T ss_dssp             CSCSCC----------------CCGGGSCHHHHHS-SCCCHHHHHHHHHHHHHHHHTTSCCSS-TTCCGGGHHHHHHTTC
T ss_pred             eecCcceecccccccCcccccCCCccccCchhhcC-CCccchhhhHHHHHHHHHHHhcCCCCC-ccCCHHHHHHHHHcCC
Confidence            99999976643321   233456778999999987 789999999999999999999 66666 4444444433332210


Q ss_pred             chhhhhcCCCCCCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 015374          338 CLIIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH  392 (408)
Q Consensus       338 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~h  392 (408)
                                         ....+..+++++.+++.+||..||++|||+++++++
T Consensus       267 -------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~  302 (313)
T 3brb_A          267 -------------------RLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQ  302 (313)
T ss_dssp             -------------------CCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             -------------------CCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                               112234478999999999999999999999999875

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=2.3e-44  Score=341.36  Aligned_cols=259  Identities=16%  Similarity=0.239  Sum_probs=201.5

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc---chHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccEE
Q 015374          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV---KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSL  199 (408)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l  199 (408)
                      ..++|++.+.||+|+||+||+|++ .+++.||||++...   ..+.+.+|+.+++++ +||||++++++|.+  ....++
T Consensus        37 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~--~~~~~l  112 (321)
T 2qkw_B           37 ATNNFDHKFLIGHGVFGKVYKGVL-RDGAKVALKRRTPESSQGIEEFETEIETLSFC-RHPHLVSLIGFCDE--RNEMIL  112 (321)
T ss_dssp             CCCCCSCCCCSCBCSSSEEEEEEC-TTCCEEEEEECCSCCSSHHHHHHHHHHGGGSC-CCTTBCCEEEECCC--TTCCEE
T ss_pred             HHhccCccceeecCCCeeEEEEEE-CCCCEEEEEEecccChHHHHHHHHHHHHHHhC-CCCCEeeEEEEEcC--CCeEEE
Confidence            567899999999999999999985 56889999998643   346788999999999 99999999999954  567889


Q ss_pred             EEEeecCCChhhhcC-------CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccC
Q 015374          200 IFEYVNSTDFKVLYP-------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP  272 (408)
Q Consensus       200 v~e~~~~~~l~~~~~-------~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~  272 (408)
                      ||||+++++|..++.       .+++..+..++.|++.||.|||++||+||||||+|||++.+ +.+||+|||++.....
T Consensus       113 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~-~~~kl~Dfg~~~~~~~  191 (321)
T 2qkw_B          113 IYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDEN-FVPKITDFGISKKGTE  191 (321)
T ss_dssp             EEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTT-CCEEECCCTTCEECSS
T ss_pred             EEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCC-CCEEEeeccccccccc
Confidence            999999999998873       38899999999999999999999999999999999999988 7999999999986543


Q ss_pred             CC---cceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCH--HHHHHHHhhhchhhhhcCCC
Q 015374          273 GK---EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNH--DQLVKIAKDCCLIIWCNSRH  347 (408)
Q Consensus       273 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~  347 (408)
                      ..   ......||..|+|||++.+ ..++.++|||||||++|+|++|+.||.......  .........     ......
T Consensus       192 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~-----~~~~~~  265 (321)
T 2qkw_B          192 LDQTHLSTVVKGTLGYIDPEYFIK-GRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVES-----HNNGQL  265 (321)
T ss_dssp             SSCCCCBCCCEEETTTCCHHHHHH-CBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHH-----HTTTCC
T ss_pred             ccccccccccCCCccccCHHHhcC-CCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhc-----cccccH
Confidence            22   2234568999999999987 679999999999999999999999985432211  011000000     000000


Q ss_pred             CCCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCC
Q 015374          348 SRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHP  393 (408)
Q Consensus       348 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp  393 (408)
                      . ..............++.++.+++.+||+.||++|||++|++++.
T Consensus       266 ~-~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L  310 (321)
T 2qkw_B          266 E-QIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKL  310 (321)
T ss_dssp             C-SSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             H-HhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence            0 00000011112223457799999999999999999999999764

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=2.1e-43  Score=332.83  Aligned_cols=243  Identities=20%  Similarity=0.283  Sum_probs=193.5

Q ss_pred             CCCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc-chHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccEEE
Q 015374          122 GDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI  200 (408)
Q Consensus       122 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  200 (408)
                      ...++|++.+.||+|+||+||+|++.  ++.||+|.++.. ..+.+.+|+.+++++ +||||+++++++.    ...++|
T Consensus         5 i~~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~----~~~~lv   77 (307)
T 2eva_A            5 IDYKEIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIESESERKAFIVELRQLSRV-NHPNIVKLYGACL----NPVCLV   77 (307)
T ss_dssp             CCGGGEEEEEEEECCSSSEEEEEEET--TEEEEEEECSSTTHHHHHHHHHHHHHHC-CCTTBCCEEEBCT----TTTEEE
T ss_pred             CCHhHeeeeeEeecCCCceEEEEEEC--CeeEEEEEecChhHHHHHHHHHHHHhcC-CCCCcCeEEEEEc----CCcEEE
Confidence            34678999999999999999999764  788999999643 456789999999999 9999999999984    247899


Q ss_pred             EEeecCCChhhhcC------CCChHHHHHHHHHHHHHHHHHHH---CCcEEecCCCCcEEEeCCCCcEEEEecccceecc
Q 015374          201 FEYVNSTDFKVLYP------TLTDYDIRYYIYELLKALDYCHS---QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH  271 (408)
Q Consensus       201 ~e~~~~~~l~~~~~------~l~~~~~~~i~~qi~~~L~~LH~---~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~  271 (408)
                      |||+++++|..++.      .+++..+..++.|++.||.|||+   +||+||||||+|||++.+...+||+|||++....
T Consensus        78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~  157 (307)
T 2eva_A           78 MEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQ  157 (307)
T ss_dssp             EECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC-----
T ss_pred             EEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccc
Confidence            99999999998873      36788899999999999999999   8999999999999999884458999999997654


Q ss_pred             CCCcceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCCC
Q 015374          272 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKP  351 (408)
Q Consensus       272 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  351 (408)
                      .  ......||..|+|||++.+ ..++.++||||||+++|+|++|+.||.................              
T Consensus       158 ~--~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~--------------  220 (307)
T 2eva_A          158 T--HMTNNKGSAAWMAPEVFEG-SNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNG--------------  220 (307)
T ss_dssp             ---------CCTTSSCHHHHTC-CCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTT--------------
T ss_pred             c--ccccCCCCCceEChhhhCC-CCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcC--------------
Confidence            2  2334578999999999987 7899999999999999999999999854433332222111110              


Q ss_pred             ccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 015374          352 WSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH  392 (408)
Q Consensus       352 ~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~h  392 (408)
                          ........+++++.+++.+||+.||++|||++|++++
T Consensus       221 ----~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  257 (307)
T 2eva_A          221 ----TRPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKI  257 (307)
T ss_dssp             ----CCCCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ----CCCCcccccCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence                0112233478999999999999999999999999873

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=2.2e-44  Score=342.43  Aligned_cols=246  Identities=18%  Similarity=0.304  Sum_probs=200.1

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEE--EEEEecc----cchHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCc
Q 015374          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERC--IIKILKP----VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT  196 (408)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~v--avK~~~~----~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  196 (408)
                      ..++|++.+.||+|+||+||+|++..++..+  ++|.++.    ...+.+.+|+.+++++.+||||+++++++.+  ...
T Consensus        23 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~--~~~  100 (327)
T 1fvr_A           23 DWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH--RGY  100 (327)
T ss_dssp             CGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEE--TTE
T ss_pred             cHHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeee--CCc
Confidence            4578999999999999999999998888865  8998863    2345688999999999789999999999965  467


Q ss_pred             cEEEEEeecCCChhhhcC-------------------CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCC
Q 015374          197 PSLIFEYVNSTDFKVLYP-------------------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELR  257 (408)
Q Consensus       197 ~~lv~e~~~~~~l~~~~~-------------------~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~  257 (408)
                      .++||||+++++|..++.                   .+++..+..++.|++.||.|||++||+||||||+|||++.+ +
T Consensus       101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~-~  179 (327)
T 1fvr_A          101 LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGEN-Y  179 (327)
T ss_dssp             EEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGG-G
T ss_pred             eEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcCC-C
Confidence            899999999999988873                   48899999999999999999999999999999999999988 7


Q ss_pred             cEEEEecccceeccCCCcceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHhh
Q 015374          258 KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKD  336 (408)
Q Consensus       258 ~~kl~DfG~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-g~~pf~~~~~~~~~~~~~~~~  336 (408)
                      .+||+|||+++............++..|+|||++.+ ..++.++|||||||++|+|++ |..|| .+.+..+....+...
T Consensus       180 ~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~pf-~~~~~~~~~~~~~~~  257 (327)
T 1fvr_A          180 VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPY-CGMTCAELYEKLPQG  257 (327)
T ss_dssp             CEEECCTTCEESSCEECCC----CCTTTCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCTT-TTCCHHHHHHHGGGT
T ss_pred             eEEEcccCcCccccccccccCCCCCccccChhhhcc-ccCCchhcchHHHHHHHHHHcCCCCCC-CCCcHHHHHHHhhcC
Confidence            999999999975433333344567788999999977 678999999999999999998 99887 333333332222111


Q ss_pred             hchhhhhcCCCCCCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 015374          337 CCLIIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH  392 (408)
Q Consensus       337 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~h  392 (408)
                                         .....+..+++++.+++.+||+.||++|||++|++++
T Consensus       258 -------------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  294 (327)
T 1fvr_A          258 -------------------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  294 (327)
T ss_dssp             -------------------CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             -------------------CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence                               0112233478999999999999999999999999976

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=1.3e-43  Score=331.21  Aligned_cols=248  Identities=15%  Similarity=0.309  Sum_probs=192.2

Q ss_pred             cCCCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc-----chHHHHHHHHHHHHhcCCCCceEEeeEEEccCCC
Q 015374          121 WGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSK  195 (408)
Q Consensus       121 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  195 (408)
                      ....++|++.++||+|+||+||+|++.   ..+|+|+++..     ..+.+.+|+.+++++ +||||+++++++..   .
T Consensus        20 ei~~~~y~~~~~lG~G~~g~Vy~~~~~---~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~---~   92 (289)
T 3og7_A           20 EIPDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKT-RHVNILLFMGYSTA---P   92 (289)
T ss_dssp             BCCTTSCEEEEEEEECSSEEEEEEESS---SEEEEEEESCSSCCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEECS---S
T ss_pred             ccCccceeeeeEecCCCCeEEEEEEEc---CceEEEEEeccCCCHHHHHHHHHHHHHHHhC-CCCcEEEEEeeccC---C
Confidence            346789999999999999999999753   35999998632     246688999999999 99999999997632   4


Q ss_pred             ccEEEEEeecCCChhhhcC----CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceecc
Q 015374          196 TPSLIFEYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH  271 (408)
Q Consensus       196 ~~~lv~e~~~~~~l~~~~~----~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~  271 (408)
                      ..++||||+++++|..++.    .+++..+..++.|++.||.|||++||+||||||+|||++.+ +.+||+|||++....
T Consensus        93 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~-~~~kl~Dfg~~~~~~  171 (289)
T 3og7_A           93 QLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHED-NTVKIGDFGLATEKS  171 (289)
T ss_dssp             SCEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETT-TEEEECCCC------
T ss_pred             ccEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCC-CCEEEccceeccccc
Confidence            5789999999999988873    48899999999999999999999999999999999999988 799999999997554


Q ss_pred             C---CCcceeeccCccccccccccC--CcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCC
Q 015374          272 P---GKEYNVRVASRYFKGPELLVD--LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSR  346 (408)
Q Consensus       272 ~---~~~~~~~~~~~~y~aPE~~~~--~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  346 (408)
                      .   ........||..|+|||++..  ...++.++||||||+++|+|++|+.||. +..+.+.+...........     
T Consensus       172 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~-~~~~~~~~~~~~~~~~~~~-----  245 (289)
T 3og7_A          172 RWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYS-NINNRDQIIEMVGRGSLSP-----  245 (289)
T ss_dssp             ------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTS-SCCCHHHHHHHHHHTSCCC-----
T ss_pred             cccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCcc-ccchHHHHHHHhcccccCc-----
Confidence            3   122344578999999999862  2568889999999999999999999984 4445555544443311100     


Q ss_pred             CCCCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 015374          347 HSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA  391 (408)
Q Consensus       347 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~  391 (408)
                          .     .......+++++.+|+.+||+.||++|||++|+++
T Consensus       246 ----~-----~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~  281 (289)
T 3og7_A          246 ----D-----LSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILA  281 (289)
T ss_dssp             ----C-----TTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ----c-----hhhccccCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence                0     01122347899999999999999999999999985

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=1.2e-43  Score=332.68  Aligned_cols=245  Identities=20%  Similarity=0.312  Sum_probs=199.2

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCC---cEEEEEEeccc----chHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCc
Q 015374          124 QDDYEVVRKVGRGKYSEVFEGINVNTN---ERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT  196 (408)
Q Consensus       124 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~---~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  196 (408)
                      ..+|++.+.||+|+||+||+|++..++   ..+|+|.++..    ..+.+.+|+.+++++ +||||+++++++... ...
T Consensus        24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~-~~~  101 (298)
T 3f66_A           24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF-SHPNVLSLLGICLRS-EGS  101 (298)
T ss_dssp             GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTC-CCTTBCCCCEEECCS-SSC
T ss_pred             ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhC-CCCCEeeeeeEEEcC-CCc
Confidence            457999999999999999999865443   35899998642    236788999999999 999999999997543 357


Q ss_pred             cEEEEEeecCCChhhhcC----CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccC
Q 015374          197 PSLIFEYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP  272 (408)
Q Consensus       197 ~~lv~e~~~~~~l~~~~~----~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~  272 (408)
                      .++||||+++++|..++.    .+++..+..++.|++.||.|||++||+||||||+|||++.+ +.+||+|||++.....
T Consensus       102 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~-~~~kl~Dfg~a~~~~~  180 (298)
T 3f66_A          102 PLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEK-FTVKVADFGLARDMYD  180 (298)
T ss_dssp             CEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTT-CCEEECSCGGGCCCSC
T ss_pred             eEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCC-CCEEECcccccccccc
Confidence            789999999999998873    38889999999999999999999999999999999999988 7999999999976543


Q ss_pred             CC-----cceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCC
Q 015374          273 GK-----EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRH  347 (408)
Q Consensus       273 ~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (408)
                      ..     ......+|..|+|||.+.+ ..++.++||||||+++|+|++|..|++.+.+..+....+....          
T Consensus       181 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~----------  249 (298)
T 3f66_A          181 KEYYSVHNKTGAKLPVKWMALESLQT-QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR----------  249 (298)
T ss_dssp             GGGCBC-----CCBCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTC----------
T ss_pred             cchhccccccCCCCCccccChHHhcC-CCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCC----------
Confidence            22     1233456778999999987 7899999999999999999997777766666555544443321          


Q ss_pred             CCCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 015374          348 SRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA  391 (408)
Q Consensus       348 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~  391 (408)
                               ....+..+++++.+++.+||+.||++|||++|+++
T Consensus       250 ---------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~  284 (298)
T 3f66_A          250 ---------RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVS  284 (298)
T ss_dssp             ---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ---------CCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                     11123347899999999999999999999999986

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.5e-43  Score=330.25  Aligned_cols=246  Identities=20%  Similarity=0.323  Sum_probs=201.9

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCc---EEEEEEeccc----chHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCc
Q 015374          124 QDDYEVVRKVGRGKYSEVFEGINVNTNE---RCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT  196 (408)
Q Consensus       124 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~---~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  196 (408)
                      .-.|++.++||+|+||+||+|++..++.   .+|+|+++..    ..+.+.+|+.+++++ +||||+++++++.+.+ ..
T Consensus        20 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~-~~   97 (298)
T 3pls_A           20 RVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGL-NHPNVLALIGIMLPPE-GL   97 (298)
T ss_dssp             GEEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTC-CCTTBCCCCEEECCSS-SC
T ss_pred             ceEEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEecCC-CC
Confidence            3457778999999999999998765554   7999998643    236788999999999 9999999999996543 44


Q ss_pred             cEEEEEeecCCChhhhcC----CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccC
Q 015374          197 PSLIFEYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP  272 (408)
Q Consensus       197 ~~lv~e~~~~~~l~~~~~----~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~  272 (408)
                      .++||||+.+++|..++.    .+++..+..++.|++.||.|||++||+||||||+|||++.+ +.+||+|||+++....
T Consensus        98 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~-~~~kl~Dfg~~~~~~~  176 (298)
T 3pls_A           98 PHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDES-FTVKVADFGLARDILD  176 (298)
T ss_dssp             CEEEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTT-CCEEECCTTSSCTTTT
T ss_pred             cEEEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCC-CcEEeCcCCCcccccC
Confidence            589999999999998873    48889999999999999999999999999999999999988 7999999999975543


Q ss_pred             CC-----cceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCC
Q 015374          273 GK-----EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRH  347 (408)
Q Consensus       273 ~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (408)
                      ..     ......++..|+|||.+.+ ..++.++||||||+++|+|++|..||+...+..+....+....          
T Consensus       177 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~----------  245 (298)
T 3pls_A          177 REYYSVQQHRHARLPVKWTALESLQT-YRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGR----------  245 (298)
T ss_dssp             GGGGCSCCSSCTTCGGGGSCHHHHTT-CCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTC----------
T ss_pred             CcccccccCcCCCCCccccChhhhcc-CCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCC----------
Confidence            22     2233467788999999987 7899999999999999999998888877666555444433321          


Q ss_pred             CCCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 015374          348 SRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH  392 (408)
Q Consensus       348 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~h  392 (408)
                               ....+..+++++.+++.+||+.||.+|||++++++.
T Consensus       246 ---------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~  281 (298)
T 3pls_A          246 ---------RLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGE  281 (298)
T ss_dssp             ---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ---------CCCCCccchHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence                     112233478999999999999999999999999863

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=7e-44  Score=329.06  Aligned_cols=241  Identities=18%  Similarity=0.292  Sum_probs=199.6

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc-----chHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCcc
Q 015374          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP  197 (408)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~  197 (408)
                      ..++|++.+.||+|+||+||+|++.  ++.||+|+++..     ..+.+.+|+.+++++ +||||+++++++.+......
T Consensus         8 ~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~   84 (271)
T 3kmu_A            8 DFKQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIF-SHPNVLPVLGACQSPPAPHP   84 (271)
T ss_dssp             CGGGCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCC-SCTTEECEEEEECTTTSSSC
T ss_pred             CHHHhHHHHHhcCCCcceEEEEEEC--CeeEEEEEecccccCHHHHHHHHHHHHHHHhc-CCCchhheEEEEccCCCCCe
Confidence            4678999999999999999999874  889999998743     245788999999999 99999999999977655788


Q ss_pred             EEEEEeecCCChhhhcC-----CCChHHHHHHHHHHHHHHHHHHHCC--cEEecCCCCcEEEeCCCCcEEEEecccceec
Q 015374          198 SLIFEYVNSTDFKVLYP-----TLTDYDIRYYIYELLKALDYCHSQG--IMHRDVKPHNVMIDHELRKLRLIDWGLAEFY  270 (408)
Q Consensus       198 ~lv~e~~~~~~l~~~~~-----~l~~~~~~~i~~qi~~~L~~LH~~~--iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~  270 (408)
                      ++||||+++++|..++.     .+++..+..++.|++.||.|||+++  |+||||||+|||++.+ +.++|+|||++...
T Consensus        85 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~-~~~~l~~~~~~~~~  163 (271)
T 3kmu_A           85 TLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDED-MTARISMADVKFSF  163 (271)
T ss_dssp             EEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTT-SCEEEEGGGSCCTT
T ss_pred             EeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCC-cceeEEeccceeee
Confidence            99999999999999873     3799999999999999999999999  9999999999999988 78999999987543


Q ss_pred             cCCCcceeeccCccccccccccCCcCCC---ccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCC
Q 015374          271 HPGKEYNVRVASRYFKGPELLVDLQDYD---YSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRH  347 (408)
Q Consensus       271 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~---~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (408)
                      .    .....+|+.|+|||++.+ ..++   .++|||||||++|+|++|+.||. +.+..+.........          
T Consensus       164 ~----~~~~~~t~~y~aPE~~~~-~~~~~~~~~~Di~slG~il~el~~g~~p~~-~~~~~~~~~~~~~~~----------  227 (271)
T 3kmu_A          164 Q----SPGRMYAPAWVAPEALQK-KPEDTNRRSADMWSFAVLLWELVTREVPFA-DLSNMEIGMKVALEG----------  227 (271)
T ss_dssp             S----CTTCBSCGGGSCHHHHHS-CGGGSCHHHHHHHHHHHHHHHHHHCSCTTT-TSCHHHHHHHHHHSC----------
T ss_pred             c----ccCccCCccccChhhhcc-CCCCCCCchhhHHHHHHHHHHHHhCCCCcc-ccChHHHHHHHHhcC----------
Confidence            2    233578999999999986 3333   37999999999999999999983 334334333332211          


Q ss_pred             CCCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 015374          348 SRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA  391 (408)
Q Consensus       348 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~  391 (408)
                              .....+..+++++.+++.+||+.||++|||++|+++
T Consensus       228 --------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  263 (271)
T 3kmu_A          228 --------LRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVP  263 (271)
T ss_dssp             --------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             --------CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                    112233457899999999999999999999999985

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=5.7e-44  Score=339.61  Aligned_cols=251  Identities=17%  Similarity=0.273  Sum_probs=199.3

Q ss_pred             CCCCCEEEEeeeeeeCceEEEEEE-----EcCCCcEEEEEEeccc----chHHHHHHHHHHHHhcCCCCceEEeeEEEcc
Q 015374          122 GDQDDYEVVRKVGRGKYSEVFEGI-----NVNTNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQ  192 (408)
Q Consensus       122 ~~~~~y~~~~~lG~G~fg~Vy~~~-----~~~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~  192 (408)
                      ...++|++.+.||+|+||+||+|+     +..++..||||++...    ....+.+|+.+++++ +||||+++++++.+ 
T Consensus        27 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~-  104 (327)
T 2yfx_A           27 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKF-NHQNIVRCIGVSLQ-  104 (327)
T ss_dssp             CCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEECS-
T ss_pred             CChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhC-CCCCCCeEEEEEcC-
Confidence            356899999999999999999998     5567889999998632    345788999999999 99999999999954 


Q ss_pred             CCCccEEEEEeecCCChhhhcC----------CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCC--CCcEE
Q 015374          193 HSKTPSLIFEYVNSTDFKVLYP----------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE--LRKLR  260 (408)
Q Consensus       193 ~~~~~~lv~e~~~~~~l~~~~~----------~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~--~~~~k  260 (408)
                       ....++||||+++++|..++.          .+++..+..++.|++.||.|||++||+||||||+|||++.+  ...+|
T Consensus       105 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~k  183 (327)
T 2yfx_A          105 -SLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAK  183 (327)
T ss_dssp             -SSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEE
T ss_pred             -CCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceEE
Confidence             467789999999999988872          38889999999999999999999999999999999999843  24699


Q ss_pred             EEecccceeccCCCc---ceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHhh
Q 015374          261 LIDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKD  336 (408)
Q Consensus       261 l~DfG~a~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-g~~pf~~~~~~~~~~~~~~~~  336 (408)
                      |+|||++........   .....++..|+|||++.+ ..++.++||||||+++|+|++ |..|| .+.+..+....+...
T Consensus       184 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~-~~~~~~~~~~~~~~~  261 (327)
T 2yfx_A          184 IGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFME-GIFTSKTDTWSFGVLLWEIFSLGYMPY-PSKSNQEVLEFVTSG  261 (327)
T ss_dssp             ECCCHHHHHHHC------CCGGGSCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSS-TTCCHHHHHHHHHTT
T ss_pred             ECccccccccccccccccCCCcCCCcceeCHhHhcC-CCCCchhhHHHHHHHHHHHHcCCCCCC-CCcCHHHHHHHHhcC
Confidence            999999875543221   233467889999999987 779999999999999999998 77776 344333333332221


Q ss_pred             hchhhhhcCCCCCCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcc
Q 015374          337 CCLIIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFA  396 (408)
Q Consensus       337 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~  396 (408)
                       .                  ....+..+++++.+++.+||+.||.+|||++|++++.|+-
T Consensus       262 -~------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~  302 (327)
T 2yfx_A          262 -G------------------RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC  302 (327)
T ss_dssp             -C------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -C------------------CCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence             0                  1112334789999999999999999999999999998864

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=2.3e-43  Score=329.78  Aligned_cols=243  Identities=18%  Similarity=0.319  Sum_probs=198.1

Q ss_pred             CCCCEEEEe-eeeeeCceEEEEEE--EcCCCcEEEEEEecccc-----hHHHHHHHHHHHHhcCCCCceEEeeEEEccCC
Q 015374          123 DQDDYEVVR-KVGRGKYSEVFEGI--NVNTNERCIIKILKPVK-----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHS  194 (408)
Q Consensus       123 ~~~~y~~~~-~lG~G~fg~Vy~~~--~~~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~  194 (408)
                      ..++|++.+ .||+|+||+||+|.  ...+++.||||+++...     .+.+.+|+.+++.+ +||||+++++++..   
T Consensus        14 ~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~---   89 (291)
T 1xbb_A           14 DRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQL-DNPYIVRMIGICEA---   89 (291)
T ss_dssp             CGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTC-CCTTBCCEEEEEES---
T ss_pred             cchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhC-CCCCEEEEEEEECC---
Confidence            467899998 99999999999995  45677899999987432     46788999999999 99999999999932   


Q ss_pred             CccEEEEEeecCCChhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceecc
Q 015374          195 KTPSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH  271 (408)
Q Consensus       195 ~~~~lv~e~~~~~~l~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~  271 (408)
                      ...++||||+++++|..++   ..+++..+..++.|++.||.|||++||+|+||||+|||++.+ +.+||+|||++....
T Consensus        90 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~-~~~kl~Dfg~~~~~~  168 (291)
T 1xbb_A           90 ESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQ-HYAKISDFGLSKALR  168 (291)
T ss_dssp             SSEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEET-TEEEECCCTTCEECC
T ss_pred             CCcEEEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCC-CcEEEccCCcceeec
Confidence            5678999999999999887   358999999999999999999999999999999999999988 799999999998765


Q ss_pred             CCCcc----eeeccCccccccccccCCcCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHhhhchhhhhcCC
Q 015374          272 PGKEY----NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKDCCLIIWCNSR  346 (408)
Q Consensus       272 ~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  346 (408)
                      .....    ....++..|+|||.+.+ ..++.++||||||+++|+|++ |..||. +.+..+....+...          
T Consensus       169 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~-~~~~~~~~~~~~~~----------  236 (291)
T 1xbb_A          169 ADENYYKAQTHGKWPVKWYAPECINY-YKFSSKSDVWSFGVLMWEAFSYGQKPYR-GMKGSEVTAMLEKG----------  236 (291)
T ss_dssp             TTCSEEEC----CCCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTTCCSST-TCCHHHHHHHHHTT----------
T ss_pred             cCCCcccccccCCCCceeeChHHhcc-CCCChhhhHHHHHHHHHHHHhcCCCCCC-CCCHHHHHHHHHcC----------
Confidence            44332    22345678999999977 678999999999999999999 988873 33333332222211          


Q ss_pred             CCCCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 015374          347 HSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA  391 (408)
Q Consensus       347 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~  391 (408)
                               .....+..+++++.+++.+||+.||++|||+.|+++
T Consensus       237 ---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  272 (291)
T 1xbb_A          237 ---------ERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVEL  272 (291)
T ss_dssp             ---------CCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             ---------CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                     011223457899999999999999999999999975

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=1.3e-43  Score=352.00  Aligned_cols=249  Identities=18%  Similarity=0.325  Sum_probs=201.1

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc--chHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccEEE
Q 015374          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV--KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI  200 (408)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  200 (408)
                      ..++|++.++||+|+||+||+|.+.. +..||||+++..  ..+.+.+|+.+++++ +||||+++++++.+   ...++|
T Consensus       182 ~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~---~~~~iv  256 (452)
T 1fmk_A          182 PRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMSPEAFLQEAQVMKKL-RHEKLVQLYAVVSE---EPIYIV  256 (452)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSSCHHHHHHHHHHHHHC-CCTTBCCEEEEECS---SSCEEE
T ss_pred             ChhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCCCCHHHHHHHHHHHHhC-CCCCEeeEEEEEcC---CceEEE
Confidence            46789999999999999999998764 567999999753  356899999999999 99999999999854   567899


Q ss_pred             EEeecCCChhhhcC-----CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCCCc
Q 015374          201 FEYVNSTDFKVLYP-----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE  275 (408)
Q Consensus       201 ~e~~~~~~l~~~~~-----~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~~~  275 (408)
                      |||+++++|..++.     .+++..+..++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+++.......
T Consensus       257 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~-~~~kl~DfG~a~~~~~~~~  335 (452)
T 1fmk_A          257 TEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGEN-LVCKVADFGLARLIEDNEY  335 (452)
T ss_dssp             ECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGG-GCEEECCCCTTC-------
T ss_pred             ehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCC-CCEEECCCccceecCCCce
Confidence            99999999999874     38999999999999999999999999999999999999988 7999999999987653321


Q ss_pred             --ceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCCCc
Q 015374          276 --YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPW  352 (408)
Q Consensus       276 --~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  352 (408)
                        .....++..|+|||++.+ ..++.++|||||||++|||++ |..|| .+....+.+..+...                
T Consensus       336 ~~~~~~~~~~~y~aPE~~~~-~~~~~~sDvwslG~~l~el~t~g~~P~-~~~~~~~~~~~i~~~----------------  397 (452)
T 1fmk_A          336 TARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELTTKGRVPY-PGMVNREVLDQVERG----------------  397 (452)
T ss_dssp             -------CCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCSS-TTCCHHHHHHHHHTT----------------
T ss_pred             ecccCCcccccccCHhHHhc-CCCCccccHHhHHHHHHHHHhCCCCCC-CCCCHHHHHHHHHcC----------------
Confidence              223456678999999987 789999999999999999999 88886 455544444443221                


Q ss_pred             cccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhc--CCCcccc
Q 015374          353 SKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA--HPYFAQV  398 (408)
Q Consensus       353 ~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~--hp~f~~~  398 (408)
                         .....+..+++++.++|.+||+.||++|||++++++  ..++...
T Consensus       398 ---~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~  442 (452)
T 1fmk_A          398 ---YRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST  442 (452)
T ss_dssp             ---CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred             ---CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccC
Confidence               011223457899999999999999999999999986  3566544

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.6e-43  Score=336.76  Aligned_cols=245  Identities=18%  Similarity=0.328  Sum_probs=194.5

Q ss_pred             CCCCCEEEEeeeeeeCceEEEEEEEcCCCcEE----EEEEecc----cchHHHHHHHHHHHHhcCCCCceEEeeEEEccC
Q 015374          122 GDQDDYEVVRKVGRGKYSEVFEGINVNTNERC----IIKILKP----VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQH  193 (408)
Q Consensus       122 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~v----avK~~~~----~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~  193 (408)
                      ...++|++.+.||+|+||+||+|++..+++.+    ++|.+..    .....+.+|+.+++++ +||||++++++|.+. 
T Consensus        12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~-   89 (327)
T 3lzb_A           12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV-DNPHVCRLLGICLTS-   89 (327)
T ss_dssp             CCTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTC-CBTTBCCCCEEEESS-
T ss_pred             cCHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhC-CCCCeeEEEEEEecC-
Confidence            45789999999999999999999998888765    6666542    2457789999999999 999999999999753 


Q ss_pred             CCccEEEEEeecCCChhhhc----CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEeccccee
Q 015374          194 SKTPSLIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEF  269 (408)
Q Consensus       194 ~~~~~lv~e~~~~~~l~~~~----~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~  269 (408)
                        ..++|+||+.+++|..++    ..+++..+..++.|++.||.|||++||+||||||+|||++.+ +.+||+|||+++.
T Consensus        90 --~~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~-~~~kL~DfG~a~~  166 (327)
T 3lzb_A           90 --TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTP-QHVKITDFGLAKL  166 (327)
T ss_dssp             --SEEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEET-TEEEECCTTC---
T ss_pred             --CceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCC-CCEEEccCcceeE
Confidence              367999999999998876    358999999999999999999999999999999999999988 7999999999987


Q ss_pred             ccCCCc---ceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHhhhchhhhhcC
Q 015374          270 YHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKDCCLIIWCNS  345 (408)
Q Consensus       270 ~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  345 (408)
                      ......   .....+|..|+|||++.+ ..++.++|||||||++|+|++ |..|| .+.+..+....+...         
T Consensus       167 ~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~ell~~g~~p~-~~~~~~~~~~~~~~~---------  235 (327)
T 3lzb_A          167 LGAEEKEYHAEGGKVPIKWMALESILH-RIYTHQSDVWSYGVTVWELMTFGSKPY-DGIPASEISSILEKG---------  235 (327)
T ss_dssp             -------------CCCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTT-TTCCGGGHHHHHHTT---------
T ss_pred             ccCccccccccCCCccccccCHHHHcC-CCCChHHHHHHHHHHHHHHHHCCCCCC-CCCCHHHHHHHHHcC---------
Confidence            643322   223456778999999987 789999999999999999999 88887 333333332222211         


Q ss_pred             CCCCCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 015374          346 RHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH  392 (408)
Q Consensus       346 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~h  392 (408)
                                .....+..++.++.+++.+||+.||++|||++|+++.
T Consensus       236 ----------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  272 (327)
T 3lzb_A          236 ----------ERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIE  272 (327)
T ss_dssp             ----------CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ----------CCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence                      0112233478899999999999999999999999873

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=3e-43  Score=329.36  Aligned_cols=249  Identities=16%  Similarity=0.256  Sum_probs=200.3

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecc-cchHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccEEEE
Q 015374          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP-VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIF  201 (408)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~-~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~  201 (408)
                      ..++|++.+.||+|+||+||+|++..+++.||+|++.. .....+.+|+.+++.+ +|++++..+..+... ....++||
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l-~~~~~i~~~~~~~~~-~~~~~lv~   84 (296)
T 3uzp_A            7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMM-QGGVGIPTIRWCGAE-GDYNVMVM   84 (296)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSCCHHHHHHHHHHHH-TTSTTCCCEEEEEEE-TTEEEEEE
T ss_pred             eccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcchhHHHHHHHHHHHh-hcCCCCCccccccCC-CCceEEEE
Confidence            46899999999999999999999999999999999864 3446789999999999 777766666665433 46778999


Q ss_pred             EeecCCChhhhcC----CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEe---CCCCcEEEEecccceeccCCC
Q 015374          202 EYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMID---HELRKLRLIDWGLAEFYHPGK  274 (408)
Q Consensus       202 e~~~~~~l~~~~~----~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~---~~~~~~kl~DfG~a~~~~~~~  274 (408)
                      ||+ +++|..++.    .+++..+..++.|++.||.|||++||+||||||+|||++   .+ +.+||+|||++.......
T Consensus        85 e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~-~~~kl~Dfg~~~~~~~~~  162 (296)
T 3uzp_A           85 ELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKG-NLVYIIDFGLAKKYRDAR  162 (296)
T ss_dssp             ECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGT-TCEEECCCTTCEECBCTT
T ss_pred             Eec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCC-CeEEEeeCCCcccccccc
Confidence            999 888888763    589999999999999999999999999999999999995   45 789999999998765443


Q ss_pred             c--------ceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCC--CHHHHHHHHhhhchhhhhc
Q 015374          275 E--------YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHD--NHDQLVKIAKDCCLIIWCN  344 (408)
Q Consensus       275 ~--------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~--~~~~~~~~~~~~~~~~~~~  344 (408)
                      .        .....||..|+|||++.+ ..++.++|||||||++|+|++|+.||.....  ..+.+..+.......    
T Consensus       163 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~----  237 (296)
T 3uzp_A          163 THQHIPYRENKNLTGTARYASINTHLG-IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST----  237 (296)
T ss_dssp             TCCBCCCCCSCCCCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHS----
T ss_pred             cccccccccccccccccccCChhhhcC-CCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCC----
Confidence            2        234578999999999987 7799999999999999999999999854321  222232222211000    


Q ss_pred             CCCCCCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 015374          345 SRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA  391 (408)
Q Consensus       345 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~  391 (408)
                                 ........+++++.+++.+||+.||++|||++++++
T Consensus       238 -----------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  273 (296)
T 3uzp_A          238 -----------PIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ  273 (296)
T ss_dssp             -----------CHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred             -----------chHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHH
Confidence                       001112347899999999999999999999999876

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=4e-43  Score=331.20  Aligned_cols=245  Identities=20%  Similarity=0.335  Sum_probs=192.4

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecccc------hHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCcc
Q 015374          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK------KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP  197 (408)
Q Consensus       124 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~------~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~  197 (408)
                      .++|++.+.||+|+||+||+|++..+++.||+|+++...      .+.+.+|+.+++++ +||||+++++++.+  ....
T Consensus        33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~--~~~~  109 (309)
T 2h34_A           33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRL-QEPHVVPIHDFGEI--DGQL  109 (309)
T ss_dssp             -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEEE--TTEE
T ss_pred             eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhc-CCCCeeEEEEEEee--CCeE
Confidence            578999999999999999999999999999999986432      36688999999999 99999999999965  4678


Q ss_pred             EEEEEeecCCChhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCCC
Q 015374          198 SLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK  274 (408)
Q Consensus       198 ~lv~e~~~~~~l~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~~  274 (408)
                      ++||||+++++|..++   ..+++..+..++.|++.||.|||++||+|+||||+|||++.+ +.+||+|||++.......
T Consensus       110 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~-~~~kl~Dfg~~~~~~~~~  188 (309)
T 2h34_A          110 YVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSAD-DFAYLVDFGIASATTDEK  188 (309)
T ss_dssp             EEEEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTT-SCEEECSCCC--------
T ss_pred             EEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCC-CCEEEecCccCccccccc
Confidence            8999999999999887   458999999999999999999999999999999999999988 799999999987665432


Q ss_pred             --cceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCCCc
Q 015374          275 --EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPW  352 (408)
Q Consensus       275 --~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  352 (408)
                        ......++..|+|||++.+ ..++.++||||||+++|+|++|..||.. .+ ...+........            . 
T Consensus       189 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~-~~-~~~~~~~~~~~~------------~-  252 (309)
T 2h34_A          189 LTQLGNTVGTLYYMAPERFSE-SHATYRADIYALTCVLYECLTGSPPYQG-DQ-LSVMGAHINQAI------------P-  252 (309)
T ss_dssp             --------CCGGGCCGGGTCC-----CCCHHHHHHHHHHHHHHSSCSSCS-CH-HHHHHHHHHSCC------------C-
T ss_pred             cccccccCCCcCccCHHHHcC-CCCCchHhHHHHHHHHHHHHHCCCCCCC-ch-HHHHHHHhccCC------------C-
Confidence              2234578999999999987 7889999999999999999999999842 22 222222222100            0 


Q ss_pred             cccccccCCCCCCHHHHHHHHHhcccCcCCCC-CHHHHhc
Q 015374          353 SKFINADNQHLVSPEAIDFLDKLLRYDHQDRL-TAREAMA  391 (408)
Q Consensus       353 ~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rp-t~~elL~  391 (408)
                         .....+..+++++.+++.+||+.||++|| |++++++
T Consensus       253 ---~~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~  289 (309)
T 2h34_A          253 ---RPSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSA  289 (309)
T ss_dssp             ---CGGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred             ---CccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHH
Confidence               01122345789999999999999999999 7888775

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.3e-43  Score=335.32  Aligned_cols=245  Identities=15%  Similarity=0.301  Sum_probs=194.5

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCC----cEEEEEEeccc----chHHHHHHHHHHHHhcCCCCceEEeeEEEccCC
Q 015374          123 DQDDYEVVRKVGRGKYSEVFEGINVNTN----ERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHS  194 (408)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~----~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~  194 (408)
                      ..++|++.+.||+|+||+||+|++..++    ..||+|+++..    ....+.+|+.+++++ +||||+++++++.+  .
T Consensus        42 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~--~  118 (333)
T 1mqb_A           42 HPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF-SHHNIIRLEGVISK--Y  118 (333)
T ss_dssp             CTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEECS--S
T ss_pred             ChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhC-CCCCCCcEEEEEec--C
Confidence            5788999999999999999999876553    35999998743    235688999999999 99999999999954  5


Q ss_pred             CccEEEEEeecCCChhhhc----CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceec
Q 015374          195 KTPSLIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY  270 (408)
Q Consensus       195 ~~~~lv~e~~~~~~l~~~~----~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~  270 (408)
                      ...++||||+++++|..++    ..+++..+..++.|++.||.|||++||+||||||+|||++.+ +.+||+|||++...
T Consensus       119 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~-~~~kl~Dfg~~~~~  197 (333)
T 1mqb_A          119 KPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSN-LVCKVSDFGLSRVL  197 (333)
T ss_dssp             SSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTT-CCEEECCCCC----
T ss_pred             CCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCC-CcEEECCCCcchhh
Confidence            6789999999999998887    358999999999999999999999999999999999999988 79999999999876


Q ss_pred             cCCCc----ceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHhhhchhhhhcC
Q 015374          271 HPGKE----YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKDCCLIIWCNS  345 (408)
Q Consensus       271 ~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  345 (408)
                      .....    .....++..|+|||++.+ ..++.++|||||||++|+|++ |..||. +.+..+....+....        
T Consensus       198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~pf~-~~~~~~~~~~~~~~~--------  267 (333)
T 1mqb_A          198 EDDPEATYTTSGGKIPIRWTAPEAISY-RKFTSASDVWSFGIVMWEVMTYGERPYW-ELSNHEVMKAINDGF--------  267 (333)
T ss_dssp             -------------CCCGGGSCHHHHHS-CCCCHHHHHHHHHHHHHHHHTTSCCTTT-TCCHHHHHHHHHTTC--------
T ss_pred             ccccccccccCCCCccccccCchhccc-CCCCchhhhHHHHHHHHHHHcCCCCCcc-cCCHHHHHHHHHCCC--------
Confidence            53322    122345678999999987 789999999999999999999 888873 333333333332210        


Q ss_pred             CCCCCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 015374          346 RHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH  392 (408)
Q Consensus       346 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~h  392 (408)
                                 ....+..+++++.+++.+||+.||++|||+.|++++
T Consensus       268 -----------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~  303 (333)
T 1mqb_A          268 -----------RLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSI  303 (333)
T ss_dssp             -----------CCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             -----------cCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                       111223478999999999999999999999999875

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6.8e-44  Score=345.10  Aligned_cols=246  Identities=19%  Similarity=0.293  Sum_probs=191.0

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCC---cEEEEEEecc----cchHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCc
Q 015374          124 QDDYEVVRKVGRGKYSEVFEGINVNTN---ERCIIKILKP----VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT  196 (408)
Q Consensus       124 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~---~~vavK~~~~----~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  196 (408)
                      ...|++.+.||+|+||+||+|++..++   ..||+|.++.    ...+.+.+|+.+++++ +||||++++++|... ...
T Consensus        88 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~~~~~~~~~-~~~  165 (373)
T 3c1x_A           88 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF-SHPNVLSLLGICLRS-EGS  165 (373)
T ss_dssp             TEEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTC-CCTTBCCCCEEECCC-SSC
T ss_pred             hceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhC-CCCCcceEEEEEEcC-CCC
Confidence            456889999999999999999875433   4689999863    2346788999999999 999999999987543 356


Q ss_pred             cEEEEEeecCCChhhhcC----CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccC
Q 015374          197 PSLIFEYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP  272 (408)
Q Consensus       197 ~~lv~e~~~~~~l~~~~~----~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~  272 (408)
                      .++||||+++++|..++.    .+++..+..++.|++.||.|||++||+||||||+|||++.+ +.+||+|||+++....
T Consensus       166 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~-~~~kL~DFG~a~~~~~  244 (373)
T 3c1x_A          166 PLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEK-FTVKVADFGLARDMYD  244 (373)
T ss_dssp             CEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTT-CCEEECCC--------
T ss_pred             eEEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCC-CCEEEeeccccccccc
Confidence            789999999999999873    47888999999999999999999999999999999999988 7999999999976543


Q ss_pred             CCc-----ceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCC
Q 015374          273 GKE-----YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRH  347 (408)
Q Consensus       273 ~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (408)
                      ...     .....++..|+|||++.+ ..++.++|||||||++|||++|..|++.+.+..+....+....          
T Consensus       245 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~----------  313 (373)
T 3c1x_A          245 KEFDSVHNKTGAKLPVKWMALESLQT-QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR----------  313 (373)
T ss_dssp             -------------CCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTC----------
T ss_pred             cccccccccCCCCCcccccChHHhcC-CCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCC----------
Confidence            321     223456778999999987 7899999999999999999996555555555444433332210          


Q ss_pred             CCCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 015374          348 SRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH  392 (408)
Q Consensus       348 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~h  392 (408)
                               ....+..+++++.+++.+||+.||++|||++|++++
T Consensus       314 ---------~~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~  349 (373)
T 3c1x_A          314 ---------RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR  349 (373)
T ss_dssp             ---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ---------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                     111233478999999999999999999999999875

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=3.1e-44  Score=341.08  Aligned_cols=258  Identities=18%  Similarity=0.241  Sum_probs=201.9

Q ss_pred             CCCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecccc----hHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCcc
Q 015374          122 GDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP  197 (408)
Q Consensus       122 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~  197 (408)
                      ...++|++.+.||+|+||+||+|+ ..+++.||||+++...    ...+.+|+.+++++ +||||++++++|.+  ....
T Consensus        27 ~~~~~y~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~--~~~~  102 (326)
T 3uim_A           27 VASDNFSNKNILGRGGFGKVYKGR-LADGTLVAVKRLKEERTQGGELQFQTEVEMISMA-VHRNLLRLRGFCMT--PTER  102 (326)
T ss_dssp             TTTTSSCSTTEEECCSSSEEEEEC-CSSSCCEEEEECCC-----CCCHHHHHHHGGGTC-CCTTBCCCCEEECC--SSCC
T ss_pred             HHhhccccceeEecCCCcEEEEEE-ecCCCEEEEEEeccccCchHHHHHHHHHHHHHhc-cCCCccceEEEEec--CCce
Confidence            457889999999999999999997 4568899999987433    23689999999999 89999999999954  4677


Q ss_pred             EEEEEeecCCChhhhcC-------CCChHHHHHHHHHHHHHHHHHHHC---CcEEecCCCCcEEEeCCCCcEEEEecccc
Q 015374          198 SLIFEYVNSTDFKVLYP-------TLTDYDIRYYIYELLKALDYCHSQ---GIMHRDVKPHNVMIDHELRKLRLIDWGLA  267 (408)
Q Consensus       198 ~lv~e~~~~~~l~~~~~-------~l~~~~~~~i~~qi~~~L~~LH~~---~iiH~Dlk~~NILl~~~~~~~kl~DfG~a  267 (408)
                      ++||||+.+++|..++.       .+++..+..++.|++.||.|||++   ||+||||||+|||++.+ +.+||+|||++
T Consensus       103 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~-~~~kl~Dfg~~  181 (326)
T 3uim_A          103 LLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEE-FEAVVGDFGLA  181 (326)
T ss_dssp             EEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTT-CCEEECCCSSC
T ss_pred             EEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCC-CCEEeccCccc
Confidence            89999999999998873       288999999999999999999999   99999999999999988 79999999999


Q ss_pred             eeccCCCc--ceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCC----CCCCHHHHHHHHhhhchhh
Q 015374          268 EFYHPGKE--YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFY----GHDNHDQLVKIAKDCCLII  341 (408)
Q Consensus       268 ~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~----~~~~~~~~~~~~~~~~~~~  341 (408)
                      ........  .....||..|+|||++.+ ..++.++|||||||++|+|++|..||..    ...... ......      
T Consensus       182 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~-~~~~~~------  253 (326)
T 3uim_A          182 KLMDYKDTHVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVM-LLDWVK------  253 (326)
T ss_dssp             EECCSSSSCEECCCCSCGGGCCHHHHHH-SEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSB-HHHHHT------
T ss_pred             cccCcccccccccccCCcCccCHHHhcc-CCCCccccchhHHHHHHHHHhCCCcccccccccccchh-HHHHHH------
Confidence            87653332  333458999999999977 6789999999999999999999999831    111111 111111      


Q ss_pred             hhcCCCCCCCccccc----cccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCc
Q 015374          342 WCNSRHSRKPWSKFI----NADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF  395 (408)
Q Consensus       342 ~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f  395 (408)
                         ............    ........+.++.+++.+||+.||++|||++|+++|-.-
T Consensus       254 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~  308 (326)
T 3uim_A          254 ---GLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG  308 (326)
T ss_dssp             ---TTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHT
T ss_pred             ---HHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcC
Confidence               000111111111    111122234779999999999999999999999988543

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=2.6e-44  Score=342.94  Aligned_cols=274  Identities=17%  Similarity=0.273  Sum_probs=199.3

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecccchHHHHHHHHHHH--HhcCCCCceEEeeEEEc---cCCCcc
Q 015374          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQ--NLCGGPNVVKLLDIVRD---QHSKTP  197 (408)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~--~l~~h~niv~l~~~~~~---~~~~~~  197 (408)
                      ..++|++.+.||+|+||+||+|++  +++.||||+++......+..|..++.  .+ +|+||+++++.+..   ......
T Consensus        11 ~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~e~~~~~~~~~-~h~~i~~~~~~~~~~~~~~~~~~   87 (336)
T 3g2f_A           11 DLDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFANRQNFINEKNIYRVPLM-EHDNIARFIVGDERVTADGRMEY   87 (336)
T ss_dssp             CTTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGGHHHHHHHHHHHTSTTC-CCTTBCCEEEEEEEECTTSCEEE
T ss_pred             ChHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccchhhHHHHHHHHHHHhc-cCcchhhheecccccccCCCceE
Confidence            468999999999999999999965  68999999998777666666666544  46 99999999986642   233467


Q ss_pred             EEEEEeecCCChhhhc--CCCChHHHHHHHHHHHHHHHHHHHC---------CcEEecCCCCcEEEeCCCCcEEEEeccc
Q 015374          198 SLIFEYVNSTDFKVLY--PTLTDYDIRYYIYELLKALDYCHSQ---------GIMHRDVKPHNVMIDHELRKLRLIDWGL  266 (408)
Q Consensus       198 ~lv~e~~~~~~l~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~---------~iiH~Dlk~~NILl~~~~~~~kl~DfG~  266 (408)
                      ++||||+++++|..++  ...++..+..++.|++.||.|||+.         ||+||||||+|||++.+ +.+||+|||+
T Consensus        88 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~-~~~kL~DFG~  166 (336)
T 3g2f_A           88 LLVMEYYPNGSLXKYLSLHTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKND-GTCVISDFGL  166 (336)
T ss_dssp             EEEECCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTT-SCEEECCCTT
T ss_pred             EEEEecCCCCcHHHHHhhcccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCC-CcEEEeeccc
Confidence            8999999999999987  4578889999999999999999999         99999999999999988 7999999999


Q ss_pred             ceeccCCC---------cceeeccCccccccccccCC------cCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHH
Q 015374          267 AEFYHPGK---------EYNVRVASRYFKGPELLVDL------QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV  331 (408)
Q Consensus       267 a~~~~~~~---------~~~~~~~~~~y~aPE~~~~~------~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~  331 (408)
                      +.......         ......||..|+|||++.+.      ..++.++|||||||++|||++|..||+.+....+...
T Consensus       167 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~  246 (336)
T 3g2f_A          167 SMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQM  246 (336)
T ss_dssp             CEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCCC
T ss_pred             eeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHHHH
Confidence            98764322         12234689999999999752      3466789999999999999999998876544221110


Q ss_pred             HHHhhhchhh-------hhcCCCCCCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHH------hcCCCcccc
Q 015374          332 KIAKDCCLII-------WCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREA------MAHPYFAQV  398 (408)
Q Consensus       332 ~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~el------L~hp~f~~~  398 (408)
                      ......+...       .......+..+...  ......+++++.+||.+||+.||++|||++|+      +.++|-++-
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~~~~~~  324 (336)
T 3g2f_A          247 AFQTEVGNHPTFEDMQVLVSREKQRPKFPEA--WKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIWERNK  324 (336)
T ss_dssp             TTHHHHCSSCCHHHHHHHHTTSCCCCCCCTT--CCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHCCCC--
T ss_pred             hhhcccCCCchHHHHHhhhcccccCCCCCcc--cccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHHHHhcc
Confidence            0000000000       00000011111110  01112245689999999999999999999999      557887765


Q ss_pred             ccch
Q 015374          399 RAAE  402 (408)
Q Consensus       399 ~~~~  402 (408)
                      ....
T Consensus       325 ~~~~  328 (336)
T 3g2f_A          325 SVSP  328 (336)
T ss_dssp             ----
T ss_pred             cCCC
Confidence            4433

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=3.2e-43  Score=329.01  Aligned_cols=250  Identities=16%  Similarity=0.255  Sum_probs=195.9

Q ss_pred             CCCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecc-cchHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccEEE
Q 015374          122 GDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP-VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI  200 (408)
Q Consensus       122 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~-~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  200 (408)
                      ...++|++.+.||+|+||+||+|++..+++.||||++.. .....+.+|+.+++.+ +|++++..+..+... ....++|
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l-~~~~~i~~~~~~~~~-~~~~~lv   83 (296)
T 4hgt_A            6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMM-QGGVGIPTIRWCGAE-GDYNVMV   83 (296)
T ss_dssp             -----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---CCCHHHHHHHHHHH-TTSTTCCCEEEEEEE-TTEEEEE
T ss_pred             ccCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccchHHHHHHHHHHHh-cCCCCCCeeeeecCC-CCceEEE
Confidence            346889999999999999999999999999999998753 3346789999999999 777777666665433 4677899


Q ss_pred             EEeecCCChhhhc----CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEE---eCCCCcEEEEecccceeccCC
Q 015374          201 FEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMI---DHELRKLRLIDWGLAEFYHPG  273 (408)
Q Consensus       201 ~e~~~~~~l~~~~----~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl---~~~~~~~kl~DfG~a~~~~~~  273 (408)
                      |||+ +++|..++    ..+++..+..++.|++.||.|||++||+||||||+|||+   +.+ +.+||+|||++......
T Consensus        84 ~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~-~~~kL~Dfg~a~~~~~~  161 (296)
T 4hgt_A           84 MELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKG-NLVYIIDFGLAKKYRDA  161 (296)
T ss_dssp             EECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGT-TCEEECCCTTCEECBCT
T ss_pred             EEcc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCC-CeEEEecCccceeccCc
Confidence            9999 88888876    358999999999999999999999999999999999999   555 78999999999876543


Q ss_pred             Cc--------ceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCC--CHHHHHHHHhhhchhhhh
Q 015374          274 KE--------YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHD--NHDQLVKIAKDCCLIIWC  343 (408)
Q Consensus       274 ~~--------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~--~~~~~~~~~~~~~~~~~~  343 (408)
                      ..        .....||..|+|||++.+ ..++.++|||||||++|+|++|+.||.....  ....+..+.......   
T Consensus       162 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~---  237 (296)
T 4hgt_A          162 RTHQHIPYRENKNLTGTARYASINTHLG-IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST---  237 (296)
T ss_dssp             TTCCBCCCCCSCCCCSCGGGCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHS---
T ss_pred             ccCccCCCCcccccCCCccccchHHhcC-CCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccc---
Confidence            22        234578999999999987 6799999999999999999999999854322  112222222211000   


Q ss_pred             cCCCCCCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 015374          344 NSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA  391 (408)
Q Consensus       344 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~  391 (408)
                                  ........+++++.+++.+||+.||++|||++++++
T Consensus       238 ------------~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~  273 (296)
T 4hgt_A          238 ------------PIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ  273 (296)
T ss_dssp             ------------CHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred             ------------hhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHH
Confidence                        001112336899999999999999999999999986

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=1.1e-43  Score=342.98  Aligned_cols=241  Identities=15%  Similarity=0.234  Sum_probs=196.5

Q ss_pred             CCCCCEEEEeeeeeeCceEEEEE-----EEcCCCcEEEEEEecccchHHHHHHHHHHHHhcC---CCCceEEeeEEEccC
Q 015374          122 GDQDDYEVVRKVGRGKYSEVFEG-----INVNTNERCIIKILKPVKKKKIKREIKILQNLCG---GPNVVKLLDIVRDQH  193 (408)
Q Consensus       122 ~~~~~y~~~~~lG~G~fg~Vy~~-----~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~---h~niv~l~~~~~~~~  193 (408)
                      ...++|++.++||+|+||+||+|     .+..+++.||+|+++......+.+|+.+++.+ +   |+||+++++++..  
T Consensus        62 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~e~~~~~~l-~~~~~~~iv~~~~~~~~--  138 (365)
T 3e7e_A           62 LGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERL-KPSMQHMFMKFYSAHLF--  138 (365)
T ss_dssp             CSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCCHHHHHHHHHHHHHS-CGGGGGGBCCEEEEEEC--
T ss_pred             ECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCChhHHHHHHHHHHHh-hhhhhhhhhhhheeeec--
Confidence            45788999999999999999999     46778999999999988888999999999998 5   8999999999965  


Q ss_pred             CCccEEEEEeecCCChhhhcC--------CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeC-----------
Q 015374          194 SKTPSLIFEYVNSTDFKVLYP--------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDH-----------  254 (408)
Q Consensus       194 ~~~~~lv~e~~~~~~l~~~~~--------~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~-----------  254 (408)
                      ....++||||+++++|..++.        .+++..+..++.|++.||+|||++||+||||||+|||++.           
T Consensus       139 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~~~~~  218 (365)
T 3e7e_A          139 QNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDL  218 (365)
T ss_dssp             SSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC------
T ss_pred             CCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCccccccc
Confidence            467789999999999998873        4899999999999999999999999999999999999987           


Q ss_pred             CCCcEEEEecccceecc---CCCcceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHH
Q 015374          255 ELRKLRLIDWGLAEFYH---PGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV  331 (408)
Q Consensus       255 ~~~~~kl~DfG~a~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~  331 (408)
                      + +.+||+|||+|+...   ........+||..|+|||++.+ ..++.++|||||||++|||++|+.||....+..    
T Consensus       219 ~-~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~----  292 (365)
T 3e7e_A          219 S-AGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSN-KPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGE----  292 (365)
T ss_dssp             C-TTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTT-CCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTE----
T ss_pred             c-CCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcC-CCCCccccHHHHHHHHHHHHhCCCccccCCCCc----
Confidence            5 799999999997653   2333455679999999999988 679999999999999999999999984332210    


Q ss_pred             HHHhhhchhhhhcCCCCCCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 015374          332 KIAKDCCLIIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH  392 (408)
Q Consensus       332 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~h  392 (408)
                                +.....    +.       ....++.+.+++..||+.+|.+|++..+.+.+
T Consensus       293 ----------~~~~~~----~~-------~~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~  332 (365)
T 3e7e_A          293 ----------CKPEGL----FR-------RLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQ  332 (365)
T ss_dssp             ----------EEECSC----CT-------TCSSHHHHHHHHHHHHCCCCTTCCCCHHHHHH
T ss_pred             ----------eeechh----cc-------ccCcHHHHHHHHHHHcCCCCCCcchHHHHHHH
Confidence                      000000    00       00135789999999999999999765444443

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=6.4e-45  Score=371.32  Aligned_cols=276  Identities=22%  Similarity=0.343  Sum_probs=208.8

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc----chHHHHHHHHHHHHhcCCCCceEEeeEEEc----cCCC
Q 015374          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRD----QHSK  195 (408)
Q Consensus       124 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~----~~~~  195 (408)
                      .++|++.++||+|+||+||+|.+..+++.||||+++..    ..+.+.+|+.+++++ +||||+++++++..    ..+.
T Consensus        13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L-~HpnIV~l~~v~~~~~~~~~~~   91 (676)
T 3qa8_A           13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKL-NHPNVVSAREVPDGLQKLAPND   91 (676)
T ss_dssp             ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHC-CBTTBCCEEECCTTTCCCCTTS
T ss_pred             CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhC-CCCCCCceeeeecccccccCCC
Confidence            47899999999999999999999999999999998642    346688999999999 99999999999754    2256


Q ss_pred             ccEEEEEeecCCChhhhcC------CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCC--cEEEEecccc
Q 015374          196 TPSLIFEYVNSTDFKVLYP------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELR--KLRLIDWGLA  267 (408)
Q Consensus       196 ~~~lv~e~~~~~~l~~~~~------~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~--~~kl~DfG~a  267 (408)
                      ..++||||+++++|..++.      .+++..+..++.|++.||.|||+.||+||||||+|||++.+.+  .+||+|||++
T Consensus        92 ~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a  171 (676)
T 3qa8_A           92 LPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYA  171 (676)
T ss_dssp             SCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCCCC
T ss_pred             eEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEcccccc
Confidence            7789999999999998873      4889999999999999999999999999999999999997622  4899999999


Q ss_pred             eeccCCCcceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhh--hhcC
Q 015374          268 EFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLII--WCNS  345 (408)
Q Consensus       268 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~--~~~~  345 (408)
                      .............||..|+|||++.+ ..++.++|||||||++|+|++|..||..... ...+.......+...  ....
T Consensus       172 ~~~~~~~~~~~~~gt~~Y~APE~l~~-~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~-~~~~~~~i~~~~~~~~~~~~~  249 (676)
T 3qa8_A          172 KELDQGELCTEFVGTLQYLAPELLEQ-KKYTVTVDYWSFGTLAFECITGFRPFLPNWQ-PVQWHGKVREKSNEHIVVYDD  249 (676)
T ss_dssp             CBTTSCCCCCCCCSCCTTCSSCSSCC-SCCSTTHHHHHHHHHHHHHHSSCSSCCSSCH-HHHSSTTCC------CCSCCC
T ss_pred             cccccccccccccCCcccCChHHhcc-CCCCchhHHHHHHHHHHHHHHCCCCCCcccc-hhhhhhhhhcccchhhhhhhh
Confidence            88776666666789999999999987 7899999999999999999999999854321 111100000000000  0000


Q ss_pred             CCCCCCccccc--cccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccccccch
Q 015374          346 RHSRKPWSKFI--NADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAE  402 (408)
Q Consensus       346 ~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~~~~~~  402 (408)
                      ......+....  +......+++++.+|+.+||.+||++|||++|+++||||+.+....
T Consensus       250 l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL  308 (676)
T 3qa8_A          250 LTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSIL  308 (676)
T ss_dssp             CSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHH
T ss_pred             hccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHH
Confidence            00001111110  1122333578899999999999999999999999999998876543

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=1.5e-43  Score=340.31  Aligned_cols=252  Identities=15%  Similarity=0.193  Sum_probs=201.0

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcC--------CCcEEEEEEecccchHHHHHHHHHHHHhcCCCCceE----------
Q 015374          123 DQDDYEVVRKVGRGKYSEVFEGINVN--------TNERCIIKILKPVKKKKIKREIKILQNLCGGPNVVK----------  184 (408)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~Vy~~~~~~--------~~~~vavK~~~~~~~~~~~~E~~~l~~l~~h~niv~----------  184 (408)
                      ..++|++.+.||+|+||+||+|++..        .++.||+|+++..  +.+.+|+.+++++ +||||++          
T Consensus        40 ~~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~--~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~  116 (352)
T 2jii_A           40 SGRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD--GRLFNEQNFFQRA-AKPLQVNKWKKLYSTPL  116 (352)
T ss_dssp             TSCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT--STHHHHHHHHHHH-CCHHHHHHHHHHTTCTT
T ss_pred             cCCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc--chHHHHHHHHHHh-cccchhhhhhhhccCCc
Confidence            36789999999999999999999887        4889999998643  5788999999999 8999887          


Q ss_pred             -----EeeEEEccCCCccEEEEEeecCCChhhhc-----CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeC
Q 015374          185 -----LLDIVRDQHSKTPSLIFEYVNSTDFKVLY-----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDH  254 (408)
Q Consensus       185 -----l~~~~~~~~~~~~~lv~e~~~~~~l~~~~-----~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~  254 (408)
                           +++++... ....++||||+ +++|..++     ..+++..+..++.|++.||.|||++||+||||||+|||++.
T Consensus       117 ~~i~~~~~~~~~~-~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl~~~  194 (352)
T 2jii_A          117 LAIPTCMGFGVHQ-DKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDP  194 (352)
T ss_dssp             CSCCCCCEEEEET-TTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEEEET
T ss_pred             cCccchhhccccC-CcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEEcC
Confidence                 56666542 46789999999 99998887     35899999999999999999999999999999999999998


Q ss_pred             CCC--cEEEEecccceeccCCCc--------ceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCC
Q 015374          255 ELR--KLRLIDWGLAEFYHPGKE--------YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGH  324 (408)
Q Consensus       255 ~~~--~~kl~DfG~a~~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~  324 (408)
                      + +  .+||+|||+++.......        .....||..|+|||++.+ ..++.++|||||||++|+|++|+.||....
T Consensus       195 ~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~~  272 (352)
T 2jii_A          195 E-DQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKG-CGPSRRSDLQSLGYCMLKWLYGFLPWTNCL  272 (352)
T ss_dssp             T-EEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSCCTTGGGT
T ss_pred             C-CCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHcc-CCCCchhhHHHHHHHHHHHHhCCCCcccCC
Confidence            7 5  899999999976543221        133478999999999987 689999999999999999999999986555


Q ss_pred             CCHHHHHHHHhhhchhhhhcCCCCCCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 015374          325 DNHDQLVKIAKDCCLIIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA  391 (408)
Q Consensus       325 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~  391 (408)
                      .+.+.+...........        ..+  ......+..+++++.+++.+||+.||++|||++++++
T Consensus       273 ~~~~~~~~~~~~~~~~~--------~~~--~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  329 (352)
T 2jii_A          273 PNTEDIMKQKQKFVDKP--------GPF--VGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRN  329 (352)
T ss_dssp             TCHHHHHHHHHHHHHSC--------CCE--ECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             cCHHHHHHHHHhccCCh--------hhh--hhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHH
Confidence            45554444333211100        000  0001112346899999999999999999999999976

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=5.3e-43  Score=328.79  Aligned_cols=240  Identities=26%  Similarity=0.416  Sum_probs=189.8

Q ss_pred             CCCEEEE-eeeeeeCceEEEEEEEcCCCcEEEEEEecccchHHHHHHHHHHHHhcCCCCceEEeeEEEc--cCCCccEEE
Q 015374          124 QDDYEVV-RKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRD--QHSKTPSLI  200 (408)
Q Consensus       124 ~~~y~~~-~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~--~~~~~~~lv  200 (408)
                      .++|.+. +.||+|+||+||+|.+..+++.||+|+++.  ...+.+|+.++.++.+||||+++++++..  ......++|
T Consensus        16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~--~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv   93 (299)
T 3m2w_A           16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD--CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIV   93 (299)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC--SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEE
T ss_pred             ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc--cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEEE
Confidence            4678887 779999999999999999999999999963  45678999998666699999999999864  234678999


Q ss_pred             EEeecCCChhhhcC-----CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCC--CCcEEEEecccceeccCC
Q 015374          201 FEYVNSTDFKVLYP-----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE--LRKLRLIDWGLAEFYHPG  273 (408)
Q Consensus       201 ~e~~~~~~l~~~~~-----~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~--~~~~kl~DfG~a~~~~~~  273 (408)
                      |||+++++|..++.     .+++..+..++.|++.||.|||++||+||||||+|||++.+  .+.+||+|||++....  
T Consensus        94 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~--  171 (299)
T 3m2w_A           94 MECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT--  171 (299)
T ss_dssp             ECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECT--
T ss_pred             EeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEeccccccccc--
Confidence            99999999988872     48999999999999999999999999999999999999973  2789999999986533  


Q ss_pred             CcceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCCCcc
Q 015374          274 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWS  353 (408)
Q Consensus       274 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  353 (408)
                                         + ..++.++|||||||++|+|++|..||..... .+....+.          .......  
T Consensus       172 -------------------~-~~~~~~~DiwslG~il~el~tg~~pf~~~~~-~~~~~~~~----------~~~~~~~--  218 (299)
T 3m2w_A          172 -------------------G-EKYDKSCDMWSLGVIMYILLCGYPPFYSNHG-LAISPGMK----------TRIRMGQ--  218 (299)
T ss_dssp             -------------------T-CGGGGHHHHHHHHHHHHHHHHSSCSCCC--------CCSC----------CSSCTTC--
T ss_pred             -------------------c-ccCCchhhHHHHHHHHHHHHHCCCCCCCCcc-hhhhHHHH----------HHHhhcc--
Confidence                               1 4578899999999999999999999843221 11100000          0000000  


Q ss_pred             ccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccccc
Q 015374          354 KFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRA  400 (408)
Q Consensus       354 ~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~~~~  400 (408)
                      .......+..+++++.+|+.+||+.||++|||++|+++||||++...
T Consensus       219 ~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~~  265 (299)
T 3m2w_A          219 YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTK  265 (299)
T ss_dssp             CSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGGG
T ss_pred             ccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhccccc
Confidence            00111112457899999999999999999999999999999987654

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=4e-43  Score=332.56  Aligned_cols=249  Identities=20%  Similarity=0.322  Sum_probs=199.2

Q ss_pred             CCEEEEeeeeeeCceEEEEEEE----cCCCcEEEEEEecccc----hHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCc
Q 015374          125 DDYEVVRKVGRGKYSEVFEGIN----VNTNERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT  196 (408)
Q Consensus       125 ~~y~~~~~lG~G~fg~Vy~~~~----~~~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  196 (408)
                      ..|+++++||+|+||+||++..    ..+++.||||+++...    ...+.+|+.+++++ +||||+++++++.+.....
T Consensus        31 r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~  109 (318)
T 3lxp_A           31 RYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTL-YHEHIIKYKGCCEDAGAAS  109 (318)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEEETTTTE
T ss_pred             HHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhC-CCcchhhEEEEEecCCCce
Confidence            3459999999999999988753    4578899999997532    45688999999999 8999999999998776678


Q ss_pred             cEEEEEeecCCChhhhcC--CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCCC
Q 015374          197 PSLIFEYVNSTDFKVLYP--TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK  274 (408)
Q Consensus       197 ~~lv~e~~~~~~l~~~~~--~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~~  274 (408)
                      .++||||+++++|..++.  .+++..+..++.|++.||.|||++||+||||||+|||++.+ +.+||+|||++.......
T Consensus       110 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~-~~~kl~Dfg~a~~~~~~~  188 (318)
T 3lxp_A          110 LQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDND-RLVKIGDFGLAKAVPEGH  188 (318)
T ss_dssp             EEEEECCCTTCBHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTT-CCEEECCGGGCEECCTTC
T ss_pred             EEEEEecccCCcHHHHHhhCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCC-CCEEECCccccccccccc
Confidence            899999999999999884  48999999999999999999999999999999999999988 799999999998776543


Q ss_pred             c----ceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCH---------H-HHHHHHhhhchh
Q 015374          275 E----YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNH---------D-QLVKIAKDCCLI  340 (408)
Q Consensus       275 ~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~---------~-~~~~~~~~~~~~  340 (408)
                      .    .....++..|+|||++.+ ..++.++||||||+++|+|++|+.||.......         . ....+....   
T Consensus       189 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~---  264 (318)
T 3lxp_A          189 EYYRVREDGDSPVFWYAPECLKE-YKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELL---  264 (318)
T ss_dssp             SEEEC---CCCCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHH---
T ss_pred             cccccccCCCCCceeeChHHhcC-CCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHH---
Confidence            2    233457778999999987 678899999999999999999999984311100         0 000000000   


Q ss_pred             hhhcCCCCCCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 015374          341 IWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA  391 (408)
Q Consensus       341 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~  391 (408)
                        .          .......+..+++++.+|+.+||+.||++|||++|+++
T Consensus       265 --~----------~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~  303 (318)
T 3lxp_A          265 --E----------RGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIP  303 (318)
T ss_dssp             --H----------TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             --h----------cccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence              0          00112233457899999999999999999999999984

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.8e-43  Score=337.06  Aligned_cols=255  Identities=20%  Similarity=0.269  Sum_probs=197.0

Q ss_pred             CCCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecccchHHHHHHHHHHHHh-cCCCCceEEeeEEEccCC--CccE
Q 015374          122 GDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNL-CGGPNVVKLLDIVRDQHS--KTPS  198 (408)
Q Consensus       122 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l-~~h~niv~l~~~~~~~~~--~~~~  198 (408)
                      ...++|++.+.||+|+||+||+|++.  ++.||||++.......+.+|.+++..+ .+||||+++++++.+...  ...+
T Consensus        34 ~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~  111 (337)
T 3mdy_A           34 TIAKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTEEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLY  111 (337)
T ss_dssp             THHHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEEE
T ss_pred             ccccceEEEeEeecCCCeEEEEEEEC--CceEEEEEEeccccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCceE
Confidence            34678999999999999999999764  889999999877667777777766643 289999999999976533  5789


Q ss_pred             EEEEeecCCChhhhc--CCCChHHHHHHHHHHHHHHHHHHHC--------CcEEecCCCCcEEEeCCCCcEEEEecccce
Q 015374          199 LIFEYVNSTDFKVLY--PTLTDYDIRYYIYELLKALDYCHSQ--------GIMHRDVKPHNVMIDHELRKLRLIDWGLAE  268 (408)
Q Consensus       199 lv~e~~~~~~l~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~--------~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~  268 (408)
                      +||||+++++|..++  ..+++..+..++.|++.||.|||++        ||+||||||+|||++.+ +.+||+|||++.
T Consensus       112 lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~-~~~kl~Dfg~a~  190 (337)
T 3mdy_A          112 LITDYHENGSLYDYLKSTTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKN-GTCCIADLGLAV  190 (337)
T ss_dssp             EEECCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTT-SCEEECCCTTCE
T ss_pred             EEEeccCCCcHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCC-CCEEEEeCCCce
Confidence            999999999999987  4589999999999999999999998        99999999999999988 799999999997


Q ss_pred             eccCCCcc-----eeeccCccccccccccCCcCCCcc------ccHHHHHHHHHHHHhC----------CCCCCCCC---
Q 015374          269 FYHPGKEY-----NVRVASRYFKGPELLVDLQDYDYS------LDMWSLGCMFAGMIFR----------KEPFFYGH---  324 (408)
Q Consensus       269 ~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~------~DvwSlGvil~ell~g----------~~pf~~~~---  324 (408)
                      ........     ....||..|+|||++.+ ..++..      +|||||||++|||++|          ..||....   
T Consensus       191 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~~~~  269 (337)
T 3mdy_A          191 KFISDTNEVDIPPNTRVGTKRYMPPEVLDE-SLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSD  269 (337)
T ss_dssp             ECC---------CCSSCSCGGGCCHHHHTT-CCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSS
T ss_pred             eeccccccccCCCCCCccCcceeChhhccc-ccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhcCCC
Confidence            66443322     24579999999999977 444443      9999999999999999          66664322   


Q ss_pred             CCHHHHHHHHhhhchhhhhcCCCCCCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 015374          325 DNHDQLVKIAKDCCLIIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH  392 (408)
Q Consensus       325 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~h  392 (408)
                      ...+..........         ....+..   ......+++++.+++.+||+.||++|||++|+++|
T Consensus       270 ~~~~~~~~~~~~~~---------~~~~~~~---~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  325 (337)
T 3mdy_A          270 PSYEDMREIVCIKK---------LRPSFPN---RWSSDECLRQMGKLMTECWAHNPASRLTALRVKKT  325 (337)
T ss_dssp             CCHHHHHHHHTTSC---------CCCCCCG---GGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred             CchhhhHHHHhhhc---------cCccccc---cchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHH
Confidence            22233333222110         0111110   01112356789999999999999999999999976

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=7.5e-44  Score=336.99  Aligned_cols=251  Identities=20%  Similarity=0.340  Sum_probs=198.4

Q ss_pred             CCCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecc---cchHHHHHHHHHHHHhcCCCCceEEeeEEEcc--CCCc
Q 015374          122 GDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP---VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQ--HSKT  196 (408)
Q Consensus       122 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~---~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~--~~~~  196 (408)
                      ...++|++.+.||+|+||+||+|++..+++.||||++..   ...+.+.+|+.+++++ +||||+++++++...  ....
T Consensus        26 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~  104 (317)
T 2buj_A           26 IDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLF-NHPNILRLVAYCLRERGAKHE  104 (317)
T ss_dssp             ETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTC-CCTTBCCCCEEEEEEETTEEE
T ss_pred             ECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhc-CCCCeeeEEEEEEeccCCCce
Confidence            457899999999999999999999999999999998853   3346788999999999 999999999998632  3357


Q ss_pred             cEEEEEeecCCChhhhcC-------CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEeccccee
Q 015374          197 PSLIFEYVNSTDFKVLYP-------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEF  269 (408)
Q Consensus       197 ~~lv~e~~~~~~l~~~~~-------~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~  269 (408)
                      .++||||+.+++|..++.       .+++..+..++.|++.||.|||++||+||||||+|||++.+ +.+||+|||++..
T Consensus       105 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~-~~~kl~dfg~~~~  183 (317)
T 2buj_A          105 AWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDE-GQPVLMDLGSMNQ  183 (317)
T ss_dssp             EEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTT-SCEEECCCSSCEE
T ss_pred             eEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCC-CCEEEEecCcchh
Confidence            889999999999987763       48999999999999999999999999999999999999988 7899999999875


Q ss_pred             ccCCCc----------ceeeccCccccccccccCCc--CCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhh
Q 015374          270 YHPGKE----------YNVRVASRYFKGPELLVDLQ--DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDC  337 (408)
Q Consensus       270 ~~~~~~----------~~~~~~~~~y~aPE~~~~~~--~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~  337 (408)
                      ......          .....||..|+|||++.+..  .++.++||||||+++|+|++|..||.......+........ 
T Consensus       184 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~-  262 (317)
T 2buj_A          184 ACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQN-  262 (317)
T ss_dssp             SCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHHC-
T ss_pred             cccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHhhc-
Confidence            432111          12345689999999987522  37899999999999999999999983110000011111110 


Q ss_pred             chhhhhcCCCCCCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 015374          338 CLIIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH  392 (408)
Q Consensus       338 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~h  392 (408)
                              .         ........+++++.+++.+||+.||++|||++|++++
T Consensus       263 --------~---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  300 (317)
T 2buj_A          263 --------Q---------LSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQ  300 (317)
T ss_dssp             --------C-----------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             --------c---------CCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHH
Confidence                    0         0111123468999999999999999999999999986

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=2.7e-43  Score=327.02  Aligned_cols=241  Identities=16%  Similarity=0.333  Sum_probs=192.2

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc-chHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccEEEE
Q 015374          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIF  201 (408)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~  201 (408)
                      ..++|++.+.||+|+||+||+|.+  +++.||+|+++.. ..+.+.+|+.+++++ +||||+++++++.+. ....++||
T Consensus        19 ~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~-~~~~~lv~   94 (278)
T 1byg_A           19 NMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQL-RHSNLVQLLGVIVEE-KGGLYIVT   94 (278)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC--HHHHHTHHHHTTC-CCTTBCCEEEEECCC---CCEEEE
T ss_pred             ChhhceEEeEEecCCCceEEEEEE--cCCEEEEEEecchhHHHHHHHHHHHHHhC-CCCCEeeEEEEEEcC-CCceEEEE
Confidence            467899999999999999999976  4889999999754 456789999999999 999999999997543 34688999


Q ss_pred             EeecCCChhhhcCC-----CChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCCCcc
Q 015374          202 EYVNSTDFKVLYPT-----LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY  276 (408)
Q Consensus       202 e~~~~~~l~~~~~~-----l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~~~~  276 (408)
                      ||+++++|..++..     +++..+..++.|++.||.|||++||+|+||||+||+++.+ +.+||+|||++......  .
T Consensus        95 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~-~~~~l~Dfg~~~~~~~~--~  171 (278)
T 1byg_A           95 EYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSED-NVAKVSDFGLTKEASST--Q  171 (278)
T ss_dssp             CCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTT-SCEEECCCCC----------
T ss_pred             ecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCC-CcEEEeecccccccccc--c
Confidence            99999999888742     8889999999999999999999999999999999999988 79999999998765432  2


Q ss_pred             eeeccCccccccccccCCcCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCCCcccc
Q 015374          277 NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSKF  355 (408)
Q Consensus       277 ~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  355 (408)
                      ....++..|+|||.+.+ ..++.++||||||+++|+|++ |..||. ..+..+....+...                   
T Consensus       172 ~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~t~g~~p~~-~~~~~~~~~~~~~~-------------------  230 (278)
T 1byg_A          172 DTGKLPVKWTAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPYP-RIPLKDVVPRVEKG-------------------  230 (278)
T ss_dssp             ----CCTTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSCT-TSCGGGHHHHHTTT-------------------
T ss_pred             cCCCccccccCHHHhCC-CCCCchhcHHHHHHHHHHHHhCCCCCCC-CCCHHHHHHHHhcC-------------------
Confidence            33467888999999987 789999999999999999998 888873 33333332222111                   


Q ss_pred             ccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 015374          356 INADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA  391 (408)
Q Consensus       356 ~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~  391 (408)
                      .....+..+++++.+++.+||+.||++|||+.|+++
T Consensus       231 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~  266 (278)
T 1byg_A          231 YKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLRE  266 (278)
T ss_dssp             CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHH
Confidence            111223457899999999999999999999999985

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=3e-43  Score=335.11  Aligned_cols=247  Identities=21%  Similarity=0.344  Sum_probs=183.5

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc---chHHHHHHHHHHHHhcCCCCceEEeeEEEc------cC
Q 015374          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV---KKKKIKREIKILQNLCGGPNVVKLLDIVRD------QH  193 (408)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~h~niv~l~~~~~~------~~  193 (408)
                      ...+|++.+.||+|+||+||+|++..+++.||+|++...   ....+.+|+.++.++.+||||+++++++..      ..
T Consensus        26 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~  105 (337)
T 3ll6_A           26 GELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTG  105 (337)
T ss_dssp             TTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTS
T ss_pred             cCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccC
Confidence            467899999999999999999999999999999988533   345688999999999559999999999852      23


Q ss_pred             CCccEEEEEeecCCChhhhc------CCCChHHHHHHHHHHHHHHHHHHHCC--cEEecCCCCcEEEeCCCCcEEEEecc
Q 015374          194 SKTPSLIFEYVNSTDFKVLY------PTLTDYDIRYYIYELLKALDYCHSQG--IMHRDVKPHNVMIDHELRKLRLIDWG  265 (408)
Q Consensus       194 ~~~~~lv~e~~~~~~l~~~~------~~l~~~~~~~i~~qi~~~L~~LH~~~--iiH~Dlk~~NILl~~~~~~~kl~DfG  265 (408)
                      ....++||||+++ +|..++      ..+++..+..++.|++.||.|||++|  |+||||||+|||++.+ +.+||+|||
T Consensus       106 ~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~-~~~kl~Dfg  183 (337)
T 3ll6_A          106 QAEFLLLTELCKG-QLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQ-GTIKLCDFG  183 (337)
T ss_dssp             SEEEEEEEECCSE-EHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTT-SCEEBCCCT
T ss_pred             CceEEEEEEecCC-CHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCC-CCEEEecCc
Confidence            3457899999974 555544      34899999999999999999999999  9999999999999988 799999999


Q ss_pred             cceeccCCCcc-------------eeeccCcccccccccc--CCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHH
Q 015374          266 LAEFYHPGKEY-------------NVRVASRYFKGPELLV--DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQL  330 (408)
Q Consensus       266 ~a~~~~~~~~~-------------~~~~~~~~y~aPE~~~--~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~  330 (408)
                      ++.........             ....+|..|+|||++.  ....++.++|||||||++|+|++|..||.... .....
T Consensus       184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~-~~~~~  262 (337)
T 3ll6_A          184 SATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGA-KLRIV  262 (337)
T ss_dssp             TCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC----------
T ss_pred             cceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchh-HHHhh
Confidence            99876543221             1456889999999983  22678899999999999999999999984221 11111


Q ss_pred             HHHHhhhchhhhhcCCCCCCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCC
Q 015374          331 VKIAKDCCLIIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPY  394 (408)
Q Consensus       331 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~  394 (408)
                      .    .                  ..........+..+.+|+.+||+.||++|||++|+++|-+
T Consensus       263 ~----~------------------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~  304 (337)
T 3ll6_A          263 N----G------------------KYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQ  304 (337)
T ss_dssp             -------------------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHH
T ss_pred             c----C------------------cccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence            0    0                  0111122335678999999999999999999999998843

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.2e-42  Score=330.50  Aligned_cols=256  Identities=18%  Similarity=0.316  Sum_probs=199.8

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEE----EcCCCcEEEEEEecccc---hHHHHHHHHHHHHhcCCCCceEEeeEEEccCCC
Q 015374          123 DQDDYEVVRKVGRGKYSEVFEGI----NVNTNERCIIKILKPVK---KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSK  195 (408)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~Vy~~~----~~~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  195 (408)
                      ..++|++.+.||+|+||+||+|+    +..+++.||+|+++...   .+.+.+|+.+++++ +||||+++++++......
T Consensus        39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~  117 (326)
T 2w1i_A           39 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSL-QHDNIVKYKGVCYSAGRR  117 (326)
T ss_dssp             CGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTC-CCTTBCCEEEEECC----
T ss_pred             CHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEEecCCC
Confidence            46789999999999999999998    46689999999987433   45788999999999 999999999999766556


Q ss_pred             ccEEEEEeecCCChhhhc----CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceecc
Q 015374          196 TPSLIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH  271 (408)
Q Consensus       196 ~~~lv~e~~~~~~l~~~~----~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~  271 (408)
                      ..++||||+++++|..++    ..+++..+..++.|++.||.|||++||+||||||+|||++.+ +.+||+|||++....
T Consensus       118 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~-~~~kL~Dfg~~~~~~  196 (326)
T 2w1i_A          118 NLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENE-NRVKIGDFGLTKVLP  196 (326)
T ss_dssp             CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEET-TEEEECCCTTCEECC
T ss_pred             ceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCC-CcEEEecCcchhhcc
Confidence            789999999999999887    348999999999999999999999999999999999999988 799999999998775


Q ss_pred             CCCcc----eeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhch------hh
Q 015374          272 PGKEY----NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCL------II  341 (408)
Q Consensus       272 ~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~------~~  341 (408)
                      .....    ....++..|+|||.+.+ ..++.++||||||+++|+|++|..||...   .............      ..
T Consensus       197 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~tg~~~~~~~---~~~~~~~~~~~~~~~~~~~~~  272 (326)
T 2w1i_A          197 QDKEYYKVKEPGESPIFWYAPESLTE-SKFSVASDVWSFGVVLYELFTYIEKSKSP---PAEFMRMIGNDKQGQMIVFHL  272 (326)
T ss_dssp             SSCSEEECSSCCSCCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHHTTCGGGSH---HHHHHHHHCTTCCTHHHHHHH
T ss_pred             ccccccccccCCCCceeEECchhhcC-CCCCchhhHHHHHHHHHHHHhcCCCCCCC---HHHHHHhhccccchhhhHHHH
Confidence            44322    23456677999999987 67899999999999999999999887321   1111111000000      00


Q ss_pred             hhcCCCCCCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 015374          342 WCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA  391 (408)
Q Consensus       342 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~  391 (408)
                      ....       ........+..+++++.+++.+||+.||++|||+.|+++
T Consensus       273 ~~~~-------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~  315 (326)
T 2w1i_A          273 IELL-------KNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL  315 (326)
T ss_dssp             HHHH-------HTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             HHHh-------hcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            0000       000011223457899999999999999999999999985

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=3.3e-43  Score=355.88  Aligned_cols=249  Identities=18%  Similarity=0.328  Sum_probs=204.6

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc--chHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccEEE
Q 015374          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV--KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI  200 (408)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  200 (408)
                      ..++|++.++||+|+||+||+|.+.. +..||||+++..  ..+.+.+|+.+++++ +|+||+++++++.+   ...++|
T Consensus       265 ~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~---~~~~lv  339 (535)
T 2h8h_A          265 PRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMSPEAFLQEAQVMKKL-RHEKLVQLYAVVSE---EPIYIV  339 (535)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTSSCHHHHHHHHHHHHHC-CCTTBCCEEEEECS---SSCEEE
T ss_pred             chhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCCCCHHHHHHHHHHHHhC-CCCCEeeEEEEEee---ccceEe
Confidence            45789999999999999999998754 567999999753  356899999999999 99999999999854   567899


Q ss_pred             EEeecCCChhhhcC-----CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCCC-
Q 015374          201 FEYVNSTDFKVLYP-----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK-  274 (408)
Q Consensus       201 ~e~~~~~~l~~~~~-----~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~~-  274 (408)
                      |||+.+++|..++.     .+++..+..++.||+.||+|||+++|+||||||+|||++.+ +.+||+|||+++...... 
T Consensus       340 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~-~~~kl~DFG~a~~~~~~~~  418 (535)
T 2h8h_A          340 TEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGEN-LVCKVADFGLARLIEDNEY  418 (535)
T ss_dssp             ECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGG-GCEEECCTTSTTTCCCHHH
T ss_pred             eehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCC-CcEEEcccccceecCCCce
Confidence            99999999999884     38999999999999999999999999999999999999988 799999999997654321 


Q ss_pred             -cceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCCCc
Q 015374          275 -EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPW  352 (408)
Q Consensus       275 -~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  352 (408)
                       ......++..|+|||++.+ ..++.++|||||||++|||++ |..|| .+....+.+..+...                
T Consensus       419 ~~~~~~~~~~~y~aPE~~~~-~~~~~~sDvwSlGv~l~el~t~g~~P~-~~~~~~~~~~~i~~~----------------  480 (535)
T 2h8h_A          419 TARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELTTKGRVPY-PGMVNREVLDQVERG----------------  480 (535)
T ss_dssp             HTTCSTTSCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHTTTTCCSS-TTCCHHHHHHHHHTT----------------
T ss_pred             ecccCCcCcccccCHHHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCC-CCCCHHHHHHHHHcC----------------
Confidence             1122345678999999987 789999999999999999999 78786 455544444443221                


Q ss_pred             cccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcC--CCcccc
Q 015374          353 SKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH--PYFAQV  398 (408)
Q Consensus       353 ~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~h--p~f~~~  398 (408)
                         .....+..+++++.+||.+||+.||++|||++++++.  .+|...
T Consensus       481 ---~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~  525 (535)
T 2h8h_A          481 ---YRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST  525 (535)
T ss_dssp             ---CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCC
T ss_pred             ---CCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhcc
Confidence               0112234578999999999999999999999999864  555543

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.4e-42  Score=356.41  Aligned_cols=242  Identities=17%  Similarity=0.333  Sum_probs=197.2

Q ss_pred             CCCCEEEEe-eeeeeCceEEEEEEEc--CCCcEEEEEEeccc----chHHHHHHHHHHHHhcCCCCceEEeeEEEccCCC
Q 015374          123 DQDDYEVVR-KVGRGKYSEVFEGINV--NTNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSK  195 (408)
Q Consensus       123 ~~~~y~~~~-~lG~G~fg~Vy~~~~~--~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  195 (408)
                      ..+++.+.+ +||+|+||+||+|.+.  .++..||||+++..    ..+.+.+|+.+++++ +||||++++++|.+   .
T Consensus       333 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l-~hpniv~l~~~~~~---~  408 (613)
T 2ozo_A          333 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQL-DNPYIVRLIGVCQA---E  408 (613)
T ss_dssp             CTTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTC-CCTTBCCEEEEEES---S
T ss_pred             cccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhC-CCCCEeeEEEEecc---C
Confidence            456677777 8999999999999765  35667999999743    357899999999999 99999999999964   4


Q ss_pred             ccEEEEEeecCCChhhhcC----CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceecc
Q 015374          196 TPSLIFEYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH  271 (408)
Q Consensus       196 ~~~lv~e~~~~~~l~~~~~----~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~  271 (408)
                      ..++||||+++++|..++.    .+++..+..++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+++...
T Consensus       409 ~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~-~~vkL~DFGla~~~~  487 (613)
T 2ozo_A          409 ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNR-HYAKISDFGLSKALG  487 (613)
T ss_dssp             SEEEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEET-TEEEECCCSTTTTCC
T ss_pred             CeEEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCC-CcEEEeeccCccccc
Confidence            5889999999999998873    48999999999999999999999999999999999999988 799999999998664


Q ss_pred             CCCcc----eeeccCccccccccccCCcCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHhhhchhhhhcCC
Q 015374          272 PGKEY----NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKDCCLIIWCNSR  346 (408)
Q Consensus       272 ~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  346 (408)
                      .....    ....++..|+|||++.+ ..++.++|||||||++|||++ |+.|| .+.+..+....+...          
T Consensus       488 ~~~~~~~~~~~~~~~~~y~APE~~~~-~~~~~~sDvwSlGv~l~ellt~G~~Pf-~~~~~~~~~~~i~~~----------  555 (613)
T 2ozo_A          488 ADDSYYTARSAGKWPLKWYAPECINF-RKFSSRSDVWSYGVTMWEALSYGQKPY-KKMKGPEVMAFIEQG----------  555 (613)
T ss_dssp             --------------CCTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTT-TTCCSHHHHHHHHTT----------
T ss_pred             CCCceeeeccCCCCccceeCHhhhcC-CCCCcHHHHHHHHHHHHHHHHCCCCCC-CCCCHHHHHHHHHcC----------
Confidence            33221    22345578999999987 789999999999999999998 98887 455555555444321          


Q ss_pred             CCCCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHh
Q 015374          347 HSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAM  390 (408)
Q Consensus       347 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL  390 (408)
                               .....+..+++++.++|.+||+.||++|||+++++
T Consensus       556 ---------~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~  590 (613)
T 2ozo_A          556 ---------KRMECPPECPPELYALMSDCWIYKWEDRPDFLTVE  590 (613)
T ss_dssp             ---------CCCCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHH
T ss_pred             ---------CCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHH
Confidence                     01122345889999999999999999999999984

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=1e-42  Score=358.34  Aligned_cols=241  Identities=17%  Similarity=0.307  Sum_probs=194.5

Q ss_pred             CCEEEE-eeeeeeCceEEEEEEE--cCCCcEEEEEEecccc-----hHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCc
Q 015374          125 DDYEVV-RKVGRGKYSEVFEGIN--VNTNERCIIKILKPVK-----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT  196 (408)
Q Consensus       125 ~~y~~~-~~lG~G~fg~Vy~~~~--~~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  196 (408)
                      ..+.+. ++||+|+||+||+|.+  ..+++.||||+++...     .+.+.+|+.+++++ +||||++++++|.+   ..
T Consensus       368 ~~~~l~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~---~~  443 (635)
T 4fl3_A          368 KLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQL-DNPYIVRMIGICEA---ES  443 (635)
T ss_dssp             GGEEEEEEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHC-CCTTBCCEEEEEES---SS
T ss_pred             hhccccCCEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEec---CC
Confidence            345544 4799999999999954  4567899999997432     46799999999999 99999999999954   34


Q ss_pred             cEEEEEeecCCChhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCC
Q 015374          197 PSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG  273 (408)
Q Consensus       197 ~~lv~e~~~~~~l~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~  273 (408)
                      .++||||+++++|..++   ..+++..+..++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++.....
T Consensus       444 ~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~-~~~kL~DFGla~~~~~~  522 (635)
T 4fl3_A          444 WMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQ-HYAKISDFGLSKALRAD  522 (635)
T ss_dssp             EEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEET-TEEEECCTTHHHHTTC-
T ss_pred             EEEEEEccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCC-CCEEEEEcCCccccccC
Confidence            78999999999999887   458999999999999999999999999999999999999988 79999999999876543


Q ss_pred             Cc----ceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCC
Q 015374          274 KE----YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHS  348 (408)
Q Consensus       274 ~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  348 (408)
                      ..    .....+|..|+|||++.+ ..++.++|||||||++|||++ |+.|| .+.+..+....+...            
T Consensus       523 ~~~~~~~~~~~~t~~y~APE~~~~-~~~~~~sDvwSlGv~l~ellt~G~~Pf-~~~~~~~~~~~i~~~------------  588 (635)
T 4fl3_A          523 ENYYKAQTHGKWPVKWYAPECINY-YKFSSKSDVWSFGVLMWEAFSYGQKPY-RGMKGSEVTAMLEKG------------  588 (635)
T ss_dssp             ------------CGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCSS-TTCCHHHHHHHHHTT------------
T ss_pred             ccccccccCCCCceeeeChhhhcC-CCCCcHHHHHHHHHHHHHHHhCCCCCC-CCCCHHHHHHHHHcC------------
Confidence            32    223346678999999987 789999999999999999998 88887 444444444333221            


Q ss_pred             CCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 015374          349 RKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA  391 (408)
Q Consensus       349 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~  391 (408)
                             .....+..+++++.++|.+||+.||++|||++++++
T Consensus       589 -------~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~  624 (635)
T 4fl3_A          589 -------ERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVEL  624 (635)
T ss_dssp             -------CCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             -------CCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence                   112223457899999999999999999999999875

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=1.4e-42  Score=331.68  Aligned_cols=257  Identities=18%  Similarity=0.233  Sum_probs=202.8

Q ss_pred             cCCCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecccchHHHHHHHHHHHHh-cCCCCceEEeeEEEccCC--Ccc
Q 015374          121 WGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNL-CGGPNVVKLLDIVRDQHS--KTP  197 (408)
Q Consensus       121 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l-~~h~niv~l~~~~~~~~~--~~~  197 (408)
                      ....++|++.+.||+|+||+||+|++  +++.||||+++......+.+|.+++..+ .+||||+++++++.....  ...
T Consensus        38 ~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~~  115 (342)
T 1b6c_B           38 RTIARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQL  115 (342)
T ss_dssp             HHHHHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCCE
T ss_pred             ccccccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCchhHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCcccee
Confidence            33467899999999999999999987  5899999999887788889999999983 289999999999976532  278


Q ss_pred             EEEEEeecCCChhhhc--CCCChHHHHHHHHHHHHHHHHHH--------HCCcEEecCCCCcEEEeCCCCcEEEEecccc
Q 015374          198 SLIFEYVNSTDFKVLY--PTLTDYDIRYYIYELLKALDYCH--------SQGIMHRDVKPHNVMIDHELRKLRLIDWGLA  267 (408)
Q Consensus       198 ~lv~e~~~~~~l~~~~--~~l~~~~~~~i~~qi~~~L~~LH--------~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a  267 (408)
                      ++||||+++++|..++  ..+++..+..++.|++.||.|||        +.+|+||||||+|||++.+ +.+||+|||++
T Consensus       116 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~-~~~kL~Dfg~~  194 (342)
T 1b6c_B          116 WLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKN-GTCCIADLGLA  194 (342)
T ss_dssp             EEEECCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTT-SCEEECCCTTC
T ss_pred             EEEEeecCCCcHHHHHhccCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCC-CCEEEEECCCc
Confidence            9999999999999987  45899999999999999999999        8999999999999999988 79999999999


Q ss_pred             eeccCCCc-----ceeeccCccccccccccCCc-----CCCccccHHHHHHHHHHHHhC----------CCCCCCCCC--
Q 015374          268 EFYHPGKE-----YNVRVASRYFKGPELLVDLQ-----DYDYSLDMWSLGCMFAGMIFR----------KEPFFYGHD--  325 (408)
Q Consensus       268 ~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~-----~~~~~~DvwSlGvil~ell~g----------~~pf~~~~~--  325 (408)
                      ........     .....||..|+|||++.+..     .++.++|||||||++|||++|          ..||.....  
T Consensus       195 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~~~~  274 (342)
T 1b6c_B          195 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD  274 (342)
T ss_dssp             EEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSS
T ss_pred             eeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccCcCc
Confidence            87655432     23457899999999997632     233689999999999999999          778754322  


Q ss_pred             -CHHHHHHHHhhhchhhhhcCCCCCCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 015374          326 -NHDQLVKIAKDCCLIIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH  392 (408)
Q Consensus       326 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~h  392 (408)
                       ..+.+........         .+.....   ......+++.+.+++.+||+.||++|||++|+++|
T Consensus       275 ~~~~~~~~~~~~~~---------~~~~~~~---~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~  330 (342)
T 1b6c_B          275 PSVEEMRKVVCEQK---------LRPNIPN---RWQSCEALRVMAKIMRECWYANGAARLTALRIKKT  330 (342)
T ss_dssp             CCHHHHHHHHTTSC---------CCCCCCG---GGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred             ccHHHHHHHHHHHH---------hCCCCcc---cccchhHHHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence             2333333221100         0000000   00111234679999999999999999999999976

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=1.3e-42  Score=324.28  Aligned_cols=245  Identities=18%  Similarity=0.285  Sum_probs=192.1

Q ss_pred             CCCCCEEEEeeeeeeCceEEEEEEEcC-CCc--EEEEEEeccc------chHHHHHHHHHHHHhcCCCCceEEeeEEEcc
Q 015374          122 GDQDDYEVVRKVGRGKYSEVFEGINVN-TNE--RCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQ  192 (408)
Q Consensus       122 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~-~~~--~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~  192 (408)
                      ...++|++.+.||+|+||+||+|++.. ++.  .||+|+++..      ..+.+.+|+.+++++ +||||+++++++.+.
T Consensus        15 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~   93 (291)
T 1u46_A           15 IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL-DHRNLIRLYGVVLTP   93 (291)
T ss_dssp             CCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHC-CCTTBCCEEEEECSS
T ss_pred             cchhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhC-CCCCcccEEEEEccC
Confidence            356899999999999999999998643 333  6899998642      346788999999999 999999999999653


Q ss_pred             CCCccEEEEEeecCCChhhhc----CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccce
Q 015374          193 HSKTPSLIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE  268 (408)
Q Consensus       193 ~~~~~~lv~e~~~~~~l~~~~----~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~  268 (408)
                         ..++||||+++++|..++    ..+++..+..++.|++.||.|||++||+|+||||+|||++.+ +.+||+|||++.
T Consensus        94 ---~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~-~~~kl~Dfg~~~  169 (291)
T 1u46_A           94 ---PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATR-DLVKIGDFGLMR  169 (291)
T ss_dssp             ---SCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEET-TEEEECCCTTCE
T ss_pred             ---CceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCC-CCEEEccccccc
Confidence               378999999999998877    348999999999999999999999999999999999999988 799999999998


Q ss_pred             eccCCCcc----eeeccCccccccccccCCcCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHhhhchhhhh
Q 015374          269 FYHPGKEY----NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKDCCLIIWC  343 (408)
Q Consensus       269 ~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~  343 (408)
                      ........    ....++..|+|||++.+ ..++.++||||||+++|+|++ |..|| .+.+..+....+....      
T Consensus       170 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~-~~~~~~~~~~~~~~~~------  241 (291)
T 1u46_A          170 ALPQNDDHYVMQEHRKVPFAWCAPESLKT-RTFSHASDTWMFGVTLWEMFTYGQEPW-IGLNGSQILHKIDKEG------  241 (291)
T ss_dssp             ECCC-CCEEEC-----CCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTSCCTT-TTCCHHHHHHHHHTSC------
T ss_pred             cccccccchhhhccCCCCceeeCchhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCc-ccCCHHHHHHHHHccC------
Confidence            76544321    23456778999999987 678999999999999999999 88887 3444344433332210      


Q ss_pred             cCCCCCCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 015374          344 NSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA  391 (408)
Q Consensus       344 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~  391 (408)
                                  .....+..+++++.+++.+||+.||++|||+.++++
T Consensus       242 ------------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~  277 (291)
T 1u46_A          242 ------------ERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRD  277 (291)
T ss_dssp             ------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ------------CCCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence                        011123347899999999999999999999999997

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=1.9e-42  Score=344.97  Aligned_cols=249  Identities=18%  Similarity=0.280  Sum_probs=198.1

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecc-cchHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccEEEE
Q 015374          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP-VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIF  201 (408)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~-~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~  201 (408)
                      ..++|++.++||+|+||+||+|++..+++.||||+++. .....+.+|+.+++.+.+++++..+..++.+  ....++||
T Consensus         5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~E~~il~~L~~~~~i~~i~~~~~~--~~~~~lvm   82 (483)
T 3sv0_A            5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQGGTGIPNVRWFGVE--GDYNVLVM   82 (483)
T ss_dssp             ETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSSCCHHHHHHHHHHTTTSTTCCCEEEEEEE--TTEEEEEE
T ss_pred             cCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccccHHHHHHHHHHHHhcCCCCCCeEEEEEee--CCEEEEEE
Confidence            36789999999999999999999999999999999863 3346789999999999444566666555533  46778999


Q ss_pred             EeecCCChhhhc----CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEe---CCCCcEEEEecccceeccCCC
Q 015374          202 EYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMID---HELRKLRLIDWGLAEFYHPGK  274 (408)
Q Consensus       202 e~~~~~~l~~~~----~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~---~~~~~~kl~DfG~a~~~~~~~  274 (408)
                      ||+ +++|..++    ..+++..+..++.||+.||+|||++||+||||||+|||++   .+ +.+||+|||+++......
T Consensus        83 e~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~-~~vkL~DFGla~~~~~~~  160 (483)
T 3sv0_A           83 DLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRA-NQVYIIDFGLAKKYRDTS  160 (483)
T ss_dssp             ECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGT-TCEEECCCTTCEECBCTT
T ss_pred             ECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCC-CeEEEEeCCcceeccCCc
Confidence            999 88888876    3599999999999999999999999999999999999994   55 789999999998765443


Q ss_pred             cc--------eeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCC--HHHHHHHHhhhchhhhhc
Q 015374          275 EY--------NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDN--HDQLVKIAKDCCLIIWCN  344 (408)
Q Consensus       275 ~~--------~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~--~~~~~~~~~~~~~~~~~~  344 (408)
                      ..        ....||..|+|||++.+ ..++.++|||||||++|||++|+.||......  .+.+..+.......    
T Consensus       161 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~----  235 (483)
T 3sv0_A          161 THQHIPYRENKNLTGTARYASVNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVAT----  235 (483)
T ss_dssp             TCCBCCCCCCCCCCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHS----
T ss_pred             cccccccccccccCCCccccCHHHhcC-CCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccc----
Confidence            21        25679999999999988 78999999999999999999999998543321  22222222211000    


Q ss_pred             CCCCCCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 015374          345 SRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA  391 (408)
Q Consensus       345 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~  391 (408)
                                 ........+++++.+|+..||+.||++||+++++++
T Consensus       236 -----------~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~  271 (483)
T 3sv0_A          236 -----------SIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKR  271 (483)
T ss_dssp             -----------CHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             -----------cHHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence                       000111336899999999999999999999998765

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=1.2e-42  Score=341.14  Aligned_cols=247  Identities=17%  Similarity=0.223  Sum_probs=187.1

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc------chHHHHHHHHHHHHhcCC-CCceE---------Ee-
Q 015374          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGG-PNVVK---------LL-  186 (408)
Q Consensus       124 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h-~niv~---------l~-  186 (408)
                      ..+|...+.||+|+||+||+|++..+++.||||+++..      ..+.+.+|+.+++.+ +| +|...         .. 
T Consensus        77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l-~~~~~~~~~~~~~~~~~~~~  155 (413)
T 3dzo_A           77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLL-RGIKNQKQAKVHLRFIFPFD  155 (413)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGS-TTCCSHHHHHHHTCBCCCCE
T ss_pred             ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhh-ccCCCHHHHHHhcccccchh
Confidence            45688999999999999999999999999999998721      246788999999988 55 32211         11 


Q ss_pred             -----------eEEEccC---CCccEEEEEeecCCChhhhcC----------CCChHHHHHHHHHHHHHHHHHHHCCcEE
Q 015374          187 -----------DIVRDQH---SKTPSLIFEYVNSTDFKVLYP----------TLTDYDIRYYIYELLKALDYCHSQGIMH  242 (408)
Q Consensus       187 -----------~~~~~~~---~~~~~lv~e~~~~~~l~~~~~----------~l~~~~~~~i~~qi~~~L~~LH~~~iiH  242 (408)
                                 .++....   ....+++|+++ +++|..++.          .+++..+..++.|++.||+|||++||+|
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiH  234 (413)
T 3dzo_A          156 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVH  234 (413)
T ss_dssp             EEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred             hcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCccc
Confidence                       1111111   22345666655 466766652          2667788889999999999999999999


Q ss_pred             ecCCCCcEEEeCCCCcEEEEecccceeccCCCcceeeccCcccccccccc---------CCcCCCccccHHHHHHHHHHH
Q 015374          243 RDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLV---------DLQDYDYSLDMWSLGCMFAGM  313 (408)
Q Consensus       243 ~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~y~aPE~~~---------~~~~~~~~~DvwSlGvil~el  313 (408)
                      |||||+|||++.+ +.+||+|||+++.....  ....+| ..|+|||++.         ....++.++|||||||++|||
T Consensus       235 rDiKp~NILl~~~-~~~kL~DFG~a~~~~~~--~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~el  310 (413)
T 3dzo_A          235 TYLRPVDIVLDQR-GGVFLTGFEHLVRDGAS--AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWI  310 (413)
T ss_dssp             SCCCGGGEEECTT-CCEEECCGGGCEETTEE--ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHH
T ss_pred             CCcccceEEEecC-CeEEEEeccceeecCCc--cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHH
Confidence            9999999999998 78999999999765432  445567 9999999993         225688999999999999999


Q ss_pred             HhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCC
Q 015374          314 IFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHP  393 (408)
Q Consensus       314 l~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp  393 (408)
                      ++|+.||.... ..+.                      ....  ......+++++.+||.+||+.||++|||+.|+++||
T Consensus       311 ltg~~Pf~~~~-~~~~----------------------~~~~--~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~~  365 (413)
T 3dzo_A          311 WCADLPNTDDA-ALGG----------------------SEWI--FRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETP  365 (413)
T ss_dssp             HHSSCCCCTTG-GGSC----------------------SGGG--GSSCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSH
T ss_pred             HHCCCCCCCcc-hhhh----------------------HHHH--HhhcccCCHHHHHHHHHHccCChhhCcCHHHHHhCH
Confidence            99999984321 1000                      0000  111224789999999999999999999999999999


Q ss_pred             Cccccccc
Q 015374          394 YFAQVRAA  401 (408)
Q Consensus       394 ~f~~~~~~  401 (408)
                      ||+.+...
T Consensus       366 ~~~~~~~~  373 (413)
T 3dzo_A          366 EYEQLRTE  373 (413)
T ss_dssp             HHHHHHHH
T ss_pred             HHHHHHHH
Confidence            99987653

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=1e-41  Score=320.94  Aligned_cols=249  Identities=18%  Similarity=0.262  Sum_probs=193.0

Q ss_pred             EEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc-------chHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccEE
Q 015374          127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSL  199 (408)
Q Consensus       127 y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l  199 (408)
                      |...+.||+|+||+||+|.+  +++.||+|++...       ..+.+.+|+.+++++ +||||+++++++.+  ....++
T Consensus        33 ~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~--~~~~~l  107 (307)
T 2nru_A           33 SVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKC-QHENLVELLGFSSD--GDDLCL  107 (307)
T ss_dssp             TTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHC-CCTTBCCEEEEECS--SSSCEE
T ss_pred             cccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhc-CCCCeEEEEEEEec--CCceEE
Confidence            44457899999999999975  6789999998632       246788999999999 99999999999954  467889


Q ss_pred             EEEeecCCChhhhcC------CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCC
Q 015374          200 IFEYVNSTDFKVLYP------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG  273 (408)
Q Consensus       200 v~e~~~~~~l~~~~~------~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~  273 (408)
                      ||||+++++|..++.      .+++..+..++.|++.||.|||++||+||||||+|||++.+ +.+||+|||++......
T Consensus       108 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~-~~~kl~Dfg~~~~~~~~  186 (307)
T 2nru_A          108 VYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEA-FTAKISDFGLARASEKF  186 (307)
T ss_dssp             EEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTT-CCEEECCCTTCEECCSC
T ss_pred             EEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCC-CcEEEeecccccccccc
Confidence            999999999988763      48999999999999999999999999999999999999988 79999999999876543


Q ss_pred             Cc---ceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCC
Q 015374          274 KE---YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRK  350 (408)
Q Consensus       274 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  350 (408)
                      ..   .....||..|+|||.+.+  .++.++||||||+++|+|++|..||...... +.+..+.......        ..
T Consensus       187 ~~~~~~~~~~g~~~y~aPE~~~~--~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~--------~~  255 (307)
T 2nru_A          187 AQTVMTSRIVGTTAYMAPEALRG--EITPKSDIYSFGVVLLEIITGLPAVDEHREP-QLLLDIKEEIEDE--------EK  255 (307)
T ss_dssp             SSCEECSSCCSCGGGCCHHHHTT--EECTHHHHHHHHHHHHHHHHCCCSBCTTBSS-SBTTHHHHHHHTT--------SC
T ss_pred             cccccccccCCCcCcCChHHhcC--CCCccchhHHHHHHHHHHHHCCCCcccCcch-HHHHHHHHHhhhh--------hh
Confidence            22   223468999999999865  5889999999999999999999998543222 1111111111000        00


Q ss_pred             Ccccccc---ccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 015374          351 PWSKFIN---ADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH  392 (408)
Q Consensus       351 ~~~~~~~---~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~h  392 (408)
                      .+..+..   .......++.+.+++.+||+.||++|||+++++++
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~  300 (307)
T 2nru_A          256 TIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQL  300 (307)
T ss_dssp             CHHHHSCSSCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             hhhhhccccccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            0000000   01112245779999999999999999999999864

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=1.6e-41  Score=350.71  Aligned_cols=245  Identities=22%  Similarity=0.402  Sum_probs=199.2

Q ss_pred             CCCCCEEEEeeeeeeCceEEEEEEEcCC---CcEEEEEEecccc----hHHHHHHHHHHHHhcCCCCceEEeeEEEccCC
Q 015374          122 GDQDDYEVVRKVGRGKYSEVFEGINVNT---NERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHS  194 (408)
Q Consensus       122 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~---~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~  194 (408)
                      ...++|++.+.||+|+||+||+|++..+   +..||+|.++...    .+.+.+|+.+++++ +||||+++++++.+   
T Consensus       387 i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~---  462 (656)
T 2j0j_A          387 IQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQF-DHPHIVKLIGVITE---  462 (656)
T ss_dssp             CCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEECS---
T ss_pred             cccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEec---
Confidence            3467899999999999999999988654   4579999986422    36788999999999 99999999999843   


Q ss_pred             CccEEEEEeecCCChhhhcC----CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceec
Q 015374          195 KTPSLIFEYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY  270 (408)
Q Consensus       195 ~~~~lv~e~~~~~~l~~~~~----~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~  270 (408)
                      ...++||||+++++|..++.    .+++..+..++.|++.||.|||++||+||||||+|||++.+ +.+||+|||+++..
T Consensus       463 ~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~-~~vkL~DFG~a~~~  541 (656)
T 2j0j_A          463 NPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSN-DCVKLGDFGLSRYM  541 (656)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEET-TEEEECCCCCCCSC
T ss_pred             CceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCC-CCEEEEecCCCeec
Confidence            45789999999999998873    48899999999999999999999999999999999999988 79999999999876


Q ss_pred             cCCCcc--eeeccCccccccccccCCcCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHhhhchhhhhcCCC
Q 015374          271 HPGKEY--NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRH  347 (408)
Q Consensus       271 ~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (408)
                      ......  ....++..|+|||++.+ ..++.++|||||||++|||++ |..|| .+.+..+....+....          
T Consensus       542 ~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwSlG~il~ellt~g~~Pf-~~~~~~~~~~~i~~~~----------  609 (656)
T 2j0j_A          542 EDSTYYKASKGKLPIKWMAPESINF-RRFTSASDVWMFGVCMWEILMHGVKPF-QGVKNNDVIGRIENGE----------  609 (656)
T ss_dssp             CC----------CCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTT-TTCCHHHHHHHHHHTC----------
T ss_pred             CCCcceeccCCCCCcceeCHHHhcC-CCCCchhhHHHHHHHHHHHHHcCCCCC-CCCCHHHHHHHHHcCC----------
Confidence            543322  23456678999999987 689999999999999999997 77776 4555455444443320          


Q ss_pred             CCCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 015374          348 SRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH  392 (408)
Q Consensus       348 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~h  392 (408)
                               ....+..+++++.+++.+||..||++|||+.|+++.
T Consensus       610 ---------~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~  645 (656)
T 2j0j_A          610 ---------RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ  645 (656)
T ss_dssp             ---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ---------CCCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence                     111234478999999999999999999999999863

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=5.5e-43  Score=334.12  Aligned_cols=247  Identities=19%  Similarity=0.233  Sum_probs=187.5

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecccc-----------hHHHHHHHHHHHHhc--------CCCCce
Q 015374          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK-----------KKKIKREIKILQNLC--------GGPNVV  183 (408)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-----------~~~~~~E~~~l~~l~--------~h~niv  183 (408)
                      ..++|++.+.||+|+||+||+|++  +++.||||+++...           .+.+.+|+.+++.+.        +|+||+
T Consensus        18 ~~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv   95 (336)
T 2vuw_A           18 PTEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFI   95 (336)
T ss_dssp             CHHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBC
T ss_pred             ccccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchh
Confidence            356788899999999999999987  68999999997432           267899999999984        377777


Q ss_pred             EEeeEEEcc----------------------------CCCccEEEEEeecCCChhhhc--CCCChHHHHHHHHHHHHHHH
Q 015374          184 KLLDIVRDQ----------------------------HSKTPSLIFEYVNSTDFKVLY--PTLTDYDIRYYIYELLKALD  233 (408)
Q Consensus       184 ~l~~~~~~~----------------------------~~~~~~lv~e~~~~~~l~~~~--~~l~~~~~~~i~~qi~~~L~  233 (408)
                      ++.+.+...                            .....++||||+++|++...+  ..+++..++.++.||+.||+
T Consensus        96 ~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~~~~~~~~~~~i~~qi~~aL~  175 (336)
T 2vuw_A           96 GLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLA  175 (336)
T ss_dssp             CEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTTTCCCHHHHHHHHHHHHHHHH
T ss_pred             hhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHhcCCCHHHHHHHHHHHHHHHH
Confidence            777764311                            156889999999998644444  45899999999999999999


Q ss_pred             HHH-HCCcEEecCCCCcEEEeCCCC--------------------cEEEEecccceeccCCCcceeeccCcccccccccc
Q 015374          234 YCH-SQGIMHRDVKPHNVMIDHELR--------------------KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLV  292 (408)
Q Consensus       234 ~LH-~~~iiH~Dlk~~NILl~~~~~--------------------~~kl~DfG~a~~~~~~~~~~~~~~~~~y~aPE~~~  292 (408)
                      ||| ++||+||||||+|||++.+ +                    .+||+|||+|+.....    ..+||+.|+|||++.
T Consensus       176 ~lH~~~~ivHrDlKp~NILl~~~-~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~----~~~gt~~y~aPE~~~  250 (336)
T 2vuw_A          176 VAEASLRFEHRDLHWGNVLLKKT-SLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG----IVVFCDVSMDEDLFT  250 (336)
T ss_dssp             HHHHHHCCBCSCCCGGGEEEEEC-SCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT----EEECCCCTTCSGGGC
T ss_pred             HHHHhCCEeECCCCHHHEEEecc-CCcceeeeccCccccccCCCceEEEeeccccEecCCC----cEEEeecccChhhhc
Confidence            999 9999999999999999987 4                    8999999999876532    458999999999998


Q ss_pred             CCcCCCccccHHHHHHH-HHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCCCccccccccCCCCCCHHHHHH
Q 015374          293 DLQDYDYSLDMWSLGCM-FAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSKFINADNQHLVSPEAIDF  371 (408)
Q Consensus       293 ~~~~~~~~~DvwSlGvi-l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  371 (408)
                      + .. +.++||||+|++ .+++++|..||............+...        ......     .....+..+++++.+|
T Consensus       251 g-~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~--------~~~~~~-----~~~~~~~~~s~~~~dl  315 (336)
T 2vuw_A          251 G-DG-DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQ--------MTFKTK-----CNTPAMKQIKRKIQEF  315 (336)
T ss_dssp             C-CS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHT--------CCCSSC-----CCSHHHHHHHHHHHHH
T ss_pred             C-CC-ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhh--------hccCcc-----cchhhhhhcCHHHHHH
Confidence            7 33 889999998777 777888888871100000011111110        000000     0111122367899999


Q ss_pred             HHHhcccCcCCCCCHHHHh-cCCCcc
Q 015374          372 LDKLLRYDHQDRLTAREAM-AHPYFA  396 (408)
Q Consensus       372 i~~~L~~dp~~Rpt~~elL-~hp~f~  396 (408)
                      |++||++|     |++|+| +||||+
T Consensus       316 i~~~L~~d-----sa~e~l~~Hp~f~  336 (336)
T 2vuw_A          316 HRTMLNFS-----SATDLLCQHSLFK  336 (336)
T ss_dssp             HHHGGGSS-----SHHHHHHHCGGGC
T ss_pred             HHHHhccC-----CHHHHHhcCCCcC
Confidence            99999977     999999 999995

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=1.4e-41  Score=321.57  Aligned_cols=243  Identities=19%  Similarity=0.303  Sum_probs=193.2

Q ss_pred             CCCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc-----chHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCc
Q 015374          122 GDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT  196 (408)
Q Consensus       122 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  196 (408)
                      ...++|++.+.||+|+||+||+|++..   .+|+|+++..     ..+.+.+|+.+++++ +|+||+++++++.+  ...
T Consensus        30 i~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~--~~~  103 (319)
T 2y4i_B           30 IPFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQT-RHENVVLFMGACMS--PPH  103 (319)
T ss_dssp             SCCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCCCCCCCCCTTGGGGTTC-CCTTBCCCCEEEEC--SSC
T ss_pred             CCHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCHHHHHHHHHHHHHHhcC-CCCCEeEEEEEEec--CCc
Confidence            357889999999999999999998743   4999998632     235678899999999 99999999999965  456


Q ss_pred             cEEEEEeecCCChhhhcC----CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccC
Q 015374          197 PSLIFEYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP  272 (408)
Q Consensus       197 ~~lv~e~~~~~~l~~~~~----~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~  272 (408)
                      .++||||+++++|..++.    .+++..+..++.|++.||.|||++||+||||||+|||++ + +.+||+|||++.....
T Consensus       104 ~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~-~~~~l~Dfg~~~~~~~  181 (319)
T 2y4i_B          104 LAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-N-GKVVITDFGLFSISGV  181 (319)
T ss_dssp             EEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC----CCEECCCSCCC----
T ss_pred             eEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-C-CCEEEeecCCcccccc
Confidence            889999999999999884    488999999999999999999999999999999999998 4 5899999999865432


Q ss_pred             ------CCcceeeccCccccccccccC--------CcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhc
Q 015374          273 ------GKEYNVRVASRYFKGPELLVD--------LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCC  338 (408)
Q Consensus       273 ------~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~  338 (408)
                            ........|+..|+|||++.+        ...++.++|||||||++|+|++|..||. +.+..+....+.... 
T Consensus       182 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~-~~~~~~~~~~~~~~~-  259 (319)
T 2y4i_B          182 LQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFK-TQPAEAIIWQMGTGM-  259 (319)
T ss_dssp             ------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSS-SCCHHHHHHHHHTTC-
T ss_pred             ccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCC-CCCHHHHHHHhccCC-
Confidence                  122334568899999999874        2457899999999999999999999983 333333332222110 


Q ss_pred             hhhhhcCCCCCCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 015374          339 LIIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA  391 (408)
Q Consensus       339 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~  391 (408)
                                       ........++.++.+++.+||..||++|||++++++
T Consensus       260 -----------------~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~  295 (319)
T 2y4i_B          260 -----------------KPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMD  295 (319)
T ss_dssp             -----------------CCCCCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHH
T ss_pred             -----------------CCCCCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence                             001111236789999999999999999999999986

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=3.9e-41  Score=350.38  Aligned_cols=242  Identities=21%  Similarity=0.294  Sum_probs=197.0

Q ss_pred             CCCCCEEEEeeeeeeCceEEEEEEEcC-CCcEEEEEEeccc----chHHHHHHHHHHHHhcCCCCceEEeeEEEccCCC-
Q 015374          122 GDQDDYEVVRKVGRGKYSEVFEGINVN-TNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSK-  195 (408)
Q Consensus       122 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~-~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~-  195 (408)
                      ...++|++.+.||+|+||+||+|++.. +++.||||++...    ....+.+|+.+++++ +||||++++++|.+.+.. 
T Consensus        77 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~  155 (681)
T 2pzi_A           77 IVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEV-VHPSIVQIFNFVEHTDRHG  155 (681)
T ss_dssp             EETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGC-CCTTBCCEEEEEEEECTTS
T ss_pred             EeCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhc-CCCCcCeEeeeEeecCCCC
Confidence            346899999999999999999999876 7899999998642    235678999999999 999999999999764321 


Q ss_pred             --ccEEEEEeecCCChhhhcC-CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccC
Q 015374          196 --TPSLIFEYVNSTDFKVLYP-TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP  272 (408)
Q Consensus       196 --~~~lv~e~~~~~~l~~~~~-~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~  272 (408)
                        ..++||||+++++|..++. .+++..+..++.|++.||.|||++||+||||||+|||++.+  .+||+|||+++....
T Consensus       156 ~~~~~lv~E~~~g~~L~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~--~~kl~DFG~a~~~~~  233 (681)
T 2pzi_A          156 DPVGYIVMEYVGGQSLKRSKGQKLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE--QLKLIDLGAVSRINS  233 (681)
T ss_dssp             CEEEEEEEECCCCEECC----CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS--CEEECCCTTCEETTC
T ss_pred             CceeEEEEEeCCCCcHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC--cEEEEecccchhccc
Confidence              1689999999999988764 69999999999999999999999999999999999999975  789999999987654


Q ss_pred             CCcceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCCCc
Q 015374          273 GKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPW  352 (408)
Q Consensus       273 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  352 (408)
                      .   ....||+.|+|||++.+  .++.++|||||||++|+|++|..||......                  ...     
T Consensus       234 ~---~~~~gt~~y~aPE~~~~--~~~~~sDi~slG~~l~~l~~g~~~~~~~~~~------------------~~~-----  285 (681)
T 2pzi_A          234 F---GYLYGTPGFQAPEIVRT--GPTVATDIYTVGRTLAALTLDLPTRNGRYVD------------------GLP-----  285 (681)
T ss_dssp             C---SCCCCCTTTSCTTHHHH--CSCHHHHHHHHHHHHHHHHSCCCEETTEECS------------------SCC-----
T ss_pred             C---CccCCCccccCHHHHcC--CCCCceehhhhHHHHHHHHhCCCCCcccccc------------------ccc-----
Confidence            3   44679999999999875  3589999999999999999998776321000                  000     


Q ss_pred             cccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccc
Q 015374          353 SKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQV  398 (408)
Q Consensus       353 ~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~~  398 (408)
                          .......+++.+.++|.+||+.||++||+..+.+.|+|+...
T Consensus       286 ----~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~  327 (681)
T 2pzi_A          286 ----EDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVL  327 (681)
T ss_dssp             ----TTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred             ----ccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHH
Confidence                000001135789999999999999999999999999987654

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=9.9e-40  Score=304.64  Aligned_cols=224  Identities=13%  Similarity=0.141  Sum_probs=179.2

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecccc------hHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCc
Q 015374          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK------KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT  196 (408)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~------~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  196 (408)
                      ..++|++.+.||+|+||+||+|++..+++.||||+++...      .+.+.+|+.++.++ +||||+++++++.+  ...
T Consensus        29 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~--~~~  105 (286)
T 3uqc_A           29 ANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRI-DKPGVARVLDVVHT--RAG  105 (286)
T ss_dssp             TTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEEE--TTE
T ss_pred             ecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcC-CCCCcceeeEEEEE--CCc
Confidence            4578999999999999999999999999999999997432      26788999999999 99999999999965  467


Q ss_pred             cEEEEEeecCCChhhhcCC-CChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCCCc
Q 015374          197 PSLIFEYVNSTDFKVLYPT-LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE  275 (408)
Q Consensus       197 ~~lv~e~~~~~~l~~~~~~-l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~~~  275 (408)
                      .++||||+++++|..++.. ....++..++.|++.||+|||++||+||||||+|||++.+ +.+||+++|.         
T Consensus       106 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~-g~~kl~~~~~---------  175 (286)
T 3uqc_A          106 GLVVAEWIRGGSLQEVADTSPSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSID-GDVVLAYPAT---------  175 (286)
T ss_dssp             EEEEEECCCEEEHHHHHTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETT-SCEEECSCCC---------
T ss_pred             EEEEEEecCCCCHHHHHhcCCChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCC-CCEEEEeccc---------
Confidence            8999999999999998854 5667788999999999999999999999999999999988 7889875432         


Q ss_pred             ceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCCCcccc
Q 015374          276 YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSKF  355 (408)
Q Consensus       276 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  355 (408)
                                ++        .++.++|||||||++|+|++|+.||...... +.+.         ..  ........  .
T Consensus       176 ----------~~--------~~~~~~Di~slG~il~elltg~~Pf~~~~~~-~~~~---------~~--~~~~~~~~--~  223 (286)
T 3uqc_A          176 ----------MP--------DANPQDDIRGIGASLYALLVNRWPLPEAGVR-SGLA---------PA--ERDTAGQP--I  223 (286)
T ss_dssp             ----------CT--------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBC-CCSE---------EC--CBCTTSCB--C
T ss_pred             ----------cC--------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcc-hhhH---------HH--HHHhccCC--C
Confidence                      22        4788999999999999999999998432221 1000         00  00000000  0


Q ss_pred             ccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 015374          356 INADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH  392 (408)
Q Consensus       356 ~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~h  392 (408)
                      ........+++++.+++.+||+.||++| |++|+++.
T Consensus       224 ~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~  259 (286)
T 3uqc_A          224 EPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNL  259 (286)
T ss_dssp             CHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHH
T ss_pred             ChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHH
Confidence            0112234578999999999999999999 99999874

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.97  E-value=3e-34  Score=291.39  Aligned_cols=183  Identities=20%  Similarity=0.143  Sum_probs=130.2

Q ss_pred             eeeeeCceEEEEEEEcCCCcEEEEEEeccc-------------chHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccE
Q 015374          132 KVGRGKYSEVFEGINVNTNERCIIKILKPV-------------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS  198 (408)
Q Consensus       132 ~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-------------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  198 (408)
                      ..+.|++|.+..++....|+.+++|++...             ..+++.+|+++|+++..|+||+++++++++  ....|
T Consensus       241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed--~~~~y  318 (569)
T 4azs_A          241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGEN--AQSGW  318 (569)
T ss_dssp             C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEEC--SSEEE
T ss_pred             ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEE--CCEEE
Confidence            467788888887777778999999998532             235689999999999889999999999965  57889


Q ss_pred             EEEEeecCCChhhhcCCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCC-Ccce
Q 015374          199 LIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG-KEYN  277 (408)
Q Consensus       199 lv~e~~~~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~-~~~~  277 (408)
                      |||||++|++|.+++..........|+.||+.||+|||++|||||||||+|||++.+ +.+||+|||+|+..... ....
T Consensus       319 LVMEyv~G~~L~d~i~~~~~l~~~~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~d-g~vKL~DFGlAr~~~~~~~~~~  397 (569)
T 4azs_A          319 LVMEKLPGRLLSDMLAAGEEIDREKILGSLLRSLAALEKQGFWHDDVRPWNVMVDAR-QHARLIDFGSIVTTPQDCSWPT  397 (569)
T ss_dssp             EEEECCCSEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHTTCEESCCCGGGEEECTT-SCEEECCCTTEESCC---CCSH
T ss_pred             EEEecCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHCCceeccCchHhEEECCC-CCEEEeecccCeeCCCCCcccc
Confidence            999999999999998543333345689999999999999999999999999999988 89999999999876543 2345


Q ss_pred             eeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCC
Q 015374          278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEP  319 (408)
Q Consensus       278 ~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~p  319 (408)
                      ..+||+.|+|||++.+  .+..++|+||+|++++++.++..+
T Consensus       398 t~vGTp~YmAPE~l~g--~~~~~~d~~s~g~~~~~l~~~~~~  437 (569)
T 4azs_A          398 NLVQSFFVFVNELFAE--NKSWNGFWRSAPVHPFNLPQPWSN  437 (569)
T ss_dssp             HHHHHHHHHHHHHC-------------------CCCCTTHHH
T ss_pred             CceechhhccHHHhCC--CCCCcccccccccchhhhccccch
Confidence            5789999999999976  567789999999998877655443

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.95  E-value=1.8e-28  Score=247.52  Aligned_cols=180  Identities=17%  Similarity=0.242  Sum_probs=140.3

Q ss_pred             EEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc-----------chHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCc
Q 015374          128 EVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT  196 (408)
Q Consensus       128 ~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-----------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  196 (408)
                      ...+.||+|+||+||+|  ...+..+++|.....           ..+.+.+|+.+++++ +||||+++..++.+.  ..
T Consensus       339 ~~~~~LG~G~fg~Vy~~--~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~~~~~~~~~--~~  413 (540)
T 3en9_A          339 IPEHLIGKGAEADIKRD--SYLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALV-KDFGIPAPYIFDVDL--DN  413 (540)
T ss_dssp             ---------CCEEEEEE--ECSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHG-GGGTCCCCCEEEEET--TT
T ss_pred             CCCCEEeeCCCEEEEEE--EECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhc-CCCCcCceEEEEEeC--Cc
Confidence            34568999999999999  445678888875321           124578999999999 999999555555433  45


Q ss_pred             cEEEEEeecCCChhhhcCCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCCCcc
Q 015374          197 PSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY  276 (408)
Q Consensus       197 ~~lv~e~~~~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~~~~  276 (408)
                      .++||||+++++|..++..     +..++.|++.||+|||++||+||||||+|||++.   .+||+|||+++........
T Consensus       414 ~~lVmE~~~ggsL~~~l~~-----~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~---~~kL~DFGla~~~~~~~~~  485 (540)
T 3en9_A          414 KRIMMSYINGKLAKDVIED-----NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK---DLYIIDFGLGKISNLDEDK  485 (540)
T ss_dssp             TEEEEECCCSEEHHHHSTT-----CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS---SEEECCCTTCEECCCHHHH
T ss_pred             cEEEEECCCCCCHHHHHHH-----HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC---eEEEEECccCEECCCcccc
Confidence            6899999999999999877     5689999999999999999999999999999997   7999999999987643221


Q ss_pred             --------eeeccCccccccccccC-CcCCCccccHHHHHHHHHHHHhCCCCC
Q 015374          277 --------NVRVASRYFKGPELLVD-LQDYDYSLDMWSLGCMFAGMIFRKEPF  320 (408)
Q Consensus       277 --------~~~~~~~~y~aPE~~~~-~~~~~~~~DvwSlGvil~ell~g~~pf  320 (408)
                              ....||+.|+|||++.. ...|+..+|+||..+-..+-+.++.+|
T Consensus       486 ~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY  538 (540)
T 3en9_A          486 AVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY  538 (540)
T ss_dssp             HHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred             ccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence                    35689999999999965 235778899999999988888877665

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.92  E-value=2e-25  Score=207.16  Aligned_cols=143  Identities=18%  Similarity=0.243  Sum_probs=118.7

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc---------------------chHHHHHHHHHHHHhcCCCCc
Q 015374          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV---------------------KKKKIKREIKILQNLCGGPNV  182 (408)
Q Consensus       124 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~---------------------~~~~~~~E~~~l~~l~~h~ni  182 (408)
                      ...|++.+.||+|+||.||+|++ .+++.||+|+++..                     ....+.+|+.+++++ +  | 
T Consensus        89 ~~~~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l-~--~-  163 (282)
T 1zar_A           89 GKVDAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKL-Q--G-  163 (282)
T ss_dssp             TSCSEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHT-T--T-
T ss_pred             CeEEEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhc-c--C-
Confidence            45677889999999999999998 88999999998632                     234688999999999 5  5 


Q ss_pred             eEEeeEEEccCCCccEEEEEeecCCChhhhcCCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEE
Q 015374          183 VKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLI  262 (408)
Q Consensus       183 v~l~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~  262 (408)
                      +++.+++..   ...++||||+++++|.. +.   ......++.|++.||.|||++||+||||||+|||++ + +.+||+
T Consensus       164 ~~v~~~~~~---~~~~lvmE~~~g~~L~~-l~---~~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~-~~vkl~  234 (282)
T 1zar_A          164 LAVPKVYAW---EGNAVLMELIDAKELYR-VR---VENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-E-EGIWII  234 (282)
T ss_dssp             SSSCCEEEE---ETTEEEEECCCCEEGGG-CC---CSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-T-TEEEEC
T ss_pred             CCcCeEEec---cceEEEEEecCCCcHHH-cc---hhhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-C-CcEEEE
Confidence            667776643   45689999999999988 42   244567999999999999999999999999999999 6 899999


Q ss_pred             ecccceeccCCCcceeeccCcccccccccc
Q 015374          263 DWGLAEFYHPGKEYNVRVASRYFKGPELLV  292 (408)
Q Consensus       263 DfG~a~~~~~~~~~~~~~~~~~y~aPE~~~  292 (408)
                      |||+|+..            ..++|||.+.
T Consensus       235 DFG~a~~~------------~~~~a~e~l~  252 (282)
T 1zar_A          235 DFPQSVEV------------GEEGWREILE  252 (282)
T ss_dssp             CCTTCEET------------TSTTHHHHHH
T ss_pred             ECCCCeEC------------CCCCHHHHHH
Confidence            99999643            3467888874

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.88  E-value=2e-22  Score=184.54  Aligned_cols=136  Identities=18%  Similarity=0.197  Sum_probs=109.3

Q ss_pred             CCEEEEeeeeeeCceEEEEEEEcCCCcE--EEEEEecccc---------------------------hHHHHHHHHHHHH
Q 015374          125 DDYEVVRKVGRGKYSEVFEGINVNTNER--CIIKILKPVK---------------------------KKKIKREIKILQN  175 (408)
Q Consensus       125 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~--vavK~~~~~~---------------------------~~~~~~E~~~l~~  175 (408)
                      .-|++.+.||+|+||.||+|.+..+|+.  ||||+++...                           ...+.+|+.++.+
T Consensus        47 ~~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~  126 (258)
T 1zth_A           47 YITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLER  126 (258)
T ss_dssp             SEEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHH
T ss_pred             CchhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHH
Confidence            3478899999999999999988778888  9999875321                           1257889999999


Q ss_pred             hcCCCCc--eEEeeEEEccCCCccEEEEEeecC-C----ChhhhcCCCChHHHHHHHHHHHHHHHHHH-HCCcEEecCCC
Q 015374          176 LCGGPNV--VKLLDIVRDQHSKTPSLIFEYVNS-T----DFKVLYPTLTDYDIRYYIYELLKALDYCH-SQGIMHRDVKP  247 (408)
Q Consensus       176 l~~h~ni--v~l~~~~~~~~~~~~~lv~e~~~~-~----~l~~~~~~l~~~~~~~i~~qi~~~L~~LH-~~~iiH~Dlk~  247 (408)
                      + .|+++  ..++++      ...+|||||+++ |    .|.......++..+..++.|++.||.||| +.||+||||||
T Consensus       127 l-~~~~i~~p~~~~~------~~~~lVmE~~g~~g~~~~~L~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp  199 (258)
T 1zth_A          127 A-KEAGVSVPQPYTY------MKNVLLMEFIGEDELPAPTLVELGRELKELDVEGIFNDVVENVKRLYQEAELVHADLSE  199 (258)
T ss_dssp             H-HHTTCCCCCEEEE------ETTEEEEECCEETTEECCBHHHHGGGGGGSCHHHHHHHHHHHHHHHHHTSCEECSSCST
T ss_pred             H-HhCCCCCCeEEEc------CCCEEEEEecCCCCCccccHHHHhhccChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCH
Confidence            9 77754  334432      245799999953 3    66665544556678899999999999999 99999999999


Q ss_pred             CcEEEeCCCCcEEEEecccceec
Q 015374          248 HNVMIDHELRKLRLIDWGLAEFY  270 (408)
Q Consensus       248 ~NILl~~~~~~~kl~DfG~a~~~  270 (408)
                      +|||++.   .++|+|||+|...
T Consensus       200 ~NILl~~---~~~liDFG~a~~~  219 (258)
T 1zth_A          200 YNIMYID---KVYFIDMGQAVTL  219 (258)
T ss_dssp             TSEEESS---SEEECCCTTCEET
T ss_pred             HHEEEcC---cEEEEECcccccC
Confidence            9999997   7899999999754

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.75  E-value=4.2e-18  Score=162.64  Aligned_cols=134  Identities=16%  Similarity=0.249  Sum_probs=99.5

Q ss_pred             CCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecccc-----------------hHH--------HHHHHHHHHHhcCC
Q 015374          125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK-----------------KKK--------IKREIKILQNLCGG  179 (408)
Q Consensus       125 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-----------------~~~--------~~~E~~~l~~l~~h  179 (408)
                      .-|++.++||+|+||.||+|.+ .+|+.||||+++...                 ...        ..+|...|.++ .+
T Consensus        95 ~iY~I~~~IG~Gk~a~VY~a~d-~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL-~~  172 (397)
T 4gyi_A           95 DVYSVGSRIGVGKESDIMIVAD-EKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKAL-YE  172 (397)
T ss_dssp             SCSEEEEEEEECSSEEEEEEEC-TTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHH-HH
T ss_pred             CEEEecCEeeeCCceEEEEEEC-CCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHH-Hh
Confidence            3499999999999999999986 568999999975210                 011        23566777776 44


Q ss_pred             CCce--EEeeEEEccCCCccEEEEEeecCCChhhhcCCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCC
Q 015374          180 PNVV--KLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELR  257 (408)
Q Consensus       180 ~niv--~l~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~  257 (408)
                      .++.  ..+++      ...+|||||+++..+..+..   ......++.|++.+|.|||+.|||||||||.|||++.+ +
T Consensus       173 ~gv~vp~p~~~------~~~~LVME~i~G~~L~~l~~---~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~d-g  242 (397)
T 4gyi_A          173 EGFPVPEPIAQ------SRHTIVMSLVDALPMRQVSS---VPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREE-K  242 (397)
T ss_dssp             TTCSCCCEEEE------ETTEEEEECCSCEEGGGCCC---CSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEE-E
T ss_pred             cCCCCCeeeec------cCceEEEEecCCccHhhhcc---cHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCC-C
Confidence            3332  22222      12369999999988866543   23456788999999999999999999999999999876 3


Q ss_pred             ----------cEEEEecccceec
Q 015374          258 ----------KLRLIDWGLAEFY  270 (408)
Q Consensus       258 ----------~~kl~DfG~a~~~  270 (408)
                                .+.|+||+-+...
T Consensus       243 d~~d~~~~~~~~~iID~~Q~V~~  265 (397)
T 4gyi_A          243 DAEDPSSITLTPIIIXFPQMVSM  265 (397)
T ss_dssp             CSSCTTSEEEEEEECCCTTCEET
T ss_pred             CcccccccccceEEEEeCCcccC
Confidence                      3789999977543

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.47  E-value=2.8e-13  Score=123.71  Aligned_cols=138  Identities=18%  Similarity=0.228  Sum_probs=111.6

Q ss_pred             CCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecc---cchHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccEEEE
Q 015374          125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP---VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIF  201 (408)
Q Consensus       125 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~---~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~  201 (408)
                      +.|++...+|.|+++.||++..  .+..+++|+...   .....+.+|+.+++.+.++..+.++++++.+  ....++||
T Consensus        14 ~~~~~~~~~~g~s~~~v~~~~~--~~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~--~~~~~lv~   89 (263)
T 3tm0_A           14 EKYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERH--DGWSNLLM   89 (263)
T ss_dssp             TTSEEEECCSCCSSSEEEEEEC--SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEE--TTEEEEEE
T ss_pred             ccceeEeeccCCCCCeEEEEEC--CCCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEec--CCceEEEE
Confidence            3578888899999999999953  367899999874   3445799999999999667788899998864  46778999


Q ss_pred             EeecCCChhhhcCCCChHHHHHHHHHHHHHHHHHHH--------------------------------------------
Q 015374          202 EYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHS--------------------------------------------  237 (408)
Q Consensus       202 e~~~~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~--------------------------------------------  237 (408)
                      ||++|.++......  ......++.+++.+|..||+                                            
T Consensus        90 e~i~G~~l~~~~~~--~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  167 (263)
T 3tm0_A           90 SEADGVLCSEEYED--EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDP  167 (263)
T ss_dssp             ECCSSEEHHHHCCT--TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSSH
T ss_pred             EecCCeehhhccCC--cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCCCH
Confidence            99999998876432  23345788999999999998                                            


Q ss_pred             ---------------CCcEEecCCCCcEEEeCCCCcEEEEeccccee
Q 015374          238 ---------------QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEF  269 (408)
Q Consensus       238 ---------------~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~  269 (408)
                                     ..++|+|+++.|||++.+ +.+.|+||+.+..
T Consensus       168 ~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~-~~~~lIDwe~a~~  213 (263)
T 3tm0_A          168 RELYDFLKTEKPEEELVFSHGDLGDSNIFVKDG-KVSGFIDLGRSGR  213 (263)
T ss_dssp             HHHHHHHHHCCCCCCEEEECSSCCTTSEEEETT-EEEEECCCTTCEE
T ss_pred             HHHHHHHHhcCCCCCceEECCCCCcCcEEEECC-cEEEEEEchhccc
Confidence                           448999999999999875 4567999998753

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.35  E-value=3.5e-12  Score=115.90  Aligned_cols=135  Identities=18%  Similarity=0.172  Sum_probs=99.9

Q ss_pred             CEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecccchHHHHHHHHHHHHhcCCC-CceEEeeEEEccCCCccEEEEEee
Q 015374          126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGP-NVVKLLDIVRDQHSKTPSLIFEYV  204 (408)
Q Consensus       126 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~h~-niv~l~~~~~~~~~~~~~lv~e~~  204 (408)
                      .|.+....+.|..+.||++. ..+|..+++|+........+.+|+.+++.+..+. .+.++++++.+  ++..++||||+
T Consensus        21 ~~~~~~~~~gg~~~~v~~~~-~~~g~~~vlK~~~~~~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~--~~~~~~v~e~i   97 (264)
T 1nd4_A           21 GYDWAQQTIGCSDAAVFRLS-AQGRPVLFVKTDLSGALNELQDEAARLSWLATTGVPCAAVLDVVTE--AGRDWLLLGEV   97 (264)
T ss_dssp             TCEEEECSCTTSSCEEEEEE-CTTSCCEEEEEECSCTTSCHHHHHHHHHHHHTTTCCBCCEEEEEEC--SSCEEEEEECC
T ss_pred             CCceEecccCCCCceEEEEe-cCCCCeEEEEeCCcccchhhhHHHHHHHHHHhCCCCCCeEEEeccC--CCCCEEEEEec
Confidence            44544344466669999995 4567789999987655567889999999995442 25568887754  35678999999


Q ss_pred             cCCChhhhcCCCChHHHHHHHHHHHHHHHHHHHCC---------------------------------------------
Q 015374          205 NSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQG---------------------------------------------  239 (408)
Q Consensus       205 ~~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---------------------------------------------  239 (408)
                      +|.++.  .....   ...++.+++..|..||+..                                             
T Consensus        98 ~G~~l~--~~~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  172 (264)
T 1nd4_A           98 PGQDLL--SSHLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFA  172 (264)
T ss_dssp             SSEETT--TSCCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHH
T ss_pred             CCcccC--cCcCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHH
Confidence            999884  33322   2356778888888888643                                             


Q ss_pred             -------------cEEecCCCCcEEEeCCCCcEEEEeccccee
Q 015374          240 -------------IMHRDVKPHNVMIDHELRKLRLIDWGLAEF  269 (408)
Q Consensus       240 -------------iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~  269 (408)
                                   ++|+|++|.|||++.+ +.+.|+|||.+..
T Consensus       173 ~l~~~~~~~~~~~l~HgDl~~~Nil~~~~-~~~~liD~~~a~~  214 (264)
T 1nd4_A          173 RLKARMPDGEDLVVTHGDACLPNIMVENG-RFSGFIDCGRLGV  214 (264)
T ss_dssp             HHHHTCCSSCCEEEECSSCCGGGEEEETT-EEEEECCCTTCEE
T ss_pred             HHHHhcCCCCCeEEECCCCCCCcEEEECC-cEEEEEcchhccc
Confidence                         9999999999999876 5567999999854

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.26  E-value=3.2e-11  Score=115.30  Aligned_cols=140  Identities=20%  Similarity=0.354  Sum_probs=107.5

Q ss_pred             EeeeeeeCceEEEEEEEcCCCcEEEEEEec--ccc----hHHHHHHHHHHHHhcC-CCCceEEeeEEEccCC-CccEEEE
Q 015374          130 VRKVGRGKYSEVFEGINVNTNERCIIKILK--PVK----KKKIKREIKILQNLCG-GPNVVKLLDIVRDQHS-KTPSLIF  201 (408)
Q Consensus       130 ~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~--~~~----~~~~~~E~~~l~~l~~-h~niv~l~~~~~~~~~-~~~~lv~  201 (408)
                      ++.|+.|.++.||+....  +..+++|+..  +..    ...+.+|..+++.+.. +..+.+++.++.+... +..++||
T Consensus        43 ~~~l~~G~sn~~y~v~~~--~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vm  120 (359)
T 3dxp_A           43 VEQFKGGQSNPTFKLVTP--GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIM  120 (359)
T ss_dssp             EEECCC-CCSCEEEEECS--SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEE
T ss_pred             EEEcCCcccceEEEEEEC--CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEE
Confidence            567999999999998643  4578888876  322    3578899999999943 3457888988854321 4578999


Q ss_pred             EeecCCChh-hhcCCCChHHHHHHHHHHHHHHHHHHH-------------------------------------------
Q 015374          202 EYVNSTDFK-VLYPTLTDYDIRYYIYELLKALDYCHS-------------------------------------------  237 (408)
Q Consensus       202 e~~~~~~l~-~~~~~l~~~~~~~i~~qi~~~L~~LH~-------------------------------------------  237 (408)
                      ||++|..+. .....++..+...++.+++..|..||+                                           
T Consensus       121 e~v~G~~l~~~~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  200 (359)
T 3dxp_A          121 EFVSGRVLWDQSLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAMDSL  200 (359)
T ss_dssp             ECCCCBCCCCTTCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHHHHH
T ss_pred             EecCCeecCCCccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHHHHH
Confidence            999998874 355678888889999999999999997                                           


Q ss_pred             ---------------CCcEEecCCCCcEEEeCCCC-cEEEEecccceecc
Q 015374          238 ---------------QGIMHRDVKPHNVMIDHELR-KLRLIDWGLAEFYH  271 (408)
Q Consensus       238 ---------------~~iiH~Dlk~~NILl~~~~~-~~kl~DfG~a~~~~  271 (408)
                                     ..++|+|+++.|||++.+.. .+.|+||+.+....
T Consensus       201 ~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g~  250 (359)
T 3dxp_A          201 MDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLGH  250 (359)
T ss_dssp             HHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEEC
T ss_pred             HHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccCC
Confidence                           35899999999999997632 36899999987643

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=99.14  E-value=6.7e-11  Score=110.35  Aligned_cols=185  Identities=17%  Similarity=0.231  Sum_probs=124.1

Q ss_pred             eeeeeeCceEEEEEEEcCCCcEEEEEEeccc-chHHHHHHHHHHHHhcCCCC--ceEEeeEEEccCC-CccEEEEEeecC
Q 015374          131 RKVGRGKYSEVFEGINVNTNERCIIKILKPV-KKKKIKREIKILQNLCGGPN--VVKLLDIVRDQHS-KTPSLIFEYVNS  206 (408)
Q Consensus       131 ~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~E~~~l~~l~~h~n--iv~l~~~~~~~~~-~~~~lv~e~~~~  206 (408)
                      +.++.|.+..||+..     ..+++|+.... ....+.+|..+++.+..+..  +.+++........ ...++||++++|
T Consensus        26 ~~~~~G~~n~v~~v~-----~~~vlR~~~~~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~G  100 (304)
T 3sg8_A           26 EISGEGNDCIAYEIN-----RDFIFKFPKHSRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIKG  100 (304)
T ss_dssp             CEEEECSSEEEEEST-----TSEEEEEESSHHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCCC
T ss_pred             EecCCCCcceEEEEC-----CEEEEEecCCcchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccCC
Confidence            358999999999862     46889987643 34678899999998844433  3344444322211 245789999999


Q ss_pred             CChhh-hcCCCChHHHHHHHHHHHHHHHHHHH------------------------------------------------
Q 015374          207 TDFKV-LYPTLTDYDIRYYIYELLKALDYCHS------------------------------------------------  237 (408)
Q Consensus       207 ~~l~~-~~~~l~~~~~~~i~~qi~~~L~~LH~------------------------------------------------  237 (408)
                      ..+.. ....++..+...++.+++..|..||+                                                
T Consensus       101 ~~l~~~~~~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  180 (304)
T 3sg8_A          101 VPLTPLLLNNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDDFYRDI  180 (304)
T ss_dssp             EECCHHHHHTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHHHHHHH
T ss_pred             eECCccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHHHHHHH
Confidence            88864 44667888888889999999998886                                                


Q ss_pred             ----------CCcEEecCCCCcEEEeCC-CCcEEEEecccceeccCCCcceeeccCcccccccccc----CCc-------
Q 015374          238 ----------QGIMHRDVKPHNVMIDHE-LRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLV----DLQ-------  295 (408)
Q Consensus       238 ----------~~iiH~Dlk~~NILl~~~-~~~~kl~DfG~a~~~~~~~~~~~~~~~~~y~aPE~~~----~~~-------  295 (408)
                                ..++|+|+++.||+++.+ .+.+.|+||+.+....+............-..|+...    ..+       
T Consensus       181 l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~~~~~~~~  260 (304)
T 3sg8_A          181 LENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYKHKDIPTV  260 (304)
T ss_dssp             HTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHTCSCHHHH
T ss_pred             HhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcCCCCcHHH
Confidence                      137999999999999984 2567899999987654322111110000001222110    000       


Q ss_pred             --CCCccccHHHHHHHHHHHHhCCCCC
Q 015374          296 --DYDYSLDMWSLGCMFAGMIFRKEPF  320 (408)
Q Consensus       296 --~~~~~~DvwSlGvil~ell~g~~pf  320 (408)
                        ......+.|+++.++|.+.+|..+|
T Consensus       261 ~~r~~~~~~~~~l~~~~~~~~~g~~~~  287 (304)
T 3sg8_A          261 LEKYRMKEKYWSFEKIIYGKEYGYMDW  287 (304)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred             HHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence              1122368999999999999998776

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.78  E-value=5.5e-08  Score=88.67  Aligned_cols=134  Identities=14%  Similarity=0.106  Sum_probs=96.6

Q ss_pred             eeeeeCce-EEEEEEEcCCCcEEEEEEecccchHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccEEEEEeecCCChh
Q 015374          132 KVGRGKYS-EVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFK  210 (408)
Q Consensus       132 ~lG~G~fg-~Vy~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~~~~l~  210 (408)
                      .+..|..| +||+.....++..+++|+-.......+.+|...|+.+..+--+.++++++.+.  ...++|||+++|.++.
T Consensus        31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~--~~~~lvme~l~G~~~~  108 (272)
T 4gkh_A           31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGSVANDVTDEMVRLNWLTAFMPLPTIKHFIRTP--DDAWLLTTAIPGKTAF  108 (272)
T ss_dssp             EEECSSSSCEEEEEECCTTCCCEEEEEEETHHHHHHHHHHHHHHHHTTTSCCCCEEEEEEET--TEEEEEEECCCSEEHH
T ss_pred             EccCCCcCCeEEEEEecCCCeEEEEEECCCCCHhHHHHHHHHHHHhccCCCcCeEEEEEEEC--CeEEEEEEeeCCcccc
Confidence            45556555 69998777778889999987666778899999999996555577888888654  5678999999998876


Q ss_pred             hhcCCCChHHHHHHHHHHHHHHHHHHHC----------------------------------------------------
Q 015374          211 VLYPTLTDYDIRYYIYELLKALDYCHSQ----------------------------------------------------  238 (408)
Q Consensus       211 ~~~~~l~~~~~~~i~~qi~~~L~~LH~~----------------------------------------------------  238 (408)
                      ...... ......+..++...|.-||+.                                                    
T Consensus       109 ~~~~~~-~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  187 (272)
T 4gkh_A          109 QVLEEY-PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKEMHKLL  187 (272)
T ss_dssp             HHHHHC-GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHHHHTTC
T ss_pred             ccccCC-HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHHHHhcc
Confidence            543221 222233444555555555421                                                    


Q ss_pred             ------CcEEecCCCCcEEEeCCCCcEEEEeccccee
Q 015374          239 ------GIMHRDVKPHNVMIDHELRKLRLIDWGLAEF  269 (408)
Q Consensus       239 ------~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~  269 (408)
                            .++|+|+.+.|||++.+ +.+-|+||+.+..
T Consensus       188 ~~~~~~~l~HGDl~~~Nil~~~~-~~~~viDwe~a~~  223 (272)
T 4gkh_A          188 PFSPDSVVTHGDFSLDNLIFDEG-KLIGCIDVGRVGI  223 (272)
T ss_dssp             CCCCCEEEECSCCCTTSEEEETT-EEEEECCCTTCEE
T ss_pred             cccCCcEEEcCCCCCCeEEEECC-eEEEEEECccccc
Confidence                  17899999999999976 5667999998864

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.77  E-value=1.2e-07  Score=88.27  Aligned_cols=137  Identities=18%  Similarity=0.258  Sum_probs=97.8

Q ss_pred             EeeeeeeCceEEEEEEEcCCCcEEEEEEeccc-chHHHHHHHHHHHHhcCCC--CceEEeeEEEccCCCccEEEEEeecC
Q 015374          130 VRKVGRGKYSEVFEGINVNTNERCIIKILKPV-KKKKIKREIKILQNLCGGP--NVVKLLDIVRDQHSKTPSLIFEYVNS  206 (408)
Q Consensus       130 ~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~E~~~l~~l~~h~--niv~l~~~~~~~~~~~~~lv~e~~~~  206 (408)
                      ++.++.|....||+.     +..+++|+-... ....+.+|..+|+.+.++-  .+.+.+.++.. ..+..++||||++|
T Consensus        24 v~~l~~G~~n~v~~v-----g~~~VlR~~~~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~-~~g~~~~v~e~i~G   97 (306)
T 3tdw_A           24 VESLGEGFRNYAILV-----NGDWVFRFPKSQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKR-SDGNPFVGYRKVQG   97 (306)
T ss_dssp             EEEEEECSSEEEEEE-----TTTEEEEEESSHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEEC-TTSCEEEEEECCCS
T ss_pred             eeecCCCcceeEEEE-----CCEEEEEecCCchHHHHHHHHHHHHHHHHhcCCCCCCCeEeeccc-CCCceEEEEeccCC
Confidence            346889999999987     467888886432 3467889999999994432  24566666642 24567899999999


Q ss_pred             CChhh-hcCCCChHHHHHHHHHHHHHHHHHHHC-----------------------------------------------
Q 015374          207 TDFKV-LYPTLTDYDIRYYIYELLKALDYCHSQ-----------------------------------------------  238 (408)
Q Consensus       207 ~~l~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~-----------------------------------------------  238 (408)
                      ..+.. ....++..+...++.++...|..||+.                                               
T Consensus        98 ~~l~~~~~~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~  177 (306)
T 3tdw_A           98 QILGEDGMAVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTLRFQ  177 (306)
T ss_dssp             EECHHHHHTTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHHHHH
T ss_pred             eECchhhhhhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHHHHH
Confidence            88765 344556666666666666666666642                                               


Q ss_pred             -------------CcEEecCCCCcEEEeC---CCCcEEEEecccceeccC
Q 015374          239 -------------GIMHRDVKPHNVMIDH---ELRKLRLIDWGLAEFYHP  272 (408)
Q Consensus       239 -------------~iiH~Dlk~~NILl~~---~~~~~kl~DfG~a~~~~~  272 (408)
                                   .++|+|+++.|||++.   +...+.|+||+.+....+
T Consensus       178 ~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~gd~  227 (306)
T 3tdw_A          178 SYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAISDP  227 (306)
T ss_dssp             HHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEECG
T ss_pred             HHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCCCH
Confidence                         3599999999999997   324458999998876543

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.45  E-value=4.6e-07  Score=86.09  Aligned_cols=84  Identities=13%  Similarity=0.151  Sum_probs=58.5

Q ss_pred             EEEEeee-eeeCceEEEEEEEc--C----CCcEEEEEEecccc------hHHHHHHHHHHHHhcCC--CCceEEeeEEEc
Q 015374          127 YEVVRKV-GRGKYSEVFEGINV--N----TNERCIIKILKPVK------KKKIKREIKILQNLCGG--PNVVKLLDIVRD  191 (408)
Q Consensus       127 y~~~~~l-G~G~fg~Vy~~~~~--~----~~~~vavK~~~~~~------~~~~~~E~~~l~~l~~h--~niv~l~~~~~~  191 (408)
                      ....+.| +.|..+.+|+....  .    ++..+++|+.....      ...+.+|..+++.+..+  -.+.+++.++.+
T Consensus        22 v~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~  101 (357)
T 3ats_A           22 VTVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETT  101 (357)
T ss_dssp             EEEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECS
T ss_pred             eEEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccC
Confidence            3445678 88999999987543  1    15678899876432      25688999999988554  356778887754


Q ss_pred             cC-CCccEEEEEeecCCChh
Q 015374          192 QH-SKTPSLIFEYVNSTDFK  210 (408)
Q Consensus       192 ~~-~~~~~lv~e~~~~~~l~  210 (408)
                      .. .+..++||||++|..+.
T Consensus       102 ~~~~g~~~~v~e~l~G~~l~  121 (357)
T 3ats_A          102 GDVLGTPFFLMDYVEGVVPP  121 (357)
T ss_dssp             STTTSSCEEEEECCCCBCCC
T ss_pred             CCccCCceEEEEecCCCChh
Confidence            32 13567999999987654

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=98.28  E-value=2.6e-06  Score=82.11  Aligned_cols=74  Identities=18%  Similarity=0.232  Sum_probs=49.3

Q ss_pred             EeeeeeeCceEEEEEEEcCCCcEEEEEEeccc----------chHHHHHHHHHHHHhcCC-CC-ceEEeeEEEccCCCcc
Q 015374          130 VRKVGRGKYSEVFEGINVNTNERCIIKILKPV----------KKKKIKREIKILQNLCGG-PN-VVKLLDIVRDQHSKTP  197 (408)
Q Consensus       130 ~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~----------~~~~~~~E~~~l~~l~~h-~n-iv~l~~~~~~~~~~~~  197 (408)
                      .+.||.|.++.||++....++..++||...+.          ....+..|..+++.+..+ +. +.+++.+.  .  ...
T Consensus        35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~d--~--~~~  110 (397)
T 2olc_A           35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--T--EMA  110 (397)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--T--TTT
T ss_pred             EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEEc--C--Ccc
Confidence            56799999999999976556788999976432          234567899999987433 33 34555442  2  345


Q ss_pred             EEEEEeecCC
Q 015374          198 SLIFEYVNST  207 (408)
Q Consensus       198 ~lv~e~~~~~  207 (408)
                      ++|||++++.
T Consensus       111 ~lvmE~l~g~  120 (397)
T 2olc_A          111 VTVMEDLSHL  120 (397)
T ss_dssp             EEEECCCTTS
T ss_pred             EEEEEeCCCc
Confidence            7999999763

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=97.95  E-value=2.8e-05  Score=72.89  Aligned_cols=135  Identities=16%  Similarity=0.232  Sum_probs=78.0

Q ss_pred             EeeeeeeCceEEEEEEEcCCCcEEEEEEecccchHHHHHHHHHHHHhcCC-CCceEEeeE-----EEccCCCccEEEEEe
Q 015374          130 VRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGG-PNVVKLLDI-----VRDQHSKTPSLIFEY  203 (408)
Q Consensus       130 ~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~h-~niv~l~~~-----~~~~~~~~~~lv~e~  203 (408)
                      +..|+.|..+.||+... .++ .+++|+... ....+..|..+++.|..+ -.+.+++..     +. ...+..+++|+|
T Consensus        37 ~~~l~gG~~n~~~~v~~-~~~-~~vlk~~~~-~~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~-~~~~~~~~l~~~  112 (346)
T 2q83_A           37 IDVIQGNQMALVWKVHT-DSG-AVCLKRIHR-PEKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYS-KHGSFLFVVYDW  112 (346)
T ss_dssp             EEECC----CEEEEEEE-TTE-EEEEEEECS-CHHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCE-EETTEEEEEEEC
T ss_pred             eeeccccccCcEEEEEe-CCC-CEEEEecCC-CHHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEE-EECCEEEEEEEe
Confidence            34577778899999864 333 588999875 334555677777666321 133444431     11 113456899999


Q ss_pred             ecCCChhh-----h------c-------CCC-------------ChHH-------------------------------H
Q 015374          204 VNSTDFKV-----L------Y-------PTL-------------TDYD-------------------------------I  221 (408)
Q Consensus       204 ~~~~~l~~-----~------~-------~~l-------------~~~~-------------------------------~  221 (408)
                      ++|..+..     .      +       ..+             .+..                               +
T Consensus       113 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~  192 (346)
T 2q83_A          113 IEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEI  192 (346)
T ss_dssp             CCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHH
T ss_pred             ecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHH
Confidence            99865420     0      0       111             1110                               0


Q ss_pred             HHHHHHHHHHHHHHHH-------------CCcEEecCCCCcEEEeCCCCcEEEEeccccee
Q 015374          222 RYYIYELLKALDYCHS-------------QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEF  269 (408)
Q Consensus       222 ~~i~~qi~~~L~~LH~-------------~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~  269 (408)
                      ..+..++..++.+|++             ..++|+|+++.|||++.+ +.+.|+||+.+..
T Consensus       193 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~-~~~~lIDfe~a~~  252 (346)
T 2q83_A          193 DGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGEN-EQIWVIDLDTVSF  252 (346)
T ss_dssp             HHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGG-GCEEECCCTTCEE
T ss_pred             HHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCC-CcEEEEehhhccc
Confidence            1111223345666652             479999999999999866 6789999998754

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.94  E-value=5.7e-05  Score=70.16  Aligned_cols=76  Identities=18%  Similarity=0.175  Sum_probs=59.6

Q ss_pred             EeeeeeeCceEEEEEEEcCCCcEEEEEEecccchHHHHHHHHHHHHhcCC--CCceEEeeEEEccCCCccEEEEEeecCC
Q 015374          130 VRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGG--PNVVKLLDIVRDQHSKTPSLIFEYVNST  207 (408)
Q Consensus       130 ~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~h--~niv~l~~~~~~~~~~~~~lv~e~~~~~  207 (408)
                      .+.|+.|.+..+|+...  ++..+++|+........+..|...|+.|..+  ..+.+++.++..  ....++||||+++.
T Consensus        41 ~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~--~g~~~lvme~l~G~  116 (312)
T 3jr1_A           41 KEKLYSGEMNEIWLIND--EVQTVFVKINERSYRSMFRAEADQLALLAKTNSINVPLVYGIGNS--QGHSFLLLEALNKS  116 (312)
T ss_dssp             EEEECCSSSSEEEEEES--SSCEEEEEEEEGGGHHHHHHHHHHHHHHHHTTSSBCCCEEEEEEC--SSEEEEEEECCCCC
T ss_pred             eEEeCCccceeeeEEEE--CCCeEEEEeCCcccHHHHHHHHHHHHHHHhhCCCCcceEEEEeec--CCceEEEEEeccCC
Confidence            56799999999999853  4667889988766667789999999988443  567788888754  35678999999987


Q ss_pred             Ch
Q 015374          208 DF  209 (408)
Q Consensus       208 ~l  209 (408)
                      .+
T Consensus       117 ~~  118 (312)
T 3jr1_A          117 KN  118 (312)
T ss_dssp             CC
T ss_pred             CC
Confidence            54

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.80  E-value=9.7e-05  Score=68.16  Aligned_cols=70  Identities=11%  Similarity=0.078  Sum_probs=45.5

Q ss_pred             EeeeeeeCceEEEEEEEcCCCcEEEEEEecccch--HHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccEEEEEee-cC
Q 015374          130 VRKVGRGKYSEVFEGINVNTNERCIIKILKPVKK--KKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYV-NS  206 (408)
Q Consensus       130 ~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~-~~  206 (408)
                      ++.|+.|....+|+.      ..+++|+......  -...+|..+++.+..+.-..++++.+  ..  .-++++||+ ++
T Consensus        23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~--~~~~v~e~i~~g   92 (301)
T 3dxq_A           23 PLERLGGLTNLVFRA------GDLCLRIPGKGTEEYINRANEAVAAREAAKAGVSPEVLHVD--PA--TGVMVTRYIAGA   92 (301)
T ss_dssp             CEEEESCSSEEEEEE------TTEEEEEECC----CCCHHHHHHHHHHHHHTTSSCCEEEEC--TT--TCCEEEECCTTC
T ss_pred             eeEcCCcccccccee------eeEEEECCCCCccceeCHHHHHHHHHHHHHcCCCCceEEEE--CC--CCEEEEeecCCC
Confidence            457899999999998      5688898764321  23457888888774443335666654  22  235899999 66


Q ss_pred             CCh
Q 015374          207 TDF  209 (408)
Q Consensus       207 ~~l  209 (408)
                      ..+
T Consensus        93 ~~l   95 (301)
T 3dxq_A           93 QTM   95 (301)
T ss_dssp             EEC
T ss_pred             ccC
Confidence            544

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.74  E-value=6.7e-05  Score=72.82  Aligned_cols=78  Identities=13%  Similarity=0.128  Sum_probs=47.1

Q ss_pred             HCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCCCcceeecc--CccccccccccCCc--CCCccccHHHHHHHHHH
Q 015374          237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVA--SRYFKGPELLVDLQ--DYDYSLDMWSLGCMFAG  312 (408)
Q Consensus       237 ~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~~~~~~~~~--~~~y~aPE~~~~~~--~~~~~~DvwSlGvil~e  312 (408)
                      ...++|+|+++.|||++.+ + +.|+||+.+....+.........  ...|.+|+......  .-....++.+....+|+
T Consensus       231 ~~~liHGDl~~~Nil~~~~-~-~~lID~e~a~~G~p~~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (420)
T 2pyw_A          231 AQALIHGDLHTGSVMVTQD-S-TQVIDPEFSFYGPMGFDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWN  308 (420)
T ss_dssp             CCEEECSCCSGGGEEECSS-C-EEECCCTTCEEECHHHHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHH
T ss_pred             CCeEEecCCCCCcEEEeCC-C-CEEEeCcccccCchHHHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHH
Confidence            3569999999999999977 4 89999999876543222111111  12355655543211  11123445567777777


Q ss_pred             HHhC
Q 015374          313 MIFR  316 (408)
Q Consensus       313 ll~g  316 (408)
                      .+.+
T Consensus       309 ~y~~  312 (420)
T 2pyw_A          309 LFNK  312 (420)
T ss_dssp             HHHH
T ss_pred             HHHH
Confidence            6654

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.68  E-value=0.00013  Score=67.85  Aligned_cols=139  Identities=16%  Similarity=0.178  Sum_probs=80.6

Q ss_pred             EEEeeeeeeCceEEEEEEEcCCCcEEEEEEecc-cchHHHHHHHHHHHHhcCCC-CceEEeeEEEc----cCCCccEEEE
Q 015374          128 EVVRKVGRGKYSEVFEGINVNTNERCIIKILKP-VKKKKIKREIKILQNLCGGP-NVVKLLDIVRD----QHSKTPSLIF  201 (408)
Q Consensus       128 ~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~-~~~~~~~~E~~~l~~l~~h~-niv~l~~~~~~----~~~~~~~lv~  201 (408)
                      .-++.|+.|....+|+.... ++ .+++|+... .....+..|+.++..+..+. .+.+++.....    ...+..+++|
T Consensus        25 ~~~~~i~~G~~n~~~~v~~~-~g-~~vlk~~~~~~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~  102 (322)
T 2ppq_A           25 TSYKGIAEGVENSNFLLHTT-KD-PLILTLYEKRVEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALI  102 (322)
T ss_dssp             EEEEEECC---EEEEEEEES-SC-CEEEEEECC---CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEE
T ss_pred             eEeeccCCCcccceEEEEeC-Cc-cEEEEEeCCCCCHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEE
Confidence            34567888999999998643 33 688999875 34567788999888884331 13334322100    0123467999


Q ss_pred             EeecCCChhh-----h-------------cCCCC-----------hHHHH--------H----HHHHHHHHHHHHHH---
Q 015374          202 EYVNSTDFKV-----L-------------YPTLT-----------DYDIR--------Y----YIYELLKALDYCHS---  237 (408)
Q Consensus       202 e~~~~~~l~~-----~-------------~~~l~-----------~~~~~--------~----i~~qi~~~L~~LH~---  237 (408)
                      +|++|..+..     .             ...+.           |....        .    +...+...++.+.+   
T Consensus       103 ~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~  182 (322)
T 2ppq_A          103 SFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWP  182 (322)
T ss_dssp             ECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCC
T ss_pred             EeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCc
Confidence            9999865321     0             01111           11100        0    00113445556653   


Q ss_pred             ----CCcEEecCCCCcEEEeCCCCcEEEEeccccee
Q 015374          238 ----QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEF  269 (408)
Q Consensus       238 ----~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~  269 (408)
                          .+++|+|+.+.|||++.+ +.+.|+||+.+..
T Consensus       183 ~~~~~~liHgDl~~~Nil~~~~-~~~~lIDf~~a~~  217 (322)
T 2ppq_A          183 KDLPAGVIHADLFQDNVFFLGD-ELSGLIDFYFACN  217 (322)
T ss_dssp             CSSCEEEECSCCCGGGEEEETT-EEEEECCCTTCEE
T ss_pred             ccCCcccCCCCCCccCEEEeCC-ceEEEecchhccC
Confidence                369999999999999976 4557999998754

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=97.67  E-value=0.00019  Score=69.73  Aligned_cols=74  Identities=15%  Similarity=0.174  Sum_probs=52.7

Q ss_pred             EeeeeeeCceEEEEEEEcC-------CCcEEEEEEecccch-HHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccEEEE
Q 015374          130 VRKVGRGKYSEVFEGINVN-------TNERCIIKILKPVKK-KKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIF  201 (408)
Q Consensus       130 ~~~lG~G~fg~Vy~~~~~~-------~~~~vavK~~~~~~~-~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~  201 (408)
                      ++.|+.|....||++....       ++..+++|+...... ..+.+|..+++.+..+.-..++++.+  .+    .+|+
T Consensus        78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~~~~~li~E~~~l~~L~~~g~~P~l~~~~--~~----g~v~  151 (429)
T 1nw1_A           78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPETESHLVAESVIFTLLSERHLGPKLYGIF--SG----GRLE  151 (429)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCCHHHHHHHHHHHHHHHHTTSSSCEEEEE--TT----EEEE
T ss_pred             EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCCcHHHHHHHHHHHHHHHhCCCCCcEEEEe--CC----CEEE
Confidence            4578888899999997543       257899999854223 56778999999885554446777776  32    2899


Q ss_pred             EeecCCCh
Q 015374          202 EYVNSTDF  209 (408)
Q Consensus       202 e~~~~~~l  209 (408)
                      ||++|..+
T Consensus       152 e~l~G~~l  159 (429)
T 1nw1_A          152 EYIPSRPL  159 (429)
T ss_dssp             CCCCEEEC
T ss_pred             EEeCCccc
Confidence            99987443

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.61  E-value=0.00015  Score=67.96  Aligned_cols=137  Identities=15%  Similarity=0.135  Sum_probs=73.2

Q ss_pred             eeeeeeCceE-EEEEEEcCCCcEEEEEEecccchHHHHHHHHHHHHhcCCC-CceEEeeEEEccCCCccEEEEEeecCCC
Q 015374          131 RKVGRGKYSE-VFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGP-NVVKLLDIVRDQHSKTPSLIFEYVNSTD  208 (408)
Q Consensus       131 ~~lG~G~fg~-Vy~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~h~-niv~l~~~~~~~~~~~~~lv~e~~~~~~  208 (408)
                      +.|+.|+... +|+.. ..++..+++|...+.....+..|+.+++.+..+. .+.+++.+.  ...+  +++||++++..
T Consensus        24 ~~l~gg~s~~~~~r~~-~~~~~~~vlk~~~~~~~~~~~~e~~~l~~L~~~g~~vP~v~~~d--~~~g--~ll~e~l~~~~   98 (333)
T 3csv_A           24 TPLAGDASSRRYQRLR-SPTGAKAVLMDWSPEEGGDTQPFVDLAQYLRNLDISAPEIYAEE--HARG--LLLIEDLGDAL   98 (333)
T ss_dssp             CC--------CCEEEE-CTTCCEEEEEECCTTTTCCSHHHHHHHHHHHHTTCBCCCEEEEE--TTTT--EEEECCCCSCB
T ss_pred             eECCCCCCCceEEEEE-cCCCCeEEEEECCCCCCccccHHHHHHHHHHhCCCCCCceeeec--CCCC--EEEEeeCCCcc
Confidence            3565555554 66664 2235667777665433256677888888774432 345666653  2223  68999997755


Q ss_pred             hhhhcC--------------------------CCC---hHHHH-------H-HH------------HHHHHHHHHHH---
Q 015374          209 FKVLYP--------------------------TLT---DYDIR-------Y-YI------------YELLKALDYCH---  236 (408)
Q Consensus       209 l~~~~~--------------------------~l~---~~~~~-------~-i~------------~qi~~~L~~LH---  236 (408)
                      +...+.                          .++   .....       . +.            ..+...++.+-   
T Consensus        99 l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~  178 (333)
T 3csv_A           99 FTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQ  178 (333)
T ss_dssp             HHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHH
T ss_pred             hHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhc
Confidence            432110                          111   11100       0 00            01112223331   


Q ss_pred             ---HCCcEEecCCCCcEEEeCC---CCcEEEEecccceeccC
Q 015374          237 ---SQGIMHRDVKPHNVMIDHE---LRKLRLIDWGLAEFYHP  272 (408)
Q Consensus       237 ---~~~iiH~Dlk~~NILl~~~---~~~~kl~DfG~a~~~~~  272 (408)
                         ...++|+|+.+.|||++.+   .+.+.|+||+.+.....
T Consensus       179 ~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G~~  220 (333)
T 3csv_A          179 LEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLGHR  220 (333)
T ss_dssp             CCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEECT
T ss_pred             ccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcCCC
Confidence               2369999999999999863   14789999999876543

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.55  E-value=0.0012  Score=60.38  Aligned_cols=77  Identities=14%  Similarity=0.104  Sum_probs=55.4

Q ss_pred             CCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc---chHHHHHHHHHHHHhcCCC--CceEEeeEEEccCCCccEE
Q 015374          125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV---KKKKIKREIKILQNLCGGP--NVVKLLDIVRDQHSKTPSL  199 (408)
Q Consensus       125 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~h~--niv~l~~~~~~~~~~~~~l  199 (408)
                      .+..-++.+|.|..+.||+.+ ..+|+.+++|+....   ....+..|...|+.|....  -+.+++++.      ..++
T Consensus        15 ~~v~~v~~~g~G~~~~vyrv~-l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~------~~~l   87 (288)
T 3f7w_A           15 REVAAVAERGHSHRWHLYRVE-LADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD------DRTL   87 (288)
T ss_dssp             CCEEEEEEEEEETTEEEEEEE-ETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE------TTEE
T ss_pred             CCeEEEEecCCCCCeEEEEEE-ECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc------CceE
Confidence            345667889999999999996 567889999986532   2346889999999884332  244555542      2369


Q ss_pred             EEEeecCCC
Q 015374          200 IFEYVNSTD  208 (408)
Q Consensus       200 v~e~~~~~~  208 (408)
                      ||||+.++.
T Consensus        88 v~e~l~~~~   96 (288)
T 3f7w_A           88 AMEWVDERP   96 (288)
T ss_dssp             EEECCCCCC
T ss_pred             EEEeecccC
Confidence            999987764

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=97.51  E-value=0.0004  Score=66.25  Aligned_cols=133  Identities=13%  Similarity=0.195  Sum_probs=82.1

Q ss_pred             eeeeeeCceEEEEEEEcC-------CCcEEEEEEeccc--chHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccEEEE
Q 015374          131 RKVGRGKYSEVFEGINVN-------TNERCIIKILKPV--KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIF  201 (408)
Q Consensus       131 ~~lG~G~fg~Vy~~~~~~-------~~~~vavK~~~~~--~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~  201 (408)
                      +.|..|-...+|+.....       ++..+++|+..+.  ......+|..+++.+..+.-..++++++  .+    .+||
T Consensus        56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~--~~----g~v~  129 (379)
T 3feg_A           56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAILQGVDSLVLESVMFAILAERSLGPQLYGVF--PE----GRLE  129 (379)
T ss_dssp             EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC---CCHHHHHHHHHHHHHHHHTTSSCCEEEEE--TT----EEEE
T ss_pred             EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCccchHHHHHHHHHHHHHHHhcCCCCeEEEEc--CC----ccEE
Confidence            356677788889886532       3468899987432  3456678999999885554456777776  32    2999


Q ss_pred             EeecCCChhhh--------------c---C--------CCC--hHHHHHHHHHHH-------------------HHHHHH
Q 015374          202 EYVNSTDFKVL--------------Y---P--------TLT--DYDIRYYIYELL-------------------KALDYC  235 (408)
Q Consensus       202 e~~~~~~l~~~--------------~---~--------~l~--~~~~~~i~~qi~-------------------~~L~~L  235 (408)
                      ||++|..+..-              +   .        ...  +.++..+..++.                   ..++.|
T Consensus       130 e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L  209 (379)
T 3feg_A          130 QYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNL  209 (379)
T ss_dssp             ECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHH
T ss_pred             EEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHH
Confidence            99998654311              0   0        111  234454544432                   223444


Q ss_pred             HH--------CCcEEecCCCCcEEEeCC---CCcEEEEeccccee
Q 015374          236 HS--------QGIMHRDVKPHNVMIDHE---LRKLRLIDWGLAEF  269 (408)
Q Consensus       236 H~--------~~iiH~Dlk~~NILl~~~---~~~~kl~DfG~a~~  269 (408)
                      .+        ..++|+|+.+.|||++.+   .+.+.++||..+..
T Consensus       210 ~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~  254 (379)
T 3feg_A          210 RKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY  254 (379)
T ss_dssp             HHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred             HHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence            32        148999999999999875   35789999998864

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=97.33  E-value=0.00097  Score=65.26  Aligned_cols=74  Identities=15%  Similarity=0.216  Sum_probs=49.8

Q ss_pred             EeeeeeeCceEEEEEEEcCCCcEEEEEEecccchH--HHHHHHHHHHHhcCCCCceEEeeEEEccCCCccEEEEEeecCC
Q 015374          130 VRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKK--KIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNST  207 (408)
Q Consensus       130 ~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~--~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~~~  207 (408)
                      ++.|+.|-...+|+.....++..+++|+..+....  .-.+|..++..|..+.-..++++.+  .+    .+||||++|.
T Consensus       113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~idR~~E~~vl~~L~~~gl~P~ll~~~--~~----G~v~e~I~G~  186 (458)
T 2qg7_A          113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEIINREREKKISCILYNKNIAKKIYVFF--TN----GRIEEFMDGY  186 (458)
T ss_dssp             EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCSCHHHHHHHHHHHTTSSSBCCEEEEE--TT----EEEEECCCSE
T ss_pred             EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhcCHHHHHHHHHHHHhcCCCCCEEEEe--CC----eEEEEeeCCc
Confidence            45788899999999976544578889987543221  1268999999995444445788777  32    2699999875


Q ss_pred             Ch
Q 015374          208 DF  209 (408)
Q Consensus       208 ~l  209 (408)
                      .+
T Consensus       187 ~l  188 (458)
T 2qg7_A          187 AL  188 (458)
T ss_dssp             EC
T ss_pred             cC
Confidence            44

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=97.22  E-value=0.00092  Score=62.18  Aligned_cols=75  Identities=16%  Similarity=0.231  Sum_probs=48.7

Q ss_pred             eeeeeCceEEEEEEEcCCCcEEEEEEeccc--chHHHHHHHHHHHHhcCCC-CceEEeeEEEc----cCCCccEEEEEee
Q 015374          132 KVGRGKYSEVFEGINVNTNERCIIKILKPV--KKKKIKREIKILQNLCGGP-NVVKLLDIVRD----QHSKTPSLIFEYV  204 (408)
Q Consensus       132 ~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~~h~-niv~l~~~~~~----~~~~~~~lv~e~~  204 (408)
                      .++ |....||+.. ..+|+.+++|+..+.  ....+..|..++..+..+. .+.+++.. ..    ...+..+++|+++
T Consensus        33 ~l~-g~~n~~y~v~-~~~g~~~vlK~~~~~~~~~~~~~~E~~~~~~L~~~g~~vp~~~~~-~g~~~~~~~g~~~~l~~~i  109 (328)
T 1zyl_A           33 PLN-SYENRVYQFQ-DEDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAF-NGQTLLNHQGFYFAVFPSV  109 (328)
T ss_dssp             EEC-CSSSEEEEEC-CTTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCB-TTBSCEEETTEEEEEEECC
T ss_pred             eec-CcccceEEEE-cCCCCEEEEEEcCCCCCCHHHHHHHHHHHHHHHHcCCeecceeec-CCcEEEEECCEEEEEEEec
Confidence            466 8888999874 345667999998743  4567788999988884331 24444443 10    0123557899999


Q ss_pred             cCCCh
Q 015374          205 NSTDF  209 (408)
Q Consensus       205 ~~~~l  209 (408)
                      +|..+
T Consensus       110 ~G~~~  114 (328)
T 1zyl_A          110 GGRQF  114 (328)
T ss_dssp             CCEEC
T ss_pred             CCCCC
Confidence            88543

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=97.19  E-value=0.0013  Score=62.35  Aligned_cols=74  Identities=15%  Similarity=0.196  Sum_probs=45.8

Q ss_pred             EeeeeeeCceEEEEEEEcC--------CCcEEEEEEecccchH--HHHHHHHHHHHhcCCCCceEEeeEEEccCCCccEE
Q 015374          130 VRKVGRGKYSEVFEGINVN--------TNERCIIKILKPVKKK--KIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSL  199 (408)
Q Consensus       130 ~~~lG~G~fg~Vy~~~~~~--------~~~~vavK~~~~~~~~--~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l  199 (408)
                      +..|+.|....+|+.....        .+..+++|+.......  ....|..+++.+..+.-..++++.+  .    -++
T Consensus        38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~----~~~  111 (369)
T 3c5i_A           38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDELYNTISEFEVYKTMSKYKIAPQLLNTF--N----GGR  111 (369)
T ss_dssp             EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGGTSCHHHHHHHHHHHHHTTSSCCEEEEE--T----TEE
T ss_pred             EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccceecHHHHHHHHHHHHhcCCCCceEEec--C----CcE
Confidence            4467888889999986543        1367889987543221  2468888898885443344676654  2    258


Q ss_pred             EEEeecCCCh
Q 015374          200 IFEYVNSTDF  209 (408)
Q Consensus       200 v~e~~~~~~l  209 (408)
                      ||||++|..+
T Consensus       112 v~e~i~G~~l  121 (369)
T 3c5i_A          112 IEEWLYGDPL  121 (369)
T ss_dssp             EEECCCSEEC
T ss_pred             EEEEecCCcC
Confidence            9999988543

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=96.83  E-value=0.012  Score=50.84  Aligned_cols=96  Identities=9%  Similarity=-0.003  Sum_probs=59.5

Q ss_pred             Chhhhc----CCCChHHHHHHHHHHHHHHHHHHH-CCcEEecCCCCcEEEeCCCCcEEEEecccceeccCCCcceeeccC
Q 015374          208 DFKVLY----PTLTDYDIRYYIYELLKALDYCHS-QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVAS  282 (408)
Q Consensus       208 ~l~~~~----~~l~~~~~~~i~~qi~~~L~~LH~-~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~  282 (408)
                      +|...+    .++++++++.++.|.+.+|.-+-. ..-..+=+.|..|++..+ |.|.+.+ +.+           ....
T Consensus        34 SL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~d-G~V~f~~-~~s-----------~~~~  100 (229)
T 2yle_A           34 SLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRD-GAVTLAP-AAD-----------DAGE  100 (229)
T ss_dssp             EHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETT-SCEEECC-C-----------------
T ss_pred             cHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecC-Cceeccc-ccc-----------cccc
Confidence            455544    679999999999999999877622 111233345688888888 6765543 111           0123


Q ss_pred             ccccccccccCCcCCCccccHHHHHHHHHHHHhCCC
Q 015374          283 RYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKE  318 (408)
Q Consensus       283 ~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~  318 (408)
                      ..+.+||...  ...+.+.=|||||+++|.-+--..
T Consensus       101 ~~~~~pe~~~--~~~te~~~IysLG~tLY~ALDygL  134 (229)
T 2yle_A          101 PPPVAGKLGY--SQCMETEVIESLGIIIYKALDYGL  134 (229)
T ss_dssp             ------CCSS--SSSCHHHHHHHHHHHHHHHHTTTC
T ss_pred             cCCCChhhcc--ccchHHHHHHHHHHHHHHHhhcCC
Confidence            3466888763  356788899999999999885443

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=96.60  E-value=0.0086  Score=56.05  Aligned_cols=71  Identities=8%  Similarity=0.178  Sum_probs=44.0

Q ss_pred             eeeCceEEEEEEEcCCCcEEEEEEecccchHHHHHHHHHHHHhcCC--CCceEEeeEEEc----cCCCccEEEEEeecCC
Q 015374          134 GRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGG--PNVVKLLDIVRD----QHSKTPSLIFEYVNST  207 (408)
Q Consensus       134 G~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~h--~niv~l~~~~~~----~~~~~~~lv~e~~~~~  207 (408)
                      |.|....||+... .++ .+++|+.....   ...|+..+..|..+  +++.+.+.....    ...+..+++|+|++|.
T Consensus        32 G~g~~N~vy~v~~-~~g-~~vLK~~~~~~---~~~E~~~l~~L~~~g~~~vp~pi~~~~G~~~~~~~g~~~~l~~~i~G~  106 (339)
T 3i1a_A           32 GADTNAFAYQADS-ESK-SYFIKLKYGYH---DEINLSIIRLLHDSGIKEIIFPIHTLEAKLFQQLKHFKIIAYPFIHAP  106 (339)
T ss_dssp             TSCSSCEEEEEEC-SSC-EEEEEEEECSS---CCHHHHHHHHHHHTTCCSSCCCCCCTTSCSSEECSSEEEEEEECCCCC
T ss_pred             cCccccceEEEEe-CCC-CEEEEEecCcc---chHHHHHHHHHHhcCCcccccceecCCCCEEEEECCEEEEEEeccCCC
Confidence            4455789999853 445 88999876543   25677777766322  224555533110    1235678999999987


Q ss_pred             Ch
Q 015374          208 DF  209 (408)
Q Consensus       208 ~l  209 (408)
                      .+
T Consensus       107 ~~  108 (339)
T 3i1a_A          107 NG  108 (339)
T ss_dssp             BT
T ss_pred             cC
Confidence            65

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=96.23  E-value=0.02  Score=55.19  Aligned_cols=74  Identities=16%  Similarity=0.205  Sum_probs=49.5

Q ss_pred             EeeeeeeCceEEEEEEEcCC-------CcEEEEEEecccch--HHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccEEE
Q 015374          130 VRKVGRGKYSEVFEGINVNT-------NERCIIKILKPVKK--KKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI  200 (408)
Q Consensus       130 ~~~lG~G~fg~Vy~~~~~~~-------~~~vavK~~~~~~~--~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  200 (408)
                      ++.+..|-...+|+......       +..+++|+..+...  -...+|..+++.+..+.-..++++.+  .    -++|
T Consensus        75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~idR~~E~~~l~~L~~~gi~P~l~~~~--~----~~~I  148 (424)
T 3mes_A           75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKFYDSKVELDVFRYLSNINIAPNIIADF--P----EGRI  148 (424)
T ss_dssp             EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CCCCHHHHHHHHHHHHHTTSSCCEEEEE--T----TEEE
T ss_pred             EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchhcCHHHHHHHHHHHHhcCCCCCEEEEc--C----CCEE
Confidence            34677788888999875421       57789998754221  23468999998885554455677654  2    2589


Q ss_pred             EEeecCCCh
Q 015374          201 FEYVNSTDF  209 (408)
Q Consensus       201 ~e~~~~~~l  209 (408)
                      |||++|..+
T Consensus       149 ~efI~G~~l  157 (424)
T 3mes_A          149 EEFIDGEPL  157 (424)
T ss_dssp             EECCCSEEC
T ss_pred             EEEeCCccC
Confidence            999998653

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=95.84  E-value=0.041  Score=52.65  Aligned_cols=31  Identities=29%  Similarity=0.523  Sum_probs=25.3

Q ss_pred             cEEecCCCCcEEEeC-----CCCcEEEEecccceec
Q 015374          240 IMHRDVKPHNVMIDH-----ELRKLRLIDWGLAEFY  270 (408)
Q Consensus       240 iiH~Dlk~~NILl~~-----~~~~~kl~DfG~a~~~  270 (408)
                      ++|+|+.+.|||+..     +.+.+.++||..|...
T Consensus       246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~n  281 (401)
T 3g15_A          246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSYN  281 (401)
T ss_dssp             EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEEE
T ss_pred             eEEecCCCCeEEEecCcccCcCCeEEEechHhccCC
Confidence            689999999999943     2367999999998653

>3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A

Probab=82.86  E-value=0.1  Score=50.94  Aligned_cols=59  Identities=12%  Similarity=0.133  Sum_probs=18.1

Q ss_pred             EEeeeeeeCceEEEEEEEcCCCcEEEE------EEeccc-----chHHHHHHHHHHHHhcCCCCceEEeeEEEc
Q 015374          129 VVRKVGRGKYSEVFEGINVNTNERCII------KILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRD  191 (408)
Q Consensus       129 ~~~~lG~G~fg~Vy~~~~~~~~~~vav------K~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~  191 (408)
                      +.++||   ||.||+|........||+      |..+..     ....+.+|..+++.+ +|+|+++.+++...
T Consensus       146 l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~-~H~niv~~h~f~~~  215 (463)
T 3cxl_A          146 IYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENE-QIPKYEKIHNFKVH  215 (463)
T ss_dssp             STTTSS---BCCC---------CCBGGGC------------------------------------CBCCCEEEE
T ss_pred             ccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccc-cccccCCCcceEEe
Confidence            345676   999999987665568888      765531     234577888888888 99999999887653

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	408
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	1e-103
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	4e-60
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	2e-56
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	2e-56
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	7e-56
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	2e-55
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	5e-55
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	9e-55
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	1e-54
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	2e-54
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	3e-54
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	9e-54
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	8e-53
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	1e-52
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	2e-52
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	3e-52
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	5e-52
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	2e-51
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	4e-51
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	6e-51
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	1e-50
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	2e-50
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	2e-50
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	3e-49
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	1e-47
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	3e-47
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	3e-47
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	4e-47
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	1e-46
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	8e-46
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	8e-46
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	9e-41
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	1e-40
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	2e-40
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	2e-40
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	3e-40
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	4e-39
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	5e-39
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	2e-38
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	7e-38
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	3e-37
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	4e-37
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	5e-37
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	1e-36
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	2e-36
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	2e-36
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	4e-36
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	9e-36
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	2e-35
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	5e-35
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	4e-34
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	1e-33
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	2e-33
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	2e-33
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	2e-33
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	2e-32
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	7e-31
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	4e-30
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	9e-30
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	3e-29
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	4e-29
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	7e-28
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	2e-18

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  305 bits (783), Expect = e-103
 Identities = 235/325 (72%), Positives = 269/325 (82%), Gaps = 17/325 (5%)

Query: 92  PAMSKARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNE 151
           P  S+ARVYTDVN  RP+EYWDYES  V+WG+QDDY++VRK+GRGKYSEVFE IN+  NE
Sbjct: 2   PVPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNE 61

Query: 152 RCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKV 211
           + ++KILKPVKKKKIKREIKIL+NL GGPN++ L DIV+D  S+TP+L+FE+VN+TDFK 
Sbjct: 62  KVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQ 121

Query: 212 LYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 271
           LY TLTDYDIR+Y+YE+LKALDYCHS GIMHRDVKPHNVMIDHE RKLRLIDWGLAEFYH
Sbjct: 122 LYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 181

Query: 272 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV 331
           PG+EYNVRVASRYFKGPELLVD Q YDYSLDMWSLGCM A MIFRKEPFF+GHDN+DQLV
Sbjct: 182 PGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLV 241

Query: 332 KIAKDCCLIIWCN-----------------SRHSRKPWSKFINADNQHLVSPEAIDFLDK 374
           +IAK        +                  RHSRK W +F++++NQHLVSPEA+DFLDK
Sbjct: 242 RIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDK 301

Query: 375 LLRYDHQDRLTAREAMAHPYFAQVR 399
           LLRYDHQ RLTAREAM HPYF  V 
Sbjct: 302 LLRYDHQSRLTAREAMEHPYFYTVV 326

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  196 bits (500), Expect = 4e-60
 Identities = 87/296 (29%), Positives = 141/296 (47%), Gaps = 22/296 (7%)

Query: 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNV 182
            +  Y   + +G G +  V++    ++ E   IK +    K+   RE++I++ L    N+
Sbjct: 18  QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-DKRFKNRELQIMRKL-DHCNI 75

Query: 183 VKLLDIVRDQHSKTPS----LIFEYVNSTDFKVL------YPTLTDYDIRYYIYELLKAL 232
           V+L         K       L+ +YV  T ++V         TL    ++ Y+Y+L ++L
Sbjct: 76  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 135

Query: 233 DYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLV 292
            Y HS GI HRD+KP N+++D +   L+L D+G A+    G+     + SRY++ PEL+ 
Sbjct: 136 AYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIF 195

Query: 293 DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPW 352
              DY  S+D+WS GC+ A ++  + P F G    DQLV+I K          R     +
Sbjct: 196 GATDYTSSIDVWSAGCVLAELLLGQ-PIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNY 254

Query: 353 SKF---------INADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVR 399
           ++F              +    PEAI    +LL Y    RLT  EA AH +F ++R
Sbjct: 255 TEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR 310

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  187 bits (476), Expect = 2e-56
 Identities = 71/290 (24%), Positives = 136/290 (46%), Gaps = 29/290 (10%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK---PVKKKKIKREIKILQNLCGGPN 181
           D Y+++ ++G G +  V   +   T    + K +    P+ K  +K EI I+  L   P 
Sbjct: 29  DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQL-HHPK 87

Query: 182 VVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHS 237
           ++ L D   D++     LI E+++  +           +++ ++  Y+ +  + L + H 
Sbjct: 88  LINLHDAFEDKYE--MVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHE 145

Query: 238 QGIMHRDVKPHNVMIDH-ELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD 296
             I+H D+KP N+M +  +   +++ID+GLA   +P +   V  A+  F  PE++ D + 
Sbjct: 146 HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIV-DREP 204

Query: 297 YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSKFI 356
             +  DMW++G +   ++    P F G D+ + L  + +       C+       +S   
Sbjct: 205 VGFYTDMWAIGVLGYVLLSGLSP-FAGEDDLETLQNVKR-------CDWEFDEDAFSS-- 254

Query: 357 NADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAESSRT 406
                  VSPEA DF+  LL+ + + RLT  +A+ HP+     +  +SR 
Sbjct: 255 -------VSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSNLTSRI 297

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  184 bits (469), Expect = 2e-56
 Identities = 70/294 (23%), Positives = 124/294 (42%), Gaps = 40/294 (13%)

Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK------------KKKIKREIK 171
            ++YE    +GRG  S V   I+  T +   +KI+                ++   +E+ 
Sbjct: 2   YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVD 61

Query: 172 ILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTD-FKVLY--PTLTDYDIRYYIYEL 228
           IL+ + G PN+++L D           L+F+ +   + F  L    TL++ + R  +  L
Sbjct: 62  ILRKVSGHPNIIQLKDTYETNTF--FFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRAL 119

Query: 229 LKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGP 288
           L+ +   H   I+HRD+KP N+++D ++  ++L D+G +    PG++      +  +  P
Sbjct: 120 LEVICALHKLNIVHRDLKPENILLDDDMN-IKLTDFGFSCQLDPGEKLREVCGTPSYLAP 178

Query: 289 ELL-----VDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWC 343
           E++      +   Y   +DMWS G +   ++    P F+       L  I          
Sbjct: 179 EIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP-FWHRKQMLMLRMIMS-------G 230

Query: 344 NSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQ 397
           N +     W            S    D + + L    Q R TA EA+AHP+F Q
Sbjct: 231 NYQFGSPEWDD---------YSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ 275

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  184 bits (469), Expect = 7e-56
 Identities = 62/309 (20%), Positives = 116/309 (37%), Gaps = 37/309 (11%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK----PVKKKKIKREIKILQNLCGGP 180
           DD+E + ++G G    VF+  +  +      K++     P  + +I RE+++L      P
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNS-P 64

Query: 181 NVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL---YPTLTDYDIRYYIYELLKALDYCHS 237
            +V              S+  E+++      +      + +  +      ++K L Y   
Sbjct: 65  YIVGFYGAFYSDGE--ISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLRE 122

Query: 238 Q-GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD 296
           +  IMHRDVKP N++++     ++L D+G++         N  V +R +  PE L     
Sbjct: 123 KHKIMHRDVKPSNILVNSRGE-IKLCDFGVSGQLIDSM-ANSFVGTRSYMSPERLQG-TH 179

Query: 297 YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK-------------DCCLIIWC 343
           Y    D+WS+G     M   + P         +L+   +                  +  
Sbjct: 180 YSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSS 239

Query: 344 NSRHSRKPWSKFINADN----------QHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHP 393
               SR P + F   D             + S E  DF++K L  +  +R   ++ M H 
Sbjct: 240 YGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHA 299

Query: 394 YFAQVRAAE 402
           +  +  A E
Sbjct: 300 FIKRSDAEE 308

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  182 bits (464), Expect = 2e-55
 Identities = 70/296 (23%), Positives = 132/296 (44%), Gaps = 34/296 (11%)

Query: 114 YESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIK---REI 170
           YE +T     +D +E++ ++G G + +V++  N  T+     K++    +++++    EI
Sbjct: 1   YEHVTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEI 60

Query: 171 KILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYP----TLTDYDIRYYIY 226
            IL +    PN+VKLLD    +++    ++ E+        +       LT+  I+    
Sbjct: 61  DILASCDH-PNIVKLLDAFYYENN--LWILIEFCAGGAVDAVMLELERPLTESQIQVVCK 117

Query: 227 ELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEYNVRVASRYF 285
           + L AL+Y H   I+HRD+K  N++   +   ++L D+G++ +     +  +  + + Y+
Sbjct: 118 QTLDALNYLHDNKIIHRDLKAGNILFTLDGD-IKLADFGVSAKNTRTIQRRDSFIGTPYW 176

Query: 286 KGPELLV----DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLII 341
             PE+++      + YDY  D+WSLG     M   + P  +  +    L+KIAK     +
Sbjct: 177 MAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPP-HHELNPMRVLLKIAKSEPPTL 235

Query: 342 WCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQ 397
              SR                  S    DFL K L  +   R T  + + HP+   
Sbjct: 236 AQPSR-----------------WSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTV 274

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  182 bits (463), Expect = 5e-55
 Identities = 64/280 (22%), Positives = 126/280 (45%), Gaps = 28/280 (10%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP--VKKKKIKREIKILQNLCGGPNV 182
           + Y +   +GRG++  V   +  ++ +  + K +K     +  +K+EI IL       N+
Sbjct: 5   EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIA-RHRNI 63

Query: 183 VKLLDIVRDQHSKTPSLIFEYVNSTD-FKVL---YPTLTDYDIRYYIYELLKALDYCHSQ 238
           + L +           +IFE+++  D F+ +      L + +I  Y++++ +AL + HS 
Sbjct: 64  LHLHESFESMEE--LVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSH 121

Query: 239 GIMHRDVKPHNVMID-HELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDY 297
            I H D++P N++        +++I++G A    PG  + +   +  +  PE+       
Sbjct: 122 NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQH-DVV 180

Query: 298 DYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSKFIN 357
             + DMWSLG +   ++    PF     N   +  I                + + +   
Sbjct: 181 STATDMWSLGTLVYVLLSGINPF-LAETNQQIIENIMN-------AEYTFDEEAFKE--- 229

Query: 358 ADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQ 397
                 +S EA+DF+D+LL  + + R+TA EA+ HP+  Q
Sbjct: 230 ------ISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQ 263

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  182 bits (463), Expect = 9e-55
 Identities = 81/298 (27%), Positives = 142/298 (47%), Gaps = 26/298 (8%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKK----KKIKREIKILQNLCGGP 180
             Y  +  +G G Y  V    +     R  IK + P +     ++  REIKIL       
Sbjct: 8   PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRH-E 66

Query: 181 NVVKLLDIVRD---QHSKTPSLIFEYVNSTDFKVL-YPTLTDYDIRYYIYELLKALDYCH 236
           N++ + DI+R    +  K   L+   + +  +K+L    L++  I Y++Y++L+ L Y H
Sbjct: 67  NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIH 126

Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNV----RVASRYFKGPELLV 292
           S  ++HRD+KP N++++     L++ D+GLA    P  ++       VA+R+++ PE+++
Sbjct: 127 SANVLHRDLKPSNLLLNTTCD-LKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 185

Query: 293 DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDC-----------CLII 341
           + + Y  S+D+WS+GC+ A M+  + P F G    DQL  I                 + 
Sbjct: 186 NSKGYTKSIDIWSVGCILAEMLSNR-PIFPGKHYLDQLNHILGILGSPSQEDLNCIINLK 244

Query: 342 WCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVR 399
             N   S    +K            +A+D LDK+L ++   R+   +A+AHPY  Q  
Sbjct: 245 ARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYY 302

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  182 bits (462), Expect = 1e-54
 Identities = 70/283 (24%), Positives = 123/283 (43%), Gaps = 26/283 (9%)

Query: 125 DDYEVVRKV-GRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNVV 183
           DDY+V  +V G G   +V +  N  T E+  +K+L+     K +RE+++       P++V
Sbjct: 11  DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ--DCPKARREVELHWRASQCPHIV 68

Query: 184 KLLDIVRDQHS--KTPSLIFEYVNSTDF-----KVLYPTLTDYDIRYYIYELLKALDYCH 236
           +++D+  + ++  K   ++ E ++  +             T+ +    +  + +A+ Y H
Sbjct: 69  RIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH 128

Query: 237 SQGIMHRDVKPHNVMIDHELRK--LRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDL 294
           S  I HRDVKP N++   +     L+L D+G A+             + Y+  PE+L   
Sbjct: 129 SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGP- 187

Query: 295 QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSK 354
           + YD S DMWSLG +   ++    P FY +        +      I           WS+
Sbjct: 188 EKYDKSCDMWSLGVIMYILLCGYPP-FYSNHGLAISPGMKT---RIRMGQYEFPNPEWSE 243

Query: 355 FINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQ 397
                    VS E    +  LL+ +   R+T  E M HP+  Q
Sbjct: 244 ---------VSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQ 277

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  182 bits (462), Expect = 2e-54
 Identities = 64/284 (22%), Positives = 121/284 (42%), Gaps = 29/284 (10%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK---KKKIKREIKILQNLCGGPN 181
           D Y++  ++G G +  V       T      K +       K+ +++EI+ +  L   P 
Sbjct: 26  DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRH-PT 84

Query: 182 VVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL----YPTLTDYDIRYYIYELLKALDYCHS 237
           +V L D   D +     +I+E+++  +        +  +++ +   Y+ ++ K L + H 
Sbjct: 85  LVNLHDAFEDDNE--MVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHE 142

Query: 238 QGIMHRDVKPHNVMIDHELR-KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD 296
              +H D+KP N+M   +   +L+LID+GL     P +   V   +  F  PE+    + 
Sbjct: 143 NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEG-KP 201

Query: 297 YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSKFI 356
             Y  DMWS+G +   ++    P F G ++ + L  +         C+       +S   
Sbjct: 202 VGYYTDMWSVGVLSYILLSGLSP-FGGENDDETLRNVKS-------CDWNMDDSAFSG-- 251

Query: 357 NADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRA 400
                  +S +  DF+ KLL  D   R+T  +A+ HP+     A
Sbjct: 252 -------ISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNA 288

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  181 bits (459), Expect = 3e-54
 Identities = 85/313 (27%), Positives = 156/313 (49%), Gaps = 26/313 (8%)

Query: 111 YWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK-----PVKKKK 165
           ++  E     W  +  Y  ++ VG G Y  V   ++  T  +  IK L       +  K+
Sbjct: 4   FYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKR 63

Query: 166 IKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS----LIFEYVNSTDFKVL-YPTLTDYD 220
             RE+++L+++    NV+ LLD+     +        L+  ++ +   K++ +  L +  
Sbjct: 64  AYRELRLLKHMRH-ENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDR 122

Query: 221 IRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRV 280
           I++ +Y++LK L Y H+ GI+HRD+KP N+ ++ +    +++D+GLA       E    V
Sbjct: 123 IQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCEL-KILDFGLA--RQADSEMTGYV 179

Query: 281 ASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDC--- 337
            +R+++ PE++++   Y  ++D+WS+GC+ A MI  K  F  G D+ DQL +I K     
Sbjct: 180 VTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLF-KGSDHLDQLKEIMKVTGTP 238

Query: 338 --CLIIWCNSRHSRKPWSKFINADNQHL------VSPEAIDFLDKLLRYDHQDRLTAREA 389
               +    S  ++         + +         SP A++ L+K+L  D + R+TA EA
Sbjct: 239 PAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEA 298

Query: 390 MAHPYFAQVRAAE 402
           +AHPYF  +   E
Sbjct: 299 LAHPYFESLHDTE 311

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  177 bits (451), Expect = 9e-54
 Identities = 66/283 (23%), Positives = 117/283 (41%), Gaps = 32/283 (11%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK----KKKIKREIKILQNLCGGP 180
           +D+++V+ +G G Y EV   +N  T E   +KI+   +     + IK+EI I + L    
Sbjct: 5   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML-NHE 63

Query: 181 NVVKLLDIVRDQHSKTPSLIFEYV-NSTDFKVLYP--TLTDYDIRYYIYELLKALDYCHS 237
           NVVK     R        L  EY      F  + P   + + D + + ++L+  + Y H 
Sbjct: 64  NVVKFYGHRR--EGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 121

Query: 238 QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDL 294
            GI HRD+KP N+++D     L++ D+GLA  +         N    +  +  PELL   
Sbjct: 122 IGITHRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 180

Query: 295 QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSK 354
           + +   +D+WS G +   M+  +   +    +  Q            W   +    PW K
Sbjct: 181 EFHAEPVDVWSCGIVLTAMLAGE-LPWDQPSDSCQEYS--------DWKEKKTYLNPWKK 231

Query: 355 FINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQ 397
                    +    +  L K+L  +   R+T  +     ++ +
Sbjct: 232 ---------IDSAPLALLHKILVENPSARITIPDIKKDRWYNK 265

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  177 bits (450), Expect = 8e-53
 Identities = 88/314 (28%), Positives = 152/314 (48%), Gaps = 27/314 (8%)

Query: 107 RPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK-----PV 161
           RP  ++  E     W   + Y+ +  VG G Y  V    +  T  R  +K L       +
Sbjct: 1   RP-TFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII 59

Query: 162 KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHS---KTPSLIFEYVNSTDFKVLY--PTL 216
             K+  RE+++L+++    NV+ LLD+     S        +  ++   D   +     L
Sbjct: 60  HAKRTYRELRLLKHMKH-ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 118

Query: 217 TDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY 276
           TD  +++ IY++L+ L Y HS  I+HRD+KP N+ ++ +    +++D+GLA   H   E 
Sbjct: 119 TDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCEL-KILDFGLA--RHTDDEM 175

Query: 277 NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK- 335
              VA+R+++ PE++++   Y+ ++D+WS+GC+ A ++  +  F  G D+ DQL  I + 
Sbjct: 176 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF-PGTDHIDQLKLILRL 234

Query: 336 ----------DCCLIIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLT 385
                             N   S     K   A+     +P A+D L+K+L  D   R+T
Sbjct: 235 VGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRIT 294

Query: 386 AREAMAHPYFAQVR 399
           A +A+AH YFAQ  
Sbjct: 295 AAQALAHAYFAQYH 308

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  176 bits (446), Expect = 1e-52
 Identities = 86/302 (28%), Positives = 141/302 (46%), Gaps = 34/302 (11%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKK-----IKREIKILQNLCGG 179
             YE + K+G+G + EVF+  +  T ++  +K +    +K+       REIKILQ L   
Sbjct: 10  SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLL-KH 68

Query: 180 PNVVKLLDIVRDQHSK------TPSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLK 230
            NVV L++I R + S       +  L+F++       +L       T  +I+  +  LL 
Sbjct: 69  ENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLN 128

Query: 231 ALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE-----YNVRVASRYF 285
            L Y H   I+HRD+K  NV+I  +   L+L D+GLA  +   K      Y  RV + ++
Sbjct: 129 GLYYIHRNKILHRDMKAANVLITRDGV-LKLADFGLARAFSLAKNSQPNRYTNRVVTLWY 187

Query: 286 KGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDC-------- 337
           + PELL+  +DY   +D+W  GC+ A M  R  P   G+    QL  I++ C        
Sbjct: 188 RPPELLLGERDYGPPIDLWGAGCIMAEMWTRS-PIMQGNTEQHQLALISQLCGSITPEVW 246

Query: 338 ----CLIIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHP 393
                  ++      +    K  +    ++  P A+D +DKLL  D   R+ + +A+ H 
Sbjct: 247 PNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHD 306

Query: 394 YF 395
           +F
Sbjct: 307 FF 308

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  174 bits (442), Expect = 2e-52
 Identities = 63/280 (22%), Positives = 121/280 (43%), Gaps = 36/280 (12%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK------KKKIKREIKILQNLCG 178
           +D+E+ R +G+GK+  V+      +     +K+L   +      + +++RE++I  +L  
Sbjct: 6   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65

Query: 179 GPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL---YPTLTDYDIRYYIYELLKALDYC 235
            PN+++L     D       LI EY                 +     YI EL  AL YC
Sbjct: 66  -PNILRLYGYFHDATR--VYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYC 122

Query: 236 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQ 295
           HS+ ++HRD+KP N+++      L++ D+G +  + P         +  +  PE++   +
Sbjct: 123 HSKRVIHRDIKPENLLLGSAGE-LKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMIEG-R 179

Query: 296 DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSKF 355
            +D  +D+WSLG +    +  K P F  +   +   +I++                    
Sbjct: 180 MHDEKVDLWSLGVLCYEFLVGKPP-FEANTYQETYKRISR-------------------- 218

Query: 356 INADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF 395
           +       V+  A D + +LL+++   R   RE + HP+ 
Sbjct: 219 VEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 258

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  174 bits (442), Expect = 3e-52
 Identities = 84/294 (28%), Positives = 156/294 (53%), Gaps = 24/294 (8%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKK-----IKREIKILQNLCGG 179
           ++++ V K+G G Y  V++  N  T E   +K ++   + +       REI +L+ L   
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH- 60

Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL----YPTLTDYDIRYYIYELLKALDYC 235
           PN+VKLLD++  ++     L+FE+++    K +       +    I+ Y+++LL+ L +C
Sbjct: 61  PNIVKLLDVIHTENKLY--LVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 118

Query: 236 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH-PGKEYNVRVASRYFKGPELLVDL 294
           HS  ++HRD+KP N++I+ E   ++L D+GLA  +  P + Y   V + +++ PE+L+  
Sbjct: 119 HSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGC 177

Query: 295 QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDC---------CLIIWCNS 345
           + Y  ++D+WSLGC+FA M+ R+   F G    DQL +I +            +    + 
Sbjct: 178 KYYSTAVDIWSLGCIFAEMVTRRAL-FPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 236

Query: 346 RHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVR 399
           + S   W++   +     +  +    L ++L YD   R++A+ A+AHP+F  V 
Sbjct: 237 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVT 290

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  174 bits (441), Expect = 5e-52
 Identities = 81/295 (27%), Positives = 143/295 (48%), Gaps = 25/295 (8%)

Query: 128 EVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKK--------KKIKREIKILQNLCGG 179
           E +  +G G+++ V++  + NTN+   IK +K   +        +   REIK+LQ L   
Sbjct: 1   EKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSH- 59

Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCH 236
           PN++ LLD     H    SL+F+++ +    ++      LT   I+ Y+   L+ L+Y H
Sbjct: 60  PNIIGLLDA--FGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLH 117

Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDLQ 295
              I+HRD+KP+N+++D     L+L D+GLA  F  P + Y  +V +R+++ PELL   +
Sbjct: 118 QHWILHRDLKPNNLLLDENGV-LKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGAR 176

Query: 296 DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK--------DCCLIIWCNSRH 347
            Y   +DMW++GC+ A ++ R  PF  G  + DQL +I +            +       
Sbjct: 177 MYGVGVDMWAVGCILAELLLRV-PFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYV 235

Query: 348 SRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAE 402
           + K +              + +D +  L  ++   R+TA +A+   YF+      
Sbjct: 236 TFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPT 290

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  172 bits (436), Expect = 2e-51
 Identities = 81/293 (27%), Positives = 144/293 (49%), Gaps = 22/293 (7%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKK-----IKREIKILQNLCGG 179
             YE + K+G G Y  VF+  N  T+E   +K ++     +       REI +L+ L   
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKH- 60

Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNST---DFKVLYPTLTDYDIRYYIYELLKALDYCH 236
            N+V+L D++        +L+FE+ +      F      L    ++ ++++LLK L +CH
Sbjct: 61  KNIVRLHDVLHSDK--KLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCH 118

Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDLQ 295
           S+ ++HRD+KP N++I+      +L ++GLA  F  P + Y+  V + +++ P++L   +
Sbjct: 119 SRNVLHRDLKPQNLLINRNGEL-KLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAK 177

Query: 296 DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK-------DCCLIIWCNSRHS 348
            Y  S+DMWS GC+FA +     P F G+D  DQL +I +       +    +     + 
Sbjct: 178 LYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYK 237

Query: 349 RKPWSKFINADNQHL--VSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVR 399
             P      +    +  ++    D L  LL+ +   R++A EA+ HPYF+   
Sbjct: 238 PYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFC 290

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  171 bits (435), Expect = 4e-51
 Identities = 65/286 (22%), Positives = 121/286 (42%), Gaps = 29/286 (10%)

Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP---VKKKKIKREIKILQNLCGGP 180
           +  Y    K+G+G    V+  ++V T +   I+ +      KK+ I  EI +++     P
Sbjct: 19  KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMREN-KNP 77

Query: 181 NVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYP--TLTDYDIRYYIYELLKALDYCHSQ 238
           N+V  LD           ++ EY+       +     + +  I     E L+AL++ HS 
Sbjct: 78  NIVNYLDSYLVG--DELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSN 135

Query: 239 GIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDLQDY 297
            ++HRD+K  N+++  +   ++L D+G   +      + +  V + Y+  PE++   + Y
Sbjct: 136 QVIHRDIKSDNILLGMDGS-VKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR-KAY 193

Query: 298 DYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSKFIN 357
              +D+WSLG M   MI  + P +   +    L  IA         N     +   K   
Sbjct: 194 GPKVDIWSLGIMAIEMIEGEPP-YLNENPLRALYLIAT--------NGTPELQNPEK--- 241

Query: 358 ADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAES 403
                 +S    DFL++ L  D + R +A+E + H +    +   S
Sbjct: 242 ------LSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIAKPLSS 281

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  171 bits (434), Expect = 6e-51
 Identities = 73/290 (25%), Positives = 127/290 (43%), Gaps = 30/290 (10%)

Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP----VKKKKIKREIKILQNLCGG 179
           +D Y+    +G G +SEV    +  T +   IK +       K+  ++ EI +L  +   
Sbjct: 8   RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKI-KH 66

Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNSTD-FKVLY--PTLTDYDIRYYIYELLKALDYCH 236
           PN+V L DI          LI + V+  + F  +      T+ D    I+++L A+ Y H
Sbjct: 67  PNIVALDDIYESG--GHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLH 124

Query: 237 SQGIMHRDVKPHNVMIDH--ELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDL 294
             GI+HRD+KP N++     E  K+ + D+GL++   PG   +    +  +  PE+L   
Sbjct: 125 DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQ- 183

Query: 295 QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSK 354
           + Y  ++D WS+G +   ++    PF Y  ++     +I K                W  
Sbjct: 184 KPYSKAVDCWSIGVIAYILLCGYPPF-YDENDAKLFEQILK-------AEYEFDSPYWDD 235

Query: 355 FINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAESS 404
                    +S  A DF+  L+  D + R T  +A+ HP+ A   A + +
Sbjct: 236 ---------ISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAGDTALDKN 276

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  170 bits (431), Expect = 1e-50
 Identities = 83/291 (28%), Positives = 146/291 (50%), Gaps = 24/291 (8%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK-----KKKIKREIKILQNLCGG 179
           + Y  + K+G G Y  V++  N N  E   +K ++  K          REI IL+ L   
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKH- 59

Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL---YPTLTDYDIRYYIYELLKALDYCH 236
            N+VKL D++  +      L+FE+++    K+L      L     + ++ +LL  + YCH
Sbjct: 60  SNIVKLYDVIHTKKRLV--LVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH 117

Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH-PGKEYNVRVASRYFKGPELLVDLQ 295
            + ++HRD+KP N++I+ E   L++ D+GLA  +  P ++Y   + + +++ P++L+  +
Sbjct: 118 DRRVLHRDLKPQNLLINREGE-LKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSK 176

Query: 296 DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK---DCCLIIWCNSRHSRKPW 352
            Y  ++D+WS+GC+FA M+    P F G    DQL++I +         W N     K  
Sbjct: 177 KYSTTIDIWSVGCIFAEMVNGT-PLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYD 235

Query: 353 SKFINADNQHL------VSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQ 397
             F   +          +    ID L K+L+ D   R+TA++A+ H YF +
Sbjct: 236 PNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  170 bits (431), Expect = 2e-50
 Identities = 85/302 (28%), Positives = 144/302 (47%), Gaps = 35/302 (11%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCI-IKILKPVK-----KKKIKREIKILQNLCG 178
             YE V ++G G Y +VF+  ++    R + +K ++             RE+ +L++L  
Sbjct: 7   QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLET 66

Query: 179 G--PNVVKLLDIVRDQHSKTPS---LIFEYVNSTDFKVLY----PTLTDYDIRYYIYELL 229
              PNVV+L D+     +   +   L+FE+V+      L     P +    I+  +++LL
Sbjct: 67  FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLL 126

Query: 230 KALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 289
           + LD+ HS  ++HRD+KP N+++    +  +L D+GLA  Y         V + +++ PE
Sbjct: 127 RGLDFLHSHRVVHRDLKPQNILVTSSGQI-KLADFGLARIYSFQMALTSVVVTLWYRAPE 185

Query: 290 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI------------AKDC 337
           +L+    Y   +D+WS+GC+FA M  RK P F G  + DQL KI             +D 
Sbjct: 186 VLLQ-SSYATPVDLWSVGCIFAEMFRRK-PLFRGSSDVDQLGKILDVIGLPGEEDWPRDV 243

Query: 338 CLIIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQ 397
            L        S +P  KF+       +     D L K L ++   R++A  A++HPYF  
Sbjct: 244 ALPRQAFHSKSAQPIEKFVTD-----IDELGKDLLLKCLTFNPAKRISAYSALSHPYFQD 298

Query: 398 VR 399
           + 
Sbjct: 299 LE 300

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  170 bits (432), Expect = 2e-50
 Identities = 68/286 (23%), Positives = 121/286 (42%), Gaps = 37/286 (12%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKK------KKIKREIKILQNLCG 178
             +  +R++G G +  V+   +V  +E   IK +    K      + I +E++ LQ L  
Sbjct: 15  KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRH 74

Query: 179 GPNVVKLLDIVRDQHSKTPSLIFEYVNST---DFKVLYPTLTDYDIRYYIYELLKALDYC 235
            PN ++       +H  T  L+ EY   +     +V    L + +I    +  L+ L Y 
Sbjct: 75  -PNTIQYRGCYLREH--TAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYL 131

Query: 236 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQ 295
           HS  ++HRDVK  N+++      ++L D+G A    P   +   V + Y+  PE+++ + 
Sbjct: 132 HSHNMIHRDVKAGNILLSEPGL-VKLGDFGSASIMAPANSF---VGTPYWMAPEVILAMD 187

Query: 296 D--YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWS 353
           +  YD  +D+WSLG     +  RK P F   +    L  IA++                 
Sbjct: 188 EGQYDGKVDVWSLGITCIELAERKPPLF-NMNAMSALYHIAQN--------------ESP 232

Query: 354 KFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVR 399
              +       S    +F+D  L+   QDR T+   + H +  + R
Sbjct: 233 ALQSGH----WSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRER 274

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  165 bits (420), Expect = 3e-49
 Identities = 65/288 (22%), Positives = 118/288 (40%), Gaps = 41/288 (14%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK-----PVKKKKIKREIKILQNLCGG 179
           +DYEV+  +G G Y    +    +  +  + K L        +K+ +  E+ +L+ L   
Sbjct: 4   EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELK-H 62

Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNSTD-FKVLY------PTLTDYDIRYYIYELLKAL 232
           PN+V+  D + D+ + T  ++ EY    D   V+         L +  +   + +L  AL
Sbjct: 63  PNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 122

Query: 233 DYCHSQG-----IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY-NVRVASRYFK 286
             CH +      ++HRD+KP NV +D +   ++L D+GLA   +    +    V + Y+ 
Sbjct: 123 KECHRRSDGGHTVLHRDLKPANVFLDGKQN-VKLGDFGLARILNHDTSFAKAFVGTPYYM 181

Query: 287 GPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSR 346
            PE +     Y+   D+WSLGC+   +     P F      +   KI            +
Sbjct: 182 SPEQMNR-MSYNEKSDIWSLGCLLYELCALMPP-FTAFSQKELAGKI---------REGK 230

Query: 347 HSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPY 394
             R P+            S E  + + ++L      R +  E + +P 
Sbjct: 231 FRRIPYR----------YSDELNEIITRMLNLKDYHRPSVEEILENPL 268

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  162 bits (411), Expect = 1e-47
 Identities = 68/289 (23%), Positives = 130/289 (44%), Gaps = 36/289 (12%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK---------KKKIKREIKILQN 175
           D Y+   ++G G+++ V +    +T  +   K +K  +         ++ I+RE+ IL+ 
Sbjct: 10  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69

Query: 176 LCGGPNVVKLLDIVRDQHSKTPSLIFEYVNST---DFKVLYPTLTDYDIRYYIYELLKAL 232
           +   PNV+ L ++  ++      LI E V      DF     +LT+ +   ++ ++L  +
Sbjct: 70  IQH-PNVITLHEVYENKTD--VILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGV 126

Query: 233 DYCHSQGIMHRDVKPHNVMIDHE---LRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 289
            Y HS  I H D+KP N+M+        ++++ID+GLA     G E+     +  F  PE
Sbjct: 127 YYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPE 186

Query: 290 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSR 349
           ++ + +      DMWS+G +   ++    PF  G    + L  ++         N     
Sbjct: 187 IV-NYEPLGLEADMWSIGVITYILLSGASPF-LGDTKQETLANVSA-------VNYEFED 237

Query: 350 KPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQV 398
           + +S           S  A DF+ +LL  D + R+T ++++ HP+    
Sbjct: 238 EYFSN---------TSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPK 277

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  161 bits (407), Expect = 3e-47
 Identities = 65/295 (22%), Positives = 115/295 (38%), Gaps = 44/295 (14%)

Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK---------KKKIKREIKILQ 174
           +  Y+V   +G G +  V+ GI V+ N    IK ++  +           ++  E+ +L+
Sbjct: 3   ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLK 62

Query: 175 NLCGG-PNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY----PTLTDYDIRYYIYELL 229
            +  G   V++LLD      S    LI E          +      L +   R + +++L
Sbjct: 63  KVSSGFSGVIRLLDWFERPDSFV--LILERPEPVQDLFDFITERGALQEELARSFFWQVL 120

Query: 230 KALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 289
           +A+ +CH+ G++HRD+K  N++ID    +L+LID+G          Y     +R +  PE
Sbjct: 121 EAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKD-TVYTDFDGTRVYSPPE 179

Query: 290 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSR 349
            +   + +  S  +WSLG +   M+    PF +  +     V   +              
Sbjct: 180 WIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQR------------- 226

Query: 350 KPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAESS 404
                         VS E    +   L     DR T  E   HP+   V   + +
Sbjct: 227 --------------VSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQET 267

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  163 bits (412), Expect = 3e-47
 Identities = 68/317 (21%), Positives = 142/317 (44%), Gaps = 35/317 (11%)

Query: 110 EYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK-----PVKKK 164
           +++  E     +     Y+ ++ +G G    V    +   +    IK L          K
Sbjct: 2   QFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAK 61

Query: 165 KIKREIKILQNLCGGPNVVKLLDIVRDQHS----KTPSLIFEYVNSTDFKVLYPTLTDYD 220
           +  RE+ +++ +    N++ LL++   Q +    +   L+ E +++   +V+   L    
Sbjct: 62  RAYRELVLMKCVNH-KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHER 120

Query: 221 IRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRV 280
           + Y +Y++L  + + HS GI+HRD+KP N+++  +    +++D+GLA            V
Sbjct: 121 MSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTL-KILDFGLARTAGTSFMMTPYV 179

Query: 281 ASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCL- 339
            +RY++ PE+++    Y  ++D+WS+GC+   M+  K   F G D  DQ  K+ +     
Sbjct: 180 VTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMVRHK-ILFPGRDYIDQWNKVIEQLGTP 237

Query: 340 --------------IIWCNSRHSRKPWSKFI-------NADNQHLVSPEAIDFLDKLLRY 378
                          +    +++   + K         ++++  L + +A D L K+L  
Sbjct: 238 CPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVI 297

Query: 379 DHQDRLTAREAMAHPYF 395
           D   R++  +A+ HPY 
Sbjct: 298 DPAKRISVDDALQHPYI 314

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  160 bits (407), Expect = 4e-47
 Identities = 73/292 (25%), Positives = 125/292 (42%), Gaps = 44/292 (15%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCG 178
           +D++  + +G G +S V     + T+    IKIL+        K   + RE  ++  L  
Sbjct: 8   EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 67

Query: 179 GPNVVKLLDIVRDQHSKTPSLIFEYVNSTD---FKVLYPTLTDYDIRYYIYELLKALDYC 235
            P  VKL    +D           Y  + +   +     +  +   R+Y  E++ AL+Y 
Sbjct: 68  -PFFVKLYFTFQDDEK--LYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYL 124

Query: 236 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY---NVRVASRYFKGPELLV 292
           H +GI+HRD+KP N++++ ++  +++ D+G A+   P  +    N  V +  +  PELL 
Sbjct: 125 HGKGIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLT 183

Query: 293 DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPW 352
           + +    S D+W+LGC+   ++    P F   + +    KI K                 
Sbjct: 184 E-KSACKSSDLWALGCIIYQLVAGLPP-FRAGNEYLIFQKIIKL-----------EYDFP 230

Query: 353 SKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREA------MAHPYFAQV 398
            KF          P+A D ++KLL  D   RL   E        AHP+F  V
Sbjct: 231 EKF---------FPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV 273

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  159 bits (402), Expect = 1e-46
 Identities = 56/281 (19%), Positives = 118/281 (41%), Gaps = 34/281 (12%)

Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK-----KKKIKREIKILQNLCGGPN 181
            +   ++GRG +  V++G++  T        L+  K     +++ K E ++L+ L   PN
Sbjct: 11  LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQH-PN 69

Query: 182 VVKLLDIVRD--QHSKTPSLIFEYVNSTDFKVL---YPTLTDYDIRYYIYELLKALDYCH 236
           +V+  D      +  K   L+ E + S   K     +  +    +R +  ++LK L + H
Sbjct: 70  IVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLH 129

Query: 237 SQG--IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDL 294
           ++   I+HRD+K  N+ I      +++ D GLA          V + +  F  PE+    
Sbjct: 130 TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAV-IGTPEFMAPEMY--E 186

Query: 295 QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSK 354
           + YD S+D+++ G     M   + P +    N  Q+ +        +    + +      
Sbjct: 187 EKYDESVDVYAFGMCMLEMATSEYP-YSECQNAAQIYR-------RVTSGVKPASFD--- 235

Query: 355 FINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF 395
                   +  PE  + ++  +R +  +R + ++ + H +F
Sbjct: 236 -------KVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFF 269

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  159 bits (403), Expect = 8e-46
 Identities = 67/290 (23%), Positives = 119/290 (41%), Gaps = 38/290 (13%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK------KKKIKREIKILQNLCG 178
           +D+ V R +GRG + EV+     +T +   +K L   +      +     E  +L  +  
Sbjct: 4   NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63

Query: 179 G--PNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL---YPTLTDYDIRYYIYELLKALD 233
           G  P +V +            S I + +N  D       +   ++ D+R+Y  E++  L+
Sbjct: 64  GDCPFIVCMSYAFHTPDK--LSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLE 121

Query: 234 YCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD 293
           + H++ +++RD+KP N+++D     +R+ D GLA  +   K +     +  +  PE+L  
Sbjct: 122 HMHNRFVVYRDLKPANILLDEHGH-VRISDLGLACDFSKKKPHASV-GTHGYMAPEVLQK 179

Query: 294 LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWS 353
              YD S D +SLGCM   ++    P F  H   D+         + +            
Sbjct: 180 GVAYDSSADWFSLGCMLFKLLRGHSP-FRQHKTKDKHEIDRMTLTMAVELPDS------- 231

Query: 354 KFINADNQHLVSPEAIDFLDKLLRYDHQDRLT-----AREAMAHPYFAQV 398
                      SPE    L+ LL+ D   RL      A+E    P+F  +
Sbjct: 232 ----------FSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSL 271

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  158 bits (400), Expect = 8e-46
 Identities = 63/285 (22%), Positives = 120/285 (42%), Gaps = 36/285 (12%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK------KKKIKREIKILQNLCG 178
           +D+ + + +G+G + +VF      TN+   IK LK          +    E ++L     
Sbjct: 2   EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61

Query: 179 GPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL---YPTLTDYDIRYYIYELLKALDYC 235
            P +  +    + + +     + EY+N  D                 +Y  E++  L + 
Sbjct: 62  HPFLTHMFCTFQTKEN--LFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFL 119

Query: 236 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDL 294
           HS+GI++RD+K  N+++D +    ++ D+G+  E      + N    +  +  PE+L+  
Sbjct: 120 HSKGIVYRDLKLDNILLDKDGHI-KIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLG- 177

Query: 295 QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSK 354
           Q Y++S+D WS G +   M+  + P F+G D  +    I            R     + +
Sbjct: 178 QKYNHSVDWWSFGVLLYEMLIGQSP-FHGQDEEELFHSI------------RMDNPFYPR 224

Query: 355 FINADNQHLVSPEAIDFLDKLLRYDHQDRLTAR-EAMAHPYFAQV 398
           ++          EA D L KL   + + RL  R +   HP F ++
Sbjct: 225 WL--------EKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREI 261

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  143 bits (362), Expect = 9e-41
 Identities = 55/284 (19%), Positives = 103/284 (36%), Gaps = 33/284 (11%)

Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK------PVKKKKIKREIKILQNLC 177
            D YE+   +G G  SEV    ++  +    +K+L+      P    + +RE +    L 
Sbjct: 6   SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAAL- 64

Query: 178 GGPNVVKLLDIVRDQHSKTPS--LIFEYVNSTDFKVL---YPTLTDYDIRYYIYELLKAL 232
             P +V + D    +    P   ++ EYV+    + +      +T       I +  +AL
Sbjct: 65  NHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQAL 124

Query: 233 DYCHSQGIMHRDVKPHNVMIDHELR---KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 289
           ++ H  GI+HRDVKP N+MI            I   +A+  +   +    + +  +  PE
Sbjct: 125 NFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPE 184

Query: 290 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSR 349
                   D   D++SLGC+   ++  + P F G        +        +  +     
Sbjct: 185 QARG-DSVDARSDVYSLGCVLYEVLTGEPP-FTGDSPVSVAYQ-------HVREDPIPPS 235

Query: 350 KPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHP 393
                         +S +    + K L  + ++R      M   
Sbjct: 236 ARHEG---------LSADLDAVVLKALAKNPENRYQTAAEMRAD 270

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  145 bits (366), Expect = 1e-40
 Identities = 58/286 (20%), Positives = 113/286 (39%), Gaps = 35/286 (12%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK------KKKIKREIKILQNLCG 178
           +D++ ++ +G+G + +V       T     +KIL+               E ++LQN   
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64

Query: 179 GPNVVKLLDIVRD-QHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHS 237
            P +  L    +                           T+   R+Y  E++ AL+Y HS
Sbjct: 65  -PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHS 123

Query: 238 QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDY 297
           + +++RD+K  N+M+D +   +++ D+GL +                      +++  DY
Sbjct: 124 RDVVYRDIKLENLMLDKDGH-IKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDY 182

Query: 298 DYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSKFIN 357
             ++D W LG +   M+  + PF+  + +H++L ++     +                  
Sbjct: 183 GRAVDWWGLGVVMYEMMCGRLPFY--NQDHERLFELILMEEIRFPRT------------- 227

Query: 358 ADNQHLVSPEAIDFLDKLLRYDHQDRL-----TAREAMAHPYFAQV 398
                 +SPEA   L  LL+ D + RL      A+E M H +F  +
Sbjct: 228 ------LSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSI 267

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  144 bits (363), Expect = 2e-40
 Identities = 58/293 (19%), Positives = 126/293 (43%), Gaps = 37/293 (12%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINV---NTNERCIIKILKPVK-------KKKIKREIKILQ 174
           +++E+++ +G G Y +VF    +   +T +   +K+LK           +  + E ++L+
Sbjct: 24  ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83

Query: 175 NLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL-YPTLTDYDIRYYIYELLKALD 233
           ++   P +V L    + +      L +         +      T+++++ Y+ E++ AL+
Sbjct: 84  HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALE 143

Query: 234 YCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE---YNVRVASRYFKGPEL 290
           + H  GI++RD+K  N+++D     + L D+GL++ +   +    Y+      Y     +
Sbjct: 144 HLHKLGIIYRDIKLENILLDSNGH-VVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIV 202

Query: 291 LVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRK 350
                 +D ++D WSLG +   ++    P F      +   +I++            S  
Sbjct: 203 RGGDSGHDKAVDWWSLGVLMYELLTGASP-FTVDGEKNSQAEISR--------RILKSEP 253

Query: 351 PWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRL-----TAREAMAHPYFAQV 398
           P+ + +        S  A D + +LL  D + RL      A E   H +F ++
Sbjct: 254 PYPQEM--------SALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKI 298

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  144 bits (363), Expect = 2e-40
 Identities = 57/288 (19%), Positives = 115/288 (39%), Gaps = 42/288 (14%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK------PVKKKKIKREIKILQNLCG 178
            D++++R +G G +  V    + +      +K+LK        + +    E  +L  +  
Sbjct: 4   QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIV-T 62

Query: 179 GPNVVKLLDIVRDQHSKTPSLIFEYVNST---DFKVLYPTLTDYDIRYYIYELLKALDYC 235
            P ++++    +D        I +Y+                +   ++Y  E+  AL+Y 
Sbjct: 63  HPFIIRMWGTFQDAQQIFM--IMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYL 120

Query: 236 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQ 295
           HS+ I++RD+KP N+++D     +++ D+G A++            +  +  PE++   +
Sbjct: 121 HSKDIIYRDLKPENILLDKNGH-IKITDFGFAKYVP--DVTYTLCGTPDYIAPEVVST-K 176

Query: 296 DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSKF 355
            Y+ S+D WS G +   M+    P FY  +      KI          N+     P+   
Sbjct: 177 PYNKSIDWWSFGILIYEMLAGYTP-FYDSNTMKTYEKI---------LNAELRFPPF--- 223

Query: 356 INADNQHLVSPEAIDFLDKLLRYDHQDRL-----TAREAMAHPYFAQV 398
                    + +  D L +L+  D   RL        +   HP+F +V
Sbjct: 224 --------FNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEV 263

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  142 bits (359), Expect = 3e-40
 Identities = 42/284 (14%), Positives = 109/284 (38%), Gaps = 37/284 (13%)

Query: 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK-----PVKKKKIKREIKILQNLC 177
                 V +++G G +  V++G     +    +K+L      P + +  K E+ +L+   
Sbjct: 6   PDGQITVGQRIGSGSFGTVYKGK---WHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTR 62

Query: 178 GGPNVVKLLDIVRDQHSKTPSLIFEYVNSTD-FKVLY---PTLTDYDIRYYIYELLKALD 233
              N++  +           +++ ++   +  +  L+          +     +  + +D
Sbjct: 63  H-VNILLFMGYSTAPQ---LAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMD 118

Query: 234 YCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR---VASRYFKGPEL 290
           Y H++ I+HRD+K +N+ +  +L  +++ D+GLA         +       S  +  PE+
Sbjct: 119 YLHAKSIIHRDLKSNNIFLHEDLT-VKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEV 177

Query: 291 LVDLQD--YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHS 348
           +       Y +  D+++ G +   ++  + P +   +N DQ++ +            R  
Sbjct: 178 IRMQDKNPYSFQSDVYAFGIVLYELMTGQLP-YSNINNRDQIIFMVG----------RGY 226

Query: 349 RKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH 392
             P    + ++            + + L+    +R    + +A 
Sbjct: 227 LSPDLSKVRSN----CPKAMKRLMAECLKKKRDERPLFPQILAS 266

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  141 bits (356), Expect = 4e-39
 Identities = 57/286 (19%), Positives = 112/286 (39%), Gaps = 38/286 (13%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIK------REIKILQNLCG 178
           D ++ ++ +G G +  V    +  +     +KIL   K  K+K       E +ILQ +  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-N 99

Query: 179 GPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL-YPTLTDYDIRYYIYELLKALDYCHS 237
            P +VKL    +D  +    + +         +      ++   R+Y  +++   +Y HS
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159

Query: 238 QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDY 297
             +++RD+KP N++ID +   +++ D+G A+             +     PE+++  + Y
Sbjct: 160 LDLIYRDLKPENLLIDQQGY-IQVTDFGFAKRVKG--RTWTLCGTPEALAPEIILS-KGY 215

Query: 298 DYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSKFIN 357
           + ++D W+LG +   M     PFF   D   Q+ +      +    +             
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPFF--ADQPIQIYEKIVSGKVRFPSH------------- 260

Query: 358 ADNQHLVSPEAIDFLDKLLRYDHQDRL-----TAREAMAHPYFAQV 398
                  S +  D L  LL+ D   R         +   H +FA  
Sbjct: 261 ------FSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATT 300

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  138 bits (349), Expect = 5e-39
 Identities = 38/276 (13%), Positives = 99/276 (35%), Gaps = 33/276 (11%)

Query: 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK-PVKKKKIKREIKILQNLCGGPN 181
           +  + ++++ +G+G++ +V  G       +  +K +K     +    E  ++  L    N
Sbjct: 5   NMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQLRH-SN 61

Query: 182 VVKLLDIVRDQHSKTPSLIFEYV-NSTDFKVLY----PTLTDYDIRYYIYELLKALDYCH 236
           +V+LL ++ ++      ++ EY+   +    L       L    +  +  ++ +A++Y  
Sbjct: 62  LVQLLGVIVEEKGG-LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE 120

Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD 296
               +HRD+   NV++  +    ++ D+GL +     +  +       +  PE L + + 
Sbjct: 121 GNNFVHRDLAARNVLVSEDNV-AKVSDFGLTKEASSTQ--DTGKLPVKWTAPEALRE-KK 176

Query: 297 YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSKFI 356
           +    D+WS G +   +       +      D + ++ K   +                 
Sbjct: 177 FSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDG------------ 224

Query: 357 NADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH 392
                    P   + +      D   R +  +    
Sbjct: 225 -------CPPAVYEVMKNCWHLDAAMRPSFLQLREQ 253

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  138 bits (349), Expect = 2e-38
 Identities = 55/332 (16%), Positives = 111/332 (33%), Gaps = 68/332 (20%)

Query: 99  VYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNER-----C 153
            Y D         W++         +++ E  + +G G + +V        ++       
Sbjct: 19  FYVDFREYEYDLKWEF--------PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQV 70

Query: 154 IIKILK----PVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTD- 208
            +K+LK      +++ +  E+K++  L    N+V LL       S    LIFEY    D 
Sbjct: 71  AVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTL--SGPIYLIFEYCCYGDL 128

Query: 209 -------------------------FKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHR 243
                                     +     LT  D+  + Y++ K +++   +  +HR
Sbjct: 129 LNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHR 188

Query: 244 DVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR---VASRYFKGPELLVDLQDYDYS 300
           D+   NV++ H    +++ D+GLA        Y VR        +  PE L +   Y   
Sbjct: 189 DLAARNVLVTHGKV-VKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFE-GIYTIK 246

Query: 301 LDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSKFINADN 360
            D+WS G +   +       + G        K+ ++         +  +  +        
Sbjct: 247 SDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQN-------GFKMDQPFY-------- 291

Query: 361 QHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH 392
               + E    +     +D + R +     + 
Sbjct: 292 ---ATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  135 bits (342), Expect = 7e-38
 Identities = 43/283 (15%), Positives = 103/283 (36%), Gaps = 35/283 (12%)

Query: 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP--VKKKKIKREIKILQNLCGGP 180
            ++  ++V ++G G++ EV+ G   N + +  +K LK   +       E  +++ L    
Sbjct: 11  PRETLKLVERLGAGQFGEVWMGYY-NGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQH-Q 68

Query: 181 NVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY-----PTLTDYDIRYYIYELLKALDYC 235
            +V+L  +V  +      +I EY+ +              LT   +     ++ + + + 
Sbjct: 69  RLVRLYAVVTQEP---IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFI 125

Query: 236 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG-PELLVDL 294
             +  +HRD++  N+++   L   ++ D+GLA      +      A    K      ++ 
Sbjct: 126 EERNYIHRDLRAANILVSDTLSC-KIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINY 184

Query: 295 QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSK 354
             +    D+WS G +   ++      + G  N + +  + +   ++   N          
Sbjct: 185 GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDN---------- 234

Query: 355 FINADNQHLVSPEAIDFLDKLLRYDHQDRLTARE--AMAHPYF 395
                       E    +    +   +DR T     ++   +F
Sbjct: 235 ---------CPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 268

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  135 bits (340), Expect = 3e-37
 Identities = 44/295 (14%), Positives = 95/295 (32%), Gaps = 48/295 (16%)

Query: 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK------PVKKKKIKREIKILQNL 176
           D +D +    +G G + +V +        R    I +          +    E+++L  L
Sbjct: 8   DWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKL 67

Query: 177 CGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTD-------------------FKVLYPTLT 217
              PN++ LL     +H     L  EY    +                         TL+
Sbjct: 68  GHHPNIINLLGAC--EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLS 125

Query: 218 DYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN 277
              + ++  ++ + +DY   +  +HRD+   N+++       ++ D+GL+       +  
Sbjct: 126 SQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGEN-YVAKIADFGLSRGQEVYVKKT 184

Query: 278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDC 337
           +      +   E L     Y  + D+WS G +   ++      + G    +   K+ +  
Sbjct: 185 MGRLPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY 243

Query: 338 CLIIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH 392
            L    N                      E  D + +  R    +R +  + +  
Sbjct: 244 RLEKPLN-------------------CDDEVYDLMRQCWREKPYERPSFAQILVS 279

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  134 bits (338), Expect = 4e-37
 Identities = 45/290 (15%), Positives = 100/290 (34%), Gaps = 33/290 (11%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP-VKKKKIKREIKILQNLCGGPNVV 183
           + Y + RK+G G + +++ G ++   E   IK+     K  ++  E KI + + GG  + 
Sbjct: 7   NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIP 66

Query: 184 KLLDIVRDQHSKTPSLIFEYVNSTD---FKVLYPTLTDYDIRYYIYELLKALDYCHSQGI 240
            +     +       ++ E +  +    F       +   +     +++  ++Y HS+  
Sbjct: 67  TIRWCGAEGDY--NVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNF 124

Query: 241 MHRDVKPHNVMIDHELRKLRL--IDWGLAEFYHPGKEYNVR--------VASRYFKGPEL 290
           +HRDVKP N ++    +   +  ID+GLA+ Y   + +             +  +     
Sbjct: 125 IHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINT 184

Query: 291 LVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRK 350
            +   +     D+ SLG +           + G     +  K  +     +        K
Sbjct: 185 HLG-IEQSRRDDLESLGYVLMYFNLGS-LPWQGLKAATKRQKYERISEKKMSTPIEVLCK 242

Query: 351 PWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTA---REAMAHPYFAQ 397
            +              E   +L+        D+      R+   + +  Q
Sbjct: 243 GY------------PSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ 280

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  134 bits (337), Expect = 5e-37
 Identities = 47/285 (16%), Positives = 102/285 (35%), Gaps = 37/285 (12%)

Query: 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP--VKKKKIKREIKILQNLCGGP 180
            ++   +  K+G+G + EV+ G    T  R  IK LKP  +  +   +E ++++ L    
Sbjct: 15  PRESLRLEVKLGQGCFGEVWMGTWNGTT-RVAIKTLKPGTMSPEAFLQEAQVMKKLRH-E 72

Query: 181 NVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY-----PTLTDYDIRYYIYELLKALDYC 235
            +V+L  +V ++      ++ EY++               L    +     ++   + Y 
Sbjct: 73  KLVQLYAVVSEEP---IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYV 129

Query: 236 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY--NVRVASRYFKGPELLVD 293
                +HRD++  N+++   L   ++ D+GLA      +            +  PE  + 
Sbjct: 130 ERMNYVHRDLRAANILVGENLV-CKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY 188

Query: 294 LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWS 353
              +    D+WS G +   +  +    + G  N + L ++ +   +              
Sbjct: 189 -GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPE--------- 238

Query: 354 KFINADNQHLVSPEAIDFLDKLLRYDHQDRLTARE--AMAHPYFA 396
                           D + +  R + ++R T     A    YF 
Sbjct: 239 ----------CPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 273

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  132 bits (332), Expect = 1e-36
 Identities = 40/278 (14%), Positives = 97/278 (34%), Gaps = 33/278 (11%)

Query: 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP--VKKKKIKREIKILQNLCGGP 180
           D  +   V+++G G++  V  G  +N  ++  IK ++   + ++    E +++  L   P
Sbjct: 3   DPSELTFVQEIGSGQFGLVHLGYWLNK-DKVAIKTIREGAMSEEDFIEEAEVMMKLSH-P 60

Query: 181 NVVKLLDIVRDQHSKTPSLIFEYVNSTD----FKVLYPTLTDYDIRYYIYELLKALDYCH 236
            +V+L  +  +Q      L+FE++         +          +     ++ + + Y  
Sbjct: 61  KLVQLYGVCLEQAP--ICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE 118

Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR--VASRYFKGPELLVDL 294
              ++HRD+   N ++      +++ D+G+  F    +  +         +  PE+    
Sbjct: 119 EACVIHRDLAARNCLVGENQV-IKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSF- 176

Query: 295 QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSK 354
             Y    D+WS G +   +    +  +    N + +  I+    L               
Sbjct: 177 SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKP------------ 224

Query: 355 FINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH 392
                   L S      ++   +   +DR      +  
Sbjct: 225 -------RLASTHVYQIMNHCWKERPEDRPAFSRLLRQ 255

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  132 bits (332), Expect = 2e-36
 Identities = 43/284 (15%), Positives = 94/284 (33%), Gaps = 39/284 (13%)

Query: 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCI---IKILKPVK------KKKIKREIKIL 173
            + D  ++ K+G G +  V  G     + + +   +K LKP             RE+  +
Sbjct: 6   GEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAM 65

Query: 174 QNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY----PTLTDYDIRYYIYELL 229
            +L    N+++L  +V     K   ++ E                      +  Y  ++ 
Sbjct: 66  HSLDH-RNLIRLYGVVLTPPMK---MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVA 121

Query: 230 KALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR---VASRYFK 286
           + + Y  S+  +HRD+   N+++      +++ D+GL        ++ V        +  
Sbjct: 122 EGMGYLESKRFIHRDLAARNLLLATRDL-VKIGDFGLMRALPQNDDHYVMQEHRKVPFAW 180

Query: 287 GPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSR 346
                +  + + ++ D W  G     M    +  + G +    L KI K+         R
Sbjct: 181 CAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKE-------GER 233

Query: 347 HSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAM 390
             R                 +  + + +   +  +DR T     
Sbjct: 234 LPRPED-----------CPQDIYNVMVQCWAHKPEDRPTFVALR 266

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  131 bits (331), Expect = 2e-36
 Identities = 46/278 (16%), Positives = 105/278 (37%), Gaps = 33/278 (11%)

Query: 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP--VKKKKIKREIKILQNLCGGP 180
           D  D   ++++G G++  V  G          IK++K   + + +   E K++ NL    
Sbjct: 2   DPKDLTFLKELGTGQFGVVKYGKW-RGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSH-E 59

Query: 181 NVVKLLDIVRDQHSKTPSLIFEYV-NSTDFKVLY---PTLTDYDIRYYIYELLKALDYCH 236
            +V+L  +   Q  +   +I EY+ N      L           +     ++ +A++Y  
Sbjct: 60  KLVQLYGVCTKQ--RPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE 117

Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNV--RVASRYFKGPELLVDL 294
           S+  +HRD+   N +++ +   +++ D+GL+ +    +  +         +  PE+L+  
Sbjct: 118 SKQFLHRDLAARNCLVNDQGV-VKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMY- 175

Query: 295 QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSK 354
             +    D+W+ G +   +    +  +    N +    IA+   L               
Sbjct: 176 SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRP------------ 223

Query: 355 FINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH 392
                  HL S +    +         +R T +  +++
Sbjct: 224 -------HLASEKVYTIMYSCWHEKADERPTFKILLSN 254

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  133 bits (335), Expect = 4e-36
 Identities = 68/328 (20%), Positives = 127/328 (38%), Gaps = 50/328 (15%)

Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILK--PVKKKKIKREIKILQNL-------- 176
           Y +VRK+G G +S V+   ++  N    +KI++   V  +  + EIK+LQ +        
Sbjct: 15  YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKE 74

Query: 177 --CGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDF------KVLYPTLTDYDIRYYIYEL 228
              G  +++KLLD    +      ++  +    +       K  +  +    ++    +L
Sbjct: 75  DSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQL 134

Query: 229 LKALDYCH-SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVAS---RY 284
           L  LDY H   GI+H D+KP NV+++       LI   +A+  +          S   R 
Sbjct: 135 LLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTRE 194

Query: 285 FKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPF-----FYGHDNHDQLVKIAKDCCL 339
           ++ PE+L+    +    D+WS  C+   +I     F          + D + +I +    
Sbjct: 195 YRSPEVLLG-APWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGE 253

Query: 340 I---IWCNSRHSRK-----------------PWSKFINADNQHL--VSPEAIDFLDKLLR 377
           +   +  N +++R                  P    +    +     + E  DFL  +L+
Sbjct: 254 LPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQ 313

Query: 378 YDHQDRLTAREAMAHPYFAQVRAAESSR 405
            D + R  A   + HP+       E  R
Sbjct: 314 LDPRKRADAGGLVNHPWLKDTLGMEEIR 341

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  130 bits (327), Expect = 9e-36
 Identities = 52/282 (18%), Positives = 104/282 (36%), Gaps = 36/282 (12%)

Query: 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKK-------KKIKREIKILQN 175
            ++  E+ R +G G++ +V +GI ++     +   +K  K        +K  +E   ++ 
Sbjct: 5   QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQ 64

Query: 176 LCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYP----TLTDYDIRYYIYELLKA 231
               P++VKL+ ++ +       +I E     + +        +L    +  Y Y+L  A
Sbjct: 65  F-DHPHIVKLIGVITENP---VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTA 120

Query: 232 LDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNV-RVASRYFKGPEL 290
           L Y  S+  +HRD+   NV++      ++L D+GL+ +      Y   +           
Sbjct: 121 LAYLESKRFVHRDIAARNVLVSSNDC-VKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPE 179

Query: 291 LVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRK 350
            ++ + +  + D+W  G     ++      F G  N+D + +I     L +  N      
Sbjct: 180 SINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPN------ 233

Query: 351 PWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH 392
                          P     + K   YD   R    E  A 
Sbjct: 234 -------------CPPTLYSLMTKCWAYDPSRRPRFTELKAQ 262

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  130 bits (327), Expect = 2e-35
 Identities = 44/286 (15%), Positives = 93/286 (32%), Gaps = 39/286 (13%)

Query: 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKK-------KKIKREIKILQN 175
           D    ++ + +G G++ EV  G      +R I   +K +K        +    E  I+  
Sbjct: 24  DISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQ 83

Query: 176 LCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKA 231
               PNV+ L  +V         +I E++ +              T   +   +  +   
Sbjct: 84  FDH-PNVIHLEGVVTKST--PVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAG 140

Query: 232 LDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELL 291
           + Y      +HRD+   N++++  L   ++ D+GL+ F           ++   K P   
Sbjct: 141 MKYLADMNYVHRDLAARNILVNSNLV-CKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRW 199

Query: 292 VD-----LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSR 346
                   + +  + D+WS G +   ++   E  ++   N D +  I +D  L    +  
Sbjct: 200 TAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPPMD-- 257

Query: 347 HSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH 392
                                    +    + D   R    + +  
Sbjct: 258 -----------------CPSALHQLMLDCWQKDRNHRPKFGQIVNT 286

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  128 bits (323), Expect = 5e-35
 Identities = 41/276 (14%), Positives = 100/276 (36%), Gaps = 31/276 (11%)

Query: 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK--PVKKKKIKREIKILQNLCGGP 180
           ++ D  +  K+G G+Y EV+EG+    +    +K LK   ++ ++  +E  +++ +   P
Sbjct: 15  ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKH-P 73

Query: 181 NVVKLLDIVRDQHSKTPSLIFEYV-NSTDFKVLY----PTLTDYDIRYYIYELLKALDYC 235
           N+V+LL +   +      +I E++        L       ++   + Y   ++  A++Y 
Sbjct: 74  NLVQLLGVCTREPPFY--IITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL 131

Query: 236 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY-NVRVASRYFKGPELLVDL 294
             +  +HRD+   N ++      +++ D+GL+          +              +  
Sbjct: 132 EKKNFIHRDLAARNCLVGENHL-VKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY 190

Query: 295 QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSK 354
             +    D+W+ G +   +       + G D       + KD  +               
Sbjct: 191 NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEG---------- 240

Query: 355 FINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAM 390
                       +  + +    +++  DR +  E  
Sbjct: 241 ---------CPEKVYELMRACWQWNPSDRPSFAEIH 267

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  126 bits (318), Expect = 4e-34
 Identities = 52/300 (17%), Positives = 99/300 (33%), Gaps = 53/300 (17%)

Query: 123 DQDDYEVVRKVGRGKYSEVFEG-----INVNTNERCIIKILKPVK----KKKIKREIKIL 173
            ++     + +G G + +V E      I  +      +K+LKP      ++ +  E+K+L
Sbjct: 21  PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVL 80

Query: 174 QNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTD---------------------FKVL 212
             L    N+V LL            +I EY    D                      +  
Sbjct: 81  SYLGNHMNIVNLLGACTIG--GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDD 138

Query: 213 YPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP 272
              L   D+  + Y++ K + +  S+  +HRD+   N+++ H     ++ D+GLA     
Sbjct: 139 ELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRIT-KICDFGLARDIKN 197

Query: 273 GKEYNVRVASRYFKG--PELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQL 330
              Y V+  +R          +    Y +  D+WS G     +       + G     + 
Sbjct: 198 DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKF 257

Query: 331 VKIAKDCCLIIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAM 390
            K+ K+            R    +            E  D +      D   R T ++ +
Sbjct: 258 YKMIKE----------GFRMLSPEHA--------PAEMYDIMKTCWDADPLKRPTFKQIV 299

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  125 bits (314), Expect = 1e-33
 Identities = 40/273 (14%), Positives = 93/273 (34%), Gaps = 32/273 (11%)

Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKIL-KPVKKKKIKREIKILQNLCGGPNVVKL 185
           Y+V R++G G +  +FEG N+  N++  IK   +     +++ E +  + L G   +  +
Sbjct: 7   YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNV 66

Query: 186 LDIVRDQHSKTPSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMH 242
                 Q      L+ + +  +   +L       +   +     ++L  +   H + +++
Sbjct: 67  YYF--GQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVY 124

Query: 243 RDVKPHNVMIDHELRK----LRLIDWGLAEFYHPG--------KEYNVRVASRYFKGPEL 290
           RD+KP N +I     K    + ++D+G+ +FY           +E      +  +     
Sbjct: 125 RDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINT 184

Query: 291 LVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRK 350
            +  ++     D+ +LG +F   +      + G        K  +          + S  
Sbjct: 185 HLG-REQSRRDDLEALGHVFMYFLRGS-LPWQGLKAATNKQKYER------IGEKKQSTP 236

Query: 351 PWSKFINADNQHLVSPEAIDFLDKLLRYDHQDR 383
                           E   ++           
Sbjct: 237 LRELCAG------FPEEFYKYMHYARNLAFDAT 263

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  124 bits (312), Expect = 2e-33
 Identities = 44/298 (14%), Positives = 103/298 (34%), Gaps = 41/298 (13%)

Query: 123 DQDDYEVV-RKVGRGKYSEVFEGINVNTNERCI--IKILKPVKKKK----IKREIKILQN 175
            +D+  +   ++G G +  V +G+     ++    IK+LK   +K     + RE +I+  
Sbjct: 6   KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQ 65

Query: 176 LCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTD-FKVLY---PTLTDYDIRYYIYELLKA 231
           L   P +V+L+ + + +      L+ E        K L      +   ++   ++++   
Sbjct: 66  L-DNPYIVRLIGVCQAEA---LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMG 121

Query: 232 LDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASR---YFKGP 288
           + Y   +  +HRD+   NV++ +     ++ D+GL++       Y    ++         
Sbjct: 122 MKYLEEKNFVHRDLAARNVLLVNRH-YAKISDFGLSKALGADDSYYTARSAGKWPLKWYA 180

Query: 289 ELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHS 348
              ++ + +    D+WS G      +   +  +      + +  I +   +         
Sbjct: 181 PECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPE---- 236

Query: 349 RKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTARE---AMAHPYFAQVRAAES 403
                            PE    +     Y  +DR         M   Y++     E 
Sbjct: 237 ---------------CPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVEG 279

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  125 bits (314), Expect = 2e-33
 Identities = 44/284 (15%), Positives = 101/284 (35%), Gaps = 40/284 (14%)

Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTNER----CIIKILKPVKKKK----IKREIKILQN 175
           + +++ ++ +G G +  V++G+ +   E+      IK L+     K    I  E  ++ +
Sbjct: 8   ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMAS 67

Query: 176 LCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDY----DIRYYIYELLKA 231
           +   P+V +LL I      +   LI + +             D      +  +  ++ K 
Sbjct: 68  VDN-PHVCRLLGICLTSTVQ---LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKG 123

Query: 232 LDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY---NVRVASRYFKGP 288
           ++Y   + ++HRD+   NV++      +++ D+GLA+     ++            +   
Sbjct: 124 MNYLEDRRLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 182

Query: 289 ELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHS 348
           E ++  + Y +  D+WS G     ++      + G    +    + K   L         
Sbjct: 183 ESILH-RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPI---- 237

Query: 349 RKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH 392
                           + +    + K    D   R   RE +  
Sbjct: 238 ---------------CTIDVYMIMVKCWMIDADSRPKFRELIIE 266

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  124 bits (311), Expect = 2e-33
 Identities = 45/284 (15%), Positives = 95/284 (33%), Gaps = 41/284 (14%)

Query: 131 RKVGRGKYSEVFEGI--NVNTNERCIIKILK-----PVKKKKIKREIKILQNLCGGPNVV 183
           +++G G +  V +G        +   +KILK     P  K ++  E  ++Q L   P +V
Sbjct: 13  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDN-PYIV 71

Query: 184 KLLDIVRDQHSKTPSLIFEYVNSTDFKVLYP---TLTDYDIRYYIYELLKALDYCHSQGI 240
           +++ I   +      L+ E                + D +I   ++++   + Y      
Sbjct: 72  RMIGICEAES---WMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNF 128

Query: 241 MHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR----VASRYFKGPELLVDLQD 296
           +HRD+   NV++  +    ++ D+GL++     + Y            +  PE +     
Sbjct: 129 VHRDLAARNVLLVTQHY-AKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY-YK 186

Query: 297 YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSKFI 356
           +    D+WS G +        +  + G    +    + K   +                 
Sbjct: 187 FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAG------------ 234

Query: 357 NADNQHLVSPEAIDFLDKLLRYDHQDRLTARE--AMAHPYFAQV 398
                     E  D ++    YD ++R            Y+  V
Sbjct: 235 -------CPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDV 271

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  121 bits (305), Expect = 2e-32
 Identities = 48/303 (15%), Positives = 95/303 (31%), Gaps = 61/303 (20%)

Query: 124 QDDYEVVRKVGRGKYSEVFEG-----INVNTNERCIIKILKPVK----KKKIKREIKILQ 174
           +++ E VR +G G +  VF+      +         +K+LK       +   +RE  ++ 
Sbjct: 12  RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMA 71

Query: 175 NLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFK------------------------ 210
                PN+VKLL +      K   L+FEY+   D                          
Sbjct: 72  EFDN-PNIVKLLGV--CAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRAR 128

Query: 211 ---VLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA 267
                 P L+  +      ++   + Y   +  +HRD+   N ++   +  +++ D+GL+
Sbjct: 129 VSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMV-VKIADFGLS 187

Query: 268 EFYHPGKEYNV--RVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHD 325
              +    Y      A      P   +    Y    D+W+ G +   +       +YG  
Sbjct: 188 RNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMA 247

Query: 326 NHDQLVKIAKDCCLIIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLT 385
           + + +  +     L    N                      E  + +         DR +
Sbjct: 248 HEEVIYYVRDGNILACPEN-------------------CPLELYNLMRLCWSKLPADRPS 288

Query: 386 ARE 388
              
Sbjct: 289 FCS 291

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  117 bits (295), Expect = 7e-31
 Identities = 53/310 (17%), Positives = 114/310 (36%), Gaps = 40/310 (12%)

Query: 99  VYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCI---I 155
           V+ D++ L P+     + + +             +GRG +  V+ G  ++ + + I   +
Sbjct: 2   VHIDLSALNPELVQAVQHVVIGP-SSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAV 60

Query: 156 KILKPVKK----KKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKV 211
           K L  +       +   E  I+++    PNV+ LL I        P ++  Y+   D + 
Sbjct: 61  KSLNRITDIGEVSQFLTEGIIMKDFSH-PNVLSLLGICLRSEGS-PLVVLPYMKHGDLRN 118

Query: 212 LY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA 267
                    T  D+  +  ++ K + +  S+  +HRD+   N M+D +   +++ D+GLA
Sbjct: 119 FIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEK-FTVKVADFGLA 177

Query: 268 EFYHPGKEYNVRVASRY-----FKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFY 322
              +  +  +V   +       +   E L   Q +    D+WS G +   ++ R  P + 
Sbjct: 178 RDMYDKEFDSVHNKTGAKLPVKWMALESLQT-QKFTTKSDVWSFGVLLWELMTRGAPPYP 236

Query: 323 GHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQD 382
             +  D  V + +   L+                             + + K      + 
Sbjct: 237 DVNTFDITVYLLQGRRLLQPEY-------------------CPDPLYEVMLKCWHPKAEM 277

Query: 383 RLTAREAMAH 392
           R +  E ++ 
Sbjct: 278 RPSFSELVSR 287

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  115 bits (288), Expect = 4e-30
 Identities = 39/285 (13%), Positives = 96/285 (33%), Gaps = 40/285 (14%)

Query: 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNER----CIIKILKPV----KKKKIKREIKILQ 174
                   + +G G++ EV++G+   ++ +      IK LK      ++     E  I+ 
Sbjct: 5   HPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMG 64

Query: 175 NLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLK 230
                 N+++L  ++         +I EY+ +              +   +   +  +  
Sbjct: 65  QFSH-HNIIRLEGVISKYKPMM--IITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAA 121

Query: 231 ALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY----NVRVASRYFK 286
            + Y  +   +HRD+   N++++  L   ++ D+GL+       E     +       + 
Sbjct: 122 GMKYLANMNYVHRDLAARNILVNSNLV-CKVSDFGLSRVLEDDPEATYTTSGGKIPIRWT 180

Query: 287 GPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSR 346
            PE +   +    S D+WS G +   ++   E  ++   NH+ +  I     L    +  
Sbjct: 181 APEAISYRKFTSAS-DVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMD-- 237

Query: 347 HSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA 391
                                    + +  + +   R    + ++
Sbjct: 238 -----------------CPSAIYQLMMQCWQQERARRPKFADIVS 265

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  114 bits (287), Expect = 9e-30
 Identities = 49/307 (15%), Positives = 104/307 (33%), Gaps = 55/307 (17%)

Query: 123 DQDDYEVVRKVGRGKYSEVFEGINVN-----TNERCIIKILKPVK----KKKIKREIKIL 173
            ++   + R++G+G +  V+EG+           R  IK +        + +   E  ++
Sbjct: 18  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 77

Query: 174 QNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL-------------YPTLTDYD 220
           +      +VV+LL +V     +   +I E +   D K                   +   
Sbjct: 78  KEF-NCHHVVRLLGVV--SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSK 134

Query: 221 IRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY---N 277
           +     E+   + Y ++   +HRD+   N M+  +   +++ D+G+    +    Y    
Sbjct: 135 MIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFT-VKIGDFGMTRDIYETDYYRKGG 193

Query: 278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDC 337
             +    +  PE L D   +    D+WS G +   +    E  + G  N   L  + +  
Sbjct: 194 KGLLPVRWMSPESLKD-GVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGG 252

Query: 338 CLIIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA------ 391
            L    N                         + +    +Y+ + R +  E ++      
Sbjct: 253 LLDKPDN-------------------CPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEM 293

Query: 392 HPYFAQV 398
            P F +V
Sbjct: 294 EPGFREV 300

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  113 bits (283), Expect = 3e-29
 Identities = 44/302 (14%), Positives = 100/302 (33%), Gaps = 54/302 (17%)

Query: 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNE-------RCIIKILKPVKKKK----IKREIK 171
            +D   + + +G G + +V     +  ++       +  +K+LK    +K    +  E++
Sbjct: 11  PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEME 70

Query: 172 ILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL------------------- 212
           +++ +    N++ LL            +I EY +  + +                     
Sbjct: 71  MMKMIGKHKNIINLLGACTQDGP--LYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNP 128

Query: 213 YPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP 272
              L+  D+    Y++ + ++Y  S+  +HRD+   NV++  +    ++ D+GLA   H 
Sbjct: 129 EEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVM-KIADFGLARDIHH 187

Query: 273 GKEYNVRVASRYFKGPELLVDLQD--YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQL 330
              Y      R          L D  Y +  D+WS G +   +       + G    +  
Sbjct: 188 IDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF 247

Query: 331 VKIAKDCCLIIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAM 390
             + +   +    N                    + E    +          R T ++ +
Sbjct: 248 KLLKEGHRMDKPSN-------------------CTNELYMMMRDCWHAVPSQRPTFKQLV 288

Query: 391 AH 392
             
Sbjct: 289 ED 290

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  113 bits (282), Expect = 4e-29
 Identities = 48/301 (15%), Positives = 107/301 (35%), Gaps = 52/301 (17%)

Query: 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCI-----IKILKP----VKKKKIKREIKIL 173
            +D  ++ + +GRG + +V E      ++        +K+LK      + + +  E+KIL
Sbjct: 11  PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKIL 70

Query: 174 QNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY------------------PT 215
            ++    NVV LL            ++           L                     
Sbjct: 71  IHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDF 130

Query: 216 LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE 275
           LT   +  Y +++ K +++  S+  +HRD+   N+++  +   +++ D+GLA   +   +
Sbjct: 131 LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNV-VKICDFGLARDIYKDPD 189

Query: 276 Y----NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV 331
           Y    + R+  ++     +    + Y    D+WS G +   +       + G    ++  
Sbjct: 190 YVRKGDARLPLKWMAPETIF--DRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC 247

Query: 332 KIAKDCCLIIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA 391
           +  K+           +R     +         +PE    +      +   R T  E + 
Sbjct: 248 RRLKE----------GTRMRAPDYT--------TPEMYQTMLDCWHGEPSQRPTFSELVE 289

Query: 392 H 392
           H
Sbjct: 290 H 290

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  109 bits (273), Expect = 7e-28
 Identities = 49/290 (16%), Positives = 96/290 (33%), Gaps = 27/290 (9%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQ-NLCGGPNVV 183
               +   +G+G++ EV+ G      E   +KI    +++   RE +I Q  +    N++
Sbjct: 3   RTIVLQESIGKGRFGEVWRG--KWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENIL 60

Query: 184 KLLDIVRDQHSKTPS--LIFEYVNSTD-FKVLY-PTLTDYDIRYYIYELLKALDYCHSQ- 238
             +      +       L+ +Y      F  L   T+T   +          L + H + 
Sbjct: 61  GFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEI 120

Query: 239 -------GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY-----NVRVASRYFK 286
                   I HRD+K  N+++        + D GLA  +    +      N RV ++ + 
Sbjct: 121 VGTQGKPAIAHRDLKSKNILVKKNGT-CCIADLGLAVRHDSATDTIDIAPNHRVGTKRYM 179

Query: 287 GPELL-----VDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK-DCCLI 340
            PE+L     +   +     D++++G +F  +  R        D       +   D  + 
Sbjct: 180 APEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVE 239

Query: 341 IWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAM 390
                   +K      N              + +    +   RLTA    
Sbjct: 240 EMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIK 289

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 80.6 bits (198), Expect = 2e-18
 Identities = 31/203 (15%), Positives = 69/203 (33%), Gaps = 34/203 (16%)

Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP------------VKKKKIKREIKILQ 174
             + + +G GK S VF   +      C++K  K                      + I  
Sbjct: 2   DAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRS 60

Query: 175 NLCGGPNVVKLLD--IVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKAL 232
                  + KL    + +    +  +++ E +++ +   +       +    +  +L+ +
Sbjct: 61  ARNEFRALQKLQGLAVPKVYAWEGNAVLMELIDAKELYRVRV----ENPDEVLDMILEEV 116

Query: 233 DYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEY----NVRVASRYFKG 287
              + +GI+H D+  +NV++      + +ID+  + E    G       +VR    YF  
Sbjct: 117 AKFYHRGIVHGDLSQYNVLVSE--EGIWIIDFPQSVEVGEEGWREILERDVRNIITYFS- 173

Query: 288 PELLVDLQDYDYSLDMWSLGCMF 310
                  + Y    D+ S     
Sbjct: 174 -------RTYRTEKDINSAIDRI 189

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	408
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.93
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.49
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	98.09
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.95
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	97.16
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	97.16
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	96.62

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=4.8e-62  Score=462.41  Aligned_cols=308  Identities=76%  Similarity=1.249  Sum_probs=270.5

Q ss_pred             CCccCcccccccccCCcccCCCCCcccccCCCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecccchHHHHHHHHH
Q 015374           93 AMSKARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKI  172 (408)
Q Consensus        93 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~E~~~  172 (408)
                      ..++++++.+.+...+.++|+++...+.+...++|+++++||+|+||+||+|++..+++.||||+++....+.+.+|+.+
T Consensus         3 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~Ei~i   82 (328)
T d3bqca1           3 VPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKI   82 (328)
T ss_dssp             CCCCCSSSTTTTTTSCHHHHCGGGCCCCCCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSCHHHHHHHHHH
T ss_pred             CCCcceeeccccccCCCccchhhhcccCCCCCcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHHHHHHHHHHHH
Confidence            34678889999999999999999999988899999999999999999999999999999999999998888899999999


Q ss_pred             HHHhcCCCCceEEeeEEEccCCCccEEEEEeecCCChhhhcCCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEE
Q 015374          173 LQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMI  252 (408)
Q Consensus       173 l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl  252 (408)
                      |+++.+||||++++++|........++||||+++++|..+.+.+++..++.++.||+.||+|||++||+||||||+|||+
T Consensus        83 l~~l~~hpnIv~~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi  162 (328)
T d3bqca1          83 LENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMI  162 (328)
T ss_dssp             HHHHTTSTTBCCEEEEEECTTTCSEEEEEECCCSCBGGGTTTSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE
T ss_pred             HHhccCCCCCcEEEEEEEecCCCceeEEEeecCCCcHHHHhcCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEE
Confidence            99996699999999999877677899999999999999999999999999999999999999999999999999999999


Q ss_pred             eCCCCcEEEEecccceeccCCCcceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHH
Q 015374          253 DHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVK  332 (408)
Q Consensus       253 ~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~  332 (408)
                      +.+.+.+||+|||+|+...........++|+.|+|||.+.+...++.++||||+||++|+|++|+.||..+.++.++...
T Consensus       163 ~~~~~~vkl~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~  242 (328)
T d3bqca1         163 DHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVR  242 (328)
T ss_dssp             ETTTTEEEECCGGGCEECCTTCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHH
T ss_pred             cCCCCeeeecccccceeccCCCcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHH
Confidence            98756799999999998877777777889999999999988667899999999999999999999999888887777777


Q ss_pred             HHhhhchhh-----------------hhcCCCCCCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCc
Q 015374          333 IAKDCCLII-----------------WCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF  395 (408)
Q Consensus       333 ~~~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f  395 (408)
                      +....|...                 ..........+...........+++++.|||++||++||++|||++|+|+||||
T Consensus       243 i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F  322 (328)
T d3bqca1         243 IAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF  322 (328)
T ss_dssp             HHHHHCHHHHHHHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGG
T ss_pred             HHHHHCCchhhhhhhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCccc
Confidence            666555322                 111122333344444455556689999999999999999999999999999999


Q ss_pred             ccccc
Q 015374          396 AQVRA  400 (408)
Q Consensus       396 ~~~~~  400 (408)
                      +.+..
T Consensus       323 ~~v~~  327 (328)
T d3bqca1         323 YTVVK  327 (328)
T ss_dssp             TTSCC
T ss_pred             CCCCC
Confidence            98864

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.8e-60  Score=431.45  Aligned_cols=247  Identities=25%  Similarity=0.486  Sum_probs=214.4

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc------chHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCcc
Q 015374          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP  197 (408)
Q Consensus       124 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~  197 (408)
                      -++|++.+.||+|+||+||+|++..+++.||+|++...      ....+.+|+.+++++ +||||+++++++.+  ....
T Consensus         5 l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~~~~~~~~--~~~~   81 (263)
T d2j4za1           5 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL-RHPNILRLYGYFHD--ATRV   81 (263)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTC-CCTTBCCEEEEEEC--SSEE
T ss_pred             hhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhc-CCCCCCeEEEEEEE--CCEE
Confidence            36799999999999999999999999999999998632      245688999999999 99999999999965  4678


Q ss_pred             EEEEEeecCCChhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCCC
Q 015374          198 SLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK  274 (408)
Q Consensus       198 ~lv~e~~~~~~l~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~~  274 (408)
                      ++||||+++|+|..++   ..+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+|+..... 
T Consensus        82 ~ivmEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~-~~~kl~DFG~a~~~~~~-  159 (263)
T d2j4za1          82 YLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSA-GELKIADFGWSVHAPSS-  159 (263)
T ss_dssp             EEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT-SCEEECCCCSCSCCCCC-
T ss_pred             EEEEeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCC-CCEeecccceeeecCCC-
Confidence            9999999999998876   569999999999999999999999999999999999999988 79999999999866533 


Q ss_pred             cceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCCCccc
Q 015374          275 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSK  354 (408)
Q Consensus       275 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  354 (408)
                      ......||+.|+|||++.+ ..++.++|||||||++|||++|+.|| .+.+..+.+..+...                  
T Consensus       160 ~~~~~~Gt~~Y~APE~~~~-~~~~~~~DiwSlGvilyell~G~~Pf-~~~~~~~~~~~i~~~------------------  219 (263)
T d2j4za1         160 RRTTLCGTLDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFLVGKPPF-EANTYQETYKRISRV------------------  219 (263)
T ss_dssp             CCEETTEEGGGCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCTT-CCSSHHHHHHHHHTT------------------
T ss_pred             cccccCCCCcccCHHHHcC-CCCCchhhhhhHhHHHHHHhcCCCCC-CCCCHHHHHHHHHcC------------------
Confidence            3455789999999999988 77999999999999999999999998 444444444443321                  


Q ss_pred             cccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccc
Q 015374          355 FINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQ  397 (408)
Q Consensus       355 ~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~  397 (408)
                        ....+..+++++.+||.+||+.||++|||++|+|+||||++
T Consensus       220 --~~~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~hp~~~~  260 (263)
T d2j4za1         220 --EFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA  260 (263)
T ss_dssp             --CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTCHHHHH
T ss_pred             --CCCCCccCCHHHHHHHHHHccCCHhHCcCHHHHHcCcCcCC
Confidence              11223457999999999999999999999999999999974

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.4e-60  Score=433.95  Aligned_cols=252  Identities=24%  Similarity=0.405  Sum_probs=211.2

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc----chHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccEE
Q 015374          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSL  199 (408)
Q Consensus       124 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l  199 (408)
                      .++|++++.||+|+||+||+|++..+++.||||+++..    ..+.+.+|+.+++++ +||||+++++++.+  ....++
T Consensus         4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~~~~~~~~--~~~~~i   80 (271)
T d1nvra_           4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML-NHENVVKFYGHRRE--GNIQYL   80 (271)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTC-CCTTBCCEEEEEEE--TTEEEE
T ss_pred             CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhC-CCCCEeeEeeeecc--CceeEE
Confidence            56899999999999999999999999999999998632    235688999999999 99999999999966  467899


Q ss_pred             EEEeecCCChhhhcC---CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCCC--
Q 015374          200 IFEYVNSTDFKVLYP---TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK--  274 (408)
Q Consensus       200 v~e~~~~~~l~~~~~---~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~~--  274 (408)
                      ||||+++|+|..++.   .+++..++.++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+|+......  
T Consensus        81 vmEy~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~-~~~KL~DFG~a~~~~~~~~~  159 (271)
T d1nvra_          81 FLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDER-DNLKISDFGLATVFRYNNRE  159 (271)
T ss_dssp             EEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTT-CCEEECCCTTCEECEETTEE
T ss_pred             EEeccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCC-CCEEEccchhheeeccCCcc
Confidence            999999999998874   48999999999999999999999999999999999999988 799999999998764332  


Q ss_pred             -cceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCCCcc
Q 015374          275 -EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWS  353 (408)
Q Consensus       275 -~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  353 (408)
                       .....+||+.|+|||++.+...++.++|||||||++|||++|+.||....+............         .      
T Consensus       160 ~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~---------~------  224 (271)
T d1nvra_         160 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKK---------T------  224 (271)
T ss_dssp             CCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTC---------T------
T ss_pred             ccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCC---------C------
Confidence             234568999999999998744456789999999999999999999855444333333322210         0      


Q ss_pred             ccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccc
Q 015374          354 KFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQ  397 (408)
Q Consensus       354 ~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~  397 (408)
                         ....+..+++++.+||.+||+.||++|||++|+|+||||+.
T Consensus       225 ---~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~  265 (271)
T d1nvra_         225 ---YLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNK  265 (271)
T ss_dssp             ---TSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTC
T ss_pred             ---CCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCc
Confidence               01112347899999999999999999999999999999974

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-59  Score=435.55  Aligned_cols=253  Identities=25%  Similarity=0.455  Sum_probs=217.6

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc---chHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccEEE
Q 015374          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV---KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI  200 (408)
Q Consensus       124 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  200 (408)
                      .++|+++++||+|+||+||+|++..+|+.||||+++..   ..+.+.+|+.+++++ +||||++++++|.+  ...+++|
T Consensus        19 ~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~--~~~~~iv   95 (293)
T d1yhwa1          19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMREN-KNPNIVNYLDSYLV--GDELWVV   95 (293)
T ss_dssp             TTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHC-CCTTBCCEEEEEEE--TTEEEEE
T ss_pred             ccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhC-CCCCEeeEeEEEEE--CCEEEEE
Confidence            46799999999999999999999999999999998632   346789999999999 99999999999976  4678999


Q ss_pred             EEeecCCChhhhc--CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCC-Ccce
Q 015374          201 FEYVNSTDFKVLY--PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG-KEYN  277 (408)
Q Consensus       201 ~e~~~~~~l~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~-~~~~  277 (408)
                      |||+++|+|..++  ..+++.+++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+|+..... ....
T Consensus        96 mEy~~gg~L~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~-~~vkl~DFG~a~~~~~~~~~~~  174 (293)
T d1yhwa1          96 MEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMD-GSVKLTDFGFCAQITPEQSKRS  174 (293)
T ss_dssp             EECCTTCBHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT-CCEEECCCTTCEECCSTTCCBC
T ss_pred             EEecCCCcHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCC-CcEeeccchhheeecccccccc
Confidence            9999999998876  469999999999999999999999999999999999999988 89999999999877543 3445


Q ss_pred             eeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCCCcccccc
Q 015374          278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSKFIN  357 (408)
Q Consensus       278 ~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  357 (408)
                      ..+||+.|+|||++.+ ..++.++|||||||++|+|++|..|| .+.+..+.+..+.....                 ..
T Consensus       175 ~~~gt~~Y~aPE~~~~-~~~~~~~DiwSlGvilyemltG~~Pf-~~~~~~~~~~~~~~~~~-----------------~~  235 (293)
T d1yhwa1         175 TMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMIEGEPPY-LNENPLRALYLIATNGT-----------------PE  235 (293)
T ss_dssp             CCCSCGGGCCHHHHSS-SCBCTHHHHHHHHHHHHHHHHSSCTT-TTSCHHHHHHHHHHHCS-----------------CC
T ss_pred             ccccCCCccChhhhcC-CCCCchhceehHhHHHHHHhhCCCCC-CCCCHHHHHHHHHhCCC-----------------CC
Confidence            6789999999999988 78999999999999999999999998 44454555554443210                 01


Q ss_pred             ccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccccc
Q 015374          358 ADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVR  399 (408)
Q Consensus       358 ~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~~~  399 (408)
                      ...+..+++++++||.+||+.||++|||++|+|+||||+...
T Consensus       236 ~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~Hp~~~~~~  277 (293)
T d1yhwa1         236 LQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIAK  277 (293)
T ss_dssp             CSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred             CCCcccCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCCC
Confidence            122344799999999999999999999999999999997543

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.7e-59  Score=432.54  Aligned_cols=259  Identities=25%  Similarity=0.414  Sum_probs=216.4

Q ss_pred             ccccCCCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecc---cchHHHHHHHHHHHHhcCCCCceEEeeEEEccCC
Q 015374          118 TVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP---VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHS  194 (408)
Q Consensus       118 ~~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~---~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~  194 (408)
                      .......+.|++++.||+|+||+||+|++..++..||||+++.   ...+.+.+|+++++++ +||||++++++|.+  .
T Consensus         5 ~r~~~p~d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~--~   81 (288)
T d2jfla1           5 TRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASC-DHPNIVKLLDAFYY--E   81 (288)
T ss_dssp             EESSCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHC-CCTTBCCEEEEEEE--T
T ss_pred             cCCCCcccCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEee--C
Confidence            3333345789999999999999999999999999999999864   3346789999999999 99999999999965  4


Q ss_pred             CccEEEEEeecCCChhhhc----CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceec
Q 015374          195 KTPSLIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY  270 (408)
Q Consensus       195 ~~~~lv~e~~~~~~l~~~~----~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~  270 (408)
                      ...++||||+++|+|..++    ..+++.+++.++.||+.||.|||++||+||||||+|||++.+ +.+||+|||+|+..
T Consensus        82 ~~~~lvmEy~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~-~~~Kl~DFG~a~~~  160 (288)
T d2jfla1          82 NNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLD-GDIKLADFGVSAKN  160 (288)
T ss_dssp             TEEEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT-SCEEECCCTTCEEC
T ss_pred             CeEEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCC-CCEEEEechhhhcc
Confidence            6788999999999998875    359999999999999999999999999999999999999988 79999999999765


Q ss_pred             cCC-CcceeeccCccccccccccC----CcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcC
Q 015374          271 HPG-KEYNVRVASRYFKGPELLVD----LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNS  345 (408)
Q Consensus       271 ~~~-~~~~~~~~~~~y~aPE~~~~----~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  345 (408)
                      ... .......||+.|+|||++..    ...|+.++|||||||++|||++|+.|| .+.+..+.+..+....        
T Consensus       161 ~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf-~~~~~~~~~~~i~~~~--------  231 (288)
T d2jfla1         161 TRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPH-HELNPMRVLLKIAKSE--------  231 (288)
T ss_dssp             HHHHHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTT-TTSCGGGHHHHHHHSC--------
T ss_pred             CCCcccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCC-CCCCHHHHHHHHHcCC--------
Confidence            432 22345689999999999853    256899999999999999999999998 4445555555544321        


Q ss_pred             CCCCCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccc
Q 015374          346 RHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQV  398 (408)
Q Consensus       346 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~~  398 (408)
                       .        .....+..+++++.+||.+||+.||++|||++|+|+||||+.-
T Consensus       232 -~--------~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~hp~~~~~  275 (288)
T d2jfla1         232 -P--------PTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTVD  275 (288)
T ss_dssp             -C--------CCCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGCCC
T ss_pred             -C--------CCCCccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCC
Confidence             0        0112234478999999999999999999999999999999753

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-58  Score=424.41  Aligned_cols=252  Identities=22%  Similarity=0.419  Sum_probs=209.4

Q ss_pred             CCCCE-EEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc-----chHHHHHHHHHHHHhcCCCCceEEeeEEEcc--CC
Q 015374          123 DQDDY-EVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQ--HS  194 (408)
Q Consensus       123 ~~~~y-~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~--~~  194 (408)
                      ...+| ++.++||+|+||+||+|++..++..||+|+++..     ..+.+.+|+++++++ +||||++++++|.+.  +.
T Consensus         6 ~~gry~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~~~~~~   84 (270)
T d1t4ha_           6 NDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGL-QHPNIVRFYDSWESTVKGK   84 (270)
T ss_dssp             TTSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEEEESSSC
T ss_pred             CCCCEEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEeeccccC
Confidence            34455 6778999999999999999999999999998632     235688999999999 999999999998753  34


Q ss_pred             CccEEEEEeecCCChhhhc---CCCChHHHHHHHHHHHHHHHHHHHCC--cEEecCCCCcEEEeCCCCcEEEEeccccee
Q 015374          195 KTPSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQG--IMHRDVKPHNVMIDHELRKLRLIDWGLAEF  269 (408)
Q Consensus       195 ~~~~lv~e~~~~~~l~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~--iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~  269 (408)
                      ..+++||||+++|+|..++   ..+++..++.++.||+.||+|||+++  |+||||||+|||++.+.+.+||+|||+|+.
T Consensus        85 ~~~~ivmE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~  164 (270)
T d1t4ha_          85 KCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL  164 (270)
T ss_dssp             EEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred             CEEEEEEeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCccee
Confidence            5688999999999998887   46999999999999999999999998  999999999999976447999999999986


Q ss_pred             ccCCCcceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCC
Q 015374          270 YHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSR  349 (408)
Q Consensus       270 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  349 (408)
                      ... ......+||+.|+|||++.+  .++.++|||||||++|||++|+.||. +..+.+.+...+....           
T Consensus       165 ~~~-~~~~~~~GT~~Y~aPE~~~~--~~~~~~DIwSlGvilyel~~g~~Pf~-~~~~~~~~~~~i~~~~-----------  229 (270)
T d1t4ha_         165 KRA-SFAKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYS-ECQNAAQIYRRVTSGV-----------  229 (270)
T ss_dssp             CCT-TSBEESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTTT-TCSSHHHHHHHHTTTC-----------
T ss_pred             ccC-CccCCcccCccccCHHHhCC--CCCCcCchhhHHHHHHHHHHCCCCCC-CcccHHHHHHHHHcCC-----------
Confidence            443 34456789999999999865  69999999999999999999999984 3444444433322110           


Q ss_pred             CCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcc
Q 015374          350 KPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFA  396 (408)
Q Consensus       350 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~  396 (408)
                            .+...+..+++++.+||.+||+.||++|||++|+|+||||+
T Consensus       230 ------~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~Hp~fk  270 (270)
T d1t4ha_         230 ------KPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ  270 (270)
T ss_dssp             ------CCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred             ------CCcccCccCCHHHHHHHHHHccCCHhHCcCHHHHhCCcccC
Confidence                  01122334789999999999999999999999999999996

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.7e-59  Score=427.47  Aligned_cols=249  Identities=25%  Similarity=0.430  Sum_probs=200.8

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc-----chHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccE
Q 015374          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS  198 (408)
Q Consensus       124 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  198 (408)
                      .++|++++.||+|+||+||+|+++.+|+.||||+++..     ..+.+.+|+.+++++ +||||+++++++.+.....++
T Consensus         3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~~~~~~~~   81 (269)
T d2java1           3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLREL-KHPNIVRYYDRIIDRTNTTLY   81 (269)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSC-CCTTBCCEEEEEEC----CEE
T ss_pred             chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHC-CCCCEeeEEEEEEeCCCCEEE
Confidence            46899999999999999999999999999999998643     235688999999999 999999999999876667789


Q ss_pred             EEEEeecCCChhhhc-------CCCChHHHHHHHHHHHHHHHHHHHCC-----cEEecCCCCcEEEeCCCCcEEEEeccc
Q 015374          199 LIFEYVNSTDFKVLY-------PTLTDYDIRYYIYELLKALDYCHSQG-----IMHRDVKPHNVMIDHELRKLRLIDWGL  266 (408)
Q Consensus       199 lv~e~~~~~~l~~~~-------~~l~~~~~~~i~~qi~~~L~~LH~~~-----iiH~Dlk~~NILl~~~~~~~kl~DfG~  266 (408)
                      +||||+++|+|..++       ..+++..++.++.|++.||.|||+++     |+||||||+|||++.+ +.+||+|||+
T Consensus        82 ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~-~~vkl~DFG~  160 (269)
T d2java1          82 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGK-QNVKLGDFGL  160 (269)
T ss_dssp             EEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTT-SCEEECCHHH
T ss_pred             EEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCC-CcEEEeeccc
Confidence            999999999998876       35999999999999999999999976     9999999999999988 7999999999


Q ss_pred             ceeccCCC-cceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcC
Q 015374          267 AEFYHPGK-EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNS  345 (408)
Q Consensus       267 a~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  345 (408)
                      |+...... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.|| .+.+..+....+....        
T Consensus       161 a~~~~~~~~~~~~~~gt~~Y~APE~l~~-~~~~~~~DIwSlGvilyel~tg~~Pf-~~~~~~~~~~~i~~~~--------  230 (269)
T d2java1         161 ARILNHDTSFAKAFVGTPYYMSPEQMNR-MSYNEKSDIWSLGCLLYELCALMPPF-TAFSQKELAGKIREGK--------  230 (269)
T ss_dssp             HHHC-----------CCCSCCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCSC-CCSSHHHHHHHHHHTC--------
T ss_pred             eeecccCCCccccCCCCcccCCHHHHcC-CCCChHHHHHhhCHHHHHHhhCCCCC-CCCCHHHHHHHHHcCC--------
Confidence            98765433 2345789999999999987 78999999999999999999999998 3444444444433310        


Q ss_pred             CCCCCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCc
Q 015374          346 RHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYF  395 (408)
Q Consensus       346 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f  395 (408)
                                 ....+..+++++.+||++||+.||++|||++|+|+|||+
T Consensus       231 -----------~~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~hp~i  269 (269)
T d2java1         231 -----------FRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI  269 (269)
T ss_dssp             -----------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred             -----------CCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence                       011234478999999999999999999999999999995

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-58  Score=429.31  Aligned_cols=254  Identities=28%  Similarity=0.485  Sum_probs=215.5

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc------chHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCcc
Q 015374          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP  197 (408)
Q Consensus       124 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~  197 (408)
                      .++|++.+.||+|+||+||+|++..+++.||||+++..      ..+.+.+|+.+++++ +||||++++++|.+  ....
T Consensus         7 p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~--~~~~   83 (288)
T d1uu3a_           7 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-DHPFFVKLYFTFQD--DEKL   83 (288)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHC-CSTTBCCEEEEEEC--SSEE
T ss_pred             CCCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHc-CCCCeeEEEEEEEE--CCEE
Confidence            46799999999999999999999999999999998632      335689999999999 99999999999965  4678


Q ss_pred             EEEEEeecCCChhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCCC
Q 015374          198 SLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK  274 (408)
Q Consensus       198 ~lv~e~~~~~~l~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~~  274 (408)
                      ++||||+++|+|..++   ..+++..++.++.|++.||+|||++|||||||||+|||++.+ +.+||+|||+|+......
T Consensus        84 ~ivmEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~-~~vkl~DFG~a~~~~~~~  162 (288)
T d1uu3a_          84 YFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNED-MHIQITDFGTAKVLSPES  162 (288)
T ss_dssp             EEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTT-SCEEECCCTTCEECC---
T ss_pred             EEEEEccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCC-ceEEecccccceecccCC
Confidence            9999999999998876   469999999999999999999999999999999999999988 799999999998765332


Q ss_pred             ---cceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCCC
Q 015374          275 ---EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKP  351 (408)
Q Consensus       275 ---~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  351 (408)
                         .....+||+.|+|||++.+ ..++.++|||||||++|||++|..||. +.+..+.+..+...               
T Consensus       163 ~~~~~~~~~GT~~Y~APE~~~~-~~~~~~~DiwSlGvilyell~g~~Pf~-~~~~~~~~~~i~~~---------------  225 (288)
T d1uu3a_         163 KQARANSFVGTAQYVSPELLTE-KSACKSSDLWALGCIIYQLVAGLPPFR-AGNEYLIFQKIIKL---------------  225 (288)
T ss_dssp             -------CCCCGGGCCHHHHHT-CCCCHHHHHHHHHHHHHHHHHSSCSSC-CSSHHHHHHHHHTT---------------
T ss_pred             cccccccccCCccccCceeecc-CCCCcccceehhhHHHHHHhhCCCCCC-CcCHHHHHHHHHcC---------------
Confidence               2344679999999999987 789999999999999999999999984 44444555544331               


Q ss_pred             ccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHH------HhcCCCccccccchh
Q 015374          352 WSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTARE------AMAHPYFAQVRAAES  403 (408)
Q Consensus       352 ~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e------lL~hp~f~~~~~~~~  403 (408)
                           ....+..+++++++||++||+.||++|||++|      +++||||+++++...
T Consensus       226 -----~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~i~w~~l  278 (288)
T d1uu3a_         226 -----EYDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENL  278 (288)
T ss_dssp             -----CCCCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCTTG
T ss_pred             -----CCCCCccCCHHHHHHHHHHccCCHhHCcCHHHHcCCHHHHcCCccCCCCHHHh
Confidence                 11223458999999999999999999999988      589999999876543

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-59  Score=442.99  Aligned_cols=273  Identities=21%  Similarity=0.310  Sum_probs=214.8

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecc----cchHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccE
Q 015374          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP----VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS  198 (408)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~----~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  198 (408)
                      .+++|+++++||+|+||+||+|++..+++.||+|+++.    .....+.+|+.+++++ +|||||+++++|.+  ...++
T Consensus         4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~--~~~~~   80 (322)
T d1s9ja_           4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHEC-NSPYIVGFYGAFYS--DGEIS   80 (322)
T ss_dssp             CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGC-CCTTBCCEEEEEEC--SSEEE
T ss_pred             CccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhC-CCCCCCcEEEEEEE--CCEEE
Confidence            47899999999999999999999999999999999863    2346788999999999 99999999999965  46789


Q ss_pred             EEEEeecCCChhhhc---CCCChHHHHHHHHHHHHHHHHHHHC-CcEEecCCCCcEEEeCCCCcEEEEecccceeccCCC
Q 015374          199 LIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQ-GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK  274 (408)
Q Consensus       199 lv~e~~~~~~l~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~-~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~~  274 (408)
                      +||||+++|+|..++   ..+++..++.++.|++.||.|||++ ||+||||||+|||++.+ +.+||+|||+|+...+. 
T Consensus        81 iVmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~-~~vkl~DFGla~~~~~~-  158 (322)
T d1s9ja_          81 ICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSR-GEIKLCDFGVSGQLIDS-  158 (322)
T ss_dssp             EEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTT-CCEEECCCCCCHHHHHH-
T ss_pred             EEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCC-CCEEEeeCCCccccCCC-
Confidence            999999999999887   3699999999999999999999974 99999999999999988 79999999999866432 


Q ss_pred             cceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCC--------
Q 015374          275 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSR--------  346 (408)
Q Consensus       275 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~--------  346 (408)
                      .....+||+.|+|||++.+ ..|+.++||||+||++|||++|+.||........+........+........        
T Consensus       159 ~~~~~~GT~~Y~APEvl~~-~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (322)
T d1s9ja_         159 MANSFVGTRSYMSPERLQG-THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPL  237 (322)
T ss_dssp             TC---CCSSCCCCHHHHHC-SCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC----------------------
T ss_pred             ccccccCCccccCchHHcC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccccccc
Confidence            2345689999999999998 7899999999999999999999999976655544433222222211100000        


Q ss_pred             ----CCCCCcc-----------ccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccccccc
Q 015374          347 ----HSRKPWS-----------KFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAA  401 (408)
Q Consensus       347 ----~~~~~~~-----------~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~~~~~  401 (408)
                          .......           ...+......+|.++.+||.+||++||++|||++|+|+||||++.+..
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~~~~  307 (322)
T d1s9ja_         238 SSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDAE  307 (322)
T ss_dssp             --------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHHHHS
T ss_pred             cccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCcCCcc
Confidence                0000000           000011112358899999999999999999999999999999876553

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2.6e-58  Score=431.38  Aligned_cols=254  Identities=27%  Similarity=0.462  Sum_probs=199.8

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc----chHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccEE
Q 015374          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSL  199 (408)
Q Consensus       124 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l  199 (408)
                      .++|++.+.||+|+||+||+|++..+++.||||+++..    ....+.+|+.+++++ +||||+++++++.+  ...+++
T Consensus         8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~--~~~~~l   84 (307)
T d1a06a_           8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKI-KHPNIVALDDIYES--GGHLYL   84 (307)
T ss_dssp             GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTC-CCTTBCCEEEEEEC--SSEEEE
T ss_pred             ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhC-CCCCCCcEEEEEEE--CCEEEE
Confidence            57799999999999999999999999999999998643    235678999999999 99999999999965  467899


Q ss_pred             EEEeecCCChhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeC--CCCcEEEEecccceeccCCC
Q 015374          200 IFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDH--ELRKLRLIDWGLAEFYHPGK  274 (408)
Q Consensus       200 v~e~~~~~~l~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~--~~~~~kl~DfG~a~~~~~~~  274 (408)
                      ||||+++++|..++   ..+++.++..++.||+.||+|||++||+||||||+|||+..  +.+.+||+|||+|+......
T Consensus        85 vmE~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~  164 (307)
T d1a06a_          85 IMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS  164 (307)
T ss_dssp             EECCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC----------
T ss_pred             EEeccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEccCCC
Confidence            99999999998887   35999999999999999999999999999999999999953  23789999999998876666


Q ss_pred             cceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCCCccc
Q 015374          275 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSK  354 (408)
Q Consensus       275 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  354 (408)
                      .....+||+.|+|||++.+ ..++.++|||||||++|||++|..||. +....+....+.....                
T Consensus       165 ~~~~~~GT~~y~APE~~~~-~~~~~~~DiwSlGvilyell~g~~Pf~-~~~~~~~~~~i~~~~~----------------  226 (307)
T d1a06a_         165 VLSTACGTPGYVAPEVLAQ-KPYSKAVDCWSIGVIAYILLCGYPPFY-DENDAKLFEQILKAEY----------------  226 (307)
T ss_dssp             --------CTTSCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSCC-CSSHHHHHHHHHTTCC----------------
T ss_pred             eeeeeeeCccccCcHHHcC-CCCCcHHHhhhhhHHHHHHHhCCCCCC-CCCHHHHHHHHhccCC----------------
Confidence            6667789999999999987 789999999999999999999999983 4444444444443210                


Q ss_pred             cccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccc
Q 015374          355 FINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQV  398 (408)
Q Consensus       355 ~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~~  398 (408)
                      ......+..+|+++.+||.+||+.||++|||++|+|+||||++.
T Consensus       227 ~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~  270 (307)
T d1a06a_         227 EFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAGD  270 (307)
T ss_dssp             CCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTTSS
T ss_pred             CCCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence            01122334589999999999999999999999999999999753

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-57  Score=425.31  Aligned_cols=258  Identities=25%  Similarity=0.448  Sum_probs=218.5

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc---------chHHHHHHHHHHHHhcCCCCceEEeeEEEccCC
Q 015374          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV---------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHS  194 (408)
Q Consensus       124 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~---------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~  194 (408)
                      .++|++.+.||+|+||+||+|++..+|+.||||+++..         ..+.+.+|+.+++++ +||||++++++|.+  .
T Consensus         9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~--~   85 (293)
T d1jksa_           9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI-QHPNVITLHEVYEN--K   85 (293)
T ss_dssp             GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHC-CCTTBCCEEEEEEC--S
T ss_pred             ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhC-CCCCCCcEEEEEEE--C
Confidence            57899999999999999999999999999999998532         246789999999999 99999999999965  4


Q ss_pred             CccEEEEEeecCCChhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCC---cEEEEecccce
Q 015374          195 KTPSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELR---KLRLIDWGLAE  268 (408)
Q Consensus       195 ~~~~lv~e~~~~~~l~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~---~~kl~DfG~a~  268 (408)
                      ...++|||||++|+|..++   ..+++..++.++.|++.||+|||++||+||||||+|||++.+..   .+||+|||+|.
T Consensus        86 ~~~~iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~  165 (293)
T d1jksa_          86 TDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH  165 (293)
T ss_dssp             SEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred             CEEEEEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhh
Confidence            6889999999999999887   46999999999999999999999999999999999999987622   59999999999


Q ss_pred             eccCCCcceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCC
Q 015374          269 FYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHS  348 (408)
Q Consensus       269 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  348 (408)
                      ............+|+.|+|||++.+ ..++.++|||||||++|||++|..|| .+.+..+.+..+.....          
T Consensus       166 ~~~~~~~~~~~~~t~~y~APE~~~~-~~~~~~~DiwSlGvilyell~g~~Pf-~~~~~~~~~~~i~~~~~----------  233 (293)
T d1jksa_         166 KIDFGNEFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPF-LGDTKQETLANVSAVNY----------  233 (293)
T ss_dssp             ECTTSCBCSCCCCCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSS-CCSSHHHHHHHHHTTCC----------
T ss_pred             hcCCCccccccCCCCcccCHHHHcC-CCCCCcccchhhhHHHHHHHcCCCCC-CCCCHHHHHHHHHhcCC----------
Confidence            8876666677889999999999987 78999999999999999999999998 45555555555443210          


Q ss_pred             CCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccccccch
Q 015374          349 RKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAAE  402 (408)
Q Consensus       349 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~~~~~~  402 (408)
                        .    .....+..+|+++++||.+||+.||++|||++|+|+||||+.....+
T Consensus       234 --~----~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~~~~  281 (293)
T d1jksa_         234 --E----FEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQ  281 (293)
T ss_dssp             --C----CCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC-----
T ss_pred             --C----CCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCChhH
Confidence              0    11222345789999999999999999999999999999999876544

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=1.1e-57  Score=434.35  Aligned_cols=256  Identities=24%  Similarity=0.443  Sum_probs=220.8

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc---chHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccEEE
Q 015374          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV---KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI  200 (408)
Q Consensus       124 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  200 (408)
                      -++|++.+.||+|+||+||+|++..+|+.||||++...   ..+.+.+|+.+++++ +||||++++++|.+  ...+++|
T Consensus        25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~--~~~~~iv  101 (350)
T d1koaa2          25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVL-RHPTLVNLHDAFED--DNEMVMI  101 (350)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHT-CCTTBCCEEEEEEE--TTEEEEE
T ss_pred             ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhC-CCCCCCcEEEEEEE--CCEEEEE
Confidence            35899999999999999999999999999999998643   345688999999999 99999999999965  4678999


Q ss_pred             EEeecCCChhhhc----CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCC-CCcEEEEecccceeccCCCc
Q 015374          201 FEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE-LRKLRLIDWGLAEFYHPGKE  275 (408)
Q Consensus       201 ~e~~~~~~l~~~~----~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~-~~~~kl~DfG~a~~~~~~~~  275 (408)
                      ||||++|+|..++    ..+++..++.++.||+.||+|||++|||||||||+|||++.+ .+.+||+|||+|+.......
T Consensus       102 mE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~~  181 (350)
T d1koaa2         102 YEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS  181 (350)
T ss_dssp             ECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTSC
T ss_pred             EEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheecccccc
Confidence            9999999998876    248999999999999999999999999999999999999743 36899999999998887777


Q ss_pred             ceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCCCcccc
Q 015374          276 YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSKF  355 (408)
Q Consensus       276 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  355 (408)
                      .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.|| .+.+..+.+..+.....       .         
T Consensus       182 ~~~~~gT~~Y~aPEv~~~-~~~~~~~DiwSlGvilyell~G~~Pf-~~~~~~~~~~~i~~~~~-------~---------  243 (350)
T d1koaa2         182 VKVTTGTAEFAAPEVAEG-KPVGYYTDMWSVGVLSYILLSGLSPF-GGENDDETLRNVKSCDW-------N---------  243 (350)
T ss_dssp             EEEECSCTTTCCHHHHHT-CCBCHHHHHHHHHHHHHHHHHSSCSS-CCSSHHHHHHHHHHTCC-------C---------
T ss_pred             cceecCcccccCHHHHcC-CCCChhHhhhhhhHHHHHHHhCCCCC-CCCCHHHHHHHHHhCCC-------C---------
Confidence            778899999999999987 78999999999999999999999998 45555566665544211       0         


Q ss_pred             ccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccccc
Q 015374          356 INADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRA  400 (408)
Q Consensus       356 ~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~~~~  400 (408)
                      ........+++++++||.+||+.||++|||++|+|+||||+....
T Consensus       244 ~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~~~~~~~  288 (350)
T d1koaa2         244 MDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNA  288 (350)
T ss_dssp             SCCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHSTTTSCTTC
T ss_pred             CCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCCC
Confidence            111223347899999999999999999999999999999986543

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-57  Score=428.68  Aligned_cols=252  Identities=26%  Similarity=0.473  Sum_probs=217.8

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc------chHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCcc
Q 015374          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP  197 (408)
Q Consensus       124 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~  197 (408)
                      -++|++++.||+|+||+||+|++..+++.||||+++..      ..+.+.+|+.+|+++ +||||++++++|.+  ...+
T Consensus         4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~--~~~~   80 (337)
T d1o6la_           4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT-RHPFLTALKYAFQT--HDRL   80 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSC-CCTTBCCEEEEEEC--SSEE
T ss_pred             hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhC-CCCCEEEEEeeecc--cccc
Confidence            46899999999999999999999999999999998632      346788999999999 99999999999965  5688


Q ss_pred             EEEEEeecCCChhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccC-C
Q 015374          198 SLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP-G  273 (408)
Q Consensus       198 ~lv~e~~~~~~l~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~-~  273 (408)
                      ++||||+++|+|..++   ..+++..++.++.|++.||+|||++|||||||||+|||++.+ +.+||+|||+|+.... .
T Consensus        81 ~iv~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~-g~vkl~DFG~a~~~~~~~  159 (337)
T d1o6la_          81 CFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKD-GHIKITDFGLCKEGISDG  159 (337)
T ss_dssp             EEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTT-SCEEECCCTTCBCSCCTT
T ss_pred             ccceeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCC-CCEEEeecccccccccCC
Confidence            9999999999998887   469999999999999999999999999999999999999998 8999999999987644 3


Q ss_pred             CcceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCCCcc
Q 015374          274 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWS  353 (408)
Q Consensus       274 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  353 (408)
                      ......+||+.|+|||++.+ ..|+.++|||||||++|||++|+.||. +.+..+....+...                 
T Consensus       160 ~~~~~~~GT~~Y~aPE~~~~-~~y~~~~DiwSlGvilyeml~G~~pf~-~~~~~~~~~~i~~~-----------------  220 (337)
T d1o6la_         160 ATMKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFY-NQDHERLFELILME-----------------  220 (337)
T ss_dssp             CCBCCCEECGGGCCGGGGSS-SCBCTTHHHHHHHHHHHHHHHSSCSSC-CSSHHHHHHHHHHC-----------------
T ss_pred             cccccceeCHHHhhhhhccC-CCCChhhcccchhhHHHHHHHCCCCCC-CcCHHHHHHHHhcC-----------------
Confidence            34556789999999999988 789999999999999999999999984 44444444433321                 


Q ss_pred             ccccccCCCCCCHHHHHHHHHhcccCcCCCC-----CHHHHhcCCCccccccc
Q 015374          354 KFINADNQHLVSPEAIDFLDKLLRYDHQDRL-----TAREAMAHPYFAQVRAA  401 (408)
Q Consensus       354 ~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rp-----t~~elL~hp~f~~~~~~  401 (408)
                         ....+..+|+++++||++||+.||.+|+     +++|+++||||+++.+.
T Consensus       221 ---~~~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~Hp~f~~i~~~  270 (337)
T d1o6la_         221 ---EIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQ  270 (337)
T ss_dssp             ---CCCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHH
T ss_pred             ---CCCCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHcCcccccCCHH
Confidence               1223445899999999999999999999     49999999999987653

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=1.9e-57  Score=433.05  Aligned_cols=254  Identities=26%  Similarity=0.491  Sum_probs=219.7

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc---chHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccEEE
Q 015374          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV---KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI  200 (408)
Q Consensus       124 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  200 (408)
                      .++|++++.||+|+||+||+|++..+|+.||||+++..   ....+.+|+.+++++ +||||++++++|.+  ...+++|
T Consensus        28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l-~HpnIv~~~~~~~~--~~~~~iv  104 (352)
T d1koba_          28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQL-HHPKLINLHDAFED--KYEMVLI  104 (352)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTC-CSTTBCCEEEEEEC--SSEEEEE
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhC-CCCCCCcEEEEEEE--CCEEEEE
Confidence            46799999999999999999999999999999998643   345688999999999 99999999999965  5778999


Q ss_pred             EEeecCCChhhhcC----CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeC-CCCcEEEEecccceeccCCCc
Q 015374          201 FEYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDH-ELRKLRLIDWGLAEFYHPGKE  275 (408)
Q Consensus       201 ~e~~~~~~l~~~~~----~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~-~~~~~kl~DfG~a~~~~~~~~  275 (408)
                      |||+++|+|...+.    .+++.+++.++.||+.||.|||++||+||||||+|||++. +.+.+||+|||+|+.......
T Consensus       105 mE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~~  184 (352)
T d1koba_         105 LEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI  184 (352)
T ss_dssp             EECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSC
T ss_pred             EEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecCCCCc
Confidence            99999999977652    4899999999999999999999999999999999999984 337899999999999887777


Q ss_pred             ceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCCCcccc
Q 015374          276 YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSKF  355 (408)
Q Consensus       276 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  355 (408)
                      .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.|| .+.+..+.+..+.....       .         
T Consensus       185 ~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvilyelltG~~Pf-~~~~~~~~~~~i~~~~~-------~---------  246 (352)
T d1koba_         185 VKVTTATAEFAAPEIVDR-EPVGFYTDMWAIGVLGYVLLSGLSPF-AGEDDLETLQNVKRCDW-------E---------  246 (352)
T ss_dssp             EEEECSSGGGCCHHHHTT-CCBCHHHHHHHHHHHHHHHHHSCCSS-CCSSHHHHHHHHHHCCC-------C---------
T ss_pred             eeeccCcccccCHHHHcC-CCCCCccchHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHhCCC-------C---------
Confidence            778899999999999987 78999999999999999999999998 45555566555544211       0         


Q ss_pred             ccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccc
Q 015374          356 INADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQV  398 (408)
Q Consensus       356 ~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~~  398 (408)
                      .+...+..+++++.+||.+||+.||.+|||++|+|+||||+..
T Consensus       247 ~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~~  289 (352)
T d1koba_         247 FDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGD  289 (352)
T ss_dssp             CCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSC
T ss_pred             CCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCC
Confidence            1122334589999999999999999999999999999999754

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=6.9e-57  Score=423.37  Aligned_cols=250  Identities=22%  Similarity=0.462  Sum_probs=216.7

Q ss_pred             CCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc------chHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccE
Q 015374          125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS  198 (408)
Q Consensus       125 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  198 (408)
                      ++|++++.||+|+||+||+|++..+|+.||||+++..      ..+.+.+|+.+++++ +||||+++++++.+  ...++
T Consensus         4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~--~~~~~   80 (316)
T d1fota_           4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIV-THPFIIRMWGTFQD--AQQIF   80 (316)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSC-CBTTBCCEEEEEEC--SSEEE
T ss_pred             hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhc-cCcChhheeeeEee--CCeee
Confidence            5799999999999999999999999999999998632      346788999999999 99999999999965  57889


Q ss_pred             EEEEeecCCChhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCCCc
Q 015374          199 LIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE  275 (408)
Q Consensus       199 lv~e~~~~~~l~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~~~  275 (408)
                      +||||++++++..++   ..+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+|+....  .
T Consensus        81 ivmE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~-g~vkL~DFG~a~~~~~--~  157 (316)
T d1fota_          81 MIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKN-GHIKITDFGFAKYVPD--V  157 (316)
T ss_dssp             EEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTT-SCEEECCCSSCEECSS--C
T ss_pred             eEeeecCCccccccccccccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCC-CCEEEecCccceEecc--c
Confidence            999999999988876   458889999999999999999999999999999999999988 8999999999987653  3


Q ss_pred             ceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCCCcccc
Q 015374          276 YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSKF  355 (408)
Q Consensus       276 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  355 (408)
                      ....+||+.|+|||++.+ ..++.++|||||||++|||++|+.|| .+.+..+....+...                   
T Consensus       158 ~~~~~Gt~~Y~APE~l~~-~~y~~~~DiwSlGvilyemltG~~Pf-~~~~~~~~~~~i~~~-------------------  216 (316)
T d1fota_         158 TYTLCGTPDYIAPEVVST-KPYNKSIDWWSFGILIYEMLAGYTPF-YDSNTMKTYEKILNA-------------------  216 (316)
T ss_dssp             BCCCCSCTTTCCHHHHTT-CCBCTTHHHHHHHHHHHHHHHSSCTT-CCSSHHHHHHHHHHC-------------------
T ss_pred             cccccCcccccCHHHHcC-CCCCchhhccccchhHHHHHhCCCCC-CCcCHHHHHHHHHcC-------------------
Confidence            345789999999999987 78999999999999999999999998 444545555554432                   


Q ss_pred             ccccCCCCCCHHHHHHHHHhcccCcCCCC-----CHHHHhcCCCccccccch
Q 015374          356 INADNQHLVSPEAIDFLDKLLRYDHQDRL-----TAREAMAHPYFAQVRAAE  402 (408)
Q Consensus       356 ~~~~~~~~~~~~~~~li~~~L~~dp~~Rp-----t~~elL~hp~f~~~~~~~  402 (408)
                       ....+..+++++.+++.+||..||.+|+     |++|+++||||+++....
T Consensus       217 -~~~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~Hp~f~~i~~~~  267 (316)
T d1fota_         217 -ELRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWEK  267 (316)
T ss_dssp             -CCCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCCHHH
T ss_pred             -CCCCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcCcccccCCHHH
Confidence             1122344789999999999999999996     999999999999986543

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2.9e-57  Score=424.44  Aligned_cols=248  Identities=27%  Similarity=0.419  Sum_probs=210.5

Q ss_pred             CCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc------chHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccE
Q 015374          125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS  198 (408)
Q Consensus       125 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  198 (408)
                      ..|+.+++||+|+||+||+|++..+++.||||+++..      ..+.+.+|+.+++++ +|||||+++++|.+  ....+
T Consensus        15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~~~~~~~~--~~~~~   91 (309)
T d1u5ra_          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKL-RHPNTIQYRGCYLR--EHTAW   91 (309)
T ss_dssp             HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEEE--TTEEE
T ss_pred             HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHC-CCCCEeeEEEEEEE--CCEEE
Confidence            4699999999999999999999999999999998632      235688999999999 99999999999965  46789


Q ss_pred             EEEEeecCCChhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCCCc
Q 015374          199 LIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE  275 (408)
Q Consensus       199 lv~e~~~~~~l~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~~~  275 (408)
                      +|||||.+|++..+.   ..+++.+++.++.||+.||.|||++|||||||||+|||++.+ +.+||+|||+|+....   
T Consensus        92 iv~E~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~-~~~Kl~DFG~a~~~~~---  167 (309)
T d1u5ra_          92 LVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEP-GLVKLGDFGSASIMAP---  167 (309)
T ss_dssp             EEEECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETT-TEEEECCCTTCBSSSS---
T ss_pred             EEEEecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCC-CCEEEeecccccccCC---
Confidence            999999999987654   569999999999999999999999999999999999999988 8999999999986543   


Q ss_pred             ceeeccCccccccccccC--CcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCCCcc
Q 015374          276 YNVRVASRYFKGPELLVD--LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWS  353 (408)
Q Consensus       276 ~~~~~~~~~y~aPE~~~~--~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  353 (408)
                      .....||+.|+|||++.+  ...|+.++|||||||++|||++|..||. +.+..+.+..+.....               
T Consensus       168 ~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~-~~~~~~~~~~i~~~~~---------------  231 (309)
T d1u5ra_         168 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF-NMNAMSALYHIAQNES---------------  231 (309)
T ss_dssp             BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTT-TSCHHHHHHHHHHSCC---------------
T ss_pred             CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCC-CCCHHHHHHHHHhCCC---------------
Confidence            345689999999999964  2468999999999999999999999984 4444455544443210               


Q ss_pred             ccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccc
Q 015374          354 KFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQV  398 (408)
Q Consensus       354 ~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~~  398 (408)
                         .......+++++.+||.+||+.||++|||++|+|+||||..-
T Consensus       232 ---~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~Hp~~~~~  273 (309)
T d1u5ra_         232 ---PALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE  273 (309)
T ss_dssp             ---CCCSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSC
T ss_pred             ---CCCCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHhCHHhcCC
Confidence               111123478999999999999999999999999999999753

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.3e-57  Score=420.40  Aligned_cols=268  Identities=28%  Similarity=0.496  Sum_probs=218.0

Q ss_pred             EEeeeeeeCceEEEEEEEcCCCcEEEEEEecccc--------hHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccEEE
Q 015374          129 VVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK--------KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI  200 (408)
Q Consensus       129 ~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~--------~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  200 (408)
                      .+++||+|+||+||+|++..+|+.||||+++...        .+.+.+|+.+++++ +||||++++++|.+  ....++|
T Consensus         2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~~~~~~~~--~~~~~iv   78 (299)
T d1ua2a_           2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQEL-SHPNIIGLLDAFGH--KSNISLV   78 (299)
T ss_dssp             EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHC-CCTTBCCEEEEECC--TTCCEEE
T ss_pred             cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhC-CCCCEeEEEeeecc--CCceeeh
Confidence            4678999999999999999999999999986322        24688999999999 99999999999954  5678999


Q ss_pred             EEeecCCChhhhcC---CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCCC-cc
Q 015374          201 FEYVNSTDFKVLYP---TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK-EY  276 (408)
Q Consensus       201 ~e~~~~~~l~~~~~---~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~~-~~  276 (408)
                      |||+.++++..+..   .+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+|+...... ..
T Consensus        79 mE~~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~-~~~KL~DFG~a~~~~~~~~~~  157 (299)
T d1ua2a_          79 FDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDEN-GVLKLADFGLAKSFGSPNRAY  157 (299)
T ss_dssp             EECCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT-CCEEECCCGGGSTTTSCCCCC
T ss_pred             hhhhcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCC-CccccccCccccccCCCcccc
Confidence            99999998887763   48999999999999999999999999999999999999988 899999999997765433 34


Q ss_pred             eeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCC-----C
Q 015374          277 NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRK-----P  351 (408)
Q Consensus       277 ~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~  351 (408)
                      ...+||+.|+|||++.+...++.++|||||||++|||++|..|| .+.++.+++..+.+..+............     .
T Consensus       158 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf-~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~  236 (299)
T d1ua2a_         158 THQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFL-PGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVT  236 (299)
T ss_dssp             CCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSS-CCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCC
T ss_pred             cceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCC-CCCCHHHHHHHHHHhcCCCChhhccchhccchhhh
Confidence            45689999999999987567899999999999999999998775 67778888888887766443221111000     0


Q ss_pred             cc---ccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccccccc
Q 015374          352 WS---KFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAA  401 (408)
Q Consensus       352 ~~---~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~~~~~  401 (408)
                      +.   ..........+++++.+||.+||+.||++|||++|+|+||||++.+..
T Consensus       237 ~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~p~p  289 (299)
T d1ua2a_         237 FKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGP  289 (299)
T ss_dssp             CCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSCC
T ss_pred             hccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCCCCC
Confidence            00   000011223568999999999999999999999999999999977653

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=2.1e-56  Score=412.31  Aligned_cols=254  Identities=26%  Similarity=0.448  Sum_probs=216.9

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecccc------------hHHHHHHHHHHHHhcCCCCceEEeeEEEc
Q 015374          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK------------KKKIKREIKILQNLCGGPNVVKLLDIVRD  191 (408)
Q Consensus       124 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~------------~~~~~~E~~~l~~l~~h~niv~l~~~~~~  191 (408)
                      .++|++.+.||+|+||+||+|++..+++.||||+++...            .+.+.+|+.+++++..||||++++++|.+
T Consensus         2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~   81 (277)
T d1phka_           2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET   81 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred             cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence            578999999999999999999999999999999985321            24578999999999559999999999965


Q ss_pred             cCCCccEEEEEeecCCChhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccce
Q 015374          192 QHSKTPSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE  268 (408)
Q Consensus       192 ~~~~~~~lv~e~~~~~~l~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~  268 (408)
                        +...+|||||+++++|..++   ..+++.+++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++
T Consensus        82 --~~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~-~~~kl~DFG~a~  158 (277)
T d1phka_          82 --NTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDD-MNIKLTDFGFSC  158 (277)
T ss_dssp             --SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTT-CCEEECCCTTCE
T ss_pred             --CcceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCC-CCeEEccchhee
Confidence              57889999999999999887   469999999999999999999999999999999999999988 899999999999


Q ss_pred             eccCCCcceeeccCccccccccccC-----CcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhh
Q 015374          269 FYHPGKEYNVRVASRYFKGPELLVD-----LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWC  343 (408)
Q Consensus       269 ~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  343 (408)
                      ............||..|+|||.+.+     ...++.++||||+||++|+|++|+.||. +.+..+....+.....     
T Consensus       159 ~~~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~-~~~~~~~~~~i~~~~~-----  232 (277)
T d1phka_         159 QLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFW-HRKQMLMLRMIMSGNY-----  232 (277)
T ss_dssp             ECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSC-CSSHHHHHHHHHHTCC-----
T ss_pred             EccCCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCC-CCCHHHHHHHHHhCCC-----
Confidence            8876666666789999999999863     2457889999999999999999999984 4444455444443210     


Q ss_pred             cCCCCCCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccc
Q 015374          344 NSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQ  397 (408)
Q Consensus       344 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~  397 (408)
                        .         ........+|+++.+|+.+||+.||++|||++|+|+||||++
T Consensus       233 --~---------~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~  275 (277)
T d1phka_         233 --Q---------FGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ  275 (277)
T ss_dssp             --C---------CCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCT
T ss_pred             --C---------CCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHHHH
Confidence              0         111223348999999999999999999999999999999975

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=3.1e-56  Score=424.58  Aligned_cols=251  Identities=22%  Similarity=0.402  Sum_probs=217.6

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc------chHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCcc
Q 015374          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP  197 (408)
Q Consensus       124 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~  197 (408)
                      -++|++++.||+|+||+||+|++..+|+.||||+++..      ..+.+.+|+.+++.+ +||||+++++++.+  ....
T Consensus        40 ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~~~~~~~~--~~~~  116 (350)
T d1rdqe_          40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVKLEFSFKD--NSNL  116 (350)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTC-CCTTBCCEEEEEEC--SSEE
T ss_pred             ccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHc-CCCcEeeccccccc--cccc
Confidence            36899999999999999999999999999999998632      235688999999999 99999999999965  4678


Q ss_pred             EEEEEeecCCChhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCCC
Q 015374          198 SLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK  274 (408)
Q Consensus       198 ~lv~e~~~~~~l~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~~  274 (408)
                      ++||||+.+|++..++   ..+++..++.++.||+.||.|||++|||||||||+|||++.+ +.+||+|||+|+....  
T Consensus       117 ~~v~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~-g~ikL~DFG~a~~~~~--  193 (350)
T d1rdqe_         117 YMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQ-GYIQVTDFGFAKRVKG--  193 (350)
T ss_dssp             EEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT-SCEEECCCTTCEECSS--
T ss_pred             ccccccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCC-CCEEeeeceeeeeccc--
Confidence            8999999999998876   469999999999999999999999999999999999999988 7999999999987753  


Q ss_pred             cceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCCCccc
Q 015374          275 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSK  354 (408)
Q Consensus       275 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  354 (408)
                      ......||+.|+|||++.+ ..++.++|||||||++|||++|..|| .+.+..+.+..+...                  
T Consensus       194 ~~~~~~Gt~~Y~APE~~~~-~~~~~~~DiwSlGvilyemltG~~Pf-~~~~~~~~~~~i~~~------------------  253 (350)
T d1rdqe_         194 RTWTLCGTPEALAPEIILS-KGYNKAVDWWALGVLIYEMAAGYPPF-FADQPIQIYEKIVSG------------------  253 (350)
T ss_dssp             CBCCCEECGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSS-CCSSHHHHHHHHHHC------------------
T ss_pred             ccccccCccccCCHHHHcC-CCCCccccccchhHHHHHHHhCCCCC-CCcCHHHHHHHHhcC------------------
Confidence            3345789999999999988 78999999999999999999999998 444444555544432                  


Q ss_pred             cccccCCCCCCHHHHHHHHHhcccCcCCCC-----CHHHHhcCCCccccccch
Q 015374          355 FINADNQHLVSPEAIDFLDKLLRYDHQDRL-----TAREAMAHPYFAQVRAAE  402 (408)
Q Consensus       355 ~~~~~~~~~~~~~~~~li~~~L~~dp~~Rp-----t~~elL~hp~f~~~~~~~  402 (408)
                        ....+..+++++.+||++||+.||.+|+     |++|+++||||+.+++..
T Consensus       254 --~~~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~Hp~f~~~~~~~  304 (350)
T d1rdqe_         254 --KVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIA  304 (350)
T ss_dssp             --CCCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCCHHH
T ss_pred             --CCCCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcCccccCCCHHH
Confidence              1122345899999999999999999995     999999999999887644

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4e-56  Score=417.31  Aligned_cols=276  Identities=28%  Similarity=0.488  Sum_probs=224.7

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCC-CcEEEEEEeccc-----chHHHHHHHHHHHHhc--CCCCceEEeeEEEcc--
Q 015374          123 DQDDYEVVRKVGRGKYSEVFEGINVNT-NERCIIKILKPV-----KKKKIKREIKILQNLC--GGPNVVKLLDIVRDQ--  192 (408)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~-~~~vavK~~~~~-----~~~~~~~E~~~l~~l~--~h~niv~l~~~~~~~--  192 (408)
                      ..++|+++++||+|+||+||+|++..+ ++.||||+++..     ....+.+|+.+++.+.  +||||++++++|...  
T Consensus         5 ~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~   84 (305)
T d1blxa_           5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT   84 (305)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred             CcCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccc
Confidence            357999999999999999999999765 677999998632     2345778888887763  799999999998642  


Q ss_pred             -CCCccEEEEEeecCCChhhhc----CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccc
Q 015374          193 -HSKTPSLIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA  267 (408)
Q Consensus       193 -~~~~~~lv~e~~~~~~l~~~~----~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a  267 (408)
                       .....+++|||+.++++....    ..+++..++.++.|++.||+|||++||+||||||+|||++.+ +.+||+|||++
T Consensus        85 ~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~-~~~kl~dfg~~  163 (305)
T d1blxa_          85 DRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSS-GQIKLADFGLA  163 (305)
T ss_dssp             SSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT-CCEEECSCCSC
T ss_pred             ccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCC-CCeeecchhhh
Confidence             335788999999998876543    458999999999999999999999999999999999999988 79999999999


Q ss_pred             eeccCCCcceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCC
Q 015374          268 EFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRH  347 (408)
Q Consensus       268 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (408)
                      +............||+.|+|||++.+ ..|+.++||||+||++|||++|+.|| .+.++.+++..+....+.........
T Consensus       164 ~~~~~~~~~~~~~gT~~Y~APE~~~~-~~y~~~~DiwSlG~il~ell~g~~pf-~~~~~~~~~~~i~~~~~~~~~~~~~~  241 (305)
T d1blxa_         164 RIYSFQMALTSVVVTLWYRAPEVLLQ-SSYATPVDLWSVGCIFAEMFRRKPLF-RGSSDVDQLGKILDVIGLPGEEDWPR  241 (305)
T ss_dssp             CCCCGGGGGCCCCCCCTTCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSC-CCSSHHHHHHHHHHHHCCCCGGGSCT
T ss_pred             hhhcccccCCCcccChhhcCcchhcC-CCCChhehhhchHHHHHHHHHCCCCC-CCCCHHHHHHHHHHhhCCCchhcccc
Confidence            87766666677899999999999987 78999999999999999999999997 56677788888877766443222211


Q ss_pred             CCCCcccc-------ccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccccccc
Q 015374          348 SRKPWSKF-------INADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAA  401 (408)
Q Consensus       348 ~~~~~~~~-------~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~~~~~  401 (408)
                      ........       ........+++++.+||++||++||++|||++|+|+||||++++.-
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i~~~  302 (305)
T d1blxa_         242 DVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLERC  302 (305)
T ss_dssp             TCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCCC
T ss_pred             cccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCchhh
Confidence            11110000       1122345578999999999999999999999999999999998653

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-56  Score=417.20  Aligned_cols=272  Identities=30%  Similarity=0.583  Sum_probs=222.0

Q ss_pred             CCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc-----chHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccEE
Q 015374          125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSL  199 (408)
Q Consensus       125 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l  199 (408)
                      ++|++++.||+|+||+||+|++..+++.||||+++..     ....+.+|+.+++++ +||||++++++|.+  +...++
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l-~Hp~Iv~~~~~~~~--~~~~~i   78 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL-NHPNIVKLLDVIHT--ENKLYL   78 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTC-CCTTBCCEEEEEEE--TTEEEE
T ss_pred             CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhC-CCCcEEEecccccc--ccceeE
Confidence            6899999999999999999999999999999998632     246788999999999 99999999999966  467899


Q ss_pred             EEEeecCCChhhhc----CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCC-C
Q 015374          200 IFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG-K  274 (408)
Q Consensus       200 v~e~~~~~~l~~~~----~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~-~  274 (408)
                      ||||+.++++....    ..+++..++.++.|++.||+|||++|||||||||+|||++.+ +.+||+|||+|+..... .
T Consensus        79 v~e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~-~~~kl~DFG~a~~~~~~~~  157 (298)
T d1gz8a_          79 VFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTE-GAIKLADFGLARAFGVPVR  157 (298)
T ss_dssp             EEECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTT-SCEEECSTTHHHHHCCCSB
T ss_pred             EEeecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeeccc-CcceeccCCcceeccCCcc
Confidence            99999987665543    459999999999999999999999999999999999999988 79999999999876543 3


Q ss_pred             cceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCC------C
Q 015374          275 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRH------S  348 (408)
Q Consensus       275 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~------~  348 (408)
                      ......||+.|+|||++.....++.++|||||||++|+|++|+.|| .+.++.+.+..+....+.........      .
T Consensus       158 ~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf-~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  236 (298)
T d1gz8a_         158 TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALF-PGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY  236 (298)
T ss_dssp             CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSC-CCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTC
T ss_pred             cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCC-CCCCHHHHHHHHHHhcCCCchhhcccccccccc
Confidence            4455689999999999887566789999999999999999999997 56666777777776655332111110      0


Q ss_pred             CCC---ccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccccccc
Q 015374          349 RKP---WSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAA  401 (408)
Q Consensus       349 ~~~---~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~~~~~  401 (408)
                      ...   +...........+++++.+|+++||+.||++|||++|+|+||||+++...
T Consensus       237 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~~p  292 (298)
T d1gz8a_         237 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP  292 (298)
T ss_dssp             CTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCCCC
T ss_pred             ccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccCCCC
Confidence            000   00000111223568999999999999999999999999999999988664

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.1e-56  Score=420.03  Aligned_cols=253  Identities=25%  Similarity=0.476  Sum_probs=218.4

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecccc--hHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccEEEE
Q 015374          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK--KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIF  201 (408)
Q Consensus       124 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~  201 (408)
                      .++|++.+.||+|+||+||+|++..+++.||||+++...  ...+.+|+.+|+.+ +||||++++++|.+  ...+++||
T Consensus         4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~~~~~~~Ei~il~~l-~HpnIv~~~~~~~~--~~~~~lvm   80 (321)
T d1tkia_           4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIA-RHRNILHLHESFES--MEELVMIF   80 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHS-CCTTBCCEEEEEEE--TTEEEEEE
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcccHHHHHHHHHHHHhC-CCCCCCeEEEEEEE--CCEEEEEE
Confidence            578999999999999999999999999999999997543  34678999999999 99999999999976  46789999


Q ss_pred             EeecCCChhhhcC----CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCC-CCcEEEEecccceeccCCCcc
Q 015374          202 EYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE-LRKLRLIDWGLAEFYHPGKEY  276 (408)
Q Consensus       202 e~~~~~~l~~~~~----~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~-~~~~kl~DfG~a~~~~~~~~~  276 (408)
                      |||++++|..++.    .+++.+++.++.||+.||+|||++||+||||||+|||++.+ ...+||+|||+++........
T Consensus        81 E~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~~~  160 (321)
T d1tkia_          81 EFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF  160 (321)
T ss_dssp             CCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCEE
T ss_pred             ecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhccccCCcc
Confidence            9999999988873    48999999999999999999999999999999999999854 358999999999988776667


Q ss_pred             eeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCCCccccc
Q 015374          277 NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSKFI  356 (408)
Q Consensus       277 ~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  356 (408)
                      ....+|+.|+|||.+.+ ..++.++|||||||++|+|++|..|| .+.+..+.+..+.....            .    .
T Consensus       161 ~~~~~t~~y~ape~~~~-~~~~~~~DiWSlGvily~ll~G~~Pf-~~~~~~~~~~~i~~~~~------------~----~  222 (321)
T d1tkia_         161 RLLFTAPEYYAPEVHQH-DVVSTATDMWSLGTLVYVLLSGINPF-LAETNQQIIENIMNAEY------------T----F  222 (321)
T ss_dssp             EEEESCGGGSCHHHHTT-CEECHHHHHHHHHHHHHHHHHSSCTT-CCSSHHHHHHHHHHTCC------------C----C
T ss_pred             cccccccccccchhccC-CCCCchhhcccHHHHHHHHHhCCCCC-CCCCHHHHHHHHHhCCC------------C----C
Confidence            77899999999999987 78999999999999999999999998 45555555555544210            0    1


Q ss_pred             cccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccc
Q 015374          357 NADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQ  397 (408)
Q Consensus       357 ~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~  397 (408)
                      +...+..+++++++||.+||..||++|||++|+|+||||++
T Consensus       223 ~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~  263 (321)
T d1tkia_         223 DEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQ  263 (321)
T ss_dssp             CHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHS
T ss_pred             ChhhccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhcc
Confidence            11223347899999999999999999999999999999974

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.2e-56  Score=417.12  Aligned_cols=253  Identities=26%  Similarity=0.452  Sum_probs=215.1

Q ss_pred             CCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc------chHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccE
Q 015374          125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS  198 (408)
Q Consensus       125 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  198 (408)
                      ++|++.+.||+|+||+||+|++..+++.||||+++..      ..+.+..|..++.+..+||||+++++++.+  +...+
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~--~~~~y   79 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQT--KENLF   79 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEEC--SSEEE
T ss_pred             CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEcc--CCcee
Confidence            5799999999999999999999999999999999632      234567788777643399999999999965  46789


Q ss_pred             EEEEeecCCChhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCC-C
Q 015374          199 LIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG-K  274 (408)
Q Consensus       199 lv~e~~~~~~l~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~-~  274 (408)
                      +||||+++|+|..++   ..+++.+++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++..... .
T Consensus        80 ivmEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~-~~~kl~DFG~a~~~~~~~~  158 (320)
T d1xjda_          80 FVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKD-GHIKIADFGMCKENMLGDA  158 (320)
T ss_dssp             EEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTT-SCEEECCCTTCBCCCCTTC
T ss_pred             EEEeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCC-Cceeccccchhhhcccccc
Confidence            999999999999987   569999999999999999999999999999999999999988 89999999999865433 3


Q ss_pred             cceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCCCccc
Q 015374          275 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSK  354 (408)
Q Consensus       275 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  354 (408)
                      ......||+.|+|||++.+ ..++.++|||||||++|||++|+.|| .+.+..+.+..+...                  
T Consensus       159 ~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvilyemltG~~PF-~~~~~~~~~~~i~~~------------------  218 (320)
T d1xjda_         159 KTNTFCGTPDYIAPEILLG-QKYNHSVDWWSFGVLLYEMLIGQSPF-HGQDEEELFHSIRMD------------------  218 (320)
T ss_dssp             CBCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSS-CCSSHHHHHHHHHHC------------------
T ss_pred             cccccCCCCCcCCHHHHcC-CCCCchhhhhhhhHHHHHHHhCCCCC-CCCCHHHHHHHHHcC------------------
Confidence            3445689999999999988 78999999999999999999999998 455545554444321                  


Q ss_pred             cccccCCCCCCHHHHHHHHHhcccCcCCCCCHH-HHhcCCCccccccch
Q 015374          355 FINADNQHLVSPEAIDFLDKLLRYDHQDRLTAR-EAMAHPYFAQVRAAE  402 (408)
Q Consensus       355 ~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~-elL~hp~f~~~~~~~  402 (408)
                        ....+..+++++.+||++||+.||++|||+. |+++||||+++...+
T Consensus       219 --~~~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~hpff~~~~~~~  265 (320)
T d1xjda_         219 --NPFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREINWEE  265 (320)
T ss_dssp             --CCCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTCCHHH
T ss_pred             --CCCCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHhCchhccCCHHH
Confidence              1122345899999999999999999999996 899999999876543

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=1.2e-55  Score=422.72  Aligned_cols=255  Identities=25%  Similarity=0.429  Sum_probs=209.7

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecccc------hHHHHHH---HHHHHHhcCCCCceEEeeEEEccCC
Q 015374          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK------KKKIKRE---IKILQNLCGGPNVVKLLDIVRDQHS  194 (408)
Q Consensus       124 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~------~~~~~~E---~~~l~~l~~h~niv~l~~~~~~~~~  194 (408)
                      -++|++.+.||+|+||+||+|++..+|+.||||+++...      ...+.+|   +.+++.+ +||||++++++|.+  .
T Consensus         3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~-~hpnIv~l~~~~~~--~   79 (364)
T d1omwa3           3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG-DCPFIVCMSYAFHT--P   79 (364)
T ss_dssp             STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSS-CCTTBCCEEEEEEC--S
T ss_pred             HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcC-CCCcEEEEEEEEEE--C
Confidence            468999999999999999999999999999999986322      2334455   5555565 79999999999965  4


Q ss_pred             CccEEEEEeecCCChhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceecc
Q 015374          195 KTPSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH  271 (408)
Q Consensus       195 ~~~~lv~e~~~~~~l~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~  271 (408)
                      ..+++||||+++|+|..++   ..+++..++.++.||+.||+|||++|||||||||+|||++.+ +.+||+|||+|+...
T Consensus        80 ~~~~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~-g~iKl~DFGla~~~~  158 (364)
T d1omwa3          80 DKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEH-GHVRISDLGLACDFS  158 (364)
T ss_dssp             SEEEEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-SCEEECCCTTCEECS
T ss_pred             CEEEEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCC-CcEEEeeeceeeecC
Confidence            6789999999999999887   458999999999999999999999999999999999999988 899999999998765


Q ss_pred             CCCcceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCCC
Q 015374          272 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKP  351 (408)
Q Consensus       272 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  351 (408)
                      .. ......||+.|+|||++.+...++.++|||||||++|||++|+.||...... +.. .+.....             
T Consensus       159 ~~-~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~-~~~-~~~~~~~-------------  222 (364)
T d1omwa3         159 KK-KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK-DKH-EIDRMTL-------------  222 (364)
T ss_dssp             SS-CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSS-CHH-HHHHHSS-------------
T ss_pred             CC-cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHH-HHH-HHHHhcc-------------
Confidence            43 3445689999999999976467999999999999999999999998543322 111 1111100             


Q ss_pred             ccccccccCCCCCCHHHHHHHHHhcccCcCCCCC-----HHHHhcCCCccccccc
Q 015374          352 WSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLT-----AREAMAHPYFAQVRAA  401 (408)
Q Consensus       352 ~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt-----~~elL~hp~f~~~~~~  401 (408)
                         ......+..+++++.+||.+||+.||++|||     ++|+++||||+++.+.
T Consensus       223 ---~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~i~~~  274 (364)
T d1omwa3         223 ---TMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQ  274 (364)
T ss_dssp             ---SCCCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTTCCHH
T ss_pred             ---cCCCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcCccccCCCHH
Confidence               0112234458999999999999999999999     7999999999988654

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-55  Score=420.74  Aligned_cols=274  Identities=30%  Similarity=0.509  Sum_probs=222.9

Q ss_pred             CCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecccchHHHHHHHHHHHHhcCCCCceEEeeEEEcc----CCCccEEE
Q 015374          125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQ----HSKTPSLI  200 (408)
Q Consensus       125 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~----~~~~~~lv  200 (408)
                      .+|+.+++||+|+||+||+|++..+++.||||+++.. .....+|+.+++++ +|+||++++++|...    +..+++||
T Consensus        20 ~~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-~~~~~~Ei~il~~l-~h~niv~~~~~~~~~~~~~~~~~~~lv   97 (350)
T d1q5ka_          20 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-KRFKNRELQIMRKL-DHCNIVRLRYFFYSSGEKKDEVYLNLV   97 (350)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-SSSCCHHHHHHHHC-CCTTBCCEEEEEEEC--CCSCCEEEEE
T ss_pred             CCcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECcc-chHHHHHHHHHHhc-CCCCCCcEEEEEEecCccCCceEEEEE
Confidence            3699999999999999999999999999999999643 23446899999999 999999999998642    33467899


Q ss_pred             EEeecCCChhhhc------CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCCC
Q 015374          201 FEYVNSTDFKVLY------PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK  274 (408)
Q Consensus       201 ~e~~~~~~l~~~~------~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~~  274 (408)
                      |||++++++..+.      ..+++..++.++.|++.||+|||++||+||||||+|||++.+...+||+|||+++......
T Consensus        98 ~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~~~  177 (350)
T d1q5ka_          98 LDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE  177 (350)
T ss_dssp             EECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCEECCTTS
T ss_pred             EeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccchhhccCCc
Confidence            9999988654442      3599999999999999999999999999999999999999875689999999999887766


Q ss_pred             cceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhc-----CCCCC
Q 015374          275 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCN-----SRHSR  349 (408)
Q Consensus       275 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~  349 (408)
                      ......||..|+|||.+.+...++.++||||+||++|||++|..|| .+.+..+++..+....|......     .....
T Consensus       178 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf-~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~  256 (350)
T d1q5ka_         178 PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF-PGDSGVDQLVEIIKVLGTPTREQIREMNPNYTE  256 (350)
T ss_dssp             CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSS-CCSSHHHHHHHHHHHHCCCCHHHHHHHCC---C
T ss_pred             ccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCC-CCCCHHHHHHHHHHHhCCChHHhhhhhccchhh
Confidence            6777899999999999987678999999999999999999999887 56666777877777655332110     00011


Q ss_pred             CCccc----cccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccccccc
Q 015374          350 KPWSK----FINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAA  401 (408)
Q Consensus       350 ~~~~~----~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~~~~~  401 (408)
                      ..+..    .........+++++.+||.+||++||++|||++|+|+||||++++..
T Consensus       257 ~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~  312 (350)
T d1q5ka_         257 FKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDP  312 (350)
T ss_dssp             CCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGCT
T ss_pred             ccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccccCC
Confidence            11100    01112234578999999999999999999999999999999987553

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-56  Score=422.81  Aligned_cols=259  Identities=25%  Similarity=0.416  Sum_probs=211.3

Q ss_pred             CCCEEEEee-eeeeCceEEEEEEEcCCCcEEEEEEecccchHHHHHHHHHHHHhcCCCCceEEeeEEEc--cCCCccEEE
Q 015374          124 QDDYEVVRK-VGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRD--QHSKTPSLI  200 (408)
Q Consensus       124 ~~~y~~~~~-lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~--~~~~~~~lv  200 (408)
                      -++|+++.+ ||+|+||+||+|++..+++.||||+++  ....+.+|+.++.++.+||||++++++|.+  .....+++|
T Consensus        10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~--~~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~iv   87 (335)
T d2ozaa1          10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ--DCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIV   87 (335)
T ss_dssp             GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEE--CSHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEE
T ss_pred             ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEEC--CcHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEEEE
Confidence            468998864 999999999999999999999999996  346788999998777689999999999965  234678999


Q ss_pred             EEeecCCChhhhcC-----CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCC--CCcEEEEecccceeccCC
Q 015374          201 FEYVNSTDFKVLYP-----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE--LRKLRLIDWGLAEFYHPG  273 (408)
Q Consensus       201 ~e~~~~~~l~~~~~-----~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~--~~~~kl~DfG~a~~~~~~  273 (408)
                      ||||+||+|..++.     .+++.+++.++.|++.||+|||++||+||||||+|||++.+  .+.+||+|||+|+.....
T Consensus        88 mEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~~~  167 (335)
T d2ozaa1          88 MECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH  167 (335)
T ss_dssp             EECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCTTCEECCCC
T ss_pred             EECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccccceeeeccCC
Confidence            99999999998872     48999999999999999999999999999999999999863  357999999999988777


Q ss_pred             CcceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCCCcc
Q 015374          274 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWS  353 (408)
Q Consensus       274 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  353 (408)
                      .......||+.|+|||++.+ ..|+.++|||||||++|+|++|+.||. +.+..+....+.....        .....  
T Consensus       168 ~~~~~~~gt~~y~aPE~~~~-~~y~~~~DiwSlGvily~lltg~~Pf~-~~~~~~~~~~~~~~i~--------~~~~~--  235 (335)
T d2ozaa1         168 NSLTTPCYTPYYVAPEVLGP-EKYDKSCDMWSLGVIMYILLCGYPPFY-SNHGLAISPGMKTRIR--------MGQYE--  235 (335)
T ss_dssp             CCCCCCSCCCSSCCCCCCCG-GGGSHHHHHHHHHHHHHHHTTSSCSCE-ETTCC--------CCC--------SCSSS--
T ss_pred             CccccccCCcccCCcHHHcC-CCCCHHHHHHhhchhHHHHhhCCCCCC-CCCHHHHHHHHHHHHh--------cCCCC--
Confidence            77777899999999999987 789999999999999999999999984 3332222222211100        00000  


Q ss_pred             ccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccc
Q 015374          354 KFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQV  398 (408)
Q Consensus       354 ~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~~  398 (408)
                        .+...+..+|+++.+||++||+.||++|||++|+|+||||++.
T Consensus       236 --~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~  278 (335)
T d2ozaa1         236 --FPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS  278 (335)
T ss_dssp             --CCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHTT
T ss_pred             --CCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhCC
Confidence              1111223478999999999999999999999999999999643

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-55  Score=405.18  Aligned_cols=247  Identities=26%  Similarity=0.436  Sum_probs=207.3

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecccc---------hHHHHHHHHHHHHhc-CCCCceEEeeEEEccC
Q 015374          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK---------KKKIKREIKILQNLC-GGPNVVKLLDIVRDQH  193 (408)
Q Consensus       124 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~---------~~~~~~E~~~l~~l~-~h~niv~l~~~~~~~~  193 (408)
                      +++|++.+.||+|+||+||+|++..+++.||||+++...         ..++.+|+.+++++. .||||+++++++.+  
T Consensus         3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~--   80 (273)
T d1xwsa_           3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFER--   80 (273)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEEC--
T ss_pred             CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEee--
Confidence            578999999999999999999999999999999986421         234678999999993 38999999999965  


Q ss_pred             CCccEEEEEeecC-CChhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEeccccee
Q 015374          194 SKTPSLIFEYVNS-TDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEF  269 (408)
Q Consensus       194 ~~~~~lv~e~~~~-~~l~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~  269 (408)
                      ....++||||+.+ +++..++   ..+++..++.++.|++.||+|||++||+||||||+|||++.+.+.+||+|||+|+.
T Consensus        81 ~~~~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~  160 (273)
T d1xwsa_          81 PDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGAL  160 (273)
T ss_dssp             SSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred             CCeEEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECcccccee
Confidence            4678899999976 5666554   46999999999999999999999999999999999999997757999999999987


Q ss_pred             ccCCCcceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCC
Q 015374          270 YHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSR  349 (408)
Q Consensus       270 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  349 (408)
                      ... .......||+.|+|||++.+...++.++|||||||++|||++|+.||..    .+   .+...             
T Consensus       161 ~~~-~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~----~~---~i~~~-------------  219 (273)
T d1xwsa_         161 LKD-TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH----DE---EIIRG-------------  219 (273)
T ss_dssp             CCS-SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCS----HH---HHHHC-------------
T ss_pred             ccc-ccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCC----ch---HHhhc-------------
Confidence            543 3345678999999999998744557789999999999999999999842    11   11111             


Q ss_pred             CCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccccc
Q 015374          350 KPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRA  400 (408)
Q Consensus       350 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~~~~  400 (408)
                             ....+..+|+++.+||++||+.||++|||++|+|+||||+++..
T Consensus       220 -------~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~~~  263 (273)
T d1xwsa_         220 -------QVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLL  263 (273)
T ss_dssp             -------CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCCC
T ss_pred             -------ccCCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCCCC
Confidence                   11123348999999999999999999999999999999998754

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-55  Score=404.67  Aligned_cols=249  Identities=16%  Similarity=0.309  Sum_probs=212.1

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc--chHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccEEE
Q 015374          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV--KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI  200 (408)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  200 (408)
                      ..++|++.++||+|+||+||+|++. ++..||||+++..  ..+.+.+|+.+++++ +|||||++++++.+   ...++|
T Consensus        11 ~~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~~~g~~~~---~~~~iv   85 (272)
T d1qpca_          11 PRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMSPDAFLAEANLMKQL-QHQRLVRLYAVVTQ---EPIYII   85 (272)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSCHHHHHHHHHHHHHC-CCTTBCCEEEEECS---SSCEEE
T ss_pred             CHHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCcCCHHHHHHHHHHHHhC-CCCCEeEEEeeecc---CCeEEE
Confidence            4678999999999999999999864 6788999999743  457799999999999 99999999998843   456899


Q ss_pred             EEeecCCChhhhcC-----CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCCCc
Q 015374          201 FEYVNSTDFKVLYP-----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE  275 (408)
Q Consensus       201 ~e~~~~~~l~~~~~-----~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~~~  275 (408)
                      |||+++|+|..++.     .+++..+..++.||+.||.|||+++|+||||||+|||++.+ +.+||+|||+|+.......
T Consensus        86 ~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~-~~~Kl~DFGla~~~~~~~~  164 (272)
T d1qpca_          86 TEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDT-LSCKIADFGLARLIEDNEY  164 (272)
T ss_dssp             EECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTT-SCEEECCCTTCEECSSSCE
T ss_pred             EEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecc-cceeeccccceEEccCCcc
Confidence            99999999988763     48999999999999999999999999999999999999988 7999999999988764432


Q ss_pred             --ceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCCCcc
Q 015374          276 --YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWS  353 (408)
Q Consensus       276 --~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  353 (408)
                        .....||..|+|||++.+ ..++.++|||||||++|||+||+.|++...+..+.+..+...                 
T Consensus       165 ~~~~~~~gt~~y~APE~~~~-~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~-----------------  226 (272)
T d1qpca_         165 TAREGAKFPIKWTAPEAINY-GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERG-----------------  226 (272)
T ss_dssp             ECCTTCCCCTTTSCHHHHHH-CEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT-----------------
T ss_pred             ccccccCCcccccChHHHhC-CCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhc-----------------
Confidence              233568889999999987 679999999999999999999888887776666655554332                 


Q ss_pred             ccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhc--CCCccc
Q 015374          354 KFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA--HPYFAQ  397 (408)
Q Consensus       354 ~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~--hp~f~~  397 (408)
                        .....+..+++++.+|+.+||+.||++|||++|+++  |+||++
T Consensus       227 --~~~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~fts  270 (272)
T d1qpca_         227 --YRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA  270 (272)
T ss_dssp             --CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             --CCCCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhhc
Confidence              112233458899999999999999999999999998  888864

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=7e-55  Score=405.06  Aligned_cols=267  Identities=29%  Similarity=0.536  Sum_probs=215.7

Q ss_pred             CCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc-----chHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccEE
Q 015374          125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSL  199 (408)
Q Consensus       125 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l  199 (408)
                      ++|+++++||+|+||+||+|++. +++.||||+++..     ..+.+.+|+.+++++ +||||++++++|.+  ....++
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~~~~~~~~--~~~~~i   77 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKEL-KHSNIVKLYDVIHT--KKRLVL   77 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGC-CCTTBCCEEEEEEC--SSCEEE
T ss_pred             CCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhC-CCCcEEeeeeeccc--CCceeE
Confidence            68999999999999999999875 7899999998642     246789999999999 99999999999965  467889


Q ss_pred             EEEeecCCChhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCCC-c
Q 015374          200 IFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK-E  275 (408)
Q Consensus       200 v~e~~~~~~l~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~~-~  275 (408)
                      +|||+.++++..+.   ..+++..++.++.|++.||+|||++|||||||||+|||++.+ +.+||+|||.+....... .
T Consensus        78 ~~e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~-~~~kl~DfG~a~~~~~~~~~  156 (286)
T d1ob3a_          78 VFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINRE-GELKIADFGLARAFGIPVRK  156 (286)
T ss_dssp             EEECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTT-SCEEECCTTHHHHHCC----
T ss_pred             EEEeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCC-CCEEecccccceecccCccc
Confidence            99999999887775   458999999999999999999999999999999999999998 899999999998765432 3


Q ss_pred             ceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCC---------
Q 015374          276 YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSR---------  346 (408)
Q Consensus       276 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~---------  346 (408)
                      .....+++.|+|||.+.+...++.++|||||||++|||++|+.|| .+.++.+++..+....+........         
T Consensus       157 ~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf-~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  235 (286)
T d1ob3a_         157 YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLF-PGVSEADQLMRIFRILGTPNSKNWPNVTELPKYD  235 (286)
T ss_dssp             -----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSC-CCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCC
T ss_pred             cceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCC-CCCCHHHHHHHHHHhhCCCChhhccchhhhhhcc
Confidence            345678999999999987677899999999999999999999997 5666677777776665533211110         


Q ss_pred             CCCCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccc
Q 015374          347 HSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQ  397 (408)
Q Consensus       347 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~  397 (408)
                      .................+++++.|||++||+.||++|||++|+|+||||++
T Consensus       236 ~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~~  286 (286)
T d1ob3a_         236 PNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE  286 (286)
T ss_dssp             TTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred             cccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCc
Confidence            000001111112334557899999999999999999999999999999984

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=6e-55  Score=404.96  Aligned_cols=245  Identities=18%  Similarity=0.334  Sum_probs=209.1

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc--chHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccEEE
Q 015374          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV--KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI  200 (408)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  200 (408)
                      ..++|++.++||+|+||+||+|++..+++.||||+++..  ..+++.+|+.+++++ +|||||+++++|.+  +...++|
T Consensus        15 ~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~--~~~~~iv   91 (287)
T d1opja_          15 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI-KHPNLVQLLGVCTR--EPPFYII   91 (287)
T ss_dssp             CGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSCHHHHHHHHHHHHHC-CCTTBCCEEEEECS--SSSCEEE
T ss_pred             cHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccchHHHHHHHHHHHHhC-CCCCEecCCccEee--CCeeEEE
Confidence            467899999999999999999999999999999998743  457899999999999 99999999999954  5678899


Q ss_pred             EEeecCCChhhhc-----CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCCCc
Q 015374          201 FEYVNSTDFKVLY-----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE  275 (408)
Q Consensus       201 ~e~~~~~~l~~~~-----~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~~~  275 (408)
                      |||+++|++..++     ..+++..+..++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+|+.......
T Consensus        92 ~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~-~~~Kl~DFG~a~~~~~~~~  170 (287)
T d1opja_          92 TEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGEN-HLVKVADFGLSRLMTGDTY  170 (287)
T ss_dssp             EECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGG-GCEEECCCCCTTTCCSSSS
T ss_pred             eecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCC-CcEEEccccceeecCCCCc
Confidence            9999999998876     358999999999999999999999999999999999999988 7999999999987654433


Q ss_pred             c--eeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCCCcc
Q 015374          276 Y--NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWS  353 (408)
Q Consensus       276 ~--~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  353 (408)
                      .  ....|+..|+|||++.+ ..++.++|||||||++|||++|+.||+.+.+..+....+...                 
T Consensus       171 ~~~~~~~g~~~y~aPE~~~~-~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~-----------------  232 (287)
T d1opja_         171 TAHAGAKFPIKWTAPESLAY-NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKD-----------------  232 (287)
T ss_dssp             EEETTEEECGGGCCHHHHHH-CCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTT-----------------
T ss_pred             eeeccccccccccChHHHcC-CCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcC-----------------
Confidence            2  23457888999999987 789999999999999999999998887666544433322221                 


Q ss_pred             ccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 015374          354 KFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA  391 (408)
Q Consensus       354 ~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~  391 (408)
                        .....+..+++++.+|+.+||+.||++|||++|+++
T Consensus       233 --~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~  268 (287)
T d1opja_         233 --YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ  268 (287)
T ss_dssp             --CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             --CCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence              122334558999999999999999999999999976

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-54  Score=398.13  Aligned_cols=249  Identities=15%  Similarity=0.335  Sum_probs=200.7

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecc--cchHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccEEE
Q 015374          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP--VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI  200 (408)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~--~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  200 (408)
                      +.++|++.+.||+|+||+||+|++. +++.||||+++.  ...+++.+|+.+++++ +||||++++|+|.+  ....++|
T Consensus         3 dp~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~E~~~l~~l-~HpnIv~~~g~~~~--~~~~~lv   78 (263)
T d1sm2a_           3 DPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKL-SHPKLVQLYGVCLE--QAPICLV   78 (263)
T ss_dssp             CCSCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSSSCHHHHHHHHHHHHHC-CCTTBCCEEEEECS--SSSCEEE
T ss_pred             ChHHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCcCcHHHHHHHHHHHHhc-CCCCcccccceecc--CCceEEE
Confidence            4678999999999999999999875 567899999974  3457899999999999 99999999999955  4678899


Q ss_pred             EEeecCCChhhhc----CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCCCc-
Q 015374          201 FEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE-  275 (408)
Q Consensus       201 ~e~~~~~~l~~~~----~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~~~-  275 (408)
                      |||+++|+|..++    ..+++..+..++.|++.||+|||+++|+||||||+|||++.+ +.+||+|||+++....... 
T Consensus        79 ~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~-~~~Kl~DFGla~~~~~~~~~  157 (263)
T d1sm2a_          79 FEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGEN-QVIKVSDFGMTRFVLDDQYT  157 (263)
T ss_dssp             EECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGG-GCEEECSCC-----------
T ss_pred             EEecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCC-CCeEecccchheeccCCCce
Confidence            9999999998876    347889999999999999999999999999999999999998 7999999999987654432 


Q ss_pred             -ceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCCCccc
Q 015374          276 -YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSK  354 (408)
Q Consensus       276 -~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  354 (408)
                       .....||..|+|||++.+ ..++.++|||||||++|||+|++.|++...+..+.+..+...                  
T Consensus       158 ~~~~~~gt~~y~aPE~l~~-~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~------------------  218 (263)
T d1sm2a_         158 SSTGTKFPVKWASPEVFSF-SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTG------------------  218 (263)
T ss_dssp             -------CTTSCCHHHHTT-CCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHT------------------
T ss_pred             eecceecCcccCChHHhcC-CCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhc------------------
Confidence             234578899999999987 789999999999999999999877776666655555544332                  


Q ss_pred             cccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccc
Q 015374          355 FINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQV  398 (408)
Q Consensus       355 ~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~~  398 (408)
                       .....+..+++++.+++.+||+.||++|||++|+++|  |+++
T Consensus       219 -~~~~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~--L~~i  259 (263)
T d1sm2a_         219 -FRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQ--LAEI  259 (263)
T ss_dssp             -CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH--HHHH
T ss_pred             -CCCCCccccCHHHHHHHHHHccCCHhHCcCHHHHHHH--HHHH
Confidence             1122234578999999999999999999999999987  4443

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.3e-54  Score=410.43  Aligned_cols=267  Identities=32%  Similarity=0.563  Sum_probs=213.1

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc-----chHHHHHHHHHHHHhcCCCCceEEeeEEEccC----
Q 015374          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQH----  193 (408)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~----  193 (408)
                      ..++|+++++||+|+||+||+|++..+|+.||||+++..     ..+.+.+|+.+|+++ +|||||+++++|...+    
T Consensus        16 ~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l-~hpniv~l~~~~~~~~~~~~   94 (346)
T d1cm8a_          16 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHM-RHENVIGLLDVFTPDETLDD   94 (346)
T ss_dssp             CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHC-CBTTBCCCSEEECSCSSTTT
T ss_pred             cCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhc-CCCCeeEEEEEeccCccccc
Confidence            578999999999999999999999999999999998642     235688999999999 9999999999997543    


Q ss_pred             CCccEEEEEeecCCChhhhc--CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceecc
Q 015374          194 SKTPSLIFEYVNSTDFKVLY--PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH  271 (408)
Q Consensus       194 ~~~~~lv~e~~~~~~l~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~  271 (408)
                      ....++||||+ +.++....  ..+++..++.++.|++.||+|||++||+||||||+|||++.+ +.+|++|||+|+...
T Consensus        95 ~~~~~lv~e~~-~~~l~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~-~~~kl~Dfg~a~~~~  172 (346)
T d1cm8a_          95 FTDFYLVMPFM-GTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNED-CELKILDFGLARQAD  172 (346)
T ss_dssp             CCCCEEEEECC-SEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTT-CCEEECCCTTCEECC
T ss_pred             cceEEEEEecc-cccHHHHHHhccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccc-cccccccccceeccC
Confidence            23579999999 45565554  469999999999999999999999999999999999999998 799999999998765


Q ss_pred             CCCcceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhh--------
Q 015374          272 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWC--------  343 (408)
Q Consensus       272 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--------  343 (408)
                      .  ......||+.|+|||++.+...++.++||||+||++|+|++|+.|| .+.+..+.+..+....+.....        
T Consensus       173 ~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (346)
T d1cm8a_         173 S--EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLF-KGSDHLDQLKEIMKVTGTPPAEFVQRLQSD  249 (346)
T ss_dssp             S--SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSS-CCSSHHHHHHHHHHHHCCCCHHHHHTCSCH
T ss_pred             C--ccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCC-CCCChHHHHHHHHhccCCCcHHHHhhhcch
Confidence            3  3456789999999999987667899999999999999999999997 4555566666655544432211        


Q ss_pred             --------cCCCCCCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccccc
Q 015374          344 --------NSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRA  400 (408)
Q Consensus       344 --------~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~~~~  400 (408)
                              ........+     ......+++++.+||++||.+||++|||++|+|+||||+.+..
T Consensus       250 ~~~~~~~~~~~~~~~~~-----~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~~  309 (346)
T d1cm8a_         250 EAKNYMKGLPELEKKDF-----ASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHD  309 (346)
T ss_dssp             HHHHHHHHSCCCCCCCG-----GGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC-
T ss_pred             hhhhhhccCCcccccch-----HHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCCC
Confidence                    111111111     1223457899999999999999999999999999999998754

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.5e-54  Score=398.52  Aligned_cols=271  Identities=30%  Similarity=0.529  Sum_probs=223.8

Q ss_pred             CCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc-----chHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccEE
Q 015374          125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSL  199 (408)
Q Consensus       125 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l  199 (408)
                      ++|+++++||+|+||+||+|++..+++.||||+++..     ....+.+|+.+++++ +||||++++++|.+  ....++
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l-~h~niv~~~~~~~~--~~~~~i   78 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKEL-KHKNIVRLHDVLHS--DKKLTL   78 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTC-CCTTBCCEEEEEEC--SSEEEE
T ss_pred             CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhc-CcCCEEeecccccc--ccceeE
Confidence            6899999999999999999999999999999998632     246788999999999 99999999999965  467789


Q ss_pred             EEEeecCCChhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCCC-c
Q 015374          200 IFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK-E  275 (408)
Q Consensus       200 v~e~~~~~~l~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~~-~  275 (408)
                      |+|++.++++..++   ..+++..++.++.|++.||+|||++||+||||||+|||++.+ +.+||+|||.++...... .
T Consensus        79 v~~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~-~~~kl~DFG~a~~~~~~~~~  157 (292)
T d1unla_          79 VFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRN-GELKLANFGLARAFGIPVRC  157 (292)
T ss_dssp             EEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT-CCEEECCCTTCEECCSCCSC
T ss_pred             EeeeccccccccccccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccC-CceeeeecchhhcccCCCcc
Confidence            99999999987765   468999999999999999999999999999999999999988 789999999998775433 3


Q ss_pred             ceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCC-------CC
Q 015374          276 YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSR-------HS  348 (408)
Q Consensus       276 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~  348 (408)
                      .....++..|+|||++.+...++.++|||||||++|||++|+.||+.+.+..+.+..+....+........       ..
T Consensus       158 ~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (292)
T d1unla_         158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYK  237 (292)
T ss_dssp             CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCC
T ss_pred             ceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhccccc
Confidence            44556788899999998756689999999999999999999999998888888887776655533211110       00


Q ss_pred             CCCcc--ccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccccc
Q 015374          349 RKPWS--KFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVR  399 (408)
Q Consensus       349 ~~~~~--~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~~~  399 (408)
                      .....  ..........+++++.+||++||+.||.+||||+|+|+||||++..
T Consensus       238 ~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~~~  290 (292)
T d1unla_         238 PYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFC  290 (292)
T ss_dssp             CCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSSCS
T ss_pred             ccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcCCC
Confidence            00000  0011223345689999999999999999999999999999998753

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.1e-54  Score=397.41  Aligned_cols=250  Identities=17%  Similarity=0.342  Sum_probs=206.6

Q ss_pred             CCCCEEEEe-eeeeeCceEEEEEEEcC--CCcEEEEEEeccc----chHHHHHHHHHHHHhcCCCCceEEeeEEEccCCC
Q 015374          123 DQDDYEVVR-KVGRGKYSEVFEGINVN--TNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSK  195 (408)
Q Consensus       123 ~~~~y~~~~-~lG~G~fg~Vy~~~~~~--~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  195 (408)
                      ..++|.+.+ +||+|+||+||+|++..  ++..||||+++..    ..+.|.+|+.+++++ +|||||+++|+|.+   .
T Consensus         6 ~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~---~   81 (285)
T d1u59a_           6 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQL-DNPYIVRLIGVCQA---E   81 (285)
T ss_dssp             CGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEES---S
T ss_pred             cccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhC-CCCCEeeEeeeecc---C
Confidence            467888888 49999999999997654  4557999998642    346789999999999 99999999999964   3


Q ss_pred             ccEEEEEeecCCChhhhc----CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceecc
Q 015374          196 TPSLIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH  271 (408)
Q Consensus       196 ~~~lv~e~~~~~~l~~~~----~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~  271 (408)
                      .+++||||+++|+|..++    ..+++..+..++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+|+...
T Consensus        82 ~~~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~-~~~Kl~DFGla~~~~  160 (285)
T d1u59a_          82 ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNR-HYAKISDFGLSKALG  160 (285)
T ss_dssp             SEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEET-TEEEECCCTTCEECT
T ss_pred             eEEEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccC-Cceeeccchhhhccc
Confidence            578999999999998875    348999999999999999999999999999999999999988 799999999998776


Q ss_pred             CCCcc----eeeccCccccccccccCCcCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHhhhchhhhhcCC
Q 015374          272 PGKEY----NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKDCCLIIWCNSR  346 (408)
Q Consensus       272 ~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  346 (408)
                      .....    ....||..|+|||++.+ ..++.++|||||||++|||+| |+.|| .+.+..+....+...          
T Consensus       161 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDVwS~Gv~l~E~lt~G~~Pf-~~~~~~~~~~~i~~~----------  228 (285)
T d1u59a_         161 ADDSYYTARSAGKWPLKWYAPECINF-RKFSSRSDVWSYGVTMWEALSYGQKPY-KKMKGPEVMAFIEQG----------  228 (285)
T ss_dssp             TCSCEECCCCSSCCCGGGCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCTT-TTCCTHHHHHHHHTT----------
T ss_pred             ccccccccccccccCccccChHHHhC-CCCCccchhhcchHHHHHHHhCCCCCC-CCCCHHHHHHHHHcC----------
Confidence            54332    23467889999999987 789999999999999999998 88887 445555554444321          


Q ss_pred             CCCCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHH---hcCCCcccc
Q 015374          347 HSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREA---MAHPYFAQV  398 (408)
Q Consensus       347 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~el---L~hp~f~~~  398 (408)
                               .....+..+++++.+|+.+||+.||++|||+.++   |+|+|++-.
T Consensus       229 ---------~~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~~~  274 (285)
T d1u59a_         229 ---------KRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLA  274 (285)
T ss_dssp             ---------CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred             ---------CCCCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHhh
Confidence                     1122345589999999999999999999999887   678887533

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-54  Score=414.13  Aligned_cols=272  Identities=25%  Similarity=0.461  Sum_probs=210.7

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc-----chHHHHHHHHHHHHhcCCCCceEEeeEEEcc----CC
Q 015374          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQ----HS  194 (408)
Q Consensus       124 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~----~~  194 (408)
                      .++|+++++||+|+||+||+|++..+|+.||||+++..     ....+.+|+.+++++ +||||++++++|...    ..
T Consensus        16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~~~~~f~~~~~~~~~   94 (355)
T d2b1pa1          16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCV-NHKNIISLLNVFTPQKTLEEF   94 (355)
T ss_dssp             ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHC-CCTTBCCCSEEECSCCSTTTC
T ss_pred             cCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhc-CCCCeeEEEEEEecccccccC
Confidence            37899999999999999999999999999999998632     235688999999999 999999999999654    34


Q ss_pred             CccEEEEEeecCCChhhhcCCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCCC
Q 015374          195 KTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK  274 (408)
Q Consensus       195 ~~~~lv~e~~~~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~~  274 (408)
                      .++|+||||+.++++......+++..++.++.|++.||+|||++||+||||||+|||++.+ +.++++|||+++......
T Consensus        95 ~~~~iv~Ey~~~~l~~~~~~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~-~~~kl~df~~~~~~~~~~  173 (355)
T d2b1pa1          95 QDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSD-CTLKILDFGLARTAGTSF  173 (355)
T ss_dssp             CEEEEEEECCSEEHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTT-CCEEECCCCC--------
T ss_pred             ceeEEEEeccchHHHHhhhcCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccc-cceeeechhhhhcccccc
Confidence            6889999999999999888999999999999999999999999999999999999999998 789999999998777666


Q ss_pred             cceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhc----------
Q 015374          275 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCN----------  344 (408)
Q Consensus       275 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~----------  344 (408)
                      ......+|+.|+|||++.+ ..++.++||||+||++|+|++|+.|| .+.+..+....+....+......          
T Consensus       174 ~~~~~~~t~~y~aPE~l~~-~~~~~~~DiwSlG~~l~ell~g~~pF-~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  251 (355)
T d2b1pa1         174 MMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMVRHKILF-PGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRN  251 (355)
T ss_dssp             -------CCTTCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCSS-CCSSHHHHHHHHHHHHCCCCHHHHTTSCHHHHH
T ss_pred             ccccccccccccChhhhcC-CCCCCCcccccccchHHHHhhCCCCC-CCCCHHHHHHHHHHhccCCCHHHHHHhhhhHHH
Confidence            6677789999999999988 78999999999999999999999887 56666666666665544221110          


Q ss_pred             -----CCCCCCCccccccc-------cCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccccc
Q 015374          345 -----SRHSRKPWSKFINA-------DNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVR  399 (408)
Q Consensus       345 -----~~~~~~~~~~~~~~-------~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~~~  399 (408)
                           .......+......       ......++++.+||++||.+||++||||+|+|+||||+...
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~~~  318 (355)
T d2b1pa1         252 YVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWY  318 (355)
T ss_dssp             HHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGC
T ss_pred             HhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCCC
Confidence                 01111111111110       01112367899999999999999999999999999998643

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.9e-53  Score=400.13  Aligned_cols=274  Identities=30%  Similarity=0.481  Sum_probs=214.6

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc-----chHHHHHHHHHHHHhcCCCCceEEeeEEEccC-----
Q 015374          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQH-----  193 (408)
Q Consensus       124 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~-----  193 (408)
                      -++|+++++||+|+||+||+|++..+|+.||||+++..     ....+.+|+.+|+++ +|||++++++++....     
T Consensus         9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l-~h~nii~~~~~~~~~~~~~~~   87 (318)
T d3blha1           9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLL-KHENVVNLIEICRTKASPYNR   87 (318)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHC-CCTTBCCEEEEEEC-------
T ss_pred             cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHh-cCCCccceEeeeecccccccc
Confidence            47899999999999999999999999999999998532     245688999999999 9999999999986532     


Q ss_pred             -CCccEEEEEeecCCChhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEeccccee
Q 015374          194 -SKTPSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEF  269 (408)
Q Consensus       194 -~~~~~lv~e~~~~~~l~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~  269 (408)
                       ....++||||+.++++....   ..+++..++.++.|++.||.|||++||+||||||+|||++.+ +.+||+|||+++.
T Consensus        88 ~~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~-~~~kl~dfg~~~~  166 (318)
T d3blha1          88 CKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRD-GVLKLADFGLARA  166 (318)
T ss_dssp             ---CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTT-SCEEECCCTTCEE
T ss_pred             cCceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCC-CcEEeeecceeee
Confidence             34688999999999887665   468999999999999999999999999999999999999998 7999999999976


Q ss_pred             ccCCC-----cceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhc
Q 015374          270 YHPGK-----EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCN  344 (408)
Q Consensus       270 ~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  344 (408)
                      .....     .....+||+.|+|||++.+...++.++|||||||++|||++|+.|| .+.++.+.+..+....+......
T Consensus       167 ~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf-~~~~~~~~~~~i~~~~~~~~~~~  245 (318)
T d3blha1         167 FSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIM-QGNTEQHQLALISQLCGSITPEV  245 (318)
T ss_dssp             CCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSC-CCSSHHHHHHHHHHHHCCCCTTT
T ss_pred             cccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCC-CCCCHHHHHHHHHHhcCCCChhh
Confidence            65322     2334579999999999987668999999999999999999999887 56666666666666554332111


Q ss_pred             CCC-CCCCccccccc--cC---------CCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccccc
Q 015374          345 SRH-SRKPWSKFINA--DN---------QHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRA  400 (408)
Q Consensus       345 ~~~-~~~~~~~~~~~--~~---------~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~~~~  400 (408)
                      ... ...........  ..         ....++++.|||.+||++||++|||++|+|+||||+.-+.
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~~p~  313 (318)
T d3blha1         246 WPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPM  313 (318)
T ss_dssp             STTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSSSSC
T ss_pred             ccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhccCCC
Confidence            100 00000000000  00         0113678899999999999999999999999999986544

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-53  Score=402.39  Aligned_cols=247  Identities=21%  Similarity=0.381  Sum_probs=205.9

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCc-----EEEEEEecc----cchHHHHHHHHHHHHhcCCCCceEEeeEEEccC
Q 015374          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNE-----RCIIKILKP----VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQH  193 (408)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~-----~vavK~~~~----~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~  193 (408)
                      ..++|++.+.||+|+||+||+|++..+++     .||+|.+..    .....+.+|+.++.++.+|||||+++++|.+  
T Consensus        35 ~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~--  112 (325)
T d1rjba_          35 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTL--  112 (325)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECS--
T ss_pred             CHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEee--
Confidence            46789999999999999999999876544     689998853    2345788999999998789999999999955  


Q ss_pred             CCccEEEEEeecCCChhhhcC--------------------------CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCC
Q 015374          194 SKTPSLIFEYVNSTDFKVLYP--------------------------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKP  247 (408)
Q Consensus       194 ~~~~~lv~e~~~~~~l~~~~~--------------------------~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~  247 (408)
                      ....++||||+++|+|..++.                          .+++..+..++.|++.||.|||+++||||||||
T Consensus       113 ~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDlKp  192 (325)
T d1rjba_         113 SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAA  192 (325)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSG
T ss_pred             CCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCch
Confidence            467899999999999998872                          278889999999999999999999999999999


Q ss_pred             CcEEEeCCCCcEEEEecccceeccCCCcc---eeeccCccccccccccCCcCCCccccHHHHHHHHHHHHh-CCCCCCCC
Q 015374          248 HNVMIDHELRKLRLIDWGLAEFYHPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYG  323 (408)
Q Consensus       248 ~NILl~~~~~~~kl~DfG~a~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-g~~pf~~~  323 (408)
                      +|||++.+ +.+||+|||+|+........   ....||+.|+|||++.+ ..++.++|||||||++|||++ |..|| .+
T Consensus       193 ~Nill~~~-~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DiwS~Gvil~emlt~g~~Pf-~~  269 (325)
T d1rjba_         193 RNVLVTHG-KVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFE-GIYTIKSDVWSYGILLWEIFSLGVNPY-PG  269 (325)
T ss_dssp             GGEEEETT-TEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHTTTSCCSS-TT
T ss_pred             hccccccC-CeEEEeeccccccccCCCceeeeccccCCCccCChHHHcC-CCCCcceeccchhHHHHHHHhCCCCCC-CC
Confidence            99999988 89999999999876544332   23567899999999987 789999999999999999998 78887 45


Q ss_pred             CCCHHHHHHHHhhhchhhhhcCCCCCCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 015374          324 HDNHDQLVKIAKDCCLIIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH  392 (408)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~h  392 (408)
                      .+..+.+.+++...                  .....+..+++++.+||.+||+.||++|||++|+++|
T Consensus       270 ~~~~~~~~~~~~~~------------------~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~  320 (325)
T d1rjba_         270 IPVDANFYKLIQNG------------------FKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF  320 (325)
T ss_dssp             CCCSHHHHHHHHTT------------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCHHHHHHHHHhcC------------------CCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            44445555544321                  1122344589999999999999999999999999976

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.4e-54  Score=396.09  Aligned_cols=247  Identities=15%  Similarity=0.311  Sum_probs=199.5

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecc-----cchHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCcc
Q 015374          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP-----VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP  197 (408)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~-----~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~  197 (408)
                      ..++|++.++||+|+||+||+|+..   ..||||+++.     ...+.|.+|+.+++++ +||||+++++++.+   ...
T Consensus         6 ~~~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~~~~~~~~---~~~   78 (276)
T d1uwha_           6 PDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKT-RHVNILLFMGYSTA---PQL   78 (276)
T ss_dssp             CTTCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSSCCTTHHHHHHHHHHHHTTC-CCTTBCCEEEEECS---SSC
T ss_pred             ccccEEEEEEEeeCCCcEEEEEEEC---CEEEEEEEEcccCCHHHHHHHHHHHHHHHhC-CCCCEeeeeEEEec---cEE
Confidence            4678999999999999999999743   3599999863     2346789999999999 99999999999843   457


Q ss_pred             EEEEEeecCCChhhhc----CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCC
Q 015374          198 SLIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG  273 (408)
Q Consensus       198 ~lv~e~~~~~~l~~~~----~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~  273 (408)
                      ++||||+++|+|..++    ..+++..+..++.|++.||+|||+++||||||||+|||++.+ +.+||+|||+|+.....
T Consensus        79 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~-~~~Kl~DFGla~~~~~~  157 (276)
T d1uwha_          79 AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHED-LTVKIGDFGLATVKSRW  157 (276)
T ss_dssp             EEEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETT-SSEEECCCCCSCC----
T ss_pred             EEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCC-CCEEEccccceeecccc
Confidence            8999999999998877    348999999999999999999999999999999999999998 79999999999776432


Q ss_pred             C---cceeeccCccccccccccCC--cCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCC
Q 015374          274 K---EYNVRVASRYFKGPELLVDL--QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHS  348 (408)
Q Consensus       274 ~---~~~~~~~~~~y~aPE~~~~~--~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  348 (408)
                      .   ......||+.|+|||++.+.  ..++.++|||||||++|||+||+.|| .+.++.+.+.........         
T Consensus       158 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf-~~~~~~~~~~~~~~~~~~---------  227 (276)
T d1uwha_         158 SGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPY-SNINNRDQIIFMVGRGYL---------  227 (276)
T ss_dssp             --------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTT-TTCCCHHHHHHHHHHTSC---------
T ss_pred             CCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCC-CCCChHHHHHHHHhcCCC---------
Confidence            2   23446789999999999652  35899999999999999999999998 455555555444432110         


Q ss_pred             CCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 015374          349 RKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH  392 (408)
Q Consensus       349 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~h  392 (408)
                      ..     .....+..+++++.+|+.+||+.||++|||++|++++
T Consensus       228 ~p-----~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~  266 (276)
T d1uwha_         228 SP-----DLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILAS  266 (276)
T ss_dssp             CC-----CGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CC-----cchhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence            00     0112334578999999999999999999999999986

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.6e-54  Score=395.11  Aligned_cols=247  Identities=18%  Similarity=0.334  Sum_probs=199.3

Q ss_pred             CEEEE-eeeeeeCceEEEEEEEc--CCCcEEEEEEeccc-----chHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCcc
Q 015374          126 DYEVV-RKVGRGKYSEVFEGINV--NTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP  197 (408)
Q Consensus       126 ~y~~~-~~lG~G~fg~Vy~~~~~--~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~  197 (408)
                      .+.+. ++||+|+||+||+|.+.  .+++.||||+++..     ..+.+.+|+.+++++ +|||||+++++|.+   ...
T Consensus         7 ~~~le~k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~g~~~~---~~~   82 (277)
T d1xbba_           7 LLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQL-DNPYIVRMIGICEA---ESW   82 (277)
T ss_dssp             GEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTC-CCTTBCCEEEEEES---SSE
T ss_pred             hCeecCCCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhC-CCCCCceEEEEecc---CCE
Confidence            34444 46999999999999754  45578999998632     245789999999999 99999999999954   346


Q ss_pred             EEEEEeecCCChhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCCC
Q 015374          198 SLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK  274 (408)
Q Consensus       198 ~lv~e~~~~~~l~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~~  274 (408)
                      +|||||+++|+|..++   ..+++..+..++.||+.||+|||+++|+||||||+|||++.+ +.+||+|||+++......
T Consensus        83 ~lvmE~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~-~~~kl~DFGla~~~~~~~  161 (277)
T d1xbba_          83 MLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQ-HYAKISDFGLSKALRADE  161 (277)
T ss_dssp             EEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEET-TEEEECCCTTCEECCTTC
T ss_pred             EEEEEcCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhccccc-Ccccccchhhhhhccccc
Confidence            8999999999998887   458999999999999999999999999999999999999988 799999999998765443


Q ss_pred             cc----eeeccCccccccccccCCcCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCC
Q 015374          275 EY----NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSR  349 (408)
Q Consensus       275 ~~----~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  349 (408)
                      ..    ....||+.|+|||++.+ ..++.++|||||||++|||++ |+.|| .+.+..+....+...             
T Consensus       162 ~~~~~~~~~~gt~~y~APE~l~~-~~~~~~sDiwS~Gv~l~ellt~g~~Pf-~~~~~~~~~~~i~~~-------------  226 (277)
T d1xbba_         162 NYYKAQTHGKWPVKWYAPECINY-YKFSSKSDVWSFGVLMWEAFSYGQKPY-RGMKGSEVTAMLEKG-------------  226 (277)
T ss_dssp             SEEEC----CCCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTTCCSS-TTCCHHHHHHHHHTT-------------
T ss_pred             cccccccccCCCceecCchhhcC-CCCCchhhhccchhhhhHHhhCCCCCC-CCCCHHHHHHHHHcC-------------
Confidence            32    23468889999999987 789999999999999999998 78887 444444433333221             


Q ss_pred             CCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHH---hcCCCcccc
Q 015374          350 KPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREA---MAHPYFAQV  398 (408)
Q Consensus       350 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~el---L~hp~f~~~  398 (408)
                            .....+..+++++.+|+.+||+.||++|||++++   |+|+|++-+
T Consensus       227 ------~~~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~~  272 (277)
T d1xbba_         227 ------ERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVV  272 (277)
T ss_dssp             ------CCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHHH
T ss_pred             ------CCCCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHhhcC
Confidence                  1122334589999999999999999999999998   567776544

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-53  Score=394.35  Aligned_cols=251  Identities=18%  Similarity=0.315  Sum_probs=208.2

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc--chHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccEEE
Q 015374          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV--KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI  200 (408)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  200 (408)
                      ..++|++.++||+|+||+||+|++..+ ..||||+++..  ..+.|.+|+.+++++ +|||||+++++|.+   ...++|
T Consensus        15 ~~~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~~~~~~~~~E~~~l~~l-~h~nIv~~~g~~~~---~~~~lv   89 (285)
T d1fmka3          15 PRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFLQEAQVMKKL-RHEKLVQLYAVVSE---EPIYIV   89 (285)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTSSCHHHHHHHHHHHHHC-CCTTBCCEEEEECS---SSCEEE
T ss_pred             CHHHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECcccCCHHHHHHHHHHHHhc-ccCCEeEEEEEEec---CCeEEE
Confidence            357899999999999999999987654 57999999743  347799999999999 99999999999843   346899


Q ss_pred             EEeecCCChhhhc-----CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCCC-
Q 015374          201 FEYVNSTDFKVLY-----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK-  274 (408)
Q Consensus       201 ~e~~~~~~l~~~~-----~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~~-  274 (408)
                      |||+++|++..++     ..+++.++..++.||+.||.|||++||+||||||+|||++.+ +.+||+|||+++...... 
T Consensus        90 ~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~-~~~kl~DfGla~~~~~~~~  168 (285)
T d1fmka3          90 TEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGEN-LVCKVADFGLARLIEDNEY  168 (285)
T ss_dssp             ECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGG-GCEEECCCCTTC-------
T ss_pred             EEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCC-CcEEEcccchhhhccCCCc
Confidence            9999999988776     358999999999999999999999999999999999999988 799999999998765433 


Q ss_pred             -cceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCCCcc
Q 015374          275 -EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWS  353 (408)
Q Consensus       275 -~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  353 (408)
                       ......+|..|+|||++.+ +.++.++|||||||++|||++|+.||+.+....+.+..+....                
T Consensus       169 ~~~~~~~gt~~y~aPE~~~~-~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~----------------  231 (285)
T d1fmka3         169 TARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGY----------------  231 (285)
T ss_dssp             -------CCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC----------------
T ss_pred             eeeccccccccccChHHHhC-CCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcC----------------
Confidence             2334678999999999987 7899999999999999999999889877777666665544321                


Q ss_pred             ccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhc--CCCccccc
Q 015374          354 KFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA--HPYFAQVR  399 (408)
Q Consensus       354 ~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~--hp~f~~~~  399 (408)
                         ....+..+++++.+|+.+||+.||++|||++++++  ++||+...
T Consensus       232 ---~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~~  276 (285)
T d1fmka3         232 ---RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE  276 (285)
T ss_dssp             ---CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSC
T ss_pred             ---CCCCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCCC
Confidence               12233458899999999999999999999999988  89998764

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=2.3e-53  Score=396.53  Aligned_cols=245  Identities=18%  Similarity=0.304  Sum_probs=192.3

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCc---EEEEEEeccc----chHHHHHHHHHHHHhcCCCCceEEeeEEEccCCC
Q 015374          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNE---RCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSK  195 (408)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~---~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  195 (408)
                      ..++|++.+.||+|+||+||+|++..+++   .||||.+...    ..+.|.+|+.+|+++ +|||||+++|+|.+  ..
T Consensus        24 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~g~~~~--~~  100 (299)
T d1jpaa_          24 DISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQF-DHPNVIHLEGVVTK--ST  100 (299)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEECS--SS
T ss_pred             ChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhC-CCCCCccEEEEEee--CC
Confidence            45789999999999999999999876664   5889987532    345789999999999 99999999999954  46


Q ss_pred             ccEEEEEeecCCChhhhc----CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceecc
Q 015374          196 TPSLIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH  271 (408)
Q Consensus       196 ~~~lv~e~~~~~~l~~~~----~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~  271 (408)
                      ..++||||+++|+|..++    ..+++.++..++.|++.||+|||+++|+||||||+|||++.+ +.+||+|||+|+...
T Consensus       101 ~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~-~~~Kl~DFGla~~~~  179 (299)
T d1jpaa_         101 PVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSN-LVCKVSDFGLSRFLE  179 (299)
T ss_dssp             SCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTT-CCEEECCC-------
T ss_pred             EEEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCC-CcEEECCcccceEcc
Confidence            789999999999998866    248999999999999999999999999999999999999988 799999999998765


Q ss_pred             CCCcc------eeeccCccccccccccCCcCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHhhhchhhhhc
Q 015374          272 PGKEY------NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKDCCLIIWCN  344 (408)
Q Consensus       272 ~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  344 (408)
                      .....      ....+|..|+|||.+.+ ..++.++|||||||++|||+| |..|| .+....+.+..+...        
T Consensus       180 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~sDvwS~Gvvl~el~t~g~~Pf-~~~~~~~~~~~i~~~--------  249 (299)
T d1jpaa_         180 DDTSDPTYTSALGGKIPIRWTAPEAIQY-RKFTSASDVWSYGIVMWEVMSYGERPY-WDMTNQDVINAIEQD--------  249 (299)
T ss_dssp             ----------------CGGGSCHHHHHS-CCCCHHHHHHHHHHHHHHHHTTSCCTT-TTCCHHHHHHHHHTT--------
T ss_pred             CCCCcceeeecccccCCccccCHHHHhc-CCCCcccccccchHHHHHHHhCCCCCC-CCCCHHHHHHHHHcC--------
Confidence            43321      12357888999999987 789999999999999999998 77776 444444444443321        


Q ss_pred             CCCCCCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 015374          345 SRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH  392 (408)
Q Consensus       345 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~h  392 (408)
                                 .....+..+++++.+++.+||+.||++|||++|++++
T Consensus       250 -----------~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~  286 (299)
T d1jpaa_         250 -----------YRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNT  286 (299)
T ss_dssp             -----------CCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             -----------CCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence                       1112234578999999999999999999999999875

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-53  Score=387.06  Aligned_cols=243  Identities=18%  Similarity=0.322  Sum_probs=205.5

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecc--cchHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccEEEE
Q 015374          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP--VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIF  201 (408)
Q Consensus       124 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~--~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~  201 (408)
                      .++|++.++||+|+||+||+|++ .++..||||+++.  ...+++.+|+.+++++ +||||++++|+|.+  ....++||
T Consensus         3 ~~~~~~~~~iG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~~~~~~~~~Ev~~~~~l-~HpnIv~~~g~~~~--~~~~~iv~   78 (258)
T d1k2pa_           3 PKDLTFLKELGTGQFGVVKYGKW-RGQYDVAIKMIKEGSMSEDEFIEEAKVMMNL-SHEKLVQLYGVCTK--QRPIFIIT   78 (258)
T ss_dssp             CCCCCCCCCCCEETTEEEEEEEE-TTTEEEEEEEEESSSSCHHHHHHHHHHHHTC-CCTTBCCEEEEECC--SSSEEEEE
T ss_pred             hHHCEEeEEEecCCCeEEEEEEE-CCCCEEEEEEECcCcCCHHHHHHHHHHHHhc-CCCceeeEEEEEee--CCceEEEE
Confidence            56788899999999999999997 5788999999874  3457899999999999 99999999999954  46789999


Q ss_pred             EeecCCChhhhc----CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCCCc--
Q 015374          202 EYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE--  275 (408)
Q Consensus       202 e~~~~~~l~~~~----~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~~~--  275 (408)
                      ||+++|++..++    ..+++..+..++.|++.||.|||++||+||||||+|||++.+ +.+||+|||+++.......  
T Consensus        79 Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~-~~~kl~DfG~a~~~~~~~~~~  157 (258)
T d1k2pa_          79 EYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQ-GVVKVSDFGLSRYVLDDEYTS  157 (258)
T ss_dssp             ECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTT-CCEEECCCSSCCBCSSSSCCC
T ss_pred             EccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCC-CcEEECcchhheeccCCCcee
Confidence            999999988875    458899999999999999999999999999999999999988 7999999999986654332  


Q ss_pred             ceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCCCccc
Q 015374          276 YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSK  354 (408)
Q Consensus       276 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  354 (408)
                      .....+|..|+|||.+.+ ..++.++|||||||++|||+| |+.|| .+.+..+....+...                  
T Consensus       158 ~~~~~~t~~y~aPE~~~~-~~~~~ksDiwS~G~~l~el~t~g~~Pf-~~~~~~~~~~~i~~~------------------  217 (258)
T d1k2pa_         158 SVGSKFPVRWSPPEVLMY-SKFSSKSDIWAFGVLMWEIYSLGKMPY-ERFTNSETAEHIAQG------------------  217 (258)
T ss_dssp             CCCSCCCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTT-TTSCHHHHHHHHHTT------------------
T ss_pred             ecccCCCCCcCCcHHhcC-CCCCcceeecccchhhHhHHhcCCCCC-CCCCHHHHHHHHHhC------------------
Confidence            234578889999999987 789999999999999999998 67776 455544544444321                  


Q ss_pred             cccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 015374          355 FINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH  392 (408)
Q Consensus       355 ~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~h  392 (408)
                       .....+..+++++.+|+.+||+.||++|||++|+++|
T Consensus       218 -~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  254 (258)
T d1k2pa_         218 -LRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSN  254 (258)
T ss_dssp             -CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             -CCCCCcccccHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence             1122334578999999999999999999999999987

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8e-53  Score=401.23  Aligned_cols=271  Identities=28%  Similarity=0.542  Sum_probs=213.8

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecccc----hHHHHHHHHHHHHhcCCCCceEEeeEEEccCC--Cc
Q 015374          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHS--KT  196 (408)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~--~~  196 (408)
                      .+++|+++++||+|+||+||+|++..+++.||||+++...    .+.+.+|+.+|+++ +||||+++++++.....  ..
T Consensus         6 i~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l-~hp~iv~~~~~~~~~~~~~~~   84 (345)
T d1pmea_           6 VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRF-RHENIIGINDIIRAPTIEQMK   84 (345)
T ss_dssp             CCTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHC-CCTTBCCCCEEECCSSTTTCC
T ss_pred             cCCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHc-CCCCCCcEEEEEeeccccccc
Confidence            3578999999999999999999999999999999996432    35688999999999 99999999999965321  12


Q ss_pred             cEEEEEeecCCChhhhc--CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCCC
Q 015374          197 PSLIFEYVNSTDFKVLY--PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK  274 (408)
Q Consensus       197 ~~lv~e~~~~~~l~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~~  274 (408)
                      .+++++|+.+++|..++  ..+++..++.++.|++.||+|||++|||||||||+|||++.+ +.+||+|||+++......
T Consensus        85 ~~~l~~~~~~g~L~~~l~~~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~-~~~kl~DfG~a~~~~~~~  163 (345)
T d1pmea_          85 DVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTT-CDLKICDFGLARVADPDH  163 (345)
T ss_dssp             CEEEEEECCCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTT-CCEEECCCTTCEECCGGG
T ss_pred             eEEEEEeecCCchhhhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCC-CCEEEcccCceeeccCCC
Confidence            34556677789998887  579999999999999999999999999999999999999988 799999999998764432


Q ss_pred             c----ceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhh-------
Q 015374          275 E----YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWC-------  343 (408)
Q Consensus       275 ~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-------  343 (408)
                      .    ....+||+.|+|||++.....++.++||||+||++|+|++|+.|| .+.+..++........+.....       
T Consensus       164 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (345)
T d1pmea_         164 DHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF-PGKHYLDQLNHILGILGSPSQEDLNCIIN  242 (345)
T ss_dssp             CBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSC-CCSSHHHHHHHHHHHHCSCCHHHHHTCCC
T ss_pred             ccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCC-CCCCHHHHHHHHhhhccCCChhhhhhhhh
Confidence            2    345679999999999876577899999999999999999999997 4555555555544433322110       


Q ss_pred             ---------cCCCCCCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccccccc
Q 015374          344 ---------NSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAA  401 (408)
Q Consensus       344 ---------~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~~~~~  401 (408)
                               ........|..     ....+++++++|+.+||+.||.+|||++|+|+||||+.....
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~-----~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~~~  304 (345)
T d1pmea_         243 LKARNYLLSLPHKNKVPWNR-----LFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDP  304 (345)
T ss_dssp             HHHHHHHHTSCCCCCCCHHH-----HCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTCCG
T ss_pred             hhhhcccccCCccCCCCHHH-----hCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCCCC
Confidence                     11111111111     123468899999999999999999999999999999966554

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-52  Score=388.86  Aligned_cols=245  Identities=15%  Similarity=0.291  Sum_probs=197.9

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCC----cEEEEEEeccc----chHHHHHHHHHHHHhcCCCCceEEeeEEEccCC
Q 015374          123 DQDDYEVVRKVGRGKYSEVFEGINVNTN----ERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHS  194 (408)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~----~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~  194 (408)
                      ..+.|++.+.||+|+||+||+|.+..++    ..||||+++..    ....|.+|+.+++++ +|||||+++|+|.+  .
T Consensus         5 ~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l-~H~nIv~~~g~~~~--~   81 (283)
T d1mqba_           5 HPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF-SHHNIIRLEGVISK--Y   81 (283)
T ss_dssp             CTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEECS--S
T ss_pred             CHHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhc-CCCCEeeeeEEEec--C
Confidence            4678999999999999999999876654    46999998642    235688999999999 99999999999954  4


Q ss_pred             CccEEEEEeecCCChhhhc----CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceec
Q 015374          195 KTPSLIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY  270 (408)
Q Consensus       195 ~~~~lv~e~~~~~~l~~~~----~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~  270 (408)
                      ...++||||+.++++...+    ..+++.++..++.|++.||+|||+++|+||||||+|||++.+ +.+||+|||+++..
T Consensus        82 ~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~-~~~Kl~DFGla~~~  160 (283)
T d1mqba_          82 KPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSN-LVCKVSDFGLSRVL  160 (283)
T ss_dssp             SSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTT-CCEEECCCCC----
T ss_pred             CceEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCC-CeEEEcccchhhcc
Confidence            6788999999999987765    458999999999999999999999999999999999999998 79999999999876


Q ss_pred             cCCCc----ceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCC
Q 015374          271 HPGKE----YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSR  346 (408)
Q Consensus       271 ~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  346 (408)
                      .....    .....||..|+|||++.+ ..++.++|||||||++|||++++.||+.+.+..+.+..+...          
T Consensus       161 ~~~~~~~~~~~~~~gt~~Y~APE~l~~-~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~----------  229 (283)
T d1mqba_         161 EDDPEATYTTSGGKIPIRWTAPEAISY-RKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDG----------  229 (283)
T ss_dssp             -------------CCCGGGSCHHHHHS-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTT----------
T ss_pred             cCCCccceEeccCCCCccccCHHHHcc-CCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhcc----------
Confidence            54322    223467889999999987 789999999999999999999888887666655554443321          


Q ss_pred             CCCCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 015374          347 HSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA  391 (408)
Q Consensus       347 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~  391 (408)
                               .....+..+++++.+++.+||+.||++|||+.|+++
T Consensus       230 ---------~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~  265 (283)
T d1mqba_         230 ---------FRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVS  265 (283)
T ss_dssp             ---------CCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             ---------CCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHH
Confidence                     112233457899999999999999999999999987

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=1.1e-52  Score=388.42  Aligned_cols=252  Identities=23%  Similarity=0.365  Sum_probs=201.9

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc------chHHHHHHHHHHHHhcCCCCceEEeeEEEccCC--C
Q 015374          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHS--K  195 (408)
Q Consensus       124 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~--~  195 (408)
                      .++|++.+.||+|+||+||+|++..+++.||||+++..      ....+.+|+.+++++ +||||+++++++...+.  .
T Consensus         6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~-~hpniv~~~~~~~~~~~~~~   84 (277)
T d1o6ya_           6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAAL-NHPAIVAVYDTGEAETPAGP   84 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEEEECSSSE
T ss_pred             cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhc-CCCCCCcccceeeeccCCCc
Confidence            57899999999999999999999999999999998632      234688999999999 99999999999976433  3


Q ss_pred             ccEEEEEeecCCChhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccC
Q 015374          196 TPSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP  272 (408)
Q Consensus       196 ~~~lv~e~~~~~~l~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~  272 (408)
                      .+++||||+++++|..++   ..+++.+++.++.||+.||+|||++||+||||||+|||++.+ +..+|+|||.+.....
T Consensus        85 ~~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~-~~~~l~d~~~~~~~~~  163 (277)
T d1o6ya_          85 LPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISAT-NAVKVMDFGIARAIAD  163 (277)
T ss_dssp             EEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETT-SCEEECCCTTCEECC-
T ss_pred             eEEEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCcc-ccceeehhhhhhhhcc
Confidence            578999999999998776   469999999999999999999999999999999999999988 7899999999876543


Q ss_pred             CC----cceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCC
Q 015374          273 GK----EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHS  348 (408)
Q Consensus       273 ~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  348 (408)
                      ..    .....+||+.|+|||++.+ ..++.++|||||||++|||++|+.|| .+.+..+.+..+......         
T Consensus       164 ~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~~~~~DiwSlGvilyelltG~~Pf-~~~~~~~~~~~~~~~~~~---------  232 (277)
T d1o6ya_         164 SGNSVTQTAAVIGTAQYLSPEQARG-DSVDARSDVYSLGCVLYEVLTGEPPF-TGDSPVSVAYQHVREDPI---------  232 (277)
T ss_dssp             ---------------TTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCSC-CCSSHHHHHHHHHHCCCC---------
T ss_pred             ccccccccccccCcccccCHHHHcC-CCCCcceecccchHHHHHHHhCCCCC-CCcCHHHHHHHHHhcCCC---------
Confidence            32    2344679999999999987 78999999999999999999999998 455555555544432110         


Q ss_pred             CCCccccccccCCCCCCHHHHHHHHHhcccCcCCCC-CHHHHhcCCCcc
Q 015374          349 RKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRL-TAREAMAHPYFA  396 (408)
Q Consensus       349 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rp-t~~elL~hp~f~  396 (408)
                             ........+|+++.+||.+||+.||++|| |++++ .|+|.+
T Consensus       233 -------~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l-~~~l~r  273 (277)
T d1o6ya_         233 -------PPSARHEGLSADLDAVVLKALAKNPENRYQTAAEM-RADLVR  273 (277)
T ss_dssp             -------CGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHH-HHHHHH
T ss_pred             -------CCchhccCCCHHHHHHHHHHccCCHhHCHhHHHHH-HHHHHH
Confidence                   11223345899999999999999999999 55554 466643

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-52  Score=386.81  Aligned_cols=251  Identities=21%  Similarity=0.385  Sum_probs=196.3

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCC---cEEEEEEeccc----chHHHHHHHHHHHHhcCCCCceEEeeEEEccCCC
Q 015374          123 DQDDYEVVRKVGRGKYSEVFEGINVNTN---ERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSK  195 (408)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~---~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  195 (408)
                      ..++|++.+.||+|+||+||+|++..++   ..||||.++..    ..+.+.+|+.+++++ +||||++++++|.+   .
T Consensus         5 ~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~---~   80 (273)
T d1mp8a_           5 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQF-DHPHIVKLIGVITE---N   80 (273)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTC-CCTTBCCEEEEECS---S
T ss_pred             CHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEec---C
Confidence            4578999999999999999999886543   46889988632    245688999999999 99999999999943   4


Q ss_pred             ccEEEEEeecCCChhhhc----CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceecc
Q 015374          196 TPSLIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH  271 (408)
Q Consensus       196 ~~~lv~e~~~~~~l~~~~----~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~  271 (408)
                      ..++||||+++|++..++    ..+++..+..++.||+.||.|||+++|+||||||+|||++.+ +.+||+|||+|+...
T Consensus        81 ~~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~-~~~Kl~DfG~a~~~~  159 (273)
T d1mp8a_          81 PVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSN-DCVKLGDFGLSRYME  159 (273)
T ss_dssp             SCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEET-TEEEECC--------
T ss_pred             eEEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCC-CcEEEccchhheecc
Confidence            678999999999998765    358999999999999999999999999999999999999988 799999999998765


Q ss_pred             CCCc--ceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCC
Q 015374          272 PGKE--YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHS  348 (408)
Q Consensus       272 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  348 (408)
                      ....  .....||+.|+|||++.+ ..++.++|||||||++|||++ |..|| .+.+..+....+...            
T Consensus       160 ~~~~~~~~~~~gt~~y~apE~l~~-~~~~~~~DiwSlGvil~e~lt~g~~P~-~~~~~~~~~~~i~~~------------  225 (273)
T d1mp8a_         160 DSTYYKASKGKLPIKWMAPESINF-RRFTSASDVWMFGVCMWEILMHGVKPF-QGVKNNDVIGRIENG------------  225 (273)
T ss_dssp             -----------CCGGGCCHHHHHH-CCCSHHHHHHHHHHHHHHHHTTSCCTT-TTCCGGGHHHHHHTT------------
T ss_pred             CCcceeccceecCcccchhhHhcc-CCCCCccccccchHHHHHHHhcCCCCC-CCCCHHHHHHHHHcC------------
Confidence            4322  234567889999999987 789999999999999999998 56555 555555555444332            


Q ss_pred             CCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccccccc
Q 015374          349 RKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRAA  401 (408)
Q Consensus       349 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~~~~~  401 (408)
                             .....+..+++++.+||.+||+.||++|||++|+++|  |+.+-+.
T Consensus       226 -------~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~--L~~i~~~  269 (273)
T d1mp8a_         226 -------ERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ--LSTILEE  269 (273)
T ss_dssp             -------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH--HHHHHHH
T ss_pred             -------CCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHH--HHHHHHH
Confidence                   0112344589999999999999999999999999987  5555433

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-52  Score=399.97  Aligned_cols=273  Identities=30%  Similarity=0.525  Sum_probs=216.3

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc-----chHHHHHHHHHHHHhcCCCCceEEeeEEEccC---C
Q 015374          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQH---S  194 (408)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~---~  194 (408)
                      ..++|+++++||+|+||+||+|++..+|+.||||+++..     ..+.+.+|+.+++++ +|||++++++++....   .
T Consensus        16 ~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l-~h~~iv~~~~~~~~~~~~~~   94 (348)
T d2gfsa1          16 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM-KHENVIGLLDVFTPARSLEE   94 (348)
T ss_dssp             EETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHC-CCTTBCCCSEEECSCSSTTT
T ss_pred             CCCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhc-CCCCeeeEEEEEeecccccc
Confidence            367899999999999999999999999999999998632     235688999999999 9999999999986431   2


Q ss_pred             CccEEEEEeecCCChhhhc--CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccC
Q 015374          195 KTPSLIFEYVNSTDFKVLY--PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP  272 (408)
Q Consensus       195 ~~~~lv~e~~~~~~l~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~  272 (408)
                      ...+++|+|+.+++|..++  +.+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+|++|||++.... 
T Consensus        95 ~~~~~i~~~~~gg~L~~~~~~~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~-~~~kl~dfg~a~~~~-  172 (348)
T d2gfsa1          95 FNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNED-CELKILDFGLARHTD-  172 (348)
T ss_dssp             CCCCEEEEECCSEEHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT-CCEEECCC----CCT-
T ss_pred             CceEEEEEeecCCchhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCcccccccc-ccccccccchhcccC-
Confidence            3446777888999999887  469999999999999999999999999999999999999998 899999999997543 


Q ss_pred             CCcceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCC---
Q 015374          273 GKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSR---  349 (408)
Q Consensus       273 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---  349 (408)
                       .......|++.|+|||++.+...++.++|||||||++|+|++|+.|| .+.+..+....+....+...........   
T Consensus       173 -~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF-~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  250 (348)
T d2gfsa1         173 -DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF-PGTDHIDQLKLILRLVGTPGAELLKKISSES  250 (348)
T ss_dssp             -GGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSC-CCSSHHHHHHHHHHHHCCCCHHHHTTCCCHH
T ss_pred             -cccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCC-CCCCHHHHHHHHHHhcCCCChHHhhhccchh
Confidence             34455788999999999888667899999999999999999999987 5666666666666655433211110000   


Q ss_pred             --------CCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCcccccc
Q 015374          350 --------KPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVRA  400 (408)
Q Consensus       350 --------~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~~~~  400 (408)
                              .......-......+++++++||++||+.||++|||++|+|+||||++...
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~~  309 (348)
T d2gfsa1         251 ARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD  309 (348)
T ss_dssp             HHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCC
T ss_pred             hhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCCC
Confidence                    000000001122357899999999999999999999999999999997654

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.8e-52  Score=389.00  Aligned_cols=249  Identities=20%  Similarity=0.332  Sum_probs=199.4

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcC-----CCcEEEEEEeccc----chHHHHHHHHHHHHhcCCCCceEEeeEEEccC
Q 015374          123 DQDDYEVVRKVGRGKYSEVFEGINVN-----TNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQH  193 (408)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~Vy~~~~~~-----~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~  193 (408)
                      ..++|++.++||+|+||+||+|++..     +++.||||+++..    ..+.+.+|..++.++.+|+||+.+++++... 
T Consensus        11 ~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~-   89 (299)
T d1ywna1          11 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP-   89 (299)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST-
T ss_pred             cHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccC-
Confidence            46789999999999999999998754     4468999998642    2456788999999887899999999988654 


Q ss_pred             CCccEEEEEeecCCChhhhcC-------------------CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeC
Q 015374          194 SKTPSLIFEYVNSTDFKVLYP-------------------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDH  254 (408)
Q Consensus       194 ~~~~~lv~e~~~~~~l~~~~~-------------------~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~  254 (408)
                      +...++||||+++|+|..++.                   .+++.++..++.||+.||.|||+++||||||||+|||++.
T Consensus        90 ~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl~~  169 (299)
T d1ywna1          90 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSE  169 (299)
T ss_dssp             TSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECG
T ss_pred             CCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccceeECC
Confidence            356889999999999998862                   3788999999999999999999999999999999999998


Q ss_pred             CCCcEEEEecccceeccCCCc---ceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHH
Q 015374          255 ELRKLRLIDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV  331 (408)
Q Consensus       255 ~~~~~kl~DfG~a~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~  331 (408)
                      + +.+||+|||+|+.......   .....||+.|+|||++.+ ..++.++|||||||++|||++|..|++.+.+..+.+.
T Consensus       170 ~-~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~~  247 (299)
T d1ywna1         170 K-NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC  247 (299)
T ss_dssp             G-GCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHH
T ss_pred             C-CcEEEccCcchhhccccccccccCceeeCccccchhHhhc-CCCCcccceeehHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence            8 7999999999986644332   234578999999999987 7899999999999999999998765556655555544


Q ss_pred             HHHhhhchhhhhcCCCCCCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 015374          332 KIAKDCCLIIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH  392 (408)
Q Consensus       332 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~h  392 (408)
                      ..+...                  .....+..+++++.+++.+||+.||++|||++|+++|
T Consensus       248 ~~~~~~------------------~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~  290 (299)
T d1ywna1         248 RRLKEG------------------TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  290 (299)
T ss_dssp             HHHHHT------------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHhcC------------------CCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            443321                  1122344578999999999999999999999999987

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8e-52  Score=389.65  Aligned_cols=245  Identities=18%  Similarity=0.305  Sum_probs=198.2

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCc----EEEEEEeccc----chHHHHHHHHHHHHhcCCCCceEEeeEEEccCC
Q 015374          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNE----RCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHS  194 (408)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~----~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~  194 (408)
                      ..++|++++.||+|+||+||+|++..+|+    .||+|.++..    ..+.+.+|+.+++++ +|||||+++|+|.+   
T Consensus         7 k~~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~g~~~~---   82 (317)
T d1xkka_           7 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV-DNPHVCRLLGICLT---   82 (317)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHC-CCTTBCCEEEEEES---
T ss_pred             CHHHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEec---
Confidence            45789999999999999999999888776    5888887532    346799999999999 99999999999965   


Q ss_pred             CccEEEEEeecCCChhhhc----CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceec
Q 015374          195 KTPSLIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY  270 (408)
Q Consensus       195 ~~~~lv~e~~~~~~l~~~~----~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~  270 (408)
                      ...++++||+.+++|...+    ..+++..+..++.||+.||+|||++|||||||||+|||++.+ +.+||+|||+|+..
T Consensus        83 ~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~-~~~kl~DFGla~~~  161 (317)
T d1xkka_          83 STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTP-QHVKITDFGLAKLL  161 (317)
T ss_dssp             SSEEEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEET-TEEEECCCSHHHHT
T ss_pred             CCeeEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCC-CCeEeeccccceec
Confidence            3467899999999887665    458999999999999999999999999999999999999998 79999999999876


Q ss_pred             cCCCc---ceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCC
Q 015374          271 HPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRH  347 (408)
Q Consensus       271 ~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (408)
                      .....   .....||..|+|||++.+ +.++.++|||||||++|||+|++.+++.+.+..+....+...           
T Consensus       162 ~~~~~~~~~~~~~gt~~y~APE~l~~-~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~-----------  229 (317)
T d1xkka_         162 GAEEKEYHAEGGKVPIKWMALESILH-RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKG-----------  229 (317)
T ss_dssp             TTTCC--------CCTTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHT-----------
T ss_pred             ccccccccccccccCccccChHHHhc-CCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcC-----------
Confidence            54332   233468899999999987 789999999999999999999544444555544443333221           


Q ss_pred             CCCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 015374          348 SRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH  392 (408)
Q Consensus       348 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~h  392 (408)
                              .....+..+++++.+++.+||+.||++|||+.|+++|
T Consensus       230 --------~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~  266 (317)
T d1xkka_         230 --------ERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIE  266 (317)
T ss_dssp             --------CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             --------CCCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHH
Confidence                    1122334578999999999999999999999999988

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-51  Score=387.18  Aligned_cols=259  Identities=22%  Similarity=0.418  Sum_probs=210.2

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEc---CCCcEEEEEEeccc-------chHHHHHHHHHHHHhcCCCCceEEeeEEEccC
Q 015374          124 QDDYEVVRKVGRGKYSEVFEGINV---NTNERCIIKILKPV-------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQH  193 (408)
Q Consensus       124 ~~~y~~~~~lG~G~fg~Vy~~~~~---~~~~~vavK~~~~~-------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~  193 (408)
                      -++|+++++||+|+||+||+|++.   .+|+.||||+++..       ..+.+.+|+.+++++.+||||+++++++.+. 
T Consensus        23 l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~-  101 (322)
T d1vzoa_          23 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTE-  101 (322)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEET-
T ss_pred             hhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccC-
Confidence            477999999999999999999874   46889999998632       2456889999999995558999999999664 


Q ss_pred             CCccEEEEEeecCCChhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceec
Q 015374          194 SKTPSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY  270 (408)
Q Consensus       194 ~~~~~lv~e~~~~~~l~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~  270 (408)
                       ...+++|||+.+++|..++   ..+++..+..++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+++..
T Consensus       102 -~~~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~-~~vkL~DFG~a~~~  179 (322)
T d1vzoa_         102 -TKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSN-GHVVLTDFGLSKEF  179 (322)
T ss_dssp             -TEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT-SCEEESCSSEEEEC
T ss_pred             -CceeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCC-CCEEEeeccchhhh
Confidence             6788999999999998887   468899999999999999999999999999999999999998 79999999999876


Q ss_pred             cCCC--cceeeccCccccccccccCC-cCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCC
Q 015374          271 HPGK--EYNVRVASRYFKGPELLVDL-QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRH  347 (408)
Q Consensus       271 ~~~~--~~~~~~~~~~y~aPE~~~~~-~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (408)
                      ....  ......|++.|++||.+.+. ..++.++|||||||++|+|++|..||.... ..+....+......        
T Consensus       180 ~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~-~~~~~~~i~~~~~~--------  250 (322)
T d1vzoa_         180 VADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDG-EKNSQAEISRRILK--------  250 (322)
T ss_dssp             CGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTT-SCCCHHHHHHHHHH--------
T ss_pred             cccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHHhccc--------
Confidence            4332  23456899999999999763 357889999999999999999999985432 22222222221100        


Q ss_pred             CCCCccccccccCCCCCCHHHHHHHHHhcccCcCCCC-----CHHHHhcCCCccccccch
Q 015374          348 SRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRL-----TAREAMAHPYFAQVRAAE  402 (408)
Q Consensus       348 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rp-----t~~elL~hp~f~~~~~~~  402 (408)
                              .....+..+++++.+||.+||++||++||     |++|+++||||+++.+..
T Consensus       251 --------~~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~i~~~~  302 (322)
T d1vzoa_         251 --------SEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWDD  302 (322)
T ss_dssp             --------CCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCCHHH
T ss_pred             --------CCCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcCCCHHH
Confidence                    11223345899999999999999999999     589999999999987654

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.8e-52  Score=389.80  Aligned_cols=248  Identities=17%  Similarity=0.282  Sum_probs=206.2

Q ss_pred             CCCCCEEEEeeeeeeCceEEEEEEEcCCCcE--EEEEEecc----cchHHHHHHHHHHHHhcCCCCceEEeeEEEccCCC
Q 015374          122 GDQDDYEVVRKVGRGKYSEVFEGINVNTNER--CIIKILKP----VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSK  195 (408)
Q Consensus       122 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~--vavK~~~~----~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  195 (408)
                      .+-++|++.+.||+|+||+||+|++..++..  ||||.++.    ...+.+.+|+.++.++.+||||++++++|.+  ..
T Consensus         7 i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~--~~   84 (309)
T d1fvra_           7 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH--RG   84 (309)
T ss_dssp             CCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEE--TT
T ss_pred             cCHHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEec--CC
Confidence            3457899999999999999999999888874  67777653    2345789999999998679999999999965  46


Q ss_pred             ccEEEEEeecCCChhhhc-------------------CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCC
Q 015374          196 TPSLIFEYVNSTDFKVLY-------------------PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEL  256 (408)
Q Consensus       196 ~~~lv~e~~~~~~l~~~~-------------------~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~  256 (408)
                      ..++||||+++|+|..++                   ..+++..+..++.||+.||.|||+++|+||||||+|||++.+ 
T Consensus        85 ~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~-  163 (309)
T d1fvra_          85 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGEN-  163 (309)
T ss_dssp             EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGG-
T ss_pred             eeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCC-
Confidence            789999999999999987                   348899999999999999999999999999999999999998 


Q ss_pred             CcEEEEecccceeccCCCcceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhh
Q 015374          257 RKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKD  336 (408)
Q Consensus       257 ~~~kl~DfG~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~  336 (408)
                      +.+||+|||+++............||..|+|||.+.+ ..++.++|||||||++|||++|..|++.+.+..+....+...
T Consensus       164 ~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~~~  242 (309)
T d1fvra_         164 YVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG  242 (309)
T ss_dssp             GCEEECCTTCEESSCEECCC----CCTTTCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGT
T ss_pred             CceEEccccccccccccccccceecCCcccchHHhcc-CCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHHhc
Confidence            7999999999987655555556678999999999987 789999999999999999999887766666655544433221


Q ss_pred             hchhhhhcCCCCCCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 015374          337 CCLIIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH  392 (408)
Q Consensus       337 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~h  392 (408)
                                         .....+..+++++.+||.+||+.||++|||++|++++
T Consensus       243 -------------------~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~  279 (309)
T d1fvra_         243 -------------------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  279 (309)
T ss_dssp             -------------------CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             -------------------CCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence                               1122344578999999999999999999999999987

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.3e-51  Score=385.51  Aligned_cols=245  Identities=18%  Similarity=0.303  Sum_probs=205.3

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEc-----CCCcEEEEEEeccc----chHHHHHHHHHHHHhcCCCCceEEeeEEEccC
Q 015374          123 DQDDYEVVRKVGRGKYSEVFEGINV-----NTNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQH  193 (408)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~Vy~~~~~-----~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~  193 (408)
                      ..++|++++.||+|+||+||+|++.     .+++.||||+++..    ..+++.+|+.+++++ +||||++++++|..  
T Consensus        11 p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l-~h~niv~~~~~~~~--   87 (301)
T d1lufa_          11 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEF-DNPNIVKLLGVCAV--   87 (301)
T ss_dssp             CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEECS--
T ss_pred             CHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhc-CCCCcccceeeecc--
Confidence            4678999999999999999999865     35678999998643    246789999999999 99999999999954  


Q ss_pred             CCccEEEEEeecCCChhhhcC---------------------------CCChHHHHHHHHHHHHHHHHHHHCCcEEecCC
Q 015374          194 SKTPSLIFEYVNSTDFKVLYP---------------------------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVK  246 (408)
Q Consensus       194 ~~~~~lv~e~~~~~~l~~~~~---------------------------~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk  246 (408)
                      ....+++|||+++|+|..++.                           .+++..+..++.|++.||+|||+++|||||||
T Consensus        88 ~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDlK  167 (301)
T d1lufa_          88 GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLA  167 (301)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCS
T ss_pred             CCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEEc
Confidence            567889999999999988762                           27888999999999999999999999999999


Q ss_pred             CCcEEEeCCCCcEEEEecccceeccCCC---cceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCC
Q 015374          247 PHNVMIDHELRKLRLIDWGLAEFYHPGK---EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYG  323 (408)
Q Consensus       247 ~~NILl~~~~~~~kl~DfG~a~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~  323 (408)
                      |+|||+|.+ +.+||+|||+|+...+..   ......+++.|+|||.+.+ ..++.++|||||||++|||++|..|++.+
T Consensus       168 p~NILld~~-~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~t~ksDVwS~Gvvl~ell~~~~~p~~~  245 (301)
T d1lufa_         168 TRNCLVGEN-MVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFY-NRYTTESDVWAYGVVLWEIFSYGLQPYYG  245 (301)
T ss_dssp             GGGEEECGG-GCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred             ccceEECCC-CcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHcc-CCCChhhhhccchhhHHHHHccCCCCCCC
Confidence            999999998 789999999997664332   2234578889999999987 78999999999999999999998766667


Q ss_pred             CCCHHHHHHHHhhhchhhhhcCCCCCCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 015374          324 HDNHDQLVKIAKDCCLIIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA  391 (408)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~  391 (408)
                      .+..+....+...                   .....+..+++++.+++.+||+.||++|||+.|+++
T Consensus       246 ~~~~e~~~~v~~~-------------------~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~  294 (301)
T d1lufa_         246 MAHEEVIYYVRDG-------------------NILACPENCPLELYNLMRLCWSKLPADRPSFCSIHR  294 (301)
T ss_dssp             SCHHHHHHHHHTT-------------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCHHHHHHHHHcC-------------------CCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            6666665554332                   012234558899999999999999999999999964

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-51  Score=376.11  Aligned_cols=248  Identities=15%  Similarity=0.315  Sum_probs=198.1

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecccc-hHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccEEEE
Q 015374          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK-KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIF  201 (408)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~  201 (408)
                      ..++|++.++||+|+||.||+|++  .|..||||+++... .+.+.+|+.+++++ +||||++++|+|.+.. ..+++||
T Consensus         5 ~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~i~~~~~~~~~~~E~~~l~~l-~HpnIv~~~g~~~~~~-~~~~lv~   80 (262)
T d1byga_           5 NMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQL-RHSNLVQLLGVIVEEK-GGLYIVT   80 (262)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC--HHHHHTHHHHTTC-CCTTBCCEEEEECCC---CCEEEE
T ss_pred             CHHHeEEeEEEecCCCeEEEEEEE--CCeEEEEEEECcHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEEecC-CcEEEEE
Confidence            457899999999999999999987  47789999997543 56799999999999 9999999999985432 4578999


Q ss_pred             EeecCCChhhhcC-----CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCCCcc
Q 015374          202 EYVNSTDFKVLYP-----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY  276 (408)
Q Consensus       202 e~~~~~~l~~~~~-----~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~~~~  276 (408)
                      ||+++|+|..++.     .+++..+..++.||+.||.|||+++|+||||||+|||++.+ +.+||+|||+++....  ..
T Consensus        81 ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~-~~~kl~dfg~s~~~~~--~~  157 (262)
T d1byga_          81 EYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSED-NVAKVSDFGLTKEASS--TQ  157 (262)
T ss_dssp             CCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTT-SCEEECCCCC----------
T ss_pred             eccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCC-CCEeecccccceecCC--CC
Confidence            9999999998873     38999999999999999999999999999999999999998 7899999999986543  33


Q ss_pred             eeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCCCccccc
Q 015374          277 NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPWSKFI  356 (408)
Q Consensus       277 ~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  356 (408)
                      ....++..|+|||++.+ ..++.++|||||||++|||+|++.|++.+.+..+....+...                   .
T Consensus       158 ~~~~~~~~y~aPE~l~~-~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~-------------------~  217 (262)
T d1byga_         158 DTGKLPVKWTAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG-------------------Y  217 (262)
T ss_dssp             ----CCTTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTT-------------------C
T ss_pred             ccccccccCCChHHHhC-CCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcC-------------------C
Confidence            44577889999999987 789999999999999999999545545555544444443221                   1


Q ss_pred             cccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcCCCccccc
Q 015374          357 NADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAHPYFAQVR  399 (408)
Q Consensus       357 ~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~hp~f~~~~  399 (408)
                      ....+..+++++.+|+.+||+.||++|||+.|++++  |+.++
T Consensus       218 ~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~--L~~i~  258 (262)
T d1byga_         218 KMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQ--LEHIK  258 (262)
T ss_dssp             CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH--HHHHH
T ss_pred             CCCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHH--HHHHH
Confidence            223344578999999999999999999999999874  54443

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.7e-51  Score=374.88  Aligned_cols=243  Identities=19%  Similarity=0.288  Sum_probs=193.9

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCC-C--cEEEEEEeccc------chHHHHHHHHHHHHhcCCCCceEEeeEEEccC
Q 015374          123 DQDDYEVVRKVGRGKYSEVFEGINVNT-N--ERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQH  193 (408)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~-~--~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~  193 (408)
                      ..++|++.+.||+|+||+||+|+.... +  ..||||+++..      ..+.|.+|+.+++++ +||||++++|+|.+  
T Consensus         6 ~~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~~~g~~~~--   82 (273)
T d1u46a_           6 GEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL-DHRNLIRLYGVVLT--   82 (273)
T ss_dssp             CGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHC-CCTTBCCEEEEECS--
T ss_pred             chHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhC-CCCCEEEEEEEEee--
Confidence            457899999999999999999986433 2  36899998632      236789999999999 99999999999954  


Q ss_pred             CCccEEEEEeecCCChhhhc----CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEeccccee
Q 015374          194 SKTPSLIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEF  269 (408)
Q Consensus       194 ~~~~~lv~e~~~~~~l~~~~----~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~  269 (408)
                       ...++||||++++++..++    ..+++..+..++.|++.||.|||++||+||||||+|||++.+ +.+||+|||+++.
T Consensus        83 -~~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~-~~vkl~DfGl~~~  160 (273)
T d1u46a_          83 -PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATR-DLVKIGDFGLMRA  160 (273)
T ss_dssp             -SSCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEET-TEEEECCCTTCEE
T ss_pred             -cchheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccc-cceeeccchhhhh
Confidence             3568999999999988765    459999999999999999999999999999999999999998 7999999999988


Q ss_pred             ccCCCcc----eeeccCccccccccccCCcCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHhhhchhhhhc
Q 015374          270 YHPGKEY----NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKDCCLIIWCN  344 (408)
Q Consensus       270 ~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  344 (408)
                      .......    ....++..|+|||++.+ ..++.++|||||||++|||++ |..|| .+.+..+....+....       
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~S~Gvil~emlt~G~~Pf-~~~~~~~~~~~i~~~~-------  231 (273)
T d1u46a_         161 LPQNDDHYVMQEHRKVPFAWCAPESLKT-RTFSHASDTWMFGVTLWEMFTYGQEPW-IGLNGSQILHKIDKEG-------  231 (273)
T ss_dssp             CCC-CCEEEC-----CCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTSCCTT-TTCCHHHHHHHHHTSC-------
T ss_pred             cccCCCcceecCccccCcccCCHHHHhC-CCCCcchhhhhhHHHHHHHHhCCCCCC-CCcCHHHHHHHHHhCC-------
Confidence            7544332    23457778999999987 789999999999999999998 78886 5555555555544321       


Q ss_pred             CCCCCCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHh
Q 015374          345 SRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAM  390 (408)
Q Consensus       345 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL  390 (408)
                                 .....+..+++++.+++.+||+.||++|||++|++
T Consensus       232 -----------~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~  266 (273)
T d1u46a_         232 -----------ERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALR  266 (273)
T ss_dssp             -----------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred             -----------CCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHH
Confidence                       11223455889999999999999999999999986

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4e-50  Score=377.01  Aligned_cols=247  Identities=21%  Similarity=0.348  Sum_probs=210.1

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEc-----CCCcEEEEEEeccc----chHHHHHHHHHHHHhcCCCCceEEeeEEEccC
Q 015374          123 DQDDYEVVRKVGRGKYSEVFEGINV-----NTNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQH  193 (408)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~Vy~~~~~-----~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~  193 (408)
                      ..++|++.+.||+|+||.||+|++.     .+++.||||+++..    ....+.+|+.+++++.+|||||+++++|.+  
T Consensus        21 ~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~--   98 (311)
T d1t46a_          21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTI--   98 (311)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS--
T ss_pred             CHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEee--
Confidence            4689999999999999999999853     46678999999743    345688999999999779999999999954  


Q ss_pred             CCccEEEEEeecCCChhhhcC---------------------CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEE
Q 015374          194 SKTPSLIFEYVNSTDFKVLYP---------------------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMI  252 (408)
Q Consensus       194 ~~~~~lv~e~~~~~~l~~~~~---------------------~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl  252 (408)
                      ....++||||+++|++..++.                     .+++..+..++.||+.||.|||+++||||||||+|||+
T Consensus        99 ~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~NIl~  178 (311)
T d1t46a_          99 GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILL  178 (311)
T ss_dssp             SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred             CCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeecccccccccc
Confidence            467889999999999988862                     48889999999999999999999999999999999999


Q ss_pred             eCCCCcEEEEecccceeccCCCcc---eeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHH
Q 015374          253 DHELRKLRLIDWGLAEFYHPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQ  329 (408)
Q Consensus       253 ~~~~~~~kl~DfG~a~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~  329 (408)
                      +.+ +.+|++|||+++........   ....||+.|+|||++.+ ..++.++|||||||++|||++++.||+.+.+..+.
T Consensus       179 ~~~-~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~  256 (311)
T d1t46a_         179 THG-RITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFN-CVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK  256 (311)
T ss_dssp             ETT-TEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH
T ss_pred             ccc-CcccccccchheeccCCCcceEeeecccChHHcCHHHhcC-CCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHH
Confidence            988 79999999999876543322   33578999999999987 78999999999999999999987887777777666


Q ss_pred             HHHHHhhhchhhhhcCCCCCCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 015374          330 LVKIAKDCCLIIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA  391 (408)
Q Consensus       330 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~  391 (408)
                      +.+++...                  .....+..+++++.+||.+||+.||++|||++|+++
T Consensus       257 ~~~~i~~~------------------~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~  300 (311)
T d1t46a_         257 FYKMIKEG------------------FRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ  300 (311)
T ss_dssp             HHHHHHHT------------------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHhcC------------------CCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            66655431                  122233457899999999999999999999999986

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-50  Score=378.73  Aligned_cols=252  Identities=19%  Similarity=0.319  Sum_probs=210.8

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEc-----CCCcEEEEEEecccc----hHHHHHHHHHHHHhcCCCCceEEeeEEEccC
Q 015374          123 DQDDYEVVRKVGRGKYSEVFEGINV-----NTNERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQH  193 (408)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~Vy~~~~~-----~~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~  193 (408)
                      ..++|++.++||+|+||+||+|.+.     .++..||||+++...    ...+.+|+.+++++ +||||++++++|..  
T Consensus        18 ~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~~~~~~~~--   94 (308)
T d1p4oa_          18 AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEF-NCHHVVRLLGVVSQ--   94 (308)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGC-CCTTBCCEEEEECS--
T ss_pred             cHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHc-CCCCEeeeeeEEec--
Confidence            4689999999999999999999875     245789999997432    24588999999999 99999999999954  


Q ss_pred             CCccEEEEEeecCCChhhhc-------------CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEE
Q 015374          194 SKTPSLIFEYVNSTDFKVLY-------------PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLR  260 (408)
Q Consensus       194 ~~~~~lv~e~~~~~~l~~~~-------------~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~k  260 (408)
                      ....++||||+++|+|..++             ..+++..+..++.|++.||.|||+++|+||||||+|||++.+ +.+|
T Consensus        95 ~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~-~~~K  173 (308)
T d1p4oa_          95 GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAED-FTVK  173 (308)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTT-CCEE
T ss_pred             CCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCC-ceEE
Confidence            46788999999999998876             236888999999999999999999999999999999999988 7999


Q ss_pred             EEecccceeccCCCc---ceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhh
Q 015374          261 LIDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDC  337 (408)
Q Consensus       261 l~DfG~a~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~  337 (408)
                      |+|||+|+.......   .....+|+.|+|||.+.+ ..++.++|||||||++|||++|..|++.+.+..+.+..+... 
T Consensus       174 l~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~-~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~~~-  251 (308)
T d1p4oa_         174 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKD-GVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEG-  251 (308)
T ss_dssp             ECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTT-
T ss_pred             EeecccceeccCCcceeeccceecccccCCHHHHcc-CCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhC-
Confidence            999999986643322   233468899999999987 789999999999999999999987766777666666555432 


Q ss_pred             chhhhhcCCCCCCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhc------CCCcccc
Q 015374          338 CLIIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA------HPYFAQV  398 (408)
Q Consensus       338 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~------hp~f~~~  398 (408)
                                        .....+..+++++.++|.+||+.||++|||++|+++      +|+|+++
T Consensus       252 ------------------~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~~~~~~  300 (308)
T d1p4oa_         252 ------------------GLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREV  300 (308)
T ss_dssp             ------------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTTHHHH
T ss_pred             ------------------CCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCCcCC
Confidence                              112233457899999999999999999999999998      7887654

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.5e-50  Score=375.33  Aligned_cols=246  Identities=17%  Similarity=0.308  Sum_probs=198.4

Q ss_pred             CCCCEEEEeeeeeeCceEEEEEEEcCCC-------cEEEEEEeccc----chHHHHHHHHHHHHhcCCCCceEEeeEEEc
Q 015374          123 DQDDYEVVRKVGRGKYSEVFEGINVNTN-------ERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRD  191 (408)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~-------~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~  191 (408)
                      ..++|++.+.||+|+||.||+|++..++       ..||||+++..    ...++.+|...+.++.+||||++++++|.+
T Consensus        11 ~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~   90 (299)
T d1fgka_          11 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ   90 (299)
T ss_dssp             CGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             cHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEeccccccc
Confidence            5689999999999999999999876544       47999998643    236688899999998789999999999965


Q ss_pred             cCCCccEEEEEeecCCChhhhc-------------------CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEE
Q 015374          192 QHSKTPSLIFEYVNSTDFKVLY-------------------PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMI  252 (408)
Q Consensus       192 ~~~~~~~lv~e~~~~~~l~~~~-------------------~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl  252 (408)
                        ....++||||+.+|++..++                   ..+++..+..++.||+.||+|||+++||||||||+|||+
T Consensus        91 --~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~NiLl  168 (299)
T d1fgka_          91 --DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV  168 (299)
T ss_dssp             --SSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred             --CCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecccceee
Confidence              46789999999999999887                   247999999999999999999999999999999999999


Q ss_pred             eCCCCcEEEEecccceeccCCCc---ceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHH
Q 015374          253 DHELRKLRLIDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQ  329 (408)
Q Consensus       253 ~~~~~~~kl~DfG~a~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~  329 (408)
                      +.+ +.+||+|||+++.......   .....+++.|+|||.+.+ +.|+.++|||||||++|||++++.|++.+.+..+.
T Consensus       169 ~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~-~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~  246 (299)
T d1fgka_         169 TED-NVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL  246 (299)
T ss_dssp             CTT-CCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH
T ss_pred             cCC-CCeEeccchhhccccccccccccccCCCChhhhhhhHhcC-CCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHHH
Confidence            998 7999999999987654332   233578889999999987 78999999999999999999854444455554443


Q ss_pred             HHHHHhhhchhhhhcCCCCCCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 015374          330 LVKIAKDCCLIIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA  391 (408)
Q Consensus       330 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~  391 (408)
                      ...+...                   .....+..+++++.+||.+||+.||++|||+.|+++
T Consensus       247 ~~~i~~~-------------------~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~  289 (299)
T d1fgka_         247 FKLLKEG-------------------HRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE  289 (299)
T ss_dssp             HHHHHTT-------------------CCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHcC-------------------CCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence            3332221                   112234458899999999999999999999999987

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.7e-50  Score=374.90  Aligned_cols=241  Identities=20%  Similarity=0.319  Sum_probs=195.4

Q ss_pred             EEeeeeeeCceEEEEEEEcCCC---cEEEEEEeccc----chHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccEEEE
Q 015374          129 VVRKVGRGKYSEVFEGINVNTN---ERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIF  201 (408)
Q Consensus       129 ~~~~lG~G~fg~Vy~~~~~~~~---~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~  201 (408)
                      ..++||+|+||+||+|++..++   ..||||.++..    ..++|.+|+++++++ +||||++++|++.+. ....++||
T Consensus        31 ~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~~~g~~~~~-~~~~~lv~  108 (311)
T d1r0pa_          31 FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF-SHPNVLSLLGICLRS-EGSPLVVL  108 (311)
T ss_dssp             EEEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTC-CCTTBCCCCEEEEET-TTEEEEEE
T ss_pred             cceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhC-CCCCEeEEeEEEEec-CCceEEEE
Confidence            3578999999999999986643   36899998632    346799999999999 999999999998653 35678999


Q ss_pred             EeecCCChhhhcC----CCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecccceeccCCCc--
Q 015374          202 EYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE--  275 (408)
Q Consensus       202 e~~~~~~l~~~~~----~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~~~~~~--  275 (408)
                      ||++++++..++.    .+++..+..++.|++.||.|||+.+|+||||||+|||++.+ +.+||+|||+++.......  
T Consensus       109 E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~-~~~kL~DFG~~~~~~~~~~~~  187 (311)
T d1r0pa_         109 PYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEK-FTVKVADFGLARDMYDKEFDS  187 (311)
T ss_dssp             ECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTT-CCEEECSSGGGCCTTTTTCCC
T ss_pred             EEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCC-CCEEEecccchhhcccccccc
Confidence            9999999988763    46778889999999999999999999999999999999988 7999999999987654322  


Q ss_pred             ---ceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCCCCc
Q 015374          276 ---YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSRKPW  352 (408)
Q Consensus       276 ---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  352 (408)
                         .....||..|+|||.+.+ ..++.++||||||+++|||++|+.||+...+..+....+....               
T Consensus       188 ~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~---------------  251 (311)
T d1r0pa_         188 VHNKTGAKLPVKWMALESLQT-QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR---------------  251 (311)
T ss_dssp             TTCTTCSSCCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTC---------------
T ss_pred             ceecccccccccccChHHHhc-CCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCC---------------
Confidence               223467889999999987 7899999999999999999999999876665554444433220               


Q ss_pred             cccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 015374          353 SKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH  392 (408)
Q Consensus       353 ~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~h  392 (408)
                          ....+..+++++.+|+.+||+.||++|||+.|+++|
T Consensus       252 ----~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~  287 (311)
T d1r0pa_         252 ----RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR  287 (311)
T ss_dssp             ----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ----CCCCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence                112234578999999999999999999999999988

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=4.5e-48  Score=361.24  Aligned_cols=257  Identities=16%  Similarity=0.219  Sum_probs=195.6

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecc-cchHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccEEEEE
Q 015374          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP-VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFE  202 (408)
Q Consensus       124 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~-~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e  202 (408)
                      .++|++.+.||+|+||+||+|++..+++.||||+++. ....++.+|+++++.+ +|+|++..+..+... +...++|||
T Consensus         6 g~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~E~~i~~~l-~~~~~i~~~~~~~~~-~~~~~ivme   83 (299)
T d1ckia_           6 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMM-QGGVGIPTIRWCGAE-GDYNVMVME   83 (299)
T ss_dssp             TTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTSCCHHHHHHHHHHS-TTSTTCCCEEEEEEE-TTEEEEEEE
T ss_pred             CCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccCHHHHHHHHHHHHc-cCCCcccEEEEEEec-CCEEEEEEE
Confidence            4689999999999999999999999999999999864 3346788999999999 666555544444322 467789999


Q ss_pred             eecCCChhhhc---CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCC--CCcEEEEecccceeccCCCc--
Q 015374          203 YVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE--LRKLRLIDWGLAEFYHPGKE--  275 (408)
Q Consensus       203 ~~~~~~l~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~--~~~~kl~DfG~a~~~~~~~~--  275 (408)
                      |++++......   ..+++..+..++.|++.||+|||++|||||||||+|||++..  ...++|+|||+|+.......  
T Consensus        84 ~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~~~  163 (299)
T d1ckia_          84 LLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQ  163 (299)
T ss_dssp             CCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTTCC
T ss_pred             EcCCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceecccccccc
Confidence            99776555443   469999999999999999999999999999999999998642  24799999999987754332  


Q ss_pred             ------ceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHhhhchhhhhcCCCCC
Q 015374          276 ------YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKDCCLIIWCNSRHSR  349 (408)
Q Consensus       276 ------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  349 (408)
                            .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||..... .+....+.........       
T Consensus       164 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~-~~~~~~~~~~~~~~~~-------  234 (299)
T d1ckia_         164 HIPYRENKNLTGTARYASINTHLG-IEQSRRDDLESLGYVLMYFNLGSLPWQGLKA-ATKRQKYERISEKKMS-------  234 (299)
T ss_dssp             BCCCCBCCSCCCCSSSCCHHHHTT-BCCCHHHHHHHHHHHHHHHHHSSCTTCCCC--------HHHHHHHHHH-------
T ss_pred             ceeccccCCcCCCccccCHHHHhC-CCCCChhhEEecCHHHHHHHhCCCcccccch-HHHHHHHHHhhcccCC-------
Confidence                  234579999999999988 7799999999999999999999999854332 2221111111000000       


Q ss_pred             CCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHH---HHhcCCCcc
Q 015374          350 KPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAR---EAMAHPYFA  396 (408)
Q Consensus       350 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~---elL~hp~f~  396 (408)
                           .........+++++.+|+..||+.||++||+++   ++|+|+|.+
T Consensus       235 -----~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~  279 (299)
T d1ckia_         235 -----TPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR  279 (299)
T ss_dssp             -----SCHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHH
T ss_pred             -----CChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHH
Confidence                 001112334789999999999999999999987   557787654

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-48  Score=362.79  Aligned_cols=252  Identities=19%  Similarity=0.217  Sum_probs=192.2

Q ss_pred             CCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecccchHHHHHHHHHH--HHhcCCCCceEEeeEEEccCC--CccEEE
Q 015374          125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKIL--QNLCGGPNVVKLLDIVRDQHS--KTPSLI  200 (408)
Q Consensus       125 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l--~~l~~h~niv~l~~~~~~~~~--~~~~lv  200 (408)
                      .+|.+.+.||+|+||+||+|++  +|+.||||+++......+.+|.+++  .++ +||||++++++|.+.+.  ..+++|
T Consensus         3 ~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~~~~~~~e~ei~~~~~~-~HpnIv~~~~~~~~~~~~~~~~~lv   79 (303)
T d1vjya_           3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVML-RHENILGFIAADNKDNGTWTQLWLV   79 (303)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHTSTTC-CCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccchhHHHHHHHHHHHhhC-CCCcCcceEEEEEeCCCcceEEEEE
Confidence            5788999999999999999975  6889999999876666665555544  466 89999999999986543  367899


Q ss_pred             EEeecCCChhhhcC--CCChHHHHHHHHHHHHHHHHHHH--------CCcEEecCCCCcEEEeCCCCcEEEEecccceec
Q 015374          201 FEYVNSTDFKVLYP--TLTDYDIRYYIYELLKALDYCHS--------QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY  270 (408)
Q Consensus       201 ~e~~~~~~l~~~~~--~l~~~~~~~i~~qi~~~L~~LH~--------~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~~  270 (408)
                      |||+++|+|..++.  .+++..+..++.|++.||.|||+        +|||||||||+|||++.+ +.+||+|||+++..
T Consensus        80 ~Ey~~~g~L~~~l~~~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~-~~~Kl~DFGl~~~~  158 (303)
T d1vjya_          80 SDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKN-GTCCIADLGLAVRH  158 (303)
T ss_dssp             EECCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTT-SCEEECCCTTCEEE
T ss_pred             EecccCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCC-CCeEEEecCccccc
Confidence            99999999999884  68999999999999999999996        599999999999999988 79999999999877


Q ss_pred             cCCCc-----ceeeccCccccccccccCCc-----CCCccccHHHHHHHHHHHHhCCCCCCCCCC-------------CH
Q 015374          271 HPGKE-----YNVRVASRYFKGPELLVDLQ-----DYDYSLDMWSLGCMFAGMIFRKEPFFYGHD-------------NH  327 (408)
Q Consensus       271 ~~~~~-----~~~~~~~~~y~aPE~~~~~~-----~~~~~~DvwSlGvil~ell~g~~pf~~~~~-------------~~  327 (408)
                      .....     .....||+.|+|||++.+..     .++.++|||||||++|||+||..||.....             ..
T Consensus       159 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~~  238 (303)
T d1vjya_         159 DSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSV  238 (303)
T ss_dssp             ETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCH
T ss_pred             cCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccchH
Confidence            54432     23467999999999987521     257789999999999999999877632211             11


Q ss_pred             HHHHHHHhhhchhhhhcCCCCCCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 015374          328 DQLVKIAKDCCLIIWCNSRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMAH  392 (408)
Q Consensus       328 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~h  392 (408)
                      +.........+         .+.....   .........++.+++.+||+.||++|||+.|++++
T Consensus       239 ~~~~~~~~~~~---------~~p~~~~---~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~  291 (303)
T d1vjya_         239 EEMRKVVCEQK---------LRPNIPN---RWQSCEALRVMAKIMRECWYANGAARLTALRIKKT  291 (303)
T ss_dssp             HHHHHHHTTSC---------CCCCCCG---GGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHhccc---------cCCCCCc---ccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence            22221111100         0000000   00011123568999999999999999999999874

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=8.1e-48  Score=369.09  Aligned_cols=282  Identities=23%  Similarity=0.371  Sum_probs=209.4

Q ss_pred             CcccccCC-CCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecccc--hHHHHHHHHHHHHhc----------CCCCc
Q 015374          116 SLTVQWGD-QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK--KKKIKREIKILQNLC----------GGPNV  182 (408)
Q Consensus       116 ~~~~~~~~-~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~E~~~l~~l~----------~h~ni  182 (408)
                      ++.++... .++|+++++||+|+||+||+|++..+|+.||||+++...  .+.+.+|+.+++.+.          +|+||
T Consensus         3 p~~~g~~~~~~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~i   82 (362)
T d1q8ya_           3 PAFKGEPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHI   82 (362)
T ss_dssp             CCCTTCEETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTB
T ss_pred             CCCCCCCccCCcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccccchHHHHHHHHHHHHhcchhhhhhhhcCcCce
Confidence            34444433 357999999999999999999999999999999997543  467788999998872          35789


Q ss_pred             eEEeeEEEccCCCccEEEEEeecCCChhhhc------CCCChHHHHHHHHHHHHHHHHHHH-CCcEEecCCCCcEEEeCC
Q 015374          183 VKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY------PTLTDYDIRYYIYELLKALDYCHS-QGIMHRDVKPHNVMIDHE  255 (408)
Q Consensus       183 v~l~~~~~~~~~~~~~lv~e~~~~~~l~~~~------~~l~~~~~~~i~~qi~~~L~~LH~-~~iiH~Dlk~~NILl~~~  255 (408)
                      +++++++........+++|+++..+......      ..+++..++.++.|++.||+|||+ .||+||||||+|||++.+
T Consensus        83 v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~  162 (362)
T d1q8ya_          83 LKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIV  162 (362)
T ss_dssp             CCCCEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEE
T ss_pred             EEEEEEeeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeecc
Confidence            9999999766566677788877655432221      458899999999999999999998 899999999999999865


Q ss_pred             CC-----cEEEEecccceeccCCCcceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCC-----
Q 015374          256 LR-----KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHD-----  325 (408)
Q Consensus       256 ~~-----~~kl~DfG~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~-----  325 (408)
                      ..     .++++|||.+....  ......+||+.|+|||++.+ ..++.++||||+||++++|++|+.||.....     
T Consensus       163 ~~~~~~~~~kl~dfg~s~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~  239 (362)
T d1q8ya_         163 DSPENLIQIKIADLGNACWYD--EHYTNSIQTREYRSPEVLLG-APWGCGADIWSTACLIFELITGDFLFEPDEGHSYTK  239 (362)
T ss_dssp             ETTTTEEEEEECCCTTCEETT--BCCCSCCSCGGGCCHHHHHT-CCCCTHHHHHHHHHHHHHHHHSSCCC---------C
T ss_pred             CcccccceeeEeecccccccc--cccccccccccccChhhccc-cCCCccccccchHHHHHHHHHCCCCCCCCccccccc
Confidence            21     48999999997654  33456789999999999987 7899999999999999999999999854321     


Q ss_pred             CHHHHHHHHhhhchhhhhcC---C--------------CCC---CCcccc--ccccCCCCCCHHHHHHHHHhcccCcCCC
Q 015374          326 NHDQLVKIAKDCCLIIWCNS---R--------------HSR---KPWSKF--INADNQHLVSPEAIDFLDKLLRYDHQDR  383 (408)
Q Consensus       326 ~~~~~~~~~~~~~~~~~~~~---~--------------~~~---~~~~~~--~~~~~~~~~~~~~~~li~~~L~~dp~~R  383 (408)
                      ..+.+......+|.......   .              ...   ..+...  .........++++.|||.+||.+||.+|
T Consensus       240 ~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R  319 (362)
T d1q8ya_         240 DDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKR  319 (362)
T ss_dssp             HHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTC
T ss_pred             hhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHC
Confidence            23344444444442211000   0              000   000000  0111122346789999999999999999


Q ss_pred             CCHHHHhcCCCcccccc
Q 015374          384 LTAREAMAHPYFAQVRA  400 (408)
Q Consensus       384 pt~~elL~hp~f~~~~~  400 (408)
                      ||++|+|+||||++...
T Consensus       320 pta~e~L~Hp~f~~~~~  336 (362)
T d1q8ya_         320 ADAGGLVNHPWLKDTLG  336 (362)
T ss_dssp             BCHHHHHTCGGGTTCTT
T ss_pred             cCHHHHhcCcccCCCCC
Confidence            99999999999996643

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=5.1e-46  Score=345.95  Aligned_cols=249  Identities=15%  Similarity=0.237  Sum_probs=198.8

Q ss_pred             CCCEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecc-cchHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccEEEEE
Q 015374          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP-VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFE  202 (408)
Q Consensus       124 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~-~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e  202 (408)
                      .++|++.++||+|+||+||+|++..+++.||||+++. .....+.+|+++++.+.+|+|++.+++++.+  +...++|||
T Consensus         4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~--~~~~~~vme   81 (293)
T d1csna_           4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQE--GLHNVLVID   81 (293)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEEEE--TTEEEEEEE
T ss_pred             CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCcHHHHHHHHHHHHhcCCCCCCEEEEEeec--CCccEEEEE
Confidence            4789999999999999999999999999999999853 3446788999999999667999999999965  467889999


Q ss_pred             eecCCChhhhc----CCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCC----CCcEEEEecccceeccCCC
Q 015374          203 YVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE----LRKLRLIDWGLAEFYHPGK  274 (408)
Q Consensus       203 ~~~~~~l~~~~----~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~----~~~~kl~DfG~a~~~~~~~  274 (408)
                      |+. ++|..++    ..+++..+..++.|++.||+|||++||+||||||+|||++.+    .+.+||+|||+|+......
T Consensus        82 ~~~-~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~~  160 (293)
T d1csna_          82 LLG-PSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPV  160 (293)
T ss_dssp             CCC-CBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTT
T ss_pred             ecC-CCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEEcccCc
Confidence            995 5665554    458999999999999999999999999999999999999742    3679999999998765322


Q ss_pred             --------cceeeccCccccccccccCCcCCCccccHHHHHHHHHHHHhCCCCCCCCCCC-H-HHHHHHHhhhchhhhhc
Q 015374          275 --------EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDN-H-DQLVKIAKDCCLIIWCN  344 (408)
Q Consensus       275 --------~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvil~ell~g~~pf~~~~~~-~-~~~~~~~~~~~~~~~~~  344 (408)
                              ......||+.|+|||++.+ ..++.++|||||||++|||++|..||...... . +....+.......    
T Consensus       161 ~~~~~~~~~~~~~~GT~~y~aPE~~~~-~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~----  235 (293)
T d1csna_         161 TKQHIPYREKKNLSGTARYMSINTHLG-REQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST----  235 (293)
T ss_dssp             TCCBCCCCCCCCCCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHS----
T ss_pred             cccceeecccCceEEchhhcCHHHhcC-CCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCC----
Confidence                    2234579999999999988 78999999999999999999999998533222 2 2222222210000    


Q ss_pred             CCCCCCCccccccccCCCCCCHHHHHHHHHhcccCcCCCCCHHHHhc
Q 015374          345 SRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA  391 (408)
Q Consensus       345 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~elL~  391 (408)
                                 ........+++++.+++..|+..+|++||+.+.+.+
T Consensus       236 -----------~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~  271 (293)
T d1csna_         236 -----------PLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG  271 (293)
T ss_dssp             -----------CHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred             -----------ChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence                       011122347899999999999999999998776643

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.93  E-value=5.2e-26  Score=196.83  Aligned_cols=166  Identities=18%  Similarity=0.210  Sum_probs=121.8

Q ss_pred             EEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecccc---------------------hHHHHHHHHHHHHhcCCCCceEE
Q 015374          127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK---------------------KKKIKREIKILQNLCGGPNVVKL  185 (408)
Q Consensus       127 y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~---------------------~~~~~~E~~~l~~l~~h~niv~l  185 (408)
                      +.+.++||+|+||+||+|++. +|+.||||+++...                     .....+|...+.++ .|.+++..
T Consensus         2 ~~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~v~~~   79 (191)
T d1zara2           2 DAIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKL-QGLAVPKV   79 (191)
T ss_dssp             SEEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHT-TTSSSCCE
T ss_pred             chhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHc-cCCCcceE
Confidence            357889999999999999874 68899999875211                     12345688899998 89999988


Q ss_pred             eeEEEccCCCccEEEEEeecCCChhhhcCCCChHHHHHHHHHHHHHHHHHHHCCcEEecCCCCcEEEeCCCCcEEEEecc
Q 015374          186 LDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWG  265 (408)
Q Consensus       186 ~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~Dlk~~NILl~~~~~~~kl~DfG  265 (408)
                      +++.  .    .+++|||+++..+..    ++......++.|++.+|.|||++||+||||||+|||++++  .++|+|||
T Consensus        80 ~~~~--~----~~lvme~~~~~~~~~----l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~--~~~liDFG  147 (191)
T d1zara2          80 YAWE--G----NAVLMELIDAKELYR----VRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEE--GIWIIDFP  147 (191)
T ss_dssp             EEEE--T----TEEEEECCCCEEGGG----CCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETT--EEEECCCT
T ss_pred             EEec--C----CEEEEEeeccccccc----hhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCC--CEEEEECC
Confidence            8764  1    269999999876543    5566677899999999999999999999999999999965  58999999


Q ss_pred             cceeccCCCcceeeccCccccccccccCCcCCCccccHHHHHHH
Q 015374          266 LAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCM  309 (408)
Q Consensus       266 ~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvi  309 (408)
                      .|............... .-.-.+.+ . ..|+.++|+||..--
T Consensus       148 ~a~~~~~~~~~~~l~rd-~~~~~~~f-~-r~y~~~~d~~s~~~~  188 (191)
T d1zara2         148 QSVEVGEEGWREILERD-VRNIITYF-S-RTYRTEKDINSAIDR  188 (191)
T ss_dssp             TCEETTSTTHHHHHHHH-HHHHHHHH-H-HHHCCCCCHHHHHHH
T ss_pred             CcccCCCCCcHHHHHHH-HHHHHHHH-c-CCCCCcccHHHHHHH
Confidence            99765433221100000 00001222 2 468899999997543

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.49  E-value=5.8e-07  Score=79.14  Aligned_cols=137  Identities=18%  Similarity=0.218  Sum_probs=89.5

Q ss_pred             CEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecccc---hHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCccEEEEE
Q 015374          126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK---KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFE  202 (408)
Q Consensus       126 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e  202 (408)
                      .|+..+..+.++.+.||+..  .++..+++|+.....   ...+.+|...+..+..+--+.+++.++.+  ++..++||+
T Consensus        15 ~~~~~~~~~G~s~~~v~rv~--~~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~--~~~~~lv~~   90 (263)
T d1j7la_          15 KYRCVKDTEGMSPAKVYKLV--GENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERH--DGWSNLLMS   90 (263)
T ss_dssp             TSEEEECSCCCSSSEEEEEE--CSSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEE--TTEEEEEEE
T ss_pred             ceEEEEcCCCCCCCcEEEEE--eCCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEec--CCceEEEEE
Confidence            45555555445557899874  455667788875432   34578899999988555556778887754  356789999


Q ss_pred             eecCCChhhhcCCCChHHHHHHHHHHHHHHHHHH----------------------------------------------
Q 015374          203 YVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCH----------------------------------------------  236 (408)
Q Consensus       203 ~~~~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH----------------------------------------------  236 (408)
                      +++|..+........  ....++.++...+..||                                              
T Consensus        91 ~l~G~~~~~~~~~~~--~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  168 (263)
T d1j7la_          91 EADGVLCSEEYEDEQ--SPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPR  168 (263)
T ss_dssp             CCSSEEHHHHTTTCS--CHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSSHH
T ss_pred             ecccccccccccccc--cHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccchHHH
Confidence            999988755432211  11222333333333333                                              


Q ss_pred             -------HC------CcEEecCCCCcEEEeCCCCcEEEEeccccee
Q 015374          237 -------SQ------GIMHRDVKPHNVMIDHELRKLRLIDWGLAEF  269 (408)
Q Consensus       237 -------~~------~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~  269 (408)
                             +.      .++|+|+.+.|||++++ +.+-|.||+.+..
T Consensus       169 ~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~-~~~~lIDwe~a~~  213 (263)
T d1j7la_         169 ELYDFLKTEKPEEELVFSHGDLGDSNIFVKDG-KVSGFIDLGRSGR  213 (263)
T ss_dssp             HHHHHHHHSCCCCCEEEECSCCCTTSEEEETT-EEEEECCCTTCEE
T ss_pred             HHHHHHHhcCCcCCcEEEEeeccCcceeecCC-ceEEEeechhccc
Confidence                   11      27899999999999976 4556999998854

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=98.09  E-value=8.6e-06  Score=70.96  Aligned_cols=134  Identities=17%  Similarity=0.114  Sum_probs=84.8

Q ss_pred             eeeeeCc-eEEEEEEEcCCCcEEEEEEecccchHHHHHHHHHHHHhcCCC-CceEEeeEEEccCCCccEEEEEeecCCCh
Q 015374          132 KVGRGKY-SEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGP-NVVKLLDIVRDQHSKTPSLIFEYVNSTDF  209 (408)
Q Consensus       132 ~lG~G~f-g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~h~-niv~l~~~~~~~~~~~~~lv~e~~~~~~l  209 (408)
                      .+..|.. +.||+.. ..++..+++|.........+.+|...++.+..+. .+.+++.++.+  .+..++||++++|.++
T Consensus        17 ~~~~G~s~~~v~r~~-~~~~~~~vlK~~~~~~~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~--~~~~~~v~~~i~G~~~   93 (255)
T d1nd4a_          17 QQTIGCSDAAVFRLS-AQGRPVLFVKTDLSGALNELQDEAARLSWLATTGVPCAAVLDVVTE--AGRDWLLLGEVPGQDL   93 (255)
T ss_dssp             ECSCTTSSCEEEEEE-CTTSCCEEEEEECSCTTSCHHHHHHHHHHHHTTTCCBCCEEEEEEC--SSCEEEEEECCSSEET
T ss_pred             EcCCcccCCeEEEEE-eCCCCEEEEEeCCccCHhHHHHHHHHHHHHHhcCCCCCceeeeccc--ccceEEEEEeeecccc
Confidence            3445543 6789885 4567678899987777777889999998874332 25667777654  4567899999988765


Q ss_pred             hhhc-----------------CCCC-------h--HHHHH-----H---------------HHHHHHHHHHHHHC-----
Q 015374          210 KVLY-----------------PTLT-------D--YDIRY-----Y---------------IYELLKALDYCHSQ-----  238 (408)
Q Consensus       210 ~~~~-----------------~~l~-------~--~~~~~-----i---------------~~qi~~~L~~LH~~-----  238 (408)
                      ....                 ..++       .  .....     +               .......+..+.+.     
T Consensus        94 ~~~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~  173 (255)
T d1nd4a_          94 LSSHLAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMPDGE  173 (255)
T ss_dssp             TTSCCCHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCCSSC
T ss_pred             ccccccHHHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHHHHHhCCccC
Confidence            4321                 0000       0  00000     0               00012233444332     


Q ss_pred             --CcEEecCCCCcEEEeCCCCcEEEEeccccee
Q 015374          239 --GIMHRDVKPHNVMIDHELRKLRLIDWGLAEF  269 (408)
Q Consensus       239 --~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~  269 (408)
                        .++|+|+.+.|||++.+ +.+-|+||+.+..
T Consensus       174 ~~~liHgD~~~~Nvl~~~~-~~~~iID~~~~~~  205 (255)
T d1nd4a_         174 DLVVTHGDACLPNIMVENG-RFSGFIDCGRLGV  205 (255)
T ss_dssp             CEEEECSSCCGGGEEEETT-EEEEECCCTTCEE
T ss_pred             CceEEeCCCCCcceEEeCC-ceEEEEEchhccc
Confidence              37999999999999976 4567999998754

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.95  E-value=2.1e-05  Score=73.36  Aligned_cols=75  Identities=16%  Similarity=0.187  Sum_probs=49.2

Q ss_pred             EeeeeeeCceEEEEEEEcCCCcEEEEEEecc----------cchHHHHHHHHHHHHhcCC--CCceEEeeEEEccCCCcc
Q 015374          130 VRKVGRGKYSEVFEGINVNTNERCIIKILKP----------VKKKKIKREIKILQNLCGG--PNVVKLLDIVRDQHSKTP  197 (408)
Q Consensus       130 ~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~----------~~~~~~~~E~~~l~~l~~h--~niv~l~~~~~~~~~~~~  197 (408)
                      .+.||.|....||+..+..+++.++||.-.+          ....+...|...|..+..+  ..+.+++.+.  .  ...
T Consensus        31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d--~--~~~  106 (392)
T d2pula1          31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--T--EMA  106 (392)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--T--TTT
T ss_pred             EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEc--C--CCC
Confidence            4568999999999998777788899996432          1224566788888877443  2455666654  2  234


Q ss_pred             EEEEEeecCCC
Q 015374          198 SLIFEYVNSTD  208 (408)
Q Consensus       198 ~lv~e~~~~~~  208 (408)
                      ++|||++++..
T Consensus       107 ~lvmE~L~~~~  117 (392)
T d2pula1         107 VTVMEDLSHLK  117 (392)
T ss_dssp             EEEECCCTTSE
T ss_pred             EEEEeccCCcc
Confidence            69999997654

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=97.16  E-value=0.00043  Score=62.38  Aligned_cols=128  Identities=14%  Similarity=0.132  Sum_probs=74.6

Q ss_pred             ceEEEEEEEcCCCcEEEEEEeccc--chHHHHHHHHHHHHhcCCC-CceEEeeE---EEccCCCccEEEEEeecCCChhh
Q 015374          138 YSEVFEGINVNTNERCIIKILKPV--KKKKIKREIKILQNLCGGP-NVVKLLDI---VRDQHSKTPSLIFEYVNSTDFKV  211 (408)
Q Consensus       138 fg~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~~h~-niv~l~~~---~~~~~~~~~~lv~e~~~~~~l~~  211 (408)
                      --.||+++ ..+|+.+++|+..+.  ..+++..|...+..|..+. -++..+..   .........+.++++++|..+..
T Consensus        35 EN~vy~v~-~~dg~~~VlK~~rp~~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~  113 (325)
T d1zyla1          35 ENRVYQFQ-DEDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEA  113 (325)
T ss_dssp             SSEEEEEC-CTTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCS
T ss_pred             cceeEEEE-cCCCCEEEEEEeCCCCCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCC
Confidence            45899995 467888999999764  4577889999998884321 11111111   00012345678899988754321


Q ss_pred             h-----------c-------C--------C-------------------CChHHHHHHHHHHHHHHHHHHH-------CC
Q 015374          212 L-----------Y-------P--------T-------------------LTDYDIRYYIYELLKALDYCHS-------QG  239 (408)
Q Consensus       212 ~-----------~-------~--------~-------------------l~~~~~~~i~~qi~~~L~~LH~-------~~  239 (408)
                      .           +       .        .                   ++......+...+...++.+..       .+
T Consensus       114 ~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~  193 (325)
T d1zyla1         114 DNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVL  193 (325)
T ss_dssp             SCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCE
T ss_pred             CCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCce
Confidence            0           0       0        0                   1111111222222333333332       25


Q ss_pred             cEEecCCCCcEEEeCCCCcEEEEeccccee
Q 015374          240 IMHRDVKPHNVMIDHELRKLRLIDWGLAEF  269 (408)
Q Consensus       240 iiH~Dlk~~NILl~~~~~~~kl~DfG~a~~  269 (408)
                      +||+|+.+.|||++++  . .++||+-+..
T Consensus       194 liHgDlh~~NvL~~~~--~-~~IDFdd~~~  220 (325)
T d1zyla1         194 RLHGDCHAGNILWRDG--P-MFVDLDDARN  220 (325)
T ss_dssp             ECCSSCSGGGEEESSS--E-EECCCTTCCE
T ss_pred             eecCCCCcccEEEeCC--c-eEEechhccc
Confidence            8999999999999754  3 5889998864

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=97.16  E-value=0.00097  Score=61.68  Aligned_cols=77  Identities=14%  Similarity=0.170  Sum_probs=53.5

Q ss_pred             CEEEEeeeeeeCceEEEEEEEcC-------CCcEEEEEEecc-cchHHHHHHHHHHHHhcCCCCceEEeeEEEccCCCcc
Q 015374          126 DYEVVRKVGRGKYSEVFEGINVN-------TNERCIIKILKP-VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP  197 (408)
Q Consensus       126 ~y~~~~~lG~G~fg~Vy~~~~~~-------~~~~vavK~~~~-~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~  197 (408)
                      .+++ +.|+.|-.-.+|+.....       ..+.|.+++... ...-...+|..+++.+..+.-..+++++|  ++    
T Consensus        44 ~l~v-~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~~~idr~~E~~i~~~ls~~gl~Pkll~~~--~~----  116 (395)
T d1nw1a_          44 HLRI-SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPETESHLVAESVIFTLLSERHLGPKLYGIF--SG----  116 (395)
T ss_dssp             GEEE-EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCCHHHHHHHHHHHHHHHHTTSSSCEEEEE--TT----
T ss_pred             ceEE-EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcchhhHHHHHHHHHHHHHhCCCCCeEEEEc--CC----
Confidence            3443 578889999999987543       245677887652 22344568999999886665556888887  32    


Q ss_pred             EEEEEeecCCCh
Q 015374          198 SLIFEYVNSTDF  209 (408)
Q Consensus       198 ~lv~e~~~~~~l  209 (408)
                      .+|+||+++..+
T Consensus       117 g~I~efi~g~~l  128 (395)
T d1nw1a_         117 GRLEEYIPSRPL  128 (395)
T ss_dssp             EEEECCCCEEEC
T ss_pred             ceEEEEeccccC
Confidence            489999987544

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=96.62  E-value=0.0013  Score=58.56  Aligned_cols=140  Identities=15%  Similarity=0.169  Sum_probs=73.7

Q ss_pred             CEEEEeeeeeeCceEEEEEEEcCCCcEEEEEEeccc-chHHHHHHHHHHHHhcCCC-CceEEeeE----EEccCCCccEE
Q 015374          126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-KKKKIKREIKILQNLCGGP-NVVKLLDI----VRDQHSKTPSL  199 (408)
Q Consensus       126 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~E~~~l~~l~~h~-niv~l~~~----~~~~~~~~~~l  199 (408)
                      ...-.+.|..|---+.|+.... +| .+++|++... ..+.+..|+.++..|.++. .+...+..    ....-......
T Consensus        19 ~~~~~~~i~~G~~N~ny~v~t~-~g-~yVLri~~~~~~~~~l~~~~~~l~~L~~~g~pvp~pi~~~~g~~~~~~~~~~~~   96 (316)
T d2ppqa1          19 SLTSYKGIAEGVENSNFLLHTT-KD-PLILTLYEKRVEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAA   96 (316)
T ss_dssp             CEEEEEEECC---EEEEEEEES-SC-CEEEEEECC---CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEE
T ss_pred             CceEeecCCCCcccCeEEEEEC-CC-cEEEEEcCCCCCHHHHHHHHHHHHhhhhccccccccceecCCCcceeeecccce
Confidence            4455566778888899998643 34 4889998653 4567778888888873221 11111111    00001123445


Q ss_pred             EEEeecCCChhhhc------------------C--------C------------------CChHHHHHHHHHHHHHHHHH
Q 015374          200 IFEYVNSTDFKVLY------------------P--------T------------------LTDYDIRYYIYELLKALDYC  235 (408)
Q Consensus       200 v~e~~~~~~l~~~~------------------~--------~------------------l~~~~~~~i~~qi~~~L~~L  235 (408)
                      ++.+..+.......                  .        .                  .........+..+...+.-.
T Consensus        97 ~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~  176 (316)
T d2ppqa1          97 LISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAH  176 (316)
T ss_dssp             EEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHH
T ss_pred             eeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcchhHHHHHHHHHHhhhcc
Confidence            66666554321110                  0        0                  00011112222222222222


Q ss_pred             H----HCCcEEecCCCCcEEEeCCCCcEEEEecccce
Q 015374          236 H----SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE  268 (408)
Q Consensus       236 H----~~~iiH~Dlk~~NILl~~~~~~~kl~DfG~a~  268 (408)
                      .    ..|+||+|+.++||+++.+ ...-|.||+.+.
T Consensus       177 ~~~~L~~giIHgDl~~dNvl~~~~-~v~gvIDF~~~~  212 (316)
T d2ppqa1         177 WPKDLPAGVIHADLFQDNVFFLGD-ELSGLIDFYFAC  212 (316)
T ss_dssp             CCCSSCEEEECSCCCGGGEEEETT-EEEEECCCTTCE
T ss_pred             CccccccccccCCcchhhhhcccc-cceeEecccccc
Confidence            2    1379999999999999987 556899999885